<SEC-DOCUMENT>0001701541-22-000007.txt : 20220317
<SEC-HEADER>0001701541-22-000007.hdr.sgml : 20220317
<ACCEPTANCE-DATETIME>20220317163833
ACCESSION NUMBER:		0001701541-22-000007
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		95
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220317
DATE AS OF CHANGE:		20220317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Black Diamond Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001701541
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39200
		FILM NUMBER:		22749098

	BUSINESS ADDRESS:	
		STREET 1:		ONE MAIN STREET, 10TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-417-5868

	MAIL ADDRESS:	
		STREET 1:		ONE MAIN STREET, 10TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aset Therapeutics, Inc.
		DATE OF NAME CHANGE:	20170321
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>bdtx-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:cee46846-3204-4f76-8bc4-0ddff9c4f904,g:517c6acc-4237-470e-8fc7-341826f4d9b3,d:f3ac37d75c1541719d9b66553792086e--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:bdtx="http://www.blackdiamondtherapeutics.com/20211231" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bdtx-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV80L2ZyYWc6MDlmY2Q0MGRkYzdjNGY1YmIyNDFlNjUwNTc4YmQ4ZjMvdGFibGU6YjAyYzk3OTY0ZDQxNDM5YmIyMmU5MzY1MWVhMTNjZTYvdGFibGVyYW5nZTpiMDJjOTc5NjRkNDE0MzliYjIyZTkzNjUxZWExM2NlNl8yLTEtMS0xLTEwMDg3_27d53b9a-3094-4c96-a025-568ad4d58d62">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV80L2ZyYWc6MDlmY2Q0MGRkYzdjNGY1YmIyNDFlNjUwNTc4YmQ4ZjMvdGFibGU6YjAyYzk3OTY0ZDQxNDM5YmIyMmU5MzY1MWVhMTNjZTYvdGFibGVyYW5nZTpiMDJjOTc5NjRkNDE0MzliYjIyZTkzNjUxZWExM2NlNl80LTEtMS0xLTEwMDg3_6da6ccd2-aa26-4f3b-8d73-769f44670fbf">FY</ix:nonNumeric><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV80L2ZyYWc6MDlmY2Q0MGRkYzdjNGY1YmIyNDFlNjUwNTc4YmQ4ZjMvdGFibGU6YjAyYzk3OTY0ZDQxNDM5YmIyMmU5MzY1MWVhMTNjZTYvdGFibGVyYW5nZTpiMDJjOTc5NjRkNDE0MzliYjIyZTkzNjUxZWExM2NlNl81LTEtMS0xLTEwMDg3_65a84fd9-ee41-4dcf-9384-b01cd22796ab">2021</ix:nonNumeric><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV80L2ZyYWc6MDlmY2Q0MGRkYzdjNGY1YmIyNDFlNjUwNTc4YmQ4ZjMvdGFibGU6YjAyYzk3OTY0ZDQxNDM5YmIyMmU5MzY1MWVhMTNjZTYvdGFibGVyYW5nZTpiMDJjOTc5NjRkNDE0MzliYjIyZTkzNjUxZWExM2NlNl82LTEtMS0xLTEwMDg3_53159a65-a391-4c99-b239-4afd2ba902e0">0001701541</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDMvZnJhZzoxYzM3OGNkZTZmMDE0MDJlYTkwMzJlMzdkOGQxZDFlNC90YWJsZToyOTZiNDRkZjY0Mzk0MjJjYWQ0ZTBjYmNkNjkxZTNiYy90YWJsZXJhbmdlOjI5NmI0NGRmNjQzOTQyMmNhZDRlMGNiY2Q2OTFlM2JjXzEtMS0xLTEtMTAwODc_bf978e11-0a08-4286-9506-1f858f6cb697">1</ix:nonFraction><ix:nonNumeric contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_60506ab5-efc5-4954-abd1-b1eb79d8d8bb">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_bf8d40bd-aa95-4835-abf8-381f9a8156f6">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6efd849321404f36ac0949e86c2f742e_I20200731" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzU4Mg_b2565059-2dc9-4865-97c8-084fe9219efb">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i1e74d76585884b418f0bcfdce485be83_I20190228" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE2NDU_becd2bb6-444f-4a5c-872f-1af74e1752f5">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE3NTk_95f433d1-6446-4971-8ff9-a46e1a446767">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEwOTk1MTE2MzI5NDU_718bdc4c-12a4-421f-9b54-25688d4ec31f">P5Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bdtx-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if04849b71fda49b0ac76f7ec9ae91cd2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i67d88009dd2c4102b42264ca253b6195_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="iebd841302b2243b09b4770b0df113b00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2aba82796ae470699e4f3168699b2c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55d6bc95d9354f76a22b6b88f8b6cd72_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b34b944847347268c17b3eccf68fb24_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e2c8b847c445b7ba67c11b436983c4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1f5d6bad537436185bfd16658adb3b4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7230d3ada8f48d998cc556aebbd612f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i735eaadfcfea49c7baa357b1962e28d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69f2151c700c4386a8c6bd633fa2a055_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5260242f659f4520a08f001cda762732_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfd940ec67e94e27ac3ac65f34d4ad9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9d4ee1015f45c7b985eb5b12743b46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i881fdb998fb24439aabee87b939b2269_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d393f5b2b3949d384d2d1dd9ad3ac38_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia824f582b29c4b53b5021124e3f932b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c371c9576a45658c2ba0c54e2990fa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id20739abaa504d80b915e1570af5c848_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29cff875ae6c440fb8662994fa11100f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9016a71b5edc4deeaf7161f48c70b705_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i137c8ff090914a21a31315f848506a70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie88f3aabe31b474cacd5e20c1fff19fe_D20200121-20200121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-21</xbrli:startDate><xbrli:endDate>2020-01-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-03</xbrli:startDate><xbrli:endDate>2020-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a73fd2a8f9a40b4aef3a1186bd43494_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">bdtx:OpenMarketSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i907bbd4101da4791b95db60038ebf1bb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c11721ec9b84ac3b344ba9856d4a137_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc1c05a8882d4e2d9d4375998f3f9c91_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bdtx:segment</xbrli:measure></xbrli:unit><xbrli:context id="i37550c3c6f8b4e1c82625f4812c1040f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb4739fe5f8942668fe0bc95945099a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3b30c861e9d4e7f886845215446bbf0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i661a7771541c4be58e3c508f387d2d4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id03ea759a2df458f9a6c7ec4e73c55d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i897eb2325f8b44d682297a1bba2a1afe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe2c5749e2da4c9a9141bcf8dea4e07a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c818a6e331498f8f622c83e82498a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cc33891b67d4cd4881a2c22172d9038_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7310d48e883404aa8278fe354dfec1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764cba0d028047519b61de1a37f180d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b98a26a73545518614cf7d9628211c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65468eff9b6d46e393fd1b4dbb2b901d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4d74d028a7d465fb5fd5451c08b99d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b492035c5974422bdb650937d138473_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25857721770b4551b695d1c7721be8c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c1e51d979ec40be896fcef26d6a787b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4cddd28a59e484c974e7e00a6968a69_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3b164f107b74b22b0f4ccf27b504098_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if58ddf76db3846139fa1a52af88ebb35_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa02d2a706504ab0b7238eba43af4d07_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i742712bb4f08433e91c7107556ee12b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d0802102ced4b2fad85fbb7b827d01a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eada741a72e43f8878c131461b998e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3676c1e9ee8641b59223f61e35dd91d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c308fd60bb34e1681722a61e79a2c56_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e67ca30eb94ec9b7f3040a7fbc0e27_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74033657d98945978e04c05451082f37_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i103bc24deb864971a2124cc0e9fa120a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i877ad9b6c45a4570a3dc9fa049cb3afe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62baf0a395b74b088a443289cccd0913_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ea1e1b54a744110b827b0b44b927c0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia09c76b66200416fa63f1c01d35e2fc1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d122ce461b9439dabdc048f86e95eef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba734827ba0945438f8b534d33166ac5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fb596f6d41142a4be91b0ac53112788_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic872a3df7fa54aa58339156e79caec93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d17648150f42bfbdf803c2674bcf29_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1b63b5b22794ba198a5427db6ccb42a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40f1fe72d2d444aeb36925e4fcc30eb6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d9ad67327bc44648c777a18474468b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2861ec10bc3748998a17ae945f43939b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ecf9843e9ef489dab03ac86e3fbbe55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05170edcf7364cda86a8e91a6c465732_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd84886daa684164b53911ab6a5ec019_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64b0a265ea36455d88e0db82a9f72d63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b957706c704a949271fa3b8ecce065_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52f0c745b901427ca91dcd2d7e618786_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f6cb93d93d54cd1bb5ad6efefe6e781_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>bdtx:vote</xbrli:measure></xbrli:unit><xbrli:context id="i5d4aa309da524f179ebe88bd9ded86f2_D20200203-20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-03</xbrli:startDate><xbrli:endDate>2020-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64e16b7860f94cd4a17def630f1e4f87_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9eb66e638b04af899a8e80564e32d1a_I20200114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48ffe9f699fa4a539801be7d17a1a76e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib81aa95c217141f292296a2bf857d7d3_D20220101-20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id325337deaca458ba4cd7cc986b6aa01_I20200114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c378bf5d47a49fa9e52b9ba3e36d859_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia475c342c2e24f7891e04263bf9fda52_D20220101-20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i409db6c3ae2948168a94cd673a222876_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3bf60c3f3c74cac874df7014c860584_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i494939f1eb09446097a4d8943229ee63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife703eee16a24418b0688374aa2d9127_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d213479013e4c85a590094a80d5821c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e7beae8caf2403f8ca0392b605a96a5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a3a672acfe3476499dfdb07a32e435a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e11f471e4864a40a07e85f2ee15dc66_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdtx:OtherAwardTypeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64d4b8a477e44a2294dafb47b8366169_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdtx:OtherAwardTypeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbd32a8c30ea4113a72bd22800a1803a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbd7ebcbc2d04c7fa4877287edf187be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d4f007a1e3a4f32b5564d78ab1f7548_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5a07f83801a4155974a26a9c19c163c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iead01dff07974c708a3ac77a441836f1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d20f61caf924e11ac009ed0ff78534e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3f540cd599244b38eb489e52a6cc2de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5d0a15d9464476f88434bfff0ae0a67_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdtx:TaxPeriodExpirationAxis">bdtx:TaxYear2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id37d6ea5602744e9b4b315730beac564_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib41127d5f7aa452f8b4b9e2bbc608eab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3697f799f56d4e558c172781bd1f5483_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54551aadbd8e4430aa8071d23c1c1c0e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide4e4eed14bf4310a962d48216c9ab68_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c27a225a3e24360be5046309795d54d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b93ad2715d94c1097f1ba1e707cc771_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86a156ce1dbe4eaf9a07508a2e9c2203_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3625da8da754dfe9f0c00bdb9a1ea06_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i493c609a43ce4f48b467af5ffd22630d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8023413c14d34199a01eff6173e632dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contract"><xbrli:measure>bdtx:contract</xbrli:measure></xbrli:unit><xbrli:context id="i6efd849321404f36ac0949e86c2f742e_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">bdtx:OperatingLeasePrincipalOfficeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="i1e74d76585884b418f0bcfdce485be83_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">bdtx:OperatingLeasePrincipalOfficeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001701541</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">bdtx:OperatingLeaseOfficeAndLaboratorySpaceNYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if3ac37d75c1541719d9b66553792086e_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">___________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8xMjY_afbbe252-1b0a-4299-98ca-5a2281f60d55">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">___________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6NjQ1MjJkOWY2ZTY0NDQ2NmIwNjQzN2NlYjdhZDY3ZjgvdGFibGVyYW5nZTo2NDUyMmQ5ZjZlNjQ0NDY2YjA2NDM3Y2ViN2FkNjdmOF8wLTAtMS0xLTEwMDg3_079d4d8a-81d0-4ee3-a3c9-1c311cfee7c5">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FOR THE FISCAL YEAR ENDED <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yMDE_6468a1df-cad1-407e-8852-fc5117e1b356"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yMDE_207d33b6-f098-4f15-a1c9-6826f6ec567d">December&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6Zjg3ZjExMTY5MDc3NDFjOGIwMzQ5N2VlNGFkMmUxNGEvdGFibGVyYW5nZTpmODdmMTExNjkwNzc0MWM4YjAzNDk3ZWU0YWQyZTE0YV8wLTAtMS0xLTEwMDg3_58befa83-9891-4210-88e2-be0746d7d9b8">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FOR THE TRANSITION PERIOD FROM _ TO _</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">COMMISSION FILE NUMBER <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yNzA_90fffbc4-9dcd-41eb-af25-39977650598f">001-38501</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">___________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8zMTc_be80d689-6e55-4f2f-af9a-c6373fa7abab">BLACK DIAMOND THERAPEUTICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">___________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8wLTAtMS0xLTEwMDg3_2ea0eec6-263c-48c1-bb63-520f5af74230">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8wLTEtMS0xLTEwMDg3_9961572f-09b1-466e-8769-40a11964bf96">81-4254660</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">(State or other jurisdiction</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">of incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">(I.R.S. Employer</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Identification No.)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8yLTAtMS0xLTEwMDg3L3RleHRyZWdpb246Yjg1YTY5NDNjMzAxNDE1Yjk1YjEwODE2NzQzOGJlNDBfNQ_a185a9ff-ddb9-467e-b4e0-d30017a81aed">One Main Street, 10th Floor</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8yLTAtMS0xLTEwMDg3L3RleHRyZWdpb246Yjg1YTY5NDNjMzAxNDE1Yjk1YjEwODE2NzQzOGJlNDBfOQ_1cfe3ca4-fa59-4be7-b405-57485d18703a">Cambridge</ix:nonNumeric>, <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8yLTAtMS0xLTEwMDg3L3RleHRyZWdpb246Yjg1YTY5NDNjMzAxNDE1Yjk1YjEwODE2NzQzOGJlNDBfMTM_5af17f7e-d2f3-4097-abd2-7f37c30b807d">Massachusetts</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">(Address of principal executive offices)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8yLTEtMS0xLTEwMDg3L3RleHRyZWdpb246YmYxZGNlMWM3OWZmNGMzNDgyM2Q2MzM1YzE0M2M4MDhfNQ_9c0efaeb-edcc-4cfe-8ecd-2e8b1a1ae6c4">02142</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">(Zip Code)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8zLTAtMS0xLTEwMDg3L3RleHRyZWdpb246MjQ4OGMwMWNiOGQ1NGI4YmE1YmNmNDhmZTdkZWExNTlfNQ_ebb01eac-baf3-48c1-8615-d473f17f55df">(617)</ix:nonNumeric> <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8zLTAtMS0xLTEwMDg3L3RleHRyZWdpb246MjQ4OGMwMWNiOGQ1NGI4YmE1YmNmNDhmZTdkZWExNTlfOA_3d20676c-db45-4cb2-a13f-a63b07621b37">252-0848</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">(Registrant&#8217;s telephone number, including area code)</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"><div><span><br/></span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#211d1e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6ZjcwY2VmYjMyOTk1NGMwY2ExYWMyZmY0MDUxN2RiZmYvdGFibGVyYW5nZTpmNzBjZWZiMzI5OTU0YzBjYTFhYzJmZjQwNTE3ZGJmZl8xLTAtMS0xLTEwMDg3_49f91f7f-f7b2-44be-936b-3ee49581484d">Common stock, par value $0.0001</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6ZjcwY2VmYjMyOTk1NGMwY2ExYWMyZmY0MDUxN2RiZmYvdGFibGVyYW5nZTpmNzBjZWZiMzI5OTU0YzBjYTFhYzJmZjQwNTE3ZGJmZl8xLTEtMS0xLTEwMDg3_8ae33817-3b77-48df-866e-ceb4a721fdeb">BDTX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6ZjcwY2VmYjMyOTk1NGMwY2ExYWMyZmY0MDUxN2RiZmYvdGFibGVyYW5nZTpmNzBjZWZiMzI5OTU0YzBjYTFhYzJmZjQwNTE3ZGJmZl8xLTItMS0xLTEwMDg3_3ff37971-cdf0-4f1c-ae5d-a44a33afc26b">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"><div><span><br/></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">___________________________________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl83MzE_75882c45-1d61-4a34-a398-03c3081b8d24">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl84NzU_704b7ce9-f8d2-440d-bd3c-b14d8d437cd0">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8xMjI5_c06db94a-ef84-4126-b324-935a927760f4">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8xNTU2_b2c490ac-99fb-40e7-96b4-2f8a4c606ba5">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MGU0OGY5NzU1NGYxNDIyOGE0NTAwMzBjOTJmMzBmNWUvdGFibGVyYW5nZTowZTQ4Zjk3NTU0ZjE0MjI4YTQ1MDAzMGM5MmYzMGY1ZV8yLTAtMS0xLTEwMDg3_532f007d-f756-41c1-8851-fee2fd576b89">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MGU0OGY5NzU1NGYxNDIyOGE0NTAwMzBjOTJmMzBmNWUvdGFibGVyYW5nZTowZTQ4Zjk3NTU0ZjE0MjI4YTQ1MDAzMGM5MmYzMGY1ZV8yLTMtMS0xLTEwMDg3_cca31733-a277-4591-aaea-95ea49cf5169">&#9746;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MGU0OGY5NzU1NGYxNDIyOGE0NTAwMzBjOTJmMzBmNWUvdGFibGVyYW5nZTowZTQ4Zjk3NTU0ZjE0MjI4YTQ1MDAzMGM5MmYzMGY1ZV80LTMtMS0xLTEwMDg3_dedf042e-971d-4f58-b7d5-c111c8b49c52">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yMTcy_96b074f6-1b64-4f93-bda1-934ac2cecaa9">&#9744;</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. &#160;<ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8zOTcw_c611bcbb-58ad-437a-b0a0-642039aebb14">&#9744;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yNjM1_f8b61f3b-8e56-45a9-98a0-8949faff0f84">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="if04849b71fda49b0ac76f7ec9ae91cd2_I20210630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yODc2_6c0a35bd-bf8f-4c83-8437-37508f6bfdff">340,487,618</ix:nonFraction> based on a closing price of $12.19 per share as quoted by the Nasdaq Global Select Market as of such date. In determining the market value of non-affiliate common stock, shares of the registrant&#8217;s common stock beneficially owned by officers, directors and affiliates have been excluded. This determination of affiliate status is not necessarily a conclusive determination for other purposes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of February&#160;28, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="i67d88009dd2c4102b42264ca253b6195_I20220228" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8zMzAw_8fe02dcf-6ffb-40bd-8a46-36cbb13dbf49">36,271,465</ix:nonFraction> shares of common stock, $0.0001 par value per share, outstanding.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Documents Incorporated by Reference</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8zOTcx_0837d8f1-0bec-4483-8666-23d2162de916" escape="true">Part III of this Annual Report on Form 10-K incorporates by reference certain information from the definitive Proxy Statement for the registrant&#8217;s 2022 Annual Meeting of Stockholders, or the Proxy Statement, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#8217;s fiscal year ended December&#160;31, 2021. Except with respect to information specifically incorporated by reference, the Proxy Statement is not deemed to be filed as part of this Annual Report on Form 10-K.</ix:nonNumeric></span></div><div id="if3ac37d75c1541719d9b66553792086e_7"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Summary of the Material and Other Risks Associated with Our Business </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our business is subject to numerous material and other risks and uncertainties that you should be aware of in evaluating our business, including those described in Part II, Item IA. &#8220;Risk Factors&#8221; in this Annual Report on Form 10-K. These risks include, but are not limited to, the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We are very early in our development efforts and are substantially dependent on our clinical-stage product candidates, BDTX-1535 and BDTX-189. If we are unable to advance BDTX-1535, BDTX-189 or any of our other product candidates through clinical development, obtain regulatory approval and ultimately commercialize BDTX-1535, BDTX-189 or any of our other product candidates, or experience significant delays in doing so, our business will be materially harmed. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Difficulty in enrolling patients could delay or prevent clinical trials of our product candidates. We may find it difficult to enroll patients in our Phase 1 clinical trial for BDTX-1535 or our open-label Phase 1/2 clinical trial for BDTX-189 with the genetic mutations that these product candidates are designed to target. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Our discovery and preclinical development is focused on the development of precision medicines for patients with genetically defined cancers, which is a rapidly evolving area of science, and the approach we are taking to discover and develop drugs is novel and may never lead to marketable products.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Our approach to the discovery and development of product candidates is unproven, and we may not be successful in our efforts to use and expand our MAP drug discovery engine to build a pipeline of product candidates with commercial value.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Business or economic disruptions or global health concerns could seriously harm our development efforts and increase our costs and expenses.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Our limited operating history may make it difficult for you to evaluate the success of our business to date and to assess our future viability.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We have incurred significant losses since inception, and we expect to incur losses over the next several years and may not be able to achieve or sustain revenues or profitability in the future.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We have not generated any revenue from our product candidates and may never be profitable.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We will need substantial additional funding. If we are unable to raise capital when needed, we would be compelled to delay, reduce or eliminate our product development programs or commercialization efforts.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">We are very early in our development efforts. Most of our product candidates are still in early clinical or preclinical development. If we are unable to advance our product candidates through clinical development, obtain regulatory approval and ultimately commercialize our product candidates or experience significant delays in doing so, our business will be materially harmed.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals for our product candidates, we will not be able to commercialize, or will be delayed in commercializing, our product candidates, and our ability to generate revenue will be materially impaired.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Our clinical trials may fail to demonstrate adequately the safety and efficacy of any of our product candidates, which would prevent or delay regulatory approval and commercialization.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">If we are unable to obtain and maintain patent and other intellectual property protection for BDTX-1535, BDTX-189, our MAP drug discovery engine and our other product candidates and technology, or any other product candidates or technology we may develop, or if the scope of intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize products and technology similar or identical to ours, and our ability to commercialize BDTX-1535, BDTX-189, or any other product candidates or technology may be adversely affected.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We rely on third parties to conduct our preclinical studies and clinical trials. If these third parties do not properly and successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval of or commercialize our product candidates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We may form or seek collaborations or strategic alliances or enter into additional licensing arrangements in the future, and we may not realize the benefits of such collaborations, alliances or licensing arrangements.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We are highly dependent on our key personnel and anticipate hiring new key personnel. If we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">The price of our stock is volatile, and you could lose all or part of your investment.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Data collection is governed by restrictive regulations governing the use, processing and cross-border transfer of personal information.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Changes to patent law in the United States and in foreign jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Changes in tax law could adversely affect our business and financial condition.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">We may be unable to adequately protect our information systems from cyberattacks, which could result in the disclosure of confidential or proprietary information, including personal data, damage our reputation, and subject us to significant financial and legal exposure.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The material and other risks summarized above should be read together with the text of the full risk factors discussed in the section entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Risk Factors&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the other information set forth in this Annual Report on Form 10-K, including our consolidated financial statements and the related notes, as well as in other documents that we file with the Securities and Exchange Commission. If any such material and other risks and uncertainties actually occur, our business, prospects, financial condition and results of operations could be materially and adversely affected. The risks summarized above or described in full elsewhere in this Annual Report on Form 10-K are not the only risks that we face. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial may also materially adversely affect our business, prospects, financial condition and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BLACK DIAMOND THERAPEUTICS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_16">PART I</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_16">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_19">Item 1. Busines</a>s</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_19">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_22">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_22">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_25">Item 1B. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_25">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_28">Item 2. Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_28">122</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_31">Item 3. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_31">122</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_34">Item 4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_34">122</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_37">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_37">123</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_40">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_40">123</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_43">Item 6. R</a>eserved</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_43">123</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_46">Item&#160;7.&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_46">123</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_73">Item 7A.&#160;Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_73">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_76">Item 8. Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_76">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_148">Item 9.&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_148">159</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_151">Item 9A.&#160;Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_151">160</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_154">Item 9B.&#160;Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_154">160</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_1099511628554">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_1099511628554">160</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_157">PART III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_157">161</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_160">Item 10.&#160;Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_160">161</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_163">Item 11.&#160;Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_163">161</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_166">Item 12.&#160;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_166">161</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_169">Item 13.&#160;Certain Relationships and Related Transactions and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_169">161</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_172">Item 14.&#160;Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_172">161</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_175">PART IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_175">162</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_178">Item 15. Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_178">162</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_181">Item 16. Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3ac37d75c1541719d9b66553792086e_181">164</a></span></div></td></tr></table></div><div style="margin-top:21pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have applied for various trademarks that we use in connection with the operation of our business. This Annual Report on Form 10-K, or Annual Report, may also contain trademarks, service marks and trade names of third parties, which are the property of their respective owners. Our use or display of third parties&#8217; trademarks, service marks, trade names or products in this Annual Report is not intended to, and does not imply a relationship with, or endorsement or sponsorship by us. Solely for convenience, the trademarks, service marks and trade names referred to in this Annual Report may appear without the &#174;, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> symbols, but the omission of such references is not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner of these trademarks, service marks and trade names will not assert, to the fullest extent under applicable law, its rights.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">From time to time, we may use our website or our LinkedIn profile at linkedin.com/company/black-diamond-therapeutics to distribute material information. Our financial and other material information is routinely posted to and accessible on the Investors section of our website, available at www.blackdiamondtherapeutics.com. Investors are encouraged to review the Investors section of our website because we may post material information on that site that is not otherwise disseminated by us. Information that is contained in and can be accessed through our website or our LinkedIn page is not incorporated into, and does not form a part of, this Annual Report.</span></div><div id="if3ac37d75c1541719d9b66553792086e_13"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Annual Report contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. All statements other than statements of historical facts contained in this Annual Report are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;expects&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221;, &#8220;estimates&#8221;, &#8220;predicts&#8221;, &#8220;potential&#8221;, &#8220;continue&#8221; or the negative of these terms or other comparable terminology. These statements are not guarantees of future results or performance and involve substantial risks and uncertainties. Forward-looking statements in this Annual Report include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the progress, timing and success of preclinical studies and our clinical trials of BDTX-1535 and BDTX-189 and any other product candidates, including the availability, timing and announcement of data and results of such studies and trials; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the initiation, timing, progress and results of our research and development programs, preclinical studies, any clinical trials and Investigational New Drug applications, or IND, and other regulatory submissions; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the continued development and advancement of our early stage programs, including our BRAF and FGFR programs, and the timing for filing INDs in each program;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to obtain and maintain regulatory approval for BDTX-1535, BDTX-189 or any of our other current or future product candidates that we may identify or develop; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our need to raise additional funding before we can expect to generate any revenues from product sales; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to identify future product candidates for treatment of additional disease indications; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to develop our current product candidates for the treatment of various cancers; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the rate and degree of market acceptance and clinical utility for any current or future product candidates we may develop; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the effects of competition with respect to BDTX-1535, BDTX-189 or any of our other current or future product candidates, as well as innovations by current and future competitors in our industry; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the implementation of our strategic plans for our business, any product candidates we may develop and our MAP drug discovery engine; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to successfully develop companion diagnostics for use with our current or future product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our intellectual property position, including the scope of protection we are able to establish, maintain and enforce for intellectual property rights covering our product candidates and MAP drug discovery engine; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to obtain additional funding for our operations, when needed, including funding necessary to complete further development and commercialization of our product candidates, if approved, and to further expand our MAP drug discovery engine;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the accuracy of our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our financial performance and our ability to effectively manage our anticipated growth; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our estimates regarding the market opportunities for our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to maintain an effective system of internal controls;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the ultimate impact of the ongoing coronavirus, or COVID-19 pandemic, or any other health epidemic, on our business, our clinical trials, our research programs, healthcare systems or the global economy as a whole; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">other material risks and uncertainties, including those discussed in Part I, Item 1A, &#8220;Risk Factors&#8221; in this Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any forward-looking statements in this Annual Report reflect our current views with respect to future events and with respect to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those described under Part I, Item&#160;1A, &#8220;Risk Factors&#8221; and elsewhere in this Annual Report. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All of our forward-looking statements are as of the date of this Annual Report only. In each case, actual results may differ materially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of or any material adverse change in one or more of the risk factors or risks and uncertainties referred to in this Annual Report or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the Securities and Exchange Commission, or the SEC, could materially and adversely affect our business, prospects, financial condition and results of operations. Some of these risks and uncertainties may in the future be amplified by the ongoing COVID-19 pandemic, including as a result of the emergence of new variants, and there may be additional risks that we consider immaterial or which are unknown. It is not possible to predict or identify all such risks. Except as required by law, we do not undertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections or other circumstances affecting such forward-looking statements occurring after the date of this Annual Report, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. Any public statements or disclosures by us following this Annual Report that modify or impact any of the forward-looking statements contained in this Annual Report will be deemed to modify or supersede such statements in this Annual Report. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Annual Report contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed as exhibits to this Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may from time to time provide estimates, projections and other information concerning our industry, the general business environment, and the markets for certain diseases, including estimates regarding the potential size of those markets and the estimated incidence and prevalence of certain medical conditions. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events, circumstances or numbers, including actual disease prevalence rates and market size, may differ materially from the information reflected in this Annual Report. Unless otherwise expressly stated, we obtained this industry, business information, market data, prevalence information and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data, and similar sources, in some cases applying our own assumptions and analysis that may, in the future, prove not to have been accurate.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART I</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Except where the context otherwise requires or where otherwise indicated, the terms &#8220;Black Diamond,&#8221; &#8220;Black Diamond Therapeutics,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;our company,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar designations in this Annual Report to refer to Black Diamond Therapeutics, Inc. and, where appropriate, its subsidiaries.</span></div><div id="if3ac37d75c1541719d9b66553792086e_19"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 1. Business</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are a precision oncology medicine company pioneering the discovery and development of MasterKey therapies. We target undrugged oncogenic driver mutations in patients with genetically defined cancers. The foundation of our company is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry. Our proprietary technology platform, which we refer to as our Mutation-Allostery-Pharmacology, or MAP, drug discovery engine, is designed to allow us to analyze population-level genetic sequencing data to discover oncogenic mutations that promote cancer across tumor types. Our goal is to identify families of mutations that can be inhibited with MasterKey therapies thereby providing precision oncology to greater numbers of patients with genetically defined tumors. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have designed our clinical-stage product candidates, BDTX-1535 and BDTX-189, to potently and selectively inhibit families of oncogenic mutations which occur across a range of tumor types that affect the ErbB-1 epidermal growth factor receptor, or EGFR, and in the case of BDTX-189 also affect the tyrosine-protein kinase ErbB-2, or HER2. We have designed these product candidates to bind to the active site of these mutant kinases and inhibit their function. BDTX-1535 and BDTX-189 are also designed to spare normal, or wild type, EGFR (EGFR WT), which we believe will improve upon the toxicity profiles of current ErbB family inhibitors. We are also leveraging our MAP drug discovery engine to identify other families of non-canonical mutations in validated oncogenes beyond the ErbB family, which has the potential to expand the reach of targeted therapies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Approved targeted therapies, such as kinase inhibitors, have transformed the treatment of cancers and demonstrated a significant benefit to certain patients by treating active site mutations in a single tumor type. Improved genetic sequencing of cancers has led to the discovery of additional oncogenic genetic alterations. These genetic alterations were previously unaddressed, unsuccessfully targeted or overlooked. Our MAP drug discovery engine is designed to reveal the oncogenic nature of families of undrugged driver mutations and their associated protein conformations. We believe this approach offers a substantial opportunity to expand the number of patients who could benefit from precision oncology medicines. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our proprietary MAP drug discovery engine is built on three central pillars: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Mutations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;Through comprehensive analysis of population-level genetic sequencing data, we identify oncogenic mutations among hundreds of unique alterations within a single gene. We use our algorithm as a machine-learning tool to predict the oncogenicity of various uncharacterized mutations, thereby isolating oncogenic driver mutations from those mutations that are not believed to cause cancer, and which are referred to as silent and passenger mutations.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Allostery</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;We confirm the oncogenicity of the identified mutations through cell and tumor models and reveal how these mutations drive conformational changes in proteins. This enables us to group subsets of mutations into families based upon similar protein structures and shared selectivity profiles. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Pharmacology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;Using these shared characteristics, we seek to develop single small molecule product candidates, each designed to inhibit an entire family of oncogenic mutations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g1.jpg" alt="bdtx-20211231_g1.jpg" style="height:284px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Our pipeline </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Utilizing our proprietary MAP drug discovery engine, we are building a pipeline of orally available, potent and selective small molecule kinase inhibitors that target a range of driver mutations in cancer. An overview of our pipeline of product candidates is shown in the table below.</span><img src="bdtx-20211231_g2.jpg" alt="bdtx-20211231_g2.jpg" style="height:307px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BDTX-1535: A brain-penetrant inhibitor of EGFR oncogenic mutations, including canonical, intrinsic resistance, and acquired resistance mutations </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Glioblastoma (GBM) is a difficult-to-treat, aggressive malignancy of the central nervous system. Standard therapy at diagnosis consists of surgical resection followed by radiation and chemotherapy, but prognosis remains poor with only approximately 25% of newly diagnosed patients surviving two years or longer after diagnosis. Almost 50 percent of glioblastoma tumors express one or more EGFR oncogenic alterations that affect the extracellular region of the receptor tyrosine kinase, consequently promoting oncogenic activation. We believe that current targeted therapies have been unsuccessful in treating glioblastoma due to (i) the concurrent expression of different EGFR oncogenic alterations within individual patients, (ii) insufficient drug potency across different EGFR oncogenic alterations, (iii) paradoxical activation of mutant EGFR commonly found in glioblastoma by earlier generation inhibitors, and iv) low levels of brain penetration. We have shown in preclinical models that the mechanism of activation for these EGFR </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">oncogenic alterations involves the formation of a constitutive dimer that exhibits a conformation which leads to ligand-independent signaling and that is shared by a family of extracellular domain EGFR alterations expressed in glioblastoma.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In non-small cell lung cancer (NSCLC), EGFR inhibitors have demonstrated significant clinical benefit in patients with primary EGFR activating mutations and are the current first-line standard of care. However, over time, almost all patients acquire resistance and relapse. Furthermore, up to half of all NSCLC patients either have central nervous system (CNS) metastases at diagnosis or will develop them while on treatment. The majority of first- and second-generation EGFR inhibitors do not adequately penetrate the CNS, and while third-generation CNS penetrant, EGFR inhibitors such as osimertinib may delay the progression of CNS metastases, there are few options remaining to patients when resistance inevitably arises.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BDTX-1535 is designed as a potent, selective, irreversible and brain-penetrant small molecule inhibitor that targets a family of EGFR oncogenic alterations including those expressed in glioblastoma that promote a constitutive dimer without paradoxical activation.  As such, BDTX-1535 has the potential to fill a critical need for a brain-penetrant inhibitor that addresses the limitations of other EGFR directed therapies previously studied in glioblastoma. Additionally, BDTX-1535 inhibits a spectrum of canonical, intrinsic resistance (Exon18, Exon 21, and others), and acquired resistance (C797S associated with resistance to third generation EGFR inhibitors) EGFR mutations found in patients with solid tumors such as NSCLC, including those with brain metastases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Investigational New Drug application, or IND, for BDTX-1535 was cleared by the U.S. Food and Drug Administration (FDA) on January 6, 2022, and the Phase 1 clinical trial was initiated in the first quarter of 2022. The Phase 1 dose-escalation portion will enroll patients harboring EGFR oncogenic alterations both in glioblastoma and NSCLC, with or without brain metastases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BDTX-189: An inhibitor of oncogenic mutations of EGFR and HER2 </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BDTX-189 is designed as an orally available, irreversible small molecule inhibitor that targets a spectrum of 48 non-canonical and canonical driver mutations of EGFR and HER2 while sparing EGFR WT while also being a potent inhibitor of HER2 wild type (HER2 WT). These mutations are present in solid tumors including NSCLC, breast, gastric, colon, and endometrial cancers. Currently, there are no drugs approved by the FDA that target all of these oncogenic mutations with a single therapy. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BDTX-189 is designed as a highly selective, potent inhibitor that targets this spectrum of oncogenic proteins defined by the non-canonical EGFR and HER2 driver mutations, while also sparing WT EGFR. In preclinical models, BDTX-189 exhibited anti-tumor activity evidenced by potent tumor growth inhibition and tumor regression.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We initiated the MasterKey-01 trial in January of 2020. Clinical data obtained from the MasterKey-01 study to date have demonstrated a favorable tolerability profile for BDTX-189 and early signs of clinical activity in patients whose tumors are driven by MasterKey mutation families, including two confirmed partial responses in heavily pretreated patients who remained on treatment for more than 10 months. The dose-escalation portion of the trial has been completed with the recommended Phase 2 dose, or RP2D, established. Due to the rapid evolution of the treatment landscape in NSCLC harboring either EGFR or HER2 exon 20 insertion mutations, we announced in January 2022 that we would gate the initiation of the Phase 2 portion of the MasterKey-01 study and determine next steps in development based on further clinical data obtained from the safety expansion cohort at the recommended Phase 2 dose.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BDTX-4933: A brain-penetrant inhibitor of oncogenic BRAF Class I, II and III alterations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FDA-approved BRAF inhibitors against V600E (Class I) mutations are not active against non-canonical oncogenic BRAF mutations. Non-canonical oncogenic mutations, including BRAF-fusions, can drive RAS-independent (Class II) or RAS-dependent (Class III) RAF dimers. In addition, the approved BRAF inhibitors can induce unwanted paradoxical activation that limits their breadth of activity and can result in cutaneous toxicity. Furthermore, the expression of BRAF mutations commonly occurs in patients with central nervous system (CNS) tumors or with brain metastasis, but currently approved drugs have poor intrinsic brain penetration. There remains a high unmet clinical need for a broad mutation spectrum and CNS penetrant BRAF inhibitor to treat patients expressing BRAF mutations with a precision medicine therapy.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our development candidate, BDTX-4933, is designed to be a highly selective, potent and brain-penetrant small molecule inhibitor that targets a family of Class I, II, and III canonical and non-canonical BRAF alterations while avoiding paradoxical activation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We initiated IND-enabling studies for BDTX-4933 in the first quarter of 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Early-stage programs </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are also progressing our early-stage research programs targeting groups of oncogenic mutations in kinases relevant to cancer and/or rare genetic diseases that we have developed utilizing our MAP drug discovery engine, including our program targeting fibroblast growth factor receptor, or FGFR. We anticipate selection of a development candidate for our FGFR program in 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Our strategy</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our vision is to build a differentiated, global biopharmaceutical company by discovering, developing, and commercializing novel precision medicines for every patient with genetically defined tumors. We are advancing the field of precision medicines through improved understanding of mutant protein conformations to (i) identify novel oncogenic driver mutations and (ii) target families of oncogenic mutations with individual MasterKey therapies. We believe our strategy will enable us to become an industry leader in precision oncology medicine and advance a portfolio of tumor-agnostic product candidates aimed at delivering safe and effective medicines to patients. The critical components of our strategy include: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Rapidly advance BDTX-1535 through early clinical development to address families of oncogenic alterations in patients with glioblastoma and NSCLC.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> We believe that BDTX-1535 could offer an improved approach in glioblastoma and NSCLC by virtue of its ability to penetrate the blood brain barrier and potently, selectively and irreversibly inhibit a broad spectrum of EGFR alterations. The Phase 1 clinical trial for BDTX-1535 was initiated in the first quarter of 2022. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Continue to study BDTX-189 in the Phase 1 safety expansion cohort to inform the next steps in clinical development as a selective MasterKey therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe BDTX-189 has the potential to treat multiple tumors with one of the many validated oncogenic EGFR and HER2 mutations. Enrollment and dosing are ongoing in the Phase 1 monotherapy safety expansion portion of our MasterKey-01 Phase 1/2 trial in patients with selected solid tumors with genetically defined alterations, including oncogenic mutations in EGFR and HER2. Eligible patients are identified by standard, commercially available NGS panels. BDTX-189 has demonstrated a favorable tolerability profile and early signs of clinical activity in patients whose tumors are driven by oncogenic EGFR and HER2 mutations. We plan to evaluate further data from the safety expansion cohort to determine next steps in the development of BDTX-189. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Rapidly advance BDTX-4933 into IND-enabling studies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe that BDTX-4933 could offer an improved approach to addressing a broad family of Class I, II, and III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BRAF oncogenic alterations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">expressed in patients with or without tumors in the central nervous system. We anticipate initiating IND-enabling studies in 2022. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Select a development candidate for our FGFR program for clinical development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe that the lead molecules in our FGFR program could overcome the limitations of current therapies. Our FGFR molecules are designed as potent and selective MasterKey inhibitors of FGFR2/3 mutations that spare FGFR1 and have activity against gatekeeper mutations. We anticipate selection of a development candidate for our FGFR program in 2022.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Expand our pipeline of potent and selective MasterKey inhibitors to fully exploit the potential of our proprietary MAP drug discovery engine.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> We believe that the general principles for mutation-driven conformational change that we have identified for our lead programs can be applied to other oncogenic proteins. We also believe that our MAP drug discovery engine has identified undrugged driver mutations for cancer for which we intend to design and develop highly selective and potent inhibitors to block the activity of these oncogenic proteins. We are advancing several early-stage programs focused on targeting a range of driver mutations, including activating mutations outside of active site. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Continue to invest in our proprietary MAP drug discovery engine to identify and characterize new mutation families. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We plan to continue to innovate our MAP drug discovery engine to enable new insights into canonical and non-canonical mutations and to accelerate our ability to identify other mutational drivers, both in oncology and non-oncology settings. We will continue to enhance our proprietary computational algorithms by leveraging both our extensive in-house expertise in MasterKey mutation families and deep understanding of chemistry, as well as both internally and externally available computational technologies. Through our strategic partnership with OpenEye Scientific we are integrating new molecular dynamic modeling tools to support our drug discovery efforts.  By continuing to strengthen and expand our MAP drug discovery engine, we believe we can exploit the growing amount of genetic sequencing data to characterize mutations underlying human disease. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Selectively evaluate strategic partnerships that may maximize the potential of our pipeline and our proprietary MAP drug discovery engine.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Given our potential to generate novel product candidates addressing a wide variety of cancers, we may consider and opportunistically enter into strategic partnerships around certain targets, product candidates and disease areas. These collaborations could advance and accelerate our development programs to maximize their market potential and expand our MAP drug discovery engine capabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Our history and team </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We were founded by Dr. David M. Epstein and Dr. Elizabeth Buck in 2014 and, beginning in 2017, together with Versant Ventures started building the MAP drug discovery engine and chemistry discovery engine. We have assembled a team with significant expertise in drug discovery and development with particular strengths in the discovery of small molecule protein kinase inhibitors. David M. Epstein, Ph.D., our President and Chief Executive Officer, was previously Chief Scientific Officer at OSI Pharmaceuticals, Inc. and founder of Archemix Corporation, where he led the advancement of multiple product candidates into the clinic across several therapeutic areas. Elizabeth Buck, Ph.D., our Chief Scientific Officer, previously led preclinical pharmacology and oncology translational research at OSI Pharmaceuticals, Inc. Brent Hatzis-Schoch, our Chief Operating Officer and General Counsel, was previously General Counsel at Radius Health, Inc. Fang Ni, Pharm.D., our Chief Business Officer and Interim Chief Financial Officer, previously served as Principal and was a member of the investment team at Versant Ventures. Karsten Witt, M.D., our Interim Chief Medical Officer, previously led clinical development at Array Biopharma Inc. and OSI Pharmaceuticals, Inc. Dr. Witt has been involved in eight regulatory approvals, four of which are related to Tarceva (erlotinib), an approved kinase inhibitor for the treatment of certain lung and pancreatic cancers. Elizabeth Montgomery, our Chief People Officer, previously served as Chief People Officer at ClearView Healthcare Partners.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Background on and limitations of previous generations of targeted therapies </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Background on targeted therapies </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cancer is a genetic disease that is caused by changes in DNA that control the way cells function, especially how they grow and divide, and has historically been diagnosed and treated based on a tumor&#8217;s organ site or tissue of origin. Oncogene addiction, which is the dependency of tumors on genetic drivers for their growth and survival advantage, has enabled the pharmacological development of targeted therapies that exploit this dependency. Recent advances in genetic sequencing and a better understanding of genetic alterations that drive cancers have facilitated more precise and histologically agnostic cancer drug development. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These targeted therapies have transformed the treatment of some cancers by providing substantial clinical benefit and have emerged as an important part of standard of care for cancer patients. Worldwide sales of kinase inhibitors, one class of targeted therapies, exceeded $35 billion in 2019. Furthermore, patients with tumors driven by oncogene addiction typically show rapid and measurable tumor shrinkage when exposed to drugs targeting the relevant alteration. Such clinical responses can be dramatic enough in many cases to support expedited regulatory approval of these targeted therapies. Yet, a recent analysis found that less than fifteen percent of patients with metastatic cancer have tumors with genetic profiles that could make them eligible for treatment with an approved precision oncology medicine. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Existing targeted therapies have been effective because they target genetically defined cancers driven by a single set of mutations. Genetic sequencing of tumors reveals that many mutations remain uncharacterized, suggesting that there are additional mutations that can lead to oncogene addiction. With its supplemental approval by the FDA in 2017, pembrolizumab, or Keytruda, was the first targeted oncology treatment approved for any solid tumor based on a molecular profile, regardless of the tumor&#8217;s site of origin. In 2018, larotrectinib, or Vitrakvi, was approved by the FDA for neurotrophic tropomyosin receptor kinase, or NTRK, driven cancers, making it the first drug to be approved to treat a specific genetic alteration in a tissue agnostic fashion. We believe that these advancements represent a fundamental change in the development of targeted therapies and will increasingly lead to cancer being characterized for treatment in a genetic, rather than in a tissue-specific manner. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Limitations of current targeted therapies</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Current targeted therapies provide clinical benefit to patients expressing ATP-site mutations but not to patients expressing other mutations. Numerous other mutations beyond the active site mutations are known to the oncology clinical and research community, but those other mutations are often not currently targeted by approved inhibitors. For example, while EGFR-targeted therapies, including erlotinib and osimertinib, have proven to be effective in patients with ATP-site mutations, limited response to these inhibitors has been observed when treating patients with cancers expressing other types of oncogenic EGFR driver mutations, including those expressed outside of the ATP site, such as EGFR exon 20 insertions and extracellular domain mutations such as EGFRvIII. There remains a significant unmet medical need for new drugs that can extend precision medicines to patients expressing non-ATP site or non-canonical mutations. The figure below depicts the oncogenic EGFR mutations, shown in magenta. These include the ATP-site mutations, EGFR exon 19 deletions and L858R (left panel), as well as an additional spectrum of mutations occurring outside of the ATP site, including EGFRvIII (middle panel) and EGFR exon 20 insertions (right panel).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g3.jpg" alt="bdtx-20211231_g3.jpg" style="height:348px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Emergence of genetic sequencing as standard of care in treating cancer </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The cancer treatment landscape is rapidly evolving, and there is now widespread recognition that cancer is a disease of genetics, as much as it is a disease defined by histology or anatomical location. This shift has been driven by the increased use of genetic sequencing coupled with the availability of approved targeted therapies. The FDA has approved Foundation Medicine&#8217;s comprehensive genetic profiling test FoundationOne CDx and the Centers for Medicare &amp; Medicaid Services announced coverage of next generation genetic sequencing tests, which we believe will further drive the use of genetic testing. A 2019 study demonstrated that 75 percent of oncologists in the United States employ genetic sequencing. As technological advancements in genetic sequencing improve and an increasing number of targeted therapies are developed, we believe that physicians will require molecular information about their patients&#8217; cancers to determine the optimal course of treatment. Not only have advances in genetic sequencing changed the standard of care for oncology patients, but they are also leading to transformations in the discovery and development of oncology drugs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe that genetic sequencing enables the discovery of additional targets for drug development. More than 400 cancer-associated genes are routinely sequenced, and analysis of this data has shown that mutations are not restricted to specific regions, but rather are spread more broadly throughout entire sequences of genes. We believe that such mutations have not yet been systematically studied as potential drug targets or their oncogenic proteins targeted in drug discovery efforts, and that our ability to do so represents a significant opportunity to develop precision medicines in areas of major unmet medical need.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">The Black Diamond Therapeutics approach </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At Black Diamond Therapeutics, our goal is to bring precision oncology medicine to patients with genetically defined cancers who have limited treatment options. Our drug development efforts leverage our novel findings that: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">mutations throughout a gene can drive oncogenic activation and change the drug selectivity profile of their active sites; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">these oncogenic mutations can be grouped into families because they drive similar protein structural changes, and exhibit a shared selectivity profile; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a family of oncogenic proteins can therefore be inhibited by a single molecule that targets the active site regardless of where it appears on the receptor. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe we can address certain key limitations of current generation precision medicine therapies in oncology by applying our MAP drug discovery engine to identify and target novel classes of oncogenic mutations. We believe this enables us to design and develop potential therapies for patients for whom there are currently no targeted treatment options. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Our MAP drug discovery engine </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our MAP drug discovery engine is built on three central pillars: Mutation&#8212;Allostery&#8212;Pharmacology. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Mutation&#8212;identify mutations and rank for potential oncogenicity </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our discovery process begins by identifying oncogenic mutations. We use population-level cancer genetic data obtained from all tumor types, to identify potential families of mutations that occur within individual oncogenes. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have developed unique insights into the specific structural features of a protein that are associated with oncogenic mutations. The algorithm underlying our MAP drug discovery engine scores each mutation for its potential oncogenicity, which we refer to as a MAP score. We use our algorithm as a machine-learning tool to predict the oncogenicity of various uncharacterized mutations, isolating oncogenic driver mutations from the silent and passenger mutations. We map these mutations onto the 3-dimensional structure of a protein to determine which of the many mutations expressed by human tumors occur at sites associated with oncogenicity. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For HER2 and EGFR, we observed that oncogenic mutations are distributed nearly uniformly throughout the sequence of these two genes, revealing many mutations occurring outside of the ATP site, which have not been targeted by drugs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For example, applying our algorithm to all currently known mutations in HER2 alone reveals a subset of mutations with high MAP scores, which we believe is a predictor of oncogenicity. For the ErbB family, we observed 3,868 unique mis-sense mutations (935 mutations in EGFR, 670 mutations in HER2, 794 mutations in HER3 and 1,469 mutations in HER4). These mutations are distributed throughout the target sequence. As illustrated in the figure below, we observed 670 unique mutations expressed in HER2, detected within a combined human tumor data set of approximately 70,000 cases (GENIE 5.0 and TCGA data sets). Through this analysis, we re-identified or confirmed the known HER2 oncogenic mutations, which are the mutations that we targeted with our BDTX-189 product candidate. We also identified an additional subset of mutations with high MAP scores, and we are currently validating these putative oncogenic mutations experimentally. Our goal is to expand our targeted mutation family to potentially include this additional group of non-canonical mutations. </span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g4.jpg" alt="bdtx-20211231_g4.jpg" style="height:236px;margin-bottom:5pt;vertical-align:text-bottom;width:432px"/></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our genetic sequencing analysis has identified a family of 48 non-canonical mutations in both the extracellular and kinase domains of EGFR and HER2. The figure below is a compilation of the non-canonical EGFR and HER2 oncogenic mutations that we are targeting in both of our ErbB programs. Each dot represents a unique non-canonical EGFR and HER2 oncogenic mutation found in individual tumors, while the height of each dot represents the frequency at which such mutation was found. The sites of two mutations defined as canonical mutations are indicated. The frequency for EGFR oncogenic mutations expressed in glioblastoma was calculated as relative frequency within glioblastoma. The frequency for all other EGFR and HER2 mutations was calculated relative to all solid tumors (approximately 70,000 tumors within project GENIE 5.0 / TCGA dataset). Specifically, the figure shows the prevalence of various types of alterations of EGFR expressed in glioblastoma (EGFRvIII, EGFRvII, EGFRvVI, three mutations affecting EGFR-A289 and two mutations affecting EGFR-G598) and various types of EGFR and HER2 alterations expressed across solid tumors (two mutations affecting HER2-S310, HER2-R678Q, six unique mutations affecting HER2-L755, four unique mutations affecting HER2-V777, HER2-V842I, 46 unique mutations that are deletions within exon 19, and 28 unique mutations that are insertions within exon 20 and EGFR-L858R). </span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g5.jpg" alt="bdtx-20211231_g5.jpg" style="height:234px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We selected 43 additional HER2 mutations to experimentally test for oncogenicity using the BaF3 transformation assay. Thirty-three of the 43 mutations tested had high MAP scores and were therefore predicted to have oncogenic behavior, while ten of the 43 mutations had low MAP scores and were therefore not predicted to be oncogenic. In this screen, we also tested HER2 WT and three HER2 mutations that we had already observed to have oncogenic behavior. HER2 WT was unable to transform BaF3 cells to IL-3 independent proliferation, while all three validated HER2 oncogenic mutations (HER2-V842I, L755S and S310F) successfully transformed cells, as evidenced by greater than three-fold proliferation over a seven-day period. Of the 33 mutations with high MAP scores that were predicted to be oncogenic, 15 were transformative. In contrast, among the group of mutations with low MAP scores that were not predicted to have oncogenic behavior, only two transformed BaF3 cells to proliferate greater than three-fold over seven days. We found newly characterized mutations to be sensitive to BDTX-189, as evidenced below with potent inhibition of proliferation against cells transformed by the HER2-R103Q mutation. </span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g6.jpg" alt="bdtx-20211231_g6.jpg" style="height:348px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Allostery&#8212;understanding the mechanism for oncogenic activation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We evaluate the oncogenicity of these mutations occurring outside of the ATP site and use our preclinical models to reveal how they drive protein conformation change to promote oncogenicity. We then use these models to determine whether drug sensitivity profile, or pharmacology, of the ATP site is altered. We use this information to group into oncogene families that share a similar ATP site pharmacology.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the ErbB space, the drug selectivity patterns of mutant EGFR and HER2 kinases provide evidence of unique conformational states driven by mutation. As illustrated in the figure below, dimerization is required for receptor activation, an important step in oncogenic signaling. In EGFR WT, the binding of a ligand to the extracellular domain promotes an active dimer conformation. In the case of EGFR WT, this is a transient dimer conformation. We have discovered that a family of EGFR and HER2 mutations activate these kinases and promote oncogenicity by stabilizing the kinase in a unique constitutive dimer conformation. Importantly, the constitutive dimer conformation results in a change in selectivity for drugs which bind to the ATP site, potentially reducing the effectiveness of currently approved targeted therapies, such as erlotinib.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g7.jpg" alt="bdtx-20211231_g7.jpg" style="height:552px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">The protein conformation for the active form of mutant ErbB receptors is unique from the conformation of EGFR WT. EGFR WT is inactive in its monomeric form and activated upon the binding of an EGF ligand (shown in dark purple) to the extracellular domain, forming an active transient dimer conformation. Oncogenic ErbB mutations (highlighted in magenta in this example) can promote a constitutive dimer conformation which has high activity and is oncogenic.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Pharmacology&#8212;develop mutation spectrum-selective drugs to our targets </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We apply molecular dynamics to simulate the conformational state for any given mutation, and in this manner deliver design ready conformations for drug discovery.  Our team of experienced medicinal and computational chemists seek to leverage these conformations to design and identify small molecules that bind to the active site and inhibit the target only when it is in the unique conformation promoted by the non-canonical oncogenic mutations we identified. Combining a multidimensional medicinal chemistry lead identification and optimization strategy with our proprietary know-how in drug design, we aim to identify small molecules with bespoke selectivity against the entire desired spectrum of mutations as a family, while at the same time sparing inhibition of the wild type form of the protein or other unwanted targets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the development of BDTX-189, our ErbB product candidate that is currently in clinical development, we utilized these cell and tumor models as biological screens that recapitulate the tumor biology for these mutations. BDTX-189 binds to the ATP-site to inhibit the constitutive dimer in a family of EGFR and HER2 mutations, while at the same time sparing inhibition of the normal EGFR WT. We have validated the activity for BDTX-189 against the most commonly occurring mutations representing each of these types of mutations (HER2-S310F, HER2-R678Q, HER2-</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">L755S, HER2-V777L, HER2-V842I, the EGFR Exon 20 insertions EGFR-ASV/SVD/NPH/FQEA, the HER2 Exon 20 insertions HER2-YVMA/GSP, the EGFR Exon 19 deletion EGFR-746-750, and EGFR-L858R).</span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g8.jpg" alt="bdtx-20211231_g8.jpg" style="height:148px;margin-bottom:5pt;vertical-align:text-bottom;width:560px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Our product candidates and development programs </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are leveraging our MAP drug discovery engine to develop a drug pipeline of orally available, potent and spectrum-selective small molecule kinase inhibitors that target genetic drivers in several cancers. We own worldwide commercial rights to all of our product candidates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BDTX-1535: A brain-penetrant, irreversible inhibitor of EGFR alterations, including those present in glioblastoma and NSCLC </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Overview </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EGFR is a potent oncogene commonly altered in many cancers, including glioblastoma and NSCLC. EGFR alterations, EGFR mutations in glioblastoma occur primarily in the extracellular domain, while NSCLC mutations more commonly impact the kinase domain. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Almost 50 percent of glioblastoma tumors express one or more EGFR alterations that affect the extracellular region of the receptor kinase and promote oncogenic activation. These include large deletions in the extracellular domain, including the mutants EGFRvIII, EGFRvVI, and EGFRvII. These also include any one of a number of short variants, single amino acid substitutions affecting the extracellular domain, the most common of which are substitutions at position A289. These mutants are constitutively active, exhibit sustained signaling that is resistant to downregulation, and are both transforming and tumorigenic. Their expression has been associated with poor long-term overall survival. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EGFR oncogenic mutations are expressed throughout the target sequence. The figure below shows the most frequent EGFR oncogenic mutations expressed in glioblastoma (EGFRvIII, EGFRvII, EGFRvVI, EGFR-G598 mutations, EGFR-A289 mutations) which was calculated as relative frequency within glioblastoma (Brennan et al Cell 2013). Each dot represents a unique oncogenic mutation found in individual tumors and the height of each dot represents the frequency with which it was found. A given glioblastoma patient may co-express multiple different EGFR oncogenic mutations. Therefore, we believe a critical challenge to overcome in drug discovery and clinical development of targeted therapies is to develop precision medicines for glioblastoma that efficiently block the oncogenic activity across all of these various EGFR species. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g9.jpg" alt="bdtx-20211231_g9.jpg" style="height:408px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have shown that the mechanism of activation for these EGFR mutants requires formation of a covalent dimer, which is always active, also known as a constitutive dimer. The formatting of these constitutive dimers is essential for oncogenicity. No current generation EGFR-directed therapy has proved effective in treating patients that express these mutations. We believe that current targeted therapies have been unsuccessful in treating glioblastoma due to (i) the concurrent expression of these EGFR oncogenic alterations within individual patients, (ii) insufficient drug potency for EGFR oncogenic alterations, (iii) reversible binding mode leading to paradoxical activation and iv) low levels of brain penetration. The figure below illustrates distinct EGFR oncogenic mutations (EGFRvIII, EGFRvII, EGFRvI, EGFR-A289V) that share the ability to promote constitutively active, ligand independent dimer conformation, which is different from the transient dimer conformation for EGFR WT. For mutants, the region surrounding each mutation site is highlighted in magenta. For EGFR WT, bound EGF ligand is shown in dark purple.</span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g10.jpg" alt="bdtx-20211231_g10.jpg" style="height:219px;margin-bottom:5pt;vertical-align:text-bottom;width:412px"/></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Current reversible EGFR inhibitors, including those proven clinically efficacious in NSCLC, have not demonstrated clinical activity in glioblastoma. We believe this is, in part, due to reversible inhibitors, such as erlotinib, causing paradoxical activation of EGFR alterations. As shown in the figure below, erlotinib demonstrates antiproliferative activity in models harboring an exon 19 deletion mutation common in NSCLC. However, in a glioblastoma model expressing EGFRvIII, erlotinib results in paradoxical activation which increases tumor proliferation at certain dose levels. We believe the irreversible binding profile of BDTX-1535 offers an opportunity to avoid paradoxical activation and inhibit the locked dimers formed by EGFR alterations commonly seen in glioblastoma.</span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g11.jpg" alt="bdtx-20211231_g11.jpg" style="height:280px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In NSCLC, EGFR inhibitors have demonstrated significant clinical benefit in patients with primary EGFR activating mutations and are the current first-line standard of care. However, over time, almost all patients acquire resistance and relapse.  For the third generation EGFR inhibitor osimertinib, acquired resistance can be associated with the acquisition of the EGFR-C797S mutation against which osimertinib is inactive. Additionally, a subset of NSCLC patients at primary diagnosis harbor intrinsic resistance EGFR mutations including complex mutations that are poorly addressed with current therapies.  Furthermore, up to half of all NSCLC patients either have central nervous system (CNS) metastases at diagnosis or will develop them while on treatment. The majority of first- and second-generation EGFR inhibitors do not adequately penetrate the CNS, and while third generation, brain-penetrant EGFR inhibitors such as osimertinib may delay the progression of CNS metastases, there are few options remaining to patients when resistance inevitably arises. Thus, treatment for patients who have progressed on current EGFR targeted agents with acquired mutations that drive resistance, including for patients with brain metastases, remains an area of high unmet medical need in NSCLC.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In November 2020, we announced the nomination of BDTX-1535 as a development candidate for the treatment of glioblastoma and NSCLC with or without brain metastases. BDTX-1535 is a potent, selective, irreversible and brain-penetrant small molecule inhibitor designed to address the critical unmet need in glioblastoma and NSCLC driven by EGFR alterations. The pharmacological activity of BDTX-1535 was optimized to inhibit a wide spectrum of EGFR mutations that drive acquired and intrinsic resistance mechanisms, as well as targeting the CNS tumor settings through its potential for high brain exposure. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In cell-based assays, BDTX-1535 achieved potent MasterKey inhibition of all members of the family of oncogenic EGFR variants expressed in glioblastoma and EGFR amplification with selectivity versus normally expressed EGFR WT as well as classical, intrinsic resistance and acquired resistance mutations expressed in NSCLC.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g12.jpg" alt="bdtx-20211231_g12.jpg" style="height:259px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anti-proliferative activity of BDTX-1535 against BaF3 transformants expressing an exemplary family of EGFR alterations associated with glioblastoma (A) and NSCLC (B) versus EGFR WT expressing H292 cells or EGFR amplified A431 cells.  </span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g13.jpg" alt="bdtx-20211231_g13.jpg" style="height:245px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Left: Oral, single dose of BDTX-1535 resulted in sustained inhibition of EGFR autophosphorylation in subcutaneous monoclonal Ba/F3 tumors expressing EGFRvIII. Right: Oral, once daily administration of BDTX-1535 showed increased survival in mice bearing intracranial PDX tumors expressing EGFRvIII and amplified EGFR</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, BDTX-1535 achieved complete and sustained inhibition (&gt;24 hours) of the phosphorylated state of EGFR in a mouse model expressing the common glioblastoma mutation, EGFRvIII, consistent with its irreversible binding mechanism demonstrated in vitro to EGFR WT. Furthermore, BDTX-1535 demonstrated tumor growth inhibition in a mouse model bearing intracranial GBM6 PDX expressing EGFRvIII and EGFR amplification, supporting its ability to penetrate the blood-brain barrier. BDTX-1535 also achieved sustained inhibition (&gt;24 hours) of the phosphorylated state of EGFR in cells harboring the NSCLC acquired resistance mutation, C797S, as well as tumor growth inhibition in a mouse model bearing PDX tumors expressing C797S. This indicated that BDTX-1535 retains its ability to irreversibly bind to the serine 797 mutant residue that can be acquired after treatment with third generation EGFR tyrosine kinase inhibitors used in the first line setting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g14.jpg" alt="bdtx-20211231_g14.jpg" style="height:292px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Left: Inhibition of the phosphorylated state of EGFR in cells harboring the NSCLC Exon19 deletion and the acquired resistance mutation, C797S, after washout. Right:  Mean tumor volume in mice expressing subcutaneous Ba/F3 allograft expressing Exon19del + C797S. Mice were treated orally with 40mg/kg of BDTX-1535 and 25mg/kg of osimertinib.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furthermore, in mouse models, BDTX-1535 achieved tumor growth inhibition and regression in multiple subcutaneous mouse models bearing PDX and allograft tumors representing a spectrum of EGFR alterations. These models were selected to cover the EGFR alterations commonly found in patients with glioblastoma as well as classical, intrinsic resistance, and acquired resistance mutations found in NSCLC patients.</span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g15.jpg" alt="bdtx-20211231_g15.jpg" style="height:297px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">% Regression in subcutaneous mouse models bearing PDX and allograft tumors expressing EGFR alterations commonly found in patients with glioblastoma as well as classical, intrinsic resistance, and acquired resistance mutations found in NSCLC patients.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Clinical development</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The IND for BDTX-1535 was cleared by the U.S. Food and Drug Administration (FDA) on January 6, 2022, and the Phase 1 clinical trial was initiated in the first quarter of 2022. The Phase 1 trial is an open-label, multicenter study designed to assess the safety, tolerability, pharmacokinetics and preliminary antitumor activity of BDTX-1535 in patients with glioblastoma and NSCLC harboring EGFR MasterKey alterations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our Phase 1 trial is an open-label, multicenter study designed to assess the safety, tolerability, pharmacokinetics and preliminary antitumor activity of BDTX-1535 in patients with either recurrent glioblastoma expressing EGFR alterations and patients with advanced/metastatic NSCLC harboring sensitizing EGFR mutations, with or without brain metastases who have progressed on an approved EGFR inhibitor. Eligible NSCLC patients must have either an intrinsic resistance EGFR mutation in exon 18-21 or an acquired C797S mutation following 1st line therapy with a 3rd-generation EGFR inhibitor. Once a provisional RP2D has been established, BDTX-1535 monotherapy will be explored in disease specific dose expansion cohorts to further evaluate safety, PK, and preliminary assessment of efficacy. The disease specific dose expansion includes: patients with recurrent glioblastoma with EGFR alterations,  patients with locally advanced/metastatic NSCLC with an acquired resistance EGFR mutation (e.g., C797S) with and without brain metastases, and  patients with locally advanced/metastatic NSCLC with oncogenic EGFR intrinsic resistance mutations (e.g., G719X) with and without brain metastases. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our regulatory strategy includes pursuing a registration path for patients with recurrent glioblastoma in parallel with NSCLC patients with either intrinsic resistance mutations or acquired resistance mutations.</span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g16.jpg" alt="bdtx-20211231_g16.jpg" style="height:303px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We expect to provide an update on the clinical data obtained from the Phase 1 trial in the second half of 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BDTX-189: An inhibitor of oncogenic driver mutations of EGFR and HER2 </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Overview </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mutations in EGFR and HER2, both of the ErbB family, are found in one to two percent of a large variety of solid tumors but are overexpressed in tumors such as advanced NSCLC, invasive breast, bladder and endometrial cancer, where incidence ranges from two to seven percent. Currently available EGFR and HER2 tyrosine kinase inhibitors or monoclonal antibodies have limited or no anti-tumor activity against these genetic alterations due to insufficient potency or lack of selectivity, which results in toxicity before adequate exposures can be achieved. There remains a significant unmet medical need for new drugs that can extend targeted therapies to patients expressing non-canonical mutations outside of the ATP site. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BDTX-189 is designed as an orally available irreversible, small molecule inhibitor that targets undrugged oncogenic driver mutations in HER2 and EGFR. These include extracellular domain mutations of HER2, as well as EGFR and HER2 kinase domain exon 20 insertions, and additional activating oncogenic driver mutations. Currently, there are no FDA approved drugs that target all of these mutations with a single small molecule therapy.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are currently enrolling patients in the Phase 1 monotherapy safety expansion portion of the trial at the RP2D in patients with selected tumor types with EGFR or HER2 mutations, including exon 20 insertions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The figure below shows the selectivity pattern for BDTX-189 for non-canonical oncogenic mutations and additional oncogenic drivers of EGFR and HER2 (with wild type for reference), each as determined by measuring 50 percent inhibition, or IC50, values. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In cell-based assays, BDTX-189 achieved potent inhibition of each of the 48 oncogenic ErbB mutant variants tested with an average selectivity versus EGFR WT of greater than 50-fold, including the family of EGFR and HER2 exon 20 insertion mutations. </span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g17.jpg" alt="bdtx-20211231_g17.jpg" style="height:297px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BDTX-189 has demonstrated in vitro activity against the canonical activating EGFR mutations (exon 19 deletion and L858R mutation), as well as potent HER2 WT activity, or HER2-positive. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A favorable therapeutic window over EGFR WT was a key design objective in the ErbB program. BDTX-189 achieved high selectivity for cells expressing the targeted oncogenic EGFR and HER2 mutants and the compound spares cells expressing EGFR WT (A431 and H292). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe BDTX-189 has an excellent kinome selectivity profile, as determined using the DiscoverX KINOMEscan methodology testing 468 kinases. BDTX-189 exhibited binding affinity for the isolated kinase domains of EGFR and HER2 of less than 1nM. All but eight kinases outside of the ErbB family showed no or very poor binding when BDTX-189 was tested at a single concentration of 100nM, with selectivity estimated to be greater than 125-fold for EGFR selectivity and greater than 30-fold for HER2 selectivity. The selectivity for ErbB kinases versus a small subset of kinases (BLK, BTK, LCK, LOK and MEK5) was determined to be greater than 10-fold. The only kinase that was bound with less than 10-fold selectivity is RIPK2, and this activity is not expected to be dose limiting. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In preclinical animal models, BDTX-189 was observed to have high potency and fast irreversible inactivation of the desired mutations. BDTX-189 displayed a favorable pharmacokinetic profile with fast absorption, good exposure and subsequent swift elimination, together with rapid irreversible target inhibition. BDTX-189 was observed to be well suited to engage and inactivate the EGFR and HER2 mutants in vivo. In acute dose pharmacokinetic/pharmacodynamic, or PK/PD, studies, oral administration of BDTX-189 to athymic nude mice bearing a range of EGFR and HER2 mutations resulted in potent and sustained suppression of target phosphorylation for at least 24 hours following dosing.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As shown in the figures below, BDTX-189 demonstrated dose-dependent tumor inhibition and regression in both engineered HER2 S310F tumor models and EGFR Exon 20 insertion patient-derived xenograft, or PDX, models. </span><img src="bdtx-20211231_g18.jpg" alt="bdtx-20211231_g18.jpg" style="height:440px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(a) Daily dosing of BDTX-189 was evaluated in athymic nude mice bearing HER2 S310F Ba/F3 allograft tumors up to 100 mg/kg daily dose; (b) Daily dosing of BDTX-189 at an oral dose of 1 to 50 mg/kg was evaluated in athymic nude mice bearing CUTO-14 PDX tumors that express the EGFR mutation EGFR ASV.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We used a PK/PD analysis of the HER2-S310F BaF3 allograft tumor inhibition studies to assess the PK/PD driver for efficacy using different doses and dose regimens to project expected human exposures to be associated with anti-tumor activity. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Clinical development</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We submitted our IND for BDTX-189 in November 2019, which was allowed by the FDA on December 13, 2019. Enrollment and dosing of patients in the Phase 1 dose-escalation portion of our MasterKey-01 trial has been completed with the recommended Phase 2 dose, or RP2D, established to be 800 mg once daily with a meal (non-fasting) which also was endorsed by the FDA. The Phase 1 safety expansion cohort is currently enrolling at the RP2D to further evaluate the safety, PK and preliminary efficacy in patients with selected tumor types and genomic alterations to inform the future development of the program. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our Phase 1 portion was designed to allow for greater flexibility and precision to determine the appropriate dose and schedule for further clinical evaluation. The Phase 1 trial was a two-step process where step one was a single-patient cohort, accelerated dose-escalation process until grade 2 drug-related adverse events were observed or until the 400 mg once daily dose level was opened for enrollment. Step 2 was designed to provide the flexibility to enroll three or more patients in dose-escalating cohorts. The study initially evaluated once daily dosing in fasted state, but also evaluated a twice daily dosing schedule. In the Phase 1 dose-escalation portion, 59 patients were enrolled in the once daily dose schedule with advanced or metastatic solid tumors for whom no standard therapy was available or for whom standard therapy was considered unsuitable or intolerable, as determined by the investigator. The patients were heavily pretreated with multiple different solid tumors expressing multiple EGFR or HER2 genomic alterations. This includes 31 patients treated at 800 mg, with 18 patients administered BDTX-189 under fasting conditions and 13 patients administered BDTX-189 once daily with a meal which was determined to be the RP2D and schedule.  The dose of 800 mg once daily either fasting or non-fasting was well tolerated with no dose-limiting toxicities reported and a low rate of typical EGFR wild type skin disorders. The pharmacokinetics of BDTX-189 showed dose-dependent increases in exposures up to and including 800 mg. There was also evidence of early signs of clinical antitumor activity including two confirmed partial responses in patients who remained on treatment for more than 10 months. We are currently enrolling the safety expansion cohort at the RP2D to inform the future development of the program.</span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g19.jpg" alt="bdtx-20211231_g19.jpg" style="height:303px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our regulatory strategy includes periodic dialogue with the FDA regarding the study design, patient population, study endpoint and companion diagnostic strategy for the BDTX-189 development program. For example, in March 2021, we met with the FDA to discuss the registrational potential and design of the then planned Phase 2 portion of the trial. At the meeting with the FDA, the FDA notified us that, because the Phase 2 portion of the trial would be potentially registrational and support a new drug application, we could only enroll up to 50 patients in Phase 2 before results of routine three-month good laboratory practice, or GLP, toxicology studies have been submitted and accepted by the FDA. This partial clinical hold on Phase 2 enrollment was not based on any safety findings from the MasterKey-01 trial and has no impact on completion of our Phase 1 study (including the currently enrolling safety expansion cohort). We have completed the three-month GLP toxicology studies and submitted the reports to the FDA who accepted the findings and lifted the partial clinical hold in January 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In July 2020, the FDA granted Fast Track designation to BDTX-189 for the treatment of adult patients with solid tumors harboring an oncogenic HER2 mutation or an EGFR or HER2 Exon 20 insertion mutation who have progressed following prior treatment and who have no satisfactory treatment options. We may also seek Breakthrough Therapy designation by the FDA.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BDTX-4933: A brain-penetrant, small molecule inhibitor of BRAF class I, II and III alterations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Oncogenic alterations affecting BRAF include the V600E mutation (Class I) active site mutation together with families of non-canonical BRAF mutations (Class II and Class III) that are active as dimers. While the V600E Class I mutation has been successfully targeted in melanoma, there are currently no approved therapies that target the full spectrum of Class II and Class III mutations that are expressed in melanoma and a range of other solid tumors. Additionally, expression of all classes of BRAF mutations commonly occurs in patients with CNS tumors or with brain metastasis, which currently remain unaddressed by approved drugs due to their poor brain penetration. Approved BRAF inhibitors can lead to unwanted paradoxical activation, which may lead to poor efficacy and secondary malignancies.</span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g20.jpg" alt="bdtx-20211231_g20.jpg" style="height:566px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Classification of BRAF mutations. Class I, V600, signals as a monomer in an RAS-independent manner and constitutively activates the mitogen activated protein kinase (MAPK) signaling pathway. Class II and III BRAF mutations signal as dimers in an RAS-independent, and -dependent, respectively, and currently there are no approved therapies for these BRAF dimer mutations. FDA approved BRAF V600E- selective inhibitors are inactive against BRAF dimers, Class II and Class III.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our BRAF development candidate, BDTX-4933, is designed as a brain-penetrant, small molecule MasterKey inhibitor of oncogenic BRAF Class I, II and III alterations expressed by human cancers, while avoiding paradoxical activation. We believe that BDTX-4933 could offer an improved approach for treating melanoma, NSCLC and other solid tumors expressing Class I mutations with brain metastases as well as cancers expressing Class I, II and III alterations, including CNS diseases such as gliomas.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In cell-based assays, BDTX-4933 demonstrated potent inhibition of a wide spectrum of BRAF alterations including fusions and exhibited dose-dependent inhibition of cell proliferation.  In preclinical BRAF-driven tumor models expressing Class I, II and III mutations, daily dosing of BDTX-4933 demonstrated dose-dependent tumor growth inhibition, tumor regression and survival, consistent with potent on-target and on-pathway inhibition.  BDTX-4933 also demonstrated robust brain penetration properties and activity in intracranial mouse tumor models expressing the Class I V600E mutation.</span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g21.jpg" alt="bdtx-20211231_g21.jpg" style="height:250px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">MasterKey property of BDTX-4933 inhibitor: BDTX-4933 inhibitor demonstrates robust anti-tumor activity and regression across preclinical tumor models representing all 3 classes of BRAF mutations. </span></div><div style="margin-top:12pt;text-align:center"><img src="bdtx-20211231_g22.jpg" alt="bdtx-20211231_g22.jpg" style="height:204px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">BDTX-4933 inhibitor exhibits CNS exposure and anti-tumor activity in intracranial BRAF mutant mouse model. (Left) Representative images of bioluminescence (BLI) of BRAF V600E cancer cells labeled with luciferase reporter in animals. The BLI from the tumor is increased in vehicle treated animals after 15 days of dosing. Meanwhile, BDTX-4933 inhibitor treated animals show very low or no BLI. (Right) Survival rate of tumor bearing mice. BDTX-4933 inhibitor treated animals show significant extended survival compared to vehicle. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We anticipate initiating IND-enabling studies for the BDTX-4933 program in 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Early-stage programs </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are applying our MAP drug discovery engine to the analysis of the mutation landscape of more than 300 genes, including 92 kinases within Foundation Medicine&#8217;s FoundationOne CDx test panel. We are advancing several early programs focused on targeting a range of driver mutations, including activating mutations. We believe these general principles also apply to targets associated with diseases outside of oncology, and we are currently evaluating additional groups of targets for drug discovery. As part of our ongoing efforts to leverage our know-how regarding mutations in the ErbB family, we continue to investigate novel potent and selective compounds directed against this family of targets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">FGFR program</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Oncogenic mutations affecting FGFR2 and FGFR3 (including short variant point mutations and fusions) are expressed across a range of cancers such as bladder and cholangiocarcinoma. While these mutations have been targeted by three first generation pan-FGFR inhibitors (erdafitinib, pemigatinib and infigratinib), clinical success has been hindered by dose limiting toxicities related to on-target inhibition of FGFR1, which causes hyperphosphatemia and the need for significant dose interruptions and dose reductions, and even discontinuation. Furthermore, current FGFR inhibitors are limited by acquired resistance due to mutation of gatekeeper positions in FGFR2/3, which are residues that modulate access to the ATP-binding site. These limitations limit the efficacy of current generation FGFR targeted therapies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our FGFR program leverages our MAP drug discovery engine to (i) define the full spectrum of FGFR2/3 oncogenic mutations; (ii) classify mutations according to unifying conformational changes; and (iii) design small molecule inhibitors that are active against the full spectrum of oncogenic FGFR2/3 mutations, exhibit improved resistance profile versus the clinically relevant gatekeeper mutations and achieve selectivity versus FGFR1. We believe that our MAP drug discovery engine drug discovery platform is differentiated by its capability to identify development candidates that are selective versus FGFR1.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BDTX FGFR program compounds are MasterKey inhibitors of oncogenic FGFR2/3 mutations with selectivity versus FGFR1 and activity against gatekeeper mutations. Tumor regression in mouse models has been observed. We anticipate selection of a development candidate for the BDTX FGFR program in 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Competition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our industry is intensely competitive and subject to rapid and significant technological change. While we believe that our knowledge, experience and scientific resources provide us with competitive advantages, we face substantial competition from major pharmaceutical companies and biotechnology companies worldwide. Many of our competitors have significantly greater financial, technical and human resources. Smaller and early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. As a result, our competitors may discover, develop, license or commercialize products before or more successfully than we do. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We face competition with respect to our current product candidates and will face competition with respect to future product candidates, from segments of the pharmaceutical, biotechnology and other related markets that pursue targeted therapies for patients with genetically defined cancers. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There are currently compounds approved and in-development which target the EGFR pathway and against which we expect BDTX-1535 to compete: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In patients with EGFR acquired resistance: combination of amivantamab, or Rybrevant, and lazertinib, the former of which is marketed by and the latter of which is being developed by Janssen Biotech, Inc.; patritumab deruxtecan, which is being developed by Daiichi Sankyo Co.; BLU-701 and BLU-945, which are under development by BluePrint Medicines Corporation; and BBT-176, which is being developed by Bridge Biotherapeutics, Inc. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In patients with EGFR intrinsic resistance: afatinib, or GILOTRIF, which is marketed by Boehringer Ingelheim and approved as first-line treatment of NSCLC patients with exon 18 mutations; osimertinib, or TAGRISSO, which is marketed by AstraZeneca plc and is being prescribed off-label for NSCLC patients with exon 18 mutations; and neratinib, which is marketed by Puma Biotechnology, Inc. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In patients with EGFR alterations present in glioblastoma: ERAS-801, which is under development by Erasca, Inc.; WSD-0922-FU, which is under development by Wayshine Biopharm International Ltd.; CM93, which is under development by Crimson Biopharm Inc.; RO7428731, which is under development by Hoffman Roche; TAS2940, which is under development by Taiho Oncology, Inc.; and epitinib, which is under development by Hutchison MediPharma Ltd. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There are currently compounds approved and in development which target the EGFR/HER2 pathway and against which we expect BDTX-189 to compete:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In the EGFR exon 20 insertion NSCLC patient population: amivantamab, which is under development by Janssen Research &amp; Development, LLC and has been granted accelerated approval by the FDA; mobocertinib (TAK-788), which is under development by Takeda Pharmaceutical Company Ltd and has been granted accelerated approval by the FDA; CLN-081, which is under development by Cullinan Oncology, Inc. and has been granted Breakthrough Therapy Designation by the FDA; DZD9008, which is under development by Dizal Pharmaceutical Co., Ltd. and has been granted Breakthrough Therapy Designation by the FDA; ORIC-114 (formerly VRN-07), which is under development by ORIC Pharmaceuticals, Inc.; and BLU-451, which is under development by BluePrint Medicines Corporation. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In the HER2 exon 20 insertion NSCLC patient population: trastuzumab deruxtecan, which is marketed by Daiichi Sankyo Company, Ltd. and AstraZeneca plc under the trade name Enhertu and is currently approved for HER2+ breast and gastric cancers; poziotinib, which is under development by Spectrum Pharmaceuticals, Inc.; and pyrotinib, which is under development by Jiangsu Hengrui Pharmaceuticals Company Ltd.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In the allo-HER2 patient population: neratinib, which is marketed by Puma Biotechnology, Inc. under the trade name Nerlynx and is currently approved for HER2+ breast cancer.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, there are other small molecule and precision oncology-focused companies with whom we may eventually compete, including Loxo Oncology, Inc. (acquired by Eli Lilly and Company), SpringWorks Therapeutics, Inc., Centessa Pharmaceuticals plc, Theseus Pharmaceuticals, Inc., Voronoi Inc., Deciphera Pharmaceuticals, Inc., Turning Point Therapeutics, Inc., Mirati Therapeutics, Inc., Relay Therapeutics, Inc. and Kinnate Biopharma Inc.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our competitors may obtain regulatory approval of their products more rapidly than we may or may obtain patent protection or other intellectual property rights that limit our ability to develop or commercialize our product candidates. Our competitors may also develop drugs that are more effective, more convenient, more widely used and less costly or have a better safety profile than our products and these competitors may also be more successful than us in manufacturing and marketing their products. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we will likely need to develop our product candidates in collaboration with diagnostic companies, and we will face competition from other companies in establishing these collaborations. Our competitors will also compete with us in recruiting and retaining qualified scientific, management and commercial personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furthermore, we also face competition more broadly across the market for cost-effective and reimbursable cancer treatments. The most common methods of treating patients with cancer are surgery, radiation and drug therapy, including chemotherapy, hormone therapy and targeted drug therapy or a combination of such methods. There are a variety of available drug therapies marketed for cancer. In many cases, these drugs are administered in combination to enhance efficacy. While our product candidates, if any are approved, may compete with these existing drug and other therapies, to the extent they are ultimately used in combination with or as an adjunct to these therapies, our product candidates may not be competitive with them. Some of these drugs are branded and subject to patent protection, and others are available on a generic basis. Insurers and other third-party payors may also encourage the use of generic products or specific branded products. We expect that if our product candidates are approved, they will be priced at a significant premium over competitive generic, including branded generic, products. As a result, obtaining market acceptance of, and a gaining significant share of the market for, any of our product candidates that we successfully introduce to the market will pose challenges. In addition, many companies are developing new therapeutics, and we cannot predict what the standard of care will be as our product candidates progress through clinical development. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The acquisition or licensing of pharmaceutical products is also very competitive. If we seek to acquire or license products, we will face substantial competition from a number of more established companies, some of which have acknowledged strategies to license or acquire products and many of which are bigger than us and have more institutional experience and greater cash flows than we have. These more established companies may have competitive advantages over us, as may other emerging companies taking similar or different approaches to product licenses and/or acquisitions. In addition, a number of established research-based pharmaceutical and biotechnology companies may acquire products in late stages of development to augment their internal product lines, which may provide those companies with an even greater competitive advantage.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Manufacturing and Supply</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We do not own or operate, and currently have no plans to establish, any manufacturing facilities. We currently rely, and expect to continue to rely, on third parties for the manufacture of our product candidates undergoing preclinical testing, as well as for clinical testing and commercial manufacture if our product candidates receive marketing approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All of our product candidates are small molecules and are manufactured via synthetic processes from available starting materials. The chemistry appears amenable to scale up and does not currently require unusual equipment in the manufacturing process. We expect to continue to develop product candidates that can be produced cost-effectively at third-party contract manufacturing organizations, or CMOs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We generally expect to rely on one or more potential partners for the manufacture of companion diagnostics for our products, which are assays or tests to identify an appropriate patient population.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Commercialization </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to receiving marketing approvals, we expect to commence commercialization activities by building a focused sales and marketing organization in the United States to sell our products. We believe that such an organization will be able to address the community of oncologists who are the key specialists in treating the patient populations for which our product candidates are being developed. Outside the United States, we may enter into distribution and other marketing arrangements with third parties for any of our product candidates that obtain marketing approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We also plan to build a marketing and sales management organization to create and implement marketing strategies for any products that we market through our own sales organization and to oversee and support our sales force. The responsibilities of the marketing organization would include developing educational initiatives with respect to approved products and establishing relationships with researchers and practitioners in relevant fields of medicine. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Intellectual property </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We seek to protect the intellectual property and proprietary technology that we consider important to our business, including by pursuing patent applications that cover our product candidates and methods of using the same, as well as any other relevant inventions and improvements that are considered commercially important to the development of our business. We also rely on trade secrets, know-how and continuing technological innovation to develop and maintain our proprietary and intellectual property position. Our commercial success depends, in part, on our ability to obtain, maintain, enforce and protect our intellectual property and other proprietary rights for the technology, inventions and improvements we consider important to our business, and to defend any patents we may own or in-license in the future, prevent others from infringing any patents we may own or in-license in the future, preserve the confidentiality of our trade secrets, and operate without infringing, misappropriating or otherwise violating the valid and enforceable patents and proprietary rights of third parties. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As with other biotechnology and pharmaceutical companies, our ability to maintain and solidify our proprietary and intellectual property position for our product candidates and technologies will depend on our success in obtaining effective patent claims and enforcing those claims if granted. However, our pending patent applications, and any patent applications that we may in the future file or license from third parties, may not result in the issuance of patents and any issued patents we may obtain do not guarantee us the right to practice our technology in relation to the commercialization of our products. We also cannot predict the breadth of claims that may be allowed or enforced in any patents we may own or in-license in the future. Any issued patents that we own, or may own or in-license in the future may be challenged, invalidated, circumvented or have the scope of their claims narrowed. For example, we cannot be certain of the priority of inventions covered by pending third-party patent applications. If third parties prepare and file patent applications in the United States that also claim technology or therapeutics to which we have rights, we may have to participate in interference proceedings in the USPTO to determine priority of invention, which could result in substantial costs to us, even if the eventual outcome is favorable to us, which is highly unpredictable. In addition, because of the extensive time required for clinical development and regulatory review of a product candidate we may develop, it is possible that, before any of our product candidates can be commercialized, any related patent may expire or remain in force for only a short period following commercialization, thereby limiting the protection such patent would afford the respective product and any competitive advantage such patent may provide. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term of individual patents depends upon the date of filing of the patent application, the date of patent issuance and the legal term of patents in the countries in which they are obtained. In most countries, including the United States, the patent term is 20 years from the earliest filing date of a non-provisional patent application. In the United States, a patent&#8217;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in examining and granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier filed patent. The term of a patent claiming a new drug product may also be eligible for a limited patent term extension when FDA approval is granted, provided statutory and regulatory requirements are met. The restoration period granted on a patent covering a product is typically one-half the time between the effective date of a clinical investigation involving human beings is begun and the submission date of an application, plus the time between the submission date of an application and the ultimate approval date. The restoration period cannot be longer than five years and the total patent term, including the restoration period, must not exceed 14 years following FDA approval. Only one patent applicable to an approved product is eligible for the extension, and only those claims covering the approved product, a method for using it, or a method for manufacturing it may be extended. Additionally, the application for the extension must be submitted prior to the expiration of the patent in question. A patent that covers multiple products for which approval is sought can only be extended in connection with one of the approvals. The United States Patent and Trademark Office reviews and approves the application for any patent term extension or restoration in consultation with the FDA. In the future, if our product candidates receive approval by the FDA, we expect to apply for patent term extensions on any issued patents covering those products, depending upon the length of the clinical studies for each product and other factors. There can be no assurance that our pending patent applications will issue or that we will benefit from any patent term extension or favorable adjustments to the terms of any patents we may own or in-license in the future. In addition, the actual protection afforded by a patent varies on a product-by-product basis, from country-to-country, and depends upon many factors, including the type of patent, the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">country and the validity and enforceability of the patent. Patent term may be inadequate to protect our competitive position on our products for an adequate amount of time. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March 1, 2022, we own 20 U.S. provisional patent applications, four pending U.S. patent applications, and one issued U.S. patent. We also own eight Patent Cooperation Treaty, or PCT, patent applications and 27 foreign patent applications. Any U.S. or foreign patent issuing from these patent applications would be scheduled to expire in 2039 to 2042, excluding any additional term for patent term adjustment or patent term extension, and assuming that conversions are timely made based upon U.S. provisional patent applications, that national phase entries are timely made based upon the pending PCT applications, and the payment of all applicable maintenance or annuity fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">BDTX-1535</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March 1, 2022, we own six U.S. provisional patent applications, one U.S. patent application, and one PCT patent application, and 10 foreign patent applications that cover our glioblastoma program, including the composition of matter for BDTX-1535, polymorphs of BDTX-1535, as well as methods of using and making BDTX-1535. Any U.S. or foreign patent issued from these pending applications would be scheduled to expire between 2040 and 2042, assuming that conversions are timely made based upon U.S. provisional patent applications, that national phase entries are timely made based upon the pending PCT applications, excluding any additional term for patent term adjustment or patent term extension. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">BDTX-189</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March 1, 2022, we own three U.S. provisional patent applications, one pending U.S. patent application, one U.S. patent, and three PCT patent applications, and 14 foreign patent applications that cover our tumor agnostic program, including the composition of matter for BDTX-189, polymorphs of BDTX-189, as well as methods of using and making BDTX-189. Any U.S. or foreign patent issued from these pending applications would be scheduled to expire between 2039 and 2042, excluding any additional term for patent term adjustment or patent term extension, and assuming national phase entries are timely made based upon the pending PCT application and payment of all applicable maintenance or annuity fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">BRAF program</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March 1, 2022, we own two U.S. provisional patent applications and one PCT patent application that cover our BRAF program, which is directed to the composition of matter for the compounds of the program, analogs thereof, as well as methods of using and making these compounds. Any U.S. or foreign patent issued from these pending applications would be scheduled to expire in 2042, assuming that conversions are timely made based upon U.S. provisional patent applications, that national phase entries are timely made based upon the pending PCT applications, excluding any additional term for patent term adjustment or patent term extension.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">FGFR program</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March 1, 2022, we own two U.S. provisional patent applications and one PCT patent application that cover our FGFR program, which is directed to the composition of matter for the compounds of the program, analogs thereof, as well as methods of using and making these compounds. Any U.S. or foreign patent issued from these pending application would be scheduled to expire in 2042, assuming that conversions are timely made based upon U.S. provisional patent applications, that national phase entries are timely made based upon the pending PCT applications, excluding any additional term for patent term adjustment or patent term extension.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">MAP drug discovery engine </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March 1, 2022, we own one U.S. patent application that covers our MAP drug discovery engine and the use thereof in developing and applying therapeutics. Any U.S. patent issued from this U.S. patent application would be scheduled to expire in 2040, excluding any additional term for patent term adjustment or patent term extension. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Prosecution is a lengthy process, during which the scope of the claims initially submitted for examination by the USPTO are often significantly narrowed by the time they issue, if they issue at all. Any of our pending PCT patent applications are not eligible to become issued patents until, among other things, we file national stage patent applications within 30 months in the countries in which we seek patent protection. If we do not timely file any national stage patent applications, we may lose our priority date with respect to our PCT patent applications and any patent protection on the inventions disclosed in such PCT patent applications. Our provisional patent applications may never result in issued patents and are not eligible to become issued patents until, among other things, we file a non-provisional patent application within 12 months of filing the related provisional patent application. If we do not timely file non-provisional patent applications, we may lose our priority date with respect to our provisional patent applications and any patent protection on the inventions disclosed in our provisional patent applications. While we intend to timely file non-provisional and national stage patent applications relating to our provisional and PCT patent applications, we cannot predict whether any of our future patent applications for BDTX-1535, BDTX-189 or any of our other product candidates or technology will result in the issuance of patents that effectively protect BDTX-1535, BDTX-189 or our other product candidates or technology. If we do not successfully obtain patent protection, or, even if we do obtain patent protection, if the scope of the patent protection we or our potential licensors obtain with respect to BDTX-1535, BDTX-189 or our other product candidates or technology is not sufficiently broad, we will be unable to prevent others from using our technology or from developing or commercializing technology and products similar or identical to ours or other competing products and technologies. For more information regarding the risks related to our intellectual property, please see &#8220;Risk Factors&#8212;Risks Related to our Intellectual Property.&#8221; </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to patent applications, we rely on unpatented trade secrets, know-how and continuing technological innovation to develop and maintain our competitive position. However, trade secrets and confidential know-how are difficult to protect. In particular, we anticipate that with respect to the building of our compound library, our trade secrets and know-how will over time be disseminated within the industry through independent development and public presentations describing the methodology. We seek to protect our proprietary information, in part, by executing confidentiality agreements with our collaborators and scientific advisors and non-competition, non-solicitation, confidentiality and invention assignment agreements with our employees and consultants. We have also executed agreements requiring assignment of inventions with selected consultants, scientific advisors and collaborators. The confidentiality agreements we enter into are designed to protect our proprietary information and the agreements or clauses requiring assignment of inventions to us are designed to grant us ownership of technologies that are developed through our relationship with the respective counterparty. We cannot guarantee that we will have executed such agreements with all applicable employees and contractors, or that these agreements will afford us adequate protection of our intellectual property and proprietary information rights. In addition, our trade secrets and/or confidential know-how may become known or be independently developed by a third party, or misused by any collaborator to whom we disclose such information. These agreements may also be breached, and we may not have an adequate remedy for any such breach. Despite any measures taken to protect our intellectual property, unauthorized parties may attempt to copy aspects of our products or to obtain or use information that we regard as proprietary. Although we take steps to protect our proprietary information, third parties may independently develop the same or similar proprietary information or may otherwise gain access to our proprietary information. As a result, we may be unable to meaningfully protect our trade secrets and proprietary information. For more information regarding the risks related to our intellectual property, please see &#8220;Risk Factors&#8212;Risks Related to our Intellectual Property.&#8221; </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Government regulation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The FDA and other regulatory authorities at federal, state and local levels, as well as in foreign countries, including the European Union, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting of drugs. We, along with our vendors, contract research organizations and contract manufacturers, will be required to navigate the various preclinical, clinical, manufacturing and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval of our product candidates. The process of obtaining regulatory approvals of drugs and ensuring subsequent compliance with appropriate federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the United States, where we are initially focusing our drug development, the FDA regulates drug products under the U.S. Federal Food, Drug and Cosmetic Act (FD&amp;C Act), its implementing regulations and other laws. Our product candidates are early-stage and none of our product candidates has been approved by the FDA for marketing in the United States. If we fail to comply with applicable FDA or other requirements at any time with respect to product development, clinical testing, approval or any other legal requirements relating to product manufacture, processing, handling, storage, quality control, safety, marketing, advertising, promotion, packaging, labeling, export, import, distribution, or sale, we may become subject to administrative or judicial sanctions or other legal consequences. These sanctions or consequences could include, among other things, the FDA&#8217;s refusal to approve pending applications, issuance of clinical holds for ongoing studies, suspension or revocation of approved applications, warning or untitled letters, product withdrawals or recalls, product seizures, relabeling or repackaging, total or partial suspensions of manufacturing or distribution, injunctions, fines, civil penalties or criminal prosecution brought by the FDA and the U.S. Department of Justice or other governmental entities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The process required by the FDA before our product candidates are approved as drugs for therapeutic indications and may be marketed in the United States generally involves the following: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">completion of extensive preclinical studies in accordance with applicable regulations, including studies conducted in accordance with GLP requirements; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">submission to the FDA of an IND application, which must become effective before clinical trials may begin;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">approval by an Institutional Review Board, or IRB, or independent ethics committee at each clinical trial site before each trial may be initiated;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">performance of adequate and well-controlled clinical trials in accordance with applicable IND regulations, good clinical practice, or GCP, requirements and other clinical trial-related regulations to establish the safety and efficacy of the investigational product for each proposed indication;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">submission to the FDA of a New Drug Application, or NDA;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a determination by the FDA within 60 days of its receipt of an NDA, to accept the filing for review;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">satisfactory completion of one or more FDA pre-approval inspections of the manufacturing facility or facilities where the drug will be produced to assess compliance with current good manufacturing practices, or cGMP, requirements to assure that the facilities, methods and controls are adequate to preserve the drug&#8217;s identity, strength, quality and purity;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">potential FDA audit of the clinical trial sites that generated the data in support of the NDA;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">payment of user fees for FDA review of the NDA; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">FDA review and approval of the NDA, including consideration of the views of any FDA advisory committee, prior to any commercial marketing or sale of the drug in the United States.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The testing and approval process requires substantial time, effort and financial resources, and we cannot be certain that any approvals for our product candidates will be granted on a timely basis, if at all.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Preclinical and clinical trials for drugs </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Before testing any drug in humans, the product candidate must undergo rigorous preclinical testing. Preclinical studies include laboratory evaluations of drug chemistry, formulation and stability, as well as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and animal studies to assess safety and in some cases to establish the rationale for therapeutic use. The conduct of preclinical studies is subject to federal and state regulations and requirements, including GLP requirements for safety/toxicology studies. The results of the preclinical studies, together with manufacturing information and analytical data must be submitted to the FDA as part of an IND. An IND is a request for authorization from the FDA to administer an investigational product to humans, and must become effective before clinical trials may begin. Some long-term preclinical testing may continue after the IND is submitted. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the 30-day time period, raises concerns or questions about the conduct of the clinical trial, including concerns that human research subjects will be exposed to unreasonable health risks, and imposes a clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. Submission of an IND may result in the FDA not allowing clinical trials to commence or not allowing clinical trials to commence on the terms originally specified in the IND. A separate submission to an existing IND must also be made for each successive clinical trial conducted during product development of a product candidate, and the FDA must grant permission, either explicitly or implicitly by not objecting, before each clinical trial can begin. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The clinical stage of development involves the administration of the product candidate to healthy volunteers or patients under the supervision of qualified investigators, generally physicians not employed by or under the trial sponsor&#8217;s control, in accordance with GCP requirements, which include the requirements that all research subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria and the parameters and criteria to be used in monitoring safety and evaluating effectiveness. Each protocol, and any subsequent amendments to the protocol, must be submitted to the FDA as part of the IND. Furthermore, each clinical trial must be reviewed and approved by an IRB for each institution at which the clinical trial will be conducted to ensure that the risks to individuals participating in the clinical trials are minimized and are reasonable related to the anticipated benefits. The IRB also approves the informed consent form that must be provided to each clinical trial subject or his or her legal representative, and must monitor the clinical trial until completed. The FDA, the IRB, or the sponsor may suspend or discontinue a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk. There also are requirements governing the reporting of ongoing clinical trials and completed clinical trials to public registries. Information about clinical trials, including clinical trials results, must be submitted within specific timeframes for publication on the www.clinicaltrials.gov website. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">While we plan to conduct any international clinical trials under our INDs we obtain with the FDA in the future, a sponsor who wishes to conduct a clinical trial outside of the United States may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. If a foreign clinical trial is not conducted under an IND, the sponsor must submit data from the clinical trial to the FDA in support of an NDA. The FDA will accept a well-designed and well-conducted foreign clinical study not conducted under an IND if the study was conducted in accordance with GCP requirements, and the FDA is able to validate the data through an onsite inspection if deemed necessary. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Clinical trials to evaluate therapeutic indications to support NDAs for marketing approval are typically conducted in three sequential phases, which may overlap. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Phase 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;Phase 1 clinical trials involve initial introduction of the investigational product into healthy human volunteers or patients with the target disease or condition. These studies are typically designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, excretion the side effects associated with increasing doses, and, if possible, to gain early evidence of effectiveness.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Phase 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;Phase 2 clinical trials typically involve administration of the investigational product to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Phase 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;Phase 3 clinical trials typically involve administration of the investigational product to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval and physician labeling. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In August 2018, the FDA released a draft guidance entitled &#8220;Expansion Cohorts: Use in First-In-Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics,&#8221; which outlines how drug developers can utilize an adaptive trial design commonly referred to as a seamless trial design in early stages of oncology drug development (i.e., the first-in-human clinical trial) to compress the traditional three phases of trials into one continuous trial called an expansion cohort trial. Information to support the design of individual expansion cohorts are included in IND applications and assessed by FDA. Expansion cohort trials can potentially bring efficiency to drug development and reduce developmental costs and time. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Post-approval trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial marketing approval. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication and are commonly intended to generate additional safety data regarding use of the product in a clinical setting. In certain instances, the FDA may mandate the performance of Phase 4 clinical trials as a condition of approval of an NDA. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Progress reports detailing the results of the clinical trials, among other information, must be submitted at least annually to the FDA and written IND safety reports must be submitted to the FDA and the investigators fifteen days after the trial sponsor determines the information qualifies for reporting for serious and unexpected suspected adverse events, findings from other studies or animal or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> testing that suggest a significant risk for human volunteers and any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must also notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction as soon as possible but in no case later than seven calendar days after the sponsor&#8217;s initial receipt of the information. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Concurrent with clinical trials, companies usually complete additional animal studies and must also develop additional information about the chemistry and physical characteristics of the product candidate and finalize a process for manufacturing the drug product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and manufacturers must develop, among other things, methods for testing the identity, strength, quality and purity of the final drug product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">U.S. marketing approval for drugs </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Assuming successful completion of the required clinical testing, the results of the preclinical studies and clinical trials, together with detailed information relating to the product&#8217;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. An NDA is a request for approval to market a new drug for one or more specified indications and must contain proof of the drug&#8217;s safety and efficacy. The marketing application may include both negative and ambiguous results of preclinical studies and clinical trials, as well as positive findings. Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a product&#8217;s use or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of the FDA. FDA approval of an NDA must be obtained before a drug may be marketed in the United States. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The FDA reviews all submitted NDAs before it accepts them for filing, and may request additional information rather than accepting the NDA for filing. The FDA must make a decision on accepting an NDA for filing within 60 days of receipt, and such decision could include a refusal to file by the FDA. Once the submission is accepted for filing, the FDA begins an in-depth substantive review of the NDA. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective and whether the facility in which it is manufactured, processed, packaged or held meets standards designed to assure the product&#8217;s continued safety, quality and purity. Under the goals and polices agreed to by the FDA under the Prescription Drug User Fee Act, or PDUFA, the FDA targets ten months, from the filing date, in which to complete its initial review of a new molecular entity NDA and respond to the applicant, and six months from the filing date of a new molecular entity NDA for priority review. The FDA does not always meet its PDUFA goal dates for standard or priority NDAs, and the review process is often extended by FDA requests for additional information or clarification. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Further, under PDUFA, as amended, each NDA must be accompanied by a user fee. FDA adjusts the PDUFA user fees on an annual basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The FDA also may require submission of a Risk Evaluation and Mitigation Strategy, or REMS, plan to ensure that the benefits of the drug outweigh its risks. The REMS plan could include medication guides, physician communication plans, assessment plans, and/or elements to assure safe use, such as restricted distribution methods, patient registries, or other risk-minimization tools. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The FDA may refer an application for a novel drug to an advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the Sponsor product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with GCP and other requirements and the integrity of the clinical data submitted to the FDA. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a complete response letter. A complete response letter generally contains a statement of specific conditions that must be met in order to secure final approval of the NDA and may require additional clinical or preclinical testing in order for the FDA to reconsider the application. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#8217;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Even if the FDA approves a product, depending on the specific risk(s) to be addressed it may limit the approved indications for use of the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess a drug&#8217;s safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS, which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further testing requirements and FDA review and approval. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Orphan drug designation and exclusivity </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug intended to treat a rare disease or condition, which is a disease or condition that affects fewer than 200,000 individuals in the United States, or if it affects more than 200,000 individuals in the United States, there is no reasonable expectation that the cost of developing and making the product available in the United States for the disease or condition will be recovered from sales of the product. Orphan designation must be requested before submitting an NDA. Orphan designation does not convey any advantage in or shorten the duration of the regulatory review and approval process, though companies developing orphan products are eligible for certain incentives, including tax credits for qualified clinical testing and waiver of application fees. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a product that has orphan designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to a seven-year period of marketing exclusivity during which the FDA may not approve any other applications to market the same therapeutic agent for the same indication, except in limited circumstances, such as a subsequent product&#8217;s showing of clinical superiority over the product with orphan exclusivity or where the original applicant cannot produce sufficient quantities of product. Competitors, however, may receive approval of different therapeutic agents for the indication for which the orphan product has exclusivity or obtain approval for the same therapeutic agent for a different indication than that for which the orphan product has exclusivity. Orphan product exclusivity could block the approval of one of our products for seven years if a competitor obtains approval for the same therapeutic agent for the same indication before we do, unless we are able to demonstrate that our product is clinically superior. If an orphan designated product receives marketing approval for an indication broader than what is designated, it may not be entitled to orphan exclusivity. Further, orphan drug exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective or the manufacturer of the approved product is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Rare pediatric disease designation and priority review vouchers </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the FD&amp;C Act, the FDA incentivizes the development of drugs that meet the definition of a &#8220;rare pediatric disease,&#8221; defined to mean a serious or life-threatening disease in which the serious of life-threatening manifestations primarily affect individuals aged from birth to 18 years and the disease affects fewer than 200,000 individuals in the United States or affects more than 200,000 in the United States and for which there is no reasonable expectation that the cost of developing and making in the United States a drug for such disease or condition will be received from sales in the United States of such drug. The sponsor of a product candidate for a rare pediatric disease may be eligible for a voucher that can be used to obtain a priority review for a subsequent human drug application after the date of approval of the rare pediatric disease drug product, referred to as a priority review voucher, or PRV. A sponsor may request rare pediatric disease designation from the FDA prior to the submission of its NDA. A rare pediatric disease designation does not guarantee that a sponsor will receive a PRV upon approval of its NDA. Moreover, a sponsor who chooses not to submit a rare pediatric disease designation request may nonetheless receive a PRV upon approval of their marketing application if they request such a voucher in their original marketing application and meet all of the eligibility criteria. If a PRV is received, it may be sold or transferred an unlimited number of times. Congress has extended the PRV program through September 30, 2024, with potential for PRVs to be granted through September 30, 2026. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Expedited development and review programs for drugs </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The FDA maintains several programs intended to facilitate and expedite development and review of new drugs to address unmet medical needs in the treatment of serious or life-threatening diseases or conditions. These programs include Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval, and the purpose of these programs is to either expedite the development or review of important new drugs to get them to patients earlier than under standard FDA development and review procedures. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A new drug is eligible for Fast Track designation if it is intended to treat a serious or life-threatening disease or condition and demonstrates the potential to address unmet medical needs for such disease or condition. Fast Track designation provides increased opportunities for sponsor interactions with the FDA during preclinical and clinical development, in addition to the potential for rolling review once a marketing application is filed, meaning that the agency may review portions of the marketing application before the sponsor submits the complete application, as well as Priority Review, discussed below. In addition, a new drug may be eligible for Breakthrough Therapy designation if it is intended to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Breakthrough Therapy designation provides all the features of Fast Track designation in addition to intensive guidance on an efficient drug development program beginning as early as Phase 1, and FDA organizational commitment to expedited development, including involvement of senior managers and experienced review staff in a cross-disciplinary review, where appropriate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any product submitted to the FDA for approval, including a product with Fast Track or Breakthrough Therapy designation, may also be eligible for additional FDA programs intended to expedite the review and approval process, including Priority Review designation and accelerated approval. A product is eligible for Priority Review if it has the potential to provide a significant improvement in safety or effectiveness in the treatment, diagnosis or prevention of a serious disease or condition. Under priority review, the FDA must review an application in six months compared to ten months for a standard review. Additionally, products are eligible for accelerated approval if they can be shown to have an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or an effect on a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality which is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accelerated approval is usually contingent on a sponsor&#8217;s agreement to conduct additional post-approval studies to verify and describe the product&#8217;s clinical benefit. The FDA may withdraw approval of a drug or indication approved under accelerated approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, unless otherwise informed by the FDA, the FDA currently requires, as a condition for accelerated approval, that all advertising and promotional materials that are intended for dissemination or publication within 120 days following marketing approval be submitted to the agency for review during the pre-approval review period, and that after 120 days following marketing approval, all advertising and promotional materials must be submitted at least 30 days prior to the intended time of initial dissemination or publication. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or the time period for FDA review or approval may not be shortened. Furthermore, Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval do not change the scientific or medical standards for approval or the quality of evidence necessary to support approval but may expedite the development or review process. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Pediatric information and pediatric exclusivity </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the Pediatric Research Equity Act, or PREA, certain NDAs and certain supplements to an NDA must contain data to assess the safety and efficacy of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission of pediatric data or full or partial waivers. The Food and Drug Administration Safety and Innovation Act, or FDASIA, amended the FD&amp;C Act to require that a sponsor who is planning to submit a marketing application for a drug that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial Pediatric Study Plan, or PSP, within 60 days of an end-of-Phase 2 meeting or, if there is no such meeting, as early as practicable before the initiation of the Phase 3 or Phase 2/3 study. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach an agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials and/or other clinical development programs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A drug can also obtain pediatric market exclusivity in the United States. Pediatric exclusivity, if granted, adds six months to existing exclusivity periods and patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric study in accordance with an FDA-issued &#8220;Written Request&#8221; for such a study. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">U.S. post-approval requirements for drugs </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, reporting of adverse experiences with the product, complying with promotion and advertising requirements, which include restrictions on promoting products for unapproved uses or patient populations (known as &#8220;off-label use&#8221;) and limitations on industry-sponsored scientific and educational activities. Although physicians may prescribe legally available products for off-label uses, manufacturers may not market or promote such uses. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability, including investigation by federal and state authorities. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first use or first publication. Further, if there are any modifications to the drug, including changes in indications, labeling or manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new NDA or NDA supplement, which may require the development of additional data or preclinical studies and clinical trials. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-market testing, including Phase 4 clinical trials, and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, drug manufacturers and their subcontractors involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with ongoing regulatory requirements, including cGMP, which impose certain procedural and documentation requirements upon us and our contract manufacturers. Manufacturers and other parties involved in the drug supply chain for prescription drug products must also comply with product tracking and tracing requirements and for notifying the FDA of counterfeit, diverted, stolen and intentionally adulterated products or products that are otherwise unfit for distribution in the United States. Failure to comply with statutory and regulatory requirements can subject a manufacturer to possible legal or regulatory action, such as warning letters, suspension of manufacturing, product seizures, injunctions, civil penalties or criminal prosecution. There is also a continuing, annual prescription drug product program user fee. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, requirements for post-market studies or clinical trials to assess new safety risks, or imposition of distribution or other restrictions under a REMS. Other potential consequences include, among other things: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings or other safety information about the product;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">fines, warning letters or holds on post-approval clinical trials; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">refusal of the FDA to approve applications or supplements to approved applications, or suspension or revocation of product approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">product seizure or detention, or refusal to permit the import or export of products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">injunctions or the imposition of civil or criminal penalties; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs; or mandated modification of promotional materials and labeling and issuance of corrective information. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Regulation of companion diagnostics </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe that the success of certain of our product candidates may depend, in part, on the development and commercialization of a companion diagnostic. Companion diagnostics identify patients who are most likely to benefit from a particular therapeutic product; identify patients likely to be at increased risk for serious side effects as a result of treatment with a particular therapeutic product; or monitor response to treatment with a particular therapeutic product for the purpose of adjusting treatment to achieve improved safety or effectiveness. Companion diagnostics are regulated as medical devices by the FDA. In the United States, the FD&amp;C Act and its implementing regulations, and other federal and state statutes and regulations govern, among other things, medical device design and development, preclinical and clinical testing, premarket clearance or approval, registration and listing, manufacturing, labeling, storage, advertising and promotion, sales and distribution, export and import, and post-market surveillance. Unless an exemption or FDA exercise of enforcement discretion applies, diagnostic tests generally require marketing clearance or approval from the FDA prior to commercialization. The two primary types of FDA marketing authorization applicable to a medical device are clearance of a premarket notification, or 510(k), application, and approval of a premarket approval, or PMA, application. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To obtain 510(k) clearance for a medical device, or for certain modifications to devices that have received 510(k) clearance, a manufacturer must submit a premarket notification demonstrating that the proposed device is substantially equivalent to a previously cleared 510(k) device or to a preamendment device that was in commercial distribution before May 28, 1976, or a predicate device, for which the FDA has not yet called for the submission of a PMA. In making a determination that the device is substantially equivalent to a predicate device, the FDA compares the proposed device to the predicate device or predicate devices and assesses whether the subject device is comparable to the predicate device or predicate devices with respect to intended use, technology, design and other features which could affect safety and effectiveness. If the FDA determines that the subject device is substantially equivalent to the predicate device or predicate devices, the subject device may be cleared for marketing. The 510(k) premarket notification pathway generally takes from three to twelve months from the date the application is completed, but can take significantly longer. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PMA applications must be supported by valid scientific evidence, which typically requires extensive data, including technical, preclinical, clinical and manufacturing data, to demonstrate to the FDA&#8217;s satisfaction the safety and effectiveness of the device. For diagnostic tests, a PMA application typically includes data regarding analytical and clinical validation studies. As part of its review of the PMA, the FDA will conduct a pre-approval inspection of the manufacturing facility or facilities to ensure compliance with the Quality System Regulation, or QSR, which requires manufacturers to follow design, testing, control, documentation and other quality assurance procedures. The FDA&#8217;s review of an initial PMA application is required by statute to take between six to ten months, although the process typically takes longer, and may require several years to complete. If the FDA evaluations of both the PMA application and the manufacturing facilities are favorable, the FDA will either issue an approval letter or an approvable letter, which usually contains a number of conditions that must be met in order to secure the final approval of the PMA. If the FDA&#8217;s evaluation of the PMA or manufacturing facilities is not favorable, the FDA will deny the approval of the PMA or issue a not approvable letter. A not approvable letter will outline the deficiencies in the application and, where practical, will identify what is necessary to make the PMA approvable. Once granted, PMA approval may be withdrawn by the FDA if compliance with post-approval requirements, conditions of approval or other regulatory standards is not maintained or problems are identified following initial marketing. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On July 31, 2014, the FDA issued a final guidance document addressing the development and approval process for &#8220;In Vitro Companion Diagnostic Devices.&#8221; According to the guidance document, for novel therapeutic products that depend on the use of a diagnostic test and where the diagnostic device could be essential for the safe and effective use of the corresponding therapeutic product, the premarket application for the companion diagnostic device should be developed and approved or cleared contemporaneously with the therapeutic, although the FDA recognizes that there may be cases when contemporaneous development may not be possible. However, in cases where a drug cannot be used safely or effectively without the companion diagnostic, the FDA&#8217;s guidance indicates it will generally not approve the drug without the approval or clearance of the diagnostic device. The FDA also issued a draft guidance in July 2016 setting forth the principles for co-development of an in vitro companion diagnostic device with a therapeutic product. The draft guidance describes principles to guide the development and contemporaneous marketing authorization for the therapeutic product and its corresponding in vitro companion diagnostic. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Once cleared or approved, the companion diagnostic device must adhere to post-marketing requirements including the requirements of the FDA&#8217;s quality system regulation, adverse event reporting, recalls and corrections along with product marketing requirements and limitations. Like drug makers, companion diagnostic makers are subject to unannounced FDA inspections at any time during which the FDA will conduct an audit of the product(s) and the company&#8217;s facilities for compliance with its authorities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Other regulatory matters </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Manufacturing, sales, promotion and other activities of product candidates following product approval, where applicable, or commercialization are also subject to regulation by numerous regulatory authorities in the United States in addition to the FDA, which may include the Centers for Medicare &amp; Medicaid Services, or CMS, other divisions of the Department of Health and Human Services, or HHS, the Department of Justice, the Drug Enforcement Administration, the Consumer Product Safety Commission, the Federal Trade Commission, the Occupational Safety &amp; Health Administration, the Environmental Protection Agency and state and local governments and governmental agencies. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Other healthcare and privacy laws </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Healthcare providers, physicians, and third-party payors will play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. Our business operations and any current or future arrangements with third-party payors, healthcare providers and physicians may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we develop, market, sell and distribute any drugs for which we obtain marketing approval. In the United States, these laws include, without limitation, state and federal anti-kickback, false claims, physician transparency, and patient data privacy and security laws and regulations, including but not limited to those described below. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">The federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, receiving or providing remuneration (including any kickback, bribe, or rebate), directly or indirectly in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, lease, order, arrangement or recommendation of, any good, facility, item or service, for which payment may be made under federal and state healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute (AKS) or specific intent to violate it to have committed a violation. Violations are subject to civil and criminal fines and penalties for each violation, plus up to three times the remuneration involved, imprisonment, and exclusion from government healthcare programs. In addition, the government may assert that a claim including items or services resulting from a violation of the AKS constitutes a false or fraudulent claim for purposes of the federal False Claims Act (FCA) or federal civil money penalties. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">The federal civil and criminal false claims laws, including the FCA, and civil monetary penalty laws which can be enforced through civil whistleblower or qui tam actions, which imposes civil and criminal penalties against individuals or entities for knowingly presenting or causing to be presented, to the federal government, claims for payment or approval from Medicare, Medicaid or other government payors that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay to the federal government, with potential liability including mandatory treble damages and significant per-claim penalties. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims. The FCA also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">The federal Health Insurance Portability and Accountability Act of 1996 (HIPAA), which prohibits, among other things, knowingly and willfully executing or attempting to execute, a scheme or artifice to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private), and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false, fictitious or fraudulent statements in connection with the delivery of or payment for, healthcare benefits, items or services relating to healthcare benefits, items or services relating to healthcare matters. Similar to the AKS, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">HIPAA, as further amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH) and their respective implementing regulations, including the Final Omnibus Rule published in January 2013, which impose certain requirements, including mandatory contractual terms,  on covered entities subject to the rule, such as health plans, healthcare clearinghouses and certain healthcare providers, as well as their respective business associates and their subcontractors that perform services for them that involve the creation, maintenance, receipt, use, or disclosure of, individually identifiable health information, relating to the privacy, security, and transmission of such individually identifiable health information relating to the privacy, security and transmission of individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. In addition, there may be additional federal, state and non-U.S. laws which govern the privacy and security of health and other personal information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">The U.S. Physician Payments Sunshine Act and its implementing regulations, which requires certain manufacturers of drugs, devices, biologics and medical supplies that are reimbursable under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program, with specific exceptions, to report annually to CMS information related to certain payments and other transfers of value to physicians, nurse practitioners, certified nurse anesthetists, physician assistants, clinical nurse specialists, and certified nurse midwives as well as teaching hospitals. Manufacturers are also required to disclose ownership and investment interests held by physicians and their immediate family members. Effective January 1, 2022, these reporting obligations extend to include transfers of value made to certain non-physician providers (physician assistants, nurse practitioners clinical nurse specialists, certified registered nurse anesthetists and anesthesiologist assistants, and certified-nurse midwives). In addition, many states also require reporting of payments or other transfers of value, many of which differ from each other in significant ways, are often not pre-empted, and may have a more prohibitive effect than the Sunshine Act, thus further complicating compliance efforts. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Federal government price reporting laws, which require us to calculate and report complex pricing metrics in an accurate and timely manner to government programs. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm customers. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, we are subject to state and foreign equivalents of each of the healthcare laws and regulations described above, among others, some of which may be broader in scope and may apply regardless of the payor. Many U.S. states have adopted laws similar to the AKS and FCA, and may apply to our business practices, including, but not limited to, research, distribution, sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental payors, including private insurers. In addition, some states have passed laws that require pharmaceutical companies to comply with the April 2003 Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers and/or the Pharmaceutical Research and Manufacturers of America&#8217;s Code on Interactions with Healthcare Professionals. Several states also impose other marketing restrictions or require pharmaceutical companies to make marketing or price disclosures to the state and require the registration of pharmaceutical sales representatives. State and foreign laws, including for example the EU General Data Protection Regulation (GDPR), which became effective May 2018 also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. There are ambiguities as to what is required to comply with these state requirements and if we fail to comply with an applicable state law requirement we could be subject to penalties. Finally, there are state and foreign laws governing the privacy and security of health information, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is prohibited in the EU. The provision of benefits or advantages to physicians is also governed by the national anti-bribery laws of EU Member States, such as the UK Bribery Act 2010. Violation of these laws could result in substantial fines and imprisonment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Payments made to physicians in certain EU Member States must be publicly disclosed. Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#8217;s employer, his or her competent professional organization and/or the regulatory authorities of the individual EU Member States. These requirements are provided in the national laws, industry codes or professional codes of conduct applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The scope and enforcement of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations.  Federal and state enforcement has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Ensuring that our internal operations and future business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations, agency guidance or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of the laws described above or any other governmental laws and regulations that may apply to us, we may be subject to significant penalties, including administrative, civil and criminal penalties, damages, fines, disgorgement, the exclusion from participation in federal and state healthcare programs, reputational harm, and the curtailment or restructuring of our operations, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws. Further, defending against any such actions can be costly and time-consuming, and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. If any of the physicians or other providers or entities with whom we expect to do business are found to not be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs and individual imprisonment. If any of the above occur, our ability to operate our business and our results of operations could be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Insurance Coverage and Reimbursement </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the United States and markets in other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Thus, even if a product candidate is approved, sales of the product will depend, in part, on the extent to which third-party payors, including government health programs in the United States such as Medicare and Medicaid, commercial health insurers and managed care organizations, provide coverage, and establish adequate reimbursement levels for, the product. In the United States, the principal decisions about reimbursement for new medicines are typically made by the CMS, an agency within HHS. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree. No uniform policy of coverage and reimbursement for drug products exists among third-party payors. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. The process for determining whether a third-party payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are increasingly challenging the prices charged, examining the medical necessity, and reviewing the cost-effectiveness of medical products and services and imposing controls to manage costs. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the approved products for a particular indication. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of the product, in addition to the costs required to obtain FDA or other comparable regulatory approvals. Additionally, companies may also need to provide discounts to purchasers, private health plans or government healthcare programs. Nonetheless, product candidates may not be considered medically necessary or cost effective. A decision by a third-party payor not to cover a product could reduce physician utilization once the product is approved and have a material adverse effect on sales, our operations and financial condition. Additionally, a third-party payor&#8217;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage and reimbursement for the product, and the level of coverage and reimbursement can differ significantly from payor to payor. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The containment of healthcare costs has become a priority of federal, state and foreign governments, and the prices of products have been a focus in this effort. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#8217;s revenue generated from the sale of any approved products. Coverage policies and third-party payor reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which a company or its collaborators receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. Further, due to the ongoing COVID-19 pandemic, millions of individuals have lost or will be losing employer-based insurance coverage, which may adversely affect our ability to commercialize our products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Current and future healthcare reform legislation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the United States and some foreign jurisdictions, there have been, and likely will continue to be, a number of legislative and regulatory changes and proposed changes regarding the healthcare system directed at broadening the availability of healthcare, improving the quality of healthcare, and containing or lowering the cost of healthcare. For example, in March 2010, the United States Congress enacted the ACA, which, among other things, includes changes to the coverage and payment for products under government health care programs. The ACA includes provisions of importance to our potential product candidates that: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">created an annual, nondeductible fee on any entity that manufactures or imports specified branded prescription drugs and biologic products, apportioned among these entities according to their market share in certain government healthcare programs; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">expanded eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to certain individuals with income at or below 133% of the federal poverty level, thereby potentially increasing a manufacturer&#8217;s Medicaid rebate liability; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">expanded manufacturers&#8217; rebate liability under the Medicaid Drug Rebate Program by increasing the minimum rebate for both branded and generic drugs and revising the definition of &#8220;average manufacturer price,&#8221; or AMP, for calculating and reporting Medicaid drug rebates on outpatient prescription drug prices; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">expanded the types of entities eligible for the 340B drug discount program; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">established the Medicare Part D coverage gap discount program by requiring manufacturers to provide point-of-sale-discounts off the negotiated price of applicable brand drugs to eligible beneficiaries during their coverage gap period as a condition for the manufacturers&#8217; outpatient drugs to be covered under Medicare Part D; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Since its enactment, there have been judicial, Congressional and executive challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#8217;s decision, President Biden issued an executive order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how other healthcare reform measures of the Biden administration or other efforts, if any, to challenge, repeal or replace the ACA will impact our business. Other legislative changes have been proposed and adopted in the United States since the ACA was enacted:  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In August 2011, the Budget Control Act of 2011, among other things, included aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect in April 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2030, unless additional Congressional action is taken. Pursuant to the Coronavirus Aid, Relief, and Economic Security Act, also known as the CARES Act, as well as subsequent legislation, these reductions have been suspended from May 1, 2020 through March 31, 2022 due to the ongoing COVID-19 pandemic. Following the temporary suspension, a 1% payment reduction will occur beginning April 1, 2022 through June 30, 2022, and the 2% payment reduction will resume on July 1, 2022. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">In January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">On April 13, 2017, CMS published a final rule that gives states greater flexibility in setting benchmarks for insurers in the individual and small group marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">On May 30, 2018, the Right to Try Act, was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a pharmaceutical manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">On&#8239;May 23, 2019, CMS published a final rule to allow Medicare Advantage Plans the option of using step therapy for Part B drugs beginning January 1, 2020. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">On December 20, 2019, former President Trump signed into law the Further Consolidated Appropriations Act (H.R. 1865), which repealed the Cadillac tax, the health insurance provider tax, and the medical device excise tax.  It is impossible to determine whether similar taxes could be instated in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, there has been increasing legislative and enforcement interest in the United States with respect to drug pricing practices.  Specifically, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, and review the relationship between pricing and manufacturer patient programs.  At the federal level, President Biden signed an Executive Order on July 9, 2021 affirming the administration&#8217;s policy to (i) support legislative reforms that would lower the prices of prescription drug and biologics, including by allowing Medicare to negotiate drug prices, by imposing inflation caps, and, by supporting the development and market entry of lower-cost generic drugs and biosimilars; and (ii) support the enactment of a public health insurance option. Among other things, the Executive Order also directs HHS to provide a report on actions to combat excessive pricing of prescription drugs, enhance the domestic drug supply chain, reduce the price that the Federal government pays for drugs, and address price gouging in the industry; and directs the FDA to work </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with states and Indian Tribes that propose to develop section 804 Importation Programs in accordance with the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, and the FDA&#8217;s implementing regulations. FDA released such implementing regulations on September 24, 2020, which went into effect on November 30, 2020, providing guidance for states to build and submit importation plans for drugs from Canada. On September 25, 2020, CMS stated drugs imported by states under this rule will not be eligible for federal rebates under Section 1927 of the Social Security Act and manufacturers would not report these drugs for &#8220;best price&#8221; or Average Manufacturer Price purposes. Since these drugs are not considered covered outpatient drugs, CMS further stated it will not publish a National Average Drug Acquisition Cost for these drugs. If implemented, importation of drugs from Canada may materially and adversely affect the price we receive for any of our product candidates. Further, on November 20, 2020 CMS issued an Interim Final Rule implementing the Most Favored Nation, or MFN, Model under which Medicare Part B reimbursement rates would have been be calculated for certain drugs and biologicals based on the lowest price drug manufacturers receive in Organization for Economic Cooperation and Development countries with a similar gross domestic product per capita.  However, on December 29, 2021 CMS rescinded the Most Favored Nations rule. Additionally, on November 30, 2020, HHS published a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers. Pursuant to court order, the removal and addition of the aforementioned safe harbors were delayed and recent legislation imposed a moratorium on implementation of the rule until January 1, 2026. Although a number of these and other proposed measures may require authorization through additional legislation to become effective, and the Biden administration may reverse or otherwise change these measures, both the Biden administration and Congress have indicated that they will continue to seek new legislative measures to control drug costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Outside the United States, ensuring coverage and adequate payment for a product also involves challenges. Pricing of prescription pharmaceuticals is subject to government control in many countries. Pricing negotiations with government authorities can extend well beyond the receipt of regulatory approval for a product and may require a clinical trial that compares the cost-effectiveness of a product to other available therapies. The conduct of such a clinical trial could be expensive and result in delays in commercialization. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Some of our manufacturers are located outside of the United States. There is currently significant uncertainty about the future relationship between the U.S. and various other countries, including China, with respect to trade policies, treaties, government regulations and tariffs. Increased tariffs could potentially disrupt our existing supply chains and impose additional costs on our business. Additionally, it is possible further tariffs may be imposed that could affect imports of active pharmaceutical ingredients, or APIs, used in our product candidates, or our business may be adversely impacted by retaliatory trade measures taken by China or other countries, including restricted access to such raw materials used in our product candidates. Given the unpredictable regulatory environment in China and the U.S. and uncertainty regarding how the U.S. or foreign governments will act with respect to tariffs, international trade agreements and policies, further governmental action related to tariffs, additional taxes, regulatory changes or other retaliatory trade measures in the future could occur with a corresponding detrimental impact on our business and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the EU, pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the cost-effectiveness of a particular product candidate to currently available therapies or so-called health technology assessments, in order to obtain reimbursement or pricing approval. For example, the EU provides options for its Member States to restrict the range of products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. EU Member States may approve a specific price for a product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other Member States allow companies to fix their own prices for products, but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. Recently, many countries in the EU have increased the amount of discounts required on pharmaceuticals and these efforts could continue as countries attempt to manage healthcare expenditures, especially in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">light of the severe fiscal and debt crises experienced by many countries in the EU. The downward pressure on healthcare costs in general, particularly prescription products, has become intense. As a result, increasingly high barriers are being erected to the entry of new products. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various EU Member States, and parallel trade, i.e., arbitrage between low-priced and high-priced member states, can further reduce prices. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any products, if approved in those countries. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Compliance with other federal and state laws or requirements; changing legal requirements </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If any products that we may develop are made available to authorized users of the Federal Supply Schedule of the General Services Administration, additional laws and requirements apply. Products must meet applicable child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act. Manufacturing, labeling, packaging, distribution, sales, promotion and other activities also are potentially subject to federal and state consumer protection and unfair competition laws, among other requirements to we may be subject. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The distribution of pharmaceutical products is subject to additional requirements and regulations, including extensive record-keeping, licensing, storage and security requirements intended to prevent the unauthorized sale of pharmaceutical products. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The failure to comply with any of these laws or regulatory requirements subjects firms to possible legal or regulatory action. Depending on the circumstances, failure to meet applicable regulatory requirements can result in criminal prosecution, fines or other penalties, injunctions, exclusion from federal healthcare programs, requests for recall, seizure of products, total or partial suspension of production, denial or withdrawal of product approvals, relabeling or repackaging, or refusal to allow a firm to enter into supply contracts, including government contracts. Any claim or action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. Prohibitions or restrictions on marketing, sales or withdrawal of future products marketed by us could materially affect our business in an adverse way. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to product labeling or packaging; (iii) the recall or discontinuation of our products; or (iv) additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Other U.S. environmental, health and safety laws and regulations </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may be subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. From time to time and in the future, our operations may involve the use of hazardous and flammable materials, including chemicals and biological materials, and may also produce hazardous waste products. Even if we contract with third parties for the disposal of these materials and waste products, we cannot completely eliminate the risk of contamination or injury resulting from these materials. In the event of contamination or injury resulting from the use or disposal of our hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees, but this insurance may not provide adequate coverage against potential liabilities. However, we do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. Current or future environmental laws and regulations may impair our research, development or production efforts. In addition, failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Government regulation of drugs outside of the United States </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To market any product outside of the United States, we would need to comply with numerous and varying regulatory requirements of other countries regarding safety and efficacy and governing, among other things, clinical trials, marketing authorization or identification of an alternate regulatory pathway, manufacturing, commercial sales and distribution of our products. For instance, in the EU, medicinal products, are subject to extensive pre- and post-market regulation by regulatory authorities at both the EU and national levels. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Centralized procedure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;If pursuing marketing authorization of a product candidate for a therapeutic indication under the centralized procedure, following the opining of the European Medicines Agency&#8217;s, or EMA, Committee for Medicinal Products for Human Use, or CHMP, the European Commission issues a single marketing authorization valid across the EU, and in the additional Member States of the European Economic Area (Iceland, Liechtenstein and Norway). The centralized procedure is compulsory for human medicines derived from biotechnology processes or advanced therapy medicinal products (such as gene therapy, somatic cell therapy and tissue engineered products), products that contain a new active substance indicated for the treatment of certain diseases, such as HIV, AIDS, cancer, neurodegenerative disorders, diabetes, autoimmune diseases and other immune dysfunctions, viral diseases, and designated orphan medicines. For medicines that do not fall within these categories, an applicant has the option of submitting an application for a centralized marketing authorization to the EMA, as long as the medicine concerned contains a new active substance not yet authorized in the EU, is a significant therapeutic, scientific or technical innovation, or if its authorization would be in the interest of public health in the EU. Under the centralized procedure the maximum timeframe for the evaluation of a marketing authorization application, or MAA, by the EMA is 210 days, excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP. Clock stops may extend the timeframe of evaluation of an MAA considerably beyond 210 days. Where the CHMP gives a positive opinion, it provides the opinion together with supporting documentation to the European Commission, who makes the final decision to grant a marketing authorization, which is issued within 67 days of receipt of the EMA&#8217;s recommendation. Accelerated assessment might be granted by the CHMP in exceptional cases, when a medicinal product is expected to be of a major public health interest, particularly from the point of view of therapeutic innovation. If the CHMP accepts such request, the time limit of 210 days will be reduced to 150 days, excluding clock stops, but it is possible that the CHMP may revert to the standard time limit for the centralized procedure if it determines that the application is no longer appropriate to conduct an accelerated assessment. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">National authorization procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;There are also two other possible routes to authorize products for therapeutic indications in several countries, which are available for products that fall outside the scope of the centralized procedure: </span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.11pt">Decentralized procedure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;Using the decentralized procedure, an applicant may apply for simultaneous authorization in more than one EU country of medicinal products that have not yet been authorized in any EU country and that do not fall within the mandatory scope of the centralized procedure. </span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.11pt">Mutual recognition procedure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8212;In the mutual recognition procedure, a medicine is first authorized in one EU Member State, in accordance with the national procedures of that country. Following this, additional marketing authorizations can be sought from other EU countries in a procedure whereby the countries concerned recognize the validity of the original, national marketing authorization. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the above described procedures, before granting the marketing authorization, the EMA or the competent authorities of the Member States of the EU make an assessment of the risk-benefit balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Now that the United Kingdom (which comprises Great Britain and Northern Ireland) has left the European Union, Great Britain will no longer be covered by centralized marketing authorizations (under the Northern Ireland Protocol, centralized marketing authorizations will continue to be recognized in Northern Ireland). All medicinal products with a current centralized marketing authorization were automatically converted to Great Britain marketing authorizations on January 1, 2021. For a period of two years from January 1, 2021, the Medicines and Healthcare products Regulatory Agency, or MHRA, the UK medicines regulator, may rely on a decision taken by the European Commission on the approval of a new marketing authorization in the centralized procedure, in order to more quickly grant a new Great Britain marketing authorization. A separate application will, however, still be required. The MHRA also has the power to have regard to marketing authorizations approved in EU Member States through decentralized or mutual recognition procedures with a view to more quickly granting a marketing authorization in the United Kingdom or Great Britain.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the EU, new products for therapeutic indications that are authorized for marketing (i.e., reference products) qualify for eight years of data exclusivity and an additional two years of market exclusivity upon marketing authorization. The data exclusivity period, if granted, prevents generic or biosimilar applicants from relying on the preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization in the EU for a period of eight years from the date on which the reference product was first authorized in the EU. During the additional two-year period of market exclusivity, a generic or biosimilar marketing authorization can be submitted, and the innovator&#8217;s data may be referenced, but no generic or biosimilar product can be marketed in the EU until the expiration of the market exclusivity period. The ten-year market exclusivity period can be extended to a maximum of eleven years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with currently approved therapies. There is no guarantee that a product will be considered by the EMA to be an innovative medicinal product, and products may not qualify for data exclusivity. Even if a product is considered to be an innovative medicinal product so that the innovator gains the prescribed period of data exclusivity, another company could nevertheless also market another version of the product if such company obtained a marketing authorization based on an MAA with a complete, independent data package of pharmaceutical tests, preclinical tests and clinical trials.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The criteria for designating an &#8220;orphan medicinal product&#8221; in the EU are similar in principle to those in the United States. In the EU a medicinal product may be designated as orphan medicinal product if it meets the following criteria: (1) it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition; (2) either (a) such condition affects no more than five in 10,000 persons in the EU when the application is made, or (b) without the benefits derived from orphan status, it is unlikely that the marketing of the medicine would generate sufficient return in the EU to justify the necessary investment in its development; and (3) there exists no satisfactory method of diagnosis, prevention or treatment of such condition authorized for marketing in the EU, or if such a method exists, the product would be of significant benefit to those affected by that condition. Orphan medicinal products are eligible for financial incentives such as reduction of fees or fee waivers and are, upon grant of a marketing authorization, entitled to ten years of market exclusivity for the approved therapeutic indication. During this ten-year orphan market exclusivity period, no MAA shall be accepted, and no marketing authorization shall be granted for a similar medicinal product. A &#8220;similar medicinal product&#8221; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. An orphan product can also obtain an additional two years of market exclusivity in the EU for pediatric studies. The ten-year market exclusivity may be reduced to six years if, at the end of the fifth year, it is established that the product no longer meets the criteria for orphan designation, for example, if the product is sufficiently profitable not to justify maintenance of market exclusivity. Otherwise, orphan medicine marketing exclusivity may be revoked only in very select cases, such as if (i) it is established that a similar medicinal product is safer, more effective or otherwise clinically superior to the authorized product; (ii) the marketing authorization holder of the authorized orphan product consents to a second orphan medicinal product application; or (iii) the marketing </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">authorization holder of the authorized orphan product cannot supply enough orphan medicinal product. Orphan designation must be requested before submitting an application for marketing approval. Orphan designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Since January 1, 2021, a separate process for orphan designation has applied in Great Britain. There is now no pre-marketing authorization orphan designation (as there is in the EU) in Great Britain and the application for orphan designation will be reviewed by the MHRA at the time of an MAA for a UK or Great Britain marketing authorization. The criteria for orphan designation are the same as in the EU, save that they apply to Great Britain only (e.g. there must be no satisfactory method of diagnosis, prevention or treatment of the condition concerned in Great Britain, as opposed to the EU, and the prevalence of the relevant condition must not be more than 5 in 10,000 in Great Britain). In May 2017, the EU adopted the Regulation (EU) 2017/746 on in vitro diagnostic medical devices, or IVDR, which will become applicable on 26 May 2022 and will repeal Directive 98/79/EC on in vitro diagnostic medical devices. Devices that comply with the requirements of the IVDR will be entitled to bear the CE conformity marking, indicating that the device conforms to the general safety and performance requirements of the IVDR, and, accordingly, can be commercially distributed throughout the EU (in-vitro diagnostic medical devices cannot be marketed in the EU without a CE Mark). The method of assessing conformity varies depending on the class of the product, but normally involves a third-party assessment by a &#8220;Notified Body&#8221;. This third-party assessment may consist of an audit of the manufacturer&#8217;s quality system and specific testing of the manufacturer&#8217;s product.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Similar to the United States, the various phases of non-clinical and clinical research in the EU are subject to significant regulatory controls. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In April 2014, the new Clinical Trials Regulation, (EU) No 536/2014 (Clinical Trials Regulation) was adopted, which replaced the Clinical Trials Directive 2011/20/EC on January 31, 2022. The Clinical Trials Regulation is directly applicable in all the EU Member States, meaning no national implementing legislation is required. The transitory provisions of the new Regulation offer sponsors the possibility to choose between the requirements of the previous Directive and the new Regulation if the request for authorization of a clinical trial is submitted in the year after the new Regulation became applicable. If a clinical trial continues for more than three years from the day on which the Clinical Trials Regulation became applicable the Clinical Trials Regulation will at that time begin to apply to the clinical trial. The new Clinical Trials Regulation aims to simplify and streamline the approval of clinical trials in the EU. The main characteristics of the regulation include: a streamlined application procedure via a single-entry point, the Clinical Trials Information Systems, or &#8220;CTIS&#8221;; a single set of documents to be prepared and submitted for the application as well as simplified reporting procedures for clinical trial sponsors; and a harmonized procedure for the assessment of applications for clinical trials, which is divided in two parts. Part I is assessed by coordinated assessment of the competent authorities of all EU Member States in which an application for authorization of a clinical trial has been submitted (Member States concerned), of the review of a Reference Member State. Part II is assessed separately by each Member State concerned. Strict deadlines have been established for the assessment of clinical trial applications. The role of the relevant ethics committees in the assessment procedure will continue to be governed by the national law of the concerned EU Member State. However, overall related timelines will be defined by the Clinical Trials Regulation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The aforementioned EU rules are generally applicable in the European Economic Area, or EEA, which consists of the EU Member States, plus Norway, Liechtenstein and Iceland.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The collection and use of personal health data in the EEA, previously governed by the provisions of the Data Protection Directive, is now governed by the General Data Protection Regulation, or the GDPR, which became effective on May 25, 2018. While the Data Protection Directive did not apply to organizations based outside the EEA, the GDPR has expanded its reach to include any business, regardless of its location, that provides goods or services to residents in the EU. This expansion would incorporate any clinical trial activities in EU Members States. The GDPR imposes strict requirements on controllers and processors of personal data, including special protections for &#8220;sensitive information&#8221; which includes health and genetic information of data subjects residing in the EEA. GDPR grants individuals the opportunity to object to the processing of their personal information, allows them to request deletion of personal information in certain circumstances, and provides the individual with an express right to seek legal remedies </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the event the individual believes his or her rights have been violated. Further, the GDPR imposes strict rules on the transfer of personal data out of the EEA to the United States or other regions that have not been deemed to offer &#8220;adequate&#8221; privacy protections. Failure to comply with the requirements of the GDPR and the related national data protection laws of the EEA Member States, which may deviate slightly from the GDPR, may result in fines of up to 4% of global revenues, or &#8364;20 million, whichever is greater. As a result of the implementation of the GDPR, we may be required to put in place additional mechanisms ensuring compliance with the new data protection rules. In addition, further to the UK&#8217;s exit from the EU on January 31, 2020, the GDPR ceased to apply in the UK at the end of the transition period on December 31, 2020. However, as of January 1, 2021, the UK&#8217;s European Union (Withdrawal) Act 2018 incorporated the GDPR (as it existed on December 31, 2020 but subject to certain UK specific amendments) into UK law, referred to as the UK GDPR. The UK GDPR and the UK Data Protection Act 2018 set out the UK&#8217;s data protection regime, which is independent from but aligned to the EU&#8217;s data protection regime. Non-compliance with the UK GDPR may result in monetary penalties of up to &#163;17.5 million or 4% of worldwide revenue, whichever is higher. Although the UK is regarded as a third country under the EU&#8217;s GDPR, the European Commission has now issued a decision recognizing the UK as providing adequate protection under the EU GDPR and, therefore, transfers of personal data originating in the EU to the UK remain unrestricted. Like the EU GDPR, the UK GDPR restricts personal data transfers outside the UK to countries not regarded by the UK as providing adequate protection. The UK government has confirmed that personal data transfers from the UK to the EEA remain free flowing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There is significant uncertainty related to the manner in which data protection authorities will seek to enforce compliance with GDPR. For example, it is not clear if the authorities will conduct random audits of companies doing business in the EEA, or if the authorities will wait for complaints to be filed by individuals who claim their rights have been violated. Enforcement uncertainty and the costs associated with ensuring GDPR compliance are onerous and may adversely affect our business, financial condition, results of operations and prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Should we utilize third party distributors, compliance with such foreign governmental regulations would generally be the responsibility of such distributors, who may be independent contractors over whom we have limited control. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Brexit and the Regulatory Framework in the United Kingdom </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On June 23, 2016, the electorate in the United Kingdom voted in favor of leaving the European Union (commonly referred to as &#8220;Brexit&#8221;). The United Kingdom formally left the European Union on January 31, 2020. There was an initial transitional period, during which European Union&#8217;s rules continued to apply in the United Kingdom, which ended on December 31, 2020. The United Kingdom and European Union have signed a European Union-United Kingdom Trade and Cooperation Agreement, or the TCA, which was provisionally applicable since January 1, 2021 and has been formally applicable since May 1, 2021. The TCA  includes specific provisions concerning pharmaceuticals, which include the mutual recognition of GMP, inspections of manufacturing facilities for medicinal products and GMP documents issued, but does not foresee wholesale mutual recognition of UK and EU pharmaceutical regulations. At present, Great Britain has implemented EU legislation on the marketing, promotion and sale of medicinal products through the Human Medicines Regulations 2012 (as amended) (under the Northern Ireland Protocol, the EU regulatory framework will continue to apply in Northern Ireland). The regulatory regime in Great Britain therefore largely aligns with current EU regulations, however it is possible that these regimes will diverge in the future now that Great Britain&#8217;s regulatory system is independent from the EU and the TCA does not provide for mutual recognition of UK and EU pharmaceutical legislation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Human Capital Resources</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to achieve the goals and expectations of our Company, it is crucial that we continue to attract and retain top talent. To facilitate talent attraction and retention, we strive to make Black Diamond a safe and rewarding workplace, with opportunities for our employees to grow and develop in their careers, supported by strong compensation, benefits and health and wellness programs, and by programs that build connections between our employees. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March 1, 2022, we had 88 full-time employees. 29 of our employees have Ph.D. degrees. The following table shows the number of full-time employees as of March 1, 2022 engaged in either research and development or administrative functions, broken out by location. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Function</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Canada</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Black Diamond is committed to a culture of diversity, equity and inclusion. This commitment is reflected in our corporate goals and underpins our social, cultural, and philanthropic initiatives. We focus on diverse recruiting strategies and work collaboratively with external organizations to attract, retain and develop diverse talent by ensuring we have a culture of inclusivity for all. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2021, approximately 63% of our new hires came from underrepresented categories including women and racial or ethnic minorities. As of March 1, 2022, approximately 52% of the Company's workforce, and 47% of our employees in managerial roles, identified as female. As of March 1, 2022, approximately 25% of our workforce, and 21% of our employees in managerial roles, identified as racially or ethnically diverse.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The success of our business is fundamentally connected to the well-being of our employees. Accordingly, we are committed to their health, safety and wellness. We provide our employees and their families with access to a variety of innovative, flexible and convenient health and wellness programs, including benefits that provide protection and security so they can have peace of mind concerning events that may require time away from work or that impact their financial well-being; that support their physical and mental health by providing tools and resources to help them improve or maintain their health status and encourage engagement in healthy behaviors; and that offer choice where possible so they can customize their benefits to meet their needs and the needs of their families. In response to the ongoing COVID-19 pandemic, we implemented significant changes that we determined were in the best interest of our employees, as well as the communities in which we operate, and which comply with government regulations. This includes having most of our non-laboratory employees work from home, while implementing additional safety measures for employees continuing critical on-site work.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We provide robust compensation and benefits programs to help meet the needs of our employees. In addition to salaries, these programs include potential annual discretionary bonuses, stock awards, a 401(k) Plan, healthcare and insurance benefits, health savings and flexible spending accounts, paid time off, family leave, and flexible work schedules, among others. In addition to our broad-based equity award programs, we have used targeted equity-based grants with vesting conditions to facilitate retention of personnel.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Facilities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We lease a facility containing approximately 25,578 square feet of office space for our principal office, which is located at One Main Street, Cambridge, MA 02142. The lease expires on August 31, 2028, subject to an option to extend the lease for five additional years. We also lease approximately 18,120 square feet of office and laboratory space at 430 East 29th Street, New York, New York 10016. The lease expires on June 30, 2032, subject to an option to extend the lease for five additional years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe that our current facilities are adequate for our current needs and that suitable additional or substitute space at commercially reasonable terms will be available as needed to accommodate any future expansion of our operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Legal proceedings</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. As of the date of this Annual Report, we were not a party to, or aware of, any material legal matters or claims. In the future, we may become party to legal matters and claims in the ordinary course of business, the resolution of which we do not anticipate would have a material adverse impact on our financial position, results of operations or cash flows. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Corporate Information</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We were formed as an LLC in December 2014 and we converted to a corporation in September 2016 under the laws of the State of Delaware under the name ASET Therapeutics, Inc. On January 2, 2018, we changed our name to Black Diamond Therapeutics, Inc. Our principal executive offices are located at One Main Street, Cambridge, MA 02142, and our telephone number is 617-252-0848. We have two subsidiaries, Black Diamond Therapeutics (Canada) Inc., which was incorporated in 2018, and Black Diamond Therapeutics Security Corporation, which was incorporated in 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012. We will remain an emerging growth company until the earlier of: (i) the last day of the fiscal year (a) following the fifth anniversary of the completion of the initial public offering (&#8220;IPO&#8221;), (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30th, and (ii) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Financial Information and Segments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The financial information required under this Item 1 is incorporated herein by reference to the section of this Annual Report titled &#8220;Part II&#8212;Item 8&#8212;Financial Statements and Supplementary Data.&#8221; The company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company&#8217;s singular focus is the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations. See Note 2 to our consolidated audited financial statements included in this Annual Report. For financial information regarding our business, see &#8220;Part II&#8212;Item 7&#8212;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of this Annual Report and our consolidated audited financial statements and related notes included elsewhere in this Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our Internet address is www.blackdiamondtherapeutics.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, including exhibits, proxy and information statements and amendments to those reports filed or furnished pursuant to Sections 13(a), 14, and 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, are available through the &#8220;Investors &amp; News&#8221; portion of our website free of charge as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information on our website is not part of this Annual Report or any of our other securities filings unless specifically incorporated herein by reference. We have included our website address in this Annual Report solely as an inactive textual reference. Our filings with the SEC may be accessed through the SEC&#8217;s Interactive Data Electronic Applications system at http://www.sec.gov. All statements made in any of our securities filings, including all forward-looking statements or information, are made as of the date of the document in which the statement is included, and we do not assume or undertake any obligation to update any of those statements or documents unless we are required to do so by law.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">55</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Careful consideration should be given to the following risk factors, in addition to the other information set forth in this Annual Report and in other documents that we file with the SEC, in evaluating the Company and our business. Investing in our common stock involves a high degree of risk. If any of the following risks and uncertainties actually occurs, our business, prospects, financial condition and results of operations could be materially and adversely affected. The risks and uncertainties summarized and described below are not intended to be exhaustive and are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business, prospects, financial condition and results of operations. Certain statements in this Annual Report are forward-looking statements. Please also see the section entitled &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks related to the development of our product candidates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to clinical development</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We are very early in our development efforts and are substantially dependent on our clinical-stage product candidates, BDTX-1535 and BDTX-189. If we are unable to advance BDTX-1535, BDTX-189 or any of our other product candidates through clinical development, obtain regulatory approval and ultimately commercialize BDTX-1535 or BDTX-189 or any of our other product candidates, or experience significant delays in doing so, our business will be materially harmed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are very early in our development efforts. Most of our product candidates are still in preclinical development and have never been tested in human subjects. Our ability to generate product revenues, which we do not expect will occur for many years, if ever, will depend heavily on the successful clinical development and eventual commercialization of BDTX-1535, BDTX-189 and one or more of our other product candidates. In addition, our drug development programs contemplate the development of companion diagnostics, which are assays or tests to identify an appropriate patient population. Companion diagnostics are subject to regulation as medical devices and must themselves be approved for marketing by the FDA or certain other foreign regulatory agencies before we may commercialize our product candidates. The success of our product candidates will depend on several factors, including the following: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">successful completion of preclinical studies; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">approval of INDs for our planned clinical trials or future clinical trials; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">FDA acceptance of our tumor-agnostic development strategy; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">successful initiation of clinical trials; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">successful patient enrollment in and completion of clinical trials; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">successful development of companion diagnostics for use with our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">safety, tolerability and efficacy profiles for our product candidates that are satisfactory to the FDA or any foreign regulatory authority for marketing approval; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">receipt of marketing approvals for our product candidates and any companion diagnostics from applicable regulatory authorities; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the extent of any required post-marketing approval commitments to applicable regulatory authorities; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtaining and maintaining patent and trade secret protection and regulatory exclusivity for our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">making arrangements with third-party manufacturers, or establishing manufacturing capabilities, for both clinical and commercial supplies of our product candidates, if any product candidates are approved; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">establishing sales, marketing and distribution capabilities and launching commercial sales of our products, if and when approved, whether alone or in collaboration with others; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">acceptance of our products, if and when approved, by patients, the medical community and third-party payors; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">effectively competing with other cancer therapies; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtaining and maintaining third-party coverage and adequate reimbursement;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">maintaining a continued acceptable safety profile of our products following approval; and</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">factors we may not be able to control, such as current or potential pandemics that may limit patients, principal investigators or staff or clinical site availability (e.g. the ongoing COVID-19 pandemic).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There is no guarantee that the results obtained in current preclinical studies or our open-label clinical trial of BDTX-1535 or BDTX-189 will be sufficient to obtain regulatory approval or marketing authorization for such product candidates. Negative results in the development of our lead product candidates may also impact our ability to obtain regulatory approval for our other product candidates, either at all or within anticipated timeframes because, although other product candidates may target different indications, the underlying technology platform, manufacturing process and development process is the same for all of our product candidates. Accordingly, a failure in any one program may affect the ability to obtain regulatory approval to continue or conduct clinical programs for other product candidates. For example, although we believe based on our preclinical studies that the conformational change to the active site receptor is similar for all of the genetic mutations we are targeting and therefore the chemical structures of our lead product candidates will suffice to bind adequately to such receptor for all such mutations, this may not prove true in clinical testing for all or any of the targeted mutations. Moreover, anti-tumor activity may be different in each of the different tumor types we plan on evaluating in the clinical trial. Therefore, the tumor response may be low in patients with some cancers compared to others. This may result in discontinuation of development of a product candidate for patients with these tumor types and/or mutations due to insufficient clinical benefit while continuing development for a more limited population of patients more likely to benefit. As a consequence, we may have to negotiate with the FDA to reach agreement on defining the optimal patient population, study design and size in order to obtain regulatory approval, any of which may require significant additional resources and delay the timing of our clinical trials and ultimately the approval, if any, of any of our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, because we have limited financial and personnel resources and are placing significant focus on the development of our clinical-stage product candidates, we may forgo or delay pursuit of opportunities with other future product candidates that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs and other future product candidates for specific indications may not yield any commercially viable future product candidates. If we do not accurately evaluate the commercial potential or target market for a particular future product candidate, we may relinquish valuable rights to those future product candidates through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such future product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Difficulty in enrolling patients could delay or prevent clinical trials of our product candidates. We may find it difficult to enroll patients in our Phase 1 clinical trial for BDTX-1535 or our open-label Phase 1/2 clinical trial for BDTX-189 with the genetic mutations these product candidates are designed to target. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Identifying and qualifying patients to participate in clinical studies of our product candidates is critical to our success. The timing of completion of our clinical studies depends in part on the speed at which we can recruit patients to participate in testing our product candidates, and we may experience delays in our clinical trials if we encounter difficulties in enrollment. We may not be able to initiate or continue clinical trials for our product candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA or similar regulatory authorities outside the United States. In particular, because we are focused on patients with specific genetic mutations, our ability to enroll eligible patients may be limited or may result in slower enrollment than we anticipate. For example, for both BDTX-1535 and BDTX-189, we cannot be certain how many patients will have each of the genetic mutations that these product candidates are designed to target or that the number of patients enrolled for each mutation will suffice for regulatory approval and inclusion of each such mutation in the approved label. In addition, some of our competitors have ongoing clinical trials for product candidates that treat the same indications as our product candidates, and patients who would otherwise be eligible for our clinical trials may instead enroll in clinical trials of our competitors&#8217; product candidates. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the potentially small populations, the eligibility criteria of our planned clinical trials will further limit the pool of available study participants as we will require that patients have specific characteristics that we can measure to assure their disease is either severe enough or not too advanced to include them in a study. Additionally, the process of finding and diagnosing patients may prove costly. We also may not be able to identify, recruit and enroll a sufficient number of patients to complete our clinical studies because of the perceived risks and benefits of the product candidate under study, the availability and efficacy of competing therapies and clinical trials, the proximity and availability of clinical study sites for prospective patients, the availability of genetic sequencing information for patient tumors so that we can identify patients with the targeted genetic mutations, and the patient referral practices of physicians. If patients are unwilling to participate in our studies for any reason, the timeline for recruiting patients, conducting studies and obtaining regulatory approval of potential products may be delayed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We intend to engage third parties to develop companion diagnostics for use in our clinical trials, but such third parties may not be successful in developing such companion diagnostics, furthering the difficulty in identifying patients with the targeted genetic mutations for our clinical trials. Further, if we are unable to include patients with the targeted genetic mutations, this could compromise our ability to seek participation in FDA&#8217;s expedited review and development programs, including Breakthrough Therapy Designation and Fast Track Designation, or otherwise seek to accelerate clinical development and regulatory timelines. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The enrollment of patients further depends on many factors, including: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the proximity of patients to clinical trial sites; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the design of the clinical trial; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to recruit clinical trial investigators with the appropriate competencies and experience; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to obtain and maintain patient consents; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">impacts of the ongoing COVID-19 pandemic on clinical trial site activation;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">reporting of the preliminary results of any of our clinical trials; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the risk that patients enrolled in clinical trials will drop out of the clinical trials before clinical trial completion. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, our clinical trials will compete with other clinical trials for product candidates that are in the same therapeutic areas as our product candidates, and this competition will reduce the number and types of patients available to us because some patients who might have opted to enroll in our clinical trials may instead opt to enroll in a clinical trial being conducted by one of our competitors. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our clinical trials at such clinical trial sites. Moreover, because our product candidates represent a departure from more commonly used methods for cancer treatment and because most of our product candidates have not been tested in humans before, potential patients and their doctors may be inclined to use conventional therapies, such as chemotherapy, rather than enroll patients in any future clinical trial. Additionally, because our clinical trials are in patients with relapsed/refractory cancer, the patients are typically in the late stages of their disease and may experience disease progression independent from our product candidates, making them unevaluable for purposes of the clinical trial and requiring additional patient enrollment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If we experience delays in the completion of, or termination of, any clinical trial of our product candidates, the commercial prospects of our product candidates will be harmed, and our ability to generate product revenue from any of these product candidates could be delayed or prevented. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We have limited experience as a company in conducting clinical trials. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have limited experience as a company in conducting clinical trials. In part because of this limited experience, we cannot be certain that our ongoing preclinical studies will be completed on time or if the planned preclinical studies and clinical trials will begin or be completed on time, if at all. Large-scale clinical trials would require significant additional financial and management resources and reliance on third-party clinical investigators, contract research organizations, or CROs, and consultants. Relying on third-party clinical investigators, CROs and consultants may force us to encounter delays that are outside of our control. We may be unable to identify and contract with sufficient investigators, CROs and consultants on a timely basis or at all. For BDTX-1535 and BDTX-189, we have entered into master services agreements with CROs to conduct our first-in-human clinical trials. There can be no assurance that we will be able to negotiate and enter into any additional master services agreement with other CROs, as necessary, on terms that are acceptable to us on a timely basis or at all. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our preclinical studies and clinical trials may fail to demonstrate adequately the safety, potency, purity and efficacy of any of our product candidates, which would prevent or delay development, regulatory approval and commercialization. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Before obtaining regulatory approvals for the commercial sale of our product candidates, including BDTX-1535 and BDTX-189, we must demonstrate through lengthy, complex and expensive preclinical studies and clinical trials that our product candidates are both safe and effective for use in each target indication. Preclinical and clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the preclinical study and clinical trial processes, and, because our product candidates are in an early stage of development, there is a high risk of failure and we may never succeed in developing marketable products. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The results of preclinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. Although product candidates may demonstrate promising results in preclinical studies and early clinical trials, they may not prove to be effective in subsequent clinical trials. For example, testing on animals occurs under different conditions than testing in humans and therefore, the results of animal studies may not accurately predict human experience. There is typically an extremely high rate of attrition from the failure of product candidates proceeding through preclinical studies and clinical trials. Product candidates in later stages of clinical trials may fail to show the desired safety, potency, purity and efficacy profile despite having progressed through preclinical studies and initial clinical trials. Likewise, early, smaller-scale clinical trials may not be predictive of eventual safety or effectiveness in large-scale pivotal clinical trials. A number of companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of potency or efficacy, insufficient durability of potency or efficacy or unacceptable safety issues, notwithstanding promising results in earlier trials. Most product candidates that commence preclinical studies and clinical trials are never approved as products. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any preclinical studies or clinical trials that we may conduct may not demonstrate the safety, potency, purity and efficacy necessary to obtain regulatory approval to market our product candidates. If the results of our ongoing or future preclinical studies and clinical trials are inconclusive with respect to the safety, potency, purity and efficacy of our product candidates, if we do not meet the clinical endpoints with statistical and clinically meaningful significance, or if there are safety concerns associated with our product candidates, we may be prevented or delayed in obtaining marketing approval for such product candidates. In some instances, there can be significant variability in safety, potency, purity or efficacy results between different preclinical studies and clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the clinical trial protocols and the rate of dropout among clinical trial participants. As is the case with all oncology drugs, it is likely that there may be side effects associated with their use. Results of our trials could reveal a high and unacceptable severity and prevalence of these or other side effects. In such an event, our trials could be suspended or terminated and the FDA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of our product candidates for any or all targeted indications. Drug-related side effects could also affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may harm our business, financial condition and prospects significantly. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, our product candidates could cause undesirable side effects in clinical trials related to on-target toxicity. For example, other EGFR inhibitors have experienced dose limiting toxicities due to rash in patients and, although we have designed our product candidates to be &#8220;wild-type&#8221; sparing to limit the risk of similar toxicities, clinical results may differ and patients may also experience similar or different toxicities that limit the dose and/or efficacy of our product candidates. If on-target toxicity is observed, or if our product candidates have characteristics that are unexpected, we may need to abandon their development or limit development to more narrow uses or subpopulations in which the undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. Many compounds that initially showed promise in early stage testing for treating cancer have later been found to cause side effects that prevented further development of the compound. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to file INDs or IND amendments to commence additional clinical trials on the timelines we expect, and even if we are able to, the FDA may not permit us to proceed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We submitted an IND for BDTX-189 in November 2019, which was allowed by the FDA on December 13, 2019. Further, we submitted an IND for BDTX-1535 in December 2021, which was allowed by the FDA on January 6, 2022. However, we may not be able to file INDs for our other product candidates on the timelines we expect. For example, we may experience manufacturing delays or other delays with IND-enabling studies. Moreover, we cannot be sure that submission of an IND will result in the FDA allowing further clinical trials to begin, or that, once begun, issues will not arise that suspend or terminate clinical trials. Additionally, even if such regulatory authorities agree with the design and implementation of the clinical trials set forth in an IND, we cannot guarantee that such regulatory authorities will not change their requirements in the future. These considerations also apply to new clinical trials we may submit as amendments to existing INDs or to a new IND. Any failure to file INDs on the timelines we expect or to obtain regulatory approvals for our trials may prevent us from completing our clinical trials or commercializing our products on a timely basis, if at all. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Failure to successfully validate, develop and obtain regulatory approval for companion diagnostics for our product candidates could harm our drug development strategy and operational results. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As one of the central elements of our business strategy and approach, we seek to screen and identify subsets of patients with a genetic alteration who may derive meaningful benefit from our development product candidates. To achieve this, our product development program is dependent on the development and commercialization of a companion diagnostic by us or by third party collaborators. Companion diagnostics are developed in conjunction with clinical programs for the associated product and are subject to regulation as medical devices. Each agency that approves a product candidate will independently need to approve the companion diagnostic before or concurrently with its approval of the product candidate, and before a product can be commercialized. The approval of a companion diagnostic as part of the product label will also limit the use of the product candidate to only those patients who express the specific genetic alteration it was developed to detect. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Companion diagnostics are subject to regulation by the FDA and comparable foreign regulatory authorities as medical devices and require separate clearance or approval prior to their commercialization. To date, the FDA has required premarket approval for nearly all companion diagnostics for cancer therapies. We and our third-party collaborators may encounter difficulties in developing and obtaining approval for these companion diagnostics. Any delay or failure by us or third- party collaborators to develop or obtain regulatory approval of a companion diagnostic could delay or prevent approval of our related product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Since the number of patients that we plan to dose in our Phase 1 clinical trial of BDTX-1535 and our Phase 1/2 clinical trial of BDTX-189 is small, the results from such clinical trials, once completed, may be less reliable than results achieved in larger clinical trials, which may hinder our efforts to obtain regulatory approval for our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The number of patients that we plan to dose in our initial clinical trials is small.  The preliminary results of clinical trials with smaller sample sizes can be disproportionately influenced by various biases associated with the conduct of small clinical trials, such as the potential failure of the smaller sample size to accurately depict the features of the broader patient population, which limits the ability to generalize the results across a broader community, thus making </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the clinical trial results less reliable than clinical trials with a larger number of patients. As a result, there may be less certainty that such product candidates would achieve a statistically significant effect in any future clinical trials. If we conduct any future clinical trials of BDTX-1535 or BDTX-189, we may not achieve a statistically significant result or the same level of statistical significance, if any, that we might have anticipated based on the results observed in our initial clinical trials. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, clinical trials by their nature utilize a sample of the potential patient population. With a limited number of patients and limited duration of exposure, rare and severe side effects of our product candidates may only be uncovered with a significantly larger number of patients exposed to the drug candidate. If our product candidates receive marketing approval and we or others identify undesirable side effects caused by such product candidates (or any other similar drugs) after such approval, a number of potentially significant negative consequences could result, including: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">regulatory authorities may withdraw or limit their approval of such product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">regulatory authorities may require the addition of labeling statements, such as a &#8220;boxed&#8221; warning or a contraindication; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may be required to change the way such product candidates are distributed or administered, conduct additional clinical trials or change the labeling of the product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">regulatory authorities may require a REMS plan to mitigate risks, which could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may be subject to regulatory investigations and government enforcement actions; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may decide to remove such product candidates from the marketplace; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we could be sued and held liable for injury caused to individuals exposed to or taking our product candidates; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our reputation may suffer. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We believe that any of these events could prevent us from achieving or maintaining market acceptance of the affected product candidates and could substantially increase the costs of commercializing our product candidates, if approved, and significantly impact our ability to successfully commercialize our product candidates and generate revenues. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Clinical development involves a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future clinical trial results. We may encounter substantial delays in clinical trials, or may not be able to conduct or complete clinical trials on the expected timelines, if at all. If our preclinical studies and clinical trials are not sufficient to support regulatory approval of any of our product candidates, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development of such product candidate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All of our lead product candidates are in early clinical development or in preclinical development and their risk of failure is high. It is impossible to predict when or if any of our product candidates will prove effective and safe in humans or will receive regulatory approval. Before obtaining marketing approval from regulatory authorities for the sale of any drug candidate, we must complete preclinical studies and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in humans. A failure of one or more clinical trials can occur at any stage of testing. The outcome of preclinical development testing and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates. Our preclinical studies and future clinical trials may not be successful. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We cannot be certain that our preclinical study and clinical trial results will be sufficient to support regulatory approval of our product candidates. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Human clinical trials are expensive and difficult to design and implement, in part because they are subject to rigorous regulatory requirements. Failure or delay can occur at any time during the clinical trial process. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, some of the clinical trials we conduct may be open-label in study design and may be conducted at a limited number of clinical sites on a limited number of patients. An &#8220;open-label&#8221; clinical trial is one where both the patient and investigator know whether the patient is receiving the investigational product candidate or either an existing approved drug or placebo. Most typically, open-label clinical trials test only the investigational product candidate and sometimes may do so at different dose levels. Open-label clinical trials are subject to various limitations that may exaggerate any therapeutic effect as patients in open-label clinical trials are aware when they are receiving treatment. Open-label clinical trials may be subject to a &#8220;patient bias&#8221; where patients perceive their symptoms to have improved merely due to their awareness of receiving an experimental treatment. Moreover, patients selected for early clinical studies often include the most severe sufferers and their symptoms may have been bound to improve notwithstanding the new treatment. In addition, open-label clinical trials may be subject to an &#8220;investigator bias&#8221; where those assessing and reviewing the physiological outcomes of the clinical trials are aware of which patients have received treatment and may interpret the information of the treated group more favorably given this knowledge. Given that our Phase 1 clinical trial of BDTX-1535 and our Phase 1/2 clinical trial of BDTX-189 include an open-label dosing design, the results from these clinical trials may not be predictive of future clinical trial results with these or other product candidates for which we conduct an open-label clinical trial when studied in a controlled environment with a placebo or active control. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may experience delays in obtaining the FDA&#8217;s authorization to initiate clinical trials under future INDs, completing ongoing preclinical studies of our other product candidates, and initiating our planned preclinical studies and clinical trials. Additionally, we cannot be certain that preclinical studies or clinical trials for our product candidates will begin on time, not require redesign, enroll an adequate number of subjects on time, or be completed on schedule, if at all. For example, at a meeting with the FDA in March 2021, the FDA notified us that, because the then planned Phase 2 portion of our ongoing clinical trial of BDTX-189 would be potentially registrational and support a new drug application, we could only enroll up to 50 patients in Phase 2 before results of routine three-month good laboratory practice, or GLP, toxicology studies have been submitted and accepted by the FDA. This partial clinical hold on Phase 2 enrollment was not based on any safety findings from the MasterKey-01 trial and has no impact on completion of our Phase 1 study (including the currently enrolling safety expansion cohort). We have completed the three-month GLP toxicology studies and submitted the reports to the FDA who accepted the findings and lifted the partial clinical hold in January 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Clinical trials can be delayed or terminated for a variety of reasons, including delays or failures related to: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the FDA or comparable foreign regulatory authorities disagreeing as to the design or implementation of our clinical trials; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the FDA or comparable foreign regulatory authorities disagreeing with our tumor-agnostic development strategy; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">delays in obtaining regulatory approval to commence a clinical trial; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">reaching agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtaining IRB approval at each clinical trial site; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">recruiting an adequate number of suitable patients to participate in a clinical trial; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the number of patients required for clinical trials of our product candidates may be larger than we anticipate; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">having subjects complete a clinical trial or return for post-treatment follow-up; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">clinical trial sites deviating from clinical trial protocol or dropping out of a clinical trial; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">addressing subject safety concerns that arise during the course of a clinical trial; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">adding a sufficient number of clinical trial sites; or </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtaining sufficient product supply of product candidate for use in preclinical studies or clinical trials from third-party suppliers. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may experience numerous adverse or unforeseen events during, or as a result of, preclinical studies and clinical trials that could delay or prevent our ability to receive marketing approval or commercialize our product candidates, including: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may receive feedback from regulatory authorities that requires us to modify the design of our clinical trials; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon our research efforts for our other product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">clinical trials of our product candidates may not produce differentiated or clinically significant results across tumor types or indications; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the number of patients required for clinical trials of our product candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate or participants may drop out of our clinical trials at a higher rate than we anticipate; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our third-party contractors may fail to comply with regulatory requirements, fail to maintain adequate quality controls or be unable to provide us with sufficient product supply to conduct and complete preclinical studies or clinical trials of our product candidates in a timely manner, or at all; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we or our investigators might have to suspend or terminate clinical trials of our product candidates for various reasons, including non-compliance with regulatory requirements, a finding that our product candidates have undesirable side effects or other unexpected characteristics or a finding that the participants are being exposed to unacceptable health risks; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the cost of clinical trials of our product candidates may be greater than we anticipate, for example, if we experiences delays or challenges in identifying patients with the mutations required for our clinical trials, we may have to reimburse sites for genetic sequencing costs in order to encourage sequencing of additional patients; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the quality of our product candidates or other materials necessary to conduct preclinical studies or clinical trials of our product candidates may be insufficient or inadequate, and any transfer of manufacturing activities may require unforeseen manufacturing or formulation changes; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">regulators may revise the requirements for approving our product candidates, or such requirements may not be as we anticipate; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">future collaborators may conduct clinical trials in ways they view as advantageous to them but that are suboptimal for us. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If we are required or choose to conduct additional clinical trials or other testing of our product candidates beyond those that we currently contemplate, if we are unable to successfully complete clinical trials of our product candidates or other testing, if the results of these trials or tests are not positive or are only moderately positive or if there are safety concerns, our business and results of operations may be adversely affected and we may incur significant additional costs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We could also encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions in which such clinical trials are being conducted, by the Data Safety Monitoring Board, if any, for such clinical trial or by the FDA or other regulatory authorities. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical trial protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from the product candidates, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Moreover, principal investigators for our future clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or comparable foreign regulatory authorities. The FDA or comparable foreign regulatory authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA or comparable foreign regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of one or more of our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If we experience delays in the completion, or termination, of any preclinical study or clinical trial of our product candidates, the commercial prospects of our product candidates may be harmed, and our ability to generate revenues from any of these product candidates will be delayed or not realized at all. In addition, any delays in completing our preclinical studies or clinical trials may increase our costs, slow down our product candidate development and approval process and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates. If one or more of our product candidates generally prove to be ineffective, unsafe or commercially unviable, our entire pipeline and MAP drug discovery engine could have little, if any, value, which would have a material and adverse effect on our business, financial condition, results of operations and prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may conduct clinical trials for product candidates outside the United&#160;States, and the FDA and comparable foreign regulatory authorities may not accept data from such trials. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may choose to conduct one or more clinical trials outside the United States, including in Europe. The acceptance of study data from clinical trials conducted outside the United States or another jurisdiction by the FDA or comparable foreign regulatory authority may be subject to certain conditions or may not be accepted at all. In cases where data from foreign clinical trials are intended to serve as the basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (i)&#160;the data are applicable to the U.S. population and U.S. medical practice; and (ii)&#160;the trials were performed by clinical investigators of recognized competence and pursuant to GCP regulations. Additionally, the FDA&#8217;s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory authorities have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA or any comparable foreign regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. If the FDA or any comparable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which could be costly and time-consuming, and which may result in product candidates that we may develop not receiving approval for commercialization in the applicable jurisdiction. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to our approach</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our discovery and preclinical development is focused on the development of precision medicines for patients with genetically defined cancers, which is a rapidly evolving area of science, and the approach we are taking to discover and develop drugs is novel and may never lead to marketable products. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The discovery and development of precision medicines for patients with genetically defined cancers is an emerging field, and the scientific discoveries that form the basis for our efforts to discover and develop product candidates are relatively new. The scientific evidence to support the feasibility of developing product candidates based on these discoveries is both preliminary and limited. Although we believe, based on our preclinical work, that the mutations targeted by our programs are oncogenic drivers, clinical results may not confirm this hypothesis or may only confirm it for certain mutations or certain tumor types. The patient populations for our product candidates are limited to those with specific target mutations and may not be completely defined but are substantially smaller than the general treated </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">cancer population, and we will need to screen and identify these patients with the targeted mutations. Successful identification of patients is dependent on several factors, including achieving certainty as to how specific genetic alterations respond to our product candidates and developing companion diagnostics to identify such genetic alterations. Furthermore, even if we are successful in identifying patients, we cannot be certain that the resulting patient populations for each mutation will be large enough to allow us to successfully obtain approval for each mutation type and commercialize our products and achieve profitability. In addition, even if our approach is successful in showing clinical benefit for tumors harboring the targeted mutations affecting the ErbB proteins EGFR and HER2, we may never successfully identify additional oncogenic mutations for other receptor tyrosine kinases. Therefore, we do not know if our approach of treating patients with genetically defined cancers will be successful, and if our approach is unsuccessful, our business will suffer. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we are pursuing a tumor-agnostic development strategy (i.e., pursuing approval based on a biomarker rather than a specific cancer indication). There is currently a limited number of approved tumor-agnostic therapies. We may not receive approval for a tumor-agnostic indication or may be delayed in receiving tumor-agnostic approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our approach to the discovery and development of product candidates is unproven, and we may not be successful in our efforts to use and expand our MAP drug discovery engine to build a pipeline of product candidates with commercial value. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A key element of our strategy is to use and expand our MAP drug discovery engine to build a pipeline of product candidates and progress these product candidates through clinical development for the treatment of various cancers. Although our research and development efforts to date have resulted in our discovery and development of BDTX-1535 and BDTX-189, these clinical-stage candidates may not be safe or effective as cancer treatments, and we may not be able to develop any other product candidates. Our MAP drug discovery engine is evolving and may not reach a state at which building a pipeline of product candidates is possible. For example, we may not be successful in identifying additional genetic mutations which are oncogenic and which can be &#8220;basketed&#8221; into a group that is large enough to present a sufficient commercial opportunity or that is druggable with one chemical compound. Even if we are successful in building our pipeline of product candidates, the potential product candidates that we identify may not be suitable for clinical development or generate acceptable clinical data, including as a result of being shown to have unacceptable toxicity or other characteristics that indicate that they are unlikely to be products that will receive marketing approval from the FDA or other regulatory authorities or achieve market acceptance. If we do not successfully develop and commercialize product candidates, we will not be able to generate product revenue in the future, which likely would result in significant harm to our financial position and adversely affect our stock price. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">The market opportunities for our product candidates may be relatively small as it will be limited to those patients who are ineligible for or have failed prior treatments and our estimates of the prevalence of our target patient populations may be inaccurate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cancer therapies are sometimes characterized as first line, second line, or third line, and the FDA often approves new therapies initially only for a particular line of use. When cancer is detected early enough, first line therapy is sometimes adequate to cure the cancer or prolong life without a cure. Whenever first line therapy, usually chemotherapy, antibody drugs, tumor-targeted small molecules, hormone therapy, radiation therapy, surgery, or a combination of these, proves unsuccessful, second line therapy may be administered. Second line therapies often consist of more chemotherapy, radiation, antibody drugs, tumor-targeted small molecules, or a combination of these. Third line therapies can include chemotherapy, antibody drugs and small molecule tumor-targeted therapies, more invasive forms of surgery and new technologies. We expect to initially seek approval of our product candidates in most instances at least as a second or third line therapy, for use in patients with relapsed or refractory metastatic cancer. Subsequently, for those product candidates that prove to be sufficiently safe and beneficial, if any, we would expect to seek approval as a second line therapy and potentially as a first line therapy, but there is no guarantee that our product candidates, even if approved as a second or third or subsequent line of therapy, would be approved for an earlier line of therapy, and, prior to any such approvals, we may have to conduct additional clinical trials. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our projections of both the number of people who have the cancers we are targeting, who may have their tumors genetically sequenced, as well as the subset of people with these cancers in a position to receive a particular line of therapy and who have the potential to benefit from treatment with our product candidates, are based on our beliefs and estimates. These estimates have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations or market research, and may prove to be incorrect. Further, new therapies may change the estimated incidence or prevalence of the cancers that we are targeting. Consequently, even if our product candidates are approved for a second or third line of therapy, the number of patients that may be eligible for treatment with our product candidates may turn out to be much lower than expected. In addition, we have not yet conducted market research to determine how treating physicians would expect to prescribe a product that is approved for multiple tumor types if there are different lines of approved therapies for each such tumor type. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to the ongoing COVID-19 pandemic</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Business or economic disruptions or global health concerns could seriously harm our development efforts and increase our costs and expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Broad-based business or economic disruptions could adversely affect our ongoing or planned research and development activities. The ongoing COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, travel restrictions and other public health safety measures. The continued spread of COVID-19 or other global health matters, has impacted and may continue to impact our target patient populations as well as the hospitals and clinical sites in which we conduct any of our clinical trials, which could lead to delays in completing enrollment of our clinical trials. For instance, the COVID-19 outbreak may continue to impair our ability to recruit and retain patients and engage principal investigators and site staff who, as healthcare providers, may have heightened exposure to COVID-19 if an outbreak occurs in their geography or due to prioritization of hospital resources toward the outbreak and restrictions on travel. Furthermore, some patients may be unwilling to enroll in our trials or be unable to comply with clinical trial protocols if quarantines or travel restrictions impede patient movement or interrupt healthcare services. COVID-19 already has affected and may further negatively affect the operations of third party contract research organizations that we rely upon to carry out our discovery work, clinical trials or the operations of our third party manufacturers, which could result in delays or disruptions in the supply of our product candidates and the conduct of experiments and studies. Any negative impact COVID-19 has to patient enrollment or treatment or the timing and execution of our preclinical studies or clinical trials could cause costly delays to our development programs, which could adversely affect our ability to obtain regulatory approval for and to commercialize our product candidates, increase our operating expenses and have a material adverse effect on our business and financial results. COVID-19 has also caused, and may continue to cause for an extended period, volatility in the global financial markets and threatened a slowdown in the global economy, which would reduce our ability to access capital and could negatively affect our liquidity.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">While our lab-based employees have returned to our labs with enhanced safety measures, our office-based employees continue to work primarily from home and we expect this to continue for an extended period. Furthermore, there has been a resurgence of COVID-19 cases, which could prompt a reinstatement of &#8220;shelter-in-place&#8221; orders and restrictions at the state and local levels impacting our reentry to the workplace and causing hospital and clinical sites to suspend our clinical trials or could deter patients from continuing to participate in our trials.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Since the beginning of the COVID-19 pandemic, three vaccines for COVID-19 have received Emergency Use Authorization by the FDA and two of those later received marketing approval. Additional vaccines may be authorized or approved in the future. The resultant demand for vaccines and potential for manufacturing facilities and materials to be commandeered under the Defense Production Act of 1950, or equivalent foreign legislation, may make it more difficult to obtain materials or manufacturing slots for the products needed for our clinical trials, which could lead to delays in these trials.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The global outbreak of COVID-19 continues to rapidly evolve. The extent to which COVID-19 impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the duration of the outbreak, new information that may emerge concerning the severity of COVID-19, new strains of the virus, including the Delta and Omicron variants and any future variants that may emerge, which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines, or the extent and effectiveness of actions taken in the United States and other countries to contain COVID-19 or treat its impact, including vaccination campaigns and lockdown measures, among others. In addition, recurrences or additional waves of COVID-19 cases could cause other widespread or more severe impacts depending on where infection rates are highest. We cannot presently predict the scope and severity of any potential business shutdowns or disruptions, but if we or any of the third parties with whom we engage, including the suppliers, clinical trial sites, service providers, regulators and other third parties with whom we conduct business, were to experience prolonged business shutdowns or other business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively impacted.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We or third parties upon whom we depend may be adversely affected by natural disasters and/or global health pandemics, and our business, financial condition and results of operations could be adversely affected. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The occurrence of unforeseen or catastrophic events, including extreme weather events and other natural disasters, man-made disasters, or the emergence of epidemics or pandemics, depending on their scale, may cause different degrees of damage to the national and local economies and could cause a disruption in our operations and have a material adverse effect on our financial condition and results of operations. Man-made disasters, pandemics, and other events connected with the regions in which we operate could have similar effects. If a natural disaster, health pandemic, or other event beyond our control occurred that prevented us from using all or a significant portion of our office and/or lab spaces, damaged critical infrastructure, such as our manufacturing facilities or our manufacturing facilities of our third-party contract manufacturers, or that otherwise disrupted operations, it may be difficult for us to continue our business for a substantial period of time.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to manufacturing and supply</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing our product candidates is complex and we may encounter difficulties in production. We will rely on third parties to manufacture our preclinical and clinical product supplies, and we may rely on third parties to produce and process our product candidates, if approved. If we encounter such difficulties, our ability to provide supply of our product candidates for preclinical studies and clinical trials or for commercial purposes could be delayed or stopped. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The process of manufacturing of our product candidates is complex and highly regulated. We do not currently own any facility that may be used as our clinical scale manufacturing facility and expect to rely on outside vendors to manufacture supplies of our product candidates. We will need to negotiate and maintain contractual arrangements with these outside vendors for the supply of our product candidates and we may not be able to do so on favorable terms. We have not yet caused any product candidates to be manufactured on a commercial scale. Our contract manufacturers may incorporate their own proprietary processes into our product candidate manufacturing processes. We have limited control and oversight of a third party&#8217;s contract manufacturer&#8217;s proprietary process, and a third party contract manufacturer may elect to modify its process without our consent or knowledge. These modifications could negatively impact our manufacturing, including product loss or failure that requires additional manufacturing runs or a change in manufacturer, both of which could significantly increase the cost of and significantly delay the manufacture of our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As our product candidates progress through preclinical studies and clinical trials towards approval and commercialization, it is expected that various aspects of the manufacturing process will be altered in an effort to optimize processes and results. Such changes may require amendments to be made to regulatory applications which may further delay the timeframes under which modified manufacturing processes can be used for any of our product candidates and additional bridging studies or trials may be required.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The facilities used by our contract manufacturers to manufacture our product candidates must be approved by the FDA or other foreign regulatory authorities following inspections that will be conducted after we submit an application to the FDA or other foreign regulatory authorities. We may not control the manufacturing process of, and may be completely dependent on, our contract manufacturing partners for compliance with cGMPs and any other regulatory requirements of the FDA or other regulatory authorities for the manufacture of our product candidates. Beyond periodic audits, we have no control over the ability of our contract manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority does not approve these facilities for the manufacture of our product candidates or if it withdraws any approval in the future, we may need to find alternative manufacturing facilities, which would require the incurrence of significant additional costs and significantly impact our ability to develop, obtain regulatory approval for or market our product candidates, if approved. Similarly, if any third-party manufacturers on which we will rely fail to manufacture quantities of our product candidates at quality levels necessary to meet regulatory requirements and at a scale sufficient to meet anticipated demand at a cost that allows us to achieve profitability, our business, financial condition and prospects could be materially and adversely affected. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If any contract manufacturer with whom we contract fails to perform its obligations, we may be forced to manufacture the materials ourselves, for which we may not have the capabilities or resources, or enter into an agreement with a different contract manufacturer, which we may not be able to do on reasonable terms, if at all. In either scenario, our clinical trials supply could be delayed significantly as we establish alternative supply sources. In some cases, the technical skills required to manufacture our products or product candidates may be unique or proprietary to the original contract manufacturer and we may have difficulty, or there may be contractual restrictions prohibiting us from, transferring such skills to a back-up or alternate supplier, or we may be unable to transfer such skills at all. In addition, if we are required to change contract manufacturers for any reason, we will be required to verify that the new contract manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations. We will also need to verify, such as through a manufacturing comparability study, that any new manufacturing process will produce our product candidate according to the specifications previously submitted to the FDA or another regulatory authority. The delays associated with the verification of a new contract manufacturer could negatively affect our ability to develop product candidates or commercialize our products in a timely manner or within budget.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to sales, marketing, and competition</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We currently have no marketing and sales organization and have no experience in marketing products. If we are unable to establish marketing and sales capabilities or enter into agreements with third parties to market and sell our product candidates, if approved, we may not be able to generate product revenue. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We currently have no sales, marketing or distribution capabilities and have no experience in marketing products. We intend to develop an in-house marketing organization and sales force, which will require significant capital expenditures, management resources and time. We will have to compete with other pharmaceutical and biotechnology companies to recruit, hire, train and retain marketing and sales personnel. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If we are unable or decide not to establish internal sales, marketing and distribution capabilities, we will pursue arrangements with third-party sales, marketing, and distribution collaborators regarding the sales and marketing of our products, if approved. However, there can be no assurance that we will be able to establish or maintain such arrangements on favorable terms or if at all, or if we are able to do so, that these third-party arrangements will provide effective sales forces or marketing and distribution capabilities. Any revenue we receive will depend upon the efforts of such third parties, which may not be successful. We may have little or no control over the marketing and sales efforts of such third parties and our revenue from product sales may be lower than if we had commercialized our product candidates ourselves. We also face competition in our search for third parties to assist us with the sales and marketing efforts of our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There can be no assurance that we will be able to develop in-house sales and distribution capabilities or establish or maintain relationships with third-party collaborators to commercialize any product in the United States or overseas.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">A variety of risks associated with marketing our product candidates internationally could materially adversely affect our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We plan to seek regulatory approval of our product candidates outside of the United States and, accordingly, we expect that we will be subject to additional risks related to operating in foreign countries if we obtain the necessary approvals, including: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">differing regulatory requirements in foreign countries, for example, no country other than the United States has a pathway for accelerated drug approval and so obtaining regulatory approvals outside of the United States will take longer and be more costly than obtaining approval in the United States; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">economic weakness, including inflation, or political instability in particular foreign economies and markets; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">foreign taxes, including withholding of payroll taxes;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">difficulties staffing and managing foreign operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">workforce uncertainty in countries where labor unrest is more common than in the United States;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">potential liability under the Foreign Corrupt Practices Act of 1977 or comparable foreign regulations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">business interruptions resulting from geo-political actions, including war and terrorism. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These and other risks associated with international operations may materially adversely affect our ability to attain or maintain profitable operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Because we have limited financial and managerial resources, we must focus on a limited number of research programs and product candidates and on specific indications. As a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future discovery and preclinical development programs and product candidates for specific indications may not yield any commercially viable products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Even if we obtain regulatory approval of our product candidates, the products may not gain market acceptance among physicians, patients, hospitals, cancer treatment centers and others in the medical community. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The use of precision medicines as a potential cancer treatment is a recent development and may not become broadly accepted by physicians, patients, hospitals, cancer treatment centers and others in the medical community. Various factors will influence whether our product candidates are accepted in the market, including: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the clinical indications for which our product candidates are licensed; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">physicians, hospitals, cancer treatment centers and patients considering our product candidates as a safe and effective treatment; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the potential and perceived advantages of our product candidates over alternative treatments; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to demonstrate the advantages of our product candidates over other cancer medicines; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the prevalence and severity of any side effects; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the prevalence and severity of any side effects for other precision medicines and public perception of other precision medicines; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">product labeling or product insert requirements of the FDA or other regulatory authorities; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">limitations or warnings contained in the labeling approved by the FDA; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the timing of market introduction of our product candidates as well as competitive products; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the cost of treatment in relation to alternative treatments; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the availability of adequate coverage, reimbursement and pricing by third-party payors and government authorities; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the willingness of patients to pay out-of-pocket in the absence of coverage by third-party payors and government authorities; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">relative convenience and ease of administration, including as compared to alternative treatments and competitive therapies; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the effectiveness of our sales and marketing efforts. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If our product candidates are licensed but fail to achieve market acceptance among physicians, patients, hospitals, cancer treatment centers or others in the medical community, we will not be able to generate significant revenue. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, although our product candidates differ in certain ways from other precision medicine approaches, serious adverse events or deaths in other clinical trials involving precision medicines, even if not ultimately attributable to our product or product candidates, could result in increased government regulation, unfavorable public perception and publicity, potential regulatory delays in the testing or licensing of our product candidates, stricter labeling requirements for those product candidates that are licensed, and a decrease in demand for any such product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Even if our products achieve market acceptance, we may not be able to maintain that market acceptance over time if new products or technologies are introduced that are more favorably received than our products, are more cost effective or render our products obsolete. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than we do. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The biotechnology and pharmaceutical industries utilize rapidly advancing technologies and are characterized by intense competition. While we believe that our scientific knowledge, platform technology and development expertise provide us with competitive advantages, we face potential competition from many different sources, including major pharmaceuticals, specialty pharmaceuticals and biotechnology companies, academic institutions and government agencies, and public and private research institutes that conduct research, development, manufacturing and commercialization. Many of our competitors have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, regulatory approvals and product marketing than we do. Our competitors may compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. As a result, our competitors may discover, develop, license or commercialize products before or more successfully than we do.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Product candidates that we successfully develop and commercialize will compete with existing therapies and new therapies that may become available in the future. Specifically for BDTX-1535, we expect competition primarily in the EGFR NSCLC and GBM patient populations, including: GILOTRIF and TAGRISSO, which are marketed by Boehringer Ingelheim Pharmaceuticals, Inc. and AstraZeneca, respectively; combination of amivantamab, or Rybrevant, and lazertinib, which is under development for NSCLC and EGFR acquired resistance mutations by Janssen Biotech, Inc.; patritumab deruxtecan, which is being developed by Daiichi Sankyo Co.; BLU-701 and BLU-945, which are under development by BluePrint Medicines Corporation; BBT-176, which is being developed by Bridge Biotherapeutics Inc; neratinib, which is marketed by Puma Biotechnology, Inc. under the trade name Nerlynx, which is currently approved for HER2+ breast cancer, but also under development for NSCLC EGFR intrinsic resistance mutations; ERAS-801, which is under development by Erasca, Inc.; WSD-0922-FU, which is under development by Wayshine Biopharm International Ltd.; CM93, which is under development by Crimson Biopharm Inc.; RO7428731, which is under development by Hoffman Roche; TAS2940, which is under development by Taiho Oncology; and epitinib, which is under development by Hutchison MediPharma Ltd. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Specifically for BDTX-189, we expect competition primarily in the EGFR and HER2 exon 20 insertion NSCLC patient populations, including: mobocertinib (TAK-788), which is marketed by Takeda Pharmaceutical Company Ltd; amivantamab (JNJ-61186372), which is marketed by Janssen Research &amp; Development, LLC; trastuzumab deruxtecan (DS-8201), marketed by Daiichi Sankyo Company Ltd. and AstraZeneca plc under the trade name Enhertu, which is currently approved for HER2+ breast cancer, but under development for HER2 mutant solid tumors; poziotinib, which is under development by Spectrum Pharmaceuticals, Inc; CLN-081 (formerly TAS6417), which is under development by Cullinan Oncology, LLC; and DZD9008, which is under development by Dizal Pharmaceutical Co., Ltd. In addition, there are other small molecule and precision oncology-focused companies with whom we may eventually compete, including Loxo Oncology, Inc. (recently acquired by Eli Lilly and Company), SpringWorks Therapeutics, Inc., Centessa Pharmaceuticals, Theseus Pharmaceuticals, Inc., Voronoi, Deciphera Pharmaceuticals, Inc., Turning Point Therapeutics, Inc., and Mirati Therapeutics, Inc, and Kinnate Biopharma, Inc.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If our drug candidates, including BDTX-1535 and BDTX-189, are approved for the indications for which we are currently planning clinical trials, they will likely compete with the competitor drugs mentioned above and with other drugs that are currently in development. Key product features that would affect our ability to effectively compete with other therapeutics include the efficacy, safety and convenience of our products. Our competitors may obtain patent protection or other intellectual property rights that limit our ability to develop or commercialize our product candidates. The availability of reimbursement from government and other third-party payors will also significantly affect the pricing and competitiveness of our products. Our competitors may also obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. For additional information regarding our competition, see &#8220;Business&#8212;Competition.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks related to our financial position and capital requirements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to past financial condition</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our limited operating history may make it difficult for you to evaluate the success of our business to date and to assess our future viability. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are a biotechnology company with a limited operating history. We commenced operations in December 2014, and our operations to date have been limited to organizing and staffing our company, business planning, raising capital, conducting discovery and research activities, filing patent applications, identifying potential product candidates, undertaking preclinical studies and establishing arrangements with third parties for the manufacture of initial quantities of our product candidates and component materials. Most of our product candidates are still in early clinical or preclinical development. We have not yet demonstrated our ability to successfully conduct or complete any clinical trials, obtain marketing approvals, manufacture a commercial-scale product or arrange for a third party to do so on our behalf, or conduct sales, marketing and distribution activities necessary for successful product commercialization. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consequently, any predictions you make about our future success or viability may not be as accurate as they could be if we had a longer operating history. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, as a young business, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. We will need to transition at some point from a company with a research and development focus to a company capable of supporting commercial activities. We may not be successful in such a transition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant losses since inception, and we expect to incur losses over the next several years and may not be able to achieve or sustain revenues or profitability in the future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investment in biopharmaceutical product development is a highly speculative undertaking and entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain regulatory approval and become commercially viable. We are still in the early stages of development of our product candidates. Our most advanced product candidates, BDTX-1535 and BDTX-189, are currently only in Phase 1 clinical studies. We have no products approved for commercial sale and have not generated any revenue from product sales to date, and we continue to incur significant research and development and other expenses related to our ongoing operations. We have financed our operations primarily through private placements of our preferred stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have incurred significant net losses in each period since we commenced operations in December 2014. For the years ended December&#160;31, 2021 and 2020, we reported net losses of $125.6 million and $67.3 million, respectively. As of December&#160;31, 2021, we had an accumulated deficit of $243.8 million. We expect to continue to incur significant losses for the foreseeable future, and we expect these losses to increase substantially if and as we: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">continue our research and development efforts and submit INDs for our lead product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">conduct preclinical studies and clinical trials for our current and future product candidates based on our Mutation&#8212;Allostery&#8212;Pharmacology, or MAP, platform; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">seek marketing approvals for any product candidates that successfully complete clinical trials; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">experience any delays or encounter any issues with any of the above, including but not limited to failed studies, complex results, safety issues or other regulatory challenges; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">establish a sales, marketing and distribution infrastructure and scale-up manufacturing capabilities, whether alone or with third parties, to commercialize any product candidates for which we may obtain regulatory approval, if any; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtain, expand, maintain, enforce and protect our intellectual property portfolio; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">hire additional clinical, regulatory and scientific personnel; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">operate as a public company. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with pharmaceutical product development, we are unable to accurately predict the timing or amount of increased expenses we will incur or when, if ever, we will be able to achieve profitability. Even if we succeed in commercializing one or more of our product candidates, we will continue to incur substantial research and development and other expenditures to develop, seek regulatory approval for and market additional product candidates. We may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business. The size of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenue. Our prior losses and expected future losses have had and will continue to have an adverse effect on our stockholders&#8217; equity and working capital.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We have not generated any revenue from our product candidates and may never be profitable. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our ability to become profitable depends upon our ability to generate revenue. To date, we have not generated any revenue from any of our product candidates. We do not expect to generate significant revenue unless or until we successfully complete clinical development and obtain regulatory approval of, and then successfully commercialize, at least one of our product candidates. Most of our product candidates are in early clinical or preclinical stages of development and will require additional preclinical studies, clinical development, regulatory review and approval, substantial investment, access to sufficient commercial manufacturing capacity and significant marketing efforts before we can generate any revenue from product sales. Our most advanced product candidates, BDTX-1535 and BDTX-189, are currently only in Phase 1 clinical studies. Our other product candidates are in various stages of preclinical development. We face significant translational risk as our product candidates in preclinical development advance to the clinical stage, as promising results in preclinical studies may not be replicated in subsequent clinical trials and testing on animals may not accurately predict human experience. Our ability to generate revenue depends on a number of factors, including, but not limited to: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">timely completion of our preclinical studies and clinical trials, which may be significantly slower or cost more than we currently anticipate and will depend substantially upon the performance of third-party contractors; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to complete IND-enabling studies and successfully submit INDs or comparable applications; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">whether we are required by the U.S. Food and Drug Administration, or the FDA, or similar foreign regulatory authorities to conduct additional clinical trials or other studies beyond those planned to support the approval and commercialization of our product candidates or any future product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to demonstrate to the satisfaction of the FDA and similar foreign regulatory authorities the safety, potency, purity, efficacy and acceptable risk to benefit profile of our product candidates or any future product candidates and such regulatory authorities&#8217; acceptance of our tumor-agnostic development strategy (i.e., our pursuit of approval based on a biomarker rather than a specific cancer indication); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the prevalence, duration and severity of potential side effects or other safety issues experienced with our product candidates or future product candidates, if any; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the timely receipt of necessary marketing approvals from the FDA and similar foreign regulatory authorities; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the willingness of physicians, operators of clinics and patients to utilize or adopt any of our product candidates or future product candidates over alternative or more conventional therapies, such as chemotherapy, to treat solid tumors; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the actual and perceived availability, cost, risk profile and side effects and efficacy of our product candidates, if approved, relative to existing and future alternative cancer therapies and competitive product candidates and technologies; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability and the ability of third parties with whom we contract to manufacture adequate clinical and commercial supplies of our product candidates or any future product candidates, remain in good standing with regulatory authorities and develop, validate and maintain commercially viable manufacturing processes that are compliant with cGMP; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to successfully develop a commercial strategy and thereafter commercialize our product candidates or any future product candidates in the United States and internationally, if approved for marketing, reimbursement, sale and distribution in such countries and territories, whether alone or in collaboration with others; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">patient demand for our product candidates and any future product candidates, if approved; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to establish and enforce intellectual property rights in and to our product candidates or any future product candidates. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Many of the factors listed above are beyond our control and could cause us to experience significant delays or prevent us from obtaining regulatory approvals or commercializing our product candidates. Even if we are able to commercialize our product candidates, we may not achieve profitability soon after generating product sales, if ever. If we are unable to generate sufficient revenue through the sale of our product candidates or any future product candidates, we may be unable to continue operations without continued funding. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to future financial condition</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We will need substantial additional funding. If we are unable to raise capital when needed, we would be compelled to delay, reduce or eliminate our product development programs or commercialization efforts. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We expect our expenses to increase in parallel with our ongoing activities, particularly as we continue our discovery and preclinical development activities to identify new product candidates and initiate clinical trials of, and seek marketing approval for, our product candidates. In addition, if we obtain marketing approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. However, we have estimated our current additional funding needs based on assumptions that may prove to be wrong. Additionally, changing circumstances may cause us to consume capital significantly faster than we currently anticipate, and we may need to spend more money than currently expected because of circumstances beyond our control. We cannot be certain that additional funding will be available on acceptable terms, or at all. Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of public or private equity offerings, debt financings, governmental funding, collaborations, strategic partnerships and alliances or marketing, distribution or licensing arrangements with third parties. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our discovery and preclinical development programs or any future commercialization efforts. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We had cash, cash equivalents and investments of $209.8 million as of December&#160;31, 2021. Our net proceeds from our initial public offering were $212.1 million, based the initial public offering price of $19.00 per share, after deducting underwriting discounts and commissions and offering expenses payable by us. We believe that, based upon our current operating plan, our existing capital resources, including net proceeds from our initial public offering will be sufficient to fund our anticipated operations into 2024, including the Phase 1 trial of BDTX-1535 and the Phase 1 safety expansion cohort of the clinical trial of BDTX-189 and IND-enabling studies for our BRAF program, with additional resources for continued development of our MAP drug discovery engine. Our future capital requirements will depend on many factors, including: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the scope, progress, results and costs of discovery, preclinical development and clinical trials for our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the extent to which we enter into collaboration arrangements with regard to product discovery or acquire or in-license products or technologies; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to establish discovery collaborations on favorable terms, if at all; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the costs, timing and outcome of regulatory review of our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the costs of future commercialization activities, including product sales, marketing, manufacturing and distribution, for any of our product candidates for which we receive marketing approval;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">revenue, if any, received from commercial sales of our product candidates, should any of our product candidates receive marketing approval; and</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the costs of preparing, filing and prosecuting patent applications, obtaining, maintaining, enforcing and protecting our intellectual property rights and defending intellectual property-related claims. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Identifying potential product candidates and conducting preclinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for many years, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks related to government regulation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We are very early in our development efforts. Most of our product candidates are still in early clinical or preclinical development. If we are unable to advance our product candidates through clinical development, obtain regulatory approval and ultimately commercialize our product candidates or experience significant delays in doing so, our business will be materially harmed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are very early in our development efforts, and most of our product candidates are still in early clinical or preclinical development. We have invested substantially all of our efforts and financial resources in the identification and preclinical development of our product candidates, including the development of our clinical-stage product candidates, BDTX-1535 and BDTX-189. Our ability to generate product revenues, which we do not expect will occur for many years, if ever, will depend on the successful development, approval and eventual commercialization of our product candidates, which may never occur. We currently generate no revenue from sales of any products, and we may never be able to develop or commercialize a marketable product. The success of our product candidates will depend on several factors, including the following: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">successful completion of preclinical studies;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">approval of INDs for our planned clinical trials or future clinical trials;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">FDA acceptance of our tumor-agnostic development strategy; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">successful enrollment in future clinical trials;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">positive results from future clinical trials that are supportive of safety and efficacy in the intended patient populations; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">successful development of companion diagnostics for use with certain of our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">receipt of regulatory approvals from applicable regulatory authorities; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">establishing commercial manufacturing capabilities or making arrangements with third-party manufacturers for clinical supply and commercial manufacturing; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtaining and maintaining patent and trade secret protection or regulatory exclusivity for our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">launching commercial sales of our product candidates, if and when approved, whether alone or in collaboration with others; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">acceptance of the product candidates, if and when approved, by patients, the medical community and third-party payors; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">effectively competing with other therapies; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtaining and maintaining third-party insurance coverage and adequate reimbursement; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtaining, enforcing and defending intellectual property rights and claims; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">maintaining a continued acceptable safety profile of the product candidates following approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If we do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize our product candidates, which would materially harm our business. If we do not receive regulatory approvals for our product candidates, we may not be able to continue our operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals for our product candidates, we will not be able to commercialize, or will be delayed in commercializing, our product candidates, and our ability to generate revenue will be materially impaired</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our product candidates and the activities associated with their development and commercialization, including their design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale, distribution, import and export are subject to comprehensive regulation by the FDA and other regulatory agencies in the United States and by comparable authorities in other countries. Before we can commercialize any of our product candidates, we must obtain marketing approval. Our most advanced product candidates, BDTX-1535 and BDTX-189, are currently only in Phase 1 clinical studies.  Whether the results from our current and future clinical trials will suffice to obtain approval will be a review issue and the FDA may not grant approval and may require that we conduct one or more controlled, randomized Phase 3 clinical trials to obtain approval. There is limited experience of regulatory authorities outside of the United States with the approval of precision cancer medicines. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Securing regulatory approval also requires the submission of information about the drug manufacturing process to, and inspection of manufacturing facilities by, the relevant regulatory authority. Further, our product candidates may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The process of obtaining regulatory approvals, both in the United States and abroad, is expensive, may take many years if additional clinical trials are required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted IND, NDA, or equivalent application types, may cause delays in the approval or rejection of an application. The FDA and comparable authorities in other countries have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical or other studies. Our product candidates could be delayed in receiving, or fail to receive, regulatory approval for many reasons, including the following: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials, including our Phase 1 clinical trial design for BDTX-1535 and our Phase 1/2 clinical trial design for BDTX-189; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the FDA or comparable foreign regulatory authorities may disagree with our tumor-agnostic development strategy; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a drug candidate is safe and effective for its proposed indication or a related companion diagnostic is suitable to identify appropriate patient populations; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may be unable to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the data collected from clinical trials of our product candidates may not be sufficient to support the submission of an NDA or other submission or to obtain regulatory approval in the United States or elsewhere; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the FDA or comparable foreign regulatory authorities may fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, as of May 26, 2021, the FDA noted it is continuing to ensure timely reviews of applications for medical products during the ongoing COVID-19 pandemic in line with its user fee performance goals. However, the FDA may not be able to continue its current pace and approval timelines could be extended, including where a pre-approval inspection or an inspection of clinical sites is required and due to the ongoing COVID-19 pandemic and travel restrictions FDA is unable to complete such required inspections during the review period. During the COVID-19 public health emergency, a number of companies announced receipt of complete response letters due to the FDA's inability to complete required inspections for their applications.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Of the large number of drugs in development, only a small percentage successfully complete the FDA or foreign regulatory approval processes and are commercialized. The lengthy approval process as well as the unpredictability of future clinical trial results may result in our failing to obtain regulatory approval to market our product candidates, which would significantly harm our business, results of operations and prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our clinical trials may fail to demonstrate adequately the safety and efficacy of any of our product candidates, which would prevent or delay regulatory approval and commercialization. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To obtain the requisite regulatory approvals to market and sell any of our product candidates, including BDTX-1535, BDTX-189 and any other future product candidates, we must demonstrate through extensive preclinical studies and clinical trials that our products are safe and effective in humans. Our product candidates may fail to demonstrate efficacy in humans, and particularly across tumor types. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process and our future clinical trial results may not be successful. Further, the process of obtaining regulatory approval is expensive, often takes many years following the commencement of clinical trials and can vary substantially based upon the type, complexity and novelty of the product candidates involved, as well as the target indications, patient population and regulatory agency. Prior to obtaining approval to commercialize a product candidate in the United States or abroad, we or our potential future collaborators must demonstrate with substantial evidence from adequate and well-controlled clinical trials, and to the satisfaction of the FDA, the EMA or other comparable foreign regulatory authorities, that such product candidates are safe and effective for their intended uses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Clinical trials that we conduct may not demonstrate the efficacy and safety necessary to obtain regulatory approval to market our product candidates. In some instances, there can be significant variability in safety or efficacy results between different clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the clinical trial protocols and the rate of dropout among clinical trial participants. If the results of our ongoing or future clinical trials are inconclusive with respect to the efficacy of our product candidates, if we do not meet the clinical endpoints with statistical and clinically meaningful significance, or if there are safety concerns associated with our product candidates, we may be delayed in obtaining marketing approval, if at all. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Even if the trials are successfully completed, clinical data are often susceptible to varying interpretations and analyses, and we cannot guarantee that the FDA, the EMA, or other comparable foreign regulatory authorities will interpret the results as we do, and more trials could be required before we submit our product candidates for approval. We cannot guarantee that the FDA, the EMA or other comparable foreign regulatory authorities will view our product candidates as having sufficient efficacy to support a tumor-agnostic indication even if positive results are observed in clinical trials. To the extent that the results of the trials are not satisfactory to the FDA, the EMA or other comparable foreign regulatory authorities for support of a marketing application, approval of our product candidates may be significantly delayed, or we may be required to expend significant additional resources, which may not be available to us, to conduct additional trials in support of potential approval of our product candidates. Additionally, any safety or efficacy concerns observed in any tumor-specific subgroup of our clinical trials could limit the prospects for regulatory approval of our product candidates for a tumor-agnostic indication, which could have a material adverse effect on our business, financial condition and results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may in the future seek orphan drug status for BDTX-1535, BDTX-189 and some of our other future product candidates, but we may be unable to obtain such designations or to maintain the benefits associated with orphan drug status, including market exclusivity, which may cause our revenue, if any, to be reduced. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition, defined as a disease or condition with a patient population of fewer than 200,000 in the United States, or a patient population greater than 200,000 in the United States when there is no reasonable expectation that the cost of developing and making available the drug or biologic in the United States will be recovered from sales in the United States for that drug or biologic. Orphan drug designation must be requested before submitting an NDA. In the United States, orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and user-fee waivers. After the FDA grants orphan drug designation, the generic identity of the drug and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a product that has orphan drug designation subsequently receives the first FDA approval for a particular active ingredient for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications, including an NDA, to market the same biologic for the same indication for seven years, except in limited circumstances such as a showing of clinical superiority to the product with orphan drug exclusivity or if the FDA finds that the holder of the orphan drug exclusivity has not shown that it can assure the availability of sufficient quantities of the orphan drug to meet the needs of patients with the disease or condition for which the drug was designated. As a result, even if one of our product candidates receives orphan exclusivity, the FDA can still approve other drugs that have a different active ingredient for use in treating the same indication or disease. Furthermore, the FDA can waive orphan exclusivity if we are unable to manufacture sufficient supply of our product. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may seek orphan drug designation for BDTX-1535, BDTX-189 and some or all of our other future product candidates in additional orphan indications in which there is a medically plausible basis for the use of these products. Even when we obtain orphan drug designation, exclusive marketing rights in the United States may be limited if we seek approval for an indication broader than the orphan designated indication and may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. In addition, although we intend to seek orphan drug designation for other product candidates, we may never receive such designations. For example, the FDA has expressed concerns regarding the regulatory considerations for orphan drug designation as applied to tissue agnostic therapies, and the FDA may interpret the FD&amp;C Act and regulations promulgated thereunder in a way that limits or blocks our ability to obtain orphan drug designation or orphan drug exclusivity, if our product candidates are approved, for our targeted indications. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On August 3, 2017, Congress passed the FDA Reauthorization Act of 2017, or FDARA. FDARA, among other things, codified the FDA&#8217;s pre-existing regulatory interpretation, to require that a drug sponsor demonstrate the clinical superiority of an orphan drug that is otherwise the same as a previously approved drug for the same rare disease in order to receive orphan drug exclusivity. The legislation reverses prior precedent holding that the Orphan Drug Act unambiguously requires that the FDA recognize the orphan exclusivity period regardless of a showing of clinical superiority. Moreover, in the Consolidated Appropriations Act of 2021, Congress did not further change this interpretation when it clarified that the interpretation codified in FDARA would apply in cases where FDA issued an orphan designation before the enactment of FDARA but where product approval came after the enactment of FDARA. The FDA may further reevaluate the Orphan Drug Act and its regulations and policies. We do not know if, when, or how the FDA may change the orphan drug regulations and policies in the future, and it is uncertain how any changes might affect our business. Depending on what changes the FDA may make to its orphan drug regulations and policies, our business could be adversely impacted. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">A Breakthrough Therapy designation by the FDA, even if granted for any of our product candidates, may not lead to a faster development or regulatory review or approval process and it does not increase the likelihood that our product candidates will receive marketing approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may seek Breakthrough Therapy designation for BDTX-1535, BDTX-189 and some or all of our future product candidates. A breakthrough therapy is defined as a drug or biologic that is intended, alone or in combination with one or more other drugs or biologics, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the drug or biologic may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For product candidates that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Drugs designated as breakthrough therapies by the FDA may also be eligible for other expedited approval programs, including accelerated approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Designation as a breakthrough therapy is within the discretion of the FDA. Accordingly, even if we believe one of our product candidates meets the criteria for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a Breakthrough Therapy designation for a product candidate may not result in a faster development process, review or approval compared to candidate products considered for approval under non-expedited FDA review procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify as breakthrough therapies, the FDA may later decide that the product no longer meets the conditions for qualification. Thus, even though we intend to seek Breakthrough Therapy designation for BDTX-1535, BDTX-189 and some or all of our future product candidates for the treatment of various cancers, there can be no assurance that we will receive breakthrough therapy designation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">A Fast Track designation by the FDA may not lead to a faster development or regulatory review or approval process, and does not increase the likelihood that our product candidates will receive marketing approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a drug is intended for the treatment of a serious or life-threatening condition and the drug demonstrates the potential to address unmet medical needs for this condition, the drug sponsor may apply for FDA Fast Track designation for a particular indication. We have been granted Fast Track designation for BDTX-189 for the treatment of adult patients with solid tumors harboring an allosteric human epidermal growth factor receptor 2 (HER2) mutation or an epidermal growth factor receptor (EGFR) or HER2 Exon 20 insertion mutation who have progressed following prior treatment and who have no satisfactory treatment options. We may seek Fast Track designation for other indications or for BDTX-1535 or certain of our future product candidates, but there is no assurance that the FDA will grant this status to any of our other proposed product candidates. Marketing applications filed by sponsors of products in Fast Track development may qualify for priority review under the policies and procedures offered by the FDA, but the Fast Track designation does not assure any such qualification or ultimate marketing approval by the FDA. The FDA has broad discretion whether or not to grant Fast Track designation, so even if we believe a particular product candidate is eligible for this designation, there can be no assurance that the FDA would decide to grant it. Even if we do receive Fast Track designation, we may not experience a faster development process, review or approval compared to conventional FDA procedures, and receiving a Fast Track designation does not provide assurance of ultimate FDA approval. In addition, the FDA may withdraw Fast Track designation if it believes that the designation is no longer supported by data from our clinical development program. In addition, the FDA may withdraw any Fast Track designation at any time. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Accelerated approval by the FDA, even if granted for any of our product candidates, may not lead to a faster development or regulatory review or approval process and it does not increase the likelihood that our product candidates will receive marketing approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may seek approval of product candidates using the FDA&#8217;s accelerated approval pathway. A product may be eligible for accelerated approval if it treats a serious or life-threatening condition and generally provides a meaningful advantage over available therapies. In addition, it must demonstrate an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit. As a condition of approval, the FDA may require that a sponsor of a drug receiving accelerated approval perform adequate and well-controlled post-marketing clinical trials. These confirmatory trials must be completed with due diligence. In addition, the FDA currently requires, unless otherwise informed by the agency, pre-approval of promotional materials for products receiving accelerated approval, which could adversely impact the timing of the commercial launch of the product. Even if we do receive accelerated approval, we may not experience a faster development or regulatory review or approval process, and receiving accelerated approval does not provide assurance of ultimate full FDA approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully validate, develop and obtain regulatory approval for companion diagnostic tests for our drug candidates that are required or experience significant delays in doing so, we may not realize the full commercial potential of these drug candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the clinical development of our drug candidates for certain indications, we intend to engage third parties to develop or obtain access to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> companion diagnostic tests to identify patient subsets within a disease category who may derive selective and meaningful benefit from our drug candidates. Such companion diagnostics would be used during our clinical trials as well as in connection with the FDA approval of our product candidates. To be successful, we or our collaborators will need to address a number of scientific, technical, regulatory and logistical challenges. The FDA regulates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> companion diagnostics as medical devices and, under that regulatory framework, will require the test to be analytically validated and used for patient selection in the clinical trial, which we expect will require separate regulatory clearance or approval prior to commercialization if not already approved. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We intend to rely on third parties for the design, development and manufacture of companion diagnostic tests for our therapeutic drug candidates that may require such tests. If we enter into such collaborative agreements, we will be dependent on the sustained cooperation and effort of our future collaborators in developing and obtaining approval for these companion diagnostics. It may be necessary to resolve issues such as selectivity/specificity, analytical validation, reproducibility, or clinical validation of companion diagnostics during the development and regulatory approval processes. Moreover, even if data from preclinical studies and early clinical trials appear to support development of a companion diagnostic for a product candidate, data generated in later clinical trials may fail to support the analytical and clinical validation of the companion diagnostic. We and our future collaborators may encounter difficulties in developing, obtaining regulatory approval for, manufacturing and commercializing companion diagnostics similar to those we face with respect to our therapeutic candidates themselves, including issues with achieving regulatory clearance or approval, production of sufficient quantities at commercial scale and with appropriate quality standards, and in gaining market acceptance. If we are unable to successfully develop companion diagnostics for these therapeutic drug candidates, or experience delays in doing so, the development of these therapeutic drug candidates may be adversely affected, these therapeutic drug candidates may not obtain marketing approval, and we may not realize the full commercial potential of any of these therapeutics that obtain marketing approval. As a result, our business, results of operations and financial condition could be materially harmed. In addition, a diagnostic company with whom we contract may decide to discontinue selling or manufacturing the companion diagnostic test that we anticipate using in connection with development and commercialization of our product candidates or our relationship with such diagnostic company may otherwise terminate. We may not be able to enter into arrangements with another diagnostic company to obtain supplies of an alternative diagnostic test for use in connection with the development and commercialization of our product candidates or do so on commercially reasonable terms, which could adversely affect and/or delay the development or commercialization of our therapeutic candidates. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, while a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA grants marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing and promotion of the product candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States, including additional preclinical studies or clinical trials as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may also submit marketing applications in other countries. Regulatory authorities in jurisdictions outside of the United States have requirements for approval of product candidates with which we must comply prior to marketing in those jurisdictions. Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we fail to comply with the regulatory requirements in international markets and/or receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to ongoing regulatory obligations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Even if we receive regulatory approval of our product candidates, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any regulatory approvals that we receive for our product candidates will require surveillance to monitor the safety and efficacy of the product candidate. The FDA may also require a REMS in order to approve our product candidates, which could entail requirements for a medication guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In addition, if the FDA or a comparable foreign regulatory authority approves our product candidates, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export and recordkeeping for our product candidates will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with applicable cGMP, GLP and GCP requirements, for any clinical trials that we conduct post-approval. For certain commercial prescription drug products, manufacturers and other parties involved in the supply chain must also meet chain of distribution requirements and build electronic, interoperable systems for product tracking and tracing and for notifying the FDA of counterfeit, diverted, stolen and intentionally adulterated products or other products that are otherwise unfit for distribution in the United States. Later discovery of previously unknown problems with our product candidates, including adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">restrictions on the marketing or manufacturing of our product candidates, withdrawal of the product from the market or voluntary or mandatory product recalls; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">manufacturing delays and supply disruptions where regulatory inspections identify observations of noncompliance requiring remediation; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">revisions to the labeling, including limitation on approved uses or the addition of additional warnings, contraindications or other safety information, including boxed warnings; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">imposition of a REMS, which may include distribution or use restrictions; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">requirements to conduct additional post-market clinical trials to assess the safety of the product; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">fines, warning letters or holds on clinical trials; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or suspension or revocation of approvals; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">product seizure or detention, or refusal to permit the import or export of our product candidates; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">injunctions or the imposition of civil or criminal penalties. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">The FDA and other regulatory agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If any of our product candidates are approved and we are found to have improperly promoted off-label uses of those products, we may become subject to significant liability. The FDA and other regulatory agencies strictly regulate the promotional claims that may be made about prescription products, if approved. In particular, while the FDA permits the dissemination of truthful and non-misleading information about an approved product, a manufacturer may not promote a product for uses that are not approved by the FDA or such other regulatory agencies as reflected in the product&#8217;s approved labeling. If we are found to have promoted such off-label uses, we may become subject to significant liability. The federal government has levied large civil and criminal fines against companies for alleged improper promotion of off-label use and has enjoined several companies from engaging in off-label promotion. The FDA has also requested that companies enter into consent decrees, corporate integrity agreements or permanent injunctions under which specified promotional conduct must be changed or curtailed. If we cannot successfully manage the promotion of our product candidates, if approved, we could become subject to significant liability, which would materially adversely affect our business and financial condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">The insurance coverage and reimbursement status of newly-approved products is uncertain. Our product candidates may become subject to unfavorable pricing regulations, third-party coverage and reimbursement practices, or healthcare reform initiatives, which would harm our business. Failure to obtain or maintain adequate coverage and reimbursement for new or current products could limit our ability to market those products and decrease our ability to generate revenue. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The regulations that govern marketing approvals, pricing, coverage and reimbursement for new drugs vary widely from country to country. In the United States, recently enacted legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenue we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if any product candidates we may develop obtain marketing approval. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the United States and markets in other countries, patients generally rely on third-party payors to reimburse all or part of the costs associated with their treatment. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product acceptance. Our ability to successfully commercialize our product candidates will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. Government authorities and other third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. The availability of coverage and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford treatments such as gene therapy products. Sales of these or other product candidates that we may identify will depend substantially, both domestically and abroad, on the extent to which the costs of our product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. If coverage and adequate reimbursement is not available, or is available only to limited levels, we may not be able to successfully commercialize our product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reimbursement by a third-party payor may depend upon a number of factors, including, but not limited to, the third-party payor&#8217;s determination that use of a product is: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a covered benefit under its health plan; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">safe, effective and medically necessary; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">appropriate for the specific patient; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">cost-effective; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">neither experimental nor investigational. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. In general, the prices of medicines under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for medicines, but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the United States, the reimbursement for products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There is also significant uncertainty related to the insurance coverage and reimbursement of newly approved products and coverage may be more limited than the purposes for which the medicine is approved by the FDA or comparable foreign regulatory authorities. In the United States, the principal decisions about reimbursement for new medicines are typically made by CMS, an agency within HHS. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree. No uniform policy of coverage and reimbursement for products exists among third-party payors and coverage and reimbursement levels for products can differ significantly from payor to payor. As a result, the coverage determination process is often a time consuming and costly process that may require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. It is difficult to predict what CMS will decide with respect to reimbursement for fundamentally novel products such as ours. Reimbursement agencies in Europe may be more conservative than CMS. For example, a number of cancer drugs have been approved for reimbursement in the United States and have not been approved for reimbursement in certain European countries. Moreover, eligibility for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale, and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services. Our inability to promptly obtain coverage and profitable payment rates from both government-funded and private payors for any approved products we may develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize product candidates, and our overall financial condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Our inability to promptly obtain coverage and profitable reimbursement rates third-party payors for any approved products that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our overall financial condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, the level of reimbursement. Reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. In order to obtain reimbursement, physicians may need to show that patients have superior treatment outcomes with our products compared to standard of care drugs, including lower-priced generic versions of standard of care drugs. We expect to experience pricing pressures in connection with the sale of any of our product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, we may develop companion diagnostic tests for use with our product candidates. We, or our collaborators, may be required to obtain coverage and reimbursement for these tests separate and apart from the coverage and reimbursement we seek for our product candidates, once approved. Even if we obtain regulatory approval or clearance for such companion diagnostics, there is significant uncertainty regarding our ability to obtain coverage and adequate reimbursement for the same reasons applicable to our product candidates. Medicare reimbursement methodologies, whether under Part A, Part B, or clinical laboratory fee schedule may be amended from time to time, and we cannot predict what effect any change to these methodologies would have on any product candidate or companion diagnostic for which we receive approval. Our inability to promptly obtain coverage and adequate reimbursement from both third-party payors for the companion diagnostic tests that we develop and for which we obtain regulatory approval could have a material and adverse effect on our business, financial condition, results of operations and prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Healthcare legislative measures aimed at reducing healthcare costs may have a material adverse effect on our business and results of operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The United States and many foreign jurisdictions have enacted or proposed legislative and regulatory changes affecting the healthcare system that could prevent or delay marketing approval of our product candidates or any future product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell a product for which we obtain marketing approval. Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to product labeling; (iii) the recall or discontinuation of our products; or (iv) additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs. For example, on July 9, 2021, President Biden issued an executive order directing the FDA to, among other things, continue to clarify and improve the approval framework for generic drugs and identify and address any efforts to impede generic drug competition. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, in March 2010, the ACA was passed, which substantially changed the way healthcare is financed by both governmental and private insurers, and significantly impacted the U.S. pharmaceutical industry. The ACA, among other things, subjects biological products to potential competition by lower-cost biosimilars, addresses a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increases the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program to individuals enrolled in Medicaid managed care organizations, establishes annual fees and taxes on manufacturers of certain branded prescription drugs, and creates a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 70% (increased pursuant to the Bipartisan Budget Act of 2018, effective as of 2019) point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part D. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Since its enactment, there have been judicial, administrative, executive and Congressional legislative challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. For example,. various portions of the ACA are currently undergoing constitutional challenges in the Fifth Circuit Court and the United States Supreme Court, and the Trump Administration issued various Executive Orders eliminating cost sharing subsidies and various provisions that would impose a fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. Additionally, Congress introduced several pieces of legislation aimed at significantly revising or repealing the ACA. It is unclear whether the ACA will be overturned, repealed, replaced, or further amended. We cannot predict what affect further changes to the ACA would have on our business, especially given the new administration.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Members of the U.S. Congress and the Trump administration expressed an intent to pass legislation or adopt executive orders to fundamentally change or repeal parts of the ACA. While Congress has not passed repeal legislation to date, the Tax Cuts and Jobs Act of 2017, or TCJA, repealed, effective January 1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#8220;individual mandate.&#8221; On December 14, 2018, a federal district court in Texas ruled the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the TCJA, the remaining provisions of the ACA are invalid as well. The Trump Administration and CMS both stated that the ruling will have no immediate effect, and on December 18, 2019, the Fifth Circuit U.S. Court of Appeals held that the individual mandate is unconstitutional, and remanded the case to the lower court to reconsider its earlier invalidation of the full ACA. Pending review, the ACA remains in effect, but it is unclear at this time what effect the latest ruling will have on the status of the ACA. Litigation and legislation over the ACA are likely to continue, with unpredictable and uncertain results. We will continue to evaluate the effect that the ACA and its possible repeal and replacement has on our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, on January 20, 2017, President Trump signed an Executive Order directing federal agencies with authorities and responsibilities under the ACA to waive, defer, grant exemptions from, or delay the implementation of any provision of the ACA that would impose a fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. On October 13, 2017, President Trump signed an Executive Order terminating the cost-sharing subsidies that reimburse insurers under the ACA. The Trump administration concluded that cost-sharing reduction, or CSR, payments to insurance companies required under the ACA have not received necessary appropriations from Congress and announced that it will discontinue these payments immediately until those appropriations are made. The loss of the CSR payments is expected to increase premiums on certain policies issued by qualified health plans under the ACA. Several state Attorneys General filed suit to stop the administration from terminating the subsidies, but their request for a restraining order was denied by a federal judge in California on October 25, 2017. On August 14, 2020, the U.S. Court of Appeals for the Federal Circuit ruled in two separate cases that the federal government is liable for the full amount of unpaid CSRs for the years preceding and including 2017. For CSR claims made by health insurance companies for years 2018 and later, further litigation will be required to determine the amounts due, if any. Further, on June 14, 2018, the U.S. Court of Appeals for the Federal Circuit ruled that the federal government was not required to pay to third-party payors more than $12 billion in ACA risk corridor payments that they argued were owed to them. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On April 27, 2020, the United States Supreme Court reversed the U.S. Court of Appeals for the Federal Circuit decision and remanded the case to the U.S. Court of Federal Claims, concluding the government has an obligation to pay these risk corridor payments under the relevant formula. On March 2, 2020, the United States Supreme Court granted the petitions for writs of certiorari to review this case, and held oral arguments on November 10, 2020. The Supreme Court&#8217;s decision in this case is forthcoming. The effects of this gap in reimbursement on third-party payors, the viability of the ACA marketplace, providers, and potentially our business, are not yet known. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On December 20, 2019, President Trump signed into law the Further Consolidated Appropriations Act (H.R. 1865), which repealed the so called &#8220;Cadillac&#8221; tax on certain high cost employer-sponsored insurance plans, the annual fee imposed on certain health insurance providers based on market share, and the medical devise excise tax on non-exempt medical devises. It is impossible to determine whether similar taxes could be instated in the future. The Bipartisan Budget Act of 2018, also amended the ACA, effective January 1, 2019, by increasing the point-of-sale discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug plans, commonly referred to as the &#8220;donut hole.&#8221; CMS published a final rule permitting further collections and payments to and from certain ACA qualified health plans and health insurance issuers under the ACA risk adjustment program in response to the outcome of federal district court litigation regarding the method CMS uses to determine this risk adjustment. In addition, CMS published a final rule that gives states greater flexibility, as of 2020, in setting benchmarks for insurers in the individual and small group marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces. Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. In August 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers up to 2% per fiscal year, and, due to subsequent legislative amendments, will remain in effect through 2030 unless additional Congressional action is taken. Pursuant to the Coronavirus Aid, Relief, and Economic Security Act, also known as the CARES Act, as well as subsequent legislation, these reductions have been suspended from May 1, 2020 through March 31, 2021 due to the COVID-19 pandemic. Proposed legislation, if passed, would extend this suspension until the end of the pandemic. In January 2013, the American Taxpayer Relief Act of 2012, or ATRA, was signed into law, which, among other things, reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. Additionally, the Trump administration also previously released a &#8220;Blueprint&#8221; to lower drug prices and reduce out of pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs of drug products paid by consumers. HHS solicited feedback on some of these measures and has implemented others under its existing authority. For example, in May 2019, CMS issued a final rule to allow Medicare Advantage Plans the option of using step therapy, a type of prior authorization, for Part B drugs beginning January 1, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, on May 30, 2018, the Right to Try Act was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a pharmaceutical manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, the FDA published a final rule, effective November 30, 2020, that allows for the importation of certain prescription drugs from Canada. Under the final rule, states and Indian Tribes, and in certain future circumstances pharmacists and wholesalers, may submit importation program proposals to the FDA for review and authorization. On September 25, 2020, CMS stated drugs imported by States under this rule will not be eligible for federal rebates under Section 1927 of the Social Security Act and manufacturers would not report these drugs for &#8220;best price&#8221; or Average Manufacturer Price purposes. Since these drugs are not considered covered outpatient drugs, CMS further stated it will not publish a National Average Drug Acquisition Cost for these drugs. Separately, the FDA also issued a final guidance document outlining a potential pathway for manufacturers to obtain an additional National Drug Code, or NDC, for an FDA-approved drug that was originally intended to be marketed in a foreign country and that was authorized for sale in that foreign country.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional health care authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other health care programs. Some of these proposed measures, including drug importation and pharmacy benefit manager rebate rule changes, face legal challenges from industry groups and participants. These measures could reduce the ultimate demand for our products, once approved, or put pressure on our product pricing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our product candidates or additional pricing pressures. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our revenue prospects could be affected by changes in healthcare spending and policy in the United States and abroad. We operate in a highly regulated industry and new laws, regulations or judicial decisions, or new interpretations of existing laws, regulations or decisions, related to healthcare availability, the method of delivery or payment for healthcare products and services could negatively impact our business, operations and financial condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal and state levels directed at broadening the availability of healthcare and containing or lowering the cost of healthcare. We cannot predict the initiatives that may be adopted in the future, including repeal, replacement or significant revisions to the ACA. The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the demand for our product candidates, if we obtain regulatory approval; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to set a price that we believe is fair for our products; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to obtain coverage and reimbursement approval for a product; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to generate revenue and achieve or maintain profitability; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the level of taxes that we are required to pay; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the availability of capital. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors, which may adversely affect our future profitability. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Inadequate funding for the FDA and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Disruptions at the FDA or other government agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Since March 2020, when foreign and domestic inspections were largely placed on hold, the FDA has been working to resume routine surveillance, bioresearch monitoring and pre-approval inspections on a prioritized basis. Since April 2021, the FDA has conducted limited inspections and employed remote interactive evaluations and risk management methods to meet user fee commitments and goal dates. Ongoing travel restrictions and other uncertainties continue to impact oversight operations both domestic and abroad and it is unclear when standard operational levels will resume. The FDA is continuing to complete mission-critical work, prioritize other higher-tiered inspectional needs (e.g., for-cause inspections), and carry out surveillance inspections using risk-based approaches for evaluating public health. Should the FDA determine that an inspection is necessary for approval and an inspection cannot be completed during the review cycle due to restrictions on travel, and the FDA does not determine a remote interactive evaluation to be adequate, the FDA has stated that it generally intends to issue, depending on the circumstances a complete response letter or defer action on the application until an inspection can be completed. During the ongoing COVID-19 pandemic, a number of companies announced receipt of complete response letters due to the FDA&#8217;s inability to complete required inspections for their applications. Regulatory authorities outside the U.S. may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic and may experience delays in their regulatory activities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our employees, independent contractors, consultants, commercial partners and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are exposed to the risk of employee fraud or other illegal activity by our employees, independent contractors, consultants, commercial partners and vendors. Misconduct by these parties could include intentional, reckless and/or negligent conduct that fails to: comply with the regulations of the FDA and other similar foreign regulatory authorities, provide true, complete and accurate information to the FDA and other similar foreign regulatory authorities, comply with manufacturing standards we have established, comply with healthcare fraud and abuse laws in the United States and similar foreign fraudulent misconduct laws or report financial information or data accurately or to disclose unauthorized activities to us. If we obtain FDA approval of any of our product candidates and begin commercializing those products in the United States, our potential exposure under such laws and regulations will increase significantly, and our costs associated with compliance with such laws and regulations are also likely to increase. These laws may impact, among other things, our current activities with principal investigators and research patients, as well as proposed and future sales, marketing and education programs. In particular, the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">structuring and commission(s), certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials. The laws that may affect our ability to operate include, but are not limited to: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Violations are subject to civil and criminal fines and penalties for each violation, plus up to three times the remuneration involved, imprisonment, and exclusion from government healthcare programs. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">federal civil and criminal false claims laws and civil monetary penalty laws, including the False Claims Act, which impose criminal and civil penalties, including through civil &#8220;qui tam&#8221; or &#8220;whistleblower&#8221; actions, against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for payment or approval from Medicare, Medicaid, or other federal health care programs that are false or fraudulent; knowingly making or causing a false statement material to a false or fraudulent claim or an obligation to pay money to the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing such an obligation. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims. The FCA also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. When an entity is determined to have violated the federal civil False Claims Act, the government may impose civil fines and penalties for each false claim, plus treble damages, and exclude the entity from participation in Medicare, Medicaid and other federal healthcare programs; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created new federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity can be found guilty of violating HIPAA without actual knowledge of the statute or specific intent to violate it; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans, and healthcare clearinghouses as well as their respective business associates that perform services for them that involve the use, or disclosure of, individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions; </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the federal Physician Payment Sunshine Act, created under the ACA and its implementing regulations, which require manufacturers of drugs, devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to HHS information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Effective January 1, 2022, these reporting obligations will extend to include transfers of value made to certain non-physician providers such as physician assistants and nurse practitioners; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">analogous state and foreign laws and regulations, such as state and foreign anti-kickback, false claims, consumer protection and unfair competition laws which may apply to pharmaceutical business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims involving healthcare items or services reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding pricing and marketing information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; state and local laws requiring the registration of pharmaceutical sales representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have adopted a code of business conduct and ethics, but it is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent inappropriate conduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could be subject to challenge under one or more of such laws. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant criminal, civil and administrative sanctions including monetary penalties, damages, fines, disgorgement, individual imprisonment, and exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of noncompliance with these laws, contractual damages, reputational harm, diminished profits and future earnings, and we may be required to curtail or restructure our operations, any of which could adversely affect our ability to operate our business and our results of operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply with multiple jurisdictions with different compliance and/or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the EU. The provision of benefits or advantages to physicians is typically governed by the national anti-bribery laws of EU Member States, and the Bribery Act 2010 in the UK. Infringement of these laws could result in substantial fines and imprisonment. EU Directive 2001/83/EC, which is the EU Directive governing medicinal products for human use, further provides that, where medicinal products are being promoted to persons qualified to prescribe or supply them, no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to such persons unless they are inexpensive and relevant to the practice of medicine or pharmacy. This provision has been transposed into the Human Medicines Regulations 2012 and so remains applicable in the UK despite its departure from the EU. Payments made to physicians in certain EU Member States must be publicly disclosed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#8217;s employer, his or her competent professional organization and/or the regulatory authorities of the individual EU Member States. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These requirements are provided in the national laws, industry codes or professional codes of conduct, applicable in the EU Member States. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological and radioactive materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological, hazardous or radioactive materials.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Risks related to our intellectual property </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to protecting our intellectual property</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain and maintain patent and other intellectual property protection for BDTX-1535, BDTX-189, our MAP drug discovery engine and our other product candidates and technology, or any other product candidates or technology we may develop, or if the scope of intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize products and technology similar or identical to ours, and our ability to commercialize BDTX-1535, BDTX-189, or any other product candidates or technology may be adversely affected. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our success depends in large part on our ability to obtain and maintain patent and other intellectual property protection in the United States and other countries with respect to our product candidates, including BDTX-1535, BDTX-189, their respective components, formulations, combination therapies, methods used to manufacture them and methods of treatment and development that are important to our business, as well as successfully defending these patents against third-party challenges. If we do not adequately protect our intellectual property rights, competitors </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">may be able to erode or negate any competitive advantage we may have, which could harm our business and ability to achieve profitability. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We intend to rely upon a combination of patent applications, confidentiality agreements, trade secret protection and license agreements to protect the intellectual property related to our product candidates and technologies. Any disclosure to or misappropriation by third parties of our confidential proprietary information could enable competitors to quickly duplicate or surpass our technological achievements, thus eroding our competitive position in our market. We, or any future partners, collaborators, or licensees, may fail to identify patentable aspects of inventions made in the course of development and commercialization activities before it is too late to obtain patent protection on them. Therefore, we may miss potential opportunities to establish our patent position. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To protect our proprietary position, we plan to file patent applications in the United States and abroad relating to our product candidates and MAP drug discovery engine that are important to our business; we may in the future also license or purchase patents or patent applications owned by others. Our ability to stop unauthorized third parties from making, using, selling, offering to sell or importing our product candidates is dependent upon the extent to which we have rights under valid and enforceable patents or trade secrets that cover these activities. If we are unable to secure or maintain patent protection with respect to BDTX-1535, BDTX-189, our MAP drug discovery engine or any other proprietary products and technology we develop, our business, financial condition, results of operations, and prospects would be materially harmed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The U.S. provisional patent applications, the U.S. patent applications, or the PCT patent applications, and the foreign patent applications currently owned by us may never result in an issued patent. The U.S. provisional patent applications may not be eligible to become an issued patent until, among other things, we convert the U.S. provisional patent applications to one or more non-provisional patent applications within 12 months. If we do not timely convert the U.S. provisional patent applications to any non-provisional application, we may lose our priority date with respect to our U.S. provisional patent applications and any patent protection on the inventions disclosed in such U.S. provisional patent applications. The pending PCT patent application is not eligible to become an issued patent until, among other things, we file a national stage patent application within 30 months in the countries in which we seek patent protection. If we do not timely file any national stage patent applications, we may lose our priority date with respect to our PCT patent application and any patent protection on the inventions disclosed in such PCT patent application. While we intend to timely convert the U.S. provisional patent applications to one or more non-provisional patent applications and to timely file a national stage patent application relating to our PCT patent application, we cannot predict whether any of our future patent applications for BDTX-1535, BDTX-189 or any of our other product candidates will result in the issuance of patents that effectively protect BDTX-1535, BDTX-189 or our other product candidates. If we do not successfully obtain patent protection, or, even if we do obtain patent protection, if the scope of the patent protection we or our potential licensors obtain with respect to BDTX-1535, BDTX-189 or our other product candidates and technology is not sufficiently broad, we will be unable to prevent others from using our technology or from developing or commercializing technology and products similar or identical to ours or other competing products and technologies. Any failure to obtain or maintain patent protection with respect to BDTX-1535, BDTX-189 and our other product candidates would have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The degree of patent protection we require to successfully compete in the marketplace may be unavailable or severely limited in some cases and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We cannot provide any assurances that any patents we may own or in-license in the future will have, or that any of our patent applications that mature into issued patents will include, claims with a scope sufficient to protect our current and future product candidates or otherwise provide any competitive advantage. In addition, to the extent that we license intellectual property in the future, we cannot assure you that those licenses will remain in force. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. Furthermore, patents have a limited lifespan, and the term of any patents we may own or in-license in the future may be inadequate to protect our competitive position of our product candidates or technology for an adequate amount of time. In the United States, the natural expiration of a patent is generally 20 years after it is filed. Various extensions may be available; however, the life of a patent, and the protection it affords, is limited. Given the amount </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Even if they are unchallenged, our patent applications, if issued, and any patents we may own or in-license in the future, may not provide us with any meaningful protection or prevent competitors from designing around our patent claims to circumvent any patents we may own or in-license in the future by developing similar or alternative technologies or therapeutics in a non-infringing manner. For example, a third party may develop a competitive therapy that provides benefits similar to one or more of our product candidates but that uses a formulation and/or a device that falls outside the scope of any patent protection we may have in the future. If the patent protection provided by our patent applications or any patents we may pursue with respect to our product candidates is not sufficiently broad to impede such competition, our ability to successfully commercialize our product candidates could be negatively affected, which would harm our business. Although we currently own our patent applications, similar risks would apply to any patents or patent applications that we may own or in-license in the future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Patent positions of life sciences companies can be uncertain and involve complex factual and legal questions. Changes in either the patent laws or their interpretation in any jurisdiction that we seek patent protection may diminish our ability to protect our inventions, maintain and enforce our intellectual property rights; and, more generally, may affect the value of our intellectual property, including the narrowing of the scope of our patent applications or any patents we may own or in-license in the future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The patent prosecution process is complex, expensive, time-consuming and inconsistent across jurisdictions. Patent license negotiations also can be complex and protracted, with uncertain results. We may not be able to file, prosecute, maintain, enforce, or license all necessary or desirable patent rights at a commercially reasonable cost or in a timely manner. In addition, we may not pursue or obtain patent protection in all relevant markets. It is possible that we will fail to identify important patentable aspects of our research and development efforts in time to obtain appropriate or any patent protection. While we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research and development efforts, including for example, our employees, corporate collaborators, external academic scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach the agreements and disclose results before a patent application is filed, thereby endangering our ability to seek patent protection. In addition, publications of discoveries in the scientific and scholarly literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Consequently, we cannot be certain that we were the first to file for patent protection on the inventions claimed in our patent applications. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It is possible that defects of form in the preparation or filing of our patent applications, or any patents we may own or in-license in the future, may exist or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we or our partners, collaborators, licensees or licensors fail to establish, maintain or protect such patents and other intellectual property rights, such rights may be reduced or eliminated. If our partners, collaborators, licensees or licensors are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised. If there are material defects in the form, preparation, prosecution, or enforcement of our patent applications or patents we may own or in-license in the future, such patents may be invalid and/or unenforceable, and such applications may never result in valid, enforceable patents. Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact on our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, we cannot be certain that the claims in our patent applications covering composition of matter of our product candidates or technology will be considered patentable by the USPTO, or by patent offices in foreign countries, or that the claims in any issued patents we may own or in-license in the future will be considered patentable by courts in the United States or foreign countries. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Method of use patents protect the use of a product for the specified method. These types of patents do not prevent a competitor from making and marketing a product that is identical to our product for an indication that is outside the scope of the patented method. Moreover, even if competitors do not actively promote their product for our targeted indications, physicians may prescribe these products &#8220;off-label.&#8221; Although off-label prescriptions may induce or contribute to the infringement of method of use patents, the practice is common and such infringement is difficult to prevent or prosecute. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The patent position of pharmaceutical and biotechnology companies generally is highly uncertain and involves complex legal and factual questions for which many legal principles remain unresolved. In recent years, patent rights have been the subject of significant litigation. As a result, the issuance, scope, validity, enforceability and commercial value of any rights we may have from our patent applications are highly uncertain. Our patent applications may not result in patents being issued in the United States or in other jurisdictions which protect our technology or products or which effectively prevent others from commercializing competitive technologies and products. Moreover, our ability to obtain and maintain valid and enforceable patents depends on whether the differences between our inventions and the prior art, including our own previously filed patent applications and scientific publications, allow our inventions to be patentable over the prior art. Even if our patent applications issue as patents, third parties could challenge the validity of such patents based on such scientific publications and we could potentially lose valuable patent rights. Further, the scope of the invention claimed in a patent application can be significantly reduced before the patent is issued, and this scope can be reinterpreted after issuance. Even where patent applications we currently own or that we may license in the future issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us, or otherwise provide us with a competitive advantage. Any patents that eventually issue may be challenged, narrowed or invalidated by third parties. Consequently, we do not know whether any of our product candidates will be protectable or remain protected by valid and enforceable patent rights. Our competitors or other third parties may be able to evade any rights we may have from our patent applications by developing new compounds or alternative technologies or products in a non-infringing manner. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The issuance or grant of a patent is not irrefutable as to its inventorship, scope, validity or enforceability, and any patents we may own or in-license in the future may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in the patent claims of any patents we may own or in-license being narrowed, invalidated or held unenforceable, which could limit our ability to stop or prevent us from stopping others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our technology and products. There may be prior art of which we are not aware that may affect the validity or enforceability of a patent claim. There also may be prior art of which we are aware, but which we do not believe affects the validity or enforceability of a claim, which may, nonetheless, ultimately be found to affect the validity or enforceability of a claim. We may in the future, become subject to a third-party pre-issuance submission of prior art or opposition, derivation, revocation, re-examination, post-grant and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">inter partes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">review, or interference proceeding and other similar proceedings challenging any rights we may have from our patent applications or the patent rights of others in the U.S. Patent and Trademark Office, or USPTO, or other foreign patent office, or in declaratory judgment actions or counterclaims. An unfavorable determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, any rights we may have from our patent applications, allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or extinguish our ability to manufacture or commercialize products without infringing third-party patent rights. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our intellectual property may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Moreover, some of our intellectual property, including any patents we may own or in-license in the future, may be co-owned with third parties. If we are unable to obtain an exclusive license to any such third-party co-owners&#8217; interest in such intellectual property, including patents or patent applications, such co-owners may be able to license their rights to other third parties, including our competitors, and our competitors could market competing products and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">technology. In addition, we or our future licensors may need the cooperation of any such co-owners of our owned and in-licensed intellectual property, including patents and patent applications, in order to enforce such intellectual property against third parties, and such cooperation may not be provided to us or our future licensors. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are generally also subject to all of the same risks with respect to protection of intellectual property that we license, as we are for intellectual property that we own, which are described below. If we or our future licensors fail to adequately protect this intellectual property, our ability to commercialize products could suffer. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with our obligations in any future agreements under which we may license intellectual property rights from third parties or otherwise experience disruptions to our business relationships with our future licensors, we could lose license rights that are important to our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the future, we may be party to license or collaboration agreements with third parties to advance our research or allow commercialization of product candidates. Such future agreements may impose numerous obligations, such as development, diligence, payment, commercialization, funding, milestone, royalty, sublicensing, insurance, patent prosecution, enforcement and other obligations on us and may require us to meet development timelines, or to exercise commercially reasonable efforts to develop and commercialize licensed products, in order to maintain the licenses. In spite of our best efforts, our future licensors might conclude that we have materially breached our future license agreements and might therefore terminate the license agreements, thereby removing or limiting our ability to develop and commercialize products and technologies covered by these license agreements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any termination of these licenses, or if the underlying patents fail to provide the intended exclusivity, could result in the loss of significant rights and could harm our ability to commercialize our product candidates, and competitors or other third parties would have the freedom to seek regulatory approval of, and to market, products identical to ours and we may be required to cease our development and commercialization of certain of our product candidates. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Disputes may also arise between us and our future licensors regarding intellectual property subject to a license agreement, including: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the scope of rights granted under the license agreement and other interpretation-related issues; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">whether and the extent to which our technology and processes infringe, misappropriate or otherwise violate intellectual property rights of the licensor that is not subject to the licensing agreement; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our right to sublicense patent and other rights to third parties under collaborative development relationships; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization of our product candidates, and what activities satisfy those diligence obligations; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the priority of invention of any patented technology; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our future licensors and us and our partners. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, the agreements under which we may license intellectual property or technology from third parties in the future are likely to be complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that we may license in the future prevent or impair our ability to maintain future licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates, which could have a material adverse effect on our business, financial conditions, results of operations and prospects. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the protection afforded by patents we may own or in-license in the future, we seek to rely on trade secret protection, confidentiality agreements, and license agreements to protect proprietary know-how that is not patentable, processes for which patents are difficult to enforce and any other elements of our product discovery and development processes, including our MAP drug discovery engine that involve proprietary know-how, information, or technology that is not covered by patents. Although we require all of our employees, consultants, advisors and any third parties who have access to our proprietary know-how, information, or technology to enter into confidentiality agreements, trade secrets can be difficult to protect and we have limited control over the protection of trade secrets used by our collaborators and suppliers. We cannot be certain that we have or will obtain these agreements in all circumstances and we cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary information. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Moreover, any of these parties might breach the agreements and intentionally or inadvertently disclose our trade secret information and we may not be able to obtain adequate remedies for such breaches. In addition, competitors may otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. Furthermore, the laws of some foreign countries do not protect proprietary rights and trade secrets to the same extent or in the same manner as the laws of the United States. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the United States and abroad. If we are unable to prevent unauthorized material disclosure of our intellectual property to third parties, we will not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, financial condition, results of operations and future prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. If we choose to go to court to stop a third party from using any of our trade secrets, we may incur substantial costs. These lawsuits may consume our time and other resources even if we are successful. For example, significant elements of our MAP drug discovery engine, including aspects of oncogenicity computational algorithms, in vivo experiments to validate mechanisms and pharmacology, drug design, and related processes, are based on unpatented trade secrets that are not publicly disclosed. Although we take steps to protect our proprietary information and trade secrets, including through contractual means with our employees and consultants, third parties may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets or disclose our technology. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Thus, we may not be able to meaningfully protect our trade secrets. It is our policy to require our employees, consultants, outside scientific collaborators, sponsored researchers and other advisors to execute confidentiality agreements upon the commencement of employment or consulting relationships with us. These agreements provide that all confidential information concerning our business or financial affairs developed or made known to the individual or entity during the course of the party&#8217;s relationship with us is to be kept confidential and not disclosed to third parties except in specific circumstances. In addition, we take other appropriate precautions, such as physical and technological security measures, to guard against misappropriation of our proprietary technology by third parties. In the case of employees, the agreements provide that all inventions conceived by the individual, and which are related to our current or planned business or research and development or made during normal working hours, on our premises or using our equipment or proprietary information, are our exclusive property. Although we require all of our employees to assign their inventions to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Such claims could have a material adverse effect on our business, financial condition, results of operations, and prospects. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in obtaining or maintaining necessary rights to product components and processes for our development pipeline through acquisitions and in-licenses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Because developing our product candidates may require the use of proprietary rights held by third parties, the growth of our business will likely depend in part on our ability to acquire, in-license or use these proprietary rights. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our product candidates may also require specific formulations to work effectively and efficiently and these rights may be held by others. Similarly, efficient production or delivery of our product candidates may also require specific compositions or methods, and the rights to these may be owned by third parties. We may be unable to acquire or in-license any compositions, methods of use, processes or other third-party intellectual property rights from third parties that we identify as necessary or important to our business operations. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all, which would harm our business. We may need to cease use of the compositions or methods covered by such third-party intellectual property rights, and may need to seek to develop alternative approaches that do not infringe on such intellectual property rights which may entail additional costs and development delays, even if we were able to develop such alternatives, which may not be feasible. Even if we are able to obtain a license, it may be nonexclusive, thereby giving our competitors access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop or license replacement technology. Moreover, the molecules that will be used with our product candidates may be covered by the intellectual property rights of others. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, we sometimes collaborate with academic institutions to accelerate our preclinical research or development under written agreements with these institutions. In certain cases, these institutions provide us with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to others, potentially blocking our ability to pursue our program and allowing third parties to compete with us. If we are unable to successfully obtain rights to required third-party intellectual property or to maintain the existing intellectual property rights we have, we may have to abandon development of such program and our business and financial condition could suffer. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The licensing and acquisition of third-party intellectual property rights is a competitive area, and companies, which may be more established, or have greater resources than we do, may also be pursuing strategies to license or acquire third-party intellectual property rights that we may consider necessary or attractive in order to commercialize our product candidates. More established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. There can be no assurance that we will be able to successfully complete such negotiations and ultimately acquire the rights to the intellectual property surrounding the additional product candidates that we may seek to acquire. If we are unable to successfully obtain rights to required third-party intellectual property or to maintain the existing intellectual property rights we have, we may have to abandon development of such program and our business, results of operations, financial condition and prospects could suffer. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Any issued patents we may own or in-license in the future covering our product candidates could be narrowed or found invalid or unenforceable if challenged in court or before administrative bodies in the United States or abroad, including the USPTO. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If we or our future licensors or strategic partners initiate legal proceedings against a third party to enforce a patent covering one of our product candidates, the defendant could counterclaim that the patent covering our product candidate, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace, and there are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of patentable subject matter, lack of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">written description, lack of novelty, obviousness, or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">inter partes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">review, post grant review and equivalent proceedings in foreign jurisdictions (such as opposition proceedings). Such proceedings could result in revocation or amendment to our patent applications or any patents we may own or in-license in the future in such a way that they no longer cover our product candidates. The outcome following legal assertions of invalidity and unenforceability is unpredictable. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate or render unenforceable, any rights we may have from our patent applications or any patents we may own or in-license in the future, allow third parties to commercialize our product candidates or other technologies and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights. Moreover, we may have to participate in interference proceedings declared by the USPTO to determine priority of invention or in post-grant challenge proceedings, such as oppositions in a foreign patent office, that challenge our or priority of invention or other features of patentability with respect to our patent applications and any patents we may own or in-license. Such challenges may result in loss of patent rights, loss of exclusivity, or in patent claims being narrowed, invalidated, or held unenforceable, which could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our product candidates and other technologies. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we or our future licensing partners and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, or if we are otherwise unable to adequately protect our rights, we would lose at least part, and perhaps all, of the patent protection on our product candidates. Such a loss of patent protection could have a material adverse impact on our business and our ability to commercialize or license our technology and product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Such proceedings also may result in substantial cost and require significant time from our scientists and management, even if the eventual outcome is favorable to us. If we are unsuccessful in any such proceeding or other priority or inventorship dispute, we may be required to obtain and maintain licenses from third parties, including parties involved in any such interference proceedings or other priority or inventorship disputes. Such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain and maintain such licenses, we may need to cease the development, manufacture, and commercialization of one or more of the product candidates we may develop. The loss of exclusivity or the narrowing of our patent application claims could limit our ability to stop others from using or commercializing similar or identical technology and products. Any of the foregoing could have a material adverse effect on our business, results of operations, financial condition and prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and patent protection could be reduced or eliminated for non-compliance with these requirements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on any issued patent are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of the patent. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process and following the issuance of a patent. While an inadvertent lapse can in some cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. In such an event, our competitors might be able to enter the market with similar or identical products or platforms, which could have a material adverse effect on our business prospects and financial condition. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We have limited foreign intellectual property rights and may not be able to protect our intellectual property rights throughout the world. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may not be able to pursue generic coverage of our product candidates or MAP drug discovery engine outside of the United States. Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and further, may export otherwise infringing products to territories where we have patent protection, but where enforcement is not as strong as that in the United States. These products may compete with our product candidates and in jurisdictions where we do not have any issued patents our patent applications or other intellectual property rights may not be effective or sufficient to prevent them from competing. Our patent portfolio is at the very early stage. We will need to decide whether and in which jurisdictions to pursue protection for the various inventions in our portfolio prior to applicable deadlines. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biopharmaceutical products, which could make it difficult for us to stop the infringement of any patents we may own or in-license in the future or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce any rights we may have in our patent applications or any patents we may own or in-license in the future in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put any patents we may own or in-license in the future at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we are forced to grant a license to third parties with respect to any patents we may own or license in the future that are relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations, and prospects may be adversely affected. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If we do not obtain patent term extension and data exclusivity for any of our current or future product candidates we may develop, our business may be materially harmed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Depending upon the timing, duration and specifics of any FDA marketing approval of any of our current or future product candidates we may develop, one or more U.S. patents we may own or in-license in the future may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent term extension of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. However, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents, or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">obtain patent term extension or the term of any such extension is shorter than what we request, our competitors may obtain approval of competing products following expiration of any patents that issue from our patent applications, and our business, financial condition, results of operations, and prospects could be materially harmed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our marks of interest and our business may be adversely affected. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our trademarks or trade names may be challenged, infringed, diluted, circumvented or declared generic or determined to be infringing on other marks. We intend to rely on both registration and common law protection for our trademarks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or customers in our markets of interest. During the trademark registration process, we may receive Office Actions from the USPTO objecting to the registration of our trademark. Although we would be given an opportunity to respond to those objections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and/or to seek the cancellation of registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. If we are unable to obtain a registered trademark or establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Numerous factors may limit any potential competitive advantage provided by our intellectual property rights. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The degree of future protection afforded by our intellectual property rights, whether owned or in-licensed, is uncertain because intellectual property rights have limitations, and may not adequately protect our business, provide a barrier to entry against our competitors or potential competitors, or permit us to maintain our competitive advantage. Moreover, if a third party has intellectual property rights that cover the practice of our technology, we may not be able to fully exercise or extract value from our intellectual property rights. The following examples are illustrative: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">patent applications that we own or may in-license in the future may not lead to issued patents; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">patents, should they issue, that we may own or in-license in the future, may not provide us with any competitive advantages, may be narrowed in scope, or may be challenged and held invalid or unenforceable; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">others may be able to develop and/or practice technology, including compounds that are similar to the chemical compositions of our product candidates, that is similar to our technology or aspects of our technology but that is not covered by the claims of any patents we may own or in-license in the future, should any patents issue;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">third parties may compete with us in jurisdictions where we do not pursue and obtain patent protection;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we, or our future licensors or collaborators, might not have been the first to make the inventions covered by a patent application that we own or may in-license in the future;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we, or our future licensors or collaborators, might not have been the first to file patent applications covering a particular invention;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">others may independently develop similar or alternative technologies without infringing, misappropriating or otherwise violating our intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our competitors might conduct research and development activities in the United States and other countries that provide a safe harbor from patent infringement claims for certain research and development activities, as well as in countries where we do not have patent rights, and may then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may not be able to obtain and/or maintain necessary licenses on reasonable terms or at all;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">third parties may assert an ownership interest in our intellectual property and, if successful, such disputes may preclude us from exercising exclusive rights, or any rights at all, over that intellectual property;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may choose not to file a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such trade secrets or know-how;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may not be able to maintain the confidentiality of our trade secrets or other proprietary information;</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may not develop or in-license additional proprietary technologies that are patentable; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the patents of others may have an adverse effect on our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Should any of these events occur, they could significantly harm our business, financial condition, results of operations and prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to intellectual property litigation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Third-party claims of intellectual property infringement, misappropriation or other violations may be costly and time consuming and may prevent or delay our product discovery and development efforts. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The intellectual property landscape around precision medicine is crowded, and third parties may initiate legal proceedings alleging that we are infringing, misappropriating, or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business. Our commercial success depends upon our ability to develop, manufacture, market and sell our current and future product candidates and use our proprietary technologies without infringing, misappropriating or otherwise violating the intellectual property rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries, as well as administrative proceedings for challenging patents, including derivation, interference, reexamination, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> review, and post grant review proceedings before the USPTO or oppositions and other comparable proceedings in foreign jurisdictions. We or any of our future licensors or strategic partners may be party to, exposed to, or threatened with, future adversarial proceedings or litigation by third parties having patent or other intellectual property rights alleging that our current or future product candidates and/or proprietary technologies infringe, misappropriate or otherwise violate their intellectual property rights. We cannot assure you that our product candidates and other technologies that we have developed, are developing or may develop in the future do not or will not infringe, misappropriate or otherwise violate existing or future patents or other intellectual property rights owned by third parties. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our product candidates may give rise to claims of infringement of the patent rights of others. Moreover, it is not always clear to industry participants, including us, which patents cover various types of drugs, products or their methods of use or manufacture. Thus, because of the large number of patents issued and patent applications filed in our fields, there may be a risk that third parties may allege they have patent rights encompassing our product candidates, technologies or methods. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a third party claims that we infringe, misappropriate or otherwise violate its intellectual property rights, we may face a number of issues, including, but not limited to: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">infringement, misappropriation and other intellectual property claims which, regardless of merit, may be expensive and time-consuming to litigate and may divert our management&#8217;s attention from our core business and may impact our reputation; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">substantial damages for infringement, misappropriation or other violations, which we may have to pay if a court decides that the product candidate or technology at issue infringes, misappropriates or violates the third party&#8217;s rights, and, if the court finds that the infringement was willful, we could be ordered to pay treble damages and the patent owner&#8217;s attorneys&#8217; fees; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a court prohibiting us from developing, manufacturing, marketing or selling our product candidates, including BDTX-1535 or BDTX-189, or from using our proprietary technologies, unless the third party licenses its product rights to us, which it is not required to do, on commercially reasonable terms or at all; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">if a license is available from a third party, we may have to pay substantial royalties, upfront fees and other amounts, and/or grant cross-licenses to intellectual property rights for our products, or the license to us may be non-exclusive, which would permit third parties to use the same intellectual property to compete with us; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">redesigning our product candidates or processes so they do not infringe, misappropriate or violate third party intellectual property rights, which may not be possible or may require substantial monetary expenditures and time; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and, if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations or could otherwise have a material adverse effect on our business, results of operations, financial condition and prospects. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition, results of operations or prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may choose to challenge the patentability of claims in a third party&#8217;s U.S. patent by requesting that the USPTO review the patent claims in an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">ex-parte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> re-exam, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> review or post-grant review proceedings. These proceedings are expensive and may consume our time or other resources. We may choose to challenge a third party&#8217;s patent in patent opposition proceedings in the EPO, or other foreign patent office. The costs of these opposition proceedings could be substantial, and may consume our time or other resources. If we fail to obtain a favorable result at the USPTO, EPO or other patent office then we may be exposed to litigation by a third party alleging that the patent may be infringed by our product candidates or proprietary technologies. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Third parties may assert that we are employing their proprietary technology without authorization. Patents issued in the United States by law enjoy a presumption of validity that can be rebutted only with evidence that is &#8220;clear and convincing,&#8221; a heightened standard of proof. There may be issued third-party patents of which we are currently unaware with claims to compositions, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our product candidates. Patent applications can take many years to issue. In addition, because some patent applications in the United States may be maintained in secrecy until the patents are issued, patent applications in the United States and many foreign jurisdictions are typically not published until 18 months after filing, and publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed patent applications covering our product candidates or technology. If any such patent applications issue as patents, and if such patents have priority over our patent applications or patents we may own or in-license, we may be required to obtain rights to such patents owned by third parties which may not be available on commercially reasonable terms or at all, or may only be available on a non-exclusive basis. There may be currently pending patent applications which may later result in issued patents that our product candidates may infringe. It is also possible that patents owned by third parties of which we are aware, but which we do not believe are relevant to our product candidates or other technologies, could be found to be infringed by our product candidates or other technologies. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. Moreover, we may fail to identify relevant patents or incorrectly conclude that a patent is invalid, not enforceable, exhausted, or not infringed by our activities. If any third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of our product candidates, molecules used in or formed during the manufacturing process, or any final product itself, the holders of any such patents may be able to block our ability to commercialize the product candidate unless we obtained a license under the applicable patents, or until such patents expire or they are finally determined to be held invalid or unenforceable. Similarly, if any third-party patent were held by a court of competent jurisdiction to cover aspects of our formulations, processes for manufacture or methods of use, including combination therapy or patient selection methods, the holders of any such patent may be able to block our ability to develop and commercialize the product candidate unless we obtained a license or until such patent expires or is finally determined to be held invalid or unenforceable. In either case, such a license may not be available on commercially reasonable terms or at all. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, or at all, our ability to commercialize our product candidates may be impaired or delayed, which could in turn significantly harm our business. Even if we obtain a license, it may be nonexclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, if the breadth or strength of protection provided by our patent applications or any patents we may own or in-license in the future is threatened, it </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Parties making claims against us may seek and obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize our product candidates. Defense of these claims, regardless of their merit, could involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement, misappropriation or other violation against us, we may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, obtain one or more licenses from third parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure. We cannot predict whether any such license would be available at all or whether it would be available on commercially reasonable terms. Furthermore, even in the absence of litigation, we may need or may choose to obtain licenses from third parties to advance our research or allow commercialization of our product candidates. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all. In that event, we would be unable to further develop and commercialize our product candidates, which could harm our business significantly. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may be involved in lawsuits to protect or enforce our intellectual property rights, including any patents we may own or in-license in the future, which could be expensive, time-consuming and unsuccessful. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Competitors may infringe any patents we may own or in-license in the future. In addition, any patents we may own or in-license also may become involved in inventorship, priority, validity or unenforceability disputes. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. In addition, in an infringement proceeding, a court may decide that one or more of any patents we may own or in-license in the future is not valid or is unenforceable or that the other party&#8217;s use of our technology that may be patented falls under the safe harbor to patent infringement under 35 U.S.C. &#167;271(e)(1). There is also the risk that, even if the validity of these patents is upheld, the court may refuse to stop the other party from using the technology at issue on the grounds that any patents we may own or in-license in the future do not cover the technology in question or that such third party&#8217;s activities do not infringe our patent applications or any patents we may own or in-license in the future. An adverse result in any litigation or defense proceedings could put one or more of any patents we may own or in-license in the future at risk of being invalidated, held unenforceable, or interpreted narrowly and could put our patent applications at risk of not issuing. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, obtain one or more licenses from third parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Post-grant proceedings provoked by third parties or brought by the USPTO may be necessary to determine the validity or priority of inventions with respect to our patent applications or any patents we may own or in-license in the future. These proceedings are expensive and an unfavorable outcome could result in a loss our current patent rights and could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms. In addition to potential USPTO review proceedings, we may become a party to patent opposition proceedings in the European Patent Office, or EPO, or similar proceedings in other foreign patent offices, where either our foreign patents are challenged. The costs of these opposition or similar proceedings could be substantial, and may result in a loss of scope of some claims or a loss of the entire patent. An unfavorable result at the USPTO, EPO or other patent office may result in the loss of our right to exclude others from practicing one or more of our inventions in the relevant country or jurisdiction, which could have a material adverse effect on our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Litigation or post-grant proceedings may result in a decision adverse to our interests and, even if we are successful, may result in substantial costs and distract our management and other employees. We may not be able to prevent, misappropriation of our trade secrets or confidential information, particularly in countries where the laws may not protect those rights as fully as in the United States. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may not be able to detect infringement against any patents we may own or in-license in the future. Even if we detect infringement by a third party of any patents we may own or in-license in the future, we may choose not to pursue litigation against or settlement with the third party. If we later sue such third party for patent infringement, the third party may have certain legal defenses available to it, which otherwise would not be available except for the delay between when the infringement was first detected and when the suit was brought. Such legal defenses may make it impossible for us to enforce any patents we may own or in-license against such third party. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims challenging the inventorship or ownership of any intellectual property, including any patents we may own or in-license in the future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may be subject to claims that former employees, collaborators or other third parties have an interest in any patents we may own or in-license in the future, trade secrets, or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our product candidates or other technologies. We generally enter into confidentiality and intellectual property assignment agreements with our employees, consultants, and contractors. These agreements generally provide that inventions conceived by the party in the course of rendering services to us will be our exclusive property. However, those agreements may not be honored and may not effectively assign intellectual property rights to us. Moreover, there may be some circumstances, where we are unable to negotiate for such ownership rights. Disputes regarding ownership or inventorship of intellectual property can also arise in other contexts, such as collaborations and sponsored research. If we are subject to a dispute challenging our rights in or to patents or other intellectual property, such a dispute could be expensive and time consuming. Litigation may be necessary to defend against these and other claims challenging inventorship of any patents we may own or in-license in the future, trade secrets or other intellectual property. If we were unsuccessful, in addition to paying monetary damages, we could lose valuable rights in intellectual property that we regard as our own, such as exclusive ownership of, or right to use, intellectual property that is important to our product candidates and other technologies. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information or alleged trade secrets of third parties or competitors or are in breach of non-competition or non-solicitation agreements with our competitors. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have received confidential and proprietary information from third parties. In addition, as is common in the biotechnology and pharmaceutical industries, we employ individuals who were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors, in some cases until recently. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed confidential information or trade secrets of these third parties or our employees&#8217; former employers or our consultants&#8217; or contractors&#8217; current or former clients or customers. In addition, we have been and may in the future be subject to claims that we caused an employee to breach the terms of his or her non-competition or non-solicitation agreement. Litigation or arbitration may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation or other legal proceedings relating to intellectual property claims and possible aftermath could result in substantial cost and be a distraction to our management and employees. Any litigation or the threat thereof may adversely affect our ability to hire employees. A loss of key personnel or their work product could hamper or prevent our ability to commercialize product candidates, which could have an adverse effect on our business, results of operations and financial condition. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and, if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. This type of litigation or proceeding could substantially increase our operating losses and reduce our resources available for development activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their substantially greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other intellectual property related proceedings could adversely affect our ability to compete in the marketplace. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks related to our reliance on third parties </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to conduct our preclinical studies and clinical trials. If these third parties do not properly and successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain regulatory approval of or commercialize our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We utilize and depend upon independent investigators and collaborators, such as medical institutions, CROs, contract manufacturing organizations, or CMOs, and strategic partners to conduct and support our preclinical studies and clinical trials under agreements with us. We have to negotiate budgets and contracts with CROs, trial sites and CMOs and we may not be able to do so on favorable terms, which may result in delays to our development timelines and increased costs. We will rely heavily on these third parties over the course of our preclinical studies and clinical trials, and we control only certain aspects of their activities. As a result, we will have less direct control over the conduct, timing and completion of these preclinical studies and clinical trials and the management of data developed through preclinical studies and clinical trials than would be the case if we were relying entirely upon our own staff. Nevertheless, we are responsible for ensuring that each of our studies is conducted in accordance with applicable protocol, legal and regulatory requirements and scientific standards, and our reliance on third parties does not relieve us of our regulatory responsibilities. We and these third parties are required to comply with GCPs, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for product candidates in clinical development. Regulatory authorities enforce these GCPs through periodic inspections of trial sponsors, principal investigators and trial sites. If we or any of these third parties fail to comply with applicable GCP regulations, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that, upon inspection, such regulatory authorities will determine that any of our clinical trials comply with the GCP regulations. In addition, our clinical trials must be conducted with pharmaceutical product produced under cGMP regulations and will require a large number of test patients. Our failure or any failure by these third parties to comply with these regulations or to recruit a sufficient number of patients may require us to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">repeat clinical trials, which would delay the regulatory approval process. Moreover, our business may be implicated if any of these third parties violates federal or state fraud and abuse or false claims laws and regulations or healthcare privacy and security laws. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any third parties conducting our clinical trials are not and will not be our employees and, except for remedies available to us under our agreements with such third parties, we cannot control whether or not they devote sufficient time and resources to our ongoing, clinical and non-clinical product candidates. These third parties may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials or other drug development activities, which could affect their performance on our behalf. If these third parties do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated and we may not be able to complete development of, obtain regulatory approval of or successfully commercialize our product candidates. As a result, our financial results and the commercial prospects for our product candidates would be harmed, our costs could increase and our ability to generate revenue could be delayed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Switching or adding third parties to conduct our preclinical studies and clinical trials involves substantial cost and requires extensive management time and focus. In addition, there is a natural transition period when a new third party commences work. As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may form or seek collaborations or strategic alliances or enter into additional licensing arrangements in the future, and we may not realize the benefits of such collaborations, alliances or licensing arrangements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may form or seek strategic alliances, create joint ventures or collaborations, or enter into additional licensing arrangements with third parties that we believe will complement or augment our development and commercialization efforts with respect to our product candidates and any future product candidates that we may develop. Any of these relationships may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute our existing stockholders or disrupt our management and business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Moreover, we may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for our product candidates because they may be deemed to be at too early of a stage of development for collaborative effort and third parties may not view our product candidates as having the requisite potential to demonstrate safety, potency, purity and efficacy and obtain marketing approval. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, collaborations involving our product candidates are subject to numerous risks, which may include the following: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">collaborators have significant discretion in determining the efforts and resources that they will apply to a collaboration; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">collaborators may not pursue development and commercialization of our product candidates or may elect not to continue or renew development or commercialization of our product candidates based on clinical trial results, changes in their strategic focus due to the acquisition of competitive products, availability of funding or other external factors, such as a business combination that diverts resources or creates competing priorities; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">collaborators may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial, abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a collaborator with marketing and distribution rights to one or more products may not commit sufficient resources to their marketing and distribution; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">disputes may arise between us and a collaborator that cause the delay or termination of the research, development or commercialization of our product candidates, or that result in costly litigation or arbitration that diverts management attention and resources; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">collaborators may own or co-own intellectual property covering our products that results from our collaborating with them, and in such cases, we would not have the exclusive right to commercialize such intellectual property. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a result, if we enter into additional collaboration agreements and strategic partnerships or license our product candidates, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture, which could delay our timelines or otherwise adversely affect our business. We also cannot be certain that, following a strategic transaction or license, we will achieve the revenue or specific net income that justifies such transaction. Any delays in entering into new collaborations or strategic partnership agreements related to our product candidates could delay the development and commercialization of our product candidates in certain geographies for certain indications, which would harm our business prospects, financial condition and results of operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We currently rely and expect to rely in the future on the use of manufacturing suites in third-party facilities or third parties to manufacture our product candidates. Our business could be harmed if we are unable to use third-party manufacturing suites or if the third party manufacturers fail to provide us with sufficient quantities of our product candidates or fail to do so at acceptable quality levels or prices. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We do not currently own any facility that may be used as our clinical-scale manufacturing and processing facility and must currently rely on outside vendors to manufacture our product candidates. We have not yet caused our product candidates to be manufactured on a commercial scale and may not be able to do so for any of our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our anticipated reliance on a limited number of third-party manufacturers exposes us to a number of risks, including the following: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may be unable to identify manufacturers on acceptable terms or at all because the number of potential manufacturers is limited and the FDA must inspect any manufacturers for current cGMP compliance as part of our marketing application; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a new manufacturer would have to be educated in, or develop substantially equivalent processes for, the production of our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our third-party manufacturers might be unable to timely manufacture our product candidates or produce the quantity and quality required to meet our clinical and commercial needs, if any; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">contract manufacturers may not be able to execute our manufacturing procedures and other logistical support requirements appropriately; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our future contract manufacturers may not perform as agreed, may not devote sufficient resources to our product candidates or may not remain in the contract manufacturing business for the time required to supply our clinical trials or to successfully produce, store, and distribute our products, if any; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">manufacturers are subject to ongoing periodic unannounced inspection by the FDA and corresponding state agencies to ensure strict compliance with cGMP and other government regulations and corresponding foreign standards and we have no control over third-party manufacturers&#8217; compliance with these regulations and standards; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">we may not own, or may have to share, the intellectual property rights to any improvements made by our third-party manufacturers in the manufacturing process for our product candidates; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our third-party manufacturers could breach or terminate their agreements with us; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">raw materials and components used in the manufacturing process, particularly those for which we have no other source or supplier, may not be available or may not be suitable or acceptable for use due to material or component defects; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our contract manufacturers and critical reagent suppliers may be subject to inclement weather, as well as natural or man-made disasters; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our contract manufacturers may have unacceptable or inconsistent product quality success rates and yields, and we have no direct control over our contract manufacturers&#8217; ability to maintain adequate quality control, quality assurance and qualified personnel. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each of these risks could delay or prevent the completion of our clinical trials or the approval of any of our product candidates by the FDA, result in higher costs or adversely impact commercialization of our product candidates. In addition, we will rely on third parties to perform certain specification tests on our product candidates prior to delivery to patients. If these tests are not appropriately done and test data are not reliable, patients could be put at risk of serious harm and the FDA could place significant restrictions on our company until deficiencies are remedied. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our manufacturing process needs to comply with FDA regulations relating to the quality and reliability of such processes. Any failure to comply with relevant regulations could result in delays in or termination of our clinical programs and suspension or withdrawal of any regulatory approvals. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to commercially produce our products either at our own facility or at a third party&#8217;s facility, we will need to comply with the FDA&#8217;s cGMP regulations and guidelines. We may encounter difficulties in achieving quality control and quality assurance and may experience shortages in qualified personnel. We are subject to inspections by the FDA and comparable foreign regulatory authorities to confirm compliance with applicable regulatory requirements. Any failure to follow cGMP or other regulatory requirements or delay, interruption or other issues that arise in the manufacture, fill-finish, packaging, or storage of our precision medicines as a result of a failure of our facilities or the facilities or operations of third parties to comply with regulatory requirements or pass any regulatory authority inspection could significantly impair our ability to develop and commercialize our product candidates, including leading to significant delays in the availability of our precision medicines for our clinical trials or the termination of or suspension of a clinical trial, or the delay or prevention of a filing or approval of marketing applications for our product candidates. Significant non-compliance could also result in the imposition of sanctions, including warning or untitled letters, fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approvals for our product candidates, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could damage our reputation and our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If our third-party manufacturers use hazardous and biological materials in a manner that causes injury or violates applicable law, we may be liable for damages. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our research and development activities involve the controlled use of potentially hazardous substances, including chemical and biological materials, by our third-party manufacturers. Our manufacturers are subject to federal, state and local laws and regulations in the United States governing the use, manufacture, storage, handling and disposal of medical and hazardous materials. Although we believe that our manufacturers&#8217; procedures for using, handling, storing and disposing of these materials comply with legally prescribed standards, we cannot completely eliminate the risk of contamination or injury resulting from medical or hazardous materials. As a result of any such contamination or injury, we may incur liability or local, city, state or federal authorities may curtail the use of these materials and interrupt our business operations. In the event of an accident, we could be held liable for damages or penalized with fines, and the liability could exceed our resources. We do not have any insurance for liabilities arising from medical or hazardous materials. Compliance with applicable environmental laws and regulations is expensive, and current or future environmental regulations may impair our research, development and production efforts, which could harm our business, prospects, financial condition or results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks related to managing growth and employee matters </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to our employee matters</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We are highly dependent on our key personnel and anticipate hiring new key personnel. If we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our ability to compete in the highly competitive biotechnology and pharmaceutical industries depends upon our ability to attract and retain highly qualified managerial, scientific and medical personnel. We are highly dependent on our management, scientific and medical personnel, including our President and Chief Executive Officer, our Chief Business Officer &amp; Interim Chief Financial Officer, Chief Scientific Officer, and Interim Chief Medical Officer. Our Interim Chief Medical Officer, Karsten Witt, M.D., is not our employee and provides services under a consulting agreement. We face a variety of risks and uncertainties relating to management transition, including diversion of management attention from business concerns, failure to retain other key personnel or loss of institutional knowledge. In addition, the loss of the services of any of our executive officers, other key employees and other scientific and medical advisors, and an inability to find suitable replacements could result in delays in product development and harm our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We conduct our operations at our facilities in Cambridge, MA, New York, NY, and Stony Brook, NY. The Massachusetts region is headquarters to many other biopharmaceutical companies and many academic and research institutions. Competition for skilled personnel in our market is intense and may limit our ability to hire and retain highly qualified personnel on acceptable terms or at all. Changes to U.S. immigration and work authorization laws and regulations, including those that restrain the flow of scientific and professional talent, can be significantly affected by political forces and levels of economic activity. Our business may be materially adversely affected if legislative or administrative changes to immigration or visa laws and regulations impair our hiring processes and goals or projects involving personnel who are not U.S. citizens. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To encourage valuable employees to remain at our company, in addition to salary and cash incentives, we have provided stock options that vest over time. The value to employees of stock options that vest over time may be significantly affected by movements in our stock price that are beyond our control, and may at any time be insufficient to counteract more lucrative offers from other companies. Despite our efforts to retain valuable employees, members of our management, scientific and development teams may terminate their employment with us on short notice. Although we have employment agreements with our key employees, these employment agreements provide for at-will employment, which means that any of our employees could leave our employment at any time, with or without notice. Our success also depends on our ability to continue to attract, retain and motivate highly skilled junior, mid-level and senior managers as well as junior, mid-level and senior scientific and medical personnel. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to our business operations and growth</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We will need to grow the size of our organization, and we may experience difficulties in managing this growth. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had 86 full-time employees. We intend to hire new employees to conduct our research and development activities in the future. Any delay in hiring such new employees could result in delays in our research and development activities and would harm our business. As our development and commercialization plans and strategies develop, and as we transition into operating as a public company, we expect to need additional managerial, operational, sales, marketing, financial and other personnel, as well as additional facilities to expand our operations. Future growth would impose significant added responsibilities on members of management, including: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">identifying, recruiting, integrating, maintaining and motivating additional employees; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">managing our internal development efforts effectively, including the clinical and FDA review process for our product candidates, while complying with our contractual obligations to contractors and other third parties; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">improving our operational, financial and management controls, reporting systems and procedures. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our future financial performance and our ability to commercialize our product candidates will depend, in part, on our ability to effectively manage any future growth, and our management may also have to divert a disproportionate amount of its attention away from day-to-day activities in order to devote a substantial amount of time to managing these growth activities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent organizations, advisors and consultants to provide certain services, including substantially all aspects of regulatory approval, clinical trial management and manufacturing. There can be no assurance that the services of independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by consultants is compromised for any reason, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain regulatory approval of our product candidates or otherwise advance our business. There can be no assurance that we will be able to manage our existing consultants or find other competent outside contractors and consultants on economically reasonable terms, or at all. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, or we are not able to effectively build out new facilities to accommodate this expansion, we may not be able to successfully implement the tasks necessary to further develop and commercialize our product candidates and, accordingly, may not achieve our research, development and commercialization goals. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our internal computer systems, or those used by our third-party CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of the development programs of our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Despite the implementation of security measures, our internal computer systems and those of our current and future CROs and other contractors and consultants may be vulnerable to damage from computer viruses, unauthorized access, natural disasters, and telecommunication and electrical failures. While we have not experienced any such material system failure or security breach to date, if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our business operations. For example, the loss of data from completed or future preclinical studies and clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely on third parties for the manufacture of our product candidates and to conduct clinical trials, and similar events relating to their computer systems could also have a material adverse effect on our business. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the further development and commercialization of our product candidates could be delayed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our operations, and those of our CROs, CMOs and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics and other natural or man-made disasters or business interruptions, for which we are predominantly self-insured. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses. We rely on third-party manufacturers to produce our product candidates. Our ability to obtain clinical supplies of our product candidates could be disrupted if the operations of these suppliers are affected by a man-made or natural disaster or other business interruption. </span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit commercialization of our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We face an inherent risk of product liability as a result of the planned clinical testing of our product candidates and will face an even greater risk if we commercialize any products. For example, we may be sued if our product candidates cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit commercialization of our product candidates. Even successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">decreased demand for our product candidates or products that we may develop; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">injury to our reputation; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">withdrawal of clinical trial participants; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">initiation of investigations by regulators; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">costs to defend the related litigation; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a diversion of management&#8217;s time and our resources; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">substantial monetary awards to trial participants or patients; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">product recalls, withdrawals or labeling, marketing or promotional restrictions; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">loss of revenue; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">exhaustion of any available insurance and our capital resources; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the inability to commercialize any product candidate; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a decline in our share price. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Failure to obtain or retain sufficient product liability insurance at an acceptable cost to protect against potential product liability claims could prevent or inhibit the commercialization of products we develop, alone or with corporate collaborators. Although we have clinical trial insurance, our insurance policies also have various exclusions, and we may be subject to a product liability claim for which we have no coverage. We may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. Even if our agreements with any future corporate collaborators entitle us to indemnification against losses, such indemnification may not be available or adequate should any claim arise.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to tax</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or IRC, if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as a greater than 50% change (by value) in its equity ownership by 5% stockholders over a three-year period), the corporation&#8217;s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change taxable income may be limited. As a result of our most recent private placements and other transactions that have occurred over the past three years, we may have experienced, and may experience, an &#8220;ownership change.&#8221; We may also experience ownership changes in the future as a result of subsequent shifts in our stock ownership. As of December&#160;31, 2021, we had U.S. federal and state net operating loss carryforwards of $209,607 and U.S. federal research and development tax credit carryforwards of $5,439, each of which will begin to expire at various dates through 2039 and which could be limited if we experience an &#8220;ownership change.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Beginning in 2022, the TCJA eliminates the option to deduct research and development expenditures currently and requires taxpayers to amortize them over five years pursuant to  IRC Section 174. Although Congress is considering legislation that would defer the amortization requirement to later years, we have no assurance that the provision will be repealed or otherwise modified. Therefore, based on current assumptions, this could potentially increase the effective tax rate and decrease the Company's cash from operations beginning in 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks related to ownership of our common stock </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to investments in our securities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">The price of our stock is volatile, and you could lose all or part of your investment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Similar to the trading prices of the common stock of other biopharmaceutical companies, the trading price of our common stock is subject to wide fluctuations in response to various factors, some of which are beyond our control, including limited trading volume. In addition to the factors discussed in this &#8220;Risk Factors&#8221; section and elsewhere in this Annual Report, these factors include: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the results of our ongoing, planned or any future preclinical studies, clinical trials or clinical development programs; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the commencement, enrollment, or results of clinical trials of our product candidates or any future clinical trials we may conduct, or changes in the development status of our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">adverse results or delays in preclinical studies and clinical trials; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our decision to initiate a clinical trial, not to initiate a clinical trial, or to terminate an existing clinical trial; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">any delay in our regulatory filings or any adverse regulatory decisions, including failure to receive regulatory approval of our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">changes in laws or regulations applicable to our products, including but not limited to clinical trial requirements for approvals; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">adverse developments concerning our manufacturers or our manufacturing plans; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our inability to obtain adequate product supply for any licensed product or inability to do so at acceptable prices; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our inability to establish collaborations if needed; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our failure to commercialize our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">additions or departures of key scientific or management personnel; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">unanticipated serious safety concerns related to the use of our product candidates; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">introduction of new products or services offered by us or our competitors; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">announcements of significant acquisitions, strategic partnerships, joint ventures or capital commitments by us or our competitors; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to effectively manage our growth; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the size and growth of our initial cancer target markets; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to successfully treat additional types of cancers or at different stages; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">actual or anticipated variations in quarterly operating results; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our cash position; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our failure to meet the estimates and projections of the investment community or that we may otherwise provide to the public; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">publication of research reports about us or our industry, or immunotherapy in particular, or positive or negative recommendations or withdrawal of research coverage by securities analysts; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">changes in the market valuations of similar companies; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">overall performance of the equity markets; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">sales of our common stock by us or our stockholders in the future; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">trading volume of our common stock; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">changes in accounting practices; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">ineffectiveness of our internal controls; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">disputes or other developments relating to intellectual property or proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">significant lawsuits, including intellectual property or stockholder litigation; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">general political and economic conditions; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">other events or factors, many of which are beyond our control. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, the stock market in general, and the market for biopharmaceutical companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance. In the past, securities class action litigation has often been instituted against companies following periods of volatility in the market price of a company&#8217;s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of management&#8217;s attention and resources, which would harm our business, financial condition, results of operation and future prospects. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may seek additional capital through a combination of public and private equity offerings, debt financings, strategic partnerships and alliances and licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a stockholder. The incurrence of indebtedness would result in increased fixed payment obligations and could involve certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we raise additional funds through strategic partnerships and alliances and licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies or product candidates, or grant licenses on terms unfavorable to us. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We do not intend to pay dividends on our common stock, so any returns will be limited to the value of our stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We currently anticipate that we will retain future earnings for the development, operation, and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. In addition, we may enter into agreements that prohibit us from paying cash dividends without prior written consent from our contracting parties, or which other terms prohibiting or limiting the amount of dividends that may be declared or paid on our common stock. Any return to stockholders will therefore be limited to the appreciation of their stock, which may never occur. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our principal stockholders and management own a significant percentage of our stock and will be able to exert significant influence over matters subject to stockholder approval. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Based upon our common stock outstanding as of December&#160;31, 2021, our executive officers, directors, and their affiliates beneficially owned over a majority of our outstanding voting stock. These stockholders, acting together, are able to significantly influence all matters requiring stockholder approval. For example, these stockholders are able to significantly influence elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our stockholders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We are an emerging growth company and a smaller reporting company, and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies and smaller reporting companies will make our common stock less attractive to investors. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act, or JOBS Act, enacted in April 2012. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002, as amended, or Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in this Annual Report and our periodic reports and proxy statements, and exemptions from the requirements of holding nonbinding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved. We could be an emerging growth company for up to five years following the year in which we complete our initial public offering, or IPO, although circumstances could cause us to lose that status earlier. We will remain an emerging growth company until the earlier of (1)&#160;the last day of the fiscal year (a)&#160;following the fifth anniversary of the closing of our IPO, (b)&#160;in which we have total annual gross revenue of at least $1.07&#160;billion or (c)&#160;in which we are deemed to be a large accelerated filer, which requires the market value of our common stock that is held by non-affiliates to exceed $700&#160;million as of the prior June 30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (2)&#160;the date on which we have issued more than $1&#160;billion in non-convertible debt during the prior three-year period. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected to not &#8220;opt out&#8221; of this exemption from complying with new or revised accounting standards and, therefore, we will adopt new or revised accounting standards at the time private companies adopt the new or revised accounting standard and will do so until such time that we either (i)&#160;irrevocably elect to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualify as an emerging growth company. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Even after we no longer qualify as an emerging growth company, we may still qualify as a &#8220;smaller reporting company,&#8221; which would allow us to continue to take advantage of many of the same exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in this Annual Report and our periodic reports and proxy statements. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We are incurring, and will continue to incur, significant increased expenses and administrative burdens as a public company, which could have an adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a public company, we are facing, and will continue to face, increased legal, accounting, administrative and other costs and expenses that we did not incur as a private company. The Sarbanes-Oxley Act, including the requirements of Section 404 thereof, as well as rules and regulations subsequently implemented by the SEC, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules and regulations promulgated and to be promulgated thereunder, the Public Company Accounting Oversight Board and the securities exchanges, impose additional reporting and other obligations on public companies. Compliance with public company requirements will increase costs and make certain activities more time-consuming. A number of those requirements mandate us to carry out </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">activities we have not done previously. In addition, additional expenses associated with SEC reporting requirements are being incurred. Furthermore, if any issues in complying with those requirements are identified (for example, if our auditors identify a material weakness or significant deficiency in the internal control over financial reporting), we could incur additional costs rectifying those issues, and the existence of those issues could adversely affect our reputation or investor perceptions of it. It is also more expensive to obtain and maintain director and officer liability insurance as a public company. Risks associated with our status as a public company may make it more difficult to attract and retain qualified persons to serve on the board of directors or as executive officers. The additional reporting and other obligations imposed by these rules and regulations will increase legal and financial compliance costs and the costs of related legal, accounting and administrative activities. These increased costs will require us to divert a significant amount of money that could otherwise be used to expand the business and achieve strategic objectives. Advocacy efforts by stockholders and third parties may also prompt additional changes in governance and reporting requirements, which could further increase costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Sales of a substantial number of shares of our common stock by our existing stockholders in the public market could cause our stock price to fall. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our common stock in the public market or the perception that these sales might occur could depress the market price of our common shares, could make it more difficult for you to sell your common stock at a time and price that you deem appropriate and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict the effect that sales may have on the prevailing market price of our common stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Unstable market and economic conditions may have serious adverse consequences on our business, financial condition and stock price.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The global credit and financial markets have experienced extreme volatility and disruptions in the past several years, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates and uncertainty about economic stability. We believe that the state of global economic conditions are particularly volatile and uncertain, not only in light of the ongoing COVID-19 pandemic and the potential global recession resulting therefrom, but also due to recent and expected shifts in political, legislative and regulatory conditions concerning, among other matters, international trade and taxation, and that an uneven recovery or a renewed global downturn may negatively impact our ability to conduct clinical trials on the scale and timelines anticipated. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, volatile business or political environment or continued unpredictable and unstable market conditions. If the current equity and credit markets deteriorate, it may make obtaining any necessary debt or equity financing more difficult, more costly and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon clinical development plans. In addition, there is a risk that one or more of our current service providers, manufacturers and other partners may not survive an economic downturn, which could directly affect our ability to attain our operating goals on schedule and on budget. To the extent that our profitability and strategies are negatively affected by downturns or volatility in general economic conditions, our business and results of operations may be materially adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The trading market for our common stock will depend in part on the research and reports that securities or industry analysts publish about us or our business. If one or more of the analysts who cover us downgrades our stock or publishes inaccurate or unfavorable research about our business, our stock price may decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to our charter and bylaws</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions under our charter documents and Delaware law could delay or prevent a change of control, which could limit the market price of our common stock and may prevent or frustrate attempts by our stockholders to replace or remove our current management. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could delay or prevent a change of control of our company or changes in our board of directors that our stockholders might consider favorable. Some of these provisions include: </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a board of directors divided into three classes serving staggered three-year terms, such that not all members of the board will be elected at one time; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a prohibition on stockholder action through written consent, which requires that all stockholder actions be taken at a meeting of our stockholders; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a requirement that special meetings of stockholders be called only by the board of directors acting pursuant to a resolution approved by the affirmative vote of a majority of the directors then in office;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">advance notice requirements for stockholder proposals and nominations for election to our board of directors; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a requirement that no member of our board of directors may be removed from office by our stockholders except for cause and, in addition to any other vote required by law, upon the approval of not less than two-thirds of all outstanding shares of our voting stock then entitled to vote in the election of directors; </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">a requirement of approval of not less than two-thirds of all outstanding shares of our voting stock to amend any bylaws by stockholder action or to amend specific provisions of our certificate of incorporation; and </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the authority of the board of directors to issue preferred stock on terms determined by the board of directors without stockholder approval and which preferred stock may include rights superior to the rights of the holders of common stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&#160;203 of the Delaware General Corporate Law, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock. These antitakeover provisions and other provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by the then-current board of directors and could also delay or impede a merger, tender offer, or proxy contest involving our company. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of your choosing or cause us to take other corporate actions you desire. Any delay or prevention of a change of control transaction or changes in our board of directors could cause the market price of our common stock to decline. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Our bylaws designate a certain court as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our bylaws provide that, unless we consent in writing to an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any state law claims for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of fiduciary duty owed by any of our directors, officers, and employees to us or our stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws or (iv) any action asserting a claim that is governed by the internal affairs doctrine, in each case subject to the Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein. This exclusive forum provision will not apply to any causes of action arising under the Securities Act or the Exchange Act. In addition, our amended and restated bylaws will provide that any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">foregoing provisions. We recognize that the forum selection clause in our bylaws may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware. Additionally, the forum selection clause in our amended and restated bylaws may limit our stockholders&#8217; ability to bring a claim in a forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage such lawsuits against us and our directors, officers and employees even though an action, if successful, might benefit our stockholders. The Court of Chancery of the State of Delaware may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Risks related to internal control over financial reporting</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">If we fail to establish and maintain proper and effective internal control over financial reporting, our operating results and our ability to operate our business could be harmed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Adequate internal control over financial reporting are necessary for us to provide reliable financial reports and, together with effective disclosure controls and procedures, are designed to prevent or detect material misstatements due to fraud or error. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing conducted by us in connection with Section 404 of the Sarbanes-Oxley Act, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inadequate internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Implementing any appropriate changes to our internal controls may distract our officers and employees, entail substantial costs to modify our existing processes, and take significant time to complete. These changes may not, however, be effective in maintaining the adequacy of our internal controls, and any failure to maintain that adequacy, or consequent inability to produce accurate financial statements on a timely basis, could increase our operating costs and harm our business. In addition, investors&#8217; perceptions that our internal controls are inadequate or that we are unable to produce accurate financial statements on a timely basis may harm our stock price and make it more difficult for us to effectively market and sell our service to new and existing customers. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General risk factors</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Data collection is governed by restrictive regulations governing the use, processing and cross-border transfer of personal information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event we decide to conduct clinical trials or continue to enroll subjects in our ongoing or future clinical trials, we may be subject to additional privacy restrictions. The collection, use, storage, disclosure, transfer, or other processing of personal data regarding individuals in the EEA, including personal health data, is subject to the GDPR, which became effective on May 25, 2018. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to processing health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR also imposes strict rules on the transfer of personal data to countries outside the EEA, including the United States, and permits data protection authorities to impose large penalties for violations of the GDPR, including potential fines of up to &#8364;20 million or 4% of annual global revenues, whichever is greater. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. The GDPR increased our responsibility and liability in relation to personal data that we process where such processing is subject to the GDPR, and we may be required to put in place additional mechanisms to ensure compliance with the GDPR, including as implemented by individual countries. Compliance with the GDPR will be a rigorous and time-intensive process that </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">may increase our cost of doing business or require us to change our business practices, and despite those efforts, there is a risk that we may be subject to fines and penalties, litigation, and reputational harm in connection with our European activities. In addition, further to the UK&#8217;s exit from the EU on January 31, 2020, the GDPR ceased to apply in the UK at the end of the transition period on December 31, 2020. However, as of January 1, 2021, the UK&#8217;s European Union (Withdrawal) Act 2018 incorporated the GDPR (as it existed on December 31, 2020 but subject to certain UK specific amendments) into UK law, referred to as the UK GDPR. The UK GDPR and the UK Data Protection Act 2018 set out the UK&#8217;s data protection regime, which is independent from but aligned to the EU&#8217;s data protection regime. Non-compliance with the UK GDPR may result in monetary penalties of up to &#163;17.5 million or 4% of worldwide revenue, whichever is higher. Although the UK is regarded as a third country under the EU&#8217;s GDPR, the European Commission has now issued a decision recognizing the UK as providing adequate protection under the EU GDPR and, therefore, transfers of personal data originating in the EU to the UK remain unrestricted. Like the EU GDPR, the UK GDPR restricts personal data transfers outside the UK to countries not regarded by the UK as providing adequate protection. The UK government has confirmed that personal data transfers from the UK to the EEA remain free flowing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, certain state laws govern the privacy and security of health information in certain circumstances, some of which are more stringent than HIPAA and many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. By way of example, the California Consumer Privacy Act (CCPA), which went into effect on January 1, 2020, gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. The CCPA may increase our compliance costs and potential liability. Some observers have noted that the CCPA could mark the beginning of a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, a new California privacy law, the California Privacy Rights Act (CPRA), was passed by California voters on November 3, 2020. The CPRA will create additional obligations with respect to processing and storing personal information that are scheduled to take effect on January 1, 2023 (with certain provisions having retroactive effect to January 1, 2022). Additionally,  some observers have noted that the CCPA and CPRA could mark the beginning of a trend toward more stringent privacy legislation in the U.S., which could increase our potential liability and adversely affect our business. Already, in the United States, we have witnessed significant developments at the state level. For example, on March 2, 2021, Virginia enacted the Consumer Data Protection Act (CDPA) and, on July 8, 2021, Colorado&#8217;s governor signed the Colorado Privacy Act (CPA), into law. The CDPA and the CPA will both become effective January 1, 2023. While the CDPA and CPA incorporate many similar concepts of the CCPA and CPRA, there are also several key differences in the scope, application, and enforcement of the law that will change the operational practices of regulated businesses. The new laws will, among other things, impact how regulated businesses collect and process personal sensitive data, conduct data protection assessments, transfer personal data to affiliates, and respond to consumer rights requests. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A number of other states have proposed new privacy laws, some of which are similar to the above discussed recently passed laws. Such proposed legislation, if enacted, may add additional complexity, variation in requirements, restrictions and potential legal risk, require additional investment of resources in compliance programs, impact strategies and the availability of previously useful data and could result in increased compliance costs and/or changes in business practices and policies. The existence of comprehensive privacy laws in different states in the country would make our compliance obligations more complex and costly and may increase the likelihood that we may be subject to enforcement actions or otherwise incur liability for noncompliance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, many jurisdictions outside of Europe are also considering and/or enacting comprehensive data protection legislation. For example, as of August 2020, the Brazilian General Data Protection Law imposes stringent requirements similar to GDPR with respect to personal information collected from individuals in Brazil. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In China, there have also been recent significant developments concerning privacy and data security. On June 10, 2021, the Standing Committee of the PRC National People&#8217;s Congress published the Data Security Law of the People&#8217;s Republic of China (the &#8220;Data Security Law&#8221;), which took effect on September 1, 2021. The Data Security Law requires data processing (which includes the collection, storage, use, processing, transmission, provision and publication of data), to be conducted in a legitimate and proper manner. The Data Security Law imposes data security and privacy obligations on entities and individuals carrying out data processing activities and also introduces a data classification and hierarchical protection system based on the importance of data in economic and social development and the degree of harm it may cause to national security, public interests, or legitimate rights and interests of individuals or organizations if such data are tampered with, destroyed, leaked, illegally acquired or illegally used. The appropriate level of protection measures is required to be taken for each respective category of data. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Also in China, on August 20, 2021, the Standing Committee of the National People&#8217;s Congress of the PRC promulgated the Personal Information Protection Law, which took effect on November 1, 2021. The Personal Information Protection Law raises the protection requirements for processing personal information, and many specific requirements of the Personal Information Protection Law remain to be clarified. We may be required to make further significant adjustments to our business practices to comply with the personal information protection laws and regulations in China including the Personal Information Protection Law.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Compliance with U.S. and international data protection laws and regulations could require us to take on more onerous obligations in our contracts, restrict our ability to collect, use and disclose data, or in some cases, impact our ability to operate in certain jurisdictions. Failure to comply with U.S. and international data protection laws and regulations could result in government enforcement actions (which could include civil or criminal penalties), private litigation or adverse publicity and could negatively affect our operating results and business. Moreover, clinical trial subjects about whom we or our potential collaborators obtain information, as well as the providers who share this information with us, may contractually limit our ability to use and disclose the information. Claims that we have violated individuals&#8217; privacy rights, failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable, could be expensive and time consuming to defend and could result in adverse publicity that could harm our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Changes to patent law in the United States and in foreign jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involve both technological and legal complexity, and is therefore costly, time-consuming and inherently uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce patents that we might obtain in the future. For example, in the case </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Assoc. for Molecular Pathology v. Myriad Genetics, Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the U.S. Supreme Court held that certain claims to DNA molecules are not patentable. Any adverse changes in the patent laws of other jurisdictions could have a material adverse effect on our business and financial condition. Changes in the laws and regulations governing patents in other jurisdictions could similarly have an adverse effect on our ability to obtain and effectively enforce any rights we may have in our patent applications or any patents we may own or in-license in the future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Recent or future patent reform legislation could also increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of any patents we may own or in-license in the future. The United States has enacted and implemented wide-ranging patent reform legislation. On September&#160;16, 2011, the Leahy-Smith America Invents Act, or America Invents Act, was signed into law, which includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications are prosecuted, redefine prior art, may affect patent litigation, establish a new post-grant review system and switch the U.S. patent </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">system from a &#8220;first-to-invent&#8221; system to a &#8220;first-to-file&#8221; system. Under a &#8220;first-to-file&#8221; system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to a patent on the invention regardless of whether another inventor had made the invention earlier. Since patent applications in the United States and most other countries are confidential for a period of time after filing or until issuance, we cannot be certain that we were the first to either (i)&#160;file any patent application related to our product candidates or other technologies or (ii)&#160;invent any of the inventions claimed in our patent applications or any patents we may own or in-license. These changes also allow third party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> review, and derivation proceedings. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use the USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. An adverse determination in any such proceeding could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights. Accordingly, the America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of any issued patents we may own or in-license in the future, all of which could have a material adverse effect on our business and financial condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax law could adversely affect our business and financial condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The rules dealing with U.S. federal, state, and local income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many such changes have been made and changes are likely to continue to occur in the future. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. We urge investors to consult with their legal and tax advisers regarding the implications of potential changes in tax laws on an investment in our common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Risks related to cybersecurity</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to adequately protect our information systems from cyberattacks, which could result in the disclosure of confidential or proprietary information, including personal data, damage our reputation, and subject us to significant financial and legal exposure. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We rely on information technology systems that we or our third-party providers operate to process, transmit and store electronic information in our day-to-day operations. In connection with our MAP drug discovery engine and product discovery efforts, we may collect and use a variety of personal data, such as name, mailing address, email addresses, phone number and clinical trial information. A successful cyberattack could result in the theft or destruction of intellectual property, data, or other misappropriation of assets, or otherwise compromise our confidential or proprietary information and disrupt our operations. Cyberattacks are increasing in their frequency, sophistication and intensity, and have become increasingly difficult to detect. Cyberattacks could include wrongful conduct by hostile foreign governments, industrial espionage, wire fraud and other forms of cyber fraud, the deployment of harmful malware,&#160;denial-of-service,&#160;social engineering fraud or other means to threaten data security, confidentiality, integrity and availability. A successful cyberattack could cause serious negative consequences for us, including, without limitation, the disruption of operations, the misappropriation of confidential business information, including financial information, trade secrets, financial loss and the disclosure of corporate strategic plans. Although we devote resources to protect our information systems, we realize that cyberattacks are a threat, and there can be no assurance that our efforts will prevent information security breaches that would result in business, legal, financial or reputational harm to us, or would have a material adverse effect on our results of operations and financial condition. Any failure to prevent </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or mitigate security breaches or improper access to, use of, or disclosure of our clinical data or patients&#8217; personal data could result in significant liability under state (e.g., state breach notification laws), federal (e.g., HIPAA, as amended by HITECH), and international law (e.g., the GDPR) and may cause a material adverse impact to our reputation, affect our ability to conduct new studies and potentially disrupt our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Some cyber security incidents may be very difficult to prevent. For example, supply chain incidents involving previously unknown vulnerabilities in widely-used software are becoming increasingly common, of which the recent SolarWinds and Log4j incidents are examples. While we are not currently aware of any impact from supply chain vulnerabilities including but not necessarily limited to SolarWinds and Log4j, these are recent events, and the full scope of the attacks are not yet known. Therefore, there is residual risk that we may experience a security breach arising from the SolarWinds, Log4j, and other supply chain vulnerabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Further, while we maintain insurance coverage, we cannot assure that such coverage will be adequate or otherwise protect us from or adequately mitigate liabilities or damages with respect to claims, costs, expenses, litigation, fines, penalties, business loss, data loss, regulatory actions or material adverse effects arising out of our privacy and security practices, or that such coverage will continue to be available on acceptable terms or at all. The market for cyber insurance is tightening, and coverage for ransomware, data breaches, and other types of cyberattacks may be reduced or eliminated. The successful assertion of one or more large claims against us that exceeds our available insurance coverage, or results in changes to our insurance policies (including premium increases or the imposition of large deductible or co-insurance requirements), could have an adverse effect on our business. In addition, we cannot be sure that our existing insurance coverage will continue to be available on acceptable terms or that our insurers will not deny coverage as to any future claim.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Although we devote resources to protect our information systems, we realize that cyberattacks are a threat, and there can be no assurance that our efforts will prevent information security breaches that would result in business, legal, financial or reputational harm to us, or would have a material adverse effect on our results of operations and financial condition. Any failure to prevent or mitigate security breaches or improper access to, use of, or disclosure of our clinical data or patients&#8217; personal data could result in significant liability under state (e.g., state breach notification laws), federal (e.g., HIPAA, as amended by HITECH), and international law (e.g., the GDPR) and may cause a material adverse impact to our reputation, affect our ability to conduct new studies and potentially disrupt our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, the computer systems of various third parties on which we rely, including our CROs and other contractors, consultants and law and accounting firms, may sustain damage from computer viruses, unauthorized access, data breaches, phishing attacks, cybercriminals, natural disasters (including hurricanes and earthquakes), terrorism, war and telecommunication and electrical failures. We rely on our third-party providers to implement effective security measures and identify and correct for any such failures, deficiencies or breaches. If we or our third-party providers fail to maintain or protect our information technology systems and data integrity effectively or fail to anticipate, plan for or manage significant disruptions to our information technology systems, we or our third-party providers could have difficulty preventing, detecting and controlling such cyber-attacks and any such attacks could result in losses described above as well as disputes with physicians, patients and our partners, regulatory sanctions or penalties, increases in operating expenses, expenses or lost revenues or other adverse consequences, any of which could have a material adverse effect on our business, results of operations, financial condition, prospects and cash flows. Any failure by such third parties to prevent or mitigate security breaches or improper access to or disclosure of such information could have similarly adverse consequences for us. If we are unable to prevent or mitigate the impact of such security or data privacy breaches, we could be exposed to litigation and governmental investigations, which could lead to a potential disruption to our business. </span></div><div id="if3ac37d75c1541719d9b66553792086e_25"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">121</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We lease a facility containing approximately 25,578 square feet of office space for our principal office, which is located at One Main Street, Cambridge, MA 02142. The lease expires on August 31, 2028, subject to an option to extend the lease for five additional years. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We also lease approximately 18,120 square feet of office and laboratory space at 430 East 29th Street, New York, New York 10016. The lease expires on June 30, 2032, subject to an option to extend the lease for five additional years. We believe that our current facilities are sufficient to meet our current and near term needs.</span></div><div id="if3ac37d75c1541719d9b66553792086e_31"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not currently aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</span></div><div id="if3ac37d75c1541719d9b66553792086e_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">122</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART II</span></div><div id="if3ac37d75c1541719d9b66553792086e_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Certain Information Regarding the Trading of Our Common Stock</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our common stock trades under the symbol &#8220;BDTX&#8221; on the Nasdaq Global Select Market and has been publicly traded since January 30, 2020. Prior to this time, there was no public market for our common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Holders of Our Common Stock</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of February 28, 2022, there were approximately 34 holders of record of shares of our common stock. This number does not include stockholders for whom shares are held in &#8220;nominee&#8221; or &#8220;street&#8221; name.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have never declared or paid any cash dividends on our capital stock. We currently intend to retain any future earnings to fund the development and expansion of our business, and therefore we do not anticipate paying cash dividends on our common stock in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our results of operations, financial condition, capital requirements, contractual restrictions and other factors deemed relevant by our board of directors. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Securities Authorized for Issuance Under Equity Compensation Plans</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information required by Item 5 of Form 10-K regarding equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We did not purchase any of our registered equity securities during the period covered by this Annual Report.</span></div><div id="if3ac37d75c1541719d9b66553792086e_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 6. Reserved</span></div><div id="if3ac37d75c1541719d9b66553792086e_46"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with our audited consolidated financial statements and related notes included elsewhere in this Annual Report. This discussion and analysis and other parts of this Annual Report contain forward-looking statements based upon current beliefs, plans and expectations that involve risks, uncertainties and assumptions, such as statements regarding our plans, objectives, expectations, intentions and projections. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under Part I, Item 1A &#8220;Risk Factors&#8221; and elsewhere in this Annual Report. You should carefully read the &#8220;Risk Factors&#8221; section of this Annual Report to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section entitled &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</span></div><div id="if3ac37d75c1541719d9b66553792086e_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are a precision oncology medicine company pioneering the discovery and development of MasterKey therapies. We target undrugged oncogenic driver mutations in patients with genetically defined cancers. The foundation of our company is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry. Our proprietary technology platform, which we refer to as our Mutation-Allostery-Pharmacology, or MAP, drug discovery engine, is designed to allow us to analyze population-level genetic sequencing data to discover oncogenic mutations that promote cancer across tumor types. Our goal is to identify families of mutations that can be inhibited with MasterKey therapies thereby providing precision oncology to greater numbers of patients with genetically defined tumors. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have designed our clinical-stage product candidates, BDTX-1535 and BDTX-189, to potently and selectively inhibit families of oncogenic mutations which occur across a range of tumor types that affect the ErbB-1 epidermal growth factor receptor, or EGFR, and in the case of BDTX-189 also affect the tyrosine-protein kinase ErbB-2, or HER2. We have designed these product candidates to bind to the active site of these mutant kinases and inhibit their function. BDTX-1535 and BDTX-189 are also designed to spare normal, or wild type, EGFR (EGFR WT), which we believe will improve upon the toxicity profiles of current ErbB family inhibitors. We are also leveraging our MAP drug discovery engine to identify other families of non-canonical mutations in validated oncogenes beyond the ErbB family, which has the potential to expand the reach of targeted therapies. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Since our inception in 2014, we have devoted substantially all of our efforts and financial resources to organizing and staffing our company, business planning, raising capital, discovering product candidates and securing related intellectual property rights while conducting research and development activities for our programs. We do not have any products approved for sale and have not generated any revenue from product sales. We may never be able to develop or commercialize a marketable product. We have not yet successfully completed any pivotal clinical trials, obtained any regulatory approvals, manufactured a commercial-scale drug, or conducted sales and marketing activities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In July 2020, we were granted Fast Track designation for BDTX-189 for the treatment of adult patients with solid tumors harboring an allosteric human epidermal growth factor receptor 2 (HER2) mutation or an epidermal growth factor receptor (EGFR) or HER2 Exon 20 insertion mutation who have progressed following prior treatment and who have no satisfactory treatment options.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To date, we have funded our operations with proceeds from the sale of preferred stock and common stock. Since  inception we have incurred significant operating losses. Our net losses were $125.6 million and $67.3 million for the years ended December&#160;31, 2021 and 2020, respectively. As of December&#160;31, 2021, we had an accumulated deficit of $243.8 million. Our ability to generate product revenue sufficient to achieve profitability will depend heavily on the successful development and eventual commercialization of one or more of our current or future product candidates. We expect that our expenses and capital requirements will increase substantially in connection with our ongoing activities, particularly if and as we: </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">continue preclinical studies and initiate or advance clinical trials for BDTX-1535, BDTX-189, our programs and other product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">continue to develop and expand our proprietary MAP drug discovery engine to identify additional product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtain, maintain, expand and protect our intellectual property portfolio; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">hire additional clinical, scientific and commercial personnel; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">seek marketing approvals for our product candidates that successfully complete clinical trials, if any; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">acquire or in-license additional product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">expand our infrastructure and facilities to accommodate our growing employee base; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">add operational, financial and management information systems and personnel, including personnel to support our research and development programs, any future commercialization efforts and our transition to operating as a public company. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, which may include collaborations with other companies or other strategic transactions. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as and when needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our product candidates or delay our pursuit of potential in-licenses or acquisitions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with product development, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had cash, cash equivalents and investments of $209.8 million, which we believe will fund our operating expenses and capital expenditure requirements into 2024. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. See &#8220;&#8212;Liquidity and capital resources.&#8221; To finance our operations beyond that point, we will need to raise additional capital, which cannot be assured. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of our product candidates or other research and development initiatives.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COVID-19 Considerations </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The ongoing COVID-19 pandemic has presented and continues to present a substantial public health and economic challenge around the world, and to date has led to the implementation of various responses, including government-imposed quarantines, stay-at-home orders, travel restrictions, mandated business closures and other public health safety measures. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have been closely monitoring the impact of the ongoing COVID-19 pandemic on all aspects of our business, including how it has and may continue to impact our operations and the operations of our suppliers, vendors and business partners, and may take further precautionary and preemptive actions as may be required by federal, state or local authorities. In addition, we have taken steps to minimize the current environment&#8217;s impact on our business and strategy, including devising contingency plans and securing additional resources from third party service providers. For the safety of our employees and families, we have introduced enhanced safety measures for scientists to be present in our labs and increased the use of third party service providers for the conduct of certain experiments and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">studies for research programs. Certain of our third party service providers have also experienced shutdowns or other business disruptions. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, our research programs, healthcare systems or the global economy and we cannot presently predict the scope and severity of any potential business shutdowns or disruptions. In particular, our ability to conduct our clinical trials in a timely manner that meets our current projected timelines could be adversely impacted. Potential COVID-19-associated risks include delays in patient recruitment and principal investigator availability, clinical trial site shutdowns or other interruptions and potential limitations on the quality, completeness and interpretability of data we are able to collect. Additionally, our drug product supply chain, early stage research &amp; development programs and activities and other aspects of our business operations could be negatively impacted by the pandemic and COVID-19-related delays or disruptions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Beyond the impact on our pipeline, the extent to which COVID-19 ultimately impacts our business, results of operations and financial condition will depend on future developments, which, despite progress in vaccination efforts, remain highly uncertain and cannot be predicted with confidence, such as the duration of the ongoing COVID-19 pandemic, new strains of the virus, including the Delta and Omicron variants and any future variants that may emerge, which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines, new information that may emerge concerning the severity of COVID-19 and the effectiveness of any additional preventative and protective actions taken to contain COVID-19 or treat its impact in the short and long term, among others. While certain measures have been relaxed in certain parts of the world as increasing numbers of people have received COVID-19 vaccines, others have remained in place with some areas continuing to experience renewed outbreaks and surges in infection rates. The extent to which such measures are removed or new measures are put in place will depend upon how the pandemic continues to evolve, as well as the distribution of available vaccines, the rates at which they are administered and the emergence of new variants of the virus. If we or any of the third parties with whom we engage, however, were to experience any additional shutdowns or other prolonged business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially or negatively affected, which could have a material adverse impact on our business, results of operations and financial condition. The estimates of the impact on our business may change based on new information that may emerge concerning COVID-19 and the actions to contain it or treat its impact and the economic impact on local, regional, national and international markets.</span></div><div id="if3ac37d75c1541719d9b66553792086e_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Components of our results of operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To date, we have not generated any revenue from any sources, including from product sales, and we do not expect to generate any revenue from the sale of products in the foreseeable future. If our development efforts for our product candidates are successful and result in regulatory approval, or license agreements with third parties, we may generate revenue in the future from product sales. However, there can be no assurance as to when we will generate such revenue, if at all. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of costs incurred for our research activities, including our drug discovery efforts and the development of our product candidates. We expense research and development costs as incurred, which include: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">expenses incurred to conduct the necessary preclinical studies and clinical trials required to obtain regulatory approval; </span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">expenses incurred under agreements with contract research organizations, or CROs, that are primarily engaged in the oversight and conduct of our drug discovery efforts and preclinical studies, clinical trials and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">contract manufacturing organizations, or CMOs, that are primarily engaged to provide preclinical and clinical drug substance and product for our research and development programs; </span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">other costs related to acquiring and manufacturing materials in connection with our drug discovery efforts and preclinical studies and clinical trial materials, including manufacturing validation batches, as well as investigative sites and consultants that conduct our clinical trials, preclinical studies and other scientific development services; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">payments made in cash or equity securities under third-party licensing, acquisition and option agreements; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">employee-related expenses, including salaries and benefits, travel and stock-based compensation expense for employees engaged in research and development functions; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">costs related to compliance with regulatory requirements; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">allocated facilities-related costs, depreciation and other expenses, which include rent and utilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We recognize external development costs based on an evaluation of the progress to completion of specific tasks using information provided to us by our service providers. This process involves reviewing open contracts and purchase orders, communicating with our personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of actual costs. Any nonrefundable advance payments that we make for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. Such amounts are expensed as the related goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered or the services rendered. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our direct external research and development expenses consist primarily of external costs, such as fees paid to outside consultants, CROs, CMOs and research laboratories in connection with our preclinical development, process development, manufacturing and clinical development activities. Our direct research and development expenses also include fees incurred under license, acquisition and option agreements. We do not allocate employee costs, costs associated with our discovery efforts, laboratory supplies, and facilities, including depreciation or other indirect costs, to specific programs because these costs are deployed across multiple programs and, as such, are not separately classified. We use internal resources primarily to conduct our research and discovery as well as for managing our preclinical development, process development, manufacturing and clinical development activities. These employees work across multiple programs and, therefore, we do not track their costs by program. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development activities are central to our business model. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. As a result, we expect that our research and development expenses will increase substantially over the next several years as we continue our clinical trials for BDTX-189, as well as conduct other preclinical and clinical development, including submitting regulatory filings for our other product candidates, including BDTX-1535. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We expect our discovery research efforts and our related personnel costs will increase and, as a result, we expect our research and development expenses, including costs associated with stock-based compensation, will increase above historical levels. In addition, we may incur additional expenses related to milestone and royalty payments payable to third parties with whom we may enter into license, acquisition and option agreements to acquire the rights to future product candidates.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At this time, we cannot reasonably estimate or know the nature, timing and costs of the efforts that will be necessary to complete the preclinical and clinical development of any of our product candidates or when, if ever, material net cash inflows may commence from any of our product candidates. The successful development and commercialization of our product candidates is highly uncertain. This uncertainty is due to the numerous risks and uncertainties associated with product development and commercialization, including the uncertainty of the following: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the scope, progress, outcome and costs of our preclinical development activities, clinical trials and other research and development activities; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">establishing an appropriate safety and efficacy profile with IND-enabling studies; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">successful patient enrollment in and the initiation and completion of clinical trials; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the timing, receipt and terms of any marketing approvals from applicable regulatory authorities including the FDA and non-U.S. regulators; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the extent of any required post-marketing approval commitments to applicable regulatory authorities; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">establishing clinical and commercial manufacturing capabilities or making arrangements with third-party manufacturers in order to ensure that we or our third-party manufacturers are able to make product successfully; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">development and timely delivery of clinical-grade and commercial-grade drug formulations that can be used in our clinical trials and for commercial launch; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtaining, maintaining, defending and enforcing patent claims and other intellectual property rights; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">significant and changing government regulation; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">launching commercial sales of our product candidates, if and when approved, whether alone or in collaboration with others; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">maintaining a continued acceptable safety profile of our product candidates following approval, if any, of our product candidates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any changes in the outcome of any of these variables with respect to the development of our product candidates in preclinical and clinical development could mean a significant change in the costs and timing associated with the development of these product candidates. For example, if the FDA or another regulatory authority were to delay our planned start of clinical trials or require us to conduct clinical trials or other testing beyond those that we currently expect or if we experience significant delays in enrollment in any of our planned clinical trials, we could be required to expend significant additional financial resources and time on the completion of clinical development of that product candidate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expenses</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and benefits, travel and stock-based compensation expense for personnel in executive, business development, finance, human resources, legal, information technology, pre-commercial and support personnel functions. General and administrative expenses also include direct and allocated facility-related costs as well as insurance costs and professional fees for legal, patent, consulting, investor and public relations, accounting and audit services. </span></div><div style="margin-top:12pt;padding-left:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We anticipate that our general and administrative expenses will increase in the future as we increase our headcount to support our continued research activities and development of our product candidates and prepare for potential commercialization activities. We also anticipate that we will incur significantly increased accounting, audit, legal, regulatory, compliance and director and officer insurance costs as well as investor and public relations expenses associated with operating as a public company. Additionally, if and when we believe a regulatory approval of a product candidate appears likely, we anticipate an increase in payroll and other employee-related expenses as a result of our preparation for commercial operations, especially as it relates to the sales and marketing of that product candidate. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Other income (expense)</span></div><div style="margin-top:12pt;padding-left:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other income (expense) consists primarily of interest income earned on our cash equivalents and investment balances, and realized and unrealized foreign currency transaction gains and losses.</span></div><div id="if3ac37d75c1541719d9b66553792086e_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Results of operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the years ended December&#160;31, 2021 and 2020</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the years ended December&#160;31, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">96,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">126,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69,570&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(126,872)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(69,570)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(57,302)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(577)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,724)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(125,596)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(67,254)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(58,342)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:21pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Research and development</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development expenses were $96.8 million for the year ended December&#160;31, 2021, compared to $48.2 million for the year ended December&#160;31, 2020. The following table summarizes our research and development expenses for the year ended December&#160;31, 2021 and 2020.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BDTX-189 research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BDTX-1535 research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other research programs and platform development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Personnel expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Allocated facility expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">96,829&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The increase of $48.6 million was primarily due to an increase of $16.7 million in other research programs and platform development as we increased research activities related to our platform and new programs. In addition, we incurred an additional $10.0 million and $6.2 million for BDTX-189 and BDTX-1535, respectively, for the year ended December&#160;31, 2021, compared to the year ended December&#160;31, 2020. Personnel expenses increased $11.7 million as we have increased our headcount and related personnel expenses. Facility costs increased $2.7 million for the year ended December&#160;31, 2021, compared to the year ended December&#160;31, 2020 due to the signing of a new lease.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">General and administrative expenses were $30.0 million for the year ended December&#160;31, 2021, compared to $21.4 million for the year ended December&#160;31, 2020. The increase of $8.7 million was primarily due to an increase in personnel expenses of $6.2 million related to an increase in headcount and external fees of $1.1 million related to legal and other professional fees due to operating as a public company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense) </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other income was $1.3 million for the year ended December&#160;31, 2021, compared to other income of $2.3 million for the year ended December&#160;31, 2020. The decrease was primarily attributable to amortization of premium on investments increasing at a higher rate in 2021 compared to 2020 and interest income staying relatively flat.</span></div><div id="if3ac37d75c1541719d9b66553792086e_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Sources of liquidity</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Since our inception, we have not generated any revenue from any product sales or any other sources and have incurred significant operating losses and negative cash flows from our operations. We have not yet commercialized any of our product candidates, and we do not expect to generate revenue from sales of any product candidates for several years, if at all. We have funded our operations to date primarily with proceeds from the sale of preferred stock. On February 3, 2020, we completed an IPO of 12,174,263 shares of our common stock, including the exercise in full by the underwriters of their option to purchase up to 1,587,947 additional shares of common stock, for aggregate gross proceeds of $231.3&#160;million. We received $212.1&#160;million in net proceeds after deducting underwriting discounts and commissions and other estimated offering expenses payable by us. Through December&#160;31, 2021, we had received net cash proceeds of $200.6&#160;million from previous sales of our preferred stock and as of December&#160;31, 2021, we had cash, cash equivalents and investments of $209.8&#160;million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Cash flows</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes our sources and uses of cash for each of the periods presented (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(100,148)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(52,146)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash provided by (used in) investing activities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">130,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(281,691)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">214,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31,194&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(118,893)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Operating activities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, we used cash in operating activities of $100.1&#160;million, primarily resulting from our net loss of $125.6&#160;million, partially offset by the non-cash charge related to stock compensation expense of $14.0 million, and an increase in prepaid expenses and other current assets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, we used cash in operating activities of $52.1&#160;million, primarily resulting from our net loss of $67.3&#160;million, partially offset by the non-cash charge related to stock compensation expense of $7.8 million, an increase in prepaid expenses and other current assets due to payments for research services and a decrease in deferred offering costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Changes in accounts payable and accrued expenses in all periods were generally due to growth in our business, the advancement of our product candidates, and the timing of vendor invoicing and payments. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Investing activities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, we had cash provided by investing activities of $130.6&#160;million primarily from the sales and maturities of investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, we used cash in investing activities of $281.7&#160;million for the purchase of investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Financing activities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, we had cash provided by financing activities of $0.7&#160;million, consisting of proceeds from the exercise of stock options.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, we had cash provided by financing activities of $214.9&#160;million, consisting primarily of proceeds from the IPO.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Funding requirements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance the preclinical activities and clinical trials of our product candidates. In addition, we expect to incur additional costs associated with operating as a public company, including significant legal, accounting, investor relations and other expenses. The timing and amount of our operating expenditures will depend largely on our ability to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">advance BDTX-1535 and BDTX-189 through clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">advance preclinical development of our early stage programs, including BDTX-4933 IND-enabling related activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">manufacture, or have manufactured on our behalf, our preclinical and clinical drug material and develop processes for late state and commercial manufacturing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">seek regulatory approvals for any product candidates that successfully complete clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">establish a sales, marketing, medical affairs and distribution infrastructure to commercialize any product candidates for which we may obtain marketing approval and intend to commercialize on our own;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">hire additional clinical, quality control and scientific personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">expand our operational, financial and management systems and increase personnel, including personnel to support our clinical development, manufacturing and commercialization efforts and our operations as a public company; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">obtain, maintain, expand and protect our intellectual property portfolio.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had cash, cash equivalents and investments of $209.8 million, which we believe will fund our operating expenses and capital expenditure requirements into 2024. We have based this estimate on assumptions that may prove to be wrong, and we could utilize our available capital resources sooner than we expect. We anticipate that we will require additional capital as we seek regulatory approval of our product candidates and if we choose to pursue in-licenses or acquisitions of other product candidates. If we receive regulatory approval for any of our product candidates, we expect to incur significant commercialization expenses related to product manufacturing, sales, marketing and distribution, depending on where we choose to commercialize.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with research, development and commercialization of product candidates, we are unable to estimate the exact amount of our working capital requirements. Our future funding requirements will depend on and could increase significantly as a result of many factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the scope, progress, results and costs of researching and developing our product candidates, and conducting preclinical and clinical trials;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the costs, timing and outcome of regulatory review of our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the costs, timing and ability to manufacture our product candidates to supply our clinical and preclinical development efforts and our clinical trials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the costs of future activities, including product sales, medical affairs, marketing, manufacturing and distribution, for any of our product candidates for which we receive marketing approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the costs of manufacturing commercial-grade product and necessary inventory to support commercial launch;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the ability to receive additional non-dilutive funding;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the revenue, if any, received from commercial sale of our products, should any of our product candidates receive marketing approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the costs of preparing, filing and prosecuting patent applications, obtaining, maintaining, expanding and enforcing our intellectual property rights and defending intellectual property-related claims;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">our ability to establish and maintain collaborations on favorable terms, if at all; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">the extent to which we acquire or in-license other product candidates and technologies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of public or private equity offerings, debt financings, collaborations, strategic partnerships and alliances or marketing, distribution or licensing arrangements with third parties. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest may be materially diluted, and the terms of such securities could include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include restrictive covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. In addition, debt financing would result in fixed payment obligations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If we raise additional funds through collaborations, strategic partnerships and alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></div><div id="if3ac37d75c1541719d9b66553792086e_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Critical accounting policies and significant judgments and use of estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States, or GAAP. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Accrued research and development expenses</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As part of the process of preparing our consolidated financial statements, we are required to estimate our accrued research and development expenses. This process involves reviewing open contracts and purchase orders, communicating with our applicable personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of actual costs. The majority of our service providers invoice us in arrears for services performed, on a pre-determined schedule or when contractual milestones are met; however, some require advance payments. We make estimates of our accrued expenses as of each balance sheet date in the consolidated financial statements based on facts and circumstances known to us at that time. We periodically confirm the accuracy of the estimates with the service providers and make adjustments if necessary. Examples of estimated accrued research and development expenses include fees paid to: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">vendors, including research laboratories, in connection with preclinical development activities; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">CROs and investigative sites in connection with preclinical studies and clinical trials; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">CMOs in connection with drug substance and drug product formulation of preclinical studies and clinical trial materials. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We base our expenses related to preclinical studies and clinical trials on our estimates of the services received and efforts expended pursuant to quotes and contracts with multiple research institutions and CROs that supply, conduct and manage preclinical studies and clinical trials on our behalf. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the expense. Payments under some of these contracts depend on factors such as the successful enrollment of patients and the completion of clinical trial milestones. In accruing service fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, we adjust the accrual or the prepaid expense accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in reporting amounts that are too high or too low in any particular period. To date, there have not been any material adjustments to our prior estimates of accrued research and development expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We measure stock options and other stock-based awards granted to employees, non-employees and directors based on their fair value on the date of the grant and recognize the corresponding compensation expense of those awards over the requisite service period, which is generally the vesting period of the respective award. We have generally only issued stock options and restricted stock units with service-based vesting conditions and record the expense for these awards using the straight-line method. For stock options or restricted stock units issued with performance-based vesting conditions, the related stock compensation expense is recognized based on the grant date fair value when achievement of the performance condition is deemed probable. The graded-vesting method would apply to all stock-based awards with performance-based vesting conditions or to awards with both service-based and performance-based vesting conditions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have historically granted stock options with exercise prices equivalent to the fair value of our common stock as of the date of grant. For grants of restricted stock units, we base the fair value on the stock price as of the date of grant.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company accounts for stock-based awards granted to employees and non-employees at fair value, which is measured using the Black-Scholes option-pricing model. The measurement date for the awards is generally the date of grant. Stock-based compensation costs are recognized as expenses over the requisite service period, which is generally the vesting period, on a straight-line basis for all time-vested awards.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We estimate the fair value of each stock option grant using the Black-Scholes option-pricing model, which uses as inputs the fair value of our common stock and assumptions we make for the volatility of our common stock, the expected term of our stock options, the risk-free interest rate for a period that approximates the expected term of our stock options and our expected dividend yield (see Note 2 to our consolidated financial statements).</span></div><div id="if3ac37d75c1541719d9b66553792086e_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recently issued accounting pronouncements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note&#160;2 to our consolidated financial statements appearing elsewhere in this Annual Report.</span></div><div id="if3ac37d75c1541719d9b66553792086e_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Emerging growth company and smaller reporting company status </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Jumpstart Our Business Startups Act of 2012 permits an &#8220;emerging growth company&#8221; such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to not &#8220;opt out&#8221; of this provision and, as a result, we will adopt new or revised accounting standards at the time private companies adopt the new or revised accounting standard and will do so until such time that we either (i) irrevocably elect to &#8220;opt out&#8221; of such extended transition period or (ii) no longer qualify as an emerging growth company. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are also a &#8220;smaller reporting company&#8221; meaning that the market value of our stock held by non-affiliates is less than $700 million and our annual revenue was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</span></div><div id="if3ac37d75c1541719d9b66553792086e_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item&#160;7A. Quantitative and Qualitative Disclosure About Market Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">134</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 8. Consolidated Financial Statements and Supplementary Data</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BLACK DIAMOND THERAPEUTICS,&#160;INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_79">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV83Ni9mcmFnOjAxMzE4MzgwMzJhMzQ4YjE5ZWUyMGZjOGIwZWYwMGE4L3RhYmxlOjU1OThmNjhjMDU1MTRmMWM5MjM1N2EwNDY3Yzg5MTcyL3RhYmxlcmFuZ2U6NTU5OGY2OGMwNTUxNGYxYzkyMzU3YTA0NjdjODkxNzJfMS0wLTEtMS0xMzU5MC90ZXh0cmVnaW9uOjdhMDk3YTBlODVhNjQ0ZjA5YWZhYmQwM2Y4ZjgyMWM1XzIxOTkwMjMyNTU2ODY_26a2ef69-e915-4233-8ba5-55ca0fbda8ba">238</ix:nonNumeric>)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_79">136</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_82">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_82">137</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_85">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_85">138</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_88">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_88">139</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:3pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_91">Consolidated Statements of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_91">Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_91">140</a></span></div></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">135</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Report of Independent Registered Public Accounting Firm </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Black Diamond Therapeutics, Inc. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Black Diamond Therapeutics, Inc. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, and the related consolidated statements of operations, of stockholders&#8217; equity and of cash flows for the years then ended, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.883%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV83OS9mcmFnOjgwZGQxMTE0MWY5ZDRlNmM5OTIxYTA4ZDI1NGJhNDcxL3RhYmxlOmM4M2Q2ZTU0Yzk3ZDRkMjE4ZDJmMjBmNzkwYTIwOGYzL3RhYmxlcmFuZ2U6YzgzZDZlNTRjOTdkNGQyMThkMmYyMGY3OTBhMjA4ZjNfMS0wLTEtMS0xMDkyMg_1d0ab452-211e-40aa-bf85-c3ea937201fc">PricewaterhouseCoopers LLP</ix:nonNumeric></span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV83OS9mcmFnOjgwZGQxMTE0MWY5ZDRlNmM5OTIxYTA4ZDI1NGJhNDcxL3RhYmxlOmM4M2Q2ZTU0Yzk3ZDRkMjE4ZDJmMjBmNzkwYTIwOGYzL3RhYmxlcmFuZ2U6YzgzZDZlNTRjOTdkNGQyMThkMmYyMGY3OTBhMjA4ZjNfMy0wLTEtMS0xMzg2MQ_82cb1ea9-c810-4343-a055-e7be3a54b4ae">Boston, Massachusetts</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">March 17, 2022</span></td></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2019.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">136</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> Black Diamond Therapeutics, Inc. </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNC0xLTEtMS0xMDA4Nw_e60c3b16-18cb-4e80-aed7-c76fa85cbb8a">65,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNC0zLTEtMS0xMDA4Nw_59f52b20-7565-4258-be6f-d3dededebd53">34,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNS0xLTEtMS0xMDA4Nw_df9417dd-6e81-4ea1-87f1-e8c653d13fe0">143,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNS0zLTEtMS0xMDA4Nw_aa4b4c96-ff8d-4f68-aab0-16b5706c79bc">280,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNi0xLTEtMS0xMDA4Nw_0b51809a-0cc3-4981-bf3d-b24c95d843e8">5,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNi0zLTEtMS0xMDA4Nw_0f12806b-510e-4602-a857-832624369fe9">4,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNy0xLTEtMS0xMDA4Nw_df28c2af-3c07-4869-bf9e-0bd2a3fbb3cc">215,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNy0zLTEtMS0xMDA4Nw_87d16c2d-eb20-4d57-8a05-8fce5bb59dc0">319,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfOC0xLTEtMS0xMDA4Nw_916760a6-238c-4e96-aefc-6c9a6fac198c">3,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfOC0zLTEtMS0xMDA4Nw_dfc00bdb-3d5a-4a06-a5a0-e198fbc81837">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfOS0xLTEtMS0xMDA4Nw_a80559e5-ae52-4484-8b34-dbc957acfe22">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfOS0zLTEtMS0xMDA4Nw_b0a9d35f-dd67-44ba-909f-049d3887aef9">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTEtMS0xLTEtMTAwODc_36156040-0ef5-43f6-9d9e-376a7c366a5e">27,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTEtMy0xLTEtMTAwODc_e455f962-eff1-4bd7-824a-ee3e2352384e">8,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTItMS0xLTEtMTAwODc_7184efd5-cd73-4a82-97fa-7830701a8ea8">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTItMy0xLTEtMTAwODc_3909222b-c0b8-4237-a056-40a5909654e6">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTMtMS0xLTEtMTAwODc_8d746af5-24e8-4eaf-bea7-d6449b1ccb43">247,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTMtMy0xLTEtMTAwODc_cb5819a2-a66e-4475-a4de-6addfc2d4ce9">329,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTYtMS0xLTEtMTAwODc_97daf099-90b3-4c6c-8ae1-f25e5241e30c">4,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTYtMy0xLTEtMTAwODc_3edb2d20-67ba-4ffb-a6df-89839ea74d58">2,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTgtMS0xLTEtMTAwODc_22470e44-45b4-4676-bb09-e66638ed7a6d">19,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTgtMy0xLTEtMTAwODc_2f72b46e-e058-4bc3-9927-5041f90df74d">11,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTktMS0xLTEtMTAwODc_cc187b77-22c7-4f08-876a-ac6d436d5129">23,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTktMy0xLTEtMTAwODc_c6731215-1b58-4aa1-83b9-80f278a8e50c">14,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-current operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjEtMS0xLTEtMTAwODc_7dae6b9f-a54a-4287-ac34-97bfd72914e7">28,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjEtMy0xLTEtMTAwODc_312f19fa-2b92-441b-bf95-643fa59e9183">7,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjItMS0xLTEtMTAwODc_568e265e-7598-477d-b0ed-d36fba914357">51,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjItMy0xLTEtMTAwODc_b3702a3a-c742-47cd-8781-37a8c06b8f1e">21,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commitments and contingencies (Note&#160;12)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjMtMS0xLTEtMTAwODc_c002590c-5f25-4efd-9b4e-25be58375432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjMtMy0xLTEtMTAwODc_69ce7493-f498-4951-9e45-6969c487e476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stockholders' equity (deficit):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="4" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml8yMQ_a520e5ff-4c5b-4638-a26d-9d41d15e686d"><ix:nonFraction unitRef="usdPerShare" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="4" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml8yMQ_acb93e29-706a-4be1-9e02-dbb9a9adc91c">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml8zNQ_23c0f6d5-be14-4010-a11d-bd340701bc0f">10,000,000</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml80OQ_dd856930-cb04-4ac2-91ce-9ac38ccdf7f3">10,000,000</ix:nonFraction> shares authorized at December&#160;31, 2021 and 2020, respectively; <ix:nonFraction unitRef="shares" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml85OA_42d55e97-1539-4656-83d9-df8d49282ab7"><ix:nonFraction unitRef="shares" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml85OA_4774e74b-a1e3-408a-baf7-783ad42de779"><ix:nonFraction unitRef="shares" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml85OA_a255f32d-2f3b-4f9e-b003-9c0e8e465b88"><ix:nonFraction unitRef="shares" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml85OA_a428a150-13b0-419f-901f-c5fdae5ede8d">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding at December&#160;31, 2021 and 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMS0xLTEtMTAwODc_3830b063-1a1e-4966-83f4-fcaea5c16240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMy0xLTEtMTAwODc_8b680ca7-c795-4c67-86b5-9e9068f1f96a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8xOQ_fb2c2e79-25e6-4c62-8d17-d5c73235945f"><ix:nonFraction unitRef="usdPerShare" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8xOQ_fddd8927-264a-423c-be92-76be56ce153d">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8zMw_012c3ecd-4294-46c5-a6c5-daf5a729e1ec">500,000,000</ix:nonFraction> shares authorized at December&#160;31, 2021 and <ix:nonFraction unitRef="shares" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF82NA_9b01e40b-62fc-4db8-b220-246119800d83">500,000,000</ix:nonFraction> shares authorized at December&#160;31, 2020; <ix:nonFraction unitRef="shares" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF85Mg_9f0b4460-01f6-482b-b573-d15c98583ba2"><ix:nonFraction unitRef="shares" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF85Mg_dec7c3f6-327c-4cbc-a571-d4fd8a6a5a85">36,234,624</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2021 and <ix:nonFraction unitRef="shares" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8xMzU_34d1781f-85f4-4eb1-8c10-42ab8e921df7"><ix:nonFraction unitRef="shares" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8xMzU_b1b7160c-d601-49d8-baf8-0ba27063535a">36,078,383</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMS0xLTEtMTAwODc_289fefb1-8615-4038-8ade-8f1cb5bc0085">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMy0xLTEtMTAwODc_162b3d37-1552-4519-ab4b-7bd5f85be38c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjgtMS0xLTEtMTAwODc_45dfcbd4-7898-4a46-a4fe-e0e5fcdbbea4">440,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjgtMy0xLTEtMTAwODc_d94957ea-97c0-41b5-9b00-9b897d1fba2a">425,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjktMS0xLTEtMTAwODc_5b1e4afc-4c97-4866-8337-ed9c10f4c653">414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjktMy0xLTEtMTAwODc_31ba5dd5-1d8b-47d5-86da-404629a46eae">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzAtMS0xLTEtMTAwODc_10432fb5-606e-4179-b2ef-d839408a4605">243,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzAtMy0xLTEtMTAwODc_919aaf78-8a7d-417c-af2a-bbb7e253295a">118,224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzEtMS0xLTEtMTAwODc_a3d050eb-3b55-4086-8cce-c76d3d28092f">195,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzEtMy0xLTEtMTAwODc_4158151d-cab0-4d4b-ad86-3faf012d9525">307,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzItMS0xLTEtMTAwODc_a7e17c17-5c9b-42b4-bd0d-62a7a3747c23">247,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzItMy0xLTEtMTAwODc_87cc291e-ccab-4705-a3e0-3ee2f3dd5669">329,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">137</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Black Diamond Therapeutics, Inc. </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMy0xLTEtMS0xMDA4Nw_5de2613f-8d68-40c0-be80-9c228c59c6c6">96,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMy0zLTEtMS0xMDA4Nw_f11658c9-9d20-4e0c-bd1f-b511a1eaee0f">48,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNC0xLTEtMS0xMDA4Nw_f7b0c409-e23b-4c08-b0a0-294882dc995b">30,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNC0zLTEtMS0xMDA4Nw_b75ca716-179f-43bd-93c1-5925bc25d43a">21,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNS0xLTEtMS0xMDA4Nw_50845b6d-f503-40a3-912f-cd09ed551d88">126,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNS0zLTEtMS0xMDA4Nw_7b924fb4-7b7c-4984-94a5-fd881bc88095">69,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNi0xLTEtMS0xMDA4Nw_aac7748c-e5aa-425a-a65f-a34a2681a360">126,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNi0zLTEtMS0xMDA4Nw_fd436453-e0ab-405b-bb2c-ad02f0c568ca">69,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfOC0xLTEtMS0xMDA4Nw_62b0b98b-7b1b-4a5b-a9b9-8f8d62911946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfOC0zLTEtMS0xMDA4Nw_0485f39f-8f1d-45d8-a040-8e0e0bdc6515">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfOS0xLTEtMS0xMDA4Nw_e5f749ca-060a-417b-b895-70a745e06882">3,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfOS0zLTEtMS0xMDA4Nw_42deda1e-305c-4ee2-9d40-0913eb8173a3">4,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTEtMS0xLTEtMTAwODc_cdb47f78-78d7-4afb-a1c2-f787a990d623">2,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTEtMy0xLTEtMTAwODc_31cd018a-5717-4809-9866-da14d229842e">1,724</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTItMS0xLTEtMTAwODc_8ecd63a0-fb2f-42ab-ac5b-60d24279fd27">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTItMy0xLTEtMTAwODc_f07d43ca-5e30-44e3-86af-3af8a5934703">2,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTMtMS0xLTEtMTAwODc_502c279e-be5a-40aa-861b-2ff8246ee50f">125,596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTMtMy0xLTEtMTAwODc_4b3032ef-5f4f-459a-808a-8bee6912cf66">67,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTQtMS0xLTEtMTAwODc_06e4115e-0115-47c8-b85b-258d2e834d0f"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTQtMS0xLTEtMTAwODc_5d315f2e-48c4-4803-9fa8-fa93c1c8db4f">3.47</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTQtMy0xLTEtMTAwODc_59036008-6c67-4712-a6bb-0e014809c9d9"><ix:nonFraction unitRef="usdPerShare" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTQtMy0xLTEtMTAwODc_7b7c9f5f-fba5-419c-a70b-8ea75c2698c2">2.05</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTUtMS0xLTEtMTAwODc_15345032-2df8-469a-918a-46b85c892955"><ix:nonFraction unitRef="shares" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTUtMS0xLTEtMTAwODc_938aa0ab-fb59-4d40-b27a-336d36e17ed4">36,189,002</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTUtMy0xLTEtMTAwODc_b926b935-446c-4859-ab73-e79a3b79919c"><ix:nonFraction unitRef="shares" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTUtMy0xLTEtMTAwODc_d0470d57-08dd-4952-b01a-a483acc17013">32,907,100</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTgtMS0xLTEtMTAwODc_12d5db37-8287-41fa-b997-54af34be4a96">125,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTgtMy0xLTEtMTAwODc_d177b8e4-f07b-45f2-86e7-9d78da86e5d8">67,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change in unrealized (loss) gain on investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMjAtMS0xLTEtMTAwODc_50d46a28-6e4a-4c16-9b6f-e7242c646c6f">1,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMjAtMy0xLTEtMTAwODc_7a846f8c-1866-4d5d-a1d1-9577c84a02f5">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMjEtMS0xLTEtMTAwODc_705309c8-43d4-4e40-a319-671b6b81afa9">126,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMjEtMy0xLTEtMTAwODc_01d11d70-6130-4134-8847-729316b5791e">66,640</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">138</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_88"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Black Diamond Therapeutics, Inc. </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMy0xLTEtMS0xMDA4Nw_b8a46987-4f30-4cbb-88cc-a71bf58b79a3">125,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMy0zLTEtMS0xMDA4Nw_5fb90023-4f7d-4782-8032-2c66689fe2c9">67,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Adjustment to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNS0xLTEtMS0xMDA4Nw_38bcc1b4-7c2e-4a31-b8fe-2f18233679e9">14,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNS0zLTEtMS0xMDA4Nw_261c81b0-2883-46d5-aa3c-fae69aed17b5">7,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNy0xLTEtMS0xMDA4Nw_931c1c8c-0cc5-4b9b-948f-ae220a789640">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNy0zLTEtMS0xMDA4Nw_87331589-46e8-4bf6-8cc8-1d34b2aa775b">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amortization of premium on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfOC0xLTEtMS0xMDA4Nw_6f68199e-ae27-496a-8c08-eb4890d419fb">2,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfOC0zLTEtMS0xMDA4Nw_bb56073d-2344-47d5-b17a-361ca253f2b7">1,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Noncash rent expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="bdtx:RentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfOS0xLTEtMS0xMDA4Nw_d71f6a5c-228b-4236-b49c-0234ebaf824c">2,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="bdtx:RentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfOS0zLTEtMS0xMDA4Nw_4cf5c2be-4f8b-49e6-9f43-1b8bc8bef292">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Gain on sale of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTAtMS0xLTEtMTAwODc_2209da19-b2dc-42f8-8413-6d4980a796a1">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTAtMy0xLTEtMTAwODc_a8e2893f-467f-4913-9413-403779c6fe70">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTEtMS0xLTEtMTI3MDY_0d4ef2e5-e357-46ad-ad39-ab4ef6ca39af">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTEtMy0xLTEtMTI3MDY_20ec27fd-9fff-4ae7-8b6c-c4bfb286a56f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTEtMS0xLTEtMTAwODc_5ae0fcfd-9341-4951-b685-ac0d8e457c5f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTEtMy0xLTEtMTAwODc_657e25f5-3400-491a-ba2b-147f726f60fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Changes in current assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTMtMS0xLTEtMTAwODc_78c4f420-9671-4971-8864-22d00a7eb991">1,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTMtMy0xLTEtMTAwODc_1acc46ac-2392-4e1c-a087-7a9125baa6ed">3,439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTQtMS0xLTEtMTAwODc_c99d0c43-5592-4e42-8005-16ce78f5083b">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTQtMy0xLTEtMTAwODc_aaea6592-d6bf-48c8-9b80-8286d6b2e976">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTUtMS0xLTEtMTAwODc_c651da8a-33da-4c7a-a791-2950d08c4065">1,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTUtMy0xLTEtMTAwODc_9446ca93-2724-4d86-bc14-634c00cc69ab">1,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTctMS0xLTEtMTAwODc_4da0b33d-e512-45b2-ba14-6401b5706875">8,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTctMy0xLTEtMTAwODc_e977e49a-7b13-4462-ac2e-f1c980c2e051">8,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-current operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="bdtx:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTgtMS0xLTEtMTAwODc_c46b8cdb-1440-4bd8-9543-3fcd526eb56e">1,725</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="bdtx:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTgtMy0xLTEtMTAwODc_397fcae2-6140-4815-a5ce-b20fe461c125">567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTktMS0xLTEtMTAwODc_b98be9ad-2f91-45bc-969b-16e5d9f53c0d">100,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTktMy0xLTEtMTAwODc_64dc3072-c90b-4dd5-9ee1-0609f5eea88e">52,146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Purchases of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjItMS0xLTEtMTAwODc_b250ab3e-4681-4261-9987-9a908f736de1">2,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjItMy0xLTEtMTAwODc_8f232bff-2f5a-4115-9814-a691e128fab1">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjMtMS0xLTEtMTAwODc_0329532b-37ea-453a-aab5-64da355b2ba5">182,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjMtMy0xLTEtMTAwODc_f32d6bb1-67ff-4f47-9aec-15ee18313428">90,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjQtMS0xLTEtMTAwODc_5866fed1-6921-4a58-8e9b-1f0e3b394d9b">49,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjQtMy0xLTEtMTAwODc_b1c4de95-7341-48fc-8466-864280f6ab3b">372,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjUtMS0xLTEtMTAwODc_be5c7b80-1bb7-45cd-b9e8-f6528d48e4d8">130,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjUtMy0xLTEtMTAwODc_5306bbf2-b03c-4194-a970-375609de66f5">281,691</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Proceeds from exercise of common stock options and ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjktMS0xLTEtMTAwODc_a762379e-a882-4a38-8073-05180a1ebe7e">729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjktMy0xLTEtMTAwODc_892cf5a6-da38-4d88-995e-8f8ed1ecd29a">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Proceeds from initial public offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzAtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyYjk3MTUxMmE4ODM0YzhjYjA2MjE4YjAzNzNhYTdmMl82OA_e783f111-3571-4986-a6c7-b270f12d8174">1,275</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzAtMS0xLTEtMTAwODc_99f652c8-16a8-4cac-8345-8a216ae56072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzAtMy0xLTEtMTAwODc_057785ba-e3ed-42b4-8352-c613fc0691c6">213,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzItMS0xLTEtMTAwODc_9c0123d2-39a2-44d5-9291-cafddb9a6606">729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzItMy0xLTEtMTAwODc_2248550d-b255-4e09-b6ae-0eb148a2c422">214,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzMtMS0xLTEtMTAwODc_577f3a6f-fa81-45a8-a430-16c0c36725b5">31,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzMtMy0xLTEtMTAwODc_6ca5bf4a-c80d-43d8-ab55-0a290f54d04e">118,893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzQtMS0xLTEtMTAwODc_4d8620b7-3fc4-4c23-a2f4-7809245cf162">35,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d6bc95d9354f76a22b6b88f8b6cd72_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzQtMy0xLTEtMTAwODc_3c92645e-73ae-4fc2-a9ee-2e975f56fd8f">154,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzUtMS0xLTEtMTAwODc_d4f65c62-416a-4978-bd82-b3f9703156a9">67,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzUtMy0xLTEtMTAwODc_347abbeb-1b63-4031-bee0-639456a4a151">35,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzctMS0xLTEtMTAwODc_ff8eb624-c140-4034-a775-22066b1a45fb">65,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzctMy0xLTEtMTAwODc_16354abb-33c5-4b07-969b-f3b9ba6d0dcd">34,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Restricted cash, end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzgtMS0xLTEtMTAwODc_aea17fc4-15c5-492d-82ed-56e52b4af8f6">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzgtMy0xLTEtMTAwODc_24633c42-2153-4f35-ae8a-a573f9b6c7cd">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzktMS0xLTEtMTAwODc_0aa48597-5cf1-470c-a4c0-34259d493b59">67,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzktMy0xLTEtMTAwODc_74a18b8e-11b6-420c-959e-aa763a6dad99">35,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Conversion of preferred stock into common stock upon closing of initial public offering</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDQtMS0xLTEtMTAwODc_a8683e26-d44e-4418-bd4e-ba8ada9efbd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDQtMy0xLTEtMTAwODc_a2ca9cd4-507b-4a7c-8c94-524eeda9b2f6">200,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDUtMS0xLTEtMTAwODc_6851a796-0707-4eed-a803-d2a09a623e0e">21,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDUtMy0xLTEtMTAwODc_0ea0bb3e-2f41-4897-958b-b437c8d9f74f">8,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Right-of-use asset derecognized upon early lease termination</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="bdtx:RightOfUseAssetDerecognizedTerminationOfLease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDctMS0xLTEtMTI3MTU_a0acac11-b786-4fe2-b8d5-6a6ffcbd0a6d">476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="bdtx:RightOfUseAssetDerecognizedTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDctMy0xLTEtMTI3MTU_0bf4548f-6413-448c-89b2-e76440848088">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">139</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Black Diamond Therapeutics, Inc. </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(in thousands, except share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.628%"><tr><td style="width:1.0%"></td><td style="width:41.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.526%"></td><td style="width:0.1%"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Additional</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">paid-in capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">stockholders&#8217;</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">equity (deficit)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">BALANCE - December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b34b944847347268c17b3eccf68fb24_I20191231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC02LTEtMS0xMDA4Nw_3b72ab1a-5adc-4c35-a8d7-11d03877c3b5">2,236,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b34b944847347268c17b3eccf68fb24_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC04LTEtMS0xMDA4Nw_b8891537-bc32-4654-88f8-1ba0b43777bf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e2c8b847c445b7ba67c11b436983c4_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC0xMC0xLTEtMTAwODc_002ac495-337c-4b80-9bf0-f424687bcf7c">3,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f5d6bad537436185bfd16658adb3b4_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC0xMi0xLTEtMTAwODc_a8999c2a-b35f-4ce5-941b-c49cb0e14099">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7230d3ada8f48d998cc556aebbd612f_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC0xNC0xLTEtMTAwODc_4c0e38da-b397-4f5e-a97e-c65b6bdc99c4">50,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55d6bc95d9354f76a22b6b88f8b6cd72_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC0xNi0xLTEtMTAwODc_f410e8c0-be2a-43c2-bd0e-25d89f2e719d">47,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion of preferred stock to common stock upon closing of the initial public offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOS02LTEtMS0xMDA4Nw_1b887681-1740-41b8-9dfe-84109606c078">21,499,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOS04LTEtMS0xMDA4Nw_9b3b7246-844d-405a-82e2-2c7cfbab2301">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOS0xMC0xLTEtMTAwODc_9d349561-ae9a-4004-a435-ec5f6a032676">200,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOS0xNi0xLTEtMTAwODc_d5f1e2dc-f173-445f-b88c-c3a5e92980ea">200,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTAtNi0xLTEtMTAwODc_e5623fca-bfb1-4b10-a29d-26b2b02f7d4a">12,174,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTAtOC0xLTEtMTAwODc_86663d5c-72a8-4674-b277-1806f24f496a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTAtMTAtMS0xLTEwMDg3_353b1226-675c-4dab-b778-d611179656a4">212,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTAtMTYtMS0xLTEwMDg3_242e57a8-8713-4cd5-a82c-bce8bf680c98">212,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of warrants to additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTEtMTAtMS0xLTEwMDg3_dc8f5237-ee9b-4972-a9f4-8cc7ba8de87e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTEtMTYtMS0xLTEwMDg3_f59e6f67-910b-4d77-8829-be27b8902521">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTItNi0xLTEtMTAwODc_61a1d733-6a29-4357-a094-308aaae1dfb8">160,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTItMTAtMS0xLTEwMDg3_f40a1f65-d266-47f8-a878-b66a3c8eb9d9">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTItMTYtMS0xLTEwMDg3_f1b02a65-69af-4fd4-a749-8d3257b2d2f3">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTMtNi0xLTEtMTAwODc_1c1e1494-63a7-4d6d-8d5f-0c07be772142">6,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTQtNi0xLTEtMTAwODc_c2355272-f39a-4e61-b179-a7045d2f9791">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTQtMTAtMS0xLTEwMDg3_ad713cf5-571a-4831-9727-322d403ccec9">7,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTQtMTYtMS0xLTEwMDg3_905c4b1e-dbab-4e95-9c76-7a9c8fa8a9f8">7,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735eaadfcfea49c7baa357b1962e28d3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTUtMTItMS0xLTEwMDg3_41ce3f5c-2bb4-4c52-bcae-81eb2ae41435">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTUtMTYtMS0xLTEwMDg3_9a4ab1b4-e89a-4e7d-8500-b5a4e32ba5c3">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69f2151c700c4386a8c6bd633fa2a055_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTYtMTQtMS0xLTEwMDg3_80ca600a-38fb-49b0-89d9-a2c43fbc01f5">67,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTYtMTYtMS0xLTEwMDg3_f95a7757-f70e-435a-8314-f8018e244db3">67,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCE - December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5260242f659f4520a08f001cda762732_I20201231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctNi0xLTEtMTAwODc_c2f9eede-7c1a-43fd-9fe6-36134ba684f1">36,078,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5260242f659f4520a08f001cda762732_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctOC0xLTEtMTAwODc_1ffd4c61-b9ca-4f97-9e46-b28e84e27d0b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfd940ec67e94e27ac3ac65f34d4ad9c_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctMTAtMS0xLTEwMDg3_d2b8e32a-64bb-4bf1-b5f1-b33d97501930">425,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9d4ee1015f45c7b985eb5b12743b46_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctMTItMS0xLTEwMDg3_798f4b2e-1a6d-4da2-8b91-bed7f1615754">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i881fdb998fb24439aabee87b939b2269_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctMTQtMS0xLTEwMDg3_0f269b81-47b9-4993-94b6-b060916371f4">118,224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctMTYtMS0xLTEwMDg3_eba2b39b-73ec-4c4f-9538-2b1d24d4a9dd">307,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtNi0xLTEtMTA3MTg_56e47e42-d270-4cb7-9065-18e5c67e1424">110,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d393f5b2b3949d384d2d1dd9ad3ac38_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMTAtMS0xLTEwNzE4_d43df92e-d53f-4eed-a1a6-00df4c99a102">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMTYtMS0xLTEwNzE4_793c0725-7542-43fc-927c-b22929de1187">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTktNi0xLTEtMTA3MTg_3c54d1c6-4d12-4866-9b66-f4041650c23e">27,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock related to ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjAtNi0xLTEtMTA3MTg_6518f149-d010-4c21-ac45-5227d5fb580d">6,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d393f5b2b3949d384d2d1dd9ad3ac38_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjAtMTAtMS0xLTEwNzE4_84eb3880-9d38-4898-9436-d4c616193dea">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjAtMTYtMS0xLTEwNzE4_ce9133b8-a026-4648-9089-52460c3815cc">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjEtNi0xLTEtMTA3MTg_3366fe01-beb1-41a1-b2bf-3ae1f589f577">12,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d393f5b2b3949d384d2d1dd9ad3ac38_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjEtMTAtMS0xLTEwNzE4_f2d08164-2749-41ce-9792-01e3230da876">14,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjEtMTYtMS0xLTEwNzE4_c8f84da4-8ebe-4ddc-90ba-f558a2ef92cb">14,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia824f582b29c4b53b5021124e3f932b9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjItMTItMS0xLTEwNzE4_2652f5ce-fdd9-4479-9d02-3f4e83ef561a">1,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjItMTYtMS0xLTEwNzE4_9dd6aafe-f533-46c8-b9f1-5f615cebdf65">1,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15c371c9576a45658c2ba0c54e2990fa_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjMtMTQtMS0xLTEwNzE4_331e7d0c-c5a2-48af-b79e-b56946dda746">125,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjMtMTYtMS0xLTEwNzE4_867cd742-eb6b-4cd6-9c93-2fc12737d231">125,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCE - December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id20739abaa504d80b915e1570af5c848_I20211231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMS0xLTEtMTA3NjQ_564fddf0-e04e-483c-a614-bf419051fe6f">36,234,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id20739abaa504d80b915e1570af5c848_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMy0xLTEtMTA3NjQ_1617b5d6-dbd8-4058-bb5b-3f470fbcdf3d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29cff875ae6c440fb8662994fa11100f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtNS0xLTEtMTA3NjQ_f998d783-120e-4707-a378-c89f7e439abb">440,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9016a71b5edc4deeaf7161f48c70b705_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtNy0xLTEtMTA3NjQ_63211428-22ec-4c8d-8f44-48f2c987253d">414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i137c8ff090914a21a31315f848506a70_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtOS0xLTEtMTA3NjQ_ea2f752d-b480-4415-8591-85b496255b89">243,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMTEtMS0xLTEwNzY0_5f909b5e-4350-48a2-abcf-3eeec8e78265">195,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">140</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Black Diamond Therapeutics, Inc. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands, except share and per share amounts)</span></div><div id="if3ac37d75c1541719d9b66553792086e_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfNzY0Mg_85d057c7-df25-43a2-a6b5-b759085fb763" continuedAt="idd3082ff3e7144888f2ee21fe27fd376" escape="true">NATURE OF BUSINESS AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="idd3082ff3e7144888f2ee21fe27fd376" continuedAt="i0eb2bbf2751c402988487b15ed991837"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Black Diamond Therapeutics, Inc. (the &#8220;Company&#8221;) is a precision oncology medicine company pioneering the discovery and development of MasterKey therapies. The Company was originally organized as a limited liability company in December 2014 under the name ASET Therapeutics LLC. In September 2016 the Company was converted to a corporation under the laws of the State of Delaware under the name ASET Therapeutics, Inc. The Company changed its name to Black Diamond Therapeutics, Inc. in January 2018. Since its inception, the Company has devoted substantially all of its efforts to raising capital, obtaining financing, and incurring research and development costs related to the development of its mutation, allostery, and pharmacology computational and drug discovery engine. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry. There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s technology will be obtained, that any products developed will obtain necessary government regulatory approval or that any products, if approved, will be commercially viable. The Company operates in an environment of rapid technological innovation and substantial competition from pharmaceutical and biotechnological companies. In addition, the Company is dependent upon the services of its employees, consultants and service providers. Even if the Company&#8217;s product development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from product sales. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On January 21, 2020, the Company effected a 1-for-<ix:nonFraction unitRef="number" contextRef="ie88f3aabe31b474cacd5e20c1fff19fe_D20200121-20200121" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMTgyNA_06e4b930-2b66-420a-992e-9db5be21a14c">3.01581</ix:nonFraction> reverse stock split of the Company&#8217;s common stock. All shares, stock options, warrants and per share information presented in the consolidated financial statements have been adjusted to reflect the reverse stock split on a retroactive basis for all periods presented. There was no change in the par value of the Company&#8217;s common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed an initial public offering (the &#8220;IPO&#8221;) of <ix:nonFraction unitRef="shares" contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjI0OA_6c458bd5-ff88-4935-894d-f8345bff7698">12,174,263</ix:nonFraction> shares of its common stock, including the exercise in full by the underwriters of their option to purchase up to <ix:nonFraction unitRef="shares" contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjM2NA_3ad7fee8-b500-493d-b55d-318649de7043">1,587,947</ix:nonFraction> additional shares of common stock, for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjQzNA_67537227-f22a-4e91-a111-b72a775f12c6">231,311</ix:nonFraction> and its shares started trading on The Nasdaq Global Select Market under the ticker symbol &#8220;BDTX.&#8221; The Company received $<ix:nonFraction unitRef="usd" contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjU1Ng_1ba6d2f3-9c67-4420-ae70-02a45d1d28fe">212,101</ix:nonFraction> in net proceeds after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. Upon closing of the IPO, all of the Company's outstanding shares of convertible preferred stock automatically converted into <ix:nonFraction unitRef="shares" contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjgxNw_f372dd61-dee7-4a6c-80d5-3a14581dc054">21,499,770</ix:nonFraction> shares of common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 1, 2021, the Company filed a shelf registration statement on Form S-3 ASR (the &#8220;Shelf&#8221;), with the Securities and Exchange Commission (the &#8220;SEC&#8221;), which covers the offering, issuance and sale of the Company&#8217;s common stock, preferred stock, debt securities, warrants and/or units of any combination thereof. The Company simultaneously entered into an Open Market Sale Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with Jefferies LLC, as sales agent, to provide for the issuance and sale by the Company of up to $<ix:nonFraction unitRef="usd" contextRef="i4a73fd2a8f9a40b4aef3a1186bd43494_D20220101-20220331" decimals="-6" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMTA5OTUxMTYzNTkxNw_c7e16ec1-b5c0-4e15-add1-d03fb3dfb5fa">150</ix:nonFraction> million of its common stock from time to time through Jefferies as its sales agent (the &#8220;ATM Program&#8221;). The Shelf became automatically effective upon filing on February 1, 2021. As of December&#160;31, 2021, no sales have been made pursuant to the ATM Program.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities and commitments in the ordinary course of business. Historically, the Company has funded its operations primarily with proceeds from the sale of convertible preferred stock. The Company expects to continue to generate operating losses for the foreseeable future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March&#160;17, 2022, the issuance date of the consolidated financial statements, the Company expects that its cash, cash equivalents and investments will be sufficient to fund its operating expenses and capital requirements into 2024. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="i0eb2bbf2751c402988487b15ed991837"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company may seek additional funding through private or public equity financings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborations or other arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company's stockholders. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts, which could adversely affect its business prospects. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations, if at all.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The ongoing COVID-19 pandemic continues to present a substantial public health and economic challenge around the world, and to date has led to the implementation of various responses, including government-imposed quarantines, stay-at-home orders, travel restrictions, mandated business closures and other public health safety measures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has been closely monitoring the impact of the ongoing COVID-19 pandemic on all aspects of the Company&#8217;s business, including how it has impacted and may continue to impact the Company&#8217;s operations and the operations of its suppliers, vendors and business partners, and may take further precautionary and preemptive actions as may be required by federal, state or local authorities. In addition, the Company has taken steps to minimize the current environment&#8217;s impact on its business and strategy, including devising contingency plans and securing additional resources from third party service providers. Furthermore, for the safety of the Company&#8217;s employees and families, the Company has introduced enhanced safety measures for scientists to be present in its labs and increased the use of third party service providers for the conduct of certain experiments and studies for research programs. Certain of the Company&#8217;s third party service providers have also experienced shutdowns or other business disruptions. The Company does not yet know the full extent of potential delays or impacts on the Company&#8217;s business, clinical trials, research programs, healthcare systems or the global economy and cannot presently predict the scope and severity of any potential business shutdowns or disruptions but if we or any of the third parties with whom we engage were to experience prolonged business shutdowns or other disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively affected, which could have a material adverse impact on our business, results of operations and financial condition. The estimates of the impact on our business may change based on new information that may emerge concerning COVID-19 and the actions to contain it or treat its impact and the economic impact on local, regional, national and international markets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The extent to which COVID-19 ultimately impacts the Company&#8217;s business, results of operations or financial condition will depend on future developments, which, despite progress in vaccination efforts, remain highly uncertain and cannot be predicted with confidence, such as the duration of the COVID-19 pandemic, new strains of the virus which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines, new information that may emerge concerning the severity of COVID-19, and any additional preventative and protective actions taken to contain the pandemic or treat its impact, among others. In addition, a resurgence or &#8220;additional waves&#8221; of COVID-19 cases could cause other widespread or more severe impacts depending on where infection rates are highest. While certain measures have been relaxed in certain parts of the world as increasing numbers of people have received COVID-19 vaccines, others have remained in place with some areas continuing to experience renewed outbreaks and surges in infection rates. The extent to which such measures are removed or new measures are put in place will depend upon how the pandemic evolves, as well as the distribution of available vaccines, the rates at which they are administered and the emergence of new variants of the virus.</span></div></ix:continuation><div id="if3ac37d75c1541719d9b66553792086e_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY4_796be45a-36b9-405c-93e2-9b36c89391b3" continuedAt="i16f1dd2cdfb1482e8b8b0565f6712498" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i16f1dd2cdfb1482e8b8b0565f6712498" continuedAt="idd9c4bf0771c4eb08d003f3238702891"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQy_75445f15-8d7f-4fc7-9e8a-b30d83615c09" continuedAt="icd6061c9bc2648cbbd3aa5106b61d932" escape="true"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQ1_67758cde-bf2e-4a9e-9069-74b79c2d2974" continuedAt="i88020101b90f4f8a9bea413492a8296a" escape="true">Principles of consolidation </ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="icd6061c9bc2648cbbd3aa5106b61d932"><ix:continuation id="i88020101b90f4f8a9bea413492a8296a">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and include the accounts of the Company and its wholly owned subsidiaries, Black Diamond Therapeutics (Canada), Inc. and Black Diamond Therapeutics Security Corporation, after elimination of all significant intercompany accounts and transactions.</ix:continuation></ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="idd9c4bf0771c4eb08d003f3238702891" continuedAt="i82f488659a8147629e07f45f7ca6afdd"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU1_67a1df9d-f6de-4ebb-8b21-43e5b14a3568" continuedAt="if11e521a9b7f4422b9919d493e842107" escape="true">Use of estimates </ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="if11e521a9b7f4422b9919d493e842107">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the accrual of research and development expenses and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results may differ from those estimates or assumptions.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The full extent to which the ongoing COVID-19 pandemic will directly or indirectly impact the Company&#8217;s business, results of operations and financial condition, including expenses, research and development costs and employee-related amounts, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international markets. The Company has considered the impact of COVID-19 on estimates within its financial statements and there may be changes to those estimates in future periods. As of the date of issuance of these consolidated financial statements, the Company has not experienced material business disruptions or incurred impairment losses in the carrying value of its assets as a result of the pandemic and is not aware of any specific related event or circumstance that would require it to update its estimates. </span></div><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjUw_53cf926c-5a8a-458d-8730-0ebc03ef61b4" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Subsequent events</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but before the final financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQz_c67baaf6-d62a-4a25-95b1-00933789c041" continuedAt="ib9811837d4f0446dbf3e2a02df061fbe" escape="true">Foreign currency and currency translation </ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="ib9811837d4f0446dbf3e2a02df061fbe">The functional currency for the Company&#8217;s wholly owned foreign subsidiary, Black Diamond Therapeutics (Canada), Inc. is the United States Dollar. Adjustments that arise from exchange rate changes on transactions denominated in a currency other than the local currency are included in other income (expense), net in the consolidated statements of operations, as incurred.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY5_e687f8e0-42b6-467b-a43a-626781c48c26" continuedAt="i457d201d377f4211b8203859c2a2ffae" escape="true">Cash and cash equivalents </ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="i457d201d377f4211b8203859c2a2ffae">The Company classifies deposits in banks, money market funds and cash invested temporarily in various instruments with maturities of three months or less at the time of purchase as cash and cash equivalents.</ix:continuation> At December&#160;31, 2021 and 2020, cash and cash equivalents includes cash on deposit at commercial banks and a money market fund that invests in U.S. Government securities.</span></div><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjcw_8a13453d-d351-43cf-ab23-70d646f919f3" continuedAt="i8885bdf587034dd690cbb8c7f9b91855" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investments consist of marketable securities with original maturities greater than 90 days. The Company has classified its investments with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities to be available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices. Unrealized gains and losses are reported as the accumulated other comprehensive items in stockholders&#8217; equity. Amortization and accretion of premiums and discounts are recorded in other income (expense). Realized gains or losses on debt securities are included in interest income or interest expense, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="i82f488659a8147629e07f45f7ca6afdd" continuedAt="ic4831428608543dab2b3ee16caee4f2f"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="i8885bdf587034dd690cbb8c7f9b91855">If any adjustment to fair value reflects a decline in value of the investment, the Company considers all available evidence to evaluate the extent to which the decline is other than temporary and, if so, marks the investment to market on the Company&#8217;s statement of operations and comprehensive income (loss).</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjUz_fcce0471-bdab-4bbd-b0de-219eb9449674" continuedAt="i376ddd6ca8614afba6689e3d6b78fac4" escape="true">Restricted cash </ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="i376ddd6ca8614afba6689e3d6b78fac4">In connection with its operating lease commitments, the Company maintains certain balances for security deposits that are classified as restricted cash on the consolidated balance sheets</ix:continuation>. As of December&#160;31, 2021 and 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzUwNzY_2fa313aa-9ce9-4b9a-9054-b7ce15b757f6"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzUwNzY_41ca9afa-b5f7-4bb8-a2ca-c882da8f0a25">1,223</ix:nonFraction></ix:nonFraction> of restricted cash, which has been classified as a non-current asset on the consolidated balance sheet.</span></div><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjcx_3303d1f6-8e99-41f0-9376-809494ae10e9" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. The Company maintains accounts for all cash and cash equivalents at accredited financial institutions, in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU5_cce12d8b-363a-42d9-ba49-adeaa5cf63cf" continuedAt="i7397404299f644bb892fbc4715dc9b43" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost less accumulated depreciation. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU0_f4fa2964-8956-40c6-9c19-dc7984efd448" continuedAt="i3bb93640a86f46cdb18cd89aa8b3dc4a" escape="true">Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset as follows:</ix:nonNumeric></span><ix:continuation id="i3bb93640a86f46cdb18cd89aa8b3dc4a" continuedAt="i740f1c54691d43dc85eb7d78ee22ee25"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Laboratory equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i907bbd4101da4791b95db60038ebf1bb_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90YWJsZTo0ZTRjZTY3ZjRiYmY0OWFhYTc1ZTRiODM1MWRmZGUzMy90YWJsZXJhbmdlOjRlNGNlNjdmNGJiZjQ5YWFhNzVlNGI4MzUxZGZkZTMzXzEtMS0xLTEtMTAwODc_fbf78c83-4f0c-4c10-b6e2-5601bab9a044">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furniture and fixtures&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c11721ec9b84ac3b344ba9856d4a137_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90YWJsZTo0ZTRjZTY3ZjRiYmY0OWFhYTc1ZTRiODM1MWRmZGUzMy90YWJsZXJhbmdlOjRlNGNlNjdmNGJiZjQ5YWFhNzVlNGI4MzUxZGZkZTMzXzItMS0xLTEtMTAwODc_e6b3d1a5-e00c-413c-878a-84901d3ca267">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Computer and office equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idc1c05a8882d4e2d9d4375998f3f9c91_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90YWJsZTo0ZTRjZTY3ZjRiYmY0OWFhYTc1ZTRiODM1MWRmZGUzMy90YWJsZXJhbmdlOjRlNGNlNjdmNGJiZjQ5YWFhNzVlNGI4MzUxZGZkZTMzXzMtMS0xLTEtMTAwODc_967d5785-9242-4a3e-9ef1-80f5ae5d6f43">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shorter of the useful life or remaining lease term</span></td></tr></table></ix:continuation></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="i7397404299f644bb892fbc4715dc9b43">When assets are retired or otherwise disposed of, the cost of assets disposed of and the related accumulated depreciation is removed from the accounts and any resulting gain or loss is included in the consolidated statements of operations in the period of disposal. Expenditures for repairs and maintenance are charged to expense as incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjUx_9baa0bd9-d959-4d45-b04b-24b9f92c6079" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Impairment of long - lived assets</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Long-lived assets consist of property and equipment. Long-lived assets to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company did not record any impairment losses on long-lived assets during the periods presented.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="ic4831428608543dab2b3ee16caee4f2f" continuedAt="i80bece0c474a4d35a7bc0c9ec418ac73"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY0_20cb8411-8677-4ca2-af7d-014ed0e3f6c8" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Fair value measurements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#8212; Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#8212; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level&#160;2 inputs include the following:</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">quoted prices for similar assets and liabilities in active markets</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">quoted prices for identical or similar assets or liabilities in markets that are not active</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g.,&#160;interest rate and yield curve quotes at commonly quoted intervals)</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">inputs that are derived principally from or corroborated by observable market data by correlation or other means</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#8212; Unobservable inputs for the assets or liability (i.e.,&#160;supported by little or no market activity). Level&#160;3 inputs include management&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying values of the Company&#8217;s prepaid expenses and other current assets, and accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU2_1025a45e-4409-4f2c-956d-6f0b1cfc7767" continuedAt="i6fc3d2d9eb8f4adface5f74d5320ebc1" escape="true">Segment information </ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="i6fc3d2d9eb8f4adface5f74d5320ebc1">The Company manages its operations as a single operating segment for the purposes of assessing performance and making operating decisions. The Company&#8217;s singular focus is the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations.</ix:continuation> </span></div><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQ0_c9601b34-4ea4-401a-aeed-9fbcaf57431b" continuedAt="id55bec71af6d409c9df67f53a5c26c11" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Research and development costs</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop drug candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical development activities. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="i80bece0c474a4d35a7bc0c9ec418ac73" continuedAt="ia4312bc54b6d4196933f2ef71d0074e0"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="id55bec71af6d409c9df67f53a5c26c11" continuedAt="id4ce03e562c2452084a53d6fb166da50">Research contract costs and accruals</ix:continuation></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="id4ce03e562c2452084a53d6fb166da50">The Company has entered into various research and development-related contracts with companies both inside and outside of the United States. The related costs are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ materially from the Company&#8217;s estimates. The Company&#8217;s historical accrual estimates have not been materially different from the actual costs.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="bdtx:PatentCostsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQ4_e7431752-f6f8-419f-a84b-019ff88b2bea" continuedAt="if99c6b693f214e86903f563f1b3610be" escape="true">Patent costs</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="if99c6b693f214e86903f563f1b3610be">All patent-related costs incurred in connection with filing and prosecuting patent applications to operations are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses.</ix:continuation> </span></div><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjYz_decb1d42-a5bb-4183-9db9-ce870e50ab1e" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company measures all stock-based awards granted to employees, non-employees and directors based on the fair value on the date of grant and recognizes compensation expense of those awards over the requisite service period, which is generally the vesting period of the respective award. Generally, the Company issues stock options and restricted stock units with only service-based vesting conditions and records the expense for these awards using the straight-line method. For stock options or restricted stock units issued with performance-based vesting conditions, the stock compensation expense related to these awards is recognized based on the grant date fair value when achievement of the performance condition is deemed probable. The Company would apply the graded-vesting method to all stock-based awards with performance-based vesting conditions or to awards with both service-based and performance based vesting conditions. Forfeitures are accounted for as they occur. </span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of each stock option grant is estimated on the date of grant using the Black- Scholes option-pricing model. The Company lacks sufficient company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The Company uses the simplified method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> prescribed by Securities and Exchange Commission Staff Accounting Bulletin No. 107, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to calculate the expected term of options granted to employees, non-employees and directors. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#8217;s payroll costs are classified or in which the award recipient&#8217;s service payments are classified.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="ia4312bc54b6d4196933f2ef71d0074e0" continuedAt="i94c7e283c6b045d1aba062d9a0b6b607"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY1_086b3ccb-d800-4bbd-96ac-59ad62025ca6" continuedAt="ic908d701baf04fbb9a426249c940314b" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#8217;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. </span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="ic908d701baf04fbb9a426249c940314b">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties. To date, the Company has not taken any uncertain tax positions or recorded any reserves, interest or penalties.</ix:continuation> </span></div><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjYx_b7761d4a-1ce1-42e3-8980-f591747e52ac" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive loss</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Comprehensive loss is composed of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on investments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU3_5d5eaaed-923d-4ea9-a6fd-4fd5ce98bf9a" continuedAt="icdf78c1705e84e15938bef7e272a98f0" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Net income (loss) per share</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated, and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. </span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="icdf78c1705e84e15938bef7e272a98f0">Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common stock. For purposes of this calculation, outstanding options, unvested restricted common stock and shares issuable under the employee stock purchase plan are considered potentially dilutive common stock and are excluded from the computation of net income (loss) per share when their effect is anti-dilutive.</ix:continuation> The Company reported a net loss attributable to common stockholders for the years ended December&#160;31, 2021 and 2020. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="i94c7e283c6b045d1aba062d9a0b6b607" continuedAt="i11f5fd15df2d433ca369023b4c863cfc"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY2_f644fef1-fd16-444f-b402-4f81cbe0281c" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at contract inception. Operating lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at the commencement date of the lease based upon the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company uses the implicit interest rate when readily determinable and uses the Company&#8217;s incremental borrowing rate when the implicit rate is not readily determinable based upon the information available at the commencement date in determining the present value of the lease payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The lease payments used to determine the Company&#8217;s operating lease assets may include lease incentives, stated rent increases and escalation clauses linked to rates of inflation, when determinable, and are recognized in the Company&#8217;s operating lease assets in the Company&#8217;s consolidated balance sheets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s operating leases are reflected in the right-of-use operating asset; operating lease liability, current portion; and non-current operating lease liability in the Company&#8217;s consolidated balance sheets. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Short-term leases, defined as leases that have a lease term of 12 months or less at the commencement date, are excluded from this treatment and are recognized on a straight-line basis over the term of the lease.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Variable lease payments are the amounts owed by the Company to a lessor that are not fixed, such as reimbursement for common area maintenance and utilities costs for facility leases and maintenance. Variable lease payments are expensed when incurred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Assumptions made by the Company at the commencement date are re-evaluated upon occurrence of certain events, including a lease modification. A lease modification results in a separate contract when the modification grants the lessee an additional right of use not included in the original lease and when lease payments increase commensurate with the standalone price for the additional right of use. When a lease modification results in a separate contract, it is accounted for in the same manner as a new lease.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU4_e5dee701-5741-4863-a20d-06b54b3d73df" continuedAt="i08e1b6215830415db4b8915d99b7f3b8" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force) (&#8220;ASU-2021-04&#8221;). ASU 2021-04 clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The ASU provides guidance that will clarify whether an issuer should account for a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as (1) an adjustment to equity and, if so, the related earnings per share (EPS) effects, if any, or (2) an expense and, if so, the manner and pattern of recognition. The new guidance is effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted, including adoption in an interim period. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company adopted this standard on December 1, 2021 on a prospective basis, and it did not have a material impact on its disclosures, financial position or results or operations upon adoption. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="i11f5fd15df2d433ca369023b4c863cfc"><ix:continuation id="i08e1b6215830415db4b8915d99b7f3b8">In December 2019, the FASB issued ASU 2019-12, Income Taxes-Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;). ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The new standard was effective for the Company beginning January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's disclosures, financial position or results or operations upon adoption.</ix:continuation></ix:continuation></span></div><div id="if3ac37d75c1541719d9b66553792086e_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90ZXh0cmVnaW9uOmJkODU0Yjk4MWFhNTRiMTRiMjE1MWYzOTE5MjE1NzcwXzE5MTE_df357fb5-c5d5-4ef4-9849-8e28283e84a8" continuedAt="i1d5b04292e2a4dfd8e882484814ebcf9" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i1d5b04292e2a4dfd8e882484814ebcf9"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90ZXh0cmVnaW9uOmJkODU0Yjk4MWFhNTRiMTRiMjE1MWYzOTE5MjE1NzcwXzE5MTI_411688c0-60fe-48f5-a1dd-62344e2180b7" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fair value measurements at December 31, 2021 using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37550c3c6f8b4e1c82625f4812c1040f_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzQtMS0xLTEtMTAwODc_21b52de4-7f7b-4449-a08a-c5663bf577ff">63,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4739fe5f8942668fe0bc95945099a1_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzQtMy0xLTEtMTAwODc_642c8881-6583-4a40-b9db-0a418fa65815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3b30c861e9d4e7f886845215446bbf0_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzQtNS0xLTEtMTAwODc_3bc63fe3-d6a0-411d-8b8d-63453090c357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i661a7771541c4be58e3c508f387d2d4c_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzQtNy0xLTEtMTAwODc_5fa77a06-1415-4320-b8e7-36f4db0be828">63,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id03ea759a2df458f9a6c7ec4e73c55d6_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzctMS0xLTEtMTAwODc_9b3d5fce-c6f6-417e-ad4b-12c0a54be42b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897eb2325f8b44d682297a1bba2a1afe_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzctMy0xLTEtMTAwODc_a26d8300-51aa-4b5f-b463-653b018ad9e7">104,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2c5749e2da4c9a9141bcf8dea4e07a_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzctNS0xLTEtMTAwODc_eb43af8a-7cc7-4e29-a884-aaf1c20e125a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0c818a6e331498f8f622c83e82498a6_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzctNy0xLTEtMTAwODc_a54e451b-b638-4edc-89fc-26186e49e606">104,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc33891b67d4cd4881a2c22172d9038_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzgtMS0xLTEtMTAwODc_a39e6ca4-5bcd-42ce-8e3e-0a2fd511658c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7310d48e883404aa8278fe354dfec1c_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzgtMy0xLTEtMTAwODc_dde98b3f-c1c6-4abb-b486-bef241ab489e">39,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i764cba0d028047519b61de1a37f180d8_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzgtNS0xLTEtMTAwODc_462523c3-adea-445b-8805-b6726f83d257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b98a26a73545518614cf7d9628211c_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzgtNy0xLTEtMTAwODc_5222fac1-9572-4cff-81b3-a113e9cda4db">39,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65468eff9b6d46e393fd1b4dbb2b901d_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzktMS0xLTEtMTAwODc_83fa64eb-1056-4489-8259-75b3f5c6fe47">63,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4d74d028a7d465fb5fd5451c08b99d9_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzktMy0xLTEtMTAwODc_5d2518d7-c734-45c2-ba87-005befc1faba">143,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b492035c5974422bdb650937d138473_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzktNS0xLTEtMTAwODc_2b95ecff-cf2a-4366-9f61-95965b60cf82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25857721770b4551b695d1c7721be8c6_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzktNy0xLTEtMTAwODc_5faaea06-88b9-4e10-b0b7-0babc0112491">207,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fair value measurements at December 31, 2020 using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c1e51d979ec40be896fcef26d6a787b_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzQtMS0xLTEtMTI5MDc_a282e19e-75b8-469b-855e-824e8f788225">32,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4cddd28a59e484c974e7e00a6968a69_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzQtMy0xLTEtMTI5MDc_232b9b7c-162d-41b6-8922-9cb41bc295c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3b164f107b74b22b0f4ccf27b504098_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzQtNS0xLTEtMTI5MDc_fbc1dfc7-ea76-4224-b22b-75cd213e18b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58ddf76db3846139fa1a52af88ebb35_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzQtNy0xLTEtMTI5MDc_0d39f3a1-4279-4297-ba39-c55d466c7019">32,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa02d2a706504ab0b7238eba43af4d07_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzYtMS0xLTEtMTI5MDc_b3b72ec2-4d47-4e4f-aded-87c2bd468b0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i742712bb4f08433e91c7107556ee12b4_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzYtMy0xLTEtMTI5MDc_c96c4796-c646-42a2-b704-9e38cc20301b">35,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d0802102ced4b2fad85fbb7b827d01a_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzYtNS0xLTEtMTI5MDc_582f8508-0b5b-4400-ace3-bc9bfc1a394e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eada741a72e43f8878c131461b998e8_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzYtNy0xLTEtMTI5MDc_4126c87e-2a53-436d-8a05-b7bbc27f781e">35,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3676c1e9ee8641b59223f61e35dd91d8_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzctMS0xLTEtMTI5MDc_265af5bc-fd73-4375-81bd-19e87929d5de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c308fd60bb34e1681722a61e79a2c56_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzctMy0xLTEtMTI5MDc_f4a4e4ab-d4db-4eba-83fb-7ccdbd4ddd5d">192,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e67ca30eb94ec9b7f3040a7fbc0e27_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzctNS0xLTEtMTI5MDc_00d86e53-8a20-41dd-a6dd-57435b45925c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74033657d98945978e04c05451082f37_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzctNy0xLTEtMTI5MDc_f94cadda-0f45-4449-a38f-3870e6525b6e">192,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103bc24deb864971a2124cc0e9fa120a_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzgtMS0xLTEtMTI5MDc_62f2a9d1-dfdc-4a79-b681-2faf0fa082e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877ad9b6c45a4570a3dc9fa049cb3afe_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzgtMy0xLTEtMTI5MDc_9bb03f5d-ce63-4d82-b16b-24be43b7485d">52,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62baf0a395b74b088a443289cccd0913_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzgtNS0xLTEtMTI5MDc_915f1e9b-aeb5-4faa-80e8-817b5a78fdc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ea1e1b54a744110b827b0b44b927c0a_I20201231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzgtNy0xLTEtMTI5MDc_1817a341-f2ea-43f4-90e0-f236061e00d7">52,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia09c76b66200416fa63f1c01d35e2fc1_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzktMS0xLTEtMTI5MDc_dd2eb730-7f62-430f-a8d0-a8279b7b833b">32,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d122ce461b9439dabdc048f86e95eef_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzktMy0xLTEtMTI5MDc_e900b5a4-2233-4434-9ca1-b63bce2c9745">280,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba734827ba0945438f8b534d33166ac5_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzktNS0xLTEtMTI5MDc_f5031307-1ddd-43ad-af5d-90932a921699">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fb596f6d41142a4be91b0ac53112788_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzktNy0xLTEtMTI5MDc_4f13d5d0-500c-4051-abf7-c143ddb424a8">312,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">When developing fair value estimates, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. When available, the Company uses quoted market prices to measure fair value. The valuation technique used to measure fair value for the Company's Level 1 and Level 2 assets is a market approach, using prices and other relevant information generated by market transactions involving identical or comparable assets. If market prices are not available, the fair value measurement is based on models that use primarily market-based parameters including yield curves, volatilities, credit ratings and currency rates. In certain cases where market rate assumptions are not available, the Company is required to make judgments about assumptions market participants would use to estimate the fair value of a financial instrument. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There were no transfers in or out of Level 3 categories in the periods presented.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">149</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90ZXh0cmVnaW9uOjNhMTBjZjZjNDViOTQ0MTJiZmZjNjkyMGE4ZjdmMWMxXzQzNQ_4985cd54-74ae-47f6-a7d7-bc5d42caef4b" continuedAt="ibd3eb0a6489d44f9bc10e9215f905352" escape="true">INVESTMENTS</ix:nonNumeric></span></div><ix:continuation id="ibd3eb0a6489d44f9bc10e9215f905352"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90ZXh0cmVnaW9uOjNhMTBjZjZjNDViOTQ0MTJiZmZjNjkyMGE4ZjdmMWMxXzQzNg_4a2b8716-2be3-41ce-842f-4260c6f99558" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, investments were comprised of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic872a3df7fa54aa58339156e79caec93_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzItMS0xLTEtMTAwODc_db26fa2e-dbcd-481e-878d-e7a2b76d7985">104,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic872a3df7fa54aa58339156e79caec93_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzItMy0xLTEtMTAwODc_134e0d04-b9f0-41d4-871f-4d3e5513ad7b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic872a3df7fa54aa58339156e79caec93_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzItNS0xLTEtMTAwODc_46bb1128-2dfd-4a09-bcc8-11ac89219377">242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic872a3df7fa54aa58339156e79caec93_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzItNy0xLTEtMTAwODc_72627e13-ca1a-4cea-a967-3b6b3b1048b3">104,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzMtMS0xLTEtMTAwODc_f69acbbb-a239-4d0d-8404-ff615ac73f87">40,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzMtMy0xLTEtMTAwODc_39c1f34e-6e68-4a37-90e2-477500a5ecb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzMtNS0xLTEtMTAwODc_04f07f8b-6746-4cac-8a6d-35b9a564a198">219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzMtNy0xLTEtMTAwODc_d66f411c-c3c2-4bf1-8076-39b59b5d3e5e">39,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzQtMS0xLTEtMTAwODc_686dff3b-2cb3-4ab5-beb5-e5b5506c5ed5">144,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzQtMy0xLTEtMTAwODc_75fe9cca-817a-4562-9849-8ab841b172a2">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzQtNS0xLTEtMTAwODc_c4e69119-bba7-4577-9f8d-244872cbfce7">461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzQtNy0xLTEtMTAwODc_66a333c2-9d84-471e-88fd-b4302a660863">143,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, investments were comprised of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d17648150f42bfbdf803c2674bcf29_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzEtMS0xLTEtMTI5MjM_98ad01ee-c42a-4547-b3f3-2f0d4465140a">35,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d17648150f42bfbdf803c2674bcf29_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzEtMy0xLTEtMTI5MjM_7e029221-9fb6-4fcb-807b-67d9a597c1de">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d17648150f42bfbdf803c2674bcf29_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzEtNS0xLTEtMTI5MjM_f466a45b-bb62-48cd-89c2-7ffac32801d5">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d17648150f42bfbdf803c2674bcf29_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzEtNy0xLTEtMTI5MjM_5cfb8473-f24b-4e2e-b4b1-989d8a35719b">35,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b63b5b22794ba198a5427db6ccb42a_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzItMS0xLTEtMTI5MjM_d482d4b9-6743-45a5-8346-6d7fdac72daf">191,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b63b5b22794ba198a5427db6ccb42a_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzItMy0xLTEtMTI5MjM_5f98a679-644f-4766-91b9-7f45d72d24ec">608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1b63b5b22794ba198a5427db6ccb42a_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzItNS0xLTEtMTI5MjM_1cf02705-af88-4b3d-99d7-14fa4cc575cb">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b63b5b22794ba198a5427db6ccb42a_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzItNy0xLTEtMTI5MjM_5ef97ed0-f560-4308-8cbe-c2f9eb7019a0">192,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzMtMS0xLTEtMTI5MjM_40e78927-237a-44a7-b8d8-3356ca1e564c">52,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzMtMy0xLTEtMTI5MjM_3d6b9ff4-4fa3-486f-a229-dd040eb7d254">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzMtNS0xLTEtMTI5MjM_979ec990-8fc8-4a2b-bb6a-8748ac916526">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzMtNy0xLTEtMTI5MjM_68e66458-5de9-477a-b488-61516d456d4a">52,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzQtMS0xLTEtMTI5MjM_6d59b2b2-9e78-4061-b10a-012acdecf7d4">279,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzQtMy0xLTEtMTI5MjM_6bcc45c6-bc7c-4a20-9a26-8301b03b1f4e">651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzQtNS0xLTEtMTI5MjM_45fd6d2e-62e1-4dec-b9c3-0fcabac46ca4">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzQtNy0xLTEtMTI5MjM_77302a6d-cf9c-4eff-8866-036583c7a450">280,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, all marketable securities held by the Company had remaining contractual maturities of three years or less.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021and 2020, the marketable securities in a loss position have a maturity of three years or less.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There have been <ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="0" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90ZXh0cmVnaW9uOjNhMTBjZjZjNDViOTQ0MTJiZmZjNjkyMGE4ZjdmMWMxXzI4NQ_70f9eda5-1543-45e9-9616-b88646148a32"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90ZXh0cmVnaW9uOjNhMTBjZjZjNDViOTQ0MTJiZmZjNjkyMGE4ZjdmMWMxXzI4NQ_eecca720-a905-405c-b1e0-9327b32d6ec4">no</ix:nonFraction></ix:nonFraction> impairments of the Company&#8217;s assets measured and carried at fair value during the year ended December&#160;31, 2021and 2020.</span></div></ix:continuation><div id="if3ac37d75c1541719d9b66553792086e_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90ZXh0cmVnaW9uOmI1MGI3Y2EyY2ZiNDQ4NjRiNjFlN2UxMzNmMzJhNWRhXzE2OA_0b110647-2e48-4954-a365-c3ded23f5646" continuedAt="i4382ce2d818240378790c9f3a433e2b8" escape="true">PROPERTY AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="i4382ce2d818240378790c9f3a433e2b8"><div style="margin-top:12pt"><ix:continuation id="i740f1c54691d43dc85eb7d78ee22ee25"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f1fe72d2d444aeb36925e4fcc30eb6_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzItMS0xLTEtMTAwODc_7d0d2518-6542-45f1-bbd0-6ea4e355378b">682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9ad67327bc44648c777a18474468b4_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzItMy0xLTEtMTAwODc_2dc28d80-a099-438e-b57d-97f361ce9222">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2861ec10bc3748998a17ae945f43939b_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzMtMS0xLTEtMTAwODc_de0e3d50-1d40-4559-b8f1-046393b9b3fe">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecf9843e9ef489dab03ac86e3fbbe55_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzMtMy0xLTEtMTAwODc_acd14dd9-5ef6-40e8-9ec2-b3a843b4581c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05170edcf7364cda86a8e91a6c465732_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzQtMS0xLTEtMTAwODc_f71a2114-0598-4905-9d8d-95919a9d8654">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd84886daa684164b53911ab6a5ec019_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzQtMy0xLTEtMTAwODc_419d9f97-5618-4777-acfc-913c6e94ce6f">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b0a265ea36455d88e0db82a9f72d63_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzUtMS0xLTEtMTAwODc_aabae7f6-8545-45ae-912b-2cfcf79d8808">2,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b957706c704a949271fa3b8ecce065_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzUtMy0xLTEtMTAwODc_e41ffbe5-e11e-467d-9c5f-5ea09caab907">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f0c745b901427ca91dcd2d7e618786_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzYtMS0xLTEtMTAwODc_90f658bd-94f1-4e9c-8ca8-64eff23e8d37">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6cb93d93d54cd1bb5ad6efefe6e781_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzYtMy0xLTEtMTAwODc_cde95593-e3bf-46fa-9db6-ae48f159b975">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzctMS0xLTEtMTAwODc_690e278b-ace6-4090-816c-7945093b23eb">3,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzctMy0xLTEtMTAwODc_8ae0f464-c107-424d-be8d-00d1777424fa">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzgtMS0xLTEtMTAwODc_270aef49-1447-4dd8-b067-19fb418da6bd">369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzgtMy0xLTEtMTAwODc_9d651fbd-53bd-4cc2-a39e-fb25abd61832">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzktMS0xLTEtMTAwODc_0fc1ef29-26e0-4f0c-b05d-5d3d0a2966bb">3,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzktMy0xLTEtMTAwODc_906e839b-57ad-40b5-87ab-b1e3b6404b1d">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90ZXh0cmVnaW9uOmI1MGI3Y2EyY2ZiNDQ4NjRiNjFlN2UxMzNmMzJhNWRhXzE0NQ_6b02d1e9-a75a-4102-8cdf-c66b21daedab">205</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90ZXh0cmVnaW9uOmI1MGI3Y2EyY2ZiNDQ4NjRiNjFlN2UxMzNmMzJhNWRhXzE1Mg_7d73db2a-f857-46d2-a02b-19c518db1f21">52</ix:nonFraction>, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">150</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90ZXh0cmVnaW9uOmJjZGZlMjk4MjkxOTQ3OTZiZGU5Y2QyOWJkMjFhOTJmXzEwMg_3df7e82a-3e5b-45d5-b9c7-8688172fc7fb" continuedAt="i18ddb0f2f3be46a38f05e97ffc34703b" escape="true">ACCRUED EXPENSES </ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i18ddb0f2f3be46a38f05e97ffc34703b"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90ZXh0cmVnaW9uOmJjZGZlMjk4MjkxOTQ3OTZiZGU5Y2QyOWJkMjFhOTJmXzEwMw_8dffbd80-4663-4ee5-9d61-c5c5952b8570" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Contracted research services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="bdtx:AccruedContractResearchServiceFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzItMS0xLTEtMTAwODc_3f2a6652-9098-420d-9dce-e9f979b9a937">12,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="bdtx:AccruedContractResearchServiceFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzItMy0xLTEtMTAwODc_37b22047-11cc-4e48-80ca-ec93c4f79a6d">5,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payroll and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzMtMS0xLTEtMTAwODc_093c6ae7-d676-42c5-824b-52462972c0fe">5,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzMtMy0xLTEtMTAwODc_0579b271-7c13-41f9-93dd-1cdb650c5ba2">3,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzQtMS0xLTEtMTAwODc_a1ce7281-1423-46f0-97be-dd9450274cf5">1,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzQtMy0xLTEtMTAwODc_e0ad0e51-dfd4-4cd7-8a48-ceba461cf619">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="bdtx:AccruedLegalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzUtMS0xLTEtMTAwODc_5adb7688-908c-4400-9085-6db76d472f91">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="bdtx:AccruedLegalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzUtMy0xLTEtMTAwODc_4569a1b0-554f-4c02-be4a-f033c858fcfb">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_60506ab5-efc5-4954-abd1-b1eb79d8d8bb"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_bf8d40bd-aa95-4835-abf8-381f9a8156f6">Current portion of operating lease liability</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMS0xLTEtMTAwODc_04d418af-03b2-4c03-a12b-ca45f8dda2fe">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMy0xLTEtMTAwODc_7b99b808-6d90-4210-8320-ac7f44045f43">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzctMS0xLTEtMTAwODc_3c4c276a-c960-4d0a-bd37-e45af72f868e">19,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzctMy0xLTEtMTAwODc_a948d954-fb53-4a0b-af4b-1b4fd4fed91f">11,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="if3ac37d75c1541719d9b66553792086e_121"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0XzEwMzQ_82e06de4-9bdd-40cb-afd5-d27fb54bb26e" continuedAt="i2c5d3148d2b5431ebcd5d58baaa1ea61" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i2c5d3148d2b5431ebcd5d58baaa1ea61" continuedAt="i94f27ed147ec4facbf7308a46253198c"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder to <ix:nonFraction unitRef="vote" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="bdtx:CommonStockVotingRightsNumberOfVotesPerShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0XzIxOTkwMjMyNTY3Njk_d0377097-4c4c-412b-bb2f-3320681c2f1b">one</ix:nonFraction> vote on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon closing of the IPO on February 3, 2020, all of the preferred stock converted into an aggregate of <ix:nonFraction unitRef="shares" contextRef="i5d4aa309da524f179ebe88bd9ded86f2_D20200203-20200203" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0XzQ5Ng_76c5c101-97e0-4155-b934-fd4b83f5f17f">21,499,770</ix:nonFraction> shares of common stock.</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="i94f27ed147ec4facbf7308a46253198c">On February 3, 2020, in connection with the closing of the IPO, the Company filed an amended and restated certificate of incorporation, which, among other things, restated the number of shares of all classes of stock that the Company has authority to issue to <ix:nonFraction unitRef="shares" contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203" decimals="0" name="bdtx:SharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0Xzc4Mw_3b0b55ea-75f6-4aaf-9e0c-796dc052cf51">510,000,000</ix:nonFraction> shares, of which (i) <ix:nonFraction unitRef="shares" contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0XzgwNw_9cc5b412-541f-4fc7-8983-ecd4bc0f5d96">500,000,000</ix:nonFraction> shares shall be a class designated as common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0Xzg3Mg_8c2cf609-1abe-42ad-90cf-92746c3e30f5">0.0001</ix:nonFraction> per share, and (ii) <ix:nonFraction unitRef="shares" contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0Xzg5NQ_59cf262a-63f5-4f87-b74b-b58670b504b6">10,000,000</ix:nonFraction> shares shall be a class designated as undesignated preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203" decimals="4" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0Xzk3Ng_cf29bd81-b18c-4a6c-b29e-45ad59b4a353">0.0001</ix:nonFraction> per share.</ix:continuation> </span></div><div id="if3ac37d75c1541719d9b66553792086e_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjM_d96a2db3-0a11-4cab-aa64-98cb1cb9174b" continuedAt="i7b313e6d0105491f8e1c7145a843c21d" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i7b313e6d0105491f8e1c7145a843c21d" continuedAt="i3a2bcf7ee96c488a923f171293aebda4"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2017 Equity Incentive Plan </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (the &#8220;2017 Plan&#8221;), provided for the Company to grant qualified incentive options, nonqualified options, stock grants and other stock-based awards to employees and non-employees to purchase the Company&#8217;s common stock. Upon the effectiveness of the 2020 Plan (as defined below), no further issuances were made under the 2017 Plan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2020 Stock Option and Incentive Plan</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2020 Stock Option and Incentive Plan (the &#8220;2020 Plan&#8221;) was approved by our board of directors on December 5, 2019, and the Company&#8217;s stockholders on January 14, 2020 and became effective on the date immediately prior to the date on which the registration statement for the Company&#8217;s IPO was declared effective. The 2020 Plan provides for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units, restricted stock awards, unrestricted stock awards, cash-based awards and dividend equivalent rights to the Company&#8217;s officers, employees, directors and consultants. The number of shares initially reserved for issuance under the 2020 Plan was <ix:nonFraction unitRef="shares" contextRef="ic9eb66e638b04af899a8e80564e32d1a_I20200114" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzEyMTY_36b1741d-5397-44f9-8970-33a95a034ada">6,665,891</ix:nonFraction>, which shall be cumulatively increased on January 1, 2021 and each January 1 thereafter by <ix:nonFraction unitRef="number" contextRef="ic9eb66e638b04af899a8e80564e32d1a_I20200114" decimals="2" name="bdtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzEzMTA_7f99d10f-f218-49f5-a238-8712dda01aa7">4</ix:nonFraction>% of the number of shares of the Company&#8217;s common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by the Company&#8217;s board of directors or compensation, nomination, and corporate governance committee of the board of directors. As of December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i48ffe9f699fa4a539801be7d17a1a76e_I20211231" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzE2MDA_7fcb7779-0f8c-4595-89fb-779a7dba1298">5,211,827</ix:nonFraction> shares remained available for issuance under the 2020 Plan. The number of authorized shares reserved for issuance under the 2020 Plan was increased by <ix:nonFraction unitRef="shares" contextRef="ib81aa95c217141f292296a2bf857d7d3_D20220101-20220101" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzE3NTQ_3b5da830-6a31-41ed-9d6c-367125ef0ac8">1,449,384</ix:nonFraction> shares effective as of January 1, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="i3a2bcf7ee96c488a923f171293aebda4" continuedAt="i19852a2d7d9f4ca08a8fb868a36ee231"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2020 Employee Stock Purchase Plan (the &#8220;2020 ESPP&#8221;) was approved by the Company&#8217;s board of directors on December 5, 2019, and our stockholders on January 14, 2020, and became effective on the date immediately prior to the date on which the registration statement for the Company&#8217;s IPO was declared effective. A total of <ix:nonFraction unitRef="shares" contextRef="id325337deaca458ba4cd7cc986b6aa01_I20200114" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzIxNTU_53b30b88-cf0d-4358-acb3-122476ffd1a0">326,364</ix:nonFraction> shares of common stock were initially reserved for issuance under this plan, which shall be cumulatively increased on January 1, 2021 and each January 1 thereafter by <ix:nonFraction unitRef="number" contextRef="id325337deaca458ba4cd7cc986b6aa01_I20200114" decimals="2" name="bdtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzIzMjU_30a602ca-f7db-4f5c-937c-c536136920e4">1</ix:nonFraction>% of the number of shares of the Company&#8217;s common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by the Company&#8217;s board of directors or compensation, nomination and corporate governance committee of the board of directors. As of December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i4c378bf5d47a49fa9e52b9ba3e36d859_I20211231" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzI2MTQ_eb699929-a66b-479b-a2b9-86130cac1773">646,566</ix:nonFraction> shares remained available for issuance under the 2020 Plan. The number of authorized shares reserved for issuance under the 2020 Plan was increased by <ix:nonFraction unitRef="shares" contextRef="ia475c342c2e24f7891e04263bf9fda52_D20220101-20220101" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzI3Njg_4ca793d0-accc-4664-b404-abf56c15ee73">326,364</ix:nonFraction> shares effective as of January 1, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Option valuation </span></div><div style="margin-top:12pt"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjQ_dd0ce142-5645-40ad-860f-ecd63903eb1f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The assumptions that the Company used to determine the grant-date fair value of options granted were as follows, presented on a weighted-average basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:72.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzItMS0xLTEtMTAwODc_f8a94496-34de-43d2-8530-f94b0f129d22">0.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzItMy0xLTEtMTAwODc_f96b1e62-d55e-4d16-a25b-83a1fd874d78">0.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzMtMS0xLTEtMTAwODc_8375a1f6-2dec-41ac-aa61-13b35c1285d4">5.6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzMtMy0xLTEtMTAwODc_85007313-4d19-4d0b-bfa6-bc9032323bbc">6.1</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzQtMS0xLTEtMTAwODc_7deb992b-528b-49de-947f-386dd90355b7">76.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzQtMy0xLTEtMTAwODc_bc320aff-c7ca-48d1-88c7-63de86338e91">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzUtMS0xLTEtMTAwODc_cfe01ba1-83ea-445e-942e-93f50bd5cc75">0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzUtMy0xLTEtMTAwODc_42f0af70-0b96-4f4b-9352-798efa86b0a4">0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Options </span></div><div style="margin-top:12pt"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjI_93da7d70-1549-4754-be3b-2b9b83cb15f1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the stock option activity under the Company&#8217;s equity awards plans:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.568%"><tr><td style="width:1.0%"></td><td style="width:46.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.454%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.454%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.454%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Exercise</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Price</span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Life</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(in Years)</span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Outstanding December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzEtMS0xLTEtMTAwODc_94c3788f-23ed-4afd-beaf-54827a30fedd">3,752,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzEtMy0xLTEtMTAwODc_70b39648-9ef9-4f75-bcd5-da7ee776e3c5">15.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzEtNS0xLTEtMTAwODc_7a9f84ee-807f-4d8a-b3a6-9bb0cd5e8196">9.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzEtNy0xLTEtMTAwODc_955047a5-55d3-44da-9790-808a34df530f">62,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzItMS0xLTEtMTAwODc_98bddd83-9a0e-4fe2-bb89-e12dfb5160ac">1,996,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzItMy0xLTEtMTAwODc_e1e218ec-ba68-425b-aa1b-c9ca10407065">21.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzMtMS0xLTEtMTAwODc_2ba318c4-6974-4e05-9b45-dfd7988ae609">110,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzMtMy0xLTEtMTAwODc_e37520c6-3d17-444e-91e7-f414903aeb41">6.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cancelled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzQtMS0xLTEtMTAwODc_04945aed-5777-4934-bbec-fa7889ab3fac">734,928</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzQtMy0xLTEtMTAwODc_24911bdf-a1ef-4edf-b2f3-bc537856b512">22.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Outstanding December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzUtMS0xLTEtMTAwODc_92e1b688-608a-4af4-908a-508e5c9b3ce0">4,903,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzUtMy0xLTEtMTAwODc_d3b660e0-4cd3-4997-911e-7af3f02df0f6">17.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzUtNS0xLTEtMTAwODc_dfac00ee-46f1-4efd-830c-db01b22caa1c">7.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzUtNy0xLTEtMTAwODc_7c823dde-4e6a-4b26-b90b-f7c5eb3f48cd">847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options vested or expected to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzYtMS0xLTEtMTAwODc_700a70a9-7abf-4ee4-bcd8-c790fe41c839">4,903,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzYtMy0xLTEtMTAwODc_67a47ba7-ab44-448a-b1e7-fe4235002efc">17.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzYtNS0xLTEtMTAwODc_97b11ddc-2071-4d4f-8287-159d97b45554">7.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzYtNy0xLTEtMTAwODc_92136a9a-d5a6-43c3-bef7-8124f69880a5">847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzctMS0xLTEtMTAwODc_3bde2fa8-6e9e-4520-a185-b40a040f9e7c">1,791,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzctMy0xLTEtMTAwODc_2546ce8d-f68e-4055-b682-d40b4251cab6">14.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzctNS0xLTEtMTAwODc_b4a766fa-b9f1-4faf-8d95-cca3306ce3fc">6.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzctNy0xLTEtMTAwODc_316e8879-655b-4636-b639-aa9b9023a363">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options is calculated as the difference between the exercise price of the options and the fair value of the Company&#8217;s common stock for those options that had exercise prices lower than the fair value of the Company&#8217;s common stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value per share of options granted during the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzM0Njk_20062a54-4446-4b72-b98c-a45a0e97ce77">12.93</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzM0NzY_0d36f932-6546-47f5-be7d-4a28f2fbddaa">15.18</ix:nonFraction>, respectively. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="i19852a2d7d9f4ca08a8fb868a36ee231" continuedAt="if949ac75394446f3bec490e18ff37a29"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The total fair value of options vested during the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzM1NzE_0ccb0e0d-b1bb-4f88-98ee-c353e9e2e22d">11,438</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzM1Nzg_07351c42-1486-4152-8871-e7e0e9604e45">4,198</ix:nonFraction>, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Restricted stock </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under terms of the restricted stock agreements covering the common stock, shares of restricted common stock are subject to a vesting schedule. The majority of restricted stock vests over a <ix:nonNumeric contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjg_256cffd9-ad15-426a-885a-4d4201a2ac1c">three-year</ix:nonNumeric> period during which time all unvested stock will immediately be forfeited to the Company if the relationship between the recipient and the Company ceases. Subject to the continued employment (or other engagement of the recipient by the Company as described in the restricted stock agreements), all shares of restricted common stock become fully vested within <ix:nonNumeric contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzIxOTkwMjMyNjE3NTU_fa08bb45-84d6-4f17-80c3-f18bc3b4b0c6">three years</ix:nonNumeric> of the vesting commencement date. </span></div><div style="margin-top:12pt"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjU_6f239ecc-2362-4cd7-aa82-d8f061f00d88" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes restricted stock activity since January 1, 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Number&#160;of</span></div><div style="margin-bottom:0.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">shares</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">average</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">grant&#160;date</span></div><div style="margin-bottom:0.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unvested restricted common stock as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i409db6c3ae2948168a94cd673a222876_I20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzEtMS0xLTEtMTAwODc_d1283774-2d90-4459-9e5a-21d04efcfed3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i409db6c3ae2948168a94cd673a222876_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzEtMi0xLTEtMTAwODc_cc6ee50a-fc5a-4d90-bf3f-79791b9e0d8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzItMS0xLTEtMTAwODc_119e5672-8d76-483a-98d3-42f3e873827d">61,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzItMi0xLTEtMTAwODc_323e199e-deb1-4160-8e0e-75bfcff55e5f">29.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzMtMS0xLTEtMTAwODc_e08619cc-71d8-4383-97a7-bd87b0ada5fe">6,664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzMtMi0xLTEtMTAwODc_3f9c452e-1ff2-4d93-9b5e-583081e270ca">30.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unvested restricted common stock as of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3bf60c3f3c74cac874df7014c860584_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzQtMS0xLTEtMTAwODc_2b37ccca-61c3-41d7-987d-0e84bef2867f">54,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie3bf60c3f3c74cac874df7014c860584_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzQtMi0xLTEtMTAwODc_9320a4c2-9118-48d0-a38a-3380bd96ea30">29.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzUtMS0xLTEtMTAwODc_a80a2de0-f147-4009-a2a2-0fc0cd0455cf">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzUtMi0xLTEtMTAwODc_a598af21-151b-4d12-aae6-09009beb6c52">28.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzYtMS0xLTEtMTE5MjQ_c47c51fd-68f0-45dc-b314-ac47bc382848">27,002</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzYtMi0xLTEtMTE5MzU_7fc3dcf1-90f7-463d-885a-236e076ee852">26.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cancelled or forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzYtMS0xLTEtMTAwODc_2b375f6e-ae17-45a3-bc00-bdaeeed7c5a6">6,667</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzYtMi0xLTEtMTAwODc_9589846e-b4b4-46c7-8b2c-01276d77a776">1.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unvested restricted common stock as of December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i494939f1eb09446097a4d8943229ee63_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzctMS0xLTEtMTAwODc_ea25d7cf-10cb-4a33-a6a6-fba6f55b4aa6">30,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i494939f1eb09446097a4d8943229ee63_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzctMi0xLTEtMTAwODc_3df86e9f-2f63-4825-ba9f-9fc75785838f">29.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The aggregate fair value of restricted stock that vested during the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzQzODY_bfaa2589-177b-406e-b774-1dc2427829e2">714</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzQzOTM_c9269184-fb8b-4b65-9259-c08f7f876169">200</ix:nonFraction>, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation expense </span></div><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzIxOTkwMjMyNjM1Nzg_15978ad4-5b67-48e9-b547-8a30895a88ac" continuedAt="i88efa26dd1174bf885597eb911d73847" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense in the following award type categories included within its consolidated statements of operations and comprehensive loss:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife703eee16a24418b0688374aa2d9127_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzItMS0xLTEtMTE5NzA_bf894f31-5aa0-44ef-9785-62a4eb8c928e">12,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d213479013e4c85a590094a80d5821c_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzItMy0xLTEtMTE5NzA_17971f28-ae44-4699-b0af-1f19934f3687">7,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e7beae8caf2403f8ca0392b605a96a5_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzMtMS0xLTEtMTE5NzA_5f7515bb-c31a-4b60-9aea-6ea89b78e451">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3a672acfe3476499dfdb07a32e435a_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzMtMy0xLTEtMTE5NzA_e5c6938a-61bd-4d2d-a83c-9617d2598fcb">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e11f471e4864a40a07e85f2ee15dc66_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzQtMS0xLTEtMTE5NzA_c929a786-1338-4036-be18-4c218011b59f">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d4b8a477e44a2294dafb47b8366169_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzQtMy0xLTEtMTE5NzA_2ac65afc-c520-495c-aa31-0bc23eb6d966">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzUtMS0xLTEtMTE5NzA_b8a7c237-5418-4326-89d6-8494d293d8d8">14,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzUtMy0xLTEtMTE5NzA_13799675-6420-4235-8f14-81c1e4ed3852">7,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company issued <ix:nonFraction unitRef="shares" contextRef="ifbd32a8c30ea4113a72bd22800a1803a_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzE2NDkyNjc0NDg0ODk_92459268-7aac-4e0c-b440-56a9ab7c62bf">12,456</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="idbd7ebcbc2d04c7fa4877287edf187be_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzE2NDkyNjc0NDg0OTk_53b7a9cc-2c99-4fa3-bf9e-78999bdeb949">505</ix:nonFraction> shares, respectively, of common stock out of our 2020 Plan under our policy where non-employee directors may elect to receive their compensation in the form of common stock in lieu of cash.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="if949ac75394446f3bec490e18ff37a29"><div style="margin-top:12pt"><ix:continuation id="i88efa26dd1174bf885597eb911d73847"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense related to stock options and restricted stock units in the following expense categories of its consolidated statements of operations and comprehensive loss:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4f007a1e3a4f32b5564d78ab1f7548_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzItMS0xLTEtMTAwODc_47da6068-c034-4d31-b029-597d69d9a34f">6,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a07f83801a4155974a26a9c19c163c_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzItMy0xLTEtMTAwODc_60fc5485-500e-4d8c-8739-052b58ef10cd">3,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iead01dff07974c708a3ac77a441836f1_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzMtMS0xLTEtMTAwODc_895c2fcf-1d26-429c-b9d0-8f32f8858d45">7,713</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d20f61caf924e11ac009ed0ff78534e_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzMtMy0xLTEtMTAwODc_4f8a326f-29ac-49b2-9e2e-a528741c02ca">4,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzQtMS0xLTEtMTAwODc_dea2054c-fb1f-4160-b0e3-a0850a2cdd56">14,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzQtMy0xLTEtMTAwODc_cf4be6a6-eff3-4ddb-826c-75900264d127">7,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, total unrecognized compensation cost related to the unvested stock options was $<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzU5MTI_36ea2200-3c7a-4184-a004-b3d40f01a981">31,192</ix:nonFraction>, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="ife703eee16a24418b0688374aa2d9127_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzU5ODU_6d0cb1ed-6b2d-442f-aa32-83a8d6a0d7cd">2.5</ix:nonNumeric> years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, total unrecognized compensation cost related to the unvested restricted stock units was $<ix:nonFraction unitRef="usd" contextRef="i494939f1eb09446097a4d8943229ee63_I20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYwODc_1e1088b4-f76a-4a2d-97ee-99d23382dcbb">636</ix:nonFraction>, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjA_9aadf78f-d40b-4f40-9552-b3a9c8d4aad2">1.4</ix:nonNumeric> years.</span></div></ix:continuation><div id="if3ac37d75c1541719d9b66553792086e_127"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">9. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzUzNTg_13038205-e174-45d4-9ac2-2a66d0844c7b" continuedAt="idaaeeec39d364a17b9938cbfc774738d" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="idaaeeec39d364a17b9938cbfc774738d" continuedAt="ia5db3454af904eed87bd3b054a7d7c2f"><div style="margin-top:12pt"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzI3NDg3NzkwODA2ODk_20f681b5-30ba-4824-8c97-1935b5ec16bd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Income (loss) before income tax expense consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzItMS0xLTEtMTUxMDQ_141014b6-6a10-4d7c-88cd-08004d4af69f">125,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzItMy0xLTEtMTUxMDQ_6f09c15e-d895-4462-a0d0-ef07ac44e0eb">66,992</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzMtMS0xLTEtMTUxMDQ_3e176704-313f-42e2-aca0-4dbfd29ea10c">268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzMtMy0xLTEtMTUxMDQ_993dbdfe-3c39-4082-a25a-266cff419a04">262</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total loss before income taxes</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzQtMS0xLTEtMTUxMDQ_6e1c0046-a1a1-4968-9976-044864dada72">125,596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzQtMy0xLTEtMTUxMDQ_6dfae177-fecc-491a-b4a6-25d45561f14c">67,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company recorded <ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzc0_595a4e2b-5a6f-4380-bc73-98848378d7cd"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzc0_81fa7206-00ca-4f95-8a39-24d6ade3b325">no</ix:nonFraction></ix:nonFraction> income tax benefit for the net operating losses incurred each year, due to its uncertainty of realizing a benefit from those items.  <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzUzNTk_7b9b19d0-f85a-4f27-940a-484bedbc034c" continuedAt="idaa6baad33ba4a55bf77496deb35c83e" escape="true">A reconciliation of income taxes computed using the U.S. federal statutory rate to that reflected in operations as of December&#160;31, 2021 and 2020, respectively, is as follows: </ix:nonNumeric></span><ix:continuation id="idaa6baad33ba4a55bf77496deb35c83e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. federal statutory income tax rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzItMS0xLTEtMTAwODc_3a667a96-eb06-4b47-9ba8-314fd4510211">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzItMy0xLTEtMTAwODc_713cec3b-a758-4ff3-9f6b-b640f980f969">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">State and local taxes, net of federal benefit&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzMtMS0xLTEtMTAwODc_c5025224-7c9e-4394-8c18-844dad902259">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzMtMy0xLTEtMTAwODc_b64b55f0-13dc-4a50-80a9-118d3135ea9f">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permanent differences</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="3" sign="-" name="bdtx:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzQtMS0xLTEtMTAwODc_e3c464f5-c75e-40ec-b247-dd2af69ea575">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="3" name="bdtx:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzQtMy0xLTEtMTAwODc_e677184a-d307-48a2-b4fb-afbf67ab1191">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzUtMS0xLTEtMTQxODk_9d9e2a48-0b25-4d4a-954f-338c733ddb50">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzUtMy0xLTEtMTQxODk_87d2e592-c52a-4bb5-8cbb-660dd118dfae">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development credits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzUtMS0xLTEtMTAwODc_6721254f-5d6f-4feb-ba46-35af0bbc313b">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzUtMy0xLTEtMTAwODc_b2499c77-62cf-4f8c-819c-8b52d567ddf7">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Change in valuation allowance&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzYtMS0xLTEtMTAwODc_f7a84259-8b84-49ec-86eb-63cf3d41197b">27.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzYtMy0xLTEtMTAwODc_ddf5c336-fc6d-45b4-9af5-5277ea703928">26.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzctMS0xLTEtMTAwODc_d20a67e8-4f15-42de-98d0-f2c76200e8c8">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzctMy0xLTEtMTAwODc_d804aea2-84b5-4836-b02b-c3657beb9d6d">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Effective income tax rate&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzgtMS0xLTEtMTAwODc_fdd4a2f4-319f-4034-a0c9-a07127de2b69">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzgtMy0xLTEtMTAwODc_3283d818-87f0-4fc7-93ec-ab87e1bd77d7">0.0</ix:nonFraction> %</span></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="ia5db3454af904eed87bd3b054a7d7c2f" continuedAt="i3a7102f9d6e44e9d96d7677616402ee4"><div style="margin-top:12pt"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzUzNjE_ae71acf0-b23b-4e84-8ce8-dfcf90eca1fe" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.328%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzMtMS0xLTEtMTAwODc_14e1fc44-e5a8-4659-b3eb-64f0d1e7a9f6">52,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzMtMy0xLTEtMTAwODc_b14b3140-efd9-4242-a4e7-7b69c5cfc4e7">24,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzQtMS0xLTEtMTAwODc_f3b33b59-da92-46a1-91b2-74d1e7111c8f">5,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzQtMy0xLTEtMTAwODc_2f2bb16c-ed7f-4df0-a6d1-ca22e63bbcec">2,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="bdtx:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzUtMS0xLTEtMTAwODc_2565a579-8be6-4dda-b9ae-d9c47e2869e7">7,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="bdtx:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzUtMy0xLTEtMTAwODc_3e4a08b1-d22f-40ba-841b-8f27e594680d">2,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accruals and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzYtMS0xLTEtMTAwODc_9189355e-6f3d-4a10-a428-9a6ffd8041a9">1,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzYtMy0xLTEtMTAwODc_47b09aa2-20cf-44d6-85ed-d60ca9530b34">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzctMS0xLTEtMTAwODc_5806c9f1-f53d-45a8-8533-fcc85a2e3457">3,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzctMy0xLTEtMTAwODc_39f91d90-93af-4aaf-ac33-3e04241453bb">1,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzgtMS0xLTEtMTAwODc_0a193e39-07ca-4c21-a073-9c7922dc48c7">70,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzgtMy0xLTEtMTAwODc_4cf3c04c-9b13-492b-943d-548ef779b707">30,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Valuation Allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzktMS0xLTEtMTAwODc_8a509539-a441-4f94-84e9-7de2438fe4a0">63,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzktMy0xLTEtMTAwODc_46fb64f1-b0db-4b1b-a89f-ee93bd305758">28,709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEwLTEtMS0xLTEwMDg3_529c63dd-2bb9-4f9e-948f-2fcc6f22ba00">7,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEwLTMtMS0xLTEwMDg3_5e9c1fd4-d128-42c5-9b43-63e2a518fb04">2,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzExLTEtMS0xLTEwMDg3_19c7eb6b-18cc-4859-b690-9631fa43a288">7,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzExLTMtMS0xLTEwMDg3_0158af1e-73bd-4eb0-a336-3e0a3a51112f">2,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEyLTEtMS0xLTEwMDg3_a3f1c05f-cc85-468e-9864-7bd7ed8407a8">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEyLTMtMS0xLTEwMDg3_b21f3b2d-84f9-4f5e-9acf-0b2db52ed5f7">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEzLTEtMS0xLTEwMDg3_2159472a-1db3-44f5-8e51-d9896e9d3ca2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEzLTMtMS0xLTEwMDg3_3b9d7c0b-4183-4f21-8ded-c25858f22c7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of December&#160;31, 2021, the Company had gross federal net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ib3f540cd599244b38eb489e52a6cc2de_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzU4MA_b538ebc8-9b1a-43b0-9e9a-d32e17da0f60">209,607</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="ie5d0a15d9464476f88434bfff0ae0a67_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzEwOTk1MTE2Mzg4Nzc_ee2ba0ca-5b2b-4451-a7f4-e2183a5483ef">2,557</ix:nonFraction> begin to expire in 2036 and the remainder do not expire but are subject to 80% limitation. As of December 31, 2021, the Company had state net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="id37d6ea5602744e9b4b315730beac564_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzU4Nw_e02a62e8-e053-49bd-93ce-1548c25214e1">135,422</ix:nonFraction> that begin to expire in 2036. The Company also has net operating loss carryforwards in Canada of $<ix:nonFraction unitRef="usd" contextRef="ib41127d5f7aa452f8b4b9e2bbc608eab_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzg2MQ_f15cece5-d8c6-450b-ba01-c8ddf0c74b20">463</ix:nonFraction> that are set to expire beginning in 2039. Additionally, the Company had federal research and development tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i3697f799f56d4e558c172781bd1f5483_I20211231" decimals="-3" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzk5Nw_8b4ec7eb-3b50-4084-af9e-2b539c64d729">5,439</ix:nonFraction> that expire at various dates through 2041.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In assessing the realizability of the net deferred tax asset, the Company considers all relevant positive and negative evidence in determining whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The realization of the gross deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of the net operating loss carryforwards. Management believes that it is more likely than not that the Company&#8217;s deferred income tax assets will not be realized. As such, there is a full valuation allowance against the net deferred tax assets as of December&#160;31, 2021 and 2020. The valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzE3NTk_45f5a065-2f0a-4722-a869-95a234cde96c">34,305</ix:nonFraction> during the year ended December&#160;31, 2021 primarily as a result of net operating losses generated during the period.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Utilization of the net operating loss carryforwards and research and development tax credit carryforwards may be subject to an annual limitation under Section 382 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section 382, which is determined by first multiplying the value of the Company&#8217;s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. Further, until a study is completed and any limitation is known, no amounts are being presented as an uncertain tax position.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">155</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="i3a7102f9d6e44e9d96d7677616402ee4"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company also has not conducted a study of its research and development credit carryforwards, which may result in an adjustment to research and development credit carryforwards. A full valuation allowance has been provided against the Company&#8217;s research and development credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheets or statements of operations if an adjustment were required. Further, until a study is completed and any limitation is known, no amounts are being presented as an uncertain tax position.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company applies the accounting guidance in ASC 740 related to accounting for uncertainty in income taxes. The Company&#8217;s reserves related to taxes are based on a determination of whether, and how much of, a tax benefit taken by the Company in its tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit. As of December&#160;31, 2021 and 2020, the Company had <ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzQ2MTg_550321e3-97f1-4459-a818-1fb6f81529a9"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzQ2MTg_8a931834-6ae9-4a6c-b61b-e52b6c10aeec">no</ix:nonFraction></ix:nonFraction> unrecognized tax benefits. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company will recognize interest and penalties related to uncertain tax positions in income tax expense. As of December&#160;31, 2021 and 2020, the Company had <ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzQ3OTA_99b72a42-517d-4e29-a851-f479e98a83ff"><ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzQ3OTA_c5c896c5-0f69-4073-b74e-27d017a25bfc">no</ix:nonFraction></ix:nonFraction> accrued interest or penalties related to uncertain tax positions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending tax examinations. As of December&#160;31, 2021 and 2020, the Company&#8217;s tax years are still open under statute from 2018 to the present.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s foreign subsidiary has incurred losses since inception and the Company had <ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzIxOTkwMjMyNjA5MTg_6f2cc0b8-55e3-44db-b12d-d5506115eadd">no</ix:nonFraction> undistributed earnings as of December&#160;31, 2021.</span></div></ix:continuation><div id="if3ac37d75c1541719d9b66553792086e_130"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">10. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90ZXh0cmVnaW9uOjM2OGU3ZmYzYmQyMDQ0ZTJiOTA2MmE1Y2I5OWI3YzhkXzEzNjc_060b7b29-54c8-45c5-bb5e-3105451c857a" continuedAt="i19e9073135a2425e93ceda2e525eb800" escape="true">NET LOSS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i19e9073135a2425e93ceda2e525eb800" continuedAt="i907b67043b3843b1b386334f369f221f"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Net loss per share</span></div><div style="margin-top:12pt"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90ZXh0cmVnaW9uOjM2OGU3ZmYzYmQyMDQ0ZTJiOTA2MmE1Y2I5OWI3YzhkXzEzNjU_1185b06b-75e0-4741-a453-a2d22652c9d6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzItMS0xLTEtMTAwODc_dd3fc3fe-b261-4bed-8d76-293d4de65aae">125,596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzItMy0xLTEtMTAwODc_664ef3ba-388b-4830-aa36-ee5e75f5b3f5">67,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, basic and diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzMtMS0xLTEtMTAwODc_5aa7aa24-7314-4a42-a7e1-20a0cee35e9b"><ix:nonFraction unitRef="shares" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzMtMS0xLTEtMTAwODc_9e23feea-7234-4049-b2ce-3124d5188404">36,189,002</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzMtMy0xLTEtMTAwODc_1b24d8f5-f31d-496a-8db3-9077be567461"><ix:nonFraction unitRef="shares" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzMtMy0xLTEtMTAwODc_c33391fd-1655-4415-9815-0c88169d16b0">32,907,100</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzQtMS0xLTEtMTAwODc_58cfe9df-c0a0-41c4-a8ae-56f0d0769874"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzQtMS0xLTEtMTAwODc_7bbdf063-4e33-437f-a136-4d76ad6e1caf">3.47</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzQtMy0xLTEtMTAwODc_2cd6c1f5-cd7a-4069-aa3d-af68168cf1c8"><ix:nonFraction unitRef="usdPerShare" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzQtMy0xLTEtMTAwODc_8c7ba103-87c8-4cd3-ba4b-a1da6b169b5a">2.05</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s unvested restricted common shares at December&#160;31, 2021 and 2020 have been excluded from the computation of basic net loss per share attributable to common stockholders.</span></div></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">156</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><ix:continuation id="i907b67043b3843b1b386334f369f221f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s potentially dilutive securities, which include options, unvested restricted stock, shares issuable under the employee stock purchase plan and warrants to purchase common stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90ZXh0cmVnaW9uOjM2OGU3ZmYzYmQyMDQ0ZTJiOTA2MmE1Y2I5OWI3YzhkXzEzNjY_8be4f85a-6e52-42ed-82c4-b01db8f7af6e" continuedAt="i136d892ffe4e402a86ee0cf1112407ad" escape="true">The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:</ix:nonNumeric></span><ix:continuation id="i136d892ffe4e402a86ee0cf1112407ad"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54551aadbd8e4430aa8071d23c1c1c0e_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzItMS0xLTEtMTAwODc_73f6ac07-41ba-4ca7-886e-fa736a7c65a9">4,903,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide4e4eed14bf4310a962d48216c9ab68_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzItMy0xLTEtMTAwODc_1821d7f4-c110-44cb-9c97-12601bb37cd3">3,752,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unvested restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c27a225a3e24360be5046309795d54d_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzMtMS0xLTEtMTAwODc_388da5cc-7a83-4693-b8ef-d6a07c988621">30,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b93ad2715d94c1097f1ba1e707cc771_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzMtMy0xLTEtMTAwODc_78e1545c-8b73-4254-bf57-d404ddb97dcf">54,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shares issuable under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86a156ce1dbe4eaf9a07508a2e9c2203_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzQtMS0xLTEtMTAwODc_c6936bbe-1f3e-4fe8-a68d-05038c2e0043">24,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3625da8da754dfe9f0c00bdb9a1ea06_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzQtMy0xLTEtMTAwODc_be85df9b-b114-47f3-b319-b0621e0f8fd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Warrants to purchase shares of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i493c609a43ce4f48b467af5ffd22630d_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzUtMS0xLTEtMTAwODc_72afecd1-78d0-4603-8d03-1c1030e604a0">10,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8023413c14d34199a01eff6173e632dd_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzUtMy0xLTEtMTAwODc_56c5cbf9-4bbf-406c-b9b5-db1769135712">10,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzYtMS0xLTEtMTAwODc_a7a28471-7b5b-4ef8-ad00-6c7f65e476e9">4,970,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzYtMy0xLTEtMTAwODc_f94eac0a-0b03-4fb4-832b-4a10f0ef6175">3,817,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr></table></ix:continuation></ix:continuation></div><div id="if3ac37d75c1541719d9b66553792086e_133"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODg_90e164ec-8a2b-46f8-a18b-f4225a93369e" continuedAt="ibacd92a330fb45979b604d718c0e8b49" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="ibacd92a330fb45979b604d718c0e8b49" continuedAt="if96154d7a04f408b90927c4de71f39b3"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has historically entered into lease arrangements for its facilities. As of December&#160;31, 2021, the Company had <ix:nonFraction unitRef="contract" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="INF" name="bdtx:LesseeOperatingLeaseNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEyMw_ae16612a-e609-460b-8cc7-fce22c86ad3d">two</ix:nonFraction> operating leases with required future minimum payments. In applying the transition guidance under ASC 842, the Company determined the classification of these leases to be operating leases and recorded right-of-use assets and lease liabilities as of the effective dates. The Company&#8217;s leases generally do not include termination or purchase options. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In July 2020, the Company entered into a <ix:nonNumeric contextRef="i6efd849321404f36ac0949e86c2f742e_I20200731" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODk_d8f7dabf-0093-4f28-a1a5-45c16af2b70b">seven-year</ix:nonNumeric> agreement with an option to extend for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzU4Mg_b2565059-2dc9-4865-97c8-084fe9219efb">five</span> additional years to lease two floors totaling approximately <ix:nonFraction unitRef="sqft" contextRef="i6efd849321404f36ac0949e86c2f742e_I20200731" decimals="0" name="bdtx:LesseeOperatingLeaseArea" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzY0NQ_bd99e4a0-d442-4d0b-8e16-6e0b29fd959b">25,578</ix:nonFraction> square feet of office space for its principal office, which is located in Cambridge, MA. The lease on the first floor commenced on August 1, 2020 and the lease on the second floor commenced March 9, 2021. The Company recognized the respective lease balances on the consolidated balance sheets when the lease of each floor commenced. Under the terms of the lease, the Company was required to issue a $<ix:nonFraction unitRef="usd" contextRef="i6efd849321404f36ac0949e86c2f742e_I20200731" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEzNjM_ce577507-027f-4750-93e2-21eb6f404add">1,168</ix:nonFraction> letter of credit as security for the lease.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company previously leased an office space in Cambridge, MA under a lease that commenced in February 2019 for approximately <ix:nonFraction unitRef="sqft" contextRef="i1e74d76585884b418f0bcfdce485be83_I20190228" decimals="0" name="bdtx:LesseeOperatingLeaseArea" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE1MzE_41d78cdd-63cf-44d7-944a-665576d84c13">2,357</ix:nonFraction> square feet of office space, which was set to expire on April 30, 2022, subject to an option to extend the lease for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE2NDU_becd2bb6-444f-4a5c-872f-1af74e1752f5">three</span> additional years. Effective June 15, 2021, the lease was terminated, and the remaining right-of-use asset and lease liability were derecognized. A gain of $<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEwOTk1MTE2MzI1MTU_3c46d4ae-c43b-4e09-9965-40c750c35fa2">5</ix:nonFraction> was recognized for the termination of the lease.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In December 2020, the Company entered into an <ix:nonNumeric contextRef="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODY_ee95e967-2bb1-4990-aa7e-e4aa102ddd11">eleven-year</ix:nonNumeric> agreement with an option to extend for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE3NTk_95f433d1-6446-4971-8ff9-a46e1a446767">five</span> additional years to lease approximately <ix:nonFraction unitRef="sqft" contextRef="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231" decimals="0" name="bdtx:LesseeOperatingLeaseArea" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE4MDI_ca831a71-c07e-493c-8dc5-c2fa379e38bb">18,120</ix:nonFraction> square feet of office and laboratory space in New York, NY. The Company has an option to extend the lease for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEwOTk1MTE2MzI5NDU_718bdc4c-12a4-421f-9b54-25688d4ec31f">five</span> additional years. The lease commenced August 26, 2021 and the related lease balance was recognized on the consolidated balance sheet.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">157</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="if96154d7a04f408b90927c4de71f39b3"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODQ_6e3cb615-f188-4468-b201-30cc7603c3f6" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table contains a summary of the lease costs recognized under ASC 842 and other information pertaining to the Company&#8217;s operating lease for the years ended December&#160;31, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lease Cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzItMS0xLTEtMTAwODc_8be773a5-cff7-4132-8ad0-9cdbec33f3dd">3,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzMtMy0xLTEtMTQ1Mzg_fb17da12-0793-4892-bc87-0eaab91cd4d5">767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzMtMS0xLTEtMTAwODc_b497c858-d13b-4fd6-84a8-2dc01c67d094">886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzQtMy0xLTEtMTQ1Mzg_2ffedb84-2118-4591-ba2f-f9fa6720e838">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzQtMS0xLTEtMTAwODc_d41ae265-d76d-4a18-85b6-75ff69f2c3d1">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzUtMy0xLTEtMTQ1Mzg_f893c975-d878-4a6e-b3b1-9b8a281f9a96">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzUtMS0xLTEtMTAwODc_c1bf5269-3db0-45db-b052-08f2159e83e4">4,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzYtMy0xLTEtMTQ1Mzg_41b3d195-2293-43b8-8452-d6380e7842db">1,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Other Operating Lease Information</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzEtMS0xLTEtMTAwODc_839116bd-e9bc-46da-b822-11b064cca9a8">2,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzItMy0xLTEtMTQ2NjE_b47005eb-1380-4330-8c24-a8d03fc5c757">432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzItMS0xLTEtMTAwODc_deb7c118-16ea-46c6-9086-f22f42761e98">8.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzMtMy0xLTEtMTQ2NjE_ab2ecc0f-1b83-4c67-8574-9db9c467d0fd">7.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzMtMS0xLTEtMTAwODc_490b8371-3381-4b6e-b819-8217ac6c7277">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzQtMy0xLTEtMTQ2NjE_39bd091f-190e-426f-9ff8-10109decd21f">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The variable lease costs for the year ended December&#160;31, 2021 include common area maintenance and other operating charges. As the Company&#8217;s leases do not provide an implicit rate, the Company utilized its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.</span></div><div style="margin-top:12pt"><ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODc_125b5345-589d-47ee-9fc7-14a45401a497" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Future minimum lease payments under the Company&#8217;s operating leases as of December&#160;31, 2021 were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzAtMS0xLTEtMTAwODc_199670cb-4c6a-4fd6-b064-3475669c3b63">2,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzEtMS0xLTEtMTAwODc_c03d9e2c-1b81-4fc2-8c3b-515a8c8a1315">4,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzItMS0xLTEtMTAwODc_e1c5320d-b231-43c4-9848-2c8a17490650">4,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzMtMS0xLTEtMTAwODc_7b8502cd-7e14-4957-98eb-db10e9373720">4,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzQtMS0xLTEtMTAwODc_31f53fa8-575d-402d-8f4a-76c4f8db93f7">4,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzUtMS0xLTEtMTAwODc_0fd6e89c-1eb9-4472-9465-af500050ca67">16,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzYtMS0xLTEtMTAwODc_e9d61e07-1ea0-41e0-99cc-33b03d3bc45b">37,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzctMS0xLTEtMTAwODc_303fc843-b8ba-433e-8178-ce12749d8f3b">8,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzgtMS0xLTEtMTAwODc_a1c19cee-7861-4a31-8ad0-b9129d1d29ce">29,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rent expense for the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyNjE_97d3be67-9160-4227-ab7e-fb865dcdfa77">3,921</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyNjg_1d9f4a48-baea-4c52-a135-05f12beb76b2">1,545</ix:nonFraction>, respectively.</span></div></ix:continuation><div id="if3ac37d75c1541719d9b66553792086e_136"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzYvZnJhZzo0ZDY0YmU2MTE2YTg0ZGE4YWZhZGU3M2MzYTE4NTY0NS90ZXh0cmVnaW9uOjRkNjRiZTYxMTZhODRkYThhZmFkZTczYzNhMTg1NjQ1XzIyNDI_6a0aabb1-0499-4112-b9f5-8241728a4caf" continuedAt="ibc8c5ebeeada4fc396506b56ec3d642d" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="ibc8c5ebeeada4fc396506b56ec3d642d" continuedAt="i233194bfc30f4cf0b89cde886e865804"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We enter into contracts in the normal course of business with contract research organizations ("CROs"), contract manufacturing organizations ("CMOs") and other third parties for preclinical research studies, Clinical Trials and testing and manufacturing services. These contracts do not contain minimum purchase commitments and are cancelable upon prior written notice. Payments due upon cancellation consist only of payments for services provided or expenses incurred, including noncancelable obligations of service providers, up to the date of cancellation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is party to license agreements, which include contingent payments. These payments will become payable if and when certain development, regulatory and commercial milestones are achieved. As of December&#160;31, 2021, the satisfaction and timing of the contingent payments is uncertain and not reasonably estimable.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">158</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><ix:continuation id="i233194bfc30f4cf0b89cde886e865804"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnification agreements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not aware of any indemnification arrangements that could have a material effect on its financial position, results of operations or cash flows, and it has not accrued any liabilities related to such obligations in its consolidated financial statements as of December&#160;31, 2021 or 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Legal proceedings</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is not currently party to and is not aware of any material legal proceedings. At each reporting date, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses as incurred the costs related to such legal proceedings.</span></div></ix:continuation><div id="if3ac37d75c1541719d9b66553792086e_139"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzQ1Nw_2165a83f-e27c-42f7-970c-d114917db86d" continuedAt="if701baf3e1fe44d4a7487a48f1772072" escape="true">BENEFIT PLANS</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:continuation id="if701baf3e1fe44d4a7487a48f1772072">In 2021, the Company transitioned from a Simplified Employee Pension (&#8220;SEP&#8221;) defined-contribution savings plan to a tax-qualified 401(k) and Profit Sharing defined contribution plan (the &#8220;401(k) Plan&#8221;). Under the 401(k) Plan, the Company provides an employer safe harbor matching contribution equal to <ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzEwOTk1MTE2Mjg1Mzk_d5dc1a6b-ae4a-45dd-85b4-5d08e6aa15a6">100</ix:nonFraction>% of a participant&#8217;s eligible contributions of up to <ix:nonFraction unitRef="number" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="2" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzEwOTk1MTE2Mjg1OTQ_b7144fc1-db7f-4fa6-87e2-4198adcdc205">6</ix:nonFraction>% of eligible compensation, subject to limits established by the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the &#8220;Code&#8221;). All matching contributions are fully vested when made. During the year ended December&#160;31, 2021 and 2020, the Company contributed $<ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="-3" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzEwOTk1MTE2MjkwNzc_b3b7f3f4-a8c9-4f70-8d65-6cebbbe687d8">927</ix:nonFraction> to the 401(k) Plan and $<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzEwOTk1MTE2MjkwODE_f735b780-5dd4-411f-948b-632e37149a39">592</ix:nonFraction> to the SEP plan, respectively.</ix:continuation></span></div><div id="if3ac37d75c1541719d9b66553792086e_142"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5Xzg3Ng_d9b2f9d7-400d-4bc0-bd37-e7c037b6e9ae" continuedAt="i7b903a4b16234835804d368d7d35af27" escape="true">RELATED-PARTY TRANSACTIONS</ix:nonNumeric></span></div><ix:continuation id="i7b903a4b16234835804d368d7d35af27"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company was party to a services agreement with Ridgeline, which was entered into in March 2017 and expired December 31, 2020. Ridgeline is an entity owned by one of the Company&#8217;s investors, and employees of Ridgeline provided the Company with scientific consulting services. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231" decimals="0" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5XzIxOTkwMjMyNTgxODk_15b30ec3-c42d-4304-b406-d6276a47150c"><ix:nonFraction unitRef="usd" contextRef="iebd841302b2243b09b4770b0df113b00_I20211231" decimals="0" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5XzIxOTkwMjMyNTgxODk_fd49cf7d-5f48-48dd-a92f-d4187fadb03f">no</ix:nonFraction></ix:nonFraction> amount due to Ridgeline at December&#160;31, 2021 and 2020. Total service fees incurred were $<ix:nonFraction unitRef="usd" contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5XzEwOTk1MTE2MzAyNjU_18f5f5d6-b631-4af3-8303-d63ac4f3d2dd">2,364</ix:nonFraction> for the year ended December&#160;31, 2020 and <ix:nonFraction unitRef="usd" contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231" decimals="0" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5XzEwOTk1MTE2MjkzNzY_d9009a87-f4d2-46e9-9a82-782da53470cf">no</ix:nonFraction> fees were incurred in 2021.</span></div></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">* * * * * *</span></div><div id="if3ac37d75c1541719d9b66553792086e_148"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">159</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">None.</span></div><div id="if3ac37d75c1541719d9b66553792086e_151"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item&#160;9A. Controls and Procedures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our principal executive officer and principal financial officer have concluded that as of December&#160;31, 2021, our disclosure controls and procedures were effective at a reasonable assurance level. The Company&#8217;s disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms; and (ii) accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely discussions regarding required disclosure. We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our management assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2021 based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in its 2013 Internal Control &#8212; Integrated Framework. Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of December&#160;31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the fiscal year ended December&#160;31, 2021, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="if3ac37d75c1541719d9b66553792086e_154"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 9B. Other Information</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">None.</span></div><div id="if3ac37d75c1541719d9b66553792086e_1099511628554"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">160</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_157"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Part III</span></div><div id="if3ac37d75c1541719d9b66553792086e_160"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference to the information in our Proxy Statement for our 2022 Annual Meeting of Stockholders, which we will file with the SEC within 120 days of the end of the fiscal year to which this Annual Report relates.</span></div><div id="if3ac37d75c1541719d9b66553792086e_163"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 11. Executive Compensation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference to the information in our Proxy Statement for our 2022 Annual Meeting of Stockholders, which we will file with the SEC within 120 days of the end of the fiscal year to which this Annual Report relates.</span></div><div id="if3ac37d75c1541719d9b66553792086e_166"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference to the information in our Proxy Statement for our 2022 Annual Meeting of Stockholders, which we will file with the SEC within 120 days of the end of the fiscal year to which this Annual Report relates.</span></div><div id="if3ac37d75c1541719d9b66553792086e_169"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference to the information in our Proxy Statement for our 2022 Annual Meeting of Stockholders, which we will file with the SEC within 120 days of the end of the fiscal year to which this Annual Report relates.</span></div><div id="if3ac37d75c1541719d9b66553792086e_172"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 14. Principal Accounting Fees and Services</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference to the information in our Proxy Statement for our 2022 Annual Meeting of Stockholders, which we will file with the SEC within 120 days of the end of the fiscal year to which this Annual Report relates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">161</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_175"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Part IV</span></div><div id="if3ac37d75c1541719d9b66553792086e_178"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 15. Exhibits and Financial Statement Schedules</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> Financial Statements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For a list of the financial statements included herein, see Index to the Consolidated Financial Statements on page 135 of this Annual Report, incorporated into this Item by reference.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> Financial Statement Schedules</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial statement schedules have been omitted because they are either not required or not applicable or the information is included in the consolidated financial statements or the notes thereto.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> Exhibits</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The exhibits required by Item&#160;601 of Regulation S-K and Item&#160;15(b) of this Annual Report are listed in the Exhibit Index below. The exhibits listed in the Exhibit Index are incorporated by reference herein.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">162</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(b) Exhibit Index</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit</span></div><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">No.</span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Index</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520023025/d857498dex31.htm">Fourth Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Current Report on Form 8-K (File No. 001-39200) filed on February 3, 2020</a>)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520023025/d857498dex32.htm">Amended and Restated By-laws of the Registrant, as currently in effect (incorporated by reference to Exhibit 3.2 of the Registrant&#8217;s Current Report on Form 8-K (File No. 001-39200) filed on February 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex41.htm">Second Amended and Restated Investors&#8217; Rights Agreement among the Registrant and certain of its stockholders, dated November 25, 2019 (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex43.htm">Warrant to Purchase Stock, dated September 21, 2016, issued by the Registrant to Roche Finance Ltd (incorporated by reference to Exhibit 4.3 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000170154120000009/exhibit44.htm">Description of Securities (incorporated by reference to Exhibit 4.4 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-39200) filed on March 24, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1#</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex101.htm">2017 Employee, Director and Consultant Equity Incentive Plan, as amended and restated, and forms of award agreements thereunder (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520010637/d758790dex102.htm">2020 Stock Option and Incentive Plan and forms of award agreements thereunder (incorporated by reference to Exhibit 10.2 of the Registrant&#8217;s Registration Statement on Form S-1/A (File No. 333-235789) filed on January 21, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex103.htm">Senior Executive Cash Incentive Bonus Plan (incorporated by reference to Exhibit 10.3 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520010637/d758790dex104.htm">2020 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.4 of the Registrant&#8217;s Registration Statement on Form S-1/A (File No. 333-235789) filed on January 21, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex105.htm">Form of Officer Indemnification Agreement (incorporated by reference to Exhibit 10.5 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex106.htm">Form of Director Indemnification Agreement (incorporated by reference to Exhibit 10.6 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex107.htm">Employment Agreement between the Registrant and David M. Epstein, Ph.D. (incorporated by reference to Exhibit 10.7 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex108.htm">Employment Agreement between the Registrant and Brent Hatzis-Schoch (incorporated by reference to Exhibit 10.8 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex109.htm">Employment Agreement between the Registrant and Thomas Leggett (incorporated by reference to Exhibit 10.9 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex1010.htm">Employment Agreement between the Registrant and Christopher D. Roberts (incorporated by reference to Exhibit 10.10 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000170154121000018/exhibit1011_q42020.htm">Employment Agreement between the Registrant and Rachel Humphrey (incorporated by reference to Exhibit 10.11 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-39200) filed on March 25, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000170154121000034/exhibit101_q22021.htm">Employment Agreement between the Registrant and Elizabeth Buck (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q (File No. 001-39200) filed on August 12, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000170154121000034/exhibit101_q22021.htm">)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000170154120000024/exhibit101q22020.htm">Lease Agreement, dated as of July 24, 2020, by and between RREEF America REIT II Corp. PPP and the Registrant (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q (File No. 001-39200) filed on August 11, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1701541/000119312520001336/d758790dex211.htm">Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-235789) filed on January 3, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231_q42021.htm">Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit311_q42021.htm">Certification of Principal Executive Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit312_q42021.htm">Certification of Principal Financial Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit321_q42021.htm">Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">163</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101INS*</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101SCH*</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101CAL*</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101LAB*</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Labels Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101PRE*</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101DEF*</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.)</span></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.945%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.137%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates a management contract or any compensatory plan, contract or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Non-material schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules and exhibits upon request by the Securities and Exchange Commission.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This certification will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.</span></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div id="if3ac37d75c1541719d9b66553792086e_181"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item&#160;16. Form 10-K Summary</span></div><div style="margin-top:12pt;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The company has elected not to include summary information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">164</span></div></div></div><div id="if3ac37d75c1541719d9b66553792086e_184"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.033%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Black Diamond Therapeutics, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date: March 17, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">/s/ David M. Epstein</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">David M. Epstein</span></div><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">President and Chief Executive Officer</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose individual signature appears below hereby authorizes and appoints David M. Epstein and Brent Hatzis-Schoch, and each of them, with full power of substitution and re-substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this Annual Report on Form 10-K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the 17th day of March, 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">165</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline" href="#if3ac37d75c1541719d9b66553792086e_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ David M. Epstein</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President, Chief Executive Officer and Director</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David M. Epstein</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Fang Ni</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Business and Interim Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Financial Officer)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fang Ni</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Erika Jones</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vice President, Finance and Corporate Controller</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Accounting Officer)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Erika Jones</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert A. Ingram</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman and Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert A. Ingram</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bradley Bolzon</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bradley Bolzon</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ali Behbahani</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ali Behbahani</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Samarth Kulkarni</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Samarth Kulkarni</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Alexander Mayweg</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexander Mayweg</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Garry E. Menzel</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garry E. Menzel</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Rajeev Shah</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rajeev Shah</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kapil Dhingra</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kapil Dhingra</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark A. Velleca</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark A. Velleca</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">166</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>exhibit231_q42021.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia9aa48b4a94c4c0cb1d7bdedeec2ea2d_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 23.1</font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (File No. 333- 252627) and on Form S-8 (No. 333-236170) of Black Diamond Therapeutics, Inc. of our report dated March&#160;17, 2022 relating to the financial statements, which appears in this Form 10-K.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;17, 2022</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>exhibit311_q42021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5fc73fd0448c4b6084fb29ed29f69e7e_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 31.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO RULE 13a-14(a) OR 15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I, David M. Epstein, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2021 of Black Diamond Therapeutics, Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.84pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.68pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8pt">(Paragraph omitted pursuant to SEC Release Nos. 33-8238&#47;34-47986 and 33-8392&#47;34-49313)&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.68pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.68pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:43.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.597%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; March&#160;17, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; David M. Epstein</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">David M. Epstein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">President, Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and Director</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Principal Executive Officer)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>exhibit312_q42021.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7e9f776fece54013a3598dd57e112395_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 31.2</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO RULE 13a-14(a) OR 15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I, Fang Ni, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2021 of Black Diamond Therapeutics, Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.37pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8pt">(Paragraph omitted pursuant to SEC Release Nos. 33-8238&#47;34-47986 and 33-8392&#47;34-49313)&#59;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.37pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.68pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:47.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58; March&#160;17, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Fang Ni</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Fang Ni</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Business and Interim Financial Officer </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Principal Financial Officer)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>exhibit321_q42021.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i06b5565eb4594e92929f2a1bd7a80e6b_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, David M. Epstein, the Principal Executive Officer, and Fang Ni, the Principal Financial Officer, of Black Diamond Therapeutics, Inc. (the &#8220;Company&#8221;), hereby certify, that, to their knowledge&#58; </font></div><div style="text-indent:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">the Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;Report&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:47.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58; March&#160;17, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; David M. Epstein</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">David M. Epstein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">President, Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and Director</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Principal Executive Officer)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:47.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58; March&#160;17, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Fang Ni</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Fang Ni<br>Chief Business and Interim Financial Officer <br>(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bdtx-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cee46846-3204-4f76-8bc4-0ddff9c4f904,g:517c6acc-4237-470e-8fc7-341826f4d9b3-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bdtx="http://www.blackdiamondtherapeutics.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.blackdiamondtherapeutics.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdtx-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdtx-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdtx-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bdtx-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.blackdiamondtherapeutics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.blackdiamondtherapeutics.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations">
        <link:definition>1003005 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1004006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsParenthetical" roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlowsParenthetical">
        <link:definition>1005007 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>1006008 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSANDBASISOFPRESENTATION" roleURI="http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION">
        <link:definition>2101101 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails">
        <link:definition>2402401 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails">
        <link:definition>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2108103 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2309302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>2410404 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTS" roleURI="http://www.blackdiamondtherapeutics.com/role/INVESTMENTS">
        <link:definition>2111104 - Disclosure - INVESTMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSTables" roleURI="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSTables">
        <link:definition>2312303 - Disclosure - INVESTMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails">
        <link:definition>2413405 - Disclosure - INVESTMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENT" roleURI="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENT">
        <link:definition>2114105 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTTables" roleURI="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTTables">
        <link:definition>2315304 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails">
        <link:definition>2416406 - Disclosure - PROPERTY AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSES" roleURI="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSES">
        <link:definition>2117106 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSESTables" roleURI="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESTables">
        <link:definition>2318305 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSESDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails">
        <link:definition>2419407 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2120107 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>2421408 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2122108 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2323306 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>2424409 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails">
        <link:definition>2425410 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock Options Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails">
        <link:definition>2426411 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails">
        <link:definition>2427412 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails">
        <link:definition>2428413 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXES">
        <link:definition>2129109 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESTables">
        <link:definition>2330307 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails">
        <link:definition>2431414 - Disclosure - INCOME TAXES - Schedule of Income (Loss) Before Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>2432415 - Disclosure - INCOME TAXES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails">
        <link:definition>2433416 - Disclosure - INCOME TAXES - Schedule of Income Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofDeferredTaxAssetsDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails">
        <link:definition>2434417 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARE" roleURI="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARE">
        <link:definition>2135110 - Disclosure - NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARETables" roleURI="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARETables">
        <link:definition>2336308 - Disclosure - NET LOSS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails">
        <link:definition>2437418 - Disclosure - NET LOSS PER SHARE - Schedule of Computation of Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails">
        <link:definition>2438419 - Disclosure - NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.blackdiamondtherapeutics.com/role/LEASES">
        <link:definition>2139111 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESTables">
        <link:definition>2340309 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails">
        <link:definition>2441420 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails">
        <link:definition>2442421 - Disclosure - LEASES - Summary of Lease Cost and Other Operating Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofFutureMinimumLeasePaymentsDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails">
        <link:definition>2443422 - Disclosure - LEASES - Schedule of Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofFutureMinimumLeasePaymentsDetails_1" roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1">
        <link:definition>2443422 - Disclosure - LEASES - Schedule of Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.blackdiamondtherapeutics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2144112 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITPLANS" roleURI="http://www.blackdiamondtherapeutics.com/role/BENEFITPLANS">
        <link:definition>2145113 - Disclosure - BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITPLANSDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/BENEFITPLANSDetails">
        <link:definition>2446423 - Disclosure - BENEFIT PLANS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONS" roleURI="http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONS">
        <link:definition>2147114 - Disclosure - RELATED-PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONSDetails" roleURI="http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONSDetails">
        <link:definition>2448424 - Disclosure - RELATED-PARTY TRANSACTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bdtx_TaxYear2036Member" abstract="true" name="TaxYear2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdtx_PatentCostsPolicyPolicyTextBlock" abstract="false" name="PatentCostsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bdtx_OtherAwardTypeMember" abstract="true" name="OtherAwardTypeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdtx_OperatingLeasePrincipalOfficeTwoMember" abstract="true" name="OperatingLeasePrincipalOfficeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdtx_LesseeOperatingLeaseArea" abstract="false" name="LesseeOperatingLeaseArea" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="bdtx_A2020EmployeeStockPurchasePlanMember" abstract="true" name="A2020EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdtx_RightOfUseAssetDerecognizedTerminationOfLease" abstract="false" name="RightOfUseAssetDerecognizedTerminationOfLease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdtx_OperatingLeasePrincipalOfficeOneMember" abstract="true" name="OperatingLeasePrincipalOfficeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdtx_RentExpense" abstract="false" name="RentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdtx_TaxPeriodExpirationDomain" abstract="true" name="TaxPeriodExpirationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdtx_A2020PlanMember" abstract="true" name="A2020PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdtx_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bdtx_LesseeOperatingLeaseNumberOfContracts" abstract="false" name="LesseeOperatingLeaseNumberOfContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bdtx_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bdtx_AccruedLegalFeesCurrent" abstract="false" name="AccruedLegalFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdtx_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdtx_LeaseOtherInformationAbstract" abstract="true" name="LeaseOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember" abstract="true" name="OperatingLeaseOfficeAndLaboratorySpaceNYMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdtx_AccruedContractResearchServiceFeesCurrent" abstract="false" name="AccruedContractResearchServiceFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bdtx_OpenMarketSaleMember" abstract="true" name="OpenMarketSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bdtx_TaxPeriodExpirationAxis" abstract="true" name="TaxPeriodExpirationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bdtx_SharesAuthorized" abstract="false" name="SharesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bdtx_CommonStockVotingRightsNumberOfVotesPerShare" abstract="false" name="CommonStockVotingRightsNumberOfVotesPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bdtx-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cee46846-3204-4f76-8bc4-0ddff9c4f904,g:517c6acc-4237-470e-8fc7-341826f4d9b3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_221c0ccc-72ca-485f-a363-ed402bd3d578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_24acef61-896f-4b40-936e-ddd6e7f08d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_221c0ccc-72ca-485f-a363-ed402bd3d578" xlink:to="loc_us-gaap_LiabilitiesCurrent_24acef61-896f-4b40-936e-ddd6e7f08d08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_035192e3-9570-4537-94f0-aec0f611c101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_221c0ccc-72ca-485f-a363-ed402bd3d578" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_035192e3-9570-4537-94f0-aec0f611c101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_86eed63f-0565-4b16-ae09-191d74ec19a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6666e5e0-ed62-40d0-b327-8901fadaf3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_86eed63f-0565-4b16-ae09-191d74ec19a5" xlink:to="loc_us-gaap_AssetsCurrent_6666e5e0-ed62-40d0-b327-8901fadaf3ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_abd4843c-823b-4580-8faa-e1d3747e78a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_86eed63f-0565-4b16-ae09-191d74ec19a5" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_abd4843c-823b-4580-8faa-e1d3747e78a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2333996e-f4b1-4d09-b943-db61b74a685b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_86eed63f-0565-4b16-ae09-191d74ec19a5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2333996e-f4b1-4d09-b943-db61b74a685b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c5c4c9ed-94c6-432f-814b-7830b7898e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_86eed63f-0565-4b16-ae09-191d74ec19a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c5c4c9ed-94c6-432f-814b-7830b7898e58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_39e7337d-69b8-40d5-92c8-8edbadb08efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_86eed63f-0565-4b16-ae09-191d74ec19a5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_39e7337d-69b8-40d5-92c8-8edbadb08efe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1a9022be-f31b-47be-8204-238897ba9787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b07529fd-b9bd-4940-9bf6-3f257410873c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1a9022be-f31b-47be-8204-238897ba9787" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b07529fd-b9bd-4940-9bf6-3f257410873c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b95b2f48-02d4-4e40-b6ba-ef0bc488c72d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1a9022be-f31b-47be-8204-238897ba9787" xlink:to="loc_us-gaap_AccountsPayableCurrent_b95b2f48-02d4-4e40-b6ba-ef0bc488c72d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_da101272-318d-44b3-8411-9cd639ac425e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0bc639ba-3cac-469b-a796-4cfc055748dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_da101272-318d-44b3-8411-9cd639ac425e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0bc639ba-3cac-469b-a796-4cfc055748dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f4a17713-d841-49e5-9751-4b7f091447bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_da101272-318d-44b3-8411-9cd639ac425e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f4a17713-d841-49e5-9751-4b7f091447bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d87395c6-87c9-4e4f-bc1b-b743bb4a015a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_da101272-318d-44b3-8411-9cd639ac425e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d87395c6-87c9-4e4f-bc1b-b743bb4a015a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4e48ec3e-f9d3-458a-ac58-2db0745c4eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c790ee3a-f778-48ad-91f7-94a4b6e8c036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e48ec3e-f9d3-458a-ac58-2db0745c4eb3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c790ee3a-f778-48ad-91f7-94a4b6e8c036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2bf2a419-aeac-4175-a969-de3a43aa628e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e48ec3e-f9d3-458a-ac58-2db0745c4eb3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2bf2a419-aeac-4175-a969-de3a43aa628e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5eb07926-05ea-4ecf-8a85-3957ef73a14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e48ec3e-f9d3-458a-ac58-2db0745c4eb3" xlink:to="loc_us-gaap_PreferredStockValue_5eb07926-05ea-4ecf-8a85-3957ef73a14a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3e540ebb-691c-4ca9-81e0-ec9d2d6b8037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e48ec3e-f9d3-458a-ac58-2db0745c4eb3" xlink:to="loc_us-gaap_CommonStockValue_3e540ebb-691c-4ca9-81e0-ec9d2d6b8037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_94757eb5-ceb6-430b-99b9-86680e2052d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e48ec3e-f9d3-458a-ac58-2db0745c4eb3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_94757eb5-ceb6-430b-99b9-86680e2052d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_aaba46fc-a660-494d-af1a-aebbbb35777a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5332763d-eb18-4630-b460-9eebf9f0ea1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_aaba46fc-a660-494d-af1a-aebbbb35777a" xlink:to="loc_us-gaap_StockholdersEquity_5332763d-eb18-4630-b460-9eebf9f0ea1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b8a7f40a-780d-4f64-aaea-41a45c080d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_aaba46fc-a660-494d-af1a-aebbbb35777a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b8a7f40a-780d-4f64-aaea-41a45c080d1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9dcc900c-1748-469c-a255-feb84d30beb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_aaba46fc-a660-494d-af1a-aebbbb35777a" xlink:to="loc_us-gaap_Liabilities_9dcc900c-1748-469c-a255-feb84d30beb8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b903e98f-e4b4-47e6-a732-45de416face7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d46dee7d-bee2-4d71-8bf2-1896a6de78a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b903e98f-e4b4-47e6-a732-45de416face7" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d46dee7d-bee2-4d71-8bf2-1896a6de78a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_55b97fb2-3106-4932-bf9d-7d127a73d493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b903e98f-e4b4-47e6-a732-45de416face7" xlink:to="loc_us-gaap_OperatingIncomeLoss_55b97fb2-3106-4932-bf9d-7d127a73d493" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3559c71c-f6c3-4053-90bd-a396a531d1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_58efeaff-0deb-4cb1-bcd3-a7e57efae85d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3559c71c-f6c3-4053-90bd-a396a531d1ad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_58efeaff-0deb-4cb1-bcd3-a7e57efae85d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2fbd9c70-8010-43e5-81f5-9754cf3b0ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3559c71c-f6c3-4053-90bd-a396a531d1ad" xlink:to="loc_us-gaap_NetIncomeLoss_2fbd9c70-8010-43e5-81f5-9754cf3b0ffd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b5817aa9-03e2-4af2-8615-c2d04e145f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1a697f40-14dd-41b1-a89e-0d73414d2ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b5817aa9-03e2-4af2-8615-c2d04e145f7c" xlink:to="loc_us-gaap_InterestExpense_1a697f40-14dd-41b1-a89e-0d73414d2ea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_13c04cf9-9a97-4874-a614-609e5368c450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b5817aa9-03e2-4af2-8615-c2d04e145f7c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_13c04cf9-9a97-4874-a614-609e5368c450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_146e1686-cffd-4926-be1e-728789373493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b5817aa9-03e2-4af2-8615-c2d04e145f7c" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_146e1686-cffd-4926-be1e-728789373493" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_84e2dfbd-1288-4ee9-b91f-5c0b3aedb5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e2d457eb-9de1-4be8-b0b4-c59ee8d9b904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_84e2dfbd-1288-4ee9-b91f-5c0b3aedb5b6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e2d457eb-9de1-4be8-b0b4-c59ee8d9b904" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_0c370de0-982f-4484-b082-a6e8de9a7bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_84e2dfbd-1288-4ee9-b91f-5c0b3aedb5b6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_0c370de0-982f-4484-b082-a6e8de9a7bad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ee6c5d73-dc7c-4a62-84b2-45aae7cf6d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_549e7642-08a1-4271-a1e7-4b786bf2179e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ee6c5d73-dc7c-4a62-84b2-45aae7cf6d56" xlink:to="loc_us-gaap_OperatingExpenses_549e7642-08a1-4271-a1e7-4b786bf2179e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f0b6cca9-357a-461b-8eba-28160f8839d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9df01eae-6c87-4dea-9da0-99d8a086604c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f0b6cca9-357a-461b-8eba-28160f8839d5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9df01eae-6c87-4dea-9da0-99d8a086604c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1820f6eb-d0d5-4ab6-9779-f3733a707ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f0b6cca9-357a-461b-8eba-28160f8839d5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1820f6eb-d0d5-4ab6-9779-f3733a707ac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_88477948-6262-4475-934f-18e4130b32c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22fab1e6-e9f2-47bc-ab76-4e771bb042c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_88477948-6262-4475-934f-18e4130b32c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_22fab1e6-e9f2-47bc-ab76-4e771bb042c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11238953-356e-4aaf-a235-d7daf7ba1d39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_88477948-6262-4475-934f-18e4130b32c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11238953-356e-4aaf-a235-d7daf7ba1d39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98309c56-4431-4521-abea-df4d8a85123a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_88477948-6262-4475-934f-18e4130b32c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98309c56-4431-4521-abea-df4d8a85123a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fced8014-ba27-482d-9926-7752e7c68853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_adf6f0c4-7d24-4f7f-a0f7-f4d094d793ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fced8014-ba27-482d-9926-7752e7c68853" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_adf6f0c4-7d24-4f7f-a0f7-f4d094d793ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_4e013f96-5370-4fec-9a2d-29cd75f223b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fced8014-ba27-482d-9926-7752e7c68853" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_4e013f96-5370-4fec-9a2d-29cd75f223b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_39b1d2c6-1f9c-4872-87b1-8a960c077560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fced8014-ba27-482d-9926-7752e7c68853" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_39b1d2c6-1f9c-4872-87b1-8a960c077560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_35701fe7-b402-4ed8-a0e9-2c76d3ce4edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_35701fe7-b402-4ed8-a0e9-2c76d3ce4edf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_36a332bc-b952-4dbe-ab24-d40a6c386a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_ShareBasedCompensation_36a332bc-b952-4dbe-ab24-d40a6c386a1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_8653e14e-8bc7-4024-a449-10676c611a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_8653e14e-8bc7-4024-a449-10676c611a15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_193a3845-d0a2-478d-80ec-44e096cbb381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_193a3845-d0a2-478d-80ec-44e096cbb381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities_3b3cd961-3126-415a-88fc-246ceb016321" xlink:href="bdtx-20211231.xsd#bdtx_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities_3b3cd961-3126-415a-88fc-246ceb016321" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_89a937a9-a653-491f-b439-fade1db1a49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_89a937a9-a653-491f-b439-fade1db1a49f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5f8e35a6-7e0a-46fc-b4b0-5dc7336b0719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5f8e35a6-7e0a-46fc-b4b0-5dc7336b0719" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_6f333996-e899-4831-9cde-c82a42afdab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_6f333996-e899-4831-9cde-c82a42afdab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_e8ab6b4c-70f9-4565-b439-0976391289c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_e8ab6b4c-70f9-4565-b439-0976391289c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0bb93007-f7e2-4389-a978-98e84b072bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0bb93007-f7e2-4389-a978-98e84b072bd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_475a846c-7466-4989-8662-69caccf9a431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_Depreciation_475a846c-7466-4989-8662-69caccf9a431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d9f56524-9a6a-49e5-93eb-2f4d489c705e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_us-gaap_NetIncomeLoss_d9f56524-9a6a-49e5-93eb-2f4d489c705e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_RentExpense_f3aeee9f-22e4-4190-a09e-01151a2c2aa8" xlink:href="bdtx-20211231.xsd#bdtx_RentExpense"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6889ae86-e250-4335-80cc-19c61e8e49ac" xlink:to="loc_bdtx_RentExpense_f3aeee9f-22e4-4190-a09e-01151a2c2aa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8dda6c68-0a81-4c9a-8184-e661aa6511b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9aed1ae8-968e-4802-9754-e92f4f4d2f59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8dda6c68-0a81-4c9a-8184-e661aa6511b6" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9aed1ae8-968e-4802-9754-e92f4f4d2f59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_6a8a2902-dbbc-4b56-b735-c9e0e740dace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8dda6c68-0a81-4c9a-8184-e661aa6511b6" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_6a8a2902-dbbc-4b56-b735-c9e0e740dace" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_07e998cd-e0df-4be8-b3d7-ee1a79e302c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_eae5fb71-c7db-41af-96c7-5c54dfcf0fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_07e998cd-e0df-4be8-b3d7-ee1a79e302c9" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_eae5fb71-c7db-41af-96c7-5c54dfcf0fb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_24781532-2772-416b-b34e-acc93e38124e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_07e998cd-e0df-4be8-b3d7-ee1a79e302c9" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_24781532-2772-416b-b34e-acc93e38124e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INVESTMENTSDetails"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_338d1cef-a0cd-460a-911a-d113cbfb2ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e747c816-9807-466a-b3b0-2f8d6117c786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_338d1cef-a0cd-460a-911a-d113cbfb2ef3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e747c816-9807-466a-b3b0-2f8d6117c786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_857a1d3e-f15d-4c6e-9649-86d8cb9ed0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_338d1cef-a0cd-460a-911a-d113cbfb2ef3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_857a1d3e-f15d-4c6e-9649-86d8cb9ed0c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_85544717-0fe0-4802-8687-b495afbd6d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_338d1cef-a0cd-460a-911a-d113cbfb2ef3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_85544717-0fe0-4802-8687-b495afbd6d59" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8750c483-344d-4e56-8c75-570b32e128f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_105335ce-ed59-47d7-8120-e4aa0c7c2a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_8750c483-344d-4e56-8c75-570b32e128f1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_105335ce-ed59-47d7-8120-e4aa0c7c2a65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_af138777-5e40-4f50-8320-5965e4449f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_8750c483-344d-4e56-8c75-570b32e128f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_af138777-5e40-4f50-8320-5965e4449f19" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ACCRUEDEXPENSESDetails"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f38233aa-535a-4afb-8acf-0b7f03ef0fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_AccruedLegalFeesCurrent_80055328-8906-4f21-bb0d-37a373ef845a" xlink:href="bdtx-20211231.xsd#bdtx_AccruedLegalFeesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f38233aa-535a-4afb-8acf-0b7f03ef0fc6" xlink:to="loc_bdtx_AccruedLegalFeesCurrent_80055328-8906-4f21-bb0d-37a373ef845a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_AccruedContractResearchServiceFeesCurrent_7a7ab272-ff00-479f-a585-0761111ea2d8" xlink:href="bdtx-20211231.xsd#bdtx_AccruedContractResearchServiceFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f38233aa-535a-4afb-8acf-0b7f03ef0fc6" xlink:to="loc_bdtx_AccruedContractResearchServiceFeesCurrent_7a7ab272-ff00-479f-a585-0761111ea2d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bbd50c22-c6bd-4d3e-b649-403f5965c1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f38233aa-535a-4afb-8acf-0b7f03ef0fc6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bbd50c22-c6bd-4d3e-b649-403f5965c1e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_db80b7f5-671c-4b33-9d85-f6f6bb811b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f38233aa-535a-4afb-8acf-0b7f03ef0fc6" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_db80b7f5-671c-4b33-9d85-f6f6bb811b6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f0c72a37-b461-43b7-a399-1a122e137709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f38233aa-535a-4afb-8acf-0b7f03ef0fc6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f0c72a37-b461-43b7-a399-1a122e137709" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_ab712e19-f21d-4195-8643-3830df0a450a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_169d51b2-5714-4d94-bf52-c5c95b67b3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_ab712e19-f21d-4195-8643-3830df0a450a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_169d51b2-5714-4d94-bf52-c5c95b67b3f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d5cdc2bc-835e-4725-a23d-7122f5cf627d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_ab712e19-f21d-4195-8643-3830df0a450a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d5cdc2bc-835e-4725-a23d-7122f5cf627d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3fbbe1fd-52e0-4f82-9f1f-c5c85c555773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c3e7546b-c36c-456c-951d-ef06d66210aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3fbbe1fd-52e0-4f82-9f1f-c5c85c555773" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_c3e7546b-c36c-456c-951d-ef06d66210aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_ed6395df-888c-4473-a807-3f0e46504113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3fbbe1fd-52e0-4f82-9f1f-c5c85c555773" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_ed6395df-888c-4473-a807-3f0e46504113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_8871fc4c-98cb-402d-847f-193bf6136f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3fbbe1fd-52e0-4f82-9f1f-c5c85c555773" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_8871fc4c-98cb-402d-847f-193bf6136f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b5295ec3-6f00-4962-b4a2-c93d8a4701a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3fbbe1fd-52e0-4f82-9f1f-c5c85c555773" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b5295ec3-6f00-4962-b4a2-c93d8a4701a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3af7e478-e92b-4a6f-aa0d-de9e338f7669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3fbbe1fd-52e0-4f82-9f1f-c5c85c555773" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3af7e478-e92b-4a6f-aa0d-de9e338f7669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_bf7004af-9299-4537-92b0-004e39984c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3fbbe1fd-52e0-4f82-9f1f-c5c85c555773" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_bf7004af-9299-4537-92b0-004e39984c25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_a61665c6-5c9f-4616-8043-3e7b7d9b0852" xlink:href="bdtx-20211231.xsd#bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3fbbe1fd-52e0-4f82-9f1f-c5c85c555773" xlink:to="loc_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_a61665c6-5c9f-4616-8043-3e7b7d9b0852" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0d0c454e-02d9-465d-a72c-da9719cc8c60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8e4143b5-0bc5-4680-979b-1190ffd4ef59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0d0c454e-02d9-465d-a72c-da9719cc8c60" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_8e4143b5-0bc5-4680-979b-1190ffd4ef59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c5cd8545-b286-4c69-b3f7-090d09a3cd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0d0c454e-02d9-465d-a72c-da9719cc8c60" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c5cd8545-b286-4c69-b3f7-090d09a3cd55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9533c429-1e8d-4c57-954e-c67fd0826972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_DeferredTaxAssetsLeasingArrangements_f83f0628-8919-472d-a61f-0329ac1de311" xlink:href="bdtx-20211231.xsd#bdtx_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9533c429-1e8d-4c57-954e-c67fd0826972" xlink:to="loc_bdtx_DeferredTaxAssetsLeasingArrangements_f83f0628-8919-472d-a61f-0329ac1de311" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_9fa81487-4a81-4e59-afb8-8f20132c8b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9533c429-1e8d-4c57-954e-c67fd0826972" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_9fa81487-4a81-4e59-afb8-8f20132c8b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_54c14214-aac6-4371-b157-e30c5b983edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9533c429-1e8d-4c57-954e-c67fd0826972" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_54c14214-aac6-4371-b157-e30c5b983edf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_6d3970ac-8a33-49bc-a04b-d944c30b168d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9533c429-1e8d-4c57-954e-c67fd0826972" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_6d3970ac-8a33-49bc-a04b-d944c30b168d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_aa8da065-cc7b-4bb8-9926-5a4d4b94cbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9533c429-1e8d-4c57-954e-c67fd0826972" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_aa8da065-cc7b-4bb8-9926-5a4d4b94cbb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_10666afb-bb1a-4b1e-93bf-b70401a050e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_ee7e9405-e26c-4f40-a344-86fa997e27d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_10666afb-bb1a-4b1e-93bf-b70401a050e1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_ee7e9405-e26c-4f40-a344-86fa997e27d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a0aa8a7b-ec66-4315-a8dd-a3722341b76f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_10666afb-bb1a-4b1e-93bf-b70401a050e1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a0aa8a7b-ec66-4315-a8dd-a3722341b76f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_070b5f76-96b0-4c68-a754-229ebc727621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_10666afb-bb1a-4b1e-93bf-b70401a050e1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_070b5f76-96b0-4c68-a754-229ebc727621" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_318410cf-a128-4e74-a4d2-42d1cbdeb011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_501637be-51c0-4df4-9300-dec0c8997e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_318410cf-a128-4e74-a4d2-42d1cbdeb011" xlink:to="loc_us-gaap_OperatingLeaseCost_501637be-51c0-4df4-9300-dec0c8997e79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_15797ec7-fa1d-4390-b655-4951bd63fae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_318410cf-a128-4e74-a4d2-42d1cbdeb011" xlink:to="loc_us-gaap_ShortTermLeaseCost_15797ec7-fa1d-4390-b655-4951bd63fae9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_2acf694d-6b71-4836-baa7-688ba41030d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_318410cf-a128-4e74-a4d2-42d1cbdeb011" xlink:to="loc_us-gaap_VariableLeaseCost_2acf694d-6b71-4836-baa7-688ba41030d5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASESScheduleofFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_470b4443-fcc3-46c2-8719-37ea68e2b98d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c5880e24-d8f2-4160-b7b4-e0376cd19f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_470b4443-fcc3-46c2-8719-37ea68e2b98d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c5880e24-d8f2-4160-b7b4-e0376cd19f03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1ac6d9e1-f1fd-43e9-bc07-1bbc441d071e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_470b4443-fcc3-46c2-8719-37ea68e2b98d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1ac6d9e1-f1fd-43e9-bc07-1bbc441d071e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_10105f41-a327-4dca-bf8a-72978977f870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_470b4443-fcc3-46c2-8719-37ea68e2b98d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_10105f41-a327-4dca-bf8a-72978977f870" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_757fa696-26cd-4485-b78b-3ea52a1da029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_470b4443-fcc3-46c2-8719-37ea68e2b98d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_757fa696-26cd-4485-b78b-3ea52a1da029" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_856f6d0a-44c1-4ab5-8558-53de1215bf55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_470b4443-fcc3-46c2-8719-37ea68e2b98d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_856f6d0a-44c1-4ab5-8558-53de1215bf55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fd79ccd6-e4c7-4de9-9243-139c95e202e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_470b4443-fcc3-46c2-8719-37ea68e2b98d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fd79ccd6-e4c7-4de9-9243-139c95e202e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASESScheduleofFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5e8014f9-3d29-476f-97f9-397e0107cfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2d6bdd1e-e7f4-44ed-8724-8382224a3632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5e8014f9-3d29-476f-97f9-397e0107cfc2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2d6bdd1e-e7f4-44ed-8724-8382224a3632" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4ceca7ca-6c79-4c53-a191-f272b97f0a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5e8014f9-3d29-476f-97f9-397e0107cfc2" xlink:to="loc_us-gaap_OperatingLeaseLiability_4ceca7ca-6c79-4c53-a191-f272b97f0a89" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bdtx-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cee46846-3204-4f76-8bc4-0ddff9c4f904,g:517c6acc-4237-470e-8fc7-341826f4d9b3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended" id="id2804771ec874132a52ddd8c26d36314_ConsolidatedStatementsofStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d71da151-00e6-4da1-a504-912f7b9df441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d71da151-00e6-4da1-a504-912f7b9df441" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8e401606-e777-4fbe-b9a4-1bafd56b5a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8e401606-e777-4fbe-b9a4-1bafd56b5a8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1f7c5661-8ab1-4672-bf4a-d4fad21c479f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockholdersEquity_1f7c5661-8ab1-4672-bf4a-d4fad21c479f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_05cdd83a-da2a-421e-b07e-10f6c60c1736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_05cdd83a-da2a-421e-b07e-10f6c60c1736" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_f6aba65e-0aea-4279-9fb3-b3fa6f6c0052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_f6aba65e-0aea-4279-9fb3-b3fa6f6c0052" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6d934d18-93e9-47e3-9948-300c5aa5281f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6d934d18-93e9-47e3-9948-300c5aa5281f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_78e29f9d-d8ac-4a04-98ea-facb9bcc06c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_78e29f9d-d8ac-4a04-98ea-facb9bcc06c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_7cafcee2-db7f-4c38-8f3a-d4ebfa0d7097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_7cafcee2-db7f-4c38-8f3a-d4ebfa0d7097" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_eccb7fdf-cda0-478e-afb6-7cdf6bc075bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_eccb7fdf-cda0-478e-afb6-7cdf6bc075bb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b51ae476-5b2d-49a8-b3ed-233446b1469c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b51ae476-5b2d-49a8-b3ed-233446b1469c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e6f2828c-d9d7-4ee1-a7b8-63e34b40f184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e6f2828c-d9d7-4ee1-a7b8-63e34b40f184" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0efd5831-1112-4a25-9a82-5224bfdb05fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0efd5831-1112-4a25-9a82-5224bfdb05fc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d465dbd6-f1da-4fde-b4cf-2874c9776f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d465dbd6-f1da-4fde-b4cf-2874c9776f11" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9bea943c-0dd5-4e97-962e-6f40d404f328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9bea943c-0dd5-4e97-962e-6f40d404f328" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4dae1b71-0bf5-49a8-ab2f-82a28decaf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4dae1b71-0bf5-49a8-ab2f-82a28decaf5d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_dc5f2791-c183-4c8a-a561-a7845c6e9e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_dc5f2791-c183-4c8a-a561-a7845c6e9e29" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_af86ede2-ac93-4165-9fa5-64c9a49fc88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_NetIncomeLoss_af86ede2-ac93-4165-9fa5-64c9a49fc88a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_647e0cd9-a135-4fdc-997c-af158c9a9298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_66749152-12bc-47e8-8a4d-435f9897e480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7af9be64-7791-43cb-81c8-47018183d712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d71da151-00e6-4da1-a504-912f7b9df441" xlink:to="loc_us-gaap_StatementTable_7af9be64-7791-43cb-81c8-47018183d712" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d8c602eb-8711-4441-8af6-446d085f5fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7af9be64-7791-43cb-81c8-47018183d712" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d8c602eb-8711-4441-8af6-446d085f5fb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d8c602eb-8711-4441-8af6-446d085f5fb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d8c602eb-8711-4441-8af6-446d085f5fb2" xlink:to="loc_us-gaap_EquityComponentDomain_d8c602eb-8711-4441-8af6-446d085f5fb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d8c602eb-8711-4441-8af6-446d085f5fb2" xlink:to="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2c1b5118-3072-4f57-aca6-632fd580228f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:to="loc_us-gaap_CommonStockMember_2c1b5118-3072-4f57-aca6-632fd580228f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ca00f76a-fb2d-4abd-85a2-6ba07b7eb974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ca00f76a-fb2d-4abd-85a2-6ba07b7eb974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d8d9756a-cc30-4a5c-bf82-ff4b86d697b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d8d9756a-cc30-4a5c-bf82-ff4b86d697b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5d3784c7-fab0-48d0-bc0b-8dcb4d429ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:to="loc_us-gaap_RetainedEarningsMember_5d3784c7-fab0-48d0-bc0b-8dcb4d429ede" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" xlink:type="extended" id="ib569c61e95c54a7c89a72bafc29cadc1_NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_e35b775f-eeaa-4641-bd7a-6a00f8a7739e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_e35b775f-eeaa-4641-bd7a-6a00f8a7739e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bc3143a1-c378-48e4-9203-c58051970f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bc3143a1-c378-48e4-9203-c58051970f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b855ccd2-e77b-4cb7-bf30-e96a0f1aefb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b855ccd2-e77b-4cb7-bf30-e96a0f1aefb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c7cf34ed-1898-4619-a9e7-a6b64412bb98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c7cf34ed-1898-4619-a9e7-a6b64412bb98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_da412318-1208-4c01-97c3-42fe12156c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_da412318-1208-4c01-97c3-42fe12156c30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_661ad79f-ced5-4b4c-b3bb-12160a21ee2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_661ad79f-ced5-4b4c-b3bb-12160a21ee2e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3b71ddde-a195-4fdf-b64b-35b39e129515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3b71ddde-a195-4fdf-b64b-35b39e129515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3b71ddde-a195-4fdf-b64b-35b39e129515_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3b71ddde-a195-4fdf-b64b-35b39e129515" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3b71ddde-a195-4fdf-b64b-35b39e129515_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0fc5a004-733f-45ce-88bc-28558c684ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3b71ddde-a195-4fdf-b64b-35b39e129515" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0fc5a004-733f-45ce-88bc-28558c684ee1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_40072cad-cb14-42cc-ab6f-7e9870abbf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0fc5a004-733f-45ce-88bc-28558c684ee1" xlink:to="loc_us-gaap_IPOMember_40072cad-cb14-42cc-ab6f-7e9870abbf6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OpenMarketSaleMember_abfdb2ba-fc15-400c-a602-be0040002a26" xlink:href="bdtx-20211231.xsd#bdtx_OpenMarketSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0fc5a004-733f-45ce-88bc-28558c684ee1" xlink:to="loc_bdtx_OpenMarketSaleMember_abfdb2ba-fc15-400c-a602-be0040002a26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_77c24d00-3939-4b0e-9f84-27bbb89edb4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:to="loc_srt_RangeAxis_77c24d00-3939-4b0e-9f84-27bbb89edb4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_77c24d00-3939-4b0e-9f84-27bbb89edb4d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_77c24d00-3939-4b0e-9f84-27bbb89edb4d" xlink:to="loc_srt_RangeMember_77c24d00-3939-4b0e-9f84-27bbb89edb4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b13109f-34fa-4b6a-9fc0-642f63146447" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_77c24d00-3939-4b0e-9f84-27bbb89edb4d" xlink:to="loc_srt_RangeMember_1b13109f-34fa-4b6a-9fc0-642f63146447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_639524d4-7448-420f-9ea6-ac45f8e18daa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1b13109f-34fa-4b6a-9fc0-642f63146447" xlink:to="loc_srt_MaximumMember_639524d4-7448-420f-9ea6-ac45f8e18daa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2de4e783-3827-45a9-a265-dd1307d192f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:to="loc_srt_StatementScenarioAxis_2de4e783-3827-45a9-a265-dd1307d192f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2de4e783-3827-45a9-a265-dd1307d192f0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_2de4e783-3827-45a9-a265-dd1307d192f0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2de4e783-3827-45a9-a265-dd1307d192f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8755a90e-dd72-4a37-9765-1ea83351dec5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_2de4e783-3827-45a9-a265-dd1307d192f0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8755a90e-dd72-4a37-9765-1ea83351dec5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_4907777b-9fa9-4db9-ae69-f251f55012dd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_8755a90e-dd72-4a37-9765-1ea83351dec5" xlink:to="loc_srt_ScenarioForecastMember_4907777b-9fa9-4db9-ae69-f251f55012dd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended" id="i62f54d6a796a4db193d2dcd03c95276b_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d50406f-3679-4044-80bb-a14880d44915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2de35663-74ba-4e20-8d43-1e60133f5125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d50406f-3679-4044-80bb-a14880d44915" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2de35663-74ba-4e20-8d43-1e60133f5125" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_39082011-5011-4484-9d77-cee60a2ce4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d50406f-3679-4044-80bb-a14880d44915" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_39082011-5011-4484-9d77-cee60a2ce4ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8b16a7bf-9c4b-4ee1-b87a-b161c4496041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_39082011-5011-4484-9d77-cee60a2ce4ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8b16a7bf-9c4b-4ee1-b87a-b161c4496041" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8b16a7bf-9c4b-4ee1-b87a-b161c4496041_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8b16a7bf-9c4b-4ee1-b87a-b161c4496041" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8b16a7bf-9c4b-4ee1-b87a-b161c4496041_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8b16a7bf-9c4b-4ee1-b87a-b161c4496041" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_15f6eca1-6c42-4b91-82c2-194e13b6f7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:to="loc_us-gaap_EquipmentMember_15f6eca1-6c42-4b91-82c2-194e13b6f7bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_bdc7ee44-0fc3-4a87-b644-640e04343a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_bdc7ee44-0fc3-4a87-b644-640e04343a5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_e143c443-a7eb-4735-af71-ca46db81d5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:to="loc_us-gaap_OfficeEquipmentMember_e143c443-a7eb-4735-af71-ca46db81d5f1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended" id="ibc155c74de3f403ca81cdbe177daa79d_FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a7cfad9d-99fb-4d58-aad5-24ba624d750b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a7cfad9d-99fb-4d58-aad5-24ba624d750b" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2c8ffbc9-46fb-4b47-a0c2-145b51f7649f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2c8ffbc9-46fb-4b47-a0c2-145b51f7649f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_42088c8b-3eb7-48aa-b1af-0fb96c07103e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_42088c8b-3eb7-48aa-b1af-0fb96c07103e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d1d52ecc-0c4e-418b-943a-eac27692cef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d1d52ecc-0c4e-418b-943a-eac27692cef6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a7cfad9d-99fb-4d58-aad5-24ba624d750b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43dc156e-c637-4df5-8185-ce0c8ab2c429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43dc156e-c637-4df5-8185-ce0c8ab2c429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_43dc156e-c637-4df5-8185-ce0c8ab2c429_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43dc156e-c637-4df5-8185-ce0c8ab2c429" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_43dc156e-c637-4df5-8185-ce0c8ab2c429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_186e99e3-2cf2-4da4-bce4-ae0e7490e938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43dc156e-c637-4df5-8185-ce0c8ab2c429" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_186e99e3-2cf2-4da4-bce4-ae0e7490e938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b0f1cabb-6d82-49c9-b9b0-004189abebad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_186e99e3-2cf2-4da4-bce4-ae0e7490e938" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b0f1cabb-6d82-49c9-b9b0-004189abebad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_74527eeb-45cb-413b-acaf-7b6e436583eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_74527eeb-45cb-413b-acaf-7b6e436583eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74527eeb-45cb-413b-acaf-7b6e436583eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_74527eeb-45cb-413b-acaf-7b6e436583eb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74527eeb-45cb-413b-acaf-7b6e436583eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_74527eeb-45cb-413b-acaf-7b6e436583eb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_72b6d076-4f1a-4b34-82a1-1513bb54de74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_72b6d076-4f1a-4b34-82a1-1513bb54de74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_069ac8de-979f-47da-a8e3-7605a1c6ce68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_069ac8de-979f-47da-a8e3-7605a1c6ce68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_89a04cc4-59be-48ef-944b-6744bb1bae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_89a04cc4-59be-48ef-944b-6744bb1bae3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_22dd88e7-ed73-44b4-9522-9a285fb6bf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:to="loc_us-gaap_FinancialInstrumentAxis_22dd88e7-ed73-44b4-9522-9a285fb6bf0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22dd88e7-ed73-44b4-9522-9a285fb6bf0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_22dd88e7-ed73-44b4-9522-9a285fb6bf0a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_22dd88e7-ed73-44b4-9522-9a285fb6bf0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_22dd88e7-ed73-44b4-9522-9a285fb6bf0a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_4a87a885-a464-479c-846e-98f6234ff48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:to="loc_us-gaap_MoneyMarketFundsMember_4a87a885-a464-479c-846e-98f6234ff48b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_533b89aa-ae02-4119-8f6e-3db062318e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_533b89aa-ae02-4119-8f6e-3db062318e74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_1606f4d8-b663-45ce-af0e-8d33b8c937f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_1606f4d8-b663-45ce-af0e-8d33b8c937f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_448b2650-cce2-43ee-9a67-bd79dd2c6101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_448b2650-cce2-43ee-9a67-bd79dd2c6101" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INVESTMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails" xlink:type="extended" id="i5e95f272d82f46909b36cca3598e126a_INVESTMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5035ef03-3bc3-44f0-9c00-921c96a20c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5035ef03-3bc3-44f0-9c00-921c96a20c1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_830a464c-bc80-4380-995e-a9ed31f3658f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_830a464c-bc80-4380-995e-a9ed31f3658f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_111dd397-e3eb-4118-80c7-8d2b2642e521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_111dd397-e3eb-4118-80c7-8d2b2642e521" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f65d8f33-be63-411a-a883-25c2eda6d1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f65d8f33-be63-411a-a883-25c2eda6d1bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_f31a27e0-0bab-4d83-b645-812df54201d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_f31a27e0-0bab-4d83-b645-812df54201d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_36c72d1a-252e-49a7-9802-8173b48090de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_36c72d1a-252e-49a7-9802-8173b48090de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9a7c3da0-80ae-42a3-a7f9-cf8b05ce15da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_36c72d1a-252e-49a7-9802-8173b48090de" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9a7c3da0-80ae-42a3-a7f9-cf8b05ce15da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a7c3da0-80ae-42a3-a7f9-cf8b05ce15da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9a7c3da0-80ae-42a3-a7f9-cf8b05ce15da" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a7c3da0-80ae-42a3-a7f9-cf8b05ce15da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9a7c3da0-80ae-42a3-a7f9-cf8b05ce15da" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_4073e2b8-05aa-4478-890d-a20440c5a6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_4073e2b8-05aa-4478-890d-a20440c5a6ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_907fc928-5ecf-494c-9626-b046624037e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_907fc928-5ecf-494c-9626-b046624037e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_67d4eb18-41f0-408d-920b-8cca77de0a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_67d4eb18-41f0-408d-920b-8cca77de0a95" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended" id="idf575f964b844cec97df44b527cb1a95_PROPERTYANDEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1ab5eb45-c59f-4cbf-8099-c938c8269bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1ab5eb45-c59f-4cbf-8099-c938c8269bbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2a17ecb4-bab6-4936-9f17-7791cdbb124f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2a17ecb4-bab6-4936-9f17-7791cdbb124f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1cf5a9c0-0096-4ebf-8be7-1c127edf03e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1cf5a9c0-0096-4ebf-8be7-1c127edf03e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_543f9b60-2fd0-4ff2-83dd-daf9d6a0cea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:to="loc_us-gaap_Depreciation_543f9b60-2fd0-4ff2-83dd-daf9d6a0cea5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_159bb983-3694-4229-82a3-8f503a964ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_159bb983-3694-4229-82a3-8f503a964ed9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79a66057-2bbc-4397-aa17-adefe307b976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_159bb983-3694-4229-82a3-8f503a964ed9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79a66057-2bbc-4397-aa17-adefe307b976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_79a66057-2bbc-4397-aa17-adefe307b976_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79a66057-2bbc-4397-aa17-adefe307b976" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_79a66057-2bbc-4397-aa17-adefe307b976_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79a66057-2bbc-4397-aa17-adefe307b976" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_579d7e09-4b30-4240-b82a-f46552feb578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_EquipmentMember_579d7e09-4b30-4240-b82a-f46552feb578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_9a06b2c6-fbd1-4ff4-9532-50ba15a0904c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_9a06b2c6-fbd1-4ff4-9532-50ba15a0904c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_d0c734cf-102a-4486-814b-5a16890d04eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_OfficeEquipmentMember_d0c734cf-102a-4486-814b-5a16890d04eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4ee55982-daa9-450c-bd04-77abab92555d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4ee55982-daa9-450c-bd04-77abab92555d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_582e23e1-adf7-4d7b-bbae-4f8a8a4ebb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_ConstructionInProgressMember_582e23e1-adf7-4d7b-bbae-4f8a8a4ebb6f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended" id="ie73d3492d9d449d1bdc6a6db1b03189a_STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_CommonStockVotingRightsNumberOfVotesPerShare_9facf043-8b59-4803-8897-ee71ce9bc345" xlink:href="bdtx-20211231.xsd#bdtx_CommonStockVotingRightsNumberOfVotesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_bdtx_CommonStockVotingRightsNumberOfVotesPerShare_9facf043-8b59-4803-8897-ee71ce9bc345" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1fc084b7-f4db-4a54-a31d-cf3b280ca8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1fc084b7-f4db-4a54-a31d-cf3b280ca8c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_SharesAuthorized_0acafc85-920d-4cb8-840e-a750540718cb" xlink:href="bdtx-20211231.xsd#bdtx_SharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_bdtx_SharesAuthorized_0acafc85-920d-4cb8-840e-a750540718cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ae5b0620-6397-4e54-aef7-512e01c8823e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ae5b0620-6397-4e54-aef7-512e01c8823e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d0bdf246-717a-4087-8d80-5384812bc5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d0bdf246-717a-4087-8d80-5384812bc5f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9e7be484-9e83-4309-8da3-fcfd452d702e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9e7be484-9e83-4309-8da3-fcfd452d702e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_62e785c4-daee-4776-bb34-54d1634d941d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_62e785c4-daee-4776-bb34-54d1634d941d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_7aaaeec1-5073-4a3b-9d24-322af9caf9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_7aaaeec1-5073-4a3b-9d24-322af9caf9f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a4cbe738-b32e-4104-b934-1609d3324653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7aaaeec1-5073-4a3b-9d24-322af9caf9f0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a4cbe738-b32e-4104-b934-1609d3324653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a4cbe738-b32e-4104-b934-1609d3324653_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a4cbe738-b32e-4104-b934-1609d3324653" xlink:to="loc_us-gaap_EquityComponentDomain_a4cbe738-b32e-4104-b934-1609d3324653_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f9079c9c-cbd8-4940-aff7-d5715fc81527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a4cbe738-b32e-4104-b934-1609d3324653" xlink:to="loc_us-gaap_EquityComponentDomain_f9079c9c-cbd8-4940-aff7-d5715fc81527" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bcf9a838-6522-44df-99ea-8494dbe0033d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f9079c9c-cbd8-4940-aff7-d5715fc81527" xlink:to="loc_us-gaap_CommonStockMember_bcf9a838-6522-44df-99ea-8494dbe0033d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="ic022c684761e476f9ba78b39fbff80b3_STOCKBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e4315b3e-6ebe-41d0-a506-1f73e4d98d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e4315b3e-6ebe-41d0-a506-1f73e4d98d97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding_baeec161-45cd-475f-987a-8ea9fb65d769" xlink:href="bdtx-20211231.xsd#bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding_baeec161-45cd-475f-987a-8ea9fb65d769" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_cbd58ef8-ed59-4ca5-8389-fc9b6c008bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_cbd58ef8-ed59-4ca5-8389-fc9b6c008bb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d043c032-31c8-4ded-aa23-6fa210d35b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d043c032-31c8-4ded-aa23-6fa210d35b42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ce166d1c-5bb8-44d6-bf2f-e60ad820b1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ce166d1c-5bb8-44d6-bf2f-e60ad820b1a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a8457688-022f-42a5-9f24-2f6fbcbc956e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a8457688-022f-42a5-9f24-2f6fbcbc956e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_69133862-28f2-4b3b-af99-d4cd2d537ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_69133862-28f2-4b3b-af99-d4cd2d537ac1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2c7c4bf2-5a8b-40ab-a025-d6cbac23fc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2c7c4bf2-5a8b-40ab-a025-d6cbac23fc32" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_bd82584a-f591-4da8-b4be-170c1af75e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_bd82584a-f591-4da8-b4be-170c1af75e23" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_537f5ae5-7fc1-4f0c-9a54-deeb8955a22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_de12d7ca-433f-4baa-b275-3539056afc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_de12d7ca-433f-4baa-b275-3539056afc5e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3a35423b-b168-49cf-ba67-6fb35917fcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3a35423b-b168-49cf-ba67-6fb35917fcc1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f4993f42-65b7-4b40-b6de-2ee3c8edb2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f4993f42-65b7-4b40-b6de-2ee3c8edb2d8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6c96630c-57d7-4eae-a495-e030a84dabf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:to="loc_us-gaap_AwardTypeAxis_6c96630c-57d7-4eae-a495-e030a84dabf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c96630c-57d7-4eae-a495-e030a84dabf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6c96630c-57d7-4eae-a495-e030a84dabf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c96630c-57d7-4eae-a495-e030a84dabf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7e6374e-f73c-40fe-a7df-84b691f44c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6c96630c-57d7-4eae-a495-e030a84dabf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7e6374e-f73c-40fe-a7df-84b691f44c17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_89ca49ee-9154-46ef-a2b8-d02ea2840fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7e6374e-f73c-40fe-a7df-84b691f44c17" xlink:to="loc_us-gaap_RestrictedStockMember_89ca49ee-9154-46ef-a2b8-d02ea2840fc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_96158496-adeb-46d2-86b7-4b3bc2210a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7e6374e-f73c-40fe-a7df-84b691f44c17" xlink:to="loc_us-gaap_EmployeeStockOptionMember_96158496-adeb-46d2-86b7-4b3bc2210a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3c6ae7d8-732d-4ed5-b455-71109d0dbf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:to="loc_us-gaap_PlanNameAxis_3c6ae7d8-732d-4ed5-b455-71109d0dbf1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3c6ae7d8-732d-4ed5-b455-71109d0dbf1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3c6ae7d8-732d-4ed5-b455-71109d0dbf1e" xlink:to="loc_us-gaap_PlanNameDomain_3c6ae7d8-732d-4ed5-b455-71109d0dbf1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d9ff1866-7e12-4c52-80f6-77973a473b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3c6ae7d8-732d-4ed5-b455-71109d0dbf1e" xlink:to="loc_us-gaap_PlanNameDomain_d9ff1866-7e12-4c52-80f6-77973a473b3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_A2020PlanMember_b0dfe9d2-387c-4ee8-9074-59991c016eea" xlink:href="bdtx-20211231.xsd#bdtx_A2020PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d9ff1866-7e12-4c52-80f6-77973a473b3a" xlink:to="loc_bdtx_A2020PlanMember_b0dfe9d2-387c-4ee8-9074-59991c016eea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_A2020EmployeeStockPurchasePlanMember_da6492f5-6760-4188-a2f3-7e67ff2e2d82" xlink:href="bdtx-20211231.xsd#bdtx_A2020EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d9ff1866-7e12-4c52-80f6-77973a473b3a" xlink:to="loc_bdtx_A2020EmployeeStockPurchasePlanMember_da6492f5-6760-4188-a2f3-7e67ff2e2d82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_65b68928-884c-471e-885e-55b7c9b0dc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:to="loc_us-gaap_GranteeStatusAxis_65b68928-884c-471e-885e-55b7c9b0dc9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_65b68928-884c-471e-885e-55b7c9b0dc9c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_65b68928-884c-471e-885e-55b7c9b0dc9c" xlink:to="loc_us-gaap_GranteeStatusDomain_65b68928-884c-471e-885e-55b7c9b0dc9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_7b9d0455-ac6e-45d3-bd98-baecfe4c1b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_65b68928-884c-471e-885e-55b7c9b0dc9c" xlink:to="loc_us-gaap_GranteeStatusDomain_7b9d0455-ac6e-45d3-bd98-baecfe4c1b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b0c79814-533e-41d2-84e2-83cfda1b6683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_7b9d0455-ac6e-45d3-bd98-baecfe4c1b69" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b0c79814-533e-41d2-84e2-83cfda1b6683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9d9335df-f109-4863-aa3b-2e83a7c7f544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9d9335df-f109-4863-aa3b-2e83a7c7f544" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9d9335df-f109-4863-aa3b-2e83a7c7f544_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d9335df-f109-4863-aa3b-2e83a7c7f544" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9d9335df-f109-4863-aa3b-2e83a7c7f544_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_816b354b-6730-4556-b90c-fc5d3075ff84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d9335df-f109-4863-aa3b-2e83a7c7f544" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_816b354b-6730-4556-b90c-fc5d3075ff84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8a2f6b36-84b5-40b2-b04a-3e063aee0f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_816b354b-6730-4556-b90c-fc5d3075ff84" xlink:to="loc_us-gaap_SubsequentEventMember_8a2f6b36-84b5-40b2-b04a-3e063aee0f45" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails" xlink:type="extended" id="i55a93c2df67246f9af5aaa81828a222c_STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_083825c6-93f4-443e-ae01-b3763ecd19c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_083825c6-93f4-443e-ae01-b3763ecd19c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5e06805c-1586-428e-a61f-bf0591159d94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5e06805c-1586-428e-a61f-bf0591159d94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ec4047c6-4c7c-47ce-9ac8-137aa50d0743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ec4047c6-4c7c-47ce-9ac8-137aa50d0743" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20faca5e-0049-48c5-8841-641e8a62b079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20faca5e-0049-48c5-8841-641e8a62b079" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1fbd22ac-4a44-4867-8c2b-9a471cfcd018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1fbd22ac-4a44-4867-8c2b-9a471cfcd018" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40f79f77-3c33-44d5-a004-ca43a2965f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_083825c6-93f4-443e-ae01-b3763ecd19c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7934e24a-72ef-490f-a4e5-b0de7e0c2653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7934e24a-72ef-490f-a4e5-b0de7e0c2653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_19e64f37-bddf-4e4d-a7d7-edd40f2b9013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_19e64f37-bddf-4e4d-a7d7-edd40f2b9013" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0061a08b-72d4-4900-8d7a-f443a3740735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0061a08b-72d4-4900-8d7a-f443a3740735" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_435cc1db-1135-4fc5-a94e-c485bcf1e2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_435cc1db-1135-4fc5-a94e-c485bcf1e2de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_876f3f10-2b88-4d88-85e6-33bf7a6a6431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a9b652ed-b99b-4371-b025-f5dc28d797bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_083825c6-93f4-443e-ae01-b3763ecd19c8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a9b652ed-b99b-4371-b025-f5dc28d797bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_947c74f6-0210-4e81-8d28-711ed68e4035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a9b652ed-b99b-4371-b025-f5dc28d797bb" xlink:to="loc_us-gaap_AwardTypeAxis_947c74f6-0210-4e81-8d28-711ed68e4035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_947c74f6-0210-4e81-8d28-711ed68e4035_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_947c74f6-0210-4e81-8d28-711ed68e4035" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_947c74f6-0210-4e81-8d28-711ed68e4035_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a843ee28-30e9-4e71-997f-7d70f00b0ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_947c74f6-0210-4e81-8d28-711ed68e4035" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a843ee28-30e9-4e71-997f-7d70f00b0ffb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_1b4ba7f3-f382-4d63-9e31-69b87642c4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a843ee28-30e9-4e71-997f-7d70f00b0ffb" xlink:to="loc_us-gaap_RestrictedStockMember_1b4ba7f3-f382-4d63-9e31-69b87642c4ba" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails" xlink:type="extended" id="i403293a387c547f9ae5e9c1ef920c07d_STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4d6f79d9-89b9-41fc-977e-847c88ef2f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_27803ed5-9e37-4c87-9a4c-24e90874d224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4d6f79d9-89b9-41fc-977e-847c88ef2f1d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_27803ed5-9e37-4c87-9a4c-24e90874d224" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_719624ea-baee-4034-99ff-f800cd942c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4d6f79d9-89b9-41fc-977e-847c88ef2f1d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_719624ea-baee-4034-99ff-f800cd942c55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_54f061cc-2480-4aad-aa4c-a67b2d49f167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_719624ea-baee-4034-99ff-f800cd942c55" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_54f061cc-2480-4aad-aa4c-a67b2d49f167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_54f061cc-2480-4aad-aa4c-a67b2d49f167_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_54f061cc-2480-4aad-aa4c-a67b2d49f167" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_54f061cc-2480-4aad-aa4c-a67b2d49f167_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eed9327c-65d4-4870-88cd-898979764703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_54f061cc-2480-4aad-aa4c-a67b2d49f167" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eed9327c-65d4-4870-88cd-898979764703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9dd514f2-1961-41e2-86a3-c0dc916d92b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eed9327c-65d4-4870-88cd-898979764703" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9dd514f2-1961-41e2-86a3-c0dc916d92b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_07d2f8d4-f58a-4bad-8a66-6cac1fedae8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eed9327c-65d4-4870-88cd-898979764703" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_07d2f8d4-f58a-4bad-8a66-6cac1fedae8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_48249831-ea4c-4201-b294-85cc8c7575ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_719624ea-baee-4034-99ff-f800cd942c55" xlink:to="loc_us-gaap_AwardTypeAxis_48249831-ea4c-4201-b294-85cc8c7575ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48249831-ea4c-4201-b294-85cc8c7575ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_48249831-ea4c-4201-b294-85cc8c7575ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_48249831-ea4c-4201-b294-85cc8c7575ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_48249831-ea4c-4201-b294-85cc8c7575ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ac54e9fb-3fca-4333-b033-49294e726b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ac54e9fb-3fca-4333-b033-49294e726b4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7aa2cce2-22a4-49b4-a91e-eb345666ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7aa2cce2-22a4-49b4-a91e-eb345666ea64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OtherAwardTypeMember_f43a8f93-6964-45dd-af54-f77e383ce4dd" xlink:href="bdtx-20211231.xsd#bdtx_OtherAwardTypeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:to="loc_bdtx_OtherAwardTypeMember_f43a8f93-6964-45dd-af54-f77e383ce4dd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended" id="ie447b0f29fd34386813b685404e32952_INCOMETAXESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1fe1141d-b7ce-4049-8d1f-a6be09ef407b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1fe1141d-b7ce-4049-8d1f-a6be09ef407b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ac1c9a2c-ab93-476e-9e8d-1c3105e9dd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ac1c9a2c-ab93-476e-9e8d-1c3105e9dd21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_2ffca974-bc64-4dcc-a75d-ee34b8fb27a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_2ffca974-bc64-4dcc-a75d-ee34b8fb27a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0c7872f7-d973-4f4f-bbc7-8113ea3b626a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0c7872f7-d973-4f4f-bbc7-8113ea3b626a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_518387b6-9207-4c21-82ef-8ca5cb99eedb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_518387b6-9207-4c21-82ef-8ca5cb99eedb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ba94b1a8-5bea-4b09-880d-2890105bd5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ba94b1a8-5bea-4b09-880d-2890105bd5b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_8aa48af6-1021-4068-b20a-c7d6660c53cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_8aa48af6-1021-4068-b20a-c7d6660c53cd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_e0c8533e-24ba-4baa-9f64-cd11273d5cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_e0c8533e-24ba-4baa-9f64-cd11273d5cb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_e0c8533e-24ba-4baa-9f64-cd11273d5cb6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_e0c8533e-24ba-4baa-9f64-cd11273d5cb6" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_e0c8533e-24ba-4baa-9f64-cd11273d5cb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_c1adbbf0-f182-4016-8ee6-565023089aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_e0c8533e-24ba-4baa-9f64-cd11273d5cb6" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_c1adbbf0-f182-4016-8ee6-565023089aca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_f4eef26b-3667-4574-93d7-11c08a1ab66b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_c1adbbf0-f182-4016-8ee6-565023089aca" xlink:to="loc_us-gaap_ResearchMember_f4eef26b-3667-4574-93d7-11c08a1ab66b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_7f102cb7-fab4-4497-8f98-cb62d320d1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_7f102cb7-fab4-4497-8f98-cb62d320d1fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_7f102cb7-fab4-4497-8f98-cb62d320d1fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7f102cb7-fab4-4497-8f98-cb62d320d1fb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_7f102cb7-fab4-4497-8f98-cb62d320d1fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7f102cb7-fab4-4497-8f98-cb62d320d1fb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_bdda28f3-5f4c-43e5-9492-41610a8941ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:to="loc_us-gaap_DomesticCountryMember_bdda28f3-5f4c-43e5-9492-41610a8941ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_86817efa-6792-41a9-b4e2-842c10510025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_86817efa-6792-41a9-b4e2-842c10510025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_631cf491-bd10-4924-a847-b1845efcf59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:to="loc_us-gaap_ForeignCountryMember_631cf491-bd10-4924-a847-b1845efcf59c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxPeriodExpirationAxis_1c0b4130-0ef3-4e09-9779-ca1ef27cba7b" xlink:href="bdtx-20211231.xsd#bdtx_TaxPeriodExpirationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:to="loc_bdtx_TaxPeriodExpirationAxis_1c0b4130-0ef3-4e09-9779-ca1ef27cba7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxPeriodExpirationDomain_1c0b4130-0ef3-4e09-9779-ca1ef27cba7b_default" xlink:href="bdtx-20211231.xsd#bdtx_TaxPeriodExpirationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bdtx_TaxPeriodExpirationAxis_1c0b4130-0ef3-4e09-9779-ca1ef27cba7b" xlink:to="loc_bdtx_TaxPeriodExpirationDomain_1c0b4130-0ef3-4e09-9779-ca1ef27cba7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxPeriodExpirationDomain_76a90cde-4795-49e1-92e2-0d3269594427" xlink:href="bdtx-20211231.xsd#bdtx_TaxPeriodExpirationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bdtx_TaxPeriodExpirationAxis_1c0b4130-0ef3-4e09-9779-ca1ef27cba7b" xlink:to="loc_bdtx_TaxPeriodExpirationDomain_76a90cde-4795-49e1-92e2-0d3269594427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxYear2036Member_02f1d9df-7f39-404d-9f95-7d62b53260d1" xlink:href="bdtx-20211231.xsd#bdtx_TaxYear2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bdtx_TaxPeriodExpirationDomain_76a90cde-4795-49e1-92e2-0d3269594427" xlink:to="loc_bdtx_TaxYear2036Member_02f1d9df-7f39-404d-9f95-7d62b53260d1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails" xlink:type="extended" id="ic2f25697df5d4616ba10f8ef8a8b2449_NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e0c4588b-54c6-4bf2-b1b9-5cec9e7671f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_860f0931-1350-4aa0-a8d7-41ae0f87376a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e0c4588b-54c6-4bf2-b1b9-5cec9e7671f8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_860f0931-1350-4aa0-a8d7-41ae0f87376a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_76435de6-b18c-45ae-ae80-aaaaf0384c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e0c4588b-54c6-4bf2-b1b9-5cec9e7671f8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_76435de6-b18c-45ae-ae80-aaaaf0384c86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_17c27044-6603-4b6f-b82e-a94e9e6cd003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_76435de6-b18c-45ae-ae80-aaaaf0384c86" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_17c27044-6603-4b6f-b82e-a94e9e6cd003" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_17c27044-6603-4b6f-b82e-a94e9e6cd003_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_17c27044-6603-4b6f-b82e-a94e9e6cd003" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_17c27044-6603-4b6f-b82e-a94e9e6cd003_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_17c27044-6603-4b6f-b82e-a94e9e6cd003" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a9a32c27-87a3-4afd-b5b8-2302fe53bb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a9a32c27-87a3-4afd-b5b8-2302fe53bb54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_77d51fb5-3ed3-4f9f-8baf-a7dcb8b5db2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:to="loc_us-gaap_RestrictedStockMember_77d51fb5-3ed3-4f9f-8baf-a7dcb8b5db2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_22e8baf3-3c99-4bfd-9383-6cc9598b7d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:to="loc_us-gaap_EmployeeStockMember_22e8baf3-3c99-4bfd-9383-6cc9598b7d35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_3e7b8d23-0f97-4293-b7c3-0018741378cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:to="loc_us-gaap_WarrantMember_3e7b8d23-0f97-4293-b7c3-0018741378cb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails" xlink:type="extended" id="i5244c8eb420743099ffcb7fa3480f3af_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_LesseeOperatingLeaseNumberOfContracts_2afe98cc-6cc6-4b5a-b6cc-9662615bdfc3" xlink:href="bdtx-20211231.xsd#bdtx_LesseeOperatingLeaseNumberOfContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_bdtx_LesseeOperatingLeaseNumberOfContracts_2afe98cc-6cc6-4b5a-b6cc-9662615bdfc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e968535f-1469-42fc-8d70-f45acd584253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e968535f-1469-42fc-8d70-f45acd584253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9bb7671f-a9e1-4f71-a959-9fbc4d88cad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9bb7671f-a9e1-4f71-a959-9fbc4d88cad4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_LesseeOperatingLeaseArea_0eba17cf-ef80-4d08-87fd-0795a1429841" xlink:href="bdtx-20211231.xsd#bdtx_LesseeOperatingLeaseArea"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_bdtx_LesseeOperatingLeaseArea_0eba17cf-ef80-4d08-87fd-0795a1429841" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_5138ad2f-bfc3-44a0-979b-2dcc5b29a2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_5138ad2f-bfc3-44a0-979b-2dcc5b29a2cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_91565371-ae20-4a85-9364-bdcccbec3dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_91565371-ae20-4a85-9364-bdcccbec3dcf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_0128bc7e-b6fe-4b65-ad8e-e722c958802b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_OperatingLeaseExpense_0128bc7e-b6fe-4b65-ad8e-e722c958802b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_6fca8ad3-3d6b-4f4e-bfc7-4d4adc6f3818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_6fca8ad3-3d6b-4f4e-bfc7-4d4adc6f3818" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_1d1a57bf-e0b9-4608-9bcb-0a140359b233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_6fca8ad3-3d6b-4f4e-bfc7-4d4adc6f3818" xlink:to="loc_us-gaap_LeaseContractualTermAxis_1d1a57bf-e0b9-4608-9bcb-0a140359b233" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_1d1a57bf-e0b9-4608-9bcb-0a140359b233_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_1d1a57bf-e0b9-4608-9bcb-0a140359b233" xlink:to="loc_us-gaap_LeaseContractualTermDomain_1d1a57bf-e0b9-4608-9bcb-0a140359b233_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_1d1a57bf-e0b9-4608-9bcb-0a140359b233" xlink:to="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OperatingLeasePrincipalOfficeTwoMember_a1e2df81-d49d-428e-882a-58c759635815" xlink:href="bdtx-20211231.xsd#bdtx_OperatingLeasePrincipalOfficeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:to="loc_bdtx_OperatingLeasePrincipalOfficeTwoMember_a1e2df81-d49d-428e-882a-58c759635815" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OperatingLeasePrincipalOfficeOneMember_9cd60ce6-5205-4b42-aedb-0e4e04ff0a84" xlink:href="bdtx-20211231.xsd#bdtx_OperatingLeasePrincipalOfficeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:to="loc_bdtx_OperatingLeasePrincipalOfficeOneMember_9cd60ce6-5205-4b42-aedb-0e4e04ff0a84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember_8fb31053-5768-4c0c-9748-12425db6d0d1" xlink:href="bdtx-20211231.xsd#bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:to="loc_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember_8fb31053-5768-4c0c-9748-12425db6d0d1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bdtx-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cee46846-3204-4f76-8bc4-0ddff9c4f904,g:517c6acc-4237-470e-8fc7-341826f4d9b3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_98750f8e-910d-4bf3-bf71-695ca81dd1e7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_1a8102c3-ca16-40b8-b16c-ef1cf081f9e9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0f0a2572-8f19-4bf4-8a52-0b0579dd6fce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_1c0b73a8-b257-4d24-9d82-08fd50287ae2_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3122779-8fd6-4154-9c05-fa83a921091c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2d21ee5a-5171-4cdb-9c2b-9095253afc6d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b04d748b-37f3-4f16-88f2-96dae14cc0e3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_eed52dda-e60a-403e-9f04-24d1032c6048_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2c56dd52-478b-46b5-bd3f-bfd65e4423f6_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e3822236-76aa-4459-a653-85cbdb833a38_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_d4dbf09d-3d76-4609-bfb1-a8d636d29a11_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_fbafa297-c8af-467c-9852-d0c9edb33948_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_ff7c32e1-6d88-4fcf-b43a-1cc1367606c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_20f99464-ea15-4bee-8a4b-6f253408bf3a_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_e90d9420-71df-44be-8700-63a6f2fcb354_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_bfed5dfb-4dc1-4eb7-9ca6-fdb04079ff1d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-employees</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f225c2b8-fe55-4048-b1f3-2fd94702ce1f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e52a052e-637a-4084-86bc-8d88969df050_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_57ff8d4f-f552-42c3-a63d-234364aaf8af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled or forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e25849d3-da76-4576-b376-404f500bd210_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_462fcf56-7344-4132-a92f-539bd57ba8c3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency and currency translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_4929e6d0-274f-4a4b-ae4f-b6a6294bbf11_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32d315d7-67f5-4022-89d3-e52e2cb4ea8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8f991007-5400-492f-8358-1a5f07f75df8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_54df4b82-8b16-41f8-b663-bc7c0c94bafc_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_09f70468-1ed2-4dbd-941d-ac1c52a5b28d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_LesseeOperatingLeaseArea_f32714c3-9d96-46a4-94fa-2b7e1cec73e9_terseLabel_en-US" xlink:label="lab_bdtx_LesseeOperatingLeaseArea" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area leased</link:label>
    <link:label id="lab_bdtx_LesseeOperatingLeaseArea_label_en-US" xlink:label="lab_bdtx_LesseeOperatingLeaseArea" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Area</link:label>
    <link:label id="lab_bdtx_LesseeOperatingLeaseArea_documentation_en-US" xlink:label="lab_bdtx_LesseeOperatingLeaseArea" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Area</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_LesseeOperatingLeaseArea" xlink:href="bdtx-20211231.xsd#bdtx_LesseeOperatingLeaseArea"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_LesseeOperatingLeaseArea" xlink:to="lab_bdtx_LesseeOperatingLeaseArea" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c7f44add-2f5c-4994-bd85-1a67a952602b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fd7d94e6-cfe5-466d-aaae-1ba1ceb9f24e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_329a1aba-bf72-459e-85ba-caa529b978fc_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party expense, service fees</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5b715014-ec42-4416-a025-fbe542eb0c33_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled or forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_291cd961-c5a6-4e75-9d9b-933e907386a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_3015cb39-1055-437b-a38d-7a7bb2d85cc0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_d3565b99-a81c-4b55-a20f-9b483bb79231_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_8d0f506d-aa69-4663-962b-5f4d2a65f5b1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_14d3a3a3-323c-49b0-bc07-7a11fb255319_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ef67a4c0-e304-47c1-bdea-cb24c9cb1011_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_53964318-6376-4079-8c55-0a2391d8a980_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_a9a596b5-1326-4772-957b-b082dad9dc60_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_f6efc63c-d1a1-47b1-a2fb-40c626823b01_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_e83bf0dc-5d17-4b83-8f0f-2d0cdfeaf7c2_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_76a3ccb7-760b-4aaf-9e0b-21655c2d5d5b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_de614494-0ec0-4ccb-b1e9-6ae9e0b5e6b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse stock split</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a4cc0fb1-e6c1-427a-9f8c-47dbef85057e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4687ac08-b09a-4ac8-85d5-1332561854ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of restricted stock vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc8e7952-c541-485a-9660-fa62810d95c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_A2020PlanMember_a89afc90-4c98-4d05-9de9-6057f9d63d80_terseLabel_en-US" xlink:label="lab_bdtx_A2020PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Plan</link:label>
    <link:label id="lab_bdtx_A2020PlanMember_label_en-US" xlink:label="lab_bdtx_A2020PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Plan [Member]</link:label>
    <link:label id="lab_bdtx_A2020PlanMember_documentation_en-US" xlink:label="lab_bdtx_A2020PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_A2020PlanMember" xlink:href="bdtx-20211231.xsd#bdtx_A2020PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_A2020PlanMember" xlink:to="lab_bdtx_A2020PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a25d3862-9d17-4a0e-a1f7-c6a7e23aa251_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_a44d70be-a07d-4c63-87c0-4d3712bba49f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0e6d91cd-c403-4cbb-80aa-9c3e353bceac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Life and Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_0969841e-c6a5-479b-8371-fc84f58f08dc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ebbebf83-62e6-45ad-8ce8-480be64ff31c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_8f8c39df-3122-4e34-bb8c-46edd7b344c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested or expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_RentExpense_3714154c-7fc6-484a-8544-ed61667e780c_terseLabel_en-US" xlink:label="lab_bdtx_RentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash rent expense</link:label>
    <link:label id="lab_bdtx_RentExpense_label_en-US" xlink:label="lab_bdtx_RentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Expense</link:label>
    <link:label id="lab_bdtx_RentExpense_documentation_en-US" xlink:label="lab_bdtx_RentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_RentExpense" xlink:href="bdtx-20211231.xsd#bdtx_RentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_RentExpense" xlink:to="lab_bdtx_RentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_839c464b-09db-4159-a6bd-2ba785780c70_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_PatentCostsPolicyPolicyTextBlock_12b1c4fe-5edc-4b65-b775-424b010a9795_terseLabel_en-US" xlink:label="lab_bdtx_PatentCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent costs</link:label>
    <link:label id="lab_bdtx_PatentCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_bdtx_PatentCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_bdtx_PatentCostsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_bdtx_PatentCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent Costs, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_PatentCostsPolicyPolicyTextBlock" xlink:href="bdtx-20211231.xsd#bdtx_PatentCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_PatentCostsPolicyPolicyTextBlock" xlink:to="lab_bdtx_PatentCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_SharesAuthorized_5f562b19-d9c8-4e2e-8574-ce59cdf95309_terseLabel_en-US" xlink:label="lab_bdtx_SharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shares authorized</link:label>
    <link:label id="lab_bdtx_SharesAuthorized_label_en-US" xlink:label="lab_bdtx_SharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Authorized</link:label>
    <link:label id="lab_bdtx_SharesAuthorized_documentation_en-US" xlink:label="lab_bdtx_SharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_SharesAuthorized" xlink:href="bdtx-20211231.xsd#bdtx_SharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_SharesAuthorized" xlink:to="lab_bdtx_SharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_c9814d4f-224f-4224-bcaf-6e26cc39fd59_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value; 10,000,000 shares and 10,000,000 shares authorized at December&#160;31, 2021 and 2020, respectively; no shares issued or outstanding at December&#160;31, 2021 and 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f2af0fde-05fa-4960-bbc6-dd078b3b788f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b13cb18e-aa7e-4bda-921d-01e20204b59d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d6e44056-98e0-4a8a-a4a0-39c83fdaa086_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_03e2d0bf-df75-4656-a419-9f350907f373_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_AuditorInformationAbstract_label_en-US" xlink:label="lab_bdtx_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_bdtx_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_bdtx_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_AuditorInformationAbstract" xlink:href="bdtx-20211231.xsd#bdtx_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_AuditorInformationAbstract" xlink:to="lab_bdtx_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_b1c27b18-17c3-404f-a035-924fc6ea24ce_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1a537aec-7551-4b7d-afa5-ba15f4a40c28_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f77dde2f-b021-4d02-be83-e6414765a0dc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_cddc2bf5-d539-479e-a58b-6b978c30bdad_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_fafd1f0c-9dd3-49dd-9e91-f29aac293ca6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock upon closing of the initial public offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9db1902c-6c07-4563-a20d-6a2f554f41e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_111bfc1b-f936-47d4-a5f4-b9d6ea3085c7_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease obligation</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_7bd60632-8b2d-4fe1-8a92-f7f20cd6c34c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_44fe0fd8-1fd0-46b2-8423-a2c2da4bf68a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_b009dc86-ac17-4338-ae8c-adc85f3f041e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_dc7b1473-2f8a-4706-bd90-8126d6e1cd73_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNonoperating" xlink:to="lab_us-gaap_InvestmentIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_2f012b44-242f-4611-befd-d2146bc8816e_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_fa8b6a19-8830-43a6-b1da-f1510f7a9c51_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to related parties</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_bc399533-c565-468e-aeb9-ebbb8da3c098_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_aaecfbfb-cb64-4c37-96ae-473955f6f3b5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding_4e49263e-56d9-478b-bd2c-62adcde9b018_terseLabel_en-US" xlink:label="lab_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase of authorized shares, percent of common stock outstanding</link:label>
    <link:label id="lab_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding_label_en-US" xlink:label="lab_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Authorized Shares, Percent of Common Stock Outstanding</link:label>
    <link:label id="lab_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding_documentation_en-US" xlink:label="lab_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Authorized Shares, Percent of Common Stock Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" xlink:href="bdtx-20211231.xsd#bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" xlink:to="lab_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5a020d21-4c1d-481b-97a0-39c5d4782abe_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_1f9e4940-97f7-4bce-9e5b-de55fbd4a067_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ed575f3f-7f97-4931-b9c7-cc5378eb548f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_26eed8b4-4be8-485e-82f2-60c111ad8c0c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted common stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6d93058a-b1cd-4437-a0a5-aafdb22d6064_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted common stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_d46540e8-0fb6-4c02-9de0-7df9eef1c6fb_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on lease termination</link:label>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_label_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Termination of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnTerminationOfLease" xlink:to="lab_us-gaap_GainLossOnTerminationOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_bb56a2fc-8996-49a8-bfdd-6b0de5212335_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_5d096f03-3b7f-4a4b-b93d-24dec6de98fc_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_3c5553f2-4f3d-4816-9ca6-ea9fd647f3b6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_2162b800-eae9-4809-907b-800bc114d936_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_90087b0c-90d6-4482-a771-c48f66e185d4_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net fixed assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_9752223a-65bb-431a-aaee-5e99acc6e1df_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development costs and research contract costs and accruals</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_TaxPeriodExpirationAxis_ff375a2f-f487-4359-9606-46217570b6d9_terseLabel_en-US" xlink:label="lab_bdtx_TaxPeriodExpirationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period Expiration [Axis]</link:label>
    <link:label id="lab_bdtx_TaxPeriodExpirationAxis_label_en-US" xlink:label="lab_bdtx_TaxPeriodExpirationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period Expiration [Axis]</link:label>
    <link:label id="lab_bdtx_TaxPeriodExpirationAxis_documentation_en-US" xlink:label="lab_bdtx_TaxPeriodExpirationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxPeriodExpirationAxis" xlink:href="bdtx-20211231.xsd#bdtx_TaxPeriodExpirationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_TaxPeriodExpirationAxis" xlink:to="lab_bdtx_TaxPeriodExpirationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_7a4a8cd8-b55e-4e55-afe8-b9ea5fb7f73f_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_f17aa962-0cee-4d0a-b9b9-3a79eeec01af_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of options vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_3554dd43-49cb-480a-92f5-33f0adc9d1ce_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_968304bb-e8bb-4725-8754-896ac3d96258_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_a6ebb128-4b58-4e47-8df2-a6c466c16c30_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_d2ca5a5a-751e-41ab-927c-a32c58f563f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_858bdd3c-5e75-47d6-ba65-1d9dbc692e02_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6a9ac72c-3e7e-441c-b619-369b8501c948_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC 842</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f039fd8a-0def-4fbd-b9f9-04a8b64fffa4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_89dac855-9e4f-4c92-8081-279c57c2ec3a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_50808ea7-ed57-4431-a1f5-2596fbe56f9a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3bab7638-324d-4cbd-8847-d08a0679abc7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_4f173965-26fd-4455-a25d-4f221b3d8053_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_6774a972-00b0-432a-b09e-a826ed530f80_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_09db9c2b-e477-4160-af85-b295e29c9269_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_7521dc8c-c219-4a02-8048-eef0ad237356_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b55bffcb-2216-41c5-a708-64ad8ed7d184_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_39f2b8b0-0270-4c0b-9bea-a653058f2e62_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_842fe292-c7c8-47a9-88c5-615f03f50bba_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_47b1faec-6f31-47d7-8c78-6a38dc66d567_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from initial public offering, net of issuance costs of $1,275</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_2ca290d4-c70d-4a15-ab70-b3cdf34a2e1f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF BUSINESS AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c4f22e22-64ee-418b-a7bd-41cfaa9b2db3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET LOSS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_ffa58a8d-9ccb-418f-b38f-f025743206d7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_78b6563f-e433-4db1-841f-c4a237b1eb20_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_09c95233-e508-4e2a-97a1-e428f8ed80ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9ca4f4e6-69fd-43a0-bed7-2ac3254b2e5a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of common stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_TaxPeriodExpirationDomain_9cd61a3d-2134-406f-a258-0297123fb923_terseLabel_en-US" xlink:label="lab_bdtx_TaxPeriodExpirationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period Expiration [Domain]</link:label>
    <link:label id="lab_bdtx_TaxPeriodExpirationDomain_label_en-US" xlink:label="lab_bdtx_TaxPeriodExpirationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period Expiration [Domain]</link:label>
    <link:label id="lab_bdtx_TaxPeriodExpirationDomain_documentation_en-US" xlink:label="lab_bdtx_TaxPeriodExpirationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period Expiration [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxPeriodExpirationDomain" xlink:href="bdtx-20211231.xsd#bdtx_TaxPeriodExpirationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_TaxPeriodExpirationDomain" xlink:to="lab_bdtx_TaxPeriodExpirationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7231391f-724b-4a9a-97f9-cdca2036bb20_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_7a38f38d-6ba1-4a19-9351-9fe9e5974108_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled or forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_cfecaf38-623d-4ede-96ab-824deaed191c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_fbfa4fc3-de64-4a0b-913f-49c64c6330e1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4726fc74-7d09-4f9c-8ce8-9308973e7c74_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_41c4c355-5cff-4ead-a933-3fe0983c7d93_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_530edbe9-cb2f-401e-a68f-789e0fc77ec6_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_22d45a6f-a1d6-45bc-a8ec-59c95bda9f66_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_4494b89e-75fc-49ae-af48-fdfbb8f41ea2_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_438a7861-7b49-466d-b9b9-44181cc0e119_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_1e987d7d-aa4a-41d0-a58b-86a1d008ece4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_68d57163-6914-43de-826b-8e39b028beaa_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_cbf4d4ef-b706-4ee6-b938-e690770bb50e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_eab1c21c-a5d9-4ebc-951b-15233aa2f633_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_0d99b791-f167-49c3-989d-7069bad63cd6_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_TaxYear2036Member_b001a07b-58df-47b3-a561-3990a5dfc381_terseLabel_en-US" xlink:label="lab_bdtx_TaxYear2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2036</link:label>
    <link:label id="lab_bdtx_TaxYear2036Member_label_en-US" xlink:label="lab_bdtx_TaxYear2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2036 [Member]</link:label>
    <link:label id="lab_bdtx_TaxYear2036Member_documentation_en-US" xlink:label="lab_bdtx_TaxYear2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxYear2036Member" xlink:href="bdtx-20211231.xsd#bdtx_TaxYear2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_TaxYear2036Member" xlink:to="lab_bdtx_TaxYear2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f5525f80-324a-421e-b311-fc8ee50b19ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ffa2dc5f-caa2-4a29-8416-79b84401d22a_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_bf434bf9-8415-4b15-b50a-9568750d28c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_b30a1145-45ea-47a0-a88f-8f2719b557a4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_f4037093-e495-4969-b7f1-6300917fa8d3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties related to uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_38712ca2-73c1-4860-9a3b-1e13e688935c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, remaining life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0269cbad-cb5a-457d-8402-e47d2d44903a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_3d64c26f-ea21-4f56-9f38-61fb149d459c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_3ec142a1-3c16-41c1-85db-c285ba7f43e1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional and consulting fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_92f1b67b-ba6c-496b-90dc-4a5b828813ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_548ece59-62e2-45f6-93cc-ffaf64ecc2c5_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_8832caad-877c-4555-b296-8d09fdd2d618_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ae122304-2c71-48f3-bc0b-11cc193b339f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.0001 par value; 500,000,000 shares authorized at December&#160;31, 2021 and 500,000,000 shares authorized at December&#160;31, 2020; 36,234,624 shares issued and outstanding at December&#160;31, 2021 and 36,078,383 shares issued and outstanding at December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_5341d8ae-6afc-486e-9803-383c54b58ffe_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investments</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Amortization of Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:to="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_cba33808-199a-4fab-861f-473d6f53881d_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_75f43372-340c-43b6-ba7a-51c692586019_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost, recognition period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2d58a320-1cf7-4e58-ac38-c2e9d7684f05_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted common stock, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2817d7bb-9048-4610-a10c-3a341a99f6b5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted common stock, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1e0472bb-4a11-402f-a457-8c3c5bc19f0f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_a31985cd-ec8e-4dfb-b2c1-4c2177745ae2_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note&#160;12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_fcb42170-c6f9-455c-8404-a050d89b5fff_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_297ec3b3-5eeb-4f3b-ac73-f45e7b681d55_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_AccruedContractResearchServiceFeesCurrent_f808d246-4e8b-4bc4-aa0f-b93d108462b3_terseLabel_en-US" xlink:label="lab_bdtx_AccruedContractResearchServiceFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracted research services</link:label>
    <link:label id="lab_bdtx_AccruedContractResearchServiceFeesCurrent_label_en-US" xlink:label="lab_bdtx_AccruedContractResearchServiceFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Contract Research Service Fees, Current</link:label>
    <link:label id="lab_bdtx_AccruedContractResearchServiceFeesCurrent_documentation_en-US" xlink:label="lab_bdtx_AccruedContractResearchServiceFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Contract Research Service Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_AccruedContractResearchServiceFeesCurrent" xlink:href="bdtx-20211231.xsd#bdtx_AccruedContractResearchServiceFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_AccruedContractResearchServiceFeesCurrent" xlink:to="lab_bdtx_AccruedContractResearchServiceFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_694ca67e-cce8-4b21-a056-9788e4e26d2d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_9ed0adc5-823e-4c37-b502-bc8a92c2a125_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_ade4b64c-1f14-4988-9fd9-94cfd25e9383_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BENEFIT PLANS</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_A2020EmployeeStockPurchasePlanMember_20e74810-dc62-4c3c-8273-c18c61787f88_terseLabel_en-US" xlink:label="lab_bdtx_A2020EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ESPP</link:label>
    <link:label id="lab_bdtx_A2020EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_bdtx_A2020EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_bdtx_A2020EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_bdtx_A2020EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_A2020EmployeeStockPurchasePlanMember" xlink:href="bdtx-20211231.xsd#bdtx_A2020EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_A2020EmployeeStockPurchasePlanMember" xlink:to="lab_bdtx_A2020EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_712ceb74-b243-417a-9458-58e7c5d9a209_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8081265f-5991-4674-b21e-b8279b61259b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_96bf5eab-fa21-4104-8077-cbf0e5ac5ff5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2df46101-cce5-4afb-ba93-cde0ce379d82_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_97b67e9d-204b-4c06-91f3-fd4cddaedde1_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_539cdf5f-2653-4981-a6a7-4b59567684db_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d246641f-36c9-4c03-9c2c-9655b2755401_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_f948abb7-aa56-48b4-9099-ee345fb245b6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_14eb542a-c21b-42bd-aaf1-fd77442a50ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1848e31-ed32-4af6-a798-846a7b8d97c7_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock issuance, net</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b65ad940-3795-4a1d-8c75-d0d2f29f03c4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_314d7b6d-86c2-43bc-9915-4f33a3630539_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_a7adeb4a-fb3b-4607-a264-0abea8c5627c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3fc52f6a-20b6-45dd-a540-779cc452f5b6_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_8533c1b2-2430-4183-a934-904991223081_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_32f1c20f-e9cf-4e88-8290-9731e1c94210_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_5a381b8f-a188-4468-9336-5cf73c1745f3_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9b0a8118-96ff-43f8-840b-c2f5c9186f6a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_fc02c8b6-4899-4bc6-91d3-b2bda348baad_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_46ddfec0-43b1-4754-b6f2-5abda4160869_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_228278b6-fc27-47f7-ab6b-54a6fe34d068_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1d9e9155-6703-4af6-b987-0a546122276b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b26ecd7a-e723-40f7-b9dd-63e683e169c2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3122e7f3-7313-41f7-ab96-49ff61dedde8_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_60e4183e-da42-4b8a-9602-15e45cb6a5df_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution amount</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_358d4b6c-c49b-488f-a769-d6319e4f0fd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_d506adaf-a186-4641-8733-56fe17d66af2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_618d71f2-5ab5-4253-86d7-d87d9b6a9203_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d415c789-c02c-4129-8afa-464f82e6dddc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98ab19a5-faa8-4c1c-8867-8c92980129fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_0e5c3ae5-4f27-4a93-a82e-188d94fce690_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fa57986a-42cf-49ad-84bd-2fa0c98fe218_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0c9a0615-db21-4409-9f32-08ac3e953cbd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_f2dc2761-73d4-4e77-9cc3-9de204f1e011_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities_ec7ee52b-5d6a-4661-b38c-3a45eaec60c1_terseLabel_en-US" xlink:label="lab_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current operating lease liability</link:label>
    <link:label id="lab_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:label id="lab_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="bdtx-20211231.xsd#bdtx_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_fbaf0ba7-727f-41a4-85c7-a329591fe816_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_45902888-735d-4fac-a217-266ac75c8125_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_4a21a8fd-4a6e-495f-9afb-35e45cf3a197_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability, statement of financial position</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_ff27d476-d0eb-4c61-9325-715e6ac62194_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8447dc25-5183-48a5-a173-6bd9c1cc1ada_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_3994dbef-f486-492e-aa02-6b3150decff3_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_32b67914-1d5e-415e-a6e2-e40b61536e71_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_ca6377b3-f55b-48f5-a7e6-58e3ad7db3a2_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8ab2c858-eaa8-4158-9b89-4055904b236a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bc4f4b26-aefc-486f-ad11-af60f8778e0b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3dc10a54-6880-4196-b72a-006d37fdb441_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b15b0997-f753-424a-bfd5-ae8d03516c8e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_107349b1-d165-4741-b85d-817905d77443_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c815a12e-7c9d-4bf9-9da5-779950b45826_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_504f5ee4-d905-4103-8d2f-1aeccdc2edf9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d6f00e10-4de7-4e96-be11-41e0eeffe71b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_69cc7c16-7be8-4006-8db6-c49c208b7ef0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ad6fb758-4a89-4490-8995-de952fbd6660_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_OperatingLeasePrincipalOfficeTwoMember_9bb26de3-b896-4daa-892d-044d02912c18_terseLabel_en-US" xlink:label="lab_bdtx_OperatingLeasePrincipalOfficeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal office, July 2020 lease</link:label>
    <link:label id="lab_bdtx_OperatingLeasePrincipalOfficeTwoMember_label_en-US" xlink:label="lab_bdtx_OperatingLeasePrincipalOfficeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Principal Office, Two [Member]</link:label>
    <link:label id="lab_bdtx_OperatingLeasePrincipalOfficeTwoMember_documentation_en-US" xlink:label="lab_bdtx_OperatingLeasePrincipalOfficeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Principal Office, Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OperatingLeasePrincipalOfficeTwoMember" xlink:href="bdtx-20211231.xsd#bdtx_OperatingLeasePrincipalOfficeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_OperatingLeasePrincipalOfficeTwoMember" xlink:to="lab_bdtx_OperatingLeasePrincipalOfficeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1d509fb6-97ae-42cb-8fca-d51cb403a059_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, end of year</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_eba6e035-7604-409d-a409-0ae3510f69f6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1615ce67-4920-42f3-ae9f-97932af9344d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_0a338a17-898d-40db-b8b7-682f2d5c1896_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_4090761a-5cdb-4b04-8e27-af12a8e6a62e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals and other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b9bdbecf-5689-4a73-85f8-d6bf8f63d401_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_9ff60113-4d61-40ef-8f63-4d5205471eaf_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of credit risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_14e8f338-d687-434b-8fd7-faa9f115dfc1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_571a6358-e429-4161-b396-2a2067172617_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_2cc40393-1901-414a-804f-6dc6b6bcb2f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_OpenMarketSaleMember_84b3550e-f882-4a83-9f3b-e2480a93b115_terseLabel_en-US" xlink:label="lab_bdtx_OpenMarketSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Sale</link:label>
    <link:label id="lab_bdtx_OpenMarketSaleMember_label_en-US" xlink:label="lab_bdtx_OpenMarketSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Sale [Member]</link:label>
    <link:label id="lab_bdtx_OpenMarketSaleMember_documentation_en-US" xlink:label="lab_bdtx_OpenMarketSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OpenMarketSaleMember" xlink:href="bdtx-20211231.xsd#bdtx_OpenMarketSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_OpenMarketSaleMember" xlink:to="lab_bdtx_OpenMarketSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_a5d0077a-7518-41c6-ba85-e5f14e1b16ad_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_fb5c4eba-d126-4474-a16c-d829aff88dc6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_c7d04b0c-8280-468c-9e67-9f2f9ab81f8c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_09c6c5f8-b92a-4a17-805a-f18e5a2c354f_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock into common stock upon closing of initial public offering</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e8bae391-12e1-4b9d-8eaa-d2008c5f0002_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock related to ESPP (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_4505b396-9ad4-4edb-b3c1-d97ceb4c5f69_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2a49c318-a1ce-4d8a-99c1-8b8729c915da_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent of match</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_32ba2461-4ef6-465e-b6ef-89d96019803e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1121b6b6-37c9-4aee-a39b-b8f354d9a264_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_54d0df86-f545-4f57-aaa7-581e70eefc46_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b788f68a-49a1-4ac1-8753-1e54de01e3c3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_e732fd66-a264-41d1-8c79-cebe45b1401f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of common stock options and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_379abe63-adc7-4642-9059-8cdec4434d87_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_165b6719-2a20-4cc9-9f84-12e824aa94ed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_39393b87-a669-4134-97cc-ff8c8dc6258f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_2f05bbe9-f17c-4ddf-be13-429cef2c8886_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b2a097a9-7e25-4748-be79-b5938670c670_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_306ee418-4607-4e6a-8fc8-0dcdce40fe32_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_9447dc8e-8d44-4343-b97d-7c25f03f8de1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_28464697-f481-4300-b923-bded1f4e40b0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a53c724-59da-40c7-b7ec-d0f6cab67e8d_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_070cdc84-02d7-4487-9634-b8f60e8544ca_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e009ef56-1517-42bc-8373-4aac0189a8c6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled or forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_48ba1abe-2aa9-441a-a60d-85f8365a1936_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cc053eb1-b029-42a9-a0fb-b7092c7daaf4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_4e3c348c-6b95-4623-9bf7-e755815fa9ee_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of warrants to additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00b6f6c1-72d0-4ff5-bd22-5bd909e85081_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_42364e42-a3f2-4ea7-8fe2-85bd7513a5d9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_OperatingLeasePrincipalOfficeOneMember_995c2841-3240-4166-858f-d87dc6bec928_terseLabel_en-US" xlink:label="lab_bdtx_OperatingLeasePrincipalOfficeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal office, February 2019 lease</link:label>
    <link:label id="lab_bdtx_OperatingLeasePrincipalOfficeOneMember_label_en-US" xlink:label="lab_bdtx_OperatingLeasePrincipalOfficeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Principal Office, One [Member]</link:label>
    <link:label id="lab_bdtx_OperatingLeasePrincipalOfficeOneMember_documentation_en-US" xlink:label="lab_bdtx_OperatingLeasePrincipalOfficeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Principal Office, One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OperatingLeasePrincipalOfficeOneMember" xlink:href="bdtx-20211231.xsd#bdtx_OperatingLeasePrincipalOfficeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_OperatingLeasePrincipalOfficeOneMember" xlink:to="lab_bdtx_OperatingLeasePrincipalOfficeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b28f1054-d70c-4aba-997c-66f58b5f9bac_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_10475edb-f707-4d86-a235-330d686a0dc4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a47f8902-91d2-4afd-a275-55460ae4387b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost, options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_310a9da1-c110-4734-b0a0-ae58e41b2aa6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_8fe32323-9fe0-40f6-b62e-74310d2b619e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_532698fd-6988-4354-b2bc-ca482984b6ff_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_b1e58651-8ff7-4bfc-a02c-35fc51473f72_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_a0b659cd-bd3a-4dba-9f87-14c0c1761b1c_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_9f9d1a86-27ed-43a3-8cd7-7609e529c752_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_ac759bd7-01f2-47f2-ae86-b1d8bbcc72db_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b09cd775-e36f-4a8c-9eb5-e676c789f297_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_20d11a3f-52fa-42b7-ac5c-61f9b8b30aea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant-date fair value per share of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ebf3f4b0-c219-4fab-bdbf-5744619c1b35_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_23fb46a3-ed7d-4640-9dd2-06d2901727f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_aeef517e-70c9-4a39-9e85-4c59585083dd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ef58192e-5c05-433c-ab96-91b410b58f70_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_474866c1-d850-4171-b36e-0ff4f0be19eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_26af51d3-295f-49bb-bb8b-da309f79a289_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_0e4e689d-f486-48c8-8625-fa23eaf7ceff_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets (liabilities):</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_72d3857c-18be-4ff7-a411-ccd9837ca312_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_b749a2dc-a396-4de5-b13a-3cd6b90fbbaa_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_4e2e412a-3390-43f7-b1d7-0b7e0590d7b0_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_97bf16f4-53f7-49e0-ac7f-e56db2f73f0f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_54586253-2dbe-4c87-b3b6-1f4df1885d8f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_da34177d-0ee0-4cc3-b913-dbd504073b63_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f266b2e1-69d0-4e9b-86fb-2b1e7c3ce31d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_655248fd-68cf-43d6-be4d-4c15d6d81297_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1b42ced1-b3ab-4ff4-aeb3-ce72578550b0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3670426d-fb70-487f-a217-a778efd50314_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a4939721-c3cb-4f94-9fff-36500c315c8c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_ccbace4c-7003-4bb1-90ff-d20bc5187a3a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_a807b82f-fcda-4486-9d62-bf3a063c3d6e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_dbb2665f-c4e6-42c8-bb43-19f93621bf34_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e63d06d2-c516-4ef3-9be6-3205dede6c57_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_784d37a8-666b-4c6b-bd43-bdf595c419c1_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_3473984f-b3c4-441d-8990-08f6c3d0606f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3fb4a730-1ede-488b-be40-819f0c4c66fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4b2a1648-8db3-4f44-be72-cb44678516cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_3e406686-e692-4a54-bdc6-bd0c1fd7b03d_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f38b64a2-62b8-4268-ae1d-7a1e10e41536_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_97907514-a09c-4d49-8f30-1f5bf6ae4925_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_1f77726b-036d-4026-a01f-4675a8797464_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ff3e3f14-2da2-4877-9751-42d9995418cb_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_bdc8419e-e81d-4cce-b079-83ca71287209_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_ffad517c-1276-4b7f-9d10-e3247ab29be1_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_80eeb2ed-d904-4a05-bc9f-0655e99c2790_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a0fae0c1-0f60-4ddf-a249-dd4c3ce46a45_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_c6e2f9be-c91b-437f-be73-b52b3e10f736_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCRUED EXPENSES</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_9a7d7203-4a16-4158-8519-0000c10e3985_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_8c1a2eeb-e51c-446b-89dd-7f08d26464f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized (loss) gain on investments, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_e193cf3f-dd8d-4fa3-b1aa-7350ab9793fb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains on investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_07b64488-10c2-4f53-9c2e-e0c7b4a083c5_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_74df8ae7-0eab-444f-a873-e2d1a79cc179_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term, optional extension</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_56b123ca-6fc7-4b79-8634-f23ec467575c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_e542b82c-b53b-40e0-b925-b39ecf2fbc3f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_d9bc5bf3-ed32-4dd6-98a3-dc20487f6166_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_bb517411-5ce9-44a5-a2f7-d926e5fffe08_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_25bc8415-a31b-40a0-8424-86275f81eeef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_af2a41f3-1bfc-4f71-a720-a607514c1a71_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_e2434978-9571-45bb-9938-d14b5e353da6_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Lease Cost and Other Operating Lease Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_035899f6-9288-427e-bea9-432873752d37_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_57ee1ef9-9be4-4c3a-a8c9-11c9b14f391e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_5a7191db-5097-4651-bd63-58494012fbf2_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_fc693e86-e494-4c2b-99c0-11a5dfd10106_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Not Included with Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_76259904-9d08-486a-a532-0765b0ea25f1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b4e62a47-84ec-4701-b8a4-62afd58d0d62_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_fb597563-abb7-4800-986c-231b0d494b8e_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_367bf123-dd79-4a11-8f4c-e06507361da1_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_12ab8d92-5988-43ef-b162-a84cf0192a41_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_723f5e41-294b-481b-9011-68d5a3848ebc_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_fac15180-018f-4998-bf3f-776a62205d78_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7df5b5aa-8c13-4bed-ac12-aa51cddaee86_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_fc9320d6-cdc9-450f-9119-5b5e6c63b781_terseLabel_en-US" xlink:label="lab_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_label_en-US" xlink:label="lab_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</link:label>
    <link:label id="lab_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_documentation_en-US" xlink:label="lab_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:href="bdtx-20211231.xsd#bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:to="lab_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2922910b-0951-4e39-9394-990776df5362_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock upon closing of the initial public offering (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f6531282-2a2d-4154-a421-800b9f5a42c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued upon conversion</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_AccruedLegalFeesCurrent_5312f656-c5f2-40c0-b60b-03fcef1a9d14_terseLabel_en-US" xlink:label="lab_bdtx_AccruedLegalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal fees</link:label>
    <link:label id="lab_bdtx_AccruedLegalFeesCurrent_label_en-US" xlink:label="lab_bdtx_AccruedLegalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Legal Fees, Current</link:label>
    <link:label id="lab_bdtx_AccruedLegalFeesCurrent_documentation_en-US" xlink:label="lab_bdtx_AccruedLegalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Legal Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_AccruedLegalFeesCurrent" xlink:href="bdtx-20211231.xsd#bdtx_AccruedLegalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_AccruedLegalFeesCurrent" xlink:to="lab_bdtx_AccruedLegalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e5f4f8d2-d74e-4131-b672-8bd7a1775a64_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_93c8d54d-4041-4143-85c2-4796f4eb24bd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_ee38f078-9ff6-40c4-bbe0-ecfe97cb9366_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_label_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossAttributableToParent" xlink:to="lab_us-gaap_IncomeLossAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_1e4afc15-4d0f-4379-8c36-6634c90aea7e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_82f6fb7f-a9b7-4cda-8a16-11cad2d54b4f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_b16936e5-8e3b-4122-b18c-a7e510e3c882_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_12ea471f-86bf-4877-80ae-6d4dfcaba341_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_eddd894c-9b2f-4911-b409-d1155a8da07b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a492d6af-c847-4c14-b694-4e081077b436_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d74bcf2d-01d6-4627-bfcb-2e2f0abe0783_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_CommonStockVotingRightsNumberOfVotesPerShare_03fa644f-a12d-4cf2-849f-9d5b487d1aa1_terseLabel_en-US" xlink:label="lab_bdtx_CommonStockVotingRightsNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, voting rights per share</link:label>
    <link:label id="lab_bdtx_CommonStockVotingRightsNumberOfVotesPerShare_label_en-US" xlink:label="lab_bdtx_CommonStockVotingRightsNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number Of Votes Per Share</link:label>
    <link:label id="lab_bdtx_CommonStockVotingRightsNumberOfVotesPerShare_documentation_en-US" xlink:label="lab_bdtx_CommonStockVotingRightsNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number Of Votes Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_CommonStockVotingRightsNumberOfVotesPerShare" xlink:href="bdtx-20211231.xsd#bdtx_CommonStockVotingRightsNumberOfVotesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_CommonStockVotingRightsNumberOfVotesPerShare" xlink:to="lab_bdtx_CommonStockVotingRightsNumberOfVotesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ee7ca9e7-adb4-4366-928c-31de1f84c18f_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d2fa9c0b-e344-45fc-b8ae-825bff045012_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_5b73633c-421b-4222-a024-c9f6ff5898d6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_dc244a1e-11fc-4ffd-9f02-fd6df0df1bc1_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9f6b76d7-36b8-4339-92e9-1bc637b7cdcf_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13a70417-7e24-4d3c-a1a2-41403b9c8313_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c03b71b9-5cdf-4786-97cc-da346d232654_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_bb5f1ab6-acf5-4f36-a981-b513d80851d9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_c4fbe37b-fa01-4f02-92f0-d5ccc3fc4072_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_7619b160-cd16-4a85-ba16-e290178ad18b_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_aeddc2d2-be1c-4b07-8608-0cdaa9458502_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_dee426cc-1db9-4b55-bdf1-3f4dcc770989_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_6aa6f371-7b64-4144-bb63-17b7256ff460_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_0fdc253e-98ae-48b0-b6e1-7c3c9e9f7053_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_127e45f1-6604-4689-a849-e833a75c4649_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_03e94dd9-106e-4146-a79f-2ee11e1aeec0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a64fdb48-515a-43e2-82d2-4e2979f1c314_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1275b62c-05dd-4aeb-94d6-462e1199feae_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Property and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_804f02b0-b334-4a9f-ada6-b4b9a673f347_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_fbaf8dce-fb1e-4f37-9b3a-3972daab3b49_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_LesseeOperatingLeaseNumberOfContracts_526e4507-f86a-4c0e-861f-1531968fff1b_terseLabel_en-US" xlink:label="lab_bdtx_LesseeOperatingLeaseNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of leases</link:label>
    <link:label id="lab_bdtx_LesseeOperatingLeaseNumberOfContracts_label_en-US" xlink:label="lab_bdtx_LesseeOperatingLeaseNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Contracts</link:label>
    <link:label id="lab_bdtx_LesseeOperatingLeaseNumberOfContracts_documentation_en-US" xlink:label="lab_bdtx_LesseeOperatingLeaseNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_LesseeOperatingLeaseNumberOfContracts" xlink:href="bdtx-20211231.xsd#bdtx_LesseeOperatingLeaseNumberOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_LesseeOperatingLeaseNumberOfContracts" xlink:to="lab_bdtx_LesseeOperatingLeaseNumberOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_d1f4a7ba-f62c-4c83-bdcc-f3ac2436a238_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_10a7cb58-8789-4f9d-a27c-b17c0e07b85f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_881fe8bf-3109-450d-b951-7320c0f9ea98_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_b3aedb46-223e-4048-8384-ba5a4e33649f_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_DeferredTaxAssetsLeasingArrangements_6e8cf474-e84a-4670-a4d3-aa1df40fcf75_terseLabel_en-US" xlink:label="lab_bdtx_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_bdtx_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_bdtx_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_bdtx_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_bdtx_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_DeferredTaxAssetsLeasingArrangements" xlink:href="bdtx-20211231.xsd#bdtx_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_bdtx_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3cc4f40d-0275-46b9-8fb7-c9c32a2ce51b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested or expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_c1824f7c-8567-4f3d-88dc-fceda4533f95_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants to purchase shares of common stock</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_71af413d-cf25-4133-aa8a-421d24c74e18_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1bc5e93c-ae30-44d4-88d6-8869a21add76_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_6c7aeb25-85ee-4ab5-be2c-c723424e4343_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_af9b7b24-2386-48a6-b776-2159aa4922d2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, remaining life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_8c57456b-bd7b-452c-a8ca-079c49b69f61_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e7a643f3-154d-45ef-8463-9517f86bd9ac_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_RightOfUseAssetDerecognizedTerminationOfLease_b83f00df-5c6d-422f-b49e-a42e9489eddb_terseLabel_en-US" xlink:label="lab_bdtx_RightOfUseAssetDerecognizedTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset derecognized upon early lease termination</link:label>
    <link:label id="lab_bdtx_RightOfUseAssetDerecognizedTerminationOfLease_label_en-US" xlink:label="lab_bdtx_RightOfUseAssetDerecognizedTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset, Derecognized, Termination of Lease</link:label>
    <link:label id="lab_bdtx_RightOfUseAssetDerecognizedTerminationOfLease_documentation_en-US" xlink:label="lab_bdtx_RightOfUseAssetDerecognizedTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset, Derecognized, Termination of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_RightOfUseAssetDerecognizedTerminationOfLease" xlink:href="bdtx-20211231.xsd#bdtx_RightOfUseAssetDerecognizedTerminationOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_RightOfUseAssetDerecognizedTerminationOfLease" xlink:to="lab_bdtx_RightOfUseAssetDerecognizedTerminationOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_270937ab-2dd5-48b0-a28c-587a592e4d33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant&#160;date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_760559dd-e554-4aa5-bbcf-16ae094aa3f0_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_e11d7237-e89c-42ae-a4b3-eda65630a100_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_ec965e2a-cb75-43e5-b2bd-530ef4b51142_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in process</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b98376a4-e78a-4481-85ea-99b37e38d5b7_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f060dacc-d257-450b-abea-552e4a18be52_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f27c5b86-0c2d-4007-96c6-23cdf4834be7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ca0217bb-e919-4f44-8677-a01927c17249_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_e595772d-c708-4aa7-926e-eee85ed6ddb0_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_de02b122-c22f-4dba-b454-ff984d910caf_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares sold</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c138d65f-24ae-42ec-aca2-28c941142d2f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_LeaseOtherInformationAbstract_d1fd8fa3-9f27-4f22-a6d2-9034971127e0_terseLabel_en-US" xlink:label="lab_bdtx_LeaseOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Lease Information</link:label>
    <link:label id="lab_bdtx_LeaseOtherInformationAbstract_label_en-US" xlink:label="lab_bdtx_LeaseOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Other Information [Abstract]</link:label>
    <link:label id="lab_bdtx_LeaseOtherInformationAbstract_documentation_en-US" xlink:label="lab_bdtx_LeaseOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Other Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_LeaseOtherInformationAbstract" xlink:href="bdtx-20211231.xsd#bdtx_LeaseOtherInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_LeaseOtherInformationAbstract" xlink:to="lab_bdtx_LeaseOtherInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_cc280105-d829-407a-8cc3-0e9d1d2b499b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5ccaa957-ae8c-4d0b-ae18-2428f7af8320_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, number of shares reserved (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_OtherAwardTypeMember_7e2bc617-ea15-45c0-985d-06cb00a0baaa_terseLabel_en-US" xlink:label="lab_bdtx_OtherAwardTypeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan and Other</link:label>
    <link:label id="lab_bdtx_OtherAwardTypeMember_label_en-US" xlink:label="lab_bdtx_OtherAwardTypeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Award Type [Member]</link:label>
    <link:label id="lab_bdtx_OtherAwardTypeMember_documentation_en-US" xlink:label="lab_bdtx_OtherAwardTypeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Award Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OtherAwardTypeMember" xlink:href="bdtx-20211231.xsd#bdtx_OtherAwardTypeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_OtherAwardTypeMember" xlink:to="lab_bdtx_OtherAwardTypeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_e0279b53-b9b9-41fc-9f78-0186518533d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_23de94e7-ba44-4046-a691-3efda43fc2fd_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long - lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_36630d98-191d-41a9-b854-80020cc69b4e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cf36438a-3d41-49b4-a7b0-a9c69c6806f2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_1b337c0a-d683-40b6-a006-bd2652642f53_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3b08ca2c-c74f-41a1-a6da-6f9f51938183_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of common stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_04517c82-e8dc-4592-a318-71d63b954d5d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c62484f3-829c-4471-8b45-10722b9b254e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common share outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_fe39ce33-4800-4dc0-8902-a34d151788fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_c60a4baf-8c4f-4e03-9454-b76b9b160ea9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_257db7eb-64fd-4500-b541-cb6a614dafd6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b710c9fa-82e2-4d03-85bf-87c5f7a9d4a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8d26164f-d359-47cc-8cb6-ff13287290a4_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_258f8afc-c980-4c12-86b3-3e404fe27dfe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_20601450-5f3d-4653-b3bd-657035b4a32c_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_b72bc161-dfd9-4c41-b01a-e3b894074e60_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_059abb0e-6ee9-4b5a-b268-ebfea39600dc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6502a84d-c01d-4f32-955e-bea9466837b6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2af45f92-f68b-4775-9bc8-5f61eee8e951_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in current assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_255d0e71-5ad8-4cb4-8057-4cf7c9dd1613_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2dc0edaf-d458-4c09-a65b-f85230df492a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock related to ESPP</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d051187c-adc6-4439-b055-004985896312_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c1dab883-2b73-461a-8ece-fd2c6379010c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_172347d0-03f8-47e7-9986-5a33d6a8876c_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_d7b609c6-f3f3-4244-84a1-97e7343ad130_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_c9435dc1-8830-4255-98f5-9aac352d4350_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_df7d95d9-9c97-4ba5-b46c-e692ed01e3c3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6de2c8f8-ce34-4206-91f4-41e9378a7175_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_e906d24d-cd63-40f3-94a1-adb674ea86a7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_b478411f-cf55-436d-b120-ce0273f29594_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_54066820-a161-4bf8-a547-103f9afadd24_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution, percent of each participant's salary</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_caaec5cd-b497-465c-a8f9-2a7a87e2cd1d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested or expected to vest, intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_00c6e109-b1dc-4ad9-8f6b-07486101498b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_94bff40c-dc22-407a-bcc2-737f4cffd31c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b7cf930f-3f32-4aa2-a071-db291435df97_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently adopted accounting pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e0be6379-4f00-4517-a2f7-a45e94356e25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b35b5522-32f9-4b0d-873b-cc7f36fd6598_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_94f4b7ae-a7b9-4a88-93c3-f26203064e60_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_c6eae78f-0769-4d4a-ad77-b7b56b07dde6_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_39be3a5b-f859-4c67-808e-2b6e0d29d6da_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_23fdb911-aa57-413f-9043-d7e1211d4ea1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_7a376bc8-0a29-49f6-aac7-f0125086af1f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember_76937094-4f3d-47bf-b6cf-d43d6dfdc655_terseLabel_en-US" xlink:label="lab_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office and laboratory, December 2020 lease</link:label>
    <link:label id="lab_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember_label_en-US" xlink:label="lab_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Office and Laboratory Space, NY [Member]</link:label>
    <link:label id="lab_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember_documentation_en-US" xlink:label="lab_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Office and Laboratory Space, NY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember" xlink:href="bdtx-20211231.xsd#bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember" xlink:to="lab_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_aaa84012-0011-4f62-8a7f-2be18ab1ff47_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RELATED-PARTY TRANSACTIONS</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ae4412fa-5629-46e4-9778-be349a4ed7c2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested or expected to vest, remaining life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bdtx-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cee46846-3204-4f76-8bc4-0ddff9c4f904,g:517c6acc-4237-470e-8fc7-341826f4d9b3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/CoverPage" xlink:type="simple" xlink:href="bdtx-20211231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4c736fae-d07d-4175-95f5-b58198f221d2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_DocumentType_4c736fae-d07d-4175-95f5-b58198f221d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_f7cdbe83-64b9-45e4-9d8e-38993a453b58" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_DocumentAnnualReport_f7cdbe83-64b9-45e4-9d8e-38993a453b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_52b03df0-7c91-4925-9c1d-a4936c4f302e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_DocumentPeriodEndDate_52b03df0-7c91-4925-9c1d-a4936c4f302e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d2280f30-fa03-4fe0-82a8-ff91f45aba3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_CurrentFiscalYearEndDate_d2280f30-fa03-4fe0-82a8-ff91f45aba3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_cf8ed4e2-c325-49dd-8471-ac6188ded51d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_DocumentTransitionReport_cf8ed4e2-c325-49dd-8471-ac6188ded51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_748d557c-2f5b-42e4-8ea0-a2602af4ac14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityFileNumber_748d557c-2f5b-42e4-8ea0-a2602af4ac14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_aec8e488-22ec-46b4-9f18-75f966ae95d0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityRegistrantName_aec8e488-22ec-46b4-9f18-75f966ae95d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ae02629e-1602-4403-bffe-3fc81f832e87" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ae02629e-1602-4403-bffe-3fc81f832e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b3e88b79-fc13-44f7-9a9d-c55ec4f87c54" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityTaxIdentificationNumber_b3e88b79-fc13-44f7-9a9d-c55ec4f87c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_705259e1-32fd-48a7-9928-d94a823d718f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityAddressAddressLine1_705259e1-32fd-48a7-9928-d94a823d718f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_be3d9a6f-2473-496d-b75e-38688eeb9757" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityAddressCityOrTown_be3d9a6f-2473-496d-b75e-38688eeb9757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_13f6d772-0e32-42b0-a99b-7e5361f255fd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityAddressStateOrProvince_13f6d772-0e32-42b0-a99b-7e5361f255fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2c2cf6fc-812c-467f-9ff1-adcd915242c1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityAddressPostalZipCode_2c2cf6fc-812c-467f-9ff1-adcd915242c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c3798185-a175-4844-9c4e-1c57346a26e2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_CityAreaCode_c3798185-a175-4844-9c4e-1c57346a26e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a091bd00-96e1-48f6-8460-cdb08bdfc4e2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_LocalPhoneNumber_a091bd00-96e1-48f6-8460-cdb08bdfc4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_24b8a2c0-b54c-4c4c-aecb-938a6986104c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_Security12bTitle_24b8a2c0-b54c-4c4c-aecb-938a6986104c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1303797c-a606-4b95-9e95-0566de9780e2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_TradingSymbol_1303797c-a606-4b95-9e95-0566de9780e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_870713c3-a838-446f-9809-ad9d48922788" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_SecurityExchangeName_870713c3-a838-446f-9809-ad9d48922788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a32b90f0-ad06-4f6c-8201-f2d88676cc13" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a32b90f0-ad06-4f6c-8201-f2d88676cc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_98854e8e-8aa8-45b8-8665-78374eed4450" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityVoluntaryFilers_98854e8e-8aa8-45b8-8665-78374eed4450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_037c19c0-266c-426a-a83e-7544eff4b544" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityCurrentReportingStatus_037c19c0-266c-426a-a83e-7544eff4b544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_97176dda-441e-4534-856b-6c925238f72e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityInteractiveDataCurrent_97176dda-441e-4534-856b-6c925238f72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2cc84d03-e932-4615-bd81-aa54232cd108" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityFilerCategory_2cc84d03-e932-4615-bd81-aa54232cd108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f54da879-3a2a-405c-9f87-1b85f7d96cf3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntitySmallBusiness_f54da879-3a2a-405c-9f87-1b85f7d96cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c43893a2-2cea-46b7-b885-e1273095dba3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityEmergingGrowthCompany_c43893a2-2cea-46b7-b885-e1273095dba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_ecaa3b94-21d9-4495-b6db-6354fe519b7c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityExTransitionPeriod_ecaa3b94-21d9-4495-b6db-6354fe519b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_3c127749-791e-424e-9b20-7a1a1e76f540" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_IcfrAuditorAttestationFlag_3c127749-791e-424e-9b20-7a1a1e76f540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3c03d2fe-da36-42bb-8475-516a64848611" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityShellCompany_3c03d2fe-da36-42bb-8475-516a64848611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_ed3b3de4-76be-4c25-9104-ee528373e747" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityPublicFloat_ed3b3de4-76be-4c25-9104-ee528373e747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_8840b04b-cbe1-4312-83b7-e5431a091112" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_8840b04b-cbe1-4312-83b7-e5431a091112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_861ade60-80fc-4b14-8d8e-1eaeaef05ad0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_861ade60-80fc-4b14-8d8e-1eaeaef05ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_fb8e665e-5e0b-415a-ad52-526f22d9f7d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_AmendmentFlag_fb8e665e-5e0b-415a-ad52-526f22d9f7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_33e76acc-b2ad-443b-a058-7719a351862d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_DocumentFiscalPeriodFocus_33e76acc-b2ad-443b-a058-7719a351862d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_95a72735-05f2-432f-847e-5cba915fef1d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_DocumentFiscalYearFocus_95a72735-05f2-432f-847e-5cba915fef1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_240efbee-2ef6-495c-8cc3-754e5d7c8bf0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_78cad36c-4bd4-40e5-9c71-7b14ec03e481" xlink:to="loc_dei_EntityCentralIndexKey_240efbee-2ef6-495c-8cc3-754e5d7c8bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/AuditInformation" xlink:type="simple" xlink:href="bdtx-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_AuditorInformationAbstract_28bfe60c-27d2-4702-aacc-2e6bcca5f443" xlink:href="bdtx-20211231.xsd#bdtx_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_cd4e8780-3eea-4c29-b333-8350bcb35cde" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdtx_AuditorInformationAbstract_28bfe60c-27d2-4702-aacc-2e6bcca5f443" xlink:to="loc_dei_AuditorFirmId_cd4e8780-3eea-4c29-b333-8350bcb35cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_03ed8cab-92ac-4a95-9023-9d8fc134bd20" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdtx_AuditorInformationAbstract_28bfe60c-27d2-4702-aacc-2e6bcca5f443" xlink:to="loc_dei_AuditorName_03ed8cab-92ac-4a95-9023-9d8fc134bd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_f04e3939-14df-493e-a138-acfa2f209d6d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdtx_AuditorInformationAbstract_28bfe60c-27d2-4702-aacc-2e6bcca5f443" xlink:to="loc_dei_AuditorLocation_f04e3939-14df-493e-a138-acfa2f209d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c5a70a56-2b07-4df9-b139-f67ca01af3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_16484de1-2f5f-45ac-9f0c-ec9524c9bcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c5a70a56-2b07-4df9-b139-f67ca01af3d5" xlink:to="loc_us-gaap_AssetsAbstract_16484de1-2f5f-45ac-9f0c-ec9524c9bcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3164f314-147c-417e-b94d-4a026bc67d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_16484de1-2f5f-45ac-9f0c-ec9524c9bcf9" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3164f314-147c-417e-b94d-4a026bc67d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_284dc79c-89de-4f7b-81af-5c6bb1125a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3164f314-147c-417e-b94d-4a026bc67d2d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_284dc79c-89de-4f7b-81af-5c6bb1125a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b716103a-d567-42ed-89a2-9b0e034feccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3164f314-147c-417e-b94d-4a026bc67d2d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b716103a-d567-42ed-89a2-9b0e034feccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_92cb9e52-b346-4395-aab2-f855ce936dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3164f314-147c-417e-b94d-4a026bc67d2d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_92cb9e52-b346-4395-aab2-f855ce936dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3ca9976a-2eff-4160-9c39-3f3acef6b591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3164f314-147c-417e-b94d-4a026bc67d2d" xlink:to="loc_us-gaap_AssetsCurrent_3ca9976a-2eff-4160-9c39-3f3acef6b591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0fbf84b0-b3c4-44d2-bb96-f614bf4badd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_16484de1-2f5f-45ac-9f0c-ec9524c9bcf9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0fbf84b0-b3c4-44d2-bb96-f614bf4badd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c1ddbc7a-87d9-4c9e-b0d2-704288acf98f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_16484de1-2f5f-45ac-9f0c-ec9524c9bcf9" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c1ddbc7a-87d9-4c9e-b0d2-704288acf98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fb3f5e72-1a08-4623-a58f-b14a723be30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_16484de1-2f5f-45ac-9f0c-ec9524c9bcf9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fb3f5e72-1a08-4623-a58f-b14a723be30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4427ee6b-e48d-4112-a1b3-b5c81fc32a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_16484de1-2f5f-45ac-9f0c-ec9524c9bcf9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4427ee6b-e48d-4112-a1b3-b5c81fc32a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3d9c2254-13cd-4f9a-88ae-157584392e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_16484de1-2f5f-45ac-9f0c-ec9524c9bcf9" xlink:to="loc_us-gaap_Assets_3d9c2254-13cd-4f9a-88ae-157584392e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_87626b9e-1004-4aa4-b079-41e27e260eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c5a70a56-2b07-4df9-b139-f67ca01af3d5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_87626b9e-1004-4aa4-b079-41e27e260eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8b252a32-73cb-4b95-bd56-aed6a8ccffd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_87626b9e-1004-4aa4-b079-41e27e260eec" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8b252a32-73cb-4b95-bd56-aed6a8ccffd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_42386847-33d8-4881-8ba8-1e299967458b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b252a32-73cb-4b95-bd56-aed6a8ccffd7" xlink:to="loc_us-gaap_AccountsPayableCurrent_42386847-33d8-4881-8ba8-1e299967458b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_181d4d69-0e11-4e1f-8d0d-d2f522c020ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b252a32-73cb-4b95-bd56-aed6a8ccffd7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_181d4d69-0e11-4e1f-8d0d-d2f522c020ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2f09919a-17d6-419e-860a-cd670bccc4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b252a32-73cb-4b95-bd56-aed6a8ccffd7" xlink:to="loc_us-gaap_LiabilitiesCurrent_2f09919a-17d6-419e-860a-cd670bccc4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_00f3a4cc-edcd-4ca6-8f67-114fa26dffa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_87626b9e-1004-4aa4-b079-41e27e260eec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_00f3a4cc-edcd-4ca6-8f67-114fa26dffa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_34eb7252-b24d-4b00-beb3-61e442c057bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_87626b9e-1004-4aa4-b079-41e27e260eec" xlink:to="loc_us-gaap_Liabilities_34eb7252-b24d-4b00-beb3-61e442c057bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ed018266-8d3f-4ea5-890f-053405bdea4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_87626b9e-1004-4aa4-b079-41e27e260eec" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ed018266-8d3f-4ea5-890f-053405bdea4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_0aaa65cf-f806-4d8e-80aa-f5683b9747bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_87626b9e-1004-4aa4-b079-41e27e260eec" xlink:to="loc_us-gaap_StockholdersEquityAbstract_0aaa65cf-f806-4d8e-80aa-f5683b9747bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_83810a88-6414-4338-8be5-6d7e9b104839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0aaa65cf-f806-4d8e-80aa-f5683b9747bc" xlink:to="loc_us-gaap_PreferredStockValue_83810a88-6414-4338-8be5-6d7e9b104839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_57c2b9bd-d57e-4a0f-a65f-e366f94cd66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0aaa65cf-f806-4d8e-80aa-f5683b9747bc" xlink:to="loc_us-gaap_CommonStockValue_57c2b9bd-d57e-4a0f-a65f-e366f94cd66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_d92b4c01-b498-42dd-86cf-3634f6f3ce82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0aaa65cf-f806-4d8e-80aa-f5683b9747bc" xlink:to="loc_us-gaap_AdditionalPaidInCapital_d92b4c01-b498-42dd-86cf-3634f6f3ce82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_20439d8b-f90b-44fe-9a72-cb029779644a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0aaa65cf-f806-4d8e-80aa-f5683b9747bc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_20439d8b-f90b-44fe-9a72-cb029779644a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fc1de65a-3660-49ae-8640-441186d705cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0aaa65cf-f806-4d8e-80aa-f5683b9747bc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fc1de65a-3660-49ae-8640-441186d705cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ffdad806-4912-488e-a9c5-cb32c57b3c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0aaa65cf-f806-4d8e-80aa-f5683b9747bc" xlink:to="loc_us-gaap_StockholdersEquity_ffdad806-4912-488e-a9c5-cb32c57b3c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b1591cc5-0c99-48a3-89f2-033766d91af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_87626b9e-1004-4aa4-b079-41e27e260eec" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b1591cc5-0c99-48a3-89f2-033766d91af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5168ab1e-d3ae-4cfb-8ff2-9b740b214671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_91d7bdfb-f257-4e95-aaf6-40dd371a2e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5168ab1e-d3ae-4cfb-8ff2-9b740b214671" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_91d7bdfb-f257-4e95-aaf6-40dd371a2e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b1526ae5-0cb5-4c45-b18c-9f06a8e61273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5168ab1e-d3ae-4cfb-8ff2-9b740b214671" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b1526ae5-0cb5-4c45-b18c-9f06a8e61273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4c44d37e-a095-422c-8e84-19c3a4691f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5168ab1e-d3ae-4cfb-8ff2-9b740b214671" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4c44d37e-a095-422c-8e84-19c3a4691f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0c3da8b6-6e69-4d82-b2fe-6c47d97c9235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5168ab1e-d3ae-4cfb-8ff2-9b740b214671" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0c3da8b6-6e69-4d82-b2fe-6c47d97c9235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3041ecb4-ef91-44ba-acef-4c0e9dad6d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5168ab1e-d3ae-4cfb-8ff2-9b740b214671" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3041ecb4-ef91-44ba-acef-4c0e9dad6d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0bf01dd1-b7db-464f-911f-b360112e67c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5168ab1e-d3ae-4cfb-8ff2-9b740b214671" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0bf01dd1-b7db-464f-911f-b360112e67c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_36ac4d1b-e543-48d4-90aa-33ea8ac4357e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5168ab1e-d3ae-4cfb-8ff2-9b740b214671" xlink:to="loc_us-gaap_CommonStockSharesIssued_36ac4d1b-e543-48d4-90aa-33ea8ac4357e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f8245d12-a85e-4198-afe2-9b045b5e1d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5168ab1e-d3ae-4cfb-8ff2-9b740b214671" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f8245d12-a85e-4198-afe2-9b045b5e1d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_ba95e9ba-2de6-4388-9061-76c9ca0b705f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:to="loc_us-gaap_OperatingExpensesAbstract_ba95e9ba-2de6-4388-9061-76c9ca0b705f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f00d6ac7-2240-4b9b-ae5f-acbad512ebcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba95e9ba-2de6-4388-9061-76c9ca0b705f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f00d6ac7-2240-4b9b-ae5f-acbad512ebcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_d8c4a721-04f1-4a68-8899-a06a4c81a843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba95e9ba-2de6-4388-9061-76c9ca0b705f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_d8c4a721-04f1-4a68-8899-a06a4c81a843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8fb70c92-735a-47c3-a60c-0e2d7ce563a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_ba95e9ba-2de6-4388-9061-76c9ca0b705f" xlink:to="loc_us-gaap_OperatingExpenses_8fb70c92-735a-47c3-a60c-0e2d7ce563a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d38b715a-936b-4ad2-a7c3-9e260319a492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:to="loc_us-gaap_OperatingIncomeLoss_d38b715a-936b-4ad2-a7c3-9e260319a492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_28536fa0-7df2-41f6-ac92-95aa51e3416f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_28536fa0-7df2-41f6-ac92-95aa51e3416f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3b4f2fd1-eea2-41d0-b7a7-f07bc9334864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_28536fa0-7df2-41f6-ac92-95aa51e3416f" xlink:to="loc_us-gaap_InterestExpense_3b4f2fd1-eea2-41d0-b7a7-f07bc9334864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_685cf930-4366-47be-8c00-586bf323c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_28536fa0-7df2-41f6-ac92-95aa51e3416f" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_685cf930-4366-47be-8c00-586bf323c88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ce000834-69d6-4c93-8a71-61e2848fd1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_28536fa0-7df2-41f6-ac92-95aa51e3416f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ce000834-69d6-4c93-8a71-61e2848fd1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_546c9a19-f667-45e2-af7f-d533ec6b910f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_28536fa0-7df2-41f6-ac92-95aa51e3416f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_546c9a19-f667-45e2-af7f-d533ec6b910f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fbdb4f36-77b4-4754-9444-780604025c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:to="loc_us-gaap_NetIncomeLoss_fbdb4f36-77b4-4754-9444-780604025c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_14680736-17cc-4f04-a1e0-4ab3660c901a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:to="loc_us-gaap_EarningsPerShareBasic_14680736-17cc-4f04-a1e0-4ab3660c901a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_641f4648-ca9f-4c26-b081-524b4a554f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_641f4648-ca9f-4c26-b081-524b4a554f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df9ad94a-0d09-4982-acec-7495e9111d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df9ad94a-0d09-4982-acec-7495e9111d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3af31d70-b4b7-44c6-b1cd-5b04566f05fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3af31d70-b4b7-44c6-b1cd-5b04566f05fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_218d82ff-6a4c-4b2f-885a-e31d5759fb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42f8abbe-3e2e-4b75-8582-cff19aa7e26e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_218d82ff-6a4c-4b2f-885a-e31d5759fb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4fb5ac7-d4ee-4cda-86a5-20bc2831b02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_218d82ff-6a4c-4b2f-885a-e31d5759fb2c" xlink:to="loc_us-gaap_NetIncomeLoss_e4fb5ac7-d4ee-4cda-86a5-20bc2831b02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_3b690b91-a762-46d4-9469-1ceae70544fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_218d82ff-6a4c-4b2f-885a-e31d5759fb2c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_3b690b91-a762-46d4-9469-1ceae70544fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_33df2510-7db5-433f-8640-b67ea18a899f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_3b690b91-a762-46d4-9469-1ceae70544fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_33df2510-7db5-433f-8640-b67ea18a899f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d7ed2f93-6784-405e-9453-909e303728b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_218d82ff-6a4c-4b2f-885a-e31d5759fb2c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d7ed2f93-6784-405e-9453-909e303728b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1936bb02-3bbe-4767-86a8-6343723b7edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f7665e-15c3-481e-8653-24c9db172dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1936bb02-3bbe-4767-86a8-6343723b7edf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f7665e-15c3-481e-8653-24c9db172dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2a0ba16c-230f-4d0b-9dfa-c2ba26379d91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f7665e-15c3-481e-8653-24c9db172dbc" xlink:to="loc_us-gaap_NetIncomeLoss_2a0ba16c-230f-4d0b-9dfa-c2ba26379d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f7665e-15c3-481e-8653-24c9db172dbc" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f459cd93-2f20-44e1-aa12-d594c1bbb2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:to="loc_us-gaap_ShareBasedCompensation_f459cd93-2f20-44e1-aa12-d594c1bbb2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ca46e167-089a-4785-88a3-139806f9c423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:to="loc_us-gaap_Depreciation_ca46e167-089a-4785-88a3-139806f9c423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_d23d446f-4747-41d3-bd32-005e1340e08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_d23d446f-4747-41d3-bd32-005e1340e08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_RentExpense_43051bed-beb7-4e0d-ba04-b65df7f62093" xlink:href="bdtx-20211231.xsd#bdtx_RentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:to="loc_bdtx_RentExpense_43051bed-beb7-4e0d-ba04-b65df7f62093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_66db9ea4-8b01-4183-a9e6-24d5f52c0820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_66db9ea4-8b01-4183-a9e6-24d5f52c0820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_309281c1-15e5-41d8-a5e4-8408673ad73b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_309281c1-15e5-41d8-a5e4-8408673ad73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_eab465f1-2c40-49e7-8cde-50e2c2724f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_eab465f1-2c40-49e7-8cde-50e2c2724f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0b8c63e8-4e55-4b67-b9ef-3d2bd71dcaed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e6c34bbc-60f5-4b27-9f28-b2b37361f53e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0b8c63e8-4e55-4b67-b9ef-3d2bd71dcaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_eb6cef86-5b06-4189-8ea0-fb7d1bfa8ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0b8c63e8-4e55-4b67-b9ef-3d2bd71dcaed" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_eb6cef86-5b06-4189-8ea0-fb7d1bfa8ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_f9808138-ade0-4663-947c-76a24d1b0d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0b8c63e8-4e55-4b67-b9ef-3d2bd71dcaed" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_f9808138-ade0-4663-947c-76a24d1b0d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_8c81d855-56c6-4006-8027-defa88cab164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0b8c63e8-4e55-4b67-b9ef-3d2bd71dcaed" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_8c81d855-56c6-4006-8027-defa88cab164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_65fbf53f-1e3b-4339-923f-6b4b66b05059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0b8c63e8-4e55-4b67-b9ef-3d2bd71dcaed" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_65fbf53f-1e3b-4339-923f-6b4b66b05059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities_f92cd573-f6d4-4035-8ae1-7711423785fe" xlink:href="bdtx-20211231.xsd#bdtx_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0b8c63e8-4e55-4b67-b9ef-3d2bd71dcaed" xlink:to="loc_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities_f92cd573-f6d4-4035-8ae1-7711423785fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6df67ea-183f-4044-b1b7-afaf9aadee74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7f7665e-15c3-481e-8653-24c9db172dbc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6df67ea-183f-4044-b1b7-afaf9aadee74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_10148ffe-f6a8-45eb-83b8-2cce54f7c91e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1936bb02-3bbe-4767-86a8-6343723b7edf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_10148ffe-f6a8-45eb-83b8-2cce54f7c91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_521173a4-46da-49f5-b113-8e3059ed88b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_10148ffe-f6a8-45eb-83b8-2cce54f7c91e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_521173a4-46da-49f5-b113-8e3059ed88b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_c08c101f-d7b2-4280-a3ce-3034005c1256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_10148ffe-f6a8-45eb-83b8-2cce54f7c91e" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_c08c101f-d7b2-4280-a3ce-3034005c1256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_05a0ea54-db8e-4d0c-aa80-ef04e7e148ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_10148ffe-f6a8-45eb-83b8-2cce54f7c91e" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_05a0ea54-db8e-4d0c-aa80-ef04e7e148ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de242e8e-a4f4-46ab-af47-fff24c104db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_10148ffe-f6a8-45eb-83b8-2cce54f7c91e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de242e8e-a4f4-46ab-af47-fff24c104db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_df9964fd-6402-47b2-aa6e-ab0f393465f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1936bb02-3bbe-4767-86a8-6343723b7edf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_df9964fd-6402-47b2-aa6e-ab0f393465f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ecf419c5-7ab1-4bae-b12f-6c9f2b26fbae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_df9964fd-6402-47b2-aa6e-ab0f393465f8" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ecf419c5-7ab1-4bae-b12f-6c9f2b26fbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_fb8d7ad7-ecd1-4b7e-b395-335f0a36a820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_df9964fd-6402-47b2-aa6e-ab0f393465f8" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_fb8d7ad7-ecd1-4b7e-b395-335f0a36a820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5d55f26-591a-4a0a-a1b5-b7f1eb6de45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_df9964fd-6402-47b2-aa6e-ab0f393465f8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d5d55f26-591a-4a0a-a1b5-b7f1eb6de45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_88244448-645a-4b43-9633-a0dcc4e1d893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1936bb02-3bbe-4767-86a8-6343723b7edf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_88244448-645a-4b43-9633-a0dcc4e1d893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_805ee96a-48f0-4366-8af4-c791d69fea35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1936bb02-3bbe-4767-86a8-6343723b7edf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_805ee96a-48f0-4366-8af4-c791d69fea35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_51e55cf7-502f-4f94-bf49-bff9a889c4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1936bb02-3bbe-4767-86a8-6343723b7edf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_51e55cf7-502f-4f94-bf49-bff9a889c4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f86b8655-3058-4db8-a450-d6c29a70cb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1936bb02-3bbe-4767-86a8-6343723b7edf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f86b8655-3058-4db8-a450-d6c29a70cb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9d69da44-817a-4e8c-81cc-acc96ad2ac71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f86b8655-3058-4db8-a450-d6c29a70cb6e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9d69da44-817a-4e8c-81cc-acc96ad2ac71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_b2cb38e5-8d21-4f9d-9ee4-4879a1a11f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f86b8655-3058-4db8-a450-d6c29a70cb6e" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_b2cb38e5-8d21-4f9d-9ee4-4879a1a11f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ea84aa0-309d-4c47-97c4-77d7ac5c6103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f86b8655-3058-4db8-a450-d6c29a70cb6e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ea84aa0-309d-4c47-97c4-77d7ac5c6103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_5c892335-f325-4157-967a-c43da26fe348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1936bb02-3bbe-4767-86a8-6343723b7edf" xlink:to="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_5c892335-f325-4157-967a-c43da26fe348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_d8df0082-9604-4fe5-8bb7-7979cbdec9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_5c892335-f325-4157-967a-c43da26fe348" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_d8df0082-9604-4fe5-8bb7-7979cbdec9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f1e2ac14-64d7-4a97-b5a4-72d7d6c10e77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_5c892335-f325-4157-967a-c43da26fe348" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f1e2ac14-64d7-4a97-b5a4-72d7d6c10e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_RightOfUseAssetDerecognizedTerminationOfLease_0d8fc586-11c1-4b51-ad05-6e6ce188d01a" xlink:href="bdtx-20211231.xsd#bdtx_RightOfUseAssetDerecognizedTerminationOfLease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_5c892335-f325-4157-967a-c43da26fe348" xlink:to="loc_bdtx_RightOfUseAssetDerecognizedTerminationOfLease_0d8fc586-11c1-4b51-ad05-6e6ce188d01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4fa2f43b-f015-4be1-9d4d-863bedda0962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_82ebc611-d8ff-4a80-99cd-caa59df0338c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4fa2f43b-f015-4be1-9d4d-863bedda0962" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_82ebc611-d8ff-4a80-99cd-caa59df0338c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_f22aa309-e492-4519-b559-6ecbc1b0c581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7af9be64-7791-43cb-81c8-47018183d712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_f22aa309-e492-4519-b559-6ecbc1b0c581" xlink:to="loc_us-gaap_StatementTable_7af9be64-7791-43cb-81c8-47018183d712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d8c602eb-8711-4441-8af6-446d085f5fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7af9be64-7791-43cb-81c8-47018183d712" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d8c602eb-8711-4441-8af6-446d085f5fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d8c602eb-8711-4441-8af6-446d085f5fb2" xlink:to="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2c1b5118-3072-4f57-aca6-632fd580228f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:to="loc_us-gaap_CommonStockMember_2c1b5118-3072-4f57-aca6-632fd580228f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ca00f76a-fb2d-4abd-85a2-6ba07b7eb974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ca00f76a-fb2d-4abd-85a2-6ba07b7eb974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d8d9756a-cc30-4a5c-bf82-ff4b86d697b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d8d9756a-cc30-4a5c-bf82-ff4b86d697b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5d3784c7-fab0-48d0-bc0b-8dcb4d429ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bfe67657-f3cc-4728-8f42-ffda8eee1903" xlink:to="loc_us-gaap_RetainedEarningsMember_5d3784c7-fab0-48d0-bc0b-8dcb4d429ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d71da151-00e6-4da1-a504-912f7b9df441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7af9be64-7791-43cb-81c8-47018183d712" xlink:to="loc_us-gaap_StatementLineItems_d71da151-00e6-4da1-a504-912f7b9df441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d71da151-00e6-4da1-a504-912f7b9df441" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8e401606-e777-4fbe-b9a4-1bafd56b5a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8e401606-e777-4fbe-b9a4-1bafd56b5a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1f7c5661-8ab1-4672-bf4a-d4fad21c479f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockholdersEquity_1f7c5661-8ab1-4672-bf4a-d4fad21c479f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_05cdd83a-da2a-421e-b07e-10f6c60c1736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_05cdd83a-da2a-421e-b07e-10f6c60c1736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_f6aba65e-0aea-4279-9fb3-b3fa6f6c0052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_f6aba65e-0aea-4279-9fb3-b3fa6f6c0052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6d934d18-93e9-47e3-9948-300c5aa5281f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6d934d18-93e9-47e3-9948-300c5aa5281f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_78e29f9d-d8ac-4a04-98ea-facb9bcc06c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_78e29f9d-d8ac-4a04-98ea-facb9bcc06c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_7cafcee2-db7f-4c38-8f3a-d4ebfa0d7097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_7cafcee2-db7f-4c38-8f3a-d4ebfa0d7097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_eccb7fdf-cda0-478e-afb6-7cdf6bc075bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_eccb7fdf-cda0-478e-afb6-7cdf6bc075bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b51ae476-5b2d-49a8-b3ed-233446b1469c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b51ae476-5b2d-49a8-b3ed-233446b1469c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e6f2828c-d9d7-4ee1-a7b8-63e34b40f184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e6f2828c-d9d7-4ee1-a7b8-63e34b40f184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0efd5831-1112-4a25-9a82-5224bfdb05fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0efd5831-1112-4a25-9a82-5224bfdb05fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d465dbd6-f1da-4fde-b4cf-2874c9776f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d465dbd6-f1da-4fde-b4cf-2874c9776f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9bea943c-0dd5-4e97-962e-6f40d404f328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9bea943c-0dd5-4e97-962e-6f40d404f328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4dae1b71-0bf5-49a8-ab2f-82a28decaf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4dae1b71-0bf5-49a8-ab2f-82a28decaf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_dc5f2791-c183-4c8a-a561-a7845c6e9e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_dc5f2791-c183-4c8a-a561-a7845c6e9e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_af86ede2-ac93-4165-9fa5-64c9a49fc88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_NetIncomeLoss_af86ede2-ac93-4165-9fa5-64c9a49fc88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_647e0cd9-a135-4fdc-997c-af158c9a9298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_647e0cd9-a135-4fdc-997c-af158c9a9298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_66749152-12bc-47e8-8a4d-435f9897e480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a3f9e34b-fe26-47ad-afa1-3decc7b4bc50" xlink:to="loc_us-gaap_StockholdersEquity_66749152-12bc-47e8-8a4d-435f9897e480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="bdtx-20211231.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eedb29d2-c54c-4295-a0e4-9af2337fae88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_3ebb0913-1fe3-4a65-a6cf-21a9d3d924fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eedb29d2-c54c-4295-a0e4-9af2337fae88" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_3ebb0913-1fe3-4a65-a6cf-21a9d3d924fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_70e886fd-8edd-4655-96ce-c48f47563ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_70e886fd-8edd-4655-96ce-c48f47563ee2" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3b71ddde-a195-4fdf-b64b-35b39e129515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3b71ddde-a195-4fdf-b64b-35b39e129515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0fc5a004-733f-45ce-88bc-28558c684ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3b71ddde-a195-4fdf-b64b-35b39e129515" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0fc5a004-733f-45ce-88bc-28558c684ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_40072cad-cb14-42cc-ab6f-7e9870abbf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0fc5a004-733f-45ce-88bc-28558c684ee1" xlink:to="loc_us-gaap_IPOMember_40072cad-cb14-42cc-ab6f-7e9870abbf6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OpenMarketSaleMember_abfdb2ba-fc15-400c-a602-be0040002a26" xlink:href="bdtx-20211231.xsd#bdtx_OpenMarketSaleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0fc5a004-733f-45ce-88bc-28558c684ee1" xlink:to="loc_bdtx_OpenMarketSaleMember_abfdb2ba-fc15-400c-a602-be0040002a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_77c24d00-3939-4b0e-9f84-27bbb89edb4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:to="loc_srt_RangeAxis_77c24d00-3939-4b0e-9f84-27bbb89edb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b13109f-34fa-4b6a-9fc0-642f63146447" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_77c24d00-3939-4b0e-9f84-27bbb89edb4d" xlink:to="loc_srt_RangeMember_1b13109f-34fa-4b6a-9fc0-642f63146447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_639524d4-7448-420f-9ea6-ac45f8e18daa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1b13109f-34fa-4b6a-9fc0-642f63146447" xlink:to="loc_srt_MaximumMember_639524d4-7448-420f-9ea6-ac45f8e18daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2de4e783-3827-45a9-a265-dd1307d192f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:to="loc_srt_StatementScenarioAxis_2de4e783-3827-45a9-a265-dd1307d192f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8755a90e-dd72-4a37-9765-1ea83351dec5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_2de4e783-3827-45a9-a265-dd1307d192f0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8755a90e-dd72-4a37-9765-1ea83351dec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_4907777b-9fa9-4db9-ae69-f251f55012dd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_8755a90e-dd72-4a37-9765-1ea83351dec5" xlink:to="loc_srt_ScenarioForecastMember_4907777b-9fa9-4db9-ae69-f251f55012dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ec4c629a-4201-4235-869b-31fb9dbd3c95" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_e35b775f-eeaa-4641-bd7a-6a00f8a7739e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_e35b775f-eeaa-4641-bd7a-6a00f8a7739e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bc3143a1-c378-48e4-9203-c58051970f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bc3143a1-c378-48e4-9203-c58051970f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b855ccd2-e77b-4cb7-bf30-e96a0f1aefb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b855ccd2-e77b-4cb7-bf30-e96a0f1aefb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c7cf34ed-1898-4619-a9e7-a6b64412bb98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c7cf34ed-1898-4619-a9e7-a6b64412bb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_da412318-1208-4c01-97c3-42fe12156c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_da412318-1208-4c01-97c3-42fe12156c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_661ad79f-ced5-4b4c-b3bb-12160a21ee2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e5bb6ae7-426b-4351-b6ac-bd487fd99bd4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_661ad79f-ced5-4b4c-b3bb-12160a21ee2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="bdtx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_32211831-f9b1-4c73-a004-59536b13f8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_7d14c0c4-f03e-40c1-a11f-b4780d4ead16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_32211831-f9b1-4c73-a004-59536b13f8df" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_7d14c0c4-f03e-40c1-a11f-b4780d4ead16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="bdtx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a127ccdf-a3b2-4526-8cf2-defb8e6a01b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a127ccdf-a3b2-4526-8cf2-defb8e6a01b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_d4b869cf-cd9e-444b-b0d2-70f578f99004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_d4b869cf-cd9e-444b-b0d2-70f578f99004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5c63c088-9472-44f5-a720-895474bb306f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_UseOfEstimates_5c63c088-9472-44f5-a720-895474bb306f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_f6da8dbd-c49d-44d6-bad4-9d9820584937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_f6da8dbd-c49d-44d6-bad4-9d9820584937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7020e058-6814-48af-ba1b-d8624f937afd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7020e058-6814-48af-ba1b-d8624f937afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_75f18e79-72df-4de6-b875-b68eb85ac9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_75f18e79-72df-4de6-b875-b68eb85ac9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_27a2ec61-65aa-43e0-a188-623cec5b6e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_27a2ec61-65aa-43e0-a188-623cec5b6e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b30344e2-99fe-42c5-b7b7-e5e42d9532d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b30344e2-99fe-42c5-b7b7-e5e42d9532d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_8677e591-32b2-438d-9c70-920b00355cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_8677e591-32b2-438d-9c70-920b00355cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f6dad2fd-8985-46d7-a97e-914be21e9c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f6dad2fd-8985-46d7-a97e-914be21e9c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3b4461d7-372e-49d1-8f89-84b0375ad216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3b4461d7-372e-49d1-8f89-84b0375ad216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_78bb19a6-4625-447e-94d1-0617b9a5a3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_78bb19a6-4625-447e-94d1-0617b9a5a3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_b74225b2-d4c8-4247-a837-e611cf3cefa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_b74225b2-d4c8-4247-a837-e611cf3cefa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_08fd691d-a03c-41c8-97e8-44ef7bfd48b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_08fd691d-a03c-41c8-97e8-44ef7bfd48b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_PatentCostsPolicyPolicyTextBlock_590c51ce-970f-4d7c-9d1d-fd970671abb2" xlink:href="bdtx-20211231.xsd#bdtx_PatentCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_bdtx_PatentCostsPolicyPolicyTextBlock_590c51ce-970f-4d7c-9d1d-fd970671abb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_70e63315-a0d9-4bda-bfb6-2116e9aefceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_70e63315-a0d9-4bda-bfb6-2116e9aefceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_119d1e5e-f8a3-4280-bbbd-1b246d09b730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_119d1e5e-f8a3-4280-bbbd-1b246d09b730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_7b2a8bcd-a360-47a9-ae40-888d6f456c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_7b2a8bcd-a360-47a9-ae40-888d6f456c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_f6d1ddad-f7cd-40cd-a984-08c8146ff29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_f6d1ddad-f7cd-40cd-a984-08c8146ff29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_56a166c1-6c2d-400b-a82a-9dc828c0c93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_56a166c1-6c2d-400b-a82a-9dc828c0c93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4b5d5ec2-77e7-4c9b-bec2-eb58585f3bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_63c416a4-a7c5-44ac-a1f7-c486e7e6ab8d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4b5d5ec2-77e7-4c9b-bec2-eb58585f3bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="bdtx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b82b88d0-7039-4f2d-93e8-ef6bab5107bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b53ba372-5d24-44b7-9d90-344aaa23138f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b82b88d0-7039-4f2d-93e8-ef6bab5107bd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_b53ba372-5d24-44b7-9d90-344aaa23138f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7e3fb9a9-c40a-4942-9b6f-2d588eb6272d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_f066cedc-abdf-4b35-b6f6-6e69c4263f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e3fb9a9-c40a-4942-9b6f-2d588eb6272d" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_f066cedc-abdf-4b35-b6f6-6e69c4263f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_da088fda-330d-4bca-bf81-e598200b17c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e3fb9a9-c40a-4942-9b6f-2d588eb6272d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_da088fda-330d-4bca-bf81-e598200b17c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_523a4b03-6e0b-4485-a699-c78a8786cb56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_39082011-5011-4484-9d77-cee60a2ce4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_523a4b03-6e0b-4485-a699-c78a8786cb56" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_39082011-5011-4484-9d77-cee60a2ce4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8b16a7bf-9c4b-4ee1-b87a-b161c4496041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_39082011-5011-4484-9d77-cee60a2ce4ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8b16a7bf-9c4b-4ee1-b87a-b161c4496041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8b16a7bf-9c4b-4ee1-b87a-b161c4496041" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_15f6eca1-6c42-4b91-82c2-194e13b6f7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:to="loc_us-gaap_EquipmentMember_15f6eca1-6c42-4b91-82c2-194e13b6f7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_bdc7ee44-0fc3-4a87-b644-640e04343a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_bdc7ee44-0fc3-4a87-b644-640e04343a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_e143c443-a7eb-4735-af71-ca46db81d5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c921b77-06e9-462b-82f8-a79ff14e6255" xlink:to="loc_us-gaap_OfficeEquipmentMember_e143c443-a7eb-4735-af71-ca46db81d5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d50406f-3679-4044-80bb-a14880d44915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_39082011-5011-4484-9d77-cee60a2ce4ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d50406f-3679-4044-80bb-a14880d44915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2de35663-74ba-4e20-8d43-1e60133f5125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d50406f-3679-4044-80bb-a14880d44915" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2de35663-74ba-4e20-8d43-1e60133f5125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bdtx-20211231.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_98d61ea7-f6b6-412f-998a-a1b6e5ce64e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_a123f7cc-8cd3-4512-ad28-0f8f938e21fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_98d61ea7-f6b6-412f-998a-a1b6e5ce64e9" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_a123f7cc-8cd3-4512-ad28-0f8f938e21fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bdtx-20211231.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_78097788-67d9-4e20-9356-0dcb5c0a1166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e7a5a670-6b13-4957-82a0-b83a18161fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_78097788-67d9-4e20-9356-0dcb5c0a1166" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e7a5a670-6b13-4957-82a0-b83a18161fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_85b2e607-eaa0-4d3b-b0af-688b78336676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_85b2e607-eaa0-4d3b-b0af-688b78336676" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43dc156e-c637-4df5-8185-ce0c8ab2c429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43dc156e-c637-4df5-8185-ce0c8ab2c429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_186e99e3-2cf2-4da4-bce4-ae0e7490e938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43dc156e-c637-4df5-8185-ce0c8ab2c429" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_186e99e3-2cf2-4da4-bce4-ae0e7490e938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b0f1cabb-6d82-49c9-b9b0-004189abebad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_186e99e3-2cf2-4da4-bce4-ae0e7490e938" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b0f1cabb-6d82-49c9-b9b0-004189abebad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_74527eeb-45cb-413b-acaf-7b6e436583eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_74527eeb-45cb-413b-acaf-7b6e436583eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_74527eeb-45cb-413b-acaf-7b6e436583eb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_72b6d076-4f1a-4b34-82a1-1513bb54de74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_72b6d076-4f1a-4b34-82a1-1513bb54de74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_069ac8de-979f-47da-a8e3-7605a1c6ce68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_069ac8de-979f-47da-a8e3-7605a1c6ce68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_89a04cc4-59be-48ef-944b-6744bb1bae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5565ced0-33b8-4dc1-8503-4e6ed6d7a63a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_89a04cc4-59be-48ef-944b-6744bb1bae3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_22dd88e7-ed73-44b4-9522-9a285fb6bf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:to="loc_us-gaap_FinancialInstrumentAxis_22dd88e7-ed73-44b4-9522-9a285fb6bf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_22dd88e7-ed73-44b4-9522-9a285fb6bf0a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_4a87a885-a464-479c-846e-98f6234ff48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:to="loc_us-gaap_MoneyMarketFundsMember_4a87a885-a464-479c-846e-98f6234ff48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_533b89aa-ae02-4119-8f6e-3db062318e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_533b89aa-ae02-4119-8f6e-3db062318e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_1606f4d8-b663-45ce-af0e-8d33b8c937f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_1606f4d8-b663-45ce-af0e-8d33b8c937f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_448b2650-cce2-43ee-9a67-bd79dd2c6101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f8b69cae-f7d7-450f-b0e2-be7d0185757a" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_448b2650-cce2-43ee-9a67-bd79dd2c6101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a7cfad9d-99fb-4d58-aad5-24ba624d750b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c56dc964-c654-4504-a161-0331a3482351" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a7cfad9d-99fb-4d58-aad5-24ba624d750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a7cfad9d-99fb-4d58-aad5-24ba624d750b" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2c8ffbc9-46fb-4b47-a0c2-145b51f7649f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2c8ffbc9-46fb-4b47-a0c2-145b51f7649f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_42088c8b-3eb7-48aa-b1af-0fb96c07103e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_42088c8b-3eb7-48aa-b1af-0fb96c07103e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d1d52ecc-0c4e-418b-943a-eac27692cef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_bbed620f-f630-4eb8-99fb-4498f7731435" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d1d52ecc-0c4e-418b-943a-eac27692cef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INVESTMENTS" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INVESTMENTS"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INVESTMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58559f5f-1173-4802-b08a-6119a247b37a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1c5e55e2-c6f9-408f-9910-d5cbd9906212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58559f5f-1173-4802-b08a-6119a247b37a" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1c5e55e2-c6f9-408f-9910-d5cbd9906212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSTables" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INVESTMENTSTables"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_034ddb8e-7455-4a3f-b8ee-b06cc1485d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_c4977fc1-3f11-43b4-8b61-ee8b6ee628e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_034ddb8e-7455-4a3f-b8ee-b06cc1485d52" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_c4977fc1-3f11-43b4-8b61-ee8b6ee628e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INVESTMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_eafe6ce9-be1c-4f37-a407-5d3abc9f02fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_36c72d1a-252e-49a7-9802-8173b48090de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_eafe6ce9-be1c-4f37-a407-5d3abc9f02fb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_36c72d1a-252e-49a7-9802-8173b48090de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9a7c3da0-80ae-42a3-a7f9-cf8b05ce15da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_36c72d1a-252e-49a7-9802-8173b48090de" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9a7c3da0-80ae-42a3-a7f9-cf8b05ce15da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9a7c3da0-80ae-42a3-a7f9-cf8b05ce15da" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_4073e2b8-05aa-4478-890d-a20440c5a6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_4073e2b8-05aa-4478-890d-a20440c5a6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_907fc928-5ecf-494c-9626-b046624037e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_907fc928-5ecf-494c-9626-b046624037e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_67d4eb18-41f0-408d-920b-8cca77de0a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b9533ef-cea7-49ff-b665-5c92c6a1ce33" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_67d4eb18-41f0-408d-920b-8cca77de0a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_36c72d1a-252e-49a7-9802-8173b48090de" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5035ef03-3bc3-44f0-9c00-921c96a20c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5035ef03-3bc3-44f0-9c00-921c96a20c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_830a464c-bc80-4380-995e-a9ed31f3658f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_830a464c-bc80-4380-995e-a9ed31f3658f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_111dd397-e3eb-4118-80c7-8d2b2642e521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_111dd397-e3eb-4118-80c7-8d2b2642e521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f65d8f33-be63-411a-a883-25c2eda6d1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f65d8f33-be63-411a-a883-25c2eda6d1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_f31a27e0-0bab-4d83-b645-812df54201d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0e1a25fb-c05f-43ce-b00c-2d9c7720299e" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_f31a27e0-0bab-4d83-b645-812df54201d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="bdtx-20211231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f6b705f4-fa38-4bc1-8db1-743cab3003c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c862bdb7-c41d-49c3-ade3-016aa7cd4397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f6b705f4-fa38-4bc1-8db1-743cab3003c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c862bdb7-c41d-49c3-ade3-016aa7cd4397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="bdtx-20211231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9cb07785-51c9-4050-b7a6-f9cb3ac49338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_02517acc-f2c1-4191-8948-32c354f2e568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9cb07785-51c9-4050-b7a6-f9cb3ac49338" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_02517acc-f2c1-4191-8948-32c354f2e568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_256182ec-36fe-46c3-90dc-3dfbccd9e97b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_159bb983-3694-4229-82a3-8f503a964ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_256182ec-36fe-46c3-90dc-3dfbccd9e97b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_159bb983-3694-4229-82a3-8f503a964ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79a66057-2bbc-4397-aa17-adefe307b976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_159bb983-3694-4229-82a3-8f503a964ed9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79a66057-2bbc-4397-aa17-adefe307b976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79a66057-2bbc-4397-aa17-adefe307b976" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_579d7e09-4b30-4240-b82a-f46552feb578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_EquipmentMember_579d7e09-4b30-4240-b82a-f46552feb578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_9a06b2c6-fbd1-4ff4-9532-50ba15a0904c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_9a06b2c6-fbd1-4ff4-9532-50ba15a0904c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_d0c734cf-102a-4486-814b-5a16890d04eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_OfficeEquipmentMember_d0c734cf-102a-4486-814b-5a16890d04eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4ee55982-daa9-450c-bd04-77abab92555d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4ee55982-daa9-450c-bd04-77abab92555d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_582e23e1-adf7-4d7b-bbae-4f8a8a4ebb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ad5e54be-3fd9-4b6b-80b6-2a79a5c18478" xlink:to="loc_us-gaap_ConstructionInProgressMember_582e23e1-adf7-4d7b-bbae-4f8a8a4ebb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_159bb983-3694-4229-82a3-8f503a964ed9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1ab5eb45-c59f-4cbf-8099-c938c8269bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1ab5eb45-c59f-4cbf-8099-c938c8269bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2a17ecb4-bab6-4936-9f17-7791cdbb124f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2a17ecb4-bab6-4936-9f17-7791cdbb124f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1cf5a9c0-0096-4ebf-8be7-1c127edf03e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1cf5a9c0-0096-4ebf-8be7-1c127edf03e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_543f9b60-2fd0-4ff2-83dd-daf9d6a0cea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_446bf4ce-4f59-411f-84c1-61c1ad40ba71" xlink:to="loc_us-gaap_Depreciation_543f9b60-2fd0-4ff2-83dd-daf9d6a0cea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSES" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ACCRUEDEXPENSES"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_52328ed4-18a4-4c3b-8ddc-574f312bbfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_6cca7845-504d-438f-b663-4e7a8e9ae239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_52328ed4-18a4-4c3b-8ddc-574f312bbfe4" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_6cca7845-504d-438f-b663-4e7a8e9ae239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ACCRUEDEXPENSESTables"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e3befa53-d4b8-483a-bce7-b5d12325ffb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_bf3b0ec1-2f35-4cad-96b8-9d8a5cac9476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e3befa53-d4b8-483a-bce7-b5d12325ffb4" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_bf3b0ec1-2f35-4cad-96b8-9d8a5cac9476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#ACCRUEDEXPENSESDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_f274d5d4-afba-47d9-952d-144a73cacbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_AccruedContractResearchServiceFeesCurrent_ae309e4f-e22b-4ffe-956e-4872206eb10d" xlink:href="bdtx-20211231.xsd#bdtx_AccruedContractResearchServiceFeesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f274d5d4-afba-47d9-952d-144a73cacbd0" xlink:to="loc_bdtx_AccruedContractResearchServiceFeesCurrent_ae309e4f-e22b-4ffe-956e-4872206eb10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_92f3d329-d77e-4000-bcc4-3092a09fc4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f274d5d4-afba-47d9-952d-144a73cacbd0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_92f3d329-d77e-4000-bcc4-3092a09fc4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_89dca3a9-34f9-43b3-a7cd-1a991108c6df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f274d5d4-afba-47d9-952d-144a73cacbd0" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_89dca3a9-34f9-43b3-a7cd-1a991108c6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_AccruedLegalFeesCurrent_9c3686cd-1669-4cc0-97b8-3028cb2f1d2e" xlink:href="bdtx-20211231.xsd#bdtx_AccruedLegalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f274d5d4-afba-47d9-952d-144a73cacbd0" xlink:to="loc_bdtx_AccruedLegalFeesCurrent_9c3686cd-1669-4cc0-97b8-3028cb2f1d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d4570fdf-42ca-49bf-b12e-d964aa176cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f274d5d4-afba-47d9-952d-144a73cacbd0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d4570fdf-42ca-49bf-b12e-d964aa176cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4f0f8b1e-f652-4d50-9a67-070fc9ab0a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f274d5d4-afba-47d9-952d-144a73cacbd0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4f0f8b1e-f652-4d50-9a67-070fc9ab0a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8be9aa44-18f6-4dff-b1b8-306af1436ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f274d5d4-afba-47d9-952d-144a73cacbd0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8be9aa44-18f6-4dff-b1b8-306af1436ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_47e25eaa-6d3c-47dc-9b68-ae1420d8659e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_009c4903-6d84-4715-ac30-419d1e7477cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_47e25eaa-6d3c-47dc-9b68-ae1420d8659e" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_009c4903-6d84-4715-ac30-419d1e7477cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3a8cbedb-7b87-4b96-8bf4-bc623ad804a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_7aaaeec1-5073-4a3b-9d24-322af9caf9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3a8cbedb-7b87-4b96-8bf4-bc623ad804a6" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_7aaaeec1-5073-4a3b-9d24-322af9caf9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a4cbe738-b32e-4104-b934-1609d3324653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7aaaeec1-5073-4a3b-9d24-322af9caf9f0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a4cbe738-b32e-4104-b934-1609d3324653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f9079c9c-cbd8-4940-aff7-d5715fc81527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a4cbe738-b32e-4104-b934-1609d3324653" xlink:to="loc_us-gaap_EquityComponentDomain_f9079c9c-cbd8-4940-aff7-d5715fc81527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bcf9a838-6522-44df-99ea-8494dbe0033d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f9079c9c-cbd8-4940-aff7-d5715fc81527" xlink:to="loc_us-gaap_CommonStockMember_bcf9a838-6522-44df-99ea-8494dbe0033d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7aaaeec1-5073-4a3b-9d24-322af9caf9f0" xlink:to="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_CommonStockVotingRightsNumberOfVotesPerShare_9facf043-8b59-4803-8897-ee71ce9bc345" xlink:href="bdtx-20211231.xsd#bdtx_CommonStockVotingRightsNumberOfVotesPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_bdtx_CommonStockVotingRightsNumberOfVotesPerShare_9facf043-8b59-4803-8897-ee71ce9bc345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1fc084b7-f4db-4a54-a31d-cf3b280ca8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1fc084b7-f4db-4a54-a31d-cf3b280ca8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_SharesAuthorized_0acafc85-920d-4cb8-840e-a750540718cb" xlink:href="bdtx-20211231.xsd#bdtx_SharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_bdtx_SharesAuthorized_0acafc85-920d-4cb8-840e-a750540718cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ae5b0620-6397-4e54-aef7-512e01c8823e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ae5b0620-6397-4e54-aef7-512e01c8823e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d0bdf246-717a-4087-8d80-5384812bc5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d0bdf246-717a-4087-8d80-5384812bc5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9e7be484-9e83-4309-8da3-fcfd452d702e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9e7be484-9e83-4309-8da3-fcfd452d702e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_62e785c4-daee-4776-bb34-54d1634d941d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_db050adc-cdbd-4efc-924c-99ed709e4fca" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_62e785c4-daee-4776-bb34-54d1634d941d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_559c400d-30f4-43aa-8a1f-65605d8e17ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0cea1cc0-b467-4620-99c6-233dfa69327e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_559c400d-30f4-43aa-8a1f-65605d8e17ed" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0cea1cc0-b467-4620-99c6-233dfa69327e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5f4f1bf7-5ddb-4a4d-a91f-00e908edd8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_45bf7998-87d4-4242-9e5d-c3b4ceac0d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5f4f1bf7-5ddb-4a4d-a91f-00e908edd8a7" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_45bf7998-87d4-4242-9e5d-c3b4ceac0d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_cc272267-ac07-44d0-b988-43c6a69785a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5f4f1bf7-5ddb-4a4d-a91f-00e908edd8a7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_cc272267-ac07-44d0-b988-43c6a69785a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_745c78be-e4a7-434c-8f54-8b7498c09e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5f4f1bf7-5ddb-4a4d-a91f-00e908edd8a7" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_745c78be-e4a7-434c-8f54-8b7498c09e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_673676c1-fa30-4681-9d98-c2cb22eda059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5f4f1bf7-5ddb-4a4d-a91f-00e908edd8a7" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_673676c1-fa30-4681-9d98-c2cb22eda059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69028d59-5b87-4578-9baf-ddee70a00f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_69028d59-5b87-4578-9baf-ddee70a00f11" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6c96630c-57d7-4eae-a495-e030a84dabf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:to="loc_us-gaap_AwardTypeAxis_6c96630c-57d7-4eae-a495-e030a84dabf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7e6374e-f73c-40fe-a7df-84b691f44c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6c96630c-57d7-4eae-a495-e030a84dabf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7e6374e-f73c-40fe-a7df-84b691f44c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_89ca49ee-9154-46ef-a2b8-d02ea2840fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7e6374e-f73c-40fe-a7df-84b691f44c17" xlink:to="loc_us-gaap_RestrictedStockMember_89ca49ee-9154-46ef-a2b8-d02ea2840fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_96158496-adeb-46d2-86b7-4b3bc2210a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7e6374e-f73c-40fe-a7df-84b691f44c17" xlink:to="loc_us-gaap_EmployeeStockOptionMember_96158496-adeb-46d2-86b7-4b3bc2210a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3c6ae7d8-732d-4ed5-b455-71109d0dbf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:to="loc_us-gaap_PlanNameAxis_3c6ae7d8-732d-4ed5-b455-71109d0dbf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d9ff1866-7e12-4c52-80f6-77973a473b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3c6ae7d8-732d-4ed5-b455-71109d0dbf1e" xlink:to="loc_us-gaap_PlanNameDomain_d9ff1866-7e12-4c52-80f6-77973a473b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_A2020PlanMember_b0dfe9d2-387c-4ee8-9074-59991c016eea" xlink:href="bdtx-20211231.xsd#bdtx_A2020PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d9ff1866-7e12-4c52-80f6-77973a473b3a" xlink:to="loc_bdtx_A2020PlanMember_b0dfe9d2-387c-4ee8-9074-59991c016eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_A2020EmployeeStockPurchasePlanMember_da6492f5-6760-4188-a2f3-7e67ff2e2d82" xlink:href="bdtx-20211231.xsd#bdtx_A2020EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d9ff1866-7e12-4c52-80f6-77973a473b3a" xlink:to="loc_bdtx_A2020EmployeeStockPurchasePlanMember_da6492f5-6760-4188-a2f3-7e67ff2e2d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_65b68928-884c-471e-885e-55b7c9b0dc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:to="loc_us-gaap_GranteeStatusAxis_65b68928-884c-471e-885e-55b7c9b0dc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_7b9d0455-ac6e-45d3-bd98-baecfe4c1b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_65b68928-884c-471e-885e-55b7c9b0dc9c" xlink:to="loc_us-gaap_GranteeStatusDomain_7b9d0455-ac6e-45d3-bd98-baecfe4c1b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b0c79814-533e-41d2-84e2-83cfda1b6683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_7b9d0455-ac6e-45d3-bd98-baecfe4c1b69" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b0c79814-533e-41d2-84e2-83cfda1b6683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9d9335df-f109-4863-aa3b-2e83a7c7f544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9d9335df-f109-4863-aa3b-2e83a7c7f544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_816b354b-6730-4556-b90c-fc5d3075ff84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d9335df-f109-4863-aa3b-2e83a7c7f544" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_816b354b-6730-4556-b90c-fc5d3075ff84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8a2f6b36-84b5-40b2-b04a-3e063aee0f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_816b354b-6730-4556-b90c-fc5d3075ff84" xlink:to="loc_us-gaap_SubsequentEventMember_8a2f6b36-84b5-40b2-b04a-3e063aee0f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_794b7461-56cc-44cc-b9f2-9e9e36aff43a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e4315b3e-6ebe-41d0-a506-1f73e4d98d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e4315b3e-6ebe-41d0-a506-1f73e4d98d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding_baeec161-45cd-475f-987a-8ea9fb65d769" xlink:href="bdtx-20211231.xsd#bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding_baeec161-45cd-475f-987a-8ea9fb65d769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_cbd58ef8-ed59-4ca5-8389-fc9b6c008bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_cbd58ef8-ed59-4ca5-8389-fc9b6c008bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d043c032-31c8-4ded-aa23-6fa210d35b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d043c032-31c8-4ded-aa23-6fa210d35b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ce166d1c-5bb8-44d6-bf2f-e60ad820b1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ce166d1c-5bb8-44d6-bf2f-e60ad820b1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a8457688-022f-42a5-9f24-2f6fbcbc956e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a8457688-022f-42a5-9f24-2f6fbcbc956e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_69133862-28f2-4b3b-af99-d4cd2d537ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_69133862-28f2-4b3b-af99-d4cd2d537ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2c7c4bf2-5a8b-40ab-a025-d6cbac23fc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2c7c4bf2-5a8b-40ab-a025-d6cbac23fc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_bd82584a-f591-4da8-b4be-170c1af75e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_bd82584a-f591-4da8-b4be-170c1af75e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_537f5ae5-7fc1-4f0c-9a54-deeb8955a22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_de12d7ca-433f-4baa-b275-3539056afc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_de12d7ca-433f-4baa-b275-3539056afc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3a35423b-b168-49cf-ba67-6fb35917fcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3a35423b-b168-49cf-ba67-6fb35917fcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f4993f42-65b7-4b40-b6de-2ee3c8edb2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e701b736-4c44-4d16-a6c6-78bc73e684ef" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f4993f42-65b7-4b40-b6de-2ee3c8edb2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_619cb109-90f5-4665-8c84-848ea2bda7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4adc35e5-7bd8-44c4-af6c-4e5f25718b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_619cb109-90f5-4665-8c84-848ea2bda7b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4adc35e5-7bd8-44c4-af6c-4e5f25718b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_809250bd-d432-4f60-8d02-6a6c0a53a404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_619cb109-90f5-4665-8c84-848ea2bda7b3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_809250bd-d432-4f60-8d02-6a6c0a53a404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40855dbe-dc5c-4988-94e5-5d6e3d3f9226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_619cb109-90f5-4665-8c84-848ea2bda7b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40855dbe-dc5c-4988-94e5-5d6e3d3f9226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b3cce635-7e5f-4dcb-8b60-3bde961013a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_619cb109-90f5-4665-8c84-848ea2bda7b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b3cce635-7e5f-4dcb-8b60-3bde961013a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6af80a33-4e10-4fef-8217-e480c0bff84b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc538f86-1323-49c7-9143-3602ed03429c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6af80a33-4e10-4fef-8217-e480c0bff84b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc538f86-1323-49c7-9143-3602ed03429c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_55dec9f2-1784-4729-a736-e0347e0ac21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc538f86-1323-49c7-9143-3602ed03429c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_55dec9f2-1784-4729-a736-e0347e0ac21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0d81eaec-8fbf-4d95-a90a-29d5e14a2024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc538f86-1323-49c7-9143-3602ed03429c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0d81eaec-8fbf-4d95-a90a-29d5e14a2024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_29bb2609-47aa-4063-956f-04510f991d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc538f86-1323-49c7-9143-3602ed03429c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_29bb2609-47aa-4063-956f-04510f991d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_bb2ee516-1352-4d9a-ac12-43725b3387bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc538f86-1323-49c7-9143-3602ed03429c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_bb2ee516-1352-4d9a-ac12-43725b3387bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bfd7a1b2-ce43-41ed-92c6-598ae1cf0719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc538f86-1323-49c7-9143-3602ed03429c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bfd7a1b2-ce43-41ed-92c6-598ae1cf0719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_cf11f500-2f36-4ff8-88c7-457e80e20925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6af80a33-4e10-4fef-8217-e480c0bff84b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_cf11f500-2f36-4ff8-88c7-457e80e20925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_00b8dfba-e83a-44c1-9cee-3c4074dff6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6af80a33-4e10-4fef-8217-e480c0bff84b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_00b8dfba-e83a-44c1-9cee-3c4074dff6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6b4b9734-4535-42e5-b3b0-c0d478f67828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6af80a33-4e10-4fef-8217-e480c0bff84b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6b4b9734-4535-42e5-b3b0-c0d478f67828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1de78496-c4d4-442d-95a0-ee36afd3c582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6b4b9734-4535-42e5-b3b0-c0d478f67828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1de78496-c4d4-442d-95a0-ee36afd3c582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_abe6e103-3c8a-4d78-a44b-b2ede268de8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6b4b9734-4535-42e5-b3b0-c0d478f67828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_abe6e103-3c8a-4d78-a44b-b2ede268de8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_137874b7-5bcc-4e78-8243-93bd3624f601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6b4b9734-4535-42e5-b3b0-c0d478f67828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_137874b7-5bcc-4e78-8243-93bd3624f601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_8c647c2a-0886-480d-be90-bd06b4a3071a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6b4b9734-4535-42e5-b3b0-c0d478f67828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_8c647c2a-0886-480d-be90-bd06b4a3071a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9053eea5-bc4f-431f-8bbb-1edf1c298328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6b4b9734-4535-42e5-b3b0-c0d478f67828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9053eea5-bc4f-431f-8bbb-1edf1c298328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_9b173555-3290-4d81-93be-ead7d8df3889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6af80a33-4e10-4fef-8217-e480c0bff84b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_9b173555-3290-4d81-93be-ead7d8df3889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_722c17ff-d92d-4079-ae5d-2c145c2c9bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6af80a33-4e10-4fef-8217-e480c0bff84b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_722c17ff-d92d-4079-ae5d-2c145c2c9bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b184dcbd-8a86-4353-8979-fb17ffb281e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6af80a33-4e10-4fef-8217-e480c0bff84b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b184dcbd-8a86-4353-8979-fb17ffb281e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_99dacb15-d32d-44b0-8e48-bad8ce3d7e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b184dcbd-8a86-4353-8979-fb17ffb281e3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_99dacb15-d32d-44b0-8e48-bad8ce3d7e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4aba5c5f-dfde-4485-a6b1-b6f18a275481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b184dcbd-8a86-4353-8979-fb17ffb281e3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4aba5c5f-dfde-4485-a6b1-b6f18a275481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_349b80d1-09b1-4af0-8a71-d1f50a8c39d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b184dcbd-8a86-4353-8979-fb17ffb281e3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_349b80d1-09b1-4af0-8a71-d1f50a8c39d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8bc02d5e-928e-4ac5-878e-e0611a88a6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b184dcbd-8a86-4353-8979-fb17ffb281e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8bc02d5e-928e-4ac5-878e-e0611a88a6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_a9b9a7d8-9b0b-4483-a79a-5766222b7b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b184dcbd-8a86-4353-8979-fb17ffb281e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_a9b9a7d8-9b0b-4483-a79a-5766222b7b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c4db5df8-5385-4fff-9656-eb83eac3d75f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b184dcbd-8a86-4353-8979-fb17ffb281e3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c4db5df8-5385-4fff-9656-eb83eac3d75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7bceeef1-5d1b-4708-8fdd-92f7ad92c87f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a9b652ed-b99b-4371-b025-f5dc28d797bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7bceeef1-5d1b-4708-8fdd-92f7ad92c87f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a9b652ed-b99b-4371-b025-f5dc28d797bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_947c74f6-0210-4e81-8d28-711ed68e4035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a9b652ed-b99b-4371-b025-f5dc28d797bb" xlink:to="loc_us-gaap_AwardTypeAxis_947c74f6-0210-4e81-8d28-711ed68e4035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a843ee28-30e9-4e71-997f-7d70f00b0ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_947c74f6-0210-4e81-8d28-711ed68e4035" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a843ee28-30e9-4e71-997f-7d70f00b0ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_1b4ba7f3-f382-4d63-9e31-69b87642c4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a843ee28-30e9-4e71-997f-7d70f00b0ffb" xlink:to="loc_us-gaap_RestrictedStockMember_1b4ba7f3-f382-4d63-9e31-69b87642c4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_083825c6-93f4-443e-ae01-b3763ecd19c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a9b652ed-b99b-4371-b025-f5dc28d797bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_083825c6-93f4-443e-ae01-b3763ecd19c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_083825c6-93f4-443e-ae01-b3763ecd19c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5e06805c-1586-428e-a61f-bf0591159d94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5e06805c-1586-428e-a61f-bf0591159d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ec4047c6-4c7c-47ce-9ac8-137aa50d0743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ec4047c6-4c7c-47ce-9ac8-137aa50d0743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20faca5e-0049-48c5-8841-641e8a62b079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20faca5e-0049-48c5-8841-641e8a62b079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1fbd22ac-4a44-4867-8c2b-9a471cfcd018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1fbd22ac-4a44-4867-8c2b-9a471cfcd018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40f79f77-3c33-44d5-a004-ca43a2965f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ce52d88-860a-437f-b4b4-04a3cecad071" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40f79f77-3c33-44d5-a004-ca43a2965f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_083825c6-93f4-443e-ae01-b3763ecd19c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7934e24a-72ef-490f-a4e5-b0de7e0c2653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7934e24a-72ef-490f-a4e5-b0de7e0c2653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_19e64f37-bddf-4e4d-a7d7-edd40f2b9013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_19e64f37-bddf-4e4d-a7d7-edd40f2b9013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0061a08b-72d4-4900-8d7a-f443a3740735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0061a08b-72d4-4900-8d7a-f443a3740735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_435cc1db-1135-4fc5-a94e-c485bcf1e2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_435cc1db-1135-4fc5-a94e-c485bcf1e2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_876f3f10-2b88-4d88-85e6-33bf7a6a6431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_80ca8a6d-45f3-448a-986e-fa757196506a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_876f3f10-2b88-4d88-85e6-33bf7a6a6431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39c1f3b4-f3db-462b-8d17-3213b538a780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_719624ea-baee-4034-99ff-f800cd942c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39c1f3b4-f3db-462b-8d17-3213b538a780" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_719624ea-baee-4034-99ff-f800cd942c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_54f061cc-2480-4aad-aa4c-a67b2d49f167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_719624ea-baee-4034-99ff-f800cd942c55" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_54f061cc-2480-4aad-aa4c-a67b2d49f167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eed9327c-65d4-4870-88cd-898979764703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_54f061cc-2480-4aad-aa4c-a67b2d49f167" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eed9327c-65d4-4870-88cd-898979764703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9dd514f2-1961-41e2-86a3-c0dc916d92b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eed9327c-65d4-4870-88cd-898979764703" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_9dd514f2-1961-41e2-86a3-c0dc916d92b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_07d2f8d4-f58a-4bad-8a66-6cac1fedae8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eed9327c-65d4-4870-88cd-898979764703" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_07d2f8d4-f58a-4bad-8a66-6cac1fedae8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_48249831-ea4c-4201-b294-85cc8c7575ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_719624ea-baee-4034-99ff-f800cd942c55" xlink:to="loc_us-gaap_AwardTypeAxis_48249831-ea4c-4201-b294-85cc8c7575ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_48249831-ea4c-4201-b294-85cc8c7575ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ac54e9fb-3fca-4333-b033-49294e726b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ac54e9fb-3fca-4333-b033-49294e726b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7aa2cce2-22a4-49b4-a91e-eb345666ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7aa2cce2-22a4-49b4-a91e-eb345666ea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OtherAwardTypeMember_f43a8f93-6964-45dd-af54-f77e383ce4dd" xlink:href="bdtx-20211231.xsd#bdtx_OtherAwardTypeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a103a1c1-31b0-4a6a-b66d-585c934ebf9d" xlink:to="loc_bdtx_OtherAwardTypeMember_f43a8f93-6964-45dd-af54-f77e383ce4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4d6f79d9-89b9-41fc-977e-847c88ef2f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_719624ea-baee-4034-99ff-f800cd942c55" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4d6f79d9-89b9-41fc-977e-847c88ef2f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_27803ed5-9e37-4c87-9a4c-24e90874d224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4d6f79d9-89b9-41fc-977e-847c88ef2f1d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_27803ed5-9e37-4c87-9a4c-24e90874d224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXES" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_18589386-a423-49ae-938c-8e33312fe37a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_87ab24a0-1a82-4034-9ab9-7570faeab17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_18589386-a423-49ae-938c-8e33312fe37a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_87ab24a0-1a82-4034-9ab9-7570faeab17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1594040c-0b7f-4635-bd30-4ee5c1c79915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_56211540-134e-4342-b0b0-15292b88eaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1594040c-0b7f-4635-bd30-4ee5c1c79915" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_56211540-134e-4342-b0b0-15292b88eaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_72f528fd-da82-4cf0-adb8-30f913aba0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1594040c-0b7f-4635-bd30-4ee5c1c79915" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_72f528fd-da82-4cf0-adb8-30f913aba0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d0b6af75-c2c2-47f2-a665-22d2599b4d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1594040c-0b7f-4635-bd30-4ee5c1c79915" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d0b6af75-c2c2-47f2-a665-22d2599b4d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5d90dfea-e0f9-4e74-83e5-96231969de42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_01805e0f-3050-4732-8c60-c881a2dc21ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d90dfea-e0f9-4e74-83e5-96231969de42" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_01805e0f-3050-4732-8c60-c881a2dc21ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d349ae6f-7609-49af-b644-4f0b52c2842c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d90dfea-e0f9-4e74-83e5-96231969de42" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d349ae6f-7609-49af-b644-4f0b52c2842c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_904f48f4-58e2-4a08-b86b-b519c978dd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5d90dfea-e0f9-4e74-83e5-96231969de42" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_904f48f4-58e2-4a08-b86b-b519c978dd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e5b41b5d-35e1-4fa9-a272-5c430f18cdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e5b41b5d-35e1-4fa9-a272-5c430f18cdbb" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_e0c8533e-24ba-4baa-9f64-cd11273d5cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_e0c8533e-24ba-4baa-9f64-cd11273d5cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_c1adbbf0-f182-4016-8ee6-565023089aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_e0c8533e-24ba-4baa-9f64-cd11273d5cb6" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_c1adbbf0-f182-4016-8ee6-565023089aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_f4eef26b-3667-4574-93d7-11c08a1ab66b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_c1adbbf0-f182-4016-8ee6-565023089aca" xlink:to="loc_us-gaap_ResearchMember_f4eef26b-3667-4574-93d7-11c08a1ab66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_7f102cb7-fab4-4497-8f98-cb62d320d1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_7f102cb7-fab4-4497-8f98-cb62d320d1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7f102cb7-fab4-4497-8f98-cb62d320d1fb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_bdda28f3-5f4c-43e5-9492-41610a8941ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:to="loc_us-gaap_DomesticCountryMember_bdda28f3-5f4c-43e5-9492-41610a8941ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_86817efa-6792-41a9-b4e2-842c10510025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_86817efa-6792-41a9-b4e2-842c10510025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_631cf491-bd10-4924-a847-b1845efcf59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b1758942-be94-40b5-8c0c-353c6c1f96dd" xlink:to="loc_us-gaap_ForeignCountryMember_631cf491-bd10-4924-a847-b1845efcf59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxPeriodExpirationAxis_1c0b4130-0ef3-4e09-9779-ca1ef27cba7b" xlink:href="bdtx-20211231.xsd#bdtx_TaxPeriodExpirationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:to="loc_bdtx_TaxPeriodExpirationAxis_1c0b4130-0ef3-4e09-9779-ca1ef27cba7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxPeriodExpirationDomain_76a90cde-4795-49e1-92e2-0d3269594427" xlink:href="bdtx-20211231.xsd#bdtx_TaxPeriodExpirationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdtx_TaxPeriodExpirationAxis_1c0b4130-0ef3-4e09-9779-ca1ef27cba7b" xlink:to="loc_bdtx_TaxPeriodExpirationDomain_76a90cde-4795-49e1-92e2-0d3269594427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_TaxYear2036Member_02f1d9df-7f39-404d-9f95-7d62b53260d1" xlink:href="bdtx-20211231.xsd#bdtx_TaxYear2036Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdtx_TaxPeriodExpirationDomain_76a90cde-4795-49e1-92e2-0d3269594427" xlink:to="loc_bdtx_TaxYear2036Member_02f1d9df-7f39-404d-9f95-7d62b53260d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_62bb6c7a-926b-4980-892b-9ee63733f499" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1fe1141d-b7ce-4049-8d1f-a6be09ef407b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1fe1141d-b7ce-4049-8d1f-a6be09ef407b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ac1c9a2c-ab93-476e-9e8d-1c3105e9dd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ac1c9a2c-ab93-476e-9e8d-1c3105e9dd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_2ffca974-bc64-4dcc-a75d-ee34b8fb27a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_2ffca974-bc64-4dcc-a75d-ee34b8fb27a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0c7872f7-d973-4f4f-bbc7-8113ea3b626a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0c7872f7-d973-4f4f-bbc7-8113ea3b626a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_518387b6-9207-4c21-82ef-8ca5cb99eedb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_518387b6-9207-4c21-82ef-8ca5cb99eedb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ba94b1a8-5bea-4b09-880d-2890105bd5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ba94b1a8-5bea-4b09-880d-2890105bd5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_8aa48af6-1021-4068-b20a-c7d6660c53cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b13a46b5-63e3-4b56-8a63-25968d4bbef9" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_8aa48af6-1021-4068-b20a-c7d6660c53cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bf1777b4-744e-4545-a58a-42ac5c62ddca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5407b35b-1694-4a8f-a779-c2b6752f64a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bf1777b4-744e-4545-a58a-42ac5c62ddca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5407b35b-1694-4a8f-a779-c2b6752f64a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_95bb9840-7ba7-4ea3-b8a9-4e55521c71bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bf1777b4-744e-4545-a58a-42ac5c62ddca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_95bb9840-7ba7-4ea3-b8a9-4e55521c71bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_bd1b771a-831d-45f3-81a2-743b412e3af0" xlink:href="bdtx-20211231.xsd#bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bf1777b4-744e-4545-a58a-42ac5c62ddca" xlink:to="loc_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_bd1b771a-831d-45f3-81a2-743b412e3af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_13ee2c39-5e2d-4f9d-88c9-9a13e5713a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bf1777b4-744e-4545-a58a-42ac5c62ddca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_13ee2c39-5e2d-4f9d-88c9-9a13e5713a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_aaf4aff1-45ea-4dab-911a-faf9cc1d19fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bf1777b4-744e-4545-a58a-42ac5c62ddca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_aaf4aff1-45ea-4dab-911a-faf9cc1d19fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_644e181c-778a-497d-9d86-51c29f4de734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bf1777b4-744e-4545-a58a-42ac5c62ddca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_644e181c-778a-497d-9d86-51c29f4de734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d896e6bc-3391-4fbb-887f-bc4b9a7cdb32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bf1777b4-744e-4545-a58a-42ac5c62ddca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d896e6bc-3391-4fbb-887f-bc4b9a7cdb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3e1d6ce4-7f85-40ed-840d-7270b9004269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bf1777b4-744e-4545-a58a-42ac5c62ddca" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3e1d6ce4-7f85-40ed-840d-7270b9004269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e4fc54bb-5a2e-4db6-ac69-be4a7b974dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e4fc54bb-5a2e-4db6-ac69-be4a7b974dd0" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f99bd43f-f803-42a0-9d13-8574e90cfe9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f99bd43f-f803-42a0-9d13-8574e90cfe9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_b04f6dde-e92a-4c30-9e66-6905136b2f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_b04f6dde-e92a-4c30-9e66-6905136b2f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_DeferredTaxAssetsLeasingArrangements_3b7bece2-60e7-47d4-82c7-5aee34b87ddf" xlink:href="bdtx-20211231.xsd#bdtx_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_bdtx_DeferredTaxAssetsLeasingArrangements_3b7bece2-60e7-47d4-82c7-5aee34b87ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_393cd305-f01b-4061-8c90-87321cf3870d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_393cd305-f01b-4061-8c90-87321cf3870d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d6f4812b-946e-4af9-a870-4cb83876c8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d6f4812b-946e-4af9-a870-4cb83876c8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0bbbdfbc-4dd6-43a4-8a96-65740b3268e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_0bbbdfbc-4dd6-43a4-8a96-65740b3268e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_61de57d4-a984-4f28-ad00-193487fbf485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_61de57d4-a984-4f28-ad00-193487fbf485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_ec17ddb4-a167-4649-b562-ce6705bd75e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_ec17ddb4-a167-4649-b562-ce6705bd75e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_ca195313-9ded-4266-b504-5434c2ae3ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_ca195313-9ded-4266-b504-5434c2ae3ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0dd43585-a363-4d65-b3e8-2e5ea326c9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0dd43585-a363-4d65-b3e8-2e5ea326c9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2ff04814-6b55-4107-9d78-425038081090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_43e8cc9d-6443-4ca9-ba3f-4bd2fb93a3ba" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2ff04814-6b55-4107-9d78-425038081090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARE" xlink:type="simple" xlink:href="bdtx-20211231.xsd#NETLOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7b255229-899d-41dc-b60c-d061788d1a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_28bdf804-7217-49e5-93ea-3ec547773462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7b255229-899d-41dc-b60c-d061788d1a03" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_28bdf804-7217-49e5-93ea-3ec547773462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARETables" xlink:type="simple" xlink:href="bdtx-20211231.xsd#NETLOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a51dc457-435e-412d-9786-95eb8d0c44a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_253f9124-4985-4c63-a0f3-167bd64c4925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a51dc457-435e-412d-9786-95eb8d0c44a9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_253f9124-4985-4c63-a0f3-167bd64c4925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0ee23f15-d2a8-46ea-9c65-3fc75849232f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a51dc457-435e-412d-9786-95eb8d0c44a9" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0ee23f15-d2a8-46ea-9c65-3fc75849232f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0c5ba23c-d341-495c-b404-b43e7a84cc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b61ec5e6-4485-4825-a16d-0d5ad64d40ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c5ba23c-d341-495c-b404-b43e7a84cc1e" xlink:to="loc_us-gaap_NetIncomeLoss_b61ec5e6-4485-4825-a16d-0d5ad64d40ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e61ecc6a-cf87-4948-a712-9344480def72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c5ba23c-d341-495c-b404-b43e7a84cc1e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e61ecc6a-cf87-4948-a712-9344480def72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6a9b7461-f3e5-4deb-aff5-dbf4ead9e527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c5ba23c-d341-495c-b404-b43e7a84cc1e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6a9b7461-f3e5-4deb-aff5-dbf4ead9e527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_75e93271-c171-4a9b-8c7d-d6b816665d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c5ba23c-d341-495c-b404-b43e7a84cc1e" xlink:to="loc_us-gaap_EarningsPerShareBasic_75e93271-c171-4a9b-8c7d-d6b816665d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3e5182e4-aecc-47e0-a18c-01f85e4dde0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c5ba23c-d341-495c-b404-b43e7a84cc1e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3e5182e4-aecc-47e0-a18c-01f85e4dde0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d9bf00f0-8215-42fa-8a41-4be71fdb543d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_76435de6-b18c-45ae-ae80-aaaaf0384c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d9bf00f0-8215-42fa-8a41-4be71fdb543d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_76435de6-b18c-45ae-ae80-aaaaf0384c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_17c27044-6603-4b6f-b82e-a94e9e6cd003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_76435de6-b18c-45ae-ae80-aaaaf0384c86" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_17c27044-6603-4b6f-b82e-a94e9e6cd003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_17c27044-6603-4b6f-b82e-a94e9e6cd003" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a9a32c27-87a3-4afd-b5b8-2302fe53bb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a9a32c27-87a3-4afd-b5b8-2302fe53bb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_77d51fb5-3ed3-4f9f-8baf-a7dcb8b5db2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:to="loc_us-gaap_RestrictedStockMember_77d51fb5-3ed3-4f9f-8baf-a7dcb8b5db2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_22e8baf3-3c99-4bfd-9383-6cc9598b7d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:to="loc_us-gaap_EmployeeStockMember_22e8baf3-3c99-4bfd-9383-6cc9598b7d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_3e7b8d23-0f97-4293-b7c3-0018741378cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7d8e53e2-0164-4403-b5a4-41f90e1ee9f4" xlink:to="loc_us-gaap_WarrantMember_3e7b8d23-0f97-4293-b7c3-0018741378cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e0c4588b-54c6-4bf2-b1b9-5cec9e7671f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_76435de6-b18c-45ae-ae80-aaaaf0384c86" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e0c4588b-54c6-4bf2-b1b9-5cec9e7671f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_860f0931-1350-4aa0-a8d7-41ae0f87376a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e0c4588b-54c6-4bf2-b1b9-5cec9e7671f8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_860f0931-1350-4aa0-a8d7-41ae0f87376a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASES" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8fe049be-2ff9-47b1-bebd-12b835f0c5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_d9db9be6-e652-4e31-89e8-131ff6daee61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fe049be-2ff9-47b1-bebd-12b835f0c5f8" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_d9db9be6-e652-4e31-89e8-131ff6daee61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESTables" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b35d7bd1-af46-4c9d-b44a-ff5d01be2dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_e5a79fcf-ccc8-4772-89b2-234a8fbeee26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b35d7bd1-af46-4c9d-b44a-ff5d01be2dd4" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_e5a79fcf-ccc8-4772-89b2-234a8fbeee26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_90b0a745-d320-400f-8dad-3d9024a399b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b35d7bd1-af46-4c9d-b44a-ff5d01be2dd4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_90b0a745-d320-400f-8dad-3d9024a399b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_15f02f0f-5715-48bc-832e-2ad13c63d224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_6fca8ad3-3d6b-4f4e-bfc7-4d4adc6f3818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_15f02f0f-5715-48bc-832e-2ad13c63d224" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_6fca8ad3-3d6b-4f4e-bfc7-4d4adc6f3818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_1d1a57bf-e0b9-4608-9bcb-0a140359b233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_6fca8ad3-3d6b-4f4e-bfc7-4d4adc6f3818" xlink:to="loc_us-gaap_LeaseContractualTermAxis_1d1a57bf-e0b9-4608-9bcb-0a140359b233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_1d1a57bf-e0b9-4608-9bcb-0a140359b233" xlink:to="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OperatingLeasePrincipalOfficeTwoMember_a1e2df81-d49d-428e-882a-58c759635815" xlink:href="bdtx-20211231.xsd#bdtx_OperatingLeasePrincipalOfficeTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:to="loc_bdtx_OperatingLeasePrincipalOfficeTwoMember_a1e2df81-d49d-428e-882a-58c759635815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OperatingLeasePrincipalOfficeOneMember_9cd60ce6-5205-4b42-aedb-0e4e04ff0a84" xlink:href="bdtx-20211231.xsd#bdtx_OperatingLeasePrincipalOfficeOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:to="loc_bdtx_OperatingLeasePrincipalOfficeOneMember_9cd60ce6-5205-4b42-aedb-0e4e04ff0a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember_8fb31053-5768-4c0c-9748-12425db6d0d1" xlink:href="bdtx-20211231.xsd#bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_14400092-5a38-48d7-bd41-e67cff682b38" xlink:to="loc_bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember_8fb31053-5768-4c0c-9748-12425db6d0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_6fca8ad3-3d6b-4f4e-bfc7-4d4adc6f3818" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_LesseeOperatingLeaseNumberOfContracts_2afe98cc-6cc6-4b5a-b6cc-9662615bdfc3" xlink:href="bdtx-20211231.xsd#bdtx_LesseeOperatingLeaseNumberOfContracts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_bdtx_LesseeOperatingLeaseNumberOfContracts_2afe98cc-6cc6-4b5a-b6cc-9662615bdfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e968535f-1469-42fc-8d70-f45acd584253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e968535f-1469-42fc-8d70-f45acd584253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9bb7671f-a9e1-4f71-a959-9fbc4d88cad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9bb7671f-a9e1-4f71-a959-9fbc4d88cad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_LesseeOperatingLeaseArea_0eba17cf-ef80-4d08-87fd-0795a1429841" xlink:href="bdtx-20211231.xsd#bdtx_LesseeOperatingLeaseArea"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_bdtx_LesseeOperatingLeaseArea_0eba17cf-ef80-4d08-87fd-0795a1429841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_5138ad2f-bfc3-44a0-979b-2dcc5b29a2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_5138ad2f-bfc3-44a0-979b-2dcc5b29a2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_91565371-ae20-4a85-9364-bdcccbec3dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_91565371-ae20-4a85-9364-bdcccbec3dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_0128bc7e-b6fe-4b65-ad8e-e722c958802b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_552abad6-9e4b-463a-bff2-08277907b3be" xlink:to="loc_us-gaap_OperatingLeaseExpense_0128bc7e-b6fe-4b65-ad8e-e722c958802b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_23d16cd6-9af8-4cf3-ae01-9421ea3fc63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_e3c07166-2c7c-427f-8340-17615a5cde9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_23d16cd6-9af8-4cf3-ae01-9421ea3fc63a" xlink:to="loc_us-gaap_LeaseCostAbstract_e3c07166-2c7c-427f-8340-17615a5cde9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_a32070db-b0b7-4d49-b0e9-ca56aab89254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e3c07166-2c7c-427f-8340-17615a5cde9b" xlink:to="loc_us-gaap_OperatingLeaseCost_a32070db-b0b7-4d49-b0e9-ca56aab89254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_e46c277c-a748-4599-b09c-78f3d9aa50de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e3c07166-2c7c-427f-8340-17615a5cde9b" xlink:to="loc_us-gaap_ShortTermLeaseCost_e46c277c-a748-4599-b09c-78f3d9aa50de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_8077e9ec-0c39-4fa4-88ea-c78c9f7e4e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e3c07166-2c7c-427f-8340-17615a5cde9b" xlink:to="loc_us-gaap_VariableLeaseCost_8077e9ec-0c39-4fa4-88ea-c78c9f7e4e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_96eb065d-977f-496d-90a1-28e2a93473ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e3c07166-2c7c-427f-8340-17615a5cde9b" xlink:to="loc_us-gaap_LeaseCost_96eb065d-977f-496d-90a1-28e2a93473ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bdtx_LeaseOtherInformationAbstract_7ddc5e09-1e70-435d-956d-bb9ad240f9a4" xlink:href="bdtx-20211231.xsd#bdtx_LeaseOtherInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_23d16cd6-9af8-4cf3-ae01-9421ea3fc63a" xlink:to="loc_bdtx_LeaseOtherInformationAbstract_7ddc5e09-1e70-435d-956d-bb9ad240f9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_d21267d8-ce14-4ce7-8a44-2ae8ef79b858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdtx_LeaseOtherInformationAbstract_7ddc5e09-1e70-435d-956d-bb9ad240f9a4" xlink:to="loc_us-gaap_OperatingLeasePayments_d21267d8-ce14-4ce7-8a44-2ae8ef79b858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e9dbbda5-0043-4fb9-99ee-ee81cfa2b220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdtx_LeaseOtherInformationAbstract_7ddc5e09-1e70-435d-956d-bb9ad240f9a4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e9dbbda5-0043-4fb9-99ee-ee81cfa2b220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_19d76fb3-8430-448a-8497-68dd5ac2c3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bdtx_LeaseOtherInformationAbstract_7ddc5e09-1e70-435d-956d-bb9ad240f9a4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_19d76fb3-8430-448a-8497-68dd5ac2c3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASESScheduleofFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_951a6c8e-6b54-435c-b2cd-0d31a0551d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_951a6c8e-6b54-435c-b2cd-0d31a0551d0d" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8d8a664e-7cb2-4afa-be73-91e003673131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8d8a664e-7cb2-4afa-be73-91e003673131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_21b391cc-e663-463c-a8ea-ef6318bdc8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_21b391cc-e663-463c-a8ea-ef6318bdc8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e146a39e-449c-43b5-b81c-3c8f5c1fd641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e146a39e-449c-43b5-b81c-3c8f5c1fd641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1d1e7774-1d24-4806-818c-6e87dffb6f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1d1e7774-1d24-4806-818c-6e87dffb6f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_39bfe753-3ef9-48df-ad7f-ad95a8485ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_39bfe753-3ef9-48df-ad7f-ad95a8485ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_393b9d88-09ed-420a-b722-f97171d85234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_393b9d88-09ed-420a-b722-f97171d85234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f2c1b299-7310-4d84-9af8-31b78a1fd642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f2c1b299-7310-4d84-9af8-31b78a1fd642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cac7e512-3c2e-4db5-b251-72267c2e0bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cac7e512-3c2e-4db5-b251-72267c2e0bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e1543120-8eed-458e-9400-52bfc6360aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b1061a39-0019-4291-be32-ee24b48673b5" xlink:to="loc_us-gaap_OperatingLeaseLiability_e1543120-8eed-458e-9400-52bfc6360aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="bdtx-20211231.xsd#LEASESScheduleofFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="bdtx-20211231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e57d09f2-239d-4fdf-a73c-96a10496e26d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_39c1cf31-63ac-4142-96b2-9444494dbf7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e57d09f2-239d-4fdf-a73c-96a10496e26d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_39c1cf31-63ac-4142-96b2-9444494dbf7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/BENEFITPLANS" xlink:type="simple" xlink:href="bdtx-20211231.xsd#BENEFITPLANS"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/BENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e35ddf0e-dd21-4316-bcaf-2d0086a8c899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_f8072f37-c0bf-4571-b8a0-628d54cc836a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e35ddf0e-dd21-4316-bcaf-2d0086a8c899" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_f8072f37-c0bf-4571-b8a0-628d54cc836a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/BENEFITPLANSDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#BENEFITPLANSDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/BENEFITPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f641a15c-abfb-4c91-b660-65a5d43c317a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_745cb03f-dd48-45c7-8d5a-89b265a294dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f641a15c-abfb-4c91-b660-65a5d43c317a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_745cb03f-dd48-45c7-8d5a-89b265a294dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5299549b-f22b-4cb0-bcfb-63e83590613e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f641a15c-abfb-4c91-b660-65a5d43c317a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5299549b-f22b-4cb0-bcfb-63e83590613e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_65564741-ab62-4c20-bdb9-87e344cb9841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f641a15c-abfb-4c91-b660-65a5d43c317a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_65564741-ab62-4c20-bdb9-87e344cb9841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="bdtx-20211231.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_6ed7b3dc-7788-4cab-9d42-357535c8df2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_e79fc242-a7fb-498b-a602-ed5a1bd6fe59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_6ed7b3dc-7788-4cab-9d42-357535c8df2c" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_e79fc242-a7fb-498b-a602-ed5a1bd6fe59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="simple" xlink:href="bdtx-20211231.xsd#RELATEDPARTYTRANSACTIONSDetails"/>
  <link:presentationLink xlink:role="http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_7ebbdfa7-a6c8-4d78-8d2a-862a864e88c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_c874e6b2-db96-4e91-90c5-30193ce0c5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_7ebbdfa7-a6c8-4d78-8d2a-862a864e88c3" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_c874e6b2-db96-4e91-90c5-30193ce0c5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_28b830dd-74bf-4f91-9671-ca2ca543ea14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_7ebbdfa7-a6c8-4d78-8d2a-862a864e88c3" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_28b830dd-74bf-4f91-9671-ca2ca543ea14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>bdtx-20211231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,Y
M,P  DI(  @    ,Y,P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4455O[^'3K8RS'GHJ#JQH L22QQ &614!Z;CC
M-.!R,CI7GU]?37]R9IVY_A4=%'H*U-#UPVC"VNVS ?NL?X/_ *U '6T4 AE!
M4Y!Y!'>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D)"J2Q  ZD]J221(HVD
MD8*BC))[5QNLZR^HR>7#E;=3P/[_ +F@#LDD25=T;JZ^JG-.K@M-U*;3;@21
M'*'[Z$\,*[:TNX;ZW6:!LJ>H[@^AH GHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<-];K- V5/4=P?0T 3T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!/'<PK+"P=&&014E</I.K2:;-SEX&/SI_4>]=I!/'<PK+"P=&&010!)1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT]A[UVMM;16ENL,"[47H* "VMHK2W6&!=J+T%2T44 %(RAE*L 01@@CK2T4
M<AKFAFR8W%J";<GE?[G_ -:J.FZE-IMQYD7*'[Z'HPKO&4,I5@"",$$=:Y'7
M-#-DQN+4$VY/*_W/_K4 =1:7<-];K- V5/4=P?0U/7!:;J4VFW'F1<H?OH>C
M"NVM+N&^MUF@;*GJ.X/H: )Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3SH3R"6 *^QS0!U4$\=S"LL+!T89!%25S.DVFL:;-S:EX&/SIYB_F.>M=-0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H)P"
M:** .4UFXU'49/*AL[E;=3P/*;Y_<\54L-#N[NY"2Q201CEG="./;/4UVU%
M$5M;16ENL,"[47H*EHHH **** "BBB@ HHHH **** "D90RE6 ((P01UI:*
M.2UC0)+>7S;"-I(F/W%&2A_PJ#3?[4TVX\R*SN"A^^AB;##\J[2B@!D,OG0K
M($=-P^ZZE2/J*?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%93>
M*/#Z7WV)]<TU;K=M\@W<8?/IMSG-:M !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !117"^-_'MSX<U2*PTR&WED\L/*9@QVY/ P".PS^(
MK6E2E5ERQ.?$8BGAJ?M*CT.ZHKR>Q^+.J-?PK?VED+9G D,2.&"YY(RQ%>L
MY&1R*JM0G1:Y^IGA<;1Q:;I/8***^.O'<\TOQ$U]I97=DU*X52S$E0)6  ]
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M]J^=_A;/+%\3M$\J5TWW(5]K$;@0<@^HKE/2/KBBBB@ HHHH **** "BBB@
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M ZGHVGSQ9Y6W+Q-CZDM_*O== UF#Q!X?LM6M59(KR(2JC]5SV./0T :%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;&SFN[N18H((VDED;HBJ,DGZ 5RNG?%7P7JVIPZ?8:VDES<.(XD:WE0.Q.
M64#)/O61\<==_LCX<S6L;XGU*5;=1WV_><_D,?\  J\@^"WA_P#MSXCVLTBY
M@TU3=O\ [RD!/_'B#^!H ^I:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH \R^,7_,&_[;_^TZPOASH6G:]JMW#JUOY\<< =
M1O9<'<!_"16[\8O^8-_VW_\ :=97PNU"ST_6;U[^[@M4:W 5II @)W#@9->Y
M3<E@;QW_ ."?'5U"6<6J6MIOM\*.C\1_#32?[)N+C1DDM;B&,NJ>875\#./F
MR>?K7E-M<RV=U%<V[E)8G#HP[$'(KV7Q3XZT>RT>YBL;V*[NY8RD:0-O )&,
MEAQQ]:\:M+66]O(;6W4O+,X1%'<DXK3!.HZ;]KMYF&;QP\:T5AK7ZV_#;J>N
M?%"X^U_!O5+C;M\ZVB?'IET-?/GPR./B=H)/ ^U#^1KZ$^*-N+7X.:K;AMPA
MMHD!QUPZ"OE:V$[W4:68D,\AV(L6=S%N,#'/.<8]Z^?=KZ'VT;\JON?4.O?&
MKPAH5XUK]HN-1E0X?[#&'53Z;F(!_ FKGA;XK^%_%MZME8W,MM>/_J[>[38S
M^P()4GVSFO+--_9ZUFZT3[3?:K;V5\R;DLS$7 ]F<'@_0&O*[JVN]&U:6VG#
M6]Y9S%&VG!1U.."/0CK2*/MNL;Q#XNT'PK")->U*&T+#*1G+2./9!DGZXIO@
MW67\0>"]*U2;'FW-LK2X[N!AOU!KR7Q)\'?$?BWXE:I?7-Q#9Z;-*&CNI'\Q
MF3 &%0'/'3!VBF!T<_[07A&*4K':ZM./[\<" '_OIP?TK>\.?%CPGXFO$L[.
M^:VNI#B.&[3RRY] >5)]LYKEH_V=O#PM2LNKZFT^.'4QJO\ WSM)_6O$/%?A
M^;PEXLO=&FF$KVD@VRJ,;E*AE..QPPX[4@/LRN7UOXD^$O#FK/INLZNMO>1@
M%XA#(^W(!&2JD#@@_C2_#?69]?\ ASH^HW;F2>2$I(YZLR,4)/N=N:^>OC/_
M ,E=UK_MA_Z(CI@?0GB/XB>'/#&D6FH7]X9([V,2VL<"[GF0C(8#C P1R<5'
MX+^(^B>.GN8](6ZBFME#/%<QA3M)QD;21^O>OFW0?#OB/XC:LD%B//-K;QPM
M-,VV."-%VH">W"] ,GD^M>S_  C^'.N>"-=U2;6?LS130+'$\$I8.=V3P0"/
MQ'>@#JM2^*/@W2-6ETW4-;2*[A?9(@@E8(WH6"D?K5OQ/XZ\/^$;..?6;X*T
MR[H88AODE'J%';W.!7R_\0_^2D>(/^O^7_T(UT7A/X=^(?B?=3:SJ%Z;6T9M
MIO)T+ER.-J+D9 Z=0!TI >JZ?\>?!U]=K!-]OL0QP);F!=G_ (XS$?E7?W&K
MZ=::2=4N;V".P$8D^TM(-A4]"#WSV]:^3O'O@2]\!ZU'97<Z74,\?F07"+M#
MC."".Q'ID]11HB^)_&T5AX1T^:2>UMV:2.%FQ'$">68^@SQ]>.M 'M]S\?O!
M\%T88H]2N4!QYT5NH0_]],&_2NT\->+=%\76#76A7BW"H<21D;7C/^TIY'UZ
M&O O&/P2U+PKX9DUB+4XM06W -S$L)0H"<94Y.X#(].*Q/A/KD^A_$G2_)<B
M*]F%I,G9UD.!GZ-M/X4P/K*N)UWXN^#] G:WFU+[7.IPT=FGF[?JWW?PS6SX
MVTZ^U;P1JUAI.3>7%LR1 /LW'TR>!D<<^M>/^&_V>;NY@6?Q1J0LV;_EVM0'
M8?5SP#] ?K0!U4/[0?A&20*]IJT(_O/!&1^DA-=YX>\5:+XJLC=:#?QW2*<.
MHRKQGT93@BO(/&GP(TS1_"][JF@ZC>-+90M.\5V48.BC+8*JN#@$]^E>?_"S
M6KC1?B1I#02,J7=PMI,@Z.LA"X/T)!_"@#ZVK \3>-_#_A&)6US4$AD<92!0
M7D<>H4<X]SQ5GQ1KL7AGPMJ&L3KO6TA+JA.-[=%7\6('XU\AW-SJOB[Q)YDS
M27NI:A,%49Y9F. H]!V'8"@#Z 7]H+PB;CRS;:JJYQYI@3;_ .AY_2N]\/\
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M)1Y:@X&0S@Y(^FVO2*^:?B%\8=:UC6+FQ\/WDFGZ7"[1HUNVV2?'&XL.0#V
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M\]D/SL6SA%],X//;\:ZG]HS_ )&/1O\ KT?_ -#K6_9P_P"0?K__ %U@_D]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^((JL//#S3IT]B,?2QM*4:^(>O1JW37H?1$;K+&LD;!D8!E8="#WKXX\<?\
M)0O$7_84N?\ T:U?4'P[U;^U/!]NKG,MH3;OSV'W?_'2/RKY?\<?\E"\1?\
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M!?HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%\/^!-5L;JYAAGN[*6WM[6/&]F="H^4=!SDGI7S7X'_Y*%X=_P"PI;?^C5H
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M!;0D_P!Q.6(^I('_  &D![-1113 **** "BBB@ HHHH **** "BBB@ HHHH
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MNL32NFUIV!)W8^A YYXKV;X#:9<:?\-O-N4*"]O)+B($8.S:B _B4)JEH'P
MT#3;E)]8O;C5BA!$1411D^X!)/TS^=>JQ1I#$D4*+'&BA41!@*!T '84 .HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BH[BXBM8&FG8(BCDFLC_A*
M['_GE<?]\K_C0!MT53T_4H]21GAAF1%XW2  $^W-7* "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHJGJ&IQZ:JO-#,R-QN0 @'T/- %RBL3_A*['_GE<?]\K_C6O!/
M'<PK+"P=&&010!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX4F"5)0#@E&!Q^5<3I>ERZG<87*Q*?G?T]A[UVMM;16ENL,"[47H* ):***
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ1G^+W/M0 :%H7G;;J]7]WU2,_Q>Y]JZGI1THH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%-DD2*-I)&"HHR2>U$DB11M)(P5%&23VKC=9UE]1D\J'*VZG@?W_ '- !K.L
MOJ,GE0Y6W4\#^_[FH=+TN74[C"Y6)3\[^GL/>C2]+EU.XPN5B4_._I[#WKM;
M:VBM+=88%VHO04 %M;16ENL,"[47H*EHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"D90RE6 ((P01UI:* .0US0S9,;BU!-N3RO]S_ZU4=-U*;3;CS(N4/WT/1A7
M>,H92K $$8((ZUR.N:&;)C<6H)MR>5_N?_6H ZBTNX;ZW6:!LJ>H[@^AJ>N"
MTW4IM-N/,BY0_?0]&%=M:7<-];K- V5/4=P?0T 3T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !4=Q<16L#33L$11R31<7$5K TT[!$4
M<DUQ.JZK+J<^3E(5/R)_4^] !JNJRZG/DY2%3\B?U/O4NC:,^HR>9+E;=3RW
M][V%&C:,^HR>9+E;=3RW][V%=G'&D,:QQ*%11@ =J ".-(8UCB4*BC  [4ZB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ILL231-'*H=&&"I[TZB@#
MBM8T=]-EWQY>W8_*W]WV-,TG5I--FYR\#'YT_J/>NVEB2:)HY5#HPP5/>N,U
MC1WTV7?'E[=C\K?W?8T =C!/'<PK+"P=&&014E</I.K2:;-SEX&/SI_4>]=I
M!/'<PK+"P=&&010!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4455O[^'3K
M8RS'GHJ#JQH +^_ATZV,LQYZ*@ZL:XB^OIK^Y,TYYZ*HZ*/047U]-?W)FG//
M15'11Z"MC0M"\[;=7J_N^J1G^+W/M0 :%H7G;;J]7]WU2,_Q>Y]JZGI1THH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"D90RE6 ((P01UI:* .0US0S9,;BU!-N3RO]S_ZU4=-U*;3;CS(N4/WT/1A7
M>,H92K $$8((ZUR.N:&;)C<6H)MR>5_N?_6H ZBTNX;ZW6:!LJ>H[@^AJ>N"
MTW4IM-N/,BY0_?0]&%=M:7<-];K- V5/4=P?0T 3T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0O.VW5ZO[OJD9_B]S[4 &A:%YVVZO5_=]4C/\7N?:NIZ4=** "BBB@ HHHH
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M05+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,H92K
M $$8((ZTM% '(:YH9LF-Q:@FW)Y7^Y_]:J.FZE-IMQYD7*'[Z'HPKO&4,I5@
M"",$$=:Y'7-#-DQN+4$VY/*_W/\ ZU '46EW#?6ZS0-E3U'<'T-3UP6FZE-I
MMQYD7*'[Z'HPKMK2[AOK=9H&RIZCN#Z&@">BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9',<R*<@,,'(]B"#6W7D2BXR<7N?54ZD:D%..S"BBBI+"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ ILDB11M)(P5%&23VHDD2*-I)&"HHR2>U<;K.LOJ,GE0Y6W
M4\#^_P"YH -9UE]1D\J'*VZG@?W_ '-0Z7I<NIW&%RL2GYW]/8>]&EZ7+J=Q
MA<K$I^=_3V'O7:VUM%:6ZPP+M1>@H +:VBM+=88%VHO05+110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(RAE*L 01@@C
MK2T4 <AKFAFR8W%J";<GE?[G_P!:J.FZE-IMQYD7*'[Z'HPKO&4,I5@"",$$
M=:Y'7-#-DQN+4$VY/*_W/_K4 =1:7<-];K- V5/4=P?0U/7!:;J4VFW'F1<H
M?OH>C"NVM+N&^MUF@;*GJ.X/H: )Z*** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=_6L*ST2W9@DKKN8\O(< 5V8?#2Y-58\G'9A3]K[LKI%[3?(OK2.WMHV-X7
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ML[%!(OS'EC[UYE).==M;'T.(<:6#BI/5G0VQ)7GI5^[AB@F"P7*W*E 2Z*0
M2.1SZ5H6FB0MX1N=5>20/%,L2(JC;SW-4+*PN;^8);0R2 L 2JY"_4]J]6+7
MW'S,D]^Y7R:KW!4/&6(PIYK2U2WM[/49H+.X^TQ(<++C&[CG]:SGM8Y5^<<F
MF]5H*-D]2^$M/L"R+<2?:MQ_=>7\N.QW9JO,6N"S2L79NI/.:II8NC8BGD4=
M@#FM/3+^72-0622"*=P&7;.F5/'<>M%W;5#LKZ,YV[L/)DWID?2K.GWKQN-[
MG@\&K5ZXVDL.O.!7/W$OS?N\CZ5C*T'='53O6C:1U=W,+N1W553>.@/M6-JG
MAS3-4AWWBRI<(H6.6)P,#/(((.?TK-AU&XA8,^2H]35Q/%FG7L3%&"LH"LH7
M&#T_I2<Z<U:8XT:]*7-3_ YVV\,VT.M1D!IHU/23'-=S=0Q26RK#&598\')S
MD^WZ5FV*FZE$H0K&.A(ZUL[E$+ KSD$-GI3HTU!/EZE8C%5935Y:HS+,GR0>
ME6)&/5JSK.\$TC*F#ESC'UKJ=.T&75(@PEMX$+^6C7$FP.V,X!^G\Q51DN6Y
MA4C)3U1@7UO<7]J;+38'N;N<;(H8Q\SMZ"N:N-'U/PR(TU[2+W3!(<(]Q"55
MSZ ]#7NGPO\ "_D^++^^NU0MIZ>3'M8,!(V<L".ORC'_  *O3]6TC3]=TR73
M]7M(KNTF&'BE7(/O['W'(KR,77:JV70^IRO!J6%YI=7_ , ^6--O<Q*$;(Q6
MK]I*Q%Z@^('@*[^&^MB>S$]QX?G(,5P_S>0Q_P"6;G^1/7ZT[PQ')XMU6VTK
M3$,K2,/.=1E8D_B9CV&/SKIHXF+A=LX,5E\XU5&*O<]Y^'.D/I7@VV:?/GWI
M^U2 C[NX# _!0/UKJJ1$6.-40851@#T%+7BRDY2<F?6TZ:IP4([(****DT"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "FR2)%&TDC!449)/:B21(HVDD8*BC))[5QNLZR
M^HR>5#E;=3P/[_N: #6=9?49/*ARMNIX']_W-0Z7I<NIW&%RL2GYW]/8>]&E
MZ7+J=QA<K$I^=_3V'O7:VUM%:6ZPP+M1>@H +:VBM+=88%VHO05+110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!1UNREU+0-0L;>4P2W-M)"DHZHS*0#^&:^+3>W>FWDFD7
M]K+;7\+>6\$J%6#?C7W!7D_Q[\+PWOA.+Q%:V2/?Z5,KR3)'F0P'*L"1R0"0
MWM@UO1J.$O4X\70C6A=K5'DFG6#QVH>5LMCFH[VYM[&WDFG*A4&>>Y["FVFO
M0RVBX8<BN$U[6'U/5DCW8@CDPJ@\$^M>U5K0IP7*?(X?"U*]5J>B1T.ENUU?
M">ZP\C=3CH/0>U>A:/)I\,@EU*&2>)5RL,;;=Y]SV%<-IED3$KIZ5L+)<QJ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !39)$BC:21@J*,DGM1)(D4;
M22,%11DD]JXW6=9?49/*ARMNIX']_P!S0 :SK+ZC)Y4.5MU/ _O^YJ'2]+EU
M.XPN5B4_._I[#WHTO2Y=3N,+E8E/SOZ>P]Z[6VMHK2W6&!=J+T% !;6T5I;K
M# NU%Z"I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHKQ#[$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^X,C)MXP *U/"VMIISF&8[1G()KAA43K7>Q[-7#SCA.6*U/2K@-'8$@G.*-
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M3\CT<AE^XE&_786BBBO,/H0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*/\ A'M&_P"@38_^ R?X4 ?(M.CC>618XD9W8X55&237UQ_PC^C?] FQ_P#
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M RRL6SDU]/2FIP31^<8BBZ522D5KNQGF),<F,^]5K32'+;KIB2.F36Y)'Y9
MW*V1GY3FI3=N;(6NR+8&SN\L;_\ OKK5NFF[F:K34>5'!:_/<C4H]+TN/-Q)
MR3MS@5OV6FI8Z>+>7YV89E8\[SCFI[2&&/7YFGPOF[<R!<D+W_\ U4W7)/*C
M86[;L$X/3([5BH*+<V=<JKFH4HZ>?=G+ZOHH$CO:1AHEPHQC@]<5A:=$!K"
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MKEXI+9U5AD8(^92,' [=A7344 8OACPIIOA/PZFBZ:LDELI8L;@AFD+'G=@
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M>5_N?_6JCINI3:;<>9%RA^^AZ,*[QE#*58 @C!!'6N1US0S9,;BU!-N3RO\
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MAT_,\_E0!Z7THHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'O7G5\+1ITW*]F>_@<SQ=>NH-7CU/:J***\@^I"BBB@ HHHH **** "BBB@
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M[+)82HZDGNK#J***\\]P**** "BBB@ KS[QYX\&GB32M%ES=GY9IU/\ J?\
M9'^U_+Z]#QYX\&GB32M%ES=GY9IU/^I_V1_M?R^O3R8DDDDY)ZDUZV#P?-^\
MJ;=$?,9KFO)>A0>O5]O) 2222<D]2:***]H^2.S\#^.)- F6QU%FDTYVX/4P
M$]Q[>H_'Z^R12QSPI+"ZR1N RNIR&![BOFBNS\#^.)- F6QU%FDTYVX/4P$]
MQ[>H_'Z^7C,'S_O*>_YGT659K[*U&L_=Z/M_P/R/9Z*9%+'/"DL+K)&X#*ZG
M(8'N*?7AGV6X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/H\IS/X<-47HST^BBBO(/J0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M )GT>59K[*U&L_=Z/M_P/R/9Z*9%+'/"DL+K)&X#*ZG(8'N*?7AGV6X4444
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M?OH>C"NVM+N&^MUF@;*GJ.X/H: )Z*** "BBB@ HHHH **** "BBB@ HHHH
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MS4C<^&KN&VBD;+6\^<)_ND \>U>OT4 <QX$\&0^"]%>U6;[1<3/OFEVX!/0
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M?,/WEU(/F/LOH*ZF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4ER5)4 XR <>PKU^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH)P.X]_4?C]/#QF#Y/WE/;\C[+*LU]M:C6?O='W_ .#^9V5%%%>6?1!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !01D8/(HKAO''Q7T#P
M9$8#,+_5'8QQ6<# D/\ [;=%'KW]J:3>Q,I**NV>&>+_  QIUG\3M7M=)/\
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MC[?\#\CV>BF12QSPI+"ZR1N RNIR&![BGUX9]EN%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4V21(HVDD8*BC))[422)%&
MTDC!449)/:N-UG67U&3RH<K;J>!_?]S0 :SK+ZC)Y4.5MU/ _O\ N:ATO2Y=
M3N,+E8E/SOZ>P]Z-+TN74[C"Y6)3\[^GL/>NUMK:*TMUA@7:B]!0 6UM%:6Z
MPP+M1>@J6BB@ HHHH **** "BBB@ HHK$\9Z^_A;P3J^N10"XDL+5YDB/1F
MXS[9Z^U &W17D&C^$?BKKNDVVJZA\3ETV6\B6?[);:3%*D089"[LKT! [_4]
M:[+P;X9\4:#=74GB;QK)XDCE0+%$^GI;^20>3E6.<]* .MHHHH **** /-OC
M)_S(7_8YZ=_[4KTFO-OC)_S(7_8YZ=_[4KTF@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K%
M\6:$OB'P[<6>T&<#S(#Z..GY]/QK:HJHR<)*2Z&=2G&K!PELSQ7X>:ZVA^)O
ML5T2D%XPAD5OX),X4_GQ^/M7M5>-_$W0CI?B$:C;J5@OOG)'\,H^]^?!^I/I
M7H_@[7?^$@\-6]TYS.G[J?\ WQW_ !&#^->AC(JI&->/7<\/*JDJ%2>"J;QU
M7I_6INT445YI] %%%% !1110 4444 %%%% !1110!#=VEM?VDEK?6\5S;RC;
M)#,@=''H0>#7GGB'X _#[Q SR?V.=+G?_EKILGDX^B<H/^^:])HH ^7/$O[*
M>KVJ/-X5UNWU #)%O>)Y+X] PRI/3KMKSJYT#XE_"R\:80:QHP0Y:XM78P/W
MY9"4;IT/IR*^Z** /DGPU^U%XMTL+%XAL[/6X@>7Q]GF(_WE&W_QVO7_  S^
MT;X$UY42_NIM$N6 !2]C^3)])%R,>[;:W_$WP<\"^*R9-1T"W@N"23<60^SR
M$GJ24P&/^\#7D/B?]E&9-TO@[7UD&>+;4UVD#'_/1!@G_@(^M 'T=8ZA9:I:
M+=:9=P7EN_W9K>59$;Z$$BK%?#=_X+^)?PNOGO4L]4TT1C)OM/D+1%<_Q/&2
M,''1L>XKJO"W[3WB[2&2+Q#!;:[;@\LRB"8#'0,HV_FI/O0!]=45Y3X4_:*\
M#>(S'#?74FAW;@ I?C$>>^)1\N/=MM>J1R)-$LD3J\;J&5E.0P/0@]Q0 ZBB
MB@ HHHH **** "BBB@ I&4,I5@"",$$=:6B@#D-<T,V3&XM03;D\K_<_^M5'
M3=2FTVX\R+E#]]#T85WC*&4JP!!&"".M<CKFAFR8W%J";<GE?[G_ -:@#J+2
M[AOK=9H&RIZCN#Z&IZX+3=2FTVX\R+E#]]#T85VUI=PWUNLT#94]1W!]#0!/
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1W%Q%:P--.P1%')-%
MQ<16L#33L$11R37$ZKJLNISY.4A4_(G]3[T &JZK+J<^3E(5/R)_4^]2Z-HS
MZC)YDN5MU/+?WO84:-HSZC)YDN5MU/+?WO85V<<:0QK'$H5%& !VH (XTAC6
M.)0J*, #M3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJEJ>LZ=HUOY^JWL%I'
MV:5PN?IZT 7:Q_$OB?3?"FE-?:K-M!XCC7[TK>@']>U8.I_%GPK9:;-/9ZBM
MY.B_)!&C N>PR17@/B3Q-J/BG5GOM4F+GD1Q@_+$O]T"@#3\:^/]3\8WF)G,
M%A&?W5JAX'^TWJ?Y=N^>>T_3;S5KU+33K>2XG?[J1KDUL^#_  5J?C'4?(L5
M\NW0@S7+CY8Q_4^@_P#UU]%>%/!NE>$+$P:;%F5Q^]N'Y>3\?3VH X3P9\%K
M>SV7OBLK<S8!6S0_(A_VC_$?IQ]:]7A@BMH5BMXDBC485(U"J![ 4^B@ HHH
MH **** /.OB]X/OO$NCVMUI2F6>Q+%H0>75L9Q[C%?/<L4D$S13(T<B$JRL,
M%2.Q%?9-<9XW^&^F^+X7G0+::ECY;E5^^<<!QW'OUH \H\!_%2^\,F.QU0R7
MFF X )R\(_V2>WM7T!IVI6>KZ?%?:;<)<6TR[DD0]?\  ^W:OD_7-"U#P[J<
MEAJUN89D/U5AZ@]Q6WX$\>7O@W4A@M-I\K?O[?/_ (\OH?YT ?3]%<E'\4?!
MS^7G6HE9USAHWX]B<8%=-97UIJ-LMQ87,5S"W22)PRG\10!/1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %-EB2:)HY5#HPP5/>G44 <5K&COILN^/+V['Y6_N^Q
MKF-9T:+5(,C"3J/D?^A]J]:EB2:)HY5#HPP5/>N,UC1WTV7?'E[=C\K?W?8U
M<)RA+FCN95:4*T'3J*Z9X]<6\MK.T,Z%'4X(-1UWVLZ-%JD&1A)U'R/_ $/M
M7"W%O+:SM#.A1U."#7T>&Q,:\?,^"S#+YX.?>+V?^?F1T445U'F!1110 444
M4 %%%% !1110 4^&:2"9)8':.1&#*ZG!4CN*910/8]H\#^.(]?A6QU%ECU%%
MX/03@=Q[^H_'Z=E7S1#-)!,DL#M'(C!E=3@J1W%>R^!_'$>OPK8ZBRQZBB\'
MH)P.X]_4?C]/#QF#Y/WE/;\C[+*LU]M:C6?O='W_ .#^9V5%%%>6?1!1110
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M[21VU%%%>4?3!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5\_?%SX7Q>&;";Q=X=E806\@-Q9,N=B.P!*MZ
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M+P)X5UZXT;7M=^R:A;;?-A^QSOMW*''S*A!^5@>#WH S/C)_S(7_ &.>G?\
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M8L0/8;L#V KH:* "BBB@ HHHH **** "BBB@ HHHH *1E#*58 @C!!'6EHH
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M5%& !VH (XTAC6.)0J*, #M3J** "BBB@ HHHH **** "BBB@ HHHH ****
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M0DT$<@Z>8DHQ^.>?TIRQ--/E;(IY=B)051(3Q.+6'1)XG5>%R@_NMV(KSIB
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M$HQ3ND%%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>;4M6D+1Y\J"WB<"21^Y/H!7>U&LN:2/"4JF$DX0=CS:'P\+-AY8XK5M]..
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MM));;^&<?A6S2(ZR1J\;!T8 JRG((]12U\W)N3;9]]"*A%16R"BBBD6%%%%
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M(YKW?.>E=>.IJ-3G6TM3S<FK.>'=*6\';^OR"BBBN ]H**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *1E#*58 @C!!'6EHH Y#7-#-DQN+4$VY/*_W/_K51TW4IM-N/,BY0_?0
M]&%=XRAE*L 01@@CK7(ZYH9LF-Q:@FW)Y7^Y_P#6H ZBTNX;ZW6:!LJ>H[@^
MAJ>N"TW4IM-N/,BY0_?0]&%=M:7<-];K- V5/4=P?0T 3T444 %%%% !1110
M 4444 %1W%Q%:P--.P1%')-%Q<16L#33L$11R37$ZKJLNISY.4A4_(G]3[T
M&JZK+J<^3E(5/R)_4^]2Z-HSZC)YDN5MU/+?WO84:-HSZC)YDN5MU/+?WO85
MV<<:0QK'$H5%& !VH (XTAC6.)0J*, #M3J** "BBB@ HHHH **** "BBB@
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M% %7^S+#_GRM^N?]4O\ A1_9=A_SXVW3'^I7_"K5% %7^S+#_GRM_P#OTO\
MA1_9EA_SY6_K_JE_PJU10!5_LNP_Y\;;IC_4K_A1_9EA_P ^5M_WZ7_"K5%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?;_@?D>ST4R*6.>%)8762-P&5U.0P/<4^O#/LMPHHHH **** "BBB@ HHHH
M**** "FR2)%&TDC!449)/:B21(HVDD8*BC))[5QNLZR^HR>5#E;=3P/[_N:
M#6=9?49/*ARMNIX']_W-0Z7I<NIW&%RL2GYW]/8>]&EZ7+J=QA<K$I^=_3V'
MO7:VUM%:6ZPP+M1>@H +:VBM+=88%VHO05+110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'S?\8]0^V_$:YB#96TBCA'MQN/ZM5KX)::MYXZ:ZD4$6
M5NTBY[,<*/T)KEO&UQ]K\=:S-U#7D@'.> Q']*],^ -M^ZUJZ(Y+11@_]]$_
MTH ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH *^5/'FFKI/CO5K2,8C
M6X+H/0-\P'ZU]5U\Z_&NW\GXAO(!CS[:-\^N,K_2@#?^ =\1>:O8$G#1I,HS
MZ$@_S%>UU\[_  2N/)^(/EG_ );6DB#\,-_2OHB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *;+$DT31RJ'1A@J>].HH XK6-'?39=\>7MV/RM
M_=]C7,:SHT6J09&$G4?(_P#0^U>M2Q)-$T<JAT88*GO7&:QH[Z;+OCR]NQ^5
MO[OL:N$Y0ES1W,JM*%:#IU%=,\>N+>6UG:&="CJ<$&HZ[[6=&BU2#(PDZCY'
M_H?:N%N+>6UG:&="CJ<$&OH\-B8UX^9\%F&7SP<^\7L_\_,CHHHKJ/,"BBB@
M HHHH **** "BBB@ I\,TD$R2P.T<B,&5U."I'<4RB@>Q[1X'\<1Z_"MCJ++
M'J*+P>@G [CW]1^/T[*OFB&:2"9)8':.1&#*ZG!4CN*]E\#^.(]?A6QU%ECU
M%%X/03@=Q[^H_'Z>'C,'R?O*>WY'V659K[:U&L_>Z/O_ ,'\SLJ***\L^B"B
MBB@ HHHH ***JW]_#IUL99CST5!U8T %_?PZ=;&68\]%0=6-<1?7TU_<F:<\
M]%4=%'H*+Z^FO[DS3GGHJCHH]!6QH6A>=MNKU?W?5(S_ !>Y]J #0M"\[;=7
MJ_N^J1G^+W/M74]*.E% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M****S-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>-?%SXAW=K?R>'M%F:#RU'VF>,D-DC.T'MQ7LM?*7CD2KX\UH3_?\
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M] '3NO\ S[+_ (4?\(9X:_Z .G_^ R_X5MT4 8G_  AGAK_H Z?T_P"?9?\
M"C_A#/#7_0!T[K_S[+_A6W10!Q_B7X;:'K.@SV=A86EA=,,PSQ0A=K#IG'..
MU?.NNZ#J'AS5'L-6@\F=1D<Y##U![BOKJOG3XTW/G_$22,-D06T:8]#@M_[-
M0!PUE8W6HWD=K8027$\APD<:Y)-?17PQ\!MX/TN6>_P=2NP/-"G(C4=%'K[F
MO,O@C;>=\0#+CB"TD;/H20O]:^AZ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHKG]=UWR=UK9-^\Z/(/X?8>] !KNN^3NM;)OWG1Y!_#[#WKD
M;FYBM+=Y[APB*,DFBYN8K2W>>X<(BC))KA-7U>75;C)RD*GY(_3W/O77AL-*
MO+R/,S#,(8.'>3V7ZOR#5]7EU6XR<I"I^2/T]S[UG445]'"$81Y8['P56K.M
M-SF[MA1115&04444 %%%% !1110 4444 %%%=SX$\"-K,B:EJR%;!3F.,\&<
M_P#Q/\ZSJU8TH\TCHP^'J8FHJ=-:AX$\"-K,B:EJR%;!3F.,\&<__$_SKV!$
M6.-4C4*BC"JHP /2A$6.-4C4*BC"JHP /2EKYNO7E7E=GW^"P5/!T^6._5]P
MHHHKG.X**** "BBB@ HHHH Q-<T,7:FYM%Q./O*/X_\ Z]<I'));S!XRT<B'
M@]"#7HU8FN:&+M3<VBXG'WE'\?\ ]>@"?1]834HMDF$N%'S+_>]Q6I7G,<DE
MO,'C+1R(>#T(-=EH^L)J46R3"7"CYE_O>XH U**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *B2[MY;AX(YXGFC^_&K@LOU'45QWQ8U;5-&\$FZT>8P$W$<
M<\J'YUC;(^7T.XJ,^A-<5\.+5U\6:28I2 8III>?F?@C!/?G!KIIT.>G*=]C
MS\1C/95X45&_,>UT5Y_\7/%\GAKPY!;6%PL5[J,_D;@WSQQ[268>G0#/;->=
MZ;X@U+2([:[TR_=9,GS(6E+(_P#O)TYS_P#JJZ&%E6BY)F6,S*GA*D835[GL
MOC3Q)_PBOAN34$C66<R)##&YP&=CCGZ#)_"N-T[XJW=G=(OB>UBBMF7)FB1E
M90>AQDY'TKS[Q]XWU+Q+<:='?"*&&V<R+!!G#/C&YL^@R!]36/)?2:P"KJYB
M@ W,YYP.PKLH82*@XU5J>3C,SJ.K&>'E[B_$]F?XOV$E^JV.G3W%D2!YY.QG
M]U0C^9&:[K3=2M=6T^.\L9/,AD'!Q@@]P1V(KY4DU2>\UZRTK1=J&YN(X$EE
M/$>Y@N3CKC-?37A'PX/"WA^/3S=->2[VDEG9=N]CZ#L. /PKEQ5.C32C#<]'
M+:^+KR<ZMN5[=U_7F;=%%%<)[044F]=VW<-V,XSS2T %%12W5O!(D<T\<;R'
M"*[@%OH.]2T!<**** .1\0?$C1/#FNC2[TR-,B+),RXVQ*W3.3R>^!VK$USQ
M]J=Z\LOA4(FF6R9DOI8_]8WHN[_#)^E>7_&W3XX/BU),MT2MW:P2RP\Y##*@
M>X(4&IXM4LQ:6<<UI<^7"#OC5R/,)/49!"\<5ZN%H4YI2:/FLSQM>E)TX/?M
MNOF>R> /%-SXCL;F/4=K75JRY=5V[U;.#CUR#^E=5)/#$Z)+*B/(<(K, 6/M
MZUX%8^)KVRU:6]T)%L'F7:($7<N.PP<YK)EU:]U359KG6+B2XO7("2.<; #T
M Z ?3%54P+E4NG9,SH9TH8=*2<I+\3Z7HKPOPWKVI>%_$4(O);A;1Y +F*4E
MAM/5L'TSG(KH_BK\3_\ A&O#>GW?AV^MW^UW/E/,I5VC&TD?*>F2.I'&/>N*
MKAI4Y)/9]3U\+F-/$4W)*S73J>HT5YEX!^*+:YJ%II.K/#+<W2$Q3PC&2!G#
M#IT'45Z;6-2G*G+ED==#$0Q$.> 4445F;A1110 4444 %%%% !1110 4444
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MU/R-O^EZ;I7G02;E#?*^X9QG!XZ@B@#,^,G_ #(7_8YZ=_[4KTFO"?'/C_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !117/Z[KOD[K6R;]YT>0?P^
MP]Z #7==\G=:V3?O.CR#^'V'O7(W-S%:6[SW#A$49)-%S<Q6EN\]PX1%&237
M":OJ\NJW&3E(5/R1^GN?>NO#8:5>7D>9F&80P<.\GLOU?D&KZO+JMQDY2%3\
MD?I[GWK.HHKZ.$(PCRQV/@JM6=:;G-W;"BBBJ,@HHHH **** "BBB@ HHHH
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M.(ONZYV"M2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M DG '4F@ ) !). .I-<EKFN&[+6UHV(!PS#^/_ZU&N:X;LM;6C8@'#,/X_\
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M .*I/^%5^#?^@*G_ ']D_P#BJZ^B@#D?^%5^#?\ H"Q_]_9/_BJ/^%6>#/\
MH"1]?^>LG_Q5==10!R'_  JOP;_T!4Z?\]9/_BJ/^%5^#?\ H"Q_]_9/_BJZ
M^N!\>?%&P\+HUEIQ2\U,C[@.4A]V/K[?_6R 9'C71/AYX,T[S+G1HI;R4'[/
M:B:3+^Y^;A?>O"Y7$DSNJ! S$A5Z+[5;U;5[[7-2EO\ 5+AI[B4\LQZ#L!Z
M>E=3\/OAU=>,;OS[DO;:7$W[R8#ES_=7/?W[4 <378> ? =[XMU:)Y(7CTR-
M@T\[# 8#^%?4GIQTKWR#P+X6MQ'Y>@V&8@ K- &/'0DGJ?<]:W(HHX(EBAC6
M.-1A508 'H!0 L:+%&L<:A54 * . *=110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8 'I0B+'&J1J%11A548 'I2U\W7KRKRNS[_!8*G@Z?+'?J^X4445SG<%%%%
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M;I3<'T._#5XXBC&K'J>;?\)M\3O^B1_^7+;?_$T?\)M\3O\ HD?_ )<MM_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDU+Q&CVUB.4@/#S?7T'ZU[K9V=MI]G':V4*001#"1HN !4U% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%<_KNN^3NM;)OWG1Y!_#[#WH -=UWR=UK9-^\Z
M/(/X?8>]<C<W,5I;O/<.$11DDU:M[>6[N%B@4N['@5LZMX$M=4T'[*TA2\4[
MTGYP&QT(_N_K5TU%R2GL95G4C3;IJ\NAY#J^KRZK<9.4A4_)'Z>Y]ZSJM:EI
MMUI&H2V5_$8IHS@@]_<'N/>JM?54XQC%*&Q^:UYU*E1RJ_%U"BBBK,0HHHH
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M)J46R3"7"CYE_O>XK4KSF.22WF#QEHY$/!Z$&NRT?6$U*+9)A+A1\R_WO<4
M:E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7S;\7/&<B_%N;1KZ?_0+6.)(UW?+&S(&+$>IW8SZ"OH^9VC@D
M>-#(ZJ2J _>..E?"WB[4[WQ%XTU"_P!=VPWES/\ O4*E1'C"A<'G@ #GTK>A
M)QGS(X\9"-2DZ<NIZ%9-:27EP]E*LK8^]G) [?A7#7/A?7M9U@^<RS32R >8
M&SGL,?X4NJZ/!H>F0WNES2)<!E#,KGY@>:W+?Q]&NEV\>E:;,]Y'_K&0$$_C
M_A7K3E"I[E72W8^7I0JT?WF&]Z^FJVL<]K.B7?AU5GB^>+.UC5O3-?NS8);V
MS,ZDY8,.GUK6C\:VFOVD6F75L+=\D8*@ALG.<]S_ (5H:W%9:3IH86Q\Q@$B
M51RQQ2C3C=SIRT'.O.T:6(I^]<HW_C:"VL%BEF:6XC7"Q*3P?;T%<N_C.]>]
M26ZBW0A@2F<\5:B!A\R2]T8M#*-LDN 6 /IWJE866BSW4J7=ZZA3\BL N1]:
MRJ5*LFK.QTT:&&IQ;<+_ (_=;8Z[3?%\&I3L88Q&&'RQYZ>]6)[^5+P,TB^3
M(/7H:Y^_TC3](TE[JV[C"N#DY[5RHO)&.9)I3D_-\YZ5K*O.%HSW,Z&74\3.
M]'1;:G>75C+/KD;6E\\<6S<ZQ]?IFL>UU>:P\5SVU^P"$A$'88Z<^^:=X-F>
M'5+N YDC8!E8DG]?I5CQIH?VB2.]M$S-]V10?R(K=X>M*C[>G'9GN4^',Q46
MY4^:G\-U;==;;V\SMKU6GCL)WV%2N %Q\HZ<U+;_ -E#3]>@UI@J2:1-]G<]
MI@59<>^1Q7%Z/KU]80QVFKJ)=Z[4)X/2M6_ACNK5(;B5P93CCMWKK^J5,30E
MRZ/L]"LKX/S2<O;I17*[6;L_7;\VB]X)OK&P\.V_G1+<RF7<$R<XR<C _#FL
MW6++P^]X#-;K'),_'EL4Y-7-.@CTR"2ULHU,;]9'4%L^Q/3\*R=?TYKZU"0(
MQNT<O&5/+<UIBL"\/A5)J[5O0]3..$EE6#6+=23G*5I6TBDT_GH[*]_D8?B+
M0VT*\5E;S+289BDSG!_NGWKG;K#J3MXKKM2A\176@@:A ODP,&957+^FX^W-
M3Z1H?AV\\!:YJ&JZFUGJ]KM^QVDFU!<*2/NYY8_>&!C''/-?.XBFXNZ329YN
M%PV(5!5*JOV?==SAH[.29?W<3N>N56D5999@NTNQ&  /3Z5WEK##'!&)28XM
MOR]JY/5)A8:Z\UH 5C<@#'7C!I3I*"3;..EB)59N-C6\$WUUIMU,#$S6\G7/
M0&N[80:F\>1N1!NQ[UA>"8DNM'>YFVDR2L<>E4_$7B8Z5JOV>Q3<4 +8X%>A
M2DJ5%.3T/!Q$)8K%RC35I(['4=.P(8G6,HV#E&#8&,]JBO\ P]IE[(GGQ+.+
M=/O1L0 /0],\US6A>)+[66F$;B%%B_?LXX'L/4UEQR:S'J#QVTDK6K-@'U6K
ME7@TG:Z9G3P=:,G'GY7$WI;*ZN-]K8,+*P8$(%'S>U<9J$0L'5D5DN$;!ZY.
M.N:] L!<--&\J[8QT!/4U0U>V_X2KQYIFD[,B22*W(@4!F#-\QZ=0.]<F)BN
M3G/3P%27M?96NG_6O<YD:'/K16Y6\@83*#\S'<OMBM?1O!EXEPD2W;W#2.$C
MMD<@2,3@#\S7T9+\"? K:3#96^G36LL)W+>0SL)R?4L<AOH1CTQ6KX=^%GA?
MPSJ,>H65M//>QCY9[J=I"#ZA?N@_05RQKTTKN.IZ4\'7D^537+Z%?X=?#I/!
ML#W=_,EWJDZ!7=%PD*_W$SSUZGO@<"NYHHKDE)R=V>I3IQIQY8*R"BBBI+"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M"0 23@#J30 $@ DG '4FN2US7#=EK:T;$ X9A_'_ /6HUS7#=EK:T;$ X9A_
M'_\ 6K-L+";4;D10CCJSGHHH RM1U&'3+4S3G)Z(@ZL?2N"O[^?4;HS7#9/1
M5'11Z"NI\?\ AF_TK4/MC.US8R?+')C_ %1_ND=OKWKC:^@P-&$8<ZU;/A\X
MQE:I5=&2Y8KIW\_\@HHHKT#P@HHHH **** "BBB@ HHHH ***TM"T*\\0ZFE
MG8)DGEY#]V-?4FE*2BKLN$)3DHQ5VPT+0KSQ#J:6=@F2>7D/W8U]2:]S\/>'
MK/PYIBVEDN2>992/FD;U/]!VH\/>'K/PYIBVEDN2>992/FD;U/\ 0=JU:^>Q
M6*=9\L?A/NLMRV.$CSSUF_P\D%%%%<)[ 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !5/4M-AU*W\N7AQ]QQU4U<HH \]N[
M2:QN&AG7##H>Q'J*W-"UW;MM+UN.D<A[>QK:U+38=2M_+EX<?<<=5-<3=VDU
MC<-#.N&'0]B/44 >A45S.A:[MVVEZW'2.0]O8UTU !1110 4444 %%%% !11
M10 4444 %%%% !1110!YM\9/^9"_['/3O_:E>DUYM\9/^9"_['/3O_:E>DT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% %:?3;&YO[6^N;.WFN[/?]FN)(E:2#>,-L8C*Y'!QU%6:** "BBB
M@ HHHH **** "BBB@ HHHH *@O;.'4+&>SNEWPSH4<>Q'\ZGHIIM.Z$TFK,\
M&0WG@7QIS\SVLF#QQ+&?\0?P/TKW.SO(+^RAN[1Q)#,@=&'<&N.^)7AC^UM*
M&IV:9N[-27 ZR1]2/J.OYU@_#'Q4+6;^PKY\13-FU8_PN>J?CU'O]:]2LOK-
M%58_$MSYO"R>7XMX:?P2UC_7X?<>JT445Y1]*%%%% !1110 4444 %%%% !1
M110!6GTVQN;^UOKFSMYKNSW_ &:XDB5I(-XPVQB,KD<''459HHH **** "BB
MB@ HHHH **** "BBL;6];6Q4P6Q#7!')_N?_ %Z #6];6Q4P6Q#7!')_N?\
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MSZG&,?7TKZ?Z=* *VGZ;9Z59I:Z;;1VT"=$C7 JS110 4444 %%%% !1110
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M2BV282X4?,O][W% &I1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !7C/Q!\+-H.K#4=/0I97#[E*?\
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M;-AKAAR?[GL*U:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "L_5M)CU*'LDZCY'_H?:M"B@#SJ:&6UG:*92DB'
MD5T^A:[]I"VMXV)NB.?X_8^_\ZO:MI,>I0]DG4?(_P#0^U<5-#+:SM%,I21#
MR* /1:*P="UW[2%M;QL3=$<_Q^Q]_P"=;U !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(S!5)8@
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MS[_!8*G@Z?+'?J^X4445SG<%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 8FN:&+M3<VBXG'WE'
M\?\ ]>N4CDDMY@\9:.1#P>A!KT:L37-#%VIN;1<3C[RC^/\ ^O0!/H^L)J46
MR3"7"CYE_O>XK4KSF.22WF#QEHY$/!Z$&NRT?6$U*+9)A+A1\R_WO<4 :E%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %</HMU\-O#VL7[:%/HUG?R/LNC ZALYSCV&>PXS6+X]^,6GZ-9ZAI^CQ/<W
MZ*\/G$A8XG^Z3ZG!_,CK7@F@V\FGW3&Y7S8F&0?4UUT</*;][1'F8K'PHP;A
M9M'TAKGQ>\,V$5[;:=?K=ZE'$QMXEC<I+)T W 8QGJ:\JU?4KSQ#>1WNMRK<
MSI'L4F-0%4\D# Z9JO!%I]S"\L<,-I+&-R *6,ASTSV/>JEP?,G6)7^JBO7H
M86%'7=GRV-S*KB[1^%=3+F2276D@MBWDJ,MCHM;M[X%TK3!%J$,MO=/=#*,H
M^;)'S9'8@\<^M=!ING:+)IEVIQ9QB5-E[-R?= @ZGN:S[S39;.Z6;2;I;NW6
M0!+A!M^;KC!Y!K913>IQNK)1]UV^?YG/O<C27,,BG.>F,$4Z\UZ>8,Y<NSC#
M,YR>.E:+Z1%=&[^US*D\2[P&.=YSR 1W[U0CTU Y\S#+V%5:6R(4J=KRW*6E
MV<JV\L^QBCN6SUP":==HK6,T@BF>1%W*B)G<*OW9=+5DM>'QC.*Y!M8U2PNF
MA9]K.-HP,GFNO^T*E&FJ=M/0_0<OXVS:&'CAX*#C%65T[V^\S/M6LZAHLTR1
MB"RW<G&68#K5V/Q';C1HXK7,MP#@H@Z#U/I75WJR:SI4D%C:-9P[ COS\HZ$
MC/<U'!X6LM)T-(T>.0LF]W!RQ^N.GTKGCB*\'>+O=6;?Z&U/CBM2BVX^^]-[
MZ='Y'F5_+=:C+YEQ)QGY8^P%11+=V+%K:1X]W4I71:UHTFFZI+#Y9\O<3"^"
M0R]L&K>G>')+VW=YYEM77E1*."/?TKP_WTJC=_>,WF\E;$2EOUZ_@5/"UYYF
MK(-5N',QXA\P<?G78:S;22VA@C0-,Y 3T^M<A)X8U2XN1%:1+*RM\KQN.OK5
M\W/B;1G1-0$<,:G:9GCW;3COSQ^->[@\<X8>5*K%^O\ F?79=Q)2E@:M&;7/
M9V>_32^MRQ=63Z7);:?-<)/;#"[%D^>/(R1CW/?WKH=-2SWHJVB,J$84C'%<
MOH?V21&NYY#+.S'+/P1S726,RR3H8 Q0C.X#C\ZXL/&*U74_(LRJU*D_>;;7
MR5_0T]4TH6=BU_>K#$T4C1?O$#,I4 GJ.@R*S])U*ZEL#>,J3PR#Y#G#X'?
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M6/PGW66Y;'"1YYZS?X>2"BBBN$]@**** "BBB@ HHHH **** "BBB@ HHHH
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M<G^Y["M6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;1[O,5E^ZI&,<\'.>G:L<32HPA>6YU9?B<56JVA:WFOR/=:***\8^N"BBB@
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MW86=_'Y=]:PW*?W98PP_6K%% &3_ ,(KX?\ ^@)I_I_Q[)_A2_\ "+:!_P!
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MM$?\#Q]"* /3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***Y_7==\G=:V3?O.CR#^'V'O0 :[KOD[K6R;]YT>0?P
M^P]ZYNWMY;NX6*!2[L>!1;V\MW<+% I=V/ KM=*TJ+3(,##S,/G?U]A[4 &E
M:5%ID&!AYF'SOZ^P]JOT44 %%%% !1110 4444 %%%% !1110 4444 9.M>&
MM+U][=]3M_,:W;<K X)']T^JGTK51%CC5(U"HHPJJ, #TI:*IRDTDWHB%3A&
M3DEJ]PHHHJ2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q-<T,7:
MFYM%Q./O*/X__KURD<DEO,'C+1R(>#T(->C5B:YH8NU-S:+B<?>4?Q__ %Z
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MXI^*M5\/?\)/+X/CT_2=:MM3?^SFNA*WE,<@;P0?E9N..<<BO6Z** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHK&UO6UL5,%L0UP1R?[G_UZ #6];%BI@MB&
MN".3_<_^O7)*LEQ, H:21S]230JR7$P"AI)'/U)-=CHVC)IT?FS8:X8<G^Y[
M"@ T;1DTZ/S9L-<,.3_<]A6K110 4444 %%%% !1110 4444 %%%% !1110
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M=MXBT*UU2R/[JX3.W.=IZ%3[@T :-%%% !1110 4444 %%%% !1110 4444
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ME%LDPEPH^9?[WN* -2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;MM+UN.D<A[>QKIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOX[[UQ_6O?:X7X7>!Y/".BR3:BJ#4KS!E Y\I1T3/ZGW^E=U0!Y_\9Y+Z/P
M_P!A+K$TZ+<E,_ZOG@^V=M?.E?9$T,=Q"\,\:RQ2*5='7(8'J".]<XWPY\(N
MQ9M!M,GK@$?UH ^6J*^I/^%;^$/^@#:]<]#_ (T?\*W\(?\ 0!M?R/\ C0!\
MMT5]2?\ "M_"'_0!M>F.A_QH_P"%;^$/^@#:]<]#_C0!\MT5]2?\*W\(?] &
MU_(_XT?\*W\(?] &UZ8Z'_&@#Y;HKZD_X5OX0_Z -KUST/\ C1_PK?PA_P!
M&U_(_P"- 'RW17U)_P *W\(?] &U_(_XT?\ "M_"'_0!M>N>A_QH ^6Z*]F^
M)?PJ1+>/4_"-BJ+$N+BTBSDCKO&>ON*\:=&C<I(I5E."K#!!H 2OH3X'M*?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*** "BBB@ HHHH ***"0 23@#J30 $@ DG '4FN2US7#=EK:T;$ X9A_'_\
M6HUS7#=EK:T;$ X9A_'_ /6K-L+";4;D10CCJSGHHH +"PFU&Y$4(XZLYZ**
M[>QL8;"V$, XZLQZL?4T6-C#86PA@''5F/5CZFK% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 53U+38=2M_+EX<?<<=5-7** //;NTFL;A
MH9UPPZ'L1ZBMS0M=V[;2];CI'(>WL:VM2TV'4K?RY>''W''537$W=I-8W#0S
MKAAT/8CU% 'H5%<SH6N[=MI>MQTCD/;V-=-0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !112!@20""1UH 6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHK&UO6Q8J8+8AK@CD_W/_KT &MZV+%3!;$-<$<G^Y_\
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MC6X06[*\MWDJ(AG]3UXKBM,N8TFC+W&1CE0U>P_#C4;);%]-AA6*5F:8./\
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M5OY<O#C[CCJIKB;NTFL;AH9UPPZ'L1ZB@#T*BN9T+7=NVTO6XZ1R'M[&NFH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]OSS775\KB*W/-VT1X6#P?U>FHU-9*X4445S'H!1110 4444 %%%% !1110
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ME$5Y%+$\3PL5##<K@'!!R#T///!J71-;T_Q%I$.J:-/]ILI]WE3>6R!\,5)
M8 D9!P>AZC(H OT5A:AXST73M4FTYY;NZO+<*9X=/T^XO&@W#*^9Y*-L)'(#
M8)'(XK6L;ZUU*QAO=/N([FUG0/%-$P974]"".M $]%%% !161K?B2ST&^TBT
MO(YWDU>\%G 8E!"OL9LMDC PIZ9^E3:-KVFZ_%=2:1<_:$M+J2SG/ELNR:,X
M=?F S@]QQZ&@#1HK(F\26<'C&U\-O'.;RZLY+Q) H\L(C*I!.<YRP[?C6O0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%8VMZV+%3!;$-<$<G^Y_]
M>@ UO6Q8J8+8AK@CD_W/_KUR2K)<3 *&DD<_4DT*LEQ, H:21S]2378Z-HR:
M='YLV&N&')_N>PH -&T9-.C\V;#7##D_W/85JT44 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?P^P]ZYNWMY;NX6*!2[L>!1;V\MW<+% I=V/ KM=*TJ+3(,##S,/G?U]A[4
M&E:5%ID&!AYF'SOZ^P]JOT44 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:C<B*$<=6<]%%=O8V,-A;"& <=68]6/J:+&QAL+80P#CJS'JQ]35B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ JGJ6FPZE;^7+PX^XXZJ:N44 >>W=I-8W#0SKA
MAT/8CU%;FA:[MVVEZW'2.0]O8UM:EIL.I6_ER\./N..JFN)N[2:QN&AG7##H
M>Q'J* /0J*YG0M=V[;2];CI'(>WL:Z:@ HHHH **** "BBB@#EO&7@V#Q':&
M: +'?1K\KX^_[&O$;VQGT^[DM[J-HY(S@AA7TO7+^,?!MOXCM3+$%CO4'R/_
M 'O8UZ>#QGL_<GM^1\YFV4+$)UJ*]_JN_P#P3R_P?XPN/#EX%<F2S<_O(\]/
M<>]=?XQ^(\/V(6FA2%GF3+S=-H/8>]>97]A<:=>26UW&8Y(VP0:K\L?4UZTL
M+2J5%4:_X)\M3S'$T*,L/%V7XKO85W>60LY+,QR2:]!\!^ VOW34M6C*VH.4
MC88,G_UOYT[P)X!:]9-2U="+<$-'$>LGN?:O6418T"(H55&  .@KBQF-Y?W=
M/?JSV,HR?VEJ^(6G1=_-@B+'&J1J%51@ =A2T45X9]H%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116-K>M
MBQ4P6Q#7!')_N?\ UZ #6];%BI@MB&N".3_<_P#KUR2K)<3 *&DD<_4DT*LE
MQ, H:21S]2378Z-HR:='YLV&N&')_N>PH -&T9-.C\V;#7##D_W/85JT44 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %9^K:3'J4/9)U'R/_ $/M
M6A10!YU-#+:SM%,I21#R*Z?0M=^TA;6\;$W1'/\ '['W_G5[5M)CU*'LDZCY
M'_H?:N*FAEM9VBF4I(AY% 'HM%8.A:[]I"VMXV)NB.?X_8^_\ZWJ "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBN?UW7?)W6MDW[SH\@_A]A[T &NZ[
MY.ZULF_>='D'\/L/>N;M[>6[N%B@4N['@46]O+=W"Q0*7=CP*[72M*BTR# P
M\S#YW]?8>U !I6E1:9!@8>9A\[^OL/:K]%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO#(P(VC<<_Q>E0RC:BX+Y]:L"J<+%E7N7)8_2K@-9,I"T445(PHHHH ****
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MX^XXZJ:XF[M)K&X:&=<,.A[$>HH ]"HKF="UW;MM+UN.D<A[>QKIJ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***QM;UL6*F"V(:X(Y/]S_Z] !K>MBQ4P6Q#7!')_N?_7KDE62X
MF 4-)(Y^I)H59+B8!0TDCGZDFNQT;1DTZ/S9L-<,.3_<]A0 :-HR:='YLV&N
M&')_N>PK5HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D:EI#0!6F4L /
M>J%ZNZ%D'5C@5HR\8X[U3FX*G\16D269-Q9R>6S^;DPKA=PX%9LRL]J)XVD#
M0 ,1NR"<<_I6KJ4PCC6(<KG+_P"U[5F6\R%9HF.3(<D'M_GI6R(,[4KW. D8
M^SVZ$HOK\O!_E^=+IYB6[OC ?+\N(,A'WB0!DG\S44UHVFR3)<YECE0+'GKQ
MT'Y?RIED'M=+9WB)=0RDLW1BWS?AG _"K2;%<LW>E![Z3R9Y#-)LPY/.#\S9
M]L 5#JUM+K$5U<V\JG[)%MV ?>XYJ2V,]IJBS3.TBSVYP3T'&./TIOA6:-;I
MK3DAVD65CT()^7^M(9+"Z:?I.G^6BO)/EGYZY'W?Y4V+3HI-#U$F/%Q&XF!)
MR2A]/8\TR]\NVTQ(I3E[.X=0,]L$J?\ /I1H+?99)5=C)&T:P'=W.W(./SIB
M+<[227,L=HH/G0IY<.T!77'.3U'X56ADBN[66Y=Y(FLHPJ(6Z,.3]1D=Z2&_
M\O4K1NUF%B8CTW8'Z$5::VCB\1:C;M_JYXA*H[#J#_2@!GVY;"]-X456E.]1
MT&&'/Y8_6I!IH760KRM) T8EFVG&YCSCZ?\ UJBO(E;0+><DMM5850#ESNP/
MY"K\JM8Z<4<XF>/S)6_NK0!5L98H5OOLT#QSW39@4#^#H*C2)3(T$&T/(^UY
M'&XHJ_U//X4L.IKIMC"Z1>?>W,:A(\_=SV]@,TVX7^SK&1I6S<R O(5[=R?Z
M"@ @OWAAOH;A&:WFS(7R &YP2/0<"HKMKR_$$L1VQ(PB+$<GL366TLG]EK<Z
MJ\:RM+'Y$2YXCR*TUN[CRO+AB$AC/F%<XR/:@#RK7X+73_'UW9:<Y^S8#3$@
M "4\G&/;&?<UDP:+9R>+K>2T7]XQPZH<;\_UJQXCFMK/Q7>%91(EPR2?+R59
ME&5^N?YTW3;9O[2EO61T182-I'4YSG]/UKTJ*4H16Y\CCFX5YR6E]/4T;C2D
MTG4&G,2>83N\L,"0WX=ZT]%O[O3KG[>7 DD7$@'0(>JUQ=M]ON=;4ARSGG:Q
M^6('H<=S76P#8XB==WED85CC..U:JTTU;0Y5ST91ES:Z:]CTJ-+>Y2VBE7[.
M]J&#D'KT(/N#G-78-R:1;7<*(9)8BLY(X/)PU96@WD&L,CJFV1(3%,A.=N#\
MI_+O6C;7+?V):V,/S/(SIDG.U-Y7/Y5Y+33LS[:$XSBI1=TRG+;>3HL%C;1^
M9<S3#RW)Q\N?T%)K5Z3/;1QQ;)+3Y'0'(.X;?ZU?E.Z_FF1L)9Q>5$!W;'\_
M\:9HUO'!=:A=3KYHA^9 ><E1@G\\TAD,ZPV822TC9;GS%AB0'@= WY\U.L5S
M#:B":2,?V>JSD@YW'^[GMWJ*X8>?:^8R@JIF9CZ^OYFFO+&N@;I 3]H8;V/?
M+=3^% Q&W2P7,K,%>YE6)AV )&/YU>LK6&XF\UT4+?1-Y48 _=JO"C\JQ@95
MT"X^U2%2C!D9UP3@8'\A^=:&DB0V,]R[<VL(11Z=: $ALOM5I%,)=WV:%DGW
MY*G!P%X^F?QICK<QR+.Z/+&6"1H1G?Q@@GVR:OVJRBWMK&S".R'SKMGX&X\@
M>_/-:,EOML8K=6WB,Y+@]Z ,:*VFC>%;I4^R6[*) AR5!!QD_A@TVT@-]J*1
MN"%D.\;>H"DG/YD?E5J!,6NMIN\P@ @_A5;PM,ZR7$TC*S"(1A@<@#FD!(R+
M)J(=I1_K':.38"3L  'YDU9M(_[2BFF=B+CF3;GC'3'MTJ*#3PEE]I<X\D&1
M>/O$\_K5J"YMX=>R/W:7,&%'8D4F,=;64LEO&KL-TB,8\<Y^OKQ_*K4,N2)7
M3 *;#CL15-))$:&+<R/"Q*,*N0'=( P^61]^1T..M0QFG;9C4!AR0,>PJ\G0
M52@8.[2?PYPM75K*1:'T445 PHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ JGJ6FPZE;^7+PX^XXZJ:N44 >>W=I-8W#0S
MKAAT/8CU%;FA:[MVVEZW'2.0]O8UM:EIL.I6_ER\./N..JFN)N[2:QN&AG7#
M#H>Q'J* /0J*YG0M=V[;2];CI'(>WL:Z:@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK&UO6Q8J8+8AK@CD_W/
M_KT &MZV+%3!;$-<$<G^Y_\ 7KDE62XF 4-)(Y^I)H59+B8!0TDCGZDFNQT;
M1DTZ/S9L-<,.3_<]A0 :-HR:='YLV&N&')_N>PK5HHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN+'KCWQD ]N*CE@5X63 ^;DY_BY[UF^)O%Z>'8O-$$1NKJ+R+>W9B02#RQ]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M].UT/*DF(VC&WH/YUU4L%K);XCE;S-HY]#^=<SJ-E97%\+W=Y<ZN,HO\7O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J>I:;#J5OY<O#
MC[CCJIJY10!Y[=VDUC<-#.N&'0]B/45N:%KNW;:7K<=(Y#V]C6UJ6FPZE;^7
M+PX^XXZJ:XF[M)K&X:&=<,.A[$>HH ]"HKF="UW;MM+UN.D<A[>QKIJ "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***QM;UL6*F"V(:X(Y/\
M<_\ KT &MZV+%3!;$-<$<G^Y_P#7KDE62XF 4-)(Y^I)H59+B8!0TDCGZDFN
MQT;1DTZ/S9L-<,.3_<]A0 :-HR:='YLV&N&')_N>PK5HHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?JVDQZE#V2=1\C_T/
MM6A10!YU-#+:SM%,I21#R*Z?0M=^TA;6\;$W1'/\?L??^=7M6TF/4H>R3J/D
M?^A]JXJ:&6UG:*92DB'D4 >BT5@Z%KOVD+:WC8FZ(Y_C]C[_ ,ZWJ "BBB@
MHHHH ***Y_7==\G=:V3?O.CR#^'V'O0 :[KOD[K6R;]YT>0?P^P]ZYNWMY;N
MX6*!2[L>!1;V\MW<+% I=V/ KM=*TJ+3(,##S,/G?U]A[4 &E:5%ID&!AYF'
MSOZ^P]JOT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTJ+3(,##S,/G?U]A[5?HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *IZEIL.I6_ER\./N..JFKE%
M'GMW:36-PT,ZX8=#V(]16YH6N[=MI>MQTCD/;V-;6I:;#J5OY<O#C[CCJIKB
M;NTFL;AH9UPPZ'L1ZB@#J=;UL6*F"V(:X(Y/]S_Z]<DJR7$P"AI)'/U)-(B/
M-*$0%W8X '))KLM&T9-.C\V;#7##D_W/84 &C:,FG1^;-AKAAR?[GL*U:**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JCJ.DV^I*/.RKKT=>OTJ]1
M0!2T[2K?34(A!9V^\[=3[5=HHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JM_IT&H
MPA+@'(^ZZ]5JU10!G:;HMMIK%X]TDAXWOV'M6C110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDES/E>AGAX/V:]I&S^_\0HHHK(Z0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2M-YBH3TWY52H]\&N_\ %WB"7PSX7N=7MM/DU-X2FVWB;!?<P7.0#@#.>AH
M:OC7P^_BS_A&4U$'5^1]F$3]DWGYMNW[O/6MVOE6W\;W4/QC/BP:',UP7=O[
M-\P[^82F-VS/0[ON_P"->W^ OB->>,]3N;2[\-W&DK!#YHEDE+ASN V\HN#S
MG\* ,W6?B?JNF_%ZW\)0Z1%+:2SP1&8[_,*R!2SCMA=Q[?PGFO3&8*I9B H&
M22>E</JGQ*&F_$^S\'_V49/M.S_2_M&-NX$_<V\]/6D^)/CJ[\(1V]M:Z!/J
MBWT4H:2.0H(L8'9&S][VZ4 >;6&L^-_BWXKU!= UR71M-M/F012O$$0DA =G
M+,<$G/H>G KUSP'I'B/1-&N+/Q7JJZI.+@F"<.S-Y6U>"6 /7=Z_4UX#\+O'
MEUX)_M3[)H,VL?;/)W>5*4\K9OQG"-G.[VZ5ZSKOQ<N="\'Z)KT_AB4KJAD5
MX7NMAMV4X )V<[@"1P.E 'IE%4])U*#6=&L]2M#F&[A69.<X##.#[CI7/_$+
MQW!X!T.&^DM/MLT\PBCMQ+Y>>"2V<'@8].XH ZRBLWP[JLFN>&[#5)[0V;WD
M"S>07W[ PR.<#/&#TK2H **X7QI\6M"\&WS:=*D]]J2@%K>  ;,C(W,>F00<
M#)Y%<G_PT$UO*AU/PA=VMNQP)/M&2?H"B@_G0![-169X>\0Z=XHT6'5-'F\V
MWER.1AD8=58=B*YOQW\2$\$:QI-E)IOVM=18AI3<>7Y0#*,XVG/WL]1TH [>
MBO*]<^.VF6FH26GAS2;G76ASOEB?9'QU*G:Q(]\ 5J>!/B]I/C2__LU[:33=
M1*EDAD<.LF.2%; R0.<$#B@#T"BBO+/$GQUTG2M6?3="TV;6YXVV,\<GEH6[
MA3M8M]<8],T =GX\N[BQ^'^MW5G,\$\5G(T<L;;60XZ@CH:Y7X%:MJ.L>!;N
M?5KZYOIDU%XUDN96D8+Y<9QDDG&2?SK U7XPZ7XG\%Z[I&H64VC:E)92".&=
MMRR';]T-@8/L0,_7BM/]GC_DGM]_V%)/_145 'JU%%4=;U(:-X?U#5#%YPLK
M66X,>[;OV(6QGMG'6@"]17DZ?'O25\*QZG<Z;(E_+,\<>GQSAR0N/G+[1@<X
MZ=JW? 'Q/A\;G45N-,?2GT]%DD\R;>NTYYSM7&,>E '=T5Y/JOQ\TF*^:U\.
M:1>:TZY^=3Y2M[KPS$?4"DT;X^:9=:I'9>(-'N-%+L%\UY/,5">[952![X-
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MC4-$N/-CSM=&&UXF]&'8UA_$;XB#X?P:?*VF&_\ MCNN!/Y6P*!S]TY^][4
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MD, 01@@]Z ./\#_$S1?'*&*S+VFH(NY[.8C=CN5/\0_7VKL:^=/BIH9^'?Q
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M<;P0JD\C:/3L30!Z;17G'BKXTZ'X=U672[*UN=6OX7,<B0?*B.."NX\D@\<
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MM_.M?X&Z=-KGB77?&>H+F261HHR>?G<[WQ]!M'T:D![;'&L4:QQJ%1 %50.
M!VIU%%,#E]7_ .$,\+ZQ+XBUHV-GJ-UM!N9SND?:H4;!R1P /E';FN3\4?%C
MP!K?AW4=+EO9+E;B!T3-I)C=M^4C*\$''-</IMG;>-_V@-2M?%Q+Q13SI%;/
M)M#>6V$CX/3 SQUP?6O4_%7A[P-X;\(WMU>:)H]JJ0.D3O9QERY!VA3C);/^
M>* .5_9SD<^&]8C+'8MVC!>P)3D_H/RK*_:'C\[7/#L1.-\<JY],LE:?[.7_
M " -:_Z^8_\ T$UG_M _\C)X9^DG_H:4 >O>&O#&E^$]'CT[1[=8HU \R3'S
MRM_>8]S_ "[5XI\1K2+0/C]H=WIB+"]T]K<R!1@%S,R-^87GZFOH*O _C!_R
M6_PU_P!<;7_TIDH ]2^)NJS:+\-=:O;9BDH@$2L.JF1A'D>XW5QOP \.VEMX
M3FUUX5:]NYWC64C)2)<# ],MNSZ\>E=?\4M-EU;X8ZW:VZLTGD"4*O4^6ZN1
M^2UR7P \06ESX1FT1I56\LYVD$1(RT;8.X>N#D'TX]: -WXN^%]+UGP+J&H7
M=NOVW3[=IH+A1AUQSM)[J?0UC?L\?\D]OO\ L*2?^BHJV/B]XJTO1? ^H:==
MW -]J$#0P6Z$%SNXW$=E'K6/^SQ_R3V^_P"PI)_Z*BH ]6K"\<?\D]\1?]@N
MY_\ 135NUA>./^2>^(O^P7<_^BFH \H_9_\ ".GW=K=>)KR-9[FWN3;6RN,B
M(A58N/?YP >V#ZU[?+:P3),DD2D3ILEXP77!&"?Q/YUY=^SQ_P D]OO^PI)_
MZ*BKL_B#J-WI/P^UF]TXE;F*V;8Z]4SP6'T!)_"@#*;Q-\/?AU$VEPW5EI[1
M\/!;(TLF?]LJ"<_[QS7EWQB\;^%/&6BV)T25YM1MKC!9[=D/E%6R,D?W@O'U
MK5^"'@SPYKV@W>JZQ:PZE?)=&,QSG>(UV@@E>AR2>3Z?6D^.UIX5TC0[+3M(
MT_3;/57NEE=;2V2-Q"$<'<5 P"2O!ZX]J0'K?@N1Y? 6@22,6=],MF9CW)B7
MFO#M'\-V'BC]H;6K/5T,MM#=7%PT6<"0J_"GVY_2O;O _P#R3WP[_P!@NV_]
M%+7D_@7_ ).2\1?6Z_\ 1BT >V3:;97&F/ITMK$UD\?E-;[ $VXQC Z"O#?@
M(6LO'7B'3HF/D+">#W*2[0?R8U[W7@GP0_Y*CXC_ .N,O_HY:8'2_M#_ /)/
M;'_L*1_^BI:X6_\ %E_XSL_#/P^T>8:;;&SM8+J><[/.?RE./=?0?Q''M7=?
MM#_\D]L?^PI'_P"BI:QO%7P[;7_A?X=\0Z&A75['2+4NL?#7$:Q*>,?QKV]1
MQZ4@/4O"/A#2_!FBKI^D18SAIIV^_,V/O,?Y#H*W:\Z^$OQ%7QAH_P#9^IR
M:S9I^\SQYZ=!(/?L??GO7HM, KYM^%_A.P\3_$_59-5436^GR23B!AE96,A
MW>PZX[\=J^DJ\*^!O_)0O%'T;_T:: /<O)BW(WEIF,80[1\H]!Z5RE_<^!O
MNI7&I:@]CI]_?.9I9&R\TA/4@<L![ 8KKJ^</AMI=CX^^)NK7'C(?:K@*\RV
MTCX#/OQC /(4<8Z4 =7\0/B?X'\3>"]3TN&Z>XN'C)MBUJX'F Y4@D<=/;@U
MK_ *1G^&K*S$A+Z55'H,*?YDT[XEZ+X+\._#_4&.CZ19W4T#0V;)9QB5I,<;
M2!G(ZY[5'\ /^2;R?]?\O_H*4 <;\:M-_MCXQZ!IGF>5]MM;:WWXSMWW$BY_
M#->WZ/X?TS0M#BTC3K2..SC7;L*@[SW+>I/<UX]\3_\ DX/P?_VY?^E3U[G0
M!X)^T!JWG^*-%T.><Q64<0N9BO."[E<X]0JG'^][UU^F_%_X>:1IL%AIUS+!
M;6Z!(XTM'  'X=??O7'_ ![T]K'QIHFO26RS6C1+%(I4%7:.0L5;ZJV.>P]J
M]2TCP_X%UW2X=0TK0-#N+:905=+&$X]C\O!'<=J /#O'_BW0+WXA:5XD\'2N
M)XV5[HB%H]SJW#8(Y)7@^N*^FZY:YT;P'I%_:17.E>'[2\GE5+9#:0K([D_+
MM&,YSWKJ: "N7U?_ (0SPOK$OB+6C8V>HW6T&YG.Z1]JA1L')'  ^4=N:ZBO
MG/3;.V\;_M :E:^+B7BBGG2*V>3:&\ML)'P>F!GCK@^M '<>*/BQX UOP[J.
MERWLERMQ Z)FTDQNV_*1E>"#CFJ'[.<CGPWK$98[%NT8+V!*<G]!^5=5XJ\/
M>!O#?A&]NKS1-'M52!TB=[.,N7(.T*<9+9_SQ7)_LY?\@#6O^OF/_P!!- &3
M\?K<7?C3P];,VT30^66 Z9DQFO9_#_AS2_"^DQZ?HUJL$* ;CCYI#_>8]S7C
MWQR_Y*%X7^B_^C17NM 'S[XNM(="_:1T9],C6#[5=6KR*HP,R/L?CW&?Q)KU
M'XL:M+H_PQU>>V9DFD18%93@C>P4G/;Y2:\T^(O_ "<9X<_Z[6/_ */KTCXN
MZ9+JOPNU>*W5FDA1;@*O<(X9O_'0U '/_ 3P[:V7@G^VS"IO-0E<><1DB-&V
MA1Z#*L3Z\>@K0^,GA?2]6\#7VJW%NHO]/B\R&X08;&1E2>Z\]#T[50^ OB"U
MO? XT;SE%WI\K_NB1DQNQ8,!W&6(_P#UBKWQE\5:5I/@B^TFXN%;4-0C\N&W
M0@L!D'<P[+QU[]J *OP _P"2;R?]?\O_ *"E>GUYA\ /^2;R?]?\O_H*5Z?0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5\[?'TX^)6E&7_4BPBSN^[_ *Z3/Z8KZ)KQW]H'PO-?Z/9:_:1E
MS8$Q7(49(C8Y#?0'C_@5 'L5%<%\,/B#I_BKPY:6MQ=1QZQ;1K%- [ -)M&-
MZ^H/4XZ'\*[34-2LM*M&NM3NX;2!>LDT@11^)H LU\Y?"KPMIGB3XEZS)K$(
MN(K!WEC@;[CN9" 6'<#TKW;PUXHTWQ9ILE_HLCR6T<[0[W0KN*@$D \XY%>0
M_ W_ )*%XH^C?^C30![!XCTJSU7PM?Z?>0(]N]NZ[<?=PIP1Z$=J\F_9ON)&
MM/$-L3^ZC>WD4>A82 _^@BO9=1_Y!=U_UQ?_ -!->*_LV_\ ,R_]NO\ [6H
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M>,2/8$5[2B)%&L<:JB* JJHP !V I@?,OAGQ7H$WQ7U+Q-XTD9H][O:)Y1E
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M?F7!PIQZ$8.?KZ4 ='J?A31M7U>QU2]LD:^L)1+#<+\KY'0$C[P]C7$?'_\
MY)O'_P!?\7_H+UV^I^*M&TC5;+3+V]1;Z^E6*"W7YG)/0D#H/<UQ?Q[B,GPS
MW#I'>Q,>.V&']: .@^%W_)+]!_Z]A_,U#\7/^24ZY_UR3_T8M'PHNX)_A7HS
MQR*5BA9)#G[A5B"#Z4?%S_DE.N?]<D_]&+0!G_ [_DE=C_UVF_\ 0S7G]H/^
M%=?M%-!D1:?J4FT<X7RYN5_!9,#_ (#7H'P._P"25V/_ %VF_P#0S7/?M!Z
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MR0.@S7D7[.O_ "*.J_\ 7]_[36O7Z /FGQ#I]SJW[0U_86%VUG<W,K1QSK_
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M ]<^*/\ R2_7O^O8_P Q6%\!_P#DF,7_ %]R_P Q6[\4?^27Z]_U['^8K"^
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MAWI'CNUB%^9+>[@!$-U#C<H/\)!ZCV_(]:XRW^ S/Y<&L>+]0O=/C(VVJQE
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MCKPD/&OA>31S>FRWR))YHC\S[IS@KD9_.O.8?@!?VT0BM_'%Q%&.B1V;*!^
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M0[I(]@5<YZ%F/8=Z77?AJ-:^).G>+/[5,/V+RC]E^S[M^QB?O[AC.?0UW-%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU;57M8Y+M@C^5#(5!90HY(!R,DC\:ATGXUZQIWB2/2?B!H<>F^8P4RQ(\?E
MG 8JQ.Y?<'\Z /9Z*3(V[LC&,YKR&]^,&NZYKEQIWPY\/+J:6Q^:YG#,K#.-
MV 5"@]LMS0!Z_17FOA3X@^*;GQ9:Z!XS\,'3I;P/Y-S$K+'E49R.20>%/1J]
M*H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\.6^H:>)G83R0NQ+'J,AP/TKVNX\42:#\/D\0^*;5K>>*VCDNK>!<E9&(7:
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MCK_DY+P[];7_ -&-0![C;V\-K;QP6T20PQJ%2-%PJ@=  .E>"F)=-_:M\NR
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MX[<MR(]X;<P]^ ,_7UKWVO$_V</^0?K_ /UU@_D]>V4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<-\9_\
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MVI:=KH:"QGW0><5.%0L&CD_W<<>V?:O=;CQAX<M=/-]/KFGK;!=WF"X5LCV
M.2?84 >)ZC;IX5_:9M!IO[F&[NXB44<8F 5Q@=LL3[<>E=M\?_\ DF\?_7_%
M_P"@O7&>&6E^)/QZD\06L3KIEA(LV]AC:J+MC'U9AG'^]Z5V?Q__ .2;Q_\
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MBKYMU:#2++X\:.GP[DC:-IX#(+5]T:N7(D (_AV<G' RU?25 !1110 4444
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M*7AW5)PWDQP1%CCM',S']&H ]\HK-MO$>BWLUO#::M93RW0)ACCG5FD !8X
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M8FR'C*L5.1QMW;?QQ3 FU+X]^$=/D,-C%?7^PX#P0A(_P+$']*\O\:^-]/\
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M&\T&_MKF-9(I;>1'5AD$%37C'P-_Y*%XH^C?^C37MFH_\@NZ_P"N+_\ H)H
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M=F[]:]/HH XK6_A/X8UK1=/TKRI["TT]V>)+-U4L6 !W%E;<3M'/7WKM:**
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<A#[E:,1;F!/?:_ /J!73GX&:E,GDWGCS4)K4\&$PM@CTYE(_2NX\&?#W0_
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MM%U%YH[:ZV[V@8!QM<,,$@CJH[4>&?#UIX4\.VNBZ<\TEM:[MC3L"YW.6.2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 445176]*;53I:ZG9G4!R;07"^:.,_<SGISTH O4444 %%%% !1110 4444
M %%%% !1110 4444 %%%0W=Y;6%K)=7UQ%;6\8R\LSA$4>Y/ H FHJO8W]GJ
M=JMUIMW!=V[$A9K>02(<<'!'%6* "BBJ7]M:7_:W]E?VE9_VCC/V/SU\[IN^
MYG/3GITYH NT444 %%%% !1110 45E-XJ\/K>?9&UW3!<YV^2;R/?GTVYS6K
M0 4444 %%%% !1110 4444 %%%47UO2H]573'U.S74&Y6T-PHE/&?N9STYZ4
M 7J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIDLL<
M$+2SR+'&@RSNV H]230 ^BLRR\2:'J5S]GT[6M/NY_\ GE!=([?D#FM.@ HH
MHH **** "BBB@ HHHH ***HV&MZ5JLDL>EZG9WKP\2K;7"R&/ZA2<=#UH O4
M444 %%%% !1110 4444 %%%% !1110 4444 %%4;'6]*U.XFM]-U.SNYH/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX)_$UYCJW_)U=G]8_P#TGKTOX9:U?^(OAUI>J:O/]HO)_-\R38J;MLKJ.%
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MC![UP_BKQSXSN_%EYX=\!Z'YC6959KV9<@$J&X)(5>O?)/I0!ZE17ANK:O\
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M@V2-&RC)3Y>IZ$ XY'I0!L_LZ_\ (HZK_P!?W_M-:]?KR#]G7_D4=5_Z_O\
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M=%"AFQD*P!P<]F7@\>N: /5Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M!\[:/NHXQN^F0H_&KO@[XO\ A:3P=9?VQJ2V5[:P+%/#(C98J,;EP#D'&>*
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M=_NAUZ ^Q!(_&O*_&?\ R<QHW_7:T_G7JGCGQM!X&TVSO[RRFNK:>Y$$K0D
MQ J3NP>IXZ9'UH \KT#X@>)OA?9PZ#XQ\/326%N2D-PGRD#.<!N4<>@R#[UZ
M_P"%?&&C>,M-:\T.X,@C($L3KMDB)Z!A_49!P>:P;CXJ^ +[1I&O-6MYK>1/
MWEM+ S,W^R4*\_RKS_X"6DLWC/7M3L(9(=(,311JW3+2!D'N0H/Y^] 'O5%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUKQ)IK:GH?DA88&.4<!"&49XR&;=@]>/6H(?$_P7:[:X;PIJ$;YSAP2A_P"
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M))%=2V0G1AD2 R[2"._R@"OH%5"J%4 *!@ #I7@GQ%_Y.,\.?]=K'_T?7OE
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M &?\Z]ETS3X=*TFTT^V&(;6%(4X[* !_*O _AQ-<_$'XRCQ!J*$K8VRRL">
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MO[1&FSW'AC2]0CP8K2Y9)!G^^!@_FN/QK#^'7_)QGB/_ *[7W_H^M;]H.VU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSYY\/Q;\YP)Y=O\ WSNQ^E=98:?9Z79QVFG6T5K;QC"10H%4?@*L44 %%%%
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MFD>););77;"*\A5MRB0$%3Z@C!'X&J'A_P  ^&/"UXUUH6DQVUPRE#*9'D8
M]0"Y..G:NBHH KWUA::G9R6FHVT5U;R##Q3(&5OP-<D_P?\  CSF4Z!'N)S@
M7$P7_OD/C]*[6B@"GI>CZ=HEF+32+*"S@'/EPH%!/J<=3[FKE%% !5#6-#TS
MQ!8FSUJQAO("<A)5SM/J#U!]Q5^B@#D],^%W@S2+U;NQT& 3(=RM*[RA3Z@.
MQ -:;>$=#?Q8GB5K '5T7:MSYC\#:4^[G;]TD9Q6S10!3U;2;+7=*GTW58//
MM+A0LL>XKN (/4$$<@=#4>AZ%IWAS2H]-T6V^S6D9)6/>SX).3RQ)Z^]:%%
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MO&(XHP2=JCH,GFJ.O>%M$\3P)%KVFP7JI]QG&&3Z,,$?@:UJ* .7T;X;>$-
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M%]$\21JFN:9;WNS[C2)\R_1AR/P-8-K\(O MI,)(O#\+,.TLTL@_)F(KLZ*
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M!NC7JW=AH,"SH=RM*[R[3Z@.Q -7O"'A&P\%:&=+TJ6XE@,S3%KEE9MQ '8
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MBUM)",&5$R^/3<<G]:VJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
2HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>bdtx-20211231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,X
M,0  DI(  @    ,X,0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            ,C R,CHP,CHQ-" Q-#HS,SHU.  R,#(R
M.C R.C$T(#$T.C,S.C4X    0@!R &$ ;@!D &$ ;@ @ $@ :0!L &P 90!R
M &D 8P!H    _^$+)&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X
M<&%C:V5T(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC
M.60G/SX-"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR
M9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R
M,BUR9&8M<WEN=&%X+6YS(R(^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(G5U:60Z9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X
M;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B+SX\
M<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D
M+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.GAM<#TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+R(^/'AM<#I#<F5A=&5$871E/C(P,C(M,#(M
M,314,30Z,S,Z-3@N.#$P/"]X;7 Z0W)E871E1&%T93X\+W)D9CI$97-C<FEP
M=&EO;CX\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D
M-2UB83-D+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P
M.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^/&1C.F-R96%T;W(^/')D
M9CI397$@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R
M+7)D9BUS>6YT87@M;G,C(CX\<F1F.FQI/D)R86YD86X@2&EL;&5R:6-H/"]R
M9&8Z;&D^/"]R9&8Z4V5Q/@T*"0D)/"]D8SIC<F5A=&]R/CPO<F1F.D1E<V-R
M:7!T:6]N/CPO<F1F.E)$1CX\+W@Z>&UP;65T83X-"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $, !P4%!@4$!P8%!@@'
M!P@*$0L*"0D*%0\0#!$8%1H9&!48%QL>)R$;'24=%Q@B+B(E*"DK+"L:("\S
M+RHR)RHK*O_; $,!!P@("@D*% L+%"H<&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*O_  !$(!*H*BP,!(@ "
M$0$#$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  "
M 0,# @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1
M\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:W
MN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ?
M 0 # 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$
M!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0T
MX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _
M /I&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \C\4_'=?#?BB^T=?#I
MNA9R^69C>^7O./[OEG'YUFP?M(0-*!<^&)(T[M'>AS^10?SKCM6_Y.0C_P"P
M_;_^C4KZ1U71=-URS>TU>RAO('&"LJ X^AZ@^XYH R?"'CS0_&UJ\FC7#":(
M RVLPVRQ^Y'<>X)%=)7RG<I-\+OC$4LY7$-E=*06/^LMW .T^ORMCZBO:OBS
M\0-3\!V>FR:1;6D[WDDBO]J5F"A0O0*P_O4 >A45X)K'[0]^LUNFAZ9:.BQ(
M;B2Y5_G? W! &&T Y )S71_$GXJZSX0;1AI5G8O]OLQ<2"Z1V*DXX&UEH ]8
MHJEHUZ^I:%87TJJCW5M',RKT!902!^=>7_#[XM:UXL\>/HFH6=A%;;965H$<
M.-O3)+$'\A0!Z[17F?Q&^+@\(:LNBZ/8+?ZH54OO)V1[ONK@<LQ&#@8ZBN'U
M#XX>/M)9%U7P_8632#<@N;*>,L/4;I!F@#Z$HKB_AGXH\0^*]%N+WQ-I2:>1
M(OV8I!)$LT94'< Y.1SU'!S7:4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVM07^I&2Q?S5^T3Q^6,#JV$''XUKWGQ:\#6-P8)_$$#.IP3#%)*O_?2*1^M
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MNK&>.XMY5W1RQ,&5AZ@B@":BN;M/B#X6O=6O--M]8B-U9*[7 ='18PAPQ+L
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MV2"2.=C\TL6<'=ZD$CGOD=^2 >JTV65(8GEF=8XT4L[N<!0.I)["G5A>./\
MDGOB+_L%W/\ Z*:@ _X3CPG_ -#/HW_@PB_^*J6V\7^&KRYCM[3Q#I4\\K!8
MXHKV-F<GL &R37SA\*/ NF>.]6O[75Y[N%+:!9$-JZJ22V.=RFO7=(^!7AC1
MM:L]3M[W59)K.=)XUEFC*EE(89Q&#C(]: /2J*P/$7CCP[X3G@A\0:DMI)<*
M6C7RG?< <9^53C\:AUWXA^%/#=V;76-:@AN!]Z)%:5E^H0$C\: .EHK.T3Q!
MI7B.Q^UZ'?0WD ."T9Y4^A!Y!^HI-:\1:/X=MQ/K>HV]DC?=\U\%OHO4_@*
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MM'BDEF4DAF<!CR>3UZF@#[!HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2[7>XP"%56#'() Q@>OOVKR;^Q_@AI=K]DO=5>\GQ@W*R3N<^H\L;/T-=/\
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MSV]M=A#YHB9C$Z$C! &<$,>QY% %+XN^!;#P3KMH-(DD^QWT;.L,AW&(J0"
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M=,COM/AN)"T,L*R"2%\[7"MP2 0?J,5Z?+XW^#4=L)4TO3)7_P">*:(-P_-
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M[J&J6[6PMS"R^3YBE3DXY(!X"YR<5SW[.?\ R,>L_P#7HG_H=,##_P";D/\
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MY#^)&!_O59^-5_/XF^*%GX?L3YAM1';1J#G,TI!/\T'X4[XYZ++H'CVS\16
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MFA N[%F(NYQR?8/Q4VK^&M)\*_"SQ)8:#9BTMFT^ZE9!(SY8PD$Y8D] /RH
M^?/AS_PFW]I7G_"OO^/GRA]H_P!3]S/'^MXZ^E>S> O^%J_\),/^$WQ_97DO
MNS]F^_QMQY7S?TKS+X+>+=$\):UJ4_B"]^R13VZI&WE/)N(;./E!KVJP^+/@
MG4]1M[&RUOS+FYE6*)#:S+N=C@#)0 9)[T@/+OVC/^1CT;_KT?\ ]#KH?"?P
M8\/ZMX'M[_67N+K4]4MENOM7FL#"9%## SAB,\ELY.>E<]^T9_R,>C?]>C_^
MAU[+X'_Y)[X=_P"P7;?^BEI@>%? >\N+'XD3Z>KDQ7%M(DB@\$H00WUX(_$U
MZ#\0?!?A*[\5IX@\:^(#:VS0+$ED7"ERN>0>6(YZ =>_-><?!?\ Y+ ?^N5Q
M57XDN)?C5=+XK>Y73UN(U/ECYEM\#&S/MG\<]Z0#_B%#\,AHL3^!+AQJ*3!7
MB G*O'@Y.9!C.<=#^%>E_"J_EO?@==I,[/\ 94N8%+=E"[@/H-U>7^/9OAJN
MBP6_@6UGDU#S TETS3;0@!R")#U)QT7L>:]&^#W_ "135O\ KK=?^BEH \I^
M%W@ZW\;>,/[/OIGBM8+=KF81G#2*K*NT'MDL.?0&NK^,WPWT?PEIUAJOAZ%[
M:"6;[/-"TK.-Q4LK L2?X6SSZ=*Y;X6^+H?!/BQM4OK:66QEA-I.\:Y,6Y@P
M/N?W?3TSCI73_&7XD:3XNL;#2?#TCW-O%+]HEG:-D!?:550& / 9L\>E '56
M>M3ZY^S)>37DC2SP6SV[NQR6V. I)_W=M9O[-O\ S,O_ &Z_^UJU8=!G\/?L
MSWEK>(8[F6U:XE1NJEW! ([';MR/7-97[-O_ #,O_;K_ .UJ8')Z3_R<A)_V
M'[C_ -&O71_M'?\ (4T'_KC-_P"A+7.:3_R<A)_V'[C_ -&O71_M'?\ (4T'
M_KC-_P"A+2 UO!'P=\/ZUX)M]3UUKB\U#4X?/\_S67R=W(P ?F/J6SFN/^"<
M]QI7Q8?3$E+1S1S02@' ;9E@<?5?U->X_#G_ ))KH'_7C'_*O#/A7_R74?\
M76[_ /07H L?%ETO/C=#:>(YY(=(0VZ;P3\D# %V'_ B_..U5OBGHWP_TO3-
M/?P3>0R7COB6.WNC.ICVGYF))VMG'''4\<4_XL7;-\86'BRWNGTF%46&. A6
M:';G*$\$[B<_3%1:-=?""TU!9[FU\1W 5@1'?")H_P 1&02/8_K0!['\(]!L
M=(\ 6%W:V0M;K4($EN6#LWFD9VM\Q.,@YP,#FNXK.T+6=,U[1X;_ $.XCGLW
M&$,8QMQ_"1U4CT-:-, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M /E/6=5@T/XZWFJ7:R/!9ZRTTBQ %B%DR< D#/XUT?Q(^,-MXRT'^PM T^ZB
MBN)$,SW 4.^""%"J3_$ >O;I6+<6T%Y^T/);W<,<\$NNE9(I4#*X,G((/!%?
M2-CX;T/2YO-TS1M/LY/[]O:I&?S %(#@?A-X0O/"_P /M1GU6)H+O45:4PL,
M-&@0A0??DG'N*\7^&GA*W\9^,XM,OIGBMEB::7R_O.JD?*#VSD<U]7ZC_P @
MNZ_ZXO\ ^@FOG#X!?\E*;_KQE_FM %GXS_#[1?"$.F7OA^)[>.X9HI86D9QD
M $,"Q)]<_A7J?AJ";QE\#K2UO;QK>2\T]K=KG[Q7:2FX\C/"\\\\\URW[1O_
M " -%_Z^9/\ T$56NY+Z+]EBT.G%QE-LYCZ^49FW?ATS[9H K1>'_@OH$)M-
M8UC^TKH?*\RR3-AO80C:/QS7&>![NTTKXUV7_"/7,LFG27[002,"#)"Y*C<"
M!V(ZCMTJ;P%_PK1-%GE\<_:I-060[(1YH1DP,;3'CG.?O$5G>%);";XQ:7+H
M]N]MI[ZJAMH9"2R1[_E!))YQ[F@#K/V@X[X>--/ENED;3C:!8<'Y=VX[P/1O
MN_ACTK8\.Z#\(?%PM8-*-QINHY4B&2Y=9688./G+(QX_AKK/&7Q$\,:;XEE\
M+^,=,,MDT*2B=XA,A+9ZIC(QV89.?2O#O'P\(GQ!;O\ #Q[AHF&9%VN%63/&
MS?\ -_D8H ]8_:!\1W&G>'K#1K.4Q_VB[M.5."8TQ\I]B6_\=KS;P_J/PNM-
M!BA\0Z-K=]J3+^^GC8*J-Z(!*.![BNV^-N@:C=^!O#NL7$;O<6,(BOB>64NJ
M?,?HRD?5JJ^ _&7PS3PK:6GBK1].M]0MD\N2:;2Q-Y^#PVY48Y(ZY[YH Y[X
M/:R-,^+,=GI4EQ_9FH-+"$FQO9 K-&6 .-PP,X]37TY7G/@[Q1\/=8\6"R\)
M:+;Q7J0O*MW%IT<("C (#8#9.[T]:]&I@%?,/QA_Y+-<?]NW_H"U]"^(_%NB
M>$K:&X\07OV2.=RD9\IWW$#/1037S1\2?$&F:_\ $R;5M)N?M%DWDXE\MESM
M50>& /4'M0!]845SGAWQ_P"&?%=_)9:!J?VNXCB,K)Y$B80$#.64#JP_.NCH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MY]_:,_Y&/1O^O1__ $.KMG\=],T?P'8:9IFG7DNIVEA%;!YE18@ZQA=V0Q)&
M1G&!GVJE^T9_R,>C?]>C_P#H=>G^"?"GAU_!6@7;:#IC7,FG6\CSFSCWLQC4
MEBV,DD\YI >6_ GP?J%UXG'BB\A>*SMD<022#'GR."IV^H +9/K@>N.>^+=N
M;OXUZE;JVPS26T8;TS#&,U]2@!5 4  #  [5\P_$W_DOEU_U\VG_ **BI@=Q
MXO\ @SX;T3X;WMU9"<ZE8P><;MY3^]*\L"F=H!&<8&1QR:;^SEJ$\VE:YI[N
M3#;2PRQ@G[I<.&Q_WP*]$^(W_)-=?_Z\9/Y5YC^S;_S,O_;K_P"UJ +NO^"O
MAYI'BS4M3\<^(#//>SM<+9&1E,:L<X(3+GK@'CCM7F'Q#C\%1ZE:2?#ZXD>!
MD/GQD2@1L",8,@SSSW/2H]#;2+CQ_<M\2Y;I8C))]I90V[SL]&Q\V.O3GI3O
MB#/X+EU*W3P#:2PVT:L)Y7:0K*Q/&!(Q(P >PZT@/6O'EUJ>L?L\Z=>6IFDD
MDM[:2]*]63;\Y/J-V#7G_P /A\,KS2?L?C.&:#5&D.+IY9%C*]L%#@>^X8]Z
M]2M/&5OX(^#/AC4;VRDO+>:."VD6,@%59&);!X/W<8XSGK7G?Q!U'X7:QH$E
M[X;1[;6V(9(K>W>)<Y&0X(V=,\KSF@#U2]%A\./A!?3>&KAI[>")I+69Y%DR
MTKX4AA@$ L,5X!X3U#P?'=7=WX^M=4U261LQI;L,,3DLSMO5B<^_K7H?@#0]
M4\1? '7M,VNZS3,U@CG[Q38^%]BZX],D^]<I\+O$7A/0[B^LO'&D6TZ3,IBN
M;BR6<PD9#*006 Z=!VH PM<U?0K+Q5;:K\/8]0TZ.$K(([LC,<@/\)#,2I&.
MI]:^N+*Y^V:?;W(7:)HEDQZ9&?ZUY3)XV^$*W<$%EH=A>R32*B^1HR+@DXYW
MJM>N !5 4  #  [4P%K@OBKX_MO"'AV6UMY5;5[V-DMX@>8P1@R'T [>I^AK
M=\;>*H?!GA6YU>:)IF3"11#^.1ON@GL.Y]A7S1I-_IOBSQO)JOQ$UHV]LS^9
M*!%([2^D:; =JCI[#I0!V?P(\#SWFLCQ3?1E+.TW+:AA_K9",%A[*"?Q/L:^
MA*X73OBM\/D6VT[3=7CB3Y88(4LYE5>P ^3 %=U0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'GOQQ_P"25WW_ %VA_P#0
MQ7EWPK^)^C^!?#]_9ZG:7T\T]QYT?V=$*XV@8)+ CD>AKU'XX_\ )*[[_KM#
M_P"ABN2^ WA_1M7\,:E-JVD6-]+'>;4>YMDD91L4X!8' H X<V^K?&/XER75
MM:-#!*Z"5ARMK"O'+>N ?J37<_M&(L6E^'DC&U5DF"CT 5*]HM;.VL8!!96\
M5O$.D<*!%'X"O&?VC_\ D'Z!_P!=9_Y)0 SX9_"'P]K?@F#5]>6:[GOU8QJL
MK1B !BHQ@\GC/.1[5R?PU$WACXZ#28)6DC6ZN+&4YQYBKO )_%0?PKVGX1_\
MDIT/_KD__HQJ\9\/?\G+2_\ 8:N__0I*0'J7Q+\&^'=:U2PUCQ=KQTZQM8C%
MY!8+YI+9X)[^H )(QTQ7F/CBW^$X\+S?\(?=.NL0E/*5?M#";Y@&R7&W[N3Q
MCI^%)\<Y+AOBA''JC3C3U@B\D*.D9^^5SQG.[\A4/C"7X5P^$V@\(6US<ZQ(
M$\NX=IAY7S MN#D*3M!' /7\: .Y^!%]>W7P\UBQMY&,MM._V;)X0NF0!_P(
M$_C7E'@]_#5IXHN8_B/9W<T1#*<,X,<N[DN%(8]^G?M7I7P%O/[.\%^);WRS
M+]F?SO+4X+;8R<?CBEU'QO\ "KQOIK7/BBRDL-1V88K WG9_V9$&& [;ORI@
M=I\/?#7@RPGNM8\#W9GBN4$4B+/O6/!SC#?,I]B:\,\7^)+3Q'\5;FZ\327D
MFCVUR\*Q6N"XB0D *"0!N(!)SW)]*W?@,+G_ (6-<_V>9C8"VD\XG@%<C9N'
M3.?Z^]8VK6L/@/XR3/K^FI?:>EV\WD2Q*ZS02;L$!N"0&[_Q+2 A\6:A\.+S
M1@OA'2-7T_449<-.P:.0=]V9&(./0=:]K^!^LW.K_#>-;R1I&L;E[5';DE %
M91GV#X_"L9_&WP:2V$JZ7ICOC_4KH@W#\TQ^M=_X+O\ 1M5\*6NH>&K!=/T^
MX9S' L"18(<J257CDJ:8&]7E?CS_ (6Q_P )-=?\(=G^Q_+7R]OV7.=HW8W_
M #YSG^E>GW<YMK.:<1M(8HV<(O5L#.!7G.C?'?PC?VH;59+C29P/GCEA:5<^
M@9 <_B!0!XG87,>B>/3<_$C2]0O+A91)-'+)M8MU#,&'SCT (!]2.*^K["^M
MM3T^WOK&59K:XC$D4B]&4C(KY>^*OBRR\=>,K>;08)GBB@6V1C'AYVW$\+U_
MBP!UKZ(\!:/<Z!X"TC3;[BY@MQYJYSM9B6*_AG'X4 =#1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5S,GPZ\*2^)!K[Z0IU,3BX$
MXFD'[P'(;;NVYSSTKIJ* (KJTM[ZTDM;V&.>"5=LD4BAE8>A!KDH_A'X&CN_
MM*^'X2^<X:61D_[X+;?TKLJ* .>M/ ?AJQ\2_P#"06FEI%J?.)ED?"Y7:<)N
MVCY>.!3-?^'WA?Q1J27^NZ4MU=(@C$GG2)\H)(!"L >IZUTE% $,ZR1V$B6*
MJ)5B(A4\+NQ\H^G2OE+PWK=CH'CJ\N_B)HTVK2G>LT5P@=TE+#+%'X8XR,'U
MKZSJCJ&AZ3JQ!U72[*](& ;FW23 _P"! T ?,_C_ ,3^%?%*6=KX,\+?V?<"
M7+2I;I$\@Q@($C)!R3G/7BO>/AAHE]H'PYTW3]65EN0KR/$W6,.Q8*?H#R/7
M-;MAX?T;2I/,TO2+"R?^];6R1G\U K1H Y#4/A5X)U.Y:>Z\/P"1CD^1(\()
M^B,!5[0_ 7A?PW=+<Z+HUO;W"@JLQW.Z@C!PS$D<5T-% %#6-#TSQ!I[66M6
M45Y;D[MDJYP?4'J#[BLG0/AYX5\,:A]MT/24MKG:5$IEDD(!ZXWL<?A72T4
M%%%% !1110 4444 %%%% ",H92K %2,$$=:Y'4/A5X)U.X,]UX?MP[')\AWA
M!_!& KKZ* ,+0O!/AOPU)YNB:/;6LN,><%+R >F]LG]:9X@\"^&O%$PFUW28
M;J91M$H9HWQZ%E()KH** .33X7^#(])ETU-"A6VF96D D<.VTY&7W;L>V<5K
MVWAC1[3PR?#UO9*NE&-HC;;V(*L26&2<\DDYSFM6B@#"\-^"O#_A%IV\/:<+
M1K@ 2GS7D+ 9Q]]CCJ>E-\1^!O#OBV:&;Q!IPNY(%*QMYTD94$YQ\K#-;]%
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MJ[10!QD/PB\"P7/GIX?A+YSAYI77_OEF(_2NPAACMX4A@C6**-0J(B@*H'0
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MN_G2/E<YQ\S''([4FL^ O#/B'6(M5UC2UN;R(*J2&61>%.0"H8 \GN*Z*B@
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M^&/#<PFT;1K>WF P)3F1Q]&8DC\ZZ"BB@ HHHH **** "BBB@ HHHH ****
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M+-_X'3?_ !5'_#.GPU_Z LW_ ('3?_%4 =C_ ,)[X0_Z&O1/_!C#_P#%4?\
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M .&=/AK_ - 6;_P.F_\ BJ .Q_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\
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M8?\ XJC_ (3WPA_T->B?^#&'_P"*KCO^&=/AK_T!9O\ P.F_^*H_X9T^&O\
MT!9O_ Z;_P"*H ['_A/?!_\ T->A_P#@QA_^*H_X3WPA_P!#7HG_ (,8?_BJ
MX+3_ -GSX<W"R^;HTQVO@?Z;,/\ V:KG_#.GPU_Z LW_ ('3?_%4 =C_ ,)[
MX0_Z&O1/_!C#_P#%4?\ ">^$/^AKT3_P8P__ !5<=_PSI\-?^@+-_P"!TW_Q
M5'_#.GPU_P"@+-_X'3?_ !5 '8_\)[X0_P"AKT3_ ,&,/_Q5'_">^$/^AKT3
M_P &,/\ \57'?\,Z?#7_ * LW_@=-_\ %4?\,Z?#7_H"S?\ @=-_\50!V/\
MPGOA#_H:]$_\&,/_ ,51_P )[X0_Z&O1/_!C#_\ %5QW_#.GPU_Z LW_ ('3
M?_%4?\,Z?#7_ * LW_@=-_\ %4 =C_PGOA#_ *&O1/\ P8P__%4?\)[X0_Z&
MO1/_  8P_P#Q5<=_PSI\-?\ H"S?^!TW_P 51_PSI\-?^@+-_P"!TW_Q5 '8
M_P#">^$/^AKT3_P8P_\ Q5'_  GOA#_H:]$_\&,/_P 57'?\,Z?#7_H"S?\
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M_#.GPU_Z LW_ ('3?_%4?\,Z?#7_ * LW_@=-_\ %4 =C_PGOA#_ *&O1/\
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M:]$_\&,/_P 51_PGOA#_ *&O1/\ P8P__%5P?_#/?PY_Z TW_@;-_P#%4?\
M#/?PY_Z TW_@;-_\50!WG_">^$/^AKT3_P &,/\ \51_PGOA#_H:]$_\&,/_
M ,57!_\ #/?PY_Z TW_@;-_\51_PSW\.?^@--_X&S?\ Q5 '>?\ ">^$/^AK
MT3_P8P__ !5'_">^$/\ H:]$_P#!C#_\57!_\,]_#G_H#3?^!LW_ ,51_P ,
M]_#G_H#3?^!LW_Q5 '>?\)[X0_Z&O1/_  8P_P#Q5'_">^$/^AKT3_P8P_\
MQ5<'_P ,]_#G_H#3?^!LW_Q5'_#/?PY_Z TW_@;-_P#%4 =Y_P )[X0_Z&O1
M/_!C#_\ %4?\)[X0_P"AKT3_ ,&,/_Q5<'_PSW\.?^@--_X&S?\ Q5'_  SW
M\.?^@--_X&S?_%4 =Y_PGOA#_H:]$_\ !C#_ /%4?\)[X0_Z&O1/_!C#_P#%
M5P?_  SW\.?^@--_X&S?_%4?\,]_#G_H#3?^!LW_ ,50!WG_  GOA#_H:]$_
M\&,/_P 51_PGOA#_ *&O1/\ P8P__%5P?_#/?PY_Z TW_@;-_P#%4?\ #/?P
MY_Z TW_@;-_\50!WG_">^$/^AKT3_P &,/\ \51_PGOA#_H:]$_\&,/_ ,57
M!_\ #/?PY_Z TW_@;-_\51_PSW\.?^@--_X&S?\ Q5 '>?\ ">^$/^AKT3_P
M8P__ !5'_">^$/\ H:]$_P#!C#_\57!_\,]_#G_H#3?^!LW_ ,51_P ,]_#G
M_H#3?^!LW_Q5 '>?\)[X0_Z&O1/_  8P_P#Q5'_">^$/^AKT3_P8P_\ Q5<'
M_P ,]_#G_H#3?^!LW_Q5'_#/?PY_Z TW_@;-_P#%4 =Y_P )[X0_Z&O1/_!C
M#_\ %4?\)[X0_P"AKT3_ ,&,/_Q5<'_PSW\.?^@--_X&S?\ Q5'_  SW\.?^
M@--_X&S?_%4 =Y_PGOA#_H:]$_\ !C#_ /%4?\)[X0_Z&O1/_!C#_P#%5P?_
M  SW\.?^@--_X&S?_%4?\,]_#G_H#3?^!LW_ ,50!WG_  GOA#_H:]$_\&,/
M_P 51_PGOA#_ *&O1/\ P8P__%5P?_#/?PY_Z TW_@;-_P#%4?\ #/?PY_Z
MTW_@;-_\50!WG_">^$/^AKT3_P &,/\ \51_PGOA#_H:]$_\&,/_ ,57!_\
M#/?PY_Z TW_@;-_\51_PSW\.?^@--_X&S?\ Q5 '>?\ ">^$/^AKT3_P8P__
M !5'_">^$/\ H:]$_P#!C#_\57!_\,]_#G_H#3?^!LW_ ,51_P ,]_#G_H#3
M?^!LW_Q5 '>?\)[X0_Z&O1/_  8P_P#Q5'_">^$/^AKT3_P8P_\ Q5<'_P ,
M]_#G_H#3?^!LW_Q5'_#/?PY_Z TW_@;-_P#%4 =Y_P )[X0_Z&O1/_!C#_\
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MP_\ Q5'_  GOA#_H:]$_\&,/_P 57!_\,]_#G_H#3?\ @;-_\51_PSW\.?\
MH#3?^!LW_P 50!WG_">^$/\ H:]$_P#!C#_\51_PGOA#_H:]$_\ !C#_ /%5
MP?\ PSW\.?\ H#3?^!LW_P 51_PSW\.?^@--_P"!LW_Q5 '>?\)[X0_Z&O1/
M_!C#_P#%4?\ ">^$/^AKT3_P8P__ !5<'_PSW\.?^@--_P"!LW_Q5'_#/?PY
M_P"@--_X&S?_ !5 '>?\)[X0_P"AKT3_ ,&,/_Q5'_">^$/^AKT3_P &,/\
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MPSW\.?\ H#3?^!LW_P 50!WG_">^$/\ H:]$_P#!C#_\51_PGOA#_H:]$_\
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MWG_">^$/^AKT3_P8P_\ Q5'_  GOA#_H:]$_\&,/_P 57!_\,]_#G_H#3?\
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M_P 51_PGOA#_ *&O1/\ P8P__%5P?_#/?PY_Z TW_@;-_P#%4?\ #/?PY_Z
MTW_@;-_\50!WG_">^$/^AKT3_P &,/\ \51_PGOA#_H:]$_\&,/_ ,57!_\
M#/?PY_Z TW_@;-_\51_PSW\.?^@--_X&S?\ Q5 '>?\ ">^$/^AKT3_P8P__
M !5'_">^$/\ H:]$_P#!C#_\57!_\,]_#G_H#3?^!LW_ ,51_P ,]_#G_H#3
M?^!LW_Q5 '>?\)[X0_Z&O1/_  8P_P#Q5'_">^$/^AKT3_P8P_\ Q5<'_P ,
M]_#G_H#3?^!LW_Q5'_#/?PY_Z TW_@;-_P#%4 =Y_P )[X0_Z&O1/_!C#_\
M%4?\)[X0_P"AKT3_ ,&,/_Q5<'_PSW\.?^@--_X&S?\ Q5'_  SW\.?^@--_
MX&S?_%4 =Y_PGOA#_H:]$_\ !C#_ /%4?\)[X0_Z&O1/_!C#_P#%5P?_  SW
M\.?^@--_X&S?_%4?\,]_#G_H#3?^!LW_ ,50!WG_  GOA#_H:]$_\&,/_P 5
M1_PGOA#_ *&O1/\ P8P__%5P?_#/?PY_Z TW_@;-_P#%4?\ #/?PY_Z TW_@
M;-_\50!WG_">^$/^AKT3_P &,/\ \51_PGOA#_H:]$_\&,/_ ,57!_\ #/?P
MY_Z TW_@;-_\51_PSW\.?^@--_X&S?\ Q5 '>?\ ">^$/^AKT3_P8P__ !5'
M_">^$/\ H:]$_P#!C#_\57!_\,]_#G_H#3?^!LW_ ,51_P ,]_#G_H#3?^!L
MW_Q5 '>?\)[X0_Z&O1/_  8P_P#Q5'_">^$/^AKT3_P8P_\ Q5<'_P ,]_#G
M_H#3?^!LW_Q5'_#/?PY_Z TW_@;-_P#%4 =Y_P )[X0_Z&O1/_!C#_\ %4?\
M)[X0_P"AKT3_ ,&,/_Q5<'_PSW\.?^@--_X&S?\ Q5'_  SW\.?^@--_X&S?
M_%4 =Y_PGOA#_H:]$_\ !C#_ /%4?\)[X0_Z&O1/_!C#_P#%5P?_  SW\.?^
M@--_X&S?_%4?\,]_#G_H#3?^!LW_ ,50!WG_  GOA#_H:]$_\&,/_P 51_PG
MOA#_ *&O1/\ P8P__%5P?_#/?PY_Z TW_@;-_P#%4?\ #/?PY_Z TW_@;-_\
M50!WG_">^$/^AKT3_P &,/\ \51_PGOA#_H:]$_\&,/_ ,57!_\ #/?PY_Z
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M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
MBJ .\_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\ @QA_^*K@_P#AGOX<_P#0
M&F_\#9O_ (JC_AGOX<_] :;_ ,#9O_BJ .\_X3WPA_T->B?^#&'_ .*H_P"$
M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
MBJ .\_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\ @QA_^*K@_P#AGOX<_P#0
M&F_\#9O_ (JC_AGOX<_] :;_ ,#9O_BJ .\_X3WPA_T->B?^#&'_ .*H_P"$
M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
MBJ .\_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\ @QA_^*K@_P#AGOX<_P#0
M&F_\#9O_ (JC_AGOX<_] :;_ ,#9O_BJ .\_X3WPA_T->B?^#&'_ .*H_P"$
M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
MBJ .\_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\ @QA_^*K@_P#AGOX<_P#0
M&F_\#9O_ (JC_AGOX<_] :;_ ,#9O_BJ .\_X3WPA_T->B?^#&'_ .*H_P"$
M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
MBJ .\_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\ @QA_^*K@_P#AGOX<_P#0
M&F_\#9O_ (JC_AGOX<_] :;_ ,#9O_BJ .\_X3WPA_T->B?^#&'_ .*H_P"$
M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
MBJ .\_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\ @QA_^*K@_P#AGOX<_P#0
M&F_\#9O_ (JC_AGOX<_] :;_ ,#9O_BJ .\_X3WPA_T->B?^#&'_ .*H_P"$
M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
MBJ .\_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\ @QA_^*K@_P#AGOX<_P#0
M&F_\#9O_ (JC_AGOX<_] :;_ ,#9O_BJ .\_X3WPA_T->B?^#&'_ .*H_P"$
M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
MBJ .\_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\ @QA_^*K@_P#AGOX<_P#0
M&F_\#9O_ (JC_AGOX<_] :;_ ,#9O_BJ .\_X3WPA_T->B?^#&'_ .*H_P"$
M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
MBJ .\_X3WPA_T->B?^#&'_XJC_A/?"'_ $->B?\ @QA_^*K@_P#AGOX<_P#0
M&F_\#9O_ (JC_AGOX<_] :;_ ,#9O_BJ .\_X3WPA_T->B?^#&'_ .*H_P"$
M]\(?]#7HG_@QA_\ BJX/_AGOX<_] :;_ ,#9O_BJ/^&>_AS_ - :;_P-F_\
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M]_#G_H#3?^!LW_Q5'_#/?PY_Z TW_@;-_P#%4 =Y_P )[X0_Z&O1/_!C#_\
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M50!WG_">^$/^AKT3_P &,/\ \51_PGOA#_H:]$_\&,/_ ,57!_\ #/?PY_Z
MTW_@;-_\51_PSW\.?^@--_X&S?\ Q5 '>?\ ">^$/^AKT3_P8P__ !5'_">^
M$/\ H:]$_P#!C#_\57!_\,]_#G_H#3?^!LW_ ,51_P ,]_#G_H#3?^!LW_Q5
M '>?\)[X0_Z&O1/_  8P_P#Q5'_">^$/^AKT3_P8P_\ Q5<'_P ,]_#G_H#3
M?^!LW_Q5'_#/?PY_Z TW_@;-_P#%4 =Y_P )[X0_Z&O1/_!C#_\ %4?\)[X0
M_P"AKT3_ ,&,/_Q5<'_PSW\.?^@--_X&S?\ Q5'_  SW\.?^@--_X&S?_%4
M=Y_PGOA#_H:]$_\ !C#_ /%4?\)[X0_Z&O1/_!C#_P#%5P?_  SW\.?^@--_
MX&S?_%4?\,]_#G_H#3?^!LW_ ,50!WG_  GOA#_H:]$_\&,/_P 51_PGOA#_
M *&O1/\ P8P__%5P?_#/?PY_Z TW_@;-_P#%4?\ #/?PY_Z TW_@;-_\50!W
MG_">^$/^AKT3_P &,/\ \51_PGOA#_H:]$_\&,/_ ,57!_\ #/?PY_Z TW_@
M;-_\51_PSW\.?^@--_X&S?\ Q5 '>?\ ">^$/^AKT3_P8P__ !5'_">^$/\
MH:]$_P#!C#_\57!_\,]_#G_H#3?^!LW_ ,51_P ,]_#G_H#3?^!LW_Q5 '>?
M\)[X0_Z&O1/_  8P_P#Q5;]>2?\ #/?PY_Z TW_@;-_\57K= !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>^_X\
M9O\ =JQ5>^_X\9O]V@!-/_Y!\7T_K5FJVG_\@^+Z?UJS0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M&?I/W9_^NE:%9^D_=G_ZZ5H4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %5)_P#7-5NJD_\ KFH CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *F7_CU?Z_X5#4R_P#'J_U_PH AHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *EM_P#6_A452V_^M_"@",]324IZFDH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *E@_UPJ*I8/]<* )+G[J_6JU6;G[J_6JU !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!=D_U;?2J579/]6WTJE0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 6X/]2*K2?ZQOK5F#_4BJTG^L;ZT
M -HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *OU0J_0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 57OO^
M/&;_ ':L57OO^/&;_=H 33_^0?%]/ZU9JMI__(/B^G]:LT %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!GZ3]V?_KI6A6?I/W9_^NE:% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !52?\ US5;JI/_ *YJ (Z*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "IE_X]7^O^%0U,O\ QZO]?\* (:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "I;?\ UOX5%4MO_K?PH C/4TE*>II* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "I8/]<*BJ6#_7"@"2Y^ZOUJM5FY^ZOUJM0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 79/]6WTJE5V3_5M]*I4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% %N#_4BJTG^L;ZU9@_U(JM)_K&^
MM #:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "K]4*OT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5[[
M_CQF_P!VK%5[[_CQF_W: $T__D'Q?3^M6:K:?_R#XOI_6K- !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 9^D_=G_ZZ5H5GZ3]V?_KI6A0 4444 %%%% !1110 4444 %%%% !1110
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M+_GY?_OTW^%>644?4:?=_P!?(/[8Q'9?C_F>I_\ "<:%_P _+_\ ?IO\*/\
MA.-"_P"?E_\ OTW^%>644?4:?=_U\@_MC$=E^/\ F>I_\)QH7_/R_P#WZ;_"
MC_A.-"_Y^7_[]-_A7EE%'U&GW?\ 7R#^V,1V7X_YGJ?_  G&A?\ /R__ 'Z;
M_"C_ (3C0O\ GY?_ +]-_A7EE%'U&GW?]?(/[8Q'9?C_ )GJ?_"<:%_S\O\
M]^F_PIX\=Z"(63[3)DG_ )XM_A7E-%'U&GW?]?(/[8Q'9?C_ )GJ?_"<:%_S
M\O\ ]^F_PH_X3C0O^?E_^_3?X5Y911]1I]W_ %\@_MC$=E^/^9ZG_P )QH7_
M #\O_P!^F_PH_P"$XT+_ )^7_P"_3?X5Y911]1I]W_7R#^V,1V7X_P"9ZG_P
MG&A?\_+_ /?IO\*/^$XT+_GY?_OTW^%>644?4:?=_P!?(/[8Q'9?C_F>I_\
M"<:%_P _+_\ ?IO\*/\ A.-"_P"?E_\ OTW^%>644?4:?=_U\@_MC$=E^/\
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MH_X3C0O^?E_^_3?X5Y911]1I]W_7R#^V,1V7X_YGJ?\ PG&A?\_+_P#?IO\
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MHH **** "BBB@ HHHH **** "BBB@ JO??\ 'C-_NU8JO??\>,W^[0 FG_\
M(/B^G]:LU6T__D'Q?3^M6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH S])^[/_P!=*T*S])^[/_UT
MK0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J3_ .N:K=5)_P#7-0!'
M1110!E>)O^1>N_\ KD__ * :\AKU[Q-_R+UW_P!<G_\ 0#7D->K@?A9\UG/\
M2'H%%%%>B>$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% &CH^L3:3<[ER\+']Y'GK[CWKT"UNH;VV2>V</&PX
M/I[5Y=6CH^L3:3<[ER\+']Y'GK[CWKBQ.&51<T=SUL!CW0?)/X?R/1J*AM;J
M&]MDGMG#QL.#Z>U35X[33LSZM-25T%%%%(84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 JL58,IP1T-:=K="=<-PXZCUK+I58JP93@CH: -NBJ]K="=<-PXZCU
MJQ0 4444 %%%% !1110 5?JA5^@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ JO??\>,W^[5BJ]]_QXS?[M ":?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!HZ/K$VDW.Y<O"Q_>1YZ^X]Z] M;J&]MDGMG#
MQL.#Z>U>75HZ/K$VDW.Y<O"Q_>1YZ^X]ZXL3AE47-'<]; 8]T'R3^'\CT:BH
M;6ZAO;9)[9P\;#@^GM4U>.TT[,^K34E=!1112&%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 *K%6#*<$=#6G:W0G7#<..H]:RZ56*L&4X(Z&@#;HJO:W0G7#<.
M.H]:L4 %%%% !1110 5?JA5^@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ JO??\ 'C-_NU8JO??\>,W^[0 FG_\
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M70H  MW  [?+'7M% !1110!\ZV?QF\4V'C*:;5;@7.B0WI@GA6W0>6A9L88
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(!#?BN: -#XM>%?#VF_"[5[O3M"TRTN8_)V306<:.N9D!PP&1P2/QK=^$?\
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M5\0O$V@ZHY33C&]U; G[VU2Z >[(2/JH%=#\$-*N+R'5O&>J#-YK%PRQL1_
M&RQ'L6X_X!5KXJ_"R[\<ZA87^CW%I;W,,9AG-R6 =,Y7&U3R"6Z^M>@:+I5O
MH6AV>EV8Q#:0K$O'7 ZGW)Y_&@#R7PW_ ,G/:]_U[O\ ^@QU[17 :1X"U*P^
M,6I^+)KBU:QNXBD<2,QE!(0<C;C^$]S7-_'<R:Q>^'?#.F;I=1N9VE6)3P ?
ME4G\=W/8 T >QT5!8V[6FGV]N[^8T,2QES_$0 ,U/0!XU\!_^0_XT_Z^8?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *L6
MMJ9VRW"#J?6BUM3.V6X0=3ZUIJH50JC '04 "J%4*HP!T%+110 4444 %%%%
M !5^J%7Z "BBB@ HHHH **** "BBB@ KE?B<[1_#'7F1BI^RD9![$@']*ZJN
M3^*/_)+]>_Z]C_,4 >6?#GX/Z!XO\%6^KZE>:E%<2R2*RV\L:H K$#@H3V]:
M]$\)?"/0?!NO+JVEW>I2SK&T>VXE0IANO"H#^M>=_#G5OB7:>"K>+PGX>TV^
MTP22&.>XD4.3N.X8,R]_:O5?!.H>-+X7O_"<Z19Z:4\O[+]E<-YF=V_.)'Z8
M7TZF@#G_ (H_$*^T&ZM/#?A6,3:[J&,,%W>2K'"X'3<3Z] ,]Q679_ U]7A6
MZ\<^)-2OKZ0;G6"4;8V] SAL_@!6;H"C4OVH=5FN\.UJLABSVVHJ#]":].\9
M^(]1\,Z5#=:3X>NM>EDF$;06I;*#!.X[58XXQT[]: .(A^&OBGP7J5M=>!_$
M-Q=V0F43Z=>. #'GD_W2<>RGTKJ/BR[1_"K7"C%3Y*C(/8R*"/R-<DWQOU*S
MU2RL]:\#7NF?:Y516N;AD)!8 D!HANQGUKK/BY_R2G7/^N2?^C%H \W^'_P:
M\/>*_ NGZUJ-YJ<=S=>9O2"6,(-LK(, H3T4=Z])\%_#+1O M]<W6D7-_-)<
MQB-Q=2JR@ YX"JO/UKS;X?\ Q#\0Z%X%T_3M.\!:GJ]M#YFR]@,FR7,K,<8B
M8<$D=3TKU#P3XMU;Q2+W^V/"U[X?^S>7Y?VHM^^W;LXW(O3:/7[PH \BU+PS
M:>-?VA]7TG5Y[E(""VZ!P'&V)< %@1C\*T_%WPF/@709_$7@[7M1@EL<221R
MR#++D D,H7IUP0<UE7^N7OA[]H;6+_3-&N-:G7*BTM]VX@QKD\*QX^E6?$OQ
M$\0>.[I/!C:9#X8-\ZI-_:$C!R,Y"Y*C&2/3)Z9]4!ZS\.O$MQXL\"V&JWJJ
MMTX:.;:,!F5BNX#WP#^-=/6-X3\.6_A/PO9Z-:N9%MD.Z0C!D8DEF_$D_ABM
MFF 4444 %5[[_CQF_P!VK%5[[_CQF_W: $T__D'Q?3^M6:K:?_R#XOI_6K-
M!7C'Q29CXR())"VZ8&>G6O9Z\7^*/_(Z-_U[Q_UKT,O_ (WR/#SW_=/FOU+V
MK?"VZTK3)[ZSU59VMT:1D,)C. ,G!W'G%:?PM\17U_-<Z7?3/<)%$)8GD;+*
M 0"N>XY&/3%9&N^+?&=UI,T-]I3V%M(I221+.1,J>HRQ.*T/A1<:1')<0AI!
MJLJ\^8 %*#G"_P SFNJHJCP\G5U?2QYN'="./@L->*ZWOK]YC?%)B?&1!)(%
MNF!GIUK27X37#V4=Q9ZPAE= P5X"@&1G[P8_RK,^*/\ R.C?]>\?]:]@T_\
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M *4GQ+T;4-9TFS33+9KAXYR652,@%3SS5II8V[[F4HREE*C%7?*CEM"^&/\
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MNS_]=*T*S])^[/\ ]=*T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N@\/>'C>LMU>J1;@Y53_RT_\ K4>'O#QO66ZO5(MP
M<JI_Y:?_ %J[8 *H50  , #M7G8G$\ON0W/=R_+^>U6JM.B[@ %4*H  & !V
MI:**\H^E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD\M%_P#6/'T(I[_"?0GD9S=:@-Q)P)$X_P#'*OZ+\/\ 2M!UB/4;&XO3+&&
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M-.&R%@<)5I5)UZS7-+HMD%%%%<9ZQGZ3]V?_ *Z5H5GZ3]V?_KI6A0 4444
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M ( ?V+_T\_#_ ()X917N=%'U_P#N_C_P _L7_IY^'_!/#**]SHH^O_W?Q_X
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M ( ?V+_T\_#_ ()X917N=%'U_P#N_C_P _L7_IY^'_!/#**]SHH^O_W?Q_X
M?V+_ -//P_X)X917N=%'U_\ N_C_ , /[%_Z>?A_P3PRBO<Z*/K_ /=_'_@!
M_8O_ $\_#_@GAE%>YT4?7_[OX_\  #^Q?^GGX?\ !/#**]SHH^O_ -W\?^ '
M]B_]//P_X)X917N=%'U_^[^/_ #^Q?\ IY^'_!/#**]SHH^O_P!W\?\ @!_8
MO_3S\/\ @GAE%>YT4?7_ .[^/_ #^Q?^GGX?\$\,HKW.BCZ__=_'_@!_8O\
MT\_#_@GAE%>YT4?7_P"[^/\ P _L7_IY^'_!/#**]SHH^O\ ]W\?^ ']B_\
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MFMFB@#&\B7_GD_\ WR:FM[-Y'_>*44=<C&:TZ* $50JA5& .@I:** "BBB@
MHHHH **** "BBB@ J_5"K] !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !5>^_X\9O]VK%5[[_ (\9O]V@!-/_ .0?
M%]/ZU9JMI_\ R#XOI_6K- !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 9^D_=G_ .NE:%9^D_=G_P"N
ME:% !1110 4444 %%%8WBO1;WQ!H$MAIFLW&C7#NK"[MP=R@')'#*>?8C^E
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M%15+;_ZW\* (SU-)2GJ:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
M6#_7"HJE@_UPH DN?NK]:K59N?NK]:K4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% %V3_5M]*I5=D_U;?2J5 !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!;@_U(JM)_K&^M68/]2*K2?ZQOK0 VBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J_5"K] !1110 4444 %%%% !1110 4444
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M-Q*G@30H$)$4LRLX'<K'Q_,TP*'_  NKQ7J]U*?#'AF.>WBY8>3+<.J^K%"
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MUPH DN?NK]:K59N?NK]:K4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% %V3_ %;?2J579/\ 5M]*I4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% %N#_ %(JM)_K&^M68/\ 4BJTG^L;ZT -HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *OU0J_0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 57OO^/&;_=JQ5>^_P"/&;_=H 33
M_P#D'Q?3^M6:K:?_ ,@^+Z?UJS0 4444 %%%% !1110 4444 %%%% !1110
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MD'_;D)Q]0171?##X4R>&;L:UX@,;:B%(@@0[E@R,$D]VQQQP/?MZG10!XO\
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M6 X. <CEF;G'\- '>VELEG906T?W(8UC7Z 8'\JFHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
M6W_UOX5%4MO_ *W\* (SU-)2GJ:2@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ J6#_7"HJE@_P!<* )+G[J_6JU6;G[J_6JU !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!=D_U;?2J579/]6WTJE0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 6X/]2*K2?ZQOK5F#_4BJTG^L;ZT -HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *OU0J_0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 57OO\ CQF_W:L5
M7OO^/&;_ ': $T__ )!\7T_K5FJVG_\ (/B^G]:LT %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!GZ3
M]V?_ *Z5H5GZ3]V?_KI6A0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M4G_US5;JI/\ ZYJ (Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "I
ME_X]7^O^%0U,O_'J_P!?\* (:*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "I;?_6_A452V_\ K?PH C/4TE*>II* "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "I8/]<*BJ6#_ %PH DN?NK]:K59N?NK]:K4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% %V3_5M]*I5=D_U;?2J5 !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!;@_U(JM)_K&^M68/]2*K2?ZQOK0 V
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J_5"K] !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>^_P"/
M&;_=JQ5>^_X\9O\ =H 33_\ D'Q?3^M6:K:?_P @^+Z?UJS0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% &?I/W9_\ KI6A6?I/W9_^NE:% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !52?_7-5NJD_P#KFH CHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *F7_CU?Z_X5#4R_\>K_ %_PH AHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *EM_];^%15+;_P"M_"@",]324IZFDH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *E@_UPJ*I8/\ 7"@"2Y^ZOUJM5FY^ZOUJM0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 79/]6WTJE5V3_5M]*I4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% %N#_4BJTG^L;ZU9@_U(JM)_
MK&^M #:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "K]4*OT %%%%
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MU'YT;AZC\Z %HI-P]1^=&X>H_.@!:*3</4?G1N'J/SH 6BDW#U'YT;AZC\Z
M%HI-P]1^=&X>H_.@!:*3</4?G1N'J/SH 6BDW#U'YT;AZC\Z %HI-P]1^=&X
M>H_.@!:*3</4?G1N'J/SH 6BDW#U'YT;AZC\Z %HI-P]1^=&X>H_.@!:OUG[
MAZC\ZT* "BBB@ H(#*0PR#P0>]%% &;_ ,([I'_0/A_[YH_X1W2/^@?#_P!\
MUI44 9O_  CND?\ 0/A_[YH_X1W2/^@?#_WS6E10!F_\([I'_0/A_P"^:/\
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MD?\ 0/A_[YK2HH S?^$=TC_H'P_]\T?\([I'_0/A_P"^:TJ* ,W_ (1W2/\
MH'P_]\T?\([I'_0/A_[YK2HH S?^$=TC_H'P_P#?-'_".Z1_T#X?^^:TJ* ,
MW_A'=(_Z!\/_ 'S1_P ([I'_ $#X?^^:TJ* ,W_A'=(_Z!\/_?-'_".Z1_T#
MX?\ OFM*B@#-_P"$=TC_ *!\/_?-'_".Z1_T#X?^^:TJ* ,W_A'=(_Z!\/\
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M^B@"A_86F?\ /E%^5']A:9_SY1?E5^B@"A_86F?\^47Y4?V%IG_/E%^57Z*
M*']A:9_SY1?E1_86F?\ /E%^57Z* *']A:9_SY1?E1_86F?\^47Y5?HH H?V
M%IG_ #Y1?E1_86F?\^47Y5?HH H?V%IG_/E%^5']A:9_SY1?E5^B@"A_86F?
M\^47Y4?V%IG_ #Y1?E5^B@"A_86F?\^47Y4?V%IG_/E%^57Z* *']A:9_P ^
M47Y4?V%IG_/E%^57Z* *']A:9_SY1?E1_86F?\^47Y5?HH H?V%IG_/E%^5'
M]A:9_P ^47Y5?HH H?V%IG_/E%^5']A:9_SY1?E5^B@"A_86F?\ /E%^5']A
M:9_SY1?E5^B@"A_86F?\^47Y4?V%IG_/E%^57Z* *']A:9_SY1?E1_86F?\
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M]% %#^PM,_Y\HORH_L+3/^?*+\JOT4 4/["TS_GRB_*C^PM,_P"?*+\JOT4
M4/["TS_GRB_*C^PM,_Y\HORJ_10!0_L+3/\ GRB_*C^PM,_Y\HORJ_10!0_L
M+3/^?*+\J/["TS_GRB_*K]% %#^PM,_Y\HORK>JA5^@ HHHH **** "BBB@
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M_P#'J_U_PJ&IE_X]7^O^% $-%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !4MO_K?PJ*I;?_6_A0!&>II*4]324 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %2P?ZX5%4L'^N% $ES]U?K5:K-S]U?K5:@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH NR?ZMOI5*KLG^K;Z52H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** +<'^I%5I/]8WUJS!_J15:3_6-]: &T444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+_T#4_[_ !_PH_X61+_T#4_[_'_"N)HH^J4>WYA_:>+_ )_P7^1VW_"R)?\
MH&I_W^/^%'_"R)?^@:G_ '^/^%<311]4H]OS#^T\7_/^"_R.V_X61+_T#4_[
M_'_"C_A9$O\ T#4_[_'_  KB:*/JE'M^8?VGB_Y_P7^1VW_"R)?^@:G_ '^/
M^%'_  LB7_H&I_W^/^%<311]4H]OS#^T\7_/^"_R.V_X61+_ - U/^_Q_P *
M/^%D2_\ 0-3_ +_'_"N)HH^J4>WYA_:>+_G_  7^1VW_  LB7_H&I_W^/^%'
M_"R)?^@:G_?X_P"%<311]4H]OS#^T\7_ #_@O\CMO^%D2_\ 0-3_ +_'_"C_
M (61+_T#4_[_ !_PKB:*/JE'M^8?VGB_Y_P7^1VW_"R)?^@:G_?X_P"%'_"R
M)?\ H&I_W^/^%<311]4H]OS#^T\7_/\ @O\ ([;_ (61+_T#4_[_ !_PH_X6
M1+_T#4_[_'_"N)HH^J4>WYA_:>+_ )_P7^1VW_"R)?\ H&I_W^/^%'_"R)?^
M@:G_ '^/^%<311]4H]OS#^T\7_/^"_R.V_X61+_T#4_[_'_"C_A9$O\ T#4_
M[_'_  KB:*/JE'M^8?VGB_Y_P7^1VW_"R)?^@:G_ '^/^%'_  LB7_H&I_W^
M/^%<311]4H]OS#^T\7_/^"_R.V_X61+_ - U/^_Q_P */^%D2_\ 0-3_ +_'
M_"N)HH^J4>WYA_:>+_G_  7^1VW_  LB7_H&I_W^/^%'_"R)?^@:G_?X_P"%
M<311]4H]OS#^T\7_ #_@O\CMO^%D2_\ 0-3_ +_'_"C_ (61+_T#4_[_ !_P
MKB:*/JE'M^8?VGB_Y_P7^1VW_"R)?^@:G_?X_P"%.'Q+F$93^S8\$_\ /8_X
M5P]%'U2CV_,/[3Q?\_X+_([;_A9$O_0-3_O\?\*/^%D2_P#0-3_O\?\ "N)H
MH^J4>WYA_:>+_G_!?Y';?\+(E_Z!J?\ ?X_X4?\ "R)?^@:G_?X_X5Q-%'U2
MCV_,/[3Q?\_X+_([;_A9$O\ T#4_[_'_  H_X61+_P! U/\ O\?\*XFBCZI1
M[?F']IXO^?\ !?Y';?\ "R)?^@:G_?X_X4?\+(E_Z!J?]_C_ (5Q-%'U2CV_
M,/[3Q?\ /^"_R.V_X61+_P! U/\ O\?\*/\ A9$O_0-3_O\ '_"N)HH^J4>W
MYA_:>+_G_!?Y';?\+(E_Z!J?]_C_ (4?\+(E_P"@:G_?X_X5Q-%'U2CV_,/[
M3Q?\_P""_P CMO\ A9$O_0-3_O\ '_"C_A9$O_0-3_O\?\*XFBCZI1[?F']I
MXO\ G_!?Y';?\+(E_P"@:G_?X_X4?\+(E_Z!J?\ ?X_X5Q-%'U2CV_,/[3Q?
M\_X+_([;_A9$O_0-3_O\?\*/^%D2_P#0-3_O\?\ "N)HH^J4>WYA_:>+_G_!
M?Y';?\+(E_Z!J?\ ?X_X4?\ "R)?^@:G_?X_X5Q-%'U2CV_,/[3Q?\_X+_([
M;_A9$O\ T#4_[_'_  H_X61+_P! U/\ O\?\*XFBCZI1[?F']IXO^?\ !?Y'
M;?\ "R)?^@:G_?X_X4?\+(E_Z!J?]_C_ (5Q-%'U2CV_,/[3Q?\ /^"_R.V_
MX61+_P! U/\ O\?\*/\ A9$O_0-3_O\ '_"N)HH^J4>WYA_:>+_G_!?Y';?\
M+(E_Z!J?]_C_ (4?\+(E_P"@:G_?X_X5Q-%'U2CV_,/[3Q?\_P""_P CMO\
MA9$O_0-3_O\ '_"C_A9$O_0-3_O\?\*XFBCZI1[?F']IXO\ G_!?Y';?\+(E
M_P"@:G_?X_X4?\+(E_Z!J?\ ?X_X5Q-%'U2CV_,/[3Q?\_X+_([;_A9$O_0-
M3_O\?\*/^%D2_P#0-3_O\?\ "N)HH^J4>WYA_:>+_G_!?Y';?\+(E_Z!J?\
M?X_X4?\ "R)?^@:G_?X_X5Q-%'U2CV_,/[3Q?\_X+_([;_A9$O\ T#4_[_'_
M  H_X61+_P! U/\ O\?\*XFBCZI1[?F']IXO^?\ !?Y';?\ "R)?^@:G_?X_
MX4Y/B7,C9&FQ_C,?\*X>BCZI1[?F']IXO^?\%_D=M_PLB7_H&I_W^/\ A1_P
MLB7_ *!J?]_C_A7$T4?5*/;\P_M/%_S_ (+_ ".V_P"%D2_] U/^_P ?\*/^
M%D2_] U/^_Q_PKB:*/JE'M^8?VGB_P"?\%_D=M_PLB7_ *!J?]_C_A1_PLB7
M_H&I_P!_C_A7$T4?5*/;\P_M/%_S_@O\CMO^%D2_] U/^_Q_PH_X61+_ - U
M/^_Q_P *XFBCZI1[?F']IXO^?\%_D=M_PLB7_H&I_P!_C_A1_P +(E_Z!J?]
M_C_A7$T4?5*/;\P_M/%_S_@O\CMO^%D2_P#0-3_O\?\ "C_A9$O_ $#4_P"_
MQ_PKB:*/JE'M^8?VGB_Y_P %_D=M_P +(E_Z!J?]_C_A1_PLB7_H&I_W^/\
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MQ_PH_P"%D2_] U/^_P ?\*XFBCZI1[?F']IXO^?\%_D=M_PLB7_H&I_W^/\
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MU_:,O]U/R/\ C1_:,O\ =3\C_C56B@"U_:,O]U/R/^-']HR_W4_(_P"-5:*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/TG[L_P#UTK0K/TG[L_\
MUTK0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J3_ZYJMU4G_US4 1T
M444 97B;_D7KO_KD_P#Z :\AKU[Q-_R+UW_UR?\ ] ->0UZN!^%GS6<_Q(>@
M4445Z)X04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-S>7&1;6B'!<CJ2>RCCGWKC+.?XR>*(5OK6;3?#UO(-\44\0W%>V0R.P_'%
M'KU%>30^*_B+X/U*VB\::9;ZKIL\RPF^LP 4+' /R@ #V*C/K7:_$+6+S0/
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M ,@^+Z?UJS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% &?I/W9_P#KI6A6?I/W9_\ KI6A0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 54G_US5;JI/_KFH CHHHH RO$W_(O7
M?_7)_P#T UY#7KWB;_D7KO\ ZY/_ .@&O(:]7 _"SYK.?XD/0****]$\(***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***V-"T*359O,EREJA^9O[W
ML*B<XPCS2-*5*=::A!:LZ#PK?7EW9LERA:./A)B>OM[X]:WZ9%%'!"L4*!$0
M851VI]>!4DIS<DK'W%"G*E24).[04445F;!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]]_QXS?[M ":?_R#XOI_6K-5M/\ ^0?%]/ZU9H **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M45L:%H4FJS>9+E+5#\S?WO85$YQA'FD:4J4ZTU""U8:%H4FJS>9+E+5#\S?W
MO85WD44<$*Q0H$1!A5':B**."%8H4"(@PJCM3Z\.M6E5EY'V.#P<,-"RU?5A
M1116!VA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M30 5CZ[XLT3PU<64&MWPM9+]REL#&[;V!4'[H./O+R<=:V*\:^/'_(?\%_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.E.6,NEU1V4L11IY7:35W%JWWC/@_*XNM4B'^K*1L?8@L/ZFM?XM?\BG;?\
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MU3LOZ^8?V/A^[_#_ "/*?^$*U_\ Y\1_W^3_ .*H_P"$*U__ )\1_P!_D_\
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MQ'_?Y/\ XJC_ (0K7_\ GQ'_ '^3_P"*KU:BCZ]4[+^OF']CX?N_P_R/*?\
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MU3LOZ^8?V/A^[_#_ "/*?^$*U_\ Y\1_W^3_ .*H_P"$*U__ )\1_P!_D_\
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M_P"?$?\ ?Y/_ (JO5J*/KU3LOZ^8?V/A^[_#_(\I_P"$*U__ )\1_P!_D_\
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M^$*U_P#Y\1_W^3_XJC_A"M?_ .?$?]_D_P#BJ]6HH^O5.R_KYA_8^'[O\/\
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MQ#8Z 5<HH **** "BBB@ HHHH **** "BBB@ J_5"K] !1110 4444 %%%%
M!1110 5F:_XBTKPOIG]H:[=BUM=XC\PHSY8]!A03V/:M.O,/C_\ \DWC_P"O
M^+_T%Z /2+*\@U'3[>]LY/-M[F)9HGP1N1AD'!YZ&J>O^(]*\+Z9_:&NW?V6
MUWB/S/+9_F.<#"@GL:J^!_\ DGOAW_L%VW_HI:XWX_\ _)-X_P#K_B_]!>@#
MTFSNX-0L8+RSD$MO<1K+%( 1N1AD'GU!KC7^,G@*.1D;7AE20<6DY'YA,&MO
MP/\ \D]\._\ 8+MO_12UY#\ M!TC6;'6VU?2K*_,4D(C-U;I+LR'SC<#CH*
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M8:5:QVMK",)%&N /\3[GDUF>*/!>A>,+9(M=LEF:,$13*2LD>?1A_(\5O44
M>7P?L_\ @^&Y$LDVJ3IG/E27"!?_ !U ?UKT+3M%TW2-)73-,LXK:S52HAC&
M!SUSW)/KUJ]10!Y4?V>?"98D7^LCV$\7'_D.M;PM\'?#_A+Q#!K.FWFIRW$
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M* "BBB@ HHHH **** "BBB@ HHHH *F7_CU?Z_X5#4R_\>K_ %_PH AHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *EM_];^%15+;_P"M_"@",]32
M4IZFDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *E@_UPJ*I8/\ 7"@"
M2Y^ZOUJM5FY^ZOUJM0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=Z]K\#_\D]\._P#8+MO_ $4M<;\?_P#DF\?_ %_Q?^@O2 [+P/\ \D]\._\
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M"?O),8\QSRS?B3^6*VJPO#?C7P_XN:X7P]J(NVM@IE'E/&5#9Q]]1GH>E;M
M!1110 57OO\ CQF_W:L57OO^/&;_ ': $T__ )!\7T_K5FJVG_\ (/B^G]:L
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!GZ3]V?_ *Z5H5GZ3]V?_KI6A0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 54G_US5;JI/\ ZYJ (Z*** "BBB@ HHJ.YN([2UEN
M)SMCA0NY] !DT 245\]?\)CXV^)GBJ33_#-[)IL 5I$BBE,0BC! W.Z_,3R.
MG<\"NBT?3/BCX5\3Z:E_?2ZQIEQ<QQ7+B9KE41F 8G> ZX!)STX]* /8Z***
M "H+R^M-.MC<:A=0VL"\&6>0(H_$\5/7SM\9KRZU7XFQ:0\Q6W@2**)<Y52^
M"6QZ_,/R% 'ONGZOINK*S:5J%K>JGWC;3K(%^NTFKE<?X+^&^F^![VYN--O+
MN<W,2QNLY4@$'.1@"NPH ***\X^*?Q$U3P/=:=#I-M9S?:D=G-RC-C:0!C:P
M]: /1Z*S] U"35O#>F:C,BI)>6D4[JG12Z!B![<UH4 %%%% !117R[X8O_&W
MC'7QIFG>*;^*XD1I-TVH3(@ Y/W<X_*@#ZBHKQ:/X;?%%9%)\:X ()/]IW+?
MH5P?I7M- !1110 4444 %%%% !1110 4444 %%%% %34-6T[28EDU6_M;*-S
MA7N9EC#'T!8BK$,T=Q"DT$B2Q.-RNC JP]01UKS[XI_#O4O'$FG2Z5=VL+V@
M=72Y9E!#8.05!YX]*ZOPAH<GAOPCI^D3S+/):Q[7D48!)))QGMSB@#9J9?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI8/]<*BJ6#_7"@"2Y^ZOUJM5FY^ZOUJM0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 79/\ 5M]*I5=D_P!6WTJE0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 6X/\ 4BJTG^L;ZU9@_P!2*K2?ZQOK0 VBBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J_5"K] !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>^_X\9O]VK%5[[_
M (\9O]V@!-/_ .0?%]/ZU9JMI_\ R#XOI_6K- !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9^D_=G_
M .NE:%9^D_=G_P"NE:% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !52?
M_7-5NJD_^N:@".BBB@ HHHH *K:EI]OJVEW.GWJ;[>YB:*10<$J1@\]JLT4
M>.WO[/5E),3I^OSV\6>$FMA*1^(9?Y5O>$O@UHGAK4(]0NIY=3NX2&B,JA(X
MV'1@HSS]2<5Z)10!RWC?P#IGCBRBCO7>WN;?/DW,0!90>H(/4<=*XK3/V?M/
MM[Y)=4UJ:]@5LF&.W$6[V+;FX^F*]>HH X3X??#)? E_>70U4WYN8Q&%^S^7
ML .?[QS^E5?$_P )D\2>.!XA.LM;C=$S6_V;=G8 /O;AUQZ5Z+10!5U/3+/6
M=,GT_4H5GM;A=LD;<9'X=#GG->47_P"SW8RW#-INO3VT1.0DUL)2/;(9?Y5[
M#10!YQX,^#MEX2U^WUA]5GO;FW#"-1$(TRRE22,DG@GO71>-O!&G^.-*CM;Z
M22"6!R\%Q& 2A/!&#U!XX]A72T4 >9^#/@W#X2\30:R^M/>O;A_+C%MY8RRE
M3D[CGAC6K\8(K&7X9Z@=1;:49&MR!D^;NPH'UR0?8FNWKGO&'@RP\:Z=!9:I
M<WD,,,OF@6TBKN;!'.Y2#U- 'E'P"T#[1K-_KLR_):QB"$GN[<L?P48_X%7O
M%8_A?PQI_A'15TS21)Y(<R,\K N['J20!Z =.U;% !7BK_L[J78Q^)RJY^4-
M89('U\RO:J* /%5_9XVN#_PE!X.>+#!_]&5UOC[X:S^.]3M9Y=>:SM;:/:EL
M+7>,D_,V=XY/ Z=J[VB@#G[_ ,&Z9?>"#X8V>79K (HF !:-AT?ZYY]^?6N<
M\'?#>?P'#JL@UPWUO=6K*T'V;RP&'1L[SVR/Q]J]#ILL:S0O&_*NI4_0T ?+
M7PT\,6/B[Q1-I>I&18VM'=7B;#(P*X(['KT->D6'[/NGPWRR:AKDUU;AL^3'
M;B(L/0MN/Z 5UGA3X7:%X.UE]3TR:^EG:,Q@7$JLJ@D$X 4>G?-=G0!G7F@:
M;?>'7T.:U0:<T(A$*\!5'3'IC (^E>63?L\VK71:#Q#,EOGB-[0,V/\ >W ?
MI7LE% 'EMI\#[#3O$VF:II^K2QPV$L4I@DAWM*Z-N)+[@!DCLO%;7Q#^&R^/
M)K&7^U#8-:*Z_P#'OYH<,0?[RXZ5W%% &?H&DKH7AZQTM)3,+.!8A(5QOP,9
MQVKBO#'PF3PWXX/B$:RUP-TK+;_9MN-X(^]N/3/I7HM% 'G/C/X.:=XKUF75
M8-1FT^[GQYO[L2HQ  SMR"#@>M5?#/P-TG1=2AOM3OY=4D@8/'&8A%'N!X)&
M23CTS7J%% '%_$3X=KX^33\ZF;!K(R8/D>:'#[<\;AC[@K=T+P_#H_A.VT&5
MQ>00P&!V=,"4'.<CG@YZ5KT4 >2:O\ -*NKMI='U:?3XV.?)DA$P7V!W*<?7
M-:?A;X':)H=TFH:E=RZK- P:.-XQ'$&]2N23]"<?6O2*F7_CU?Z_X4 <QXW\
M*+XR\-/I+79L]TBR"41[\%?;(_G4/@'P8O@;P_+IBWQOC+<M<-*8O+P2JKC&
M3_='>NGHH \Z\3_"9/$GC=?$)UEK;YHF:W^S;\[ !PVX8SCTKT6BB@ KS7Q/
M\$M#UV_DO=.N9=*FE):1(T#Q%CW"\8_ X]J]*HH \=L?V>[&*X5M1U^>YB!Y
M2&V$1/XEF_E7JFC:-8>']*AT[2;=;>VB'RJ.I/<D]R?6KU% 'S)XXMXKOXWW
M5M<+OBFU"&-USC*D("/RKNKG]GNP>_+VNO3PVI.1"]N'<#TW[A_Z#76:C\*M
M U/QA_PD=Q-?"[\Y)C$DJB,LN,<;<]AWKM: ,?PQX8T[PEHJ:;I,96,'=)(Y
MR\KGJS'UXKC_ !C\&=+\4:M)J=G?2:9=3G=-B(2([=VVY&"?K7I%% 'E5I\!
M](MM%N[>74)+B_GC"1W;PC;!R#E8\]3C'+?2NM\&>"8/"GA.70I[D:C%/)(T
MK/%L#!P 5VY/&!ZUU%% 'C^H?L^6$UZTFFZY-:6[-D0R6XE*CT#;A^HIUW^S
M]ITD-JEEK4T#1@^>\D D,Q)[?, H ^M>O44 9OB'0;+Q-H5QI6IJQ@G R4.&
M0@Y# ^H(KS*P^ -M9ZO!=OX@DEAAE601"U"L<'.-V\^GI7K]% ',>,_ .D>-
MK:-=2$D-S""(;F$X= >Q!X(]C^&*\^_X9XC\W/\ PDK^7_=^PC/Y^9_2O:**
M .;\$>"K/P/I,ME97,USYTOFR22X'. . .@P*Z2BB@#R'XK0MX=\?>&O&"+^
MY258+DC_ &3G\RC./^ UZ7X@TO\ X2+PS>Z;#=FW%[ 8Q<(-VT'OC(R,>_(I
MOB7PY8>*M#FTK50_D2D,&C(#HP.0RD@X/X5:TK3TTG2+73XIIIH[6)8DDG8%
MV &!D@#)Q[4 >7Z?\%M8TF%HM*\?7UE&[;F2V@>,,>F2%F'-:-E\,O$UM?V\
M\OQ'U:>.*57:)A)AP#DJ<RD<].0?I7I5% &7XB\.Z?XHT673-7B,D$A# J<,
MC#HRGL17GB_!6^@@:RL_&^I0::W#6@1MI'H<2!3_ -\UZO10!A>$O!^E^#=*
M-EI*,2Y#33R'+RMZD_R':N4\8?">?Q1XN.O0>(Y=/E"H(U6W+F(J."K!QCGG
MZUZ110!Y?_PJOQ3_ -%-UC\I?_CU=CX0\/ZAX<TJ6UU77KK7)7F,BSW(.47
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M1110 4444 %%%% %N#_4BJTG^L;ZU9@_U(JM)_K&^M #:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "K]4*OT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %5[[_CQF_W:L57OO^/&;_=H
M 33_ /D'Q?3^M6:K:?\ \@^+Z?UJS0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &?I/W9_^NE:%9^D
M_=G_ .NE:% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !52?_ %S5;JI/
M_KFH CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *F7_CU?Z_X5#4
MR_\ 'J_U_P * (:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "I;?_
M %OX5%4MO_K?PH C/4TE*>II* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "I8/\ 7"HJE@_UPH DN?NK]:K59N?NK]:K4 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% %V3_5M]*I5=D_U;?2J5 !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!;@_U(JM)_K&^M68/]2*K2?ZQOK0 VBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ J_5"K] !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>^_X\9O]VK%5[[_C
MQF_W: $T_P#Y!\7T_K5FJVG_ /(/B^G]:LT %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!GZ3]V?_KI
M6A6?I/W9_P#KI6A0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 54G_P!<
MU6ZJ3_ZYJ (Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IE_X]7^
MO^%0U,O_ !ZO]?\ "@"&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M J6W_P!;^%15+;_ZW\* (SU-)2GJ:2@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ J6#_ %PJ*I8/]<* )+G[J_6JU6;G[J_6JU !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!=D_U;?2J579/]6WTJE0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 6X/]2*K2?ZQOK5F#_4BJTG^L;ZT -HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *OU0J_0 4444 %%%% !1110
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MOJ/SHW+ZC\ZSO^$=TC_H'P_]\T?\([I'_0/A_P"^: -'<OJ/SHW+ZC\ZSO\
MA'=(_P"@?#_WS1_PCND?] ^'_OF@#1W+ZC\Z-R^H_.L[_A'=(_Z!\/\ WS1_
MPCND?] ^'_OF@#1W+ZC\Z-R^H_.L[_A'=(_Z!\/_ 'S1_P ([I'_ $#X?^^:
M -'<OJ/SHW+ZC\ZSO^$=TC_H'P_]\T?\([I'_0/A_P"^: -'<OJ/SHW+ZC\Z
MSO\ A'=(_P"@?#_WS1_PCND?] ^'_OF@#1W+ZC\Z-R^H_.L[_A'=(_Z!\/\
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MA:9_SY1?E1_86F?\^47Y4 7MP]1^=&X>H_.J/]A:9_SY1?E1_86F?\^47Y4
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M0!>W#U'YUH5@_P!A:9_SY1?E6]0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 57OO^/&;_=JQ5>^_X\9O]V@!-/\
M^0?%]/ZU9JMI_P#R#XOI_6K- !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 9^D_=G_ZZ5H5GZ3]V?\
MZZ5H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5)_\ 7-5NJD_^N:@"
M.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J9?^/5_K_A4-3+_P >
MK_7_  H AHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *EM_\ 6_A4
M52V_^M_"@",]324IZFDH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *E@
M_P!<*BJ6#_7"@"2Y^ZOUJM5FY^ZOUJM0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 79/]6WTJE5V3_5M]*I4 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% %N#_4BJTG^L;ZU9@_U(JM)_K&^M #:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "K]4*OT %%%% !1110 4444 %%%% !1110
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M_P )/H'_ $'--_\  N/_ !H]G/L'/'N:E%9?_"3Z!_T'--_\"X_\:/\ A)]
M_P"@YIO_ (%Q_P"-'LY]@YX]S4HK+_X2?0/^@YIO_@7'_C1_PD^@?]!S3?\
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M_P )/H'_ $'--_\  N/_ !H]G/L'/'N:E%9?_"3Z!_T'--_\"X_\:/\ A)]
M_P"@YIO_ (%Q_P"-'LY]@YX]S4HK+_X2?0/^@YIO_@7'_C1_PD^@?]!S3?\
MP+C_ ,:/9S[!SQ[FI167_P )/H'_ $'--_\  N/_ !H_X2?0/^@YIO\ X%Q_
MXT>SGV#GCW-2BLO_ (2?0/\ H.:;_P"!<?\ C1_PD^@?]!S3?_ N/_&CV<^P
M<\>YJ45E_P#"3Z!_T'--_P# N/\ QH_X2?0/^@YIO_@7'_C1[.?8.>/<U**R
M_P#A)] _Z#FF_P#@7'_C1_PD^@?]!S3?_ N/_&CV<^P<\>YJ45E_\)/H'_0<
MTW_P+C_QH_X2?0/^@YIO_@7'_C1[.?8.>/<U**R_^$GT#_H.:;_X%Q_XT?\
M"3Z!_P!!S3?_  +C_P :/9S[!SQ[FI167_PD^@?]!S3?_ N/_&C_ (2?0/\
MH.:;_P"!<?\ C1[.?8.>/<U**R_^$GT#_H.:;_X%Q_XT?\)/H'_0<TW_ ,"X
M_P#&CV<^P<\>YJ45E_\ "3Z!_P!!S3?_  +C_P :/^$GT#_H.:;_ .!<?^-'
MLY]@YX]S4HK+_P"$GT#_ *#FF_\ @7'_ (T?\)/H'_0<TW_P+C_QH]G/L'/'
MN:E%9?\ PD^@?]!S3?\ P+C_ ,:/^$GT#_H.:;_X%Q_XT>SGV#GCW-2BLO\
MX2?03TUO3?\ P+C_ ,:T?/A_YZI_WT*EQ:W0U)/8?13//B_YZI_WT*//B_YZ
MI_WT*0Q]2V_^M_"J_GQ?\]4_[Z%207$(DYFC''=A0 'J:2F&>+)_>I_WT*//
MB_YZI_WT* 'T4SSXO^>J?]]"CSXO^>J?]]"@!]%,\^+_ )ZI_P!]"CSXO^>J
M?]]"@!]%,\^+_GJG_?0H\^+_ )ZI_P!]"@!]%,\^+_GJG_?0H\^+_GJG_?0H
M ?13//B_YZI_WT*//B_YZI_WT* 'T4SSXO\ GJG_ 'T*//B_YZI_WT* 'T4S
MSXO^>J?]]"CSXO\ GJG_ 'T* 'T4SSXO^>J?]]"CSXO^>J?]]"@!]%,\^+_G
MJG_?0H\^+_GJG_?0H ?13//B_P">J?\ ?0H\^+_GJG_?0H ?13//B_YZI_WT
M*//B_P">J?\ ?0H ?13//B_YZI_WT*//B_YZI_WT* 'T4SSXO^>J?]]"CSXO
M^>J?]]"@!]%,\^+_ )ZI_P!]"CSXO^>J?]]"@!]%,\^+_GJG_?0H\^+_ )ZI
M_P!]"@!]%,\^+_GJG_?0H\^+_GJG_?0H ?13//B_YZI_WT*//B_YZI_WT* '
MT4SSXO\ GJG_ 'T*//B_YZI_WT* 'U+!_KA5?SXO^>J?]]"GPW$(E!,T8'NP
MH LW/W5^M5JDN+F!E&)HSSV<5!Y\7_/5/^^A0 ^BF>?%_P ]4_[Z%'GQ?\]4
M_P"^A0 ^BF>?%_SU3_OH4>?%_P ]4_[Z% #Z*9Y\7_/5/^^A1Y\7_/5/^^A0
M ^BF>?%_SU3_ +Z%'GQ?\]4_[Z% #Z*9Y\7_ #U3_OH4>?%_SU3_ +Z% #Z*
M9Y\7_/5/^^A1Y\7_ #U3_OH4 /HIGGQ?\]4_[Z%'GQ?\]4_[Z% #Z*9Y\7_/
M5/\ OH4>?%_SU3_OH4 /HIGGQ?\ /5/^^A1Y\7_/5/\ OH4 /HIGGQ?\]4_[
MZ%'GQ?\ /5/^^A0 ^BF>?%_SU3_OH4>?%_SU3_OH4 /HIGGQ?\]4_P"^A1Y\
M7_/5/^^A0 ^BF>?%_P ]4_[Z%'GQ?\]4_P"^A0 ^BF>?%_SU3_OH4>?%_P ]
M4_[Z% #Z*9Y\7_/5/^^A1Y\7_/5/^^A0 ^BF>?%_SU3_ +Z%'GQ?\]4_[Z%
M#Z*9Y\7_ #U3_OH4>?%_SU3_ +Z% #Z*9Y\7_/5/^^A1Y\7_ #U3_OH4 /HI
MGGQ?\]4_[Z%'GQ?\]4_[Z% &A)_JV^E4JL275N8VQ/'T_OBJGGQ?\]4_[Z%
M#Z*9Y\7_ #U3_OH4>?%_SU3_ +Z% #Z*9Y\7_/5/^^A1Y\7_ #U3_OH4 /HI
MGGQ?\]4_[Z%'GQ?\]4_[Z% #Z*9Y\7_/5/\ OH4>?%_SU3_OH4 /HIGGQ?\
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M_P#Y!\7T_K5FJVG_ /(/B^G]:LT %%%% !1110 4444 %%%% !1110 4444
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M*U&5&7+(]ZE5C5C=!1116)J%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5)
M!.T#Y7D=QZU'10!M1R+*@9#D?RIU8\$[0/E>1W'K6M'(LJ!D.1_*@!U%%% !
M1110 4444 %%%% !5^J%7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "J]]_QXS?[M6*KWW_ !XS?[M ":?_ ,@^
M+Z?UJS5;3_\ D'Q?3^M6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7>>"O&OV7R]+UB3]Q]V"=C_ *O_ &6/]WT/;Z=.#HK*K2C5CRR-
M*=25.7-$^AJ*\U\%>-?LOEZ7K$G[C[L$['_5_P"RQ_N^A[?3IZ57SE:C*C+E
MD>]2JQJQN@HHHK$U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KO/!7C7[+Y>EZQ)^X^[!.Q_P!7_LL?[OH>WTZ<'1656E&K
M'ED:4ZDJ<N:)]#45YKX*\:_9?+TO6)/W'W8)V/\ J_\ 98_W?0]OIT]*KYRM
M1E1ERR/>I58U8W04445B:A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2$%B ,<D <_A7+>)_A)X:\4ZJVIW*W5E>O@R364H0R'U(((S[@5V]% 'G3?
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MD>#=-DLM#ADCCED\R0R2%V9L 9Y]AVK)\7?"SPWXRO!>ZC%/;WF K7%HX1G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%.BB:
M5PJ#)_E0 11-*X5!D_RK6@@6"/:O)[GUH@@6!-J\GN?6I* "BBB@ HHHH *O
MU0J_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 57OO\ CQF_W:L57OO^/&;_ ': $T__ )!\7T_K5FJVG_\ (/B^
MG]:LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!GZ3]V?_ *Z5H5GZ3]V?_KI6A0 4444 %%%% !11
M10 4444 %%%% !16%XO\76'@K0QJFJQ7$L!F6$+;*K-N()[D#'![UJV%Y'J.
MFVU[ &$5S$DR!Q@A6 (S[\T 6**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *J3_P"N:K=5)_\ 7-0!'1110!P7Q?\
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M48 'I3Z^=KUY5I7>Q[M&C&E&RW"BBBN<W"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3H4ZU>ISK9GS]X<\>^)?A[XH_L7Q5)//9Q2!)X9F\QHE/1XV],'..A'I7?\
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MTK0H **** "BBB@ HHHH **** "BBB@#Q#X[V/B9=/EO+C5;=_#SW42P6(B
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 444Z*)I7"H,G^5 !%$TKA4&3_*M:"!8$VKR>Y]
M:((%@3:O)[GUJ2@ HHHH **** "BBB@ HHHH *OU0J_0 4444 %%%% !1110
M 4444 %<;\7/^24ZY_UR3_T8M=E6=X@T.U\2:!=Z1J!D6WNDV.8F 8<@@@D$
M9R!VH Y?X,?\DBT7_MO_ .CY*X+X^76G7^K:)9Z2\<^MI(RL+<@NH)&Q21WW
M=!VY]:Z#_AGCPG_T$-9_[_Q?_&ZZ3PM\*O"_A*[6\L+62YO$^Y<7;[V3W
M!]P,T 8OQQ$B_"DB=@THN(0[#H3SDUTGP]C2;X8:%%,BR1OIZ*Z.,A@5Y!'<
M5>\6>%;'QCH+Z3JDD\<#2+)NMV"N"O3D@C]*N:+I,&A:)9Z79M(T%I$L4;2$
M%B ,<D <_A0!XYX,<_#OXW:CX7=BFF:H<VP8\ GYH_\ V9/<XK3^.^JS7,&C
M^$M..ZZU2X5W0=2 =J#Z%CG_ (!7:>*?AYI'BW6-/U2^FN[:\T\CRI;615)P
MVX Y4]#DC&.IIUUX TJ]\>P>+;J:[EOK=0L4+2+Y*8! (7;GN3UZT <E:?"7
MQ186<5K9?$G4(+>%0D<4=JRJ@'8 2UQ'C+P[K'PT\8Z'XIO=;FUQWN!YMQ)%
ML?Y0 4.6;.4)'7M7T96)XM\)Z=XST)M*U8S+#YBRJ\#!71AW!((Z$CIWH Y3
MXU3QW/PBN9X'#Q2R0.C#HREP0:VOA=_R2_0?^O8?S-37W@/3-1\!P^$[FXO&
ML841$E$B^;A#E>=N.V.G2M;0=&MO#V@VFDV+2/;VD?EHTI!8CW( &?PH T**
M** "BBB@ JO??\>,W^[5BJ]]_P >,W^[0 FG_P#(/B^G]:LU6T__ )!\7T_K
M5F@ KYO^.G_)1_\ MSB_FU?2%<5XM^%FA^,M874M2N+Z&<1"(_9I$"D#..&4
M\\UVX&M"A5YI[6.3&495J7+'<T[WQ[X2M;.66?Q!IDJ*IW1Q7*2LPQT"J237
M@?PSMI-2^+=G-I,316\4\DY '^JBP>#^!"_C7IZ? +PJCAFO-6<#^%IX\'\H
MP:[;P[X3T7PI:F#1+)(-^/,D)W/)]6/)^G2MXUZ%"G*-)MN7<QE1K5JD95+)
M(\(^.G_)1_\ MSB_FU>SP^//"EAHMN]QXAT[Y(4#+'<+(X.W^ZI)_2J?BWX6
M:'XQUA=3U*XOX9Q$(B+:1 I )QPRGGFL:/X!^%$<,UWJT@_NM/'@_E&#3E5P
MU6C"$VUR]D*-*O3JSE!)W/,/%NK7?Q3^(L<>AV\C1L%MK5&'(0$DNWH,DD^@
MKZ4TVQCTS2;2PA.8[6!(4..RJ%'\JS/#G@[0O"D+)H=@D#N,23$EI''NQYQ[
M=*W*Y\5B(U5&%-6C$WP]"5-N<W>3/F/XK?\ )9=1_P"NEM_Z)CKZ<KA_$'PF
MT#Q)XFDUR^GOX[F0H72&50C%5"C@J3T4=#7<4\57A5ITXQ^RM?P%AZ,J=2I*
M75_YG@/QL\5R:UXA@\,:86DBM)!YJI_RUG;@+[[0<?5CZ5)X[^%::%\-].OK
M) ]]IZ_\3!UZR!SDGWVL<?3GM7?Z-\(?#VB^)(];2XU"[NHY#*HNI49=Y_BX
M0$D$YZ]:[>YMXKNUEMKF,20S(8Y$;HRD8(/X5N\9&DH1H[+?S,5A)5.>57=[
M>1YE\$?%_P#;'AYM"O),W>FJ/*)/+PYP/^^3Q]"M/F^ OA>:=Y3?:LI=BQ"S
M1X&3_P!<ZU?#7PFT+PKXACUC2[O4C-&' BEF0QD,",$! 2.<]>H%=S6-;$*-
M5RP[:3-:5!RIJ-=7:/*_$7P=+>"K?0?"M[M5+\WDC:C*?F)CV=43M@=O7FL*
MU^%?Q*LK5+:R\6Q6\$8PD46I7**H]  F!7N-%3''5HJVC]45+!TF[[>A\E^%
M]&UO5/&PTW1=1^QZINE NO/>/E0=WSJ"W(![<YKZ1N=:TSPOH.E6/C'4H?/F
MMUA>69699W15#DG'<G/..M9V@_"S0_#WBDZ]97%\]UF0A)9$*#>"#P%![GO6
MKXL\%Z1XSM(8-:CE/V=BT4D4FUDR.?;L.H[5OBL32KU(W^%?>8X?#U*-.5OB
M_ YC6O%'PY\-6,NHZ;#H-QJ"H6MTL88G=G[9*#Y1GJ217&_ G0;F]\0WOB2Z
M5O)A1HHW(^_*YRV/7 Z_[PKK[/X$^$K:X629]1NU!SY4TZA3[?*JG]:]!L;"
MUTRRBL]/MX[:WB&U(HUPJBIGB*5.E*%)MN6[?8<:%2=13J))+HCG$^)?A?\
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MMX3_ .@5_P"3,O\ \51_PK;PG_T"O_)F7_XJNHHH]O5_F?WL/8T_Y5]QR_\
MPK;PG_T"O_)F7_XJC_A6WA/_ *!7_DS+_P#%5U%%'MZO\S^]A[&G_*ON.7_X
M5MX3_P"@5_Y,R_\ Q5'_  K;PG_T"O\ R9E_^*KJ**/;U?YG][#V-/\ E7W'
M+_\ "MO"?_0*_P#)F7_XJC_A6WA/_H%?^3,O_P 57444>WJ_S/[V'L:?\J^X
MY?\ X5MX3_Z!7_DS+_\ %5(OPT\)&W9O[)Y!Z_:9?_BJZ2IE_P"/5_K_ (4>
MWJ_S/[V'L:?\J^XY'_A6WA/_ *!7_DS+_P#%4?\ "MO"?_0*_P#)F7_XJNHH
MH]O5_F?WL/8T_P"5?<<O_P *V\)_] K_ ,F9?_BJ/^%;>$_^@5_Y,R__ !5=
M111[>K_,_O8>QI_RK[CE_P#A6WA/_H%?^3,O_P 51_PK;PG_ - K_P F9?\
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M*V\)_P#0*_\ )F7_ .*KJ**/;U?YG][#V-/^5?<<O_PK;PG_ - K_P F9?\
MXJC_ (5MX3_Z!7_DS+_\57444>WJ_P S^]A[&G_*ON.7_P"%;>$_^@5_Y,R_
M_%4?\*V\)_\ 0*_\F9?_ (JNHHH]O5_F?WL/8T_Y5]QR_P#PK;PG_P! K_R9
ME_\ BJ/^%;>$_P#H%?\ DS+_ /%5U%%'MZO\S^]A[&G_ "K[CE_^%;>$_P#H
M%?\ DS+_ /%4?\*V\)_] K_R9E_^*KJ**/;U?YG][#V-/^5?<<O_ ,*V\)_]
M K_R9E_^*H_X5MX3_P"@5_Y,R_\ Q5=111[>K_,_O8>QI_RK[CE_^%;>$_\
MH%?^3,O_ ,51_P *V\)_] K_ ,F9?_BJZBBCV]7^9_>P]C3_ )5]QR__  K?
MPF/^85_Y,2__ !5;\6G6D,2Q0PJD: *JJ2 !Z59HJ)5)S^)W*C",?A5B#[%;
M_P#//_QXT?8K?_GG_P"/&IZ*@L@^Q6__ #S_ /'C4D-A;/)AH\C']XT^I;?_
M %OX4 5#96^3^[_\>-)]BM_^>?\ X\:L'J:2@"#[%;_\\_\ QXT?8K?_ )Y_
M^/&IZ* (/L5O_P \_P#QXT?8K?\ YY_^/&IZ* (/L5O_ ,\__'C1]BM_^>?_
M (\:GHH @^Q6_P#SS_\ 'C1]BM_^>?\ X\:GHH @^Q6__//_ ,>-'V*W_P">
M?_CQJ>B@"#[%;_\ //\ \>-'V*W_ .>?_CQJ>B@"#[%;_P#//_QXT?8K?_GG
M_P"/&IZ* (/L5O\ \\__ !XT?8K?_GG_ ./&IZ* (/L5O_SS_P#'C1]BM_\
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MMFD :/(_WC4E2P?ZX4 0SZ=:HHVQ8Y_O'_&H?L5O_P \_P#QXUH7/W5^M5J
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M/&C[%;_\\_\ QXU/10!!]BM_^>?_ (\:/L5O_P \_P#QXU/10!!]BM_^>?\
MX\:/L5O_ ,\__'C4]% $'V*W_P">?_CQH^Q6_P#SS_\ 'C4]% $'V*W_ .>?
M_CQH^Q6__//_ ,>-3T4 0?8K?_GG_P"/&C[%;_\ //\ \>-3T4 0?8K?_GG_
M ./&C[%;_P#//_QXU/10!!]BM_\ GG_X\:/L5O\ \\__ !XU/10!!]BM_P#G
MG_X\:/L5O_SS_P#'C4]% $'V*W_YY_\ CQH^Q6__ #S_ /'C4]% $'V*W_YY
M_P#CQH^Q6_\ SS_\>-3T4 0?8K?_ )Y_^/&C[%;_ ///_P >-3T4 0?8K?\
MYY_^/&C[%;_\\_\ QXU/10!!]BM_^>?_ (\:/L5O_P \_P#QXU/10!!]BM_^
M>?\ X\:/L5O_ ,\__'C4]% $'V*W_P">?_CQH^Q6_P#SS_\ 'C4]% "Q:;:M
M&"T63_O'_&H7L;<2,!'P#_>-:$'^I%5I/]8WUH K?8K?_GG_ ./&C[%;_P#/
M/_QXU/10!!]BM_\ GG_X\:/L5O\ \\__ !XU/10!!]BM_P#GG_X\:/L5O_SS
M_P#'C4]% $'V*W_YY_\ CQH^Q6__ #S_ /'C4]% $'V*W_YY_P#CQH^Q6_\
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M10 4444 %%%% !1110 4444 %%%% !4R_P#'J_U_PJ&IE_X]7^O^% $-%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !4MO_K?PJ*I;?_6_A0!&>II*
M4]324 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %2P?ZX5%4L'^N% $ES
M]U?K5:K-S]U?K5:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH NR
M?ZMOI5*KLG^K;Z52H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +
M<'^I%5I/]8WUJS!_J15:3_6-]: &T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %7ZH5?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?Q!,)6LEMQ<X1?G*D C )Z\CO7D/[0O_ "$]#_ZXR_S6NV\2?\D%D_[!$/\
MZ"E &9_PO[PM_P ^&L?]^8O_ (Y6CI/QH\(:I<+#)<7&GLQP#>1!5S[LI('U
M)Q7"_ C1=+UC^WO[6TVSOO*^S^7]I@639GS<XW XS@?D*Z'XG?"[1F\,W>L:
M!9)8WEDAF>. ;8Y4'+?+T! R01Z?D >KHZR1J\;!T8 JRG((]0:6O'?@+XFN
M+NUO?#]W(TBVJB>VW'.Q"<,OTR01]37L5 %/5M3@T71[K4KS>8+6)I9 @RQ
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M-O#82PS7M^%#&&+"J@/3<QZ<>@-<M:?M$VK-Y=[X=FAB)Y>*[$C#_@)5?YT
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MZ_E0!Z]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %2P?ZX5%4L'^N% $ES]U?K5
M:K-S]U?K5:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH NR?ZMOI
M5*KLG^K;Z52H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +<'^I%
M5I/]8WUJS!_J15:3_6-]: &T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %7ZH5?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *KWW_'C-_NU8JO??\>,W^[0 FG_\@^+Z?UJS5;3_ /D'
MQ?3^M6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH S])^[/_UTK0K/TG[L_P#UTK0H **** "BBB@
MK&\5VVOW>@2Q>$KZWL=3+J4FN%W*%S\P^ZW;V/\ 6MFH+V^M--M'NM1NH;2W
M3&^:>0(BY.!ECP.30!\_?$_2OB+9^$DE\9:]I^H:?]J0"&VC ;S,-@\1+QC/
M>NPT[0OC#Y5J_P#PE>D?9MJ'9Y2YV<<?ZCT]_P :M_$^YT'QKX272]+\7>'H
M9UN4FW7&I1A< ,#]W)SSZ5UMCXO\+I;V]LOB;1Y)%18P$OXCN. ./FH Z"O+
M?V@I)$^'-NL>=KZC&KX]-DA_F!7J5<M\1_##^+? M]IMN ;H 36V3C,BG('X
MC(_&@"SX!CCB^'7AY80 ITV!C@_Q&,$_J3705XU\*_B9IVE:(OACQ;/_ &9>
MZ<S11O<@JK+G[K'^%EY'.. *[#Q%\6?"F@V1DAU.#5+DC]U;6$@E+GT++D+^
M/Y&@#+^/'_),9?\ K[B_F:SO$W@S_A*_@=H$]G'NU/3=+MY[?:/F<>2N]/Q
MR/<"K/QHN7O/@]%=30-;R32V\C0OUC)&2IZ<C.*[3P/_ ,D]\._]@NV_]%+0
M!Y_IOC+_ (2_X!ZV;F3=J-C8O!= GEOE^5_^! ?F#6W\#O\ DE=C_P!=IO\
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M2OH3Q^C2?#S7512S&RDP ,D\5\]_#SQ__P ('=7TW]F_;_M:(N//\K9M)/\
M=;/6@#V#P'\)_P#A"?$#ZI_;;7NZ!H?*%MY0Y(.2=YSTZ5PG[0'_ "-^F_\
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M#Y2TP/"O@OFW^*1AB8A#!,A]P,'^8%'C:=/"_P <Y=3U2!+^ 3)<^3N!RA0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 6X/\
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M?G1N7U'YT +12;E]1^=&Y?4?G0 M%)N7U'YT;E]1^= "T4FY?4?G1N7U'YT
M+12;E]1^=&Y?4?G0 M%)N7U'YT;E]1^= "T4FY?4?G1N7U'YT +12;E]1^=&
MY?4?G0 M%)N7U'YT;E]1^= "U7OO^/&;_=J?<OJ/SJO?,/L,W(^[ZT &G_\
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M?G1N7U'YT +12;E]1^=&Y?4?G0 M%)N7U'YT;E]1^= "T4FY?4?G1N7U'YT
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MH_.C</4?G0 M%)N'J/SHW#U'YT +12;AZC\Z-P]1^= "T4FX>H_.C</4?G0
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MU'YT;AZC\Z %HI-P]1^=&X>H_.@!:*3</4?G1N'J/SH 6BDW#U'YT;AZC\Z
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MCND?] ^'_OFC_A'=(_Z!\/\ WS6E10!F_P#".Z1_T#X?^^:/^$=TC_H'P_\
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M:/\ A'=(_P"@?#_WS6E10!F_\([I'_0/A_[YH_X1W2/^@?#_ -\UI44 9O\
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MG_/E%^5']A:9_P ^47Y5?HH H?V%IG_/E%^5']A:9_SY1?E5^B@"A_86F?\
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M+\JOT4 4/["TS_GRB_*C^PM,_P"?*+\JOT4 1/X>TD1L180YQ_=JK_86F?\
M/E%^5;DG^K;Z52H H?V%IG_/E%^5']A:9_SY1?E5^B@"A_86F?\ /E%^5']A
M:9_SY1?E5^B@"A_86F?\^47Y4?V%IG_/E%^57Z* *']A:9_SY1?E1_86F?\
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MH **** "BBB@ HHHH **** "BBB@#/TG[L__ %TK0K/TG[L__72M"@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ JI/\ ZYJMU4G_ -<U $=%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !4R_\>K_7_"H:F7_CU?Z_X4 0T444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %2V_P#K?PJ*I;?_ %OX4 1G
MJ:2E/4TE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4L'^N%15+!_KA0
M!)<_=7ZU6JS<_=7ZU6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M +LG^K;Z52J[)_JV^E4J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@"W!_J15:3_ %C?6K,'^I%5I/\ 6-]: &T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %7ZH5?H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *KWW_ !XS?[M6*KWW_'C-_NT )I__ "#X
MOI_6K-5M/_Y!\7T_K5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** ,_2?NS_\ 72M"L_2?NS_]=*T*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "JD_P#KFJW52?\ US4 1T44
M4 %%<E\1];U#0?#D%UI-Q]GF>[6-FV*V5*.<88$=0*\S_P"%D^+/^@K_ .2T
M7_Q-=E'!U*T>:+1RU<5"E+E:9[S17@W_  LGQ9_T%?\ R6B_^)H_X63XL_Z"
MO_DM%_\ $UK_ &=5[K\?\C+Z]3[/^OF>\T5X-_PLGQ9_T%?_ "6B_P#B:/\
MA9/BS_H*_P#DM%_\31_9U7NOQ_R#Z]3[/^OF>\T5X-_PLGQ9_P!!7_R6B_\
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M_$T?V=5[K\?\@^O4^S_KYGO-%>#?\+)\6?\ 05_\EHO_ (FC_A9/BS_H*_\
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M_'11]MN/^>G_ (Z* -6BLK[;<?\ /3_QT4?;;C_GI_XZ* -6BLK[;<?\]/\
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MG_CHH^VW'_/3_P =% &K165]MN/^>G_CHH^VW'_/3_QT4 :M%97VVX_YZ?\
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M.BC[;<?\]/\ QT4 :M%97VVX_P">G_CHJ:WOFWXG.0>^.E %^BCK10 4444
M%%%% !1110 4444 %7ZH5?H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *KWW_'C-_NU8JO??\>,W^[0 FG_\@^+Z
M?UJS5;3_ /D'Q?3^M6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH S])^[/_UTK0K/TG[L_P#UTK0H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *J3_P"N:K=5)_\ 7-0!'111
M0!P7Q?\ ^11M?^OY/_1<E>-5[+\7_P#D4;7_ *_D_P#1<E>-5[^ _@GB8S^*
M%%%%=YQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5);W$UI<1SVTC12QMN1U."#4=%+<#V'PEXMA\06
M_DW&V*_C7YTZ"0?WE_J.U=+7S[;W$UI<1SVTC12QMN1U."#7KOA+Q;#X@M_)
MN-L5_&OSIT$@_O+_ %':O#Q>$]G[\-OR/8PV)Y_<GN=+1117G'>%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!;M+OR\1R'Y.Q]*T>M8=6[2[\O$<A^3L?2@
M#1HHZT4 %%%% !1110 5?JA5^@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ JO??\>,W^[5BJ]]_QXS?[M ":?_R#
MXOI_6K-5M/\ ^0?%]/ZU9H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:S7!W3200*C2GKEB!SU/7UHDTC39=3CU*73[5[Z(;8[IH%,J#G@/C(ZGOWH
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MS?\ IK_X[_\ 7H_LW_IK_P"._P#UZ *-%7O[-_Z:_P#CO_UZ?'I7F-CSL?\
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MHJ]_9O\ TU_\=_\ KTZ/2M[[?.Q_P#_Z] &?16E+I'E@'S\Y_P!C_P"O4?\
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MHJ]_9O\ TU_\=_\ KT?V;_TU_P#'?_KT 4:*O?V;_P!-?_'?_KT?V;_TU_\
M'?\ Z] %&BM1M%VJ3]HZ#^Y_]>H?[-_Z:_\ CO\ ]>@"C15[^S?^FO\ X[_]
M>C^S?^FO_CO_ ->@"C15[^S?^FO_ ([_ /7H_LW_ *:_^.__ %Z *-%7O[-_
MZ:_^._\ UZ/[-_Z:_P#CO_UZ *-%7O[-_P"FO_CO_P!>C^S?^FO_ ([_ /7H
M HT5>_LW_IK_ ..__7H_LW_IK_X[_P#7H HT5>_LW_IK_P"._P#UZ/[-_P"F
MO_CO_P!>@"C15[^S?^FO_CO_ ->C^S?^FO\ X[_]>@"C15[^S?\ IK_X[_\
M7H_LW_IK_P"._P#UZ *-%7O[-_Z:_P#CO_UZ/[-_Z:_^._\ UZ *-%7O[-_Z
M:_\ CO\ ]>C^S?\ IK_X[_\ 7H HT5>_LW_IK_X[_P#7H_LW_IK_ ..__7H
MHT5>_LW_ *:_^.__ %Z/[-_Z:_\ CO\ ]>@"C15[^S?^FO\ X[_]>C^S?^FO
M_CO_ ->@"C15[^S?^FO_ ([_ /7H_LW_ *:_^.__ %Z *-%7O[-_Z:_^._\
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M]-?_ !W_ .O0!1HJ]_9O_37_ ,=_^O1_9O\ TU_\=_\ KT 4:*O?V;_TU_\
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M3:)A0I0=XQLSB/$WPF\,^*-2?4+I+BTNI.97LY%3S#ZD%2,^^.:B3X.^%(M
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MM\3=5\":A>RWEG$C/;F0GY" K*0#G *-DCIFKOQ/\3:UJ/C#3O ?A6Z:SGO
M&NKA"0P#9.W(Y "@L<<D8]\@'K=%>0S?L_Z>+0S6GB'4AJP&5N7*["V/0#</
M^^JM?![Q=J]]=ZIX5\32M/J&E,=LLAW.5#;&5CWPV,'WH ]4HKY_\1)KUY^T
M'KNE^&+C[+<ZE;Q6TMSD@PQ>5"[L#V/R8_'CKFN\T'X<VOPY74]<TG4+Z^N!
MITH:"X(*R2##[@  >JXQR>3S0!Z)17@7@'P=IWQ2L;S6/%FO7UWJ?GE3;Q3A
M3"O&#@@\'MC &,5Z[X-\+-X1T:733JESJ41N&EA>Y.6B0JHV=>@()XQ]X\4
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MG[J_6JU6;G[J_6JU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!=
MD_U;?2J579/]6WTJE0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M6X/]2*K2?ZQOK5F#_4BJTG^L;ZT -HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *OU0J_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% %N#_ %(JM)_K&^M68/\ 4BJTG^L;ZT -HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *OU0J_0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 57OO^/&;_=JQ5>^_P"/
M&;_=H 33_P#D'Q?3^M6:K:?_ ,@^+Z?UJS0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &?I/W9_P#K
MI6A6?I/W9_\ KI6A0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY#<$9<%U (*@9&[;\I!]<\5O_L^?\@+6/^OE/_0: )? _P ._#VA>.TO]/\
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M*_\ A]XBN[J1&+'S8F22%AC!W%%!!YXQ]>M>H_$C5VU[X%V.J. KW36\C@=
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M5U%PL4*_*N<&1NR#W)_QKS7X+:)>W-_JOC+4T,;ZDSK",8WAGWNWTW  ?0T
M7_BKXIU6+4]-\(^&9C#J&IE?,F4X9$9MJ@'MD@DGJ />J4WP(MA8&>WUZ_\
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MSY<<T;1CL,-(I_\ 9?RH ]BHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "I8/]<*BJ6#_7"@"2Y^ZOUJM5FY^ZOUJM0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 79/]6WTJE5V3_5M]*I4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% %N#_4BJTG^L;ZU9@_U(JM)
M_K&^M #:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "K]4*OT %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZD,K#/TQ6E9> =&L/!=SX8M_M L;G=YKF0&0DXR<XQG@=J /.OV=_P#F8O\
MMV_]JUQW@B^A\!?%;9KNZ"*W>6UE=E/R9! ;'IT_ YKW7P9X!TKP,EX-(FNY
M3>%#(URZL1MS@#:H_O&CQ1\._#OBZ43ZK:,MT!C[3;MLD(]#V/X@XH YOXE_
M$#P]_P (+?66G:K:WUW?1>5'';2"3 )Y+$9VX&>O-9W[/^DW%KH6J:G,I6*]
MECCBR/O",-DCVR^/P-:MC\#/"-G<++,VH7H4Y\NXG7:?KL53^M>AVUM#9VL=
MO:1)##$H2.-%PJ@= !0!\W_!'_DI<'_7M+_*N[_:!_Y%72_^OW_V1JZ3PO\
M"O0?"6N_VKID]]).$9%2>5610W7&%!_,UL>*_!.F^.;&&QU>6YBCAD\U&MG5
M6SC'\2D8Y]* ,?X/_P#)*-'_ .V__H^2NUK,\.Z!:>%] MM'TYI7M[;<$:9@
M7.YBQR0 .K'M6G0!XY\.%&F_&WQ9I[C9YAFDC!]/-# ?]\O^E>L:KJMGHFES
MZCJ<ZP6L"[G=OT ]23P!7EGB^/\ X1#XWZ+XC/R66I@07#8X#8\MB?H"C?@:
M]%\4^&++Q=H;:5J<D\<#.LFZ!@K KTZ@C]* /,;'3]3^,GB(:KJPEL_"MG(1
M;6^<&<CK^/JW;H.YKV2""*VMXX+>-8HHU"HB# 4#H *\R_X4#X6_Y_\ 6/\
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M-S=;<>>?Z_[*]NI["O6='TBRT+28--TN$0VT"[44=_4D]R>I->>?\*!\+?\
M/_K'_?Z+_P"-U);_  (\,6UU%.E]JY:)PZ@SQ]0<]H\T >ELP12SD*JC)).
M!7CWP(C^TWGB;5 ,+//&J'\78_S6N[^(VMKH'@#5+K=MEDA,$/N[_*,?3)/X
M50^$F@MH/P]LQ,A2XO2;N4$8(W8VC_OD+^M ';4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !4L'^N%15+!_KA0!)<_=7ZU6
MJS<_=7ZU6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +LG^K;Z5
M2J[)_JV^E4J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"W!_J15
M:3_6-]:LP?ZD56D_UC?6@!M%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !5^J%7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "J]]_QXS?[M6*KWW_ !XS?[M ":?_ ,@^+Z?UJS5;3_\
MD'Q?3^M6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH S])^[/_ -=*T*S])^[/_P!=*T* "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "JD_^N:K=5)_]<U $=%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7.Q> ?#,/B0Z]%I:KJ1E,
MQG\V3[YZMMW;<\GM7144 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5,O_ !ZO]?\ "H:F7_CU?Z_X4 0T444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %2V_^M_"HJEM_P#6_A0!&>II*4]324 9FO>'-)\3V"V6N6:W
M<"N)%4LRE6'<%2".I[UHQQK%$L:9"H HR2>![FG44 %%%% !1110 4444 %%
M%% !1110!EZ[X:TGQ-;PP:Y:?:X8)/-1#(Z@-C&2%(SP3U]:U  J@*, < #M
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !4L'^N%15+!_KA0!)<_=7ZU6JS<_=7ZU6H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** +LG^K;Z52J[)_JV^E4J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@"W!_J15:3_6-]:LP?ZD56D_UC?6@!M%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !5^J%7Z "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J]]_QXS?[M6*KWW_'C
M-_NT )I__(/B^G]:LU6T_P#Y!\7T_K5F@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,_2?NS_]=*T*
MS])^[/\ ]=*T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JD_\ KFJW
M52?_ %S4 1T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %3+_QZO\
M7_"H:F7_ (]7^O\ A0!#1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5+;_P"M_"HJEM_];^% $9ZFDI3U-)0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5+!_KA452P?ZX4 27/W5^M5JLW/W5^M5J "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@"[)_JV^E4JNR?ZMOI5*@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH MP?ZD56D_UC?6K,'^I%5I/]8WUH ;1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5?JA5^@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO??\>,W^[5BJ
M]]_QXS?[M ":?_R#XOI_6K-5M/\ ^0?%]/ZU9H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/TG[L_
M_72M"L_2?NS_ /72M"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JI/_
M *YJMU4G_P!<U $=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4R_
M\>K_ %_PJ&IE_P"/5_K_ (4 0T444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %2V_\ K?PJ*I;?_6_A0!&>II*4]324 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %2P?ZX5%4L'^N% $ES]U?K5:K-S]U?K5:@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH NR?ZMOI5*KLG^K;Z52H **** "BBB@
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M*/L-I_SZP_\ ?L4 =GN7U'YT;E]1^=<9]AM/^?6'_OV*/L-I_P ^L/\ W[%
M'9[E]1^=&Y?4?G7&?8;3_GUA_P"_8H^PVG_/K#_W[% '9[E]1^=&Y?4?G7&?
M8;3_ )]8?^_8H^PVG_/K#_W[% '9[E]1^=&Y?4?G7&?8;3_GUA_[]BC[#:?\
M^L/_ '[% '9[E]1^=&Y?4?G7&?8;3_GUA_[]BC[#:?\ /K#_ -^Q0!V>Y?4?
MG1N7U'YUQGV&T_Y]8?\ OV*/L-I_SZP_]^Q0!V>Y?4?G1N7U'YUQGV&T_P"?
M6'_OV*/L-I_SZP_]^Q0!V>Y?4?G1N7U'YUQGV&T_Y]8?^_8H^PVG_/K#_P!^
MQ0!V>Y?4?G1N7U'YUQGV&T_Y]8?^_8H^PVG_ #ZP_P#?L4 =GN7U'YT;E]1^
M=<9]AM/^?6'_ +]BC[#:?\^L/_?L4 =GN7U'YT;E]1^=<9]AM/\ GUA_[]BC
M[#:?\^L/_?L4 =GN7U'YT;E]1^=<9]AM/^?6'_OV*/L-I_SZP_\ ?L4 =GN7
MU'YT;E]1^=<9]AM/^?6'_OV*/L-I_P ^L/\ W[% '9[E]1^=&Y?4?G7&?8;3
M_GUA_P"_8H^PVG_/K#_W[% '9[E]1^=&Y?4?G7&?8;3_ )]8?^_8H^PVG_/K
M#_W[% '9[E]1^=5)V'G-R/SKE_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?
MG1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZ
MP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8
M?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'
MJ/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\
M?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8
MH Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SK
MF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?
M8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3
M</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-
MI_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_
M )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?
MG1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZ
MP_\ ?L4?8;3_ )]8?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8
M?^_8H Z3</4?G1N'J/SKF_L-I_SZP_\ ?L4?8;3_ )]8?^_8H Z3</4?G4RL
M/LK\CKZ_2N5^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_
M #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_G
MUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&
MX>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP
M_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[
M]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_
M.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?
ML4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#
MI-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^
MPVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8
M;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]
M1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_
M #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_G
MUA_[]B@#I-P]1^=&X>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=&
MX>H_.N;^PVG_ #ZP_P#?L4?8;3_GUA_[]B@#I-P]1^=2V[#S>HZ>M<M]AM/^
M?6'_ +]BC[#:?\^L/_?L4 =*6&3R/SI-P]1^=<W]AM/^?6'_ +]BC[#:?\^L
M/_?L4 =)N'J/SHW#U'YUS?V&T_Y]8?\ OV*/L-I_SZP_]^Q0!TFX>H_.C</4
M?G7-_8;3_GUA_P"_8H^PVG_/K#_W[% '2;AZC\Z-P]1^=<W]AM/^?6'_ +]B
MC[#:?\^L/_?L4 =)N'J/SHW#U'YUS?V&T_Y]8?\ OV*/L-I_SZP_]^Q0!TFX
M>H_.C</4?G7-_8;3_GUA_P"_8H^PVG_/K#_W[% '2;AZC\Z-P]1^=<W]AM/^
M?6'_ +]BC[#:?\^L/_?L4 =)N'J/SHW#U'YUS?V&T_Y]8?\ OV*/L-I_SZP_
M]^Q0!TFX>H_.C</4?G7-_8;3_GUA_P"_8H^PVG_/K#_W[% '2;AZC\Z-P]1^
M=<W]AM/^?6'_ +]BC[#:?\^L/_?L4 =)N'J/SHW#U'YUS?V&T_Y]8?\ OV*/
ML-I_SZP_]^Q0!TFX>H_.C</4?G7-_8;3_GUA_P"_8H^PVG_/K#_W[% '2;AZ
MC\Z-P]1^=<W]AM/^?6'_ +]BC[#:?\^L/_?L4 =)N'J/SHW#U'YUS?V&T_Y]
M8?\ OV*/L-I_SZP_]^Q0!TFX>H_.C</4?G7-_8;3_GUA_P"_8H^PVG_/K#_W
M[% '2;AZC\Z-P]1^=<W]AM/^?6'_ +]BC[#:?\^L/_?L4 =)N'J/SHW#U'YU
MS?V&T_Y]8?\ OV*/L-I_SZP_]^Q0!TFX>H_.C</4?G7-_8;3_GUA_P"_8H^P
MVG_/K#_W[% '2;AZC\Z-P]1^=<W]AM/^?6'_ +]BC[#:?\^L/_?L4 =)N'J/
MSJ6!AYPY'YURWV&T_P"?6'_OV*/L-I_SZP_]^Q0!UMRR[5Y'7UJMN'J/SKF_
ML-I_SZP_]^Q1]AM/^?6'_OV* .DW#U'YT;AZC\ZYO[#:?\^L/_?L4?8;3_GU
MA_[]B@#I-P]1^=&X>H_.N;^PVG_/K#_W[%'V&T_Y]8?^_8H Z3</4?G1N'J/
MSKF_L-I_SZP_]^Q1]AM/^?6'_OV* .DW#U'YT;AZC\ZYO[#:?\^L/_?L4?8;
M3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_/K#_W[%'V&T_Y]8?^_8H Z3</4?G1
MN'J/SKF_L-I_SZP_]^Q1]AM/^?6'_OV* .DW#U'YT;AZC\ZYO[#:?\^L/_?L
M4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_/K#_W[%'V&T_Y]8?^_8H Z3</
M4?G1N'J/SKF_L-I_SZP_]^Q1]AM/^?6'_OV* .DW#U'YT;AZC\ZYO[#:?\^L
M/_?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_/K#_W[%'V&T_Y]8?^_8H
MZ3</4?G1N'J/SKF_L-I_SZP_]^Q1]AM/^?6'_OV* .DW#U'YT;AZC\ZYO[#:
M?\^L/_?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_/K#_W[%'V&T_Y]8?^
M_8H Z3</4?G1N'J/SKF_L-I_SZP_]^Q1]AM/^?6'_OV* .DW#U'YT;AZC\ZY
MO[#:?\^L/_?L4?8;3_GUA_[]B@#I-P]1^=&X>H_.N;^PVG_/K#_W[%'V&T_Y
M]8?^_8H Z3</4?G1N'J/SKF_L-I_SZP_]^Q1]AM/^?6'_OV* .DW#U'YT;AZ
MC\ZYO[#:?\^L/_?L4?8;3_GUA_[]B@#L9&7RVY'3UJEN'J/SKF_L-I_SZP_]
M^Q1]AM/^?6'_ +]B@#I-P]1^=&X>H_.N;^PVG_/K#_W[%'V&T_Y]8?\ OV*
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M^Q1]AM/^?6'_ +]B@#I-P]1^=&X>H_.N;^PVG_/K#_W[%'V&T_Y]8?\ OV*
M.DW#U'YT;AZC\ZYO[#:?\^L/_?L4?8;3_GUA_P"_8H Z3</4?G1N'J/SKF_L
M-I_SZP_]^Q1]AM/^?6'_ +]B@#I-P]1^=&X>H_.N;^PVG_/K#_W[%'V&T_Y]
=8?\ OV* .DW#U'YUH5Q?V&T_Y]8?^_8KM* /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>bdtx-20211231_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ,^!GH# 2(  A$! Q$!_\0
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M+1?^@G:_]_T_QKXA_P"%)_%3_H9-2_\  A/_ (]1_P *3^*G_0R:E_X$)_\
M'J/JM+_GX@]M4_D9]O?\)EHO_03M?^_Z?XT?\)EHO_03M?\ O^G^-?$/_"D_
MBI_T,FI?^!"?_'J/^%)_%3_H9-2_\"$_^/4?5:7_ #\0>VJ?R,^WO^$RT7_H
M)VO_ '_3_&C_ (3+1?\ H)VO_?\ 3_&OB'_A2?Q4_P"ADU+_ ,"$_P#CU'_"
MD_BI_P!#)J7_ ($)_P#'J/JM+_GX@]M4_D9]O?\ "9:+_P!!.U_[_I_C1_PF
M>B_]!.U_[_I_C7Q#_P *3^*G_0R:E_X$)_\ 'JS/$GPM^)_A[1[F]F\2:ELC
MC9_]>O92?^>I]*:PE-NRJ(/;U%]AGW_I^K6>J(6M;F*X Z^7(K>GH?<5<KX7
M_9'\?>*;SQ@^EZEK-W=Q+*4999-P.)(5/]?SK[H7H*X\11="?*W<WI5/:QYD
M@HHHKF-@J"[O8+&,R7$T<* 9)=@O\_I4]?*G[:GCG7O"UC;1:3J5Q8K*J@^2
M^W.1./Z#\JWHTG6FH(SJ3]G%R9](_P#"9Z+_ -!*U_[_ *?_ !5'_"9:+_T$
M[7_O^G^-? G@GX>?$[QIX=LM6M_$FI>5=1B0?Z0O<GUE'IZ5O?\ "D_BGQ_Q
M4>I9_P"OA/\ X]7<\'3B[.HCE6(FU=09]N_\)EHO_03M?^_Z?XT?\)EHO_03
MM?\ O^G^-?$/_"D_BI_T,FI?^!"?_'J/^%)_%3_H9-2_\"$_^/4OJM+_ )^(
M?MJG\C/M[_A,M%_Z"=K_ -_T_P :/^$RT7_H)VO_ '_3_&OB'_A2?Q4_Z&34
MO_ A/_CU'_"D_BI_T,FI?^!"?_'J/JM+_GX@]M4_D9]O?\)EHO\ T$[7_O\
MI_C1_P )EHO_ $$[7_O^G^-?$/\ PI/XJ?\ 0R:E_P"!"?\ QZC_ (4G\5/^
MADU+_P "$_\ CU'U6E_S\0>VJ?R,^WO^$RT7_H)VO_?]/\:/^$RT7_H)VO\
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MM[_A,M%_Z"=K_P!_T_QH_P"$RT7_ *"=K_W_ $_QKXA_X4G\5/\ H9-2_P#
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MO?\ "9:+_P!!.U_[_I_C1_PF6B_]!.U_[_I_C7Q#_P *3^*G_0R:E_X$)_\
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MC_A,M%_Z"=K_ -_T_P :^#O#?PO^)_B#34NXO$FI;&S_ ,MU]2/^>H]*T_\
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M"=K_ -_T_P :^(?^%)_%3_H9-2_\"$_^/4?\*3^*G_0R:E_X$)_\>H^JTO\
MGX@]M4_D9]O?\)EHO_03M?\ O^G^-'_"9:+_ -!.U_[_ *?XU\0_\*3^*G_0
MR:E_X$)_\>H_X4G\5/\ H9-2_P# A/\ X]1]5I?\_$'MJG\C/M[_ (3+1?\
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M7_@0G_QZCZK2_P"?B#VU3^1GV]_PF6B_]!.U_P"_Z?XT?\)EHO\ T$[7_O\
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M*22V.=RMQ7T=\>/^22^(O^N2?^C4KY2^'?Q-U3X9WEY<Z7;V<\EU&(W%XCL
M <\;66GT ^C-)_9@\*Z/JEG?Q7VKR2VLR3HDDT6TLK!@#B,'&1V(KFOVNO\
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MJQ2#S-29+2,J>JM\S=.VQ6'XTAG1>%/BKX6\;ZB]CHNJ?;;M(S*T?D2Q_*"
M3EU ZD?G7RC\*?\ DLFB_P#7^W_LU>K?LF>%S'9ZSX@E3!E9;.!B/X1AG_ D
MI_WR:\I^%/\ R631?^O]O_9J8CWK]J;_ ))G%_V$(O\ T%ZQ?V2/^1;U[_K[
M3_T"MK]J;_DF<7_80B_]!>L7]DC_ )%O7O\ K[3_ - I=!]3S#]I'_DK6I_]
M<H/_ $4M?7'AO_D7=+_Z]8O_ $ 5\C_M(_\ )6M3_P"N4'_HI:^N/#?_ "+N
ME_\ 7K%_Z *&'4T:***0PHHHH **** "BBB@ HHHH *\\^/'_)-M9_Z]IO\
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M\._$[P%\8;BRL]4L8[;6$D5H(;Y0&W@Y CE7KS_#D$^AKV"D 4444AA1110
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M '=_M&>#M T/X<FYT[0]-T^Y^UQ+YUK:1QO@[LC*@'%5/V1O^0+XB_Z^(O\
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M,*1EAT)"@9_2A@6J***0PHHHH **** "BBB@ HHHH *\\^/'_)-M9_Z]IO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1110 44Q9DD)"NK$=<'-/H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O!_VQ?^267'_ ?_ $?!7O%>#_MB_P#)++C_ (#_ .CX*Z<-_&AZF%?^%+T/
M,_\ @G[_ ,BU=?\  ?\ T.YK[$KX[_X)^_\ (M77_ ?_ $.YK[$K;'?[Q(G#
M_P &(4445P'2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %<)\;/^2<ZO\ ]<)O_1,E=W7"?&S_ ))SJ_\
MUPF_]$R5K2^-$R^%GQ[^RI_R5B^_Z^Y/_1\-??J_=%? 7[*G_)6+[_K[D_\
M1\-??J_=%=V8?Q3EPO\ #"BBBO,.P*^-_P!O'_5:=_O1_P#MQ7V17QO^WC_J
MM._WH_\ VXKOP7\9'-B/X;/;/V6?^2+>&?\ KRC_ /0GKURO(_V6?^2+>&?^
MO*/_ -">O7*YZ_\ %EZLUI_!'T04445@:!1110 4444 %%%% !1110 4444
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M4VK7\\]Q"1"J@O(P7:H]6.._?O7H?PQ^*M]X7^S:I9ZA)"BE6DC\]ER!L8C
M8>@ZFN6TW0=/\3V+Y1&F.X%L+]!V/J*YOQ5X8O="\NWM)2D4A (#,.N1V [
M5T1PZC3]DEH<\\8L963ORU8]>Y^JOP ^,5K\4/#<+"57NXT <;@2<1QDG[['
MJU>LU\(_L$ZM'I&J_8+F8^9)!*WS,,9"0^I_V37TU\>OBT/A3X?2^*M\V><<
M??C']]?[]?'5\.X5O9PU/U; 8E5L,JKE>V[/5**\$^'_ .U;X=\46437,\<$
MAS\S/&HZMZRGTKK(?V@O"TVJQV2WL1+L%WB6+'+8Z^964L/5BW%QU1T1Q="4
M>=35CT^BJECJMIJ5FMS;7,4L!7=O5P0!C/)!]#7GGQ'^/GAWX=W$,-S=1SR.
MK$B&2-MN& P<N,&L5&4G9(WG4A37-)V1Z+?:E;:9#YMU/'!'_>D<*.N.Y]Z=
M9WT%_%YEO*DJ>J,&_E]*^ ?VC?VRO[:>+3?#[2JO.6C//_+)NJ3'T;M7NG[+
M?QCA\0:+!IVI7&+Z1MJ>:XR27E./F<GH!77]5G['VMCE^M0]O[&Y[3\2O$1\
M*^#=2U!3M:."4J>F"(V8=QZ>M?G)>?%+Q'XM^(&I2:IJ,[:2L\OEQO/(5P)>
M.&8K]UCTKZY_; ^+VF^"?!<VE7+;)[R-E4L5 ^>.91U<'JI[5\8^%;>R\2:>
MUW'-&IW;R0R@G@$^OK7J930A4FY2/D^*,=*A25!?:,CXY>(-3U#3(;?1II%5
M1C]VS#O'_=/L:PO@O\0-;\!ZM')))/')SDDN,_+)_M#^]7?RZ-#<2,!'YR(<
M<J&_I[5BW7ANWNI-Z(D+K[!?Z5]-6PT&M$?"8?,DZ,:=K<NMS] /AC^T1I'B
MR-8+V>.VFVY#2.B9)<CO(?:O4[7Q-I=[@0W]NY;IMF4_R-?F59^)(M&L0\$L
MB7*]"C >I'0@^E)#\;O%EC>1-9W\^Q"/E\Z;L?9_I7@5LG>]-GVN&XIIM6KQ
ML?J2K!U#*<@\@BEKXG^$_P"U%K%QJVG6&KW!V2/&C-([\ LBGEI?K7V;I-_'
MJFF6EW"ZRQS1*X9""#D>HKP:^'J8=VFCZ[!YAA\?%RH2O8MT445RGI!1110
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M\-FQ^Q%_R3M/P_\ 1,%?2=?-G[$7_).T_#_T3!7TG4XO^-(6'_A1"BBBN0Z
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M_7E'_P"A/7KE<]?^++U9K3^"/H@HHHK T"BBB@ HHHH **** "BBB@ HHHH
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MKRE+H=T<9.G%4:5.SOJT?I9\(=<N]>\(VEQ>'=(43G)/_+-#W)]37<UXS^S
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M@ HHHH **** "BBB@ KY4_;P_P"12M_^ _\ HNXKZKKY4_;P_P"12M_^ _\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7GGQX_Y)MK/_7M-_P"B9*]#KSSX\?\ )-M9_P"O:;_T3)6E/XT3+X6?/7[$
MO_(<UC_KY;_T*YK[(KXW_8E_Y#FL?]?+?^A7-?9%=6-_C,PP_P#"04445PG2
M%?GO^UY_R4"W_P"!?^BH:_0BOSW_ &O/^2@6_P#P+_T5#7J9=_&./%_PF?9/
MP3_Y$NV_X%_Z,DKOZX#X)_\ (EVW_ O_ $9)7?UP5?C9U1^%!1116104444
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MFHZE+9D/)&RH%SG\_45XC\)=6NEUF.&1V$08?*2?[R#UKZ'O-*CUNSB3Y5&
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M *$]>N5SU_XLO5FM/X(^B"BBBL#0**** "BBB@ HHHH **** "BBB@ HHHH
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MCQT)KNKX"5.M[.&J/7P>!QN(H4JM2%G-'I&O_M&>$M!UIM,EN;AKE,;@MLQ
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M$O\ R'-8_P"OEO\ T*YK[(KXW_8E_P"0YK'_ %\M_P"A7-?9%=6-_C,PP_\
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M\44\."*#3RY.  =I']X=F'H*\1CTFXT^\D5SB6)RIZ=0?K[5:F:6\*B8Y8$
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MD82*&4Y5AD'UI:CMXQ%;QHIW*J@ YZX%25\Z?;!1110 4444 %%%% !1110
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M2RX_X#_Z/@KIPW\:'J85_P"%+T/,_P#@G[_R+5U_P'_T.YK[$KX[_P""?O\
MR+5U_P !_P#0[FOL2ML=_O$B</\ P8A1117 =(4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7RI^WA_R*5O_P !_P#1
M=Q7U77RI^WA_R*5O_P !_P#1=Q7;@_X\3"O_  V;'[$7_).T_#_T3!7TG7S9
M^Q%_R3M/P_\ 1,%?2=3B_P"-(6'_ (40HHHKD.@**** "BBB@ HHHH ****
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MF#^(!L_=?N&J72_"FEW5GYKV\<@[Y4^I'K6UI_A7RYEC\,:7$)VSEXRJ'O\
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M $.YK[$K;'?[Q(G#_P &(4445P'2%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5\J?MX?\ (I6__ ?_ $7<5]5U\J?M
MX?\ (I6__ ?_ $7<5VX/^/$PK_PV;'[$7_).T_#_ -$P5])U\V?L1?\ ).T_
M#_T3!7TG4XO^-(6'_A1"BBBN0Z HHHH **** "BBB@ HHHH *\(^+'[4&B>
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MA/C9_P DYU?_ *X3?^B9*[NN$^-G_).=7_ZX3?\ HF2M:7QHF7PL^/?V5/\
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MZ]IO_1,E>AUYY\>/^2;:S_U[3?\ HF2M*?QHF7PL^>OV)?\ D.:Q_P!?+?\
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MSK.[._#X>GAH\E-:!1116!U!1110 4444 %%%% !1110 5X/^V+_ ,DLN/\
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MB_Y)VGX?^B8*^DZ^;/V(O^2=I^'_ *)@KZ3J<7_&D+#_ ,*(4445R'0%%%%
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M[D_]'PU]^K]T5\!?LJ?\E8OO^ON3_P!'PU]^K]T5W9A_%.7"_P ,****\P[
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M$O\ R'-8_P"OEO\ T*YK[(KXW_8E_P"0YK'_ %\M_P"A7-?9%=6-_C,PP_\
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MZU@Z:J+WCKAB/9R53KV._P!'UZ36L.6V8[$X]/<^M'B;5H])TV2ZDE7:C*"
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M_P#!B%%%%<!TA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME<]?^++U9K3^"/H@HHHK T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1^VTXT[<T%N-CC6)0JC"_6G445F;!1110 4444 %%%% !1110 4444 %%%%
M!1110 5X/^V+_P DLN/^ _\ H^"O>*\'_;%_Y)9<?\!_]'P5TX;^-#U,*_\
M"EZ'F?\ P3]_Y%JZ_P" _P#H=S7V)7QW_P $_?\ D6KK_@/_ *'<U]B5MCO]
MXD3A_P"#$****X#I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *^5/V\/\ D4K?_@/_ *+N*^JZ^5/V\/\ D4K?_@/_
M *+N*[<'_'B85_X;-C]B+_DG:?A_Z)@KZ3KYL_8B_P"2=I^'_HF"OI.IQ?\
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M"JEF9C\JP@=6/J:^@:_/*U.5*;A/<_<,+B(XJC&K#9A1116)U!1110 4444
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M$O\ R'-8_P"OEO\ T*YK[(KXW_8E_P"0YK'_ %\M_P"A7-?9%=6-_C,PP_\
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MZ/X;UB&YBUV3R@%;;\LA_N@?<(]6K@/'^DZ?I/B9X-)?=99<AL-_>8#[QST
MKLHXR='X7<\O%Y1AL7'6-CZ+TCQ1IVO7!MHU /T/H3Z#TK:FU2U\*6=Q,L:L
MRH?E VYXZ=#ZU\V>%-0OM%N$DCY1L\_+Z-['UKW;X?VS:Q\2O#5G=CS(I[Z)
M2O3@$9Y&/2OH*6.E*DYR6J/@L1DD8XJ%"#]V3/KK]B'7M4UZXGF2 VUD68D"
M16R,P'T!Z']*^UJYSP#H5EH?A32([2'RA]CA!^9C_P LU]2?05T=?(8BLZ]1
MS9^JX7#QPM*-*.R"BBBN8Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<@A>X9BQQG>QZ\>M+V<NP<R/7/,7^\OYTX$$<'->4S>)KO8(X[EF9OFR'/\
MC6GI/CV2VC\JX!=_5LGU/=J7))!S(]#HKD;/Q,U[(7#X4=L__7]JW+76!=?=
M Q_GWI<K'<TJ*16W*#2U(PHHHH *\\^/'_)-M9_Z]IO_ $3)7H=>>?'C_DFV
ML_\ 7M-_Z)DK2G\:)E\+/GK]B7_D.:Q_U\M_Z%<U]D5\;_L2_P#(<UC_ *^6
M_P#0KFOLBNK&_P 9F&'_ (2"BBBN$Z0K\]_VO/\ DH%O_P "_P#14-?H17Y[
M_M>?\E M_P#@7_HJ&O4R[^,<>+_A,^R?@G_R)=M_P+_T9)7?UP'P3_Y$NV_X
M%_Z,DKOZX*OQLZH_"@HHHK(H**** "BBFNX09/% #J*R=1U0QL$C/^?SK&N/
M%S6#X;Y_7//]?>JY6P.OHKB)OB)&UO(T:9^4X( _^*JC#\2@L,BO_K#D GKT
MX_BJO9R%='HFX9QD9I:\AN/B%<6<Y=I6(8Y W'U_WJWM)^)T$UF3,5\P$<'&
M>@]6H]G(+H] I%8-T(/TKS&Z^+4C$QQVV ?X]A_GOIFC^.+BUO-L[ET?@;B3
MV/JWKBCV<@NCU$NJ]2!^-+7F-]XHOKBZ/E,R*#N&"PXR?>B/XK/;J;>6+YHQ
MM+;>N..NZG[.071Z=17#:;\3+>XB+3;4 Z$X&>O^U5R;X@6HM]\15V].#W_W
MJGE871UM%>?K\3W&TM;87/)V=/\ QZNDTOQ;8ZA:B4SQH>X+J.P/K[TN5VN!
M=UO6K7P_ILU]>.([>%6=F+ <!23U('0&OA#]J3]L+6+RQDT+PHL4EE=8WN;=
M92=IA<?,'/?=VKZ%_:8^(5I8^!;ZUAG!,D;J=CCO%*.S5^<VMW=OFT9R/XLL
M<>U>EA</&JG*3/&Q^,GAIPA%;E'0?%\]G;#3;B2-)&ZY '<MW/\ 2O1-)N;*
MQTE[ 2J5GW*?G!^]QZUX3XTT74H=2^W6A?RCT9=V/NJ.H'KFMOP[=:C.EH\L
MTC,9 #\S''S5[V'Q$XOE>K7Y'QF/P,*D.>$[7U?J?9/[,_B3P[\-M8S<3>7]
MI?KYJ=6:+^\P_N5]PZ1J]MKEA#>6DBRP2J&5E8'@@$="1T(K\M=+!C%E(SLS
MKL;.>_%?97P#^)$L/AL6\[&7RE 16)/ 2,#JWUK@S/!J+]K%6N>UD.93KQ^K
MU'?EZGT;06 &<UYQ)\6U694%OG/7Y/;_ 'ZAU'XE&]D\B#]VWJ./0]FKP/9R
M['V5UN>FTC2*O5@/J:\Z;XF_V; B3IEL ;B/;W;VK'U+QI=7CB>&X9$ZA0Y'
MJ<<-[T_9R"Z/7/,48RRC/O21S)*Q".KXZ[3FO&YO'5]-Y:-*T148'S,-WO\
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MR*XRIR*X"WU%WN-B=#_A]*Z[32RL%SQW_6L6K!?4TJ***104444 %<)\;/\
MDG.K_P#7";_T3)7=UPGQL_Y)SJ__ %PF_P#1,E:TOC1,OA9\>_LJ?\E8OO\
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M3CU_OUB6FE^9:P(G^M9OZD>M'*+F.RMU?RGE4;H"IVY/]/I518?,\TXVC/\
M6NPTNU2S\)A)/]<L>?\ R&/ZBN;5A>6\JD_.K\#\O\:$ACM%UA;6U;SX\8_V
M<]S[U'<:I!=HURL>QDZ?+CKQ6='=+=:AY+_+C\>V:M74*:?ILQGZ_+M_[ZYZ
M?6FT(U+.65M+DO5]"2,_[.:DT^U^V6KW5PO7.WH>P(K+\(ZDTMB!*,18Y_)?
M;TK8FU'SG2&$_N5(S_+N/2I<1^8VUGMT=H\DRY.,CM5QX5\GS-F6]>/6J+6:
M?:A)'_=Y^N:TM%U#;$T<AR/I]:SDAQ+.FS!%V1YRW_UZZ_1\6\?S'=^OI7+Z
M:R!)"#R<8Z^];F@S>9"X[\_R%825C4["SF$L8Q4]9NGY54Y[C^E:5<\MRPHH
MHJ0"O//CQ_R3;6?^O:;_ -$R5Z'7GGQX_P"2;:S_ ->TW_HF2M*?QHF7PL^>
MOV)?^0YK'_7RW_H5S7V17QO^Q+_R'-8_Z^6_]"N:^R*ZL;_&9AA_X2"BBBN$
MZ0K\]_VO/^2@6_\ P+_T5#7Z$5^>_P"UY_R4"W_X%_Z*AKU,N_C''B_X3/LG
MX)_\B7;?\"_]&25W]<!\$_\ D2[;_@7_ *,DKOZX*OQLZH_"@HHHK(H****
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M3_T?#7WZOW17=F'\4Y<+_#"BBBO,.P*^-_V\?]5IW^]'_P"W%?9%?&_[>/\
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M1: US9:G(TRL+8DH-PP/O#^E=3)>6^EVLI8JK7!WH<]LUDWFZY:-8DP/+#'
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M>(M/BLHU9&PX]"/;VKK@9R,;5C'Y2PI(/.'.,?0U@ZI>QQPQ88-.C <>P/\
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MC!QT-=0+.UDF$F0 W';VK*0RUI4DEU>&9^%'K]0:[+39Q(N >AQ_*N-MU*7
MCB/RGT^OM73::KP[!W./Z5S3-(G7P?ZI/I4E16P/V>/UQS4M<IJ@HHHI#"O!
M_P!L7_DEEQ_P'_T?!7O%>#_MB_\ )++C_@/_ */@KIPW\:'J85_X4O0\S_X)
M^_\ (M77_ ?_ $.YK[$KX[_X)^_\BU=?\!_]#N:^Q*VQW^\2)P_\&(4445P'
M2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5\J?MX?\BE;_ / ?_1=Q7U77RI^WA_R*5O\ \!_]%W%=N#_CQ,*_\-FQ
M^Q%_R3M/P_\ 1,%?2=?-G[$7_).T_#_T3!7TG4XO^-(6'_A1"BBBN0Z HHHH
M ;)]PUCZIEOE7O\ _6K:K+U!=I/&/\BJB!Q^N*ZQX09;M^E<3JUE+YJ33+@
M@\@^Y[UZ#?KA@WI_]:N(\8:B2AC!_P _-[5W0V,9;F'J$DC*DCM^X7H,\<9_
MI7+:IJ0OKX)&^Q5XP#CL/?VKJ)(SJVB-;+]_&?\ QW']:X34+-[$_9U7,ZDC
MK[_ETK>,7<RDSJYK5KO1F@5]H/4YQ_%FLAM-<:%-8E-TS*?+.,DG#>WJPJ>_
M,RV*!.#SD<>HI@UAK?4=.+'YP_3'^TOM3=UH);7*/@32Y[2>Z%WNC$)8X;(Z
M%?4?6M>RMY_$&M3B*4K#'N'WB!PWMGL:U]45(K&YNI6YF1L<'N":X[PK=M9Z
MI,RO^[=V[>K"FHRW(Y];&];L59DE3SD7U&ZF-IEMK#&X?&$[<=^/3VIUQKD=
MK<_9E&7/U],^E7[6WCM[1@W5OKZU18ZRU%%L'LE_UK$E&[C(P._K5?[)-=1R
M)=R&-H\E&9B,XZ<G\:<^D"/6+7RSP=O/_ OK5KQ-<1QS6T$AX&W)Y]2*D0-.
MS:*+=I2VUAAMV> !WK+GN'T]EEC7<O\ >QGVZ_C6E)J,&I0Q:=;KPH#,V3V&
M.A_#O7)^(-<:.\^RP\Q?_6![BB]AG7:QX@%UH^R-?.;N,;OXA[U\@?'SQ1JN
MAZM!:Q^9':R%=T?S@<M(#QD#H*^EM#U!;;(B^=OR]:^>OVC/$4,WB&VL)$S+
M(Z\Y/&7E7T]:NF_?2.+&Q_<R?D>4Q6;:I);7LR^5&I5LXQG'/?ZUKPQP7MZ#
M,0\*#:,X([^OX5K26Z6^A6\1^8,%]1C*8KG6U6WCODT]1ACDGK[^W^SZU]7.
MT8),_'Z3GBJC4.AZ3X MIM0U);:T0QKW901V8]1]#7TWHNF8CBMDEXS\PW>Y
M/I7S3X)\0+X3U12> W;_ ("WL?[U?2_AVZ@NM._M"-OE7YCP>S$?T]*\3'Q]
M_FCM8_1.'YPE1<&_>NRS=6\BZ@D"@JBX&>0#SBHXY7C>[27A45]I/MTZUJW&
MJ+J=HLJ#F/C\AGT]ZQ=4MC<>00V#(5!&/7->7'4^I4>7=E/3(5O)+AW;:-W)
MSC/)J_I$\]JY,"%H!W )'?TXZUIM%:V>D1P%?WFT9.3Z@UCZ3J"VN^%7PO'R
MX^II[@3:O>KK$B3,,;#_ $_^M3X=#6>(3JWS]AG\?2N?W2);S.XVIQ@\>AK>
M\/PRW6FM<*WRQ^P[*#3Z 3-9S1[6A#,Z_>P#^/2LYXYEU S&-E;/WMI&>,5U
MUA.9K>-+<99B!(?P&>M:6N:<HT=>,,JC)]R1[TK@<5<227TFZ:,J/[Q4C^?T
MJQ'I[?V8S,2>< Y_WJMZQ(8_":.OS/S[?\M!5V&S:]TVWC3@98G\S2OH"*6D
MNL,0M&&3)_%]<"M%-'D5AMC+#J&P3_2DFL8M-L][G]XIP.OI_P#6K3M]2\O2
MHV1LLP Z?[/TK-EC[.,V\P9USCV]JZ_3)S-(".5__77)V<A;@\YKJ]'V\(#Q
M_P#KK"1:.OM7WQ@#H*L56M?E0*/\\U9KC>YJ@HHHI#"N$^-G_).=7_ZX3?\
MHF2N[KA/C9_R3G5_^N$W_HF2M:7QHF7PL^/?V5/^2L7W_7W)_P"CX:^_5^Z*
M^ OV5/\ DK%]_P!?<G_H^&OOU?NBN[,/XIRX7^&%%%%>8=@5\;_MX_ZK3O\
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MU#XRUR.XOOLV!M/3IZ*?6LRWTF339Q.#N8CGH.OXU3U[3VU*X2[4[6CS\OU
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MZ<-_&AZF%?\ A2]#S/\ X)^_\BU=?\!_]#N:^Q*^._\ @G[_ ,BU=?\  ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6$CM4JV?<FES EW*R1'TS5VUC^8'%.2V/I5V"WQ@FLW(M(L6L?S+6[8Q]/\
M/I6=9PAL&MBSB.0!TKDJ2.B$=3;L%/IS_P#KKK]%CY _SWKF[&$K@=?\FNNT
MF'H1_GK7DUGHSN1T$?W13J1!A12UYQT!1110,*X3XV?\DYU?_KA-_P"B9*[N
MN$^-G_).=7_ZX3?^B9*UI?&B9?"SX]_94_Y*Q??]?<G_ */AK[]7[HKX"_94
M_P"2L7W_ %]R?^CX:^_5^Z*[LP_BG+A?X84445YAV!7QO^WC_JM._P!Z/_VX
MK[(KXW_;Q_U6G?[T?_MQ7?@OXR.;$?PV>V?LL_\ )%O#/_7E'_Z$]>N5Y'^R
MS_R1;PS_ ->4?_H3UZY7/7_BR]6:T_@CZ(****P- HHHH *:S84FG56NY"O
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MX/\ MB_\DLN/^ _^CX*Z<-_&AZF%?^%+T/,_^"?O_(M77_ ?_0[FOL2OCO\
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MP\"M8:>?XAC\Z?\ V>3T_D:GVB'R,S(X/3FKL-J&/K5R/3SP/Z&M"'3R#_\
M6-9RJ(N,"M:VH]*U[.W[8I;6P.X8_K6Q;6)&./YUR2FCIC&Q8TVU/'^?6NKT
MV/RU _SWK,T^UV_Y^M;UHH7'%>;5E<Z$BU1117,:A1110 5PGQL_Y)SJ_P#U
MPF_]$R5W=<)\;/\ DG.K_P#7";_T3)6M+XT3+X6?'O[*G_)6+[_K[D_]'PU]
M^K]T5\!?LJ?\E8OO^ON3_P!'PU]^K]T5W9A_%.7"_P ,****\P[ KXW_ &\?
M]5IW^]'_ .W%?9%?&_[>/^JT[_>C_P#;BN_!?QD<V(_AL]L_99_Y(MX9_P"O
M*/\ ]">O7*\C_99_Y(MX9_Z\H_\ T)Z]<KGK_P 67JS6G\$?1!1116!H%%%%
M !44@$FX>U2TQSCY>],#-E&W/>J%Q;^8:U)DVGU-5I$![5M%B.?O+7;TZUF2
M6NX=*Z6>U+<FJ4UKD9'%=,)=#"4>QRTUD&)XJG)8E>HKJ);,[CBJ[66>370I
MF=NYS$EAQG%0BTZ@BNJDL]ZX"_SJL;%%(W2*A]&.*M5+D<GNW9SK6.WG-1K:
MC'2NBGM[=.7N(T7U+#_&N/'Q T%=3>R>[B0J2-YF3!^;']ZM%*3V)E[*.DY6
M9=6QW'@9I[:62N2,#_/O6/XM^*'ASPOI$THU"&:9HVVJD\><[6(ZMZBO)_"/
MQJFFURZNKE_.T]I#M56C! PQ'('NO>MH1J3U1PXC%4,.XQF]SVQ;$-TH_L\G
MCH15:+XF>%5C6635+="W\!GBSUQ_?K>T;4+'Q'F2PN(YD')VN&]?0GT-8N<H
MIMH[%RRGRQ/$OVAOA!!XX\*RWBG9+9QF0GDYV1R'^^/[U?$^EZ7-<>()-,D.
MZ*WE,78?=<+Z_P!:^]?C?\4--\.Z7=Z*H,]U,CQ$)(G&Y9$Z9SU%?,.@^&86
MO+K4'=8FE=I@&SGDAL=:]'#4I5/>9\MG.(I8=63]X\0^*VD_V1,JJV$''3V3
MW]ZQ? /CZ;18'M[?YV;'H.A8]U/K7U_X-^".G_%;5'2XGC5%/\6_T;^ZP_N5
M[5X3_8]\(>'9"TL8F8=U:<>O_37WKFQ,U2Q"G'2QU8#"K,,&H5EHT?%EWXG7
M3=$CNV_UK,=P^F[V]JDM?C!;1Z9& /FX!Z_W?]RNM_:I\(V/P[U6V*0-)9W$
MNS:NX$8C0GJ3ZGO7%^!;'PSXAL0HB990N64R'(X7T?WKO6+]M4W/*K931PT/
MWJ;UZ'>>!=:MO$2_:ONX^8=3S\I]!ZUT^U=1F:>;YI>QZ=L=OI7!W>O:3X(L
MRL<+R*O97]O=C_=K7\(^*H?$C>?"/+0=F8'^\.WTKHC.+ERW."I3FZ7+2C:!
M4U.:XT37HSLP&S\V1V0?7UKV;1]>NK:\L8TF\SS748V@=7QZ>U>3^)]2%S?(
MDP,:#/S,<=A77^%O$%KH>H6=\R&\CA8$+&P!X<-_3]:E]4:TVX.#;MW/IG2[
M1YM/ADD&&90?T%6ETOS.0,_Y^M>80_M%6T<\;-H]UY( 4#S%]?IZ5B>*/C=/
MJDWFZ?"]E$O)$A0]S_LGU'Y5Y7).[/L%C,+96D>V+IK*N2/U_P#KTK6>.,8K
MY=N?VH+G6KX:;:121N.LI:(CIN_N^Q%>L>"?CC:PPB#4H9"__/3>BCJQ]O:H
MY9<O,7];H<_(]#U".QZ<59CT_<W3'^?K6K8JE]917,:_NY%# ]>HS5F.Q,C?
M+SBN5U#OC%O62LC-@L0&%:L-F&X[U9BL2O&,'\:O0V>>>E8RGW-5'L,L[90P
M!KH+.$*P'2L^WM]K5LVL>WYB.:Y)RN;I6+*C:,44+17,6%%%% !7GGQX_P"2
M;:S_ ->TW_HF2O0Z\\^/'_)-M9_Z]IO_ $3)6E/XT3+X6?/7[$O_ "'-8_Z^
M6_\ 0KFOLBOC?]B7_D.:Q_U\M_Z%<U]D5U8W^,S##_PD%%%%<)TA7Y[_ +7G
M_)0+?_@7_HJ&OT(K\]_VO/\ DH%O_P "_P#14->IEW\8X\7_  F?9/P3_P"1
M+MO^!?\ HR2N_K@/@G_R)=M_P+_T9)7?UP5?C9U1^%!1116104444 -=]IQC
M-5;A.C=JM.VWFHIE#KFJ0C*N%W\"LRZM1MSWK:D7&:I30[^U;Q=B96.9G@W$
MU1FLQSD5T]Q9]>]4I+/'-=<9(P<3F)K'J158V9.>*Z>2S-0M:A,@C)K53L0U
MI8Y5K/:W-(;'N!BNBDT\8RQ"CWI%M87C+)-&R#J0U6JA,J>J1S+6GS<\T-9A
ML<58\0:]I7AVW\V>[B8YQM$B@]">[>U4K'QSX=NK-[I]1MXE522K31YX /\
M>K12D]2&Z-[*6I:CTLRCA>/K_P#7J*73]IXKPKQ/\:+JX\77\.DS*]E!,R*5
M,;;QC&00#W![UZSX;^*&A7VDJ]Y>1VTW.5DFC!^\?]H=L5I*,X*]CAHXNA6K
MRHQ>J-I=.SG/^?UJ*[T1+RQNH91N22)UQTZC'K4^F^/?#FMW0MK+48)I>.%F
MC;J<#HYK5UV\MM#TF6]NG"0^62&+ 9^4GN?0&L^>2T9VPM43ET/SE^/WP_?P
MWXXN&A/[JZF8[?\ >ED]6/I7.>(/!K:=X?:57P%]O]L#U]Z]@^.NJ6WB;Q)]
MHM?WD2R?>5@W1Y#V/H15KPSX$?QUY6GP#SDDSEU#$#&6_A_W:]6G%.#<CXK%
MU6\7&%!75SXGM]2_LV[6??ROM[8]/>O</ ?CB3Q,&>XX1 VT\=B/11ZFOL;2
MOV&?#EB%%[)'.W?9YX]?^FH]14?Q>_9ZT#PGX(GN-)B\IH$>0\RG.$D;NY]!
M7F86N\-4DT[W/>QF6QQU*\E[W1GRM-\3(-%U!H6'W3@'GUQ_=/I70^%?'5IX
MPU(6I.P88[N3T'^Z/6O/-$N=%U/Q3<65_;R(T4K)N+X!PX']X>IKT*UT/1]/
MG\ZR7  Q]XGK_P "->E"O.LTT_D?.5,#A\-.,.5N2^X[#4-<2^N%B8Y6'I^(
M!]*H:AJ*WTG"9'U^GM[53T/5K>:1U>TD'3G)]Z?Y@M[CS NV/T)]J]*<U&-U
MI)'Z!D^65,57OB:%H25KOH=AH6MS:7;YB?;@9"X![#OCVKW?X5S7.O:,\]P.
M1G'3^ZA[8]:^;=-O(+FZCF# A""5R,G!!]:]4T7XX1>'K&*SATRX8J I8.N#
M@ =P?2O*K5)U%:VI[>(X;I86*E@XN_J>V_V2\C\#]?\ Z]21Z4R-@K^O_P!>
MO&]8_:"?4K2.TM+*:UN6&?,D9".QZ;?8_G7%>(/VH+CP+;B&ZADOIF_BA:,=
MP?[OHP_*N1PJ1LWU/G*LE1J_5JRM)'TW)8[6Z<TZ*P[XKYN\ _'6^OM1M]0O
M$9K4N-T>4!QRIYVCTKZ=\*^(+/Q7IT5U;*5#*"5+ GH#V/\ M"HJ)P.>CB*=
M:\8;HB6PYZ5;AL>!6M]E#?*!C\ZLPV)C'(X_&N1U#T%&RUW*%O9>U:]E:*&I
M\5OVQFK]O9E"#6$YFL8ERTA$:K6Q$NU5/M5"WB/!QQ6BGW17%)W-[(6BBBLQ
MA1110 5X/^V+_P DLN/^ _\ H^"O>*\'_;%_Y)9<?\!_]'P5TX;^-#U,*_\
M"EZ'F?\ P3]_Y%JZ_P" _P#H=S7V)7QW_P $_?\ D6KK_@/_ *'<U]B5MCO]
MXD3A_P"#$****X#I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *^5/V\/\ D4K?_@/_ *+N*^JZ^5/V\/\ D4K?_@/_
M *+N*[<'_'B85_X;-C]B+_DG:?A_Z)@KZ3KYL_8B_P"2=I^'_HF"OI.IQ?\
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ME+738_187DKSW*:6ZQ]A5J"$MP!5I;$-UZU-#"(NE9N1J$2>6N#UJ6DVTM9
M%%%% PHHHH *\'_;%_Y)9<?\!_\ 1\%>\5X/^V+_ ,DLN/\ @/\ Z/@KIPW\
M:'J85_X4O0\S_P""?O\ R+5U_P !_P#0[FOL2OCO_@G[_P BU=?\!_\ 0[FO
ML2ML=_O$B</_  8A1117 =(4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7RI^WA_P BE;_\!_\ 1=Q7U77RI^WA_P B
ME;_\!_\ 1=Q7;@_X\3"O_#9L?L1?\D[3\/\ T3!7TG7S9^Q%_P D[3\/_1,%
M?2=3B_XTA8?^%$****Y#H"BBB@ -)CBEHH C52&YZFHIH0QZX-3MQ@]Z7AP"
M13$9SQ;6P:AEB(Z#%:VT=?PJ*>'=R.*M2 RC'N6HFMRJUJ" JIHCBW'!'%5S
M$VTN<9X\T$Z]X(U?3\9-Q!,G_?43+ZCU]:_-K4? MMX/^(6H6!&96NI)._>4
MK_>/]WUK]"/VAOB</ACX.N943YI(F .>YCE/]UO[E?F4_P 1I=<^(U[KLYW*
M\SD=!UFW]E'KZ5ZN7U%SV9X><PY\.U'<ZSQI=0PJ$'#_ (_[->:KX/DOM82:
MX'R<^G]W'8U:U:\N=<\1?:91LM^W0_P >QZBNNT6_P!VH1M(N8USW]C7TL(J
MI*S6A^<5JL\+3Y:;W6HMQHJZ3M,0^7_/J?:LK4+B_*F.UCW%N,Y4=<^M=[XN
MURQA=$489@,+\WO[5B6NO6\##>NST/)_I6M6$?A70\G"8F=.7/*-[F'X?O=0
ML9#!=KRV3U7V]/H:[BWNKA;-E=]T9_AP!WJ"WUBTNF^[O./O9(_I5[4IHSII
M2'K^/]X>M)+ECJ=<L1S332M<R_#>ALPEN(C\O&?U'<UU4"6XFB@+</C/![G%
M<7H-S=Z3I\S-WV\<>I_QKQX?$C4;'Q-Y\K?NED^[A>SY_N^U85J\</%*74]&
MCEM3'3J3A+X?Q/HKQJ\/AF.U=)\+)M^78>^[Z^E<EXGU?4;[24%I-MB903\J
MGNI[BN0\1>*)?'%M9/'SY>PGIV!]A_>JAIE[?2ZHEDS[857'13T#?X"HNL1:
M,=CJA2K8>"ES6E$['P[X=2;20+AM[GVQ_$?0UV]GX=.G:/-*K_P'M[D>OO61
M9Z2UO&%#?I_]>JMU?7_V>2U!^0CT7ZUU^SC%W:."ABU6JI3G:-U?]2G:^!DE
MU@ZA(<ONW#_OK=_>_I76-;I'&H ^8# KD;.;4 V!\VW_ '>U:NGZI(9"LP^9
M?I[>@KDJ4IQ5UL?T1DV*RG$I0PC5[%BZ\QM\;)UZ<BJ^EVD]FQ#C:GX>]:<-
MP;F3.*N+;B\E",<?A3IU9RDH&N/RK 8;#U<1.&CU97O+AKZ(0#B+/)^O_P"L
MU5L?A_'JVHQ?9US+D'J?7W;WJ]?1I'J4-NO"YY_\=_QK<L+Z71+B.YMQDICT
M[$'OGTI2CS:,_!95'!VI[,OR:'=>'K1+>5>@ ZCTQZGTKB]<URYT^]983M?)
M[ ^GJ*Z/Q%\4([Y@EY^[9>,\GU]%]S7N_P"S-X6T?Q=;O>WEK]I1@K(WF.N?
M]:.@(]!6>(Q$:-%K<TR_"SKUTIZ7.B_9MUW6M7TD17H_T?\ O?)_>E/89Z@5
M[FL 60XY(J>QT6STJ$0V<7DQ^FXMW)[GW-7%A Y KX^=3F=S]'HT_8PY-RHL
M??%2QVY9LD8JQM"L*?Q4.1JD)MP*7M114%!1110 4444 %<)\;/^2<ZO_P!<
M)O\ T3)7=UPGQL_Y)SJ__7";_P!$R5K2^-$R^%GQ[^RI_P E8OO^ON3_ -'P
MU]^K]T5\!?LJ?\E8OO\ K[D_]'PU]^K]T5W9A_%.7"_PPHHHKS#L"OC?]O'_
M %6G?[T?_MQ7V17QO^WC_JM._P!Z/_VXKOP7\9'-B/X;/;/V6?\ DBWAG_KR
MC_\ 0GKURO(_V6?^2+>&?^O*/_T)Z]<KGK_Q9>K-:?P1]$%%%%8&@4444 %%
M%% !32F6!S3J* $;V-'6EHH 8(13&AW2@^@J:B@!DD>Y"HK\[/VT/AOXI.H'
M4P__ !+1U&(O2!?[V?O>U?HM7Q1^W/\ % :3JEAH(ES'+YFY=OHMNXYV^_K7
M3AE>JCDQ<U3P\V]D?&/AR*7Q-:_9R<0#M@>I/MW%6[>W;3;AK6<8A4X7\#@=
M/85Z5##I^FVJK&GEGZL>_P#]>L;Q7K%CH5N)YD\P,.#EAU!/8'TK]#IX=1C=
ML_#Y9A/$XATX1=F&@ZPFFV\OEGY50L./8>WM7-67BJ7Q/XGN+0G"QNRCI_MG
MT']VM72]4M]<TN=[:/[R-W/=1Z@>M<=I>GSZ/K=U<JFV1Y&*C(]6]_>L:CES
M)+8=&$$JCDM5L=M-%JFFSF)A^[['Y/3/]:Z&UN)+*V\QVR!UX]ZKZ'XH"*/[
M4&T'OGZ_W1]*P?$&O6VJ7;)9R;HEQN^4CC /<>QK?W(JW4P@ZE67P^ZNQIM8
MVNIZ@+O.2IW=_7/]:RO'V@OX@TTQVY^6-?Y!O4CUJQI5_ 52"(YD?"GKWP*V
M+H2:?"$"\R#U]1_]:N>6'E5@['I83$RI5E+:VUSYIO-0N_">H/;J<;&*GIV_
M ^M>D1Z7!X@T,30MEC][@_WL#J1Z5V.L> ;+7+!YY$_?M\QY;J6'^T/2O#9+
MC4_!>K/:OQ;MC'W?[N?<]6KPU&K@VG+6)]FZ\<TA?#OEG'?S/=OAW:I:V,L>
M,E5_]F8UTTUI'?+@\$?7_/>O(/ GC1]+N;A)/G2=0@[8Y_W?>O4-$U-;WD_Q
M=/T]J^@HU(58)QT/@\92K4:SDQMSHZ1=#G_/UIJV=HC"(M\_T/UKI9;9/L+N
M!EL$C\JX*2&3^T/M'4^G'IBE4CRO0TH59R5FSK5T)9-F7VCGMG^M6A;G3;M!
M$=W3V[U1NM4N8[=&$?'/\0]?I4\FM6BZ=YLLNR?GC:3TSCMBL6U<ZJ;K2:ZH
MZ>*8W%G*IXD9"/TKDUO_ .P=2D><?>+#/U/MGTK&D\3SQW4+QG=&SKD\=,_2
MNZBM;;6-+25UWR,BGJ1Z'V]:QG/56/6C2=&SGLS(U"\2YL3/;-S]/<#O^-.^
M#[:_XN\616AAQ;<Y;?'_ ,\W/L>JUZC^S9X5L-0\9?8[^+S(O[NYA_RSE/4'
MV%?:FE>!]$T63?967DMZ^:[>OJQ]37AXW%N,^5'TN78"G6A[1ZJYI:;:_8]-
MMK?.?+B5/R %3%2>.W2I:*\"[O<^NMT&!-L>!UIRYV\]:6BD,**** "BBB@
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M^CX*Z<-_&AZF%?\ A2]#S/\ X)^_\BU=?\!_]#N:^Q*^._\ @G[_ ,BU=?\
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M":R+'7;8PF)5WGIE0#VQZUFI.,K'=0Q=6C%5*'NM=3JETQ)+.-X9OFQR-W^
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M_P#T)Z]<KR/]EG_DBWAG_KRC_P#0GKURN>O_ !9>K-:?P1]$%%%%8&@4444
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M_P#@G[_R+5U_P'_T.YK[$KX[_P""?O\ R+5U_P !_P#0[FOL2ML=_O$B</\
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MT^#2[.*VMHUBAC4*JKT   'Z"K-%%>0?1!1110 4444 %%%% !1110 4444
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M"C).36C17R#E*6[/TY14=D%%%%24%%%% !1110 4444 %%%% !1110 4444
M%>>?'C_DFVL_]>TW_HF2O0Z\\^/'_)-M9_Z]IO\ T3)6E/XT3+X6?/7[$O\
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M4K?_ (#_ .B[BNW!_P >)A7_ (;-C]B+_DG:?A_Z)@KZ3KYL_8B_Y)VGX?\
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MO7[ >F/2O:M!T>/0]-BLX@-L>>F.[$^@]:T*^.G+FDY(_3(+EBDSE?"/PO\
M#G@= NCV+6Y QN:>1S_#_>8_W175445)84444@"BBB@ HHHH **** "BBB@
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M8E?'?_!/W_D6KK_@/_H=S7V)6V._WB1.'_@Q"BBBN Z0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OE3]O#_D4K?\
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M "1;PS_UY1_^A/7KE<]?^++U9K3^"/H@HHHK T"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** *NI:9;ZK:36]S#'+'*C1L'4-P00>H]Z^)_
MC3^Q5+XP\;2SZ7<R6EE,YD*Q1P@ F60]-Z]F';M7W%15QFX;&<X1J*TC\G?&
M'PSN_@GXN72+MGN(5+*LTI7/" ]%)_OBOT0_9]A,?@U'  5LXVC'222MKX@_
M"/1/B-L;4HLR+T;<_P#L]E<?W173>']"M_#FF16-J,11YQR>[$]R?4UTU*[J
M046<='"1HU7./4TJ***XST HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10 4444 %%%% !1110 4444 %%%% !7@_P"V+_R2RX_X#_Z/@KWBO!_VQ?\
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M?A_Z)@KZ3J<7_&D+#_PHA1117(= 4444 %%%% !1110 4444 %%%% !1110
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M*\C_ &6?^2+>&?\ KRC_ /0GKURN>O\ Q9>K-:?P1]$%%%%8&@4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YY\>/^2;:S_U[3?\
MHF2O0Z\\^/'_ "3;6?\ KVF_]$R5I3^-$R^%GSU^Q+_R'-8_Z^6_]"N:^R*^
M-_V)?^0YK'_7RW_H5S7V175C?XS,,/\ PD%%%%<)TA7Y[_M>?\E M_\ @7_H
MJ&OT(K\]_P!KS_DH%O\ \"_]%0UZF7?QCCQ?\)GV3\$_^1+MO^!?^C)*[^N
M^"?_ ")=M_P+_P!&25W]<%7XV=4?A04445D4%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %>#_ +8O_)++C_@/_H^"O>*\'_;%_P"2
M67'_  '_ -'P5TX;^-#U,*_\*7H>9_\ !/W_ )%JZ_X#_P"AW-?8E?'?_!/W
M_D6KK_@/_H=S7V)6V._WB1.'_@Q"BBBN Z0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "OE3]O#_D4K?_@/_HNXKZKK
MY4_;P_Y%*W_X#_Z+N*[<'_'B85_X;-C]B+_DG:?A_P"B8*^DZ^;/V(O^2=I^
M'_HF"OI.IQ?\:0L/_"B%%%%<AT!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7"?&S_DG.K_\ 7";_ -$R5W=<)\;/^2<ZO_UPF_\
M1,E:TOC1,OA9\>_LJ?\ )6+[_K[D_P#1\-??J_=%? 7[*G_)6+[_ *^Y/_1\
M-??J_=%=V8?Q3EPO\,****\P[ KXW_;Q_P!5IW^]'_[<5]D5\;_MX_ZK3O\
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M_P"#$****X#I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *^5/V[\?\(C!_P'_T7<5]5U\W?MF>$-1\4^%8UL+>6X=
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MO;XW_P#/AJ7_ 'YOO_BZ/[/G_,@^MQ_E9^C-%?G-_P +V^-__/AJ7_?F^_\
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M .+H_L^?\R#ZW'^5GZ,T5^<W_"]OC?\ \^&I?]^;[_XNC_A>WQO_ .?#4O\
MOS??_%T?V?/^9!];C_*S]&:*_.;_ (7M\;_^?#4O^_-]_P#%T?\ "]OC?_SX
M:E_WYOO_ (NC^SY_S(/K<?Y6?HS17YS?\+V^-_\ SX:E_P!^;[_XNC_A>WQO
M_P"?#4O^_-]_\71_9\_YD'UN/\K/T9HK\YO^%[?&_P#Y\-2_[\WW_P 71_PO
M;XW_ //AJ7_?F^_^+H_L^?\ ,@^MQ_E9^C-%?G-_PO;XW_\ /AJ7_?F^_P#B
MZ/\ A>WQO_Y\-2_[\WW_ ,71_9\_YD'UN/\ *S]&:*_.;_A>WQO_ .?#4O\
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M?G-_PO;XW_\ /AJ7_?F^_P#BZ/\ A>WQO_Y\-2_[\WW_ ,71_9\_YD'UN/\
M*S]&:*_.;_A>WQO_ .?#4O\ OS??_%T?\+V^-_\ SX:E_P!^;[_XNC^SY_S(
M/K<?Y6?HS17YS?\ "]OC?_SX:E_WYOO_ (NC_A>WQO\ ^?#4O^_-]_\ %T?V
M?/\ F0?6X_RL_1FBOSF_X7M\;_\ GPU+_OS??_%T?\+V^-__ #X:E_WYOO\
MXNC^SY_S(/K<?Y6?HS17YS?\+V^-_P#SX:E_WYOO_BZ/^%[?&_\ Y\-2_P"_
M-]_\71_9\_YD'UN/\K/T9HK\YO\ A>WQO_Y\-2_[\WW_ ,71_P +V^-__/AJ
M7_?F^_\ BZ/[/G_,@^MQ_E9^C-%?G-_PO;XW_P#/AJ7_ 'YOO_BZ/^%[?&__
M )\-2_[\WW_Q=']GS_F0?6X_RL_1FBOSF_X7M\;_ /GPU+_OS??_ !='_"]O
MC?\ \^&I?]^;[_XNC^SY_P R#ZW'^5GZ,T5^<W_"]OC?_P ^&I?]^;[_ .+H
M_P"%[?&__GPU+_OS??\ Q=']GS_F0?6X_P K/T9HK\YO^%[?&_\ Y\-2_P"_
M-]_\71_PO;XW_P#/AJ7_ 'YOO_BZ/[/G_,@^MQ_E9^C-%?G-_P +V^-__/AJ
M7_?F^_\ BZ/^%[?&_P#Y\-2_[\WW_P 71_9\_P"9!];C_*S]&:*_.;_A>WQO
M_P"?#4O^_-]_\71_PO;XW_\ /AJ7_?F^_P#BZ/[/G_,@^MQ_E9^C->??'9"W
MPUUD@=+:;_T3)7Q/_P +V^-__/AJ7_?F^_\ BZS?$'Q6^,OB32Y["\T_4F@E
M5E9?)O3P5*GJY'0FKAE\XR3YD3+%)JW*SV/]B;_D.:Q_U\M_Z%<U]D5\E?L5
M^#M8T2&:]U.UFMI+C$C"6-U.29\_> _O#\Z^M:Y<:TZ[L=&'35)7"BBBN$Z
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M]^;[_P"+H_L^?\R#ZW'^5GZ,T5^<W_"]OC?_ ,^&I?\ ?F^_^+H_X7M\;_\
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ME_WYOO\ XNC^SY_S(/K<?Y6?HS17YS?\+V^-_P#SX:E_WYOO_BZ/^%[?&_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\
M@+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K
M44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&
M3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?]
M 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%
MC_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$
M1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * N
MG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_
M (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S
M[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB
M.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_
M /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH
M_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_
M * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\
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M * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\
M@+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K
M44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&
M3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?]
M 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%
MC_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$
M1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * N
MG_\ @+'_ (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_
M (5K44<S[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S
M[A9&3_PB.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9&3_PB
M.A?] 73_ /P%C_PH_P"$1T+_ * NG_\ @+'_ (5K44<S[A9%:STRTT]0MK:0
MVR_W88P@_0>YJS114C"BBB@ JG>:/8:E_P ?=C;W7_7:)7_F/8?E5RB@#)_X
M1'0O^@+I_P#X"Q_X4?\ "(Z%_P! 73__  %C_P *UJ*KF?<5D9/_  B.A?\
M0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !
M8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A
M$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG
M_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A
M6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%
MD9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.
MA?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T_
M_P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\
M"C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_
MZ NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@
M+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11
MS/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_
M  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\
M0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !
M8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A
M$="_Z NG_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG
M_P#@+'_A6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A
M6M11S/N%D9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%
MD9/_  B.A?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D9/_  B.
MA?\ 0%T__P !8_\ "C_A$="_Z NG_P#@+'_A6M11S/N%D5[73[6Q7;;6T-NO
MI%&%'Z?4_G5BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !11GG'>B@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)=:E'H[7DMK TGFK9[MQAC)^\F>I/6O>?#\W@CX6>'DM=,O=/MM/##Y898$
M^0#.%VC[J"@#\7?$UOXZ_9+^/7B2_AM+R"%=0G\J;RYU#J0R@Y'EYXG'3U_/
M[R^ /_!3;1/B'J4&F:]#'I;_ #;I952'/RR-U>Y/]U1T[U]!_$#X8?"+XU8N
M]:N-%NWD&\NKV;MR%^\75N?D%?CM^UK\/M,^#/Q =/"EZHA.-ALY5X_=0Y_U
M:KWD;]?>@#]Z]+U:UUJRCN[*>.XMY,[9(W# X)!Y!(Z@U;KPO]C7Q!<^(/@?
MHTMWYIG7SMS2YR?])G ZD]@*]TH **** "BBB@ HHHH **** "BBB@ HHHH
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M9MW7)C4FMF@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >3_ !<^
M#8\<L+BU.VY7D'KS\Y[N!U85Y6OPP\86N=)67]Q]S[L/3[O][T]Z^K*.^>]
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M0 4444 9&J>%['6+E);I&D*#@!R!W]/J:U8XUB4*HPHZ"G44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1^)[>.RU)%BN><.K.V>7/<'L!WH ]JHH!R,BB@ HHHH **** "BBB@ HHHH
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M3:)XLT7Q)&'TK5K'41QG[)<I+C(S@[2>U?E;_P %.O'GB/3?B+#I^G:S?:?
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MX-DU#P5-JC3?ZN-FV[1SAE'K[>E><?"?X82^+KI)UN1"(7#$% <X*'^\/[U
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M]"OYU]3:7\<OA/H&DRRZ'XFTN>%<ED@NGD/"@G^\>@%(#\LOVNOV7?%/P?\
MBA>^*M)3.G_:GN(I,Q?\]YI%.&E8]$'4?X5Z%^S'_P %'-<\)M:>%_$ZYL[?
M$8DS'T2$KTCMR>L:]^]?>U]^TQ\#_&UNVFZKXTT<R _/:273QLIP5(XVG^(B
MOS*_X*/6OP\O/%FEW/P[U&TU.1[:0RQV,\DY#^?G^)C_  D_E0!^QG@KQMIO
MCS1H]3TN7SK9\X;:R]&9?XE!ZJ>U;]?*7_!.5=6C^!5K'JMG-:2+OVB9-I.;
MJYSQ@>WYU]6T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'Y ?\ !351)\;M+C;[KS1*?QN;H5X3\6O -SX9T;PGXFT\?N!8
M@RMD<,RH.C,3_P M.PKW'_@IY(J?&S2\LH/FQ=3_ -/-W7T!\,_A"/C%^Q[_
M &?:6;WNI 6@C6,G.-EHQXW*.B-0!XW\1OCS+\<O@#'%-Q]DSZ?Q7:GLB?\
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MH _.OQQ_P2U@UCXBVFN:?J*P6ZSQ2-&LX4?((QT%MC^$]^]?;/PK^&4'P^\
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>1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>bdtx-20211231_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g4.jpg
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M]_ZV^Q:%_P#A"FH$KH^X]45R&0/)B<Z0!4'4VV!31[<5NI7$,SS"XUD?<:J
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M><CV=*+4U#;U(.$,MHC]Z=VC+ZV .N5O:814 UU(# 3&T3@SQ@PETWO31)\
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M.&&7SI':+Y.'SR6JIDJ*CITQJ #<8P]M/4M:T@1PMWT\0=3OWD<QBE=ES@)
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M)T5T]%%75;?=&6"6Z51G<ZNKJIS8RS.WV.N/NRT^\6F^%Q\\IQ/O8A.SA,K
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MT4U%'!H@+ TAL]#42:CJ.H[S!X8 40_MRG4C^][PA\QWS]8>9G[B;7_.:_\
MK*?_  RWG]X;9/\ ">T7YS;?V4GVY3J1_>]X0^8[Y^L/'W$VO^<U_P#64_\
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M -93_P"&3]X;9/\ ">T7YS;?V4GVY3J1_>]X0^8[Y^L/'W$VO^<U_P#64_\
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MY&0FT1^A!I(Q_0XZ]U?S&3DX&3W_ !]V/CRC>1QRR<?;VJ4.04EY!/=,M_\
MIP<Z?_&T77_Z84G]W+R*33&T9QC/?_*)[UG:2;331-X<-7=_Q'>GYEO#]R._
MN.87_P ?7K_;AL\)CE^<YX!8ZN?KGU?B-'AE30ZD->+IWYZ3O6U:5POREKLE
M&G-[[T>=UVTVII]*][^YI"F'M*W[-M.:WX-^;?A#TCYU9'D?0?F4*?<B]=NC
M\#?;>O%R-=]]]HTG2OV2,3W2K3+>W-?!\/C4LC>E)VWZ9*4)88D_G\7TE19R
M^/Z MGV04TPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(J/8+!
M"U:(-GK#(CQ41'I:44:3M7@0HA]H05AMMM*WB"C#'QPP0QFW2S32!PQ&7B7V
MFED5CQ'-/%,],@5^&O=?D9F4+/"CH\8O:WS"(Q._.Z8^!I"VF7D/!>9TORSL
MH,9$LO.2818C)"""01@C@0>!!',$*N<DM*?XZOS"(PB;6]2[2TB&$>D!RI=3
MD&<A,8,1$H<E6"#][T*R]&-KD&G'4K#0HE+:=WUK<&W.W.,K:<-KJ1QG<V-S
M80*B,[US9B(G-C^&6RD1D##SIRK:L!=1U;0PRDTTX$8+@9"8G ,!80\%_P $
M%I#AGS3G"@%TLE'O<,7\E)]?MVOLA1K#%BM83(T,9Z&"C-$Q:07PUPFGX9Y:
ME^9C=.K47)$!'>A/CWD:WKRF!C;I0,93]!Q0DNH'O$KH2Z>0MF<]V)CTA@:6
MME  ;$)(O>I&K1/)NV06BH?-41U[I*D$7&%FZBJFM9IW;8VRS0M=3/#V.,3@
MXAS6S:I6N>_+7FI7XIX0^10'T7G-=/Y/R?K71>'8?$>Q/-2OQ3PA\B@/HO&G
M\GY/UIP[#XCV)YJ5^*>$/D4!]%XT_D_)^M.'8?$>Q?@I4CNQTA+L?Q6.VJ[U
MI*W*\% ZE=)W(([Z&4B/;>1O?WUL+2^GMK;:M;]N,8^]\,=?I^Q3AV'QSU>@
M?Z+23[K/_==2'_Y>TG_]F0SK.Q__ ),W_P#<S_\ ^5]A^1/_ .!XO_Y2X?/$
MM9N;2NN+5_;K7S!6>6N:=5J2N$D'RMR$[P)5V%F2A43Q]:Y&B<5R=1N<2,\^
MH2)!C@9WD:2E'PFQVWBHF/4^MQ3/9.GU$]?#77#<OG>RMJO<N$%SW1TE0^EH
MGP5$8)TQM8V2K?(6X!=&S.<%<6N%=M!17W:+H4UPFBOEU=LO0M,D\D%IKYK7
M8YZ"XP1N<8X(H8ZJ\3SNB:P.?!%J+BWA8\C:.8B>->-ZQ1OLL6.<XHC>1.49
MJ4C9CS!\A)07,%EA^.8.]2$]8(DR:KA]>K-P9EXQGU\>2/ZE4S!$,Z96BT=-
M<'4=)#3=.EEHFU5;(]DF7N='7S1TD=2^65CI(7Q0U D8-ZX@1XB(P1C):[:%
M]GL]%;/=ZLJK'#=[W43PU ?---3;05E/:*:YS5=73R5-'-24=P;40-Z5*]G1
MBVED:&K,]29Y%Y9ZA+'>*9,3L128RV\,VOUK(7RVB1ZZ',<,5V:EJ(!QFVV]
M5915DD)1HH^6-4(_"'ME$L[6>G2',C *NNNDM33R2QTS)[?.'OJJAK#2R6^*
M22F91@&"3?.D#G/<6F-P+AEW [#0,O%]VLK+G;ZBJI[9!7[/5V^FNE?'$;74
M;.4=1/;(;, Z@G-7-.U\L\AC=32B1[291ASG_D7D&-YJ'ME8C>1":+T_.TQ5
MO76W0T5*1]^!"3>1V+2 [-@GS2H7CLZ .KWJV#L.X^9?+6_J,[;?6NE75,N
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MY5 ]'(]8/4>PK8CDU%,(F$3")A$PB81,(F$3")A$PB81,(F$6,>:!;<;Q1R
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M46.6*DQX?TC8RB1"A]/*1MX=YO2FU9"T[P76V&)S&2BX46[?('&-DG28]#I
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MUO =?2-P!Y^GI&:K?DZ%Y,RUUDF,4M1-3=*]Y?6%W3@3$Q\C)]Y&R41Y<V2
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0,(F$3")A$PB81,(F$7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>bdtx-20211231_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g5.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #__@ 23$5!1%1/3TQ3('8R,"XP /_; (0
M!04%" 4(# <'# P)"0D,#0P,# P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0$%" @*!PH,!P<,#0P*# T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-_\0!H@
M 04! 0$! 0$           $" P0%!@<("0H+ 0 # 0$! 0$! 0$!
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M?]V7_P!!BKHJ?[M'Y?J<U+_>Y_\ ;QZI7D'N!0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % %#5?^/.?_ *XR_P#H#5I3
M^./^)?F8U?X<_P##+\F<5\-O^0?+_P!=S_Z+2N[&?&O\/ZL\[ ?PY?XOT10T
MK_D:[C_=D_\ 08JTG_NT?E^IE2_WN?\ V\>IUY)[@4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!0U7_ (\Y_P#KC+_Z
M U:4_CC_ (E^9C5_AS_PR_)G%_#;_D'R_P#7<_\ H"5W8SXU_A_5GG8#X)?X
MOT10TK_D:[G_ '9/_08JTJ?[M'Y?J94O][G_ -O'J5>2>X% !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 4=4_P"/.?\
MZXR?^@-6E/XX_P")?F8U?X<_\,OR9Q7PV_X\)?\ KN?_ $!*[L9\:_P_JSSL
M!_#E_B_1%#2O^1KN?]V3_P!!BK2I_NT?E^IE2_WN?_;QZE7DGN!0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % %'5/^/.
M?_KC)_Z U:4_CC_B7YF-7^'/_#+\F<5\-_\ CPE_Z[G_ -%I7=C/C7^']6>?
M@/X<O\7Z(H:5_P C5<_[LG\HJTG_ +M'Y?J8TO\ >Y_]O'J5>2>X% !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 $@#)X H \]U'XB6=K(8[:-KG:<%P0BD]]I()/UP
M>W'-;*FWOH>S3R^<E><E'RM=_,V-!\76FNMY*!H9\$B-_P"(#J58<''<<'OC
M%3*#CZ'-7PD\.N9VE'NNGJCJJS//"@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * *.J?\
M'G/_ -<9/_0&K2G\<?\ $OS,:O\ #G_AE^3.+^&__'A+_P!=S_Z E=V,^-?X
M?U9Y^ _AR_Q?HBAI7_(U7'^[)_**M)_[M'Y?J94O][G\SU&O)/;"@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H Y_P 5M(FE7)A^]Y?;CY20&Z?[.:N/Q*YVX5)UH*6U
M_P ;:?B?.E=Q]D:.CM*E[ 8,^9YJ;<>[ 'I[9S[5,MG?L8U4G3FI;<KO]Q]-
M5P'PP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0!1U3_CSG_ZXR?^@-6E/XX_XE^9C5_A
MS_PR_)G%_#?_ (\)?^NY_P#0$KMQGQK_  _JSS\!_#E_B_1%#2O^1JN/]V3^
M45:S_P!VC\OU,J7^]S^9ZC7DGMA0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0!1U3_CSG_ZXR?\ H#5I#XX_XE^9E5_AS_PR_)G&?#C_ (\)
M/^NY_P#0$KMQGQK_  _JSSL!_#E_B_1%'2O^1IN/]V3_ -!BK2?^[1^7ZF5/
M_>Y_/]#T^O*/;"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@7^#UWG_ 'W)=#TVQ_X]XO\ KFG_ *"*U9\W4^.7^)_F6:1F% !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 4=3_X])_\ KC)_Z :TA\<?5?F95?X<_P##+\F<;\.?^/"3
M_KN?_0$KMQ?QK_#^K/.P/\.7^+]$4-+_ .1IN/\ =D_E%6D_]VC\OU,Z?^]3
M^?Z'I]>4>T% !0 4 % #9)%B4NY"JH)8DX  Y))/  ')- TFW9:MZ)&=I>L6
MNLQF6S?>J,588((/;*GD!ARI[CZ$"FG'1FU6C.@U&HK75UV^_P NIIU)@% !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MGS.4T+PQ=ZZP:(;+?=AI3P!C&0HZLW/ Z>I%:2FH^O8]"MB88=6D[RZ16_\
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MO^O"V^#_ +<_]O\ ^GG,>FV0Q;Q#_IFG_H(K0^;G\<O\3_,LTC,* "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M<X4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % &3J^BV^LHJ7&]3&=R,C%65B,9!%4FX['31K2H-N%M=&FKIHP/[-
MUG2!NM+I+N%?^6=T,-CVD&/S-5>+W5O3_([/:8>MI4IN$GUAM]Q8T3Q4NJ7)
ML)HC!<HI8@,KH<8SAE/O_P#7H<;*ZV(K87V,/:QES0;[-/7R9EP_\C9)_P!>
MH_DE5]CYF[_W*/\ C_5GH-8GC!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0!#<_ZI_P#<;^1H+A\2]5^9YSX1MGO/#LT$7#R&95^I48_/I6\])W]#VL5)
M0Q49RV2BW][,JYE&LV$&C6EJZWD0 <LFQ8=@(8[_ /;Z>ASSS5+W6Y-Z?F=$
M5["I/$U*B]F]DG?FOMIY%V]U>VU*SM](M(WBNUEA7R2A'DE&^9B<8P.3D<D'
M)[U*3BW)[6>O<SA2G2J3Q%22=/ED^:_Q7V5CU0<5@?/!0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!P_Q!XTO'_3:/\ F:UI
M_%]YZN _C?\ ;K.PM!B",?["_P#H(K(\Z?Q2]7^98H,PH * "@ H * "@ H
M* "@ H * "@ H \H^(ND2N\>HQ*60+Y<F 25P258_P"SR03V./6NBF[>Z?0Y
M?523HMV=[KS[KU/*ZZ3WCVCX?:1+8V\EW.I0W!4(I!#;%SR0>FXG(]N>]<E1
MW=ET/FL?54Y*G'7EO=]+OI\CT.L3Q0H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H I:E_QZ3_ /7&3_T UI#XH^J_,RJ?!+_"_P F<=\._P#C
MPD_Z['_T!*[<7\:_P_JSS\#_  Y?XOT11TS_ )&BX_W9/_08JN?^[Q^7ZF5/
M_>I?/]#TRO+/:&NZQ*7<A54$DDX  Y))[ =Z!I-NRW>R/'/%'B9M78VUL2MH
MIY[&4CN?1 >57O\ >;L!TQCRZO?\CZ7#894%SS_B/_R7R7GW?R1Q^VM3T@VT
M &V@!-M !MH 7;0!?TS49](G%Q;'##AE/W77NK#T]#U4\BI:35F8U*<:T>2:
MTZ/JGW7]:GN.CZO!K, G@.".'0_>1O0^WH>C#D=P.5KET9\K6HRH2Y)?)]&O
MZW70U:DYPH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M'D5+G=6:,JF+]K'DG35NFKNGW7]:G9UF>6% !0 4 % !0 4 % !0 4 % !0
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M4 #^59/74\:<G.3F]VV_O+%(@* "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M484;0C*"=DEUZ7/2:Q/""@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M!_I_PYW-9'DA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M^O4DH)"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M/\CT>L3PPH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MH(0 @^^:E[NW<PK-.I-QV<I6^\T:1@% !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M %ZC^2UM]CYGLO\ W)?X_P!6>@UB>,% !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % $-S_JG_W&_D:"X?$O5?F<5\.O^02/^NTG_LM;5/B/3S#^-_VZOU.[
MK$\D* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % %/4?^/6;_KE
M)_Z :N'Q1]5^9G4^"7^%_D<A\/\ BQD_Z['_ - 2NW%_&O3]6<&"^!_XOT13
MTW_D99_]V3_T&*KG_N\?E^IE3_WJ7S_0]'KS#V H * ,7Q%_R#YOHO\ Z&M5
M'<Z\-_%C\_R9Y9MK8^A#;0 ;: #;0!UW@\8GE_ZYK_Z$:B1YN,^&/J_R._K(
M\4* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H \^A_Y&N3_ *]1_)*V^Q\SV7_N4?\ '^K/0:Q/&"@
MH * "@ H * "@ H * "@ H * "@ H * "@"&Y_U3_P"XW\C07#XEZK\SB_AU
M_P @D?\ 7:3_ -EK:I\1Z>8?QO\ MU?J=U6)Y(4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!PGQ"_Y!R_\ 7>/^M:T_
MB^3/7R_^*_\ "SMH/]6G^ZO\A61Y<OB?J_S):" H * "@ H * "@ H * "@
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MIXTY<\I3?5M_>RS2,PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MFVV/!Q6*^L6C!6@OO;[LS] _Y&#4OHG_ ++3E\,?F;5_]UH_/]3T$C-8GC"
M!>G% Q:!!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M=?\ ()'_ %VD_P#9:VJ?$>GF'\;_ +=7ZG=UB>2% !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 <)\0O^0>G_ %WC_K6M
M/?Y,]?+_ .)+_ _T.WA^XO\ NC^59'E2W?JR2@D* "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!4U#_ (]9
MO^N4G_H)JX?%'U7YF=3X)?X7^1R7@+BRD_Z['_T!*[,5\:]/U9P8+X'_ (OT
M13TX?\5)/_NR?RBJY_[O'Y?J13_WF7S_ $/1*\T]8* "@#)UP?Z%+]%_]"6J
M6YTT/XD?G^3/.]M:'NAMH$&V@8;: .F\+C$TG^XO_H1J)'GXKX8^OZ':5!Y(
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0!Y]#_P C9)_UZC^2UM]CYGLO_<E_C_5GH-8GC!0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 5-0_P"/:;_KD_\ Z":N'Q+U7YF<_@E_
MA?Y')^ QBRD_Z['_ - 2NS%?&O3]6<.#^!_XOT14TX?\5'/_ +LG\HJN?\"/
MR_4SI_[S+Y_H>A5YIZP4 % &7K7_ !YR_0?^A+36YTT/XD?G^3//]M:GM!MH
M -M !MH Z3PT,2R?[B_S-1(X,3\,?7]#L*@\L* "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \^A_Y&
MN3_KU'\DK;['S/9?^Y+_ !_JST&L3Q@H * "@ H * "@ H * "@ H * "@ H
M * "@ H AN?]4_\ N-_(T%P^)>J_,XOX=?\ ()'_ %VD_P#9:VJ?$>GF'\;_
M +=7ZG=5B>2% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M .ZT?G^IZ#6)XP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% %34/\ CVF_ZY/_ .@FKA\2]5^9G/X)?X7^1RG@3BR?_KJ?_0$KKQ7QKT_5
MG#@_@?\ B_1%33O^1BG_ -U_Y15I/^!'Y?J9P_WF7S_0]!KS3U@H * ,S6?^
M/.3Z#_T(4UN=%'^)'Y_DSA-M:'LAMH -M !MH Z'PZ,2R?[@_F:EG#B?A7K^
MAUM0>8% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 >?0_\C9)_UZC^25M]CYGLO_<E_C_5GH-8GC!0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!#<_ZI_\ <;^1H+A\2]5^9Q7P
MZ_Y!(_Z[2?\ LM;5/B/3S#^-_P!NK]3NZQ/)"@ H * "@ H * "@ H * "@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M 4 % !0 4 % !0 4 >?^)?\ D-:9_OM_,5M'X9?(]G#?[O7]/T/0*Q/&//\
M0/\ D8-2^B?^RUM+X8_,]FO_ +K1^?ZGH%8GC!0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 5+_P#X]I?^N3_^@FKA\2]5^9G/X9>C_(Y;
MP-Q9O_UU/_H"5UXGXUZ?JSBPGP/_ !?HBIIX_P"*AF_W7_E%5S_@1^7ZF</]
MYE\_T._KSCU0H * ,_5?^/63Z#_T(4T;T?XD?G^3.*Q5GKAB@ Q0 8H W=!&
M)'_W1_,U+./$?"O7]#J*D\T* "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H \^A_Y&R3_KU'\DK;['S/
M9?\ N2_Q_JST&L3Q@H * "@ H * "@ H * "@ H * "@ H * "@ H AN?]4_
M^XW\C07#XEZK\SBOAU_R"1_UUD_]EK:I\1Z>8?QO^W5^IW=8GDA0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ' _$/\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0!P/Q#_P"/&+_KX3^35M3W^3/8R_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0!5O_ /CVE_ZYO_Z":N/Q+U7YF<_A
MEZ/\CE_!'%F__74_^@)75B?C7I^K.+"? _\ %^B*M@/^*@F_W7_E%6D_X$?E
M^I$/]XE\_P!#O*\X]0* "@"AJG_'K)]!_P"A"FC>C\<?ZZ,XVK/5"@ H ,4#
M-S0O]8_^Z/YFI9QXCX5Z_H=+4GG!0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'GT/_(V2?]>H_DE;
M?8^9[+_W*/\ C_5GH-8GC!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!#
M<_ZI_P#<;^1H+A\2]5^9Q7PZ_P"02/\ KK)_[+6U3XCT\P_C?]NK]3NZQ/)"
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MS2#:'.>BKZ8YSFDX\O57[$5J'L$N:<7-O6*ULO,Z&H.(* "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@"K??\
M'O+_ -<W_P#035Q^)>J_,SG\,O1_D<QX*XLW_P"NI_\ 0%KJQ/QKT_5G'A/@
M?^+]$5;#_D/S?[K_ ,HJN?\  C\OU,X?[Q+Y_H=W7GGJ!0 4 4-4_P"/9_H/
M_0A31O1^-?/\F<ABJ/5#%, Q2 ,4 ;6B<2/_ +H_F:3..O\ "O7]#I*D\\*
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H \^A_Y&R3_ *]1_)*V^Q\SV7_N2_Q_JST&L3Q@H * "@ H
M * "@ H * "@ H * "@ H * "@ H AN?]4_^XW\C07#XEZK\SBOAU_R"1_UV
MD_\ 9:VJ?$>GF'\;_MU?J=W6)Y(4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0!P/Q#_X\H?^OE/Y-6U/=^C/8R_^)+_
M_P T=Z.@K$\ABT""@ H * "@ H * "@ H * "@ H * //]>YU_3AZ!OYFMH_
M#+Y'LT/]VK?UT1Z!6)XQY]H'_(P:E]$_]EK:7PQ^9[-?_=:/S_4]!K$\8* "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#S76?B$EG,T%C&)MA
M(:1FPI(/(4#DC_:R,^G>MXT[J[T/<HY>Y14JLG&_1;_._P"1J^&_&4.N/]FE
M3R+C!*C.5<#KM/!R.NT]N<U,H..O0Y\1@W07/%\T.O=>OEYG:UD>6% !0 4
M% !0 4 % !0 4 % !0 4 % !0!Y_\0_^/6V_Z^D_]!>MJ>[]&>SE_P <_P#
M_P T6?$<K6>HV=V8);F.))LB)"Y5FV[3P, ]<9_"E'5-72VWT(PRYZ52FI1@
MVX[NVFMSG[[4H[_4H+Z2PNFCA1PRF!LL^08R1C!"\]>F>E6E9-*2^\[(4G3I
M2I1JP3DU9\RT77TOY'<Z/K@U1VC%O<6VQ0098RBGG& 3W'IZ5BX\O5?)GDUJ
M'L4I<\97?V7=F]4G&% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MU Q'H>C#\""*X&K.Q\35I^RG*GV?_#?@:%(Q"@ H * "@ H * "@ H * "@
MH * "@#S_P"(?_'K;?\ 7TG_ *"];4]WZ,]G+_CG_@?YHW-=U2ZM9(;+3T5K
MFZ+8:3.Q$0#<QQR<9'^!Z5$4M6]D<E"E"2E5K-J$+:+=M[(PW\0:I*XTE(DA
MU+=\S_>A$0&?-7J>>F#G![9X%\J7O7]W\;]CK6'HQ7UAR;HVT6TN;^4V-#U"
M\-S-INI%'G@59%DC& Z/GM@8*D8/3K[9J))63CL<U>G3Y(UZ%U&3::?1K_,Z
MBH//"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H K7O\ Q[R_]<W_ /035Q^)>J_,B?PR]'^1S7@SBT?_ *ZG
M_P!!6NK$?$O3]6<6$^!^OZ(J6/\ R'IO]U_Y1U<OX*^7ZD0_WB7S_0[FO//3
M"@ H HZE_P >S_0?S%-&]+XU\_R9R6*H]07% "4 +B@#8T7_ %C_ .Z/YFDS
MDK[+U.BJ3SPH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M ^(?_'G /^GE/Y-6U/=^C/8R_P".?^!_FCOQP*Q/'"@ H * "@ H * "@ H
M* "@ H * "@#S_6_^1AL/]QO_9JUC\$OD>S0_P!UJ^OZ(] K(\8\^T#_ )&#
M4OHG_LM;2^&/S/9K_P"ZT?G^IZ#6)XP4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % 'DOC[P\X?\ M2W4%-H$P& 00<!_?/ /?(R>M=-.7V7\
MCZ+ XA6]A-Z_9].WR//]/TBZU200VT;,2<$XPJ^[-T&/>MG)1W/7G5A27--I
M+\7Z+J?16DV TNTBM%.?*0*3ZGJQ_$DFN%N[N?&5:GM9RJ=W^'3\#0I&(4 %
M !0 4 % !0 4 % !0 4 % !0 4 >?_$/_CUMO^OI/_07K:GN_1GLY?\ '/\
MP/\ -&_KFDW%Z\-W8R+#=6Q;:7!*,KC#*P )P<#L?ZU$6E=/9G'0JQIJ5.K%
MRA*U[;IK9HP#X>U*W;^U!<1R:GNY!R(&BQCR0" 1Z@\<_P#?57S+X;>[^-^Y
MV?6*4E]7Y&J-O^WE+^;J:^A:=>+<3:EJ7EK/.J1JD?*HB9[Y.2QP>IZ=><5,
MFK*,=D<U>I3Y(T*%^6+;;>[;.IK,\\* "@ H * "@ H * "@ H * "@ H *
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M$OD>S1_W6KZ_Y'H%8GC'G^@?\C!J7T3_ -EK:7PQ^9[-?_=:/S_4] K$\8*
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#GO%?_(*N?\ <_\
M9EJX?$CMPO\ &AZ_HS,\%?ZJZ_Z^W_\ 0$ISZ>G^9T8W>G_@7YL[2LSR@H *
M "@ H * "@ H * "@ H * "@ H * //_ (A_\>MM_P!?2?\ H+UM3W?HSV<O
M^.?^!_FC2UB[>WU>Q02&.)UFWC=A6P%QN'0^WZ5*7NOY&-&"E0JNUY)QMIJO
M0S)-/C\4:I<I=.S6UF(TCC1\*6=<LQ([]O\ ]55?D2MNS=5'A*,'324YW;;6
MMET+V@1MI-_<:2KO);I''-%O.3'N)#)GTS@K]#4RU2EUV9C7:K4H8AI*;;C*
MVE[;,[.LSRPH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MJN/;4$DH*ZC?^KL[*WN(KI!+ RR(W1E((/XBLMM#RY1<'RR33[/0FH)"@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H X#XA_\ 'G!_
MU\I_)JVI[OT9[&7_ !S_ ,#_ #._K$\<* "@ H * "@ H * "@ H * "@ H
M* //]7_Y&2Q_ZY-_[/6J^"7JCV:/^Z5?7_(] K(\8\^T#_D8-2^B?^RUM+X8
M_,]FO_NM'Y_J>@UB>,% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MGM_7SV.HTC_6/_NC^=2SGK[+U-ZD< 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Y]#_R-DG_ %ZC
M^25M]CYGLO\ W)?X_P!6>@UB>,% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % $-S_JG_W&_D:"X?$O5?F<5\.O^02/^NLG_LM;5/B/3S#^-_VZOU.[K$\D
MX#Q[_J[3_KZ2MJ?7T9[& WJ?X&=5J^H66GP;]0*B)OEVL-VXX^Z%P<FLTFW[
MIP4:=2I*U&]UU3M;YGGMCIMY=W/VC1(Y-+MFZF4DJ_NL!SCMCH/1NU;-I*T_
M>?E_F>S.I3IPY,4U5FND5JO67]>AVNEZ?JEM-OO+M;B+:1L$00Y['=GMZ5DV
MNBM\SRZM2C*-J5-QE??FO^!T50<(4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M2M^IZ?4G(% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H KWG^HD_ZYO_ .@FJC\2]41/X9>C_(Y[PD,6K_\
M70_^@K73B/B7I^K.3"_ _7]$5K+_ )#4OT?^4=7+^"OE^IG#^/+Y_H=E7">D
M% !0!3U#_4/]!_,4S:E\:_KH<U3/2/(OC1=W^FZ+'>:=>'3WAN!N*2O%),&1
ME6*/RQEVW?.5.%"J7)&VCH8U-(Z.VWZZ?U^AY-:^%?B;=VPNENKQ-ZAEBDOR
MDQ!&1\C2#:2/X7*L.A /%(PY9]_Z_+\3)T >/M72YGL+^Y>?379+BUENSYZ,
MN3S;RG# E64<'<RLO7@BN)<_1Z]OZ5OO/IKX+^,)_&>DM=W@7[7;N;>9E 4.
M5"NLFT<*65AN  7>&*@ X *<N:"?F_P_X='L=(Y@H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#SZ'
M_D;)/^O4?R2MOL?,]E_[E'_'^K/0:Q/&"@ H * "@ H * "@ H * "@ H *
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ML4C,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \_^(?\
MQZ6__7TG_H+5M3W?HSV<O^.?^!_F>@5B>,% !0 4 % !0 4 % !0 4 % !0
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % %>\_P!1)_N/_P"@FJC\2]41/X7Z/\CG_"?%
MJW_70_\ H*UTXCXEZ?JSDPOP/U_1%:R_Y#4OT?\ E'5R_@KY?J1#^/+Y_H=C
M7">B% !0!4O_ /4/]!_,4&U+XU_70YNJ/0/&_C9X>OM9TF&ZTU6EETV?SVB0
M;F*%<%U7!WF,@$K@_(6.#@T>AC43:TW33^ZYPMO^T:5@ N=-WW0 #%+C9$S
M<MM,+.@)R=NYL=-U*YG[6W3^OZ\F9WAG4M:TVSUSQ_=1^0]Y&J6RLA"2233Q
MJ'1#RT<"D!&.0YR,L0],%=)S:[:?E^GKJ>Q?L^>'[K0M$D>]1H9;Z8SJC@JP
MBVJB%E/(WE689 )4J>XI;*QE).,%?NW]Z7^1[Y2, H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#SZ
M'_D;)/\ KU'\DK;['S/9?^Y+_'^K/0:Q/&"@ H * "@ H * "@ H * "@ H
M* "@ H * "@"&Y_U3_[C?R-!</B7JOS.*^'7_()'_7:3_P!EK:I\1Z>8?QO^
MW5^IW=8GDG >/.ED/6Z7^E;0Z^A[&!_Y>_X/\S;\1:/<:J('M)%AEMI?,5F&
M1G&/?I[C%1%J-[K1HY</6C1YU4BY1DK-(YVZTG5[EXVFO[8M!)YB?*!A\$9P
M%&>">#Q5IQ6R>OF=T:M""DHT9VDK/?;[SH=)M-6AFWWMS%/!M/RH@4Y['(4<
M#ZU#<>BL<56=!QY:5.497W;_ ."=+4' % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % 'G_Q"_P"/:V_Z^D_DU;4]WZ,]G+_BG_@9Z!6)
MXP4 % !0 4 % !0 4 % !0 4 % !0 4 >?ZC_P C1:?]>[?REK9? _7_ "/9
MI_[G4_Q+_P!M/0*Q/&//M _Y&#4OHG_LM;2^&/S/9K_[K1^?ZGH-8GC!0 4
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M#T./QX--^]'F>]_O+JR]O0]O.*4XR2YDK<R?^1W%9'DA0 4 % !0 4 % !0
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M9)_UZC^2UM]CYGLO_<E_C_5GH-8GC!0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0!#<_ZI_P#<;^1H+A\2]5^9Q7PZ_P"02/\ KM)_[+6U3XCT\P_C?]NK
M]3NZQ/). \==;$>MTO\ -:VAU]#V<#_R]_P?YG:7]A!J4+6URHDC?J#ZCH01
MR".Q%9)VU1Y=.I*E)3INS1R?_"$HORQWEXB=E$N0!Z5IS^2^X]'ZZ^M.FWWL
M7=+T^PT&Z%K'YCW5RC.99"79E0C(+'IR1@ <]^U)MR5^B,JM2IB(.H[*G!I<
MJTU?D=569YP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MQS_P/\T>@5B>,% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5=EZFS2.,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M 4 % !0 4 % 'G_Q!_U%K_U])_(UM3W?HSV<!\53_ ST"L3Q@H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M?\@D?]=I/_9:VJ?$>GF'\;_MU?J=U6)Y)P'CG[]@/6Z7^:UM#[7H>S@=JO\
M@_S.CU[6#H\*F*,SSS.(XHQQN8^OL._X#CK6<5?R74X:%'VTGS/EC%7D^R.;
ME\3ZFI&GFT$>I2$;!NW1>7@DR9!_AP01NQWSQBM.5;W]W\3N6&H_QE4O12UT
MM*_;Y^AJ:-JU\+HZ;JJ(D_E^9')'G;(H.&_$>V/IZRTK<T=CGK4J?)[?#MN-
M[-/=/H=969YP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 >?_$'_46O_7TG\C6U/=^C/9P'Q5/\#/0*Q/&"@ H * "@ H * "@ H *
M"@ H * "@#S^[Y\56_M:M_*6ME\#]?\ (]F/^Y3_ ,:_.)Z!6)XQY]H'_(P:
ME]$_]EK:7PQ^9[-?_=:/S_4]!K$\8* "@ H * "@ H S]5-H+63[>5%N1A]_
M3!_7.>F.<].::O?3<WI<_.O8WY^EOZV//8],L!;/=6.J7$-G']]5<_+GHN/E
M89Z*"I)[9K:[O9Q5_0]EU*G.J=6A"51[.V_GU7KJ;G@\Z2!(-.=Y)S@RM-GS
M6'8\@?+GIC\><5,^;[6W2VQR8OVWN^V24?LJ/PK_ (/](JZY_P C%IW^X_\
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M'\5?X4=U61Y(4 >?_$/_ (];?_KZ3_T%ZVI[OT9[.7_'/_ _S1Z!6)XP4 %
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M1B'D>1MTDLF N]C@*.  %154=ADDD)J)1BDNYWM(Y@H * "@ H * "@ H *
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M/^Y2_P :_.)W]8GC'GV@?\C!J7T3_P!EK:7PQ^9[-?\ W6C\_P!3T&L3Q@H
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M;#>TJZRC.R?5I[G>UD>.% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MR0H \_\ B'_QZVW_ %])_P"@O6U/=^C/9R_XY_X'^:/0*Q/&"@ H * "@ H
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ME;?8^9[+_P!RC_C_ %9Z#6)XP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@O6U/=^C/9R_XY_X'^:/0*Q/&"@ H * "@ H * "@ H * "@ H * "@ H *
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M<3*R'RF1&(0. 3&'+%2.,D@=,4]C&5U%7[O]+?J>^4C(* "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M \^A_P"1LD_Z]1_)*V^Q\SV7_N2_Q_JST&L3Q@H * "@ H * "@ H * "@ H
M * "@ H * "@ H AN?\ 5/\ [C?R-!</B7JOS.+^'7_()'_7:3_V6MJGQ'IY
MA_&_[=7ZG=5B>2<!XV_X^-.'_3T/_0HZVAM+T/9P7PUO\'Z2._K$\8* "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * //\ Q]]R
MS'_3TO\ *MJ?7T/9P&]3_ >@5B>,% !0 4 % !0 4 % !0 4 % !0 4 % '
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MQ?A[_P @D?\ 763^8JZGQ'3C_P"-_P!NQ.WK(\H* //_ (A_\>MO_P!?2?\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H AN/\
M5/\ [C?R-5'=>J)E\+]'^1D>'^(&_P!\_P#H*UO6^+Y'-A_A?K^B(;;_ )"4
MGT;^254OX:^7ZD1_C/Y_H='7(=P4 % $%S_JV_#^8H-(?$C)H.PXWQQXUM/
M>G?VC=JTK.XBAA0@-+(06QN((154%F<@X&  6(!")/E1\XS_ !ZL+B;[1+X>
MLI)LY\QWC:3/J7-H6S[YIW]?O_X!CSKS^_\ X!ZU\-OBTWQ!O9K V2V0M[?S
M@RS&3.'1-FTQ( /GSD'C&,<\(TC*_P#7_ 1[E9?>;Z#^=!-39>IHT',% !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 >?0_\C9)_P!>H_DE;?8^9[+_ -R7^/\ 5GH-8GC!0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0!#<_ZI_]QOY&@N'Q+U7YG%_#K_D$C_KK
M)_[+6U3XCT\P_C?]NK]3NJQ/). \:_\ 'UIG_7T/_0HZVAM+T/9P7P5_\'Z2
M._K$\8* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * //\ Q[TLO^OE?Z5M3Z^A[. _Y>_X#T"L3Q@H * "@ H * "@ H * "@
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MZ([6LCRPH \_^(?_ !ZVW_7TG_H+UM3W?HSV<O\ CG_@?YH] K$\8* "@ H
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M % !0 4 % !0 4 % 'G_ (]Z67_7RO\ 2MJ?7T/9P'_+W_!_F>@5B>,% !0
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M^!_FCT"L3Q@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * (KC_ %3_ .ZW\C51W7JB9?"_1_D9.@_Z
MAO\ ?_\ 95K:M\2]/U9S4/A?K^B(;;_D(O\ 1OY+52_AKY?J1'^,_G^AT-<I
MW!0 4 0W/^K/^>XH-(?$C*Q0=9RWBWPGI7BRU6#6U+6]LYG!$IA"$(59F<$
M*%)SDX'6@EJ_]?Y'B.G>$?A?J^HIH]A))<WDI<(L<UT8SL5G;$VT1$!58@AB
M#C@G(IF5EMI^/Z.WXGIW@+P?X7TC=JWA<^:LZ&!I%G>9<!E9D*MRCAE4D$!L
M=L')1<4EM_7XL]5L_O'Z"@FILB_0<P4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!Y]#_R-DG_ %ZC
M^25M]CYGLO\ W)?X_P!6>@UB>,% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % $-S_JG_W&_D:"X?$O5?F<7\.O^02/^NTG_LM;5/B/3S#^-_VZOU.ZK$\D
M\_\ &G_'YI?_ %]#_P!#BK:&TO0]C!_!7_P?I(] K$\<* "@ H * "@ H *
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MM"X@;_?/\A6U7XEZ'-0^%^OZ(AM_^0B_T;^2U4OX:^7ZDQ_BOY_H=!7*=H4
M% $-Q_JS_GN*"X?$C,Q0=9X%^T+J$]MHUI91.88+Z[V7#C.-D:[E5L<E=Q\P
MKW,8]*#*7^7XW_R,"P\$Z9X-\;:#:Z27DCN;.YDDF,F\S$P7"^:I7Y%!7E=@
MV@8/)R2$KW7?U_+J)\)+>/PYXRU?P_ID[76F1PLP<D-^\B>(+DKA2\9EEA9E
M W%<X & #CH[?U_7^1]46G#'Z4!4V1>H.<* "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \^A_Y&N3_
M *]1_):V^Q\SV7_N2_Q_JST&L3Q@H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M$5Q_JG_W6_D:J.Z]43+9^C,O0^(6_P!_^@K:K\2]#FH?"_7]$0V__(0?Z-_)
M:J7\-?+]28_QG\_T-^N4[0H * (I_P#5G_/>@N&Z,R@ZCG/%?A.R\9Z=)I6H
M*QC<AT=,>9%(N=LB$@C(R00>&4E3UH):/FR3]G+7(9Q]EU* Q("J2,+B.14;
M.X!%#A<@G*K)@Y//)H,K6Z_U]Y[A\._AI:?#NVD6-VN;RZV^?<,NP$+DK'$F
M3L0$DG+%G;EB %50N*2V/4+3[Q^E JFR+U!SA0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'GT/_(V
M2?\ 7J/Y)6WV/F>R_P#<E_C_ %9Z#6)XP4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 0W/^J?_<;^1H+A\2]5^9Q?PZ_Y!(_Z[2?^RUM4^(]/,/XW_;J_
M4[JL3R3S_P 9?\?VE_\ 7S_[-%6T-I>A[.#_ (=?_!^DCT"L3Q@H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \_\=];'_KY'
M_LM;0Z^A[.!_Y>_X/\ST"L3Q@H * "@ H * "@ H * "@ H * "@ H X"WY\
M53>UL/Y+6WV%ZGLR_P!RC_C_ %9W]8GC'GV@?\C!J7T3_P!EK:7PQ^9[-?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M3[Q^E 5-D7J#G"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_P!6=_61XQY]H'_(P:E]$_\ 9:VE\,?F>S7_ -UH_/\ 4]!K$\8* "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M-+FTZ'T';$&%".FQ<?D*XCX^?Q2]7^9Y["VKW5_>O8W Q;3!1!-S&P(/ /\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M (O_ .0CIG_7Q_[-'6T-I>A[.$_A5_\ #^C/0*Q/&"@ H * "@ H * "@ H
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M+#3X-,B\BU7RXP20H)(!)R<9)IMMZLNI4E5?/4=WM?T+E(R"@ H * ,G7O\
MD'7/_7&3_P!!-4MUZHZ</_%A_B1E^">-(@^C?^AM53^)F^-_CR^7Y'55F>>%
M 'G_ ,0_^/6V_P"OI/\ T%ZVI[OT9[.7_'/_  /\T>@5B>,% !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M7J:E!R!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % 'GT/_ "-DG_7J/Y)6WV/F>R_]R7^/]6>@UB>,
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $-S_JG_ -QOY&@N'Q+U7YG%
M_#K_ )!(_P"NTG_LM;5/B/3S#^-_VZOU.ZK$\D\_\6_\A/3/^N__ +,E;0VE
MZ'LX3^#7_P /Z,] K$\8* "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * //_''^ML/^OD?S6M8?:]#V<%\-;_!_F>@5D>,% !0
M4 % !0 4 % !0 4 % !0 4 % 'G^G?\ (TWGM;I_*&MG\"]?\SV*G^YT_P#&
M_P#VX] K$\<\^T#_ )&#4OHG_LM;2^&/S/9K_P"ZT?G^IZ#6)XP4 % !0 4
M% !0 4 % !0!Y_KG_(Q:=_N/_)ZVC\$OD>S0_P!UK>J_0] K$\8* "@ H *
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M54_B9MC/X\_E^2.IK,\\* //_B'_ ,>MM_U])_Z"];4]WZ,]G+_CG_@?YH]
MK$\8* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M.E_C?_MQZ!6)XYY]H'_(P:E]$_\ 9:VE\,?F>S7_ -UH_/\ 4]!K$\8* "@
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MN+_^@FJCNO5'5A_XT/\ $BCX,&-(MO\ =/\ Z&U.?Q,UQG\>?JOR1T]0< 4
M>?\ Q#_X];;_ *^D_P#07K:GN_1GLY?\<_\  _S1Z!6)XP4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M H * "@ H * "@ H * //_&W_'QI_P#U\?U2M8;2]#V<%\-;_#_F>@5D>,%
M!0 4 % !0 4 % !0 4 % !0 4 % 'G^E\^*+T_\ 3NG\H:V?P+U?ZGL5?]SI
M?XW_ .W'H%8GCGGV@?\ (P:E]$_]EK:7PQ^9[-?_ '6C\_U/0:Q/&"@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@".;_5M_NG^54MUZDRV?HS
M/TG_ %1_WOZ"M:N_R,*'POU_1$<'_'Z_T;_V6J?\-?+]2(_Q7\_T-BN8[ H
M* *M[_J6^@_F*#6G\2_KH<_5'>>.?&W3;S5M%BM=/LCJ$K7(SLC=Y( (V/F)
ML(VY/R-N#(0<%<[2#H933:LE?^F>4Z7XF^)FEP):K:7,Z1*$0S66]PJ@!07V
M!FP!C+ECZFD9+G6EOZ^31ZK\-_$/BW5[Z:+Q-;-;6R0;HV:V, ,N] !N/WOE
M+';[9X[AK%R^TK?UZGNVF??;Z#^=!%79>IL4CC"@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * //H?^
M1LD_Z]1_)*V^Q\SV7_N2_P ?ZL]!K$\8* "@ H * "@ H * "@ H * "@ H
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M%8GC!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 1S?ZMO]T_RJENO4F6S]&4-*_U1_P![^@K6KO\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % $<W^K;_ '3_ "JENO4F6S]&4-*_U1_WOZ"M:N_R,*/POU_1$</_ !^-
M^/\ [+3?\-?UW)C_ !7\_P!#7KG.L* "@"K??ZEOH/YB@UI_$OZZ'E_Q _Y%
MK5/^O&?_ -!JO\G^1V2V?H_R9\W^ _B[IWA3P_\ V+<VUS+-FY.^,QA/WP^7
M[S!N/XN/IGI232_K_@G/&:BDOT\[]T9WPL^*-AX#L;BTO;>XG>XG656A,8
M0)@[R#G(SQQBA,4)J*L_R]/-=CZ#\$?%*P\=W4EE96]Q;O#%YQ:8QE2H=4P-
MC$YRP/3&,^V7_7]:G1&2EM^5OU9Z_IGWV^@_G2,ZVR]39I'&% !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 >?0_P#(V2?]>H_DE;?8^9[+_P!R7^/]6>@UB>,% !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % $-S_ *I_]QOY&@N'Q+U7YG%?#K_D$C_KK)_[+6U3
MXCT\P_C?]NK]3NZQ/)//_%'_ "%],_ZZ'_T):VC\,O0]G"_P*_I^C/0*Q/&"
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#S_
M ,:?\?6G?]?']4K6&TO0]G!?!6_P_HST"LCQ@H * "@ H * "@ H * "@ H
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MZVW_ %])_P"@O6U/=^C/9R_XY_X'^:/0*Q/&"@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H CF^XW^
MZ?Y52W7J3+9^C*.E_P"K/^]_05K5W^1A1^%^OZ(BA_X_&_'_ -EIOX%_7<F/
M\5_/]#7KG.L* "@"I??ZAOP_F*#6G\2_KH<O<VT5Y$]O<(LL,JE)(W *NIZJ
MP/!![BJ.^QS/_"!>'/\ H%V/_@/'_A1_6R_R%RKLON7^0?\ "!>'/^@78_\
M@/'_ (4?ULO\@Y5V7W+_ "-+3/#>E:)(TVG6=O:2.NQGAB6-BN0=I*@9&0#C
MU H&DELE]R7Y'6Z7]]O]T?SI'/6V7J;5(XPH * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H CF^XW^Z?Y52W7J3+9^C*.E_ZL
M_P"]_05I4W^1A1^%^O\ D1Q?\?;?0_\ LM4_@7]=R8_Q'\_T-:N<ZPH * *E
M_P#ZAOP_F*#6G\:_KH<Y5'HA0 4 % &GI?WV_P!T?SI,YJVR]3;I'$% !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 >?0_\C7)_UZC^25M]CYGLO_<E_C_5GH-8GC!0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0!#<_ZI_\ <;^1H+A\2]5^9Q?PZ_Y!(_Z[2?\
MLM;5/B/3S#^-_P!NK]3NJQ/)//\ Q+_R&M-_WS_Z$*VC\,CV<-_N];T_0] K
M$\8* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M //_ !G_ ,?FF_\ 7Q_6.MH;2]#V<'_#K?X?T9Z!6)XP4 % !0 4 % !0 4
M% !0 4 % !0 4 >?Z%SXAU _[*C]5K:7P1^9[-?_ '6CZ_HST"L3QCS[0/\
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M\8* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@".7[C?[I_E5+=>I,MGZ,I:9_JS_O?T%:U-_D84?A?
MJ1Q?\?;?0_\ LM-_ OZ[BC_$?S_0U:YSJ"@ H J7W^H;\/YB@UI_&OZZ'.51
MZ(4 % !0!IZ7]]O]T?SI,YJVR]3;I'$% !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >?0_\C9)_P!>
MH_DM;?8^9[+_ -R7^/\ 5GH-8GC!0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0!#<_ZI_]QOY&@N'Q+U7YG%?#K_D$C_KM)_[+6U3XCT\P_C?]NK]3NZQ/
M)//_ !+_ ,AK3?\ >/\ Z$*VC\,CV<-_N];T_0] K$\8* "@ H * "@ H *
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MF*N'Q+U.W"?QZ?\ B_0?X6XTJV_ZY+_6B7Q/U%BOXT_\1OU!QA0!Y_\ $/\
MX];;_KZ3_P!!>MJ>[]&>SE_QS_P/\T>@5B>,% !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MA_\ =ZW]=#T"L3Q@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H \_\9?\?VFC_IX/_H4=;0VEZ'LX/^'6_P /Z,] K$\8* "@
M H * "@ H * "@ H * "@ H * //_#__ "']1_X#_,5M+X8_,]G$?[M1_KH>
M@5B>,>?:!_R,&I?1/_9:VE\,?F>S7_W6C\_U/0:Q/&"@ H * "@ H * "@ H
M * //]<_Y&+3O]Q_Y/6T?@E\CV:'^ZUO5?H>@5B>,% !0 4 % !0 4 % !0
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M !#_ ./6V_Z^D_\ 07K:GN_1GLY?\<_\#_-'H%8GC!0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ,
ME^XW^Z?Y4UNO4E[/T91TS_5G_>_H*UJ;_(QH_#\R.+_C[;Z'^E4_@7]=R8_Q
M'_78U:YSJ"@ H JWW^H;\/YB@UI_$OZZ'.8JCT Q0 4 &* -/2_OM_NC^=(Y
MJVR]3:I'&% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M 4 % 'G^N?\ (Q:=_N/_ .SUM'X)?(]FA_NM;U7Z'H%8GC!0 4 % !0 4 %
M!0 4 % 'DWQ-/S6P]I/_ &6NBEU^1]%ENT_5'/8QKMH/0V7_ *+BJ_L/Y_F=
MG_,/4_[B_G(]0\(?\>LQ];NX/_C]82W7HOR/"QGQQ7_3N'Y'D>N_\AN;_KY'
M_H2UTQ^#Y'T5#_=X_P"#]"G:<ZDI_P"GM/\ T=3?P_+]#27\)_X'_P"DGM'A
M'_CVF/K=W'_H=<DMUZ+\CYG%_''_ *]P_(ZJH/."@ H * "@ H * .<\7_\
M((NO^N?_ +,*N'Q+U.["?QZ?K^C)_#7_ "#+;_KDM*6[]2,3_&G_ (C<J3D"
M@#S_ .(?_'K;?]?2?^@O6U/=^C/9R_XY_P"!_FCT"L3Q@H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* &2_<;_ '3_ "IK=>I+V?HRCIO^K/\ O?T%:U-_D8T?A^8R+_C[;Z'^E-_
MB8_Q'_78U*P.H* "@"K??ZEOH/YB@UI_$OZZ'.U1WA0 4 % &GIGWV_W1_.D
M<]79>ILTCC"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * //H?^1LD_Z]1_)*V^Q\SV7_N2_P ?ZL]!
MK$\8* "@ H * "@ H * "@ H * "@ H * "@ H * (;G_5/_ +C?R-!</B7J
MOS.+^'7_ ""1_P!=I/\ V6MJGQ'IYA_&_P"W5^IW58GDGG_B'_D.Z=_P+^=;
M1^&1[.'_ -VK?UT/0*Q/&"@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@#S_QC_P ?VF?]=S_Z%'6T-I>A[.#_ (=?_#^C/0*Q
M/&"@ H * "@ H * "@ H * "@ H * "@#S_PY_R'-2/NO\ZVE\,3V<1_N]#^
MNAZ!6)XQY]H'_(P:E]$_]EK:7PQ^9[-?_=:/S_4]!K$\8* "@ H * "@ H *
M "@ H \_US_D8M._W'_D];1^"7R/9H?[K6]5^AZ!6)XP4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M9P_^[5OZZ'H%8GC!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0!Y_XP_Y"&F?]=S_ .A1UM#:7H>SA/X5?_#^C/0*Q/&"@ H
M* "@ H * "@ H * "@ H * "@#S_ ,-\ZUJ1_P!H#_QXUM+X8GLXG3#T/3]#
MT"L3QCS[0/\ D8-2^B?^RUM+X8_,]FO_ +K1^?ZGH-8GC!0 4 % !0 4 % !
M0 4 % 'G^N?\C%IW^X_\GK:/P2^1[-#_ '6MZK]#T"L3Q@H * "@ H * "@
MH * "@#Q_P")A_?VX_Z9M_Z%732ZGTF7?#/U7Y&/*,:];#T-G_Z*CJE\#^9U
M+_=Y_P#<7_TJ1Z=X-_Y!^?6:8_\ D1JYY[_)?D>%C/XO_;L?R/(=9/\ Q.IC
M_P!/!_G75'X/D?1T?X$?\!3TW_C^C/\ T\Q?^C13>WR?Y&E3^&_\$O\ TD]J
M\'?\>+>]Q<?^C6KEGO\ )?D?,8S^(O\ !#\CJJS/."@ H * "@ H * .9\9?
M\@BY_P!P?^A"KA\2]3OP?\>'K^C+OAW_ )!MM_UQ3^5*6[]3+$?Q9_XF;-2<
MH4 >?_$/_CUMO^OI/_07K:GN_1GLY?\ '/\ P/\ -'H%8GC!0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ,E^XWT/\J:W1+V?HREIO^K/^]_05K4W^1C2^'YD<7_'TWT/]*;^!?UW
M%'^(_P"NQJ5@=(4 % %6]_U+?A_,4&M/XE_70Y_%4=X8H ,4"#% S2TT8=OH
M/YTCFJ[+U-BD<@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0!Y]#_R-DG_ %ZC^25M]CYGLO\ W)?X
M_P!6>@UB>,% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $-S_JG_W&_D:"
MX?$O5?F<5\.O^02/^NTG_LM;5/B/3S#^-_VZOU.[K$\D\_U__D/Z=]&_F:VC
M\,OD>SA_]VK?UT1Z!6)XP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 >?^+_ /D(:9_UW/\ Z%'6T-I>A[.$_A5_\/Z,] K$
M\8* "@ H * "@ H * "@ H * "@ H * //\ PS_R&=3/^V/_ $)JVE\,3V<3
M_N]#T_0] K$\8\^T#_D8-2^B?^RUM+X8_,]FO_NM'Y_J>@UB>,% !0 4 % !
M0 4 % !0 4 >?ZY_R,6G?[C_ /L];1^"7R/9H?[K6]5^AZ!6)XP4 % !0 4
M% !0 4 % !0!XY\2S_I4 _Z9-_Z&:ZJ6S/I<N^"?^+]#+N!C7K8>AL__ $5'
M37P/YG3'_=Y_]Q/_ $J1Z=X-_P"08A]7E/\ Y$:N>>_W?D>#C/XS](_DCQ_6
M#_Q.9O\ KNW\ZZH_"O0^DI?P(_X$4])YO(C_ -/$/_HT4Y;?)_D:5/@E_@E_
MZ2>U^#?^0?GUGN/_ $<]<L]_DOR/F,9_%_[=A_Z2CJJS/."@ H * "@ H *
M.7\9_P#((N/]T?\ H0JX?$CT,'_'AZO\C1\/_P#(.M_^N*?RI2W?J88C^+/_
M !,UZDY@H \_^(?_ !ZVW_7TG_H+UM3W?HSV<O\ CG_@?YH] K$\8* "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@!DOW&^A_E36Z]27L_0I:;_ *L_[W]!6M3?Y&-+9^HR+_CZ;\?Z
M4W\"_KN*/\1_UV-.L#I"@ H K7G^I;Z#^8H-*?Q+^NA@XIG<&* #% !B@#1T
M[[[?0?SH,*NR]36I'(% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >?0_\C9)_UZC^25M]CYGLO_<E
M_C_5GH-8GC!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!#<_ZI_\ <;^1
MH+A\2]5^9Q?PZ_Y!(_Z[2?\ LM;5/B/3S#^-_P!NK]3NJQ/)//\ 7_\ D/Z<
M/9OYFMH_#+Y'LX?_ ':M_71'H%8GC!0 4 % !0 4 % !0 4 % !0 4 % !0
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M_(]R\&_\@U/^NDW_ *->N.>_W?DCY7&?QG_AC_Z2CJ*@\\* "@ H * "@ H
MY3QMQI$_T7_T(5I#XD>C@OX\?G^1KZ&,6%O_ -<4_P#014/=^ISU_P"+/_$S
M4I',% 'G_P 0_P#CUMO^OI/_ $%ZVI[OT9[.7_'/_ _S1Z!6)XP4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % #)?N-]#_ "IK=>I+V?H4]._U9_WOZ"M:F_R,:7P_,9%_Q]-^/]*;
M^!?UW%'^(_Z[&E6!TA0 4 5[O_5-^'\Q0:0^)&-BF=@8H ,4 &* +U@,,WT'
M\Z#"ILC3I',% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 >$^/\ _D+-_P!<H_Y&NRG\/S/K,#_ 7^*1SFFZ3<:LSI:@
M.T:%R"P4E1_=!ZGV%6Y*.YVU*L:*3J.R;LM+Z^?8;INE7&JR-%;*&:-2[;B%
M 5>"23QWZ4-J.K'4J1I)2F[)NRLKZLN+X<OG:W0(NZ]5FA^<<JH#$G^[P0>:
M7,M?+<S=>FE-WTIM*6CT;_,KR:+=16\EVR@102F%SN&1(#M( ZD9/4<4^972
M[JY2JP<E33]Z4>9*W0RCTJCH/8M-_P"1D_[<8_\ T!*Y'\'S/G*O^Z?]Q9?^
ME,]*K$\(* "@ H * "@ H * "@ H * "@ H * "@ H * (;G_5/_ +C?R-!<
M/B7JOS.*^'7_ ""1_P!=9/\ V6MJGQ'IYA_&_P"W5^IW=8GDGG^N\^(=.'^R
MW\VK:/P2^1[-#_=:WK^B/0*Q/&"@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@#Q7XD?\A"+_KW'_HR2NJEL_4^GR[^%+_'^B.*L+"74YUM;< R/
MG:&(4<#)Y/L/QK9OE5V>I.<:47.>RWLKDD.EW,]W]@1/](WE-N<8*YSD],#&
M<],<TKI+FZ"=2,8>U;]RU[^3*US;O:2O!)C?&Q5L$$9'!P1P::=]47&2DE*.
MS5UT+,&EW%Q:RWT:@P6Y D;(!!.,8'4]1TI72:CU9#J1C.-)OWI;*W8SZHU/
M0X/]1H7_ %VE_P#1ZU@]Y^AX[^+%_P"&/_I#/:*Y3Y@* "@ H * "@ H * /
ME>7[[?[S?S->B??+9>B_(O1Z5<2V;Z@B@V\3[&.X9#';_#UQ\PYJ;I/EZF3J
M14U1;]]JZ5M+:]?D/MM&NKNW-W$H,2NL>2P!+L0 H!Z\D?G0Y).S%*K"$E3D
M_>LY6MT74MMX9OTDFB*+NM4$DOSK@*1D8/<X!.!2YUIYD+$4VHR3TF[1T>_Z
M&!5G4=1X+_Y#%O\ ]M/_ $6]9S^%_+\SAQG\"?R_-'H?A3_D*ZI_UV'_ *$]
M83VCZ'CXK^#0_P /Z(] K$\8\^T#_D8-2^B?^RUM+X8_,]FO_NM'Y_J>@UB>
M,% !0 4 % !0 4 % !0 4 >?ZY_R,6G?[C_R>MH_!+Y'LT/]UK>J_0] K$\8
M* "@ H * "@ H * "@ H \6^)'-_%[0#_P!&/752V?J?3Y=I2E_C?Y(S+\[=
M=C]C;?\ HM*:^!_/\SIA_N[_ .W_ /TIGK'@\8TFW_W6_P#0VKGG\3/G<7_'
MGZK\D>+ZE_R%YO\ KO)_[-74OA7H?3T_X,?\*_0S]-.)4/I+#_Z&*I[?)FM3
M9^DOR/=?!PQID?N\I_\ (KUQSW^[\CY7&?QGZ1_])1T]0>>% !0 4 % !0 4
M <EXXXTB?_@/_H0K2'Q(]'!?QX_/\C:T48L;<?\ 3%/_ $$5#W?J<U?^+/\
MQ/\ ,TZ1SA0!Y_\ $/\ X];;_KZ3_P!!>MJ>[]&>SE_QS_P/\T>@5B>,% !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MZ#VCT.WYAT(?]-I?_1ZU@_M^B/'E\6+_ ,,?_2&>T5RGS 4 % !0 4 % !0
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M?#'YGLU_]UH_/]3T&L3Q@H * "@ H * "@ H * "@#S_ %S_ )&+3O\ <?\
MD];1^"7R/9H?[K6]5^AZ!6)XP4 % !0 4 % !0 4 % !0!XG\1CG44'I O\
MZ&U=5+9^I]1E^E)_XG^2,O4CMUI3Z-!^D:52^#[SII_P'_V]^;/7_"8VZ5;?
M[A_]":N:7Q,^;Q7\:?K^B/$M0XU6;_KO+_-JZE\*]$?4T_X,?\,?T,^P.)%_
MZZ1?^A53_1FL]GZ2_(]X\(#&EQ?63_T8]<<MW_70^3Q?\:7HOR1TU0< 4 %
M!0 4 % !0!R/CDXTB;_@/_H0K2'Q(]+ _P >/S_(W='&+* ?],8__014/=^I
MR5OXD_\ $_S-&D8!0!Y_\0_^/6W_ .OI/_07K:GN_1GLY?\ '/\ P/\ -'H%
M8GC!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 ,E^XWT/\J:W1+V?H4]._P!6?][^@K6IO\C*EM\Q
MD7_'TWX_TIOX%_7<F/\ $?\ 78TJP.D* "@"&X_U9_SWH+CNC+Q3.D,4 &*
M#% %NS&&/TI&4]D7Z# * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H \(\?\ _(6;_KE'_(UV4_A^9]9@?X"_Q2.+Z5J>
MF;.J:_>:PB17;AEB^Z H7D@#)QU.!W]_6H45'8YZ="G1;E35G+?6_P#PPY/$
M5ZC6[AES9*5A^0<!@ =W][@#D_7K1R+7SW$Z%-J:L_WFLM7K;MV()-9N9();
M5F7RKB4S.-HR7)R2#V&>U/E2:?96*5*"E&HE[T8\JUZ%6RL9M2F6VME+R.<
M#L.Y)[*.I)Z4VU'5FDYQI1<YNR7]6]3UNQC,7B=HSU6S13CU"H*Y7\'S/GYO
MFP=UUJ-_>V>C5B>&% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $-S_JG_
M -QOY&@N'Q+U7YG%?#K_ )!(_P"NLG_LM;5/B/3S#^-_VZOU.[K$\D\_UOGQ
M'IX_V'/_ *'6T?@E\CV:'^ZUO7]$>@5B>,% !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M!DOW&^A_E36Z)>S]"GI_^K/^]_05K4W^1E2V^8R+_CZ;Z'^E-_ OZ[DQ_B/^
MNQI5@=(4 % $4_W#_GO05'=&;BF= 8H ,4 &* +5J,$_2@RGT+M(R"@ H *
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MCCD8Z'/O_6G;2YLX15-36^@MA=S2F0S@*B$C/3!!Y'OCUH:ML*I",>50W?\
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M_P#07K:GN_1GLY?\<_\  _S1Z!6)XP4 % !0 4 % !0 4 % !0 4 % !0 4
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MC.H8_0$YI6?0Q5.<DY1BVEU2=CS+Q7X<DU#6(5CEVF]5B-V?W8A5=VW'7(Y
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M'YLY!_\ D!:-_P!A2R_]*VI5/B?J1C/X]3Y?^DH]>J#SPH * "@ H * //\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % #)/N-]#_*FMT)[/T*FG_</^]_05I4W^1C2V^9'%_Q\M]#_
M $JG\")7\1_UV-*L#I"@ H 9)]TT#*N*!AB@ Q0 8H FA&":!$] @H * "@
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MC:PB=E4\X(4]1[^E5NTO-'1'EJ5J<5MS)-KU&ZM?20Z1!<+MWN;3.1Q\[)G
M_'BA+WFO7]1TH)UYP=[+VGX7L7-9NWM[RPC3&V:=U;(YP(V/'I22T?DOU,J,
M%*G6;^S%-?>9^J:A+#KMG:KM\N6-RV1SG$G0]N@JDO=;]#:E33PU6H[W35NW
M3_,Y77_!.H7VH23PLLD4[;M[-@Q@_P )'4A?X=O;'>M(S45;L=]#&4J=*,)7
M3BK62W\_GYG=_P!FK%=6)=F>2UBD0-G[V8T5F;N2<9Z]36-]'YV/*]HW"JDD
ME.47;MJVDB*33XCK:7F6\Q8"H&1MQ\W;&<\^M%_=MYE*HUAW2TMS7\^A<TJT
M2WN+N1,YFF#-GIG8HX]J3>B]/U,JLW*%-/[,;+[RO9V(3[:(20\\[,<G^(HG
M ]!Q3;V\E^I<Y_PN;:,4OE=C-*LIX9M[J4500<]_8?SS0V.K.+C9.[93\,:A
M+>7>H1R;=L$^U<#!QND'/K]T4Y*RC;JC3$TU3A1<;^]&[^Z/^99T.]DN+6[D
M?&8KFY5<# PAXS[^M*2M;T1->"C4IQ6SA!OYF?\ VC+_ ,(S]L^7S/L^[I\N
M=V.E5;W[>9K[-?6_9:\O-;SV$LFW^)BQ_BT>W/'O=35CU/-DK-K^\QOB&(3Z
MU:Q-G;)IFJJ<=<,U@#CWIK1I^8Z;Y9QDMU*+^YFEJ6G13Z*MFQ;RUBA4$$;L
M)LQSC'89XK1.TK^;.NG4<<0ZBM>\GY:W)KFPC=-/4[L6\D93GNL1 W<<\=<8
MI)[^?^8HU&G6>GO*5_G+H6=4M$N+BT=\YAF++@]]C#GVI)V3]/U,Z4G&%1+:
M4;/[RCJ-A/).652X;&".WL?3%--(UISBHI-VL4?$-[-I]QIL*[3YLP1R1D\&
M(<>GWC515U)]D:X>$:D:\G?2-U_Y-_D:NH7;PZK8VZXV3+<%LCGY8P1@]N>M
M2EHWVL<]."="K-[Q<+?-B17;G6Y+;CRUM$<<<Y,A'7TQVHM[M_/]!N"6'C/K
M[1KY6*$7FZN=4LE<1$2"-'4<C=$O7!YYX/?&:?P\K_K<V?+0^KU6KZ7:]'T.
M:\+^#;_3;];JY*Q1Q;ON/N,F01C Z*<Y.?0<5I.::LCMQ.+I5*;IPNV[;JUO
M^#Z'>V=HD6H75PN=\JP!LGCY%8# [<=:Q;T2[7/(G-NE3AT3E;YL;I%G':K=
M!,_O;F:1LG^)@N<>W'%#=[>B'5FY.FW]F$4O17.-UBU2RTO2H(\[4U6PQDY/
M-R3ST[FE)W=_,5>3G5E)[OMZ(].I'*% !0 4 % !0!Y_KG_(Q:=_N/\ R>MH
M_!+Y'LT/]UK>J_0] K$\8* "@ H * "@ H * "@ H \(\>'.K/[)%_Z#793^
M'[SZW _P(^LOS,/7#C49_:0_RJH_"CKH_P ./H>_:",:?;?]<(__ $ 5QO=^
MK/CZ_P#%G_B?YGSWJ1_T^<_]-Y?_ $)J[5\*]$?8T_X<?\,?R103C\Q_.J-6
M?17A;C2[;_KD/YFN&7Q/U/C<5_&GZF]4'&% !0 4 % !0 4 <7X_.-(D_P!^
M/_T(5K3^)'J8#^.O1G4:=Q:P_P#7*/\ ] %9O<X*GQR_Q2_-ERD9!0!Y_P#$
M/_CUMO\ KZ3_ -!>MJ>[]&>SE_QS_P #_-'H%8GC!0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ,D
M^XWT/\J:W0GL_0J:?]P_[W]!6E3?Y&-+;YD<7_'RWT/]*I_ OZ[DK^(_Z[&E
M6!TA0 4 -?[IH K4#"@ H * )8NIH FH$% !0 4 % !0 4 % !0!YUK'C]=)
MUV#0_(+K+Y:O+G!5I3A-JXPRCC<<C'/I73&ES0<[]]/0Y)5N2:IVTT5_7_AT
M>BUS'6% '%^-/N:?_P!A:Q_]&&DQHQK'Q+:MKMPV'"R1B)#CJT&]FX[ @';G
MTYQD5T.+4%Z_G9(]JK0E'#4XNWQ7?ESV2_%JYG:%J3:]_:%E;@P2WI>XC?.0
MOW%*,1@C(P,CU/'%5)<O*WTT.FM36']C5G[T:=H-=]]5Z=CJ?!>@W>AQ2B[8
M?O&4K&K;@N,Y;/3+9&<>@S6<Y*3T//QE>%=Q]FMD[MJU[]/D=K61Y9STEP=&
MMW>ZP?,E"H%ZL\AP!Z#)]>@I[M)'5)J<HJ'DM?(K_:U_L_R<'<,1'\L[OICM
MU[55M?Q-N1^UYNF_Z"^7<ZM;QRE1&R[E:/=E<JQ 8-CG(&>0",XI?"3%JE*4
M9>MUV.@M(F@B6-SN91R?Z?ATI'+-J4FUHC"\6:;=:K8FVL]N\NC,&.,JIW8!
MZ A@IYZ@$=ZJ#47=G7A:D*-3GJWM9I6[OR]#B_&=S+;6EC#?,'NUD\V0H,*0
MG!QT&?F ]SD\"M8*[E;:UOO/3P<8RG5E15J;7+&^^HS6-=M[G6=.NHPQC"(W
M3!(F8A>#Z=Z(KW9+S:^[<6'I26'K0TNW)?.&C_%%B#P?J<6KB\:4>4)?,,NX
M[V7.=FWKR/E(SMQ1SKEY;?UW%+%T71]FHZ\MN6VB=M[_ (]SU2N<^?*+VS-<
M+,,?*,9[X[C'XGFGY&RDE!P,R;44M+L22 A9BMNAXR9"6*C'^T00#VZG HV1
M;5J:76]_DQVFR2S"0RJ(I)_GPK;@O&-N<#)Q@D],D@=*!R7*H_W=&:5G;M;@
M[L#/8=/K^-!G.2E:Q=I&)P-@+GPQ9WUSJA5DDF:51%R6:3Y2?8,=F ?NX)-:
MNTVE'M8]B?)BJE*&'O=12=^B6OX:^IR\7B&&/PT;,*QE!-L<\ &3?(&![C;G
MCKGVYK7E]^_S.YT)/%^U;7+\:[Z65OO+=Y8W7C#3K2>Q^40 Q/$[;1N7:OF
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MA)6)%0$]<* !GWP*YWKJ>1.7/)S>[;?WZGD5SX$OIM09FVM;RR.Y=6 *ABQ
MVGG(. <#'/%="J)1MU/HXXVFJ:2NI))6:[6ZK0XO4-)N-(F-O<A5< ,=K!A@
M\CTZ^E=M.FZL>:.WG_7YG/5SC"49JG)RN][1=E?O^>ESUSPWX@AA\C19$=9X
MXPI./EWA=Q7CV[]*YIT)*#K:6WMUL^O_  #YNMC*=3%3I0NTY.TNC=OO^?\
MPYWE<1L% #9'6)2['"J"2?0 9)_*@3TU9Y]H/Q)T[7YI[>%)4:WC>92RC]['
M']YEP3@\C"M@G-=$J,H)-VUT]+G+&O&5U9JR;^[]23P-XX'C'[0#";=K=E(^
M;<&1]VTDX7#?*=P_6BI3]G;6]QTJOM;IJUOU._KG.H* .-\>H7TF15Y.^/\
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M%8S@Z;Y6=-*HJT>>-UTU[FE61N% '*>+/%]KX0@CFN5>5IF*QQQXR< %CDX
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ME5RYKMWT3VL=]"T5[BM9NSO=ZI-ZL[;7;BZF^'D5\MQ+%<"TMIY)(VVO*S%
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MX.TE"B[9;JR+C'WC)+AR?]X$@^HXK--^TEZ,U:2I15OM?_)'NR(L2A$ 55
M4   #@  < #L!7">CMHAU QDGW3]#_*FMT)[/T*FG_</^]_05K4W^1C2V^8R
M/_CY;Z'^E#^!"7\1_P!=C1K$Z H * &O]TT 5J!A0 4 % $L74T 34""@ H
M* "@ H * "@ H XWQ!9F?5M)FW;?(FN3C'WMUN5Z]L=:Z(?!4]%^9R5':I2\
MW)?@G^@KV9_X28788?\ (,,>W'?[0&SG],4_^77_ &_^@O\ E_;_ *=_^W'
M1W&HC41\TOVKS<%<GIN^8;>FW;GVQ7IM0Y.G+;^OF>(I5?:;OGOM_70[_4;P
M1^(;"VVY,MO=-NSTV[.,=\YKRX_PI+SB>Y)?OH/RDOO7_ *NG7@?Q5?VNW!C
ML;-]V>NYYAC';&*YNIV] \&W@NKO6$"[?(U-X\YSNQ! <^W7I0A,YC3=0OKK
MP1-=:2K)=XN_+"G+C;=2JY3 ^_L#,F!G.,<TN@^IYS\&+W69M9="]Q+9&.0W
M7FL[*LG\!^?I*7X('.W/%"&SV+P;8FTTS48]V[S;_47SC&-[DXZ\X]>]'03W
M.>;2S_PKG[!O&?[-V;\''3KC.?UHZ!U+7Q5TPZCX;AM@X0K/:G<1G[H/;(ZT
M/8%N.^(4M["MLL32+:^7\Q0D R#& Y7VQMSWS0QHI:EJ%W:>$#<7X>1EN+=4
MWG#M&US"J$D\\9.,]0!1T#J==\1+P6&E+*5W_P"EV:X!Q]ZXC7/X9S38D8'B
MO4A;>+=%M-A8SK/\V<;<8[8Y_.EU!;&]<W@7Q;;6FWEM,N)-V>FVXA&,?CG.
M:?470^:KG4?$X\3D![K^T!=$)%E_+\OS.%"_<,!3J<8VY.:DL]ZU#32_CJRO
MMX&RPD39CKGS^<Y]_3M5=2>AMVMF5\6W-UNX;3((]N.F)Y#G/X]*.H=!/"5F
M;;5-:DW;O/OHWQC&W%K"N/?IFA ^ARVDV]YIGA69+%F:7[;>,S1@AA&]Y,S;
M>IR <9';)I=!]2U\-Y[V2697,CV@0'+DD"7=_"3W(SN^@H0F;W@Z]%U#JA"[
M?)U.]CZYSL"<^V<]*8'-VNJ!_A\]_L( T^X?9GGY3)QNQWQUQ2Z!U-7Q=?BV
MT*QFV[O,NM+7&<8\R:$9SCMG\:.@=3BOCI=:I;I:"U::.P;S/.:$LN9<KL$I
M7D+CE,X!;/4T,$0:7%J>K^ ;F'4VD!9T%O),"7,"RP%2<\D;@RH3_"!UHZ#Z
MGIGC2R-W)I!#;?)U6VDZ9SM248]LYZTR4&K69D\4Z7<[L>5:WZ[<==_V?G/;
M&/QHZAT, Z:?^$^%]O&/[.\O9CGJ><YQ^&*74?0YC4+K5QK# -,+D3$1H"VW
M9N^4*.AC*]3TZ\TBCT=KW'BR*T9?F.DO*6SQQ<JI7'UYSFJZD=#'T?4A+XVU
M&RV$&*TA;?G@Y$'&,<?>]>U'4?09\-]2%_?:T@0IY%^R9)SN^:49Z#'3I20,
MP9=1U&;PGJ4VCJZ7*:A>I^[.9!&EVRR/'@9W;,D  D#-'0?4YKX'WFK3WUPD
MC32Z?Y1+F5G95GW#;L+9^=ANW@'H!FA ST'X2::=,L;U"XD\S4)GR!C&5C&.
MI]*$)D>C:88? LUCO!+6M^N_''SR7!SC/;=Z\XI] ZFKJT7D>&+2+.=BZ:N>
MF=LD S^E+H"W(OB1->Q10B NEN2WFF,D?-CY0Y'(7J1_M8H8(YZXO[NV\%ZA
M<WH>18HV,.\D,T?R=SDX#9"D]J.@^IUWC.]%I:Z8Q4MYNIV$>,XQO8\^^/3O
M3$B?7+P0^(M'M]N?/6_^;/W=D,9Z=\Y_"@70P;S4@GCNVL=ARVGL^_/ YFXQ
MCVZYI=1]#PCQ7J/B1/$TJJ]TMXMP1:1H7V>7G]V(U'RM&RXWG!'+9/6D4>^:
MUILESXDTB\E8(\,+AT SEB&W8.<  FN^FOW4WZ?H>74E:O"/?]+G02V9/B>*
M[W<+ITD>W'/-PC9S^F*S7\)O^_\ H:M_OTO[E_N;_P PT:S,.N:K<;LB<6?R
MX^[LA8=>^<YHG_#I_P#;WYA3?[VJO\'Y&%I]K<Z?I>I?96+22:C=290895=U
MW =\A<\C\*WM'VD%/;E7ZV.6\O9573O?GEMO963_  (/!$UTUXR@NT&PF3<2
M5#<;>O1NO3M6V(45'I>^GZG-@W+G:5^6VO:_3YG1^&+P7-[JL87;Y%Z$SG.[
M]Q&<^W7I7%4^&'^']3TZ2M*H^\K_ *?H9>@:B)_#-Q=A"H0:@=N>3Y<DXZX[
M[?3C-:3_ (L?^W?T,J:M0DO*;^^[_4BU;4A#X0BO=A(-O9-LSS\[PC&<=L^G
M.*</XS?G+]15%_LRCVC'\&C'^,%QJ,%G!]D,B6K.XN&B)!SM&P.5Y"'YO;<!
MWQ104;N^_0>)<DE;X>OKI:_X^1C>&DU'4_!^HP7S/Y3QR);22Y8["GS8SR45
MN%_$ UI)1]K%1WOJ9PE*-&4GJEJOENEY?K<[[Q18&YTNQA#!?*N]/;.,Y\N1
M#C';./PK"FKSEZ2-JCY:<'YQ7WJWZES7[,SZOI,P;;Y$MR<8^]N@V]>V.M3#
MX*GI'\RZCM4I+OS?DG^@OV,_\)/]KW<?V;Y6W'/_ !\[LY_3%'_+K_M_]!7_
M ']O^G?_ +<<+KD]^FI29:591)^Y"DCY<_)M X.1CZG.:].FH>S6UK:_K<\:
MM*HJKU:E?W;=NECL[B]9->TVVE4^9+9W+LV<89?)W#'N3^%>=IR32VYE;\3V
M+/VE.4MU%IKS:O\ H9J:D/\ A,FL=AR+(/OSQVXQC]<U5_W%O[Q'+_M'-_=M
M;Y7-GPK>"ZN-34+M\F_>/KG.(XSGVZ]*SJ;0_P *-**LZC[S?^7Z'+W-_>3Z
M3KC:8KK<P7T\:E#ER%\GS&3T/EEB,<C''.*U=G*GS;<B_4Q5U"JX[^TD].UU
M?\+GG_PEN]1DU@HKS/:F-S<;BS(& _=D[B</NX&.2,]LUM745'I?H8X=RY[+
M;KVV>_SM;J>G?#[33I]QJK%P_GWK/@#&WYGXZ\]:PKJRA_A_R.C#OFE4Z6E;
M[FS'ETDCPCJ=GO&99KUMVTX&^Y9L8SSCI[UE65FO\,?R-\.[Q;_O-?=I^@_4
MM+,GP_6PW@$6-NF_''RM%SC/?'K7-T.OJ+\1);R(VRHTBVGE<E"0#+GHQ4Y^
M[C&>.N*;VT$K7U+,5Y=0^#KVXO0[F*VNFCWG#-$L9*\GGU )[8HZ:@M]";Q5
MJ M_#-G<;<AY-+&W.,>9/;CKCMG\:70?4U/%EX+;5=$BV[O/O95SG&W%K,V<
M=^F.U-@NHMQ>!?%MO:;3EM,FDW9X&+B-<8]\YS1U#H?._P 1=0\01>)955[J
M-TD'V%8BX4I@;#&%^5B?X^OS9!J2D>]3VEQ<:UH-U=D)<16EYYR8ZR200!\'
M/&U@?K5=B>Y=M+,IXNNKK=P^F6T>W'(VSSG.??/2CJ+H)I]F4\67]UNXDL+-
M-N.FV2<YS[YHZCZ$7A2TDM+C7'B(>2;49)$&, -]E@"J<]>1U]Z ['">&KK5
M6UB,%IVD,F+A7+8V9^?<#P !]WISC%2AGHOAZ\$^NZS %QY#V0W9^]OMRW3M
MCI5$]CF? FJ"\?70$*?9[R53SG=@2<]..E)#?0CCU0?\*\%_L./[.#[,\_3=
MC]<4= ZG,>,M1U-_!>FW&F>;%#*D9N3$3O6,QDJ"5Y\LM]\C Z9Q1T'U-?X(
MW.J7&GW(OC*]HKJ+5Y2Q/(;S50MR4!VD=1N+4(3-;2=,,7@26QW@DVEZN_''
MSO,<XSVSZT= ZEKQ1IQN/"UI:A@I0Z9\V.OER0'IGOC\*.@+<U?%UF;C4]%D
M#;?(OW?&,[LVTRX]NN:;!=3S_P :7-^FJR+,TJ("/("EE79@8*[3@G=G/?/6
MAW^0E;YG4:I?W5MI>D/?JS3RZG9QG<<-AG<(S>^T L."2:0S=UN\$/B+2+?:
M29TOCNS]W9"AZ=\Y_"GU%T&6UX&\6W%IMY73()-V>#FXD7&/PSG-'4.A!X;O
M'GU#7HX% E@NT5,GAG-G$RYZ8&2 >?>@?8^=?">H^(W\31 O=/=FX NHY"^T
M0^9^]#J?E$:IDH< <+@]*DH^D=%LS#XEU>YW9\Z'3QMQ]W9'*.O?.?PJB.@S
MP99&TCU4%MWG:K>R=,8WB/CWQCK0'8P-*T@_\("=-WC+6,\?F;3@;FDYVYSQ
MGIFKA'G:AM=V(J3]G%SM?E5[!#:W.D^%;&V@=F6)%65T!4E<MCOD*3C/ZUVT
M81A4<)6;6WJ>9B*DJE&-2":3>MNB]2WX<N;E-.OGDWO!' [)N)QN".7"D\]A
MGL#6E914X6MS7U]+JQCAG)TZE[\O*[7[V=[%7Q%J(3P$;W8<&RMGV9Y^9X>,
MX[9]*\K%+GYUM=_J?29=+V-2E+?E3\KVBT87C?5!;>%-'N-A82R6(VYQC= Q
MZXYQTKBJ1O3@K[6_!'KX:KR8FM.VZFK=KR1W7C6Z%M=Z,NW=YNJ1IUQC,4IS
M[].E;U%=P?:29Y^&GR1K*WQ4VO35._X'@'Q;O]<A\1,F^YBA7RS9"%G"'Y1R
MFW@R[\AAR>@(QBL:C?-^1W890]GI:_VKV_$]3U^SO=1L_#\FI'R[R*:&2<$9
M)?$>X'GAL]?0YKV\+%RA-O1J/Z,^3QLXTZD%!73DTO+6)V^OVWFZSI$N<>3)
M=G&.NZ#;U[8ZU%-7IU'VY?S'5ERU:4>_/\K)"BV_XJDW.>/[,\O;C_IYW9S^
MF*+?N>;_ *>6_P#)0YO]IY/^G5__ "8I:;;S6^H:Y-;G=+*UN47'1EMMH^N2
M,BK<4HTG+9WO]Z,XR;G74%[T5&WFVI,P?"UQ?-J2C=*P)/GARV ,'EL]&!Z=
M.:ZJR@H=/[MOT//PTJGM5J_[U[_B=9I]X)/$=]:[<&*UM&W9Z[S+QCMC%<$O
MX<5YR_0]:*M6G+R2^[_AQ?"EX+J?4U"[?)U&2/KG.(XCGVZ]**FT/\"_4**L
MZC[S;_3]#%TG4Q+X0EO=A 6WO6V9Y^1IAC..^/3O6L_XR?G']#&FO]G<?[LO
MQ;*'C6[U#_A%K:?3?,3?';-,8R=ZQ-&"<%><;BH<C^'.<#-*'*ZLN;N[>MPJ
M<RHPY=K1OZ<O^9SOPLGU&XLKY)VD>Q\D^4TA8@2E6WA"W)&W!8 XSCUK6LH\
MT;;W7W&5%RY)_P JB_2]NGZ_(Z.73C_P@@LMPR+*--^..&7G&?TS24?]HY+]
M7^1I*?\ L_M+=G;_ +?19^)5@;[0H80P3$\!R1GHC]O>EAX\U1KR?YHG%3Y*
M496OJOQC(V?%MK]H&F8.WRM2M9.F<[0_'MG/6LZ2O[3RA)FM>7+[+SJ07WG(
M^-I[U-1VEI$B 4P[2P7IR1C^/=G/?IVQ7J850]G=)-Z\W]=K'BXV515;-M1T
MY>VRU7G>_G^!N^(KR>VT&VEO%)G,]HK@\'+3*H)]\$$^^:X(N,*TN3X;2M;T
M/3G&<\/!5-):-WWTO:_FU:_F:GB6Z$&IZ1'C/G74JYSC;B!VS[],5C3=H5%W
M2_,Z:L>:I2=]FW^0LUT!XHAML<G399-V?2=%QC\<YH3_ '+C_?O^ ./^T*?_
M $[M;_MYAH]UYFNZM"%P85LN<\'?"Q'';&*)N]*FNW/^+%3C:M6EWY/PB?/M
MO?>(?^$@ W7!O_M&&C)?;LW_ #*5^[Y.W./X=O(-=K4.3IRV_KYG G/GZ\]_
MQ[>GX6/H*ULRGB:YNMW#V$$>W'3$LASGWSTK@:_=)_WG^1Z2?[YKM!/[VO\
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M_P  Y*+E[32^^OIY_P#!UN>X^%[,VM[JK[MWGWN_&,;?W48Q[].M<=32,/\
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MI3?P+^NXE_$?]=C1K$Z H * &O\ =- %:@84 % !0!+%U- $U @H * "@ H
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M..A##GH.]3U*Z&[;_P#(QS_]>,/_ *->GU%T,FRU V3ZW<6X$LD4P=5!SG;
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M\C\:!EWQ+-&GBO0E9E!5=1R"0"-\,:IG_?8$+_>(('- NAXMK/C&]A\="\2
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M!SOC88ZXP>AKIJ1:C"_8XZ4E*4TN]_Q91\-.L?@Z[+$*,:F,DX&3-< #ZDD
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M/X;SI;DEK2VM[>4$$8DCD@W8[%3P01VZX.14XF+CS7ZZK[SHP,E*4;=+I_\
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M0@XZCKWJ8:1FO)?F7-WE!KS_ /;0N)HQXR@7<N?[+E7&1G<;A&"X]2H+ =<
MGI0E^Z?^+]!77MK7^ROSD<'X'\4WM_XINDFB"_;LB9<$&'[*K+%G\/D;/4MF
MNBI!1IJSVV\[[_YG-1J2=5W7Q;^5E^FQ[]M&<XY]:\\]0Y.WNHCKTT8;Y_LR
M)C!ZJQ8]L8PPY[]*ZW%JC%].9O[]#@C)?6)+KR)?-:_D3Z&0MUJ)/ %R,_\
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MK6+BWUN)53/DX1%QRZR@;S_08Z;:Z:=.+I/7?5^5MCCK591KQLOAT2[J6_\
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MY'YQC 5UP>A.0.E=+BU23\[_ *'&I+VS7E;YZ/\ )%WP>PCU#6V8A0+\$D\
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M3JO4[0RS%Q*;!C(O <O;[A_P+?G]:XN9VMK;M?0]+DC?FLKKK;7[R?[?=_\
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MO4Z:*XGMUV16+1J.RO;J/R#@5RMMZN[^9VJ*BK1LEV2L/:]NG!5K-R",$&2
M@@]01YG2D59'+^(]+N]4TF72M/M6LMX&SRW@2/ALE&"/PC]&VC//0UM"?+)3
MDK_F83I\T'"%H_*R_ \\U3X=:O?:;96B[FGL_-5_,EC,>V5]W[O#%OW?W5!
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M2*A>]DD= *DL9)]T_0_RIK=">S]"I8?</U_H*TJ;_(QI;?,9%_Q\M^/]*I_
MOZ[B7\1_UV-&L#H"@ H :_W30!6Q0,7'M0 8- "8- $L7!- B:@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@!DGW3]#_*FMT)[/T*EA]P_[W]!6
MM3?Y&-+;YC(_^/EOQ_I0_@7]=Q+XW_78T:Q.@* "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M8]D'V>/^Z/RHYGW8<L>R#R(_[H_*CF?=ARQ[(/L\?]T?E1S/NPY8]D'V>/\
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)U*]]RDDM$?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>bdtx-20211231_g6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g6.jpg
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MK)9LIG^S54SS[].??SY=]=>CKT===5AE!234,4LL#7O<Z0.<2ZYRR. V<!L
M-!R7/U]74Q54D<<KFL 98 --KL:3N+[DG=06^N^UDN^_9S(AC^YUTU&?P?\
M\#_[]^GGJ=AM#?\ %FC_ !/^KK?Z%>;R^LMI([QLT^QOU^A8<^O^XT_3[.<D
ML?W/\5%?^T?W_P"_\/,3L.HA<B%NFXS/^KK>_H63RZJ_MCR_-;_T^OM6'OMC
M[Q2[R]G813'KY^^N_<PW?_)\XW_\O^KF)U#1@?U#;^+O^I9A5U'.4^%FZ_\
M+M[CM&&/]HK_ $>^_9V26Z_<]#$'_P!78OO_ /USSOHZ86M$/6[VW]>O8L@J
MI]+O<";Z6'CV?Z+$7FV>Q2?IZ3M$QCZ/V_< '?\ UB>_^;__ +S&ZEI@">B%
M^6KM_6KMJ)R0.D/J;]RQ1YN%LLGZ?4M<UCUU^W\/CW_M#]\P.IX /ZL7Y:N^
M]9>GE^6?J^Y8J[W1VA3]/J6Z<Q_:ZZ^&QO\ ]H7F/H(OD#Z_O6422;%QO;7;
M?LT]]NU8L]W?VL2]/L[D/X_N>@9&?_:#[_\ RYC='%R8/'77PU4](_Y16+NM
M[=ML.^_4NJ0X_N=_"XO^UZ?3]T#W_P!7,;HV 7RCP[>SGIZ%D#W&^IML#?4]
MI^W:WUK&G6_6X"?I]6\)'C]WOKT"HKW\W_* [YC+!V;:>_W_ %JV8]N_OI_D
ML;=>0;<I/K+U;VDF/H^?_P DQ/\ YOGCW[GI_P#?KF)PMR_R&P]9^Q7!.GJO
M]9/B-/'7M6-.?(INFGWWZM]R;K^ 1$?V^_N?/'?W.561?-AY%]U>_3Z;]D_\
MDQ']7>9"T6T[+C733?UW65K6D V7LZ\BVZGIZ]-^2;T?M_Y(B'ZN\D-;8'M%
MO3]EK%>ED<;AYH)RW'C_ *KV=>13=/O'[_<F]/S_ /FB(_=^?_\ EWE@QMQ<
M?6?O6=D$).K!MIJ?O7ZZ\BFZ7[_<F^?_ -41']7?FYEZ)@_-^LGVE>F.EISO
M$W<7N7;>OQ7ZZ\BFZ??7?7U^Y+]ST_\ DB(^GYN_W?D[S/T,7R!ZSK]:]3*&
MD)U@:>>[_L<OWCY$MT>\>O\ =ZDWS_\ JF(_N_Z.\L((;MO&+'O.]R.WP7J;
MAM#FUIVG4"V9_,#^]VKS]L1W1_?ZDW\DQ+]7N91307_JQZW;\MCVKTLPO#RX
M TK"/G/_ .I?O[8CNAZOI^OU)?3UW\_^2(C^KO\ !S+Y'3?V0^D__J7L;@V%
MDV-(SZ<O_<7L^V(;G_O\R7^2(C^KO,S:*E('X%OK=_U+T,P3"CO1Q\_SI>ZW
MY_BOUCY#]SN_1Z;XDOW>^N_\DQ+]SYO_ $>Y84-)9WX%M]+:N[==,R]$> 8.
MX]:BC.ORY1RTVD[5[/MANYO[_$E_DF)?J]RS*&D-[P-OXN_ZEZF<.X(2;T$?
M=UYO3^D3[8;N;^_Q)?Y)B7ZO<R-P^C)%X&V^<_\ ZEZ6<-8$;7P^+?7KS=O_
M -7L7[^V&;F]X>GZ_$E]/_T3$OW?]'OW.9CAM#?\7;L/SI.8']]>IO"^ $V.
M&P[?+F_[J_?VPO<S]_>2_P E1/\ 5[F0890:#R9GF@[O]/YR]4?"?#KM\+A.
MX_K*CLORF7G[87N9^_O)/Y)B7?\ UQ[EQA6'D'^C-N.>:0?4'KV1\'\-&U\)
M@.MOZRH_[R\?;"]S/W]Y+_),3_5[F083AUA_16;#\Z3_ *UZF<&<,$D'"*<_
M^I4?][O7ZQ\A6Y?K=?[N\E[_ /JF)_N?Z/<L,(PZQ/DK-+?G2<_\:]#>">%2
M/R/3WY_A*G_O+V=^0G<KT??VDG7_ -4Q/[G7?^CW[?7/0W!L,LP^1LUWZTIU
MV^7Z5ZH^!>$G#7!:<FP_2U7I_3KQ]L)W*ZRZ_P!W:2_/UW_YIB??W/1W^W'N
M9V8)A1O>BC^E+_UKU1<!<'G? Z<[C^MJO'_>.Q>>_(5N5Z._]W:2?<[_ /-,
M2_5[EQ@>$_[G&?\ %+RW_/7L'P>\&$ _$5-_Q:OT_P#Q"=>0K<OOKKOZ^TD_
MDF)?J]R[,!P@WO11W^?+_P!Q9F_!WP60#\04W_&K/_<IUY"=RON_7VDO\E1/
M_P!L?YD& 8/<7H8_IS?]Q>R/X-^"''7A^E.H_35FQ\*E>>_(3N7Z._\ =VDG
M\DQ+]7N>D<.8+U3\7QZW!_"3'VR]R](^#3@6XOP]2VO_ &U;_P"Y4<&-K-@Y
M!8\0MLU9IPA84$2Q:QB1Y(C&KA@QZ<N'2PU1N/8-&;X:\S=NTB#%^W<MW[1T
MX9NTUFJN2/?M9A&&QTLU''21MIJC6:*[R'NL 'W<XN:YH#2US2"US0YI#A=;
M^EX-X9IL)KL$@PBGCPO$7%]92YIGLEDR,8V4.DD?)'+&&,=%)&YCXGL;)&6O
M:'+M::KW#*+WH^&67,8._@1TZTR]Y'.L?9L3&#?U,$Y1'4E5E2"4;/==]NQ2
M13!)W@GZ^*2A(=TP-$_D6+446'U\]+#4-J(XW:.'G,OJ8I2 &F6/S7EEVD[A
MCLT;/QEQG@-'PWQ%7X10XC'B5-3/&25AO+ 7W)HZLM:(C5TWF3&$EA-B1#+T
ME/#8?FM7+)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MBA2_;F:T5 ?EHK'GLM>NY !C 6-#WB(]V8+GGGNZ+=)VNBY31]BV3=O,N^T%
M/6P;98?L.LNU<+-;F-KV[U#C87443[<*,1$)2SX+%"DP,W0+A\@'1Y@1:,UX
M]')DZ!"AA4RZS0=8==K'9$P#,FJ:'61!TB3[253P&N.2&$EPO;+??NO]WO=0
M76MWZ^"G56Y:N1;I.E9J&Q;KR>1PU!;VB^6"TFB+8@\DHE+O%#OVBP5J*(K/
ME<?2V2Q:*_X?O+U>LJY3V'8'T'0>ODIN.WN]_#GV**XMN+04FA>4\7FC6, O
ME03B:'RDZQ:OGC\>X=X)N&;-BH05<,GS!K\:15P]*C02N@Y*I#^\^T\9+' V
MMWZ;>O;0Z>*C,WM7Y/;D4  D,+!KS5J]:S8/(#S.2CL>G4<&# +U07BY*.^L
M\77LS)5L_'A<QK(BFY5'N5E\VS/)LY< QQN;;>_V;IF;VK[A.T=8M(9%Y98\
MKAL(SF71DA'V+22JR=%[&F!IT,8R+WMH'8K(CG3=)LN]>.&"(T:Z<9,5""N:
M.6?;(;V )M;E;6VV^_I0.%M2!?;UK,Y#L'2D5/-8Q(;+BHL^]5!)-1BY#K)=
M;J388J U\>T<%4NF3_!1#+ ADIBQ1Q=,NW+A'IZT]L#7'8'_ $]_;V)F&UUD
M02U*^DLN-00!*!Y:51WI[\:%L<72_3!08X9M2;95_BW^&9O1CH@R;DF"3Q1Z
M/7<I)/$$<^_5ZBQ !(T.RFXO:^JD#D*4X1.$3A$X1.$3A%B16"0XZ\5(%XZ,
M(/5^D^EG+EOTHJITDG@DGUEEZ>O3ZB6&&&/[F./77/3'6543!''/(QC;V:UU
M@,Q)-O$F_CJL#Z:GD<7OAC>XVNYS02;"POX!<-G4=9J?Y\* Y?PL^O\ O<OY
M?6G>IF/^,J/)*:UN@CM\T+Y<Z5JA3_/@4<R_A8X]_P#:Y7RZK.]1(?\ $GDE
M-_81_1"^3.AJ<4_\97,7R_A'X_\ >Y!K*H[SR?2]^Q3Y-3_V3/4ODSUWH]3_
M #ZQB67I_=&X]_\ :Y!JJ@[S/]:GR>'^S;ZE\N6M5"9_Y]4PW+T_NB\._P#M
M<CRFH_M7^M3T$/\ 9L^B%\N>KNO2G^?4,)R_A$X=_P#:Y'3S?VCO7[^^NZGH
MH_D-]2^?/5+7!3_/IJ"Y?PAT^_\ M<KTLGRW>M3T<8V8%\N>HVLRG^?2<!R_
MA#)]_P#;XZ60[O=ZTZ-GR0OFRTYU<S_SJ,KW+^$(G^W_ /U\CI'_ "BIR-[/
M:OGSTNU3S_SZ&KK+^$&G_P!_D9G=OO[\DRM[/:OGSTDU+S_SZ K;+T_=](%/
M_O\ *WONI  V^WW]*^;+1G4+/_.UZK/+^$ GW_\ Y.%*_/V"NG_7S]:\5E_(
M*?\ 6<FY[3ZU-R-B5Y^P7U _!XK+^0$_ZSBY[2K"1XV<1X:+S]@QJ#^#S6?\
M@I_UG&8]I]94B:4;/<+=Z\_8,ZA?@\UE_P#V^E_W^6Z1_P HJWE,XVE</2GV
M#.H7S_\ Q>JS^?\ ]0)_UG)Z63Y;O6KBLJAM/)]+W]6R=:,ZA=?<UZK/^04_
MZSCII?[1WK5O+JP?_$2_27G[!O4/\'JL_P"0$_ZSEA/,/TC_ %JPQ&N&HJIO
MIE/L&]0_N?8]UGZ/_H!/^LY/E,_]J_UJWQIB/^^3_3*\_8.:B?@]UI_(*?\
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MWS<,@^*&XA:LJ)'B?.ZFZ$P43XGEL;*J,@S6D #S(#&UC7"P?IF^AQ\)X?\
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M&'\,?DM+;'(ZQYZE6\-F/<HQCSV:$(:?2IH<-]]Z:KSE>W<1V<%7@R*'KO\
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MFQ8+>@K<4&IK:O3K4\I#;BDEZTYLGL-'K4#W%LW;D\3E[F3U?5L3M2V8U!&
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M")PBKW?FQ\)H08,1)H$9=84L6^'UY5<52[(32;EU,NTD$!X]'!95F+P7]'1
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M2X@Z9U.**."5U69V%S7P^3AIEZ5A:X/CR9FEK@X"Q6*M;MIM]#7]B,;6KIY
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MI;,_N>\(GRGVW_>1US_I2V9_<]X1/E/MO^\CKG_2ELS^Y[PB?*?;?]Y'7/\
MI2V9_<]X1/E/MO\ O(ZY_P!*6S/[GO")\I]M_P!Y'7/^E+9G]SWA$^4^V_[R
M.N?]*6S/[GO")\I]M_WD=<_Z4MF?W/>$3Y3[;_O(ZY_TI;,_N>\(GRGVW_>1
MUS_I2V9_<]X1/E/MO^\CKG_2ELS^Y[PB?*?;?]Y'7/\ I2V9_<]X1/E/MO\
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M2?9HML,G9!ZZ>N.U'+A57(BV&<(H"VHNHMKCKC=E]!*\(VJ_I^MI98G4#&2
M)%5SC.)B')DGVXD)]3IB)%C1K1V6,.V[0R:P%,7F,=C<F/Y#8^2*0+D#M-E2
M 7LZ\N_96PP4/U\Z7M;7Z)6]&:0LE:?+F6#9 J[$1JSR=D5GEG $F0!2Q(1
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MF:R*4 2QNBD:^*9DD,C'QO<TMDC<-;@!P:1FL*A<8KJ)1V"PL0W 12*"680
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MT+Y:.JG12F8W-HJMOY )P&GDRF=LR$87V K0*!,7+;47Q#W+-I-%8W+AL6F
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M58I;V7DV33GG9GJMDZ-KCNC<7/O'P'Y-9I/^YIF*Z_WE\2RL?&38&LD^O?\
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M5.=C_0[^J!==41?SNVPBO_B7LO\ /Z[1ADT?.O:>CY__ ")DEWGZ?_V/H_\
MU?1S]'<.W9\ 7$)E\QTU?T=]K.K*)C;?^MF_Q+Y_B&O'.'ANXCAS>B&<GQZF
MJWT[0;.UMJ55N=IV6C)RS9]*HE7T+A,#"]26P[,LJ?&6\?A%=5_',G8],U+9
M.6<8MQ[5R1',$$$G9$F18#&+QXA^:5]% NJ'*>9.C1X-!"04+M.'N3[*1/4!
M_K6A!H!([J86\\K%]; G+%G&;1+08I#B\9;,DT)2'G#]H.>F1[@\B( )DCC
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MR7>/C]>@B,1=XG&,/;9*FFA60#R(99TT+R]9$QT'A;(*L]6:DWK@RZ7;=C6
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M*."CAKDOFR=NVRY2"1J/?Q[52Z7^&+QO3ROZDK*4Z^D'L2H\E/CM=H#;LO\
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M7N$3A%K[L[Q::+7%4ZU'6'2Y U5J]^2_9]:+,[=N^-XJ7K.GL@(R:>Y&(O9
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M<>'&&<I!4TW,P&1NTFP,_(V60=X9!NW 5QF1P>.1JC=9ZP'.<U&:1001:_,
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M9=3S&<6=OK"K@DS=S%^FZIQ%W$Z^29Y&D72.3I@PCSQT^]E@W6]F49ATF_5
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EPB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>bdtx-20211231_g7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g7.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0 B17AI9@  34T *@    @  0$2  ,
M   !  $       #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T      ! !+
M  $  0$L     0 !_^%F[VAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M( H@(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $,
M @$! @$! @(" @(" @(#!0,# P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*
M#0H*"PP,# P'"0X/#0P."PP,#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_
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M X Q7]5U !17X"_\'9/_  4%O/B5\8?#G[-O@^\N+BQ\/F+4_$\%DY8WVHS
M&TLV5#\_E1L)-A!^>=.Z"O<OB[\!M0_X(L?\&SOBGP^MY>:?\1O'"P-K$UO=
M-$]OJ.IRP13Q1L.5\FSC,9"\,T3-QO- 6/V(HK^2G_@FI_P0\^+G_!4[X;^(
MO%7P_P!:\ Z+I/AO4ETJX/B*]O+=YYS$LI\OR+68$*KIG)!&X<'K7V%^SY_P
M:/\ Q\\#_'CP7K?B;QS\'_\ A'=&URROM3&FZGJ4UXUM%.DD@A1[&-6D*J0
MSJ,D9(H'8_H4HHHH)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?^U<?#GQA^)GP7O[AOLOB2PC\4:3&5&U+FV(AN5!Z[I(I86P<C%L>AX;[_\
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M->HT V%%%%!(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,'/'Z?\ _!I-\4U\;_\ !,34M ;Y9_!?C*^L@N[.8IHK>Z5L=@7FE&/]@^M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5A_$K2-4U_P"'/B"QT.YAL]:OM-N+?3[B9F6."X>)EB=BH+!0
MY4D@$X''-;E% 'X\_P#!$S_@W2^)G_!/']M2#XJ?$KQ-\.=8M=%TF[M=*MM
MN+NZG6YN%\II&,]M"(P(FE7*EB?,(X&<^E?\%^_^",GQ@_X*M?$OX;WW@/Q-
M\/\ 1M!\%Z;=V\T/B&^O()C<7$L;.\:PVTRE2D,8Y*G*^F*_3RB@+G!_LN?
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M!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!_//\ \'3O[=.M?M*_M;^'_P!FGP9;ZA>Z?X)N8)=0M+:)FEUC
M6[J-?)B5,9<10RJJXZO<2#!VJ:_3_P#X)_\ _!$+X(_LT_LB>"_"?CKX3_#'
MQYXVM+%;C7]9USPQ8:I<SWTO[R9%FEB9C#&S&.,9^XBGJ37VS10.Y^;/_!<K
M_@F7\$]$_P""5OQ=UCP/\'?A=X1\4>'M.M]6M-4T/PG8V%Y;I;W<$LP66&)7
M :%95(SC#'-?+W_!F5\0KR72/CSX4DBF:PMYM'U:"0*?+25Q=Q2*3TW,L<1
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MQ;;C3[0K_H=DVY0RE(V,CH>5DFD4YVBOT)HH'<^$_P#@Y(^*MY\*_P#@C_\
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M\>^)?#OP]\/?$31[SPM81ZC=R>(=/M+>%XWD\L*C07,WS9YPP7C."<&OB/\
MX*7?$=?^"P?_  5"TWX Z;=32? ?]G-)_%GQ*O[60^3?SVR9G@#C #HI-JGS
M J\MTW(C%<3_ ,&YOQ@\-_LJ_L<?M6_M7^-[5;'2I-:BMS!:HL2L\2M/]DM@
M2%W2S:A;Q*O !V"@#]V**_$_P)^UA_P4K_X*-? G7OCQ\*]>^''PA^&UJEY/
MHVA2V5M<7FM6]OO#M"]U:7/F,K1LA>1[='<-M4+T^BO^"7W_  6H\0?M;?\
M!+#XN_%SQ]I^DZ7XL^#MKJ)O9].B,=KJ(ALOM5O(L3LVV1L^64W$,R@C ?:H
M*Q^DU%?A'^R)_P %%/\ @H=^W+^PAXH\6>"->\&Z+9_#^*_U+6?'WB/3K*WN
M=9,*B;[!80):&U'EPK\SRQ8+2D&5" *^J_\ @E5_P6JUGXF?\$@_'7QZ^.S6
MLEU\*=4N='N]0L88[5_$;)!:208B&V)+B66[2'"!4+%2 N2 !8_3&BOQ/\"?
MM8?\%*_^"C7P)U[X\?"O7OAQ\(?AM:I>3Z-H4ME;7%YK5O;[P[0O=6ESYC*T
M;(7D>W1W#;5"]/HK_@E]_P %J/$'[6W_  2P^+OQ<\?:?I.E^+/@[:ZB;V?3
MHC':ZB(;+[5;R+$[-MD;/EE-Q#,H(P'VJ!8_2:BOP;_98_X*1_\ !0S]M']@
M+Q=XV\&Z_P"#M%TWX;6^HZMKGC[Q%IUC;W&L_9U$YL;"!;4VH\J!#N>6+!,I
M!E0@"NB_9#_X*J?MV_\ !2W]CG5&^%\/P]\)ZE\.()Y?%/Q)UF"-!JLD:F>.
MVM;7R);=)S#@R$PE/F0_N<C<!8_<*BOR]_X(_?\ !:OQ%\6O^"7/Q0^-'Q^O
M+2Z/PCU&2TN-5LK2*TDUE/L\#Q1^4@6(7#RS+& @16:6,87FOCSQ]_P6Q_:R
M^/WP>USXS>&OC[^S/\%?#>FI<76G_#Q]7T[4/%&IQ1DA8A;36]S,TS&,@;S;
MAB^X*JE2 .4_H%HK\D/'O_!;7XJ:M_P;RG]H**/3/!_Q6U36(_#.FZA;V*2V
M=Q,EZ(Y+N*"<.AW0Q7 VL'42(Q P,#E?V /V^?V^?VD_$7PW^*WBS0AI/[-V
MBZ-<W?B74?[.TN*Y\4+::;))+=&-@+E?.N8CY;6L440\Q5RX4D@6/V9HK\+?
MV5?^"AG_  4 _P""L$OBSQ]\$_B1\$O"&G^$]0\H?#:<6C:G>0@B5&/GVTLI
MCD5_),S3VZ.T3[ A!-?ME\*9/$4WPM\-MXO2QC\6MI5J=;2R_P"/9+XPK]H$
M7)_=B7?MY/&.3UH$=!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ?D?^TC_P<N?%;]E^YU:^\4?L1_$O
M0?"-GJDFFV>OZ[JM[I%I?_.XB(:72MBM(B%P@=CC."<9KO\ ]CG_ (+J?'#]
MK7XM_#_2!^Q'\3/#?@WQU=6W_%8SZE>R:396,P#_ &X2MI<<4D8B.]?WJA^
M&^85XM_P=]>/;CQ7X,^ 7P?TE6N=8\8>)+G58[<, -\4<=I;[N_SM>R $<?(
M^>U?7G_!8CXL77_!/?\ X(P>+%\(ZG?:'JVAZ#IOA+0;S3+AK*XM'=X+020R
M(=T;)#YC@J01LX(/("C[>HK\-_\ @F+X!_;B_:<TGX*_'/X@?&+6/"OP%\ L
MFH7MC>>([Y-3\4:7:[YY[JYB"R&\2=HRF;F3.QAY:A-I+?V9O$?[6'_!PM\2
MOB%\1/"?QZ\4?L[_  I\':HVE^&['0O/C:YEQYJPSK;7$)ED6)X6EDD=U!F
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M&EZ;=6_AS0KC4#::?864@3,<*,8E,JV^&.  I'>L'_@MM_P2A^(GQA_X)0?
MSP'\*=!DU_5O@Q#807>B0R(MU>0K8"VDDC!($DBR ,5!RP=R,D8/ZT44"/QM
M_8\_:;^+'B#XH>%]/^'_ /P2_P##'P<\1S75E:ZSXRU#PVNB6EG;M+'Y]PBM
M86CX0KYHC6>1AL PQP:Z3_@K?^S5\1/VQ/\ @N5^R]H]MX!\:WWPM\"?8]6U
M7Q)!H]U)H\,GVU[FXADN0GDQDQV=NG+@YE4==N?UNHH&%%%% @HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %0WU]#IMG-<W$L<-O;H9)9'.
MU8U R6)[ "H=:U6+0-'N[Z99GALX7N)%BB:60JBEB%102S8'  ))P!7XB_MK
M?\%GO'W[<7B1/"_PO\-7^D^"]-U"47J27!AN-9C7]V8;GD!%()8IVW $DK54
MZ;J2Y49UJJIP<W_E^/0_2CP'_P %8_A?X[\8W%FK:M8Z'YICL]<GMB+:\ X\
MS8/WL<9/ 9U'J0HKZ>K\%/"&N>)]%TU6US1-/L=/N-V+>%O]4I &TR ECC&>
M#C\S7W;X=_X*D?$+0?#MG8:IH'A?4-0\M%75IIVM8;H$<2N@PJD^BD#T Z5[
MF(R9N$989-OJGH_)V/E\)Q)",I+&227V;7=^ZTOJM#[^HKY:T?\ X*9:;XX_
M:%\+^$?#7A^YU31-<FCM9M6=VB;S9%W?NH64.4CP=S.%S@X&!D_4M>-4HU*=
MN=6OJCZ6AB:59-TI*23M=;?>%%%%9&X4444 %%%% !1110 4444 %%%% !11
M7*_&SXB2?"/X2>(O$T=C)J4FA6$MZMLAP9=BYP3V'<G'0&A7;LA2DDKLZJN>
M^*'Q0T3X.>"[OQ!X@O/L6F6>T.XC:1V9F"JJHH+,Q8@8 ]2< $CY*D_X*T?V
MG\'[&_LM#TRR\9+?B*\TN_N'%K/:B-V,UO,  6+>6!&WSC+?*P&:\1_:T_;O
M\8?'+P9:17FFZ7H/A^*YWQVD1,TNHSA=JDR,,J$W%@% S_$3TKTZ&4XB<O?B
MTEN>%C.(,+3IM4IJ4[>ZM;-O;_@ZZ'V%^S?_ ,%%O!7[1_Q2N_!]K:ZGHVM;
M'N-/2]",NIPH,N49"P5UZE&.=O() ./H*OY\?BAXL^+?AZ!=2\-Z-:6^KMB3
M3M3LYA;7.GL/D++M89)7(SCO7Z!?\$D_^"Q.J?M:>/+7X2^/O#%[IOCJPT?[
M2NHP*TT%^(0$DDGQD1,Q!8,2%+';P2H.688:%&H_97Y?R]3?*<PEB:?[QIR\
MFG^'0_0RBBBN$]<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BJFMZQ:^'-&N]0OIEM[.QA>XN)6SMBC12S,
M?H 37Q59_P#!9O3X?AIK'B"[\#W\DBSL^D6UM>Q[9[;( :9VQY;8R_RJP(('
M7-;4</4JW]FKVW.?$8JC0M[627-HCRG_ (. O^"B^M_LR:EX(\#^"?&5]H>J
MZA!=:CK\>E2M#?00YA6U_?*,Q[S]IX5@3L!. 5S\<^*OV8]'^-'@[11HLJZ3
MJNN$W4>K6P,4\S,HVKYC;2><Y).*ZS_@H7XXTG]HOQ';^,/%?@[3M-\2?$F*
M+2H(]+EEN972S((GD))$9"RHAX3( (#88CA_!?BG3O%WP<L_#=_?:KI2PA[2
MVM$AE\RSB!.U4DP3AL\\U[F7X65.,H55O]_I<^3S?&NOR5L*Y))[VT:M:Z75
M)IKL[>AYY^S+X ^*7A;2/&&M^+EU6;P[96)F>XU2<W+#:ZKN3<S-MY[=<UW_
M .S]^TCX>\2_#3SKBXDO)+2+RG2YM?, 8G;M4[3@@$8/I7IVKWNN:EI%];Z:
MPNEF@,=U;3;ELU8X!B((Y..>_"]>:YKP?\$=-\+:78^&_#]E!'+-+]HU&1@-
MNU03\N>AR<X'&!QVKU:>'G1DE2=UUOOJ>+B,=1Q*G+$12DVFN72R2UOV_4V_
MV4/%'_"H?&6C^-]*6'16L]9\^.6*WYCMVF,<ZLJCD&,N" .03WKZ#_X+!?MO
M^%]9\1_#74/ 'Q N)KCP[->3:E'I]U/;V\0EB002,_RIYH(<#!+J&/05XW=W
M5MH6EV&AB\MCIL:RR6$>P(9=SL&."-YRP;ANG;C%>8_M@?#_ ,&^+?@7_8\N
MN'3?%?VI!]E>!C' FY3O+#C!YSGG'3I6&,P,6HU8?%'H^O4ZLKSB5Y8>47RS
M>^K:6W_#GJ/P#_X*'?$[XG?#VX_LCXIZM_8EY,8-1$TCW-]:L"!LBN9,R194
MCYHSWXP>:^D/V?\ _@JU-\!?!\^E_$*WUSQ58VKO);ZM'<?:;Z)653'%*&Y8
M,Y(#LX(##.0!7QO^R!\"-#^'/P4OK#2]:AUS4))WN?+BC^5V1 [NY.-B*J]S
MS@^]>!_MU?#'Q)X?MK/4]#U34KC3-8EQJ=K%(0GVD8$;X)S@J%7:.,IG&2:S
MQ&$A'"*<Z:;T;L]?EW\SHP..J3S'V5.JU%724MFM_P!'9^A]I?%_]JKXM?%K
MQ9?S#XB>+_#NHWT0C:#0M0FL+&R4# $**<;N<ESECZ]*\[_9W35?V)_#*W5G
MX\\0:??9,!E21U9H@=Y$F<AAN(.&KQ_X;ZY\9%U)=,\;-:V.I31+)9(HM\R1
M)PQ;RR0&!*]2#]:P?VD_BKXNT6U_LWQ@]YJ?]L>8;240H/.8 94;.A *]0,U
M7-AX0]LJ;6B5FK?AW9BH8VK65)UT[N_NO5^<7;\C[O\ ^"HO[5=[^U-^PM\.
M-)\%ZQJ3>.M*UG3=<\1JUO):030165RDK,V!'(CW$D+JBEAPIP"HQXWX#^,&
MI>*OAQI,E_91Z>J[4F@,7E3:BZNN[=CEAQP6X Z5\Y?%;]J*X_X9-T72_"+7
M$7B&.SM]/U@SP,TBVBQ@NJAQCB5(SN'./;->B?L+:_JWQ!T#2M4\>:C))H\8
M9;66UM8WG&$(&=HSZ##8&#GJ*G+Y4J-?V=%O57\KAFD<17PWM\4HIP;2WYG;
M[]WJ>]>,;RSO?'EYH^AZ9'->EBPL&7>&64#RPH/ 95?MD\ G!%</+:W%G8G3
M;[46TZ^MKDN]A!)M56''ED>G')'7GM3OVB_B+9^'O&UIXXT&^U)M>M) 9)Y8
MEAX"^4N53Y/N8[9S[US/P2^(=AXD6Z^(%\UO,TY>U$H1KEX$!&6,8#$MN+'!
M4D@]#Q7JRJ1=3DEO^EM3PZ>'DJ'M8WMZ:\W;T>Z.R\.^$([&<0^6BWVH.S1+
M$1&%SC)S_#C );MBOU(_X)]_$_Q+\5OV<=,OO$EL_F6CM96=^[@OJL$>%6=E
MZALAE)/WMN[O7Y#0?MA^$9_#?B*\6\6631WDCFQ92K, %R2GR@JI!P5&,XQB
MN]_8#_X+.7WA;XC:?X;TFWU;7/#DCR--I$@6-4#!CYB2,I\LAL':I ;G(SR/
M*S:-.O3C"FTY7TTU=KW1[_#TL1AJTZN(C)1M9Z:)[W?DD?M916=X4\2V_C/P
MOINL6?F?8]4M8[N#S$VOLD4,N1V.".*T:^3/OPHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ ILCK$A9B%51DD\ "G5\-_M^?\
M!43P]\&M3^+?PYUC1O.M]%T);*:2'4A#>7,E]:JP,2;3A56=03G.>:J%.<W:
M",ZU:%)<TWU2Z[O;8A_X*H?\%A_ _P"S!\(O$7AOP7K2^*OB%JVDW5O;R:!>
M1SIX:DDA=(;FXE3<(W#E61#\QVY.!@G\ZOA#XTM?#'PXTG6M0LK73XM647%_
M&P437TSXWL6/.]V.?QKDOV=?A;X)\>?L\>-/'EWXEOK+5[[39(-0TUTC,,DD
M>Y NT+N7Y$0DD]22.M=WK'@Z#0O@;HGB#6;BPN]%L8UNKF>Q;-K;KV4OR/,
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ME8Z,'[1OV<6^;1?*_3LS4^$?C/P38_%=]+\'ZLMO)-8F6XCBN&(EYYX8GJ
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M5GL5,!0EC$H*TEI:^G*U]G:UNJ['OOPXUGP?\?"VI:I;6NFZS+!Y7[IL1!&
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M3_X/<^!J2FM()/S;T\O,Z#P@EK^QI\$;[_A*I;&XUW6#'/\ V4;C]XRC"E<
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M:._:;TWX>_$_P_#XBAOM6U!;>*W66\E^6U@\PX<':2%49SCGBO-?VY?AE=^
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M1I-#"F*2U@V73_>^8%1M+CNQP>G/%?3_ /P;F^*-!?\ :X\;6FE-?6]UK/A
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M7[9'AZZT/49)H+$BU!M2889)&C*#.#\P)(SQS6_X0_;8\.O\%)+'78;IGAB
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M&IZ7\,->O[>WTJ2'04DNI[UY7,DPB7+HBA,YP#P2!R.:^H_V@M#N?C-XGO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_;*U/X5?M#?MT^/=2^&,]CX9\ 7TZ3:6T6E7?DS.0OG2"#87A5Y2[@,J!00
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M(JF0L?D89)#5\]4PLH1YDTUW1]=1QRJ5/9.+B]=[6TML[ZK7_.Q]*^)/V=O
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M137^F'3V:748&16'V>X) "NT;HY&=N 1R>/F<'B5[63K-V:?R?3\3[3%Y?\
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MH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M65*+T=K^9]ID^,CCJ$:\[<T6_*W3OV/CCX8_\$'_ -FWX9>/?^$A_P"$1O\
MQ!=1R>9%!K6I27=K&0P9?W7"L%Q@!]PQU!KYQ^.?PM_X)V^.[K4O#T&LQ^#[
MS4;_ ,^YU7PS]I"12Q,2RJ9(IH CEB#LC*G:,$ "OLO_ (*<?M=>*OV+/V;_
M /A,?">@Z;K5[_:4%E+)J(=K6Q23/[R1(V1V!("C#  L,GM7\_?B"8W5^TS/
MYDES(TCG&/F8Y)]N37F:IGN1BNI^E7QW^(?[$7PR_9(\9>%O!6DZ%XG\2?\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /FO\
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MK!$3F.*9=KD@DC SBOW6\0Z!:^*M OM+OH5N+'4K>2UN(CTDC=2K+^()%?R
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MR,["N0-I/']*U/CS>SZ%X2@U'P_IZ7M]<#RV580K60R-I#C&<C))Z\<UVXK
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M79_UU.;_ .">?[/'QH^.\UKI-Q\+6U3P_HFJ+8W.M7L4$5HK+(/,60R_ZX
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MH_X?5_LL_P#1:/"O_?-Q_P#&Z_EL\A?[B_E1Y"_W%_*CVT@Y$?U)_P##ZO\
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MO[;Q[92VNB^6QC$DBV]P%F<% ,_9\,0/E((R/WYMED%O'YS(TP4!RBE59NY
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MMM$2/#'ORG3+L?QQ0&Y::+5/#G]I6;-]@TO2X4MC''M#W*E<J"Q^ZP+')YR
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M=I]BEO#:2;<R&.5F?/JH'ZFO./%LY\::[X9U*22%M)2;S]0M[1E1I;G"X=.
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MJ3(S?%'BW2O ^BS:EK6I:?H^FVXS+=WMPEO!$/5G<A1^)K\Y?VNO^#G+X,_
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MK/4=/TF6>VN0CM&Y1U&#AT93Z%2.U$6T] W/V._XBOO@U_T3_P"(W_?NW_\
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MU&QU"Y-W;HI,(MXI3)(V!QA<DK[G@9KD/#'CN/Q9X?6"9HHM8T.[@U&T@,@
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MH:&/4IM2/+6<:D;54GAF;&,=.#[UX#\1/AIX7^+WA6:PT76EO--LG$EQ>6N
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M:#RH_P!/;FM&J=@N$7GTQ5RO#-)!11102%%%% !1110 4444 %%%% !1110
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M&VDA\U3RH.&R/88XS7W1\%/VB+#X[^,;C0[3P[?64UM:F\:X$RS11IN "N<
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M/NQ#_/TIR^&E_NPG_/TH^NLGD/)8?!#X^[FIXO!3#^$#\*]47PR,?=BS]/\
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MZ_LN6GA.]\2-<0Z7*)TO&#?:=3=92T9N96)9M@;:,8SM4G)%9_4JCMR._?\
MX!TRSNG%\M2+3Z==7Z;?,XCP)\.YO&?BOQ9X^O)M.TO4->O+C4)894\E\R2L
M1Y:@,H.TJ2,C%7]"_P""*&M?MA7J>/[+QII_A[P[XBC#PI+:R7%T=K&,R*H
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M52-T>9>=N?F7IS7!_!/]GO4OA_;:WHNEZ/I]W]KN4O-7FD4R1B!22JP@#=@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3)WP,;,GY5&,[G_!3W]G6R^.'[-VH:INM[?6_!J/J=C<2R"-60 >= 6/&'4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSZB@IM4W==#HC>VNX4445F,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M^?DOO?\ F'LH=E]QY#_PP7\(O^A)T_\ [_S_ /Q='_#!?PB_Z$G3_P#O_/\
M_%UZ]11]>Q/_ #\E][_S#V4.R^X\A_X8+^$7_0DZ?_W_ )__ (NC_A@OX1?]
M"3I__?\ G_\ BZ]>HH^O8G_GY+[W_F'LH=E]QY#_ ,,%_"+_ *$G3_\ O_/_
M /%T?\,%_"+_ *$G3_\ O_/_ /%UZ]11]>Q/_/R7WO\ S#V4.R^X\A_X8+^$
M7_0DZ?\ ]_Y__BZ/^&"_A%_T).G_ /?^?_XNO7J*/KV)_P"?DOO?^8>RAV7W
M'D/_  P7\(O^A)T__O\ S_\ Q='_  P7\(O^A)T__O\ S_\ Q=>O44?7L3_S
M\E][_P P]E#LON/(?^&"_A%_T).G_P#?^?\ ^+H_X8+^$7_0DZ?_ -_Y_P#X
MNO7J*/KV)_Y^2^]_YA[*'9?<>0_\,%_"+_H2=/\ ^_\ /_\ %T?\,%_"+_H2
M=/\ ^_\ /_\ %UZ]11]>Q/\ S\E][_S#V4.R^X\A_P"&"_A%_P!"3I__ '_G
M_P#BZ/\ A@OX1?\ 0DZ?_P!_Y_\ XNO7J*/KV)_Y^2^]_P"8>RAV7W'D/_#!
M?PB_Z$G3_P#O_/\ _%T?\,%_"+_H2=/_ ._\_P#\77KU%'U[$_\ /R7WO_,/
M90[+[CR'_A@OX1?]"3I__?\ G_\ BZ/^&"_A%_T).G_]_P"?_P"+KUZBCZ]B
M?^?DOO?^8>RAV7W'D/\ PP7\(O\ H2=/_P"_\_\ \71_PP7\(O\ H2=/_P"_
M\_\ \77KU%'U[$_\_)?>_P#,/90[+[CR'_A@OX1?]"3I_P#W_G_^+H_X8+^$
M7_0DZ?\ ]_Y__BZ]>HH^O8G_ )^2^]_YA[*'9?<>0_\ #!?PB_Z$G3_^_P#/
M_P#%T?\ #!?PB_Z$G3_^_P#/_P#%UZ]11]>Q/_/R7WO_ ##V4.R^X\A_X8+^
M$7_0DZ?_ -_Y_P#XNC_A@OX1?]"3I_\ W_G_ /BZ]>HH^O8G_GY+[W_F'LH=
ME]QY#_PP7\(O^A)T_P#[_P __P 71_PP7\(O^A)T_P#[_P __P 77KU%'U[$
M_P#/R7WO_,/90[+[CR'_ (8+^$7_ $).G_\ ?^?_ .+H_P"&"_A%_P!"3I__
M '_G_P#BZ]>HH^O8G_GY+[W_ )A[*'9?<>0_\,%_"+_H2=/_ ._\_P#\71_P
MP7\(O^A)T_\ [_S_ /Q=>O44?7L3_P _)?>_\P]E#LON/(?^&"_A%_T).G_]
M_P"?_P"+H_X8+^$7_0DZ?_W_ )__ (NO7J*/KV)_Y^2^]_YA[*'9?<>0_P##
M!?PB_P"A)T__ +_S_P#Q='_#!?PB_P"A)T__ +_S_P#Q=>O44?7L3_S\E][_
M ,P]E#LON/(?^&"_A%_T).G_ /?^?_XNC_A@OX1?]"3I_P#W_G_^+KUZBCZ]
MB?\ GY+[W_F'LH=E]QY#_P ,%_"+_H2=/_[_ ,__ ,71_P ,%_"+_H2=/_[_
M ,__ ,77KU%'U[$_\_)?>_\ ,/90[+[CR'_A@OX1?]"3I_\ W_G_ /BZ/^&"
M_A%_T).G_P#?^?\ ^+KUZBCZ]B?^?DOO?^8>RAV7W'D/_#!?PB_Z$G3_ /O_
M #__ !='_#!?PB_Z$G3_ /O_ #__ !=>O44?7L3_ ,_)?>_\P]E#LON/(?\
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M*/KV)_Y^2^]_YA[*'9?<>0_\,%_"+_H2=/\ ^_\ /_\ %T?\,%_"+_H2=/\
M^_\ /_\ %UZ]11]>Q/\ S\E][_S#V4.R^X\A_P"&"_A%_P!"3I__ '_G_P#B
MZ/\ A@OX1?\ 0DZ?_P!_Y_\ XNO7J*/KV)_Y^2^]_P"8>RAV7W'D/_#!?PB_
MZ$G3_P#O_/\ _%T?\,%_"+_H2=/_ ._\_P#\77KU%'U[$_\ /R7WO_,/90[+
M[CR'_A@OX1?]"3I__?\ G_\ BZ/^&"_A%_T).G_]_P"?_P"+KUZBCZ]B?^?D
MOO?^8>RAV7W'D/\ PP7\(O\ H2=/_P"_\_\ \71_PP7\(O\ H2=/_P"_\_\
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ME#LON/(?^&"_A%_T).G_ /?^?_XNC_A@OX1?]"3I_P#W_G_^+KUZBCZ]B?\
MGY+[W_F'LH=E]QY#_P ,%_"+_H2=/_[_ ,__ ,71_P ,%_"+_H2=/_[_ ,__
M ,77KU%'U[$_\_)?>_\ ,/90[+[CR'_A@OX1?]"3I_\ W_G_ /BZ/^&"_A%_
MT).G_P#?^?\ ^+KUZBCZ]B?^?DOO?^8>RAV7W'D/_#!?PB_Z$G3_ /O_ #__
M !='_#!?PB_Z$G3_ /O_ #__ !=>O44?7L3_ ,_)?>_\P]E#LON/(?\ A@OX
M1?\ 0DZ?_P!_Y_\ XNC_ (8+^$7_ $).G_\ ?^?_ .+KUZBCZ]B?^?DOO?\
MF'LH=E]QY#_PP7\(O^A)T_\ [_S_ /Q='_#!?PB_Z$G3_P#O_/\ _%UZ]11]
M>Q/_ #\E][_S#V4.R^X\A_X8+^$7_0DZ?_W_ )__ (NC_A@OX1?]"3I__?\
MG_\ BZ]>HH^O8G_GY+[W_F'LH=E]QY#_ ,,%_"+_ *$G3_\ O_/_ /%T?\,%
M_"+_ *$G3_\ O_/_ /%UZ]11]>Q/_/R7WO\ S#V4.R^X\A_X8+^$7_0DZ?\
M]_Y__BZ/^&"_A%_T).G_ /?^?_XNO7J*/KV)_P"?DOO?^8>RAV7W'D/_  P7
M\(O^A)T__O\ S_\ Q='_  P7\(O^A)T__O\ S_\ Q=>O44?7L3_S\E][_P P
M]E#LON/(?^&"_A%_T).G_P#?^?\ ^+H_X8+^$7_0DZ?_ -_Y_P#XNO7J*/KV
M)_Y^2^]_YA[*'9?<>0_\,%_"+_H2=/\ ^_\ /_\ %T?\,%_"+_H2=/\ ^_\
M/_\ %UZ]11]>Q/\ S\E][_S#V4.R^X\S@_8Z^&EM D<?A.Q6.-0JCS9> .!_
M'17IE%3]<K_SO[V5R1[!1117.4%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !117SO_P4@_X*;_#G_@ES\)-)\7_$2#Q)J%OKNI#2["PT*TBN+RXDV-(S
M 2RQ1A%5<DLXZJ "30!]$45\]_\ !.+_ (*6?#O_ (*@_!O4O&GP[A\16-GH
M^IOI-]8ZY:1V][;3!$D!(BDEC*LCJ0RN>X.""*P_^"D__!7+X1_\$L=!\/W'
MQ&D\0:AJ7BAY/[-T;0;6*ZOYXXRHDF*R2Q1I&I=1EW!8DA0Q5L 'U!17B'_!
M/S]O?P?_ ,%(?V>(/B9X'TSQ-I.@W&H7&G+!KUK%;W?F0D!VVQ2RH5.X8(<]
M#D C%>WT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17YN_M:_\
M''_@OX5?'B_^%GP7^&7C3]HOQ]I,CPWEKX:W+9)(C!9(XY8XIY9F3+!BD)0,
M -Y).WU3_@E__P %?U_X*%^/_%W@7Q%\(_''P=^(W@>TCOM6T77 9(X8I)2B
M 2/'#*'(VL5D@3[QP6"DT ?9U%%% !1110 445\S?&7_ (*L_#?X)_M^>!?V
M;[[3O%^J?$#QY;1W5K-IUE!)IU@DAFV_:)'F1U.V!V(2-\+@GK0!],T5\I_\
M%>?VN?C7^QW^SEI6N? ?X47GQ8\9:IK<5A)9Q:/>ZM%IML8I9'GDM[,K,P)1
M4!#*JF0$D\*T/[5'_!5/0_\ @G1^Q;\-_B5\>?#NNV/B7Q?!86>H^'O#5O%=
M3V>J2V9GN8D$TT:>5$R2*6,A/W0-V<T ?65%9G@SQ/%XV\'Z3K5O!=6L.KV<
M-['#<H$FB61 X5P"0& ;! ) (/)K3H **X_]H#XWZ#^S3\$/%GQ!\327$?A_
MP;I5QJ]_]GC$DS10QEV6-20&=L;5!(!8@9'6N%_8#_;I\*?\%&/V<['XG^"]
M*\3Z/X?U"\N+*&'7K:&WNF:!]CMMAEE3;NR 0^>#D"@#VJBOB?\ 85_;:_:2
M_:)_;^^+_@WXA?!&3X>_!OP<+N+PWX@O-)OK2ZU:6.\2&#$\S^3=+-")ILP1
MA4 0%FW*6^V* "BBB@ HHKY!_P""Q/\ P5FT_P#X)*?!GPQXHG\&3>.]1\5:
MN=,M--751IBJJ1-))*TODS'Y<(-H0Y+CD8H ^OJ*_(OQ%_P<]?$#X*"QU3XN
M_L5?%SX;>$;Q_+_M>[O+D;F(RJQK=:?;1R$\<>:.#GFOT5^#G[9?AC]J']D)
MOB]\*_M'C/2[S2;J^TVQB0Q7=U<P*^;)D/*3>:GEX/<@@D$$@'K]%?)'_!(3
M]JS]H#]KKX->*/$7Q^^%</PIU.VUHVNAV']DWFESW-F(U)>2"[D>7(<E0^$5
MAT7C)^MZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU+P)\-?AO?W5C8VOANXT^VNM>UI)8@\=W>I+;E46?RG;9;20NBR\1J '"_\
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MVGQ-_84_8V\-M<7VBZ>MK974:$+/=QO-:V*W3X^X=D5Y(S# !=S_  \>A?\
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MIZM\4=+T/1+[XD^)'@\+^'WN;8%KB4^=,GGNH$C00*)Y=A8*6.T%3)FO@/\
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M0_9$_97^%/@SQIXP\-Z1JT]SXE\1Z3HEU=6MG=RR11M=W#1JT<*N]Y>2_O&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAO;S/HL%CO:6HU?XG*FTMM>Q]N4445RGH!1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?!SP]=:CXC\&V_CZ_$RWNA66HQBX5DED"LMNSM*H>)!)@YP&//%?1%?SD_\
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M1M/L)R$,S,TAD8#C<>3Z#GI3O$OP-T'3M TO5M&L[>QFN+J62]M[5 BS11[
MI.WG(W,<D#VXK7#8)T:?+%\VFO?Y?J?S=C<RC6K_ +WW;?"EJEZZZM^6QX'H
M'_!)/X[?&/\ 9?U+XK1S:/>^'?#5M/<?8+W7&EU PP@M,8H0&2/:JD['>-B
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M7+7Q/H=GJ5C,MQ8ZA ES;RK]V6-U#*P]B"#^-7*\S8]P**** "BBB@ HHHH
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M\>D3>G/]#?B'Q%I_A#0;S5-6O[/2]+T^%KBZO+N98+>VB499W=B%50 222
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M[/(5&2PC)7]\O^"9/_!//PO_ ,$S?V4])^&_AVX;5+I9&U#6]8DA6&76+Z0
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M"7VF:3\5/!]N]G"M^3':Z]8EB_V:20 F.1'+M&Y!7,CJV P= -GJ> _LM_\
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M"/O6R1(U58@W<(!MSWQ7S\H^ZG^/_ /KHR;JN*V5M+=>]_-&Q1114F@4444
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ML"K*P[@@D$>] (_FH^&OP(B\-_M#W<T'B:34-/A-S,DBOM%W;ARMNS9[,HW
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M /X*E?MY7GA#XB1?#GP[>>(M'ET&6.\UJ]T_$<LS-%%+!'&RMNV 2*S$@98
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M +-OKRTBLKB^N;J6[NI8HR2%WR,=@+'<P3:&(4D?*N/:***^7NWJS[T****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#X>_P""CG['GQ0\<?$>Y\?>#1%XZM[BTATS_A''9+2XT6W16>6:
MWED?;+YDBKNC"J^2N"P''PUK?PKT;6O!TUK,TEU#K]IYEV)H]DEI(V?E89.'
M4@J0<$$$8K]QJ_,G_@KK^QA\/?V=]&\;_'"Z\;>+O!NE^)98EO-)T+2H;YKO
M696PEP@DDC"AP&,BE@"06W9.VO8R_-%0@Z-6/-'HO._XW/G<UR%XF?M\/+EG
M=7[.VWHUTMIW/AOX1_"'Q]\$/#LFAV=]9ZAX:BF:>-KI6B:W7?N8)@D')R.O
M&:]B^''QCM_%^LV>JV%G )M+5HI_/?[1%.X)7Y@>O'&/45X7\,OV^_!NK^$=
M'T[Q'+?6-Y#B*:6X3?$[<Y<[2< \$\=?7K7OG@+6/#NI2KK=MIMEJ5G>!7C=
M3^[D"E<D => 1SBOI,#*E)*.'E>/5=F_RL?%YG3K)R>*I6EKJE9-]?)WW/K/
M_@G?\=[7X6_%V]\.ZMKVGVWAWQC;)?V,2)MA&IR2+'Y?3]VQC !4\?*O/2OO
MVOQ1LM%L?$8U6UL;.[DM;]I,0(I_=JP/'^Z,]:Y+XE?$[4+:WU*R/B3Q5-J6
MK6<=G>OY[2M<0(Z[(Y79LF$&-?EP>%KR\RRB4I^UBTK]SW,BSY4Z<<)5BW;1
M/R??T_(^P_\ @X)_X2'7?!7PVTWP[-K=P)+B_NKVQT^0^5/&JVX1Y0I&2"S!
M.#G<]?#?PT_X)W7WC_0-/O\ 6-372[RZMFG?3]@5K?\ N[GW#YNAV@=Z^B/A
M)\5+A?#,ZW5Q;V-QJT:D>4OF-<8!SL;C:.?F[]*A^._Q*L?AQH.EZU+,&MK1
MD@EA2?,LW.2(P0.#DY!]*YZ.5X>"]I5;?X'H5LZQ52:HT8\KZ/>_Z'R'\6/V
M(/$'P\LIKC[5%JD(8^7LB,;%>S$$GL#Q5']C']DBZ_:T_:)\+^ H[Z/1(=?E
ME\Z]*>8UO%##),[*F1N8K&0!D<D9.*^VO"_B#3?B#X%L-72X9;6Z!N5(PQ@!
MZ!Q[9P:^I/\ @F3\"?!<<5YXQLOAO:Z1J5C/-#IWB:6-UEU59"XF:-68@*"2
MF]0 5X'0UY^88&--*=%Z'J93F-2LW3JKWEUM^!Z-^P7_ ,$[O!O[!'@V\M=#
MDEUCQ!JQ']IZW<Q".:[568I&J@D1HH(&T'YB,G)QCZ HHKS8Q2T1Z[=PHHHJ
MA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^=W_!
MTG_RA_\ &'_8;TC_ -+$K^?+]GG]DZ3XZ_L)?'[QYI]LT^K?".^\-ZBY1-S_
M -GW3ZA;W( ZX#FVD)YPL+$\9(_H-_X.D_\ E#_XP_[#>D?^EB5\$?\ !I?\
M(M'_ &@/ /[67@7Q!#]HT3QAX?TC1KY,<F&==4B8CT8!L@C!! (((S04MCWC
M_@T"_;%_X3C]GGQU\$]3NBU_X%OQKVC(X'-A=G$R+CM'<J7.1UNQR>@_2S_@
MH+^U59_L2_L8?$7XH7;0^9X5T>6>QCE<*MQ>OB*UBY_OSO$O0]>AK^:?_@E#
M\8]6_P""5?\ P68T32O%3_8H=-\077@'Q0/+(0PS3&V:3YL$(DRPS9ZE8QP<
MX/Z ?\'A/[9O]F>%/AW\!])OBLVIRMXL\0Q138(ACW0V<3J.2K.;B3#8 ,,9
MP>" .I^7_P"Q]^RU>?M*_ G]IKXP^)(Y=4M?AOX5^W?;+G<[3ZS?WL:1N3T9
MA%]K<DDD-L..<C[P_P"#-?\ Y.;^,O\ V*]I_P"E=>J?!_\ 9"7]E;_@T_\
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MQ)_P5ON].U&UM;_3[_XO/;75K<Q++#<Q/K)5T=&!5E9205((()!K^FG]HO\
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M)(Y(V#)(I&0P(X((.<B@)$M%%%!(4444 %%%% !1110 4444 %%%% !1110
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M/B\?E+E6J56K7:2;OKYJR=W]W<^CSX;AT*;4M(T-HI(I+QFAN[9,^8G]Y?\
M:Z$>E>J? CXU:]^S!##J'A#6I#/,D9U"QN;8BVO=N=QF)/S/QPZ@,-S<C.#\
M1^!=.^+:I:ZOHMQ=:/I,DV+&U/ELRYQU9P?F^IQQ7N6@Z+XUTW3&N=8U0W5Q
M^\>6UVQ;W8G)Y08W$YZ<<UZ,)0KPY*E-VMU5OR/'Q%"IAIJ=.LN9/H];^?\
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MHHH **** /SN_P"#I/\ Y0_^,/\ L-Z1_P"EB5\8_P#!E]_R,_[1'_7KX?\
M_0]2K]._^"QO["WB3_@HQ^PAXD^%_A/5M$T77]2O+*]M;C5VE6S)@G60H[1(
M[KD C(1L'M7@/_!OU_P1I^(7_!*(_%"\^(7B3P9K5YXZ_LV&T@\.S7-Q';QV
MOVDEY))X83N8W& H0@!,[N< *Z'YC_\ !U_^R/\ \*,_X*$6/Q"T^V6'1OBY
MI*7LC(& _M&T"V]P.?EYC^S/P>6D8D#JWR_\-+KQU_P6;_X*5_#W1_%U]/J.
MN>-KO2]#O[B(D&"PL[:-+B9!R%(MX)IB ,%RYXR:_HN_X+??\$M[K_@JE^RE
M8>%=!U31]#\:>&=735]%OM3,BVI/EO%+!*T:.ZI(KJ=RHQ#1)P1D'YK_ ."$
MW_!OIXR_X)J_M%Z]\2_B?XB\%Z]J_P#9#Z3H5MX>N+FXCMO.=#-/(T]O"0^U
M BA01B1\GI0%]#Z:_P""Z>C6OAS_ ((T_&G3[&".UL;#PY!;V\,8PL4:7-NJ
MJ/8  ?A7Y<_\&:__ "<W\9?^Q7M/_2NOV9_X*5_LOZS^VC^PK\2OA?X=OM+T
MS7/&&E_9+&YU%G6TCE66.1?,,:NZJ=F"55B,YP>E?%__  0%_P""(_Q0_P""
M5OQ6^('B+XA>(_ 6L0^*M)M].LX?#MW=W#(R3&1FD,]O#M'0 +NSD],<@=#Q
M#_@\XT6XG^&/P#U)4S:VNJ:S;2/_ '7DBLV0?B(G_*O<_P#@TN^(>E>*/^"7
M]UH=I=))JGACQ;?PW]OGYX?.2*:-L?W65B >A*,.QKZG_P""L/\ P3<T/_@J
M'^R9??#[4;]=#UNSNDU;P_JYA\W^SKZ-65=Z\%HG1W1P#G#!ADJ*_#'X:_\
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M  5:UKX9ZE\/?$G@K1;CP7!?VMY!XBGNK=)EN&@97C>""8D@PD%64?>SGC%
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M9@#QD]:"D?T?45_-W_Q![?M,?]#Q\"__  <ZK_\ *ZOU5_X('?\ !+WX@?\
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MYUA@@7U9V(51[DU^ G[4/_!IA\?/BA^TCX\\3>&?'GPADT'Q)K][JMB=3O\
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M[22[?@>)D]+FQ-.@U\+O?=WZIM:<NFF^I^AU%%%?)'Z$%%%% !1110 4444
M%%%% '(_'BRDU#X(>,;>.:&W>;1+Q!+-"TT<>8'&61068#N%!)[ ]*_'+4=4
ML?'O@[;=64UO8V-K<74<^GS17,\UTENWV>"2(MCR3(5W,!D#US7[=D9%?B;X
M_P#A=;_ 7XG:YIL,-QX?:ZU*Z2*QU17MHY(!*Q3RD;!^[M(P2"O3->WDK3<Z
M3Z_H?-\1>[&G72NXMZ--K7O9^1G?#W4+#Q;X.5K6ZA^W-:*T@B4PK"P !&"
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M(=DOR"BBBLSH"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HIKN$'-5[_ %F#3H]TC,WL@W'\J LV6J*PX?B)H\MZMN;R
M.&5CMQ*#&-W]W)XW>U58?BQH<U]=0B[*BU@^T-*R$1.N[80K=&8-@8'/(I%<
MC.FHK@]/_:%T&^U6ULF6^AN+J?R5W0_(IYP2PXQ@9.,XSST-;FN_%+P[X96-
MKS5[&%97>)3YH8;T^\I(Z$9Q@]^*+W#V<EH=!17)^'OC#H^O#4G::.WATX&8
M2LX99X-Q03+C^$LK#'7@>HJCI?[07A_4)Y4G:[TW:C/&;J+:+C;]\)@G++Z=
M3VR*8<C.QU6YM;/3+J:^DMXK*.)FN'G8+$L8'S%BW 7&<YXQ7\X'_!5GP_X-
M\'_M4ZGXB^#GAJ3P/X#DGDT<W=A*WEZY=J[O/<0H78"!F ";,(RJ"  0!^W'
M_!07XL_#W7/V-?B)IGB34F^PZIISZ?:Q(I$UY=N"UMY _P"6F)45LC@!"3P#
M7Y3CX4MXV^$>@Z%\0K6XO+/2F$J7(D++&S*=@QVZOSGFN[!8&5=2E&Z:V_X<
M\?-<R6$<(R2:D]5UM;HO4^>?V1=6\>?M-:]HOPC@.CZM9W4[7%G;ZA=BTDN6
M!+>7YS'9M7[Y4X+!2H)) /\ 1=^RS\#T_9N_9_\ #'@E+K[8VAVQ2695VHTL
MDC2R;!V0.[!0>0H&<G)K\R_V,/A/X'3X^>!=!72K6:?5KN'9#"BQSWT=N#,6
MD;KL18]YZ@A-O&[-?J_JOC"QT;?]HE:-8_\ 6/M.V,9QDGL!Z]L56/IU*/+1
MG+F:U]/(,HJ4JZE6HT^57:]>K?;7]#5HKGT^*/A]]%DU#^U+5;.,%F<MT'/.
M.N.#^%<Y?_M/^#]/L(9FU!F,\)N!$(SO$:E@Q(]1L)V]3Q@<BO.N>QR2['H=
M%>=^'/VH_!?B>ZCCM]4\M)I!''+/&T<9.,\L?N^GS8YJ36OVF/!VES26L.MV
M-YJ:DI%:++L:63@!<G@9)X/H"><&FM=@]G+L>@45YK<_M/Z#IT%O)<VNI*LV
M4+1QB14D7AUR#R W&[H3TXYJ/6/VH]%M]'2XT^SU#5+G+&2V2,HT809?YB-K
M%?0$@]0<<TU&3Z#]G(].HKR?4_VM=%@T?^T+&QNK^TVK('5U0F/'SG')RK94
MCIE3SCFK>H?M6>%[.[MS%<?:+"9T1[I#@1;NI*D9*J.I[>AHY7V#V<CTVBO/
M;C]HG27>5;.TOKX@LT#1!=EQ&H^:16)^Z"._."#T-+:_M":?=L473]0AFA^:
MX2?9&(P.NULX9L]%')I\LNP>SD>@U\1?\%L_V5+WX[_!OP_XCTE;:XU+PI?%
M6CO-0AL8(()5):<228_>*Z1C:"<JS<$@5]2^'OCGI>K:Q':W7E:;]K+BU>:X
M3]Z5QN4CC:V"" ,YYYXKRW]LCQ_X1^*W[)_B*3][?Q*GG6&%:*3[5$=R[ ?F
MW*H+8Q@CC/(JJ,W&HFM##%4W[*5U?0_G'^+OQA\7^+/B%?76H:RRRZ7&=,MI
M;!F6*2*-MJD9YP0"<D#)/0=*_5[_ (-WO"?P8M?#VDSZEX3MM.^.UJMW-9ZY
M?-(TFM64YD;?;%G,8D2+=&ZHJL%0GD%J\)^)'P0\ _%&RANI[,36]]<-?0F"
M 1&\D;)$A"]VR21DBNW_ &;$7X7_ +6?PIUSQQ,NC^ ?",[><K;F2&86\WV=
MSMZ*+EX6P.!U/&:]C$9544959RYK;6U/G<+GM!RITJ45!-V=]++R[NY^T=%<
MCHGQJT#5M)ENI+R.S\E2[1RL"S)V9",APP((VD]1WK%U?]I+3-)U:&,Z?J4E
ME,3"+K9M'GXRL6UL'+< $X&3Z<UX>M['U/LV>D45YEI_[3VCOX@L[2_M;C3;
M:_C9H;F1@Z;E4,5;:"%X.!R>01@<9FC_ &E=%1[V.XCFM[BWA66"+<&-V3GY
M%/0..,@],]\&GRL/9R/1Z*\[N/VA[$3+Y.DZM/;K)Y<T@15,3#[PVYR2,CIU
MR<9Q4UY\>K.#3#>1V-RT$@/V=I76'S2O# @\K@\=#GFE9]@]G([ZBN7T+XK:
M7J^F232R+:SPR>5);,P>0'( ( Y8'(.1V],&M>P\26]] TFV:/:P7;(FUCGI
MQ^M*XN5FC138Y5D'%.IDA117\H__  5DMH9?^"FWQV:2.-F_X3&^Y91G[]1.
M?*5&-S^KBBOXQ?L=O_SQA_[Y%'V.W_YXP_\ ?(K/VWD5[,_LZHK^,7[';_\
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MOT1J7(E"VI[S113))UC*Y_B.T5H9CZ*R[_Q9:Z9N\X3A5;!81$J.<9^GO[5
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M'BAO!\/@R/PKJUS-J&M::\<C7]]^\O'BS@;.X48;@'C->O+"X>I[Z5NUI?\
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MRO\ >SQC;GK7EGN<K.LHKSF^_:1TNRU%0;'4/[-9_)^VLFQ?-,9D1-IY^;&
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M#7[.VU"U7-XPM6M63=#N2!]MS@\>82%8'J,5X'^U?=_#[P+I?BFU_L?PFOQ
MO)[2ZDO8=&C\_3HX?+RRSA.#*%4$!B6WL2,&O6(?$FM_VBUG8QR3ZU=WL4^D
MJ"J^9:&WDW %L+E2PY/S'(ZUX)^V5\!?#OC;PGJ7B.ZL[K3?$4=G;SVMQ'J,
MC?:9HKA(;B.2%7*\1[CG:,A!US12M&HD^YQYC3G/"S4++1WNOLVUM_>[>5^I
M\V?"[X96^A6UUXV\;:E(]AXBU0-K"6S,KR01M\D>U<L8R%17(_A+U^CWAM['
M0?A=I<VGZQ;W&E7<2Z=:PV%MY-E%!<+N>.+& $CR N !EFX!S7YP_'C5FO?@
M[(MG="SCT^>UM+VV2/#+%+(L9<-CU;G'K7U+^QI\8%\8?!?1=.ND^W:?X)O7
MTB3[/* M]M2-V;V(W+RO=3W-=F,P[E45.EVN>+P[C&X356UV]--DDDE]S5CZ
M4\):;I%_X_F74&AN&M[YK-+0P [HC$ TCMCG8JHPS_$S'K5H>!M0\5PVILKV
MY@NO$MO$[I=3$L JC=.R]O-*L>A_U:DGD9YOP)XOM]'?Q9XNU1D6%(9H$9EP
ML;%$"(N!EGVGDX.2>IQ76_"_XI6D.AV^L:@ZMJ5R'34BD1DEC1"JV]NH483Y
M2V,  \\G%>;*,HWDUMN?4/72)BV,<^D:;>:G>-8M8Z=%YMU801LB6TUP"D3D
M]&&^(%@,CO5V\\-6=E\-M,N;WS!)K4IO MOAP;=2L9=!@X8A]P'4CWI'\:^&
M_&%CK6F:KK$-K#X@LH5=XH&V6<L,AVQ@[?FX=B2>.*FT/XIZ;X;U&RM;6UFU
M+3='M#8VMRP4%B,#>$/\) Z?3BJC0J2?N(3J1[G1:#X.M/%MG=17#-:WVFWD
M<,KSH)$\B4_NP%Y7&U4XZ8^E;GAFW6&^A6WCAF'S"-L8D;(,+KGK\K\@>G->
M>Z3XKFENKB0&\4WBVUH;8D-'<A'"HY8'<K 8( QR,<UW7@B]6WU6:&/<\RRX
ML)V&&;"'?D=.#G\JQJ49+XMQJ2Z,]B\+AU@5&D$GE JSYW;V!_IT_"N@B79&
M!7,>$!)% JLVY8U R /F8]3^)-=/%_JQ7G25I!(=1112,PHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *PM<A\ZUVR':&;&<UNUG:A9B[C\LYZDY'44=2
MH[GF'C'PN_B75XXUN)K188RGF(^&<-P<^P7GFO)]<GL]*T.\\MFN]-\.SK/)
M$2WD7"LWREH\;3M!#9 SD9ZU['X^BF@T?4&MU/VB21+>, XW;B%)S^/Y9KS&
M+PQ_PAFNM#>7+7%O<(L31^42DWOA0>^1STZ\"NZC&Y5['E&G^-KCQQXNTO[0
MK-<7>HPWZW$1^7R,E7*@G"XR%Y&2%QV(KH]2-G=WNH>(+?6-1N)&CCL;]GD:
M4S7%Q&(HX]I'\#%B&' X["ENOAYI]OJ5Q>1VTUGA9;>"$2']S$6.W@''4LW7
M@MVQQR?C/7K>R\-+I=E]HCU@VB1[%A8"XN(97<E2!M!",AR2.HYKJEAY12D$
M:B;]#:T?P9-\!5\1) PU*T:>P%C=2)@?99EF,G X&YE.1_L9(K8L8](N_A39
M75O''<W45E-%>3R?/)*;>6,R,IE&=SQ,@)QR$QT%<?\ %OXMWT'PJT_[/%=0
M6UM'#%= QAIDA^\CX&2=I,WU!JA=7UY)H$NFV4D"S-LDL_,.Q6&6,L9?I\R;
M0"3GCBJIX><H.<>G04II249=3L;N&ZT+7WT'6+.UDN=%>%8DC42V4D%R_-R(
MVR!C<  .AZ"MK14OO$\UOH8NYM+F\+Z@#(+>389+<*XFE+@_>+!5SG(#8[&N
M0\4?$-[CP;I?BI2TQ&C'1KDLN)#,LT<T6X=AL5AZUT6E_$#1M4\%ZUXBANA-
MJ%Q>S27[+&Y^S6T:.(XM@P.9/+)(&222<\UCJM&/?8V;^Y6]^'=S)8Z*;'1Y
M-7/F^5/G[8I=5CB )W-C.6'3.[OFN7N?&%YX7\4ZA%OL7^WP(+RT@<1RQL)5
M,0"KP$3Y4#,<X&WH,5RG@SQ;JD7BNZM);P7CZ78VTGA]$4L%,J![J4Q\!G16
MD.V3TRHZ4_7]*L]&\):AX@CUJS36O$4]JTL7D R74*2I\S,W*A0H?: I)R!G
MN)WV*Y;;GGG_  4*TG1[;X9KXPUR&&X\6WU_86VC3VD0673S)+\\<DH7<4V
M_*2%+/TS7S%X<\(^%;WXQZ[>W$ZZ?:-HX_M4RQR-!/O9P'=%!W-P5R1G %>E
M?\%2/B+=?#[P_/H]K(T>F7%G/,NJ)#YL=_=H/,@M!N!\ME*A\X#'?MSP17CH
MUS[%\*;=8](DNI-<TF.YU.XGE;S(E"DE&7.22<\ 8YKU,ME%7<M4M3XSB).5
M=*-UIRZ:;V>[WLKV\SL/@E?Z3IR6.H>&FL8K3P[,EYIDL=MAFG&<3%67.1M
M7(XRV*^__!MA8WOC31]/O-,ALX)O+L[J"./_ $>Z812,DI_VR2I#=3MYZ5^7
MW[(_Q8T7QAX.;3K"U33=0L8FN+J5FRLK,#G=GCG;^OTK[D^!7C35[GPO::78
MZ]#XC\0F]MKC26CC:+Y%BD+1 S*K'RB5P7Y;?P6 XSQDHSHPJQMUV-\@]K2Q
M57#3OT>N_P#3NV>N:SX+O;$W7EZA]A^V:M']HDED;RA!:QLDORIU5OW:' R=
MS"J-EI%Q+-XA\3:MH\<VE:MYTFFG>%))!)5.=PCW+&-IXPQ%6CXHDM[U?[6>
M&SC@\.7"1JUPC>;?)(&EB8 DC?(-Q/?;CO7)ZC\5]:\5_"Y=.@L8X=:T?3!%
M9QSLL=M=A)%E=P2<+F-3P>>,=:X8TY2]Y+1;GU7,=;=2WFG_  [AGU#4OLXM
M1]EA$4?EQL;AB\R$CCY"=H[9) J6"RTN;Q+=0W,D,<FGS);0Q^4"9(WB ,CL
M.HB"%QSU8]P*XFS\>+XLT;2H=7M[C4M)1VO'A\P0/.TA+;3M( "':1T)VCC!
M-=+X<UZ&1O%?B:^7=;Q6=U#$&3 0&!5BB&!EI/G;) .2PYK26'J12DT["C4B
MVTFC?@T&\\0Z#I\D$VH?;=:M4$OFSC=<* 5\_D_\M-C@ C $:DGFJ^B:5<:5
MIEUJ]ZMBMKI<1NM0TZ")E"-(#''(6Z-\R*6 R#CVK2^%?Q1-UI4=Y>6@-QLD
MAG(BW210IM6WM4VCY<C)R.['G.::/B-H'B-=2TO5M1ALK?7-/\BY$<+%=/>.
M3*)NQ\Y.6ZY'%9\LKVL6_,Q[/PS#:_#O2[V3S'75C/+&40'S(8]B!E7'RMEV
M(!Y-==IND6VHQM;O<7%O=P7MO$'N/FC-C("(05'RX**F1T.>167HWQ7T7PU=
MZ?:V-E=:I8:3#Y%I<OA/JVQN<' X/-46\8S3:E)<^7<%[H16(A)4QS()/W;D
MCE6 X 'KWH>'J)>\F3&HGU1ZCX;A3P]J30VWD7L; [7C7#@_ZIXSCD8?! Z8
M(->H>#X9+:%(I&5FA^61\[LGKC/MT_"O'O!DUQ#K,D*QLODRAX)3P9" P8$=
MS[^WTKU[P?YD<$:L<[5RQ ^\S-D_J>U<5:'*M17.FA;=&#UIU-B^X*=7,0%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 -D<*.>]<WXNTR2^5EWA89/
ME<Y^95/7;[GUKH)Y &(/85CZ]/F%O;I3A\1<=#SKQ/&MG!Y<2^6D9VJ!_".F
M/TKSOQ++N=L'H,<FO1/%FZ0/W^?M7 >(;?F08.WZ5[^%T1A,X#7M/%[.K[I%
M>,$91BN\'&5;U7@<'CBL/6='CNY!++&K31'*2?Q(1T(]Q76ZA9_.W6L>\MV+
M?=)]J]:%FK,YY.5SFM2A87-Y>.LMU/<[KN6.- K2NL2J$10.2P0#&,Y)KXR7
MXJ6_[3^D^'?$6J>']-CU[PK)<+]@@B9!9R2E"R3;B6=U,0P#MVDMQS7VAXX\
M4Z3X \*7^N^(+R#2M'TN)I[JYFD$:HH'3)[D\ =R17Q?\#OB98_&/Q1J/Q 2
MST>S7Q;);W5[IVDS>8]LT6X$R[B?W[ALL0 I*CBM8RCSQAI;L>#Q!.=/".=V
MG=;=?(ZK]GKX@>'_  U\0K5+JZ6SN;*&6[1E3=,'!5=K+@D%0[,<C&!7T9XO
MTZU^(6CZ-:K'-+HMN@NR[R!I;VX?)>0NGWD(;('O7RCXV_9[TO3?C+#KDFH3
M&SO"&NGL[A/+FMW<%L<$J0%((." .E?9&D:3;1:9;_82K6/EK]F9&W(T>!L(
M(X(VXY%3+#J4[UH[;$</XM^Q<:,M-_.[W_)&3;Z28'3 +;>-TF6+#MDU8AO;
MC3+9((Y%CCAB:$ (,LK2^:<MC/WN_P#2M9[!R/O53N[ @<J:UY(27*UH>[SS
MOS7*EIXTFTBRU*W\B.2&_M'M4"MM-NQSME'.-P))YR?T Y[4KBXN]:N-0\X_
M:+J.-'V@*@V @84#C.<D]<]ZV+C3O+=CM;/2L^\M3N/RUI3PM&+NHHB5:;TN
M0Z+XIU#P_),JRL\-Q@30.<QS 9X/'N>>O)K'N!/J-K-%<7$]Q'(ICV22%U5,
MY"#/.T=N:U)K/$FX!B3ZU$]G\OW3SZ"M5AZ//[3E5S/VU3EY;F8+!;>-5^\B
M#: 1SBG01QM%)$R2>5(Q8@'!![$$U>^PX/1OQ--2S:)LJ*Z;HP]XKZ7NTNX6
M6.6X3:2K>2V&931H=Y-HGB:VU:%5CO;.X2YC/.T,K9''!QTSZ\U8-BS-G:U!
MLF/534N,6VWU-%.222Z$GB;Q'<>*M:.H7$<*W#,"5CSY:?,6^4,3C+,3BJL,
M[@[>=H;<,@<>OI4T5GM/W6Z^E31VQSPM3&,8148K1 Y2D^9[CDU&X,%O'POD
MJZA^#N# #&#Z>M6K-61;-&_>+8Q+#'N /R@YP?7G'6DBL&/.WFM*ST]CU45$
MN4J,GT':A/>:QI]O;BZDB6W96A=6*R6V,9"$=B!C!R,9K*\8Q:+HFAW5UK4T
M=M:F*2V623<^PR YPH]_F; S@$UTUEI1('RX]ZXG]J?PO:Z[\$-6L[FZ6TN)
MI839,KJLAE$BYV[L@X3>2,?=S7(J<(R<HQ5PQ=:4:,G?9,^7';3OB-;/;QPP
MZO9W\1M;CR,F,*AV[RW9B5!7/H#7H'P'^,<_@;XE>&?A9H?AF;4O#]KIKFYU
M&U@<RZ:V797N67Y"&(QN(4D^M5/@M\+K'X-_"/4$DN&NKS6" B%UEF+"97:3
M QL4!=O(^;.>E5?@C^T]HOP5_:,A\ ZDMFS?$F]$Z7T5P#-:W.Q(8+:4=&B9
MD&S&"'D?.<@U,VX*,YV3;W_0^3R6LIXN5.DWRJ]O/_AEL?4AL%DC^;<X1MPC
M9OW8?IOQZX _ #I6KHVOWFCZ=J%K;B'[/J:(ERL@;)VDLI!!&"":>=*9!MW,
M1TY_S_DU(MAQ]UORJI1@URM'VD924N9,HV%FEO$(U7<B@CY@#G/7/U[UM:3:
M?.HQM&.,=![4VVTL'^%ORZ5JZ7I["=0%/'J*F4M C'H;GAB'R[J-APR,&4X!
MP1]:]%^'VD+9O@?,^>&?YB.N<'MG-<7H.GF-UX;\J]-\%V6'C.ULFO'Q<M#J
MIZ'HWAM-MHO0+CD 5NQ?<Z8]*R=$C\JS48.3US6M%]SV[5\W+XF=#V'4444$
MA1110 4444 %%%% !1110 4444 %%%% !1110 5#.GS=QD=?2IJK7-RH)]N]
M)E1.+\2Z/(LRO+("L19E4<Y8Y&3^?ZUP7BV0J\QW, V.IXSQVKTCQ3<>8DG^
MR/ZUYKXI1V:3Y??I7IX%621,MC@]>/+].AKB[[2X(;^6Y56\V0'<<^OWB/0G
M S]!7<:U#ND;KT]*YN_M3M8X_"O?HO0Y971RK:='8W4DUJOV=YHVBD*KG>K#
M!!!R.^1Z=JH2V$:VODM&'C50H##/08%='<6IY^7]*HOIY/5#77'E3NC*7,UJ
MS-M9U33[RQN+>:ZTW5&(NK>)Q'Y9(XE0D<,,8_&L;1_"&GZ7-&K?VG]BDN4E
MND@F"R7"*^0')!#<=>F3[5U*Z9@YVL".G%1OI&\,NTG=U)6LZF'I5+\RW+C5
MG&WD<M>^&H=8^(%YXB9;B'4+PL@*2;5BB \M5"C@?NP Q[DMZU?@T]+1XV\M
M2(I$=<H'4,K @XZ'D#BMIM)9XMNW"@8&!TI'TMA$L)&Y6P/<UI"G3A'EBM"'
M*<G>Y\:?M>>-X?BK^TU'X'\9K>6FFZ3<1>(-!L(9$CM=6GD.&NI0!E\.K(%!
M&W8P.237/?$;Q\UOXDN/#RZWH]CJ,FF,/M%TH2.U@ ;83_MA]P&>U<Q^VIX&
MM?'?[;$/B32?&$&L7$$5F]A;6TZIY20,PEMLG[P!5CO7()<CJ#7;>)/@)\-/
MB6DFO:E8ZE'X@M8?+"S7*F.>/T;: 5(+,0W(XKCHQG:<802UMONCY3.*E)8F
M-2K)R5MK7L].CZ?J<'\/_P!F70]5\(Z;JV@Q:YIWDVL2W:6]P/+N>,_/\OS=
M#T(K[%^"?@[[+X"MKO[:9M2U"&(R2QRX&F%,YCBV\AL-AMY."!Q7R1X.MF^!
M_AZ2/3=3N-8T'3[G!6Z;RYFC89R",9*\C&.]?37[+WC_ $;QVEI=>']4L=6M
M]>1FNX(=WG6$L8RK.O;=D@G'.!Z5M3HT73]DU9]5^/S-\'BJE/%QJ2O)-M*7
M6-^YZM_8J_;3,=TC;"BEFS@$Y)],GN>]3/I*W=L8IU5XVP2IYSCI^6!6LNDX
M9?O;MO/-!TK-=2<5HCZ&49:7>QE_9/DVX*J.@%)+;G/65T4@K&S80'^_C^]P
M/R%;(TXC_)IKZ;EJ&T]P5T,T+7M0\/6FH1V4XC74HA#<*P/0$L&4@C:P."#T
M'H:IZ?9+;0B-5W*O]_YB^>I)]ZT!IN!G#59M=*R<[7//I6=HIN2W96KT;T'Z
M9:?/WQ75^'K?8\?R_P"K<2H<=&!X_P#U5CZ98L9?NG\JZ_PYIJG;N5O>N>M+
M0TBG?4[3P/;YN@S*=V,!CV^GIGVKUWPNH6U0#A1V':O./!ECL*_*<X'->EZ
MABM%XQQS7S..=V=D5I=&U%_JQ3J;%_JQ3JX0"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M].,5S_CGXVW7Q;^),6I:AH\,FC>&I&F-DA"H+P<JY./E"C'7CJ36+^S_ /M
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M3\.[[3?$@U#P?%."]K8I-!>>;<22K@^8"KXE!8.%&<G)%>AB_K=+DG3?-?\
MR/E<MHY;6G4IU8\K:WN]5>]O)['??L@_L&Z#^S7\,_#<%]I/AV^\=Z3'<_:=
M=MXY)&WSS2N?):0 J!'((\A5)5<=#BO:+?P#;074]U%:VZW5UM$\JQCS)@O
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MBJ%M=7T/1RG'5,6G*4=%U-:ST#8WW5V_2M:TTKRV7*KT].M:B:<J*6Q^E6!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+7V.',<5+#PYY+W-6W?9>G4=\)_CUK/QE\;WEKXOTZ6;0X;8SV$"6S^3<8&
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ME@<95E"@Y:=V]%?8]/\ %WPCM?$FBW?AG79+_2+>Z=]1M'E@P99BN]5.1T)
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M6-P@8)-&>1N 9AA@00Q!!!KS*<4I1=5/E?Y>1] [V?+N?F1\7_\ @HO\>O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\$GO@Q:?'GQ'X\U3PS9^)I?$$KW":/K-M#>:5ITDG^N:&!DV_.WS8;<%)8J
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M<?%3]G^5_#?B337-]<Z!:R_9XI2.6DLVR!$_4F(_(P)"[<!&\K_9O_X*4_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"J,%L?*/2NDHHHNWN 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ABBI **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>bdtx-20211231_g8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g8.jpg
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M=X&Q"B0E.75VD:&TT? 8,S0X4E-FL\'"X?$G0D-&8G-T@H68I-?_Q  < 0$
M @(# 0               0(#! 4&!PC_Q !2$0 "  ,#!0D.! 0"!PD!
M 0(#$00A,04205'1!A-487&!D9*A%!87(C)24U63L<'3U/!"I-+A!R-R\39#
M)#,W<X*BLT1B8W1U=I2RM*/_V@ , P$  A$#$0 _ ._C & , 8 P!@# & ,
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M>K]M_P .NK6M;WL6]:UK8A=76+JUU=>^SK6NO?W]]6M:Z_O:UKS9C,A_< 8
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M;U8!B70-PME.M,KE\,7D1E+.28R7%C3-3D!9SQM$>$P3Z$DM+L\&Q::=!%V
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M3EJ ;([L8<=<ZJ\II\E*C-IF\5>W]S;HDDI.4400460006 DDDD 2RB2BPZ
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MOK\W6)]7:_JU_1][-&9&XG?KQ]_;CB;$$-*NE$^WC.@S,1D& , 8 P!@# &
M, 8 P!@# & , B6Z6_\ @MJK_']P_1U7F>1C%R+WF.9HY_@0,9LF,G_Z)?\
M@-L/^==9^B$3S5G^6OZ5[V9)>GF^)*CF$R# & , 8 P!@# & , 8 P!@# &
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M3^3]_5_]'XOQ]?X][UO$Z7F0P<ZYJ(SVVS[S+DQ4IG11+H4+^_W.B_-<XX8
MP!@# & , 8 P!@# & , 8 P");I;_P""VJO\?W#]'5>9Y&,7(O>8YFCG^! Q
MFR8R?_HE_P" VP_YUUGZ(1/-6?Y:_I7O9DEZ>;XDJ.83(, 8 P!@# & , 8
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M6RIE=V!Y.DRYBDPVA3<^;!*:<S>7!3/IG5S(\*TI?B=$M36G&KGA+784.32
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M/EOU]CO(L/#+7T2?ECP";G?7.6OR/TH\LY=WJHJOY\M^OL=Y%AX9:^B3\L>
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MT_0.EEOD0@AW :BZMBUK?4V3+\.]:]-,;PO.?0AGOB[=IT!YK&48 P!@# &
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M3)_S)?ZN!1:ET(=Z)?R9/^9+_5P*+4NA#O1+^3)_S)?ZN!1:ET(=Z)?R9/\
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M1N47359%Y4'XM1JK)G#5DVATU16J=)"623/,G:VUU*:H+%&=\=M*VM>2X+4
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MDKJ77\J^+Z">:%82BT.$_+"F*P8BW>:6)Q:O:L*\C):YK9R7.42VI93%(DQ
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M-\6=!F:IE& , 8 P!@# & , 8 P!@# .:JXC"RNE[:S#1@++!>%(B&88+0
M#J.0#>Q#&+>@A#K7GWO>]:UK[^>GV)5W&1I7ON"W_P#5M)]9Y"3B_@;.4*;;
MW.[H4DE5O_2\IX)7LZ0_#+/\JMOMR7Z7/,LR/S8NJ]A\H[Q/]#-]G'L'AEG^
M56WVY+]+C,C\V+JO8-XG^AF^SCV#PRS_ "JV^W)?I<9D?FQ=5[!O$_T,WV<>
MP>&6?Y5;?;DOTN,R/S8NJ]@WB?Z&;[./8/#+/\JMOMR7Z7&9'YL75>P;Q/\
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MP>&6?Y5;?;DOTN,R/S8NJ]@WB?Z&;[./8/#+/\JMOMR7Z7&9'YL75>P;Q/\
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M+]E2O_N1:W_P"1_@WU_D>-_7FOI0S'Q=NPGFS6,HP!@# & , 8 P!@# & ,
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M-""YIJKL>.TRT<\:18J_6J(ZYS1>]-C6[,;JX-6IV<W$NLV0*3$CS(7TH 0
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38=;&+?5K +AP!@# & , 8!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>bdtx-20211231_g9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g9.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0 B17AI9@  34T *@    @  0$2  ,
M   !  $       #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T      ! !+
M  $  0$L     0 !_^%5X&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H
M# ,!  (1 Q$ /P#]_**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB;1K/1/V0?ABMG:6UFMQX5TRXE$,2QB25[2)GD;'5F8DDGDDY->I5Z'#.5+
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M_P!C8?\ T=9U]N5Y.6?\C/&>M/\ ](/IN(_^2;RCTK_^G6%%%%?1'P(4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'>(O^OZP_P#2E*\?B'_D65_\+_(^NX!_Y*7 ?]?J?_I2/7/V.?\ DT3X5_\
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M+96YI-+6R5V?$?\ P5S_ .2L_L[?]C8?_1UG7VY7Q'_P5S_Y*S^SM_V-A_\
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MM<_#/P?\";SX4_!^;1?%7B7Q+9RZ'HFB>&B+JVM_M(97D+QYC55$C,1NSGJ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9O[-WR_=M^ 4445L<@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S3_P %&_\ @F[I/[>_
MAWPWJ-CXHUCX<?$_X?W3W_A#QGH__'YH\SJ Z,,J9('PNZ/<I.T889(/$_\
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MNK6ZC66&:)P\<R,,JRL."I!!!'!%6*_#G_@D5_P6/O\ ]EB_TWX<_$BZFO\
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M_L8;;_TIU.OG<S_Y&F"]:G_I!^A<,_\ )-9S_AH?^GHGW91117T1^>A1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P
M?[17[,7P_P#VM?AO<^$?B3X2T?QAX>NCN-K?P[O*?M)$XP\4@[/&RL.QKY'/
M_!%GQ=\'[::U^!O[5OQR^%^D[56ST74[B+Q1I.FA5P%AAN=K*F0#MW^HS@C'
MWI7DOQ(_;L^$'P;^/UA\+_%WQ \.>%O'&K:;#J]CIVKW/V,7MO-+/#&8I9 L
M3L9+:9=@<N,#Y?F7(!\OV7_!)W]HCQA:2V/C[]NSXLZMILWR.GA?PY9>&;G8
M>H$\;RL&_P!H8Q7O'[''_!,7X/\ [#MY=:KX/\/SZAXRU)2NH^+_ !!=-JGB
M#4LA0WF7<GS*K;5RD81#M!VU] 12K<1+)&RNC@,K*<A@>XIU !7C?[17[ /P
MC_:Q\56>M?$+PB/$VHV%M]DMGFU.\A2"/<6(6..54&2<D@9/&2<"O9**35QI
MM;'YS_\ !2?_ ()1_L__  6_8F^('C#PO\/H='\1:#IRSV-W'JU^_DN9HU)*
M-.4;Y21\RGK7XI>5]:_HV_X*ZC/_  3>^+'_ &"4_P#2B*OYT-E92BKFD9::
MD'E?6O3/V+OASH_Q8_:Y^&GAGQ!9_P!H:%X@\2V&GZA;>:\7GP2SHCIO0JZY
M4D94@C/!%>=;*]F_X)U)C]O7X-_]CCI?_I5'4V'S'[8P?\$4?V8;:%8U^%=F
M54<;M9U)F_$FXR:][^"WP1\,_L\?#RS\)^#]/ETGP_IQ<VMFUY/<K;[V+,$:
M9W95+$G:#@$G &37645MRHRYF%%%%4(**** "BBB@ HHHH **** /B/_ (*Y
M_P#)6?V=O^QL/_HZSK[<KXC_ ."N?_)6?V=O^QL/_HZSK[<KYW+/^1GC/6G_
M .D'WW$?_)-Y1Z5__3K"BBBOHCX$**** "BBB@ HHHH **** "BBB@ HHHH
M*^$_^"0?_)P?[2W_ &,-M_Z4ZG7W97PG_P $@_\ DX/]I;_L8;;_ -*=3KYW
M,_\ D:8+UJ?^D'Z%PS_R36<_X:'_ *>B?=E%%%?1'YZ%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YO^V-_R:)\5/\ L3]6
M_P#2*:O./^"2/_*/?X?_ /<1_P#3E=5Z/^V-_P FB?%3_L3]6_\ 2*:O./\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<KXC_P""N?\ R5G]G;_L;#_Z.LZ^W*^=RS_D9XSUI_\ I!]]Q'_R3>4>E?\
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M/_2E*YW_ ((F_P#)MWC;_L>K[_TELZZ+_@LA_P F'>(O^OZP_P#2E*^*I_\
M),?]PW^I^RXK_DY4/^PBG^<3US]CG_DT3X5_]B?I/_I%#7I%>;_L<_\ )HGP
MK_[$_2?_ $BAKTBOJ\%_N]/_  K\C\NSO_D8XC_'/_TIA11174>6%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %?GS_P %/-7\1?L'?MR_#W]KK3?".L>,O ND^$;S
MX?\ Q#@T<>9J&FZ9)=+>6MXD1(#1I<;BYR  %!(#97]!J^5?^"D__!5OP?\
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M2:SG_#0_]/1/NRBBBOHC\]"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \W_ &QO^31/BI_V)^K?^D4U><?\$D?^4>_P_P#^
MXC_Z<KJO1_VQO^31/BI_V)^K?^D4U><?\$D?^4>_P_\ ^XC_ .G*ZKPY?\CF
M/_7J7_I<3[RC_P D75_["J?_ *:JGT?1117N'P84444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"E*5Y)Y=>P?\$^DQ^W-\(_^QMTW_TI2KY3*,]4?T94445B=P4444 %%%%
M!1110 4444 %%%% 'Q'_ ,%<_P#DK/[.W_8V'_T=9U]N5\1_\%<_^2L_L[?]
MC8?_ $=9U]N5\[EG_(SQGK3_ /2#[[B/_DF\H]*__IUA1117T1\"%%%% !11
M10 4444 %%%% !1110 4444 %?"?_!(/_DX/]I;_ +&&V_\ 2G4Z^[*^$_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *\V^,/[9/PA_9X\30:+X_^*OPW\#:
MQ=6JWL-AX@\366F74MNS.BS+'/(K&,O'(H8#!*,,Y! ])KX3_P""GG_#"/\
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MKR($$;H[B"-)48=0RL#FOF'_ ((S?L>? ?XY?LR^+-.\1?!7X.^,+CX8^/\
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M"D7PKN/^"@W_  5"^'/[,OB[Q#X@\._!V+P#=?$'6+'3+PV9\9W<=^+5+!Y
M,E85 F*@_=<G 8(Z_HO7QS_P49_9U^%7[:OQM\$?#U_B)JWPU_:*\-64OBGP
M1KFA)(-6TRU+-%-)D ));.8F5XVD4D@<C=\P!Y#_ ,$<OV:?!7['W_!3_P#;
M@^'/P[T<^'_!_AT> AI]@;R>[\CSM)N[B7]Y.[R-NEED;YF.-V!@  >I_P#!
M$+Q9>>)O@E\9+=KJZU#P_H?QH\6:;X:O9[K[1]LTQ+M6A=">50,\B!3TV9&
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M^D'Z%PS_ ,DUG/\ AH?^GHGW91117T1^>A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >;_MC?\ )HGQ4_[$_5O_ $BFKSC_
M ()(_P#*/?X?_P#<1_\ 3E=5Z/\ MC?\FB?%3_L3]6_](IJ\X_X)(_\ */?X
M?_\ <1_].5U7AR_Y',?^O4O_ $N)]Y1_Y(NK_P!A5/\ ]-53Z/HHHKW#X,**
M** "BBB@ HHHH **** "BBB@#XY_X(F_\FW>-O\ L>K[_P!);.NB_P""R'_)
MAWB+_K^L/_2E*YW_ ((F_P#)MWC;_L>K[_TELZZ+_@LA_P F'>(O^OZP_P#2
ME*^*I_\ ),?]PW^I^RXK_DY4/^PBG^<3US]CG_DT3X5_]B?I/_I%#7I%>;_L
M<_\ )HGPK_[$_2?_ $BAKTBOJ\%_N]/_  K\C\NSO_D8XC_'/_TIA11174>6
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 8^O?$'0?"OB#1])U36](TW5/$4LD.E6=
MU>1PW&IR1KO=((V(:5E7YB$!(')XKX%_X+"?LS?M%?%[]I/X;>-OV?? ?AW_
M (2SX<V?VG2?',_B2&RNK66>66.\TV:RE4QW-K);B,Y;!#3-M(PP;T;_ (*U
M?L^?%GQ-X@^#/QH^"&BZ=XL^(?P)UV]OT\-W]Y]FBUS3[ZT-M>1(S,J>?L"[
M"Q! 9RI)^1_@D?\ !4_]I:U_X*\_\)9-^R'X\D\6Q_![^Q)/AW%XG?<UJ-:\
MTZXKBS*[#+FV"^6?7S#]V@9]&6/QK_X*LV=G%%)\(?V9KJ2-0K32WEP'D/\
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M_P!WI_X5^1^79W_R,<1_CG_Z4PHHHKJ/+"BBB@ HHHH **** "BBB@ HHHH
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M HHHH \W_;&_Y-$^*G_8GZM_Z135YQ_P21_Y1[_#_P#[B/\ Z<KJO1_VQO\
MDT3XJ?\ 8GZM_P"D4U><?\$D?^4>_P /_P#N(_\ IRNJ\.7_ ".8_P#7J7_I
M<3[RC_R1=7_L*I_^FJI]'T445[A\&%%%% !1110 4444 %%%% !1110!\<_\
M$3?^3;O&W_8]7W_I+9UT7_!9#_DP[Q%_U_6'_I2E<[_P1-_Y-N\;?]CU??\
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M8Q'8Z1XB:\CD+/.V4C>6U8Q+NV\M]XY( !Q=U_P<&_$;X;6Z^)/B9^Q7\</
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M?"?_  2#_P"3@_VEO^QAMO\ TIU.OG<S_P"1I@O6I_Z0?H7#/_)-9S_AH?\
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M_P"3E0_["*?YQ/7/V.?^31/A7_V)^D_^D4->D5YO^QS_ ,FB?"O_ +$_2?\
MTBAKTBOJ\%_N]/\ PK\C\NSO_D8XC_'/_P!*84445U'EA1110 4444 %%%%
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M?_!7/_DK/[.W_8V'_P!'6=?;E?$?_!7/_DK/[.W_ &-A_P#1UG7VY7SN6?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXTZA?ZU+JL>M^++N6YO;6)X((A:HTDLA$2M"S@!@-TS\<DD&>Y4444"/&_\
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M,'@#]FWP?)>HT:ZQ:W,LDMB2#AU62\G4D=LQ.,XR,9KZD_X)._L#WW_!._\
M91_X1#7O$$7BOQGXBUJ[\4>*=7A5EAOM3NM@D9-P#%0D4:[F +;"VU=VT SZ
M9HHHH$0:AIMOK%E);7=O#=6TR[9(IHPZ./0@\&L3_A4/A/\ Z%?P[_X+8?\
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ML<_\FB?"O_L3])_](H:](KS?]CG_ )-$^%?_ &)^D_\ I%#7I%?5X+_=Z?\
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M ,)9X<TW4Y-&N;O^SKNQ\N[2**9H]ES%&YQ'/$=P4J=^ <@@7O\ AC7X/_\
M1*?AM_X3-E_\;KK? 7PS\-_"K1Y-/\+^']#\-Z?-,;B2VTNQBLX9)2JJ7*1J
MH+%549QG"@=A0(W**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ^(_\ @KG_ ,E9_9V_[&P_^CK.OMROB/\ X*Y_\E9_9V_[&P_^CK.OMROG
M<L_Y&>,]:?\ Z0??<1_\DWE'I7_].L****^B/@0HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?$?\ P5S_
M .2L_L[?]C8?_1UG7VY7Q'_P5S_Y*S^SM_V-A_\ 1UG7VY7SN6?\C/&>M/\
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M4 %%%% !1110 4444 %%%% 'F_[8W_)HGQ4_[$_5O_2*:O./^"2/_*/?X?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XC_X*Y_\E9_9
MV_[&P_\ HZSK[<KXC_X*Y_\ )6?V=O\ L;#_ .CK.OMROG<L_P"1GC/6G_Z0
M??<1_P#)-Y1Z5_\ TZPHHHKZ(^!"BBB@ HHHH **** "BBB@ HHHH **** "
MOA/_ ()!_P#)P?[2W_8PVW_I3J=?=E?"?_!(/_DX/]I;_L8;;_TIU.OG<S_Y
M&F"]:G_I!^A<,_\ )-9S_AH?^GHGW91117T1^>A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 >;_ +8W_)HGQ4_[$_5O_2*:
MO./^"2/_ "CW^'__ '$?_3E=5Z/^V-_R:)\5/^Q/U;_TBFKSC_@DC_RCW^'_
M /W$?_3E=5X<O^1S'_KU+_TN)]Y1_P"2+J_]A5/_ --53Z/HHHKW#X,****
M"BBB@ HHHH **** "BBB@#XY_P"")O\ R;=XV_['J^_]);.NB_X+(?\ )AWB
M+_K^L/\ TI2N=_X(F_\ )MWC;_L>K[_TELZZ+_@LA_R8=XB_Z_K#_P!*4KXJ
MG_R3'_<-_J?LN*_Y.5#_ +"*?YQ/7/V.?^31/A7_ -B?I/\ Z10UZ17F_P"Q
MS_R:)\*_^Q/TG_TBAKTBOJ\%_N]/_"OR/R[._P#D8XC_ !S_ /2F%%%%=1Y8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'Q'_P5S_Y*S^SM_P!C8?\ T=9U]N5\1_\
M!7/_ )*S^SM_V-A_]'6=?;E?.Y9_R,\9ZT__ $@^^XC_ .2;RCTK_P#IUA11
M17T1\"%%%% !1110 4444 %%%% !1110 4444 %?"?\ P2#_ .3@_P!I;_L8
M;;_TIU.ONROA/_@D'_R<'^TM_P!C#;?^E.IU\[F?_(TP7K4_](/T+AG_ ))K
M.?\ #0_]/1/NRBBBOHC\]"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH \W_;&_Y-$^*G_8GZM_Z135YQ_P $D?\ E'O\/_\
MN(_^G*ZKT?\ ;&_Y-$^*G_8GZM_Z135YQ_P21_Y1[_#_ /[B/_IRNJ\.7_(Y
MC_UZE_Z7$^\H_P#)%U?^PJG_ .FJI]'T445[A\&%%%% !1110 4444 %%%%
M!1110!\<_P#!$W_DV[QM_P!CU??^DMG71?\ !9#_ ),.\1?]?UA_Z4I7._\
M!$W_ )-N\;?]CU??^DMG71?\%D/^3#O$7_7]8?\ I2E?%4_^28_[AO\ 4_9<
M5_R<J'_813_.)ZY^QS_R:)\*_P#L3])_](H:](KS?]CG_DT3X5_]B?I/_I%#
M7I%?5X+_ '>G_A7Y'Y=G?_(QQ'^.?_I3"BBBNH\L**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/V.?^31/A7_V)^D_^D4->D5YO^QS_P FB?"O_L3])_\ 2*&O2*^KP7^[T_\
M"OR/R[._^1CB/\<__2F%%%%=1Y84444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Q'_P %
M<_\ DK/[.W_8V'_T=9U]N5\1_P#!7/\ Y*S^SM_V-A_]'6=?;E?.Y9_R,\9Z
MT_\ T@^^XC_Y)O*/2O\ ^G6%%%%?1'P(4444 %%%% !1110 4444 %%%% !1
M110 5\)_\$@_^3@_VEO^QAMO_2G4Z^[*^$_^"0?_ "<'^TM_V,-M_P"E.IU\
M[F?_ "-,%ZU/_2#]"X9_Y)K.?\-#_P!/1/NRBBBOHC\]"BBB@ HHHH ****
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MG_Z4PHHHKJ/+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!G2?_ N/_&OYV:*/^(B5?^?"_P# G_D'_$N-'_H/?_@M?_)G]$W_  GFA_\
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MO_.?T$22+$C.S*JJ"22< "LO_A/-#_Z#.D_^!<?^-9OQO_Y(MXO_ .P)>_\
MHAZ_GKKZ+B3B665U(0C34N9-[VV^1^<^&WAG#BJE7JSQ#I>R<5I'FOS)O^96
MM8_HF_X3S0_^@SI/_@7'_C1_PGFA_P#09TG_ ,"X_P#&OYV:*^;_ .(B5?\
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MM:7YMFU:]NI^X?[('C31[3]DOX712:MID4D?A'24='ND5E(LX@01G@BO1?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF;?QX_X*?_IN!^@<&_[E6_Z_XG_U(J!1117F'U@4444 %%%% !1110 4444
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M1_\ !0OQY:Z_^T WAC29C+X>^&EA;^$=-Q@*XM%V2R8'&6F\PYYR-O)KZ9^
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MX?P&%%%1WDQM[2611S&A8?@* )**\]_X7!??\^MK_P"/?XT?\+@OO^?6U_\
M'O\ &L_;1-/9R/0J*\]_X7!??\^MK_X]_C1_PN"^_P"?6U_\>_QH]M$/9R/0
MJ*\]_P"%P7W_ #ZVO_CW^-:W@SQ]<>)=8-O+##&OEE\IG/&/?WH56+=A>S:5
MSK****T("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVTNC\,Z*_<CQS^R'^S[\,O"UYK7B#P'X#TG2;!-\]S<6$:H@[#IDL>@ R22
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MUC7'?2:X>P<>?%49Q7FXW?HKW?R/S1K[F_X(+_\ )R/C#_L6F_\ 2J"LZ/\
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M"01YS_>Z<%$92#D-7CR_\%P-3_M7=_PKNP^P_P#/+^V&\WK_ ,]/)QT_V/\
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MYCC\2> ;B&'/[RXTW41*P'M%(BC_ ,B5]7? #]JGP/\ M,Z5-<>$]82[N+4
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MU0R33SR".*%!R69F("@>IKR91E&7+):]CZ*%2$X\\6FGK=;6]2S17R/\7?\
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M97Q/\*^#H[/2[K0[G4+_ $VRBC\J%_)G4""/;@1\,=N!@$*. <C[6_X)#_\
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M:WLELC7%N?,A7Y),;E^4D<'H2*VO^"TW_)K6@_\ 8U6__I)>4SXE?\H;K?\
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M[+O@71=-_P""3.O:U;Z3IL.L:EX6\0&[ODMD%S<;6O47=)C<0$4* 3P!5/\
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M (%^2.K+8I9?ES2WJO\ ]*D</^W#^S[9>+O^"@\/@KPS:Z7X?_X2"WM1$L4
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MFJSG-272*C%VC;IW_P""-\"V\<__  6HUJ%T1HW^THR%<JR_V8!C'I[5QO\
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M^655KG\M+V\KL\7$U/K-*OAJU9SA03]FOYO>M=OKRK3\M+GJ'[67@?1?!O\
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MQ%4$F-P4%F. <<FN._X(I:#8^)=.^*EGJ5G::A:2_P!D[X+F%98V_P"/WJK
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M<6R,5@NP5R\#C^&>,,61^A!!Y&]1]1_\%7_^3'?#_P#V%;#_ -)YJ\@_:O\
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M_CCNC:DBXMHW3/G8Z-%U5U/&T\@J6Q]Y_P#!/[_E&E/_ ->FL?\ H4U>"?\
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M_P E\^(W_7D/_2@U)\(M?LO"O_!7'Q]J6I74-CI]@FI3W%Q,VV.&-85+,3V
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MK:6/B:P-G;:C<H4-B)'!29<\>6Y386'0'.0 P/M7[(1W?\%:?B81R"VK=/\
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MDZ;J5QIEK:-:275LDS6K,\NXIN!VD[1R.>*_2.OSQ_X(@?\ (W?$+_KSLO\
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M;W#)B"]B&=L,N.1@_=< E<D8(QCZ/HKSJV=8JIB%B.:S6R6R_P"'ZGM87AG
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M?*^Q^5O[(_\ P33\9?'S58;WQ':ZCX1\'JZR33W41ANKX8R!!&PSR#_K&&T
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MMU>>';74O%7@R20R13VT1FN;( $XN(T'\(R/,4;2.NTG;6A^TA_P4>B_:/\
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M*7]I_P#:(\5_\%*?%WAW3_"_@'4(_P#A'1.(H;1WO9&,YB#-*X14C4&)<$X
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M?\;/^"K.J?M!_!74O \/@-+?5O$$(LYKB&_>=?O GRX?+#;CC@%SCWH_8O\
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M;WP] ,2PMG):V'1T)&?*ZJ?N@C"K^A5%>71SG%0Q#Q/-=O==&NUOR/<Q'#.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&J?%OP_\$]5TJTT+Q?JDRW&H3QWEH\DNG75PJA9[BTDBVN_+8F4-@C:/M&@
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M5?!?]G+PG9>%?%3?#W_A8?CO2/!VK^,E16;PCI]VTGG7JEP41CY:0K(V C7
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M6M3^&MG8W'BSQ-XZN[F'2+*XO81<6]G#';LDDLA@*N6#$+N ('!:O\)?$_\
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MV3X#+H-EX'T>5]/_ +*TW3_[-;1KE.9;>>U*J\,P)RP=<L6W98,&/MM?(_\
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MM' )7Q_$WE[C[F@#LZ***!!1110 4444 %%%% !1110 4444 %%%% !1110
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M--FM=9U3S[86:3:J['RR\5J"H$9*NS;R 0#0,^X****!!1110 4444 %%%%
M!1110 4444 ?(/[9'CGXW?&;]KS2_@?\&/B'HOP=-GX/'C/7?%EYX<BUZ[D2
M2^:TM[6TMIV6$\PS-*S9*AXL8+#/S?X/?]I;_@HS^T[X\^ ?BWXU#X9Z=^S_
M !6\?BGQ-\+KH6.I>-+J_P!TUBRY+26(CMXR)8U8CS=XY!7;]K_ME?\ !/KP
MC^VC<Z'JFH>(?B!X \8>&TEM],\5^!M>?1=;M+>4J9K<3JK!H7*(2CJPRH(P
M<FO$]=_X(C:+\,_"NCS? 'XH>-O@C\0M.2YCO_%\877+KQ6MQ*)9#JL<[*+Q
MQ("R,64QEFQP< &=/_P30^(7C[PI\7OC7\!?B'XTN?B3J7P9N](N=)\4WL*Q
MZAJ.EZK;2S6\5WMX>XA:WF5GQ\ZE#U-?7E>#_L&?L,6?[$_@SQ#]K\6:_P#$
M/QUXYU/^V?%GBS63BZUNZ""-,1@E88HXU")&I(4#J>WO% @HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_-/]GWX5_'#_@L/\+1\
M8=9_:-\<?!WX?>+;F\3PSX/^':1:=>:99PW4T"->7Y+2O=-Y8+J  C!@-N=J
M_I97Q+\4O^"/>JZ'\1_$GBG]G_X]?$3]GVZ\674FHZGHFG0Q:QX;EO9'WRW2
M:?.RK%)(3EMCJ.F H&" <#\5_P!B+X^?\$^/@[KWQ,^'/[5OQ&\=)X!TZYUW
M4/#7Q2EBUG3]=M;>*2:6W-TVV6V<@';(&X( )"\C[I_9]^+MK^T#\!?!'CVQ
MMIK.R\;:!8:_;V\W^L@CNK>.=4;_ &@) #[BOCJR_P"",GC;XRQV5C^T-^U%
M\3OC1X7MYQ/=>&;6Q@\,Z/K&TY2.[BMV=YHQP2AD&2H.1TK[KTC2+7P_I-K8
M6-M#9V-C$EO;V\*!(X(T4*J*HX"@   <  4#+-%%% @HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KYI_X*C?M+>._V=_@IX3T[X7Q:3_P
ML;XJ>,]-\">'KO58_,LM+GNQ-(]U*F1N$<%O,P'.6"_*WW3]+5Y?^UI^RQI'
M[7/PTL?#VJ:IK/A^YT;7-.\1Z5K&D/&E_I5[97"3130F170,0'0[E8;9&X-
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M#H^DV,/AFWMY+[1$><,^J*T,;[/LNT2Y8J/D^\#04?J!11102%%%% !1110
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MQK,=HEFNKWJ0HL]R(4^2(2R!GV+\J[L#@5T-% !1110 4444 %%%% !1110
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M^HHHH)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCK]_JGQF\5VOA'0QIT$<D<%S--#%YMPSR)LB7SE)*AV/930![E1110 4444
M%%%% !117RC_ ,%OOVE?&W[(/_!+[XG?$3X=ZU_PCOC+P[_97]GZA]C@N_L_
MG:M96\O[J='B;=%+(OS*<;LC! ( /JZBOSC_ ."OG[>7Q7_9=_X(U> ?BMX%
M\5?V'X^UK_A'_MNJ?V99W7G?:K,R3_N9HGA7<XS\J#'08'%?HY0 445\H_\
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MW_ '5O"]U='Q/X?UJ'0;C6?$*7*C^SY=2E0I;*+0F6-21YI$PPQ3BO\ L*_
MGX$>$/VG_#NI>"OVZOBE\;/$EHET;7PAJ_QJL/$=GJ0:VE1V>QA4/-Y:,TH[
M(T8<_=KSW_@K;\7OV=_@E_P50^&.M?M+76C^*O \GP^NK&R\-:CI<FJP>'K^
M2_+IJTEH(W$T<\<,MOE0[(UNF8\.'7NOV$_VPO\ @GA\6_VI?#.A? ?P]\-;
M7XI72W;:-/I'PSGTB[A"6LS7!6Z:RC$0-N)E.77<&*\E@"%=#]#JX/\ :AU+
MP#I'[.WC6X^*?]E_\*YCT>X_X2(:BNZV:R*$2JX')RIP OS$D;><5WE>!_\
M!3WP7X;^('["7Q TOQ9XRT?X>Z1);VTZ>(M58"QTN[BO()K.2<$@-&;I(%9,
M_.&*]Z"3\Z_V8?V7OV>_VF#\4(M3\2_MM6OPE^!NGV/B"]^''Q U>ZA\/WNG
M21W4]LUKI_S74UL%LIBJ-M9LKC=D@?J1\*_A9\/=?\86'Q?\,Z;"=4\3>$[#
M2++4HY95C.C*SW5M!%"6\J)-T[-\B*3E02=JX_/.X^&_[<'Q%^//QS@D^"O@
M'P?)\<O#>B^$KOQNOC:WOM&T2"RAOX9KZVM OVN9I%OV:.*2--AB&XL&R/TJ
M^!GPGT_X"_!/P?X%TEI)-+\%Z'9:#9L_WFAM8$@C)]]J"@9U5%%% @HHHH *
M*** "BBB@ HHHH **^9_V!_^"BG_  W!\8/C[X4_X0__ (1?_A1OC6Y\'_:O
M[6^V_P!M>3/<1?:-GDQ^1GR,[-TF-^-QQD_3% !117FFD_M>_#W7/VK-2^"5
MGX@6X^)FCZ#_ ,)+?Z0MI/\ Z)8>9!&)&F*>5EFN(L('+8.< <T >ET444 %
M%%% !1110 445\@?\%!?V_\ QE^RA^VU^RK\-O#NF^&;W0_CEK^HZ7KT^HV\
M\EW:16YL AM6CF1$8_:I,F1)!PN ,'(!]?T5\@?M _M_^,OA3_P6#^ O[/NG
MZ;X9F\&_%'0=5U35;VXMYVU.WEM;6^FC$$BS+$JEK:,,'B<D%L$$@CZ_H **
M*^0/^"FO_!0#QE^QA\>/V8_"_A?3?#-_I_QH^(5IX3UN35;>>6:UM9;BUB9[
M8QS1A90L[D%Q(N0ORGD$ ^OZ*** "BBB@ HHHH **** "BBL'XG^,+CX>_#3
MQ%X@M-'U#Q%=:'IESJ$.E6"AKO4WBB:1;>('@R2%0B@\984 ;U%>,_L"?M3Z
MS^V?^R]H'Q"U_P"'?B+X6:IK#SI-X>UDLUQ;>7*T8=6:.)FC<*&5FC0D'IC!
M/LU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 445Y'^W=9_%Z__ &3O&$/P&NM'L?BS
M)# - GU01FVB;[3%YQ(D5H]WV?SMF]2N_;D8S0!ZAK_B'3_"FCW&H:I?6>FZ
M?:KOGN;J98885SC+.Q  R1U/>OE.X_X+=_L_:W\?O#OPR\$^)-2^*7B[Q!JE
MKIIB\&Z;)JEIIJSW*6YN;BZ7$"P1%]\C*[%44G!RH/Y\^'?#_P *="\965U_
MP4%T7]J2X\21S0,E[\09Y-0\ 03DF,"V;22;95#GD2#9B12>&)K[7_X-U]0\
M$R_\$JOA?;^&)O"K:U'ITAU^/2W@^U+<_:9_^/H1_,),$?ZSYL&@9]ST444"
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX7_X.
M4_\ E"E\:/\ N!_^G[3J^Z*^%_\ @Y3_ .4*7QH_[@?_ *?M.H XC]F?_@M'
M_P (=^SA\/\ 1_\ ADW]M;5?[*\-Z=9_;=.^&'GV=YY=K&GFPR?:1OC;&Y6P
M,J0<5V?_  5-T7XP?$G]DSP+^T'\"]6^(_@GQO\ #^VMO&%SX&O[FYL1KNFO
M$D]QIFI::DAB:ZB7@HP9@5EC!R5(WOV5/^"L_P"S+X5_9>^&VEZE\=OA?8ZC
MIOA;3+6ZMIO$%NDEO*EI$KHP+9#*P((/0@U7_P""CW_!6?P]\$_V.-#\0?!O
M6-%^(GC[XQ7K>&OAG;Z7<)=0ZMJ#3_9I)U(.UH[>0D-D[3)Y:$C=D SY[\=_
M\%"_$'_!:7XI_!OX2?L[^*O%'@3PWJ&F6OCGXI^*=#U"2TU#PY:ABHT43P,&
MCN7D5E.&&08V&Y!(*X'_ (+[_L9)+^W7^ROJD?Q3^-%O'\3_ (EZ3H*V">*6
M:T\'A#IUJ+O2%=&:UNSCSFF9I"TV7/)Q5/\ 9]^%'B+_ (-N?VJ/ -YXOU^Y
M\0_!G]H2QL])\<ZY>-E?#OBE!(_GY ^6W)E?YF)+)YS,?W2@^R?\'&'B2T^%
MWQ0_8P^(VM2-:^#_  3\7["^UG4 C/'9PK-;7!8X!_Y9VTS =3L.,T#ZGH?[
M=WP5U_\ X)U_\$9OCI'X7^,GQN\6:_##_;%EXH\6>+9+_7],=Y+.$PV]W&L3
MQ0@1E@J]&FE.?FP)O^"6/PZ^.G[25MX#_:.^)_Q;\06>A^(M%6XT+X:6&?[)
MM]/FMBD$]Y,2&N[J1?+N/,=?E9SCJ E__@L7\=?!?[0__!%3X[>(/ ?BSP[X
MST)=)6V_M'1=0BOK7S5N;9F021LREE#KD9R"<'!R*]3_ &&-5UC0O^"/?P=O
MO#MJ;[Q!9_!S19],M@NXW%TNB0-$F.^YPHQ[T"Z'BO[1W[%5]HEYJWB#XH?M
M\?%CX?ZE<7<^H:4+7Q'I?A71M.@,DACC>U*#ST2,A26D 8H6/8"#_@BM_P %
M)]>^/7[,?Q>A^*7BC1_&&I?L^ZW>Z5?>,=*:-[;Q+IMNDCQWZF/]T^Y(9"'1
MB'4(W5BS?(G_  27\=?L9>*?V8=5^)G[4FN?#_Q5^T'<:OJ'_":1_$MDO]5C
ME6XE6"*VL+H,740>5Q!$=KEDXV!1V/\ P0U^%&E_M)_#W_@H#X-TG09O GA_
MXE>(M0T[3-'N-/\ [-;0['4;>_6WA-NJCR/+AGC'EJN$"X XQ0,]-_9 \)_'
M+_@MGX U#XS>+?C7\3/@;\)_$FH3V_@SPE\.[V+2M1-E;3/$;FYOS&\AD>5&
M4@#!"$C"L%KVO]K#XTZ__P $:O\ @FEXP\1WOCCQ7\9O%T-_]D\,W7BG9/>W
M%Y>,D5M;R>4$$D<6'D(4*S*K 8)%>!_\$0?^"F/P_P#V8_V7;/\ 9T^/7B+2
M/@Y\5/@Y>76BW=EXKN8]+@O;=IY)H9HIY"(6 639]_Y@JNNY9%)ZC_@N;X?T
MG_@J-_P2@U37O@IJ5C\4K7X>^*[?7WMM#G:XBU<6B2Q75NIBP9=L-VTF(SD^
M7\I+8! *WQB_8-_:4^"7[*NL_&Z']J?XNZK\=/"^A/XDO_#TUW;MX)NV@3[3
M/IZ:8(U0 JCQ++N!/!P <#-_X*L?M56_[;O_  ;%>)/BI;VL-BWC+2- N[JU
M@D,D=I=+K]A%<Q*QY*I/'(H)YPO/.:\P^$/[,_\ P2&^+/P@L?%S?\(#X<^T
M6ZRW6DZW\1]8L-5L9.CPM:RWRRLRMD91&5L9!*D$^P?\%B/@[\-?@/\ \&VW
MCCPW\';.WL?AG'9:)J/A^."]GO8GM[SQ#8WGFI-.[RNLC3M(-S' ? P   #S
MO_@OW_RKQ_"W_N5/_2!J]O\ ^#D#XU>,O@;^RQ\(=0\$^+/$W@_4-2^+NC:;
M=W.B:I/I\UU:R6FH,]O(\+*6B9D0E&)4E%)' KQ#_@OW_P J\?PM_P"Y4_\
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M4"B4%1A&'ZK5^9W_  7O_P"3O_V!?^RU:=_Z6Z?7Z8T""BBB@ HHHH ****
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M/@]X1^.GA"7P]XV\+>'/&.@32)+)IFN:;#J%G(Z'*,8IE9"RGD$C(/2IM?\
MA;X9\5^!/^$6U3PYH.I>&/(2U_LB[T^*:P\E  D?D,ICV*  %Q@ #%;U% '"
MZ=^S#\-='^$EU\/[/X>>!K7P'? BY\-PZ#:II%QDJ3OM0GE-DJIY7JH]!75>
M%_#&F>!_#&G:+HNG6.CZ-H]K'96%A8VZ6]K96\:!(X8HT 5(T0*JJH 4  #
MK0HH X>?]F3X;W7Q*7QI)\/? \GC!"2NNMH5JVI+E@QQ<;/,Y8 _>Z@&M3PC
M\'_"7P_\6>(->T'POX=T/7/%LL<^N:C8:;#;7>LR1AA&]S*BAYF0.X4R%B S
M8QDUTE% '%_%+]G+X>_'$Q_\)KX#\&^,/+"JG]MZ+;:AM"MO7'G(V,, P]",
M]:W_  ?X'T7X>Z*FFZ!H^EZ'IT9W+:Z?:1VL"G@9"( O0 =.PK5HH \YUO\
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M1'&0<,BD<@&M31M&L_#FCVFGZ?:VUAI]A"EO;6UO$L4-O$BA41$4 *JJ  H
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M2Z>]0A)8CF2&6;<Q!"@&?K51110(**** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7,_&?X4:3\>?@]XL\#:^MPVA>--&O-"
MU(6\GES&VNH'@EV-@[6V.V#C@X-%% %KX8_#_3_A-\-O#WA72?._LOPSIEMI
M5GYS[Y/)@B6*/<V!EMJ#)P,FMRBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
B*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>bdtx-20211231_g10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g10.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X6U0:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N
M8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY-:6-R;W-O
M9G3"KB!0;W=E<E!O:6YTPJX@,C Q-CPO<&1F.E!R;V1U8V5R/@H@(" @(" @
M(" \<&1F.DME>7=O<F1S+SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*(" @
M(" @(" @(" @>&UL;G,Z>&UP1TEM9STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+V<O:6UG+R(^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^061O
M8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L
M/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C R,"TP,2TQ-U0P.3HT-3HQ
M-BTP-SHP,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z36]D:69Y
M1&%T93XR,#(P+3 Q+3$W5# Y.C0U.C$W+3 W.C P/"]X;7 Z36]D:69Y1&%T
M93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,"TP,2TQ-U0P.3HT
M-3HQ-RTP-SHP,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM<#I4
M:'5M8FYA:6QS/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QX;7!'26UG.G=I9'1H/C(U-CPO>&UP1TEM9SIW:61T:#X*
M(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:&5I9VAT/C$S-CPO>&UP1TEM
M9SIH96EG:'0^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.F9O<FUA=#Y*
M4$5'/"]X;7!'26UG.F9O<FUA=#X*(" @(" @(" @(" @(" @(" @/'AM<$=)
M;6<Z:6UA9V4^+SEJ+S1!05%3:UI*4F=!0D%G14%304))04%$+S=107-51VAV
M9$<Y>F%'.7=)1$UU34%!-%%K;$Y!*S!!04%!04%"04%304%!04%%028C>$$[
M05%"24%!04%!44%"+RLT041K1FMB,DIL04=404%!04%!9B]B04E104)G445"
M055%0F=51D)G:T="45E*0W=G1T)G9TQ$06]+0W=O2R8C>$$[1$)!341!=TU$
M07=11$$T4$5!.$]$0DU41D)15$5X=V)'>'-C2'@X9DAX.&9(>#AF2'=%2$)W
M8TY$03!914)!64=H55)&4F]F2'@X9B8C>$$[2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF+SA!
M04519T%I045!07=%4B8C>$$[04%)4D%135)!9B]%06%)04%!04A!445"05%%
M04%!04%!04%!04%11D%W24=!44%(0T%K2T-W14%!9TE$05%%0D%114%!04%!
M04%!028C>$$[05%!0T%W449"9V-)0U%O3$5!04-!44U$06=10T)G8T1"04E'
M06Y-0D%G35)"04%&25))>%%614=%,D5I8UE%54UP1VA">%=X46E00B8C>$$[
M571(:$UX6FDX0U)Y9W9%;%%Z4E1K<4MY63-00TY546YK-D]Z3FAD55I(5$0P
M=4E)2F]-2D-H9UIH2E)&4G%3,%9T3E9+0G)Y-"]0128C>$$[,4]4,%I85T9L
M85<Q>&18;#E76C)H<&%M='-B5S5V63-2,61N9#1E6' W9D@Q*V8S3T5H66%(
M:4EM2VDT>4YJ;RM#:S535FQP95EM6B8C>$$[<6)N2C)E;C5+:G!+5VUP-FEP
M<7%U<W)A-G9O4D%!24-!44E$0E%514)1645#04U$8E%%04%H141"0T53355%
M1E523FA)9UIX9UI%>28C>$$[;V)(=T9-2%(T4TY#1E9*:6-V17I*1%)$9VAA
M4U5Y5VE9-TQ#0C-04TYE2D5G>&15:W=G2D-H9UI*:EI&1VED:V1&53,X<4]Z
M=WEG<"8C>$$[,"M0>FA*4VMT3515-5!2;&195U9P8EA&,658,5)L6FUD;V%7
M<')B1S%U8C)2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;R8C>$$[
M*T1L2E=7;#5I6FUP=6-N6C9F:W%/:W!A86YQ2VUQ<39Y=')Q*W8O84%!=T1!
M44%#15%-4D%$.$$V6'!'<F9M:F)8=FYN>D1Q1VQA:R8C>$$[3'%'>6DO465I
M5#A:-U%49U--16=J=%I:4%<K17AC,U0T;5!)9D-A2T965U@X=R]Z5&MV6&5Z
M.'5.*VI)8FU)9G9T3W95;FUT;G5V428C>$$[8F=$279">$9(2DU3>6UI;$)X
M*TMU1E5N=%!Z32]--GEA,C!X.48T,W%7=C%I9E0U3$A5<FTT-$%7-&QM:FUK
M=4=E6E9N=7E/0T(R5B8C>$$[56]45V=#<DI03#-N8CAZ3E<X,E=T;&-A3$9P
M5VE34$Y*2DID,E=O:60W8U-Z0T5*2W%M,FEK155A1GA--C%,9D-V5$%R1GA,
M-35U0B8C>$$[9C,X:S)T,CAD+W)%,$]O47!A87HV,6IP:GE4*V@V169Q*VQ-
M2#E'2&LY;D5S:V%-4GE(2V]6461V82]M<F4V3G$Y-C%R<6QT8U(R9"8C>$$[
M=G K;%)I*S%I,V5/939D-C-#,G-J6%1456IU:SE34U=:=E-+1VXR9FA+<W$P
M;E4O>D,P8GE80CE5<W)U-C%E.3%+*S5186ML-7%(,28C>$$[2S!T-#5N5F95
M9&]P-6<U=#%%3$UY.'I)04MB1$%Q9W8U:"]M-49D=F$S4&PT3S=O<5<X<T=M
M,S5I*W-3<EI%2S=M47%)-&IC>C@S2B8C>$$[05!P-U4S=W%G3$@X=R]Z;&<T
M4EA':U-8<FU5>GE-*VDS.%(Y0C=I6&Y#:DI)<4M926]2=TQC;69M=7IC5V1L
M55-F3S,U>6DK=$)E5R8C>$$[161R1D-S-WIM,S!J55HT2C56<TE*:V=C>&TT
M;6I4-GAC3V=L4F1Z1V1J47%W5E!B;GIV-3=G,%1Y=F-R<$UK,F]A:S5B5W)D
M3DQV928C>$$[8TU)2BMZ1TI3:T)P,VUN-61X1W@K04MS5G-V3VXU,&%(;U5.
M:$QO.&UO-F=S6'),95-A9G%&>5=M94-/-$YT259L1R]Q6$)4,6514B8C>$$[
M941,>$I!1T95.6HX-&9N02MQ85AB2%1,2S-T9%)U6G5C."MN-FUF4G1O<F]W
M26MH9V%D56UL:7!+1VPT4F=D>C)#<#%9*V$O3S$Q*R8C>$$[66HV33)L1S,X
M=E)36$-09%-75GE+>'=W>&U/4F(P=71U>&UL;%!&1FI.1E4Q3F5I<D=J*UI(
M-7-88U%.:C5A83(T44Y,8U-896TS*R8C>$$[,&MC9#%-.&%2:5)'8R]U<F5*
M2T@T;EDP3DM52W!&9BMC4'I!9W9H<E8R<'-%,&5+6%9T4C!*>F9H<#%L=C%S
M27AW8355<GEH9VMK:"8C>$$[:DLK;EAF9V582E95-"]X:BMC83-&-4Y$-653
M3S=:3V-I>E<K;WEW56E7,TUC35-#8C!G-64Y9$AK:C8K:WIK14QS<6UE:"]M
M4C4V=B8C>$$[=CA54$IO;D]B4F)!6$YT<$ET8FTS=6IC>79-26)C=$DW9750
M5&=$1C0T=T1Y;W1D:5%Q6#-8-6IF;7I&2DUL;F]8-E--56)'2G8P4"8C>$$[
M<61M<S-+,F%26F<P.')C06QW56A-2DAQ34]4+T%!3&EQ>E=V4'8U>%)1,V1N
M8F%3<EAK565O2W0Q8F%2<41Q6&<U2F)Y25I8.4E",B8C>$$[56Q+97%Z-T@P
M=W!R:7%G,VUF.$%/1WDQ1S9U1F=E-6EJ:75M:DDP:E5M:G979T5%3G5403 P
M;C%::GEL;#1X.$]96#=*6G9H2W$R;R8C>$$[*V)0>E<Q6%9(:G0Y3VYS.4EU
M,45.=%I0<#$O13=X>F%O8E Q<&)Y1U=#5S%L:G0P.68W42M"<3A4.7!1<7)A
M9FU"*V-T,TQP35 X028C>$$[:#)$5%9U-49H=7)M.'-T4VM25V@Y3DIY1G1V
M5V5.6EI*5TU,5&-5-&]35U!)5598+VU2-6PO36E46$QJ4W1$,'4W1FA94V5P
M1SA&<B8C>$$[96<S4E=Y95=-;3EG;&E14DYC<VM44G X97A*6F1G5E<Q.#4O
M;D)B>4ES5V=X>3)-8VM)4T9R3RMA-&$R82ML=&5,5%-4<U!6*W)1*R8C>$$[
M=7IS1'AQ=%%E97A635!*2&UR.#%T8C%3>E168D-Y,#=4-45M=6)X>G K<'A0
M1VET0TDW54YE1S(O9FXQ2D]4:%=487$Q,W=+;#$Y*R8C>$$[66XU<F5S-'-.
M0W$P:VQY26)76%-D4E!";TIV5&=T,W5F5FII8C9W:F5P.5E!5TI!0U!J2C)6
M4WI8+T](-7%A;6)04UIR56%5;7$S328C>$$[1%=W=#=E.71R<&]G.3-/.7(V
M>&YI8FUB87E1>71(>$LK<%1A;TE+<&IP,VXW.#-*-UE-9$-6230W5U<X958Y
M33%&5W)B,GEY=EI,1B8C>$$[3DUK<GI.331I:FQ.03E'6E502&-+-C0X*V9N
M3EIR>75T1'0U5F%:;V$R*VUA:DM5469646)G<DA,2WIO:EA-;$58-'!"1WA(
M2$95028C>$$[,VTS.#4W>"]5=61-8C!74S%*,'%,5'(K,4UI;31N95(P=3!N
M1%%3<D1$1T=6<$=5;'%C859,1E5A;C5G+VY*4$$S,6)126U94DYC3"8C>$$[
M4$YP;6]12WA!=&PK<D-'4U53.'A.3S8K;S%!55%U16]-0W998U9D:7%K8D\P
M3C),=W=2+U<Q:DU)=65+*V])>7=9<'IP>31L9T14<"8C>$$[6$966$9867$W
M1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ;#AN;#-Y+TQ.4%!*<&QO.#%Z3$9C
M6$UR45)L<$IR96YO>4]X5W)01E0T1R8C>$$[3S8Y<U941$951'!/:&%*;SA5
M:T]K869B861$2R]Q4W@R:TUC0W,U,C5-27=O2CDX5E(R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+;V545"8C>$$[9$]K=C1T46MT65AV-V1':F=U,FI5>E)O+W="
M=%5K235+<E4S04\K2V]J1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W
M1EA9<28C>$$[-T9867$W1EA9<3=&6%EQ-T9867%K-#@R-DDP-6=75C)L17!H
M2W)&269I5G5*3WDO6D).2S0P<F1J-7(P4SEU23=E0UIV56Q8;DAZ:B8C>$$[
M9$%24FHQ64%B:$-2:7$Y+TTR:DEZ9WI-4DA-,79)>7AY37%Y3'12:49)1RMW
M4&,T<7!7+VY$>2]/.&%*8VM.3%%*>6IK559:+U1'-28C>$$[5V=Q,DY+;6QR
M8W=85G9(8U%.>FAL2$M.-D5653E$=E1R:7%R:7)S5E,O571E,'I46EEO<GE5
M>'1-<DUL1EIH>%-N26YI1%1R:7%%9B8C>$$[>FQO84%&,VQ5;%$S17=3,4%:
M>D=+:FHQ3$1B1VQ233-M4%)95$(V;'E&1GE),F=.1V]W;"MX=E0Y9E1&5BMM
M83-9-FLP9W1F5E!P0B8C>$$[4WAK:6MJ2'AG371#-$A64T0X:FEQ4'A6,DMU
M>%8R2W5X5D%,-6<P3FEO1B]B:W-X:E5E;W4W0VQ2,3DX5EA7=71A4F1V=W1R
M,D=:*R8C>$$[2F9I:G%4>$)O5%-V45EQ,4YR;6M19T8W=4]J2C9G;V58=U5$
M8W9H<G129V-64C)+=7A62R]-9710<$9G;'EK85--.'%X56MF,#%(228C>$$[
M13%,55!H:7%24BMF<FE75FMI<U59<E8S55-/5U9&57-E9$DV0FA48V1S3DET
M17@K9$A/;GA83#),:5(R94EO<&)G2E!I16$X>6=(>"8C>$$[<W1+2&-60C99
M,&Q-=$(Q=515,W9&94U2+U9:5VE&0U18:3=,+W=!831&5&)&6%EQ>&979D]C
M;6YA;F-7470T,E=&5DEK95AH=7EH<28C>$$[<T%R14PR<C0P2&9$4V]D4%!L
M>7=H:T]N:C9V3$E%16=D+W,O0T=/.%DV8W@O1VU.271(;GI7-V%G;&ML;WEK
M>7AO-WDX:TE357 V8B8C>$$[8T=65W%W6G1J,$LT,&QK3T)867%W,WIA4$I(
M;&UW+U-U<G!,>&MU9C-%56)Y33AS-S%L.4I&-4)D*T)A:$E',E1H07E.0G%Y
M-5DT-"8C>$$[;55U45ET-60O36HX<TQU2C4W-C!';&DR84-Z:E=C;5E3;&ML
M57)W5&LW8UA6=S-*4#5#9'E!3'-M;6Q%9V,W8UA$,FAJ;4-4-F5'=28C>$$[
M9FUI3E8X-B]L:%ER2DQ9*W!D>G=T1W%,8G9,2$A0231L,TQK9T]!05$W,$DK
M3E)V5VU'1VQN26=65F]Z9'!965)*0C1J2&]%,#AM6"8C>$$[=FMF>DXY66AS
M3$LU:&QT;U%K<5A$369H;$HU8T-*2#-6=C)T:C1:2$YP-5DV=G$R851863@Y
M.$XW9#=025E9-%E5:&E8:$9';U)&2"8C>$$[44MO;T(Y,EDW;4PX5F1I<DA0
M3VPS-5(P,GI85F9-8S9W47=+.&-D6D=1=4AP>5%+<$A,=#AU<&]-;$-*:V%$
M1$IK:D%75U!E5DYE+R8C>$$[3$A8<E(R9W!A=7)Q:E<K<%-#3UIU1&5Q1U5.
M22]*4U@S;V0K*U=:34UO2&1P=V%Q1U5817)F379M9CA!3$=W9VE6,"]35'<K
M<D5%,"8C>$$[.6QK:S5,2$AZ6C(Y4D]48U=18VEX,RMN1&EW5&UA1$A5-GI(
M:$9Y4%=M6&57.58X=&%N2&-81V@S361W<DUH=4%H87%L545A8VMA:"8C>$$[
M6#19-D1B=&QC.&-O;7!#;3=&;6AK1GA)2V-:0G1D:7)S5F1I<G-666I,-58P
M0WEU3&%'-#%/4T-7-FPT,CA44$9','9(-&=G2$=R528C>$$[3&945V@W6DE!
M;&E30GHV<&).9F51.4<X=W!P:VPQ8VI5:V$S=&A!<&MO5$UQ1D1Y5VA(4E=9
M:'4Y3VTR5&IJ:U)9-4TK03!44F]*="8C>$$[2C52.'5Y6$(P+S8V=W5W:W-N
M,5E34BMO27!G<UEB9U%7-&]%5E9Y=&I9-4UQ=TID:7)X;5@X+S1:4$Y-;&Q&
M<"]R-D%N<6A,=W%22B8C>$$[24960VMI<7@T1E1Y<G5Y;6@V035N63E%6D1B
M;39F4#)T2$A),DQI1%<S4#A71"M.;5)F;&@K6G1X-7-U2G)/.7,T;V)K46TU
M5U<R2B8C>$$[369%36E-:E9,9D5#-&]A+T500VTY96\P,VAG1RMB9F]D9C0U
M:TMR:%1N.'@O3W@X;V%083,V,F$S:'5B=&)9>'1)26=O355K=D]P0B8C>$$[
M<E0P<694;%=,2'AY<'ET4FTX3U!&5G-8,&(X*TY(=F)I,E-7=VQT-U9L5F(R
M-D]X4UER5BM%641&,%9T<3%R-V)53C4P57%S3T=/,28C>$$[26-10D9E8C K
M,G5)8FTS:75)2$5K17E,2D9)3VI)-'%P2'I">D5)<#)124ES2E@U=#@P868U
M63!/9E9R-#%33VE246<P85=6>E)5528C>$$[045K.7I11V="4&)*46AX14)H
M;7EJ2$%Y4%(T,68O.$%/45=S>F%D6E,R=&AA,CAS<GE26#EY-G9)<3A11UAI
M<$E+:7%U<CAU6&%N="8C>$$[;G@P235K*VPP<RLR2E59>&I5>#,X<3)E=F%0
M-7HX=C,K:'AA<3DW8G=*-F%'-E(U14)H95%(-$A(23A72E4P2&9T6$U'5TM1
M;'<Q=28C>$$[-V5';VA+2$=#3T8U2&]F-2]W1&U"<F5A3%5,1T<T,4-52S!%
M:V%'3T=%2U1Y.5E-,TDK=T(V,3-/6F\P6$969D8Q574Q*T1I<UAV-B8C>$$[
M9E W+T%-9'HQ;GE6-7IS9DY';D=A14=+.&=64')T=G51:G5$5&EX041+94IO
M9G9Z17HT2EEZ4F1L<$Y:1%!'-&YL>CAM4EI3-51Y2"8C>$$[."]F3"MV6#<V
M2&4V6F%8=#5B,C5M4SE3>FI&>'A,3D59;6%!8VY/=VM(2D9.4&)-=E-:67=0
M<61:,FYP.&U7045!1#AA94=Y,S$Y3B8C>$$[1D,W5U)T16%S<V,Q87AK2T$W
M3EAJ>$1,5E%19#DO<'IA4WI8<U(U=7(W3S=#>6%G>3A/44EJ64XR4&=L,S%$
M5F])5$YP:7<S361O."8C>$$[:S=7:7AY16]S4CE5<W!#;'5-8V%S5TI0=VIX
M>D9L231W3V]$=4Y4,DAK.54U8W8V379G96(Q+SAH9$4Q;2\X04U5979Y45AL
M<F\X3B8C>$$[=35T;F5&8F%'5C-01E%P2EIP1DML:3-$87%I=$]H<3%E<$5X
M42LU=W5Z97HU67!C56@X465F=F915V$Y,VIS5F1I<C4P+U!R5G1/8B8C>$$[
M>C=B5V8V4T1V8E<S-RMX;40X3&0S6&Q73G$P0FU4:%5C84AJ-#5S3D))5V)P
M,"]A,FYY>D$T0DM8=3<W,C)E8W@V=&)E<D4Y=EEV0R8C>$$[8EIU3#(X:5)Q
M=U$P56M+:FLP,T9$-&108EE$3$5N66)H,$5T3$]!.55G4DQZ4$UD+W=#3V%7
M<'%L,UIA;&)V9DIY:4-#13-1;5!O;B8C>$$[;%5%-W-Y,4)+,7EO6FI'431V
M=C)C:S916DUC:FHW-W%T+THV;B]Z:G0U='18.#,V:%IY>GE2<F523$1A=T@Q
M,E=74F8S:7-Q;&5)-"8C>$$[24AQ-4,Y9G5X3EA,:D8Q>65J,$A:8W-'3&EV
M;GI&5E@V+WAU6#!H;79C=#)+=7A6,DMU3F%B9&4R2W9L5'IB92M9,CAZ86QO
M,G)4,R8C>$$[:S@P1GIC1T8U565+:V-T=S5A83)J;%HQ4TM39S0X6#95,C)R
M;38P<&=10DAN5R]E.&XR;$1,1U)L4#9E3&)N=RM8-BM696%'9SAI*R8C>$$[
M9G14=#5D66MT-'8P9&)43$LY.3EE=%(V8U5505923B]P0S!#24%V16UG1DMF
M1&Q-=%)%1W!#=#=D;&AX6GA#<V53>'<P9E9T9G<X=B8C>$$[2S8U<$Q986HU
M;W9D6&YS=$UA.79.5F%:<$IB,GEU2D=K.4XR5T]14U-W1U@T0S5#:FEZ<61H
M,4\X4FUX.%!#4C5T8SE.;D=1>D(S<28C>$$[=G@K;FPX;C%X-5(P*SDP-WET
M<$YJ97E'5S=T<E='2UIM<%5-<4%C4U%"6&HY;79E;&,Q.'IC:5AD-&\X35%/
M-$DS5DQ(-B]P.7A::28C>$$[96$Q339&1G5B9'I(3$=33FY2:#!+;F9W.&1S
M04Y-<$-X5#54.'AE6'9.3V<S1W-&<D]5,G5N6$UK560Y9F]91FUT>DHV8V,T
M:TI94R8C>$$[=$DO1VY!0W1A.49B:G1C97-!:4%/8GI78G-K>7E%;F%/-74W
M-B]J=E-E>C%$571,=G)L.4(Q4F\U<FE"4S=X<S!-8D=6560V8U-(-"8C>$$[
M:50Y,D-7;V5)3DUT<FE'-#,U,2ML<&E+;D=-6E5$565,8V9$-&-Z<T4Q=C5B
M-WI#8E9.93%U-G0W945%3F-Z3DQD9E9K8W)Z6D%+128C>$$[;FMG04AF63EC
M<7DT:4%:06-*9&M/2$A/3T]E4T]58S=U-CAU=C9L4'DS-4\X-5A*<S=',G-R
M='A*2TE"<4%6-7)-<S5"65!.1VI.0R8C>$$[:UE95F%L4G5/;WE0-6YH2$-B
M16<P1',X6DIC8V5%=VPY;C0V=G$S>2]P,&UM841P=6UY=4I*3$LQ:'0S:T):
M9WI24G%H3E<K23$T.28C>$$[.3@Q<VI:2F0O0U!$141U668K9&YL2%=V33-K
M-6)F4T]$6%9H8W)F;4)Q:#569VEK+V1W<V]*5U9M64)4=#-Y5TMF1$LR<E4T
M=D5G628C>$$[=FYS,F5S<%!P-#%#,&QT3DEV1F52<$1$2DAC4$=H47IE9W-O
M:C5-4%9&1TIO,TEB.6,S27IM93!+3WIY<#!C8U93>F-59E985#AC:R8C>$$[
M<&AH=E9V0EIT95!A:$0V9U)I>%EX8U90*S=U635++U%D=#A413A66"M0:7-C
M:V5#>D=W9FQD;F]+*V%94657-6)N5T50;&E#-G9'=B8C>$$[3% Q8C1Z6$5-
M16E40FEB:#1662]V13-8,"MR14%M;5EW;$Q%4UIC<$]W;FIH<5%)=S5W<FU/
M9C0V=F8O04UK9DIM=658.4EU<GI6,R8C>$$[26XQ3EE$1F)0-F=L:E-%4%0Q
M565I;S='5&166'1U4V5M2'%-,T=F8S=04F%4=U%F-EA4=65L6FIU8S@P+U!)
M96%L,&943&I1>&1V1B8C>$$[0F-U,3%(<#AC<C-(2F]M4TYQ=VQ75TY1>C@K
M,U1-:E1'06PV=51H83A:5&IR2'HO04(O63A(=G1-,3=7=S8V2#E895=.;$5!
M865+1B8C>$$[5U9W04%R4$E'8T5T,#(R2&9.<G%C:$5B1'HO6E%L1$EE1U)G
M5'-A3F-Z>39D,U,Q6'I8-5$Q9GEL2$M.5FAT-U<V339Z4DM,<4AL4"8C>$$[
M1W-V15,K:W-J,TA'4E$R+W!B9'=+2$U33V]G96TY=3!Y86)555DX5C0V-5@K
M:EEF37929BMC9F1/.#!897%81W)856PU6C920D-O="8C>$$[3%<V36I*3$AC
M+T504E-8:W%)9E)6:7E..%<S8DM.4FMI9G!(3G8P3T1*1#9Z9$0X9FEN=D]9
M:G-N67$W1EAG9B]/4BMN869B*UEV3"8C>$$[*W-Z44E*6C1,:7IA-%II43-P
M=6MK84UJ1&=O2'%/959A;71$,$=:,FAK0DQC=78W4WHU;UDV>$5G;FU2>G(X
M9'IZ3%9)=DUU<%)X1R8C>$$[>#!U92]T;TI$1DIB4F]Z<7%66F<S,E-Q+UID
M+VAP.#AZ=%)L16%.8RMJ;TY&<'!:8DA%5'=J63E!5'I!.39H9F%492M78F1&
M,5,S=B8C>$$[<E=Z;6I+,T9J9&E90UI$5FQ52D]Q2S529W-N2&%H;V%!9UIJ
M>'E9:E)*=75H8S-*:#%!-&=!23,Q1S-Z<F0V="]W030Q959B94<U,28C>$$[
M3%A5:E(T,FI73S-N.4XT:4=K9&UD5D@W=$-/2W)7<59',T4P2G)J86]X,D53
M-U!16DUX175/-CDY.&YV5UEJ;G5X5C)+=7A6,DMP2B8C>$$[-7@X<S)F;5!1
M3')4<#15:VY+33%H335+3D1C:%-)<%5L54TX8DM4.7!2,'%+145J2E)K46)$
M0V-"25528C5G8E9:8F4T,6)Y>F181"8C>$$[375M4R]69%=14%,S;FMT6#1C
M,C-53W9.4U8U0V\W9V1-,TE-331V<DAV955)>F%/5F9W>E!2.4%F;$8U5'1.
M2#AR,G0T.6A9=V%H9B8C>$$[4FE9,V1O=%AE0UI6:U)(8V]J9D0P-&HT9'$U
M<4UV,48V:E0O045!.#=:,6QB8S=&6&QN-7DO;#ER+VU#97<Q4%(T;'9R:3-+
M=VUY-"8C>$$[,C95:F\W.#-K;5I#-#4P04%A<3%.0CA415I/;7I#0C-D9C)H
M<'!:63%(;CAT=G@P95%F;5HK5T=O*U=023AE<C9O:71E,VPU1F)7="8C>$$[
M<$)V3F%Q>5!.>6561'AK6E)'-F-"5E)7;V),<W5P-'I54G0Y<FIA6%%(1$,U
M;3566&PO87!A0C5.,3=Z6&)Y,BMH3T)Q:TYU2C)J=28C>$$[3&=W9T%Y2S-*
M5E=-+W9&8W(Q96UZ03%Q37ED5DUX05!F.2].=T]Z8TUC:W!2,G5**UDU5C=V
M4#-06%!Y9B],2'I(-64Q:38Q;E<S:28C>$$[:6XT4&%P86]/65E/5F1P5F-0
M>"LP=G=N:'EO5%5$34A56GA/;F,V3%-(1F1L-C-M2S4W<U9E1"]!2GEE5&9.
M9BM--'18,'%Y8E5B8B8C>$$[5E9305)7:T5H84IO;$E9,TQ$;6\U.#9R24]0
M4VA',51N85!/25A:+T<W<"LQ9$A,3G<X23<O,$U+=%AT24Y!=G1(,5AY,61$
M>FIE9B8C>$$[5C0Y2DUP:W-P235#<VE)-DY)16U+.&E7-&UQ=C!.2U9Y,TYK
M;$]P45!,;3)D;61L17=Y0U5B04XW,7E0,F)6=CA%,#AQ9FM2*UET>B8C>$$[
M93)K970K;' Y;$-O;2MT339436]A:#E"26MF:W),,$Y7-&QE*U9(5TAH<&=/
M>30X9#E$>B]B,W9P;DU&,C=S5F1I<G=0.#5V2V5L*R8C>$$[54QI1'I*<$YL
M86%4;S!Q0S-U,71E14HK=&)T17E7-G%G,U)46&<Q935554Q:;C9054-&:5A)
M=6PW5S!-<V]%;V961DLO2V5I,R]N9B8C>$$[>F9(93-W<SE2=5E$1F,V:4Y1
M,V%70D=294594DI&030W16-14'9Y>E8T;S1X<T]B6#):<34U-4AI3SAF="M$
M-D]J:FII:E=/3E%K828C>$$[04MI2T%&5E%+04%$;T)M<V0X=7A6,DMU>%94
M=6)A,W5B95,R=5EK;G0U;$UC,$UI:#!D1T9'5FQA;TE)-F<T<2MF9GI(,&U4
M.'90328C>$$[35=P859+='!:,SAX:S!M1D<K3T]:0VAL4VI(:55,4R]!=FAY
M0C)P6&$V8D]*=TU*-W9..6]A3V5,2TUU3%ED9DPT9#%+=C5B*U9,5"8C>$$[
M>F@U>'5T6C%Y,&HQ35=T2'9P3'1I>&52*U-W<C9:1$(P2' O6F)9041R5$M.
M5FE'3V=(3S=.,5)Z,TDY3VYV9E%#;W%I:6=+0U-3028C>$$[2V)K,4HK:S5G
M=3)B>%8R2W5X5C)+<V$Q4'HY;RMN,S!L;$I$8U-Z4D5H=E-60TMJ+U=D8TEJ
M87%1+TU84T-V3#9P9#!Q0E1H1EAC028C>$$[:B]D;G9K=D1+3&5$969V3$AK
M*S<O34YB+U1O=%0P-7158UAU<'9',%$U0C5637!H5FDT4$TX:3-.<6-Q8E5Z
M3# K3U9%9S!1-G)8-28C>$$[64-567E(14-F>%AM.7@P+WHU-65S-T\S<V)A
M,'9&9W1O:VEH5FQJ66E.0457<$UH2C)(6$U9=VM46F1N05)I0D5C9VE2*UEU
M:2MS:R8C>$$[8G=8569Q14%/>5(X4EAX;S5/44U31U%+8S9X<FQL<$YG3#8U
M1'1#4T%"1T%73E%4,TLK1U)3:V-F-6LV3DE10F%89T(V355I<"]Y8R8C>$$[
M>69!55=X2#@Q=%@X<2MA=DID-5EA:%IA:%,S<&1W1T@P;S)75TU&5DI03FAX
M;S5$5E4W8C!R5$IW9V)A.'-G26MN;W@O=T1*1S4X=28C>$$[*U=D2W5,,E-/
M+W5,-C9O1EIV5&1)<F5G9%DT-G-R04AA=%(R2%1,.51#46]8-EA"-U!-2EA/
M<6YD13DO=2]3.5%0-6DV3T%4.59U.28C>$$[:%@W1694+VM:;4PT6F1L>$IV
M;UAM1W<Q<48U8E%/;G!M:G!+04=(+T%!2EE:06A+6&%N-3DP9E0W,E-Z:VAU
M2EIO>5$S<$MH1E(O<B8C>$$[3W5%0S%+:69Z1S!G1VAT3'-'=$MC67$Y=BM,
M4#AR2F5'56-4>$@X>G1-,$16=E!T=&513G$X4S-P:G5R,6UK5C!615I%<F)"
M,F)I4R8C>$$[9V-52F]$4V=#-6UA9DA)>% T*V)G-G9T0U='46E#94=7>$AV
M-W9.-V-0>D8P9S$O,%,X*T=N3#1).7$Y4#DR93)99FAL>G5*=R]-8B8C>$$[
M4E!5:E)O3'!"25%!-TI(>#,W;6IK-$1%:%%5+S%45DQ85$Q2<G$T-4=.97E!
M16XU5DEY2U=02BM:3VIU9FAT3'EM,B]#2VTU<"]V>B8C>$$[2FE"4F%1965T
M5CAM96)V3$8S<%=S861E>3(T2')X1TY)=E935TU':GA(,4-!-$)),S=62&9#
M24<R36E+3$)V>4AU9$DX=#(R;UAL,28C>$$[1F1Z,T8P259T-G%J3$1#03%2
M2'ED4T]B9%%",D=:5W!X>4%!=EHQ=EHK5T5Z26=$:4A51&XK3W9W970O.')$
M,&MF.$%(<&0Y2R]9:B8C>$$[+W=#<6U9;FAL,FY%;65G95IB1%A&;4YQ:W-:
M9TMH,6U#<69I<E%J:7IE1U))4VTR0E5U,7I8<DQ2<E583C)(6D-A05)G13=F
M37)I<28C>$$[5'AF;4IO.&Y3,75W2S U1DDV9$LY<$1K+T1+3THU.2MD4CAQ
M*V-02WEY6$5..6(S5VQ-6C=/.&EI:69H>F]R2S,W,%52>49Q93%!9"8C>$$[
M*VU763A:='!Z>D%G4U5,*U-&-7 S;%A1<C)A.&MV-WDX=C5&33-.14E267DU
M:D%:<&5417),.%)O4$0S>3=5=VY90DYU2#)B3$=9;28C>$$[54)6."LW8G4X
M;G!J9FU&<$-Q5TYR9#!(6#1)+RMQ;5EV:&PR4$5N1VEA-5IA>&%'-711-F]'
M-'-K9T%92#-!3%I":VU'2W5X5C)+=B8C>$$[2'90340V9C5I;75664]K<VAC
M<#-O,U5:9FA&<UI*4&)E6E-Q:U1W:#)&46A8<# W:G9M6#18;3!C5$5F36YM
M63-8;6DR9$4O9C)8<"8C>$$[;4].:4I+>',O2FI4:W9#:#0Q,C=$>#)U>%%!
M<V0O,T]P-U%Y4S0T:V10=C9F<%IH+VED0SE28D1G86MI=E=O,D(W57)L6&<K
M8G123B8C>$$[8RMQ1%5R<%E,94%X:#-Q<DTQ5#1D:&Q'849"=&=B96LK8W1/
M969Y:D1%6$%E05)L;4YD*TM53UEG-71R>7E,5W W6#DS-E-U1DI$5B8C>$$[
M-W)V=#E'6CA)5S!33DM(;6IZ9$1$;TXV16E:65AI355R8V=H-'EF05<V9TAJ
M6&M&<G8P>5AH5GI,5FQY15).1&1!950Y95<R,'E3,R8C>$$[14%A3DI3,$1#
M9W%R8C%&0V1V,35F;7@R8F1F,EA-:DA2-F9G<V@O>%)#,$)$5W!--7 X6$MG
M-S$W9DQ+1&@X,V%#5$XO=T%R;W!M5R8C>$$[-W4R*T9*84)51F-W36Y.=DA*
M:G9N>3-K<U!-36PP<D(P;&9K53<P8F1H=FQM2&1%:VYI.'I!32]Q5S1+-VE+
M;EE5249A;F9-=G=V3B8C>$$[;S1M265:=DUK.7IR,7(V8UI0,4%X37%&9R])
M3350,F53.$]*038K2&9T9FEH44ED4C)J:R]E45!55U(W.79*;41E848U<T9T
M<5)S828C>$$[<TLY841916)I;%-F=GER=V9.,B](-4]F56PQ1S531S)T+U-5
M=#A*3%9)0DY",$AG37@X<TM$6D$R.5HX,C)"=2],.&MF34Q):6AL2B8C>$$[
M-D5J<FU)1S$T-T9R13%O1U%2:&IY2$5N*U=U-C5N6317,'E.3#E2.#-P8F%F
M3DY&8G1Z:5(R235R2'E!0B]A2C)Q=50X13DW5V-L0B8C>$$[:B]K;E=H85<Q
M-T,X26QJ85)8:6%N145B9V9&>4HV061S>4TX3TDR-FYS;59223DS>C9S;U1Z
M5$59;4UT<UAN3%96=59!0G9T5VQF1"8C>$$[2T1H.#-B:6)-+WER.5=6-RLT
M2VA%65)Q1D9E,TQ-1$E.,TE$,$A+,'-:+TU#=U<W,%$Q8FDP8F-H-VIV:$-V
M231T6G4W8T--2W)Q<"8C>$$[;U%W-G)V<V9V>EE19T,P4TI#1C@Q96)!9$-U
M,&QG65%3>$-+6&EW05AN4E,U1$9A:&5V6$I$2%)U,FI55%!!84A21"M5+TUD
M=VUH>"8C>$$[>%!B<C9Q37=::5-A;F8T=7!R-&I,8VU0:4YK=4PR96%X,4AK
M1'-N8F5:6D=G15ET535G,35'=F-!9'9P+T1+6EEW3W)S0DEV4V9Y>B8C>$$[
M=%I99$EM;&LR.5IW=U5B055'82M83GE'65I&6%EQ-T973&5:9DM#86\U:U5$
M;517=5-J2VQE138O<EHP+U8W:E0T-T=R,G1X3F)-5R8C>$$[3&9',$Q-=$9Q
M<3EA5B]I8S)/2$1+56)V;39J5F1P4GA436$U8R]C>'$Y5S!L,4-384IN=#E6
M=51667=353E-34-W8FMP53!63FA8628C>$$[;G!43'A#55-!1#9U<G(U-FE'
M45-N365N879)+V5M8V5O6#%U3TMC2DLP4E=K<55$0V=/=S-(5$)L9V9C,V%4
M5C%S3B]*-V@U2#AM328C>$$[='1:-FQE,GAH;6MJ5U%W4W%!>6LP3S8Y5G(Q
M;V1X,S-Z5C5*8C%B=G-D;4E*1D9M=7 R0UAT;UE'2'=N=&Q43C5&*UEE:&IY
M,5E2-B8C>$$[9V)C>G)C6$@Q9$95:U5:;S5*069H1&8W-W R*V5:5VY%<'DT
M430R<C%%8TU/379-3E(Q4S(Q8E17:G9,57<R-G589#%,3CEG34=7:28C>$$[
M:7)C5W R>D]'0W1Y9&Y46D\P=D4Y04AQ=C=0:C5+1VQM94]->3)K>GDR<E5&
M<GIA<VAJ4VY(;7=#,4IO83$K-&(U3TU:;4\K-U1,3B8C>$$[:6I-:49X3$\O
M=T%V=%!V=DUE<'I13F)G,FM312MV1W)C54DT,$5J<V502G%M:6IF=C!R;41N
M.4DU-W4W,#)A57IU3G$U=F1D1C!Q2"8C>$$[5$Q&3&5.479%0W!(8S5H175A
M:S-M6'EI=7%S6D%">DIR6$I2;%-V0W9-1W1(5&18=4Y04WA"83%U2F)D,EIM
M<3=216EI06]V,G5T828C>$$[+V9M>'<T6E-J>%<V:E9D<%)X5#1+-6,O8WAU
M+TYN3F9Z5%<W4U$V;&1M<TM"-GAM3E=(,G=Y:TY21DY+9$-4='9L-'AZ:E%"
M,S9U=B8C>$$[>6%N1FLT<'IJ-F1U2'DW-SDV65<K<#,X1G91:4IP6$-Q<&-S
M541$6G%B,7!V:V-M33$S3U1P.5I224AQ930K4R]*56MC1G9F-FAA1R8C>$$[
M,G5(54TQ=$IX3$MF96A0>G Q.&0X,6,U,F5B=DDX=59--'9R4F)Q0F]M-D5D
M37):4$IV4&9L=&9,*VQT<7)11V%,,5DT:6DQ0G)+,R8C>$$[14@T5F8X8WE-
M2DUP0TDV=$]O>6I(07I04C5D8S9Z1G%6:E!A,TYQ<UE:;#5L2%DP555::S96
M63!P6&).:$A4:TAC-V184C5/,5)/2B8C>$$[:4)24$I!5TUR:'$V9D\X=6YU
M;VIT,VQF;$Q52G5E86AA-RM0*S-+15IK8FUW,7IZ65E34$%$03E78RM2-U!5
M9DU7<U-7<V1M<VQN128C>$$[:71,4$9T-E9A,$QL;30P8G-"=61Z,D]995EC
M235U-# R8S5$>64V-D)O<T=L5VAH:E5+5V]727!V5$U);3-/5%!!<48Q0WAJ
M=DE$1B8C>$$[24MG*T]+=DI0>D4P<3 X<E=D=F5.871C:39L849&4V]!64EZ
M:7!#<TXK4&5M6D=!4VY+9S0R<3%%8TU/279,9&(Q4%0Y63!W4E@Q<B8C>$$[
M-D5%5&PU2C0R6C%B:4-V=V]&66YI5#$S-EIN9FQZ1WE4<S9I6&%8:3%%0W!7
M3W94*WA:851835ID-$AE4T8S3#)W8W%(34E.5C5C5B8C>$$[07)X8F5V9G=Y
M,VAM4C9N2'@U.%5*15EY66HT=E-F>3 P>51Z3DQE=&-7<7AW5WA8:$Y'4&<S
M2BM":7@S9F%T1D<S9G%+-C=.-F5R=B8C>$$[.5!M33<R<#=663)K5G!B2D)%
M;U9&,D%',EER:W$K2W5X5C)+=7A6.# V<BM5+S5P6&YM6%9,<#E*1%<R;S-%
M=#1S>5A6=CA!=6IC3B8C>$$[-G)22GIE=$$W14@T93-C1W5B4%0V<4524DQZ
M*W8W3WE4;5IX1FXW+T%,=5%31S,X:&5C=%$Q9#E$<TE9,3%Z4VTY95=W;G!'
M16A&228C>$$[>%5T>5)V-S!&5U9T>'5+-&-M<&]#550Q4F<W4'-M37=15$AN
M9EAY930K5B]Y8CAT5V1V8EAE<U<W6&US0VMK:&%:+U-J63=M3D5J.28C>$$[
M3EA12"MD5%@X37<X,G!L3U)04C)M;#!-355!2W,O<&5H-6IU83=&6&UF-35E
M6%!/;FU(4SE+<V9,;&M,<4]#-64X=D<Y5DEM1%)2;28C>$$[3TM-8S5)=U9K
M17HX=D-G>2]4-4)#5G5(<F-">7<T44QE4#9T*U@O;E!18D],5DY9,"\X05(Q
M;WA73S1F;D9/:UA),$593G5Z1D%7<"8C>$$[.%1#;&4K.4TR43%52E92,V1"
M+TIU5TXX475)."MF;GI4=GE:*U0O;FTO=DQ1-FM)-%!,,7="9&DK:65)>5!&
M34));TMF8CE3:E4S5R8C>$$[;%18='9J+VY305(Q-D]E97E9>6Q'6%1A.2]S
M2'8K>#<U-6(X<S92-61S1%IA6D=Y4G4S<5133WAD-4I/255U>$\Q5'@V2T%V
M9T)M1"8C>$$[3UIK8DQU35=+3TU6155%,7E$63=&6'I0969L4"MB1C-R5V]8
M3C%P=VQ';U-M-V573S1T5E=.-7=*6D54;2])8UI7661+8F130T1M,"8C>$$[
M,"MP:$5C3C=03S8S<S=,:VQX9T%Y+TAM3U%35TPX=2]0=7$V;$Q9-F9B26UQ
M85-W;'5,0V1"17%P24]-64Q316]A+T562VYC8C%W6B8C>$$[9%9Y25!6;G K
M>F9Q:DE%5T]D=E=V>2\O04-B5S-T2'5F3CAA,T8T-T%X,F-C:#E.3TY#6%IK
M2S%,3BMZ6&E"-#EQ8RMS371O.&Y+,"8C>$$[9EIK8V4X=#58=#505TUW;F%U
M>%8U>BMD9FPS>G U:3!/,3!Z>35#:GA#5#9Z95!Z:E-8;$4X87AX>&U2;$AX
M3$I)>F)J-TY+-SA7=28C>$$[=WE%5%IC6%8T-51H=V=!:GHK>C=8:FUP+VPU
M-3DP:7=/<#9N<%)S-%57<SAG84LU4T=-535B5WIL;$A(-&563S-B3FXK8F=A
M;S=V4"8C>$$[:G-V2D<W1G@Y-%)V;%@X;'9Z16UL='I-25ED2'9'1G=,;&U1
M4V]S<F-I>F]+3WA#;EIF9G%->&]A=F=S8S-0>F1L*TIW:V)D*R\S4"8C>$$[
M;TQY>C50,%!Y,T9+;6U237-L=T5&>DY)-T\X:&I"0VMJ-TDK,&9S<4UW.&U7
M52MB=&-/0T=-5D55;E=6='IS5F1I<GI$.#@O2TAN2"8C>$$[>DA:84]03&M8
M,6HV;$Y,3&0R=VMJ:4PX:T%J*TM1<#A/>$)O,V5T1%%5>4Y0:T5$6F-(6&%E
M5U=(0TMR.&-V=&5283$U13@T95AO228C>$$[-S-78DTR9'1-=U-A8W1(36]9
M.49$5S=0-F173F9I1E!N;7DO3E)*,DQO;SEM-4EG;55D:'DS6D8U3"]*1'IZ
M.6-G<W9-0W@R3VU7-"8C>$$[1F)Y,VMI85(P<#EL14A,.3551#1N1D(Q,S9:
M:417:U%R<3=+6%I);&TT=C1E;S@S=E=H95@Y2C!+>4YL<&-(,64S3&U6;#5-
M-4QT428C>$$[1FE83$AT;49/6FMB3'1S94]-0G=X-4IH:U=B<U9D:7)S5F1I
M<G-663E.-74X=G!Q85)/:D<X5FIB2DQW56MC,U5-;V%T47!:1G(X:"8C>$$[
M:W5&:F))8VEY9&ER<U9D:7%$,6)58D=W=$1,92]W0GA)9E1)<'E"-4%M:$AH
M45E13%%44VIO97,V6'%53')P,C!6='AJ-&-E0555*R8C>$$[14M",F]-4T9"
M5$Q!;#)+=7A6,DMP1&9E9$Y&<W)P-V%B,5!6:EEX='A5159R5'AY6$-J:50W
M27!D:7)S5F1I<6IE6%56<&)36$TQ9B8C>$$[5&E(2G%B;6U%0E-L;6IE6CE)
M,4LV3FI:0C%E2TUV>$MH5D-+471"46XK65EK56=&3V-#6%EQ-T9867$W1E5R
M.'EA,7 R:S9D-G5O428C>$$[=%!B5'0Y6&%*46I"=6%S4T=%:DEP56A46$96
M;FPW>DY9839K-S)K8VE#07%(.5@P.2M6854T3R]H:7%B-'$W1EA9<3=&6%EQ
M-T98628C>$$[<3A!;C%'85AZ;T5";V\Q14PY,#E-:VM192\U1D1S5F1I<G-6
M65(K8G0P,70U6G0S6'$Q-&DO9D9)9C19459Q,'8O2F5A4V%W,5)N3B8C>$$[
M5#8P9% K0D]*4UDP.4AW261I<G-69&ER=T1Z9'%->F5B<BM*5%%*94]V,U!4
M2DI%3&4O-49$<U9D:7)S5E-0>GA-669+97!Y:G%S5B8C>$$[9BM'1TE6-7HK
M5#DS3% U<75I-3(K<%-%1"]N=$9H2V5'9SEI=TED:7)S5F1I<G-6658K8E O
M2T]7,R]-66XO2G%40T5&0F9L0B]V4"8C>$$[<68X07)W+W%F17%(;U="3'-6
M9&ER<U9D:7)S5E$R<#-6>F$R371X8E=Z6&MS435#,U)G<G-",30Q-FXR>%-!
M*V1H92\X-T8K:U!38B8C>$$[+V5V-G@V2#=8.3=Z-&90=&PT:',W0T=(6CE%
M-F)C,T8Q6E)81GAB3F%3>6IK8F1Y1UI196=A;F5N8DM3-$5G06$U;VY!>&1I
M<G-6928C>$$[6F9N2G%.>6)+,S R4WID241/<SA6-WE":F9J1S9L2U4K1FAZ
M>6-"8F9G:%I1=C5.-FAC>'E89&A&6G9,2$MY>5186$E,2$5O0D%",B8C>$$[
M,TQD9TUL3TY.=6]X54QE<C55-&)S5F1I<6IE>EA%3G!,3&)W1S5M4F5344)G
M:&-J<T-D<31P1#4P,7$X3C$U:'9,,6]7:&%7-656;R8C>$$[2"LR:$PQ2VXS
M2%1,-'=D:&IW-U!O5%(W*S5V.5!J=3=I,&5Y85@T;'0U0T,T53E#,4%+12M'
M56M5-$4T9T=R=$<T1TQS5F1I<D50>B8C>$$[3S%#-71F3%9Z0W1M.#EV9$HV
M8VQY:D-K5&-G4GI7;&%(>'E54EIB355B3'IN.'-.4G5,2'I+9G$Y;3DW3&-W
M3D%S845,>'$V3UA::B8C>$$[54)6-&(U6DM'>FPU8U!P-VYU=55U03=&6%EQ
M-T9867$X*R].93EU+W%C1FLQ;U)B1UI:63<P3E935E)L2T9A9D-F:7(Q=VA"
M45 U528C>$$[,W0S2&-85G)$84=72UEO.#%Z>31P149$1&99,4Q6,D=*55!4
M.$-867$W1EA9<3=&6%EQ;&UV95I.23!+0T]B57!J16MZ8TDK2W,U2B8C>$$[
M07%D;$)Y8TE'6$IU=S1*6D1547=R+T4S-5=F<"]W1%1V2B]R,5 X069-;D1N
M+W8S:G@K,S<O5#$S>3-W<#%4;69L9%)W.$YB93E/=B8C>$$[*U9Q*U,O.$%L
M<6LO-45Y9C!Y4&=3878U3WID,S)U+S57<C5,+W=#5W%4+VM42B]42'=*3"]*
M,F)U*S$S+TLQ9DIF.$%Y,5-F.&E:4"8C>$$[-EDK0DIF-4]Z9#,R=2\U5W(U
M3"]!3U=Q5"]K5$HO5$AW2DPO04-D;3=V=%%M<2]M1"M8=7$R371J9E103&)Y
M:6I+65I+9SEM53 R228C>$$[-TA#34UW>6IO8S!464@R<65I*V4O=T%U.4<P
M*T]X<TIP2315,TI-36A:,E!6,U!(9&IJ3$1-<'EA3%!-,E(Y<5 O-5=R-4PO
M04]7<28C>$$[5"]K5$HO5$(T16U(.&Y:=3<W6&8X<E8X;"\X04Q62B]Y2FLO
M<&HT16PO:S=.,V9A-R]L879K=B]!2F%P4"M236XY369!:W8X;EIU-R8C>$$[
M-UAF.')6.&PO=T1,5DHO>4IK+W!J-$5L+VLW3C-F86MT>C5M+TMY-3%Y3%=P
M5V1R,DEF-S5K-$UW*WDW3'@S6F5X+W-P25EP,51A3B8C>$$[3'%"2&AR8C-P
M,2]Y=%AY6"]W0715;B]);50K;5(X0U16+THR8G4K,3,O2S%F2F8O04,Q4V8X
M:5I0-EDK0DIF-4]Z9#,R=2\U5W(U3"8C>$$[+W=#5W%4+VM42B]42'=*3"]*
M,F)U*S$S+TLQ9DIF.$%Y,5-F.&E:4#99*T)*9C5/>F0S,G)*9GI1.&I44E!&
M3&-.2D9)0W)O,$5H5B8C>$$[;$]X0D)8<&HT13!J<R].,V9A;&5G96)0>7@P
M150O;S934D=U2$Q/-U)333%+,4-!;&9S<C)'4VQI;5=Z2G!-."M96F9O2&UN
M4F1F4R8C>$$[6G1-;4UV,6-Q2FQ:1U%J;EAJ.6]$<GA/5E1X;5!.=S@R;FYJ
M<FE(3DYS9S!S65 U:RM59U-0<E1M;F-24U4O5FAP8F$O=T-6;&55=B8C>$$[
M*U=L+RM256XY36%7,V8X04MY=DM8+TQ3+W=$>4MK+W!J4S)H-R]Z,S5(=C=3
M4S!U-5=L9VQ&2%%X4V9E3G1I3WAX<$-N<%!N4'E(<"8C>$$[3FML;EI3=DA#
M;350<$]76FHQ6FI48VY&55HO>7-R>6PO=T%T3"\X04EQ5"MM3DIT,R]+>79+
M6"]!0S!V+W=!:7!0-EDP='4O-5=6-28C>$$[4R\U85@O-4939C!X<&)4+T%%
M>E5R4%4W1TLY<S-,,C@Q941%1E-E3$94<V%(<4U#;VY&6%EQ>$1Z>B]X,G9+
M=B]B4E@O:EA,<UA+6"8C>$$[=6,S4V924"MQ>2]+6$-D:7)S5F1I<G-6659A
M9FU62#9*,4Q63$$R3VA833AT<G!.,4<X;#-D6$TP37)2;$1:45%T2W!C4D\V
M8T,O=R8C>$$[<5,S2$96669M>C5"36-K<39K-U%X>$I/6FQT3'1O,E=263-5
M4G5):7-J;%HP4$)#5S,V67%G-W(X-'9,8T0S2"MI-FIW<S58:'5&:R8C>$$[
M,"LK:FQ9<4DO=T,T4F]/36AR379*5V1'0R]&46EL5E5X,4@X>E!+=&QA,G1W
M5W4W;&)U-&$P:FET<DLV;&U%:U9Y8E-8;D5S9G%+228C>$$[-6Q+;F%P4#)1
M4U)65D1(.#-023ET;W Q6%9.4E-Z:5)I:W$K;&1%<65+3U!G94-+6&1*52]W
M0C$O85!(<4U69'%V-6DQ=#E%=69,3B8C>$$[<$9R8T=U45A.,6)3>5A$,F$K
M:F%X:5)U4$M#5G5B5F]&64QV,4EX5E0P+S@S+TM%*VY7=#ED5'9!;#AI5%=Y
M4E<Y-6-K4GEI34HV>"8C>$$[:F<T>'58;%9+5DE,14)72D]+<F@K8S,U86TY
M3F=.6D)V5F<K=$YB0S-U=E5%9$]60VYP5D5L3B]4*S,O04I/2W O;TAM:E(Y
M949Y9"8C>$$[36%D>%IU27)J,3=7-71E36A&4VXK:U)X5EIF,C%'-FY:<4A&
M53)X5C)+=7A6,DMS4CAQ9CAP<#5U+S1Y5V8X07EB9DQS;C!X8S-59B8C>$$[
M,T]0-'-U>6QW;4EE46YV53AJ>'19>%)Z,UEA57=W>GE.1$=Z96]D;6M62FU5
M9311+TQ#5D-'.'4O;6Y96"MK0SDQ4WIM=$QN,$DW>28C>$$[4S(P*T,O,4Y9
M-V5907AM4V%'>E)1-7%A;TLP07)7;&%"55DO-7%E4E539'IF>4=/,U5/.&DR
M;#)Y<T,P4U5I65)%4W17-6EQ<V9):B8C>$$[:TMJ1E5/+S5U*U(W6%599$TQ
M3%4T<E158G%36DQ3,3183$]Y47E.2%=13D)(-E1L:UEC5S=I:6QS5E)7;F9M
M6C57,5!63$A4<D$S:R8C>$$[.#$O-FYP=CE3=30P5# P:FPO96U73D-G94]D
M1U)I3TI"<EAC5E934W@O3G$U;'4W6DQZ4UEB3WHQ1RMN,"]3-W,S8GEC-6)B
M555S2"8C>$$[5V%.3&)L17IM5&Q(>#5Q5'-Z25!I0W%:4F9N2"M88VM!=41Q
M8VM6<UDO5D9X4%HS<T5247A.3V@U>7=O=C=Y2D=:3B]J-&YJ5VAX5B8C>$$[
M1F%,*UDS:S=Z2VYO-D9F4&9.3F%T8W$P9'1C:4Y9:3!K44UK:E)Q:UI,=T]!
M<FM%,#)'2W$S-60O=T1+2&%F+T%-.78K5#<T4W))."8C>$$[0W5X5FA8-6HS
M8TYL96588C8T<71T8EAW:VUC071244%E,WEY+T-,0DAK-2MI:5I#64A->%8O
M.$%L879K=B]L<6LO-45Y9C!W94)*:B8C>$$[+THR8G4K,3,O2S%F2F8X07DQ
M4V8X:5I0-EDK0DIF-4]Z9#,R=2\U5W(U3"]!3U=Q5"]K5$HO5$AW2DPO04-D
M;3=V=&0O=T%R5CAL+R8C>$$[.'15;B]);50K;5!G4U@K5',S9#ER=CA!;&%V
M:W8O;'%K+S5%>68P>#A#4R]Y9&TW=G19<%!**U-K.')Y=$AC<$DX>EA-6FEL
M,4-(,"8C>$$[6G!'3%-35W=J:U%7-6M,2&XV4$AL*S%82'=*<"]K+TXS9F%R
M9G!$.&Y"<'$V8D5S.79A24M);',Y.4%Y9WA2=VM,2D4V3T%9;U519R8C>$$[
M3G50;6%V9U12+THR6'4K,6%,>CAM4D)*07%80W=32W%E;7-L.'%Q1FA304=-
M0U0Y,C-P>$M#>55*;T-46&9(=TIR+THR6'4K,7=V9B8C>$$[>6-$5$U$94)P
M-5!86FA0<4E+>2MU='E8:E!Q+W5M85I1-T9+8VI7=&%N2'=*<B]*,EAU*S$Q
M>&1F:W!C37IY5S<K<3!344-:9G)A4R8C>$$[2VMC-'5536-I<TA2>$MO8FUP
M1&)$96='4&=46"M4<W9D.7%),5!84'EO,5,R<W)E+VUV6C$P.5I%='!$4'%#
M>F-*;$-Y3$I-<V=L;"8C>$$[1'%+34I'86]X.$-39C50>F0S,G1X-C<K54U8
M3#!O;6I$3D=X5D5U1E5'1UI*-#9+1%)1<VM3;6<R,G P,G@X0V%0-4]Y.3,R
M;V%'.28C>$$[+TIU0V5E84%835@Q<6AU;V\U8CE)6FU"<4AL:%=14D\T,F]Z
M2U-!04LW1$AW2G(O04-D;#=V=%145%!/9C5A-EIF-FAQ1G!08V983B8C>$$[
M561:3#)A53-C-5EO5TM+=G).24DP5&TS1D5O;S=$2'=*2B]K+TXS9F%M9B]!
M0W18>5@O>3%39CAI6E V62M"2D@X;EIU-S=89CAR5B8C>$$[.&PO.'15;B]!
M0TIK+W!J-$5L+VLW3C-F83<O;&%V:W8O;'%K+W=#4DUN.4UF06MV.&Y:=3<W
M6&8X<E8X;"\X04Q62B]Y2FLO<&HT128C>$$[;"]K-TXS9F%H=DE/;U<R<"M9
M+TTK;S)H6C=3-&MT9E-K2VQA.%5C2'(T66-O<4E"6C9Y0FAJ:$4X>&)..&]D
M93@X.&YE8G1,,&I1628C>$$[8D,Y4S17-&IE475Q>$U13U1K-&%19V(R,R]+
M5SDP4CE$=71,=5I.3&LY05!B5G5G0TQ556AQ>7E"+VA(=G8S<FEQ<DDO=T-7
M1#9C3B8C>$$[4$9L97A7<7!*16]H93AH8TI-27A)=G%2>7)*4GA!9V(T='AT
M,$IQ<7-I5#AR25HQ;G0W1RMT<$92;U=-16PW0TI);F1N36-Y>'EQ2B8C>$$[
M535/>$-Y5D%Q85EQ:EET5B],>4A564Y2:'1B>4LX=&E$1DMH=58R14M18U=5
M4T)86# T:TA&9U)S1#$S>%9!,C!8-54R.3 Q,4AP,28C>$$[,EIM;D8P:&MA
M-VQ73U5885AX849*2E=714YC>$Q)-GAH43%0:4)',DY*=&9+4'EP;3 V4%1P
M9$QN97EH:6AG:FA:8F=G4C(Q=3ER0R8C>$$[2VPV,5-'5FQ"<E@Y<C=10GAP
M561P*W8K4W1-*W-Y,E-A9SDQ8S(V5S!L>&109#-C:E)W=DY*17!K=5I*5RM&
M-VU4=C-P,$%O,'1P-R8C>$$[*UAQ3VYL1%0Q9%-R1#%A9VEH,VUC-&Q8+SEK
M/3PO>&UP1TEM9SII;6%G93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]X;7 Z5&AU;6)N86EL
M<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I
M<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<$U-/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @("!X
M;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E
M+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(^
M"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z1#0W1#E&1C4S
M-S,Y14$Q,3DX.#9&.34W.#=&-3,R-3$\+WAM<$U-.D1O8W5M96YT240^"B @
M(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z1#0W1#E&1C4S-S,Y
M14$Q,3DX.#9&.34W.#=&-3,R-3$\+WAM<$U-.DEN<W1A;F-E240^"B @(" @
M(" @(#QX;7!-33I296YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD
M:71I;VY#;&%S<SX*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)
M1#YU=6ED.C@W-3(Y,D$Y+41"1C M-$0Y-BU"0D$U+3)#,CE%1#0P,T8P1CPO
M>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ1&5R
M:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.D0S-T0Y1D8U,S<S.45!,3$Y
M.#@V1CDU-S@W1C4S,C4Q/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @
M(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.D0S-T0Y1D8U,S<S.45!,3$Y
M.#@V1CDU-S@W1C4S,C4Q/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @
M(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z.#<U,CDR03DM1$)&
M,"TT1#DV+4)"034M,D,R.45$-# S1C!&/"]S=%)E9CIO<FEG:6YA;$1O8W5M
M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD969A
M=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*(" @(" @(" @/"]X;7!-33I$
M97)I=F5D1G)O;3X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @
M(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D0R-T0Y1D8U,S<S.45!,3$Y.#@V
M1CDU-S@W1C4S,C4Q/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 Q+3$W5# Y.C0T.C0X+3 W.C P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS
M;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E
M9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T
M179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E
M240^>&UP+FEI9#I$-#=$.49&-3,W,SE%03$Q.3@X-D8Y-3<X-T8U,S(U,3PO
M<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H
M96X^,C R,"TP,2TQ-U0P.3HT-3HQ-RTP-SHP,#PO<W1%=G0Z=VAE;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL
M=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA
M;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @
M(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N
M9STB>"UD969A=6QT(CY0;W=E<E!O:6YT(%!R97-E;G1A=&EO;CPO<F1F.FQI
M/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^
M"B @(" @(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*
M(" @(" @(" @(" @(" @/')D9CIL:3Y$951O>2P@36%R:7-H:V$\+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T
M;W(^"B @(" @(" @(#QD8SID97-C<FEP=&EO;CX*(" @(" @(" @(" @/')D
M9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F
M875L="(O/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z
M9&5S8W)I<'1I;VX^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC871I;VXO
M<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" \+W)D9CI$97-C<FEP=&EO
M;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @
M(" @(" @>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O="]P9R\B"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B"B @(" @(" @
M(" @('AM;&YS.G-T1FYT/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M<U1Y<&4O1F]N=",B"B @(" @(" @(" @('AM;&YS.GAM<$<](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]G+R(^"B @(" @(" @(#QX;7!44&<Z36%X
M4&%G95-I>F4@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" \<W1$:6TZ=SXW,C N,# P,# P/"]S=$1I;3IW/@H@(" @(" @(" @(" \
M<W1$:6TZ:#XU-# N,# P,# P/"]S=$1I;3IH/@H@(" @(" @(" @(" \<W1$
M:6TZ=6YI=#Y0;VEN=',\+W-T1&EM.G5N:70^"B @(" @(" @(#PO>&UP5%!G
M.DUA>%!A9V53:7IE/@H@(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!4
M4&<Z3E!A9V5S/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A
M<F5N8WD^5')U93PO>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^"B @
M(" @(" @(#QX;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#Y4<G5E/"]X;7!4
M4&<Z2&%S5FES:6)L94]V97)P<FEN=#X*(" @(" @(" @/'AM<%109SI&;VYT
M<SX*(" @(" @(" @(" @/')D9CI"86<^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \<W1&;G0Z9F]N=$YA;64^0V%L:6)R:3PO<W1&;G0Z9F]N=$YA;64^"B @
M(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/D-A;&EB<FD\+W-T
M1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT
M1F%C93Y296=U;&%R/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @
M(" @/'-T1FYT.F9O;G14>7!E/D]P96X@5'EP93PO<W1&;G0Z9F]N=%1Y<&4^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/E9E<G-I
M;VX@-BXR,CPO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @
M(" @/'-T1FYT.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/F-A;&EB<FDN
M='1F/"]S=$9N=#IF;VYT1FEL94YA;64^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1.86UE/D-A
M;&EB<FDM0F]L9#PO<W1&;G0Z9F]N=$YA;64^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IF;VYT1F%M:6QY/D-A;&EB<FD\+W-T1FYT.F9O;G1&86UI;'D^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C93Y";VQD/"]S=$9N
M=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G14>7!E
M/D]P96X@5'EP93PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IV97)S:6]N4W1R:6YG/E9E<G-I;VX@-BXR,CPO<W1&;G0Z=F5R
M<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F-O;7!O<VET
M93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z9F]N=$9I;&5.86UE/F-A;&EB<FEB+G1T9CPO<W1&;G0Z9F]N=$9I
M;&5.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IF;VYT3F%M93Y#86QI8G)I+4)O;&1)=&%L:6,\
M+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N
M=$9A;6EL>3Y#86QI8G)I/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$9A8V4^0F]L9"!)=&%L:6,\+W-T1FYT.F9O
M;G1&86-E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=%1Y<&4^3W!E
M;B!4>7!E/"]S=$9N=#IF;VYT5'EP93X*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.G9E<G-I;VY3=')I;F<^5F5R<VEO;B V+C(R/"]S=$9N=#IV97)S:6]N
M4W1R:6YG/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z8V]M<&]S:71E/D9A
M;'-E/"]S=$9N=#IC;VUP;W-I=&4^"B @(" @(" @(" @(" @(" @(#QS=$9N
M=#IF;VYT1FEL94YA;64^8V%L:6)R:7HN='1F/"]S=$9N=#IF;VYT1FEL94YA
M;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI"86<^"B @(" @(" @(#PO>&UP5%!G.D9O;G1S/@H@(" @(" @(" \>&UP
M5%!G.E!L871E3F%M97,^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" \<F1F.FQI/D-Y86X\+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:3Y-86=E;G1A/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D^665L;&]W/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0FQA
M8VL\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \
M+WAM<%109SI0;&%T94YA;65S/@H@(" @(" @(" \>&UP5%!G.E-W871C:$=R
M;W5P<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \>&UP1SIG<F]U<$YA;64^1&5F875L="!3=V%T8V@@1W)O=7 \+WAM
M<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<%1Y
M<&4^,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G.E-W
M871C:$=R;W5P<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F
M.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X
M<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( -L!G ,!$0 "$0$#$0'_Q  ?  $
M @(# 0$! 0          !P@)"@0%!@L" P'_Q !:$  !! ("  (&! D%"P<)
M"0 $ @,%!@$'  @)$1(3%!4A5Q8Q0=07&!DB4926E]8C56%QI HD,SA"=H&1
MH<'3)3*SM;?1\#525F=W@K&VX3=#4W*2H[*T\?_$ !T! 0  !P$!
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M<H5FZ;)[S3 =,@M?Q[FMM(BVR=J,^9LF0M.P(6(@Y> D:I965 QA\[F?. $
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M2#O8>%ZIS^P:M-:J>CH+>4O$N2Q\$/K8_8@6Z['4:$A'L6T=EP6N"Z-19%)
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M'E1%A,',$4<MK**SB[@9B[-6V3($=RX02M"8:6)#4.<'8Z XWAHJ5%"W6US
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MR9$V5<OA,7NX75QFT27GX;L1-Q$YMZZS9RI3!COJ2IR.@N!Y#8=>4Z1A*55
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MX1M3*V;=&^#"R[.N3,93\N-\*,*C]V1%YB93C"G5/..(><3R6D!@/*:"&U'
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M;?<[]*@J;E)  &0?21^$D8P5)U*2DJ3U2"1E6!G>M4/25?VQ7^S]MES]EV&
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M;).")D@R"Q,XCVB7TD"DOM.M/BZZC\+W)X:B&64J4"CGN(0XXA>?OA8U<Q&
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MEHI.@&LPM-J E3"0&$TEEO"<>EC"<8\\^6<?5C&/C_\ #'Z>8U675W<Y#L3
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MXCMBI$J)(6LRE,.S!S%,I;*D<M#:-24\]Q94TMQ"5<A)"U!6="N4NW/MAO?
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M;<-O_<I/\JND'U!TE#<U6Z#4M  .Z0CYR(U*Y'KIX"Z'%6=P8BR1L"H,EG+
M-@.##E9H1W+S$I-B"SAJ'I<=HU#NDK\FD?L7/X:A\$W7\VW#^IR?Y=<Z/UGT
MWBIW5=FC('1D?8-(43\%^II<(RJC&T77*87Z.M4>#>9,1EJK#0F5QX<(]ZX
M)EU_(C#+A#ZW'=)7Y+(_8N?PT^"KM^;;A_4Y/\NO)T#KOT!U8/9!-=ZSZT5
M6X4^=UY:A84&BC#6'7UER'B9H<NQZQ31U*+: #%15'T+@ P!VX\&/&!QD?+N
MDK\FD?L7/X:B;5=CUMMQ_J<G^77M*3K[J#KB-Q$4B*TI7HW%"QJU0@<G6EMO
M:YQ-V.R?0LG))[ZRJZJ=M]GE5QA*G1W#)V2=6E625XR[I*_)9'[%S^&GP5=C
MUMMP_J<G^77GY32?1V9UC0=,R%/T&O6&JE#.:QIXY-6 C=>/"A&1K9-*< -&
M.K!:XV2DHXHN%+").CY*2"-=(%D#&GG=)7Y-(_8N?PT^"KMG/P;<<^?<Y/\
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FZTY6AAI/JT*2TC",>@VGSSYR%DE1SZOHJ<C\$?+]-6RYXKU7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>bdtx-20211231_g11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g11.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,Q
M-P  DI(  @    ,Q-P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+/\ Y](/^_8H^P6?_/I!_P!^Q0!RW]H/ZT?V@_K74_8+/_GT@_[]BC[!9_\
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M"S_Y](/^_8H^P6?_ #Z0?]^Q0!RW]H/ZT?V@_K74_8+/_GT@_P"_8H^P6?\
MSZ0?]^Q0!RW]H/ZT?V@_K74_8+/_ )](/^_8H^P6?_/I!_W[% '+?V@_K1_:
M#^M=3]@L_P#GT@_[]BC[!9_\^D'_ '[% '+?V@_K1_:#^M=3]@L_^?2#_OV*
M/L%G_P ^D'_?L4 <M_:#^M']H/ZUU/V"S_Y](/\ OV*/L%G_ ,^D'_?L4 <M
M_:#^M']H/ZUU/V"S_P"?2#_OV*/L%G_SZ0?]^Q0!RW]H/ZT?V@_K74_8+/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %07/^K-3U!<_ZLT <KJ'^L-=38?\
M(-MO^N*?R%<MJ'^L-=38?\@VV_ZXI_(4 6**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ*ZN[>QM);
MJ^N(K:WA4O)-,X1$4=22> *KZ5K6EZ[:-=:)J5GJ5NKF-IK.=9D#  E25)&<
M$''N* +M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?KG_(%G_X#
M_P"A"M"L_7/^0+/_ ,!_]"% '/:?_K!756O^K%<KI_\ K!756O\ JQ0!/111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '.>+?&-K
MX6@C5XS<7<P)CA!QP.['L*X>W^+FJK<@W5C9O#GE(PRMCV))_E65\23,?'5Y
MYV=H2/R\_P!W8.GXYKE:]_#X2DZ2<E=L^)QV:8E8F482Y5%V^X^BM$UJTU_2
MX[^P8F-B05;AD8=5(]:T*\T^#YF\K5<[O(W1;?3=\V?TQ^E>EUX^(IJE5<$?
M58'$2Q&'C5DM7_PP4445@=@4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %9^N?\@6?_@/_ *$*T*S]<_Y L_\ P'_T(4 <]I_^L%=5:_ZL
M5RNG_P"L%=5:_P"K% $]%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?]6:GJ"Y_P!6: .5U#_6&NIL/^0;;?\ 7%/Y"N6U#_6&NIL/^0;;?]<4_D*
M+%%%% !7P_\ 'H2#XX>(O-SN\R'&3V\B/'Z8K[@KYA_:C\#W,6M6OC*RB9[2
M>);:]*C/E2*<(Q]F!"_5?<4 ?0FLQW=[X#OX_#+F*\GTV1=/97VE9&B/ED-V
MP2O-?)_B/2/CAX2T.75_$&K>(+2QA95>7^W_ #,%B .%E)ZD=J]+^#'QXT+_
M (1:S\/>,KU=.O;",0074V?*GB487+?PL!P<\'&<Y.*O?'[QYX4U3X47VF:5
MXBTV_O;B6$QPV=RLQ(60,<["<< ]<4 9W[,'BS7_ !!/XBM=>U>]U..%8)(C
M>SM,T9)<'!8D@' X]OK7!?M0_P#)7(?^P7#_ .AR5TO[)/\ R%/%'_7&V_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5GZY_R!9_^ _\ H0K0K/US_D"S_P# ?_0A0!SVG_ZP5U5K
M_JQ7*Z?_ *P5U5K_ *L4 3T444 %%%% !1110 4444 %&:*:.M #J*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMI?01W-M,A26&5 RNIZ@@\$5-10!X?XD_9<\+:I=27&@ZC=Z*7R?)VB>)3[
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.NKD/Y<DBJB\#/6MZ>65%!3K)I/;_@F><4<PRZC#$>S]Q]6?6(.1D<BBN?\
M Q9O!6FEW,A\KEB<D\UT%>3*/+)Q[%4Y^T@I]U<****DT"BJ]U?VED5%W<1P
M[_N[VQFIU8,H93D$9!'>@5U>PM%%% PHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L_7/\ D"S_ / ?
M_0A6A6?KG_(%G_X#_P"A"@#GM/\ ]8*ZJU_U8KE=/_U@KJK7_5B@">BBB@ H
MHHH **** "BBB@ IBGYJ?4:_>% $E%%% !1110 4444 %%%% !1110 4444
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M11169T!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4%S_JS4]07/\ JS0!
MRNH?ZPUU-A_R#;;_ *XI_(5RVH?ZPUU-A_R#;;_KBG\A0!8HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&K*[,0>Q(0C/O7@GP7^#\'Q.;4;O5=1FL[&Q9(RMN%,DKMD]3D* !UP<Y]J
M-#]H+Q9X'\976D:CX-O([F^3S4O72TDA+K\I0L71=V#N]>M>N_LQS22_!\)(
MQ98M0F1!_=&%;'YDG\:\;^./PG\/_#.UT=]"O=0N);YY1(E[+&V%4+@@*B]V
M]Z]A_9?_ .212?\ 82F_]!2@#YW^,_\ R6;Q+_U^'_T$5](_#+X*>%M)\!VG
M]OZ/8ZMJ5]"L]S/<PB39N&0B9^Z #C(P3U^GS=\9_P#DLWB7_K\/_H(K[:\/
M?\BSI?\ UYQ?^@"@#F?&/PT\'>(5TB[\2Q"&PT"-EBB\X0VXC(4;7_V1M&,$
M>^1Q66?BU\)?#EI_9MMK6F06H&SR+&T>2/'I^[0KBO'?VH_%.H7'C6V\-K,\
M>FVEJD[0J<"25B?F/K@  >G/K6Q\/?V:=&U_P9IVM>)-8OQ-J-NMRD-@T:+&
MC@%02RMDX//3DX[4 >*^/[G0Y_B%J]UX/=?[)EN/-M6CC:(#(!.U6 *@,2 ,
M#IQ7UO\ &?Q!<:-\#=4NX9-MS=V\5L''!_>E5?\ \=+5\E?$;PY8>$OB'JVA
M:3/-/:64JQQR3NK.?D4G)4 9!)'0=*^H_CW9R77P!N7B!/V?[+*P SQO53_Z
M%G\* /%?V;O"-CXE^(LUWJUO'<V^E6WGI%(,J92P"$CN!\Q^H%>X?'KP'I'B
M3X=ZCJ\L*0ZGI-NUS!=(@W,JC)C;U4C\C@^H/DW[*>HP0>.]7L)6"RW5@'BR
M?O;'&1]<-G\#7NGQFU6RTKX0^(6OYUA^TVCVT(/621P0J@=SW^@)[4 ?-'[.
M/_);-,_ZX7'_ **:NW_:O\13'4M#\-QN5A6%KZ9!T<LQ1,_3:_YUQ'[./_);
M-,_ZX7'_ **:NC_:NL98_'^C7[#]S/I@A4X_B25R?TD6@#O_ -FCP5IMCX C
M\42VT4NI:E+)Y<[J"T42.4"KZ996)(ZY'H*I_M/^#-.F\'P>*;:UCAU&UN4B
MGF1,&:)\CYL=2&VX)]373?LXZC;WOP5TVV@=6DL9IX9E!Y5C*T@S_P !D%4O
MVF]6@L?A*;&211/J%Y%'&G<A#O8_0;1S[CUH Y#]DW6KAD\0Z)([-;Q^5=Q+
MV1CE7_,!/RK@_P!H'X?_ /"&^/6U'3XMFEZPS7$.T<12Y_>)[<G</9L=J[3]
MDO3YCJ'B342I$"Q0P!L<,Q+,1^  _,5B_M+^/QKWBJ+PKIL@>STARUPRG.^Y
M(P1_P ';]2P[4 <5XY^)NM?$;2_#NDWB.SZ? (G"\M=7!.WS"!U)4*,8ZEO6
MOK+X3^!8_A_X L]+95^W2C[1?..=TS 9&>X484?3/>OC37/#OB#X<^(M-;4$
M-EJ B@U&U=>2F<,O_ E8$$>JGK7VW\/O&-MX[\$6&NVNU7F3;<1*<^5,O#K^
M?(]00>] 'R#\=?\ DMWB/_KM'_Z)2OI+QAX@F\-?LSC4+1V2X.BVUO$RG!5I
M42/<#V(#$_A7S;\=?^2W>(_^NT?_ *)2O?\ XG64U[^RK&+=2[0Z;83,H_NJ
M8BQ_ 9/X4 >+?L[^$;'Q7\3=VKP)<VFFVK7?DR %9'W*JA@>H^8G_@(KZYUS
MPQHGB33&T_7=+MKVU9=HCEC'RC_9/53[@@BOEW]EG48+7XF7UG.P62\TYUAR
M?O,KJQ ]]H8_@:^M))$AB:25U2-%+,[' 4#J2>PH YWQ!X$T7Q'X$_X1&ZCF
MM]*6***-;>3#Q+$5* %@>FT#G/%<M9^*?A%\,(3IMAJ.DZ>\(VR"V4SS$C^^
MR!F)^M8G[1_C&ZTOX96*:!> 1:W.$:ZMY,AX-A;Y6!Z-\O(ZC/K7DGP6^"EI
M\2M-O=6UG4I[6QMKC[,L5KM\QW"JS$E@0!AAV.<GTH K_'WQ)X+\5^)-.U7P
M3<QW$KP.E\\=K)#N8$;"=ZKN."PSSP![5[[^SO-)+\$-'$C%O+DN$7/8><YQ
M^M?/WQQ^&6A_#34-'MM!O+ZX-[%+),+R5'9=I4+C:BX!RW7/2O?OV<_^2(Z5
M_P!=KC_T<U 'RGXB_P"2KZK_ -AN;_T>:^_:^ O$7_)5]5_[#<W_ */-??M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9"-C!5N^UN,X] ><8KN:* /C.P\)?&3X6ZI<?\(]IVJ1&4A7?3H!=PS =#M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9,^PI4J-E4II;:>@4445D= 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !6?KG_(%G_X#_Z$*T*S]<_Y L__  '_ -"% '/:
M?_K!756O^K%<KI_^L%=5:_ZL4 3T444 %%%% !1110 4444 %583^]%6JJ0?
MZY: +=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !6'IGAUM/\2:AJIU":<7G2!Q\L
M?.?7G'0<=*W**J,G%-+J9SIQFTY=-4%%%%2:!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !4%S_JS4]07/^K- '*ZA_K#74V'_ "#;;_KBG\A7+:A_K#74
MV'_(-MO^N*?R% %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "LZYU_3+3Q!9:)/=*NHWT<DD%N 2S*@RS''0?7K6C7E=WX:L-#^/?AJ^M
MC/->:G%J,MS<7$I=FPJ;4&>%102 HZ4 =7XD^)/A3PEJD6G:]JJV]U(H<HL3
MR>6A. SE00@]SBK7B3QQX>\)Z;;7VM:@L<-V<6PB1I6FXSE50$D8YR.*Y?P?
M;0:AX@^)#W\:2O-J7V63S%SF%;9 JGVPQX]S7+?"-FO_ !!X2>^)E:T\(,;8
MOSC-T4)'_ %0?2@#V'1-;T[Q%H\&J:+=I=V5P,QRIT/.",'D$'@@\BK]<'\-
MD6VUGQO:6ZA;:+Q [1HHX4O#$S@?\")/XUT&LR>*EO5'A^WT>2UV#<;V:5'W
M9.>%4C&,4 ;E%>->,?%_Q LO$4>DHMO9O':BY>32D-P'#L5 ;S(^"-C'CKFL
M3_A+OB+_ -!'4?\ P71__&Z[*6#JU8<\;6]3AK8ZE1GR2O?T/H"BOG6Z^(/C
M73W07^OSVQ?E%GM84W_3*#->A> O'NL^(_$LFG:I#;QI' SG9&58,"!SD^]7
M/ 5H1<W:R\R89A1G-05[OR/2****X#T HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $<%D8
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M9LC[R.V67!)RK#G'KFNKOOBSXV@^!>E>,K/0+2[U*\GD,Z16LSP6]LAD_>,
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MP >OT5XO\,_BSXX\1^.D\.>,_"2Z6TEN\_FBVFMVC50.2LA.020.".HKVB@
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M61E'RJX'  [5Y3\;OAY8_#KQO%9:-+(]A>6PN8DE;<T7S,I3/<?+D'KS[9H
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M[-7_ "1FV_Z_)_\ T*O6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2O&X,H0 *0!@_>/7OZGXY\'6/CSPC=Z!J<DD,4^UDFB^]&ZG*L >#]/0GZT
M>=?LPZ?#8?"EKHNGFZCJ$K_>&<*JJ%_\=8_C7G7P_%OXG_:RU6\UUT>2WN[N
M6W24C#/&VR-1GJ57D?[F>U>E?#7]GRR^'_BY-?FUR35+B!'6W3[((1&64J6/
MSMD[21VZFJ7C3]F?2O%/BRYUK3]<FTH7DIFN;?[*)E+DY8H=R[<G)YSR?PH
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MH5CJMG;WUI+]H\RWN8EDC?%O(1E6!!P0#]17V!_PKCP1_P!";X?_ /!7!_\
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MJ2*.UT>%BHE7SYL'[PR0H^F03^ JI\,?"MO>J^LZC$LJQOLMXW&1N'5B._7
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MR=+6ZC-C=/PBNVY'/H&]?8UTNH:58:K"8M1M(KA2,?.N2/H>H_"O#_&'A_\
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MZ:@#YE_:Q?R]=\+OC.V&<X_X$E>DZSJ5MXP^"%OXGN-.AANY[:-X_P"-H<R
M$!L9[5F_M.P0M\)O/:)#,E]"JR%1N4'=D ]1TI=&_P"35M,_Z\HO_1HKHPK:
MKPMW7YG-BDGAYW[/\CL?A7_R3ZS_ -^3_P!#-=C7 _"S6M-'A2RTLWL(OB\A
M%OO^?[Q/3Z<UWU/%IJO._=DX.2>'A9]%^04445S'6%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M J"Y_P!6:GJ"Y_U9H Y74/\ 6&NIL/\ D&VW_7%/Y"N6U#_6&NIL/^0;;?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML4 3T444 %%%% !1110 4444 %9EF?\ 2D_'^5:=9=G_ ,?:?C_*@#4HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBYT^RO8DCO+2"X1/N++$&"_0$<5M1Q\::I)KX+_.YE5P<JCJM/X[?@<WK/\
MR2O_ +<8?Y+4/PP_Y%23_KZ?_P!!6NM>U@DM?LTD$;0;=OE,@*X],=,4EK9V
MUE#Y5E;Q6\><[(D"#/K@5@\4GAY4K;RN;+#M5HU;[*Q*RAE*L 01@@CK7A5\
MTVB76KZ2I(CDD\M\=PKY4U[M5.?1]-NK@W%SIUI-,<9DD@5F..G)&:TP&,CA
M7+F5T[?>MB,9A7B$N5V:_4X[Q!HGE?"NUB _>6:1SG(YR?O#_P ?/Y5S?A1I
MM>\7:2LY9EL(1@]<+'DK^I KU^2-)HVCE171AAE89!'H15>TTO3["1GL;&VM
MG88+0PJA(].!6M+,>2C.$E=N]GVN9U,!S58S3T5KKO8M5Y;X<_Y*Y>_]?%S_
M #:O4JK1Z;8PW;74-E;QW#DEIEB4.V>N6QFN3#8A485(M?$K'3B*#JRA)/X7
M<@U;0M.UR.--4M_/6(DH-[+@G_=(J+2O#&D:)<M<:99^1*Z;&;S';*Y!QR3W
M K5HK!5JJAR*3MVOI]QLZ5-RYW%7[VU/'_ &M:?HFJ74NJ7'D))#M4[&;)W
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MRK>\1_\ )+G_ .O6'^:5TEW86=^JK?6D%R$.5$T8?;],T^2UMYK8VTT$<D!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7.^(_&VF>&;N*VOTN))9$\P+ @.%R1DY([@UT5>/\
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MPPR/YUYUX@TSP&_B*Y;4M5NK>[:0F:*(,5#'KSL./SKT**2SL-'22-U2RMX
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M$G"CJGX&@#Z*HKS;Q+XH\(?$?X0^(9=/\3O9Z2BB&ZU*.UE!@(*-C8P5F!!
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MX9UN&]N(TWM"8WB?;G!(5U!(R1R/45U- !1110 4444 %%%% !1110 4444
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M8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2?\ >E_DM>E5YK\8?^/?2?\ >E_DM8X+_>(_UT.G-_\ <I_+\T<SX/\ &O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5Y!\6U/\ PE5JV#@V2@''^V]>OT5OAZWL9\]KG%CL
M+];H^RO;\3!\$(T?@G3%=2K>5T(Q_$:QOB7X;;5M(34+.,O=68.Y5&2\9Z_E
MU_.NWHHC6E&K[5=QSPD*F&^KRVLE]W4^:[2&2:]ABB1GD9P BC))S7T)KNE)
MK>A7>G2-M$\> W]UARI_,"M"BML1BW6E%I6L<N!RR.%A.$I<REY6[^?F> V\
MFK>"/$:R/"8KF$D%7'R2KWY[@^HK=USXH7VJZ5)96UDEGYR;)9!(78@]<<#&
M?QKUNYL[:]C"7EO%<(.0LJ!A^1JM#H.D6T@DM]*L8G!R&2V12/Q K9XRE-J5
M2%Y(XXY5B*2=.C6M!^7]?H>=?#;PC<G4$UO486BAB!^SHXP78C&['H!^OTKL
MO'>E2ZOX0NH;9"\T>)40=6VGD?7&:Z*BN6IB9SJJJ^AZ5' 4J.&>'6SO=^IX
M'X4\43>%-2EN$MA<)*GER1,^SOD'.#S^'>O8/"&OR^)-#^WSP) QE9 J$D8&
M/7ZU>GT/2;J8S76EV4TI.2\ENC,?Q(JW##%;PK%;QI%&O"HBA0/H!6F(Q%.L
MKJ-GW,,!@:^$?+*I>':P^O-_C C&TTMPI**\@+8X!(7'\C7I%%84:GLJBG:]
MCMQ>'^LT)4KVO_F>">&_&.H>%X9X]/AMI!.P9O/5CC'IAAZUM_\ "VM=_P"?
M33O^_;__ !=>P45URQ=*;YI4]?7_ (!Y=/+,32BH0Q#27E_P3BO&7BB:Q\#6
MLJ#R[S4X5 *CB,%07(_/ [\^U<M\+_#_ -NU=]5N4S!9_P"JR.&D/^ Y^I%>
MO45C'$\E)TXJU^IU5,O=7$QKU)W4=E;\=^^NQXE\1/#QT7Q$]Q F+2])E3 X
M5OXE_/GZ&O1/A]KS:WX:1;C)N+3$,C'^,8^4_EU]Q74T4ZF)]I24)+5=18?+
M_J^)E6A+272WZW_0\'\<Z9/I?C"]:1"J7$IGB<#A@QSP?8DBNW\+_$6ZUW7+
M#2Y;&.,R*PEF#D[BJ%L@8XY'O7=W5G;7L7E7MO%<1YSLE0./R-16FDZ=82%[
M'3[6V<\%H850_H*TGBH5*2C..J6C,*66UJ&(=2E4M%N[5O/8\P^)7A2Y@U63
M6K*%I+6< S;!GRGQ@D^QZY]<U%HGQ2O=,T^*TO;)+U85"(_F^6V!TSP<\5Z_
M6?+X?T:9R\VDV,C'JSVR$G]*(XJ$J:A6C>P5,MJPKNMA:G*Y;JUSS9/B/XAU
MG5+:UTNVB@#2J"D<?F,PR,Y)[>^!76?$Q&?P1<;%+;98R<#.!NZUT]M96MDA
M2SMH;=3U$484'\JFK*5>'/&4(V2_$Z:>#K.C.G6J<SDON]$>1_"-6_X2*\;!
MVBU(SCC.]:[;XB*6\ ZB%!)Q&>!_TU6NFHI5,1SUE5MM;\!T,#['"/#<U[IZ
MV[^1Y'\(U/\ PD5XV#M^R$9Q_MK5KXI>&Y_MBZY:QEX60)<;>=A' 8^Q&!^'
MO7J5! 92&&0>"#WK1XQ^W]JE\C%97'ZG]5E*_6]NIXQX?^)%]H6BC3S:1W0C
M!$#NY79DYP1W'Y5A:W#J]QY>M:PCC^T'8H[C&[;CH.PP0!]*]T70-'2;S4TF
MQ63.=XMD!_/%:%;+&TX2YH0U>YRO**U6FJ=:K=+;3^KG,_#M2O@'30P(.)#R
M/^FK5TU%%>=4ESS<NY[M&G[*E&G>]DE]QR7Q,5F\$S[5)Q+&3@=!FN-^$BM_
MPE5TVT[19,"<<9WI7K]%=$,3R472MN<-;+_:8N.)YMNEOU"BBBN0],\@^+:M
M_P )5:M@[39* <<9WO79?#-&3P3!O4KF60C(QD9KK:*ZYXGGHJE;8\RC@/98
MN6)YM^EOU"O*==\4^)/"WC"]+%Y+.60M%%< M&R=MI[?@>O6O5JCF@AN8C'<
M1)*AZJZA@?P-9T:D:;?-&Z9OB\/.O%>SFXM.]SRRZ^+M[)9&.UTV*"X((\YI
M2X'N%P/U)K%\'>$[SQ%JT=S<1.+!)-\TS='P<[1ZD_I7L"^'=%5]ZZ/8!LYW
M"U3/\JT%4*H50  ,  =*ZOK<(1:HQM<\W^RZU:I&>+J<R72UA:***\X]X\!\
M9(Z^--3#*P+7#$ CKGI7L%ZC_P#"N[B/:V_^RF7;CG/E=,5O45V5<5[105OA
M/*PV7>PG4ES7Y_+;?S/#?ARC'Q]IY"DA?-W<=/W35['KP+>'-2"@DFTE  [_
M "&K]%37Q'MJBG:UB\%@?JM"5'FO=OIW5CPSX<JQ\?:?@'Y?-SQT_=-7N=%%
M+$U_;SYK6*P&#^ITG3YKW=]K=O\ (****YCT HHHH **** "BBB@ HHHH **
M** "H+G_ %9J>H+G_5F@#E=0_P!8:ZFP_P"0;;?]<4_D*Y;4/]8:ZFP_Y!MM
M_P!<4_D* +%%%% !1110 4444 %%%% !1110 4444 5[^]ATW3;F^NB5@M87
MFD(&2%4$GCZ"O'F^./B37_G\ _#?5=2M#]R]N\Q(X]@ 1_X]7M) 92&&0>"#
MWKFO"GCO1O%DEU:6326FI6+F.[TV[7RYX"#C)7NOHPXY_"@#SG_A9GQ>TU3+
MJWPM^TQ#DK93$MC_ ("7.?PKMOA]\3+'Q\;ZVCTV_P!*U'3PGVJSO8MK)NS@
M@]Q\IZ@'VKSZY^-/C!-*OO%<&F^'1X9L[QK=K26Z<7[*LFS^]M#'KC'3UZGW
M.)DE19T7'F(#DC!(ZC/YT /HHHH **** / _%?B'1M<\:^)(_$]_XA":3*+6
MR@T43$6(6,%KJ3R^.78@;L\)TKH6M)_&OB#PYX9U37Y[_2X= _M.ZN;"5K?^
MT79Q'&Q*G., MC/6K-Q'X@\#>*_$TFE^%;G7[3Q%,MU;2VCH/*F\L(T<VXC"
M9&0W/4U1T[PUX@^&R^&-4M-)FU[[+H[:9J=M8%?-0F3S59 Q&X!BR_3F@#J/
MAC<7<-KKN@7UY->_V%JLEI;SW#[I&@*))&&;N0'QGVK<UCQCHF@7JVFJW4D,
MS() JVTL@VDD=54CL:ROASI.J6=AJVJZ_:_8K_7-1DOGM-X8VZ%51$8C@L%0
M9QW-=C0!Q'AO7=/\0?$G6+G29GFB32[1&9X7CP?-G/1@#WKMZYFT_P"2J:I_
MV"+3_P!&SUTU !1110!\Q>)/V>?'.H^-M8UG2=3TZVCOKR6:,BZD1]CN6 .%
M^E5O@#'JVF?'35-$U>_EN9;&TN(9!Y[.A=9$!(S7U-7S1\*?^3KO%OUO?_1R
MT ==\2+[^S?BI97VSS/LT<$NS.-V&)QFO:$;?&K=-P!KR7XU(@O]'<*H=ED#
M,!R<%<<UZQ#_ *B/_='\J]'%-2P]*7DU]QYF$3CB:T?-/[Q]%%%><>F%%%%
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M]F>.'>DK''+(#6E',WDIGKC@5'*5<V=Z[L9Y%.SFJ%J[.Q9^M75-2,=1112
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%?\ W6E_V]^9YN'_ -[K?]N_D/HHHKSST@HHHH **** "BBB@ HHHH ****
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ME!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTZN<\ <^!--_W'_]#:NCK@J1Y)N/8]JC4]K2C4[I/[PHHHJ#4**** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJT);--_K^5SB=1OY;_5[B^9V$DTK2 YY&3FO?M"U)=2\.65^SC]Y K2,3C#
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M>_[L?_H"UT82"IXJ4%T7^1PYG6E7RZG4ENVOR9V?ASQWX>TSPK8VUU?,+B"
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M[K_^AM71UX=?^++U9]A@_P#=J?\ A7Y!11161U!1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\*FJ#I,T>Q&_=]_6KJQ3[8Q&5V@#[U8R@T[&JDFKFM;2M"SP[<B/[M:< "J
M."W)K+M$)8ENO>M2$;CGTK"12+:TZF)3ZR- HHHI %%%% !1110 4444 %%%
M% !1110 4444 %%%% !6?KG_ "!9_P#@/_H0K0K/US_D"S_\!_\ 0A0!SVG_
M .L%=5:_ZL5RNG_ZP5U5K_JQ0!/1110 4444 %%%% !1110 5S.D'_B:0_\
M O\ T$UTU<QHY_XFL/\ P+_T$T =/1110 4444 %%%% !1110 $!E(89!X(/
M>ODGXI_ WQ#X6\23Z[X'M+B[TIY#/&MCDSV3$YV[1\Q4'HRYP.N,9/U+XAO;
MG3O#.IWMC%YUU;6DLL,?]]U0E1^) KYI^"/Q@\::K\0M,\.:SJJZC87AD#&[
M0&1-J,_RN,$DD ?-D>F*45S3LMU_7Z%-\L+O8\V_X69\1@?[._X2?7/-QL\O
M[0_F_G][/ZUVOPN^"/B+QAXFBUKQK:7=II22B:8WP99KTYSM ;YL'NQ[=/;Z
M[HJXOE=^I$E=6Z !@8' HHHJ1A1110!Q7Q>OM;L?ACJH\+V5W>ZG<J+:)+2%
MI9$#G#, H)X7=SV.*^-?^%<>-_\ H3?$'_@KG_\ B:^_Z*E1LVRF]$CX _X5
MQXW_ .A-\0?^"N?_ .)KZ%_9@\.ZWH%IXC&O:/?Z89G@,0O;5X=^ ^<;@,XR
M.GK7O5%:*5DUW,W&]CXU^)/@?Q9?_&76KVQ\+ZS<VDFH[TN(=/E>-UR.0P7!
M'O7UUK.C6?B#P_=Z1JD?F6EY 895[X(QD>A'4'U%:%%0DE35/HBFVZG.?&/B
M7X,?$+X?^(6NO#5OJ-] CD6NHZ.6,VT^JH=Z''!XQZ$TOACX*^/_ !]XA6Z\
M36^H:?;R./M>HZMN\X@>BN=['' SQ[U]FT4XZ;Z@]=BII.EVFB:/::7IT0BM
M;.%88D'95&!^-6Z**;;;NQ))*R/B7]H/_DNWB'_MV_\ 2:*OMJOB7]H/_DNW
MB'_MV_\ 2:*OMJD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***9*)#"
MX@94E*G8SKN4'L2 1D>V1]: 0^BO*?\ B[G^?LE95_XF^(NF:Q;:5?7?E7MU
MM\F+RK<[MS%5Y P.01R:]N&3SJ.T*T&_*7_ /HJ>05*KY:=>FWY2O^A[717E
M/_%W/\_9*]!\,?VO_P ([;?\))_R$OG\[[G]\[?N?+]W'2N/$X+ZO#F]I&7E
M%W9P8O+_ *K34_;0GK:T97?KML:M%%%<!Y@4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S_CK_D1]3_ZY#_T(
M5T%07MG;ZA9RVEY&)8)1M="2,C\*NG)1FI/H95H.I2E!=4T>+?#;_D>[+_=D
M_P#0&KW"L33/!^A:->K=Z=8"&=00KF5VQG@_>)K;KHQ=:-:IS1['#EF$GA*+
MIS:;O?3Y!7S_ .*8GM?&FIBYC/\ Q^/)M;C<K-N'Y@BOH"L37O"6D^(]KZA
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M6D:Q0Q*%1%Z "J>KZ!IFO1QIJUJ+A8B2GSLI7/7E2/2L(8A+$>VEL=E7 R>
M^JP>MEZ;W9QWPA_Y NH?]? _]!K ^*]JT7BF&XYV3VRX..X)!'\OSKU+2=$T
M[0K9K?2K86\;MO8!BQ)Z=22:9K>@Z?X@LQ;:G#YBJ<HZG#(?4'_(JXXJ,<2Z
MMM&8U,NG/ +#77,ON.+\)>/=&TWPK:65])(ES!F/RUC)W L<$'IT/K1\7_\
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MY L__ ?_ $(4 <]I_P#K!756O^K%<KI_^L%=5:_ZL4 3T444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME92D6D/B6KD*U#&E78DKFFS6*+,*]*O1CBJT*U<08KCFSIB/%+116)84444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ J"Y_U9J>H+G_5F@#E=0_UAKJ;#_D&VW_7%/Y"N6U#_6&NIL/^
M0;;?]<4_D* +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 <S:?\E4U7_L$6G_HV>NFKF;3_DJFJ_\ 8(M/_1L]=-0
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M*?R% %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWPW_ - .P_[\+1_PAOAO_H!V'_?A:VJ*T]M4_F?WD>QI?RK[C%_X0WPW_P!
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M20Y13Z:!3JS+"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<31+-"\3YVNI4X]"*,9B(5914'HAY3@*N'A.556D]/E_7Y'@7@[_ )'+2O\
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M*5-BDQ3N*Q"4I-E3[: N:?,%CQ?XW:'<S:II6J);EM/MT(N7'0$]*Y.QVK;
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ME5%Z61G45Y<SU,J#5_L.H1W,,C031ME'&3MKWKPU>WFIZ+%<:C;F"0@8)/\
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M /\ ",DD5[6&P='!2Y(+VM?>VEE]_P#P_DD?0X/ 8?+IN%-*MB4KVNDH_?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSPBG@#3O"6IV+:C8V,GV@,\SQ-),00TA*,#SN(QG &!VH \I_P"$4_ZN:_\
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MWB'_ +=O_2:*OMJH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&)E=1VTLO)V_KL%%%%>,?/A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !116)IEGKL/B/4)]1OHIM-D_X]H5'S)SQVXP,CJ<U2
MC=-W,Y3<6E9N_P"'J;=%%%2:!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^@U!_P!^F_QKV"BC^TL3W_!!_9>%_E_%GD,?P8U!)4<ZU =K X\IO7ZUZ\.
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M>K'NQZ^K'@< 8R/$GC:3XJ_$*"Z\8:L-%T?>50"-Y4LX>N%502SG')QR?0
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M9]NZ"-S\S$D_,Q/)[U]VTAA1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MQ--TG5+3Q)J%[=ZH]Q97 _<6Q)Q'SZ=!@<<=<\UMUB:9HVHV?B34+^YU62YM
M+D?NK9LXBYS]!CIQUK2#LI:F%6-Y0=F]>^VG7N;=%%%9FX4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5T89#*<@_C0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMF\<>!+'Q#<V:V3WC2D0*Q8(JR,HY(&>%!S@53;FW,FR@E$ZBBBBI*"BBB@
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M_::[?X6_'JU^)'B2;1)= N-,N1"9H7CE-S&P7[V]@B^7U7!/!)QD':&];HH
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M? -CI=PFR]V![L"=I5\SH=I)X& .!@4 =A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M#>6D-_9RVMTF^&9"CJ>X/45-10!C:#X2T7PS&R:-9);JW7'/\ZV  .@%+13;
M;W$HJ*L@I-B_W1^5+12&&,]:YS7/ /AOQ'J/V[6=-CN;C8$WDD<5T=% 6N>1
MZ_\  JTN+^.X\-7_ /9"Q\E I;->5:Q/J$$=Q;W,3)+;LR G^+'\5?6->2>/
MOASX@U[QD=1T06:V;0!&21L9;N<5TT:SB^5O0\[%X6-1*<8WDCRK1]?A;1UW
MMYER!@Q]R:WO W@J^U[Q, VJ>3;+B:2+;G>N>5JOK_@C7O"BBZU:VM1 Q_UE
MN,A?J:[7X12A_$LZ@_\ +MFNUU.>DW?8\B.']EB8Q<=)/5/4]/TKPQI&BR-)
MIMFD#-U(K6HHKRFVW=GTT8QBK15D%%%%(H**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ K/US_D"S_\  ?\ T(5H5GZY_P @6?\ X#_Z$* .>T__ %@KJK7_ %8K
ME=/_ -8*ZJU_U8H GHHHH **** "BBB@ HHHH *XCP]_R'K?_@7_ *":[>N(
M\/?\AZW_ .!?^@F@#MZ*** "BBB@ HHHH **** /*?'W[/GA7QE++>Z?G0M3
M?DS6L8,4ASU>+@$^X*GUS7ANM?LX_$+1+DOI=O;ZK&IRLUE<JC >ZN5.?89K
M[(HI)6V&W?<^(AX.^,$*FS73O%"Q\J4627RSGKT.*OZ3^SU\2-?N]^H6,>G*
M_+7&HW2G/X*6;/U%?9U%,1XKX'_9H\->'I4O/$T[>(+M>1$Z;+93_N9)?'/W
MC@_W:]HBBC@A2*%%CC10J(@P% Z #L*=13NQ604444AA7@WQ)_:5@\-ZU<:-
MX0T^#4KBU8QS7ERQ\E7!P555P7QT)R.1QGK7J7Q(UR3PW\-=>U6 D36]F_E$
M#H[?*I_-A7RQ^SYX*T[QG\0Y3KMLMW8Z?;&X:&3E))-P50P[CDG'?'/&:F-Y
MSY>RO_7W#E:,.;Y?U]YV?AC]JW4/[22/QAHEH;-V :?3=Z-$/78[-O\ ID?C
M7TGI^H6FJZ=;W^G7"7-I<QB2&:,Y5U(R"*^<_P!I3X<Z#HGAW3O$7A[2[73)
M%N1:W$5I$(HY%9696VJ-H(*D9XSNYS@5U/[+NNR:C\-KK3)G+MIEXRQY.=L;
M@,!]-V^M(M33[K^OU)E>+7G_ %^A[75;4M2L]'TNYU'4YTM[2UC,LTK]$4#)
M-6:\Y^/=M>W7P5UQ-.5W=5CDD5.OEK(I?\  2?8&LIMQC=%Q5Y6/*_$O[5U]
M]O>/PAH5JMJC$+/J19VD'KL0KM[\9/\ 2I_"7[5<TNH1V_C71K>*WD8*UWIV
MX>4">IC8L2/7!SZ U0_93&A'7M9^V"'^VQ'']C\W&[R_F\SR\\Y^[G';'O6=
M^U&VA'QUIPTHVYU-;9AJ/D$9!W#R]^/XL;NO.-O;%6_W;BM[DKW^;I8^KK:Y
MAO+2*ZM)5F@F021R(<JZD9!!]"*EKC?A%:WUG\(O#D&JJZW*V:Y5P0RJ22@(
M/HI6NRJIQY9-$P?-%,^)?V@_^2[>(?\ MV_])HJ^VJ^)?V@_^2[>(?\ MV_]
M)HJ^VJDH**** "BBB@ HHHH 9+%'/"\,\:R12*5='7*L#P00>HKG?^%=^%/M
MGVG^QXO,\SS-OF/LSG/W-VW'^SC';&*Z6BMJ=>K2O[.35^SL;TL37HW5*;C?
MLVOR&111P0I#!&L<4:A41%PJ@<  #H*?116.Y@VWJPHHHH **** (+NRM;^(
M17UM#<QAMP2:,. ?7![\FL2]\!>'+UI7;3EADD7&Z!V0(<8R%!V@_A]<UT5%
M 'G%[\)4+2MI^JLJ[?W<<\63G'0N".,]]O'O7/W?@;Q/H4HNK-&E:-<B:PE)
M92?EP!PV>><#H?K7L]% 'BUCX]\2:.[6\\WVCRMR&*]0LRMGG)X;(Y&">/RK
ML-,^*>EW+!-2MIK%BQ^<'S4 QU) #9SQ@*>WX=A>:;8ZAL^WV=O=>7G9YT2O
MMSUQD<=!7'ZG\+-+N6+Z;<S6+%A\A'FH!CH 2&SGG)8]_P  #LK2]M;^(RV-
MS#<QAMI>&0. ?3([\BIZ\1O_  CXD\-2->1Q2;8>EU92$[1M))XPRC&020!^
M=7M$^)>K:=E-2']I0[ J!V".I'?< =W'7.3TYZY /8**P=$\9Z-KTJ06=PR7
M+J6%O,A5N/?[I..< GCZ&MZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH \G^,^DL)=.UA Q4J;64EAM4C+)
M@=<G+\].!T[]+\+-7CU'P5!;&9I+BQ9H91(V6 R2F.<[=I"C./ND#I6SXQTW
M^UO!NJ6@65W:W+HD0RS.GSJ ,'.64#%>5_"+5FLO%KZ>Q;R]0A*A54$;T!8$
MGJ!MWCCN1^'T]/\ VS*)0ZTW?Y?\-?[C[&C?'Y%*G]JB[KTW_)O[D>W4445\
MP?'!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8FF>'
MI-/\2:AJC:C/.EX.+=Q\L?.?7G'0<# -;=8>F>&_[.\2:AJPOYIOM@P8'^ZG
M(/KSC&!Z UI!V4M;?J<]6/-*#Y;V?>UM-_,W****S.@**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *@N?]6:GJ"Y_U9H Y74/]8:ZFP_Y!MM_UQ3^0KEM0
M_P!8:ZFP_P"0;;?]<4_D* +%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!3U72K/6]-EL-3A$]M,,.A[
MU@>#/ UMX3CF9I!<W3NP6;&-L?9/PKJZ*I2:5D0X1E)2:U04445)84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5GZY_R!9_\ @/\ Z$*T*S]<_P"0+/\
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MYUN+F>[N&GNYI)YFQNDE<LQP,<D^U6M(U>\T/4H[W3Y-DJ<$'E77NK#N#_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!MM_UQ3^0H L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?^W;_P!)HJ^VJ^)?V@_^2[>(?^W;_P!)HJ^VJ0!1110 4444 %%%% !1110
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M1\3T4L5'$PVJ13^[_@6"BBBOGCY4**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /%_B?I<]IXL>]=28+U%9'[950I7] ?QKC:^D=0TVSU6S:UU
M&W2XA;JK#]0>H/N*YR#X:^&X+D3&VEE .1')*2OY=_QKV*&/A"FHS6J/E,9D
ME6I7=2DU:3OKT,GX2Z7/;:;>ZA,I6.Z9%B!_B"[LG\SC\#7H5-CC2&-8XD5$
M4855& !Z 4ZO,K5'5J.;ZGT6$PZPU&-).]@HHHK(Z0HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "H+G_5FIZ@N?]6: .5U#_6&NIL/^0;;?]<4_D*Y;4/\ 6&NI
ML/\ D&VW_7%/Y"@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %5M1L8M4TN[T^YW>3=PO!)L.#M92IP?7!JS10!SW@CP7IW@'PQ'H6C2W,
MUM'(\@>Z=6<ECDY*JH_2LC3_ (3:%IVF>*K&"ZU!HO%+N]Z7E0M&7W9\OY./
MOGKN[5W%% '#WOPGT&^^&%MX$FN=0&F6Q4I,LJ"?(<OR=FWJ3_#TJWXG^'&C
M^+++0[74I[R./1)TGM_(D52Y0  /E3D<=L'WKK:* .,\8?"[0O&.KVVL7$^H
M:7J]JNR+4=*N?(G"^F[!'<\XSSUK1\)>"['PA'=&TO=2U"YO"IN+S4[MIYI=
MH(7)/'&3T ZUT5% 'EGQ]\,:GKG@NQU/P[:RW6K:)?QW<$4,9DD=<X(51R3G
M:WT4UT6H^"],\;:KX6\5ZG_:%G>Z4JW5O; B/#/M8K*K*6R" ,9!ZUV-% ',
M'P%I7_"RAXW\Z[&I_9/LGE;U\DKZXVYS_P "Q[4FB^ -)T+QCKGB2UDNI;S7
M-HN8YG5HE [* H//N37444 >7R? 'PJ7N(;34=?L=+N9/,GT>UU$I:2GW3!/
MIW["MWQ+\+/#OB7PWI&@RBYL-/TB=)K6*R=5P5! 4EE;(Y.>Y/>NSHH Y?Q'
MX TKQ/XJT'7]0GNX[O0I3+;)"ZA')*GYP5)(RHZ$5G^)OA/HOB;Q7'XC.HZQ
MI.IK$())M*O/LYF0?PL<$]..".,>E=Q10!R]AX TK3OB5J?CB">[;4]2M5M9
MHG=3"J@1C*C;D']TO5CWJA8?"C0-/D\6-'/J#_\ "5S>=>AIP/+;<[CRBJ@K
M@R$\D]!7;T4 <'X>^$>B:#XF@U^XU/6]<U&U0I:S:Q??:/LZD$$)P,<$]<]:
MP/ N@ZKJ?QW\8>,M7T^[L;:-1ING"ZB:/S5&T&1 1RO[L$'H=]>MT4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN=H^I!R<^H&!@UUU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@M8+2&)XYBT:*IPHQD#'K0!N45C_ /"2V?\ SRG_ .^1_C1_PDMG_P \I_\
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MRG_[Y'^- &Q16/\ \)+9_P#/*?\ [Y'^-'_"2V?_ #RG_P"^1_C0!L45C_\
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M_C1_PDMG_P \I_\ OD?XT ;%%8__  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT
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M_P"^1_C0!L45C_\ "2V?_/*?_OD?XT?\)+9_\\I_^^1_C0!L45C_ /"2V?\
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M^- &Q16/_P )+9_\\I_^^1_C1_PDMG_SRG_[Y'^- &Q16/\ \)+9_P#/*?\
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MG_SRG_[Y'^-'_"2V?_/*?_OD?XT ;%%8_P#PDMG_ ,\I_P#OD?XT?\)+9_\
M/*?_ +Y'^- &Q16/_P )+9_\\I_^^1_C1_PDMG_SRG_[Y'^- &Q16/\ \)+9
M_P#/*?\ [Y'^-'_"2V?_ #RG_P"^1_C0!L45C_\ "2V?_/*?_OD?XT?\)+9_
M\\I_^^1_C0!L45C_ /"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT ;%%8__
M  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT ;%%8_P#PDMG_ ,\I_P#OD?XT?\)+
M9_\ /*?_ +Y'^- &Q16/_P )+9_\\I_^^1_C1_PDMG_SRG_[Y'^- &Q16/\
M\)+9_P#/*?\ [Y'^-'_"2V?_ #RG_P"^1_C0!L45C_\ "2V?_/*?_OD?XT?\
M)+9_\\I_^^1_C0!L45C_ /"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT ;%
M9^N?\@6?_@/_ *$*K_\ "2V?_/*?_OD?XU6U'6K>]L)+>*.4,^,%@,<$'U]J
M ,_3_P#6"NJMO]6*YS38"7!Q72P+M04 2T444 %%%% !1110 4444 %<1X>_
MY#UO_P "_P#037;UQ'A[_D/6_P#P+_T$T =O1110 4444 %%%% !1110!G^(
M--_MGPUJ>F9Q]MM);?.<??0K_6OD/X-_$)/A+XTU.P\36DT=K=$6]YM7,EM)
M&S ';W )8$=><CI@_9E>5_$WX#Z'\0;Q]5MKE](UEE >XC0/'/C@;TR,G QN
M!'OG I*\9\R]"G:4>5FK_P +S^&_V7S_ /A*;?9MW8\F7=C_ '=F[/MC-?.G
MQI^(T7Q6\6Z9I_ABUFDM+1C!:EE(>ZED*@D+V&0 !U_D-K_AE+Q?]JV_VUHG
MV?/^L\R;?C_=\O'ZUZQ\,?@)HW@#4%U>^NCK&KH/W4SQ;([?/4HN3\V#C<3]
M *:C%M.6R)<FDU'<]&\.:5_87A;2])W;OL-G%;[AWV(%S^E:5%%.3<FVQ17*
MK(****0P)"J2QP!R2>U?,/Q)_:6U4:W<Z9X -O;V=NQC_M&2,2O,P/+(&RH7
MTR#GKQTKV_XK:S)H'PH\0ZA;MLE2S:.-@<;6?" _@6S7SA^S+X;L];^)%S>Z
MA;QW":7:&:)9%# 2E@%;![@;L>AP:F*<ZG+V0Y/EAS=]/Z^\3PQ^TSXUTO4D
M;Q%);ZW9,P\V-X$AD5?]AHP!GZ@_A7U=H&NV'B;0+/6='F\ZSO(Q)$V,''<$
M=B#D$>HKQ3]JCPW92^$=.\11P(M_;W:VSS*H#/$RL<,>^"HQZ9/K5G]E;5WN
M_ &IZ9(2187VY/99%!Q^:L?QK2+4U+R_X'^9,URN/G_P?\CW.BBBI&5M1U&T
MTG3;C4-2N$MK2VC,DTLAPJ*!DFOD?6OVB_&^I>,)Y- U3^SM)DN MO:FT@<K
M'D 99D)R>IYX)XKJ/VA?B#<>)-=@^'?A1FN<3JEX(#DS3YPL(_W3R?\ :Q_=
MKQ37_#DWA+QU+H5W,LT]E/&DCH,*6(4D#V!.,]\44?>J)O:_W]_Z_P QU/=@
MUU_(_0-3E 3Z4M(G^K7Z"EH)6Q\2_M!_\EV\0_\ ;M_Z315]M5\2_M!_\EV\
M0_\ ;M_Z315]M4#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** *FH:58:K%Y>I6<-RH5E4R("5S
MUVGJI]QZ5PWBGX:Q-;I/X8AV2I\KVK2DAQG[P9CP1Z$X(]QSZ)10!XQX8\:7
M_A>7[!>1-+9+*1) X(DA/.[;GH<\E3W';)->P65[;ZC917=E*LT$J[D=>_\
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M[,\=V6^;RHKK=;2?+G=N'RKTXRX3G^F:YJUM;B]N5M[."6XF?.V*)"[-@9.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7T% '+_V8WI1_9C>E=1Y*^@H\E?04 <O_9C>E']F-Z5U'DKZ"CR5]!0!R_\
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MT% '+_V8WI1_9C>E=1Y*^@H\E?04 <O_ &8WI1_9C>E=1Y*^@H\E?04 <O\
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M(WA?XD>++G1(O EA8-!;/<&9TBD#;75<8\L?WNOM3^*5EV_SU)VBV^Z/%_\
MAHSXD_\ 09@_\ 8?_B:/^&C/B3_T&8/_  !A_P#B:^O/^$5\/?\ 0!TS_P
MX_\ "O,_B[XST+X6MI@7P+I.IKJ"R88^7"8RFW^'RVR#NZY%)M(:3>QZ/X*U
M*ZUGP'H6IZ@XDNKS3X)YG"A=SM&"3@<#DUMUGZ!?6VI^&]-O[")8;6ZM8IH8
MT  1&4$* .. <5H5I/XWI8B'PH****@H\Y^/J._P/U_R\\+"2 ,Y F3->1_L
MFD?\)/XA&WYOL<6&ST&\\?R_*OH'Q]H+^)_A]K>C1+NFN[-UA&<9D RG_CP%
M?(GP6\=VWPW^(3W&NI-'8W$+6EUM0EH3N!#%>IP5P1UP3P>E*D[5&GV_1H=2
M[I*W?_(]^_::<+\'G!/+7\ 'O]X_TKD_V2D;^S_$[X^4RVXS[XDKG?V@?B]H
M/C;2=/T+PI</>6T4_P!JN+EH6C4L%*JJAP&_B8G@#IUYKTS]FCPY-HOPM-]=
M1F.35KEKA W4Q !4/XX)^A%.DFE-]_\ @?Y$U=>1?UU/8*\X^-?Q)7X>>#&-
MF_\ Q.=1#0V*XSY?'S2GM\H(QZDCMFL_7_VB/"?ASQ7=^'[[3]9DN[2?R'>&
M"(QEO4$R XY]*A^./PIUSXFMHK:#=:?;BQ6;S/MLCIG?LQC:C?W3Z5$KRBFM
MF:1:C*SW1YM^SWIOA73+J7QEXP\3:-!J+%DLK:[U&)98\DAY75FR&/(&>V3W
M%>=_%+4+/4/C5K-]87<%U:27J,EQ!*'C8;5Y# X(XKM/^&5/&_\ T%?#_P#X
M$3__ !FO*O$?AB]\,>+;OP[?RP27=K,(7>!B8R2 >"0#CGTK1/\ >1:Z;+[C
M.WN2OU_X)]@_$CXB6]I\)-<UCP'XBT^XU#3Q;?O;.:&Y\G?.B?,OS#D%AR/7
M'2OF_P#X:#^)W_0S?^2%M_\ &Z]^^!?PJUSX:'6FUVZT^X&H"#ROL<CMMV;\
M[MR+_?'3/>O7*<DD]!1V/SN\0^(=4\5:]<:SKUS]KU"YV^;-Y:INVJ$'RJ !
M\J@<#M7Z(U\2_M!_\EV\0_\ ;M_Z315]M5)04444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %9'B/PY9^)---M=C9*F3#.HRT3?U![CO]0"->B@#P_4+'6? 6O;K>=HV96$
M-RBC;,G<$'(STRIS@X/H:]+\*>,K/Q%:I'*\=OJ(^5[<MC><9W)GJ, G'4=^
MQ/F_C+Q7/XBU)HXWVZ= Y$"+D!^WF'..2/7H#CU)YJ@#Z2HKSCX?>,WFE.DZ
MW>-)([#[+-,<EB>J%B>3TQGW&>@KT>@ HHHH **** "BBB@ HHHH **** "B
MBB@#%\6>'?\ A*-!;3?MLMGF17WH-P;'9ER-P[XR.0#VK@_^%)?]3!_Y)?\
MVRO5J*]##YEBL-#V=&5EZ+]4>IA<VQN#I^SH3LM]D_S3/*?^%)?]3!_Y)?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7$>'O^0];_ / O_037;UQ'A[_D/6__  +_
M -!- ';T444 %%%% !1110 4R:))X'BE!*2*58 D9!&#R*?10!\>^/O!GQ.\
M-^,KZPT2;Q9JNF!O,M;JU:XF4QMR%)7(W#D'/IGH17FWAVW\2W&J2)X2BU66
M_$9,BZ8LAE"9&<[.<9Q[9Q7Z%GD<UY'"OP<^#?B:>YCOH-,U:2(Q31B>>Y=4
M8JV&0;MN<*>0#CVI1T=FRI:IM'SM_9?Q?_Y\?&__ 'YN_P#"FV_PV^)?BW6(
M8;W0]=>9B$^TZK%*B1KZEY.PZX'/M7T^/V@?ABS #Q,,DXYL+D?^TZBO_P!H
M;X;64,C1Z[)=R(,B*WLYBS^P+*%_6GHM61Z'>^'])30?#>FZ1$V]+&UCMPQ_
MBV*%S^E:%4-!U>+7_#NGZO;1O'#?VT=S&DF-RJZA@#CC/-7ZJ5^9\VXHVY58
M****DH*\H^(?[/WASQUJ<NK6MS-HVJ3<RRP1AXI6_O-&<?-[AAGOD\UZO12:
M3=QW9X1X9_98T#2]22Z\1:S<:TD;!EMD@%O&V.S_ #,2/H17ND,,5O!'#;QI
M%%&H1(T4*J*!@  = !VI]%5=VL397N>%^*OV;/\ A)O'5_XC_P"$K^R_;+K[
M1]G_ +.W[.G&[S1GIUQ7N:C"@>@I:*2TBHK9#>LN9[A7AWB_]G#_ (2KQY?>
M)/\ A*OLGVN=9OLW]G;]F !C=YHST]*]QHH6DE);H'JN411A0/04M%% 'Q+^
MT'_R7;Q#_P!NW_I-%7VU7Q+^T'_R7;Q#_P!NW_I-%7VU0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'S?+&\,SQ3(T<B,59&&"I'4$=C3:]@\7> (M>GDU"PF\
MC4'VAA*Q\MP!CG@D'&.G''3G-<M!\*]:>?;/<V<42N%+AV8E< EE&.>I&#CD
M>F#0!R-EIUYJ3R)86TEP\2>8R1+N;;D#('4\L.E=SX1^(SV[?8_$L[20[?W=
MT5RR8'1L#+ XZ\G/7.<CM_#/AFU\,Z>UO;.TTDK!I9G4 L< 8&.B]2 2<9/-
M8/B_X?0:MY^H:0/)U!OF:+($<QYS]&/KT)'/4F@#M8I4FB26%UDC=0R.IR&!
MZ$'N*=7C'AWQ;JGA*]6QU".8V2-^\M)4VO'NP<KGD'OCH<GIG->N:9JMEK-F
M+O3;A9X2Q7< 001V(/(/U]0: +=%%% !1110 4444 %%%% !1110 4444 %4
MM9TV/6=%O-.FVA;F%HPS)O"$CAL=R#@CW%7:*J,G"2E'=%0G*$E..Z/!/A?J
M7]G^/+9&:)([M'MW:0XQD;E YZEE4?CCK7O=?/6O1_\ "+_$N=Q#$R6E^MU'
M#$=J["PD5!QQP0.G'O7T%%+'/"DT$BR12*&1T;*L#R"".HKZ+/XJ<Z>(CM*/
M]?@SZSB>"G4I8J&TX_\ !_)CZ***^;/D0HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
M@G%%13OL0F@!LEPJ=34!OT]:QK^](8@&JQAOS_RZS_\ ?LT =#]O3UH^WIZU
MSODW_P#SZS_]^S_A1Y-__P ^L_\ W[/^% '1?;T]:/MZ>M<[Y-__ ,^L_P#W
M[/\ A1Y-_P#\^L__ '[/^% '1?;T]:/MZ>M<[Y-__P ^L_\ W[/^%'DW_P#S
MZS_]^S_A0!T7V]/6C[>GK7.^3?\ _/K/_P!^S_A1Y-__ ,^L_P#W[/\ A0!T
M7V]/6C[>GK7.^3?_ //K/_W[/^%'DW__ #ZS_P#?L_X4 =%]O3UH^WIZUSOD
MW_\ SZS_ /?L_P"%'DW_ /SZS_\ ?L_X4 =%]O3UH^WIZUSODW__ #ZS_P#?
ML_X4>3?_ //K/_W[/^% '1?;T]:/MZ>M<[Y-_P#\^L__ '[/^%'DW_\ SZS_
M /?L_P"% '1?;T]:/MZ>M<[Y-_\ \^L__?L_X4>3?_\ /K/_ -^S_A0!T7V]
M/6C[>GK7.^3?_P#/K/\ ]^S_ (4>3?\ _/K/_P!^S_A0!T7V]/6C[>GK7.^3
M?_\ /K/_ -^S_A1Y-_\ \^L__?L_X4 =%]O3UH^WIZUSODW_ /SZS_\ ?L_X
M4>3?_P#/K/\ ]^S_ (4 =%]O3UH^WIZUSODW_P#SZS_]^S_A1Y-__P ^L_\
MW[/^% '1?;T]:/MZ>M<[Y-__ ,^L_P#W[/\ A1Y-_P#\^L__ '[/^% '1?;T
M]:/MZ>M<[Y-__P ^L_\ W[/^%'DW_P#SZS_]^S_A0!T7V]/6C[>GK7.^3?\
M_/K/_P!^S_A1Y-__ ,^L_P#W[/\ A0!T7V]/6C[>GK7.^3?_ //K/_W[/^%'
MDW__ #ZS_P#?L_X4 =%]O3UH^WIZUSODW_\ SZS_ /?L_P"%'DW_ /SZS_\
M?L_X4 =%]O3UH^WIZUSODW__ #ZS_P#?L_X4>3?_ //K/_W[/^% '1?;T]:/
MMZ>M<[Y-_P#\^L__ '[/^%'DW_\ SZS_ /?L_P"% '1?;T]:/MZ>M<[Y-_\
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M_P#SZS_]^S_A0!T7V]/6C[>GK7.^3?\ _/K/_P!^S_A1Y-__ ,^L_P#W[/\
MA0!T7V]/6C[>GK7.^3?_ //K/_W[/^%'DW__ #ZS_P#?L_X4 =%]O3UH^WIZ
MUSODW_\ SZS_ /?L_P"%'DW_ /SZS_\ ?L_X4 =%]O3UH^WIZUSODW__ #ZS
M_P#?L_X4>3?_ //K/_W[/^% '1?;T]:/MZ>M<[Y-_P#\^L__ '[/^%'DW_\
MSZS_ /?L_P"% '1?;T]:/MZ>M<[Y-_\ \^L__?L_X4>3?_\ /K/_ -^S_A0!
MT7V]/6C[>GK7.^3?_P#/K/\ ]^S_ (4>3?\ _/K/_P!^S_A0!T7V]/6C[>GK
M7.^3?_\ /K/_ -^S_A1Y-_\ \^L__?L_X4 =%]O3UH^WIZUSODW_ /SZS_\
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M /SZS_\ ?L_X4 =%]O3UH^WIZUSODW__ #ZS_P#?L_X4>3?_ //K/_W[/^%
M'1?;T]:/MZ>M<[Y-_P#\^L__ '[/^%'DW_\ SZS_ /?L_P"% '1?;T]:/MZ>
MM<[Y-_\ \^L__?L_X4>3?_\ /K/_ -^S_A0!T7V]/6C[>GK7.^3?_P#/K/\
M]^S_ (4>3?\ _/K/_P!^S_A0!T7V]/6C[>GK7.^3?_\ /K/_ -^S_A1Y-_\
M\^L__?L_X4 =%]O3UH^WIZUSODW_ /SZS_\ ?L_X4>3?_P#/K/\ ]^S_ (4
M=%]O3UH^WIZUSODW_P#SZS_]^S_A1Y-__P ^L_\ W[/^% '1?;T]:/MZ>M<[
MY-__ ,^L_P#W[/\ A1Y-_P#\^L__ '[/^% '1?;T]:/MZ>M<[Y-__P ^L_\
MW[/^%'DW_P#SZS_]^S_A0!T7V]/6C[>GK7.^3?\ _/K/_P!^S_A1Y-__ ,^L
M_P#W[/\ A0!T7V]/6C[>GK7.^3?_ //K/_W[/^%'DW__ #ZS_P#?L_X4 =%]
MO3UH^WIZUSODW_\ SZS_ /?L_P"%'DW_ /SZS_\ ?L_X4 =%]O3UH^WIZUSO
MDW__ #ZS_P#?L_X4>3?_ //K/_W[/^% '1?;T]:5;Y">M<YY-_\ \^L__?L_
MX4C&Z@PTT,L:DXRZD#- '71RAQP:DK#TZZ+8!-;2'*T .HHHH **** "BBB@
M HHHH *XCP]_R'K?_@7_ *":[>N(\/?\AZW_ .!?^@F@#MZ*** "BBB@ HHH
MH **** ,_P 0:E_8WAK4]3QG[%:2W&,?W$+?TKXL^'?PWUGXO>(-3D748[?R
M?W]W>7 +LSR$X&!U)(8]1TK[3\0:;_;/AK4],Z?;;26WSG^^A7^M?)_P \77
M?@CXE3>&[S3I)#J\Z6<R?=>WE1F 8@]AELCC],4H).JT^VG]?UT'-VI77?7^
MOO.3\'_#2Y\4_$B[\'3ZA'IUY;&9&E:(N&>(X( R#V)_"K7B;X8'X?>/M-TC
MQO>,-(O6#?VA8+D^7G!.&'!4XR.< \9KJ_B3=3?#']IL>(X[<O!))'?*BGF2
M-UV2@$]R1)6-\;?BQ9?$Z_TM-'L;FULM/20AKK:))'?;GA20 -H[G.>U*,M(
M2^\<E[TETZ'V#H.EV^B>'=.TJQD>6VLK:."%Y""S(J@ D@ 9P.PJ_6'X)M[J
MT\ Z!;Z@"+J+3;=)@>H81J"/SK<K6II-F4-8H****@L**** "BBB@ HHHH *
M*** "BBB@#XE_:#_ .2[>(?^W;_TFBK[:KXE_:#_ .2[>(?^W;_TFBK[:H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** .&^)D>B#3X)=3287[*ZV
MKP 9.!T<GC8"1[\\=Z\XT37]1\/W1GTR?9OP)(V&Y) #G!']1@\G!&:U?B)(
M[^.;U7=F6-8U0$Y"CRU.!Z#))_$US% 'L'A'Q_%KUQ'I]_#Y&H/N*F)3Y;@#
M/')(.,]>..O.*[*OF^.1X94EA=HY$8,KJ<%2.A![&O3O#'Q+2X9+/Q$%BE9@
MJ72#"'CJ_/RG/<<<] !F@#T*JUYJ5CI^S[?>6]KYF=GG2JF['7&3SU%<_P"-
M?%?]A:'#)ISQR7-[Q;O]Y0N,F0=CC*X^H/(!%>,2RO-*\LSM)([%G=CDL3U)
M/<T ?1T<J31)+"ZR1NH9'4Y# ]"#W%.KY]T?7+_0KQ;C3IVC.X%XR3LD SPR
M]QR?IGC!KWG3K^#5--@OK1MT4Z!UY&1Z@XSR#P1ZB@"S1110 4444 %%%% !
M1110!XY\:+*1->TZ^)7RIK8PJ ?F!1B3GV_>#]:]#\!WW]H>!-)F\OR]L AQ
MNSGRR4S^.W/MFL+XNZ2M[X334%"^;I\P8LS$'8Y"D ="=VP\]@?QJ?!G4Y+C
M1;_3I-S+:3+(C,^0!(#\H'8 H3[EC^/TM7_:,FA-;P=G_7S1]?7_ -JX?A-;
MTY6?Y?K$](HHHKYH^0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JWA_=&K55+S_5&
M@#E;T_O#7:UQ5[_K37:T %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !61XE_Y!L?_78?R-:]8_B7_D&Q_P#78?R- &9I
MC?.*Z>'[@KE]-^^*ZB'_ %8H DHHHH **** "BBB@ HHHH *XCP]_P AZW_X
M%_Z":[>N(\/?\AZW_P"!?^@F@#MZ*** "BBB@ HHHH **** *]_>P:9IMS?7
MC^7;VL332N?X54$D_D*\0\%^/_AI\1_B3INI2:#<:7XM1F,$K#*SD(PP60X8
MA1U=1C  ->W:E80:KI5WI]ZI:WNH7AE /564@_H:^&]+UFP^&?Q5M=8\-ZA%
MXALK&9FC?RI(2\;!D96#J"'VD\C(S@\]*4&O:68Y)^S;1]@>/OAMX?\ B-IL
M5KK\,BRVY)@NK=@LL6>H!(((.!D$$<5QWA;]F[P=X;UN'5)Y[[59;=@\4-VR
M>4K Y#%54;B/0G'L:@M/VH? D\(:X@U>V?'*/;*W/L5<U-_PTW\/O[^I_P#@
M)_\ 94U[KNA/WE9GK]%4]'U2WUS1++5;'=]FO8$N(MZX;:ZAAD=C@U<IM-.S
M!.^H4444@&RR)#"\LK!$12S,>@ ZFOD3X@_'CQ7XN\22:;X)NKO3],,GDVL=
MBI%Q='. Q8?,">RKCKCDU]#_ !CU231_@]XCNH&VR&T,(;GCS&$?;_>KP+]E
M?2H;OXAZCJ$RJSV-@?*R/NL[ ;A_P$,/QJ8+GJ6Z)#D^6%^[M^7^9S>F?%3X
MG_#[78UUJ]U9R<226&NB1O-3V\SYE'7E2.G>OKSP=XJL?&OA.QU[2\K!=)DQ
ML06B<'#(?<$$5Y5^U/I,-S\.]/U,Q@W%E?JBR8Y".K;A^:I^55?V4=3>?P9K
M6FNV5M+U94'H)$_Q2M(/G4D^G_ _S)FN5Q:Z_P#!_P CWJJ6LZM::#HMYJNI
M2>5:6<+32OC.%49.!W-7:\E_:5U233_@[/#$VW[?>0V['G[N2Y'_ (Y64VU'
M0N"O+4\+\2_&;X@^/_$3VWAJXU&R@D<_9=.TC<)=H]63YV..O;V%.\+?&KQ[
MX!\1K:>*+C4+^VC<"[T_50QG4''(9_G5L<@$X]J[[]DS2H?L_B+5V53/OBMD
M;'*K@LP_$[?^^:@_:STF%9O#NKQQ@3R":VE<#[RC:R#\,O\ G5R_=61,?WE_
MZV/HK2=4M-;T>TU33I1+:WD*S1..ZL,C\:MUY5^SAJ;ZC\&K**1MQL;F:W'T
MW;Q_Z'7JM7-)2T(@VXZGQ+^T'_R7;Q#_ -NW_I-%7VU7Q+^T'_R7;Q#_ -NW
M_I-%7VU4%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YQ\1/!]U=
MWG]LZ5"T[.JI<0Q@LY(X#@=QC ('3&>>2/-*^DJHW&B:5=SM/=Z99SS-C=)+
M;JS' P,DCTH \B\(>#[K7]0BFN(6CTU&#R2N"!* >44\9)P02.GUP#UWB?X:
MV]VKW?A\+;3A2QM?X)6SG@D_(>HQTZ=.37>T4 ?/%Y)?PQ1:;J FC6U9F2"9
M2IB+X)X/(!P#C\>YJI7O>O>&=,\16^R_AQ*,;;B( 2* >@;!XY/!R.?7FO*?
M$W@C4?#FZ?\ X^[$;1]I1<;2>S+DD<]^G(YR<4 <U7N7@6WEM?!&G1SKM9D:
M0#(/RLY93QZ@@UY)X<?18M5CEU\W'DHZ%%BC5E)W<[\_PXZ@ DY_/W:WN8+N
MW6>TFCGA;.V2)PRG!QP1[T 2T4V21(8GEF=8XT4LSL<!0.I)["O-M8^*LJ7C
M1Z':0O C$>=<!CYG3D*"-HZ]<YXZ=* /2Z*\KTSXJW\4L::M:0W$(4*SP@I)
MVRW7:3C/&!SW%>FV5[;ZC917=E*LT$J[D=>_^![8[4 3T444 %%%% &+XQTW
M^UO!NJ6@65W:W+HD0RS.GSJ ,'.64#%>7?!_4_LOBJ>PDEV1WL!VIMSOD0Y'
M..,+YGH/QQ7M=?/.FLOAOXGQ);W'E0VFIF S3%>(MY1BQ(Q]TG)XQUXKZ;*?
MW^$KX9]KKU_I(^PR/_:<#B<&^UUZ_P##I'T-1117S)\>%%%% !1110 4444
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MB@ HHHH ",@BOG"3]DGS)7?_ (37&YB<?V5T_P#(U?1LDB11M)*P1$!9F8X
M ZDU\A>/_C%XO^(GBJ;1O!$E_#IF\QVUMIRL)KH#J[E?F(/)V\ #&<G)J?M6
M2U*7PN^QUA_9( 8 ^-P">@_LKK_Y&I?^&1O^IV_\I/\ ]NKAO@]HVJZ!^T7H
MVGZ_;26U_&96EBE(+#=;.PR03U!!KHO$WQ<\4> _C[K$TS7IT=[H+)IMR&"2
MPJH3?&&^Z3MR&7@]\BKLKQ5]R7U\K?B?2WAO1_\ A'O"VEZ-Y_VC^S[2*V\[
M9L\S8H7=MR<9QTR:TZBM;F*]LX;JV<20SQK)&XZ,I&0?R-2TY-N3;W%&UE;8
M****D9YU\?(FE^"'B )G*I"W!QD"9":\A_9-D \4>((_ERUG&P]>'_ES_*OH
MKQAH0\3^"]7T0E0U]:20HS=%<K\I/T;!KXS^&_C*[^$?Q'EN-5T^9E17LK^T
M^[(HW#.,\;@5!YZ],C.:5-I56GU7Z6_R'43=)6Z/_(^A?VG)5C^#Y1C@R:A"
MJ^YPQ_D#7+?LE1,-+\32D?(TUNH/N%<G^8KA?C9\:;7XDV=AI>A65U:Z;;2?
M:)&N]JO+)@J/E4D  $]SG/;'/N'[//A2?PQ\*X);Z(Q76JS&]9&!!5" $!_X
M",_\"JJ2:4V^O_ _R)JM-P2_K?\ X!ZG7BO[4L3/\*[-USB/5(BPSQ@QR"JO
MBK]I/_A&?'5_X<_X13[5]CNOL_VC^T=F_ISM\HXZ],UWGQ?\+3^,OA7JNFV,
M7F7@1;BV0<EG0AMH]R 5'UK*>M-36VGZ,TAI4Y7O_2/./V39 ?"GB"/Y<K>Q
ML?7E/Y<?SJ+]K251H/AN$GYVN9F ]@J@_P Q7EWP8^*D?PNUO4$U>RN+G3[Y
M56=(,>;$Z$X(5B ?O$$$C],5'\9/BB/BCXBLO[+L[BWTZR0QVT4V#)([D;F*
MJ2 3A0 ">G7G%:5??Y;>7X?\,12]R_-Y_C_PYWW@"+7H_P!DW7G\+#4!JLFI
M VW]F^9YY'FP!MNSYONALX[9]ZX#_B]__50/_)VOJKX4^%Y?!_PQT?2+M EV
MD1EN%_NR.2Q'U&<?A785I4^+^NA%/X?ZZGYW>(?[<_MZX_X2O^T/[6^7[1_:
M6_S_ +HV[M_S?=VXSVQVKM_^+W_]5 _\G:/V@_\ DNWB'_MV_P#2:*OMJLRS
MXE_XO?\ ]5 _\G:/^+W_ /50/_)VOMJB@#XE_P"+W_\ 50/_ "=H_P"+W_\
M50/_ "=K[:HH ^)?^+W_ /50/_)VC_B]_P#U4#_R=K[:HH ^)?\ B]__ %4#
M_P G:/\ B]__ %4#_P G:^VJ* /B7_B]_P#U4#_R=H_XO?\ ]5 _\G:^VJ*
M/B7_ (O?_P!5 _\ )VC_ (O?_P!5 _\ )VOMJB@#XE_XO?\ ]5 _\G:/^+W_
M /50/_)VOMJB@#XE_P"+W_\ 50/_ "=H_P"+W_\ 50/_ "=K[:HH ^"=/\:_
M$75[^.QTKQ+XHOKN7/EV]M?W$DCX!)PJL2< $_05N?\ %[_^J@?^3M'[/O\
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M,-3\C;YOV*ZNIO+W9QNVDXS@XSZ&M/\ XO?_ -5 _P#)VO2/V1NOB[_MR_\
M:]?25 'Q+_Q>_P#ZJ!_Y.T?\7O\ ^J@?^3M?;5% 'Q+_ ,7O_P"J@?\ D[1_
MQ>__ *J!_P"3M?;5% 'Q+_Q>_P#ZJ!_Y.T?\7O\ ^J@?^3M?;5% 'Q+_ ,7O
M_P"J@?\ D[1_Q>__ *J!_P"3M?;5% 'QIX=/Q'TM5M]5\%^(M0M]W^L;3I_.
M7)'\17Y@.>#Z]0!7=R+JL>GNJOKVAK.Q =1<6$C,HZC(4L!O[@C)KZ0J.XMH
M+N!H+N&.>)L;HY4#*<'/(/O0!\K6%MXQM/$ ENO&^L7^E;'#6US?3.9-P*[&
M4MM(P<Y[D=!6W7J6N?"VUN,RZ#/]E?\ YX3$M&>G1N6'<\[LGTKSC4]*O=&O
M#:ZE;M!,%#;2000>X(X(^GH: *E<SXO;XA/<6A\$7OB:2V6(I):Z0UP4A.XD
M,1&< MN/8?=/7MTU>X>!=)BTGPM"L-PMPUPQFE9'5E#D %05)! VXSD\@_2@
M#Y'_ .+W_P#50/\ R=JCJNM?%K0;5;K7-3\::;;NXC66\N+N%"Q!(4%B!G )
MQ[&ONBO$OVJO^25Z=_V&8O\ T3-0!X)I6M_%K7K5KG0]3\::E;HYC:6SN+N9
M%8 $J2I(S@@X]Q5[_B]__50/_)VO;/V5/^26ZE_V&9?_ $3#7MU 'Q+_ ,7O
M_P"J@?\ D[70:.?$9T\?\)C;:I#J88[GU42":9?X7_>#<1_".OW?PKZZKR?X
MU6"B72M02%MS+)!+,,[<##(I[ \N?4\^E>[D-3DQJ7\R:_7]#Z7AFM[/,8Q_
MF37Z_H>!77_"Y?M<W]G3^/;FTWMY$R/>.LB9^5@PX((P<C@U%_Q>_P#ZJ!_Y
M.U]6?#"_6^\!6:^<TTMLSP2;LDH0Q*KD]@C+C' '':NNKRL53]E7G3[-GBXV
MC[#$U*79M?B?$O\ Q>__ *J!_P"3M'_%[_\ JH'_ ).U]M45SG(?$O\ Q>__
M *J!_P"3M'_%[_\ JH'_ ).U]M44 ?$O_%[_ /JH'_D[1_Q>_P#ZJ!_Y.U]M
M44 ?$O\ Q>__ *J!_P"3M'_%[_\ JH'_ ).U]M44 ?$O_%[_ /JH'_D[1_Q>
M_P#ZJ!_Y.U]M44 ?$O\ Q>__ *J!_P"3M49?'?Q2\':S"VIZYXDL+Q4,D<&J
MR2L&4Y7<8ILJPZX)!Y''(K[HKY*_:K_Y*CIO_8&C_P#1TU 'TSX)U&ZU?P!X
M?U+49?.N[S3+>>>3:%WN\2LQP  ,DG@#%;E<U\-_^25^%/\ L#6G_HE*Z6@
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MV/\ Z[#^1K8K'\2_\@V/_KL/Y&@#+TW[XKJ(?]6*Y?3?OBNHA_U8H DHHHH
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M44 %%%% !1110 4444 %%%% !1110 4444 %5+S_ %1JW52\_P!4: .5O?\
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MK$F* 8CB4_--(?NHON3^0R>U?"VK^(=0\5^-)=;U>7S+N\N5=R.BC( 4>@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !52\_U1JW52\_U1H Y6]_UIKM:XJ]_UIKM
M: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD)"J2QP
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M%(%E'R.1QFNRE/FCO<\G%4G3J:QY1TT]LFG75J+5;B5F'E3]U%5G:9K5$23
M7DBJ=AJ$EG+)!>;<KPA-3:&8[O4&DOF8V8/1#R:=UTZDN,DM=D,CM29&ESL!
M.3[UZ-\-M?DL-6%I=73BTF&$AQP')ZUQLZVDU[(EIN6V!^0,>0/>MSPKXGMM
M%UH7-Y"DB[/+  ''/4>]9UZ?-1:2-\%6]GBH3D[)/7T/>**S-)\0Z;K-K%+9
MW49:49$1<;Q[$5IU\TTXNS/T*,HS7-%W04444B@HHHH **** "BBB@ HHHH
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M8Y-B0@]/,?!P>^T GUQD&AM($FSP3_AFSXB_\^%E_P"!J4?\,V?$7_GPLO\
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MY8U4J&9LD,C'.6/>O0Z*5DQW:,OPSX?M?"OAFQT/3Y)I+:QB$4;SL"Y&>Y
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MO#]C'8V47*QQYY)ZDD\L3ZDDUIT44VV]P"BBBD 4444 %%%% !1110 4444
M%4]8TR'6M$OM+NFD2"]MY+>1HR P5U*D@D$9P?0U<HI-)JS&FT[H\T\#_ GP
MSX!\3)KFCWVK37*1/$$NIHF3##GA8U.?QKTNBBJNV39(Y3QM\-?"_P 0($7Q
M'I_F3Q*5ANX7,<T8] PZCV8$<]*XW1OV9_ .E7RW-P-2U0*01#?7"^7GU(C5
M2?H21[5Z[127N[#>NXR&&.W@2&"-8HHU"HB+A54<  #H*?110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6)IFBW]
MEXDU"_N=5EN;6Y_U5LV<1\@^N.,8XK;K%TW0[NQ\1:AJ,^J37$-U_J[9@=L7
M.?7MT& .M:0=E+4PJQO.#Y;V?>UM/Q-JBBBLS<**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *J7G^J-6ZJ7G^J- '*WO\ K37:UQ5[_K37:T %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA[V3JJJ<U477^M!]%%%<![84444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !6)IOA^;3_$FH:H^IS7$=V/EMG'RQ\Y]><=!P.#6W6'IGAUM/\2:
MAJIU":<7G2!Q\L?.?7G'0<=*T@[*6MOU.>K'FE!\M[/O:VF_F;E%%%9G0%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %5+S_5&K=5+S_5&@#E;W_6FNUKB
MKW_6FNUH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEK>.,,ZR')SWQ7HR@N:]SY^%::@THWOI?_(Y2;1I7ODO([01%CEY!VK2N?#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JI>?ZHU;JI>?ZHT
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MQDY597[">'M(_L'P_::8)FG^SQA#(PP6]ZTJ**Y&[NYZB22L@HHHI#"BBB@
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MOVB?B'IFH)-=ZK'JD /SVUU;1A6'^\BAA^?X5,;2?,5*\5RGH'_#(W_4[?\
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M4K2_^P2G_HV2O8/ 'C3PYX.^"'ABX\3:O;:>KV0*)(V9) &.=J#+-^ ->/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI=_R/1O^$)\*?]"SH_\ X 1?_$T?\(3X4_Z%G1__   B_P#B:W**\P]4P_\
MA"?"G_0LZ/\ ^ $7_P 31_PA/A3_ *%G1_\ P B_^)K<HH ^6OB)IMCI7[5'
MAFWTNRM[*#S;%O*MXEC7)E.3A0!FOJ6OF7XX>&_&,WQHM/$'A30[^\^QVUN\
M-Q!:F5!(C,?3!QQQ53_A._VA/^@1J'_@F7_XB@#ZEHKY:_X3O]H3_H$:A_X)
ME_\ B*KWWQ)^/6F6,U[J%A>6UK I>6:72$544=R2O H ^K:*\S^!/C/6O'/@
M.XU/Q'<)<727SPJZ1+& H52!A0!U)KTR@ HHHH **** "BBB@ HHHH ****
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M-Q)A9F4&6/NA]".U:%>.TT[,^JC)2BI+J%%%%(H**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_$O_(-C_P"NP_D:
MV*Q_$O\ R#8_^NP_D: ,O3?OBNHA_P!6*Y?3?OBNHA_U8H DHHHH **** "B
MBB@ HHHH *XCP]_R'K?_ (%_Z":[>N)\/_\ (=M_^!?^@F@#MJ*** "BBB@
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M_P#0&UO_ +]P_P#QRKFTWIV7Y$15KGN5%4-#U:'7_#^GZO:I)'!?VT=S&D@
M95=0P!P2,\U?J6FG9E)W5T%%%%(84444 %%%% !1110 4444 %%%% !1110
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MY9^RI_R475?^P8W_ *,2M/\ F*J>C_\ ;C-_[O#U7Z#?VJ_^2E:7_P!@E/\
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MH **** "BBB@ HHHH *J7G^J-6ZJ7G^J- '*WO\ K37:UQ5[_K37:T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_@G_
M %GB3_L.7'_H*5U%<OX)_P!9XD_[#EQ_Z"E '44444 %>)?#*\FM/B1=6@C&
M+KS5DW @J%)88_&O;:\AT/\ Y+]>_P#72;_T"O1P;3IU8O\ E_(\S')JK1DO
MYK?>>O4445YQZ84444 %%%% !7&_%[_DC_B?_L'R5V5<U\1=(O=?^&^NZ5I4
M7G7EW9O%#&6"[F/09/ _&@#SK]EK_DEEW_V$Y/\ T!*]JKY6_9TN]=T;XJWG
MA.^NIHK:VAN&GL1(#&)E*J3QP3QC-?5- !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<-XY^(47AR5+&Q03W;Y
M$G./*'K[UW-9.H^&M,U34[2^O+=6FM6+(<#YLC^+UJX.*E>2NC*K&<H-0=GW
M/$?%_P 2O#&H6PN-8\/07>IB(V\<[/RF>_YUR>APVMII:K-)Y\AR2Y[TFO\
MAG3;+X@7]O?WT$\<UPTX2)P?+!/W?8UJ?V9I+22-I_G>1M'EACW]Z]O"P7QQ
M6Y\=F562_<U)-M=;(QH+58]>^W67-N%*/'V+>M=I%XDL$\,C3+W2$>X((CN"
MW*GUKS;4+\K9RVT9)Q<#+Q]OK75Z,L/VB W[>;9\;RARV/:MX\LKKYG%44X)
M2;\M>PMSXGFT+0IE%R8[9CAEQU;UKFM.UBSDVB.3[1=S-\^1C K2U466H>(C
M#;G_ $4$[$D]/?WK;E\(P6VF0ZO#+:L,Y\N,C?Q[4/F<KK84?9PI\LDV]_\
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MA1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /-'^,*AV$>B%ESP3=8)'TV4W_A<7_4"_\
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M-)")=WG;  688^Z?[M:/A'PQ#X9T=81A[J4!KB7U;T'L/_KUY[\6O^1LMO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCU))/ZUV?PZ\&?V>8]<O)HII)(S]G6)MP0'@DD<$XR,=LFH?BEX;A%C'K5E
ML;QOLN=BXW ]&/N#QGWJI\*-=:.\GT6=_P!W(#+ #V8?> ^HY_ TYR4\*Y45
M9=411@Z69*&+?,_LO\OZ[GJ=%%%>*?7!7SAI/_(:LO\ KXC_ /0A7T?7SAI/
M_(:LO^OB/_T(5ZV7?#/Y?J?,9]\='U?Z'T?7GOQ>_P"0+I__ %\'_P!!KT*O
M/?B]_P @73_^O@_^@UQX/^/$]7-?]RJ?UU/-;:ZO8=%O8;?<+2>2(7#*.I&\
MJI/H>3_P&NT^$T6FMJET\W.HHG[@-T"?Q$>_]/QIOPTTNWUG2O$%A=KF.981
MGNI_>88>X/-<I(FH>$O$Q /EW=G+D-CAAZ^X(_0U[-1JM[2BM'_P%_PQ\G14
ML+['%R5XZ_+5_P##KS/H6O'_ (M?\C9;?]>*?^AO7I^@ZS;Z]H\%_:\"08=.
MZ,.JFO,/BU_R-EM_UXI_Z&]>9@8N.(L_,^ASF<9X'FB[IM'7_#;>/ :>2%,G
MF2[0W3.>,UY-I<MK'K\$FMHTML)LW"X))]<_C7K?PQ_Y$B'_ *[2?SJ#Q-\-
MK+6;B2\TZ;[%=2$LX*YCD;UQV/T_*MJ=>%.O4C/2[W.6O@ZN(PE"=+5Q2T[[
M?Y%K_A'/!WBBQSI\-I@#B2RQ&Z?4#O\ [PKI[2V2SLX;:'/EPQK&NXY. ,#^
M5>!:CINK>#M:5))&M[E1NCFA?AU]0?3CH:]L\+ZJ^M^&;+4)@!)*A#XZ%E)4
MG\QFL<51E""DI<T3KR[%0JU90E3Y)K<UJ\R^,7_,&_[;_P#M.O3:\R^,7_,&
M_P"V_P#[3K/ _P"\1^?Y&^<?[C/Y?FCD_#GC34?#%K-!80VLBS.'8S(Q(.,<
M885U7A_XEZQJOB"RL;BULA%<2A&,<;A@#Z98U=^$/_(%U#_KX'_H->A5TXJM
M25247"[[W.#+L)B)485(UFH]K>?J9VO:/#KNBW&GSX E7Y'Q]QAT;\Z\/TF_
MNO"7BI)94*R6LICGC_O+T8?ET_"O?Y)%BC:21@J("S,3P .]>":_>R>*O&$T
MNGP;C<2".!%&"X' )]SC-&7MR4H2^$6>1C"5.K!^_?3^O)_F2WT]WXY\:_N0
M0;F01Q \^5&.Y^@R3^->OS>%-'NM%M=+N[036UH!Y:[V4@XQG*D'G)KR#P3K
M2:!XJAFNE ADS#*S+S&"?O>V#C/MFO> <C(Y%&.E*G*,8Z);#R:%.M"I4J>]
M*3UN?.4-O$^OQVS+F(W0C*Y/W=V,9^E>Y:7X/T+1KX7>FV/DSJI4/YKM@'KP
MS$5XE;_\C3%_U^C_ -#KZ(J\PG)<J3W,<BI4Y<\I13::MIMOL>">,-3?6_&%
MV[R_NDE,$18_*J*<9]AU/XUZ/::9X!MM,6S>XT>?Y0'FDN(S(Q[G=G(_ UY+
M?0%-<N+>8^65N&1R1]WYL&O0?^%._P#4=_\ )/\ ^SK?$*G&$(RFXKR./ RK
MSJU)PI*;;UO;3?N<0TR^'_%K2Z9<+-%:7),4J,&#H#ZCKD<5Z=\5_P#D4(O^
MOM/_ $%JR5^#RAQOULE<\@6F"1]=]:WQ7_Y%"+_K[3_T%JQG5IU*U/D=['72
MPU?#X3$*K'E3V5T^_P#P#B/A]X;M?$6L2C4"S6]J@D,0X\PDXP3Z<5T?Q+\,
MZ98Z'#J&G6D5K+',L;")=H=2#U [Y Y^M5/A!_R$M2_ZXI_,UT7Q3_Y$W_MY
M3^M%6I-8Q1OIH+#X>D\JE-Q5]=?1F)\(+I]VIVAR4PDJ\]#R#^?'Y5@?$K4G
MOO&,T.[,5FJQ(/?&6_4_I6Q\(/\ D):E_P!<4_F:Y?QK$T/C75%<8)G+?@0"
M/T-;0BOKDGY?Y')6G+^R::Z7?ZGI7A;P/H\?A>W.H6,5S<742R2O(,E=PR I
MZK@>E>9>+="7P[XBGL8G,D. \1/4*>@/N.E>XZ%(LWA[3I(SE6M8R#_P$5Y'
M\3Y$D\:R"-@Q2%%;!Z'&<?K7/@ZM25>2DSNS7#4:>"A*"2:M^1Z1\/\ _D1-
M-_W7_P#0VKHZYSX?_P#(B:;_ +K_ /H;5T=>;7_BR]6>_@_]VI_X5^1Q/Q7_
M .10B_Z^T_\ 06KB_ASKNG:#JMW-JUQY$<D 13L9LG<#_"#7:?%?_D4(O^OM
M/_06K@_ OAFS\3ZE<V]_)/&D46]3"P!)R!SD&O4P_(\(^?8^<QSJK-(NDES6
M5K[=37\?^.+/7+%--TG>\(D#R3,I7=C.  ><<YY]JO?";19XWNM8F0I%)'Y$
M.1]_D%C]. /S]*WK'X8^';.8221W%V5Z+<29'Y*!FNMCC2*-8XD5$4855& !
MZ 5SU,13C2]C16GF=^'P&(GBOK6*:NMDCQ3XF_\ (\7'_7*/_P!!J]X?^)?]
MA:#;:;_9/G^0"/,^T[=V6)Z;3CKZU1^)O_(\7'_7*/\ ]!KN_ ^A:1=^"]/G
MNM+LIYG5]TDENC,WSL.21774E3CAH.HKK3\CRZ,*\\QK*A/E>O2_43PM\0AX
MEUG[ =,-J?+9P_G[^F.,;1ZUF_$/P1=:E>'6-(3SI64"> ?>; P&7UXXQ["N
MYM-'TRPF,MCIUI;2$;2\,"H2/3(%7*\U5U3J\]%61] \'.OAW2Q4N9WW6A\[
M:=K&J>'[PM87$UK(#AT/0^S*>#^->I>#?B$FNSKI^J(D%Z1^[=/N3>WL?Y_I
M6_K_ (7TSQ%:LE[ HFVX2X48=#]>X]C7A&G/);ZS:O"Q$D<Z%67U##I7I)TL
M;!NUI(\"2Q.4U8I2YH/I^>G1GT?1117AGV)\]^*_^1OU;_K[D_\ 0C7KGBK_
M ))K=?\ 7HG_ ++7D?BO_D;]6_Z^Y/\ T(UZYXJ_Y)K=?]>B?^RU[>(_Y<_+
M]#Y# ?\ ,5Z/]3R?PEHL?B#Q);V%Q(T<+9=]O4A1G ^OK7I'C+P?HT/@^YEL
M;&&VFM$WQR1C!.#R&/5N,]:XKX9?\CQ;_P#7*3_T&O4O&?\ R)>J?]>[5.*J
M3CB8Q3TT_,O+</2G@*DY13>OX(\T^%ET\/C#R5/R3P.K#Z88']/UKV:O$OAE
M_P CQ;_]<I/_ $&O;:YLP_C?([\B;>$^;_0****\\]T**** "JEY_JC5NJEY
M_JC0!RM[_K37:UQ5[_K37:T %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 -EE2"%Y9F"1QJ69F/"@<DUPND?%O2-6U2QM_[+U>SLM3E\G3
M]3NK79;W;\X"MG(W8.,@9KJ/$U_;Z7X3U:_O8#<6]M9RRRPCK(JH25_$#%>*
MVNBZ]X=\,^"=:\0:M%J7AZWOK62#1D7:;7S2%@(EZRF/>.#C./:@#T37/BQI
M&B:O>VG]FZM?6^F,JZE?V=KYD%D2 <.V<D@$$X!Q7;P3Q7-O'/;NLD4J!T=3
MD,I&01^%>7^$#"GP_P#'XOBNY=6U7[5N],'K_P !Q75?#(2CX5^&!<9\S^RX
M,[NOW!_2@#J:Y?P3_K/$G_8<N/\ T%*==Z'XJFO)I+3Q@MO [DQP_P!EQOY:
MYX7<6YQZU5^'4-S;VFO17UU]LN$UJ<23B(1^8=J<[1P* .PHHHH *\@^,'_(
MU:)_US_]J"O7Z\@^,'_(U:)_US_]J"O0R[_>%\_R/-S/_=GZK\SU\=!10.@H
MKSST@HHHH **** "BBB@ HHHH **** /./C]_P D1U[Z0_\ HY*H_LW_ /)%
M=/\ ^OFX_P#1AK5^.-C=ZE\'-;M=/M9KJXD$6R&",N[8E0G ')XKY\\(^,_B
MWX)\.Q:)H?AN\6SB=G43:/*[98Y/./6@#[#HKY7_ .%P?&[_ *%R?_P22T?\
M+@^-W_0N3_\ @DEH ^J**^5_^%P?&[_H7)__  22T?\ "X/C=_T+D_\ X)):
M /JBBOE&[^-GQEL+22ZOM%:VMXQEY9M'D1$'J2>!7MWP6\9:KXZ^'JZQKS0M
M=FZEBS#'L7:N,<?C0!Z!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5'<6\5W;O!<()(I!M93T(J2B@#PGX[> _#&B_#Z74],TB&VOOM,:^>@
M.<$\UX/X3U*WT2[N'O6^5E&T'O7W1<VEO>P^5>01SQYSLE0,/R-<OX@^&/A?
MQ&\37NGQQ^6<CR%"9^O%;4ZKIM21RXC#JO!PELSY0B\8QW.J,;Q/]$!.%]:[
M+P[XAMI72?3Y_)DC.8N.AJEXI^&\W@3Q5*][ );*X=FMI54E I/"MZ&H8=$M
M[N8K;AEWC"^5QS7KX>I4DN;<^6Q]"A3ER)-6ZFO)J4>H:I*[XGN"QWMCO73^
M'QI<<_FWUNES+_# P^^?2N8M-.CT^%T0'S%'S%NN:L:?%,;&.;=N=F(4*?F%
M=RO:S/$DU?FAT/2OA_#ID_BZXNI&%K>*2+>T'15QSS7JM?-"^:+J-_-DBD5P
M2P8AAS7T?I]Q#<V$,EO,DR% -Z-D$X]:\7'TN6:E?<^OR/$*I1=.UG'\;EBO
M,_BUXMTZSTMM'5%N;V08:/)!B!'WJ[K7]970='DOFMIKD(0!'"NYN>^/2O _
M%L%WX@U]]1GGMA<2*!A#P%[#ZUR4Z4IZH]7$8B%&RD[7."*E>,MG_>-++E8O
MO,">G-;>K:$UM:I- PD8#$@'.3[56&B7DD43>4?WAP!C[ON:UE2FG9HYH8BE
M)<R95T^VL&TV<ZFX2;/[MCZ5GDE05#'9G'3[PK9U#P[<VJJ C2GN%&>:](^&
MOPO74;6UU378RD<,N^*$C#$C^\/2E-\NC5K#I152\E*Z?X'*?#+P7)K_ (F@
MFN-.\W2HSF8MP >U?2LUE;SV#6<T2M;M'Y;1GH5QC%.@MH+92+:&.$'J(T"Y
M_*I:YV[NYWQBHJQEZ)X;TGPY"\6BV26J2'+!,\UJ444FV]RDE%604444AA11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5C^)?^0;'_P!=A_(UL5C^)?\ D&Q_]=A_(T 9>F_?%=1#_JQ7+Z;]
M\5U$/^K% $E%%% !1110 4444 %%%% !7'Z$/^)U!_P+_P!!-=A7(:'_ ,AF
M#_@7_H)H Z^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M (W7L%%=<L;&3NZ:/+CE,X1Y8UY)>IQ/CFYUJ3PC:6=C8W4]Q>H!=-!$6*
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M\EK:OV9(SZ=LYQ7=44 <3KGPH\/Z]K-U?W$VI6ZWQ4W]G:7C16]Z5X!E0=>
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M/XE_Y!L?_78?R- &7IOWQ740_P"K%<OIOWQ740_ZL4 24444 %%%% !1110
M4444 %<EHG_(8@_X%_Z":ZVN3T3_ )#$'_ O_030!UE%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5
M+S_5&K=5+S_5&@#E;W_6FNUKBKW_ %IKM: "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *Y?P3_ *SQ)_V'+C_T%*ZBN7\$
M_P"L\2?]ARX_]!2@#J**** "O/\ XR?\B9!_U^I_Z"U>@5D^(_#=CXHTU++4
MC,(ED$H\I]IR 1Z'UK?#U(TZT9RV1SXFG*K1E".[.7\*>._#6G^$M,M+S58X
MIX;=4D0HYVD=N!6O_P +(\)?]!F+_OV__P 363_PIWPU_P ]+_\ [_C_ .)H
M_P"%.^&O^>E__P!_Q_\ $UV2^HRDY-RU]#BA]?A%148Z>IK?\+(\)?\ 09B_
M[]O_ /$U>TGQ=H6NWC6NDZ@ES,J%RBHPPO3/('K7-_\ "G?#7_/2_P#^_P"/
M_B:Y?X96T=E\3-3M8=WEP1S1IN.3@2 #-'L,+.G*5)N\5UL+ZQBX581JI6D[
M:7/9:***\P]8**** "BBB@ HHHH **** "BBB@ HHHH Y_QWX:D\8>!M4T"&
MY6U>^B$8F9-P3Y@<XXSTKP!_V3M2CB9O^$LM<*"<?8V_^*KZ?J.Y_P"/67_<
M/\J /FG]D]2FO>*$)SMA@&?^!/7TU7S/^RE_R,7BO_KE#_Z&]?3% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[]'DTVY2(;G:)@H
M]20<5X)X/\%>*8YI+#6/#TD45PY NG8$0Y/WNM?0=%:TJTJ3O$Y<1A:>)253
MH?*'Q<^$FK>'!'JJ7C:E9LP1G*A?*). *3PE_P 2G2?L$C;\KD9[9KW_ .*/
MA;4?&/@>;2-'DBCN7E1P93@8!YKP;7? ?B+P#-:W>KE+BUN7\I6MR6\L@=6]
M!79A*ZC/FGNSRLSP<IT5"DO=6I2UO5ETNU;[1D$N"O':EL=;M=291 >&&",=
M:;XAUJTU?7-.L[H0HD<."V  ?K2&QDM]0^T6BQ&R4#:4'>O3YI.3:V/G?9TU
M32DK2:OY&PL/E2#9PN.14NFZG81ZL%NHA<B/!,1[U AN+C]Y"I*X["J<,/V*
MX'F*/,8\MBMV^VQQQ75[D?C369H_.ET[3=EHQYVG_5^U<_HOB&S:V2UO[8H-
MV0V#7:Q7%VD,UI)]E-M<-G,@YSVKVSP/X,M])\*P6VL6-A/<[BY=85;@].2*
M\[$SE1:E^#/?RZE#%0=.UK:\R?4YJR^&5EK>A:/J.AWC:7N@W3!%SYQ/<UZ+
MH&D'1-)2R,QG*DG>1UK0CC2&-8XD5$4855& *=7D2FY:=#ZBG1C"SZVM<***
M*@V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "L?Q+_P @V/\ Z[#^1K8K'\2_\@V/_KL/Y&@#
M+TW[XKJ(?]6*Y?3?OBNHA_U8H DHHHH **** "BBB@ HHHH *Y311_Q-X?\
M@7_H)KJZY71A_P 3>'_@7_H)H ZJBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;)(D4322L$1 69B<
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MR?XT?\,W_#C_ *!EU_X&R?XT ._X:.^''_04N?\ P"D_PH_X:.^''_04N?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M['FJ(R"1GD%B>OT&/K7#S+=^%_$SK')BYL9_E<=&P>OT(_G7O>C_ /(#L/\
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M#E9IV*\_PYP/TQ73>"_$']F>$_$-N6(9(?.AP>C-^[)_,I6+H^@-J7AO6=1
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M;0;"25B[O;1LS,<DDJ,FKM>>U9V/2B[I,****0PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#YE_:?_P"2@>%/^N)_]&BOIJOF7]I__DH'
MA3_KB?\ T:*^FJ "BBB@#F_B/_R2SQ7_ -@6\_\ 1#U\S_!#XPZ!\-=#U.SU
MVSU*XDN[E98S9Q1L  N.=SKS7TQ\1AGX6^*@.O\ 8UY_Z(>OGS]GKXE>$_ W
MAW5[;Q3JWV&:YNEDB7[-+)N4)@G**0.?6@#W"R\>6GC+X3ZKXF\.K>6B+:77
ME&X54D1T1OF^5F'4<<U\\> ;OXO?$G19])\/^)+R&ULYFFFU*ZOI4<LRKMB\
MT;G(&TD*./F.>HKZ"F\>>&_'7P]\42^%=2^WI:Z?.LQ\B2/86B<C[ZC/0]*\
M]_9._P"12U__ *_D_P#1= '+?%N&\MOCK\/8-4E$U[%8::EQ(#G?(+EPQSWR
M<UWGQR^)FNZ'KFD^"_!3B'5]5V%K@ %D#OL1%SD L0<GJ!C'7-<A\=?^3D_!
MO_7&Q_\ 2R2IOVA;"^\.?%?PQX\6U>XT^V:WWE1PLL,QDVD]MP(QZX;TH ?X
MR\(_%'X:^&&\6VWQ(U#5GM61KNUE9VCC#,!E5=F5P&(_A7CGM4_C[4M1^*'[
M/%GXQBUB?2A8Q2+J6FVX;RKU_,C3#8<8 *[@"&^]^-2?%KXX>$_%'PTN=#\+
M3SW^HZKY<7DFV=#"-ZL<Y !/& %)Y-:-KX(U71?V1]0T>YMW&I2VKWDEOMRR
M9D$FW'J$49'KD4 8_P"SKX*UJYTG3/%$7C&_@TN&YF5]"4/Y$IP5R?WFWJ0W
MW#T_&K7@CQ1KU[^U3KVE7FLW\VFQ/=+'927+F% I 7"9VC&.PI_[./Q"\.VO
MA.Q\(7%V\>M37LWE6_DN0ZD;]V\#:!@$<D'(Z5C_  ^_Y/ \1?\ 76]_F* (
MO$7BKQ]+^TIJWAOPCKDT;W9%M;PW,S-;VR^2CM((SE00%8YP3UX)-0>+M5\>
M_!'QUH]QJ/C2]\1:??\ [V:.Y+;&56 D01LS!>&&"I'Z5:L?^3Y&_P"NTO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M MJ0D3[U*DE,8SACTQUYS7F_[5'_ "*V@_\ 7Z__ *!0!F_\-7_]29_Y5?\
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MS)K37_PWNM,D;+:;>LJ#/2.0!Q_X]OH ]EHHHH **** "BBB@ HHHH ****
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MB"16D^A:3)<FXDTNR:=FW&5K="Q/KG&<U?I5L7SN$HJW*5A,L]C"K"H[J?\
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M>/3: "BBB@ HHHH **** "N7\$_ZSQ)_V'+C_P!!2NHKE_!/^L\2?]ARX_\
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MT '7K["_10HI$RKRDK-+[E_7]>EBBBBK, HHHH **** "BBB@ HHHH ****
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MXA37DES)<AK?[7?"Z8)M&<,&; SVS7S3\8?^2P>)/^OP_P#H(K[@KX?^,/\
MR6#Q)_U^'_T$4 :WBKXC?%N/3C8^*KS5=.M[I2NV;3UM#(.A 81J2/H:[_\
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M/>?!^ZF09^QW<,[?3=L_]GH P?V644>!]9<#YCJ."?4"-<?S-<S^U4)/[?\
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MO_P,C_QKP?\ X9*C_P"AM;_P"_\ LZ/^&2H_^AM;_P  O_LZ />/^$M\.?\
M0?TO_P #(_\ &C_A+?#G_0?TO_P,C_QKP?\ X9*C_P"AM;_P"_\ LZ/^&2H_
M^AM;_P  O_LZ />/^$M\.?\ 0?TO_P #(_\ &C_A+?#G_0?TO_P,C_QKP?\
MX9*C_P"AM;_P"_\ LZ/^&2H_^AM;_P  O_LZ />/^$M\.?\ 0?TO_P #(_\
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MQ7+Z;]\5U$/^K% $E%%% !1110 4444 %%%% !7.Z6/^)E%^/\C715SVE_\
M(2B_'^1H Z&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *X'XB^%++Q[8QZ9KFEZF(;&?S_M-C(@8+@@%-RG?G/*XR,'
MK\N[OJ*33>S-*<HQ?O1O]Y\_?\,\>&4_UUMXI79\TVRZMWVH>A7$7SMZJ.F#
MU^7=>T/X&^'_  ]K]AJ\=CXDDGTVX2[*/<P.GRL&0C;&"YR!E001@]?EW>YT
M5/++N:^UI?\ /M?>_P#/^M/.^#<ZE<75K);:CX<GE@92+F,[9%,9Z8'_ "T/
MJHZ8/7Y=WC_B+X!:%J=Q/<:9IVK:+(1ODBA=+B&,$\%%/S.>N4##&#C/RAO?
MJ*.67</:TO\ GVOO?^?]:>=_FJ']G"WCG<WUSK#1(JEUAACW(.,D')\PGGY
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !117S??M)<:O<M(Y>22=LLQR22W>NO#8;V[>MK'EYAF'
MU)1?+S7\[?HSZ0HKQR7X5>((4WQ364K#HL<K _JH'ZUF6VN^)?!^I?9YI9XV
MC.6MK@ED8?3T/J*V6"C-?NYILY99M4HM?6*+BN^_Z(]VHK'\,^(K?Q+HZWD
M\N0';-%G)C;_  ]#6Q7!*+@W&6Y[=.I&I!3@[IA1114EA1110 4444 %%%%
M!1110 445'/&9;:2-&VLZ%0WH2.M /8K1ZUI4MT+:+4K-YR=HB6=2V?3&<U=
MKQC3OAUXEBUFW:6U6*..96,XG0@ $'( .?TKV>NG$4J=-KDE<\_ XBO74G6I
M\M@HHHKF/0"BBB@ HHKYK)GOKLEF:6>5B26.2Q-=F&PWM[ZVL>7F&8?4N7W>
M;FOUMM;R?<^E**\D^%NO2P:TVDSS,8+E"8D9N%<<\>F1G\A7K=95Z+HSY6;X
M+%QQ='VD5;R"BO./BOKLD$-MI%M*R&4&6<*<97.%'TR"?P%>7LDD$@W91\!A
MV(R 0?R(KJH8%U8*;E:YYV,SF.&K.DH<UMW>WZ,^EZ*JZ4[2Z/9R2,6=H$9F
M)R22HYJU7GM6=CW8OF284444AA165XFU671/#=WJ-NB22P*"JR9VG+ <X^M<
MQX&\<ZCXFUJ:SOX+6-$MS*&A5@<AE&.6/]ZMHT9RINHMD<E3&4J=:-"7Q2V.
M\HHHK$ZPHHHH **XCQUXUO\ PQJ%K;V$%M()8B[-.K'OC P16WX/URX\0^'8
M[^[CCCE9V4B($+P?<FMY4)QIJH]F<D,92G7>'7Q(U[BY@LX3-=SQP1+U>5PJ
MC\33+/4;+4%9K"\M[I4.&,,JN!]<&N?^(&AWVO\ AV.VTM!)-'<+*4+A=P"L
M.IX[BL;X<^$]7T'4+NZU6%;=9(A&L?F*Q8YSGY21QC]:J-*FZ+FY:]C*>)KQ
MQ2HJG>+Z_P!:'H-%%%<QZ 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %5+S_ %1JW52\_P!4: .5O?\ 6FNUKBKW_6FNUH ****
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M>U:MN9[2W$%U'Y=O,V#'Z*>]17+SRW$3 PS9Y7'( K2U"1OM$;C:S #S4/\
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M*!4E8LL****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6/XE_Y!L?\ UV'\C6Q6/XE_Y!L?_78?R- &7IOWQ740_P"K%<OIOWQ740_Z
ML4 24444 %%%% !1110 4444 %8&F?\ (1B_'^1K?K!TW_D(1?C_ "- &]11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX!_[Y&:@\91)!XPU"*%0L<<@55'8!0 *Z/X3Z5]HUJYU.0?):Q[$_P!]O_K
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M'-' %;"$2@!LCO\ =&* .!\'^2OP_P#'XOMNX:MJOVK=]#U_X#BNJ^&7F_\
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M '13J;'_ *I/]T4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH **** "BBB@ HHHH *Q_$O_(-C_Z[#^1K8K'\2_\ (-C_ .NP_D:
M,O3?OBNHA_U8KE]-^^*ZB'_5B@"2BBB@ HHHH **** "BBB@ K"TX?\ $PC_
M !_D:W:P]._X_P"/\?Y&@#<HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYNN6"ZK*QX G)/\
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M]'^/\C6W6-8?\?T?X_R- &S1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 445!?7]IIEG)=ZE=06EM
M$,R37$@C1![L>!0!/15#2M=TG787ET35++48XSM=[.X24*?0E2<5?H ****
M"BLK4/%7A[2;Y;/5==TRRNFQM@N;R.-SGI\K$'FM4$,H*G(/(([T %%%9GB#
MQ%I7A71I=5U^\6SLHB TK*S<DX  4$D_04 :=%8WA?Q=H?C/3'U#PU??;;6.
M4PM)Y3QX< $C#@'H1V[ULT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!13)YX[:WDGG;;'$A=VQG  R3Q7,^%_B5X1\9W\MEX:UA+RYAC\QXO)DC.W(
M&1O49&2.GK0!U-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5+
MS_5&K=5+S_5&@#E;W_6FNUKBKW_6FNUH **** "BBB@ HHHH **** "BBB@
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M]T<>Q.*U?%G@S^W[F*^L;@6M[$ NXCAL'(.1R"/6NJHI/'U^=35DU?9+KO\
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MCJ2I]T7ELDH7Z;@:-+T#1]#0IHNDV.G*PP5M+9(@?^^0*T** "BBB@ HHHH
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M&3P!^%86E^&OCGK6DVNIZ9J.O3V=W$LL,G]OA=ZD9!P9@1^(I_[3'_)5XO\
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M7/:@#ZIJCK6L6?A_1+O5M3D,=I9Q&65@I) 'H!U-?-_Q?^)'B'7_ (G1>%_
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MWMHASD]N!C+8R3^ J?QMX:\??#;PZ^@:Y=?:-!U$IM,,C2P!T8, I8 HW'3
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M^K!0&/Y@UTE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !116)ILOB!O$FH)J<$*Z6!_HKH1N//'?/3.<]ZI1NF[[&<Y\K2LW?^M3
M;HHHJ30**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=2K#U!IU% 'C'Q5\+Z/X>T_3GT>R6V::1U<JQ.X!1CJ:]9T3_D :?_UZQ_\
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MNGN! &]2BE6)'UQ7K'A_QQHWB#P'#XMBG^RZ8\+32O<84P["0X;Z%2/?MUH
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MK% $E%%% !1110 4444 %%%% !639?\ 'XGX_P JUJRK(?Z6GX_RH U:***
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M(\):3_8/@S1]*88:SLHH7]V5 &/YYK7H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Q-,;Q"?$FH#4TA&E@?Z*4(W'GCWZ9SGOTK
M;K$TQ?$(\2:@=3:$Z61_HH0#<.>/?IG.>_2M(;2V^?Z&%7XH;[]-MNOE^IMT
M445F;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !52\_U1JW52\_U1H Y6
M]_UIKM:XJ]_UIKM: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA_(T 9>F_?%=1#_JQ7+Z;]\5U$/^K% $E%%% !1110 4444 %%%% !679_\
M'TGX_P JU*S;3_CZ3\?Y4 :5%%% !1110 4444 %%%% !1110 4444 %%%%
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M8?\  Q7OE% 'G7P*\1MXC^$VFF;/GZ=FQD)[^6!M(_X 5_$&O1:** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M #)+$\ 5L44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 5-5NOL6CW=SNV&*%V#>A XKYFLKF#7[P>(=2075Y,W[R
M1L#=BOI;6U#>']05AD&VDX/^Z:^(]*\0W-ANM&_U#.0N.HYKNP=2,)OF1XV;
M4*E:DE3=CTZ9X9_-P!Y>2=OI658:A:3W<MM;1 %1SCO4$EM=I'$+59%FGCW
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MZ%&)M&LHX#,@+.O5L\UY3\-M%N]=\20ZG<6,UM;V65EBNH]N\GH0#UKW$
M 8 Z 5XF*E%R2CL?6Y93J1IN51:OON%%%%<9ZH4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_B7_D&Q_P#7
M8?R-;%8_B7_D&Q_]=A_(T 9>F_?%=1#_ *L5R^F_?%=1#_JQ0!)1110 4444
M %%%% !1110 5G6O_'RGX_RK1K/M1_I*_C_*@#0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *Q-,L]=A\1ZA/J-]%-ILG_'M"H^9.>.W&!D=3FMNL33-/UNW\1ZA
M<W^H)/ITW_'M ,YCYX[<8&1P3FM(;2V_KL855><-'OT].OD;=%%%9FX4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 54O/]4:MU4O/]4: .5O?]::[6N*O?
M]::[6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N7\$_ZSQ)_V'+C_P!!2NHKE_!/^L\2?]ARX_\ 04H ZBBBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/X/R^&O%UEXD\/\ CBWUO0!'*)5M,QB9RFT*RAF4@9SR<@JO'H >]5C^)?\
MD&Q_]=A_(UL5C^)?^0;'_P!=A_(T 9>F_?%=1#_JQ7+Z;]\5U$/^K% $E%%%
M !1110 4444 %%%% !5"V'^D+^/\JOU1M_\ CX7\?Y4 7J*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"M-=K7%7O^M-=K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <+K/Q9T31=7O;1[#5KNVTUQ'J.HVEIYEM9L0#AVSGC(S@'%=Q
M%*DT*2PN'C=0RLIR&!Y!%>4^%/(7X3^._MNW(U#5_M6[URW7_@.W]*[3X="8
M?#+PU]ISYO\ 9=ONW=?]6M '25R_@G_6>)/^PY<?^@I3KK2/%\EW*]KXJM(8
M&<F.)M*#E%SP-WF#./6N8\):1XMDDU_[/XJMH=NL3+)G2E;>VU,M_K..W% '
MIM%<I_8?C3_H<K7_ ,$R_P#QRC^P_&G_ $.5K_X)E_\ CE '5T5RG]A^-/\
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M/K!?&U[XDU?2SXKM$&G" B0:0I+^8I;IYG&,5K?V'XT_Z'*U_P#!,O\ \<H
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M(VMYJTL<UVTDR221Q[%;9*Z [<G'"BM^@ HHHH **** "BBB@ HHHH ****
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M)1110 4444 %%%% !1110 53M_\ 7K^/\JN54@_URT 6Z*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M00B+,"EAWS6]2*JHH5%"J.@ P!2UPMW=SVHJRL%%%%(84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !6/XE_Y!L?_78?R-;%8_B7_D&Q_P#78?R- &7IOWQ740_Z
ML5R^F_?%=1#_ *L4 24444 %%%% !1110 4444 %58?]<M6JK1?ZT4 6:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNJEY_JC0!RM[_K37:UQ5[_K37:T %%%% !1110 4444 %%%% !1110 4444
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ML[<P6Z00Q.L0)RS#>#ACP">N!BN@\-:-J&B6$L&J:]=ZY*\F]9[J-$9!@#:
M@ QQG\: -FBBB@ H) !)Z#K110!\T^+O'OAKQ5=KKU_K-NL]IK%K#IM@Q;=;
M6L=PIEG88P&?;GU"@#N:^D+*\M]1L8+RRE6:WN(UEBD7HZD9!'X5C^)_"5EX
MFTZWM)S]G6"\@NPT2+EC$X<*<]CC!K> "@ # '0"@ HHHH *XOXP3RV_P?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K'\2_\@V/_KL/Y&MBL?Q+_P @V/\ Z[#^1H R]-^^*ZB'_5BN
M7TW[XKJ(?]6* )**** "BBB@ HHHH **** "J\7^L%6*@C_U@H GHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *P],\-_V=XDU#5A?S3?;!@P/]U.0?7G&,#T!K<K
M#TOPW#IOB34=6CNY99+S[T+'Y4YS^/MZ UI!V4M;?J<]6/-.#Y;V?>UM-_,W
M****S.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J7G^J-6ZJ7G^J- '
M*WO^M-=K7%7O^M-=K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %8_B7_D&Q_\ 78?R-;%8_B7_ )!L?_78?R- &7IO
MWQ740_ZL5R^F_?%=1#_JQ0!)1110 4444 %%%% !1110 5"GWQ4U1I]X4 24
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 >=?$7QI=:;<_V/I,AAEV;KB9?O+GHJGL
M<<Y]Q7FUMJVH6=Z;NVO9X[ACEI%D.6^OK^-=-\3]+GM/%CWKJ3!>HK(_;*J%
M*_H#^-<;7TN%ITU15EON?G^95ZTL7+F;5GIY+H>Z>!_%#>)M'9KD*MY;,$FV
MC ;/W6 ]\?F#735Y[\)=+GMM-O=0F4K'=,BQ _Q!=V3^9Q^!KT*O"Q,8QK24
M-C[++ZE2IA83J[M?\-^ 4445SG<%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 54
MO/\ 5&K=5+S_ %1H Y6]_P!::[6N*O?]::[6@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *\_\ &/Q=L?!%_>0ZKX7\436EGL\S4[;3U:T.\*1B
M5G ZL%_WN*] KS;]H/\ Y(3XA_[=O_2F*@"QH7Q93Q-9SSZ1X,\5!5L9+RWE
MN[ 10W6U<JB2!F!9N ,9S71^"_$&H>)_"\&J:OH-SH%U*SAK&Z)+H Q )RJG
MG&>0/ZUS/A:>6V_9PL9[:1XIHO#F^.1&PR,("001T(->73^*_$*_LC6NLKKN
MI#5#?E#??:Y//*^>PQYF=V,#'7I0!]*T5\Y>-7\9^$=2\&:GI_CO5KB_\2RB
M&Y2ZVM:QL^S#1P#"J!YG3D\#D5O6T^O> _VA-!\.R^*M6US3-<LGDGCU*42%
M) LAR@P @W(O '0D<T >WT5\R7_C;7?&/CCQ,D\_CR*TTRZ:UL8/!]OO2(JS
M+NG((+$[<X^O(Q7L'P=U7Q1JWP]AD\<6=W;:K!.\)-Y 89)D&"KE2!ZXSCG;
MF@"+XC>/M2\,^(?"_A_P[;VMQJ>NWHB;[4C,D4((#-A64Y^;(YZ*W%>@5XGK
MW^F?MB>&XYN4M-'=XU[9*S\G_OK]!4?B&?Q!K7[2<GA:R\4:II&F7&DJ\R6D
MO( ^8^6&RJ.2!\X&<9'>@#W"BOGGP-8>*_$_B_Q;X,N_'^NQ:9H5RRQW,4H^
MURDLRIF8Y8*-N2!USVJ;P?\ %'Q!8?L\>)M:U&Z.HZMH=X;."XG&XL',2HS$
M_>*M(3SU  H ^@**^==;T_Q;X>^#5G\2K?Q_KT^KM!:WLUK/<!K-EF9 $$.,
M#'F+ZC@\#-7_ !?XH\1:YXV^&B:-KEWH:^(M,$MPMNY9%\U 2=A^5F 8[20<
M'![4 >]UBZ!XOT/Q1<ZE;Z%?"ZETN<V]VOE.GE2 D8^8#/*GD9'%>3>'_P"W
M-$^-VK?#VX\5ZUJ>DZAI#RQW%W=;KJU=E'SQR8^5A\V, #D<<5C_  %\*>;X
MX\677]O:XG]D:N8_)2\Q'>_-(-UPN/WAXSGCDF@#U;P!\1!XYU3Q'9C3#8G0
M[XVF_P _S//^9ANQM&W[G3GKUKM:^9?A[X6U+Q)K7Q)^P^*=4T**WU.5@NF.
M(VEEWRE2S_>VC'W01G/6M?1O&/Q \2_LSS:CH4UQ=Z];7K6TEQ"H:X>!<$LH
MQR^& X&< GKS0!] 2^887\@J)=IV%QE0>V<=JX7X2^/K[QWX?OVUVU@M-8TR
M]>TO(+=65 1T(#,Q]1UZJ:P?@QK>EZC?7]OIWB_Q%JEQ' IN-*\1G=<6SAL%
MU;TR<$#..,]JS_A*?LGQU^)MG =T$ETD[$= Y=R?QR[?E0![71110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %8_B7_D&Q_P#78?R-;%8_B7_D&Q_]=A_(T 9>F_?%=1#_
M *L5R^F_?%=1#_JQ0!)1110 4444 %%%% !1110 4Q?O4^F@<T .HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH K:AIMGJMFUKJ-NEQ"W56'Z@]0?<5SD'PU\-P7(F
M-M+* <B.24E?R[_C7645I&K4@K1;1A4PU&K)2J03?FAL<:0QK'$BHBC"JHP
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M2,QR/;,A7_@%>S44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^)?^0;'_UV'\C6
MQ6/XE_Y!L?\ UV'\C0!EZ;]\5U$/^K%<OIOWQ740_P"K% $E%%% !1110 44
M44 %%%% !2 4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !52\_U1JW5:[7,9H Y.]_UIKM:XV^
MC(D-;?\ PDEI_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SR
MG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_ .^1_C1_PDMG_P \I_\
MOD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD?XT :]%9'_"2V?\ SRG_
M .^1_C1_PDMG_P \I_\ OD?XT :]%9'_  DMG_SRG_[Y'^-'_"2V?_/*?_OD
M?XT :]8_B7_D&Q_]=A_(TO\ PDMG_P \I_\ OD?XU1U;58-1M4BA216$@;+@
M 8P1Z^] $&F?ZP5U$/\ JQ7.Z9"=P-='$,** 'T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>bdtx-20211231_g12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g12.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,X
M-   DI(  @    ,X-   ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M_P"4/[2P?_/Q'=45PO\ PMK0O^?34?\ OVG_ ,71_P +:T+_ )]-1_[]I_\
M%T?5:_\ *']I8/\ Y^([JBN%_P"%M:%_SZ:C_P!^T_\ BZ/^%M:%_P ^FH_]
M^T_^+H^JU_Y0_M+!_P#/Q'=45PO_  MK0O\ GTU'_OVG_P 71_PMK0O^?34?
M^_:?_%T?5:_\H?VE@_\ GXCNJ*X7_A;6A?\ /IJ/_?M/_BZ/^%M:%_SZ:C_W
M[3_XNCZK7_E#^TL'_P _$=U17"_\+:T+_GTU'_OVG_Q='_"VM"_Y]-1_[]I_
M\71]5K_RA_:6#_Y^([JBN%_X6UH7_/IJ/_?M/_BZ/^%M:%_SZ:C_ -^T_P#B
MZ/JM?^4/[2P?_/Q'=45PO_"VM"_Y]-1_[]I_\71_PMK0O^?34?\ OVG_ ,71
M]5K_ ,H?VE@_^?B.ZHKA?^%M:%_SZ:C_ -^T_P#BZ/\ A;6A?\^FH_\ ?M/_
M (NCZK7_ )0_M+!_\_$=U17"_P#"VM"_Y]-1_P"_:?\ Q='_  MK0O\ GTU'
M_OVG_P 71]5K_P H?VE@_P#GXCNJ*X7_ (6UH7_/IJ/_ '[3_P"+H_X6UH7_
M #Z:C_W[3_XNCZK7_E#^TL'_ ,_$=U17"_\ "VM"_P"?34?^_:?_ !='_"VM
M"_Y]-1_[]I_\71]5K_RA_:6#_P"?B.ZHKA?^%M:%_P ^FH_]^T_^+H_X6UH7
M_/IJ/_?M/_BZ/JM?^4/[2P?_ #\1W5%<+_PMK0O^?34?^_:?_%T?\+:T+_GT
MU'_OVG_Q='U6O_*']I8/_GXCNJ*X7_A;6A?\^FH_]^T_^+H_X6UH7_/IJ/\
MW[3_ .+H^JU_Y0_M+!_\_$=U17"_\+:T+_GTU'_OVG_Q='_"VM"_Y]-1_P"_
M:?\ Q='U6O\ RA_:6#_Y^([JBN%_X6UH7_/IJ/\ W[3_ .+H_P"%M:%_SZ:C
M_P!^T_\ BZ/JM?\ E#^TL'_S\1W5%<+_ ,+:T+_GTU'_ +]I_P#%T?\ "VM"
M_P"?34?^_:?_ !='U6O_ "A_:6#_ .?B.ZHKA?\ A;6A?\^FH_\ ?M/_ (NC
M_A;6A?\ /IJ/_?M/_BZ/JM?^4/[2P?\ S\1W5%<+_P +:T+_ )]-1_[]I_\
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MVG_Q='_"VM"_Y]-1_P"_:?\ Q='U6O\ RA_:6#_Y^([JBN%_X6UH7_/IJ/\
MW[3_ .+H_P"%M:%_SZ:C_P!^T_\ BZ/JM?\ E#^TL'_S\1W5%<+_ ,+:T+_G
MTU'_ +]I_P#%T?\ "VM"_P"?34?^_:?_ !='U6O_ "A_:6#_ .?B.ZHKA?\
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M\^FH_P#?M/\ XNC_ (6UH7_/IJ/_ '[3_P"+H^JU_P"4/[2P?_/Q'=45PO\
MPMK0O^?34?\ OVG_ ,71_P +:T+_ )]-1_[]I_\ %T?5:_\ *']I8/\ Y^([
MJBN%_P"%M:%_SZ:C_P!^T_\ BZ/^%M:%_P ^FH_]^T_^+H^JU_Y0_M+!_P#/
MQ'=45PO_  MK0O\ GTU'_OVG_P 71_PMK0O^?34?^_:?_%T?5:_\H?VE@_\
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M3$1,H!R #V)X^85$Z%6"O)61K2QF'K2Y*<TV:U%%%8G6%%%% !1110 4444
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MH7_/IJ/_ '[3_P"+H_X6UH7_ #Z:C_W[3_XNCZK7_E#^TL'_ ,_$=U17"_\
M"VM"_P"?34?^_:?_ !='_"VM"_Y]-1_[]I_\71]5K_RA_:6#_P"?B.ZHKA?^
M%M:%_P ^FH_]^T_^+H_X6UH7_/IJ/_?M/_BZ/JM?^4/[2P?_ #\1W5%<+_PM
MK0O^?34?^_:?_%T?\+:T+_GTU'_OVG_Q='U6O_*']I8/_GXCNJ*X7_A;6A?\
M^FH_]^T_^+H_X6UH7_/IJ/\ W[3_ .+H^JU_Y0_M+!_\_$=U17"_\+:T+_GT
MU'_OVG_Q='_"VM"_Y]-1_P"_:?\ Q='U6O\ RA_:6#_Y^([JBN%_X6UH7_/I
MJ/\ W[3_ .+H_P"%M:%_SZ:C_P!^T_\ BZ/JM?\ E#^TL'_S\1W5%<+_ ,+:
MT+_GTU'_ +]I_P#%T?\ "VM"_P"?34?^_:?_ !='U6O_ "A_:6#_ .?B.ZHK
MA?\ A;6A?\^FH_\ ?M/_ (NC_A;6A?\ /IJ/_?M/_BZ/JM?^4/[2P?\ S\1W
M5%<+_P +:T+_ )]-1_[]I_\ %T?\+:T+_GTU'_OVG_Q='U6O_*']I8/_ )^(
M[JBN%_X6UH7_ #Z:C_W[3_XNC_A;6A?\^FH_]^T_^+H^JU_Y0_M+!_\ /Q'=
M45PO_"VM"_Y]-1_[]I_\71_PMK0O^?34?^_:?_%T?5:_\H?VE@_^?B.ZHKA?
M^%M:%_SZ:C_W[3_XNC_A;6A?\^FH_P#?M/\ XNCZK7_E#^TL'_S\1W5%<+_P
MMK0O^?34?^_:?_%T?\+:T+_GTU'_ +]I_P#%T?5:_P#*']I8/_GXCNJ*X7_A
M;6A?\^FH_P#?M/\ XNC_ (6UH7_/IJ/_ '[3_P"+H^JU_P"4/[2P?_/Q'=45
MPO\ PMK0O^?34?\ OVG_ ,71_P +:T+_ )]-1_[]I_\ %T?5:_\ *']I8/\
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M6#_Y^([JBN%_X6UH7_/IJ/\ W[3_ .+H_P"%M:%_SZ:C_P!^T_\ BZ/JM?\
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M ,71]5K_ ,H?VE@_^?B.ZHKA?^%M:%_SZ:C_ -^T_P#BZ/\ A;6A?\^FH_\
M?M/_ (NCZK7_ )0_M+!_\_$=U17"_P#"VM"_Y]-1_P"_:?\ Q='_  MK0O\
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MSZ:C_P!^T_\ BZ/JM?\ E#^TL'_S\1W5%<+_ ,+:T+_GTU'_ +]I_P#%T?\
M"VM"_P"?34?^_:?_ !='U6O_ "A_:6#_ .?B.ZHKA?\ A;6A?\^FH_\ ?M/_
M (NC_A;6A?\ /IJ/_?M/_BZ/JM?^4/[2P?\ S\1W5%<+_P +:T+_ )]-1_[]
MI_\ %T?\+:T+_GTU'_OVG_Q='U6O_*']I8/_ )^([JBN%_X6UH7_ #Z:C_W[
M3_XNC_A;6A?\^FH_]^T_^+H^JU_Y0_M+!_\ /Q'=45PO_"VM"_Y]-1_[]I_\
M71_PMK0O^?34?^_:?_%T?5:_\H?VE@_^?B.ZHKA?^%M:%_SZ:C_W[3_XNC_A
M;6A?\^FH_P#?M/\ XNCZK7_E#^TL'_S\1W5%<+_PMK0O^?34?^_:?_%T?\+:
MT+_GTU'_ +]I_P#%T?5:_P#*']I8/_GXCNJ*X7_A;6A?\^FH_P#?M/\ XNC_
M (6UH7_/IJ/_ '[3_P"+H^JU_P"4/[2P?_/Q'=45PO\ PMK0O^?34?\ OVG_
M ,71_P +:T+_ )]-1_[]I_\ %T?5:_\ *']I8/\ Y^([JBN%_P"%M:%_SZ:C
M_P!^T_\ BZ/^%M:%_P ^FH_]^T_^+H^JU_Y0_M+!_P#/Q'=45PO_  MK0O\
MGTU'_OVG_P 71_PMK0O^?34?^_:?_%T?5:_\H?VE@_\ GXCNJ*X7_A;6A?\
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MH7_/IJ/_ '[3_P"+H_X6UH7_ #Z:C_W[3_XNCZK7_E#^TL'_ ,_$=U17"_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD]<?*3632C*,E>+N.=.=.7+-6?F%%%%40%%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7L'PE_Y%.Y_Z_G_ /0$KQ^O8/A+_P BG<_]?S_^@)7!
MF'\ ]O(_]\7HSNJ***^>/N@HHHH **** &R?=_&B/[OXTDGW?QHC^[^- #Z*
M** "BBB@ HHHH X7XM?\BG;?]?R?^@/7C]>P?%K_ )%.V_Z_D_\ 0'KQ^OH<
MO_@'PN=_[X_1!1117>>(%%%% !1110 4444 %%%% !1110 5Z/\ !_\ X_M4
M_P"N<?\ ,UYQ7H_P?_X_M4_ZYQ_S-<F-_@2_KJ>IE/\ OL/G^3'_ !A_UVD_
M[LO\TKS6O?/$FG^&KYK<^)GME*!O)\^Z,/7&<?,,]JY?6-#\ PZ'?26$UB;I
M+>1H0FH%F+A3MP-YSSCBN3"XJ,*<8.+_ *9Z>99=.KB)UE.*79O71>AY]X=T
MK^V_$5GIY)"S2?.1U"@9;] :]OU_5(?#'AF:ZBB4+ @C@B P,]%'T_H*\P^%
MBAO&>2.5MG(]N@KK/BV2/"]H!T-XN?\ OAZ6*_>8F%-[%9;_ +/E]6O'XCRF
M_P!0NM4O'NK^=YYG.2SG]!Z#VJ&&:6WF66WD>*13E71BI'T(KJ/ ECX>OKR[
M7Q-) B+&IA\ZX,0)SSSD9[5W]GX-\#ZCO_L^"WNO+QO\B]=]N>F</QT/Y5U5
M<53HOD<7IY:'FX?+JV*BJL9J[[MW_(\AU/5[[6;A)]3N&N)8XQ&KL #M!) X
MZ]3S7LOPW_Y$.R_WI/\ T8U><?$+1+#0?$45MI<)AADMEE*%RV&+,.I)/\(K
MT?X;_P#(AV7^])_Z,:N;&2C+#1E%65_\ST,IIU*>83A4=VD[_>CR[QW_ ,CS
MJ?\ UT'_ *"*Y^O;=6^'&D:SJL^H75S>I+.P9ECD0*.,<94^E<;XY\#Z;X9T
M6&\L+BZDDDN!$5F=2,%6.>%'H*VP^+I-1IK<Y,;EF(A*I7:7+=O?S-_X1?\
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MFO2]+^$</V=6UF_D\TC)CM@ %]MQ!S^0JG\(]-26_OM1D7+0(L49/8MDG\<
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MVS!_+("YV_?Z=NGX5PGAK0F\1ZY'IZSBWWJS&0KNP ,].,_G7NVH?\B_=?\
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MF]3S^&*[CX::G<:EX1_TMVD>VG:$.S9++A6&?^^L?A6=6>(C35;FWZ'1AZ6
MJ5Y814]KZWUNM_\ @'BLL3PS/%*I21&*LI'((X(KLO"?PZN=>M5OK^9K.S?_
M %8"Y>4>HST'OW].]5?%&GI<_$^>Q3Y%N;N)"5[%PN3^;&O6/$=^/#_A*[NK
M55C-O"$A '"DD*O'L2*VQ&)FHP5/>1R8' 4G4JRK:QIW^=K_ .1S;_"31C'B
M.]OU?U9D(_+:/YUYMXDT&7PWK4FGS2K-M4.LBKC<I]NU5$U2_COC>1WMPMRQ
MR9A(=Q^IK:T-[CQ9X[L/[7E^T/)(#(2H&Y44MC &,87%:PC5I7E.=U8YJU3"
MXI*G1I\LFTEKH;7AGX8SZI9I>:Q.]I%(,I"B_O".Q.>!^1K>F^$>D-$1;WUZ
MDF.&D*, ?H%'\ZZ'QA'K,WAYX/#L;-=2N$+)(J%$Y)()(] /7FN%\*>&?%^A
M^(K:Y>S=+9Y0+D&ZC(93P6(#<D9SZ\5PJM5JQ=3VBCV1[,L)A\/.-'V#FGO+
M7^OR.3\1^'+WPUJ7V6] 96&Z*9?NR+Z^Q]1_^NLBO9?BG91W'A(7# >9;3JR
MG'.&^4C]0?P%>-5Z.%K.M2YGN>!F6%CA<0X1VW0Z-&ED6.-2SL0JJ!DDGM7I
M&C?"5I8%EUR]:)V&?(MP"5^K'(S]!^-><P3/;7$<\1Q)$X=3CH0<BNNN+SQG
MXU!>&"<VN,!( 8H3^)/S?B31B/::<LE%=6/ ^PU=2#G+HD=5/\(](:(BVOKV
M.3'#2%& /T"C^=><>(O#]UX;U9K*\*OQOCD7HZ]C[=.E>@?#[P_XDT+5Y!J=
MN\-A)"<J9T9=^1@X#'GK5;XPJ-VCMCDB8$_]\?XUR4:TXU_9.7,F>IB\+1G@
MGB(TW3DNGSM^ID>&/ATWB/1%U$ZF+8.[*L?D;^AQR=PJ_H/PKENM\NMW+01!
MBJ1P@;W .-V3T!],?E75?#/_ )$:V_ZZ2?\ H1K@OB-KE_=^)KG3WF9;2U8*
MD2$@$X!W'U.?RI1JUZM:5*,K)#GA\'AL)3Q$X7;2TONVNIT&K_"6W6R=]%O)
MS.HR([@J0_MD 8->7NC1NR2*593AE88(/I7N/P[U"XU'P= ]W(TLD;O%O8Y+
M 'C/X''X5YOK6F17/Q2EL%0F*XOT#@>CD%OYFKPM::G.G4=[&.8X2BZ5*O0C
M;FLK>IJ>%?AF^K6$=_J]Q);0S+NBBB WL#T8D\ >V*U-6^$EN+-FT6]F\]>0
MER5*O[9 &/UKKO%NIOHGA*]N[7Y)8XPD1 ^Z6(4'\,Y_"O&-!\3ZAH>L"^CG
MDE#MFXC=R1,.^??T-9TI8FNG4C*UMD=&)IX#!.-"I"[:U?5>9[=XE_Y%/5_^
MO&;_ - -?/%?0_B7_D4]7_Z\9O\ T U\\566_!(SX@_BP] KKO"GP_O/$=LM
M[-.MI9%B%?&YI,'!P.PZC)_(UR-=1I/B#Q-<Z+%H&A))Y<18[K9#YF&)."W8
M9)YX^M=U?VG)^[=O-GC8/V/M?WR;71+JSMQ\)-$V<WFH;O7>F/RVUR'B_P
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MM>?:+HUWKVJ1V%@H,CY)9ONHHZL3Z4ZQ\0:KIMO+!97TL<,J%'CSN4@]< \
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M57)1DMK^MSSCX=6DEUXXLVC4E( \DA_NC:1_,@5W7Q7N5B\*10'EYKE0!GH
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M5Z/KNBVUMI5T;B1+@2-^Z=0!M8?Q >M<MX,U*UTCQ=97U_(8[>+?O<*6QE&
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M=A"X9&RCXZ]>1].?K6/X/U;PM=^$;72M=:U$UN7R+I0!\SL<JQ]CZYK=L)O
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MX_+XT5-*4>_]=C!^$-E/%8ZE=R1E8;AXTC8_Q%=V<>WS#]?2L7XM?\C9;?\
M7BG_ *&]=5#\1O#MIJ:Z=;D0:=#$0)TB;;N!&%50,XQGG%<-\0];L->\10W.
MES&:%+58R^QE^8,QZ$ ]Q3HJI+%>TE&R8L7+#T\N5"G-2:?ZW?R.4HHHKUCY
M<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.>*YL/[2"?\ D31RU4\:J-:2MOZ^1RGCOP;8>%[6TFT^>YD\]V5A.RG&!GC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5Z3\'W47.JJ6 9DB(&>3@
MM_C7FU%8UJ?M:;A>USJPF(^K5XU;7M_E8] ^+DB-KEBBL"RVY+ 'D98UY_11
M3HT_94U"^PL57^L5I5;6N%%%%:G,%%%% !1110 4444 %%%% !1110 4444
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M/^1YTS_KH?\ T$U[7K>L6^@Z3+J-XDCPQ%0RQ %CD@=R/6O%/ G_ "/.F?\
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MEBOGJOH3P_\ \B9IG_8/B_\ 18KHS+X8^IP9!_$J>AYE\)T#^+IB>J6;L/\
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M(/'6MX4%[:,I5+O^O,Y*V,E]4G3A0Y(OKT_(];^'VJ?VIX.M=S9EM<V[_P#
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MTG_KSB_]!%>9?%?_ )&^+_KS3_T)Z]-\*_\ (H:3_P!><7_H(KS\1_NM,]S
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M/^1TTO\ Z^%KVKQ)K7_"/:#/J7V?[1Y14>7OV9RP'7!]?2O%?!G_ ".FE_\
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M7NO=%S2-4GT758-0M AF@)*B094Y!'/X&M?Q%XXU/Q-81VE_#:QQ1RB4>2C
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M<L5'K@@$_A7*TX5(5%>+N*K0JT7RU(M!70>$O"DOBN]GA2Z6VC@0,[E-YY/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-"\4QFVA<-(R_/:W*#)'?CHWX9K@_B1X1L]%$&I:6@A@GD\N2$'A7P2"OH"
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MC&KS*G^Y0]?\SZ'#_P#(WJ_X?_D3F/%_C^]TS57TK0%2UCM&V/(8PQ8CL >
M/UKM_"NL-XA\,VU]<1JLD@9)5 ^4D$@_@<9_&O&?&?\ R.FJ?]?#5ZG\,_\
MD1K;_KI)_P"A&KQ-&$,/&45KI^1EE^*K5<?4A.6FNG31GD7B"R73O$>H6D8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1S/_  KKPM_T"_\ R8E_^*H_X5UX6_Z!?_DQ+_\ %5TU%'MZW\S^]A]2PO\
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MX5UX6_Z!?_DQ+_\ %5TU%'MZW\S^]A]2PO\ S[C]R.9_X5UX6_Z!?_DQ+_\
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M1S/_  KKPM_T"_\ R8E_^*H_X5UX6_Z!?_DQ+_\ %5TU%'MZW\S^]A]2PO\
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MX5UX6_Z!?_DQ+_\ %5TU%'MZW\S^]A]2PO\ S[C]R.9_X5UX6_Z!?_DQ+_\
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M@#PM_P! S_R8E_\ BJV6N0*A:['K1[>M_,_O8?4L+_S[C]R,H^ ?"W_0,_\
M)B7_ .*I/^$"\+?] S_R8E_^*K1:\'K3#>CUH]O6_F?WL/J6%_Y]Q^Y%#_A
M_"W_ $#?_)B7_P"*H_X0/PM_T#/_ "8E_P#BJN_;1ZT"]'K1[>M_,_O8?4L+
M_P ^X_<BG_P@7A;_ *!G_DQ+_P#%4H\ ^%O^@9_Y,2__ !571>CUJ1;P>M'M
MZW\S^]A]2PO_ #[C]R* \ >%O^@9_P"3$O\ \53A\/O"W_0,_P#)B7_XJM);
MH>M2I<@]Z/;UOYG][#ZEA?\ GW'[D90^'OA7_H%_^3$O_P 52_\ "N_"O_0+
M_P#)B7_XJMM9P:E67-'MZW\S^]A]2PO_ #[C]R,#_A77A7_H%_\ DQ+_ /%4
MO_"NO"O_ $"__)B7_P"*KH@].!H]O6_F?WL/J6%_Y]Q^Y'-_\*Z\+?\ 0+_\
MF)?_ (JC_A77A;_H%_\ DQ+_ /%5TV:*/;UOYG][#ZEA?^?<?N1S/_"NO"W_
M $"__)B7_P"*H_X5UX6_Z!?_ ),2_P#Q5=-11[>M_,_O8?4L+_S[C]R.9_X5
MUX6_Z!?_ ),2_P#Q5'_"NO"W_0+_ /)B7_XJNFHH]O6_F?WL/J6%_P"?<?N1
MS/\ PKKPM_T"_P#R8E_^*H_X5UX6_P"@7_Y,2_\ Q5=-11[>M_,_O8?4L+_S
M[C]R.9_X5UX6_P"@7_Y,2_\ Q5;&D:+8:%:-;:5;^1"[F1EWLV6( SEB3T J
M]14RJU)*TI-_,TAAJ%.7-""3\DD%%%%9FX4444 %%%% %74/^/=?][^AHT__
M (]V_P![^@I-1_X]U_W_ .AHT[_CW;_?_H* +=%%% !1110 4444 4=7T6PU
MVT6VU6W\^%'$BKO9<, 1G*D'H36/_P *Z\+?] O_ ,F)?_BJZ:BM(U:D5:,F
MOF83PU"I+FG!-^:3.9_X5UX6_P"@7_Y,2_\ Q5'_  KKPM_T"_\ R8E_^*KI
MJ*KV];^9_>S/ZEA?^?<?N1S/_"NO"W_0+_\ )B7_ .*H_P"%=>%O^@7_ .3$
MO_Q5=-11[>M_,_O8?4L+_P ^X_<CF?\ A77A;_H%_P#DQ+_\51_PKKPM_P!
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MBCV];^9_>P^I87_GW'[D<S_PKKPM_P! O_R8E_\ BJ/^%=>%O^@7_P"3$O\
M\57344>WK?S/[V'U+"_\^X_<CF?^%=>%O^@7_P"3$O\ \51_PKKPM_T"_P#R
M8E_^*KIJ*/;UOYG][#ZEA?\ GW'[D<S_ ,*Z\+?] O\ \F)?_BJ/^%=>%O\
MH%_^3$O_ ,57344>WK?S/[V'U+"_\^X_<CF?^%=>%O\ H%_^3$O_ ,51_P *
MZ\+?] O_ ,F)?_BJZ:BCV];^9_>P^I87_GW'[D<S_P *Z\+?] O_ ,F)?_BJ
M/^%=>%O^@7_Y,2__ !5=-11[>M_,_O8?4L+_ ,^X_<CF?^%=>%O^@7_Y,2__
M !5'_"NO"W_0+_\ )B7_ .*KIJ*/;UOYG][#ZEA?^?<?N1S/_"NO"W_0+_\
M)B7_ .*H_P"%=>%O^@7_ .3$O_Q5=-11[>M_,_O8?4L+_P ^X_<CF?\ A77A
M;_H%_P#DQ+_\51_PKKPM_P! O_R8E_\ BJZ:BCV];^9_>P^I87_GW'[D<S_P
MKKPM_P! O_R8E_\ BJ/^%=>%O^@7_P"3$O\ \57344>WK?S/[V'U+"_\^X_<
MCF?^%=>%O^@7_P"3$O\ \51_PKKPM_T"_P#R8E_^*KIJ*/;UOYG][#ZEA?\
MGW'[D<S_ ,*Z\+?] O\ \F)?_BJ/^%=>%O\ H%_^3$O_ ,57344>WK?S/[V'
MU+"_\^X_<CF?^%=>%O\ H%_^3$O_ ,51_P *Z\+?] O_ ,F)?_BJZ:BCV];^
M9_>P^I87_GW'[D<S_P *Z\+?] O_ ,F)?_BJ/^%=>%O^@7_Y,2__ !5=-11[
M>M_,_O8?4L+_ ,^X_<CF?^%=>%O^@7_Y,2__ !5'_"NO"W_0+_\ )B7_ .*K
MIJ*/;UOYG][#ZEA?^?<?N1S/_"NO"W_0+_\ )B7_ .*H_P"%=>%O^@7_ .3$
MO_Q5=-11[>M_,_O8?4L+_P ^X_<CF?\ A77A;_H%_P#DQ+_\51_PKKPM_P!
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MBCV];^9_>P^I87_GW'[D<S_PKKPM_P! O_R8E_\ BJ/^%=>%O^@7_P"3$O\
M\57344>WK?S/[V'U+"_\^X_<CF?^%=>%O^@7_P"3$O\ \51_PKKPM_T"_P#R
M8E_^*KIJ*/;UOYG][#ZEA?\ GW'[D<S_ ,*Z\+?] O\ \F)?_BJ/^%=>%O\
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M\F)?_BJN"]'K3A>CUH]O6_F?WL/J6%_Y]Q^Y%(> ?"W_ $#/_)B7_P"*IP\
M>%O^@9_Y,2__ !57UO!ZU*MT/6CV];^9_>P^I87_ )]Q^Y&:/A]X6_Z!G_DQ
M+_\ %4X?#WPK_P! O_R8E_\ BJU4N0>]3K.#1[>M_,_O8?4L+_S[C]R,3_A7
M?A7_ *!?_DQ+_P#%4O\ PKKPK_T"_P#R8E_^*K?67-2!Z/;UOYG][#ZEA?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !2$T$TQFH 4M4,DF*223%4
M9[C'>@!\UQBLZXN\9YJ&ZN\9YK)>>6YF$-NK22,<!5&2: +%S?8SS3;/3[[5
MFS FR+/,K\+^'K6SI?A=$VSZIB63J(@?E7Z^O\OK71 !5 4  = .U &/8>&+
M*T(><&YE'>0?*/HO^.:V  J@*  .@':EHH **** "BBB@ HHHH **** "BBB
M@!KHDJ%)%5U;JK#(-8=]X4M)\O9,;63T'*'\.WX5O44 <!<VM[I4FV\C(7.!
M(O*M^-3VU]G'-=M)&DL;1RHKHPP589!KF=4\+M'F?2<^I@)_]!/]* )(+O..
M:T89\UR,%VR.4D!5E."K#!%:]M=YQS0!T229J4-69!/G'-78WS0!8!I:8IIP
M- "T444 %%%% !1110 4444 %%%% %/4_P#CU7_?'\C1IG_'JW^^?Y"DU3_C
MU7_?'\C1I?\ QZM_OG^0H NT444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#3#4X&J\;YJ930 ^BD!I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@T4TF@!&-0R28
MI9'P*HW$V,T -N)\9YK(N[O&>:6[NL \UFV]O/JMZ+>W^KN>B#U- !!#<ZK=
M^1:C)ZLQZ*/4UV.EZ1;Z7#B(;Y6'SRL.3_@/:I=/T^#3;40VX]V8]6/J:M4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN=M+K('-:\$V0* -(&G"H$?-3 T +1110 4444 %%%% !1110 4444 %%%%
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ML?!'A.\\0ZK%<36EGL\Q+95:0[W5!@,0.K#OTH VZ*\2_P"&J_!'_0*\0?\
M@/!_\>H_X:K\$?\ 0*\0?^ \'_QZ@#VVBO$O^&J_!'_0*\0?^ \'_P >H_X:
MK\$?] KQ!_X#P?\ QZ@#VVBO$O\ AJOP1_T"O$'_ (#P?_'J/^&J_!'_ $"O
M$'_@/!_\>H ]MHKQ+_AJOP1_T"O$'_@/!_\ 'J]2\'>*['QOX3L_$.E17$-I
M>;_+2Y55D&QV0Y"DCJI[]* -NBBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TUC0!'(V*HW
M$F :LRMBLJ[EP#0!0O9\ \U7T.P_M35-\HS!!AF_VCV%5;Z8G(')/0"NRT:P
M&G:7'$1^\8;Y#_M'_./PH OT444 %%%% !1110 4444 %>2S0_\ "7_%5[>[
M.ZUMV(V?["=OQ/\ .NI\6>/[;0IFL;%/M5]CD?PQD^OJ?:N(TI]8\-:Y#XDU
M>PE2VNG82-MQPW/3MZC/7%>GA:4X1E/9M:'SN98FE5J0I+51:<NR7F>S1QI%
M&L<2A$4850, "G5E1^)]&ETU[Z/4(&@C3>Y#C*^Q'7/M7+6OBGQ+XEO-_ARQ
MC@L$DP9IQ]X=^3_(5QQH3E=O2W<]:IC*-/E2U;V2U.^/0UY7\*/^0[J7_7/_
M -FKU/G9SUQS7EGPH_Y#NI_]<_\ V:MZ'\"K\CCQO^^8?UE^1ZI165XB_MH:
M:#X=\DW089$N.5]L\5A^'_&TEQJ3:3XBMOL%^OW2WRJ_YUSQHRE#FCK;[SNG
MBJ=.JJ<[J^SZ>E^YH^--#M]:\.7 E0>=;H98I,<J0,X_$5A?"G4I+K1+JRE.
MX6D@*$G^%L\?F/UJ[XO\96%EIDUC8S+=WUPIB6*([MN>#G'UZ=:XG1[W7/A[
M<^9?:<PM;L*7##KC.,,.A&3Q7;2I3GAW![O;]3Q\3B*5+'QJQV2M)K7TN>S4
M5FZ'KMEX@T\7=@^5SAT/WD/H16E7FRBXNS/H(3C.*E%W3"BBBD4%%%% !2,H
M=2K@,K#!!'44M% '!7]FVD:JT SY3?/$<_PGM^'2M&RGR!6IXFT_[9I9EC&9
MK?YU]Q_$/RY_"N:L)\XH ZNWDR!5U#6/:29 K4B;@4 6!2TT&G4 %%%% !11
M10 4444 4-8_X\T_ZZ#^1HT?_CS?_KH?Y"DUG_CS3_KH/Y&C1O\ CS?_ *Z'
M^0H T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *X/QO\ %*U\*:JNC6.F7.JZO)&'6"+A5!Z9/)SWP!^(KO*X7Q;\
M(] \9:X=5U.YU"&X:-8V%M*@4@=#AD/- '*-8?$#QUSX@\06?AG37_Y=+24>
M85]#M;/3U;\*Z7PW\-? WAQEF M]0NQR;B^E60Y]0OW1^6?>LG_AGCPG_P!!
M#6?^_P#%_P#&Z/\ AGCPG_T$-9_[_P 7_P ;H [M"B^,E,16-)K ;3]X3A6X
MV_W=N[G^]O'!VY&W7+:'H]OX<UFTTJR:18(=-$2-.0[7 5^Q  4KNYZ;MXX^
M7(ZFHAU.G$?8_P *_K^F_ELH[FY@L[66ZO)HX+>%#)++*X5(U R68G@  9)-
M-M+RVO[.*[L;B*YMIE#Q30N'1U/0AAP1[BL'XC_\DL\5_P#8%O/_ $0]9/P[
MBO)_@5H<6F2I#>R:,BV\K_=20IA2>#P#@U9S'27'BOP[::L-+N]>TR#4"0!:
M2WD:RDGH-A.?TK3FGBMH'FN)4BBC4L\DC!54>I)Z"OF3Q3\'/#O@3X.ZKJ?C
MBX2Z\42RN;6\@NI"'D9OD4*<!LC);*D_>YX%1^,;S7)_@_\ #3PKK5Q/"=;G
M5;IF)WF$.HB#9]%=3@^@]* /I'2?$.BZ^LC:%J]AJ:Q'$AL[E)@A]]I.*T:^
M<]9\,:7\(_CUX*?P@LUG9ZN#:W5N9F</E@A)+9/.Y3CIE>,5[1XN^(/ACP)]
MC_X2O4_L'VW?]G_T>67?LV[ON*V,;UZXZT =)17FW_#0?PQ_Z&;_ ,D+G_XW
M7;^'O$.E^*M!M]9T&Y^UZ?<[O*F\MDW;6*'Y6 (^92.1VH TJ*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **XWQ-X?\<W^LM=>&?&\.DV1
M10+&728YP&'5O,)W<^G:L8#XRZ.@8MX7\1QJ,LF)+6=O8'[@_&@#TNBO.K'X
MPV%KJ$>F^/-(OO!]]*<1F_ >VE/HLZ_*?J<#WKT1'62-7C8.C %64Y!'J* %
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#44C8J1C5:5L4 5K
MB3 -8E[/@'FK]W+@&N>OIB<@<D] * +6AV']J:IOE&8(,,W^T>PKMZH:-8#3
MM+CB(_>,-\A_VC_G'X5?H ***;+*D,323.J(HRS,< "@!U5[J_L[$ WMU!;@
M]#+(%S^=<E=^*M1UV[DLO"$2F).)-0E!"#_=]:6T\$6.XSZU))JMT_+O.?ES
M["NCV48*]1V\NO\ P#A^LSJNV'C==WHOEW^6GF=/=7$-UHUS+;31S1F%\/&P
M8'Y3W%> 1+F!/GQ^[Z8;CD\\"O3M#C72==\1Z1;96T-OYT,6>$^4@XKRW#^5
M'L3<-G7:3W/'%>I@X*',D]-/R/G,VK.JH2:U7,G\FD>B?"G_ )"6K<Y_=P\^
MO!KT"35]-BN3;RZA:I,#@QM,H;\LUYI\/+DV<.OW'0Q6T;?0X:M7PWX5TO4O
M#4%UJ=J)[NYW2/.Q^?))QS]*Y<5"+J2G-Z:+\#T<NK5%AX4Z23?O/7_$>A @
M@$'(/0BBN$_L[7_"V9-"N#J-BO)LKAOF4?[)_P _2NCT#Q-8^(+?-LQCN$_U
MMM)P\9^E<<J32YHNZ_K<]6GB5*7LZBY9=GU]'U_,V****Q.L***R?$NMIH&B
MRW;#=*2(X4'5W/0548N34414G&G!SELBAXF\4-ITT>F:1']JU:X'R1CD1#^\
MU4]+\)QQW']H:[*=2U%ADO+RL?LH]J7PYI(TJRDU35G!U"Y'F7$TA^X/[N>U
M9&KZW_PDDIMM-GGATFW1I;V[1"-P'\*DUV1B_@I[=7_7X+J>3.:25;$*\G\,
M>W_![OH=3<Z[I5G&[3ZA:IY8R5$JEO\ OD<UB+XX:=?.L]!U.XM?^>R0]?<>
MU4?#C>"=2D2W_LUK>9?FC:]/^M [[LX/TJMXH\67J>)5B\/WP%M:F-!'#RDC
M$\CC@]:N&'CS\G*[^>GY&57'5/9*KSI+;W=7^-MC;_X3_13$AB-Q+,W6!(6W
MKZYXQ5S3/%FE:M<_98I6BN.T,Z%2WTSUKH$L+*VEEN$MX8WD^:1PH&?<FN#U
MO5M)\5:D-+TR-HK^-B;._"X0NO.,CG!QC-90A3J748OUOL=-6KB*"3G.+;V5
MK7]-=_P-35O"<,\_V_1I#IVHIRLD7"N?1A5OPWXGEO;IM)UN'[+JL(R5_AF'
M]Y?\*RVU_6]!>/\ X2C3T^RMA3=VIRJGU(["KOB31O[7L8K[3GV7]J/-MID/
MWN^W\:=G90J[='V_X DXW=7#JTE\4=K_ "[]GU.MHK'\,:XNO:+'<$;)T/ES
MQ_W7'6MBN247&3BSTZ=2-2"G'9B,H=2K@,K#!!'45P=_9MI&JM ,^4WSQ'/\
M)[?ATKO:Q_$VG_;-+,L8S-;_ #K[C^(?ES^%269=E/D"MJWDR!7*6$^<5T%I
M)D"@#80U(*KQ-P*G!H =1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?,WB33O%>I^-M0N/$7AGQ!KEK'=2"VA195A";CM"E4/RX_ND?6OIFHYYX
MK6VEN+AQ'%$A=W;HJ@9)/X4 >):-XU\1>'K;R-$^$ES91XP?*MI@S?5O+R?Q
M-:UO\4_&\MU%')\-]11'<*S&*88!/7)CJ23XZ175S*/#_A75-5MHVV^>@*Y_
M *V/QYIT/QEU.6=(SX!U=0[!=QW<9/7_ %= '>:#\E[J\7^KVWC-Y Y5-P#;
MMW<OG<1V)QCN=FL;0?DO=7B_U>V\9O('*IN ;=N[E\[B.Q.,=SLU$/A.G%?Q
M7\OR7]=?5[A5;4-.L=6L9++5;.WO;63&^"YB61'P<C*L"#R,U9HJSF,^?P_H
MUSHR:1<Z38S:8@54LI+9&A4+]T!"-HQVXXK+_P"%<>"/^A-\/_\ @K@_^)KI
M** *ZV%FFGBP2T@6S6,1"V$8$83&-NWIC'&*K:3X>T70%D70M(L-,64YD%G;
M)"'/OM S6C10 5YM^T'_ ,D)\0_]NW_I3%7I->;?M!_\D)\0_P#;M_Z4Q4 '
M[/G_ "0GP]_V\_\ I3+7I->;?L^?\D)\/?\ ;S_Z4RUZ30 5YM^T'_R0GQ#_
M -NW_I3%7I->;?M!_P#)"?$/_;M_Z4Q4 ?$M%%% !1110 4444 %?;7[/G_)
M"?#W_;S_ .E,M?$M?;7[/G_)"?#W_;S_ .E,M 'I-%%% !1110 4444 %%%%
M !5'6;6_O=&N;;1]1_LR]D3$-YY"S>2W][8W#?0U>HH \V.@?%W3_GL_&FAZ
MNP_Y9ZCI7D*?QB.:B;XHZ[X391\3_"<NFVA(7^V-+?[5:@DXRX'SQCZY/M7I
MU-DC26-HY45T<%65AD,#U!% $&GZC9ZMI\-_IES%=VDZ[XIH7#*X]015FO*;
M2P'PP^+6G:9HY\OPQXK\X"P'W+*\1=VY/[JN.-H[^P%>K4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 !J-S3S4,AXH JW#X!K$O9< UJ73XS
M7/ZA+UH -$M?M^NIN&8X/WC?4=/U_E7<5@^$K7R]->Y8?-._!_V1P/US6]0
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M;\.M(\ ^(-2T_P />3=V>F7,\$GVVX;8Z1,RG!D(."!P1BJW[*G_ "2S4O\
ML-2_^B(*])^(_P#R2SQ7_P!@6\_]$/7FW[*G_)+-2_[#4O\ Z(@H ]MHHHH
M\ \1_M1?\(_XJU71O^$0^T?V=>S6GG?VGL\SRW*;MOE'&<9QDUF?\-<_]23_
M .5;_P"TUXE\1_\ DJ?BO_L-7G_H]ZYN@#Z1_P"&N?\ J2?_ "K?_::/^&N?
M^I)_\JW_ -IKYNHH ^D?^&N?^I)_\JW_ -IH_P"&N?\ J2?_ "K?_::^;J*
M/O\ ^'WB[_A._ FG^(_L7V#[;YO^C^;YNS9*T?WMJYSLST'6NDKS;]GS_DA/
MA[_MY_\ 2F6O2: "BBB@ HHHH **** "BBB@ HHHH J:GI=AK6G2V&K6D-Y:
M3+MDAF0,K#Z'^=>9627/P>\6Z=I/VF:Y\$ZU.+:T^TR%VTJY(^6/<>L;]L].
M?0EO6*\V_: _=_!;5[I.)K2:UFA;^ZXN(QG\B: /2:*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXTV]C\3:0/\ 2+88N8ATFC[_ (XKKM.OX=3TZ&\MCF.9 P]O:L:D8V4X;/\
M!G7AZDU)T:OQ+KW7?_,LUQ.K_P#$\^(5I8,=UKID1N)!V,AX /\ .NVKB/"Q
M^TZ_X@OB/FDN50>P4$4Z/NJ4^R_/06*]^5.ET;U]%K^=A/%P;4=6T?1"[)!>
M2LT^W@L%&0/YUE6GC^*Q-]8W>EPQ6<2M';11C[Q7C8WKGUK75#JWQ.C24XBT
MNW\R-1QEV/7Z8KF_'_AE]*U ZG;@-9W$NXKT\J4CG\#C-=M%4WRTI]K_ #_X
M:QX^+E7BYXFET=ODDE]U[_F8^DZ'J?B2:;^SK.(1>9N#.Q6& _W1U)I^L:+>
MZ%>1Q:I%&ICB,T'V-RJG'7DC.:T=%\::EHMC:Z?:0:;+!$P4I'O,C$GGGIFI
M?'NLIJNO_8X5;9:JUN2HW,TIZ@#OBNOFJ^ULU[IYGL\-]6YU)\^GIJ9=Q_;C
M:2EU?QZA]AF4,LKSY3GD9P,XJ]X0U/3M"NWN]5M+J:Y4;86MH@\<:GTYSD^]
M7O"GASQ$^I6LEWYT-C$ DD=RV5DCQC:$^E;>N> (A#/<^&Y9+2<C)ME<^5+[
M8Z@GZUE4K4[^RD]^QTT,+B&EB()W726_JMOZ[E6Z\<P:Y<#2!I,IM;[, >9@
M'#$<'9[?6K'@S46BM3H5^DD%_9 C9)_$F>"#WK"^&\EM_P )$ZW,"R3SQLT$
M\A+.A7[R\_S]JZ#Q.J+X^T%[0?Z8V\2;>\>._P"M<]6$$W12MI?YK^K';AJU
M648XN4KN_+;R;7_#H33C_87Q'EM5^6UU>'S%7MYJ]<?AFNVKB/&'^CZGH-\G
MWH[T1#Z/U_E7;UR5?>C&?=?D>KAO<G4I=$[KYZ_G<****YSM. N[;^S=8FMA
MP@;*?[IY'^'X5KV4N0*/&%MAK:\4=#Y3']1_6J=A)P* .E@;(%7%-9MLV0*O
MQF@":B@44 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/XMT\ZKX-U>
MP6986N+.2-9';:JDJ<9/8>M:5U>6UC!YU[<16T6X+YDSA%R3@#)[D\5%J>G6
MNLZ3<Z??(9+6ZB,<BJQ&5(]10!P7PL\6Z!!X%M=+N;RTTV]T[,%S;SRK&=X)
MRPR?FSUR.^:[-?%/A]F"KKNFDDX %Y'S^M<E_P *.\#_ /0/N/\ P*?_ !IT
M7P2\$12I(FGS[D8,,W3]1^- '3Z#\E[J\7^KVWC-Y Y5-P#;MW<OG<1V)QCN
M=FLG3UATW4;BVFN[>.2]G>>WLQ(-V.K, >22<L<<#/XG6J8*R-\1)2J-KR_+
M^N_J]PHHHJC **** "BBB@ KS;]H/_DA/B'_ +=O_2F*O2:\V_:#_P"2$^(?
M^W;_ -*8J #]GS_DA/A[_MY_]*9:])KS;]GS_DA/A[_MY_\ 2F6O2: "O-OV
M@_\ DA/B'_MV_P#2F*O2:\V_:#_Y(3XA_P"W;_TIBH ^):*** "BBB@ HHHH
M *^VOV?/^2$^'O\ MY_]*9:^):^VOV?/^2$^'O\ MY_]*9: /2:*** "BBB@
M HHHH **** "BBB@ HHHH \V^)O_ "/?PY_[#3_^BC7I->;?$W_D>_AS_P!A
MI_\ T4:])H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1JK3'
MBK#=*J3GB@#-O'ZUS>H2$Y K>O6ZUBP1_:=:M8CT:5<_0')H [>PMQ::?! !
MCRXPI^N.:L444 %%%% !1110 4444 !.%)/:O(]#B_X2[XF7%W=G?!#(T@7J
M"JG"#]!7K4@S&P]0:\L^%S+:^)M2M)<"4J0 >ORMS7=AO=IU)+>QXV8+GQ%"
MG+X6W^&QZ=>VQO+&:W69X#(A421G#+[BO/KZQ\4^"E.H6NI-JMBA!FCFSD#Z
M$G\P?PKTBLSQ)=0V7AJ_FN?]6(&7&,Y)& /S(K&C4<7RVNGT.O%T(U(NI=Q<
M5HT]CDH_B)J>IX_L/P]+,HX9W<D9].!_6K$'CK5;>[C@UCPY<1!V"[X26Q^&
M/ZU+\+[:>#PHSS;@DT[/&".HP!G]/TKL^M;5I4H3<%#1>;.7"T\56I1K2JM-
MZVLK"9RN?:O+/A1_R'=3_P"N?_LU>J'H:\K^%'_(=U/_ *Y_^S44/X%7Y!C?
M]\P_K+\CU2N:USQUI>@ZD;&ZCN99PH8B*,$ 'W)%=+44EK;ROOE@C=L8W,@)
MKD@X)^^KH]*M&K*-J3L_-7.3NOB1HC:)<7%K*_VD*1';R)M8L>![>_6H_AII
M,]GH]QJ%V"LE^X<*1_",X/XDFJ_Q#\+6)T:75[.)+>YMB&;8,"1<@<CIGG^=
M=/X7U!M4\,V-VZA7>/#!>@(X_I79-P6'O3V;U/+I*K+&VQ#5XJZMUOHW^@>)
MM(CUSP[=63CYF0M&?1QR/UKC?A-J4C)>Z7(25B_>IG^'G!'\J]&DD6*)I)#M
M1 68GL!7EOPJ^?Q#J<BKA3%V' RXI47?#U$]E8>*2ACZ$X[NZ?H>J4445PGL
MA1110 4444 %9VOV_P!IT.Y7'*IY@_X#S_2M&D=0Z,C#*L,$>HH X'3Y.E='
M:/P*Y:S!BF:-NJ,5/X5T=FW H VHC4ZU5A/%65H =1110 4444 %%%% &=K?
M_'DG_70?R-&B?\>3_P#70_R%)KG_ !XI_P!=!_(T:'_QXO\ ]=#_ "% &E11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M $=RTJ6LK6T8DF5"8T)P&;' SVYKSBT^,]A97(L?&ND7_A^]'#>9$9(S[@@;
MB/P/U->EU6OM.LM3MS!J5G;W<)ZQW$2R+^1&* ,.U^(W@Z\4&+Q+IJY&?WUP
ML7_H6*CO/B;X+L58S^([%@O7R'\[_P! SFJMS\(O MW)OE\/Q*?2*:6,?DK
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M3J<.L:5!?6QRDRYQZ'N*80&!# $$8(/>N5T.4^%O%DVC2DC3]0)FM&8\(_\
M$O\ GVI1_>4^7JM?EU'4_<5U4^S*R?D^C^>WW'<T445SG>9VOV_VG0[E<<JG
MF#_@//\ 2N1T^3I7?.H=&1AE6&"/45YW9@Q3-&W5&*G\* .IM'X%:D1K%LVX
M%:\)XH M+2TU:=0 4444 %%%% !1110 4444 %%%% !1110 4444 9^N:'I_
MB/1YM,UB#S[6;&Y-Q4Y!R"".00:\Z?X5^)- 8GP'XSNK2'^&SO27C7\<$?\
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M^E4KCI0!C7S<&J.A)YGB6 D9"!F_0C^M6[\]:A\,#=XA<_W86/ZB@#LJ***
M"BBB@ HHHH **** "O)O%%O<^#O'B:U:(3;7+^8?0D_?4_S_ !KUFN;\?JC>
M"[S?$LF ",C[ISUKJPL^6I;H]&>;F5'VE!S3LXZI^ALZ9J=KJ^GQ7MC()(9!
MD'N#W!]#5B>"*YA:&XC62-QAD89!KC/A5"(_"+N&R9;EF(]. ,?I6UXC\6Z?
MX:B7[6QDN)!F.!/O-_@*F=)JLZ<-36EB8RPL:U:R36IM1QI%&L<2A$4855&
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M9Z79O=ZE=0VENGWI9G"*/Q-6*\D\4Z1'X[^-D'AW69I%TK3=.^UBW1ROG,6
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M1QSD%AQTKTFO(M#M-$\3:_;6FL_$:7Q+);2B6*PV"WBE=>0<='QUP#^E>NT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "F/TI],?I0!2N/NUAW_0UNW
MXK#OAUH A\+''B"3_K@W_H2UV-<5X=;9XD4?WXV7^O\ 2NUH *XNU/E?%+5T
MZ"2TB(]^G^%=I7&:Y_H/Q'TJZQA+J%H7/JW(4?J*Z*.O-'NG_G^AQ8O3V<^T
ME^.GZB>,=-O;Z.QGL[87T=K.));,OM$HINFZ/J6IZQ'K'B5$B: ;;6R0Y6'W
M/;-=/125>2AR(<L'3E5]JV^FG2ZV_K8J2Z5I\]ZMW-9PO<+TE9?F%6Z*/TK%
MMO<ZE&,;V6YS4P^T?%*QC'/V>R:4^V3BNTKB_"O_ !-O&6L:R@)MX@MI _\
M>QRWZUVE;U]&H]DO\SDP?O1G4_FD_P#+]#G?'D/G>#;PXSY8$GY&K&DR^=HU
ME*#G?;HWYJ*O:M9#4='NK-NDT3)^8KF_!%Z;GPZEM+\MS8L;>9#U4@\?IBC>
MCZ/\_P#A@^'%Z_:C^3_X)LWNG6>HQ"._MH[A%.0LBYP:J:OH-GJVC-I[HL2
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M.A7/0=Z]LKS?XGZEJ7A?7O#?B*RO[E++[8MG>V8E/E2JV6SLSC=@/SC^[Z4
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M])KS;XF_\CW\.?\ L-/_ .BC7I- !1110 4444 %%%% !1110 4444 %%%%
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MQ5A: %HHHH **** "BBB@#+\0?\ (/3_ *ZC^1H\/_\ (/?_ *ZG^0I/$/\
MR#T_ZZC^1H\/?\@]_P#KJ?Y"@#5HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KQKQ/J=_X5^.4^NIH.H:E;/IRPK]E
MA8@DX[XQQBO9:XS7O&=]:_$;1_"FBVL$TMTGGWDLV[$,63TP1SA6Z]ROK0!Q
M^@ZU>>+?CAIVLR>'M1TZWATU[8FZA.%8%VSNP ,[\5W7Q+O[;3OAKKLEX5VR
MV;P(&[NXVKCWR0?PKJ:Y/XDZOJ.@^#Y-4TVRLKY;65'N8+R,N#'G!*X(P02#
MGGC- %CX>6<UA\.="M[D$2K9HS ]1N&['X UTE4](U*'6=%L]2M?]3>0),@)
MY 8 X/N,U<H Y_Q]<SV?PV\2W5G-)!<0Z3=212Q.5>-A"Q#*1R"",@BLGP3K
MTEM\$M*U[5IYKJ2'2!=3RS2%GD*IN)+'DDXZFM+XC_\ )+/%?_8%O/\ T0]<
MUX8L)M4_9IL[&V&Z:Y\/&*,>K&(@#\Z /(H;CXF>)/ .H_%2#QK=V0M9GDAT
MF%F\DQ(V&^4';QD\,ISMR378^-_BSK-U\*/"4OAN1;/6_%3K!YJ<>200K[<]
M,N0 >P)]C7(^%O''A_3_ -E35]#NM2@BU8+<6RV+N!*[2-\I5>I&&Y/08-4O
M$>EW'A[X5_"?5]1BDCMK*\,MQE>4$D@E7CW52: .QT>Z\8_"GXNZ#X=\1^*[
MKQ+I7B!-N^[+LT4G3Y=S,1AMO0X(;D"O?Z^>_'NN:5XZ^/GP_M/"]]#JHLI/
MM$\MI()$1=X?EAQD!"2.V17=_%SX1_\ "U/[(_XG?]E?V;YW_+IY_F>9Y?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG#Q%:;<9P=P;_ODC/Z5Y[XD\2)\7/&&D>'/#$4TNE65T+J\NV0JI XW 'D
ML!G!);I6H^B_!)YO-:72@V<X74) O_?(?'Z5U&B^*/AYHENMEH>J:/:1LP^2
M"15WGW/4GW- '9T444 %%%% !1110 4444 %>;?M!_\ )"?$/_;M_P"E,5>D
MUYM^T'_R0GQ#_P!NW_I3%0 ?L^?\D)\/?]O/_I3+7I->;?L^?\D)\/?]O/\
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M\QVW.$=NI+1AMC$YYRO-=-JNBZ;KFDRZ7J]E#=V,RA7@E3*D#I],=B.E7J*
M.7\*?#;PCX(N);CPQHL-E/,NUYC(\K[?0,[,0.!P.*ZBBB@#F_B/_P DL\5_
M]@6\_P#1#UYM^RI_R2S4O^PU+_Z(@KTGXC_\DL\5_P#8%O/_ $0]>;?LJ?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/&?ID@CK@ T =AX@^)5QH6L7=D/"NIW<5L>;F+&QQC.1QTK<\%^+8/&GA_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &,*
MJS)G-7"*AD7- &#>19!K"D9[.\CN8OOQ.&'O[5U-S'D&L*^@R#0!V5M<)=6T
M<\1RDBAA4E<OX4U#8SZ=,?5X<_J/Z_G744 %%%% !1110 4444 >>>)?C#I/
MACQBV@WME<MY902W"XVKN .<=3@$5Z#%*DT*2Q,'C=0RLIR&!Z&O"M8T&#Q-
M\?/$.DW &+C3L(V,['\I-K#Z&NL^#GB.>XTBX\,:QN74]%<PE7ZM&#@?7'3Z
M 4 =#X=\=6WB'Q9K.A06DL4FE.5>5R,/AMO%4O%7Q,L] UE=$TVPNM8U9ADV
MUHF[9WY_#TZ5R_PR_P"2R>./^NS_ /HTUG3:N?AO\:]4U'Q#;2MIVK9\N[5"
MP0$@\?3H0.: .S\/?$N74?$-OHNN>'M0T>ZNMWD-/&0CX!.,_0&NOUC6=/T#
M3)=0U:Y2VMHAEG<]?8#N?84FEZMI>OVJ7NE74%Y$/NR1D$KGU[@^QKR[XEEO
M$_Q2\.>$9)#]BW?:)XA_'@$\_P# 58?C0!>_X7-/>CSM#\'ZS?6:D[IUMR01
MZC&1^===X-\<:;XUM+B33TG@GM6"W%O.FUXR<XSV['\JW[:VAL[:.WM8EBAC
M4*B*,  4V&QM;>ZFN+>WCCFGV^:Z* 7VYQGUQD_G0!S/@WQW#XOU;6[*&SDM
MSI4PC+.P._)89_\ '#^==;7CWP3_ .1O\<?]?:?^AS5Z]-)Y,$DAZ(I;\A0!
MRWC#XBZ-X.>*WN_,N[^8C99VHW2$'N1V_'K7,CXS2V;B77?".L:?8L0!<R6[
M #W.0/TK/^$EFGBCQ3K_ (PU/%S<?:C!;EQD1@#M_P !*C\*]?F@BN(6BGC6
M2-AAE89!% $=C>P:EI]O>V;^9;W,:RQ/C&Y6&0?R-3U';V\5I;1V]M&L4,2!
M(T48"J!@ 5)0 4444 %%%% !574[U=/TZ6X;JJ_*/5CT%6JX_P 37_VS4%LX
MCF.W.7]W_P#K?U- &;91L[EW.68Y)/<UT-G%@"LVQ@QCBMVVCP!0!;A7 %65
M%1QK@5** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O#QI/B7
MXJ^+M=GB\1SZ/IFEW;6MM'%N()4D9VAEYP,DDYYQ]/<*XWPCX9U'PUXO\2-M
MB;1]3G%Y;LK_ #)(?OJ5].?T% 'F@L/%?C7Q)%\._$FI2+%H^^:]NXSEKF+Y
M?+)S]X_,,9]<G)%6]9\(/\'=8TGQ!X;U.[ET^>[2UO;>X*DLK<_P@ C /;(.
M*]1L_"4=GX_U'Q0+MFDOK9+<VY0 )MV\YSS]T5C?$G0-5\4SZ!I5C:EM/%^M
MS?W.]0(T3H,$Y)(9N@["@#NJ*** "BBB@ HHHH **** "O-OV@_^2$^(?^W;
M_P!*8J])KS;]H/\ Y(3XA_[=O_2F*@ _9\_Y(3X>_P"WG_TIEKTFO-OV?/\
MDA/A[_MY_P#2F6O2: "O-OV@_P#DA/B'_MV_]*8J])KS;]H/_DA/B'_MV_\
M2F*@#XEHHHH ^U?C'\6KCX6_V-]FTF+4?[2\_=YDQC\OR_+] <Y\S]*\P_X:
MUU'_ *%.U_\  UO_ (BN]\?_  =_X6E:65W#XZN;E;4,;4S002Q .%W8,2H>
M=J\DMTKQ77_V;O'VC[GLK:UUB(,<-93@-CL2K[3^ S0!M^(OVG=0\0>%]3T9
MO#5M;KJ%I+:M*+IF*"1"I(&T9X->%U?U;0=6T&X$&MZ9>:?*<[4NH&C+8ZXW
M#G\*H4 %?;7[/G_)"?#W_;S_ .E,M?$M?;7[/G_)"?#W_;S_ .E,M 'I-%%%
M 'G'CGQ!XQTSQE8VN@6\K6$B)]RV$BRL6(8%L'';N/6L[Q=XC^(5GXJO;?0[
M&\:PC91"T6G^:K#:.=VTYYSWJ3Q7\6[_ ,/^*+W2[?3+>2.V8*'D9MS?*#GC
MZUC_ /"\]5_Z!%G_ -]M0!%_PEOQ4_Z!^H?^"G_["O2_ -_KNI>&S/XHADAO
M?/90)8/*8I@8.W [Y[5YS_PO/5?^@19_]]M7H_@3Q1-XM\.'4;FV2WD$[1;8
MR2#@ YY^OZ4 =+1110 4444 %%%% 'FWQ-_Y'OX<_P#8:?\ ]%&O2:\V^)O_
M "/?PY_[#3_^BC7I- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY',CK&, L>]%SH>F7>K6VIW-G')>VH(AG8?,F>N*OT4 %%%% !1110 4444
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M5+./#W=GO#E%SSD;1CKU0G'TKN?&/A6^UGQYX1U:RMXW@TR>1KMV< JOR%,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'@585: '*,4ZD I: "BBB@ HHHH **** "BBB@#'\3?\@R/_ *[#^1H\,_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ"196UC/R+_>/]XTNK:Q+K$OE0@QVBGA>[^Y_P *+.TQCB@!]G:XQQ6U;08
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MWA2(.1C=M4#/Z58HHH **** "BBB@#S;XF_\CW\.?^PT_P#Z*->DUYM\3?\
MD>_AS_V&G_\ 11KTF@ HHHH **** "BBOC_XI_$?Q;KGQ0UR'PEK6K6NG:4&
MC$5A=R1*$BXDD(4@'YMW/IB@#[ HKR3]G7QS=^+_  #-::Q>2WFIZ7<&.2:>
M0O))&WS(S$\D_>7G^Z*];H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "$4QES4
ME)B@"K)%FJ<MOG/%:A6HWCS0!S\]F#GBLVXL<YXKJI(,U4EM<]J .8@>\TV0
MO9S-'GJO4'ZCI6Q:>+G3"ZC;$_\ 32'_  /^-.ELL]JI36&>U '36FLZ?>C]
MQ=)N_N,=K?D:O5Y])I_M1"]]9_\ 'M<S1C^Z&./RZ4 >@T5Q4?B+6(?O/'-_
MOQ_X8JPOBV]7_66D3?[K$?XT =;17+#QE)CG3LGVF_\ L:#XQE/33@/K-_\
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MQ^'^B6VHJRW,=F@=7ZKQP#[@8'X5T- !1110 4444 %%%% '-_$?_DEGBO\
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MY\#/W^>F*\3M?"NG3Z5XO>61X;K1I<6ZE_X0[ @CO]W'U(KU#X/SQ3> 8Q%
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MS%A[ BO=J* /+_AA\%XOAMXFU35HM:-^+Z(Q) +00B%2^[KO.>@'05ZA110
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MGDD9SZU]8T4 ?'LOPL\>:5\6- O-8L;[5[FZO+:]OKVW@>6*%S-EE:4#;E0
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M[&X&^WL^_EPQGY0!ZXZC(Q3/BA\_C7X=1/S&=<+E3TW+&2I_"O2: $50JA5
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MX=;;91^1]FM!9K)]LW(I/)!8_,67Y2.GK0!](45F>(?$6E>%=$FU?7[L6=C
M5$DQ1GP20!PH)/)'05!X6\7Z%XUTE]3\,7XOK1)C"T@B>/#@ D8< ]&!Z=Z
M-JBBB@ HHHH **** "BBB@ HHHH **\"\3?M0IX>\6:KHT?A%KH:==RVIG;4
M?+\PQL5)V^4<<@]S65_PUS_U)/\ Y5O_ +30!])45GZ'JHUGPWIVKM"UJ+VT
MBNC#(>8MZ!MI/J,X_"O*_%O[2_A'P_>R6>D07&NS1G#26[!(,^@<]?J 1[T
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M/?CI:* "BBB@ HHHH **** "BJFK:G;Z+HM[JE\66UL;>2XF*KDA$4LV!W.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF6O2: "O-OV@_P#DA/B'_MV_]*8J])KS;]H/_DA/B'_MV_\ 2F*@#XEHHHH
M^GOVJ;&YO_"?AK6++<VGP2R+*%SM!E5#&QQQ_ PS_M>]>?\ _"T=!_X9C_X0
M+R[S^V=^W/E+Y6/M?G[MV[IMXZ9SVQS78_"7XT>';[P?'X*^)/DK#%$+>"XN
MH]\,T0^ZDG'RE> ">, <@CGJXOAW\![1DU?[3HS6P?*>9K6^$G/3!DPW^Z<_
M2@##^&=K=:?^R3XGEU,D0W5MJ$MH''2,P[!C/JZL1]:^8:^@/CC\:-'UKP]_
MPAW@=A)8$JMU=1ILC*(1MBC'&5R 2>F  ,@U\_T %?;7[/G_ "0GP]_V\_\
MI3+7Q+7VU^SY_P D)\/?]O/_ *4RT >DT444 >>_%KQ=>>'=*M;/2IC!=7K,
M6E7[T:+C./0DD<^QK@4N_'W@K[+K>HR7C6D[@LEQ<>:LF><.,DJ2._!K;^.#
M^7K.BN1D+&YQZ_,M9OC+XIP^*_#<NEII+VS.Z.)&G#8P<]-HH =?^+?&/Q!U
M&6T\-PW$%CN("0?)A>WF2=C[9Q]:]-^'OAF[\*^%_L.HRQ23O.TS>420N0!C
M)ZGBO-/"?Q7M?#'AFVTH:(TK0[B\JSA=Y+$YQM/J!^%>J>#?%*>+]#;4H[5K
M4+,T1C9]W0 YS@>M &_1110 4444 %%%% 'FWQ-_Y'OX<_\ 8:?_ -%&O2:\
MV^)O_(]_#G_L-/\ ^BC7I- !1110 4444 >8_%WXRVOPR6VLK>R_M#5KN,RQ
MPL^Q(H\X#L>IR00 .N#R*\Y'Q^^)VFJM]KW@!4TP_-Y@L+F %?\ KHQ9?QQ7
M1?M ?"#6/'%Y9>(/# 6YO;6V^S36;.$,D89F4H3QD%VR"1GC'I7*:%^T-XP\
M':G#HWQ-T.24)@/,T)@N0N<;\'Y7''8#/K0!]!>+_%FF>"?#-SKFMR,MM
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M?D;WG60RMO )P0X ZX'!KC/V9M"F\0?$?5/%6H#S38QLPD8=;B8G)S_NA_\
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MI<?P+\/MKYM1IW]D0^?]KV^5MV#.[=QBO(/VMO\ D*>%_P#KC<_^A1UR-W\
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M5K[0KXOU'_D[!/\ L;(?_2E:^T* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$\5_\ (*C_ .NP
M_P#06H\*?\@J3_KL?_05H\5_\@J/_KL/_06H\*?\@J3_ *['_P!!6@#;HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML\;1VXQDXZYQBNJ^&O@WQ!I6N7.O>))?WMS;-#Y<DIDE)+*VYCR!]WIG/TH
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M;,JR#8LKC!8$=5';I78?&/X$Z=\/O"\?B#P[J=Y/#'.D4T-X49ANSAE957N
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M@FN6N7>[=6?>553RJJ,80=J\I_9._P"12U__ *_D_P#1=>_4 %%%% !1110
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M!;>$;C4+.)F\F.73Y+I8LG)VO"W0DD\D]3BOJRB@#QWX9^(?BWXA\9B;QKI
MTK0EMW+1?95AS)QMX<F3U]O6N4^-OP<\17/C3_A-? L+W,TK)+/;PD"6&9 ,
M2(#]X':.!SGGG/'T;10!\T+XS^/OBRR&BVOAR729' 234#8/:/CH3OD.T?5
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MEVG:"3P!G'6O _@C\&_%&A?$&;Q/XYLA;O!'(8 ]Q',\DTG!<E&;^$MUYR:
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MOMBVKF'RA,KE_, VXVC/6OK*BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q/%?_(*C_Z[#_T%
MJ/"G_(*D_P"NQ_\ 05H\5_\ (*C_ .NP_P#06H\*?\@J3_KL?_05H VZ***
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M+(^,^2OAWYOIS$%_6O7?$/A30?%=FMMXCTJUU&)"2GGQY9">I5NJ_@17)P?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M->;?M!_\D)\0_P#;M_Z4Q4 '[/G_ "0GP]_V\_\ I3+7I->;?L^?\D)\/?\
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M:9/0<-_-C0!WM%%% !1110 4444 >;?$W_D>_AS_ -AI_P#T4:])KS;XF_\
M(]_#G_L-/_Z*->DT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M55& !Z4M97AC3[#2_"^GV6CW#75A%"H@F9PYD0\@Y  /7M6K0 4444 %%%%
M!1110!S?Q'_Y)9XK_P"P+>?^B'KS;]E3_DEFI?\ 8:E_]$05Z3\1_P#DEGBO
M_L"WG_HAZ\V_94_Y)9J7_8:E_P#1$% 'MM%%% 'P!\1_^2I^*_\ L-7G_H]Z
M7X>>*8O!7Q TOQ#<6SW45E(Q>)&"LP9&0X)[C=G\.U)\1_\ DJ?BO_L-7G_H
M]ZYN@#ZK_P"&K_#/_0 U;\XO_BJ/^&K_  S_ - #5OSB_P#BJ^5** /<?BY\
M>-)^(/@H:%I6D7EL[7*3/+<LF %SP I.22?:O#J** /MK]GS_DA/A[_MY_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8GBO_D%1_\
M78?^@M1X4_Y!4G_78_\ H*T>*_\ D%1_]=A_Z"U'A3_D%2?]=C_Z"M &W111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7,^-M;\0Z)96LGAC0_[8EDD*RIDCRUQP>/>NFHH ^>OAYXJ\9Z5I6IQ:!X4
M_M*&74I99I,G]W*53<G'H /SKH-9\2?$WQ'HUUHP\$);"^B:!Y7)PJL,'EB
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M **** "O-OV@_P#DA/B'_MV_]*8J])KS;]H/_DA/B'_MV_\ 2F*@#TFBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"CK[M6&4\+^./"4?B+6=,46PBDD9Y01)&B%@WS(<X^4G I?BK_R3+5?^V/\
MZ.2N$T/QWH=C\(Y= N)Y1?M9W4001$KN<R%>>G\0H ZSPKX/^'^J0'4="M%O
MXXY2F^<R$*P .-KX!X(Z@]:U-!\;V>L^+-1\.VUE+ ^G"0>82-K"-PAP!TY/
M'M7G_P ,?'>A^%_#-Q9:O/+'-)>-*H2(L-I1!U'NIJ3X87D.H?%S7[VU):&Y
MBN98R1@E6G0CCZ&@#V:BBB@ HHHH **** "O-OV@_P#DA/B'_MV_]*8J])KS
M;]H/_DA/B'_MV_\ 2F*@#TFBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTF\635+:U^9(265N""PQE,9W'DBJNM^*-,^+?QY\%)X/,M[::3_I5U.T+1A
M&#$$, >-JC/0E@.:^BIH(KF!X;B))8I%*O'(H96'H0>HJCI/A[1= 61="TBP
MTQ93F06=LD(<^^T#- '&?$#X*>'/B/K\&KZY>ZI!<0VJVJK9RQJA4,S D-&Q
MSESW]*\H^*7[/_A7P1\-=4\0Z5?ZQ-=V?D^6ES-$T9WS(AR%C!Z,>_6OINO-
MOV@_^2$^(?\ MV_]*8J #]GS_DA/A[_MY_\ 2F6O2:\V_9\_Y(3X>_[>?_2F
M6O2: "O-OV@_^2$^(?\ MV_]*8J])KS;]H/_ )(3XA_[=O\ TIBH ^):***
M"BBB@ HHHH *^VOV?/\ DA/A[_MY_P#2F6OB6OMK]GS_ )(3X>_[>?\ TIEH
M ])HHHH **** "BBB@ HHHH **** "BBB@#S;XF_\CW\.?\ L-/_ .BC7I->
M;?$W_D>_AS_V&G_]%&O2: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY;]E3_DEFI?]AJ7_ -$05D>+/V:O!^@^"];U>SU+7'N-/T^>ZB66>$HS)&S
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M+RW>$N.J[AC/X=:\6UBV^)WAKX?WV@W>G:;>:';VKQ/>JXWI".X^=3T]5)H
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M_MY_]*9:^):^VOV?/^2$^'O^WG_TIEH ])HHHH **** "BBB@ HHHH ****
M"BBB@#S;XF_\CW\.?^PT_P#Z*->DUYM\3?\ D>_AS_V&G_\ 11KTF@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH Q/%?_(*C_P"NP_\ 06H\*?\
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MWIC':I:* ,[2?#VBZ LBZ%I%AIBRG,@L[9(0Y]]H&:T:** .;^(__)+/%?\
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MVP8/ !0>G(P>M=;K6IIHNAWFIRPR3I:0M*T<0RS #.!7FG_"_=+_ .A=U?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8GBO_D%1_\
M78?^@M1X4_Y!4G_78_\ H*T>*_\ D%1_]=A_Z"U'A3_D%2?]=C_Z"M &W111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2_\ HB"O2?B/_P DL\5_]@6\_P#1#UYM^RI_R2S4O^PU+_Z(@H ]MHHHH ^
M/B/_ ,E3\5_]AJ\_]'O7-UTGQ'_Y*GXK_P"PU>?^CWKFZ "BBB@ HHHH ^VO
MV?/^2$^'O^WG_P!*9:])KS;]GS_DA/A[_MY_]*9:])H **** "BBB@ HHHH
M**** "BBB@ KS;]H/_DA/B'_ +=O_2F*O2:\V_:#_P"2$^(?^W;_ -*8J /2
M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2T444 %%%% !1110 5]H_ [4+72/V==)U+4)?)M+.&\GGDVEMB)<3,QP 2<
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M_P!%&O2:\V^)O_(]_#G_ +#3_P#HHUZ30 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 8GBO_ )!4?_78?^@M1X4_Y!4G_78_^@K1XK_Y!4?_ %V'
M_H+4>%/^05)_UV/_ *"M &W1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7(3?"GP3<7$DTV@PM)(Q=V\V09).2?O5U
M]% 'FNN^#_A1X95#KMG8V9D&41YY2[#U"AB2/?%4]$T3X.>(KH6VD0V,]PWW
M8FEFC9OH'()_"J7@3PMIOCW7O$7B;Q5"-0F74GM8+:5CLA5 ".._# #/'!K4
M^(7PR\-Q^#[_ %31[&+2K_3H&NH9[8F/E!NP0..<<'KG'- 'HVG:=::3IT%A
MIT*P6MNNR*-22%'IS5FL+P1JT^N>!M(U*[.9[BU0RM_>8#!/XD9K=H ****
M"BBB@ HHHH YOXC_ /)+/%?_ &!;S_T0]>;?LJ?\DLU+_L-2_P#HB"O2?B/_
M ,DL\5_]@6\_]$/7FW[*G_)+-2_[#4O_ *(@H ]MHHHH ^ /B/\ \E3\5_\
M8:O/_1[US==)\1_^2I^*_P#L-7G_ */>N;H **** "BBB@#[:_9\_P"2$^'O
M^WG_ -*9:])KRWX':A:Z1^SKI.I:A+Y-I9PWD\\FTML1+B9F. "3@ \ 9JS_
M ,-!_#'_ *&;_P D+G_XW0!Z317FW_#0?PQ_Z&;_ ,D+G_XW1_PT'\,?^AF_
M\D+G_P"-T >DT5YM_P -!_#'_H9O_)"Y_P#C='_#0?PQ_P"AF_\ )"Y_^-T
M>DT5YM_PT'\,?^AF_P#)"Y_^-UZ30 4444 %%%% !7FW[0?_ "0GQ#_V[?\
MI3%7I->;?M!_\D)\0_\ ;M_Z4Q4 >DT444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^"?A/X>ZJ^IZ2+R[OBI1)[Z57,2GJ%"JH&?7&>O->AT4 %>;?M!_\D)\0_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH Q/%?_(*C_P"NP_\ 06H\*?\ (*D_Z['_ -!6CQ7_ ,@J/_KL/_06
MH\*?\@J3_KL?_05H VZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /,/%MU\*O"]_)%K6E6$M^QWO!!:B23)YR
MW8$^Y%9FB^(/@YK=XEJND6=E+(=J?;+,(K'TW#('XD5-\,- TN^\2>*KCQ%:
M0W>OP:I('6Y4.8XSRK*#V)W<CL!6W\4O#/AEOA_J=Y>V%I:S6T!:VN(XE1Q+
M_ H(QD%L#'O0!W5E96VG645I8P);V\*[8XHUPJCT J>N?\!->/\ #_0VU/=]
MI-E'OWCYL8XS[XQ704 %,FABN8'AN(TEBD4J\;J&5E/!!!ZBGU2UJRN=1T*]
MLK"]-A<W$#Q1703>8688#@9&2,YZB@#Q7QSK[>+)[CX5_"33K9(V<KJ][;1K
M';6J%LNORC&2<[B.3R!DYQD?%CPU;^"Q\*]'M')LM/O@CS/A0S^9$S.?3)W'
MVK2TK]G#Q!H4<L>B?%/4]-29M\BV=K)$';U(6<9/O7<:E\)(?$/PQM?"GBK7
M+S5;RTD,L6L/GSA)N8@X9FR,-MP2>/3C !QWQC/F?';X:QP$>>+G<1CG;YJ?
MX-76?%S_ (6=_P 2C_A57_3;[?\ \>W_ $S\O_7_ /;3[OX]JJ>!O@BGACQ8
MGB3Q'XEO?$^J6\?E6DETA40+C'\3N20"0.0!D\5ZI0!\M^(_^&B?^$5U7_A(
M?^03]BF^W?\ (/\ ]1L/F?<^;[N?N\^G-=O^RI_R2S4O^PU+_P"B(*])^(__
M "2SQ7_V!;S_ -$/7FW[*G_)+-2_[#4O_HB"@#VVBBB@#X ^(_\ R5/Q7_V&
MKS_T>]<W72?$?_DJ?BO_ +#5Y_Z/>N;H **** "BBB@#ZV\!_P#)FUU_V!=5
M_P#0[BOF31O^/-_^NA_D*^F_ ?\ R9M=?]@75?\ T.XKYDT;_CS?_KH?Y"L,
M1\!Z^3_[TO1FA1117G'V04444 9.N?\ +#_@7]*_0ZOSQUS_ )8?\"_I7Z'5
MZ5#^&CXC-/\ ?)_+\D%%%%;'FA1110 5YM^T'_R0GQ#_ -NW_I3%7I->;?M
M?O/@MJ]JG,UW-:PPK_><W$9Q^0- 'I-%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 55U33;;6-*N=.OT,EM=1F*50Q4E
M2.>1TJU10!Y7KGPN^&?ANQ2\UJ&>V@DE6%7\^9\NV<#"Y/8UI?\ "CO _P#T
M#[C_ ,"G_P :E^,&DW^L>#[2WTJSFNYEU&&1DA0L0H#9./3FN]H Y#P_\+O"
MWAC68]4TBSFCNHE949KAV ##!X)]#77T44 %%%% !1110 4444 %>;?M!_\
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M7P?H.OZAI%YINN/<:?=26LK100E&9&*DJ3*#C(XR!5'_ (:K\$?] KQ!_P"
M\'_QZNH^?/;:*\2_X:K\$?\ 0*\0?^ \'_QZC_AJOP1_T"O$'_@/!_\ 'J /
M;:*\2_X:K\$?] KQ!_X#P?\ QZC_ (:K\$?] KQ!_P" \'_QZ@#VVBO$O^&J
M_!'_ $"O$'_@/!_\>KJ?A_\ &OPY\1]?GTC0[+5(+B&U:Z9KR*-4*AE4@%9&
M.<N.WK0!Z)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_KL/_06H\*?\@J3_ *['_P!!6@#;HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!:CPI_R"I/\ KL?_ $%: -NBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\=<_Y8?\"_I7Z'5Z5#^&CXC-/]\G\OR04445L>:%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !15+6;R\L-'N;G2]-DU6\C3,-G'*D1F;
MH!O<A5'<GL < G /!_\ ";?$[_HD?_ERVW_Q- 'I-%>267Q7\=ZCKVIZ-9_"
MSS-0TH1&\A_X2& >5YJ[D^8I@Y SP3COBM+_ (3;XG?]$C_\N6V_^)H ])HH
M'3GBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSX<:_!I&N66J3W$UJMTK6<4;(%+,H!+2*<Y0]O2N6_X:K\$?] KQ!_X#P?\
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M6Y+.^M7V30R:?<Y4]>HCP00001D$$$$@TBCNZ*\V_P"&@_AC_P!#-_Y(7/\
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M_P!^%_PH_L72_P#H&V?_ 'X7_"J^KON9?VQ3_E9ZQ_PU7X(_Z!7B#_P'@_\
MCU'_  U7X(_Z!7B#_P !X/\ X]7D_P#8NE_] VS_ ._"_P"%']BZ7_T#;/\
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MWX&?%;7/B:VN#7K73[?^SA;^5]BC=-WF>9G=N=O[@QC'>BS6Y491E\+N<O\
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M^A-\0?\ @KO?_B:/^%<'_H3?$'_@KO?_ (FOLVBCV_\ =7W#_L__ *>S_P#
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M -!6@#;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV^4,XSG&17-_"KXZ?\*R\*W.C?\ "._VGY]ZUWYWV[R=NY$3;M\MO[F<Y[T
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MAXF\4^$K7^R/^$7^+WCB\\W4X8M1\^_N1Y-F<^;(N8ERP^7 ^;K]TUM_V_\
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M]Z#ZIB/^?;^YGM=SX^\'V=U+:WGBS0X+B%S'+%+J4*O&P."K MD$$8(-1_\
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M4'@]JSO&WCG1_ &BQ:IX@,XMI9Q OD1[VW$$],CCY37!_P##3?P^_OZG_P"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M &6/'KUKW1'62-7C8.C %64Y!'J#1]5H?R+[D'UO$?\ /Q_>S"_X0GP__P!
M_P#\C2?_ !5'_"$^'_\ H'_^1I/_ (JMZBCZK0_D7W(/K>(_Y^/[V8/_  A/
MA_\ Z!__ )&D_P#BJ/\ A"?#_P#T#_\ R-)_\56]1TZT?5:'\B^Y!];Q'_/Q
M_>SAO&GAG2-)\ ^(-1T^T\F[L],N9X)/,=MCI$S*<$D'! X(Q7$?L_Q)XW\
MWVH^)Q]NNXM3>!),^7A!%$P&$P.K-SC/->@ZIXK\$^);:_\ "LOBK33+J,$E
ME)'!>Q^9^\4H0N<C?SP.>>U1^$?"7ASX/^#[RWAU.:+3#<-=S7.IS)\C%53&
MX*HQ\@P,9R:/JM#^1?<@^MXC_GX_O9J_\(3X?_Z!_P#Y&D_^*H_X0GP__P!
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M+M8[91%=QRR;$4*&;;[#J !734?5:'\B^Y!];Q'_ #\?WLP?^$)\/_\ 0/\
M_(TG_P 51_PA/A__ *!__D:3_P"*K>HH^JT/Y%]R#ZWB/^?C^]F#_P (3X?_
M .@?_P"1I/\ XJC_ (0GP_\ ] __ ,C2?_%5O5E7GBGP_IUV]KJ&NZ9:W$>-
M\,]Y&CKD9&03D<4?5:'\B^Y!];Q'_/Q_>SPGXF7D_A[X]>$O#FCO]GTG4?L?
MVJWP'\SS+IT?YFRPRH X(]N:]M_X0GP__P! _P#\C2?_ !5<5XFT#X<>*_'N
MD>+=1\8VT=_I/D^1'!JEN(F\J4RKN!!)^9CG!''IUKOK/Q5X?U&Z2UT_7=,N
MKB3.R&"\C=VP,\ ')XH^JT/Y%]R#ZWB/^?C^]E;_ (0GP_\ ] __ ,C2?_%5
M@_#/_F)_]LO_ &>N\K@_AG_S$_\ ME_[/7'4I4Z>+H\D4OBV7D=M*K4J8.MS
MR;^'=WZF5\?_ /D0;+_L)Q_^BI:[;P7_ ,B#X?\ ^P9;?^BEKB?C_P#\B#9?
M]A./_P!%2UVW@L@> - )X TRVR?^V2U]%/\ W2'JSYR'^]2]$;=?-OP=_P"3
MJ/'?_<0_]+(Z]V/C;PJ#@^)M'!_Z_P"+_P"*KB/#6@?#CPMX_P!6\7Z?XQMI
M-0U;SO/BGU2W,2^;*)&V@ $<J,9)X]>M<)VGJ=%4=-US2=8,G]D:I9W_ )6/
M,^RW"2[,],[2<=#5Z@ HHHH *YSXB_\ )+O%7_8&N_\ T2];E[?6FG6CW6H7
M4-I;IC=-/($1<G R3P.:YW6O$7@W7=!U#2+OQ3I26]_;26TK1:C"'574J2"2
M1G!XR#0!YU^RI_R2[4_^PS)_Z)AKVZO.OA_:_#_X;Z#/I&A^+K.>WGN6N6:\
MU.W9PQ55P"NT8P@[>M=]97UIJ5JMUIUU#=V[YVS02!T;!P<$<'F@">BBB@ H
MHHH \3_:J_Y)7I__ &&8O_1,U>C_  V_Y)7X4_[ UI_Z)6JGQ"\'^'OB)X26
MTU_4I;;3;6X^UM<VD\:!6170[F964 ;FS[BK7@S6/"K:/9Z#X6\066J)I=K'
M;*(KN.638BA0S;?8=0 * .FHHHH **** "OFWXS_ /)T/@/_ +A__I:]?0&M
M>(]%\-VZ3Z_JMGIL3G"-=3K'O/H,GD_2N+O_  /X.^)GC#2?'%GKDUY/I)A6
M'^SKJ)H"8I#*H<;2<Y;D9'&.G6@#T:BL"Z\;Z!:>+K/PPVH1R:Q=[MMK$=S1
M@*6)?'W>!QGDUOT %%%% !113'GBBDCCDE1'E)$:LP!<@9( [\4 ?.'P?_Y.
MI\=?]Q#_ -+(Z^DJ\PL_#/@#X;?$C4_$][XH6RU;61,9;;4;Z%$ EE$C%5VA
M@-RX!)(Q7ID$\5S D]M*DT4@W))&P96'J".M #Z*** "O$_^;KO\_P#/C7ME
M>)_\W7?Y_P"?&N_!_P#+S_"SBQ?_ "[_ ,2/;****X#M"BBB@ HHHH ****
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M6.I0)ODL[C!)7IN5APPR1Z'VKOZ "BBB@#R#X\_\P'_MX_\ :5>OUY!\>?\
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M-J0W&6XB(3:K#<"^-WW2W<Y)P* /I33-(TW1+,6FCV%K86RG(AM85C0'UPH
MJY7S[X C\1_"[XTVW@+4M>?6]*U.T,T&\D>20&((5B=GW&! .#D&OH*@ HHH
MH **** .%^+7PXC^)7A#^SXYDMM0MG\ZSF<':'Q@JV.=I'ITX/.,5Y#I^O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC65PMQ9:38V\R9VR16R(R]N"!FO0/--"BBB@ I';9&S'G:":6D(#*0>01@T
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M)/->/YMPR_+YA9_E4@=5WNQ_X"*]4^.7PTN_B)X6MCHI0:MITID@21MHE5@
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M6'_W.O\ ]N_F97Q__P"1!LO^PG'_ .BI:[7P:H?X?:"IZ-I=N#_WZ6N*^/\
M_P B#9?]A./_ -%2UVG@XL/A[H)3[W]EV^/KY2U[T_\ =(>K/ A_O4O1'A.N
M_"+X+Z)K_P#9FM>-M2M-0D;YH6NX3L)Y&XB$A.O\1%5?%'PK^"?@Z\BM-?\
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M;>91YQ#R>6(@#\P!V].,=>*]U^!PN5^"_A[[8"&\ABF?[F]MOZ8H [ZBBB@
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M2."1DDD<9/?&: /3J*** "O$_P#FZ[_/_/C7ME>)_P#-UW^?^?&N_!_\O/\
M"SBQ?_+O_$CVRBBBN [0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?+GPQ^#GCN#QI9^(_LR>$].2X25[07<@DEB!!,>T%FP<8(D(^E?4= !1110
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M." <;E() '2OH1V"(S'HHR:^:='TKQQ\?+S5=7D\7RZ!HEO=-;065N6;&,$
MHK*#P1\S$DG/:@"X?A5\5?AP[VOPNUY;O3[Q5>X67R5990H#-ME! ![$'.,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLOEL <$,3WY^COA%I&I:%\*-"T_6T>.\B@)>*3[T89BRJ?0@$#':@#LZ***
M"N/^)7Q&TWX:^&AJ>H1-=3S/Y5K:(P4S/C)Y[*!U.#V]:["O$_VEO!VK^(O#
M.F:IHML]Y_9,KM/;1J68HP7Y@HZXV\^QSZT <'J?[1OQ*M5M[N3PS8:?97G-
MH]Q8S[9E[;7+@/UZBNK\-?'B_N_$-OX6^*_A2/3&U B-9&MW1#N.%W129)4G
MC<#CVQS7GWC7XG:M\:-+T?PEH7A5X;J*=9'$,IEW,%*C VC8HR223Q^&:Z#X
M@>$?%OBWQUX9\%V>E.]MX?M((I-7"L5.40N[2$8&-O"\D_CP ?3P    P!T
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MP#@'G;YF, ^U 'U/7!_#/_F)_P#;+_V>N\K@_AG_ ,Q/_ME_[/7GXC_>Z/\
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M,M3_ &9/ M[>"YTZ34]+P01%;W >/_R(K-_X]0![$#D9%%-C3RXU0<A0!3J
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRS_FX?\ S_SZ5ZG7
MEG_-P_\ G_GTI >ITCDK&Q49(!('K2T$@ DG '4TP/G&Y^,?Q$.I+=2?"DR7
M-ON6*X;3;@N@/!PV,C(]*K:;^TAX[UGS?['\#17_ )) E^RPSR[">F=N<=#U
M]*]XG\;>%?L\@_X2;1\[3_R_Q>G^]7@?[,>O:1I%QXI_M75;*Q\Z2$Q_:;A(
M]X!DSC<1GJ/SH ]*^#NOZIXANM<N]:\#P^%[AFB9I8[)X&NR=^2Q8#<1Z^]>
MHU1TW7-)UCS/[(U.SO\ RL>9]EN$EV9Z9VDXZ&KU !7EGP5_YC?_ &P_]J5Z
MG7EGP5_YC?\ VP_]J4@/4Z***8'"?$/X1>&OB);M)J$'V/5 N(M1MU D'H&'
M\:^Q_ BO%_$5OK/PR\,ZEH?C?PAI>M:;<6LD%AXBLK&,21.RD)YAV]<XZX(Y
MP6KZ@GGBMH'FN94ABC&YY)&"JH]23TKRSQC^T#X T.":TCN/^$AF8%6M[)!)
M$>/XI&^0@]/EW?2@ ^ &A:2/A/H6J#2[+^T/WQ^U_9T\W_6./OXSTXZ]*]6K
MPOX:?$GQIXV\8:?%IWA*/0_!R^8TCPVYVD;6P/-("GY\?<4'UKW2@ HHHH \
M@^//_,!_[>/_ &E7K]>0?'G_ )@/_;Q_[2KU^NBI_"A\SS</_OE?_MW\CS'X
MO_&"#X;16MC:Z?\ VEJM^C-'"SE4C3.-S8Y.3P ,9P>17(_"/XLZ5;ZU/X9U
MWPG8^#KH0M.98HC K[5W'S XW [<D,2<^W?(^-=Q#;_M(>#9;R9(K>);5W>5
M@J(/M#9))X ]ZY_X\MHOBKXTZ'#9ZQ8FUNK:""XO89T=(<RL"6(.!@'/)KG/
M2.\;X]7_ (O^(VE^'?AYITLE@;Q/ME\\.YWA##>57HB8S\S<\_PFO=ZX?P1#
M\//!VF0Z-X5U;1U:1E5F6^B>:Y?H"Q!RQ/8>^ !7<4 %%%% !1110!XK^U*[
M+\+;-0>&U.,'W^1ZXWXNZ1I]M^S?X)NK:TAAFC^S[7C0*?GA+/R/4@$^]>K_
M !K\,:3XK\%VUEKOB:U\-VZ7JRK=W2JRLP5ALP77DY)Z]J\Q@_9674+"":W^
M(/VFTD0/"Z:;N1E(X*_O\8QZ4 =+\&O@SI-KI-CXO\3XUG6-0C6[C^T?.D&X
M;@<'[S\@[CT/3ID^W5\Z)^RI=1H%3Q_,J@8 &FD ?^1Z]Z\/Z4="\-Z=I33F
MY-E;1P&8KM\S:H&[&3C.,XR: -&BBB@ HHHH *\1^,-WX5\::QI_AZZ^)%KH
M4-NSB^MXW9UE)*X5R"(P1@_>/&>E>I^-+V;3O FNWELQ2:WT^>2-E."K",D$
M5\M?#_X9:'XG^"/BCQ-J(G;5;,S&VD$I"Q^7&'^[T.22#G\,=: /<O#WP;^&
MW@C3_P"U9K2WO5B3S#J.K2K*H7J&P<1CV(7/O77>#_&>B^-=/NKOPW(\UG:7
M!M?-,>Q7*J#E0>=OS <@=*^6_ 7ACQI\9=(T[0[G4FM/"VA?NFF.<$DYP%S\
M[@' SPHQZ\_4G@OP5H_@/P\FCZ!%(D 8R2/*^YY7( +,>F>!T 'M0!T%%%%
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MDJ1N[ '81D^H]: &^$OVF?"5_>0:7J.EW&@V_$4$S,LD,:@8 ;&"HZ#H0.Y
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M,_X0GPJ.GAG1_P#P B_^)H VT8.BL.C#(S2T    # '0"B@ HHHH \J\9_M
M^&_!'BNZT#4M,U2>YM0F^2W2,H=RAAC+@]#Z5@C]JSP<J@+HNM@#@ 1P\?\
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M_P#;+_V>N\K@_AG_ ,Q/_ME_[/7GXC_>Z/\ V]^1Z6'_ -SK_P#;OYF5\?\
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M^6RM+E[V[N7$EU=.FSS"!@ +DX4>F3U- ';4444 %>)_\W7?Y_Y\:]LKQ/\
MYNN_S_SXUWX/_EY_A9Q8O_EW_B1[91117 =H4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNRE"!EE^5_F(."HQBO9* "BBB@#R#X\_\P'_ +>/_:5>OUY!\>?^8#_V\?\
MM*O7ZZ*G\*'S/-P_^^5_^W?R/)_B;\._ 'C3QE8GQ9XEFT[5G@6"VLX;V&)I
M5WMM(1T8DDDCBLK_ (94\$?]!7Q!_P"!$'_QFN=^,/\ R<WX)_[=/_2AJ/C#
M_P G-^"?^W3_ -*&KG/2.PT3]FKP?H.O6.K6>I:X\]C.D\:RSPE2RD$ @1 X
MX]17K]%% !1110 4444 >)_M3_\ )+['_L*1_P#HN2N<^,?_ ";'X-_[<_\
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M5<Q3V\I!>%QS@XZC!!!]#^%=37SQ^RA%+]C\3S("+-KB%8\]-P#$_H5KZ'H
M**** .)^,>H7^F?"'Q!=:4SI<K;[0\9PR*S!6(_X"37SKX<\)_#2?X$7^LZS
MJD'_  DPCE:-#>[)8I 2(T6'/S!L Y(/4\C''UW<Q07%K+#>)')!(A21) "K
M*1@@@]C7CEW^S5\.[G56NX[S4K:)FW?9(;R/RQ[ LA;'_ OQH \,&@^%I/@
M-<OX5L/$2W[064B2N3?HI4ME"2/E#'Y@!T'X_4GP<U*_U;X1Z!=ZLSO<M;[3
M)(26=58JK$GKE0.:-3^&/@75M)TC2KRPA.G:.6-K:I.57)QG<0<MG&3D\G.<
MUV5K#!;VL4-FD<=O&@2-(@ JJ.  !P * ):*** "OG/]JX,7\*!&*-YD^&'4
M']WS7T97E/QL^&6H_$)='GT_4;&QBTLRR3/>.RC!VG.0#C&TYS0!RUO\2O'W
MPE,5A\2M)EUW1N!!K5H<OM[!B>&/08;:W7D]:[;2?C_\.=5A0_VZ;.5ADP7=
MM(C+[$@%2?H37;:3J.E>(=#673KJUU.Q<&%I(F$D4F/E89Z$9!KS]/AQ\'_&
MVIW3:;I^G27MG(8[B/3[AH&A96(.Z)& '(/.WF@#U)6#*&4Y!&0:6D10B*J]
M%&!2T %%%% 'A7Q#U_QSXO\ BRW@+P#JBZ-'8VRW%W<[S&6) .2R@M@!E  Z
MDG/MR_\ :?Q=\2Z\?A<VMPV>I:;NEO-6BF9&FAPI3YU4-_%V +9&>AKN_B+\
M*_%5WX\3QI\-M:ATS59(1#=1S,5$@ QD?*P/&,J1CY0>M<S-\%_B/HXC\6Z)
MXI6Y\:R2.UZ?,'ERQM@*BEUVMC'1@%Z8^Z,@%SX<ZIXV\"?%R/P%XVUAM9MM
M0MFGM9WF:8J0"00S_, 0K J> 0,>_OE>*_#'X<>+H_B!+XT^)VIQ7&KB PV]
MNLBLR \$D( J@#. O]XGBO:J "BBB@!D_P#Q[R?[I_E7QQ\)8O'UO=:[K'PZ
MG2=["5#=Z7*<K=HQ;HIP"1M/0AN>#VK[(D4O$ZCJRD"O'?A)X*_X51KNH6'B
M+7M)DO=>=#9VL,Q\U]F\GY6 )'/4>E $6@_M+>'7E-CXUTV_\.:C$2LZR0M+
M&A';@;P?8IQZUZ5X8\<>&_&:3MX9U6+4!;A3+L5E*;LXR& ]#6?X]L? 4]K;
MGX@V^EB.X?[/!<7RA6#8)VB7@IP#W%3>#/A]X7\$?:I?"5F;6._"&3%P\JL!
MG:068_WCWH ZFBBB@ KQ/_FZ[_/_ #XU[97B?_-UW^?^?&N_!_\ +S_"SBQ?
M_+O_ !(]LHHHK@.T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\L_
MYN'_ ,_\^E>IUY9_S</_ )_Y]*0'J=%%%, HHHH **** "O+/@K_ ,QO_MA_
M[4KU.O+/@K_S&_\ MA_[4I >IT444P"BJ&J:[I&AQB36M5LM.1NC7=PD0/XL
M16+#\3O T\PCB\7Z*7/0&^C&?Q)H ZFBH[>Y@NX%GM)HYXG&5DB<,K?0BI*
M"BBB@#R#X\_\P'_MX_\ :5>OUY!\>?\ F _]O'_M*O7ZZ*G\*'S/-P_^^5_^
MW?R/)?BG\#C\2_$]MK"^(CI9M[98!$++SLX9FW;O,7'WNF.U<3-^RBWF"2X\
M?'?V:33.?S,U:O[1/BW7?[8T3P-X8N'MIM6PTSQ2%&DW/L2,L.BDY)]>*X_X
M]>';CPUX,\ :!>WHO9;..:!KA4VAAF/& 2>@X_#M7.>D=CX;_9PGT?Q)IVK#
MQW)>I8W4<[0?82!)M8';GSCC./0U[U7RYX5TZY^"G[0&F:!%J,EYI>MP1HY=
M=F[?D*2N<95QU]"?6OJ.@ HHHH **** .+^+/C>3X?\ P]O-8M8UDO&98+4/
MRHD;HQ'<  G'?&*\B@U/Q_%^S?XC\2>)=9NA<:C)#<:?,MPR31(9%4X"X"*W
M! 7L3P,UWG[1?AZ[U_X33O8(TLFG7"7;1H,ED *M^0;/X&LCX:?%/P'K_P ,
MM/T'Q9>:;;S65M';7-GJH412A,!6&_Y6!P#CJ#^!H \AL]8^('@WP[X:^(,G
MBB^U#3KVZ:-K.:\ED'RD@HZL2I#!6P>WUK["T^]AU/3+:^MCNANH5FC/JK $
M?SKYC^-OC/PYXFTW1O ?PVMX+I$O!)MTZ )"'.56-   22Q)(X^N3CZ0\,Z6
MVA^%-*TJ1M[V5G% S>I5 #_*@#4HHHH **** ,'QU;SWGP]U^VM(9)YY=.G2
M.*)2S.QC(  '))]*^6?"^H_$_P *> =5\)V7P_U.:TU/S/,FFTJY\Q-Z!#C
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M 4444 >%?&KX=^)/^$NL/B#X C>?4[,*)[>%=TA*YPZK_'D?*5ZXQUYQ@_\
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M /25974,A#*PR"#D$4M5]/L8=,TRUL+7<(+6%(8]QR=JJ ,GZ"K% '!^%O\
MDHFL_P#;?_T:M>0?%2"]^)?[15AX%GO9+73+4*,+SC,?F2.!TW$?*">F*]?\
M+?\ )1-9_P"V_P#Z-6O&_'UMXU\/?M&7GBSPSX3U'55A">4ZZ?-+#)F (?F0
M<XR>AZBO/R_^$_5GI9E_&7HOR/2_^&;_ (<?8?(_LV[\S;M^T?;9-^?[V,[<
M_P# <>U>=?"V&[^&G[1FH>!K:\EN=+N@P"N1SB/S(W(Z;@/E)&,YK1_X7/\
M&+_HF,__ (*;S_&L?P#;>-?$/[1EEXL\3>$]1TI9@_FNVGS10QX@*#YG'&<#
MJ>IKT#S3ZAHHHH *9/\ \>\G^X?Y4^F3 F"0 9)4X'X4 ?.?[+)(;QB0<$-#
M@_\ ?RK_ .S;KVKZU_PEHUC5;W4!"T7EBZN'EV9\S.-Q..@_*O/O 6H?$WX;
M3:NNC^ =3NUU%AO-SI5R=NW=C&T#^\:9\/=1^)_PY_M3^ROA_J=U_:6TR?:=
M*N3M*[L8V@?WC0!W/[*?_'SXN_ZZ0?SDKZ+KP/\ 9D\/ZYHC>)7U_1K_ $PW
M#0&/[9:O#OQYF=NX#.,C\Z]\H **** .*^+_ (@U/PO\+=6U?0KG[+?6XC\J
M7RU?;F10>&!!X)ZBN1L?B3XBM/V9D\:W$T%]K*@DR7$("-_I&SE4VC[OIBMS
MX_?\D1UWZ0_^CDKP/_A:>@_\,X?\(+Y5[_:V,;O*7RO]?YGWMV>GMUH ]=U+
MXB^(-0_9CD\913Q6&L.!B2UCPJ8N-G ;=_#ZUUWP;US4O$?PITC5-;NFN[V<
M2^9,X +8D8#@ #H!7SI_PM/0?^&</^$%\J]_M;&-WE+Y7^O\S[V[/3VZU[W\
M /\ DB.A?2;_ -'/0!Z11110 5YK\;_B5<?#GPA%)I2HVJZA(8;9W&Y8@!EG
M([XR  >Y[XQ7I5> _M5Z5<2^']!UF&-I(+&Y>.8CHN\*5)_%,?C0!D>-M;\?
M:+^SKI%_KVK7UEK5SJ@?SX+EHIC"ZNRJY7&/]WL /2L;P[XJ\<_#7QAX4O?%
MGB.ZUC1_$5NDACGO))U2-R!G]Y]UUW*<CMQFO;;'6O 'Q4\%69U*?3KVV14F
MDL[B<(UM(%P=RY!&,D9Z'J*\8^,6KZ+XU\;>$/!?@5XKN'3W%N)+5M\2[R@"
MJPSN"JN21D?D: /J@'/2BFHNR-5'.T 4Z@ HHHH \'^,_P 3/$\?C6S\ ?#X
MO#J5P$\^>(#S"S\A%)^Z /F+?J,&N?\ C-JGC,?$SPOX?TSQ'>Z5=W]A;Q3+
M9WTL4'GM(RLV%(R,]\9P*3Q[>Q> ?VK-/\2ZTC+IETB/YVW(53%Y3,,?W3R1
MUQ7L6K+\-M6N;3Q=JUYHMQ)9A3;ZB]XN$VMN7!#8)R>E 'G/P7\7^)=(^).L
M?#OQOJ<VJ7,)9[>YGG:5@Z@$J&?YBK*0P!Z8/K7OM?,W@*_C^(/[55_XFT=7
M.F6D;N)64C<HC$2GVW$Y ]*^F: "BBB@ Z=:^?M ^)7C/XB_'-;7PR?(\,Z3
M.WVF,X59(AE"[MC)9CDJO3@<<$U] .N^-E/&X$5\P? SQ!IWP\^)'B?PUXKG
MCTV:XE$<4]RP1-T;-\I8\#<&R">#^(H Q;R;XA>+?BGXPTOPYXPU2T73)+JY
M2 ZG.B[$DP$0*< \@ <"O:/@%X_N_''@-DUB4SZGI<HMYIF.6F4C*.??&03W
M*YJSKNH_#?X<KJ?BF-M.AU6\AD8^1/OFNRQW85=QSEL<XP/85Q?[*NE7$>@:
M_K4R%(;ZZ2.+/\6P$L1[9?'X&@#WVBBB@ K&\7^(X/"/A#4M>NHS+'8P&3RP
M<%VZ*N>V20,ULUQ'QCT>XUSX0Z_962-)/]G$J(O5MC!R!^"F@#S#P%XO^('B
MKP;XW\5ZY=M%ICZ;,NGF(^5Y,J*QS$!S@9P6)SD#DX./,=+UKXF0>"&\>VWC
M+4IK*PU!;9[>XU&:0EN""R,2K(<@8/KTKU_X!>+_  OJWPL7PAJ]W:0W4)EA
MFM+B01FXCD8G*Y(W<,0<<C'N*S_C-K7@7P?\+K[P=X1-DMUJ4Z.]I92^9Y6&
M5F=^3M.%  /)STZT >U^#_$47BWP=IFNP+L6^MUD9,YV-T9?P((K:KB/@WH]
MQH7PAT"SO%9)S;^<Z,,%?,8N ??#"NWH **** /$OVFO%VHZ'X1T_1M)F>!]
M8E=)WC.&,2@90'MDL,^PQW-<G\1O -YX/_9QT;1$EGU&Y.II<2B-"PC9XW)5
M0!G:#Z]3D\9Q79_M*>#[[Q#X)M-6TJ)II]&E:62-%RQB8#<P_P!TJ"?;)[52
M\)?M-^%9O#MNGB=+RQU*"(+-Y</F1S,!C*$<C/7! QTR>M 'F&H:#_PI_6OA
M_P"*]&FNE.HVR2WD<[ G<0OFH  #M*OC!].M?8*,'16'1AD5\IZ[XBN_VA/B
MMHNGZ%IMQ!HFFN&DDF W+&6!D=\9"Y"@ 9//UX^K% 50HX &!0 M%%% !7#?
M$+X2>&_B2UO-K0N;>\MUV1W5HX5RF<[3D$$9]N,GUKN:* .%T3X3:%X8\!:K
MX9\/M+#_ &I!)%/>W&)96+*5#-C:"!G@# _,FF?#;X1:#\-(II=/>6]U&X7;
M+>W  ;;Q\J@<*N1GN?4G KO:* "N#^&?_,3_ .V7_L]=Y7!_#/\ YB?_ &R_
M]GKS\1_O='_M[\CTL/\ [G7_ .W?S,KX_P#_ "(-E_V$X_\ T5+7;>"_^1!\
M/_\ 8,MO_12UQ/Q__P"1!LO^PG'_ .BI:[;P7_R(/A__ +!EM_Z*6O>G_ND/
M5G@0_P!ZEZ(X;Q;^SWX,\5>(IM<NGU"PFG;S+E+.5%25N[896P3WQU^M49M"
M\!_%[P3;^$/!>M-:Z=H5S&\JP6D@91M<!09 O)))W?-R.>M:GQ,\8?$+P_K4
M=KX+\)QZS826H>2X:)VV.2P*Y5@.@!_&O ?@[XI\<^'KC6CX*\,IK37#1FZ#
M1NWDD%L?=88SD]?2N$[3ZO\ !W@[2/ WAV+1M @,=NAW.[G+S.>KL>Y./IZ8
MK=JAH-U?7OAZPNM6MA:WTUNCW$ !'E2%067!R>#Q5^@ HHHH P/&_A2#QMX-
MO_#]U<R6J7B ":, E&#!@<'J,@9'IW%?).A?"*&7XHW?@?Q9K$FD7RC-E,EN
M)([KJ1@EAC(Y'T(ZU]JUPGB'Q?X(TKXD6.C>*+2SAU6:!)K/4+JW0J/G8!?,
M/*'(R.@YZYH \Q_X9)LO^ANG_P# !?\ XNO9_ 7A)/ W@NR\/QWC7JVF_$[1
M["VYRW3)]?6IO%/C/0?!FC'4_$.H16T!'[M<Y>8^B+U8_3\:9X(\60>-_"5K
MK]G;26T%TTGEQRL"P"N5!..,G&<<X]30!OT444 %>$?M2:_?67AC2-#LI6BB
MU2=S<%21O5-N%/MELD>PKW>O./C;\.)_B)X+6'2S&-5L)//M0YP).,-'GMD8
MQVR!GUH W?ASX+M/ ?@JTT:RGEGP/-EDD;[TC ;BH_A&>@KP#XH^&$^#7Q/T
M+Q-X0N)X8;Z9G>W:0M@AAYB9/)5@W0Y_EBSIOQQ^(_@C3XM$\4>$7NKBV3RH
MIKB*6*1P. 20"'^HQGU[TNB>&O'?QN\?:=K_ (XT]M,T*P8,J-"T*L@.[9&K
M?,Q8@9;ICOP!0!].QOYD2OTW &G4 8  Z"B@ HHHH **\9\?3?'%/&EX/ EM
M%)H>$^SLQM,_<&[_ %C!OO9ZUSGVG]IC_GR@_P"^K#_XJ@"%_P#D]E?]W_VT
MKZ/KYP\!^ ?B=)\<++QAXZTE4'S_ &BY6XML#]T47Y(W^@X%?1] !1110 CM
MLC9CSM&:^8?@UI#_ !+^+^M>,O$%Y,TVF7"RPQ(Y7YF+!!GLBJN-O?/Y_3_7
MK7S'KOAKQU\%OB)J/B+P/IK:IH>H,SO$D+2JJDEMDBK\R[23AAQ^9% 'L_Q/
M^'.F?$7PT;6_:6*ZM5>2SGC<@1R$=UZ,#@9[^A%>>_LN^(K^^\-ZMH-_*\T>
MDS)]G+-G8C[LH/8%21]:Y74OCG\1O&MG)HGA;PD]I<7*&*66WADFD7/!*D@!
M.O4YQZCK7J_P1^&T_P ._!\B:J4.K:A()KH(VX1 #"IGH2,G)'<GKC- 'I5%
M%% !7B?_ #==_G_GQKVRO$_^;KO\_P#/C7?@_P#EY_A9Q8O_ )=_XD>V4445
MP':%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO=/J?G;;D7 01^9&$Y7:<XQGK5[X2?&JR^&6@7EA)X=:_GNKCS6N4N!&2NT
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M![!97D&H6%O>VC^9!<Q++$^"-RL,@X/L:FID$$5M;QP6\:Q0Q($C1!@*H&
M/3%/H X/PM_R436?^V__ *-6N\K@_"W_ "436?\ MO\ ^C5KO*\_+_X3]6>E
MF7\9>B_(****] \T**** "BBB@ HHHH **** "BBB@"MJ&G66K6,EEJMG;WM
MK)C?!<Q+(CX.1E6!!Y&:Q/\ A7'@C_H3?#__ (*X/_B:Z2B@#F_^%<>"/^A-
M\/\ _@K@_P#B:V]/TZQTFQCLM*L[>RM8\[(+:)8T3)R<*H ')S5FB@ HHHH
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MG\'?A3#\1+C6DDUJZTS^SVC4&! ?,W%NO(_N_K7UYH.E#0O#UAI23-.ME;I
M)7&"^U0,GZXH T**** "O$_^;KO\_P#/C7ME>)_\W7?Y_P"?&N_!_P#+S_"S
MBQ?_ "[_ ,2/;****X#M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP)/,W;?]D8^[^M>F6W[6%H1%#_PB4^>%S]O'T_N4 ?15%-C?S(E?&-P!Q3J
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!U26XBM;L*'>V95<;6##!8$=1Z5Y9_PRIX(_Z"OB#_P(@_\ C- '')KND?\
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M\+.+%_\ +O\ Q(]LHHHK@.T**** "BBB@ HHHH **** "BBB@ HHHH ****
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M\(6=E::9>J+B,65NL*/N ^8JH'/ !SSQ6U7CO[,=]<7?PF:"<DI:7TL4)/\
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M[>/_ &E71AOXJ/-S3_<Y_+\T>OT445SGI!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% &-XH_Y!<?\ UV'_ *"U'A?_ )!<G_78_P#H
M*T>)_P#D&1_]=A_Z":/#'_(,D_Z['_T$4 ;-%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7!_#/\ YB?_ &R_]GKO*X/X9_\ ,3_[9?\ L]>?B/\ >Z/_ &]^1Z6'_P!S
MK_\ ;OYF5\?_ /D0;+_L)Q_^BI:[7P8H;X?Z K<@Z7;@_P#?I:XKX_\ _(@V
M7_83C_\ 14M=MX+_ .1!\/\ _8,MO_12U[T_]TAZL\"'^]2]$>*_'/X?^"?!
M?P]>_P!&\-017MU=);K=&65O(W98O@M@G"D<^M=9HGP3^%=SX-MYX]/AOK:6
MW$C:DUY)E^.7W!@%^@P/:NS\?6_A34O"\^E^.+ZRL]/NQM#W5RD)##D,C,?O
M \BOGE/@E\/[W4A!IOQ=TW[/)(-EJS0O(WH-PE )Y_N_A7"=IW/[-\FG03>+
MM*TE8KBTL;\+;Z@D8#W$)+[ S #=C!(/^UZ5[G7-^!O VB^ /#JZ3H$;^4S>
M9+/*P:2=R,;F( '0#@<"NDH **** #IUKG8OB!X/GU8:9#XGTF2]+^6(%O(R
MQ;IM'/)SQCK6-\:]3N=)^#OB"YLI&BF:!8@ZG! =U4X/T)KYO7X4Z8?V=_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGS=P3 '12W(YZ#!.,FOHWX>^#/"G@O29[3P<RRI*RFYG^T^<\C 8!8@X'&>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>6?\W#_ .?^?2O4Z\L_YN'_ ,_\^E(#U.BBBF 4444
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MH **** /(/CS_P P'_MX_P#:5>OUY!\>?^8#_P!O'_M*O7ZZ*G\*'S/-P_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MR#X\_P#,!_[>/_:5>OUY!\>?^8#_ -O'_M*NC#?Q4>;FG^YS^7YH]?HHHKG/
M2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %>0?'G_F _\ ;Q_[2KU^O(/CS_S ?^WC_P!I5T8;^*CS<T_W.?R_
M-'K]%%%<YZ04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!E>(O^0>G_ %U'\C1X=_Y![_\ 74_R%'B'_D'I_P!=1_(T>'O^0>__ %U/
M\A0!JT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'EG_-P_\
MG_GTKU.O+/\ FX?_ #_SZ5ZG2 ****8!1110!Y9\%?\ F-_]L/\ VI7J=>6?
M!7_F-_\ ;#_VI7J=) %>>'Q%H7Q \>:_\/==\/1W46DQ+,TMPP=9"=GW1C*D
M;^H->AU\ZZ]9_$SPE\;_ !-XC\&>%5U*#4DCB66XC+QL@2,Y&UU.<KCFF!M^
M!?A]\(?$^NZR-&\,77FZ'>&VF2_FD:(OEAE5\Q@R_*?O?E7;_#OQ]#XQO?$&
MFVVD+ID?A^\^Q($E#K(H+*"%"C;]SIS]:\1\'R_&?P5?ZW=Z5X&BFDUJZ^U7
M N868(^6.$VRC ^<]<]J]$^ /A[Q+I$GBN_\6Z2^F7&JWR7*HP #$[V;:,DX
M!;O0![%1110!P?A;_DHFL_\ ;?\ ]&K7>5P?A;_DHFL_]M__ $:M=Y7GY?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>6?\W#
M_P"?^?2O4Z\L_P";A_\ /_/I2 ]3HHHI@%%%% !1110 5Y9\%?\ F-_]L/\
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M (3]6>EF7\9>B_(****] \T**** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5Y/<W5O9?'YKB\GCMX4QNDE<*JYM<#)/'4UZQ7)Z
M]\.=&\0ZM)J-Y+>13R !_(=0#@  \J>P% &O_P )3X?_ .@[IO\ X&1_XT?\
M)3X?_P"@[IO_ (&1_P"-<M_PIWP__P _FI?]_8__ (BC_A3OA_\ Y_-2_P"_
ML?\ \12 ZG_A*?#_ /T'=-_\#(_\:/\ A*?#_P#T'=-_\#(_\:Y;_A3OA_\
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M_"7>&_\ H8=*_P# V/\ ^*KD/^%'^&_^?W5?^_L?_P ;H_X4?X;_ .?W5?\
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M_P#C='_"C_#?_/[JO_?V/_XW1RT>[#VF._D7WG7_ /"7>&_^AATK_P #8_\
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MEWAO_H8=*_\  V/_ .*H_P"$N\-_]##I7_@;'_\ %5R'_"C_  W_ ,_NJ_\
M?V/_ .-T?\*/\-_\_NJ_]_8__C='+1[L/:8[^1?>=?\ \)=X;_Z&'2O_  -C
M_P#BJ/\ A+O#?_0PZ5_X&Q__ !5<A_PH_P -_P#/[JO_ ']C_P#C='_"C_#?
M_/[JO_?V/_XW1RT>[#VF._D7WG7_ /"7>&_^AATK_P #8_\ XJC_ (2[PW_T
M,.E?^!L?_P 57(?\*/\ #?\ S^ZK_P!_8_\ XW1_PH_PW_S^ZK_W]C_^-T<M
M'NP]ICOY%]YU_P#PEWAO_H8=*_\  V/_ .*H_P"$N\-_]##I7_@;'_\ %5R'
M_"C_  W_ ,_NJ_\ ?V/_ .-T?\*/\-_\_NJ_]_8__C='+1[L/:8[^1?>=?\
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M_P!_8_\ XW1_PH_PW_S^ZK_W]C_^-T<M'NP]ICOY%]YU_P#PEWAO_H8=*_\
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M-T<M'NP]ICOY%]YU_P#PEWAO_H8=*_\  V/_ .*H_P"$N\-_]##I7_@;'_\
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MWG7_ /"7>&_^AATK_P #8_\ XJC_ (2[PW_T,.E?^!L?_P 57(?\*/\ #?\
MS^ZK_P!_8_\ XW1_PH_PW_S^ZK_W]C_^-T<M'NP]ICOY%]YU_P#PEWAO_H8=
M*_\  V/_ .*H_P"$N\-_]##I7_@;'_\ %5R'_"C_  W_ ,_NJ_\ ?V/_ .-T
M?\*/\-_\_NJ_]_8__C='+1[L/:8[^1?>=?\ \)=X;_Z&'2O_  -C_P#BJ/\
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MAATK_P #8_\ XJC_ (2[PW_T,.E?^!L?_P 57(?\*/\ #?\ S^ZK_P!_8_\
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M<Z1_S\7O_?:?_$T?\*YTC_GXO?\ OM/_ (FCVF-_D7WA[/ _SO[C>_MW2/\
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M^+W_ +[3_P")H]IC?Y%]X>SP/\[^XWO[=TC_ *"EE_X$)_C1_;ND?]!2R_\
M A/\:P?^%<Z1_P _%[_WVG_Q-'_"N=(_Y^+W_OM/_B:/:8W^1?>'L\#_ #O[
MC>_MW2/^@I9?^!"?XT?V[I'_ $%++_P(3_&L'_A7.D?\_%[_ -]I_P#$T?\
M"N=(_P"?B]_[[3_XFCVF-_D7WA[/ _SO[C>_MW2/^@I9?^!"?XT?V[I'_04L
MO_ A/\:P?^%<Z1_S\7O_ 'VG_P 31_PKG2/^?B]_[[3_ .)H]IC?Y%]X>SP/
M\[^XWO[=TC_H*67_ ($)_C7)?#/_ )B?_;+_ -GJ_P#\*YTC_GXO?^^T_P#B
M:V-#\/6>@1S+9-*QF(+M*P)XSCH!ZFHC3Q-2O"I4BDHWZ]T7*IAJ>'G3I2;<
MK;KLS@_C_P#\B#9?]A./_P!%2UVO@UMOP^T%L9QI=N<?]LEKBOC_ /\ (@V7
M_83C_P#14M=MX+_Y$'P__P!@RV_]%+7T,_\ =(>K/G8?[U+T1\Y_#O5O$?B_
MQ_XG\<76K-+=Z#:7$EMIS@MN#(X5$7.$52!G@Y/N<UE?#WX6#XN:!KOBOQ)X
MEN$OTG==Y ?Y@@;=)G^'G  Q@"O3O&W[/+:EXGG\1^!=?DT&_N&,DD7S*I=N
M6970ADR>2,'KVZ5YIK7P,U+P79F[\7>.K/2M-OYA!-+!'<SF5CD@%%4;NA/)
MQ7"=IZ'^R]XDU+5/#6K:-J%P]S!I<L8M9');8C!LH">PVY [9KW:N3^'7@#2
M?AWX973-':2<RMYL]U*,/,Y'4CL . .WUR:ZR@ HHHH **** "BBB@ HHHH
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M_P"NA_D*-<_X\4_ZZ#^1HT/_ (\7_P"NA_D* -*BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BN<\/^+1KNJS68LC!Y<9</YN[.& Z8&.M='6%#$4L1#GI.Z-:M&=&7)45
MF%%%0WEY!86DES=R>7#&,LV"<=N@K:4E%7>QFDV[(FHJIIVIV>K6QN-/F\Z(
M,4+;2N#P<8('J*MTHSC.*E%W3'*,HOEDK,**JZG=266EW-S#'YLD49=4]2!6
M/X1\0W>OPW+WD$<?DLH5H@0&SG/4GIC]:PGB:<*T:#^*6WR-8T)RI.JMD=%1
M11728!1110 45R6L>*K_ $_Q3'IMO:1R1,4&2K;WW=<<X_3M76US4<33K2G"
M&\79F]2A.E&,I?:5T%%%%=)@%%%% !1110 4444 %%<EHGBN_P!2\32Z=/:1
MQPJ7Y56#)CIG)_H*ZVN;#8FGB8.=/9.QO6H3H2Y9[[A116;:^(-,O=0:QM;H
M/<ID%-C#IUY(Q6LJD(-*32;V\_0SC"4DW%7L:5%%%:$!1110 4444 %%%% !
M1110 4444 %%%% !1110 45%=74-E:R7-T_EQ1C+-@G _"H--U:RU>%I=.G$
MR(VUCM*X/T(%9NI!34&U=].OW%\DG'G2T[ERBBBM" HJEJ6L6.D1H^HS^2LA
MPIVLV3^ -6;>XBN[:.XMW#Q2*&1AW!K-5(.;@FKKIU+<)*/,UIW)**Y/PQXJ
MO]:UB:UN[2..-$+916!0@@8.3[UUE98;$T\53]I3V-*]"="?)/<****Z3 **
M** "BBB@ HHHH **** /+OC_ /\ (@V7_83C_P#14M=KX-7=\/M!4'&=+MQG
MT_=+7%?'_P#Y$&R_["<?_HJ6NU\&,%^'^@,W &EVY/\ WZ6NZ?\ ND/5G%#_
M 'J7HCY6\>>$_B#X#UP-KGB363H4TV%U:TN)9$0$\;DW@J?8GGL35?QSX,OK
M7P#8>(HOB$_BG3;J\2&--TA".58Y(9SM88Q@@$9KZ@\.?$#P=\0?MNFZ-J$&
MH-&I2XM)X60LAX/R.!N7L<9'K7FGC']FBTO]0^T^"M3_ +(@EE62?3YMS0$C
MH5QR.IX.<9.,#BN$[3M?A5X UOP1%?MKGB>?71>",Q"4O^YVYSC<QZY'3TKT
M.FQ)Y<*(>=J@4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "O$;;XTZUXG^-EMX9\(::MQHEK<,E[/LR\B+E6DW$X5 Q&
M.YP.><5[8ZEHV4'!((!KYK_9OO;31/B%XIT'576#5)G"Q+*=K2&-WWJ,]3SG
M'H#Z4 9^K?$CXMZE\1/$^D>$=6\R'29;B7R?LMKF."-\<%TRQ''<DU[)\&/B
M'+\0_ RW>H!1JEG)]GO-BX#L!D.!T&0>@[YI)O!O@[X=ZAKWCJ>:6":[AE-T
MUQ,#&V]MQ55QU)  'X5Y]^RG9S?V=XEU':4M9[F..,=MRAB<?0,M 'T)1110
M 5XG_P W7?Y_Y\:]LKQ/_FZ[_/\ SXUWX/\ Y>?X6<6+_P"7?^)'ME%%%<!V
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?.MYJ&I:5\8M0O=#
ML_MM]%>W'E0>4TF_(8'Y5()P"3QZ5]%5\]G7+;PW\:[W5;Y)9(+>]N=ZP@%C
MN5U& 2!U8=ZZ\-]KT/&S6R]E=V][?MYGH'A'Q?XTU?Q)!9Z]X=^Q63JY>?[%
M-'M(4D?,S$<G KBM61-=^//V;40&@^VI$8VZ%448'T./UKN++XS>';[4+>T2
MUU*-IY5C5WB3:I8XR<.3CGL#7-_%3PMJ6G>)$\6:*CLF4DF:)<F"1, ,1Z$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!G:W_ ,>2?]=!_(T:)_QY/_UT/\A1K7_'DG_70?R-&B_\>3_]=#_(
M4 :-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 >;_#_ /Y&F[_Z]W_]#6K.J^+M6T_Q5<VT
M)$\*-LCMR@Y) QR!D\GUJM\/_P#D:;O_ *]W_P#0UIDO_)4Q_P!?2_R%?#T:
ME6& I*G)Q;G;0^JJ0A+%U.>-[0N27?B3Q7H]Q%+JBA8Y?F6)XTVL.XR.1^>:
MT_&5SJ5[X?@NM/XTV:$/<#Y<C)4KUY_*F_$K_CQL?^NC?R%3W0)^%2X_Y]D_
M]"%=<HU8RQ.%E4DTHW3;UVO;T?5=CFC*#C1KJ"3<K;:?\.8?@W_A(/W7]F?\
M@W[4/M'^K_V=W7YONXZ5>U[Q9JFE^+;BV@<26\84) 4'),8(YQGJ<]:G^'^I
M65MH\EM/=11SR7?R1LV&;<J@8'?D5FZI_P E63_KY@_]!2L$YTLOI.C5=Y27
M7;?2W;R-FHU,9452"LHOIOMKZ^9M:=>^)HM/U2XUE=@CM&E@+(@VL 2.GTZ&
MI/ ^M7^L0WAU&;SC$R;#L5<9SGH!Z5MZ[_R+NI?]>DO_ * :Y7X:?ZC4?]Z/
M^35ZEJF'QU"A[235I7N]]]S@O"MA:M7D2=ULMMC.LO&'B"XN9K2W NYY6Q$/
M+'[L#.> !G\?2I[7Q7KNEZ['::_AE9@'5D4%03U!7K^M1?#_ /Y&F[_Z]W_]
M#6CX@?\ (TVG_7NG_H;5XT:F)C@EB_:RNI6M?2U^O<]*4*#Q+P_LU9J][:_\
M W?&'B:ZT>:"ST]5$TR[S(XSM&<#';L>M5]+N_&$.K6J:K"TEM*X#L(T(4'O
ME.GXU<\56FAZC/%;:G?+9WBINBD/'RDXYSQC(/>N7T_4[SP_X@@L;74DU"T=
MU4B-]R$,<<>A^E=^+K5*6,YJE1\ETERR6GE*)R8>G"IAN6$%S6=[IZ^:9L:_
MXCU.Q\8Q65M<!;8M&#&8U.<XSR1FM/Q;XG;0HHX+55:ZF&X%NB+ZX[US'BK_
M )*!#_O0_P!*D\?H\'B:UN) 6B,2XX_NL<C]<_C657&8BG#$N,GI))>2=]C2
MGAJ,Y4$XK6-_5DRZWXPL(X[^_MVEM&()5HD'!_W?F'XUZ#6+<>+M%@L1<_;4
MD##(BC(,GTV]OQQ6U7NX&$:;E&-9U-MW>V_7S[>1Y6*DYI-TU#?96O\ \,<9
MXP\1ZAHNM6D=G-M@,8>2/8IW_,<C)&1P.U2:%J7B6ZU*.ZU2/RM,D1G^XH"C
M&0?[WIUZUC?$?_D.6O\ U[C_ -":N^U*)I=)NXHAEW@=5 [DJ<5YM)5JV-K/
MVDK0::2>C\O338[:GLZ>&I+D5YIW=OZUU.)?Q3X@UW49(O#<6R).F%4G'JQ;
M@9]*M:%XIU./71I/B% )'.U6*!65L<9QP0:YCPX@DEFB;7I-'8X(P2%DZ]3N
M&,>_K6[9Z-8-XDLY9?% O[I9595"%R^WD#?N('2O,PN(Q=5PK*;NY:WE'EM?
M;EO?^M#NKT</!2I.*LEI:+OZWM8L:UXGU>;Q$^DZ"JHZ-L!(7<[8Y^]P!6GX
M:NO$37\UOX@A8(L>Y)#&H&<CC*\&LS7],T'5M4GDAU>&QOXVVRB0[5+#COCG
MW%0^"];OSK;Z7<W7VN *VQRV[&WN"><&NVG6J0QR]M4;4I.UI)Q]''H<LZ<)
M83]W!*RUNG?U3)] \1ZG?>,);&ZN ]N&D 3RU&,9QR!FF:MXGUJZ\12Z5H*K
M&T;E!D+N<CKRW%9WA7_DH$W^]-_6M'7=+T'5-2N)K;6(;&^C<B59#M4N.#UQ
MSQU&:PIU<35P=XU'?G?VK-KLFS6=.A#$V<-.5=+I/NTBS8W7B][2_M[J$BZ6
M-6MY#&@!;<,C/W3QFN/TK^V/^$@?^R_^0CE]WW.O\7WN*Z;P1KE_-JLNF75P
M;J%48I(3N*X('!ZD'WK+\/W,-CX]G>\E2!!),I:0[0#D]2>E<]7DKK#S]I*W
M,U=O5:[W[Z[^AM3YJ3K1Y([7T6_R[>1TVI7OB6UT33TMK<RW\NX7#",-L(Z=
M/E'_ -:L.\UCQGI$:7.HX$+-@;HXR,^AV\BM#QCXHN+9;6'2)U2.X3S#<)SD
M9Q@'\*P-=B,>F(TGB@ZG)(P/V979E'O]XXQ[@5OCZ]IS5*I.\$OM)+;[Y7\C
M+"4KQBZD(^\WT;>_X'976O33^!'UBS_<3F,$<!MK;]IZ_C7.6/B7Q3JUH(=,
MC\V6($RW C7)]!S\HX[8R:N1?\DA/^ZW_HXU<^'/_(NS_P#7VW_H"5TN=?$X
MBC3]HXJ5--V[_P!=3#EI4*-2?(GRS:5R'PCXIOM0U-].U;#R[24?8%((Z@@<
M?_JI/$?BV]BU;^RM"0-.K!6?;N);^Z!TK+T/_DJ%Q_U\7'_LU117,>C_ !*G
MGU E(_M$A+$?=#@X/TY%<T<9B/JL82J-7GRN76WJ;O#4?K#FH7]SF2Z7-O1]
M6\2VVN6UEK\!>.YR%?8ORD G@KQVY%1ZYXKU*76VTGP]%F6-BC/M#,S#KC/
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M7?I_P"8X:,JU!J&CBKZ:;=2?7[K6;WP78W,+;X9("U\V$&?NXZ_CTK(\(_\
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ME%1NG>[3]3-4J=14:DZ:BW*UK:->A''XC\5ZI8>=IL.(H$Q+,L:DN1U//'X
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M!B^[H0!TVUZ'7*^#?'_AGQS/?_\ ",3M-)9E1<LUNT9YSCD@9Z&NJH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ) !)X
MZFO$?&_PC\(?%?6+C6O!WB>R@UB/;]K:RF2YC=OX2ZHV4;CKGG'3/->US_\
M'O)_NG^5?.?[+G^N\9?[T7_M2@"*T_9HUW5[I#XM\;K<VMOP!"9)W"^@+D!/
MR/TKVCX?2>#;701HG@.^L[FUT\ 2+;RB1@S9^9R.K$@\UXY^RY_KO&7^]%_[
M4I_[*W_']XN_ZZ0_SDH ^C**** "O$_^;KO\_P#/C7ME>)_\W7?Y_P"?&N_!
M_P#+S_"SBQ?_ "[_ ,2/;****X#M"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCM^9&:?>Z-I>I",:CIMI=B(8C\^!7V#VR.*NT478<D-=-Q%544*@"JHP !@
M5F-X8T%YO.?1-.:7.=YM(RWYXK4HH3:V&XQENA%541410JJ,!0, #TJG;Z+I
M=I>O>6NFV<%T^=T\<"J[9ZY8#)S5VBB[&XI[HIWVCZ9J;H^I:=:7C1\(;B!9
M"OTR.*?=Z98ZA$L5_96]S&HPJ31*X'T!%6:*+L7+'73<I6.C:9IC%M-TVTM"
MW4V\"QY_(5=HHHNWN-1459!1112&%%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"AK'_ !YK
M_P!=!_(T:/\ \>;?]=#_ "%&K_\ 'HO_ %T'\C1I'_'HW_70_P A0!?HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M .%O^?#6/^_,7_QRCZEB/Y&'UNA_,CU&BO+O^%_^%O\ GPUC_OS%_P#'*/\
MA?\ X6_Y\-8_[\Q?_'*/J6(_D8?6Z'\R/4:*\N_X7_X6_P"?#6/^_,7_ ,<H
M_P"%_P#A;_GPUC_OS%_\<H^I8C^1A];H?S(]1HKR[_A?_A;_ )\-8_[\Q?\
MQRC_ (7_ .%O^?#6/^_,7_QRCZEB/Y&'UNA_,CU&BO+O^%_^%O\ GPUC_OS%
M_P#'*/\ A?\ X6_Y\-8_[\Q?_'*/J6(_D8?6Z'\R/4:*\N_X7_X6_P"?#6/^
M_,7_ ,<H_P"%_P#A;_GPUC_OS%_\<H^I8C^1A];H?S(]1HKR[_A?_A;_ )\-
M8_[\Q?\ QRC_ (7_ .%O^?#6/^_,7_QRCZEB/Y&'UNA_,CU&BO+O^%_^%O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!1U;_CT7_?'\C1I/\ QZ-_OG^0HU;_ (]5_P!\?R-&
MD_\ 'JW^^?Y"@"]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% $%[86FHVQM]0M8+N!CDQ3QAU/X'BLO_A"_"W_0M:/_
M . $7_Q-;=%4IRCHF2XQ>Z,3_A"_"W_0M:/_ . $7_Q-'_"%^%O^A:T?_P
M(O\ XFMNBJ]I/NQ>SAV1B?\ "%^%O^A:T?\ \ (O_B:/^$+\+?\ 0M:/_P"
M$7_Q-;=%'M)]V'LX=D8G_"%^%O\ H6M'_P# "+_XFC_A"_"W_0M:/_X 1?\
MQ-;=%'M)]V'LX=D8G_"%^%O^A:T?_P  (O\ XFC_ (0OPM_T+6C_ /@!%_\
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MO^A:T?\ \ (O_B:/^$+\+?\ 0M:/_P" $7_Q-;=%'M)]V'LX=D8G_"%^%O\
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MY&C2_P#CU;_?/\A0!=HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *XCQ?\7?"7@N\:RU.\DN+Y!E[6SC\QT_WB2%!
M]B<UK^.]>?PSX#UC5X?]=;6S&+V<_*I_[Z(KP7X%^ -/\:WVI^(/%*'4$MY0
MB0RL2)96!9G?N<9''<GGI7T65Y=AJF&J8[&-^SA966[;Z?BC&<VFHQW/4/#O
MQY\&>(M3BL%DO-.GG<)%]NA"J['@#<K,!^.*R?&WQ=UKPS\6;/PQ9V5A+8S/
M;K(\J/YO[P@'!# #KZ&NLU;X1^"]5FMIET6#3Y[:5)4DT]! 3M.<$*,$'&#Q
MGT(KQ;XM?\G&:=_UULO_ $(5ZF5X?*L9BVJ,';DDVI:V:M9IHB;G&.I].T5Y
MS\4_B3JG@>XTRRT+11J=WJ"R,-P9@H7' 5>2>?48KSV7X]^/-"NH'\5^$(;:
MUE/"O:SVS..^UG8@_E7C87(<;BZ,:M)*TMDY)-V[(TE5C%V9]$45P?BOXJZ9
MX=^'5EXIM8&O!J006<!.TLS*3ACSC;@Y]QBO-$^.WQ!@ACU._P#!L7]CR .L
MRV=PBLAYR)22IX[XJ<+D6.Q4'.$4E=K5I7:W2N.56,78^AZ*\W^*OQ7_ .%?
MO9V&G:>+_5+U2Z(Y(2-<X!('+$G( &.E<WX3^+GCFZ\8:9I/B[PFMA;ZA*(D
MF^R3VY&0<$>82#TJ:.28RMAOK,4N6S:NTFTM[('4BI<IN^*_C3;^%_B-#X5?
M19+D,\*272W&TJ9,8PFT[L CN*]/KQ#Q]X_;1/C;INE#PYH5YA[91>W5IOND
MWL/N29^7&>.*[7XG?$^R^'6FPDP?;-2NL_9[;=M&!U=CV'\S^)'5B<LE4CA8
M8:C:52-][\WGY$QG;F;>QW5%?/=G\?O&%E);:AXE\))'H=PPVW$5M-%N4]U=
MB5;CMQGVKK?B5\5=?\+>*X_#_ACP\-3N6MEG,C)))G<2  B8/;KGO6<^'\?"
MM&BTKM-WYE;3?7RNA^UC:YZO7GOQ@\?ZG\/O#UC>Z/;VD\US=>2PNE9E VD\
M!64YX]:\]MOV@?%>B:U!;^.O"T=G!(065+>:WE5/[P$A.['IQGUK5_:5FCN/
M VASP.'BDO=Z,.C Q,0:[,%DE7#YC0IXN*<)M[.Z=EY$RJ)P;B>H^"->G\3^
M"-+UJ\BCBGO(!)(D6=H.2.,DG'%;U<;\(_\ DDOA[_KU_P#9C795\_CH1IXJ
MK""LE)I?>S6.L4SQOQ3^T;HNB:M-8:-I4VKF!S'),9Q#&6!P=IVL2/? _K5K
MP1\?](\5Z];Z1?Z9-I-S=,(X&,PFC=ST4G"D$]!QUKR/PKK$?P8^*FIP:Y9+
MJ(MXY+8/"59QG#(ZD\#( !'49/<8KI/"?AO5/B!\3!\1-6T^+P_H5M,E]YC_
M "+((@"N"<9'RY9^!U^E??8G)LKHT).5.T.2\:G-\4GLE'_@'+&I-O?Y'TE1
M5+3-9TO6H'FT;4K34(D;:TEI.LJJ>N"5)P:NU^<2C*#Y9*S.P**\(U?XU^.+
MCQ!J%CX2\'"[AL[F2#>;6>X9MC%<G81CIG':M#X>?'&^U_Q='X;\6Z1%I][,
MQCBDA5T"R $['1R2,XZYZ\8YKW9\/8^%%UG%-)7:33:7H9*K!NQ[/17F7Q3^
M,5OX GBTS3[1;_5I4$AC=B(X5/0MCDD^@_/IGF_#'QK\6/XJTO2_&OA86$&K
M3I!;S);30'+D!6 D)#C)'3'K6='(L=6P_P!9C'W6FU=I-I;V0W5BG8]QHKR'
MXG?&V3PEKX\/^&M/BU#4TV^<\VYD1F *H%4@LV".XQD#GMS-]^T)XGTC2IK3
M6_#$>G:\"C0BXMY4B="><QLP8''0Y(//XZT.'<PQ%*%6$5:6UVKV[V["=:"=
MCZ$HKS;7OB-JNE_!"S\96]M9MJ%Q% [1.C&(%R < ,#W]:V_AAXLOO&W@2VU
MK5(;>&YEDD1DME8)\K$# 8D]O6N"IEV(I8>6(DERJ7)OU12FF['75YA)\:;=
M/BP/!8T60C[4+7[;]H_C(Z^7MZ9[[O>J?PS^*^M>-/B'JN@ZG:6$-K9P2RQ/
M;HX<E)40 DL0>&/0"LJX\?M'^T4NA?\ ".:$W^EI;_VB;3_3,&,<^;GWQTZ5
MZ^%RB=*M6HXFES.--R5I6MV?GZ&<JETFGU/<**\>^(_QEU'P)\1+;2%L;2?3
M/(CFG9E8S'<6R%.X*.@Z@U/\//BGXG\4^(IQX@\/1Z7H9LI+N"\\F5 %4CDR
M,=KC!/0"N%Y'C5AEBFER-7W6OR[^1?M(\W*>M45X%J/Q_P#$6KZW/:?#SPP-
M0AA)PTEO+/)(H_BV1D;1]<UTOPQ^,[^,=<D\/^(=.33M6 8Q>7N"2%1ED*MR
MK  GJ>AZ8YTK</YA0H.M..B5VKJZ7=H2JP;LCUBO./C%\0]4^'NDZ;<Z-;6<
M\EW.T;_:T9E "YX"LO/XUA?$GXXW/AGQ0?#OA738=0OXBJ323!G42-C$:HI!
M8\COU.*\L^)_Q$UGQ;I-AI?BG07TC5+*=I2/+>,.C+C[C_,O3U.?;%>IDO#^
M(J5Z-;$03IRULVKVMH[;VO8BI5232>I]2>&=3EUOPGI&JW*(DU]8PW,B1YVJ
MSQAB!GG&36G7/^ /^2:^&?\ L$6O_HE:@^(_B:[\'?#_ %+7=.BAFN;01^6D
MX)0[I43D @]&SUKYJ6'=7&.A26KE9?-V1M>T;LZ>BOG>+]H/Q;JNG6ZZ!X8@
MO+Z&-I-0:.WFEC3YCC:JME1M R6)Y)]*['XA?&I?!T=CI]CIHN]<NK=)I8'8
MA+;<,A6QRS>W''->E/A[,(58T7%<TKZ773J^R(]M"USU>BOGVW^/WBW1-3ME
M\<^$UL[.<Y!2VFMY"G=E\PD-CTXSZBO1?B'\4K+P5X3L-6M(!J,FJ &R3=M1
ME*AMY..F"..^:SK9%CJ56G2Y;N?PV::=M]?(:JQ:;['>UYM\3/C!#\.M9L=/
M;1GU%KF'SF<7 B"+N*\?*<G@^E<5I_QM^($=_92Z[X.CATNZF1!,+.XARK,!
MD.Q*GKZ5J?'/QPWA77=(MQX>T/5M\+2A]4L_.:,[L80Y&WI7H8/)*E+'4Z.)
MIJ:DI:*79=UV(E43BW%V/9+2Y6\LH+E RK-&LBAA@@$9Y_.IJ\^^)'Q1C\ ^
M&M.O%LA=7^IJ3;P%]J* H+,Q]!N7COGM7#Z3\:/'ZZSIJ>(_!Z6VG7UQ'$LW
MV.>'AV R'<E3]X'IS7GX?),9B:/MZ<4HZVNTKVWMWL6ZD4[,]HU/Q#HNBR1Q
MZSJ]AI[RC,:W5RD1?Z!B,UH@@@$'(/0BOD;XWZWKVK>.I8=>TS[##8RS6]@_
MD/']H@$AVR98D-D8Y7 KV#P#X_\ &-QX=UR]\7>&C96VCZ=]HM0MI-;FYVHQ
M*AI"0<A1R!QFN[%\.U*&"I8F,DW+=775I*W??7L1&LG)Q/6:*^>3\</B3>P-
M>Z5X*C:Q4;C+]@N95"^I=6 _&N^^$_Q87XB)=VE[9)9:E:*)&6)B4E0G&Y<\
MC!P"#GJ.?3CQ60X["T76FDU'>S3MZE1JQD[(](HKP6__ &A-4T?QKK^DWNC6
MUW#9W$UK8I;!EDDD278N]BQ&"H8_*N<X%5;+]H7Q)I?B.&U\;>&X;&TD*EU2
M"6&:-#_'AR=PQST&?6MUPSF4H\RBMKK57?71"]M ^A**Y;Q[X]TWP'X9_M6\
M'VEYCLM8(VYG8C/7L,<D_P#UJ\?A^/\ XX,/]KR>$('T,/@S);SA?IYV2N?P
MKDP628W&TO:THKEO;5I7?97*E4C%V9]$T5Y_XR^+>F>%/!.EZXMN]Q<:Q;I-
M9698*2&0-ECV W#..YQ7FI^/OCRS@BU34O"-NFD3$>7,;:>-9!_LRDE3^5:8
M7(<?BH>TA%)7LKM*[6Z0I58Q=F?15%8OA+Q18^,O#-KK6F;A#< AHW^]&X.&
M4^X/Y\&CQAK4_AWP9JVL6D<<D]E:O-&DN=I('&<8.*\GZO5]O[!JTKVMYWL:
M75KFU17SSI_[0_B;5=+6TTKPQ%J&NEG=Q;0RO$L0 P1&K%R>N3D <>O$FC?M
M+72V=Y%XBT%'U!!BV2S+(LCYQL<,6*^N1GIC%>]+A?,TG:";72ZOZ^AE[:!]
M!45\]VW[0OB;2O$4-MXS\-0V-I(5+((989D0_P 8WD[AWZ#..M=Y\8/B-J?@
M#1M+O-"@LKEKV9D8W*LZ[0N01M9?6N>ID..IUZ="25ZE^5W5G;?4:JQ:;['I
M%%<[;>(KF;X80^)7BB^U/HZWYC .S>8?,QUSC/'7.*X'P#\5O$WC'P7XHU(Z
M792ZEI42M9V]I#(1,Q5C@KO);E1P"":Y*>68BI3G4C:T&HO7JW;\RG-)I'I\
M7B'19]7;2H=8L)-10D-9I=(9E(&3E,[N![5HU\8Z7XD\46OQ=?7K+1O.\1M<
MSR-IWV65L.R.'7RP=_ +'&<C'->\:O\ %'Q'X?\ A;HVMZIX<_XGNI7+V[V1
MBDA$1#/M.PY?E54XSSG->UF/#=;#3I0HR4N>W5)W=V_EIN9PK*2=SU:F3316
M\$DUQ(D44:EWD=@JHH&223T '>OGBZ^.OQ&TF-+S6?!UO:V#MA7FL;B$-[!V
M;&?PKH_'/Q(U37_@Y#JOA+1VN+;58;BVU-6A>8V2>65<Y0@#')#-QC!(KEEP
M[C(5*:G;ED[73328_;1:=CUG2];TK6XI)-%U.SU%(SM=K2X24*?0E2<5Y]\0
M/C3;^ _%UOHCZ++?>9$DLLRW&S8&) "KM.X\>HKQ3X3>+/&/ALWL/@_0/[6@
MNIHOM3_8YIO*QD#F,@+D$]?2O3?C#X];PQ\1=(L1X=T/4\VL<XN-0M/-FCW2
MNN$;(V_<ST/)KU5D$<+F7U><?:Q:=ES<KT2WMMOIW(]KS0OL>VT5QGQ(^)&G
M_#K1XI[F%KN]NBRVUJKA=^!RQ/91D<X/45Y.WQZ^(,=FNK2^$;9=(8C%P;.X
M"$'_ *:[MOZ5X>"R/&XVE[:G%*+T3;2N_(UE5C%V9]%T5R/PY^(-C\0_#S7]
MK"UK<P.([JV9MWEMC((/=3V/'0^E>1Z3^TCKMU;W5O+X>M[S4Y71;"&S20+C
MYMV\;F9C]W 7&>>E*AD>.KSJ4X0]ZG923:5K_II>_8'5BDGW/HJBO"O"'Q[U
MFX\:0:!XWT6WT]KB86^Z*.2%X';A=Z.3QD@'IC.:ZGXJ_%I_ 5Y9Z3I.G#4-
M6O(Q*JR$[$4L57@<L201@$=*=3(L?#$QPW+>4E=6:M;O<%5BX\QZ917B_@[X
ML^-[[QKINB>,?"BZ=%J#LB2_9)K<J0I.<2$[ON^U>T5QX[ 5L#44*UM5=6::
MMMT*C)25T%%%%<!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %/4_\ CV7_ 'Q_(T:9
M_P >S?[Y_D*-3_X]E_WQ_(T:9_Q[-_OG^0H N4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <I\4-*N-:^%^O6-FI>
M=[4NB#JQ0A\#W.W%>0_LW^+M,TY-3T#4KF*UGN)5N+9I7"B4[=K*">,C ('?
M)]*^B:\C\7_L]:!XBU2;4-)OI=%FG8M)''$)(2QZD+D%<GL#CV%?395CL)]3
MJY?C&XQFTU)*]FK;KY(QG&7,IQ/1M:\4Z'X=\H:UJ=O:/,ZQQ1NV7=B<#"C)
M/UQ@5\\?%K_DXS3O^NME_P"A"NU\-?LWZ1H^K6]]J^M7&I_9Y!(D,< @5B#D
M;OF8D?0BMSQ7\'$\4?$BU\5MK;6P@>!FM1:[]WED'A]XQG'H:[<MKY7EN*<H
M5G).$DWRM*[M9):OO>Y,U.<=49GQ>^*^J^%-?LO#?AB*W6_N8U>2ZN "L>]B
MJJ <#/&23P 17G'Q<A^(%MX<LE\=^)-)OX);E9(;&UV"9&V-\_$:G: 2,[B,
ML.O6O9OB3\)-,^(LEO=RWDNGZC;Q^4EPB"163)(5E)&<$DC!'4UQ,7[,-BNG
MSQS>)9I+M\"*8685(^<G*;\L2./O#K77E.891A:-&<FHSC\5X.4F^ZET7IJ3
M4C4DW_F7[/PKHWC']G_PSI6LZI#I<[1A[*>611^]&[C:2-PP3D#Z]JXJ\U;X
MA_ VZL;2[U.VU/2),B"!I/,C9!C(&</'U[<?6O4M:^#5IKGP\T3PQ<ZO-&^C
MY\N[CA'[S(.<H3[^O:N7T?\ 9DTRUOTEUGQ!/J%NK F"*U$&_P!BV]CCZ8/O
M3PF99<HU%B:O-!RD^1P;W;LXRZ?/\ E">EEKWN:_Q%\$Z7\4K71K^RUBWTK7
M6LDFMH)Y 3+$_P R@J#N&#G# 'G/7MQ^@_$'QS\/O']EX3\:7,>JV\TD<1)D
M$CHKG:'63@GGL_/TZUWWQ$^"MAX[U"SO(=3?2I+2T6T1$@$D?EJ6*C;E<8W'
MO6?X+_9\T?PQKD&JZGJ<NKSVKB2",P"&-7'(8C<Q)!Y'.,UAAL?ET<![+$U.
M=6=H.&L6^TQRC/GNE\SS_P"+7_)QFG?]=;+_ -"%/_:&S%\6=)EU$!K+[%"0
M,9&P2OO!'KU_ BO3O%?P<3Q1\2+7Q6VMM;"!X&:U%KOW>60>'WC&<>AK?\?_
M  ZTCXA:7%;ZH9(+BW)-O=0XWQYZC!X*G R/;M6M#/,'1J8.3=U"#C*R>C=O
MOVZ"=.34O4OZQK_A>U\+"_UJ\L#HLJ*5:7#QRC@@*O.[MP >E>8^/_BOXC7X
MCKX+\$BSMKA72)[NZP=TC*&P-W  !QR"2>G;,.D_LQZ9;:DDVK^()[^U5@QM
MXK40EQZ%M[<?0 _2NB^(GP/TSQWK9UB#4I=+OY%59V$(E27:  =N5(. !G/8
M<5PX59)A<2E.JZD;2U<7RIZ6]W=];_(J7M)1VL>+?&&'QE:W6EV_COQ!IFKW
M"K*88K(*'MP=F=X$:?>P,9S]T_CWGQY_Y)+X2_WXO_1!J=OV8;'^RQ$GB687
MOF!FN&LP4VX/RA-XQR0<ECTKN?'OPP7QOX1TK1/[6-C_ &<R%9_L_F;]J;/N
M[ACUZUZU3.,NC6PG)45J;E=J#BM>JBE^6O<CV<[2NMRW\(_^22^'O^O7_P!F
M--^+FNZCX<^&&JZAH[/'=@)&LR=8@[A2P]#@G![$@UN>$] 7PMX3T[1%N#<B
MRA$?G%-F_G.<9..OJ:OZAI]IJVG3V&HP)<6MPACEB<9#*>U?&RQ-)9B\0US0
MY^:W=<U_Q1T6?)8^:/AE\-/#GQ \"ZF]QJ97Q(TY\LF3F  9!*9^8,2<GVXP
M0:PCXQ\4?#[1-=\!:GY=Q;W$+P)^]W" /PS1L.JL"?E/<]CD'TK5/V8M,N+M
MGT?Q%<64+'(BGMA.5]@P9?UK3T']G#POIZ.=:N[O5I60J.?)1,C&X!23D>Y(
M]J^\EGF6.4YUJSJ0;34'!WBUV>BMY?\ !OR^SGLE;S+/[.VEQV'PT:X$\,LU
M]=O,ZQR!C&  JJP'0_*3CK\U>JRR)#"\LAVHBEF/H!UKSCX>_!RU^'OBR]U>
MRUB:[AN+9K:.WEA"M&"ZMDN#\Q^3'W1UKTFOA\XK4:^.G6I3YXRUVM\M>VUS
MIIIJ*3/GS2_B7\0_B;XDO+3P/=:;HEK;KO7[2%+;,\$EE;)XYVK@?K7(Z,=5
M/[2&G?\ "0:G9ZKJ0OHEGO+(@Q2$1@#&%4<#"G@<@_6O0M;_ &9]+OM6EN='
MUZ;3;:1RWV9[43;,GHK;EP/3(-:&@_L_6/ASQ=I.M:?KDS+I[*\D$MN"9W&<
MG<&&T<CC!Z5]E',\FH4ZGU>2CS0<4N1\R=NL];W?R.?DJ-J_?N>?>,9H;#]J
M=+GQ T8M%OK5R\@^14\M-I.>P.,^X-?1&L:QX?M)--CUJYLR]U<Q"P24!V>9
MCA&0<G.3]X=,]17-_$7X3:/\0VAN;F:2PU&!/+2ZA4-N3.=K*>H!)QR#S7,>
M#_V>--\-^(K35]1UN;4I+.99X(DMQ H=3E2WS,3@C..*\;$8K+<=A:,ZM5PG
M3AR\J3=[;6>ROYFBC.,G9;G!Z3<V5C^U;=2ZXRQQ?VE<!'F/RJY5O+)S[E<?
M45T_[36H:<^D:18+/ VHQW)D:($&1(]AY/H"2.O7\*ZOXB?!+2O'FK#5H;^3
M2M090LTB0B5)@. 2N1\V.,YZ 5Y%\4OA-IWPY\'V%S#?3:A?7-YY<DSH(T"!
M"<*@)QSW)->U@,5E^.QN%KJHU4C%1Y+/=)ZWVL9RC.,9*VAVOB\$_LF:7@=+
M>TS[?.*W?@/K.FVOP=1[J^MX$L;B;[2TD@4198L-V>F0:W?!NB67B3X&Z/I&
MJQF2TN],C20 X(XR"#V((!'N*X6W_9ATU-3$ESXDN9;(-GR%M520CTW[B/QV
MUY?UG 5<-7P6*J.#55R32;OTM_PY?+)-2BKZ'/?L_2I<?&379H6#QR6%PR,.
MX-Q$0:@O/^3ME_["D?\ Z+%>K^!OA#:>!?'&H:[IVI&2VNK=[>&Q,&/(5G1A
M\Y8EL;,=!UJ&;X.)+\7!XW_MM@!<+<?8OLO<*%QYF_IQG[M=4\YP,L=7K*?N
MRI<JT>^FFWX[>9*IRY4O,\L^.<:2_'#3XY5#H\-JK*PR""YR#7O'Q&CD_P"%
M7>(H[-2&&FS +'QA=AR!^&:YKQM\'$\9>.[3Q&VMM9BW6)6MA:[]^QBW#;QC
M.?0UZ6Z+)&R2*'1@0RL,@CT->-CLRH3H8)4G=TEJM=[K_+H:Q@[ROU/E+X/6
M_C>]MM0MO ?B72=*<R*T]M>*IEEXX89B<E1R.#QZ<UV/A_X:^)HOC'8:_P"*
M/$_A^XU$3>=/#;3XGE"IM^6(1J.@&3QW/)K2U_\ 9IT;4-1DN=#UF;2HI&+?
M9WMQ.B9[+\RD#ZDUL?#[X'6'@7Q#'K3ZQ/J%W"C)&/)$2#<,$D98G@GO7O8W
M.<%4C5KT*J4IQ:Y?9^]JMG/L91IR5DU^)YGX3N;*Q_:FU*36F6,'4[U87F/"
MNS/LY/3@X'U%;_[36H:;+;Z-913P/J,4LCR1J071"!C/H">QKL/B%\#M*\<:
MPVKVVH2:5?R@"=UA$J2X  )7*X.!C.?2L'_AF?2%\//:IK<QU-Y58WSV^55
M#E5B#C&2<Y+$\?6II9GE<\3A\=4JN,H147'E;[J]^VO2[!PFHN*1Z=X _P"2
M:^&?^P1:_P#HE:Y_XZ?\D7UW_MW_ /2B.NPT'2QH?AO3=)$OGBPM(K82E=N_
M8@7=C)QG&<9JAXX\+#QIX,O] :[-F+P)^_$?F;-LBO\ =R,_=QU'6OD,/B*<
M,SA7D_=4T[^7-?UV.AI\EO(X+]FZ&)/AI<RK&HDDU&0.X'+ (F,GVR?SKRSQ
MX=3B_:0NVLK^WTV^^UQ&VN[[!BB/E+L8Y5ACI@X.*^A/ASX'7X?>%3HRWYU
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MQ"C$=F^9B1[<5QY=F&7PP?L\75YX^]^[<+M-M_#+IW_R*G"?->*^9RW[3O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!4U+_CV7_?'\C1IO_'LW^^?Y"C4?^/=?]_^AHT[_CW;_?\
MZ"@"W1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %8OB;PAH?C&QBL_$EB+V"&3S(U\UX]K8QG*$'H:VJ
M*TIU)TIJ=-M-=5HQ-)Z,JZ9IMIH^EV^G:;"(+2VC$<,88G:HZ#)R3^-6J**B
M4G)N4G=L84444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *NH?\
M'NO^]_0T:?\ \>[?[W]!110!:HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
9** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>bdtx-20211231_g13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g13.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,S
M-P  DI(  @    ,S-P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ I'Z4M-D^[^- "ITI:;']W\:=0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4CNL:,\C!5499F.
M !ZTM>4?$_Q/+/J!T.TDVP0X-P5/^L<C.WZ 'IZ_2MZ%%UI\J./&8N.$HNI+
MY+NSJM0^)?AZPF,22S7C+P3;1Y /U) /X5'9?%#P]=S".1KFTST:>(;?_'2:
MYGP1\/;?5M/74]:,GDR$^3 C;=P!QN8]<=>!]:Z#5?A;HMU W]F>;8S8^3YR
MZ9]PV3^M=<H8.$N1MW[GETZV:58>VBHV>R_K_,[6*6.>)98762-QN5T.0P]0
M:=63X7TF?0_#5IIUU(DLL ;<R$E3EB>,_6IM4U[2]&53J=]#;EN55CEB/4*.
M<5P./ON,-3VHU+4U.I[NFM^AH45SD7Q \+S2!$U5 3_?BD4?F5Q700SQ7,*S
M6\J2Q.,JZ,&5A[$42ISA\2L.G6I5?X<D_1W'T56O-1LM/56O[RWM5<X4SRJF
M[Z9-1W&LZ;:Z>+^>^@6U;[LWF JWT(Z_A249/9%.I!7N]B[16#9>-_#NH72V
M]KJD9E8X4.C1Y/IE@!6IJ&IV6DVIN-1N8[>(<;G/4^@'4GZ4W3FG9IW(C7I3
MBY1DFEUN6J*PK#QKX>U*Z6WL]3C:5CA5=&3<?0;@,FMVE*$H.TE8JG5IU5>G
M)->3N%%4H]9TR:[^RQ:C:/<9*^2LZE\CJ-N<U2U+Q?H.D7!@O]2CCE'WD16<
MK]=H./QIJG-NR0I5J48\TI)+U-JLWQ!K"Z!H-SJ3PF<0!?W8;;NRP7K^-.TK
M7=,UN-GTN\CN-OWE7(9?JIY%9/Q%_P"1!U'_ +9?^C4JZ</WL8275&5>M;#3
MJTWLFT]^A6\(^/5\4ZG+9?V<;5HX3*&\[>" P&/NC^]77UX_\)?^1LN?^O%_
M_0TKU]F"J68@ #))/2M<93C3J\L%H<N5XBIB,,IU7=W8M%<]<^//#-I,8IM5
MC+*<'RT>0?FH(K0TO7]+UH-_9=[%<%1EE4X8#UVGG%8.E4BKN+L=L<11G+EC
M--]KHT:*H:OJ=IIME(UU>P6KO&WE>;*J%B!VSU[5XYX;\3ZI_P )/8G4-:NO
MLQF'F^?<MY>WOG)QBMJ.&E5BY+H<F*S"GAJD:<E?F_ ]RHJI9ZMIVH2,EA?V
MMTZC++#,KD#UP#4EY>VVGVS7%]/';PKU>1@!_P#K]JYN5WM8]#GBX\U]">BN
M;_X6%X7\S9_:JY_ZXR8_/;BMVSO;;4+9;BQGCN(6Z/&P(_\ U^U5*G."O)-&
M=.O2JNT))^C3)Z***@V*6K:Q9:)8->:E,(HEX'<L?0#N:X2X^,%NLK"UT>26
M//#23A"1] I_G6?\79Y3K5A;ECY*VY=5[;BQ!/Y 5I?#70-%O_#LEU=V<%W<
MF5D?SD#[!Q@ 'IZYKTX4:-.@JM17N?/5L7BJV,>&P\E&W5EC3/BQIMU<+%J-
MG+9!C@2!_,4?7@''X&N]1UD17C8,K#*LIR"/6O _&=KI]EXKN[?2 JVZ$#:I
MR%;'S ?C7L'@H3+X*TL7.=_D\;O[N3M_\=Q4XJA3A"-2&E^A>6XVO5K3H5FF
MX]5ZV-VBBBO./>"BF33Q6T+37$J11(,L[L%51[DUSS_$'PNDFQM54GU6&0C\
MPN*N-.<_A39E4KTJ7\227J['2455T_4K+5;;S].N8[B+.-T;9P?0^GXTRYUK
M2[*<P7FI6=O*,9CEG56&?8FERRO:Q7M(<O-=6+M%(CK(BNC!E89# Y!'K5.Y
MUK2[*<PWFI6=O*.L<LZJWY$TDF]$.4HQ5V[%VBD1UDC5XV#HP!5E.01ZBL?4
MO%V@Z1<&"_U**.5?O(H9ROU"@X_&G&,I.T5<F=2%-<TVDO,V:*Q],\6:'K$P
MAT_48I93TC8%&/T# 9K'^(6NI8^'9X+#4T@U .@,<4X64*3GH#D<5I&C.4U!
MJS,:F*I0HNLFFEV9V%%>4_#GQ/+_ &I=C7M:;R?)!3[;=<;MPZ;CUQ7J%K>V
MM_#YUC<PW,6<;X9 ZY],BG6H2HRY61@\9#%4U..GEU)J*RM3\3Z+HS[-1U&&
M&3O&"68?55R15.V\=^&KN98H=5C#,<#S$>,?FP J%2J-747;T-I8FA&7+*:3
M[71T-<OKGQ TC0-4?3[N.ZEGC +^2BD+D9'5AV(KIU8,H92"",@@]:\\\7>$
M-(U+Q'+>W?B2VTZ:8*7@FV9X4*",N.PK3#QIRG:IL<^.J8B%)/#VO?K;;YG=
MZ=J%OJNFP7UFQ:&==RDC!^AJS6?H=A;Z1H-K:6LWFP0Q_+*2,.#R6XXP<YJ2
MUUC3;Z8PV6H6ES*!DI#.KL!] :RE'5\NQU0F^6/M&N9K\?(N45@WOC?P[I]T
MUO=:I&)5.&"(TF#Z94$5IZ=JECJ]K]HTVZCN(LX)0]#Z$=1^-#ISBKM.PHUZ
M4Y<D9)OM<MT45C:EXNT'2)S#?ZE%'*OWD4%V7ZA0<4HQE)VBKESJ0IKFFTEY
MFS16-IOB[0=7G$%AJ44DK?=1@4+?0,!FMFB491=I*P0J0J+F@TUY!15+4]9T
M[1H1+J=W';JQPNX\M] .35'3O&7A_5;I;:QU*-YF.%1T9"Q]!N R::IS:YDG
M8B5>E&7)*23[7U.7_P"%L1_VK]E_LAO+\[R_,^T<XSC.W;^F:]#KYS_YC_\
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M;H8R5;$4^>#_  /4_!7A&X\*2ZBLMU'<0W#1^45!! 7=G([=1T)Z5YK\1?\
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M9G"_"7_D;+G_ *\7_P#0TK3^*?B2:.:/1+20HA027)4X+9Z+]._XBLSX2_\
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MZDC\JK?"32=EM>ZM(O,A$$1]ARWZ[?RI4/W.&E5ZO8K&_P"UYA3P_2.K_/\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'-]P?6I*BG_P!6/K0
ML/W#]:DJ*#_5GZU+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4G@YZXK&$Z=+%3YM+G95I5\1EM)PUMNOO2)Y_A)I\EDIL-3G$Q7(>0*R,>W
M ('XFNKT6U?PQX.CAU"19#8PN\C1DXP"6XS[5X]8Z_XB\)7?V<27%OLY:UN5
M)4C_ '3T^HQ7HVH:^OB+X67]_"ACD,1CEC'.U@1D?3!S]#66(IUO=C.5XM[G
M1@L1A%SSI0Y)J+T]#SI#J'CSQ>B32[9+AC@GE88QDX ] /S/UKK-=^%EK9:'
M-=:;>7$EQ;QF1DE"E9 !DXP!CC/K7":%;:K=ZJD6@M*MZ5)4Q3>6V,<_-D=O
M>NG?PY\19(V2234'1@0RMJ2D$>A^>NVK>$THS44NAY&%Y:E.<JE&4Y/JK_U<
MG^%>NS0:PVCRNS6]PK/&I/W' R<?4 _D*G^*^NRO?0Z- Y6&-!+,!_$QZ _0
M<_C2>"O!6O:5XNM+[4;(06\(<LQF1NJ,HX4D]36%\1B?^$]U#/3$6/IY:UE&
M-.>+YHZZ7^9TSGB*65\E1->];732U_S-?PI\-XM;T,:AJ-U+!YX/D)$!P <;
MFSUZ=./K7*>(-%O/#^JMI]Z2VP9B?^%T)X(_7\<U[CX7V?\ "(Z3Y>W'V.+[
MOKL&?UKS?XN?\C)9_P#7H/\ T-JC#XFI/$.,MM37'9?0HX&-2"][37O<Z[X8
M_P#(D0_]=I/YUU]<A\,?^1(A_P"NTG\ZZ^O,Q/\ &EZGT. _W2GZ(\^^+6HW
M%MI5C90NR173N9<?Q!=N ?;+9_"L#P3X&T[Q+I$MW>7TRR+(4$4!4%.."<@]
M?PZ5Z%XN\+Q>*-*%N9/)N(6WPRD9 ..0?8UY%?:%XB\)7'VAH[BV"G NK=SL
M/_ AT^AQ7HX62E0]G"7+(\',:<J>,]O6AST[?<>D>$_ LWA?Q%<7:WJ7%K);
MF-05*N"64\CIV/.>]<E\6O\ D;+;_KQ3_P!#>MSP%X]NM5OUTG62LDSJ3#.
M%+$#)5@..G?VK#^+7_(V6W_7BG_H;T4556+_ 'N]@Q<L/+++X?X;[=F=[\/_
M /D1--_W7_\ 0VK@OBU_R-EM_P!>*?\ H;UWOP__ .1$TW_=?_T-JX+XM?\
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MA^+>E>7>66J1KQ*IAD('<<K^A/Y5URFEBN1[-?YGETZ+EESJQWA._P""_P"
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MJ^%E+G<'?\#RZ>#S*G#V4:JY?Q_+]3)2TOO&/PN1;\[M0G5I$9E"999#MXX
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M6+H.:JJ+YC&&68Q4GAW47)^/]?,XGX0?\@_4_P#KJG\C7*_$G_D>[W_=C_\
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M:99Z;8Z<'&GV=O:A\;A!$J;L=,X'-..(2P[I6W%4P$IXZ.*YM%T^\Y7XI_\
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MW>N]UY>7X>:OYAX/\:_\(I;W47]G_:_M#*V?.V;< _[)SUKH_P#A<7_4"_\
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M1'SI'D&7./7'"CGU-:WP=_YC/_;#_P!J5WEEX?TG3K%[2TT^!().)$*;M_\
MO9SG\:L6>FV.G!QI]G;VH?&X01*F['3.!S1/$T_8NE"-D%'+ZZQ4<36FFUO]
MS6AY!\4?^1T;_KWC_K7HOP__ .1$TW_=?_T-JV+O2=.U"19+_3[6Z=1M#30J
MY ],D58AABMX5BMXTBC085$4*J_0"LZN(4Z,:=MC?#X"5'%SQ#E=2OI\[CZQ
M/%GAV/Q+H4EH2$G4^9 Y'W7'K['I6W17+&3A)2CNCT:E.-6#A-:,\ LKO5_!
M/B L8F@N(_EDBD'RR+Z>X]Q7>P?%W3C;DW.G7238X6,JRD_4D']*[B_TRQU2
M'RM1M(;E!T$B X^GI^%8C?#SPLS;CI0S[3R ?ENKT98FA6UJQ=_(\*GE^-PK
M<<-47+V?_#,\:UW4_P"V==NM06+RA<2;@F[..W6O>]"5D\.Z<C@JRVL0((Y!
MV"H+#PMH>F/OLM,MXWSD.5W,/H6R16M66)Q,:L5&"LD=.78"IAISJ5)7<NQ\
MW1S_ &755G*[O)F#[<XSALXKT&7XPR&)A!HJI)CY6>Y+ ?4!1G\Z[^3P[HLL
MC22Z/8.['+,UJA)/J3BFCPWH:G(T73P?46J?X5M4Q="K;GA>WF<=#*\9A[JC
M523\CQ2VL-8\::_++'$TLT[[I9<82,>Y[ #H.O%>RWMC'IG@>ZL8.8[?3Y(P
M3WQ&>:UH88K>,1P1I$@Z*B@ ?@*<ZK(C(ZAE88*D9!'I7/6Q3JM65DNAWX/+
M5AHR;E>4MV>&?#K_ )'[3O\ MK_Z*>O5/'&E_P!K>$+V)5S+$OGQ_5>?U&1^
M-:=MHNEV<XGL]-L[>49Q)% JM^8%7:=?$^TJJI%6L+!Y?[##2H3=^:_XI(^:
M(8GGGCAB7<\C!5 [DG KZ+TG3TTK1[6PBQMMXE3([D#D_B<FF1Z%I$-PL\.E
MV4<RG<LBVZ!@?7.,U?IXK%>W225DB<MRWZDY2D[MGSYK_P#R.FI_]A"7_P!&
M&O=-<TP:QH=WI[$+Y\156/0-U!_/%+)H>DS7)N)M+LI)F.XRM;H6)]<XS5ZE
M7Q/M.3E5N4K!Y>\/[53=U/\ X/\ F?/^BZE=>$/%"SS6Y\VW9HYH&."0>"/Z
MC\*Z7Q=\1X=;T5M.TRVFA6;'G/-@' .=HP3W Y_2O2-5\.:1K3!M3L(IW P'
M.5;'IN&#5*U\"^&K.998=*C+J<CS'>0?DQ(KH>+H3DJDXOF1P1RS&4H2HTJB
MY'WW_+]3DOA7X<GCFDUN[B*1M&8[;<.6R>6^G&/Q->FT !5 48 X ':BN"M6
M=:;FSVL'A8X6BJ40HHHK$ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** .._X5AH?]I?;/-O=WF>9Y?F+MSG./NYQ^-=C116DZDZEN9W
M,*.'I4;^SC:X4445F;A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFO"_!W_(Y:5_U\K7=A\/&K"4I/8\?'XZIAJU.G!*TM[^J/H"BBBN$]@****
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MJL57LO\ 4G_>_I5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$5C T\+6URR G;;RMO\ P! S]!7IRP,(6YJEK^7_  3YVGG%6KS>SHMI>?\
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M5Y;#X:\8>,<7E[(RQ2<J]W(47U^5 "0/H,5ZYJ>I6ND:=+>WTGEPQ#+'J3Z
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MJMC(4&J%-25][I=%YGI<<B31+)$ZO&ZAE=3D,#T(/<5\^^*_^1OU;_K[D_\
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M[(9U<X]< UYCK/PO_LC1;K4/[7\[[/&7\O[+MW>V=YQ65\-O^1[LO]V3_P!
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MLXKV1Y;A&A$KN<DMM.>?K7#>"M-;6O&5HLPWHCFXF)&<A>>?J<#\:]%^*?\
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M/H:\ZT3PMKOBKSKVV?(0\SW$I&]NN >235_XHS-+XT=&/$4"*OL.3_,FO1_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"<CISMSPV*H4:DG=VZ:'3F&58[%X>"LN9;ZJWY_U9]F=[H__ " [#_KVC_\
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MI_\ (F_]O*?UJ[I-R=(TN&PTO0M0:%03;^8 ID7.6+YQL;/0-@G(]]L6O?\
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M^(^F:A8QQZQ<)9WJ@*YD&$D/]X'H/H<5G_$GQ#I%]X<%E9:A!<SF9'VPMO&
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M<72]@Z53Y:"Q63XMXV&)HI>>J7]:?D^S.C^(>E?VGX.N2BYEM2+A./[OWO\
MQTFO&+?4KBVTV[L8G(ANRGFC/7:<BO=)-;EN(FC70[Z1)@4B61 GF'^(-D_(
M!SRV,X.,\9XA_ NDRN6M]-U[$AQ I:- Q'W@VY?D ]6ZX.,\9O"8VE3@X5/R
M,LTR3%UZJJT4KVL]4OZTO?T?9VN?"32_+LKW5)%YE801GV'+?J1^5:?Q3_Y$
MW_MY3^M7=)NAI&EPV&EZ)J!A4%;?S5"F1LY??G[F"3RV,X.,\9BUYE\2:8;&
MXT?4_*D<- RA8V9UZ[MWW .>6ZX.,\9P>*A+$^U>USLCE->& >'BE>W=;O\
MK\'V=N-^$?\ R,EY_P!>A_\ 0UK0^,7_ #!O^V__ +3K2\.:1:^&[R6YTK2M
M8FDN(_*B^T[%#8(+ \#9C'5NN#C/&9O$EC!XK6W%UI.K Q;A:F/;'O)QO#[@
M=@&W@MC.#C/&=GC*3Q2J]/3R.2.38Q9:\,TN9^:[I_UZ/L[4OA#_ ,@74/\
MKX'_ *#7*?$W_D>+C_KE'_Z#7>>'8(O#=G+;Z3I&JRK<ONC:YVJ78##!N@C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?[Y_D*N53TS_ (]F_P!\_P A5R@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "J6J?\ 'JO^^/Y&KM4M5_X]5_WQ_(T &E_\
M>K?[Y_D*NU2TK_CU;_?/\A5V@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ JCJW_'HO\ OC^1J]5#5_\ CT7_ *Z#^1H
M72?^/1O]\_R%7JH:1_QZ-_UT/\A5^@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ JAK'_ !YK_P!=!_(U?K/UG_CS3_KH
M/Y&@!='_ ./-O^NA_D*OUGZ-_P >;_\ 70_R%:% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445YOX
MM^//@;PAJ$MA<WTVH7D)VRP:?$)-C=U+$A<CN,Y'>@#TBBO*O#_[1G@'7KV.
MT>XO=+EE8(GV^W"JQ/3YD9@/J2*]!\2^(M/\)^'+S7-8=DLK- \A1=S')"@
M=R20/QH U**X'X??&/PU\2=1N;#0X[ZWN[>+SFBO8E4LF0I8%68<%@.N>:[Z
M@ HHHH **** "BBO./BW\7$^%D>E$Z,VJ/J1EVJ+GR0@CV9R=K9SO';M0!Z/
M17.^ ?%J>.O ^G>(XK1K);T2?N&DWE"DC(?FP,\J3T%=%0 4444 %%%% !11
M7B_B']HB+0?B9+X2'AI[A8KM+5KO[:$.6(&0FP],_P!Z@#VBBBB@ HHHH **
M** "BBB@ HHHH ***\[\>?&WPI\/=:32=76^NKTQB1XK*)7\I3TW%F4<]<#)
M_.@#T2BJ6BZO::_H=EJVG,S6M[ L\)==IVL,C([&KM !1110 4444 %%%% !
M17G'CGXY>$O /B#^Q=56_NKU45Y4LH5<0AAD!BS+R00<#/!%=YI6I6VLZ/9:
MI8,7M;VW2XA9EP2CJ&4D'IP10!;HHHH **** "BBB@ HJ&\N[?3[&>\O9D@M
MK>-I9I7.%1%&68GT !->>G]H+X8@_P#(S?\ DA<__&Z /2**X?2/C-\/=;N%
M@L/%%F)';:JW*O;[CZ#S%6NX!R,CD4 %%<3;_&+P'=>)E\/P>((WU-[G[*L/
MV>4*TN[;M#[-IYXZUVKNL:,[L%51DL3@ >M "T5P^E_&7P#K.O0Z-IGB&.XO
MYY/*BC6WF"NWH'*;3^==Q0 45YM\=_&D_@SX97$NFW+6VI7\JVMK)&V&0GEF
M'IA5//8D5S'[,]SXEUCP]J^M>(]:U+4;>6X6WM%O;EY0I09=AN)/.Y1Q_=-
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MJ-J,*HC'_>5F _$BO50<C(Y% !1110 4444 %%%% !1110 45XMX_P#VB8/
MGCV[\-OX;DOEL_*\VY%Z(\[XU?A-AS@,.I%>TT %%%>"-\>?$&B_&J3PCXJT
M[3(-,6_^R^?"D@E5'_U4A)<C!#*3\HX)H ][HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L[6O^/)/^
MN@_D:T:SM;_X\D_ZZ#^1H -%_P"/)_\ KH?Y"M&L[1/^/)_^NA_D*T: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCA02<D@<#O6;X1\?^&?'4=T_A75!?BS*B?\ <R1E-V=O#J#SM/3TKF?V@_\
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MQL[=6**R9/J3MZU\F?#/P?<>/O&EMX<CO6M+6?\ ?73*?^6:<G Z%N<#/3-
M'TG+^T_X!CU+[,B:M+%NQ]K2U7R\>N"X?'_ :]3T76].\1:/;ZKHMW'>65PN
MZ.6,\'U'J"#P0>0:\%^+OP&\*Z#\-;K6/"MM-:7NF*LDA>X>07"9 ;<&) (!
MS\N!QC'-9_[)_B&<:EKGAR20M T*WT2$_<8,$<CZ[D_(4 >??M!_\EV\0_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5FZY_P >*?\ 70?R-:59NN_\>*?]=!_(T &A_P#'B_\ UT/\A6E6;H7_ !XO
M_P!=#_(5I4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% &;KWB'2O#&EG4M?O8[*S$B1F:0' 9C@#@>IZ
M]!U/%6U:TU.P!4PWEI<)P1B2.53^A!KG/B1X)C^(/@>[T![HV;RLLD4X7<%=
M3D9'<'I^-?./_"F/C/X59[3PU>7+6S$DMI>L>1&WU5G0_I0!C?M!>&O#_ACX
ME"U\,1Q6T<UHD]Q:P_<@E+,, ?PY 4[>V>.#7LP^TC]CC_3=WF?V)\N[^YN^
M3\-FVN(\'?LS:]J6M+J'Q"O8X+;S/,F@BG\V>X.<D,XX7/<Y)^G6O?O&?A=M
M?^'6I>&]),%H;BS^S6^\$1Q@8"C@' &,<"@#P']DW_D9O$/_ %YQ?^AFN1_:
M._Y+9J?_ %PM_P#T4M>V? _X/Z[\--5U6[UV]T^X%Y"D4:V<CMC#$DG<B_UK
M#^+'P$\2>._B)<Z]I&HZ5#:W$<2%+J2174JH4\*A!Z9ZT >\:=_R"[7_ *XI
M_P"@BOB;P=_R<5IW_8P?^UC7VY:Q&"TAA8Y,:*I([X&*^?-!_9Y\1Z5\7+?Q
M+/JNEMIT&IF]"HTGG,N\L!M*8![?>_.@"K^UAK6GLVA:&;0/J,8:\%R6P8HF
MRFP#ON9<^VP>M8FG>"_CHGA&#P_HMXL_AZ[MQL>"]MR@C<9*AR?, YQA>.?2
MI?VI_$&G7GBK3]$@L4-_80[Y[TDA@K\K$!G!'\62#U&,<YR[#]F3Q^]C!?1W
MFDV<SQA_(>ZE66/(^Z<1D \\X- 'L_P5^#Q^&MI=7VK7$5UK-\@C<PY,<$8.
M=BD@$DG!)]ACID\%^US_ ,RC_P!OO_M"N!\#>,O&'PW^*5OH6H7UU)"E^MG>
MZ?).98V#,%)4$D \Y!&,\=N*]W^.?PIUGXG1Z&="O+"W?3C/Y@O7=0PD\O&"
MJMT\O]: ,+PC9RW_ .Q?+!;J6D.G7SA0,D[;B5L#\J\2^#?@OP[X]\92Z)XF
MO[NSWVS26OV61$:60$97+*V?EW'&.QKZV^&7A&Y\%_#33/#>JRV]S<6JRB9H
M<F-M\KO@;@"1A\<BO#/'/[,^MVFNR:C\/KF&:U>0RQVLDWE2VYSG"L>"!V.0
M1P.>M '9_P##*G@C_H*^(/\ P(@_^,UZ#\/_ (<Z+\-](N-/T&2[F2YF\Z66
M[D5W8X  ^55& !Z5\ZK\,OCU?H+:]O=62#IBXU\,GIT$I[>U?0'PD\(:GX'^
M'=KHNN7$4]XDLLKF%RZ+O<G ) SZGCJ3]: .VKXN_:.L7M/C9J<S@A;R"WF3
M/<")8^/Q0U]HUY9\:_A!_P +)T^VO=)FAMM:L5*1M-D)/&>?+8CD8.2#[GUR
M #O/#.L6FK^#M,U:UE0VMQ9QS!RW"C:,@GMCD'TP:^,O%6K66N_'ZXU+2YQ<
M6D^LQ&*5>C@.HR/;BNHTGX&_%V2)M!DEETO1Y6_>J^J@V[#/)\I&)/XK743?
MLOZII_BK2;K0-6L9+"U,,ER]V[K+)(K9<JJH5QZ#=]?6@#5_:QL99/"N@7R@
MF*"\DB<XZ%TR/_0#6S^S!JMK=_"V73XI%^U6-[)YT>>0'PRMCT/(^JFO2_&/
MA/3O&WA6\T+5U;[/<KPZ?>B<<JZ^X/Y]#P:^8KOX ?$_PEJ[S>#KHW(.52ZT
MZ_%K(5_V@S+CZ F@#N_VK]8M8_"&C:+YBF[FOOM8C'4(D;ID^F3)^.#Z5J_L
MT0?V-\&;K4-2DCMK6?4)[L32L$58E1$+$G@ &-N?:O.]!_9S\<>)]=6^^(.H
M&TB9@;B2:[^U74@] 06'MDMQZ&OHC5?!MG<?#:\\(:1ML+633WLK<X+"(%"H
M)[GGD]SS0!YOXT_9P\,>+'DU;PK??V/<7(\T"("6UE)YR%!RN?53CVKQOX7:
MUKWPX^-=MX=:YS'+JBZ9?VT<I:&0M)Y>\#U!((. >,=R*UQ\&OC1X:#V'A^Z
MNFLV)!_LW61#$WOM9T/.?2NU^$G[/FIZ#XHM_$WC:YA-Q:OYMO9POYA,O9Y'
MZ<'D 9YP<\8(!YW^TO92VOQDN)I 0MW9P2QG'4!2G\T->C>&/V<? 'B7PMIN
MLVFM:Y+'>6Z2YCN8<!B/F7_5<$'(P>1BN]^+OPFM/B=I$!CN%LM6LMWV:Y9<
MJP/5' YP<=1R#Z\@^#V_P<^-/AAY+;PX]W% S99M,UE8$<^N"Z'\Q0!Z]HG[
M-/@O0]>LM5AO=:N);*=)XXI[B(HS*<C=MC!QD#N*]?KYT^&7PD^(]E\2-+\2
M>--0/DV)D9A<:@UQ*^Z-EP,$CJW.2.,]:^BZ .-^+NK#1?A#XDN]VUFL7@4@
M\AI<1C]7KPG]E#2/M'C#6]789%G9+ O'1I7SG\HC^=>W?&#P7J_C[P$VA:#=
M6MM/)<QR2&[9E1D7)QE58YSM/3M6?\%/AE>_#3PW?VNKW-K<WM[<B5FM"Q14
M"@*,L 3SN/3O0!\__M':JVL?&>YLXLN-/MX;1 .<DCS#C\9,?A7UMH>GP>&O
M"5AI_P L<&FV<<1/8!$ )_3->'7'[/WB74_C')XJU75-+;39-6^W-&CR&4Q"
M3<(]I3&=H"_>KW#Q1IUYJ_A'5M-TR:."\O+.6"&67.U&="H)QSQGWH ^/_A-
M$_C']H:POYXR_FW\VI2[C]TC=*"?^![?Q-?:M>'_  6^!VL_#OQ9=:UX@O=/
MN"UHUO!'9N[8+,I+$LB]EQWZU[A0 5\1"YB\&_M)//=R""UL?$3&21NB0F8Y
M8]?X#FOMVOG3XF?L[>(_%OQ"U/7M"U'28K6^99/+NI)$=&"*&^[&P/()SGO0
M!YW=/?\ Q]^.FV#?%92/L5L?\>UE&?O'W.2?]Y\5]&_%ZYMO"OP*UN"RC$$"
MV*V$$2<!5<K$%'T5C^ IOP?^%4'PST&9;B6*[UB\(-U<Q@[0H^ZB9&=HZ^Y/
ML,2?&;P-K7Q"\$Q:+H%W:6L@O$GE-V[JKHJL-N55CU(/3M0!Y!^R;I'FZ]X@
MUEE_X][:.U1B.OF,6;_T6OYT[]K2QV:SX:U #_76\\!/^XRL/_1AKUGX+_#>
M\^&OA&ZT_5;FVN;VZNS/(]KN**NU5506 )Z$]!UJO\;?ACJ'Q,\/Z?;:-=6E
MM>65P9 ;LLJ,C+@C*JQ!X!Z=J /GKQG\3?[7^#_A/P9IDA;R+=6U$J#RR,RQ
MQ?@!N/U7TKZ'^#W@.3X>_#(K<1[-8O4-W=Y7E'V_)'_P$?J6]:X;X8?LWWGA
MKQ;#K7C&\T^\2S/F6UM:,[JTHZ,Y=5X'4 9YQZ5]!T ?#_P+>%_CEX>>_<;6
MFE.YSUD\F3;U[EL?C7V'XT\5V/@KPC?ZYJ4BJEM&3&A/,LA'R(!W)/\ 4]!7
MSW\0/V;?$$'B2XU7P T-Q:32F>.U,PAFMV)SM4G"D ]#D$<>F:RH?@7\6?%]
MY!'XOOI88(3A9=3U/[48U[[%5G_+C\* ,;X :!=>)_C)::C,#)%IQ>^NI67.
M6Y"^V2[ _@?2OL^N2^'7PZTCX;^'?[-TG=--*P>ZO)!AYW]<=E'9>WN22>MH
M Y+XJ_\ )(_%'_8+G_\ 0#7RI\!O"6B>-/B))IGB6R^VV:V$DPB\UX_G#( <
MH0>Y[U]?^,-$E\2^"]8T6WF2&6_LY+=)'!*JS*0"<=LUY'\&?@=XA^'GC6;6
MM<U#3)HFLWMTCLY)'8EF4Y.Y%P/E]Z /0]"^$G@/PW=)<Z3X9LTGC.4EFW3L
MA]09"Q!]Q79444 ?"GA[_DX#2_\ L9XO_2H5WG[2/PU.@Z^OB[1X-NGZE)B[
M6->(+CKN]@_7_>!]170Z9^SGXEL?BM:^(I-5TIM.M]76_P *TGG,BRB3;MV8
M!.,?>KWSQ%H%AXH\.WNBZO%YMI>1&.0=QZ,/0@X(/8@4 >=? 3XF_P#"<^$_
M[-U2;=K>E($F+'F>+HLON>S>^#_%57]I;Q5_8?PR&E02;;G6IA!@'!\I,-(?
M_0%/L]<EX(_9^\;^"/B#8ZU8:]I'V2WGQ*0\OF30'[RE-F,D?[7!P<\5Q7[0
M>OS>+_C"NAZ;F==.V6$$:_QSL07Q[[B%_P" T >F?LL^%OL'@[4/$<\>)=4G
M\F!C_P \8^"1]7+#_@ KW>LGPKH,/A?PGIFB6V#'8VR0[A_$P'S-^)R?QK6H
M ^"?".E6>N?%W3=+U2'S[.[U413Q;BN]"^",J01^!KZYTWX(?#C2K@3VOA:U
M=P<@7,DEPO\ WS(S#]*\N\+?LZ>)="^)]CK]SJNE26%I?BZQ&\GFNH;(&TI@
M$_[W'O7T=0 V**.&)8H46.-!M5$& H] *^,?VCO^2V:G_P!<+?\ ]%+7VA7@
M/Q=^ GB'QWX_FU_0M0TR*&>"-'CO))$965=O&U&&, =_6@#V'PC-'!\/M"EG
MD6.-=,MBSNP '[I>I-?/O[2/Q0TK7;.U\)^';N.]2&?[1>W,#[H]R@A8P1PW
MWB21P, >N,I/V4_&ID EU;053/)6>8D?AY0KN/!W[+>E:9?1WGB[5#JWED,+
M.",Q1$_[39W,/8;?QH TOV8O"L^B?#VZUB\C,<FM3B2($8)A0$(?Q)<CVP>]
M>U4R**."%(8(UCBC4*B(N%4#@  =!3Z .5\:>$_"OC^W_P"$?\1>3-=1)Y\2
MQS!;FW4G;YB]P"1CD%3CG.*^8OBU\$;CX8V<&N:7J_VS3GN1$OF+Y<\+D%EY
M'#?=/(P1QQWKU/XU_"#Q3XM\86OBCP=>0K<0VJP&$SF&565F(9'Z=&QR1T[Y
MX\Y_X4E\8/%MU#!XJN9E@C/RRZIJPN%C'?:%=S^@H ]K_9^\7:EXO^%ZSZU,
M]Q=6%V]D;B0Y>555'5F/<X<#/4XR:^<O@ ZP_'3P\92%&ZX7GU-O* /S.*^M
MOA]X)L_A]X.M=!L)3/Y9,DUPR[3-(WWFQV[ #G  Y-?/'C?]GGQGI_C*YU/P
M,B7EI+<FXMC#=+!-;$G=CYBOW3T(/ITH ^H-9A-QH5_"#@R6TB XZ94BOCC]
MG>XB@^-FD^=(L?F1SHFXXRQB; ^IKZ&^"?A7QEX;T;4Y/']]-<WM[.C1QSWA
MN7C55(.6R1R3T!/2O(_'G[./BBQ\4SZCX"2.\L99O/MXDN%@FM23G:"Q PIZ
M$'/% 'J7[2&MZ?I_P?O]-NKA4O-3DA2UAZM(4F1V./0*O7U('>N%_9&_YF[_
M +<O_:]0:-^SKXK\1VM[J?Q$UIY-3-H\5C!/=M<,DFTA#+)DX53SM4G^A] ^
M!GPIUGX8QZX==O+"X?43!Y8LG=@HC\S.2RKU\S]* /G7QH1X:_:&U.ZO0PCM
MM?\ MKC'.PS"7^1K[8NM5L++1Y-5NKN&*PCA\]KEG&P1XSNSZ8KQWXW? ZY\
M=:BGB'PO)!'JHC$=S;S'8MR!]U@W9@..>" .1CGSC1?@3\5-:C@T7Q%?3:5H
M43 F*XU$3QH!W2)'89],X^M '+?#.ZBOOVA=*N[<DQ3ZM)(A(QE6+$?H:^K_
M (I^$_\ A-/AKJ^D(F^Y:'SK7U\Y/F4#ZD;?HQKROPU^SMJGA;XM6&NZ?J%B
MVAV,XD1))7-RP"8Y&S;DG/?'\J^@J /A'P3\0KKP=X7\5Z1#YA&M60@B(;'E
M2;MI;V_=O)R.X7\/7?V4?"XVZUXIG3G(L+9B/H\G_M,?G7DOQDT.R\._%O7;
M'394D@,_GA$'^I,@#F/\"W;MCOFOK[X6^&!X0^&>BZ2RXG2W$MQ_UU?YW'X%
ML?0"@#K:Y3XHVC7WPG\3PHI=O[,G<*.I*H6_I75U'<V\=W:RV\Z[HID,;KZ@
MC!% 'RC^RI<K'\2-4MVZS:4Q4Y[K+'Q^OZ5]5WE]::=;^?J%U#:P[E3S)Y B
M[F.%&3QDD@#U)KXT^%\DWP^_:'L]-U$E/*OI-,F)&-V_,:GZ;BASZ5]2?$[P
M0WQ!\"76@Q7:V<TCI+%*R[E#*<X(]#R/;WZ4 ==7Q]^TX=*/Q83^S/+^U"PC
M^W>7C_6[FQN_VMFS/MMJW)\)OCCHD?\ 9VDWU_-9H-JBQUSRXL>RNZ''X5L>
M"?V8M7NM7CO_ (@7<,5J)/,DLX)3)+.<Y(9QPH/<@DGGIUH V=:T:[N_V+K%
M61S-;6T5V%/4Q^=G/TV-GZ"LK]DS6(8M2\1:/+(!+<10W,*$\D(65_K]]*^D
M+C3;.ZTF32YK:-K&2 V[0;<*8RNW;CTQQ7RWXC_9R\:^'/$+7WP_NOMD"N6M
MI(KL6US"#V))49 .,AN?0=* .S_:NUB"+P;HVC"4?:;B^^T[ >=D:,N2/3,@
M_+VJY^S?H\EA\&-1OIE*_P!I7,\L9QUC5 G_ *$KUY_HW[/'C_Q9KB7GC^_:
MTBX$T]S>"[N74'[JD,P_$GC/0]*^GK'1+32?#<6BZ5$+>TM[;[/"G7:H7 R>
M_N>] 'R!^SC_ ,ELTS_KA<?^BFKW_P#:,_Y(CJO_ %VM_P#T<M<A\)_@)XD\
M"?$2VU[5]1TJ:UMXY4"6LDC.Q92HX9 !USUKT_XK>#[WQW\.[[0-+GMX+J=X
MG1[DL$^5PV"5!/;T- 'E/[)7_((\3?\ 7>W_ /07K,_:V_Y"GA?_ *XW/_H4
M=>C_  /^%^L?#/3=7AUV[L;B2^EC=/L;NRJ%##DLJ\_-Z53^./PDUOXF7.CS
M:%>:?;FP25)%O7==V\J0051O[M &A\+O^3;-/_[!ES_Z%)7SS^SWK-AHOQ?L
M9-4N4MH[B&2WCDD.%\Q@-H)[9(Q]2*^G_#OAFX\'?!A= O9XI[BRTZ=))(<[
M"2';C/..<5\@?#7P/_PL+Q3)H27?V.9K22:&4KE=ZX(##K@]..1UYZ4 ?6_Q
MOUFWT7X.Z\UPZJ]W;_9(4)Y=Y#MP/H"3] :\1_90L))/'FM:@,^5!IOD-_O2
M2HP_]%&LR_\ @;\7M9O(=/U=GO+6VRD%Q=ZJ)88Q_LJ6+@?1:^B/A7\-[7X:
M>%3IT<RW5]</YMY=!=OF-C  '90.!]2>] 'RY^T'_P EV\0_]NW_ *315<^+
M?@J^^$OQ+@U;P\SVUC<3?:]-F0<0.#EHO^ D].ZD=>:])^*'[/WB7QO\3-1\
M0:7J6E0V5[Y/RW$D@D39$B'A4(/W<CGO7KOQ$\#67Q"\&W6B7I6.5OWEK<%<
MF"8?=;Z<D$=P30 SX;^.K3XA>"[76;7;'/\ ZJ[@!SY,P W+]#D$>Q%>7_M8
M7"KX,T*V/WY-0:0<]EC(/_H8JY\&OA#XS^&OBBYN-0U?2YM(NX2D]M;22,SN
M/N, R* 1D\YZ$UP7[5>NK>>-M)T6-LC3K1I7YZ/*PX_[Y13^- 'I7[,-F;7X
M0M*5Q]JU&:8'UPJ)G_QS]*]BKE?AEX>;PK\,=!TB5/+FAM%>=#_#*^7<?@S$
M5U5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5F:]_QXI_UU'\C6G67K_\ QX)_UU'\C0 N@_\ 'B__ %U/
M\A6G67H'_'@__74_R%:E !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI\?ZC'=WD,_VF.VBD:4O-G(>60]2&YP,Y.,GJ*^@*** "BBB@ HHHH ****
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M\/EO'MK !'EV_P!]P69L9P2$7 STR?6C]HXK??$_P1IL#;K@L,J.2 \R!?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1]0?\)9X<_Z#^E_^!L?^-'_"6>'/^@_I?_@;'_C7R_11]77</[8J?RH^H/\
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M7R_11]77</[8J?RH^H/^$L\.?]!_2_\ P-C_ ,:/^$L\.?\ 0?TO_P #8_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K(\2?\@V/_ *ZC^1K7K(\2_P#(-C_Z[#^1H /#?_(-D_ZZG^0K7K(\
M-?\ (-D_Z['^0K7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ$WP_P#^"N#_ .)KI** .;_X5QX(_P"A-\/_ /@K@_\ B:/^%<>"/^A-\/\
M_@K@_P#B:Z2B@#F_^%<>"/\ H3?#_P#X*X/_ (FC_A7'@C_H3?#_ /X*X/\
MXFNDHH YO_A7'@C_ *$WP_\ ^"N#_P")KY?_ &E=$TK0?B1I]KH>F6>FV[Z3
M'(T5G;K"C,9I@6(4 9P ,^PK[$KY)_:K_P"2IZ;_ -@:+_T?-0!L_LJZ3IVJ
M?\)7_:>GVMYY?V/9]HA639GSLXR#C.!^5?0W_")^'/\ H :7_P" 4?\ A7@G
M[(W_ #-W_;E_[7KZ2IW9#IP;NT9'_")^'/\ H :7_P" 4?\ A1_PB?AS_H :
M7_X!1_X5KT4<S[B]E3_E7W&1_P (GX<_Z &E_P#@%'_A1_PB?AS_ * &E_\
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M<_Z &E_^ 4?^%:]%',^X>RI_RK[C(_X1/PY_T -+_P# */\ PH_X1/PY_P!
M#2__  "C_P *UZ*.9]P]E3_E7W&1_P (GX<_Z &E_P#@%'_A1_PB?AS_ * &
ME_\ @%'_ (5KT4<S[A[*G_*ON,C_ (1/PY_T -+_ / */_"C_A$_#G_0 TO_
M , H_P#"M>BCF?</94_Y5]QD?\(GX<_Z &E_^ 4?^%'_  B?AS_H :7_ . 4
M?^%:]%',^X>RI_RK[C(_X1/PY_T -+_\ H_\*/\ A$_#G_0 TO\ \ H_\*UZ
M*.9]P]E3_E7W&1_PB?AS_H :7_X!1_X4?\(GX<_Z &E_^ 4?^%:]%',^X>RI
M_P J^XR/^$3\.?\ 0 TO_P  H_\ "C_A$_#G_0 TO_P"C_PK7HHYGW#V5/\
ME7W&1_PB?AS_ * &E_\ @%'_ (4?\(GX<_Z &E_^ 4?^%:]%',^X>RI_RK[C
M(_X1/PY_T -+_P# */\ PH_X1/PY_P! #2__  "C_P *UZ*.9]P]E3_E7W&1
M_P (GX<_Z &E_P#@%'_A1_PB?AS_ * &E_\ @%'_ (5KT4<S[A[*G_*ON,C_
M (1/PY_T -+_ / */_"C_A$_#G_0 TO_ , H_P#"M>BCF?</94_Y5]QD?\(G
MX<_Z &E_^ 4?^%'_  B?AS_H :7_ . 4?^%:]%',^X>RI_RK[C(_X1/PY_T
M-+_\ H_\*/\ A$_#G_0 TO\ \ H_\*UZ*.9]P]E3_E7W&1_PB?AS_H :7_X!
M1_X4?\(GX<_Z &E_^ 4?^%:]%',^X>RI_P J^XR/^$3\.?\ 0 TO_P  H_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** .;^(_\ R2SQ7_V!;S_T0]?-O[*G_)4]2_[ LO\ Z/@KZ2^(_P#R2SQ7
M_P!@6\_]$/7S;^RI_P E3U+_ + LO_H^"@#ZVHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\3?\ (-C_ .NP
M_D:V*QO$_P#R#(_^NP_D: %\,_\ (-D_Z['^0K8K&\,?\@R3_KL?Y"MF@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BO(-;_:5\'Z#KU]I-YINN//8SO!(T4$)4LI()!,H../051_
MX:K\$?\ 0*\0?^ \'_QZ@#VVBO$O^&J_!'_0*\0?^ \'_P >IT?[5'@F2147
M2]?RQ &;>'_X]0![712(P=%8=&&12T %%%% !1110 4444 %%%% !1110 5\
M2_L^?\EV\/?]O/\ Z32U]M5\2_L^?\EV\/?]O/\ Z32T ?;5%%% !1110 44
M44 %%%% !1110 4444 %?)/[5?\ R5/3?^P-%_Z/FKZVKY)_:K_Y*GIO_8&B
M_P#1\U '2?LC?\S=_P!N7_M>OI*OFW]D;_F;O^W+_P!KU])4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1139)$AB:25U2- 69F. H'4DT .HJE8:SIFJ,ZZ9J
M-I>%!EQ;SK)M^N"<5=IV:W$I*2N@HHHI#"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***1F5%+.0JJ,DDX % "T51L=;TK
M4YFBTW4[.[D0;F2WN%D*CID@&KU-IK<2DI*Z84444AA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S?Q'_P"26>*_^P+>
M?^B'KYM_94_Y*GJ7_8%E_P#1\%?27Q'_ .26>*_^P+>?^B'KYM_94_Y*GJ7_
M &!9?_1\% 'UM1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !6-XH_Y!<?\ UV'_ *"U;-8OBG_D%Q_]=A_Z"U "
M^%_^07)_UV/_ *"M;-8OA;_D%R?]=C_Z"M;5 !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >0:W^S5X
M/U[7K[5KS4M<2>^G>>18IX0H9B20 8B<<^IJC_PRIX(_Z"OB#_P(@_\ C->V
M].M?'7CKXP>./&'CBZT_PG?ZE:VB3O#9V>E;EED"DC<2GS,3C.,X% 'K'_#*
MG@C_ *"OB#_P(@_^,TJ?LL>"(G63^U=?^0[N;B#''_;&OG^U\1_%2]U6;3++
M6?&%QJ%OGSK2*ZNGECP<'<@.1@GN*DT@?$3QWX@'AI]7U:^N4;,MCJ6ILF-I
M^;*2N,D=P 3QTH ^YT4+&JKR  !2TV)2D**>H4 TZ@ HHHH **** "BBB@ H
MHHH **** "OB7]GS_DNWA[_MY_\ 2:6OMJOB7]GS_DNWA[_MY_\ 2:6@#[:H
MHHH **** "BBB@ HHHH **** "BBB@ KY)_:K_Y*GIO_ &!HO_1\U?6U?)/[
M5?\ R5/3?^P-%_Z/FH Z3]D;_F;O^W+_ -KU])5\ >$?B#XG\"?;/^$4U/[!
M]MV?:/\ 1XI=^S=M^^K8QO;ICK72_P##0?Q._P"AF_\ )"V_^-T ?;5%?$O_
M  T'\3O^AF_\D+;_ .-T?\-!_$[_ *&;_P D+;_XW0!]M45\2_\ #0?Q._Z&
M;_R0MO\ XW1_PT'\3O\ H9O_ "0MO_C= 'VU17Q+_P -!_$[_H9O_)"V_P#C
M='_#0?Q._P"AF_\ )"V_^-T ?;5%?$O_  T'\3O^AF_\D+;_ .-T?\-!_$[_
M *&;_P D+;_XW0!]M45\2_\ #0?Q._Z&;_R0MO\ XW1_PT'\3O\ H9O_ "0M
MO_C= 'VU17Q+_P -!_$[_H9O_)"V_P#C='_#0?Q._P"AF_\ )"V_^-T ?;5%
M?*WPQ_:,\0+XN@L?'U['?Z9?ND/VEHHH#9,3@2$J%4IS\V[H!D'@AOJF@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ^?KSXF^-)]=GMM.OV^:X:.&WB
MM(W/WL!1\A)-/N?'WQ'TC;+JC74$9.!]JTY8U/X[!7/:3>V^G?$*VO;V3R[>
MWU$22/M)VJ'R3@<FO4/&WQ-\,7_A*^L-.G;4)[J(QJGD.JH3_$2P'3J,9Y K
MU)146DH7/D*52=2$YSKN+6ROO\KFK\.OB&?& FL[^".#4+=/,/E9VRIG!(!Z
M8)'?O53XM>+=8\,1:4NB7(MFNC*9'\M7)"[,#Y@?[QKG?@OX:O5U277KF%XK
M3R#% S#'FL2,D>H !Y]?QJQ\>?\ F _]O'_M*L.2'UCE6QZ#KUWEKJ2;4N_6
MUT<_9^-_B7J%M]HT][ZZ@R1YL&F(ZY'49$>*GL/C!XHTN]$>M0Q7:J<212P^
M3(/H0!@_4&NZ^#7_ "3]?^OJ3^E7?B7X9M==\(WEPT2_;;&%IH90/FPHR5SZ
M$9X]<4W.GS\CBK$0P^)^KJO"J[VO9FAIOBB#Q+X1N=3\/DO<+"^V%AEXY0I(
M4CZX^M>4_P#"3_%C_GWU7_P4+_\ &ZC^"^J2VGC-[ ,?)OH&#+GC<@W _EN'
MXU[W42M0FXVN=%'GS"C&ISN+6CL?.MM\3/'=Y<);V>I23S2'"1Q643,Q]@$R
M:Z/0/$7Q-G\2:=%J5OJ/V.2YC6X\W3%11&6&XEM@QQGG-<=\./\ DHNC_P#7
M8_\ H)KZ8K6O*--\JBCDRZG6Q,?:2JRT?=GAOB;QYXU\+^,+FQN=162&&7?&
MC6T066(G*\A<\CCKP<U[)I.KVVL:';:I;.!;SQ"3)/W?4'Z'(/TKB/C!X5_M
M?0%U>TCW7>G@EP!DO#W_ .^>OTS7END^.+[2?!>I>'X<E+QAY<F<&('B0#Z@
M ?B:GV:K4TXJSZFGUF>!Q$X56W%JZOK_ %V.EU+XE^*-9\9M8^%+P16TTX@M
M8Q!&V\9QN)92>>OL*]O@61+>-9W\R15 =P,;CCDX[5Y)\%O"V!+XDNTY.8;0
M'\G?_P!E'_ J]>K+$<JERQ6QVY:JLJ;K56VY;+L@K+\0>(]-\,:;]MU>?RXR
M=J*HRTC>BCO6I6!XI\'V'BY+./5))EBM9#)MB8#?D8P3CI]*PCR\WO;'?6]H
MH/V7Q=+GD6N_&/Q!>WY;1'73;5>%3RTD=O=BP//L/UKUWP-JEWK7@G3M0U&0
M2W,R,9'"A=Q#L,X''05Y#\8-,LM'U[3;/3+:.VMTLAA(QCG>W)]3[FO4OAC_
M ,DWTC_<?_T8U==90]DI15CQL#.O]<G3JSO9?+IT(?B?K^H^'/"*WFCSB"X:
MY2/S"BM@$,3PP([5YC9>-OB9J5OY^G/?7<.2OF0:8CKD=LB/%=Y\:_\ D1(O
M^OV/_P!!>L3X9^.O#GA[P>MEJ^H_9[CSW?9Y$C\'&#E5([4Z:2I<RC=W)Q4G
M+&>SE5<(V[V&^%?$'Q(NO%5A#K,&H?87EQ.9M-$:A<'.6V#'YUW7C_7[[PYX
M4DO=*C5[II4B3<N[;N[X[FM+1_$NC>(%8Z/J$-T4&613AE'J5.#C\*U"<#)X
M%<\YIS3<;6Z'HT:+5&48U7*_7>QX)):_%74X'OBVL(F-Q5)_(/X1@@_@!5?P
MI\3M=T;6(8M9O9KVQ:0).ER=SQC."P8\Y'H:]EO/'/ABRMGFEUVP<+_##<+(
MQ^BJ2:^?#;3^,_'$ZZ7;,IU"[>14 _U:,V23] <DUV4W[1-3C9'B8J#PTX.A
M5<I/I>Y](>(+R73O#.J7ML0)K:SEEC)&<,J$CCZBO#+#X@_$35&==,NKJ\:,
M N+?3XY"H]\1G%>V>+ACP/K@_P"H=<?^BVKQGX3^)](\,W^I2ZW=_9DFB18S
MY;ON()S]T&L:"7LY.UV=V82E]8IPYW%.]W>Q./$_Q8S_ ,>^J_\ @H7_ .-U
M[I"9&MXS.H64J"ZCH#CD5B:3XX\-ZY<+!IFK0RS-]V-PT;-] P!/X5O5C5E?
M3EL=V#I*"<E5<T_.X5YW\9=>;3/"<>G0/MEU&38V#SY:\M^9*C\37HE>!_&F
M_-SXX2U_AM+5%Q[L2Q/Y$?E58>/-41GF=5TL+*W73^OD=I\%M$6R\*RZI(G[
MZ_E.UB/^6:<#_P >W?I6%\0_'OB;1O'%QIFC7WD01I&$C6WC<DLH/\2DYR:]
M.\*62Z?X/TFU08\NTCW>[%02?S)KQ/XF2+#\6II)#M1&MV8^@"+6M*U2M)M7
M.+%J6&P-.,';5;:='<N?\)/\6/\ GWU7_P %"_\ QNO0_AMJ/B?4=-O7\71W
M"2I,!";BV$#%<<\!1D>^*GB^*/@V:0(FM*"?[\$JC\RH%=1;74%[;)<6DT<\
M,@RDD;!E8>Q%9U)OELX6.K"T4JG-&NYVZ7O^IYW\3_B)<>')$TC1&5;Z1-\L
MY /DJ>@ /&X]>>@^M<"W_"R#I']NFZUC[%CS/,%T0-O7=Y>[.W'?&*H>*7;5
M_BE?QSDMYFI&WY/\*OL'Z"OI,PQF PF-?**[-F.-N,8QZ5M)JA&-E>YQ4X3Q
M]6HW-I1T5CS+X7?$2[UV[;1==D66Z"%[>XQ@R =5;'4XYS['->H5\S>$B=,^
M)NFQH2OEZB(.>N"VS^M>B?%7QKKWAKQ!9VNBWHMHI+82.ODH^YMS#JP/85-6
MC>HE#J:8/'N&%<ZUWRNWF>JT5X;=^)O'GCH/+X;AN[>RME 8VK^47; R=V02
M>^T'@'\:H^%?BIK.@7,L.N2W&I6^Q@$F;,B2 <?,><9X(/3K]8^K2MH]>QO_
M &K14TFFHOKT/H"BOG[6-4^(M]I[>(IY-0L].8AE-M*8D13T.P'.WI\Q'/K7
M;?";QQ?>(/M.E:Q+Y]S;Q^;%,1\SID AO4@D<^]3+#RC'FO<THYE"I55)Q:O
MM?J>ET5Y/\4_&^O^&O%%K9Z->BW@:S69D\E'W,7<=6!/11TK%O?$GCOQY/<3
M^&(;NVTZ G:MK((CCW?(+-[ _A1'#R:4FU8*F94X3E346Y+HD>Y5P7QD9E^'
M[[21FYC!P>HYK@/!?Q)UG1O$$=EX@NY[JSDD\F873%G@.<;LGG@]0:[[XR_\
MD_;_ *^H_P"M4J3IU8IF<\7#%8.I*.ED[HR?@4S'1]64DD"=,#/3Y37JE>1?
M!B^M]-\-:[>7LJPV\$B/([=  IK,A^(?C+Q9XM^Q^&)A:P2O^[B,".(XQ_$[
M%2?<_7 JJE*4ZDFNAGA<73P^%IQE=M[);[GN%%,B5TA197\QU4!GVXW'N<=J
MI:_J!TGPYJ-^IPUM;22)D?Q!21^N*Y$KNQ[,I*,7)GG/C_XKS:7J$ND^&O+\
MZ$[9[MU#!6[JH/&1W)SZ8KEK:R^*&M6OVZVGU@Q,-P/VSR=P]0I89_ 5E?#K
M2H]>\?V45\/-B5FN)0W._:"1GZMC-?2E=U24:%HQ6I\_AJ=3,.:K4FTKZ)'S
M[IWQ&\7>%=5-MK3S7*HW[VUOE^?'LQY'MU%>Z:+J]IKVCV^I:>^Z"=-PSU4]
MU/N#Q7G7QQTF*31+#5E4">&?[.S=V1@3C\"OZFCX%W[RZ+JEBS92WG211Z;P
M0?\ T"IJ1C.E[1*S-<+4JX?%O"SES)[7^\P_'7Q'\3:7XUU"QTN_%K:V[*B1
MB"-_X1DY92>235-_&7Q0@A%Q.NH+#C.]]+4*1]?+K"^(_P#R476/^NP_]!%?
M1^G?\@NU_P"N*?\ H(JYN%.$7RIW.>A"MBJ]5>UDK/H_-GD/AOXUW:720>)[
M:.6!C@W,"[63W*]"/IC\:]BAF@O;1)H'2:"9 RL.5=2.OTQ7CWQJ\,VMFUIK
MEE"L+7$AAN @P&;&5;ZX#9]<"N@^"VJRWOA">RF);[#.5C)/1&&X#\]U9580
ME352&AUX2O6IXAX6L[]F>=)(WP]^++!<K;VUUM8>L#_S^5@?J*^BP<C(Y%>$
M_&ZS6'Q?:W2#'VBT&[W96(S^6*]9\%7YU+P/I%T_+-:HK'U*C:3^8IU_>A&8
MLO?LJ]7#]$[K^ON-VBBBN,]L**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** .;^(_\ R2SQ7_V!;S_T0]?-O[*G_)4]2_[
MLO\ Z/@KZ2^(_P#R2SQ7_P!@6\_]$/7S;^RI_P E3U+_ + LO_H^"@#ZVHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ K$\5?\ (+C_ .NP_P#06K;K$\5_\@J/_KL/_06H /"O_(+D_P"NQ_\
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MNAM;XM]3U!)L??<HR_\ ?(4']:VOB!XXN?!<NEO#91W=O=-()@S%2-NW 4]
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7,77PT\(7DQEFT2)68Y(BD>,?DK 5U-%)2E'9E3I4ZGQQ3]496C^&-%T#/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH **** "BBB@ HHHH **** "N;^(W_)+/%?_ &!KS_T0]=)7-_$;_DEGBO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6)X
MK_Y!4?\ UV'_ *"U;=8GBO\ Y!4?_78?^@M0 >%/^05)_P!=C_Z"M;=8GA3_
M )!4G_78_P#H*UMT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+MX>_P"WG_TFEH ^VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N;^(W_)+/%?\ V!KS_P!$/725S?Q&_P"2
M6>*_^P->?^B'H ^ *_2,=*_-ROTC'2@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %<W\1O^26>*_P#L#7G_ *(>NDKF_B-_R2SQ7_V!KS_T0] 'P!7Z1CI7
MYN5^D8Z4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ._[5_M+SO\ ET\CR_+V?[;9SYGMC%=)^RK_ ,E4U'_L#2_^CH: /K:BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_$;PO!\)/C5IS^'9&CM5>&_M4=BQB&_!0GJ1E3[X/XT ?9M%(C;T5AT(S2T
M%%%% !1110 4444 %%%% !1110 5\2_L^?\ )=O#W_;S_P"DTM?;5?$O[/G_
M "7;P]_V\_\ I-+0!]M4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!\W?M<]/"/_;[_ .T*YK]E7_DJFH_]@:7_ -'0UTO[7/3PC_V^
M_P#M"N:_95_Y*IJ/_8&E_P#1T- 'UM1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.2^\3ZBEA;R/Y:,R,Y=L9P%4$G\JD\,^*]$\8Z3_ &GX:U"._M-YC+HK*58
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD9!![@BI:XCX-Z??Z9\(/#]KJJNEPMN6V2##(K,64'_@)%=O0 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]E3_ )*GJ7_8%E_]'P5])?$?_DEGBO\ [ MY_P"B'KYM_94_Y*GJ7_8%E_\
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M/"=GX>TJPT>:TL]_EO<PRM(=[LYR5D ZL>W2@#[1HKY)_P"&J_&__0*\/_\
M@//_ /'J/^&J_&__ $"O#_\ X#S_ /QZ@#ZVHKR3X&?%77/B;_;O]O6NGV_]
MG?9_*^Q1NF[S/,SNW.W]P8QCO7K= !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6)XK_Y!4?_
M %V'_H+5MUB>*_\ D%1_]=A_Z"U !X4_Y!4G_78_^@K6W6)X4_Y!4G_78_\
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M/"LA)X3D9 XP<CW /K)%V1JHYV@"EHHH **** "BBB@ HHHH **** "BBB@
MKXE_9\_Y+MX>_P"WG_TFEK[:KXE_9\_Y+MX>_P"WG_TFEH ^VJ*** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK@_^)KI** ,W2/#FA^'_ #O[!T;3],\_;YOV*U2'S-N<;MH&<9.,^IK2HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *Q/%?_(*C_Z[#_T%JVZQ/%?_ ""H_P#KL/\ T%J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC_&GPK\)>
M/59]=TQ1>;<+?6Q\N=?3YA]['8,"/:NPHH ^<=3_ &2X6N&;1O%;QPD_+%=V
M8=@/=U8 _P#?(JO;?LDSF4?;/%\:Q]Q%8$D_G(,?K7TM10!YEX0^ /@?PG,E
MTUE)J]ZARL^HL) I_P!F, +UY!()'K7IO3I3(Y8YE+0R+( Q4E6S@@X(^H-/
MH *\@^.?C"]2WLO /A7?)KWB$B-A&>8H"2"2>V[!'LH8^E>OU\CIJ/Q/T'XK
M:UXJMO U]JU]/-)%#/>:1<R+%'NP/+V%0/E &>>/J: -G]F_2SHGQ@\3Z4TH
MF:RMI+<R!=N_;,JYQVZ58TS2[+Q[^UMK<?B"WCO[/3DDV03 /&?+"HH*G((R
M2<=,]JXKX7^*O%]A\8+V\TO0?M-]J=UY>J0?8YG^R(\P,C;5.4VGNV0.]=GI
M&IV?@']K37'\0W":?9Z@)=EQ.=L8$@5U)8]!D$9Z9H =<Z;:> OVO-+M_#\2
M6-EJ2)OMH5VHHE5E*A1P!N4-CH*E^(MK#XQ_:LT+P]JB_:-/MXHP\!/RD;6E
M8$9[\ ^U17.I6GCW]KS2[CP_*E]9::B;[F%MR,(E9BP8<$;F"YZ&G_$.ZB\&
M_M7:+X@U5C;Z=<QQ,TY'R@;&B8Y]C@GV- %?XP:)IOP^^,W@[6/#%I!I:SR(
M98;2,1IE) K':HP,J^#CK5KXBVL/C']JS0O#VJ+]HT^WBC#P$_*1M:5@1GOP
M#[55^,&MZ;\0?C-X.T?PQ=P:HL$B"6:TD$B9>0,PW*<'"IDXZ58^(=U%X-_:
MNT7Q!JK&WTZYCB9IR/E V-$QS['!/L: *_Q@T33?A]\9O!VL>&+2#2UGD0RP
MVD8C3*2!6.U1@95\''6K7Q%M8?&/[5FA>'M47[1I]O%&'@)^4C:TK C/?@'V
MJK\8-;TWX@_&;P=H_AB[@U18)$$LUI()$R\@9AN4X.%3)QTJQ\0[J+P;^U=H
MOB#56-OIUS'$S3D?*!L:)CGV."?8T 5_C!HFF_#[XS>#M8\,6D&EK/(AEAM(
MQ&F4D"L=JC RKX..M?3E?,?Q@UO3?B#\9O!VC^&+N#5%@D02S6D@D3+R!F&Y
M3@X5,G'2OIR@#QOQK\<OAUJ_@'Q!ING^(?.N[S3+F""/[%<+O=XF51DQ@#)(
MY)Q7EO[*G_)4]2_[ LO_ */@K2\1_LN_\(_X5U76?^$O^T?V=937?D_V9L\S
MRT+[=WFG&<8S@UF_LJ?\E3U+_L"R_P#H^"@#ZVHHHH **** "BBB@ HHHH *
M*\;^,7QW_P"%>ZJN@Z#86]_JQA6:66>7,5KEN%9%.YF*@G!*X#(?F!Q7$>$?
MVJ-2F\200^-M.T^'29?DDN-/BD$D!.,.0SMN4=P!G!R,D;2 >I?&3_F0_P#L
M<]._]J5@?M$_$[4?!>C6>B>';B.#4=620S7*2_OK6$8&57JI<E@'[;&QSRN_
M\9/^9#_['/3O_:E<!^U%X#OM1_L[Q=I4%Q=_9H6M+V*)&?RHEWRK+A5^51F0
M,S' RG'4T >(Z?\ %;Q[IE_'=VWB_6'ECSM6YNWN(SD$<QR%E/7N#@\]17VE
M\//%?_";_#[2/$+1>3+>0_OD"[5$J,4DVC)^7>K8R<XQGFO@2VMI[RZBM;.&
M2>XF<1Q11(6>1B<!5 Y)). !7W1\'_"%UX(^%^F:1JEO;P:B/,FO!!@Y=W)&
MYA]Y@FQ2>1\N 2 #0!V]%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %8GBO_D%1_P#78?\ H+5M
MUB>*_P#D%1_]=A_Z"U !X4_Y!4G_ %V/_H*UMUB>%/\ D%2?]=C_ .@K6W0
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MM&**."%(H46..-0J(@P% X  ["E "J . !@4M !1110 4444 %%%% !1110
M4444 %?$O[/G_)=O#W_;S_Z32U]M5\2_L^?\EV\/?]O/_I-+0!]M4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\W?M<]/"/_;[_P"T
M*YK]E7_DJFH_]@:7_P!'0UTO[7/3PC_V^_\ M"N:_95_Y*IJ/_8&E_\ 1T-
M'UM1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %>&^(/V8],\0>)-1U>7Q'=PO?7,EPT:VRD(68G&<^]>Y5\Q>#/%GB*Z_:FN
M=)NM?U2;35U"\06<EY(T(55DVC83MP,# QQB@#:_X9,TG_H:;W_P%3_&C_AD
MS2?^AIO?_ 5/\:E\4_%KQ7I7[0L'A*SN;==)>]M83&UNI;;($+?-U_B->_4
M<_X&\)Q>!_!MEX?M[I[N.TWXF=0I;<Y;H/K70444 %%%% !1110 4444 %%%
M% !1110 4444 <W\1_\ DEGBO_L"WG_HAZ^;?V5/^2IZE_V!9?\ T?!7TE\1
M_P#DEGBO_L"WG_HAZ^;?V5/^2IZE_P!@67_T?!0!];4444 %%%% !1110!QO
MQ4\>I\.? 5SK2Q1SWC.MO90R[MDDS9(W%1T"JS$9&=N,@D5\F_\ "]/B3_:O
M]H?\)3<>=Y/D;/(B\K;NW9\K9LW9_CV[L<9QQ7T3^TIH-]K?PC:;3X_-_LN]
MCOIT"L6,01T8@ '[OF!CG "JQSQ7QO0!]=>#_P!HF#Q%HT9?P;XDO]3@11?#
M1+ 7,*,<X(.\,H;:2 PXY&6QDZ^H?':QTBPDOM5\"^.+&TBQYEQ<Z0L<:9(
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S=^UST\(_]OO\
M[0KFOV5?^2J:C_V!I?\ T=#72_M<]/"/_;[_ .T*YK]E7_DJFH_]@:7_ -'0
MT ?6U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8GBO\ Y!4?
M_78?^@M6W6)XK_Y!4?\ UV'_ *"U !X4_P"05)_UV/\ Z"M;=8GA3_D%2?\
M78_^@K6W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'S#XM_9J\8:]XRU?5K/4M#2"^O)9XUEGF#!6
M8D @1$9Y]36/_P ,J>-_^@KX?_\  B?_ .,UU_A/XH^,-3_:.N/"][J_FZ,E
M]=Q+;?981A$#[1N";N,#O7$>-OCE\1-(\>:YIVG>(?)M+6_FAAC^Q6[;45R
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MMS78USO@'PU_PB'@+2-#.#):6X$I4Y!D/S.?^^B:Z*@ HHHH **** "BBB@
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MIPO0 'I-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8GBO_D%1_P#78?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5B>*_P#D%1_]=A_Z"U;=8GBO_D%1_P#78?\
MH+4 'A3_ )!4G_78_P#H*UMUB>%/^05)_P!=C_Z"M;= !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO*J8Y%!]=I4CWKSGX@>.I?BE\4]/U#1+"6T8&&ULXRP,C,'R&..ARW3G&.M
M'VXB[(U4<[0!2TU PC4/RV!GZTZ@ HHHH ***XS7_B]X#\,WC6FL>);5+A6*
MO% KW#(1U#"-6VGV.* .SHKG?#'C_P *^,MP\-:W:WTBC<T*DI*!Z[& ;'OB
MNBZ=: "BO.9OC]\,X)GBE\2X>-BK 6-R<$'!Y$=(O[0/PR=PJ^)LEC@#[!<_
M_&Z /1Z*16#*&7D$9%+0 5\2_L^?\EV\/?\ ;S_Z32U]M5\2_L^?\EV\/?\
M;S_Z32T ?;5%%% !1110 4444 %>>?$+Q1<BZ7P]HY/GRX$S+UYZ(/ZUZ&>E
M>2^"X_[9^)%W?W"^9Y;R2C/\)SQ^5=F%C&\JDOLH\G,JD[0H0=G-VOY=3KO"
M7@6RT&VCGO8TN=1(RTC#(C/HH_KUHUKP%;7^H'4=)NY=+OCU>'A6/J0,<_0U
MUE%9?6*O/SWU.KZCAU25+ET7]7OW/)]'TJZUKXA-I_B6[:^&FHS /]U\$ #'
MX@^^*]61$BC"1JJ(HP%48 %<E?\ A2^C\=6NO:/+$B,V+I)"1D="1ZY'Z@5U
M]:8FHJG*T]+;=GU,,OH.CSQDM;O7NNFIY[\7?^0-I_\ U\'_ -!KK?"__(IZ
M5_UZ1?\ H(KDOB[_ ,@;3_\ KX/_ *#76^%_^13TK_KTB_\ 0155/]UAZLRH
M_P#(RJ^B+6IZ7::Q8R6E_"LL;C R.5/J/0UY7X:TO6=3O+_1++6Y;2RM)#NV
MG)(R1QC'IZUZOJ"W3:=.NGE%N2A$1?H&K!\%^&)?#UG<27TBRWMV^Z5E.0 .
M@_4FE1J^SI2U[67ZEXO#>WQ-/1VUNUIIVT\RQH'@_3- MI$BC^T2S#$LTX#%
MAZ?3VKDO&G@D:8/[=\-@V[0'S)8D.-N/XE]/I7HEY?6NGPB6]GC@C)"AG; S
M4DD:3P-&X#QR*00>A!J(8BI"?.W>_P")K6P.'JTO8Q25MK;KS_K<P/!?B;_A
M)=%$LVU;N$[)E' )_O#ZUT5>3_#PR:9X\O\ 3%_U?[R-O^ -Q7K%/%4U3JVC
ML]19;7G7PZ<_B6C^04445RGHA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!\^?M8:-J-YHOA[5;6TDEL=/>X2ZF09$)D\H)N'4 E"
M,],X&<D9^7Z_1^YMH+RUEMKN&.>WF0QRQ2H&212,%6!X((."#7G7_#/GPQ_Z
M%G_R?N?_ (Y0!\2T5]M?\,^?#'_H6?\ R?N?_CE'_#/GPQ_Z%G_R?N?_ (Y0
M!\2T5]M?\,^?#'_H6?\ R?N?_CE'_#/GPQ_Z%G_R?N?_ (Y0!\2T5]M?\,^?
M#'_H6?\ R?N?_CE'_#/GPQ_Z%G_R?N?_ (Y0!\2T5]M?\,^?#'_H6?\ R?N?
M_CE'_#/GPQ_Z%G_R?N?_ (Y0!\2T5]M?\,^?#'_H6?\ R?N?_CE'_#/GPQ_Z
M%G_R?N?_ (Y0!\2T5]M?\,^?#'_H6?\ R?N?_CE'_#/GPQ_Z%G_R?N?_ (Y0
M!\2UM^$?%VL>"/$D&M>'[CR;F+Y61N8YD/WHW7^)3@<=00""" 1]?_\ #/GP
MQ_Z%G_R?N?\ XY7Q*>IH _171-6@U[P_I^KVB2);ZA:QW42R@!U5U# $ D9P
M><$U>KFOAO\ \DK\*?\ 8&M/_1*5TM !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !63XJAO;GP?K$
M&E$K>R64RVY!P=Y0A<?C6M6;XCL+K5/#&I6&G3_9KNYM9(H9BQ7RW92 V1R,
M$YR* /ES]FOPSX:U[Q1JZ>)K*VO;RV@7[-9WD8=""2';8W!(PHY'&:Z#]IKP
MMX1T/1-*NM(TZQTW5YKDKY=G&L7FQ;269D7 .&V_-C/.,UFO^R]XUDO#>2>)
M=,:Y9MYG:68N6]=VS.?>FR_LM>,IKCSYO$>ER39!\QY)BW'3G90![K\(++4]
M/^$GA^VUL2K=I;<I,,,B%B44_12HQ7:5\P?\,V_$'_H<+/\ \"KC_P")KZ,\
M-:;<:/X5TO3;V59KFTM(H99%)(=E4 D$\]1WH TZ*** "BBB@ HHHH ****
M"BBB@ HHHH YOXC_ /)+/%?_ &!;S_T0]?-O[*G_ "5/4O\ L"R_^CX*^DOB
M/_R2SQ7_ -@6\_\ 1#U\V_LJ?\E3U+_L"R_^CX* /K:BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L3Q5_R"X_
M^NP_]!:MNL7Q3_R"X_\ KL/_ $%J $\*_P#(+D_Z['_T%:VZQ?"W_(+D_P"N
MQ_\ 05K:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KC/']_X TM;*_\ '[::DMM();-[A-\ZLK Y
MC"@N1D#../6NR=MD;,>=H)KXBLM*U_XY_%R[4W(CEG=Y9)I<LEK IP ![9
M'4GZF@#VSQ3\8_@[XVLCH_B7[5=V8;>DS6DB^6W]Y2OS@\^GUK;^%/@OX512
MMK?@*2+5+J/I//,SRV^?]A@"A//)4'KS7*?\,F:1]@V?\)1>_:\?ZW[,GE_]
M\9S_ ./5Y/<:=KWP(^,%HGVGS3$Z.LL7RI>6S'!!7/&<$8/0C/H: /MJBD1@
MZ*PZ,,BEH **** /-OCQX@U70/AA<C0([DWE]*MMYMLK%H4.2S97D<#&?]JO
M$/@U\#+/X@Z->:QXEO;VTMHYS;PQ6I59'8 %F8LK8'(&,>M?7%8WBKQ7I'@S
MP_/K&O7*P6T(X'5Y6[(@[L?3\>@)H ^./B-X0NO@Y\2K:/0]4E<QJE[97) 6
M1!N(PV."05(]".W.*^M+OQ2Y^#\OBA@(9&T8WF!T5S%N _,U\M"/7?V@_B^9
MD@:WM6*B1A\RV5JIXR>['GZL?3I](?%O2=1/P9O]#\*:;+=S/#%:Q6\ ^98@
MRYX[_*,4 ?,'PG^%<OQ4U+4HCJW]F)91K(TWV;SM[,2 ,;EQT)SFO48OV2?+
MF1_^$USM8'']E=?_ "-7G_A3X$?$;Q#I]U&L/]AVC. \6J2R0"=ES@^6%).,
M\$C'/!J"QUOQU\!O&RZ?>2R+"I#RV1E+VUW$3C<OIG!PP ((Y[B@#[41=D:K
MG.T 9IU85]XIMX/A[=>++*+[5;PZ8^HQQ;]OF*L1D"[L'&<8S@XKPK_AKG_J
M2?\ RK?_ &F@#Z2KXE_9\_Y+MX>_[>?_ $FEKTC_ (:Y_P"I)_\ *M_]IKS?
M]GS_ )+MX>_[>?\ TFEH ^VJ*** "BBB@ HHHH P_&&LMH?ABZNHC^^*[(O9
MCQG\.M<U\*]%:WTV;5IL[[H[(QG^$'D_G4OQ:W_\([:[?N_:/F_[Y-=#X-5%
M\&Z6(^GV=2?KCG]:[O@PFGVF>-;VN96EM".GJ^I#XGNO$MJT4GART@N8@I,J
MN?FS[<CM6;H_Q%LIA+!KZ'2[R ?.L@.&^G&<^U=G7FOQ+M+4^(-$D6-&N)G*
M2)_?4,N,_F12PZA5?LI+YK<O'.MAD\13GV]U[=M.INGXE^'!)M$\Q7/WQ"V/
M\:W-)U[3-<C9M+NTGV_>49#+]0>:6'0M+CMA$NG6R(0,H(QBET_1--TJ2233
MK.*W:3AR@QGVK&;HM>ZG<Z:4<6I+VCBUY)I_F<9\7?\ D#:?_P!?!_\ 0:ZW
MPO\ \BGI7_7I%_Z"*Y+XN_\ (&T__KX/_H-=;X7_ .13TK_KTB_]!%;5/]UA
MZLY*/_(RJ^B-1W5$+.P55&22< "J46MZ5/,(H-3LY)#P%2=23^M3WMG#?V4M
MK<J6BF7:X!QQ7+3_  RT%[<I;B>"7'RRB3<5/K@UA35)KWVT=U>6(BU[&*:\
MW;]#*^)UU]ON=-T*T.^ZDF#E5_ASP,_F:]"AC\J".,?PJ!7F'@_3QHGQ%ET_
M6%,UWY;?9IB21TSGGU7->I5MB;04::V2O?O<X\O<JLZE>>C;M;M8\D\40S^$
M/B$FK6O^JNG\[&>N3\ZG\<_G7K$,J7$$<T1RDBAE/J",BO/?BZJ_8--8_?\
M-<#Z8%=KH'_(M:9_UZ1?^@"JKOGH4YO?;[B,$O98RM1CMH_OW-"BBBN$]D**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ K\W#U-?I'7YN'J: /O[X;_\DK\*?]@:
MT_\ 1*5TM<U\-_\ DE?A3_L#6G_HE*Z6@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK/&R@L1*3C)YP#7&_LJ?\E3U+_L"R_\ H^"@#ZVHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR%I(YM)6VNX78J2KQX9,@@CAB.#D5B_\,^?#'_H6?_)^Y_\ CE>DT4 >;?\
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MN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 '3K7QQX[\0^)?C=\46T#0=\EC!.\=E:[MD:JO#32>YQG)Z @#
MW^QG7?&RGC<"*^-?A?XEM?A7\:K^/Q,C0V^Z:PGE*$F [P0^!R1\HSCL<T =
M/_PR;KG]G[_^$ET_[9MSY7DOY>[TW]<>^W\*Y[P!K_B3X*?%5/#WB M%8W$Z
M17EL7W1,K\+.A]L@Y'4 @^WU%_PL/P9]E^T_\);HGDXSO_M"+_XKK[5\K_$_
MQ):_%;XUZ?%X81IK<M#802[=IG.\DO@]!\QQGL,T ?9?7I12(NR-5'.T 4M
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M9Z?IBNGHHKS:DW.;D^I[]&E&C3C3CLE8****@U"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *_-P]37Z1U^;AZF@#[^^&__ "2OPI_V!K3_ -$I72US7PW_ .25
M^%/^P-:?^B4KI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** .;^(__)+/%?\ V!;S_P!$/7S;^RI_R5/4O^P++_Z/
M@KZ2^(__ "2SQ7_V!;S_ -$/7S;^RI_R5/4O^P++_P"CX* /K:BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "OS</4U^D=?FX>IH ^_OAO_P DK\*?]@:T
M_P#1*5TM<U\-_P#DE?A3_L#6G_HE*Z6@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_B/_R2SQ7_ -@6\_\ 1#U\
MV_LJ?\E3U+_L"R_^CX*^DOB/_P DL\5_]@6\_P#1#U\V_LJ?\E3U+_L"R_\
MH^"@#ZVHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV)G(  /)QG)XQCGR6Q^+_P 2-$NX;T^(M1D$@W*E[F6.5?8.,8]Q^= '7_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '-_$?_ ))9
MXK_[ MY_Z(>OFW]E3_DJ>I?]@67_ -'P5])?$?\ Y)9XK_[ MY_Z(>OFW]E3
M_DJ>I?\ 8%E_]'P4 ?6U%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %9?B#_D'I_P!=1_(UJ5EZ_P#\>"?]=1_(
MT 'A_P#Y![_]=3_(5J5EZ!_QX/\ ]=3_ "%:E !1110 4444 %%%% !1110
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M3#, ?]&D]?\ KI0!]<44V-B\2,>K*":=0 4444 %%%% !1110 4444 %%%%
M!7Q+^SY_R7;P]_V\_P#I-+7VU7Q+^SY_R7;P]_V\_P#I-+0!]M4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "LS7O^/%/^NH_D:TZS==_P"/%/\ KH/Y&@!-!_X\
M7_ZZG^0K3K-T+_CQ?_KH?Y"M*@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .?N? /@^\NI;F\\*:'<
M3S.7DEETV%F=CR225R2?6H_^%<>"/^A-\/\ _@K@_P#B:Z2B@#F_^%<>"/\
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M*=ZY9 X7>IPO0!0   *ZW_A-OB=_T2/_ ,N6V_\ B:/V??\ DA7A_P#[>?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %9NN?\>*?]=!_(UI5G:W_P >2?\ 70?R- ":'_QX
MO_UT/\A6E6=HG_'D_P#UT/\ (5HT %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 45F:MXET+061=<UK3M-,GW!>7:0[OIN(S5JPU&RU6S6[
MTN\M[VV?[LUO*LB-]&4D4 6:*** "OB7]GS_ )+MX>_[>?\ TFEK[:KXE_9\
M_P"2[>'O^WG_ -)I: /MJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\W#U-?I'7
MYN'J: /O[X;_ /)*_"G_ &!K3_T2E=+7-?#?_DE?A3_L#6G_ *)2NEH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#MSWK;_X9\^&/_0L_P#D_<__ !R@ _X:#^&/_0S?^2%S_P#&Z/\ AH/X8_\
M0S?^2%S_ /&Z/^&?/AC_ -"S_P"3]S_\<KRGXMZ=\(/AU(-)TSPC'JFO.A9H
M3J=T([0%<HTA$F222#L&"5Y)7*[@#H/@[\8O GA7X3Z/HVO:[]EO[;S_ #8?
ML<[[=T\C#YE0@_*P/![UVW_#0?PQ_P"AF_\ )"Y_^-U\T_#'4_A[)J$&D?$/
MPO'.D[I%#JD-[-$8V:3&9P9E0( WWE VA.0V<CZ6_P"&?/AA_P!"S_Y/W/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5G:U_QY)_UT'\C6C6?
MK/\ QYI_UT'\C0 FB_\ 'D__ %T/\A6C6?HW_'F__70_R%:% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5R7Q/\7MX&^'>IZW %:ZB01VP89'F
MN=JDCN!G/X5UM>(?M42LGPTT^-3\KZFF[WQ&] 'CWPY^%NM?&B_U76-2UUK9
M(I )KR>(SR32L,X W+T'OQD<4FE7^O\ P#^+QT^YNC+:)(@NDC)$5U;MT?:>
MC '(]"",XSGVG]ER-$^%5RZJ SZE+N/KA$%>7_M31*GQ0LG4?-)ID>[\)'%
M'UM'(LL:R1D,K@,I'<&G5S'AC68+/X4Z5K.JRF*WM]'BN;F4@MM180S-@#)X
M!/ S7._\-!_#'_H9O_)"Y_\ C= 'I-?$O[/G_)=O#W_;S_Z32U](_P##0?PQ
M_P"AF_\ )"Y_^-U\M_!WQ#I?A7XL:-K.O7/V33[;S_-F\MGV[H)$'RJ"3\S
M<#O0!]VT5YM_PT'\,?\ H9O_ "0N?_C='_#0?PQ_Z&;_ ,D+G_XW0!Z317FW
M_#0?PQ_Z&;_R0N?_ (W1_P -!_#'_H9O_)"Y_P#C= 'I-%>;?\-!_#'_ *&;
M_P D+G_XW1_PT'\,?^AF_P#)"Y_^-T >DT5YM_PT'\,?^AF_\D+G_P"-T?\
M#0?PQ_Z&;_R0N?\ XW0!Z317FW_#0?PQ_P"AF_\ )"Y_^-T?\-!_#'_H9O\
MR0N?_C= 'I-%>;?\-!_#'_H9O_)"Y_\ C='_  T'\,?^AF_\D+G_ .-T >DT
M5YM_PT'\,?\ H9O_ "0N?_C='_#0?PQ_Z&;_ ,D+G_XW0!Z317FW_#0?PQ_Z
M&;_R0N?_ (W1_P -!_#'_H9O_)"Y_P#C= 'I-%>;?\-!_#'_ *&;_P D+G_X
MW1_PT'\,?^AF_P#)"Y_^-T >DT5YM_PT'\,?^AF_\D+G_P"-T?\ #0?PQ_Z&
M;_R0N?\ XW0!Z317FW_#0?PQ_P"AF_\ )"Y_^-T?\-!_#'_H9O\ R0N?_C=
M'I-%>;?\-!_#'_H9O_)"Y_\ C='_  T'\,?^AF_\D+G_ .-T >DT5YM_PT'\
M,?\ H9O_ "0N?_C='_#0?PQ_Z&;_ ,D+G_XW0!Z317FW_#0?PQ_Z&;_R0N?_
M (W1_P -!_#'_H9O_)"Y_P#C= 'I-%>;?\-!_#'_ *&;_P D+G_XW1_PT'\,
M?^AF_P#)"Y_^-T >DT5YM_PT'\,?^AF_\D+G_P"-T?\ #0?PQ_Z&;_R0N?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBN$^+'Q.M?AEX;BNVMQ>:A=N8[2V+[02!D
MNQZ[1QTZD@<9R #NZ*^>O"_[0_B.'Q18:=\1_#<>E6FI%1!<QV\MN4#' <B0
MG>F>I&,=>:^A>O2@#F_B/_R2SQ7_ -@6\_\ 1#U\V_LJ?\E3U+_L"R_^CX*^
MDOB/_P DL\5_]@6\_P#1#U\V_LJ?\E3U+_L"R_\ H^"@#ZVHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .?\9^-M%\ Z =7\
M1SR16Y?RHEBB9WFDVLP10. 2$."Q"^I%>-Z-^UAIUWK-M;ZUX9DTVQE?;->1
MWOGF$'^+R_+4L <9P<XR0">#S_[67]J?\)3X?\[_ )!/V*3[-]W_ %^_]]_M
M?=\CKQZ<[J\ H _1^VN8+RUBNK.:.>WF0212Q.&212,AE(X((.014E>;?L^?
M\D)\/?\ ;S_Z4RUI^(?"WCO4=>N+K0?B+_8VGR;?*L?[#@N/*PH!_>,<ME@6
MYZ9QVH [:OB7]H&TOK;XVZV^H+_Q\>3+!((6C62+RD52,D[L;2I8'!96X'W1
M](_\(3\3O^BN?^6U;?\ Q5<MXL_9_P#$'CFZM[GQ1\0X[VXMD,<<H\/Q1.%)
MSM)212P!R0#G&3C&3D ^3J_1'PW9WVG>%=)LM7N?M=_;64,-U<>8S^;*J .V
MYN6RP)R>3GFO#=&_9>O= UFVU72_',<=Y:/YD,DFAI*$;LVUY2N1U!QP0",$
M UW?_"$_$[_HKG_EM6W_ ,50!Z317FW_  A/Q._Z*Y_Y;5M_\57HMM$\%K%%
M+/)<O&@5II0H>0@8+,% 7)ZG  ] * /SR\2?VI_PE6K?\)#_ ,A;[;-]N^[_
M *_>?,^Y\OWL_=X].*TOAU:7U[\3?#<.E+F[_M.W>,F%I53;(&+LBD$JH!8\
MC@'D=:^MOB-\#_#7Q$OCJER]QINK>28_M5IMVRG&$:5"/GVXQP5)'&<!<'PY
M^!_AKX=WZZI;/<:EJWDB/[5=[=L1QAVB0#Y-V<<EB!QG!;(!Z31110 4444
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M4FJZ+X=N+RTDS';7'VN&W7>K+N;$A!D7&Y?EP-W?Y2I .)KZ(^&?[25CX?\
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MS>-=-\975G]ATFSWE3=AHY+H20. T2X^9?G4[C@$'@D@@?5U !1110 4444
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M2/\ CT;_ *Z'^0J_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>.?M/:;+>_"=+J%"PL;^*63'\*D,F?S85['5'6]&LO$.AWFD:K%YUG>1&*5.
MG![@]B.H/J* /&?V5M5@N/ .IZ8'7[1:7QD9,\['1<'\U8?A7F/[2VHQZI\7
MUL[1A*]G9Q6[A3G#DLVWZX<5HZG\ ?B3X/UN2?P#?RW4,A*I<6-^+2<)Z/EE
M_0G\*Z7X6?L]ZO:>)X/$OQ"EC,MO+Y\=D)?.>27.0\CC(X/. 3D]2.X![/\
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MW_4[?^4G_P"W5])44 ?-O_#(W_4[?^4G_P"W4?\ #(W_ %.W_E)_^W5])44
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M#X;?\DK\*?\ 8&M/_1*T =+1110 4444 %%%% !1110 4444 %%%% !1110
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M\JW_ -IH_P"&N?\ J2?_ "K?_::])_X9\^&/_0L_^3]S_P#'*/\ AGSX8_\
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M/_E6_P#M-'_#7/\ U)/_ )5O_M->D_\ #/GPQ_Z%G_R?N?\ XY1_PSY\,?\
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MT#6;;5=+^$T<=Y:/YD,DFOS2A&[-M="N1U!QP0",$ UW?_#7/_4D_P#E6_\
MM->D_P##/GPQ_P"A9_\ )^Y_^.4?\,^?#'_H6?\ R?N?_CE 'FW_  US_P!2
M3_Y5O_M-'_#7/_4D_P#E6_\ M->D_P##/GPQ_P"A9_\ )^Y_^.4?\,^?#'_H
M6?\ R?N?_CE 'FW_  US_P!23_Y5O_M-'_#7/_4D_P#E6_\ M->D_P##/GPQ
M_P"A9_\ )^Y_^.4?\,^?#'_H6?\ R?N?_CE 'FW_  US_P!23_Y5O_M->.?$
MSQK:_$'QD_B"VT;^R)9X42XC^U&?S74;0^2JX^0(N ,?+GJ37U9_PSY\,?\
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M Q!"DCH2#CT/2OM;_AGSX8_]"S_Y/W/_ ,<H_P"&?/AC_P!"S_Y/W/\ \<H
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MY=B>BCCIQ0!N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBBB@ HHHH **** "BBN+OOBGX?L?B5:>!RMU/JMT!\\*(8H25+;7)8$' S@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX0UY/#/AC25UC7F51(NYF2%VZ(%7YG;GH".H^@Y[0/VB]>TSQ#;Z9\4O"_\
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MI0!] :)<WUYH-C<ZM;+:WTUNCW$"YQ&Y4%EYYX-7J** "BBB@ HHHH ****
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M 9002>)"<@<?,,#FO+_C!;+>?M.>$8)%5T<6FY6Z$><QKZ5H **** "BBB@
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M]YSW/MT':OD;_AGSXG?]"S_Y/VW_ ,<I\'[/WQ-2XC9O#. K@D_;[;U_ZZ4
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M([5],4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0?A;HOQ(?3FURZOX#IS.T7V.1%W;MN=VY&_NCIBNS10B*HZ*,#-+10 4444
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M3?%U]=:A'J&F^7Y,<,B")MC%AN!0D\GL17:T44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %5=0_X]U_WOZ&K55;_P#X]U_WOZ&@ T__ (]V_P![^@JU
M56P_X]V_WOZ"K5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !5:^_U _WOZ&K-5[W_4C_ 'OZ4 )8_P"H/^]_059JO9?Z
MD_[W]*L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9NK^(]$T#RO
M[>UG3],\[/E?;;I(=^.N-Q&<9'3UK-_X6/X(_P"AR\/_ /@T@_\ BJ\3_:V^
MYX7^MS_[3KE_AY^SO_PGO@FS\0_\)1]@^TLX^S_V?YNW:Y7[WF+GIGI0!]2:
M7XHT#7)#'HNN:;J+CJMI=QRD?@I-:E?''Q#^ OB#X<Z7_;VG:FNJ65LP,L\$
M9AEMSG ?;D\9QR#Q^M>P_L]?%"[\::)<Z+K\YGU73%5EG;[UQ"> 6]64\$]\
M@]<F@#V:BJ>JZOIVAZ>]]K-];V-K']Z:XD"*#V&3W]JX;_A?GPS\_P G_A)T
MW9QG['<;?^^O+Q^M 'HM%9]AK^D:IHW]K:?J=I<:=M+FZCF4QJ ,DELX&.^>
MG>JVF>,/#.M7@M-&\1:3J%R5+"&TOHY7P.IVJQ.* -FBD9@JEF(  R23TK&T
M[QGX7U>^6RTGQ)I%]=MDK!;7T4DAQR<*K$\4 ;5%<WXF^(7A/P<XC\2:[:V4
MQ7<("2\N/78H+8]\5CZ7\;?ASJ]VMM9^*;59&.!]ICDMU)_WI%4?K0!WE%("
M&4%2"",@CO2T 9.J^+/#NA72VVN:_I>FSLN]8KR\CA8KG&0&(..#S[51_P"%
MC^"/^AR\/_\ @T@_^*KYN_:I_P"2EZ=_V"T_]&25<\)?LR?\)1X0TO7/^$M^
MR_VA;)/Y']F[_+W#.-WFC/UP* /I;2_$V@ZV^S1=;T[4&QG;:7<<IQZ_*36G
M7Q#\2?A7K?PDU&PNUU(7-O.Y-M?6P:)TD7G!&<J>X()KZ<^"7C6[\<_#6VOM
M4?S=0M9&M;F3;CS&7!#?4J5S[YH ]"HK \2^.O#'@]%/B36K6P9AE8G;=(P]
M0BY8CW K+T#XN^ _$]Z+31_$MK)<,0J13J\#.3V42*NX^PS0!V=%%<WXF^(7
MA/P<XC\2:[:V4Q7<("2\N/78H+8]\4 =)17!Z7\;?ASJ]VMM9^*;59&.!]IC
MDMU)_P!Z15'ZUV.H:MIVD6!OM5O[6QM%P#<7,RQQC/ ^9B!S0!;HKY(\/_%S
M6_$?QRTF;Q/X@BM]%MKV3;&)1#:QJ%<*QYP>HPS$GGK7U9IFK:=K5D+S1[^U
MU"V8E1/:S+*A(ZC<I(H MUAGQMX574_[.;Q-HXOO-\G[*;^+S?,SC9LW9W9X
MQC-;E?$5W_R<K)_V,W_MQ0!]NT5E:MXI\/Z!-'#KNNZ;ILLB[D2\O(X69>F0
M&(R*S_$7Q$\)>%+.WNM>UZTMHKE \&UC*TJ'HRJ@)*^X&* .EHK!\+^-_#?C
M.TDN/#.KP7Z18\Q4RKQYZ;D8!AG!ZCG%8FH?&GX>:7JS:=>>*+47*MM;RHY)
M44^A=%*C\^* .YHJ"ROK74K&*\TZYBNK69=T4T+AT<>H(X-9MYXP\-:?J?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY*V]AJ&,_P!ZVD_^P;\Q71_LK?\ )3-0_P"P6_\ Z,CKH?VJ_">V72?%=M&
M&!LKH@<D\M&3^&X?E0!ZQ\9/%(\,?"?5KZ&3;/<Q?9;8@]6DXR/HN3^%>/\
M[+/A<M-K7BN2,LUNGV.USW8C<Y_+8/Q-<7\1OB6WB[X9>#=#CE,EQ:PEKY0<
MDR)^[CS[E06_X$*^G_AKX=B\"_"[3+"]>.!H+?[1>2.P55=OG<DGH!G&?04
M?'VB'2/%OQ)N)OB3KESIUM=2R27%VB;G,F>%Z$*/?!  Q]/5[W]G?PIXCL8Y
M/ACXTAO9U8><MU=1SJ$/?]TH*GIP1^5;'B3X??"CXH>,)X?"_B>.S\07*M,Z
MV(\Z"4C&YB,!2W.<*XSR<'DUYOX\^ WB3X=Z3+XACU6SN[&TD3]["[13H2V
MVTC'4CHQ- 'U!\-_"FI>"O!EOH>K:P-7:W8^3*(2GEQGI'R22 <X/'!QVKJZ
M\9_9P\=ZSXO\+ZC9>(+J2]GTR5%BN9>7>-@<*S?Q$%3R>>>:]FH ^2OVJ?\
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MUZM\3_V?=*\#_#>37M-U:]NKVT:,7*SA/+D#,%)4!<K@D=2:X_PN W[3-L&
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M!))Y[8X]0 <UX5_9>TY_"PN_'6IWUAJ9#,\5K-$(H ,XW,5;=ZG! [>]>5>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ J*X_U8^M2U%<?ZL?6@ M_]6?K4M16_P#JS]:E
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *CG^X/K4E,F^X/K0 D'W#]:DID/W#]:?0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4R7[OXT^FR?=_&@!(ON_C3Z;
M']W\:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4U^E.I&Z4 (G2G4B]*6@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ H-%%  **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
IHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>bdtx-20211231_g14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g14.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,Y
M,P  DI(  @    ,Y,P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MO^%M:[_SZ:=_W[?_ .+H_P"%M:[_ ,^FG?\ ?M__ (NN%HH^JT/Y0_M+&?\
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M /Q=<+11]5H?RA_:6,_Y^,[K_A;6N_\ /IIW_?M__BZ/^%M:[_SZ:=_W[?\
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M+KA:*/JM#^4/[2QG_/QG=?\ "VM=_P"?33O^_;__ !='_"VM=_Y]-._[]O\
M_%UPM%'U6A_*']I8S_GXSNO^%M:[_P ^FG?]^W_^+H_X6UKO_/IIW_?M_P#X
MNN%HH^JT/Y0_M+&?\_&=U_PMK7?^?33O^_;_ /Q='_"VM=_Y]-._[]O_ /%U
MPM%'U6A_*']I8S_GXSNO^%M:[_SZ:=_W[?\ ^+H_X6UKO_/IIW_?M_\ XNN%
MHH^JT/Y0_M+&?\_&=U_PMK7?^?33O^_;_P#Q='_"VM=_Y]-._P"_;_\ Q=<+
M11]5H?RA_:6,_P"?C.Z_X6UKO_/IIW_?M_\ XNC_ (6UKO\ SZ:=_P!^W_\
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M '[?_P"+KA:*/JM#^4/[2QG_ #\9W7_"VM=_Y]-._P"_;_\ Q='_  MK7?\
MGTT[_OV__P 77"T4?5:'\H?VEC/^?C.Z_P"%M:[_ ,^FG?\ ?M__ (NC_A;6
MN_\ /IIW_?M__BZX6BCZK0_E#^TL9_S\9W7_  MK7?\ GTT[_OV__P 71_PM
MK7?^?33O^_;_ /Q=<+11]5H?RA_:6,_Y^,[K_A;6N_\ /IIW_?M__BZ/^%M:
M[_SZ:=_W[?\ ^+KA:*/JM#^4/[2QG_/QG=?\+:UW_GTT[_OV_P#\71_PMK7?
M^?33O^_;_P#Q=<+11]5H?RA_:6,_Y^,[K_A;6N_\^FG?]^W_ /BZ/^%M:[_S
MZ:=_W[?_ .+KA:*/JM#^4/[2QG_/QG=?\+:UW_GTT[_OV_\ \71_PMK7?^?3
M3O\ OV__ ,77"T4?5:'\H?VEC/\ GXSNO^%M:[_SZ:=_W[?_ .+H_P"%M:[_
M ,^FG?\ ?M__ (NN%HH^JT/Y0_M+&?\ /QG=?\+:UW_GTT[_ +]O_P#%T?\
M"VM=_P"?33O^_;__ !=<+11]5H?RA_:6,_Y^,[K_ (6UKO\ SZ:=_P!^W_\
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M+KA:*/JM#^4/[2QG_/QG=?\ "VM=_P"?33O^_;__ !='_"VM=_Y]-._[]O\
M_%UPM%'U6A_*']I8S_GXSNO^%M:[_P ^FG?]^W_^+H_X6UKO_/IIW_?M_P#X
MNN%HH^JT/Y0_M+&?\_&=U_PMK7?^?33O^_;_ /Q='_"VM=_Y]-._[]O_ /%U
MPM%'U6A_*']I8S_GXSNO^%M:[_SZ:=_W[?\ ^+H_X6UKO_/IIW_?M_\ XNN%
MHH^JT/Y0_M+&?\_&=U_PMK7?^?33O^_;_P#Q='_"VM=_Y]-._P"_;_\ Q=<+
M11]5H?RA_:6,_P"?C.Z_X6UKO_/IIW_?M_\ XNC_ (6UKO\ SZ:=_P!^W_\
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M?\_&%%%%=)YX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 45?CT+5IK<7$.EWLD+#<)%MW*D>N<8JA
M233V*E&4=T%%%.BBDGE6*%&DD<X5$&2Q] *8MQM%7+O1]3L(A+?:==VT9. \
MT#("?3)%4Z2:>J'*,HNTE8****9(4444 %%6+/3KW4&9;"SN+ID&6$,3.5^N
M!3;JSN;&;R;VWEMY<9V3(4;'K@TKJ]BN67+S6T(:***9(4444 %%%% !1110
M 445/:6-W?R&.PM9KEP,E88RY ]<"DVEJQI-NR(**GN[&[L)1'?6LULY&0LT
M90D>N#4%":>J!IIV84444Q!1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNF<=++J]3$/#Z*2[GEU%>U:5X,\.^'+,OJRVDTDTA DO=I49)VHN[C./Q)_
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MY 5O6Q,:34;7;Z(Y,)@*F*BYW48K=L\3HKV^W\,^#?$D"WME8VTT7W<V[-$
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MG/D2;?D8X7+9UZ?MI248]V>)T5Z-X[TCPXWAR/6- ^S(WGK$?L[?*X(/&T<
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M_P#(-TW_ *[/_(5T.@Z+X?;41KOATQJLD31,L'W#D@_=_A(QTXZ]*Y[XO_\
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M5^+]$3P_XFN+*'/D<20Y.3M/;\#D?A71^"?'>E^&]">RO;6Y:4S-)O@12&!
MZY8<\5G?$.Z75/'4L-F/,:-4MQM.=S]Q^9Q^%8FI>'=7TAB-1T^>$+U?;N3_
M +Z&1^M=RC&M1C&J]6>.YU,+BJE3#+1-K:Z1[7H7C#1_$;&&PG99PNXPRKM?
M'MV/X$UQ?Q"\$O#%-KEE<SS@',\<[ERHZ94]<#T[5B?#K2;ZY\66=[%!(+:
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MKIJ2A]22]/O/.HTZO]KR=GNW\K:&5\8/^/[2_P#KG)_,5UOPZ_Y$'3O^VO\
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MGQ5J;SNTC"ZD4%CV#$ ?@ !7M7@IVD\%:67.3Y 'X D#]!7B/B#_ )&;4_\
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M*P&/U5JY(J7U23Z7/4J2A_:<$]^5_P!?F3>)/AR_B+79M1DU@PB0*%B-OOV
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M@8'>?SH^<E"#D?CP*S:*PI8:G2;<5N=F)S#$8I*-1['JNF_%RS-H@U:QN%N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M=-\.O^1^T[_MK_Z*>N9KIOAU_P C]IW_ &U_]%/6-?\ @R]'^1UX+_>J?^)?
MF>Z4445\J?I04444 %%%% !56$_O15JJD)_?+0!;HHHH **** "BBB@ KYEK
MZ:KYEKV,L^W\OU/E>(O^77S_ $"BBBO8/E HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEM+V,Q3Q'#H2#@_A4%---71#3B[,****8@HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M= 2!EF_/)KP;6M3DUC6KO4)<YGD+ '^%>@'X# _"O-P_^T8EU7LMCW\=_L6
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M_P#D)VO_ %V3^8JO5C3_ /D)VO\ UV3^8KV);,^6A\2/?_$O_(IZO_UXS?\
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M$9R0IQ^N#^%:7Q:_Y&RV_P"O%/\ T-ZYSPMJRZ'XFLK^7/E1N1)C^ZP*D^^
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M:>BVU/HW5[JXM-#N[NPC6:>*%I(T()#$#.,#DUY9_P +:UW_ )]-._[]O_\
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MDJ;];G;557%<U&GB%UTM^%[_ )'D7@3_ )'G3/\ KH?_ $$UZ=\3/^1&N?\
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M,9XX82K.4*C)8G'(!JU3G]=<K:?\ Q=:E_9"I\RYK[7U^+L<?2JI9@J@DDX
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M?,N:^U]=WT/8M2B_M7PW=Q6Y!-W:.L9Z_>0@?SKYV92K%6!!!P01TKTKP/\
M$*UM-/BTK77,0A 2"XP2-O96QTQZ],=>G/07%MX!O;W[?<3:2\Q.XDW*@,?4
MKNP?Q%8492PDI0E%M>1VXNG3S2$*E.:36Z;_ *_X)-\.+1[7P1:^:I5IF>4
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M4Y2]GRQV_#8Y,MKTX?6/:35WU>E]SQRBBBO5/F0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*Z;X=?\ (_:=_P!M?_13US-=-\.O^1^T[_MK_P"BGK&O_!EZ/\CKP7^]4_\
M$OS/=****^5/TH**** "BBB@ K-M/^/I/Q_E6E69:?\ 'TGX_P J -.BBB@
MHHHH **** "OF6OIJOF6O8RS[?R_4^5XB_Y=?/\ 0****]@^4"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KUGX;^*M-708='NYT
MMKF!F">:P42AF+<$]\G&*\FHK"O1C6ARL[<'BYX2K[2"OT/:[_X;>']4O7O
MUS"TKEW$$HVL2<GJ#C\*MMJ'ASP-H_V:.:.)%RX@1]\LC'OCK[9/%>$T5R_4
MI224YMH])9O3IMSHT5&3Z_TD7M;U236M:NM1F4(T[[MH_A'0#\@*HT45Z"2B
MK(\*4G.3E+=A1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEHKZ:HH_M/\ N?C_ , /]7?^GOX?\$^9:*^FJ*/[3_N?C_P _P!7?^GOX?\
M!/F6BOIJBC^T_P"Y^/\ P _U=_Z>_A_P3YEHKZ:HH_M/^Y^/_ #_ %=_Z>_A
M_P $^9:*^FJ*/[3_ +GX_P# #_5W_I[^'_!/F6BOIJBC^T_[GX_\ /\ 5W_I
M[^'_  3YEHKZ:HH_M/\ N?C_ , /]7?^GOX?\$^9:*^FJ*/[3_N?C_P _P!7
M?^GOX?\ !/F6BOIJBC^T_P"Y^/\ P _U=_Z>_A_P3YEHKZ:HH_M/^Y^/_ #_
M %=_Z>_A_P $^9:*^FJ*/[3_ +GX_P# #_5W_I[^'_!/F6BOIJBC^T_[GX_\
M /\ 5W_I[^'_  3YEHKZ:HH_M/\ N?C_ , /]7?^GOX?\$^9:*^FJ*/[3_N?
MC_P _P!7?^GOX?\ !/F6BOIJBC^T_P"Y^/\ P _U=_Z>_A_P3YEHKZ:HH_M/
M^Y^/_ #_ %=_Z>_A_P $^9:*^FJ*/[3_ +GX_P# #_5W_I[^'_!/F6BOIJBC
M^T_[GX_\ /\ 5W_I[^'_  3YEHKZ:HH_M/\ N?C_ , /]7?^GOX?\$^9:*^F
MJ*/[3_N?C_P _P!7?^GOX?\ !/F6BOIJBC^T_P"Y^/\ P _U=_Z>_A_P3YEH
MKZ:HH_M/^Y^/_ #_ %=_Z>_A_P $^9:*^FJ*/[3_ +GX_P# #_5W_I[^'_!/
MF6BOIJBC^T_[GX_\ /\ 5W_I[^'_  3YEHKZ:HH_M/\ N?C_ , /]7?^GOX?
M\$^9:*^FJ*/[3_N?C_P _P!7?^GOX?\ !/F6BOIJBC^T_P"Y^/\ P _U=_Z>
M_A_P3YEHKZ:HH_M/^Y^/_ #_ %=_Z>_A_P $^9:*^FJ*/[3_ +GX_P# #_5W
M_I[^'_!/F6BOIJBC^T_[GX_\ /\ 5W_I[^'_  3YEHKZ:HH_M/\ N?C_ , /
M]7?^GOX?\$^9:*^FJ*/[3_N?C_P _P!7?^GOX?\ !/F6BOIJBC^T_P"Y^/\
MP _U=_Z>_A_P3YEHKZ:HH_M/^Y^/_ #_ %=_Z>_A_P $^9:*^FJ*/[3_ +GX
M_P# #_5W_I[^'_!/F6BOIJBC^T_[GX_\ /\ 5W_I[^'_  3YEHKZ:HH_M/\
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MZ>_A_P $^9:*^FJ*/[3_ +GX_P# #_5W_I[^'_!/F6BOIJBC^T_[GX_\ /\
M5W_I[^'_  3YEHKZ:HH_M/\ N?C_ , /]7?^GOX?\$^9:*^FJ*/[3_N?C_P
M_P!7?^GOX?\ !/F6BOIJBC^T_P"Y^/\ P _U=_Z>_A_P3YEHKZ:HH_M/^Y^/
M_ #_ %=_Z>_A_P $^9:*^FJ*/[3_ +GX_P# #_5W_I[^'_!/F6BOIJBC^T_[
MGX_\ /\ 5W_I[^'_  3YEHKZ:HH_M/\ N?C_ , /]7?^GOX?\$^9:*^FJ*/[
M3_N?C_P _P!7?^GOX?\ !/F6BOIJBC^T_P"Y^/\ P _U=_Z>_A_P3YEHKZ:H
MH_M/^Y^/_ #_ %=_Z>_A_P $^9:*^FJ*/[3_ +GX_P# #_5W_I[^'_!/F6BO
MIJBC^T_[GX_\ /\ 5W_I[^'_  3YEHKZ:HH_M/\ N?C_ , /]7?^GOX?\$^9
M:*^FJ*/[3_N?C_P _P!7?^GOX?\ !/F6BOIJBC^T_P"Y^/\ P _U=_Z>_A_P
M3YEHKZ:HH_M/^Y^/_ #_ %=_Z>_A_P $^9:*^FJ*/[3_ +GX_P# #_5W_I[^
M'_!/F6BOIJBC^T_[GX_\ /\ 5W_I[^'_  3YEHKZ:HH_M/\ N?C_ , /]7?^
MGOX?\$^9:*^FJ*/[3_N?C_P _P!7?^GOX?\ !/F6BOIJBC^T_P"Y^/\ P _U
M=_Z>_A_P3YEHKZ:HH_M/^Y^/_ #_ %=_Z>_A_P $^9:*^FJ*/[3_ +GX_P#
M#_5W_I[^'_!/F6BOIJBC^T_[GX_\ /\ 5W_I[^'_  3YEHKZ:HH_M/\ N?C_
M , /]7?^GOX?\$^9:*^FJ*/[3_N?C_P _P!7?^GOX?\ !"BBBO'/J@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LFR/^F)^/\
M*M:LBQ_X_$_'^1H UZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "L>Q_X_8_Q_D:V*QK#_C^C_'^1H V:*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L73
MS_IT?X_R-;58FGG_ $Z/\?Y&@#;HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *P]._P"/^/\ '^1K<K"T[_D(1_C_
M "- &[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5@Z;_ ,A"+\?Y&MZL#3#_ ,3&+\?Y&@#?HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXRP[C6ELSZ.\>^,1X'\.+JIL3?%IUA$7F^7U!.<X/]WTKS;_ (:-_P"I6_\
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MC:'*+E;6W\J2X52%<EB0 3U R>?<UZ1\%T?0OA/<ZCJ"NL#3S7BC;SY:HH)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"$?^@FN_&12P\DO+\SY+AJI*><TI3=V^;?SBSK_A'_R2S2/^VW_H]ZX3X_\
M_(3T7_KC+_-:O?#;XD^']%\$V>DZI<217=O*Z+&L+-O#N6!R!C^+')'2J/Q_
M_P"0GHO_ %QE_FM<U6<98*T7LD>W@,-7H<2N56+2E*HU=;K5Z=]SN?A[_P D
M?L/^O6;_ -">O&?A38VVH?$?3H;V%9XU$D@1QD;E0D''L0#7LWP]_P"2/V'_
M %ZS?^A/7D/P=_Y*;8?]<YO_ $6U155Y4+^7Z'1@).-/-7%V=Y?^WGKOQ?AC
ME^%^IO(@9HFA="?X3YJKD?@2/QKB_P!G^8BZUV''#) ^<],%Q_7]*[?XN?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF=(/_$TA
M_P"!?^@FNFKF-(/_ !-8?^!?^@F@#IZ*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BL>?Q+8VOBJ+0;IO*N)[=9H'8_+(2S+L]C\O'KG\]B@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH ***QY_$MC:^*HM!NF\JXGMUF@=C\LA+,NSV/R\>N?S
M-BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N7T?\
MY"T/_ O_ $$UU%<MHW_(6A_X%_Z": .IHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH \3^,K%?&EFRDAA8(00>G[R2NF^'?Q$&K+'I&N2@7P&V&=C_ *_V/^U_
M/Z]>8^,W_(Y6G_7@G_HR2O/E8JP920P.00>E 'U=17G/P[^(@U98](UR4"^
MVPSL?]?['_:_G]>OHU !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7B?QE8KXTLV4D,+!
M""#T_>25[97B7QF_Y'*T_P"O!/\ T9)0!T_P[^(@U98](UR4"^ VPSL?]?['
M_:_G]>OHU?**L58,I(8'((/2O:/AW\1!JRQZ1KDH%\!MAG8_Z_V/^U_/Z]0#
MT:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y71C_Q-X?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#F?&/C6W\'_8_M-I+<_:]^WRV
MV[=OK_O5S/\ PNO3_P#H$W7_ '\6JGQO_P"8'_V\?^TZ\GH ]C_X77I__0)N
MO^_BT?\ "Z]/_P"@3=?]_%KQRB@#V/\ X77I_P#T";K_ +^+1_PNO3_^@3=?
M]_%KQRB@#V/_ (77I_\ T";K_OXM'_"Z]/\ ^@3=?]_%KQRB@#V/_A=>G_\
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M]OEL!MV[?7_>KIJ\H^-__,#_ .WC_P!IT 6_^%UZ?_T";K_OXM'_  NO3_\
MH$W7_?Q:\<HH ]C_ .%UZ?\ ] FZ_P"_BT?\+KT__H$W7_?Q:\<HH ]C_P"%
MUZ?_ - FZ_[^+1_PNO3_ /H$W7_?Q:\<HH ]C_X77I__ $";K_OXM'_"Z]/_
M .@3=?\ ?Q:\<HH ]C_X77I__0)NO^_BT?\ "Z]/_P"@3=?]_%KQRB@#V/\
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M_P"_BUXY10!['_PNO3_^@3=?]_%H_P"%UZ?_ - FZ_[^+7CE% 'L?_"Z]/\
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MW!( 4^:N0",$9['FO0OV<?AYJNC/J7BWQ+:RVEU?KY5M#,FU]A;<[D'E<D
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MH **** /*/C?_P P/_MX_P#:=>3UZQ\;_P#F!_\ ;Q_[3KR>@ HHHH ****
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MHH **** "BBB@ HHHH **** "O*/C?\ \P/_ +>/_:=>KUY1\;_^8'_V\?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *Y'0_\ D,P?\"_]!-==7(:'_P AJ#_@7_H)H Z^BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S;]
MH/\ Y(3XA_[=O_2F*N;_ &5/^26:E_V&I?\ T1!72?M!_P#)"?$/_;M_Z4Q5
MS?[*G_)+-2_[#4O_ *(@H ]MHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML#ZXX(^HK@]?T&Y\.:H;"]E@DF"!V\ARP7/8\#FLRB@ HHHH **** "BBB@
MI54LP502Q.  .M"J68*H)8G  '6O:/AW\.QI*QZOKD0-\1NA@8?ZCW/^U_+Z
M]  ^'?P[&DK'J^N1 WY&Z&!A_J!ZG_:_E]>GHU%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7'Z$?^)U!_P+_T$UV%<=H1_P")U!_P+_T$T =C1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!YM^T'_R0GQ#_P!NW_I3%7-_LJ?\DLU+_L-2_P#HB"ND_:#_ .2$
M^(?^W;_TIBKF_P!E3_DEFI?]AJ7_ -$04 >VT444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!S/C'P5;^,/L?VF[EMOLF_;Y:
M@[MVWU_W:YG_ (4II_\ T%KK_OVM>F44 >9_\*4T_P#Z"UU_W[6C_A2FG_\
M06NO^_:UZ910!YG_ ,*4T_\ Z"UU_P!^UH_X4II__06NO^_:UZ910!YG_P *
M4T__ *"UU_W[6C_A2FG_ /06NO\ OVM>F44 >9_\*4T__H+77_?M:/\ A2FG
M_P#06NO^_:UZ910!YG_PI33_ /H+77_?M:/^%*:?_P!!:Z_[]K7IE% 'F?\
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M^UKTRB@#S/\ X4II_P#T%KK_ +]K1_PI33_^@M=?]^UKTRB@#S/_ (4II_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /-OV@_^2$^(?\ MV_]*8JYO]E3_DEFI?\ 8:E_]$05TG[0?_)"
M?$/_ &[?^E,5<W^RI_R2S4O^PU+_ .B(* /;:*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **QO%/BG3_"&C?VEJOG-$9%B1(4W.[')P,D#H">2
M.GK@5QG_  O?PQ_SXZM_WYB_^.5C.O3@[2=CTL-E>-Q4/:4*;E'N>F45YG_P
MO?PQ_P ^.K?]^8O_ (Y1_P +W\,?\^.K?]^8O_CE1]:H_P QT_V!FG_/EGIE
M%>;0_'3PM+/'&]MJD*LP4R/"A5 3U.')P/8$^U>D]:UA5A4^!W.'%8#%8-KZ
MQ!QOM<****T.(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /$_C*I;QI9JH)8V"  #K^\DKIOAW\.QI*QZOKD
M0-\1NA@8?ZCW/^U_+Z].NG\-6-UXJBUZZ7S;B"W6&!&'RQD,QW^Y^;CTQ^6Q
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5Q/A\_\3VW_P"!?^@FNVKB/#W_
M "'K?_@7_H)H [>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "LWQ#XATOPKH-QK.O7/V33[;;YLWEL^W<P0?*H
M)/S,!P.]:58GC'PI8^-_"=YX>U66XAM+S9YCVS*L@V.KC!8$=5';I0!XW\8O
MC%X$\5?"?6=&T'7?M>H7/D>5#]CG3=MGC<_,R #Y5)Y/:M+]E3_DEFI?]AJ7
M_P!$05R/Q2_9_P#"O@CX:ZIXATJ_UB:[L_)\M+F:)HSOF1#D+&#T8]^M==^R
MI_R2S4O^PU+_ .B(* /;:*** "BBB@ HHHH **** "BBJ.E:WI6O6K76AZG9
MZE;HYC:6SN%F16 !*DJ2,X(./<4 7J*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S3X[?\B)
M:?\ 81C_ /1<E>E+]T?2O-?CM_R(EI_V$8__ $7)7I2_='TKFA_&GZ+]3V\5
M_P BO#?XJG_MHM%%%=)X@4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!XW\5=.^)GC#Q8/"WA-_[-\.O;(UYJ&/+#EB0RE_O,
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M=\&IO"^FRP0WL]O:HKW3,J QR1N<E0Q'"'L>: .YHKY)_P"&5/&__05\/_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-9T[2+>WNFF64P02K(I2)W&-TA Y4 Y'K7T15G.TT[,****!!17S'XI_:/\
M&FC^.=9T/3=)T:>*QOY[:'=;3-(RQNR@G$HR<#G %4/^&E?B1_T+>D_^ -S_
M /':ERBMV;0H5:BO"+:\D?5=%?*G_#2OQ(_Z%O2?_ &Y_P#CM'_#2OQ(_P"A
M;TG_ , ;G_X[2]I#N7]4Q'_/M_<SZKHKY4_X:5^)'_0MZ3_X W/_ ,=H_P"&
ME?B1_P!"WI/_ ( W/_QVCVD.X?5,1_S[?W,^JZ*\,^"OQK\1_$?QK=:/KEEI
M<%O#8/<JUG%(KEA)&H!+2,,8<]O2O<ZLY@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "N(\/?\ (>M_^!?^@FNWKB/#W_(>M_\ @7_H)H [>BBB@ HHHH ****
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MT[6D_M"P'. >6VC\-X_X *U?CQ=SZO'X>\!:>^VX\17ZB<CDI A!8_G@_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?/OPR^&/B_P
M]\=M3\1:QI'V?2IWNS'<?:87W!WRORJY;D>U?05% ',?$+P39_$#P;=:%>R&
M R$203J,F*1?NMCN.Q'H37S[%\+_ (X:7HLW@S3[B,^'YV*N\5W"(MK'+<MB
M4*>X YR>#DU]4T4 </\ "?X<P_#;P>-.,J7-_</YUY<(,!GQ@*O?:HX&?<\9
MQ7G/Q*^"_B9/'I\<?#"Y1-0=_.EMC(L;K+C!9"WRD,,Y#$=^N<#WZB@#YT\)
M_!OQQXJ\?VWBKXNW",+5E86S21N\I3E5Q'\BIGD@=>>.<U]%T44 %?-O[7/_
M #*/_;[_ .T*^DJ^;?VN?^91_P"WW_VA0![=\./^26>%/^P+9_\ HA*Z2N;^
M''_)+/"G_8%L_P#T0E=)0 5\ ?$?_DJ?BO\ [#5Y_P"CWK[_ *^ /B/_ ,E3
M\5_]AJ\_]'O0!S=%%% !1110 5Z3^SY_R7;P]_V\_P#I-+7FU>D_L^?\EV\/
M?]O/_I-+0!]M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCXI\7K+%JVJ+M2&9MTJH3N9Y/1F..#R,<\G  /;**** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ;)(D,323.L<: LSL<!0.Y->3>-/VC/!WAC?;Z1(WB"^7(V6; 0J?]J4\?\
M?(:H?VA/ GBKQMH>G#PK_I$5FTC7-D+CRS-G;M(4X5B,'J<\\9KQ3X>>(_!W
M@'539_$3P%</J<3_ #7=P#(\7(QFWDPHQUW#GTH ^HOAKXKN?&_@&P\07UO%
M;379D)BASM4+(R@<]> .?Y5U59GAS7]+\3Z!;:MH$_GZ?< ^5)Y;)G!*D;6
M(P01TK3H **** "BBB@ HHHH **** "BBB@ HHHH \V_:#_Y(3XA_P"W;_TI
MBKF_V5/^26:E_P!AJ7_T1!72?M!_\D)\0_\ ;M_Z4Q5S?[*G_)+-2_[#4O\
MZ(@H ]MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M &$8_P#T7)7I2_='TKFA_&GZ+]3V\5_R*\-_BJ?^VBT445TGB!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5\V_M<_\ ,H_]OO\ [0KZ2KYM_:Y_YE'_ +??_:% 'MWPX_Y)9X4_
M[ MG_P"B$KI*YOX<?\DL\*?]@6S_ /1"5TE !7P!\1_^2I^*_P#L-7G_ */>
MOO\ KX ^(_\ R5/Q7_V&KS_T>] '-T444 %%%% !7I/[/G_)=O#W_;S_ .DT
MM>;5Z3^SY_R7;P]_V\_^DTM 'VU1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?-W[7/W?"/UO/\
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M>ZR9!0^X(K=KY8^,EAK_ ,0?V@+?P9'=BWMUC06:SL1$H,>]Y,#J3AAZ\ 4
M>\^%9/!W@[PY;Z)H^O6/V.V+F,37\;, S%L9R,X)KH;+6M*U*8Q:=J=G=R*N
MXI!<*[ >N >G-?.H_9(N=HW>,8@<<@:<3_[4KNOA1\#9?AGXGN=7DU]-1$UJ
M;?REM#%C+*V<[S_=Z8[T >NT444 %%%07M]:Z;92WFH7,5K:PKOEFF<(B#U)
M/ H GHKA+/XV?#J^U8:=;^*+7[0S;09(Y(XR?^NC*$_6N[Z]* "BN(UCXR_#
M_0=6?3-3\2VZ7<;;'2**28(V<$,R*5!!Z@GCO76Z;JECK.GQ7^DWD-Y:3#,<
M\#AU;Z$4 6J*R_$'B;1O"FF'4/$6HP:?:@[0\S?>/7"@<L>.@!-8WAGXI^"O
M&%]]C\/:_;W-UV@='A=^,_*LBJ6_#- '6T444 >;?M!_\D)\0_\ ;M_Z4Q5S
M?[*G_)+-2_[#4O\ Z(@KI/V@_P#DA/B'_MV_]*8JYO\ 94_Y)9J7_8:E_P#1
M$% 'MM%%% !1110 4444 %%%% %?4+^VTO3;G4+Z3RK6TA>>:3:6V(H+,<#)
M. #P.:\Z^#WQ1;Q_'JUMJ0CAO[:Y::"$%<FU=CL'8N4/REMH&#'G))KF_P!I
M+QC]BT6T\)6C?OM0Q<W?'2%6^1>5Q\SKG(((\O!X:O'OA;XQ_P"$'\?V6I3-
MML9O]&O>,_N7(RWW2?E(5\ 9.W'>ON<MX=>)RBIB'']Y+6'I'_Y+5?<SFG6M
M42Z'VE1117PQTA5?4+K[#IEU=[/,^SPO+LSC=M!.,]NE6*S_ !!_R+.I_P#7
MG+_Z : /%M+_ &B?$NMV?VO1OA/JNH6VXIYUI<22IN'4;EMR,UI:?^T,MKJM
MO9^//!>K^%4N7"17%PK,GU;<B''T#5ROP*^+'@KP;\-QI?B36OL5[]LEE\K[
M+-)\I"X.40CL>]7OBI\1_#/Q2T&U\%>")_[5U34KR+RI9(F@C@VG)):4*<XR
M..Q/T(![=XEUP>'_  GJ6MK"+I;&U>X$0DV^9M7.-V#C/K@UX_8?M!>*]4LH
M[S3/A%K-Y:RC,<]O-+(CC..&%N0>:[_QEIYTGX&ZMIS2^<UIH;P&3'W]L6W/
MZ54^!7_)%/#W_7)__1C4 <UIO[1-I!J\&G^//"NJ^$Y+@X22Z5F0<]6W(C >
MX4_UKU+7=7FTSPO>:MI=B^KRP6YF@M;<DM<G&0JD!NOL#6/\3/"EEXP^'^J:
M??0))(MN\ULY'S12JI*L#U'H?4$BN6_9SUZXUOX1VT=W(9)-.G>T5CUV##*/
MP#8_"@#"NOCYXPLK66ZO?@]KEO;PJ7DEEDF1$4=22;? 'O4>G_M">*M6L8[W
M2OA'K%[:R9V3VT\LB/@X.&6W(/(Q7IWQ-_Y)7XF_[!D__H!KG_@!_P D1T+Z
M3?\ HYZ &W_Q.\0V'PK7QC/X%N898I&%WI=S=-#+;QAB!)\T62.A/ P#GFNP
M\(>*M/\ &GA:SUW26S!=)DH3EHG'#(?<'BM>:&*YMY(+B-9(I5*.CC(92,$$
M>F*^:KC4]1_9O\>:C EK-?\ A/6$>:QA#\1R@<+D]"#A3ZJ0>2,4 >M^//BA
M'X2U[2O#VD:4VO:_JD@$=A'<"+RT/\;-M;'Y= QR,5W<1<Q(9E5)"HW*K;@#
MW .!GZX%>1_!?P9J$LUU\1/&8$WB#7/WD =>;6 C@ ?PDC''90!W->O4 %8/
MC+QAI?@?PS<ZUK4RI%$N(XMV&GD_A11W)_09)X%;U>#?$7X5W=WH7BKQ=XXU
MR;5[FUMKA]*LHR5@LTY*'H,L!CL!D<[NM 'K/@7Q3_PFO@G3_$'V/[%]M1F^
MS^;YFS#%?O8&>GH*Y[XH?%&3X=S:/;66@2Z[>ZK(Z16T,YC?Y=O0!&+$EL8Q
M1\"O^2*>'O\ KD__ *,:O-_BMXKMM/\ VC_#K7EO=7T6BVGFQV=G%YDDL[[B
MJJ/4_(?PH W5^./C<L ?@QX@ )Z[I^/_ "7KUG6?$%AX>\.3ZWK<OV2TMHO-
MF+#)7_9 ZDY. .YKRNP_:&%MKMO8>._!NJ>%(;IML-U=EBO7JP:-"%Z9(SBO
M0/''@C3?B+X=CTK5;V\ALC*LY-C(BF7 . 2RME><\>U 'FO_  T=<NC:G!\.
M]<E\.J>=5&<!1U.-FS_Q^O6_#'B;2_&'AZVUK0KCS[.X!VDC#*1P58=B#7(^
M.OBCX-^&^G/HE^[/>1V8$&EPP,=\9!51NQL X[GIV-4OV?O"U_X8^&V[5 D<
MFI7+7D<*.'$<;*H7D<9(&>/4=Z *GB[XVZEH7CZ^\+^'O U[XDFL8T>5[.=]
MPW*#RBQ-@#<!G-6/"/Q7\5>(O%%GI>J?"_6-$M;@L)+^X,NR'"DC.Z%1R1CJ
M.M>7^$/B/)I/Q/\ '.LZ=X>U+Q-JU]=&*WM;"(D+"CD;F958@8" ?*>E>K>
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M0%D .2IVVP;!Z'!!]"*]I'3FM3S@HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ^N/YQ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *XCP]_R'K?_ (%_Z":[>N(\
M/?\ (>M_^!?^@F@#MZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.VH,P'L(R#_,4 >Q^$=:/B/P;I&LL,-?6<<S #&&903Q]<UL5QOPBB:'X/\
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MC/?OTK5^+'_)(O%'_8-F_P#0:Z^L+QOH=SXE\"ZSHMB\4=S?6CP1/,2$#,,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O"/%GPZ^)_P 3O$=]
M!K>MP:%X9CN'CMK>,EC+$&.US&I^8D?WV&.P%>[UX9\7_CU>>$_$1\,>#K.&
MYU*,*+FXF0N(V89"(@(RV"#D\<XP>P!)IW[*W@ZWC4ZCJ>KWDH'S;9(XD/T
M0D?]]59N_P!ESP).F(+G6+5NQCN4;\PR&HOB=\7M8\%?#/P^856+Q/K%HDDA
MFAQ]G^0%VV'C=N. ",=>.,5Y<?B%\9_ 4EEKWB4WTNG7K!A%J$2F*4'G;P,Q
MDCD#Y3[$4 =H/@-XV\!7;ZG\+_%^]\[FL[A?*\P#HIY9)#_O!17O6ARZA/H%
MA+K<*0:B]NC742?=27:-P')X!SW-1>&]>M?$_AG3];T_(M[Z!9D#=5R.5/N#
MD'Z5IT %%%% !1110 4444 %%%% !7S;^US_ ,RC_P!OO_M"OI*OFW]KG_F4
M?^WW_P!H4 >W?#C_ ))9X4_[ MG_ .B$KI*YOX<?\DL\*?\ 8%L__1"5TE !
M7P!\1_\ DJ?BO_L-7G_H]Z^_Z^ /B/\ \E3\5_\ 8:O/_1[T <W1110 4444
M %>D_L^?\EV\/?\ ;S_Z32UYM7I/[/G_ "7;P]_V\_\ I-+0!]M4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %<1X>_Y#UO_ ,"_]!-=O7$>'O\
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MTG[0?_)"?$/_ &[?^E,5<W^RI_R2S4O^PU+_ .B(* /;:*** "BBB@ HHHH
M*Q[[PAX:U2]DO-3\/:5>74F-\]Q91R.^  ,L5).  /H*V**N%2=-W@VGY"LG
MN<__ ,(!X._Z%/0__!;#_P#$T?\ " >#O^A3T/\ \%L/_P 37045M];Q'_/R
M7WL.5=CG_P#A /!W_0IZ'_X+8?\ XFMRWMX;2VBM[6&.""%!''%&H544# 4
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M'23=.4RDLSQE!$#D<[7+$@'& #C<#7UY0 4444 %%%% !1110 4444 %%%%
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M*>'UGSEHI'7)_A,C$?I7H506-E;:;I\%C80K!;6\:Q11(,!% P *GH ****
M"BBB@ HHHH **** "OFW]KG_ )E'_M]_]H5])5\V_M<_\RC_ -OO_M"@#V[X
M<?\ )+/"G_8%L_\ T0E=)7-_#C_DEGA3_L"V?_HA*Z2@ KX ^(__ "5/Q7_V
M&KS_ -'O7W_7P!\1_P#DJ?BO_L-7G_H]Z .;HHHH **** "O2?V?/^2[>'O^
MWG_TFEKS:O2?V?/^2[>'O^WG_P!)I: /MJBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^;OVN?N^
M$?K>?^T*^;:^DOVN?N^$?K>?^T*^;: "BBB@ HHHH *^_OAO_P DK\*?]@:T
M_P#1*5\ U]_?#?\ Y)7X4_[ UI_Z)2@#I:*** "BBB@ HHHH **** "BBB@
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M )*MJ'_8'E_]'0U];U\D?LK_ /)5M0_[ \O_ *.AKZWKZX_G$**** "BBB@
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M--^UQ-Y4>$&[R@-XX5>2<<^]<'\)KB&T^-7Q/N+J:."&.X#/)(P55 DDY)/
M% 'NE%9VD^(=%UY7;0]7L-26/AS9W*3!?KM)Q6C0 45RWQ)UK6M \!:A>^%M
M/N-0U;"QVT5O;M,RLQ W[%!SM&3Z<#->7:7^SC%XAT:WU7QSXEUR?Q!<1B61
MEF7$#$9"D.K,2O0\CIVH ]ZHKQ?X+:YKVF>,O$?P\\2ZB^J'1<26EW*27\O(
M&TDY.,,I )..1Z8PO'_AJR^*/[24'AG4+BYCL=.TG=.]JRJZMRV 64C^-.U
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MD7</E^7)]HE;;F5%/#,1T)[5I>&?A?X/U#PGI-Y>:1YEQ<64,LK_ &F8;F9
M2<!\#D]JP]I7Y^2RO:_7_(]1X/*EAEB>>IRN3C\,;W23_FVU.M_X3'PQ_P!#
M'I/_ ('1?_%5LUQG_"I/!'_0$_\ )N;_ .+KL(88K:WC@MXTBAB4(D:*%5%
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M &O1J**VITXTU:*/+Q>.KXR2E6E>VRZ)=DMD@HHHK0XPHHHH **** "BBB@
MHHHH ***X#XI?%*U^']A#9V$']I^)=1PFG:9&"S,2=H=PO.W=P .7/ _B90
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M+J*VM/%FASW$SB.**+4H6:1B<!0 V223@ 5T% !1110 4444 %%%% !1110
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M&_\ R2OPI_V!K3_T2E '2T444 %%%% !1110 4444 %%%% !1110!\8?&_\
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MW:\/,?XJ]/\ ,_6."_\ D7S_ ,;_ /28A1117FGVP4444 :G[*__ "5;4/\
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M&4XZ$'M0!9HHHH **** "BBB@ HHHH **** "BBB@#S;]H/_ )(3XA_[=O\
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MNKOR'C2%%/\ M@'C.22,<8&2:TOV@-+M[?0/ FDNOFVT>IQ6Q5OXD"A<'\*
M,ZS\0I^T/\0I=&EOC8>$]*Q<?V<&*SZE@X#-Z+GMU ([G(^@;&QM=,L(++3K
M>.VM;=!'%#$H544=  *\=^,'@V;PW_9OQ"\"VT=IJ'AY52>V@3:DUJ.,;1V4
M9!_V2?[HKTWP;XMT[QMX5M-<TB3=#<+\Z'[T3C[R-[@_GP>] &Y1110 4444
M %%%% !1110 4444 ,FFBMX))KB1(HHU+O([!510,DDGH .]9/\ PF/AC_H8
M])_\#HO_ (JMFOEKXA>&/^$4\975C$N+27]_:\_\LF)P.I/RD%<GD[<]ZY,5
M6G1BI)71]%D65X?,ZLJ-6;C)*ZMU[_I_2/8/B?XET+4/AOJEM8:UIUS<2>5L
MBANT=VQ*A. #D\ FM7PGXK\.VW@S18+C7M,BECL($>-[R-61A&H(()X(/:OF
M2BO-^O2Y^>W2Q]R^$Z#PBPOM'92<KV75)?H?6L/BOP[<3QPV^OZ7++(P1(TO
M(V9V)P  #R2>U6M5UC3]#L6O-7O(;2W7/SRMC<<$[0.K-@' &2<<5\S>!-6?
M1-?^VV.ES:KJHC=+&WC5B%8JVZ0A>6P,C;CD,3E=HSZMI?PSU;Q!>Q:I\2]4
M?4&"DIIT;E4C)51R5P%/'(08) .X\@]M+%3JQ]V.OX+U/E<PR'"Y?6_?56H6
M\N:3[17;S=E<JW'C7Q/\0YCI_@&SFTNQ^83:I=?+GY!\F0&"'+?PDM]T_* :
MZGPC\.=-\,7!U"YE?5-9=G9]0GSN^8\X4DX..K<L<MS@XKK888K:WC@MXTBA
MB4(D:*%5% P  .@ I]=$*.O--W?Y>B/&Q&:-TWA\+'V=/JEO+_%+=^FWD%%%
M%=!XX4444 %%%% !1110 4444 %%%% !117 ?%+XI6OP_L(;.P@_M/Q+J.$T
M[3(P69B3M#N%YV[N !RYX'\3* 'Q2^*5K\/["&SL(/[3\2ZCA-.TR,%F8D[0
M[A>=N[@ <N>!_$RYGPM^%MUHM_-XR\>3_P!I^,M1R\DDA#+9 C&Q,<;MORDK
MP!\B_+DL?"WX6W6BW\WC+QY/_:?C+4<O))(0RV0(QL3'&[;\I*\ ?(ORY+>I
M4 8GBKP?H7C;2H]-\3V/VZTCF$Z1^<\>'"LH.48'HS<9QS7(_P##/GPQ_P"A
M9_\ )^Y_^.5Z310!YM_PSY\,?^A9_P#)^Y_^.4?\,^?#'_H6?_)^Y_\ CE>D
MT4 >;?\ #/GPQ_Z%G_R?N?\ XY7I(X'%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7D?Q+^*WA'X9:PL=MH=KJ7B)QYK) B1-$&_B>7:2"03Q
M@DCKC(KUROE+2F\.0_M1^(7^)?V981/,;8WX_<;\CRRV[C'E]">.GM0 Z7]J
M_P 3F5C!H&DI'GY5<RL0/<AAG\A73>$OVJ;.]OX;3Q=HHL(Y&"F]M)2Z(2>K
M(1D+ZD$GVK$_:$UGP%)IND'P9/I4FMPW/F"XT@I^[C /WGCXSNVD G(P:T/C
M;>>%7^%.DC7[.*+QI=V5M<1&.VVS#('F%W  V_>&">O04 ?1L,T=Q!'-;R++
M%(H='0Y5E(R"#W&*?7!?!%[Q_@QX=.H;_,^SD)O/)CWML_#;C'MBN]H ****
M /"OVJ_[0_X0/2OLV[[#]O\ ])V]-VP[,^WWOQQ4?A3QG\-[;]G5-.O[W34*
MV#I=:=(R^?+<8.3Y?WF);!#8XXY&./;M5TFPUS2Y].U>TBO+.X7;+#*N58?Y
M[]J\FG_9>\!37YN(YM8@B+9^S1W2&,#TRR%L?\"H X[]DM+[S_$CX?\ L\K"
M,G[IERW3WV]?PKG_  1J%I\,OVF=5M_$$PL[.26XM_/E^1$60[XV/8*?EYZ#
M-?4/ASPUI'A/1H]*\/6,=E9QG(1,DL>[,3RQ]SS7/^//A1X6^(GER:]:RQWD
M2;([VUD\N55SG&2"&'^\#C)QUH \#^/6MV/Q%^)^@Z'X3NXM4\N,6_FVKB1#
M)(_16!P<#&2./?BOIC5?"VE:_P"%#X=URV^UZ<\<<<D.]H]P0JR\H01RH/![
M5S'@7X+>$/ %]]OTF"XN]0 (2[OI!(\8/4* %4<<9 SCO7?T >;?\,^?#'_H
M6?\ R?N?_CE>)?M%_#[PQX$_X1S_ (133/L'VW[5]H_TB67?L\K;]]FQC>W3
M'6OK:OFW]KG_ )E'_M]_]H4 >W?#C_DEGA3_ + MG_Z(2NDKF_AQ_P DL\*?
M]@6S_P#1"5TE !7P!\1_^2I^*_\ L-7G_H]Z^_Z^ /B/_P E3\5_]AJ\_P#1
M[T <W1110 4444 %>D_L^?\ )=O#W_;S_P"DTM>;5Z3^SY_R7;P]_P!O/_I-
M+0!]M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'S=^US]WPC];S_P!H5\VU])?M<_=\(_6\_P#:
M%?-M !1110 4444 %??WPW_Y)7X4_P"P-:?^B4KX!K[^^&__ "2OPI_V!K3_
M -$I0!TM%%% !1110 4444 %%%% !1110 4444 ?&'QO_P"3C=3_ .N]G_Z(
MBJ2H_C?_ ,G&ZG_UWL__ $1%4E>+F7QQ/U#@G_=ZOJOR"BBBO+/O@HHHH P-
M"_Y+IX?_ .PS8_\ HR.ONJOA70O^2Z>'_P#L,V/_ *,CK[JKZBA_"CZ+\C\#
MS;_D85_\<O\ TIA1116QYI\+^(O^2\>(?^PS??\ H<E;M87B+_DO'B'_ +#-
M]_Z')6[7AYC_ !5Z?YGZQP7_ ,B^?^-_^DQ"BBBO-/M@HHHH B^"G_)QVE_]
M?%Y_Z(EK[0KXO^"G_)QVE_\ 7Q>?^B):^T*^KI_ C^>L7_O%3_$_S"BBBK.8
M^%_$7_)>/$'_ &&;[_T.2MVL+Q%_R7CQ!_V&;[_T.2MVO#S'^*O3_,_6."_^
M1?/_ !O_ -)B%%%%>:?;!1110!J?LK_\E6U#_L#R_P#HZ&OK>ODC]E?_ )*M
MJ'_8'E_]'0U];U]<?SB%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q'A[_ )#U
MO_P+_P!!-=O7$>'O^0];_P# O_030!V]%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5\Q_%:&]^)7[1%AX%FOWL].M@J@#D F/S'<#NQ'RC/I7TY7B'QJ^$.N:_X
M@M?&/@*4QZU;JHEA2;RG<K]QXV. & X()&0!]" 9'PI\*6/@K]I#Q#H&DRW$
MEK:Z4-CW#!G.[RF.2 !U)[5!\ ;JZTKXQ>,_#C7;7%N'EE8]FD2;;OQG@D-S
M_P#6KA+?3/C</%U[J\&EZQ%K&HP_9+B\%FB;DP!C?M"K]T?,,'CK7MGP,^$]
M]X!L[W5O$DBMK>I *\:N'\A,YP6_B8GDXXX')H ]<HHHH **** "BBB@ HHH
MH **** "BBB@#S;]H/\ Y(3XA_[=O_2F*N;_ &5/^26:E_V&I?\ T1!72?M!
M_P#)"?$/_;M_Z4Q5S?[*G_)+-2_[#4O_ *(@H ]MHHHH **** "BBB@ HHHH
M AO+2#4+&>SNT\RWN(VBE3)&Y6&",CD<'M7)?#;P1_PA>EWJ3OYMW=7+;I,8
MS$C%8^ Q'(R_J-^#TKLZ*ATXN2F]T=4,76IT)X>+]V33:]-OZ\D%%%%6<H44
M44 1W%O#=6[P74,<T,@P\<BAE8>A!ZUDV/@WPQI=X+O3/#>D6=R#D36]C%&X
M_P"!!0:VJ* "JNHZ7I^L6AM=6L;:^MVZPW,*R(?P8$5:HH S=)\-Z'H._P#L
M+1M/TWS/O_8[5(=WUV@9J2_T32M5N+:XU33+.]FM'WV\EQ;I(T+<'*%@2IX'
M(]!5ZB@"C<Z)I5[J=OJ5YIEG<7UJ,6]U+;HTL/\ NN1E>IZ&I=0TZRU:QDLM
M5L[>]M9,;X+F)9$?!R,JP(/(S5FB@"*UM;>RM8K6R@CM[>%0D<42!$11T  X
M ]JK6&B:5I5Q<W&EZ99V4UVV^XDM[=(VF;DY<J 6/)Y/J:O44 9VK>'M%UY4
M77-(L-26/E!>6R3!?IN!Q5C3]-L=)LTM-*LK>RMD^[#;1+&B_15  JS10!1N
M]$TJ_P!0MK^^TRSN;RT.;>YFMT>2'O\ (Q&5_"KU%% &3:>%?#UAJ;ZE8Z#I
MEM?2;M]U#9QI*V[KEP,G/?FIK#P_HVEV,]EIFD6-G:W!)F@M[9(TE)&#N4
MY''-:%% %33-)T[1;(6>CV%KI]LK%A!:PK$@)ZG:H S3#HFE'6AJYTRS.IJG
MEB]-NGG!>FW?C=CVS5ZB@"C'HFE0ZQ+JT6F6<>I3+LDO5MT$SKQP7QN(X'&>
MPJ./PWH<4U[+%HVGI)J'_'XZVJ W/?\ >''S]3US6E10!G:3X?T;04=-#TBP
MTU9#EQ9VR0AOKM S6C110!2U71=+UVU6VUO3;/48%;>L5Y LJANF<,",\GGW
MK(_X5QX(_P"A-\/_ /@K@_\ B:Z2B@#)TKPGX=T*Z:YT/0-+TV=EV-+9V4<+
M%<YP2H!QP.*M:EI&FZU:_9M8T^UOX,Y\JZ@65<^N&!%7** *.EZ)I6AVYM]$
MTRSTZ%CN,=I;K$I/KA0!1J6B:5K#0-J^F6=^;9_,@-U;I+Y3?WEW X/ Y%7J
M* ([BW@O+62VNX8YX)5*212J&5U(P00>"#Z5#IVF6&D6*6>DV5O8VL>=D%M$
ML:+DY.%4 #FK5% %&'1-*M]7FU6#3+.+49UV2WB6Z":1>.&<#<1P.I["O&/A
M1;07OQI^)]M>01W$$MP%DBE0,KCS'X(/!%>ZT4 4-*T'2-"B>+0]*L=-C<Y9
M+.V2$,?4A0,T[4=%TO6/(_M?3;._^SR>9#]J@67RG_O+N!P?<5=HH ;)&DL3
M1RHKQN"K*PR&!Z@BJ6DZ%I&@P/#H>E66FQ2-O>.SMTA5FQC)"@9..]7Z* "B
MBB@ HHHH **** "BBB@ HHHH *X#XP>&/[>\&M?0+F[TK=.O/WHL?O!R0.@#
M9Y/R8'6N_IDTT5O!)-<2)%%&I=Y'8*J*!DDD] !WK.I!5(.+ZG9@L54PF)A7
MI;Q?W^7S6A\;U-9VD]_?06=HGF3W$BQ1)D#<S' &3P.3WJ?5T@_M2>>PMIK:
MPN)7DLTE!SY.]@O))SC!&<GD'FO2_@;X8^UZK<>([E?W5GF"VYZRLOS'@]D.
M,$8._P!17S=*DZE101^WYAF$,%@I8J71:+SZ+[]_F>I^%/!>D>$K"*/3[2'[
M7Y86>\V?O)3A=QR22H)4':#@&N@HHKZ:,5%6BC\*K5ZM>HZE63<GU844451B
M%%%% !1110 4444 %%%% !1110 445Y=\4OBE<Z'?0^#O D']I^,M1PD448#
MBR##.]\\;L?, W 'SM\N P!9^)?QBTOP1YFCZ2O]K^*YMB6NEPHS[7D^X9-O
MX'8#O;<N  VX5?A;\+;K1;^;QEX\G_M/QEJ.7DDD(9;($8V)CC=M^4E> /D7
MY<EM+X6_"VV\ V,U]J,_]I^)M1R^HZE(2Y8L=Q1"W.W/))Y<\G^%5] H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-+7FU>D_L^?\EV\/?]O/_I-+0!]M4444 %%%% !1110 4444 %%%% !1110
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MF^_]#DK=KP\Q_BKT_P S]8X+_P"1?/\ QO\ ])B%%%%>:?;!1110!J?LK_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\*KZ!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"3CM+_ .OB\_\ 1$M?:%?%_P %/^3CM+_Z^+S_ -$2U]H5]73^!'\]8O\
MWBI_B?YA1115G,?"_B+_ )+QX@_[#-]_Z')6[6%XB_Y+QX@_[#-]_P"AR5NU
MX>8_Q5Z?YGZQP7_R+Y_XW_Z3$****\T^V"BBB@#4_97_ .2K:A_V!Y?_ $=#
M7UO7R1^RO_R5;4/^P/+_ .CH:^MZ^N/YQ"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *XCP]_R'K?\ X%_Z":[>N(\/?\AZW_X%_P"@F@#MZ*** "BBB@ HHHH
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M#_V[?^E,5<W^RI_R2S4O^PU+_P"B(* /;:*** "BBB@ HHHH **** "BBB@
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M]US1)M3\27<GF06*,Q>&)V5=JC#%6 )XY(10O'S"I_\ A:'B?_HFVK?G+_\
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MHHH *^_OAO\ \DK\*?\ 8&M/_1*5\ U]_?#?_DE?A3_L#6G_ *)2@#I:***
M"BBB@ HHHH **** "BBB@ HHHH ^,/C?_P G&ZG_ -=[/_T1%4E1_&__ ).-
MU/\ Z[V?_HB*I*\7,OCB?J'!/^[U?5?D%%%%>6??!1110!@:%_R73P__ -AF
MQ_\ 1D=?=5?"NA?\ET\/_P#89L?_ $9'7W57U%#^%'T7Y'X'FW_(PK_XY?\
MI3"BBBMCS3X7\1?\EX\0_P#89OO_ $.2MVL+Q%_R7CQ#_P!AF^_]#DK=KP\Q
M_BKT_P S]8X+_P"1?/\ QO\ ])B%%%%>:?;!1110!%\%/^3CM+_Z^+S_ -$2
MU]H5\7_!3_DX[2_^OB\_]$2U]H5]73^!'\]8O_>*G^)_F%%%%6<Q\+^(O^2\
M>(/^PS??^AR5NUA>(O\ DO'B#_L,WW_H<E;M>'F/\5>G^9^L<%_\B^?^-_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%>9?&'P'XO\:KI7_"&:Y'I)M3+]H\R[F@\S=MV_ZM3G&#U]: ,3XC
M?$3Q)X>^.'ACPYI5ZD6F:A]G^T1&!&+;IF5L,1D<#M7M%?$/BWP%XPT+XD:-
MH.MZ[%>:S?>5]DO%O)I!%ND*K\[*&7# G@'%>U?#GX2_$?PSX[L=5\2^*H+_
M $V#?YMNFHW$I?*$#Y70*<$@\F@#W2BBB@ HHHH **** "BBB@ HHHH *^;?
MVN?^91_[??\ VA7TE7S;^US_ ,RC_P!OO_M"@#V[X<?\DL\*?]@6S_\ 1"5T
ME<W\./\ DEGA3_L"V?\ Z(2NDH *^ /B/_R5/Q7_ -AJ\_\ 1[U]_P!? 'Q'
M_P"2I^*_^PU>?^CWH YNBBB@ HHHH *])_9\_P"2[>'O^WG_ -)I:\VKTG]G
MS_DNWA[_ +>?_2:6@#[:HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** /F[]KG[OA'ZWG_ +0KYMKZ
M2_:Y^[X1^MY_[0KYMH **** "BBB@ K[^^&__)*_"G_8&M/_ $2E? -??WPW
M_P"25^%/^P-:?^B4H Z6BBB@ HHHH **** "BBB@ HHHH **** /C#XW_P#)
MQNI_]=[/_P!$15)4?QO_ .3C=3_Z[V?_ *(BJ2O%S+XXGZAP3_N]7U7Y!111
M7EGWP4444 8&A?\ )=/#_P#V&;'_ -&1U]U5\*Z%_P ET\/_ /89L?\ T9'7
MW57U%#^%'T7Y'X'FW_(PK_XY?^E,****V/-/A?Q%_P EX\0_]AF^_P#0Y*W:
MPO$7_)>/$/\ V&;[_P!#DK=KP\Q_BKT_S/UC@O\ Y%\_\;_])B%%%%>:?;!1
M110!%\%/^3CM+_Z^+S_T1+7VA7Q?\%/^3CM+_P"OB\_]$2U]H5]73^!'\]8O
M_>*G^)_F%%%%6<Q\+^(O^2\>(/\ L,WW_H<E;M87B+_DO'B#_L,WW_H<E;M>
M'F/\5>G^9^L<%_\ (OG_ (W_ .DQ"BBBO-/M@HHHH U/V5_^2K:A_P!@>7_T
M=#7UO7R1^RO_ ,E6U#_L#R_^CH:^MZ^N/YQ"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *XCP]_R'K?_@7_ *":[>N(\/?\AZW_ .!?^@F@#MZ*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#(UWQ9H'ACR?^$AU>TTWS\^5]IE";\8SC/7&1^=>0^*M
M#^"/C'Q)<ZYK/BRW-Y<[?,\K4E5?E4*,#'H!7:?%+X36GQ0&FB\U2;3_ +!Y
MFWRH@^_?MZY/&-OZUYX_[)VCQHSOXJO%51DL;9  /7K0!77X>_  ,"?%4; '
MH=57!_2O4OAPWPYTR&71OAU>:=(Q'G3QVUQYTCXXW,Q))'/T&>*\7A^!'PZN
M+T6=O\4K&6Y9MJPI/;EBWH 'R3QTKU'X9_!"Q^&OB*?5K36;B^>:V-N8Y850
M %E;.0?]F@#U&BBB@ HHHH **** "BBB@ HHHH **** /-OV@_\ DA/B'_MV
M_P#2F*N;_94_Y)9J7_8:E_\ 1$%=)^T'_P D)\0_]NW_ *4Q5S?[*G_)+-2_
M[#4O_HB"@#VVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH S]=TB+7]#N=+N+BXMXKE0CR6SA'VY!
M(!(/! P1CD$BN#_X41X8_P"?[5O^_P!%_P#&Z])F$K02"W=$E*D(SH656QP2
M 1D9[9'U%>%7OQL\7:??W%E=Z;I,=Q;RM%*GE2':RG!&1)@\CM7'B70BTZJ/
MILDIYI6C.G@*G+;5J]M^OX%SQS\)="\,^#+[5["[U&2XM_+V+-(A0[I%4Y 0
M'HQ[UH:!\%_#NJ^&],U"XO=366[M(IW5)8PH9D#$#*'C)KB?$7Q:UWQ-H%SI
M%_::=';W&W>T,;AQM8,,$N1U4=JLZ9\:/$6E:3::?;V6F-%:0) C/%(6*JH4
M$X<<X%<'M,+[2]M+?B?7/!\0?4U!5/WG,W>Z^&RM^-SH/%_PR\&^#O#\FIWM
MWK,IW"*&%)H\RR$$A<^7\HP"23V!ZG /4_##P?=:9:MXB\0R7<NNZA'MD^U.
M2\461M4Y)))"J3GD8"X&#GSG0->UWXA_%31KB^CAF6SE$H@576"W1,%G !)!
M) P2<%MH/&!7T-75AH4ZDW4BK);?YG@9WB,;@\/'!XBIS3FKR=]ETBO+2[[Z
M=$%%%%>B?%!1110 4444 %%%% !1110 4444 %%%>-_$;XC:OKOB,_#GX5'S
MM<FRFHZFC8CTY!PX#C[K#.&8<J2%7,A 4 /B-\1M7UWQ&?AS\*CYVN3934=3
M1L1Z<@X<!Q]UAG#,.5)"KF0@+VWPY^'.D?#?PX-.TL>==38>]OG7$ERX[G^Z
MHR=JYP 3U)))\.?ASI'PW\.#3M+'G74V'O;YUQ)<N.Y_NJ,G:N< $]223UU
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M_1[T <W1110 4444 %>D_L^?\EV\/?\ ;S_Z32UYM7I/[/G_ "7;P]_V\_\
MI-+0!]M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'S=^US]WPC];S_VA7S;7TE^US]WPC];S_VA
M7S;0 4444 %%%% !7W]\-_\ DE?A3_L#6G_HE*^ :^_OAO\ \DK\*?\ 8&M/
M_1*4 =+1110 4444 %%%% !1110 4444 %%%% 'QA\;_ /DXW4_^N]G_ .B(
MJDJ/XW_\G&ZG_P!=[/\ ]$15)7BYE\<3]0X)_P!WJ^J_(****\L^^"BBB@#
MT+_DNGA__L,V/_HR.ONJOA70O^2Z>'_^PS8_^C(Z^ZJ^HH?PH^B_(_ \V_Y&
M%?\ QR_]*84445L>:?"_B+_DO'B'_L,WW_H<E;M87B+_ )+QXA_[#-]_Z')6
M[7AYC_%7I_F?K'!?_(OG_C?_ *3$****\T^V"BBB@"+X*?\ )QVE_P#7Q>?^
MB):^T*^+_@I_R<=I?_7Q>?\ HB6OM"OJZ?P(_GK%_P"\5/\ $_S"BBBK.8^%
M_$7_ "7CQ!_V&;[_ -#DK=K"\1?\EX\0?]AF^_\ 0Y*W:\/,?XJ]/\S]8X+_
M .1?/_&__28A1117FGVP4444 :G[*_\ R5;4/^P/+_Z.AKZWKY(_97_Y*MJ'
M_8'E_P#1T-?6]?7'\XA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<1X>_Y#UO_
M ,"_]!-=O7$>'O\ D/6__ O_ $$T =O1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %?-WQPUO7_&_P 4+'X9>')C# 0AN 'VK*[+O)<C^%$YQZYX/%?2-?,_QJLM
M;^'GQCL/B/I%O]HM)=GF,P)175=C1L?X0R=#]?2@!]S^R5*NF%K3Q:LE\%R$
MDL=L;'TR') ]\'Z5M_LY^,-:>]U?P+XFDDDN-'!,!E;<T05MCQY[@'&/Q[8J
MI<_M9:9_9!:S\,W?]HE.(Y9U\E6_WAR0/]T9]J=^S;X=U6^U;7/'^N(R-JA:
M.!BI7SBS[Y' _NY  _'TH ^@Z*** "BBB@ HHHH **** "BBB@ HHHH \V_:
M#_Y(3XA_[=O_ $IBKF_V5/\ DEFI?]AJ7_T1!72?M!_\D)\0_P#;M_Z4Q5S?
M[*G_ "2S4O\ L-2_^B(* /;:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPWXY^&/LNJ6WB.V7]
MW>8@N>>DJK\IY/=!C &!L]37N59GB/1(/$?AR]TFZ.U+J,J'P3L8<JV 1G#
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MYE'_ +??_:% 'MWPX_Y)9X4_[ MG_P"B$KI*YOX<?\DL\*?]@6S_ /1"5TE
M!7P!\1_^2I^*_P#L-7G_ */>OO\ KX ^(_\ R5/Q7_V&KS_T>] '-T444 %%
M%% !7I/[/G_)=O#W_;S_ .DTM>;5Z3^SY_R7;P]_V\_^DTM 'VU1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ?-W[7/W?"/UO/\ VA7S;7TE^US]WPC];S_VA7S;0 4444 %%%%
M!7W]\-_^25^%/^P-:?\ HE*^ :^_OAO_ ,DK\*?]@:T_]$I0!TM%%% !1110
M 4444 %%%% !1110 4444 ?&'QO_ .3C=3_Z[V?_ *(BJ2H_C?\ \G&ZG_UW
ML_\ T1%4E>+F7QQ/U#@G_=ZOJOR"BBBO+/O@HHHH P-"_P"2Z>'_ /L,V/\
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MF(4445YI]L%%%% &I^RO_P E6U#_ + \O_HZ&OK>ODC]E?\ Y*MJ'_8'E_\
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MX T <EX/C^"'BZ^6X\/Z;H+7\A&+.XMA&X;&<+"_!QZJ"/>O7$18XU2-0B*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** "BBB@ HHHH **** "BBB@ HHHH ^,/C?_ ,G&ZG_UWL__ $1%4E1_&_\
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M+QX@_P"PS??^AR5NUA>(O^2\>(/^PS??^AR5NUX>8_Q5Z?YGZQP7_P B^?\
MC?\ Z3$****\T^V"BBB@#4_97_Y*MJ'_ &!Y?_1T-?6]?)'[*_\ R5;4/^P/
M+_Z.AKZWKZX_G$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KB/#W_(>M_^!?\
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M/C8AA@C(S_6OGC_A _VAO^?SQ!_X4:?_ !^OK*""*UMX[>WC6.&) D:*,!5
MP /PJ2@#XN\8^$OC)IGA.\N_&ESK#Z)'L^TK<ZVMQ&<NH7,8E;/SE>QP>>U>
MR?LJ?\DLU+_L-2_^B(*Z3]H/_DA/B'_MV_\ 2F*N;_94_P"26:E_V&I?_1$%
M 'MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCXP^))_ /PTN/)T6+Y=<U]>8RAX,:$=5.".#F0@@$1AF8 /%_B_6/C#XDG\
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M%% !1110 4444 %%%% !1110 4444 ?&'QO_ .3C=3_Z[V?_ *(BJ2H_C?\
M\G&ZG_UWL_\ T1%4E>+F7QQ/U#@G_=ZOJOR"BBBO+/O@HHHH P-"_P"2Z>'_
M /L,V/\ Z,CK[JKX5T+_ )+IX?\ ^PS8_P#HR.ONJOJ*'\*/HOR/P/-O^1A7
M_P <O_2F%%%%;'FGPOXB_P"2\>(?^PS??^AR5NUA>(O^2\>(?^PS??\ H<E;
MM>'F/\5>G^9^L<%_\B^?^-_^DQ"BBBO-/M@HHHH B^"G_)QVE_\ 7Q>?^B):
M^T*^+_@I_P G':7_ -?%Y_Z(EK[0KZNG\"/YZQ?^\5/\3_,****LYCX7\1?\
MEX\0?]AF^_\ 0Y*W:PO$7_)>/$'_ &&;[_T.2MVO#S'^*O3_ #/UC@O_ )%\
M_P#&_P#TF(4445YI]L%%%% &I^RO_P E6U#_ + \O_HZ&OK>ODC]E?\ Y*MJ
M'_8'E_\ 1T-?6]?7'\XA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<1X>_Y#UO
M_P "_P#037;UQ'A[_D/6_P#P+_T$T =O1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?.7Q'^(7BSP7^T%:K<:K<V'AN=K8%"FZ%X/E\T@,"-V=V2O(XKZ-KP3XF
M?L_ZWXZ\>7VNVFN65O;7&SRX9E<E,(JGH,<E: /;[/6-,U&V6XL-1M;J%QE9
M(9U=2/J#5E)HY#B.1'([*P-?+7_#*'B#<1_PD>EY')&R3_"O0/@]\$M5^&WB
MRZU;4=5L[R.:T:W"0*P8$LISR.GRT >T4444 %%%% !1110 4444 %%%% !1
M110!YM^T'_R0GQ#_ -NW_I3%7-_LJ?\ )+-2_P"PU+_Z(@KI/V@_^2$^(?\
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M\R>$R6M*A@+NIUE*SY?*.BL^[W6RUO9D,,5M;QP6\:111*$2-%"JB@8  '0
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MHMX=.US]S<B< 9=$<P[6.,,7.T#H=^,$[2/LF@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N(\/?\AZW_P"!?^@FNWKB/#W_ "'K?_@7_H)H [>BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *^?_CE\0/$EUXQL_AWX%>:&\N53[1);MMDD9^1&
M&_A4+\S'T/7 -?0%?,/Q7N;[X:?M%6'C=[1KJPNE5ACC=B/RI$![,!@C/J*
M,E_V9O']A;C4[/5=-;4(_P!Z(X+J59=W7Y7* ;OQ'UKTS]G_ .)6K^*8-0\-
M>*VDDU;20")I1B21 =I5_P#:5N,]3GGD$U/<_M-^ HM(-U;G4)[K9E;/[-M?
M=Z%B=H]R"?QKE/V;['4-?\;^)_'=Y#Y,-XSQ*%^ZTDCB1@/4* /SH ^C****
M "BBB@ HHHH **** "BBB@ HHHH \V_:#_Y(3XA_[=O_ $IBKF_V5/\ DEFI
M?]AJ7_T1!72?M!_\D)\0_P#;M_Z4Q5S?[*G_ "2S4O\ L-2_^B(* /;:***
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M."_^1?/_ !O_ -)B%%%%>:?;!1110!%\%/\ DX[2_P#KXO/_ $1+7VA7Q?\
M!3_DX[2_^OB\_P#1$M?:%?5T_@1_/6+_ -XJ?XG^844459S'POXB_P"2\>(/
M^PS??^AR5NUA>(O^2\>(/^PS??\ H<E;M>'F/\5>G^9^L<%_\B^?^-_^DQ"B
MBBO-/M@HHHH U/V5_P#DJVH?]@>7_P!'0U];U\D?LK_\E6U#_L#R_P#HZ&OK
M>OKC^<0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "N(\/?\AZW_ .!?^@FNWKB/
M#W_(>M_^!?\ H)H [>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEKRXL9HH '"DNR$+R2 .3UH ^/\ Q;;#X-_$,_\ "OO%_P!JE3(D6+EH>?\
M52\;'^GMR!Q4'AH#XN_$9#\1/%WV(RX"O,,&3G_51\;(_P <#)X!)KW3X8_L
MZZ1X7\G5/%WE:OJRX=(,9M[9OH?]81ZGCT'&:M_$W]GW0_&7G:EX>\O1M:8%
MCL7%O<-_MJ!P3_>7\0: /3?#OA_3?"WA^UT;1(3!96JE8T+ECR<DDGDDDD_C
M6G7'?"G1M7\/_#73-*\1AQJ%IYD<FZ7S.!(VW#9.1MQCVKL: "BBB@ HHHH
M**** "BBB@ KYM_:Y_YE'_M]_P#:%?25?-O[7/\ S*/_ &^_^T* /;OAQ_R2
MSPI_V!;/_P!$)725S?PX_P"26>%/^P+9_P#HA*Z2@ KX ^(__)4_%?\ V&KS
M_P!'O7W_ %\ ?$?_ )*GXK_[#5Y_Z/>@#FZ*** "BBB@ KTG]GS_ )+MX>_[
M>?\ TFEKS:O2?V?/^2[>'O\ MY_])I: /MJBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^W;_P!*8JYO]E3_ ))9J7_8:E_]$04 >VT444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=)0 5\ ?$?\ Y*GXK_[#5Y_Z/>OO^O@#XC_\E3\5_P#8:O/_ $>] '-T444
M%%%% !7I/[/G_)=O#W_;S_Z32UYM7I/[/G_)=O#W_;S_ .DTM 'VU1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?-W[7/W?"/UO/_:%?-M?27[7/W?"/UO/_ &A7S;0 4444 %%%
M% !7W]\-_P#DE?A3_L#6G_HE*^ :^_OAO_R2OPI_V!K3_P!$I0!TM%%% !11
M10 4444 %%%% !1110 4444 ?&'QO_Y.-U/_ *[V?_HB*I*C^-__ "<;J?\
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MO^0];_\  O\ T$T =O1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]WPC];S_ -H5\VT %%%% !1110 5]_?#?_DE?A3_ + UI_Z)2O@&OO[X;_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'MG+I;L^_H>I+*<6\MC0LN93;MSPV<8K^:VZ/6:*\S_X6AXG_P"B;:M^<O\
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MR+_?&,9[T ?9/PX_Y)9X4_[ MG_Z(2NDKF_AQ_R2SPI_V!;/_P!$)724 %?
M'Q'_ .2I^*_^PU>?^CWK[_KX ^(__)4_%?\ V&KS_P!'O0!S=%%% !1110 5
MZ3^SY_R7;P]_V\_^DTM>;5Z3^SY_R7;P]_V\_P#I-+0!]M4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ4Q5S?[*G_)+-2_[#4O_ *(@H ]MHHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6M*^)C:*=,TZ\M5T]I3*+G;\X;9TVD_W37I]O^U3X5M[:*&/P_JRI&@10OE
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M -$05TG[0?\ R0GQ#_V[?^E,5<W^RI_R2S4O^PU+_P"B(* /;:*** "BBB@
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M*-2[R.P544#)))Z #O5G,DV[(?7 ?&'PQ_;O@UKZ!<W>D[IUY^]%C]X.2!T
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M?A)IFK6^EZCI'ANUO[G'D6LRQK))DX&U3R<GBM3_ (5/X!_Z%#2/_ 5:\?\
MC#_R<WX)_P"W3_TH:OH^@"II>DV&B:;%I^D6D-G:19\N"%=JKDY.!]235NBB
M@ HHHH **** "BBB@ HHHH *^;?VN?\ F4?^WW_VA7TE7S;^US_S*/\ V^_^
MT* /;OAQ_P DL\*?]@6S_P#1"5TE<W\./^26>%/^P+9_^B$KI* "O@#XC_\
M)4_%?_8:O/\ T>]??]? 'Q'_ .2I^*_^PU>?^CWH YNBBB@ HHHH *])_9\_
MY+MX>_[>?_2:6O-J])_9\_Y+MX>_[>?_ $FEH ^VJ*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBCXT\;>+KK3_ !580V]I%9M,C1VCQ$N'48RQ/8FN57]K:Z"_/X/A)]M0(_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N.T'_D-P?\"_\ 0378UQVA?\AJ#_@7_H)H [&B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *^6_&@TFP_:ZAF\8QQMI4IA8?:(]\9S
M#M0D$<KO'TKZDKA_B'X+\%ZVUCK_ (SECL3I,JO'>O.L0(#!A&^[AE)'3KR<
M8S0!YC90^$O"/[07BO1O%<&EV^C:M:)=6_V^*,0JQ ) +#"@Y<<>F.M0?LYZ
MZL7Q \4^&]'G>?P_NDNK+=DA LFT$9Z;E8?7:*WO%6D_#CX_:TEKHGB.1=<T
M^ GSK>U<JT.X9#;U 8 MQANYZUU?PC^'7AKP+IEZ?#^I#5[N:4PW=[N7*LA(
M\L*,[<'.0><_A0!Z)1110 5Y9X]^"%KX^\=6GB*_UJ2..W$2&Q-L'1XT;<5S
MN&-V6Y]Z]3KBOB?\2M.^&OAG[==+]HOK@E+*T!P97 ZGT4<9/T'4T <%^T[=
M:%9_#BRTR6. :BURAL(D"AHD7[Y [+CY?3)'I7,7#ZGX8_8SBBN2\,NI3;45
ML@B&24MC_@2@GZ-4_P /OA3K/Q-UQ?'WQ2E>6WN"LMK8MQYZ=5R/X(O1>K=3
MURW=_M&Z<US\%KO[-'\MG<02E5X"J&V]/0;J */[.?AW3G^#!>XLXI#JTTZW
M1>,'S4!*!3ZK@'CW->>?L[7$FA_&O7= B8BV>*>(H2>L4@VGZXW<^]>H?LX:
MA#<?!>TC$B;K.XGCE&?N?.7&?P8&O+/@"C:O\?M;U6 ;H%CNIBP/'[R48_G0
M S5]GB_]L&.SU-!<VL%^L(B<;EV0Q[MI![%@<]N372?M7Z-:II>@:S%"J72S
M/:M(HP2FW<H/T(./J:YQL>'_ -LO?>D11SZD2K.>")HOE_5@*ZS]K*]C7PSX
M?L=P\R2\DF"]\*F,_P#C] 'KGPYU276OAIX>U"Y;?-/81&1B2<L% )Y]Q72U
MRGPNL9--^%/ANUG7;(FGQ%@3T)7=_6OG3_AE3QO_ -!7P_\ ^!$__P 9H ]M
M_:#_ .2$^(?^W;_TIBKF_P!E3_DEFI?]AJ7_ -$05XWXQ_9_\5>"/"=YXAU6
M_P!'FM+/9YB6TTK2'>ZH,!HP.K#OTKV3]E3_ ))9J7_8:E_]$04 >VT444 %
M%%% !1110 4444 %%%% !1110 4444 %%%8VK^+_  ]H7G#5=8M()(=OF0>8
M&E7.,?NURW<'ITYZ4I245=LTI4JE:7)3BY/LE<V:*\SNOC7IT]T+/PSHFHZQ
M=F0JB!=@D4 DLN-S'IG!4<9)QC%53)\6_$\"1B*Q\/020,QD!",X8# /+NC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %?,_PWM+?5OVL/$UQJJ+
M)/:274MNKCHXD" CW"DXKZ8KYF^,_A;Q%X ^):?$GP?&QMY6$EPR)O$,FW:X
M=?[CCOZD\@XH ]6^-'@#5?B-X-MM)T2XLX)XKQ9V:\=E4J%88RJL<_,.U<Q\
M9/#L>F_LTP6&JF%[O2(;1$DCR5\U2L9VD@'!!;M7+VG[6V+-1?\ A'=<A?F:
M&_VHQ]0"A*CVR:Y#Q!XU\9?M!>(+/P_I&F"TT^.02&WA)=(NWFS28' &<<#T
M )- 'T!\"I9I?@IX>-QR5B=5_P!T2,!^E>@UE^&M!MO#'A?3M$LN8+&!858C
M!; Y8^Y.3^-:E !1110 4444 %%%% !1110 5\V_M<_\RC_V^_\ M"OI*OFW
M]KG_ )E'_M]_]H4 >W?#C_DEGA3_ + MG_Z(2NDKF_AQ_P DL\*?]@6S_P#1
M"5TE !7P!\1_^2I^*_\ L-7G_H]Z^_Z^ /B/_P E3\5_]AJ\_P#1[T <W111
M0 4444 %>D_L^?\ )=O#W_;S_P"DTM>;5Z3^SY_R7;P]_P!O/_I-+0!]M444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'S=^US]WPC];S_P!H5\VU])?M<_=\(_6\_P#:%?-M !11
M10 4444 %??WPW_Y)7X4_P"P-:?^B4KX!K[^^&__ "2OPI_V!K3_ -$I0!TM
M%%% !1110 4444 %%%% !1110 4444 ?&'QO_P"3C=3_ .N]G_Z(BJ2H_C?_
M ,G&ZG_UWL__ $1%4E>+F7QQ/U#@G_=ZOJOR"BBBO+/O@HHHH P-"_Y+IX?_
M .PS8_\ HR.ONJOA70O^2Z>'_P#L,V/_ *,CK[JKZBA_"CZ+\C\#S;_D85_\
M<O\ TIA1116QYI\+^(O^2\>(?^PS??\ H<E;M87B+_DO'B'_ +#-]_Z')6[7
MAYC_ !5Z?YGZQP7_ ,B^?^-_^DQ"BBBO-/M@HHHH B^"G_)QVE_]?%Y_Z(EK
M[0KXO^"G_)QVE_\ 7Q>?^B):^T*^KI_ C^>L7_O%3_$_S"BBBK.8^%_$7_)>
M/$'_ &&;[_T.2MVL+Q%_R7CQ!_V&;[_T.2MVO#S'^*O3_,_6."_^1?/_ !O_
M -)B%%%%>:?;!1110!J?LK_\E6U#_L#R_P#HZ&OK>ODC]E?_ )*MJ'_8'E_]
M'0U];U]<?SB%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q^A?\AJ#_ (%_Z":[
M"N0T,?\ $Y@_X%_Z": .OHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OF/XK0WO
MQ*_:(L/ LU^]GIUL%4 <@$Q^8[@=V(^49]*^G*\0^-7PAUS7_$%KXQ\!2F/6
MK=5$L*3>4[E?N/&QP P'!!(R /H0#(^%/A2Q\%?M(>(= TF6XDM;72AL>X8,
MYW>4QR0 .I/:H/@#=76E?&+QGX<:[:XMP\LK'LTB3;=^,\$AN?\ ZU<);Z9\
M;AXNO=7@TO6(M8U&'[)<7@LT3<F ,;]H5?NCYA@\=:]L^!GPGOO -G>ZMXDD
M5M;U(!7C5P_D)G."W\3$\G'' Y- 'KE%%% !7@GQ?^"OC+XC>.&U6QU+2(M/
MB@2&VBN9Y5=0.6)"QD<L3WZ8KWNB@#Y)_P"&5/&__05\/_\ @1/_ /&:]R^'
M'PVE\._">3P?XL^R7JW#3"<6SL49'/0$JIS^'%>B44 ?-5Y^S9XQTJ[N[7P9
MXQC@T>\RLT4UQ- SH>-KK&"LF <9.,^@KUKX5_"ZP^&.A36T-P;V_NV#W5V4
MV[L?=51SA1D]^23]!W=% 'E?Q;^"EM\1;B#5M,O5TS6[= @F924F4<J&QRI!
MZ,,\<8/&.,T#]G/Q!J/B2VU/XG>)UU:*U*[88[B6X:50<A"\@!5<]@#WZ5]#
MT4 (JA5"J  !@ #I2T44 >;?M!_\D)\0_P#;M_Z4Q5S?[*G_ "2S4O\ L-2_
M^B(*Z3]H/_DA/B'_ +=O_2F*N;_94_Y)9J7_ &&I?_1$% 'MM%%% !1110 4
M444 %%%% !16?JVO:5H,'G:QJ%O9J59E$T@#.%&3M7JQY' !/(]:XG5/C3H,
M,BVV@6UWK5W+M$211F-'8MC9EANW>F%.<@>N,IUJ</B9WX;+L9B]:%-M=[:?
M>]/Q/1J9--%;023W$B111J7>1V"JB@9))/0 =Z\P_MWXH>*9MNC:/#X<M/,Q
MYUZO[Q<)DAMXRRDG@K'UP,\&B+X.76J>2_C'Q7J.I>7&=L2,3Y3G&[:\A;*\
M8^Z">#QC%9^WE+^'%OUT.[^RZ%'_ 'S$1CY1]]_AHOO_ .#T>M?%+PEHJ'=J
M:7TNT,L5A^^+ G'WA\@(Y."P./J,\XOQ-\5^(-@\'>#9FCEE;R;R\W&*1%W=
M2-JJW']\C((Y-=?I/P_\*Z'/Y^G:+;K+N5UDFW3,C*<@J7)VG/<8[>@KHZ.2
MM+XI6]/\V'UK+*"_<T7-]YNW_DL?U;_R\I/@CXB>)($C\4>+$LK9X&#0VJY8
ME@,QR*@16&,C[S#TX)-;NE?![PAIFUI;.;4)4D$BR7DQ.,8PI5=JE>.A!SDY
MR.*[FBG'#TT[M7?GJ9U<ZQLX\E.7LX]H)17X:_B0VEG:Z?:I;6%M#:V\>=D4
M,81%R<G ' Y)-3445T;'CMN3N]PHHHH$,FABN8)(+B-)8I%*/&ZAE=2,$$'J
M".U9/_"'>&/^A<TG_P  8O\ XFKFJZWI6@VJW6N:G9Z;;NXC66\N%A1F()"@
ML0,X!./8UY_K/[0OPYTB.Y\O69-2N+=]AM[&V=S(0VT['8+&P')SOP0.">,R
MXQ>Z-85JM-6A)KT9VG_"'>&/^A<TG_P!B_\ B:/^$.\,?]"YI/\ X Q?_$UY
M7_PN[Q?XJ^3X;?#?4+N&Y_X\M4U(E(&V_P"LW8P@Y5U'[[J!W^6C_A&?CEXQ
MYU[Q3I_A+3[O_6VFFKNGMMO3:R\_,R@G$_1C_N4O9P[&GUO$?\_'][/3[GPM
MX1L[66ZO-"T6"WA0R2RRV<2I&H&2S$C   R2:YW7OCC\//#^])_$=O>S"$S)
M%IP-SYG7"!T!0,2,89AU!. <URUM^S/H-W=1:AXP\1:YX@U/>&NII9PB7(4X
M"MD-(!L"J?WF>.".,=YH/PK\#>&MATCPQIZ2QS">.>>/[1+&XQ@K))N9<;00
M 0 >1R35**6R,JE6I4^.3?J[GG__  O[6/$OR_#?X>:QJ\4O[A+ZZ&R*&X/0
M/L#+M&Y&),B<$YVCYJ/LO[0WB+_2_M_A_P *[/W7V+:DGF8Y\S.V;KG&-P^[
M]T=3[;13,SQ+_AG'^VO^1\\?>(/$'D_\>GS[/(S]_P#UIESG"]-OW><\8\$^
M+_P^G^'WCR[M(K:2/2+IVFTV4@[&C."8P2S$E"=IR=QP&( 85]T5S_C#P1H/
MCK1I-.\16$<X*,L-P% FMB<'=&Y&5.54^AQ@@CB@#\_**^A/$'[)^JQW6[PK
MXAL[BW=W/EZDC0O$N1L&Y X<XSDX3IP.<"SX9_9/G,BR^,?$,:(KL&MM*0L7
M7;\I$L@&T[NHV-P.O/ !P?P!\"77B_XCVNH_<T[09HKRYD$@5MX):% "#G+I
MSP!M5N02N?M*LCPSX5T3P=HRZ5X:T^.PLU=I#&A+%F/5F9B68]!DD\ #H *U
MZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5ZCZ5T%><? #_DB.A?2;_P!'/7H] !1110 4444 %%%% !1110 5\V_M<_\
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M4 %<EHG_ "&(/^!?^@FNMKDM$_Y#$'_ O_030!UM%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!XG^T1\0?$_@5=!/A74_L'VLS^=_H\4N_;LQ]]3CJ>E>3Z?\5_C
MCJUNL^E3ZI?0L<+);:'%(I/L5A(KZ=\:?#OPW\0+6"+Q-9/<&V#>1+',\;1%
ML9(P<'H.H->1:I^RZVGW)O? OBZ[T^=!\BW0^;/_ %UCVD#_ (": ..'CO\
M:&9@!::_R<<^'$'_ +0KTGX-Z[\5M3\774/Q%AU!--%FS1&YTZ.!?-W+CYE1
M3G!;C->6ZC\1/BA\+M06QN_%^G:Y'&Y5D^V17V3Z.3^^7\<5ZQ\&/C=J?Q'U
MVXT?6-)M+:>"V:X^T6KL%;#*NW8V2/O==W:@#V:BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %%%% !1110 4444 %%%% !7*:+_P AB#_@7_H)KJZY71?^0O#_ ,"_]!-
M'54444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'CG[0'Q+\0_#ZSTB+PT]O#)J'FB2
M:6'S'39MQM!^7^(]0:^??^$DNO'32'X@_$>\M+=B#]G^S33KGVB3;&/P-?6W
MCOX9>'_B*+(>(Q='[%O\K[/-L^]C.>#G[HKC_P#AF3X??W-3_P# O_[&@#R;
MP_I/P L2LFL^(M7U1P,-'-;2Q1-[@1IN'_?5>U_##6_A1>:E+8_#>WM(KZ*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!?XL-\3-&NDU&VCMM6T\K]H6'/ERJV=KJ#DCH01D_K@<A\3?C)XHD\?#P/\
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M^WG_ -)I: /MJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ^;OVN?N^$?K>?^T*^;:^DOVN?N^$?
MK>?^T*^;: "BBB@ HHHH *^_OAO_ ,DK\*?]@:T_]$I7P#7W]\-_^25^%/\
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M/!_7$ERVOOK;T_'T,_:Q4N4VOV=?A7/KVOP^+]<M)$TC3W\RP8N4^T7*,-K
M8RR(0<G(!8 ?, X'UC117@&H4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\W?M<_=\(_6\_\
M:%?-M?27[7/W?"/UO/\ VA7S;0 4444 %%%% !7W]\-_^25^%/\ L#6G_HE*
M^ :^_OAO_P DK\*?]@:T_P#1*4 =+1110 4444 %%%% !1110 4444 %%%%
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M]#DK=KP\Q_BKT_S/UC@O_D7S_P ;_P#28A1117FGVP4444 :G[*__)5M0_[
M\O\ Z.AKZWKY(_97_P"2K:A_V!Y?_1T-?6]?7'\XA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<QH__(5A_P"!?^@FNGKF=(_Y"L/_  +_ -!- '34444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MQ+Q#\.OB%X1\2:AXD^%^OF\AO;E[JYT2\("LS'+;03M.>>?D8#@$U[;7A_BG
MXP^-+[QUJ'ASX7>&8M4&EOY5W=3QLXW]P,,JH 01R3G'% %23XOZ!XUT._\
M _Q3T^Y\):C=1B&1Y8SY2OP5?YAE.<$;AMP/O5E6?P9^*4>G1V/A_P"),$GA
M]D @>*_G4&+'&U5! &.P;%:>A>*'^(OB@^ _C5X*M;;4I(FELIDB:)@ ,D*2
MQ89VD[E;!QC%+<_"?QW\,[I]0^$>OR7UANWR:-?L#N]< X1CQU&QL< F@#U'
MX;^ [7X=>#H=#M+AKI][37%PR;?-D;J<=A@  9/2NKKC_AKXPU/QEX<FN=?T
M231=2M+DVMQ;/N&6"J=P# %0=W0Y^IKL* "BBB@ HHHH **** "BBB@ KYM_
M:Y_YE'_M]_\ :%?25?-O[7/_ #*/_;[_ .T* /;OAQ_R2SPI_P!@6S_]$)72
M5S?PX_Y)9X4_[ MG_P"B$KI* "O@#XC_ /)4_%?_ &&KS_T>]??]? 'Q'_Y*
MGXK_ .PU>?\ H]Z .;HHHH **** "O2?V?/^2[>'O^WG_P!)I:\VKTG]GS_D
MNWA[_MY_])I: /MJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ^;OVN?N^$?K>?^T*^;:^DOVN?N
M^$?K>?\ M"OFV@ HHHH **** "OO[X;_ /)*_"G_ &!K3_T2E? -??WPW_Y)
M7X4_[ UI_P"B4H Z6BBB@ HHHH **** "BBB@ HHHH **** /C#XW_\ )QNI
M_P#7>S_]$15)4?QO_P"3C=3_ .N]G_Z(BJ2O%S+XXGZAP3_N]7U7Y!1117EG
MWP4444 8&A?\ET\/_P#89L?_ $9'7W57PKH7_)=/#_\ V&;'_P!&1U]U5]10
M_A1]%^1^!YM_R,*_^.7_ *4PHHHK8\T^%_$7_)>/$/\ V&;[_P!#DK=K"\1?
M\EX\0_\ 89OO_0Y*W:\/,?XJ]/\ ,_6."_\ D7S_ ,;_ /28A1117FGVP444
M4 1?!3_DX[2_^OB\_P#1$M?:%?%_P4_Y..TO_KXO/_1$M?:%?5T_@1_/6+_W
MBI_B?YA1115G,?"_B+_DO'B#_L,WW_H<E;M87B+_ )+QX@_[#-]_Z')6[7AY
MC_%7I_F?K'!?_(OG_C?_ *3$****\T^V"BBB@#4_97_Y*MJ'_8'E_P#1T-?6
M]?)'[*__ "5;4/\ L#R_^CH:^MZ^N/YQ"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *YK2?^0I#_P "_P#0372US>D_\A2+_@7_ *": .DHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \V_:
M#_Y(3XA_[=O_ $IBKF_V5/\ DEFI?]AJ7_T1!72?M!_\D)\0_P#;M_Z4Q5S?
M[*G_ "2S4O\ L-2_^B(* /;:*** "BBB@ KR[7O@%X:\1^(+W6-3U;7'NKR9
MI7Q<QD+GHJYC)"J,*!G@ #M7J-%=>%QN(P<G/#S<6^Q,HJ6YX]_PS1X._P"@
MEKG_ '_A_P#C5'_#-'@[_H):Y_W_ (?_ (U7L-%>A_;^:?\ /^1/LH=CR*W_
M &;_  I:7,5Q:ZQX@@GA<21RQW42LC Y# B+((/.:]=HHKAQ>/Q6,:>(FY6V
MN5&,8[&/XC\):#XMLA:^(],@OHU^XS@AX\D$['&&7.T9P1D#!XKS*[^"VM^&
M-6;4OA/XGDTDS/F6QO7+0X^?OM8.%# *KJQ')W9KV6BM<+F>*PL?9TY7@]XO
M6+^3T%*$9:L\2M/C3X@\%R+IOQ8\,7<,X3$5]9(I%P0J=MWEL?F)9D; ) VB
MO5?#GBW0?%MD;KPYJ<%]&OWU0D/'DD#>APRYVG&0,XR.*U+BWAN[:6WNHHYX
M)D,<D4BAE=2,%2#P01QBO+O$/P \-ZC?-J7ARZN_#FHAUEB>T.Z&.0/NWA."
MI[ (RA<+@<<]KJY7C/XD71GWC[T/_ =U\FR;3CMJ>JT5X<^N_%WX91+-XDM(
M/%VC10CS)K9B7@"J_5P@<<*&9W1A@#Y@2:[7PC\9?!_C"Y%I:WLFGWK/LCMM
M158FER5 V$$JQ); 7=N.#QCFL*^3XFG#VM*U2'\T'=?/JOFAJI%NST9WE%%%
M>.:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A7B
M?X6?$+0_&^K^(OA7KL%M#J[B6YM)&"L')R>'4H1DD@\$9(KW6B@#QOX>?##Q
MC%X^7QK\3-9AU#48+8PVL,+;O+R"#G"JJX!/"YR6)SZ^R444 %%%% !1110
M4444 %%%% !1110 5\V_M<_\RC_V^_\ M"OI*OFW]KG_ )E'_M]_]H4 >W?#
MC_DEGA3_ + MG_Z(2NDKF_AQ_P DL\*?]@6S_P#1"5TE !7P!\1_^2I^*_\
ML-7G_H]Z^_Z^ /B/_P E3\5_]AJ\_P#1[T <W1110 4444 %>D_L^?\ )=O#
MW_;S_P"DTM>;5Z3^SY_R7;P]_P!O/_I-+0!]M4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S=^U
MS]WPC];S_P!H5\VU])?M<_=\(_6\_P#:%?-M !1110 4444 %??WPW_Y)7X4
M_P"P-:?^B4KX!K[^^&__ "2OPI_V!K3_ -$I0!TM%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5SFE#_ (F<7X_^@FNCKG=*_P"0E%^/\C0!T5%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-O[7/\
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M'^1H Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#AAD'!!'U%>?C,NQ6":]O!I/9[I^C6C+C.,MBQ1117 4%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_JAE?:7WA]8F8L]G);QAW*D$XX-?:?[/G_)"?#__ &\_^E,M?'.I_P#'JO\
MOC^1K[&_9\_Y(3X?_P"WG_TIEK\ZX@P%' 8YT*'PV3UUW.NE)SC=GI-%%%>
M:A1110 4444 %%%% !1110 4444 ?-W[7/W?"/UO/_:%?-M?27[7/W?"/UO/
M_:%?-M !1110 4444 %??WPW_P"25^%/^P-:?^B4KX!K[^^&_P#R2OPI_P!@
M:T_]$I0!TM%%% !1110 4444 %%%% !1110 4444 ?&'QO\ ^3C=3_Z[V?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF@#Z1HKYM_X:Y_ZDG_RK?_::/^&N?^I)_P#*M_\ :: /I*BOFW_AKG_J2?\
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M]H+_ )(3XA_[=O\ TIBKXXTS_CU;_?/\A7V/^T%_R0GQ#_V[?^E,5?'&F?\
M'JW^^?Y"OK>$/^1HO\+,,1\!=HHHK]D/."BBB@"O?_\ 'C)^'\Q7T[^RI_R2
MS4O^PS+_ .B(:^8K_P#X\9/P_F*^G?V5/^26:E_V&9?_ $1#7Y+QK_R,8?X%
M_P"E2._#? >VT445\0=)XE^U5_R2O3O^PS%_Z)FKYBL/^/&/\?YFOIW]JK_D
ME>G?]AF+_P!$S5\Q6'_'C'^/\S7VW!7_ ",9_P"!_P#I43FQ/P%BBBBOULX
MHHHH I:G_P >J_[X_D:^QOV?/^2$^'_^WG_TIEKXYU/_ (]5_P!\?R-?8W[/
MG_)"?#__ &\_^E,M?C?%_P#R-'_A1Z&'^ ])HHHKY(Z HHHH **** "BBB@
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M\%/^3CM+_P"OB\_]$2U]H5]73^!'\]8O_>*G^)_F%%%%6<Q\+^(O^2\>(/\
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M^AR\/_\ @T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\
M@T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\ @T@_^*H
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M[O\ /5>29QJJ_:<Y]W45\[0?'#Q[<6\<R1^!U610X675H(W (SAE:Z#*?4$
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M*?4&@!U?-O[7/_,H_P#;[_[0KZ2KYM_:Y_YE'_M]_P#:% 'MWPX_Y)9X4_[
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M\V_X:#^&/_0S?^2%S_\ &Z/^&@_AC_T,W_DA<_\ QN@#TFBO-O\ AH/X8_\
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M &ZC_AD;_J=O_*3_ /;J^DJ* /FW_AD;_J=O_*3_ /;J/^&1O^IV_P#*3_\
M;J^DJ* /FW_AD;_J=O\ RD__ &ZC_AD;_J=O_*3_ /;J^DJ* /DGX@_LZ?\
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M;_RD_P#VZOI*BO*QV88G'S53$RYFE;9+3Y)&D81@K(^;?^&1O^IV_P#*3_\
M;J/^&1O^IV_\I/\ ]NKZ2HK@*/FW_AD;_J=O_*3_ /;J/^&1O^IV_P#*3_\
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ML7]8QD[<J]W1N[?71/9?BUV,:RE*-HGSM17T#_PRW_U.'_E,_P#MM'_#+?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^4?V?!
MM^/NLB?/G""Z')SSYJYKZNKY7\::/XB^#/QHG\;Z3I;7VC74LDQ9%/EA9/\
M61.P!V')R">.G7!% %G]K0K_ &]X; QO^S3$\=MRX_K7L?C:^\2:5\%9+KP@
MER^NQ6MJ(%M[<7$A)>,/A"K;OE+=CQD]J\'0>(/VB?BCIVI2:,^G:%9A8Y9
M2\<4:MN8>80 SL21@#N..":^LU4(H50 JC  ["@#Y*_X3S]H;_GS\0?^$XG_
M ,8KF_%T7Q?\=_8_^$KT#Q!?_8M_V?\ XD;1;-^W=]R-<YV+USTK[:HH ^0-
M-\6?'S2-*M--T_3_ !!#:6<*001_\(ZK;$10JC)A). !R3FK/_">?M#?\^?B
M#_PG$_\ C%?6U% 'R3_PGG[0W_/GX@_\)Q/_ (Q7G^I>"?B#J^JW>I:AX2\0
M37=Y,\\\G]DRKO=V+,<! !DD\ 8K[VHH ^ /^%<>-_\ H3?$'_@KG_\ B:/^
M%<>-_P#H3?$'_@KG_P#B:^_Z* /SITK1=5UZZ:UT/3+S4KA$,C16=NTSJH(!
M8A03C) S[BM?_A7'C?\ Z$WQ!_X*Y_\ XFO2?V5/^2IZE_V!9?\ T?!7UM0!
M\ ?\*X\;_P#0F^(/_!7/_P#$UI>'O#/Q+\*Z];ZSH/A?Q!::A;;O*F_L>1]N
MY2A^5D(/RL1R.]?=M% 'R3_PGG[0W_/GX@_\)Q/_ (Q1_P )Y^T-_P ^?B#_
M ,)Q/_C%?6U% 'R3_P )Y^T-_P ^?B#_ ,)Q/_C%><Q?#[QW"Q:/P?X@4D8_
MY!4W_P 17WY15TZDZ4U.FVFMFM&)I/1GP1_P@_Q _P"A1\0?^"F;_P"(J.Y\
M(>.;.UENKSPQKD%O"ADEEETR54C4#)9B4P  ,DFOONN;^(W_ "2SQ7_V!KS_
M -$/7?\ VMF/_/\ G_X%+_,GV<.Q\-:1I?B7Q!YW]@Z5J&I^1M\W[%9M-Y>[
M.-VU3C.#C/H:TO\ A!_B!_T*/B#_ ,%,W_Q%>R_LC?\ ,W?]N7_M>OI*C^UL
MQ_Y_S_\  I?YA[.'8^"/^$'^('_0H^(/_!3-_P#$5I^%-)^*O@C59-2\,>&_
M$%C=RPF!Y/[%>3*%E8C#QD=57G&>*^Y**YJ^+Q&)M[>I*5MKMNWWE**6R/DG
M_A//VAO^?/Q!_P"$XG_QBC_A//VAO^?/Q!_X3B?_ !BOK:BN89\@:EXL^/FK
MZ5=Z;J&G^()K2\A>">/_ (1U5WHZE6&1"",@GD'-<'%X \>09\KP?X@7=U_X
ME4Q_]DK[[HK6E6J49JI2DXR75.S^]":35F?!'_"#_$#_ *%'Q!_X*9O_ (BH
M[GPAXYL[66ZO/#&N06\*&26673)52-0,EF)3   R2:^^ZYOXC?\ )+/%?_8&
MO/\ T0]=O]K9C_S_ )_^!2_S)]G#L?#6D:7XE\0>=_8.E:AJ?D;?-^Q6;3>7
MNSC=M4XS@XSZ&M+_ (0?X@?]"CX@_P#!3-_\17LO[(W_ #-W_;E_[7KZ2H_M
M;,?^?\__  *7^8>SAV/@=O OC]U*MX1\0$$8/_$IF_\ B*WO",/Q?\"?;/\
MA%- \06'VW9]H_XD;2[]F[;]^-L8WMTQUK[:HKEKXJOB6G7FY-=VW^92BELC
MY)_X3S]H;_GS\0?^$XG_ ,8H_P"$\_:&_P"?/Q!_X3B?_&*^MJ*YQGQOXAUO
MXY>*M!N-&U[2O$%UI]SM\V'_ (1_9NVL&'S+""/F4'@]JXV+P%X]A4K'X0\0
M*"<_\@J;_P"(K[ZHK:C7JT)\]&3B^Z;3_ 32>C/@C_A!_B!_T*/B#_P4S?\
MQ%5M0\,^,](L)+[5?#VL6-I%CS+BYTZ2.-,D 99E &20/J:_0"O-_P!H+_DA
M/B'_ +=O_2F*NS^ULQ_Y_P __ I?YD^SAV/D/2M"\6:]:M<Z'HFJ:E;HYC:6
MSL7F16 !*DJI&<$''N*N_P#"#_$#_H4?$'_@IF_^(KZ*_94_Y)9J7_89E_\
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M3+S3;AT$BQ7ENT+LI)&X!@#C((S[&OT6KY*_:K_Y*CIO_8&C_P#1TU 'FO\
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M]QX3^(]WKUQK-QX5\0/J%S,\\LW]D2C<[DECM"8&23P!BI_[ ^)__0L^(/\
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M2M:PWEF(,(Y67[R%6RR, "<$G.#T/! /9**** "BBB@ HHHH **** "BBB@
MHHHH **** ,3Q7X.T+QOI4>F^)['[=:13"=(_.>/#A64'*,#T9N,XYJSX>\/
M:7X5T&WT;0;7[)I]MN\J'S&?;N8L?F8DGYF)Y/>O!OB9^T/XD\(_$/4]"T.P
MTB:TLF1 ]U#*SEB@+9*R*.IQTK/\&?M(^+_$7C?1]'O=-T2.WOKN."1H8)@X
M5C@D$RD9_ T ?3=%%% !1110 4444 %%%% !1110 4444 %%%<]X\U^Z\+^
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M$/?TKW*BJ6JZQIVAV#7NL7D-G;*0#),X4$GH!ZD^@YH NT4 Y (Z44 %%%%
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M#_AH/X8_]#-_Y(7/_P ;H ])HK/T'7M-\3:);ZOHES]IL;D$Q2^6R;@"0>&
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M%% !1110 4444 ?)7Q U75/C#\=(O!]M>M!I5M=M:Q(IRJ[,^;*1_$WRMCV
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M1QD_J:]Y^'7_ "3/PW_V#+?_ -%K0!PG[2GB:YT'X9+96,C12:M<"V=UZ^4
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M/;[7E1>RRQL$8CGC(//T%?3E?*7P2_TK]I76;B'F/-[)GV,G'\Z^K: /G?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M59)KBX(-Q>3D&27'0<# 4<X ]>_6NPHH **** "BBB@ HHHH **** "BBB@
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MK7/EG*Q*N=L8/?&22?4^V:\U\+>%?$-O^U==:O<:#J<6F-?W;B]>SD6$J4<
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MD'V:S3;&CX^](@!QD=\T ?6=%?+^J^,/V@_!-K_:WB2 36$1!D\RVM98P/\
M:,'S*/?(KV/X3_%&S^)OA^6X6 6>I6;!+NU#;@">CJ>ZG!]P01[D [VBBB@
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M2++Y2285FP1AP1^E 'H=%?+'AOQ-^T-XNT2/5_#UW]LL9694E\O3X\E3@\.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K.M?\ CY3\?Y5HUGVO_'ROX_RH T**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY2^ __ "<9K7_7.]_]
M&K7U;7R-\&]8TS0_V@-:N]:U&TTZVVWB>==SK$FXRC W,0,\'B@#ZTN[6&]L
MYK6Y19(9XVCD1AD,I&"#^%?)W[.$SZ;\;+_3H&/D26MQ$PSU"."#^GZU[UXH
M^,?@KP_X>NKV'Q'INH7"1MY%M9723O(^/E&$)P,]S@"O&?V7_#UY?^+-7\77
M,9-O#"T".1_K)G(9L?0#G_>% '1>.?A1\1_B-\0YTUK68;'PT2QMS!,9(XD'
MW1Y.5+2'.23[\\ 5Y7J4.J?!'XG6EGX?\5+J$:F.28VYVHX+8:.6(,PSQT)S
MR#Q6CIWB&/XJ?$Z^M/B=XMNM&T?]X8;9;D0PJRMA8_FRB\9RQ&3CKFN=^)5E
MX)T[Q[:6'@";SM.MXXTN;A9FE627>=Q5CD'C;RO'I0!Z/^TWX>ETKQ/HOC73
M%,9G"QRR+_#-'\T;?4K_ .@5Z_KWQ%AM?@;)XTMF4//IZO I/ F<!0OX.>?H
M:E^+7A0>,/A1J6GPH9+F& 7-J .3)&-P ^HR/QKY,D\:ZAK'PST?X?6T4A:+
M4FD!S_K-QQ&@^C._Z4 >C_!NPU#PS\)_&'Q#M(/-U-H'ALG<;L*IS(^._P Q
MS_P"N?\  .B>"_B,MY>?$WQW?6VN/,1&L]RD:E,<'S)58'GC:",8Z=*^E[*'
M1OAA\*[:WU?":;IEHL=TR0-*&)X<E5!)!9CGCOS7BG_"._ ?XA"[N]-U9O"5
MQ'(=T<URELLF>=RQR$KM]E*XQT'< ]#^$GPZ\3>";V>2?QC%JWA^8-]FM%#2
M@KGY)%8G"''4+D'\C7J]?(?P<O[SPW\>8_#WA;6GU71)II(I74%8KB-4)\S9
MD@$$<-_0U]>4 <!\;?%3>$_A3JES!)Y=W=J+.W(Z[I."1]%W'\*\A\(_#E;[
M]E36;IHS]MOF;48CM.<0$A1^(5_^^J7]IK7)=>\9:'X,TL^9+$1))&.\TI"H
M#]%Y_P"!4^V^!OQDM+".RM/'D-O:1IY:6\>L7BQHN,;0HCP![4 =/^RWXG_M
M+P->Z!,^9M*N-\8)_P"64F2/R8-^8KF_VG? .R7_ (3C^TL^8T-E]B\CIPQW
M;]WMTV_C7*?">XO_ (6?'P>']::-3.YTZY*,2C%L&-E) XW;<$CH37KG[4/_
M "2>'_L(Q?\ H+T >>_"3X&?\)/X,_X2/_A(?LO]IVMQ:?9_L._R\DINW>8,
M],XP/K7GWA[X:?V]\7KCP/\ VMY'D3SP_;?LV[=Y6>=FX==O][CWKZ;_ &>?
M^2)Z/_OS_P#HUJ\4\*:I8Z!^UAJ-UK5W!8VPU"]5I[B541-P?&6)P/\ Z] &
MO\3_ !#K_A^3P[\(O".IR"2WMH+:YNX?W+W,CX"+U)1<8)P3G=[5E^+?A%XJ
M^#FBQ>+M!\5O++#(@N_LZ-"4)(Q_$1(N[@A@.O3K6?\ '*STZ3XS6^L7=PT^
M@:S'!.+NR=6WQ#".8VP02-I/?J*Z6Z^&?P'L[6">;XA7K)<,%00WT$K#(S\R
MI"2@]V Q0!Z!JGC$^._V6]5UR5%CN)=/DCN$7H)$;:V/8XS^-?/W@'P/XQ^)
M^DRZ)H5W#!I.FR&9Q=2M'#YKX_NJQ9L+Z< =L\^_:IX;\/>%_P!FCQ#9^#]3
MDU32Y;:6>.YDF27<20#AD4# *^E9'[)Z@>"=;?'S'40"?81K_C0!ZG\.?"]U
MX-\ Z9H>HW?VN[MHSYTHD9U+%B<*6P=HS@<#ITKC?VE/^2,W7_7W!_Z%7K->
M3?M*?\D9NO\ K[@_]"H E_9P_P"2*:=_U\7'_HQJR?VH].M[CX86M](@\^TO
MT$;XY =6##Z' _(5'\ O&7AC1OA#86>K^(](L+I)YRT%U?11.H,A()5F!Y%<
MM^T=\3="U_0['PSX9U&'4W-R+BYEM6WQJ%!"J&'#$EL\9QCWH W_ (<^.V\)
M?LM?VY<!99;!IK>U1SP[F0[ ?;+<^P-<#X0^&_B[X[077B/Q-XHEMK43%(&F
MC,P9QU"1[E5%&<<=^U=GKGP\U'3_ -DF+2C;L=0MMNI30JIW+ERS#'JJ-S]#
M3OV=_B5X9T[X?GP_KFK6FE7=E/(ZF]F6))4=MV59B 2"2,=: .6\*^*/%7P4
M^*L'@WQ+J1O]%FDC0AV9D1).%ECSRN#U7IP>^#5[]H+Q9J4OQ-L?"NHZK=:/
MX:\N%[B2V#$R*Y^=V Y?&,!>>F<9K!^(6I0?%K]H+3;/PHWVJV0PVJW,:G#*
MK%Y)/]T9//?'O7J_Q6\4_"BXUJ'PWX_M)KB^A*J)DMW1K56 (;S1M)7G)"[A
MQT.* .+M/@MX>U":SO/@Y\1BM\C[IC+>JTBI_> B564@]F'.>H[^D_%JVO[/
M]GK5K;6+U+^^BM8DFNDB\H2L)%^;;DXS]?RZ5X+\3/ GP_\ "ND1ZMX%\<I?
MW?G*([%+F.X<9YW!X\%,>X_'->D2ZUJ^O_L=7=]K\KSW1A\M9Y"2\J+.%5F)
MZG Z]\9H K? [_DW+Q;_ +UW_P"DZUYI\(/"?B;Q\FJ>'='UUM%T?Y)]0E12
M3(<%47 (+#[W!('<\XKTOX'?\FY>+?\ >N__ $G6JW[)2#=XG?'S?Z.,^W[R
M@#D?!3ZY\(_C]!X6_M(SVLEXEK<(I(BG20#:^SG##<#['(SBO5?VCOB-J7A'
M0;'1M!N'M+W5-[27,9P\<2X!"GL23U] :\W\>?\ )WEK_P!A*Q_]!CK<_:QT
M>X^W:!K2JS6_E26KL!PK [E_,%ORH K>'?@9XWT'P]%XTT?Q.;3Q (?M8L!&
MQ\Q<;MCR;OF)'52I&>,]ZK?LNSO=?$S7+B8 22V+.P P 3*I->LV?QK\%1?#
M.'5I-;M/M$=D%;3_ #!]H\T+C9Y?WOO<;L8[YQ7D?[+#^;\1=9<C&[3R<?\
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MH **** "BBB@ HHHH **** "BBB@ JA;?\?"_C_*K]4;;_CX7\?Y4 7J***
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M,&VA<#:J\8%=;10 5SWCCP7IWC[PS)H>L374-K)(DA>U=5?*G(Y96'Z5T-%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J5N/WZ_C_*K
MM4X/]>OX_P J +E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %,G_X]Y/\ </\ *GTCJ'1E/1A@T ?*_P"RY_R4K7?^O%O_ $:M
M>B?M0_\ ))X?^PE%_P"@O73> O@YX?\ AWKEWJNB7FI3SW41B=;N6-E +!N
MJ*<Y'K6SX\\":9\0_#RZ-K4]W!;K.LX:T=5?<H( RRL,<^E 'G7@/_DT:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JI!_KEJW56'_7
M+0!:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LCQ-X6T7QCH[:
M5XDL5O;-G63RR[(0PZ$,I!'X&M>B@"OI]C;Z9IUO8V2LEO;1K%$K.SE548 W
M,23QZFK%%% !1110 4444 %8&C^!_#V@>(-0US2M/\K4]2)-U<O/)(TF3D_?
M8A1GL,=O05OT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %5H?\ 6BK-5XO]8* +%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !4$?^L%3U#']\4 34444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
K 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>bdtx-20211231_g15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g15.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,R
M-0  DI(  @    ,R-0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY(6W_P ;KZ(_9_\ &.N^-_ -[J7B>^^W7<6IR0))Y*1X011,!A% ZLW.,\T
M>I4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3CL9XC-,-AZCI3;NO(]@HKQ__A;6N_\ /IIW_?M__BZ/^%M:[_SZ:=_W[?\
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MP\26)N-/=LH0)(G&&C/O_C4U<-5I*\EH:X;,,-B9<M.6O8UJ***YCO"BBB@
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M6@N9HSHYMA*TU",K-]SM:***XSU HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HJ"^EDAT^YE@&94B9D&,Y(!(KP:+Q;XA%ZLRZM>.^\$(
M9F*D^FWI^&*Z\/A95TVG:QYF.S&&#<5)-W/H"BBBN0],**** "BBB@ HHHH
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MC7T=7@_CV!;;QUJ:1]"ZO^+(K']32P%:4VZ<]4&=86G14:])<KO;3[U^1[+
MFF^)=)L[VYLK>YCDC$B+/$LFS(Y'(_#\*Q_%F@:/;>$M2FM])L8I4@)5X[9%
M93Z@@<4OPVG,W@6S4C_5-(F<]?G)_KC\*O\ C/\ Y$O5/^O=JX5S4Z_(GHG^
MI[+Y*V#]K)*[C?;R/%_"D,5QXLTV&XC26)[A0R.H96'H0>M>X?\ "-:%_P!
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M\?CIR>%:C%=_^&9:\-^.M+\1R"WCWVMWC(@EQ\W^Z>_Z&NE9@BEG(55&22<
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M4]BT[]S-8C-)T7BDTH[VLMON_4](T_4+75+&.[L)EF@D&59?Y'T/M7F?Q?\
M^0EIO_7%_P"8IOPEU22/5;O3'<^5-%YJ*>@=2 <?4']*=\7_ /D):;_UQ?\
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M!F3:1D*,>_W>M17^K./[M-,VP:S!5%[>2E%K=6_R1MT445PGL!1110 4444
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M9E_R+(_]NG5?"C_D4)?^OM__ $%:S_B__P @_3/^NK_R%:'PH_Y%"7_K[?\
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M^ZG_ *&M>9?#;_D>[+_=D_\ 0&KT\+_NE3Y_D?/YE_R,Z/\ V[_Z4SNOBO\
M\BA%_P!?:?\ H+5S'PC_ .1DO/\ KT/_ *&M=/\ %?\ Y%"+_K[3_P!!:N8^
M$?\ R,EY_P!>A_\ 0UHI?[E(6)_Y&\/E^IZ5XE_Y%/5_^O&;_P! ->'>%/\
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MTWFR*>J#&%4_AS^-167L<&J<MW_G<TPLOK>:NO3^%?Y6/./B3_R/=[_NQ_\
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M6^%6FS7'B5[X*1!;1,"V."S< ?ED_A7363J8=RK1LT>=A9+#XZ-/"SYHO?\
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M'\&(Q^9KAI1K4YRE0U5['LXB>%KT:<,8[2:O<X*PU;6?#%\RV\L]I*C?O()
M0#[,IKVSPMKZ^)-!BO@@CDR8Y4'17'7'MR#^->0>-/$\/BC5(KBVM6MTBCV
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M(CB1E*C;[''YU@>,O#)\+ZV(H79[:9?,@=OO =P?<'^E=M\(?^0+J'_7P/\
MT&M7XD:-_:GA22>-<S6)\Y<#DK_$/RY_X#73]8E#%N+>C/.^HTZV61J1C[Z5
M[]]2'X<>)I-;TA[2^D\R[L\#>>LB'H3ZD=/RKLZ\#\&:U_87BBVN7;$$A\F;
M_<;O^!P?PKWRN3&T?9U;K9GJ91BGB,/:3]Z.G^05YI\7-5Q'9:3&WWB9Y1^B
M_P#LWZ5Z77S]XMU7^V?%-[=J<QF39'_NKP/SQG\:K 4^>KS=C/.Z_LL-R+>6
MGRZB^&_%%WX8FGFL+>VEDF4*6G5CM .<###K_05IZO\ $;5M:TF?3[RUL1#.
M &*1N&&""",L>XKTCP]X1TNT\.V4-_I=G-<B(&5YK96;<>2"2,\9Q^%:7_"-
M:%_T!=._\!$_PK>>+H.IS.%WW..CEF-5%056R:V]=SP;1-2;2-<M+],GR)0Q
M [KW'XC(KZ*CD66)9(V#(X#*P[@]Z\#\9:2-&\67MK&@2$OYD048 5N0!].G
MX5ZK\.]5_M3P?;J[9EM";=^>P^[_ ..D#\*>/BITXU8DY+.5&M4PL_Z:T9XK
M9?\ (0M_^NJ_SKZ3KYLLO^0A;_\ 75?YU])TLSWC\RN'OAJ?+]3YK_Y?_P#M
MK_6OI2OG#4[673]9NK:0%9()F4_@:]5TKXH6>I7>GV0L)UNKF18I#D!$).,@
MY)(_ 5ICJ4ZD8R@KVN<^2XBEAYU(579MK]3S_P =;O\ A.-3WYSYHZ^FT8_2
MK^E_#;5]7TN"_M;JQ6*==RAY'##ZX4UH?%30Y;?64UB-2T%RJI(P'W7 P,_4
M ?D:@\'?$/\ X1_3UT[4;9[BU1B8WB(WH"<D8/!&<GJ.M;*=26'C*CN<SHT(
M8ZI#%Z)MV?J[H=_PJ77?^?O3O^_C_P#Q%=IX#\)W?A:WO%OYH)7N&0@0DD +
MGN0/6L>]^+MBJ'^SM-N)6QP9V5 #^&<UTO@W7KCQ'H'VZ\CBCD\YDVQ @8&,
M=2?6N'$3Q3I?O%9'L8*EET<0OJ[;DK]['EWQ)_Y'N]_W8_\ T!:]-^'_ /R(
MFF_[K_\ H;5YE\2?^1[O?]V/_P! 6O3?A_\ \B)IO^Z__H;5IBO]TI_+\C#+
MO^1G6_[>_P#2D6/%NOCPWX?EO50/,6$<*GH7/K[  G\*\@@D\2>--4,*7$]U
M+@N5,FV.,>N.@%>C_%*TENO!X>%2PM[E)9,=EVLN?S85Y[X)\51^%M3FEN;=
MYH)T"/Y9&Y<'.1GKWXXJL'&U!S@KR(S2IS8R-&M)QICM<\ ZKH&DG4+Z:T:-
M652D3L6!/U4#]:M_"[_D=%_Z]Y/Z5)XQ\>MXEM?[/TZU>*TSYCM( 7;'/09
M ZU'\+O^1T7_ *]Y/Z5T2=5X:3J[ZG!".'CF%-8=WC=?>=K\4_\ D3?^WE/Z
MUR7PE_Y&RY_Z\7_]#2NV^)%F]WX)N3$-Q@=)2!Z X/Y Y_"O+/"'B$>&=?6]
MDB:6%HVBE5#\Q4X/&?<"N?#1<\)*,=]3OS":HYG3J3T6GZGOM?/?BO\ Y&_5
MO^ON3_T(U['X7\7VWBJ2]%G;2PI:E/FE(R^[=V'3[OK7CGBO_D;]6_Z^Y/\
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MT0(0[V4@'_=(K4HK+GGS<U]3H=&FX>S<5R]K:?<4-)T/3M"MW@TJV%O&[;F
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /$OVJ_^26:;_V&HO\ T1/1^RI_R2S4O^PU+_Z(
M@H_:K_Y)9IO_ &&HO_1$]'[*G_)+-2_[#4O_ *(@H ]MHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q+]J
MO_DEFF_]AJ+_ -$3T?LJ?\DLU+_L-2_^B(*/VJ_^26:;_P!AJ+_T1/1^RI_R
M2S4O^PU+_P"B(* /;:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH \2_:K_Y)9IO_8:B_P#1$]'[*G_)+-2_
M[#4O_HB"C]JO_DEFF_\ 8:B_]$3T?LJ?\DLU+_L-2_\ HB"@#VVBBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* /$OVJ_^26:;_V&HO\ T1/1^RI_R2S4O^PU+_Z(@H_:K_Y)9IO_ &&HO_1$
M]'[*G_)+-2_[#4O_ *(@H ]MHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\ED5RPDD8D!8V&,.._K0!Z=_PL?P1_T.7A__ ,&D'_Q5'_"Q_!'_ $.7A_\
M\&D'_P 57S;_ ,,J>-_^@KX?_P# B?\ ^,T?\,J>-_\ H*^'_P#P(G_^,T =
ME^TKXL\.:]\-M/M=#U_2]2N$U:.1HK.]CF=5$,P+$*2<9(&?<5K_ +*G_)+-
M2_[#4O\ Z(@KPWX@?!3Q'\.- @U?7+W2Y[>:Z6U5;.61G#%68$AHU&,(>_I7
MN7[*G_)+-2_[#4O_ *(@H ]MHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6:;_ -AJ+_T1/1^RI_R2S4O^PU+_ .B(*/VJ_P#DEFF_]AJ+_P!$3T?LJ?\
M)+-2_P"PU+_Z(@H ]MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#Q+]JO_ ))9IO\ V&HO_1$]'[*G_)+-
M2_[#4O\ Z(@H_:K_ .26:;_V&HO_ $1/1^RI_P DLU+_ +#4O_HB"@#VVBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'B7[5?\ R2S3?^PU%_Z(GH_94_Y)9J7_ &&I?_1$%'[5?_)+--_[#47_ *(G
MH_94_P"26:E_V&I?_1$% 'MM%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+-2_[#4O_HB"C]JO_DEFF_\ 8:B_]$3T?LJ?\DLU+_L-2_\ HB"@#VVBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5L;Z]@A5F!X#C.6'MQGOD<5/^TQ\1-2T"WT_PQH=U)9RWT1N+N:)MK^5DJJ
MCD D-G_= [FO$/%'PF\2>$/!%CXGU_[+!!?SI#';"0M.I=&<%AC:.$/&2>>E
M 'V%\0/!P^(7@M]#BU:33K>X>.1YH(Q()44Y"XR."=IX/85#\-?ASI_PT\-R
M:5I]S)=O/.9Y[B50I=L   #H !TY[^M<SJ]A_:?[)B0LS#;X6MY\AL$^7 DG
M_LE<K^R?JLMQX;\0:7)(SQV=S%-&I)(3S%8''_?N@#Z HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /$OVJ_^26:;_V&HO\
MT1/1^RI_R2S4O^PU+_Z(@H_:K_Y)9IO_ &&HO_1$]'[*G_)+-2_[#4O_ *(@
MH ]MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /E_P#:OT"Y3Q%HOB%49K66T^PNX'".CLX!]R'./]TUF_%SXQZ)\1_A
M1I5C;K-;:U%J$<]U:O&=JA8I%9E?H1N88Z'GI7T!\0?$?@.RT\Z'\0;VS2"_
MCW"VN%9BR@_>&T$K@CAN.1Q7E,_[,/AGQ#;1:IX0\57,%A=+YL)E@6X4J?[I
MRAQ]<F@#*UWXZ:!!\";'PGHGGW6K3:+#IUP3$4CM_P!RJ29)^\<;@,<=\^N_
M^RCHEQ:>%]<UF9&2+4+F*&$L,!Q$&R1[9D(SZ@^E/T/]E+0;.Z277M?O-3C4
MY,,,(ME?V)W,<?0@^]>XZ;IMEHVF6^G:7;1VMG;((XH8QA444 6J*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q+]JO_ ))9
MIO\ V&HO_1$]'[*G_)+-2_[#4O\ Z(@H_:K_ .26:;_V&HO_ $1/1^RI_P D
MLU+_ +#4O_HB"@#VVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M->J44?V;#^8/]8*O\B/*_P#A)?BE_P!!KQ?_ .!=U_C1_P )+\4O^@UXO_\
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MDOQ2_P"@UXO_ / NZ_QH_P"$E^*7_0:\7_\ @7=?XUZI11_9L/Y@_P!8*O\
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MY-X\@MX4,DLLKWBI&H&2S$\  #))K[?KF_B/_P DL\5_]@6\_P#1#T ?&O\
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M7^->J44?V;#^8/\ 6"K_ "(\K_X27XI?]!KQ?_X%W7^-'_"2_%+_ *#7B_\
M\"[K_&O5**/[-A_,'^L%7^1'E?\ PDOQ2_Z#7B__ ,"[K_&C_A)?BE_T&O%_
M_@7=?XUZI11_9L/Y@_U@J_R(\K_X27XI?]!KQ?\ ^!=U_C5BRU?XNZE++'IV
MH>-KN2%5:1()[MR@;.TD \ [6QZX/I7IE=Y\%_\ D9_$W_7G8?\ H=U7/B<%
M&C3YTSOP&;3Q=?V4HI'@?_%[_P#JH'_D[1_Q>_\ ZJ!_Y.U]M45YA]"?$O\
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MQKU2BC^S8?S!_K!5_D1Y3)XJ^)T,3R2Z[XM2-%+,[7ER H'4DYX%:W_%[_\
MJH'_ ).UU_B'_D6-4_Z\YO\ T U]5UP8K#JA)).]SV\MQTL9"4I*UCXE_P"+
MW_\ 50/_ "=H_P"+W_\ 50/_ "=K[:HKC/5/B7_B]_\ U4#_ ,G:R8_%7Q.F
MB22+7?%KQNH976\N2&!Z$'/(K[PKY4\/?\BQI?\ UYP_^@"NS"X=5Y--VL>5
MF6.E@X1E%7N>>?\ "2_%+_H->+__  +NO\:/^$E^*7_0:\7_ /@7=?XUZI17
M?_9L/YCQ/]8*O\B/*_\ A)?BE_T&O%__ (%W7^-'_"2_%+_H->+_ /P+NO\
M&O5**/[-A_,'^L%7^1'E?_"2_%+_ *#7B_\ \"[K_&C_ (27XI?]!KQ?_P"!
M=U_C7JE%']FP_F#_ %@J_P B/*_^$E^*7_0:\7_^!=U_C1_PDOQ2_P"@UXO_
M / NZ_QKU2BC^S8?S!_K!5_D1Y7_ ,)+\4O^@UXO_P# NZ_QH_X27XI?]!KQ
M?_X%W7^->J44?V;#^8/]8*O\B/*_^$E^*7_0:\7_ /@7=?XT?\)+\4O^@UXO
M_P# NZ_QKU2BC^S8?S!_K!5_D1Y7_P )+\4O^@UXO_\  NZ_QH_X27XI?]!K
MQ?\ ^!=U_C7JE%']FP_F#_6"K_(CRO\ X27XI?\ 0:\7_P#@7=?XT?\ "2_%
M+_H->+__  +NO\:]4HH_LV'\P?ZP5?Y$>5_\)+\4O^@UXO\ _ NZ_P :/^$E
M^*7_ $&O%_\ X%W7^->J44?V;#^8/]8*O\B/*_\ A)?BE_T&O%__ (%W7^-'
M_"2_%+_H->+_ /P+NO\ &O5**/[-A_,'^L%7^1'E?_"2_%+_ *#7B_\ \"[K
M_&C_ (27XI?]!KQ?_P"!=U_C7JE%']FP_F#_ %@J_P B/,+77/BS?W0M;'4_
M&=S<%#((H;B[=]H(!; .< LHS[CUJ_\ \7O_ .J@?^3M>T_"O_DJ<?\ V!;O
M_P!'VM>XUY>(IJE4<%T/I,%B'B</&JU:]_SL?$O_ !>__JH'_D[1_P 7O_ZJ
M!_Y.U]M45@=A\,WNK_%W398H]1U#QM:23*S1I//=H7"XW$ GD#<N?3(]:K_\
M)+\4O^@UXO\ _ NZ_P :^D/C1_R,_AG_ *\[_P#]#M:X.O3PV"C6I\[9\]C\
MVGA*_LHQ3/*_^$E^*7_0:\7_ /@7=?XT?\)+\4O^@UXO_P# NZ_QKU2BNC^S
M8?S'!_K!5_D1Y7_PDOQ2_P"@UXO_ / NZ_QH_P"$E^*7_0:\7_\ @7=?XUZI
M11_9L/Y@_P!8*O\ (CRO_A)?BE_T&O%__@7=?XT?\)+\4O\ H->+_P#P+NO\
M:]4HH_LV'\P?ZP5?Y$>5_P#"2_%+_H->+_\ P+NO\:/^$E^*7_0:\7_^!=U_
MC7JE%']FP_F#_6"K_(CRO_A)?BE_T&O%_P#X%W7^-'_"2_%+_H->+_\ P+NO
M\:]4HH_LV'\P?ZP5?Y$>5_\ "2_%+_H->+__  +NO\:/^$E^*7_0:\7_ /@7
M=?XUZI11_9L/Y@_U@J_R(\K_ .$E^*7_ $&O%_\ X%W7^-'_  DOQ2_Z#7B_
M_P "[K_&O5**/[-A_,'^L%7^1'E?_"2_%+_H->+_ /P+NO\ &C_A)?BE_P!!
MKQ?_ .!=U_C7JE%']FP_F#_6"K_(CRO_ (27XI?]!KQ?_P"!=U_C1_PDOQ2_
MZ#7B_P#\"[K_ !KU2BC^S8?S!_K!5_D1Y7_PDOQ2_P"@UXO_ / NZ_QH_P"$
ME^*7_0:\7_\ @7=?XUZI11_9L/Y@_P!8*O\ (CRO_A)?BE_T&O%__@7=?XT?
M\)+\4O\ H->+_P#P+NO\:]4HH_LV'\P?ZP5?Y$>=6US\:+RUBNK.;QY/;S()
M(I8GO&212,AE(X((.014O_%[_P#JH'_D[7UM\./^26>%/^P+9_\ HA*Z2O$/
ML#XE_P"+W_\ 50/_ "=H_P"+W_\ 50/_ "=K[:HH ^$CXE^*2R.C:UXO#QNT
M;J;JZRK*2K*>>"""".Q%)_PDOQ2_Z#7B_P#\"[K_ !KU:Y_Y#FM_]AK4/_2N
M6FU[%/+XS@I<VZ/E:^>5*565-06C:^YGE?\ PDOQ2_Z#7B__ ,"[K_&C_A)?
MBE_T&O%__@7=?XUZI15_V;#^8Q_U@J_R(\K_ .$E^*7_ $&O%_\ X%W7^-'_
M  DOQ2_Z#7B__P "[K_&O5**/[-A_,'^L%7^1'E?_"2_%+_H->+_ /P+NO\
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M>J45[']FP_F/E?\ 6"K_ "(\K_X27XI?]!KQ?_X%W7^-'_"2_%+_ *#7B_\
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M ,"[K_&C_A)?BE_T&O%__@7=?XUZI11_9L/Y@_U@J_R(\K_X27XI?]!KQ?\
M^!=U_C5VSOOC)J-JMSI]SXZNH&9E$L$EXZDJQ5AD<9!!!]""*]'KV+X/?\DQ
MLO\ K\O_ /TLFKCQ6%C0BFG>YZN6YE/&3E&4;6/EW_B]_P#U4#_R=H_XO?\
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M7^->J44?V;#^8/\ 6"K_ "(\K_X27XI?]!KQ?_X%W7^-'_"2_%+_ *#7B_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2^GL(+:V,H\QV67=(0O7&P]?]D^E>J?LTZ[H>G?"WQ!#JE[;1207LMS<12.
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M HHHH **** "BBB@#T_X)?\ (#\0_P#8:/\ Z26U>EUYI\$O^0'XA_[#1_\
M22VKTNOE:_\ &EZO\S]*P7^ZT_\ "OR"BBBL3K/GKQE_R4[Q3_U^0?\ I';U
ME5J^,O\ DIWBG_K\@_\ 2.WK*KZ?"_P(GYUF7^^5/4****Z3SPHHHH ****
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MCKP7^]4_\2_,^F****^5/TH*YOXC_P#)+/%?_8%O/_1#UTE<W\1_^26>*_\
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MGB'_ )%C5/\ KSF_] -?5=>)F7QQ/L.'_P"%/U"BBBO*/I0KY4\/?\BQI?\
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MW_?*?J?0M%%%?,'Z*%>:?&W_ ) ?A[_L-#_TDN:]+KS3XV_\@/P]_P!AH?\
MI)<UM0_C1]5^9R8W_=:G^%_D>84445]4?FH4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %>Q?![_DF-E_U^7_ /Z635X[7L7P>_Y)
MC9?]?E__ .EDU>5F7P1/I>'_ .+/T.XHHHKQ#[ *^>O&7_)3O%/_ %^0?^D=
MO7T+7SUXR_Y*=XI_Z_(/_2.WKOR_^.>+G?\ N;]495%%%?0GP@4444 %%%%
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M\@_]([>LJOI\+_ B?G69?[Y4]0HHHKI//"BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH *U?!O\ R4[PM_U^3_\ I'<5E5J^#?\ DIWA;_K\G_\
M2.XKFQ7\"1Z&6_[Y3]3Z%HHHKY@_10KS3XV_\@/P]_V&A_Z27->EUYI\;?\
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M\<^[R3_<UZL****X#VCA_C#_ ,DQO?\ K\L/_2R&O':]B^,/_),;W_K\L/\
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M#/\ UYW_ /Z':UP=?0Y?_ /A<[_WQ^B"BBBN\\0**** "BBB@ HHHH ****
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M_C+T_5GVN0?[K+_$_P D%%%%>:?0!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5XE^T=\/\ Q)XWM_#\OA?3_M_V!K@3HLJ(R^9Y6T@,1D?(>GM7
MMM% 'PY_PHKXD_\ 0K7'_?\ A_\ BZ/^%%?$G_H5KC_O_#_\77W'10!\.?\
M"BOB3_T*UQ_W_A_^+KZ2_9^\)Z[X.^'5QI_B>U:TN9=1DGCA:17*QE(U'W20
M/F5CCWSWKU&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /$OVJ_\ DEFF_P#8:B_]$3T?LJ?\DLU+_L-2_P#HB"C]JO\
MY)9IO_8:B_\ 1$]'[*G_ "2S4O\ L-2_^B(* /;:^9[G_D.:W_V&M0_]*Y:^
MF*^9[G_D.:W_ -AK4/\ TKEKTLM_C/T_5'S^?_[K'_$OR8VBBBO>/B@HHHH
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MMZRJ^GPO\")^=9E_OE3U"BBBND\\**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *=;?\AS1/^PUI_\ Z5Q4VG6W_(<T3_L-:?\ ^E<58U_X
M,O1_D=>"_P!ZI_XE^9],4445\J?I05S?Q'_Y)9XK_P"P+>?^B'KI*YOXC_\
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#J?A7_ ,E3C_[
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M0?\ I';UE5]/A?X$3\ZS+_?*GJ%%%%=)YX4444 %%%% !1110 4444 %%%%
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M*'J:-%%%>V?'A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5[%\'O\
MDF-E_P!?E_\ ^EDU>.U[%\'O^28V7_7Y?_\ I9-7E9E\$3Z7A_\ BS]#N***
M*\0^P"OGKQE_R4[Q3_U^0?\ I';U]"U\]>,O^2G>*?\ K\@_]([>N_+_ ..>
M+G?^YOU1E4445]"?"!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?^0YK?\ V&M0_P#2N6O2RW^,_3]4?/Y__NL?\2_)C:***]X^*"BBB@ HHHH
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M?"_P(GYUF7^^5/4****Z3SPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\BQJG_7G-_Z :^JZ\3,OCB?8</\ \*?J%%%%>4?2A7RIX>_Y%C2_^O.'_P!
M%?5=?*GA[_D6-+_Z\X?_ $ 5ZN6_'(^:X@_A0]31HHHKVSX\**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .I^%?\ R5./_L"W?_H^
MUKW&O#OA7_R5./\ [ MW_P"C[6O<:^;QW^\2^7Y'Z!D_^XP^?YL****XSU3R
M'XT?\C/X9_Z\[_\ ]#M:X.N\^-'_ ",_AG_KSO\ _P!#M:X.OH<O_@'PN=_[
MX_1!1117>>(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'NWPX_Y)9X4_[ MG_P"B$KI*YOX<?\DL\*?]@6S_ /1"5TE?'GZJ%%%%
M 'S/<_\ (<UO_L-:A_Z5RTVG7/\ R'-;_P"PUJ'_ *5RTVOJJ'\&/HOR/S7&
M_P"]5/\ $_S"BBBMCD"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "M7P;_ ,E.\+?]?D__ *1W%95:O@W_ )*=X6_Z_)__ $CN*YL5_ D>
MAEO^^4_4^A:***^8/T4*\T^-O_(#\/?]AH?^DES7I=>:?&W_ ) ?A[_L-#_T
MDN:VH?QH^J_,Y,;_ +K4_P +_(\PHHHKZH_-0HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *]B^#W_),;+_K\O_\ TLFKQVO8O@]_
MR3&R_P"OR_\ _2R:O*S+X(GTO#_\6?H=Q1117B'V 5\]>,O^2G>*?^OR#_TC
MMZ^A:^>O&7_)3O%/_7Y!_P"D=O7?E_\ '/%SO_<WZHRJ***^A/A HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH =;?\AS1/^PUI_\
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MN=_[F_5&51117T)\(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% #K;_D.:)_V&M/_ /2N*OIBOF>V_P"0YHG_ &&M/_\ 2N*OIBO!
MS+^,O3]6?:Y!_NLO\3_)!1117FGT 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!XE^U7_R2S3?^PU%_P"B)Z/V5/\ DEFI?]AJ
M7_T1!1^U7_R2S3?^PU%_Z(GH_94_Y)9J7_8:E_\ 1$% 'MM?,]S_ ,AS6_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4ZV_Y#FB?]AK3_ /TKBIM.MO\
MD.:)_P!AK3__ $KBK&O_  9>C_(Z\%_O5/\ Q+\SZ8HHHKY4_2@KF_B/_P D
ML\5_]@6\_P#1#UTE<W\1_P#DEGBO_L"WG_HAZ /":***^P/RH**** "BBB@
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M0 4444 %%%% !1110!U/PK_Y*G'_ -@6[_\ 1]K7N->'?"O_ )*G'_V!;O\
M]'VM>XU\WCO]XE\OR/T#)_\ <8?/\V%%%%<9ZIY#\:/^1G\,_P#7G?\ _H=K
M7!UWGQH_Y&?PS_UYW_\ Z':UP=?0Y?\ P#X7._\ ?'Z(****[SQ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]V^''_)+/"G_8%L
M_P#T0E=)7-_#C_DEGA3_ + MG_Z(2NDKX\_50HHHH ^9[G_D.:W_ -AK4/\
MTKEIM.N?^0YK?_8:U#_TKEIM?54/X,?1?D?FN-_WJI_B?YA1116QR!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6KX-_Y*=X6_P"OR?\
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M -*XJ^F*\',OXR]/U9]KD'^ZR_Q/\D%%%%>:?0!1110 4444 %%%% !1110
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MZ6Z5K.*17+!64 EI&&,.>WI7N7[*G_)+-2_[#4O_ *(@H ]MKYGN?^0YK?\
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M 'A-%%%?8'Y4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:O*S+X(GTO#_ /%GZ'<4445XA]@%?/7C+_DIWBG_ *_(/_2.WKZ%KYZ\9?\
M)3O%/_7Y!_Z1V]=^7_QSQ<[_ -S?JC*HHHKZ$^$"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@!UM_R'-$_P"PUI__ *5Q5],5\SVW
M_(<T3_L-:?\ ^E<5?3%>#F7\9>GZL^UR#_=9?XG^2"BBBO-/H HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "L+QI9>(-1\(7MKX.U"'3M9DV?9KJ?[B8D4MGY6ZJ&'0]?QK=HH
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MO':]B^,/_),;W_K\L/\ TLAKQVO;RWX)'Q_$'\6'H%%%%>J?-!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Z?\$O^0'XA_[#1_\
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M45L<@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5J^#?\
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M_1$% 'MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^XS^7YHY:BBBOI#\_"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#.\0_\BQJG_7G-_P"@&OJNOE3Q#_R+&J?]><W_ * :^JZ\3,OC
MB?8</_PI^H4445Y1]*%?*GA[_D6-+_Z\X?\ T 5]5U\J>'O^18TO_KSA_P#0
M!7JY;\<CYKB#^%#U-&BBBO;/CPHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ZGX5_\E3C_P"P+=_^C[6O<:\.^%?_ "5./_L"W?\
MZ/M:]QKYO'?[Q+Y?D?H&3_[C#Y_FPHHHKC/5/(?C1_R,_AG_ *\[_P#]#M:X
M.N\^-'_(S^&?^O.__P#0[6N#KZ'+_P" ?"YW_OC]$%%%%=YX@4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 >[?#C_ ))9X4_[ MG_
M .B$KI*YOX<?\DL\*?\ 8%L__1"5TE?'GZJ%%%% 'S/<_P#(<UO_ +#6H?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /$OVJ_^26:;_V&HO\
MT1/1^RI_R2S4O^PU+_Z(@H_:K_Y)9IO_ &&HO_1$]'[*G_)+-2_[#4O_ *(@
MH ]MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** .'^,/_ "3&]_Z_+#_TLAKQVO=?B#X?OO%'@FZTK2FM
MUNY)K>6/[2[)&?+GCD(+*K$9"$=#S7F?_"J_&_\ SR\/_P#@SG_^1J]3 XBG
M2BU-V/F\XP6(Q-2+I1O9=U^IRU%=3_PJOQO_ ,\O#_\ X,Y__D:C_A5?C?\
MYY>'_P#P9S__ "-7H?7L/_-^#/$_L?'?R?BO\SEJ*ZG_ (57XW_YY>'_ /P9
MS_\ R-1_PJOQO_SR\/\ _@SG_P#D:CZ]A_YOP8?V/COY/Q7^9RU%=3_PJOQO
M_P \O#__ (,Y_P#Y&H_X57XW_P">7A__ ,&<_P#\C4?7L/\ S?@P_L?'?R?B
MO\SEJ*ZG_A5?C?\ YY>'_P#P9S__ "-1_P *K\;_ //+P_\ ^#.?_P"1J/KV
M'_F_!A_8^._D_%?YG+45U/\ PJOQO_SR\/\ _@SG_P#D:C_A5?C?_GEX?_\
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M\4_]?D'_ *1V]95?3X7^!$_.LR_WRIZA11172>>%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %.MO^0YHG_8:T_P#]*XJ;3K;_ )#FB?\
M8:T__P!*XJQK_P &7H_R.O!?[U3_ ,2_,^F****^5/TH*YOXC_\ )+/%?_8%
MO/\ T0]=)7-_$?\ Y)9XK_[ MY_Z(>@#PFBBBOL#\J"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KO/@O_R,_B;_ *\[#_T.ZK@Z
M[SX+_P#(S^)O^O.P_P#0[JN#,/X![>2?[XO1GKU%%%?/'W05X=\5/^2IR?\
M8%M/_1]U7N->'?%3_DJ<G_8%M/\ T?=5V8'_ 'B/S_(\K./]QG\OS1RU%%%?
M2'Y^%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &=X
MA_Y%C5/^O.;_ - -?5=?*GB'_D6-4_Z\YO\ T U]5UXF9?'$^PX?_A3]0HHH
MKRCZ4*^5/#W_ "+&E_\ 7G#_ .@"OJNOE3P]_P BQI?_ %YP_P#H KU<M^.1
M\UQ!_"AZFC1117MGQX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#CGBYW_N;]495%%%?0GP@4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!\]>,O^2G>*?^OR#_ -([>LJM7QE_R4[Q3_U^0?\
MI';UE5]/A?X$3\ZS+_?*GJ%%%%=)YX4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4ZV_Y#FB?]AK3_ /TKBIM.MO\ D.:)_P!AK3__ $KB
MK&O_  9>C_(Z\%_O5/\ Q+\SZ8HHHKY4_2@KF_B/_P DL\5_]@6\_P#1#UTE
M<W\1_P#DEGBO_L"WG_HAZ /":***^P/RH**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N\^"__(S^)O\ KSL/_0[JN#KO/@O_ ,C/
MXF_Z\[#_ -#NJX,P_@'MY)_OB]&>O4445\\?=!7AWQ4_Y*G)_P!@6T_]'W5>
MXUX=\5/^2IR?]@6T_P#1]U79@?\ >(_/\CRLX_W&?R_-'+4445](?GX4444
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MFO2Z\T^-O_(#\/?]AH?^DES6U#^-'U7YG)C?]UJ?X7^1YA1117U1^:A1110
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MU9]KD'^ZR_Q/\D%%%%>:?0!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'B7[5?_)+--_[#47_HB>C]E3_DEFI?]AJ7_P!$04?M
M5_\ )+--_P"PU%_Z(GH_94_Y)9J7_8:E_P#1$% 'MM%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH *[SX+_\C/XF_P"O.P_]#NJX.N\^"_\ R,_B;_KSL/\
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M50_@Q]%^1^:XW_>JG^)_F%%%%;'(%%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[>2?[XO1GKU%%%?/'W05X=\5/^2IR?\ 8%M/_1]U7N->'?%3_DJ<G_8%M/\
MT?=5V8'_ 'B/S_(\K./]QG\OS1RU%%%?2'Y^%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% &=XA_Y%C5/^O.;_ - -?5=?*GB'_D6-
M4_Z\YO\ T U]5UXF9?'$^PX?_A3]0HHHKRCZ4*^5/#W_ "+&E_\ 7G#_ .@"
MOJNOE3P]_P BQI?_ %YP_P#H KU<M^.1\UQ!_"AZFC1117MGQX4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 =3\*_^2IQ_P#8%N__
M $?:U[C7AWPK_P"2IQ_]@6[_ /1]K7N-?-X[_>)?+\C] R?_ '&'S_-A1117
M&>J>0_&C_D9_#/\ UYW_ /Z':UP==Y\:/^1G\,_]>=__ .AVM<'7T.7_ , ^
M%SO_ 'Q^B"BBBN\\0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M *1V]?0M?/7C+_DIWBG_ *_(/_2.WKOR_P#CGBYW_N;]495%%%?0GP@4444
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M/V5/^26:E_V&I?\ T1!0![;1110 4444 %%%% !1110 4444 %%%% !1110
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MO4445\\?=!7AWQ4_Y*G)_P!@6T_]'W5>XUX=\5/^2IR?]@6T_P#1]U79@?\
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MKYGMO^0YHG_8:T__ -*XJ^F*\',OXR]/U9]KD'^ZR_Q/\D%%%%>:?0!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'B7[5?_)+-
M-_[#47_HB>C]E3_DEFI?]AJ7_P!$04?M5_\ )+--_P"PU%_Z(GH_94_Y)9J7
M_8:E_P#1$% 'MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]=)5;4M/M=7TJ[TW4(O.M+R%X)X]Q7>CJ589!!&03R#F@#YNHKV+_A3W@O\
MY\+_ /\ !S>?_':/^%/>"_\ GPO_ /P<WG_QVO;_ +2A_*?'_P"K]7^='CM%
M>Q?\*>\%_P#/A?\ _@YO/_CM'_"GO!?_ #X7_P#X.;S_ ..T?VE#^4/]7ZO\
MZ/':*]B_X4]X+_Y\+_\ \'-Y_P#':/\ A3W@O_GPO_\ P<WG_P =H_M*'\H?
MZOU?YT>.T5[%_P *>\%_\^%__P"#F\_^.T?\*>\%_P#/A?\ _@YO/_CM']I0
M_E#_ %?J_P Z/':*]B_X4]X+_P"?"_\ _!S>?_':/^%/>"_^?"__ /!S>?\
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M^1G\,_\ 7G?_ /H=K7!U]#E_\ ^%SO\ WQ^B"BBBN\\0**** "BBB@ HHHH
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MOU1E4445]"?"!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 ZV_P"0YHG_ &&M/_\ 2N*OIBOF>V_Y#FB?]AK3_P#TKBKZ8KP<R_C+
MT_5GVN0?[K+_ !/\D%%%%>:?0!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'B7[5?_ "2S3?\ L-1?^B)Z/V5/^26:E_V&I?\
MT1!1^U7_ ,DLTW_L-1?^B)Z/V5/^26:E_P!AJ7_T1!0![;1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY)QZ'O97@:F#A*-1IW?3_AD%%%%<1ZX5\J>'O^18TO\ Z\X?_0!7U77F%O\
M K2+2UBM[?Q)X@2*% B+NM3A0, 9,'I7;@\1&A)N74\C-,#4QD(QIM*SZ_\
M#,\THKT__A26F?\ 0S^(/SM/_D>C_A26F?\ 0S^(/SM/_D>O1_M*CV?X?YG@
M_P!@8K^:/WO_ "/,**]/_P"%):9_T,_B#\[3_P"1Z/\ A26F?]#/X@_.T_\
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M:KG'9GU& P\L-AHTI[J^WJV%%%%<YVGD/QH_Y&?PS_UYW_\ Z':UP=>X>,?
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M=I_\CT?VE1[/\/\ ,/[ Q7\T?O?^1YA17I__  I+3/\ H9_$'YVG_P CT?\
M"DM,_P"AG\0?G:?_ "/1_:5'L_P_S#^P,5_-'[W_ )'F%%>G_P#"DM,_Z&?Q
M!^=I_P#(]'_"DM,_Z&?Q!^=I_P#(]']I4>S_  _S#^P,5_-'[W_D>845Z?\
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MSM/_ )'H_P"%):9_T,_B#\[3_P"1Z/[2H]G^'^8?V!BOYH_>_P#(\PHKT_\
MX4EIG_0S^(/SM/\ Y'H_X4EIG_0S^(/SM/\ Y'H_M*CV?X?YA_8&*_FC][_R
M/,**]/\ ^%):9_T,_B#\[3_Y'H_X4EIG_0S^(/SM/_D>C^TJ/9_A_F']@8K^
M:/WO_(\PHKT__A26F?\ 0S^(/SM/_D>C_A26F?\ 0S^(/SM/_D>C^TJ/9_A_
MF']@8K^:/WO_ "/,**]/_P"%):9_T,_B#\[3_P"1Z/\ A26F?]#/X@_.T_\
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M:O*S+X(GTO#_ /%GZ'<4445XA]@%?/7C+_DIWBG_ *_(/_2.WKZ%KYZ\9?\
M)3O%/_7Y!_Z1V]=^7_QSQ<[_ -S?JC*HHHKZ$^$"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@!UM_R'-$_P"PUI__ *5Q5],5\SVW
M_(<T3_L-:?\ ^E<5?3%>#F7\9>GZL^UR#_=9?XG^2"BBBO-/H HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HKE;/XF^#M1\7KX7T_78+K5V+ 00H[J2JEF'F!=F0%/&[M
M754 %%5=3U2PT73Y;_5[R"RM(AEY[B0(B_B:X=/CO\-7O/LH\40^9NV[C;3!
M/^^RFW'OF@#T*BH+*^M=2L8KS3KF*ZM9EWQ30N'1QZ@C@TMW>6VGV<MW?W$5
MM;0J7DFF<(B*.Y)X H FHKSZ7X[_  UAO#;/XIA,@.,I;S,G_?80K^.:[72M
M7T[7-.CO]&O8+ZTE^Y-;R!U..HR._M0!<HHHH **** /$OVJ_P#DEFF_]AJ+
M_P!$3T?LJ?\ )+-2_P"PU+_Z(@H_:K_Y)9IO_8:B_P#1$]'[*G_)+-2_[#4O
M_HB"@#VVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\T^-O
M_(#\/?\ 8:'_ *27->EUD>(_"VD>++&&TUVWDGA@F$\0CN)(61PK+D-&RG[K
ML,9QS5TY<DU+LS&O3=6E*FNJ:^]'SY17L7_"GO!?_/A?_P#@YO/_ ([1_P *
M>\%_\^%__P"#F\_^.U[']I0_E/E?]7ZO\Z/':*]B_P"%/>"_^?"__P#!S>?_
M !VC_A3W@O\ Y\+_ /\ !S>?_':/[2A_*'^K]7^='CM%>Q?\*>\%_P#/A?\
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M6K#;''.K,<741X /I7U+7AY@TZJMV_S/L<BC*.&DI*WO/\D%%%%><>\%%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#*\3221>'+MX9&B=57#(<$?,.]8NG^
M']0O=.@N?[>NH_-0-M^8XSVSNK9\4_\ (LWG^Z/_ $(5-H'_ "+]C_UQ7^5
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M_P (KJ'_ $,5U^3?_%UT]% '"7FFZA:Z[9Z?_;5T_P!H&?,W,-O7MN]JU/\
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M$5U#_H8KK\F_^+KIZ* .8_X174/^ABNOR;_XNC_A%=0_Z&*Z_)O_ (NNGHH
MYC_A%=0_Z&*Z_)O_ (NC_A%=0_Z&*Z_)O_BZZ>B@#F/^$5U#_H8KK\F_^+H_
MX174/^ABNOR;_P"+KIZ* .$T73=0U<7)_MJZA\B79]YFW>_WA6I_PBNH?]#%
M=?DW_P 71X,^[J7_ %\5T] ',?\ "*ZA_P!#%=?DW_Q='_"*ZA_T,5U^3?\
MQ==/10!S'_"*ZA_T,5U^3?\ Q='_  BNH?\ 0Q77Y-_\773T4 <Q_P (KJ'_
M $,5U^3?_%T?\(KJ'_0Q77Y-_P#%UT]% ',?\(KJ'_0Q77Y-_P#%T?\ "*ZA
M_P!#%=?DW_Q==/10!S'_  BNH?\ 0Q77Y-_\71_PBNH?]#%=?DW_ ,773T4
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M0!S'_"*ZA_T,5U^3?_%T?\(KJ'_0Q77Y-_\ %UT]% ',?\(KJ'_0Q77Y-_\
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M_P"ABNOR;_XNNGHH YC_ (174/\ H8KK\F_^+H_X174/^ABNOR;_ .+KIZ*
M.8_X174/^ABNOR;_ .+H_P"$5U#_ *&*Z_)O_BZZ>B@#F/\ A%=0_P"ABNOR
M;_XNC_A%=0_Z&*Z_)O\ XNNGHH YC_A%=0_Z&*Z_)O\ XNC_ (174/\ H8KK
M\F_^+KIZ* .8_P"$5U#_ *&*Z_)O_BZ/^$5U#_H8KK\F_P#BZZ>B@#F/^$5U
M#_H8KK\F_P#BZ/\ A%=0_P"ABNOR;_XNNGHH YC_ (174/\ H8KK\F_^+H_X
M174/^ABNOR;_ .+KIZ* .8_X174/^ABNOR;_ .+H_P"$5U#_ *&*Z_)O_BZZ
M>B@#F/\ A%=0_P"ABNOR;_XNC_A%=0_Z&*Z_)O\ XNNGHH YC_A%=0_Z&*Z_
M)O\ XNC_ (174/\ H8KK\F_^+KIZ* .8_P"$5U#_ *&*Z_)O_BZ/^$5U#_H8
MKK\F_P#BZZ>B@#F/^$5U#_H8KK\F_P#BZ/\ A%=0_P"ABNOR;_XNNGHH Y=_
M"^H)&S?\)#=':"<8;_XNL[0M*U#6=/-S_;=U!B0IM#,W0#G[P]:[:?\ X]Y/
M]T_RKG_ W_(OM_UW;^0H C_X174/^ABNOR;_ .+H_P"$5U#_ *&*Z_)O_BZZ
M>B@#F/\ A%=0_P"ABNOR;_XNC_A%=0_Z&*Z_)O\ XNNGHH YC_A%=0_Z&*Z_
M)O\ XNC_ (174/\ H8KK\F_^+KIZ* .8_P"$5U#_ *&*Z_)O_BZ/^$5U#_H8
MKK\F_P#BZZ>B@#F/^$5U#_H8KK\F_P#BZ/\ A%=0_P"ABNOR;_XNNGHH YC_
M (174/\ H8KK\F_^+H_X174/^ABNOR;_ .+KIZ* .8_X174/^ABNOR;_ .+H
M_P"$5U#_ *&*Z_)O_BZZ>B@#F/\ A%=0_P"ABNOR;_XNC_A%=0_Z&*Z_)O\
MXNNGHH YC_A%=0_Z&*Z_)O\ XNC_ (174/\ H8KK\F_^+KIZ* .8_P"$5U#_
M *&*Z_)O_BZ/^$5U#_H8KK\F_P#BZZ>B@#F/^$5U#_H8KK\F_P#BZ/\ A%=0
M_P"ABNOR;_XNNGHH YC_ (174/\ H8KK\F_^+H_X174/^ABNOR;_ .+KIZ*
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M?DW_ ,773T4 <Q_PBNH?]#%=?DW_ ,71_P (KJ'_ $,5U^3?_%UT]% ',?\
M"*ZA_P!#%=?DW_Q='_"*ZA_T,5U^3?\ Q==/10!S'_"*ZA_T,5U^3?\ Q='_
M  BNH?\ 0Q77Y-_\773T4 <Q_P (KJ'_ $,5U^3?_%T?\(KJ'_0Q77Y-_P#%
MUT]% ',?\(KJ'_0Q77Y-_P#%T?\ "*ZA_P!#%=?DW_Q==/10!S'_  BNH?\
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M,MZ;NGXT?VYK4<[+-I%NY10[VMO>*]Q&I[E,<UO[.VT?O?\ PQQ.O?>I_P"
MJZ^^S+O_  F MN=6T?4+%.\GEB5!]2I-;5AJ5EJEN)]/N8[B,]T;./J.WXUS
MTFNZG;0FYN_#UU':#EG616=%]2@YI)M&M;]4U70)_L-VZAX[B 860>CKT(J9
M0CU5OQ1I"K4O[KYO)JS^6R?W+U.LHK%T+77OY);#4HEMM3MA^]B!RKKV=/53
M^E;582BXNS.VG4C4CS1"BBBI+"BBB@!D_P#Q[R?[I_E7/^!O^1?;_KNW\A70
M3_\ 'O)_NG^5<_X&_P"1?;_KNW\A0!T=%%% !1110 4444 %%%% !116=K6N
MV.@6)NM1EV+G"J.6<^@%.,7)V1,YQA%RD[)%Z::.WB:6>18XU&6=S@#\:Y^;
MQ_X8@E,;ZJA9>ICB=Q^:J17)K#JOQ'UE)+A)[+0H^0,XW8]/4GUZ"NXL_"FA
MV,(B@TRWP!C+H')^I-=4J5*EI4;;[+H>=#$8C$MRH)*/>5]?1::#M+\3Z-K4
MGEZ;J$4TG_/,Y5C^# &G:IXCTC12%U.^B@<C.SEF_P"^1DUQGC_PI9Z=IG]N
M:,GV*XM74N(?E# G (]""147P_\ #-MK-M-KNNK]MFFE(03'<..K'U.?Y5I[
M&CR>UN[=NMS#ZWBU6^K<JY][ZVMWMN=1%\0/#$L@1=44%NF^&11^97%;\%Q#
M=0K+;2I-&W1T8$'\16;=>%M#O(?*GTNV*XP"L84CZ$<UP]Q8:I\.]:^V::L]
MYHLG^LCSG8/?T([&LXTZ572FVGY]3:>(Q.']ZNDX]7&^GFUKH>G45EZ%XAT_
MQ#9^?ITN=O#QMPR'W%:E<THN+M+<]&$XU(J4'=,****DL**** "BBB@ HHHH
M YCQU_R"K7_KX'_H)KIZYCQU_P @JU_Z^!_Z":Z>@ HHHH **** "BBB@ HJ
MEJ6KV&CP>;J-U' I^Z&/S-]!U-5-,\3Z?JE[]DA%Q%,R%T6XA:/S%'4KGK5J
M$FN9+0R=:G&?(Y*_8S%^(NB-;SREI4,+ >4P4/)DX^49YKH-+U&'5M,@OK8,
M(IUW*'&#UQ7@;@?:"3NSO/1<_P 9KUGP]K5IHW@71VN_,9YD*Q10QEW<Y.<
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M->UV^T65&AT::^M=I:6:%QE/^ XYJ?2O$FEZOIWVRVND2->'$K!3&?0UJD@
MD\ =2:\NTC0M+\2>/M6E^S>;ID1R-K%4+\>F.^34TX4ZD'S*UNIIB*M:C5BH
M/FYG:STMIO=+;N5_'-^?$^LP_P!@02WR::A:66%25.2#Q^5=IX=\<:;K[K;_
M #6E[T-O+W/L>_\ .MVRT^TTVW$%A;1V\0YVQK@$^OO7(^/?"D-Y82:QIR^3
MJ%J/,+1\>8!US[CL:U52E52I-62V?^9SRH8G#.6)BU)O62MV[>B^\[:BN:\"
M^(7\0>'5DN3FZMV\J8_WO1OQ'\C72UQS@X2<7T/5HU8UJ:J0V84445!J%%%%
M !1110!S&L?\CQI/^Z?ZUT]<QK'_ "/&D_[I_K73T %%%% !1110 4444 %%
M%8'C/7V\/>'9;F''VB0^5#GLQ[_@/Z54(.<E%;LSJU(TH.I/9#?$7C33/#K>
M3,S7%V1D6\7)]LGM7"^#]0?P_P"(Y+O7K:6S@U)28Y94. <YZUT'@'PK&+5-
M>U8&YOKK]Y&9#NV*>_U/K7:7=E;7]N8+VWCN(FZI(H85VN=*C>DE>^[_ ,CR
M(T<1BW'$R:C;6*M^?JON*>H^(M+TS33?7%W&T/1?+8,7/H,=:IZ%XAO=;NB3
MHL]I9%-R7$S@%O;;BN-\2Z!I7ASQ;I-TMH8],D?]\-Q90P/OT[&O4%*L@*$%
M2,@CIBLZD*<*:<5>_7L=%"K7K5I1FU'DMHM;^=VMCS_XN?\ ((T[_KX/_H-=
MKI7&AV6!D_9TX_X"*XKXN?\ ((T[_KX/_H-=MI/_ "!;+_KWC_\ 013J?[M#
MU9%#_D85O2)SY\;FPU 6_B'2;C34=RL<Y;?&?<D 8_6MG4O$.EZ59FYN[R(+
MMW*JN"S^F .M9_CJ:SB\'WHOMIWIMB4]2_;%97@KP=IBZ%:7VHZ>LEY(-^9\
MM@9X^4\=,=J.6DZ?M&FM;677[Q^TQ,:[H1:EI>[TMZVW\MCD] UFX\-Z]<:Y
M?Z7<BPU'?M?;C:&?<".QKU;2M8L=:LQ=:;.LT><''!4^A':K4L$4\#0S1K)$
MPPR,,@CTQ7ENK6\GP[\7V]YII?\ LV[/SPELC&?F7\,Y!K1N&+>BM+IYF"C4
MRR*;?-3OKW3?7TN>JT4V.198DDC.Y'4,I'<&G5YY[@4444 %%%% !1110!S'
M@S[NI?\ 7Q73US'@S[NI?]?%=/0 4444 %%%% !1110 5%=74%C:O<W<JQ0Q
MC+.QP!4M>7ZW/<^./'0T."5H].M&/F;3UV_>;W.>!6]&E[23N[):LX\7B?J\
M%RJ\I.R7F5O&.OMXT,5GX?L;FXCM6:1Y0A^;CT_QKM_"OB/3M2T>VB2>.*YB
MC$<D#G:RD#'0]:V-.TVTTFQ2TL(5AA08  Z^Y/<^]9.O^$=)U>VN)FL(_MA1
MBDL>48OCC..O/K6TJM*<53LTEL_\SDAAL32F\1S*4GNMEIV_K4KZCXVABU!]
M/T6QFU:[3[ZPG"+]6YKHK266:SBDN8/L\K*"\1;=L/IGO7&?"Y[5-&N;54$=
M]%,?/!^\1V_#J*[FLL1&,)<D5MU[G1@JE2M35:<M^G1?K?N>9?#C_D<M<_X'
M_P"C*[C7=4OM*ACEL-)DU%23Y@CDP4'KC!S7#_#C_D<M<_X'_P"C*]-K;%M*
MO=J^B_(Y<LC*6#M%V=WK\_,Q=$\5:;KEO(\,A@EA_P!;#/A63_ZU<=\0=2B\
M1M;:/H2M?W$+F:0P#<% !&,CZTW4-+T_Q'\5#;Q0^;;1QYNS&2H+ 'J1^ KT
M'3=(T_2(3%IMI%;J>NQ>6^IZG\:?[O#R4TG>U[=B4J^-IRHR:44[-K=V[+9?
M>SE_"GCC3Y[>VTG4%>PO846';-T<@ =>Q]C7:5S7C'PG;>(=.>1$"7\*DPRK
MP6/]T^H_E6?\-_$4VJZ;-I]^Y>ZLB &;JR>_N.GY5G4A"I!U:?S1O1K5:-58
M:OK?X7WMT?F=K1117(>H%%%% !1110 5@>-/^1;?_KHO\ZWZP/&G_(MO_P!=
M%_G0!L6/_(.MO^N2_P A4]06/_(.MO\ KDO\A4] !1110 4444 %%%% !6/K
M_BG3/#D(-_*3*PRD,8R[?AV'N:GU_5DT/0KK4' 8PI\JG^)CP!^9KA_ WA\Z
M_<2>)?$!-U))(?(5^5R.Y'MT ]JZ:5*+BZE39?BSS\3B*BJ1H45[[UUV2[F1
MINJS6WC3_A)]2L)[?3[N1E$C*2$R..<5ZA)KVEQ::]^;Z VR+DNK@_AQW]JN
M36\-Q T%Q$DL3##1NH*D?2O-?'OA;3=(2RU"PL3'!Y^+I8V.W'&..W>MU*GB
M9J+T>QR.%?+Z,YQ:DMW?1W>[TZ'4Z1XKN=;U!!8Z+<#3V)S>2L%'U"XY_.JO
MQ._Y$F;_ *[1_P ZZBQEMY]/@ELBIMVC!CV]-N.*Y?XG?\B3-_UVC_G65)Q>
M(CRJVIT8F,U@JG/+F;3_ "Z&CX(_Y$K3?^N1_P#0C574?&,VC:B\>KZ-<P60
M?:EY&P=2/4C''YU:\$?\B5IO_7(_^A&K^N36<&AW;ZEM^S>4P<,,YXZ5,N7V
MTE)7N_U*@I_5(2A+EM%>FW4277=+AT];V6_@6W9=RN7'S#V%>6+K%Q;^-)?%
MT.F7,NFM(RA]I (V[<YQ^-;?P^\):=?:/_:.JV/G.\A\GS22NT=]O0\YKT58
M8TA$21JL8&T(% 4#TQ6W-3P\I02YNC]#E]G7Q].%634+:JVNOG?IY&=H?B+3
MO$-L9=.FW%?OQL,,GU%:E>7^,-(?P=K%OX@T#,$<DFV6(?=!ZXQ_=//%>C:;
M?QZGIEO>P?<GC#@>F>WX=*QK4HQBJD/A9V87$SG.5&LK3CVV:[HM4445S'>%
M%%% !1110 5S$G_)1X?^O?\ H:Z>N8D_Y*/#_P!>_P#0T =/1110 4444 %8
MFN:^UE.FG:7$MUJDPRD1/RQ+_?<]A_.K&OZN-%TIIU3S;B1A%;Q9_P!9(>@_
MK]!5#0](.FV[RW3B?4+EO,N9\<LQ[#V'0"M8I1CSR^1S5)2G/V5-V[OLO\W^
M&Y7L]"MUOENM:N%U'4V^8-+C">R)V ]:3Q03&FESCK%J,.#Z;CM_K6%K-@Y\
M0ZI*B$ZC"L-[9,,[FC0X=!_A6EJVN:'K.DBU%S--),%D1+-"\L; Y!P.A!]:
MZ>67-&>_Z'GNI35.I2LHOI=[V?YZ>>Z/.O$,0?Q-JA(SB]FQ\P'\9KK/#I\R
MR\+0=OM=W+C_ '/_ -=,@T6V07W]L/'93:C&T5J=1*^<\K$L9& ^YD\5/HT=
MMX?O(I];AU"S>%66(2+OMXRWWF5E]?>NVK44J?*NG^5CR,/1E3K^TEHGOY>\
MGK\E^)U^J:=IVH6VW58HF0'Y7<[2I]F[&LV+4+[PK(D>I2M?:.QVK=-S);>@
M?^\OO67KE]8:S=23$I=:9IEJ\LC DI),PPB>YKH="LY(?"]E:WR^8PMPLBN,
MYR.A_/%>?9TZ:YNO3_+S_P SW5)5ZTO9Z-;277U[K=?)VL;Z.LL:O&P9&&58
M'((IU<IHLK^'=970YVW6%UN>P=C_ *L]6B/\Q75USSCRO38[:-3VD=59K1KS
M_K8Y76B=<\3PZ0<FRL56YNQV=S_JT/MQFLG5M7CU*ZGM;W4/[-TA9S:,R)E[
MAQC<,_PJ,XS[UI^'WWR:W?D%GDO9/KM08 _0_G61#X9?Q!X!6XAE7[9-/+>*
M#]W+$@I[<#\Z[8<L96ELK+YOJ>35=2<+TU=RN[=TM$ON>W<SI?$VH:)XFN+3
M2+I;ZVC;9%;*A,8 XV* ,Y7U'!P:H:?XA?3/%LVLZE#YDK;E=/\ 5$.P'&UN
M< #C-/\ !6L76F3-%IVF17<TLBB4[7,BKG&,@8 ZFK&IR:CXB\;7-SX?MI#+
M;.JAMJX&T%=S%N 22<=>!7;RQC)Q:TMN>0JDYPC.,VWS:1LW;TOO;L6;[QIJ
M/B#4[6UTZ>/2X&;/F-,,'U+,>, 9^4=:TM4BT72=TWAK4HX=1B4R_9HIMT<X
M'+*5Y R,XQ5B/P(][IBRZK.D>K$EGEA4,C^F]2-K'WP*Q/!EG%:^.)K'5(D>
MYAW^3LX5'7&3M& <J>"?I6%Z3B^3:/3O_FCMMB(S2K+6;5F^GHELS?U9_MFD
MVOB/2"&N;-1.NT_?CQ\\9_#/XBNLL[J.^LH;J YCF0.I]B,URNA1PC7->@L0
M#IWGJ%4?<$A7]X%]LU>\#LP\,) W_+K/+ OT5R!7%4BN6W:WW/7\#U</-NHG
M_,G?UB[7^?Z(Z*BBBN8]$**** &3_P#'O)_NG^5<_P"!O^1?;_KNW\A703_\
M>\G^Z?Y5S_@;_D7V_P"N[?R% '1T444 %%%% !1110 444C,$4LY"JHR2>PH
M 6O+M;5?$7Q8@TZ];=:VY"B//!P-Q'XU:U'Q)JWB_66TCPH[6]I&<37?3(]<
M]A].35L?#&&VM4FL-2G35HW\Q;INA;TQV'YUZ-*,</K4=FUIY>;/!Q-2>-2C
M0CS0B[M[)VZ+O^1W:(L<:I&H1%&%51@ >E!90P!(!/09ZUY[KGBCQ9X>TT1Z
ME8VA>4^5%>1/D;O7;Z_E6SH?@J*VE@U+6;B>^U12)"[R':C>@'M[USRHJ,>:
M<O2VMSNAC'4J>SI0=UO?2W^?Y>9-\0?^1#U+_=3_ -&+47PW_P"1$LO]Z3_T
M-JE^(/\ R(>I?[J?^C%J+X;_ /(B67^])_Z&U7_S"?\ ;WZ&3_Y&:_P?^W'4
M;EW;=PW>F:&4,I5@"I&"".M<UKG@NVU&XEU#3[B:QU-OF$\<A 9@.,CT^E8.
MA^*/%NL6;V=C8VTEQ;GRY;R9\ 'UV^O^<5$:*G'F@]M[Z6-IXMTJGLZL'KM;
M6_\ D_P\RC!&GASXO"UT\^7;7! >// ##./P->I5P@^&<=[;2SZSJ,TVJ3-O
M:XC^ZA] #U'Y?A5"TUW6? ^K)IWB1WO-.DXBN>I4>H/\P:Z*L8U[<CO)+[_0
MX,/4G@K^VARPD[I_RWZ/M^1Z5138Y$FB62)@R. RL.A![TZO./>"BBB@ HHH
MH **** .8\=?\@JU_P"O@?\ H)KIZYCQU_R"K7_KX'_H)KIZ "BBB@ HHHH
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MEMM.TR&Y::91/(JN9$4] 3C  '/YT7+ZGXD\87-_X=M9 \,N V% 4;=F6+<
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MVO\ /]#H:***YCT0HHHH YBP_P"2BZE_U[C^4==/7,6'_)1=2_Z]Q_*.NGH
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M0\[_ 'K_ #N%%%%8G4%%%% !7,>'O^1IUO\ ZZ?^S&NGKF/#W_(TZW_UT_\
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M_P CE?BY_P @C3O^O@_^@UVVD_\ (%LO^O>/_P!!%<3\7/\ D$:=_P!?!_\
M0:[;2?\ D"V7_7O'_P"@BM*G^[0]6<]#_D85O2)-<6EO>($NX(YU4[@LB!@#
MZ\U*, <<"L_6=&AURR%K<SW$*!@V8)-I/L>.E<IJW@>[T[3YI_#6L7T4BH=T
M,DV5D'< \8-8TX0FK.5F==:K5I-RC3NO77[O^"7M \07NK>.-6MEE$FG6R;8
M\*,!@0.O_?50_$_2Y;_PN)[= QM)/-?UV8(/^/X5+\-5L?\ A$D>RC*2F0BX
M9CDLX]_3!&*ZB[6-[*99L>68V#9],5M.:I8B\5L<M*D\3@FJDK\]WZ7U7W&+
MX(UB+6/"MJT?RR6Z""1<]"H S^(P:Z"O-_A"3Y.KCG;OBQ_X_7I%9XJ"A6E%
M&V7595L+"<M[?EH%%%%<YWA1110 4444 <QX,^[J7_7Q73US'@S[NI?]?%=/
M0 4444 %%%% !1110!4U348=)TNXOKD_NX$+$>OH/Q.!7!?"ZPGFN]0UJ9-L
M<Q*1D]2<Y;\.E;'Q0,@\%OY><&=-_P!.?ZXK2\$)$G@S3A!]TQ9./[Q//ZUV
MQ]S#-K[3L>34_?9A&#V@K_-Z!K7BZRT&]6WOK6]*E0QGCAS&/QS5^TUS3+VQ
M%Y;WT+0'^,N%Q['/0U>=%=2KJ&4]01D&O+H_#^E77Q3N=/CMA+8JAD>)7(6-
M\#/3W[5%*%.I%WNFE<TQ%;$4)JUI*3LEM;YZW7R/0+2]T0W,DEE<6/GRG]XT
M;+N?ZD=:TJYZ?P+X<GC"'343'0QLRG]#6Y;6T=I:QV\ (CB4*H))X'N:RGR;
MQ;^9U4?;*ZJ)+T?_  #S?X<?\CEKG_ __1E>FUYE\./^1RUS_@?_ *,KTVM\
M;_&^2_(X<H_W7YO\R&&TMK:21[>WBB>4YD9$ +GU/K6#XYUR;0O#K2V<HCNI
M9%2+(!/7G ^E,O? =A?7DUU)?ZDDLK%LK<<(?;BN4FTF;3/'VE6OB2[FU.T<
MXM'D;.#G@,#Z'&?P^E.C3IRES<U[:VMV%BZU>%-P4.6[LG?:_5]O\STC37FF
MTFTDN_\ 7O"C2<8^8@9XKS;1I?\ A%/BE=6U\FR*_9DC<< !VRI^F1C\Z]3K
MS'XL!%U/2'3B8A\D=< KC^M/"/GFZ;VDA9G%TZ,*Z>L&OGT9Z=1117">P%%%
M% !1110 5@>-/^1;?_KHO\ZWZP/&G_(MO_UT7^= &Q8_\@ZV_P"N2_R%3U!8
M_P#(.MO^N2_R%3T %%%% !1110 4444 <#\4]40:;;:/"I>YNI ^U>RC@?F?
MY5U'ARP?1?"]I:S+^\AAS(J#/S=2!ZUPVNJ)/C-9+=']T#'LS_NY'_CU>GUV
MUO<HP@NNIY&$_>XJM6>Z?*O1',6GC[1[B\%K="YT^4G"B\BV _CDX_&MF]O]
M*$1AU"ZM-D@P4E=<,/H:I^++&PO/#=Z=21-D<3.LC=48#@@_6N6\ ^%]+U'P
MXE[J6GK-,\C /(S'<![9Q24*4H>TU5OG_D4ZN)A65#25U>^JT\UJ=U97%E)"
ML>GRP-&@PJPL,*/H*YGXG?\ (DS?]=H_YUJ6?@_1-/U)+ZRM##.G3;(VW\LX
MK+^)W_(DS?\ 7:/^=31Y?;QY7U1>*]I]3J>T23L]O3T1H^"/^1*TW_KD?_0C
M6U/;PW4+0W,231-]Y'4,#^!K%\$?\B5IO_7(_P#H1K3U/3TU33Y;.:6:))!@
MO"^UA]#6=3^-+U_4WP]_JL+*_NK\BRB)%&J1JJ(HP%48 %<H?$%[<?$Q-)M)
M0UE%"3.H4'#8)Y/_ 'S4-SX!:UA:70-9U"UNU!V^9-N5_8X JM\,8[<0:EYL
M;?VHDY6ZD<Y+<G&#]0<UO&%.,)33YNFW?J<E2M7G6IT91Y-;WO>Z73^NAN>-
M],EU;PC=V]L@>90)$'<[3D@>^,UE_#'6(KWPR+#&V>Q)5AG[RL20?YC\*[0]
M.:\Q^'X5/B)KB0_ZH+*% Z8\T8HI>_AYQ?346(_=8ZE4C]J\7^9Z=1117$>N
M%%%% !1110 5S$G_ "4>'_KW_H:Z>N8D_P"2CP_]>_\ 0T =/1110 444C-M
M4L>@&: .0O;@7_BRZNI%:6UT. [$7G=,PR3]0,#\:P)=5.JPBYN[BXO6:/SS
M96,_DPVL>./-D[M[5T?A#][HCWK<M?7$EP<^A;C]!5;7XK5KJTTA$C@M9"UW
M?>6H7,4?)!QZGBO0A)*IR6V_3<\2K3E*BJO-\6MN[>WW*RUNNMC"232M/LK/
M7;B"_MKI6,EI9K=F0RJ!RYR,JOJ>XK<W2ZIJ4.F6>-+B%JMW>M9 1N[OT0-V
M]2:SG2/5;S4!$%E.M:=YEC(_!C &##Z#!J:"74+6WUG6+NSDLMMA'"@E(W%T
M7!(QVSWK2>J\_P#/_+7YG-2O%V^SULNR=VVN]E\G8=_Q(;&:YMK/2+K5B/DO
M+A(S/M'7!8]3["G-;QV&B-K/A6_G-O&/,:SDD+Q.H/S+M;E3BNI\-6":9X;L
M;:-0I$*M)@?><C+$_C7.7%H\.N^(M,LT %Y:+<Q1]!O(*M^9Q6*FG)I/;OU.
MN5%QA%M+7:RLXNS:L^OGW?W%;5KO1+_48-(OT?3[23R[R":U(1'+CC?QP<YP
M:S?W-M>7<;:?JMD]F^);BVOVE>,'HY0_>4^HJ<B2+3;V^U33)(X8]-AT^*WN
M!AI9 >P'N>M32R#34M+@3M/?:(8K;47/_+2*08(]PI( /L:Z%HK+\^O]:'#*
M\GS2TZ[:VU_*S:M9V3\F.%U/KVDWUFMQ%=WFFA+BTO[?I(<;ER.S<8(]Z[;1
M]135M&M;^/@3QAB/[I[C\#D5#!;P6ZD6L4<:L=Q\M0 ??BLWP8?(AU/3NUG?
M2!?96^8#]:XIR4XNRM;^G^)Z]*$Z-2*D[\R:^[5?A=?(A\,_N9-7M3]^'4)"
M1[-A@?UK*N9;KP];:CI$5RMA#>2&6PO'R(XRQ&Z,M_ >N#[UK:D/[$\81WK<
M66JJL$K=DF7[A/U'%;,L4<T;1S1K(C=5<9!_"J<^67,U=.W]?>1&BZE/V:=I
M1;7R?^:M\UY'GMQX3U3PQIL6O:3J*2RPKOF$?W=OL?XQZY^HKJ$\5[_"-GJ=
MG:H;W4'$,<0X4RY())]!@FL+4+ZTT*U\2:$\ABAF@$EE%M8@,ZG*C X&0/SJ
MCX<U"VDTWPSIZ2$W4%_(\D>P_*I#X.<8[UURBZD.>:O;\K7/+IU(X>K[*D[7
M5FKWM+F4=+^6IU@T?69E#W?B6Z64]5MXD1%]AQG\ZK_\(>'NWN9]8O7ED79(
MZ!$=U]"P&<5T=%>?[::V_)'NO"47\2;]6W^I!8V-MIMHEM91+%#']U1_/W-9
M6ERG0/$LFFS'_0M2=I[5S_!+U=/QZBMRL[7=-74])EBW>5+'^]AE'6-UY!I0
MEJU+9_U<=:FU%2IK6.W^7S_R.@HK-\/ZB^K>'[2]E7;)+'\X'3<."1[9%:59
MRBXMIFT)J<5);,****18R?\ X]Y/]T_RKG_ W_(OM_UW;^0KH)_^/>3_ '3_
M "KG_ W_ "+[?]=V_D* .CHHHH **** "BBB@ KF_']\]CX-NVC;:TN(@0<'
MD\_I725YE\0)I=8\8:=H*LPBRI8#N6/7\JZ<+#GJJ^RU^X\_,:KI8:5MWHO5
MF_\ #73TL_",<X4"6Y<N[=R,X%==4%M:0V=C':6R^7%&@10O&!7):EX;UK2$
MEU#P_K=U,Z9=K6Z;>KCK@?Y_&D[5JCDW:XXJ6$H0A&/,DM;?Y=3;\4^'H_$F
MC-9M)Y4JL)(I,9VL*NZ3!=6NDVT&H3+/<QH%>100&QT//MBN-TGQ-XL\2VIN
M-(LM/AA1MC/+(3EL#/&<]_2MG3KWQ<FHQ0:MIEG);L</<6\V-@]<'K],5<Z=
M2,>236G2Z,Z6(HSJ>VA&7O:7L[/^NXOQ!_Y$/4O]U/\ T8M1?#?_ )$2R_WI
M/_0VJ7X@_P#(AZE_NI_Z,6HOAO\ \B)9?[TG_H;4_P#F$_[>_0E_\C-?X/\
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M<IZ(4444 %%%% ',>.O^05:_]? _]!-=/7,>.O\ D%6O_7P/_0373T %%%%
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MK?\ UT_]F-=/7,>'O^1IUO\ ZZ?^S&@#IZ*** "BBB@ HHHH **** "BBB@
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M.KMV KF$\0ZUX6U2"R\5[+JRG.V*_B7!!_VA_D_6CXIW5LOA>."0JT\TJF$
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M>UQ_[+44W=.+VU?X&M=<KC4CO=+U3=M?T-<J#U /X4!5'10/PI:*Q.L****
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MR!.NQ?ZFMVG4:TBNA-",KRG)6YGMY62"BBBLCI"BBB@ KF/#W_(TZW_UT_\
M9C73US'A[_D:=;_ZZ?\ LQH Z>BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,GQ3_R+-Y_NC_T(5-H'_(OV/_7%?Y5#XI_Y%F\_
MW1_Z$*FT#_D7['_KBO\ *@#0HHHH **** "BBB@ HHHH P_%'A6S\3V82?\
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M8D&%1%P!7!>*O#NHZ3XA7Q-X<B\PK\T\"#GIR<#J".M:FE?$C1;Y1'?NVGW
M'S),#MS[-_CBNNM!U(1=%>ZNG9GF86K&A5G'%.TV]WHFNEO\B7QIX8?6;2*Y
MTJ)$U."0,D@(4D=QFMN43+X?<76#.+8B0@_Q;>:KGQ3H*Q[SK%EM_P"NZ_RK
MEO$GCV"^MY-*\,)+>W5P/+\U$.U0>N/4_I64(5JB4+:(Z*M7"T'.JI:R6R>_
MR[D/PA/_ !+M1'?S4_D:V-:\-7FN>-+.>]"OI%NF=A;JWH1]<5R&D_VO\.-0
M6;5;0RV-V@\TPG=M/UZ9'IWKO[+QKX>OHE>/5((RW\$S>6P]L&NBNJBJNK3U
M3ZG%@G1GAHX:N^647JGI?6ZWW1MHBQH$C5451@*HP!7#_$'2([&UC\1:8!;7
MMK*I9XQC>"<<_P">E;MYXU\/64;/)JD$A'\,+>83^5<9J^K:I\0[A-,T.TD@
MTY7#2SRC /N>WX<FL<-3J1FIO1=;]CIQ]>A.BZ47S3>R6KOT?E8BU+5M1^(\
MUMINE6K06D>U[F9ONAL<\^@YP.IKTW3[*+3M.@L[?_5P1A%SWQWJ+2-+@T;2
M8+"U'R0KC..6/<GZFKM95JJE:$%:*.G"8:5-NK5=YRW_ ,D%%%%<YWA1110
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MVW_/S#_W\7_&C[7;?\_,/_?Q?\:A_P"$.\/?] BU_P"^*/\ A#O#W_0(M?\
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M?44 :=%%% !1110 4444 %%%% ',:Q_R/&D_[I_K73US&L?\CQI/^Z?ZUT]
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M0 4444 %%%% !1110 5@>-/^1;?_ *Z+_.M^L#QI_P BV_\ UT7^= &Q8_\
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M%%% !1110!S'CK_D%6O_ %\#_P!!-=/7,>.O^05:_P#7P/\ T$UT] !1110
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MXFT?4_#YURTO4.F@,3<2 HH"D@D[L=Q7$^"[F;PU>ZSX$U&0L+2-[G3)'/\
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MC73US'A[_D:=;_ZZ?^S&@#IZ*** "BBB@ HHHH **** "BBB@ HHHH ****
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MT.,W+0:CN-U-+,7EE9@ 6+'O@"L>V^%<%G%%%;>*/$<44("QQ)J#!5 Z  <
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M44 %%%% !1110 V3_5M]#7BO@_PN?%'P.$5J?+U*TO9;FQF'5)5;(&??I_\
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M#&CW4MO#96KW^I2P,5(51\J9'J?YBJM_J<7PK^)>H7%P"FBZY UPH4<+.O8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*YB3_DH\/_7O_0UT]<Q)_P E'A_Z]_Z&@#IZ*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &3_\>\G^Z?Y5S_@;
M_D7V_P"N[?R%=!/_ ,>\G^Z?Y5S_ (&_Y%]O^N[?R% '1T444 %%%% !1110
M 4444 %9VM:!I7B*S^RZU8PWD/4"1>5/J#U'X5HT4 <-_P *>\'[ANL[AH@<
MB!KJ0QY_W<UUMGI%AI^DKIEE:QP62(46%!A0IZC]35RB@#@T^#/@V-ALLK@
M'.T7<F/RS73Z%X9T?PS:M;Z'816B.07*#YG(]2>36K10!DV7AG3-/\07VM6L
M++?7X43N7)#8Z8'05%JG@_1-9UZRUC4;,2WMC_J7W$ 8.1D=#@G/-;=% &=K
MNA6/B/2)=,U6-I+:7&Y58J>/<5<M;:*SM(K:W7;%"@1!G. !@5+10 4444 %
M%%% !1110 4444 <QXZ_Y!5K_P!? _\ 0373US'CK_D%6O\ U\#_ -!-=/0
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N8\6?\A/1/\
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M&_QH_P"$4T7_ )\5_P"_C?XT 6/[=TK_ *"-M_W\%']NZ5_T$;;_ +^"J_\
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M=TK_ *"-M_W\%5_^$4T7_GQ7_OXW^-'_  BFB_\ /BO_ '\;_&@"Q_;NE?\
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M #XK_P!_&_QH L?V[I7_ $$;;_OX*/[=TK_H(VW_ '\%5_\ A%-%_P"?%?\
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M +^-_C1_PBFB_P#/BO\ W\;_ !H L?V[I7_01MO^_@H_MW2O^@C;?]_!5?\
MX131?^?%?^_C?XT?\(IHO_/BO_?QO\: +']NZ5_T$;;_ +^"C^W=*_Z"-M_W
M\%5_^$4T7_GQ7_OXW^-'_"*:+_SXK_W\;_&@"Q_;NE?]!&V_[^"C^W=*_P"@
MC;?]_!5?_A%-%_Y\5_[^-_C1_P (IHO_ #XK_P!_&_QH L?V[I7_ $$;;_OX
M*Q/%FJ6-WH+Q6UW#+)YBG:C@GK6G_P (IHO_ #XK_P!_&_QK&\4:%INGZ(T]
MG:B.0.H#!F/!^IH VK/6],2Q@5[^W#+&H(,@X.*G_MW2O^@C;?\ ?P51M/#&
MCR64#O9*6:-23O;DX^M3?\(IHO\ SXK_ -_&_P : +']NZ5_T$;;_OX*/[=T
MK_H(VW_?P57_ .$4T7_GQ7_OXW^-'_"*:+_SXK_W\;_&@"Q_;NE?]!&V_P"_
M@H_MW2O^@C;?]_!5?_A%-%_Y\5_[^-_C1_PBFB_\^*_]_&_QH L?V[I7_01M
MO^_@H_MW2O\ H(VW_?P57_X131?^?%?^_C?XT?\ "*:+_P ^*_\ ?QO\: +'
M]NZ5_P!!&V_[^"C^W=*_Z"-M_P!_!5?_ (131?\ GQ7_ +^-_C1_PBFB_P#/
MBO\ W\;_ !H L?V[I7_01MO^_@H_MW2O^@C;?]_!5?\ X131?^?%?^_C?XT?
M\(IHO_/BO_?QO\: +']NZ5_T$;;_ +^"C^W=*_Z"-M_W\%5_^$4T7_GQ7_OX
MW^-'_"*:+_SXK_W\;_&@"Q_;NE?]!&V_[^"C^W=*_P"@C;?]_!5?_A%-%_Y\
M5_[^-_C1_P (IHO_ #XK_P!_&_QH L?V[I7_ $$;;_OX*/[=TK_H(VW_ '\%
M5_\ A%-%_P"?%?\ OXW^-'_"*:+_ ,^*_P#?QO\ &@"Q_;NE?]!&V_[^"C^W
M=*_Z"-M_W\%5_P#A%-%_Y\5_[^-_C1_PBFB_\^*_]_&_QH L?V[I7_01MO\
MOX*/[=TK_H(VW_?P57_X131?^?%?^_C?XT?\(IHO_/BO_?QO\: +']NZ5_T$
M;;_OX*/[=TK_ *"-M_W\%5_^$4T7_GQ7_OXW^-'_  BFB_\ /BO_ '\;_&@"
MQ_;NE?\ 01MO^_@H_MW2O^@C;?\ ?P57_P"$4T7_ )\5_P"_C?XT?\(IHO\
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M )\5_P"_C?XT 6/[=TK_ *"-M_W\%']NZ5_T$;;_ +^"J_\ PBFB_P#/BO\
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MV[I7_01MO^_@H_MW2O\ H(VW_?P57_X131?^?%?^_C?XT?\ "*:+_P ^*_\
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M=TK_ *"-M_W\%5_^$4T7_GQ7_OXW^-'_  BFB_\ /BO_ '\;_&@"Q_;NE?\
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MV[I7_01MO^_@H_MW2O\ H(VW_?P57_X131?^?%?^_C?XT?\ "*:+_P ^*_\
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M\: +']NZ5_T$;;_OX*/[=TK_ *"-M_W\%5_^$4T7_GQ7_OXW^-'_  BFB_\
M/BO_ '\;_&@"Q_;NE?\ 01MO^_@H_MW2O^@C;?\ ?P57_P"$4T7_ )\5_P"_
MC?XT?\(IHO\ SXK_ -_&_P : +']NZ5_T$;;_OX*Q?#,L<WB769(G5T=]RLI
MR"-QYK2_X131?^?%?^_C?XUE^%X(K;Q%K$4*;4C8*@SG R: .KHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#)\4_\ (LWG^Z/_
M $(5-H'_ "+]C_UQ7^50^*?^19O/]T?^A"IM _Y%^Q_ZXK_*@#0HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKVOU?_T,UM4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<QXL_Y">B?]?']4KIZYCQ9_R$]$_P"OC^J4 =/1110
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MO)_NG^5<_P"!O^1?;_KNW\A703_\>\G^Z?Y5S_@;_D7V_P"N[?R% '1T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 <QXZ_P"05:_]? _]!-=/7,>.O^05:_\ 7P/_ $$UT] !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S%A
M_P E%U+_ *]Q_*.NGKF+#_DHNI?]>X_E'73T %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %4]8_Y =]_U[2?^@FKE
M4]8_Y =]_P!>TG_H)H H^$/^17M?J_\ Z&:VJQ?"'_(KVOU?_P!#-;5 !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;$B@# !Y'/..YKQZ&]^(7CCXM:SH&@^,-0LY!=W31K+J4\4*(DA&T!,XXQ@
M8H ^N:*^4=9U[XK?!GQ!8G7]=EU2WN2719[I[F&X5<;ES(-RD9'3'45]1:/J
M46LZ'8:I;@K%?6T=P@)SA74,/T- %RBBB@ HHHH **** "BBB@#F/!GW=2_Z
M^*Z>N8\&?=U+_KXKIZ "BBB@ HHHH **** "BBO$/VEO$6M:!I&@#0]5O--,
M\\WFM9SM$S[57 )4@X^8\4 >WT5\T:-\-/C'KF@V&K6GQ!D2"_MH[F)9=:O
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M_F1A@67:4P<@$8/!KH_C-\8G\!>5HV@11SZW<H)"T@W);H> 2.['' Z=SV!
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MU'17 ?!KQ[=?$#P+]NU-$74+2<VMPT8P)"%5@^.V0W3U!KOZ "BBB@ HHHH
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MYY->R444 >-V_P 'M<A^/K>.#>Z>=,-TTXB#OYV#&5QC9MZG^]73?%[X<O\
M$;PE'96,D$&I6LXEM9IR0@SPZD@$X(YZ=5%=]10!R/PP\.:WX2\!VFA^([JU
MNKBS9TBDM79E\K.5&653D9(Z= *ZZBB@ HHHH **** "BBB@ KF/#W_(TZW_
M -=/_9C73US'A[_D:=;_ .NG_LQH Z>BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,GQ3_R+-Y_NC_T(5-H'_(OV/\ UQ7^50^*
M?^19O/\ ='_H0J;0/^1?L?\ KBO\J -"BBB@ HHHH **** "BBB@#Y&^*?\
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M*]T_:$5F^"^J;03B6 G Z#S5JA^S_8PZA\#Q97T(EMKF>XCDC<<.C'!'Y9H
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MJK!"%BR#AB2/O>O:O)_&OQWOOB%X.N_"]OX4:":\\OS)(KEIF&R17X0(#R5
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M^5<_X&_Y%]O^N[?R%=!/_P >\G^Z?Y5S_@;_ )%]O^N[?R% '1T444 %%%%
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M_(9^V7FW_4_<\P[O];\O]:]U^&7_  N'_A*Y/^%CX_LC[*^W/V3_ %NY=O\
MJ?FZ;O;]*\,TWQH_PY^-VN:S+IC7K1WEW$;=I?)/S2'G.UOY5ZWX1_:0_P"$
MI\7:;H?_  B;6WVZ<0^<NH>88\_Q;?*&0._(XH XKPV$O_VO[DZQC*:I=^4K
M]"41_*_15(]P*]4^*7CKX@^%_$-I:>"O"G]L64EJ)9;C[#/<;9-[ I^[8 8
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M//->K6FD:AHW[(=QI^J6<UI>1V%PSV\J$.@:=W&1U'RD'':F?LM*1X#U<D$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D^*?^19O/]T?^
MA"IM _Y%^Q_ZXK_*H?%/_(LWG^Z/_0A4V@?\B_8_]<5_E0!H4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <QK
M'_(\:3_NG^M=/7,:Q_R/&D_[I_K73T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% ',>#/NZE_P!?%=/7,>#/
MNZE_U\5T] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !6!XT_Y%M_^NB_SK?K \:?\BV__71?YT ;%C_R#K;_ *Y+
M_(5/4%C_ ,@ZV_ZY+_(5/0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5S$G_ "4>'_KW_H:Z>N8D_P"2CP_]>_\
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M7F\BRM4WRR;2V!G'0<GD@5\^>)OVG=9COT?PQH%O#IK@F*75(W9YP#C< C*
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M#G!(Z8'4]*]5^/7Q-UW1==L/"7A"XDMKRXC62>: #S"78JD:GL>,DCGE>>M
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M5I":IX?OH[VS=BHD0$8(Z@@@$'V(!YJ76=:T[P]I$^J:U=I:65NNZ29\X7G
MX')))Q@<F@"]17(>&_BKX+\7:NNE^'];6ZO61G6(V\L98#DX+H >.U.\3?%+
MP;X/U4:;XBUE;2\,8D\H6\LA"GH244@=.E '6T5PVF?&CX>ZM=+;V?B:V$C$
M!?M$4D )/^U(JC]:[D$,H*G(/(([T %%%% !1110 4444 %%%% ',:Q_R/&D
M_P"Z?ZUT]<QK'_(\:3_NG^M=/0 4444 %%%% !1110 4444 %%5]0U"UTK3;
MC4-1F6"UM8FEFE;HBJ,D_E7,^&OBGX,\7ZM_9GA[6EN[PH9!$;>6,E1UP74
MT ==139)$AB>25@B(I9F8X  ZFN#M/C?\.KV_BLX/$L?G2N(TWVTR+D^KL@4
M#W)Q0!WU%%<OXI^)'A+P7>16OB76$L[B9/,2(122MMSC)"*<#@]?2@#J**R?
M#WBG1?%>B_VMH%\EW8[F0S;63:5Z@A@"/Q%<BWQZ^&J.5/B49!P<65P1^8CH
M ]$HKG?#?C[PMXO=D\.ZW;7LJKN,()20#UV, V/PKHJ "BBB@ HHHH ****
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M\B^W_7=OY"N@G_X]Y/\ =/\ *N?\#?\ (OM_UW;^0H Z.BBB@ HHHH ****
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MXW7_ (M^!_"^L2Z7K>O);WL./,B2WEEV9&0"40@'';.: .RHK(?Q7HD7A/\
MX29]0C&C>0)_M>UL;#T.,9SSC&,YXQ7)#X]_#4D >).OK8W(_P#:= 'HE%96
M@>*-$\4V9NO#VIV^H1*<.87R4/HR]5/U%:M !1110 4444 %%%% !5/6/^0'
M??\ 7M)_Z":N53UC_D!WW_7M)_Z": */A#_D5[7ZO_Z&:VJQ?"'_ "*]K]7_
M /0S6U0 4444 %%%% !15+6-8L- T>YU75[A;:RM4WS2L"=H^@!)^@&:X?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D^*?\
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M=2 =POF!0N?Q^AKWW0=#L?#6@V>CZ3%Y5G9QB.-2<GW)/<DDDGU)H T****
M"BBB@ HHHH **** .8UC_D>-)_W3_6NGKF-8_P"1XTG_ '3_ %KIZ "BBB@
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MED6,,Z.<<9PA&1_>->J_$CXYZ/\ #_5O[(BL9=6U)4#RQ)*(TA!Y 9L'DCG
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M<8#'KZT <5^RS_R/6L?]@W_VJE?4=?+G[+/_ "/6L?\ 8-_]JI7U'0 4444
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M'PIM_#W@_5?%6JZO>:QK-S?(%EF8A(8V<X4#))P,#DXXX KT?]GG_DB^F?\
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MSZ^9^E=]\4_"_P#PB'[-/AC2G7;<+J44US_UU>&9F'X$[?H!0!TM]_R9RO\
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M0 4444 %%%% !1110 5@>-/^1;?_ *Z+_.M^L#QI_P BV_\ UT7^= &Q8_\
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MK?\ UT_]F-=/7,>'O^1IUO\ ZZ?^S&@#IZ*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH R?%/_(LWG^Z/_0A4V@?\B_8_P#7%?Y5
M#XI_Y%F\_P!T?^A"IM _Y%^Q_P"N*_RH T**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .8UC_ )'C2?\ =/\
M6NGKF-8_Y'C2?]T_UKIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#F/!GW=2_Z^*Z>N8\&?=U+_KXKIZ "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "L#QI_P BV_\ UT7^=;]8'C3_ )%M_P#KHO\ .@#8L?\ D'6W_7)?Y"IZ
M@L?^0=;?]<E_D*GH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *YB3_DH\/\ U[_T-=/7,2?\E'A_Z]_Z&@#IZ***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** &3_ /'O)_NG^5<_X&_Y%]O^N[?R%=!/_P >\G^Z?Y5S_@;_ )%]O^N[
M?R% '1T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 <QXZ_Y!5K_P!? _\ 0373US'CK_D%6O\ U\#_ -!-=/0
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M_P!T_P!:Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH YCP9]W4O^OBNGKF/!GW=2_Z^*Z>@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K \:?\
MBV__ %T7^=;]8'C3_D6W_P"NB_SH V+'_D'6W_7)?Y"IZ@L?^0=;?]<E_D*G
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *YB3_DH\/_ %[_ -#73US$G_)1X?\ KW_H: .GHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9/_ ,>\
MG^Z?Y5S_ (&_Y%]O^N[?R%=!/_Q[R?[I_E7/^!O^1?;_ *[M_(4 ='1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!S'CK_ )!5K_U\#_T$UT]<QXZ_Y!5K_P!? _\ 0373T %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ',6'_
M "474O\ KW'\HZZ>N8L/^2BZE_U[C^4==/0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 53UC_D!WW_7M)_Z":N53
MUC_D!WW_ %[2?^@F@"CX0_Y%>U^K_P#H9K:K%\(?\BO:_5__ $,UM4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M<QXL_P"0GHG_ %\?U2NGKF/%G_(3T3_KX_JE '3T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<QX>_Y&G6_^
MNG_LQKIZYCP]_P C3K?_ %T_]F- '3T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGXK_ .@1;_\ ?7_V5=/10!S']I^*_P#H$6__ 'U_]E1_:?BO_H$6_P#WU_\
M95T]% '$W4?B2ZU:VOY-+02VXPJJPVGKU^;WJ_\ VGXK_P"@1;_]]?\ V5=/
M10!S']I^*_\ H$6__?7_ -E1_:?BO_H$6_\ WU_]E73T4 <Q_:?BO_H$6_\
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M1;_]]?\ V5']I^*_^@1;_P#?7_V5=/10!S']I^*_^@1;_P#?7_V5']I^*_\
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M_P!]?_94?VGXK_Z!%O\ ]]?_ &5=/10!S']I^*_^@1;_ /?7_P!E1_:?BO\
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M_LJZ>B@#F/[3\5_] BW_ .^O_LJ/[3\5_P#0(M_^^O\ [*NGHH YC^T_%?\
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M4?VGXK_Z!%O_ -]?_95T]% ',?VGXK_Z!%O_ -]?_94?VGXK_P"@1;_]]?\
MV5=/10!S']I^*_\ H$6__?7_ -E1_:?BO_H$6_\ WU_]E73T4 <Q_:?BO_H$
M6_\ WU_]E1_:?BO_ *!%O_WU_P#95T]% ',?VGXK_P"@1;_]]?\ V5']I^*_
M^@1;_P#?7_V5=/10!S']I^*_^@1;_P#?7_V5']I^*_\ H$6__?7_ -E73T4
M<Q_:?BO_ *!%O_WU_P#94?VGXK_Z!%O_ -]?_95T]% ',?VGXK_Z!%O_ -]?
M_94?VGXK_P"@1;_]]?\ V5=/10!S']I^*_\ H$6__?7_ -E1_:?BO_H$6_\
MWU_]E73T4 <Q_:?BO_H$6_\ WU_]E1_:?BO_ *!%O_WU_P#95T]% '+OJ/BI
MT93I$&&&/O?_ &54M(7Q)I%D;>WTN-T+E\R,,Y./]H>E=K10!S']I^*_^@1;
M_P#?7_V5']I^*_\ H$6__?7_ -E73T4 <Q_:?BO_ *!%O_WU_P#94?VGXK_Z
M!%O_ -]?_95T]% ',?VGXK_Z!%O_ -]?_94?VGXK_P"@1;_]]?\ V5=/10!S
M']I^*_\ H$6__?7_ -E1_:?BO_H$6_\ WU_]E73T4 <Q_:?BO_H$6_\ WU_]
ME1_:?BO_ *!%O_WU_P#95T]% ',?VGXK_P"@1;_]]?\ V5']I^*_^@1;_P#?
M7_V5=/10!S']I^*_^@1;_P#?7_V5']I^*_\ H$6__?7_ -E73T4 <Q_:?BO_
M *!%O_WU_P#94?VGXK_Z!%O_ -]?_95T]% ',?VGXK_Z!%O_ -]?_94?VGXK
M_P"@1;_]]?\ V5=/10!S']I^*_\ H$6__?7_ -E1_:?BO_H$6_\ WU_]E73T
M4 <Q_:?BO_H$6_\ WU_]E1_:?BO_ *!%O_WU_P#95T]% ',?VGXK_P"@1;_]
M]?\ V5']I^*_^@1;_P#?7_V5=/10!S']I^*_^@1;_P#?7_V5']I^*_\ H$6_
M_?7_ -E73T4 <3JZ>)-7MXX;G2T14D#@QL,YP1_>/K5_^T_%?_0(M_\ OK_[
M*NGHH YC^T_%?_0(M_\ OK_[*C^T_%?_ $"+?_OK_P"RKIZ* .8_M/Q7_P!
MBW_[Z_\ LJ/[3\5_] BW_P"^O_LJZ>B@#F/[3\5_] BW_P"^O_LJ/[3\5_\
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MB@#F/[3\5_\ 0(M_^^O_ +*C^T_%?_0(M_\ OK_[*NGHH YC^T_%?_0(M_\
MOK_[*C^T_%?_ $"+?_OK_P"RKIZ* .(A3Q)#KD^I+I:&:9-C*2-H'R]/F_V1
MWK0_M/Q7_P! BW_[Z_\ LJZ>B@#F/[3\5_\ 0(M_^^O_ +*C^T_%?_0(M_\
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MH_M/Q7_T"+?_ +Z_^RKIZ* .8_M/Q7_T"+?_ +Z_^RH_M/Q7_P! BW_[Z_\
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M4?VGXK_Z!%O_ -]?_95T]% ',?VGXK_Z!%O_ -]?_94?VGXK_P"@1;_]]?\
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M(M_^^O\ [*C^T_%?_0(M_P#OK_[*NGHH YC^T_%?_0(M_P#OK_[*C^T_%?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
6*** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>bdtx-20211231_g16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g16.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,X
M-@  DI(  @    ,X-@  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ6(_E_%?YA_;&!_G_!_Y'M=%>*?\)YXI_P"@M_Y+1?\ Q-'_  GGBG_H+?\
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M\31]2Q'\OXK_ ##^V,#_ #_@_P#(]KHKQ3_A//%/_06_\EHO_B:/^$\\4_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:K?:I)OU*\FN3Z._RCZ#H*HM)432UZ-/"48=+^IX-;,\56TORKR_SW)MX7H
M*:9*K-+4;35TW25D<'+*3O+4M&6FF6JT?FW$@C@C>5ST5%))_ 5N6G@?Q5?X
M^SZ%>@'H98_+'_CV*B52,=V:PP\Y_"KF49J3SJZV#X1^,)O]9:6\'_72X7_V
M7-7%^"GBAAS<Z8OL9G_HE9?6::^T=*R_$/[#.&\VE$U=PWP4\4*N1<Z8WL)G
M_JE4Y_A%XPA4F.TM[CVCN5&?^^L4+$TW]H'E^(7V&<J):<):T+SP1XJL%)N-
M"O<#.3%'Y@'_ 'SFL642VTACN(WB<=5=2I'X&M8U(RV9S3P\X?$K%T24\25G
MK-4BRU:D8NF7P]/#5266I5DJU(R<"V&IP-5E>I%:K3,W$FS2U&&IP-,@=2TV
MEIB%HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT3.>42R#2U$K5(#5F;0ZEIN:6F2+1110(**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *?!--:W"7%I,\$R'*R1M@BF45$X1FN6
M2NC6E5G1ESTW9GI?A7XC+<-'8^(F6*8\)=]$?_>_NGWZ?2O0 0P!!R#R".]?
M.9 (P>E=3X3\<76@21VE\S7&F=,'EH?=?4>WY5XF)P3I^]#5?D?89?G$:]J=
M;27X/_)GL=%16MU!>VL=S:2K+#(NY'4Y!%2UYI] %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML"/N1=V_X$?T'O7J->'BZW/+E6R/L<LPJI4_:2W?Y!1117$>N%%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYD8=V)R?YXK3+J'"%E#'HN>33@01D<UYW<73:I\9+5+1RT=G&1)M/ P#G]6
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ H-%(: &M7S[K5S]KU[4;C.1)<R,/IN./TKWR\E\BRFF_YYQLWY#-
M?.@.8P3R3R:]#+XWK7[(\+/)\N&4>[1%)528U:DJG,>M>S(^4IGH'P1LQ/XP
MO+MAD6]H0I]&9@/Y!J]UKR3X$6^+76KDC[TD48/T#$_S%>MU\_BG>JS[?+8\
MN&CYW"BBBN8]$**** "BBB@ KRCX@ S_ !$TVWE/[H^2.>G+\UZO7FOQ6T^6
M*6PUBW!'EMY;L/X3U4_H:[<$TJUN]SR<WBWA6UT:?R/25&% '0"D=%D0I(H9
M6&"",@U0T'5H=:T6WO8#D.N&']UAU%:-<DDXNS/3A*,XJ4=F>2P^&=,?XI76
MDR0M)9@>8L:-C82H;''89KMY_ 7AV>'RSIZI_M(Q!_.GZ-X3ATO7K_5I)WN+
MBZ<E2P_U:DYQ_3\!6])(L4;22$*B LQ/8"NNMB).2Y)/1+[SS,)@*<(2=6"U
M;?31="GI&DVNB:>ME8AA$I)^9LG)KS?Q?_R5O3O^NEO_ .A5Z1I.LV.MVK7&
MG3>;&CE"<8YKS?Q?_P E;T[_ *Z6_P#Z%5X3F]M+FWLS',N3ZK#V?P\T;6/5
MJR/$?A^/Q'8I:RW4UNJON)B/WO8UI75U%96DMS<OLBB4N[>@%1:;J5KJVGQW
MEC)YD$F=K8QT.#7%%RC[\3UJBIU+TIZW6WD<+?> =0T6UDN_#.K7 G126C+;
M=X]L=_K4WPL@LVT^]NLLVHM+MN"_51U'YG/Y5WU<EX-\.7VB:EJ]Q?;%6[E#
M1!&SD98Y]NHKK]NZE&2F]=/F>9]2C0Q5.=*/NZW[+3?R['6UY3KZ+#\9++R^
M-T\#-CU)&:]4DD2&)I)6"(@+,Q/  [UY-H9?Q9\4&U%0QMX)/-#?W57[F?Q
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M_P ](U;\QFI:^6/T@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3$7_ ,50!Z__ ,)+H7_0:T[_ ,"D_P :/^$ET+_H-:=_X%)_C7D'_"N_%/\
MT"__ "8B_P#BJ/\ A7?BG_H%_P#DQ%_\50!Z_P#\)+H7_0:T[_P*3_&C_A)=
M"_Z#6G?^!2?XUY!_PKOQ3_T"_P#R8B_^*H_X5WXI_P"@7_Y,1?\ Q5 'K_\
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MWL6J***X#V@HHHH **** "BBB@ KS3XY1@^$+"3NM^J_G&_^%>EUYM\<B/\
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MH8M<NS.EJ>+RQ\Z]Z+O^OY,\Y^'_ /R/FF_[S_\ HMJ]%^*/_(EM_P!?$?\
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MZGB+&3SG!SDXX!Q^E:FE>$O#GA[3H+?5([&:ZEX:6\"DR/W"ANWL*O\ @?\
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M<OIN7O<S5GL:9Y7C"U-P3;6_5>AZWX4\"^']0\*V5W?6333S1EG<S.O.3V!
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M&?)R68G(&-O /)_74TRQ\&>(+61=,L=.N$3Y7V6X1US^ 8=^:YWXP3RK;Z5
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MD_QH_P"$ET+_ *#6G?\ @4G^->0?\*[\4_\ 0+_\F(O_ (JC_A7?BG_H%_\
MDQ%_\50!Z_\ \)+H7_0:T[_P*3_&C_A)="_Z#6G?^!2?XUY!_P *[\4_] O_
M ,F(O_BJ/^%=^*?^@7_Y,1?_ !5 'K__  DNA?\ 0:T[_P "D_QH_P"$ET+_
M *#6G?\ @4G^->0?\*[\4_\ 0+_\F(O_ (JC_A7?BG_H%_\ DQ%_\50!Z_\
M\)+H7_0:T[_P*3_&C_A)="_Z#6G?^!2?XUY!_P *[\4_] O_ ,F(O_BJ/^%=
M^*?^@7_Y,1?_ !5 'K__  DNA?\ 0:T[_P "D_QH_P"$ET+_ *#6G?\ @4G^
M->0?\*[\4_\ 0+_\F(O_ (JC_A7?BG_H%_\ DQ%_\50!Z_\ \)+H7_0:T[_P
M*3_&C_A)="_Z#6G?^!2?XUY!_P *[\4_] O_ ,F(O_BJ/^%=^*?^@7_Y,1?_
M !5 'K__  DNA?\ 0:T[_P "D_QH_P"$ET+_ *#6G?\ @4G^->0?\*[\4_\
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MD_QH_P"$ET+_ *#6G?\ @4G^->0?\*[\4_\ 0+_\F(O_ (JC_A7?BG_H%_\
MDQ%_\50!Z_\ \)+H7_0:T[_P*3_&C_A)="_Z#6G?^!2?XUY!_P *[\4_] O_
M ,F(O_BJ/^%=^*?^@7_Y,1?_ !5 'K__  DNA?\ 0:T[_P "D_QH_P"$ET+_
M *#6G?\ @4G^->0?\*[\4_\ 0+_\F(O_ (JC_A7?BG_H%_\ DQ%_\50!Z_\
M\)+H7_0:T[_P*3_&C_A)="_Z#6G?^!2?XUY!_P *[\4_] O_ ,F(O_BJ/^%=
M^*?^@7_Y,1?_ !5 'K__  DNA?\ 0:T[_P "D_QH_P"$ET+_ *#6G?\ @4G^
M->0?\*[\4_\ 0+_\F(O_ (JC_A7?BG_H%_\ DQ%_\50!Z_\ \)+H7_0:T[_P
M*3_&C_A)="_Z#6G?^!2?XUY!_P *[\4_] O_ ,F(O_BJ/^%=^*?^@7_Y,1?_
M !5 'K__  DNA?\ 0:T[_P "D_QH_P"$ET+_ *#6G?\ @4G^->0?\*[\4_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO+8]*CF&$J>^Y*,O/1KRU.HKS#XLSH-1TE;=B+N,.WR]0"5V_J#BKVJ_%2U
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M^#GK72_\+B_Z@7_DY_\ 85Y4J5>&(=6$;_,^EIXC!U<!'#U9\K7D^[\CA?\
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MXE9Y@HZ*PQ@$_P![]*SPL*U"3@XZ-[F^95<+C*:K*I:26UCT/P/_ ,B3I?\
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M>,?&)\6-9_Z"+06N_ \W?NW;?8?W:Z+PY\4+;3M'MK#4K&4_9HQ&LEN0=P'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#*\4_\BCJW_7G+_Z":\E^''_(]V/^[)_Z+:O6O%/_ "*.
MK?\ 7G+_ .@FO)?AQ_R/=C_NR?\ HMJ0'M]%%%, HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KQ+XD_\ (\W?^Y'_ .@"O;:\2^)/
M_(\W?^Y'_P"@"DP/5O"7_(GZ5_UZI_*M>LCPE_R)^E?]>J?RK7I@%%%% !11
M10 4444 %%%% !1110 4&BB@!C5X1XMMOLGC#5(L8S.9/^^QN_K7O#5Y+\4K
M#R/$-M>*,+=0[3[LA_P(KJPDN6O$\W-*?M,)-+IK]QP<@JI**NN*JRBOH)'P
M\&='\*]0&G_$:R#G:ETKVY.?49'_ (\!7T97R7:7<FFZI;7T'^LMIDF3ZJ01
M_*OJZSNH[ZQ@N[<YBGC65#ZJPR/T->)CHVDI'U^3U+TY0[$U%%%<![84444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5K>$[;[7
MXRTJ+&<3B0_\ &[^E9-=I\+K'[1XBNKUAE;6#:/9G/\ @#7%CI\M!^9[&34O
M:8R+[79ZO1117SA]Z%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 97BG_D4
M=6_Z\Y?_ $$UY+\./^1[L?\ =D_]%M7K7BG_ )%'5O\ KSE_]!->2_#C_D>[
M'_=D_P#1;4@/;Z***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5ZU\,M.-IX6-U(N'O9FD&?[H^4?R)_&O*;:TDO[V"S@_UMQ(L:^V3C
M-?0-G:QV-E#:P#$4,:QH/8#%>)F52\E!=#Z_(*'+"59]=%\OZ_ FHHHKRCZ8
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH RO%/_(HZM_UYR_\ H)KR7X<?
M\CW8_P"[)_Z+:O6O%/\ R*.K?]><O_H)KR7X<?\ (]V/^[)_Z+:D![?1113
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\2^)/\
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M"@#G/B/86NJ?&+PE9:A MQ;3*ZR1/T85K^,/A;X53PQ?WNG62Z7=6EN\\5Q
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MZ:#H%M8)@LBYD8?Q.>6/Y_I6G7RM2HZDW-]3]*P]&-"E&E'9!11169N%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 97BG_ )%'5O\ KSE_]!->2_#C_D>[
M'_=D_P#1;5ZUXI_Y%'5O^O.7_P!!->2_#C_D>['_ '9/_1;4@/;Z***8!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJBGBD IU69 *6BBF(****!!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5WGPS\._:;MM<NDS%"2EL#_$W=OPZ#WSZ5RF
M@Z)<>(=8CL+;*J?FFEQQ&G<_7TKW.QLH-.L8;.T39#"@1![#^M>+F&(N_91^
M9]=DF!<5]9FM]O\ ,GHHHKR3Z<**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** ,KQ3_ ,BCJW_7G+_Z":\E^''_ "/=C_NR?^BVKUKQ3_R*.K?]><O_
M *":\E^''_(]V/\ NR?^BVI >WT444P"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "O$OB3_R/-W_N1_\ H KVVO$OB3_R/-W_ +D?
M_H I,#U;PE_R)^E?]>J?RK7K(\)?\B?I7_7JG\JUZ8!1110 4444 %%%% !1
M110 4444 %%%% !1110 4TBG4E '/>+?#47B/2&AX2YBR]O)_=;T/L>__P!:
MO$;BWFMKB2WNHFBGB;:Z,.0:^C2*Y#QMX.37K4W=DH3485^4]!,/[I_H:ZL-
MB'1EY/<\W,,#'%T]-)+;_(\8=*K21U?D1D=DD0I(A*NC#!4CJ#4#I7OIJ:YH
M['Q#4J<G":LT4H9KBQNXKJSE>&>%@\<B'!4CO7O?P^^(]OXI@6QU-H[?5T'W
M>BW _O+[^J_B..GA,D=0#S()5EA=HY$8,CH<%2.A![&N6O0C56NYZ>#QL\/*
MZVZH^N**\F\"_%V.98]-\6R+%*,+'?GA7_ZZ>A_VNGKCJ?6%974,A#*PR"#D
M$5XE2G*F[2/KZ&(IUX\T&+11169N%%%% !1110 4444 %%%% !1110 4444
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M+_D3]*_Z]4_E6O61X2_Y$_2O^O5/Y5KTP"BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** ,KQ3_R*.K?]><O_H)KR7X<?\CW8_[LG_HMJ]:\4_\ (HZM_P!><O\
MZ":\E^''_(]V/^[)_P"BVI >WT444P"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/Q;C]*X00^U/$-:QPE)=#FJ9GB)_:MZ%G4_$&MZWG^U=3NKI2<['D.P?\!'
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M[(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9
M7BG_ )%'5O\ KSE_]!->2_#C_D>['_=D_P#1;5ZUXI_Y%'5O^O.7_P!!->2_
M#C_D>['_ '9/_1;4@/;Z***8!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ!?_ ),2_P#Q5']I_P!S\?\ @!_J[_T]_#_@GC5%>R_\*[\+?] O_P F)?\
MXJC_ (5WX6_Z!?\ Y,2__%4?VG_<_'_@!_J[_P!/?P_X)XU17LO_  KOPM_T
M"_\ R8E_^*H_X5WX6_Z!?_DQ+_\ %4?VG_<_'_@!_J[_ -/?P_X)XU17LO\
MPKOPM_T"_P#R8E_^*H_X5WX6_P"@7_Y,2_\ Q5']I_W/Q_X ?ZN_]/?P_P""
M>-45[+_PKOPM_P! O_R8E_\ BJ/^%=^%O^@7_P"3$O\ \51_:?\ <_'_ ( ?
MZN_]/?P_X)XU17LO_"N_"W_0+_\ )B7_ .*H_P"%=^%O^@7_ .3$O_Q5']I_
MW/Q_X ?ZN_\ 3W\/^">-45[+_P *[\+?] O_ ,F)?_BJ/^%=^%O^@7_Y,2__
M !5']I_W/Q_X ?ZN_P#3W\/^">-45[+_ ,*[\+?] O\ \F)?_BJ/^%=^%O\
MH%_^3$O_ ,51_:?]S\?^ '^KO_3W\/\ @GC5%>R_\*[\+?\ 0+_\F)?_ (JC
M_A7?A;_H%_\ DQ+_ /%4?VG_ '/Q_P" '^KO_3W\/^">-45[+_PKOPM_T"__
M "8E_P#BJ/\ A7?A;_H%_P#DQ+_\51_:?]S\?^ '^KO_ $]_#_@GC5%>R_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KQ+XD_\ (\W?^Y'_ .@"O;:\2^)/_(\W?^Y'_P"@"DP/
M5O"7_(GZ5_UZI_*M>LCPE_R)^E?]>J?RK7I@%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 &*3%+10 W%&*=1B@!A6D
MV5)BC% $6RC94F*,4 1[* E28HQ0 S92[:=BEQ0 W;2XI:* $Q2XHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#*\4_\BCJW_7G+_P"@FO)?AQ_R/=C_ +LG
M_HMJ]:\4_P#(HZM_UYR_^@FO)?AQ_P CW8_[LG_HMJ0'M]%%%, HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ+XD_P#(\W?^Y'_Z
M *]MKQ+XD_\ (\W?^Y'_ .@"DP/5O"7_ ")^E?\ 7JG\JUZR/"7_ ")^E?\
M7JG\JUZ8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !11FDS0 M%)FDW4 .S29II:DW4 /S1FH]]&^@"3-&:CWT;Z
M),TN:CW4H:@!]%-W49H =129I<T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO/:*/[-I=W^'^0?V_BOY8_<_\ST+_A;;_P#0!_\ )S_["C_A;;_] '_R<_\
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M<_\ L*/^%MO_ - '_P G/_L*\]HH_LVEW?X?Y!_;^*_EC]S_ ,ST+_A;;_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7B7Q)_P"1YN_]R/\
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MU%<_X:\8:?XDBV1G[/>*,O;.>?JI_B%=!7E[:,^C335T%%%% PHHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRR6I]S1K0K052F[IA1114&H4444 %%%% !1110 4444 %%%% !1110 4444
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MPM_T%/\ R7E_^)KPVBBX'N7_  L3PM_T%/\ R7E_^)H_X6)X6_Z"G_DO+_\
M$UX;11<#W+_A8GA;_H*?^2\O_P 31_PL3PM_T%/_ "7E_P#B:\-HHN![E_PL
M3PM_T%/_ "7E_P#B:/\ A8GA;_H*?^2\O_Q->&T47 ]R_P"%B>%O^@I_Y+R_
M_$T?\+$\+?\ 04_\EY?_ (FO#:*+@>Y?\+$\+?\ 04_\EY?_ (FC_A8GA;_H
M*?\ DO+_ /$UX;11<#W+_A8GA;_H*?\ DO+_ /$T?\+$\+?]!3_R7E_^)KPV
MBBX'N7_"Q/"W_04_\EY?_B:/^%B>%O\ H*?^2\O_ ,37AM%%P/<O^%B>%O\
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MUX;11<#W+_A8GA;_ *"G_DO+_P#$T?\ "Q/"W_04_P#)>7_XFO#:*+@>Y?\
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M6)X6_P"@I_Y+R_\ Q->&T47 ]S_X6)X6/_,4_P#)>7_XFI4\=^&I/NZM$/\
M>5A_,5X/11<#Z(MM>TB\Q]EU.TE)_A69<_EG-: .1D<BOF>K]AK>IZ81_9]_
M<6X'\*2';^72BX'T317D.E?%35;4A-4ABOH^[ >6_P"8X_2N\T/QSHFNLL<-
MQ]GN#_RPN,*2?8]#^!S3 Z*BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<IRYI'VM*E"C!0AL%%%%0:A1110 4444 %%%% !1110 4444 %%%% !1110
M44T2(6VAU)] :=0 4444 %<'\2?A]'XGLFU'345-7@7C' N%'\!]_0_@?;O*
M*N$W"7-$RJTH5H.$]CY'&^&5HY49)$8JR,,%2.H([&K,;UZE\7? P*OXFTF+
M#+_Q_1(.H_YZX_G^?K7DD3U[U&JJD;H^*Q>%E0J.#-)&J935.-ZL(U=:9Y<D
M3@TZHU-/%69#J*04M,04444""BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ;RKN22,Y#"OE\1A:F'E:6W<^BH8B%>-X[]B>BBBN4Z0HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI)ZTRBOJ,/AZ="/+ ^=K5YUI7D%%%%=!@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !73^#/'6I^#;[?:MY]G(?WUH[?*_N/[K>_
MYYKF**F<(U(\LE=%0G*$N:+LSZP\,>*M,\6:6MYI4V<<2PMP\3>C#^O0ULU\
MBZ+K>H>']3CO])N&@GC/4=&'HP[CVKZ%\"?$G3_&$(MI]MGJBCYK<M\LGNA/
M7Z=1[]:^:Q> E1]^&L?R/?PN-C5]V>DOS.UHHHKS#T0HHHH **** "BBB@ H
MHHH **** "BBB@ HHK%\6ZV- \-W-XI_?$>7 /5ST_+D_A0!YQ\2O$G]J:O_
M &9:OFULF(;!X>3H3^'3\ZXBE9BS%F)))R23UI*D HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH Z3P1XC/AW7E:9C]CN,1SCT'9OP_EFO
M= 00"#D'H17S/7MGPZUTZQX96"9MUQ8D0OGJ5_A/Y<?A30'64444P"BBB@ H
MHHH **** "BBB@ HHHH **** "O$OB3_ ,CS=_[D?_H KVVO$OB3_P CS=_[
MD?\ Z *3 ]6\)?\ (GZ5_P!>J?RK7K(\)?\ (GZ5_P!>J?RK7I@%%%% !111
M0 4444 %%%% !1110 4444 (:SM<U)=(T2[OWQB",L >[= /Q.!6B:X#XJW_
M )6C6EBIP;F;>P]50?XD?E51BY-174BI-4X.;V6IY:SN[-)*Q9W)9F/<GDU!
M(:E<U7D-?4**A%170_.)3E5J.<MV[E>5JZGX7>'1X@\:12SKNM=/ N).."P/
MR+^?/T!KD9FKWOX/Z(-+\%+>R+B?47,S9Z[!P@_F?^!5PXJIR4W;J>QEM#VM
M97V6IWM%%%>&?9!2,P12S$*H&22>E+7#ZS?W?BO6)M#TF0PZ?;G%[=+_ !'^
MXM:4Z?.^R6YSUZRI15E=O1+NQ]_XFO\ Q!=/IWA-=L2G;/J+CY5_W?6K6D^$
M]/TR0W$@:]O&^]<7'S$_0=JEO9[3PGX9>2VM_P!S;J L:\;CVR?ZU3T'Q'>7
MNJ-IVL6:VUPT0FB*-D,I&:Z'S.#]FK1_%G$E3C6BL0^:;\M%Z=O7=D7CP"/2
M[&[ PUK>1NI';FN2^(WS^+Y?FV[K2+DGWKM/'=L]SX.NQ$I9T*. .N P)_2N
M#\2WL6OZZMYIV)(9((8=S@@*Y(X/O_A77@MD^U_T/,S?24H]^5_^E)_H9.CH
M4UJP!;=_IL/<G'S>]>FV1^T_$S59FY-O;K"I],\UP,VFW&A^(H4OQ'_HMQ#+
M-)$2P5<]3FNY\)3)J6NZ]JUN&-M<S(L+L,;@ <_TK3%.\7-;6_-HPRR+C45)
M[\U[>B?ZFSJN@:=K,6V]MU+CE94^5U/KFL2.\UCP5)B[,NJZ+P!+UE@^OJ*U
M?$>MR:-:0_9;?[1=W,@BACS@$^IJ/0-9FU<WMEJ=HL%U:,$FC!RI!%>?#VBI
MWDKQ_K8]RLJ,J_+!\M3NE^#Z/3H='8W]MJ5E'=V4JRPR#*LM6*X"=+CP+J!O
M[$-+HL[_ .D6_P#SP)_B7VKO()H[F!)H'#QR*&5AT(-8U*:C[T=4SIH5G.\)
MJTEO_FO)CZCN)X[6VDGG8)'$I=V/8#DU)7*?$*YD70(]/@)$NHSK;J1[GG_"
ME3ASS433$5?8TI5.Q0\,0R:WJ,_B?45YF)2TC;I'&.__ ->F7VL:EXE>YTSP
MQ;Y@'[N:_D;:J^H7\.]:^KQKIO@V[BM<1K#:,B<XQ\N/SKAM3N+[2O#_ (=?
M2[B2UB>W,Q*<!I1R=WKFNZE%59<_R796/&Q,WAJ:IMO:\FMW=V^1?NM5U#P3
MJB:;I]C;I:QH"&E0AKHXY._UIWBCQG;:]H"V=A;7"!BLER\@V(BCDKGN<UC1
M/J_Q!\11CS/+$:B1=W*0+QR!W)-=#K7P\M=.\/W%W;W]W+<P+YI$K#RW(Z_+
MCC\ZZ&J4)1]I\?\ 6YPQEB:M.I[#^%KO;;R_K\2?X>ZUIFG>&6BO-0AC9[AY
M$C=^57@ ?I3/$WQ$,;K#X;:.4)S)<.I*L>RJ.YKCK&VAU"ZNC=:O;Z:D(3R_
M,MPVXL"< #TQ[T^2VO-%U.VN[A8BRD-#++'NMI!V88QBJ>'INJYRU?8S6.KK
M#QIPTBM+K?\ /3]>AW$/@RXNK4:G87]QI-]=H)I(%P8Q(0,\=LFK?AW6+J[N
M+O2M914U*S.'VCY9%[,/K7*:CXZU^;;;+=6,+L<#["C22,>V-W&*T;JWUW2;
M>S\57062Y6 1W\!7#%<_>XXSC%<TZ4W&U1J[V_KL=]+$TH3YJ"=E\7:W5VOO
MUT\R[;'_ (1+QDD2?+I>KO@+VBE_^N?TKNJXWQ3#'K?@J2ZM3DK&+J!AU&!G
M\ZZ/0M0_M30;.]/WIHE9AZ''-<E6\H*;WV9Z>'M3JRI+X7[R^>Z^_7YE^BBB
MN<[SYV^*?AT:!XTEFMTVVFH#[1'CH&S\Z_GS]&%<K$U>[_%_0QJO@E[R-<SZ
M:_GJ<<[#PX_+!_X#7@<+5[F%J<]-7Z'QN94/95G;9ZFA&:L*:IQFK*&O0B>'
M)$XI1313JLR%HHHIDG??#CPOI6O6U]-JUN;CRG5$7S&4+P23\I%=5=^$? >G
MS"*_CM;:0KN"37[H2.F<%^G!K,^$'_(,U+_KLG\C6)\6O^1LMO\ KQ3_ -#>
MO'E[2IBG3YFD?5T_8X?+85W3C)^:7=G3?\(_\./^>VG?^#,__%UY&\:M=-':
M[I%+E8^,EAGCCUJ.NU^%^D)J'B9KN90T=C'O /\ ?/"_^S'Z@5V*+PT)3E)O
MU/)E46/JPI0IJ&O1?UL;WAGX76ZVZ7/B/=)*P!%JC85/9B.2?IQ]:UKNZ^'^
MD2&WN8=+#J=I5;83%2.QPIP?K47Q,\0S:1HT5G92&.>]+!G7JJ#&<'L3D#\Z
M\;KEHTJF)7M*DFEY'IXK$T,OE["A33:W;U/:DT7P/XFC\NQCLF?&0+5O*<>^
MT8/YBO)_$6EIHOB&\T^*1I$@?"LPY(P#S^=9\<CQ2+)$[(ZG*LIP0?4&EGGE
MN9FFN97EE<Y9Y&+,Q]R:[*-"5*3]YM>9Y.+QE/$P7[M1EW75'LVE_#WPU)I%
MI)<:>997A1G<SR#<2 2<!L56_P"$?^''_/;3O_!F?_CE=?I7_(&LO^O>/_T$
M5\X5YV&C4KRE>;5O,]['SH8*%/EHQ=^Z72W^9VGCS3O#%C;V9\-26[2,["40
M7)FXP,9^8XKH?!7@K0=5\(VE]J-D9[B8N68S.O1V4< @=!7E5>Z?#K_D0=._
M[:_^C7K?%\]&@DI.]]_O.++/98O&RE*FDN7:VG0HOX5\ 1W1MI!9I.IVF)M0
M8,#Z8WYJ'5OA9H]U;%M(>2SF ^3+ET;ZYR?R/YUYUXS_ .1TU3_KX:O5_AT+
MH>";3[8&'+&+?G/EYXZ]O3VQ6-55:-.-55'KW.S#2PV+KSP\J*5KZI=G8\4O
M;.?3[Z:TND*30N4=3V(J"ND^(+I)X\U(Q$%=R X]1&H/Z@US=>O3DY04GU1\
MM7IJG5E!;)M?<SIO 6C66N>)OLNIQ&6 0L^P.5R1CN.>];_Q%\*:-H6BVUSI
M5H8)'N!&Q\UVR-K'^(GTK.^%?_(Y'_KV?^:UU/Q<_P"19L_^OP?^@-7G5:DU
MBXQ3T/=P]&D\KG4<5S:ZVUZ=3R*BNW\"^";#Q/I]S<ZA<7,9BE$:K 5';.3D
M'UK:L_ACIUE>75UKEX1IT3D0J\@3<OJ[<8_#'3\*Z9XNE"3B]T>?2RO$U81J
M12L_/\SRZBO:+CX<>&-0L,Z=&8"ZYCN(9VD'UY)!%>=:5X7$OCQ/#^K.\8#N
MKO$0"0$+*1D'K@?G13Q=.HFUT"OEF(H2C&5GS.R:VN6M)^'&L:QI4.H6\UG'
M%,NY%ED8-C..RD?K7+7,#VMU+;RXWQ.4;!XR#@U]%Z5IL.D:7!86S.T4"[5,
MA!8CWP!7#^)?AUI%OINIZLMS>>>J27 5G39NY.,;<XS[UR4<=S3:GMT/4Q>2
MN%&,J2U2][7R/***[?P+X)L/$^GW-SJ%Q<QF*41JL!4=LY.0?6NCTCX6:=#>
MW4FJ-)=6^\K;Q%ROR_WF*XY[<?7OQUU,92IMQ>Z/,HY5B:\8SBE:7G^9YEHT
M4$VNV$5YC[.]S&LNXX&PL,Y/TKU[Q=H/A^V\(WTPT^RMG2$F*2.)4;?_  X(
MY.3BN'\8>&M/T_QOI^EZ<C6]O=K%N&XMM+2%21GV K8\2_#;2M(\.7=_:75X
M9K= P$K*5/(SP%!_6N>M.%25.7,U<[L+1JT*=>G[-2MN[[:=--?P/-**ZCP+
MX8M?$^I7,-]--%'#%O'DD!B2<=2#_*NI_P"%4VB:XS/=RKI4<88F1EWNW.1D
M   <<X[_ (UU5,52IR<9/4\ZCEN(KTU4IK1L\NHKVF+P#X/U*R+:?$LB'*B>
MWNV?!^NXC/X5Y=XI\/R^&M<>QD?S(RHDADQC>A_KD$?A2HXJG6ERK1^8\5EM
M?"P525FGU1CT5Z)X+^'4.J:?%J>MO)Y4O,5NAV[E]6/7GL!^==$/!?@>[E>T
MMA#]H7AEBO69U/\ N[C_ "J)XVE"3CJ[=C:CE&(JP4[I7VN]6>,U[Q<^'/"Z
M:#(QT^P6V$!/GB-0P&/O;^N??->.>)](30?$EWIL4C2QPE=K-U(90PS^=>@7
M7PLTF'1IKA+V]\^.!G!+)MW!<]-N<?C66*E"2A+F:O\ \ WRV%6FZL%34FM'
M=[;^3/*J*GL;*?4;Z&SLXS)-,P5%'K_A7K.F?#'0]/L?,UMVNI0N9&:4QQI]
M,$''N3^5=5;$4Z/Q'GX3 5L7?V>RZO8\?HKV"?X?^%-7L9&T258V .V6WN?-
M4'WR3Q^5>/TZ->%:_+T[BQ>"J81KG::>S04445N<(4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !N>-E
MDB8K(A#*P[$<BO?=%U)-7T2TOX\8GB#$#LW0C\#D5X%7J'PJO_-T6\L&.3;3
M;U'HKC_$'\Z\;,J>L:GR/K.'Z^DZ+]5^3_0[NBBBO(/J0HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q?$_BO2_">EF\U2;!/$4"
M',DI]%']>@K#\=_$JP\(1&UMMEYJK#Y8 WRQ>[D=/IU/MUKY[UG6K_7]3DO]
M5N&N+B0\D]%'8 =A[5Z>$P$JWOSTC^9YV*QL:7NPUE^1K^,O'.J>,K[?>-Y-
MI&?W-I&WR)[G^\WO^6*YFBBOI80C3CRQ5D>!.<IRYI.["BBBJ)"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "GQ2R0
M2I+"[1R(0RNAP5(Z$'M3** /;OA_\7DNS#I7BN18I^%BOCPK^@?T/^UT]<=_
M6P00"#D'H17QM7HO@#XJW?AOR]-UG?=Z7G"MG,EN/]GU7V_+TKQ,9EU_?H_=
M_D>OA<?;W*OW_P"9]"457L-0M-4L8KS3[B.XMY1E)(SD'_/I5BO!::=F>TFF
MKH****0PHHHH **** "BBB@ HHHH *\H^+&K>?JMMI<;?+;)YD@_VVZ?D/\
MT*O5Z^>O$>H?VIXDO[P'*R3ML/\ LCA?T I,#,HHHI %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !77?#;5O[-\61P.V(KU?)/\ O=5/
MY\?C7(U+;7#VMW#<1'#PNKJ?<'(H ^DZ*BM;A+NSAN8N4FC61?H1D5+5 %%%
M% !1110 4444 %%%% !1110 4444 %>)?$G_ )'F[_W(_P#T 5[;7B7Q)_Y'
MF[_W(_\ T 4F!ZMX2_Y$_2O^O5/Y5KUD>$O^1/TK_KU3^5:], HHHH ****
M"BBB@ HHHH **** "BBB@!IKQWXE7WVKQ<;<'Y;.%4Q_M-\Q_0C\J]A:O O$
M=S]K\4:I,#D&Y=0?4 X'Z"NO!QYJZ\CR\VJ<F#E;KH9+FJLIJQ(:J2FO?D?$
MP0RVM9-1U*VLH.9;F58DX[L0!_.OJ^RM(K"Q@M+==L4$:QH/0*,#^5?//PLT
M[^T?B+8DC*6JO<-[;1@?^/%:^C*\3'2O)1/K\GIVIRGW"BBBN ]LYKQIK,VG
MZ=%8Z<?]/U!_*A ZJ.[5-H>CPZ)I<=I!RP^:63N[]S6'ILBZSXRU36[ALVNG
M_P"C6^>BX&6/Y_SJI-?WOB.WDU";4'T30$.U)%.))^V0>HKN]F^54UIW]7LC
MQUB(J;KM7;NHKR6[\DWU[6.B\1V2:KX>O+-'7S'C)C&X?>'2N5-X\^EZ/XGM
MHS+/IJ?9[^->&"XP215%#X1EN8H(EUF624A8Y0YW,WJ!6U';Z5X%OI46\N-0
MN[_"):2,#G=W?\36T8>SCRZM]K?)G'4K>WG[31):-IWL]XO9=?ON6G\:+?DP
MZ!I=SJ+D<DKM0?7UK.FTV2*:&_\ %<ECIEC;2><MC9J TKCID#O6IK-S=ZAK
MR>&]$E_LZ""/S;J:W4*0".%7'3J*:/#/A_1!]NU:9KAU_P"6]]+NR?IT/Y5$
M90II65K_ #?^2^XVG&M7;<G=1ZO2/W;NWF[&?,T/BF\&K>'+F*WU$)Y=S8W@
M&V1>V0?I5R/Q%?:$@AUO06M85.!+9KF/\ /\:E-EX8\7L9[9T-RO_+2!MDB^
MY J#S-2\':G9K/J$VH:/=2>2ZW&&>)CTY]*=XS]QK7L]_D_\T+EJ4G[52T?V
ME9KU<7MYV9##J,7B'Q,FKC*:/HT;/YL@P'D(_P#U5;\%KYD%]JUPP234;AG4
M.V#L'W>OXT[6Y-)U:ZG\+7,ATM]ZRQ-$ J3Y]?\ "L'4]-\,Z%J TZ_35KF<
M*")/,(RO^SCJ*?*IPY%=?CIO^9#G*E5]JVI6;N[V]YZ6MJ]$K(]!G@BN[9X9
ME62*12K \@BN=\*7$F@Z[<>&;IRT&#-8NQ_@/5?P_P :R+!98H7OO!>JSWL4
M)W3:9=G+[?;/(JSKMVFL^&+7Q)I8:.YL'\P _>4 _,I_*LXTG&\&]'IZ/H=$
M\2JEJL5:4=>Z<>MGU_1GH=<=XL/F^,/#\#<J)#+CW%=387D>H:?;W</,<\:R
M+]",URWBT>3XM\/7+<*93%GW-84%:I;R?Y'9C&G136UX_FB+X@,1X9VDE86G
MC$Q']W<*WM5\/V.N: EA*H6-4!A=.#&0."*9JVGIJND7-E)TFC*@^A['\ZYB
MQUG4[GP/<Z5IVY-:L0(7B_Y:% <;E]\5I3O*"Y79I_GU,:[C3K2=174H_E?3
MYW.%LENH-3:Q@DO$NWD,6()Q%G;VZ5U6KR:_I/@:+3]2\YS>3L)'8^8Z1@ A
M<^I.:H+X UR72)+_ ,ORY<[A:OS*_JV[LWM70^ O%]S=77]B:N6>9%/DRN,,
M<=5;W%>C6FFN>%I<NYX&%I.,O956X.:LGTU[F7I'PYOM3CCO-1FCLEE )C5-
MTA7'&<\ XKT2ST2QL]%ATH0B:UB7:%F ;/?)S]:R?$GB2YM+Z'1]"B6?4YUW
M9;[L*_WC6>-#\43 /=>*&$AZB*$*!^E<%2=2JDZDDET/:HTJ.'DXT:;D]F]/
MNU:7R1RGB_2$\+>(HWTYWAA9/M%OR?W3@\HI]#_6N[\3:Y#;^"S+< >??6X6
M. ]69UZ8]LUD7/A#5KW9]MU_[0$.5\VW5MOTR.*O:;X1MK6^6^U"YGU*[3_5
MR7#9$?T%:3JTY1BY2NU^)C1P^(A.HJ<.6,^]M/N;^19T73GM?"=O8W7+_9]K
MCT)'(IGPX=G\$VNXYVNZCZ;C6U7+>')F\->)IO#\Y(L[HF:Q9CT]5KFBW4A-
M==_SO^9W3BJ%6D_LI./WVM^1W%%%%<QZ)%=VT=[93VLXW13QM&X]5(P?YU\H
MWEG)IFJW5A/S):S/"WN5)']*^LZ^=/BMI_\ 9_Q&O65=J72)<*/7*X)_[Z5J
M[\#*TW$\3.*=Z<9]F<W$:M(:I1&K<9KVXGR$T65IPIBT\5J<S'44@I:8CU7X
M0?\ (,U+_KLG\C70^(M4\)V6H1Q^)([5KHQ!D,UF93LR<<[3QD'BN>^$'_(,
MU+_KLG\C6)\6O^1LMO\ KQ3_ -#>O$E357&2BW;T]#Z^&(EA\JA4BD_7;=FE
MXDUGP-<>'+R+28;(7C(!$8K$QL#D=&V#'YT?!W&[6/7]S_[/7F==E\,M933/
M$QMKAPD5\GE@G@!P<K_4?4BNNMA^3#RC%M]=3R\+CO:X^G4J)+IIIO?_ #-'
MXO!O[6TXG.WR&Q]=W/\ 2J_@;5/"=EHLT?B2.U:Z-P60S6AE.S:N.=IQR#Q7
M8_$3PU+K^BQS62;[NS8LB#JZG[RCWX!_#WKQ1T:.1DD4HZG#*PP0?0U.&4:^
M'4+VMV-<PE4P>.=;E33VOML>]Z9IWA;6+%;S3=*TZ:!B0K_8E7)!P>"H->/>
M,;2"Q\7ZC;VD2Q0I+\J*,!<@'C\Z]3^&?_(C6W_723_T(UYCX[_Y'G4_^N@_
M]!%98.\<1.%]%_F=&:<L\#2J\J3=MEW3/;]*_P"0-9?]>\?_ *"*Y#_A'_AQ
M_P ]M._\&9_^.5U^E?\ (&LO^O>/_P!!%?.%882BZDIVDUZ?,[,SQ4</"GS4
MU*]]^FQU?CNQ\/6-Y:+X9D@=&C8S>3<&4 YXYR<=Z])^'7_(@Z=_VU_]&O7A
M=>Z?#K_D0=._[:_^C7KIQT7##QBW?7_,X,GJ*KCIS45&\=EMNAXO?",_B*2T
M,=@=563#>9; .7]F*\GZ&G^,M0U?2_#\MUHL,3-&,R.QRT:_W@O0X_R*\B\8
M.T?C?4WC8JRW)*LIP0?6O9O#6JKX@\,6MY(%9I8]DRXXWCAN/3(_(URUJ/L5
M"INO,]'"XMXJ57#_  R5[-?=]Y\_22/+*TDK%W=BS,QR23U--K5\2Z0VA>(K
MNP(.R-\Q$]T/*_7CCZ@UE5[L9*44UL?&5(2A-QENCM/A7_R.1_Z]G_FM=3\7
M/^19L_\ K\'_ * U<M\*_P#D<C_U[/\ S6NI^+G_ "+-G_U^#_T!J\JK_OL3
MZ3#?\BBI\_T&?"+_ ) -]_U\_P#LHK!^*]]<R>(HK)I6^S10K(L7;<2<GW-;
MWPB_Y -]_P!?/_LHKF?BI_R.0_Z]D_FU%-)XV0\0VLGA;R_-G3?".XD?1+Z!
MV)CBG!0$],KS_*N7^*,:IXT9E&"]O&S'U/(_D!71_"#_ )!FI?\ 79/Y&N>^
M*G_(Y#_KV3^;55/3&R_KL1B-<GIW[_YGI'@?_D2=+_ZX_P!37B&M?\A[4/\
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MF24^@'I[]!7SKXP\;ZIXROA+?OY5M&?W-K&?DC]_=O<_ITK)U?6+_7=3EO\
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M?V'JW_0+O/\ P'?_  H_L/5O^@7>?^ [_P"%?1-%%@/G;^P]6_Z!=Y_X#O\
MX54GMYK64Q7,4D,@ZI(I4C\#7TI7B7Q*_P"1YNO]R/\ ] %%@,F#Q/KEK;I!
M;ZI=1Q1J%1%D("@=A4G_  E_B'_H,7?_ ']->Q>%+6W;PCI;-!&2;5,DH.>*
MU_L=M_S[Q?\ ? HL!X-_PE_B'_H,7?\ W]-'_"7^(?\ H,7?_?TU[S]CMO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !37_P!6WTIU-D_U;?2LZGP/
MT-\.KUH+S7YEV+Q7KUO"D,.JW*1QJ$10_"@< 4[_ (3'Q#_T&+K_ +^5[5HV
MGVRZ#8*]M"6%M&"3&.3M%7?L-I_SZP_]^Q7R5C]./"/^$Q\0_P#08NO^_E'_
M  F/B'_H,77_ '\KW?[#:?\ /K#_ -^Q1]AM/^?6'_OV*+ >$?\ "8^(?^@Q
M=?\ ?RC_ (3'Q#_T&+K_ +^5[O\ 8;3_ )]8?^_8H^PVG_/K#_W[%%@/"/\
MA,?$/_08NO\ OY1_PF/B'_H,77_?RO=_L-I_SZP_]^Q1]AM/^?6'_OV*+ >"
MR>*]?E W:S>C']V=E_E4?_"2Z[_T&M1_\"G_ ,:^@$M;>)MT<$:-ZJ@!J6BP
M'SU_PDNN_P#0:U'_ ,"G_P :/^$EUW_H-:C_ .!3_P"-?0M%%@/GK_A)==_Z
M#6H_^!3_ .-'_"2Z[_T&M1_\"G_QKZ%HHL!\Y7FJ:AJ"JM_?7-TJ'*B>9GV_
M3)JI7LGQ%T/4->BTVWTR RLLKEV)PJ# Y)-5M!^%MC9[9M;E^VS#GRDRL:G^
M;?H/:E8#C=!U7QC+I=U::"]U/"(F&X+N\GC^!CT;T /X5Y3<>9]JE\\R&7>=
MYD!#;L\YSWS7V%#!%;0K#;Q)%$@PJ(H  ]@*XCQ[\,K#Q9$]W9;+/5@,B8#Y
M9O9P/_0NOUKU<OQ4:$G&>SZGG8[#2K13CNCYPHJ[J^CW^A:G+8:K;M;W$9Y5
MNX[$'N#ZBJ5?3)IJZ/GVFG9A1113$%%%% !1110 4444 %%%% !1110!]DZ#
M_P BYIO_ %Z1?^@"O*K+]GFTCN5;4/$,T\(ZI#:B)C_P(LW\J]5T'_D7--_Z
M](O_ $ 5\[>!OBCKFC>)+8:SJMU>Z;-($N%NY3+L4\;P6R1CKCOS7S&%C7?M
M'1E:WX[GT.(E17(JJO\ IL>R>*_&NA_#K08[&+:;J*W"6=BG)P!A2Q[+QU/)
MP<9-?-=C<2WGB6WN;ES)--=K)(Y'WF+Y)_.OIKXD^$X?%O@^YB2(/?6Z&:T<
M#YMP&=H/HPX_(]J^8=)_Y#5C_P!?$?\ Z$*[\M]FZ4FOBZG'F'.JD4]NA]:^
M+H);GP3KD%M$\TTNG7"1QQJ69V,;   <DD]J^</#?PO\3:YJ\$%SI-Y86GF#
MS[BZB,6Q.Y 89)QTP#S7TSK6H_V/H&H:GY7G?8K:2X\O=MW[%+8S@XSCKBO'
M)OVB)FC(M_#2(^."]Z6 _ (/YUQ8&6(4)*C&_F=>,C0<XNK*QZEXSUJW\.>#
M-0OIF5=D#)"I/WY",*OY_IFOD6NA\5^-];\97*2:Q<+Y49S';PC;'&?4#)Y]
MR2:Q+.SN-0O8;2RB::XG<)'&HY9CT%>M@L,\-3?,]6>9B\1]8FN5:(O^&O#]
MWXG\06NE6"DR3OAGQD1I_$Y]@/\ #O7UC<W.G^%?#1EG806&G6X4>R*, #U/
M  %<W\// =IX$T)IKMHVU&9-]W<D_*@'.Q2>BCN>_7T \D^*WQ(;Q7??V7I$
MA71[=\[AQ]I<?Q'_ &1V'XGMC@JMX^NH0^&/7^OP.VFE@J+E+XGT_K\3AM:U
M276]<O=3G&V2[G>8KG.W<<XSZ#I^%?7>@_\ (N:;_P!>D7_H KXVK[)T'_D7
M--_Z](O_ $ 56;)*$$O,G+6W*;9\;5V_P>N)8/BEI:Q-A9A+'(/[R^6QQ^8!
M_"N(KTCX'Z'-J/CU=2"M]GTV)G=^V]U**OZL?^ UZF*:5";?9GG89-UHV[GJ
M/QKMTF^&%Y(X!:":&1"1T.\+_)C7S-7T3\>-5CM/ \&G[E,U]<KA2>=B?,2!
M]=H_&OG:N3*TUA]>YU9BTZ^G8****],\X**** "BBB@ HHHH **** "BBB@
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M5K=T>)G<.;"W[-?Y&+)5.;O5V054E%>U(^2IGK'P(N,VNM6Q/*212 ?4,/\
MV6O6Z\*^"5Z(/&-Y:,<"YM"5&.K*P/\ (M7NM?/XI6JL^WRV7-AH^5PK+\36
M+:EX9O[1/O20G;]1S_2M2@C(P>E81DXR370[JD%.#@]GH<OX2OA?^%[*3/S)
M'Y3 ]05X_D*V:Y30]VA>,-3T28XAN6^UVOOG[P_I75UI7BE-M;/7[SGP<W*B
ME+=:/U7]7"BFRRQP0M+.ZQQKR7<X _&N4N]<O_$5PVF^$U(CSMGU!UPB#_9]
MZFG3E/;;N76Q$**UU;V2W8NJ./$OBZPTBT.^VL91<7;CH"O1/Z5W8XZ5EZ!H
M%KX?T\6UKEW8[I9F^](WJ:U*JK-.T8[(G#TYQO.I\4M_+LOD%<1XB)\.^,;7
M7&!^PW<?V:Y('^K/4,:[>H+VRM]1LI;6\C$D,J[64]Z5*:A+79[E8BDZL/==
MFM5ZHK(ZR(KQL&5AE6'0BEKCR-3\"SF.99+_ $$GY)%&9+?V/M73V&HVFIVX
MGL)TF0]=IY'U':G4I./O+5=R:.(51\DM)+=?Y=UYEFF32K!"\LAVJBEB3VI]
M<WXVO9$TF/3+/F[U*00(HZE3]ZHIPYYJ)I7JJC2E-]"7X>1/)H]WJ<@(.H73
MS#/7&<5UU5=,L4TS2K:RBQM@B5,CO@=:M4ZLN>;DB<-3=*C&#W2_'J%<5+_R
M5F3_ +!X_G7:UQ4O_)69/^P>/YUI1^UZ,RQ>]/\ Q+]3IJ***YSM"BBB@#,U
M#Q'I.E7(M]0O%AE*[@I5CQZ\"J,WCK0(E_=WC3N>D<<3$G]*K&WAN?BK''<1
M)*G]GD[77(ZUV$6FV,!S#:0(?41BNIQI02YDVVK[_P# /.C4Q-64N1Q23:V;
M?YG&16&I>-;V*74K>2PT6%@ZP2</.?<=A7=JH50JC  P .U+1652HYV2T2Z'
M31H*E=MWD]W_ %T"BBBLCH"O)?CO<A;'1K;/+RRR$?[H4?\ LU>M5X7\;[T3
M>+K*T4DBWM-Q'HS,?Z 5TX57JH\_,I<N&EYV//H15R.JD(JY'7T$3X>H3IVJ
M45&M2"MD<K%%+2"EIDFGH_AS5=?\W^R;0W AQO.]5 STY8CTK3_X5UXI_P"@
M7_Y,1?\ Q5=?\(/^09J7_79/Y&K/CGQSJ7AG7(;.P@M9(Y+=929D8G)9AV8<
M?**\V>)K.NZ5-(^@I9?A%@XXFO*6O:W?T//KWP3XCL(3+<:5-L'4QE9,?@I-
M85>Y>"O&/_"50W"S6PM[BWV[@K95@<X(].AX^E</\4]'M]/UNWO+5%C^VHQD
M11@%U(RWXY'Y55'%3=7V5569EB\NI0PZQ.'DW'S^[RZG"T5-:6=S?7"V]E!)
M/,W1(U+$_E6^/A[XH*;O[*;'_7://Y;LUVRJ0A\32/)IT*M57IQ;]$V<U15B
M^L+O3;HV]_;R6\R\E)%P<>ON/>H41I)%2-6=V("JHR23V JDTU=&;BT[-:C:
M*Z*'P!XGGA$B:4X4C(#R(A_(L#65J>C:CHTPBU.TEMF;[N\<-]#T/X5$:D).
MT6F:SP]:$>:<&EYIFOX>\#:KXDL7N[)[>*%7*!IW8;B.N, ^M96M:-=Z#JDE
MA?A1*@!RARK C@@UUO@CQ7JNDZ/)9V6@7&JPK*6#P!AL) X.%/U_&N<\5ZO=
MZUX@FNK^U:SE"JGD,"#& .AR >^?QK"$JSK-2MRG96IX586$X7YWOO;_ ",:
MBM/2O#>KZVI;3+"6=!P7X5<^FXX%6[WP1XCT^W::YTN41J,L8V63 ^BDUNZM
M-/E<E<XUAZTH\Z@[=[.Q@T5L^&=(NM1URP=;":YLQ=QK.RPED"[AN#$# &/7
MM7IWC?PQ8_\ ")W/]D:+!]K#)L^RVH\S[XSC:,],UC5Q,:=10?4Z\/E]2O1G
M63MR_CZ'C%%6;S3;[3MG]H65Q:^9G9Y\3)NQUQD<]:FTS0M3UERNF64UQ@X+
M*OR@^A8\"NCFBES7T.%4YN7(D[]BA1722?#[Q1&A9M*8@?W9HV/Y!JYZ:"6V
MF:&XB>*5#ADD4JRGW!I1J0G\+3*J4:M+^)%KU5AE%6K/3+_40QT^QN;H)][R
M(6?;]<"I+/1=2U"_:RM+*:2Y0X>/9@I_O9Z?C3<HK=DJG-VLGJ4:*WKWP1XC
MT^U:XNM+D$2#+%'63 ]<*2:P:(SC-7B[CJ4JE)VJ1:]58**L65A=ZE<K;V%O
M)<3-T2-23CU]A[UN'X>^*!'O_LIL?]=H\_ENS2E4A!VDTBJ="M45X1;]$V<W
M14UW9W-C<-;WL$D$R]4D4J1^=2Z=I5]JUQY&FVLMS)W"+D+]3T'XU7,DKWT,
MU"3ERI:]BI172/\ #[Q0D>]M*8C&?EFC)_(-FN>F@EMIFAN(GBE0X9)%*LI]
MP:F-2$_A:9=2C5I?Q(M>JL,HHHJS$Z&U\!^);RUCN+?3&,4JAD+31J2#T."P
M-9^K^']4T)T75;-[?S/N$D,K?B"17OPG^S:*)R-WE6^_'KA<UB>.--37?!=P
MT&)'B07,) SG SQ]5)'XUX]/'S<TI)6N?5U\DHQHN5.3YDK]/\CPNK%C876I
MWB6EA"T\\A^5%[U7KT_X2:1B.\U>5>6/V>(D=N"Q_P#01^!KT:]7V--S/ P6
M&>*KQI=.OH<L?AUXI'_,+_\ )B+_ .*KG)H9+>>2&="DD;%'5NJD'!%?2%I=
MQWL;R0G*+*\>?=6*G]0:^?\ Q+_R-FK_ /7]-_Z&:YL)B9UI.,UL>CF>7T<)
M3C.DV[][?Y(S**OR:%J\5N;B72[U(57<9&MW"@>N<8Q5"N]23V/$E&4?B5@H
MJ^^A:O';&XDTN]6!5W&5K=PH7USC&*M>&=(NM1URP=;":YLQ=QK.RPED"[AN
M#$# &/7M4N<5%RN:1HSE-0MJS&HKV?QOX8L?^$3N?[(T6#[6&39]EM1YGWQG
M&T9Z9KR&\TV^T[9_:%E<6OF9V>?$R;L=<9'/6L:&(C6C=:'5C<#4PD^5ZZ7N
M5J*OZ9H6IZRY73+*:XP<%E7Y0?0L>!6K)\/O%$:%FTIB!_=FC8_D&K656G%V
ME)+YG/##UYQYH0;7DF<W13YH);:9H;B)XI4.&212K*?<&O2?AKX:#?VBVOZ-
MD8B\@WMKP?OYV[A].GM4UJT:4.=EX7"SQ-94HZ?H>9U>T?2+K7-4BL+$*9I,
MD%SA5 &22:Z[X@^&;@>(T_L+19?LQMUW?8[4[-VYL_=&,XQ7.^&M0O=!\313
M6UE)<7,9:-K7:0S<$%<8R"/IVJ55]I2YH;V+EAO88A4ZWPWLW_D6_$'@35O#
ME@MY>/;RPEPA,#L=I/3.0*YJN]\:^+=6U31EL[S0+C2H9) 6><-\^.0!E5^O
MX5P5&'E4E"]3<,="A"M:A?E\_P#@A16_9^!_$E]")8-*F"-T\UEC)_!B#4.I
M>$M=TF$S7^FS1Q#[SKAU7ZE2<?C6GM:;=N97]3%X:NH\S@[=[,QJ**N_V-J?
MV/[7_9UW]FV[_.\AMFWUW8QCWJVTMS&,92V12HK7TKPKK>MP&;3-/DFBSCS"
MRHI^A8@'\*BU;P]JNAE?[5LI+<.<*YPRD^FX$C/M4^TAS<MU<T="JH>T<7R]
M[:?>9M%%;MCX*\1:C;K/:Z7*8VY5I&6/(]1N(IRG&"O)V)ITJE5VIQ;]%<PJ
M*U-5\-:QHB!]3L)8(R<>9PRY_P!Y21671&2DKQ=Q3A.F^6:L_,****H@****
M "BBB@ HHHH *0HTI6-.6=@H'N32UH^';?[7XJTN#&0;I&(]0IR?T%<^)ERT
M9/R.[+X<^+IKS7X:GN\,8AA2->B*%'X"GT45\N?HX4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% &'XI\(Z7XNTTVNJ0_O%!\FX08DB/J#Z>W0U\Z
M^,/!&J>#;X17Z>;;2']S=1CY)/;V;V/Z]:^IJK:AIUGJMC)9ZC;QW-O*,/'(
M,@_X'WKOPN-GAW9ZQ[?Y'%B<)"NK[,^/Z*]#\?\ PLN_#/FZCI&^[TK.6&,R
M6X_VO5?]K\_4^>5]-2JPK1YH/0^>J4ITI<LT%%%%:F84444 %%%% !1110 4
M444 ?8N@SQ?\(KITWF)Y0LXB7W#&-@[U\=445Q87"?5W)WO<Z\3B?;J*M:Q]
M3_"SQ$/$7@&QDDD#W5HOV:<9R<IP"?JNT_B:\1\>:)#X=^+4D,+(MM+<QW*
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MZ[=RA11178<H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***UO#F@7/B+5X[.V!"9W32XXC3N?\!0!TOPT\-?VCJ9
MU:[CS;6C?N@PX>3_ .QZ_7%>NU6T_3[?2]/ALK*/RX85VJ/ZGW/6K-4 4444
M %%%% !1110 4444 %%%% !1110 4444 %>)?$K_ )'FZ_W(_P#T 5[;7B7Q
M*_Y'FZ_W(_\ T 4F!ZKX2_Y$_2O^O5/Y5L5C^$O^1/TK_KU3^5;%, HHHH *
M*** "BBB@ HHHH **** "BBB@!#6;KFFKJ^BW=@_2>,J">S=0?P.#6D::PH
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M5U##MC$4HEST!)!&!R>>G%<7X+LSIWQ3@LF<.;::XB+@8W;4<9_2JG_"PO%
MCV?VJV,8SY,>?SVYK"6]NEO3>)<2I<EBYF5R'W'J<CG/)I4J%:--TYM6M9#Q
M.,PLZ\:]*+O=-W\NVK/6?BU_R*=M_P!?R?\ H#UG_"KQ!"MM+HES*$E\PRVX
M8_>!'S*/<8S^)]*\ZO-6U'4(U2_O[JZ13E5FF9P#Z\FJJLR,&0E64Y!!P0:(
MX3]Q[*3"IFC^N+$P72UCUSQC\.I-=U5M2TNYBAFE $L<V0K$#&00#C@#C':M
M;PAX4A\(:?</<7"R3S8::7[JJJ] ,]ADG->6VWCSQ-:0K%%JLA51@>8B2'\V
M!-5-4\4:UK,?EZEJ$LL?>,813]54 &LOJN(E!4Y27*=2S' PJO$0IOG?W7^_
M]"_X[\0IXA\1M):L6M;=?*A/][G);'N3^0%>Q>&O^13TC_KQA_\ 0!7SQ5^/
M7=7AMU@AU2]CA4;1&MPX4#TQG%:U\)[2G&$7:QRX/,_8UYUJBNY%"OH3PK_R
M*&D_]><7_H(KY[J_%KNKP6ZP0:I>QPJ-JQI<.% ], XK3%8=UXI)VL99;CHX
M.<I25[HTO!?A^W\2ZW)8W<LL2+;M(K18SD$ =1TYKH9/A#J(N@L.I6KP=W96
M5A_P'D?K7!6UU/97"3VDTD$R'*R1L5(_$5OI\0O%")M&JL1_M0QD_F5HJPQ#
ME>E)6\Q8:K@53Y<1!M]U_P .CUS6]0@\.>$Y'N9_,:*W\J,R-\TS[<#\3U/X
MU\_U=U+6-0UB82ZG=RW+CIO;A?H.@_"J5&%P_L(N[NV&8XY8R:Y5:,=@HHHK
MK/+"BBB@ HHHH **** #:\C+'$I:1R%51W)X%>^Z+IJ:1HEI8)C$$04D=VZD
M_B<FO*/A]I!U3Q5'.ZY@L!YSG_;_ (!^?/X5[+7SV.J\]6RV1]WDN']CAN9[
MRU^73_/YA1117 >T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !6+XG\*:7XLTLV>JPY(YBG08DB/JI_IT-;5%5&4H/FB[,F45)6E
ML?+GC+P-JG@V^V7B^=:2']S=QK\C^Q_NM[?EFN9K[!OK"UU.REL]0@CN+>5=
MKQR+D$5X)X_^%-UX<\S4M$\R[TS)+IC,EN/?U7W[=_6OH\'F$:ON5-'^9X6*
MP+I^_3U7Y'G-%%%>J>8%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %/BBDGE2*%&DD<A51!DL3T '>KFBZ)J'B#4X[
M#2;9IYY#T'11ZL>P]Z^A? GPVT_P?"+F?;>:HP^:X*_+'[(#T^O4^W2N/%8N
M&'6NK['5A\+.N]-NYS/P_P#A"EF8M5\5QK+/PT5B>53T+^I_V>GKGMZV
M, = ***^8K5YUY<TV?14:,*,>6""BBBL#8**** "BBB@ HHHH **** "BBB@
M HHHH *IZKI=KK.FRV5_'YD4@_%3V(/8BKE% '@/B7PQ>^&M0,-TN^!R?)G
M^60?T/J*Q:^C=3TRTUC3Y+/4(A+#(.0>H/J#V->.>*_ M]X==IX-UU89XF Y
MC]F';Z]/I4V Y6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK?\,^$=0\2W
M'[A?)M5.)+EQ\H]AZGVH H:+HE[KVH+9Z?%O<\LQ^[&/4GL*]S\.^'[3PYI:
M6EH-SGF64CYI&]3_ $':GZ%H%EX>TX6E@F.\DC?>D/J36E3 ****8!1110 4
M444 %%%% !1110 4444 %%%% !1110 5XE\2O^1YNO\ <C_] %>VUXE\2O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4$9&#R***
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%+UZ5*EI<R?ZNWE?\ W4)H AHK6MO"NNWF/(TF
M[(/1FB*C\S@5O6'PNUVZP;LV]DO<.^YOR7(_6@#BZMZ?I=]JUR(-.M9+B3N$
M7I[D]!^->JZ5\+-(LR'U*66_<?PG]VGY Y_6NQM+*UL+<06-O%;Q#HD2!1^E
M.P' >'/A;'"RW/B)Q*PY%K$?E'^\W?Z#\S7H<$$5M D-O&D42#"HBX"CV I]
M%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ+XE?\CS
M=?[D?_H KVVO$OB5_P CS=?[D?\ Z *3 ]5\)?\ (GZ5_P!>J?RK8K'\)?\
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MH1LCXG$5Y59N<MV/C6K"K346I5%=*1P28H%.% %+5&8"EHHIB"BBB@04444
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M]);C_P!F7WZCOZUYK7T]*M"M'F@SYVK2G2ERS04445J9A1110 4444 %%%%
M!1110 4444 %%%% !116CHFA:CXBU-+#2;9IYGZX^Z@_O,>PI.2BKL:3D[(H
MPPRW,Z0V\;RRR$*B(I+,?0 =:]N^'_PABL/)U7Q4BRW0^:*R."D7H7_O'VZ#
MW[=-X&^'&G>#H1<.1=ZHZX>Y9>$]50=A[]3^E=E7SV,S%S]REHNY[F%P*A[]
M7?L%%%%>.>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI'!*0JBG@4 4M68L6@44M,04444""BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBD)"C)Z4FTE=E1BY.RW G R>E>@^ O!7G&
M+6M8C^3[UK PZ^CL/Y#\?2HO!G@)KPQ:GKT96#AH;5AR_HS>WMW^G7U # P.
M!7@XS%^U?)#;\S[7*\L^K+VM7X_R_P""%%%%><>\%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+_D3]*_Z]4_E6Q6/X2_Y$_2O^O5/Y5L4P"BBB@ HHHH **** "BBB@ HHHH
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M_$^M**\(T+XSZWIZK%K-O%J<0XWY\J0?B!@_E^->@Z1\6O"VJ!5FNI-/E/\
M!=I@?]]#*_F17GSP]2'0]NEC\/5VE;U.VHJ"TOK34(?-L+J&ZC_OPR!Q^8J>
MN<[4T]4%%%% PHHHH ***KW=_::?"9;^ZAMHQU>:0(/S- FTM66**XG5OBUX
M5TP,(;M]0E'\%HA8?]]'"_D:X#7/C3K=_NBT6VATV(\"0_O9/S/ _+\:Z(8>
MI/H<57'X>EO*_IJ>SZKK>FZ':FXU:]AM8^<&1L%O8#J3["O)_%/QIFFWVOA6
M#RD.0;R=?F/NJ]OJ<_05YC>75YJ=TUSJ-S+=3MUDF<L?UIJ15WTL'&.LM3Q,
M1FU2>E/1?B$\UQ?73W-[-)<3R'+R2L69C[DTY(JE6.IECKT(QL>%.HV,2.IE
M2G*E2!:U2.>4A%6I * *7%69MABEHI:9(4444""BBB@ HHHH **** "BBB@
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M_;U6BBOEZU>=:7--GT5*C"C'E@@HHHK$U"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O$OB5_R/-U_N1_^@"O;:\2^)7_ "/-U_N1_P#H I,#U7PE_P B
M?I7_ %ZI_*MBL?PE_P B?I7_ %ZI_*MBF 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "O$OB5_P CS=?[D?\ Z *]MKQ+XE?\CS=?[D?_ * *
M3 ]5\)?\B?I7_7JG\JV*Q_"7_(GZ5_UZI_*MBF 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %)2T4 -(II6I*,4 0E*84JQBFE:
M*LD"2(5=0RG@@C(-8MUX-T&[),VE6V3U,:["?^^<5T96FE* .&N?ACH4N?)%
MS;>GES9_]"!K.E^%%L?]3JEPO^_&&_PKTDI3=E6IRCLS*5&E/XHI_(\P;X3G
M^'62/K:@_P#LU-_X5.__ $&O_)3_ .SKU#91L]JKVU7^9_>S/ZIA_P#GW'[D
M>7_\*GD_Z#7_ )*?_9TO_"II/^@U_P"2G_V=>G[/:C91[:K_ #/[V'U3#?\
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M_LZ])HH]O5_F?WL/J6%_Y]Q^Y'FW_"I'_P"@]_Y)_P#V='_"I'_Z#W_DG_\
M9UZ311[>K_,_O8?4L+_S[C]R/-O^%2/_ -![_P D_P#[.C_A4C_]![_R3_\
MLZ])HH]O5_F?WL/J6%_Y]Q^Y'FW_  J1_P#H/?\ DG_]G1_PJ1_^@]_Y)_\
MV=>DT4>WJ_S/[V'U+"_\^X_<CS;_ (5(_P#T'O\ R3_^SH_X5(__ $'O_)/_
M .SKTFBCV]7^9_>P^I87_GW'[D>;?\*D?_H/?^2?_P!G1_PJ1_\ H/?^2?\
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MW_DG_P#9UZ311[>K_,_O8?4L+_S[C]R/-O\ A4C_ /0>_P#)/_[.C_A4C_\
M0>_\D_\ [.O2:*/;U?YG][#ZEA?^?<?N1YM_PJ1_^@]_Y)__ &='_"I'_P"@
M]_Y)_P#V=>DT4>WJ_P S^]A]2PO_ #[C]R/-O^%2/_T'O_)/_P"SH_X5(_\
MT'O_ "3_ /LZ])HH]O5_F?WL/J6%_P"?<?N1YM_PJ1_^@]_Y)_\ V='_  J1
M_P#H/?\ DG_]G7I-%'MZO\S^]A]2PO\ S[C]R/-O^%2/_P!![_R3_P#LZ/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#QCQCIOB#5=9O-4N-,N([6($(6'
M"1+W_F?QKEK*QN=1NTM;&%IYWSM1>IP,G]!7O?BG_D4=6_Z\Y?\ T$UY+\./
M^1[L?]V3_P!%M2 [SX<QZO8:9-IFL64T"0MOMW<<8/WE_/G\3Z5V=%%, HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ+XE?\CS=?
M[D?_ * *]MKQ+XE?\CS=?[D?_H I,#U7PE_R)^E?]>J?RK8K'\)?\B?I7_7J
MG\JV*8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM?\ E8?VE@_^?B/6J*\E_P"%I:__ ,^NF_\ ?N3_ .+H_P"%I:__ ,^NF_\
M?N3_ .+H^JU_Y6']I8/_ )^(]:HKR7_A:6O_ //KIO\ W[D_^+H_X6EK_P#S
MZZ;_ -^Y/_BZ/JM?^5A_:6#_ .?B/6J*\E_X6EK_ /SZZ;_W[D_^+H_X6EK_
M /SZZ;_W[D_^+H^JU_Y6']I8/_GXCUJBO)?^%I:__P ^NF_]^Y/_ (NC_A:6
MO_\ /KIO_?N3_P"+H^JU_P"5A_:6#_Y^(]:HKR7_ (6EK_\ SZZ;_P!^Y/\
MXNC_ (6EK_\ SZZ;_P!^Y/\ XNCZK7_E8?VE@_\ GXCUJBO)?^%I:_\ \^NF
M_P#?N3_XNC_A:6O_ //KIO\ W[D_^+H^JU_Y6']I8/\ Y^(]:HKR7_A:6O\
M_/KIO_?N3_XNC_A:6O\ _/KIO_?N3_XNCZK7_E8?VE@_^?B/6J*\E_X6EK__
M #ZZ;_W[D_\ BZ/^%I:__P ^NF_]^Y/_ (NCZK7_ )6']I8/_GXCUJBO)?\
MA:6O_P#/KIO_ '[D_P#BZ/\ A:6O_P#/KIO_ '[D_P#BZ/JM?^5A_:6#_P"?
MB/6J*\E_X6EK_P#SZZ;_ -^Y/_BZ/^%I:_\ \^NF_P#?N3_XNCZK7_E8?VE@
M_P#GXCUJBO)?^%I:_P#\^NF_]^Y/_BZ/^%I:_P#\^NF_]^Y/_BZ/JM?^5A_:
M6#_Y^(]:HKR7_A:6O_\ /KIO_?N3_P"+H_X6EK__ #ZZ;_W[D_\ BZ/JM?\
ME8?VE@_^?B/6J*\E_P"%I:__ ,^NF_\ ?N3_ .+H_P"%I:__ ,^NF_\ ?N3_
M .+H^JU_Y6']I8/_ )^(]:HKR7_A:6O_ //KIO\ W[D_^+H_X6EK_P#SZZ;_
M -^Y/_BZ/JM?^5A_:6#_ .?B/6J*\E_X6EK_ /SZZ;_W[D_^+H_X6EK_ /SZ
MZ;_W[D_^+H^JU_Y6']I8/_GXCUJBO)?^%I:__P ^NF_]^Y/_ (NC_A:6O_\
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M1R!B/J.U6Z@U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#*\4_\ (HZM_P!><O\ Z":\E^''_(]V/^[)
M_P"BVKUKQ3_R*.K?]><O_H)KR7X<?\CW8_[LG_HMJ0'M]%%%, HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH RO%/_ "*.K?\ 7G+_ .@FO)?AQ_R/=C_N
MR?\ HMJ]:\4_\BCJW_7G+_Z":\E^''_(]V/^[)_Z+:D![?1113 **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\2^)7_(\W7^Y'_Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!E>*?\ D4=6_P"O.7_T$UY+\./^1[L?]V3_ -%M
M7K7BG_D4=6_Z\Y?_ $$UY+\./^1[L?\ =D_]%M2 ]OHHHI@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %>)?$K_D>;K_<C_\ 0!7M
MM>)?$K_D>;K_ '(__0!28'JOA+_D3]*_Z]4_E6Q6/X2_Y$_2O^O5/Y5L4P"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@!*0FE-8/BWQ GA[0I;D$&X?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7B7Q*_Y'FZ_W(__ $ 5[;7B7Q*_Y'FZ_P!R
M/_T 4F!ZKX2_Y$_2O^O5/Y5L5C^$O^1/TK_KU3^5;%, HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %>)?$K_D>;K_<C_\ 0!7MM>)?
M$K_D>;K_ '(__0!28'JOA+_D3]*_Z]4_E6Q6/X2_Y$_2O^O5/Y5L4P"BBB@
MHHHH **** "BBB@ HHHH ****  TQC3C63XEU4:-X=O+[(#QQD1^[GA?U(H
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M!)'=AS\IKSYXR4:KIQA=KS/<HY7">&CB*E7E3\O^">$T5[!_PMK0O^?34?\
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M!VCK^7]?>=>&RRK4C>I[O5/K?S5_\F>27OB;7=2:.S76)KLS'$:64'E-(?\
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M+_KLG\C6KXM\>_\ "+:M%9?V;]J\R 3;_/V8RS#&-I_N_K7B2E..,DZ:N_\
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M'$2Y8KY]#"_X1K7?^@+J/_@(_P#A6=)%)#*T4R-'(A*LC#!4^A%?07AG7/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "O2_A1?;]/O]/8\PRB5![,,']5_6O-*ZCX=7IL_&D41.$NXGB/
MU W#_P!!Q^->=F$.:ES=CWLCJ\F*Y/YE^6I['1117@'VX4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!E>*?^11U;_KSE_]!->2_#C_ )'NQ_W9/_1;5ZUX
MI_Y%'5O^O.7_ -!->2_#C_D>['_=D_\ 1;4@/;Z***8!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7B7Q*_Y'FZ_W(_\ T 5[;7B7
MQ*_Y'FZ_W(__ $ 4F!ZKX2_Y$_2O^O5/Y5L5C^$O^1/TK_KU3^5;%, HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG^-%P/</[5T__G_MO^_R_P"-']JZ?_S_ -M_W^7_ !KP_P#X0CQ)_P! B?\
M3_&C_A"/$G_0(G_3_&BX'N']JZ?_ ,_]M_W^7_&C^U=/_P"?^V_[_+_C7A__
M  A'B3_H$3_I_C1_PA'B3_H$3_I_C1<#W#^U=/\ ^?\ MO\ O\O^-']JZ?\
M\_\ ;?\ ?Y?\:\/_ .$(\2?] B?]/\:/^$(\2?\ 0(G_ $_QHN![A_:NG_\
M/_;?]_E_QH_M73_^?^V_[_+_ (UX?_PA'B3_ *!$_P"G^-'_  A'B3_H$3_I
M_C1<#W#^U=/_ .?^V_[_ "_XT?VKI_\ S_VW_?Y?\:\/_P"$(\2?] B?]/\
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M\:/^$(\2?] B?]/\:+@>X?VKI_\ S_VW_?Y?\:/[5T__ )_[;_O\O^->'_\
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M2VC7\E%7*1$$<:HOW5  ^E+7RA^EA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%>\H22\CKQ.$P.#M"K3D[KXOZT)/ _A+4-5U"VU6"2".&QO4\U)68.=I5B
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M^OW,?A7P'*MKE?(MQ;P>NX_*#_7\*]/%U?:4XPA]H^=RO#>PKU*M3:G?[_\
MAOS-/1=375]/:[B.8VFD1"#U57*@_CC/XUX1XE_Y&S5_^OZ;_P!#->O?#?\
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M/3]IC(^5W_7S/6Z***^</OPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJTT@:103C/& JCN<=JY(*#C*,XMS/3K2K*<)T9QC25K[?=_PQ!\7/^19L_\
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M445Y)]0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>';V3]_:@R6I8_>CSROU!.?H?:O5*^=J0=.;BS[S#UE7IJ:ZA11169N%%%%
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M>OY<#\*VZ^5JU'5FYOJ?I6&H1P]&-*/0****S.@**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!]._O]!73T45\ZVV[L^]C%12C'9!1112&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^T^TZ/?0W<7?8?F7V93RI]B!7DU*,Z;]Y'TU#%4JZ]QZ]NIH4445D=04444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME=%>J?\ "J=%_P"?W4O^_J?_ !%'_"J=%_Y_=2_[^I_\11_:4/Y0_P!7ZO\
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M\*IT7_G]U+_OZG_Q%'_"J=%_Y_=2_P"_J?\ Q%']I0_E#_5^K_.CRNBO5/\
MA5.B_P#/[J7_ ']3_P"(H_X53HO_ #^ZE_W]3_XBC^TH?RA_J_5_G1Y717JG
M_"J=%_Y_=2_[^I_\11_PJG1?^?W4O^_J?_$4?VE#^4/]7ZO\Z/*Z*]4_X53H
MO_/[J7_?U/\ XBC_ (53HO\ S^ZE_P!_4_\ B*/[2A_*'^K]7^='E=%>J?\
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M>.V!9C^)P!^1KT^BN2>+K3WD>G1RO"4=5"[\]3"TGP9H>CX:VL4DF'_+:?\
M>-GUYX'X8K=HHKE/2V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "DQ2T4 -Q2;:?1B@",K32E
M2XHQ0! 4I"E3XHVT 5S'1L]JGVT;: (/+]J/+J?;1MH A"4X)4NVC% $82G!
M:?BC% #0M. I<44 )2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
<4 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>bdtx-20211231_g17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g17.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,T
M.0  DI(  @    ,T.0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MBBB@ HHI%Z4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:GW?QIU,B^[
M^- #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\GU[5X-
M"^,3:C=I(\,*C<L0!8Y@VC&2!U/K7K%<0_AW5#\6TUH6W_$O"\S>8O\ SQ*_
M=SGK[5UX648N7-V9Y>94ZE2--4]^==+VWU]$<_8FY\:?$BWUBSLI8+*W9&:2
M0=DY&3TR3V%55TAM<^*>IV(NI+6-Y)#*\7WF4$94?7BO8:X71O#>JVOQ,O\
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M.6L?"$FM> 3K5UJ4YE@@<VL.?W<:1DC;CWVGIC\:=)JMUJ?P;F^URM(]O>+
M'8\E1M89/?[V/PHT2V\97'@F.ST=()]-O5<!BZJ\(WLK+R1U.3WZ]JW+GP5?
MVGPT.CV:+<7TDZSR*KA1G(S@G X %5*<5*TY+XM/)$4Z,Y4^:E!J]/7?5]+=
MS(U?7+O3/A=H=M9RM$UXKJ\BG#;%/(![9R*Z'1OAQ'H^H65_!JEP+F%@UP,
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M6O#MK!=)< X\QU 7<!G(+ ]>>*MZWX>UG4/'>AZHMLKPV\4/VF19% 5E=F;
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M!=4M-!:[>&Y=E#7>T-YB@%2,#IG'ZUP^B?:O$.H:+X>N Q@M)W++W"D[GS^
M(_&IC1I2;TLHO7T-*F*Q5.*3E=U(I*VW->VGRU]3VG2+BYN]&M+B_2-+B:)9
M)%C!"J2,XYKRGQEISZK\1]0MHO\ 6?9O,0>I6$-C\<8_&O8J\Y_YKM_VR_\
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MDZR55^Y9K;6_RV\C2\?>($TW^QI(M/L+]+DNRM=P[]@&S!7D8SN_05F^,/\
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M1ZYKE?AE;R7]]JWB&Z'[RYE,:'ZG<W_LOY5WMU;1WEG-;3C,<T;1N!Z$8/\
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M;VSGG/344[.][O[V+VJM;DC_ . Q_P C"72M8@@$,&IV[11#$4<EHH60'J)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ JGIO\ Q[-_OG^0JY5+2_\ CU;_ 'S_ "%
M%VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZ3
M_P >K?[Y_D*O50TC_CT;_?/\A0!?HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4DLQ))/TYH ]!,T2R"-I%#D9"EN:?7FUUXFMO#;VFG6T3ZGJ-Y(JLJ$?,S'
MW$]!SCFO0; 7(L8OMJHD^,NB-N"^V>^.F: +%%%% !1110 4444 (6 8 D G
MH,]:KG4+?S6C#%BC;6(4D*?3->7>-+_6[/XIQP1W@@TZX@@8N'^:-0S!E [$
MD9^E=\M[8;$A2=,8^5(UY)]30!N9STHKG;_5[FTCMH(=L<;$*]P>2H]AZ^]6
MO[0N8)%=V$D!QGY.1[\4 ;%%<[XE\8V7AJ;3HKC:[ZA(R1$OM4D8R,^OS?SK
M:M+V*[WK&PWQXWJ#G&>E %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKQ+PW=_9=0U3_BEO^$@W2C_EEO\ (Y;_ &&QG\/NU[;7EVBZ5XV\-7FH/IFC
MVTRW<@),TR'A2V,8D'][O7?A914)IVUMN['BYE"<JE*44[*][+FMIVU(?'5V
M9-)T+3H;#^R8;HF:6T1-NQB0 ",#IDGIWKN4\$^'4L4M?[*@94Q^\(Q(2.Y<
M<_K6)KGAO6/%WAFVDU2*"RUBVD<I&C?(5/;(+8)P.<]J@AE^))MTLS;6D97
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MG-O3?6_;R/.<<3&E&-IJT5;E_F_O?\$L^(/&6L"^T,Z"5VZC;*XMV12&=C@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M].M5%O;J8TP'7@L<M^= &S%*)5R 0>X/44^J&E*XCG:0GYI3M![# '],U?H
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M#7_(-D_Z['^0K7K'\,_\@R3_ *['^0H V**** "BBB@ HHHH *YKQ;X_\/\
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M/6OCAX]U#2[N.[LY[?3VBFB;*L/('3\<_CF@#U>BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $+!5+,0 !DD]J\1^)O
MQ-.H-+HGA^;%H#MGN%/^N_V1_L_S^G7U'Q9X?OO$FF?8+75SIL$G$VR#>T@]
M,[A@>H[U\V^)]&'A_P 27FEK.9Q;/M\TKMW>^.<4@/6/AE\31>K%H?B&;%P,
M+;W+G_6>BL?7T/?^?K%?+O@?PP/%OB$:<;MK,^6T@E5-^,>V17T?H&G7VDZ5
M'9ZCJ7]I-%\J3M%L;;V#?,<GWI@:=%%% !1110 4444 %%%% !1110 4444
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MYXOU?4?#GBC1CHGB+34#S6V3MD3@%E!Y&"5XR<A@037&S:Y^T-8!8KC1M$=
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M,"JFG>#= TGQ-?\ B'3M.2#5=17;<W =R9!D$_*3M&2 3@#.* .6_P";GO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC 48 ]*=110 4444 %%%% !1110 4444 %%%% !1110 456U+C2KO'_/%_\
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MGOX+?\C\/^O:2OH2F 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[YW8V]?F_P!?][GYO$J /2?&W_)"?AA_W%O_ $I6O-J])\;?\D)^&'_<6_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5\Q?$G_DHFK_ /7;^@KZ=KYB^)/_ "435_\ KM_04@-G
MX+?\C\/^O:2OH2OGOX+?\C\/^O:2OH2F 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5@>-KC5[#PAJ-YX9M5N-5CB_<KL#-C(S@?Q$#)
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M75M)2[@218&_U9D&"P]1[9Z4FFG9E1E&:YHO0UJ***104444 %%%% !1110
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M/NJ\'+\RJXEUO:)>YM;Y^O8]K'9?3PZI<C?O[W^7IW/5_P#AH/X8_P#0S?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCY5]!7SO7T5X>^V?;/CA]B\C[-]IO/[3\[._R,W./)QQOQYGWN/N>]>%1_\
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MQ %V5+A6(4$@9P.,D5U,7[0VB3PI-!X0\8212*&1TTQ"K \@@B3D5P5KY?\
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M?\8O^X)_Z,%3_#O[5_P@.F_8_)\K;)CS<[L^8V[IVSG'MBH-1_Y /Q/^T?\
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M1/YAH/\ R,7C7_L:;_\ ]#%6/#7_ !X_&W_L"P_^D<]5]!_Y&+QK_P!C3?\
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M0!YEX-_Y$30?^P;;_P#HM:ZC]GS_ )(5X?\ K<_^E,M<OX-_Y$30?^P;;_\
MHM:ZC]GS_DA7A_ZW/_I3+7JYA\%/T_R/S_A'_><9ZK\YGI-%%%>4?H 4444
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M_DNWB?Z6G_I-'7V)7QW\:/\ DNWB?Z6G_I-'6E?^&SCRO_?(?/\ )F]^S?\
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MKGQ]X/LKJ6UO/%>AV]Q"YCEAEU&%7C8'!5@6R"#P0:^6?@S_ ,ET\+_6Z_\
M2:2N?\9012?$KQ:9(D<_VY>#+*#_ ,M6K*-1QI*3.ZM@E5QTJ%/1?\!'VII'
MB30_$'G?V#K.GZGY&WS?L5TDWEYSC=M)QG!QGT-:5?.W[+"*FI>,E10J@66
M!@=)J^B:Z(NZ3/*JTW3J2@^CL%%%%,S"BBB@ HHHH **** "HI9-G.:E-5I@
M"?F/%- 5YVRI8+GCINK,FOYK?RGBD;,AQP<YJW)D3E=W"]O6LV)@]RZ.H^63
M</:M%$FY,S7QD,T+@O'G:7;) /48_6LN2\DN!*2C2W"Y.TG&"#@__JJ[/=20
MVH)W1LTH1C_LD]:@=_L\(^P?ZUYVC\R3^[US5J*)N1:?K-S'"L5M)MW*&&1D
M9QG!ST]_I4K7]W>7$+/=/ TKCY%.% /<52>W062J%5F8R/G')0#DG\^*MV^U
MUMTD&':'?G'([ ?I3Y4%V20WTUO?36L4RK*=L> O5?[WL>?TJ7[.K)+-$""0
M?*=>"2!U!K$N&&GZL;V61B&MWZGC>!@?SK1N)94NK Q.PC@@5V4=#DX-/E07
M(CJ=S,R!&E<N!D22$?-V8?E6B-;U 71@25)9%;80R8QQDD_2L6^O9-+U"61=
MNVU)$>X<'<<GC\14E]=/)'%-%!(CWL01FW#+'.3Q[TN5"NS2&KO)=$)=W$6!
ME&;E7/<\\?A4^G:Q<*01)]I292QEE<!58'G'^%8NI*\=I%90L'E3$DA''U7/
MTS4=W))(ODQV_D1W3@J@/S1G&,@>AHY4.[-Z7Q)<FV%TD$;0MO B)QO"@Y;/
M8<5Y)#HFIZ=:V.L6VN32"X?S'LW4+$NXY(4?P@9XQ7IKZ<LRR11$;+>/RL#^
M(L,,*\O^($>H^&K46-O<K>6T2X3<F'4Y'RY!YX/6LYPML-,/&.E7VDW\.K^9
M/;V=PRPW"1ME6!/!]NM:UK+:Z)=P2Z#<S7,[ *\>\MCGN3TJUJ#ZQX@\(V<-
MQ L=NJ*9(P,L<= QJ_IOA!8/#YMM.N$_M&\)EEF9<[ 1C 'MQ699TMW+-,SI
MM>$Q1>82&PQS].W%,76;UK2-OM$HE4A58 ;#]1WS[UCV6EWWA^RB2XOY;V[N
M6(GG89"H.@ [>GXU)IUT8F9V'F222LOV?=T;/RG'I6L(W6I$F:3ZG? S6IOG
M=O,^="F6VD9R,=J3^TQ:1N;61OM1^X8S\C^G%1RW*VLDE]<)LN5C\F15.[S&
M/I^@K-O%DM-)MCP-TB@;1ER_4X]A6G*A79JPWSW8$MSNE:,%Y<]R.V.W_P!>
MF'?&D#QD;959V4C(BYZ?CG%5M/,\VN&WD.'N(RLFW[I''S8[''%7KJVCCD@6
M+*;HY"X!X*CD9_'%.PKA:GS+F<*\MNQBY3>?FP.A_#^=/DC=8X[B"5Q+,H\P
M!ONH>.?4<U4,NU)KV0@EE'F0D8*KC@CUIMLI5YW4_-;6X=4]5)YHL%R^KQ";
M=M5H_*YXXSG&:3[A:XCB0QQD9/J3]WC\:JV) T>X3<&?R/E]\M_]>M"2.WB6
M&P6W9Y=N3)GN!G\Z5AW%*2Q&65R2N0 RJ,9/7-2B>ZBA5&??%OVJ@Q^%4+:6
M5XY)+O>8V.#&&PK-Z_2KV(Y;=+F+?'(N"R9]N#4M F:4=P4?:H )&.*T8VR!
M_C6-!F"*('!>0%F8UJ1'YL>V:RDBT6:*!14#"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L3P
MI_R"I/\ KL?_ $%:VZQ/"G_(*D_Z['_T%: -NBBB@ HHHH **** "O/_ (FW
MOP\TS4/#^H_$2=H+BTG>?3'"SMAU*%CB($'D)][_ !KT"LO6O#.A>(Q"/$&C
MV.IB#/E?:[=9?+SC.-PXS@?E2=]+#5NI\_-'^S,[EFN),L<GC4/\*[;X4)\'
ME\57!^&<KOJOV1O-#"Z_U.],_P"M&W[VWWKBM=\2:!>>)[[1_AK\']*\0IIS
MF.YO/[/5D+#@A0J\#(."3S@X'>N[^#/B+PGX@NK]-.\'6GA7Q)8KY5Y:I;+&
M^PGL=JMC(&00,''7@U5/75=OZ^0IW3U[GK-%%%( HHHH *XGXJZ?_:7A6VA_
MX3K_ (0C;>JW]H^?Y7F_(X\G/F)USNQG^#IW';5YW\:[_P &Z=X+M)?B'I-Y
MJNF-J"+%#9N5=9O+D(8XD3C:''7N./0 \-^&]IY/_"X/^*F_M+R-%OHO];N_
MM/\ UG^E_?.[&WK\W^O^]S\WB5>R?#"Z\/3?\+7_ +)L+B#SO#]]+I?F,3Y%
MG\VZ-_F.6^:#GYON-\WKXW0!Z3XV_P"2$_##_N+?^E*UYM7I/C;_ )(3\,/^
MXM_Z4K7FU 'Z1T45FZOXCT/P_P"3_;VLZ?IGG[O*^VW20^9MQG;N(SC(SCU%
M &E7SWJO_)=O'G_<._\ 285[);>/O!]Y=16MGXLT.>XF<1Q11:E"SR,3@*H#
M9)). !7C>J_\EV\>?]P[_P!)A7CYW_R+ZGR_]*1ZN3_[]#Y_DS)/_(X^,O\
MLGM]_P"C*O>%?^1.T;_KP@_]%K5$_P#(X^,O^R>WW_HRKWA7_D3M&_Z\(/\
MT6M?-9A_R+,.?08'_D8USG/^:=_]U1_]I5T?BK_D3M9_Z\)__1;5SG_-._\
MNJ/_ +2KH_%7_(G:S_UX3_\ HMJVS;^-AO1?FC++/X6(]7^I1'_(X^#?^R>V
M/_HRI]>_Y&+P5_V--A_Z&:@'_(X^#?\ LGMC_P"C*GU[_D8O!7_8TV'_ *&:
MVQ7_ ".X?(QPW_(HG\PT'_D8O&O_ &--_P#^ABK'AK_CQ^-O_8%A_P#2.>J^
M@_\ (Q>-?^QIO_\ T,58\-?\>/QM_P"P+#_Z1SUO@?\ D<UO1_G$RQO_ "*J
M/JOR8GA7_D3M&_Z\(/\ T6M9:_\ )L_PS_[&E/\ T?=5J>%?^1.T;_KP@_\
M1:UEK_R;/\,_^QI3_P!'W589/_S%?U_,:YK_ ,PW]?RC?B;_ ,DYU/\ [9?^
MCDKK?B+_ ,G"6_\ V*R_^E3UR7Q-_P"2<ZG_ -LO_1R5UOQ%_P"3A+?_ +%9
M?_2IZQP/_(FK>K_*)MC?^1K1]%^;*&E?\EV\!_\ <0_])C5#0?\ D8O&O_8T
MW_\ Z&*OZ5_R7;P'_P!Q#_TF-4-!_P"1B\:_]C3?_P#H8HJ?\B*'K_[<PI_\
MCF?I_P"VHL>&O^/+XV?]@6'_ -(YZ3PK_P B=HW_ %X0?^BUI?#7_'E\;/\
ML"P_^D<])X5_Y$[1O^O"#_T6M&;?\B[#>B_])099_O\ B/5_F9:_\FS_  T_
M[&E/_1]U3?B;_P DYU/_ +9?^CDIR_\ )L_PT_[&E/\ T?=4WXF_\DYU/_ME
M_P"CDKMS;_D8X;U7_I2.3*_]QQ'H_P F;VJ_\EU\>?\ <._])A1I7_)=? ?_
M '$/_28T:K_R77QY_P!P[_TF%&E?\EU\!_\ <0_])C6'_,__ *_D-?\ F2?U
M_.8/PR_Y)UIG_;7_ -&O5+5_^1/^,7_<$_\ 1@J[\,O^2=:9_P!M?_1KU2U?
M_D3_ (Q?]P3_ -&"C*O^1M7_ .WO_2D&9?\ (LH_]N_^DL[BNN_9\_Y(5X?_
M .WG_P!*9:Y&MSX*>(]#\/\ P*\,_P!O:SI^F>?]K\K[;=)#YFVYDSMW$9QD
M9QZBCAG_ )>_]N_J'$7_ "Z^?Z'K=?/>J_\ )=O'G_</_P#285[);>/O!UY=
M16MGXLT.>XF<1Q11:E"SR,3@*H#9)). !7C>J_\ )=O'G_</_P#285[.=_\
M(OJ?+_TI'E9/_OT/G^3+_P .O^3A)_\ L5V_]*DKW6O"OAU_R<)/_P!BNW_I
M4E>ZUME7^Y4_0RS+_?*GJ>;_ +07_)"?$/\ V[?^E,5>=^*?^1.UG_KPG_\
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M^5_LCCH3Z^U3+/+_ &5(V UU:1&-OEQY@(P1^%-BM8'M9I(]JN\!>+'!CV'
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MYO\ M!?\D)\0_P#;M_Z4Q5YWXI_Y$[6?^O"?_P!%M7HG[07_ "0GQ#_V[?\
MI3%7G?BG_D3M9_Z\)_\ T6U>-G_\;#^K_.)ZN2?PJ_HOU%\2?\>/P3_[ TW_
M *1P57U__D8?!7_8T6'_ *&:L>)/^/'X)_\ 8&F_](X*KZ__ ,C#X*_[&BP_
M]#-&/_Y'-'T7YR#!?\BJMZO\D7]6_P"2[>//^X?_ .DPJ_\ #K_DX2?_ +%=
MO_2I*H:M_P EV\>?]P__ -)A5_X=?\G"3_\ 8KM_Z5)13_Y'L_3_ -M03_Y$
MT?7_ -N9!X=^*/Q5\3:#;ZO86O@Z.WN-VQ9H[H.-K%3D!R.JGO6;XA\8ZUXS
M\#Z-/XDAL(KW3?B%!IY%@KK&PCC)S\[$GECSQQCBI/A'_P DMTG_ +;?^CGK
M"_YDT_\ 95O_ &G7WM2A"G"G..[L?DN#S3$XO$XW#U6N6',EIV;1V_C'_D1=
M>_[!MQ_Z*:LA/$/C$7'@WPYX8\3?V):?\(597[_Z!#<[GSL/WQD<;>^..G-:
M_C'_ )$77O\ L&W'_HIJP=+_ .1Z\'?]D[LO_1HKJQ<8SQ%.,MCP.'\14PV4
M8NM2=I*UG\O,OS^(?B+X?\0^&?[0\<_VG::CKEK83V_]D6\.Y)'^;Y@">@(X
MP>>M>_UX!XR_Y#'@C_L:[#_T)J]_KSL93A2J\L%H?9<.8VOC< JV(E>5WK9+
M\K&)XUU"ZTGP#X@U+3Y?)N[/3+F>"3:&V.D3,IP00<$#@C%>,Z-J/Q.U?0K#
M4O\ A8_D_;+:.?R_["MFV;U#8S@9QGKBO7?B-_R2SQ7_ -@:\_\ 1#UYEX-_
MY$30?^P;;_\ HM:UP-&G5DU-7.'BK,L5E]&G+#2Y6V[Z)]/-,[KX.^(=4\5?
M"?1]9UZZ^UZA<^?YLWEJF[;/(H^50 /E4#@=J[>O-OV?/^2%>'_^WG_TIEKT
MFO//L HHHH X#4OCE\.M(U6[TW4?$/DW=G,\$\?V*X;8Z,589$9!P0>0<56U
MCXA>&/'?PM\;?\(IJ?V_[%HUSY_^CRQ;-\,FW[ZKG.QNF>E<1X._Y#7C?_L:
M[_\ ]"6H](Z_&_\ [ L'_I%-774PW)1C5ON?/X3.?K.95<![.W(F[WWLTMK>
M?<TO!O\ R(F@_P#8-M__ $6M=1^SY_R0KP_];G_TIEKE_!O_ "(F@_\ 8-M_
M_1:UU'[/G_)"O#_UN?\ TIEKJS#X*?I_D?/\(_[SC/5?G,])KQ;QG_R<;#_V
M*@_]*VKVFO%O&?\ R<;#_P!BH/\ TK:N/"_QX^I]+G__ "*Z_P#A*G_-=?A]
M]=2_])J]TKPO_FNOP^^NI?\ I-7NE7CO]XE\OR1S<+?\BBC_ -O?^E2/-_V@
MO^2%>(?^W;_TIBJ@.@J_^T%_R0KQ#_V[?^E,54!T%=F5_;^7ZGS?'7_,/_V_
M_P"VG@GB?_DB_P +OKJ__I0*X>__ ./&3\/YBNX\3_\ )%_A=]=7_P#2@5P]
M_P#\>,GX?S%?8Y!_R3V*_P"W_P#TA'WE7^+'Y?F?H4.@HH'045^;'8?*T'[2
M_CZXA$B:;X<"MG&8)\]<?\]:WM;\>ZM\0_V6_%^IZ]!907-MJ,5H%LD=4*K+
M;-GYF8YRY[^G%>$:;_R#X_\ @7\S7J6@?\FB^.O^PXO_ *':5A3J2E.2?0];
M&86G1PU.I'>25_N/,KK_ (\YO^N;?RK[&\'>(]#\/_"OP?\ V]K.GZ9Y^C6O
ME?;;I(?,VPIG;N(SC(SCU%?'-U_QYS?]<V_E7J/Q@17^'/PB5U#*=&;((R/^
M/>VK+#NT&SNS>FZF(I0773[V?1EMX^\'7EU%;6GBS0Y[B9Q'%%%J4+/(Q. J
M@-DDDX %?+?QH_Y+MXG^EI_Z31US?A""*/XC^$S'$B'^W+,950/^6RUTGQH_
MY+MXG^EI_P"DT=54GST6SGPN&>&S"%-N^_Y,WOV;_P#DL%]_V I/_1\5>1Z;
M_P @^/ZM_,UZY^S?_P E@OO^P%)_Z/BKR/3?^0?']6_F:SJ?P8G;A/\ D9U?
M1_FCU+0/^31?'7_8<7_T.TKS*Z_X\YO^N;?RKTW0/^31?'7_ &'%_P#0[2O,
MKK_CSF_ZYM_*G6^Q_78SRW_F(_KN=G\2O^/KP)_V)-A_-ZQ?"?\ R47PG_V'
M;/\ ]&K6U\2O^/KP)_V)-A_-ZQ?"?_)1?"?_ &';/_T:M$_XZ##_ /(KG\Q?
M%_\ R4CQ;_V';S_T:U;/PT_X_P#QQ_V).H?S2L;Q?_R4CQ;_ -AV\_\ 1K5L
M_#3_ (__ !Q_V).H?S2G'^.PQ'_(KA\CC+3_ (\X?^N:_P J]@^&/Q"/PU^"
M=_JZZ5_:C7'BI[00?:/)P6MT;=NVM_<QC'?K7C]I_P ></\ US7^5=:/^3<F
M_P"QY'_I)4T-)2*S.*E1HQ?6WY'I#_M472(S-X$PJC)/]L#I_P!^:X_XW:Q_
MPD/C3PUK/D?9_P"T?"UM=>3OW^7YDDC;=V!G&<9P*\ZNO^/.;_KFW\J[/XD_
M\?/@3_L2K#^;U7M'4IR;,I8.GA<;2C!O7N2?!G_DNGA?ZW7_ *325A>+_P#D
MI'BW_L.WG_HUJW?@S_R73PO];K_TFDK"\7_\E(\6_P#8=O/_ $:U2_\ =T;P
M_P"1M+T_1'K?[+7_ "%/&7TL?Y35]$5\[_LM?\A3QE]+'^4U?1%==/X%Z'S^
M+_WBIZO\PHHHJSF"BBB@ HHHH ****  U7F4GIT%6*8_"\TT!E3MY7F2==G(
M^M<\[3"X60+NP203QC/>NANHS+'Y0_C.6^E5;N+>!M.TKT.,UT1U,I:'/7UH
M(Y4N;?'FW&8V7L<]_P!*K):/;6<,+-\OF*)-HQQTZULO H<.Y:1QT9CT^@JG
M=+NB=<9R"!75"G=:F,IV>AD:G&VG6@B55<6UR60=AQG^5:-[=1QZ?'-(=Q-L
MT$I/0\94_P"?6LYK1KAW,[S&(@'9(>K#J?ITJ-H/]%>UE7;!(NUG+[B#Z_2I
M]G)*]BN>+=B;3;@6EQY[KM,HVG'(^8G.?S%6]*N]VL/%,X(YMF7/5=ORG]*R
M+)'-HT,S>8L;E$DZ;U'0U(Z2&XAFXW0 X(ZOR.OY5M*@VDX=3.-6SM(T],N(
M$BM8I3CRGE@;UP,\?E@U;LA';VIN1\INY6$"@9*H._UQ_.L34U#,E]9[RA<E
MPJYV-CKBFP:BXTM(KH.TZ@+;>6?7C/'X5S6=KFUU>Q=AU*17AT^U)AN;S<S2
MD?=0'M^%,U+_ $B-;*P,J1JV"Z+\Q'0L/7T_.L^]GN+>_LX[9/.EM8PAE48V
M@XR&SQT_I5VVN_LTLCVT+;& VK*_W3W./0^E.,)RV0.48[L:'EAU*:..%H3%
M&K!2<MP,9/I6)XIO)-)D_M+/G)9XC,I( )<J/+^H/?M6TMU,M]=W<DB>9)#M
M((^_[ >WYUY]XAN(-7\8R>%=+U"*:*_3_2WD8*D,F<DCWQV]:BI":O&Q4&GJ
MCTZTLX[".35KZ[MX[N6T\N#;P!NYQ[G.*Y_P3!8'5=4<ZCS%*T6QF^_(.-Y/
M4G]!72W%G9M)I]LT\4L=G;EHY0!PR#'->(:/8ZPDUQXBL[6>YTY[IMSQK\S@
M$Y8#TS7*:'N6LW%M;VQEN6=)PA4Q!<^8#W&.W?\ "F3W@M+R:&)MCW$<2B0#
MZ\UQOBCQ3>S>'H]5LHIK5(V2V6&=,-.#DG*XR1Z=#6K92R26$<FI6K-/<0J;
M=B<>5P."?8UUPA+D3[F<FCH28IKR[5/F^SH(\9X1 ,DGZU'I5W =)AA@/+3-
M)(,8;IGIZ<UG+>3BZE>&&.%9(/*?C.[WJO#"MO.)HA\XQG)^]CL:WC0J25[&
M+JP3L7=/U.!IUFPQC4R!G()&_/(_2FQ$);7=Y*ZDNA1H0W);/!Q[U55 9IY/
M)CB$S;O+7H.G]1FG%<JVW )!&:TCAI.-V0ZR3L:EG;"WT:X6Z;:^Y(LD_P )
MY/Z&M:R>.?RKV5FQ-@00 X557@']?UKF)YFGL8[.(.D08-*S\LY%7;&Y;R_)
M,GEO#$P@([Y[<U@Z<E'F9MSQ<N4U[QX4U"WD!W&.Y!DD'W5[8^O-06UI<6?B
M&YO9%*Q L5<GCGTK&DG>=&A1W6 ,,*P&21W./>IY+JZND5+F8NB\[?7ZU4:$
MY69+JQ6AKQ&WMK-+F)E:56!'S?='?^=$%P5BDC8;4^T%XI >"3SBLJ.%-V=H
M]_>K20+NB(R%#@L,G %*=%Q5[A&JF:MOG++]V107*^];%LV?FQ@* JBL2",L
MP;D,><D]L]*W;9,@=A7--6-4[F@G2G4Q*?7.:A1112 **** "BBB@ KF_'7_
M "+R_P#7=?Y&NDJM?:?:ZE;^1>Q>;'N#;=Q'/X5R8VA+$8:=*.[5CHPU54:T
M:DMDSFM TK0[6XL[R'4PUV4'[HW"'YF7!&,9[]*S/%/S>(;EM*#^8EO_ *68
M^F.A_0C-=5!X6T:WN(YH;/;)&P=#YKG!!R.]6[;2+&T:X:" !KG_ %I9BQ?K
MZD^IKQ9956J898>T8*][QN^F^JW?7R/26/IPK.M>4G:VMN_K_3*_AIK5O#UK
M]B&$"88=PW\6??-5O$OB$:1$MO;X:\F'R;NB#IN.:TM/TRTTN)H[&(Q([;BN
M]FY_$FHK_0M-U2=9KZV\V15V!M[+QDGL1ZFO2G1Q:P2I4FHSLEUM\M/T..-3
M#O$NI43<;W\_GJ8V@6%G;V=RHO[:ZU*[C;?Y<RL1D=!SSZDU1\+:I9V/A^^@
MNYUBE5V;8YP6RH& .YR*Z2R\.Z7I]TMQ9VOERJ" WF,<9&.A-)<^&](N[DSS
MV2M(QR2&9<GW .*X(Y?B:<:<J:BI1NK7;33ZWM>]SJ>,H3<U/F:E9]+W73>U
MC+\!P-'HLLK<"68[>.H  S^>?RJ/7/\ D>](_P!U?_0C74Q0QP0K%"BQQH,*
MJC  JO/IEG<WT-Y/#NN(?]6^XC'X9P:ZGE\E@Z>&@]8N+^YW9@L9%XF=:2W3
M_%61RVG6%M?>.M3%Y"LRQ[F57&1G('3O3-'A@AU;Q#;%O(M1%(K;1G8N2,_@
M":ZR#3+.VOYKV&';<3#$C[B=WX9QVIL>CV$4]S,EN-]T")B6)W@]>"<5S1RJ
M<7&7NW4I-^:=[+;[S:6/BTUK9QBOFK'#VKP:1>6B/_9^I0-,&CEAP)D.1@G'
M/X'(KT6LRU\.:39W*SV]DBRJ<J2S-@^H!.*TZZ\LP=7"1E&HUKLEK;YM)OY[
M&&.Q,,1).%_._7Y;!1117K'GA1110 4444 %%%% !1110 5B>%/^05)_UV/_
M *"M;=8GA3_D%2?]=C_Z"M &W1110 4444 %%%% !110?NFD]$!X'J7QFU#5
M_$-_I_PV^'@URVL)#'->/ 2&(R,[5'R@D'&3DCL.E=C\*OB59>-;N^TR\\/G
MP_X@T]<W-H\>TE<XR,@,.<94CC(Y->2> ?B!X@^&\FM6&G_#S6+_ $N\O7NK
M=7ADBEA)&-K,(V##A0, =SWP(?#WQ#\3:1\1]=\9W_PVU6]O]5184CB66%+>
M(;1M_P!2Q8G8N6XZ'CFG"VE^WXCJ+5V[_@?5E%8/@GQ%=>*_"-GK-_I$VC7%
MP7WV4S%GBVN5&254\@9Z#K6]3::=F2G<****0PJCJNBZ5KUJMKKFF6>I6Z.)
M%BO+=9D5@" P# C."1GW-7JY;X@7_C+3M @E^'FDV>JZFUTJRPWCA46':Q+#
M,B<[@@Z]SQZ 'AO@W3;&U_X7W]FL[>'[)#>6]OY<2KY,1^U9C3 ^5?D3@<?*
MOH*^=Z]V^'UUXAF_X73_ &M86\'G:9>RZIY; ^1>?OML:?,<K\T_/S?<7YO7
MPF@#TGQM_P D)^&'_<6_]*5KS:O2?&W_ "0GX8?]Q;_TI6O-J /TCKQGXU_\
ME&^'O_<2_P#1,=>S5XS\:_\ DHWP]_[B7_HF.N/'_P"Z5?\ #+\F=>"_WJG_
M (E^9R6O?\C%X*_[&FP_]#-7]5_Y+MX\_P"X=_Z3"J&O?\C%X*_[&FP_]#-7
M]5_Y+MX\_P"X=_Z3"OE*?_(BGZ_^W(^EJ?\ (YAZ?^VLR3_R./C+_LGM]_Z,
MJ]X5_P"1.T;_ *\(/_1:U1/_ "./C+_LGM]_Z,J]X5_Y$[1O^O"#_P!%K6.8
M?\BS#FN!_P"1C7.<_P":=_\ =4?_ &E71^*O^1.UG_KPG_\ 1;5SG_-._P#N
MJ/\ [2KH_%7_ ")VL_\ 7A/_ .BVK;-OXV&]%^:,LL_A8CU?ZE$?\CCX-_[)
M[8_^C*GU[_D8O!7_ &--A_Z&:@'_ "./@W_LGMC_ .C*GU[_ )&+P5_V--A_
MZ&:VQ7_([A\C'#?\BB?S#0?^1B\:_P#8TW__ *&*L>&O^/'XV_\ 8%A_](YZ
MKZ#_ ,C%XU_[&F__ /0Q5CPU_P >/QM_[ L/_I'/6^!_Y'-;T?YQ,L;_ ,BJ
MCZK\F)X5_P"1.T;_ *\(/_1:UEK_ ,FS_#/_ +&E/_1]U6IX5_Y$[1O^O"#_
M -%K66O_ ";/\,_^QI3_ -'W589/_P Q7]?S&N:_\PW]?RC?B;_R3G4_^V7_
M *.2NM^(O_)PEO\ ]BLO_I4]<E\3?^2<ZG_VR_\ 1R5UOQ%_Y.$M_P#L5E_]
M*GK' _\ (FK>K_*)MC?^1K1]%^;*&E?\EV\!_P#<0_\ 28U0T'_D8O&O_8TW
M_P#Z&*OZ5_R7;P'_ -Q#_P!)C5#0?^1B\:_]C3?_ /H8HJ?\B*'K_P"W,*?_
M ".9^G_MJ+'AK_CR^-G_ &!8?_2.>D\*_P#(G:-_UX0?^BUI?#7_ !Y?&S_L
M"P_^D<])X5_Y$[1O^O"#_P!%K1FW_(NPWHO_ $E!EG^_XCU?YF6O_)L_PT_[
M&E/_ $?=4WXF_P#).=3_ .V7_HY*<O\ R;/\-/\ L:4_]'W5-^)O_).=3_[9
M?^CDKMS;_D8X;U7_ *4CDRO_ ''$>C_)F]JO_)=?'G_<._\ 284:5_R77P'_
M -Q#_P!)C1JO_)=?'G_<._\ 284:5_R77P'_ -Q#_P!)C6'_ #/_ .OY#7_F
M2?U_.8/PR_Y)UIG_ &U_]&O5+5_^1/\ C%_W!/\ T8*N_#+_ ))UIG_;7_T:
M]4M7_P"1/^,7_<$_]&"C*O\ D;5_^WO_ $I!F7_(LH_]N_\ I+.XKA](_P"1
M/^#O_<;_ /1AKN*X?2/^1/\ @[_W&_\ T8:X\G_W3%?X?TD=>:_[UAO\7ZQ-
MS7_^1B\%?]C18?\ H9J_JO\ R7;QY_W#_P#TF%4-?_Y&+P5_V-%A_P"AFK^J
M_P#)=O'G_</_ /285M3_ .1%/U_]N1E4_P"1S#T_]M9?^'7_ "<)/_V*[?\
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M-T#_ )-%\=?]AQ?_ $.TKS*Z_P"/.;_KFW\J=;[']=C/+?\ F(_KN=G\2O\
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M?RKL_B3_ ,?/@3_L2K#^;U-/^%(UQG^_423X,_\ )=/"_P!;K_TFDK"\7_\
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MS=7TCX4_YN$_[>__ &\KYNH ])\;?\D)^&'_ '%O_2E:\VKTGQM_R0GX8?\
M<6_]*5KS:@#](Z\9^-?_ "4;X>_]Q+_T3'7LU>,_&O\ Y*-\/?\ N)?^B8ZX
M\?\ [I5_PR_)G7@O]ZI_XE^9R6O?\C%X*_[&FP_]#-7]5_Y+MX\_[AW_ *3"
MJ&O?\C%X*_[&FP_]#-7]5_Y+MX\_[AW_ *3"OE*?_(BGZ_\ MR/I:G_(YAZ?
M^VLR3_R./C+_ +)[??\ HRKWA7_D3M&_Z\(/_1:U1/\ R./C+_LGM]_Z,J]X
M5_Y$[1O^O"#_ -%K6.8?\BS#FN!_Y&-<YS_FG?\ W5'_ -I5T?BK_D3M9_Z\
M)_\ T6U<Y_S3O_NJ/_M*NC\5?\B=K/\ UX3_ /HMJVS;^-AO1?FC++/X6(]7
M^I1'_(X^#?\ LGMC_P"C*GU[_D8O!7_8TV'_ *&:@'_(X^#?^R>V/_HRI]>_
MY&+P5_V--A_Z&:VQ7_([A\C'#?\ (HG\PT'_ )&+QK_V--__ .ABK'AK_CQ^
M-O\ V!8?_2.>J^@_\C%XU_[&F_\ _0Q5CPU_QX_&W_L"P_\ I'/6^!_Y'-;T
M?YQ,L;_R*J/JOR8GA7_D3M&_Z\(/_1:UEK_R;/\ #/\ [&E/_1]U6IX5_P"1
M.T;_ *\(/_1:UEK_ ,FS_#/_ +&E/_1]U6&3_P#,5_7\QKFO_,-_7\HWXF_\
MDYU/_ME_Z.2NM^(O_)PEO_V*R_\ I4]<E\3?^2<ZG_VR_P#1R5UOQ%_Y.$M_
M^Q67_P!*GK' _P#(FK>K_*)MC?\ D:T?1?FRAI7_ "7;P'_W$/\ TF-4-!_Y
M&+QK_P!C3?\ _H8J_I7_ "7;P'_W$/\ TF-4-!_Y&+QK_P!C3?\ _H8HJ?\
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M_P"A-1X._P"0UXW_ .QKO_\ T):/&7_(8\$?]C78?^A-1X._Y#7C?_L:[_\
M]"6C_F.^0?\ -+_]O_J4-4_Y'OQ?_P!D[O?_ $::W?!O_(B:#_V#;?\ ]%K6
M%JG_ "/?B_\ [)W>_P#HTUN^#?\ D1-!_P"P;;_^BUHP_P#O50,X_P"1'@_F
M<G;?\FX?##_L:X__ $?<UI_%S_DENK_]L?\ T<E9EM_R;A\,/^QKC_\ 1]S6
MG\7/^26ZO_VQ_P#1R5S83_=JGS_(]OB'_D<X+UC_ .E(Z#QG_P G&0?]BH/_
M $K:JO\ S77X??74O_2:K7C/_DXR#_L5!_Z5M57_ )KK\/OKJ7_I-2C_ +A+
MU_5!6_Y*NGZ?^V2*G@[_ )#7C?\ [&N__P#0EJ/2.OQO_P"P+!_Z135)X._Y
M#7C?_L:[_P#]"6H](Z_&_P#[ L'_ *134Z_^YP_KN/*?^2EQ7^%_G$TO!O\
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M)_V)-A_-ZQ?"?_)1?"?_ &';/_T:M;7Q*_X^O G_ &)-A_-ZQ?"?_)1?"?\
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MCNO1@2",\$\9H TO 'Q2\1Z[\/\ QT^JW-K/JGANTDD@O[9%*2GRY2K8'RL
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M\*OASXHTSXBW7BSQ#I&E^&XI+5H!INFL-CL2O.U695'RY^]UQQ7MM !1110
M4444 %%%% !1110 5B>%/^05)_UV/_H*UMUB^%O^07)_UV/_ *"M &U1110
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MX;C:<=.1W%?2OBS2I]=\%ZUI%HT:7&H:?/:Q-*2$5GC906(!.,GG -8WPO\
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MM$249DC525) .,CC(%<E\2/A_JOC#QEX(U;3+BSB@\/Z@;JZ6X=E9U\R%L(
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M3J]Q9:O:O9W<3X>-QT]P>X]Q7VAY/K7GOQ@TR!O#UIJ<ME!.]G<#$CJ"ZYZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6-X7_Y!<G_ %V/_H*ULUC^&?\ D&R?]=C_ "% &Q1110 4444 %%%%
M !01D$45Y%\>OB7KOP^L=(A\.M:0RZHTR/=7$1D, 39AE'3^,]0W3I4R:M9]
M1Q3;,'4?V8?"%K%/?ZEXHU*VA7,DL\\D*H@]2Q7 'UI_P<\/_#SP_P#$R\M_
M!7B6]US45T^19MR*8$3S(\X<* QSMQMR.M>=>*/"UQXB^'.I^,M>^)4/B:^L
MT21+"SE+) 7D1,E6P4&&/RB-><5[Y\'_  9X>T'P'HNJZ3I-O;ZA?Z;#)<W>
M"TLA=%9AN8D@$\[1@<#BM()J[?33[T3)\VO?]+'H-%%%2,**** "BBB@#F?B
M!X2T;QGX.NM,\0LL5N 98[AI-GV>0 A9,YQQGH>#7GFD_##X5Z/I.DZ=XRB\
M/#6YH5&4U)T%T<X5T#."=W'08R2!77_%WPMJGBWP;!9:-!%>-!?P7,]A+-Y2
MWL2$EHBW;.0?PKCO%_PET3P[X*U"T\.>';/6-2UJZ^SVS:I<QHVGAU(40R.,
M[4(X0'<<]3TJ5I=VZ_U^?X#>ME?^OZ7XZ=3=\3^&8_"WB_PYXFTO5-#TG3-/
MM%TBY@UF4J@M2P/[IB?]9@$<GD=<]*Y2Y\"Z3K?C;3KWX7^*])GTM-7M]4U+
M0H;Q'5'C?F:(+G;E2<KP#Z\ #1\6^#-=L=:\+ZE=>'(?'EEIFCC3YK&>X10E
MQQF?;("'W 8Z9XSQ@5E>'/A;KUC/X=OX_#VG:)=GQ%+J4TL4T?FZ?9XXM"P&
M9=V6 Y.W@<9.-(64UKL__;OQ7VO^#8F3?+ZK]/Z1[[55YG#L W /I5JJ4G^L
M;ZFI&.\^3^]^E'GR?WOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*
MCHH D\^3^]^E'GR?WOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*C
MHH D\^3^]^E'GR?WOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*CH
MH D\^3^]^E'GR?WOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*CHH
M D\^3^]^E'GR?WOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*X#PQ
M\7_#?BSQI=>&=-2]2[MQ*5FGC18I_+;:=A#$GN1D#@&N[H D\^3^]^E'GR?W
MOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*CHH D\^3^]^E'GR?WO
MTJ.L/QEXML/!'ABXUW5HKB:UMV162V56<EF"C 8@=3ZT =!Y\G][]*//D_O?
MI7+:WX_T#P[X2M?$6L7+6UG>1H\$93=+(77<%"C.3CKV'K5'PY\3=/\ $.LP
M:8^B:_I%Q<JSVQU73S"DX5=QVMD@\#/.* .W\^3^]^E'GR?WOTJ.B@"3SY/[
MWZ4>?)_>_2HZ* )//D_O?I1Y\G][]*P?$WBS2O"5@EUJ\DO[UBL,,$+2R2L!
MDA54'MSGH*A\%>,M/\=^&TUO2(;F&V>1XPETJJ^5.#PK,/UH Z3SY/[WZ4>?
M)_>_2O.KSXRZ##JUU8Z5I>NZZ+)S'=7.DZ>9X8&'4,V1[\@$<5W\;B6))%R
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M D\^3^]^E'GR?WOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*CHH
MD\^3^]^E'GR?WOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*CHH D
M\^3^]^E'GR?WOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*CHH D\
M^3^]^E'GR?WOTJ.B@"3SY/[WZ4>?)_>_2HZ* )//D_O?I1Y\G][]*CHH D\^
M3^]^E'GR?WOTJ.B@"W Y="6.3FI*BMO]6?K4M !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@"U;?ZL_6I:BMO]6?K4M !1110 4444 %%%% !1110 4444 %%%% !1110
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M%7?+3^ZOY4>6G]U?RH I45=\M/[J_E1Y:?W5_*@"E15WRT_NK^5'EI_=7\J
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M%;'7_$GB34K73+_33!$JN]TJ.%3<>@7/)X/?M7I>G?#FPBF$FLK::BRYVO\
M91&SY_OG)S].GK7W9\8<S8_$[P?=W%Q907_V>196$3>4=LG/&T]\^E=9<ZLL
M>ER-I[+=7ODDP6RGYG?' QZ9J'4/A/X.U+5(KZ32$@>/GR[5C"CGL2JXY]QB
MN@TCP]I>A1LNEVBPEC\SEB[M]68DX]LT#,GPSX2^P6-I=:U++=:OM\RXD,S;
M#(>3A,[<#H..U=1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"LS0/^/!_P#KJ?Y"M.LW0O\ CQ?_ *Z'^0H TJ*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "JDFK:=%(T<M_:HZG#*TR@@^A&:MUYHTVE0^)=3.LVTMQ&9Y-@C."#O/\
MM"O)S+'2P:ARV]YVN[V7W'?@L+'$<U[Z+IN>CP7,%U'YEM-',F<;HW##/U%2
M5S#7@TSPK'?^'+15MV<N\<^YB!G&?O>H]:DMO$LNJ:M:6VEQ1M&T8DN7<$^6
M.X&#U[?4BJCF-*+C"H_>:6VSOV[H3P<W>4/A5]^ENYT=%<H?$VK:A=3C0=/C
MG@A."\A^][CD?ER:GM?%,EUX?OKH0+'=V8^>-LE<GH?7UX]J(YKAI-I-]6G9
MV=M[/K8)8"O%7:73JKJ^U^QTE%<8WBS6FT];^/3(OLJX$DC9P3T..>!GCO75
MV%XE_I\-U&"JRH&P>WM6N&Q]#%2<:=[VOJFKKNB*^$JT(\T[=M'?46XO;6TQ
M]JN88<]/,D"Y_.I(IHKB,202)*AZ,C @_B*Q]5T'29I+C4=3WGY/F8R$! !C
MC'?\ZYOPW)=6/A[5[V,LL6S$6?[_ ",CZ9%<M7'UJ&)5.I!<K4GH[M*/5JW4
MWIX2G5H\\).ZLM5I=]%Z';/J-C'-Y,EY;K+G&QI5#?EFK-<!;:#9S>"9-2D#
M&Z(>0/N/&&(QCH>GZUTWA.Y>Z\-VS2DLR93)/4 \?IBG@LPJUZJIU8)<T>96
M=]//S%B<)"E!SIRO9\KTZ^1LT445[!YP4444 %%%% !1110 4444 %%%% !1
M110 UW6.-G<X5023Z"N;_P"%B^%O^@I_Y+R__$UO:A_R#;K_ *XO_(UXSX0O
M?LME<+_PB']O;I ?-\G?Y?'W?N-]:[,/0C4A*4KZ>:7YGDX[&5,/4A"%E>^Z
M;V]#V:QOK?4K&*\LI/-@E&4?:1D?0\U8KAO%&J:MX;M=)U+3(UMM+PBW-@L*
M 1D\XSC(SDCM@@>M-TK5_$/BNZU:[T:\6TL(QY5DLL2X9^/F)VD].2/]H5/U
M=N/.FK?UH:_7HJ?LFFY]DM]+W6NWXG9VM_9WV_[#=P7/EG:_DR!]I]#CI5BO
M)?AK;ZY)?3R6%Y!%91W"_;(G4%I.OW?E/OW%6M(UWQMXBN;R#2[R!1:RDM++
M&@P/X4'RGT/;\:TGA+2:4E9=S"CFBE3A*4'>5[)=;=M3U"BO/M?U/Q7!JMYY
M6LZ5I5M$28(IY8]\JCI@$,<GWQ3M.\>7?_"N[C6+Q(Y;R&X-LF!A78A2"0/9
MOTK/ZK-Q4DT[_J;?VC24Y0DFK)O5=OQ._HKA="D\=W$VGW]Y<6T]A=,K20A4
M5DC/.[@#L<XR365=^,M;UC6;R/1]5T[2;6U8JGVN1%,V">?G!R3CM@#C--86
M3DTFM!2S*G&"E*$E?96U?6^YW'B?71X<T.34#;_:=KJHCW[,Y..N#_*LS4_&
MPTZUT&;[!YG]L(K8\['DY"'^[\WW_;I7(ZGXEN?$?PSO3?A/M-K=1H[QCAP3
MP?KUZ4_Q/_R#? ?_ %Q3^4-=%/#15HS6MW^5SAK9A.2E.C+3EBUHNLK,]5HK
MC4U[4C\5I-&-Q_H"P[A#Y:]?+#9SC/7WI;77M1D^*MYHSW&;".$,D6Q>#Y:'
M.<9ZD]ZY/J\OPO\ (]/Z[3[/XN3Y_P"1H>$_%0\41WC"S^R_9I G^MW[LYYZ
M#'2NAKS#X>R7L7A_Q ^EHCWBR*8ED("YP>N>*K7WBOQ3HHAN[K7-*OE:0*]G
M \;LO?Y@H! XZ@UT3PO-5E&G96_R.*CF7L\/"=9-MWNTE;>WE^!ZQ17 >*/$
MVNV_BO3[#077%[9JZ0R(I&]BPW$D9X '?'%=9X?BUB#2]GB&XBN+P2-^\B "
ME>W0#^5<LZ+A!2;6OWGH4L7&K5E3BGIUZ&G1116)UA1110 4444 %%%% !11
M10 4444 %%%% !52PU;3M4\W^S+^UO/);;)]GF638?0X)P:MU\NZ!XMN= T/
M7=+TP^7?:Q=I"D[':L*?,&.X\ _,![9)[5G.?(U<[<+A'B(RL]5;\?\ (^BK
MGQ=X?M--O;^35[1[:P*BZ>"02F$LVT!@F2"3QC%7M-U*TU?38+_3IA-:W"[X
MI I&X?0X(KSZ^T*U^&'P<O\ [/9V>I7"B)KH7D6^*X=I$7E>,J,\#VJMJ_Q(
MO/#'@WPA?66EV7EZD@,]M#&45% 4E8@#\I^8XSFESV^(KZJJB_<ZZM)^BN>J
M45Y1;?$[Q5IWBS2['Q?X=@TVQU60) 5)\Q,D#).X@X)&1@$9K<\4^(_'5OXA
MDT_PAX8BO((HU8W=T<(Y(R0I+(..G4T_:*US-X2HI*+:U5[W5OO.[HKS/P_\
M5KF]\(^(=0UC2TBO]"VB6&%B%D+$J!SG'S*<\GBF^"_'OC'Q!JEC+?Z#9'1K
MUF475E)O:#"DC?AVV\@#Y@O6CVD78;P=6*DW96\UVOI\CTZBO++[XD>*=8\0
M:A8?#_0+?4+?37,<\]PWWB"1\OSJ!R#@9).,UU'P^\:_\)KHDUQ-:_8[RUE\
MFXASD!L9R,\X/H>F#34XMV1-3"U:<.>7YZJ^UT=71115G*%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 5[^RAU+3KBQNU+07,312 '!*L,
M'G\:\@L/%MIX'\/7/AC5?M$M[I4Q@*0P,V^$G*29 QRI'6O9ZSY-#T^74S?O
M;@W#;=QW':Y7[I*YP2.Q(H ^?=5CAO/C#HFI7FE7>B:?<!&$E_#Y(F*J?P&1
MCCK5/XGZCX=BUZX3PI LMUM\V\FBN66+TX (#'U(KZ#\4^'T\06%NABMY9;6
MX6XC6Y3<C$ @@\'&03V]*\MU[P_<:=XE?[?H%FEG>1"!)$7,2YX^\!P?8@>U
M '%?#?Q1:/#/8:I)J%Q.[JUM8,[20LW8Y[ ?[1XKT6PM=5/C!;"Y\5));W*E
MFM(H%'_  W4#WK*7X#:=>ZC##:ZE>6=F LLXW9:4'.50\;3D=3GKTK!U[2M7
M\#^/]$M-*L[B]N+5Y#!(_P#R]6Y/ 9^F1T/H1[T >KZMIOAZP*76K6T!\K/E
M^:N[!'IGO7D_Q)\1Z1K\D*:;" ULV3*H Z>XI_Q$NO&GB.SEO+K0KJPTDIGS
MD*R!%S@GCD9/<]O:O+(["]5EADGD2)C\LF#M/MFL*K;7*CU<!3A"2JS5^UK;
M^9J7%B]_*%M_FG)#&3;EN>@%=EX9\+SV3M;W^GS3W5RBO'*PSY8YXP.F>/?B
ML_PKHES>:@1:%9O+4/,7 /R]"0/6OH;2Y[<Z6CV^U5B08P.3@5R>P=>FX7LC
MU\9C(86::C>3W5]NQX[/IMS._P#86O:5,TLGS6TIB)4'L2W;%,U3X=WF@^#Y
MM5O;CS+V.=1Y4)W1^4W .<9W9KUNPU:[U*%KUX(A!O*@;LR  XR?2M Z3;ZS
M8ZCIUZKFWGV@LK;2. 1M/8@\UMA<)#"J2@]SY[$XJ6):<EL?,<<"7ETL$\R6
M@Y.^8$ $=OK7JOPT\/>'M4T6>XM[#^T-19C'+)=Q I$1Z'&.>O<UW=G\-/"U
MK&1/IJ7TK'+S79WLQ_E^0KH['3[/3+1;73K6*U@7[L<*!5'X"NNRO<Y;NUC*
M\,^'8=!BE$5E9VC28W?9<X<^I) _*MVBBF(**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#%\9:C<Z3X+U:_L)/*N;>U>2)]H;:P'!P>#7FD/Q3U6
M#X76$K3?;O$VJ3206P6)<C#[0^Q1@]@!CD^N#7H/Q#_Y)QKW_7E)_*O!]#LK
MWPOHGA[Q]9Q_:[>">2"ZBD^;RQO8 C/W<@D9[-CUKGJ2:EH>S@:-.I1O):\V
MGGIM?S/3_$B:E9>#]$C\6^.;C1M3DN"9+BTMR?-8C_58BVC ]3QFNQU/QGX>
MT;56T[5-4BM;I8//*2*P 3IG=C&?;.3Z5YM\9-4M-:\-^%M1TZ42VUS=%XV]
ML#@^XZ$>HIOBK2;+7/VC-)T_5(1/:R6@9XR>&VI*P!]LJ*.9INWD*-"-2$74
MTTD[))6L_0]*\/\ C3P]XIEEBT'4X[N2$;GCV,C 9QG# $CW%4M2^)O@_2-0
MDLK_ %N)+B-RCHD4DFUAP02JD UPUEIUGHO[2D5KI-M'9V\EFS-#"H5,F(DX
M X'(!XKF;[6],U>#Q#+IFC>$].A5Y=S:J[/>3,<_-$.H;/( X!H=227F$<%2
ME/2_*TGTZ_UV/=9?$NC0^'QK<FI6ZZ8RY6YW?*><8'J<\8ZYJKX?\;>'?%,\
ML.@ZFEU+$N]X_+=&"YQG# 9&2.?>O(-'TW3M8^ MI9ZMJ\>D@ZLWV>><$QF3
M:V%;'0$;N>Q'X59\&ZN;;7=6TE-.T9]6329UM]4T,J$EPH8 A/E)) YP"",8
MYI^T=T*6!@HSLW=-_=W\_DSTN_\ B9X/TW4FL+S7(%N$;:RJCNJGT+*I4?GQ
M72V]Q#=6\=Q;2I-#(H9)$;*L#T((ZU\R^%+>*]\)WML\W@R%I6</+K+R)>)Q
MU1A^FWOUS7M_PLLGL/AUI]NU]!?(ID,<\&[85\QN!N53USV_2G3J.3U,\9A*
M="%XMW3MJ:GB#QCH'A7RAKVI1VC2C*)M9V(]=J@G'O7F_AK4[35_VCM4OM-N
M4N;6:P4QRH<J1Y46?USQZU4UDZ.?VBKG_A,?L_\ 9XMD^S_;,>3GREQG/&-V
M_KQFHO!W]E?\+VUC_A$?)^P_87^S>1]S=LCW;<]M^[V].*B4FY+U.BEAX4Z4
MFKW<+WZ:V/3-7^(_A+0M0:QU/68HKE#AXTC>38?0[%(!]C6BWBG1!X<?7AJ,
M3Z7&NY[F/+@<XQ@ G.2!C&:\7^%I\%-H^KMXW-@=3-PQ?^T=N[R]H^[NYW;M
M^<<]*I^'%<?!KQPT <:>;B,6V[I]\9_'&S--57N3+ 4T^57T:3[._8]>E^*/
M@R">"*37H \Z*Z81R & (W$+A>".&P1WJ:3XC>$8M9&EOKEM]K9P@ W%-Q[%
MP-H_.O)]7\,:-:_L]66JPZ?"NH.T<C76W]X2SX(W=<8[=*7QKX6T;3?@?X?U
M&RL(8KV46\DER%_>.9(BS MU(ST';'%'M)_J-8/#-I7EJW'INNOH>QZ_XOT'
MPN(_[>U*.T:4$HA5F9@.^U03BF:/XNT'Q197+Z%JL<XA0F0JK*\8P?FVL ?Q
MQ7FWC+7[!_$6@V$VD:-<ZE)IL;M?Z[(1;1*P)P5S@\@G)]<5D_#5PWQ.\2[/
M[."G2ICC2@1;9W1?ZL'MU_6G[1\UC.."C[!S=TTK]+;G>>"=;TO1O!.H:O>^
M,;G7K"&ZQ)?7,$H,)(0; K98\LO3CYJU9?B=X-ANXK:37K<2RA2N%<J,C(W,
M!A3[$C'>O(M!_P"3:?$W_833_P!"MJO:_P"%M%L_V?[#5+?3H4OW6"5KK;^\
M9G;#?-UQSTZ5*J22T[7-IX2C*H^=N[ERZ6[+R/>00R@J001D$=Z6L;P:[2^!
M=!>0[F;3;<L3W)B6MFNA.ZN>+*/+)Q[!1113)"BBB@ K.T/BQ?\ ZZ'^0K1K
M.T7BR?\ ZZ'^0H T:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N%MIM2T;Q'J=S'H]U=
M)/*X4JC 8WD@@[3FNZHKAQ>$>(<)1GRN+NG9/RZG5A\0J*E%QNI?UT.9U'5=
M2O?#KB'2KF&YN',/E[&;:N.6/ QG.*I:9IE[X:\00+'%+<VMS&JRO'&6"-WS
M@<8/Z&NSHKGGEKJ5(UIU&YQM9Z=-]-M>IM'&\D'3C!*+O=?E]QP^G'6/"\ES
M:QZ5)>1R/E)(P2/0'@'\N*EL]&OX?#.KRW$+"YO<,(5&6X)/0?4\5V=%90RB
M$5RN;<4I**TTYE9^OS+EF,I:J*3;3;UUM^1RWV.Y_P"%<_9OL\OG^7CRMAW?
MZS/3KTK7\/120>'[..9&CD5/F5Q@CD]JTJ*[*."C1J1J)[14?NZG/4Q,JD'!
MK>3E]YQ7BEM3O-8%M]@NI]/A*G;"C 2G )^8 ^N*T+.:?5]-N=*;1I=,B^SD
M1L^=N>PY4=^:Z6BN>.6R5>=5U&U/=66W:^]D:O&ITHP4-8[.[W[VVN<%$^N6
M^A/H?]D3-N)43!3@ G)&<8]><UUNAZ>=+T6WM7QO127(_O$Y/\\5H45IA,O6
M&GSN;DTN57MHNVA.(QCK1Y5%*[N[=6%%%%>F<(4444 %%%% !1110 4444 %
M%%% !1110!#=QM-93QIRSQLH^I%>9^'--\=>&+::"PT6UD69][&:9"0<8XQ(
M*]2HK>G6=.+C9-/N<>(PD:\XU.9Q<;[6Z_)G":WI7B3Q2-(L=1LTM+0$2W[Q
MR+@-D_*!N)Z?7EO:IO">@ZOX9\1WUFL!DT2=B\4WFK\A[<9ST^4\=0#7:T53
MQ$N3DLK?UJ0L!3555N9\RZ_*UMMCSSPQH7BCPWK\UO#:P-I=Q<!I9RZD[ 3T
M&[(.#Z&M'P#H&I:)/JYU.W\D7$RM$=ZMN +<\$XZCK79443Q,IIII:VO\A4<
M!3I2BXM^[>WS^1Y7<^$/$EOKFI/!IEAJ4=[(Q6ZN]CF,$DY 8\'GT-7]+\#Z
MC)\/;[1[Y%MKMKPSP9<,IPJ@9*YX.&%>BT5;QE1I+3I^!E'*J$9-W;O=6]=^
MAPF@IX[@ET^PO;>V@L+9E62;<C,\8_AX)[#'0&LJ?P=KNBZU=RZ5I&FZQ:7#
MET%XB.4&2<?,00>>QP>*]0HI+%23;26I4LMIRBHRG)VV=]5Y;6_ \]N?#&MW
M/@&[LY-/LXM0FNED6"T2.)0@QP2, G[QY)Z]:?KOAC5[VQ\)1VUKO;3HU6Z'
MF*/+($>>IY^Z>F>E=_126*FG>RZO[U8;RZDXM-O5)?<[]NYP7B+P_P"(+;QL
MGB#PW#%<LT85XY&4;2%VD')&01CH<TGASP]XA@\>/K.N1QMYT!WRQNN Q  4
M#.> ,=.W6N^HH^LSY.6RVMYV'_9]+VOM+O?FM?2YYMH_@[6HO"6OZ=/$MM<7
MCH8295(<*<D94G&1QSZUC7'@OQ1<Z1%9_P!A6$'V<@^9$8Q-,>GS/N.>O3BO
M8J*M8VHFW9:ZF,LHH2BHW>BMTVO?L<1?>'=4F\>:%J,=MNM+2UCCFD\Q?D8;
M\C&<GJ.E=O117-.HYVOT.^C0C1<G'[3N%%%%9G0%%%% !1110 4444 %%%%
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M181$$'EA=NW'&/2JE_I%AJ>DRZ;>6L4EG*A1HMH  ]O0U=HH \VU#PE%\/\
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M&GV%O96<?EV]O$L429)VHHP!D\]!4U%%,AMMW84444""BBB@ JAH_P#QYO\
M]=#_ "%7ZHZ1Q:-_OG^0H O4444 %%%% !1110 4444 %%%% !1110 4444
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MIDQ1%MA$C,XQP[?+D!L9X8=>@%3:QXX^(N@VFF^*-3-E'H]_*NS3XT4E5(+
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MW2]TMHW2)EC9\!D50?N$$$9Y!H ]XID\\5M;R3W,J0PQ*7DDD8*J*!DDD\
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M5>*%@M75DM3J($) .=I0(!M/<>] '+?"Y)Y-:\>Z>MY]AU^2\8BY:(2,@W.
MX5N& 8YQTY'K4NEZ[XFC\=^*O"FOZY_:]O8Z-),LGV..#+E(SG"C/ D(ZGUK
ML?$/PYT3Q#JRZLSWFFZFH ^VZ=/Y,K8Z9."/QQFF:%\-=&T*ZO[Q+G4;V^U"
M!K>>[O;GS)61L9&< 9^4<X[4 <%\'O\ A-O^$-M_[!_L#^ROM;[_ +;YWG]1
MNQM^7Z5627Q-#\;O&,G@Z.PEO$M\NEZ'.Y<1\)M_BSC&>*]:\)>%;'P;H*Z3
MI<MQ+ LC2;KAE9LMUY  _2HM-\&:=I?C+4O$MO-<M>ZD@25'=3&H&W[H"Y_A
M'4F@#C/@S<Z?'X/UG7KB[EDOY[F2?56E4+Y;+EN!Z88G/J3TQ4OP<MI=4&N>
M,KU,3ZU>,(<_PQ(3P/Q./^ "CQ7\.[G3M#\0'P/%=37OB*55N;9IXTAB3<69
ME!"^I7&3P_2N]\/:/%X?\.6&DV^"EI L6X?Q$#EOQ.3^- 'BWPE_X3/^S=8_
MX1+^P?L_V]O-_M/SM^_ ^[LXQC'6J'A[[1_P@/Q.^V^7]H\X>;Y6=F_>^=N>
M<9SC->T^$?!FG>"[2[M]*FN94NYS.YN'5B&( P,*..*S[;X9Z+:Z;X@L8[B^
M:+7W+W1:1,H<D_)\O'+'KF@#!^%FC>)1X8T*^;Q7G2?)W?V7_9T?W>1M\W.[
MKSFN4M)_%%K\5_',_@Z*PEN(U+2I=ARS*#QY87@MGUXKT#2OA;;Z,]I]B\5>
M*%@M75DM3J($) .=I0(!M/<>];.D>#-.T7Q5JNOVLURUWJF/.21U,:\Y^4!0
M1^)- '(_!>72X/ 5[K)O6:XGN9)M3DGP@BD R?PP<Y[Y[=!E:)#<_%+XHP^*
MFA>#P]HK;+)G&#<2*<@_]]$,?0 #KFNJ?X3:&;'6[.&\U*WM=:F6:XABF0+&
M5<L @V<#)Q@YXQZ4W3?A5;:2MO'8^+/%45O;L"ELNI 18!SMVA ,'TH [NBB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^?OB]X=^*OCV[ETF'PQ
M9/HMG>M+97$-S$DLJX*@MOF]#_=%?0-% 'B^N>$OB!\1_A'/I/BBQL=&U>TO
M8Y;2&&4>7<1(F,.0[X)+-W'*C@=:YS6_!_QA\>Z'IWA;Q#H^CZ9IME(A%XLB
M9;8I0'"NQZ$\*JU]%T4 5M.LQIVEVMDLC2+;0I$'<Y9@J@9/OQ7FOPC\%Z]X
M6\6^.+S7+(6UOJM\DMFXF1_-0/,2<*21PZ]<'FO4Z* /)O@WX(\0>%-"\36V
MOV(M);ZZ9[=?.1]Z[2,_*QQR>^*P/"?PC\1-\ ->\)ZS;QZ=JEYJ!N[97F5U
M^58=N2A(&3&P]LYKWBB@#YNU3P3\8_$7PUC\,:EIVG066E)$EO DT?GW@0A5
M!?>5 5<G)VD[>^:Z_P")GP[\1Z]\/_"4>@012:QH(B+6[RJN2(U!PQ.TX9!U
M/([^OL5% '@_CGP;\2O&_A[P[JNIZ7IDNJZ;<RR7&B^:!#(I*[,Y<JW"D$;^
MAX-5_!?PY\:VWQDT/Q5K?AO1]'LHXIEF@TCRHH[?,,B*"BL26)8<C=[GBOH"
MB@#RSX9>"]>\.?$KQUJNL60@LM6O6FLI1,C^:IED;.%)*\,.H'6L[P%\.->L
MI?B7;:Y:+9P>)&>.SE,R/O1OM W81B1Q(IP<'FO9** /$_ACX?\ BGX7\/:C
MX:N;'3K&S@L[EM.O3*DCFZ?F/HS?(&)/S)^?2L ?#CXB>+/&VDW_ (A\.Z%H
M#6%VD\^JV)5);G:P))".VYOEXRJ]>M?1=% !1110 4444 %%%% !1110 53T
MW_CV;_?/\A5RJFG?\>[?[_\ 04 6Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?&/CS2_!!T_^UH;N3[?(T<9
MMT5MI&,ELL./F'3-=-7B_P"T+_S*_P#U\R_^TZWH052HHR,:TW"FY(]HHKRO
M4]9U./\ :4T?2X]0NET^2S9GM%F81,?*E.2F<$Y /3L*2XU?4O\ AI*'2?[1
MNQISV)+6@G81$^4QSMSC.><]:?L'WZ7%[9=NMCU6LKQ%XFTCPIIR7^OWGV2V
M>40J_EN^7() PH)Z*?RKPK6/&?BCP#J?B+PC-J=UJ,UTRC3[VXNB\D ?'.YC
ME3L/MAAGOFK/QA\+:IHW@#09]1\07M^89$M[B"XE>19)V61S+N9CT *#CIWK
M6.%7-%2>CV,I8A\K<5JCW^.198DDC.Y'4,I]0:=7DUYH>N>%OAF$F^(30-<7
M4<C:A?EPT4)C/[F/YF).0#@8X!Z5QWAKQ;?Z7\2M$L=+\=7GBBQOIEAN1<QR
MHJ;CMP!(3]014QPW,FXO;R9;Q'*TI+?T/HJBO#+J7Q?XE^-'B'PUHWB:ZTRT
M"B21][-Y,:A!^[7(P2SCH0??USO#$/C_ %_Q#K/@U?&=Q;QZ9*YFO69GE;:V
MT!6R&P3SC=Q_,^K:7<EM<7UC6RB^Q]"45XCX*\?:YI?@7QC_ &Q=MJ5YX?=4
MAEG8N2SLR#+'E@&7//-<0WC35ET<:ZOQ)O&UO>'.D>1-Y>-W3./*Z<XQCWJH
MX.;;5]A/%123L?4M%>%>+_%OB?4]8\#-H.HRZ==:Q8KNB$A$/FR':69>A SD
M9!QQ5&^C\?\ ACXCVWA.U\97%[+K%NK+<W19EB5BVXA6+;2-C8Q[=.R6%;6L
MDG_D-XA)Z)GT'7!_#7QSJ/C.ZUZ/4K>UA73KD10_9U8$J2_WLL<GY1TQ7+>"
M[[Q)X8^,DWA#6]?N-;MI[8R))<,S$';O!&XDKT(QG%<K\/\ PUXC\2ZAXF@T
M'Q))H-M'=[IF@#>9*^7VC*D$ <YY[]#5*A%1ES/HFF2ZTG*-EWT/H^BO"/#O
MC/Q#<?"WQK9:EJ,[ZCH858[U9#Y@W,RXWCDX*'GKS6AX$TSQIJOAVW\6WWC1
MX8A93I!:W#L8@!&Z++*Q.,AP')(/3KVK.6&<4W)[:?J6L0I-66Y[/17S!K7B
M34=%@6^T[XJ7>K:HL@WV44<_DX[D,WR,!Z8KM/B)XF\2MJ?@7^P-1DLKO5K=
M28TD*Q-+)L ++T8 MW!JGA)72OO?OT)6)5F[;'M=%>'PS>+? 7Q8T'3=6\3W
M&MVVL$+*DQ;:I8[3A6)Q@X((QGT[5G>,?'%YJ_Q%U+2;OQC<>$]*TYVBC>VA
ME=Y74X.?+P3DYZD  #O26%;>CTM>^HWB$EJM;V/H&BO*/@KXOU+7'UG2=3U)
MM6CT]U-K?LI#2H2PYW -V!&>>3FO5ZPJ4W3FXLWIS52/,@HHHK,L**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4</W#]:
M** )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>bdtx-20211231_g18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g18.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &X G # 2(  A$! Q$!_\0
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MK%FUCF(J_P YEE^3:['9N/5CMS6#;>*/AG?:?!X>L]'AOK!XH=073+/PW//
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M A+$8XKO_A/X=UR3Q#J?B?QAI-]:^*;N 6_FRRV[6EO;[]PM[<13.V,@,6<
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MVTN[:*WO[BTFMEO%,TX 59(TW;8TB.]-R'S1AB037J5 !1110 4444 %%%%
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MG@'CC%_;NU6T^%_A?QCK?@O0?":>)M06STZ#Q-XBO=+BCC%C->2RSS7.EQC
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MV8X_#^EVA;7'U+4[6/3UFOX[%([NZ%G%,R@-Y@57:[G>XS]T$[2#]^JO[/\
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MR9CE;?$TEU:I&_RXW-/&,,P!)8*?3?A';I9_"_PM!':QV21:="BV\*0HL8"
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M4\L*,Y)KWV@ HHK+U[6FTNRN6M88[Z_BB\U;,W"0DIN +LS'Y4')+<\ X!.
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MBBB@ HHHH **** "BBB@ HHHH **** "M6LJM6@!:*** $;[IK*K5;[IK*H
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MWA'3_$3:8URC(VGWJ7T)BVC,B!@ V0<J0QR* ,'_ (7M\-?^BA^%?_!W;?\
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MT^%NBV=CHUI&)_+TG4YM6MRS+N\V0S%E;Y>4_P!(D '7 '/'(!6_X7M\-?\
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MG3;MXQTQ5'P?X&T+P#ITUCH&FPZ;;32^?*(R6:638J!G9B68A(XT!).%10.
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M#ZYHKXJ\6?MF>-M2L_%-WX$N?!MYI^EW?B1[+4;BTGO;>\M--TVSO(MK172
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M!I?:(_[XH^T1_P!\5FT4 :7VB/\ OBC[1'_?%9M% &E]HC_OBC[1'_?%9M%
M&E]HC_OBC[1'_?%9M% &E]HC_OBC[1'_ 'Q6;10!I?:(_P"^*/M$?]\5FT4
M:7VB/^^*DK)K5H 6BBB@!&^Z:RJU6^Z:RJ "BBB@ HHHH *\F^+7Q5U#P+XV
M\,:9#$?L-[&TKK'Y7GW<GVFV@2",2,,_Z_+! S8P1C&']9HH ^7=/_:$\374
MUJB:[H]XKV,&HPO':A1>W4AM=^F+^\.UU^T'&,R#S(L@[&W^[W7Q2\-V/C*P
M\*W%Y/%KE].UM;0-8W&R218)+@J)=GE_ZJ*1LEL?+CK@5U=>>?$__D=OA%_V
M-$__ *9=4H ]#IDT\=K#)--(L44:EWD<@*J@9))/0 4^A@&!!&0>"#0!\O\
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MY_:,TGPA-\+]#UBR\.V%S)YUC)J$>GW=U(^SRKIHFD4K&H#*!(5D4LQ**.:
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MX<Z7X1TG4%T'0K+4=0U >7>S:S=.TMZA)W">X9)9''S-A6!49P,"CX0^$9_
M/@#2/#LVDZ1HZZ;;QVZQ:+(6AD(0;Y,&*/:S-N8C!ZYR2: .SHHHH *TX?\
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M ^,'C#]MF\^$ND^'-+TO19]3FTNVBU?2YS=VD2!F%W*HE4DE%W[#M&& R.M
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MW]OU&_:WTYV>VMA=7T]RMO$S*I*1+,(U)5<A!\J]!A:C_P ))_POCPE_:O\
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MG*E&516DTKKL^J"BO%/V@?VD(O@[X;2ZL-&O-1U&2\^R*+VRN+:V& Q9O-9
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M_%+5_B'XE\5V^H?98;#3YFBL85TZ:WFD1;JYA\_>\KK)&PA0 A5(=91@C:2
M>KUXS!_R>1??]B%;_P#IPGKV:O&8/^3R+[_L0K?_ -.$] 'LU:M95:M "T44
M4 (WW3656JWW3650 4RXN(K6"2::1(88U+O)(P554#)))Z "GU#?+')8W"S0
M?:H6C8/!L#>8N#E<'@Y'&#ZT ?,7P$DDC_:.\8QZ5J!U'PW=1ZI>L([G4%@A
MGDOXG7RXIM5N+>3?OF8RPVL(&.-@DV'ZCKY1_9MOIIOCYXGB9%T56M=1F&CZ
MA;+8WCP->PFT:&T:SAD2*&(^5(ZR2([LAR_#5]74 %07=A;:@L2W5O%<K%(L
MT8F0.$D4Y5QGHP/(/45/10!S=O\ #/P?:_9_(\*:'#]GF^T0^7IT*^5*-GSK
MA>&_=1<CG]VG]T8P/B?_ ,CM\(O^QHG_ /3+JE>AUYY\3_\ D=OA%_V-$_\
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M,YP,>M/IOB'X> ^<;ZUTY3G^T/#D37EFJ@'B73I"\D*]/^/9F!.6.P9KQ/\
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MBYCD+I++),\K,N54A<OPN.!QEOO'UBBB@ HHHH **** "BBB@ HHHH ****
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ML=R26P4445@,\W\;>%[[P[JX\6^&V2*[CXN[60E8;B/)+*^.BDDMN )C8F0
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M(7[15GX[TO6[3P[X9EFM[G4-'M+3RG$D04-Y!3:J^9L!+<$,SMR37U(GP4\
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M,'&TC=Q'_%]3?LX_#.7X.? OP7X+GFFGN-'TY+>:2=45C)DLW",RX#,0,$\
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M0L..:UO#?PG\)^%=3_M2RT>.;6MNPZQJ$CWM^RX VFYF9Y2O ^7=CVK5\CQ
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M]V[M^;?5OJSR:DW4FYRW;N>;_%CXL2> ])CEL-/DN+N2X\G=>6\J0K@$D[B
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M"EJJD%2/F;JLC2+W[.S'\?2@#3HK+A\+Z5;M&T=FJ-'Y>Q@3D>66*=^Q=_\
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MNXHH X?_ (43\-?^B>>%?_!);?\ Q%'_  HGX:_]$\\*_P#@DMO_ (BNXHH
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M%FF__(]>A44 >>_\*\\8?]%3UO\ \%FF_P#R/1_PKSQA_P!%3UO_ ,%FF_\
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MQ.-6OXK"ZC-IKFHVLUI'=A][-'%#-;Q,HB 0%AO1MXPV0P !['1110 4444
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MV^T7-LYD@>78HW[7.X9YS]3GI_#WA'0_",=W'H6BZ?HL=W,;FX73[6. 32D
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MR_W?U%'V67^[^HHHH /LLO\ =_44?99?[OZBBB@ ^RR_W?U%'V67^[^HHHH
M/LLO]W]11]EE_N_J*** #[++_=_44?99?[OZBBB@ ^RR_P!W]11]EE_N_J**
M* #[++_=_44?99?[OZBBB@ ^RR_W?U%'V67^[^HHHH /LLO]W]11]EE_N_J*
M** #[++_ '?U%'V67^[^HHHH /LLO]W]11]EE_N_J*** #[++_=_44?99?[O
MZBBB@ ^RR_W?U%'V67^[^HHHH /LLO\ =_44?99?[OZBBB@ ^RR_W?U%'V67
M^[^HHHH /LLO]W]11]EE_N_J*** #[++_=_45=C4K&H/4"BB@!]9UQ_KG^M%
M% $5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
I0 4444 %%%% !1110 4444 %%%% !1110 4444 %:M%% "T444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>bdtx-20211231_g19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g19.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,R
M-   DI(  @    ,R-   ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2JE%
M%OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2
MJE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'
M_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ
M4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_
M +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6
M_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J
M44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?]
M[]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1
MY\?][]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\
MO?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\
M^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI1
M0!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WO
MTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'G
MQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]
M^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX
M_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2JE%
M%OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'_>_2
MJE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ4>?'
M_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_ +WZ
M4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6_/C_
M +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J44 6
M_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?][]*J
M44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1Y\?]
M[]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\ O?I1
MY\?][]*J44 6_/C_ +WZ4>?'_>_2JE% %OSX_P"]^E'GQ_WOTJI10!;\^/\
MO?I2K*C-A3D_2J=20?ZY: +=%%% !1110 4444 %%%% !1110 4444 %%%%
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M.PH ]-\6?$[P?X'U"&Q\4:RMC<SQ>='%]GEE)3)&[Y%.!D$<^AK"'[07PQ+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !4D'^N6HZD@_URT 6Z*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@#YX_:U_Y!'AG_KO<?\ H*5TG[+_ /R2*3_L)3?^@I7-_M:_\@CPS_UWN/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "OGKXI_L_>)/&WQ)U#Q#I&IZ5%:WHAS'=/(KH4B2,\*C _<SU'6
MOH6B@"MIMJ;'2K2T9@YMX$B+ 8SM4#/Z59HHH \;^.'P?UWXEZKI5WH5[I]N
M+.%XI%O)'7.6!!&U&_I7HG@3P_<>%? >D:'>RQ37%C;+%(\6=C$>F0#C\*Z"
MB@#YW^(_[/'B/QC\2M1U[3M5TN&QOGC8B=I!+'A%4_*$(/W>/F&?:O5_BAX
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M21^[HP'!/<'@G)S7OE% 'R-!\,?CS;Q+8V]QJ\-HORJJ:^JQ >RB7I^%>P_
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M7MY/I.A,W[Q7U0/;X)Y(AC<Y/L0,^HKKM!_9OU?PW\4M,UG3M4L9-%T^ZAF
MFD?[0X4 M\H3;DL#CYN :^B:* /-_C9\.=4^)/A6QT[1+JSMY[:\$Y-VS*K+
ML9<956.?F]*G^$OP]N_ WP[F\.^();6\DN+B6246S,8RCJ%VY8*>@].]>@T4
M ?)>O?L[^/?#/B1KOP)*;V!)"UK<6]XMM<0J>@8LRX(SC*GGKQG%:L?[-OB_
M7]#O-2\4ZZDGB.4(MM'=W3RJ@##<99<,2<9 "Y'?-?3]% '!?!WP)J/P\\"'
M1=8N+6XNFNY)RUJS,@#!0!EE!S\OI7F?QL^!&N^)O%TWB;P@L-TUXB_:;-Y1
M&X=5"AE+84@@#()'/KGCZ)HH \,^"?@7XD:%XJEU+QY>W0LH[%K:"UN=1^TG
M)=", ,RJ %/?T]ZSO%'[/_B76_B]/XHM=2TI-/FOX[K9))()0JE21M"$9X_O
M5]"44 8'C;P=IWCOPI=:%JX8138:.5/O0R#[KCW'IW!([U\RS_ 3XI^$=4DE
M\(7+3AB56ZTS41:NR?[09E(^@)_&OKFB@#Y6\.?LX>,?$>O+?_$._P#LL+,&
MN"]U]INI@/X=P) ],ECCT-?2QT2VMO"K:'I4:6MLEF;6!!]V-=FT5IT4 >"_
M"#X%>(_A_P"/1KFLZAI<]LEO)$J6DDC.2V,'#(H'3UKTKXJ>#KOQY\.[_0--
MN(+>ZG:-XWN,[,HX;!(!(SCK@UV%% 'D_P #?A3K'PQAULZ[>V-S)J30;%LV
M=E01^9R2RKR?,Z8[5ZQ110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!@T445W'CA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5<T_\
MUQ_SZU3JYI_^N/\ GUK.I\+-J'\1&E1117*>D%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/^?6LZGPLVH?Q$:5%%%<IZ04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_&.M6WB..VU>Y#0K-Y4R&)1MYQG(&>.M>A:A>+I^FW%W)C;#&SX/? Z5YO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH6EV-J]O;6,*Q2<.K+NWCT).<U;Q%-M3<=481P%>$94HS7*_O.6^&7_'E?\
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M.7/_ %U?'Y;L5TQG1Y4IQU//J4L6IMTIJS[]#SS0=/N?$/B99&4LIF\ZX<=
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MH4#\!2=5.DJ=AQPS6*=>^C7^1Y3X[_Y'"Z_W8_\ T 5VOBO_ ))[-_URA_\
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MG0C/,+1V6K_KU.OHHHKS3Z$**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "KFG_P"N/^?6J=7-
M/_UQ_P ^M9U/A9M0_B(TJ***Y3T@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "KFG_ZX_Y]:IU<
MT_\ UQ_SZUG4^%FU#^(C2HHHKE/2"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHS0 449HS0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!@T445W'CA1110 4444 %8?B7QIX=\'PQR>(]5AL?-SY:,"S
MOCJ0B@L1[XK<KX^^.WV__A;^J?VCOV[8OLV[.WRM@QM]L[OQW5$Y<JN:TH*<
MK,^J_#OBK1/%EB;SP[J,-]"I <QY#(3T#*0"OX@5K5\J?LX_VC_PLU_L>_['
M]CD^V8SMV\;<]L[L8_'WKZKHA+F5Q58*$K(****LS"BBB@ KF/B1K%WH'PWU
MO4M.8I=0VQ\IQU0L0NX?3.?PKIZJZIIMKK.DW6FZA'YMK=1-%*F<95A@TGL-
M63U/"/@;\-_#/B3PI-X@\0VRZK>S73Q[)G)6(#'4 \L<YR?48]3WA^"GAJS\
M7:9X@\/>;I%Q8W F>&%BT4P'5<$_+GIP<8)X->97'@GXB_!W5KB_\$RR:KH\
MC;GC2/S-RCH)8NN0/XD_,9Q7=_#[X\:3XLO8=)UNW_LC596"1Y;=#,_3:">5
M8]@?IDFLH\NS1TSYVW*+NCU*[N[:PM9+J^N(K:WB&Z2:9PB(/4D\"N*NOC5\
M/;.?RIO$L+-ZPP2RK_WTJ$?K6_XN\)Z=XTT!]'UAIUM7D21O(<*Q*G(&2#Q6
M3:_"3P):68MH_#-BZ8QNF0R.?^!,2?UK1\W0PCR6]XWM"\2Z-XGLS=:!J5O?
MPJ<.87R4/HPZJ?K7GWQL\=:#8>#M9\,RZEY>M7%LGEVPAD.Y68?Q!=HR >IK
MB/"VG1^ /VHWT#1Y&BTN\1D\HL6PC0>:J\]<.  3GC\:] ^-GAS1I_AWKFM3
M:7:OJ<4"!+QH@9%'F*.&Z]":F[<6:*,8S79G)_!CXE^#/#?P_L=&U755M-2>
MXD,D7V:5LLSG:2RH5Z;>]>ZR2)#&TDKK&B#+,QP%'J37COP1\&>&M5^&&FZE
MJ6A6%U>F:4FXFMU9SME;')'; K-_:!\237.N:)X(AOUL+6^:.:^G=MJ!6DV)
MN.0 JX9B#Q]T]J2;C&['**G4LCOKKXS_  ^L[O[-+XEMVDSC,,,LJ?\ ?:J5
M_6NKTG6M-U[3UOM%OH+ZV;@2P.&&?0XZ'V/->=Z9HWP6TS2$T];KPG<JJ[6G
MNKNWEE<]R7)R"?; ],5P7@Z]T[P5^T-_8_A#4X;WP[JXV;+>X$R(2A91N!()
M5QC/7:2*?,UN+V<6G:YT/Q_\<:!-X3O_  M;ZENUF*XA,MJ(I.!PWW]NWH0<
M9JW\.?B[X)TOP'H6D:EKGE7\-ND,D1M9VVMG &X(1Z=\4?M!^'=&C\ WFMQZ
M9:KJDES"KWBQ 2L,XY;KT 'X5I_#'P)X4OOAOH%_>>'M.GNY+99'GDME9V;)
MY)QUI>]SE>Y[)7.NF\>>&K?Q@GA:?4U367("VS0R<DKN W[=O(]_;K70UX'^
MT3H\^D:SH'C?3!LGMYE@D<=G0^9$?T<?@*]MTC6;76?#MGK-NP6VNK9;A2Q^
MZI7//T[_ $JD]6F92BE%21GW7CCP[9^+8/#%SJ2KK%P 8[41.<Y!(RP7:.!G
MDBM^OG[X00MXY^,OB+QQ<IN@MW86I9>A?*IU[B)<'ZBOH&G%W5PJ1478*X_6
M/BQX'T'4&LM3\0VZ7"-M=(D>;8>X)12 ?8]*SOC=XIN?"OPSN9M/E:&[OI5L
MX94R"A8$L01T.U6P>QQ7,?"CX-^&Y/ UCJWB33DU*_U.$7'[YFVQ1MR@4 CG
M;@DGG)I.3O9#C&/+S2,_]H36],\0?#71[[1+Z"^MFU+ DA<, ?*?@^A]CS7M
M.A?\B[IO_7I%_P"@"OFKXW?#*U\#P6^H>'[B2+2+ZX"OI[R,PBF"L0RYZC;N
M'/(]3GCZ1TNW2[\(V=O+G9-8HC;3@X,8!J8WYG<J=N16,+5OBQX&T2X:#4/$
MEIYJ':RP!IRI]#Y8;%7?#GQ"\*>+)_(\/ZW;W<^"WD$-'(0.I". 2/PK&T3X
M*^!-$MA&-$COY/XIK\^<S?@?E'X 5Y/\;O"NG?#SQ%X?\1^$(%TV5Y79HHB0
MHDC*E6 [ @D$# X]S3;DE=A&,)/E5[GN_BCQKX?\%V]O-XEU 64=RQ2(^4\A
M8@9/"*3WKY[^ OC_ ,/^#3X@/BK5&M#>&W:',,LN\KYN\_(IQ]Y>O6OH[5=!
MT7Q-:P#6=-M=1A3YXA<Q!PN1U&>G%?/?[.?AG1/$7_"1_P!O:5::A]G^R^5]
MIB#[-WFYQGIG _*E*_,K#I\OLY7/H70/$.E^)]%BU;0[K[58RE@DOELF2I(/
M# $<@]JP-4^+?@31IVAOO$EH9%;:RVX>?!]#Y8:M^/P]I=MX>FT2PM([*PEB
MDB,5LH0*'!W$8Z'DUR^C?!CP)HMJ(ET*&]?'S37Q\YF_/@?@!5OFZ&2Y.IL^
M'/'WA;Q;(8O#VM6]W,%W&'E),>NQ@&Q^%="3@9/2OFKXP>'--^&GCSPSK_A:
M(::)Y&D>*(MM5HF3) [ J^"!QP>.:];^-$VH0?"+6WTDR++Y:"1H_O"(NHD_
M#;G/MFDI/6_0MP5UR[,EO_C#X!TV^-I=>)+<RAMI\F.250?]Y%*_K74Z5J^G
MZYIZ7VCWL%[:R9"S0.&4D=1D=_:O'_@OHGPZUSP-:VSZ?I=_K.UOML=Y$CSA
MLGD!N0N,8*\?CFO3O"G@S1_!=O>V_A^*2"WO+C[0T+2%EC;:%PN>0/ESR3U]
M.*(MO44XQCHKW-#5];TS0+!KW6K^WL;93CS)Y H)]!ZGV%<K:?&;X?WMX+6'
MQ+;K(3@&:*6),_[[*%_6O(KO4M'^)'QTOU\:ZO;V7A[1C)';P7-TL"2E&"[0
M21RQRQ(YP /IZ#K6B?!G6-%EL!>^%+)F0K'<VEU;QRQMV;<K G'H<@]Z7,WL
M5[.,?BN>H-<PK:&Z,J^0$\SS <KMQG.?3%?,?Q0\?^'O$/Q2\+:OHNJ-<:?I
M[0F>7R94\O$VYCM903\N.@-=E^SAX@N=0T/6/#FH2BZATUT,!)W+Y;[@4'^S
ME<C_ 'C7,?%OPSH>D?%[PE8:9I5I:6ET8//@AB"I)F?:<@=<CBIDVXW1=.*C
M4:9[3X=^*'@_Q9JPTSP_J_VN\*&01_9IH_E'4Y9 /UKK*Q-*\%^&M"OA>:-H
M5A8W(4J)H(%1L'J,BMNM5?J<\N6_NA7':K\6_ NBZ@UEJ'B*W6X5MK+"CS!3
MZ$HI /U-8_QW\577ACX;2#3I7ANM1G6T25#AHU(+,0>W"X_X%6-\,?@OX93P
M/8W_ (CTU-1U#48%G<SLVV)7&515!&" 1D]<YY[5+;O9%QC'EYI&'^T3K&G:
M[X&T"_T:]AO;62]?;+ X9<[.1['VZU[O8?\ (.MO^N2_R%?+GQL^&MOX$-K=
M:%=2+H]_,?\ 09)&;R90O4$]1CUY'OV^A/%7B(^$_AK>ZVH4R6ED#$'^Z9"
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M6V)(YCD3DY(XW#/?'I3YI+5BY(2;2>I]+5S'B#XD^#_"]TUMK>O6UO<+]^%
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M]:IU<T__ %Q_SZUG4^%FU#^(C2HHHKE/2"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **,TTMB@!U&:
MB:0"HVN .] %C=32XJD]V!WJN]^!WH U#(*:9@.]8KZD!WJ%M4'K0!O&<>M)
M]H'K7.-JH_O4PZJ/[U '2_:1ZT?:1ZUS']JC^]2C51_>H Z?[0/6G"<>M<R-
M5']ZI%U0?WJ .D$HIPD%8":F#WJ=-0![T ;(:ES6:EZ#WJ=+D'O0!<HJ%9@:
M>'S0 ^BD!I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!J*>&J5$FNIM7S"A0DXRN[;V5[>IZ=16'X1U;4M:T/[7K%HMK,TA"*L;(&3
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ML[2CKNP ,C&<"JGB/]G_ ,0:]8K?7OB:/4_$,TRF>>\9TACA /R( K$G)!Z
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M2L$I+D:;N>&>!?"?A_5?C=XA\/>-K/SSYEQ]F1IGBW2"7/!1@3E,D>U>R?\
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M:B\*/+\BL+3!/?,S@?KQ7HWPA\"ZC\/O!]QI6KW%K<7$UZ]SNM68H 410,L
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M&?:NEKQJD7&;BSZRA4C4I1G%6304445!L%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8-%%%=Q
MXX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 -DW^4_E!3)M.T,<#/;/M7EWPN^%NJ^%/%&K^)/%=Y9WNJ7^0C
M6K.P7>VZ1B64<DXZ#H#SS7J=%)I-W*4FDTNH4444R0HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<U::@&QS6O!=!@.: -"BHT<&I : "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHKG?$&C>)-1U!)="\5_V-;K$%:#^SH[C<^22VYCD<$#'M
M[U48J3LW;^O*Y,FTKI7.BHKB?^$7\=?]%$_\HD'^-'_"+^.O^BB?^42#_&M?
M90_Y^+_R;_(S]I+^1_A_F=M17$_\(OXZ_P"BB?\ E$@_QH_X1?QU_P!%$_\
M*)!_C1[*'_/Q?^3?Y![27\C_  _S.VHKB?\ A%_'7_11/_*)!_C1_P (OXZ_
MZ*)_Y1(/\:/90_Y^+_R;_(/:2_D?X?YG;45Q/_"+^.O^BB?^42#_ !H_X1?Q
MU_T43_RB0?XT>RA_S\7_ )-_D'M)?R/\/\SMJ*XG_A%_'7_11/\ RB0?XT?\
M(OXZ_P"BB?\ E$@_QH]E#_GXO_)O\@]I+^1_A_F=M17$_P#"+^.O^BB?^42#
M_&C_ (1?QU_T43_RB0?XT>RA_P _%_Y-_D'M)?R/\/\ ,[:BN)_X1?QU_P!%
M$_\ *)!_C1_PB_CK_HHG_E$@_P :/90_Y^+_ ,F_R#VDOY'^'^9VU%<3_P (
MOXZ_Z*)_Y1(/\:/^$7\=?]%$_P#*)!_C1[*'_/Q?^3?Y![27\C_#_,[:BN'/
MAKQP.OQ'7_P20?XT?\(WXW_Z*.O_ ()8/\:/90_Y^+_R;_(/:2_D?X?YG7:C
MIMEJ]B]GJ=K%=6\GWHI5# __ %_>N6_X5'X'\WS/["7=G./M,V/RWXJ+_A&_
M&_\ T4=?_!+!_C1_PC?C?_HHZ_\ @E@_QK2%X*T:J7_@7^1G*TW>5.__ (#_
M )G7:=IECI%DEGI=K%:6Z?=CB0*/K]?>K5</_P (WXW_ .BCK_X)8/\ &C_A
M&_&__11U_P#!+!_C4.G%N[J+_P F_P BU4DE90?X?YG<45P__"-^-_\ HHZ_
M^"6#_&C_ (1OQO\ ]%'7_P $L'^-+V4/^?B_\F_R'[27\C_#_,[BBN'_ .$;
M\;_]%'7_ ,$L'^-'_"-^-_\ HHZ_^"6#_&CV4/\ GXO_ ";_ "#VDOY'^'^9
MW%%</_PC?C?_ **.O_@E@_QH_P"$;\;_ /11U_\ !+!_C1[*'_/Q?^3?Y![2
M7\C_  _S.XHK&\/6.KZ=;S)KWB!=:D=@8Y/LB6_EC'3"GGZUK[T_O+^=9223
MLG<UBVU=JPZBF[T_O+^=&]/[R_G4C'44W>G]Y?SHWI_>7\Z '45BZO8:O>7:
MR:5XA7380@5HOLB2[FR?FRQST(&/:J/]C>)_^AS7_P %D7^-:J$6KN2_'_(Y
MI5IQE94V_P#P']9'445R_P#8WB?_ *'-?_!9%_C1_8WB?_H<U_\ !9%_C3]G
M'^=?C_D3[>I_SZE_Y+_\D=117+_V-XG_ .AS7_P61?XT?V-XG_Z'-?\ P61?
MXT>SC_.OQ_R#V]3_ )]2_P#)?_DCJ**Y?^QO$_\ T.:_^"R+_&C^Q?$__0YC
M_P %D7^-'LX_SK\?\@]O4_Y]2_\ )?\ Y(ZBBN7_ +%\3_\ 0YC_ ,%D7^-'
M]B^)_P#H<Q_X+(O\:/9Q_G7X_P"0>WJ?\^I?^2__ "1U%%<O_8OB?_H<Q_X+
M(O\ &C^Q?$__ $.8_P#!9%_C1[./\Z_'_(/;U/\ GU+_ ,E_^2.HHKE_[%\3
M_P#0YC_P61?XT?V+XG_Z',?^"R+_ !H]G'^=?C_D'MZG_/J7_DO_ ,D=117+
M_P!B^)_^AS'_ (+(O\:/[%\3_P#0YC_P61?XT>SC_.OQ_P @]O4_Y]2_\E_^
M2.HHKE_[%\3_ /0YC_P61?XT?V+XG_Z',?\ @LB_QH]G'^=?C_D'MZG_ #ZE
M_P"2_P#R1U%%<O\ V+XG_P"AS'_@LB_QH_L7Q/\ ]#F/_!9%_C1[./\ .OQ_
MR#V]3_GU+_R7_P"2.HHKE_[%\3_]#F/_  61?XT?V+XG_P"AS'_@LB_QH]G'
M^=?C_D'MZG_/J7_DO_R1U%%<O_8OB?\ Z',?^"R+_&C^Q?$__0YC_P %D7^-
M'LX_SK\?\@]O4_Y]2_\ )?\ Y(V-5T'2];51JEE'<;/NLV0R_0CFLV#P#X8M
MY1)'I2%@<C?([C\F8BH?[%\3_P#0YC_P61?XT?V+XG_Z',?^"R+_ !K1-Q5E
M5T_[>_R,)*,Y<TL.V^_N?_)'3HJQHJ(H55& H& !Z4M<O_8OB?\ Z',?^"R+
M_&C^Q?$__0YC_P %D7^-9^SC_.OQ_P C?V]3_GU+_P E_P#DCJ**Y?\ L7Q/
M_P!#F/\ P61?XT?V+XG_ .AS'_@LB_QH]G'^=?C_ )![>I_SZE_Y+_\ )'44
M56L4FM[&**]O!=SJ,//L";SZ[1P*L;U_O#\ZR>C.I.ZN+12;U_O#\Z-Z_P!X
M?G2&+12;U_O#\Z-Z_P!X?G0 M%)O7^\/SHWK_>'YT +12;U_O#\Z-Z_WA^=
M"T4F]?[P_.C>O]X?G0 M%)O7^\/SHW+_ 'A^= "T4FY?4?G1N7U'YT +12;E
M]1^=&Y?4?G0 M%)N7U'YT;E]1^= "T4FY?4?G1N7U'YT +12;E]1^=&Y?4?G
M0 M%)N7U'YT;E]1^= "T4FX>H_.C</4?G0 M%)N'J/SHH PJ***[CQPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***BN;NWLK=I[R>*WA7[
MTDKA5'U)XH EHK/TWQ!HVM,ZZ/JUCJ!0986MRDNWZ[2<=:T*0;!1113 ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *N:?_KC_ )]:IU<T_P#UQ_SZUG4^%FU#^(C2
MHHHKE/2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M IC/BAWP*HW%R%!YH ?/<A0>:QKS4 ,\U!?7^,X-3Z7H<EVRW.H@K%U6(]6^
MOH* *MG876L290^7 #S(PZ_3UKI['3K?3XMENF"?O.>6;ZFK*JJ(%10JJ,
M8 I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "D=%D0JZAE88((R#2T4 <YJ7AYHB9]+Z=6A)_\ 0?\ "J%I?E6V
MOE6!P0>"#795F:KHL6H#S8R(KD#AP.&]C_C0 RVNPP'-:$<@85R"2SV-P8+I
M2CKV/?W'M6W:7@8#F@#9!S2U!%*&%3 T +1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%4I]9TNV8K<ZE:0L.HDG5?YF@"[165_P )
M1H'_ $'--_\  N/_ !H_X2GP_P#]!W3?_ R/_&@#5HK*_P"$I\/_ /0=TW_P
M,C_QH_X2GP__ -!W3?\ P,C_ ,: -6BLK_A*?#__ $'=-_\  R/_ !H_X2GP
M_P#]!W3?_ R/_&@#5HK*_P"$I\/_ /0=TW_P,C_QH_X2GP__ -!W3?\ P,C_
M ,: -6BLK_A*?#__ $'=-_\  R/_ !H_X2GP_P#]!W3?_ R/_&@#5J*>78N%
M^\?TK-D\5Z JY&MZ<Q[ 7<?^-4SXFT-F).M:>2?^GI/\: -*BLS_ (230_\
MH-:?_P"!2?XT?\))H?\ T&M/_P# I/\ &@#3HK,_X230_P#H-:?_ .!2?XT?
M\))H?_0:T_\ \"D_QH TZ*S/^$DT/_H-:?\ ^!2?XTH\2:&3@:SIY_[>D_QH
M TJ*JP:G8738MKVWF/I'*K?R-6J "BBB@ HHHH ,TM)10 M%)2YH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* %S1FDHH 6BDI<T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_A;?Q&_Z)K??^ EQ_P#$UZ#\/_$FN>)M&N+KQ)H,VB7$=P8XX94="Z;0=V'
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M<W>JQV@\R>*>1V*J.I"R%E('?I^-9ZC4_@9\2;[4+K3I+WP[J991/$/NH6W
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MA^5=/<?#GXLZ/$;G2/',VHRH-WDS7<A+8[ 2;E/XXK-^#?\ R7SQ5_URO/\
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MGPSX2UZ/5M#BN8;A(6A(:<NKAL9)![\=L#VKM*XOP!X.U_PK)?-K_BN[U\7
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MASXLT'Q1::EJ_CV_U:SAW^993/*5ERC*,[I"."0>G:I4GS/0TG"*@G<7X@^
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M3ZT 9MG>!@.:U8I-PKD<3Z;>&WN1AEZ'LP]16Y9W08#F@#8!S2U%&^X5*#0
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M67_T U>JCK@)\/:B ,DVLN /]PTAK<\H_9K _P"$+U8X&3J&"?\ MFM=/\<
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MLQ9-&&\X@A]^[H1Z;>?J*\MU72O$GPE^*M_XITS2)=6T>^:4N8P3A)&#LC$
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MJH6,ZB>FFA;HHHK0Q"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR3DJY7!Y[$YZU[S14..MT:1FE'E:N> ^,?'&J_%S2T\.^"O#-^;6>9'FO+I
MH 4Y'(RJC/.2WMBO9O"6@CPQX1TW1O,$K6<"QO(!@,W5B/;)-;%%-1L[L)3N
MN5*R"BBBJ,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "KFG_ZX_P"?6J=7-/\ ]<?\^M9U/A9M0_B(TJ***Y3T@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ***0F@!KM@5FWEQM4\U:N)-JFN>U*ZP#S0!6D\
MV_O4MH.6<XSZ#N:Z^TM8[*U2"$85!U]3ZUF>'=/-O;&[F'[Z<9&?X5[?GU_*
MMF@ HHJ.XE^SVLLVW=Y:%L9QG S0!)17Q?:_'7XLZQJ:VNE:Q+<7,['RK6UT
MR"1CU.%7RRQP/J<"MK_A//VAO^?/Q!_X3B?_ !B@#ZVHKSO7O%'B+0?V?6\1
M7@,'B&+2H9)?-A"E)VVJ2R$8!!;.W&,\8'2OGC2?C-\9=>N'@T+4KW4IHUWO
M'9Z/!,RKG&2%B.!D]: /LNBOD-_CC\7_  I<)_PDL+_,W$>JZ2(-WM\JH:]Q
M^%/QHTKXE1O92PC3=:A7>]HS[EE7NT;<9]QU'OUH ]+HHKQ+]H3XJZQX%;2=
M*\*WJVFH72M<3RF%)"L0.U0 X(^8[N<?PT >VT5\R?!CXX^*M<^(UKH?C'4T
MO;74%>*(M;11&*4#<O**N<X*X.>2*^FZ "BBN-^+7B74/"'PKUG6]'=8[ZV2
M-8790P0O*B;L$$' ;/- '945\:Z3\8_C/K\LD>A:A?:G)$H:1+/1X9B@/0D+
M$<"M4>//VAMP_P!#U_\ 'PXG_P 8H ^M:*CMFD:UB:<8D* N,=#CFI* "BBB
M@ HHKSGX_P LD/P,\0M$[1MBW7*G!P;B($?B"10!Z-17S?\ LCNQC\6H6)13
M9D+G@$^=D_H/RKZ0H **** "BBB@ HHHH **** "BBB@ HHHH **^*OA#/-)
M^T3I<CRNSR7MQO8L26^23J>]?:M '+:[8&QO!>0#$,I^<#^%O\#4^GW6Y1S6
M[<V\=U;/!,,HXP:X]%DT^^>VF/S(<9]1V- '70R;A4XK+LY]RCFM%#D4 /HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;C!#J$BVY/92J,0/;<2?J34)M2LS248N'-$]8HHJEJ^L:?H.ES:EK%U':6D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !5S3_]<?\ /K5.KFG_ .N/^?6LZGPLVH?Q
M$:5%%%<IZ04444 %%%% !1110 4444 %%%% !1110 4444 ,<X%9E]+M4U?F
M;"FL'4YL*>: *-M!_:.L10GE =[_ .Z/\X_&NSK!\+VV()KMA\TC;5/^R/\
MZ_\ *MZ@ HHHH *KZC_R"[K_ *XO_P"@FK%% 'PY\"O^2W>'/^NTG_HEZ^XZ
MQ['PAX:TS4?M^F^'M*L[WG_2;>RCCDYZ_,%SS6Q0!P7QP5G^"GB0(I8_9T.
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MG?1?:7<W4T>$<Y081P/N;3TZDU[!JGA+PYKEVMUK6@:7J-PJA%FN[*.5PHY
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 7-%)10 M%)FES0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 +FBDHH 6BDI<T %%%% !1110!0HHHKN/'"BBB@ HHHH *^3/CCI>H6/Q
M2U"ZOD?R+T));2D?*Z!%7 /L1C'^-?6=5=0TRPU:W^SZK8VU[#G/EW,*R+GZ
M,"*B<>96-:=3DE<^:_V>=*U&X^(+ZE;HZV-K;.EQ+CY6+#Y4SZYPV/\ 9KZ>
MJ"RL+/3;5;;3K6"TMT^[%!&$1?H!Q4]$8\JL*I/GE<****LS"BBB@ JCKO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *Y+68?LFO,R\+,H<?7H?Y?K76UA>*8<VD
M%P!S%)@_0_\ UP* )+"7*BM9#D5SNF2Y45OPG*B@":BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJBFD95)*4KH****LS"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%V/_ $%/_)=O_CE5_:M'L_P_S(_LVKW7X_Y'A^:0FO</^%%6/_04_P#)=O\
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M% !1110 4444 %%%% "YHI** %HI,TN: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *7-)10 M%)1F@!:*,T4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!1HHHKN/'"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ JYI_P#KC_GUJG5S3_\ 7'_/K6=3X6;4/XB-*BBBN4](****
M "BBB@ HHHH **** "BBB@ HHHH #5:X.%-63TJI<GY30!SFJOP:W]#C\O1+
M4>J;OS.?ZUS>JMUKK+%=FGVZ?W8E'Z"@">BBB@ HHHH **** "BBB@ HHHH
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MCC5-<9HH':PL^@CB;YW'^TW]!Q7-JBK]T8KT*. J5%>6B/"Q>=4*#Y:?O/\
M#[ST.[^*J;B-/TF1QV>>4)^@!_G6<_Q/UH_ZNRL%_P!X.?\ V85QU+BN^.74
M5NVSQ)Y]BI/W4D==_P +.U__ )]M-_[]R?\ Q='_  L[7_\ GVTW_OW)_P#%
MUR-%7_9]#S,_[<QG=?<==_PL[7_^?;3?^_<G_P 71_PL[7_^?;3?^_<G_P 7
M7(TN*/[/H>8?VYC.Z^XZW_A9VO\ _/MIO_?N3_XNC_A9OB#_ )]M-_[]R?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBHYYA"F>K'H* &7,_EKM7[Q_2J-(S%F)8Y)HS0 449HH **** "BBB@ HHHH
M 6C-)10 M+3:7- "T4F:6@ HHHH **** "BBB@ HHHH *,T44 +124UW6.-G
MD8*J@EB3P!0!GZ]KMKX?TM[R\.?X8XQ]Z1NP'^->,ZMJUYKFH->ZC)N<\(@^
M[&OH!5SQ1KTGB/6GN 3]DA)2V0C&%_O?4_X>E9&*]K X5)*K/Y'R&<9DW)X>
MD]%N_P!/\Q*7%%%>N?+A112XH$)2XHI<4P$I<44M "4M%+0(2EHHQ3 *,4M%
M !11BEH$)BEZ4A:F%J L/)IA:FEJ:6I7*2'%J8QZ$$@@Y!!P0:0M32U1)*2L
MS6FY0DI1=FCU+P-XU.I;=*U>3_35'[F8_P#+8#L?]K^==S7SFDKQ2I+"Y22-
M@R.IP5(Z&O;_  AXA7Q%H4=PY N8OW=PHXPWK]#U_P#U5\YBL/[&>FS/OLMQ
MWUNG:7Q+?_,W:***XSU0I<TE% "T4E&: %HHS10 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% "YHI** %HI,TN: "BBB@ HHHH **** "BBB@ H
MHHH **** *-%%%=QXX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %7-/_ -<?\^M4
MZN:?_KC_ )]:SJ?"S:A_$1I4445RGI!1110 4444 %%%% !1110 4444 %%%
M% "&J=U]TU=/2JER/E- '*:L.M=I$VZ%&]5!KCM67K75V#^9IML_]Z)3^@H
ML4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% '*:^=VOJ/[L*C]36EIX^45E:N=_B.4?W0H_0'^M:]@/E% &HG04^FITIU
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>N?\+FA'_,'_ /)H_P#Q%/C^,UF2/-TME'?;/G^:BO'&DJ-I*/['H?S/\/\
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MHH **** "BBB@ S2TE% "T4E&: %HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "C-%% "T4E% "T49HH **** "BBB@ HHHH 6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *D@_URU'4D'^N6@"W1110 4444 %%%% !1110 44
M44 %%%% !1110 &JUP,J:LU#,,J: .8U5.#6[H4GF:';'T4K^1(_I63J:9!J
MWX6DW:;)$3S'*<#V(!_QH VZ*** "BBB@ HHHH **** "BBB@ HHHH ****
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M:4S>"=-9CDB,K_WRQ']*WZYWP$GE^!M-4_W7/YNQ_K715\N?HP4444 %%%%
M!1110 4444 %%%% !1110 N:*2B@!:*3-+F@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "ES244 +1249H 6BC-% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2TVUBLHB(K*[DA4ELDDA2,G_  K(L/#/Q[O](M=7L+_Q#/9W,*7,#C7@2Z,
MRG89L\@C@C/M4/[3'_)8YO\ KQ@_D:^H_AQ_R2SPI_V!;/\ ]$)0!\QZ+\=/
MB+X"UXZ?XO$VH1Q$+/9:E%LF4>JO@-D^IW _K7U3X6\3:;XP\-VFMZ+*9+2Z
M7*[AAD(."K#L0<@UY3^T_P"&;34/AY%K_EJM]IEPBB7'+1.=I3_OHJ?;!]:P
M?V3-7GDL/$>CR,3!#)#<Q#^ZSAE?\]B?E0!]%UXM^TOXGUKPYX.TH:#J5SIK
MW5Z5EEM93'(55"0NY<$#/IZ5[37@/[6/_(I:!_U_/_Z+H \J^'?QG\4>&?&-
MC<^(M<U+4='N'"745[</,!&3M,B;B2"IR>.N"*^T8I4FA26%U>-U#*RG(8'D
M$5\6:OX&:]_9\\/>,;&+,EC+/:WV.\33ML;\&)'_  ,>E>T_LU^/_P#A(?"+
M^&=0EW:AHRCR2QYDMB<+_P!\GY?H4H \Y^'?CGQ5?_M%06%[XBU.XLI=0N8W
MM9;MVA*A9,#83M &!C XQ7UE7QA\,/\ DYJS_P"PI=?^@RU[_P#'+XGS?#KP
MM!'I!3^V=29DMF==PA10-\F.Y&0 #QD]\8H ]0HKXO\ #GPQ^(GQ@LY->EU
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M95)-/S9H:;K>HZ-,TNF7<ENS<,%/#?4'@U?N_'?B2\@:&;59 C#!\M$C/YJ
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MZ4>?'_>_2J=%'LHA]9F7//C_ +WZ4>?'_>_2J=%'LHA]9F7//C_O?I1Y\?\
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M:IQ['O7C7PS^/>H_#CPW)H-QHR:I;1RL]ONN#"T!;EE/RMD9R<<')/- %O\
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M^=<EIL3.^]^68Y)]30!N6$>%%:J#BJEJF%%710 M%%% !1110 4444 %%%%
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M-UG0=,U"3^_=V<<K?FP-7;#3;'2K46VEV5O90 Y$5O$L:C\% %6:* "BBB@
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M=)IL&%'%9L;O?W\ES*.9&R!Z#L*Z*SAVJ* +L*X45-35&!3J "BBB@ HHHH
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M@!:*2B@!:*3-+0 4444 %%%% !1110 4444 %%%% !1110 9I:2B@!:*2C-
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M@CN*6L'PWJ!9#83GYXQF,GNOI^'\OI6]0 4444 %%%% !1110 4444 %%%%
M!117@'[0_P 6M:\+:I:>&?"UV;*>2W%Q=W4:C> Q(5%)^[]TDD<\C!ZT >_T
M5\X?!FS^+J>,=%U/Q'<:O<>&=0BDDD>]O1.I4PL8SM9BR9;9C@5]'T %%%%
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MXJ,ZRG:VRZ'GOP]_Y&I?^N+_ -*[GQ/XDB\/6:$();F7(CC)Q^)]JX;X>_\
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M  3I]DZ>72N][/\ %&I\/E#>%"K $&9P01UX%<9XUM;:S\43QV:+&A569%&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD48I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0FIOL-Y_SZS_ /?LTGV&\_Y]9_\ OV:GVL.Z*]G+L0DTW-3_ &"\_P"?2?\
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MK<OSI56J>(T??I\^Q[91FJNG:C;:M817EC()(9!D'N/8^A%6:\H^E%I:;2T
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M57JQ9?\ 'XGX_P JF7PLNG\:-:BBBN,]4**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I",TM% %6>+<IK$O[/<#Q71LN:J7$ 8&@#"T;5#ITWV2
MZ/\ H['Y&/\ RS/^%=57*7]CD'BIM&UDVS+97[?N^D<I_A]C[>] '2T444 %
M%%% !1110 4444 %?''[3'_)8YO^O&#^1K['KS?QQ\#?#'C_ ,2C7-9NM4AN
M?*6)DM9D5&"],AD8]^QH ZVQEGA\!6\MH,SIIBM$,9RPB!''UKXS^$O_  B^
MH?$R&3XC3QM8R+)(7O)"(Y)SR#(WI]X\G!.,U]Q6MO'9V<-M "(X8UC0$YP
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MF,"I/_ :^G_ANO@VU\)Q6'P_O+2ZT^W/SF"4.Y<]6D[[C[@=L<8KRW5/V9_
M-CH4M^_BC4K.)(RWVNYN(#"..I^0<?C7EW[.]SJ%M\:M.ATR1F@GCF2["YVO
M$(V.3_P((1[XH ^T**** "BBB@ HHHH ***H:KJL>FP?WYW'R1_U/M0!'K.K
M#3H0D6&N9!\B_P!WW-<_96K22&20EG8Y9CU)I((9;NX,]RQ>1SDDUO6EJ%4<
M4 26MOM4<5?1<"FQI@5** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M10!F_P#".Z+_ - >P_\  5/\*/\ A'=%_P"@/8?^ J?X5I44 9W_  CNB_\
M0'L/_ 5/\*/^$=T3_H#V'_@*G^%:-% &=_PCNB?] >P_\!4_PH_X1W1/^@/8
M?^ J?X5HT9H SO\ A'=$_P"@/8?^ J?X5)'HFE1$&+3+-".FVW0?TJ]10 BJ
MJ*%10JCH ,4M%% !1110 9I:2B@!:*2ES0 4444 %>>>"/\ DKWQ&_Z[:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVFVB6MC$(H4SA02?U/)JQ112;;=V-))604444#"BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%&B>)HYGT#5+;4%@8++Y#[MA.<9^N#^5:M(;36X4444Q!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !5BR_P"/Q/Q_E5>K%E_Q^)^/\JF7PLNG\:-:BBBN,]4****
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M_P \YM@_(5"=2U<?\S!J_P#X&O72LNQ';\3G^OT.Y[Q17@AU36!_S']6_P#
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MF:,T +1110 457>_M([Q+1[J%;EQE83( [#U ZU8H%=,****!A1110 4444
M&:6DHH 6BDHS0 M%%% !1110 4444 %%%% !1110!4HHHKN/'"BBB@ HHHH
M*9--';PO+/(D4:#<[NP"J/4D]*?7@?[3VJZA!9Z'ID+O'I]R999@IP)73;M!
M^FXG'OGL*F3Y5<N$>>7*>VZ9KVCZT9!H^JV.H&(XD^RW*2[/KM)Q5^OA?P5J
MVI:+XTTJ\T5W6[%S&BJA_P!:&8 H?4-G&/>ONBIA+F1=6G[-A1116AB%%%%
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M,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JQ9?\ 'XGX_P JKU8LO^/Q/Q_E4R^%ET_C1K4445QGJA11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(1F
MEHH C>,&JDUJ&'2K]-*YH Y^YT\-GBLQK6:TF\VV=HG'=3BNN>(&JDUH&[4
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M*Y20XM32U-+4TM4W+41Q:FEJ86II:IN6D.+5W?PITLWGB4WC#,=HA?/^T?E
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M_P#:->R^!],NM&\!:)INHQ^5=VME%%-'N#;6"@$9'!_"O//CUX"\1>-SX?\
M^$:L5N_LAN!/F=(]F_RMI^8C/W#TS3DGR6%3:56[.]\<^&+WQ=X=&FZ;KEQH
M<PF67[5;JQ8@ _+@,IP<^O:O.?\ A17B;_HJ>K?]^9?_ (_7M-%4XI[F<:DH
MJR.6\76KV/P?URTEG:YDM]"N(FF?[TA6W8%CR>3C/6N&_9F_Y)IJ'_87D_\
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M8;OL]E"L*%NK #J?<]3]:<=]-A5&G%7W/"_V6CAO%2G@_P"B<?\ ?ZO?+_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 58LO^/Q/Q_E5>K%E_Q^)^/\JF7PLN
MG\:-:BBBN,]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $9@BEG(55&22<
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M>&TMH[>VC6**-0J(HP *DKQIS<Y<S/KJ-*-&"A'9!7D?[2G_ "2N'_L)1?\
MH$E>N5Y'^TI_R2N'_L)1?^@25!J<=^RQ_P A+Q+_ -<K?^<E?1V:^<?V6/\
MD)>)/^N5O_.2OHV@!:*2B@!:*,T4 %%%% !1110 4444 +FC-)10 M%)2YH
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MBJ22V)E)R=V%%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR?\ Q5+Z_P#W?Q_X _[$_P"GGX?\$\"+4TM7O_\ P@'AG_H&?^3$O_Q5'_"
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MGJ<U.!@8%*!CI2XKUDCY=RN)12XI<4R1N*,4[%+BF S%&*?BC% #,44[%&*
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M+5[KRS='R(Y-WF28 .X'&%4GC'#5[%7S]X#7_A-?VEM>\0N/,MM+\P0L3D9
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M8:G9713GR42UR_MR@_F*U?AE\8[[7O$DGA3QI8I8:TA98W12@D91\R,ISM;
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M3X(9+F=(81N=S@"I<DE=EJ-]$=9\./#[:[XH@0KF)&^<^@ZM^G'XBOIH84
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M88B'-'YH=FC-)161TBT4E+F@ HHHH **** *]%%%=QXX4444 %%%% !1110
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MHHL@NV%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !5BR_X_$_'^55ZL67_ !^)^/\ *IE\
M++I_&C6HHHKC/5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M49HH **** %S1244 +124N: "BBB@ HHHH 7-&:2B@!:*2ES0 4444 %%%%
M!2YI** %HI*6@ HHS10 4444 %+FDHH 6EIM+0 M%)FB@!:*** "BBB@ S11
M10 M%)1F@!:*** "BBB@ HHHH ,UY)^TG_R2R'_L)1?^@25ZW7D?[27_ "2R
M'_L)1?\ H$E '(?LM?\ (1\2?]<K?^<E?1E?.7[+7_(2\2?]<K?^<E?1F: %
MHHHH **** "O+OB%\1-GFZ-H$WS<K<72'IZHI]?4_E3/B%\0_P#6Z-H$WJMQ
M=(?S13_,_E7FD%ONPS].P]:]+#86_OS/G\PS&UZ5)^K_ ,A((-WS...P]:N
M4H%+BO62L?,2E<,4N* *=BJ,[B8I<4N*7%,0F*7%+BEQ3$>H_!51NUIL<@0
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MHHKN/'"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5B1^,M D\73^&$U!?[8MXO-EMC&XVKM#9W$;>C XSWH%9LVZ*XJ\^,7@&QU
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%0W%[:VBYN[F& >LD@7^= $U%9C>)M!0X?6].4^ANXQ_6F_P#"4^'_ /H.
MZ;_X&1_XT :M%97_  E/A_\ Z#NF_P#@9'_C1_PE/A__ *#NF_\ @9'_ (T
M:M%97_"4^'_^@[IO_@9'_C1_PE/A_P#Z#NF_^!D?^- &K165_P )3X?_ .@[
MIO\ X&1_XT?\)3X?_P"@[IO_ (&1_P"- &K165_PE/A__H.Z;_X&1_XT?\)3
MX?\ ^@[IO_@9'_C0!JT5E?\ "4^'_P#H.Z;_ .!D?^-'_"4^'_\ H.Z;_P"!
MD?\ C0!JT5E?\)3X?_Z#NF_^!D?^-!\5>'U4DZYIO'I=QG^M &A<3I;0EW_
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MHI** %HHS10 4444 %%%% "YHI** %HHHS0 4444 %%%% "YHI** '44E&:
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MS3WYC;#21)(OR@="=S+UX'7G&*]D^!7_ "170O\ MX_]*)*X?X:?\G/>-/\
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MI_\ V%X__1,U$DE%V%3DY5%<3X=?!C1YM!M-<\:+_;>I7T"2!9I&,<$94;%
MS\Q"X'/ Z#ID\7XM\/V_PI^.?AV\\,;K:QOI(V,&\MM!?9*G))*E3D9[GV%?
M0'A'_D2=#_[!UO\ ^BUKQ;X_?\E+\&_[R_\ HY:F44HW1=.<I3:9Z1\8/%MQ
MX.^'%Y?6#^7>W#K:VTG='?.6'N%#$>X%>>_"S0OAE8>$[;4?%.J^'[_6;]?.
MN%U*[A<PYY";'/!QU)&<D^U=%^T?8RWGPL2:(96SU"*>3CHI5X_YN*SOAO\
M"WX=>*_A[I6JS:,+JZDA"73B\G4^<O#Y < <\XQT(IN[F$;*G?S./^*\?A+P
MSJFC^*?AEJNEPZA%<;9;?3+I'7ID-L1OE'!4C@'->_7=E:>-O!!MKSS8[35K
M-2_E,%=5=0>"0>>?2N8;X%_#=5);P\ !U)OKC_XY5[XE>))/ 'PSN;W1H42:
M!8[:T4C*Q$D*#@]=H[>PII6NV3*2E91W$TOX/>!-*M!!'X=M;GC#278,SM[Y
M;I^&*\C\3:'9_#7]H;PS)X:'V*SU"2$R0JS$())3'(H_V2.0/7Z"M/PA\([C
MXB^&K;Q'XZ\4ZM=/J ,J00S#"+G Y8,.P.  !TKDO&'@/2/A_P#%[PKIVB75
MU<)-/;32?:I$9E;S\?PJN!@>E1+:]C2'Q-.5SZKHHHK<Y KR_P#:&_Y)'<?]
M?</_ *%7J%>7_M#?\DCN/^ON'_T*IE\+-*?QHY[X5_!W2M3\.6/B/QGG6+F\
MMXS;022,8X(0H"+CC<=H'!X'0>M<M\5/#=E\)_B)X=\0>%5:R@G=I3 K$A6C
M9=X&23M97 Q]:]R^&?\ R2WPW_V#8?\ T 5Y+^U-_P RK_V]_P#M&LY)*%S:
M$I2JV9ZO\3?%$O@_X=ZGJ]J0+I$$5OD9Q([!0<=\9W?A7EWP=^$VC^(/#B^*
M_&,3ZK=:C*\D4<\C;0 Q!=L'+,Q!//&,5VGQ\LYKOX0ZBT"EOL\L,S@#)VAP
M"?PSGZ"K'P0UBWU;X2Z2L+J9;)6M9D!Y1E8XS]5*G\:IZSLR$W&E==SC/B_\
M'= LO!]UX@\+6?\ 9UYIX$LD<+G9+&#\W!/! YR,=#7=?!WQ3<^+?AK8WFH2
M&6\MV:UGD/5V3HQ]RI7/OFG?&+6+71_A3K;74BJUW ;6%"<%WD^7 ]<#+?13
M6)^SOI<NG?"E)IE9?M]Y+<H&_NX6,'\?+S1M/0&W*E=]SU*L+QOXB3PGX)U7
M6F*A[6W)B#=&D/RH/Q8BMVO"_P!H_7)KE=#\':<=]S?3">2-3R>=D2_0L6_%
M152=E<SIQYI)&G^SEH#67@J\UZZ!:YUBY)#MR6CC) /XN7_2N5E)^&G[46__
M %6FZX_/'&R<\_0"8?D*V-,^'GQHT?3+?3M,\8:/;VEL@CBB4G"J.W,%<7\5
M? GQ$M-%B\0^--9L-6BLW$*M;$[X@YZG]VG&[ ZGDCWK)W45IL=,;.;NUJ?4
M]?)?AF?QC;_&3Q._P^M(;K4C+=B5)B@ A^T#)^=E&=VSOGFOI#X>^)!XM\ Z
M3JY8--- %N,=I5^5_P#QX$_0UXS\%O\ DX3Q;_URO?\ TJCJI:M&=/W5*YM#
M4_V@LC.AZ?\ B]M_\=KV]-WEKYF-^/FV],TM%6E8RE+FZ6"BBO'/&FL?$[Q'
MXUO_  OX*M#I>FVQ1)-592F[<@8GS#TZ]$!;WH;L*,>9FG\6;?X8?9W?QO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 N:,TE% #J*2C- "T4E+0 4444 &:6DHH 6BDS1F@!:*** "C-%% "T4E%
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M7QEX1T>:2]T70;A+UU(!<@*/8?,=H^@JAX>^($EAK&HW.KPM<Q:@P:018RA
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MV!N4*1@ ,1Z=ATK2-%QK*\;IJW_#G//%J>%:4TI*;EUU]/GT.WUWPZFM>,M
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M^.8;;2G8G EEC9<]2$"D*?HPJ35_V=919:8^C:I%<ZHET9]1O=0=U,X.#\H
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MS]TLH;>!VRO^->Z44.*>XXS<=CPZU^!7B'Q%JL%Y\3?%CZG% <BVMY'<$9Y
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M*LS"BBB@ JQ9?\?B?C_*J]6++_C\3\?Y5,OA9=/XT:U%%%<9ZH4444 %%%%
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M.\M8KB!MT<J!U/L:EKYH^A%HHS10 4444 +FBDHH 6BDI<T %%%% !2YI**
M%HI*6@ HHS10 4M)10 N:*2B@!U%)1F@!:*** "C-%% !2TE% "T4F:6@ HH
MHH *,T44 +1249H 6BC-% !1110 4N:2B@!:*2C- "T49HH **** %S1244
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 58LO^/Q/Q_E5>K%E_
MQ^)^/\JF7PLNG\:-:BBBN,]4**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHHH ***\'NF;_ALJR&3CR",9[?8W-2W8N,>:Y[Q1115$!1110 4444 %%%%
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M#J%S1244 +129I: "BBB@ S2TE% "T4E+F@ HHHH *7-)10 M%)10 M%&:*
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ME_="BBBM# **** "BBB@#YUL_P#D\QO^NLG_ *1-7T57SK9_\GF-_P!=9/\
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MNTSXJG2?#=Q;:YIZ^&,Q,;5HT\S[/N^9<^5G.,X^;\:Z?]H;_DD=Q_U]P_\
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M.,HYQQU)'\J]2\=>%8_&O@R_T*68VYN5!CEQG8ZL&4D=QD<^V:\9T?Q;X_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !5BR_X_$_'^55ZL67_'XGX_RJ9?"RZ?QHUJ***XSU0HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** "C-%% "T4E% "T4F:6@ HHHH *,T44 +1244 +129I: "BBB@ S2YI**
M%HI*,T +1110 4444 %+FDHH 6BDHH 6BC-% !1110 5!?65MJ5E+:7T*S02
MKM=&'6IZ*-A-)JS/!_&/@V[\*7PGMR\MA(W[F?NA_NM[^_>H--U!;M=DF%F
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %6++_ (_$_'^55ZL67_'X
MGX_RJ9?"RZ?QHUJ***XSU0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** ,'Q1X.TKQ9:>7J$6V91A+A -R^Q]1[']
M*\)\5_"?6M :2:WB^UV@Y\V($@#W'5?QX]Z^E**Z*.(JT'>#,*U"G65IH^+Y
MH)H#B:-E]R./SJ$FOKK5O!GA_6F9K[3(3(W62/,;'ZE<9_&N0OO@=X?N&)MK
MBX@)[,JN!^0!_6O6AF^GOQ^X\R>5O[$OO/G,FDS7O3_ "P)^75R![VQ/_M2F
M_P##/UC_ -!C_P E6_\ CE;?VM1[/\/\S+^S:O=?C_D>#9II->T77P7TV"<Q
MQZIYNWJWD,.?^_E0?\*=L?\ G_\ _(+?_%TO[5H]G^'^8_[-J]U^/^1XZ329
MKV/_ (4Y8?\ /]_Y!;_XNC_A3EA_S_\ _D%O_BZG^U*/9_A_F/\ LZKW7]?(
M\;S2$U[+_P *;L/^?[_R"W_Q='_"FM/_ .?[_P @M_\ %TO[4H]G^'^8_P"S
MJO=?U\CQDFFDU[/_ ,*:T_\ Y_O_ ""W_P 71_PIG3_^?[_R"W_Q=+^TZ79_
MA_F/^SZO=?U\CQ?-)FO:?^%,Z=_S_?\ D%O_ (NC_A3&G?\ /]_Y!;_XNE_:
M5+L_P_S'_9]7NOZ^1XKFD)KVO_A2^G?\_P!_Y";_ .+I/^%+:;_S^_\ D)O_
M (NE_:5+L_P_S']0J=U_7R/$\TF:]M_X4MIO_/[_ .0F_P#BZ/\ A2NF_P#/
M[_Y";_XNE_:-+L_P_P Q_4:G=?U\CQ'-(37M_P#PI73/^?W_ ,A-_P#'*/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ JQ9?\?B?C_*J]6++_ (_$_'^53+X673^-&M11
M17&>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !69JVH_9U,$)_>L.2/X1_C4^HWZV4/RX,K?=']
M:YEF9W+.26)R2>] !1244 +129I: "ES244 +1249H 6BC-% !FES244 +12
M49H 6BBB@!<T4E% "T4E+F@ HHHH 6C-)10 M%)2YH **,T4 +FC-)10 ZBD
MHS0 M%)2T %&:** %HI*,T +129I: "C-%% "T4E% "T4F:6@ HS110 N:*2
MB@!:*3-+0 4444 &:6DHH 6BDI<T %%%% !2YI** %HI** %HHS10 4444 +
MFBDHH 6BBC- !1110 M&:2B@!:6FTM "T4F:6@ HHHH ,T444 +1249H 6BB
MB@ HHHH ,TM)10 M%)FES0 4444 %%%% "YHI** %HI,TM !1110 4N:2B@!
M:*2B@!:*,T4 %,EBCGA>*9%DC<%61AD,#V(I]% 'B_CKP'+H$K:EI*L^G,V6
M4<M;G_XGT/Y^\'A_7Q=[;2];$_1'/_+3V^O\Z]M=$EC:.55=&!5E89!!Z@BO
M&_'G@)]#D;4]'1FT]CET')MS_P#$^_:O5PN*O[L]SYG,<NY;U*2TZKM_P#8Q
M2XKG?#WB(76VTOVQ-T20_P ?L??^==-BO4O<^><6B/%&*DQ1B@5B+%8VNZXF
MF1F*'#W3#@=D'J?\*=K^O)IB&"W(>Z8=.HC]S[^U4?!O@V[\67YN[UG2P5\R
MS'[TI_NK[^I[5G4J*$;LWH8>=::C%#/"'@Z\\7:@US=,\=BCYFG/5S_=7W]^
MU>X6-E;:;916EC$L,$2[411TI;2TM["SBM;.)88(EVHBC@"IJ\&M6E5?D?:8
M3!PPT=-7U8N:*2BL#M%HHHS0 4444 %%%% "YHI** '44E&: %HI*6@ HHHH
M ;1117<>.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !5BR_X_$_'^55ZL67_ !^)
M^/\ *IE\++I_&C6HHHKC/5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "H+NZ2S@,DGX+ZFI)94@B:20X5
M1DFN7OKU[VXWMPHX5?04 13W$ES,TLIRS?I4>:** %HI*,T +124M !FES24
M4 +1249H 6BBB@ S2TE% "T4E&: %HHHH 7-%)10 M%)2YH **** %S1244
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445#=W
MEO86DES>S)!!&,O(YP!0!-534-6T_28?-U*\AMD[&1P"?H.I_"O.M;^(U]J3
M-!X<0V=MT-Y*N7?_ '5[#W//TKDGA62=KB[=[JX8Y:6=B[$_C7=0P-6LK[+S
M..MC*5+3=GI-U\4M#B8K8Q7E_P#[4,.%_-L?RK.?XK2_\L?#TK#MONE7_P!E
M-<27J,R5Z,<JI_:D_P"OO."693^S%';?\+7N_P#H6_\ R?'_ ,12?\+9NO\
MH6__ "?'_P 17#-)3&DJ_P"RZ/=_A_D3_:-7LOQ_S.[_ .%MW(_YES_R>'_Q
M%)_PMRX'_,N?^3P_^(K@6DJ)I*?]E4>[_#_(7]I5>R_'_,]"_P"%O3_]"[_Y
M/#_XBD_X7!,/^9=_\GA_\17G325&ST?V51[O\/\ (7]I5NR_'_,](_X7%+_T
M+W_DZ/\ XBD_X7))_P!"]_Y._P#V%>:-)4;24_[)H]W^'^0?VE6[+\?\STX_
M&5A_S+__ ).__84G_"YS_P!"_P#^3O\ ]A7EQDJ-I*?]DT>[_#_(7]IUNR_'
M_,]4_P"%TX_Y@'_D[_\ 84G_  NL#_F _P#DY_\ :Z\H9ZC:2C^R:'=_A_D'
M]IUNR_'_ #/6O^%V+_T ?_)S_P"UTG_"[T'_ # O_)S_ .UUY$TE1EZ?]D4.
M[_#_ "%_:=;LOQ_S/4]0^,/V[:/[*\N-?X1<DY/_ 'Q5#_A:$7_0-_\ )@__
M !%>;M)4;24?V10[O\/\@_M2MV7X_P"9Z9_PM*$?\PW_ ,CG_P"(I5^*=M_'
MIY'TGS_[+7ES25&TE/\ L>AW?X?Y"_M2MV7X_P"9[':_$G2)V"S1S1$]QA@/
MUS^E=!8:YINI\65Y'(W]S.UOR/-?/#/3XKR>!@8I&7';/%85,GTO3E]_]?H;
MT\UU]^/W'TI17CWA[XE7MBR0ZB?M$'3YSR/HW7\\UZEI6L6>LV@GL9=P_B0\
M,OU%>+6H5*$N6HK'JTJU.LKP9?S2TE%8FPM%)1F@!:*** #-+244 +1249H
M6BBB@!<T4E% "T4F:7- !1FBB@!<T4E% "T4F:6@ I<TE% "T4E% "T49HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI5BRD9[D!CD8/:DZ;2N5&O&3LC2HHHK,W"BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %6K#_CZ'T-5:
MM6'_ !]#Z&HG\+-*7QHU****Y#U HHHH **** "BBB@ HHHH **** "BBB@
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MYF';@FO3?A9XO\0>)['4K;Q;IGV#4M-F6)SY31^9D9^Z>_';@Y&* .\HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JU8?\?0^AJK5JP_X^A]#43^%FE+XT:E%%%<AZ@4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %> ?$BU-EX\U 8PLQ65??<HS^N:]_KRGXT:02MCK$8X -O(<=.K+_[-^E=
M>#J*GB(R?]7.7%P<Z$DCRII*C:2HF>HVDK[*Q\K<E:2HR]1-)4;24Q$K25&T
ME1-)49DIV$2M)4;25$7IA:F!(7IA:F$TF:+@.)KV8?M"84#_ (1@<#M?X_\
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MA@CB7HBA1^ I])2YKYH^@"BBB@!<T4E% "T49HS0 4N:2B@!:*2EH **,T4
M+1FDHH 6EIM+F@!:*3-+0 9I:2B@!:*2C- "T444 &:6DHH 6BDHS0 M%%%
M"YHI** %HI,TN: "C-%% "YHI** %HI,TM !2YI** %HI** %HHS10 4M)10
M N:*2B@!:*,T9H *7-)10 N:6FTM "T4F:* %HHHH ,TM)10 M%)FC- "T44
M4 &:6DHH 6BDHS0 M%%% !FES244 +1249H 6BBB@ HS110 M%)10 M%&:*
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MOV7_ /D(^(_^N5O_ #>@"C\*/^3D-8_ZZWW_ *,-.NY9!^UVN'8?Z=&O7MY
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M49S^0-1*C3E!RIO8TABJ\*L85XI<VUB[X[UZ1;NU32-4(4*WF"UGZ-GOM/\
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M%>BURUXP4O=9Z6#G5E37M%;:WF%%%%8'8%%%% !1110 4444 %%%% !1110
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M$U-QV'$TTFDS29J;E6%S29I":;FIN.P[-(33<TF:5RK#LTF::32#+, HR3P
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M:+ITM[G/VE[1&D_[Z(S4QT72FUA=6.F69U%5VB\-NOG 8QC?C=C!QUZ5<HH
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M HHHH *M6'_'T/H:JU:L/^/H?0U$_A9I2^-&I1117(>H%%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M117<>.%%%% !1110 445YM\6?BW'\.EM;*RLTO=5NT,BI(Q"11YP&;')R00
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M[[3YY9)$V'[RKN)!//H*]<KSGP-X@^)VI^(_(\:^&;#3=,\EF,\'#!QC:/\
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M4B]&4C(-"DF.4''<LT5X;#^T))I^J^)+37=/AFDL;LVVF6UDCK)<$.Z_.Q)
M^ZO('?@&JNH?&CXD:$L>J:[X'BM='D88WPRHZ@] SEB%/U4?2ESQ*]C,]\KD
M/$/Q+T7PUXVTKPM?PWKW^J>5Y+PQJ8T\R0QKN)8$?,#T!J_H/BN'Q9X(77O#
MD?FO- [16\IP1*H(\MO3YAC/IS7S1XVUCQU>?%GP_>^(M#M+/Q!#]F^PV<0_
M=S8G8Q[OWAZN2#\PX';K2E*RT'3I\S:9];T5YWX$U_XEZGXA>#QOX;L=,TT0
M,RSV_P!XR97 _P!:W&">W:O1*M.YG*/*[!15'6]:L/#NBW.K:O.+>SM4WR.>
M?8 #N2< #N37BZ?&WQMXIN9C\/?!8N;.)MIFND>3/U*LJJ?;)I.20XPE+5'N
MU%>)Z'\>K^P\0QZ+\2O#YT660J/M"*R*F3@,R/D[/]H$_C7HOCS4_%6F>'X;
MCP)I=MJM^URJO%<?=$15B6'SKSD*.O?I0I)H'3DG9GDFH:]XS^*/Q8U7PWX9
MU^70=,TLR*TD#LA(C<(6)4AF+-T&0,?CGU;X?^'_ !)X;TRZLO%.OG7#YP:U
MN'+%U3: 0Q;GK[GZU\Z_#_6?'5C\0M?NO"VAVE]K$QE^W6TP^2',N6Q^\7HW
M'4_UKZ:\'7NOZAX7MKGQ?I\.GZJY?SK> _*H#$*1\S=1@]340UU-JJY596L;
ME<CJ'Q)T;3?B'9^#9X;UM1NPI21(U,*[@2 3NSV[ UT&N3ZA;:!?SZ);I=:C
M';NUK!(<+)(%.U3R."<=Q]17ROK6L^.YOC9IVH:CH=I#XG01_9[!1^[? .W/
M[P]1G^(54I6(IP4[W/K:O%KG7]87]K"TT==4O!IC0G=9"=O)/^B.V=F<9W#.
M<=:ZOX?ZY\1-5U6ZB\=^'K+2[1(=T,EOU:3<.#^\?C&3T%>8^+?$%AX6_:J&
MM:N[):6EMN<HNYCFT90 /4D@?C2D]$QTXZM>1]&45X1??&7XB3V;:WHG@4)H
M*_.);F&61VC_ +^5*@#'.0"!Z\5Z)\-/B-9?$709+J"$VE[:L$NK8MNV$CA@
M>ZG!Q]".U-23=B)4Y15V=G17*?$#XA:5\/=$6]U(-/<3DK;6D9 >9AUY[*,C
M)]QU) K@D\??&.]M1J=CX!LET]AN6.4GSBO7[ID5O_'*;DD["C3;5SVBBN%^
M&_Q0LO'T=S:R6CZ9K%E_Q\V,AR0 <%E) .,\$$9!Z]B>ZIIIJZ)E%Q=F%%4=
M<OI-,\/ZC?PJKR6MK+,BOT)5"P!]N*\8TC]H:ZO?"]NBZ*NI^*;F=XXK"P1Q
M&$&,.<[F[G@9SM/2DY);E1A*2NCW6BO!;CXW>._"M_ WCSP;%;6$[85H8Y(V
MQWPS,RLP'\/'X5[=I&JV>N:/:ZIIDHFM+N(2Q/Z@^OH>Q%"DF$H..K+E%>(2
M_'^?2?$?BK3]8L+>8Z;=O:Z7!:JXDN765DPY)(Q@ D@#V!R!70> O&WQ!UOQ
M0EGXM\)+IFG3P-+'<I;RIL(QA6+,1DYZ'!]J7.F-TY)79Z?17G'Q(^,-AX%O
M8](L;)]6UJ8 BV1MJQAON[B 3D]E R?;(SQT_P 5OBSIUJ=2U+P'"FG*-SXM
MIE=5]2=YV_4K0YI J4FKGO%%<;\.?B5I?Q%TJ6:RC:TO;8@7-I(P8IGHRG^)
M3@\X'3I4'Q*^)UE\/;2VC%H^H:I>DBVLT;&1TW,>2!DX  R3QZD/F5KD\DN;
MEZG<T5X;J_Q%^,NCZ1)J][X+TRWL$7S&9D:1XU]659MPQW)48K3^%WQ&\?>.
M-5MKC4-$TM?#[F1)KRUW*T;JI(&#*QSG;P5Z'-+G5[%NDTKGK]%>6^/?BS<>
M"/B=I6BW4=HNBSV8N;N=XW:9,M(,+AL?P#C!SFL73_BW\0->U*WOM$\#EO#D
M]RL:S/#(\I0MC?N4X]R0I YYXS1SJ]A*E)JY[917#?$;XA7?@R33K'1] N=;
MU+4M_DQ19VJ%VY)P"3]X< ?B*XFZ^(WQBT^V;4;SP'9K81C>ZK&[2*N.2<2$
MCZ[:;DD$:<FKGM]%<;\-?B+9?$709;RWMVM+NU<1W5LS[MA(R"#QE3@]AT-8
MGQ*^*-WX#\9>'=/$5G_9E^P-]/.CL\4?F!69=K#H"3R#1S*UQ<DN;EZGIM%>
M'7?QG\;:VL^H> O!3W.C0,1]JNH))&E ZD!& !]@6Q5S0OVC-#N?"MW>Z_:-
M9ZG:E56R@;?]I)S@H3C &#G/3CDYQ2YXE>RF>RT5X)J/QI^(VEVZ:SJ'@6.U
MT-R,&:.4. >F7S@9[$IS7K_@WQ98^-O"]MK>F!DCFRKQ/]Z)QPRGZ>O<$&FI
M)Z"E3E%79N44451F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5:L/^/H?0U5JU8?\ 'T/H:B?PLTI?
M&C4HHHKD/4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK,UCQ'I
M.@QAM5O8X6(RL?WG;Z*.:XV^^*4DA*Z-H[LO::[?8/\ OD<_K5PA*;M%7)E.
M,%>3L>BT5Y#/X\\53G(NK*U]H8-W_H1-5CXQ\6?]!T#V%G%_A72L#B']G\CF
M>,H+[7YGL]%>*GQGXL'_ #'O_).+_P")II\:^+!_S'?_ "3B_P#B:?U#$_R_
MBO\ ,7UW#_S?@SVRBO$3XX\6#_F.?^2D7_Q--/CKQ8/^8W_Y*1?_ !-/^S\3
M_+^*_P P^O8?^;\&>X45X:?'OBP?\QO_ ,E(O_B::?B!XL'_ #&O_)6+_P")
MH_L_$_R_BO\ ,/KV'_F_!_Y'NE%>$GXA>+!_S&?_ "5B_P#B::?B)XL'_,8_
M\E8O_B:/[/Q7\OXK_,/KV'_F_!_Y'O%%>"GXC^+!_P QC_R6B_\ B::?B5XL
M'_,7_P#):+_XFC^S\5_+^*_S%]>P_P#-^#_R/?**\!/Q,\6#_F+?^2T7_P 3
M33\3O%@_YBO_ )+1?_$4_P"S\5_+^*_S#Z]A_P";\'_D?0%%?/I^*/BP?\Q7
M_P EXO\ XBFGXJ>+!_S%/_)>+_XBC^SL5_)^*_S#Z_AOYOP?^1]!LP52S$
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M0MO,"7#%R,_+"PX "]3]W\*]9\66]G\4OA%J">')Q=1WL;-9R;2F^2*3@?,
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ME^#?]Y?_ $<M?0%>#?M)Z=>6UQX<\26D9:.SD:*1\9"/E73/L<-^5=K#\=/
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M,U\]7ET_P<_:"O-6U*VD.C:P96$T:Y_=RL';;ZE' R.N/J*)*R0X2YI2?<[
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M90O0XZC!SQR/0T/1JXXIRC+E/H?XA:9;ZO\ #G7K2[160V$KJ2,[752RM^#
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M &X?^ECUL_LQ_P#(BZM_V$C_ .BDK"^.TG]A?&+PCXCN48VL"PL<#.?)N"[
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M^1[F$QS;Y*OW_P"9[714%I=PWMK'<6S;HY!D'^E39KPCV1:,TF:6@ S2TE%
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M51@ #  I:*$DM@<F]S"T3P5X?\.:O?ZGHVGBVO-18M=2^:[^82Q8\,Q Y)/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX!-J>EWMG$S; ]Q;O&I;&<9('. ?RJ5.#=DT4X32NT56DJ-I*CW%F"J"23@
M=ZT6\+^(O*\S^P-4\O&=_P!CDQ^>*MRC'=DJ+>R,XR5&TE1NQ5BK @@X(/:H
MRU78DD:2F%Z8329H 4FDS29I,U-QV%S29II-(32N.P[--)I":3-3<=A<TF:3
M--)J;E6/1_AQXE*3_P!FW;Y20@+D]&['\>GY5ZA7S?8W;6=]',I(VMSCTKZ!
MT:_&I:1;W6069</C^\.#7RV84%2JWCLSZ/ UG4IV>Z+]%)FBO/.X7-%%% "T
M4E&: %HS110 M%)10 M%)FEH 7-%)10 M%)FES0 9I<TE% "T4E&: %HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 9I:2B@!:*2C- "TN:2B@!:*2C- "T444 +FBDHH 6BDI<T %%%% "YHI**
M%HHS1F@ I<TE% "T4E+0 449HH 6C-)10 M+3:7- "T4F:6@ S2TE% "T4E&
M: %HHHH ,TM)10 M%)1F@!:*** %S1244 +129I<T %&:** %S1244 +129I
M: "ES244 +1244 +11FB@ I:2B@!<T4E% "T49HH *7-)10 N:6FTM "T4F:
M* %HHHH ,TM)10 M%)FC- "T444 &:6DHH 6BDHS0 M%%% !FES244 +1249
MH 6BBB@ HS110 M%)10 M%&:* "BBB@"U1117<>.%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !5JP_X^A]#56K5A_P ?0^AJ)_"S2E\:-2BBBN0]0**** "BBB@
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M-)10 M%)1F@!:,T9HH 7-%)10 M%)FEH *7-)10 M%)2YH **,T4 +FBDHH
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M445W'CA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTE% "T4E% "TM)FB@!<T4E% #J*2C- "T9I*6@!:*2C- "T9I,TM "YHI**
M%HI,TM !FEI** %HI*,T +2YI** %HI** %HHS10 N:*2B@!:*2ES0 4N:2B
M@!<T4E% "T49HH 7-%)10 ZBDHS0 M&:2EH ,TM)10 M%)FB@!:,T44 +124
M4 +129I: %S1244 +129I: "ES244 +1244 +11FB@ I<TE% "T4E+F@ HHS
M10 N:*2B@!:**,T %+244 +FBDHH =129HS0 M&:** %HI** %HI,TM !1FB
MB@!:*2C- "T4F:6@ I<TE% "T4E&: %HHS10 9I<TE% "T4E&: %HHHH 7-%
M)10 M%)2YH **** %S1FDHH 6BDI<T %%%% "YHS244 .HI*,T +124M !1F
MBB@!:*2C- "T4F:6@ HS110 M%)10 M%)FEH *,T44 +FBDHH N4445W'CA1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 N:*2B@!:*3-+F@!<T4E% "T4E+F@!:,TE% "T4E+F@ I<TF:* %S2TVEH
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MBBBNX\<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "K5A_P ?0^AJK5JP_P"/H?0U
M$_A9I2^-&I1117(>H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,TE% "T4E+F@ I<TE% "TM-I: %HI,T4 +FC-%% "T4E&: %HI*6@ S2TE%
M"T4F:,T +FES244 +1249H 6BBB@!<T4E% "T4E+F@ HHHH 7-%)10 M%&:,
MT %+FDHH 6BDI: "BC-% "T9I** %I:;2YH 6BDS2T &:6DHH 6BDHS0 M%%
M% !FEI** %HI,T9H 6BBB@!<T4E% "T4F:7- !1FBB@!<T4E% "T49HH *7-
M)10 M%)10 M%&:* "ES244 +FBDHH 6BC-% !2YI** %S2TVEH 6BDS10 M%
M%% !FEI** %HI,T4 ;M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5)!_KEJ
M.I(/]<M %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ JGJFI1:99F:7ECPB?WC4]U=16=L\\[;409/O[5Y[JFI2ZI>--)PHX
M1/[HH ANKJ6\N7GG;<[G)]O:HJ2C- "T9HS10 M%)10 M%&:* %S1244 +12
M9I: %S1244 +129I<T +FBDHH 6BBC- "YHI** '44E&: %HS24M "T4E% "
MT9I,TM "T4E% "T4F:6@ S2TE% "T4E+F@ I<TE% "T4E&: %I<TF:* %HI*
M* %I:3-% "YHI** %HHS1F@!<T9I** '44E&: %HS24M !2TE% "T4F:6@ S
M2TE% "T4E&: %I<TE% "T4E&: %HS1FB@!<T4E% "T4F:6@ I<TE% "T4E+F
M@ HHS10 N:*2B@!:**,T +1FDHH 6EIM+F@!:*3-+0 9I:2B@!:*2C- "T9H
MHH 6BDHH 6BDS2T &:6DHH 6BDI<T %&:** %HI** %HHS10 4N:2B@!:*2B
M@!:*,T4 +FC-)10 M%)2YH *6DHH 7-%)10 ZBDHS0 M&:2EH ,TM)10 M%)
MFB@!:,T44 +1244 +129I: "C-%% "T4E% "T4F:6@ I<TE% "T4E% "T49H
MH *7-)10 M%)2YH **,T4 %+FDHH 6BDI: "BC-% "T9I** %I:;2T +129H
MH WJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTN: #-+244 +124N: "ES244 +1249H 6ES244 +1249H 6ES29HH 6BDI:
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M 1T5)Y$G]W]:/(D_N_K0!'14GD2?W?UH\B3^[^M $=%2>1)_=_6CR)/[OZT
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M]:/(D_N_K0!'4D'^N6CR)/[OZT^*)UD!88'UH L4444 %%%% !1110 4444
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M4E% "T49HH 7-%)10 M%)2YH 6C-)10 M+3:6@!:*3-+0 9I:2B@!:*3-&:
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MS1FB@!<T4E% "T4F:6@ I<TE% "T4E+F@ HHS10 N:*2B@!:**,T +1FDHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 9(*G'4@CKCN*[\'./MI<[?.^ZMH<6*C+V2Y$N1=G<YFRN%M=0MYW!*Q2JY
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MDHS0 M&:3-+0 N:*2B@!:*3-+0 9I:2B@!:*2C- "TN:2B@!:*2B@!:*,T4
M+FBDHH 6BDI<T %+FDHH 7-%)10 M+29HH 7-%)10 ZBDHS0 M&:2EH ,TM)
M10 M%)FB@!:,T44 +1249H 6C-)FEH 7-%)10 M%)FEH *7-)10 M%)1F@!:
M*,T4 %+FDHH 6BDI<T %%&:* %S1244 +111F@ I:2B@!<TM-HH =129HS0
MM&:** %HI** %HI,TM !1FBB@!:*2C- "T4F:6@ HHHH [*BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#P#XG:<=,\;W;!<1W6)T/KN'/_CP:N-:2O</BYX?.
MI>'DU.!<S6)._'>-L9_(X/T)KP9GP2#U%?3Y764Z/)UB?.YE2<*O/T9*SU&T
ME0M)4;25Z]CS"9I*C:2H6DJ,R4[")FDJ-I*B+4TFF(>7II:FYI,TKCL+FDS2
M9II-3<=AV:0FFDTA-*Y5A2:]WT3XM>$M;\*QZ3XT@,++$D<RO 9(I=O1AM!(
MZ XP,'H37@V:3-<M>A"NDI=.QT4:TZ+?+U/>],\6_"3PB\E[X>0M=;2!Y<$[
MR'V5I>!GZBO*O'OC*;QMXD;47B^SP1H(K>'=DJ@).3[DDG\AVKF"::36=+#0
MI3Y[MONW<TJ8B=2/)9)=D.S29IN:3-=%SGL+FM+0_$6J^&[\7FB7LEI-C#%#
MD./1E/!'UK+)I":B5I*S+C=.Z.H\8^/]7\;I8C64M5-B'$;6\94MOVY+9)_N
MCIBN7S32:0FHC&,(\L59%2E*;YI;CB::329I,T[A87-)FD)IN:FX[#B:0FFY
MI54NZH@RS'  [FI;*2.U^&U@;C6#<,N5CYS].?YE:]9KF?!&C_V7HBLP^>4=
M?;_ZYS^E=+FOF<14]I5<CZ&A3]G341:7-)16!L+1249H 6ES29HH 6BDHH 6
MES29HH 6BDHH 6ES29HH 6BDI: %HS29HH 6EIM+0 M&:3-% "YI:2B@!:*3
M-+0 9I:2B@!:*3-+0 9I:2B@!:*3-+F@ S2YI** %HI*,T +2YI** %HI*,T
M +2YI,T4 +124M "T9I,T4 +2TVEH 6BDS10 N:6DHH 6BDHS0 N:6DHH 6B
MDHS0 M&:** %HI** %HHS10 N:*2B@!:*3-+F@!<T4E% "T4E+F@!:,TE% "
MT4E+F@ I<TF:* %S2TVEH 6BDS10 N:*** %HI*,T +1FBB@!:*2B@!:*3-+
M0 N:*2B@!:*3-+F@ S2YI** %HI*,T +1110 N:*2B@!:*,T9H *7-)10 M%
M)2T %+29HH 7-%)10 ZBDS1F@!:,T44 +1244 +129I: #-+244 +1249H 6
MC-%% "T4E% "T49HH ,TM)10 M%)2YH **** %S1244 +124N: "ES244 +F
MBDHH 6BC-% "T9I** %I:;2T +129HH 7-&:** %HI*,T +124M !FBBB@#L
MZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,TM "T4E% "T4F:6@!<T4E% "T4E+F@!<T4E% "T4E+F@!<T9I** %HI*7-
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ME8^N_![2=$5%.J>?._(B$## ]2?,.*7]J4>S_#_,?]G5>Z_KY'C6:0FO3/\
MA7=A_P ]?_'6_P#BJ3_A76G_ //7_P =;_XJI_M2CV?X?YC_ +.J]U_7R/,R
M::37IW_"NM/_ .>O_CK?_%4?\*YT_P#YZ_\ CK?_ !5+^TZ79_A_F/\ L^KW
M7]?(\P)I,UZA_P *XT[_ )Z_^.M_\51_PK?3O^>G_CK?_%4O[2I=G^'^8_[/
MJ]U_7R/+LTA->I?\*WT[_GI_XZW_ ,52?\*VTW_GI_XZW_Q5+^TJ79_A_F/Z
MA4[K^OD>6$TF:]5_X5KIO_/3_P =;_XJD_X5KIO_ #T_\=;_ .*I?VC2[/\
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M3-+0 9I:2B@!:*2C- "TN:2B@!:*2C- "T9HS10 N:*2B@!:*,T4 %+FDHH
M6BDI<T %%&:* %S1244 +111F@!:,TE% "TM-I<T +129I: #-+244 +1249
MH 6C-%% "T4E% "T4F:6@ S2TE% "T4E+F@ HS110 M%)10 M%&:* "ES244
M +1244 +11FB@!<T9I** %HI*7- !2TE% "YHI** .VHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %+FBB@ HHHH *6BB@ S2T44 %%%% !1FBB@!:*** "C-%% "T444 %%%%
M!FEHHH **** "ES110 4444 %%%% "YHHHH **** "ES110 9HHHH *6BB@
MS1110 M%%% !1FBB@ S2T44 %%%% !1FBB@!:*** "C-%% "YHHHH **** "
AES110 4444 %%%% !2YHHH **** "BBB@!<T444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>bdtx-20211231_g20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g20.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,S
M,P  DI(  @    ,S,P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M,-*#W%>L^!K[Q5?Z#)+XYTZVT[41.RI%;'*F/ P?O-SG/>@#I**** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&< 8%4O#WPOU/PC\7K[6O#_V&'PY?PF.2T5RKQY4'Y5VXP''KT)H POV9/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7J_@SQ1\2M4\2QVOBWPC:Z7IC1N7N8G)8,!\H^^>OTKSGQ19^+_#_P"T'?\
MBO0_">H:M"F!$4@<QR;H0IPP';G\J[#0_B=\0M1U^QL]1^'%W96EQ.L<URR2
MXB0GECE<<4 >:OXHN_"/[1OB34]/T:?69O-FB^RP9W8.WYN >!CT[U<GU+5O
MC[\1M,LCI\6CVFC9DN4DES*J[QOZ@$G*@8QQWKJ_!_AO6[3]IC7]7NM)O(=-
MF$_EW;PL(GR4QANAS@U%X[\+:]X1^-&G>-?!^D7>H6]V<W\%G$7.>DF0/[RX
M(_VA0!A_'6^DTGXV>&K^WMGNY+6"&5+=,[I2LS$*.#R>E5?&_P 2->^*(L_
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M2W#IYTSAPJE6!ZLJ@<CN:]C^''A^\\+?#O2-&U,Q_:[6';*(VRH)8G&>^,T
M=/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#?<W_QR@#V^BO$/^%(>,?^BD7_ /WW-_\ '*/^%(>,?^BD7_\ WW-_\<H
M]OHKQ#_A2'C'_HI%_P#]]S?_ !RC_A2'C'_HI%__ -]S?_'* /;Z*\0_X4AX
MQ_Z*1?\ _?<W_P <H_X4AXQ_Z*1?_P#?<W_QR@#V^BO$/^%(>,?^BD7_ /WW
M-_\ '*/^%(>,?^BD7_\ WW-_\<H ]OHKQ#_A2'C'_HI%_P#]]S?_ !RC_A2'
MC'_HI%__ -]S?_'* /;Z*\0_X4AXQ_Z*1?\ _?<W_P <H_X4AXQ_Z*1?_P#?
M<W_QR@#V^BO$/^%(>,?^BD7_ /WW-_\ '*/^%(>,?^BD7_\ WW-_\<H ]OHK
MQ#_A2'C'_HI%_P#]]S?_ !RC_A2'C'_HI%__ -]S?_'* /;Z*\0_X4AXQ_Z*
M1?\ _?<W_P <H_X4AXQ_Z*1?_P#?<W_QR@#V^BO$/^%(>,?^BD7_ /WW-_\
M'*/^%(>,?^BD7_\ WW-_\<H ]OHKQ#_A2'C'_HI%_P#]]S?_ !RC_A2'C'_H
MI%__ -]S?_'* /;Z*\0_X4AXQ_Z*1?\ _?<W_P <H_X4AXQ_Z*1?_P#?<W_Q
MR@#V^BO$/^%(>,?^BD7_ /WW-_\ '*/^%(>,?^BD7_\ WW-_\<H ]OHKQ#_A
M2'C'_HI%_P#]]S?_ !RC_A2'C'_HI%__ -]S?_'* /;Z*\0_X4AXQ_Z*1?\
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MAXQ_Z*1?_P#?<W_QR@#V^BO$/^%(>,?^BD7_ /WW-_\ '*/^%(>,?^BD7_\
MWW-_\<H ]OHKQ#_A2'C'_HI%_P#]]S?_ !RC_A2'C'_HI%__ -]S?_'* /;Z
M*\0_X4AXQ_Z*1?\ _?<W_P <H_X4AXQ_Z*1?_P#?<W_QR@#V^BO$/^%(>,?^
MBD7_ /WW-_\ '*/^%(>,?^BD7_\ WW-_\<H ]OHKQ#_A2'C'_HI%_P#]]S?_
M !RC_A2'C'_HI%__ -]S?_'* /;Z*\0_X4AXQ_Z*1?\ _?<W_P <H_X4AXQ_
MZ*1?_P#?<W_QR@#V^BO$/^%(>,?^BD7_ /WW-_\ '*/^%(>,?^BD7_\ WW-_
M\<H ]OHKQ#_A2'C'_HI%_P#]]S?_ !RC_A2'C'_HI%__ -]S?_'* /;Z*\0_
MX4AXQ_Z*1?\ _?<W_P <H/P/\8X_Y*1?_P#?<W_QR@#V^BJ.B6,VF:#8V-U<
MM=S6\"123MG,C 8+'))YJ]0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 R7[@_P!Y?YBGTR7[@_WE_F*?0 4444 %%%% !1110 4444 %
M%%% !1110 R'_41_[H_E3Z9#_J(_]T?RI] !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 0W=K'>V4]K."8IXVC< ]588/\ .O!K'P]\2?@Q)>)X
M7LX/$GAZ24R^2!^]7WVCY@<  XW#CI7N>L:9%K.BWFF7#,L5W \+,AP5##&1
M[UXKH6F?%OX96<VB:-I%CXCTXS,]O<O-ADSZ@L"!WQSWYH Z+P?XN\,^,_"'
MB34-'T:#2=82TE7481$JR$E&.2P + D'KWZUYEX.EEB_95\6M!D,;K:Q']TF
M(']":]!^'/PSU[1+'Q3J_B,PC6M>AD06T+C:F[<>3TR6;MP *G^%?PVU#2OA
M;J_ACQC:K =0FDW+'*LGR,B@$$<9!'Z4 'P\UAO"G[/.CZGIFCW&KS8):TM!
M^\D9I6!/0]/Z57^'GC/0?$OB/Q)#IW@\Z!JBVKRWLKL-\AW8*L !SDYK'T'2
M?BW\+[:70M!TBQ\0Z5YS/;3-*%,8)YX+*1GKCGG.#6W\,?AWXFT?7/$7B7Q4
M;6*_UJ)U^R6[;MK,VXDGH.>,9/UH \7\'^'=0B\!S^._#C,-4\/ZD&=1R'@V
M*3Q[9.?8GTKLXO$]GXQ_:,\(:WI[#9<6D9=,\Q.$DW(?H:]"^"/@;6/!_A/5
M-.\46<43W5T7$8E6570H%.<9'8\5R6A_!76O"_QOM=6TNWCD\.P7+3)*9E#1
MJR'Y-N<G!./I0!/\=]8MM9\9^&?!<][':6AG6ZOYI7"I&I.!DGC[H<_B*J^"
M-8TGPK^T/J.E:%>VMQHFOQAH#;2AXXY<;@N1QUWC'N*UM)^$M[XH^)GB#Q!\
M2]*CDLK@XL8!=9X!PI.QLC"J.O<U'X_^"*6?]DZE\+-*CM=2L[L22)]J*[@.
M5.78]".WK0!3\3_\G=Z#_P!>\?\ Z!)7O=>&>./!?C^[^*^G^,O#&E6DDMM9
MQ#;<7*!5EVL&4C<"0-W45T_A?4/B]-XEM(_%>CZ/;Z2Q;[1);R NHVG&/G/?
M':@#C?@E_P CK\1?^NK?^C):\U\(^'=1'@^_\;^''==5\.ZDLA5>=\.W+<>W
M?U!->V_##P%X@\->)O&-YK%I'#!JLC-:,LROO!=SR >.&'6K'P1\"ZUX.T#6
M;+Q/9Q1&\NMZ()5D#IMP<X)_*@#@%\4V?C+]H;P7K=@0$N+-/,CSDQ2 2[D/
MT/Z8K8^'(%Q^T]XRENN9HEF$6[J!O1>/^ XJ/1O@KK/ACXX6FKZ3;QOX=AN3
M,DAG4-$K*?DVDY."<?2MWQM\/?$^E?$0>._AQY$UY*NV\L9V"B7C!QG (( R
M,@Y&10!G>.?BCI2>((+/Q;\.;JX6VO'BLKN[8*KD, 73*^P/Y5[D#D UX!KG
MA/XF_%;5=)_X2G2-/\/V.G2F3>)=S')&[Y0S$G"C'05[^!@ 4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '#>*OB9!X;UI]-BTY
MKR6)5,K&;RPI(R /E.>"*Q?^%U?]0#_R<_\ L*Y7XE_\E$U/_ME_Z*2O4_\
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M_P F9?\ XJC4#EO^%U?]0#_R<_\ L*/^%U?]0#_R<_\ L*ZG_A6GA+_H$_\
MDS+_ /%4?\*T\)?] G_R9E_^*HU Y;_A=7_4 _\ )S_["C_A=7_4 _\ )S_[
M"NI_X5IX2_Z!/_DS+_\ %4?\*T\)?] G_P F9?\ XJC4#EO^%U?]0#_R<_\
ML*/^%U?]0#_R<_\ L*ZG_A6GA+_H$_\ DS+_ /%4?\*T\)?] G_R9E_^*HU
MY;_A=7_4 _\ )S_["C_A=7_4 _\ )S_["NI_X5IX2_Z!/_DS+_\ %4?\*T\)
M?] G_P F9?\ XJC4#EO^%U?]0#_R<_\ L*/^%U?]0#_R<_\ L*ZG_A6GA+_H
M$_\ DS+_ /%4?\*T\)?] G_R9E_^*HU Y;_A=7_4 _\ )S_["C_A=7_4 _\
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M9E_^*HU Y;_A=7_4 _\ )S_["C_A=7_4 _\ )S_["NI_X5IX2_Z!/_DS+_\
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M+_\ %4?\*T\)?] G_P F9?\ XJC4#EO^%U?]0#_R<_\ L*/^%U?]0#_R<_\
ML*ZG_A6GA+_H$_\ DS+_ /%4?\*T\)?] G_R9E_^*HU Y;_A=7KH'_DY_P#8
M5VG_  EUG_PA/_"2^7)]G\O=Y?&[=NV;?^^N,UYM\3_#6D^'?[+_ +'M/L_V
MCS?,_>.^[;LQ]XG'4UJ_\V\?Y_Y^Z  _&H9.-!R.V;S_ .PH_P"%U?\ 4 _\
MG/\ ["LKX8>&M)\1?VI_;%I]H^S^5Y?[QTV[M^?ND9Z"N^_X5IX2_P"@3_Y,
MR_\ Q5&H'+#XTY8#^P.I_P"?S_["O4ZY8?#7PD#D:3_Y,R__ !5=33 *\WU;
MXM_V7K-Y8?V)YOV:9XO,^U[=VTXSC8<=*](KF[OX?^&+Z\FN[K3/,GG<R2/]
MHE&YB<DX#8H Y#_A=7_4 _\ )S_["C_A=7_4 _\ )S_["NI_X5IX2_Z!/_DS
M+_\ %4?\*T\)?] G_P F9?\ XJEJ!U0.5!]:* ,# HI@><ZS\6?[)UJ\T_\
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MPWJE_+>WVG>;<3'<[^?(N3TZ!@*K?\*T\)?] G_R9E_^*I:@<M_PNK_J ?\
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M@#BO^%U?]0#_ ,G/_L*/^%U?]0#_ ,G/_L*ZG_A6GA+_ *!/_DS+_P#%4?\
M"M/"7_0)_P#)F7_XJEJ!OZ5??VGH]G?^7Y7VJ!)MF[=MW*#C/?K5NHK2UAL;
M.&UM4V0P(L<:Y)VJ!@#)YZ5+3 X/Q1\3/^$:U^;3/[)^T^6JMYGVG9G*@]-A
M]?6LC_A=7_4 _P#)S_["NUU3P3X?UK4'O=3T_P ZX< ,_G2+D 8' 8#I5/\
MX5IX2_Z!/_DS+_\ %4M0.6_X75_U /\ R<_^PKT?2-0_M71;._\ *\K[3"LO
ME[MVW(SC.!FL'_A6GA+_ *!/_DS+_P#%5TEG:06%E#:6B>7! @2-,D[5 P!D
M\TP)JX7Q5\2O^$9UZ33?[)^T[$5O,^T[,Y&>FT_SKNJPM5\%:!K=^U[J=AY]
MPP"E_.D7(' X# 4 <3_PNK_J ?\ DY_]A1_PNK_J ?\ DY_]A74_\*T\)?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTZXCNK69=T4T3!E<>H(ZT 6***S--\2:)K%]<V6E:K9WEU:G$\,$RNT7./F
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ->@_P#1+UZ_X1?4)/!ND/K08:@UG$;C?][?M&<^_K7D&J_\GA:;_P!>@_\
M1+T 'AC_ ).X\0_]>K_^@Q4GPG_Y.&\>?[TO_HZE\,?\G<>(?^O5_P#T&*D^
M$_\ R<-X\_WI?_1U 'HOQ>_Y)%XB_P"O3_V85XU\ =0E\,^,+73KIS]C\3:?
M]HMR>!YL;,,?^.N/RKV7XO?\DB\1?]>G_LPKQ8V-U;? 'P=XQTQ0;WPY>/+G
MUB:8Y!]LX_ F@ ^/-Y/XI\9ZC;6K_P"@^%[%6F(Y!ED=1CZ_,!_P$U#\1?\
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M** "BBB@ HHHH **** / OB7_P E$U/_ +9?^BDKWT=*\"^)?_)1-3_[9?\
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MHM:\*Z#XBV_V[I%G?E!A6GA#,H] >M:U% %'2M$TS0K7[-HVGVUC#G)2WB"
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MR?\  1V%=+10!S_@CPG:^"?"-GHEFWF>2I:68C!ED/+-^)_3%=!110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 R7[@_P!Y?YBGTR7[@_WE_F*?0 44
M44 %>!?$O_DHFI_]LO\ T4E>^UY_XG^&#^(O$=UJBZJMN)]G[LV^[;M0+UW#
MTI,#T"BBBF 4444 %%%% !1110 R'_41_P"Z/Y4^F0_ZB/\ W1_*GT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 >!?$O_DHFI_\ ;+_T4E>^CI7@7Q+_ .2B:G_VR_\
M125[Z.E( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!X;\4/"=MHGBA];AN)9)M;<M+&X&V/RU11MQSSN[UO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[-\-/^2=Z9_VU_\ 1KTNH'1VUC:66[[':PV^_&[RHPN['3./K4]%%, HHHH
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M%%%% !1110 4444 ,A_U$?\ NC^5/ID/^HC_ -T?RI] !1110 4444 %%%%
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MG1_$FI65K<-;Z 7WL2O^D!03E.>AQWH [/[/#YGF>3'OSNW;1G/KFGD!E(8
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MWXW^3$J;L=,X'/4U8I@%%%% 'F.LV^MW'QTD7P[?VME<#04+O=6YF5E\YN
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MNBZJ8A"]W9,O[U!T5T8%6QV.,BK/AOPE9^''NKA;BYO]0O2#=7]X^^67'0<
M *.R@ 4 8GP=_P"2967_ %WN/_1SUPDN/^%%Z[Y/_'I_PD#_ &7'W?+^UKC'
MMG-=I8?"V:QTXZ4OB_61I)9RUG#Y<60[%F7>%W8))Z&M[5_!6FZEX+7PS;;M
M/L(_*\L0 90(X8#GU(Y^M '%?$#1&\1?$:'3(#MN7\/32VLG]R=)D:-L]OF
M_.I;K7A\0[3PIH\8^6\'V_5XO^>:0'!C;ZR@#_@-=Q-X:@F\:6OB,W$@GMK)
M[-80!M968-D]\\54\/\ @;2_#GB#6M7L2YFU>0.ZMC;".253T!8EOK0!Y:3,
MWP!T$VWEB<Z]%Y?F [0WVML9QSC/I7JND+XT&HI_;TF@M9;3O%E',),XXP68
MCK67+\-+5O =KX8AU2ZA2UNQ=Q72JID#B0R#@C'4_I5S3_"NNVFHP7%SXUU*
M\AC<,]O);P*L@_NDA 0/I0!Q.@Z]XBT.3QM<:+X<CU6U@UJZF>3[:(W! !*A
M-I)X&>O-7=)\-Z9JOPR=M9UR"*;Q)J U&.\@.Q([EV#1K&&ZD%0,'DX-=UH'
MAR#P_)JK03R3?VG?R7L@D ^1GQE1CMQ67!\.=)CT+4-$GDFFTRZNC=00;MIL
MG)W?NF'(PW(]* ,+5=3\0^'+>WB^(%AI>OZ%)<11-?VR%)(G+ (\D+9!^;'*
MGBO2JXM?AU]JN8/[?\2:OK5G;2K-#9W3H(]RG*ERJ@OCW-=I0 4444 %%%%
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MC(T>YN6*!U)0GVKH/#WA^P\,:-%IFE(ZP(68M(Y9Y&8Y9F8]22<YH TZ***
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M$NU5JS10HI;%3J3G\3N%>+_&[Q'=ZOJ%A\._#I\R^U*1#=[3]U,Y53[<;C[
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MYZFNVKFM \":3X<\3:OKNGM<F[U=R]P)9 R EBWRC''+&NEH **** "BBB@
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M*\1O_BWXV\33._ABVM](T_.(Y9E#R./J01^0_&NJ=2,%>3/(P^%JXAVIJY]
M45\\6WQ%^)6B-Y]W-::Q;KR\31 -CV*@'^=>O^!?'FF>.](-UI^8;F$A;FTD
M/S1-_4'L:4*L*GPLO$8*OAOXBL=11116AQA1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5O%%,P #.&8E?7(R*SO"W@E]0^#<7ASQ%;26<[-,PSC? _FLR.,=QP:]$HH
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M .2B:G_VR_\ 125[Z.E>!?$O_DHFI_\ ;+_T4E>^CI2 ****8!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >$_$SPDF
MB>+;C7%O&F;7'+M"8\"'RU5>#GG.[VKTCX>VT%Y\--.@NX(YX7\W='*@96Q,
MY&0>.HKRKX@^*+_6/'VJ:-=B$6NC2*ML40AB)$4MN.>>5'I7K/PT_P"2=Z9_
MVU_]&O2Z@=!9Z98:=O\ [/LK>U\S&_R(E3=CIG YZG\ZM444P"BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !3)98X(6EGD6.-!N9W. H]2:?7E'QOU"<QZ-HJ2,EK>O)+<*IQY@C
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M %>/?&W_ )&#PW_USN?Y+7L->/?&W_D8/#?_ %SN?Y+6U#^*CS\R_P!TGZ'
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M@L8[S3I+6*W6YD,WVAHU4.Q CV[R.3QG&:L_\V\?Y_Y^Z0!\%?\ F-_]L/\
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M^BDKWT=*\"^)?_)1-3_[9?\ HI*]]'2D 4444P"BBB@ HHHH **** "BBB@
MHHHH **** //OC5_R3L_]?MO_P"AUY >M>O_ !J_Y)V?^OVW_P#0Z\@/6O4P
M7P,^/SW^/'T"BBBNX^?"BBB@"]X;_P"2@>&O^O\ '_H+5])5\V^&_P#DH'AK
M_K_'_H+5])5Y&+_B'VF1_P"[/U"BBBN0]P**** "N#^,W_),;W_KM!_Z,6N\
MK@_C-_R3&]_Z[0?^C%JH?$C#$?P9>C/&SUHH/6BOH#\V"BBB@ JSHO\ R.GA
MS_L*1?UJM5G1?^1T\.?]A2+^M95OX;.O!_[Q#U/I>BBBO"/T4**** "BBB@
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M7/\ UR;^5+I__(-M_P#KDO\ *DU'_D&7/_7)OY4NG_\ (-M_^N2_RJ/MFO\
MRZ^?Z%BBBBK,@HHHH IZO_R"IOP_F*^I[7_CSA_ZYK_*OEC5_P#D%3?A_,5]
M3VO_ !YP_P#7-?Y5YF-^)'UF0?PY^I+1117 ?2!1110 4444 %%%% !1110
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MCW,EI2EB>=;)'H5%%%>2?:!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@7Q+_ .2B:G_VR_\
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M< =OK7K84#H /H*6HI8>%-W1OB\UKXJ/++1!11170>45M1!;2[H 9)A< ?\
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MP6"DJ#]:O7NJ66GV@N;NX1(F^ZV<[OICK1RL+HMT5G:9KVG:NS+8W =U&2C
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MOB_X=Z1XO=+F<R6>HQKM2\M\!\>C#HP]C7!2_!CQ''(1;:]I\T>>&FMV5OQ
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MV=@64'%/G]ZPN7W3A(;2^;P;<2HK_9OM*L0!U !!/TSBLJVBEFNHH[96:9F
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M9;>)W2-"&9 2/FK9O40Z;.K*I3RS\I''2FY["4=SR?0HIYM>LUM03()E;([
M'D_3%1:K%/#JUTEV")?-8MN[\]:]+T6SM[2ZD\B".(M#&3M4#/'--UJSM[J\
M)GMXY66V8@LH..:?/[UA<ONG#16M\?!<TJJ_V;[4K8]@I!/TSBLFUBFGO(H[
M4,9F<! O7.:]C@5!IR*%4)Y0&W'&,5D:+96UO>0O#;QQN]N6+*@!/S4E4T8W
M'8\?^(%RLGBJZMWN8YKF"5O.56R4R 5SZ<5N>$[2^E\"W\ELK^1\NX#^+#DG
M'T%<YX^\-ZEI/Q"UC5KV-%M-6D1K1E<$L$10V1VY(KO](U6YT3X&Q:A8%5N(
MMVTLNX<W)4\?0FL%.TKFG+I8Y=59V"(I9F.  .2:V?%%O=P:I&;[<6:",*Q[
MX4 _KFI?AKJTVM:Q<R7T5OOB(*M'"%.6#9Z?05Z!K%M#=+:QW$22J9UX=<UO
M[2[1GR:'G7A^UOKB#4S8A]OV5E?;_$<CCZX!K%QVQSZ5[#HL,<&FJD2*BAVX
M48[UFFPM?[7^T?9XM_VO;OV#/W<T*>K!QT1Q6OVM];VVF&^#[?LH5=W\)R>/
MK@BCPM;W<^K/]AW!E@DW,.@RI _7%>CZU%'-IC),BNI9>&&>],T:VAM1=QV\
M21*)R,(N.PI<_N#Y?>/(G5HW9) 593A@1R#6UJ=I?1>&M*DN%?R!YFT'^')R
M,_45V>H6-K+J5Q-);Q,ZR1?,4!-:VJHCZ3<*ZJR[#P1D4W/5"4=SR_PW#<3>
M(;06>=ZON+#^%>Y/M5&[BF@O)H[H,)E<[PW7.:]4T:T@M+BY6WACBX3[B@?P
MU6UJRMKB\F>6WCD=+<$,R@D?-34_>L+E]TXE[6^'@N*5E?[+]J+8QVV@ _3.
M:S]+BGFU:U2U!,IE4KCM@]:]>F5#ISKM79Y1^7'&,5E:+9V]M> P01QLULI)
M50,\U*J:,;CJCSO7HIX=>O%N@1(96;)[@G@_3%6K.TOW\)7TL2O]F\Z,D#OC
M.3]!Q7>:U9V]W=1">".4K#(1N4''%:5BB+IL"*JA/+'R@<=*'4]U!RZL\:BC
MDFF2.!6:1F 0+U)[5J^*(+J'Q!+]MR68*58]",#I7<:38VT%_!+';Q([I(2R
MH ?O5=U:T@NYK..XA253*>'4'M5.?O"4=#Y1OO\ 5ZC_ -?;_P#H5>GQ M&@
M R2  !WKS?5U"76K*HP%U"0 #M^\KZ5T^QM5N[:X6WB$AF<;P@S]VKE*QYN"
M5Y3]3CO$MM>V\]F;_<2;6-5)]0.1]<T>&[6^N)[PV 8$6LBL1WR.!]:]%UJ"
M*XLXXYHTD4S(,,,]Z-%@BM[.2.&-8U69QA1CO67/[AZG+[QY"05)!&"#@@]J
MVM:M+Z#1](:[5Q&("%W#[IW$@'\,5VEQ8VK:I).UM$9!=1C>4&>E:>LQI+I,
MR2(KJ<<,,]Q3<]4)1T9YKX7@NIM?B^Q9#JK%F'0#:1S^E94L<D,SQSJRR*Q#
MANH->M:1:P6DMY';PQQ*)!PB@=JHZM96T]_<2RV\3NB1D,R D?-34_>$XZ'%
M7=I?)X1L)90_V;SI"H/\.<8/T.#_ )-5=!BGFUZS6U!\P2JV1V /)^F*]7OT
M1M,G5E4IY9^4CCI6?HMG;VEU,(((XBT,9.U0.HJ54]UE..J/,M4BGAU6Y2[!
M$PE8MGOSUK1CM+X^"Y90K_9OM0;&.VW!/TSBNXUNRM[J\8SP1R,MLQ!90<'-
M:L2)_9RJ%79Y0&W'&,4.>B$HZL\=LXIIKZ".U#&9G&S;USFO.?%@8:]XD$AR
MW]HS9/K\]?26BV-M;7<3PV\<;/;Y+*H!)W5\W^,/^1C\2_\ 81F_]#K12O*Q
MYV.5J<?4]5T2TOI?".H26ROY&R+<!_%CDX^@ZUDJK2,$C!9F.% ZDUZ]H"*G
MAVP5%"K]G3@#VK/L+&UBU*WGCMXE=Y)<L$ -0I[GH<NB.*\46]W!JR?;MQ9H
M(]K'OA0#^N:- M;ZXMM3-D'V_92K;?XCD''UP#7HFLV\-TMK'<1)*IG48=<^
MM.T2*.'352)%10[<*,=Z7/[A7+[QX_CG&.>F*VO$%K?6]OIAO@^W[*JKN_A.
M3Q]>E=I]AM?[6\_[-%YGVS&_8,_=K2UN*.;32DR*ZEUX89[U3GJB5'1GG'A>
MWNY]4D^P[@RV\@9AT&5( _/%8[*T;%9 593A@>H->O:/;PVJW4=O$D2B=AA%
MQ6??V-K)J4\TEM$SK+%\Q09H4_>8..AQ>J6M]%X;TI[A7\C#[0?X<MD9^HJ'
MPU#<S>(K06>0ZON+#^%>^?:O3]61'TFX5U5EV=",BJNC6<%G<726\,<7W,[%
M _AJ5/W65R^\>5744T%Y+'=!EF5R'#=<UK26E\/!<,K*_P!E^U,V,=BH ;Z9
MS7;:S96UQ>S236\<CI;A@S*"1\U;$Z(=/D0JI3RB-N.,8IN>B$H[GD.E13S:
MO:I:AC+YJE=O;!ZU+KL4\.O7BW082&5FR>X)X/Y5Z)HME;VMV#!!'&SVR,2J
M@$\T_6K.WN[J/SX(Y2L,A&]0<<<4^?WK"Y?=."M+2^?PC>RQ*_V;ST+ =\ Y
M/T&1_D5D0QR33)' K-(S (%ZD]J]EL41=.@154)Y8&T#CI6-I%E;07\$L5O&
MCR1R?,J $_-253<;CL<1XHANH=?F^VY+L%*L>A&!TI^BVM]-HVKO:JYC\E0V
M!]XA@2!^&:]"UBU@NY;2.XA24&0\.H/:I=&C2+2(4C144 \*,=S2Y_='R^\>
M&:?H%EI^IW=[9QO]HO6S+EB=QSG@=N375^);:]M[BT-^&)-K&JD^H'(^N:Q_
MASJ%U??&OQ9;7DS36]I=2"WC<#$7[QQ\OX 5Z[K4$5S:Q1SQI(K3(,,,]Z.=
M75D+ET9YUX;M;ZXEO?[/#9%JZL1WR.!]:Q2"I((P1P0>U>OZ+!%;V;I#&L:B
M5AA1CO6?/8VK:J\[6T1D%W&-Y09Z52G[S$XZ(XO6[6^@TG26NU<1^057/\)W
M$X/OC%,\+074VO1_8LAU1RS#H!M(Y_'%>DZU&DNDRI(BNIQPPSW%1Z/:P6DE
MW';PI$!+T10.U3S^Z5R^\>2RQR13.DRE9%8A@W4&M>\M+]/"=A+,K_9O-D*@
M_P .<8)^O.*[;5;&VFU"XFEMXG=%C(9D!(^:M>_1&TR=&52OEGY2..E-U-A*
M.YY3H$4\VOV0M0QD$JMD=@#R?IBH-3BG@U2Y2[!$PD;=N[\]:]-T6RM[2ZF$
M$$<68HR=B@=N:9K5E;W5VS301R,ELS LH)!S3Y_>L+E]TX9+6^/@J24*_P!F
M^UAL8[;<;OIFLJSBFFOH([4,9F<;-O7.:]BC1!IRKM79Y6-N.,8K(T6RMK>\
MB>&".-GMLDJH!/S4E/1C<=4<%XCAN(?$-V+O.]I"P)_B7L1[5/IMI?2>&=4D
MMP_D9CW ?Q8)SCZ<9KO]9M(+NXM5N(8Y>),;U!_AJWI:(FE6ZHJJOEC@# I.
M?NH?+[QXVB-(ZI&I9V.%"CDFMGQ3;W<&L WNXLT,>UCT.% /ZYKM=/L;6+4;
M>:.WB5V>7+! ":OZQ;0W7V2.XB253..'4'M3<_>1*CH>=Z!:WUQ::H;(/M^S
M%6V_Q'(.![XS6+CMCVQ7L&BQ1PZ8J1(J*&;A1CO6:+&U&KB?[-%YGVPC?L&?
MNTU/5CY=$<7X@M;ZWBTTWP?'V553=_#C.1]>E<!XT!^S:<<<?:L9_P" FOH7
M6X8Y].V3(KJ9%&&&>]>4_%^WBMO#NF1P1)$JZNPPJX_Y9FB$[HY\5&U*1Q?@
MW_C[U7_?C_\ 037HNJVM]%X<TE[E7$(5]H(^[ELC/U%8/P?M()WUV6:%)&CN
MK;:S*#MR#FO9]61'TFX61592G1AD42E:20L)&]!,\P\-0W,WB&U%GD.K;BP_
MA7'.:S[J*6"[ECN599E<APW7->K:/9P6=Q=I;PQQ#*?<4#^&JNM65M<7DTDU
MO&[I "&9 2/FH4_>.CE]TXB6UOE\&02LK_9?M3,!CH"  ?IG->=^,O\ C]TK
MZR_R%?24Z(=.D4JI3RB-N.,8KP[XN6D%I>>'?L\*1;XY&;8N,G:M$)<QS8R-
MJ+,/P5_QYW__ %]G_P!!%=_:VE\WA"]EC5_LWGHQ [X!R?ITK*^$5I!=Z'J@
MN((Y=MW,1O4''[M*]CLD0:;"JJH3RP-H''2B<[%86-Z4?0\:ACDFG2.W5FE9
M@$"]2>U:GB>&ZA\03_;<EVP58]UP,8KN-(LK:"^@EBMXD=XG)94 )^:KVKVL
M%W-:)<0I*"YX=0>U#G[QNHZ'GNC6M]-HFKO:JYB,2AL#[V&R0/PS6* 6(502
M3P .]>PZ-&D>DP+&BHH'11CO67:6-JFJ13K;1"1KB4;P@STI*>K&XZ(XOQ-;
M7MO=6OV_<2;6,*3[+R/KFCPY:WUP]]_9X;BU=6*]\]!]:]%UJWBN;:&.:-)%
M:=!AAFET6"*WLFCAC6-1*XPHQWI<_N#Y?>/'R,$@C!'!%;>N6M]!I>DM=JXC
M^SE5!'W3N)P??&*[2:PM6U9KAK>(N+M!N*#/2M/68TETJ5)45U..&&>XIN>J
M$HZ,\V\+074VNI]BR&6-RS#L-I'/XXK)EC>*5XYE*R*2&##D&O6M(M8+22[C
MMX4B42]$7':J.J65M-J%Q+);Q.Z"/#,@)'--3O(3CH<5>VE^GA/3Y9E?[-YL
MA4'^'.,'\><56T"*>;Q!9K:@^8)0V1V /)/MBO5M01&TR=752OEGY2..E9^B
M6=O:7,X@ACCS'&3M4#J*E3]UE<NIYCJ,4\.I7$=V")A(V_=W.>M:2VM]_P (
M4TH5_LWVO?CVVXW?3-=QK5G;W-V[301R,ML6!902#FM5%3^S0NU=GE8VXXQB
MFZFB$HZL\>LHII[Z".T#&9I!LV]0<]:N>(X;B'Q#>"[!WM(6!/\ $IZ$>V*[
M_1;*VMKR)X;>.-GMLDJH!/-3ZU:07=Q;K/#'+A)"-Z@]%I\_O6%R^Z<!IUI?
MR^&-3DMP_P!GW1[@/XL$YQ].,UC(C2.J1*6=CA0HY)KV73$1-+MU155?+' &
M!6/IMC;1:E;S1V\2N[2_,$ /!I*>XW'8V(%D33K=9^9%6,/]>,U:IDOW!_O+
M_,4^N8V"BBB@ KP+XE_\E$U/_ME_Z*2O?:\U\6?#34O$'BB[U.VO+6**?9M2
M3=N&U%7L/:DP/2J***8!1110 4444 %%%% &?HI_XEP']UV'ZU60XAAE[&])
M_,D5<L87@CFP/E<AT]\J,_K49LI!HZ0@9E4A\9[YS6MU<BSL2:ERMNG]Z=?\
M:+ XGO$])B?S J2XA>:[MFQ\D9+-]<<40P-%?SOC]W(%(/N.#4W7+8?4SY^8
M[V3^[<)^F*N:L?\ B7./[S*/U%,6S=M-N(W&))F9_P <\?TJ6>&2XAMD9<8=
M6DYZ8'^-5=70K.PVV^75+M?4(P_*JMXOF2ZB1_#"H_K5[R674_.4?(T6UOJ#
MQ3(K5C]L,G'GL0/IC I)I.X6Z"W<G_$GD?UAS^8J&V'EZE&I[VJ_H:<]O-)I
M$=N1\Y"JW/0 \U-) WV^"9!\JJR-[#M1HE896NE\S4I%]+5OU-36LG_$GC?T
MAS^E/C@;[?/,X^5E5%]QWJ%+>9-'>W ^<!E7GJ,\?I1I:P=2O9KY<VG?[4+#
M^M6KCYM5M%] ['\L4Z6U8&S,?/D, ?IC!IWDNVI^<P^18MJ_4GFAN[N*W0^4
M-2&V_P!0'IJ3_P#HVOIVTXM]/D_O3-^N:^9=9&-4U4#_ *"<N/\ O[7U(+-U
MTNUC09DA*-^/?^M;5'HCS,"O>GZDE^<W%FOK-G\@:--X2X3^[.X_K4DL+R:A
M!)C]W&&)/N>!1;PO#=W+8^20AE^N.:PTY;'J=3/<YADF[?;@?R(%6]6YLU7^
M_(H_6F"RD.CM"1^]8E\9_BSFI[F%YGMN/E1][^V!Q^M5=7%9V/E73_\ D+6/
M_853_P!'5]-W7S#4G_NM'^F*^8]._P"0M8_]A5/_ $=7U0MFS6]VK\-.[$?3
MH*UF[-'F8!74O474V_XE,Q'\2@#\33+<>7JTR>L*'\N*=-!+-801,,-E/,YZ
M =:D:%_[32=1\IC*-[<Y%8:6L>IUN4[M?,O+P#^&UQ_,U:,G_$FW_P#3#/\
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M;LO^/&PE]9_Y@U\S^(N-6UW'_03F_P#1E?4,-FXT&UB09EC"/^/4UM-Z(\O
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MM;>,C!WJ9.>@')IYA8:FLZCY3$58^^<BEI:P^MRE>#S)[_'\-N%_F:M32?\
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M_P Q3ZR+"BBB@ HHKG]3\<^'M'U*6PU&_,5S%C>GDR-C(!'(4CH10!T%%%%
M!1110 4444 %%%% %'3Y&GCG;<=N[8OMA14)NY#HL;;CYK,(]W?.<5+HHQIH
M/]YF/ZU53[D4787Q_3)K6VI'0O74KQ7EKACL=BC#UXXI8)6EU"Y&X[(PJ@>_
M4TS4N(X'_NSH?UQ18#,UX_K.1^0%3]FX^I$+J2/2[HEB9(79 3UZ\?SJ6ZD>
MWM[9]Q^615?GJ#P:IW'"WD?]ZX3]<5<U8?\ $MD/]TJ?U%5970N@\2,^K&,$
M[(XLD>I)_P#K5''<-&;X.<^2VY<]@1FEM?FU*\;_ '!^E5+UO+FU ?WX5/\
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M]JD;1HV#'S681[N^<XJQ<RM%>6F&.UV*,/7CBJ$8^6&+L+UOTR:NZGPEN_\
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M@-IA];_']:NZIQ:HW]V5#^M597%T'Q2M)J<ZY.R-%&/<\U MT\5E>EV):!V
M)_3^=267-Y>M_P!- /R%4[K@:@G]YX_UQ0DKV] OI<MW$DEOI]NY8[E9-YSU
M'0U(TC-JJ1 G8L19AZDG INJ+G2YO]D _D:;;'?JEP_I&@_3-+I<?6PL5PR3
MWJN21$0ZY]"/_K5&99AH0FWGS0HDSZ\YJ*]/EW=X?[UKG]<5;=/^).4_Z88_
M2C31B/!_BXP?XF.PZ-IT1_5J]"^#<K+\/M-B8Y1HW=0>W[U@:\X^*3;OB"A_
MZA<'\VKT'X4'R_A[HS>MO<?I*QK:2]Q(\RA_O<V=O#)+-I,TN]M[;V4YZ>G\
MJ5[EY(;'82#,REB/3&34FGI_Q*85/>/G\:HV9WMIJ_W5D/Y<5EI=GIE]Y635
M8T).R2,X'N#_ (4EI(\ZW+%CCS"J>P Q3;SB_LF_VV'YBC2?^/$-_>=C^M3]
MFX^I";J1M'A8,1+(RQ[AUSG!_E5FYD:*^M<,=CEE8>O'%9\72VB[+>-^F35[
M41C[,_\ =G7]>*II7L);#K>5I;ZZ&3LCVJ![XR:K"ZD32)R6)EC=HP3USGC^
M=3Z>,O=O_>G8?EBJ,PPMU'_>ND_7%"2O8.A>NI'MX[5MQXD57]P1BG+(SZLZ
M G9'$,CW)_P%-U4?Z Q_NLI_44EI\VHWK>ZC]*G[-Q];"1W+(E]O.3"Q*Y],
M9%-EDEBT>*;>2ZA&8YZ\\_SJO>'9)J0_O1H?Z5=OD_XE,R>D?\A5::"%>5CJ
M<,2G"B-G8>O84D<S)?W4;DE559%SV&.?Y5#:-YFI;CVMD_7FFW9\N_F/]ZT;
M]#2MK8+]1RR3-H;3;V\PJ7!].<U)+<-)+9+&<>:=[8] ,TZ)/^).J?\ 3''Z
M54LCYES8_P"S;$_KBC34#P[Q]XBU'5?B)K.E7LJM::5(BVJ! "@= 6R>_(%>
MH> [&+4?A;!:WD:SPR>;^[<9'$C$<?49KE_C!I5A9ZA87MI:0PW5Z93<RH@#
M2E0@4L>^ 37:_#0?\6\TWW\W_P!&O6:W++>GV%AIEC =*M(;1[QXUE,*[=V,
M]?U_.M6:5H]2MUR=DBLI'N.:S[;D6"?W99/TS5V^XNK)O27'Y@UJTD[>I">@
MZUD>:XNR6.Q7V*/3 YJM]JD_L0MO/F[O+W=\[L5/IG-O*W]Z9S^M4\?)Y/\
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M+?@FVS2M8/K<R_HBUZO9Q_\ $IB3UB_F**FCN5A=:,?09)<O(MCL.#,P+8]
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M/(/7-;.I17R^&M*:X#^1^\V9[9/'Z=*IPV$I;G<Z!JMEJ%U<BVG5W(0[3P2
MN#P:K:[K-A:W\T,MRHD: (5&3@[LX..E<3X<6X?Q%9_8\^8'R2.R]\^V*HW2
MS)>3+=!A,'/F;NN<\T<BYKAS/E/7IKRV&CO<F>/R#$2)-WRGCUK(T'6+&\OU
MC@N%:06ZJ%/!)'7&>M<8\5Z/!<3D/]E^UL1_WR,'Z9S^-9^F+,^K6HM<^=YJ
M[=OUI*&C&Y:H]&U_5K*PO8UN+A5<PN"HY(R.,XK3T^\MI-'BN$GC,*QC+[N!
M@<YKRS75G37[T76?,\YB<]QGC\,59M(KYO"-^T0?[+Y\98#OC.?P^[FDX+E0
M*6K.OT?6]/N-2MX([E2X5U /&26R ,]:T-<U2TTZ>S:ZG5")"VWJ<8ZX%>4Q
MJ[RHL(8R%@$"]<]L5K>)TND\03?;LER%*D]Q@=*IP7,)2T/'-5<27&K.IRK7
M\A!]M]?1NGZ[IS7EM +M,B9CD\+RO'/2OFR^_P!5J/\ U]O_ .A5Z?'S$@'/
MRC%6U<\W!.TI^IZ[K]_:V-G$UU,L?[U2 >IP><"D\/W]M?6<KVTRR?O6+ =1
MD\9%>?>)([Z.XL_[0W9^R1A2WTY'USUH\-QWTEQ>?V?NS]DD#%?IP/KGI67(
MN3<]3F]XZVYUW34U62$W:9-S&2?X1@<\]*V-=O+>VT:22>945L;23][GMZUY
M">.OXUM:U%>IH^CF[#^7Y#!-W8[C_P"RXJG#5$J6C.]T+5+/49KLVDZR$N&V
M]#C'7!K/UC6M/M]2N(9+E0[*BD#G!#9.<5Q_A=+I_$$/V'(D"L21V&T]?QQ6
M5(KI*ZS!A(&(<-USWS0H+F!RT/8=0O+9-'EN'GC$+1G:^[@Y'&/6LS0-6LKZ
M]E6WN%9_*C 4\$X'.,UQ-W%?CPC8-*'^R^=(5SVSC'X?>Q570EG?7[(6N?,\
MY3QV&>?PQ4J"Y6-RU1WFO:Q8V=^T4]PH<V[*5')!)XSCI6Q%>6QT=;D3Q^0(
ML^9N^7&/6O)=36=-5NA=Y\[S6WY]<UH1Q7I\%RN _P!E^U@^WW>3],XIN"L@
M4M6=AH>M6%U?PPQ7*F00; IR,G=G SUXKYW\8?\ (Q^)?^PC-_Z'7HEHLSWT
M"VNXS&1?+V]<YXKSGQ9O&O>)/,Y?^T9LX_WZM1M*YYV.=Z<?4^F_#UW;R^&;
M.6.9&C2!0S!N%P.<^E96GZYITVJ6\"72;EDDQG@'/3!KC]%BOF\(ZBUL'^S[
M(M^.^.N/PQFLI0S, @)8G"@=2:A06IZ'-HCUC7M2M-/6U:ZG6,B8,!U) SDX
MI^@7MO>:7OMYED =MV#RO/?TKSSQ1'=IJZ_;]V\P1[2>_P HS^N:- BOI+;5
M#8A]OV0A]O?D<?7&:7)[@^;WCK/[=TW^V/)^UQY^U[L_P],=>G6M?7[VVL],
MWW,RQ@NNW)Y;GL.]>1UM>((KZ.#3/M^_;]D4)N[<G(^N,53AJA*6C._T'4K3
M4%NFM)ED/G%B.A /0XK,U#7-.BU2>%[I-QEBSCD#'7)Z5R7A>.\?5I/L&[>+
M>3)'^Z<?KBL=@58A\A@>0>QH4%S,'+0]?UB[MX=%FEEF18V3Y6SPV>F/6J>@
MZM9ZA<W/V:=7<[3M/!P!C.#7"ZG%?+X;TEKD/Y&)-F>V6X_3I[5#X;2Y?Q%:
M?8L^8'R2.RXYS[8J5#W6/F]X[77-9L+74)H9;E0[0A"!DX.[.#CIQ6W/>6RZ
M0]R9X_(,1(DW?*>/6O(+I94NYEN0PF#G?NZYSS6K)%?#P7"[!_LGVMB/^^1@
M_3.:;@K(%+<[/0=8L;V_$<%PK2"W50IX)(ZXSUI^OZO96%ZB7%PJN87!4<D9
M'&<5YUI:S/J]H+7/G><NW'UJ37%G37KT76?-\YB<]QGC\,4^1<UQ<WNGJEA>
M6SZ1%<)/&85C&7W<# YS6'HVM6%QJ4$$=RA=4=0#D9);( SUKD;2*^;PC?-$
M'^R^>A;'0X!R?I]W-9,2R/,BP!C(6 0+USVQ24%J-RV/5-=U2STZ:T-U.J$.
M6V]3C'7 J?0KRWN=&BD@F1U4'<0?N\]_2O./%"72>()_MN3(0I!/<8'2GZ-%
M>OHVL&U#^5Y*A\=_F&?TS2Y%R!S>\5O!7Q NM9^)^NZ1J,]JMA87<@LW1=I;
M+LO+9YX KTG7[^VL+6%[J98_WRD ]3@\X%>-6NE65G=SW5I:I%/<G,KJ#F0Y
MS_,UTGB2.]CN;3^T-V[[+&%+?3D?7/6GR:J[#FT=CT'P_?VU]9R-:S+)B5BP
M'49/&167/KNFIJSPF[3/VI&)_A&!@\]*Y+PY'?237O\ 9^[/V1PVWZ<#Z^E8
MQXZ_C34%S,3EHCUW7;RWMM'>2>9$5L;23][GMZU#H.IV>HRW9M9UD)DW;>AQ
MCK@UP6M17J:3I!NPXC\@A-W;YC^N,4WPLET^OQ?8<APCDD=AM/7\<5/)[@^;
MWCL-7UO3[?4KB"2Y0,PC!QDX(;G)%;>HWEO'H\UP\T8A:,[7W<'(XQZUX](K
MK*ZR@APQ#!NH/?-:]Y%?+X3T]IM_V7SI"F>@SC'_ +-BFX+0%+<[C0-7LK^]
ME6WG5G\I %/!.!S@&H]>UBQL[YHIKA1(;<H5&202>,XZ5P6@K,_B"R%KGS!,
MIX[#//X8J#4EG35+E;O/G>:V_/KFGR+FN+F]T];CO+8Z.+D3Q^1Y63)N^7IZ
MUBZ%K-A=:A##%<J76#8%/&3NS@9ZUQZ17I\%2, _V7[6#[?=Z_3./QK+LUF>
M^@6UW&8R#R]O7.>*2@K,;EJCTW7]5LK"ZMA<W"HX#_*.2 5P.!5[2;NWFT6&
M:*9&B5/F;/"XZY]*\Q\1I<)XBO/MF?,,A()[KVQ[8J?3HKYO#.J-;[_L^8]^
M.^#SC],TG!<J#F]XZW3=<TZ;5+>".Z0L'DQG(!STP:TM>U*TT_[(UW.L?[X-
MCJ2.YQ7DZAF8! 2Q.% ZDUL>*4NTUD?;MV\PQ[2>_P HS^N:IP7,A*6AZ'H%
M[;W>EA[>99 K-NP>5Y[^E9*Z[IO]KB'[7'G[66S_  ],=>G6N3T"*^DM-5-B
M&V_92'V]^1Q]<9K%H4%=@Y:(]<\07MM9Z:'N9EC!==N3RV#V'>O*/BSJ-KJ'
MAW37M9ED_P")LS$=" 4..*U/$$5_'%IIO]^/LBA-W;KD?7I7 ^-/^/?3O3[5
M_P"RFB$;(PQ4OW4C=^$NIVMC+K<5U,(S+<VY7(., '/->T:Q=V\&BS2S3(L;
M)\K$_>STQZU\Z^#?^/K5?]^/_P!!->B:I%>KX<TAKD-Y&U]F>V6X_2G*-Y)B
MPDK4$=WH6K6>HW5U]EG5V.T[3P< 8S@U3UW6;"UOYH9;E1(T(0@9.#NS@XZ<
M5Q7AI+E_$5I]BSY@;)([+CG/M5"Y65+J5;D,)@YW[NN<\TE!<QT<SY3U^>\M
MET=[DSQ^08B1)N^4\>M>'?%;4K;4+SP_]EDW^4DBMP1@[5KIY8KX>#+=F#_9
M?M3$?D,'Z9S7G?C+_C]TKZR_R%$(V.;&2O19U7PHU2TT_1=3%U,$9[N4 8)/
M*)CI7L=C>6SZ/%<)/&8%C&9-W P.<U\[^"O^/2__ .OL_P#H(KOK6*^/@^]:
M,/\ 9/M"%L=\ Y/TSMHG&Y6%E:DO0Z_1=:L+C48(([E2XC=0#QDELX&>O%7M
M=U2STZXM#=3JA#$[>IQCK@5Y9$LCS(L 8REAL"]<]L5I^)TND\07'V[)D.""
M>A7 QBAP7,;J6AZ1H=W;W&C1203(Z*#N(/W?KZ5CVFNZ:^JQ0K=ID7$A!/"G
M/3GI7)Z-%>OHFL&U#^5Y2A\=_FY_3-8N,\#DGIBA05V#EHCUK7]0MK"V@>YF
M6/\ ?*P'<@=<"ET"_MKZR=[699,2,6 ZC)[BO/O$T=['=VO]H;MWV6,*3].1
M]<]:3PY%?227W]G[\_9'#[?T'U]*GD]PKF]XZV;7M-75VA:[3_CZ1B?X>!CK
MTZUL:[>6]KI#R7$RHK8VDG[QSV]:\AZ=:VM;BO4TO2#=AQ']G(3=V^8_KC;5
M."NB5+1G?:%JEIJ,EV;6=7/F;MO0XQUP:SM7UK3X-3N()+E [",$#) (/.37
M(>%DNGUZ/[%D.(WR1V&T_P!<5DR!UD82@AP2&#=<]Z%!<P.6A[!J-Y;1Z/-/
M)/&(6C.U]W!R.,>M9V@:M97]Y,MO<*S^6@"G@G YP#7#WL5\OA/3FF#_ &7S
M9-F>@SC']<57T!)W\060M<^8)5/'8=\^V*E0]UC<M4=WKVL6-I?/%-<*)#;E
M"HY()/?'2MA+NV.CBY\^/R/*SYF[Y<8]:\DU%9TU*Y6[W>=YC;]W7.:T5BO?
M^$*9@'^R_:\^WW>OTS^M-P5D"EJSL="UFPN[^*&&Y4R+;[ IR,G/09ZU8U_5
M;*PNK<7,ZH^Q\J.2,K@<"O,K-9GOH%M<^>9%\O;USFKOB);A/$5X+O/F&0G)
M[CMCVQ3Y%S"YO=/3M*N[>;1H9HID:)4^9PW"XZY]*Q-,UO3YM4MX$NDW*T@&
M<@')XP:Y+3XKYO#&J-;[_L^Z/?CO@G/],UCJ&9@(P2Q.% ZDT*&X.6Q[9+]P
M?[R_S%/JK )1IMN+C_6A8]^?7C-6JY3<**** "O,_%WPUU7Q!XIN]3M+NSCA
MGV;5E9@PVHJG.%/<5Z910 4444 %%%% !1110 4444 5[&U@M+...VB2)-H.
MU%P,U"NB:8MU]I6Q@$V<[M@Z^M6X?]1'_NC^5/IW8$%W96U]#Y5Y DR9SM=<
MXI+.PM;",QV5O'"I.2$7&:L44K@49=$TR:Z^TRV,#S9R7*#D^M6;BV@NH##<
MQ)+$>J.N14M%.[ JV>FV6GAA96T<&[[Q1<$_C3+G1M-O+@3W5E#++_>9.3]?
M6KM%%V*R(WMX9+<P/$C1$;3&5&W'IBL+4[[P]X+M3>3116[OPB1+F23V'^<5
ML:C?0Z9IMQ>W3;88$+N?85Y5HMA+XVUB;Q%KXWVX?9;VY^[@=OH/U.:Y,1B'
M27+'=F]*DI^]+9#KWQ#K_B^3S=)T"VB@!PEQ<(&8C_>.!^0-3)+\1+2#8C6<
MT(&/(V1[<>F,"NJOM0L-'L3<ZC=6]E:IA3),XC1<\ 9/%9]KXS\,7UPMO9>(
M=+GF<X6..\C+'Z#-<'-5EJY,Z+P6T49F@>-;#3=6%OXCT./2;IC@7$<9VC/J
M#T'N,BN_U*'2;BR^UZH+9K:-=_GRD!57UW>E<]K&C6>MV+6U]'N'\#C[R'U!
MKR'Q''JMNL?AK4[QY-/LI3(D ^[+G[I/J!R<=B377A:\Y5%3J/?9G+B^6G0E
M5A'X5>QR&HW=JU_?_9LM U^[QLBG:4\S((/IBOJ71K?P_J$$6J:/'9W"N,K/
M!AAG\.AKYW  7:  /0"M[X=ZQ-X<\>64%NY6QU:3[/<0#[OF$'8X'8YX_&O?
MK8=J%T]CY#+LQC[;DE'XCWN\L+6_C$=[;QS*#D!USBEM;*VL8?*LX$A3.=J+
MC-3T5Y]V?5E$Z)IC77VDV,!FSG=L'7UHUB338=+EEUMK=+.,;G>X("K^)J]7
M@GQ/UF;7_'-QIDKG^SM(VJL&?EDF*Y+L.^,X%:4X.I)11R8O$QPM)U&CSRPO
MK>'4+-V++#'J"2F38=H02YSGZ5]4PV6AZVL>I016EZDHW+.F&#_B.#7SG@;<
M8&/3%7O#^K:QH9N]-T.8I;:DH0P#^"0D#<GH2.#6^,@J-)U6]CQ<HQGMJ_L.
M7XCUGQ3\0--LI'TC3K(:M=9V-$!F-3Z<=3["N=M?^$YW-+IUI8Z4LG\"1H#C
MTR<FMWPSX7M?#]FIVK)>.O[V8\G/H/05/J/BKP_I%V;75=;T^RN H8Q7%RB-
M@]#@FOFW5K5-VUY(^SM3ALK^;.:NK[Q;9R?:M=T:RU:-1\SB-=P'U3G\P:[;
MPMXOT?Q3:FT@C%O,B8>SE Z>W8BJ^FZUI>LQM)I&HVM\B_>:VF63'UP:YOQ;
MX=,!_P"$@T/-M?VI\U_+XW@=3CU_F*<:]6D]7==F')3J:6LST>TTC3["4RV=
MG##(>K*O-+>:58Z@5-[:Q3%>A9>1^-9_A+Q GB7P[!?@!9ON3H/X7'7\._XU
MMUZT9\R4DSBE'E?*R.*WA@@$$,2)$!@(JX&/I56WT73;6Y^T6]E#'+V94Y'T
M]*O455V(K7FG6>H(%O;:.<+TWKG%26UI!9PB&UA2&,?PH,"I:*+L"BNB:8EU
M]I6Q@$V<[@@Z^M3W=E;7T/E7D$<R9SAUSBIZ*+L+%>SL+6PB,=E;QPH3DA%Q
MFH9-$TR:Z^TRV,#39R7*#D^M7J*+L+$5Q:P7<!AN8DEC/5'7(J*STVRT]6%E
M;1P;OO;%P3^-6J*5V!2N=&TV\N//NK*&67^\R<GZ^M67MX9+<P21(T1&TQE1
MMQZ8J2BG=@4[/2;#3W9[*TBA9N"RKS^=%YI.GW\@>\M(IG7@,R\U<HHN]Q61
M&L$*6X@2)%B V^6%&W'IBJUKHVG64YFM;*&*3^\J\CZ>E7:*+L95O=,LM1"_
M;;:.;;T+KR/QKS/XE^.M4\$ZG9Z5H%K;6UL\'FF1XMP<DD%0.G&.>_->K57N
M["SOXPE]:PW*#D+-&' _.BYG4BY1M%V9X%I'Q<GLKY;B^\/Z;.0<EX%,3CW'
M49_ 5ZOX>\7^&OB!;^2B*;F,;FM+E0'7W'J/<4[6/AGX4UB%E?28;60C FM!
MY3+[\<'\0:\'UBQO?AUX],=K<[YK"19890,;T(R 1[C@BB[.1RJT/CU1]/6M
MG;6,/E6<"0IG.U%Q58Z)IC77VDV,!FSG=L'7UJS9W*WEC!<H,+-&L@'H",_U
MJ:B[.[0ANK2WO83#=PI-&>=KKD4RST^TT^,I96\<"MR=BXS5FBE=C*,^BZ;<
MW/VB>Q@DESDLR#GZ^M6IK>&X@,,\221$8*,N1^5244[L"I9:78Z<6-E:Q0EN
MI1>3^--N]'TZ^F$MW9PRR#^)EYJ[11=BLCP#XD(L?Q U%(U"(HB 51@ >4E>
MY6>D:?82&2SLX87(Y95YKP_XE_\ )1-3_P"V7_HI*]]'2DFQE2\TJQU!E:]M
M8IF7H67D?C4\5O#!;B"&)$B P$5<#'TJ2BG=@4;?1=-M;G[1;V4,<O9E3D?3
MTJ6\TZSU! M[;1SA>F]<XJS11=A8BMK6"S@$-K"D,8Z*BX%5ET33$NOM*6,
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MN:;9Z?::?&4LK>.!6.3L7&:L4478%&;1-,N+K[1/8P/+G)8IU/OZU9GMH;F
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M(;F+&]/)D;&0".0I'0BMZO OB7_R434_^V7_ **2D![[1113 **** "BBB@
MHHHH 9#_ *B/_='\J?3(?]1'_NC^5/H **** "BBB@ HHHH XCXL7;V_@DQ(
MV/M%PB-[CEOZ"IM$M5L]!L;=!@) OYD9/ZFF_%6R>[\#RR1C)MIDE/T^Z?\
MT*D\/7B7_AVQN(SG="H;V(&"/S%>3B?X^O8[:?\ "7J<9\<PI^%\P?!7[;;9
MSTQY@I_BW1_ANOA+46O;;08(UMW*R6XB616VG;L*\[LXQBF?'-5?X7S*XRK7
MML"#W'F"MZV^&_@NUN$GM_#&F)*A#*WV<'!]>:::4%Z_Y$;L9\,IM2N/AEH4
MNM&0WC6HW&7[Q7)V$^^W%8OQ0M46?3[M1AV#1L?4#!'\S7H@&!@<"O./B=>)
M)>V-DART:M(_MG@?RK"3;E[N]]/O+7*HOFVL[^ECB*LZ-_R.?AO_ +"L'_H5
M5JLZ-_R.?AO_ +"L'_H5?=5OX;/RS!_[Q#U1]+T445X)^C!7S?XH_P"2B^)?
M^OP?^@"OI"OF_P 4?\E%\2_]?@_] %=>$_B'AYW_ +K\T9]=)X MEN?%\;N,
MB"-I!]>@_G7-UT/@2\2S\70B4[5G1H@3ZGD?J*C.;^PC;;F7ZG#PUR_6YWWY
M7;[T>NUY6]IHEW\?M<7Q##I\T2Z/;F,7RH5#;NV_OBO5*\JD\.Z/XC^/VN0:
M]IMOJ$46CV[QI.FX*V[&17@4^OH?:R(=8M]!T[XM^$QX&%I#J$TLBZC%INW8
MUKMY,@3@<],UZT5# JPR",$'N*RM%\+:#X=,AT+2+.P:3AV@B"LP]">M:DDB
M11M)(P5$!9F/8"IE).P)6.8^%K&SUW7]*4_NHI Z*>V&*_RQ^5>EUYK\*HFO
M-2UW6",1SS!$SWY+'^8KTJN[!W]BB,1_$84445UG.%%%% !1110 4444 %%<
MWKOC*TTJ4VMHAO;WIY:'A?J?Z5S,^M^)+]BSWJV2$\1PJ,C\>OZUY&+S?"X5
M\LG=^1UT\)4FK[+S/2J*\N$FLAMPUV[S[N<?SJU;^)/$6G,#))'J,(ZJZX;\
MQ_\ 7KCI\182<K231J\#.VC1Z/16+H/BBQUU=D1,-THR\$G4?3U%;5>_3JPJ
MQYX.Z.&<)0?+)684445H2!.!D]*\3\6_&R\74)K3PM%#'!$Q7[7,N]I".I5>
M@'US^%>SW4/VFSF@#;3+&R9],C%?*UA)-X,\8*=5TV*ZEL)2LMK<+\K=L_U!
M^E!QXJI*-DG:YHMXV\<ZRY6'5-2F+?PVJ%?_ $ 5?T#X8^*/$^IK/J\%Q9VS
ML&GN;TGS&'? /S$_7BO5O#GQ4\*ZPD< G&ES8 $%R B_0,/E_E7;JRNH9"&4
MC((.0:9$,/&>KE<;!"EO;QPQ#;'&H11Z # I]%%([PHHHH **** "BBB@#P+
MXE_\E$U/_ME_Z*2O?1TKP+XE_P#)1-3_ .V7_HI*]]'2D 4444P"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#Q[XV_\ (>\-_P"Y<_R6N KO_C;_ ,A[
MPW_N7/\ ):X"O7PG\(^'SG_>WZ(J:K_R"+K_ *Y&OIS0O^1=TW_KTB_] %?,
M>J_\@BZ_ZY&OIS0O^1=TW_KTB_\ 0!6&-W1Z60?#,OT445YY],%%%% !1110
M 4444 %>1_'#_C^\,_\ 72X_] 6O7*\C^.'_ !_>&?\ KI<?^@+6U'^)$X,Q
M_P!TJ>AYW5;4O^07<_\ 7)OY59JMJ7_(+N?^N3?RKVY;,^ A\2/I/PI_R)VC
M?]>,/_HL5K5D^%/^1.T;_KQA_P#18K6KY][GZ9'X4%%%%(H**** "BBB@ HH
MHH **** "BBB@ HHHH \5^*WAG3M(UZ/6+-9!=ZPSM=%GRI,80+@=N&->@?#
M3_DG>F?]M?\ T:]>-^.-9U"_^)OB#3[R\DFM-/EC%K"Q&(0T8+8^I KTC1M6
MN="^!T.HV.SSX=VS>N1S<E3Q]":74#T:BN'^''BW4O%']I?VIY/^C>5Y?E)M
M^]OSGG_9%=Q3 **** "BBB@ HHHH **** "BBB@ HHHH *^?OB-_R5;5_P#K
MWM__ $"OH&OG[XC?\E6U?_KWM_\ T"NK"_Q4>/G/^Z/U1@5+IO\ R-7A[_L+
M6W_H8J*I=-_Y&KP]_P!A:V_]#%>I5_AL^0PG^\0]4?3=%%%>"?HX4444 %%%
M% !1110 4444 >!?$W_DJU[_ ->4']:YRNC^)O\ R5:]_P"O*#^M<Y7M8;^$
MCX#,_P#>YA!_R&]&_P"PI;?^C!7U!7R_!_R&]&_["EM_Z,%?4%<6,^-'OY%_
M EZA1117$?0!1110 4444 %%%% !1110 4444 %%%% !1110!YWX'\!:IX;^
M(WBK7K^6V>UUB8O;K$Y+J#(S?," !PP[FO1*XKPG\0_^$H\;>(?#_P#9QMO[
M%E,?G^;N\W#LN<8&/NY[UVM !1110 4444 %%%% !1110 4444 %%%% 'E.@
M-_:?Q*U_4)?F:%VCC/H-VT?HM=I7%Z2!H_Q1UO3YOE^U$RQ>^3N _)C^5=I7
MA*]W?>[/0GNK=D>3^&K'P[=_$SQX?$-OI<SK?Q>4;Y8R0/+YV[_Z4[38M'L?
MCQ;6_@?R$MI=-D;5X;$CR%8']V2%^4-GTIGAOPIH'B3XF>/'U[2;74&AOXA&
M9TW; 8^<?E7I&C^'](\/6[0:'IEK81N<NMO$%W'WQUKIE)+[OT,$KEN[MTN[
M*>WD&4EC9"/J,5X,!M9E_NDBO=M0NTL--N+J4@)#&6.?IQ7A(.XLQ_B.:WRV
M_P!<C;L[GEYYR_V=/F[JWK_PPHZUZU\$/^1'NO\ L)3_ -*\E'6O6O@A_P B
M/=?]A*?^E?18SX$?,Y%_'EZ'HU%%%>4?8GG?QN_Y$.#_ +",'\S7D9ZUZY\;
MO^1#@_[",'\S7D9ZUZF"^!GQV>_QX^@CG"FO9_"EHEEX5L(T'WHA(WN6Y/\
M.O&'&5->R>#[Y+_PI9.I^:./RG&>A7C_ .O7AYM?ZTK_ ,OZL]_A[E^HRMOS
M._W*QB_&#_DD7B#_ *]Q_P"AK57^Q_ARWA&,ZK:>'DB-FIFDQ"KCY!DY'.?U
MS5KXP?\ )(O$'_7N/_0UI=&^&W@LZ787!\,::TI@C<LT .3M!SS7#%I0^?\
MD>X]R#X-37D_PPL&O7F=!)*ML\V=S0!R(^OMT]JE^)"&"#3-2B^66WN,!AV_
MB'ZBNT1%CC5(U"(HPJJ, #T KBOB&YO)M)TB#YI[BX!VCW^4?S/Y5A5?,FT;
M4=)(]6@D\VWCD'\:AOS%/IL2"*%(QT50*=7NGGA1110 4444 %%%% !1110
M4444 %%%% #)?N#_ 'E_F*?3)?N#_>7^8I] !1110 5X%\2_^2B:G_VR_P#1
M25[[7F7B[X:ZMK_BJ\U.TNK*.&?9M65W##:BJ<X4CJ*3 ]-HHHI@%%%% !11
M10 4444 ,A_U$?\ NC^5/ID/^HC_ -T?RI] !1110 4444 %%%% $5U;17MI
M+;7*!X9D*.I[@C%>26TUU\.]>ETO5 \FDW#EH)PN<>_^(_&O8*IZKI-CK5BU
MGJ=NL\+=FZ@^H/8US8BA[576C1M2J<FCV9AQ2VU];+)"T=Q"W(88934U<O<?
M"_4-.G:3PMKDENC'/E3$C'XCK^(J+_A#/'=Q^[N-?A2/H2KG./P45Y[IUEHX
MG1^[>JD:GB#Q+8^'[5FG=9+@C]W;J?F8^_H/>O*/$46KP36NL:[;O'#JI8QS
M,,!6'12/X<CI["O7- ^&6G:9=+>ZI,^J78.X&480'UQSG\:ZS4M+LM8T^2QU
M2UCNK648>*1<@UV86C*%15:BVV1R8Q*M0E1INW-U/FFM?P+IDNO?$33([92\
M&FRB\NI!]U-H^1<^I..*XS4;3[+J%_!!/.D$-\\"1B0X""3:!Z]*^J= T#2_
M#FEI9Z-9QVL. 6"CESZL3R3[FO?KXB\+);GR&79;^^YY2^$TZ***\T^L"OG_
M .)&ERZ'\1;R>=2MKJ^V:"4_=+A0K)GUXS]#7T!5#6=%T[7],DL-8M([JV?D
MHXZ'U!Z@^XK6E4=.7,<>,PJQ5%TV['S=5SP_HNJ>)M1NAHD>]-/A,DDO0&3(
MVHI_O=37+6=IYU]:P27$Y@EOE@:/S#C89-N,]>E?5^D:-IV@Z<EAI%I':6T?
M2.,=_4GJ3[FNC&5(U:3IM;GB91@I4J_M^;X3@_"_BZ'5(19:DWV?4HOD=)/E
M\PCN,]_45TVQ0Y<(H<C!;')'UJ+Q-X!TGQ)(;EPUI>X_X^(?XO\ >'0_SKSM
MX->T[5O[,T;7Y=2"\?N 6V^QW9'ZXKYBI3J4=):H^RG6HI<S=O+_ "/2F8*I
M9B%4<DDX K@O&'B?^T%_L?1Y!Y<K!;BZ)P@'H#Z>IK7MO"&HWZ*?$&JS.N.8
M4;/YGI^E;-IX4T6T7Y+%)#_>F^<_K3]C5FNQRK$SO>$?O_R16T#Q)X6\,Z'!
MIMO?&7RQF21(7_>.>IZ5I)\0_#C=;N1?]Z%O\*G73[)!A+2!1[1"E-C:-]ZU
MA/UC%=L?:Q5DU]W_  3G;K-W;7W?\$FM_%V@W1 BU2WR>@=MO\\5KHZ2('C9
M74\AE.0:Y:Y\.:/=*1-I\'/=%VG\Q68?"<VGR>=X=U2XLG'_ "S=MR'_ #^-
M5[2K'=)^@N>JMU?T.^HKBK7QE?:3.MKXLL]BL<+>0C*'ZC_#\J[&">*Z@2:W
MD66)QE70Y!%;0JQGL:0J1GL24445H:!7*^,?$,MDJ:7IK?Z;<#YG!_U2>OU-
M=2[B.-G<X5023[5Y3;3MJ6HWFJ3#YYY"%_V5[#^5>%G>.>%P]H?%([<'24Y.
M4MD/L[*.SCPOS.W+.>I-6:D@MYKF39;Q-(W7"C-.ELKF"18YH'1W.%##K7YT
MX5)KVEFUW/6<E>S9#15W^QM1_P"?.7\J8NEWSRO&MM(73&Y<=,]*MX7$+>#^
MYD^TAW,JZM&>1;FT<PW49W)(IP<UW7A;Q -=TX^< EY =DZ>_P#>'L:Y>XLK
MFT -S \8/0L.#5;2;DZ5XPM)DXBO#Y,H]ST/YXKV\GQE7"8E4:ETGT9E7IQK
M4]-UL>FT445^B'AA6#XD\%Z'XKC U>S#RJ,)<1G;(@]F';V.16]10)I25F>%
M^(O@;J-HKS>';Q;^,<_9YL))CV/W3^E8_@+QUJG@[78]+U1I?[-,WDSVTV<V
MYSC<N>F#U'0U[1XP\<:5X-L1)?OYMU("8;2,_/)[^P]S^M?/T46I_$7QX[Q0
MJ+F^F#R>6/DA08&3[ #KW/UIGFU8QIS7LM^Q]2T4V-!'$J#)"@ 9IU(],***
M* "BBB@ HHHH \"^)?\ R434_P#ME_Z*2O?1TKP+XE_\E$U/_ME_Z*2O?1TI
M %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH \N^-FDSRZ;IFN01M
M)'ILKK<!1DK'( -WT! _.O+T=9$#QL&5AD$'@U]/NBR1LDBAT8$,K#((]"*^
M:OB1H=EHOQ"O++1E>QM?L\<WDPN0H9LYP.W3I7=AJ_*N5H^<S; JH_;)VZ%%
M[.?6+J#1=/0RWE\XC1!_"N?F8^@ R<U]/VENMI906R<K#&L8^@&*X3X.Z#IM
MGX%L-7AM5_M"^B+7%RWS._SD8R>@X' KT&L:]7VDO0[\MP:PM+>[>H4445SG
MJ!1110 4444 %%%% !7FGQJTBXN=!T_6+6-I1I4[/.BC)$3C#-^&!7I=(RAU
M*N RL,$$9!%5&3C)21E6I*M3=.6S/EZ.1)8U>-@Z,,@@]:BG@GU&6+2;!#->
MWS>3%&O7GJQ] !SFM3XFZ'9:-\0I[31D:PMWM4G,4#$+O8G) [=.@KTOX+Z#
MIMOX(M-:2V4ZE>!Q-=/\SD!R  3T& .!7I3Q7N72W/D\/E5\0X2EI$[_ $VS
M&GZ5:62G(MX4B!]=J@?TJS117EGV.P4444 %%%% !1110 4444 %%%% !111
M0 4444 >1?&*:QDO-.CM9+=KF,S?:%C92ZDB/;O Y'&<9JU_S;Q_G_G[KA_'
M>@:EIGQ(US4[VU,5IJ<J-:2[E/FA$ ;@'(P2.M=Q_P V\?Y_Y^Z0!\%?^8W_
M -L/_:E>IUY9\%?^8W_VP_\ :E>IT( HHHI@%%%% !1110 4444 %%%% !11
M10 5X;\7-+FTOQPFL2 _8M3@2+S<<1RIQM)[9&,?C7N55=1TVRU>PELM3MH[
MJVE&'BD7(-:4YNG+F1RXO#K$T739\TUJ^"M,EU_XA:7!;*7AT^87EU(!\L>W
M[H)]2V.*X[6+7[%J&JP6L\\<%M>R0QQB0X"!\ >O2OJ;PWX?TOPYH\5IHUG'
M;1%0S;>6=L=6)Y)^M=U?$7A9+<^<R_+?W_/*7PFM1117FGUH4444 %%%% !1
M110 4444 >)?&'2IM.\86VN,I-E?0+;/)CB.12< ^@(/Z&N,KZ8O["TU2QEL
M]1MX[FVF7;)%(N585\H>(K)=-UK6[:QFFAM[2]EBBB$A(50V .>:]##U[1Y6
MCY?-<OYJGM8O<Z?PGIDGB'QYI5E;J7CM)UO+IU'$:H<@$^I.!7TA6+X5\/:7
MX=T.&#1[..V61%>1ARTC8ZLQY)K:KEK5'4E<]G X186ER7NPHHHK$[PHHHH
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MTDSK'&HRS,< ?C7*_P#"%>.+3]W:>((I(QP"[MG'X@T^/X9:QJDJGQ-K[2Q
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M=*\"^)?_ "434_\ ME_Z*2O?1TI %%%%, HHHH **** "BBB@ HHHH ****
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M\;:GJ6GRV]E?SLUM,^,2CS7.1SZ$&O5J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\J^/'_(#T3_ *__ /V1J]5KRKX\?\@/1/\ K_\ _9&J
MZ?Q(YL5_ D5?@/\ ?\2?]=H/_06KU^O(/@/]_P 2?]=H/_06KU^G4^-DX/\
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M;5/^PI)_Z-KZRC_U:_05O5V1Y> ^*?J.HHHK ]0*#T-%!Z&@#Y*T[_D+6/\
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M 4444 %%%% !1110 4444 %%%% !7SS\6_\ DJ-Y_P!>,/\ 6OH:OGGXM_\
M)4;S_KQA_K6M'XCS\P_@?,]6^%'_ "2O0_\ KBW_ *&U=A7'_"C_ ))7H?\
MUQ;_ -#:NPK.6[.RE_#CZ(****1H%%%% !1110 4444 %%%% 'S[\7O^2GR?
M]@^+_P!":O2_@[_R2O2?^VO_ *,:O-/B]_R4^3_L'Q?^A-7I?P=_Y)7I/_;7
M_P!&-6\_X:/*P_\ O=0[>BBBL#U0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ^??B%XHO]9\>ZIHUVL(MM&D5;8HI#$2(I;<<\\J/2N]T75[G0O@?#J5
MD$,\.[:)%RO-R5/'T)K"^+NAZ;IVJ6>HV5HD-WJ)D:[E4G,I0(%S] 35_P#Y
MMX_S_P _=(#<^'/B[4O%7]H_VFL ^S>5L\I"OWM^<Y)_NBNWKRSX*_\ ,;_[
M8?\ M2O4Z8!1110 4444 %%%% !1110 4444 %%%% !1110!\E>(O^0OKO\
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MMIBR[-C.3G[V.U=Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7E7QX_Y >B?]?\ _P"R-7JM>5?'C_D!Z)_U_P#_ +(U73^)'-BOX$BK\!_O
M^)/^NT'_ *"U>OUY!\!_O^)/^NT'_H+5Z_3J?&R<'_ B%%%%9G6%>/?'C_CY
M\-_[]Q_Z"E>PUX]\>/\ CY\-_P"_<?\ H*5I3^-')C/X$B_\"/\ D6M7_P"P
MDW_H"5ZE7EOP(_Y%K5_^PDW_ * E>I4JGQ,K"_P(A1114'2%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 R7[@_WE_F*?3)?N#_>7^8I] !1110
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MP1@A "/PIC6-H]R+A[6%IQTE,8+#\>M3U<I\UCEP^']BY.][A1114'4%%%%
M!1110 4444 %%%% !7RCXS_=>+O$5K("L\FHRE(R/F8%LC [YKZNJ![&TEN!
M<26L+S+C$C1@L/QZU<)\K.7$X?V\4KVL%BI73[=6&"(E!![<5/114'4%%%%
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M\"^)?_)1-3_[9?\ HI* /?:*** "BBB@ HHHH **** &0_ZB/_='\J?3(?\
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MFEM.BWNHOY2-[A>I%9VEV,WQ U)?$WB2-O[.5C_9>FL?D50?]8X[D_YXKN
M  !@#@ =J .9_MCXE(-YL- D_P"F8D<'\\U):_$V73KE+;QQHLVBF1MJ7:'S
M;=OJPZ?K715%=6L%[:R6UY"D\$@VO&XR&% '003Q7,"36\B2Q2*&1T;*L/4&
MGUY;ID\WPV\16]BTKR>&-4E\N'S6R;&8]L_W3_GW]2H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#Q'XI^%;+1?$G]M6TLS7&M,S7"R,"JF-45
M=H R/O'.<UM_\V\?Y_Y^ZXCQWX@U+4_B/KFEWMSYMII<J+:1[%'EAT!;D#)R
M0.M=O_S;Q_G_ )^Z0!\%?^8W_P!L/_:E>IUY9\%?^8W_ -L/_:E>IT( HHHI
M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %<C\3-9GTCP7,EBY6\OY$LX"IY#.<$C\,UUU>?_ !.Q_:WA 2?ZO^UU
MS]<<?K0!H:-I=IX:\.P64;+%!:Q9DD<@ GJSD_F:CTGQ5H.O7+V^C:M:WDR+
MN:.*3+8]0.X]QQ61\3<?\(2XF_X]3>6HN_3R/.3?GVQU]J?JUTMMXX\.QW.B
M0O#).\-AJ$=UAXR8F9AY87[N%QUQT.* +UMXV\,WFI?V?;:W9O=F0Q"+?@EP
M<%1G@G/84_5O%V@:%>BTU?58+2X*"01OG.TD@'@=.#^5<7;+:'X&:R=0"^6L
ME^T9;J)1/)Y97_:W;<8YS5V"[UVW^($K6.F0W]RVA6?VD37?D;&WR9_A;/.:
M -'QE#;Z]X037="N8YKC3R+VRNH&# [3E@".Q _2M"R^*4%]803VN@ZO<F2,
M%FBM\KG'(!SR,]ZKZ'HD^B>%=675# LU[+<WDL-MDQ0^8"=BD@9 '? R2:E^
M&A;_ (5QI&[_ )Y-CZ;VQ6M/E;]Y$RO;0M?\+&=?]=X6UM!ZB '^M2V_Q0\.
MO*(KYKO3G/:[MF0#\1FMO-1S0Q7$9CN(DE0]5=0P/YUMRTWT_$B\C1L=1LM3
M@\[3[J&YC_O1.& _*K-<'>>!M/,YN]$EFT6][2V;;5)]UZ&G6'C'4= O(M.\
M;Q((Y&V0ZK"/W4A]''\)_P ^]0Z-]8._YE*7<[JBD5@ZAD(96&00<@BEKG+"
MBBB@ HHHH **** /-? /@G6?#_Q,\7:UJ44*V6JS,]JR2AF8&1FY';@BO2JY
M#PQ\0;7Q/XPUWP_!8S02Z+(8Y)G<%9,.R\ =/NUU] !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5XW\(/\ DJ7Q"_Z_O_:DE>R5
MXW\(/^2I?$+_ *_O_:DE 'LE%%% !1110 4444 %%%% !1110 4444 %%%%
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M >M^&O&FEZS=:KI\T-E.)7CC5]S#!'&1[UZ5\)O^23>'O^O0?S-=A0 4444
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M4 %>!?$O_DHFI_\ ;+_T4E>^UX%\2_\ DHFI_P#;+_T4E)@>^T444P"BBB@
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MK<616W.3A6)SN53Q\Q '- ':45S?B'QI!H&LV.E1Z5J.J7E]"\\4=@BL=B$
MD[F'J*L^'_%>G^(I+BWMX[FTOK3'VBQO83%-$#T)7N#V()% &TRAU*N RL,$
M$9!%>=WD<GPN\51:SI@8>'M0D$=]:K]V!CT8#MZC\1Z5;L_BE#?V)O[/PKXB
MGL%=U-U#;(Z_*Q#$ /DX(/:MVZ.F^-_!$K6,JW-EJ%L6AD []C@]"&'3VH [
MF*5)X4EA8/'(H9&4Y# \@TZN%^#^KR:I\/K>*X;,UA(UJV>N%Y7]"!^%=U0
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M>U>]T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 R7[@_WE_F*?3)?N#_>7^8I] !1110 5Y;XQ^'6M:[XLO-2LFM1!-LV
MB20AN$53QCU!KU*B@ HHHH **** "BBB@ HHHH 9#_J(_P#='\J?3(?]1'_N
MC^5/H **** "O#?VG/\ D!^'_P#KYE_] %>Y5X;^TY_R _#_ /U\R_\ H H
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M5W-9'B?0(O$FA2V,CF*3(D@E'6*0<JU:TI*,M=B9*Z(19VJMN6UA#>HC7/\
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M92/?M7=5%9VM#L5'N%%%%<Y84444 %%%% !1110 4444 > _$;Q7<ZUXWO\
M1)[>&.'1) L,B$[I/,16.[/'&WM75_\ -O'^?^?NLOXL^'=-TK68-5LH#'>:
MJTC7;EV/F% @7@G P">E=IX&TVTU?X66-CJ,/G6TOF;T+$9Q.Q'(YZ@4NH'/
M_!7_ )C?_;#_ -J5ZG69HWAS2?#_ )W]CV@MO/V^9AV;=MSCJ3ZFM.F 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!Q&M>&-0TC4Y=<\'A2\QW7FFL<)<?[2_W6J71?%FG:RQ@
M+-9WZ'$MG<_)(I^AZ_A795CZYX4T;Q"H_M.R1Y0/EG3Y9%^C#FNB-5-6G]Y#
MCV%HKG6\&^(]+X\/^)FEB'W8-2C\P >FX<_I4>[X@6_RR:1I5WC^.*X*9_ U
MI:+VDB=>QTU%<U]J\=O]SPW8I[O>@TJZ3X]U#BYO]+TJ,]1!&97'TSQ19+=H
M->QNWE[:Z?;M<7UQ';Q*,EY& %<N=1U?QM(;3PVLEAI1)6?5)%P7'<1C^O\
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MZG#!<1XWQMG(R 1V]"*V*\"^)?\ R434_P#ME_Z*2@#WVBBB@ HHHH ****
M"BBB@!D/^HC_ -T?RI],A_U$?^Z/Y4^@ HHHH *\-_:<_P"0'X?_ .OF7_T
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MH?\ Z_Y5Z9HVBV'A_2XM/TFW6WMXAPJ]6/J3W)]: +D<:0Q)%$H1$4*JJ,
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MH:74#T.BN,^'WC&_\6?VA_:$-O%]E\K9Y"L,[MV<Y)_NBNSI@%%%% !1110
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M(U4\8]0:3 ]4HHHI@%%%% !1110 4444 ,A_U$?^Z/Y4^F0_ZB/_ '1_*GT
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M\@/P_P#]?,O_ * * /0OA-_R2;P]_P!>@_F:["N/^$W_ "2;P]_UZ#^9KL*
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M^2B:G_VR_P#125[Z.E>!?$O_ )*)J?\ VR_]%)7OHZ4@"BBBF 4444 %%%%
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M]81Z9Y^N!VKUZBO)1BJ:WW?^0_(****XQ!1110 4444 %%%% !1110 4444
M%%%% !1110 R7[@_WE_F*?3)?N#_ 'E_F*?0 4444 %>!?$O_DHFI_\ ;+_T
M4E>^UX%\2_\ DHFI_P#;+_T4E)@>^T444P"BBB@ HHHH **** &0_P"HC_W1
M_*GTR'_41_[H_E3Z "BBB@ KPW]IS_D!^'_^OF7_ - %>Y5X;^TY_P @/P__
M -?,O_H H ]"^$W_ "2;P]_UZ#^9KL*X_P"$W_))O#W_ %Z#^9KL* "BBB@
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MPO* >(U4\?4&O5J* "BBB@ HHHH **** "BBB@!D/^HC_P!T?RI],A_U$?\
MNC^5/H **** "O#?VG/^0'X?_P"OF7_T 5[E7AO[3G_(#\/_ /7S+_Z * /0
MOA-_R2;P]_UZ#^9KL*X_X3?\DF\/?]>@_F:["@ HHHH **** "BBB@ HHHH
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MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH \:^+7B#3=3UBVTNRN/,O-+:1;N/81Y9<(5Y(P<@'I6E_S;Q_G_G[KD_B
M+X4N]%\<ZAK=Q/#)!K4@:!$SN3RT53NR,<[N,5Z7X'TRTUCX56-AJ,7FVTOF
M;TW%<XG8CD$'J!2Z@8'P5_YC?_;#_P!J5ZG65HGAG2?#GG_V/:FW^T;?,_>,
M^[;G'WB<=36K3 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#)TWPOHNCZM?:GINGQ6][J#;KJ9,[I3DG)Y]236M7D?P
MS75Q\7O')U!;X6AN&^S&</Y9'FO]S/'3'2O7* "BBB@ HHHH **** "BBB@
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M5<+8>7/.N]K6.;&R2IJ/<EHHKFOB#X@O?#'@RXU/2U@:Z2:&)!.I9!OD5,D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% &3IGBG1=8U>^TO3-0CN+W3VVW4*@YB.2,'(]016M7G7@
M;P'JOAOXC>*]=OY+9K35YB]N(G)< R,WS @8X8=S7HM !1110 4444 %%%%
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MC%+8O>::EJ]NURAF^T+&5+J<1[=^.>F<9JS_ ,V\?Y_Y^Z0!\%?^8W_VP_\
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M^2B:G_VR_P#125[Z.E>!?$O_ )*)J?\ VR_]%)7OHZ4@"BBBF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17(^,OB9X<\
M%1,NI7?G7N/ELK?#2'Z]E'N:\WTS]HF==5+^(- -OI4Q_<R6Y)D0>ISPWX8K
M6-*<E=(I1;/=J*S-!\2:1XFT];W0[^&\A/78WS(?1EZ@_6M.LVFM&2%%%%(
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ME^X/]Y?YBGTR7[@_WE_F*?0 4444 %>!?$O_ )*)J?\ VR_]%)7OM>!?$O\
MY*)J?_;+_P!%)28'OM%%%, HHHH **** "BBB@!D/^HC_P!T?RI],A_U$?\
MNC^5/H **** "O#?VG/^0'X?_P"OF7_T 5[E7AO[3G_(#\/_ /7S+_Z * /0
MOA-_R2;P]_UZ#^9KL*X_X3?\DF\/?]>@_F:["@ HHHH **** "BBB@ HHHH
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M7"SIG-*FXGJE%(CK(@=&#*PR&!R"*6N4S"BBB@ HHHH **** "BBB@ HHHH
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M.1^!!KU>N=T+QSH_B+Q'JNB:<TYO-)<I<B2+:H(8KP>_(-=%0 4444 %%%%
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M+Z5X:\_^R(&B^T;?,W2,V=N<=?\ >-:], HHHH **** "BBB@ HHHH ****
M"L+Q-XST3PA';MKUT8/M+$1!8V<MCJ< >XK=KG?&W@RP\:Z"UC?#RYDRUM<
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M_P"$W_))O#W_ %Z#^9KL* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO);,VLES(UNTIE,1/RESU;'K0Z%WW5T]0Y"?5-<O]:,1U&59#%G9MC5,9Z]
M/2L^BBNA)15D:;$-Y_QXS_\ 7)OY5Z)^SI_R3FZ_[",G_H"5YW>?\>,__7)O
MY5Z)^SI_R3FZ_P"PC)_Z E>?F'P(QK;'K-%%%>(<@4444 %%%% !1110 444
M4 %%%% !1110 4444 >/?%[6M.U#4K+3[*[CFN]/,HNH5/S0E@A7/U -=O\
M#3_DG>F?]M?_ $:]>3?$'PQJ&C^/]5UB\,/V76)%:VV.2V(T4-N&..6'K7H7
MA_69/#_P5M]3@B6:2#=A') .ZX*]OK2Z@>@T5R'@/QG<^+OM_P!JM8K?[+Y>
MWRR3NW;NN?\ =KKZ8!1110 4444 %%%% !1110 4444 !.!D\"N:UKXA>%=
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MV\">(-9\8WU_I]HDEO-Y>QC,BYQ&JG@G/4&DP/6Z***8!1110 4444 %%%%
M#(?]1'_NC^5/ID/^HC_W1_*GT %%%% !7AO[3G_(#\/_ /7S+_Z *]RKPW]I
MS_D!^'_^OF7_ - % 'H7PF_Y)-X>_P"O0?S-=A7'_";_ ))-X>_Z]!_,UV%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%8U]XP\.:;(8[[7+
M"!QU5KA<C\,U0_X65X-_Z&.Q_P"_E6J<WLF!U%%<O_PLOP;_ -#'8_\ ?RC_
M (67X-_Z&.Q_[^4_95/Y7]P[,T?%?AVV\5^%K_1;S 2ZB*J^,['ZJWX$ U\U
M_"/X>W&I_%"6#6(-L.@2E[I6'#2JV$7\2,_05]!_\++\&_\ 0QV/_?RJUMXZ
M\ V=U=7-KK>FQ37CB2X=6P9&"A03^  H]E4_E?W!9G8T5R__  LOP;_T,=C_
M -_*/^%E^#?^ACL?^_E'LJG\K^X+,ZBBN7_X67X-_P"ACL?^_E'_  LOP;_T
M,=C_ -_*/95/Y7]P69U%%8%KXZ\+7L@2V\0:>[-T'VA1G\ZW4=)$#QLKJPR&
M4Y!J7&4=T(=1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 >!?$O_DHFI_]LO\ T4E>^CI7@7Q+_P"2B:G_ -LO_125[Z.E( HHHI@%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\Z_&3_DM>F_\ 7DG\
MWKZ*KYU^,G_):]-_Z\D_F]=6$_BHTI_$4JE2UN);>2>."1X8L>9(J$JGU/:H
MJZKP'<I)J5UHUR1]GU2!H3GLX!*G^=>_4DX1<ET.R3LKG+QQO-*L<*-)(YPJ
MJ,ECZ 4Z2":&<P2Q.DRG:8V4A@?3'6NI\%6/V+Q!>W]^N(M&B>23=_?&5 _G
M5[P?!+=6NM>(6DMTO@^V.XNC\D);EG/N >*RG6Y6_*WWLERL<7<V5U9[/M=M
M-!O&5\V,KN'J,]:?!IE_<P&:VL;F:(=9(X691^(%;7B#2M3D@M]3NM575[29
M_*6YCD+!&/\ "0?NUJ^+=;O]$\46]AI=S);6MA%$L<4;85L@$Y'?.>]/VK=E
M'?7\ YGT.'"LSA54EB<!0.2:L7.G7UDBO>6=Q;JWW6EB90?S%>B_8X+/XD:Q
M>PQ*&M]/:\C7' D*CG^?YUC>%M2O==M];L-6N9;N&2R><"9MVQUY!&>GX5'M
MVUS)::?B+GZG+6^DZC=PB6TT^ZGC)P'BA9E/X@4VZTR_LHP][8W-NC' :6%D
M!/IDBNVL+35;SX8Z>FB2O%,+MRY6X$65Y[Y&?I7,:[;:Y9>3%K=S+*),M&K7
M7G#CC/!..M5"JY2:NM_F-2N[&!>?\>,__7)OY5Z)^SI_R3FZ_P"PC)_Z E>=
MWG_'C/\ ]<F_E7HG[.G_ "3FZ_[",G_H"5S9A\"(K;'K-%%%>(<@4444 %%%
M% !1110 4444 %%%% !1110 4444 >%?$WQ:FM^+)]#2T:%M#<HTQ<$3>8JM
MP,<8VUT7_-O'^?\ G[K#^*7A6ST7Q(=:MI9WN-:9FG20@JAC5%&W S_$<YS6
MY_S;Q_G_ )^Z0!\%?^8W_P!L/_:E>IUY9\%?^8W_ -L/_:E>IT( HHHI@%%%
M% !1110 4444 %%%% !535-5L=%TZ6^U2YCM;:(9:20X'T]S[5;KYO\ B#H_
MQ&\0ZY-+JVCWDUI#*PMX;4;XD7/! 4DY([GFFE<Z*%%596;LC/\ B%XJL_'>
MO Z'I$-M%$<&]9-LL_NV.@]!R?Y5G6EL+2V6(,6V]S5<PZSID8CG\/7D"KV,
M#K_,4VVU=9[D0/ \;DXP>U=U+V<=GJ?4X>-*G%1BS1HHKI_ATB2>/-/615=3
MORK#(/R&NF3LFS>I/D@Y]CE\CUHR#TKTCP]KTFL+KL&IV-C/;6%J]S;0_9E5
M8V1N!P.1]:SI=0E\2?#Z_O-5C@>ZL;N(0S1PJA"MU7Y0.*SYW?5'/]8ES6<>
MJ6_?;H<3FK=IIEU?65[=VR*T-BBR3DL!M4G X[\UVFNQ1K\8]/C5%"&2URH4
M8/RKVK2@UN^L5\;Q6LB(EC(7@7RE.PM*<]N?QI.H[*R)EB9<J<5ND_O=CRZB
MG.[22,[G+,2Q..YIA.%)/89K8[2AJFGM>HK1OAT'"GH:] ^&/Q,T'PUI[Z5K
MNFQ:;+&I/VRWA),Y'9^^[T/3Z5YTNLM,Y2TLY9F]%&3^0IG]@>(]2F\\:'J,
MX]%M7QCTZ5Q5N26J.#%0I58VDS5\9:Y!XY\2/>:3I$&FVRD@R*F'E_VGQP3[
M#\S201""W2($L$&,GO51_P"U]/0)<Z#=P*O8P.N/S%%EJB7DYB\IT< GGFM*
M7)'1/4VH*G"*C%E^BBNM^'.P:_>O+%',J:=,^R1<J< =:WD^57-JD_9P<NQR
M.1ZT9KT31O$,^J>$]:O=1M+&>?2Q'+9DVJ 1%B5Z 8('H:BEN6UWPMHNK:A'
M"U\FL+;&5(E0NG!P0!@U'.[ZHY_K$D[2CL[;^5^QP.:MPZ9=3Z3<ZE&BFUMG
M6.5MPR&;IQ7<VT49^.[QF-=GVE_DVC'^K]*98Z_J-OX UWR9E7[+>1PP_NE.
MU&8Y'3GZFAU'I;R_$4L1+3E6_+^+//J**;)((HFD;)"@DXK4[#-U737NB)H6
MRZC&P]_I7KOPH^(^@K:1:!?6-MHEZ,*KQKLCN&]23T;Z]>WI7D4>KRW#%;.P
MFF/H@+?R!J23P_XBUG!M_#-^S=G2V?\ PKBJ^SEJF>=BJ=&K&S=CZZHKS/X0
MIXWL[:>P\6VLL>GPQC[+)<L#*#G[O7)7'KTKTRN,^9J0Y).-[A11109A1110
M 4444 %%%% &=8Z]I.I:C=6.GZA;W%W9G;<0Q."T1R1AAVY!K1KS/P!X*UKP
M_P#$WQ?K6IP1)9:K,SVKI*&+ R,W('3@BO3* "BBB@ HHHH **** "BBB@ H
MHHH "0 23@#J37SI\8M:\&ZIJ#67A[38[K6=^);^U.U 1U7 XD/OV]:T/C)X
MK\7SZM=:#8Z?>V>DQX#30Q,?M0(!R7 ^[[#\:\ML=0M=*3;)93)+CYG;K^O2
MN[#T5?FD['FXJNTG&,;FOH]G/9V96YDW,QR%SG9[5?K+A\0V,SJH,BEC@97B
MM2O:@XVM$^=J*7->2"BKFD1I-K=C%*H>-[B-64C@@L,BO0(4T2\^(=SX9;P]
M8QVC/)'YR!A*K!<Y#9X''0"IJ5>1[=+ETJ/M%O;6QYG17<61TOQ!9:[9KHEG
M9?8+5Y[:> -Y@VG&&)/S9K+\365K:Z1X<DMH(XGN+$/,RK@R-NZGU-*-6\N5
MK7^F.5!J/,G=?\&QA6EE<W\YALH'GD"ERJ#)VCJ:@KUBS%II'Q&N["QTVS2)
MM.,H;ROF4^4"0#Z'O7EMW<B[NY)Q!#;B0Y\J!=J+[ =J*=5S>VEE^(5J*IK?
M6[7W$-4M5M)[RR,=M)L8'.,XW>U7:S)]?LK>1D8NS*<':O&:TFXVM(SIJ7->
M**/A]OLFLVJ21M$Z.4?)ZDY&?UKT*O.[K5HK^2,VT,BR(<B3&?Y5W&E:@FI6
M"3*1OQB1?1J_/<YH>SQ#DM4S]1R+$>UPJB]&BY1117AGO%[1;Q-/URRNY?N0
MS*S?3/-;'BG0K[_A(KBXM+:6ZM[Q_.ADA0N&#<XR*YFK]KK>J6,'DV>H7$,7
M]Q)" *WA./(X3VW,)TY<ZJ0WM;4VTT2/1/$6@Q/.SWDLB23PX&(LD8'\ZU;K
MQ??:;X\G@NKEFT]9_+:/ ^52.H/7CK7"&>8W'GF60S;MWF;CNSZYZTDLLD\C
M23.TCL<LSG)/U)K18AP5J>FMS)X93=ZNNECLK3PXUOX_<7;-+:6X-X9G.=Z#
ME<GOS_*FQ^*M#7Q#_:HTNZ%T9-QE^T\<\=/3':N5.HWK(4:\N"I385,K8V_W
M>O3VJM1]8Y?X:ZWUU_JP?5G+^([Z6TT]?O/0=,TT:9\4'6$8@FA>:$CIM89X
M_'-<I<>(]:<RQ/JETR,2I4R'!'I5$:A>"1)!=SAXUV(WFME5] <\#VJ#.>M*
M=>ZM#35O[[%4\/:7-/71+[KB4445RG4%9WB"40Z%<D_Q*%'XFM&LF2QF\6>*
M;'PYI^6#2!KAUZ(H^\?P&?Q-;48.=1)&5::A!MGM_P +;5K/X9:+&Z[6:$R8
M_P!YBW]:ZVH;2UBLK.&UMEV0PHL:*.R@8 J:OK8JR2/BYRYI-A1115$A1110
M R7[@_WE_F*?3)?N#_>7^8I] !1110 4450N=>T>RN&M[S5;&WF3&Z.6Y167
M(R,@G/0T 7Z*** "BBB@ HHHH **** &0_ZB/_='\J?3(?\ 41_[H_E3Z "B
MBB@ KPW]IS_D!^'_ /KYE_\ 0!7N5>&_M.?\@/P__P!?,O\ Z * /0OA-_R2
M;P]_UZ#^9KL*X_X3?\DF\/?]>@_F:["@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHID\T=M;R3SN$BB4N['HH R30!D>*?%6F>$-&?4=7FVK]V*)>7E;^Z
MH_SBO(_/\<_%8F9[DZ#H#$[%C)!E7]"_U.!4>EV\WQ:\=W.NZJ'_ +!T]_+M
M;=NC]PN/?[S?4"O6T18T5(U"JHPJJ, #T KT8QC05K7E^16QP%C\%_"UL@^U
M_:[U^[/-L!_!<5H?\*I\&_\ 0)/_ ($2?XUV%%)UJC^TQ79Q_P#PJGP;_P!
MD_\ @1)_\51_PJGP;_T"3_X$2?\ Q5=A11[6I_,PNSC_ /A5/@W_ *!)_P#
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MS7K?AO7;?Q-X<L]7L^([F,,5SRC=&4_0@BN>O2C%*<-G^#!FI1117*(****
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M\Q3Z9+]P?[R_S%/H **** "O OB7_P E$U/_ +9?^BDKWVO OB7_ ,E$U/\
M[9?^BDI,#WVBBBF 4444 %%%% !1110 R'_41_[H_E3Z9#_J(_\ ='\J?0 4
M444 %>&_M.?\@/P__P!?,O\ Z *]RKPW]IS_ ) ?A_\ Z^9?_0!0!Z%\)O\
MDDWA[_KT'\S785Q_PF_Y)-X>_P"O0?S-=A0 4444 %%%% !1110 4444 %%%
M% !1110 5P?QFU632OAG?>2Q5[MTM@1V#'YOT!'XUWE>7_'Z-F^'<3+T6^C)
M_P"^6%;X=)UHI]QK<O\ P_TI-'\":7;HNUY(1/(?5G^8_P P/PKHZHZ%(LOA
MW39(\;6M(B,?[@J]6\VW)MB"BBBH *\N@G\9^)_B!XJT_2O%W]CV>D7$4<47
M]G13Y#INZG!ZY]>M>HUX]I&E^)-1^*WCP^&_$46C*EW )5DL5N/,/E<'DC&.
M?SJ9 =+X8\0>(;'Q_<^#?%ES;:E+]A%]::A;P^273=M*N@. <^E5OBKXMU[1
M&T_3?!P5]3=);ZX4H&Q;0KEA@@_>/'KQQ57X46[76N^(+_Q+=377B^UG-E>&
M; 6.$',?EJ  $8<_A6/I'BRZN?B'XC\20^%-8URSEQIEC-91J8Q#$2'Y8C[S
M<TKZ >M:/JD&MZ'9ZI9L&@O(%F0CT89Q^'2O,/!0\?>-/#IUA?'?V!6N9HE@
M&DPR;0CE1\W'I5_X-:G+%8ZOX7O;*YT^72KII;:VNUVR);2DL@(Z<'(X]JP_
MA5X:U_4O!'VG3/&E]I-NU[<@6L-G#(JD2')RPSS1>]@/5?#UAJVFZ88->UG^
MV;KS"PN?LRP87C"[5XXYY]ZU*J:7:W-CI<%M?7\FHW$:X>ZE14:4YZD+P/PJ
MW5@%%%% $-[9Q:A8SV=PNZ*XC:-P?0C%<-\!KN6WMM>T"X8EM/N]RCL,Y5L?
MBGZUZ .HKSCX/#SOB+XRN8O]3YVWCIDR/C^1K7>C-/R_,:V/9****\\04444
M %%%% !1110 4444 %%%% !1110 4444 %%%% '@7Q+_ .2B:G_VR_\ 125[
MZ.E>!?$O_DHFI_\ ;+_T4E>^CI2 ****8!1110 4444 %%%% !1110 4444
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M@_X"V-G*FH^-;G^U[T_,;<$^2A]SU?\ 0>U>IZ3H^G:%IZ66CV<-G;)TCA3
M^I]3[FKM>/6Q4ZGDCFE4<B.""&U@2"VB2&*,;4CC4*JCT '2I***Y#(****
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MNJII&A0R3W)#,5C/)VC)Y]JU?B?;/H/Q2U?R5P+K$R<?WP"3_P!]9KU[X0^
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M=<?PJW<'IST]Z];KCKS4Y<R._#4Y4X<CZ";1NS@9]<4M%%8'2%%%% !1110
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M;&[+MN(X XYK;HHL 4444 %%%5=2U2RT>PDO=3N8[:WC&6=SC\!ZGV%-)O1
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MIT\TQO6  EQ^Z0$D*,=>O7Z5V-%%-MMW8HQ459!1112&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R7[@_WE_F*?3)?N#_
M 'E_F*?0 4444 %4+G7=)L[AH+O5+*"9,;HY;A%9<C(R"<]#5^O OB7_ ,E$
MU/\ [9?^BDH ]]HHHH **** "BBB@ HHHH 9#_J(_P#='\J?3(?]1'_NC^5/
MH **** "O#?VG/\ D!^'_P#KYE_] %>Y5X;^TY_R _#_ /U\R_\ H H ]"^$
MW_))O#W_ %Z#^9KL*X_X3?\ ))O#W_7H/YFNPH **** "BBB@ HHHH ****
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MFI_]LO\ T4E>^CI2 ****8!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%0WERME8SW4BLRP1M(P7J0!GC\JP/ WC>P\>Z'
M)JFEP7$$4<Y@*7  ;( .>">.: .EHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /&/BSX<TW2M:@U6RA9+S56=KMS(Q#E @7
M)P.">E=[\-/^2=Z9_P!M?_1KUXSXVU/4+OXH>(K2\NIY;6SEB%M%(Q*1!HP6
MVCMD@9KU#P[K3>'O@O;:I'")V@W8C9MH.ZX*]?QI=0/0**Y+P-XTE\7_ &[S
M;-+7[+Y>-LA;=NW>W^S76TP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *\C_:-_P"1!T__ +"<?_H#UZY7D?[1O_(@Z?\
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MX#M$Y831N1[></\ XDU[A0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ,E^X/]Y?YBGTR7[@_P!Y?YBGT %%%% !7@7Q+_Y*)J?_
M &R_]%)7OM>0^./ _B+6/&5]?:=I_G6TOE['\^-<XC4'@L#U!I,#UZBBBF 4
M444 %%%% !1110 R'_41_P"Z/Y4^F0_ZB/\ W1_*GT %%%% !7AO[3G_ " _
M#_\ U\R_^@"O<J\-_:<_Y ?A_P#Z^9?_ $ 4 >A?";_DDWA[_KT'\S785Q_P
MF_Y)-X>_Z]!_,UV% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG5_LUUXMTQN#!>*<?BZG_P!!H ]PHHHH **** "BBB@ HHHH **** "BBB@
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MJV2V-S=1"4VZN6\L'E03@<XQ6M0 4444 %%%% !1110 4444 %%%% !1110
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MZRO+/@K_ ,QO_MA_[4KU.F 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7D?[1O_(@Z?_V$X_\ T!Z]<KR/]HW_ )$'3_\
ML)Q_^@/0!ZM9_P#'C!_US7^535#9_P#'C!_US7^534 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% '+^'O'NF>)/%&LZ#8PW*76CN
M4G:50$8ABORD'GE3745Q?A3X>+X7\:^(/$"ZBUR=:D,A@,.WR<NS8SDY^]CH
M*[2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH "<
M#)X%>"Z0W_"T_P!H*;5,>;HOAX 0D_=9E)V?F^YOHHKL_C3XX_X13P>UC8N3
MJNJ@P6ZI]Y%/#/\ K@>Y]JT/A-X)7P3X)@MYT U&[Q/>-WWD<+_P$<?G0!V]
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R7
M[@_WE_F*?3)?N#_>7^8I] !1110 5X_XY\%>(-7\:7U]IVG--;2^7L<2H,XC
M4'@G/4&O8** "BBB@ HHHH **** "BBB@!D/^HC_ -T?RI],A_U$?^Z/Y4^@
M HHHH *\-_:<_P"0'X?_ .OF7_T 5[E7AO[3G_(#\/\ _7S+_P"@"@#T+X3?
M\DF\/?\ 7H/YFNPKC_A-_P DF\/?]>@_F:["@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *.G6N&\??$VR\'[;"RC&H:S-@1VB'A,]"^/T'4UPJ>$_'
M7CC_ $KQ?KDNFVLGS+90\$#TV @#\23733P[E'FD[(=CVA]6TZ,XDO[53Z-,
MH_K3?[:TO_H)6?\ W_7_ !KR1/@=H 7][?Z@[=SN0?TIW_"C_#G_ #^:A_WV
MO_Q-:^PH_P [^X-#UG^VM+_Z"5G_ -_U_P :/[:TO_H)6?\ W_7_ !KR;_A1
M_AS_ )_-0_[[7_XFC_A1_AS_ )_-0_[[7_XFCV%'^9_<&AZS_;6E_P#02L_^
M_P"O^-']M:7_ -!*S_[_ *_XUY-_PH_PY_S^:A_WVO\ \31_PH_PY_S^:A_W
MVO\ \31["C_,_N#0]9_MK2_^@E9_]_U_QH_MK2_^@E9_]_U_QKR;_A1_AS_G
M\U#_ +[7_P")H_X4?X<_Y_-0_P"^U_\ B:/84?YG]P:'K/\ ;6E_]!*S_P"_
MZ_XT?VUI?_02L_\ O^O^->3?\*/\.?\ /YJ'_?:__$T?\*/\.?\ /YJ'_?:_
M_$T>PH_S/[@T/7X+VUN6Q;7,,QZXCD#?RJ>O$Y?@CIT?[S2]:O[2=>5<X.#^
M&#4*>(O'OPRF0Z\3K^B9"F;<69!_O'E3[-D4OJT9?PY7?;8+=CW*BLOP[XCT
MWQ3H\>I:/.)H7X8'AHV[JP[&M2N-IIV8@HHHI %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!X%\2_\ DHFI_P#;+_T4E>^CI7@7Q+_Y*)J?_;+_
M -%)7OHZ4@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!XE\:]$N_#GB/2OB-H2D36<J1W@7^( X4GV()0_45
MZ[H.M6?B+0;/5M-??;7<8D0]QZ@^X.0?I4NJZ7:ZUI%UINHQ"6UNHFBE0]P1
M_.O%/ASJUQ\+_'UYX \23$6%U+YFFW+\*2W3Z!NGLP]Z /=J*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** /F[QK:ZA#\4/$4UY#<I:
MS2Q&U>56$;@1C=L)X.#C.*[[_FWC_/\ S]T?&K_F"?\ ;?\ ]IUM^#=(MM=^
M$MGIU]O\B;?N\ML'B=F'/U I=0,3X*_\QO\ [8?^U*]3K#\-^$M-\+?:?[+,
MW^D[=_FON^[G&.!_>-;E, HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O(_VC?^1!T__L)Q_P#H#UZM=FX6RF-DL;7(C8Q+
M(2%+8X!QVS7RG\1?BSJWC+3UT35M'M[![.\\Q_+D8L'3*E2#]30!]66?_'C!
M_P!<U_E4U>0?"WXKZ]X\\0?V:=%L[>QM8-]Q<)(Y*]E SQDG] :]?H ****
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MFI_]LO\ T4E>^CI2 ****8!1110 4444 %%%% !1110 4444 %%%% !1110
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MMWL,?=_6NKI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5\R?M"^#?['\41>(K./%KJO$P4?=G4<_]]#GZ@U]-UG:YH.G>
M([!;+6+=;B!)DG"-_>1MP/Z?D30!R'P9\&_\(CX"@-U%LU#4<7-SGJN1\J?@
M/U)KT"CITHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>8Y!U']1[&MNM&G%V8@HHHJ0//?B82/%'@$C_H.C_P! KE-5UBX\ MXK\%6
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MEI=MS%:0K$I/? Y/XGFKK>[147NW<?0OT445PB"BBB@ HHHH **** "BBB@
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M&^*R:SJ']A>*K;^RM;0[ K@JDS>@!^ZWMW[5Z37-4IRIRY9""BBBLP"BBB@
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MH!4]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%>4?"[6M3U'XF>.;2_O[BYM[2[VV\4LA98AYCC"@].@H ]7HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \
M"^)?_)1-3_[9?^BDKWT=*\"^)?\ R434_P#ME_Z*2O?1TI %%%%, HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *K7^G66J6K6VI6D-W W6.:,.I_ U9HH \J\0_L_P#A
MG49C=:!-<:%=@[E-NVZ,'_=)R/P(K"_L;XS>!1G3-1A\36*?\LI#O?'T;#?D
MQKW*B@#Q:R_:$&G3"T\;^&+[2KD<,T:D@^^U\']37>Z)\4/!OB *-/UZU61O
M^65PWDN/;#8_2NCOM-LM3@,.HV<%W$>J3QAQ^1K@=<^!/@?669XK"3396ZM9
M2;!_WR<K^0H ]&5E=0R,&4C((.0:6O#W^!OB;07,G@KQQ<VZCE89RR?AE20?
M^^:#J?QS\-86YT^TUZ%/XT5'+#_@)5OTH ]PHKQ!/C_JFD,(O&'@F]LGSR\9
M9!^ =?ZUOZ;^T'X&OBJW,]Y8,>OVBW) _%,T >H45S6G_$7P?JF/L7B33G)Z
M*\X0_DV#70075O<H'MIXYE/1HW# _E0!+1110!Y9\:O^8)_VW_\ :=:OAK6O
M^$=^#5MJGV?[1Y&_]UOV;MUP5ZX..N>E97QJ_P"8)_VW_P#:='_-O'^?^?ND
M!U/@KQK_ ,)A]M_T#[']E\O_ );>9OW;O]D8QM_6NJKRSX*_\QO_ +8?^U*]
M3I@%%%% !152ZU:PL;RVM;V\A@GNR1!'(X4RD8R%SU/(XJW0 4444 %%%% !
M1110 4444 %%%% !6+XR@:Y\#ZU#'DL]C,!C_<-;5-DC66)HY%#(X*L#W!IQ
M=FF!Y+\&9UE^'D<:XW0W,JM^)W?UKOJ\H\'2M\/_ (C:GX1U-C':7DOF64C]
M"?X>?<<?5:]8KT:Z]_F6SU&]Q****P$.7[P^M> :39SQ_"IO$VGH6OO#?B&Y
MO4 '+Q>9B5/H5.?PKWX'!K(T?POI6A:1<:9I]NPM+F2226.1R^XR??Z]CZ4F
MK@>=17L7CC7?%/BRV;SM+TC2);#37_A:1HB\SCWY"YK%UB-9OV5_#\;YVO):
M*<''!E->MZ1X1T;0O"[^'M,MFATV1)$:/S"6(?.[YCSGFJUUX#T&\\%P>%9K
M>;^RK?9Y<:SL'&TY'SCGK4\K SK/X1>%K*\M[NW@U$2P.LB%M1G8;@<C(+8/
MTKEOB'X:7Q;\:M"TB>]GM+6;2)C<F X:6,2$F//8'BNH_P"%3^'?^?G7/_!Q
M/_\ %5T!\-::WB&SUMHY#?V=J;2&0RD@1GJ".Y]S3L!QG@/4;GP?K9^'GB&3
M=Y*&31+PC NK?^X>V]?2O2*R/$'A?2O$T=J-6A=GLYA/;312&.2)QW5AR/I6
MN.!Z_6FM "BBBF 5YE<C[?\ M)Z5'"<FTM\R$=L1N>?^^A7HFI:E;:1IEQJ%
M_(([>W0N['^0]STKA/@]IUSKWB?6?'.H(R"Y=H;4'T)&[\  J_G6T/=A*;[6
M^\:/8J***\X04444 %%%% !117E/Q;\>>,O"T+IX?T%DL\?-JY F5?H@^[]6
MH ]!U_Q-HWA>Q-WKVH0V47\/F-\S^RJ.2?I57P;XOL?&VAMJVE1S1VWGO"GG
M !FVG&<#IFOB[5-7U#6[YKW5[V:]N'ZRS.6/T'H/85ZI\,_%WQ!T?P<MEX1\
M+)JE@+B1A<M&S?,3R,A@.* /IRBO$/\ A-OC7+]SP9;Q_6$_UDH_X2#X[7'^
MK\/64/U2,8_.2@#V^BO$A+\?9^D.G0?7R./U- T'X[7W^O\ $-A9@]=I0?\
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MX>_Z]!_,UV%<?\)O^23>'O\ KT'\S784 %%%% !1110 4444 %%%% !1110
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M@V>DZ>@2WLXEB08ZXZD^Y.3^-7Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** / OB7_R434_^V7_HI*]]'2O OB7_
M ,E$U/\ [9?^BDKWT=*0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#RSXU?\ ,$_[;_\ M.NI^&G_ "3O3/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^V'_ +4KU.A %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M )*)J?\ VR_]%)7OHZ5X%\2_^2B:G_VR_P#125[Z.E( HHHI@%%%% !1110
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MY'*Q \M_P)A^2U[;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 R7[@_WE_F*?3)?N#_>7^8I] !1110 5X%\2_\ DHFI_P#;
M+_T4E>^UX%\2_P#DHFI_]LO_ $4E)@>^T444P"BBB@ HHHH **** &0_ZB/_
M '1_*GTR'_41_P"Z/Y4^@ HHHH *\-_:<_Y ?A__ *^9?_0!7N5>&_M.?\@/
MP_\ ]?,O_H H ]"^$W_))O#W_7H/YFNPKC_A-_R2;P]_UZ#^9KL* "BBB@ H
MHHH **** "BBB@ HHHH **** "BBJ>KZI:Z)H]UJ6H2".WMHS(['V[#W/2FD
MV[("MXB\2:7X6TI]0UJY$$*\*.K2'T4=S7E,_P 0?'/CF5X_!&FC3=/#8^V3
M8W$?[QX'T4$^]4-#TJ^^*_B.3Q-XH#IH\+E+2S#?*V#]T>WJ>YXKUF&&*WA2
M&WC2**,;41%PJCT KT%3A1T:O+\$5L>9K\/O'-^-^J^.KB-VY*0R2L/YJ/TH
M_P"%6^(_^A\OOSD_^+KT^BG[>?2WW(5V>8?\*M\1_P#0^7WYR?\ Q='_  JW
MQ'_T/E]^<G_Q=>GT4>WG_2079YA_PJWQ'_T/E]^<G_Q='_"K?$?_ $/E]^<G
M_P 77I]%'MY_TD%V>8?\*M\1_P#0^7WYR?\ Q='_  JWQ'_T/E]^<G_Q=>GT
M4>WG_2079YA_PJWQ'_T/E]^<G_Q=+_PJ[Q(.5\>7P/;F3_XY7IU%'MY_TD%V
M>7MX8^)^AYET?Q6=1"\^7-(23[8?(_6M;P_\8Y;74ET?X@Z:VDWF0HN54B,^
M[#L/<9'TKNJR/$GAC3/%6EM9:K#N[QS+P\1]5/\ 3H:.>$]*D?FMPOW.SCD2
M6-9(F5T8 JRG((]0:=7B_P /O$&H^!O%G_"#>)I?,M)CG3[ECP,] /\ 9;T[
M'CO7M%<=:DZ4K=.@/0****Q$%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!X%\2_^2B:G_VR_P#125[Z.E>!?$O_ )*)J?\ VR_]%)7OHZ4@"BBB
MF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% #)?N#_>7^8I],E^X/]Y?YBGT %%%
M% !7C/CWPIKNI>-[^[L-,GGMY/+V2(!@XC4']0:]FHH **** "BBB@ HHHH
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MHZ5X%\2_^2B:G_VR_P#125[Z.E( HHHI@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!Y9\:O^8)_P!M_P#VG1_S;Q_G
M_G[H^-7_ #!/^V__ +3K9\(Z-!X@^$-IIEV\D<,^_<T1 8;9V88R#W%+J!C?
M!7_F-_\ ;#_VI7J=<_X6\'6/A+[5]@GN)OM6S?YQ4XV[L8P!_>-=!3 ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 R7[@_WE_F*?3)?N#_>7^8I] !1110 5$]U!&Y62>-6'4,X!%2UX%\2
M_P#DHFI_]LO_ $4E 'OM%%% !1110 4444 %%%% #(?]1'_NC^5/ID/^HC_W
M1_*GT %%%% !6#XN\%Z+XWTR.QU^W:6.*3S(VC<HR-C'!'L:WJ* /+O^&>O
MW_/*_P#_  +/^%'_  SUX&_YY7__ (%G_"O4:* /+O\ AGKP-_SRO_\ P+/^
M%'_#/7@;_GE?_P#@6?\ "O4:* /+O^&>O W_ #RO_P#P+/\ A1_PSUX&_P">
M5_\ ^!9_PKU&B@#R_P#X9Z\#?\\;_P#\"C_A1_PSWX&_YXW_ /X%'_"O4**
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MKVN:UX'U6[BMHI])F>;446;(#-&%.SCYN?I4OC?PA>ZEJ%AXD\*R16_B/3&
MC:0[4NH2?FAD/IC./2NSHHL R!I7MXVN(Q%*R@O&&W!6QR,]_K3Z**8!114-
M[>VVG6<MW?3I;V\2[GDD. HI@<?\6M673/ %U#NQ+?,MN@[D9RWZ#]:Z[X<Z
M1)H?P\TBRG0I,(!)(IZAG)8C]:\PT:WN/BY\0X]1FA>/PWI#?(K\>8V<@?5C
M@GT  KW6JQ#Y(*EUW8WHK!1117"(**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#P+XE_\E$U/_ME_P"BDKWT=*\"^)?_ "434_\ ME_Z*2O?1TI
M%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /+/C5_S!/^V__M.NI^&G_).],_[:_P#HUZY;XU?\P3_MO_[3K6\+
MZTOA[X.VNJ20M.L&_,:MM)W7#+U_&EU [VBN9\'>-(O%_P!L\JS>U^R[,[I
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MV?[VDXO>.J_4>Z/:Z***\X04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)?
MN#_>7^8I],E^X/\ >7^8I] !1110 5X%\2_^2B:G_P!LO_125[[7C'C[POKF
MH^.-0NK'3+B>"3R]DB)D-B-0?U!I,#V>BBBF 4444 %%%% !1110 R'_ %$?
M^Z/Y4^F0_P"HC_W1_*GT %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '(>//AWIOCBS!E/V7481^XO$7D?[+#NO\ +M7G7]N>._AU
M_HOB73&UG3(SA+V(EB%[?/\ T8?C7NE!&1@\BNFGB'%<LE=#N>.6WQM\,R*/
MM,%_;OW'E*V/Q!JQ_P +G\(_\];W_P !O_KUZ3<>'-%NF+7.D6,K'J7MD)/Z
M5!_PA_AO_H Z;_X"I_A6OMJ'\K^\-#SW_A<_A'_GI>_^ W_UZ/\ A<_A'_GI
M>_\ @-_]>O0O^$/\-_\ 0!TW_P !4_PH_P"$/\-_] '3?_ 5/\*/;4/Y7]X:
M'GO_  N?PC_STO?_  &_^O1_PN?PC_STO?\ P&_^O7H7_"'^&_\ H Z;_P"
MJ?X4?\(?X;_Z .F_^ J?X4>VH?RO[PT//?\ A<_A'_GI>_\ @-_]>C_A<_A'
M_GI>_P#@-_\ 7KT+_A#_  W_ - '3?\ P%3_  H_X0_PW_T =-_\!4_PH]M0
M_E?WAH>>_P#"Y_"/_/2]_P# ;_Z](?C/X1 _UEZ?^W?_ .O7H?\ PA_AO_H
MZ;_X"I_A2CPAX<!R-!TW_P !4_PH]M0_E?WAH>67?QMTQ_W6B:3>WUPW"*P"
M@GZ#)-1VW@OQG\2;N.Y\8R-HVD(P9;)!AF'LO8^[<^@KV6TTNPL/^/&RM[;/
M7R8E3^0JU2>)4?X<;/ON%^Q2TC1['0=+AT[2K=;>UA&%1?YD]R?6KM%%<;;;
MNQ!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P+XE_\E$U
M/_ME_P"BDKWT=*\"^)?_ "434_\ ME_Z*2O?1TI %%%%, HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)_&MJ>D9R?;\QH]JHHHKSA!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,E^
MX/\ >7^8I],E^X/]Y?YBGT %%%% !113&FC5L-(H/H6% #Z*** "BBB@ HHH
MH **** &0_ZB/_='\J?3(?\ 41_[H_E3Z "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_9O?9I_B:U/#17ZDKZ9!'_LM>UT %%%% !1110 4444 %%%% !1110 4444
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M+_H^W=\H;[V<=![5L_VKJR??B/XQ&N9^$/\ S&/^V'_M2O2JN,FT2XJYS?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,E^X/]Y?YBGTR
M7[@_WE_F*?0 4444 %>+>/\ PUK6H>.=0N;+2[J>"3R]LD<1*MB-0>?J#7M-
M% !1110 4444 %%%% !1110 R'_41_[H_E3Z9#_J(_\ ='\J?0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'A_P=_XE/QA\<:*WRYE:15]0LI_HXKW"O#M8/\ PBW[5.G78_=P:W;J
MC]@Q92G_ *$BFO<: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?RJU4E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,E^
MX/\ >7^8I],E^X/]Y?YBGT %%%% !2%@.I'YTM>!?$O_ )*)J?\ VR_]%)0!
M[[1110 4444 %%%% !1110 R'_41_P"Z/Y4^F0_ZB/\ W1_*GT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!Y!^T-HTS^&=-\26((NM'N@2Z]51B,'\&"_G7IGAK6H?$7AC3M7MF#)
M>6ZR<=B1R/P.1^%2ZWI%MKVA7NE7R[H+R%HG]LCK]1U_"O(O@3K<^C:EK'P_
MUE]MUI\[R6P;@L <.!^C#V8T >UT444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!X%\2_^2B:G_VR_P#125[Z.E>!?$O_
M )*)J?\ VR_]%)7OHZ4@"BBBF 45GWNMV-AE99=S_P!R/D__ %JK6OB>QN91
M&^^$DX!<<?G3LQ71LT44=.M(845$]PB]#N/M4#W+MT^4>U/E8KHY6X86'BF1
M[H97S"V<=CT-:LNLV,2Y\[>?1!FI;W3X+\#SP=PZ.#R*I1>';9&S+))(/3I6
MZ>ABXZE:;Q&[?+:P 'L7Y/Y"HO*UC4?O[U0_WCL'Y5OPVD%N,00HGN!S^=34
M<P<IA0>&QUN9\^H0?U-:,.E64&"D"L?5^:N45-RK(0 *, 8'H*6BB@ HHHH
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M6 )[!ABJ&B65Q_PI^\U35M?DT2;6IFO[J^;):*)VX1>>,K@#'K1<+'J(922
MP)'4 ]*Y;5?$5]9_$W0M!A\K['?VD\TV4R^Y.F#VKRS7IO#.AV>G:MX&L=<L
MK^&\A OYK>=(;I&;#!V?ALCVKOM?_P"2Z>$_^P?=_P J5QV._HHHJB0HHHH
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MQA4&!4E9V1KJ%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFF=+14-M>6]Y'OMI5D'L>1^%35!84444 %%%% !1110 4444 %%%% !1110
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MHV&KV>H#]Q)A^\;<-_\ 7J]6>QIN%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)?N#_>7^8I],E^X/\
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M<KXY\,7FOV.GW>BS1P:QI%R+JS:7[C,!AD;V([U6L]6\=ZG?6L$OARTT6%)
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MCK4+BRTJ]N(7\O;)%;LRMB)0<$#U%>V44 %%%% !1110 4444 %%%% #(?\
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MU<WEF)EFP588(/>N1N?#\J3LUA+A#T#-@CVS6L&935S1O=5M[+*LV^3^XO\
M7TK&:74-:DVH-L6>@X4?4]ZN6?AY5;?>OYA_N+T_$ULHBQH%C4*HZ #&*MLE
M1,^QT6WM,/(/-E]6' ^@K2HHJ2@HHHH \/\ B'_R/FH_]LO_ $4E>X5X?\0_
M^1\U'_ME_P"BDKW"HCNRGL%%%%62%%%% !1110 4444 %%%% !1110 4444
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MB;O0K^*]@5MK-&3E3Z$'D'ZUQ7A;3[2X^,_C6ZN+:.6>$VZQ.Z@E 4YQGIG
MJ7PC%':_&3QK!;(L4)CM9#&@PNXJ<G'K1<#T.BBBF(**** "BBB@ HHHH *"
M,]:** ,R\T.VN<M%^YD]5'!_"LO;J.BOD9,6?JA_PKIZ0@$$$9!Z@T[B:1FV
M6N6]SA9?W,GHQX/XU=N+2"[CVSQAQV/<?0UGWN@P3Y>W/DOZ?PG\.U9RW&HZ
M.VR52T78-RI^A[55R&K!?6$ND2I<VLS;=V%/0J?3WKL-/NOMNGPW&,%UR1Z'
MO7&W=_<:PT<$4.!G(53G)]2:ZO3 MG8Q6S?P+C=ZGO431<#0HHHK$V"BBB@
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &2_<'^\O\
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M2DTC=:H****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P +#\+_ /03_P#)>7_XFL/_ (4K_P!1_P#\D_\ [.C_ (4K_P!1_P#\D_\
M[.CF8<J-S_A8?A?_ *"?_DO+_P#$T?\ "P_"_P#T$_\ R7E_^)K#_P"%*_\
M4?\ _)/_ .SH_P"%*_\ 4?\ _)/_ .SHYF'*C<_X6'X7_P"@G_Y+R_\ Q-'_
M  L/PO\ ]!/_ ,EY?_B:P_\ A2O_ %'_ /R3_P#LZ/\ A2O_ %'_ /R3_P#L
MZ.9ARHW/^%A^%_\ H)_^2\O_ ,31_P +#\+_ /03_P#)>7_XFL/_ (4K_P!1
M_P#\D_\ [.C_ (4K_P!1_P#\D_\ [.CF8<J-S_A8?A?_ *"?_DO+_P#$T?\
M"P_"_P#T$_\ R7E_^)K#_P"%*_\ 4?\ _)/_ .SH_P"%*_\ 4?\ _)/_ .SH
MYF'*C<_X6'X7_P"@G_Y+R_\ Q-'_  L/PO\ ]!/_ ,EY?_B:P_\ A2O_ %'_
M /R3_P#LZ/\ A2O_ %'_ /R3_P#LZ.9ARHW/^%A^%_\ H)_^2\O_ ,31_P +
M#\+_ /03_P#)>7_XFL/_ (4K_P!1_P#\D_\ [.C_ (4K_P!1_P#\D_\ [.CF
M8<J-S_A8?A?_ *"?_DO+_P#$T?\ "P_"_P#T$_\ R7E_^)K#_P"%*_\ 4?\
M_)/_ .SH_P"%*_\ 4?\ _)/_ .SHYF'*C<_X6'X7_P"@G_Y+R_\ Q-'_  L/
MPO\ ]!/_ ,EY?_B:P_\ A2O_ %'_ /R3_P#LZ/\ A2O_ %'_ /R3_P#LZ.9A
MRHW/^%A^%_\ H)_^2\O_ ,31_P +#\+_ /03_P#)>7_XFL/_ (4K_P!1_P#\
MD_\ [.C_ (4K_P!1_P#\D_\ [.CF8<J-S_A8?A?_ *"?_DO+_P#$T?\ "P_"
M_P#T$_\ R7E_^)K#_P"%*_\ 4?\ _)/_ .SH_P"%*_\ 4?\ _)/_ .SHYF'*
MC<_X6'X7_P"@G_Y+R_\ Q-'_  L/PO\ ]!/_ ,EY?_B:P_\ A2O_ %'_ /R3
M_P#LZ/\ A2O_ %'_ /R3_P#LZ.9ARHW/^%A^%_\ H)_^2\O_ ,31_P +#\+_
M /03_P#)>7_XFL/_ (4K_P!1_P#\D_\ [.C_ (4K_P!1_P#\D_\ [.CF8<J-
MS_A8?A?_ *"G_DO+_P#$T?\ "P_"_P#T$_\ R7E_^)K#_P"%*_\ 4?\ _)/_
M .SH_P"%*_\ 4?\ _)/_ .SHYF'*C<_X6'X7_P"@I_Y+R_\ Q-'_  L/PO\
M]!/_ ,EY?_B:P_\ A2O_ %'_ /R3_P#LZ/\ A2O_ %'_ /R3_P#LZ.9ARHW/
M^%A^%_\ H)_^2\O_ ,31_P +#\+_ /03_P#)>7_XFL/_ (4K_P!1_P#\D_\
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M6A,BOY@BW].V,C^=/F#E,3_A8?A?_H)_^2\O_P 31_PL/PO_ -!/_P EY?\
MXFL/_A2O_4?_ /)/_P"SH_X4K_U'_P#R3_\ LZGF8<J.MTCQ)I.NR2II5WY[
M1 %QY;K@'_> K4K"\&^ QX2N;J5K\7OVA%7!@V;<$G^\<]:ZWRT_N+^54I!R
MF)J>J6>CV1N]1F\F!2%+[2W)Z< $UB_\+#\+_P#03_\ )>7_ .)K<\4^'%\2
MZ&^G+.+0LZOYHBWXP>F,C^=</_PI7_J/_P#DG_\ 9TG)] Y3<_X6'X7_ .@G
M_P"2\O\ \36AI'B72==EDCTJ[\]H@&<>6ZX!_P!X"N3_ .%*_P#4?_\ )/\
M^SKI/!O@(>$[JYF;4!>^>@3:;?9MP<Y^\:.9ARF[534]4L]'LFN]1F\F!2 7
MVEN3TX )K;\M/[B_E6/XI\.+XDT*33A.+4NZMYHBWXP<],C^=/F#E,+_ (6'
MX7_Z"?\ Y+R__$T?\+#\+_\ 03_\EY?_ (FL/_A2O_4?_P#)/_[.C_A2O_4?
M_P#)/_[.IYF'*CK-(\3:1KLTD6E7?GO&NYQY3K@=/X@*U:P?!W@$>$[VXN&U
M 7OGQA-IM]FWG.?O&NN\M/[B_E5*7<.4Q-2U.TTBQ>\U&7R8$(#/M+8R<#@
MFL7_ (6'X7_Z"?\ Y+R__$UO>)_#R^(]!FTT3"U,C*?-$>_&"#TR/3UKA?\
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MUJ7Y%J_4R?\ A9?A+_H+?^2TO_Q-'_"R_"7_ $%O_):7_P")KEO^%*_]1_\
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MO^@M_P"2TO\ \31_PLOPE_T%O_):7_XFN6_X4K_U'_\ R3_^SH_X4K_U'_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#NW88Z"O1*\C*5)PE.75GJ4KVN%%%%>T;!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[L?4U9HHKZ*,5%<L=CN"BF2310[?-D2/<=J[F R?2GU0!1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !6!K7AHZM>3RK<^4DUJ8RH7_EI@A7S_NLP/UK?HIIM.Z+A
M.4'>)REGX-$1C>Y-O(PD20@H7QAY&(!;GGS!^51KX.N2D5M/<6\EI'L)4QG+
MD"(,#VQ^Z/\ WU[<]?15>TD;?6:M[W.4C\)7!U:>YGGMS&\H=0D9! $A<<=
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M!'6EH Y#3+G5(9H8I6E2!9HD$(C.XJ0><[<8SR>?X3T[]?110 4444 %%%%
M!1110!RWB='&H!A&9/,M@511DOY<R2,H]25SQWP:YC4X=1OH)HDL[X1R3S36
M]N(\*58S99O<Y7\Z]0HKHA7Y%:QE*G=[G [;S^T+[4[:TNK:&8(H98\2(@:%
M9"H]<*WY9JG!IEVEK"UQ%>0V[ Q2E8@\FUXR,D?H3VS7I5%-8AI6L'L_,\WO
M])OCIL,<=E,Y6*Y7&WDY>7&?KD?G6UIC&YU^"1;>2 /=27 CD7:RHMNL1)';
M+G ]<5UU%)UVU9KO^(*G8****YS4**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
IHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>bdtx-20211231_g21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g21.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,X
M,0  DI(  @    ,X,0  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]6^\]QHHHKR3Z8R]7\2Z1H+QIJMZL#R#<J[&8D>N%!JA!X_\,7$R11:HN]R
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M5TB526F5B22H/9AZU%\()9?)U:!V;9&T3*AZ*3OS_(?E7,?$G_D>[W_=C_\
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M%:E>3?"+_D.7_P#U[#_T(5ZS4XFDJ-1PB:Y?B9XK#JK-:Z[!1117,=X4444
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M]M?_ $4]%+"PGAW5;=]?P#$9E5I8Z.'BE9M+SU^9[I1117G'OA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %>3?%W_D.6'_ %['_P!"->LUY-\7?^0Y8?\ 7L?_ $(UW8#^
M.CQ\Z_W.7JOS#X1?\AR__P"O8?\ H0KTO5M9L=%LI+G4+A(E12P4L-S^P'<U
M\]V>GWFH2,EA:3W3J,LL,1<@>IP*EN=%U2RC\R\TV\MT_O2P,H_,BO0K82-6
MKS.7R/!P>:5,-AO9PIWWUZ?E^I5(,LV(U)+M\J@9Z]J^@_#6GOI7AFPLYO\
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MI4ZCO;8\[\8?$B\34)M/T!UABA)1[G 9G8<';V ]^M<O#J7C"\B-U;76M31
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M4KTVO,O@[_S&?^V'_M2O3:SQW^\2^7Y'1D_^XP^?YL****XSU0HHHH ****
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MK5>PLE/_ (^]-^$R@^+;@D E;)R,CI\Z5[]-^SP=X]CXG$+ZQFO)/:Z7R1[
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M$*]9KR;X1?\ (<O_ /KV'_H0KUFLL?\ QW\CHR7_ './J_S"BBBN$]D****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "J>L?\@._P#^O:3_ -!-7*IZQ_R [_\
MZ]I/_0351^)$5/@?H?.-?1ND$+H-B6. +:,DGM\HKYRK23P[K<D:O'H^H.C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5X!7OOB^19? ^I21L&1[8LK#N#WKP*L<M_AR]3IS_P#CP]/U/H?_ (1K0O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_K&6PJ=VOOUN:/PITRPU'^U?[0LK>Z\OR=GGQ*^W._.,CCH/RKT3_A&M"_Z
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MQ]U<\D^P&37T7668QBIIK=G3D-2I.C*,MD]/U"L3QG_R)>J?]>[5MUB>,_\
MD2]4_P"O=JX*7\2/JCV\3_ GZ/\ (\ KZ:KYEKZ:KU,S^Q\_T/G.'?\ E[\O
MU/ _''_([ZI_UV_H*]"^$O\ R*=S_P!?S_\ H"5Y[XX_Y'?5/^NW]!7H7PE_
MY%.Y_P"OY_\ T!*TQ7^Z+Y'/EW_(SG_V]^97^+W_ "!=/_Z^#_Z#7&_#K_D?
MM._[:_\ HIZ[+XO?\@73_P#KX/\ Z#7&_#K_ )'[3O\ MK_Z*>BA_N3]&&-_
MY&T?6/Z'NE%%%>&?9!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=/>=S<%=[3."?ESCH .YK;HHI2E*;YI/4=.G"E!0@K)!1114F@4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7LE#^8LM[Y@.5('R[CWQ7HE<=6FJ<K*2?H>KAJ\J\.:4''R84445D=(4444
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M3^*<[_Y'M-<9I'Q"75?%@T0::8LR2()O/S]P,<[=O?;ZUV=>+^#_ /DK$?\
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M(^$/B%!XAN18WT*VMZ02FULI+[#/(..W-:7B_P 5CPI9V\WV(W9G<ICS-@7
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M  L_Y$W_ +>7_I79UQGPL_Y$W_MY?^E=G2Q/\:7J5E_^Z4_1'%^'/B&/$'B
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MZE'JM5_7];GS5#_95A\4MG[K^]_U\CVZN,^)NM?V;X9^QQ-B:_;R_<(.6/\
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ME2,W5]C/E*V @/0L?Z5T6H78L--N;MAE;>%Y2/7:"?Z5Y%X!TU?$OC"XOM6
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M[PC9?>>]AJ=:$6JT^9^E@HHHK(Z3RKXO_P#(2TW_ *XO_,5W7@S_ )$O2_\
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M%OB7_A*=6BO?LGV7RX!#L\S?G#,<YP/[WZ5UEO\ %WR+:*'^Q-WEH%S]KQG
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M_P!R7J$?^1M+_#_D='K'_(#O_P#KVD_]!->7?"/_ )&2\_Z]#_Z&M>HZQ_R
M[_\ Z]I/_037EWPC_P"1DO/^O0_^AK1A_P#=J@8[_?\ #_,T_C"#Y.DG^'=*
M#QWPG_UZZ?P RMX$TTH,#8X_$.P-0_$'09-<\,L+5-]S:MYT:CJPQA@/PY_
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M_P A^!KTJHQDESJG':.AME-.7LI8B?Q3=_ET/%OAS_R4"/\ W)?Y&O7=8_Y
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M?P/<Z*PK7QIH-[J%O96=^)I[@D(%1L=,\DCCI6[7!*$H:25CVJ=6G45X23]
MHHHJ30\J^+__ "$M-_ZXO_,5W7@S_D2]+_Z]UKA?B_\ \A+3?^N+_P Q7=>#
M/^1+TO\ Z]UKTJW^Z0_KN>!A?^1I6]%^A8\2_P#(IZO_ ->,W_H!KSWX0?\
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MY%OXV93QE<J<?E7JG@S_ )$O2_\ KW6N"^*FA2P:K'K4",89U5)6'\#C@?F
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MLC]^1\Q]NG\JXZN%JNLTENSU,/F.&CA8SE):):=;KR.2\'_\E8C_ .OBX_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'W^V7D@PL@0[(_?D?,?;I_*N.KA:KK-);L]3#YCAHX6,Y26B6G6Z\CDO!_\
MR5B/_KXN/_0'KN_B8C-X'N"HR$EC+>PW ?S(KS_P-#<0?$NSCO59;@-+Y@?[
MP;RG)S[UZ]KFF+K.A7>GL=OGQE58]FZJ?S KHQ4E#$0D^B7YG#EM.57 5H+=
MN7Y(\?\ "'@@>*[2XF_M'[*8'";?)WYR,Y^\*Z+_ (4[_P!1W_R3_P#LZP/"
M/B"7P5KUS:ZK#(L,F$GC ^9&'1@._4_@:].3QOX;>/>-7@ QG!R#^1&:TQ-3
M$PJ>Y\+VTN89?A\NJT5[9)36]VU^IR*?!Y0ZE];++GD"TP2/KOKTRN57XB:'
M/J]KI]B\UU)<2K$)$CPBD\?Q8/7T%=57GUYUI6]J>[@J6$I\WU6WG9MGB_PN
M_P"1T7_KWD_I7M%>+_"[_D=%_P"O>3^E>T5OF'\;Y'%D7^Z?-_H%%%%>>>Z%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!C7?A+1+[5O[3N[$27FY6\SS''*@ < X[#M6S115.4I
M))O8B-.$&W%)7W\REJNCV&MV8M=4MQ/"&#A2Q7!&><@@]S1I6D6.B6?V72[<
M00EBY4,6R3WR23V%7:*.:7+RWT%[.'/SV5^_4*QAX2T0:S_:HL0+WS/-\WS'
M^]ZXSC]*V:*(RE'9V'.G"=N=)V[A67KGAS3/$,"QZG;[RGW)%.UT^A_ITK4H
MHC)Q=XL)PC4BXS5T<7;_  K\/PW D=[R=0<^7)*-I_)0?UK?O_#&C:G8V]G>
M6*-;VW^IC1F0)]-I%:M%:2KU9--R>AA#!X>G%QC!6>^A#9VD%A9Q6MI'Y<$*
MA40$G _&FW]A:ZG926E_"L\$@^9&[_X58HK*[O?J='+'EY;:'$'X4: 9-PFO
M@,_<$JX_]!S^M==IVGV^EZ?#962;((5VHI.?UJS16DZU2HK3=S"CA:%!N5.*
M39RFJ?#C0-4NFN#'-:2.<M]F<*"?7!! _"K&A^!-$T&X%Q;0O/<+]V6X8,4^
M@  !]\5T=%-UZKCRN3L2L%AE/VB@K^ADV?A?1M/U:34K.Q6*[D+%I ['[W7
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MBGI>DV6BV0M-,@\B ,6V;BW)ZG))-7***&VW=A&,8KEBK(R->\+Z7XCC0:E
M3(@PDT9VNH],]Q[&L.T^%OAZVN!+(;NY .?+FE&W_P = /ZUV=%:QKU8QY8R
M=CGJ8/#U)\\X)LRM4\,:/K,-O#J%BDD=L"(41FC" XR!M(XX'Y5I00QVUO'!
M NR*) B+Z # %/HK-RDU9O0WC3A&3DDKLQK_ ,):'J>I_P!H7UB);KY?WGF.
M,XZ< X[5LT44.4I))O8(TX0;<4DWOYE'5M&L-<LUM=5M_/A5Q(%WLN& (SD$
M'N:DTW3+/2+%+/3H1! A)" D\GKR>:M44<TN7EOH'LX<_/97[]1DL23PO%*N
MY)%*LOJ#P:S-(\+:-H5Q)/I5F()9%V,WF.V1G./F)]*UJ*%*232>C"5.$I*4
MDFUL^P5SFL^!-"UNX:XN+=H;ASEY8&VEC[CD$^^*Z.BG"<H.\78FK1IUH\M2
M*:\SB8?A3X?CD#/+?3 ?PO*H!_)0:ZS3],LM)M!;:=;1V\(YVH.I]2>I/N:M
M454ZU2II)W,Z.%H4'>G!(*QM,\):)HU\;S3;$03E2NX2.W!Z\$D"MFBH4I)-
M)[FTJ<)M2DDVMO(****DL*K:AI]KJMA)9:A%YUO+C>FXC."".1SU JS133:=
MT*45)6>QGZ1H>G:%;O#I5L+>.1MS#>S9/U8FM"BBAR<G=BC",(\L59&+_P (
MAH7]L?VI_9Z_;/-\[S/,?[^<[MN<9SSTK:HHIRE*7Q.Y,*<*=^1)7[%+5=(L
M=;L_LNIP">'<'VEBN".^00>]+I>DV6BV0M-,@\B ,6V;BW)ZG))-7**.:7+R
MWT'[.'/SV5^_41E#*58 @C!!'6N3U'X:^'M0F,JQ36;-R1;2  GZ$$#\*ZVB
MJA4G3=XNQ%:A2K*U2*9QUG\+O#UK,))!=70'\$\HV_\ CH%=;!!%:P)!;1)%
M$@PJ(N H]A4E%$ZLZGQNXJ.&HT/X<4@KF=9^'^A:W=-<S126T[G+O;,%W'U(
M((S[XKIJ*4*DH.\78JK1IUH\M2-T<KI7PYT#2KE9Q%+=R*<K]J8,%/K@ #\Z
MU;KPQI%YK,>JW-F'O8F5DE\QA@K]TX!QQ]*U:*J5:I)W<F9PPM"$>6,%;?;J
M%9VKZ#IFNP"+5+1)MOW7Z,OT8<BM&BLXR<7=&\X1G'EDKHX=OA-H+-D7%^H_
MNB5,?JE:.F_#SP[ILJRK:-<R*05:X?=C\.!^E=/16SQ-9JSDSDC@,+!\RIK[
M@K&C\):)%K1U:.Q"WID,IE\Q_O'J=N<=_2MFBLHRE'9G5.G"=N=)V"BBBI+"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ K&B\):)#K)U6.Q O3(93+YCGYCU.,X[
M^E;-%5&4H[,B=.$[<Z3ML%9NL>']+U](EU:U%P(23'\[*5SC/*D>@K2HI1DX
MNZ=ASA&<>6:NO,KV%A;:98QV=C$(;>($(@)..<]_<U8HHH;;=V-)15EL8VG^
M$M$TK4?MVGV(AN>?G$CG&>O!.*V:**<I2D[R=R84X4U:"27D86O>#M'\1.);
M^!EG QY\+;7(]#V/XBLW3_AEX?L+E9G6XO"IR$N7!7/T &?QKKZ*T5>K&/*I
M.QA+!X><_:2@F_0R-5\*Z+K4\4VIV*S/$FQ")&7"YSC"D"M>BBLW*323>QO&
MG"+<HI)O?S,_6=#L-?LOLNIP"5 <JP.&0^H/:N9C^%&@),':6^D4'[C2K@_D
MH/ZUVU%7"M4@K1E8PJX3#UI<U2";(Q!$+;[/Y:F'9L\LC(VXQC'IBN1N_A;X
M>NIVDC^U6H8YV0RC:/\ OH&NRHI0JSI_"[%UL-1K)*I%.QA:-X.T;0X9$M+;
M>\JE'EF.YV4]1GL/IBK.C^&])T%I6TFS%NTV-YWLQ..GWB<=>U:E%$JDY7NW
MJ$,/1A;EBE;;38JZEIEGJ]B]GJ,(G@<@E"2.1TY'-1Z3HUAH=FUKI5OY$+.9
M"N]FRQ &<DD] *O45/-+EY;Z&GLX<_/97[]0K&7PEH:ZS_:JV(^V^89?-\Q_
MO>N,X_2MFBB,I1V=@G3A.W.D[=PK U_P7H_B.83WL<D=P!M,T#!68>^00?RK
M?HHA.4'>+L*I2IU8\E171R^B?#[1M"U%+ZW-S//'G89W!"DC&< #UKJ***<Z
MDJCO)W)HT:=&/+35D%%%%0;&7K'AO2=>:)M6M!<-$"$.]E(!_P!TBKUG:06%
MG%:VD8C@A4*B DX'XU-15.4FN5O0S5."DYI*[Z]0KG]=\$Z-X@G^T7D+Q7!&
M#- VUF^O!!_*N@HIPG*#O%V"K2IU8\M171R>E_#;P_IET)S'->.IRHNG#*#Z
MX  /XYK5U'PKHNJZBE]J%D)KE  '\QUZ=. 0#6O15.M4;YG)W,HX3#PCR*"M
MZ!6-'X2T2+6CJT=B%O3(93+YC_>/4[<X[^E;-%1&4H[,VG3A.W.D[!67K'AK
M2=>>)]6M!<-$"$/F,N ?]TBM2BB,I1=XNP3A"I'EFKKS([>"*UMHK>W0)%"@
M1%'\*@8 _*H[^PMM3L9;.^B\VWE&'0DC/.>HYZBK%%*[O<;C%QY6M#.TC0--
MT&*2/2;;[.LI#.-[-DC_ 'B:T2,C!Y%%%$I.3NV$(1A'EBK(Y34OAOX>U&=I
MA#+:.QRWV9PH)^A! _#%06GPM\/6TP>3[5<@'.R:48/_ 'R!7945LL162MS,
MY'@,*Y<SIJ_H1V]M#9VZ6]K$D,,8PB(N H^E-N[2"^LY;6[C$D,JE70]P:FH
MK&[O<[.56Y;:&9H_AW2] $PTBU^S^=CS/WC-NQG'WB?4UIT442DY.\G<F$(T
MX\L%9>04444BS/U?0].UVW2'5;87$<;;E&]EP?JI%3Z?I]KI5A'9:?%Y-O%G
M8FXG&22>3SU)JS15<TN7EOH0J<%/G25^_41E#*58 @C!!'6L?3?".AZ1??;-
M.L%AN,$!_,=L9ZX!) K9HH4I132>XI4X3:E))M;>05FZQX>TO7UB&K6HN!"3
MY?SLNW.,_=(]!6E12C)Q=XNPYPC4CRS5UYD-G:06%G%:VD8C@A4*B DX'XT^
M:"*Y@>&XC66)QAD<9##W%/HHN[W*Y4ERVT..O/A=X>NIC)&+JU!_@@E&W_QX
M&I-.^&GAZPF$KPS7C+T%RX(!^@ !_&NMHK;ZS6M;F9QK 852YO9J_H(JJB!4
M4*JC  & !2D9&#R***P.TY+4OAKX?U&Z:<)/:,YRPMG"J3]""!^%6M$\":'H
M5P+BV@>>X7[LMPP8K[@8 !]\5T=%;.O5<>5R=CD6"PT9^T4%?T,J+PQI$.N'
M6(K,+?EF8S>8W4C!.,XZ$]JU:**SE*4MV=$*<(7Y%:YD:UX6TCQ H.I6BM*!
MA9D.UQ^(Z_0YKGO^%3:#NS]IU#'IYJ8_] KN**TA7JP5HR.>I@L-5ES3@FSG
M](\#Z#HLR3VMIYEPARLTS%V!]AT'Y5ONBR(R.-RL,$'N*6BHE.4W>3N;4Z-.
ME'EIQ27D9&D^%=&T.[>YTJR$$TB%&;S';*D@XP21U K7HHI2E*3O)W*A3A37
M+!)+R"BBBI+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *QHO"6B0ZR=5CL
M0+TR&4R^8Y^8]3C.._I6S151E*.S(G3A.W.D[;!6;K'A_2]?2)=6M1<"$DQ_
M.RE<XSRI'H*TJ*49.+NG8<X1G'EFKKS*]A86VF6,=G8Q"&WB!"("3CG/?W-6
M***&VW=C2459;&-I_A+1-*U'[=I]B(;GGYQ(YQGKP3BMFBBG*4I.\G<F%.%-
M6@DEY&)KWA'2/$15]0@(F48$T3;7QZ>A_&LFQ^&'AZSN%ED%S=[>0EQ("OY*
M!FNQHK2->K&/*I.QA/!X><^>4$WZ&1JGA;1=:>%]2L5E,*;(\.R;5],*16JB
M+'&J(,*H  ]!3J*S<I-6;-XTX1DY123>Y1U?1K'7;$VFIP"6/.5.<%#Z@]C7
M+)\*- 67<9KYUS]QI5Q^BY_6NWHJX5JD%:+L8U<)0K2YJD$V1QV\,5JMLD:^
M2J",(1D;0,8_*N2O?A?X>N[AI8Q<VFXY*02#:/H&!Q78T4H59P=XNQ57#4:R
M2J13L86A^#M&T ,;.W\R5P5::<[V(/;T ^@JQI'AG2-"EEETJS%N\HP[;V;(
M]/F)Q6K11*K.5[MZA##T86Y8I6VTV*VH:?:ZK82V5_$)K>4 .A)&<'(Y'/4"
MH-(T+3M!MWATJV^SQR-N8;V;)Z=6)K0HJ>:7+RWT-'3@Y\[2OWZA6,?"6AMK
M/]JFQ!O?,\WS?,?[WKC./TK9HHC*4?A=@G3A4MSI.W<*P-?\%Z/XCF$][')'
M< ;3- P5F'OD$'\JWZ*(3E!WB["J4J=6/)45T<OHGP^T;0M12^MS<SSQYV&=
MP0I(QG  ]:ZBBBG.I*H[R=R:-&G1CRTU9!1114&QFZQX>TO7UB&K6HN!"3Y?
MSLNW.,_=(]!5NRLK?3K**TLH_*@B&U$!)P/J>:GHJN:3CRWT,U3@IN:2N^O4
M*P=>\&:/XBF$U]"Z7&,&:%MK$>_4'\16]11&<H.\78*E*%6/+45T<CIOPT\/
MZ==+.R3WC*<JMRX90?H  ?QS6OJGA;1M9O(KK4K(331*$1O,9<*"2!@$ \DU
MKT5;K5)/F<G<RCA,/"'(H*WH%8P\):&-9_M46(%[YGF^;YC_ 'O7&<?I6S14
M1E*/PNQM.G"=N=)V[A69K'AW2]?$(U>U^T>3GR_WC+MSC/W2/05IT4HR<7>+
ML$X1J1Y9JZ\R&TM(+&SBM;2,1PQ*%1!V I+VRM]1LI;2]C\V"4;70DC(^HYJ
M>BB[O<?+'EY;:&;H_A_3- 25=)M?LXF(+_.S;L=/O$^IK2HHHE)R=V[A"$81
MY8*R\CE=3^'/A_4YVF\B2TD8Y8VS[03]""!^ JM:_"SP];RAY#=W(!SLEE&#
M_P!\@&NSHK98BLE929R/ 864N9TU?T(;6TM[&V2WLX4AA085$7 %.N((KJVE
MM[A \4R%'4_Q*1@C\JDHK&[O<[.56Y;:&5H_AK2-!>5])M/L[2@!SYC-D#_>
M)K5HHIRE*3O)W)A"%./+!67D%%%%264=6T:PURS6UU6W\^%7$@7>RX8 C.00
M>YI^F:79Z/8K9Z;"(8%)(0,6Y/7DDFK=%5S2Y>6^A'LX<_/97[]0K%T_PAH6
ME:B+ZPT]8;D9PXD<XR,' )P.#6U10I2BFD]Q2IPFTY)-K;R"L[6/#^F:]'$F
MK6HN%B)*?.R[<]>5(]*T:*49.+NF5.$9QY9JZ\R"RLK?3K**TLH_*@B&U$!)
MP/J>:DF@BN8'AN(UEB<89'&0P]Q3Z*+N]QJ*2Y4M#CKSX7>'KJ8R1BZM0?X(
M)1M_\>!J33OAIX>L)A*\,UXR]!<N" ?H  ?QKK:*V^LUK6YF<:P&%4N;V:OZ
M"*JH@5%"JHP !@ 4I&1@\BBBL#M.2U+X:^']1NFG"3VC.<L+9PJD_0@@?A5K
M1/ FAZ%<"XMH'GN%^[+<,&*^X&  ??%='16SKU7'E<G8Y%@L-&?M%!7]#*B\
M,:1#KAUB*S"WY9F,WF-U(P3C..A/:M6BBLY2E+=G1"G"%^16N9&M>%M(\0*#
MJ5HK2@869#M<?B.OT.:Y[_A4V@[L_:=0QZ>:F/\ T"NXHK2%>K!6C(YZF"PU
M67-.";.?TCP/H.BS)/:VGF7"'*S3,78'V'0?E70445$IRF[R=S>G2ITH\M.*
M2\C&TSPEHFC7QO--L1!.5*[A([<'KP20*V:**4I2D[R=QPIPIKE@DEY:!111
M4EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]_)__BZ/^$(\1_\ 0Z7OY/\ _%T>RI?\_%]S_P @^LXC_GR_OC_F=U17"_\
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M_P _%]S#ZSB/^?+^^/\ F=U17"_\(+X@_P"AVO\ \G_^.4?\(+X@_P"AVO\
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M.4>RI?\ /Q?<P^LXC_GR_OC_ )G=45PO_""^(/\ H=K_ /)__CE'_""^(/\
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M ,@^LXC_ )\O[X_YG=45PO\ PA7B7_H<[O\ )_\ XNC_ (0KQ+_T.=W^3_\
MQ='LJ?\ S\7W/_(/K.(_Y\O[X_YG=45PO_"%>)?^ASN_R?\ ^+H_X0KQ+_T.
M=W^3_P#Q='LJ?_/Q?<_\@^LXC_GR_OC_ )G=45PO_"%>)?\ H<[O\G_^+H_X
M0KQ+_P!#G=_D_P#\71[*G_S\7W/_ "#ZSB/^?+^^/^9W5%<+_P (3XD/7QG>
M#Z!__BZ/^$(\1_\ 0Z7OY/\ _%T>RI?\_%]S_P @^LXC_GR_OC_F=U17"_\
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M6<1_SY?WQ_S.ZHKA?^$*\2_]#G=_D_\ \71_PA7B7_H<[O\ )_\ XNCV5/\
MY^+[G_D'UG$?\^7]\?\ ,[JBN%_X0KQ+_P!#G=_D_P#\71_PA7B7_H<[O\G_
M /BZ/94_^?B^Y_Y!]9Q'_/E_?'_,[JBN%_X0KQ+_ -#G=_D__P 71_PA7B7_
M *'.[_)__BZ/94_^?B^Y_P"0?6<1_P ^7]\?\SNJ*X7_ (0KQ+_T.=W^3_\
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M/_H=+W\G_P#BZ/94O^?B^Y_Y!]9Q'_/E_?'_ #.ZHKA?^$(\1_\ 0Z7OY/\
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MOB#_ *':_P#R?_XY1_P@OB#_ *':_P#R?_XY1[*E_P _%]S#ZSB/^?+^^/\
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MXT\+27_V&/Q+H[7><?9UOXC)GTV[LUMT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:1>%_C!;OY5PX1+V2-4:+)P'W)\LD>>I'(YYXQ7T:,!1MQC'&*\ _:QCL_\
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M^FZA:ZOI5IJ6GR^=:7D*3P2;2N]'4,IP0",@C@C-6:YOX<?\DL\*?]@6S_\
M1"5TE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAK2O_0+>@#ZVHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ^2? ?\ R>3=?]AK5?\ T"XKZVKY)\!_\GDW7_8:U7_T"XKZVH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$31)[/6=BZYIX!F*+M%Q&>!( .ASP0..A'7  /5:*** "BBB@ HHHH ****
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M%?6U?)/@/_D\FZ_[#6J_^@7%?6U !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH YOX@^+$\$> M4U]D$CVL6(8ST>5B%0'VW,,^V:^2? 'CKPOIOBRZ\5?
M$6RU+Q!K3S"6W(5&C1O^>C!F&6'11C"X&.<;?M.\L;34;8V^H6L-U Q!,4\8
M=21TX/%9O_"'^&?^A=TG_P  8_\ XF@#R3_AJ[PG_P! 36O^^8O_ (NO1?AU
M\1=-^)6BW.IZ1:75K%;7!MV6Z"ABVT-D;2>,,*UO^$/\,_\ 0NZ3_P" ,?\
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M>3=?]AK5?_0+BOK:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU^6__I+%724 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5\D^//\ D\FU_P"PUI7_ *!;T ?6U%%% !1110 4444 %%%% !1110 4444
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MDR@*5 ^?_EF/F/S<'CK7FFA?LP>+M;8W?BG5K72FF^=PQ-U/N/7=@A<_\#-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***CN+B&UMWGNI8X88UW/)(P
M55'J2> * )**\9\7_M,>$]!DDMO#\,VOW2$C?$?*@!_ZZ$$GZJI!]:\KU/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^,4NK!,16EK--,R@[0TGRA?QW$CV4T ?7M%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5\D^//\ D\FU_P"PUI7_ *!;U];5\D^//^3R;7_L-:5_
MZ!;T ?6U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW3M0!0^'UC:6FDZBUK:PPDZQJ"DQQA<@7<H X[ <5U=<WX&_Y ^H?]AG4?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y#XH>#[OQWX
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M0 4444 %%%% !1110 5'<00W5M);W4230RJ4DCD4,KJ1@@@]014E% 'F>@_
MGPMX7^(-MXJT%[JV:W\PK9,^^)2Z%,J3\PX8]2:],KA_BYX_/PY\!RZM;Q)-
M?32K;6<<F=ID8$Y;'8*K'WP!D9KY;B^)'Q;\3327&G:KKMWACN_LZ!@BGTQ&
MN!U% 'T7\7_A!-\4-1T26'5(M-CL%F6=VB,C.&*%=HR.FUNI[BNJ\!^ -%^'
MF@_V9H43$NV^XN92#)._JQ'IV X'XDGY0_X2'XU_\]O%_P#WXG_^)KOO@MK'
MQ,O/B?9P^+9/$3:889C(+^*58MVP[<EAC.>E 'TQ1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %?)/CS_D\FU_[#6E?^@6]?6U?)/CS_ )/)M?\
ML-:5_P"@6] 'UM1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** /DGP'_P GDW7_ &&M5_\
M0+BOK:ODGP'_ ,GDW7_8:U7_ - N*^MJ "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVO\ V&M*_P#0+>@#ZVHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H)
M &3P!17C7[1?Q&_X1;PC_P (_IDVW5=80JY4_-#;]&;V+<J/^!>E 'AWQO\
MB$_Q!\>&#37:72=.8V]DJ<B9L_-(!WW$ #V"^]?2?P7^'B_#[P+%#=1@:M?X
MN+YNZMCY8_HH./J6/>O#OV;OAS_PD/B9O%.J0[M.TEQ]G##B6YZ@_1!@_4K[
MU]:4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %?.7[6MW>+:^&+-686,CW$KJ/NM(H0+GW 9L?[QKZ-KR?\
M:+G\-1_"^2/Q*DKW,DP_LP0$"03@'G)R N,AL]CQSB@#C/"_[+>CW_ANQO=<
MUZ^-U=0),RV818TW#. 6!+8! SQFM?\ X91\)_\ 0;UK_OJ+_P"(KR3P;^T+
MXP\'Z);Z0L=CJ=E;+LA%XC>9&@& @96' [9!P..F*Z7_ (:O\3?] #2?SD_^
M*H ]F^'/P9T7X::O=ZAI&H7]U)=0>0ZW10@#<&R-JCGBO1*\;^#'QGU;XE^(
MM0T_5--LK..UM?/5K<OECO"X.2>.:]DH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#Y)\!_P#)Y-U_V&M5_P#0+BOK:ODGP'_R>3=?]AK5?_0+
MBOK:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML_&CP)<_$'X>2:;ITJ1WMK.MY;B1MJR,JLI4GME7;GIG&>*/A1\*=.^&FAD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9-RJ[L1#D'@[$C( /< ]17T-XL\*:7XR\-W.CZS;1RPS1E4<H"T+8X=#V84
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#,U>XUZ%XO["TW3KU2#YAO=0D
MMBI[8"PR9_2L6YUOQG:7%G#)X<T(M=S&&,KKLV PC=^?]$Z80_CBNMK(UG_D
M*:!_V$&_])IZ *7V[QO_ -"]X?\ _!]/_P#(==(,X&>#WQ110 4444 %%%%
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MRC_V^_\ M"@#V[X<?\DL\*?]@6S_ /1"5TE<W\./^26>%/\ L"V?_HA*Z2@
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MN3TQ7?\ P6\>W?COX63RZNWF:CIQ>UGE[S ("KGW(.#ZD$]ZZ;XF^+=.\'>
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M5[=2K$"$5G@F8A023C)XR37V;7R3X#_Y/)NO^PUJO_H%Q7UM0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61K
M/_(4T#_L(-_Z33U;U?5[#0=)N-3UBZCM+*V3?+-(<!1_4YX '))P*^>_$O[4
M6G-KEI_8OAV:[M;"Z,RS3W0B,W[MX\!0C;1\^<Y/3IS0!](45YY\-OC-X>^(
MX-K;AM.U906:PG8$L!U*-P&'Y'@\8YKT.@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,SQ'HD7B3PSJ.BW$KPQ:A;/;O(@!90PP2,]^:\6
M_P"&3O#_ /T,>I?]^X_\*]3^)/BUO WP[U77X8EEGMHPL",,J9'8(I(R,@%@
M2,] :^1+*Z^*GQ&NY[W3KG7]5*OB22"5TAC;&=HP0B\=ACZ4 >T?\,G>'_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOVR- FB7#3&V#X.,EE9,_EC\J .@_:;\7WFF^'=.\*Z2SK<:V[>?Y9^9HE(
M3_@3,/J%([UK^%OV=?!.F>&X+;Q!IO\ :FI21#[5<O/(N'(Y"!6  !X!Z^IK
MB/C6OVG]IKP+:RDF%A8 K_O7C@_H!7TG0!\M+I\OP#^/VG6^G7,S^'M:"(RR
MMG]V[;"&/0M&WS ]<''<U]2U\V?M;*(Y_",R963%V-P//!A(_F:]T\5>+[+P
M?X*N/$VK0W$EI;)$TD=LJM(=[J@P&(!Y<=QQ0!OU\D^//^3R;7_L-:5_Z!;U
MZ3_PU7X(_P"@5X@_\!X/_CU>-W?BNQ\;_M.Z3XATJ*XAM+S6M.\M+E560;#"
MAR%)'53WZ4 ?:-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#(4T#_ +"#?^DT] &LJJB!44*JC  & !2T44 %%%% !1110 4444 %%%%
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M2VMLIW-CEI&[LS'DD_\ UA@<5LT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 9.N^%M"\3VX@\0Z19ZBB_=^T0ABG^Z>J_A7G6H_LT_#R]S]FMM0T
M[(_Y=KQFQ_W\#UZW10!XQ:_LM^!+>8/+=ZW=+_SSEN8PI_[YC!_6NS\/_"'P
M'X9E6;2_#=H9U8,LUSFX=3Z@R$[?PQ7:44 '3I1110 4444 ?-7P_P#^3P/$
MG^_>?S%?2M>!>"?"/B"Q_:@U[7+S1[N'2YVNO*O'B(C?<1MP?>O?: .6\+?$
MCPQXRU:]TW0+]IKRQ&9X9('C*C=M/W@,X/''J*ZFOGSX@?"'Q9X?\>2>./A-
M,PN;AVEN+-7575V.7*AOE=&/)4]#T!XQEWNO_M!^*;1M&CT-]+\P;);J& 6[
M$=#^\=L#ZK@^E !\.FBOOVNO$5QHA7[&ANVF,:_*W*JQ^AD(.>_XU)%+_P (
MO^VE+]L/EP:H=J2,P ;S8!M_\B+M_P \^E_!SX3P?#/1)FNY8[K6;X+]JG0'
M8BCI&F>< DDGC)^@QG?&WX1W'C^WM-8\.S);Z_IR[8]S;!/'G<%W?PLIR5/3
MDYZY !ZS7S7=2_\ "4_MI0+:!98-*8*\B\A?*@);/IB0[?KBHQXE_:&&FC0A
MHDWGA?*_M VR&7'KYN[R\X_BQGOG/-=_\$_A'<^ HKS6O$DZ7/B#45VR%6WB
M!"=Q7?\ Q,QP6/3@8SU(!PO[1&- ^,/@KQ1,6$$8CR1SC[/<>8<#'7$@KZ1C
MD26-9(V#HX#*RG((/>N,^*GP[M_B3X-?2VE6WO87\^RN&!Q'(!C#8YVD$@_@
M<'%>*Z->?'KP#IB^'+30VU"V@S';3/"+D1)V"NK?=] W0<8 &  6OVF9%\0?
M$#P?X6M6W71R"H&=IN)$1?Q_=]/\:^@M?\.Z5XHT"?1-<M1<Z=<!1+ )&CW;
M6#+RI!&"H/![5XU\*/A%XC/C9_'WQ.E\S5B2\%M(ZN^_&T2/M^487A5'3CI@
M"O>* /-O^&?/AC_T+/\ Y/W/_P <KP#6_#VE^%?VK--T;0;;[+I]MK6F>5#Y
MC/MW>2Y^9B2?F8GD]Z^R*^2?'G_)Y-K_ -AK2O\ T"WH ^MJ*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 0D*I+$  9)/:OBSXO_%_5/'FNW5EI]W+;^'87VP6R97SL'_62
M=R21D \#CODG[,O[8WNFW-J&V&>%XPW]W<",_K7YWZMIMWH^L7>G:C"T%U:R
MM%+&W56!P10!4))ZDFOK3]ES4='G^'UY86$'E:G:W.^_8\F7?GRV!]-JE<>J
MD]Z^2Z^F/V3]%O(;/7M9FC9+2X,4$#'I(R[BV/IE?S/I0!]%T444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!RWCGX<^'?B'IT=KXBM6:2#=]GN87V2P%NI4]#T'!!' XKY[\
M5?LL^(K!WF\*:C;:O ,E89SY$WL.?D/U)7Z5]6T4 ?%,GA;XU>'!Y<-OXK@5
M>,6%S+(/_(3$=J(=&^-NM-Y#1^,Y.V+R:XC7GWD(':OM:B@#Y&\/_LR^-M:G
M$WB.YM=&C<DR&67[1-]=J':?Q<5[S\/O@SX7^'<HO-/CEO-4V%3?7398 ]0J
MCA1^OO7H%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?)/@/_
M )/)NO\ L-:K_P"@7%?6U?)/@/\ Y/)NO^PUJO\ Z!<5];4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-GQW^..[[1X2\%
MW?R\QZA?Q-U[&*-A^3,/H.]2_'?XXB-;CPEX,NOWG,>H:A"WW>QBC/K_ 'F'
M3H.^.-^"?P4F\<74>N^(XWA\/PO\B'*M>L#]T>B ]6[]!W( )/@E\$IO&=S%
MX@\2Q/#H$39BB/#7K ]!Z)GJ>_0=R/KF&&.W@2&WC6**-0B(BX55 P  .@I+
M>WAM+:*WM8DA@A0)''&H544#   Z "I* *&HZ[I&D.BZMJEE8M("4%S<)&6
MZXW$9K%N_$FAZIKV@6^F:SI]Y/\ ;W;RK>Z21L"VGR< DUTDUK!<$&>".4CI
MO0''YTV.QM(I!)%:PHZ]&6, C\: )Z*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]OO_ +0KZ2KYM_:Y_P"91_[??_:% 'MWPX_Y)9X4_P"P+9_^B$KI*YOX<?\
M)+/"G_8%L_\ T0E=)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<YXV\=Z'X T)M3U^YV Y$%NG,MPW]U%
M_F>@[FN?^*7Q@T;X;V!A)6^UN5,P6*-]WT>0_P *_J>W<CY2 \9?&CQU_P M
M-2U&?J?NPVL>?R1!G\3ZD\@%KQS\0O$_Q=\306_DRM"TNVPTFURP4GH<?Q/C
MJQ]\8'%>]?!_X!6GA(0:[XM2.\UOAXK?AHK,]O9G'KT';UKJOA=\(=&^&VGB
M5 M]K4R8N+]UY'JD8_A7]3W[ >A4 %<W!_R5.^_[ UM_Z.GJ>^A\6->R'3;W
M1H[7/[M;BSE9P,=R)0#S["LE-"\9)XBFU@:IH7G2VL=J4^P3;0J.[ _ZW.<N
M?RH [.BL73HO%"WR'5[S2);7!WI:VDJ2'CC!:0@<^U;5 !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% %75-3L]%TJYU+5+A;:SM8S+-*_15'4__6KY
MD\5_M3ZU<7\D7@[3;6TLE8A)[U#)-(/7 (5?I\WUKO/VI-1N+3X6VEK Q6.]
MU*..;!^\JH[A?^^E4_\  :K?##P7H>E?L\W6L16EO<:EJ.EW4TUXT89Q\K@(
M">0  !@=\F@"+PE\7?$-U^SYXD\8ZS<PS:GI]ZUM;,( JY*PA 57&?FE-=A\
M'OBS;_$W1IEN8$L]9L0OVJ",G8X/21,\X)!&,DCU.03R/[,=A::I\'=7LM2M
M8;NUFUB59(9T#HX\B#@@\&N#^"UO'H?[36J:7I!)L8Y+ZT7DMF%'.WGORB\F
M@#ZQHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "ODGQY_P GDVO_
M &&M*_\ 0+>OK:ODGQY_R>3:_P#8:TK_ - MZ /K:BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWEMC.\D[0?H?J*^C='T?3_#^CV^EZ-:QVEE;)LBACZ*/YDD\DGDDY-9'@O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O /CG\<O[&%QX5\&W.=1YCO;Z,_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>4?'KXGWOP\\-V=OH3(FK:H[K%*ZAO(C0#<X!X+990,\=>N*]7KQ']
MIGP-?^)/"MAKFDPO<3:,TGGPH,LT+[<L!WVE1T[$GM0!X9:Z]\8?$<?]H:9?
M>,KZ&0G$M@UR8SR0<>7\O4$<>E3_ /%[_P#JH'_D[7T1\-_C!X'U'P3I=O-J
M]AHES:VT=O+9WDJP"-D4#Y2Q *\9!!Z$9P>*Z[_A8_@C_H<O#_\ X-(/_BJ
M/(_V?/\ A8/_  E>J?\ "<_\)+]D^Q#R?[8^T>7OWK]WS.-V,].<5] 5E:3X
MI\/Z].\.A:[IFI2QKO>.SO(YF5<XR0I.!GO6K0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'R3X#_Y/)NO^PUJO_H%Q7UM7R3X#_Y/)NO^PUJO
M_H%Q7UM0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X5\<_C>/#2
M3>%_"-P&U=UVW=Y&<_8P?X5_Z:?^@_7I)\<OC<OA:&7PUX3N%;6I%VW-RAS]
MB4]A_P!-#_X[]<8\9^$GPDU'XF:TU[J#2P:'!)FZNS]Z=NIC0GJQ[GMGUP"
M2?"#X17_ ,2=8_M#4_-@T&"3-S<G.ZX;J8T/<GNW;ZXK[*T[3K/2--@T_3+:
M.UM+=!'%#&N%11V%)IFF66BZ7;Z=I5M':V=L@CBAC&%4#_/7O5J@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH S?$6OV/A?P[?:WJTACM+*(RR$#)/HH]220![D5\PZM^U5XKGOG.C:3
MI=G:9_=I.CS28_VF#*/R KW+XW:)>Z_\'==LM+1I;A8XYQ$H),BQR*[  =3M
M4X'<@5YU^S5X?\&ZOX)NIKK3=/O]<ANV%P;N%)9(D(&S:&!VJ1GGN=WI0!PO
M_#4?CS_GVT7_ ,!7_P#CE=O\(OCIXK\<_$:TT/68=-2TFBE=C;P,KY5"1R7/
M<>E>V_\ "'^&?^A=TG_P!C_^)J>S\.Z)IURMQI^CZ?:SJ"!+!:HC#/7D#- &
ME1110!YQXV^#]IXU^(6C>*+W4F"Z:8E?3Y8!)%.B2%\=1C);G((.,8KT>BO%
M_BI\<$TFX?PK\/Q_:GB6=_LYD@7S%M7/! '\<@].@/7H5H X_P")B0:I^UAX
M7M_#P!OX9+0WKQ8.'20NQ88Y(B )]L#M7T)XF75G\*ZFGAMPFK-;2"S9MN%E
MVG:?FXZ^M>;_  5^$4O@R.7Q)XID:Z\3:@I,F]]_V96.6&[^*0GEF_ =RWKE
M 'S7KOP.?1_A]XD\6>/-6DUSQ']C>1#YC&.%L#G)Y<CH,X ]. :[S]FO_DC%
MG_U]S_\ H==)\8/^2.^)_P#KP?\ I7-_LU_\D8L_^ON?_P!#H C_ &E]8ETO
MX/R6\+,IU*]AM6*G^'#2'\#Y>/QKI?@WHEOH7P@\.PVR*#<V:7DK <N\H$A)
M]<;@/H!7#?M5PN_PUTN91E8]60-@=,Q2\_I^M>I>!+A+OX=^'+B/[LNEVS@'
MMF)>* /,_P!J'08+_P"&D&K^6/M.F7B;9,<B.3Y67Z%MA_"O0OAIJ\NN_##P
M[J-S)YL\UA$)9">7=5VL3[D@URO[1LBI\$]35C@R3VZK[GS5/\@:V/@I$\/P
M7\-+(,$VI8?0NQ'Z$4 =U7S;^US_ ,RC_P!OO_M"N;_X0/\ :&_Y_/$'_A1I
M_P#'ZXCXBZ#\0]$_L[_A9,VH2^=YOV+[;J0N\8V>9MP[;>J9Z9X]* /LGX<?
M\DL\*?\ 8%L__1"5TE<W\./^26>%/^P+9_\ HA*Z2@ HHHH **** "BBB@ H
MHHH **** "BF2R"&%Y&!(12Q ]J\_P#^%S:%_P! _4/^_EK_ /'JTA2J5/@B
MWZ(5TMST.BO-[?XW^'KE7:*PU$A)&C;+6P^93@]9JZCPKXQL?%R7+:?;W$(M
MBH?SFB.=V<8V.WIWQ52H58QYI1:7HPNCH****Q&%%8WB/Q?X?\)6?VGQ)JUK
MI\9&5$K_ #O_ +J#YF_ &O#O&'[5-M#YEMX(TEKA^@O=0^5/J(U.3^)'TH ^
MAY9HX(7EGD6.- 6=W8!5'J2>E>6^,/VB/!7AC?!87+:[>KD>78$&,'WE/RX_
MW=WTKYEU+Q+X_P#BMJHM)KC4=9D8Y6RM4/E)[^6@VC']X_B:]%\'_LMZYJ/E
MW'C'4(M)@/)M;<B:<CT)^XOURWTH X?XE_&+7/B6L-M?VUM9:?;R&2&V@!)W
M8QEG/4XST 'M7GU?=_A+X2>"_!D:G2M&AEN0,&[O )IC^)X7_@( KSKXE_L^
M^%#:W.NZ/)<:5(98P]K!M:'+R*I*J1E?O9P#CC@"@#Y<L;&YU+4+>QL86GN;
MF18HHD&2[,< #\:_07PEI,F@^#-&TBX97FL;&&WD9>A94 )'MD&N3^'WP5\+
M_#VX^W622ZAJ>,"\N\%H\C!V  !<^O)Y(S@XKT.@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /'?VF]$OM6^%<
M=S81M*NFWR7-PB@DB/8Z%L>Q<9]!D]J3X#^&O!&I?"W3KRVTG3+[4,.E_-<6
MZ2S++N)*L2"0,;2!TQ@UV/Q7E\1P_#B_;P6D\FKEHEB6"$2L5+@.-I!!&W/:
MODJT^'GQ/T^[>ZT[P]KME,YRSVD30]\_PXP/84 ?9W_"'^&?^A=TG_P!C_\
MB:GL_#NB:=<K<:?H^GVLZ@@2P6J(PSUY S7QW_PCWQK_ .>/B_\ [_S_ /Q5
M=]\%M'^)EG\3[.;Q;'XB73!#,)#?RRM%NV';D,<9STH ^F**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ KY)\>?\GDVO_8:TK_T"WKZVKY)\>?\
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M!Y[M>11JI7<%P-KMSDUZ!0 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"*%R?<XK)\*?#SPKX(5_^$9T:&SED&'G):25AZ;V);'MG'M72T %?-O[7/\
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M!@#FL:E6516=ODDOR2':Q)11160PHHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *Y/X@_#O2?B3HUMIFN7%[;PVUP+A
M&LW16+;2N#N5AC#'M765Y3^T!X8\2>*?!VG6OA"UGN;J*_$DBPS+&0GEN,Y)
M'<B@#(_X94\$?]!7Q!_X$0?_ !FC_AE3P1_T%?$'_@1!_P#&:\6_X4_\6_\
MH#:A_P"!\?\ \<K(\0>!OB-X6L&OM=TW5;:T0@/.)C(B9Z;BC$ >YH ^K?A[
M\&_#_P -M5NM0T*\U.XENH/(=;R6-E"[@V1M1><BO0*^=_V8="U3S+[Q)/JL
M%[8W%N;41+<.\L,H=6(=6&!QSD$]17T10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'R3X#_Y/)NO^PUJO_H%Q7UM7R3X#_P"3R;K_ +#6J_\
MH%Q7UM0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2H W,>Y.,FOB;P3XONO _B:+6K&TMKJ:-&0)<J2 &X)4@@@XR,^YKZ-\)_M
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M MZ /K:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ,8XQD@'U'17RQKVC_%/X&R0:_#XADUK1Q(J3J\TDD0)/W9(W/R@G@,I_$9
M/T=X1\36?C'PGI^O:;D07L6_8QYC8'#(?<,"/PH V:*^=OB1\0/%OC?XEO\
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M>&QWQR".X)%>%:%X7^.'PJEN-.\-62W^GRN7 B,<T+-P-X#$.IP/;\:^IZ*
M/GOP!X#^+FJ^-!KWC;Q#J&D69F$T]LE[S<XQA!$A**O&#G!QT'.:^A*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ;)$DT31S(LD;C#(PR"/0BJ7]@Z1_P!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH X+XD_%O2/AE/I\6L6-[=&_61HS:A#MV%<YW,/[PKB/^&KO"?_
M $!-:_[YB_\ BZ]!\>_"SP]\1YK&3Q$;P-8JZQ?9I@G#8SG(.?NBN0_X9A\
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MLP4<*">I%:U<U\0/!L7CWP9=>'I[Q[)+EHV,R('*['#="1Z4 <I_PT7\-?\
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M,=EIEG/?73](;="Q ]2>P]S@#UKZ#\"_LV1PK'=^-[@=B-.M'P/H\@Z_1?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSWY->F5\Q?&JR@^''QQ\-^,M(46B7CB>Y2)<!FC8+*<#^_&X! '7)ZFOIV@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ,GDW7_8:U7_ - N*^MJ^2? ?_)Y-U_V&M5_] N*^MJ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS
MWXM?%?3_ (;:'A#'=:W=(?L=F3T[>8^.B#]3P.Y$WQ5^*6G?#70/,?9<ZO<J
M19V6[[Q_OMCH@_7H/4?)FB:+XH^,WQ!D_>M=7UVWFW=W*/W=O'TR<= !@!1[
M 4 .\->'/$_QD\?2[IY+BYN'\V^OY@2D">IQ^2J,=,# ''V=X+\&:3X$\-0:
M-H<.V*/YI96 WSN>KL>Y/Z# ' J/P-X'TGP!X:ATC18N!\T]PP&^XD[NQ_D.
MPXKHZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB9;A)P#&8\?-NSQC&<YKY)_9W*I\=Y%T<NU@;>Z&YNIAS\A.?<)0!]?T444
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M*88Q^\MT;C\15ZBO/C*47>+L6<[<?#[P==',_A;1V8G)86,8)_$#-95Q\&_
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M-'705TXG^(O\,?\ TE"CL%%%%<PPHHHH **** "BBB@ HHHH **** "BBB@
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MMS<H<BR4]@?^>A_\=^N* (_CI\;QX:CF\,>$;E6U=P5N[N,Y^QC^ZI_YZ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@C/F+)E0=Z]&XZBLJE.47=Q:3&F/HHHK(84444 %%%% !1110 4444 %%%%
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M10 4444 %%%% !117B_QN^-L7@RVE\/^&94EU^5,2RCE;)2.I]7(Z#MU/8$
MC^.'QMC\(V\WASPM.LFNRKMGG0Y%DI_]J$=!VZGM7B7PG^%&I_$_77N[UYH-
M&AES>7K'+2MU*(3U<YY/;.3V!C^%7PLU3XI>(9+B[EFATF&7=?7['+2,>2BD
M_><]2>V<GJ ?L_1=%T_P]HUMI6C6L=I96R;(HD' 'J?4GJ2>2: %T?2+#0-(
MMM+T>UCM+*U39%#&.%']2>I)Y).35VBB@ HHHH **** "BBB@ HHHH ****
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M)\!_\GDW7_8:U7_T"XKZVH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG;WF%%%%?GQUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %8GB?P=H7C*VM;;Q+8K?06L_GQQ.[*N_!
M&2 1G@G@\5MT4 5=.TO3]'LUM-)L;>QMD^[#;1+&H_ #%6J** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "ODGQY_P GDVO_ &&M*_\
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M0!A^'/!7AOPC;B+PYHUI8#&TR1QYD8?[3G+-^)-;E%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'R3X#_Y/)NO^PUJO_H%Q7UM7R3X#
M_P"3R;K_ +#6J_\ H%Q7UM0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=\,?]>"?UKEOC=\1+O2(+?P7X2+2^)-;'E Q/@VL3<;L_P +-S@_P@%LC R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%8?B7QIX>\'+9MXEU2+3UO9#% 9
M Q#,!D] < <<G Y'/- &Y14%E?6NI6,5YIUS#=6LR[HIH7#HX]01P:GH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^2? ?\ R>3=?]AK
M5?\ T"XKZVKY)\!_\GDW7_8:U7_T"XKZVH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*S&<_H7_ "-7B?\ Z^X/_2:.N@KG]"_Y&KQ/_P!?<'_I-'705TXG^(O\,?\
MTE"CL%%%%<PPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV/K_ $K7HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *I:SK%AX?T>YU76+E+6RM4+RROT _J3T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWE6ELN3@99V/ 51W8G@5K5\Y?M::G<):>&M*1L6TKSW,B_WG4(JG\ [_ )T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:5_Z!;U];5\D^//^3R;7_L-:5_Z!;T ?6U%%% !1110 4444 %%%% !1110
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M *&C3_\ P3G_ ./4 =)14-HEQ'9Q)>S)/<*H$DL<?EJY]0N3CZ9-34 %%%%
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MU[&?^/DCK&A'\'J?XOIU *7QT^-C>*IY?#7A6X*Z)$V+BY0X^VL.P_Z9@_\
M?1YZ8K<^ OP1\_[-XO\ &-K^ZXDTZPE7[_<3./3^Z#UZ],9H_ ?X(_VT]OXL
M\7VW_$N4A[&RD7_CY/:1P?X/0?Q?3[WU*!@8' H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGP.LC*>" S.Q&?48->G?LW_"_4/#JW/BOQ%:R6EU=0^19V\J[76(D,SL.Q)
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MF>!M+\6:MKDT'@.2[CU%;9GD-I>"V;RMR@Y8LN1N*\9]/2OK/XH?\DK\1_\
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M=)UC08=L&GPI8W8 Y8?PRGW+$@G_ &EKI/V=_'']JZ!+X7OY<W6FKOM=QY>
MGD?\!)Q]"/2O;XAE'-\NAF&';M!M-=O/\ODS*C^[FX,U=9_:#\)Z)KE]I5S8
MZQ)/8W#V\CQ01%2R,5.,R XR#VK4\'?&7PWXUU&[L]/@U"T:SM'O)9+R)%01
MJ5#'*NW]X59U'X-^ ]6U.YU"_P!!$MU=2M--(+N==[L<DX#@#)/84MK\*?"^
MAZ?JR^%M,6PO=0L);+SGN)9 %<="&8\9"G@9XKYR=3(I4.6$)JI9:NUK]7OM
M\C:U6^MK'AMLEW\=/C0TLPD71[<Y(SCRK5#POLSD_FQ]*[/]IF*.W\+^'H8$
M6...X=411@* @  %<G_PS1XQ_P"@EH?_ '_F_P#C5<IX[^%>M_#VSM+G6KK3
MYTNY&C06DCL00,\[D6ON**P&(Q^'>'Q*Y::M&"7D[ZWW^70YGSJ#NM^I[U^S
MQ_R2>/\ Z_)OYBO#?B%HFJ?#WXK3WT$31)]N^WZ?.5^1QOW@9[[3P1[>]==\
M OA_JL^OZ=XU2ZM5TVW>>)X=[^<Q\MDZ;=N,L#U[5] W5UX?U>XET:^GTR^F
MC8>;8S/'(RDC(W1G)!P>X[UX6(Q\<IS>O*G^]C._.MK:O3KM^-S51]I35]+'
M@&K?M(:IJ^ARZ;9>'+>&ZNHFA>4W#2@[ACY4"@@\\9)KE/@0C-\9M&*G 1;@
MMSU'D./YD5[G\0=3\&_#GPMJ,FFZ?I-CK%Q;O#:PV=O'',6==N[Y1D*,Y)]L
M=Z\T_9J\.RW7BJ_U^1"+>Q@,$;>LKX_DH.?]X5Z-#$82.38JKAZ'LH--*[;Y
MFU;KT5_S(:E[2*;N>H_&+5_&ND:-ITG@&&[DN)+AEN/LED+E@NWC*E6P,]\5
M\W^-M=\;ZK<0IX\;4E*'='#=VYMU!QR0FU1G'?%?7<'C/PY<:Y=:.FLV@U&T
M?9+;22;&!QGC=C=U[9Q7._&74-"M_AGJUMKLT'FS0$6D+L/,:;^ J.O#<DCM
MFO$R/,G@JE+#RPJ<F_BM:5GUVVL_N-*L.9-\QS/P UCP<='N-*\/I<6^K'$U
MVMXRF2<#C<I'!5<],#&??-=1\7=3\6:3X/@G\!Q7,NHM>HD@MK07#B+8Y)VE
M6XW!><=Z^>?@;#=3?&#1S9DJ(_->8@\"/RVSGZY ^I%?4S>,O#L?B&?0IM8M
M(=3@"F2VFDV-\P##&[ 8X(.!GK1GN%^I9O[6$?:Z*;3UZVU\O7T"E+FIV>A\
MD^./$'C_ %6.*+QVVJ1Q!MT<-U:&V0MCJ%"J"<9YQZUZ]^SUK'@Z.&XTO2X[
MBWUZ=0\S7;*QG5>T9&.!UVXSWYQQZ+\3-0T&V^'VKQ^(I[<0S6D@BBD8;I'*
MG9L'4MNQ@CIU[5\N?"6&ZG^+/AY;+=YBW8=MO]P E_\ QT-7N4JT,YR>M'V?
ML5"[]W2+LK[67S7S,VG3J+6Y]HT445^7':%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >1?M*>';W7?A7]IT]&E.E7:WDR*,DQ!&5FQ_L[@Q] #1^SU)X3
MO?AC91:3!9_VG"&&HHRJ9_,W'YFSR5(Q@],<=B*U?CIXYO/ GPY>ZTDA;^_G
M6S@D*AA%N5F9\'C(52![D<&OE'PY\-O&WBNS&J^'M#O+J N2MUN6,,P/)5F(
MS@]QW!]* /N_[#:?\^L/_?L4Z.UMXGW101(PZ%4 -?%W_"G_ (M_] ;4/_ ^
M/_XY7??!;X=_$'P[\3[/4?$^FWD&GQPS*[RW2.H)0@<!R>OM0!],4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7R3X\_P"3R;7_ +#6E?\ H%O7
MUM7R3X\_Y/)M?^PUI7_H%O0!];4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %9?B/Q)I7A/0Y]7UZ\2TLX1R[
M=6/95'5F/8"LSQWX_P!$^'N@MJ6NS_.V1;VL9!EN&'91Z=,D\#\J^.O%_C3Q
M3\7_ !?"CQ2SO))Y=AIEMEEB![ =SCJQ].P&  :?Q3^+VL?$W5!96B2VFBI(
M!;6"'+3-G :3'WF/8=!VR>3ZI\&_V?4T_P CQ%X]MEDN^'M=+D&5A]&E'=O]
MGH.^3P.F^#_P,LO L46L^(!'>^(&7*_Q1V>>R>K>K?@/4^OT %%%% !1110
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MFW6ULXQ]L8'J1_SS!_[Z/'3-4O@A\%Y?&]XFO>(HFC\/P/\ )&<@WKC^$?[
M/4]^@[D?7L,,5M!'!;QK%%&H1(T7"JH&  !T % #D18T5$4*JC 4#  ]*6BB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!YS\<_!\?C+X:SVXN[>TNK.9;JVDN95CC9P"NPL
M>!N#$#/?%<'\(/CCX5T3P/9>&_%ERVE7VFYMP_D,\<J[C@Y0'!&<'.!QG//'
MK'Q)\&OX^\"WGAZ*]6Q:Y>-A.T?F!=CANF1UQCK7B'_#)-W_ -#?#_X+S_\
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M:K_Z!<5];5\=_"G58->_:JAU>S21+?4-0U"ZB64 .JO%.P# $C.#S@FOL2@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 <#\;M$OO$'P=URRTN-I;D)'.(E!)D$<BNP
M'4X4X'<@5YW^S5H/@[5O ]U+<Z;I]_K<5TPN?M4*2R1H0-FT,#A2,\CJ0WI7
ML_C.35(?!&LR>'A(=56SE-F(D#-YNT[< Y!.>U?&K^ /B@VL2ZI'X;UFWO96
M+M-:VQ@.3UP$  S[4 ?9G_"'^&?^A=TG_P  8_\ XFI[/P[HFG7*W&GZ/I]K
M.H($L%JB,,]>0,U\=_\ "/?&O_GCXO\ ^_\ /_\ %5WWP6T?XF6?Q/LYO%L?
MB)=,$,PD-_+*T6[8=N0QQG/2@#Z8HHHH **** "BBB@ HHHH **** "BBB@
MKYM_:Y_YE'_M]_\ :%?25?-O[7/_ #*/_;[_ .T* /;OAQ_R2SPI_P!@6S_]
M$)725S?PX_Y)9X4_[ MG_P"B$KI* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]?)/@/\ Y/)NO^PUJO\ Z!<5];4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45RWB+XF>#?"NY=<\0V4,J]8(W\V4?\ 3
M+#\17E/B+]JS1K;?%X7T.ZOW' FO'$*?4*-S$?7;0![_ %1U77-*T*U^TZUJ
M5II\/_/2ZF6,'Z9/-?''B+]H3X@:_N2+4TTF!O\ EGIT?EG_ +[.7_(BLC2O
MAO\ $+QW=_:X='U*\:;DWM^Q16'KYDA&[\,T ?1_B+]I3P+HV^/3)+K6IUX
MM8BL>?=WQQ[@&O*?$7[4OBK4-\?A[3[+1XCTD8?:)1^+87_QVM7P[^RCJ,VV
M7Q5K\%HO4P6$9E8CTWM@ _@:]6\._ /X?>'=C_V/_:<Z_P#+;4G\[/U3A/\
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M*-&QLVYSN=?[PZ9H [FBO$O^&J_!'_0*\0?^ \'_ ,>H_P"&J_!'_0*\0?\
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M^%/BBZ\7_#G3M3U(AKSYH9W QO9&(W8'&2,$XXR37$_M,_\ (AZ7_P!A(?\
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M1D[3STZJ1ZU];12QSPI-"ZO'(H9'4Y# \@BOG>)F\/1HX?#)+#M737VGYO\
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M7/ _[._B[Q7Y=UJL8T#3VP?-NT)F<?[,7!_[ZVT -\;_ +0OB_Q;YEKIDO\
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M/X&IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+>1S>:BG_;7:"![C/T'6O7=9\;>&/#UJMQK6O:?:1N@=-]PNZ12,@JHY88]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB$KI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDH X+X:?M!V7@+P'9^'I_#\]Z]L\C&9+D(&WN6Z%3ZXKJ_\ AK33?^A4NO\
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MJ@#B_!7PF\(^ T1]&TU9;T#F_NL23GZ,1A?HH%=I110 4444 %%%% !1110
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M^"/BM>Z/:7.C6>MM831*]LT-T50QD?+@;N!B@#[@HKXJ_P"%?_&7_GQ\0?\
M@8?_ (NC_A7_ ,9?^?'Q!_X&'_XN@#[5HKP+]G_PSX[T/Q5J<WC2WU.*VDLM
MD)O)S(I?>IX&X\XS7OM !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?)/@/_D\FZ_[#6J_^@7%?6U?)/@/_ )/)NO\ L-:K_P"@7%?6U !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD_3IZ"NBHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9=O7S8'C_+<!G\*GHJYRC)MI:^O_  "8QE%)7"BBBLC0**** "BBB@ HHHH
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M'%33P0W4+0W,231,,,DBAE/U!J2B@""TL;2PC*6-K#;(QR5AC" GUP*GHHH
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M^SG!J79II_<---719HKS_P#X7I\.?^AB_P#)&X_^-T?\+T^'/_0Q?^2-Q_\
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M$-V?"FV=BYLAY(?!/$VW.=W;=^%>M>,OA/X6\<77VS5K:6"^P%:[M)-DC #
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MPX_Y)9X4_P"P+9_^B$KI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT)R/XJT;6Z:XW;[6>WVX_P!:%Y^F":>+G.K4=20L/&%."A$L4445QG2%%%%
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M=>E?0X.CF.7X+$5,QDZEUHM9='?T3^Y&4G"<DH:'UA1117Y&=X4444 %%%%
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M#\"*B?"'MH\^"Q$9K^NJN'UBWQ*Q]C2RQP1-+/(L<:#+.[8"CW)JE_;^C_\
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M'_LW7C7L=UXUO84MU;<;.T<L\GLSX 4?3)]Q7T);6T-E:Q6UI$L,$*!(XT&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUQ-^\.YB-H/08!].?QKB?B;\3].TKP<K>&_$L>M75\_E"$/"ZHF,L7"*&'8
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M):+OHQU(MSBT>Y5\X?M&>.?MNI0^$M/ES#:$37I4_>E(^5/^ @Y/N1Z5]%W
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MZQ\#_ >L;F_L?[!*W_+2RE:/'T7E?TK@M8_9AB.Y_#_B)U_NQ7T ;/U=<?\
MH-8>VX8QOQP=)_/]+K\!VK1\SUW1_'OA37]HTGQ!83NW2+S@DA_X V&_2NAK
MY$UCX#^.])W-%IT.HQKU>RG#?^.MM8_E6%#K?CKP-,L*WFLZ-M.!!-YB(?\
M@#?*?RI/A;"8K7 8I2\G9_E_D'MY1^*)]L45\K:/^T9XRL-JZG'8ZJG=I8?+
M<_BF!_X[7?:/^TSH-SM77-&O;!CP6@99T'N?NG]#7DXCA;-*&JAS+^Z[_AH_
MP-%7@^I[717(Z/\ %3P3KNT6/B*S5VZ1W+&!L^F'QG\*ZR.1)8UDB=71AE64
MY!'UKY^MAZU!\M:#B_--?F:II[#J***P&%%%% !1110 4444 %%%% !1110
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M"N>I@(_=_EAE^BBO6*QQV#G@L3/#SWB_^&?S0XR4HW04445Q%!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %?-O[7/_ #*/_;[_ .T*^DJ^;?VN?^91_P"W
MW_VA0![=\./^26>%/^P+9_\ HA*Z2N;^''_)+/"G_8%L_P#T0E=)0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR+597QAX98 KXBTD@]"+Z/G_ ,>K)X7$+>#^YCYEW-FBJ"Z]I#,%75;(DG
MN$Y_6H=9\2Z7H>BW>IWEW#Y-K$TK!9%RV!T'/4G@>YJ%1JRDHJ+NPNC5HKQ?
MX*?%2?Q/J&L:;XCNE%R\K7EJTCX"QL?FB&>@7C ]"?2O79=6TZ!09M0M8P>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
MS;^US_S*/_;[_P"T*^DJ^;?VN?\ F4?^WW_VA0![=\./^26>%/\ L"V?_HA*
MZ2N;^''_ "2SPI_V!;/_ -$)724 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !117':A\6_ 6EWS6=[XIT]9U8HRI(9 K X()4$
MCWH [&BJ>E:QINNZ>E_HM];W]HY(6:VE#J2.HR.X]*N4 %?)/CS_ )/)M?\
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M?\DL\*?]@6S_ /1"5TE<W\./^26>%/\ L"V?_HA*Z2@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV_X:#^&/_0S?^2%S_P#&Z/\ AH/X8_\ 0S?^2%S_ /&Z /2:*\V_X:#^&/\
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M]#-_Y(7/_P ;H ])HKS;_AH/X8_]#-_Y(7/_ ,;H_P"&@_AC_P!#-_Y(7/\
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M)**Y7JW8==-PT/>-#_Y%[3O^O6/_ -!%?+.J*OA_]IIGN?EC_MY)F+'&U99
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MR.[!1N/YYKFQTO9</X:E+>4G+Y*Z_5#CK5;->BBBOD#H"BBB@ HHHH ****
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MO$'_ (#P?_'J /;:*\2_X:K\$?\ 0*\0?^ \'_QZC_AJOP1_T"O$'_@/!_\
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MX#P?_'J/^&J_!'_0*\0?^ \'_P >H ]MHKQ+_AJOP1_T"O$'_@/!_P#'J/\
MAJOP1_T"O$'_ (#P?_'J /;:*\2_X:K\$?\ 0*\0?^ \'_QZC_AJOP1_T"O$
M'_@/!_\ 'J /;:*\2_X:K\$?] KQ!_X#P?\ QZC_ (:K\$?] KQ!_P" \'_Q
MZ@#VVBO$O^&J_!'_ $"O$'_@/!_\>H_X:K\$?] KQ!_X#P?_ !Z@#VVBO$O^
M&J_!'_0*\0?^ \'_ ,>H_P"&J_!'_0*\0?\ @/!_\>H ]MHKQ+_AJOP1_P!
MKQ!_X#P?_'J/^&J_!'_0*\0?^ \'_P >H ]MHKQ+_AJOP1_T"O$'_@/!_P#'
MJ/\ AJOP1_T"O$'_ (#P?_'J /;:*\2_X:K\$?\ 0*\0?^ \'_QZC_AJOP1_
MT"O$'_@/!_\ 'J /;:*\2_X:K\$?] KQ!_X#P?\ QZC_ (:K\$?] KQ!_P"
M\'_QZ@#VVBO$O^&J_!'_ $"O$'_@/!_\>H_X:K\$?] KQ!_X#P?_ !Z@#VVB
MO$O^&J_!'_0*\0?^ \'_ ,>H_P"&J_!'_0*\0?\ @/!_\>H ]MHKQ+_AJOP1
M_P! KQ!_X#P?_'J/^&J_!'_0*\0?^ \'_P >H ]MHKQ+_AJOP1_T"O$'_@/!
M_P#'J/\ AJOP1_T"O$'_ (#P?_'J /;:*\2_X:K\$?\ 0*\0?^ \'_QZC_AJ
MOP1_T"O$'_@/!_\ 'J /;:*\2_X:K\$?] KQ!_X#P?\ QZC_ (:K\$?] KQ!
M_P" \'_QZ@#VVBO$O^&J_!'_ $"O$'_@/!_\>H_X:K\$?] KQ!_X#P?_ !Z@
M#VVBO$O^&J_!'_0*\0?^ \'_ ,>H_P"&J_!'_0*\0?\ @/!_\>H ]MHKQ+_A
MJOP1_P! KQ!_X#P?_'J/^&J_!'_0*\0?^ \'_P >H ]MHKQ+_AJOP1_T"O$'
M_@/!_P#'J/\ AJOP1_T"O$'_ (#P?_'J /;:*\2_X:K\$?\ 0*\0?^ \'_QZ
MC_AJOP1_T"O$'_@/!_\ 'J /;:*\2_X:K\$?] KQ!_X#P?\ QZC_ (:K\$?]
M KQ!_P" \'_QZ@#VVBO$O^&J_!'_ $"O$'_@/!_\>H_X:K\$?] KQ!_X#P?_
M !Z@#VVBL3P=XKL?&_A.S\0Z3%<0VEYO\M+E560;'9#D*2.JGOTK;H ****
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M_AE3P1_T%?$'_@1!_P#&:/\ AE3P1_T%?$'_ ($0?_&:]MHH \2_X94\$?\
M05\0?^!$'_QFC_AE3P1_T%?$'_@1!_\ &:]MHH \2_X94\$?]!7Q!_X$0?\
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MN/J8:C5H))QJ*S3\MFO-$2BFT^P4445YY84444 %%%% !1110 4444 %%%%
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MB#_PHT_^/U];44 ?)/\ P@?[0W_/YX@_\*-/_C]'_"!_M#?\_GB#_P *-/\
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MO.,<UM_\('^T-_S^>(/_  HT_P#C]>D_LJ?\DLU+_L,R_P#HB&O;: /DG_A
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MJCQ+FT=JS^Z+_-"]C3['QN/@C\3._A1O_!A:_P#QRG#X(?$GOX6<?]O]K_\
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M "?N?_CE>DT4 >;?\,^?#'_H6?\ R?N?_CE'_#/GPQ_Z%G_R?N?_ (Y7I-%
M'FW_  SY\,?^A9_\G[G_ ..5Y=\?_A;X.\$^ +/4O#&C_8;N74XX'D^U3290
MQ2L1AW(ZJO.,\5]-5Y=\?_!VN^-O %GIOABQ^W7<6IQSO'YR1X012J3EV ZL
MO&<\T 3_ +/?_)"O#_UN?_2F6O2JXCX.>'M4\*_"?1]&UZU^R7]L9_-A\Q7V
M[IY&'S*2#PP/![UV] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 4444 %%%% !1110 444A(526(  R2>U "T5XO/\
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M%5)DR% [ 2KP.P&*^FJ^:OBLLK?M8^#A!NW;K G:<?+]H;=^F:^E: "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M /=$J[3Z8)[5]/5QOQ%^&.A?$G2X[?6!)!=6^3;7L&!)%GJ.>&4X&0?PQUH
MZ34=:TW2='DU74;Z"WL(T\QKAY $V]L'OGMCK7SU\#EF\;_'/Q/XY,)2R3S/
M)++@AI&PB_41J<X]1ZU-;_LH2&>**_\ &DDMC&V1''8[6QWQF0A3[X/TKW'P
MAX/T;P/X?BT;P];>1;(Q=V8[GE<]7=N[' ^@  P !0!N4444 %%%% !1110
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MW\,O@QH7PVWW<$LFI:M*FQ[V9 NU>ZH@SM![\D^]>BT %%%% !1110 4444
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M^AO /@^V\">"=/T"U?S3;H3--C'FRL<NV/3)X'88% '1T444 %%%% !1110
M4444 %%%% !1110!\M?M2Z:#\1O#U[<L4MKJQ%NS],;)F+'/TE%?3]G;6]G9
M06UE$D5O#&L<4<8PJ*!@ >V*X'XS_#4_$CP>EO9.D6JV#F:S9^%<D8:,GL&P
M.?4#MFO(=&^.WC/X::9'X=\<>%9;N:S7R8)KB5K=RHX4%MC+( . PZC')ZD
MVOVLK*S_ +)\/7Y51>B>6$-W:/:"1[@''TW'UKWC0);B?PWILMZ,7,EI$TH/
M9R@)_6OFW3=!\9?'WX@6.L^+=,?3/#-B>(V5D0IG)1-W+LW 9\8P.V #]1
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MNZICS$+;S!'G.TMW8GEN>P]*];H **** "BBB@ HHHH **** "BBB@ KQ/\
M:J_Y)7IW_89B_P#1,U>V5XG^U5_R2O3O^PS%_P"B9J /0/A7_P DE\+_ /8+
M@_\ 0!737=W;V%G-=WL\=O;0(9)996"JB@9))/0 5S/PK_Y)+X7_ .P7!_Z
M*\7_ &IO&UTEQ8^#;-VCMWB%Y>D?\M?F(C3Z#:6/N5]* &>+_B/XE^-6M2^#
M?AC;2PZ2V5N[Z0F/SH^A+G^",_W?O,.".JU['\-/AEI/PUT'[)88N;^< WE\
MZ8:9O0#^%1V7^9R:\!\%_M":/X#\.0Z/H7@$(B &:9M5_>7#XY=SY/)/Y <#
M %=!_P -<_\ 4D_^5;_[30!])45';R^?;12XV^8@;&<XR,U)0 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHKSGX^S20? [Q!)!(T;K]FPR,01_I,7<4 >C
M45\*^ /!OBWXCWEY;>']4"/9QK))]JNY$!!.!C /I76ZE\#_ (L>'K5K^RNV
MNWB&XKIVHOYH'7@':3TZ#)H ^O:*^8/@M\=M7B\0VWACQQ=R7MM=2""WO;@Y
MF@E/"J['EE)XR>03R<=/I^@ HHHH **** "BBB@ HHHH **** "BL+QKXIM?
M!7@W4=?O0&2SBW)'G'FR'A$_%B!GMUKP_P#9QLM4\5^*]=\=:_=37#+(T,(9
MR4\Z3YG(';:I4 =@_M0!]&T444 %%%% !1110 4444 %%%% !17S?\?_ (P^
M(M#\1W'A#P](--B6%&GO8F/G2;USA3_ .>HY]Q7T#H3%O#NG,Q))M8B2>_R"
M@"_117#_ !<\=77P\\!2ZSIUK%<W33);Q+,3L0L#\Q Y.,=,CZT =Q17C/[.
M?BC6?%^D>(=4\17\M[=/?( SGY478/E51PJ^PKV:@ HHHH **** "BBB@ HH
MK)\5:V?#?A'5=:6 7!T^TDN!"6V[RJDXS@XZ4 :U%?.GP.^)/B3XA?&/49]?
MO/\ 1TTB5H+*'*PP_OH1PO<^YR?>OHN@ HHHH **** "BBB@ HHHH **** "
MBBOE[7?C)XE\1_&_2O#EO+_9NCVGB*"U>"W8[KD)<JN9&ZD''W1@<\YZT ?4
M-%<Q\1O#+^+OA_JNDV[-'=R0E[5U8J5F7YDY'0$C!]B:\C_9H^(ES?PW?@S7
M)Y)+FT#3V3S,2Q3/SQG/]TD$=\$]A0!]!T444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!\A?M1_\E:M_^P7#_P"AR5ZO\(_AGX,UKX3Z%J&J^'+&[O)X
M&:6:6/+.?,8<GZ"O*/VH_P#DK5O_ -@N'_T.2OH#X'_\D4\-_P#7NW_HQJ .
M-^)W[/GAF\\*WVH^$-/_ +-U:UB:=(X9&,=QM&2A5B0"0#C&.<9XKRG]F_Q?
M<:#\38=':5OL&M*89(R?E$H!:-_KP5_X'["OL1E#*58 J1@@CK7P'\-G9/BK
MX5*,5/\ ;-H,@XX,R@C\J /M[QGXTT?P'X<EUG7YF2%3LCBC ,D[GHB#N3@^
MP )/%>"WO[6EV;AO[/\ "D*0@G:9[PLQ'8G"@#Z<_6O8?B9\-_#_ ,0-/MV\
M3ZA>6,&GAW26"X6-$W8RS;E(_A')]_6N#T?Q/\%/AEX?&D6VH6>L3 L99DM!
M<RW!)/WG"[, ' &0/UH ?X#_ &F-*\2ZW;Z3XATIM'FN7$<-PDWFQ%SP V0"
MN3P#R.><=:[?XF_$^W^&5K876H:3=7UO>NT8DMW4"-P 0#GU&<?[IKXT\9ZI
MI&J^-M1U+PK8OIFF33"2VMBH0Q<#/"DA?FR< X&:^R/BMX7;QM\(=0LUC\V]
MCMUO+; Y,R#=@>[#<O\ P*@"]\-_B+IWQ*\/3:IIEO-:^1<&WD@G(+*0H8'C
ML0WZ&KOCOQG9> O"-SK^I123Q0,B+#$0'D9F"@#/'<GZ U\V?LO>*/[+^(%U
MH,SX@UBW)C!_Y[198?\ CAD_2N@_:O\ $VZ?1/"\+@A U_<+[G*1_IYGYC\0
M#U3X9?%JT^)TVH#3=(N[**P5#)+.ZD,SYPHQ[*37*_$#]I+1_"FM3Z/H6FMK
M5W;.8YYC-Y4,;CJH."6(/!Z#WK<^ WA-_#7P>LRP$=[JP:^D;TW@"/\ \<"'
M'J37REX<U >!/B'%<^)] CU)M.G=+G3KSCY\%>X(R"<C((X^AH ]BL_VM+P7
M"_;_  I \.?F\F\*L!ZC*D'Z<5[KX%\>:-\0O#XU709'VJ_ES03#;)"^,[6'
MT/!&0?SKQC4_B1\'/B3H+:5KUE+X>G<@179L5WPMD<H\8;CL=P ]?6O1_A-\
M/?"/A"QN-2\%:Q<:M!J"*DEPUTDL;%">FQ0 021ZC)% 'HM%%5-6O?[-T6^O
MCC%K;R3<_P"RI/\ 2@#Y$^)>J7/Q4_: CT.VE8V<5XFEVVWHBJ^)9/3KO.?0
M+Z5]?1Q0:9IBQ6T0CM[6$+'&G 55& !^ KXX_9VM#J/QOT^XG<NUO%<7!+')
M9C&5R?4Y?-?9%]_R#KG_ *Y-_(T >1>&/VD_#7B'6#9W-A=:5 D,D\EW=2)L
M147/;DD] !U) KDM7_:RV:HZ:'X8$MBC866ZN2LDH]=JJ0OTRW]*\2^'GAJ+
MQ?\ $31M"N7*07=P!,5ZF-068#T)52 ?>OM>Z^&_@^\\.'0I/#NGK8%"BI'
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M:]DN(KI+8SJZ!"6QSSSCYJPOV5=?FOO!NK:)-(773+E9(@?X$E!.T>VY'/\
MP(UX=\:O^2S^)/\ KZ_]D6@#W#QM^U!I6BZK)I_A33!K(A8K)>R3^7"2/[F
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'S-^T]XAUK1_&>CQ:1J]_81OIY9TM;EX@Q\QADA2,FN1
M\,^#/C%XN\.VVN:)K.I2V-UO\IWUID)VN4/!?(Y4UN_M7_\ (\:)_P!@X_\
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M&3Q=I'Q L?#GBO4+G4;.[NQ92I?,7FMY6;8"'/S<-@$$D8STZUTWQ^\:>/?
M?C2V?0]?GMM)U*WWP1"&)A'(F%D4$J3W5N3_ !T ?1M%<G\,/%9\:?#?2-9E
MD$EU)"([HX _?)\KG Z9(S]"*\D_:#^+/B#PKXLT_1/"6J-8/%;&:[9(T?>S
MGY5.X'& N>/[] 'T/17D6L>/-=^'7P!T[7?$,S:CXCOE1$-Q&%"RRAG 8*!@
M(@/'<KC/->*:'!\:/BE'+JVEZOJD]LDAC:8:@+6+> "0J!E'?J%H ^R**^0]
M/UKXV_#KQ3#:7D.MZF>'-E,7OHIX\XPK#=MZ?PD$=Z^L-'OVU71+*_DM+BR>
MY@25K6Y0I)"6&2C ]".A^E %RL+QKXJM/!7@[4=?OOF2TBRD><&60\(@^K$#
MVZ]JW:^;OVK_ !)(O]A^&89,(P:^N$SR>2D?X?ZS_(H O?LZ3>(_%WB#7?%_
MB'5[ZYME<PPV[W#F'S7.]]J$X 52H [!_:OH.N!^".AIH/P<T")0-]U;_;9&
MQ]XRG>/R4J/PKQWXW_%3QIX5^*5[I>@:[+9V4<,+)"L,; %D!/+*3UH ^H**
M^6M1UGXP?&-9-3\'PWNFZ!%E+=8;Q;7SRO!);<I<D^GR C'4$GG_  A\9/&_
MPY\6?V5XPN+V^LX9A%>V>H,9)H1GED<\Y Y R5(^H( /L6BLK5/$FF:1X4G\
M175PITV&V^U>:G.],9&WU)R /4D5\I:K\5/B7\5_%#Z9X/>]LXI,F&PTV3RV
M1 ?O22\'N 22%Y QSR ?85%?'&KO\:/A1)#J6J:EJJ6S. )9+S[9;EO[K E@
M"?< ^E?0GP?^*<'Q,\.223PI:ZO8E4O($/RG(XD3/.TX/!Y!!'/!(!Z'17R5
MXT^+'COX@_$&;PWX$NKJTMC</!9V]C)Y,L^S)+M)D$9"DXR !U[DU-4\(_'+
MPC8?VO-?:X88L&0VVJF<IR/O(')(_ CCF@#[ KQ3X[?&;4_ %[!X?\/6R)J%
MW:"Y-_+AA"K.RC:AX+90G)X''![;7P1\:>+/$^AW%KXWTB]MKNT"F&_GM&A2
M[0Y]5 W#'..H(XZY^6/B'=^,[SQ!!)\15NEU,6JK$+J%8F\G>V,  <;B_/UH
M ^S/A=?W>J?"W0+[4;B2YNKBT626:5LL['.23765\V? +4/B3)K>C6VII?CP
M@+600E[91#M"G9A]N>OO7TG0!F>)-;C\-^%]2UJ:%ITT^VDN&B0X+A5)P#VZ
M5X=\(OBUXB^)'QCF34Y%M=,CTZ9X-/@^XAWH S'J[8/4^^ ,UK?M'W?C.#1K
M:+PNMV='EM+@:N88%=!'A?OL02HQNZ8KYQ\ 77C"S\1O)\/ENFU4V[!A:PK*
MWE97=P01C.WF@#[\HKQ3Q_XM\8^&/V>M'U>2\GL/$3RPQW<DD*!\D/N!4K@=
M!VKR&U^,GQ(\4>'#X9TNYO[_ %>ZN6D:ZLX@)Q"%4!$\L J-VXEO3'.,T ?9
M-%>"?"34?%7@;P/XG\1_$Z[UA;.Q*K;V>HLQ=FQDE#)S\Q9%&#MSFO-7\;_%
M7XR>)IK;PS<7MO"GSBTT^X^SQ6\>>-\F5W'_ 'CR0<#M0!]BT5\=CQK\5_@W
MXBMX/$]Q>W$$AW_9M0N/M$5P@/.R3+;3_NG(R,CG!^I] \7Z9X@\$6_BFUD*
M:?-;&X<MR8@H.]3CNI# X[B@#=HKX\U3XF?$CXL^,Y-,\'7%]:02%C;V-A+Y
M&R(?Q22 CMC)+8R<#J!5+Q$GQA^%TEM?:SK.K6L4[[8I?[2^T1.P&=I7<PSC
M/##UQ0!]H5\S?&[XZ:_8^(=1\)>&1_9<=JWDW%\K9FD)4'Y#_P LQSU'S=P1
M7=^$_B'X@\>_ 35-7TN-AXFLUDMA]EC!+S*%965#D<JPXZ9S7RAXIFUNX\47
MTOBL3#6&DS=">,(^[ ZJ  .,4 ?H:.@HKQ7X3:K\2Y-/\33?$(7\7D6:O8M=
MVR188!RQ&%&>B]:\@\,_M >/[757^UWLNN2S1&&TLV@3#3L0$)"*&;'/RCJ<
M"@#[)HKXW\;6_P :O#]G%XE\4ZIK%K#*X7?;Z@%6%CR 8XFPF<>F,\=36QHW
MQR^(_BSP_:^$_#EK]J\1RNP;4HE0.T( /0C8K=07.!C'<YH ^L**^*/$6H_%
MKX8:];MKNNZO;7,RF2%Y+\W,4P'7@EE;&>01Z>HKZE^'7CM/&'PRL_$^HB.T
M<1/]MQPD;1DAV'HO&[O@&@#LJ*^1/$_Q>\>?%#Q<VB> FO+*SDD*VMK8/Y<T
MJC^.23((R.2,A0#@YZFGJEY\9?A%/;:AK&I:DEM-(%4W%V+RWD;&=C LP!(!
M]#@'!XH ^QZ*X_X8_$"U^(_@V+6((A;W*.8+NW!SY4H )QZ@@@CZXZ@U\[>(
M/C?XTT#XNZG;RZU/+HVGZY*C6211#?;QSD&,-MSRHQG.: /KFBOE#Q GQS\<
M:;+XICCU*PTO89K>RL;KR"(NH*QJP=^.<D$GMUJ7X%_&3Q&?&UCX:\2:E-J>
MGZ@3#$]TV^6"3!*D.?F()&W!)ZC&.X![G\6?B$WPU\%C6(K$7T\URMK#&S[5
M#LK-N;O@!#P.O'3K7+?L^>,]<\<:5K^I^([UKF;[:JQJ %2%=F=JJ. /U/<D
MUYA^TG=^,W\3WMM?K=_\(BES UB6A40F;[/SM?&2<F7C/KZ5R7PMU#XD6BR1
M^ 4OVTY[I#>&UMED7/'4E3CY: /5?VA;OQ+X)\7:)XN\.ZM>PVLQ$<ML)W\C
MSH^1N3=@AUX(Q_ ?6O;?!_B>S\9>$=/U[3^(;R(,4)YC<<,A]PP(_"N5^.VA
M+KOP;UI2H,ME&M[$Q'W3&<L?^^-X_&O./V4?$DDMGK?AJ=\K"R7MNI.<!OED
M'L,A#]2: /HNBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ KS;]H+_ )(3XA_[=O\ TIBKTFO-OV@O
M^2$^(?\ MV_]*8J /)_V3/\ D8_$7_7I%_Z&:^H:^7OV3/\ D8_$7_7I%_Z&
M:^H: /B#XYZ5'H/QJUM+%1#'+)'=)Y9QM9T5V/L=Y8U]/^)_'U[HOP4MO%6F
M6<E]J%Y8P26\:Q,X#RH&WL!R% )/;ICC-?,?Q^U&/4?C9KAA97CMS%;@KZI$
MH8'W#;A^%?3.K^,-/^#_ ,(]$DUN.6>>VLK>QAM8^'FE6(#&?X0-I))Z>A)
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M17-O=M)%<+GGKPV#U5A^&""?<OV4XD'PTU68#YVU=U)]0(8B/YFN>_:X4?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ^0OVH_^2M6__8+A_P#0Y*]S^"NL:9;_  :\.Q3Z
MC:12+;L&1YU!'[QNH)KB?C=\&_%7CWQ[%JV@)9FU2QC@)GGV-N#.3QCI\PKS
MK_AF7X@_\\]-_P# O_ZU 'OWQ/\ BQX=\)>$=0%MJUI=:O- T5I:6\JR/YC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/F[C:#S7\K'WU'^R>O!X.>U>-^!/VH+W3;.:W\>VMQJ\A<O%>6JQQN!@?(4
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M-&Q7 96C4Y'J,Y&?4&@#[1US_D6]1_Z])?\ T U\7_ 6".Y^.7AU)EW*))G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=?6T06Y"$HLBC:4)[' !Y]:]$^!/Q=U_QUKC:%JMA:16=AIFY;FWC<%Y%9%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** .;\2_#[PKXPO(;KQ+H\-_/#'Y<;R.XVKG..".YK
M&_X4?\./^A5M?^_DG_Q5=[10!R6D_"OP-HEREQIOA?3HYD.Y)'B\QD/J"^<'
MZ5UM%% %'5]%TS7]/:QUNPM[^U8Y,-Q$'7/8X/0^]8.C_"WP/H.H+?:5X9L(
M;I&W)*T>\H?5=V=I]QBNLHH Y+7?A;X*\2ZQ-JNN>'[>[OI@HDG9G!?:H49P
M1T  _"CQ?\1_"_P[^Q6_B2\FMOM,;&WVPO+N"8!R0#SR.M=;7(>/?AEX>^(Z
M6(\1K<YL=_D-;S;"-^W=G@Y^X* /DSXK^,4^*7Q.6ZT"RD$;)%86:%<27!W'
M!(]2SX ],5]B>!_#4?@_P/I.@Q;2;*V5)608#R'EV'U8L?QK"\'_  :\%^"+
M];_1],:2^3[EU=R&5X^,?+GA3UY SS7=T %<GK'PM\#Z]=/=:IX8T^6X=MSR
MI%Y;.?4E,9_&NLHH YS0?A[X1\,7 N-"\/6%G<*,+.L(:0#V<Y8?G71T44 %
M>8?'_P %R>+_ (93R641DO\ 27^V0*HRSJ 1(GJ<J2<#J5%>GT=>M 'B7[+W
MB>/4_AY<:!(ZBXT>X8JG<Q2DN#_WWYGZ>M>._M(?\EJU#_KWM_\ T6*^F?#'
MPG\-^#_%MWX@\/\ VNUGO ZRVXF'D;6;=@)C@ @8YXJAXP^!_A/QQXDFUO6S
MJ NYD1&\BX"KA1@<;3V% %ZR\#^&?%W@7P\?$FBVFH/'IMN$DE3#J/+4X#C!
M ]LUO>'O"'A[PG \7AS1[33EDQO:&,!GQTW-U/XFM'3[&+3-,M;"VW>3:PI#
M'N.3M4 #)]<"K% !6-K_ (1\/>*8U3Q#HUEJ.P81IX0S(/9NH_ ULT4 <IHO
MPO\ !/AZ\6[TCPU807*'<DS1^8R'U4MDJ?I75T44 9>N>&=$\36RV_B#2;/4
M8T.4%S"K[#ZJ3R#]*YRV^#/P\M9Q-%X3L&8=I5:1?^^6)'Z5V]% $5M;06=M
M';VD,<$$2[4BB0*J#T ' %4];\/Z1XDT_P"Q:_IMMJ%MNW".XC#A3ZC/0^XY
MK1HH Y;0?AGX,\,Z@E]H?AVRM;N/.R<*7=,C!VLQ)'!(X]:ZFBB@ KC]1^$O
M@/5=1:^OO"VGO<.V]W5"@=B<DD*0"2>N1S7844 8-_X'\,ZGX:A\/WFC6K:1
M X>*SC4QQHPR<@+CNQ/XT[PSX+\/>#HKB/PSID6GI<LK3"-F.\C..I/J:W**
M "N>\0> ?"GBJ;S_ !!H%C?3X"^>\0$F!T&\8;'MFNAHH YK0/AUX0\+W0N=
M"\/6-I<+D+.(]TB_1FR1^!KI:** .4UKX7^"?$-^]]J_AJQGNG.YY@FQG/JQ
M4C<?K5YO!/AD^&)O#JZ)91Z1/@RV<40C1R"""=N,G*@YZ\5NT4 <]X9\!^&O
M!LMQ)X9TJ/3VN559O+=R'"YQD$D<9/YFI?$?@KPWXN6,>)-&M-0,0Q&\L?SH
M/0,.0/;-;E% '/:%X"\+>&;>XBT'0[2R6YC,<S1I\\B'^$L?FQ[9JEHGPK\%
M>'-9@U71- M[2^M]WE3([DKN4J>K$=&(_&NNHH H:WH>F^)-&GTK6[5;NQN-
MOFPN2 VU@PZ$'JH/X5G>&? GAGP;)</X9TF+3VN@HF,;,=X7..I/3)_.N@HH
M P_$W@SP]XQAMXO$VF1:@ELQ:)9&8;"<9Z$>@J?P]X9T?PII9T[P]8I8VAD,
MGE(21N.,GDGT%:M% &1K_A/0/%,*1^(M'L]1$>0AN(0S)GKM;J/P-8^D_"CP
M+HEXEUIWA?3XYXV#)))'YA0CH1O)P?<5U]% !7'3_"7P-<ZY)K$_AVW?4)+@
MW3SEWR92VXM][&=W-=C10 5QT/PE\#6^MQZQ#X=MUU".X%TDX=\B4-N#?>QG
M=S78T4 1W-M!>6TEM=PQSP2J4DBE0,KJ>H(/!'M7')\'?A['>&Z7PGIQD)SA
MHRR?]\$[?TKM:* /#?VHO$R:9X#LO#T#J)M5N \B#_GC%S^'S[,?0_AU/P(\
M&2>#?AA:+>1F._U)OMMPI'*;@-BGTPH7([$FM+Q)\)?#7BWQE:^)=>%W=75J
M(UB@:4>2%0E@I7'(R22,\Y/:NWH **** "BBB@ HHHH **** "BBB@ HHHH
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3 HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>bdtx-20211231_g22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bdtx-20211231_g22.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R86YD86X@
M2&EL;&5R:6-H   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,W
M-@  DI(  @    ,W-@  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MO-O;"<V[SXYF7:"K'_:YP?IGN:\VUWPU\1?BA\0I[+5X[_1=%WN83/&WD11
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!AT^0^3-'_Y.BD_[&.X_]&O7UG7R9H__ "=%)_V,=Q_Z->OK.M>*_P")A_\
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MI?Z;;7>FR)+:31+) \?W60C((]L5X%^TWJVGSR:)I<4D<M_;M++*%;)B1@H
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MVVT_Q))X\;3[9[D>)/MKQ%EN@)?M 8ACYN[&[<#\V[GUKZ1BUH>"/@SIUO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 >1>/O@3_ ,)QXQN==_X2/[#YZ1KY'V'S-NU
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M^2201A&.QXK9?L]/HGBV/6_#GBQK V]QYUM"]AYGEKG[A;S1N&.#P,BO:AG
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YY^"_\ R<9\1O\
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MJZ'<>'KRY?POK\WE7-G-(66,AE#?4J'#*3SP1GJ: /I"21(HVDE9411EF8X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6BBBN8H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1+W19=5NYKAUL[1T95DD+["ZS+N )]!TSBG_ /"C?&__ $6CQ!_WS/\ _)%
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MO@MX \':QXF\1>%/'FEK<:SI\^+</<RPEU4E7 ".N<$ ]SAO05](>#/!>C^
M_#L6C>'X&C@4[Y))#F29R.7<\9)P/0#   %<KX_^">@^.-736X;JYT76TQ_I
MUE@%ROW2R\98=F!!X SP, %#6_@Q\'O#>C7&K:YHD=G8VR[I9I+^ZP.P  DR
M23P ,DG@5U_PYA\*1>";5OA^C+H<CR/ 2)OF.XAC^]^;[P/MZ5Y[#^SO+J5U
M"?'?CW6O$MI ^]+65G1<_5I'(_#!]Z]DLK*VTVQ@LK"".WMK>,1Q11KA44#
M 'I0!/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_M2!@H_*J_[1=Q(WBC2+<L?*2S+JOHS.03_XZ*]K\)65M9^"=(M+9$\A;*(
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M)6/SKV,CU4!\#]!7QF4VQ.6XVC-:)*:\FK[?<D=%3W9Q9]34445\@= 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7"?&7Q
M+)X8^&.H3VS[+F\Q9PL#@@OG)'N%#'\*[NO#_P!IV1QX8T.(-\C7CL1ZD)Q_
M,_G7L9'0CB,RHTY[7_+7]#.J[0;+_P"S=H2V'@.ZU=U_?:G=$!L?\LX_E'_C
MQ>F?%"R^)'BOQ3)X;\,1M::"8D\VZ_U22$CY@TG5AVVK^(-=?\'H5@^$/A]4
MZ&W9_P 6=B?U-=K77BLRG1S:MB>52=VES*Z5G9/U26A,87II'QGI.A-X9^.6
MD:*\XN'LM<M8FE"[0Q$J9(%?6/C/57T/P/K6IPDK-:V4LD1'9PIV_KBOF?6/
M^3HH_P#L8[?_ -&I7T-\5(&N/A3XB1 218N_ SPOS']!7NY^_K&)P+JZ\RC?
MYM7,Z6D96/%OV:M%@U'Q3J^K7<*S26,,:Q._.QY&;YAGOA#S[FJ/[0&F1>'?
MB?9:GI"?9);FVCN2T2[0)D=AN&.^%4_7GO70_LN2()O$\1/SLMJP'J!YN?YB
MLS]IR53XOT:(9W+8EC]#(1_0UZD*M1\4SIM^[RVMY<J?YF=E["Y]%:1??VIH
MEC?X"_:K>.; [;E#?UI=5NGL=&O;N$*9+>WDE4,."54D9]N*I^$D:+P5HB2#
M:RZ? &'H1&M2^(O^17U7_KSF_P#0#7YHX16(Y%M>WXG;T/!=$_:3UN47,>J:
M':7=RZA;*"PCD0M(3_$2S'&.P&2?SI\?[1'BG1]>6V\7^&(+6'(,D"PRP3HA
M[_.QS^0SZBL#]F^SANOBA/).@9K73998B1]UM\:9_)V_.M3]IU1_PE6BM@;C
M9,"<=?G/^-?I4\%E?]K?V=]75I1NW=Z:=%\OO.)2G[/GN;?B+X_:Y-+=7/@7
MPY]KT>S.V74;JVE=#[G:5"#TW'/TZ5U_PG^+:?$3[597UFEEJEJ@E*1,2DL>
M<%ESR,$@$'/4<^FGX(TNVLO@CIEM'&OESZ.)I %QN,L>]L_BQKPO]G)V7XI.
M%8@-I\H8 ]1N0X/X@5X_U7+\5@<4J5+E=':5VV]]_6WXZ&G-.,HW>YW?Q%^-
MFN^#/B//H=K9Z;)I\/DLTDL4C2[656;D.!W..*RM1^/_ (RFADU30O",<>B(
MQ'VFZMYI1C/>12J@^W-<;\=D63XTWZ2-L5DMPS'L/+7FOJRWTNRM=(CTN"VC
M6RCA\A8-OR[,8VX],5>+679=@L)5GAU.4XJ^K717?J[A'GG*2OL<7\+_ (JV
M7Q$M)H6@%EJMJH::VW;E9.F]#Z9.".V1ZUX7\6/^3BKS_KZLO_1,5/\ A O]
MF?M!P6-F_P"X\Z\M^#]Y%CD(_5%-4?C9/);?''69X3MDB>V=#C."+>(BO8R_
M+J."SN=/#Z1G2YDNUY)6_ SG-RIION>S?%GXSCP->1:3H$5M>ZMP]P+@%HX%
M(X!"D'<>#C/ ^HKJ_AWJOBO7?#JZGXQM+&Q>YP]M;6T3HZI_>?<S<GL.PZ]<
M#Y:\':C!IWQ.TO5/&]I)<P3SK/*UT",[^5F.?O $AO0@5]HJP90RD$$9!'>O
MFL^P5#*\/2PM.G>4E=S[^2[?Y6\S:E)S;DW\CYEBN#\-?VG)HXCY6GWMT$=1
MPOE7&&_)78?]\5]-U\M_M')]C^*EG<0$K(^FPRD\<,))%!_)17U)6?$"57#8
M/%/XIPL_/EMK^(Z6DI1"BBBODC<**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KRW]H#QCKO@CP#9:EX8OOL-W+J<<#R>2DF4,4K$8=2
M.JKSC/%>I5XE^U7_ ,DKTW_L,Q?^B)J -O\ 9_\ &.N^-_ -[J7B>^^W7<6I
MR0))Y*1X011,!A% ZLW.,\UZE7B7[*G_ "2S4O\ L,R_^B(:]MH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK;J=EO!-,S'G#RM@#\BWY5ZI\6];_P"$-^%FI(U]-<WVJ9M(GF8;CO&&(
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MBRS\/:=8ZK%=WF_RWGAC$8VHSG)$A/13VZUZ10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(\4:UGU&H2Y_]"K)N3FWXX.<57N#_H:#IB@#1@\>>+VOHU/BW6\$]#J,W/\
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M 'H6G^.O%[Z TC^*M;:3G#'4921^.ZJZ^/?%Y5?^*KUS/_81F_\ BJR-./\
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M>+.$GKL&?RKZM^#)S\(]%Q_TW_\ 1\E '<T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\]ZS\$
M_%_CSQ9J.K?$#Q"\6DP3S-96D,@>01;CM"C&R/*A>?F)[C-<-^RY_P E:N/^
MP7-_Z''7UM??\@ZY_P"N3?R-?)/[+G_)6KC_ +!<W_H<= 'LO[2>J/IWP;N8
M8Y-AO[N&V.#@D9+D?E'^6:H_LOZ9%9_"F6]55\V^U"1W?OM4*@'T&"?^!&G_
M +4%DUU\(HYE#$6FIPS-CL"KIS^+BIOV9KB.;X.11QMEH+Z>.0>AR&Q^3"@#
MQ[73_P (G^UXK:<@A!UJW9E7NMP$,F/J)6_.K?[5.IRW/Q'T[3M^8+/3E=4S
MT=W;<?Q"I^55/'>[4?VNT6W7<QUG3X\#G[JPJ3^A)]*/VHK5H/BS!,5;;<:9
M$X)Z'#NIQ^5 'TGXE\-VK?"/4O#R0)Y$>D/;Q1J!A2D7R$=N" 1[BO#/V3-2
ME37/$6F;F,4MO%<!<\!E8KGZD/\ H/2OH7Q)?Q0^!=6U#(,*:;-/DG VB(MU
M^E?.7[)UO(WB[7K@#]W'8I&Q]VDR/_030!]'ZKXL\.:#=+:ZYK^EZ;<.@D6*
M\O8X7922 P#$'&01GV-4U^(O@EF"KXQT L3@ :I#S_X]7#_%7X%_\+-\56VL
M_P#"1?V9Y%DMIY/V'SMVUW?=N\Q?[^,8[5Q'_#)DUO\ OK;QBDTT?SQQR::4
M5V'(!82DJ">^#CT/2@#W7_A.?"7_ $-&B_\ @PB_^*H_X3GPE_T-&B_^#"+_
M .*KY%^'^@77Q'U^?2-#DA@N(;5KIFO&*H5#*I *ACG+CMZUZ+_PSMXM_P"@
MCHO_ '_E_P#C5 'NO_"<^$O^AHT7_P &$7_Q5'_"<^$O^AHT7_P81?\ Q5>%
M?\,[>+?^@CHO_?\ E_\ C5'_  SMXM_Z".B_]_Y?_C5 'NO_  G/A+_H:-%_
M\&$7_P 51_PG/A+_ *&C1?\ P81?_%5X5_PSMXM_Z".B_P#?^7_XU1_PSMXM
M_P"@CHO_ '_E_P#C5 'NO_"<^$O^AHT7_P &$7_Q5'_"<^$O^AHT7_P81?\
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MF7!W*#G*GMZ4 ?5/AZ_\.:5X:TW3=+URSN+.QM8[6&4W<;EUC4("2N 3\O.
M.:T?[>TC_H*V7_@0G^->-?#CP3J.K_#_ $V^MIK58I?-VB1V##$KCLI]*ZC_
M (5OJ_\ S\V7_?Q__B:]:GA<)*"<JMG8\Z=?$J34:=T=[_;VD?\ 05LO_ A/
M\:/[>TC_ *"ME_X$)_C7!?\ "M]7_P"?FR_[^/\ _$T?\*WU?_GYLO\ OX__
M ,35_5,%_P _B?K&*_Y]G>_V]I'_ $%;+_P(3_&C^WM(_P"@K9?^!"?XUP7_
M  K?5_\ GYLO^_C_ /Q-'_"M]7_Y^;+_ +^/_P#$T?5,%_S^#ZQBO^?9WO\
M;VD?]!6R_P# A/\ &C^WM(_Z"ME_X$)_C7!?\*WU?_GYLO\ OX__ ,31_P *
MWU?_ )^;+_OX_P#\31]4P7_/X/K&*_Y]G>_V]I'_ $%;+_P(3_&C^WM(_P"@
MK9?^!"?XUP7_  K?5_\ GYLO^_C_ /Q-'_"M]7_Y^;+_ +^/_P#$T?5,%_S^
M#ZQBO^?9WO\ ;VD?]!6R_P# A/\ &C^WM(_Z"ME_X$)_C7!?\*WU?_GYLO\
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M^_C_ /Q-'_"M]7_Y^;+_ +^/_P#$T?5,%_S^#ZQBO^?9WO\ ;VD?]!6R_P#
MA/\ &C^WM(_Z"ME_X$)_C7!?\*WU?_GYLO\ OX__ ,31_P *WU?_ )^;+_OX
M_P#\31]4P7_/X/K&*_Y]G>_V]I'_ $%;+_P(3_&C^WM(_P"@K9?^!"?XUP7_
M  K?5_\ GYLO^_C_ /Q-'_"M]7_Y^;+_ +^/_P#$T?5,%_S^#ZQBO^?9WO\
M;VD?]!6R_P# A/\ &C^WM(_Z"ME_X$)_C7!?\*WU?_GYLO\ OX__ ,31_P *
MWU?_ )^;+_OX_P#\31]4P7_/X/K&*_Y]G>_V]I'_ $%;+_P(3_&C^WM(_P"@
MK9?^!"?XUP7_  K?5_\ GYLO^_C_ /Q-'_"M]7_Y^;+_ +^/_P#$T?5,%_S^
M#ZQBO^?9WO\ ;VD?]!6R_P# A/\ &C^WM(_Z"ME_X$)_C7!?\*WU?_GYLO\
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M^_C_ /Q-'_"M]7_Y^;+_ +^/_P#$T?5,%_S^#ZQBO^?9WO\ ;VD?]!6R_P#
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M_P#09^ >TJ_RGT#_ ,)_X._Z&S0__!E#_P#%4?\ "?\ @[_H;-#_ /!E#_\
M%5\_?\,T>,?^@EH?_?\ F_\ C5'_  S1XQ_Z"6A_]_YO_C5']CY'_P!!GX![
M2K_*?0/_  G_ (._Z&S0_P#P90__ !5'_"?^#O\ H;-#_P#!E#_\57S]_P ,
MT>,?^@EH?_?^;_XU1_PS1XQ_Z"6A_P#?^;_XU1_8^1_]!GX![2K_ "GT#_PG
M_@[_ *&S0_\ P90__%4?\)_X._Z&S0__  90_P#Q5?/W_#-'C'_H):'_ -_Y
MO_C5'_#-'C'_ *"6A_\ ?^;_ .-4?V/D?_09^ >TJ_RGT#_PG_@[_H;-#_\
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MV/D?_09^ >TJ_P I] _\)_X._P"ALT/_ ,&4/_Q5'_"?^#O^ALT/_P &4/\
M\57S]_PS1XQ_Z"6A_P#?^;_XU1_PS1XQ_P"@EH?_ '_F_P#C5']CY'_T&?@'
MM*O\I] _\)_X._Z&S0__  90_P#Q5'_"?^#O^ALT/_P90_\ Q5?/W_#-'C'_
M *"6A_\ ?^;_ .-4?\,T>,?^@EH?_?\ F_\ C5']CY'_ -!GX![2K_*?0/\
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MPS1XQ_Z"6A_]_P";_P"-4?V/D?\ T&?@'M*O\I] _P#"?^#O^ALT/_P90_\
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M6A_]_P";_P"-4?\ #-'C'_H):'_W_F_^-4?V/D?_ $&?@'M*O\I] _\ "?\
M@[_H;-#_ /!E#_\ %4?\)_X._P"ALT/_ ,&4/_Q5?/W_  S1XQ_Z"6A_]_YO
M_C5>;^+/#%[X.\3W6A:G+!+=6NS>]NQ9#N0.,$@'HP[5UX7AO*L9-T\/BG)V
MO9);$RK5(J[B?<MO<0W=K%<VDT<\$R!XY8F#*ZD9# C@@CO4E<[\/O\ DFGA
MG_L$VO\ Z*6NBKX.M35.K*"Z-K[CJ3NKA11160PHHHH **** "BBB@ HHHH
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MR6Z:);12$,CEMN=W.,XH Z7_ (:+^&O_ $&IO_ &;_XFC_AHOX:_]!J;_P
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M>AY.:?!'U/:QTHH'2BO"/6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN^FF]NI:E*<$XG$Z%^TOH]_J$<&N:)/I<4C;?M$=P)U3W8;5('TS7M4,T=Q
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M3F1>?E&12( %[4_U]* (+I,VR<=S5$PIR=M:5T0+)3_M&L^Z!A51D'>,\=J
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M>O;--M6CA7ACQWH V]\:PGG.ZL2=/W<DD6#L;OWK42,DD%&QCDCI44D"BVE
M7()R : .8FU:WDTVZMY=JY4C:>F:^9?$DJ/KDZHOR(VS']:]R\06\\=S,+=9
M".>G>O#O$]K);ZQ)Y@(W\\C% %"V"B0X[UI1H-@#"LB ,&!YXK4BN5*X-  0
M QKZJ^#?_))=&_[;_P#H^2OE@?.W/3-?5'P<Y^$NC?\ ;?\ ]'R4 =O1110
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M9X8U5M=\(Z/J\B;&U"QANF7^Z7C#8_6@#4HHHH **** "BBB@ HHHH ****
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MC&KWWPC_ ,B5HO\ UX0?^BQ75FO_ "),'_V\3#^+(UI98X(7EF=8XXU+.['
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MG,MW;RO;R3'K+MQAC[X(SZD9KQ?Q;\0O$WQFMK/0-!\-R11I*))4@D,N]P"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5\0>/!_Q<SQ+C_H+W7_HYJ^WZ^(?'>1\3/$N.?^)M=?\ HYJ
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M]7;C;+T_"O?[IH8(WEFD6)5&6:O+/B#HD(=-9LCN2Y.YF'Y4 >=ZAQ&,>]9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>*:]_P C'J7_ %]R_P#H9KVNO%->_P"1
MCU+_ *^Y?_0S7NY-_$EZ'DYI\$?4]K'2B@=**\(]8**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "OC_XZ_P#)9];^EO\ ^D\=
M?8%?-_Q8^%/C3Q-\3=4U;1-&^TV-P(?+E^U0INVPHIX9P1R".E?7\(XBCA\?
M.=::BN1J[:76/<Y\0FXZ'M7PWN(;GX8>&WMI8Y473((RT;!@&6,*R\=PP(([
M$$5TU<=\)]!U+PS\,M+TG6[;[-?6YF\R+S%?;NF=ARI(/!!ZUV-?.8]06+JJ
M#NN:5GW5WJ;1^%7"BBBN,H**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "OB7QW"S?$SQ'LZ_VM=?^C6K[:KXL\:'/Q-\1^VK77_HUJ ,6.WZ;
MOO5J*OEVX^E42ZH<FKMF3<7$$;=&D4#\Z /H+P9HL$/A^QD,85FMU/([XZUV
M]DB0'+ $D]:YS2F%K9P0<#RXU7K5C4-<M]/B+W,P /:@#KTOXBP4$>XI4D$L
MV5^[W'K7#6&O1ZA\UJY=L\D=A756,DJ0C/?O0!K8^88%,D/.X+@TP2LR<#IW
MJ$W/)!R?>@!DFHQ[]I(#=,5CZC"EPY+@'/ZU1UFY^Q7+2,VT$]>U)%J2W$4<
MJD,K+G% 'GWQ"\$KJ%@UQIT ^TI\Q"C&X5X-<VTT-S()D*E200>U?5]W,'DY
M/!XXKP7XE:;#8>+)!&,).HD*^A- '#@?C6@W.C!2> QJN;8A,@@U8!)TC'0A
MC0!E>66)V\"E=5C7D9^E38PO6K>DZ:VLZU;Z>G.]P6/H.] '8?#6SD74A=O
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MQCOWKZQ^#+;_ (1:(?:;_P!'R4 =Q1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"F\>R/!))^M49[?S(&-P,H!WK:-D">22*JZE'MA$:C(/7CK0!Y)J-E$^K.I
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MXGFDNWR< @&NNOKC??.,X4\\4 7=!L4O+\1[1M49;VXZUZ=I=NT%ND2.<KC
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MB,'\* ,65RP  Z"OK#X*G/P@T7_MO_Z425\EC);CUZ5]:_!<;?A#HHZ?Z_\
M]'R4 =U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?,]C\1/B#)^T$VARZE>'1!X@EMA";5 GD"9E"[MF<;0.<U],44 ?+W
MQ@^)'Q%T#XK:QIOAS4KR#38/(\F.*T1U&8(V;!*$GYB>]<5_PN#XM_\ 09U#
M_P  (_\ XW7L7C']H.Y\"?%C5O#VJ:/'?:5;&'RY;=RDZ!X4<YSE6Y8X'R_6
MN_\ "/Q<\&>-=D>D:Q''=O\ \N=W^YFSZ 'AO^ DT ?+W_"X/BW_ -!G4/\
MP C_ /C=?7?@N\N]1\!:!>ZF[27MSIEM+<.Z[2TC1*6) Z')/%;=% !1110
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M7H>3FGP1]3VL=**!THKPCU@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTH MZ?>OINL0SYPI.UC[5WL%R)7<ENO(KSF_4A0_X9K8T'6@UND,G$B\#W%
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MTR914E9D5K.;FSAG,;Q&1%<QR+M9<C.".QJ6BBN%[Z%!1112 **** "BBB@
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MNN$^"W_)(=%_[;_^CY*[N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .2^
M(_\ R+D'_7TO_H#UG_#+KJ?_ &R_]GK0^(__ "+D'_7TO_H#UG_#+KJ?_;+_
M -GKW8?\BN7K^J/(E_O\?3]&=[1117A'KA1110 4444 %%%% !1110 4444
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MM'#C_ODD_@*^=[6XU+Q9+X?\-!]RP2&VML\[?-DRQ/L,C\!0![U\"/#W]D^
MSJ,J;9]5E,O(P?+7*H/_ $(_\"KTVJ]A90:;IMM8VB[(+:)8HU]%48'Z"K%,
M#YC^,F__ (7')O\ N[;?9]-H_KFOH7Q=L_X0G7/,V[/[.N-V[ICRVZUXO^T)
MX=N(M;LO$,$3&VFA%O,ZCA)%)*Y],@X_X#6IXH^-&B:K\,;BTM7E.L7]K]GE
MMS$0(BPPY+8P1@MC'/3@4 9'[.?_ ",>L_\ 7HG_ *'7T%7D'[/OAR>P\/W^
MMW493^T75( W4QIG+?0EL?\  :]?H *^*O&Q_P"+F>(_^PM=?^CFK[5KXK\;
M<?$OQ'_V%KK_ -&M0!F'J,U<=O\ 1<'T_*JHR:EE;$- %2+YI0 "!GMZU[GX
M'A/]G0ES\Q KQ73(3<:E"B]W&:]Z\/6@MX(E[ #B@#O--W)CYO\ Z]=%;2%E
M 8_K7.V#)Q@] *V[5R%&._Z4 71)DXXI^<9]JB"@D>_>AEVKSG- %6^D#)CI
MQ7G?B$%9GQ_"V:] N4&UF)Z5PWB! Y+'Z<=Z /#_ (C _P!O;CT:,8KBT;+$
M&O0OB/;-^XGV]!M)KSI3FY'/:@"TI( Z^N<4DY!B'L:<#GKG/I3)N(>: *IX
MQ3)#E5]S3BU,E. H'<B@#U'X;N6TZZ0] P/\J]ET$YAC7L!FO'OAQ$%TF5\<
MO* ,>F!7L^DQ;+9"...: .H@F^4(>XJSYV%Q^6:H0@-M(JPQ^0_+SZT 4+Q_
MWI [>E9UPF4+=JU)X6W$^HJE<KB'GD#M0!YOXRA8V;'/&1S_ $KQKQ5#AHI/
M^ FO=O%D6ZR;CZ"O'?$5L9;>:/NGS+[T <M%@("*O*V8U_I6=#RF#5V,@QC-
M "W'^K7'3)JL<]>U69SF%!@ 9-5FQMXH A<_.,#J:TK"+[1>118/S$=JR9FV
MR#CO77^#+ WFK(^,B,9^M 'L/A:R6VLXH]O 4=J[RRSY0_2N7TF,QPJI&.!7
M1VK%(EH UXF)8+@>U3.@:,$J :JVYS@\^]7L%N<<8XH S+H,$*L!Q7.ZL5$9
M!Y)&*Z34,KR>O\ZYC4"I5BO;K0!P>NQB2W9&7(/'->/:K!]FU255&!G(Q7M.
MIQ[U? XKR?Q7;^5>^8!P2<F@#+,GW0#VI&.<Y_G4,A^5,?6I2<KGVH [#X(G
M/QFT3/\ T\?^D\E?7-?(WP2_Y+1HG_;Q_P"D\E?7- 'Q?\0#_P 5]XA'7_B:
MW7_HUJSK;BUC/? K1^(7_(_^(?\ L*7/_HUJH0#-G'G&-HH R[ILS$>];G@^
M+S=6!["L&YQYQY[UUW@*V#732$=.G% 'O/@F (HW=U!YKT6W(**!_*O//"Q"
M8'^R*]!LB7CSZ4 6Z*** $=MJ\USVLIN8L.*W9S\N.YXK+O5+;@Z]J /"/BG
MX>FO+7[5 ,M'SP.M>*1ML8JWRY.#[5]:ZOIPNX7AD VD=J^;O'WAP^']:_=_
MZJ<DCCI0!BH<L/J*NZRN)(3W* UFP2$J/4&M/6.?LQ)_Y9B@"&/F,'M5JU.2
M<?\ ZZJQ % #Z5:MSC.1TZ>U $-Z?WH'4^M;'@ZR^T:NKG&%[5AW.?/YYP*[
MGP+8G:LV,[FXXH ]<T*+:T0'&%KK[:0A,;=I''-<MI"A-H!P?>NEM3YA [8Q
M0!8#E]NWKFI?,&TXX'I1'&-Y;H0>E(W"]/QH AEE&S+9KF/$4(N;=P%^4CO7
M1RCYN>:Q]1^?>.V.AH \I\6Z6VH:"VWB:V^8#U%>1.V)^>]>_P"I1A)V!7Y)
M05;TKPWQ)8MI>N30'A5?<OT- $*\@>E6K7!,H//R55C^9!M/:K-H1O;&>4-
M&:O^L(J^!DC/TJ@.)??-7\$ 9H THEQ"!GFJE\>@'2K5OS&/7UJCJ!_> $_K
M0 S38FFU*)!S\WYU] >&83%I\60.5_2O%?!UI]HUA2W1.F.:]XT5 L80#C&*
M .BT]CN&#6_;R889Y-8-FH!X) ]36U:'F@#70?(,U%<*-I/>IZ9*!M- '*:R
MA#,R^@K@->B,D<I'4J1^E>BZFH)93Z=JXW5;;._ &: /F&]5H=8N8W'/F'K]
M:MVTF5VD\"M7Q_I36'B,3*/EFYSCO6';']X,]Z -A<&UB]-]=Q\'1CXLZ-[>
M>/\ R!)7#I_QZQ^F^NY^#I/_  MC1O?S_P#T1)0!]25\V?M&8_X6%IW_ &#(
M_P#T;+7TG7S7^T:?^+A:=G_H&)_Z-EH \K)R/?O2:;;/=ZW%$@).<E?2C) .
M>..*[;P9I5K'IG]IW*$S3$HI]O\ (H ZDW9-C!;+_" /PKI='8JHSZ=/:N1M
MAYUZH(^5>E=78<8P2..E '46.3U'UK;A4% !]['!-8>GO\@*C'M726 #H=WI
MZT 0NO7/?BLVY;C:?3%;LT:^6QYSZ5@7F!D9H YG4VVS=0<YJAX=FQJ+ ^I-
M7-6PV2!CWKG]*N3!JAWGOS0!P_Q0O6N_&4H)W+&H05QVW#?C70^/-Q\77#'J
MS9%8#X/Y4 )Q@\=*FU+'V*R.,?NL5$X(!V]"*FU,$:?8Y'5* (8.8E!].*O6
M?WL&J4 _<+[5=LQB4'K0 W46^55'3UJYX3M/M&M1C&0O451U/ 9,-^%=7\/[
M,M(TY'4\'% 'K>A1;%15[]JZRR?:=HQ7+V.847'!/M706,W0'CUQW- '1V;%
MVP#UYJ\%QSBLVPDW,"3S6I0!5NA\N3^7K7+:U& 2>#V/-=3>-M3<& KF-2 =
MW.<#'>@#QGXF:9]ITUKA!EX>>/2O&8)/WGT.*^E-=LTN[*:+&[>I'(ZU\X7]
MI)8:Q<6\R%&5CU'49H TE*X&>!CDU->8_LR,\YW56A/F6ZG(YZU8O&(TR(8_
MB(H SV&7DX].:@D.%/Z5.3\TGX8JI<-A".GK0 EA!]KUJRMUZS3*M?2N@60M
MK&-0FT*,8KPCX>:-+JWBJ"X"_NK9E;.>_:OH^RMQ'&-W/K0!I68*D*PP"*W(
M<A5V\\=:Q(\J0P&/2M>T<.!@$ F@"^5^3Y?_ -=9>H +SC!QZUL%6\G)[>HK
M'U?@KVP.G:@#CM;7<3GG%>6^-HO-TZ0>ASCTKU/4SNSW/2O//%-J9+>48^][
MT >11G$@_(UK0,&C'85ER1F&[:,CE6P16C;ME&!'3I0!;R2OL.*^IO@W_P D
MET;/_3?_ -'R5\LC..G:OJ;X.#'PFT;_ +;_ /H^2@#MZ*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X;Q%X^^'&BZ_
M<Z?XDU#38=3AV^<D]L7<94,N3M.?E([UF?\ "TOA#_T%='_\ F_^(KF/B+^S
MM<>.O'VH^(X_$<5DM[Y6(&LRY39$B?>WC.=F>G>N9/[)-Y@X\7P$]LV!_P#C
ME 'IO_"TOA#_ -!71_\ P";_ .(KT/3+JSOM)M+O2W1[*X@26W:-<*T;*"I
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M*GJ7_8%E_P#1\%?6U?)/[*G_ "5/4O\ L"R_^CX*^MJ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KYM_:)_P"2AV/_ &"X_P#T;+7TE7S;^T3_ ,E#
ML?\ L%Q_^C9: /5_@M_R2'1?^V__ */DKNZX3X+?\DAT7_MO_P"CY*[N@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .2^(_P#R+D'_ %]+_P"@/6?\,NNI
M_P#;+_V>M#XC_P#(N0?]?2_^@/6?\,NNI_\ ;+_V>O=A_P BN7K^J/(E_O\
M'T_1G>T445X1ZX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <IK7PR\(^(=7F
MU36-(^T7D^WS)?M,J;MJA1PK@#@ =*I+\&? 2L"-!&0<\W<Y_P#9Z[BB@#-T
M;P]I'AZU-OHFG6]E&W+>4F"WU/4_C5C4=-LM7L)++4[6*ZMI!AXI5W*:M44
M<C8?"OP5IE\MW::!!YRMN4RR/*H/J%=B/TJP?AWX6_X2;_A(!I>W5//^T?:%
MN)5^?UVAMOU&,&NFHH X/QO\4O#?AN+4]+N)FN-5ABV?8O)<ABZ!ERV-NW##
M/.:\O^ /AM[_ ,63Z[-'_H^G1E(V(X,KC''T7=^8KV36OAOX3\1:N^IZQI"W
M-XX4-)Y\B[MH &0K '@ =*W=,TJQT:P2RTJTBM+:/[L42X ]_<^] %NBBB@"
M&[L[;4+.2UOH([BWE7;)%*H96'H0:Y.+X2>!H;S[2GAZ R9SAY9&3_O@MM_2
MNRHH ;'&D4:QQ(J(@"JJC 4#H *=110 5\5>-CCXE>(_^PM=9_[^M7VK7Q5X
MW_Y*9XC]/[6NO_1S4 9X]NGO2RG]S@_6FYSSCZ5%+)D!1U[T =#X.LA<:JLC
M<A2*]TT.W(C&<8KS#P#IZI;),W5CD9KU?3N% 'TXH W+(GE0>:V;1@%P6Y]1
M6):@J3V-:UE'[[@: -F$?N^O-2,,KS3(5VQBGM]T_2@#)O R@@=*Y;4[8M&S
M8!'-=7=JRJ=W?I6%?)L4@\@T >3^,]+.H:7-'&N749%>)S9BN/FX9#@\5])Z
MU C1,H&.#GWKP#Q?8FPUZ3:,)+\ZB@"LA!YYILYQ#SSDTVV;=&O<BEG/R#/K
M0!6'Y"HIL;E'N*EXW=*A*[[R*,<EB* /:OAW:%=)M@?XCN->M6(VKM)S]*X'
MP=9^1I]NH'"J*]"M(]JY/X4 :\#X&#^-3JX8^V.:I[L.-I[5938 ,GKS0!*T
M>^/<.:S[V+$9&?Q]:TQ_JSCI568;D;- '!:ZGF0.,<9 YKR_7K';(S8YY'%>
ML:[%\D@/ K@M2M_,!'?W% 'D$\)M;MX\Y&<BI(#SM//I6CXHM/(NUE4'!.#Q
M65&=K ]N_M0!9N!^YC^IJMC"\FK4YS#'CIN-56(VF@"C.W[Y O4GK7K7PQL]
M\#RLH.37D,A,FHHO3V%>Z_#^#[/I,78GDT >B6R(J_-^%7HB3PI'!K.@?)4=
MO6M*(8Y _&@#6M&)QD=>U:N"% SBL:R).,>M;(;"C=0!DZDQ#],@US-]A]VP
M=:Z75 6R4X-<[(I)(;/(]* .5U")CFO/?%&FF:%RH^8<BO3=00 LI_.N4UB%
M70LO/!XH \<F.T%#V/-3QMN@Y]*9JR"WUB6'MG(%)"RBW..M ':?!(_\7IT,
M?]?'_I/)7UW7R%\$?^2UZ%S_ ,_'_I/)7U[0!\7?$$X^('B+/_04NO\ T:U9
M]OG[)%_NUH?$'_D?O$7<_P!J76/^_K51MQ_H<7^Y0!C2G,K?6O2O ULL=JI[
ML,FO-G/^D'/3->E^$9=D,([$"@#UKPXWDNN>,\8KT33Y0R;17FNCR!2"^![B
MN^TNX#*I&30!M44 Y&110 C#BJ%VK ].,=:T*IWS';M X]: ,*Z@+)S]0!7C
M/QFT99K.UGQ@HS8(_"O<)%SU/ .,UYY\5;,W&@# SM)/2@#YC1O)NMA/>MO5
MSNBM#ZQBLK5(3%/OQCG!K1U'YK6R;//E@4 ,BYC'ZU9B]!5:(_NJF5MB-]*
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MQ[7(O)U)FQ]X]:6V^85<\3Q8F#>^*HV9W*3G- &@&XQ7U-\'?^23:-_VW_\
M1\E?+(Z U]3?!W_DD^C9_P"F_P#Z/DH [>BBB@ HHHH **** "BBB@ HHHH
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MS@W>7%]FA?;N8L>60D\DGK5[_A=/C_\ Z#__ ))P?_$4 ?6%%?)__"Z?'_\
MT'__ "3@_P#B*/\ A=/C_P#Z#_\ Y)P?_$4 ?6%%?)__  NGQ_\ ]!__ ,DX
M/_B*/^%T^/\ _H/_ /DG!_\ $4 ?6%%?)_\ PNGQ_P#]!_\ \DX/_B*/^%T^
M/_\ H/\ _DG!_P#$4 ?6%%?)_P#PNGQ__P!!_P#\DX/_ (BOK"@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH Y+XC_\ (N0?]?2_^@/6?\,NNI_]LO\ V>M#XC_\BY!_U]+_ .@/6?\
M#+KJ?_;+_P!GKW8?\BN7K^J/(E_O\?3]&=[1117A'KA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC[X'?\ENT/\ [>/_ $GDK[!H ^+?B%S\0/$7'']J7//_ &U:J,'-I%_NU?\
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MQ?\ Q-;M% &%_P (-X2_Z%?1?_!?%_\ $T?\(-X2_P"A7T7_ ,%\7_Q-;M%
M&%_P@WA+_H5]%_\ !?%_\31_P@WA+_H5]%_\%\7_ ,36[10!A?\ "#>$O^A7
MT7_P7Q?_ !-'_"#>$O\ H5]%_P#!?%_\36[10!\7^,H(;7QWKUO;1)##%J5P
MD<<:A511*P  '  ':OM =*^,O'/_ "4/Q%_V%+G_ -&M7V:.E !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!R7Q'_P"1<@_Z^E_] >L_X9==3_[9?^SUH?$?_D7(/^OI?_0'K/\ AEUU
M/_ME_P"SU[L/^17+U_5'D2_W^/I^C.]HHHKPCUPHHHH **** "BBB@ HHHH
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MEKX2KT8XKEK-A]E/7I0!VWP.'_%[M$/_ %\?^D\E?8-?'_P,Y^-FBD=A<?\
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MT20Q(,+'&H55'H .E/H **** "BBB@ HHHH **** "BBB@ HHHH ^2?V5/\
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M=L$*Z]_K7:_![CXL:.!_TW_]$24 ?4=?-G[2;;?&VFD=?L$?_HV2OI.OFO\
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M/_AK'P__ -"YJ7_?R/\ QKVW0=6CU_PWINL01M%%J%I%=)&Y^9!(@8 X[C-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<_=S6;=IB%@N.10!\V>.+,0ZN\RC'S8-8*L3&!Z5W?Q!M4#3X'>O/[=MT9%
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MB@#WW0[;SK4N>/?%=)IN8B-QX/K6;H<:QVB\'8P&[VK2G7[(_P ARK#*MVH
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M[TV5MR&-C_K8CR,]3E3@D8/M]EPS1W$$<T+AXY%#HPZ,",@T /HHHH ****
M"BBB@ HHHH **** "BBB@#Y)_94_Y*GJ7_8%E_\ 1\%?6U?)/[*G_)4]2_[
MLO\ Z/@KZVH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \RU;X#^&-8UF]U.YOM66:]N'N)%CFB"AG8L0,QDXR?6J
MG_#.WA+_ *".M?\ ?^+_ .-5ZQ10!Y/_ ,,[>$O^@CK7_?\ B_\ C5'_  SM
MX2_Z".M?]_XO_C5>L44 ?+WQ=^'6D^ ?[(_L>XO9OMWG>9]J=&QLV8QM5?[Y
M]>U>D_L[?\D]OO\ L*2?^BHJPOVE.GAK_MZ_]HUN_L[?\D]OO^PI)_Z*BH ]
M8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** .2^(__(N0?]?2_P#H#UG_  RZZG_VR_\ 9ZT/B/\ \BY!_P!?2_\ H#UG
M_#+KJ?\ VR_]GKW8?\BN7K^J/(E_O\?3]&=[1117A'KA1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?%?Q-
M4I\4-=(_Z"$Y_P#(AK[4KXO^)<>[XF:WD\?VA.3_ -_&H YBY_>210K_ !$"
MOHCP39"VT:VB( .P<5\\0IY^KVR#NZC]:^G_  U;;M+A0D%E08- $-[ 8)V(
M&&!Z>U-AG7;\WKUK7U&#?&V1^\48-<N\PAF*YXSTH W+<KYF0<CUK;LRHX/U
MS7-Z?<JRGH:U[:?YAWH Z))/DP#C-.\S(Z\=!5 3;@,_2I2V!GH/:@"61A@Y
MSCOCO5*64;R!T[TLUQE..E4I;@!B#TH M.ZNF2..U4;U@R$ <@<5&;X+)@'.
M.E122AT/.!UH \?^(<8\V<'TZ5Y;:G"O]:]+^)MR$DD&[)(KS6V3RX1[^M "
M389H\_WQ7TIX"B%OH-LR=T%?-DHQ@CJ#FOHOX=7\=WX9M64[BJ!6]C0!Z##+
MYH&0 :E(.,JV#6?%-LS@Y'8U/]IP,\\T 3"XW, PPQ&:D\\ <]JSI),N2#Q3
M&N/X6;!H M33?+CUIL9&TD\541S(2>W:GR3^7"V>N.M %75)=D;$?SZ5R<S^
M9<A6/7K6KJE\HC;GI7-PW):<OG!S0!N(J"$G/"BO*/B1J(EO1:* 3G+$5Z)+
M<3SP&.V7GNU>-^)R\GB6X1VR4('Z4 9R'"#U%1S#>A^G J60;"J^U1LPSCIZ
M4 ;_ ,.M433/$RB4L(YD*\?WNU>_0:P?LZEU)!'#"OFBQ/D7Z31]5&<5[_X#
MU===TD'R?F3AA[T ; UE"<(V".<5834E;')YZUYY\1[Z]\.RQ7%FFQ&;#>AI
M_ASQ2FL6<;[@LP'SH3R#0!Z2EZH^[^%64NE9>?QKEH+O=SUQ6O%.=I /;(H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/CF2_M_!_P"UA=7_ (E8K;1:W-*[N,^6DNXQL<]E$B'V XK[ M;NVOK2.ZLK
MB*XMY5W)+$X97'J"."*\L^,7P1M_B,T>K:1<QV&NPQ^66E!\JY09PKXY4@GA
M@#QP0>,>!2_ CXI64DEG!HDLD3G!,%]%Y<F>,\N/U H Z3]J#Q+H^M^+-*L=
M(N8KJ?3H)%NI82&569AA-P[C:21VW?6OIGP=97&F^!=!L;[<;JVTVWAFW==Z
MQ*&S^(->$_"[]FV]T[7+36_'<EN%M7$L6FPOYFYP<CS&'& >=HR#W.,@_1]
M!1110 4444 %%%% !1110 4444 %%%% 'R3^RI_R5/4O^P++_P"CX*^MJ^2?
MV5/^2IZE_P!@67_T?!7UM0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'A7[2G3PU_V]?\ M&MW]G;_
M ))[??\ 84D_]%15A?M*=/#7_;U_[1K=_9V_Y)[??]A23_T5%0!ZQ1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <E\1_
M^1<@_P"OI?\ T!ZS_AEUU/\ [9?^SUH?$?\ Y%R#_KZ7_P! >L_X9==3_P"V
M7_L]>[#_ )%<O7]4>1+_ '^/I^C.]HHHKPCUPHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OCGXIVXB^(6M
M.>K7DQ_\B&OL:OC_ .)J-<?$34XB"5^VSY/_ &T:@#A1*T-U%,HY0AA7U#X!
MO8]5T.WFC^\4 Q[U\UW\2Q!-HZ<5[=\"/,N-'N@Y8A90%YH [OQ%(MG"\S'R
MF4$D]B*\VE\0V5].3;S(S9PP!JG\<?$=S+K?]C6\K+%;?ZS8<$GTKRF%I%&8
MW8'U!Q0![KIT[AOEZ'I[UT%O=LN-QQ7C7A+Q,;24VU[*2K$;&8]/6O2;748Y
M%5@P(;H0: .VM;C>O7FIY)PL9.1BL2P==G#^YYJ6XG55)+4 27%V02"?EQ69
M<WY!_'BJ=U>A2?F)^O:N"\3>,C#))::<W[P'!<]J .YEU*.*7]]($YYR:T$:
M:YLFD@7"8Y-?.=W>7CW>^:XE<L<D[S_*OHOP>J7/@:,R$AG@SDGH<4 >%?$"
MX:?6VMP<D'+'-<V4)4!5/K5S5 3XDN@S%L2L 2<YYIS@#&%Z>E &<T3./>O4
M/@WK'D:K)I4[8212T9)Z'TKST<=#BKFFW,UC=K<VS;)$.Y<>U 'TW<++$NY$
M)7O@50.LV\,HBN)XXG)P%=L$U-X.U*;7_#$%VNTN5^8$]Z\S^-FGWEC-8W@+
M(K9&Y>,'WH ].$RR*2K9Y]:/O9VD' KQ_P *?$>2W\N#6,E<8$@_K7J^EZE;
M:A LD#AU/(QTH NQX2/I^M4;Z\\M3\W6M.9"(<JV1GTKC_$FHQ6-NSR$  $D
MYH R]7U*-87:>540=2QQ7*:?XB;5/$EOIVG1&5'?#,HKF-;\02ZM*R+E;?/
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M<DC% 'RZL?EKMY*>H'2I[:^N;"836TI4KR!ZU9*JT9X')[52FCV2%2<@\C%
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M>)MNU"J\]2:^?$DDN;QY9SEW)9C[UZ%\7]8GN+^VL5.(L;RH[FN!@39&,]:
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M^&6J:*B+Y(TF6V1<8  B*C'IC KP#]DV^D3Q)XAL!GRIK2.8\]&1R!Q_P,T
M?4-%<EXK^*7@[P1JL>F^)]8^PW<L(G2/[+-)E"S*#E$(ZJW&<\5A_P##0?PQ
M_P"AF_\ )"Y_^-T >)?LJ?\ )4]2_P"P++_Z/@KZVKY)_94_Y*GJ7_8%E_\
M1\%?6U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 >%?M*=/#7_ &]?^T:W?V=O^2>WW_84D_\ 1458
M7[2G3PU_V]?^T:W?V=O^2>WW_84D_P#145 'K%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!R7Q'_P"1<@_Z^E_] >L_
MX9==3_[9?^SUH?$?_D7(/^OI?_0'K/\ AEUU/_ME_P"SU[L/^17+U_5'D2_W
M^/I^C.]HHHKPCUPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!"OHW_ (+XO_B: /C9^!Q3#QQGK7V8? _A,C!\,:-_X+XO_B:/^$&\)?\
M0KZ+_P""^+_XF@#XWMV^;CG%7;1<ZE:D$ ^:N3^-?78\#^$U^[X8T8?33XO_
M (FG#P5X6# CPUHX(.0181<'_OF@#S+R':!%P2I4$@5YGXYT&2PUN:\C1A!<
M'( 'W:^J4TK3XQA+"V4>T*C^E17.@:/>)LN])L9U_NRVR,/U% 'Q2P*W2<\Y
M%>YZ3)%_9-OF10Y&=I/;%>K'P/X3)!/AC1LCH?[/B_\ B:MCPYHBL&71M/!
MP"+5./TH ^0O'EY]JU]T!^X<<5C6Z=&Z8K[,E\$^%)Y#)/X9T>1SU9["(D_C
MMH'@CPH!@>&-& ]M/B_^)H ^/U^]SC/;WK:\*Z8=4\26L<89EC.]N/2OJ?\
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M!_\ %T#X,^/?^@!_Y.0?_%U]5T4 ?+(^#GCQ>FA8[?\ 'W!_\77OOPTT:_\
M#_P[TS3-7@^SWD'F^9%O5]NZ5V'*D@\$=ZZFB@ HHHH **** "BBB@ HHHH
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MWQV. 0<'!'N: .J\2ZK#%\/-6U4,ODKI<UP&/(QY18=.M?//[)MI(_BGQ!>
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MU_[1K=_9V_Y)[??]A23_ -%14 >L4444 %%%% !1110 4444 %%%% !1110
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M Y[\5-7@RM=V/75[:A1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%?#/Q,Y^(WB+_L+77_HUJ /N:BO@KPR,WHQ5C7F
M)NAGU- 'W;17PC9C_1N.3FK5N<22$_C0!]R45\16%O-=WT<<*;G8_*!75P:#
MK%CI\LPB0@Y.T]10!]945\0%F$C;UY+'/M3=0.0F>!Q0!]PT5\):GR$^E0:5
M_P ?G':@#[THKX%\2Y^V^V*AT8G[02>O% 'Z 45\+7;$W;YQT_I7,O\ Z]O]
MZ@#]#Z*^&=,_Y!THZ';6)$<7!_WJ /T!HKX8G(\F//3-6BP-F,#'I0!]NT5\
M7:+9/>WZ1(VW=W]*W-7\(7-A:B6*4ONZKB@#ZUHKX@ :*XVL,$'&#5:Z :8^
MM 'W117P9J+?O!V^6K.@L=N,^M 'W517Y^:N!]ND!]:M:;S;<],4 ??-%?".
MJC.G1_[M<Y%_KX_4,* /T1HKX:U/G34/^S63:$^9']: /ONBOAVZ'^DPD]15
MF8 HF1WH ^V:*^5_#/AV"XMF-\"1( 1@D5#XD\,P6:G^SRRC&2&.: /JZBOA
MY3\I#=C50$Y<=LT ?=E%?G_,6#_C6]J/SZ!&3_=H ^XJ*_._N".QJ[J(RL1)
MYVT ?H'17RQ\)R7^*7@YO]FX'_DM+7U/0!Y^OQT^'3L57Q%DKU_T&X_^-TP_
M'GX;*V#XCP?^O&Y_^-U\@VF#=2Y]35.7FX/- 'VK%\9? 4\!FBU[=&.2?L<X
M_P#9*@/QQ^'8?:?$//I]BN/_ (W7R[I( T.7/7;6(Y'VIL?WJ /L$_&KP !D
MZ_\ ^25Q_P#&Z<?C-X""Y.O<?]><_P#\17R9*?D'TZU88_Z.O]* /JY?C#X%
M="ZZYE1U/V2?_P"(H/QA\"A0QUW@_P#3I/\ _$5X'X+T:+48&:YB+1E@%/K5
M_P 9>%4MK9);&/&SE@!U% 'M@^,?@1AQKN?^W.?_ .(IH^,_@(L5&O<C_ISG
M_P#B*^68/E)'O4,7,\G/0&@#ZF?XX_#M#\WB''_;E<?_ !NID^,_@&2$RIKV
M4')/V.?_ .(KX[N#\S=^:U[8_P#$G?\ W>: /J+_ (7W\-<X_P"$DY_Z\;G_
M .-U93XU> )(C(FOY0#)/V.?_P"(KXI(_>&NFM!_Q+'Q_=% 'U9+\<?AW"H:
M3Q#M!Z?Z%<?_ !NDA^.GPZN'VP^(MS>GV&X'_M.OD+5#BWCYSS46D+_I1QUQ
M0!]CW'QK^']KCS]?V[NG^A7!_E'1%\:_A_/GRM?SCK_H5P/_ &G7R9KWWHO3
M'6DTH9WGTH ^M4^-'@%W*IKV6';['/\ _$4X_&3P&&(.N\C_ *<Y_P#XBOE&
MTV_:6R?6I2NZX)R<9Z4 ?5K_ !=\#HL;-K>!(,K_ *)/S_XY4<GQE\!Q-B37
ML'_KSG_^(KP31O#LU_-9-.O[C&>>IK>\4>$;)]-<VL&V=?NE>YH ]<_X7/X!
M";O[>^7U^QS_ /Q%-_X75X V%O[?^5>I^Q7'_P ;KY7N()((VBE4JP."#VJH
M6Q;R@],T ?6"?'#X>22!$\0Y8]!]BN/_ (W3[CXT^ +5 T^O;5/0_8K@_P H
MZ^0+7C4$YS6AKIQ9QX]* /JB/X[?#B9ML?B+<>O_ !XW'_QNK ^-'@!E8C7^
M%&3_ *'/_P#$5\9Z?Q=@GT-;\0_=SD_W* /J1_CQ\-T8J_B/!'7_ $&Y_P#C
M=6(/C5\/[J(R0:_N0=3]CN!_-*^+KO'VF3ZUT&@\Z4^10!]6GXX_#L,0?$/(
M_P"G*X_^-U*/C1X!,/FC7OD]?L<__P 17QVW%P^..:UXN=)/MTH ^L%^,G@-
MUW+KN1C/_'G/_P#$4L?QB\"3.$CUW+'H/LD__P 17RQ;I_H8(/5:O:!I<NIZ
ME%%$VWU;TH ^FF^+_@920=;Y'7_1)_\ XBF#XR^ FZ:]G_MSG_\ B*\&U;P3
M<64$ERMQNV@G!'6N*CW))@^^: /JP_&CP"K;3KW.,_\ 'G/_ /$5&_QO^'D9
MP_B#!_Z\KC_XW7RK,V+A3[51O"OF^O% 'U[%\9O 4\)EBU[<B]3]CG'_ +)5
M5OCQ\-U8@^(^1U_T&Y_^-U\OZ4V[29LCBN6N#^_?/K0!]F'XZ?#H0^:?$7R>
MOV&X_P#C=2I\:? $E@]ZFOYMT.&?['/Q^&S-?')_Y!*_6M6QP_@B[7'(?- '
MU3%\>/AO-*(X_$>YVZ#[#<C_ -IUO>'?B'X7\5ZI)IV@:G]KNXH3,\?V>5,(
M"%)RR@=6'&<\U\+Z:?\ B919]:]X_9Y_Y*AJ(_ZA,G_HZ&@#Z5KS'XD?&/\
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M>"?#L5],UU?Q[HP?D!Z&KGBGPO$MT]Q9)CIE* .W_P"&COWFW_A%N_7^T?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.>M.U)L,GIMJ+2#F\SZ4@&>),"]Y]!4.C<SD?2IO$O\ R$/?:*AT88G(' H
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M'&3QP#7M%PX="&)VUYWXLP\,B'G'0XH \VE.+A<?W:H7F2W7MSBK]RI%WTX
M-9-VQ64D'F@#<T4YTF;G\*YJX_U[\=ZZ/0_^07/FN=N!_I#XZ9H LCYM*Y]:
MU=*&[PI?*>V3Q]*RT!_LL^F:U-$)/AZ_7'\#?RH YW3_ /D(1?6O>OV>,?\
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M+=+MR6W<8H ]5\/VT=OIT:#J>2?4UU/!MMI&1CO6!H=HS0HK#)P,UUBVRK$
M/QS0!PNOVR26TR,O7D<=*\MN21$PZD'%>]ZKIL4]NX5<''45Y%X@\//:R2-"
M#L)R1Z4 <LW^IE ]*S[9B;Z('UJ_)\L,H!YQS6=:M_IT6..: -W7/^0<#Z5S
MM@-]]&"<9;K70:\<:>/7-<[8X-W&#ZT =2+?RFDVR*_R'I7+WQQ=-[5T<'64
M#_GF:YN__P"/IJ -?PV1Y<N:KW/-Y)5CPY_Q[RYJI<C-V_- &EIY_P!"D]ZV
M-#B\](X3T9L?2L/3WQ:25N>'YS;3VY897?R* /7='TY+2WC1!@(M2:E9+*K'
M!SC-6]%/VF-2O-:TVG@J0W6@#PGQ5;+!?+(JX.<$ =ZYJY;$B?6O6O&/A>6Z
MA8P)N;J,5Y5J%C<VDB"X@:,[NN* ,J_<C;@\U>\-M^\D/?%9]]]X5>\-',LN
M!VH R]5Q]ND^M%GQ;S>N*=JV?M[D^M%F/]'F^E &IX4/[Z[XS^[KZK^!(Q\%
MM#_WKG_TIEKY9\%X:_N=W3R37U1\#!M^#.B#_:N?_2F6@#T"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XN+XN^!YO%A\,
MQZWNU<7;69MOLD_^N#%2N[9MZ@C.<>]=I7C%K^SY]F^++>-O^$FW9U9]2^Q?
M8,?>D+[-_F>^,[?PH F\5ZM\%M"^*4VJ>*)O(\66DD,LDNR\;8PC3RSA 8S\
MFSM]><UL?\-!_#'_ *&;_P D+G_XW7-_$']G3_A._'>H>)/^$H^P?;?*_P!'
M_L_S=FR)8_O>:N<[,]!UKFO^&1O^IV_\I/\ ]NH ])_X:#^&/_0S?^2%S_\
M&Z] TW4+75]*M-2T^7SK2\A2>"3:5WHZAE." 1D$<$9KYV_X9&_ZG;_RD_\
MVZOH#PYI'_"/^%=*T;S_ +1_9UE#:>=LV>9Y:!-VW)QG&<9- &E1110 4444
M %%%% !1110 4444 %%%% 'R3^RI_P E3U+_ + LO_H^"OK:ODG]E3_DJ>I?
M]@67_P!'P5];4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!X5^TIT\-?\ ;U_[1K=_9V_Y)[??]A23
M_P!%15A?M*=/#7_;U_[1K=_9V_Y)[??]A23_ -%14 >L4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ')?$?_ )%R#_KZ
M7_T!ZS_AEUU/_ME_[/6A\1_^1<@_Z^E_] >L_P"&774_^V7_ +/7NP_Y%<O7
M]4>1+_?X^GZ,[VBBBO"/7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^*?'<$C?$3Q(>W]K76/^_S5]K5\
M3>.I'_X6-XE /']K77_HYJ ,O1U*ZP58X( J#62&OB.OS'I3[,.ET9HVY/'(
MIMU"?M'FR'DGTH 6Q1A",CG-;>GVYC$MVSHC1C<JMWK)L9S$X? (SSFKU[=;
M[?<HPN.*]O(\O^OXR--[+5^B_P S:C!2E=[+485OM6NV2SC>5B2254D"K<GA
M?7((!-]GE;C)41G-=E\--,A2W>Z#$R,QXSZBN]>4Y,;?=QBOM,XXHIY37C04
M--$?G.:<5XJEC)0I+1'@JW,ZG9*SJXZJQ.14MVTEY;E\YD'7Z5M>/O#ZZ/J'
MVNVRT<Q Y.>>35#187N8;AHEW-'$7QCTQ75G5/#8W*I8E*]E=/LS[W+LQIYG
M@_:K>Q@ZA$9"N#@A>E0:8ACOP#QBK-W)NN"3QFHTMU\EILD,/>OR8LK^)!NO
MQW.T4S28&CD)?C-$B"9Q([9_&K=F09.H/- %JZ7%TV/[HZUCF$?,/5LUM78!
MNGYS\HJI;QHZL6'(/>@!+)9'/E"1@IZU:C1( 57H#U]:L62H6Q@4LL:)N.W-
M "P7 B._&[VK8T.UDENDN6B#!FPB8ZFN?B822*N,*3S7K&@)9Z3I\>J7L3/;
MV>'P@R350A*<E"*NV-)MV18O+QO".EQ7UZJQ7,H/D0\_,1UR1TKR:_U66_U"
M9UW$RN7* D@5J>-]<77O$MW=69D$,[@Q))_#P!T[5WOP^\'0P0QR,JF[E3>#
M)RN"*_1:<L%PMECQV+^)K7_+Y?F<69YD\M4:5*/-4GHEY]CS2+3M4-OYXML0
M]<[OZ4D%PEQ"5#;2N><=:]C\7/+H-GOL8X3'D"?<N><]J\Y\3Z58QJFMZ.'2
MSN#Y>R0_-O YX]*\3)^*L'Q;*>#K47"^L6G?;OIH]=-^IZ=.CF=&A3K9E&*I
MU'96>JE:]G\CB[S_ %YW<'TJ>VM%^SAU)!/I27*YN&++DU?MV5+0*>".U?*2
M5FT8&*T(%PS_ ,72K$*8W-WQTJP40R$D8INWYFP.,<4@"_0O#"N<?+6:;5\X
MR*U;DXBAS_=JF6VKNZT /T^'9,?FR:O.KB0],50L)2;@\<5HR-OB)_E0 ^V0
MS7<<8.=QKUKP3X;^U:K;1RC9:I'O;'\1]*\DTJ0IJ,!4<[L5[UX/G\FTA'\3
M&@#F/BOK$>EQQ:;I%S%LF#"YC0Y9"",9]*\GB%WJM]':6Q=Y'. 3EL5M?$3/
M_"::KC_GM_04?#QH$UW?*X$FX;<CI7['EM"&7Y4JE-7?+S;:MM7_ . 89OC9
MX#!.5):VN:,GPUU%++SDOH#($R4P<Y]*Y&[$D E@N5*RQ-M.1C-?1OFZ>FDS
M%U7[05RIQR37B'C@6Q\20B$*0\9,F/6OALAX@QO$ZQ6"Q5#EY4^5M:7_ ,SY
MO)<TQ4\1##UZJJ*HKZ?9?F<;Y;AL\=:VH(=\(DXR5[5F!<MA?NYZUHP7!BAV
M**^5V/JRK+$X?I5>[7.!WQ3YKYA(<BJMS>*S#"D4 >G_  .^;XAZ)D'*S3_^
MDTM?55?*OP(;=\0M*Z_ZV8_^2\E?55 'P#;J%N& [YJ.>$;<J/FJ6$8F;/&<
M]:E"XD //O0!=L[D)HTD;#YF7&*I0P@HS-D'=P#6D4580Q].F*I3.[-@#Y<T
M :=M"LJ@9&X\8KU[P-X>*V$<WE1 MSR#FO'-+#M?Q!/[RY_.OI+PY)%)9P(B
M8"H,T :4%M:):%9(E$XZ$?=I9[.WN;)(XX5\T,=[=B*T$L/.(95XJXEL( 05
M% 'EGB;P[/';2SP[0!V4&O(M9LUM+N0?*K \K7T_?M%);RQNG#+BOG'Q_:FV
M\22 \!AF@#C9(A)&X4<X[=ZFCNQ!IKQ.C;RN,40(ZS*3SS278#S9!'2@#(MH
M S,SJ>O0UOPKBQE';:*H")CP.E:,?R64I;I@9H H7*AHU##C'0U!8E;>]9BI
MVX[5:F*RJ-IZ5#'%N;!P!0!-J<GVR:,JC!!U-.M5"*0@ZGFI[F(K:HB\CN:7
M24#WB1G&6<#% 'I/@/PZT\(D4JJ2<G>#7IMMIODPJ-\6?I5'PW:*EC"BKM5%
M&>.M;R<R!4 )S0!)'ID5QM9$5?+&'(_B-<[XKL?LMC)<PH (^< =J[O3SY 9
M'48;G&.]5-8MH[O3+F$8Q(A&* /GKQ/ 0J3JR@.,\5QE[&BIE6#>M>J>,M*"
MZ>T4<>!&F%/TKR::,L-M $#*PN(ID4D*.<"C5+EKJW2(1LN.N:T[6V8 #VJ"
M\MV60 $&@"A9P)$P*KSBM*/FWG[<"J\43(P8^E65_P!1/WX% &#/&'D<$<]J
MO:3="WLI(G'S'I3)+=BQ(QR<]:([8K(I<]Z $CM2TC22*<'L16M:6Z2QI%D*
MIHF0^6"H[5J>$+,7NO6T,B[EW9(H Z3PYX;G%Q&ZHAXX)4\5ZOH.G+;^6;N)
M'C!^<#/-7])TN&"W79&H<@ _2MA[>*.$G8* ,.6"W%P1L4QDG SR!7(>)-%>
M=7,4<8&.P-=O)&PE0K$6&<8 IL5YINI/<16DJ2O:OMG4#E&]#5*+:;2V ^<]
M=TMK34<R!4'3IBN3O(5:9AG//!%>X_$K2(9E=XUV\9X]:\3GC;SFX[]ZD"72
M+E8+.>)E.3TJC%:^?)(TJE><@$5K:=;F1#T!!I;J)ED- %.2-5M0JC ]*M:*
M,6-XB=#$Y/Y5#*N(.>N:GT;(6X7N8G_E0!S,:^5?)UVAAS7NO[.<BR?$[4"O
M/_$IDY_[;0UXFR/NV[>_6O9_V:6_XN+?)CII,G/_ &VAH ^GJ^9?VC_^2D6?
M_8'C_P#1TU?35?,_[1L>_P")%D!U.D1_^CIJ /%9(-_,8&<ULO<9T<VRH0WZ
M57BM7$@&0>:T);;RXR<YS0!C00[2-_W@<XKI-*M5NHI&4!M@R<]JPG1Q-_LC
MK76>!XWDOI@$W1,H#9H ]/\ !OA^5=%BNI5BVR#(KK!I2O -B8D!^8YXHTVX
MB32(;2!<!!@<5U%E;*;=6)SN% '-RZ:/(B\E")%!WECP3[5BZCIDUU92_)&Q
M P,UZ%<V:_9RP XKGKJWD0-@ +CD4 ?.'B*W%IJEPN KC[P%<K+"'5C&OS>M
M>K_$/P[)*YOX(B".'P.M>91P.)N: %%XB:6\# [R,5DV]MU:0<YX%:4R$R$#
M&:8L;DC*T 7X@!I\F/\ 9JC>(KJJL.*T5R+&0'U%4[F(N%*GI0!4TQTM+TO(
M#LQQBKFH,+VXB,>=@ZFH8X#NP2 :OO\ N[=5"Y]Q0!5MXU3>J\\\YKLO">DO
M),'C57W\@D]*X^ $,=PQFO6/AY$D]DC(/N'!H [:PT>2"%  %X!/-:%YII,4
M9@EDSC]X#Z^U;-HJR*I*] ,U;Q&6 *@GTQUH X>XMI8Y#Y3L8\?Q&L#7;(S6
M9;R@2,@\UZ1JED5@D>./D<XKE;U4>/[ON0: / =5M_L\LP(&"3P.U8<:".[C
M?^$&NW\;VL<=T[1#&]SQ^5<G;1OYP^7/UH FUF^CGL_+3);/'%4;&T1'1SRU
M6+V0HPS$"?:FPW"[QE2H'M0!IP\";_<K!NX0\S<X-;5O,DL<^WLG>LV:-C(3
MC(- $^@.B03!NU0;/-O)2#@9]*;'&ZN!C:,UJ2*B1C:,''84 ,L[?Y/+4\L:
M[OPEHMLUHLTX+SJ>/05P]KNR,9SGBO=_AWHRKX?BENTS(QSR.: -SP_!'''"
ML8VE@,L1TK9N+9OMGV<2*Q+!0V..:UH+2%H5;RU&!@ "K#:>DD.0N#ZT <-J
MD;VEQ)$S*Y0D9Q7G_BU;2YL3YD85U.00*]JU#2XA!ED!..IKSGQ)H4=S;.BC
M&<\B@#Y[U2#_ $A@O'/'TJ?PV-ES(.^TU=\2Z3)I>HE&8N&&0:QX%=9MR;@>
M^* (;V,SZC(B]<U9@M?)M7R<EOTJ:?[/$VX *Y')-(LT;0/AP: +GA!/)U*X
MW<J86''TKZH^"'_)'=%QTW7/_I3+7RUX3<?VM)CG]TW\J^J?@NNWX1Z./]JX
M_P#2B2@#NJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KY*\9?'[Q]HWCO7M,L-1MDM;+4KBWA5K.-B$25E49(YX KZUKE!X
MX\#S^(FT4:OICZJ;@VYMN#(90V"N,=<@B@#Y;_X:/^(__03M?_ */_"C_AH_
MXC_]!.U_\ H_\*^H=7\=> ] U6;3=9UC2[.]@V^9!+@,F5##(QW!!_&J7_"T
MOAG_ -#'HWYC_"@#YK_X:/\ B/\ ]!.U_P# */\ PKZU\&ZE<ZSX$T'4[]@]
MU>Z;;W$S*H4%WB5F.!TY)KGO^%I?#/\ Z&/1OS'^%=I8W5M?:=;7>GR)+:7$
M2RP21_==& *D>Q!% $]%%% !1110 4444 %%%% !1110 4444 ?)/[*G_)4]
M2_[ LO\ Z/@KZVKY)_94_P"2IZE_V!9?_1\%?6U !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%?M*
M=/#7_;U_[1K=_9V_Y)[??]A23_T5%6%^TIT\-?\ ;U_[1K=_9V_Y)[??]A23
M_P!%14 >L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% ')?$?_D7(/^OI?_0'K/\ AEUU/_ME_P"SUH?$?_D7(/\ KZ7_
M - >L_X9==3_ .V7_L]>[#_D5R]?U1Y$O]_CZ?HSO:***\(]<**** *.M:DF
MD:/<7K\F-?D7^\QX _.N;^'UF\D%WJ]UEY[F0J';N!R3^)/Z5%\2KHK965J.
MDDC2-_P$ #_T(UT?AJW%KX9T^,#;^X5R/=OF/ZFO3M[+ \RWF_P7_!."_M,7
M;I%?BSG?$\/B'5M<6QLXYX+#(42+D*W'+,1V]O:L/6=$OO!KV]U9ZDS>8Q&Y
M%V$$=B,G(KU(UY1KT>M?;+>X\513FV+$+Y;)P.X&. ?KR<5UY?7E4:IZ**6J
MZR.;&4HP3GJV^O8])T2_;5-%M;QU"O*F6 Z9Z'^57JHZ+/97.CVSZ7Q:[-J+
MW7'&#[U>KQ:J2J225M=CU:>L%=W*]SJ%E9,HO+N"W+#*B655S],FB?4+*U56
MNKN"%7Y4R2A0WTR:X3XE_P#']8_]<V_F*=:^"EU'P_\ VE?WL[7<L/FIR"H&
M,J#D9/&/2O0C@Z/L85:D[<WD<4L34]K*G"-['?)-'+$)8Y$>,C(=6!!'UJ&#
M4K&YF,5M>6\T@ZI'*K$?@#7E7AJUO-6NVTB*[D@M)?WLZJ>H7V]>0/RZXJ?Q
M7X?C\-WUJUC/,5D!96<C<K*?48]16W]FTU5]BZGO/;3\S/Z]-T_:J&G74]7J
MK%J=A/<?9X+VWDFY'EI*I;CKP#FFZ1=/>Z+9W,O,DL",YQCDCFO*(K6XOO%4
MMI:2F*2>=T+@XPN3N_3/%<V%P:K.:G*W*;U\2Z2@XJ_,>LC5-/-Q]G%];&;.
M/+$R[L_3.:M5Y[KO@*WT_1I;NQN9GD@7>ZRXPP[XP!CU[UJ^ =9FU'39K6Z<
MR26I7:[=2AZ#\,']*53"T_8^VHRNEOI8*>(G[7V56-F]CFF_Y*=_V_?UKTRY
MO+:R0/>7$-NK' :5PH)].:\MO+F*R^(<MS<-MBBO"S$#. #4I>[\=^)PA?R8
M$!(4G_5Q@\G'<GC_ /4*]/$87VW)*3M%1U9PT<1[+FC%7DY:(],M[NUOHF:U
MGAN(\[6,3AQGTXKAM"N#X:\;7.CR,1:W$F(P3PI/*'\0<?7'I7<6-C;Z;91V
MMI&$BC& !W]S[UP7Q$C:VURRO(B5=HN&'8JV0?U%<&!4:E2=!?#)?ELSKQ;E
M"$:O6+_X<]%HJ*VF%Q:13+TD0,/Q&:EKS&K.S/03NKA1112 **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KXC\=
MY_X61XF_["]U_P"CFK[<KXE\<(6^)'B7'_07NO\ T<U &?I[A5^Z#[T7*$YW
M#*FDM5*2%3SBK$[#81TXH FT#2?[3U*. <)G+?2KOBC1I=,N'3R62!C^Z8CA
MOI57P]<M;:M"4SR<'%=KXHTZ^UC3[+[#;2W14L"(UW8KZ3AG%?5\PC>UI)IW
MZ=?T-Z#]YQ?5'/>#_$1TS*;]K#(QFO2+3Q!97EJLERZQ<<NS5XE=V<\$[H 8
MI$8JPZ$'N*>UY>&U$"RRCWW<5^AYED>%S./[Q)IGP^:\+NO6YH=7N=7\0/$<
M.H3I:V+B18R&RISZU)\-X?-U*[23H;9LY^HKFM)T2_U:=DL;:2[F5<L(UW$#
MUKT[1_!.H>%KAYII4E,]OMV(I!4G!P:\_.)X/ 97+!1DD[62ZL^IRS+*>687
MV=];'F>M6J6^K3QK@KNXJC<CR[3;@<]Q717^B7UU=SOY>UU<Y4]ZP+]&BB:.
M12KCJ#VK\H.@R#&IZU);_NYEV>M,&._X5)!S,@/'(H U+D9N2W'052N&*L O
M''-7+I3]K89XP*HS'=+Z8XH L:?D2DYXJ]*<QMBJ.G_?/%796 C8=\T 58E/
MFJ.^ZO9+?2[G5O!CV%F 9Y8U"[C@&O'[2%Y;R*.(;F+# '>OH#PI%)9QPI/&
MWW1GC@5I2J2HU(U([II_<.,G%IH\)UW3Y]#UE[6\ $MNV'VG..,U[#X3UB*Z
MTVWGBF&Z.,(<]>E8?Q(\!:M/KKZI8P/>QWSDB.%"3%@ ?-7F:&_T>XD2V<PR
M*Q#*PZ'O7Z=C\OPO%.51H5)ZM*]NCZZ>IYF=Y36Q[AB</*TXZKU/=_$=NFM:
M,UM:*#(SJS[N <'G]*X#XE2V5K%;Z7I8\N"-@_E^A(Y-8=OX_P#$-M;B+SU.
M!@'RQ_A6'/<W6I7K7-\^^0]\8KY[A?@.60XUXF5;FBD[+UMO]V@8>IGN,5+"
MXZWLZ;YM+W;M9-W[(COAMO7"]@*=G$(// JU)ITNIW4TUFA;;'N*CJ .]5C_
M *CD=N17S&+P]7#5G3K1L]SU9PE!VD9RS%9BS9()JZC^9#D=*SB?F/&*GBN4
MCA"OG/>N4@N78^6$=MM4IR!&<9JY.X>.$CIMK.?EV^M $NFC-P1VK8>!WC;8
MC$ =A5_X=>'/[>UTK+_J8>6'K7HOBV#2?#FCS0BW59'0X.WB@#RW0[9I]2A*
MC*JW.*]U\)A-L2X^93TKS7X;Z4]W<-<.H%NIZFO9-*TJ.&=)H,8/6@#RWXI>
M!;ZTU"?7(-US:W+&25E0X@Z  GWKS2UFNM+O!<6;%6!R<#K7VHVEVE]IQM[R
M%)X7 WQN,JWU%<?XJ^$>@>(4M_)C72O()R;2)1OSZ\5][E7%$*5&.'Q<;I:7
M\NEU^!K45'$T_9UT>!Q?$B\6#9<6LDC]-V:YVZO9M6U'[5,I7 . >PKV'2_@
M4LJW1UJ[FM2LQ6WV;6\R/^\>.M;%C\#=+M+@3->372 8\MU !_(5Z;SK)<%S
M_5X^\^RW=N^QP8/*,OP-;VU):GSLGWP,]35H@XXXKU_Q)\'_ "FD.EA0P&54
MUY9=V$]E?26=PNV:,[6'O7Y@]6=1@W*Y8]AFJ<O;]#6E<V\@<G&>:H2HV_I2
M ]5^ ;;OB)IPS]TRG'_;"2OJROD_]GSGXE6H/!7S/_1+U]84 ?  &93D]ZG3
MEN:A'$Y&.0:G488?6@#51-T('6JT\?EMQW_2K<(S$*OVGAK5=9D1+"T>16/W
M\<"@!WA"R-UJ#MC(0#^=>[^'X6BMUQ@#%87@WX:W&G6?^F@"5OO8%>DV&B1V
MRA",X% %BRBD>)6#8J>2!GC(W<U<@@54^7C;4HC4Y Y!H XR_5TD=221ZUXE
M\3[3_38KD=,[#7T=?Z-%<*YV\L.M>5^.O!\FH6LB1@G:,K@=#0!X5&@S_*J%
MV,W!K=N-+N]/<K=0/&<X!88%85XI^T'/% #(Y=F:O)(7T^?CTK/ S5ZWP=,G
M ZY&#0!4%2*"6&#3[:UEN;A(;>-I)'. JC))KTKP_P#!R^O[03:E.;9F'$8'
M(^M 'G]QE[<*/2MKP'HO]H:F96QMB=>OK7L6A_!O3H(B;IC<-ZM70Z?\/--T
M,,;2)4+'<?K0 [2;/;"$3GM706.BQE@[G#9[5%91+&NT)^-;=M"-H.2* (Y]
M/\NW+1-SC))KGWDV%@V?\:[)DS&5![5R>M1&W5I I(R<@"@#S3XBW7V*PD(&
M0ZX^E>'2,"W6O5/B;?2/IV"&V,W&>U>4 \]* +D09<?,2:K3SNMU@G(]*LH2
M5%4IA_I8STH M#G^E/&1;3$=@,U'T7-#MFSGQD=.: *+3;F]!FFB4F50WK3.
MP.:5>9ESQS0!L.Y\CCI6GX1O/LGB2T;&07 -9LB9CSC@"K?AY)#K5M)&A<)(
M"<=J /I>QN@Z1E002!6C=[GC55Y.<U@Z PN!&RY8E?2NUMK E0S@4 9&H69O
MM'GM2[P-+'M\V(X9/<>]<?I/A=?"OVE;:\GNFNF#R/.1DD5Z9):AOO$#TQWK
M(U*QW_PYK:->I&E*DG[KW7H4I-+EZ'G'B*17MI1<("0#BO KIBU[-_OGC\:^
MCO%FF,;!RB'..PKY]U/3+JUNYFEMY$7>>2O%8DD$!:%<@X)]*JW<S^9]XYJT
MG,>?2J=WGS/PH J332%>6S6CH$FZ[96YS&W\JRY?N&M+PSEM71<<,K#]* ,]
MB=S8]:]?_9H_Y*3J'_8(D_\ 1T->1.,,V?[QKUW]FG'_  LK4/\ L$2?^CH:
M /J"OFK]HE@OQ)L<G'_$IC_]'35]*U\R?M(9_P"%E6&/^@1'_P"CIJ /+1<?
MO!CKFKKYDCPQXQTK+CYD7ZUIDA4S0!3D78Y4_A7I_P -[:W.E.[1!G8X+5YA
M*V^3<1QVKU;X>0M;:&C,C,96R !0!ZEI=F=J$* *["RC5(L$?A6-I-LWV5&=
M<''2MZ%4*C/6@"=H4>'D?2L2^M "V.:WO-7;@U4N8T<XZDB@#S3Q+:![:>,X
M^9"!]:^>[A/*OI48897(KZF\0:$]W$3%\A[&O$?%GP\U2UD:[LX?-W.2P7K0
M!YA.<3-30SCHQJ:^M9[:Z9+F)XG'4.,5 /<T :$$C?V;)NYRXJM+(6;'058A
MVG2VZY\RJTN QQ0 L;?O!6FR;K<;N.*RXAF0>]:HR8@.G% %/D,<&O4_A7\U
MFR+UW]*\P6)I)-J#+'TKV;X>^'=2TW3T?R@IE.XD]A0!Z?8Q;8QGJ>HJTT9\
MQ6'%3V=GB!<C+8YS5LPH,9' ]: *KP^8H$@RIZCUKCM;TY4EEV)M7M7>-(@
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\8>-4"_$3Q(VT
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MK0!Z5I<XDMER><5:F8;:R])C46ZGS,'%67;9D[]WXT 5;N41GYL8[5-!/'Y
M&X8/:LS4I!(<%N0.M<Y>:\T+I:QC=,> PZ4 =)?CS9B1SQWKQ3XD>#+A-6&J
M:3'Y@E'[U/0^M=W-XR@L+A+;5=T+MT?'RU-<:A;R1B0LLL1/W@<CZT ?--T[
MQ3M'-$4<'!!JI<QA2&QUKI?B')"WC&9;4*%&,[:YZZQM4T =[^S]G_A:%MZ8
ME_\ 13U]85\H? (@?%2S [I+G_OT]?5] 'P%G-QGWJRO+ "H5BWR_*1P:M)Y
M<3 L<^PH ]#^'OA#_A(+T37/%I"1O_VCZ5[OH^D6MA:QP6\:I'&,+Q7GGPH
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M#/%86FW0,R%1VY-;33KOXY'>@!2%(P!S5.X4,<'BIWD^;* \U4N9L'YEYQ0
M@TZ"X7#J&'?-8>M^%M.O(=D]O'(I/ Q6W:7@.]1Q@=*K75T'48(R#0!X_P"-
M/AC;"P>XT. 1SQ_,R#HPKQ;4+.2.0AAR."/2OKN=(Y8CNP=W4>M?.GQ!T>+2
M/%=Q;Q<1R?O$'H#0!YZ\+M$3CCI5[PTA_MJ$=N1^E.F14@(4<9J7P^-NM6VW
MKNH S7B)F<=/F/X5Z[^S:@7XC7^.O]DR?^CH:\IN04N)0/[QKU/]FIRWQ*U#
M/_0)D_\ 1T- 'T_7S+^T>,_$BQ/_ %"8_P#T=-7TU7S1^T:N?B+9'_J$Q_\
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M%!E>%SS]SID<MVYJE+\'C:?&R/X?7^M&!9UW6^I"TW"3,1<?N]XQR&7[QY%
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M\%?6U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI^S4;G!7P,:T^=NQXI_8.K_] J]_\!W_ ,*/[!U?_H%7O_@._P#A7M=%=/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*)*^0+([;R/V(_G7U]\)F+?#'2V/4M<?^CY* .RHHHH **** "BBB@ HHHH
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M_L"R_P#H^"OK:ODG]E3_ )*GJ7_8%E_]'P5];4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X5^TIT
M\-?]O7_M&MW]G;_DGM]_V%)/_14587[2G3PU_P!O7_M&MW]G;_DGM]_V%)/_
M $5%0!ZQ1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %>2>-_^1QO?^V?_HM:];KR3QO_ ,CC
M>_\ ;/\ ]%K7LY/_ +P_3]4>9F?\%>OZ,]+T#_D6]-_Z]8O_ $ 5H5GZ!_R+
M>F_]>L7_ * *T*\JK_$EZL]"G\"] HHHK,L**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#R,&NJM/N<L?:N0TMF54)YXZ5U=EN$8[^Q- %EHP<Y__ %U T8"':,>YJT9
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M#D8KSSQ -GA6]8#GRSTH \4$C7-Y<3R9+.Y.:E7C(ZU6LS\K\G[U62<J/7-
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M'P5];4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!X5^TIT\-?]O7_M&MW]G;_DGM]_V%)/_14587[2
MG3PU_P!O7_M&MW]G;_DGM]_V%)/_ $5%0!ZQ1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>
M2>-_^1QO?^V?_HM:];KR3QO_ ,CC>_\ ;/\ ]%K7LY/_ +P_3]4>9F?\%>OZ
M,]+T#_D6]-_Z]8O_ $ 5H5GZ!_R+>F_]>L7_ * *T*\JK_$EZL]"G\"] HHH
MK,L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M85/]:^YE)/W7/Y4 >YT45B^+XM9G\)7\7AAS'JCH%MV#*NT[ADY;@?+G^G-
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MQJ$6Y7W+C@\BO$_BI92?V*[*,A'W5[IJ!P3@9&.M><>.--^WZ3=0D%@R' H
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M HHHH \*_:4Z>&O^WK_VC7CFG>)-<T>W:WTG6=0L86?>T=K=/&I; &2%(&<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7DGC?_ )'&]_[9_P#HM:];KR3QO_R.-[_VS_\ 1:U[.3_[P_3]4>9F
M?\%>OZ,]+T#_ )%O3?\ KUB_] %:%9^@?\BWIO\ UZQ?^@"M"O*J_P 27JST
M*?P+T"BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNT^;>P/3T]J .LLI" N1SVK>MF+19-<Q82$D G/O71V/^K)- %EEW#!JE=*
M">OK5^L^^/RD4 95PB2!MV<D5RFM6V^,@CI772+A?4XK"U!%;=D?A0!\S^/]
M%.F>(I+F('RI/F/L:QM..ZZ09P":]4^(NGK/8SMC)"\'%>2Z:?\ 2XP3T?!H
M T[P?Z=)WJO+_JV]A5B^!&I2 =/:JET^RW8^U $.G#[3?+&..<5[?X?M1;V,
M:)Q@#FO&O!\9FUI#UP<FO<=/95A15XH Z.QYR._K73Z2Q9@#P!7+Z>AW<=_2
MNKTD ,!GCN* .AB7]SP><TR<;5 ZFG#A>*CN'6-![]Z ,?4TRN0<5SMXG2N@
MO),L<<G^58][&>,<T <1K2"2-]W?J#7BOB2 6]],!ZYKW368@=Q/6O+?%^C"
M6VFNHOOJ/TH Y"R8F-AZ59/W1ZYJE8GISVJ\.<?7I0 EW_Q\ '^Z*KE2!P:G
MO!_I)^@J G*_2@"7P^@DUY5/]X<XKW?0XUCLA@=Z\3\#VPNO$VUSPIS7NMA&
M(HPOY"@#:M)0K@'CBMBU;>,J<\5@QH1ANGM6UII(AR.] &M9C+<5L(3Y/S'(
MK'LFR_/YUK!\P[0./6@#*U-MRGV%<A=\[A74ZGA2<],5R,TH^T,"?H* .9U+
M$<S5P/C"'-D)-G"MUKMM:D+WVU>">U8?B>!#I#PL,G&: /-HBP *]*=<']R1
MWIMN?WNWWITZY#C/0=: .N^!_/QFT/\ [>/_ $GDKZ\KY#^!_P#R6;0_^WC_
M -)Y*^O* /@Z(8F.?6K0R><U4CYGY]:MJ.@SQ0!8E;%OVX'>K_A2P^W:LI(R
MJFLFXY1?<UW/@2R$<*RE2"YSF@#T?3(##: +@ <5U.G$Y3 QBN>M%_<\?6M[
M3<JR$YYH ZRU8F#C]:L'Y8^Y!JI:-^[&#S4Y8]^XYH JW)W9 !P:Q;Y-JGC-
M;,[ ;L5DZADHQ'IQ0!QFM6HFA(8>HKPCQCHQTG6F9%Q#-ROL:^A;X!HCGK7E
MGQ*LQ-HYE5/GB;/':@#SFW;=&03TJ[(=ND #_GI659O\^.QK4N,+HH(Z^;S0
M!B7KEG"CJ:]:\#:*++18Y'4%Y &.:\D&9=1B7KEQFOH#1H0NGVZ*, (* .OT
M<C"^E=M91_N@2<^E<1IV0R[>F*[.PRUN#N.0.E &B1^[Z?@:KL6 ('2K7!0$
MG)Q^5596 !Q^!H I2[E+;A@=JQ[Y25+=O6MJ5PRG<?I6/."48-W[4 <;J4>V
MX+9YZBHM<":OX)U&U^\ZQ[E^HK5OX-P)Q[5B#]P[)G"2*58&@#Q*S<A&0^X^
ME1M_K3[5+<*+?5+I!P$E8#\ZA8@MD=S0 $D+^-$W%K'Z9-(>^32SC;:Q<\\T
M 5SQ@4L1Q<+CKFDIL9_TE3VZT :4437=Y'"@RS$"O>/!^CBQL8E(^Z!7EG@3
M2?M>I1W,B$JI.*]XTV%(K=.P(H UK6,*P)]*U[;&>WM63$277/05IVK!3B@#
M50?+GUJG><)E1P/UJZGW152\(">U '.:B>"<=N:X[55XX]:[&_X=B>E<MJ"=
M<^O% 'EOCFT$UD9 .5.:\\4G9TXKUSQ3:>9:NJY.0<BO(Y4:*9D88(.,4 .5
M@8R>O%9[$!LD\YJ[$2=^*H2_>]\T :6I'-Q&>_E+U^E>E_LU.&^)^HCO_9$O
M_HZ&O,M4ZQ'_ *8K_*O2?V9%)^)NI/V_LF0?^1H: /J6OFW]H?\ Y*-9'_J$
MQ_\ HZ6OI*OFS]HC_DHUE_V"8_\ T=+0!Y:O#<=:;+^]E"KR>E!.U<FI=,7S
MM7A!&06Y% 'J/P\TP6^FJS* 7.2:]'AX.T#@5RGAI0EG$BCBNPM5#]1SWH U
M+$'>!P<=JZ.WC)A7M6%:)@C'2NBM\+".: "5&\CDXK,N"I9@1SCJ:U9L^5QZ
M5ER[MQR..] &!J$3$$D\>E<AK4&R,N@PP.<UWMX@,9XX[UR>K0 V[9[YH \)
M^(<.WQ!%=IP)D^;ZBL-&#I74?$> QJA X4YSZ5R%JV01F@#1NC^XM@.P/!JO
M[U9O/]5;9_N56. >O% #58>;QS@5L>&]/.HZQ&H'"G<:PU/[\BO1OA[9!4:8
MH,N>": /0M,MO(B"XXQTKI+4@(,G!K,M4"1CZ5H1') H UH) 1\V16O:.N..
M?2L:$!5"L#[?6M2Q<J1QWH V."N,8%9>I<1^@K2WJT??':LO5779B@#EK[G(
M["N3UBWW1LQ.,]J[*:+>_P HS7.ZO& S*<=* /%O'VFD0QW48.%.#Q7(VSY4
M9KU+QO$'T.?8,D#BO*+0]0: -6=QY,''\)J CGBIIL".'/\ =J$]\T -1]LX
MQQ7H?PZL8Y?.N)!N8. IQ7FXS]L7 _AKV3X?V7DZ(CLN"[;J /2[(JL0VCM6
MC$26&*R[ ?( >E:D2X<$\#L* -W3^ ":OY )(JC8'*>]7,8'(H QM4Y#$&N9
MN%)!!':NBU5P"P%8,O )]J ./UQ-T;9[UY?XFT]FA\P#E.:]9UCYMP/<X%<5
MK%H&LWRN10!YRA^13Z\4CX*L3Z4V0>7(Z'C:U&0T9(]* *0^]GWK[$^$/_)*
M=&^DW_HYZ^.';:?QK['^$/\ R2G1O]V7_P!'/0!VE%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?&^O7S?#+]J&[UC4
MK>22"/5)+P@#!>&?<2R^N!(?Q7&:^F;+XL> K_3UO(?%VD1QLN[9/=I%(/8H
MY# ^V*Y/XA:/\.OBKK4GAF\UN"S\4:>WDPR)\LH)&[R\-@2KSG:#D'/(YKRV
MY_91\5)>;;/7='EMLC]Y*98WQ_NA&'_CU &1\?\ Q_IGQ"\6Z99>%]][;Z>C
MQ+.B-_I$LC#(1<9(&U0#W)..Q/U?X6TM]#\'Z-I,IR]A806S'/4I&JG^5>8?
M#/\ 9XTKP5JT.M:W??VQJ=NV^W"Q^7# V/O 9)=AV)P!Z9 ->R4 %%%% !11
M10 4444 %%%% !1110 4444 ?)/[*G_)4]2_[ LO_H^"OK:ODG]E3_DJ>I?]
M@67_ -'P5];4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &%XX_Y)[XB_P"P7<_^BFKY
ML^"W_)7M%_[;_P#HB2OI/QQ_R3WQ%_V"[G_T4U?-GP6_Y*]HO_;?_P!$24 ?
M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %>2>-_^1QO?^V?_ *+6O6Z\D\;_ /(XWO\ VS_]%K7LY/\
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MD$<=JPKV,M'@#@5M79+R<^OY5FW_  H ^7WH XG6(<LPQ^=>/^*K7[)JSE>
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MS@Y/3MFJEL2IX[U._P RG/6@#$U09;@UE21YMF.>@K4U%-QY[]*QYV"0.-U
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M3U+_ + LO_H^"OK:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH PO''_ "3WQ%_V"[G_
M -%-7S9\%O\ DKVB_P#;?_T1)7TGXX_Y)[XB_P"P7<_^BFKYL^"W_)7M%_[;
M_P#HB2@#ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KR3QO_ ,CC>_\ ;/\ ]%K7K=>2>-_^1QO?^V?_
M *+6O9R?_>'Z?JCS,S_@KU_1GI>@?\BWIO\ UZQ?^@"M"L_0/^1;TW_KUB_]
M %:%>55_B2]6>A3^!>@4445F6%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP7ZT ,O^-289!X'2LN^;$T.1P&%:E^<:BX'3BLR^'[R(_P"T* /5= .;>,8
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M3U+_ + LO_H^"OK:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH PO''_ "3WQ%_V"[G_
M -%-7R1X8\17?A/Q):ZUIT<,MS:[]B3J2AW(4.0"#T8]Z^S;ZRM]2T^YL;V/
MS;:ZB:&9-Q&Y&!##(Y'!/2N,_P"%+> /^@!_Y.3_ /Q= 'D__#1/BW_H':+_
M -^)?_CM'_#1/BW_ *!VB_\ ?B7_ ..UZQ_PI;P!_P! #_R<G_\ BZ/^%+>
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MDK#>7L-O(T<,H8*[A21F0C.#Z5] 5\9>!_\ DH?AW_L*VW_HU:^S: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *\D\;_\CC>_]L__ $6M>MUY)XW_ .1Q
MO?\ MG_Z+6O9R?\ WA^GZH\S,_X*]?T9Z7H'_(MZ;_UZQ?\ H K0K/T#_D6]
M-_Z]8O\ T 5H5Y57^)+U9Z%/X%Z!1116984444 %%%% !1110 4444 %%%%
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MP^:L+PR/^)5;*.1L%=1#",8;D4 .C8F-1WJ5#\XW'\JCEA*+E?NT^WPQ!.*
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M>8]WM6=,A2;<!@5HVKGR^M5[@ R<<#T]: )[9L*, X]#6B%&W.2..E9T3!5
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M5_Y([H7^Y-_Z.DH [NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'N+;$10JC)))P .2<T 6:*** "BBB@ HHHH **** "BBB@ HHHH ^2?V5/\
MDJ>I?]@67_T?!7UM7R3^RI_R5/4O^P++_P"CX*^MJ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^,O _\ R4/P[_V%
M;;_T:M?9M?&7@?\ Y*'X=_["MM_Z-6OLV@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O)/&__ ".-[_VS_P#1:UZW7DGC?_D<;W_MG_Z+6O9R?_>'Z?JC
MS,S_ (*]?T9Z7H'_ "+>F_\ 7K%_Z *T*S] _P"1;TW_ *]8O_0!6A7E5?XD
MO5GH4_@7H%%%%9EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5\4>._^2D^(^/\ F+77_HUJ^UZ^*/'O_)2/$G_86N?_ $:U &>I]*U_"I67
M6@6_@'&*Q?X00>U:7A!B-< [DX% 'L6FVGF2+(HX%;HA"C*]12Z=;*MF@ Y
MS4S+ACMH T].@#1KSSW K>CML1(0*Q-)?<RX//TKIHGW1J,YV]J &1VVX'US
M4OE,@' Q3BP3E1G-*79TX'UH JSHK<YX'7-9=R,9VUI3%CG)P,51D&W@CC-
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MWX]: .$^(+1QZ-<1YP_ Q7ER#$:#VKKOB-?O-XGGLD.(HV .?6N5E0*!@]*
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M$>Q<EL=>U6B/49JA>HTL1VK@4 <SJ3,[/M/'K663MZCFMZZMMH.>M9<L6,X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***\H^._P 5+GX>:!;6FAE!K.I;O*D=0PMXUQNDVG@G)  /'4\XP0#U
M>BODZYTKXW:9X.'CZ7Q3>&W,2W3VAOG9XXS@AS"1Y8&,$@<@=NM>U?!7XEO\
M2/"$DNH"--7T^017BQC <$920#L&P1CU5NV* /1Z*** /DG]E3_DJ>I?]@67
M_P!'P5];5\D_LJ?\E3U+_L"R_P#H^"OK:@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /C+P/\ \E#\._\ 85MO_1JU
M]FU\9>!_^2A^'?\ L*VW_HU:^S: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *\D\;_P#(XWO_ &S_ /1:UZW7DGC?_D<;W_MG_P"BUKV<G_WA^GZH\S,_
MX*]?T9Z7H'_(MZ;_ ->L7_H K0K/T#_D6]-_Z]8O_0!6A7E5?XDO5GH4_@7H
M%%%%9EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMR,;^E 'O%O;"3:8FW#O[5HIM">4_456MH7M8FD125Q\PJ"34(]X>+D \^U
M%VWC99ZVK;(P.<CK6!;7NZ0/@'GC%;4%T2V5_BZYH UXP3$3R1_*H9%PG7O3
M[:9O)91@ ]_6F,GRD,U &==G:<9_^O65.OS<G/\ 2M6Z5.=QYK+F(+GG% $<
M@"J%7GWJG<H-C#'-6'F5/>JEY.H1MC?-CKZ4 >-_$ZX'F>2IY)KE](C(V@#!
MVFM'QU<K>>(6BC.X1GYCZFJE@A1LKGA3F@"JQPS?6F'D&I%C+N0/6IA !C=R
M* -CPUK$^B7]O/"V!N 93T(KZ.\-7@UC1A.A#!LC*\U\Q386%0O7UKW+X*W[
MGPM+"V?W<F030!XYKVI7FG^/]2EAD9&6=@5SP:[#POXN-\/*O&2.0?=R?O51
M^+NA16?C9KZV8;;T;BOH:XD(8\9RI'0CM0!] 6ERV%X!!%:BRL(<^HKRSX?>
M(YKFX;3K^0N47,;MZ5Z9>7L%II GE8+&@RQ- &+JER49L. <5YIXJUUFD-I;
M2 C^-E/Z5:\5^-X)MR:=D;P1N/;WKAHBS9)RQ)R30!*1E3[U[/\  :X-OI-Z
M)F^0.< UY!%"JKEL[L5ZM\*5\KPY<,.2\A.* .$^(B(/'UX4;Y7;=BN?E7*C
MV-;OCUS)XTG(]!Q6(3D$9ZT =/\ !/\ Y+5HGUN/_2>2OKNODCX+(5^-.AG_
M *^/_2>2OK>@#X1O!_Q,YAZ2'^=$R;XB!UZTMXN-5F!P3O.34N * )M$N&L[
MZUG0X*OS]*]MT.\%SIB2+SN&2*\/1"BAEZ9S7I?PXUD7BMIES$2\8^1UZXH
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M-MC8XX-<#H/C'4-)6))G-Q IYW'D"@#WZWN/,9?F-:.X<<FN.T/6XM1M(KB
M_*_3(Z5TPN3LX':@".\N<9RU8%]>!5R[<?6H?$&L_9$=V^4*,DUY5K7C::]C
M:*S8HO(+]Z /1K;6%N]0%K:N'D'\(-;\EE);V[7%WU49"^E>;_!'27U/Q9=W
M<[%H[>+)R>I)XKN_B[?-X>\.+'"3Y]T=B\]!0!XSXLU/^U]>E<-^[C.U<=ZQ
M2NSZ8JQ&G[LLW6H9/O?44 9K'+MZYKZ_^"G_ "1W0O\ =F_]'R5\A.,2,.O-
M?7GP3S_PIW0\]<3_ /H^2@#O**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY"_:
MBNFG^+,$))VV^F1( >G+NQ_G^E?7M?)?[5&F2VWQ(T[4"N(;S3E56QU='8,/
MR9/SH ^F_$>GQ2^!=5TX "%M-F@P5R-IB*]/I7SE^R=<2+XNUZW!_=R6*.P]
MUDP/_0C7O?B;Q):+\)-3\0QSI]GDTA[B*12"&+Q?(!VY) 'N:\,_9,TV5]<\
M1:GM8116\5N&QP69BV/J GZCUH ]:^('QK\.?#C7X-(URRU2>XFM5NE:SBC9
M I9E ):13G*'MZ5RW_#5?@C_ *!7B#_P'@_^/5Z!XK^%O@[QOJL>I>)]'^W7
M<4(@23[5-'A S,!A' ZLW.,\UA_\,^?#'_H6?_)^Y_\ CE 'S3\%/B!I7PX\
M:7>KZY;WD]O-I[VJK9HK.&,D; D,RC&$/?TKW+_AJOP1_P! KQ!_X#P?_'J\
M;_9_\':%XW\?7NF^)['[=:1:9).D?G/'AQ+$H.48'HS<9QS7T1_PSY\,?^A9
M_P#)^Y_^.4 <W_PU7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\ X]72
M?\,^?#'_ *%G_P G[G_XY1_PSY\,?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B#_P'
M@_\ CU'_  U7X(_Z!7B#_P !X/\ X]72?\,^?#'_ *%G_P G[G_XY1_PSY\,
M?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\
MX]72?\,^?#'_ *%G_P G[G_XY1_PSY\,?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B
M#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\ X]72?\,^?#'_ *%G_P G[G_XY1_P
MSY\,?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !
MX/\ X]72?\,^?#'_ *%G_P G[G_XY1_PSY\,?^A9_P#)^Y_^.4 <W_PU7X(_
MZ!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\ X]72?\,^?#'_ *%G_P G[G_X
MY1_PSY\,?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#
M_P !X/\ X]72?\,^?#'_ *%G_P G[G_XY1_PSY\,?^A9_P#)^Y_^.4 <W_PU
M7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\ X]72?\,^?#'_ *%G_P G
M[G_XY1_PSY\,?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B#_P'@_\ CU'_  U7X(_Z
M!7B#_P !X/\ X]72?\,^?#'_ *%G_P G[G_XY1_PSY\,?^A9_P#)^Y_^.4 <
MW_PU7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\ X]72?\,^?#'_ *%G
M_P G[G_XY6)XU^!OPZTCP#X@U+3_  ]Y-W9Z9<SP2?;;AMCI$S*<&0@X('!&
M* *W_#5?@C_H%>(/_ >#_P"/4?\ #5?@C_H%>(/_  '@_P#CU>;?LZ?#[PQX
M[_X2/_A*],^W_8OLOV?_ $B6+9O\W=]QESG8O7/2O;?^&?/AC_T+/_D_<_\
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M?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\
MX]72?\,^?#'_ *%G_P G[G_XY1_PSY\,?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B
M#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\ X]72?\,^?#'_ *%G_P G[G_XY1_P
MSY\,?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !
MX/\ X]72?\,^?#'_ *%G_P G[G_XY1_PSY\,?^A9_P#)^Y_^.4 <W_PU7X(_
MZ!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\ X]72?\,^?#'_ *%G_P G[G_X
MY1_PSY\,?^A9_P#)^Y_^.4 <W_PU7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#
M_P !X/\ X]72?\,^?#'_ *%G_P G[G_XY1_PSY\,?^A9_P#)^Y_^.4 <W_PU
M7X(_Z!7B#_P'@_\ CU'_  U7X(_Z!7B#_P !X/\ X]72?\,^?#'_ *%G_P G
M[G_XY7EWQ_\ A;X.\$^ ++4O#&C_ &&[EU..!Y/M4TF4,4K$8=R.JKSC/% '
M6_\ #5?@C_H%>(/_  '@_P#CU'_#5?@C_H%>(/\ P'@_^/5F?!SX.^!/%7PG
MT?6=>T/[7?W)G\V;[9.F[;/(H^57 '"@<#M7;_\ #/GPQ_Z%G_R?N?\ XY0!
MS?\ PU7X(_Z!7B#_ ,!X/_CU'_#5?@C_ *!7B#_P'@_^/5TG_#/GPQ_Z%G_R
M?N?_ (Y1_P ,^?#'_H6?_)^Y_P#CE '-_P##5?@C_H%>(/\ P'@_^/4?\-5^
M"/\ H%>(/_ >#_X]72?\,^?#'_H6?_)^Y_\ CE'_  SY\,?^A9_\G[G_ ..4
M <W_ ,-5^"/^@5X@_P# >#_X]1_PU7X(_P"@5X@_\!X/_CU=)_PSY\,?^A9_
M\G[G_P".4?\ #/GPQ_Z%G_R?N?\ XY0!S?\ PU7X(_Z!7B#_ ,!X/_CU'_#5
M?@C_ *!7B#_P'@_^/5TG_#/GPQ_Z%G_R?N?_ (Y1_P ,^?#'_H6?_)^Y_P#C
ME '-_P##5?@C_H%>(/\ P'@_^/4?\-5^"/\ H%>(/_ >#_X]72?\,^?#'_H6
M?_)^Y_\ CE'_  SY\,?^A9_\G[G_ ..4 <W_ ,-5^"/^@5X@_P# >#_X]1_P
MU7X(_P"@5X@_\!X/_CU=)_PSY\,?^A9_\G[G_P".4?\ #/GPQ_Z%G_R?N?\
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M(IIGV#[:;GS_ /2)9=^SRMOWV;&-S=/6@#TC_AJOP1_T"O$'_@/!_P#'J/\
MAJOP1_T"O$'_ (#P?_'JL>"?@;\.]7\ >']2U'P]YUW>:9;SSR?;;A=[O$K,
M<"0 9)/ &*W/^&?/AC_T+/\ Y/W/_P <H YO_AJOP1_T"O$'_@/!_P#'J/\
MAJOP1_T"O$'_ (#P?_'JZ3_AGSX8_P#0L_\ D_<__'*/^&?/AC_T+/\ Y/W/
M_P <H YO_AJOP1_T"O$'_@/!_P#'J/\ AJOP1_T"O$'_ (#P?_'JZ3_AGSX8
M_P#0L_\ D_<__'*/^&?/AC_T+/\ Y/W/_P <H YO_AJOP1_T"O$'_@/!_P#'
MJ/\ AJOP1_T"O$'_ (#P?_'JZ3_AGSX8_P#0L_\ D_<__'*/^&?/AC_T+/\
MY/W/_P <H YO_AJOP1_T"O$'_@/!_P#'J/\ AJOP1_T"O$'_ (#P?_'JZ3_A
MGSX8_P#0L_\ D_<__'*/^&?/AC_T+/\ Y/W/_P <H YO_AJOP1_T"O$'_@/!
M_P#'J/\ AJOP1_T"O$'_ (#P?_'JZ3_AGSX8_P#0L_\ D_<__'*/^&?/AC_T
M+/\ Y/W/_P <H YO_AJOP1_T"O$'_@/!_P#'J/\ AJOP1_T"O$'_ (#P?_'J
MZ3_AGSX8_P#0L_\ D_<__'*/^&?/AC_T+/\ Y/W/_P <H YO_AJOP1_T"O$'
M_@/!_P#'J/\ AJOP1_T"O$'_ (#P?_'JZ3_AGSX8_P#0L_\ D_<__'*/^&?/
MAC_T+/\ Y/W/_P <H YO_AJOP1_T"O$'_@/!_P#'J/\ AJOP1_T"O$'_ (#P
M?_'JZ3_AGSX8_P#0L_\ D_<__'*/^&?/AC_T+/\ Y/W/_P <H YO_AJOP1_T
M"O$'_@/!_P#'J/\ AJOP1_T"O$'_ (#P?_'JZ3_AGSX8_P#0L_\ D_<__'*/
M^&?/AC_T+/\ Y/W/_P <H YO_AJOP1_T"O$'_@/!_P#'JQ;_ .)7AGQ5?2:S
M;:A#8Q7&-MO?SQ1S)M 7YE#'&=N1ST(KOO\ AGSX8_\ 0L_^3]S_ /'*^>/V
M@?!N@^"/'ECIWA>Q^PVDNFI.\?G229<RR*3EV)Z*..G%=>$Q3PTW-*^ECGQ%
M!5X<K=C["T1'B\/Z?'*K(ZVT896&"#M'!%7J1/\ 5K]!2US2ES2<NYO%<J2"
MBBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7QK\11CXB
M^(".,ZC/_P"C#7V57QYXZ@$OQ%U]W/RC4KCC_MHU ',C(QFKD:[XV'7-5Y$+
MRD+V_2KD"F->>30!H>&?$=SX;U2-UY@9P)(ST(KW?[/;^*O!4M[8J/-:)C$5
MZY%?.-]]P''>O;_@WJ$T7@UTE)"1R'9N]* /%H_$^K6%Y)#=YD,;%2''(-=3
MH'C1?/C#-]GF)X]#57XG?8;KQI++8Q*G'[W:."WK7'N /NC!'0^E 'TUH^OM
M=6RB=L'%7KO54CMRP;M7G7PXU;^T=+6.0[I(QM;/6NTO0@LG=@ %&<4 <%XF
M\6+:S/YSDM@[$KS'6]0N-3D#SR':3PG85+KMVVH>()Y-WR!R%'M5.6$N=['Y
M?2@#U+0QIUCX=@@TUQ(S)EV'7=WKRGQ$Q;QHY?\ OC%=;X2U4(J6A500V <=
M:B\8^'S)>1:E;Q\;AOQ0!S>HY-Y(.Q7BHO#U\VD:Q;7J#<R2C(/<5;NH&DNF
M=CVQ6=.GE2*$'\5 'UOH]U'<Z7]H:)=IB#<>F*^<M7\87L/C>\DL)66W\TKY
M3'CBO;O!]TP\-+#,<,]N N?I7SOKMH]OXNO5<=)C_.@#T;P]X]CN+@0W7[EC
MTST->B:?J4=QM*L,>QKYQ(R01QCO7<>"_%92[CL;SY6'"/V- 'NUI<%T.PC'
MK4K2!D^9\$5@:7=>='E'!/7BKMRY"[LC- !=SQ)U;Z&N;U'7[6TRTLRJ!G.3
M69XM\2V^CV[/,=S=%4=S7D.LZU=:W=*TGR G"*/?UH ]A\+:U%XLU*9;9F6.
M(XW8ZU'XXUG3?#VGSQ+<*UV5PL8Z\UI_#3PT/#/ATS7$JM-*N]E Z5XAXUU'
M^UO'%[*A^17*KSZ4 9>TW=PTTOS,QRQ-6;<%9G Z;#20Q[5P#SWJ>*(B27''
MR<&@"G:D?-GKFGL2HR/7@41PX&U.K$ #U->E>#O!-H+B.[U-?,"*&*MT!H H
M>"O!']LXO=3WI;(<B,KC?7?7NL6?@[276PAC3C(4'%,US6OLVGRFS BMX1CY
M:\BU[69=:NP=S^4HX#4 5]=UR\UW4FN[V0L2?E7LHJH26CR>HI5B51D\FI!T
MH 72+U[#68;B-MI7(.:]AUX_;?AP\IY+1Y_&O$I_DD4D< ]J]I\PW7PG9HP=
MHBZXZ4 >&71VLB]>.<U;M$&W/;%49VWS''TK3A7;$HQ0!*?]6<5[)X,LOL'A
M"W93AY5R1BO-_#7AY]:NT:9A%91MF:1CC %>XZ5)I^I:? =-"BU1=@8C@@<4
M >#^-XO+\:2G^\H-8A +<=S7HGQ8T VFHKJ,8Q$P50:\[S^\H Z[X,9'QHT0
M=1FXY_[=Y*^LZ^5/@W O_"W]%DZ%3/\ C^XDKZKH ^&-0CV:M-G^^:8%.2!U
MJ?407U250.-YYI\<83KR?>@"18]T !XXK3\*:O\ V#XE@N'_ -43M<GTJ@,C
MKT]*21!)U% '8?&'4['5[C3S8S*Y"EFP<XKB])U632)?,B4,#]X&E>)),9&1
MV]JJRQ["0.G:@#V;PGKT=W:QR1GY6:NY:3,/R]Q7@7@753:WJVS-P\@P/2O=
M$)-J6SQLH P]6U2.RADDE8*J#->+^*/$<FMWC!0%A4\<=:V_'VORS:I/8Q/B
M)0 V.YKB /,:@#Z(^$\EKH_AF:42#?-&O!/L:YWQN+:X^TS,<LY^4 UY99:E
MJ-JI2UNY8@1R U2R^(KMEVS.9&4CECU% %B_T]9]-EW@KL&X<UEL?^)/" /X
M^34LNI3W;M\V%88VU'*C?V='&.I>@"IG.:8+9@2Z]!5F.#;G=5A5/(% 'M.@
M:+!J'@NSDBES,8LGGH:X9?%KZ3JTNG:O$5>.3:' X(]:U_A?KLB&;39GR$^9
M![4_XB^$&U&Z_M*P4>8$)= /O8H Z"PU."2%)(G#HV,$&NHMI!+&K+S7SQI&
MN7>CS QDM%G#PFO:?#6M07]E#+;-\K]03TH Z.Z56AW$X]JQ;VXB@A9W<*%]
M36U<JC0$EN@]:\?^(FMNL8L[:3!=B'P>U &5XT\4"_9[6RPT0.&?UKJ_@8;B
MX_M"$(/+3:V[W/:O*TA$C1QEMNY@"?05]'?#_3=(T+16CTQP[R8=W!SD[10!
MY#\7-4FN_%S:><%+;I@=ZXB*/8O(Y-=/\1(YX_'MU-/&560Y4D=:P>)%H =8
MD"ZZ< 'I5.;FX?/KS6C91D7!/;'%5##ND+,>I- %4QEU.,UVOPYUA-+NQ;7A
M"Q2MP?0UR^ .!TJ4)M4%,@^QH ^EX[5YK99H#DXROI6<-<@COWMI'59AC<F>
M:I?"GQ NM:'%8S2$7,089)^]BN%^,^BWVB>+(-6M)9%@NHP!(I^ZPZB@#UZW
MOE)7OFM);C.W'Y5\]:!\2[ZSDCBU-?,C48,@Z_6O9_#^K1ZK:QS0N'1QD'/%
M &]<R>9'M!P#UK.OKI4CVDY"U;G<[".#CIBN1\0ZK'8VLDT[!%7J30 S4;K(
M9A@#WK-L[P7$[0V^)) .0*\^\1>/)+EF@TW\9.WX5U_P+T^>Y.I:K>[FCR%5
MF_B/>@#H;VV>UL3<7C",*,@>E>*^(+X:IJSR1\HIVJ?7WKTSXT:XUE)#I%O(
M!),NZ3:>57TKR>"/Y<D?A0 TQX3 ZBJ,X!R#D-VK0(PQR?QIO]D7MXV^SM9)
M0?130!4V%M%ER#Q(.:]-_9G+K\2]15ON_P!DR'\?.AKA--TJ[U 26"?NY=_(
M<8QBO9/@9X3_ +!\:7=R\_F2OISQD=AF2,_TH ]YKYM_:'4M\1K$#_H%1_\
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MUSP__P )1_;VC:AIGG_9/*^VVKP^9M\[.W<!G&1G'J*]_HHH **** "BBB@
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MJ:C3YK20Y\M\C)[&O*_**#)[UT_PVNS!XJ6VSE)A@B@#W>^U>QM% FN$1FZ
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M:1K=<9W2!3M'YXH P?B)X\T[X>^$[C5M0='GVE;.U+8:XEQPH]NY/8?A7/\
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M_AW!((-;5?-W[)FK3$>(](=B8%\FZC7LK'<KG\0$_P"^:^D: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KG_&OC71_ 7AN36=>E98%81QQQC,DSG)"
M*#C)X)Y(& :Z"N'^)/PLTOXFPV$>KZCJ%HM@SM&MHZ!7+@9+!E.2-O'ID^M
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MC\&^+I=#T'38-5:U&VZFDF*JDO=!@<X[^^1VKVG3;HWVE6MVRA&GA20J.@R
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M@'_Y.3__ !==M10!Q'_"G/ G_0"_\G)__BZ/^%.>!/\ H!?^3D__ ,77;T4
M<*/@MX #AQH.&!R#]MN/_BZZ:'PWI4%D;2*V(@*[-AE<\?4G-:E% '#-\&?
M3S-*V@Y=CN)^V3\G_ONG#X.>!!_S O\ R<G_ /BZ[>B@#B/^%-^ ^?\ B1=?
M^GR?_P"+IH^#'@%3D:#_ .3D_P#\77<T4 <1_P *=\"?] +_ ,FY_P#XNC_A
M3G@0_P#,"_\ )R?_ .+KMZ* .'_X4WX#QC^PN/\ K\G_ /BZ!\&O 0Z:#_Y.
M3_\ Q==Q10!Q/_"G? G_ $ O_)R?_P"+K3T?P!X:T!91I.F_9Q*<O^_D;/\
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M-OO)) K*?P(J[10!D2^$_#LR(LV@:7(L8P@>RC(4>W'%1_\ "%>%O^A:T?\
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M">I_L^+_ .)I?^$(\*?]"SHW_@OB_P#B:W** ,/_ (0GPK_T+.C_ /@!%_\
M$TO_  A/A7_H6='_ / "+_XFMNB@#$_X0KPK_P!"SH__ ( 1?_$T?\(7X6QC
M_A&M(QZ?8(O_ (FMNB@##_X0GPK_ -"SH_\ X 1?_$UL6]O#:6Z06L,<,*#"
MQQJ%51[ =*DHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ."^.'
M_)%/$G_7NO\ Z,2O-OV2_P#D"^)?^OB#_P!!>O3?C1;SW?P<\0P6L,D\SP*%
MCC4LS?O%Z <FO//V6-,O]-T?Q&NHV5Q:,]Q 5$\3)N^5^F1S0!ZMXV\#^&?&
M]A;P^+;;SHK9RT+?:'BV,1@GY6 / [YIFE_#OP98^&UTFQ\/Z;)ITD8SOA60
MS C[S.<ECT^;/IBN0^//POO/B%X=M+K0@K:OI9<Q0LP7[1&V-R9/ ;*@C/'4
M=Z\K\._%#XJ>#/"R^%/^$/NI[FU3R;.>>QF,D2] -H&' Z+VX'44 8WPQW^$
MOVGCI.DN_P!E34KO364G/F0@N!GZ%%;ZK7V+7S[\"?A%K6F^(Y/&_C>*2"_;
M>UK;3?ZTO(#OE<?PG#, IYY)..,_05 !1110 4444 %%%% !1110 4444 %%
M%% !1110 4=.M%>6?M!:[K&E_#@Z?X=MKJ:[U:7[-(]M&S-'#@ESP#UX7Z,:
M /,?C+\9+SQEJ#>"/AYYMS:3/Y%Q<6H+/?-T,<>.?+]2/O?[OWO0?@A\&/\
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M(< \%LG_ ( * //OB7\2M<^,OB:/PEX%MKB32/-PD48*M>L#_K9,_=C'4 X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@>V* /GGX6D']H'2".0=3DP?P>OMJ[N[>PLYKN]GCM[>!#)+-*P544#)))X
M [U\._!V%[?XW>'H91M>.]*L,YP0K UZU^U5XMN8(]*\*6LWEPW"&\NU!YD
M;;&#[95SCU ]* .JUK]ISP-IEZUO91ZEJH0X,UM"JQGZ%V4G\L5T7@?XU^#O
M'EXMCIMW-9:@^=EG?((WDQ_=()5CWP#G':O/_@Y\"/#-[X%LM=\6V7]IWFI1
M^='$TKK'#&?N@!2,L1@DGIG Z9/G'QT^&UI\,_$^FWWAB2:WL+\-) GFL6MI
M8RN=K]<?,I!)SG//% 'V'=75O8V<UW>SQV]O ADEEE8*J*!DL2>  .]>/ZO^
MU!X'T^]>WLH-4U-5.//MX%6-OIO8,?RK*\7^)=4\<?LDC68A(UU(D:W_ )8Y
M81S;)&P.Q*[CZ#VS7C_PKU;X86$-Q%\2-%NKNZDES#=*6:*./ ^4HK YSDYP
M>O;N ?1'A/\ :%\$>*]3ATX2W>E7<[B.);^(*LC'H ZLP&>@W8R>/2NU\;3:
M#!X+U&7Q>@DT58P;M2K-E=PQPO/7'2O#;/X4?!OQ_KHF\)^*7M8Y$'_$LMYM
MLA()RRB8%_3C! KTSXQ6WV/X#Z[;"66;R;../S9FR[X=!ECW)[T 4_A1?_"^
M\U+4!\,[98;E8E-T5BF3*9.W_6>^>E;?BWXM>#_!&L+I?B/49+:[:$3!%MI)
M!L)(!RH(ZJ:\1_9-_P"1D\1?]>D7_H9K$_:C_P"2LV__ &"XO_0Y* /=/&/Q
MX\&>#9DMKB>XU"]:-9#;6489HU89&\L0JG';.>1QS4G@3XX>$?'VI+IFGR7-
MCJ3@F.UO8PIEP,G:RDJ3CG&0>O'!KD?AC\"/"-]X!L-7\4V;ZOJ.KVRW;RRS
MR*(UD 8*H5AS@C+')SGH.*\'O]+7P'\<Q86-PZQ:7K,?DRL?F$8D!7..ORG!
M]>: /N>>>&UMY+BYE2&&)2\DDC!510,DDGH *\>U7]I_P/I^I/:VMOJFHQ(V
M#<VT*!&_W=[J3^0JE^U)XDN-,\"Z=HMK*8_[6N&,V.KQQ $K]-S(?PKF_@'\
M&O#GB/P>?$OBNS_M%KF9X[6!I65(T0[2Q"D98MNZY  '>@#U:7XW^ X?#=EK
MDFL,+.\D:)-MN[.DB@%D=0"5(##KUR",CFNL\-^(],\6^'[;6M"G:>PN=WE2
M-&R$[6*'A@".5-?(OQX^&]A\//$]H-!,D>E:G$9([=Y"WE.APRY/)&&!!//)
M%?0G[/?_ "0KP_\ 6Y_]*9: /2J*** "OD34[O\ X7#^T[;6DA\[2H;OR(TZ
MH;:#+-^#E6/_  ,5]1^+]3;1O!.MZG&<26>GSSISCYEC8C]0*^8OV6+);CXF
MZA=O@_9],?:/1FD09_('\Z /K7H/85Y+XG_:/\$>'=3>PMS>:Q+$Q622QC4Q
MJ1U&]F&[_@.1[UJ_'CQ#/X<^$&JS64ABN+O99HXZJ'.&Q[[ U>%?L^?"O1_'
M=QJ6J^)HVN;&Q9(HK59"@DD(R2Q7!P!C@'G/MR =#\;_ (F>&_B)\'[.7P]=
M/Y\.L0F:TN%V31 PS<D9((]P2*Z3]E'_ ))_K'_84/\ Z*CKB/VA/A)H7@O3
M;#Q!X6A:RM[BY^RW%IYC.H<JSJR[B2.%8$9QTQCOV_[*/_)/]8_["A_]%1T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBN&_:K_Y*GIO_8&B_P#1\U>V_!CX::A\,]#U&QU2]MKQ[NY696MPV% 7&#N
MKGOC)\$M8^)/C"TUC3-3L;2*"P2U*7 ?<6$DC9X!XPX_*@#T7X<?\DK\*?\
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M'0/#FG:1;?ZJQMH[=#ZA%"Y_2@#0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956281547832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BLACK DIAMOND THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-4254660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Main Street, 10th Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">252-0848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BDTX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 340,487,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,271,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Part III of this Annual Report on Form 10-K incorporates by reference certain information from the definitive Proxy Statement for the registrant&#8217;s 2022 Annual Meeting of Stockholders, or the Proxy Statement, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#8217;s fiscal year ended December&#160;31, 2021. Except with respect to information specifically incorporated by reference, the Proxy Statement is not deemed to be filed as part of this Annual Report on Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001701541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284574024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956281409288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 65,799<span></span>
</td>
<td class="nump">$ 34,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Investments</a></td>
<td class="nump">143,987<span></span>
</td>
<td class="nump">280,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,917<span></span>
</td>
<td class="nump">4,487<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">215,703<span></span>
</td>
<td class="nump">319,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,035<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,223<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">27,705<span></span>
</td>
<td class="nump">8,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">247,682<span></span>
</td>
<td class="nump">329,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">4,107<span></span>
</td>
<td class="nump">2,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">19,535<span></span>
</td>
<td class="nump">11,680<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">23,642<span></span>
</td>
<td class="nump">14,218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liability</a></td>
<td class="nump">28,140<span></span>
</td>
<td class="nump">7,694<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">51,782<span></span>
</td>
<td class="nump">21,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note&#160;12)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 10,000,000 shares and 10,000,000 shares authorized at December&#160;31, 2021 and 2020, respectively; no shares issued or outstanding at December&#160;31, 2021 and 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.0001 par value; 500,000,000 shares authorized at December&#160;31, 2021 and 500,000,000 shares authorized at December&#160;31, 2020; 36,234,624 shares issued and outstanding at December&#160;31, 2021 and 36,078,383 shares issued and outstanding at December&#160;31, 2020</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">440,129<span></span>
</td>
<td class="nump">425,363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(414)<span></span>
</td>
<td class="nump">614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(243,820)<span></span>
</td>
<td class="num">(118,224)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">195,900<span></span>
</td>
<td class="nump">307,758<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 247,682<span></span>
</td>
<td class="nump">$ 329,670<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282351896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">36,234,624<span></span>
</td>
<td class="nump">36,078,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">36,234,624<span></span>
</td>
<td class="nump">36,078,383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956281276808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 96,829<span></span>
</td>
<td class="nump">$ 48,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">30,043<span></span>
</td>
<td class="nump">21,361<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">126,872<span></span>
</td>
<td class="nump">69,570<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(126,872)<span></span>
</td>
<td class="num">(69,570)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Interest income</a></td>
<td class="nump">3,464<span></span>
</td>
<td class="nump">4,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(2,188)<span></span>
</td>
<td class="num">(1,724)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">1,276<span></span>
</td>
<td class="nump">2,316<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (125,596)<span></span>
</td>
<td class="num">$ (67,254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in dollars per share)</a></td>
<td class="num">$ (3.47)<span></span>
</td>
<td class="num">$ (2.05)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in dollars per share)</a></td>
<td class="num">$ (3.47)<span></span>
</td>
<td class="num">$ (2.05)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">36,189,002<span></span>
</td>
<td class="nump">32,907,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common share outstanding, diluted (in shares)</a></td>
<td class="nump">36,189,002<span></span>
</td>
<td class="nump">32,907,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (125,596)<span></span>
</td>
<td class="num">$ (67,254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Change in unrealized (loss) gain on investments, net</a></td>
<td class="num">(1,028)<span></span>
</td>
<td class="nump">614<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (126,624)<span></span>
</td>
<td class="num">$ (66,640)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282330648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (125,596)<span></span>
</td>
<td class="num">$ (67,254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustment to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">14,037<span></span>
</td>
<td class="nump">7,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeAmortizationOfPremium', window );">Amortization of premium on investments</a></td>
<td class="nump">2,186<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_RentExpense', window );">Noncash rent expense</a></td>
<td class="nump">2,012<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss', window );">Gain on sale of investments</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in current assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,628)<span></span>
</td>
<td class="num">(3,439)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">90<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">1,569<span></span>
</td>
<td class="nump">1,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">8,714<span></span>
</td>
<td class="nump">8,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Non-current operating lease liability</a></td>
<td class="num">(1,725)<span></span>
</td>
<td class="num">(567)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(100,148)<span></span>
</td>
<td class="num">(52,146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of equipment</a></td>
<td class="num">(2,710)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">182,831<span></span>
</td>
<td class="nump">90,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(49,508)<span></span>
</td>
<td class="num">(372,477)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="nump">130,613<span></span>
</td>
<td class="num">(281,691)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of common stock options and ESPP</a></td>
<td class="nump">729<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering, net of issuance costs of $1,275</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">213,844<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">729<span></span>
</td>
<td class="nump">214,944<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">31,194<span></span>
</td>
<td class="num">(118,893)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of year</a></td>
<td class="nump">35,828<span></span>
</td>
<td class="nump">154,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of year</a></td>
<td class="nump">67,022<span></span>
</td>
<td class="nump">35,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">65,799<span></span>
</td>
<td class="nump">34,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash, end of year</a></td>
<td class="nump">1,223<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of year</a></td>
<td class="nump">67,022<span></span>
</td>
<td class="nump">35,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of preferred stock into common stock upon closing of initial public offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease obligation</a></td>
<td class="nump">21,505<span></span>
</td>
<td class="nump">8,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_RightOfUseAssetDerecognizedTerminationOfLease', window );">Right-of-use asset derecognized upon early lease termination</a></td>
<td class="nump">$ 476<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_RentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rent Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_RentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_RightOfUseAssetDerecognizedTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset, Derecognized, Termination of Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_RightOfUseAssetDerecognizedTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeAmortizationOfPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of purchase premium on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeAmortizationOfPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287498744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 1,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956281816776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated other comprehensive income</div></th>
<th class="th"><div>Accumulated deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,236,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">$ (47,157)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 3,812<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (50,970)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Common stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock upon closing of the initial public offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,499,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock upon closing of the initial public offering</a></td>
<td class="nump">200,573<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">200,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,174,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">212,101<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">212,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Reclassification of warrants to additional paid-in capital</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">7,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Unrealized gains on investments</a></td>
<td class="nump">614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (67,254)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67,254)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">36,078,383<span></span>
</td>
<td class="nump">36,078,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 307,758<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">425,363<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="num">(118,224)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Common stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares)</a></td>
<td class="nump">110,621<span></span>
</td>
<td class="nump">110,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">$ 665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock related to ESPP (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock related to ESPP</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">14,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Unrealized gains on investments</a></td>
<td class="num">(1,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (125,596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125,596)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">36,234,624<span></span>
</td>
<td class="nump">36,234,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 195,900<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 440,129<span></span>
</td>
<td class="num">$ (414)<span></span>
</td>
<td class="num">$ (243,820)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287455864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">NATURE OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text">NATURE OF BUSINESS AND BASIS OF PRESENTATION<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Black Diamond Therapeutics, Inc. (the &#8220;Company&#8221;) is a precision oncology medicine company pioneering the discovery and development of MasterKey therapies. The Company was originally organized as a limited liability company in December 2014 under the name ASET Therapeutics LLC. In September 2016 the Company was converted to a corporation under the laws of the State of Delaware under the name ASET Therapeutics, Inc. The Company changed its name to Black Diamond Therapeutics, Inc. in January 2018. Since its inception, the Company has devoted substantially all of its efforts to raising capital, obtaining financing, and incurring research and development costs related to the development of its mutation, allostery, and pharmacology computational and drug discovery engine. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry. There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s technology will be obtained, that any products developed will obtain necessary government regulatory approval or that any products, if approved, will be commercially viable. The Company operates in an environment of rapid technological innovation and substantial competition from pharmaceutical and biotechnological companies. In addition, the Company is dependent upon the services of its employees, consultants and service providers. Even if the Company&#8217;s product development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from product sales. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On January 21, 2020, the Company effected a 1-for-3.01581 reverse stock split of the Company&#8217;s common stock. All shares, stock options, warrants and per share information presented in the consolidated financial statements have been adjusted to reflect the reverse stock split on a retroactive basis for all periods presented. There was no change in the par value of the Company&#8217;s common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed an initial public offering (the &#8220;IPO&#8221;) of 12,174,263 shares of its common stock, including the exercise in full by the underwriters of their option to purchase up to 1,587,947 additional shares of common stock, for aggregate gross proceeds of $231,311 and its shares started trading on The Nasdaq Global Select Market under the ticker symbol &#8220;BDTX.&#8221; The Company received $212,101 in net proceeds after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. Upon closing of the IPO, all of the Company's outstanding shares of convertible preferred stock automatically converted into 21,499,770 shares of common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 1, 2021, the Company filed a shelf registration statement on Form S-3 ASR (the &#8220;Shelf&#8221;), with the Securities and Exchange Commission (the &#8220;SEC&#8221;), which covers the offering, issuance and sale of the Company&#8217;s common stock, preferred stock, debt securities, warrants and/or units of any combination thereof. The Company simultaneously entered into an Open Market Sale Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with Jefferies LLC, as sales agent, to provide for the issuance and sale by the Company of up to $150 million of its common stock from time to time through Jefferies as its sales agent (the &#8220;ATM Program&#8221;). The Shelf became automatically effective upon filing on February 1, 2021. As of December&#160;31, 2021, no sales have been made pursuant to the ATM Program.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities and commitments in the ordinary course of business. Historically, the Company has funded its operations primarily with proceeds from the sale of convertible preferred stock. The Company expects to continue to generate operating losses for the foreseeable future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of March&#160;17, 2022, the issuance date of the consolidated financial statements, the Company expects that its cash, cash equivalents and investments will be sufficient to fund its operating expenses and capital requirements into 2024. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company may seek additional funding through private or public equity financings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborations or other arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company's stockholders. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts, which could adversely affect its business prospects. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations, if at all.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The ongoing COVID-19 pandemic continues to present a substantial public health and economic challenge around the world, and to date has led to the implementation of various responses, including government-imposed quarantines, stay-at-home orders, travel restrictions, mandated business closures and other public health safety measures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has been closely monitoring the impact of the ongoing COVID-19 pandemic on all aspects of the Company&#8217;s business, including how it has impacted and may continue to impact the Company&#8217;s operations and the operations of its suppliers, vendors and business partners, and may take further precautionary and preemptive actions as may be required by federal, state or local authorities. In addition, the Company has taken steps to minimize the current environment&#8217;s impact on its business and strategy, including devising contingency plans and securing additional resources from third party service providers. Furthermore, for the safety of the Company&#8217;s employees and families, the Company has introduced enhanced safety measures for scientists to be present in its labs and increased the use of third party service providers for the conduct of certain experiments and studies for research programs. Certain of the Company&#8217;s third party service providers have also experienced shutdowns or other business disruptions. The Company does not yet know the full extent of potential delays or impacts on the Company&#8217;s business, clinical trials, research programs, healthcare systems or the global economy and cannot presently predict the scope and severity of any potential business shutdowns or disruptions but if we or any of the third parties with whom we engage were to experience prolonged business shutdowns or other disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively affected, which could have a material adverse impact on our business, results of operations and financial condition. The estimates of the impact on our business may change based on new information that may emerge concerning COVID-19 and the actions to contain it or treat its impact and the economic impact on local, regional, national and international markets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The extent to which COVID-19 ultimately impacts the Company&#8217;s business, results of operations or financial condition will depend on future developments, which, despite progress in vaccination efforts, remain highly uncertain and cannot be predicted with confidence, such as the duration of the COVID-19 pandemic, new strains of the virus which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines, new information that may emerge concerning the severity of COVID-19, and any additional preventative and protective actions taken to contain the pandemic or treat its impact, among others. In addition, a resurgence or &#8220;additional waves&#8221; of COVID-19 cases could cause other widespread or more severe impacts depending on where infection rates are highest. While certain measures have been relaxed in certain parts of the world as increasing numbers of people have received COVID-19 vaccines, others have remained in place with some areas continuing to experience renewed outbreaks and surges in infection rates. The extent to which such measures are removed or new measures are put in place will depend upon how the pandemic evolves, as well as the distribution of available vaccines, the rates at which they are administered and the emergence of new variants of the virus.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284801640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Principles of consolidation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and include the accounts of the Company and its wholly owned subsidiaries, Black Diamond Therapeutics (Canada), Inc. and Black Diamond Therapeutics Security Corporation, after elimination of all significant intercompany accounts and transactions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the accrual of research and development expenses and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results may differ from those estimates or assumptions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The full extent to which the ongoing COVID-19 pandemic will directly or indirectly impact the Company&#8217;s business, results of operations and financial condition, including expenses, research and development costs and employee-related amounts, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international markets. The Company has considered the impact of COVID-19 on estimates within its financial statements and there may be changes to those estimates in future periods. As of the date of issuance of these consolidated financial statements, the Company has not experienced material business disruptions or incurred impairment losses in the carrying value of its assets as a result of the pandemic and is not aware of any specific related event or circumstance that would require it to update its estimates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Subsequent events</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but before the final financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Foreign currency and currency translation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The functional currency for the Company&#8217;s wholly owned foreign subsidiary, Black Diamond Therapeutics (Canada), Inc. is the United States Dollar. Adjustments that arise from exchange rate changes on transactions denominated in a currency other than the local currency are included in other income (expense), net in the consolidated statements of operations, as incurred. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company classifies deposits in banks, money market funds and cash invested temporarily in various instruments with maturities of three months or less at the time of purchase as cash and cash equivalents. At December&#160;31, 2021 and 2020, cash and cash equivalents includes cash on deposit at commercial banks and a money market fund that invests in U.S. Government securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investments consist of marketable securities with original maturities greater than 90 days. The Company has classified its investments with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities to be available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices. Unrealized gains and losses are reported as the accumulated other comprehensive items in stockholders&#8217; equity. Amortization and accretion of premiums and discounts are recorded in other income (expense). Realized gains or losses on debt securities are included in interest income or interest expense, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If any adjustment to fair value reflects a decline in value of the investment, the Company considers all available evidence to evaluate the extent to which the decline is other than temporary and, if so, marks the investment to market on the Company&#8217;s statement of operations and comprehensive income (loss). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Restricted cash </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with its operating lease commitments, the Company maintains certain balances for security deposits that are classified as restricted cash on the consolidated balance sheets. As of December&#160;31, 2021 and 2020, the Company had $1,223 of restricted cash, which has been classified as a non-current asset on the consolidated balance sheet.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. The Company maintains accounts for all cash and cash equivalents at accredited financial institutions, in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost less accumulated depreciation. Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.171%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Laboratory equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furniture and fixtures&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Computer and office equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shorter of the useful life or remaining lease term</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">When assets are retired or otherwise disposed of, the cost of assets disposed of and the related accumulated depreciation is removed from the accounts and any resulting gain or loss is included in the consolidated statements of operations in the period of disposal. Expenditures for repairs and maintenance are charged to expense as incurred. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Impairment of long - lived assets</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Long-lived assets consist of property and equipment. Long-lived assets to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company did not record any impairment losses on long-lived assets during the periods presented.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Fair value measurements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#8212; Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#8212; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level&#160;2 inputs include the following:</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">quoted prices for similar assets and liabilities in active markets</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">quoted prices for identical or similar assets or liabilities in markets that are not active</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g.,&#160;interest rate and yield curve quotes at commonly quoted intervals)</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">inputs that are derived principally from or corroborated by observable market data by correlation or other means</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#8212; Unobservable inputs for the assets or liability (i.e.,&#160;supported by little or no market activity). Level&#160;3 inputs include management&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying values of the Company&#8217;s prepaid expenses and other current assets, and accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Segment information </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company manages its operations as a single operating segment for the purposes of assessing performance and making operating decisions. The Company&#8217;s singular focus is the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Research and development costs</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop drug candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical development activities. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Research contract costs and accruals</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has entered into various research and development-related contracts with companies both inside and outside of the United States. The related costs are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ materially from the Company&#8217;s estimates. The Company&#8217;s historical accrual estimates have not been materially different from the actual costs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Patent costs</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All patent-related costs incurred in connection with filing and prosecuting patent applications to operations are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company measures all stock-based awards granted to employees, non-employees and directors based on the fair value on the date of grant and recognizes compensation expense of those awards over the requisite service period, which is generally the vesting period of the respective award. Generally, the Company issues stock options and restricted stock units with only service-based vesting conditions and records the expense for these awards using the straight-line method. For stock options or restricted stock units issued with performance-based vesting conditions, the stock compensation expense related to these awards is recognized based on the grant date fair value when achievement of the performance condition is deemed probable. The Company would apply the graded-vesting method to all stock-based awards with performance-based vesting conditions or to awards with both service-based and performance based vesting conditions. Forfeitures are accounted for as they occur. </span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of each stock option grant is estimated on the date of grant using the Black- Scholes option-pricing model. The Company lacks sufficient company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The Company uses the simplified method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> prescribed by Securities and Exchange Commission Staff Accounting Bulletin No. 107, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to calculate the expected term of options granted to employees, non-employees and directors. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#8217;s payroll costs are classified or in which the award recipient&#8217;s service payments are classified.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#8217;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties. To date, the Company has not taken any uncertain tax positions or recorded any reserves, interest or penalties. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive loss</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Comprehensive loss is composed of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Net income (loss) per share</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated, and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common stock. For purposes of this calculation, outstanding options, unvested restricted common stock and shares issuable under the employee stock purchase plan are considered potentially dilutive common stock and are excluded from the computation of net income (loss) per share when their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December&#160;31, 2021 and 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at contract inception. Operating lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at the commencement date of the lease based upon the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company uses the implicit interest rate when readily determinable and uses the Company&#8217;s incremental borrowing rate when the implicit rate is not readily determinable based upon the information available at the commencement date in determining the present value of the lease payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The lease payments used to determine the Company&#8217;s operating lease assets may include lease incentives, stated rent increases and escalation clauses linked to rates of inflation, when determinable, and are recognized in the Company&#8217;s operating lease assets in the Company&#8217;s consolidated balance sheets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s operating leases are reflected in the right-of-use operating asset; operating lease liability, current portion; and non-current operating lease liability in the Company&#8217;s consolidated balance sheets. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Short-term leases, defined as leases that have a lease term of 12 months or less at the commencement date, are excluded from this treatment and are recognized on a straight-line basis over the term of the lease.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Variable lease payments are the amounts owed by the Company to a lessor that are not fixed, such as reimbursement for common area maintenance and utilities costs for facility leases and maintenance. Variable lease payments are expensed when incurred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Assumptions made by the Company at the commencement date are re-evaluated upon occurrence of certain events, including a lease modification. A lease modification results in a separate contract when the modification grants the lessee an additional right of use not included in the original lease and when lease payments increase commensurate with the standalone price for the additional right of use. When a lease modification results in a separate contract, it is accounted for in the same manner as a new lease.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force) (&#8220;ASU-2021-04&#8221;). ASU 2021-04 clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The ASU provides guidance that will clarify whether an issuer should account for a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as (1) an adjustment to equity and, if so, the related earnings per share (EPS) effects, if any, or (2) an expense and, if so, the manner and pattern of recognition. The new guidance is effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted, including adoption in an interim period. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company adopted this standard on December 1, 2021 on a prospective basis, and it did not have a material impact on its disclosures, financial position or results or operations upon adoption. </span></div>In December 2019, the FASB issued ASU 2019-12, Income Taxes-Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;). ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The new standard was effective for the Company beginning January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's disclosures, financial position or results or operations upon adoption.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287437896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fair value measurements at December 31, 2021 using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63,730&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">143,987&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">207,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fair value measurements at December 31, 2020 using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">192,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">192,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32,501&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">280,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">312,963&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">When developing fair value estimates, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. When available, the Company uses quoted market prices to measure fair value. The valuation technique used to measure fair value for the Company's Level 1 and Level 2 assets is a market approach, using prices and other relevant information generated by market transactions involving identical or comparable assets. If market prices are not available, the fair value measurement is based on models that use primarily market-based parameters including yield curves, volatilities, credit ratings and currency rates. In certain cases where market rate assumptions are not available, the Company is required to make judgments about assumptions market participants would use to estimate the fair value of a financial instrument. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There were no transfers in or out of Level 3 categories in the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956288111976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENTS</a></td>
<td class="text">INVESTMENTS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, investments were comprised of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">144,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">143,987&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, investments were comprised of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">191,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">192,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">279,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">280,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, all marketable securities held by the Company had remaining contractual maturities of three years or less.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021and 2020, the marketable securities in a loss position have a maturity of three years or less.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There have been no impairments of the Company&#8217;s assets measured and carried at fair value during the year ended December&#160;31, 2021and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287481896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December&#160;31, 2021 and 2020 was $205 and $52, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287381144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text">ACCRUED EXPENSES <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Contracted research services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payroll and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_60506ab5-efc5-4954-abd1-b1eb79d8d8bb"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_bf8d40bd-aa95-4835-abf8-381f9a8156f6">Current portion of operating lease liability</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,535&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11,680&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284780472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon closing of the IPO on February 3, 2020, all of the preferred stock converted into an aggregate of 21,499,770 shares of common stock.</span></div>On February 3, 2020, in connection with the closing of the IPO, the Company filed an amended and restated certificate of incorporation, which, among other things, restated the number of shares of all classes of stock that the Company has authority to issue to 510,000,000 shares, of which (i) 500,000,000 shares shall be a class designated as common stock, par value $0.0001 per share, and (ii) 10,000,000 shares shall be a class designated as undesignated preferred stock, par value $0.0001 per share.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284777160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2017 Equity Incentive Plan </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (the &#8220;2017 Plan&#8221;), provided for the Company to grant qualified incentive options, nonqualified options, stock grants and other stock-based awards to employees and non-employees to purchase the Company&#8217;s common stock. Upon the effectiveness of the 2020 Plan (as defined below), no further issuances were made under the 2017 Plan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2020 Stock Option and Incentive Plan</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2020 Stock Option and Incentive Plan (the &#8220;2020 Plan&#8221;) was approved by our board of directors on December 5, 2019, and the Company&#8217;s stockholders on January 14, 2020 and became effective on the date immediately prior to the date on which the registration statement for the Company&#8217;s IPO was declared effective. The 2020 Plan provides for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units, restricted stock awards, unrestricted stock awards, cash-based awards and dividend equivalent rights to the Company&#8217;s officers, employees, directors and consultants. The number of shares initially reserved for issuance under the 2020 Plan was 6,665,891, which shall be cumulatively increased on January 1, 2021 and each January 1 thereafter by 4% of the number of shares of the Company&#8217;s common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by the Company&#8217;s board of directors or compensation, nomination, and corporate governance committee of the board of directors. As of December&#160;31, 2021, 5,211,827 shares remained available for issuance under the 2020 Plan. The number of authorized shares reserved for issuance under the 2020 Plan was increased by 1,449,384 shares effective as of January 1, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2020 Employee Stock Purchase Plan (the &#8220;2020 ESPP&#8221;) was approved by the Company&#8217;s board of directors on December 5, 2019, and our stockholders on January 14, 2020, and became effective on the date immediately prior to the date on which the registration statement for the Company&#8217;s IPO was declared effective. A total of 326,364 shares of common stock were initially reserved for issuance under this plan, which shall be cumulatively increased on January 1, 2021 and each January 1 thereafter by 1% of the number of shares of the Company&#8217;s common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by the Company&#8217;s board of directors or compensation, nomination and corporate governance committee of the board of directors. As of December&#160;31, 2021, 646,566 shares remained available for issuance under the 2020 Plan. The number of authorized shares reserved for issuance under the 2020 Plan was increased by 326,364 shares effective as of January 1, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Option valuation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The assumptions that the Company used to determine the grant-date fair value of options granted were as follows, presented on a weighted-average basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:72.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.526%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.380%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.526%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Options </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the stock option activity under the Company&#8217;s equity awards plans:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.568%"><tr><td style="width:1.0%"/><td style="width:46.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.456%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Exercise</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Price</span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Life</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(in Years)</span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Outstanding December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,752,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,996,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(110,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cancelled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(734,928)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Outstanding December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,903,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options vested or expected to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,903,839&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,791,964&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options is calculated as the difference between the exercise price of the options and the fair value of the Company&#8217;s common stock for those options that had exercise prices lower than the fair value of the Company&#8217;s common stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value per share of options granted during the years ended December&#160;31, 2021 and 2020 was $12.93 and $15.18, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The total fair value of options vested during the years ended December&#160;31, 2021 and 2020 was $11,438 and $4,198, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Restricted stock </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under terms of the restricted stock agreements covering the common stock, shares of restricted common stock are subject to a vesting schedule. The majority of restricted stock vests over a three-year period during which time all unvested stock will immediately be forfeited to the Company if the relationship between the recipient and the Company ceases. Subject to the continued employment (or other engagement of the recipient by the Company as described in the restricted stock agreements), all shares of restricted common stock become fully vested within three years of the vesting commencement date. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes restricted stock activity since January 1, 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Number&#160;of</span></div><div style="margin-bottom:0.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">shares</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">average</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">grant&#160;date</span></div><div style="margin-bottom:0.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unvested restricted common stock as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6,664)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unvested restricted common stock as of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54,336&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,002)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cancelled or forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unvested restricted common stock as of December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29.53&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The aggregate fair value of restricted stock that vested during the years ended December&#160;31, 2021 and 2020 was $714 and $200, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation expense </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense in the following award type categories included within its consolidated statements of operations and comprehensive loss:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company issued 12,456 and 505 shares, respectively, of common stock out of our 2020 Plan under our policy where non-employee directors may elect to receive their compensation in the form of common stock in lieu of cash.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense related to stock options and restricted stock units in the following expense categories of its consolidated statements of operations and comprehensive loss:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, total unrecognized compensation cost related to the unvested stock options was $31,192, which is expected to be recognized over a weighted average period of 2.5 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, total unrecognized compensation cost related to the unvested restricted stock units was $636, which is expected to be recognized over a weighted average period of 1.4 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284785336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Income (loss) before income tax expense consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(125,328)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(66,992)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total loss before income taxes</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(125,596)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(67,254)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company recorded no income tax benefit for the net operating losses incurred each year, due to its uncertainty of realizing a benefit from those items.  A reconciliation of income taxes computed using the U.S. federal statutory rate to that reflected in operations as of December&#160;31, 2021 and 2020, respectively, is as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. federal statutory income tax rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">State and local taxes, net of federal benefit&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permanent differences</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development credits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Change in valuation allowance&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(27.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Effective income tax rate&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.0 %</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.328%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.371%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.330%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accruals and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">70,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Valuation Allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(63,014)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(28,709)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(7,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,063)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of December&#160;31, 2021, the Company had gross federal net operating loss carryforwards of $209,607, of which $2,557 begin to expire in 2036 and the remainder do not expire but are subject to 80% limitation. As of December 31, 2021, the Company had state net operating loss carryforwards of $135,422 that begin to expire in 2036. The Company also has net operating loss carryforwards in Canada of $463 that are set to expire beginning in 2039. Additionally, the Company had federal research and development tax credit carryforwards of $5,439 that expire at various dates through 2041.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In assessing the realizability of the net deferred tax asset, the Company considers all relevant positive and negative evidence in determining whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The realization of the gross deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of the net operating loss carryforwards. Management believes that it is more likely than not that the Company&#8217;s deferred income tax assets will not be realized. As such, there is a full valuation allowance against the net deferred tax assets as of December&#160;31, 2021 and 2020. The valuation allowance increased by $34,305 during the year ended December&#160;31, 2021 primarily as a result of net operating losses generated during the period.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Utilization of the net operating loss carryforwards and research and development tax credit carryforwards may be subject to an annual limitation under Section 382 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section 382, which is determined by first multiplying the value of the Company&#8217;s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. Further, until a study is completed and any limitation is known, no amounts are being presented as an uncertain tax position.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company also has not conducted a study of its research and development credit carryforwards, which may result in an adjustment to research and development credit carryforwards. A full valuation allowance has been provided against the Company&#8217;s research and development credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheets or statements of operations if an adjustment were required. Further, until a study is completed and any limitation is known, no amounts are being presented as an uncertain tax position.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company applies the accounting guidance in ASC 740 related to accounting for uncertainty in income taxes. The Company&#8217;s reserves related to taxes are based on a determination of whether, and how much of, a tax benefit taken by the Company in its tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit. As of December&#160;31, 2021 and 2020, the Company had no unrecognized tax benefits. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company will recognize interest and penalties related to uncertain tax positions in income tax expense. As of December&#160;31, 2021 and 2020, the Company had no accrued interest or penalties related to uncertain tax positions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending tax examinations. As of December&#160;31, 2021 and 2020, the Company&#8217;s tax years are still open under statute from 2018 to the present.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s foreign subsidiary has incurred losses since inception and the Company had no undistributed earnings as of December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287486024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET LOSS PER SHARE</a></td>
<td class="text">NET LOSS PER SHARE<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Net loss per share</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(125,596)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(67,254)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, basic and diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">36,189,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32,907,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3.47)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2.05)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s unvested restricted common shares at December&#160;31, 2021 and 2020 have been excluded from the computation of basic net loss per share attributable to common stockholders.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s potentially dilutive securities, which include options, unvested restricted stock, shares issuable under the employee stock purchase plan and warrants to purchase common stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,903,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,752,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unvested restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shares issuable under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Warrants to purchase shares of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,970,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,817,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284734440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has historically entered into lease arrangements for its facilities. As of December&#160;31, 2021, the Company had two operating leases with required future minimum payments. In applying the transition guidance under ASC 842, the Company determined the classification of these leases to be operating leases and recorded right-of-use assets and lease liabilities as of the effective dates. The Company&#8217;s leases generally do not include termination or purchase options. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In July 2020, the Company entered into a seven-year agreement with an option to extend for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzU4Mg_b2565059-2dc9-4865-97c8-084fe9219efb">five</span> additional years to lease two floors totaling approximately 25,578 square feet of office space for its principal office, which is located in Cambridge, MA. The lease on the first floor commenced on August 1, 2020 and the lease on the second floor commenced March 9, 2021. The Company recognized the respective lease balances on the consolidated balance sheets when the lease of each floor commenced. Under the terms of the lease, the Company was required to issue a $1,168 letter of credit as security for the lease.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company previously leased an office space in Cambridge, MA under a lease that commenced in February 2019 for approximately 2,357 square feet of office space, which was set to expire on April 30, 2022, subject to an option to extend the lease for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE2NDU_becd2bb6-444f-4a5c-872f-1af74e1752f5">three</span> additional years. Effective June 15, 2021, the lease was terminated, and the remaining right-of-use asset and lease liability were derecognized. A gain of $5 was recognized for the termination of the lease.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In December 2020, the Company entered into an eleven-year agreement with an option to extend for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE3NTk_95f433d1-6446-4971-8ff9-a46e1a446767">five</span> additional years to lease approximately 18,120 square feet of office and laboratory space in New York, NY. The Company has an option to extend the lease for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEwOTk1MTE2MzI5NDU_718bdc4c-12a4-421f-9b54-25688d4ec31f">five</span> additional years. The lease commenced August 26, 2021 and the related lease balance was recognized on the consolidated balance sheet.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table contains a summary of the lease costs recognized under ASC 842 and other information pertaining to the Company&#8217;s operating lease for the years ended December&#160;31, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lease Cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,362&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,580&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Other Operating Lease Information</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The variable lease costs for the year ended December&#160;31, 2021 include common area maintenance and other operating charges. As the Company&#8217;s leases do not provide an implicit rate, the Company utilized its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Future minimum lease payments under the Company&#8217;s operating leases as of December&#160;31, 2021 were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(8,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29,468&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rent expense for the years ended December&#160;31, 2021 and 2020 was $3,921 and $1,545, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287432440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We enter into contracts in the normal course of business with contract research organizations ("CROs"), contract manufacturing organizations ("CMOs") and other third parties for preclinical research studies, Clinical Trials and testing and manufacturing services. These contracts do not contain minimum purchase commitments and are cancelable upon prior written notice. Payments due upon cancellation consist only of payments for services provided or expenses incurred, including noncancelable obligations of service providers, up to the date of cancellation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is party to license agreements, which include contingent payments. These payments will become payable if and when certain development, regulatory and commercial milestones are achieved. As of December&#160;31, 2021, the satisfaction and timing of the contingent payments is uncertain and not reasonably estimable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnification agreements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not aware of any indemnification arrangements that could have a material effect on its financial position, results of operations or cash flows, and it has not accrued any liabilities related to such obligations in its consolidated financial statements as of December&#160;31, 2021 or 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Legal proceedings</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is not currently party to and is not aware of any material legal proceedings. At each reporting date, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses as incurred the costs related to such legal proceedings.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284784504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">BENEFIT PLANS</a></td>
<td class="text">BENEFIT PLANSIn 2021, the Company transitioned from a Simplified Employee Pension (&#8220;SEP&#8221;) defined-contribution savings plan to a tax-qualified 401(k) and Profit Sharing defined contribution plan (the &#8220;401(k) Plan&#8221;). Under the 401(k) Plan, the Company provides an employer safe harbor matching contribution equal to 100% of a participant&#8217;s eligible contributions of up to 6% of eligible compensation, subject to limits established by the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the &#8220;Code&#8221;). All matching contributions are fully vested when made. During the year ended December&#160;31, 2021 and 2020, the Company contributed $927 to the 401(k) Plan and $592 to the SEP plan, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956288141560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED-PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED-PARTY TRANSACTIONS</a></td>
<td class="text">RELATED-PARTY TRANSACTIONS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company was party to a services agreement with Ridgeline, which was entered into in March 2017 and expired December 31, 2020. Ridgeline is an entity owned by one of the Company&#8217;s investors, and employees of Ridgeline provided the Company with scientific consulting services. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There was no amount due to Ridgeline at December&#160;31, 2021 and 2020. Total service fees incurred were $2,364 for the year ended December&#160;31, 2020 and no fees were incurred in 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956281299688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting</a></td>
<td class="text">Principles of consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and include the accounts of the Company and its wholly owned subsidiaries, Black Diamond Therapeutics (Canada), Inc. and Black Diamond Therapeutics Security Corporation, after elimination of all significant intercompany accounts and transactions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text">Principles of consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and include the accounts of the Company and its wholly owned subsidiaries, Black Diamond Therapeutics (Canada), Inc. and Black Diamond Therapeutics Security Corporation, after elimination of all significant intercompany accounts and transactions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">Use of estimates The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the accrual of research and development expenses and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results may differ from those estimates or assumptions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent events</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Subsequent events</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but before the final financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currency and currency translation</a></td>
<td class="text">Foreign currency and currency translation The functional currency for the Company&#8217;s wholly owned foreign subsidiary, Black Diamond Therapeutics (Canada), Inc. is the United States Dollar. Adjustments that arise from exchange rate changes on transactions denominated in a currency other than the local currency are included in other income (expense), net in the consolidated statements of operations, as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text">Cash and cash equivalents The Company classifies deposits in banks, money market funds and cash invested temporarily in various instruments with maturities of three months or less at the time of purchase as cash and cash equivalents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investments consist of marketable securities with original maturities greater than 90 days. The Company has classified its investments with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities to be available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices. Unrealized gains and losses are reported as the accumulated other comprehensive items in stockholders&#8217; equity. Amortization and accretion of premiums and discounts are recorded in other income (expense). Realized gains or losses on debt securities are included in interest income or interest expense, respectively.</span></div>If any adjustment to fair value reflects a decline in value of the investment, the Company considers all available evidence to evaluate the extent to which the decline is other than temporary and, if so, marks the investment to market on the Company&#8217;s statement of operations and comprehensive income (loss).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted cash</a></td>
<td class="text">Restricted cash In connection with its operating lease commitments, the Company maintains certain balances for security deposits that are classified as restricted cash on the consolidated balance sheets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of credit risk</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. The Company maintains accounts for all cash and cash equivalents at accredited financial institutions, in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Property and equipment</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost less accumulated depreciation. Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.171%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Laboratory equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furniture and fixtures&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Computer and office equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shorter of the useful life or remaining lease term</span></td></tr></table></div>When assets are retired or otherwise disposed of, the cost of assets disposed of and the related accumulated depreciation is removed from the accounts and any resulting gain or loss is included in the consolidated statements of operations in the period of disposal. Expenditures for repairs and maintenance are charged to expense as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long - lived assets</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Impairment of long - lived assets</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Long-lived assets consist of property and equipment. Long-lived assets to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company did not record any impairment losses on long-lived assets during the periods presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value measurements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Fair value measurements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#8212; Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#8212; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level&#160;2 inputs include the following:</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">quoted prices for similar assets and liabilities in active markets</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">quoted prices for identical or similar assets or liabilities in markets that are not active</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g.,&#160;interest rate and yield curve quotes at commonly quoted intervals)</span></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">inputs that are derived principally from or corroborated by observable market data by correlation or other means</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#8212; Unobservable inputs for the assets or liability (i.e.,&#160;supported by little or no market activity). Level&#160;3 inputs include management&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying values of the Company&#8217;s prepaid expenses and other current assets, and accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment information</a></td>
<td class="text">Segment information The Company manages its operations as a single operating segment for the purposes of assessing performance and making operating decisions. The Company&#8217;s singular focus is the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development costs and research contract costs and accruals</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Research and development costs</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop drug candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical development activities. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. </span></div>Research contract costs and accrualsThe Company has entered into various research and development-related contracts with companies both inside and outside of the United States. The related costs are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ materially from the Company&#8217;s estimates. The Company&#8217;s historical accrual estimates have not been materially different from the actual costs.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_PatentCostsPolicyPolicyTextBlock', window );">Patent costs</a></td>
<td class="text">Patent costsAll patent-related costs incurred in connection with filing and prosecuting patent applications to operations are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based compensation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company measures all stock-based awards granted to employees, non-employees and directors based on the fair value on the date of grant and recognizes compensation expense of those awards over the requisite service period, which is generally the vesting period of the respective award. Generally, the Company issues stock options and restricted stock units with only service-based vesting conditions and records the expense for these awards using the straight-line method. For stock options or restricted stock units issued with performance-based vesting conditions, the stock compensation expense related to these awards is recognized based on the grant date fair value when achievement of the performance condition is deemed probable. The Company would apply the graded-vesting method to all stock-based awards with performance-based vesting conditions or to awards with both service-based and performance based vesting conditions. Forfeitures are accounted for as they occur. </span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of each stock option grant is estimated on the date of grant using the Black- Scholes option-pricing model. The Company lacks sufficient company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The Company uses the simplified method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> prescribed by Securities and Exchange Commission Staff Accounting Bulletin No. 107, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to calculate the expected term of options granted to employees, non-employees and directors. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#8217;s payroll costs are classified or in which the award recipient&#8217;s service payments are classified.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#8217;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. </span></div>The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties. To date, the Company has not taken any uncertain tax positions or recorded any reserves, interest or penalties.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive loss</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive loss</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Comprehensive loss is composed of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on investments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net income (loss) per share</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Net income (loss) per share</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated, and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. </span></div>Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common stock. For purposes of this calculation, outstanding options, unvested restricted common stock and shares issuable under the employee stock purchase plan are considered potentially dilutive common stock and are excluded from the computation of net income (loss) per share when their effect is anti-dilutive.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at contract inception. Operating lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at the commencement date of the lease based upon the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company uses the implicit interest rate when readily determinable and uses the Company&#8217;s incremental borrowing rate when the implicit rate is not readily determinable based upon the information available at the commencement date in determining the present value of the lease payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The lease payments used to determine the Company&#8217;s operating lease assets may include lease incentives, stated rent increases and escalation clauses linked to rates of inflation, when determinable, and are recognized in the Company&#8217;s operating lease assets in the Company&#8217;s consolidated balance sheets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company&#8217;s operating leases are reflected in the right-of-use operating asset; operating lease liability, current portion; and non-current operating lease liability in the Company&#8217;s consolidated balance sheets. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Short-term leases, defined as leases that have a lease term of 12 months or less at the commencement date, are excluded from this treatment and are recognized on a straight-line basis over the term of the lease.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Variable lease payments are the amounts owed by the Company to a lessor that are not fixed, such as reimbursement for common area maintenance and utilities costs for facility leases and maintenance. Variable lease payments are expensed when incurred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Assumptions made by the Company at the commencement date are re-evaluated upon occurrence of certain events, including a lease modification. A lease modification results in a separate contract when the modification grants the lessee an additional right of use not included in the original lease and when lease payments increase commensurate with the standalone price for the additional right of use. When a lease modification results in a separate contract, it is accounted for in the same manner as a new lease.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently adopted accounting pronouncements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force) (&#8220;ASU-2021-04&#8221;). ASU 2021-04 clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The ASU provides guidance that will clarify whether an issuer should account for a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as (1) an adjustment to equity and, if so, the related earnings per share (EPS) effects, if any, or (2) an expense and, if so, the manner and pattern of recognition. The new guidance is effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted, including adoption in an interim period. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company adopted this standard on December 1, 2021 on a prospective basis, and it did not have a material impact on its disclosures, financial position or results or operations upon adoption. </span></div>In December 2019, the FASB issued ASU 2019-12, Income Taxes-Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;). ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The new standard was effective for the Company beginning January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's disclosures, financial position or results or operations upon adoption.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_PatentCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patent Costs, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_PatentCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287360872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.171%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Laboratory equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furniture and fixtures&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Computer and office equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shorter of the useful life or remaining lease term</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284784504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fair value measurements at December 31, 2021 using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63,730&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">143,987&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">207,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Fair value measurements at December 31, 2020 using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">192,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">192,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32,501&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">280,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">312,963&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287387432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, investments were comprised of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">144,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">143,987&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, investments were comprised of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">191,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">192,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. Government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">279,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">280,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284784504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.171%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Laboratory equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Furniture and fixtures&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Computer and office equipment&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shorter of the useful life or remaining lease term</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287421416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Contracted research services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Payroll and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_60506ab5-efc5-4954-abd1-b1eb79d8d8bb"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_bf8d40bd-aa95-4835-abf8-381f9a8156f6">Current portion of operating lease liability</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,535&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11,680&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956288093288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Stock Options Valuation Assumptions</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The assumptions that the Company used to determine the grant-date fair value of options granted were as follows, presented on a weighted-average basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:72.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.526%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.380%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.526%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the stock option activity under the Company&#8217;s equity awards plans:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.568%"><tr><td style="width:1.0%"/><td style="width:46.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.454%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.456%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Exercise</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Price</span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Life</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(in Years)</span></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Outstanding December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,752,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,996,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(110,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cancelled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(734,928)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Outstanding December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,903,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options vested or expected to vest at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,903,839&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,791,964&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes restricted stock activity since January 1, 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Number&#160;of</span></div><div style="margin-bottom:0.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">shares</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">average</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">grant&#160;date</span></div><div style="margin-bottom:0.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unvested restricted common stock as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6,664)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unvested restricted common stock as of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54,336&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,002)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cancelled or forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Unvested restricted common stock as of December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29.53&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense in the following award type categories included within its consolidated statements of operations and comprehensive loss:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company recorded stock-based compensation expense related to stock options and restricted stock units in the following expense categories of its consolidated statements of operations and comprehensive loss:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956364064840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Income (loss) before income tax expense consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(125,328)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(66,992)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total loss before income taxes</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(125,596)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(67,254)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Income Tax Rate Reconciliation</a></td>
<td class="text">A reconciliation of income taxes computed using the U.S. federal statutory rate to that reflected in operations as of December&#160;31, 2021 and 2020, respectively, is as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. federal statutory income tax rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">State and local taxes, net of federal benefit&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permanent differences</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Research and development credits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Change in valuation allowance&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(27.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Effective income tax rate&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.0 %</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.328%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.371%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.330%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accruals and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">70,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Valuation Allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(63,014)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(28,709)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(7,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,063)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284405400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Net Loss per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(125,596)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(67,254)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, basic and diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">36,189,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32,907,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3.47)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2.05)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share</a></td>
<td class="text">The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,903,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,752,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unvested restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shares issuable under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Warrants to purchase shares of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,970,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,817,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956371209496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Lease Cost and Other Operating Lease Information</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table contains a summary of the lease costs recognized under ASC 842 and other information pertaining to the Company&#8217;s operating lease for the years ended December&#160;31, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Lease Cost</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,362&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,580&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Other Operating Lease Information</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:2pt;margin-top:2pt"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Future minimum lease payments under the Company&#8217;s operating leases as of December&#160;31, 2021 were as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(8,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29,468&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956279278952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 03, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Jan. 21, 2020</div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.01581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Gross proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 212,101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold | shares</a></td>
<td class="nump">12,174,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares) | shares</a></td>
<td class="nump">1,587,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Gross proceeds | $</a></td>
<td class="nump">$ 231,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from stock issuance, net | $</a></td>
<td class="nump">$ 212,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares issued upon conversion | shares</a></td>
<td class="nump">21,499,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=bdtx_OpenMarketSaleMember', window );">Open Market Sale | Maximum | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from stock issuance, net | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=bdtx_OpenMarketSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=bdtx_OpenMarketSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956287457848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash | $</a></td>
<td class="nump">$ 1,223<span></span>
</td>
<td class="nump">$ 1,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956277868872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Property, Plant and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Computer and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282874504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 207,717<span></span>
</td>
<td class="nump">$ 312,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">63,730<span></span>
</td>
<td class="nump">32,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,559<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">104,066<span></span>
</td>
<td class="nump">192,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">39,921<span></span>
</td>
<td class="nump">52,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">63,730<span></span>
</td>
<td class="nump">32,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">63,730<span></span>
</td>
<td class="nump">32,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | U.S. Government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">143,987<span></span>
</td>
<td class="nump">280,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,559<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">104,066<span></span>
</td>
<td class="nump">192,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | U.S. Government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">39,921<span></span>
</td>
<td class="nump">52,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3 | U.S. Government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282235976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 144,401,000<span></span>
</td>
<td class="nump">$ 279,848,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">47,000<span></span>
</td>
<td class="nump">651,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(461,000)<span></span>
</td>
<td class="num">(37,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">143,987,000<span></span>
</td>
<td class="nump">280,462,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale', window );">Impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,543,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,559,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">104,261,000<span></span>
</td>
<td class="nump">191,977,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">47,000<span></span>
</td>
<td class="nump">608,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(242,000)<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">104,066,000<span></span>
</td>
<td class="nump">192,573,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. Government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">40,140,000<span></span>
</td>
<td class="nump">52,328,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(219,000)<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 39,921,000<span></span>
</td>
<td class="nump">$ 52,330,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282780040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 3,404<span></span>
</td>
<td class="nump">$ 549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(369)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total Property and Equipment, net</a></td>
<td class="nump">3,035<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">682<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Computer and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">2,437<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in process</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956279196584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_AccruedContractResearchServiceFeesCurrent', window );">Contracted research services</a></td>
<td class="nump">$ 12,192<span></span>
</td>
<td class="nump">$ 5,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related expenses</a></td>
<td class="nump">5,088<span></span>
</td>
<td class="nump">3,729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional and consulting fees</a></td>
<td class="nump">1,852<span></span>
</td>
<td class="nump">1,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_AccruedLegalFeesCurrent', window );">Legal fees</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 19,535<span></span>
</td>
<td class="nump">$ 11,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Current portion of operating lease liability, statement of financial position</a></td>
<td class="text">Total accrued expenses and other current liabilities<span></span>
</td>
<td class="text">Total accrued expenses and other current liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_AccruedContractResearchServiceFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Contract Research Service Fees, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_AccruedContractResearchServiceFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_AccruedLegalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Legal Fees, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_AccruedLegalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282726600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 03, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_CommonStockVotingRightsNumberOfVotesPerShare', window );">Common stock, voting rights per share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_SharesAuthorized', window );">Total shares authorized</a></td>
<td class="nump">510,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares issued upon conversion</a></td>
<td class="nump">21,499,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,499,770<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_CommonStockVotingRightsNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number Of Votes Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_CommonStockVotingRightsNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_SharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares, Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_SharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956283140216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value per share of options granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.93<span></span>
</td>
<td class="nump">$ 15.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,438<span></span>
</td>
<td class="nump">$ 4,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,037<span></span>
</td>
<td class="nump">$ 7,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost, options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=bdtx_A2020PlanMember', window );">2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, number of shares reserved (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,211,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,665,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding', window );">Increase of authorized shares, percent of common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=bdtx_A2020PlanMember', window );">2020 Plan | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in number of shares authorized (in shares)</a></td>
<td class="nump">1,449,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=bdtx_A2020PlanMember', window );">2020 Plan | Non-employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,456<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=bdtx_A2020EmployeeStockPurchasePlanMember', window );">2020 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, number of shares reserved (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding', window );">Increase of authorized shares, percent of common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=bdtx_A2020EmployeeStockPurchasePlanMember', window );">2020 ESPP | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in number of shares authorized (in shares)</a></td>
<td class="nump">326,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Unvested restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted stock vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,964<span></span>
</td>
<td class="nump">$ 7,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Authorized Shares, Percent of Common Stock Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=bdtx_A2020PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=bdtx_A2020PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=bdtx_A2020EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=bdtx_A2020EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956288353048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of Stock Options Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.93%<span></span>
</td>
<td class="nump">0.91%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">63.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956281963576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">3,752,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">1,996,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(110,621)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled or forfeited (in shares)</a></td>
<td class="num">(734,928)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">4,903,839<span></span>
</td>
<td class="nump">3,752,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested or expected to vest (in shares)</a></td>
<td class="nump">4,903,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">1,791,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 15.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">21.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">6.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled or forfeited (in dollars per share)</a></td>
<td class="nump">22.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">17.38<span></span>
</td>
<td class="nump">$ 15.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested or expected to vest (in dollars per share)</a></td>
<td class="nump">17.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable (in dollars per share)</a></td>
<td class="nump">$ 14.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Life and Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, remaining life</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options vested or expected to vest, remaining life</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable, remaining life</a></td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, intrinsic value</a></td>
<td class="nump">$ 847<span></span>
</td>
<td class="nump">$ 62,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options vested or expected to vest, intrinsic value</a></td>
<td class="nump">847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable, intrinsic value</a></td>
<td class="nump">$ 583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956281397848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of Restricted Stock Activity (Details) - Unvested restricted stock - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted common stock, beginning balance (in shares)</a></td>
<td class="nump">54,336<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">61,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(27,002)<span></span>
</td>
<td class="num">(6,664)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled or forfeited (in shares)</a></td>
<td class="num">(6,667)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted common stock, ending balance (in shares)</a></td>
<td class="nump">30,667<span></span>
</td>
<td class="nump">54,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant&#160;date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted common stock, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 29.68<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">28.69<span></span>
</td>
<td class="nump">29.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">26.46<span></span>
</td>
<td class="nump">30.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled or forfeited (in dollars per share)</a></td>
<td class="nump">1.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted common stock, ending balance (in dollars per share)</a></td>
<td class="nump">$ 29.53<span></span>
</td>
<td class="nump">$ 29.68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956281974072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 14,037<span></span>
</td>
<td class="nump">$ 7,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">12,964<span></span>
</td>
<td class="nump">7,344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bdtx_OtherAwardTypeMember', window );">Employee Stock Purchase Plan and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">6,324<span></span>
</td>
<td class="nump">3,607<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 7,713<span></span>
</td>
<td class="nump">$ 4,158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bdtx_OtherAwardTypeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bdtx_OtherAwardTypeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956277849176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Income (Loss) Before Income Tax Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Domestic</a></td>
<td class="num">$ (125,596)<span></span>
</td>
<td class="num">$ (67,254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Foreign</a></td>
<td class="num">(125,328)<span></span>
</td>
<td class="num">(66,992)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Total loss before income taxes</a></td>
<td class="num">$ (268)<span></span>
</td>
<td class="num">$ (262)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282769960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">34,305,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to uncertain tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">209,607,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Tax Year 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">2,557,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">135,422,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">463,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research and development | Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 5,439,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123452999&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_TaxPeriodExpirationAxis=bdtx_TaxYear2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_TaxPeriodExpirationAxis=bdtx_TaxYear2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956279216616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Income Tax Rate Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes, net of federal benefit</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent', window );">Permanent differences</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(27.20%)<span></span>
</td>
<td class="num">(26.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282858664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Schedule of Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets (liabilities):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 52,568<span></span>
</td>
<td class="nump">$ 24,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credits</a></td>
<td class="nump">5,439<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_DeferredTaxAssetsLeasingArrangements', window );">Operating lease liabilities</a></td>
<td class="nump">7,172<span></span>
</td>
<td class="nump">2,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Accruals and other</a></td>
<td class="nump">1,251<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">3,835<span></span>
</td>
<td class="nump">1,434<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">70,265<span></span>
</td>
<td class="nump">30,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation Allowance</a></td>
<td class="num">(63,014)<span></span>
</td>
<td class="num">(28,709)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Subtotal</a></td>
<td class="nump">7,251<span></span>
</td>
<td class="nump">2,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right-of-use assets</a></td>
<td class="num">(7,236)<span></span>
</td>
<td class="num">(2,063)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Net fixed assets</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956281884344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE - Schedule of Computation of Net Loss per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (125,596)<span></span>
</td>
<td class="num">$ (67,254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">36,189,002<span></span>
</td>
<td class="nump">32,907,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common share outstanding, diluted (in shares)</a></td>
<td class="nump">36,189,002<span></span>
</td>
<td class="nump">32,907,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in dollars per share)</a></td>
<td class="num">$ (3.47)<span></span>
</td>
<td class="num">$ (2.05)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in dollars per share)</a></td>
<td class="num">$ (3.47)<span></span>
</td>
<td class="num">$ (2.05)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282792344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities (in shares)</a></td>
<td class="nump">4,970,069<span></span>
</td>
<td class="nump">3,817,837<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities (in shares)</a></td>
<td class="nump">4,903,839<span></span>
</td>
<td class="nump">3,752,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities (in shares)</a></td>
<td class="nump">30,667<span></span>
</td>
<td class="nump">54,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">Shares issuable under employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities (in shares)</a></td>
<td class="nump">24,806<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities (in shares)</a></td>
<td class="nump">10,757<span></span>
</td>
<td class="nump">10,757<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956285020136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>contract</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Feb. 28, 2019 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_LesseeOperatingLeaseNumberOfContracts', window );">Number of leases | contract</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Gain on lease termination | $</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense | $</a></td>
<td class="nump">$ 3,921<span></span>
</td>
<td class="nump">$ 1,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=bdtx_OperatingLeasePrincipalOfficeTwoMember', window );">Principal office, July 2020 lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease term, optional extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_LesseeOperatingLeaseArea', window );">Area leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=bdtx_OperatingLeasePrincipalOfficeOneMember', window );">Principal office, February 2019 lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease term, optional extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_LesseeOperatingLeaseArea', window );">Area leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember', window );">Office and laboratory, December 2020 lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease term, optional extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_LesseeOperatingLeaseArea', window );">Area leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_LesseeOperatingLeaseArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Area</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_LesseeOperatingLeaseArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_LesseeOperatingLeaseNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_LesseeOperatingLeaseNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=bdtx_OperatingLeasePrincipalOfficeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=bdtx_OperatingLeasePrincipalOfficeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=bdtx_OperatingLeasePrincipalOfficeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=bdtx_OperatingLeasePrincipalOfficeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956282146072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Summary of Lease Cost and Other Operating Lease Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 3,032<span></span>
</td>
<td class="nump">$ 767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">444<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">4,362<span></span>
</td>
<td class="nump">1,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bdtx_LeaseOtherInformationAbstract', window );"><strong>Other Operating Lease Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of lease liability</a></td>
<td class="nump">$ 2,464<span></span>
</td>
<td class="nump">$ 432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bdtx_LeaseOtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Other Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bdtx_LeaseOtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bdtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956283011272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Schedule of Future Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>ASC 842</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 2,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">4,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">4,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">4,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">4,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">16,972<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">37,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: interest</a></td>
<td class="num">(8,028)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">$ 29,468<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956284537176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BENEFIT PLANS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution, percent of match</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employer contribution, percent of each participant's salary</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer contribution amount</a></td>
<td class="nump">$ 927<span></span>
</td>
<td class="nump">$ 592<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139956364043992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED-PARTY TRANSACTIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party expense, service fees</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,364,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>bdtx-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bdtx="http://www.blackdiamondtherapeutics.com/20211231"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bdtx-20211231.xsd" xlink:type="simple"/>
    <context id="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if04849b71fda49b0ac76f7ec9ae91cd2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i67d88009dd2c4102b42264ca253b6195_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="iebd841302b2243b09b4770b0df113b00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2aba82796ae470699e4f3168699b2c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17ab82435ae3468596555e6d8030d824_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55d6bc95d9354f76a22b6b88f8b6cd72_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9b34b944847347268c17b3eccf68fb24_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie2e2c8b847c445b7ba67c11b436983c4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib1f5d6bad537436185bfd16658adb3b4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia7230d3ada8f48d998cc556aebbd612f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i735eaadfcfea49c7baa357b1962e28d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69f2151c700c4386a8c6bd633fa2a055_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5260242f659f4520a08f001cda762732_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icfd940ec67e94e27ac3ac65f34d4ad9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f9d4ee1015f45c7b985eb5b12743b46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i881fdb998fb24439aabee87b939b2269_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8d393f5b2b3949d384d2d1dd9ad3ac38_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia824f582b29c4b53b5021124e3f932b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i15c371c9576a45658c2ba0c54e2990fa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id20739abaa504d80b915e1570af5c848_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29cff875ae6c440fb8662994fa11100f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9016a71b5edc4deeaf7161f48c70b705_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i137c8ff090914a21a31315f848506a70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie88f3aabe31b474cacd5e20c1fff19fe_D20200121-20200121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-21</endDate>
        </period>
    </context>
    <context id="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-03</startDate>
            <endDate>2020-02-03</endDate>
        </period>
    </context>
    <context id="i4a73fd2a8f9a40b4aef3a1186bd43494_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">bdtx:OpenMarketSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i907bbd4101da4791b95db60038ebf1bb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4c11721ec9b84ac3b344ba9856d4a137_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc1c05a8882d4e2d9d4375998f3f9c91_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i37550c3c6f8b4e1c82625f4812c1040f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb4739fe5f8942668fe0bc95945099a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie3b30c861e9d4e7f886845215446bbf0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i661a7771541c4be58e3c508f387d2d4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id03ea759a2df458f9a6c7ec4e73c55d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i897eb2325f8b44d682297a1bba2a1afe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe2c5749e2da4c9a9141bcf8dea4e07a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0c818a6e331498f8f622c83e82498a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7cc33891b67d4cd4881a2c22172d9038_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7310d48e883404aa8278fe354dfec1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i764cba0d028047519b61de1a37f180d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58b98a26a73545518614cf7d9628211c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65468eff9b6d46e393fd1b4dbb2b901d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4d74d028a7d465fb5fd5451c08b99d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b492035c5974422bdb650937d138473_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25857721770b4551b695d1c7721be8c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c1e51d979ec40be896fcef26d6a787b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4cddd28a59e484c974e7e00a6968a69_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3b164f107b74b22b0f4ccf27b504098_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if58ddf76db3846139fa1a52af88ebb35_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa02d2a706504ab0b7238eba43af4d07_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i742712bb4f08433e91c7107556ee12b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1d0802102ced4b2fad85fbb7b827d01a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0eada741a72e43f8878c131461b998e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3676c1e9ee8641b59223f61e35dd91d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c308fd60bb34e1681722a61e79a2c56_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66e67ca30eb94ec9b7f3040a7fbc0e27_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74033657d98945978e04c05451082f37_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i103bc24deb864971a2124cc0e9fa120a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i877ad9b6c45a4570a3dc9fa049cb3afe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62baf0a395b74b088a443289cccd0913_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ea1e1b54a744110b827b0b44b927c0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia09c76b66200416fa63f1c01d35e2fc1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d122ce461b9439dabdc048f86e95eef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba734827ba0945438f8b534d33166ac5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5fb596f6d41142a4be91b0ac53112788_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic872a3df7fa54aa58339156e79caec93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i96d17648150f42bfbdf803c2674bcf29_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1b63b5b22794ba198a5427db6ccb42a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40f1fe72d2d444aeb36925e4fcc30eb6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d9ad67327bc44648c777a18474468b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2861ec10bc3748998a17ae945f43939b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ecf9843e9ef489dab03ac86e3fbbe55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05170edcf7364cda86a8e91a6c465732_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd84886daa684164b53911ab6a5ec019_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64b0a265ea36455d88e0db82a9f72d63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i21b957706c704a949271fa3b8ecce065_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52f0c745b901427ca91dcd2d7e618786_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f6cb93d93d54cd1bb5ad6efefe6e781_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5d4aa309da524f179ebe88bd9ded86f2_D20200203-20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-03</startDate>
            <endDate>2020-02-03</endDate>
        </period>
    </context>
    <context id="i64e16b7860f94cd4a17def630f1e4f87_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="ic9eb66e638b04af899a8e80564e32d1a_I20200114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-14</instant>
        </period>
    </context>
    <context id="i48ffe9f699fa4a539801be7d17a1a76e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib81aa95c217141f292296a2bf857d7d3_D20220101-20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="id325337deaca458ba4cd7cc986b6aa01_I20200114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-14</instant>
        </period>
    </context>
    <context id="i4c378bf5d47a49fa9e52b9ba3e36d859_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia475c342c2e24f7891e04263bf9fda52_D20220101-20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i409db6c3ae2948168a94cd673a222876_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie3bf60c3f3c74cac874df7014c860584_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i494939f1eb09446097a4d8943229ee63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife703eee16a24418b0688374aa2d9127_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d213479013e4c85a590094a80d5821c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3e7beae8caf2403f8ca0392b605a96a5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0a3a672acfe3476499dfdb07a32e435a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e11f471e4864a40a07e85f2ee15dc66_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdtx:OtherAwardTypeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i64d4b8a477e44a2294dafb47b8366169_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bdtx:OtherAwardTypeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifbd32a8c30ea4113a72bd22800a1803a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idbd7ebcbc2d04c7fa4877287edf187be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bdtx:A2020PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d4f007a1e3a4f32b5564d78ab1f7548_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5a07f83801a4155974a26a9c19c163c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iead01dff07974c708a3ac77a441836f1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4d20f61caf924e11ac009ed0ff78534e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib3f540cd599244b38eb489e52a6cc2de_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5d0a15d9464476f88434bfff0ae0a67_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bdtx:TaxPeriodExpirationAxis">bdtx:TaxYear2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id37d6ea5602744e9b4b315730beac564_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib41127d5f7aa452f8b4b9e2bbc608eab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3697f799f56d4e558c172781bd1f5483_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54551aadbd8e4430aa8071d23c1c1c0e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide4e4eed14bf4310a962d48216c9ab68_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c27a225a3e24360be5046309795d54d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b93ad2715d94c1097f1ba1e707cc771_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86a156ce1dbe4eaf9a07508a2e9c2203_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3625da8da754dfe9f0c00bdb9a1ea06_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i493c609a43ce4f48b467af5ffd22630d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8023413c14d34199a01eff6173e632dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6efd849321404f36ac0949e86c2f742e_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">bdtx:OperatingLeasePrincipalOfficeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i1e74d76585884b418f0bcfdce485be83_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">bdtx:OperatingLeasePrincipalOfficeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001701541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">bdtx:OperatingLeaseOfficeAndLaboratorySpaceNYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>bdtx:segment</measure>
    </unit>
    <unit id="vote">
        <measure>bdtx:vote</measure>
    </unit>
    <unit id="contract">
        <measure>bdtx:contract</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV80L2ZyYWc6MDlmY2Q0MGRkYzdjNGY1YmIyNDFlNjUwNTc4YmQ4ZjMvdGFibGU6YjAyYzk3OTY0ZDQxNDM5YmIyMmU5MzY1MWVhMTNjZTYvdGFibGVyYW5nZTpiMDJjOTc5NjRkNDE0MzliYjIyZTkzNjUxZWExM2NlNl8yLTEtMS0xLTEwMDg3_27d53b9a-3094-4c96-a025-568ad4d58d62">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV80L2ZyYWc6MDlmY2Q0MGRkYzdjNGY1YmIyNDFlNjUwNTc4YmQ4ZjMvdGFibGU6YjAyYzk3OTY0ZDQxNDM5YmIyMmU5MzY1MWVhMTNjZTYvdGFibGVyYW5nZTpiMDJjOTc5NjRkNDE0MzliYjIyZTkzNjUxZWExM2NlNl80LTEtMS0xLTEwMDg3_6da6ccd2-aa26-4f3b-8d73-769f44670fbf">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV80L2ZyYWc6MDlmY2Q0MGRkYzdjNGY1YmIyNDFlNjUwNTc4YmQ4ZjMvdGFibGU6YjAyYzk3OTY0ZDQxNDM5YmIyMmU5MzY1MWVhMTNjZTYvdGFibGVyYW5nZTpiMDJjOTc5NjRkNDE0MzliYjIyZTkzNjUxZWExM2NlNl81LTEtMS0xLTEwMDg3_65a84fd9-ee41-4dcf-9384-b01cd22796ab">2021</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV80L2ZyYWc6MDlmY2Q0MGRkYzdjNGY1YmIyNDFlNjUwNTc4YmQ4ZjMvdGFibGU6YjAyYzk3OTY0ZDQxNDM5YmIyMmU5MzY1MWVhMTNjZTYvdGFibGVyYW5nZTpiMDJjOTc5NjRkNDE0MzliYjIyZTkzNjUxZWExM2NlNl82LTEtMS0xLTEwMDg3_53159a65-a391-4c99-b239-4afd2ba902e0">0001701541</dei:EntityCentralIndexKey>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDMvZnJhZzoxYzM3OGNkZTZmMDE0MDJlYTkwMzJlMzdkOGQxZDFlNC90YWJsZToyOTZiNDRkZjY0Mzk0MjJjYWQ0ZTBjYmNkNjkxZTNiYy90YWJsZXJhbmdlOjI5NmI0NGRmNjQzOTQyMmNhZDRlMGNiY2Q2OTFlM2JjXzEtMS0xLTEtMTAwODc_bf978e11-0a08-4286-9506-1f858f6cb697"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_60506ab5-efc5-4954-abd1-b1eb79d8d8bb">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_bf8d40bd-aa95-4835-abf8-381f9a8156f6">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i6efd849321404f36ac0949e86c2f742e_I20200731"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzU4Mg_b2565059-2dc9-4865-97c8-084fe9219efb">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i1e74d76585884b418f0bcfdce485be83_I20190228"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE2NDU_becd2bb6-444f-4a5c-872f-1af74e1752f5">P3Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE3NTk_95f433d1-6446-4971-8ff9-a46e1a446767">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEwOTk1MTE2MzI5NDU_718bdc4c-12a4-421f-9b54-25688d4ec31f">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <dei:DocumentType
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8xMjY_afbbe252-1b0a-4299-98ca-5a2281f60d55">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6NjQ1MjJkOWY2ZTY0NDQ2NmIwNjQzN2NlYjdhZDY3ZjgvdGFibGVyYW5nZTo2NDUyMmQ5ZjZlNjQ0NDY2YjA2NDM3Y2ViN2FkNjdmOF8wLTAtMS0xLTEwMDg3_079d4d8a-81d0-4ee3-a3c9-1c311cfee7c5">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yMDE_6468a1df-cad1-407e-8852-fc5117e1b356">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yMDE_207d33b6-f098-4f15-a1c9-6826f6ec567d">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6Zjg3ZjExMTY5MDc3NDFjOGIwMzQ5N2VlNGFkMmUxNGEvdGFibGVyYW5nZTpmODdmMTExNjkwNzc0MWM4YjAzNDk3ZWU0YWQyZTE0YV8wLTAtMS0xLTEwMDg3_58befa83-9891-4210-88e2-be0746d7d9b8">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yNzA_90fffbc4-9dcd-41eb-af25-39977650598f">001-38501</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8zMTc_be80d689-6e55-4f2f-af9a-c6373fa7abab">BLACK DIAMOND THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8wLTAtMS0xLTEwMDg3_2ea0eec6-263c-48c1-bb63-520f5af74230">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8wLTEtMS0xLTEwMDg3_9961572f-09b1-466e-8769-40a11964bf96">81-4254660</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8yLTAtMS0xLTEwMDg3L3RleHRyZWdpb246Yjg1YTY5NDNjMzAxNDE1Yjk1YjEwODE2NzQzOGJlNDBfNQ_a185a9ff-ddb9-467e-b4e0-d30017a81aed">One Main Street, 10th Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8yLTAtMS0xLTEwMDg3L3RleHRyZWdpb246Yjg1YTY5NDNjMzAxNDE1Yjk1YjEwODE2NzQzOGJlNDBfOQ_1cfe3ca4-fa59-4be7-b405-57485d18703a">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8yLTAtMS0xLTEwMDg3L3RleHRyZWdpb246Yjg1YTY5NDNjMzAxNDE1Yjk1YjEwODE2NzQzOGJlNDBfMTM_5af17f7e-d2f3-4097-abd2-7f37c30b807d">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8yLTEtMS0xLTEwMDg3L3RleHRyZWdpb246YmYxZGNlMWM3OWZmNGMzNDgyM2Q2MzM1YzE0M2M4MDhfNQ_9c0efaeb-edcc-4cfe-8ecd-2e8b1a1ae6c4">02142</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8zLTAtMS0xLTEwMDg3L3RleHRyZWdpb246MjQ4OGMwMWNiOGQ1NGI4YmE1YmNmNDhmZTdkZWExNTlfNQ_ebb01eac-baf3-48c1-8615-d473f17f55df">(617)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MWZlNjc0ZTFlNzI4NGI0OGJlZmE5N2E5MDhkZWYyMmQvdGFibGVyYW5nZToxZmU2NzRlMWU3Mjg0YjQ4YmVmYTk3YTkwOGRlZjIyZF8zLTAtMS0xLTEwMDg3L3RleHRyZWdpb246MjQ4OGMwMWNiOGQ1NGI4YmE1YmNmNDhmZTdkZWExNTlfOA_3d20676c-db45-4cb2-a13f-a63b07621b37">252-0848</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6ZjcwY2VmYjMyOTk1NGMwY2ExYWMyZmY0MDUxN2RiZmYvdGFibGVyYW5nZTpmNzBjZWZiMzI5OTU0YzBjYTFhYzJmZjQwNTE3ZGJmZl8xLTAtMS0xLTEwMDg3_49f91f7f-f7b2-44be-936b-3ee49581484d">Common stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6ZjcwY2VmYjMyOTk1NGMwY2ExYWMyZmY0MDUxN2RiZmYvdGFibGVyYW5nZTpmNzBjZWZiMzI5OTU0YzBjYTFhYzJmZjQwNTE3ZGJmZl8xLTEtMS0xLTEwMDg3_8ae33817-3b77-48df-866e-ceb4a721fdeb">BDTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6ZjcwY2VmYjMyOTk1NGMwY2ExYWMyZmY0MDUxN2RiZmYvdGFibGVyYW5nZTpmNzBjZWZiMzI5OTU0YzBjYTFhYzJmZjQwNTE3ZGJmZl8xLTItMS0xLTEwMDg3_3ff37971-cdf0-4f1c-ae5d-a44a33afc26b">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl83MzE_75882c45-1d61-4a34-a398-03c3081b8d24">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl84NzU_704b7ce9-f8d2-440d-bd3c-b14d8d437cd0">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8xMjI5_c06db94a-ef84-4126-b324-935a927760f4">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8xNTU2_b2c490ac-99fb-40e7-96b4-2f8a4c606ba5">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MGU0OGY5NzU1NGYxNDIyOGE0NTAwMzBjOTJmMzBmNWUvdGFibGVyYW5nZTowZTQ4Zjk3NTU0ZjE0MjI4YTQ1MDAzMGM5MmYzMGY1ZV8yLTAtMS0xLTEwMDg3_532f007d-f756-41c1-8851-fee2fd576b89">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MGU0OGY5NzU1NGYxNDIyOGE0NTAwMzBjOTJmMzBmNWUvdGFibGVyYW5nZTowZTQ4Zjk3NTU0ZjE0MjI4YTQ1MDAzMGM5MmYzMGY1ZV8yLTMtMS0xLTEwMDg3_cca31733-a277-4591-aaea-95ea49cf5169">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGFibGU6MGU0OGY5NzU1NGYxNDIyOGE0NTAwMzBjOTJmMzBmNWUvdGFibGVyYW5nZTowZTQ4Zjk3NTU0ZjE0MjI4YTQ1MDAzMGM5MmYzMGY1ZV80LTMtMS0xLTEwMDg3_dedf042e-971d-4f58-b7d5-c111c8b49c52">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yMTcy_96b074f6-1b64-4f93-bda1-934ac2cecaa9">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8zOTcw_c611bcbb-58ad-437a-b0a0-642039aebb14">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yNjM1_f8b61f3b-8e56-45a9-98a0-8949faff0f84">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="if04849b71fda49b0ac76f7ec9ae91cd2_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8yODc2_6c0a35bd-bf8f-4c83-8437-37508f6bfdff"
      unitRef="usd">340487618</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i67d88009dd2c4102b42264ca253b6195_I20220228"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8zMzAw_8fe02dcf-6ffb-40bd-8a46-36cbb13dbf49"
      unitRef="shares">36271465</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xL2ZyYWc6NTc2Mjg2N2VkNTMzNDM0M2EwODM1MGFlZjJiNjhmMmIvdGV4dHJlZ2lvbjo1NzYyODY3ZWQ1MzM0MzQzYTA4MzUwYWVmMmI2OGYyYl8zOTcx_0837d8f1-0bec-4483-8666-23d2162de916">Part III of this Annual Report on Form 10-K incorporates by reference certain information from the definitive Proxy Statement for the registrant&#x2019;s 2022 Annual Meeting of Stockholders, or the Proxy Statement, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#x2019;s fiscal year ended December&#160;31, 2021. Except with respect to information specifically incorporated by reference, the Proxy Statement is not deemed to be filed as part of this Annual Report on Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV83Ni9mcmFnOjAxMzE4MzgwMzJhMzQ4YjE5ZWUyMGZjOGIwZWYwMGE4L3RhYmxlOjU1OThmNjhjMDU1MTRmMWM5MjM1N2EwNDY3Yzg5MTcyL3RhYmxlcmFuZ2U6NTU5OGY2OGMwNTUxNGYxYzkyMzU3YTA0NjdjODkxNzJfMS0wLTEtMS0xMzU5MC90ZXh0cmVnaW9uOjdhMDk3YTBlODVhNjQ0ZjA5YWZhYmQwM2Y4ZjgyMWM1XzIxOTkwMjMyNTU2ODY_26a2ef69-e915-4233-8ba5-55ca0fbda8ba">238</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV83OS9mcmFnOjgwZGQxMTE0MWY5ZDRlNmM5OTIxYTA4ZDI1NGJhNDcxL3RhYmxlOmM4M2Q2ZTU0Yzk3ZDRkMjE4ZDJmMjBmNzkwYTIwOGYzL3RhYmxlcmFuZ2U6YzgzZDZlNTRjOTdkNGQyMThkMmYyMGY3OTBhMjA4ZjNfMS0wLTEtMS0xMDkyMg_1d0ab452-211e-40aa-bf85-c3ea937201fc">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV83OS9mcmFnOjgwZGQxMTE0MWY5ZDRlNmM5OTIxYTA4ZDI1NGJhNDcxL3RhYmxlOmM4M2Q2ZTU0Yzk3ZDRkMjE4ZDJmMjBmNzkwYTIwOGYzL3RhYmxlcmFuZ2U6YzgzZDZlNTRjOTdkNGQyMThkMmYyMGY3OTBhMjA4ZjNfMy0wLTEtMS0xMzg2MQ_82cb1ea9-c810-4343-a055-e7be3a54b4ae">Boston, Massachusetts</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNC0xLTEtMS0xMDA4Nw_e60c3b16-18cb-4e80-aed7-c76fa85cbb8a"
      unitRef="usd">65799000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNC0zLTEtMS0xMDA4Nw_59f52b20-7565-4258-be6f-d3dededebd53"
      unitRef="usd">34605000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNS0xLTEtMS0xMDA4Nw_df9417dd-6e81-4ea1-87f1-e8c653d13fe0"
      unitRef="usd">143987000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNS0zLTEtMS0xMDA4Nw_aa4b4c96-ff8d-4f68-aab0-16b5706c79bc"
      unitRef="usd">280462000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNi0xLTEtMS0xMDA4Nw_0b51809a-0cc3-4981-bf3d-b24c95d843e8"
      unitRef="usd">5917000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNi0zLTEtMS0xMDA4Nw_0f12806b-510e-4602-a857-832624369fe9"
      unitRef="usd">4487000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNy0xLTEtMS0xMDA4Nw_df28c2af-3c07-4869-bf9e-0bd2a3fbb3cc"
      unitRef="usd">215703000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfNy0zLTEtMS0xMDA4Nw_87d16c2d-eb20-4d57-8a05-8fce5bb59dc0"
      unitRef="usd">319554000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfOC0xLTEtMS0xMDA4Nw_916760a6-238c-4e96-aefc-6c9a6fac198c"
      unitRef="usd">3035000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfOC0zLTEtMS0xMDA4Nw_dfc00bdb-3d5a-4a06-a5a0-e198fbc81837"
      unitRef="usd">385000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfOS0xLTEtMS0xMDA4Nw_a80559e5-ae52-4484-8b34-dbc957acfe22"
      unitRef="usd">1223000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfOS0zLTEtMS0xMDA4Nw_b0a9d35f-dd67-44ba-909f-049d3887aef9"
      unitRef="usd">1223000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTEtMS0xLTEtMTAwODc_36156040-0ef5-43f6-9d9e-376a7c366a5e"
      unitRef="usd">27705000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTEtMy0xLTEtMTAwODc_e455f962-eff1-4bd7-824a-ee3e2352384e"
      unitRef="usd">8402000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTItMS0xLTEtMTAwODc_7184efd5-cd73-4a82-97fa-7830701a8ea8"
      unitRef="usd">16000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTItMy0xLTEtMTAwODc_3909222b-c0b8-4237-a056-40a5909654e6"
      unitRef="usd">106000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTMtMS0xLTEtMTAwODc_8d746af5-24e8-4eaf-bea7-d6449b1ccb43"
      unitRef="usd">247682000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTMtMy0xLTEtMTAwODc_cb5819a2-a66e-4475-a4de-6addfc2d4ce9"
      unitRef="usd">329670000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTYtMS0xLTEtMTAwODc_97daf099-90b3-4c6c-8ae1-f25e5241e30c"
      unitRef="usd">4107000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTYtMy0xLTEtMTAwODc_3edb2d20-67ba-4ffb-a6df-89839ea74d58"
      unitRef="usd">2538000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTgtMS0xLTEtMTAwODc_22470e44-45b4-4676-bb09-e66638ed7a6d"
      unitRef="usd">19535000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTgtMy0xLTEtMTAwODc_2f72b46e-e058-4bc3-9927-5041f90df74d"
      unitRef="usd">11680000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTktMS0xLTEtMTAwODc_cc187b77-22c7-4f08-876a-ac6d436d5129"
      unitRef="usd">23642000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMTktMy0xLTEtMTAwODc_c6731215-1b58-4aa1-83b9-80f278a8e50c"
      unitRef="usd">14218000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjEtMS0xLTEtMTAwODc_7dae6b9f-a54a-4287-ac34-97bfd72914e7"
      unitRef="usd">28140000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjEtMy0xLTEtMTAwODc_312f19fa-2b92-441b-bf95-643fa59e9183"
      unitRef="usd">7694000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjItMS0xLTEtMTAwODc_568e265e-7598-477d-b0ed-d36fba914357"
      unitRef="usd">51782000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjItMy0xLTEtMTAwODc_b3702a3a-c742-47cd-8781-37a8c06b8f1e"
      unitRef="usd">21912000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjMtMS0xLTEtMTAwODc_c002590c-5f25-4efd-9b4e-25be58375432"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjMtMy0xLTEtMTAwODc_69ce7493-f498-4951-9e45-6969c487e476"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml8yMQ_a520e5ff-4c5b-4638-a26d-9d41d15e686d"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml8yMQ_acb93e29-706a-4be1-9e02-dbb9a9adc91c"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml8zNQ_23c0f6d5-be14-4010-a11d-bd340701bc0f"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml80OQ_dd856930-cb04-4ac2-91ce-9ac38ccdf7f3"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml85OA_42d55e97-1539-4656-83d9-df8d49282ab7"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml85OA_4774e74b-a1e3-408a-baf7-783ad42de779"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml85OA_a255f32d-2f3b-4f9e-b003-9c0e8e465b88"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjpmZGZjNjM1MmE1MGI0ODUxYTlhYjM5NGI4YTNkY2M1Ml85OA_a428a150-13b0-419f-901f-c5fdae5ede8d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMS0xLTEtMTAwODc_3830b063-1a1e-4966-83f4-fcaea5c16240"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjYtMy0xLTEtMTAwODc_8b680ca7-c795-4c67-86b5-9e9068f1f96a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8xOQ_fb2c2e79-25e6-4c62-8d17-d5c73235945f"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8xOQ_fddd8927-264a-423c-be92-76be56ce153d"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8zMw_012c3ecd-4294-46c5-a6c5-daf5a729e1ec"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF82NA_9b01e40b-62fc-4db8-b220-246119800d83"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF85Mg_9f0b4460-01f6-482b-b573-d15c98583ba2"
      unitRef="shares">36234624</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF85Mg_dec7c3f6-327c-4cbc-a571-d4fd8a6a5a85"
      unitRef="shares">36234624</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8xMzU_34d1781f-85f4-4eb1-8c10-42ab8e921df7"
      unitRef="shares">36078383</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyZGJkNDE0OGJmYzA0MTgyYWY0NzRkNDg3NDdiMTNmNF8xMzU_b1b7160c-d601-49d8-baf8-0ba27063535a"
      unitRef="shares">36078383</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMS0xLTEtMTAwODc_289fefb1-8615-4038-8ade-8f1cb5bc0085"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjctMy0xLTEtMTAwODc_162b3d37-1552-4519-ab4b-7bd5f85be38c"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjgtMS0xLTEtMTAwODc_45dfcbd4-7898-4a46-a4fe-e0e5fcdbbea4"
      unitRef="usd">440129000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjgtMy0xLTEtMTAwODc_d94957ea-97c0-41b5-9b00-9b897d1fba2a"
      unitRef="usd">425363000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjktMS0xLTEtMTAwODc_5b1e4afc-4c97-4866-8337-ed9c10f4c653"
      unitRef="usd">-414000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMjktMy0xLTEtMTAwODc_31ba5dd5-1d8b-47d5-86da-404629a46eae"
      unitRef="usd">614000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzAtMS0xLTEtMTAwODc_10432fb5-606e-4179-b2ef-d839408a4605"
      unitRef="usd">-243820000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzAtMy0xLTEtMTAwODc_919aaf78-8a7d-417c-af2a-bbb7e253295a"
      unitRef="usd">-118224000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzEtMS0xLTEtMTAwODc_a3d050eb-3b55-4086-8cce-c76d3d28092f"
      unitRef="usd">195900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzEtMy0xLTEtMTAwODc_4158151d-cab0-4d4b-ad86-3faf012d9525"
      unitRef="usd">307758000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzItMS0xLTEtMTAwODc_a7e17c17-5c9b-42b4-bd0d-62a7a3747c23"
      unitRef="usd">247682000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84Mi9mcmFnOjA3ZGM2Mzk2YWFlZDQwNTQ4MzhjN2I3YzMxZTQ0NDczL3RhYmxlOjc2ZmQxYzMwMDliZTQwNGM4ZDUxMjk4N2Y0ZGJkZWViL3RhYmxlcmFuZ2U6NzZmZDFjMzAwOWJlNDA0YzhkNTEyOTg3ZjRkYmRlZWJfMzItMy0xLTEtMTAwODc_87cc291e-ccab-4705-a3e0-3ee2f3dd5669"
      unitRef="usd">329670000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMy0xLTEtMS0xMDA4Nw_5de2613f-8d68-40c0-be80-9c228c59c6c6"
      unitRef="usd">96829000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMy0zLTEtMS0xMDA4Nw_f11658c9-9d20-4e0c-bd1f-b511a1eaee0f"
      unitRef="usd">48209000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNC0xLTEtMS0xMDA4Nw_f7b0c409-e23b-4c08-b0a0-294882dc995b"
      unitRef="usd">30043000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNC0zLTEtMS0xMDA4Nw_b75ca716-179f-43bd-93c1-5925bc25d43a"
      unitRef="usd">21361000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNS0xLTEtMS0xMDA4Nw_50845b6d-f503-40a3-912f-cd09ed551d88"
      unitRef="usd">126872000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNS0zLTEtMS0xMDA4Nw_7b924fb4-7b7c-4984-94a5-fd881bc88095"
      unitRef="usd">69570000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNi0xLTEtMS0xMDA4Nw_aac7748c-e5aa-425a-a65f-a34a2681a360"
      unitRef="usd">-126872000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfNi0zLTEtMS0xMDA4Nw_fd436453-e0ab-405b-bb2c-ad02f0c568ca"
      unitRef="usd">-69570000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfOC0xLTEtMS0xMDA4Nw_62b0b98b-7b1b-4a5b-a9b9-8f8d62911946"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfOC0zLTEtMS0xMDA4Nw_0485f39f-8f1d-45d8-a040-8e0e0bdc6515"
      unitRef="usd">1000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfOS0xLTEtMS0xMDA4Nw_e5f749ca-060a-417b-b895-70a745e06882"
      unitRef="usd">3464000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfOS0zLTEtMS0xMDA4Nw_42deda1e-305c-4ee2-9d40-0913eb8173a3"
      unitRef="usd">4041000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTEtMS0xLTEtMTAwODc_cdb47f78-78d7-4afb-a1c2-f787a990d623"
      unitRef="usd">-2188000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTEtMy0xLTEtMTAwODc_31cd018a-5717-4809-9866-da14d229842e"
      unitRef="usd">-1724000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTItMS0xLTEtMTAwODc_8ecd63a0-fb2f-42ab-ac5b-60d24279fd27"
      unitRef="usd">1276000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTItMy0xLTEtMTAwODc_f07d43ca-5e30-44e3-86af-3af8a5934703"
      unitRef="usd">2316000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTMtMS0xLTEtMTAwODc_502c279e-be5a-40aa-861b-2ff8246ee50f"
      unitRef="usd">-125596000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTMtMy0xLTEtMTAwODc_4b3032ef-5f4f-459a-808a-8bee6912cf66"
      unitRef="usd">-67254000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTQtMS0xLTEtMTAwODc_06e4115e-0115-47c8-b85b-258d2e834d0f"
      unitRef="usdPerShare">-3.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTQtMS0xLTEtMTAwODc_5d315f2e-48c4-4803-9fa8-fa93c1c8db4f"
      unitRef="usdPerShare">-3.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTQtMy0xLTEtMTAwODc_59036008-6c67-4712-a6bb-0e014809c9d9"
      unitRef="usdPerShare">-2.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTQtMy0xLTEtMTAwODc_7b7c9f5f-fba5-419c-a70b-8ea75c2698c2"
      unitRef="usdPerShare">-2.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTUtMS0xLTEtMTAwODc_15345032-2df8-469a-918a-46b85c892955"
      unitRef="shares">36189002</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTUtMS0xLTEtMTAwODc_938aa0ab-fb59-4d40-b27a-336d36e17ed4"
      unitRef="shares">36189002</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTUtMy0xLTEtMTAwODc_b926b935-446c-4859-ab73-e79a3b79919c"
      unitRef="shares">32907100</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTUtMy0xLTEtMTAwODc_d0470d57-08dd-4952-b01a-a483acc17013"
      unitRef="shares">32907100</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTgtMS0xLTEtMTAwODc_12d5db37-8287-41fa-b997-54af34be4a96"
      unitRef="usd">-125596000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMTgtMy0xLTEtMTAwODc_d177b8e4-f07b-45f2-86e7-9d78da86e5d8"
      unitRef="usd">-67254000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMjAtMS0xLTEtMTAwODc_50d46a28-6e4a-4c16-9b6f-e7242c646c6f"
      unitRef="usd">-1028000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMjAtMy0xLTEtMTAwODc_7a846f8c-1866-4d5d-a1d1-9577c84a02f5"
      unitRef="usd">614000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMjEtMS0xLTEtMTAwODc_705309c8-43d4-4e40-a319-671b6b81afa9"
      unitRef="usd">-126624000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84NS9mcmFnOjQ1ZmE0ZjlhZTA5MDRkMjU5NTRhYTM3MDdhNGJhOWRjL3RhYmxlOmQxYjIzM2VmNTMxNzQ4OTFhOGU0NzY4ODRjNmQwNTI5L3RhYmxlcmFuZ2U6ZDFiMjMzZWY1MzE3NDg5MWE4ZTQ3Njg4NGM2ZDA1MjlfMjEtMy0xLTEtMTAwODc_01d11d70-6130-4134-8847-729316b5791e"
      unitRef="usd">-66640000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMy0xLTEtMS0xMDA4Nw_b8a46987-4f30-4cbb-88cc-a71bf58b79a3"
      unitRef="usd">-125596000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMy0zLTEtMS0xMDA4Nw_5fb90023-4f7d-4782-8032-2c66689fe2c9"
      unitRef="usd">-67254000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNS0xLTEtMS0xMDA4Nw_38bcc1b4-7c2e-4a31-b8fe-2f18233679e9"
      unitRef="usd">14037000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNS0zLTEtMS0xMDA4Nw_261c81b0-2883-46d5-aa3c-fae69aed17b5"
      unitRef="usd">7765000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNy0xLTEtMS0xMDA4Nw_931c1c8c-0cc5-4b9b-948f-ae220a789640"
      unitRef="usd">205000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNy0zLTEtMS0xMDA4Nw_87331589-46e8-4bf6-8cc8-1d34b2aa775b"
      unitRef="usd">52000</us-gaap:Depreciation>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfOC0xLTEtMS0xMDA4Nw_6f68199e-ae27-496a-8c08-eb4890d419fb"
      unitRef="usd">2186000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfOC0zLTEtMS0xMDA4Nw_bb56073d-2344-47d5-b17a-361ca253f2b7"
      unitRef="usd">1725000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <bdtx:RentExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfOS0xLTEtMS0xMDA4Nw_d71f6a5c-228b-4236-b49c-0234ebaf824c"
      unitRef="usd">2012000</bdtx:RentExpense>
    <bdtx:RentExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfOS0zLTEtMS0xMDA4Nw_4cf5c2be-4f8b-49e6-9f43-1b8bc8bef292"
      unitRef="usd">548000</bdtx:RentExpense>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTAtMS0xLTEtMTAwODc_2209da19-b2dc-42f8-8413-6d4980a796a1"
      unitRef="usd">10000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTAtMy0xLTEtMTAwODc_a8e2893f-467f-4913-9413-403779c6fe70"
      unitRef="usd">24000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTEtMS0xLTEtMTI3MDY_0d4ef2e5-e357-46ad-ad39-ab4ef6ca39af"
      unitRef="usd">5000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTEtMy0xLTEtMTI3MDY_20ec27fd-9fff-4ae7-8b6c-c4bfb286a56f"
      unitRef="usd">0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTEtMS0xLTEtMTAwODc_5ae0fcfd-9341-4951-b685-ac0d8e457c5f"
      unitRef="usd">-3000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTEtMy0xLTEtMTAwODc_657e25f5-3400-491a-ba2b-147f726f60fa"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTMtMS0xLTEtMTAwODc_78c4f420-9671-4971-8864-22d00a7eb991"
      unitRef="usd">1628000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTMtMy0xLTEtMTAwODc_1acc46ac-2392-4e1c-a087-7a9125baa6ed"
      unitRef="usd">3439000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTQtMS0xLTEtMTAwODc_c99d0c43-5592-4e42-8005-16ce78f5083b"
      unitRef="usd">-90000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTQtMy0xLTEtMTAwODc_aaea6592-d6bf-48c8-9b80-8286d6b2e976"
      unitRef="usd">47000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTUtMS0xLTEtMTAwODc_c651da8a-33da-4c7a-a791-2950d08c4065"
      unitRef="usd">1569000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTUtMy0xLTEtMTAwODc_9446ca93-2724-4d86-bc14-634c00cc69ab"
      unitRef="usd">1069000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTctMS0xLTEtMTAwODc_4da0b33d-e512-45b2-ba14-6401b5706875"
      unitRef="usd">8714000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTctMy0xLTEtMTAwODc_e977e49a-7b13-4462-ac2e-f1c980c2e051"
      unitRef="usd">8026000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <bdtx:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTgtMS0xLTEtMTAwODc_c46b8cdb-1440-4bd8-9543-3fcd526eb56e"
      unitRef="usd">-1725000</bdtx:IncreaseDecreaseInOperatingLeaseLiabilities>
    <bdtx:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTgtMy0xLTEtMTAwODc_397fcae2-6140-4815-a5ce-b20fe461c125"
      unitRef="usd">-567000</bdtx:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTktMS0xLTEtMTAwODc_b98be9ad-2f91-45bc-969b-16e5d9f53c0d"
      unitRef="usd">-100148000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMTktMy0xLTEtMTAwODc_64dc3072-c90b-4dd5-9ee1-0609f5eea88e"
      unitRef="usd">-52146000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjItMS0xLTEtMTAwODc_b250ab3e-4681-4261-9987-9a908f736de1"
      unitRef="usd">2710000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjItMy0xLTEtMTAwODc_8f232bff-2f5a-4115-9814-a691e128fab1"
      unitRef="usd">142000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjMtMS0xLTEtMTAwODc_0329532b-37ea-453a-aab5-64da355b2ba5"
      unitRef="usd">182831000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjMtMy0xLTEtMTAwODc_f32d6bb1-67ff-4f47-9aec-15ee18313428"
      unitRef="usd">90928000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjQtMS0xLTEtMTAwODc_5866fed1-6921-4a58-8e9b-1f0e3b394d9b"
      unitRef="usd">49508000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjQtMy0xLTEtMTAwODc_b1c4de95-7341-48fc-8466-864280f6ab3b"
      unitRef="usd">372477000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjUtMS0xLTEtMTAwODc_be5c7b80-1bb7-45cd-b9e8-f6528d48e4d8"
      unitRef="usd">130613000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjUtMy0xLTEtMTAwODc_5306bbf2-b03c-4194-a970-375609de66f5"
      unitRef="usd">-281691000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjktMS0xLTEtMTAwODc_a762379e-a882-4a38-8073-05180a1ebe7e"
      unitRef="usd">729000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMjktMy0xLTEtMTAwODc_892cf5a6-da38-4d88-995e-8f8ed1ecd29a"
      unitRef="usd">1100000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzAtMC0xLTEtMTAwODcvdGV4dHJlZ2lvbjoyYjk3MTUxMmE4ODM0YzhjYjA2MjE4YjAzNzNhYTdmMl82OA_e783f111-3571-4986-a6c7-b270f12d8174"
      unitRef="usd">1275000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzAtMS0xLTEtMTAwODc_99f652c8-16a8-4cac-8345-8a216ae56072"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzAtMy0xLTEtMTAwODc_057785ba-e3ed-42b4-8352-c613fc0691c6"
      unitRef="usd">213844000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzItMS0xLTEtMTAwODc_9c0123d2-39a2-44d5-9291-cafddb9a6606"
      unitRef="usd">729000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzItMy0xLTEtMTAwODc_2248550d-b255-4e09-b6ae-0eb148a2c422"
      unitRef="usd">214944000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzMtMS0xLTEtMTAwODc_577f3a6f-fa81-45a8-a430-16c0c36725b5"
      unitRef="usd">31194000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzMtMy0xLTEtMTAwODc_6ca5bf4a-c80d-43d8-ab55-0a290f54d04e"
      unitRef="usd">-118893000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzQtMS0xLTEtMTAwODc_4d8620b7-3fc4-4c23-a2f4-7809245cf162"
      unitRef="usd">35828000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i55d6bc95d9354f76a22b6b88f8b6cd72_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzQtMy0xLTEtMTAwODc_3c92645e-73ae-4fc2-a9ee-2e975f56fd8f"
      unitRef="usd">154721000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzUtMS0xLTEtMTAwODc_d4f65c62-416a-4978-bd82-b3f9703156a9"
      unitRef="usd">67022000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzUtMy0xLTEtMTAwODc_347abbeb-1b63-4031-bee0-639456a4a151"
      unitRef="usd">35828000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzctMS0xLTEtMTAwODc_ff8eb624-c140-4034-a775-22066b1a45fb"
      unitRef="usd">65799000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzctMy0xLTEtMTAwODc_16354abb-33c5-4b07-969b-f3b9ba6d0dcd"
      unitRef="usd">34605000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzgtMS0xLTEtMTAwODc_aea17fc4-15c5-492d-82ed-56e52b4af8f6"
      unitRef="usd">1223000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzgtMy0xLTEtMTAwODc_24633c42-2153-4f35-ae8a-a573f9b6c7cd"
      unitRef="usd">1223000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzktMS0xLTEtMTAwODc_0aa48597-5cf1-470c-a4c0-34259d493b59"
      unitRef="usd">67022000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfMzktMy0xLTEtMTAwODc_74a18b8e-11b6-420c-959e-aa763a6dad99"
      unitRef="usd">35828000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDQtMS0xLTEtMTAwODc_a8683e26-d44e-4418-bd4e-ba8ada9efbd3"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDQtMy0xLTEtMTAwODc_a2ca9cd4-507b-4a7c-8c94-524eeda9b2f6"
      unitRef="usd">200573000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDUtMS0xLTEtMTAwODc_6851a796-0707-4eed-a803-d2a09a623e0e"
      unitRef="usd">21505000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDUtMy0xLTEtMTAwODc_0ea0bb3e-2f41-4897-958b-b437c8d9f74f"
      unitRef="usd">8474000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <bdtx:RightOfUseAssetDerecognizedTerminationOfLease
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDctMS0xLTEtMTI3MTU_a0acac11-b786-4fe2-b8d5-6a6ffcbd0a6d"
      unitRef="usd">476000</bdtx:RightOfUseAssetDerecognizedTerminationOfLease>
    <bdtx:RightOfUseAssetDerecognizedTerminationOfLease
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV84OC9mcmFnOjA2MGJlYWYzNDc3NjRlYjViYmIwNzQ4ZmY2Mzg2NDFmL3RhYmxlOjg4ZjE5NjMwNzMwNzQwOWM4NTU0ZmVjZmQ2MWIzZjM2L3RhYmxlcmFuZ2U6ODhmMTk2MzA3MzA3NDA5Yzg1NTRmZWNmZDYxYjNmMzZfNDctMy0xLTEtMTI3MTU_0bf4548f-6413-448c-89b2-e76440848088"
      unitRef="usd">0</bdtx:RightOfUseAssetDerecognizedTerminationOfLease>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9b34b944847347268c17b3eccf68fb24_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC02LTEtMS0xMDA4Nw_3b72ab1a-5adc-4c35-a8d7-11d03877c3b5"
      unitRef="shares">2236672</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9b34b944847347268c17b3eccf68fb24_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC04LTEtMS0xMDA4Nw_b8891537-bc32-4654-88f8-1ba0b43777bf"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie2e2c8b847c445b7ba67c11b436983c4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC0xMC0xLTEtMTAwODc_002ac495-337c-4b80-9bf0-f424687bcf7c"
      unitRef="usd">3812000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib1f5d6bad537436185bfd16658adb3b4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC0xMi0xLTEtMTAwODc_a8999c2a-b35f-4ce5-941b-c49cb0e14099"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia7230d3ada8f48d998cc556aebbd612f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC0xNC0xLTEtMTAwODc_4c0e38da-b397-4f5e-a97e-c65b6bdc99c4"
      unitRef="usd">-50970000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55d6bc95d9354f76a22b6b88f8b6cd72_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOC0xNi0xLTEtMTAwODc_f410e8c0-be2a-43c2-bd0e-25d89f2e719d"
      unitRef="usd">-47157000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOS02LTEtMS0xMDA4Nw_1b887681-1740-41b8-9dfe-84109606c078"
      unitRef="shares">21499770</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOS04LTEtMS0xMDA4Nw_9b3b7246-844d-405a-82e2-2c7cfbab2301"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOS0xMC0xLTEtMTAwODc_9d349561-ae9a-4004-a435-ec5f6a032676"
      unitRef="usd">200570000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfOS0xNi0xLTEtMTAwODc_d5f1e2dc-f173-445f-b88c-c3a5e92980ea"
      unitRef="usd">200573000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTAtNi0xLTEtMTAwODc_e5623fca-bfb1-4b10-a29d-26b2b02f7d4a"
      unitRef="shares">12174263</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTAtOC0xLTEtMTAwODc_86663d5c-72a8-4674-b277-1806f24f496a"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTAtMTAtMS0xLTEwMDg3_353b1226-675c-4dab-b778-d611179656a4"
      unitRef="usd">212100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTAtMTYtMS0xLTEwMDg3_242e57a8-8713-4cd5-a82c-bce8bf680c98"
      unitRef="usd">212101000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTEtMTAtMS0xLTEwMDg3_dc8f5237-ee9b-4972-a9f4-8cc7ba8de87e"
      unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTEtMTYtMS0xLTEwMDg3_f59e6f67-910b-4d77-8829-be27b8902521"
      unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTItNi0xLTEtMTAwODc_61a1d733-6a29-4357-a094-308aaae1dfb8"
      unitRef="shares">160509</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTItMTAtMS0xLTEwMDg3_f40a1f65-d266-47f8-a878-b66a3c8eb9d9"
      unitRef="usd">1100000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTItMTYtMS0xLTEwMDg3_f1b02a65-69af-4fd4-a749-8d3257b2d2f3"
      unitRef="usd">1100000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTMtNi0xLTEtMTAwODc_1c1e1494-63a7-4d6d-8d5f-0c07be772142"
      unitRef="shares">6664</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i365ee5d210ff4fc7a9a71d6b3ce91c7d_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTQtNi0xLTEtMTAwODc_c2355272-f39a-4e61-b179-a7045d2f9791"
      unitRef="shares">505</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaadb81411559429587a46fa4f369ad8b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTQtMTAtMS0xLTEwMDg3_ad713cf5-571a-4831-9727-322d403ccec9"
      unitRef="usd">7765000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTQtMTYtMS0xLTEwMDg3_905c4b1e-dbab-4e95-9c76-7a9c8fa8a9f8"
      unitRef="usd">7765000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i735eaadfcfea49c7baa357b1962e28d3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTUtMTItMS0xLTEwMDg3_41ce3f5c-2bb4-4c52-bcae-81eb2ae41435"
      unitRef="usd">614000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTUtMTYtMS0xLTEwMDg3_9a4ab1b4-e89a-4e7d-8500-b5a4e32ba5c3"
      unitRef="usd">614000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i69f2151c700c4386a8c6bd633fa2a055_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTYtMTQtMS0xLTEwMDg3_80ca600a-38fb-49b0-89d9-a2c43fbc01f5"
      unitRef="usd">-67254000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTYtMTYtMS0xLTEwMDg3_f95a7757-f70e-435a-8314-f8018e244db3"
      unitRef="usd">-67254000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5260242f659f4520a08f001cda762732_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctNi0xLTEtMTAwODc_c2f9eede-7c1a-43fd-9fe6-36134ba684f1"
      unitRef="shares">36078383</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5260242f659f4520a08f001cda762732_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctOC0xLTEtMTAwODc_1ffd4c61-b9ca-4f97-9e46-b28e84e27d0b"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icfd940ec67e94e27ac3ac65f34d4ad9c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctMTAtMS0xLTEwMDg3_d2b8e32a-64bb-4bf1-b5f1-b33d97501930"
      unitRef="usd">425363000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f9d4ee1015f45c7b985eb5b12743b46_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctMTItMS0xLTEwMDg3_798f4b2e-1a6d-4da2-8b91-bed7f1615754"
      unitRef="usd">614000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i881fdb998fb24439aabee87b939b2269_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctMTQtMS0xLTEwMDg3_0f269b81-47b9-4993-94b6-b060916371f4"
      unitRef="usd">-118224000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTctMTYtMS0xLTEwMDg3_eba2b39b-73ec-4c4f-9538-2b1d24d4a9dd"
      unitRef="usd">307758000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtNi0xLTEtMTA3MTg_56e47e42-d270-4cb7-9065-18e5c67e1424"
      unitRef="shares">110621</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8d393f5b2b3949d384d2d1dd9ad3ac38_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMTAtMS0xLTEwNzE4_d43df92e-d53f-4eed-a1a6-00df4c99a102"
      unitRef="usd">665000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMTYtMS0xLTEwNzE4_793c0725-7542-43fc-927c-b22929de1187"
      unitRef="usd">665000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTktNi0xLTEtMTA3MTg_3c54d1c6-4d12-4866-9b66-f4041650c23e"
      unitRef="shares">27002</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjAtNi0xLTEtMTA3MTg_6518f149-d010-4c21-ac45-5227d5fb580d"
      unitRef="shares">6162</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i8d393f5b2b3949d384d2d1dd9ad3ac38_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjAtMTAtMS0xLTEwNzE4_84eb3880-9d38-4898-9436-d4c616193dea"
      unitRef="usd">64000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjAtMTYtMS0xLTEwNzE4_ce9133b8-a026-4648-9089-52460c3815cc"
      unitRef="usd">64000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0d4653f4afec4763abe7ebaeef21378b_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjEtNi0xLTEtMTA3MTg_3366fe01-beb1-41a1-b2bf-3ae1f589f577"
      unitRef="shares">12456</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8d393f5b2b3949d384d2d1dd9ad3ac38_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjEtMTAtMS0xLTEwNzE4_f2d08164-2749-41ce-9792-01e3230da876"
      unitRef="usd">14037000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjEtMTYtMS0xLTEwNzE4_c8f84da4-8ebe-4ddc-90ba-f558a2ef92cb"
      unitRef="usd">14037000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ia824f582b29c4b53b5021124e3f932b9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjItMTItMS0xLTEwNzE4_2652f5ce-fdd9-4479-9d02-3f4e83ef561a"
      unitRef="usd">-1028000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjItMTYtMS0xLTEwNzE4_9dd6aafe-f533-46c8-b9f1-5f615cebdf65"
      unitRef="usd">-1028000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i15c371c9576a45658c2ba0c54e2990fa_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjMtMTQtMS0xLTEwNzE4_331e7d0c-c5a2-48af-b79e-b56946dda746"
      unitRef="usd">-125596000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMjMtMTYtMS0xLTEwNzE4_867cd742-eb6b-4cd6-9c93-2fc12737d231"
      unitRef="usd">-125596000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id20739abaa504d80b915e1570af5c848_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMS0xLTEtMTA3NjQ_564fddf0-e04e-483c-a614-bf419051fe6f"
      unitRef="shares">36234624</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id20739abaa504d80b915e1570af5c848_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMy0xLTEtMTA3NjQ_1617b5d6-dbd8-4058-bb5b-3f470fbcdf3d"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i29cff875ae6c440fb8662994fa11100f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtNS0xLTEtMTA3NjQ_f998d783-120e-4707-a378-c89f7e439abb"
      unitRef="usd">440129000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9016a71b5edc4deeaf7161f48c70b705_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtNy0xLTEtMTA3NjQ_63211428-22ec-4c8d-8f44-48f2c987253d"
      unitRef="usd">-414000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i137c8ff090914a21a31315f848506a70_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtOS0xLTEtMTA3NjQ_ea2f752d-b480-4415-8591-85b496255b89"
      unitRef="usd">-243820000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85MS9mcmFnOjA2MjY3NTVkZjM0ZDRhNThhZjVhMmZhMWYxZmZkY2VhL3RhYmxlOmVmNjQxYjU0Y2Y2NjQ5YmFhMTVmZmFhYzdjMmYwMDAxL3RhYmxlcmFuZ2U6ZWY2NDFiNTRjZjY2NDliYWExNWZmYWFjN2MyZjAwMDFfMTgtMTEtMS0xLTEwNzY0_5f909b5e-4350-48a2-abcf-3eeec8e78265"
      unitRef="usd">195900000</us-gaap:StockholdersEquity>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfNzY0Mg_85d057c7-df25-43a2-a6b5-b759085fb763">NATURE OF BUSINESS AND BASIS OF PRESENTATION&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Black Diamond Therapeutics, Inc. (the &#x201c;Company&#x201d;) is a precision oncology medicine company pioneering the discovery and development of MasterKey therapies. The Company was originally organized as a limited liability company in December 2014 under the name ASET Therapeutics LLC. In September 2016 the Company was converted to a corporation under the laws of the State of Delaware under the name ASET Therapeutics, Inc. The Company changed its name to Black Diamond Therapeutics, Inc. in January 2018. Since its inception, the Company has devoted substantially all of its efforts to raising capital, obtaining financing, and incurring research and development costs related to the development of its mutation, allostery, and pharmacology computational and drug discovery engine. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry. There can be no assurance that the Company&#x2019;s research and development will be successfully completed, that adequate protection for the Company&#x2019;s technology will be obtained, that any products developed will obtain necessary government regulatory approval or that any products, if approved, will be commercially viable. The Company operates in an environment of rapid technological innovation and substantial competition from pharmaceutical and biotechnological companies. In addition, the Company is dependent upon the services of its employees, consultants and service providers. Even if the Company&#x2019;s product development efforts are successful, it is uncertain when, if ever, the Company will realize significant revenue from product sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;On January 21, 2020, the Company effected a 1-for-3.01581 reverse stock split of the Company&#x2019;s common stock. All shares, stock options, warrants and per share information presented in the consolidated financial statements have been adjusted to reflect the reverse stock split on a retroactive basis for all periods presented. There was no change in the par value of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;On February 3, 2020, the Company completed an initial public offering (the &#x201c;IPO&#x201d;) of 12,174,263 shares of its common stock, including the exercise in full by the underwriters of their option to purchase up to 1,587,947 additional shares of common stock, for aggregate gross proceeds of $231,311 and its shares started trading on The Nasdaq Global Select Market under the ticker symbol &#x201c;BDTX.&#x201d; The Company received $212,101 in net proceeds after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. Upon closing of the IPO, all of the Company's outstanding shares of convertible preferred stock automatically converted into 21,499,770 shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;On February 1, 2021, the Company filed a shelf registration statement on Form S-3 ASR (the &#x201c;Shelf&#x201d;), with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;), which covers the offering, issuance and sale of the Company&#x2019;s common stock, preferred stock, debt securities, warrants and/or units of any combination thereof. The Company simultaneously entered into an Open Market Sale Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;SM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; with Jefferies LLC, as sales agent, to provide for the issuance and sale by the Company of up to $150 million of its common stock from time to time through Jefferies as its sales agent (the &#x201c;ATM Program&#x201d;). The Shelf became automatically effective upon filing on February 1, 2021. As of December&#160;31, 2021, no sales have been made pursuant to the ATM Program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities and commitments in the ordinary course of business. Historically, the Company has funded its operations primarily with proceeds from the sale of convertible preferred stock. The Company expects to continue to generate operating losses for the foreseeable future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;As of March&#160;17, 2022, the issuance date of the consolidated financial statements, the Company expects that its cash, cash equivalents and investments will be sufficient to fund its operating expenses and capital requirements into 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company may seek additional funding through private or public equity financings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborations or other arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company's stockholders. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts, which could adversely affect its business prospects. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations, if at all.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The ongoing COVID-19 pandemic continues to present a substantial public health and economic challenge around the world, and to date has led to the implementation of various responses, including government-imposed quarantines, stay-at-home orders, travel restrictions, mandated business closures and other public health safety measures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company has been closely monitoring the impact of the ongoing COVID-19 pandemic on all aspects of the Company&#x2019;s business, including how it has impacted and may continue to impact the Company&#x2019;s operations and the operations of its suppliers, vendors and business partners, and may take further precautionary and preemptive actions as may be required by federal, state or local authorities. In addition, the Company has taken steps to minimize the current environment&#x2019;s impact on its business and strategy, including devising contingency plans and securing additional resources from third party service providers. Furthermore, for the safety of the Company&#x2019;s employees and families, the Company has introduced enhanced safety measures for scientists to be present in its labs and increased the use of third party service providers for the conduct of certain experiments and studies for research programs. Certain of the Company&#x2019;s third party service providers have also experienced shutdowns or other business disruptions. The Company does not yet know the full extent of potential delays or impacts on the Company&#x2019;s business, clinical trials, research programs, healthcare systems or the global economy and cannot presently predict the scope and severity of any potential business shutdowns or disruptions but if we or any of the third parties with whom we engage were to experience prolonged business shutdowns or other disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively affected, which could have a material adverse impact on our business, results of operations and financial condition. The estimates of the impact on our business may change based on new information that may emerge concerning COVID-19 and the actions to contain it or treat its impact and the economic impact on local, regional, national and international markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The extent to which COVID-19 ultimately impacts the Company&#x2019;s business, results of operations or financial condition will depend on future developments, which, despite progress in vaccination efforts, remain highly uncertain and cannot be predicted with confidence, such as the duration of the COVID-19 pandemic, new strains of the virus which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines, new information that may emerge concerning the severity of COVID-19, and any additional preventative and protective actions taken to contain the pandemic or treat its impact, among others. In addition, a resurgence or &#x201c;additional waves&#x201d; of COVID-19 cases could cause other widespread or more severe impacts depending on where infection rates are highest. While certain measures have been relaxed in certain parts of the world as increasing numbers of people have received COVID-19 vaccines, others have remained in place with some areas continuing to experience renewed outbreaks and surges in infection rates. The extent to which such measures are removed or new measures are put in place will depend upon how the pandemic evolves, as well as the distribution of available vaccines, the rates at which they are administered and the emergence of new variants of the virus.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="ie88f3aabe31b474cacd5e20c1fff19fe_D20200121-20200121"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMTgyNA_06e4b930-2b66-420a-992e-9db5be21a14c"
      unitRef="number">3.01581</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjI0OA_6c458bd5-ff88-4935-894d-f8345bff7698"
      unitRef="shares">12174263</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjM2NA_3ad7fee8-b500-493d-b55d-318649de7043"
      unitRef="shares">1587947</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjQzNA_67537227-f22a-4e91-a111-b72a775f12c6"
      unitRef="usd">231311000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjU1Ng_1ba6d2f3-9c67-4420-ae70-02a45d1d28fe"
      unitRef="usd">212101000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i1856d3eb487b42729a250b7688f050fb_D20200203-20200203"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMjgxNw_f372dd61-dee7-4a6c-80d5-3a14581dc054"
      unitRef="shares">21499770</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i4a73fd2a8f9a40b4aef3a1186bd43494_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV85Ny9mcmFnOjQyODlmOWYwMzc2NDRkZTk5ZTI0NjRkNDZjNDFkODYzL3RleHRyZWdpb246NDI4OWY5ZjAzNzY0NGRlOTllMjQ2NGQ0NmM0MWQ4NjNfMTA5OTUxMTYzNTkxNw_c7e16ec1-b5c0-4e15-add1-d03fb3dfb5fa"
      unitRef="usd">150000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY4_796be45a-36b9-405c-93e2-9b36c89391b3">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of consolidation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and include the accounts of the Company and its wholly owned subsidiaries, Black Diamond Therapeutics (Canada), Inc. and Black Diamond Therapeutics Security Corporation, after elimination of all significant intercompany accounts and transactions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the accrual of research and development expenses and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results may differ from those estimates or assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The full extent to which the ongoing COVID-19 pandemic will directly or indirectly impact the Company&#x2019;s business, results of operations and financial condition, including expenses, research and development costs and employee-related amounts, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international markets. The Company has considered the impact of COVID-19 on estimates within its financial statements and there may be changes to those estimates in future periods. As of the date of issuance of these consolidated financial statements, the Company has not experienced material business disruptions or incurred impairment losses in the carrying value of its assets as a result of the pandemic and is not aware of any specific related event or circumstance that would require it to update its estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent events&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company considers events or transactions that occur after the balance sheet date but before the final financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign currency and currency translation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The functional currency for the Company&#x2019;s wholly owned foreign subsidiary, Black Diamond Therapeutics (Canada), Inc. is the United States Dollar. Adjustments that arise from exchange rate changes on transactions denominated in a currency other than the local currency are included in other income (expense), net in the consolidated statements of operations, as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company classifies deposits in banks, money market funds and cash invested temporarily in various instruments with maturities of three months or less at the time of purchase as cash and cash equivalents. At December&#160;31, 2021 and 2020, cash and cash equivalents includes cash on deposit at commercial banks and a money market fund that invests in U.S. Government securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Investments consist of marketable securities with original maturities greater than 90 days. The Company has classified its investments with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities to be available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices. Unrealized gains and losses are reported as the accumulated other comprehensive items in stockholders&#x2019; equity. Amortization and accretion of premiums and discounts are recorded in other income (expense). Realized gains or losses on debt securities are included in interest income or interest expense, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;If any adjustment to fair value reflects a decline in value of the investment, the Company considers all available evidence to evaluate the extent to which the decline is other than temporary and, if so, marks the investment to market on the Company&#x2019;s statement of operations and comprehensive income (loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted cash &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;In connection with its operating lease commitments, the Company maintains certain balances for security deposits that are classified as restricted cash on the consolidated balance sheets. As of December&#160;31, 2021 and 2020, the Company had $1,223 of restricted cash, which has been classified as a non-current asset on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of credit risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. The Company maintains accounts for all cash and cash equivalents at accredited financial institutions, in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Property and equipment are recorded at cost less accumulated depreciation. Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Computer and office equipment&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Shorter of the useful life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;When assets are retired or otherwise disposed of, the cost of assets disposed of and the related accumulated depreciation is removed from the accounts and any resulting gain or loss is included in the consolidated statements of operations in the period of disposal. Expenditures for repairs and maintenance are charged to expense as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of long - lived assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Long-lived assets consist of property and equipment. Long-lived assets to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company did not record any impairment losses on long-lived assets during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#x2014; Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#x2014; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level&#160;2 inputs include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;quoted prices for similar assets and liabilities in active markets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;quoted prices for identical or similar assets or liabilities in markets that are not active&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g.,&#160;interest rate and yield curve quotes at commonly quoted intervals)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;inputs that are derived principally from or corroborated by observable market data by correlation or other means&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#x2014; Unobservable inputs for the assets or liability (i.e.,&#160;supported by little or no market activity). Level&#160;3 inputs include management&#x2019;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The carrying values of the Company&#x2019;s prepaid expenses and other current assets, and accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company manages its operations as a single operating segment for the purposes of assessing performance and making operating decisions. The Company&#x2019;s singular focus is the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop drug candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical development activities. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research contract costs and accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company has entered into various research and development-related contracts with companies both inside and outside of the United States. The related costs are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ materially from the Company&#x2019;s estimates. The Company&#x2019;s historical accrual estimates have not been materially different from the actual costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Patent costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;All patent-related costs incurred in connection with filing and prosecuting patent applications to operations are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company measures all stock-based awards granted to employees, non-employees and directors based on the fair value on the date of grant and recognizes compensation expense of those awards over the requisite service period, which is generally the vesting period of the respective award. Generally, the Company issues stock options and restricted stock units with only service-based vesting conditions and records the expense for these awards using the straight-line method. For stock options or restricted stock units issued with performance-based vesting conditions, the stock compensation expense related to these awards is recognized based on the grant date fair value when achievement of the performance condition is deemed probable. The Company would apply the graded-vesting method to all stock-based awards with performance-based vesting conditions or to awards with both service-based and performance based vesting conditions. Forfeitures are accounted for as they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option grant is estimated on the date of grant using the Black- Scholes option-pricing model. The Company lacks sufficient company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The Company uses the simplified method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; prescribed by Securities and Exchange Commission Staff Accounting Bulletin No. 107, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Payment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;, to calculate the expected term of options granted to employees, non-employees and directors. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#x2019;s payroll costs are classified or in which the award recipient&#x2019;s service payments are classified.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#x2019;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties. To date, the Company has not taken any uncertain tax positions or recorded any reserves, interest or penalties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Comprehensive loss is composed of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net income (loss) per share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated, and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common stock. For purposes of this calculation, outstanding options, unvested restricted common stock and shares issuable under the employee stock purchase plan are considered potentially dilutive common stock and are excluded from the computation of net income (loss) per share when their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December&#160;31, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at contract inception. Operating lease assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at the commencement date of the lease based upon the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company uses the implicit interest rate when readily determinable and uses the Company&#x2019;s incremental borrowing rate when the implicit rate is not readily determinable based upon the information available at the commencement date in determining the present value of the lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The lease payments used to determine the Company&#x2019;s operating lease assets may include lease incentives, stated rent increases and escalation clauses linked to rates of inflation, when determinable, and are recognized in the Company&#x2019;s operating lease assets in the Company&#x2019;s consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating leases are reflected in the right-of-use operating asset; operating lease liability, current portion; and non-current operating lease liability in the Company&#x2019;s consolidated balance sheets. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Short-term leases, defined as leases that have a lease term of 12 months or less at the commencement date, are excluded from this treatment and are recognized on a straight-line basis over the term of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Variable lease payments are the amounts owed by the Company to a lessor that are not fixed, such as reimbursement for common area maintenance and utilities costs for facility leases and maintenance. Variable lease payments are expensed when incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Assumptions made by the Company at the commencement date are re-evaluated upon occurrence of certain events, including a lease modification. A lease modification results in a separate contract when the modification grants the lessee an additional right of use not included in the original lease and when lease payments increase commensurate with the standalone price for the additional right of use. When a lease modification results in a separate contract, it is accounted for in the same manner as a new lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force) (&#x201c;ASU-2021-04&#x201d;). ASU 2021-04 clarifies and reduces diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The ASU provides guidance that will clarify whether an issuer should account for a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as (1) an adjustment to equity and, if so, the related earnings per share (EPS) effects, if any, or (2) an expense and, if so, the manner and pattern of recognition. The new guidance is effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted, including adoption in an interim period. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company adopted this standard on December 1, 2021 on a prospective basis, and it did not have a material impact on its disclosures, financial position or results or operations upon adoption. &lt;/span&gt;&lt;/div&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes-Simplifying the Accounting for Income Taxes (&#x201c;ASU 2019-12&#x201d;). ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The new standard was effective for the Company beginning January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's disclosures, financial position or results or operations upon adoption.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQy_75445f15-8d7f-4fc7-9e8a-b30d83615c09">Principles of consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and include the accounts of the Company and its wholly owned subsidiaries, Black Diamond Therapeutics (Canada), Inc. and Black Diamond Therapeutics Security Corporation, after elimination of all significant intercompany accounts and transactions.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQ1_67758cde-bf2e-4a9e-9069-74b79c2d2974">Principles of consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and include the accounts of the Company and its wholly owned subsidiaries, Black Diamond Therapeutics (Canada), Inc. and Black Diamond Therapeutics Security Corporation, after elimination of all significant intercompany accounts and transactions.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU1_67a1df9d-f6de-4ebb-8b21-43e5b14a3568">Use of estimates The preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the accrual of research and development expenses and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results may differ from those estimates or assumptions.</us-gaap:UseOfEstimates>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjUw_53cf926c-5a8a-458d-8730-0ebc03ef61b4">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent events&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company considers events or transactions that occur after the balance sheet date but before the final financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQz_c67baaf6-d62a-4a25-95b1-00933789c041">Foreign currency and currency translation The functional currency for the Company&#x2019;s wholly owned foreign subsidiary, Black Diamond Therapeutics (Canada), Inc. is the United States Dollar. Adjustments that arise from exchange rate changes on transactions denominated in a currency other than the local currency are included in other income (expense), net in the consolidated statements of operations, as incurred.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY5_e687f8e0-42b6-467b-a43a-626781c48c26">Cash and cash equivalents The Company classifies deposits in banks, money market funds and cash invested temporarily in various instruments with maturities of three months or less at the time of purchase as cash and cash equivalents.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjcw_8a13453d-d351-43cf-ab23-70d646f919f3">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Investments consist of marketable securities with original maturities greater than 90 days. The Company has classified its investments with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations. The Company considers its investment portfolio of marketable securities to be available-for-sale. Accordingly, these investments are recorded at fair value, which is based on quoted market prices. Unrealized gains and losses are reported as the accumulated other comprehensive items in stockholders&#x2019; equity. Amortization and accretion of premiums and discounts are recorded in other income (expense). Realized gains or losses on debt securities are included in interest income or interest expense, respectively.&lt;/span&gt;&lt;/div&gt;If any adjustment to fair value reflects a decline in value of the investment, the Company considers all available evidence to evaluate the extent to which the decline is other than temporary and, if so, marks the investment to market on the Company&#x2019;s statement of operations and comprehensive income (loss).</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjUz_fcce0471-bdab-4bbd-b0de-219eb9449674">Restricted cash In connection with its operating lease commitments, the Company maintains certain balances for security deposits that are classified as restricted cash on the consolidated balance sheets</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzUwNzY_2fa313aa-9ce9-4b9a-9054-b7ce15b757f6"
      unitRef="usd">1223000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzUwNzY_41ca9afa-b5f7-4bb8-a2ca-c882da8f0a25"
      unitRef="usd">1223000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjcx_3303d1f6-8e99-41f0-9376-809494ae10e9">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of credit risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. The Company maintains accounts for all cash and cash equivalents at accredited financial institutions, in amounts that exceed federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU5_cce12d8b-363a-42d9-ba49-adeaa5cf63cf">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Property and equipment are recorded at cost less accumulated depreciation. Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Computer and office equipment&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Shorter of the useful life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;When assets are retired or otherwise disposed of, the cost of assets disposed of and the related accumulated depreciation is removed from the accounts and any resulting gain or loss is included in the consolidated statements of operations in the period of disposal. Expenditures for repairs and maintenance are charged to expense as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU0_f4fa2964-8956-40c6-9c19-dc7984efd448">Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Laboratory equipment&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Computer and office equipment&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Shorter of the useful life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Computer and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Property and Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i907bbd4101da4791b95db60038ebf1bb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90YWJsZTo0ZTRjZTY3ZjRiYmY0OWFhYTc1ZTRiODM1MWRmZGUzMy90YWJsZXJhbmdlOjRlNGNlNjdmNGJiZjQ5YWFhNzVlNGI4MzUxZGZkZTMzXzEtMS0xLTEtMTAwODc_fbf78c83-4f0c-4c10-b6e2-5601bab9a044">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4c11721ec9b84ac3b344ba9856d4a137_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90YWJsZTo0ZTRjZTY3ZjRiYmY0OWFhYTc1ZTRiODM1MWRmZGUzMy90YWJsZXJhbmdlOjRlNGNlNjdmNGJiZjQ5YWFhNzVlNGI4MzUxZGZkZTMzXzItMS0xLTEtMTAwODc_e6b3d1a5-e00c-413c-878a-84901d3ca267">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="idc1c05a8882d4e2d9d4375998f3f9c91_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90YWJsZTo0ZTRjZTY3ZjRiYmY0OWFhYTc1ZTRiODM1MWRmZGUzMy90YWJsZXJhbmdlOjRlNGNlNjdmNGJiZjQ5YWFhNzVlNGI4MzUxZGZkZTMzXzMtMS0xLTEtMTAwODc_967d5785-9242-4a3e-9ef1-80f5ae5d6f43">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjUx_9baa0bd9-d959-4d45-b04b-24b9f92c6079">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of long - lived assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Long-lived assets consist of property and equipment. Long-lived assets to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company did not record any impairment losses on long-lived assets during the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY0_20cb8411-8677-4ca2-af7d-014ed0e3f6c8">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#x2014; Unadjusted quoted prices in active markets that are accessible to the reporting entity at the measurement date for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#x2014; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability. Level&#160;2 inputs include the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;quoted prices for similar assets and liabilities in active markets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;quoted prices for identical or similar assets or liabilities in markets that are not active&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;observable inputs other than quoted prices that are used in the valuation of the asset or liabilities (e.g.,&#160;interest rate and yield curve quotes at commonly quoted intervals)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt"&gt;inputs that are derived principally from or corroborated by observable market data by correlation or other means&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#x2014; Unobservable inputs for the assets or liability (i.e.,&#160;supported by little or no market activity). Level&#160;3 inputs include management&#x2019;s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The carrying values of the Company&#x2019;s prepaid expenses and other current assets, and accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU2_1025a45e-4409-4f2c-956d-6f0b1cfc7767">Segment information The Company manages its operations as a single operating segment for the purposes of assessing performance and making operating decisions. The Company&#x2019;s singular focus is the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQ0_c9601b34-4ea4-401a-aeed-9fbcaf57431b">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred to discover, research and develop drug candidates, including personnel expenses, stock-based compensation expense, allocated facility-related and depreciation expenses, third-party license fees and external costs of outside vendors engaged to conduct preclinical development activities. Non-refundable prepayments for goods or services that will be used or rendered for future research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered. &lt;/span&gt;&lt;/div&gt;Research contract costs and accrualsThe Company has entered into various research and development-related contracts with companies both inside and outside of the United States. The related costs are recorded as research and development expenses as incurred. The Company records accruals for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ materially from the Company&#x2019;s estimates. The Company&#x2019;s historical accrual estimates have not been materially different from the actual costs.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <bdtx:PatentCostsPolicyPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjQ4_e7431752-f6f8-419f-a84b-019ff88b2bea">Patent costsAll patent-related costs incurred in connection with filing and prosecuting patent applications to operations are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses.</bdtx:PatentCostsPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjYz_decb1d42-a5bb-4183-9db9-ce870e50ab1e">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company measures all stock-based awards granted to employees, non-employees and directors based on the fair value on the date of grant and recognizes compensation expense of those awards over the requisite service period, which is generally the vesting period of the respective award. Generally, the Company issues stock options and restricted stock units with only service-based vesting conditions and records the expense for these awards using the straight-line method. For stock options or restricted stock units issued with performance-based vesting conditions, the stock compensation expense related to these awards is recognized based on the grant date fair value when achievement of the performance condition is deemed probable. The Company would apply the graded-vesting method to all stock-based awards with performance-based vesting conditions or to awards with both service-based and performance based vesting conditions. Forfeitures are accounted for as they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option grant is estimated on the date of grant using the Black- Scholes option-pricing model. The Company lacks sufficient company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The Company uses the simplified method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; prescribed by Securities and Exchange Commission Staff Accounting Bulletin No. 107, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Payment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;, to calculate the expected term of options granted to employees, non-employees and directors. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient&#x2019;s payroll costs are classified or in which the award recipient&#x2019;s service payments are classified.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY1_086b3ccb-d800-4bbd-96ac-59ad62025ca6">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#x2019;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. &lt;/span&gt;&lt;/div&gt;The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties. To date, the Company has not taken any uncertain tax positions or recorded any reserves, interest or penalties.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjYx_b7761d4a-1ce1-42e3-8980-f591747e52ac">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Comprehensive loss is composed of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU3_5d5eaaed-923d-4ea9-a6fd-4fd5ce98bf9a">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net income (loss) per share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated, and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. &lt;/span&gt;&lt;/div&gt;Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common stock. For purposes of this calculation, outstanding options, unvested restricted common stock and shares issuable under the employee stock purchase plan are considered potentially dilutive common stock and are excluded from the computation of net income (loss) per share when their effect is anti-dilutive.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjY2_f644fef1-fd16-444f-b402-4f81cbe0281c">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at contract inception. Operating lease assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at the commencement date of the lease based upon the present value of lease payments over the lease term. When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company uses the implicit interest rate when readily determinable and uses the Company&#x2019;s incremental borrowing rate when the implicit rate is not readily determinable based upon the information available at the commencement date in determining the present value of the lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The lease payments used to determine the Company&#x2019;s operating lease assets may include lease incentives, stated rent increases and escalation clauses linked to rates of inflation, when determinable, and are recognized in the Company&#x2019;s operating lease assets in the Company&#x2019;s consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating leases are reflected in the right-of-use operating asset; operating lease liability, current portion; and non-current operating lease liability in the Company&#x2019;s consolidated balance sheets. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Short-term leases, defined as leases that have a lease term of 12 months or less at the commencement date, are excluded from this treatment and are recognized on a straight-line basis over the term of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Variable lease payments are the amounts owed by the Company to a lessor that are not fixed, such as reimbursement for common area maintenance and utilities costs for facility leases and maintenance. Variable lease payments are expensed when incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Assumptions made by the Company at the commencement date are re-evaluated upon occurrence of certain events, including a lease modification. A lease modification results in a separate contract when the modification grants the lessee an additional right of use not included in the original lease and when lease payments increase commensurate with the standalone price for the additional right of use. When a lease modification results in a separate contract, it is accounted for in the same manner as a new lease.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDAvZnJhZzo0ODllZWMzMzAxOTA0NDA0OTFiMjRjOTg2YzVlYjZhZi90ZXh0cmVnaW9uOjQ4OWVlYzMzMDE5MDQ0MDQ5MWIyNGM5ODZjNWViNmFmXzMyMjU4_e5dee701-5741-4863-a20d-06b54b3d73df">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50), Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force) (&#x201c;ASU-2021-04&#x201d;). ASU 2021-04 clarifies and reduces diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The ASU provides guidance that will clarify whether an issuer should account for a modification or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as (1) an adjustment to equity and, if so, the related earnings per share (EPS) effects, if any, or (2) an expense and, if so, the manner and pattern of recognition. The new guidance is effective for annual and interim periods beginning after December 15, 2021, and early adoption is permitted, including adoption in an interim period. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company adopted this standard on December 1, 2021 on a prospective basis, and it did not have a material impact on its disclosures, financial position or results or operations upon adoption. &lt;/span&gt;&lt;/div&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes-Simplifying the Accounting for Income Taxes (&#x201c;ASU 2019-12&#x201d;). ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. The new standard was effective for the Company beginning January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's disclosures, financial position or results or operations upon adoption.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90ZXh0cmVnaW9uOmJkODU0Yjk4MWFhNTRiMTRiMjE1MWYzOTE5MjE1NzcwXzE5MTE_df357fb5-c5d5-4ef4-9849-8e28283e84a8">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Fair value measurements at December 31, 2021 using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;63,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;63,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;104,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;104,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;U.S. Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;39,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;39,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;63,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;143,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;207,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Fair value measurements at December 31, 2020 using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;32,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;32,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;35,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;35,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;192,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;192,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;U.S. Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;32,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;280,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;312,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;When developing fair value estimates, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. When available, the Company uses quoted market prices to measure fair value. The valuation technique used to measure fair value for the Company's Level 1 and Level 2 assets is a market approach, using prices and other relevant information generated by market transactions involving identical or comparable assets. If market prices are not available, the fair value measurement is based on models that use primarily market-based parameters including yield curves, volatilities, credit ratings and currency rates. In certain cases where market rate assumptions are not available, the Company is required to make judgments about assumptions market participants would use to estimate the fair value of a financial instrument. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;There were no transfers in or out of Level 3 categories in the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90ZXh0cmVnaW9uOmJkODU0Yjk4MWFhNTRiMTRiMjE1MWYzOTE5MjE1NzcwXzE5MTI_411688c0-60fe-48f5-a1dd-62344e2180b7">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Fair value measurements at December 31, 2021 using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;63,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;63,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;104,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;104,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;U.S. Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;39,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;39,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;63,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;143,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;207,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Fair value measurements at December 31, 2020 using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;32,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;32,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;35,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;35,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;192,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;192,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;U.S. Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;32,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;280,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;312,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i37550c3c6f8b4e1c82625f4812c1040f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzQtMS0xLTEtMTAwODc_21b52de4-7f7b-4449-a08a-c5663bf577ff"
      unitRef="usd">63730000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibb4739fe5f8942668fe0bc95945099a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzQtMy0xLTEtMTAwODc_642c8881-6583-4a40-b9db-0a418fa65815"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie3b30c861e9d4e7f886845215446bbf0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzQtNS0xLTEtMTAwODc_3bc63fe3-d6a0-411d-8b8d-63453090c357"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i661a7771541c4be58e3c508f387d2d4c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzQtNy0xLTEtMTAwODc_5fa77a06-1415-4320-b8e7-36f4db0be828"
      unitRef="usd">63730000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id03ea759a2df458f9a6c7ec4e73c55d6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzctMS0xLTEtMTAwODc_9b3d5fce-c6f6-417e-ad4b-12c0a54be42b"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i897eb2325f8b44d682297a1bba2a1afe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzctMy0xLTEtMTAwODc_a26d8300-51aa-4b5f-b463-653b018ad9e7"
      unitRef="usd">104066000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibe2c5749e2da4c9a9141bcf8dea4e07a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzctNS0xLTEtMTAwODc_eb43af8a-7cc7-4e29-a884-aaf1c20e125a"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if0c818a6e331498f8f622c83e82498a6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzctNy0xLTEtMTAwODc_a54e451b-b638-4edc-89fc-26186e49e606"
      unitRef="usd">104066000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7cc33891b67d4cd4881a2c22172d9038_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzgtMS0xLTEtMTAwODc_a39e6ca4-5bcd-42ce-8e3e-0a2fd511658c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie7310d48e883404aa8278fe354dfec1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzgtMy0xLTEtMTAwODc_dde98b3f-c1c6-4abb-b486-bef241ab489e"
      unitRef="usd">39921000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i764cba0d028047519b61de1a37f180d8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzgtNS0xLTEtMTAwODc_462523c3-adea-445b-8805-b6726f83d257"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i58b98a26a73545518614cf7d9628211c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzgtNy0xLTEtMTAwODc_5222fac1-9572-4cff-81b3-a113e9cda4db"
      unitRef="usd">39921000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i65468eff9b6d46e393fd1b4dbb2b901d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzktMS0xLTEtMTAwODc_83fa64eb-1056-4489-8259-75b3f5c6fe47"
      unitRef="usd">63730000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia4d74d028a7d465fb5fd5451c08b99d9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzktMy0xLTEtMTAwODc_5d2518d7-c734-45c2-ba87-005befc1faba"
      unitRef="usd">143987000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2b492035c5974422bdb650937d138473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzktNS0xLTEtMTAwODc_2b95ecff-cf2a-4366-9f61-95965b60cf82"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i25857721770b4551b695d1c7721be8c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTpkM2ZlZjg2ZDNmMGQ0MGVmODNmMzMwMjEzOWQ2Zjc2Yi90YWJsZXJhbmdlOmQzZmVmODZkM2YwZDQwZWY4M2YzMzAyMTM5ZDZmNzZiXzktNy0xLTEtMTAwODc_5faaea06-88b9-4e10-b0b7-0babc0112491"
      unitRef="usd">207717000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8c1e51d979ec40be896fcef26d6a787b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzQtMS0xLTEtMTI5MDc_a282e19e-75b8-469b-855e-824e8f788225"
      unitRef="usd">32501000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib4cddd28a59e484c974e7e00a6968a69_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzQtMy0xLTEtMTI5MDc_232b9b7c-162d-41b6-8922-9cb41bc295c6"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia3b164f107b74b22b0f4ccf27b504098_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzQtNS0xLTEtMTI5MDc_fbc1dfc7-ea76-4224-b22b-75cd213e18b9"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if58ddf76db3846139fa1a52af88ebb35_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzQtNy0xLTEtMTI5MDc_0d39f3a1-4279-4297-ba39-c55d466c7019"
      unitRef="usd">32501000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ifa02d2a706504ab0b7238eba43af4d07_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzYtMS0xLTEtMTI5MDc_b3b72ec2-4d47-4e4f-aded-87c2bd468b0a"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i742712bb4f08433e91c7107556ee12b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzYtMy0xLTEtMTI5MDc_c96c4796-c646-42a2-b704-9e38cc20301b"
      unitRef="usd">35559000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1d0802102ced4b2fad85fbb7b827d01a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzYtNS0xLTEtMTI5MDc_582f8508-0b5b-4400-ace3-bc9bfc1a394e"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0eada741a72e43f8878c131461b998e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzYtNy0xLTEtMTI5MDc_4126c87e-2a53-436d-8a05-b7bbc27f781e"
      unitRef="usd">35559000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3676c1e9ee8641b59223f61e35dd91d8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzctMS0xLTEtMTI5MDc_265af5bc-fd73-4375-81bd-19e87929d5de"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0c308fd60bb34e1681722a61e79a2c56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzctMy0xLTEtMTI5MDc_f4a4e4ab-d4db-4eba-83fb-7ccdbd4ddd5d"
      unitRef="usd">192573000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i66e67ca30eb94ec9b7f3040a7fbc0e27_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzctNS0xLTEtMTI5MDc_00d86e53-8a20-41dd-a6dd-57435b45925c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i74033657d98945978e04c05451082f37_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzctNy0xLTEtMTI5MDc_f94cadda-0f45-4449-a38f-3870e6525b6e"
      unitRef="usd">192573000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i103bc24deb864971a2124cc0e9fa120a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzgtMS0xLTEtMTI5MDc_62f2a9d1-dfdc-4a79-b681-2faf0fa082e6"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i877ad9b6c45a4570a3dc9fa049cb3afe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzgtMy0xLTEtMTI5MDc_9bb03f5d-ce63-4d82-b16b-24be43b7485d"
      unitRef="usd">52330000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i62baf0a395b74b088a443289cccd0913_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzgtNS0xLTEtMTI5MDc_915f1e9b-aeb5-4faa-80e8-817b5a78fdc0"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0ea1e1b54a744110b827b0b44b927c0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzgtNy0xLTEtMTI5MDc_1817a341-f2ea-43f4-90e0-f236061e00d7"
      unitRef="usd">52330000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia09c76b66200416fa63f1c01d35e2fc1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzktMS0xLTEtMTI5MDc_dd2eb730-7f62-430f-a8d0-a8279b7b833b"
      unitRef="usd">32501000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2d122ce461b9439dabdc048f86e95eef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzktMy0xLTEtMTI5MDc_e900b5a4-2233-4434-9ca1-b63bce2c9745"
      unitRef="usd">280462000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iba734827ba0945438f8b534d33166ac5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzktNS0xLTEtMTI5MDc_f5031307-1ddd-43ad-af5d-90932a921699"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5fb596f6d41142a4be91b0ac53112788_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDYvZnJhZzpiZDg1NGI5ODFhYTU0YjE0YjIxNTFmMzkxOTIxNTc3MC90YWJsZTowMzU3ZDk5ZGE1ODE0Zjc5OTg0OThhMDZiODNiYzJhMy90YWJsZXJhbmdlOjAzNTdkOTlkYTU4MTRmNzk5ODQ5OGEwNmI4M2JjMmEzXzktNy0xLTEtMTI5MDc_4f13d5d0-500c-4051-abf7-c143ddb424a8"
      unitRef="usd">312963000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90ZXh0cmVnaW9uOjNhMTBjZjZjNDViOTQ0MTJiZmZjNjkyMGE4ZjdmMWMxXzQzNQ_4985cd54-74ae-47f6-a7d7-bc5d42caef4b">INVESTMENTS&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, investments were comprised of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;104,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;104,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;U.S. Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;40,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;39,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;144,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;143,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, investments were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;35,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;35,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;191,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;192,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;U.S. Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;279,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;280,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, all marketable securities held by the Company had remaining contractual maturities of three years or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021and 2020, the marketable securities in a loss position have a maturity of three years or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;There have been no impairments of the Company&#x2019;s assets measured and carried at fair value during the year ended December&#160;31, 2021and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90ZXh0cmVnaW9uOjNhMTBjZjZjNDViOTQ0MTJiZmZjNjkyMGE4ZjdmMWMxXzQzNg_4a2b8716-2be3-41ce-842f-4260c6f99558">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, investments were comprised of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;104,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;104,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;U.S. Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;40,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;39,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;144,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;143,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, investments were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;35,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;35,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;191,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;192,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;U.S. Government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;279,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;280,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic872a3df7fa54aa58339156e79caec93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzItMS0xLTEtMTAwODc_db26fa2e-dbcd-481e-878d-e7a2b76d7985"
      unitRef="usd">104261000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic872a3df7fa54aa58339156e79caec93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzItMy0xLTEtMTAwODc_134e0d04-b9f0-41d4-871f-4d3e5513ad7b"
      unitRef="usd">47000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic872a3df7fa54aa58339156e79caec93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzItNS0xLTEtMTAwODc_46bb1128-2dfd-4a09-bcc8-11ac89219377"
      unitRef="usd">242000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic872a3df7fa54aa58339156e79caec93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzItNy0xLTEtMTAwODc_72627e13-ca1a-4cea-a967-3b6b3b1048b3"
      unitRef="usd">104066000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzMtMS0xLTEtMTAwODc_f69acbbb-a239-4d0d-8404-ff615ac73f87"
      unitRef="usd">40140000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzMtMy0xLTEtMTAwODc_39c1f34e-6e68-4a37-90e2-477500a5ecb8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzMtNS0xLTEtMTAwODc_04f07f8b-6746-4cac-8a6d-35b9a564a198"
      unitRef="usd">219000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b2e1c6c8b0f4eabb970e47f580d872b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzMtNy0xLTEtMTAwODc_d66f411c-c3c2-4bf1-8076-39b59b5d3e5e"
      unitRef="usd">39921000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzQtMS0xLTEtMTAwODc_686dff3b-2cb3-4ab5-beb5-e5b5506c5ed5"
      unitRef="usd">144401000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzQtMy0xLTEtMTAwODc_75fe9cca-817a-4562-9849-8ab841b172a2"
      unitRef="usd">47000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzQtNS0xLTEtMTAwODc_c4e69119-bba7-4577-9f8d-244872cbfce7"
      unitRef="usd">461000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTo5ODQ1NmRkYjdmMjI0ZTAyYWMxMWI0NmQ1ZGUwMjc2YS90YWJsZXJhbmdlOjk4NDU2ZGRiN2YyMjRlMDJhYzExYjQ2ZDVkZTAyNzZhXzQtNy0xLTEtMTAwODc_66a333c2-9d84-471e-88fd-b4302a660863"
      unitRef="usd">143987000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i96d17648150f42bfbdf803c2674bcf29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzEtMS0xLTEtMTI5MjM_98ad01ee-c42a-4547-b3f3-2f0d4465140a"
      unitRef="usd">35543000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i96d17648150f42bfbdf803c2674bcf29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzEtMy0xLTEtMTI5MjM_7e029221-9fb6-4fcb-807b-67d9a597c1de"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i96d17648150f42bfbdf803c2674bcf29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzEtNS0xLTEtMTI5MjM_f466a45b-bb62-48cd-89c2-7ffac32801d5"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i96d17648150f42bfbdf803c2674bcf29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzEtNy0xLTEtMTI5MjM_5cfb8473-f24b-4e2e-b4b1-989d8a35719b"
      unitRef="usd">35559000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id1b63b5b22794ba198a5427db6ccb42a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzItMS0xLTEtMTI5MjM_d482d4b9-6743-45a5-8346-6d7fdac72daf"
      unitRef="usd">191977000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id1b63b5b22794ba198a5427db6ccb42a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzItMy0xLTEtMTI5MjM_5f98a679-644f-4766-91b9-7f45d72d24ec"
      unitRef="usd">608000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id1b63b5b22794ba198a5427db6ccb42a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzItNS0xLTEtMTI5MjM_1cf02705-af88-4b3d-99d7-14fa4cc575cb"
      unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id1b63b5b22794ba198a5427db6ccb42a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzItNy0xLTEtMTI5MjM_5ef97ed0-f560-4308-8cbe-c2f9eb7019a0"
      unitRef="usd">192573000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzMtMS0xLTEtMTI5MjM_40e78927-237a-44a7-b8d8-3356ca1e564c"
      unitRef="usd">52328000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzMtMy0xLTEtMTI5MjM_3d6b9ff4-4fa3-486f-a229-dd040eb7d254"
      unitRef="usd">22000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzMtNS0xLTEtMTI5MjM_979ec990-8fc8-4a2b-bb6a-8748ac916526"
      unitRef="usd">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9e4dfacc3a6d4f3eaa13b8e3fdc1045e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzMtNy0xLTEtMTI5MjM_68e66458-5de9-477a-b488-61516d456d4a"
      unitRef="usd">52330000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzQtMS0xLTEtMTI5MjM_6d59b2b2-9e78-4061-b10a-012acdecf7d4"
      unitRef="usd">279848000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzQtMy0xLTEtMTI5MjM_6bcc45c6-bc7c-4a20-9a26-8301b03b1f4e"
      unitRef="usd">651000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzQtNS0xLTEtMTI5MjM_45fd6d2e-62e1-4dec-b9c3-0fcabac46ca4"
      unitRef="usd">37000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90YWJsZTpjMTVjODdmZDgxZWU0YTBlOWQ4N2RiNTBkMGI5YTQ3OS90YWJsZXJhbmdlOmMxNWM4N2ZkODFlZTRhMGU5ZDg3ZGI1MGQwYjlhNDc5XzQtNy0xLTEtMTI5MjM_77302a6d-cf9c-4eff-8866-036583c7a450"
      unitRef="usd">280462000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90ZXh0cmVnaW9uOjNhMTBjZjZjNDViOTQ0MTJiZmZjNjkyMGE4ZjdmMWMxXzI4NQ_70f9eda5-1543-45e9-9616-b88646148a32"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMDkvZnJhZzozYTEwY2Y2YzQ1Yjk0NDEyYmZmYzY5MjBhOGY3ZjFjMS90ZXh0cmVnaW9uOjNhMTBjZjZjNDViOTQ0MTJiZmZjNjkyMGE4ZjdmMWMxXzI4NQ_eecca720-a905-405c-b1e0-9327b32d6ec4"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90ZXh0cmVnaW9uOmI1MGI3Y2EyY2ZiNDQ4NjRiNjFlN2UxMzNmMzJhNWRhXzE2OA_0b110647-2e48-4954-a365-c3ded23f5646">PROPERTY AND EQUIPMENT&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Computer and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Property and Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Depreciation expense for the years ended December&#160;31, 2021 and 2020 was $205 and $52, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i40f1fe72d2d444aeb36925e4fcc30eb6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzItMS0xLTEtMTAwODc_7d0d2518-6542-45f1-bbd0-6ea4e355378b"
      unitRef="usd">682000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4d9ad67327bc44648c777a18474468b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzItMy0xLTEtMTAwODc_2dc28d80-a099-438e-b57d-97f361ce9222"
      unitRef="usd">253000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2861ec10bc3748998a17ae945f43939b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzMtMS0xLTEtMTAwODc_de0e3d50-1d40-4559-b8f1-046393b9b3fe"
      unitRef="usd">17000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1ecf9843e9ef489dab03ac86e3fbbe55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzMtMy0xLTEtMTAwODc_acd14dd9-5ef6-40e8-9ec2-b3a843b4581c"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i05170edcf7364cda86a8e91a6c465732_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzQtMS0xLTEtMTAwODc_f71a2114-0598-4905-9d8d-95919a9d8654"
      unitRef="usd">120000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibd84886daa684164b53911ab6a5ec019_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzQtMy0xLTEtMTAwODc_419d9f97-5618-4777-acfc-913c6e94ce6f"
      unitRef="usd">83000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i64b0a265ea36455d88e0db82a9f72d63_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzUtMS0xLTEtMTAwODc_aabae7f6-8545-45ae-912b-2cfcf79d8808"
      unitRef="usd">2437000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i21b957706c704a949271fa3b8ecce065_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzUtMy0xLTEtMTAwODc_e41ffbe5-e11e-467d-9c5f-5ea09caab907"
      unitRef="usd">66000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i52f0c745b901427ca91dcd2d7e618786_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzYtMS0xLTEtMTAwODc_90f658bd-94f1-4e9c-8ca8-64eff23e8d37"
      unitRef="usd">148000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6f6cb93d93d54cd1bb5ad6efefe6e781_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzYtMy0xLTEtMTAwODc_cde95593-e3bf-46fa-9db6-ae48f159b975"
      unitRef="usd">147000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzctMS0xLTEtMTAwODc_690e278b-ace6-4090-816c-7945093b23eb"
      unitRef="usd">3404000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzctMy0xLTEtMTAwODc_8ae0f464-c107-424d-be8d-00d1777424fa"
      unitRef="usd">549000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzgtMS0xLTEtMTAwODc_270aef49-1447-4dd8-b067-19fb418da6bd"
      unitRef="usd">369000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzgtMy0xLTEtMTAwODc_9d651fbd-53bd-4cc2-a39e-fb25abd61832"
      unitRef="usd">164000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzktMS0xLTEtMTAwODc_0fc1ef29-26e0-4f0c-b05d-5d3d0a2966bb"
      unitRef="usd">3035000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90YWJsZTowMTlhZjE1MzliYmU0NDM3OTk4NzU5NDE1NzIxYzVjNS90YWJsZXJhbmdlOjAxOWFmMTUzOWJiZTQ0Mzc5OTg3NTk0MTU3MjFjNWM1XzktMy0xLTEtMTAwODc_906e839b-57ad-40b5-87ab-b1e3b6404b1d"
      unitRef="usd">385000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90ZXh0cmVnaW9uOmI1MGI3Y2EyY2ZiNDQ4NjRiNjFlN2UxMzNmMzJhNWRhXzE0NQ_6b02d1e9-a75a-4102-8cdf-c66b21daedab"
      unitRef="usd">205000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTIvZnJhZzpiNTBiN2NhMmNmYjQ0ODY0YjYxZTdlMTMzZjMyYTVkYS90ZXh0cmVnaW9uOmI1MGI3Y2EyY2ZiNDQ4NjRiNjFlN2UxMzNmMzJhNWRhXzE1Mg_7d73db2a-f857-46d2-a02b-19c518db1f21"
      unitRef="usd">52000</us-gaap:Depreciation>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90ZXh0cmVnaW9uOmJjZGZlMjk4MjkxOTQ3OTZiZGU5Y2QyOWJkMjFhOTJmXzEwMg_3df7e82a-3e5b-45d5-b9c7-8688172fc7fb">ACCRUED EXPENSES &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Contracted research services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;12,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Professional and consulting fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_60506ab5-efc5-4954-abd1-b1eb79d8d8bb"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_bf8d40bd-aa95-4835-abf8-381f9a8156f6"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;19,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;11,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90ZXh0cmVnaW9uOmJjZGZlMjk4MjkxOTQ3OTZiZGU5Y2QyOWJkMjFhOTJmXzEwMw_8dffbd80-4663-4ee5-9d61-c5c5952b8570">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Contracted research services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;12,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Professional and consulting fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_60506ab5-efc5-4954-abd1-b1eb79d8d8bb"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMC0xLTEtMTAwODc_bf8d40bd-aa95-4835-abf8-381f9a8156f6"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;19,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;11,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <bdtx:AccruedContractResearchServiceFeesCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzItMS0xLTEtMTAwODc_3f2a6652-9098-420d-9dce-e9f979b9a937"
      unitRef="usd">12192000</bdtx:AccruedContractResearchServiceFeesCurrent>
    <bdtx:AccruedContractResearchServiceFeesCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzItMy0xLTEtMTAwODc_37b22047-11cc-4e48-80ca-ec93c4f79a6d"
      unitRef="usd">5102000</bdtx:AccruedContractResearchServiceFeesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzMtMS0xLTEtMTAwODc_093c6ae7-d676-42c5-824b-52462972c0fe"
      unitRef="usd">5088000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzMtMy0xLTEtMTAwODc_0579b271-7c13-41f9-93dd-1cdb650c5ba2"
      unitRef="usd">3729000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzQtMS0xLTEtMTAwODc_a1ce7281-1423-46f0-97be-dd9450274cf5"
      unitRef="usd">1852000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzQtMy0xLTEtMTAwODc_e0ad0e51-dfd4-4cd7-8a48-ceba461cf619"
      unitRef="usd">1603000</us-gaap:AccruedProfessionalFeesCurrent>
    <bdtx:AccruedLegalFeesCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzUtMS0xLTEtMTAwODc_5adb7688-908c-4400-9085-6db76d472f91"
      unitRef="usd">83000</bdtx:AccruedLegalFeesCurrent>
    <bdtx:AccruedLegalFeesCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzUtMy0xLTEtMTAwODc_4569a1b0-554f-4c02-be4a-f033c858fcfb"
      unitRef="usd">199000</bdtx:AccruedLegalFeesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMS0xLTEtMTAwODc_04d418af-03b2-4c03-a12b-ca45f8dda2fe"
      unitRef="usd">320000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzYtMy0xLTEtMTAwODc_7b99b808-6d90-4210-8320-ac7f44045f43"
      unitRef="usd">1047000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzctMS0xLTEtMTAwODc_3c4c276a-c960-4d0a-bd37-e45af72f868e"
      unitRef="usd">19535000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMTUvZnJhZzpiY2RmZTI5ODI5MTk0Nzk2YmRlOWNkMjliZDIxYTkyZi90YWJsZTo1YWJmMWYwZDg1ZGM0NjQ2YjM1YTU4ZTczYTUyNDQ3NS90YWJsZXJhbmdlOjVhYmYxZjBkODVkYzQ2NDZiMzVhNThlNzNhNTI0NDc1XzctMy0xLTEtMTAwODc_a948d954-fb53-4a0b-af4b-1b4fd4fed91f"
      unitRef="usd">11680000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0XzEwMzQ_82e06de4-9bdd-40cb-afd5-d27fb54bb26e">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#x2019;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Upon closing of the IPO on February 3, 2020, all of the preferred stock converted into an aggregate of 21,499,770 shares of common stock.&lt;/span&gt;&lt;/div&gt;On February 3, 2020, in connection with the closing of the IPO, the Company filed an amended and restated certificate of incorporation, which, among other things, restated the number of shares of all classes of stock that the Company has authority to issue to 510,000,000 shares, of which (i) 500,000,000 shares shall be a class designated as common stock, par value $0.0001 per share, and (ii) 10,000,000 shares shall be a class designated as undesignated preferred stock, par value $0.0001 per share.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <bdtx:CommonStockVotingRightsNumberOfVotesPerShare
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0XzIxOTkwMjMyNTY3Njk_d0377097-4c4c-412b-bb2f-3320681c2f1b"
      unitRef="vote">1</bdtx:CommonStockVotingRightsNumberOfVotesPerShare>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i5d4aa309da524f179ebe88bd9ded86f2_D20200203-20200203"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0XzQ5Ng_76c5c101-97e0-4155-b934-fd4b83f5f17f"
      unitRef="shares">21499770</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <bdtx:SharesAuthorized
      contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0Xzc4Mw_3b0b55ea-75f6-4aaf-9e0c-796dc052cf51"
      unitRef="shares">510000000</bdtx:SharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0XzgwNw_9cc5b412-541f-4fc7-8983-ecd4bc0f5d96"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0Xzg3Mg_8c2cf609-1abe-42ad-90cf-92746c3e30f5"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0Xzg5NQ_59cf262a-63f5-4f87-b74b-b58670b504b6"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i64e16b7860f94cd4a17def630f1e4f87_I20200203"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjEvZnJhZzo0ZGRhMjY0ODAyNWU0NTcwODJkNTgwNTg2NWMwZmNmNC90ZXh0cmVnaW9uOjRkZGEyNjQ4MDI1ZTQ1NzA4MmQ1ODA1ODY1YzBmY2Y0Xzk3Ng_cf29bd81-b18c-4a6c-b29e-45ad59b4a353"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjM_d96a2db3-0a11-4cab-aa64-98cb1cb9174b">STOCK-BASED COMPENSATION&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;2017 Equity Incentive Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (the &#x201c;2017 Plan&#x201d;), provided for the Company to grant qualified incentive options, nonqualified options, stock grants and other stock-based awards to employees and non-employees to purchase the Company&#x2019;s common stock. Upon the effectiveness of the 2020 Plan (as defined below), no further issuances were made under the 2017 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Stock Option and Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The 2020 Stock Option and Incentive Plan (the &#x201c;2020 Plan&#x201d;) was approved by our board of directors on December 5, 2019, and the Company&#x2019;s stockholders on January 14, 2020 and became effective on the date immediately prior to the date on which the registration statement for the Company&#x2019;s IPO was declared effective. The 2020 Plan provides for the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units, restricted stock awards, unrestricted stock awards, cash-based awards and dividend equivalent rights to the Company&#x2019;s officers, employees, directors and consultants. The number of shares initially reserved for issuance under the 2020 Plan was 6,665,891, which shall be cumulatively increased on January 1, 2021 and each January 1 thereafter by 4% of the number of shares of the Company&#x2019;s common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by the Company&#x2019;s board of directors or compensation, nomination, and corporate governance committee of the board of directors. As of December&#160;31, 2021, 5,211,827 shares remained available for issuance under the 2020 Plan. The number of authorized shares reserved for issuance under the 2020 Plan was increased by 1,449,384 shares effective as of January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The 2020 Employee Stock Purchase Plan (the &#x201c;2020 ESPP&#x201d;) was approved by the Company&#x2019;s board of directors on December 5, 2019, and our stockholders on January 14, 2020, and became effective on the date immediately prior to the date on which the registration statement for the Company&#x2019;s IPO was declared effective. A total of 326,364 shares of common stock were initially reserved for issuance under this plan, which shall be cumulatively increased on January 1, 2021 and each January 1 thereafter by 1% of the number of shares of the Company&#x2019;s common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by the Company&#x2019;s board of directors or compensation, nomination and corporate governance committee of the board of directors. As of December&#160;31, 2021, 646,566 shares remained available for issuance under the 2020 Plan. The number of authorized shares reserved for issuance under the 2020 Plan was increased by 326,364 shares effective as of January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Option valuation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The assumptions that the Company used to determine the grant-date fair value of options granted were as follows, presented on a weighted-average basis:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;63.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following table summarizes the stock option activity under the Company&#x2019;s equity awards plans:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.568%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Life&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;(in Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Outstanding December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,752,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;15.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;62,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,996,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;21.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(110,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(734,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;22.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Outstanding December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,903,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;17.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Options vested or expected to vest at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,903,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;17.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Options exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,791,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;14.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options is calculated as the difference between the exercise price of the options and the fair value of the Company&#x2019;s common stock for those options that had exercise prices lower than the fair value of the Company&#x2019;s common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value per share of options granted during the years ended December&#160;31, 2021 and 2020 was $12.93 and $15.18, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The total fair value of options vested during the years ended December&#160;31, 2021 and 2020 was $11,438 and $4,198, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Under terms of the restricted stock agreements covering the common stock, shares of restricted common stock are subject to a vesting schedule. The majority of restricted stock vests over a three-year period during which time all unvested stock will immediately be forfeited to the Company if the relationship between the recipient and the Company ceases. Subject to the continued employment (or other engagement of the recipient by the Company as described in the restricted stock agreements), all shares of restricted common stock become fully vested within three years of the vesting commencement date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following table summarizes restricted stock activity since January 1, 2020:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Number&#160;of&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.75pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;grant&#160;date&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.75pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Unvested restricted common stock as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;29.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(6,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;30.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Unvested restricted common stock as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;54,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;29.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;28.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Unvested restricted common stock as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;30,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;29.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The aggregate fair value of restricted stock that vested during the years ended December&#160;31, 2021 and 2020 was $714 and $200, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based compensation expense &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company recorded stock-based compensation expense in the following award type categories included within its consolidated statements of operations and comprehensive loss:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;12,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Employee Stock Purchase Plan and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;14,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021 and 2020, the Company issued 12,456 and 505 shares, respectively, of common stock out of our 2020 Plan under our policy where non-employee directors may elect to receive their compensation in the form of common stock in lieu of cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company recorded stock-based compensation expense related to stock options and restricted stock units in the following expense categories of its consolidated statements of operations and comprehensive loss:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;6,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;14,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, total unrecognized compensation cost related to the unvested stock options was $31,192, which is expected to be recognized over a weighted average period of 2.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, total unrecognized compensation cost related to the unvested restricted stock units was $636, which is expected to be recognized over a weighted average period of 1.4 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ic9eb66e638b04af899a8e80564e32d1a_I20200114"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzEyMTY_36b1741d-5397-44f9-8970-33a95a034ada"
      unitRef="shares">6665891</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <bdtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding
      contextRef="ic9eb66e638b04af899a8e80564e32d1a_I20200114"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzEzMTA_7f99d10f-f218-49f5-a238-8712dda01aa7"
      unitRef="number">0.04</bdtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i48ffe9f699fa4a539801be7d17a1a76e_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzE2MDA_7fcb7779-0f8c-4595-89fb-779a7dba1298"
      unitRef="shares">5211827</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ib81aa95c217141f292296a2bf857d7d3_D20220101-20220101"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzE3NTQ_3b5da830-6a31-41ed-9d6c-367125ef0ac8"
      unitRef="shares">1449384</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="id325337deaca458ba4cd7cc986b6aa01_I20200114"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzIxNTU_53b30b88-cf0d-4358-acb3-122476ffd1a0"
      unitRef="shares">326364</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <bdtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding
      contextRef="id325337deaca458ba4cd7cc986b6aa01_I20200114"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzIzMjU_30a602ca-f7db-4f5c-937c-c536136920e4"
      unitRef="number">0.01</bdtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i4c378bf5d47a49fa9e52b9ba3e36d859_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzI2MTQ_eb699929-a66b-479b-a2b9-86130cac1773"
      unitRef="shares">646566</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ia475c342c2e24f7891e04263bf9fda52_D20220101-20220101"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzI3Njg_4ca793d0-accc-4664-b404-abf56c15ee73"
      unitRef="shares">326364</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjQ_dd0ce142-5645-40ad-860f-ecd63903eb1f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The assumptions that the Company used to determine the grant-date fair value of options granted were as follows, presented on a weighted-average basis:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;63.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzItMS0xLTEtMTAwODc_f8a94496-34de-43d2-8530-f94b0f129d22"
      unitRef="number">0.0093</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzItMy0xLTEtMTAwODc_f96b1e62-d55e-4d16-a25b-83a1fd874d78"
      unitRef="number">0.0091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzMtMS0xLTEtMTAwODc_8375a1f6-2dec-41ac-aa61-13b35c1285d4">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzMtMy0xLTEtMTAwODc_85007313-4d19-4d0b-bfa6-bc9032323bbc">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzQtMS0xLTEtMTAwODc_7deb992b-528b-49de-947f-386dd90355b7"
      unitRef="number">0.760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzQtMy0xLTEtMTAwODc_bc320aff-c7ca-48d1-88c7-63de86338e91"
      unitRef="number">0.638</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzUtMS0xLTEtMTAwODc_cfe01ba1-83ea-445e-942e-93f50bd5cc75"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTplNWYyNWZmOTZmNmQ0NDg1YmVkNzdiMTVhMzJhODI0Ni90YWJsZXJhbmdlOmU1ZjI1ZmY5NmY2ZDQ0ODViZWQ3N2IxNWEzMmE4MjQ2XzUtMy0xLTEtMTAwODc_42f0af70-0b96-4f4b-9352-798efa86b0a4"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjI_93da7d70-1549-4754-be3b-2b9b83cb15f1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following table summarizes the stock option activity under the Company&#x2019;s equity awards plans:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.568%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.456%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Life&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;(in Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Outstanding December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,752,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;15.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;62,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,996,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;21.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(110,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(734,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;22.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Outstanding December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,903,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;17.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Options vested or expected to vest at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,903,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;17.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Options exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,791,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;14.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzEtMS0xLTEtMTAwODc_94c3788f-23ed-4afd-beaf-54827a30fedd"
      unitRef="shares">3752744</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzEtMy0xLTEtMTAwODc_70b39648-9ef9-4f75-bcd5-da7ee776e3c5"
      unitRef="usdPerShare">15.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzEtNS0xLTEtMTAwODc_7a9f84ee-807f-4d8a-b3a6-9bb0cd5e8196">P9Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzEtNy0xLTEtMTAwODc_955047a5-55d3-44da-9790-808a34df530f"
      unitRef="usd">62842000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzItMS0xLTEtMTAwODc_98bddd83-9a0e-4fe2-bb89-e12dfb5160ac"
      unitRef="shares">1996644</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzItMy0xLTEtMTAwODc_e1e218ec-ba68-425b-aa1b-c9ca10407065"
      unitRef="usdPerShare">21.61</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzMtMS0xLTEtMTAwODc_2ba318c4-6974-4e05-9b45-dfd7988ae609"
      unitRef="shares">110621</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzMtMy0xLTEtMTAwODc_e37520c6-3d17-444e-91e7-f414903aeb41"
      unitRef="usdPerShare">6.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzQtMS0xLTEtMTAwODc_04945aed-5777-4934-bbec-fa7889ab3fac"
      unitRef="shares">734928</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzQtMy0xLTEtMTAwODc_24911bdf-a1ef-4edf-b2f3-bc537856b512"
      unitRef="usdPerShare">22.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzUtMS0xLTEtMTAwODc_92e1b688-608a-4af4-908a-508e5c9b3ce0"
      unitRef="shares">4903839</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzUtMy0xLTEtMTAwODc_d3b660e0-4cd3-4997-911e-7af3f02df0f6"
      unitRef="usdPerShare">17.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzUtNS0xLTEtMTAwODc_dfac00ee-46f1-4efd-830c-db01b22caa1c">P7Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzUtNy0xLTEtMTAwODc_7c823dde-4e6a-4b26-b90b-f7c5eb3f48cd"
      unitRef="usd">847000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzYtMS0xLTEtMTAwODc_700a70a9-7abf-4ee4-bcd8-c790fe41c839"
      unitRef="shares">4903839</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzYtMy0xLTEtMTAwODc_67a47ba7-ab44-448a-b1e7-fe4235002efc"
      unitRef="usdPerShare">17.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzYtNS0xLTEtMTAwODc_97b11ddc-2071-4d4f-8287-159d97b45554">P7Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzYtNy0xLTEtMTAwODc_92136a9a-d5a6-43c3-bef7-8124f69880a5"
      unitRef="usd">847000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzctMS0xLTEtMTAwODc_3bde2fa8-6e9e-4520-a185-b40a040f9e7c"
      unitRef="shares">1791964</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzctMy0xLTEtMTAwODc_2546ce8d-f68e-4055-b682-d40b4251cab6"
      unitRef="usdPerShare">14.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzctNS0xLTEtMTAwODc_b4a766fa-b9f1-4faf-8d95-cca3306ce3fc">P6Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpjYjY0N2E3ZTZiYWQ0MDQxODViOWRmZGYxMzJjY2Q1Yi90YWJsZXJhbmdlOmNiNjQ3YTdlNmJhZDQwNDE4NWI5ZGZkZjEzMmNjZDViXzctNy0xLTEtMTAwODc_316e8879-655b-4636-b639-aa9b9023a363"
      unitRef="usd">583000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzM0Njk_20062a54-4446-4b72-b98c-a45a0e97ce77"
      unitRef="usdPerShare">12.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzM0NzY_0d36f932-6546-47f5-be7d-4a28f2fbddaa"
      unitRef="usdPerShare">15.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzM1NzE_0ccb0e0d-b1bb-4f88-98ee-c353e9e2e22d"
      unitRef="usd">11438000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzM1Nzg_07351c42-1486-4152-8871-e7e0e9604e45"
      unitRef="usd">4198000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjg_256cffd9-ad15-426a-885a-4d4201a2ac1c">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzIxOTkwMjMyNjE3NTU_fa08bb45-84d6-4f17-80c3-f18bc3b4b0c6">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjU_6f239ecc-2362-4cd7-aa82-d8f061f00d88">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following table summarizes restricted stock activity since January 1, 2020:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Number&#160;of&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.75pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;grant&#160;date&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.75pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Unvested restricted common stock as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;61,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;29.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(6,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;30.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Unvested restricted common stock as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;54,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;29.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;28.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Unvested restricted common stock as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;30,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;29.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i409db6c3ae2948168a94cd673a222876_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzEtMS0xLTEtMTAwODc_d1283774-2d90-4459-9e5a-21d04efcfed3"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i409db6c3ae2948168a94cd673a222876_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzEtMi0xLTEtMTAwODc_cc6ee50a-fc5a-4d90-bf3f-79791b9e0d8d"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzItMS0xLTEtMTAwODc_119e5672-8d76-483a-98d3-42f3e873827d"
      unitRef="shares">61000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzItMi0xLTEtMTAwODc_323e199e-deb1-4160-8e0e-75bfcff55e5f"
      unitRef="usdPerShare">29.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzMtMS0xLTEtMTAwODc_e08619cc-71d8-4383-97a7-bd87b0ada5fe"
      unitRef="shares">6664</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzMtMi0xLTEtMTAwODc_3f9c452e-1ff2-4d93-9b5e-583081e270ca"
      unitRef="usdPerShare">30.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie3bf60c3f3c74cac874df7014c860584_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzQtMS0xLTEtMTAwODc_2b37ccca-61c3-41d7-987d-0e84bef2867f"
      unitRef="shares">54336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie3bf60c3f3c74cac874df7014c860584_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzQtMi0xLTEtMTAwODc_9320a4c2-9118-48d0-a38a-3380bd96ea30"
      unitRef="usdPerShare">29.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzUtMS0xLTEtMTAwODc_a80a2de0-f147-4009-a2a2-0fc0cd0455cf"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzUtMi0xLTEtMTAwODc_a598af21-151b-4d12-aae6-09009beb6c52"
      unitRef="usdPerShare">28.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzYtMS0xLTEtMTE5MjQ_c47c51fd-68f0-45dc-b314-ac47bc382848"
      unitRef="shares">27002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzYtMi0xLTEtMTE5MzU_7fc3dcf1-90f7-463d-885a-236e076ee852"
      unitRef="usdPerShare">26.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzYtMS0xLTEtMTAwODc_2b375f6e-ae17-45a3-bc00-bdaeeed7c5a6"
      unitRef="shares">6667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzYtMi0xLTEtMTAwODc_9589846e-b4b4-46c7-8b2c-01276d77a776"
      unitRef="usdPerShare">1.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i494939f1eb09446097a4d8943229ee63_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzctMS0xLTEtMTAwODc_ea25d7cf-10cb-4a33-a6a6-fba6f55b4aa6"
      unitRef="shares">30667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i494939f1eb09446097a4d8943229ee63_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTo3ZWJmZDI3OWNlMDk0YjZkYmFmZjEzOWUyYTg0NGNlMC90YWJsZXJhbmdlOjdlYmZkMjc5Y2UwOTRiNmRiYWZmMTM5ZTJhODQ0Y2UwXzctMi0xLTEtMTAwODc_3df86e9f-2f63-4825-ba9f-9fc75785838f"
      unitRef="usdPerShare">29.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzQzODY_bfaa2589-177b-406e-b774-1dc2427829e2"
      unitRef="usd">714000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2539fb7cb5eb42c7901ebadf69072259_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzQzOTM_c9269184-fb8b-4b65-9259-c08f7f876169"
      unitRef="usd">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzIxOTkwMjMyNjM1Nzg_15978ad4-5b67-48e9-b547-8a30895a88ac">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company recorded stock-based compensation expense in the following award type categories included within its consolidated statements of operations and comprehensive loss:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;12,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Employee Stock Purchase Plan and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;14,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company recorded stock-based compensation expense related to stock options and restricted stock units in the following expense categories of its consolidated statements of operations and comprehensive loss:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;6,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;14,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ife703eee16a24418b0688374aa2d9127_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzItMS0xLTEtMTE5NzA_bf894f31-5aa0-44ef-9785-62a4eb8c928e"
      unitRef="usd">12964000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5d213479013e4c85a590094a80d5821c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzItMy0xLTEtMTE5NzA_17971f28-ae44-4699-b0af-1f19934f3687"
      unitRef="usd">7344000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3e7beae8caf2403f8ca0392b605a96a5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzMtMS0xLTEtMTE5NzA_5f7515bb-c31a-4b60-9aea-6ea89b78e451"
      unitRef="usd">812000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0a3a672acfe3476499dfdb07a32e435a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzMtMy0xLTEtMTE5NzA_e5c6938a-61bd-4d2d-a83c-9617d2598fcb"
      unitRef="usd">404000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7e11f471e4864a40a07e85f2ee15dc66_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzQtMS0xLTEtMTE5NzA_c929a786-1338-4036-be18-4c218011b59f"
      unitRef="usd">261000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i64d4b8a477e44a2294dafb47b8366169_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzQtMy0xLTEtMTE5NzA_2ac65afc-c520-495c-aa31-0bc23eb6d966"
      unitRef="usd">17000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzUtMS0xLTEtMTE5NzA_b8a7c237-5418-4326-89d6-8494d293d8d8"
      unitRef="usd">14037000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZTpiYmZjMzc0MTA1ZjM0OGQ0OGU2ZTcxMWZkZDVjMjIyZC90YWJsZXJhbmdlOmJiZmMzNzQxMDVmMzQ4ZDQ4ZTZlNzExZmRkNWMyMjJkXzUtMy0xLTEtMTE5NzA_13799675-6420-4235-8f14-81c1e4ed3852"
      unitRef="usd">7765000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ifbd32a8c30ea4113a72bd22800a1803a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzE2NDkyNjc0NDg0ODk_92459268-7aac-4e0c-b440-56a9ab7c62bf"
      unitRef="shares">12456</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="idbd7ebcbc2d04c7fa4877287edf187be_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzE2NDkyNjc0NDg0OTk_53b7a9cc-2c99-4fa3-bf9e-78999bdeb949"
      unitRef="shares">505</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4d4f007a1e3a4f32b5564d78ab1f7548_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzItMS0xLTEtMTAwODc_47da6068-c034-4d31-b029-597d69d9a34f"
      unitRef="usd">6324000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if5a07f83801a4155974a26a9c19c163c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzItMy0xLTEtMTAwODc_60fc5485-500e-4d8c-8739-052b58ef10cd"
      unitRef="usd">3607000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iead01dff07974c708a3ac77a441836f1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzMtMS0xLTEtMTAwODc_895c2fcf-1d26-429c-b9d0-8f32f8858d45"
      unitRef="usd">7713000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4d20f61caf924e11ac009ed0ff78534e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzMtMy0xLTEtMTAwODc_4f8a326f-29ac-49b2-9e2e-a528741c02ca"
      unitRef="usd">4158000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzQtMS0xLTEtMTAwODc_dea2054c-fb1f-4160-b0e3-a0850a2cdd56"
      unitRef="usd">14037000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90YWJsZToxYmZiOTQzY2I2OWY0MTdmOTFjOWNjMTk5ZTcxOGY2My90YWJsZXJhbmdlOjFiZmI5NDNjYjY5ZjQxN2Y5MWM5Y2MxOTllNzE4ZjYzXzQtMy0xLTEtMTAwODc_cf4be6a6-eff3-4ddb-826c-75900264d127"
      unitRef="usd">7765000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzU5MTI_36ea2200-3c7a-4184-a004-b3d40f01a981"
      unitRef="usd">31192000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ife703eee16a24418b0688374aa2d9127_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzU5ODU_6d0cb1ed-6b2d-442f-aa32-83a8d6a0d7cd">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i494939f1eb09446097a4d8943229ee63_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYwODc_1e1088b4-f76a-4a2d-97ee-99d23382dcbb"
      unitRef="usd">636000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="if7d8c490ce604371897d0b4072e739ca_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjQvZnJhZzo0MDFhYjM1M2U3OTk0M2MyYTlkMWQ1YzAzNzM1NTg1MS90ZXh0cmVnaW9uOjQwMWFiMzUzZTc5OTQzYzJhOWQxZDVjMDM3MzU1ODUxXzYxNjA_9aadf78f-d40b-4f40-9552-b3a9c8d4aad2">P1Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzUzNTg_13038205-e174-45d4-9ac2-2a66d0844c7b">INCOME TAXES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Income (loss) before income tax expense consists of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(125,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(66,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total loss before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(125,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(67,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021 and 2020, the Company recorded no income tax benefit for the net operating losses incurred each year, due to its uncertainty of realizing a benefit from those items.  A reconciliation of income taxes computed using the U.S. federal statutory rate to that reflected in operations as of December&#160;31, 2021 and 2020, respectively, is as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;State and local taxes, net of federal benefit&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Permanent differences&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Research and development credits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(27.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(26.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Effective income tax rate&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.0 %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Tax year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;24,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Research and development tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Accruals and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;70,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;30,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Valuation Allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(63,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(28,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(7,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(2,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"&gt;As of December&#160;31, 2021, the Company had gross federal net operating loss carryforwards of $209,607, of which $2,557 begin to expire in 2036 and the remainder do not expire but are subject to 80% limitation. As of December 31, 2021, the Company had state net operating loss carryforwards of $135,422 that begin to expire in 2036. The Company also has net operating loss carryforwards in Canada of $463 that are set to expire beginning in 2039. Additionally, the Company had federal research and development tax credit carryforwards of $5,439 that expire at various dates through 2041.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;In assessing the realizability of the net deferred tax asset, the Company considers all relevant positive and negative evidence in determining whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The realization of the gross deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of the net operating loss carryforwards. Management believes that it is more likely than not that the Company&#x2019;s deferred income tax assets will not be realized. As such, there is a full valuation allowance against the net deferred tax assets as of December&#160;31, 2021 and 2020. The valuation allowance increased by $34,305 during the year ended December&#160;31, 2021 primarily as a result of net operating losses generated during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Utilization of the net operating loss carryforwards and research and development tax credit carryforwards may be subject to an annual limitation under Section 382 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section 382, which is determined by first multiplying the value of the Company&#x2019;s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. Further, until a study is completed and any limitation is known, no amounts are being presented as an uncertain tax position.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company also has not conducted a study of its research and development credit carryforwards, which may result in an adjustment to research and development credit carryforwards. A full valuation allowance has been provided against the Company&#x2019;s research and development credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheets or statements of operations if an adjustment were required. Further, until a study is completed and any limitation is known, no amounts are being presented as an uncertain tax position.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company applies the accounting guidance in ASC 740 related to accounting for uncertainty in income taxes. The Company&#x2019;s reserves related to taxes are based on a determination of whether, and how much of, a tax benefit taken by the Company in its tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit. As of December&#160;31, 2021 and 2020, the Company had no unrecognized tax benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company will recognize interest and penalties related to uncertain tax positions in income tax expense. As of December&#160;31, 2021 and 2020, the Company had no accrued interest or penalties related to uncertain tax positions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending tax examinations. As of December&#160;31, 2021 and 2020, the Company&#x2019;s tax years are still open under statute from 2018 to the present.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s foreign subsidiary has incurred losses since inception and the Company had no undistributed earnings as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzI3NDg3NzkwODA2ODk_20f681b5-30ba-4824-8c97-1935b5ec16bd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Income (loss) before income tax expense consists of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(125,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(66,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total loss before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(125,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(67,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzItMS0xLTEtMTUxMDQ_141014b6-6a10-4d7c-88cd-08004d4af69f"
      unitRef="usd">-125328000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzItMy0xLTEtMTUxMDQ_6f09c15e-d895-4462-a0d0-ef07ac44e0eb"
      unitRef="usd">-66992000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzMtMS0xLTEtMTUxMDQ_3e176704-313f-42e2-aca0-4dbfd29ea10c"
      unitRef="usd">-268000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzMtMy0xLTEtMTUxMDQ_993dbdfe-3c39-4082-a25a-266cff419a04"
      unitRef="usd">-262000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzQtMS0xLTEtMTUxMDQ_6e1c0046-a1a1-4968-9976-044864dada72"
      unitRef="usd">-125596000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo5OTk2ZDAyYjVlYjg0NjA4YjAwYzRhNzllMTNhZDhiMi90YWJsZXJhbmdlOjk5OTZkMDJiNWViODQ2MDhiMDBjNGE3OWUxM2FkOGIyXzQtMy0xLTEtMTUxMDQ_6dfae177-fecc-491a-b4a6-25d45561f14c"
      unitRef="usd">-67254000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzc0_595a4e2b-5a6f-4380-bc73-98848378d7cd"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzc0_81fa7206-00ca-4f95-8a39-24d6ade3b325"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzUzNTk_7b9b19d0-f85a-4f27-940a-484bedbc034c">A reconciliation of income taxes computed using the U.S. federal statutory rate to that reflected in operations as of December&#160;31, 2021 and 2020, respectively, is as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;State and local taxes, net of federal benefit&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Permanent differences&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Research and development credits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(27.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(26.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt;padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Effective income tax rate&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;0.0 %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzItMS0xLTEtMTAwODc_3a667a96-eb06-4b47-9ba8-314fd4510211"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzItMy0xLTEtMTAwODc_713cec3b-a758-4ff3-9f6b-b640f980f969"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzMtMS0xLTEtMTAwODc_c5025224-7c9e-4394-8c18-844dad902259"
      unitRef="number">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzMtMy0xLTEtMTAwODc_b64b55f0-13dc-4a50-80a9-118d3135ea9f"
      unitRef="number">0.034</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <bdtx:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzQtMS0xLTEtMTAwODc_e3c464f5-c75e-40ec-b247-dd2af69ea575"
      unitRef="number">-0.001</bdtx:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <bdtx:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzQtMy0xLTEtMTAwODc_e677184a-d307-48a2-b4fb-afbf67ab1191"
      unitRef="number">0.000</bdtx:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzUtMS0xLTEtMTQxODk_9d9e2a48-0b25-4d4a-954f-338c733ddb50"
      unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzUtMy0xLTEtMTQxODk_87d2e592-c52a-4bb5-8cbb-660dd118dfae"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzUtMS0xLTEtMTAwODc_6721254f-5d6f-4feb-ba46-35af0bbc313b"
      unitRef="number">-0.026</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzUtMy0xLTEtMTAwODc_b2499c77-62cf-4f8c-819c-8b52d567ddf7"
      unitRef="number">-0.022</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzYtMS0xLTEtMTAwODc_f7a84259-8b84-49ec-86eb-63cf3d41197b"
      unitRef="number">-0.272</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzYtMy0xLTEtMTAwODc_ddf5c336-fc6d-45b4-9af5-5277ea703928"
      unitRef="number">-0.265</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzctMS0xLTEtMTAwODc_d20a67e8-4f15-42de-98d0-f2c76200e8c8"
      unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzctMy0xLTEtMTAwODc_d804aea2-84b5-4836-b02b-c3657beb9d6d"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzgtMS0xLTEtMTAwODc_fdd4a2f4-319f-4034-a0c9-a07127de2b69"
      unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZTo3ZjlhZjQ5OGIwNTI0ZTZhOWQ2Njk2NTVhZGM4ZjcwZS90YWJsZXJhbmdlOjdmOWFmNDk4YjA1MjRlNmE5ZDY2OTY1NWFkYzhmNzBlXzgtMy0xLTEtMTAwODc_3283d818-87f0-4fc7-93ec-ab87e1bd77d7"
      unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzUzNjE_ae71acf0-b23b-4e84-8ce8-dfcf90eca1fe">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Tax year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;52,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;24,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Research and development tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Accruals and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;70,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;30,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Valuation Allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(63,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(28,709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(7,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(2,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzMtMS0xLTEtMTAwODc_14e1fc44-e5a8-4659-b3eb-64f0d1e7a9f6"
      unitRef="usd">52568000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzMtMy0xLTEtMTAwODc_b14b3140-efd9-4242-a4e7-7b69c5cfc4e7"
      unitRef="usd">24059000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzQtMS0xLTEtMTAwODc_f3b33b59-da92-46a1-91b2-74d1e7111c8f"
      unitRef="usd">5439000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzQtMy0xLTEtMTAwODc_2f2bb16c-ed7f-4df0-a6d1-ca22e63bbcec"
      unitRef="usd">2477000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <bdtx:DeferredTaxAssetsLeasingArrangements
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzUtMS0xLTEtMTAwODc_2565a579-8be6-4dda-b9ae-d9c47e2869e7"
      unitRef="usd">7172000</bdtx:DeferredTaxAssetsLeasingArrangements>
    <bdtx:DeferredTaxAssetsLeasingArrangements
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzUtMy0xLTEtMTAwODc_3e4a08b1-d22f-40ba-841b-8f27e594680d"
      unitRef="usd">2147000</bdtx:DeferredTaxAssetsLeasingArrangements>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzYtMS0xLTEtMTAwODc_9189355e-6f3d-4a10-a428-9a6ffd8041a9"
      unitRef="usd">1251000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzYtMy0xLTEtMTAwODc_47b09aa2-20cf-44d6-85ed-d60ca9530b34"
      unitRef="usd">680000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzctMS0xLTEtMTAwODc_5806c9f1-f53d-45a8-8533-fcc85a2e3457"
      unitRef="usd">3835000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzctMy0xLTEtMTAwODc_39f91d90-93af-4aaf-ac33-3e04241453bb"
      unitRef="usd">1434000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzgtMS0xLTEtMTAwODc_0a193e39-07ca-4c21-a073-9c7922dc48c7"
      unitRef="usd">70265000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzgtMy0xLTEtMTAwODc_4cf3c04c-9b13-492b-943d-548ef779b707"
      unitRef="usd">30797000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzktMS0xLTEtMTAwODc_8a509539-a441-4f94-84e9-7de2438fe4a0"
      unitRef="usd">63014000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzktMy0xLTEtMTAwODc_46fb64f1-b0db-4b1b-a89f-ee93bd305758"
      unitRef="usd">28709000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEwLTEtMS0xLTEwMDg3_529c63dd-2bb9-4f9e-948f-2fcc6f22ba00"
      unitRef="usd">7251000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEwLTMtMS0xLTEwMDg3_5e9c1fd4-d128-42c5-9b43-63e2a518fb04"
      unitRef="usd">2088000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzExLTEtMS0xLTEwMDg3_19c7eb6b-18cc-4859-b690-9631fa43a288"
      unitRef="usd">7236000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzExLTMtMS0xLTEwMDg3_0158af1e-73bd-4eb0-a336-3e0a3a51112f"
      unitRef="usd">2063000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEyLTEtMS0xLTEwMDg3_a3f1c05f-cc85-468e-9864-7bd7ed8407a8"
      unitRef="usd">15000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEyLTMtMS0xLTEwMDg3_b21f3b2d-84f9-4f5e-9acf-0b2db52ed5f7"
      unitRef="usd">25000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEzLTEtMS0xLTEwMDg3_2159472a-1db3-44f5-8e51-d9896e9d3ca2"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90YWJsZToyYTAxZmNlZDMyYjY0YTMxYjFkOWQ3NDdkMmQxYmE3My90YWJsZXJhbmdlOjJhMDFmY2VkMzJiNjRhMzFiMWQ5ZDc0N2QyZDFiYTczXzEzLTMtMS0xLTEwMDg3_3b9d7c0b-4183-4f21-8ded-c25858f22c7c"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ib3f540cd599244b38eb489e52a6cc2de_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzU4MA_b538ebc8-9b1a-43b0-9e9a-d32e17da0f60"
      unitRef="usd">209607000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie5d0a15d9464476f88434bfff0ae0a67_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzEwOTk1MTE2Mzg4Nzc_ee2ba0ca-5b2b-4451-a7f4-e2183a5483ef"
      unitRef="usd">2557000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="id37d6ea5602744e9b4b315730beac564_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzU4Nw_e02a62e8-e053-49bd-93ce-1548c25214e1"
      unitRef="usd">135422000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ib41127d5f7aa452f8b4b9e2bbc608eab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzg2MQ_f15cece5-d8c6-450b-ba01-c8ddf0c74b20"
      unitRef="usd">463000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i3697f799f56d4e558c172781bd1f5483_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzk5Nw_8b4ec7eb-3b50-4084-af9e-2b539c64d729"
      unitRef="usd">5439000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzE3NTk_45f5a065-2f0a-4722-a869-95a234cde96c"
      unitRef="usd">34305000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzQ2MTg_550321e3-97f1-4459-a818-1fb6f81529a9"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzQ2MTg_8a931834-6ae9-4a6c-b61b-e52b6c10aeec"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzQ3OTA_99b72a42-517d-4e29-a851-f479e98a83ff"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzQ3OTA_c5c896c5-0f69-4073-b74e-27d017a25bfc"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMjcvZnJhZzoxNjFiNmQ2M2JkZTU0ZjAwOWNhMDk4MGVkOGQ3NjNiMi90ZXh0cmVnaW9uOjE2MWI2ZDYzYmRlNTRmMDA5Y2EwOTgwZWQ4ZDc2M2IyXzIxOTkwMjMyNjA5MTg_6f2cc0b8-55e3-44db-b12d-d5506115eadd"
      unitRef="usd">0</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90ZXh0cmVnaW9uOjM2OGU3ZmYzYmQyMDQ0ZTJiOTA2MmE1Y2I5OWI3YzhkXzEzNjc_060b7b29-54c8-45c5-bb5e-3105451c857a">NET LOSS PER SHARE&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net loss per share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(125,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(67,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;36,189,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;32,907,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(3.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(2.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unvested restricted common shares at December&#160;31, 2021 and 2020 have been excluded from the computation of basic net loss per share attributable to common stockholders.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s potentially dilutive securities, which include options, unvested restricted stock, shares issuable under the employee stock purchase plan and warrants to purchase common stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,903,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,752,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;30,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;54,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Shares issuable under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;24,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Warrants to purchase shares of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;10,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;10,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,970,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,817,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90ZXh0cmVnaW9uOjM2OGU3ZmYzYmQyMDQ0ZTJiOTA2MmE1Y2I5OWI3YzhkXzEzNjU_1185b06b-75e0-4741-a453-a2d22652c9d6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(125,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(67,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;36,189,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;32,907,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(3.47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(2.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzItMS0xLTEtMTAwODc_dd3fc3fe-b261-4bed-8d76-293d4de65aae"
      unitRef="usd">-125596000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzItMy0xLTEtMTAwODc_664ef3ba-388b-4830-aa36-ee5e75f5b3f5"
      unitRef="usd">-67254000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzMtMS0xLTEtMTAwODc_5aa7aa24-7314-4a42-a7e1-20a0cee35e9b"
      unitRef="shares">36189002</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzMtMS0xLTEtMTAwODc_9e23feea-7234-4049-b2ce-3124d5188404"
      unitRef="shares">36189002</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzMtMy0xLTEtMTAwODc_1b24d8f5-f31d-496a-8db3-9077be567461"
      unitRef="shares">32907100</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzMtMy0xLTEtMTAwODc_c33391fd-1655-4415-9815-0c88169d16b0"
      unitRef="shares">32907100</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzQtMS0xLTEtMTAwODc_58cfe9df-c0a0-41c4-a8ae-56f0d0769874"
      unitRef="usdPerShare">-3.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzQtMS0xLTEtMTAwODc_7bbdf063-4e33-437f-a136-4d76ad6e1caf"
      unitRef="usdPerShare">-3.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzQtMy0xLTEtMTAwODc_2cd6c1f5-cd7a-4069-aa3d-af68168cf1c8"
      unitRef="usdPerShare">-2.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZToxOTFiMzA1ZTY1MzU0N2E4YmE4NTE1NjIyYjc0YTg5OS90YWJsZXJhbmdlOjE5MWIzMDVlNjUzNTQ3YThiYTg1MTU2MjJiNzRhODk5XzQtMy0xLTEtMTAwODc_8c7ba103-87c8-4cd3-ba4b-a1da6b169b5a"
      unitRef="usdPerShare">-2.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90ZXh0cmVnaW9uOjM2OGU3ZmYzYmQyMDQ0ZTJiOTA2MmE1Y2I5OWI3YzhkXzEzNjY_8be4f85a-6e52-42ed-82c4-b01db8f7af6e">The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,903,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,752,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;30,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;54,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Shares issuable under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;24,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Warrants to purchase shares of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;10,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;10,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,970,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,817,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i54551aadbd8e4430aa8071d23c1c1c0e_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzItMS0xLTEtMTAwODc_73f6ac07-41ba-4ca7-886e-fa736a7c65a9"
      unitRef="shares">4903839</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ide4e4eed14bf4310a962d48216c9ab68_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzItMy0xLTEtMTAwODc_1821d7f4-c110-44cb-9c97-12601bb37cd3"
      unitRef="shares">3752744</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3c27a225a3e24360be5046309795d54d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzMtMS0xLTEtMTAwODc_388da5cc-7a83-4693-b8ef-d6a07c988621"
      unitRef="shares">30667</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0b93ad2715d94c1097f1ba1e707cc771_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzMtMy0xLTEtMTAwODc_78e1545c-8b73-4254-bf57-d404ddb97dcf"
      unitRef="shares">54336</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i86a156ce1dbe4eaf9a07508a2e9c2203_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzQtMS0xLTEtMTAwODc_c6936bbe-1f3e-4fe8-a68d-05038c2e0043"
      unitRef="shares">24806</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie3625da8da754dfe9f0c00bdb9a1ea06_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzQtMy0xLTEtMTAwODc_be85df9b-b114-47f3-b319-b0621e0f8fd4"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i493c609a43ce4f48b467af5ffd22630d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzUtMS0xLTEtMTAwODc_72afecd1-78d0-4603-8d03-1c1030e604a0"
      unitRef="shares">10757</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8023413c14d34199a01eff6173e632dd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzUtMy0xLTEtMTAwODc_56c5cbf9-4bbf-406c-b9b5-db1769135712"
      unitRef="shares">10757</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzYtMS0xLTEtMTAwODc_a7a28471-7b5b-4ef8-ad00-6c7f65e476e9"
      unitRef="shares">4970069</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzAvZnJhZzozNjhlN2ZmM2JkMjA0NGUyYjkwNjJhNWNiOTliN2M4ZC90YWJsZTo2ZjU5MjFmMjdmNGQ0Yjg5OTY3M2Y5ZTExYTA3ZmNlNy90YWJsZXJhbmdlOjZmNTkyMWYyN2Y0ZDRiODk5NjczZjllMTFhMDdmY2U3XzYtMy0xLTEtMTAwODc_f94eac0a-0b03-4fb4-832b-4a10f0ef6175"
      unitRef="shares">3817837</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODg_90e164ec-8a2b-46f8-a18b-f4225a93369e">LEASES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company has historically entered into lease arrangements for its facilities. As of December&#160;31, 2021, the Company had two operating leases with required future minimum payments. In applying the transition guidance under ASC 842, the Company determined the classification of these leases to be operating leases and recorded right-of-use assets and lease liabilities as of the effective dates. The Company&#x2019;s leases generally do not include termination or purchase options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company entered into a seven-year agreement with an option to extend for &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzU4Mg_b2565059-2dc9-4865-97c8-084fe9219efb"&gt;five&lt;/span&gt; additional years to lease two floors totaling approximately 25,578 square feet of office space for its principal office, which is located in Cambridge, MA. The lease on the first floor commenced on August 1, 2020 and the lease on the second floor commenced March 9, 2021. The Company recognized the respective lease balances on the consolidated balance sheets when the lease of each floor commenced. Under the terms of the lease, the Company was required to issue a $1,168 letter of credit as security for the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company previously leased an office space in Cambridge, MA under a lease that commenced in February 2019 for approximately 2,357 square feet of office space, which was set to expire on April 30, 2022, subject to an option to extend the lease for &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE2NDU_becd2bb6-444f-4a5c-872f-1af74e1752f5"&gt;three&lt;/span&gt; additional years. Effective June 15, 2021, the lease was terminated, and the remaining right-of-use asset and lease liability were derecognized. A gain of $5 was recognized for the termination of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company entered into an eleven-year agreement with an option to extend for &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE3NTk_95f433d1-6446-4971-8ff9-a46e1a446767"&gt;five&lt;/span&gt; additional years to lease approximately 18,120 square feet of office and laboratory space in New York, NY. The Company has an option to extend the lease for &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEwOTk1MTE2MzI5NDU_718bdc4c-12a4-421f-9b54-25688d4ec31f"&gt;five&lt;/span&gt; additional years. The lease commenced August 26, 2021 and the related lease balance was recognized on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following table contains a summary of the lease costs recognized under ASC 842 and other information pertaining to the Company&#x2019;s operating lease for the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Lease Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Other Operating Lease Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The variable lease costs for the year ended December&#160;31, 2021 include common area maintenance and other operating charges. As the Company&#x2019;s leases do not provide an implicit rate, the Company utilized its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under the Company&#x2019;s operating leases as of December&#160;31, 2021 were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;16,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;37,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(8,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;29,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Rent expense for the years ended December&#160;31, 2021 and 2020 was $3,921 and $1,545, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <bdtx:LesseeOperatingLeaseNumberOfContracts
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEyMw_ae16612a-e609-460b-8cc7-fce22c86ad3d"
      unitRef="contract">2</bdtx:LesseeOperatingLeaseNumberOfContracts>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i6efd849321404f36ac0949e86c2f742e_I20200731"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODk_d8f7dabf-0093-4f28-a1a5-45c16af2b70b">P7Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <bdtx:LesseeOperatingLeaseArea
      contextRef="i6efd849321404f36ac0949e86c2f742e_I20200731"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzY0NQ_bd99e4a0-d442-4d0b-8e16-6e0b29fd959b"
      unitRef="sqft">25578</bdtx:LesseeOperatingLeaseArea>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i6efd849321404f36ac0949e86c2f742e_I20200731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEzNjM_ce577507-027f-4750-93e2-21eb6f404add"
      unitRef="usd">1168000</us-gaap:LettersOfCreditOutstandingAmount>
    <bdtx:LesseeOperatingLeaseArea
      contextRef="i1e74d76585884b418f0bcfdce485be83_I20190228"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE1MzE_41d78cdd-63cf-44d7-944a-665576d84c13"
      unitRef="sqft">2357</bdtx:LesseeOperatingLeaseArea>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzEwOTk1MTE2MzI1MTU_3c46d4ae-c43b-4e09-9965-40c750c35fa2"
      unitRef="usd">5000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODY_ee95e967-2bb1-4990-aa7e-e4aa102ddd11">P11Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <bdtx:LesseeOperatingLeaseArea
      contextRef="ie2ad25572c8a4cb3ba422bc7a840bfd2_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzE4MDI_ca831a71-c07e-493c-8dc5-c2fa379e38bb"
      unitRef="sqft">18120</bdtx:LesseeOperatingLeaseArea>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODQ_6e3cb615-f188-4468-b201-30cc7603c3f6">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The following table contains a summary of the lease costs recognized under ASC 842 and other information pertaining to the Company&#x2019;s operating lease for the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Lease Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;3,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;1,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"&gt;Other Operating Lease Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzItMS0xLTEtMTAwODc_8be773a5-cff7-4132-8ad0-9cdbec33f3dd"
      unitRef="usd">3032000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzMtMy0xLTEtMTQ1Mzg_fb17da12-0793-4892-bc87-0eaab91cd4d5"
      unitRef="usd">767000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzMtMS0xLTEtMTAwODc_b497c858-d13b-4fd6-84a8-2dc01c67d094"
      unitRef="usd">886000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzQtMy0xLTEtMTQ1Mzg_2ffedb84-2118-4591-ba2f-f9fa6720e838"
      unitRef="usd">769000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzQtMS0xLTEtMTAwODc_d41ae265-d76d-4a18-85b6-75ff69f2c3d1"
      unitRef="usd">444000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzUtMy0xLTEtMTQ1Mzg_f893c975-d878-4a6e-b3b1-9b8a281f9a96"
      unitRef="usd">44000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzUtMS0xLTEtMTAwODc_c1bf5269-3db0-45db-b052-08f2159e83e4"
      unitRef="usd">4362000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzU5NWU2Y2U1NmY0NWJkOTYxNmMwNWQ3NmU2NTcxMy90YWJsZXJhbmdlOjIzNTk1ZTZjZTU2ZjQ1YmQ5NjE2YzA1ZDc2ZTY1NzEzXzYtMy0xLTEtMTQ1Mzg_41b3d195-2293-43b8-8452-d6380e7842db"
      unitRef="usd">1580000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzEtMS0xLTEtMTAwODc_839116bd-e9bc-46da-b822-11b064cca9a8"
      unitRef="usd">2464000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzItMy0xLTEtMTQ2NjE_b47005eb-1380-4330-8c24-a8d03fc5c757"
      unitRef="usd">432000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzItMS0xLTEtMTAwODc_deb7c118-16ea-46c6-9086-f22f42761e98">P8Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzMtMy0xLTEtMTQ2NjE_ab2ecc0f-1b83-4c67-8574-9db9c467d0fd">P7Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzMtMS0xLTEtMTAwODc_490b8371-3381-4b6e-b819-8217ac6c7277"
      unitRef="number">0.053</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZToyMzkzNjI5NTRlYmU0MzJhOGRkNDMzYTY3NDhiY2I3NC90YWJsZXJhbmdlOjIzOTM2Mjk1NGViZTQzMmE4ZGQ0MzNhNjc0OGJjYjc0XzQtMy0xLTEtMTQ2NjE_39bd091f-190e-426f-9ff8-10109decd21f"
      unitRef="number">0.054</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyODc_125b5345-589d-47ee-9fc7-14a45401a497">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under the Company&#x2019;s operating leases as of December&#160;31, 2021 were as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;4,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;16,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;37,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;(8,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;29,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzAtMS0xLTEtMTAwODc_199670cb-4c6a-4fd6-b064-3475669c3b63"
      unitRef="usd">2845000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzEtMS0xLTEtMTAwODc_c03d9e2c-1b81-4fc2-8c3b-515a8c8a1315"
      unitRef="usd">4244000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzItMS0xLTEtMTAwODc_e1c5320d-b231-43c4-9848-2c8a17490650"
      unitRef="usd">4359000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzMtMS0xLTEtMTAwODc_7b8502cd-7e14-4957-98eb-db10e9373720"
      unitRef="usd">4477000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzQtMS0xLTEtMTAwODc_31f53fa8-575d-402d-8f4a-76c4f8db93f7"
      unitRef="usd">4599000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzUtMS0xLTEtMTAwODc_0fd6e89c-1eb9-4472-9465-af500050ca67"
      unitRef="usd">16972000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzYtMS0xLTEtMTAwODc_e9d61e07-1ea0-41e0-99cc-33b03d3bc45b"
      unitRef="usd">37496000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzctMS0xLTEtMTAwODc_303fc843-b8ba-433e-8178-ce12749d8f3b"
      unitRef="usd">8028000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90YWJsZTo3NTY1YWEzNzlkMDk0MmM1YWIwZjRkNDg2ZWIzZjA5YS90YWJsZXJhbmdlOjc1NjVhYTM3OWQwOTQyYzVhYjBmNGQ0ODZlYjNmMDlhXzgtMS0xLTEtMTAwODc_a1c19cee-7861-4a31-8ad0-b9129d1d29ce"
      unitRef="usd">29468000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseExpense
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyNjE_97d3be67-9160-4227-ab7e-fb865dcdfa77"
      unitRef="usd">3921000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzMvZnJhZzo0OGFkMjU1YTJiYzc0N2ZhYWM5ZTYwNzU4ODViNWVkMi90ZXh0cmVnaW9uOjQ4YWQyNTVhMmJjNzQ3ZmFhYzllNjA3NTg4NWI1ZWQyXzMyNjg_1d9f4a48-baea-4c52-a135-05f12beb76b2"
      unitRef="usd">1545000</us-gaap:OperatingLeaseExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzYvZnJhZzo0ZDY0YmU2MTE2YTg0ZGE4YWZhZGU3M2MzYTE4NTY0NS90ZXh0cmVnaW9uOjRkNjRiZTYxMTZhODRkYThhZmFkZTczYzNhMTg1NjQ1XzIyNDI_6a0aabb1-0499-4112-b9f5-8241728a4caf">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;We enter into contracts in the normal course of business with contract research organizations ("CROs"), contract manufacturing organizations ("CMOs") and other third parties for preclinical research studies, Clinical Trials and testing and manufacturing services. These contracts do not contain minimum purchase commitments and are cancelable upon prior written notice. Payments due upon cancellation consist only of payments for services provided or expenses incurred, including noncancelable obligations of service providers, up to the date of cancellation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company is party to license agreements, which include contingent payments. These payments will become payable if and when certain development, regulatory and commercial milestones are achieved. As of December&#160;31, 2021, the satisfaction and timing of the contingent payments is uncertain and not reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not aware of any indemnification arrangements that could have a material effect on its financial position, results of operations or cash flows, and it has not accrued any liabilities related to such obligations in its consolidated financial statements as of December&#160;31, 2021 or 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company is not currently party to and is not aware of any material legal proceedings. At each reporting date, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses as incurred the costs related to such legal proceedings.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzQ1Nw_2165a83f-e27c-42f7-970c-d114917db86d">BENEFIT PLANSIn 2021, the Company transitioned from a Simplified Employee Pension (&#x201c;SEP&#x201d;) defined-contribution savings plan to a tax-qualified 401(k) and Profit Sharing defined contribution plan (the &#x201c;401(k) Plan&#x201d;). Under the 401(k) Plan, the Company provides an employer safe harbor matching contribution equal to 100% of a participant&#x2019;s eligible contributions of up to 6% of eligible compensation, subject to limits established by the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the &#x201c;Code&#x201d;). All matching contributions are fully vested when made. During the year ended December&#160;31, 2021 and 2020, the Company contributed $927 to the 401(k) Plan and $592 to the SEP plan, respectively.</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzEwOTk1MTE2Mjg1Mzk_d5dc1a6b-ae4a-45dd-85b4-5d08e6aa15a6"
      unitRef="number">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzEwOTk1MTE2Mjg1OTQ_b7144fc1-db7f-4fa6-87e2-4198adcdc205"
      unitRef="number">0.06</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzEwOTk1MTE2MjkwNzc_b3b7f3f4-a8c9-4f70-8d65-6cebbbe687d8"
      unitRef="usd">927000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xMzkvZnJhZzo5M2Q2NmRhNTM3MTM0Yjk2YjVlYzQzODVmOTYzMTlkNC90ZXh0cmVnaW9uOjkzZDY2ZGE1MzcxMzRiOTZiNWVjNDM4NWY5NjMxOWQ0XzEwOTk1MTE2MjkwODE_f735b780-5dd4-411f-948b-632e37149a39"
      unitRef="usd">592000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5Xzg3Ng_d9b2f9d7-400d-4bc0-bd37-e7c037b6e9ae">RELATED-PARTY TRANSACTIONS&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;The Company was party to a services agreement with Ridgeline, which was entered into in March 2017 and expired December 31, 2020. Ridgeline is an entity owned by one of the Company&#x2019;s investors, and employees of Ridgeline provided the Company with scientific consulting services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;There was no amount due to Ridgeline at December&#160;31, 2021 and 2020. Total service fees incurred were $2,364 for the year ended December&#160;31, 2020 and no fees were incurred in 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="if2aba82796ae470699e4f3168699b2c7_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5XzIxOTkwMjMyNTgxODk_15b30ec3-c42d-4304-b406-d6276a47150c"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="iebd841302b2243b09b4770b0df113b00_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5XzIxOTkwMjMyNTgxODk_fd49cf7d-5f48-48dd-a92f-d4187fadb03f"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i17ab82435ae3468596555e6d8030d824_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5XzEwOTk1MTE2MzAyNjU_18f5f5d6-b631-4af3-8303-d63ac4f3d2dd"
      unitRef="usd">2364000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ib8fade6d48aa48db982595f4519897e2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzYWMzN2Q3NWMxNTQxNzE5ZDliNjY1NTM3OTIwODZlL3NlYzpmM2FjMzdkNzVjMTU0MTcxOWQ5YjY2NTUzNzkyMDg2ZV8xNDIvZnJhZzphOWM4ZDlhMTQ5NmQ0NmQ0OWM4N2EzYThiMmJhN2IxOS90ZXh0cmVnaW9uOmE5YzhkOWExNDk2ZDQ2ZDQ5Yzg3YTNhOGIyYmE3YjE5XzEwOTk1MTE2MjkzNzY_d9009a87-f4d2-46e9-9a82-782da53470cf"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>90
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MXG";=GA1?-]<2#UPI7C9/.:4:-H&H'_?<2W0[8NYX^KN-+?_ U!+ P04
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M64 ])B2*DFR*/%9 :5A S1737&SF4 *^'I*(=5> F:D(V7-I#E/01DAG:RC
MM:TYN?2ZY5/.Q#E2]9@MXVQ"7JF55QJ65]<Q5#%];KYM^5_@FYDO6 ;UR\&9
MCLD&V#3I3>Z<Z\?9^+358S0NW!8GUTH-DUMSVZ:0.=\8[F>.7X\W>G?F'FOT
M_3/^M!KNY6PWPS7AKX4$E57@UP:ZC#YF@$<.-V_#2R?VYO)J+;I.-.9QQPH(
MCS: _V^$Z%Y?] #'^\_;OP%02P,$%     @ S81Q5)!\Z^8> @  =@0  !@
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M=',O<VAE970Y+GAM;+5:;6_<-A+^*X*ON!=@8WMMITG;)(#C.-?TFA?$:7O
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M@S4-T,D/8?'?C"9\\(/J!G S;>7I87%ENE+S'/2AEQR9;K#&!A$A2]OS Y)
M=<&PX_&']D#/ZC5J!_[#!*< !L2Y1.2":A:%7044#KJUEL3J-@N..Q8<'&."
M$E"YLKX%A])ZS.K@I>A=1L\<+[1^.X28WC#*$G[VLD9?*_!ZA"4!(0Y$<O-:
M;MA,T*@[@$K/W0R,8]O_087AW1E_[?G1 >YRM+, @-+4<#F-P$::_2.X:9/@
M3]_#[V3ZRL"/9=V)/::KP/YNSPL"!*7JBA40 !!Y/SA%D0FU"M-X4.XMGWSG
M[_?9SB NF,8/9:F]7P\4*[*DT7#B0F94E?X\$ A[1Q8Q5A'".U>:6)SFEIB.
MLU&*.UL-9?#)%L2+1\O0HM-D#.%N0[[NV%2G-P-":XD(>DRP15C8B!MS+@JS
MCB-HS60%.5V[4M"X1;XW-V('*Y"'XG[X5G=;XVR7@$/<4HV[,R56-UT'*W)I
MF ">7:B#$5<YVR9L<7Y%/$WCRS<S IA'5%69VQEFR&=08!79-?16H.*UVQKX
M+*<8 FCW6L,9X!L/1:*H+K&5,I3<M37@$2QVN=4=.>VN>$:OSD"3$IBX: 0.
M_![(O(SU8E?KCJ.!9]U\&QP5B,8&7%QXL^G,&B[@*,.804>GQ<6]:L@I[R=\
M)!7_>#XK# ,\B=R+Y2/8^.CT\'CY^.F29W4>*P4+RO,]J#[1Z\T-Q^3DD8?%
M.<ST"!UY4AZV3'NX!!6[[%5@1\8!%**,*?*]B 7B78E3F?4$[JVS=/"C=*C5
M%IFO-<7_/TAX83(HTX9)!7/<N1<,QQ?!65&U)$P1"DI2(EY89VSE1WL2B5!!
M H-(=4A&]LH52*Y!_SX7(2JO]<IQ6$[OBDJF$THKD#LG2#^L&E-BA;54^JER
M>//A?58-,&%YLE@^.5N<?'T:0Y%0/K5C016B&:JD&O072G;/FR)6*U8L$:1V
M[ARJODL5UK@85/)T/X FH>J16W2Y7#Q^^F3QS=F3G(ZJF5@QMX#=O=F J(@L
M-\YZSI]2ZXI'?W4"H7JZ7$I!PP;B1 B_" *GV'[,2,3T3OE*?2[^WM@5R4MN
M7"!XW#5:LU$"@$^N"7S[=H5F(7KPY:M/_SR,/IR1'.27!CXJV$)N/5X63+=A
MM%.MX1JD.R4>&9,=1A=<_88$>MJ]\:3FY-J2!BNT#Z9E@.?@ZB]@+(^=]FI/
MQ)N"$:TZ+'XB(BM1C'G[@CJ@8)%DPV3P7^#*(1#1LJ^FL6!A96A^ !U+.U(A
MG"5J0-^DF'JYOB4)AH)LB4O.OOEF\>3)\3V1G6,\]AISC*]-P[2#QJM94ZDR
MU  PJ')R4URI<RRN'IU"M'V<8?Z*'DRHIZH5:E%_&KK'L&P@%U]^B;EZD7T_
MG^;R8C));5#R6:YXGBP%!,D"S<"2@4L"Z/7WY/KBIE\7P,D*])QMG+/B$?)A
MZ CHF#PRP0JD)[E&!&37\QKL3<NU2MO!-R2Q@,44)I#'>\ H9< 5&7V.9!/?
M7KT5G_V@>8^:]?B"5#X7#^0E1BTXPZ7P905SVQ5S=)+Q0@9?+1\?H^=NFMC[
MW>0@*5I /\MK^5\[.VRF9L$B3OW1JED SS^]18]I-TZU*9#B(@8(*D-)ZGV.
M9RE[1/LL"(#%R"(W,8MZYJ63B)W-:08SJH"8-!:@%KJ/^)#<$Y*>GM@G=JDR
MMDRLX_] ?0.64&F()J+<Y9(EB0RR&:@;PY7(,BFY(AAR[PWAJTGO4>!8!>$;
MOU9E^CYU=2EYF*^"V!%KG75@$?(0:(V**IY:#6 A2)K#XGLD,7I'=O+M/F=-
MS"@\/MJ(78'\G&GV L=,JP(--E*2[0&ZFN<$D6<I[5+T#,,+R&&]FA:']\&?
M1+()V/B/<J^9<-=#&)Q.\7_+O<#R"0?_9#%/@RJVF[]+K]S07\E4TN2<'<K7
M"_Y;H(4P4!4Z%0^#[?L8C+$+64,&&BUP(P=/W3LM)!Q.:1J!"DSM=(HK,?KQ
MR=G<B:T"N6A]/2WC-+_(!<E1A&[+>W=)G=#$83^VHCX2WO0&VL5&K6S&*/,^
M^+^DVF7(HV)MR[3%Y%M1<3"K07#J@-.23C5A"I/G1K9R>P.=#>0E#BAV&9NE
M; RKP)+Z<AFA70M[2),$LF7,DP?F9,85)\XW1O-(?;]M(Z^4.'XTAZ97%8M5
M.@!@DN+U:]N0XWT1@>KHI-3?KO.<##28NY0WLZ^ET[CI"HGH3?DY-!7M$?E0
MBIRN=*/V1"<0.1QO30=!'07?VY;O3,XK[FV>>^%!O\B-2H^^:(V$L814)2?5
MF&SL/1-[Q19JK-%DXRUGT>J)CF@-S^E%74FH&;*MZI2$(G.#CRK6$TW4,+WH
M&]5)HE)[XA\^,KCC1("X<CR7F>1H2B B<(; %'UV-FM*Y\3M]-2$V*EC9Y *
MH&RWL33DXOW/;UX]6GX#W0BN;9%3\UU*.T.R:])ZQ]RM42N"Q$SC*<M/UUA"
MDWQ22/F8#3OKFBHFAQ7V(WIOQC,D0_U+.SWUW8+B(5$(&JBXGH3/V'Z,9Q:/
M\*3UF.@SJC"9UTD?J?:/5'A4"]0(W0O2_@ 630AJ**-;$%ZAW@P"TLB#TU.]
M/=^O5VL=Z%!5\;@YB="^N/;2-(0S2!=#)2XV33 7U3,EXOU1(*(!2I3@\3[I
MF(R>^J:V.SHF($-D,>X**^:*:76+EMPU[:38)D*;W(HYZX<>C3%[=JN[RCH9
M/"83.JZ.OTZK!W5-9=*)3]$G*>9G%<^=>Q*:/8LL$1BLY.C!E4X5J"+EN-8(
M*!UE^A"+26/YQ&= SHI*?N!XAQQ#EI"BU#VC',0$<OI52T$>(!/H"&8\G<J.
M2='KYKS!LE:*TGX:"C!9/'QEOT-/E'OABGA.1**>:M)8,0$HR"2J:%'.&%>Q
M*_=W'2N]%F>VD"&++$HB/N^!3#ZW8A/6"F*;NXJ;+D*!8L:%RW57$Y%5-Y'/
M*WHF*N-%/JUTI@PC3D*!2VJDA+BD5.5# A\5T /[RSN"^YC[2=/%@R^2*<ZT
M6>OX )='DW(U2=7CL+B(C]WCE(?-8$&M&F_CJEJ<40^ALKMIW<Z @/QP@YQB
MS>FALMJS(-BCO[KND*HL(^GT1'\)\2"TM_2)B):K*"\@R/-)R=]/!"4Z$S[J
M!,G!YL5M;RPBD95\N+A'%K19)VSD)$3H?!\U8$<&Q[ V= I,KY.$.7P)8HA@
M!B7'AH+/BO,FLE=F'INX"","U:>=R((N8W<,"X66U?X.E$X#46+H1']'!3=,
M T/;;"R_B;E[80G59'D(N '+QK=3T@,(W(9)2&,W@WK1D4+K<E-%32B]\O-3
M%S4TK!J%$9W6N/B:!H]V='X%HLLZA(_1)SI%()<?2[IE0D!3XSC(Z.K]O)N3
M#,\M!6V+:48@F0Z1<G&Y>VZI&W(BLN+TM72<M9N=PK+$H8&HX8Y?M- )=3<K
M;:F2)&Z/S99BGF#\@1Y$D$5+TA-97(P6,N$O^!2(:!/-]?0UDB&)G>](6Q 3
M,689%A=W9_/@/G8'0I)R[>%$N]OEV,<='A?))V\5R'SI%:=*-^E4:G\\FBXM
MZ1J1MX7L2Z<Z6=>B'R/GU9#V,'I\)S!)6J%CRE9^_1,(7MT:K(;!"]*?-958
M?HDWN"R]>-\W%<F"@TY5SG09,JB0D&CB20I_#)!+L )&TD]!8-2=NYCZ@/M"
MJ'@=>8&.>5T^;Q[KFDQ$5>L/ %%>XHPDE78H^H189U*&>WY)$I2H$18G\EYN
M(DY$1$Q@+"?[2<#=!C16@AK<" /=E"B* >4VS&%X.!Y636S:@1-\.G&>;(":
M?W[E2<0!3465E3EN9PA+]+LAFI!$@CA 9X0+(F.#L9/N)8=,HDA%@B &NC@L
M?JD-&H\$M*P#QA,G>C7\15[&I%%$WQDPW GP 9VH 5JZ&^B@C(?TVJ(/D/GR
M.7K>YQAV\6 :U_*[3UH3O OO,="YRU2TQK0CFI<*Z#R](T8;P@HCXYMDC@*G
MW0U?W,T@G$79%>0N6$0O1LGIA,_9=_T0IH:.K,#GBG44!!E%>FN;+>T8V]AI
M;@C2+S8FYQNHN%ME&NX*1R=QWR\Q#-%6W-JS&:HBS>OE[#?S+.<,XV_-EE,/
MQB?-TW0_O.L'-T>3GT/Q+/2C+\9D%^274?EN_EW9N?R<:APN/TI[J]R&**;1
M:SQZ?/CD\8$<7Z2+8'O^<=7*AF!;_@A! Z5& _#]VB)5XP4MD']M]^*_4$L#
M!!0    ( ,V$<519NE"V7AX  )]=   9    >&PO=V]R:W-H965T<R]S:&5E
M=#$P+GAM;+5<6W/;1I;^*RCMI>PJDI9D>Y+)K4I6[(RJDM@5V9G:VMH'$&B2
M/08!!@U(9G[]GN^<TS>0E.79V1=;)-'=YWYO?'??]1_=QIBA^+1M6O?]V688
M=M\\>^:JC=F6;M'M3$N_K+I^6P[TL5\_<[O>E#4OVC;/+L_/__)L6]KV[(?O
M^+MW_0_?=>/0V-:\ZPLW;K=EOW]EFN[^^[.+,__%;W:]&?#%LQ^^VY5K<VN&
M#[MW/7UZ%G:I[=:TSG9MT9O5]V=7%]^\>H'G^8'?K;EWR=\%,%EVW4=\N*F_
M/SL'0*8QU8 =2OKOSER;IL%&!,8?NN=9.!(+T[_][F\8=\)E63ISW35_M_6P
M^?[LZ[.B-JMR;(;?NON_&<7G)?:KNL;QO\6]//OB^5E1C6[HMKJ8(-C:5OXO
M/RD=D@5?GY]8<*D++AEN.8BA_+$<RA^^Z[O[HL?3M!O^8%1Y-0%G6S#E=NCI
M5TOKAA]N/_SRR]5O_U6\?5/<WOSTZ\V;F^NK7]\75]?7;S_\^O[FUY^*=V]_
MOKF^>7W[W;.!SL.J9Y7N_4KVOCRQ]\5E\4O7#AM7O&YK4^<;/"-  [27'MI7
MEP_N^*.I%L7SBUEQ>7YY\<!^SP/VSWF_YR?VNZJJ;FP'VZZ+=UUC*VM<\=]7
M2S?T)"W_\\ !+\(!+_B %_\OY'UP;ZCK-VY75N;[,])'9_H[<_8%!Q;O>MM6
M=M<0SMVJJ+K6$0GJDI7E_<:0PE3==E>V>Y G_FSJ8F7;DI:63>$&^H)T='#%
MIKPSQ=*8MB!H=F5/S]F6-^EK>MJ08 \;_JP4W\7SUZ8U?=DT>_QN=H.L'0B(
M#ZW%IUN<PW!>;4UOJ[)X<O;3U=6[LZ=%V>+AJAEKPROT!'X8GZ\%"7F.OK[?
M=#BHNV]I7S<NG:UMV1/G9\6KIJP^%C_:<MO1PT2#OMR9<;"5*YY<EVU9ET]G
MQ4U+,HC-'GCZUE1C;X<]'=[ONIYI.BO*U6#ZPC26]%C(3" 2UH6SZ]:N"*MV
M(%3HH<K#[''!>224K2O9F+E%\<$9+#=NL%NF#5@FE ][)^C_Y[]]?7GQU;?N
M$8PDRM-#L/? @+D&4I,)_F.T)&AD?EJRUWBX&#KZ]-$D8 #2TI&-WS&@!$,Y
M$.8KLL(,#T'8]3B;R.;91,\;1;*QY=(V=K"ZU:DEYA.Y)4</U41H$J;X'(L6
MR4A7$Y5N$\J>AI$< ;Q$D#HB[6/(Q#(W*Y8C(=B;HNV& KS%BJ&;>6'L1UI'
M$$-%R[[:\.FUN2-_N&,:!E0\OG=E,P8>D@>H/L[A> CF^[('5N\3L<8OC@4[
MXD<K-Y860E$:WI_DFU1P5GQL2>Y)DDQ;RWD='=@3#_N/9IB[G:E K:+K]8>>
MW.<=B+<BP>MZ9:<=2-$;2S@X2, 2I"]=UY;+QA0CV?J>\:AL7XU;(AD=35"_
MCO0G:@F+ " I8V_NR-T*_1OX4;9(F[)=&Y''=*<9 R/@1]P6Q75\WF1']08V
M*-H4.1J?[C>6&$+?$1WIH:T1 BV*JVH VXAGY-TA\?NBMB3$?;'JNRVMZ%PJ
M]$2O1)Z$0:NQ >T'59-P%'%GW4%(K]_^?O/C_.*O!?&Q-ELB^[VE)37I6#7
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MRV'T['):5Q$Q-&  *LNR85 D4>-3X7:6AI1"PAYPI3DA( "8>,I^B6*$[HX
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M^-.+F)%J.%[,1V":(;'9.%WYP6RE'8UY?IG37(V&!>A[IJE"VPT;Z"?UL[\
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M*DM-QT\KZO*HG0"=ETK9W<(9Z/\W9G\!4$L#!!0    ( ,V$<52*LGACMP(
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MJI8  B8RF&4-6$HVDA?@1?@E])W+!UTD;,&_LSMZ)_72=.1-II#VK:>!7E$
M9J :EFW!T?A %!P!/0BJ.D29+14DH>!PME] 1K!_W@!/@'KR0Q?">W*[]P^E
M!8B4!N!6Y;):=-C=ABW$"RWV@1.'3&$K!#(5D$#@S1[C7(!PI<T@ZX,R' I.
MC9)!AV8(5HA#(.&>K:-TK32&S@+B7%=D>U1&-HT0G;;[E'UV0;88:&"-ZT$2
MB,+0FT3C3G(ML/M#U-UQ6?!9(1YU]2YH>-LLE9;_04QW1/\7U&S@,$,8),G4
MBR=)1VN3:3@IM8V7R*7=KC2ZM'K358GMG/O@KKV$>W5[<W-OPOU>']^7@#%A
M/Y9PO3]KQKT +@TO4-4X2KTX3081N!5M5#*_-YU(PVKJ5_ZXY!'^'R2//RIW
MI$GJC=+TSYHY=I#X:-YPK1=4U=::#67CP+*TI1_X\6:K!VZ1$\17[[!-?W%"
M\3;G4A-!,K!K(>P&.$FQP+$Q*:#)--AL@[:TA$Z#=:SL(C_AX# 8JG%BE>;%
MOBNL%3Y(\^5DK@7&%\@#C04C?P?^-&8_X)\0_EQ]JP6U&R@R.Y856PNNS7,V
M\E.6^N%FPYW"&"MP?ABG?@!GT]B?#$GTW<A:BB)GN 7_73L]T7Y6-XR AA!A
M[PO PX9L->RM[%"/[#;NW06^L/.,ZX@P.8 ].GZ_.'NQ"V>OJV]"9Q+S.;18
M8G_] R$6A?N'G LRQC^M,=Y6T)551F;L,WD/EP":K8%0@N7K0=CO>B-@L3<>
M1=XX2=@S%H[\<<BF8+YG+(V\21*QGYS[0V\ZA0:)MD6AGX:]O#"5A6'@I5'X
M'(_Y0<0N$?=%@=#0& MS(9'&\3A.O&DTP7V X2AY4+20P>8@]B;Q%$4;^_&$
MC<'MS]@D&?=FO /D6#ZBQXJBMPSP_S2:PFI&$#A()/3&T"5.4[)9XD,_DOKX
M/)K$-@X7"ZA75.%ZU^P%%M2+C!<9U@9,0Q9BN83 UP+3QDPT*R'<#-AAHR9L
MN/S74>I&HNT ?K0<V-JIS(80Y8PESW?X&09101CGU1,8V;RYEQ\.9YX:1VO,
M@8=R4-YJ"DX@1WF V5N!?0>A10C=F&>?A1$F%7SW#! >3FC&J6U^+=96/-L2
M'$Z!#F-/Y0Y-(<",V"=>.-UC_V%WJOID,PJDO+ZN[T]>@#!J@=#68-%.LJ'A
MO4%S,""P!0*TM&EGOX(X&#B<E$5B> F;MX6;4$O^*Y0Z2&;;I"P-/ ),0 HX
MWRQ!L!,T$/I2JMYNKI>3T UB9]16SJRNU9+P;MB-S,0@<VR/BTQV1BFH]IFE
MK+?"!8?=6F)_N'-;P#(LN- FW&Y4ME:#T;IJL4^D)IMZRV.(#WO7(ZH%=S=U
MO3\Z#MM-#Z.>TV1:SNB.Z3'G/??(&(_["?IH!9:;M]B(.LNM)'2=E;6X@Z03
MKW,BDL!D0J)CJ/F/U;E]6;LZ9_ &8J<1"5ZP][L-85^XM@*=[0;ZI\[_]R+S
M0.,3T(@31B\AV79/785*0R\(L')%4S\=L<^6^C%.]0E6G#CP8?D[V>[7R5'B
MQ7'JR$\V=3'HN$[\=-ISC<;P.J)"!Z4AO;<BHG1CW!;ZD#B>*%P(NB$=*]QH
MMP9M)[4]!U/2_VTI;APF-K]%0;";W6X']Z3#GI_J=04E9G!AC&&E=-Z)]M I
M%UH;)%.7Q9IU#=$,6B\@7=%=4%:T^296).7+RJA"YMS:P(V2QF9\84?,[JZI
MA"YWB1^"H!,OE+F_G[T=WKNA/R/7'XR]&)JFO1Q/EVUL$D8L"9*'1WN4Y)KR
M4 1M5SBFIL,+XC%1'P/6?W13\/?YS-O.I3 S((XC+QFEM&<4C%PL;_O2VYN/
M8: DJ[5Z,-K8?AC?U6#E; V)'T>'X5WX8!(L^9K1AS),Q3B HJ5!/KD](6[\
M#7/ KABP5DC1TGMNEOX3(47EQ!:;K5M4,LKAV])]&';$!AC$R]L_"G: *_ Y
MU%6Z;Q7@)E53LH=.W(LC!&#LI<&8_20JX%'0/I[#^.=N4X !8"B,H3$.1Y-]
M:-T[3]N&">^$,[6H: K>LFJF<*3;F!3-M%/S._M2#@'*X33J;D^DV>KG9U1Q
M.SZNTUCM%AK7;X"\D3^RP?# A<!O4N >.) F:9S^3FJ$,%58-0Y]%CP=?'LM
MA5[0%V;$65LU]C-L_[;_B'UAO]UNMMLOX.^X7L"8P@HQAZ.!/QX=V9OZ[D>C
M:OJ2.U--HTIZ7 H.@8X;8'VN5-/]0 ;]I_WS_P)02P,$%     @ S81Q5-&T
M:;#;"@   QX  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULS5EM;]LX
M$OXK1*Y[: #%D>77=-L":=K%]4.W1=/=.^!P'VB)LKF512])Q?'^^GMF2"ER
M8B>;!0ZX#[9EB1S.RS//#*G76V._NY527MRNJ]J].5EYOWEU?N[RE5I+-S ;
M5>-):>Q:>ORURW.WL4H6/&E=G6=I.CU?2UV?O'W-][[8MZ]-XRM=JR]6N&:]
MEG;W3E5F^^9D>-+>^*J7*T\WSM^^WLBENE;^E\T7BW_GG91"KU7MM*F%5>6;
MD\OAJW=C&L\#?M5JZWK7@BQ9&/.=_GPLWIRDI)"J5.Y)@L3/C;I2546"H,;O
M4>9)MR1-[%^WTG]BVV'+0CIU9:I_ZL*OWIS,3T2A2ME4_JO9_D-%>R8D+S>5
MXV^Q#6-'HQ.1-\Z;=9P,#=:Z#K_R-OJA-V&>'IF0Q0D9ZQT68BW?2R_?OK9F
M*RR-AC2Z8%-Y-I33-07EVEL\U9CGWW[\^>KSIP_BV^6_/ER_/O>02/?/\SC[
M79B='9D]S,0G4_N5$Q_J0A7[ LZA2J=/UNKS+GM4XGN5#\1HF(@LS8:/R!MU
M]HU8WNB8?75NUDI\D[?BO79Y95QCE?CWY<)Y"T3\YY$EQMT28UYB_!==^.=G
MBZCM2ZCI3L5"(>F4T.&FAPGJ%LGHE,@-LL)Y)TPI_$J)TE3(+ETO7PDX4*T7
MRG9.I*]4O(<(YW4N7HB7PVR2C++Y*5U/I\G%178J '$ N!8OLRD>X!OWOADO
M*T&Z/%1%N5;2Y&(:),V2;#)F2:S33DGKA")<'%!*U@4KEO#8*[/>R'J'+,^-
MI0FUZ9N]4+4JM8>9070-L@(M6>EA,BL(=3"^L19SE<Q7O'HBB@8"( J>:NI<
M60^6\COR&@BLTG_0='DGWIHUY!LX6'NU=@-QR1K5N:ZT9!+!S#T?X'+3>"S:
M.))%ROTRN!Z(4A50KQ+.2]]X8V&:]*R+7TE/;$:TA'FZ;BU!2(7DB#[F+:O<
M1C&35;M$:)X2HN^.QOZ(1CT'LW+9<)"*']J?:T_W:.'*Y)C']B;!]64GK77=
M>##$G-%@C.\O"FQ9J]J+0I>EL@J>=^)E.AB>XFD:I9O\.WL/> ZNQ8 Q#<#O
MG'Z_*H<8(I2D0Z%@L-FL26J.(%-$L\&4U!UD^+Y:R7I)^!0WLFJ"0$E>D5@<
M<)X-,I:=30<3NOB,2-FH2SJ8X?L#5&6_/O!+.XJ^OZUB(O+HD']JO3$6!6W/
M7 [S4D*<U8X#[Y!>NM2YA F8$ (>\Q=E1#%V2;8$G"%Z"U%[T24.(U@?S:F0
MZ =$O01\%\"PU\J=OA(_/T@?D4MK=TBOK;0%9?8D2R;3.2ZR<9).+HX'@U9I
M S))QJ,+D27CV4Q\OI.O4#1%3P,Q2X:S#..&XYFXS'/;R,JQ8,-1&8)'AF(Z
M3P-*SJCH%OM8&27ST00#QZ-Q9*E#'IRE23:=B%&:S"YFXM<.&)=WP)B.DG0X
M)L*;)[/TXE1<-PO/ F>L19:D\[G@5N7,E&>-4YU/,6 TI9E).AV=LE-+?0L-
MV@'#"3V=A$>']'LA_OZW>3;,?NQ=71YF@'V:7,E"+"W%K<W#AXQX+Z00^B)+
M+Y)I.DOHSW:E$<T7"/-DABQ>(G. 4=07S32/14=3C@FM:Q6U=UA)% ;4[-MQ
MB\8+B5_7+'Y#.I"$>?H#8KW6GET]^//V..:;/V7'< 2D95G(L2.Z#SA5VP4
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M!O<QXKC 6]^/[YEUSQ7T*K/I3HW'6-5UOZ[G0>:W*F-+I*JF5*D*2?05UCJ
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M*D\&>%\YE**[H0V& ^C9OU!+ P04    " #-A'%4MJ^O,60#  !"!P  &0
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M:6Q]RHXSZPA_IG0NQ*]30HXT0M$*L8,-"27";862C',<PEWKW]+1[I!I\)*
M^@_K%/6;5_%%=+-O1"^4%M'I2QV<$?#U=7+I\O*?I_7(U^?7R?Z.RM*7RH""
M-@WZJ2QVPU]U8G@TUVK4I9_>AKRVTG8C[G!Z^$#,N[GXT[S[NGQBNN24$($%
M0:/AY7D NIO8W<:JQD_)5%F:N7Y9T4<.M3.@^T(IN]\X!X?/YNQ?4$L#!!0
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MF-K&,/<2Z525AG@2/,&]!%DATL$1>MN6<-);3O9DF#[ 9 F:!?"(I7WP/\3
MNO_\K]D&LU_6'9.=/25HX-6;U@& #RY_:S[AWS[^C.+4(CBA%,%V"VXNF>2Q
M//4KFC_T3LI4&,T)?KY#T %C)0'5VP-F%%!W.NN)X&1.5KH<_VH^/W\+&F!<
M@"&EA14N8=5[LJ'^Q"B*V/R;<ZI?X;O+WC<)(CR,BM=R9!##E[T&7N*S+65[
M,*)F +XEQN4H(9P>.P(VT;5&B>G"]R1ALD%90X'M94[@%\RX-&(6R(EDSE&2
MF6U..#0A"_,>;$T@-N!$C1"!R.I-FA-JQH$<PH7<(/PBBBGPUPZ3B[!1E)O
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M!#/=EXU13=<&/NN2NH[9]7R'Z^^Z&5 ##EEYQ'2C#)V=;=Q#S2S1LQ+2',C
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MS>?W3W>/R[NOL+J_6<Z7BS6</;*-0',^#BT1._<PW9-<-231"9)>!+=*VL+
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M6=(01F4#Z+Z0TAPWMD _UF=_ %!+ P04    " #-A'%4\LT2PJD%  !U#@
M&0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6RU5VUOVS80_BL'KQM20)'U
M8DMVF@1PTK3KMC9!DK88AGU@I+--1!)=DK+C_?K=4;+BYL7H NR#+4H\/O?V
MW)$\7"E]:^:(%N[*HC)'O;FUBX-^WV1S+(7QU0(KFIDJ70I+KWK6-PN-(G>+
MRJ(?!4'2+X6L>L>'[MN%/CY4M2UDA1<:3%V60J]/L%"KHU[8VWRXE+.YY0_]
MX\.%F.$5VL^+"TUO_0XEER561JH*-$Z/>I/PX"1E>2?P1>+*;(V!/;E1ZI9?
M/N1'O8 -P@(SRPB"'DL\Q:)@(#+C6XO9ZU3RPNWQ!OV=\YU\N1$&3U7Q5>9V
M?M0;]2#'J:@+>ZE6OV+KSY#Q,E48]P^K1G9 PEEMK"K;Q61!*:OF*>[:.&PM
M& 7/+(C:!9&SNU'DK'PKK#@^U&H%FJ4)C0?.5;>:C),5)^7*:IJ5M,X>7UV?
MG_Z^?S*Y.GL+I^<?+\X^74VN/YQ_@KUK<5.@>7W8MZ2&A?M9"WG20$;/0(81
M?%25G1LXJW+,OP?HDWV=D='&R)-H)^);S'R(0P^B( IWX,6=T['#BY]S>BXT
M[G,R<[@0:^*8A8G6HIJA&_\UN3%6$V'^WJ%LT"D;.&6#YY11'>5U@:"F<&55
M=@OG"R:D@2^BJ(7CYL10431?GXKW;@77<P1Q#P!V+BS](9RJ<B&J-=3LIU5$
M5HN:.(1N=D;^VOU<6(2ID!J69(TS4K4X3H!6KE"S IBJ@DK8>$#5;]!-<5G1
M/#,?\WVQ1$V%S%4BS0%0UK"\0=UECO\"N)3F=G^J$4$2!D%9T&Q$X(]C^)D?
M(3W.[A94MVPWF0Q[LH(U"FU>P]!/(/'#>X&E*BB(A;1K2!,_H+5)[(^V(7*Y
ME#E6.:PE%CFP"/UVI';8I7;XHM3"A'L-6?14,G="<@\^, N1X5'/A5DOL><R
MW$1?5C.P7)AM%Y7_H''9-$Y]D[JFU7% :BI O<V%7WX:16'ZQ@!^JUE K(3.
M#2P*45'&-L3\VF84)FU&S^Y09](@7&B9X>/Y2^3^S\;](:?HTO5GDZX/E=62
M6GCFV-Y,V;FJC:ARFCZOK;$TY*4/^1) [*7#R$L' W@%X=!/0QA3@E]!$GFC
M003O6X*&WGB<>(D3BT(_"3M[<]@+P\!+HO U+_.#"$Y%E=$>P.35%%0]1<D8
M>VD\\,;1B.6BR(\&.TT+@82#V!O%8S8M]>,1I$3,5S :I%T8E\3M1@]V;%;N
M*U"%O@P3&\\<!9X$";UT3 %)7,P&?I22VSP>CF+80?FDHWSRPY2_)$^(#^Q7
MP_Y=M-\)^R+:ZWOU#?L[VAM).8;?1%73.0-:-AW I]J%BBPWO %L\7S3N5S+
M@X<]\7/59G)+8Z;*DBJM56P8]($^<+46O:'8;T8;PB:A%P1,Y&CL)T/XTJ#O
M$8>3 1,P#GR:_D&UC\MF./#B.&GA1_=E$FRTCOQDW&F-4OH<.=X34Y)G"X2M
M2UDL](EF+S0N)-\8IS%NN).2:4?)]+]UX?T3M[-SRZ/3H]MAGV+D3M3G&;G9
M535F2N<;\K6GB6Q+IZOZRO ^YUKP/95=UP6[7B!DQ+69TI+82*0M:@9<23NG
M-=(:PJN,*B0SDA71@P\HIMFFB;--4Z NY31KG/-Q>8E0*//\#GRUM5<83FC4
M]HO4BZF)7CZLJ[IB4T9TKAL$ S@K%X5:T_;=P%S4.IL+WAIH#W&6G).SFLA$
MO2AU3<@+XM2AIT3VEX508R':_FF^LYX5/FH$C<&/PKX!VXHYQ?%_"S/%D?;
M;.[6Y;BD"]#"'2]I)_+BB ,>>TF0PGNL2$?AY$1.!S3)IT^^K7#,PI@VAG X
M>AS*IVJGOW45*%'/W(6'':PKV]P*NJ_=G6K27"7NQ9L+V4>A9[1U0X%36AKX
M*9U<='/):5ZL6KB+Q8VR=$UQPSG="U&S ,U/E;*;%U;0W32/_P502P,$%
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M\@H?%.A&"*:.-UC*P\(;>:>-3WQ?&+OA+^<UV^,&S>_U@Z*5WZ/D7&"EN:Q
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M-.AW^UFZ:D?(=_5V$-\QM;=OEA)W9!H,)U0QU0ZW=F%D[0;*5AH:3TXLZ'L
ME56@\YV4YK2P#OHOC.4_4$L#!!0    ( ,V$<50):E[VD0,  -8+   9
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M L7 JR&R6DB6ET//GDDU0I671S5X ]<;U/,#8_)MH>>H9I2?_@-02P,$%
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MUY(=T1AT90\L;7" -DI37C-%60XS7M*4HH3OT4HJH=_UCR,!+KH %S; Q8$
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M,O&-'OXF[83\"B^F&:]_P:&Q]4(+Q#LN:-XZ2P9Y6C3_^'>;B",'&&@<4.N
MSAT\C8/;.KCU1!MF];1NL,"+&:,'P"IKB59=U+FIO>5LTJ)ZC4O!Y--4^HG%
MW=>GV^7W^]NOWY?@W0T1.,WX>S "C\L;\.ZO]S-;R""5J1VW@-<-(-( 0@3N
M:2&V'-P6"4E. 6S)KJ.(GBE>(R/B#8G'P(4? '(05!"*+G=W#'3<+F-NC>=J
M\58"+$F\8ZE("?\ KO8R:7B5D9&LJA''&0$_OT@G<"=(SO\QA/2ZD%X=TM.$
MO,HI$^E_) $1Y4+U3AI_O_:O*G>_@)[G.=!QY)3WQ\D:6J))./6FQY8G)/V.
MI&\D^5A(&<EJEI^E?' 5S08A. KN3884AU:!#[7\@HY?<"F_+Y1SHB08#$*/
MO$"1186=.]%2G'04)T:*GW#*P!/.=D3%;3*("3TWG"H2.+1$4\<+D);@M",X
M-1*\RTM)4:JX )G,H8KE=!#[G)W)XH15V+$*C:PBFN>$Q2G.0(E+P@P5!YU>
M%YVW*G-X),;P=84>M0#'V7-]WW.UKQ:B/CAZ;0%'+<3)TM*7)NPU%;JO+LZH
MQ3BI.E\?O%=7:)978]E%K?-9QOU0'[A73&B6S(BRDC(L"%C1(N&F)=2K' S>
M;-WVN@7-PO7R!@45ZN5X2*6M*M,0AA.]OL)>OZ!9P"[9I.!0H%2[E,(L</3;
M*.S5#)KE[**-JL4XJ07D(05-A2'4[P2H%TCDO&*S:IW/WK<3!$.&*M,0^1.]
MIJ%>4)%94!_'RS'X3/>$%?6N)3N3(D[/4WH*W@LF0F]5:JA72F16RI=+#0UE
M4IX$/4>1^:&ECURD7\2HUU1DUM1+"@T-E77 <&B"#(NW5UYT\6%57V-H>! =
M(1@J\J@R=/0T>S%'YC/K"S46#,[R;A@BA:0J+.6+=A44[:-64AZJ-G6'S4%,
M=X5H6K;N;M?%7]6]Z]G]:]G=-[UX#]-\&KC';"-7!,C(6D(ZXXFDQ9INNQD(
M6M8-ZXH*V?[6EUN"$\(J _E\3:EX'E0!NF\>B_\!4$L#!!0    ( ,V$<51N
MO *+MP,  #H.   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;+U776_;
M-A3]*X31AQ9((Y'ZL!W8!A([Q0(DG9>/#<.P!T:ZMHE*HDM2<?+O2U*VI$BR
MU@%I7BR2NO?<PR/RF)SLN/@F-P */:=))J>#C5+;,\>1T092*D_Y%C+]9L5%
M2I7NBK4CMP)H;)/2Q"&N&SHI9=E@-K%C2S&;\%PE+(.E0#)/4RI>+B#AN^D
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MX''I+@O\H %E ?@\E])L!_;,K#^1^G\!4$L#!!0    ( ,V$<50'SH9=#0,
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MFR2*)E),%,]L'=YPI:NZ'<:Z[Z(P&_3ZEG-UFA@'52<?_P%02P,$%     @
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M]O_Y<$UP3+A>H/Y?,28/-]I!>>@S^P]02P,$%     @ S81Q5/[FAIF. P
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MQ5;2Z# !0QE'GTOR/)N0\[,+<D:8(/-<EIJ*3/=]@U)M0#^M98TJ6<$16=V
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M):EJSE4;(]=N5"RDP<'CECG^&D!9!SQ?2FEV&QN@^=DD?P%02P,$%     @
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MON?,BW@!Z0F)Z3O"(D;W$!J_/CSRT(EK^>(2+SZ ]VD)3B\Y)Q^5,62,\OW
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M=A24W8#?"RG-;F(-M WN^"]02P,$%     @ S81Q5%N%GHEQ P  ^PH  !D
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M<?U)W'NJ*)%)#LP)FR)Y,M5_-+6LZQPE)EE,#R*?K8:7R+XW[Q#WA; ?1</
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M;;H&/8".C6;D0W\-)='9%!2A3)ZC+XBVZ+GFG21M)0M?Z8*,K;_8PF]Z.#X
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ S81Q5'8W_0&K!   !24   \
M  !X;"]W;W)K8F]O:RYX;6S%FEUSFS@40/^*QB_;?<C:YB-M,W5G",8)4QN\
M@#/-TXX"<JPI((^0DVU__0H<;\3:OK,O-WG"" R'"[I'5_#E6<@?#T+\(']7
M9=U,!ANEME?#89-O6$6;/\26U7K+6LB**KTJ'X?-5C):-!O&5%4.K='H<EA1
M7@^^?CD<:RF'YHI0+%=<U+JQ;;CC[+EYW=ZNDB?>\ =><O5S,NA^EVQ *E[S
MBO]BQ60P&I!F(YYOA>2_1*UHF>92E.5D,-YON&-2\?RH.6TA,_K0="V*/B14
M@TP&ER-]P#67C>KVZ(Y/->,3TSOOUW9*S'BIF)Q2Q6ZDV&UY_=@>1E_%T+B,
M+@Z'Y3Z(5_+_A%&LUSQG4Y'O*E:K?1PE*UO NMGP;3,@-:W89."+)R;)DCZR
M]J+T6<)B?X%*DQGADE=<;Y!AT3'B\7B[@BL2UOL_ZZT&E@5@6;A8OEX7)2_T
MV0MR34M:YXQTM[<Q &T T'XW0/)A20U(!X!TWA R;2':/S1$K$F\9=* = %(
M]]T@?=IL#,A+ /+R'2'_L@S(CP#DQW>#3)7(#<A/ .0G7,C(RU9)0.(9N5ZE
M812D*?&B*;GVTC#5K0;D9P#R,RYDNEHLO.2^I4S#FRB<A;X79<3S_7@59:&9
MND=0[A[A8LZ\,"%WWGP5D$7@I3JNBR#*4A,/5 NR6\+H+DBS(R1(*V-DKRR3
M>!DDV7WWS 5_KL)EBV?204X9(TM%/U_)*M!@WY=!E :]J$$:&2-[),UB_]MM
M/)\&2?I;%[;LWF2#[#%&UD?'=J'3AXZ;'R_:P'E9&$<F'R2.,;(YPDA3!23S
MOO?O)^2),;(HHB C\UAG7MT72'KK)8%)!LEAC&R'N4YC_3A!%A@C:T#?N46X
M3V!=PO!CG?RCFR#RPQZD!4G 0I; =1 %LS CR[D7]:"@U&\AI_XDF'M9,+U8
M>FVRS1*-YOEMM^P1@@4&L@E Q?=&=!:D! M9"3"F;6)"AK"0#7%F)$(^Z!*\
M9&;-9D&RL)!E88Q(#FB_FVR0*"QD49P>FIS$A-QA(;OCOV.4DX"00BQDA9P;
M$+R FIB06RQDMYCC@E,QM"&GV,A..1X@G$2$#&,C&V8_4CB)!6G%1M8*6-[V
MM&*#LU?OJA7'Q(2T8F,7'B"F:V)"6K&1M7+.?A<DU4<O3$S(,#9Z*6+8;\H4
MY66_XT!>L9&]<DY_+YPF)F07&]DNQ_H[%4A(+#;VW-6)8ET_B1&54N_\9,Y,
M0XIQD!5S5M-[5!,3THR#K!D L^W;)B:D'0>[FH$P>]IQ(.TXV-H!,<UJQ@%?
MF[S%?-=93-..#J0=![V:,8:0+Z[9E:R=[P_K7)B8D':<-YP!,Q(1>TF=)B8D
M( =90& T^UT($I"#+"  <\K6O80$6<A!MM")"L*$-5\]0A9RW[[0><7LW707
MLI#[-L7.<>?ICSM<2$$NLH+^94QW547ES_:)G#/:,.*+1A$3$U*0BZR@5TRC
MY\QV:B<967#S\P<74I"+K*#>K.[IFPV^LT=6S_GYW8[5Q(34XW;J&1X^NRG8
MFM>LB/0I&MV>TS)?2M(N]B\.';=]';#>E:6OV^)Z+FAQ^(KG\ 72UW\ 4$L#
M!!0    ( ,V$<50,/Y#\Y0$  '\A   :    >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'/-VCM.PT 4A>&M1%X D_N8\%!"14.+V( 5)@^1Q)9G$,GNB4(1
MCD5!@^94UMCR]=_XDV5[_I)V;=EVA[S9]GERW.\.>=%L2ND?0LC+3=JW^:;K
MT^%\9-4-^[:<E\,Z].WRO5VGH-/I+ P_9S2/\Y\S)Z^G/OUE8K=:;9?IJ5M^
M[-.A_#(X?';#>]ZD5)K):SNL4UDTX;B[[L[ALI&;\^1F\ORV:(;G-VE"[2"%
M(*T?9!!D]8,<@KQ^4(2@6#]H!D&S^D&W$'1;/^@.@N[J!]U#T'W]()FBC%."
MI!'6!%H+<BT$7@N"+01B"Y(M!&8+HBT$:@NR+01N"\(M!'(+TBT$=@OB+01Z
M*^JM!'HKZJT$>NOH89M ;T6]E4!O1;V50&]%O95 ;T6]E4!O1;V50&]%O95
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MC:"(RE%(Y2BF<A14.8JJ'(55CN(J1X&5H\@J4&05*+(*%%D%BJP"15:!(JM
MD56@R"I09!4HLDH4626*K!)%5HDBJT215:+(*E%DE2BR2A19)8JL"D56A2*K
M0I%5H<BJ4&15*+(J%%D5BJP*15:%(FN&(FN&(FN&(FN&(FN&(FN&(FOVG[*^
M&[/\ZS?Y[36M==D<\EGWN<3D$U!+ 0(4 Q0    ( ,V$<50'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ S81Q5$=)\H+N    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ S81Q5)E<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #-A'%4
M@-W_E_T&  ">&P  &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ S81Q5*[QIO(B @  > 4  !@
M     ("!0 \  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M ,V$<525I XN7@4  -\4   8              " @9@1  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    " #-A'%4 ;^8QL\"  !Y"0  &
M            @($L%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#
M%     @ S81Q5-?4$?^(!   SA   !@              ("!,1H  'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ,V$<51>0U,A$0<   L=
M   8              " @>\>  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"% ,4    " #-A'%4D'SKYAX"  !V!   &               @($V)@
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ S81Q5.E*H"ZL
M!0  D1D  !@              ("!BB@  'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;%!+ 0(4 Q0    ( ,V$<5130()C.P\  'DG   8              "
M@6PN  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #-A'%4
M6;I0MEX>  "?70  &0              @('=/0  >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;%!+ 0(4 Q0    ( ,V$<50SHIP]Y@0  +4+   9
M      " @7)<  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%
M  @ S81Q5"KRR8>8 P  *0@  !D              ("!CV$  'AL+W=O<FMS
M:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #-A'%4J0!QW.T"  !#!@
M&0              @(%>90  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+
M 0(4 Q0    ( ,V$<52*LGACMP(  -X%   9              " @8)H  !X
M;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ S81Q5$+;BIZT
M @  S@4  !D              ("!<&L  'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6Q02P$"% ,4    " #-A'%44%#BJ4X*  #F'P  &0
M@(%;;@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( ,V$
M<531M&FPVPH   ,>   9              " @>!X  !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&UL4$L! A0#%     @ S81Q5(7CZ(U$!   N H  !D
M         ("!\H,  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
M    " #-A'%4+>]\G,,%  !S#0  &0              @(%MB   >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( ,V$<50H2:([* 8  (P.
M   9              " @6>.  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
M4$L! A0#%     @ S81Q5+:OKS%D P  0@<  !D              ("!QI0
M 'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #-A'%4?#"1
MW]D"  !&!@  &0              @(%AF   >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;%!+ 0(4 Q0    ( ,V$<53W+QIFV!H  !U7   9
M  " @7&;  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @
MS81Q5#COP.=K P  00<  !D              ("!@+8  'AL+W=O<FMS:&5E
M=',O<VAE970R-"YX;6Q02P$"% ,4    " #-A'%4_A7\2HT#  !$"   &0
M            @($BN@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4
M Q0    ( ,V$<53Z8D7E'P,  +X&   9              " @>:]  !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ S81Q5$SR\\]. P
M-P<  !D              ("!/,$  'AL+W=O<FMS:&5E=',O<VAE970R-RYX
M;6Q02P$"% ,4    " #-A'%4X+$?)LL"  #B!0  &0              @('!
MQ   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( ,V$<53R
MS1+"J04  '4.   9              " @</'  !X;"]W;W)K<VAE971S+W-H
M965T,CDN>&UL4$L! A0#%     @ S81Q5#Q3"2JP!   UPH  !D
M     ("!H\T  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,V$<53J9$M!F (  +H'   9              "
M@0?A  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ S81Q
M5,?;)"T0!0  !1P  !D              ("!UN,  'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6Q02P$"% ,4    " #-A'%4"7]PE1@$  #_$   &0
M        @($=Z0  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0
M   ( ,V$<51NO *+MP,  #H.   9              " @6SM  !X;"]W;W)K
M<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ S81Q5)LED?L* P  +@D
M !D              ("!6O$  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q0
M2P$"% ,4    " #-A'%4!\Z&70T#  "'"@  &0              @(&;]
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( ,V$<50UG,\4
M+ 4  $,7   9              " @=_W  !X;"]W;W)K<VAE971S+W-H965T
M-#$N>&UL4$L! A0#%     @ S81Q5-S1&B/' @  U0<  !D
M ("!0OT  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " #-
MA'%4)X^\AWP$    $@  &0              @(%   $ >&PO=V]R:W-H965T
M<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( ,V$<53^YH:9C@,  !T,   9
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M970T."YX;6Q02P$"% ,4    " #-A'%46X6>B7$#  #["@  &0
M    @(';%@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    (
M ,V$<53#^KR[% ,  +,(   9              " @8,: 0!X;"]W;W)K<VAE
M971S+W-H965T-3 N>&UL4$L! A0#%     @ S81Q5 =JGSA< P  =0P  !D
M             ("!SAT! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"
M% ,4    " #-A'%4VL>N;]X#  "=#@  &0              @(%A(0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( ,V$<53AQ75O0P,
M   *   9              " @78E 0!X;"]W;W)K<VAE971S+W-H965T-3,N
M>&UL4$L! A0#%     @ S81Q5 @9FPR4 @  80<  !D              ("!
M\"@! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " #-A'%4
M&-9 78<"  !K!@  &0              @(&[*P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4U+GAM;%!+ 0(4 Q0    ( ,V$<53+ W$!8 (  +4%   9
M      " @7DN 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%
M  @ S81Q5$3KMQL@ P  &!(   T              ( !$#$! 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " #-A'%4EXJ[',     3 @  "P
M@ %;- $ 7W)E;',O+G)E;'-02P$"% ,4    " #-A'%4=C?] :L$   %)0
M#P              @ %$-0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MS81Q5 P_D/SE 0  ?R$  !H              ( !'#H! 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ S81Q5(_AMVG3 0  -B$  !,
M             ( !.3P! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $
,0 !W$0  /3X!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>125</ContextCount>
  <ElementCount>378</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>43</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlowsParenthetical</Role>
      <ShortName>Consolidated Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION</Role>
      <ShortName>NATURE OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/INVESTMENTS</Role>
      <ShortName>INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2114105 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2117106 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSES</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2120107 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2122108 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - NET LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARE</Role>
      <ShortName>NET LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2139111 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2144112 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2145113 - Disclosure - BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/BENEFITPLANS</Role>
      <ShortName>BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2147114 - Disclosure - RELATED-PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONS</Role>
      <ShortName>RELATED-PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - INVESTMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/INVESTMENTSTables</Role>
      <ShortName>INVESTMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/INVESTMENTS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2315304 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENT</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2318305 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2323306 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2330307 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/INCOMETAXES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2336308 - Disclosure - NET LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARETables</Role>
      <ShortName>NET LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARE</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2340309 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/LEASES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails</Role>
      <ShortName>NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - INVESTMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails</Role>
      <ShortName>INVESTMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/INVESTMENTSTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2416406 - Disclosure - PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2419407 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2424409 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2425410 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock Options Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of Stock Options Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2426411 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2427412 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2428413 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2431414 - Disclosure - INCOME TAXES - Schedule of Income (Loss) Before Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Income (Loss) Before Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2432415 - Disclosure - INCOME TAXES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2433416 - Disclosure - INCOME TAXES - Schedule of Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails</Role>
      <ShortName>INCOME TAXES - Schedule of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2437418 - Disclosure - NET LOSS PER SHARE - Schedule of Computation of Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails</Role>
      <ShortName>NET LOSS PER SHARE - Schedule of Computation of Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails</Role>
      <ShortName>NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2441420 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2442421 - Disclosure - LEASES - Summary of Lease Cost and Other Operating Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails</Role>
      <ShortName>LEASES - Summary of Lease Cost and Other Operating Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2443422 - Disclosure - LEASES - Schedule of Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>LEASES - Schedule of Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2446423 - Disclosure - BENEFIT PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/BENEFITPLANSDetails</Role>
      <ShortName>BENEFIT PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/BENEFITPLANS</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="bdtx-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2448424 - Disclosure - RELATED-PARTY TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONSDetails</Role>
      <ShortName>RELATED-PARTY TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONS</ParentRole>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="bdtx-20211231.htm">bdtx-20211231.htm</File>
    <File>bdtx-20211231.xsd</File>
    <File>bdtx-20211231_cal.xml</File>
    <File>bdtx-20211231_def.xml</File>
    <File>bdtx-20211231_lab.xml</File>
    <File>bdtx-20211231_pre.xml</File>
    <File>exhibit231_q42021.htm</File>
    <File>exhibit311_q42021.htm</File>
    <File>exhibit312_q42021.htm</File>
    <File>exhibit321_q42021.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>bdtx-20211231_g1.jpg</File>
    <File>bdtx-20211231_g10.jpg</File>
    <File>bdtx-20211231_g11.jpg</File>
    <File>bdtx-20211231_g12.jpg</File>
    <File>bdtx-20211231_g13.jpg</File>
    <File>bdtx-20211231_g14.jpg</File>
    <File>bdtx-20211231_g15.jpg</File>
    <File>bdtx-20211231_g16.jpg</File>
    <File>bdtx-20211231_g17.jpg</File>
    <File>bdtx-20211231_g18.jpg</File>
    <File>bdtx-20211231_g19.jpg</File>
    <File>bdtx-20211231_g2.jpg</File>
    <File>bdtx-20211231_g20.jpg</File>
    <File>bdtx-20211231_g21.jpg</File>
    <File>bdtx-20211231_g22.jpg</File>
    <File>bdtx-20211231_g3.jpg</File>
    <File>bdtx-20211231_g4.jpg</File>
    <File>bdtx-20211231_g5.jpg</File>
    <File>bdtx-20211231_g6.jpg</File>
    <File>bdtx-20211231_g7.jpg</File>
    <File>bdtx-20211231_g8.jpg</File>
    <File>bdtx-20211231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="555">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>96
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bdtx-20211231.htm": {
   "axisCustom": 1,
   "axisStandard": 17,
   "contextCount": 125,
   "dts": {
    "calculationLink": {
     "local": [
      "bdtx-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bdtx-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bdtx-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bdtx-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bdtx-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bdtx-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 440,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 7,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 11
   },
   "keyCustom": 13,
   "keyStandard": 365,
   "memberCustom": 8,
   "memberStandard": 33,
   "nsprefix": "bdtx",
   "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.blackdiamondtherapeutics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - INVESTMENTS",
     "role": "http://www.blackdiamondtherapeutics.com/role/INVESTMENTS",
     "shortName": "INVESTMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114105 - Disclosure - PROPERTY AND EQUIPMENT",
     "role": "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117106 - Disclosure - ACCRUED EXPENSES",
     "role": "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSES",
     "shortName": "ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120107 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122108 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - INCOME TAXES",
     "role": "http://www.blackdiamondtherapeutics.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - NET LOSS PER SHARE",
     "role": "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARE",
     "shortName": "NET LOSS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139111 - Disclosure - LEASES",
     "role": "http://www.blackdiamondtherapeutics.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://www.blackdiamondtherapeutics.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144112 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.blackdiamondtherapeutics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145113 - Disclosure - BENEFIT PLANS",
     "role": "http://www.blackdiamondtherapeutics.com/role/BENEFITPLANS",
     "shortName": "BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147114 - Disclosure - RELATED-PARTY TRANSACTIONS",
     "role": "http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONS",
     "shortName": "RELATED-PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - INVESTMENTS (Tables)",
     "role": "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSTables",
     "shortName": "INVESTMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315304 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "role": "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318305 - Disclosure - ACCRUED EXPENSES (Tables)",
     "role": "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESTables",
     "shortName": "ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323306 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - Consolidated Balance Sheets",
     "role": "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330307 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336308 - Disclosure - NET LOSS PER SHARE (Tables)",
     "role": "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARETables",
     "shortName": "NET LOSS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340309 - Disclosure - LEASES (Tables)",
     "role": "http://www.blackdiamondtherapeutics.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ie88f3aabe31b474cacd5e20c1fff19fe_D20200121-20200121",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
     "shortName": "NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ie88f3aabe31b474cacd5e20c1fff19fe_D20200121-20200121",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "i907bbd4101da4791b95db60038ebf1bb_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Property, Plant and Equipment (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "i907bbd4101da4791b95db60038ebf1bb_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "i25857721770b4551b695d1c7721be8c6_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "i25857721770b4551b695d1c7721be8c6_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - INVESTMENTS (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails",
     "shortName": "INVESTMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416406 - Disclosure - PROPERTY AND EQUIPMENT (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails",
     "shortName": "PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "bdtx:AccruedContractResearchServiceFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419407 - Disclosure - ACCRUED EXPENSES (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails",
     "shortName": "ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "bdtx:AccruedContractResearchServiceFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bdtx:CommonStockVotingRightsNumberOfVotesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bdtx:CommonStockVotingRightsNumberOfVotesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424409 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425410 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock Options Valuation Assumptions (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of Stock Options Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "if2aba82796ae470699e4f3168699b2c7_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426411 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock Option Activity (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ie3bf60c3f3c74cac874df7014c860584_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427412 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Restricted Stock Activity (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "i409db6c3ae2948168a94cd673a222876_I20191231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428413 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "i3e7beae8caf2403f8ca0392b605a96a5_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431414 - Disclosure - INCOME TAXES - Schedule of Income (Loss) Before Income Tax Expense (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails",
     "shortName": "INCOME TAXES - Schedule of Income (Loss) Before Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432415 - Disclosure - INCOME TAXES - Narrative (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433416 - Disclosure - INCOME TAXES - Schedule of Income Tax Rate Reconciliation (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails",
     "shortName": "INCOME TAXES - Schedule of Income Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails",
     "shortName": "INCOME TAXES - Schedule of Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - Consolidated Statements of Operations",
     "role": "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437418 - Disclosure - NET LOSS PER SHARE - Schedule of Computation of Net Loss per Share (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails",
     "shortName": "NET LOSS PER SHARE - Schedule of Computation of Net Loss per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails",
     "shortName": "NET LOSS PER SHARE - Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "bdtx:LesseeOperatingLeaseNumberOfContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contract",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441420 - Disclosure - LEASES - Narrative (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "bdtx:LesseeOperatingLeaseNumberOfContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contract",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442421 - Disclosure - LEASES - Summary of Lease Cost and Other Operating Lease Information (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails",
     "shortName": "LEASES - Summary of Lease Cost and Other Operating Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443422 - Disclosure - LEASES - Schedule of Future Minimum Lease Payments (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails",
     "shortName": "LEASES - Schedule of Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446423 - Disclosure - BENEFIT PLANS (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/BENEFITPLANSDetails",
     "shortName": "BENEFIT PLANS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448424 - Disclosure - RELATED-PARTY TRANSACTIONS (Details)",
     "role": "http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONSDetails",
     "shortName": "RELATED-PARTY TRANSACTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "iebd841302b2243b09b4770b0df113b00_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - Consolidated Statements of Cash Flows (Parenthetical)",
     "role": "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlowsParenthetical",
     "shortName": "Consolidated Statements of Cash Flows (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "i9b34b944847347268c17b3eccf68fb24_I20191231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)",
     "role": "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "i9b34b944847347268c17b3eccf68fb24_I20191231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION",
     "shortName": "NATURE OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bdtx-20211231.htm",
      "contextRef": "ib8fade6d48aa48db982595f4519897e2_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 43,
   "tag": {
    "bdtx_A2020EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Employee Stock Purchase Plan",
        "label": "2020 Employee Stock Purchase Plan [Member]",
        "terseLabel": "2020 ESPP"
       }
      }
     },
     "localname": "A2020EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdtx_A2020PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Plan",
        "label": "2020 Plan [Member]",
        "terseLabel": "2020 Plan"
       }
      }
     },
     "localname": "A2020PlanMember",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdtx_AccruedContractResearchServiceFeesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Contract Research Service Fees, Current",
        "label": "Accrued Contract Research Service Fees, Current",
        "terseLabel": "Contracted research services"
       }
      }
     },
     "localname": "AccruedContractResearchServiceFeesCurrent",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdtx_AccruedLegalFeesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Legal Fees, Current",
        "label": "Accrued Legal Fees, Current",
        "terseLabel": "Legal fees"
       }
      }
     },
     "localname": "AccruedLegalFeesCurrent",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdtx_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "xbrltype": "stringItemType"
    },
    "bdtx_CommonStockVotingRightsNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number Of Votes Per Share",
        "label": "Common Stock, Voting Rights, Number Of Votes Per Share",
        "terseLabel": "Common stock, voting rights per share"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberOfVotesPerShare",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bdtx_DeferredTaxAssetsLeasingArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Leasing Arrangements",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdtx_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bdtx_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Operating Lease Liabilities",
        "label": "Increase (Decrease) in Operating Lease Liabilities",
        "terseLabel": "Non-current operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdtx_LeaseOtherInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Other Information [Abstract]",
        "label": "Lease, Other Information [Abstract]",
        "terseLabel": "Other Operating Lease Information"
       }
      }
     },
     "localname": "LeaseOtherInformationAbstract",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bdtx_LesseeOperatingLeaseArea": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Area",
        "label": "Lessee, Operating Lease, Area",
        "terseLabel": "Area leased"
       }
      }
     },
     "localname": "LesseeOperatingLeaseArea",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "bdtx_LesseeOperatingLeaseNumberOfContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Contracts",
        "label": "Lessee, Operating Lease, Number Of Contracts",
        "terseLabel": "Number of leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfContracts",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bdtx_OpenMarketSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Sale",
        "label": "Open Market Sale [Member]",
        "terseLabel": "Open Market Sale"
       }
      }
     },
     "localname": "OpenMarketSaleMember",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdtx_OperatingLeaseOfficeAndLaboratorySpaceNYMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Office and Laboratory Space, NY",
        "label": "Operating Lease, Office and Laboratory Space, NY [Member]",
        "terseLabel": "Office and laboratory, December 2020 lease"
       }
      }
     },
     "localname": "OperatingLeaseOfficeAndLaboratorySpaceNYMember",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdtx_OperatingLeasePrincipalOfficeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Principal Office, One",
        "label": "Operating Lease, Principal Office, One [Member]",
        "terseLabel": "Principal office, February 2019 lease"
       }
      }
     },
     "localname": "OperatingLeasePrincipalOfficeOneMember",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdtx_OperatingLeasePrincipalOfficeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Principal Office, Two",
        "label": "Operating Lease, Principal Office, Two [Member]",
        "terseLabel": "Principal office, July 2020 lease"
       }
      }
     },
     "localname": "OperatingLeasePrincipalOfficeTwoMember",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdtx_OtherAwardTypeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Award Type",
        "label": "Other Award Type [Member]",
        "terseLabel": "Employee Stock Purchase Plan and Other"
       }
      }
     },
     "localname": "OtherAwardTypeMember",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdtx_PatentCostsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent Costs, Policy",
        "label": "Patent Costs, Policy [Policy Text Block]",
        "terseLabel": "Patent costs"
       }
      }
     },
     "localname": "PatentCostsPolicyPolicyTextBlock",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bdtx_RentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rent Expense",
        "label": "Rent Expense",
        "terseLabel": "Noncash rent expense"
       }
      }
     },
     "localname": "RentExpense",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdtx_RightOfUseAssetDerecognizedTerminationOfLease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset, Derecognized, Termination of Lease",
        "label": "Right-of-Use Asset, Derecognized, Termination of Lease",
        "terseLabel": "Right-of-use asset derecognized upon early lease termination"
       }
      }
     },
     "localname": "RightOfUseAssetDerecognizedTerminationOfLease",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bdtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Authorized Shares, Percent of Common Stock Outstanding",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Increase of Authorized Shares, Percent of Common Stock Outstanding",
        "terseLabel": "Increase of authorized shares, percent of common stock outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfAuthorizedSharesPercentOfCommonStockOutstanding",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bdtx_SharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares, Authorized",
        "label": "Shares, Authorized",
        "terseLabel": "Total shares authorized"
       }
      }
     },
     "localname": "SharesAuthorized",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bdtx_TaxPeriodExpirationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Period Expiration",
        "label": "Tax Period Expiration [Axis]",
        "terseLabel": "Tax Period Expiration [Axis]"
       }
      }
     },
     "localname": "TaxPeriodExpirationAxis",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bdtx_TaxPeriodExpirationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Period Expiration [Domain]",
        "label": "Tax Period Expiration [Domain]",
        "terseLabel": "Tax Period Expiration [Domain]"
       }
      }
     },
     "localname": "TaxPeriodExpirationDomain",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bdtx_TaxYear2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2036",
        "label": "Tax Year 2036 [Member]",
        "terseLabel": "Tax Year 2036"
       }
      }
     },
     "localname": "TaxYear2036Member",
     "nsuri": "http://www.blackdiamondtherapeutics.com/20211231",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r206",
      "r217",
      "r252",
      "r254",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r428",
      "r459",
      "r460",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r206",
      "r217",
      "r243",
      "r252",
      "r254",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r428",
      "r459",
      "r460",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r206",
      "r217",
      "r243",
      "r252",
      "r254",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r428",
      "r459",
      "r460",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r99",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r99",
      "r104",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r99",
      "r104",
      "r190",
      "r253",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r28",
      "r395"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails",
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r30"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional and consulting fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r26",
      "r180"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r17",
      "r41",
      "r42",
      "r43",
      "r448",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r40",
      "r43",
      "r50",
      "r51",
      "r52",
      "r91",
      "r92",
      "r93",
      "r340",
      "r461",
      "r462",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r15",
      "r296",
      "r395"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r293",
      "r294",
      "r295",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r257",
      "r260",
      "r299",
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r205",
      "r231",
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Reclassification of warrants to additional paid-in capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustment to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r260",
      "r289",
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r83",
      "r133",
      "r141",
      "r145",
      "r165",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r337",
      "r341",
      "r355",
      "r393",
      "r395",
      "r433",
      "r447"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r37",
      "r83",
      "r165",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r337",
      "r341",
      "r355",
      "r393",
      "r395"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r347"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r153",
      "r172"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r149",
      "r154",
      "r172",
      "r435"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r151",
      "r172"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r261",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Accounting"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r2",
      "r90",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "NATURE OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r23",
      "r74"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r9",
      "r75",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r69",
      "r74",
      "r79"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of year",
        "totalLabel": "Cash, cash equivalents and restricted cash, end of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r69",
      "r356"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r244",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds that is excluded from cash and cash equivalents.",
        "label": "Commercial Paper, Not Included with Cash and Cash Equivalents [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperNotIncludedWithCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r32",
      "r189",
      "r437",
      "r452"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note\u00a012)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r191",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock, number of shares reserved (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r91",
      "r92",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r14",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r14",
      "r395"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock; $0.0001 par value; 500,000,000 shares authorized at December\u00a031, 2021 and 500,000,000 shares authorized at December\u00a031, 2020; 36,234,624 shares issued and outstanding at December\u00a031, 2021 and 36,078,383 shares issued and outstanding at December\u00a031, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r241",
      "r242",
      "r255",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "BENEFIT PLANS"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/BENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets (liabilities):"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r45",
      "r47",
      "r48",
      "r55",
      "r439",
      "r455"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive loss:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r123",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of credit risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r80",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in process"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r76",
      "r77",
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of preferred stock into common stock upon closing of initial public offering"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain (Loss)",
        "negatedTerseLabel": "Gain on sale of investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r315"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r317"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r317"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r320",
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "terseLabel": "Accruals and other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r316"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Net fixed assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Employer contribution amount"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/BENEFITPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employer contribution, percent of each participant's salary"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/BENEFITPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer matching contribution, percent of match"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/BENEFITPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r72",
      "r178"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r88",
      "r195",
      "r197",
      "r198",
      "r202",
      "r203",
      "r204",
      "r390",
      "r436",
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to Related Parties",
        "terseLabel": "Due to related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r56",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r105",
      "r107",
      "r109",
      "r110",
      "r111",
      "r115",
      "r116",
      "r345",
      "r346",
      "r440",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share attributable to common stockholders, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations",
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r56",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r107",
      "r109",
      "r110",
      "r111",
      "r115",
      "r116",
      "r345",
      "r346",
      "r440",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share attributable to common stockholders, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations",
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r86",
      "r308",
      "r330"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r308",
      "r330"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r308",
      "r330"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r308",
      "r330"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r308",
      "r330"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r308",
      "r330"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Research and development credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost, recognition period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost, options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Shares issuable under employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Options to purchase common stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r50",
      "r51",
      "r52",
      "r91",
      "r92",
      "r93",
      "r95",
      "r101",
      "r103",
      "r118",
      "r166",
      "r231",
      "r238",
      "r293",
      "r294",
      "r295",
      "r325",
      "r326",
      "r344",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r461",
      "r462",
      "r463",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r207",
      "r210",
      "r211",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r348",
      "r401",
      "r402",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r347",
      "r348",
      "r350",
      "r351",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r207",
      "r244",
      "r245",
      "r250",
      "r251",
      "r348",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r207",
      "r210",
      "r211",
      "r244",
      "r245",
      "r250",
      "r251",
      "r348",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r207",
      "r210",
      "r211",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r348",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair value measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r207",
      "r210",
      "r211",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r401",
      "r402",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r352",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r157",
      "r158",
      "r161",
      "r162",
      "r163",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r173",
      "r174",
      "r175",
      "r176",
      "r209",
      "r229",
      "r343",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign currency and currency translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.",
        "label": "Gain (Loss) on Termination of Lease",
        "terseLabel": "Gain on lease termination"
       }
      }
     },
     "localname": "GainLossOnTerminationOfLease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r256",
      "r258",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r177",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of long - lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "auth_ref": [
      "r52",
      "r58"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "totalLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r85",
      "r329"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r85",
      "r329"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Total loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESScheduleofIncomeLossBeforeIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r182",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r86",
      "r309",
      "r313",
      "r319",
      "r327",
      "r331",
      "r333",
      "r334",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r87",
      "r102",
      "r103",
      "r132",
      "r307",
      "r328",
      "r332",
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r49",
      "r305",
      "r306",
      "r313",
      "r314",
      "r318",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in current assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r53",
      "r131",
      "r365",
      "r366",
      "r441"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeAmortizationOfPremium": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of purchase premium on nonoperating securities.",
        "label": "Investment Income, Amortization of Premium",
        "terseLabel": "Amortization of premium on investments"
       }
      }
     },
     "localname": "InvestmentIncomeAmortizationOfPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNonoperating": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.",
        "label": "Investment Income, Nonoperating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r164",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r347"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r160",
      "r431",
      "r443",
      "r468",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "INVESTMENTS"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r383",
      "r385"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease Cost"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Lease Cost and Other Operating Lease Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease term, optional extension"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letter of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r29",
      "r83",
      "r142",
      "r165",
      "r192",
      "r193",
      "r194",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r338",
      "r341",
      "r342",
      "r355",
      "r393",
      "r394"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r20",
      "r83",
      "r165",
      "r355",
      "r395",
      "r434",
      "r450"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r31",
      "r83",
      "r165",
      "r192",
      "r193",
      "r194",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r338",
      "r341",
      "r342",
      "r355",
      "r393",
      "r394",
      "r395"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r69",
      "r70",
      "r73"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r44",
      "r46",
      "r52",
      "r54",
      "r73",
      "r83",
      "r94",
      "r96",
      "r97",
      "r98",
      "r99",
      "r102",
      "r103",
      "r108",
      "r133",
      "r140",
      "r143",
      "r144",
      "r146",
      "r165",
      "r192",
      "r193",
      "r194",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r346",
      "r355",
      "r438",
      "r454"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations",
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently adopted accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Computer and office equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r133",
      "r140",
      "r143",
      "r144",
      "r146"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r376",
      "r385"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "ASC 842"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Current portion of operating lease liability, statement of financial position"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r372",
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liability"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r382",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r381",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r38",
      "r39"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Change in unrealized (loss) gain on investments, net",
        "verboseLabel": "Unrealized gains on investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations",
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "OtherNoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale",
        "terseLabel": "Impairment loss"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedTerseLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r261",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r13",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r13",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r13",
      "r395"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value; 10,000,000 shares and 10,000,000 shares authorized at December\u00a031, 2021 and 2020, respectively; no shares issued or outstanding at December\u00a031, 2021 and 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r21",
      "r22"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from initial public offering, net of issuance costs of $1,275"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r63",
      "r64",
      "r150"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r67",
      "r292"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of common stock options and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r26",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r184",
      "r471",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r25",
      "r179"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r181",
      "r395",
      "r444",
      "r451"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r24",
      "r181",
      "r471",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r10",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTTables",
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r10",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Related party expense, service fees"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r387",
      "r388",
      "r390",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED-PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/RELATEDPARTYTRANSACTIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r302",
      "r429",
      "r476"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and development costs and research contract costs and accruals"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r9",
      "r74",
      "r79"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash, end of year"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r6",
      "r12",
      "r79",
      "r469"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Unvested restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r16",
      "r238",
      "r296",
      "r395",
      "r449",
      "r464",
      "r466"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r91",
      "r92",
      "r93",
      "r95",
      "r101",
      "r103",
      "r166",
      "r293",
      "r294",
      "r295",
      "r325",
      "r326",
      "r344",
      "r461",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r380",
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease obligation"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Proceeds from stock issuance, net"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares sold"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ACCRUEDEXPENSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r260",
      "r288",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r260",
      "r288",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r26",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r261",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r266",
      "r277",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Stock Options Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r33",
      "r81",
      "r119",
      "r120",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r224",
      "r229",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Cancelled or forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancelled or forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested restricted common stock, ending balance (in shares)",
        "periodStartLabel": "Unvested restricted common stock, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number\u00a0of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested restricted common stock, ending balance (in dollars per share)",
        "periodStartLabel": "Unvested restricted common stock, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average grant\u00a0date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of restricted stock vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Increase in number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Remaining Life and Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Canceled or forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled or forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant-date fair value per share of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options outstanding, intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r268",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options vested or expected to vest, intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options vested or expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options vested or expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r259",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofRestrictedStockActivityDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r261",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "auth_ref": [
      "r256",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-based Payment Arrangement, Nonemployee [Member]",
        "terseLabel": "Non-employees"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r283",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options exercisable, intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable, remaining life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options outstanding, remaining life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options vested or expected to vest, remaining life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r377",
      "r385"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r36",
      "r50",
      "r51",
      "r52",
      "r91",
      "r92",
      "r93",
      "r95",
      "r101",
      "r103",
      "r118",
      "r166",
      "r231",
      "r238",
      "r293",
      "r294",
      "r295",
      "r325",
      "r326",
      "r344",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r461",
      "r462",
      "r463",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r118",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r35",
      "r208",
      "r231",
      "r232",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Number of shares issued upon conversion",
        "verboseLabel": "Conversion of preferred stock to common stock upon closing of the initial public offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r13",
      "r14",
      "r231",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock related to ESPP (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r13",
      "r14",
      "r231",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r13",
      "r14",
      "r231",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Vesting of restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r13",
      "r14",
      "r231",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r13",
      "r14",
      "r231",
      "r238",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of common stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails",
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r36",
      "r231",
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of preferred stock to common stock upon closing of the initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r13",
      "r14",
      "r231",
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock related to ESPP"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r13",
      "r14",
      "r231",
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock, net of issuance costs",
        "verboseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r36",
      "r231",
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of common stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r14",
      "r18",
      "r19",
      "r83",
      "r148",
      "r165",
      "r355",
      "r395"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets",
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity (deficit):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r82",
      "r216",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r230",
      "r238",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Reverse stock split"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r363",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r363",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r363",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent events"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r157",
      "r158",
      "r161",
      "r162",
      "r163",
      "r209",
      "r229",
      "r343",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r89",
      "r244",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. Government agencies"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.blackdiamondtherapeutics.com/role/INVESTMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r303",
      "r335",
      "r445",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed earnings of foreign subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r304",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties related to uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r378",
      "r385"
     ],
     "calculation": {
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/LEASESSummaryofLeaseCostandOtherOperatingLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants to purchase shares of common stock"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossperShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r106",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common share outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations",
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r105",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.blackdiamondtherapeutics.com/role/ConsolidatedStatementsofOperations",
      "http://www.blackdiamondtherapeutics.com/role/NETLOSSPERSHAREScheduleofComputationofNetLossperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28200-109314"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123386189&loc=SL77918607-209975"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r477": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r478": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r479": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r480": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r481": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r482": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r483": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r484": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r485": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r486": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r487": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r488": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r489": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r490": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r491": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r492": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r493": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r494": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r495": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.20)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0001701541-22-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001701541-22-000007-xbrl.zip
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MN<)U2>C*V/&6(%%N$:7F76C\^>!]<:[*7!\YAF4"#F\I7B\F2UX6#11,)>(
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MHGNF8/]0MH*_00+_(;(5&IB@?O>:W$#KYJCN9G KSC]S'/@&,M^24)O6IG\
MJ LGELC Z+]'K/O7V9Z2:<%P,.KS(OMMRCWP-S>G- ]YR7O7;=+'-&:I2W&"
M<\4L8(L7)RG\,N&=/Q*@GI4XM^[?2\+,)\_@: 3<B+A<LX<EUM./3L7%H0NZ
M]6EGM-<[ _VX ]^W+V&]HZ/^H=/9^GS9=?=3^'RC8J-[]?;TZ.M1VKG:]?=@
MC8?P_;"W<W)X]6?_Z/331;>W[1V]A\\9K/%ZNA&-DY@D86(G(2C9E')EQU[
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MQBN\0J-'0Z.Q#8<JDBCRH@^B!^!7#@=-FXW2.C91O!/%,@T<9#QY*X-Q,6!
M-6K1=Y59,$. 'P'>:+6UJ)J?43/+[QOE6D'Y9YE%:^^!9E(:\Q1,2*U_(\GW
MV9F:U8-0#*&5B_J0,6E-7G+#%5K=:JPHH^S <[2(*9H$1WU*,JR':/6DC*=9
M6H]6@'Y, U/'J8'4L)V6G+%UL@)A C^A$83_:!(?<WZDP]8M+1!AS.E:&4#
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M6NO<>TVEG[#PO?D^Y7_"@HCA>+(N9A2L*'<I*!=!3CRZHMPEI]Q&,%O1QI2
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M&]9NOWFM.=)I:FT(V&P2")S@V&S=^81#M;=C63V)T)E66G,. ;F4QG>&Q<^
M],,<[FJ2+# ]9*:4:PP C #!(C!<@7&2O>]2P36)C6GZB)XZUM<N&G3TH0G?
M3E/(1)6ZH4 U> U\A555(5(-MI;C@;TT]I@9VFTY@C8 M.INR"'1X)]I##9)
M*1U=HR$C66<%ZTG1Q%I;)&F:-]RJ<BZ^L+VNWWT7LD;SU)P5J[C1W-=>0."\
MK*Q>K])N_[[E=4NB7JM(5\^70F@VA[B_]YI^JFB2E.I$Y14RPK&?%BGFGCJY
M=IM/A.8<O<OD6IT@;\!J'LTF4KC'+%=+,0UKPGCQ:9H1C+/8LN.BA)/Z)I>@
MCVEF\'(8,=9AH+HHLNF(_@R[2LUH@[9C!"@V8,$ ]X<]O (V-%[K^EAY3ZLB
M,T+B.T9A$XDH*G7=6FB["C9L3/-1D\!FQ(31$"=I"M,10'B_"K2<IDIN@"W+
M04>=>NZ&M:+21Z/2L96[ %3Z57L2,;HS%YUU#,Q07CJ-Q>-NR4)W6<@;JQ'S
M#%36]L'3,OVDN)BR!LS%&LMG)++V)DPR3XS,;F>8J!S]SU5CT8-A-!QHZ:SJ
M:U8T=F&>* LF?JE5_-;W=\._T43!3G38J[7XINV ^TGF%1W\#!U,^W@6@!0^
M5XVK#QO,&HR8\/#*.,A $%5*G4WW%6JD2=7'I*Y^ 2@TS.9['K2Y-:WVML8P
M5L7H#(_6RISO7O@.+O[R,<I@50J["C?>@9=I_]BJ2@%X+^M+VW5<0ER/?#LF
M&Z>#XS74%6\[-$ME;D0'E^T$OH:&Y@SDT4LPAQL<"N)@<(G8]NQ6WOQHCK;R
MTH$>([3H%NEG[/QU-=7^XV[;=+UM08(&JDD7FKRN3BLW:=%M\<!ZXSF;=0=?
MY_0WO$S-7"$3^9ER_\X+^!A5W:2XG^-\(=B<MD7%U,KF^%]!+ZI.,!.F\0'K
M@7=H#!078^?=;0COWH[P[CR$]YSP92+\V.O\VMJT>,E@10.T0;&3_ 2B" 'M
M49XCDZ>3S\:.6_RQ+D&!U:G^8.W6D_(K)IH$[\F!*918<*)[GZ4%SU@%$&;6
M;^_?=OZ!>,AT!ET*U%## FWM^X27/=8]L9%B^AH_X%7'-D7K$\H!Y]%<-H6>
M&S@C-Y>L;-VY(YQ+T[2&,C-<<,^:]N>P(<*DKC<-ADR^M<E?*YE,)]EQ&*DL
MFEN:#%XL-S4W+55?)PL/BJ)LBBWRK&G,>ZGS'N&;Z_]/4T.@"];T@M"YV/K\
M,+D.# ?4'R\*:Z28J3')"FU6FXSV\7M@[F\?9][X#I:$B,;S?#R]N28(UV80
MSM2S7$/%:1?']:@2$"3HKV"B#='Z*=5Q$RHVWG\34AH'AQI.MO[_L_>FS6TD
M2;;H7TE[RYAH%V1QTU;U;,PH2JI65TGBB.JJN?=; DB0V0(R,9E(4JA?_^+X
M$N&1"TBI2TVH&Q^FIT0 F;%X>/AR_#@M,T5@D KC5&<<I:"@=B@""H%4)#$E
M:=(-S!O0G8TADP+3<'FT!JA'<U;RHWQ/$2^FXHYDBV<3"@@W+(U$?P"$N<FG
MQ"<EFS=R;W"O<#+00(IS B;B_B#M[V16,GGW>0T]RST,O2NFR"D!">E72[U5
M?03HB4C8*)&/A8CF[\08C."YI.BESZ=-9U!&[68O0;Z;0FAT-$B1):+(_"[1
MZOLKPW+.B]/NV^$M,OCB>4VE^6;T0I%:BPCNG)$A9^3ISAG9.2,/?EGWZT$I
M_ZZUQFCA-5-*BG^5KQHR<Z=N+%(IY<M"TBAH)\'E>99.*3*'&M]B2A&O949A
M+TJ9IG-M:Z*5!1)=&:.K;HAXQ)?5M,2US)K&CC^4>[?4Y;:GK-\4E-UG[X'"
MIO.&C49 B!Z]NSS_]7Q/  S&F1 XADE$VS2TU^&::NR R)Q;A-[FLI"BS-U[
MX[2I=FG6"W:65_5JG]R/6DTR2D!7V4'R%V=DW2#!0" I[J68LD6#N?GWBZEK
M+5T.#,_39>V>\YK)]6#4C))FR;C\^8QDT3V'5B0\+<N9:P3KT6\^)H_.WUWN
MH>#$200C3JSUR$"1N0_<N<<M(,+2,%%!  RM6Z1_1RZ(!),70[Q 5,WLF^NX
MO5]2K)E.G07%MJ->Q+S";H@^,S//N(["/L]]GG@?I"L.BFUP,UK ^RKRL5#>
MHEFV;74DIQK/"RLBV2=NA@9?4THHV CF))?-9&>%W3TG#C<Y'$UW<*N\WGZ8
M2$ 56< !9??8M1\%O]XY;15R%A57[F*+VAYAR_,/#J+Q^.M(IVTP2-MD*8.*
M+88<]FII[??=;W8>),D92XY%O_6B@V8X(.X5J"N?T &3[O3I!O>8O0Y!B/!#
MJ=69EOW/!.A$BS'-*RZB"GZ!09IP;5)7MR=G'M8"?)/9U\)?352H7C4+0<IL
M<L631Z\^E\71,W>^/E,#0],HJ=X;=M0?G3]]_O32PDN4@T6_P863U3095A%[
M_ >3XU7K/];<SOC-%8WISSTIQ2[3#OV [?YPV+?]='[TO6(WM[,*W:RB)CG)
MK5L/JN<.3 %_.[A$M[YR2EM(#SJ;.ALZK\452AZ]?GFV!X7_U[1H<#$^&27'
MA\?'H6KSXAKQO*,67Q6]39I_^=)<OAI0L5NM& 6$1_$-HH^9NOW9SVKW(!X
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M"J=,W766WN04#\_(5;31?R!^V8-BPH0 *)]IT)XZ6!\=NG\4JVLIWQJR#"1
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MBM*DI1M3%)X+$7&F8F"@, TW6@+Q73+*G_D0!K\2\HC8'EEF0-KU_MXC3 3
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MVODBJZ!KA/ WYZ(RN?%MU.<@8!]Q(FOC)C$!(;4Z#<>QYS8C1^Q.__(KY*G
MD9X'NT*]VY *\\I#O3X_&2OZBQ*)C7*Q("42PER6$UH@+$3PDGH(/D)!BB=H
MY]DHK19# >B_=S[?H,_W9.?S[7R^!U?GE!D?!;3-KS'<AJ*?4#FONARFC$RZ
M_.V'R]]>_O#NXB\_O/ZO5V<CGQ_M^PD]^G__]O;LAY\O+]I/-T2N_.RGIT_V
MGSX^''4@.-\$@?-LV(]^UN=''WUM@NCQDVU!X Q7]@ZU6^WKE+KE!LOOC"(U
M';CO+"%7QRSEK_AVOT3T'S?,UL@I]^KI^F^M1IJ=1BF6.J/3$(@BN=Q=TK?-
M<].!UW_KF[#@+L\JZH58<>&D@":U67%G*[\_YYDMF<<GCW],SI)QY:R9_276
MJDIA*^85,FU53:U&0FM";WX%M&.7SUM;$[31FMC.=Y?GOYYO@7A_88SK_0U(
M,=W3'W[DFSNG8'.XA(V/D,\D>O-44I&F98[TN C;V+]K!SU;'U./=W:<ZT:=
M#^I6)V?79#B.QN8["TAX)'$#^L'GBV4JQ;D1D'[K7;RS.3D)CP\M9VFT5H(.
M%NPP]7HBEZS*.NLN.3?*(O4L*+,MJI/3:G+2GV\S6<LV6_P<>M3 @#?NH54%
MF41Z ^6^ 6>K^7$C1/RU%L')6R&992&5S(%1M;Y&4R= L5.B$Q72)+=CA5/0
MDWS*7;O(?XRQS\-C;GEP<2/7UN/0JIR]I 3X<5MI2:415>S XKC1G37R#%UU
M4PMM@<_^>A\>G9VIY1CS1-X6TK/*!^KP?*XM4?R<-HTCZ<D%H?J1V-ZTXX ;
MJ^<W;E=N+TLG&/.RN-H'WH% @U0;( WRMOY8#19A8*4"#/^N>M=.S4VH5R#)
MD-*+U=<4?6RL4? U!NT^#%R>X/^XIX7*7UE!DCQ"9^H"[2K09RTY1^#G^/#H
M9.^.&I\OJN/Q---?4L1#<BB]'5>V=N=,8M71/(0&R%U="$GOJ[;T/<:GN3OQ
MU::MDKX?,^J"9PJ_TV12Y>1E(.D_GV<"'L*9F*!)8'\_^-X&U/W<SWE]%Z,K
M(DSQI4 ])=&#.>?@WGA>3C[%:"N3T>%J$S%4.;RD92NT',3ZL9'(9!=#>KJ+
M(>UB2%\9[W@^'.]XWA?O.#W\?KMCW(N)R)"%QYA7V'4!Z!KR!MZAX"YW!+ C
MO1A@ ,AX4PFAI-=-9V ^A=[F(HN2R1S2NC=3+E<_/7ZE+1XU\=CZ+BEPW/'"
M)-4JB@)Y?A\C']WFT[SB\BN^#=9DD0G2*^KIU>VZI6V%*VXVVDJNM'G0AUO2
MF<Z931%J=:*71G?/M*'[[U&^IXD9?;BQ+/UZM:Y;ZZUT*;5"/X!'N7M\[L:C
M=YR$A^"]]A?:1OZG^[G[O0E5*+(#J2S;6F"95NFT_,S='6(*Y?QFC^IVB&F,
M,C$4#4DD&N)]HE95MD>+UD2MXAR7#>;AH!'XQIA[O^U9F"^EG@)MO+IL ^Z%
MX%=LO5<7"F).2K"3/-QF$VHE; 3R9,A7RAD=B8])'J=S&ZC'ND]R!12&X*#[
M$2[\1 ]&'9.!:5 Y>9WTX7*^3<SZZ'!8B>MGK;K1H^=?R1!R-,00TJ_%=\5,
M=]ANSW:VV\YV>W#C1[NKFFN)X[*FE7LW9DY=/M6;G*_9ZTLGY+PYO4=QT5&@
M?8OZ(85NI^H*=A@DVD2\.0V"VM2/]*KO"_GWP<Y'"8CJV4KIO59[T@148N&U
M>+>X(K1!-3-#1,'Y]:&0]":+IBB %7=?CLM*,)CM!I;A$I+XGB[F0?*7\A8S
M'DG_8FO\T)-MT\YP@8>1FDJ!@860^U;ZB-4"EVE5QJX\Q_,4HL!V2&O'LC@C
MHV:.:?'@\SGN'[.,@C'M9C+I39E/-YI"!HB#0(,3+3%]0ZUN)QCM@_,U;,NV
MX'V;._IHPQU]U'M'/SO\U_2TWGC5T-(Q2@5KU(3M,]3I[]QI*,QI&]UP$90(
MU:0A:7(/1.E1;_1]2NVV>X*9 T?5Z4!GP4FC$"N"5O[]Z83;GFE ?)))'^=Y
MNJS=<SP+HU-EU;3M;=E\I6VG+$^=VL=*0XYV7)QQ7^[K=008(U/]_.GSIY=!
MJR@03)A5PPLM/-UI/T^Z >BCI:CDC%>8^\JO_#2GYO"Y:C@4!U;@\IW8*71R
M<'JS &D[SS[W4;,@[@_O@3GF==;>>0P-"I/7W*YO0>'29LG4!?,9<_7,VX//
M<D)@DN@IP;?;FQM<8MR!*WET_NYR+UED*Z<@N !L928*<G<TOM,HJ7O<0C*#
M96$[U7TD_MJ_@RF44($L=PP9<,9',=T?E(H:/;APAZ;3['\:9CQ29X^%V0U1
MR!2%ERJ6LE$[7]YY@5Z95AP0LG:72KI6U.J5<:+=&\V:C)B-A+9JYO2$$-A+
MKVKOTNII!6K9"(0[>^Z"=.83NNSE-?>9;/!0SX@?,>K[_E$Z)G!B%EX::&X^
MGD >FV@(?Z!:$L9%N6%$UMR)WTS 8O*V[>1]2VYN<(;UH=*%GJ;<_C+?\D05
MU+13>I3'='?5(>.N?8--1J,ZG\/;3^$ZI]"5S2X$\*]6V)A6![,AS 6CPIG@
M'(FP]K(?F%<:!,'( [ZS%BH$CVZ?@Q8T)RAB1ILS]8EVMJ!K0W,NO+>ZIP-S
M")6[7?.2RI!"04AL#D<+BAR3(.=Y0&KVI-28-H*NMY2K$6\O_&PX]2AF'^VL
MHV;I@7M/5(U8A>XZ6$G+->:MC;G/L==T"GCCG&E:U@TNU>V7?*3<]\?42)>X
MH=QZ&/&>7,/&G2IBY6T*WH1?LG4+L$V"10>HUNNXK]\2;9@"!#:D97TG>=14
MA:H*.B6VQ 'BWM0"%8=;YI^H56AF:ZD;"B1OU"\17([6M4(&\LAW:+9=O.?Y
M+MZSB_=\K0]YO,&'/.[U(1]_99QWVWW(,W?#[ ]$66)31'R=%NN?T;0^"(-V
MV_!AVG4[)G#0=KIBP,K9GKGX'[W84TVL:M>\\"_'SX^%6$SS"*+5W://3D^.
M^$/GS7R;:,3)!DDZZ94DIV+^;>O%?T77Q.1]A5M2\'L4]XHDC4-K? T&R%QL
M$?!&-V[*UV7M_J]:"T$R_68\088J@^>)HO#)G*HK7Z0_0'0CK*4-[QTD'VBH
M,KX2M_,TS<E7=E=$7J^J'A,=<4T:'L?YIAY 1T'*?()(GA:A 8+H3@Y,NHN7
M_[UA*&PM>#G&G[?<U(MC'#TF'D<DI BW=UL?_<?5ZJ?CT^0:W>GW?(FGV6"L
M+E4TJP10\'91-DK@9->2$]<4]HW#N[[^.<1UD5EU^PL;E-01S._>H&M ,431
M-3<.IS&K$AY%2)7:\$E8D>B';/Y?5>4MWAK6HC.Q7B'Z^<7;)R1)0R+4M7(1
MTJ?(,#T,,2>39XX"(>-Y64[WV>,8IU65 S)A-A8 "[^[?^*&LC(/<7W\AF^"
M3>;S**'87.QM?>GB]A]*>C!QVM:!%IS=0:NT5A2W:"VI$:)U5):.8U9DB7NT
MDF)@4I2,(2R'Q":]HSDCHD_OZTNDLB\"NEI7SKHO^HICFMKR6U7N-N=@+7N?
M.V]CT-LX/MQY&SMOXVMMQ UM9X[Z^\X\_S?F%&(;\4VG8O_K[PV4P]JLL$+5
M[W>?D.:]36M$3KV)F+S-?,NJ&Z?3&"-.YIZY.2)+E,U/9Q^ASG.VBNYL&B!N
MHO^EM\U;/$IHJ3.:L)1*DN8_/5Q<_?#IJN6A@93_L?_ Y!^V/4(>64J4V_=W
M<W^\<.AFYTRA3Z[@45H=T/(*P@NBVY_L;K]%8@M$# YI-T;<CD6'1],&>OY]
M=_5/./MYW5/8Y7/IOL@BSI7$(<Q[!QY']X@\^C?&*;UOE,#?T)OAJ+\YP_.G
M_[[J\/]-/D0"_0_(<<M+^%>1OAU"\GXV[-'.AMW9L%M88'_>4T:WY08+$LYO
MWKTTM%":7)Z@JW3@A_O;P240[B6GBE^BON$L#B8^>OWR; ^8B[^F18.H^9,1
M4 +'(V^F7ES#C3\*L"VG9MW_XFWN#ZL\9JV&5_\_[D$KKIK&HSA!KH_A7^<"
M$LR*_7DZSISZ)DN)-91;SF:ZCA/W=:UY^SJ=9>C!O2KG[OK@6,?(Y]\_Y42Z
MH>3.V3P'M($J)E&[L%":[$Z"X8XKQ^<#@H5/EUC(&5LS;,OE!YPPW]U^","K
MRGRED]V@3<8%-SFWSTJG-[ "IC\(" 4T+>WM%<;]/_PC+=_;'8B6(6 38$5*
MLQT#MPZ25^Z.IF!O"]BV:-R1HF?)"H#:_4XT7N+[I3W;/SY*B((S&$(M(.&L
M=+;:+29ZI$$YK1;CY4I.J@VH-B*6S;CO^TTN9)(?+HY?ANK_#'SJ\[R^SJ;6
MHT)Z)+QICE H=M*= M8IT[Q&5H.KAV?@TD&ZACH!UXRK!BL#%3?/V(D+?2%4
M+B]^&76%C\1784N"=U^SHKKKG<(34?_8DJD!P:3/NO0EK1_/2X;>#PLF;T31
M:\S&._\H.[@ZD #"GOYN.BBKO#I?-YX6^*4?BQ1*T7A@/SNCXK_O,;"MQQ=!
MC0I/1EFM PNJ2@B*Q>J&O7;4J?E+UZWU=0\<<4""!.,_GV=S_EY+05CM>,<.
MD+;=X Q](Y=[0[>>H_YV/8<G_YIXA]])DQ!Y3NG;A[AA-$M"50I)>&!V0$_Y
M<BRY+5\OV;J["TGI 'OL(=)NB4^VP [Y*FJP9\]_3,Z*F/PKJ!KF4[-2W69F
MW>)I?]\D7V\MWU:TYB/?R]FWV%&R98*2:Y"E9$X^=!DT=%2I<#T!/9FQ)1@U
MKATW7#Q C5\L3E$^5]"[7E=:F)(7-VD-4!%""NBCZ)3J=)IQ/^RLF);NMJ$S
MQ%1DJ%+.J'WL1!KZ5.C!4LO)NZ4$.W<VE,$?).>A@8JR"+:D<4-&E&BV/$($
M)O&XG/J*>9@K''I/P#$%J%3+8C94P.[!2CAH;5^IKXOJW+7$'01,Z>03K7;
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M8.1'4I0K)G%L.&[F[O<,+70R<V7WOR"Y+1NGPL99&*\[DJVI</">&/W0+5L
M_+ 2YY[Q[Q:I>CR*TM%BV;#: H[.&#4Z'"DST H$-ZJJ;%9L@CJ#:)\4!F=M
MW%T.:Q_"M:R@LB8< _CYUXL1JVU&1VB$++0B#%$2Y@A!K_*.@^\N3E5S7D5>
MES07/]I@Z9&J15Z< 744>_>(T1EC&^I0QM43\TBI@@L/T8;SI8]_F&B)CSJ0
MN#^*$7%]^G- =^Z1TN6>&3[(PF(8UMDM9=]*2II,UI#%?*G5N"I^N 7\TG)&
M0U8!/Y_G,_U[_RKG@9> F 2V//;F#.&_-O.UM%G0-;A"?P(WS==(5GVL4''#
M9Y[-8[=:$=ZUTU4A=9;.JAWFL59AU(0J(+"BU)M4@$?&8C>KX[_=5[\>TFO.
M_RLM'23W*RFU19B3ME5>SYSTXEB:N2S%(/T]HY8D9)346?8I>8&0B#8?^"@V
MN%TD<RIW,:C!&-3C70QJ%X/:UJK>T^<G)S\F9^W&+1O*=. 3?3A[S21?R9M1
M(K3"1"\<'-PMOQ3>]W8F3KGULE.F-$6M(X*2^^W)X>$K0^=PSM/?DXZ[W-'6
M?QQC46@&N)W=VL6%$_0:@Z*6I_**ZC_>[(5&7?(V^.+4B,^I;6E)I4.47X6Q
M^(Q-:/+L;D,/#B9V!V?:NC6UU4C!7D&5J]8DF4I/4Y?$7AW0,H8%L7\J?<W'
MHMIA'8MX\AZ[0J4^T0W;[J$6=Z&&])*(\K*W%MHSVY63"4 JG8R-;\-3*Z-,
MBPD#_3(Y,!)6BCWKI"E"'S5W1;8*NJ3VUTTGKP1?VVTO?::_$3GTM<G %Z.-
M-1[1%+=LP_1W<-3QX5+7G]#[?)XJ-$>#+;>@RS(M)FCT]DU<\.,-K92/>ULI
M/W[RY-^7Y9$.36A%U)'B SU6(SKZ(PH<I4 (U<1E#CA[13B.(OEP=KEOFX$O
MX,M6XHIW.XA3KU7R8W.HLL+_%6D(YWBZAPJ"^=';LXM?]N354JYW[4R7@U@!
MX.BWSB#_)*BR_I$RSGG?_!N1+2Z9(!X#S,"?P*B:LD=KB2GOQDV#X<;F9D&C
M DSZ"BG5_=#TS![&M/+(R"ST0O$/=AJB7PGNK.5A:_G)SEK>6<L/;QXVE1SD
MOCZ+@OF$[3SJ%,#?:4IW&MJUJ73HQ>>;S6MC-#D3@]%?3)?"=@GZ,:*[\W!3
M[E9#:6U<@4EI9!#9+B*V6XA&)-6("M.91AJX_XF:C]*2PPVW:ZY%W3-:-NI
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M;AFW9LS#M<548.>+@6QG+S[)=!3<H9ME4]"+CJ@FD],7\Q*6Z!R'HM, 2/.
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M\G#MFS6-@"(6TV4:TG0,$V@_.E[KQ/T:U6D95S OW0^%FD%!B77C]H%K^/%
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M4X8)^?)_"QR2H76F ,]WO6'\GDB'OG>;WH7O[%@PUOB%JRM%QMH7.V0(E7.
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M. VVIDWE+ 2,GE $P29:H=*:?]:NL'T#N>/YG&^41JX\HB!@WL_C.X6VD:9
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ML\FDIJ*-&\4H0[>(GG<O#C-0Z1/-Z[TI30&U9)N737Z;\JI(*V634)EJ75
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M@3] GHA-'$T+TMH"+(R#*MT@WC<89ZI]/>9'P,0(EBJC[$CKT[%(B4NQR=^
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M3.KGT'Y%"8=Q"IUHT-"<D5$B\*OT6?3I3^.93U53E&37ZWQ./A:9&U%4'3M
MB>6/0L;ALR4C,/6^<]=U':O37([R^?F=J:&%N+RF";Y\]5\OGY^<?1L&-'B
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M9&2$$K)7TF^*81G._-&9_W<Z\T8\DAKP6$I[ (X]8UXILD21I+O5OF);Z"&
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M)C*P'];YXOWL>4GB-G30$.I5OG4KTCBT:Y%'RW@[Q?J1FM)$6X])R.M;$1E
M>Z[L&9*E#TX_] R$_)SCD?!0M23B5/TOBWW(.'AB58RP,8B'HE0V5#7W]@L>
MR?FN7,/[K/1(4'19\KQ'-L4#Y:*GQW+1L5STV:WL!2SGS\ F"R VXS!S.?OF
MFQF)O)\ RN@V]?FW:FVC98)/_?KZ]/EI,$SD'0LPP&D L2-[+95M$AB;<[5H
MY":25D^>BS1EPG9 E"1,#@:K=@91]?+R9=@6%&HSRXJ3;)DW]7N8*L#G%541
MC94\J9H<.H1." ^3;]OB._W']Z20N\[WWY451A5?^EXF5>P4[44B6R&/06P.
M5AS_.6[3TR>\5;LF_/]2[RQ_/L6?ONB6P[]]_?3TVR?3?WYR>C;YMT.7/3L[
M_?+S7O8+C 2/1AAPFI;_\Q]/_Z,W)[1UPLZ9A1.@7,YTKPC!<_C+A]E9:O I
MUNU/",_%[[[[[MI\3YC=^>S9$Z/'UE$YOO#_KU_XCK7],%[NR5V!!=[N1[&I
M]YC0 Z_%;MB#>K%?W_YKKX1$_X-ZH\N\RI?YQRS$>8A>0K 17*(3><C%HBB"
M-^;VYMD#W9O],1G?G&\FO(?[V*??>W ^ZR88'YZOGDT.Q/GO.!!/9@]L XV/
MQOGXV?5[K@<,Q)/[#\-OV\4K_-\?:J->)*[\;]J>=[_U ]R!3Y_\IATX\JY_
MD$TF<B<?N=7&Y_;?LYO2;2YQ7[K3_U!;[5W=Y>O?X0 <'XE):_@'VYC?_!Y'
MX[\R1'^0_?RO'9K_XAKZ[0;@"R1S'FS.[A=0.O<S< 3Y:0JI=W+N?YV'P9KM
M*BZ0-(G0A?1W$1(IO)3R(&I=FQ19(WLR[L3)^?";ZW(KU8I^;0*=B_6#[V]+
M"S-E[-04^N[%;HWZ(_ANP(9,;,J$@!9 %DKFK: %[?O,G4IUR=6:*45+KH?$
M]JI8NT*F>4N$SO0)H+I(,P1WIG\!8G5=KO.*"LI;="H1W +$HIB<5;W8 7S/
MSPC=D"8\(GJFR%4JKDI1TD!Q&(G+><T^E.+?B;>\H?IUVLL6JV.9EL9\R4GO
M*$4Q:L%5()HBE))1E/$R,M)\_2 @2W>5'X7+BMKJ/Y0;;C=^]O1/NO4(QWY=
M-F"-(2UHJC9C6OTNC K>KJ7MMMX44D#,49XDD&-'$M>SX.@*XA!H_6%N/GV<
MK\[_I,AUJ7S^[Q;3#30A+Z,OO_[3T%J ?*K*KPKT^%$;,S$/+YGOG0'*JV*3
M$^G"/1[C_"N[1>_FYV>_[>8\,"38HD,C%#]8>0_=PE#EH]TM%M*\Z8&6T.8+
MRR1G'"$K[E2FP4PS2578DWDAC8*]BNJ%9T&Z9:1G8K^X&,Q%W40<2HN[L!X*
M?>B=(8R2"-_'L)0FR<*O NL(.B.&,T82^VP6;-X'8#S >T.T>!48J ]7E^.>
ML)*T[VU- ,2$NRD6P<P0^1#><P\:*-B;;9$+96O)]U?4DZB&X*J,_T<G"_-S
MY+>Y].# 1 ++%3Y7AIVTZ'0D#!<;Y^5[_IP4VK67\WK?&O./H$3E[>=[ASKO
MZEH.@4:A&-#=*=9;;OD,MR>>9J@V$ HXMQ*_7(Z9PAD#42W")8AUD*MC2N#-
MGR18:1B>TC@K\-C</;6XKHFC"\J*$:'C!S:<+\$S$E'%LG%35(.95WY=%<72
MEH[\9 VNNH[0V^.%YM$N6UT!AGWYZK]>/C\Y^W:&[NA-N<#*]OBL1$+B.J^N
ME-KLMHBJVTO6LQ(0T9Q:9E6V?+"1,D\%P@#KS4:!%P9BORT$]EQX"F??0.;:
M!!+H&?R"V'C,4,Y-'9^$N*+D/"8$4]R#6(E8D]>U-,FLBY0\R#5=R?[>%'EK
MK"7Q6@)W41)^K,YPW^#0%+C/0[>CSE U]9R(_CR.A;$INB@C0D7VDB[1N"1[
MIM1UFZ'=.5_GK'/-"#6[H"(DMS70/MCA%8'%EF6[:-"236#.>5WMF,:Y(_GY
MG$ ^M,YF7SXY>_3^\>QU<.8RV9A0-6-7,LP;\.;Z(IGM<BP:WEEF75LED2,V
MO%T%28R\7"KEY"KC';<'?%A6K7T92ZM=7!?+'8Y<<H"ON.]R.!PXM)HZ7YXP
MLX'ZO_1:SH*KP[=#BQU!!#O[L'Q3FN6Q7VZ$(<YZ##!?#FAED*K88U05ZX>S
M4,<A=C\: /;!/.CDCEI3.V18EC+H^X0(O^?695]]_<VL_>\=+==5P?1+-3&I
MTTJD$U<Q:B(Y O8I^K-K[@/ @KRZ;O:J(A!S,*]ONQ!HAN#B,M_,FW)Y%3[_
M\\4L^-M?"A\;/R04F[C%^&)W1?M?L-[?9+[?D32]M[IN68H)&Y\OPO(,-TFO
M*FC!X B!2%^&)'GYLV^R,&03+T_;REEO'HOP@E\^?3)[D8?G//\V+'9]2YJ[
M_S?LO?BOV=F3)V?/)EX5_0-/G]"+/CW_75[TX2]*:4T7!X6"9D$6.V@Y;*:V
M[.G"T\]Y+P2NF1#\N[%0*8>RVW5%G+.$0[0)(QD^#+!R0=2E2I24W^0A&L<5
M6]Q,L@4+]&(LE3Q%H,N18T6.G=@]=01%'@!%?GD$11Y!D9_]-/\;.&_ UU.0
ML_70#_4?T>A 'B %5MQ:K]0-H)P6'F%D)-?]EYN1]I[KVV9&07#/[IJVZ"<P
M-"'47:L>)?T[G/,7[!2_ 9DBG@#A&"BSI-FRJ]$P13YD 2I\,IETWB(1Q$\6
M?NS0W-UP[VR4*6/;VG\WO7+OZTR_"][,Z?>*W:_2KTEF4ZRV18#+FM\A>*7D
MX72JMR5Y3GM\Z:_5[$'-R=^8/E#S/-552R^<M]=H$'](7;7C>^32DMJ.RO/!
M//.DGX$E2<\K) S5[&]_NZ058MV$8"+F=%4JAIU;(E^XMMZ2RI5^YYGC3_!\
M,$Q(&7YX'LYQK/OXN8KRQA=O7[Q#8Z6(/X7%^+):G,Y>Q0;,<Z:IP\KG[,>2
M<P@Y;_FTH#%VK<1#+SX4BQWSX,&;9<_J(]UT#BWI*8*W7&ROJ28ED.Y@"YZ=
M?7UR_M7YR9-OOOP&;C8V"]&9D@=6+DN)M*>??/:((6N/\0:^MS*A22DK&1IZ
MF@-7>ZN9P\LXAW=<]-L_@-O,:03M^RV"'WM%EIR:A#J3ZE1BI#Q*HHE)_,MN
MLVT[(EBE%?*#IJC?TJ]VVQ;$+F'I4J\B9E'$"3:B.C9Q/R^YFP?/ 2C_[R!I
MQ;N#N.SR?50':Q<2J4":T;4,7*MV6%Y5R/S3;G#DMI$/CYFNN"%YNYNO22B8
MTIR0OI;A>?GZE?9$9Y!F]'D^7J"$?M#L3G@I8L-CCA=PU'8(M+K9_SP[??+U
M;*Y<2Z1-M4BO1O,2Z:HH?.#V2632UP4O,^*,:(P>JLA%W55$QTAQUPY?;OB6
MS!+GJ%O6V9WOD4K,PTY>EZ#2*CXL$ O]SZ^IL\#X:W+']$V"7Q)E4I$ XHXJ
MKI5J3.O(",5,I->F,= AH%<']SV;2^2:EL6\\V+"(AM,I-Q>:/KA[+&)Q(X=
MWYZQF@;L;7&U8:_V@;S ="G*BU/&ES!.+SV0PI)Z26VT9]Q(ZPPBU0C"',_W
M3F]<<OAML8A[L.\%SD1&1#:@4#D+R@OW^D9^B.., Y-;Q#',I '%!&5A[Q/S
MU*G:LW=B!=B)I'IB"YY4SU32>O9P3)A1/6]W#;/9)<(=7I"$F5/>HQ#'UPS_
M4HXE:7"ZC#867<ETD1T)1W!]ON0]G?0FK43VSXD_2^8^>)=E8;E2X2@565LV
MW MZL.#>+JG5%#-2AXFB3[;,U)H+]H,X1-L.BNF;7:>IA[<%-9>'#7ZN*5["
M>!"$AL]^8LJ!9=+9:.-L2!I<#H_^5#-5S]1*NY*&UY1RACK]IY?&U_+#SYA:
M>@8;Y.?AR-@Q!Q;-T465K_=MB9F,"^DR"LN&S[R)/O<K6Q^ZDL87KSHX]Q\B
M+NH)6V#=%6[0BG5;<*UM?/@>C!D9MX,7EO[ZX[C[Y-.\I&Q61>KFRV4CY??;
MV]O3.;F*2_84.^<HG@:#POYR,CW(RX8%'HSCDY._9K/_#'YYN'#8F"-__\_@
M,$M6LO_7;^C+L>A=?+@NYR7KFM<?%%P4-TYO:44.OZA?W,@=F("*MN"NJ9C3
M/ABX=D<5T_#AM]JH??8T^%C9C#1:Z))G7SU:/K98A9UDRK6^^,"!AKJ 9]\^
M_1(U4Z&K,.(3_\&,_5%;*IX+0WTPR$P3J]'_RC?;[VFJ;1="A"&F3&^+.0J5
M8$TC\JYK]J""C:W9G[%D+977R?HQ60HKBMP*ZTZ4!J<A8@HFB]G)SF9NU&:0
MAN9TP-L7EZ?)J2\1O3Z74)%1_F'"@%"JH]I;"A@MJVT<8_+8*/^RJ\#RK?0M
MHOQT^/B-0959&/]LMMK'; UA)D'D(30^HGE,>3^FP+![O$("@Y_2V!3#N"AC
M%>-"HMR6_MT,-;:?7!^LD2]L2F877A)#U:2ZV777;;_[X@O:I&&L3J_J&Z)2
M3,PLZ:NS^K(-[G!8_3XC#805T?(WRY-U7;]GC)Q=CQC?$OYMTL(#[\](IJLP
M#IOH\<,1TNO-8N5?)+!=$BFXT1L@.^!T=<03@;<($<M5KI6=W=;J";@E[?/T
M<2.-CBP>B3D\3VNX95LS#/1V^G@YUAR^FJXYT..7R__S'W<GO,_/_^-8J'@P
MS_)_2Z&"P[6+T]F;LGT_^Y'Y C^_5S;)!3CNIUT&R[7:K0UN+KX/TS82IARA
MCL2;,3O4T#NS1"F,?8)>0<(?!V[B3Q4(_[KKB8.1_2_YHI.9$J09' A_#N*V
MI%&Z4P%,"P@M>HAU$_9]I-(RR.HXK4=B$!8:#5J6]**L?5;%I%DR#(HI5][0
MDJ/!'2-H%^%H)*+P)/8R_LY1YD^%)XZ4*18Z+>I$K?E=^_2B*F8W]7SA( P+
M$N)9C"UO%TTYAU#SFBB.I'1$"+YJ:7FTX#'GN];4Z?13C":DEX6X44'K@J#+
ML?@_]1C, P:X=OCZ^ZJ^Y2.X-30H)=W9G4<<#H"F.9 @5B4("55]RN9W&N33
MV:50>"?Q]^B2Y7K&A&MS.GLMV!9Z1HJW?<[&9%[%.7\K4BO($+RQH/U'N?S?
MY/(Q0Z.IF,]O<@Z:R3>8^QYA<2\EPR FDQ]?(MQ_ +;T@.4\=!@/7ME4?<8:
MW1_>23$^D5+Q"(9FC]+"7BVIG\QBM4)$K/8!F)\<P$UL8*4'E'!.!R8\"\&H
MAVL@F_WP_-W_<W+VU=.ON,J$G[[Y%B99_.Z=0(9JEH%?%/$[F7UA-!X<WL^"
MJ;$I"V9\#L/@V ]-^!'6;=TI@BT"FPC#'5\B/,9'/A)"9*+;:TKD?CT<>QG6
MV![6B3FUVSH]:@Q!Y<X+XE*D\^'S+\#[%-CNM=Q.9S\[=/?(K&(I=C06))[1
M%&.S*T2P)'H"^DSPP9*H,F==KT'DJ/)4')[G4>B5":B[N(:C2$@?S,#4B3PU
M\ ^8 Y.6 A"#&5&@L\ %$W1BUQ R^:;$*<OG"+>XP'>;>AOT7^QP[,75:%HC
M8[L$CE/%[0]U4]RU-GNJ(9B>9G>5/(A!N0GJ2@AP4#H.#P'AAT=3G6J$V^@A
MM]6VM-C)-2A:3L-)W])>9#.;>MM XT5R^;-MO34)Q<NQZ_>5H)T :]X.%,I1
MDR D++6*!'>+/,:YBK^*D*7QUJKPP8_/+P O$:>"AU)IS;TE"4MH4>**H'P5
MI$UJ2,;7-SM[O::GD6W@EQ,\<DA4>C]>DS:)F_O=O6S%,TIB<!?P";76?W?V
MC68:2AC][T[H-Y_)G,!9>F;.TF=P&-*Q^?+T["L:#+^-DZ*ZMU)MMR,!N.^/
M\_#)YL$+.+_\Y7DD@ WVJD+QKZ?JC+PU\,:]OQQGZ=/-$ME2RGMOH:VHEJ[;
MA;/J1&UZ<JY(,_;^."G_%A.F??)LPHX;XW/,@?H^146"KUHKX<Y@?\ <9^=S
MS,Y]G%Z</:3Z;$P?0U_N.%V?<+K0UYN%>(#0@A+C(9XBR*[(6U(^VGD)8YF$
MG#.$U##;LH^]UP28! 7H6AH)!43[:M^+*-1).4[^IYO\X'87Y;9CG97^P!^<
M<.2\JOW4GJ8^$:<J,S+=1Q?_D\XL,-'4MXG)I9FRBOTV3-+)<+H=N5"KDB['
MZ?M,T\>Y5TP/H*&E-4Y37Y!DO#I(1K4%40/T"4S<E!4?4E*DXQG[[YY-@?;F
M34, MDT$WD(?\(0;RZ+0%;15* _>4F=QV5Z#TB/1P5KD6SZKT=Q"LSJO.Y?(
M%P]8DFG@CUF+[NSX]",/2V9B(J&L:;_C,OETRR29;U+^:C-_+%/M6A4=:9O[
M-2 \ ;MJ<2UJV#;U^7HP[SK;Q#-35#:WE'\ND+'-UY(7#\&4HW.C9@UXZ2#R
M."Z%3YBA&^1][IHZ8GX24#^C2C6?KWQ#*O$:+<XVW]<'I_$(V7N6CLV1)N#_
M7O3=T9#]IC,-$"TF @6E%LZR>(I(G]&,6R..4<5GBBK\L0#R7D*H,-A.:'":
MHMS,B<Z W-=[X;".<_3;8H4X*[G3+!:/ -1L3,4G>;F^@^ 0FS&%%J;R.&6?
M:LH$4J @!H*]$%!"<%HBG9YQ0U#>&I$4M6$:T=]6""D=@2BTUYU3%WD52L;W
M7N6LVDZ.2+Y:,9&)5M'1G,,-4IS3?52<7IT>9L-\_'": R=[C!OIAYI=[7*B
M^RNBV&^$N,+.,91)1WL$8C"39$B]+4"16:Q[=:($.)2@V11JUNXH2XX2%+6Y
M3B/FTM0V)]$$G;0"75A8&V-8EU^**Y85U'<30H414.FZR)=CX7N"'%XPZ9D#
M<QUX:,T63:/U1!Z1DO]KO"2=[*C *8<-,T9".IK0/HM\UQ);Y#J, $$/)[&)
M]-3,\ABBWA4:Q:BVM]1&+@YRV!?<XP@K%M=56(=7>X(Q=(3%SWI9$W 1M>U
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MY]KKHJHEV>U'>U:O)4NV6S.6[26IQW>=;R )%F&1 !L@JLS^]3=C1T1F))!
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MEE$F,6H(QV^B-[*5(,=CWC//>DO&#2!TQ(Q;L"CSQ>1\7GO828)$*\A%;$O
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M==D9X(UDC&LW-1?<<4!D1%B=9E+D4T'9A48N =@(Z[N41LPI6 =AOK5@&1Y
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MXY/\!(B/AS?)W#-V>!,Z?VK_6THB+VM"HE#1*)-@PX?JO+SW]:YP+TPVR9G
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MZ<VR_TIX+6UK4[\!W@TY49"XA5:.J;@''M'4D_N_)AY3M!+3, )[$;:^.UF
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M@3L6-AOF8EL3'VG3<-,>Y!H$NVNS\_7.]@6-+.FOYFE\J&GTA($WSG_DXFM
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M[#(X2+#L:F(%2AT;@HN(RS!&RY8TPZ+]%.T>( L[8+SN3.!@*6C8#<##,:;
MPQ+\>U9US%+EST]#O]TF? M#BSHJ09Z+'X$/RK6$K#-6\DTLX=Z0J5[8L'@E
MTB^[77TSE[(>5O$A+-F8("E!CC2GR!YL&@SW7RR$HTPP"?X8S;'V1#;F27JH
M20(;P&]A+IG+#A_$@!55XXX,U5^<M\>';MM#FO*Z\#D(^![I:0@-P*K+>LTJ
MK0S=B5KKU>VD9!-![;0]\% ?)&Z<ZWH?9H/UO'06,B!_85VJ_>.3BS"QW,\M
MR:ZY(OLH=3?/=Y-L6V)F9*Z^@ ]L9K7YP#/D<2=E+$L]+KS$^.;W$PAF80DU
MM!*-X!&].T\D$J<^M41TSWG2'UI=26L(ILCI"Z*$9VWRM3L<BU7#H-NCM&W4
MD:!:\:L+F%L"5)QFS."C3.8N[ZI5?_O>"F,0,5HT$(0"RDQ <2:3&@=Y3"!X
MUTE<GCSG6(:O[HE07-)]716X@H*I/N2GF?7K8<]94'9!VUH)M)3OJ!9^4.'8
MFF?A,0X^NQO*JNT:[#T <2GWCS*U5DXCNI]YNC[ =/7!5[> J2SNBO%4,_'.
MP\Z4W4JYZ3LRB %)K!B*Y_2Q%JHN/E \^U(KU[^E@N<A&+$TGWO;-E"'$,^0
MLL+N*<'>!"Q%QHWO!#.]E2<D)V*Q,3ZU.W)Z< 42]^M5N7N">-%K*L8U'=B/
MA@(1A\C2\H^81G_;!CYC&D<QC7^>,8TSIO$,,4D!#@1[*#M<-9TIK-PPDR,^
M$R XYKSWZ,'?8EX8/=>W+Y%P&>3"%>CG[I]45QV''>:WJW:FD$/E_I#36SW>
M^?V__GKVA^F/XTR+PIVL]"Y]O5_WY[(9MK;V42X]F >^0J=KIM!:V_139%[6
M0NM!:!^IF_7[HCC@T[N<^M[II]8M5-83\\IQ4%H]0E@,S;K[FI^!4C19KY?(
MK0]J$\]9W14_HD %_*;"<IMB*W!>@UL431FEB^>8TNX=MSQ7Y13AZ?(4:009
MYEW:F;B>IRZ]7'P=R=/U #JW\MCL.P*:C8&"/[2*W>)G27M!M=>6#B.>F4"1
MW2\E8J<SRX"Q= %TY:E4M#T0"@Y^1=.DJ4=TU>3<D!+@6O0G%3=4U+'J^U@?
M4VA>=B#Y=E^L]VXRUO+>GPSKGX/G!(B*1/M:KPMG_,]>#<>LC[H[@I9<7/IX
M:>G&M.*2@/:43(S #.-(49&7>?;6Z6VQXII($INZ:VN=*Y'$(14ND&BP8#@D
MU1BUN"12.4 /B84AR5/M)BD3VA$2CE%D5/Q9]Y.69I:G3!;QKKC. [+9SMCI
M<O%MU]!Z'SO>K'ON\U:9DN5A/^WK=2%ZA?X37!@RS$H ?9(_U)9L5"!6ZJOH
MELJ>= A^=2M "TQB;UP,XE[33107=@UY4T$&7((%G]1)]!<8*D60[Y DFLF3
M=^WY"]>^XS#9(QLGF2"SA0MPMN-6/E\V=4YBY6UH"^&II080@S-%<GE</<P*
MFIDN#%)';>41*?R7>!;'< XMT%,/_6LX8G)HA1;,73\"R3R>B/."@8*_:BJ[
M<@MN=SQ-Y!3*ZKK>71-H^P71>O&AEE@NAWI7XIA<\][J(X/)&M9K(0>3HY'/
MC:)R#ZRX!#-P[E6/G6#0PWG-K1/F*L,6<O)QB]Q%YBSD1_/XZH>7V>('$8,+
MS$2V?Q$#U&:&IBRXU[$5IL?Y)=B4O+*783RM>A-W]@MXRUMJ+V(S: HE0(^>
M0-=T..,V]+QH8J&L$?P(^VIB7URP198#Q@!P=FH\8K%9P_2#MFQ[C$[K V<1
ME#T2QF-W)+&H5DJK92((SHIP[-"X15SNN&L'N9(L>6AX?#>Q)6)IS"CD1VD<
MIN4>*V7>HGF'U5BV^553%,'1X6 "82Y9*7#*67#]0-PU3#?]>>"G,DF47)46
M2^SWFN_\Z=FMW_KBR[E@<?:K: ;U/OI,ILBA[R&<>:\%P$A4#@/\\4)^%"4>
M%(DJ/C;MY/((L?)#W>+,69OS,?<=CBEH)*[9E4=](<^-B[/HT( #=P:W?G"3
MH3D'KQP7_&P-Q?9%P<'BC@P!@,ITJM"L1J2SJZ'.\+W7HW6=YJE_1!O#=F'@
M>8J&;1MK=+'/*DJZ2,K@B6 MI/9*:G+S9OYCG/_0GW(!2O =$><@+9GHC%O4
M \=RGNB'G6C,!Z$CF8F;F:0&!/)WR+'%_+16;CW.'KIW_X$7E\2GYJ^-R>>F
M@LQD0@BTSVUQ0UG?>;6<H5G0_(& .QG-.2)HB'2#SP2K^F,2BR]*D-)X[J4@
M(XC^B.SC#*3Z .JP@VQDG#O\S8$&+:E8GX SD(Q&$AA20]GY1K,1@52!K-UH
MAFV&Z4S =#Z;83HS3.?1RTBQN@DK%;QV!N'99ZQ/D'F;XMP22BP<*5U@M%F(
MI9B0T4;-G@H53.MA&!0YH2T]!YXORQ145/KGQ8___>KEQ=,O%VXT7-Q#^8EJ
M00_.!Q0%+IU[V<7&^<6'HD'IE +<J]JY5D8?IE]#3Z$*Z6):R3_D*T%TJZ'%
M"U'Y.>3T0<,-S:>0GKUAS!+YWQ?&LPJE6<%CVEIM<-1+%*(,,1J0S)W/)8T/
MB[1C4>#?%(076?% TTN["UKY,F9M8Q$6?Z/P1-$\2*&):UJ7BY?A+^$16%)A
M6^0[-R.%\P8(1T+K9U%UI'%ANG!18:SJ#G@-T_GI'\H]^Z$FOG'WKR/Y(>;E
MW:O\WVT,937?2[S'ANMN91.MO<LSK^7^R"?WSCU,84:04G],0A618%&EW1G*
M/3$D02>^ A%1'^/+HV0\@I0;T*NZ:3FX1Y%,%=)WR#)55\?M\&NLY.,>)V=X
M0U>YO>!V^M&HCB=!,C['Q94^^EGIJ,C)%?LR$<! IYSJM7?",<=>S@#*G-F4
MF]'^4'Y86F5G 46Y)_#RQV%Y*8HC;'9)VUEV)\ED#WD/A*_I5E(H'G.#LT!!
M=)2];0#(.X>1GH9@^*7)=M/9(S+G:7!J6*DL'4>[97H4PPGC2WM9+ F#"R#H
MOT70DH!U<0Z1:?9PG $TF$H>I:A$?7W='^' (@Y+$FY4MIT;XO%"^=@2M 0;
M? F&BL0Z@"NW(5NNAS&ZX7+QHL^%:N$L'FW21[0,:$TE3PH:_Y+L+YWOL!B>
M)/5R\:U[<%;"J820+6=H CD-]CCM&3P+;ZB[$;*DR"SZ=)":=X/4.MX#!-0#
M]]0NG*B$W]6,1FBS8=)LMR?=2WMFC3[>YTX(GG\!0B?K'S%'.BN/ILX%H<A^
MC4H@'C'>]72Y^,GY-B8W%H%]!JJWB5S[:.),@50W@+5AGW@^7Z\]H)W3U/$S
MV)IP<BU6QKEC:T MF1;#$[6")&^WNP@ SR&&(&?1\HF:)*^A;UZ;!.*=,P<9
M6P-XE6/$D.E:);MH'O/G_/FS.%<GK?V+E"4TH%O=J[&=->8,=I_/T\"/_/O<
M&] AMS!4E4@\9M)#0=MR&?>'$8Y./3*2Y>1GJ9OPB&IWEL7QIBBH2$RJ:;2G
M$BEL7E7[Q+Y5%]ZYLH4[:-H4;,^@W(QE=(;3_:XMD$=BQ"*13-1NDDF?41['
MD'ZV#"U?P\!X0S(L5D?@/.[;W?*E=(,,#37?U@.R,:-PR^L#@71S-\]7@Z_A
MD"K=^CQR:URODFM%;D>Y\@2WYE86TV@4JN+4*IUTM+"F"1U";YZO%OO;N>UW
M<(^B/"VV>&P/?X+V%CF926);LF7E8=^.K"IZ]J*IAMT8M_3_Q;BY*1!OQ)1]
MYK9#U=5Q<H4I3H9LZZR77LW1*4JG==NU!($L):ZG4U>[G4-14$*X*M^=6FU*
MNO$2KU==3KT$A=21^Z= ]AN. 6YD\ \1K7B6>%W7RB3<^/?W*94 3/#-(XQM
MG1+."1GFG^_Z:K_YS5BZ::3]".!64$2'%+C?F*9NE_>A6P:A4\CJ&!#58>:7
M;LU=2R-:;"9<4"Z60,3A]+6-O>FM.!HG[PG4?/[\*P:*YD1?E>+#>+]J(L8P
M#D^70..#:W=2F\ =>MY26#$!N+91B)]4P(P8BY.4]IED"/%<YA*JI5#9%PW>
MW>UOUI>2)J<[<09[RVEG'I$%%A = ?2"M$FNW.%Z& &0R@;CW@;QKCF#@<E*
M>1O36E43*U@'E6\)M'?N&QRYU:W5IHZ%R+Z&I$N@]*91+XW?GDC&S"6EB9+2
MYW-):2XIG6$"\F>VV.*RB\_;%L5[9_@.)&$/D"MZ8MH8R]Y+>+4BK0@O^K;$
MU[([+E)@.HFW$+8R$EX+Z T'7$Q:@F?UP+F!&SMX<!O<2-!F:/#LN<,=./0.
M P4Z5HIA_?7SUY+X.ZUMC-.//!PO:3B>KXYQ]8V[5W7$PH@#P\)#Z(9^64)?
M=A72 N2;.#M%SE,#2H"R+:BC@36L50-H[28(764D<I3ZB,AAI])#5)<H;O .
M[M&>/7F2N0%+)G=8U"9UC2MZQ+M<@AG9CMI,"S$$:NW!NF2!!QD6]>-6HKPA
M]9_ 4,4\F\%OT7;1>!B3?;?<<TRMZNY4CH6,DM_@=(U[H/X-+G7262[<3"MR
M6N*>L;2'N/;2L\;O0:@UY"^28YV^,OE:1WK4?,$()E)N]^Z#VW_T@6O*(-#F
MIFHV/#6BMU,OE1<CR;US=>DF;]9M/XI77=?\5^XUIP(;QU54>KZ@TO--7I);
MXYRZS5$V :UW7+X=>P'>%^"$H!D"T#[D/_%IS4 'SU*N139#=L%J!Y _EV$I
MU^HAW>.3LJZ+%AZOVQ?7Q8G;Z/3=%L+ T9(>/2]2RF'K)M'VX7XS8E0MESST
MV1NM5QN3T<7*WN:C$X9,+"UC1"'2L,<9Z$W9N&6.9DC;LY>;.@6S4M#H7E$]
M5.%1&%TQ5$$%MN0'Z1]+/LF/YZ4</N\!5E#CI]:_ILZ;P@U5%! '/32!#X8J
M4JQX&8XSWJR924?ZW)\W-_IB^*T);A$9(L(5H1KWD-3&"5 'TPFLRF;5[25_
MZ;=N3JL1E8@(+]$!F- (&L".S>!<MBRT/DV%(7 V8VU&95OOUEQR!^)BY!(T
M.XB?W6.)D2[A<9!S  #,U@>3ONQMT@+_Z"BC'W"8\9UH;#4_1Q)OK"LGC)VF
MC3!UP(5%Y,W(C7M8747D23QOT05$$57F$P[@B;A-KM;OC6AUZ4BNL('I5-'E
MQ$N)L0NRO1 /AEQR>E>0?4,RV!VG6G_J+R8J(O, ^"(8Y93BQX%E3CRT)$-C
M/3(#@;5S)534\>"<O6D3/WO@65N#=KM[W5CMK5N\;.0F0HY$;FJJ<O0!OS39
M\<D5!N8&^+!SOC#RF<N\+3U^!XO!L^-IJ?ER@3PJW"@JL+$?/WK4ZM1;P66A
M@$QZ.A(HJ%7BU8*QC V\?;\%ZGWJ_=D][?>>_;0VM=-MR+<S)FD')W)=D(0B
M,&<FFP<W"C>W,TE;W+!($?NE9]R0"UN =XP)$Y,U:9[\(7DWTS3JH_=$.PDT
M!O3!C8IG(%%ZVZ+EE3A%'0BM,"4@'(1WSF) \"^G-'NP&&35G?/=$/II'9)O
MSMG)FW7 Q'G7AQ14R[7'!N')1IZ:#C'@XSF4$7H?39\=E=HW&U#^Q+GT;U_^
MNWOFKUY08&4+VK@_44=UNRN6KZ0=AGP#0[=OB+^#5A&6-.+;Y:Y>O6_[)&73
M.VG1>\7H'"@G=0$#_;1RLW'=/MH5Y^\R_E@MGG=7%-5\0JC8IY]GE)6YHC7C
M]@$6CD[?FT+2XB*=1W/F=@M_R8V!^\P;YZ7C?YF4$)7JV:TVJE/6[J0LPR5]
M7Q_A2XM?2X:VF!49EW\R9I8PQ% 28@-E"1,2UZ>3KA7W%47^"?R=EA_VIFR+
M<$##62.<5UEW[>[D9YV_&#F&D8W DH/Q]%P88PM-\8=792MA-Z5.&@(L'H#E
M(/Q20?$4G#G>MV(_>[D),H+[97G5\<,:7B;C(U-\?%51;=G8=.M+,#Q6S,1.
M\#>WNJPDM=H4-?#)<@:]H%G98<^L%\]]QS4VMU\\A,/V*\YM,/BA&W: M%O#
MK9^VWQ^(HY*<5!>,Z**2M^Q]TJ\Z]UA8G +?R^$'4>TI;SF%T12",&Y!Y5OU
M3SR<BASO'_L,.'QE).9P(34;_H!=83WYB'KXY4!! _B8#$%3%.[;G2[I_HQK
M3&T-)Q!ETDF#*J(4R=]7]8VS:E ]X*#836EDG?UXQZMU[.)QVE,A9GP:JPP1
MW8+",,4H[,GXN''@@DG$MOL2,I588S2_;C;U2_89]P1RHU[^7BYB["%[\K:^
M."NU&R&I7!TGDY)S >:+N0 S%V#.L #S?/$UK3>%_;Z#ZWF*3;;/(8;\ )*9
ME"-&V#,)--*DTJ[(UYS7W^0M1S1&FZU))!$M(Y=%QSH;Z7.69;5JX#+0(^[*
M]\6NW-:UG&93HK[J5J3H1,_<Z;3!_*VS=\^H?C2>OURXX]G>["@W*]M>H:5?
M;E#_4*LW64\NR+E<&K<B3V=I\$W&R%R2D1A: :)1)"@A^!HWQ85[0*J[ !R6
M3(IQUT9!L4]%2,L >E- K80@UO<;O!93RP6/V2)SW9%(?BXO;8H]O7?N8SN@
M'2P;:T#46:2*Q^%E/OUI;X0Q4&%V0#@\-L1+N*=%UK^MDWLCY.66@'F&9(6[
M<V+^2^Y'</M9 ,3:L-%5/A$BD%'U0C2FU;##8I&0IML6NT-$-X2$!65%"I^3
M..1NJ40-Z-:<W&Q),L)-KYOB?VJH'MJG?(;BL,M7[-FZ]>MQR(*;)HODMBU%
MH2^Q N\R&)9$AU8(&%ZI/=#Y(*7 I6194V%OC822M7+.LN[C%/MJ5>Q GKK^
MXYBHE[UDQZCIH"TO;K"A?@PH=&=V5L2=[4:"D%%Z_MS0^MP%V8QQS%A1'-D!
M7KDPBS)B@VS9Z//%M6I/N2+\ND<ZSWQ6#H<1LL;OAQDF3G.Y8Q(-3UHS\PV/
M^=VL>*K;0 _7T"&7/%[E],Q2)RM#^3@3%2[LFW@TJZ6'O7Z-LTE575V$=<SQ
M,3>)!LPVVE;UO);LHGO8<H]F!;V>K51&2<&H)!'D44;F^Q^=<WR(H6S<6ME)
MU=QJ8 BUZ<VJ7KB3Z@I\TWX9Z3'"&3Z^GV%!);@''GDTE?G!CFR?8 FGA/L*
M8?WIN&0F[7Y70"4)8#1.:R-#Y# E=W*TV!_?-MW;"?[6[9G%.W>&O1]Q??^U
M;FP6;XK_/SJQ*+;#J3*N87K%3KMXL5_G737CFO'&#; )FKWU&AFSKMH71T\^
MP"4,?@;F,E CY"^K3@O.=F3 -IR['5M"@\I_2&\CN11\+8VI)B[D34%ZG-9T
M!L3E%V00&9]+@/1F63=2MW<6I*8%3.WZU$NY* YDY_=N'*Z:^H;<*R#!L<@.
M],.SQ4=_^^;-LX\7^^[H\_]W^>)'WWSW[9N/Z=/T_<4WO]:$AZ)#E)0N@ OR
M:4FA@8<GQ)67T'C("=WPSFA@T&\XRQ7CU\/0'*288 .GB5%F]\R6*KE'WA#I
MDN,9"X7? C>TX*Z>@54+@QW-("0L/T$]TFH-$;:O=3&;9RI.>YT"V+ME7>Z8
MXU&6,-?J])BGY*X=D6#3:,3T5-T@:)!*@)BWSD/]?%Y3VN+5 :A1WE]'B009
MD[%IZ/L+0,235Q6=MQ (4$\BP<YN?0I-#F_A&=3DNP5_4W5LZT;].)Z']-.Y
M4*Q.>:+1-D]TAK9Q%(!)[N-YIDYBOU"0@U6G19^U/$H5W'=VZ>DP]A9&6,WH
M=OP^!Y(@9)74_.E9PS+(I$(I?.?N/K?-/5V?7C$,@UNQ?KXMOJKG,MHSFZS@
MNLEOQN[F1JL\ZA3:>-]^IC6NH/1X\'H.'(LQ^54\=!33W>41:96//*;I(9_S
M[!-Y]B_G//N<9S_'$".1Q9DSZ^<6E%@',=:?&KPJ%42O!DB,5+(.N4IG7RB#
MKA<2J%?D#R2_R\<3?-GV7H$0RPL"2<?'*,/K?*]V0'@C01VU#'"FI'=BN<<8
M4%*0\^][]]S3=8T[[,#4(FEKG_SW#0TG7DM %PD75#@WI:E&0*GAA>J@%Q0?
MG3TXBTDIYUK6]OY&<FJ8)FZ:/,,=B\>+L)J'O;; (KHO;$H2Z^+@@[F4I-_!
M=W!S4$8D".O2S3TY7"..01"D4QQ*YEQMQI-XH WK@P77.A>VM8APCM<ORPBZ
M?RHPL!5O7@* Z8&*^SC[M7\.1:F<<J6I6T,%N\N[RGTUA@Z.^:HC-[^[IWJ_
M%,PMR^..KBBUZ??\T<<W=+]9@S5 02,6 O=:,'V9#C<S%8U3E&R4:[:O*D$D
M3$&3-9:Q4'4+(Q>&'NA)76LBP@-O1EM':\49G9TBM3!'9E6:+AI%$_>>Y!PF
M<3J%1M73JA+N2(^V348AXD;T!WMC$AD18U*4MBZJJYQQ9(V0;14M<W/Q0J@;
M+PVY$AG"Q0,S)8^N[O10N4>[+IT]?TPAW:G-8*N=VDF(!J.C+Y&%%D:J3%_1
M5J/<%Y>A&P";BYU4,($F#V>]'*LA4!VL]+<=C/OP^5K)-BR!O%\K?UF*5L#P
M<)7IE1FU1$VP(;RK8UXSRYH5DV2Q<G/!R0=-ZEJNT1;E8K(7I-:[VHIXF[57
M;JRHHB_L-JNM<YH*@LV%G)%\VBV%>57?:55C,6A6W5F)<L59P<QG"_-(:W33
MY/OBIF[>9QI"J%M78(-(]S.H:XZ"DM#S:*W=EQPS^=W#FR'H",;+-0M\]MQ@
M&]^X+8C>)&9L7+DX2\[^R)T0PK@!2R4Y-TAA[MPYM [@Y[,_5WZVMK\IH(G<
M,_Z^65&$L/L:VK9Y*C#^3KD!''84'<3+4BZ!=?>1"L;WP:1%DTA))WKLFO\8
MS 3L(17NZ>&,WCOXI @QB^-1.,.<O\Y*I*O:,XLH2YT0NUANQL@6!3I>;<=.
M< C*P+5%>M^XU_'!840%1S0U.VJ-(W!U:(54DU\>3W]2_A=T7X2MHAL%T453
ML+TMN<4CBV1@P@?'YFQ4Y[3/ICA@#[;X=DUU3 O48-2!81H<-(>#^X/E4.IY
M.GEZP8V *#)^$ Z8N0%%< %3U+A6=L4,=L2,&@^HA$6#YT)=JL_Z&5-!NOLZ
MWY=44RG:*0D%1<%'T5MTV2T\GVX K%2]+E-KN3B1D)KYUL5W.Q[VX[9N0<>U
M(6;T/@-=?S='&[G8NR5['9/8RIIF,H;5MBRN>R^0M+R9SJ0,;[IA+8_DFULW
M*Q+CXV9&Q@Z%I>.)JF[5FCK_54A[<141S8G8;,Z1^VU!DWK(Z2$-QF#"^F6]
M^"<5\_2WHP]IIJRJF)D0S'-7 0$T[_9E.MS$[T^1\ F]W+V#,<EZ#IY!*8;'
M[MAK9;XK?W>*9,IW.9@N2B(%I\,[[EBT]H4G^:1R.<ZN6;4<*T5<H_BH6@-$
M^2RLC_'F'+,8XA,).H?6.O%*'@M)2B:\[[ZM'CHKXY J.:"YC.1&;5L>E(N6
M8&[#]Z<W-<U@ ,BY*_GZ>T]SP1S=>=-0Q\H^X!?R2C# P]M8PAX6&U)=ZIV[
M8,4G?W_03#]Y*D+YG>.TKJDTC 6DW]N=0NZ3!Z,=2Z9)5X^[XI]JY40?[.QF
M_)G21G<N%XZ7"[]X,I<+YW+A&69C?PR1 Z(I)AX;\^O&;5+)30:_N/.D7;,,
M3$AJ4X8HQGA&69>89O?^]X7=MG<^_XSJ!QGV'ANM&?L>#QW\ :&<&]%H# P]
M]EZ9-$#DB%80@^MY<NN<IAZ=#FWA:JF**SY80]WON$T*6_C"LJZ%/L]"8:B/
M#4%6 L=5;])QFV&A'6&?+2O/3QNM1*[,H3EC5"LQLX_"B#8NHHVJ$G"JJ49P
M[V*U!D74Y]%X,"(.J@C<XA\_ELHFB+J!)CS8(6)R<NIJ0?F5^8"-)%-KF'0H
MK&87W++09?)X:1X[TW,2B%ONIAU+N8@AS2R8<H6O.[6FU!%$1,55S/%Y3-J3
M5Q5+5,2C6'?'E@']@W=,-E%(E=:S$S -;KE?=LXQ@]LE;>O"ZM3_+)'D\9BZ
M_6P?);#PHTE>&;M*@ZT/F;;5%BI/FA +T,R6%VK;+7^1$/N<ZHQW 53H\Q/C
M<)+_V<RPV3IO1A=#>KYE7\;D/3!<T3Z*^EC2Z(Y8\10+!#7\4\CWAO?PN[ZW
M.,-I,B&PU6J<X<8"*0[<.O&%Z!4X= A=/\.B:!;GB?@FFG#M]!<,)*6#@9DR
MKIDM',LRRJ[$*[+R14,S6YP,T?R8#%?@ !IY$Q0>)5X3? *-:ZMAD <&\&(A
M6S\\(82E0*1?)%$3&"W!F>I3;(;>9I"3D*]&^8@IK-.R\'F!L]Z)4P[_&U)Y
MY_!>N -%A<),6;UTP1KOU,=_SWOZT@9HHHOI7MY<%KO'W@A/#Y-L,$[QK!<#
M3(JE_4WO8W,(LSI385-J\;.X/^>2$![=A6,[,$XO=E7()\'G<3MNWTXI=)SY
MTO]??WU>);7E@E"/+HO>T9M -FKYJ;DNW"]R$8EQCEQY]&1&25V\I+\84];@
MD-1;Y(LWW[Q^&Q$A>1K%26T]MNFD_%CN$L>>5&5AUJ\Z=VAFB\/VU+H)SZM>
MW_9AEW/KBUV(.[E8$'>%D%/7%J%!735'"_18N!^7';M\A3LFUT:.BQJL6YP>
M;)R9L<>9(VW=5C+H>C= (T:2UOD=!2E\$;8='<5!&!!J6-EBEU.C (4&AWSU
M/K_"C_8=LZ!I<,UO2$4B?*QU3Y)?%?*)8]GR=32HR A+YSY+[(2L"\+P-#?]
M[XOB(%[$;8>1,0E!P0]C.S16=G$HB+%W-%,\(.3,;5N*E+A9X=*-%.,C&91H
M5=;H?9"#OY+(!0,5X"+!3/;]('/JK[Y[_5.V^.[[GW#1[U[\%#ULY@'325U"
MH\:%IPT.]+<& 64K$FX1KYKRP*$[%3_4^[$5-!*E->,@Q7&5IO-*5$P9ZOS[
MLC*!)Y@3^9?$Y&UWRB#L6W8E[6HJ]C;.V*R$<P&E#!J<]M0>R4P;2"<I *_>
M:_!*_]"?-]SF5&Y.!L+,)5]4&#=%>:1E3<N4JD%NY>Z*2LIA1VWOH80U-1Q*
MT=0[AWU"1H/H"T6!K@(>B5E;PWNGXM++Q??<I$T5$_=()W;9/:=<5Q$Q5W6G
MHRJ.<<U&Q<*.CSZB)FZ$('@#IDU :]V__ V B;A@OO%X40Q*.<:(U(U/R]SM
MA,YB)R%%#OB7.YW!GU&>GVQH=76Q*S;N?/Q"D_$E<!!_N:#?/-(Q32#Z9Y]]
M]7A@IM[8?'KY],\T&)&$MN2[@K4;S/24'RF-7AYTZC\%%$2X,%W5V1"W&RE1
MQ+=8\\+0;[BCP>W!]JMYXA]LXN-YE;H[2!C8H#N+U'3<6RRLA1'W9M >]]!.
M)N?1IF*"AU7FQ.,]SZ<TN6GXW#S!#[FSKTMV:X0P/OAWX9P 1:[46:N0]R-E
MTH7X_.J6<A.^=Y9O\J92YE8" ?0ZRME^BS=EG"9[\V7]*S6-R(4FUL)<RGTZ
MEW+G4NYL#7^[-:3XLPUV# D(FZ72<##RV 5.8WVD^<1ZR!/+!(9I-4H3C0]C
M87!*H$,GI*IB5W2>O8>;/6+)I#" C_/%KC@>)5@D:G($%[T9FV?C(??2IFNC
M+GR;954N[:A(63/]ATF">G\PS;73R7=:RM^+O71>9[WRP#V?C9ZG^N&F6H/F
MMBC_Z>$PDLG*>$YX+:"4TJ@P+F=DI4!BVC^&L?U7B OG"7PPWZ3ZI:M6?A/J
MY 1W955>ESL 4QK0^NY"2>SLZU/O^B02H1:2!$#(!P/?EM$>8(R0=P:N*&-:
M[:78X@G^E7ZB G$_)VBY<"08@$SDH3UN[%X54ZN]KAP/,8M(MJCRH^Q$T2AW
M5TL^;>C^RAM*'2-5)FTR5O8#A:H(')4+&*XHA= M@0ZA;X$.S#9SM+L:G %&
M%&F='XX"TH&D0EDMC.)*7$WEE "SSB'+XY9)_S-&7J$Q\F/H%_0"9$/L7\@6
M^49W4GQ<,.Q^ )S3VH<'\#'V3\ 0ICF#VVX*.:QP5W>)37D4L,0Y[*%[EOVU
MM)K>3424@;HC&J9WU%^UJ9N5L-WD-VU*3VE;+DNO0!?! >O-Y@+)(^2%SF&T
M;B7?G.(6BB2:=*W0[S9UQV UK";0G+OSDDEFW&@064,T$AQ<U$:J+0L AA4!
MXTS%TH(?W"+7E7>WB>3X<^<M51%/$K7W[/)R;YI)T=Y#G![+NCO&!;_PL.7&
MCP,JT('A3T&VZCNRW\"1E0N1VV*OM/8T!HTSWZ#=J=8@3=X[NU7DZT&]%,^2
MFSRC/ HA%R/--MVY,O &V"@M+J;N9C0]+0LC[W:B9AG?'E3-W^P*A7&:0#$<
M5WIES9Y:4QHO&+]*^+;14OEM"V-3D.):=- 1P^..,#;T1(2H9-\ >!QU#A")
MN=?,B<A;>ZRDKYGZ_Z_H=65U3^QT7!0Z<=4O->PJJH9*BLB7I/,*#!J"%0Q7
M\!>.Z2D]$(0EDN5TUNN9=BGBYBZ ^%LU18$\<W.H&T8B'XLK1CSXWF><.T34
M6M&7K$O%7?F<ZI$VXF(=;QY)-'A&(YR#X&99=50]WQ7^")63/VJ$=#?-KXJ$
MX1RKTX9]EW'UGCOR[K0T?',_OF1Z^ :]5I&VT4@WX#E8\]]P]I654A6A;)Z+
M<QCCFH5CEIV4W>FB;W;:2(WJ<O'C",M^<MMVU2:_KAF@0*!G@S]ADAE;/Y]X
MR .T)5;B+&T+DHE<,4,0R+M*$O&&R]?&,T_0S)Y(UK>A\I[HLO T8!-/ _0$
M<TH)1Y<ERZ?;BNL<0TV]/+(]#)D&O!"BO=XWM"%] 9>\F^+]/ ^OXEV ^7)1
MC0P7&^8T9E<617:7X681&#1.W)1KVL(PK(P_/G$N%#^.*<<3R ]\:AKUV. !
MK'_!E.PB+3?O3O>!RU0ZLL&3=FV8 (PQU]S600=&Z-X>DD,0#P]Z!113'="
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M\B>/[N/3.QK?1-.P%OL4Y6][&3/E@F/-8SP%A/V,"7./18B>R\4/A+ H@8
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M(2;<=W=-_PPA9=?C"=4]@@\L#)96C[0\G[]>[EC9;,=>3-&Q0 XQUC!\0$:
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M<>VK<W'M7%S[Y#Y>V/*3B<TB2W:0=,!O*&2WMO9@L+H#Q!>8;B*VH#B;4S:
M%HA>4">AG@=I-M[L$MKGCC?=7NC+S/<F%R,,<.((X 2/\%[J(>)/Q>ZG=3]Q
M-H=9!=*F>B,I<*CALOAP1-/#H60B<.U&U/P4^8IGE,S'1,DH_OQ%6(+/_D/.
M0'A7$V5#.'6M9]>P0#V!JII438EZ2[KXP*^PWQ/-^9W2F B=#E'NXY^0T1.H
M^G5]QYN&3L[#=-1BZF]B9$A_TY,:_#V7W)_)K56_K00VSPXL=:3Q3USAD%^O
MY=_HGUO7PXX_&ZY+/76L:SBM^;I(%Y \%2WV:M6THVI8,5ND>KBN^ZU2T6MI
MIT-G /['"74\K3#6)?H35QTI[X4@0AHVR$<"=)X])"?*K=5*P>03X[NH%G;[
M1AZ;W+-*_.#Z!.%-6HXQ8!%-GNDX1K_OA4PVW82L%E$^:<Z-,I8HO*+$017.
M/5;#OME<F?:/L7/US!JU18Y=M:9NV@YBYNV8%""4< 24@-0%S)]#%\E_Z3^'
MW/=;APGAW..ZAPP<218<E4(*LAQ*D 0Z/[MH6-'[2:GRA/,+FY'GW:U,L:LL
MU!G"^$XZ%. VOPN+=K"N2U\\F[,.9<7>C*$,5G0(ZT ;VICKWV5,V)^.BV60
M(C* ''1[-V:F\'-JZT=%/Z:4";8=D^:B3'X&L%A*@[G%[O@T,U@S$0DWTV!A
MN?RCU=9IL!JMK::M,T.]I1"ZO^P@A!!"/5:/X<97<+?ZH$A0;.%IUE!(.F->
M/][YH0NHM-&P D21PN(C_F"8L6:D&H%*XW!W6YOPG.=+R* $W'-C-XJ7M1V=
M7HIY&?DCPI_PCZE=C?7!D2?('\(MAG'?7*)G2O_,:7DZ^JZ(H&Q<>7$W-8-B
M2,KG8SP2J<NRD0B/3J*:*S-<@Y _(D'$[[UUS7F^GI)@0"NSTU5,&:;V/NUP
MCIQ,A5W]M7O:0_U63F9]4#4$*(R(:9)"-I6:3Y@)IDZ8<]738KC3--Q<UP.S
M$Y^(R/ E+D]^+W0 6J>N;[IV(Q\*L8@2'O)!YY_B(J'+,%P2Z.A%K,410+U\
ML:*4 5<+1U("V70X^82Z1&;-7! "ZCM8+O>>M5O^*FBHF^; 9Z8L0-3XC%1O
MUS@< <.B%H97_&YZ0F;O P7UP$5BD>F.A,=L0 $U.K7P:55R%!.+;I?-KMYO
M\Q/$8U$H5TU?NHGGLIX*(I!&'4 [SMK [S%[("R<=R0*V8"80UR,=H@%O>AB
MB+.P21Z%-_K<>A1.5#4E^,9)S\!9,_$-QN!P4FFR/M17BA3#@2\U*GEP/HV,
MN5P@U_.=ZR*^$]2$Y[/LEXF%_LI&\V_69OJ*^!TD=*69>K%&HDY_)>2YS__T
MIS_ !/_U;Z]>O##8C]!A$\K+%JF>7N(-BTFV%.%2#"6"JW)ZU,$9)I$[/D#X
M;T1+L!K6.Y+' *.&UA3N_()28@KE5Z)C Y$_"/P/3<V;MF1NJ$&].8)NI&_D
MQ%))=\YR'MJ!=X2!I]C&\U^#92)4U>T1>#9\)UI8Y$0V$J0Q;TNWK>YY^DHH
MZ5& ,AKD8&L5/"&0!MP?QO"W&-:E0::W9FG6*CMO8)WHWR$R(,3J$53?Q,?9
MB\:>1W9M:T[\RBD*2R=_D[NX<Q1)[35!4[FZ;Y6QV*>_K;)>_:HP*$-5# 7V
MM2X3]Y5#C6(^H89$-Z*[/RZ@]34+ >78W'8$'KV:VCT#Y^0("#?&CC"RQ0^-
M#<]V\./90;%=Y!R([(<H')M1C-G"-\UZ=R0.)8;[&"$[[:>7FA>4[QG!^&=_
M$AOYYMN7?S7T#A 5C ZY:1:9G;(@P)?^/<>2$IB=5-,4]8_ZF'P.<+!PU[!.
M*9YU):G90\;4K!8(U8QSWX#K5>"$T$& 1"X7.W%:R',^T3Z/SAIAC6BMAKT
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M$A$<EL9]J%#ETQBH'X5F?</PH& 1IVLHO_A3@+DY&U9E-B$% (.V['/4^P2
M1,%;3^6,@9B1QKQA(5R"PD>?_8_>LR31BZ8X#2?N<_T0]!%*QK6^TU=[0M=&
M@"P]U>5=EFB1M)Y_PQ5_@5%G'EDMJ0?VCOTQ$6[VCZE=OZ5S:^*!DVI:?UV+
MH%-\6M::PB+2,23T-*U=C2C\FM6S BR&@-L0=IZB7//?5#I5>/AIPO:6DV,R
M%9D*AH'?63K6H,D\[WBS&K[#P [P#>-XI&HUHW)-!-TR5U;J*1'.>=D0PEV0
MH&/7K=#[%%TM67O>O\;]#L+Y1]\VH"'1#[@$0'=-+L9T-"IY(\GG)227EK%\
M\MOU39=X+'Y%ZCM@)(AYPOHO"GMWV?\4_2)/^'!BKRU':?<[>5_'[!%WM_!J
M%39[MA!,_ @H@KEZ75]\(^7[80]:4K'./D/4+=$8R%*KE))B(IV*U8S TKY/
M*63I0N27<OU%FT_* ]1J4$'/"K.*[.D[99L1)3WI+F _4]#+-V&C;*3;!"0/
MV(%N!+QYM>J%*.P-3:Y9-PO@T2N2R;C/=ED>>KQ'K)X'DG&U+D2SY*1;Y)U$
M!%%6@NJ(K8)8"LA-4<[L.S%8MYI<=MQ(=)S_"@+4-ZI%9* %Z*H4SN+1/EGZ
MJY0-7KU\4_Z[UF2TU:BTP03,OH_46JM)8.^DS>AEP(\L6;61ZS#XYR'OD?2H
MA&A&6V6DI)=?F%6KRHR8J"H<;YC0]H%W)POEP)9HN[[G*[1)PBL__YP0Z>,N
M#S5%S?%]GH0V3OX$[C-VXD$\A4U0R_0R9'Z*B8,'W5IK*TO'KC_]#7/">*A@
MSAYR"P&#22!?7I2:.OOP58 SL(Z@A0&.?N&.,I5??"93Z=P:2<:TQVBT0:TS
M&Z/R]/,CT'S>]Q##^TSKP@A^V$26+TJ\F?0RMSYN^(!%_MCM5B=W?/#4YNY,
M^>78:'"]5%2#"4K'76M18<C<ZOGC+:2T[1S<GLY<FP0DVU',45CI*%!9$";'
MO;7PN2S6PJU/W3-;L$FR;<G_IO,D:2;8+/OJU2Q[SN2),V>CT2?UU3OR BF2
MDJL_P".Y[WUSA^-$AOZVX0FY])Z3MEBRE\E>(Q,7)]'<'7-:AC^*.V/\CID
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M/BR'(S=)^+!',IY]?0VJ):1N:F086F[P0W]=\(J:/K@9A/U\5Q/Y)W'/Q[K
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MECSTO!3 VLY*2]3K[#!;JL]%O^=.E'GWRKPWI=R#4FY8D6(Q/0L._BFBE,O
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M@&)M!P3PA('[IL_(N(F3?!;+ABIN5YA@X\XNCBFJ;+4>-M*GWB;:.O)<4 V
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M&O;RTCJ)S,*)D8>+2L3SHF!N9(Z@%MUWM\F^2]2.2MOOQS2>-PH_QT%A#X/
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MKXM?[G@4SJ9U]XS^M= &3568+&$^>//@I&8*VJEAU@^5M+Y(+9CX#)QFGW6
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M46"H:0:5D39I8V%V.GJ9UJM,^X"X=A,B5C:W)S**C6JN+37%#MLLZ$.4$F*
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M?LKWQ[#?IH $(Q*",AA@I'T> >Z@Q#=,VQKOOR91I[9!S[]>9M\AQH?2L*S
MLMU2-[OT^#DKGR?I/]NXN<<*266&K=<I*XDTJ?E,C9Q8V':^K R00L#/\M?M
MD4=9IQVG79 C:5%_S%RS%$_AL^X3TJ=$U^3*?Y99[3CIM"YO5L4M)$U:567%
M0:^9JTBRU%$NC2A4DN8O#&_0H45,@B^!.Y Q%2!) %"*4X!9Y9ZHZKK+-ZRG
MF1 :2K$A"^UQ/W1I4LRP*9;(8A>E=^P6MEK568CF9<84CU1K*WT@]PV L:!D
M6O8=$D6B5!)5.? "S8D_A":KO?(<201!/R)A[+M)40PE7">9BQ'N?^)L]#>@
M&=X@6.%2"AL'TT(M[0<)[@U:7_,R8?73J*5@"-R[O9-#FZ^L+JSZ8BHFP,'7
MND37W](=%<:BOBKB;3<LB!9/Q4!2]D)EH@[K%]WY2/V"QZQ W9JTC-I@R[-U
M5%XI7./5M@0A6,Y '+G4>J6W2@U<GS:@LZF;RRX&'+.[0-SWFF5$R]_$8(7M
M=CVE^UHF.!$^<04D%9U#*;>ET+M/;\+,LJ6E+M<$@HY8RO6BT:*\I=KN")!)
M3XE9+6>-(1RNJ0VJ;4R61Q*'8L[J2FG0R,^(I/!4+[\Y7D[9<:\]<'ISD5#_
M7?%*-B=QG5G&"$MO$FI7QSZST?RU(_'LS5 WP*<<LB#DS;WFW*&]@RH?;C>I
M'SYI?D)_(&/OUA'M2/*P\+=[BQ)7R[, ]@P\4&H^B:#9W!R.^<IAF[;F=<OT
MJ)IH])MM&E9%F:OT9W[X(=_3]GP9-]0D-E>7MA./]3N)^F1,_!F]KBW5H(F4
M4#*E*7'PGTS*"L%-RJK-&$-EP[&>>#]]. S%GKC(A\4/ '<%B_ 6;081SMU!
M3^ J[7$="R,S<HV76T-%Z2*@\-%#LO,<2U8]"8+M7L0&[*A3[YC IGL/RBT]
M4A$?#Y)R\9QH.*P]'-ESX75L\HZ1?U@2.J>.YIF"]L8J;VFV@DO[X8?GOMMN
MO[E(J4D&'A#1\>ZD#?[KY9NW:ET0.&/IJR9S(7XV\S^_HN9?XZ<\-?H&/>C6
M[,()-8.5JOYZ:C0 SCZ'MFHB/4HK[D'CT\$6'KF[-KND.8>S]2<3?)\CX)R$
M\U9+YNFEV%/0LM^D\CA'@: )/3&:_<4TS[Q=2!.6[N+GW(N6'2*>M+W![*&[
MY[BMPI=]X6!IU2+G1@ D$L^,A $A/L^LT=;V4E2\#J@OR&X1?%-GW=P *?.
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MTTOF32J1XNEE*NJU>&?"[)4XQ1EYV<I(:5"$0YB,3O*=>T*6-,P?6@KEQT5
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M:K)KIJ"'$,5^(AM4\E[ V P]^\0)U%93K[T6VS]F[/,J7KJCZI,]BRSP&Q7
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M1=DV&U4HP3;+U_D0=/I!H\Q9#3)?5Z#Q,M.?-#N 2NP7 ^%#^%M"U%+X#5\
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M2,Z HM=F>L;0^.NK]S^\^.OCJ*> @>)4\E52/50__MCR"K#.[9&B4EPA*;G
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MI5//+$G.QXAXDEE"[K[T>2.ZYCI "TJU+6D ^C@-R770$/+:7+N"DG?UQLY
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M/XT.9F$-?#IZF>;FQM!H7IOO&7L<[J=MF.8EQ.SO;2C+N*W5/ T2(+R+%8=
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MLK4MFES=N[IM-A3=QU#TT :B)PY7#V =RL"T.F!:3'!F7'K,F0>"J:C6">&
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M'^ABWR-^^$'ZJS@<79NQ-$X&Z1;\KY_O&X)1YA+2)&E*_0"3N/S[-SW/U7X
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M&M =&,7:[1,;(;8K8Q2+8ILE\S:2.<\+J W,8N,!#4DRE>= !4H ,M)8:7S
M"F]M,[I8UVQ-<OE\S!)OJD*.0UUF?SY36\0CASK/VT#-:*;ZVEQ=M@]5Z<VT
M4V6H80:CY:,)#Q;K+&(,E=-( 8.=C3PA2" I(B#NJ))0"\4UBEK*?0I(9(M#
M+27W ;P767(?4G+GRK]HZ;%4) #*1?RBHM"J)+D4$B&4Y<&+Y()<6Q#PL[0K
ME%7 XVJ#PKS0'OGNW:C#ABHH:Z4.Q>)7EIW2ZIE5EKM@S6SEOK>DM7OX&3H:
M]1+/@"=,1,#1#FA'4O>_^'MN-5$Z1)WE_E6FLA'A:1H1EA#166-@:%]X![[[
M03^+[FU%]_*JZ&+H+1;! 16O<D"U%T :;H&E)A@LN6:ID/K__U\2(_Q[-CD\
MMC F*IQ,#BDRM#_4G3(:(B4'C2X;NN<:_G_.VV?)!/&<+!"UR+4>:RK[O:2_
M)*=IN2WO.KHW>CW>E@Q0=^865:<'[6&P": (1:E++ (F7C5 VWC%>,J$91&@
M2%U\I-D*46N"L:S09K:Q8K91"C-G$7)98(#$HY&,$AH8C0U 5 2!>> PZ)6Q
MC9J9)^I+,LKF5<.4=FS/!T7,@QX._6A8,(Q.6YMV)R<@+\\H59TW^]W G^FV
M&T>UE'O<+[O37=G\9Y:)O%;35-1U!UX/_:XO_WW;J[9IUP<?-\55:O!.SQ4J
M\DZQ0SE"9G5W56NQ'86T-% ,@>(B$<_X14I. <8.0BV\42JYOIH\MQA[JG+^
M &&W6<[7+N=SG!1I:RG7%F"B,* >6:"A%$!HA3 S6G/OHH+9I$350\Y7ZBZK
M-5>9<9?=GYH\BYS#AS-W+4+7Q%A?[LT8JS(<W0*.WB_0#JN4@Y82P%@!1S05
M\((,(&Z]D(%!2<S6MEJ,N,F9P_66XIH1CRR]*Y'>^:@;[35/@NNX"8!**X$R
M$@*))8^_PEX)OK5-%XL;/9(K_ $SBFO-)':LC?,8#1MG^C)%G3TSXT:];!OC
MS7A7[L7!(#XPZSBK@Z6_%TD%9\AIJ0$A+K5+%QIHH>(.*@8=E)9"SI(M@_%%
M'2>777LRLOT(M"++]H/+]ASE4)1RJQ4!6& *J),<&(LHX(1:"*WE2ILDV[!6
MLOV\Z[#5G2L-SOT//40S/L%LBUDODTI;]==T.\:6X_UQ_>B9US(.KPZ'[0+'
MHDY#$_D5\ QA0)G!P.B$PQ0BPP3D4D2.)9L"+>9<9-O-DY'ZQ^%86>K7)?5S
M[,LK(3Q5&@B3DJLHQT"GVM8!625A_ XRE*0>XGN79LJ&G[M5<IDXCZ8]%3I)
MD"8LYO*968/6VZNJ*!AQC3UZ EWIYXQ?#X)?QXN6(<J-M"Z%8%((J'$2*$8)
M(,$ZAKDWC/N;RE#E*)<G(>*K;_MT>Q'/4GP[*9YC(42)8+7'@*,DQ1(QH)GU
MP& 8/.7((AQU#\;OXW?*$2QW;.[YT[Y.]S&A+-WE^ D"UX/VT4P=B-\-^E_;
MSKL_+O^.VS<#8#N3O<OL9'6X]F6!G<0M-5YI!W!0*-E4+%!<1;+"/7,J,&*A
M2^5G8!-=4Q#KUC[UV[0,WQ1KRXUS>NKH\*#=+#,ZK ,=YK/)J+,$"@RL@@90
MYQA0WB, .8S8X+V6TJ<:_A$<[M."]U:"=$]*-!Y%=>I5(?:K5GF6^(R?3_8^
MG[Z&$3ZA)#YQ?1)?8IFAT_\V;(1!OUL5)\P-1&^ES=1A>V](VSL?V!.=O+']
ML,ZB#QMS_:_<^_I.7Q:E/@_Z.S:N_\!?R1W?Z;D;TL?SK7^/6__T[:).@!G4
MAG@025W4"3!'0"DI@-(*RB (=QZETM5B?54IL\6R]M3^[K*=Q?=VXCM'VF7
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M0Y_J_)N1CG]8-&3U5;&3)!V-_ID?Z$)OZQ35M_J1/Q[KM$6/$JF\(<!\IYC
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MH1;V= &4-T6<FL$#W@'5^$&L/',X&+GJ"GQG/0I<=%OH<%C>C5 [6#[!, J
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M/B08X.(&JV17AZDU$%1LR]DH)(6<%M6Y> <"?>T:;#26PI[CUI[!#&'0;7I
M!U("LT L\9D@<R3^B0/,A8N'J%F<H0#@TXT612.V^GFORDM#3Y+(@T>3AJ"!
M?X-X&U82B;,BGZ(F>J#@*J\%![5Q%MTU\!H_Z&>V0BV,92N:P,J6ZX8'(4_]
MA&,2\CE:"*UG&*0GQ,2.D##S^1)S&60E+SJ%%)V.Z!1$G,XA"^'5M7BY?MR&
MF)2,"A?BXZH )3U!%:<>8>'FRG/3&=,%(%991UAU)H F7)_]A+ &$A_R?8_
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M0G,/E@=O7L6O;9*E+K.4"*X2(@ ZB121) E/THQID6F^UNI!Q*GAE)DH39V
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M?,#/]<#S34V@CS$";5*5]G\^*M\^QN(3<_SMWI&,-X*^?QU%-#+,)22S.4
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MX_G..8OS5;I>3G'#0[^2H%?%1&U"_A=M%=:P9L-N'Z1J&=O(,=GEID"WC ]
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M>[VQ>G0NQ^7_/"#16N$\0,K=B<%_]EJ\W. 6>C (]EMX]_OYP\GBG)BI#V[
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M[WGR5A[FU?@@SKF3FI$\3CF![7,D8PK.-F.1S;61PJ@MY,FWZN3?]OB@]0(
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M<]=>V'R.WO# 0HBT$V/E*MH._-FI-&*WNS&%'.FRM==M<^7&F-Q<]5;%5AI
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MRQL%Y\JE[5;^S^N)LXZ;^MTG67G3?H$V)*Y].9(.TT"B058)BSC!%&D?$O+
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MQ<Y>@O=B]W/L_)4?YMZDFA=;\L1Z";C;C;<J>_C=6>CNS[W]L\OJ:?6JMG_
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M$!X8&<&S6-TLHVME=&T*WO5"P"I7-]\.:(VP,"N,MHD21 1QB ="D;51(FP
MOUQTT@L*+$QOR!=7E5R]Z-I*KFXNXQ8S/(_5S=5A8>7JYKP [6ZIW!T!]WSD
MN?*"I("D3AAQ$3QRC'!DX0/GF::::P T!2R,OF!Y\_UN+WN:+:]FX.MIS_:F
M"5BYO#EGO*K?P:OK;T<J>19\(LC@I+(&>.BKX% F(U8R1ET0,+G!9Q7&+\-@
M3[#QC[;E8Z,10Z7=N14*>C-1L7=.R#X-.[3D9//E9+=KE2+)B&PD@''",N0\
MQL@%&V,,0-BL[.\X&R^45.XX>WU*MDPQL9*2#='J A"WY&/SXV.#94FAC>:
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M-%FF21(7$ \T(*N91T82%:@P.GFWMLGQBPG%K,SV/<2[ADN/E7[@Z_-%QY^
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M? 0M;7FD#@DK$^),8^2\8LAHS353NI]M\WJP7?;F2WI3DP2,% -!Q=XBGHQ
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ME[@GY5ZJ)KPJ69O&0:ZU\\;W"_B::\3!MN/)&N-90[R$R^G@\ML="O?E9U;
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M!Z 0*&@O$1= 30'3"/(ZA(2]XH["),8GK./V1TH!1;%W9ZP48Z>51T)_U!@
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M*Z2>#JL"RS21^X+1<W*%$+AAQ%&$.JYZVYP0:<("Y838Q]58&$4#21G0%DA
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MV(- E5J&W\_$L-#!BLGBV& _\;X(E)+AB;(V\FW+KG9U)56'%4P9"1LG#_-
M\5[H5?"*48+X&H.JIG 4+*H0US>GG)D)]T1UR//GG5>XK1;/'1X\[LJ8=TM]
M'Z8@D\!"N92.J**\]8WA5L:K<SS!\[LGQ[9M6"81ENZ[$<$#=E]G'O%T$@5.
MY!';]+$KSH,'(-?[>,=]])AO$<^B.K"/KU/FA'K@D$ 7MADX(3&8P*:OPV3!
M>;CH39Q4EKZ* @"8STAZ2']^.1' 5T!K@>X) *N1 (,5 S&KF+=<8&:S4D,Z
M*X:9> Q$?%A.VI-S@@^^%HNQ/>1[^2K)=D6"U]RVR&TPWNUC$$FNR:BIV\3%
MY&P34=,F>D1=7_@>\ZPH>H2HXWJO'V&O0SOT?">T=2-R %FQ^'G@4J&;+C>(
MRTP[B%9%5J:6>@I&J.*M@47/"H!!C15*H4W%>)(.Y=DGZIIA&@?*R5FHF7UV
MGA4.O]-)&F<\+EWTA8.T< .BWKZGW.Y#)%C49B=I)ET(P22#(679+.S&6=5C
M*7ZS4FE'/VL>&8.(K<Y19@: QC1:;U-7J;0:\!/X3_K8AV/0Q\$DP[-SZ:>5
M4J)\278;45%:(_@P/"A0UD<V1J$&ZU!XDG'$$QBS/-L ?/ *Y3W7Z9^1N5=.
M&3VS\<D0]RR+><Q2=4H ,EB=:.0'D_,G%$50YU,+6QYG8R!PV!7>8BG&?V3[
MT2<UI\-B2L#N-=XNX.W>[_WNV7G[M'W1.=VV4:MU(C,,C<#3;5M@,AP/]("8
M7.=@MCB$V()QOA1[D3^F&Z&)?">N#;]8R0DOM^1FQZ9E;&T T[G+_>=&L^",
M/$_D'D)%9MF@H/RO(I6-I;KP\(_])#Q[:IJ^W"YH^K)SVNMWS)\#I.GVZ;;1
M^?S]XNCT[+QS^F>O\Z,3[W?AG6:;_MR9I^FVN?_YN_43QSKX!L_^9OSL_@GW
M;YOM08L<F7OV_H\]Z^BR=X8)2IW3\-APC, -0$NT:>CIU 9M(@ALH5O$L&%=
M0\]VV5;NE@$%81M1@8 F"<H&L6QF4M,6&&',F0D&G2T"SP!X %'*1K#J8U J
MMCYT6EWMR_[AH?:U=: =_F?[H+68#52E[Z7^])M?.CM(N#EP7 ,0T_+@!X%_
M',L"U=7Q(],DT1/YW^43W\=C!D+[>HXPBR1]>;0X0IF*!+N&W'Q83CH,>X)/
M^F(_FN>ICRR+0]#C=V,\Q>/R'.5U\]GW8T(\.S"<0'=M8>C4I41GU+9T9G+3
M=&PS]+DSSS=/IOA,?;4R>0\4G@$&9EWF+F\\#)B,2^]R@-NM#DW4ALNC\5FJ
MU=A8B3SY/% %X1D#C.7$R( RB&4V N.-C&%))C ;/#L2OU&A*AXG?27EP]69
MP]OW!7/DPRX.F&62(RQ@GXTR\;[XY0^0PZ,^NW@?#^4RR"_]D;-1?BJ-!Z_S
M%3OP>%%=GI[)-@UU+IL7#,G?G%]NRDMS&9OJFFLU+=.^\K+1)%=>N^ZQA#2I
M<?7EZQY[_37+I0\SV-4&=$-1EOD4_$5TS+<5@P8J>'E]NNE",0!_X85+LN]5
M(,)&Y9I7D\)F\H@W8UDK-19634O>\ 5'T7EE";YUIENO_/HK;ZQ#XO?5#>-)
M)UTJBRL(VWNK!O[22Y&L/?_-KC>R3J6]>\C,P)!<^&W>=@!*59[_+\^G7>(M
M#8>\ZLCO_>ZG&)Y!?G:/2/ORN]$Q6_1HT**=;HMT3O?@^Z%QU#VQ]P_GJXZT
M[/:/O<OV[E]],"0N85[64;<7P[T$QFRV3_^,.Y<'O?W=,_OOR[V%+F2<6U%H
M14(/3(?H-!!<][CKZ*9O<0J[:S,&I@8Q[8;MWZ4$][I\\D0%->]7@M:H6:/F
M/&H2EP6>22V;"8LZ'G"5;=N HIYA&1PN2-0T"M1<6J^I1LU'1\VY=F^.0T5D
M!4RW/"_0J6<9.F.6HPMA"]>.;*R^L_7!P2Y+=^G=^%B@N:*!]QPPZ(?\ X-)
M,0OX1)3*+7J",BV9C+,QD^>=C47/U KUT)]A]>0KP4FMR?UJ=0L'B\6&;*O]
MZ$S0Q; ?24]PMC_=#ND57@VUGOR \5F@5GM!UP-=SF7,I+IK$:I3# -BKL!]
M9 8@C64+/]A0<LG/"A:HIB:8AR087YA@&@BFNZ8%!&-0'\R$$$__3,IMXGD4
MNXI93H-X?L,P%BL&K5>E\.'T_T=RE+TB,7%'-;;F^XWB^SGUE@3 WUYDZY%%
MN$Y]A^D>%G7V#=<-A.VXU"$;2C"U7O'XY!):EN63B.L$]E2GE-BZ[\$/(_0\
MXOB<.($!8L)L /TT &PV0$R\*G]_>1*^@LFSHBVZO&"P<5W-X-?ET[J/!=IL
M?>%:IU<1ZW._UH)YI>]K:8Q1#>QK ?NW18/1"R/A\T@/P4+4*0FISCPF=-N)
M#&ZXCN^Y]/ILD:>F@UQ_K"GACI3@!@&/#,?2J;#@A^5&.B.6HU/N.HP[@H0L
M A'?I(O5C._-_WD/D/J:3I5J$5V+Z%M \QWMM%I$/S PS]E>9LB=D("I'G*7
MZ=1P?#R)XCJ+'+"]0'Z3T+N5B'XT.JA%]/U0@A>Z 2.&I7LNIFJ$W-(#1@.0
MTYPY =CA@<VV/IC-)74X7X*(7JV;S+5=8S8_Q7 R_"4R/-W$)%R8&?XZ>\#)
MQC?E:U8**8K?6!D9JZ_($I-7Q>[?+EY_G=)P:S7WJ>O)E?7DG+J>W.NK)W=3
M4M=B<MP*R6Z;@G!EK:?^A7)18GWZ3(235#:@*\N.RIKNL%RC/-M]&3)*-&H4
MR!AGV40NL<I EV7=!Z-^<B&*.KBC21KV6":T49^IO.QSEJ8,RY4!Q)57JUC7
M6 =-K\M_4JE3($HQV[^LYB;+W?%)*,J2HK/?RW/Z,?-<I>&?SX>_#.6YB*I*
M>T4@C#;)5/$&$*WA!$LY: "2O=42MV(U\(QAM>-'2RG<!A(IJ..P)(Y6O@&?
M8/UWIDN_F('XNK,-CXZ]0-#(LYGN"-O4J8E!OV9(]< @'/;)!>-!+&3U6J#[
M^R80*!74,!G EC# O("=HH;+^'QV8K6B1LD9XYGLP6I=MPIM-BHE :=EZ_*Z
M@56ZQ:8?#,! U:+&XO&-V_!>E*25XO!8L(&#EBG?+D(&S#';06*0LZ=D?"S6
M(+%B'.LE7"DN?G]5%O/R_.6;EO<Y92V:3=>^77KAR\I:?)C!.L\H%Y(L#XG9
M_ RQ.AFR3H9\/2MO;.K*OX8XC7UEPUQI8ZP0E?Y &4:;=Z*Q7LR936V;,,8#
M[@E*+8,QSW )-ZV0P/\-L6YP\AW-CG7Z23US+[CY\_2[W3[]-&B?\D'G\S?C
MZ/3$WN_"#,PC^V>W]?NHNVUAE_7.0A=U^+0+X_AQ=-$QCXR?NP<Q>KP[I^'E
MS]-^O]W]U&OO\L&1^=U:EL_H6I'#0L/5*0F83D/FZA[HTD"-KN4P-W1L+ M,
M&[YA-;PEO037;*/^*M,::P!:%8 X6G-"<$*#B%K$8+YC<NJ9Q E]%CC>ND&O
M-0!M'@#-QT[#[G+L]!T28NB4AH'NA[ZK$],Q2!!8;LBMK0]6P[7-ADL7LP-K
M +IOE3"2_WM6*N'WJ[S9M](%ERS BT1;*S1=9IHVLX1)+<<(A&U0QS)\U[>Y
M37FM[CUSM%W,4+,\CS,[#'67>99.'=_2 T]$.G>8X88^J'XF ;0U&HZS&)FX
M)M0NQY$'1=.Y5SZA.O=:,,0(?(MQTR4V]VE(#.PN$C B7""GT'5)K;$]?PR9
MT]A<3Q";VJ'N!2Y@B&E3/8AL5^?4H)P'OLO#:.N#31N6M5@!I\:0U^&D.UP:
M1'!= ,%=W'8O'F8]AQ';"07A 1C(+/)!7-N&QTSAAZ9I6+6J]LQA=C&%) 3E
MS D"H9/($CJ-A*<SQ^.Z81N6%YK","@8QB9M>,:=878YP#R%X5MS_Q+N%Y9C
MVIR!ZNZ"618)/S)"PPA UH*FQ0QG Y2L3>QK\5P8?TZ_"H1G\\C'#AA8=L:-
MP$:SB*\'!AAGPHB\B-.M#S("T/SCY7!^[?):KW#7LE#+(E@QNON!Z&LQ8*EO
MA8[A,VJ%@D;4"ZCCLLB.(FPD8!FU$^RY ^SWQ3-/DT4BY$1W/6[HU,$<( X_
M2$@,RQ".09F!W7,:KET[P6HGV K6F6%:E%@AH1S^]<$X(R#A'.):PK%,SC=
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M!6V<>R= T(^7!"',Q3Z4)JE2-T$O@#?=T,KI?<%,SZ<U@-6T3/LY5=M_H-8
MJPWHKHG?5U:A\%]96?[;K]2+K/=>5]K?C$K[CU0Y"Q;N\<._Y8RE#J6A$K4*
MQ=VINNTJ''SKJCT/,LA'*NOQ&+M_56>#614G7$('=TZVW[A*)JOWHUXVQ6>:
M;_8(AV2S3D_$E)<=BI*GCEVT+[_;G1_?S2/S.^D,CHS.CS_/]KM'OSN#]GGG
M!XQY\!W>&?YN+Z2.[5UVNF?D9_?GZ<_N=_/GZ3=R-/AF=TY;YA$V*-X-36Q2
M#'.]7-9*P0N$ZUK,UL,HPGX*EJE[C!NZ'_) A)8561C*8C4,RWPY%0%J6'KA
ML'3''-C58*E&GC60IUJ1]QMI7YX<1P%Q.2.F;K@82N[YIAZ$GJL;@K' )R&G
MW-[ZX&Y42>\7I,I?50$W2<<Z!DQ<H\V]UC*7CZ#^R/7'^(H:9VZ-,W,:3D Q
M6\+V=$XPFBCBCNY1YF$VA4%"Q^6&3[<^>%Y=C_8%,^J]*P0UH]Z14;\M* 38
M%YD''M4!*#V=VC[1 V9&>N1'S'%-0WB6APK!?97@>1*%X+EY=_YB:2S/G>ZH
M#KS JHJ/H X4JU^#S*U!9DX;X)0P83JVSEV'8X$<3_?LP-%=.XH</S)#BY.M
M#_3N/=LVS]M1\^F#:0,UG]Z-3[\O>@<\WPI]%_C4<T$98([0 RL@NA]XS/1(
MY#/?03[=(#9]\<Z!+F:,W^:49Y6"85<?K;UH-^Q]+LV+P>=[UZ/JPZ2' >WY
M[C\DB&S3\76+!P98<#S0 \,V=<.+3&+[8, )BJ54+>?.ATGWR#=/[*2I4;-&
MS<W4:FO4? #4/%I0=2D)P.CT;=TT\2#,"L DI8":W+$\0[@>-3GF+35L;S%M
MZ?FAYFREU)L3;^NHYSKJN8YZ?B$^YN7QH_LRL6*N>J&V-TVTN)= YN=!!77<
M=AVW_5@SWF%93QNQ6-428++P5U;41Y4EF#!5:0#<.$E5,8(DFJ^W<DO5XY:]
M&5Z,R;+"_%^,7?+ ,<)?\]K&K\5(.;OLG.[9G>Y!_V@ [[K\L[?_^>"LL]N^
M/.H>69W=7GQD[EF=G44C9;_;-MNG9Z3S^:_X9_?;97O0HC\_?X-G='J=TQ#&
M\^?I$?S[]V5K,4[8\@EQ JX+/PAUZG"F@[%IZH0$AD/#D/G,PS)>U+FS2WY=
M3GD>_IL:\5X/XCUP^/$4\6I06P/4]JJ>%[-SVCH.*!@DM@AT8GF&3BW+T+W0
MI#K#SJI1:(>N[6Y]H'=/?7@L2'M!IN(5#:3E'X+K#(;$3JKU ?,RHB(=W"H+
M\>:5V%A(6E[R+> >)99A!B8@46#X0.RN$1@\(@3^-&0=JJ4E,6;!IECQ;;7@
M!\5ZEY7@R-("<%C@H$:EU5!I/D1)!&Z((9#$$0Q4K=#1?<-S],@T(VJZ#A$^
MJ%I>T[NR*<]#! V])MZ)3!8PSW1]APD0$0X66X\LXGCP6V"&[M7E$FO>>4S>
M:2](=!:8(@R-2">!9^DT=%S=LUVJ^V!VAA2#_2.^]<%MVM?RSHOW_"R(41YG
M(;I_-*!>4>?[*!P8REY6\_4=UY"K4Y7^!HU^#BAV\]TX@,WX*E)TEI:ZOF[6
MT+ :-,R)5>H;@ DNT2W+(SH-,*+0([Z.E9I8Z(2NZ8*R;S>MS4@O> I.^/==
MZG?424@KH,<ZFD6-'D^&'M\6% O+#[CA$U L?$/HU'0BW8\BT-$-8O@<B^1C
M75*[>5_>SV>/'DOB/.95KHTL'/AK,>$IFRG;=WW5OJ*[(%:>!31@J6 ::OUC
M,93E8J>%!*>E <,>S#[O_KFLB&#>R3#O7SA*DU\QQR=I\6#4C\-8:6VSU>$G
MX[@OZQC&ZDA/'>"QOA8D::H*(^*7L&YAJ?NI&1>](HL&&ZF(^B(<9WE#I]_8
MLQ&_R<;Y#=77PH/Z/'\'ELUEF@S1&6,+1CF<@&6Q>I0Z;YRMPEB\NSA[S #U
MM'"2IF(87C34,:66Q;#UL _HZFG@G=./L&-4,@!S3@Q_Q6DRQ(>M4^7_\7L8
M?RD.4MML+%L U75(05<CIAW8%K5UV_.Y3ETA &U#5R>449L:A%'?7:A#^A2(
M\6FVS^H<%4_*WF WU 4MFIM> 2JRIPG+\J*FV?NR->GS"8[SFJ[W ,%Q?M,@
MJSWVQ=OTV.GH+EK&"SU^?)DGC+?S0BP+\;Y&)!7GC+L3T8$W=\]%_Y=HPS!Z
MKR/8 D33$3GZT8)G]L_:NV=&>]"&O_?.?YZBP0'O^+%W^?-TVSXZG#<V0M(Y
M_:MWA./_\>U\O_OMXN@2_C[]..B P8'S.3KM#-J[_=[?E]L+K@KB^XYKA $Z
M,)DJ68)1%KI%7=MQ_- *'-DSS:.+39#J6@@/B;!67?Q@4R#I"&RQ[GE2(]']
M(=%BV%=H6-P79HCG*020*#1U#^!'MXG-O-!CQ"(V9O29=2;V(R,1K4]I-@J)
ML -FC47WAT6+<1&"A+9E&EP/8.=T:H54]SWJZ=AIC;C4-QS;D-G%=ETAZG&Q
MR*ZUHDW"HD_))*VAZ/Z@:/$LV0T\VS!#KKN"4)WZM@M0) *=!\00ON5:KBFA
M"/:Z5HL>%8J<6BW:*"B*?]5:T3U"T6)!.XM$MA4Q3[==F^O4,+GN193IKA/2
M",^IK ACV!NV7VM%C\B7W9Y(A>Q;6>M&FP)(V[@=-2K=/RHM5H(R(NX(SP]U
M(@)?I]0U=9\ZMLXB&\C/-D*&O;B)T_#=3>HK\N(UI&H)O^*8^BX:TQW*3]70
MM09TU6AU?VAUM.A9\KE#A.$"6C%#I_"K[OMAJ%NPE1:W@I#:P=8'RVU0_[ZZ
M!#Q"D:67K%XAW[S7,*PN%:^N(OF;30.J[\,BAE#PUN\0;MV6P7TU:MT?:H6+
MEA_F*'O4T@,O8)B]+'2/N)X>"F*ZU.=>9 %J>0W#]!9 ZVVM73VP=G77"CEU
MO<^ZWN?C0/L5H%Z#]_V!]\D">#,2$A^H6G<]A^B4643UW0Q\8OJ<<!,N;GTP
M_09U%M'[N5?]G$^]+0+SKZX_5UY\[ #O RQ[)GZ/Q! PO9H&DEV?!X)Y'IC*
MI9VS3/N?S:F6U5)3>=G,?9?T TSV\ETP^H3CZC[LJ4Y-T]59X H]"CS'YB&/
M&*:*6@T?:S7.\:;<^74V_(&+!=4;?N.&GQP3[D<4V$T/&);<"&U39\2R=<..
MB!F(P'4"4Y9@7A)PV]# !!T)^..7Z%_,91OAS;C;\7 B*YFJ_".YQI'%0LOE
MKAT2FQ*7^-P/'-A[R_5-PW/$,;&<K96REAZY9JO$16(VM0=.E]I)!H-X+#U@
MVT.^(U?Q1 S#6&28XMI/L"SEYF1*'964^W/WR#@:?#?;W99YU#TQ?GYN 47^
M[/W\_-UJFYBGVJ*@=QB=PWG*!9WC]" &"O_=[O[L[>\>G!UU>SV@WK.?W?#R
MZ++3:W=/0._X1OZ^W+OH[.X=.\Q@+ B(;E#?URDL)*@0D:T#<!#7]!@-6:0
M!TA0\&T$@"#T0EL$0C#.:!1:@#B&$]B.""WN4)//9U;M[+?;>]UVJ],]U+8[
MN]K.?J>[U_G<ZNSLM0ZO+*0AZ7:._-4>W?S^V?&:ED5\&L"=1D3#R @\/^3"
M QX!./8,NK3*[1.GDOX0FBQQBSZJ1,X'\:),;!PB&/<Q73(%O2*)M&"2P3.R
M3#N/Q[WR?H06T#7"GI:D)VP87\I5S+0W6SL'^]G6V\;T3ACQ)()?)BEFE2W<
MWL;;*]FGXUZ<<FW$0&<3*K]UE(H0YH$JW/2UV7C"X8:&ME-<ZJ8QR!WYI+'(
M9 H;_C[[>EBT7W&(*:W=GI!9M,7\\R16_(#!6A2)<Z,)O$WEVY9,+Y_+4O@,
M,V?[,M5M,@(B&J4QC/<\C<=C,<3'P:N:6N$MU_@DOT]]KZ\H#]Z8Q=E82X;]
M"USP,DD/YUZ,MTBNA55*"ZU/IL]B"BIOY-F].$.@^,JPD@!TWGRQX=GYXXJG
MI;!^DQ&FVN+6<TR>A9NJHULG1_6!J%D^\7T\!NT]7 '_O\#\4"7>/DF%F#U&
M>FJ!=75N=Y&E'&>2\B]P2_KY1%@YD2+Q>9K*G4N><4DT!5V71'0>]_M:((!Z
MY8>2*.)(4O!Y#X@T!.,(Z9T+4!*2$7X)]8:3">Q_DE[(&Y'T11H">P%;](&W
MDB$FAF+J9]B+X8M<9HA?F2;:R%.FQW$6Y6JGY-)X(!%!Y5DOF0PNQV18C!"_
M@AR:@O*8#&$B%QJR^0"GM))RD^]KOO@4,TM'21;C#>]3@?3^2TP32O\]"]ZY
M<6I,O\(",$4GXZN_,D=>BU7&'Y_@+!\U)-N;6Z[*SUXZ;5)P(O0 5OM,E^$B
M[UG_G%UD6^]F)PDSK*[HBHMQ]=2CZ,&FKG8 3(LDE63Q7J9!XUTP'+8Q8]%Z
M*6JJ_UI!$3< /A3.1QKJH0KNV'R-_*LUG@W58-;$_#U8N\$PCD /4.CR7+!_
M3RE=20JBFZ472]2NV>(9 W91EMF(YR8-7_H%SY!:3IB,1*X)I8,,I<DO,>0)
MRGO [TS^4BIV*'&&H M4E+!"_9(Z7VY%XE,*+ 9[?8S?*-4.?-Q8PG,?4'T,
M>LHX@7<EF2PAD,:91/J)K*J!F(**(Z@C$_AWNEFHVT1I,I#'IWVL[3$!D0/S
M'0F4B?$P0AU.%?P/^RR&F0W EM."BUFML:G!NJ)O$-=E=@%!E5/JKVPC #.:
M7\7*:.3D!U*>2>&&!4N"A,%[X \>@U8*$E*MFO@MP@G*#[@$C\(OC'M8AP2E
M;RK^F<#=U7$TL,@(KDBA\@Y/<*>GP\$9B0&,!E8;=,-BW8NS&]P;^0(D"%Q>
MN0A*,N8"-48@9^.)7-5"[X/93P<.GQ>CE6H#/.RWTGD3!!(4]]-2*)&J)U&*
MYB6U540Q4]Q\>-B9F-:9R!;IM;+2<2;+I0SDP[#J!*BEPYR08&B)5$T7-Q+)
MK5"!-<4>L+.Q-%^P. [<PI!Z)_UQ26USH\AG7M&_\*'L')6;))(/71AWFK*<
M"O--4//O,=A^-AV#B"+D&D1:5.9C++.#GQ<*1",?FJ2MO.R&5--37(.>%F%%
MC88DKWA<SI>%(9B^:KI5:I *C%IY.<^JXA^K(:"A@<YS>=]T/$@E^6RNK?4!
MXT(W7U-[>DQ=UR00)PI'0B$0K#9=*BRA2%5J: PZ;VD?2,)80J\E ?;GIPU:
M^EB3V)N*49)*$WF1L\0OU@<5 =&_)U1!J%2]I0(,B.PE.J0SER1WR(8L>$\L
M3== *BDXXF7:>Z4<C11N66&NRFI,DW$O 8M:JN?:R03H%\M52<8#C$^%$C&A
MC/+ &:'97!H382SF6+PTGMG4?LX-$,2,>3Y:7,3[]*/Z&^Q'M1[#CXI[(==M
M>\A;@U$_N1#BHQB**!Y_[</H-\>+>E9X4>VV^<WL# YZ^,QVMVT<G9Z91Z=_
MP3._7>[O_C78[QY=MKO],ZST-^M%/;O\N7MD_OS<(NW+$)YY$.]W?^)9P6EG
MMTT[/X[LSFD;QX"5_DCG_-@DCLT\*]*%Z88Z-2-7]UTCU#DAU"<N#SQGP2D9
MN08)6&0)$@E*.64N]5S8HHBXKFFXYKP3]6.KT_JTU]6^?MGNW. TW3BD7&[4
MW+@"J'=/'1,%,HP!N91H1OF(>BC3#F4ENRB&3PKRU+X"S>*[WF#1+-/XX[#U
M5?Y&_GBK<:!<^+HN_8HQZ,1X8\9^(7)H(Z!HB=S:F/W6_P'E5CV9&N3-F?*!
M?DT3('WML,>DNS)_G#;S./F8-SCR? #Y]Y%ABH$TM>\EIE8NSTXXMR10A=6$
MFAVHBBP2H&VD < HB)*P)PL!5M\O<.0XC_4JC-[Q_-B<1X]=M38[E:'A%/-M
M2MOYV&>NJZ*C^Y&\N$FU1Q\;75KG^]TS@N= [=,3N/_LF-L\),P)="8HPQ;9
M7/?L@.HV-SSA,$9LYH!4,!9;O?Y;:A[*^ ICH*QQ64U.@!(:HX2O$I 4[<KM
M_%PIJ":=@G3VN]^. Y=0&H5$YX$;Z31BCN[!=N@4]H7QD(>F86]]6 Q0EX13
M(9&I-M  Y2LXS9T.TA#,4%T$93'.>EBL4]K'8.:#JCL$,#H0OP0(0$ V+E5/
M>+'3D/;?0 ;#*#,*,2]W;4LR!/P;3/HG2M_#M#BEAU:A%1\XQ=1ML.:78J+R
MAD>3/JBUOV"@(O>NHWNBJ>VJLZ?5ZK06\3F-.1,[?YE8+X;CWH-V;N 9//].
M!7[*THOJ347<]<;$<SPEVYR==R[#X\ "=K$B[.H4^L VKJ%[W+%U)Q1!$ C'
M<[FW]<$W%S/UBQ.[BF1_^NB>FC+NA3+V=UO'D6O9@>L9('PYQ=B)2/>I%^B.
M90H+P-9G:#G:_F*&8D$9H)-*/7$A!FC!7%U0\%>T7:FYP;8K?7#;]4#Y";ZB
M-Z:+AH/:@ T, .KL[N4$/>KM_VA3>&ZOW?UF=P;?#/P//^N8K<NC;B]N#_[L
M=<R]W_OS 4"#EGUTV3O;_]&"YYV9/W>_X7_PV8EUU.WT]C_O71P-6M;1:<O^
M&S[KG!P#P9B1SUT=+#>NTR T](!;KB[<T+#<P!$^$_.FJQOXAL5H0!S3HIZ%
M!U#<<CSN<H"IR%RHK'S0^K+=;>WJ7[</ND=:]P ,V.V=[M[^37;L4JOQQI=O
MH/U;=6QA/._4.3B-'"G][.I XR#F)P*?5$03G"\>B6AM&6,#J._FQQLCZ=:O
M=H+/G<'EX]#3AW8D+"L,(3D?*C4-C.G"DS=?:CH>HJHDSZ+D2W+[6IH'T\>6
M@2]5=4C.) MC?%NDN!M=Z;,1/AONNY"%&.3JKR&U;]>FPUB0U1/132H0%HML
M1WF8MX>\DPQS=_-L;*XLL:]?BC0IA;7QZK -OM\].V^?MB\ZW9/?^[MGQ\0.
M+$.$EAY2$X#.,J@>4,/1N6.Z#J,NL8WP$=)GZCU^P#V../7#R.4Z* F>#BH#
MUYEO1CJGQ'-!EP@,*]KZ,$P6]+$E4?CJT 1C 0%KISC'QC=9A'@2BFE\Q6%N
M)"HA@*H4_Y,: %>H1'F<?_8)K.VJIO0#,+SZE>>1"/#XU%@Q#RZW+SJGWX^)
M%]F1C;6W':PWR2)+]RS# L0!K1W$ 3<YQRK<UI*6YRMWC#$DW3V>JV$!O^Z5
MG&I<L^<,31C+$2CIAN$SS]4CRDV=@E*NPY^F[GHF9[8%&D:X'-<4^$C,*1$H
M5H<JZ\1B+M?$KLBSV^"X2JG0_:]6_O_V5K6WNE5]PS+5<:Y8;K>.<WUM<:X;
MYXW:&XN!YC>UG1Y&QLAP+!2MNW$V'VRXK:)8F(R%'!9_%IDLG\J0K:F3:<-M
M7# SYF/SUP!#FVRNBQ$W5>E+_G93TF2:Y-E'7S%8B,/F;$Z<V?(YM%2D5QX\
M/"6JC9_.<F+;GV#$PI"IV,R&8BD95%:<3!=332:850:*"WS67PS>E=.>7I^&
M2N;7&V6,G/)*J4A/>( ,I\Z?SZ?+&5:7<U0NI_8&PW'S" \ A8,) !RQF$[L
M-^)MX35K_0XE;@ :C-_F$9KRI4->_#J"]4HP2.27=.*I<.@L#_)K:A]9AGEC
M0Q4S)\I-;]QU'53(*\Q.IB/Q/";OVD2@%5=&*I;ELJ)MS*:1@QC&#-^688!]
M3%N:"? KW8LKO 8/;;G(0%-1$7]%:/W25\G9Q4-E52 A5:.= U&\3VW 1,*\
MVH$B%AR;5*((2_%P>Q"/*V&/U4W6WL1O-;E](5:^X TUXBS#7[/) )A--JQ4
MT93X K3^8PPBE\\:QX.")#(-SWY4D%%^];"U4ZY0"@2GU@0GE?TA?WT3P^M9
M&$X&$Q4)662 33#-<EP$=T_9;)IZ>&>VP@/[$<;[I[$*2TTTAHT%Y9SZ%W*)
M)YD*#TW%"4OE:\M]F.YX4_LA8$_ZF)R6DV5!!%IVD0%V-[1ADJ<Q:#UXP[GH
M]Z>T(#,A9$@V+GK(AC/]37.%>)XV9":'C%J 29=\.OM:27(#,6[DZ6P5=I2I
MEP6APBMO?!\L3?GT&"[E>XD) WB3'$&4L@FFA\K0X$9!)DP&6Z@P^E^X4 (3
M ,<P<L$W(./S6J'5+DFOI.,#R06(<&5 2"[!M'V Q(KB=%#$/6_,)%<190H-
MLA$F"B,FH0NGC(:9YCG',G-9_LTQ1F\L5!W"(9O2"8J("N=-X\ 715%6R*)(
MA282F^=_+<>MIH:C7OV->%Y40-OJ*#QE>WP_F+-%52A)[<LF-N1Y9+D /:#D
MM*7Y#W)A?^<3&$U2L(%S?3U$+)8#D%K%Y^WMKR!81<@F*EU+-3/&$YUAG@*E
M8HP::RP(YO(HG,%H)AE7KYA2&P![EZ/$,*0LD5)!8DT>4%<)W<^G.*N6P,(6
M.3RY;$ HJH19R?6,L[,BIR5'(AQ5GC\,8RX(*YA./9R:-? EE70%\Y9NQAP5
MN4!#1P$<QM-.%U+N3(*]HH7,?*D(9WPQSA]SZN&5FX-+*[$LP[2$[#H%<2W>
MO#HM)YAJ=R!LTE@F?VB9&",UPPKGH7*J9LE8[<(A0DDB@]+V9^HQY#*K"ZS'
MSV']Y;>DP"V2B$R#6(LP*Z'8_$->.)%24_N4LH$X3]*S&044F5ZNC-(=DME%
MPR2G.75RO9629]E3M?&:==L<<EHNYBK.@I<BU/(#;_P!BD\%-M;;XR56T]6B
M:JD1Q:?QF%&,IP$WAV4V%#4B@1;Y5:"/,DEJJ"("=$DA728W]>,SU%BEKCQW
M?V.]"=_!?T(WVW^B^1]!:9 I9GM3NVK#J?AN+BW#]VU"'-.S-W]S=II5G]!!
MJ7A]2E*X>:C]"6R4\3A7021_?,U5E[VA"CJ$"QN_G6.T.4$#65)'I#Y-J9RF
M.,;5IRGK@)*[59_!;,Q8'OT,Y@GH>0'C)#UCD("VM[=W:RAWC T'<&(@@.?5
M'AJ@ Q7^N/VB1@7J2CL)F+FHLFN?40-!]6/33Y70V[O4$5LX)D 5BW$%8AD?
M54R0JQH9$1KIH2A,WNJ#<EWT:YK\OM ."XM;N@7P<U $36U[.,3TQ[80X[QZ
MU>$X"<]Z25_54\N#:H6J_2$]OJ6E>]C:*5QP,!.- \0M<>=7=5(8I'J@G%3^
M[MS?I5+5YQ/2UZ%@:],IF#0K9%M-%Z\I]'50Z 87FE44:C:U0R#0%#V0^^=8
M1JD7CZ2(S$OVJ&H&TJ13UR7JMBN>(O@S#URK;A3<(FLLU93^.BA]@TN!*$JW
MFB5-2W)%XPYH/9LAX&I$9B,/<U$:B(9%VD;H8ZD5C-="U.X&YP@JHJ9-V(SB
M1+H2;_5)Y*>IAWDZ44VQSYMB:S=.X<8A]^+&<>W:C5.[<9[4C2.!3[EQ_KJ]
MB%H:< ^C"768(:8[O%<Q5Q=_;)+<LM$P[L5!G%>CGYX&3C'Z,.P)CJ=C&RZ[
MWK"WVO0\]K%+1BX?T[(%W?1U_"0+,?9E+X%";"X)<HF+\W4\CHVQU(X04CG_
M7<C_G6JAT&4+@6?YB/5@%-CJ7?.2N#&K9<B\<GF7)-^JTK$Y!_'+5]5\!I3Y
M;%C]TR)!:EDQ]DHP8B)C57@99@14>2'CE40LCXM5'X!<Q2W*DY:G>%J>XCBC
MQU8(/P^%O;D>;OX<>+JLMPP$.TXVG5ZM3:/70DYM^+JA!24*D5K2%B#5--/#
M,8BL35&6$-,.]?]*\3N]A]AO@K?+,5$2,,+SE 3SM<GA-Q#]Y%P%LY<CN>Y^
MIK(OKS#F%+RO2ZZ;DE2XB@:V04:5^?B9AG?349_<9IH9?D[N?SSY %]+3B*"
MU R8%*.6G5"G?"M;K\*@^FR4B??%+W_P.!OUV<7[>"@?+;]4T%[.[$BZ\_VO
M<=G5Y2E5-PU%V7G[[?S-^>6FO#371U9=<YN^3:Z\:C1O>\TFWJV^>=U8/;])
MK-4&=$,K\C4[CI>];I<3X$/0G[%2]$5.>S<)IYR6GFZ<G7E]K]C :_;&P)U9
MNN;3Z?RQ=!>6"=\57OBT+=5O7$C)WTO!9A6*O[+],XYWS16 ASSX])=W3[>:
M9&;2&T)!][FX5:RY;[7CQD4F]M.J'7<<8*YV],;C4?;^W;OS\_,FC+-YDOQZ
MMYV&/<PG?"?X"4O?@;7*WA'70*WD'8R7$-\BIFT:AFD9IOV.>[9+?0^8S"+-
MWGB ;J$)YH%LJTK(^6FM-'*Y/-!5G6VD&K-7&A-QV4<(S1VP05*&^1J8GU%V
M(@&;).]Q\^;:(Z6"]8$'%I]9)O'EM<DJR7R?P'C7/+"PWGS"(R. 8@WFJUN@
M@!EOY3&23"KY)()T@LVS+%6W"'6PMTLXX'XEZU-"B;F)4%*CQ?-&"U.AQ5*8
M^'BA]]EY]@"(8#X&(KQ=8I:])$2@FZE<U(CPK!#!();EO..N[;F^ 8A <_WA
M4&!:[W+]8:\HX9LSK7: H\VFS9?S/H>S'*Y*2N2Q9'GR=#83,:)\\IWDERHW
M;-K(R,1?$5;HM8I&\9%RX);'$ 6\'.JD B^69>FF9;N>7\&7/]GP=<'+;12.
M&AA>+#!8"AA^R$Z8LG; UPD\C&5"!7X5_'LH1N.<@64:+7$:JE!)V<"E@@E8
M##<)X3-U1BBT+V.^,K];-;_?)[];-;^_/GY7OYJ*O/QW^90H5<R^*[(PC4>%
M8R#/><"J':OR*+V&1V?/20O6),:-JG[>J("^#LXD1I/\ZP6H^FH%:_;>"'%.
MC%S1E^T^BBZ7C6GBALH2E0TV4%"W_IE@LM/>$(_<,2]/-9:<-EO+*],I$Z$Q
MK2\GJQ2=8__T2MW3:M^UE8 $>:"6]O>**>9M,*5&@R<?X'V@ 3$<RYU! [-
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MO@AK4G\AI'[[;5TD]J?O1K>YR0O.U<D+[X*$7\ _O?&@_^'_ U!+ P04
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M557$-7F=\D0+)SW> UI'G@?ZI#\TC)$^-O[2QOK>#])NP CGL.U3)7LABR(
M!@$H!N @]66AVFPV'TP\HSUK9^_J9!FIX[QVPYNK/,66O6'4*]\>H(!-_98(
M&W.(JTYO*ND4I\ES52E#]'JR3*EE/ZEBP#0#JAIPW<?4F69)\P+'<MR0S2$-
M]NP ?Z1 ?S+=T$(6>YWUKXB=PU@ECJX+5<E<G-@:76G#P,HRD)@6O0#\&(-Y
M,=C7M0I; F-I<;&^5++W%2+!VOFY6EU>PQ"68U5N9R_R1>)U+,%1SP]U[:
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M*EL.+A8!W'D3Z*^L"WVJG#="&E+P<7<N7#8?;330OD7SG'A:1V]+K*5]1BF
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MA"J^<23.F8BR,F41G^.NCI^Y? )=*VE@6AOIF.*$\1#+^:@EULM$I%#966=
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MOQ7*:!;L]LS 14]I-MJ3/#FS]B$1JSPG.GAJ@H'@3)TCWWMA/0<BM*?W"K/
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M1G24&*8'QQ!.Y(0Y"4P$G5$553AR"\@.N<Z/-=:<GC./U70%/_G#N.E/KB!
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MQ\S+?3*2A @XH(""D8Z"$W6ZG&V-0 \<7>X"?U8QRH9X,[R<ER_.4FAFT8=
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M?PIG)2AO?AR<G?MN,^DBB;2_-41N2=7) E5D@!(:?*GR0N!!RY*MSE-6Y5*
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MML@V,I@6*N)*C'XJ_:0._=E%"ZEE9*I:JU-#JNV4^JQ!EE6WP39EZ:?"8F]
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MUR9G#CQ9OKP)'WC;$[=KF[JL,/E.DE(*.C\:3SMW:!6T+1?26RN1?88!?J>
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M[+N!V9;& *#;^<NUO^VW_;;?]MM^VV_[;VIR;I9.UI9.3,KV+U[8N-E;V0$
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M@'M^;=9E_-ETC8;3+OC<,)Y&?D=E6 I?:CMX]VR9 4EKRZ<,KN8)$EUV=@+
M9_/WBX\KXJ5O3.S?IG;BKCYU#W*^,]=P9O, - $W80M"X764>P<N/X;?/?E6
MWR3+*GS:I!_"H/\VG2'OG56!>PYI*P4XF&+IHF='[9LP%-DRQDY,NL8D+"H&
MK,"_PW>"+@*I\^K#[H4HI-TGXQ?GY6@_9HK_D-?24C/^J:"YK3Y^;HY\D?7+
M9WWM?75O@W9&RH5[Q2)A!W=MZ]*$,[[SC:2MI6G_5-2<\!N]?.CPQGQNSNE5
MLKA1#*1&.0C.0F%#?=(S?CZ.\[D-<;:RRQD>3?+1'$_TB&MOVO["V09<8(_P
M6@.]:E:!W(QK&3I]H_M9^4-3C-.I%-DMU4WX1G,.U+8S3J#GXFY/4>ES$1)6
M]_3'U^7>AY/155KX;@;'3V*2^,X@U#<X11;D_:YQ;EU3_!/FID>B^BX:4V;7
MVK>#3W*)-GM0XK#-B#*GZC)S'8JS.@JG4;D[28=4_/'ZRM1,)Q6IQPUY=9,_
M-][6]M)M[<\, Q8J%3Z(.EC38[AB\P4JT\N&OIE"1HV^J[%5UU7")9^!V$VL
M JBI\VOJ<USC8+"G$.+Z?MOU&Y/TYW'4 V]._8FRGP\\*^]^&PIA3YQ_E)G^
M#BM-!E^SN+RGF;C+'-M?)=^[5'6B0N@F>X>M#WEWR'WK9W?HA %V? V^J4;B
M! ;!^M'JS  <]=2OTA\*]NDUJ"U!M+)HP&X3IB,QCO-^&L6'D.\ZTWQQEFP^
M0MU5$'T-.T>].VQD[<D4(P.2WL>E<DCH^JU>!INO]7/23=0)VV;JL%YH* *^
MSWW G3VN7NO,E<U[O0\Q/#F" X2HG-#Y>C"22!,:>]MVI3@8X5T-P8U61O"F
MQN95<%QL<-Y+\8VWD6$=3!G4SL6E&KPD[75UYM^/-TSG_WS*7+R+8AGSYRF,
MN?*%.W+%1'9]J;*)9 7(;FM@[<TUDZZ(1.\+H@$*1N)O]X6-HJN8^:!W]1>3
MMA,)SD3+UTXC,)/)SPH-6"JC@6.]:JRY;08IV'!3D=GR=D:USKPAN\-;>@:^
M6V(=$NV2>^#7[A1M]))WO#[U%G7SP!^$"#8XN+"POL,YJ[-"X9B+S)KLW#;J
MSYNAIN?9B*PFB7V;Y87+@&Q8FR;?FC-O7Z;L\"PR5ZWED$0L*?NC@:6'.-CN
M/:(,K\9P9H4THP-OC'J*55\I&1F6YSY-[JD];)VB5]17'EDSO?>V>'97W)HF
M_*U+G?";ZXUBNJ*6XVWU/9R;Q/&M]*@^^.9I[/W:9?V$X;7<I$ #QHMK:"#8
MP/52RCMTSXRA[7NAB]F N?@MWW/G">(\;,B*7OO)8.G'%R\VFIJ2GH80S*E8
M.T66\*M<8)F49\$-.GQKBXAR+,ORWX@0L431+.D1=:\ 3V3ZI4^2X+VFJ#Z$
MN] GYZB3^X\7E0+:?$;6^=  =@43@@N*!O9&(D^KE!M"U75?HH&#^UA@^"KQ
MBAW.CM&?_=[IWP')P35*9$?;7AMJ_!-/A#A%5L7S.I>=*92_:SN]XJD)?3OD
M&GD3/ 9EL7RZC)&G4P:=>W(CFE/.9JC]ZWH.+N2%B4QL+BO6TPWJ_1;.]&A@
M)8?>5.[)UQ*C.>>ZSOB$;LA-P9R?F3%QU*PU]>'\.]F6GOXWUC;Z-W?-=!W=
MN;(F#(3W=0S?B?/^E.VKL(%KQE?[<3%L<-+.E.__B,VWQW$&DF+3Z%Q/*FBJ
M:]).#VF-/7D>#).0>;&N5G>(QV>>-OFD/X-W]50_IIG>=>YR*BKWUZJ_-.]H
MT5ES6A:?8^LM-+WI?P[K6UM]&:*)LR=_3G-!NAI77X,0*YD/7[A3&X75:R).
M>&XTHW&F79">.')G)H;"B\^)EV]$K$=J=W.QXOWI:!M'Z^:$^%E/!8&=09S#
M:4R<HIXHY',/O=Z%TU,LY+72; I$!11"L53V.FZH=CH!5;ZT)RQPB7U-)Z J
MX_";R*GOE%.U9O7R\]I3@Z',Y*%N$^)G+MY@&8>!_;+R8T<C8_LNXZ4G0]JU
M[\@\15<2Y,3'V"^=*IOE5_= G9^CA/94:>6Z[E,/*J_-XJM<K&:N+-H@95=:
M./4R&1R_?:FNWU^Q;--RZ/=7@7EU!W(A7I>8FRS(VQ9^8[?;SX?PO>7%)\<:
MH>=]&6WAX8[Z;D82K5,YMS.><-"+#4 .BD#'90=$_H:PG*B*V\/#YV7E^:+Q
MM-6'@SDR/K^>_D?>55:S))?J8.F.H[2H)Q\FRB]+J%PY=$L:0,^;[ZX.+M+8
MOZJP9YKGB'72>9^Z5ME%)*&#\W/@QTE;E/1MV,:G"Z>JTK*6=0O*2'F6O3Y<
MZY)$42:48-O-D[<G:"!"7#KOY8;*^JO\>-\J%C+6RZR&BNQ6 4R,-YUJVXM
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MZ.UP?UM,E9O*(//$5R3T?CG_+P<!/Y'V4N^G"$OG!ZXE_4+=92Q8@XDSN"B
M\/CYT7+P\J'J3\AN]?(%=85<(:BW[18:6,_W#D6U83K_>UP %ZP)I1*(B=%F
MRY=\O[(8#&<HPT%7D,%?7U&[,(9Z(9.O0*B6B"/!H*.$.3643<6E+QJ8$S(^
MQ03DQ/(F-&!BB;E3QB?4F/D1%V1^&C5:LER5@ P3.KA8(T:]FL#:71)7@$1D
MWR'"8IQ] P)-/.P.K#DL"L8\QWMO+U1GVO*%D,/."!VD7PI.>16R#SG6-1@(
M!/UZIPU=OB0TAFQ-%H*FQ3?JK*"+%)OZDS:'98[3[HG\*EL ?;\HSJ[9]8K
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M.EMP4+=Y(N<<FPJWN);W="\<-10#8AP9X]QM]9O$J<;\1X[Y7$^3&*\$Y^O
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MY5!ADI"]0?LN@'/ GQ(FW\W "(_/*GTN'I[Q_<D JTWP^K,71*'LH%VS306
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M=-S\K1()>&>)[#I@C<J@VM_LKCZ!B7L\]*-;A;T,//O%"B+@5FW5L]EA33K
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M]2NNT0Z>^X#9((IA-OKVR[=KQ%7[OPNT@DG+CC$OZI)&@,8/K;($8M3BL?C
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M$$?)2_%7@A9@ZV_W4B755P8OI?@WWB[5H A()TG5?I)@1*->ST(<^U\P]H'
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M^9@/Z5@7+Q6B71+JL<U14W[:I+JL$Q0BJ*7%9(W&6O@IU*X#;QR8N536[YX
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M?V7XJH?79B21LV&E)]FZ:!UYP?+@\GX)=,C?]_GU5@L3)Q18W2"<@;3L K$
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M(HT1(S0RE8)ZPWUB*2!GSS79J?I\J>^C]\#FK,PJ/[>-#&G0^Y>$RD3QGXN
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M093N>AMQQLTE)!_4/GI9+K9H40?C;@ )A[:-7)Z++9K#E(X<)T ((0U&6==
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MPXXW;>?A#E6M "Y.FKD^W,S:P;KYO!=#RL1QJ3-#TCE6Z)BBN@ XTM3)LR=
MN+N1S;H65N.$5+M8!3DG9=USIH& Q;(TG6]JLN!#"LL <OHW>7*V^R,]8PTL
MF*' .I 7GQOB>&P7"1QU"7M.9;WH!XU!7^G8/<J1J/7SDIQ0'9Q9XC2%?)!=
M0S77>2?O3FAL8:M52D"U:<4JE41L<+9'%PFLB-OAF-Y=P):(S01WJ+/[Y F
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M5LT^N<*T(S82V (OXID9+<B#$1A1T33*9<A&49>:63_LRR!-?YF;CAD[>BF
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MK41+R(^5U]B44E09 %@_N -M<R6!JXYLRS6#!.<%"TQVU\G>:X15@8&%!(V
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M43Q[U!5B/D"13"UR\/TYI@;G!/%A%7%7M4#D2M'>Y[5TTO)>=\K+DSM<(-E
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MHJO]W<>74MD:-@D]!H_!C7)TNU>G-WS1\S;&#P<2-L2\*'X?T/%:8#CJK#K
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M?@M+V0Q!NR\+QM@=??=R74')R/O1AFZ$_T_C3W8;>^CG?TS'_,&Q()PQFP_
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M+_GBYS)%A,\TRDVR,XBTU2;'$<)J@@P%5?1V,.PTO)&.U@\"G%[[CYH=5QW
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MZ7D3I(IOI/=9/-L-JW#OVRINZ1ESVYUQ8HIX%JCL'B8@-)P;Z81!@,\QVN:
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M "4I/ZD9ONSJ2[-<94?8$" ]].DB0S-UOI8)#O%DH(1^GWY:S28QG&N(JC^
M+)P:$+I_BVEQA+ZPOW<KU#3,F$[39$RH7VUD>5)G7X)?3"9Z2=Q(/FSEE$;H
M6M7^,G%\#VA[+.R*^<H8P3^=SB[<;[L+H/H :+-(L7A_Y!/"AU:\4V[!LAW5
MYI2[J$G\0^\S<5;JNL3N&=P7P$_W9T[NTQ%&)],C5Y!V]3 ,[K*7&%BY^):L
M=.#&A<;NA.Z%MRIRP((OF\ ?['FMG@Y'TBT+G..>&#F7!FHW3G/:#-]35F_H
MAY<166/BA7C*CI)/M.'_\L8^OC;;L&"5)Y.#96'"*JFCX$&)3;NA-\>F#XI3
MR?=+O]-MG1<+);W/EB3J(3\,O57V.)8;V4?6#B?#%S3X.J.Y:JOT;JFYFZ^9
M!8. HRTP1:P,QCHR_L2.Y9W13I&L\M/[8HA]9MY6XC?WB4\6>2+-J<P=XH=5
M8F1^2"H[)V [9Y,F MH.*5[FWQ;P/S(4X7:X)BUC^-VJ#5+EIVMD]P4D)0FO
M2<;<OL]!)+OP^ZT=XE5ANTZ99Z983*OWFW>!C6H<7-UT@KN9B#$/  #N?NJC
MP[9+SN9$4/!Z'6>T6JO"!CG1)_UV#+TZQ*GG6Z9_)^#F"VNL[E-R),R)N%#
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MGB<HTP7*/_+S!6Q+:\+H>K/J(=(8P;G!P?28QP^ 3A09:OG+,(]S+YX%LO+
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M/NBLSYRUJR.YY0XVK<6-2\*<JQPJ,BJ]""%.:U^;?*O'XU >N>DM+M7 Z*0
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M+UM=&B_7$"'MIOAV;S5OZRGY*"[$X4@?Q8QQQ8KVQW>9]<Y,;PK 9TE>;^V
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MP%6\O.*![N<<?^G86CJ]X=)'\&Y;T_X]+Z@-W79Y71?[Z=,.D@P+0@(#57&
MXG/%_D'DYWCICK5# SIEQ:@ZW9=@NARN/YG(>6>!W*(C#"T'AP(5UI/G0HR-
M!;*.H@\M;*P?XD/JTY'7R^SP1M3")JEE3R4/#@8D^N,5\+!IN(XB>O59%W5]
M,YR9[*.;T%VN";.S%@M%JR@,N_05_5U/, #]9\_>/RH;0VM#80Y=:$1<@_N7
MBV:!#]RT+=^O)\''1WWO78@,"=+;P;@QF&"OZP1/IQQO3 / S5H/^AEP]PGF
M_A5 Y(4SS!42O'LAX'3&?%B@&T' 55?E&X5T1'5U5'@$$,!I'SJ]7B#.E](%
M\8LB)-H=YKR3-F2YGNPZT9HH'^K6E6W9'Q5;(X+\#P?NF.4:9';$\)KO//(Z
M:#KY<@4\&50[(G3,Y\N7^C+4JI0VY7<],=_X7_[MOE0J0(H7+9?SAMY9_[U-
M-?"25X.HJ_*F#E9G:>]:.)7J6[3PL%UM_I5JFQYM+>['9!RX\)\5 Y[E;+"M
MQV29]\N_>C$*R51YNW2JMB1GG_V0KX[*<9:EW(_>H#KT=HR2Z/L+C5V=4<VF
MIGC%6HYI;OD_Y3[EC1XBW:03J8F%Y/OM1U/U\1@^CT:AFNZG@1D=0W^_DY67
M,V,>M/'':8[32"TOB;AP'7%F4A.ZZ#RA[Q)GV$[T;27W599]97X/?T:3C4G.
M%SYW69#4,;)_<A37C3@)*KC@RV+.C%Q*,OX,B1,_$AET*=0Z39"5',U9)C0\
M%&S"5<8-4MF0WMW_*="L"4?\^Y3'[JE"Y\S"QQ^4;,U*G(1;$O4_VF&E!)N_
MDNSS6ZUPF8R))\JT7NYIQ5'L4.5JFYF4-;0;[*\V&#RFA"J@>_ZR"."*$[.K
MS93,&#S#@6*VO=;B_WTN6=+><8WC0G'0Y&SI&X(9S8DN*H'8Q\*\5*[  5)=
M5(=O;RR@V(M_#Z<L3Z/729N/Q6KG[1ORK#"<=@''=@<WFG>\H-MN'KZX7KJ(
MAA_]53D657']_EPS6S">VZ,9 O*= G0#-^OTL?2G?^S5M6N)3&77E)US92Z*
M4@6,C8DK$:N+.+%ACA<)L_JAJ, 'KZ$7H#W,E;'A2>B/[,+MM![FPOIDGAA2
M7H.1D@Z;Z#4] .EK.^^I/4$-M>'RUE;Z+..=J^M;D!!.8$B+R6['[I%DAE;\
M[S_JWWC*:<$,9>N9B5\9-@UL:_$M5K( MWV"]Z*WK+FBK%3&L&?DPD-JF@IM
M=V(U/>)ASFTU7>G^KK=U\2ZG:,_..VB!!-SORIF(G6CNZKBVRM3B$5*3V>DW
M;^P3G(X+^1D:,G8]([;,J6U4+>=L&BY?)VJWG''7L/?E:60,YWRWZPV#O%0)
M'7F"B FR]K1VM<V6(#C.KR02-RAWG.*EC>KJ*HRC/Y?*M*S#6%BK<>1E//G&
M[NQ[;VURJXL[_VU99TBY\+$HY'4N<48](BO8U]#6W#6['3'%,O[<1,E_\+[C
MV5@# 4.46ID'6NN0==7MHC-F[]>,OM>3->9I7G@(#9=1G\,/!CVI7CH8D#O-
M-VP]>P,++V?V77PCCC4U=5[G84K.NZZEHK ANS/.)/0HGX[EG/G\:Y4/:(3U
MR--;;@?66U\)B+$<D]I)D:'Y=PF)2>0C]<5A)E(5VH1)KW133[Z1>1A+]EDJ
M2JG$E<FN\2ED4HV 8=X\3\HK_-J'&;4EV^S:4A71W]#;;+]I+(\9VWG&Q$$O
M(;Z#+2,F.[.CSU#%7,Y>[HME=H;U32ICXB.%*N;V"L<#(>&W]K*C7O1IEJXW
MX<HE4EEHI*W?'@AU1R2W5ZSE'T>MK-35)(^N[7L*B_5,=L_91Q@NR.*_ACXX
M;FE^7!W&S<A8"9R9@L(YE,QGR8?+XS=#^H2AHD+M7K#9#A<YCP?/5X?+US)^
MOK)X -U4#+UV%W%5(VB$BUQI2K&^XH"E4/J+T6RK#<["=U[!,ZA'54"YKH-Q
MO$JI5*9B.:_)GV:CT().E:;0Y!#C^H6A:8DG(XX4/2T>%(F^A-MA?J+VF)\E
MU&UN= J:WMIW%X2.Z8%&.+>55A7+*O9W=D*(,WX. ][,2W:F%DW '^59B9<J
MS;T,5H,9U\0)BF1ANVV^A*%HL-A,9N=FID9XUSNDBW/=1%Z,%H>MI&9GE%7R
M\+KHCA\U$Q?F70\B<<2 @< H04<UOK''!Y7VE,DLQ]\BYSM:268:V/_-+[>=
M@@&\=5$MQ/;R>Z"\-)E5*,&A*8<P6XRWZT?6QP2"Q07FKXMSV%S*6<@*:R,!
MPP9E?+2)(,:S)1^N;:X%%$]);.LL7^3BU-(#29;Y-_P/''QIT ^+389W1Y2'
MK6W3%FR>:CY;C^B\X%=/#P?',IL=201%]8T<?]'<?8CTU?]J :8KYCQI^6>$
MZGZ1I%]:T6"ED>LW'EA-&74Y@&H WFS&J!UKO9<QOX'%;HA:K2#!AHZ=94CA
M41N_*6KX>'3!X%<0BP^D9D0,0*-TP\/2:1)!\=PD"T&TYTDM[[C,?II*$;5A
M0VCJ5E3.*>@,9#&8]DYPP\RX(C'MJ[1D4(2N<$#1909S(?RMS<=5Y"6DZ2!_
M\IIW9/X%WB&65G)MJK>?6-N2XCM)B'1L>5\!B;;_/"6RGM2>Z4+?6*&#\R4F
M=QS\S4/N;CX[?OZS!#N)*L)-)P7T]F'Q/<FASDQ=.6+)YCNUN.A(1N6]\+0G
MI8KD]5:"YS'GI;@;WNC[FZ_W1ILFO#P+Q4)]LR1;0^WD? L]6+^3?@)I5=)&
M/OV$Y5N/>T!P8]-#[JMMNCGWI'/DMM\L6_#NCG?72I&B&*!>7U(&-=BWW3:H
M@11UI6.)4&HF(P+=+%'O^'U1:*Q(M1F"&\%7P%W3P*8UM&SG*R#9^$_ '@L!
MNP2<KH"+._J(PEHZ-'S4_0%LWT%T^74(\EC_FCK\^5)N\PH0[D$15HD!;WU;
MB!>*SX#U*P")U;0@<?$DB>2:/. DCZ"\8R\8;< _X>D'CE;]PQLCM5? P+>?
M6O:_/)3#WPQEI^E@JVE!V^DGW=0/G*0H2QDP-3 P-W!J91L@>.)2LI[@&#YZ
M4%27LD%!-DK1JN;?E2@NP8<E]&*'<3/O= 0N.Y"\]T"RU>B%-8GAX'P5JN\Y
M&5=TV%BZ.WGAAP<Z\D]:)$B6HO3%O)XA2-U$9&(\+\BEMW YZ3O#),0H&E?J
M>^;#JA+W@)[PQ^4196M2]RXMUSS^(<;^^U9SZ:J[[ZHUP;/++^B/] YJ $AV
MZI9V*K[9SCJYHR/.<3V6;&S>EE>Y[Y ]I>NB"8G_4L@\ZQET%\PN582O/KH\
M:L/^4\U >7@B? 0+;)6NKX=PL/4^\0]R%XK=N/#_S1V)UV3#[H,!A<:6%Z%6
M62$/7UTE@:*8XJ??TV97X5L(2DMVFLS\)]JW^<(YFA.N@#V1_K)\-<[T/LIT
MW*#<X)S<$:V@]X)W)WN#<RTZU9KE#$,1IB(7\@?%;UYIP%7"7J:%,EQ;ON$/
M8N%<DE &NI:\4$"(WG)E$Q;MKIOLZ]>LW#RR''ZI;W<-"Q-V?IEG_XRK#TLW
MMZ9<1TYX'_(3C\+HR2*U>RG8ASJ#_ ?]]<(TXE8"6:#3DRRT('>)O2O@:.VF
M-TA#5IHYTH"%P*OG<M=>Z[^-@N1$[LQJ!_GQ+;JGG^_E^_4<D8O9SQ%Q62N+
M(Z1JAU;8\.W)'+N#5C6F*)</!<"A9_@ZZJTAZOI$YC3TDG?HLV*3OR(I;YVL
MWJDU'US-II\S'&@S%(IV4U1L>K;MI)Y\H;/GE42"6"(:>WB/<"==)**:9X#,
M4\J$(A$8L((EKC<^AI9_W"XZ[#G19/?JU%*ZMGJ[M'+7M' C/S4@VJR&QCBT
M-W>!01Q?O6:KD7./]N)I(VF4@N289F\PUK.:[Z:&X3[^M(@B'CEDOJNI4\BB
MIT9:I7%7')6Q,7IJNYS$</UYQRP/M%[&/EO"ZVD@J2D[TWU3+&3[RD!*)TA9
M8U]?JN!F4=';=]B]JPDX+75T!D]3X*H6[KR]_>GYQ O+.ZQMQZ;()@/JL\+P
M1*$?$8_=E[9,3U0H3R/B=LIGI&%J(_#ZTJC>P!?-[7>%FLD_%D=3C=+6PPK*
M"Q]:D,9_G)<R%I2H\5N"%W'HR[I)M/JWS((@\CRR[BS'D9H3+KN&:P(XP 5C
M+*%<&&<Z]H $<W%(,2U_Y;*GJS[L:Y48@3K&]FV">)C+3*L+1^B!S//;A 15
M:@C)B#Y!^_J@NT7S1&<X1\PW?I9E0HO80V\+PV^-6QO>?1W&_K2+@X6[K7"$
M3S )29Z/K[-WG.VQW[.@$)RE36/4&"-R%+96U]1*NZZGOU<E'XX;HO2ZZE7A
M3,&#'EP^+/843S\"DB1FI5XMS0ZNS('8NP)P=<I>JB/B6ZQDZOD!J7+F4NDK
M98+6'DI.\R?;M:=)7?.X!-/(\/85(0E+7:UORZ,NNVK].$(.N.NZ*E&M^&DR
M#)2==N#>&X;;FWJW#1<MIYBUM&<PB)I7=--NZ?:$MZ+S%7QUMIQ15HU;U:B.
M7#SJQ*!,L (.T5) KU55OM>HU+J\[@]T2@V2ENJ6V1..3:MG;?4XSESPQ7O)
M2EVM+?'IWI=,ZL"1T1)OC@3P&HKA0O[:9%NV>GC/!=D6SFV["BOW9NJFDTJ!
MZ-<C^2/:A3;!120J2U$31T)>+(;R>+)=C%PCN1N<ZE_=T!=#+.,"LJ+R!=FG
M9YX\D[_;+DG<BI.(KJ@7KP'-9G!8CH")XF&]XIN_-CHF-O\</?J+QS>EOI-+
MI0"?;E#-XV3 J(LL [<J*M+?WFAE0XF@*DC^'FI+$IZ.\]7")&'I\!6YQIGZ
M;5]?X70GDVJK/Q?Q$+N\. L;BEOX]N>4&+7BU)8%54+7/="]KR9*/WIB^%_X
M"%M=F_5MP3^H]#4\6,XX<'_#W/3-5]K83Y?C,&B<4B2XCN7^YZ5T0I?6EX/%
M@J*YF8E^1DEZHB>&^LIZJPN[N!-(Q]?:,M1=@CWT(,ZP#=^4;8F@>I%KC/',
MFBF6ZH IPVN8)Q?E7V$!&WA;*E>V#&GQ'M..Z<"@<-_D0;H_OC:L'XY_!=9R
M-[2L^*.;8EEQA.'A>1;+!#=6JURB-*8Y.8H>.0E]/"*L2;6L<YG4JR*G_'1\
MS%61:UZRH8;2J><]#^?/+:+9&;8D#0QT;L4)*J5(>R>$"?Z[J"]CAY<C@J%5
MXQN,59 R=T/MX<G6<&,R]IH,7Y9@Y6%SN\=11X4GH3L[3XLUC]P>2P@M>.N#
MUA&TS.)95R[+ B7H"SV*PI<$\!N89PHVO-EW/9M$/YZVI\)#%$X)X)_JG<CS
MBQ$2K7/(ET5%J]=+.%9G3+:;P0JZ4S\*0>=3#,=VE[]@O (FSE&!,OH79)B[
M/D1NC@OM03D6#[P$1I\V5L=0:T>'GP],IB20N:PV !ZJ?W+$J>,O@H)]$9!-
M&(GIQ1,]-NA%6-.ZATWTZ@N:9>S]QH4$4_3P%##0B^RZ M@?7H9[N**@Q5+%
M&'L#D"M@@6'4"]?P&M\D@SEM67]4XGNG:XSX#. ;?+'"KEYNM((/@J1/_M\.
M@[^US?LPKM_9%/-7#G8XMJV4/R$-1:&#$D&87/[.:0-9TJ>>$C./:)&D5?..
MI^!M+L9'1T(L*^V^-?:DXG(<H>%-05I[ONBS/0M-Y#^PN\:Q"LWM!!SLS]C0
M$<5RD-V2X>Q1"TCBCRO@F\G]XF$/D<V=<XC#]1+K_=L/9/_+[7?4@62VDDFE
MV4I4!Z\+=3V;>C74FBPT-T2E*)-S:0+^XV,=.:FX++\(MQ57*X[\B5  0,(=
M&N?D8S5N&4B6O..).?K+]?<_B$N@]XL0EU\!I1>ODMY4:U<;?K:'PLVO1V&A
M[U<;.8X\M9Y>L+6>?8)"M.)>WH)I[ZU*LJ_'V122K'9&I'PZN[/DDX)RAD^R
M9-.$%6ENL'F?F\>\V/6_'G:Q65Z<3ZYI[N0/H<0V!Z8<LMMVDNB3A7\Y_5J?
MSFU$6=>P?;+PT)2>NN>6<)ZP@N]CQK4!,K=P;+06_H#A/M#D+;$GLM.QMI_M
MMV2]BJ3>2O'11IJAC:-N:(!X-*"8"")>U29VB341Z6/PHL^#=70II+=9?YUQ
MO4F-C0#/O2L@_+UNQ3\E->G/30=55W0J4&@5?Y)(\>)"N'7V'?9O0+8##\\S
M+>WZ$QP\ J,HL;Y>M9A=H=8/8L14,(S\C?V-*N*?&<X19Y[)'INM!IEZ>A)?
MOYC<;VZM3^HY\GGQFSOZT\!GO"_9($PNPIB%FF/Q"3-3UQ@VI_/W:[PN^:8;
M7L57?*713X5^"1W$\_V^R.15S=%\$L65B*&@5F@;5&6]4/1[TBUKDU?0"B/&
M-]G/VMTXDE&TI["2ITSV>>*IBN*$*F]NK+_\M0?_P'FSN[YHH*GY3>[\^GZ'
M3W'UGS) _K#<X&^1\^;G<"GF%5QBLR71YK47Q>)_X.$7AA309!)UL<5B"ANC
M3JH+I0^^+$7.OMF+"7\E2/&!9*O<VX"+KE+J0[7B >M)PP_ XA^+V!ELH)X-
MENL+V7+=#1U,=?'C:$ 2MZ._]$0#VX=$?7LE9^]7GQA1(^;>GKSGU[_POG%X
MQ8][68L/[9-0,]IA49/ZGEQ4ZAI]@?[TXK 8-NG3&'8CFT<@.4O-H5S93.J:
M #)CS/5:AX8JWH&P).JRD?JG9XRL\9XYUL^R+PY4[5R3V]YX7C)VE>?W6?2K
MQ) >EWY-9UP1'W^,UTD8"]]])+5W;_&6NH<3NZ@!L>1C%CZZ#Z4FY-\T]@X+
M:SBKBY)XAX^$UP2^1*.%.^HE8<8YS0P=?&UPR1<?N!AJ1^9I>WI[C'@/U;A\
M(L[X%"DYH!PW W7&YIZ3,]5N = ^[M\HXE$:,1X5-' T2O$SIJ0]]P]%J<XD
M8YDAS!4+>TNYEQF7 YAZ.FZMAC<>5;"XK':7\SW#_&PHDR1;I[_+@'14'3DB
MU1WKEA&W?VPCXSEZGF^6-*OV\;/+X6$1NGC9Z"%C^U,B,%^\&?D4^68>](@T
MW>:CBMAY4^*[:T(/*S0?;1#QMC#XV$HW=@DM2OYR!>!.O#I@7G$8K-[OW'K1
MR;43A_N#U#+RS:B!\WXGMBO)Q9?UFMB\(^)V,;?CH%MCM5HZHL08)51A58]M
M;OD8F13\P'L2EM-;F% L-Y')),CP@OYQ-J0P*&^&)]LF:"@NL- \:RUJHZP;
MNX#M:TAJ_W*[N)#CU*:>E/U>B(X,GZF,S*V97L5O=02'(#<C6 (ROQT#NVE\
M4A->^9[@(XF)\T *.9_@X6+N6A5"3Z,"&I"D,>$[ ^P-5Z\;F+?+L;N:%H)[
M[0F?D'P> 5_T9TO#N.A93$:/+(-!:N9$1E_=6N^ Z,AOPBD)#PF+JK+US!ES
MQ5SOEC/69+IBXD.Y/?!V]85"0@S((C*K3>RX)7=<:8O1P)U0YS[A=K3;JRR]
MF,O(BZ9"I[=L)0EJE:7-[WOSAG-97>/C];^.(K.U()I[E=F^MD^G)SY]TNJ*
M>I>7SM2$8.Z8S9 '(5.9X17^2@:8H>YA)&7PRT4.G0>6)F=G][1%:K_'&A\6
MKED748GOJW26AI:NEZL-9DLUB\,DEPL_MHF7Y^E']Z29EKC)+Y*'K<1\VCPI
MG9JCM&:"WZ/;FD!#&[QD3-F3!Q\.W%U[8%&;T51+]BJXYW6;$<.E/2S3:]67
M:6SDU1THUHT!/6RI1=LJI-_P</^F0J2GI897#@!_(Y@DY&DZJ$YHA>G0(%)W
M =&_E]#-";4\'KH"OH8)-WGNW6MOU8)VB^]C?VIK<J%K%E _$CR/V^3*+522
MA ]'9X"I[M4$WN-Q/.RS&]+J2;4HK97X"-Y2/2K*FD2*43U(AW!6W>W&$1&N
MF @"?W!W,8V"Q!<JJLP\.ZX\V4B>?-"9\_:)@NUD1Q+WR6*!H*E:C=(][]+Q
M4G0TURM YT"5RS*[O.I<IG)^>M<6MI_'':MHP5X0<V*T39:78*2VT[5_Q+N8
M 1-YN=*P&!*/C2/C_7+#6%+=R@+N&C/^_3M7*\^'.=5PXNRF&',CTB])$L(K
MM<4$9I63W[6-JC\9^*<\HFX(TQDN&.N?H4Q(H&M7CV3$4#J.*H\),A:43I62
MCCI)N@)2=G'6[9$"FM^@3,1&U16,CUN-V"A7]-L>".6O]\A4LVXMUI9'& >J
M3H=G/P:?)CV<X]BQ2EF':)WX!KF8F\Y;WH_B;%<8KN,Q87)('W>Z8 P!2>.%
M&H-$QSOWN$R5[.)KI]?7TL#[N+G_>,W/E#^3H4% $HBT0U>RC(1QM;IH30Z5
M @M??$%7@%:8HPZ/<6$AZ7T<XJ"?NT#^%ZCS(Z<>9<Y5VK3'&QW#><\<O/(=
M:'E'0A)F(K$E%(->5W#(.7@\Q2GP9O1K:DI6K.70^;=@7QH*Y2V^UF<W(40H
M(4;AEZ\^N&"7!ZY#0@)ZR^C?+O>0/VX"<5]OS"Y)O+^W]>9F6H2K'YTYRTI>
M1_5T^FQ9;LC22XGIQMZ5=E $UQFDFJDG/8$.]S>SR[,^.2\MSN7:\:% '"4'
M<?XH_Z83U?LMXD!R-OL,!^KFV3KF0S9"--SE(,_>+=%'Z9&\)J!6Z'7,2+ I
MK'%!.V-<8V47L9I4YAL4^;-.B_R;/X*A#$F96:VYVJ<."/@.[T96D>)S"D]7
M<ZZP5E'^A2#1<8BB=AQ1795UYJ;],!^NK:&V5DP\3J;M<D\KI!J>%[=HLTU3
M6FUFJL.VYHFW08<VF%-D^A+FLEW>8,,O\61[RS+K+SO1:TAW U$W5*L;H8*L
MZ0":K.#P9 I:K@DM2$G6>;372WIDU]DV4/AIZ?!01EVR?+1AF/!AD.T,Q9*1
M#^<->-]B<B LLHLV$(6KMQGG]%JU>)O3^%F",V5XLHYZMM>S&@1%8;:.1=+-
MX<+R"1[WAY\*<_S,OCA^>RZ22CD'SIT'!>O=\KVQKCBU.:D75UEIWT&=.=K]
M$D&HD$'X%E?O\F!7LPF'BQ2$Y_5FK[%AH;1)/))1VZ16[*E _@?EFE@8 !>>
M/[GS3DCOW\_SX?X-%?K-]3\O2ZC><3$<<IF\^*HIP)YP?X?*)<)-) MWT7)\
M\^L>"G)9O, 8%E+KJ3_7\7Z@!^H[QW?)6(RA/C$FGSYXP/%:9(SMFXQSWNE#
M0<J",-=6HEBKA:Q[RWT#3V#^R<7H>X5Y^\D?)CNB<F;,V7EZ[!JM1"\K-D3P
MKLT +%]E,=>3H4@(FWU+8HQM*'[.=,,/3%=D6/^O37_^I]$@="'XE"=C\DV+
MH0VEN_/G MS[&).MT>L[M[WR]<6]S")5D,YT$ &]1:XHBJ\#!S<;'5,P'M<D
MC1G'3)H_B7!7#P-'(,$G\@'Z#VAA)J@V6":N&T$Y?M4=!?[<(Z'-YLT4!&D?
M"'*H;&.WLL_F<3GLOKX=!YP5@1E(*Z.93#V-9]C;V[F.K.Q$^ &_7:WA+6J\
M.0ONRAWW*:;N['V:_"N@13G%=]!2_@KX_OD*(#E]>;:XLH%RW\UP9R'OBDC.
MM3I04$ ?FT-\7@,=DHQ< 0AJD78(4MH)]PS[9[2$(!FN3S7T'*3M^^M^1!;H
M!T76N+*O@'EIWS"O*#' V_H*P)![?P6\:!"Y FXJ7YA= 1^RGU^OQ+'D*^ ]
M/8IK7Y;@QE'5!34_^N6=:])X@2&_5TR"C-A[>7P%*"5+(RYA409XXR/?KP#.
MCJ9>D:#UL?I:,*#N&A$BV;OE3ATNE:_UFNA$:S2Q8:M1M;XL388&8S+S'2W$
M(O?ZVR.P%%MMR13>E:8%/!< >+/'] .-8O0QUMEU;E);\H;L;";Z5?RSA#BK
M1S.N73.61G/U:_NX"\<4AX!E[6Y4[5A7D_O0$JAU2V@SXI<B*Y9?1$:J9?75
M8U6K_Y3J"1F9/H?ID6(S[.\+]K:R!>*0+QWKY^]C__J.,6<"]:$6O _NAJ4(
M58O^\NF5G?%KWB3^^VQ8PK^DN^HOU!B&<(:'"E-DT:1ERUI0_&'0I.$]GF&8
M$A<FF"TO'<"5QB/B':54R$G'S&,##C.+XXOU5)==O%'W;LNCR\<(''FW7-L2
MQ^J_9B_:8)S/7+)6ANQYS[M%(#\/3LAPD+)E<^N1>$J!^Q+;@^NM9=RC.F5'
ML^H$[V50QS6X3\$X_#5)LU!/Z*"*.4 /+7=X,G_X&&:<OHF1*_;M-74+Y*MO
MPPX=FM)_TBCCV"Z255VO.USG^# :\? 54D,Z8UX!@D [7,,2-L*# F'J<!FN
M=LJ 1I/ORY#<HV(?9&9>4>+\O7-G+QV+9_&\$@XZ]SL0NNV-/O+8A06*A>W/
M,8E=L8Q<N#;?$&Q-CI^&[JCHI&4=49:-'<X8ZIQS?^4-5F77[2(6B2VN<"&!
M?62MEUAPJ^?+F?B^.*'R0I Z\A5#W8L=7.);AG%[S#8/A^MEJ"I#[\ .WC*.
MH%>X:*&'%K(LQ%B_*N"8RM($13L3UIMB%D=^&R53SM3&OJV.>3D6??8-%;NP
M8(29D9] 9,*8 *WM.S.+TY[NP[@%Y%9X1(T@\E$@V*K?[5&F87J2YRH23 :Q
MAO:GBXG%LR(?,Z^ X,;F+RUTJIBI$L^!HO)"4F7!*EJ&A-&9F2,.YB?E4!9*
M:/K7T'6B[U(#MPY^Z%4_>_'@M2KD7'9$>#3D3B)-E*"2AG3GZW>FQ(#:5HRV
MH3+3BM)]07>K<.\@X H(X-6;LI!5I3 :J:5O*<[OA]CBT6,P1PKQ)V>*Y?X0
MVLGZ]%C\_7UT9S+G?'J:PSN<$WYJKRG2QPKN/J#S_S[A0NN!=TJ&<M:I[U%R
M/R6'=2;:8I%83CZCN2^:YQ_*_2S9AS=/K2JR1S!2[]4"Z<XG]^,^SJ 8(Q;5
MF\?*71E0994D,Z>I&R2"H1B1:I@$%*<7.5&5.0I@V^@KH)4,%NHD,<I2*!;%
M&D]Y7S%<9%YU&&G8^D!+4Y(ZFC+$=I?::DO'B9Q/>#3*,W5:S*XHLJ9:_G-=
MDD2%QLCND0SM.4N*9J'1F[:;XI*[X-50%0L^KGR!;"7'E-QV=9EL92WQ&O=%
MH_U!B7>D9,G?74^*'*Z YCCG7O4J]9'9 4]&$^SP?#+#Z?M2%W>+EF.L/2SC
MXR4-PP7<_.^^1S,R#!>RGX:Q+OY(EGS#ZBH>'&@TH @3=+ZE.O:!%N35@:%6
MP9!<Z](83\ I0)DQ50$U[%$1P.O<!(-WK@#EZ$<_/I/+H5MTP.KE(N>TN-Y'
M;>&]TZ.</@.O._6Y]!^/%JFQEUK#[3;![?@?&CKK-#;SI2LX\U4"=I$$S!6T
MT,_M.O5#X5^6? CC'X;05(TM5E2?;H\BD->;M2R:=J4P>^WG%D66YQK3.-<$
MG"2_V,UFD5PL^778SI/HD-07O:9"N,@QI81IOOG=W%%,SG35X;Q"9^>#N1TA
MC ?T&>"E]B)TAL).0NJB!--&BE<F4AF\JC=+O$1R7KM,6#P@<$N'WTN(FPM?
MD9$:?JY%K["CIM?F6OSR@9*Z($-)-)_#=+S>4-S02LF8>K=Q*!&Y1RAXWDF
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M11OY$/(ZS%]> .L.&E(=FI3@5.SE_[V1J KOU ,[\"W R'D#0HY!FWLB9.E
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M:J;F)!Q]+7D^97'>JGS(J^?;F2],.F+#.N\6"B9YI*=F*M*23E/F=&G2O?Z
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M(LZ,E6X5.4\$G+GFJ1%I,9TH9<YLYBCO,P(U(*WN3.EO%OT=LB2/+.RM6ZX
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M"_+O-]0$B@FF=SH[*ZIXKX#&^#/<_FK](!_\ZCUY\&-%?%)&4TV;C(YN K*
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M)ZAB:-=\9A;-\9[J=T9U(YH,44<J$O5P[%P&)5'U>C]D?]A>J7PVR)_<ECN
M["_6:NI?RB-T0XEH?;+QH^_8]:8S@].U//8E[CRM38.HBL*^_>4!VS5Q5JJ;
M@Z*+OQ@F>R%X=0KX'2O[;S3[_0\S 7YT^8@XM(#=X.I<L!.'SY!LI0L!X7:_
M"ED9M!Z+VN2!TP8JVY-'TJOO40XEE'.YG0VN)("$GKBS'ZZTJ>L$-'!;VNJV
MK;M.QJHQ!"V6D+U"%QZ2O(QMRH2918H?KHBI^1/T].#NJD9<Z7KQ!/5,-"AE
M.#D:G0]FHA5*7,B5J=[!4U3NK \%5\4=WH@T)IQIMC,I6&SP.IC#PQ\-K0@1
M/XP?%(76U%."\!S/L8>3CM%[0!ODT.@6864G_$S>\XC]!!L+[O3@AEX6P7/8
M0O#ZA/)?;*=_.A5(/>F2O:-HTLWP$DB^!_CE+@Y=H75#2;:S[@'+P$$!\J'%
M< R1Z9S0PG;BO.!86>J6&OC22X^+])O;AIP_321GZ%_F!>I+)CX/5_+ZTH="
M'G_IL?EL"T$</NUTG7/SS>@FK[M+)<3#J/SQF7FG1K>IZ6\<R+1_UJH-#KS3
M)+.C07&[(?[-$[WD FPQ/Z]1[Q?TA&'7"4OC5^6K7NMG2@3 5XYY&8^ 0&Q(
MPGMUC6[:_!?D6N_E9F1U6*KL)"QHG\DM\.C"/;P &F"J;CX1D2=EX/DBR'@0
MB?^V=9]_9POY+]*JX3;=.<I>P8!C/KXA.M68/>H;S]0;S%:JPH>)U#[+%&-*
MIT,W@=4'W=/*-=QEY^;IHMB$OK24LD@5LBVAD2_WP^OW3':UIQ5)XIX9OD3&
M5:_<OJ8">3+^33+7VI]D+JO_NLSUAY:]-!T[ QD_P_0*I7/Z="/9Q6T(3)@#
M<9R&KFMS8N8"H]:"C09U\"LTI 67B69=GNS,O?5\':F*Y58JFU0&OP!V+P\;
M'][2)FAL'(V>Z5ROL [=+JJ/"_/07(4*A-@#>Y)!J\>?V]\IP-.'568=N.5)
MTB[:Z\*1-EYAQ;!-.PJ0$ 3:3TN_J6=F6*V#5.HPO*2D#?%4WS2?G-DB^"+4
M [OLX1[*W5'$H!I,MG7S=*6Q-SOI-AT)NYM?G^>ZZ D2<RBY!MT)@1:+YG.)
M3&Q%3:K66IU93:S5FCB*_#4=9X40+Y5I=TC=34XGU73UA0977<X?5:S-BTCP
M6OG"&W<!>8@>:\]KZF28J4(V;,\6/>QMUY7EF+-[]C=F9!5D-'B#64I[J8U>
M"6B@(I&191MN3^_R:*5^W]86N5-]A[<>PVY7]DTX[YCD*6'\==*83-5'+5GR
MDTR-TMN9WBYW$VX3X[(E:6IMTYW^_"<!@7N&0OJO/2HNSVX1>#M89]O7';@&
M%XJSK3PHFJOCY(WMEH.1W;?(2)QN31+X.#AMZ"ORD*P\/"[!)"#9Q BUE*%S
M<P99T_VH39<LQY*YF=+RZ/=A/&1&[&H8<_3Z:DIE.!&O^6Y9M>V!%.5+A1-,
MA5\A@LSRBHQYX.5VG:I$*=8!FKJ\R\*<9'L%"5K6H6*?&"*3)N.FKE/\H&X]
MPIN;HXW7MF.VFH,I([  U5HK6%4E.2H3W$P^Y14R?8/(=$J<ZY-H#2-% S]$
M3;TPVK#1W;-$8,XUAA3&>P_SECSV4,G"!(YQ(D6FLH]Y69<&ZRXA-NAE105,
M_<.G^7RB_#G-2ZPFK'O-J*B.!$W'84$K^5>W_+2A=5!V6EXGD,62 GZ2 <\O
MR0+']^.ZXPSP&M.70'Q 9URA\LUA_CZA1Q<(14F+G6_BUH+>R%AF<TYPXA4?
M_KX;)VC!-,'.2F,&$)%<WWBET #,G-%JMRT4M3QW]8*S#][G%(94ZL/(.JQ@
M+BL&K>UX7TI9[8:RK2'!Z1JQLF(NXQN$AI@I+QKB3@?;--168Q"6WR_%3533
MZ[RK&C7@M.JGWXU'_OA%M653XN"TX,BT&J>NW;3M_9=(9O<6M+2$SHBLA,/V
MB'(\RM%&RM*3?A6+3I(7TU++A6F;(7?RR2?/6)BX;I]85]FHMSO3)S5[L%:]
MAK)O/N\YZCJO&L4(\S!S+*+MIS475/>WI(>+N//@N882J:N8 M==:LQ$,[;X
M0>FI)'[@RJ=(.&@H)8,NN\0QI^+M_);M+L11.9L<#O0FCN0FA!<$.)@#(0:)
MW-S\K!"N8L;8Y5&"TK7!9I9'K*VD=<T!*4\F["U?F-Q1)"I6\KR3ORPT)SY@
M5O/8C@BQ;1UT<2BR9LMKPXG=4-8)[%0N-%:?!Q[S3SPP&=RKQ3\TB_FGL!G5
MJS_3@W1$\4NBN2'#,,GOIA7;US@D3FR_;]9(T3CTEQUMX>A.+D/M";K3:@P2
MZVKO+[,L%6X13<>+4;"#[%/I/##W6&:KN-Z?#*DUM_<^8"I-RI*_BS0B*P_Y
M/ :ZJ76ROB"T5U!YH!?\]14)74OIR5;MZ;OB>: !%*V9JM&SFBW"@.I2$.BG
MJC_6G+_5F[#@-A556'_2G"!_7J<RT4W_'A"/<M?-SWL/,%7)@O[^!_]^=?W_
M:BB>T9/)CB\>V].^!RM4G:UY!.3=T*QA04SF,*FZI&(E-T] *DMOBK*:0MT.
M22[7N.:;O0G#N]E[YV'P'=.**?K*.5:Y@>;DLYYP[1XQ^VPJ9LSCF9G0L6-:
M_4GUL",9QI[#+T?BP6R.*/1GI^^LJ[:D/,+03#7<E*'I'\L[C:RWA_#D/4D1
MM[0[^L#96F^IMY%ZV..LE]R1-Z,X(@S5:NE>?Y1=IM4!C:1V?]BX^]$)N4-S
M/&F^P?Q2#6NE^LA08>>P/S*+31*A<+.]*XA31$!B#&%0@.H5>O(IKS8_<V-F
ML,[%HJR3?74/F"H(:49N$*1PX%_5V9?DNAD;&?*)FP)>G:$;)+:;=-X#M'UQ
MEKM\7&86BB?('U!2@3TL<ZG-V37F@NEA@&XGI2*=V@C:N[OEWF8$W ,,L.%O
M7I6]NG0!M:7,9"C<88%\W%4OR_W.=>\.3CBBEF7]B;PX!^/WAP5)OH%CI]<)
M9E3WS0W4/L<XDN7WD#9L-:&+69>K?]Y)_.1Y;GK ID5#CRE6#0%-I7#AP"46
M8DA0GE"4%!/R2$UQ3,WXYH=%)W2TOEF[!SSK'Y,3M2'^_A?%KI_JO]I(EFE^
M>.0?*2XH+XW\ZZ$#S\_:%H#M)]J%7?AW,) I>_QDTTL7!3B/_4J@ZMQ_;]-3
MJ32GX)<D[N4)C[@'I)^#:7X5RH2(@T4_;:H?3(M,SW-0;(9YAD]>WP-XYO]S
M$+^L0;I8 P9LAZIGCRQC7>)<[WMLWU%4 ML\.)W2YG>8-CE&#5$$YZ4KPP=>
M$\*?(IZQP:V[A-Y<Y>3:>CJTYM9&9'WS#HFT53KGZNZ;/5T!F<+T1%([4L@J
M1O=@K(*#"[/"_21]3?D5HV9F16F5/M.OB1ITN5J%K #="D(DO$YD2U7YRZZP
M[+KJ6(@T(HLL:43#LSYT'9 [F:4E=G:1\ODF!M4W4IJ0)X!/R)%! )K&.;_D
M&P^MLR).ZMLI/51!]5)1P,-TT$:[= ^X>F1REWJTF[HD=0] JO*^!PAI"8(]
M5Z8$VRJ-TU!38:)VZ ^7_-)++W5)_(:T#O$6CNV7=GRRAR!3*GC:NQ?F\'=>
M=9Z:]X#N,D\_%EDDF(NJ-L>(V:.R&%[S;\_1ES0>IJ,?\VPPZT(G[3L5_WDI
M$%N5;DV@E#F1KPO^RGNR/-*F?K!EEP=&Q1&EW_ZNG@_N/O*!C]#WU]UD$3N0
MHS3T)+?719T/?^E+DZOD#MWW:7$,64: P_<7>#W%A6DIM(5.&]76Y/)4^I^'
M?8>AW;8BYR>]J'WR[R<SJ0E]GB$5.\.HE\/W&-'[,^8$C""'NOWZ%>(WZ"0B
M5/"0S?]T-NJO]\9;W_M5\1)M;*AV1,%"UIH\I*T<K<BKZ&%B.F&Z7(!.NGZ$
M^]G86'CZ[Q-[/!ZH?T6C^]Z"0O4)_EPU+;R/^(5L0:KD^$\][6*#<JG9HEQ(
ML;G$9"1,+_X&X_O_,^!_SX]L(G[;S&YS/!!LK+LG/9"Q;'T1_0OBT/:B'#G[
M,I8Q18&Q)/ZC>?X".U_;]K<]\[1B?]:@TM D_R/6F<-[P#2O1E,9Y/0:Q3FK
MNCJ!6M]0.Y*+)LT#$'4/>%1L54QRFVY&5ZF%*%$5:5Y=.EOQU>MDS?QU.(27
M5IW35H)P,A=;M):7K//FS7)GL*P6#Y50PTQE%FVDN(Q Y;2PI<VT8EG%2"=F
M:%&.$.KW4VT8&*4]P2"+QV^@XTVS'0>U7M+5Q$#Q5W/SFZ.\@;7%FR\IS-IG
M>)5/!H<"N^1#MJM%/3\4@F N5U/90-Y(;(>>S2_/+_'P.C4.]WZX^ 7UD^N_
MYWKM)V$ )M*4)4Y!_]:"@!XS%P8[[[W9$?\ B44,XXIZ,\DPLD"9K4E:6YM9
M&J,>J7B;+'K@(<C2U%BHI3[95D@@D^=6\\VA=U,04U[8E9P#:,GRP;MDD..F
M]NQ6VLCM_9&%K^O#U-[&ITW[U4(\\>5LP2[7XBD_=6['>9R5,$*2^O*R03L5
MB>WLE6+!B(U+#!V]J*3 @<ILLV=:>]X6JQ9K2(?03(J,\"MOF I./LQC^QCH
M*AHS^PJ#V38:<5+%_=GKZNF;Q]JV6YIG S.:FL)&*.XISO[P+Y+SNGT\DDU4
M<A' _:T3!=G]F D3I_PL[;)H0.N[V&8/EI;](2M>%7Y"-*Q\<@NYD^3V2G?X
M(H\?RS-OF^HA9[UG1))L)_1+QMB/:U;SN2DI2XNQ.'0,:R+QEB.I,W7#"=/\
MQ8B$$=.+\15"UIP*2;1D0K9$('',A8)?I]V?@-":&.8<\-#GKJ##@N@"",8)
MZ/X6*] /ZHT3N2\G$OM;O)%/P[G;;9,79"4/99].3LOF-50O:>,RN9591]UA
MGW7[H(T<:B>>CQM$]5V^O=V+YV6]!\!U:AEQ"\O(]O0CY"N :)C"XY>UV6&?
M,V\XI5D52\>**6.7-V?J9!2>2#)O KAQ29(_=S,U-<X&7]=T.;HD+-RFVR6[
MP=HEQK$-4L6.WR$I24B92!'--**XU? ?A8T/5LW12BD;MG8Y@V=1$WV;>HY.
M\MZHL=<KT\V:3$"=6?)Z-IGE52OPWWGO/98B=6MA0AL:/BM,>5ER#_C2=3[?
M+L6"T<VI0NU30EF<X[+H*!AJM?""CRJ%"!::9Q)K[FX5U#<<W\O"9( 88H]'
M;C1=!0K*E5&6W%UM,Q@O?6Z35"O/RWL=R#Z M[N_P8B:6%:#)^\*3=C11ANC
MTS.\G3WTKGD?Q@H+2X.^70J5ISIEI)X62R%UC+L'\)M65:_0.M-U9@C-ZS:1
M*\L_Q69/QO\F'U7.UB:.+5*1#U&1V+91%RB;ML@TLS"(GLY_/<S=>@7--+6=
MEL[J9 AVRJLF?TIV1R[075/,UB!%V2A6J2;P0XB<:TW66OT"BJ_(U#']WL"*
MAXK/'1@;:H144YV^N5Q24+'$EN"1X#88V055*XM(X(_J'+/8462'L?,;OJA:
MZ'U!$E\^M*1\P[I"I3]C8@>(SA=2M3Z[@HKG]:]N13:8XI:TK2YB "NI%'.S
M*O@")4&H(AL^ZYNV">*^KSF4$_QN;R+?OU^PF U/YRY.$\#.JK?LJS!Y_)F,
MF0S^1(^[^W.8X*W2VDL'R2O&@S?HI*&3> 23IRC:U8?AXL'2PPPY+*QS0TR8
M&QF+^E1GUUVUS"\^9NM7EVY_HJ29+.S=L_VE(LVQ;.X?SQWX[Y&6/Z-NBA72
M\+*'9Q%5$-W)HIGDR;6DZU33T8S"! F;!1$B+N[\RH+MAU^4^/QW9A/_F)U#
MV!VP@+N7J>=GW3>DJ8</@%S_IMGH;O1:)?5";&]&0*>Q'G<O[%\JL4@4."DL
MIP95ZJ![MLDR^JY 3I--9Q0\=]?K,*JCNU]9/B:)20SC[B9MM/C[K;[_B>CZ
M72V$/Q"._^/A>=I8F/?*XT/' .D^<]?>H3BS@-1$$J=PX3LLN$J0Z?DT1;BM
MIR-IAC"F .Z*-> ;8FVG6WS>@G3^M@I.]0=M8""^./D%)3L#"&3*L[:B95IM
M,]LW-U=#W&+W*&\8L=8-]7!CJB(1Y&)_NP9Q9C(JHUZ]H_^E74<1],EA7.?+
MNHTO*R5!3ZIK('*ZD>S<J#5+W1[.0XV.%0"Y]S_RLI/\/K)(<#TJ)>EJP@WM
M:VK.1=#.W*/MWA$BB%;&N:$DQGEX&;XR.^$PF,Y1UL.:L-)V#SAE,EF /6]>
M$2(84T9_N.;EOURSE?K+-=F_7C-G?0\@0;EC@ZL7_?2 %*R7/*]PV0YND'2.
M,N\P4U'T[L30>',\5Y8\N[PX\XH883)\C/> MPC)4)*CP^85B7O TVZ_YLU/
MD.;#UW^ZA.3A$OJ0AUL)Y]H-W;@QPD;_];;H6__VK!4=?#<.MF8LBD*+[]5C
M8NO=)N+S-UWH&YI0+SXA-\X5*8(NW1+>2]9CZ](:[BLK3^3].V885'*\8L:<
M1"(2Y6#^:<HZYRQ9EQ@";]+)G?4J%MSY!QORTH! WT)4?X5O)N/'J7XW!H4P
M^4M#R#YN9\2Z1NT;0G=!D#MG&M!AGG089"]%=EWX97!VPV13\=I7")_M[UAD
MP=;A_'ANENXCM:->2\:OZ@[V]):ZHKH^+J[S=[>#G5W^/,#//$#IZN\O(_]'
M O7WEK"S/O'?-E_(5/Z]7@)(%9_ E _6_R[E1\)R#W"=5<YV_O';'@\.Z@(E
M"=$:Y&V:5)=QU_/+7NQ_U=/:>\<%HU6%VNV8Z[6_D+!U-\W! T7%1I+:((>M
MR5HLIDJ>!=%D4N+8O5O"CUB+'+Y\ZH:YTHSJI'2&)M6.PXAIT"_6=X![9O>X
MY*:IIHB(&51<:NLV$O>V3?")M'NUFDNQOQV_#1EQ:9::#O4](.5\>^.$C+3N
M=6!D66S>8F$<)&:6*%& ?L)^)IE1D63J /\HLG!H0^O BP]HZ6I--/##Y+Q0
M\+O83HS>9.K)EC;4^5!\Z6PN:=BSC1\+02&5!T_S?>Y4(->5W7DQRI%16_FB
M+(F&^N9T=%QLW//XI/=I$LC[+<IDODE65CS$M!G^%#:%!N6;5GHL5Q_;3SB-
MB'-Q/)="Q3R?:PH_R:239641/'Q"_LWV] ;8-'+#:+0TX<\;=YD]??(!R1#9
M/4 V6_;-#V6Z+-*>E8R208_*T&7/%PNTPK:V^+O!\*\!/4-NSSQR&I]()B.L
MW9*UI9 V,=.X,O[8/%">LWBC0>'\N?=%1;!/^ZP*U1YQ1+%OGM@/, O'Z96^
M\D1,@7CAI'O!)%HC$AUK0N4Y+CM5ZJ QM%]^H8&+/*Q]OHX\>M3:B(B;A\4Z
MX=BH[D;@" [*AVB4-R^9'N=FL=_B/O$*\\ +32H/)M@F0"MA8<D&XKG,?:*^
MS2:_$>)^MD&VHXUHH/>HCWZ&@O)SC1[7#2U$X.7<])13@#SD=>VW=A;:F2(O
MAN6LC?"#3^$MKBH1.@A+./(;8Y_*C2?RD9\)J%CV'&O)MD@L69+HF$ QZT4M
ME#7,#HU":^7=K6S0:XKS=QL.=J\]*SV+C^-^M-S1V5Z-.:K+)+L[/AG?\ZOL
M[*S]P=*/42Y^2JZO5+<8/9:1:1YNFHR#')E\494<S@%;.<\ZE"XZ#)WXMOV"
M?7H%AO3IZ3FJRFF1CG\33L41_<Y.79&)O;G^,J]QTJ-0BI%8LG1D)(#++>TD
MA3_M=V*"KZ.J601:1&]IT470U7L;)]P$EZ08*9;7^V6"R.EB>Y2>"4X)WSXQ
MP3\.I92V9\[W]?OPP1ICL^K%63.:L0KZ)^B512K-S0#B]X@5@<R@!R 7G,)0
M-7Y6"'3'@$E9FC_%Z(=K<:#,61J#.P@#^DW88Q8 5:9#O'SM>?O@[0&10C<(
M3PSX?JP@<^7)E5;DS/N\!6*IR$M@U@7*; @Y44[D 7F,DFF&$#@C*@.*T_-S
M& K>4_(?&M-$?->F?I<(I<N$R69K@W"GF5WL:;?N\".O!K)/(C@PB%1MT-3*
M#_.;RV(U\.+<C%"+1\)+\Y$NF^1;JC\6B7E40MRX#R$[\_0!']082,NCV>(\
MWL)5"NU$/F.Q$L2?8,D"_0@SC3[":"9O9..;L@/NI/)HN')/$QBAL&WAT3ZE
MA+=]EO2-MGG$C;MH9[0UW3V=_,19?O2)8<L@)S&O"L3!X^7(;@.+'5)11,5$
M2#<YX]!W=/GN?$HP$$4$II+FY-KQ5KDD\BR>=4UC0 "VPM4E)G;P(R'(/A.W
MUY$#Y)<LT28Y;7D/ *Q7-/LZ3E3)N>=JZPC0L8C17]"DBMB@Z(W!:4>D;6ZE
M;U$;AJ\W2?52,#>&*X0MW)J.9)3&2/2J?]C.#<B6/A'A> "RRH9+?QVE8@#(
MD^#&$@#_JLG8J/^NJ8'<[YH>&$ZJ2N?-?DTGM#?B?[C!Y\\<F3:D7ZS'DT[E
MM!I_$E^""7#-Z+\P/>,I)RYREU;]IZP4_]P&W?^]\8_L<?9?C3_$!A!MLJ/3
M_MOL3!_9J-4>H2&",M9N"/;>>,^-V*'C#04QP?&GEL8J2X[9J) DF^;PTS3T
M[WGY#.:K%76Q\_93=#)R8^>O%H/<DV,&T^UB)SY*\ U:Y>.O)@!./;TI=& ?
MBD4\"SBDF\.NH203C><U.G[SB%%M/'11IC2^\@VMT<_<LHDP!?,OKE3LA8@]
MCU*D-F\ ]X#/#*5LF]5O6.^*4]"K'*"#,>?OAKNM4=KY@'3RU"KBFOZ(>62-
MMJ&'&VT,G8G"%;T[7N)G:>BQ><7Y@DL:L+=W7AR-ML/W@%"20]#-ZWN $('.
MP_L*!;A5B[H_X%SDA3:24[C*K;" 7WJ<^5DNH5\!IL^&WC[ V>,Y[#/*&UI/
M),]A!.BQX(KX_W^<PT-R]/"$S?_4$V["82/_=K*3\O X^+4ZVJFF-S<T[ZK#
M%0Y#@S(Z:FHJ@KG)P$<I3<L-)B.9-I'4R@H^14S":8^+TP40*W);6)ZREFAS
MA5-6X0B"@>UN@NES3N&:U:.[@)-<?HT,+Q;91=IM';1-Y3N"P[.<&&"?T'=#
M?JUP\CN*OX[5_HGY[W]$_&'V4*@$W@@=7@16Z&"8JJ\E-R3$)KJU5,2NV$TL
MYCV1/)OI5MJ#8N]%*U<4]$779MCJ6HT=L=TF2X?'F8,^CW,.-%!TDA_T[9'!
MK"?/.]_FJ79[Y@R8O[KN4221/&,,]L"JJ?;7>6F,-&]#I24SQR/[_!X0^_WN
M^"A5B;BM(79'I]Q/J6'M]2$"NJWV'J$HS[#YUBRL01NAZF59"+M&CLVT0V+A
M)@:KR67MVPFR+FE['HY"9R!7HE+5N^C>QH^AO=Z3&R SD6%PBJ!5F\KK"?E)
M M<0QXU&_063R.U22S5\IDRKF8F*!RCD6KRJQR=9S#A/WG"58*TM_N9$<RJ<
M"F$V&&K)3:*I--.?_"YZO/\%Q4&DL9<6.-/[^)2?EE$*PGC7<:W@TAEZ3'.8
MN3":6P,L)*@NJ7O"D51F%')UY<%>M:,06B@U)Q %V1> YFAH6J*O=Q37NA!Z
MF7:ZW2X5X\[#-.2K(Y35V,[?6'Q22&Y/>OZTY=4M;7$5;.3I.,G>M).O;.ND
MLC0$]=E3[:2K9RDY#<@U/-^BY,9)+/T'\I1\;-U 6WICA1N,P2*X360ZW]=9
M8M]/'7NLF),PKOG"H'JY-PKC]DCJ3A-3?+,Q?IE#D;RV*;(3I?MF9F!Z==?E
MZCB<Q[6S+'U3JTWBW.>YLD\Y"W4[#*,S][-FKL-P9(;![*ZR?$S^&.^5R=Z4
M3A3-.XGI5RL8"U@U^ MZ;FFYOJ/?_7P\EN$E IZE@H><Y:!4)\R11Y<J7>)0
M<N%MTI9^7HQ)V8BB<S=B,-Z;/,D_!28:+^PQVX:$YG(5T/C)8#]S!Q3+U'F3
M;W,?=.I/.M$JCE<&?SW]CN'>TH>71('#SWTP8#.1V0,.EWT:?#X4JQ'IQ@>S
MN&.]5AHXF553:WO42=/=49PB-*0)-S/1"&D7>#YR0VFL.TKO\W[[<7DUBU2X
MPBTB-KHW&VWS,R>9!=DQ(GQ[1P<D&TSK0=;Y.II%B]US/:QO#Y]X\/^<'.@_
M(O[AYI"_$-[>Y(^>$AG#&?^?15=_))2%V)_">I@#RH05'%.;K=LE.#CIO^^G
M\PX30[J"EMV\/ASO\EZBB)*K/K8 K['L&5S&, $0CP<<Q_X*=!,\*FY348E4
M!ZH;I$>+A1+U!+*XK#)W:^<T^@0!#M%]F[#'UH_LU#NJ1H4-#(OCR;7J)_,_
M%J;D)J7*=J@TC_R?3)/](=-FOP32X^=BPMNT77=\L Q&1"<1-'2I$;,^X"-%
M(U?KM38$%A'OT'L A_!>"+1,A?$(8Z$]COA9C2S.#$HBJ4B&]W7KZR5)XH$A
MG6+3O.W==]-RYO4DY%LI['657N)N^/9*TVFZU:?->*JF+^AHRMY:(7#T(* /
M!U4"TW-2S8.U.  _F$:9YU([H&_,\[:N'$.^FSZG%7VF8$5H,22XI+W!KL[7
M,"K &84>M'%N-0[,O$47EYY!T. FA. [)'QH^.#@55^Z)5M! BR[5DK HQ][
MI(6@)+P5-1VYKBSU-/;53" J]U;(^0UPN"F.CQ9H*/VFL;7T1 OW'6)_S0KW
M*=&50Y'S&8?:NY='3RF(;-^5;K\<B>](L>J6'&35%'[$(Z)]OK@6)J#8W6A
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ML4AH!J[8P%%NZ5-M_ 5-[>K=>A/<]^LW[4GC5#._W$D1.V.+/-C'(F@I%G+
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MBUCN\;;EPSFW8EIO"?YP&" >GZQIYSRZUE.+/2^SIM[.F-YN/]VID'&:UN%
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MY*>'#=I.DM4\VV8J6<(Q#UFQL[0D^EJ\)]$K0M/#8J\8Y/S"2!D859]/HB!
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M%BZN#NS6NP:Z:O&D7?&\LZ*CG,U"WTB79T.KS=,/AB&E19/_W0_O?]. X,]
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M5,S#N=B\^>5RXQ0Q;SK6:G1CKEK,?(BD 5)Z]-)84MN3^3&\/KY934BL9@@
MOE_GM>?G$Q\ZU55U_/Z0TQJM\_US-P"2M%?MH9K4CZNABH$1"(?O"Q E3X-M
MTA7P/&52-6>MX "^_KBI7K\GC4YQ)K:0:%.W)S=$__T!3:-@X/"=BXT6L\M]
M#7N'X;@P8U;:7&%$UM(G1C'S-GX..(W/VJ6K*]!JYIRQ5_5ST<*UW^+[0+]<
M[/FS_3KPPF'=UU(XC;2DW55ZQ8919X2]O63H4V9XR-*:WCB&7,YQZ00&B<[
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MN/#J,+HN2D)P]I?$QR0,&_#%-<5R"U=>RF$OHN3P[]G-^#&H[1: (,Q#4/!
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MI"\ O_"'T8;-4?Z1*;1Z\.GQC0X;)F[>^ -ZOM8<Y19D" B]D]]Q63+0^@Q
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M2(.[B+U'V.DWJW[.H!O7=WSTF5#@J%GM\*JPH\CMF]$"+Q*J>]B+FUA:&AJ
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MF82R1FNN^"&C8%7/X!]F".$GOGNSURXN:K<W38H[E5=FWVBTQMZ(WXR-B(L
M4 0VO(Q9:-;+N0(.I27F\[DSHRL.1,!Z7?ZR7M])A9X,959I*<WI'RYN<?FS
M_PX#>9'2YP='[YR.I3:)  U>D0A<ZPFH''PX_I&@G^*T_0\VT'KY -%>IWW+
M]_XD7@MKN&0V*78O1;7:$]_P:<]2,'67Q^'AQ_CAQZ99__=_='FAS8+.]2.E
M+ H-3;6RMT2">']GO/\:$Z7/\V^SE^=\RC\)(S?H)EB"?U5JNDW0^/-87#!T
MIGQ _:1WT#N-GJP;+X?S5R S]_DHQ0,_^?4D)8I3;X#*@BW&OPK4"0[)ZC%,
M_.'N]LKBA'I)8 8__("7LR%$SF?:105@:,-UH")PI=VS9F'PJNC,WV^^M9WX
M$=YJW$2D?.KVL,@L.8@ KO6VK>K';R^1N3;L&I0>4>O9,Z1%?H\3NW\KO4'\
MSVL?R^DBTC589>)OC[KVEJQ-./)/NK&%F?+5USZJIOVC>OPL]??P2^WG]TV8
M.H8I$&2>[O;WS/XO]MXKJJGO71M=B#1I@H#T*$60JM(A$) ?341 I$BO4D(
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M%OFNJO/[*2W!N;[54E1@'<_[(M.#[CVAXLSPCM&!UK67"O=?45 %C%U,0I4
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MM1GUA>=OX2E\KB%P4L=/^"M5L )3'+0R7O C%ABPBGU(]4QR2V3NG=1IX3G
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M\Y@Z0R%-L%NMLI."F[$03TV'[OK(7P42OA+Q'_WRB-OQXG:&IE[M49P0-O=
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MM9J.MS#Y5]A!6HTT+C-!"$3\G"# Z(F6X646N<*LC#$Y6=<YIO>UN+G:5T(
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MJS"GE7$424"OC"\,LF0TJL1$J[QQB,EHPH5X6%)]]_9G7A?A9>09>G%C70+
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M#'EX8?+6TWO!R''3QXIB*3>OWTV%(ZSSPD9[%*4^['Z:63?*^^5;(BF-%15
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M/X\'?0SYNLB\)@F3LHSH=CGY8XAX#NW'%2=C2?[X5Q@0)4\J 5"_"TQ@Q[G
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MOAU^N2;L\GTE80!V PV.8+; J6._*:L798O8O*HL%PK:")$A +V5"V$!]/=
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M42,()(CW^J[G#@XL\\IGPVL.XM?3PWK6=8^ENAJ.;^D:[M[Z%(B%AJ8V#3>
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M;NE/;SZC-+20I8@0:IX.T[\=Q":.U)/WRT&4RW&=J-6/NH^5NQT2\1IHH!E
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M/@P#$M)<RS4;F8MR)B\G^%W<GP;^.2Z(+JAPY:CI$?&>''R]1W!@ \L]'GD
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MY[!#*2=IV;1ZICV,$%-#5G1J0M-*$.]R_U1.Q;300K9T++E6.:*:V+^L]G;
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MVN8+CF6VNPIBI/W^)1U:.L8B5!--IEOX>ABK49PBV75@>_CE_,M/U6O0+"_
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M\T/R&W7XNF-)Q D:%[832_!S+UNA9Q-9\&012JQ&.6#=2=!*]:<=@$<'Q,G
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MX@9M^T/X8J.F<6 7"-FM:DPOM@)CKC#GG5H#FHPG/2:A;RX5]XJSST:05>R
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M4[53,K<V>.2Z8OYJR<09 8P65U1*-\:'\Q28 AX<\T7\Q *1O"8R;[!*&,.
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M+3)A!J4=J4*SZF"U:7-TD[CJ+ \SUN=NICI.4Y>R*' &F5OQ)*M;2ETWJY6
M4O/VYI:'8+_#V-1 ID,-R[X12XI#5. 3'\-U/<4VN/C-"*9_9IQW4$#=QS!
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M6OX\ZDF"+S/Z[U\_\JC:PA#OBJB"9F3B>!_<GI_/*M9[HP!^[.Q(B"Z4=5#
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M$=5M/)J*>A,AAV\*VFEY?%]]X,#]C7A]SKMS:6>\G_-0RA-0#BTX@"*N>$=
M9;1'[$5DIG!DP!I1$*(PR*3<5-6E?RL-Z_/[;$^=O[3TZ)LQ;,"!S5B#(/UN
M3%>#2OL!/XMUPK!0O_21<I!$P[%UUQ\]"&/TVKIHDY:+FJI7#V0$ZE0\.-<7
M@%L::XQ96)#'-=M249&YSY=)@B]'B5-I 4ZZWT@CO$8C-CTG;SXO;]XU1_BJ
MXTP13-D._EFLH!P)"=5'3U2D+$$;LV&-60-684_V;:([+C=U/E?;']8OB-7V
M5<"V1A?>,_DN@*8WRDII/W.'JLUDWGL>82_KGDBUE!/+J6\5-?A,FDO4VCX?
M=CUPN8SS<USY8"9GY'6\WR<OX:2,-72!:\$733:-1&7,EHDPA!\ZE:UYV=.-
M\[ES/O.!)4E]I)][W1FZ]<QL-&E5M-D&5Q7HD)WQ2$ E.] [&-]0(?PLG.95
MOA.@A08R8MH9\6<W]*@5"9X^ORFA.,&_1F$1-^*:';#9QF!(TT+G&DMH L;E
M,O%QO\N1RD)I(W$XR\G291M>JA\R,QH!"R KVQ:&_NQ9CL:(>P2&" PS>_+'
MW5]I&3$H\;2GDI3;%-5N_,/38[#G-6?T/PF<01T@) A-CXE[:MI2BH>]Y5CU
M7(Q6I>]]@,*!X_^6?&MKJW=ZAMFLN^W]><5,:NO986T5;&JS*\CTESXL/>5)
M^IK(0[QS8+2!]>1,+?._ZY3TS[UH"K=9_3SMZUG0((XL*4[A63JS/E6RNN[0
MH-.MO'BF+>J;":5!G2]]]4<+\^S\1JF5G/"MN[A17ZUD8W#D2XQFKI<KLH,:
M5BL452RN$I'D S>>V$&RGF/&=R;)I,KPSF%Z;<!L:5)3=MR+L8J\D+X1^W5
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MUA^5MOGQ1@.RUM)G)\OUW\A _<N+X*ZOA+S7QKZ4L;O%M_K<L<HRN!B>!AK
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M5,\#<RX>LG3AE'$9"BN1*_"\ Z3K9LR/(7DU-YLL2QDLJV.90CL\1=XT^F?
M#N+)$71VL[# //;/1ZIO\G O/5/0XO-[S)<KJP)BH1==,;U01M8PK4=2LCFQ
M(/K0]7Q;H=$5J[Z/LE]S_"&8YM&T-?J@;LZ23)R>M_@VVT0JVZ+L/7Y/Z8)N
M@7EB>W7 SB379"_V5>P#[W5*716O>(*1OMNCSFL#D=0'KJY0H;LML5!CXZ+6
M$7P,ZDHUC\V%D'2ZG!3W>L9"-3J^WB=R'AW2OGWNGF[ZG'B4=&C%*L6B1E%H
ME=7OCF=#&_9;H*R#&^=W#) OQDQD!]CUTH4Z.*_(T ]@F_EG7+Z0B?.;;F=J
M+6V%8W^YBDAG"CU3/676#%70>G5Y*T7K.A6*$\_AI0NIMQ]%QTIE&UILY,QD
MASK8POT5>/+C!%XIDVVIY:,M-N6XY#VL9P[DN*+\F ):\T48D0)20V,A='RJ
MCM\BI 3)I?8&1*DE-,KJEA/E=T?\^.KG=Y6J)Y4!NW8!.HCVC57DLRK,1CSZ
MC:D^+HE+]85@/6O4W:7$44^9]],@N7=1#[? &C\7:[=:"XQ%K1)/03]:IGB'
M#<+?-0X>!09)%"YF'"[VS]Y(/#'/;"Q]^;=VGD*CU>B#>3/U-ZI"M[[>466.
M/1\K=-KE6^BPN&-6GL[9WJL@A5\3O?2B7.B(!C1C6>H)2(A"E./>'1%&Z0AD
MHF6\TA-4<*T*)+RAMRU[O&/(74MZKNG S0U"%;*S4&%Z7%+@:DI-W41!=_ \
M"5<O[TR2Y[0M=EUH\JIM,.N&>80@>(N<%[;#EGS(Y]TS]6@+;12J=HJ,9+QR
M',H\ZC+=A<Q&2YDY4ZN3'93GCV\>,-B=G .1=TCG0:X0SL*9^ =O>*BLM*V2
M%/:YH+8::C\]$@E[>EN)N#Z5$J63Q.#=]TIL1+=O!D\HE5^V$9V)7RG3$)$A
M7V DK9ECQ&3L47\&M5:"MD*^43\VF1 ]=J>)\WNT"#:/Y'&LS&B/QY""<:W4
MXN;9I+Z]LPH[\P2)QO<)T0NI:6Z8E)PTGD@/)IW":J$Z WK]^@^A\\#T?%!#
MPS/!P75NB+C+*O>WGM'/M88#D+/-,)&>TBLGG1UA2*+HO-IF;$C?&53CI5I%
M!/>+KLWG.<M9+"M<6>'Y2@4MC(?-]USP?(MJ5J\:S_W&5YEX8N.\!B%&#1^E
M"Y"[0-'=#0'M:$(QT55BMFME3_9%8R#NHDO8ZW1Z0>66A-Z SN2.U,LM@<16
M2JK;%D(R4LCW24PG"GP9$ T),>E%M37Y)6+^^F-A9%!@4?O<*;\V%5/NW.C3
MS.]![6<C4&(C0!3<,[0C*)2D55RS^B40]Y>+$$KL]OQ1^8K]"A1(*A]8'<@J
M@Q>T-5\<1&$1#2LN.TV 4^9-:8ES3:BATD>P6;.5=?)J$S;P[FSQPMV9!1('
ME'?D]A49#9F/2&QO;KG1VJ1OF[#<S_"G6,/;E,S'%6"%Y^2,FV# X*JZA)JR
M/-S2JWD")29^+)-=E<6\BGU>5WAXT)#>9[&B:1$MM<]2QLYR%M'$Y_#37=0B
M8=UXBM :Q*8Z(+-9^YS)QF'UNL&WI >-\9909!W&*T^GF]Y(ROO9!5^ O#CZ
M]*8I8KOD1\]FO"Y&]VKR\9[RS4-I;+KN_:Z2OGMY\P[W7JG7(Z3ESY)SEV>S
M.&[@;M,O1[29 )R4OY";K48E_5+^1N\&P]_7/(@GL!(@N1F])XJN/:DY/(NW
M<:Y4TU=7/!KJ2P7 06Y UQY?/$SOA>K]SPAB(<':B70]7WF=X]Q"$S6G5/6<
M>=BT(!P0(TC8IR"*J363T#,YOHSZOG"4?%$3X5/DKO'/()M&887^6S=;$3<T
MW$PNE+PQ\V3/9K$:0TM\51I=ZCKO8^UC<_2&I5W&> 9Y1&?8V QO\]3S)-PW
M16IC1UJ^('( <0\H]-*8J!-[-J71+2@M3P(:) J>,2G0NZ='$IVU>=I5=_26
MK+>#A#L#[6]0(B4DY64@D J6UH5FVCA#PKFQ4H5%M"1F?_KCR5[T_:Q:QX#<
M_PG^ZB>61GLVAP=->4_A-7Z-6?3HB&:(9%.CG&$_VU^(XIK\:[U3(&'%Z9S_
M?A94A=IR3)1?'YBO!'@S$IS9?!!5#5\Z7V\9R>#L:YWY09\I%,%0QA"[KW@F
M@%,<!7Z)Q<G6X"U>]W=^Z]D<>05+0G'YL&"!1J"F;Y&1T0RN2O*50<&MY>4J
M+ 3;LJ_"BL;_#BWZ:MH<IF#-&_&7G;/^5()?A3QL?E8%\'P-&:GZ0EFRG\D!
M<]IJTX 21<KY.4(T1HR7&I#W6)$%/=U>UVZQ>P[[^ 37W88+%Y@&\KE^ )6!
M>S)DS"T*H!%1#M2Z92ES^I8LT)FHCDHBO/,):QG-ZYT^&H(DZV#&!PPK6\13
M$ B#E.$4'],<E( 3*L_T7J"#MG>G\%-SN>8-#NS(SS>#RLXN8SXRODW[-Q7M
M&DO9[^+[M'SCD]),HIHO'"WLK.3*D.6/(4#.0R<ZKLI\.\T.S_J*_;ZM 0?Y
M_8VYS.9]:U<C:+:FR?Z:E<H*Q'E@E8L5UQ?-^D#+W"?16'CSH9*%#>X@:O@/
MP"&'2G(P%%)+$HAKX$/W2N>2!2Y86_IC4+=+O[]T5\.CSVX7B>W=V%G?0Q*O
M%,8^!>Q(K-S%Q174QV;ILUF0[JR,:V^BJA]95[,WOF<7.N@=Z>IY1BVU*Y5W
M)RZ@!<#TB:E_^BB+B&D;FVOHI:8;2%*1W9Z K NK_?CC=.=+ 7^5ZE]2>AS=
MK<U^>O>OWI=V_AL2=$VGEO>@?%G([*\AA,F&M1) A@!W"N=EX,::B^C0\NTF
MG3QO1>'MH<3]+&H!NX6X4-,?ZH66@0>_?K&SLK+R0E/,589:+@,N(K:_B<?(
MAKI(/])+$.=_L:'?DR<L# V53UWQH[\77:H\_(;^LW%.N':SX% &FRKCS,KW
M8XR05O8,$.C%EE%3I,=?WM4 A;($RK^3C NNG77^ILPV?&Y/DH"\@O<N6-=0
MG4I<MD! $X.8T>.S]-WN2873Y-_DS*Q2Q<Z>Y8WSK3](^[O@&[_PRI]:O"'$
M5KS?X@HF=UEUULK[6:2$2R9SV,J<453\^$8&\J.HQ.,I\]A/)5M)+\=@W\.W
M*Z=%=ALS+R=.J$N.?*)#%:[(#X7ELP=.) @/PO7!:=+NE(9.C7'TQ5OE\ZG<
M;CTTOP_J@P43H4>BQSR-<(*A[:;85_71%/:K+8U8E..@ISIO8. R0ZU'[1.Z
MRM+'@KI<A6FLQL*BGMX%N(^LJY!/6*Z1DM[>!1%6*ZXP&B=L)<V5>:"4:U&^
M_ ('9^5$>)KIK[ZB0!]]A-H_F"Y\0AK+&^"MLCGQ$3MH4<E6.F\ C4<_;\RP
MD>H%#=AG'U9J/9(C@01/86YDE,^'T.]M%]/WO93* SY+32N(Q$'_7+R\;P*I
MK]0:UQJA[#Y-GY9Q:&5)](P%*GROB/#Q;A=U8)Y-9%2ME3GW\'(W-L-IJF9\
M<VQ3&1IN@Q1IPU2!Y"H_M\>QI9=P'" AC-=Z^0X:#OF=C#0R[TU/MZ=-NC4?
M('T,YIA!\2-WA?E@<<OY3Y8#1NZ/NAR2_+P:3%5)]G?TD%Y2&.AV>Z54CYY;
MF5)4);HLFE503+BE.OEM:1:#;:FL9(SMF_$W>!RX20]2U)T8)YN?HZ:?.,LS
M&I&UYBPA]L&G@^M9X*/.62]&)&#13SX_FC?@X+];L/5)AU[H%7D=GNH@ISXR
MB_'W^44 8=]E '>C05O+*#(,7.KH6'IBGD;.24\_>OL$:)7"!BV.$3:HA]E%
M<, Y7-;^B/)7YOQWJQ)TW^:"R]0T8OF=)Y#*$^!HCJR&(UY+;,"Z<MR:D2@F
M[0X)3X/Y9?E_7_V:]#Q29P*64X\J9*L"(?L!7O:(=C[T9OF #>25:D'3PK\'
M!6X_?L_D:1FX0F.^$2;TK.[/+X-J1]U<BFMK\I#7JC'$Q#%6EQO+/JO,2D"Z
MM+2NE5/MM,PPR\.'R2S6[--CW[WC7MH)]22VL-T4-%:)_R6ZQ5]K:UI/-)ZA
M?UEUT]\J^6$21'U/_L(9_,U8:%V$736!\21?^:VF!'+6S]E2B4AH6K-(AG1L
M2ROS$[X&B>G%;M ZN9G>OMOT4P(7Z-AWW]%,#A-_ +(#]^OU#3#;@(LY@[#N
M[Z#5N2TE072_%T,:;;T,8=OT8L("[EW3\7F-]^AXN;@*U3]8M$;#O2WR_.IV
MOBBVP8$5#IN/(Y@/CMQ")!7.Z@X0?N99M\GMYZ*=NSYI#UG2_2C_=T5_=)NW
M9J7F<IL$>7R_"/O1U/30N3N-M<X1G)P]\KHM#C#5.P'HZHD(7+W?^Z4;975A
MB[A[\+#I$PDS3V/]*86=-XC?S?VG[4)VA%4CN.>FN\1F"#><;R'JEL3<>"$$
MA6I/SBA;]*.I%U7C)19I_"R&F6W@_N+B.VKGY7/E_:"H\)\>VX#4)B%@26H=
M4XU(&5?KLNKC]3;0O^=,W9&<<6?<H+)Z>A:31>E& 3#Z8]H2/',(XN:7(]*Z
M*0;K+B]G$&7-379LRO\_R)H%IF/UA_^A'00WT_%N:LKI<E1'W$?&\Y6MNWP"
MNGE]/A/F>='8%XU1CJGW2UNZCGSQ2!MFQ'I9Z8DT&F3;4D4H"D!445$W1M=2
ML&]P@()]OW-L;&H6"RL5:)^ZL/=I4Y:PN&UY.7B[1B&J7(1_%WWS_%]R;^P@
MX]JAXK.,H);1K, WMTG&"1L+,31LRI-*OZV,.C(']&*N^+]P>A.:E,HN^A5M
M8@Z.YRH5H<N/$+^XB#[GJ6G3S/3UIF/4SE*-!'R9)UI<1=!VU/1.%/7Z!CB?
MR:B5='8WN9=OL(6=[173TH9\;P/4T(UI2Q%@^?WS@X!':DL(Z:A-854J4\;S
MZ"Q>Y#SH:0>)SJW6RF'3\_ F4<*7\)M\<@5T?O2IUSL"T1P#^"Q#7AVX,7^$
M!4UB-H6U7;'AS:6#'J9.DJGL !%=3ZH?*]_O6:C)"> G)%ZG:]FFN$U<EDZ+
M9,R+C+\/(06V,K(PRE,T_'/Y5#^TG ;^G.!W%8(T:XT"!D1ZGM__Z4A,%#KV
MBT<H'G-NT!]XT\LB&U05V$IF4SS^N^4&+<Q8-</GOFJ7PX3DUQ0;-4\OO*6]
M&F[P>>6ZPAQWE=I7S<"AV[BJR01D2A"]5B\;>)>08-2'OH[Z78XK#-8:;_\3
M\\M58_LAS"@S4O6%YT=W^D_NO$LV59N.]Z1]\L3V^3:(Y5Z*N_./M(\[Z_H]
M<$@&C??)40DI$=F10]B8%(9_=J)&S<-5#BUP^]=OU+J#PIE;9M($U.)H)3M@
M6^7Z(6"\:M*C<OV7<A7@>*G+LN;R(C*W5PW&M-$2,\'N-,T+]M LCX*[@D=_
M.-^^J^"))\$UIH##G\J^K*7);6_C,H&+&M8//3_13I(GI95X_CYQ#VRX K>T
MT="8$>H_E;IWWW..:25,GR<M>&)^[[9,.33-1W_/LDM#:"ZR^Z62C2G(";W<
M-QQG'4V68*<QQ1U,*F\KD6;F8H=>MWJ(>[V["+0.F.ITQ(:IF:63A]5]>&X^
MT4UD3>[OB^L<G(MQ;)XI(9$RD($BV16-^N'(BK%,WB)24L,6@(GIXI;I#Y_F
MY>I7QB]_XMWZ1?\OB=]_(]4AL[RZ<V#VN'C^16C_L @L\H:CFN[/7H5+D1'6
M[!!<DZ*=%%-EY2<N^>2EDA+Q[DA&+;_KB=$ +7]T\2/;ZS?;?+.^VKM$Y#_(
M\[O,RS-),FP1,390="8S":PRA[9W'[B=L5#/IUAGO.%!L^ J"XUPUH_!(EI1
M6>/O1O="X;J]$@JF+4FE;7YL9B2] (1H96/,?#G(P*LJE*A>N3/M5'98$" W
M+O:SFOJNH:/@J]LI,DK=SRF#1A-?KTD.CFDEZ\\8/!81)Z]_#DP? E(?>#QD
M_G'"I6-@,/5[2=-1%+4>+73O-J/%DH_2DF'F ,1+I?S@E:E9K;7)X.B$Q.%_
MMU+: (7.Q<-23*+&1@YAXG5N@SS.'E#N5$<QV=HO].JC>0IB@M@X<7MW-X;Z
MC[19_O=K2%^;2?\XN?X=F2TT)3UCIPNK'[*.1H3JQ'55K DP/V#!P-GWY)0'
M47SB X//NTH8 T>"%XWYAXH_+(27%Q=RVU? O"X4D5JXNA&VB*@RH AZK+Q<
MU1DU4\%&%*?GCXA(T?/_>O&Z;7SS:KM-P*AE3^&>X!<%,#2\TJR%TA0WLR%H
MM;/C^;!OZ5,#R89XB8[3"^')PL<_N",4R PE^M3(+%#Y!&*&CIFB'C* 8N !
M5US.B%"P6^6#$*]247 !TFKD?-)\>?XOX?]]# TVROM4$MA$/5F[6W98]V-A
M:5Y'?VAV-ZG&FH-N,"=@JW_RF>C=025-KJ')5I5T_)V02[4?6>;#-6J$$X4S
M<F>O1R# 0EY(@ZFO?..^!2GN'#Q3]H'17?OC^%CRA:4!UEW+PZVG]T0W&. (
M;C$5Q.&)M@PEF\: OH*9HB <ZY4DZMXK>4FW*S[Y!WI76T8(\*:ZP\_EBYRD
M#DVBM(5\%)EWKTWY%D] _2.OL23[EL7#"AT^H79_DL#@1XO4"L7).Z=9U,N@
M=;]CYL1R YF*AD,VY@A\I.OQ#T&94@X=+W?DST?EZ>G+FK [@(?QKYT.*QO7
M)+X4YZECEKW>W@OC]LCD.U7?KAMC_Y">E[3AV3,W^]@P ._%--,"_W&>$V[4
MO)%4_/Z'R^'=QGU%AZ#Y1=B<(#Z??.V_6PN_!89;;D4LW'JQ%Z)B.^C7:##K
M:'K#9FT2?:MUU5W1>;Z7G1'YJVY)9T"6,M\NODU;T5)(H_$>/]&YV1J]G&/O
MX<-.'5\*>'EETGA';H?%S#0M0BXB\(E+>-0?ZQ3O#B0L[1/<WB-M#>>;(>#
M%<.3&(6+J]8BM+ !L<.&."-\^5Q1N3X0K#+^L^'2?"/TU)ZKA?V);S,\82FK
MU;\[4&6B_M6RT'/9A:?:6AT@:] W&Q!F("XODC.U.XB2\8NVOY*"'_&#/_RA
M0%=R2P:4,M#?6G(L@;*1^<8+U"17N0G&F%7D(YDY7FF84,ZA\]T?[%'/#[>U
ML1N,71 /9V"A7]U;ENVAPK;PW"L!K31@'"7*+XD""O?*["G@KRE_.J"Y>O&9
M_/[ZVV5CTL\O+X_^X=V\+&W?6,P7A+NB%A=1%;M7+,*WW,U&S9J>V1-?5IFK
M1]8D/5R1EI&:"2BN<1S*ATPS-SP=(-KT*S4<;D?&*<4S6Q!B.UC5E:,55@8X
MZ*.>L"Z)4=J[8J)!IWL4"D2H!>^"U,+8X6#,TN;C20+U#Y/5\>/[GH/UD\Z#
M-;X52C,?4(_5B>57%\H>P0)B?V^AMGSU8("FS(Z3T*SUYZ0#A5.L1W)/P(G;
MT_?6+NI'2;$)[9Y =Z*I,/B!<,//TI<+S13*O\ 73HU"40G^"?#N[4V*IUT$
MM0;A@O@KV60#C,RF(O]8OYP@ACIQR]#9^2)F!U:.(I<0:HC.R@ L3+&E,G<X
M4W@>>L40NO4RG. ):B&X\20@U373C6<,5]1^(=[VB'Y05J"ZL[,K:KL%M9JZ
MDC_BS#35=");$>"J8FEM+N]O4[']_U#UEE%M,-&[+]KB#L4]N%N#:X$$B@2*
MEZ*E2(! @4*A@KL$=R@)'MRMQ;6X!P\4IWB10L][[UWGW/-?>ZWY,)]GGO5[
M9NW]C'=,2;CN>\<0&S#^<S=.V25J4@)9?NV;%EB,.[M==F0<Q'X)UE*@YKBC
M=.$:]%.91PVIU#P?;FF4!8;W:MNB0&H0X[1L; )!_OF"+RF'D&A(H@J+(I&
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MG:[$O1U557M530>YR9EI5M_4%MTF^_2[99]*<2-6KB)1'@*2-QUN*L7IF>]
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M,\+<+/X?Y?O_:\:U'UWQ,<+<]^V;1NDXH$S3H4;7&&.9PR>B;LA%G;5;RE,
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M4OY*YF"4BPZW\KC0YW_SVKIC2X(^BHO;97X-[M!X(97<F4*N5F@AMKUS9<L
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M[BT7\.I-%E)45/"",G1WYM+H5Z4%A6=#\B^!@(![5=HJ1IZ\>1FI:.^7=#-
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MQU2<D)D?J)\UYM.\FIEX" 7!&^JL";CD<&;I*@^G60AW*G>T3<@$*SX81;]
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M448';[6T=JR_<@J+; +O+O+UZ>^ZE(L.[[XO#2$V0IH-%TI&]=FR&GO0=_!
M_]Z%Q#<3B/ORBRN7P?S=7:")Y$Z"PF?3]*6$ZLRXJH.,8:P<^^.0!,JKG/_
M1XP9#Z/,LZYOY;!]&YB*I:B:[R&K7]MY>C$>N/QF[MK^X/RN->UY/S;_S-B
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MB)^;MO7Y#<L(;C@52.7YW''LJ'\W\ 2O?L8T/.W#K+O-9PYW(VV_JB[Y);M
M0])(5O?YG5G.46K;ZJ=$BX8!'#HF&P,_&"]SHN4]"+R](QN9F[J<VR],:3KW
M9G1P<W$7]E23:LXB39GDXN!W""CFRH:!@7 :W1;YC?M(%UU(=V,Y0"'%B2JY
MM2^DE8)GW;R'(.%.#0(AX>CG4+J-!&TT!.%8E6W =++W$[_!M(B.2J-+F)";
MT4'EL(]%IAVB]^(MNO$U2]9U/BO?B!26PO/[QJS,8K)6;YEHQI#G<OVY55[S
MM,L:8=XM6J,2N@(4INS<@*J&T1@>WX?&70,=6:Y]PR3-?HDIM4[8;;=R,J-$
M>UA K@]\#:L#__AGYJF:!"8 =8%B(L !3'K]<#DIO7)]#5*F8;M18WZK#RG^
MI8HY+B]$C-?$@=9 P5?1<Q,0E80.8TT,NR[TT#005Y9F1\1X+>.Q9U(+T'2Q
M:;174\^IJ92-(S7"-E!M7QXON!<!!)!32![N,D9N'N$%E7M(CT&!N,:DC9*U
M\K?(N*R93&"/Z"T=@F;Y3DSF] 3MYA*5QJ,'HBK''Q7.K$=,JWG_5GFO8VAS
M.H%3I)5TI9)F.CHH+GE RP(4FA;4=HQDO853$TC-V<+<_;+^XA4GW-IJCV/H
MBP *F1Q>;>FX240\2G36+B5,F]3PM>#R$SFA=WD_XDZCU#XYEDV@J?HSWF7F
MJVE@Y3Y"R-&4#SA$RUV)(AZ8&!8.R=56,Q#PJ3EK7D3@%N@B!+CVR^4NQQZ7
M_L7C#$XU="MJ,XYH2CH%@C/AN\']<E>SRIS6BP<'/U_^HY;CHI2"72L0/PL)
M%:Z2'9B,TVOEKZ:UAYJ/\HY.AUY]N/C-Q>YM9XE0$-R;_G"]]'+[E>=64H])
M;DC)V@M?W2\=WQH7^BI5BN'^?V8JV;CWC<B)>.F$T"]K2%Z5[G;+&U!J\HR9
MY2(/TS]/N]^G&OPA(.+[F.!K>O>!(V[S<&/Y]8S88TE49]N$A5\F4HWDN6]+
MQ?V*71HD>E^4Q$#01.X%KF U(#GJ1\WOX8P7=V+*S![2;(;B#UGTV?(F$DY;
M\FT/NRY[%JMAM%;8Z&P7'0C(H1,KSSQRQA$1 I3DWSP$UN!63A:\!F@$FAJ/
M9P(E+VL8*#+Y!*(&1SR"RU0XLMY89\XS^T  OD'R00'05?[V$'69C$]9U?-=
M*"9H3C#P6Z8Y>IPP#RM(8T2'-%> ,X2YF0C@J$!I+NF#\$8PJSL2N7,:#@=4
MJ-"5 %?/2@ 99C$X0]%1GHYWD1-JS>O78:OD(YZ)-WK?F-CT[ZI_=F*1!![/
MQB<?47/Y$G\@L'C3 @2GNL?RNAOETI<PC+P65I#186<&6W,0RLRB>_QR/HRL
M9#]_E@K>\'5YWWE*/>TN%RM2#((%8YJ:PO:<T95T28:)H@,%X6P/8CJ/8EXH
M?+Q[10%+=W[C=3?Y3$0[!45FX83"&)ULHKWIHXQ!11WFJ1PC)<&!@K8>0*AA
MO'()I_3'B;01]-6.G=B$T2>BZ:D&XQ]8;1OI?K(4%4JE3>M6<.;EQO9FW@M_
M2T;[\@PVW;-ID:B1C*6]&I+ HP>S(6 \M5@4>9)J:E5'D? [H,O0#9Z3#$FP
M)PKSF3>C%'?:;#]N,Y)D(]C' :/408V%30&!FSO:AAK"CH0+B*52IZ#F.AS5
MIP_O)(,&<H/;3_3\.QBZT#; H^,EZ,01LZW,M/V37E:ML%3:YMQ4D?1NBA;$
MLWN:6JE1O%?AUNPM&S9/I5A0L,!PCJI2V/T<;/T2\T<>A$G#LY)C%5*AH1@^
MQJY.C6!D4/>:,GG6G;MZ\$RJ_)%EEM%&?=/TUH7%7[PWN!6 =%9#YU"!M@FF
M3VEJTQ/YK82W:.E%9!+]I3N5,B5 XG>*TXR:\R!UDU02]OBSPD\CG)E7"=.T
M*\PMY'/ELK"&J*/Z>;V\@HK\P.RP#7'P!*% L*EAI0GVA+L*OZI<045N,V(?
M&_8<+YU&!I!_LD[\N"5I@_ER"*E'EV?_6>^?%LM%';UV$_@7SUK)R"W]7Q/]
MU1EQSPPBP9=TNT9YI2 3R8NQX%]_WC3.G<P^WA@5PF_Y=M)A@Q[MII?_5A X
M"]XP'Q\__8N7?S"G#4_[(<!0K_U+\SOGZ?N^E@U660N$F&]<G^JHAAHXJ^0]
M'"#()(I&I@A++&@G<T]SP\&:DY-)OTH/*D!'/F<$/+HC3?6+:U_N#^TJVI5!
M8WG<P-CAUON2.N4M9=[OUA\"E;XS&2ULJAI/:)/KF_@*8WM\SJ*^#\C>G"V?
MEAD!34;>)KM#'.DYTKXO37C#XE!?;M2ES2W\&:IF=?S&U5Q)8BKI==R0']QY
MDVT:$ULH\LN0/'G5*CU\#Z(LS!JF?H(UQR<F'(6]ALV=RR8%2)@C2#['K WI
M>_4/-Q=^5&3/MOO$R>I;_..2CU@M\3Z% _&TY\-TZ3TY"")<M*WIY*'HZ'YX
M2?WO'G2=L$^>O$]W-5T_=>=(]_>2S6CDEW@PW36+Y"W<KA_;V5DG=]625GPS
MFU*!,:;GZG^RG@+>\DFLT325BN=S6GT&^&AC[SDA\X:'1Y;*07H?N3NC2/.Q
M:4:1685J:AS@Y&0SXU)A[LAGIINT-1H,XX4SHL.5A5]W( (/<_7L97;9#'4$
M:[]0$Z=<<J)4VH-<0"I0;-U:,'J$(].+G<VA,/2+"3(<E,9J9$9G#4\<,Q(H
MJW!O_*YTPYDJ(YW!Z=(%0;E/NHRVX5(*U5C9.S%TGQ(PK> GWF=/)7ZE#O6<
M2_,#LR+*>#)<9JF9_K!AQ"F;;LQ1PQR</(1.RN_>?]I@&'NQ;M+!?G>9-SPK
M<ZF_D ,+SJ/L"EA6A4O =P<(%6H&/?=ZI#[<[UZ4S%E:=&_JK(?$G3;*2O7*
M I^64QX:^471UKGP8:,YA.6T6[?\$];O/)L>,O_V<^LV\R>J#ZN\1R"L:_99
MNLHLD)YYTA39V+,-&*NIOM<\EIL9B+%/Q0_G"VD0G7MB)Q$_XT;9S3$XF2 1
M6G7J4L$*<3*L@6Z[I9  E-JI^[J+VF0@\'?UK[>4'OKM";\=FWF+<UB1GO;0
MZ5HH2!/TSD5+ELD*?SE>8960\U? ;B31@<NK3A5+W7Y3LYDFQQIES>O-@DFL
M;H($C>.9/I?<=]O82F3.C.4)-;'BT$^DTR:2'D.JS2FT58\ZC];"L9KU0/4R
MP4A! 0&( 3YW%67LP.17#N$J^D9H8!R950I361@VW7X!I W'8M,P="80YGM:
MU4W#$JG9:J"?:?^HX+M_2>$QR=_,8_*[?:9\<8;_$2:8-UM,-_DF#1O.^2Z-
M4Z\V0^QEWNIO5=X[W9".K6^$UJ*D=EC,6M[N&'P3HM3K<IH>)9+1R5#Z\<X:
M=-PR?KC^>2MVN8/VI7J9+)5%^D9A0O1 R(_4-6^'E8P%ADRZ3?66C1ASY;1N
MWX^5#V>X%LB,<V-VICZ.UR=-=J^?G7W@WBP;TG]-=JIL =,H88/O:P;QS5DR
MRA^?2V^7MTC7OQ6];[+,P5OA]ERNB"-:)_@WAYR-P6$M)LW/OLSM!#T)>6SK
MB!L2>I(@@>&C2O9W5?H2#-8>;#ME89$_CG)0Z=9TT;ETW!B$H29B3M]M>0M(
M93/J%I<_X- ?A&(X48C+<A=24E.RB8YM]^>R]#R&HINJ+96;X3ZQGGT:=KNX
M1:;=Q6D#OZKZ5!XQ2:#$AX1]4[I_F9^A(;_/N_C.%#)MH@U7_,TBQT3](#].
ME?D8OT2-JQ#=ES*F\*H[QO*(@&(GF7?GDC)H*PJ'8"FB0PMU]'&-0NG.W;)T
MB\!,I.'\,#A,6]_9ARU(#!G07_SG8FSY]"DW#TRO7DOOXO.;L$7W723]BC+@
M-;]T1>E;.M$A,\H>H+"'CG!81'P0;]M&F8;C6)J0T/()'L2=QV[$-X/@=#/8
MH.U/3HW*D9W@KR=3*D^E8TA8<U,9OYLX3DU8!@BSI6<]T+N.I]+NC T$,<8]
M =D:BL@M]$FM R/[&70G(:IE6IX]#9OE+=%;>5$Y#F**VHAP=] 0E[A-+03N
MI:<+>]54(/NBK8N)]S01>4X5S,,50[-9+5&*I,ADH@6KKMF*0V&4_*#XXP=<
M^@;6P"6EP]D0IZ_,2S^C]C37>O@\/WRY$3PRE']>).&*7*'#\>LD9<90<>H.
M#G7M=EBF)7%4J*9*JKW5E$J%Q,<[K.''ODO[T1]<*6;YP<)?[)X+*?)<^4Y7
MK@_JF=?KR'-/EP?TCZ1W!4&]H<GN:ST*K?^H7+:,F,O]=;H%[)[$6C2G3D8.
MNJV_ZJT3.3Q/7*F\<_>#'X\>![.[TX>L1'>%?STE^HLGE2? 8N+SS_Z8]<G[
M]<\^V<L[>ES*O)M^%7Q!=38B]OV"]$-NOJ'.L-_R';X*N?5$%B#\HD'1' ]Q
MSW_>.9'* MM[-J:9*8;!=XQ0H% S_C$Y0)2BWCGL*^[T:YLC(NL[+)P$MVG_
M$ U7R[M!71[Y&!#VXC9BIPYE:4G]TFE\F;XY,3<PGBUI[=5VY@_[@Y(N&#/V
MQ(86&S293B-/%IU<*CV?K9X-*1C1HE)]_0P<<+CA4>H:<-R0?"K6P*!%@- V
MOR9;Y-U>ST-&1M-\"3BP\@&[(5&3$>'LT+CRX+/J %:;17Z[;98;G73'WM A
MR8XRB.-(;OC7]X#R#FO'3K"5BK^^H[8?E:8F%B0F_T9RM+Y% J+(<+G/YCX,
M-%$,69-<Y(=RZZ4]?TT[MHL,/'O,,79>[6%_G#(M=&_B3(K,D*I\;+=\J1LA
M&?6KSVPT;'F%9(HB+?WHS&L%:7$O TSP["TCG>13(8T6/NTXL]10["Z$3LSH
M!0P]+K<A.ITPL>^(\:NDOU H+7F/UNV;)X$F\MM[ZR\<C#NZDAH&D;%!X8=O
M):Z\C3;B".=5Y!X)K'UX5IWQ@6Z-LV_4<L>D)[%[GI>\M72C\,43$6VJZ+@"
MM&B$=B:M?P=[TM2$35UXR<PQYNPW;F,)Y5E9)&%T5N0<@]BD7R"P!U/.C:6)
M^(WNCV: 2I:KGFE,A3LGJ@<VK-R+PZ2JC1[QVFZV/'V S&E_VX]MWS3ON.(>
MQYZB6*I3IC9CBYI.DT!+4%6;^CX!M4GT3#DIP+7J4>8%VR\MUX]8>9X'L:8'
MDH&=@PE=JK/Q[A7KG5H!C]@U*17=$9X&AQ6:V:+=F\^ERLJ1@0'/ RRT_:+&
M.;H[V@MJW;>?J#]@9*;J-%HX?O@>)BLX\[G66\:&K_+HX( 8J^^,G&_ZJ-DT
MW0 P)WP;I*)T.FJ!%HYE><9KS\N@[H*L+[<85?YI9#PC;":,ZL44S4FZ+$%C
M!8A[IEL+)D4W\7YU5>Q^VWXQ!>?M/W5+RDHU6D15WXN8\%9L,:&-A,)$:.;W
M<>LTIHW@WD$WC\5_S6P:/Y)E0X1G-\^DA>Z<7L"EO$>KA1 :B7&4>[- B"9#
MN^UK,[_-<E)X>L2M ,LL.HGX+G")= !PC9=V:?I6O-VRPM/GNT];;HZ'$?1/
MPV;&R>BX5KN@="H-(=V^CW&?*_M']")8M,+J@O!I=/ML)WG$/7H75I<*=E)W
M K5\T$#MJZ@=_C7?SC$*ICU8!*QO5T2Q=S36X&,G&P)NS,TC)G)$T1L!,A>-
M-)UK6&>+'.\H'@F6M2W\L/![ZMZ&CG]]1VTA&<(\V;,P,$9,$G."B-[^$$<_
M0VP(MBNF[%_$Y"3_&DR+8UBI'X=7"' E$FO"V_$M\@/%,W87PI:4ZMT[;&U"
M)3&EI(Z[,^J;L')E<-0+@.+^X4RND+3_=E>71Q \-^FNF3E25!O6.\#4IL@X
MVK+HP+3LW?1U*A3/7OAH^F%%R)B1!T=RL!T;V%$K^7FG9?T%=LF !4JI2'>\
MX*2+C:S0T]]XM&ZC;?BT":EMB%:^?*.[=/10M*N&YU+:"Y#7IJNE-_I$9VV/
M649&)>NC0%1*G&V6:;).N"?!B:B YH30H_%M-S"O#._#-[1H_8Y-]];ML,NS
MV%?9$@H;;CGKG+9/I-M (L06 ,PD'0=J5AL.@?LF)7],FK'L\SIB,L_NU="B
M5R32[&"RSGG;D4WGRF3EN.VV]2V%%0IT:\>=JCYQ$!7IM- =/HWT<?BNYA/>
MX.MKY+,LWSEOYU:J.^,D*:F2R+[?=(>8\26<S-![,TNI#Q>3)'!((-ACBZ4,
M+XLS5-__[B$6[=FZV:C'K_ N _'L ^-W_4B(V+$_H(*0NM[3QSP8A*^A0,]A
M"X/(ZS7O%$Q_>=X/:OKZ0EPG[FLNKS7-5HF:. GE"*_H[+Q GR;M7A?^C_HZ
MI8US*=&>4B%>6'7"=$]80, /MX=+/MKKN>!Q4H_M5K_V9;V?K-E$;C]GT.(Q
M1A@;4SGNM)9+;X>HA#<27JD4<02M#[A(A,#F3E>9C!<)#?R&HB3'D:0ID?Q@
M!G:A0!Y;O>J%E!UM<AY*NC(<WJ  ?\^'UJ3IC_[!,^6QLUL-\(Q+8_D1>0Z2
MF'9PF9:Z(?!&+2>;/$B5@.%R21-;1+1LVA6U//^OOP*K/J!1KO[Q[Q79?#[S
M<267GDQ9)MVY2YAX:>L,O-^-S<1,A(/&X"JNS,9%)@Q7VKZ1,NOY**&I1<F*
MI:OZE@0WOQ&9A)34ZE&B2B%%? Q8;\##5;V:4BV1%[D>+IGMKU9.8AA/V1(I
MUT=9!/(0ANIA>8!0.:@*@.PV2\?C-G;KZ(T +A!](97I,6!YP]360+.9$$%E
M&@QZP32N%8H&TQ%R'YNYI;U5@2J=[)%9-)UH)Q&W:(X;>KF7K]JU.W8_3;K"
M?<])=C$P#4RZ*L[8?QHZ"(MUKU'TMJ+L2G!%+Y71M5"_G5U&U:,CM_Z([)RR
MK])Z>@%F=D,C'GITC<9U7=J9-?KDI'+0$YE_0?!FTV+*>[%:Z(5WD$0>;PN+
M,@TG,%,VZZ.D.0 W;_L#-FC^2Y4V]0RD_$P:K93C$ZW!/&G?."BSTR[TH>=X
M?U:I5XLWSH<MHO/FD+U3;(T?609>1 UA]Q(KP)OP\-Y,ADW_Y= FNDB9\G17
MG@!]0I-5][0?<89,SBNK&3^"]K5?:IRLCSPW]G/$#,2)T=(^O*WK[YQTZ%\J
MB01"+"H0>*+ZN+GN!W4=?6)'CYX:I-/6?%$M\ E5G\QG=JA0]=4\,G)7,K$Y
M*F+_%ITCK#G;NPJG?)$0+H45S??TVGWF_LO<(UN!/FRY\WP(.2@*^EC)@4+Y
M=,78-%W=_Y)45CV+=%-@:CL/XI]?:_O#_WGLBW/K%JLUK=3#^#C;ZDD=#02K
M+4K;@[\:/,\O,E@C_3Q>@@8H_8"[Q; ZD/B$/V_;\G!]F:P@+KDNW X6-=5M
MO.U5][Y]Y"'*8$^2+S"MJ@2NWGR^6V=W"@XSX0S264M5"U ?)U8;<F#7&OUL
M5K<@1BT]?%D.U0G(^%[F$HA9P&PT "D4&EPM7?A5\Q I!%Q/@-!KBY60PALD
M>H]3I&-U]VTA\:);AZ+R47 BOIYF_G;XM$MY@[O_B])WE>D(CHA(.:-.:D4.
M4OC^5'+GT9.@>Y:?4$&C0KY7)F\;FXAB. \D6:>'C'?#8SV%.-_ :6:>&: _
M@<;)%!#FGPLE5+5\5G<CF9T/Y1?CY$J>TDW#&J2SYEG>;]F515Z&82)JD=WP
M2B-?"L8C: AM^_-QITW\^Z'UFFQ@BTZ]5\1^@P.GMI?15NBR5I9).D.6?[30
M/=&N[PO8^A<1$?M/L_J<KO_/UZK#J4J0JJMR "?DHV:4]F%*G3#(YLF:.5%O
MG0"9"7Q1M#YPR##=B?2'O?P/-/2V]N9+N[U'__5-O#>']!)5R:8)0N.-=O+#
M6%GN)<A7 KBSCFXS"U @:E\\%?%38=5.(\3>]$A2B+6)OI2G4L$P=/DO'M5&
M).Z3ER/ME.U,;+0A+\"M[:#^AD>A<Y9V)J0,=Y)<D<&TOG">#N+M#[Y9'5%^
MW"\0\\-N5'[R#-)MWI!$3$_V23&JGM9^K# HYOTH5E 6W]!QZ F<.M 5%ESG
M0[#Q*30])AETE]IVQU":,G_IW9[S'HYZ_\(N;V"TFH[1*>;U:R;UY_;D#AB'
MC3Q"8;\*@H='\5-2K1709V#V+C&B;/:R^[S-!+!H4RE\9W]PRHA_GC-AV&XA
MB[9H-\%U/KYCZUS75/+PC!7J(G#!7JMKK@]A!DKHS-+Q;?7C=3C*#:'+%=S_
M[E(* =L6\>C)4GC4^ES7IU7)L/AJLY!%,"_,3@K!%03ON/',0J>;55;Q9X+5
M#+0^EH<YB_0X9K+Q<1\-NWB[F+F["7^AU\1]J,MTH;$PKL??[VW9L--7^WP@
M&,A,ZK+4C2F2/W=%D</I,% MB%>TDRSY=P*T)[5J[_B/<>Y1?_:7%P^91A]Y
M8LNZ]YYV\=NF<MQ LU+:!A-V+?P5.'FPP%&K_D9]W)&?+(\1!^$#BC-LD=X,
MM&[1[5D?,JX6S!/JSH9M1\7*6Q<O-Q^HV"EKQ)V>)YG3/OPEA2$#Z>YW_!&-
M=&K;]#AQK+QMZ&#:8CD*8SJ9PB QV+;2.5=U_6J\<FTXW@%(-PC*.ASV0J+O
M0I9QM=-**58"D<AQE_CS9.:^==*B(W6[T/+W -N,8IWV+3Y9=S10+Q/[ [O
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MK'J,5BR\VAJ,?T0.!5;MDM_8$]G^:HGOW-/CYU6P[GXC6C4'NLE.+S\<CC=
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M8MJ#H( O\ Z@L>[_>$CXRN2T/[NPS*FRJ/V*ZRY/DLN*O^<QRLP^P[YI4'^
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M 53SQFC8=R@S[)P.[8KMN/_#%V@[=;-C?%V9K(4<D3YVW%0N-%MP2S0%OCZ
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M2#?"^),TS++$FH6-BH7"/NOZ/0LP(DAL8MDA'TK/QU[^4Z=Q7ND>V UDF&X
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M_QT#!K!\,&*\2F&MDMIZY7ZIUCQPR*EW/2*# ?2LIG7T\WS/X?QPL?4O/S#
MY1]MDRMF=(2:.)!&T'YMLT-ST6( !+%F&,"3B3\./8M78F# >"_XB1GPFI;J
M!D]1\+GW&%REC[+<_RD*NM/K?RDF&'5IKG3O\#2G,B>2_^VU%,)X)AP#./-Q
M>WS6G_$?00\BV8NM1,UBRSCJ3AN^@N9MF(*4>U,B$O";']R1D>N?9'H(6*:1
M?*_!&*[!_JBG=)1DKJ+P_=@GKC$YO:&$^['WPR94693Q%W%[X1G[@S?K/&N5
MH_YU#.!M8\]2V.%]AN)A=(C%XP3(PC^W"DV#;E8_JX@EVJ/V/0S CIAJ5. F
MC72:_#& H!L^\J6<1L>!)PXS'1@ @Q,&L%.N;74>! OZ^V<+T*':K&>Z\K[/
M3 6'-#:CO73[Q>X=C?70?#C[L+D,AHJH5V5.DEE_W;+D[X58CB#QPF: 78[?
M%]'L(XYMGXBY^:=_/1B$*[<15.HUK!J"=>'2,H,(6UBC:\JQY3N]'%KA\*QY
MAIQT%Z,Q0V&L^.@/5";GN_QCT)Y"9[['7FB;/%Z'!*1/$J)_/+7ES.K$K6VV
MJ\(;RH%Z;VCE\ITT1LN$+-Y5%^WQ4WD8YE&^*_!R>==E%Y&>]ZU4R7PZ;B&-
MS';[=E! TW&@LD^LKZ&'&"_;J =#.ZGNZ)#-02[/QNJ\'EH31>PS_@ F!!M\
M."*%[8^\:H-ZH'Q)'L3NF^KK39649<C/@'*?M<644\T49E,;<7 _.N;AB?P,
MF/.QHKO\:.[S/A%,I2E,W()6:O7&@F9/4A=,!B-:F*4]E8;><<"GV#N(<1D\
M87.[M>6.(\JVJVA)F0;U$RJ2?L;2A+L)J8.3M69(Y]&!KQR:$J::T]AQ;O$K
MHG[0"YKZ5:^Q-K3094-'<]<B:H3O<]2^T?:>Y4?$!>])?U8DN&Y,K<%K-A8Z
MM^G9F@1A(G#Z&*M[8G,&45S;:+Y/%.UZ8 GVMY3KI+KLO$01X9Z&BY6;3R&
M7"<$QK-&VT[GL5#[=ZBVLIC*W=I/#^<86HT5ETV*U\IY[2[=GVFFUBIVIOX*
M,PGDIC":%*6P'U@?+)_##:XC/JYCW8G1<^6]'=,O[4O'A1R=/F=+]%JB+D3
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ML+)QE&0];&QE9;0QEV35$53A47&6L;"V4?!QM=#P>:%IYF-G)FK."I8BP)6
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MX/ZK%_T'M):4A+F9F-D?[^3D^B_P&A8N_SUOV]M(_1>"_2]51>?\2P*-@>Z
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MO03S!,P">(/WRA [=E#GU%6RT[KQLV%INHS  %H(=+D[P\5I>6N3VUUMSL!
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MG4MKGN4EQ2LH8+H'J63Y"<T'N,"G&CJ32,;)TT6\+1VQEGKWFAKMGPV*M,<
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MO5N23QMYG/+D)UH21L[$5:P4J\>JII-\E>J2K,V-5[2I0<@B /[3")ZPJA#
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M4/D ;2S7)[L!FS"P].)I_^K]P'2H)=*G*S4ERI]B3Y(_C&@,Y/Q84&'T@>A
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M_[:SJ_^$W+O5%6XW0E/=5 9L%V^:8DZ=E>\VX%5SWZ]F<&4VJ<TST?6 E9(
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M&/\3RGDA>:UQM(9ET8)T>6=XH!&S0KFQF6(R%J"JPI8JCMX$5#/ABQP8>'1
MB.+NS5D+&38J9=B_'9QS=Y;8FIIO1(I':!25SQT-(9[V?EQ:+MY9][TLW6YR
M];Y_(4KP2WY;;EV7Y7?^0*A1NBNXH$41\4D/3&5Z3Y6!1]1_BG$MV;0D6B<#
MW.Y H"A=NS@^:I_7U<9^J7^-C/U9031C/3H961]_\/'IV8[+RSR(A>\>S-@
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MK?6QWYKA<O)DD?NI!F9KMG4(?M1+XM A(SK1(@:+XI,YW+QB]Y*'/__0$O*
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M\#I_;E_[K(Y,EJ@N)JJ)6Q4Y&R#3GPD6ZM7[K,[B.]K]896L@]&E'1\\82*
M&(./Q4HIKN4CMJ+1;$V&RO8GE[GSMNXQ[TG?]+][P49*L,LSSP7XCUG[#/X#
M_>'"S9S" F:)=LM!,Y$;KO]'LJ( SG]%+B6.S"O@-73)AF:]+,2T[U+][OQ_
MEEM30=GN;!-5A$^I#?^ [6?<,6'N]1"-Q,!%I*YM JH4"V"+ZV$^)\[" N2>
MX6QA 8@9?P(L(%LW7!;!!,1(*Z)%3(-DMRGA0#1^,!80IWO+[?!]I0M0I?#>
MF#S;V16;J4-?+$"463#1?8[-Z>0)GN\@$+_63QD+N'^)Z,.$9*&S&K& M>\X
MK8AK.$<\DE6^8?J4R^%1Y/+J0I.)0LEU4*FYG05-E_>Y2'/9GK=EF&MQ+9_S
M.3V]N(*)=1K &^CL@S-0(D.!L A<C1$RENV\\JRL2]5Z%K'9$I(>()S"=JK1
MZV3ZR/<3*L0'2=^78/A'F:U).[UWY5U]')N22YPPXY\XM2]$@'-IC_-2Q$92
M5T_V=GU3ME8@;Q6Q*\BI2U0F6\<MY<#6C"W;1H:L(4CJ>-R4MY#Y911ZKP!E
M=RWMZ=)U)45MPE<9I3?++C=9T#=R'P\+N%.HT/>R3UJ\Q]T[I5,-8%-7?G?L
M:TU14JB8P0)?,Q!%X:,*4%Y5B\BD1T78/LMD;/PV8H^3.0^73N@&OE1\%.>H
M5+)")L-CQ7R_)QR:VY:I<H!Y[^[$\YLX.K'Q.\X)Z9D:[*B31  &"3\S?O6Z
MK2%Y'L,68V<)^.'8G97NQA" 0TNS:SN !=@Z7!)YFF(:%K& ;8UQ?$,L@$1W
M->[JKN>MK'!6;\=]QD'YYI<O;9FMCL'GMHP*1;Z-3L/>XX5N2OTY+LZ'B=&9
M[5"2:UDT'\(C!HWK4^R9I7CMMFB0_HTMRR95ZE$D!R[!JIO%%NUFJTW7JFY7
MAH!F':02L1J[.:N=2BU63U([O<Y 2R 5^_53@)B4UUHK)VPE3%<?F@Q78G*K
M5SKX)MS\FPU B)M;N7X.%L,"0DL1BC=W6EY@ 0$($')7]I]]:7_XCV)P$-!8
M\-DV6OO732L?2T@.DV_\%UY36:=0;](:G#UOCX/GJ\1[@8S],ZX;G$R?9TJ2
MF+" 9@O9 N^*I%+KJ\TTJIR\Y5<^ED^'75["DB!DZ-(M8"P(KT4$)GM/+!S]
MA&)68=E<^2#5(IZ6X:"?5^4.(2,R$GS-M5<? 8^Q[-I4L'WRI6W^0>;#UZYO
M Q=8WH&6*'#.&$7UJ6A,=&$:*H+G%+N*\K?_O:=#\^B" F=U7O9 I="FC;=V
M<J5+E^I<5Y?GCG':[]'F'UP6<1: K71!M.URZ>8*B:?IZE-4R.>;.+CA0BG2
M,^MS57S6_J9ZUZ<P09(54<$4B0NP/Y(ZXED<X7;5[O+C%D,>FG"=I*2T!$<
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M\MDFYX,:]UTV;O?$G^)CY7Y\\@"OB]XC@BP:7Y[I\M7P 1]SF04;"O.4:(:
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M),VUY5SLJ-<74#_]QEA[_'WUH:2/O8+A.D%S88&/K). ()W$N E9K<YUZH=
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M)2A=<WNZE66A="]+K>N@*VE)-?:)5^6_,*+O/B(QN63ER\K/]EQ<(L U%D0
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MC8(7'QS#P\^?P&MN<4>N=U^26B1)F.)(.5R&5O25BAP%51,0VU387!\F@KW
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MX2S$[_/X ,K)S;LQ5#*83E08 @AX(D8H1:4%HLHB$A.$"S3EH9Q -W*E!7I
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M)-&4) GZN-W^\;X"/#.\4I8$06?ROVPO^U].@!J1"SW9N@/0K8%MR_D.T7>
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MG].1/H"5Z%@$"K11-KJ5NPU!82O"3ZU/KH0XZ5.DNM_G97A0B)-? D51G!U
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M8'WKK=U=]TBBV7TMF6L(%AD4L<Q>5&SL%[6*"MP0/KVJA^61;,T>=MJ_&N^
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MT62DA)EW0BI<;V4I",2+<N^:,Z;RT08KFUOT3EVZ5@:O$ZP9?XLEXEXX_Y$
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MW]!Q4TR!8HPY'K"S3!1_>C/VK#U[-=Y5%H8D6U$M%F"Q\-B*!K4=!PI!%J[
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M4^BWX]Z1%[1>1(3$]<><+30E0>9(.HWPE>)$LRD-7) 9&DNYSB"@+=WMH(=
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M10)&>TP:AO#-HSD(;Z<?=18=G<T:\TN?A7F7FW%@^6Y;;0C_BU_Q]HP @CO
MR\(3+7B7MVVX6W5$NXE?X5LMSU*W2W<=,=Z5_G+4&=3?SUA0[*_GZD=EV50@
MCA)@W:)'A#LN:1+@A26PVSWKN7_)'R?_(4?Z+TO)_]#[:MIE06#C<BLQ8(HL
MY>TC!6VL=(F )L\6(72"\<4U)G))>Z*8<+ZY<5!A=1H@?RL.&I.R?!DLO1RX
M6%_ZV.-0#F7Q72=)A?%WCMF&:+/ OD_]\HM51N_2+ +AZS>8PY"5CSZ@<:V!
M0A_VJ_<R\36:SZ;OD?:[\#5K#=H7Q0.#]5S.B@O< 90F7)!0V\KF"/#KO>7
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M^=+3QOJYX3Y:V.?C3'RS/S]\I@CE=^?C#H\Y;5F9:93%4B""FC>I;@ Q9#>
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MGO]N\ZS_OXW_;S0#N],@<E9X^T/G;.B4&O3D/:(6$HR=@!ZINL"N"'BQH5Z
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MYU""0@+XIQ;7ITPSG:/-H\UU0HIJ"&A%.7'7Y74TWE3XE5DKEG;3WN[7V-X
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M 7>XVINDMG>\46RMBS,1H"H8<>-@EYAIF/.ZR/K.!2++YTZ$(A;?\HZZ$I<
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M*IP<39MGUEP#S<MN5HLG^'4W@.8P!0S/'PFL/Y71^:$-*,\$FG DB!UNNP&
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M=_?[YIW9O6;F^F9W?W\47-T\5)VJ>NJ<^ZXZYY0I"LA4J;5<\WZ, G[YY:&
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MS<BX>D-W/ >ZVE$^^P):KX><3V;T<GXVSVL<P;H^CT1>D7CE$%SLT]V<,?_
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MUJ:[9$HH=HU3V"X%1.Y8S.I=J';-%1=AX 6%AZ;JPM3>_DEE3>IG>#L9?WM
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M-DJM_E-)(?ZWDD84-7BTP;D"=H;WVX13*U,Q*]O<9CC73C ;+#6ALU/36RB
MCB%(Y9-(,)K)$;B-'W:GQQO(=M<!KOVCF'P8,UKS<,N$!W.;$]SZ.OWI2TED
M]TO$)$B-JKD"OF?[(:KD*MXF:(C3IW)D&M81U3X)4'/&2*TN\=,>\Y0P\WP\
M="U0F]KX\\WZ6QG;F57G**5<\1,,G;^BSVO.\(E0T**Q)0_,WX@WE7-*A[@@
MMSM#^_MTY7&,3.='CPF)FX9ET"71(@IH;H$<DF",*^M!S\[#T(A!/@@%8-U#
M 6W*_Y)'U'F7Z4CQK!PS%WXA1\?75@AV'3M^-BN)"*^$ 'O,)4I7'AV0DZ>M
M:"WFC^;&S,BY0^C-/5LTZE@$(4* [7_-$PPJAY$AY<GFZ_4')N^?I#&369<$
MK4>W<!TX]N!4_?/=7(*2@E9V1)E.2U' 4)^A_$2@:R;ZCZ&B"H=*\H>9&V ;
MQI3W[=]&&=XS):PVGMWE37&$2?]=N5G3\I>Y2,W/7FZ=-T<'AY6V'FUM*&Y2
M/T8+48CS/SA6ZK_'RNKQMDKC@8G1W#!CDDIM+7&%E.+=?LO)B6N3%PS-ML<H
M0/F/?\<LRJ@![>Y3H(UK(@$2GQ@%!&?^50O_LD>JO=@ZO%G&/RK,)OHQ<-_+
M#EH;&Z09^C54=0!Q4]#[[QF,OYFB9/0468X?]9DM_.J6%*W<K=.4..Y8I4((
MFU#^STV1RXM#VLQ\L$NMQH^,<,ZU<>R2N],5*<)UPA$OR)^_TB?]?]/G:TUD
MWO2;!C0'-^,AO564\2>,3RM5NP.IB0W"GT];L5 _\$?&'W4$.!D7(CZA )5Q
MEYDY2;8B#Z2U>H3PA!1M9&5\B:UQ*40]=P"<4AF=E4SS=%I%CTA("DFYMC,.
M9EFI(TP(LNNL<$%R1X!W!=962(/7,VSO.-"2_XA5KTAKKE'P]]LWB)=S3GD7
MB4D0O)8M/.+1H S?B)VVI-1OZ'[&<V=S4P7L;C-]<L%@%\1V!)5;[*UM"FP:
M6C87X,*-[2KVPFTG@_OU@.WS1CYVQZUHO@&WP\SX\]='FT?]SD:3['0RUCY[
MLA>/O/EZWI]I>36F(-\R9RS[-._Q"M[6PJEXW$2MWXO:*\DV'CV]-_979"X)
MD&RKS:3NK?^/O?<,BZI;TH8W@I)!)4L209 L.4<E2Y0<%5!"VR YTP0)DH.
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MY_LJ C1%PQY]SLG\&S[UOZK<KOC;3;ZF)63@-1"WNT)_[GH-C%L7[18"A]<
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M:FV$!+72E?@RN<>![YK<@#VKO_TIRWU-B.>K67-S '?2][?J6*F6M%G-=F$
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M"^^+1/; I>2C!7;U<*6QG:-M[X]OEA5OIS?JR$:O29/_X2,.TOB4OW-(6:N
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MC15;UW?DX_'XIY[LFE!$-DD0^U<3 ^Z5RBV3](:3]EDF\GN@+ZZ-Q-4?'[,
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M8[T)\(F:!#MTUPA:VTUH"A\HL!9=VV9EH(,Y!^E)8)B_93.?MS5Q95-)3LN
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M1)2T<;1Q! R>GX<R*NFT8BK@+.GJ'ZBA3%UK'U;3!W!@41=G@+181LBH"G8
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MG[A(37T0M/:L-L8(*S;*B6I8>C]VMB6XS$DR)_&! *QJ'.)V@4^OT'6DU:U
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MS(0'/F1(VPIMEXZOR'JO"5WI,#,(;VG@%0&.BT$XZCCL,_ I&QZ8Y!S)A<N
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M0*Q<[!\SBS^'YLD.F2!AKXJZ&R+P<%_LLJ8ZKR)[*F&]9(,#>N_58LHMC%Q
MLP^=\F81SY:#,M<-\DC.,F0O)PKRP=1AN[%7V?YI33A;K8C]?[Q+C&4P]^IK
MAANHT!X'&M4).RO64H-JXA^G^]38(EC'.L&4.&85U*3F$']M3UM-776)?F+
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MA8HA!,$++PY4[ISG-BSA9-@KO+@+T$'J>\;A;*-'[EX]M3VQKBSI8;[4'@!
M^$LGSTMF[V':WM!"4=Q'#->/]XF6S]Y!4(*040.A<V%&3\]*3M^]43_S>?N0
MN(E["0Q;E4*/6S].<LUR+,5L*++OI<,J6-C'[%4@\'58=N1GG?XS'))E]RD>
MT$9**RND;(RM/;"X)\:R8#P!PBDC@J';DWA ,1U>6?!W+;G_HVS)@$Y72H4Q
MYG,1#Z[I 1[(> ,OW%SJGX#CE+3C\(#)9SPP4*KM.".)S. /:N%1&V$^15GC
M%&8#H9N=4#XCDG.MUIX]EF>?5ZW7K:ZH.7#%XU[7[_Z5+FGQ. ?UK2\M==V'
MM?1#)_^*F]VQOU([FJ/CUR,6'!'G,[E8GE6<15\0:GL:&B/!,C?EKQ;@0\>)
MN-2ELWS,ZN.ETPLN#RM@;T]<?A'#5'YMIL,$TAFRAJ/$_=2S]Q>G; #OW4ST
M=CJ6<[(4^"HW5:AL:_*CJHD]*AFD*G* /4MI5PM+?MU4:FNT=3.,LOFJ)D'7
MH:91G3GSX2K84E??>O;LO(VX2W%VZ.P\HJR.BDIZCNG2@RMT_)/OY-/V1Q$/
MHIY&/HEZ*IAI12.?2G@I1=5Q)>:U_W*(S+U/YOX*29&E#Y[+&]P(F?=AQH!_
M2M)OT,8ET*QD.; M/7EP>:GD.\"X5T&;L&N1IR>6GIS_(V1C=.:LSUK_EVD5
MXAN98]O=0)WGCZ2)<^_612\>FZ*(SN 3B[AA?Z9&;(A8R;(W;[<Q&,5Q?.V!
MKM&\-Y?&0+FA6,N$1$-<^H2\^5N;VM>!CYO#EK"*K-%JK$DC&_?S;1$NK$5_
MY4CA%?\G=V.E03RP19ER)JATTA]@O"^'N2 <1C*G"2C(7Z^S3H,7/1Z(%II/
M.=L'_QA01JN-'9D68+36SUB:(%95\3ZLEHY)V][<4ET[;#&0'Q?=&2(54?8M
M;"YSNAR8AM:(_I #Z$1*LZMH8$ 6.KJ;ZO90_'S-! DGPUP!V*0Q GV]6&V>
M9_MR-IJEB7,>#]RP1(Q!WI@+1H]_L.UNK1PEZPFC=*>;.UR,5;PX27:A!WC@
M46YBTMME^\T=D?X).:V81=G]O"[8Q&5[T^_@)5EOT[FO"2!@[8;"H__&WGM'
M-=5NZ^)!5 1$!$2DBX @5>D]-KJ @/0.TIOT&H(@H/0B(#72:Q+IO3<!*=(B
MO?>64$* D%S<Y^Y[OF^?<^XY^YY]Q[[C-WY_S(R1K#<K66O-=[YS/N\SY^S-
MGPZ2)D^J0GT"J2US=*L],7TD O<DE2,VN\H%6#GCXC<6C/$]S[P7?T.#,W0L
MZGGA$<!42U-5R.&L 0\P\1&TTW+?:.G'AB%(ER'!S128]Z[\PFF*IBU3=^8F
MO[/&!6[0WR\!*7!4>;UY4_EE2 3IU>I\S9M?*T:SLJ9^C-_,<7B@4*G<1WY<
M2TM'9H52TKSI83@7[%=I[!^?QE^>".\2_)1_"G(1J88'Y%&?*&R:D'J7X)31
M!7B !14>L"D+&I%05\/<QM6SC.&D\ !8*<:DB\M1!KCUT) QD\5:QNP[Z] 0
M, 3T,YT$LXZ.1$(183C.@5)Y*MXDV%UOR]?OV !$AF<K3F>/87,F4YD#V!O#
M\KG&_!^GIOOF/Y]+]$;ZO*]HN( V@"KF\LE/B'D1QV>W[([3-B[-WMB!"2$X
M'^LSHD_^1:8:UJ(F*MU4LI?Z.QBR1T*[:U"/[5WE5#)CZ!4.1-Y9OM.BD6DL
MPW+OD/R4C_]L=N%Y<7-ZK>@1__99K4X:9FA!/@CK6-Q<X'=M @+B=DH%R6A%
M_@#IZ>FY[0$XZN *V=G?&])C@IMIO>W;Z!P\4[4JDZ_=$\L\QJ[?O.5:=ZJ9
M&?!:?*U^B[.@MOI/L<,Z%HP'L$UWMJ!)ZB^55L7HFAL.>*FUCDLFY]>,P!OY
MI5O^E$=">5B%LYQ5Y\G+>\O;<N$SA T!:2YOI(+#F%@_"=95-L0^=AGZ/'Y0
MLS..![ GS>,:UW'/FSOK:Z+W1NQM$>Z:K'++8Q3!^A,JHXJ>X#2!W%,[D7/<
M1\PAVC:6HUOASF[_Y& .\*GWR?(IXF<+W:IN "DF+GV!_G7.EM'3"Q5_B*5,
M$=)^^4J_A]U;B&*=Z<\G7'P/3'7NGPFD!P_9[3?S^X-'L6X+\QAYK&C!O(&\
MZQ8B?NZJ9I7J0CAUFKCI+45&";?.,;L\]O[-"]#J,U<MKV-<\R+0DC.E^;[=
MP?N#_-1G,FNR/0?"QQ[>P)VJ1<6C(9(M&9;&CST710]Z'&MOZW,>7CK&;.!6
M^SENO4W+27";0)C.97372M*'$@V#^NLLINV2J\?;[,)S#E:\[Q$1WD<JL-9D
M0?6Y'R9H6Q55[D7++^YW@%@78<D>%EF&\X:R'H]3!E8^_J"W87#46@[?+LPN
MJCYAY[[V1W#M'[:]ENJ44C+M'8\[.-$\E_VP?')W!K<?%RUQ\V:TQ+%PC6ZJ
M55S1E'?,ZZ:&<::EP>4+E2*VCZ=# =<E7!!-MD26O*J^98U9.;Y'?K:(NLN5
M7-OZZ3^J*-!_DOGQ_TF)C2U69@ (*.YJA1:8#S?V>Q%'/TE^MTQZ++33Y9X1
MR?]1AEOF%C)]*O4E.ZA=^%I9D!^.^G =';4>O4 CL=IO#"WC#0.ZTVT'B-H4
M=*9V-5W 2A-L?QK<1B,'TELLWG?Y> 59I*F<OZQ(?C+C7\3L$J-NG'3K;KQK
M]/J0595/%COQ%K2@2-EX]-B(V/A0M3Y>4F.&*UHF,:O 9(#_0_.X^P=32L.)
M\RW1<COEW*9RF8P'/I&#*2QA#J,>.C4)SVHK+17Z^>X^?JPVK..;9_U(=O,7
MRO+C>B2+6/Y>!L)LRG*U"@VYBZ#T#XS3B].?,O0.7X1"VV8 7L>%0HQD0E"Q
M?JGXZVX'14Y!]4#RR4VT'$Y%EMW6&'@$RB#T&X?9RDE][S;\7 "TYB6WP>@4
MS6PQT6;2?_*N<KECL@/C'FRT7.+5:9>1:C8 J4SI47@IQQ(SABT:8I^[Q\H[
M>T@]>!%?5F<(:6_$ WH>;]\].T(I,XY*<JZ]2A+NTH@I2RNJ!Y&;A_*:;\J%
M3-E#A^RK,!E+Q$*"=I."RJ$& S-?C[H\YHA1Y\JV4DSWDW'2H^"I+RLUTC?@
M-,B!Q"F,E;A5N'DXP.O^HEI6,=U:18G--D\LJW1I1-656\_P /NIZ@P2F;Y=
M?3S@?:\R?81NR(T^]$\3*S_KJ #V-I$T-/BFB:-5FU_E0H$TX$$CO)-N*-Q?
M<:7M(5PJ5FZ24^&T)&E$RLS1)[__;K[(#!'!<U2<P39T:MH@B#4VQJFR2*.C
MEAO<QL1!%:UED)Q7SR@?C'T&7M@NXYY)KG8[GW;UMA@]A*TO.4<E!C#Q3GSB
M3W56_%A\O/E=>#%UK69MBFW"L7+E"E.U!Z.1$)BLP\_WU2?.]NY;[UP0=[2S
ME'+K$JKJ8T@C.Q<7OR-$13YYOO4E_ZBQU&F@=GUZYC(D+_SB<T?),_( Q!W[
M$ZM28#P;%/LXI7GOFB?%YD%7@6#_G?>6S*QQW?;EGT]SFH8XJ!5'BTI]Y%6D
MRVT1VMGC3NQ63&\NQK2L;5/'*=A:C16*/>D^)+GV7EN;@=]04<GZLG=\/?[T
MRV3P3_*'&0C5W-I>7L\7K%4/Y9(E"<1ECC?FR:I.>83-;#W<ET;,/H0Q$'%
M72J@N8AR]OS5:J*5FSZ$<S52W$M^CC3Z-**QN1$5_0""'FGY)FMCB/#=>-$V
M;;1WH:IJKS2(W#N[0@AR>[-^H%1C<E9.7SV.PJ71CT+?XU!%K$'PB+-/T/"G
MUS/9.QJ<?\NT_\_D#]1]>_,_L?H#!?[*WX>9_)72_V\3'O[K53++I0P*#.UP
MI!.5T^QD;CYF4A3<#%=V:=6'G%3L?RHI*NI%\W;EQT3B 8MI,@_P@*&09-SU
M/&;D (0"O-[>CP<0:C3_@/-A,E"C+S!^[Z8<&SFT)YY>@UHDF#\G5WN"?.>W
M"X 8OJ6C5Z!T0*IAK(8^MAPN6E[J=)$\5M"ZT^0467ZY[HU!AS!V\S0@N!>:
M[Q/:'P\HF13!@IO6+([@QA@+U/0+3)B[4'^$6Z[]5<JD$25&#D)83VMOCZ0"
MT:B8L*)H&6]>W8RWX*NZG_ZD69M>6R4>U@5M5_N@L8RO"8/GXPS>J*MJN#I^
M4^K[WH&"5;DMMA#:2PR$R[(/A*0G=%9<>5U>=/_V#;$S"A,!/*!#"S./>V_,
M?/FO?/  S#'(PLO6&6S-"SUNU!$9?:1HED*8&^X;5! D'64*;J]%RE\0-U\.
M;C-DQJK(9NQI)\G8H^"=TM9+8:WG3?*&565!*J(&[ZEV7.J#H'=2!M><7.7S
MO)C+'18;GRS=$XWJ]:'?/>JC@&"]CN"RJ)8.%6X=C"W4&]SAJPK)5_8,TDV:
MF&312;GQ=G"82&PZLQ71SWPKX,$V,U&C>B';E'5F><R#<[6,R%>TQ&UDP57O
M.<H6(% QQ4>]7I>W^ S>J:'2S5^#93[$DAM>0#FT?OH+.P4<SJ@N;U#+XWYP
MYUY\<9QC_N#(&G3U+'*PT0-P^8"%A0_7._F9[4WN^9N\-1N]*:NS@Y8 -= :
M\+CZM,YT+J?? BQ'(GXQW\+R^-,BSQ6'TTM4[(GV)WUI[R6!X6PQ[1E"R[2*
MQ[@6V9/P'%5UY8+C,QR1LO&C<V7OM9..@-M5PY6M%@F&AY3V@>\TJ*?KB!J<
M"&52CI=34 6[%$M#M_P5QK! BX*-$7U]8Y\;A\\>Q<(9XMD(I<YT2K'/,9I9
M6!7<D*/O]NL:$19L2YG"IXQSMXSO\[-,B6FJ[S0,!$9?IZFY^Y\@+9:\W@?0
MV>I0;?D&E'G C!DKU*Y2"+ETD_=]U'_JLZ5Z797(U/X]:O[3#E8-):B!HOZ@
MV6/KX5KQ0/6K H!$'!"7*6V_,8^Q5+L*'M;I9,90$/UN#9;>Z+48 ;SI_VJL
M4=*,YT!??Z:4\_";P.WGF0H :XC23Y&M[NDC[(VJK^?@#HCL-H0:O&B)?8B2
MP(I6H:XUPPLB5)I?^5D['L+\6]@GF[=D?%UV4U%J_UH[(1OC@BQY@;'AGWY>
M/\9WZROK8<#D Y'9M+(:._Z3(4,T;"D="KI&_PO#\1JITVEDC%/>U>DPYFQN
M2&:R[!H(Z8R7 1#R]"FV D#70+N_\T[^/33/9[V3/&B.$1,'>U;\FZ1-U>;$
M.^ZP&O6FT,HA]GN/N,5<TZUP[5=>-OW(H;!=?^[%-$9RM7A;WE)S"KG#;WQR
M?K& (9F@2NL@[A*?^W6?'H9J/6)SY;3T8+UZVS=(4G,C_V*WLU);/G:;N4(T
MT$,975=#EYE4ZFI:7F?"+]/^TEPF<'FJ0>V:ORBRI^/<AZK#%YPHU'?7OLBP
ME^>K;]F&Y(*IGXZ6K-!.Z?OMVM\%!O\C&WDX])'Y6J,DBM4P6 O![Z' $31C
M4#S93U?T^L<D2URT:T^3!XX6>0$/\1>TR-H<46&OBC1^XRQY9<6Z#G#S<(-;
M(_QN^'<FV,Y;I*R',QO-$[;AOCRV:-F;L%S3(/+7\G8'*A9H*^2MH@"$R++F
MR'CTJ[LZW*OKOQ0BY8<9_'3@ZDI])X2)2)T.\$U_8$V<E&C!J>:K+*OZQ!_Q
M?40E3,'-UXFJ/-ZHOYGV"VV[7 +^W83L/F'RR>EVWYB(=13#671E3<)<VL3+
M3)9[KN=(@@BQH6;0]OA&=DCVJ@'A^*'TCZ';&&<%E'',P^0E^AOPTI7[7U:^
MMS&2Q 45S-RV[Y??:5A@ :-C*NT?\IXW_W!*Z.\Y<:OP!"[HG< MLT-R:MW+
M4B[C^EN;,M0_ET8:@1:,49\-2UW6XWWCU7C4BM@F,NYH.C:U7M[9I_^F>)B:
M[BC+1*7R+M]FK@*_XTI-7,[]QSH:N4'/:-N.A%W#51Z6=J>I;ARJ$6*)D4.!
M_J]2UV) )2JN<5+/^/(_)=P47[30A'0W\5V&W9,B"JM2CDA$.QYP^[XLB@FR
MID:9&+I'\V3@WM%-B1BKJVXCM;/T:&ODK43_&E%"C?$KL2]%$:2KZV,?QQ7/
M*.6K?'?O)#=\FVN(#+VWNZ!@&F4>+DSR,2)$BP$ V'AT] ]BS_]'8FZ;RGN1
M_$F8]#Q#VR#- '*L/9 N_UVF=OG>4O4VC<KPWHZ_;*&=X%:"X0L/'&SR_32-
M^/'NL.FMJES&SU6/2^@'R9/0H%U'()5=.&?I0/L_:H>HV!A<+.ST^U6(H&\.
M#X *3R&H_7"5"/O_N[?CGR@,,9V%Q[U2;,L=#DLN]P5V6&5T4#H?3+P_R.8J
MFSFZML&O#_$P'X>--*>.>X$MYD[M]'"#YT_W/%,QR9JC6*7D-9PCW:E%2+_U
M=U.:U+V.B=<1$0:9,L#KVV^B%'KS89Y0[IE-[CQ]"D>7CJKV SD)J':P7&,-
ML82J[GK"MB$\C+]*;#^O]JF^@.JJ63QYGK-M,T?0NK9(?8D0&<6I^)3@OO%G
MKG9/U^'3J5K?L?0<4J$JJ_*F=M4'20NGNWWYDEH]HZ8^%'NQBD+67.M5.HT"
M<QPIIJ^+:^;W3R>@5:7QTZT#7$Z?EQ-. JH0=^!6/@F.;!.1!;RUF::C-[-C
M&EXFVY6U))SWJ!\40&V&&"B->.A\%;GE@*!H5[^X72WK\\<S2-C/F&29*N-0
MKXT^YT)A:/GL$$TRU^TWOMK&.5 [WX$3-+15E+=5"]@17N'FP3A_QCL2EY >
M#AI#V4R44='&W5NX1EMJ6=)T)&\)='$]V#IS%W'PUW9V_VFV$J&@<''$F@N]
MV"I9HB<M 1//S"FD\>8]+[RP)Y>;R!KWH+WZ3L"!C0'&7511G6 T5EKYB,VJ
MLN&+K&O@02&X8</6C?_M%+DU^Z=(-FC-]\,!FN<CCD?OI<JANV/S E3=0W:;
M0D9/]D>X-6GV,[[E(*;J]NF\79T),"/;*B,<-)Z%*R^S:H0L?C9M#;Y?2LLI
MGUH3"5H1I:1X;^CM6SFE-"'M$'"WT2!95*3FZ)%W</O)3^_/FT'FU)_X@.LI
MC$4>I,H;7R-4Q]ELDUZ4<TA'&8PG:RJ?U-I_?R.B^M8YI3F1(^RX=CV0#75:
M7/IN4.!9L7J88,3/"E%M>$7D>*H)Z.(5G,0V:%X_:<XDR2;M!JYJDZQPOM^N
M^G!&\!EM7T]TV$3=)_8*W.1'@XQX('N4._&[;WW1L&AY55=B6/'M2-;^7X=E
MB=;:=L[%XE&^@\>3>=6:CSB 2C6.GF21GALM%I]1/5)G$]MS2\A^KJ]6XMS1
M3U3'UT;TK1M':4[4Y>OBFE%F"&K#]/)ZJX#Q/A(RQ[)>/49'X>YRKD%F,=>
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M9;D/<4GW7=\)/-US>4K31B0FWF-B][1/M]!4UX-VTUA^(:T?#[B)(5RBGAW
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M15?$+)'ZA<OP\5)=OQHY9EFO'+D?XO\B5U_?-I7]!^6L7=QLV+F=P4)W$9-
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MZG!CLZ55?F/YBK-U,25FV\3[3YMX5GC WY3]<%>7B^V,>Q[!8).E?MN4DQ'
M&*)1'A&.J\$#!.B<E$P0S\9^;^3X%Z&F.[R Y,W<MG/B/Q],._J\J^$@/<CK
MNZVG=K[@="+9Q+U57U2T*>%49>4HG"&#>%W-<Z_#BZ0OA?'6Q%6KI&(E97=I
M.A>_)ZE\<'NXC;9^=>;YKK.IXA*;6U6H'&CK6.?;Z$YER;V=R@8Q'JCY]VA2
M[R2A5^GI7(%$#TNU)$V>:^W^!JQ"J8.78ZC:%N:O;OGN#I)/WN>EHXHZ8*(
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M#>9_E3Q@II^!-4NDP@89U8DVSE,"@&PS#U.6-8^N2)2?%G>Y#V8:TXENB"8
M;A]F-M:4!J"U<Q(D'('OPT:1X0N<- 90PWYFQ*M*:(:#(+B:I.SC',\E#:A+
MNZQ5\%*"W"5QYV824?6?-$"G3U "@-J8H]M>?OV=MYE^1AZ_T//$XCJP.32R
M[=0A@(6^@5:%IS'V&1T-8,=9F5X)$I2@[45G6#IE=OU.<BIX#^7$]09>%^:^
M.9[T;C1:3; K10QX0UI5==/%T7;R4>69]-C[VNTIGX:R.UNG%C)]9HBDVS5/
MQZ.W O;&YU4?LBVZPV2/?,D[3O6"),"_2C_MR1@\)Q&]:TKJ+5*4I$2E'>TT
MYB:_165'\33)QE#HU#,93!^+P$5",,O?X1I?ERLC>)@]@;_PV2$+\$6*UR_N
MA+0IJ/4#ERM.40KR"H9Y&$/V,2SNO7R53?_ "A%[#><4>;282HSXO'CQP+ZB
M1J.R24A4.2_E$&:&VI:7R0J=.HQ=%+W>W/JSF(^OBB,@=3@!SFV8J$RKI%V7
M%U\S/9)6]0Q_>TWS7;0-."M<$W+_T6V@R!3S_&4EF<T4$'^36=C-D]]VS*T&
M9\WS#!TC#H>%%OZ% I-\XOOW>>5<U&SWSR-5TG*M6>JRJK(Z?+,[3?D6K[S*
MW;E^F..V>U,?ZMRR;1CVQ5XZ0IPXJ9^<X\5+,?&"2-D90QMXF</,[$JR9WQD
MK47AVBS/&<</=T&TOLZOVTH\2?MQI!F<3+?V?TV*!94>^S<*1F;-;1K'1QQZ
MJSFT/O?-KH*:SESCOOJL_Q$'<MW<L33<;+;CN1<<]..M=IXY42%NV+HA1RZ
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MH*TAQ&:*\)A;J-E-_8?Q*&?UH*X[RQ2M\_/>XU;GH@W!1)9X]XL J+<DZB[
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MSXK,B+S\G/;;6(CFRN?UD_4AN/(0F!X-?^USO-!PPGKH<'I&-)(>2VRF\!,
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M,KKESAC=#=NN7.4<F^B:!>]/'=X6=:YX3A9CEY.*\74784QCRRY<=450?.T
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MGRT!D#Q -<S:7DTA"L[X;2.YSFWO='1Y0KH#>ZN0$_=,D9L &&!7)@"N?B8
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M#P3',DX3GR[R$_';WF>@1AQSMKK$Q3<ST1!N:GG:UCY^YURA>M, Q4@7%_0
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M])2?5%NQ'J&4G?MEKRL<SVI96Q>CJS$9\MKY4F>;N0$!CGRP^"I.V9='ZF>
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MGQP%T@CV50P#6)B"M\*@62!K:+@I"5PXS-W7B71GV3QU8]LR/&"8(^TS$]X
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MP!Z&S$>P<8>F/LD_WBXK4O0$Q<>&-WT%-)4?S2TM6#1[DOW& -7RJ(@YHNN
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M\!^$Z#%/K''Y/_>$OH#?K8"5><IEGO?XD!I2CX N.8LE-X\\8LP2CAT7?WG
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M=^"F?318#ZW.QP"2,TL88.1RXB=26"RQ>ZHT:0X2QIQT5Y/+XKFE%L7VC0+
M250<\T4BP&0)!./^8/BHP%FB)Z7 ;H[CHU,\BPG7TRB2=ED0?V:]5">YR,@
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MEY1X!S#F_!@0X5)L2/I=Q1$^JN8V?2;_"<G:!5?V='4G2;@#? Y+\(J,)9;
M_RAQ,W-H8!SZY:QI\?6[&Z%Q[I&PJA1+0MI4RFTF2%RW-P&<X))0D/?BXQW@
MC=Y*ZU_LS+/.=P"C^Q A)]\^M!1=PJYKY61:7N$)81RX/72?UZZ81;U>AE.I
M? 6SA4%.##@I&17*)*88>-\'."88<,RANGKC!7O,R/);#8\V.]MDEO<#;&=9
MT\0]Z*S3F1V++$U'I2E9F^>U4'65J[FCI:3K'[]R=P"%1^55AQK*3XI$%3\$
M-%W'[9C^7-T9#Q:;U(O8G;Q_G%!V*$I;'^$?L6=-JI;",6S+WFZ7[?*0#L^+
MWM]'WGN-GL"PPY7U>EZM_+T'%P5MWO4&G>WPV1V SL:/:=ROR]?>*LXSX'TG
MA)I)JM37MA E?@?@R[K^=(]#.4L(*9M?)6HT)%]F6CS(%UF?>#EXK"!Y2]GM
M$?W;J*(I7$+QI'H@%3+HP"+N/+.QGC8R4IU%L;AKR_.596TVB?&M]@^6(<]+
M=X)-?2 Y>$/T_C>->N\ KP4G??CN ''/Z:\.V4Z*B\*^.8P6F<,6E&F>LJ6H
M!"94ZB\;9;Z5DFR9<&E[,"<@K-[ANB5+4RG/^%2E*RO%.^(W2K?41BQX*X?T
M]JQ[C-FJGRVV=3QA)#.Q$&F,EL5NVS\$GI*5$OP'JZ7!B,+*)J>-^V1Z[O?7
M3YKT3RVFX;Q4RC^^C L4SKH_MXLWL.S_.$+@?.4GV&UM1( DC^2>_\ ?2$U<
M:_M+GY]PFH;(KX4C*VK;.X;:!L3^2[>6P"0;XPKG?/$Q26!7HXO:"PU]*P3@
M#F"FV6^LD4/^J&3/5"7K/)/_1_$REYOQU[62^T%X:/MX89"92#[@D\4B3>3,
M>@ZMYYYDR9P [6=N[[=U$PS4;TM."IPK0A_Z@?,=@!3<(PKY!AC7/41,]!^$
MXFZ&M_7^DW>58THJHQ.$6MCZ.W>N%P:I('=1KX:KVZAMO?P*>+;:&ILP##Q?
MJ0P$)3(0O9J)!>.,MB&2(P6CI)3MU:5L0?R>_+_"'ZR+XD(PHA?H;;9OA'*:
M-?-* #(M0<_DC=.U1TE;.>HFM]*?EPV]K\-!3N25*,]*DEZU%D;=B".5-Z-;
M'G]W?/7;TF5)1U[T>.%V[-5X)L%44TR8%$M6UQSS9_A!8Z-3&&JH&W.+:3D6
M2'4,)H!X#+_'_'J;0ZYZM<,YV<J(LMN&4W&IFC3] =$T]F:UYCEAM0'0I!1A
M'W521+]<"+9KPI5X2ZCL#D'+FU=TKKFHCX9(R$?C_$ZQDD3^Q?<*%NW,^$_^
M2):4(5B3UPP)X$ZZ-G'#YV1?O[-<P*F9'JE*>YN6B3L:J(2O95AV.BO88_5_
M/V&!=M+873G(P-016=&E-^][9M>$ZOJ;(+*595CJA5=@L5+]TA^G*L"X3)WR
M^'3Z5YID%WNN FJR'J$S_\H5HE!C!%:G,@%<F$JN!$FM5=UD3?#=+M1);L!)
M,]64H\7S88S7E5>K$J(M$DVBL],87!<C0!VE9-#8TN#=!*MZ0KWEUC/-A8.,
M3MD6P-AMI;_-])$T]2RPF;./<"U),8GG3'DP3!DAG<=_:J2Q7F=S[G6YOK+=
MLXQGA28>]6'Y69O/?3&G-X=U_.:%=LJE2>V?#O_=;E^"O[T1I1_+5-LJ+:(G
MIR12%X:7CO=\OC.ON53L!>;$6C-G%_K%*!3-@E+]T!2/7M=JOC9+R^_:K2K8
MS=>9),3D\:G&M.H%/$VW: TO+5DFT%WV2'X_S6HMNY1*,]I.6AZD"/@2?0^B
M/ON+T&-=<B+N +UKUW:K)39M-HNGDN 5D;*2U>1[:(!3TD5O-9QZF_S8W?4Z
MD#[_P[04\8[8GRIW7\&I0ENZ;,T:7$ZE*AKR?#F,."PC !;%H%MY%VTS8=<#
M+D>Y'$(2DQ>8 !S -L]I#/EOSU>SJ.(A7#<GT_#JV$URB0=+)D.2CII^M+*N
M> 4M=#E.R=J<4!7FU.?'71E%?0;I?A9-.)LWQ.@J>-8YS5\II^K^8A'_; R/
M5:/\;POE&8@>*"7$N,+TRTS77M(C8*ZFT3[W_FUDJA&A*9GYG'?S8L=QO>CZ
MO<#DE?&?B>1V-,-W>"ME-'J+8A7,ESM/R?S)8UAP5)L $8-^^^(.L+]FO&W8
M+<?*09I/<9#JH:OHPLAN-Z(F2SKD\K?5;M*,$MLKBY#G8OG#<=N6OR\IZTPI
MK[.O(MJH2RM*<OK+'])_L%E@_I$W!4D4:1 I+*:5)=$@^;>(2+<1%N;20KBF
MK'X@/1;PX8M%'[VTHS:VHGT2SE%?JLI+@S$WN402M0\?_H]<)7NC) O03!0J
M$MW7=8]XRTGE,*8%;X_[JAO?SIPNOD'18.PUQ=S7E027\:#U%/<TWM> @:8_
M2&DXK8(W*]>/<'8L>Q3:!RW?%><E?GBR_]70(?CBY;=2R._O9D\HWFZ^;#C5
M&YC6$>.N_7:MX[N ,YL2"ZT[,H5,^;RL]#MV:'7<K\N&YBNE*?;8%'+IK+N=
M7^E).%W6J15,BVS@GVF-JYG:V#$F#&@=J=9'7=@'4@\_)7@M/JG#U3KL^:KP
MJI">PXU48Z>&-:^:9(^3C4R!90$A ;(U3V *./ZSJP?Z*9E9QP0D#'XD.6A)
MRB2N<_T4J6R>=#7>ESC*0YS+URZ8H<A#=<I#2E(M #W3]-B>"#(R[U0H=QY5
MU<MW#G1T=RY02BE[]J +92LLZQVI5)1NBOOM$YN<U(^">OVO5EF?/5HGGO"D
M7CJ>EJ:;>S/)LMA6J8-YKSDXS7W'&B&]MW> \V+H>5*C:U(&SJ(='OM<RHX-
MI\*1FDPC87(OB[QJOF*VLAM,E.O5^/BNOCR>4-G HE5ACK'QY)=FR=7OLV=<
ME,9\O4.J3*1;4OACO-HRL9(-VMK6!L2C"BM3DLN1?T"MC,NX+57SW9SR-,X^
MOV,<O">OVT@CQ?L^+XRR_ 9QI_, .VLZ?W8TU&WXH$'J4%LUB,O"+R1-,K&-
MFEYG\/@112_2M,7.VBN_^_(X<Z9S],715.G<'I5;UM82H(ZXJ#.KF4_39!)T
M9JCXJ!+2S15O4D0!;0 )7=:)7#;L]'!0<]\,77125>DM<R?.+EE<Q@W?5)V7
M_5Q\96!#A+GU;L2$7F^M&LJOGZ&9])J40<2-UMF0WU"9NZ$S^--Q(,0,9[M$
MH3&]7'*AM3H_1+UH6?7U1-V8OE7M((=GJ!4+N.EMVIZ-@^1@S, HVT!F2O&3
M)S1]W>%[3];2&36CQO@VPQ]3F_18795"O??<O#V6%K&3-)K+/9C%I2;>)%UI
M%D'L34EKZJZ8;9:;,3,Z<R(6/X4SJ<4& C*KUREX(&#_#0*]MN(2PQ:%JZ[6
MGHRM/('Z Y-*ZJXRDJN(B=IX<>^OMB"ZQZ.<Z6=L/\LL0!?"1BXSU'XK1IVE
M>C;TGQ2>/7;O48N1N/+ES-0PIV"GEBLU*+5;,I*W+](WN$Q90>\5RUOC9W!-
MCZI0#V$]NR+6Q3X>\MG/.H/]QN_:50D@8 _'/\P<<(X8_909526L^R6NY/&/
M$BODH^."[[ 64;O:=^0#*Q"*-JA&%,:7N&&HCC=8_#>[?W_[]E2!B[JVK%R)
MO?HI?T_=BW@I)J#W7!UW_9? ;[T/*H->NUU^>V3?\E7O_*?0SP,Q;>9U4ZNF
MY#51M<P:0;G<L;PRBR_W-HOAW^B$.P27PULYZF\+N&YHLVUL\>-H)P@-I+ES
MP0(/B91/2+E$%IH)(5IU/?:0*@\MCQO>E;;3+&(#_A(2B-*YR;+KZV,JN77<
M0'\GKPC N1[G;_-R5,$= +,LY_L')1CEXC-D2O-/*NS?/*9/A0H0.:UVHA)T
M&%!PX)5PI OPP6U6[W35XEZ\H43)>616M81:;#:C3_HQQ9G(8@3@S\Y_05/[
M=T*>MI__0>/3G__?U3S+C/]=X!,0_[^G]997K]X!B+'O /0;MF[EIW\I^,8@
M[V\6_N]PY/[_J7%N[2?A%O?W^K,QWP&6-4^C'+6!.*><WXLL3XYR3VA:X7%"
M92H._'GKR+(;4@\UI^T]C]1:G%KV-[,N;3OZW]=40YY#*HV;>Z_#,0/ +Q]Y
MMD%N3-DBRG(CEEA#^HG>J]4M.8'#UMOJ;/[(=X(>TGR'2E]3W@=[8= 6^@XO
MLG".04L+*E=1W0+Q&=]7[3>/K'%2]'C3R+_TU-+S=_?.3CI"O&9^H1Q7PUV4
M>91^[YP;+IEN2)K*C- [3Q^7$:])I5R!(78L<V^U390IS];QK@(O(\ZOAJ:J
M.0F>Z=PFJX=Z!7XS<>CSE2DM^KQ@VYBPY_*YLF\8N_STU'$2W'$F>@_X/>;?
M-2 .J[6G1_0,]=\RQ;$ZI,Z]Q&8KDW5H(_11 L'VG\D7MJ7:6@5KO3<1YZ,.
M.U\AZ&QD;R6 CQ$_KMS)")Q_#$SY=%.B_1IEGF\MS.[LSKD\$/J"^<-/@K(E
M9U3:3M1[;O;&"E!K+YZB:!)K?-=$A))2TY%]JOOJGP2>A%5LLE4W)8>MU6_1
MV@X /W_M*!UP7Q?H/L16N(^ (Z[XZW>D**P<;-26N.I*1_N9":LCZQBVZ=U%
M;FPEI#CXOFT"JUU,*^<2&>4R:'.6-]P$_W&19"2Q=\9'8-3E4!UWA[6%7X8A
MCG!#O0&+">5\->6AA\BG+'*] P2 4DWVUFS4$X&59S? OCU!@LO'B^!I<K1<
M,WW'\K&HM?'9<<W16$_5:V0;QY[&+9Z3EV47B%IQDJ&M+O-LX^O%CU_/$X=7
MLM'5GTHZO[%1NC[MPM(FU/NV6FW4YB6Z#,'EG1.H%3UVZ\,J."@#O]?(PCL#
MXN]>,4.]):$M5WT#1Z(8$2NFUL ^9\.ENIP95*"*D!?$/$$\\=MJ[%6@@2@*
M2) 15UH?"729QYNY^H-.A(I-F+^9U7"K& SK_%RT;L0*T8 M%X1RKA]ZC</I
MF,FI_+8"*-XRSICZ449+GUZV*9X!']P!^F(*P--,?^E(Y#@BAJ4S.^<F_<:Q
M_2M.F%R7&;]8.G(XCYA2] J.6>M]$9-+?A1<Y!;Q:"Y_2.<D$RP&D?7ZF$OE
ML /ZVK'&_KG0J*9E<[PU]"O*%BTWR(1NR[E'H]U>A=W 2V+PX280*M6[FA3^
MJ:C#]^ET_DJB^5MKDC*9/C3-^1GTT/U-#1(_Z8L]))+09/6'"07AV>-J:$2A
MV$C:+,4G_KW3\D1KQ>FDWG2?O^=2T=9$BJ/?AK?M5X.'8"CGCC3[$+8TVR<\
MS/'FV#WN6)BBZP"MD(8?<_M7^C/&E&1LC'5OVU\R;)@R3 ER=NHDJH%R)D,[
M)@N3?Q/PAA>B,D%_K\1@5&5P!PB5H"Q ?5ZS/F!IB-M2AEBZBE .4SQHQ/E-
MJBYHTR!OFLO=-8P7HK%G_U-[V.\>G,:UW4]/V#UV/V4T?JW-6'AS/\<6_S;'
MK!EBWX4=LQL$QMV(WMH:<'NH0R8:[P =+P?*71T%V16S9KW0]!M6J&DE]#0B
MZ@ G^Q>5Y^@=H+D9G<N$A&'^ZGG5F^\K:/#QAG.$;F=PRZ@X:7&3*[+:VW=A
M'0E]Z?%S-!(RY#/-7121;J-><VX1X^^2=9"%-5=2-FN'-<=\5:=ZXP[R!$8#
M-]PG@?MUIZ1'-CD:'/X "@!^8K_-'0#?!62I]?U#?=*QJ 5#8_?S8#:*/WGG
M9T5=GTUQQHJD"E)N6ET=RG/E#^:/A;A-;&'877:A>-P1V6P3O1&(98)EGJ@U
M;\ZF?$;N;3JK7@XQ.LF2'4X/HKFI%\^'^F*?;Y<!VLN <&.\+X(M,D>@LLP>
M3P5KA^^3,67\+\%4+^O#9/I?S4;R=V@5%TWD(M\4+K!%-KOGSZ/\=*I__[3G
ML<M]$4EMAXW=87%Z16<[*$''MR[)1==F;;QME)A]PS?N\KVFL36CYHDI0P^4
M#HXU4:8"%JLS1^S+ET^-:X3HUR:)^DS*Q;EAW@%\ML^@.<8$<D1!/$<36]#
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M0^MFB5Y!4=#/7VOY2[6I8)D113Y C9X/SLEM6,^-U,(N4HN]F0.C4D66H[2
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MI*;8';Z>QH7L_]BAI>@OMM[26(X4N?X51.K3\^-Q4TOLN _F^UKBW2Y/UN8
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MY)\ML@X:+#LF5/[0Z9!UO R_I&9=@1L!=HHJL\Y \YU*\*EY9KY.;X-:[JO
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MC'3C_2U 3" =>_2-<D;LP!:WR.,Z?R,FOF?SK1SAE6B\%H8:K;JN0>2O%&J
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MQZ1(*TSLEDFGA4TTND3=1FR*YMI8<#F7NLK(-'E^2YWU[TX'2\=UF-'Z2R-
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M= 9F>%^_RI,QR-T940B_(\Q5$KFLZN&)LN_Y/10SV?(2M*1A;QU#FE'Z^MO
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MG;O#MN6O611F=G?R:CHE!06^FLGZ,ZEW@/@Y5FXX&:.TOP5Y\UJW2$MW4]W
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MM;L+8+M=UL_KWJV_B!_*';^G6TJ_7A]ONI B/F^=NS.J42R2^NA$N+B*[ 8
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ME[%AYGG!R]B3\"KN!G OIF@Q>_V*.0B]"?"<-'AR';&N<<E4'H1\W8IQBSL
M,02-;CK< $+>W0#6O^),_9M&YW/^HT5DXFR)5IV%!^I://3TW?"7O,$Y2N4O
M4L/N<&",0Y Y>@(;P6.&H>2[ 3!EDU5$;?[#WVC]W3B")1IXOOX=AXK_, K
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M9^2[4MX _#_H"TNSJDT?8/O+=L\;PFI7E]46B;FM/"3?4*0"CBOG$I5,)->
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MUI,EEYVC$:?95P2I7:%LUA-,#UZT<+B[80M944+CJ@]B'W&)S%X3J.R4'TD
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M&UEKE+8VM+UVVM2</<NZW[\,HLDNU6_]22>+U<_RB6/6A4+'GS+.-;R- )2
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M=UPX5]Q_'T"&A\\B>)7\H2J!L2,%J] ;0LI'T1GEWXG8A-7@5"9./XEOL8O
M.!"_0_LCLO^YP-[^WXKL[X'](ZYIX!HN#G;R<,D $' F'PJ#PFQ?&QULY&.
MA4H,L+B. 0*K,J"#N5D8P&\$ X25IA=.H-4'T</?,<!@N[N&-@D&(($\P@#I
MSQ70%WD8@%H!Q5M"@O8593H_3D<9,FF6H3(N<@*P![S?S2^E1M\:#\0 LDE1
M%^<J:+XHI+X>->K,&G2R T+6RQ89G3X^5R;  ""R.54#_C\;@E=7\I\>CD+W
MIJ$(%U^MEOW@XP12M!];?6:MT9_,@/XIA+,2Z KI#@\3"J7@*N?0\B<[T-;I
MH9:U$54,T&*% 3I^'NEA@!],TSJ@4V3DYG^.1M9F%0:( U5^@1X@&,:H6C'
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MK?<:W%%1+*-'WCL6,,[17;I%G26RHB_ #MX'\:W1 W O? ']1(K_)!L#_(P
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M\)67(I"G*;RIK&1?M-O8.P$EML\<XRVQY=?R,%<;GA71QWM -L/)OO9FQQ!
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MZ5A[O>W/>Y[?;P>CDV@KC[6C#,0+7Z-?+)=E0 X/*E;Y<FM_Z*!0:J9]_Z-
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MM&U_M="M2ZJ\L]EV)1FYWBYUPAFS,S85S$PV%'IPGBH_A[*ZGQV8-%5UM9:
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M[>I@$D)W?Z71D9(5_7;=TP\%)Q'D=65X 7LVT[?;IE*@Q*N:?_ZQ[[_W'+;
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MJ^SD5;'3KKA$F[H&0222L:&LW8Y[/WU_@<;.JBD,3D*,"SIN?FT%:5@K*I3
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MJ+D*R=O%5/4(R9H(Y%&PI]2W!ZJB]V8Y-JKCWWW3I\L<R] *8K,SY@A_V1S
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MX8H?IH<L7:LJ,GQV5US;?F_-@RK_D4^PXJF5P15=I&_<=K&_#@R]65WP96!
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M>V:Q<.Y &27VK-!D[0(\J1VT_3T,JLS@=YY_"SA];K2X%G%)Y*I\M78#\0C
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M1:J/ 7) V\H6:*PEKY-U16= ZB233Z+1!X#6#W? \_OIC>#O-_CI4%JM5WT
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M[_[^-/A+;4UCW!T+>"BWK S!<ZZ%DY(84 [%NIAPL3L&.&])ULR]\OH)U]G
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M)9W(DV6D/:\<98[;TGW(T\W?JU0__.'>[?;2KJ(O:'I8:292G_S%2=:MZ.Q
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M_'<1+KERS;/$-@H#S49>',+=60W)J5:>;IWJ#\#(^8,>GF[@$=IZ<T!W(G1
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M1-7=VAM7XJ.#^"X]N B>.L@LVY$,@XO!F!(*!G>W!8\=-MC2OTD1'-#55F.
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M)EB@"A[NIX0%X@L66R](S,'KIZ5.@;+OL4!(/18HXL("/'/H_%BD ^0\'GR
MFX^3#JN;W/@;+'^X8OOG#[<X90?*8@&D_^(>4@-UO0 9NVWQ],(Y#1.[>M8H
MICJ,WBG^M#TH#VM0_7LQ6.[_U A3,U(LH78C/^UA<;/&CQN?ASPG+I$-/8-_
M-.(8_+I'O3&I.6E=OZ]1+5%3=?$X>$JUGFTEUF6+X610P_^ZLV&9&#H3Y+EO
M8M"@P5F5"K,UN2@58*-#A6>2J?P+F,R_4..E;(L78Y_4,4]??6NQLA1"ETG<
MB",VW6'^@+G2_(4/\^@E?R5-^)EVH1JLIHG#866C['7':CH2M!U#L)4*S/YR
MLA7*./>I^I4<S_J9%^!92N@;"6&>^Y EZ)PIAP6$8^C78S?T40;>LK7%7,%'
M:]Q167OY+.V0F?/4=7Y^RXK*B,F)2PH4P7I4(ZVN5()5)P=F@[*>74]>79#/
M]9\<F04L\6 !HV$4/S%U1<"*\MGM<"$YIGY[8[.O_G9,_;EO#9_3Z3-M?1S/
MCF$)\W&KC:"?/9_9><.V*R:#MO-CD-SH\\\V5RT23=Q^<K];ZX@-=?HYB7W#
M%7IZ.X/3X<:&:J^XG5^\PYY%7-];5F2D#VWPS?5M14W=! S5JL=^TY=8?@[_
M\I4:11/;[VMO>8>EC;P7TA5M6X;=73B6Z8A.2"T(D)K54AWTVB%2%\5=9@(D
M#^XYV!!''Y('?3^'N_-D#$"$C3>0S&)<9#L(QO?Q]CL;I>@+>VBK;MK^6#%9
M*$K+<SY->5SME0HK/,?K-8BW0_+U$LOZ-[#HU:9CMWZ09H.:)I7QK'$3@7.:
MDRM)&P%K[9IYI$.)G:OAQQU!5C$$IP8#@QQS4HSP+%)_[Z@<GL1!8%>5JE]K
M-N6I8*;6E:J1$, OL&8I@.=?'!=X?JYGYMJ!!1QMC_T)Y9V+%/%[;K^J)%,\
MAPNS1PJ^<X=:&^KEC3OY%3_M.WPY<!4G6-L;T4(3)4=I:C;W;2V?<(V],1S@
M>:L3<P&"HV(^BS+?ZZ6B:70HW3)P])TPC>U@YE#WF%G,$'8N-$'54N^,L6CO
MF%1W>J7V+JDWQW9.XF:#<@UM?9A;*FX!Q_"6CI8MC!VM._/'6'W$)W.V[\ZU
M>B'Q$@M<=5_85%<9+D8(-,/!AWSPF\58H/-PD2HOB G6\%QQ4?[G-R\ 9Z%V
MBL/VRR\T6A>)%F7M!/0(OF@I2,IN)EX(#LH_:S[3S1MN]J=N37^'>.6HI#]\
M]& [SERU7W:6Z H=_AE,KR!VL5P<)NYC>L^H$\I4I1W;9! =O04QAC^1K.U<
M']$-JVH$"XDROOAY?/ZLOI4%^>((*K?I,2^:WMD8<720QP9I6Q*=4M#UJRK
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MA+;W,+,F8.K$,>^J?\*I%F 3BPHL<]$IY[A_=L<6*!48.[.@K'9;9Z\*BPV
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M(";L;3/7;T<F>O]^D@1P,HD;*%G@5S\<FKA^Z'_ULV<ZXP8AQ^G;(F09IL,
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M;M>S\ 7UT1,=F7>+!/K"N\%,FA6FVZF2;AJT:JLJ%%^(5,42'=]? *$/1RZ
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MS[_R+3$"W^K[5[YU 1Q0_2%<YR0C2W&G9!J$;1F'?\-/;///XJP&9IRUVP7
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M2QHR\E3NIFW_>^T_L7\]*+/%.G8;A;W%J=F6V^U%^-FL+@NGI\8_?:-PF3=
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M\.H>\?(H2:_D;[KN;PHKR@ I+:SW8@,.2JQBR=%]IYW95#RF(8AE+@-]#DG
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M*3'G4)C3*[)HH!#=*;Y.DT5I;YE>1:3XY/[<:HK,Z#4\1( E065^B"@)S;A
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M]<9KO.A,JDBAGL8[4/=@9%Z$2(7=(?]X7O(?<_GK37P:U\7?G[ +K I4O^W
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M*PEAWY"C#G4O[DY/VS]JLIWGY!4H'>KVA%N9W?B#LSU8/JBTX.[ZY=PJ\.@
MQT"T]2]HY@)CEY)/$UA<"+\KG&V7:\=T8\M%Q>N9 RB+[;2QZSG:%B<TQ]9K
MBH45\:?>>NJQ%&50]OO@]:ZZ-2MU5N[<<IX*9 L!PK[$]C:;5@4E"!O.JX:G
MG0D'AAKZ_R2%G@@KT^TULK>AO^%(W>$<1:#C(J8;/J_TEM<Z!YHZZC$SDD0C
M.,]?P09E6(]O9A:]'EE;QJY)GWJ2TLB2"MM/Y,U3SY*=X9)Z0LT9( 4B+Z3?
M-<F.!ECY(&/Q*TG77_PZT93Q @*-5]W,E.D;62&&T/OH/!SO-=%*&/F7K]8L
M?2W/O1S)"F8C76=M&TE?;S*EBV,1&#=5#$TX3L0#F2;4MMUD,^1A_WI@[[-O
M@9R\+R60ESI$YH,A7@:'*7% T/9LJTD%BNT31>XEM@P.[W7% W6U\N349D;J
MLY8^HXB08':<U+B"8HX)Y,;<O(^2V6P;7:?TH]AW1@]\!5$3C1_&H0+(?M]-
MI\I^8MVQ4EH2B,CJ)[?[^7PAI.]E>P2XUNI[ES\'U0ME0UDFG2L05';',J[^
M&;V_JGY$RM'+T :'/B=Y3:<4&BA]"?PO[#ASYG=<4%;3A,X(K8P2Z<]K$8ZZ
M;8ZZ^ER-G<,51RF!GVP@W!$GPDF&9X7C;XC>/3BW#9@]U5VU1@4$H&9J'9=S
MW68X)JW1GY<UPYSK0:"@1KY3(<HGU[WOWLU:H!RFJ4UPW4]<O.+=S!$DM[6$
M]4)S#7\T/G\</=&RG_ZFLI'.;?3J(YGS/&4=H UK"_'(P_<H"7Q^RJ?FX9BO
M:\?A'MWVPUJIM%ASHM$*D:DDB[,;/D+0P%HY%SWI3.B*/#S8'**_TU;=[F(U
M#]3># 2ZI0XN_AM=V8G6FYCJ+7R0<W<F!G6^M'CX]ID^/Q_^OBQ[R!<_6%9*
M>A?GOXCXN>T;_3G&7CZHQ]5UK?CK.K6X3H(\&N*\''SJ.Q"Y\EK8R77[0.0-
MMG<I54D(/5MK:B_J,+"QI)$J?<]MU"Z3#(RM[E2^X<'JJ"!#U<XD'TY.UA."
M6M/^<VX+,CU<"&MDK4,C0O!M^;T,'^M1$CX/XVH :X&"I?K15A@C"BJ&3'&\
M;1<CI/:KODC68J5,KG-TBPQI6;"XP) 7=2@]EE4),2B7U)#VGP/D!LA* .>_
M30W\=[IMDGW!66![(>@>Q^*2G:8**<BOOK+6P3(>N"QU5T$/"7!_<5]H0+-K
M+V+Z;<EQPR*IWCW<_,L?-8&,ET!I] L8A['ZN0J4>T+!U<=FB8:2M*:ALNI<
M<L(!21D?^L;P R;.XB<YZS)7XF\[<(5,M )G05L65&]HY1,_<=_0E[L/UMG1
M <8<GL1*%42'S%&X%[G> FTR]]>J>44J "!??+_F/#]K+ .C0($&8^V<PY-W
M$N:PRLT%KKF=[<SGMSJ&#10MQ0NI%0MATQDFY["0>IYI:+I36L#(7''4B1DY
M* G&&%^4_I\5#00J@O_KL@-:[-$E($"N?%$+VR"WD&G;"\F@%U&2L,??P6A\
MJEI&&>K[>!RG!'CQ7CWE=3HO:]XS'^Q"G,IJ7P*HT4M 10<X0W3@A4<5Z)$I
M:6YF\4G3 /",U<?\8NS)ECXVG=1;%"<ITZ[GJ>V$ RT^^S5J_>KZ1<+21CX7
M@O4Y&=>XWW%E79HDC'*J-&!0JJ/]IZ^SNDI35L,[/ 5\>2> <E0S^(GQ0S&G
M"@I)3")?*NX2D'9+KQ\B*\+Q8Y<A&+HS"_9G96R6E6P$RMNK>1_>4*T0"IJ3
M6TY-=Y7IR(B9 %'E1CVJ+,>/3O##^_8?I?"&T#Q8)UE9#N%*TV0] (4M7%?B
M-X6^&<4]7XH1=.R:SD[?WT9)XW8UJ/8UYDZLW\_7I#G<K3DW9?'PH']XAC/X
MJ3T<S_K\V7H5 Z4!F0T9BG%Y3K@M'UO4O,T5)<?.'SOAY__;KSCVA1G<*N-M
MR;FF=W5[;4BM/>]#0:3MN=0L6XJ9]N?X+ '[C_)D\[Q.$AW^8A[VSO[V(B5'
M]<;2!X+:-[\29Q5L75.@M50]U[^3UWHM$7ANH7,#8 $<?8$#FN!&16Q$EMW9
MFQCD(#G,;N,=^)7NPLYY6+,7^R7@6WS#>BQ6?C('ZHCM+\5)8YA2\NP\[WNT
MFD]_7?%K]Y2;?T94.<FI>#9^"4P5X;7ZJR\"] F!DG$2GO#-OI)=TS'5)3"-
M4.%*P^@N(2(4V!>5J;SA:J,5I];CM 'CQQ7Q$P+>P=]+)RR;E 6&C&W1@YTP
M=#J66'\RC3=RZ66/&\.+&8[(]AOBVBW-O.D?C&66$)2P5K-SF8X\C91=>HWJ
MFFIBQ%<.G44:MZ F])U]Q-1@UQ A2E6Z6];DNFHR(XV@H(^9,8; NV@I@.U*
M6*PECW.LT"*"RG[:IB.N*;9G]2N?O7;W@=G-9O8 IZY=/,-"!(RS7G6Q*3(#
M';-9ZY0B%1V@<9+V6KP*3=Y"#6R_;RF5.'XSE(LA:_=_VF$:>* 7[="JP>G$
M+R"@O$M@HHTAKZ"^E\#'#QGX.>5#DDP:E8M<J/;2%X=5]$5C1%/;TQ;*T2W8
MF_@JG5NRX'N<42?&01*#OQ#*6-WEA?!T9O3L!!<Y^O/Q1)K(N:XP(89.=_S)
MH"[8P'('5Y@7W^DVTC!Y'$UP8;R%E\ D!';!41GV]^<4!*&:V,TE,&$DC-1A
MKCF;B._!E-^?<H3Z<+^4^2'?NG)C$=K49CE9L,V4;!Q6>I02051>6>67ZZ'X
MQ-@+9"!$"&C?PL@OZEJGO2)067VU#DVVOUXJKWX*6Q78P(*.AR8YBZ'ZS$T_
MTT(3; =R;K5NB@?^<;XC+.N<.RBB/S9$]AW*@&U8@D6D\XZACAPE]*I'BTO:
MTQT+M8I+^S\8ONB6(QI4/8%,"8A'^5#],/IR<[\M]<J?9:4IQ.V+E/J[[J 0
M5_! BI/'U^2-]?QH:!D\E\@9R^D[!WAKML)CS]:C\#=E0J$O\C8G]/G>75/J
MY0AO?;V2Y>2)OS&?&KFK)(93ST!6!XT:CBY6_VJJJ3'S\]XE$APJ%Z-0Y28]
MXH@'*T&?57U&9J 8:E<3&$/-OE2:)&K.4RXT@#L^!&] GAXG3 Y&-G)O!' .
M_S$O9MJPOA: JR9A9+D$O'IY+[: (TZ:9:EQ1(O8<A/;GYDNX1-1JK3*R)_7
M8UVRUM^T_.[6'E0?D#>^3H8BQ<@;16^9@M[S_!KQXM#FC.E;?+D(ES*Y"Z,X
MS.#$W>+BP4I8+5[P>"-_C1BQBG ]IM/F?1#F>=^)LDLI3VKI#!2+YX=2EH>I
M3QZ")#1C-6@UW4#=U^G:->^_?IWPF'HWC\!'-)%[D6\PB,!#5,!N[P[]G$^0
MKDM'E;C.<'HFEZ<M9[F%B)LE$:8S#4/6ZK*=;%BO,_ JF5SI4)S21GNOA81K
M,39-*">3)MJ]=UM/YKBXMG[,R:JB,JS]LR/?03?M#9^?[TS0I/YF9.TT5V=G
M-4FKH]P%<Q.#-#E\/PD/M"\"Q*\3_(R[/WK[CG; *M+SOFV)ZW&6G(0[+<<O
MON2@D59KX8[&;$#F#@FX$-;BZYD'\6?**>T^'N7[G6"N5AGY@YOC(;7LCCJ@
M>:Z';5U707/FQECQJDM7"W4)%;3LW[BRI903YR\N/P'>V497:^F3JRVAG'ZS
MSYRO6]L)J/0ZLY69AR@X\=%G/++F6)<_KAQ=@\ HMW2RV]AGS6IVBEM88?=*
M3HV_X6C''.O5T3*/JJJ_9,>IWHK&OSC][J(U.&EO!'JBPA7BD_MG2SIWQJ"\
MNC8PFB4OPD+KL(6ET)(+W1B%E)=#*<CG=>3-S)I+]<4_?#QZ$Z C4G IO'=/
M=A,LA-.]R"!$P198<0L8G@Z, MVU6]I7:EFU=>WT\HD9W;3,.Q?JWD,77EA,
M)2F^>J[RV!/.3_]^0UP;IP?X@%I%3^\+@<_P302V(6'\YPB=&X$$81_C)?61
M3547P:CJ2=@FEW%*^<L$_;H:M[0O6_<G*[%>Q^;X9HS&YV)8ZRN"F[2=5W=;
MO9ORH[&+JMHKV3756E:2*.K<#-;]M/42..I<OP0>Q#; FIUSNM"B;2A$RI,\
MV&NU]0N$<V+URP'4[*OZX..J2R N+^02V(X9Q(=POI.! 1XWT;DSG<E&Q9\[
M=6\U)#?/,+R.+EV;GHE=NJJO&J=, 92@WRV@P!7J4=[VKYEH+69U/A#OFSFZ
MR/@Q<KO-1IYK-'I=)%7.78%8J&E$Z02-6L0H3-89OBA%=G.:I-5ILQ(#*QP>
MB.^WB3N5[2^(SW61'^X70[ZZI[1[.MC2]NS?(P!HM"TZ#]]W?^$8WIHW.O?S
MS&(G_O:A9GOPD2VN: 1J^PU.A^4U&?XA8SG50T<_]3LM#^W =NJ\2!/=]0&&
M%(]%1EIK^?T9_]7WP_8Z_.E:P">B/IQ&PEX7B %G56@BFL(8I5!,('K"-U^'
MN>"DDT\04VZ6^&&LHT=VW1N].YB@Z,-8_538\KR-:U.Y_H>L2:CBLE#=T1S7
M-[)C$\\59&)TQAG#FQJ"69^W+Z _8"?;C4R_T0H<.^SK1+N>SS@T*N_%WP*T
MBP1PPLK3"SM-VR+?QB;X+8M6S40'E,)ZG<^W&FL0GV$V_?QZ9IUG)Q%[$KPS
M+:MA5A,O,MSNG;327@)7$/GYQ$L7FOC'+<H[#@0@US%J'$)$'8%.Y4DN@;*?
MH M!T_,'_Y^KJO][E]A?:5_N_'_52:6 ==_Y?W12LSI@^Q3_4F.?APO*_G]7
M8]\ILH89;)_S>OYKV&,Y<Z.*60]R+?S&0.]VK'8+R<KBZU>(2Z"U G-RP1#5
M]%L??[=F3K33M#H89U^JE(A4-/+GPB-S(,8AG[JD7?JB&6+R1KG24P_!Z%H/
M_3.!LZ:U!9Q3H"*O:EG=J"2[KJ+.:>7U?.L9D=%U\0Q+[1**P2$/.:FTJZ-/
MD@?,6._R4D_L7VQ<P(E/C4( AB<F\V)C_"/UM"4+TV(O4,7\2=*<7PWB8/>!
MCG'\72S-@\G'\$+OA&GV54<XBZ9'3'FT1&&BH?Q*M%?IQZ>3D@WL&A^-QD47
MJT:755!NO#%?%._YK?.R;"=CE]ON-X6]PD*\KB(6.37-)6:9QNI5F1B+]]OL
M8@UCB;KXZ&H$4B=],/S+.F,*C.@VU2'1N[M0^7R+]_AX?IL[K/36<?=+C\$.
M?@9D-=Y/E_0_0!U=19I"I?*=;4.\%/AE(H[/0CP,-7GC.SP8#];_B=R!90J&
M>:DT#-U[+G_N.VGP"S]\ $64:<"K>Z?29M)@C6+1)YE4HO_%9@!O1T8%(OAH
MCW3;5ST]I?16Y[>\00B]+LE-QG1I Y,([4Y]V:N5EX"-_NFMY,\7H3D$N+QA
M0%;U5TB*)FN'G=X)^$N#8'P=#_>M1.>I!;=G,$*5<RUO^_G<;4_( M2*7W8_
M"_X3TG(V#OZ'_01E DC>4$7"(LZH$;XM(IFUUR72PV,I) *((G"WB8>;WBJZ
MS'JOZP^]C)5%56RK"E[[PJ]-(W=,400O0'ABJN$X.727VLCZ1,5,Q+<ZKF>Z
MUB2.U6^#N]^84_H:?PX8AEV7:O R#>YH9"W_:!A3DL1>Y^>QP(,2<(C,2B+A
M<.WN].62U9T1C8(Q[U;,L;\8=<*E2(0DK[7ME#U\3"S?./PQVD5N^;T*5]BY
MQHS]/"]6%[G ;&_4+*3/GI5X;9L$P]1&8_$[U2T6LL9VYG4<D3S:FG$-*K/8
M^Z*ZFXO/8L'G6Y!B#OR;\-,CQ)=\8A3BOSR^<+L8S@@!HV.QII? L^?4QYA5
MQEIFOCOK,WS&82^:VJG>C<!H7UALT;41BXG?&A@2ZR5]M$^6R4!TJ,Y_="#M
MQ(Y)JUGGJD2Z08TPTF6Y4_:^DL)25_7*!RG]5A++.X=GHE\OE[I&;C6R867:
MV8QJW!#>">#YV1E))?.$K[?X?E:M*;P_\;55U@$.:_\64PZ:X!]['-$R[?JT
MTQW<#_R3O<?P'R:_&Z<$#,'V'T#5+@&GA;.GC("O2&6]9U*96;-T%P6)Z@;0
M7/"O=RD\V7:9=OP]Q6'^Q?R!VS#:$_\KDQK<#F/$T2#EUWY.0M4<24=2%<2*
M^C;\632*GUVXFG(Q8Q9"H78)U:%2X:)]W)+A[Q.'N#X4 9JK8'8LA3[9E/?
M,2BJBGFT<R8^]I1836GO2_>-,,4SV_2NZC'P=2@O^A+033ZQQ#K['$?Y_9E@
MM=;]>$<S^!>ES$#)H(9R"."IQ(U1BD":$?DLB3R>T0],%7J,O>O/X&&]0U1J
MJXN=0N^9-)CIBC*8D7\)>>+*$"<H\,.>47,;+.9]TG',)82=\_)8%A3-15\D
MKB3UDD8\Y0X55[G&$BASCS06%KZ<F8]S+<3QC2DHEC?74M?EO.W>>KYK+FEX
M-^#EZ=?NY?@*:O]\XFU8>)<R!>Z9)N\YT\$E\%#1F_GO%<">H-?;F0F1S,ZW
MI>=-\6L?]7Z,"2=IRMUB6O"-/B>[?LC8^_?%TX _^Q(-_48ZXP_F=)XQ5 66
MO+5B+VA]6--(J9EMS;TI)H/Z*&J\XB=&_<?7\.?,M-I7$ORNQC\+J#Q@AD/!
M5DM-,9->EN()9\XT4Y;:#C],$L6O6?,![\.)W0"3=6SL?0IX%QNB54^M;4;A
M>N9VK5%Q;([E:ILZS_H:S=?46#EVE?7I0*79OWHKF6=$*-W&"K7*.$(0V-")
MZ5771A(JR0C\?B<+O-TX$:>,C<K?O 1^-A85]TIH^WRO2&(:U>XA.7W%NU<]
M\.30W)@>38,,B,<P+9M,0*W6P6J.=SI_G.[DVH.$!W:N.3_&);BI@+0V+@%:
MZ"W$1G5R:7SIC/FT2>OHG/B*@E@^7_E-HL!FQ3KC/OP];(N7%Z9'2H2LHS8!
M^^(NZII63K(L-,<$-]O6HK#7+338Q+C+1M,,I_2&=!C7)GT:+4V#Y>E9N>7\
M[AA.>E#3]O$7Y95[[WP&-(36]3FPN@^'F^S@6 W)&5$!S7/_:.4W!Q:-VG0\
MRZZW:N[.80<9B(Z<PQ1@2)IPIMIH+M X$U[(.[#N*4F9HR:E<HRQ(HW. 2+X
M#-2J"^*PT%OD]#UY.IXTAV$<<BG3,+DJ^&5(QBJU&I3FRQ2"WFN=)QVMU$"7
M?A)FVZ=\##V]=9=!6NE<6@FS"9;YA\+HP]"/&.,6W_5(_3#)?D?^\>!ZF.T]
MG:^O!Q99/PGRDGU#6? 7%4[9^>H-Y!7.BE2F%;_1SGFII<Z)EE-6[8?&8$Q'
MP*%-%0^V/;4,69U>C;\B[USL/Q_'F6B);4#&8?;.3!W.Z*HN_;*OX'/?UR]5
MSX>XZ>B4%S64!P+E-3!Y@7A>;UZP5J5SQ<;Q\:J'X$/Q5JL'V>MK!KZ""L0C
M-4U!M<YMG&R*;[>1Q]5>!;4:H<>0H=_#&C*T@=:JL>0#-(\K^[$";2 T'-_C
M>S';4[5N_*.F'AKKR2#$<N9HL("^TW'QZ6;LTD&'2]^WY83Y.4Y]#9+N:YF4
M-)%@EKN5HA$_++V%""_7+CY;SLS^39!X\^H!ZTQ&.\?D4+)S)YCH[;%IS'P&
MHOB'_8_K4572Y7F?N19KVKA%>HB)!9)/PY9!']P)J] \2GU(N+$GK\)HQ^K
MXM3Z -K7?G"$R*O8"VXD'W:?,QU4'^[X,E["-K"*'Q;.[IQ/^;.<[GW(0(1
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M;K()PZ-/A9 +*9M]JC#3HX4;V*>J&(OD&6^X3N78JP<Z/IC5N/0<LT(\B;$
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M"('.:08GX;M.$\?RX6/QCFYUKL:'O:]CNV11EGE(V#2XQ3?](SLVP;["[,B
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M 2^YHOY'<F6_2:BP% <EOBX9V'WL#M]EF*A11^57@:I[QMX=Q#=3$)V4/J1
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M.*X3T2"'V_B\3)++R7Q<0Y,9)&N0S(>'/G/TU<HQ;OEFI.X6>)4N#'&TG._
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MH/3=O1#A(CW@;*+:".>R\>?J7N>@ZHO[;&QWT<>@SZ#TAN(+IRM3W,44C\G
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M_&/:G>Q#UQD5Z@Z];9]SYTE*D'\&WE4D. 6<5> C#E"#$7)@6'/P$0:+0LC
M>"^$)%"C!WXE-@?1<P8')QT%0;=)SZ%HDNN6(2LOB:4E:%&^Q8L+L\WPM,=K
MY\).MKQYQ<6N]FK<Y=38C>,EF<2V%?G*7_Q$429AH+ZB9.VAD?ZS8I^%<M?_
MZJ/U2/V_VFC!SY"!^D]]L-D83U'0>2TE Q,YG4B\8Z.1YII'A7Z#Z.&OHTU(
MD8GA*]&7C_($!.D?M&"6#XK0_RJ7#YN&>VV<9EDM(TI$@KK#*H$F'M_;&6!H
M#?,8R5+2]2R_X(CW@%89J9.5I/\UU6UTVNOU:/GP3L")%F^A_F\J.B_KEUW(
MP%%_64)E/?1HB>@1:R.S6 ^JK.>?ON=/>QF[G3O9.0C(%LY*TTZ3 6S:GL(5
M@@1_O :T)Q']JDU:6])'M.8@I*AT@_RYWEOZY=\FG5<;;FOKU+P$[Z5!S?<Z
M:*+,04Y4YP="#U>.=%=+5TC%=  B;91@IZ4FNI16&OOVW0?ZG/G;+ZX_M:(.
M"U!7MEEW'\&2OF83LR2T(N%,;A#(W+8<,JAXL^SS4FKIL_1W'T0^A1YC/77E
MPN.OM&A0JD^""!,8#OX>U2:,^#!+1[5OP.D/Q__RPPK1(#1W%7P"\VS(*JAD
M5/1:\9/9MNDMO>]\N:7'7YB[/66X[<YUQ+G/&!M,3#H4LPZZ.6IC1=GJ"F8S
M#G10(4U5:@X;UT60(I9WF?R/S;*7(SD\SV":^_5*!_0W'VHXGGS!80F4JES^
M6! ?"N#0=+YT<=.?\%4*/EES,<)3S^B=/CU59Z2T2[2*=MW2F_<%>MBO[IB5
MY)I<9;AN>94#S57R\FZF9^I$:4DN!LH\:ETA%SLY-#P\;,6'RM+32614O[SP
MV B!2R_1VC[+CI["$%T>R:DT-V.N?UY:?'"/R7BXN?!J .$V/<6M?O^ ]-:W
MLQ?CW0:B,7)5/NS3CM7\Y2!*27?_< >_TVK=?;3!XB^LH";A;W[TKM&7&@5Z
MJM6B*M8@X9Z!6NQQ*(L%Y&H#B6I7<$T:+>O>M767#!P@Q6YSF<5"L*D3%[0V
M6XEH/O"+#[S>_(W$*#5LHHO+T[&VOW236Z"/]YW&RW,T9U=EG](GGCKPE=-B
MDI+GZ,<NX?U+@>8DM*D3]KN.9CTUDD2Y@?4$>T$-/*>+F2GZ);V+L2;CP\7*
MI -3:Y2RT4 KCRYT<).DIA],!O[^VN3?= B&XZ6"99US%H2=L2O<+2E?G^IJ
M7.TY]>'R<ONJO#I_-P!P6O$]>GA;_YGOE5)"TCC\P/Q>D4 @<@,D'5X(T%_%
M10XKHWU#D3Z)Y@^]N6-[(52^-WB@!&/DEKTQ G][+UH@C)6C:QJ2&VWP3&UV
M)D2,73UPJ3.&*[>^=IT^_ E-IP)U2AWG3/8^E4(<]57#90:4G%V45<W9C9@V
M>-H*'?P6<U9=VR5451<6Z\X"4L8E<-9/0V^ 0GH=L2UMM"DN5!-G'F[@W9%N
MN8;1NMV>TU$OI?H.4;]& 'U,I>,DM1'$GDOG[7L9?%K/P:?E ".,^OHH^Y&!
M[=B7"%D2 11R?M%^2S\6;&1H\I'/)&'"C&%5OVSE$5W0$2WLV#",3/BF^(EX
M\&/=Y NYW _@5,SA9DA!HL2H#W]8&;9T["75_5TK6 V,&.)GZ1?Y#KWOU]RX
M6?&88%EKA^ @=VCI;HP5<N<9[V"EC/]VV(S-W!R<8: ;^GX&@U?M_4P&[/1C
M$G$U=!2/LI^EG[NL,EQB;V1ZJC+^%NJ<^AD_*N5C^C-6!K]EO:*N\#V.G7#6
M9:Y3$S)V<Z?NE\4KTV<1QE\H?"0>,<VS]V@:@@3=$RVPC=L(9F,JFE;9YFF#
M?GHDVZ!.N(OG4#0<4,7?#TST8&:SB#A]4HH[3:1==)S:\=KGX'HH2YSG$)S#
M2.+NXSM'L[I@JYVYM@B. M')<CBEI\N*-NMLU^G1>B9.VT,:+&:8FP)!C[%=
M',3KA<7]1(6)R,*Y6U*ON=*S>)WT6@3.2T>D%?XQ/OCG1&4]VMJ^U[,,.R4B
M=64[LSU//&TKB@%QP,9?[.CQ%L>@WN$[)ASA>0IU@M.9T.NLNW95A&S<-WE>
M@BV'&DJ^+LOPNHC0\L,IP<F#W 3Y41KJQ'OE6C2^I_$6-?)%>*LF")/1PG%O
M"Q^ANR74MLGMF%,483&U?(G,GBET4!9?!/YX?8U :2$.]I0,E+IM"<79B,"*
M'$0N?C*MT^QY1_E-]])"UP>4,#XRPO\\ 5/OD<S=YP\U4;+Q*FKWL6==LN#@
M,KE3Q-2GZA"[;G^,8O5E0)4K/KB.^V@1;B,6MSUAIR%',AZ9+;,_.;8X<]J
M(<_'+1]-,$%R@#"<B/C&L F2451:5@HD 8%U\05YT5MG,O"3#(8DDNL9TYPL
MC1]XLB(+FQ@6EKEJ7)_L1GDC281W\%0%;A6?E+):#:FQFZM8[=KZ@ #A6_XG
MBN^.1$'(-BB\4R"5LU+]^0NX2X\:) B--4!\@8-JB-Z1AOWL_YVX&GN"%!G@
MUYS$[("V8^Z!&\4W)"X/-@^Z#M&8W23HS_[W:U,&?"7) &T#Z2T9V )1=G#
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M*,?VH?,R*G/VCS-0]W-HO1:@V+^T-/D$2D]X;!ZN>(H,F)MR N=AWY)@^TW
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MU#&$#2/60(4&?W$]BS2\E[DG(LA OHE_?:;Y'+KD/**+ %N5S,I#+J&W/<A
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MEHG2M(5)>X$N-Z)3(Q^#5(7OG2T-+VIX/5J?>KL8O11C\.PW&T-L9=E\?.5
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M!EFI@ */TS?41]II:)1J\SG"<#/E\-?TV5JM):O/WX>GBRKT<X]O2XEBD+E
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MU6U%B403O?>)@;HRUF7C-(M:V"@=7L>/B)0+[C)77J+2G+LJ#74T::=1SQT
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MW3Q__A.FJMCH.M9'*/]RRRBP":4CGWW<1!$G2J)Y4@=0/WC%?K3>99/<27M
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M2_;31L>#ZQM1O>J7[B[^.+P[J#DOLID!<]YM2H4YEZI9#4R1"X?*6\NH@%_
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M\YH6=_Q"=\3E6KU2:[A[[!G/YW?^D_WMAI]EG)!"&UY@O,DNGF5[PG@_PL1
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M*]<*@ZI]X[!2FU@9_3WS_:'SKM6+5UR''V84;W/(O\F67:J%AUX"J(/8(9>
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M5E92]N+.;7@)'5*IRWI^":B[]H5L$$[>R((5Z@P2P?B;JIZD^V1 0O4A):9
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MN:,VF1E^JL&2 JGZ\VZ!-/ZT3@WHP5U&U':A?L:RDU,\Y39M(ONP:?N:TB7
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MQV(.:9JQT_Q,3>^L+:QM&SYXNB0X=Z>F.W'(* +.=N;EU6U3L#X1Z-4UJ83
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M7'; 94CRLE.J(8PR(5[X4Q8HOP))@7.7KW/(H)4;WOW^W4NDRNM!1Z?/;#*
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MTPW>A&T,<ZD69^%"(_,;M-4KS>LR<%;5;VH /#7$BRY$,GK,</MSN,%YBJ;
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MP.6BQJM61'(5ZS82<:*.P_[L(C];J+=?8 J+8Z;9/,X9KN$!4^:6 ]L+@WB
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M?8\,]72]S2^$\/,>D!@#,AQ+TAK'RKZ?G^<7E-G_L.DXRA'MN&7TLO7)%P=
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MR$\ )5)_Z9\CHI62GN1C%8JMA#!/K;PZ<2E<<<\$)C<S6(593,5MV64U08:
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MW'Y"DP] */;LJ3#-W3@N=.=$T<C<=[&D*T;6 Q?M+D734CF_TF&S#(K?=#8
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MW 1>; $D * \\TO0=129OX]K7KH..L#P; /I;.R64Y%(0M9J1",9 9L_%@\
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M\AWR=EP'<CG86AF9D>-!Y]:[O@*M$2Z_)$!(1C'!79U;?!Y>?G(:9M^*'4L
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M+7*+GN;(_AHC+PE@W%X/AT>U/JC^/GJHBW9I+O6OI5JKJ L0*7?];($N@_6
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M5WDWPU%7U(I?E#*F 83CH4;0#:WF5J,IB9=XP)VUD[-];GJYA*Y)_I)&%K6
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M,">7,)<@#9>@, ^G,!_WO[R'0B( 5X IP!%@\=<W#4 .8 NP1WTL4?=M >8
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MSZ7Z^$6_Z:7&>ZV#K>QA:W,^X_A,VKAV\/XU):^:M$2%FMQ007!Z4%%DG#*
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M"]T?\1YUA9@?I\7D>D P(1LX!9"9[[\=[K#A=C?NEEMJ>2KH^*=DFO;SG.;
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MK%&1T3(\:=2+15BB!FNCA'OBVNFB>\-Q%7I1S;*3;M!X+9A4GG?5J%*T"<&
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M\M14ZG=V&O>"WP%:M-;;;BD)J>RDA'J^L0(,?B./(;'@$)",UB96K!,?A'"
M("S"6T+[VY$P\$AL=ZY;S9L#= TV9K)39,YJ5%G)"F,&_*^N@C+)J:A2I?=H
M'%I,HP\P )];[JI/"B[OC$SG_>='$/^C4W!L@M&?[9L^Q==8W323F$E>:(&
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M@<(,-+M&B^T]C)8LJ7#+GX<T96O1(Z.(ZBJFQ:S+!]@=^:M5;G*3R.1[&O<
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M+$C%[*7[R[*E/>'9%A56-$44% -AW =5NF_>^$^GX!I T)P&+ACOTZ/KRUL
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MG/9QM3:(K33*=IQ7@(V%BJP>!1@+EC*O 8V5;'71'-.,#4&:#:5WQ,B_ZS
M:9''FN-MJOX6$]/CF(?]BH(=DZ$_V(73]6X!+9(VH:M-G/6\_B-<CVEV_H:J
M]MHI5 "Q%60+!+L(-09$RR!9SP7Y >%KX;@JL@\*5,]CXQ,S<K@$XPG>9.![
M#E[-GTKY_6E@TD&4U,,9$]6$9_KO45*4I]P_V);=,.ANCZ)<W"-^D5C0NP4F
M\_ZL)K+TY>X=XOQU[TKUUN/Q\^A$ 0(IBV&]&4W_@/2S=9=3%>EO:3TJTG;-
M9#J)K<$63"(/B(A5!BV4Z<<LZ0;XR1L#.=2K]DN<U;5BT$PF?^ONK*X?7#\3
M':9>JLI !H88T+T6E7*6<;\%%)8D!E8YR=P"!(<COWB2=AY;CV&<EY8S=GYH
MI7L^-Q5G024P\[2TL.7VZ^=V;)JL6;0R!X8"[[A[5KY].&@PUM16F'0-9+8#
M_CIMANJYT<]*.S3A?%JZ-Z[X1+E[/?U\KHYS(\6->6WF='OBO')-K0Y\)'8+
MH+Z,;^#_\^CG$[$77Z)EG\BGN,>^6O?!V^62:$GCF@1^F(Z 6%O3\MW#1Q02
ME W3QLUHT2'5-*_-OC.51E30_7!E9%BS >]4>CN-6S31F7N3Z.OZJ*[NWJ^S
M577]PG#1EP=].S,>1/]"K_=H!C'%6:7O."ER^%I2HNH6@'<L\7=(//3\"K3(
MK?;6R3K6-BM!5GIG:35,OV CVI:7N9 D:*8MJUPXL))PP>=J\?R2EPKN1 7,
M7SP?,%%VG6MF[]Y(/HT*=/]>CVA(*-E(&_OTFW14+P9U6&RYLBBND#WD*6Q%
M*\,RHE)][K*TS%3]IW:8?CD5U.HR%*DJK_XF@):VK/5&T- 6L:68J#K%^UZ5
M:L!9E=WV/,6:&MV+YN2 U^Z(%\\R?94!S7XR"0ZW64XZ<-2*N@6T94]#MHZ4
M;P'-V!<=6M1>%JSI>?JS QI9L/@_]L&,\<RT'G8&CUO5\@[P$['1+VIE>K;-
MO#M2A<;B(X/\J*$8<5NJO2M3_(M*1#G[1X*H%)+T0ZV<2R.%]'>(R9Q4E^>*
M+W'\!9YH);"%^\ZLUEJIY"H9"M9N&]MI["E,<H@6VGI@@JK(5/2[__ROZ-]_
M;UI#-/Z]#D7ZE26&\FQ?*VAC'0RDE]L92+1;QMNFIKE]4JN/J[$!]5CPE'RG
M'_>!7G(V=.,6</=JSJU3MV%I*,S"[6^XI84B00\O]SZ,5CWXV%P3NP8VQ=_A
M6#"A+P"_=W>$REX&[:?=F0CE5POI>KW_^0-$82L_,%X\QM_C3"+/5'T/OJ7+
MI5U8=5P[-FH$-*<A'PZI>FWR&2G+\>;J9W0-PRLKYPOX]'?'D(C.YL1O9#:L
M8VHUWG?O0/"W$_!3OO3M6NU@;V@U]]=4/K$%/B&4[18 ."_@ZO(41)*JC=F,
M$1KJ\')?6$/X-N5N6G?MMB$*IU%D%O*KD(?]A$6_DD:4;/I</]W70C!%==46
M&&<K6 JZ2^5Z,_ %L?[(E3=4S&B4]KP%P"-L; E=0Y_&U9H0;BS([B:MFTPX
MH4+/;XQT86,-(.&" >@3Z28@PUG S8A45J@3HCR3A;RXM]54':F^(5SKYG)Z
M:#YJ!+*@$/'F0:K;*3*]A DDL29>%TY&77J3'R&[RM[%=/&%9*B;B=Y)8"+*
M>PEUUL2E18:JKI<;>F!P\_Z$;D@R_B]@$)=7&\D:]_MG4+$KST MN[ @:60#
MNU25B>)DD5,AJ&HG[OO*@M8W53&ZTE="F\O_GI.'8<@@/1F\-U[-&+^J>6Z@
M)K5&4]$QQUJ!(@.WH&*\US4V%D*Y0L[:\G;GIM(SYHJ["NUY5DUGLO(_@0U]
M2.>@6FEH0RQA?Y%^"S#"^UM5.T]-@Y-=*I=5N*'TTDTC<GO?,0+R?OI/K!+K
MMC[W.[PK:H6X\: [E5:#WL20[J9BS*E1;^%8_BI'@88^Y>N/=D\ZC-<T/9I/
ML-A:*O'_>AO;_Q>MW%/#02@]4.AIF X-1Z9OJ/B9VBZ7;AG0[!;PW##_%F!X
MH*LZE>7UGI^P0-"J ATE=ND%M9SV%JB&U4\<'CZ+^;Q(.RZ8W_9$E&U"\Q;0
M::!Z"U VX'"\G@]3>?:C.>:9TLQL^-JN5<RE]5]OG\3K<L@VH0'#?Z^78-@H
MU[U7IKF#,>M7R1?Y,1&_>(3JZ"J;;%!;/9!:?C>^\:.(TWO\VQAMDW:T 6J%
M@,"EVWMFKB2^R%5"4SI9C6#=+6;0]ED[P1F>_R7-*3@@% 0GK_M*\&OJ[AJT
M)WU-78K/=WV'C?8P\8I%5+.:;2:K2$F?31CGTX;P9O&%X93X\OT]Z"H#X6LW
M*:F1K$[A^SC&R\B[#%TPJ\"_AA?/4X=OO)LQ/O&+6O$AH8$ZT@Q*OOF<->;*
M>I5?+G^I_I)%3![<%. E4QW[!LG(XX*"'"ZU$MKA4"K7;LK$<H%.-LX+>S(C
MHW@ ,_'O3O?-W'S='1I'&&S,[5N'0'>^E _1^G3R,MJ@7I!O_.6V*O_( O\G
M+\2#3B=C22C7N8K6X;#(2Q1,'-4I$]]$/CVP*23)JX]0SG[L-K<D<^]/\I):
M%;+U%!UR9-BXLNB$?@O/XV7KGB/[F=/2PBV!8?2_G(YVC>N\P'#H.4T\JX[:
MWPAUPV^7*$O9B/H-E;E4P?Z\@.:S\UL "G]:68!P1#6O<<V?LY!J[8NROV>$
MTQ5=E=TM@ 0^2?E:\>;Y^>;,'+\@\Q.RI6!<-KP4$E3R/D=Y5]P;I$+&Z$0A
MQ_;K7:[>7)"9$--.&9E7%8=:8XD;I!U"::!8*)58N*3X[<7]C[%NCQZO7=J#
M[5!1[MEKS51&"Y<Q1956\V&N/.!X3!2'$?_UZ=XP0Z"#^.+O$4\U!]O<A:W]
MN$V.#RGY>(QF$XZHT/E+BYQY2RD>'9MU@ZD\TTAA8+U_*UHPO:^Q5S7[/I)B
M;)[A*9@TI)!JQ=9LT&HY8_O;XB"<^$Y8L<VF57_>N,-5.85I3!TC6^G.):FA
MV5/7L&Y41TALY<^GH8GS9%RGMX"S.(/$SOE@)8JV>Z+R;-Q+&UI1-P^F'\&Q
M-WMI*!$POE(5=W!/,6GT^YIH%Y5[<O^CA^+*1:J;9IHFNH](:87DA90Y#.<;
M'U8I$7=(W:\)6EEP>SW_4+(H*U]TB,CNBF30/=>O0<Y3,>/A)C[L RQ15,4'
M;,J@<F/5#WR]-@CN<#<O:X)5R'7XO1IENM\S7,B@N^M-C'=\9O]ZYKVHZ!I(
M"I)-56"?P)!6H-\CL(L($E-MKX:_B!K;DBQQS=0N13:NL6:[K,\O53.2\KTI
M6':Q??_1)%LO3AII&[GJI:JI#OOZ\UGLFU#9/[QGDEY6*?]1G_UB4!0G>\Z'
M[R['+>!W*->$^K.'K[E*6S^XSE593/[: %M=5;0WB*Q*OFU#S17V/F\I=W,1
M'G!M$04Z/V_LPIS3B8#3CG>JV^]0VHNON'M,^U^VX*SQ:.$R[/"B]\8\(< 8
M3Y&(#RM*ZYG7D<T#^.$:HA/Q(C#AS22;YZ[N3FL>>=:7*:R9JSP>7<EM<[J5
M&2Q?WUH\,GYU"[":CLS"_+A1:_%F'/FJ_*=+Y-W3+.&QV-$HM98;05VCA\]D
MD>3K1;\;G)<YF'*T31LMS557E^2^/,V,4> [N_MQ'/K=U3TTY4DY!3&O]BY1
MHX4(FX<;O17BI&O:1==O&S6P">$'SVY&;\"(G..6F439TB:SD6R=+KK<'RSF
MK'[:O'A</R#^QPS78E\>+]WRQ);0E)?*XC7X.8IE&#ITS^D60.EX8:#0KM*W
M'\MT7["'4]'Q%N#K':^6H?0I,R?J1# [O$.1)ZVN,]N[VO1%ZHH1B96[^>0G
M\UN JXCLUOMWL1Y1F%KR=*O\RV2O-Y+"R^H3]UHA')]$PG_:_'+[B)?MA*+L
M?&H@T5ZJLZ0]S#)8I$AF*E!/R][2"XSDGYD6@^M9-9.XHIZVTLO57W_>Q^O[
MZ;6<OZ*)C =[38:6SZRG D&'F4&_[!,[7.8JD[MB$$ESYYOF9Z(QN'TL_>%]
M>$MX)>/AFPV'TUTTV^,O',^:ZFIB#T8UEC1=5(8T''H68\;'&L&KO.@0\?]F
MXI>/5<_50T^A5()#OH.-%8KT'L(;^ICW5K\(V:\?3L0VP=!1;_DBP"5C&<K6
MAAS>5D=EN2N\A'MSX+#G-1/<FWYX@6%E'U_WK-#2U^Z[%5 *N#9WBYP4U_4E
MQ-0:^#;4Q.%E@#H@@H9=<AHLD8#UN+F&+?U+*'G5>.L?79Z6MU%2IL_TMO%$
M+P:_*%3I3M)FWEU>=_S$]].3AVH\7R-OL=[)P]LPF*7XDDT?T9G7E"R7QOC*
MPCH+](PM?!W7 -8.(EO<1>KOS*4, J=VF2.UQ$S?K_AYK*RENZ^=I8?45<.R
MAG,7]728!5?X(QB^M=[]F, $RS;W_*?L9M6X+FD"O7*YEFQJ0*%"FM0C_&6N
M15!2XMI?%V,8\8M:EG9=^6^W +.3%^_")F("%^RZ2PN:GHXW@+T(MMIY[<L*
M<7AC')]M57L;)Q]Z_[O(/P'Y9^]MH$$16V7YC0AMZ0>W]-)-YR,OY]J8-6N1
M3O[YJLX%&&$.2^4C49%7.3<%1&HN;!!/CVE!^#R/_3GJ'6)>&?:(7K]=-&2_
MYR@FS:[3_:C#Z.JQ$\/UEUM IFI-5 #D6, 0,OVW@.M4/,W1;GEJ0CH"OW-E
MM8)*==/[O'X7-G/80&Q6K&-NW[TJFW08T2[@-GY51&JYEI*V@C2@(].*$*OM
M[3V3*H\04DCV<X%Y#1&OIN5ZY5J@(.=>Z^<Y\D9N06\"2^^+T5Z4*+Z?0JNM
M*E*=\@B[K7_3V:RQ4%[-K1!;Y]UU,&#HO 5<X>VDGTUB^58F'' +>#4Q#!$&
MK5M-YJP1/,__/(?5@YN%74X5LK*I65/5!U8I4M L*WJBR4S2 >/4H,LM6#2\
M]FP%<[^.:17TY')7]&4QAV=$#''50$2IV$X"TY];0+GXR71U8A?#&<U_;=UG
M+ORK0F4#2U+8%VRU*;J9[[XGGL XV1=D!VMLD*V;@ G@D0E$I);$D+JM5$MW
MF[*5@R^J.LF/PFWE?T?#N]S];P@]> .<JI%X0<5'I@!PGZ*O;XT+VA4489=.
MI7Y_= :GYKNOZ'I4'%K) BWPHW5%KU;]CDE-O(]43TY%!\@Z*$*S2IR/WU6_
MS=6UV7D:3<KGZ;)6WUO%4=E([PR#^8;;]U.W*[3[X>SC*8M/.3(0 14]/O$F
M?=*ANJ^=\^.[WFD+6JX(1-0%2^,:5UUW"^-9\&C%<)<.>A%J&>9.DADK47]$
M[+W\L??IZ;%!%!'B(ES(EL#2;^E</JM*7AALS<^<0T0D.!*E<,X#UH*-.W)4
M:4E])NG<?#%^<7+Q2FH]:JC!917X$"_2%E@*B%'IH<^6@735&3U9Z%G&>UD\
M&,<6]]3#)Y<!]2#;\ =GG8/"PGP4WO?"((UMF/>[@^.1M9SZ::!U"3?+TJJ%
M_.R#K[)4*$> ^^2@B0*2P7\_NZ+^AV3@ZM57$WLD_]["G>+NW]ON4\-M5!-[
M- %9GGLV!<1E-I#HDOGNLJPTO E80?4$02T=$7S0X+UL14E>5JVC0/N*5Q.1
M=K[2R=ZEXU6:Q;^S]&%KZ>3I!#OF/&^J#H8TZ18"< M)EJFIR+>,")K776&W
M@!)5R+:0U6I5N^+JS"J06[@/@(J5OP5(_=#(*E@=2Y@B>/%<V[-$->A0$QU*
M8Q0,E%XS88&G#[R:$5SL<TXXI;J+>4O668\D]G$JNQO[\C-@\\GUGR3O])_#
M*FK;RR1"!L3RP<H5U67FQD-3L2+<]O)B[<2Z TB&[T= L!W!-&*^"Y$A?4P6
M[N<P)%\23U/^*WRUEN@AF!!?(9NC'SO0M22SSZB<(/<'(=:8DM7!!5PTFT4/
MFD@6;LB[<G1%6PE%7>F>1MW_+MN6_R[#Y[A$V(:A_<3Q?,AJ\!\C2OV?YGDR
M15K@2[;LJ+S=84)5O7I0S]_U!"@9:JW?F_%RZ4#HH:,7O:GOLRNS9,$@T\/?
MY[AS96N7=JMZOW"\-9\Q$;91LTI9T'GQ205LUA:&U3[5CD4BCJD'<B'/(O=/
M#"!HGF(7C-?+HVLL:40;>!&7YRN01-QM& Y =3&0:CIT]EZQC!C=N>R[!D\9
MCU7IK">,F1T')]N/U*[8>YCY26A&=71-G18K/[VF4SY_*A'XL)QCED($-P?G
M4 R]YY-PZ 4VM&H+9:NM.<'O(!(1-//MW3,\6^5YL:R-N%E,G>=DDM&66SX>
M#'[63+R1W$[2+U-I9GTA\<UPG#(@7UK^NOG1]2FF/F6Y_8@"8KXM0F()HZXI
M53WB#E<$&K@PZ-L3P_55D/>;5YLI'S@NOCF>?)$]3ZNBW%?&>/A*TJ>W1(,E
MEIC_4[3/KDI?RGW]+0;E>^ZV;4H"\_L7R4E.'JE+<LI(*!XHZK284S6(3KE
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MWRG4I]M16*:'SR?V2?G^ZFNIQD"]?ZIHU-\"@BFBYR]9Q^0^<"U0NCVMI^N
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MW?@FW44H/U9KR=@^8(7 7BP?R(5D7=:M"VU7]=%=[''NVG:@#1Y/4[]V."L
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M< _.=0MXQ',YP0J+.V"5]+MO$E%?D>)[ [_2$K)\^2<E4Z)I2I+@!2^)JDK
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M.L"8-=+T!=T1,I*#]K\==*RW:-!88X_]6F&HG\0J%98ZB#)M1',&/""[APO
MZ>+JQSRQD"CA=;*@#*!_]RYR*X$)T;UEF*EGLFOXQV^6-HF%$I^H"/8+TZRV
MY64X>0HF-=#K;JVJE=+I_FB?>]SIT3A52&M(DZCY_BY%#MP%4E^#?[P<6LU@
MBE1WL;JP62$ 7RL>IX_P&-9/O_6D@ 6['!FJF-J[X>BY," >XZT9:&2>A:@F
MGMV8N\THI*L6A^3."C?I>9L1?\D=SN_V>NG&.H7[;6O"!JM+@1CR:33K!##J
M\<*LX&/8A\_$FFHQ*(IBAL Z<0/SNH9Q:*^C5-_3>0LLY<X@[JL9)EYH"ER3
MD/WY0_C"4+VI74+OE+6.4UY3@\-9U'S<5>=#1W/E(N;:6]8!Z7X+L(Y,_UB,
M*9=)FKX9Q3[*#(:^8C3;.&88/A\V16657RJZF\<'4IWL02LW71N%ISVVKRYC
M?DN?90-"48#PSR!$V PP:TA36LZI\<?7Q7]VF <5IR\$<0D(QR9[[*.-V8=K
MP08Y-7;H0."3EWM;4?]5+[$0*Y%.EU'4T(S_^9W<!+0]6P@HD%AM^?2? GE%
M&EX@S.OJYK-.4'2)5G<:[P20ER5VYWQ$[@5N@MMDR!HM <F>H2='7[:RW*%'
MO%4[L>R<^JSV?B%OQ]R/.5 0U/;@ W"D^P>!@( <-5HPO:UA&$/Q=XY!*MGE
MYAJ">='XI+L#.TC;GMZO+;*N)J2XNN,?O@5@!Y[,[^F!"57#E"U1*3\J\*GR
M^EYFF\9-S;NE61$'-1BOT1H:]O23I10N]JAX>:L#HJ7\R>/S=]RW_)S8_8>F
MCOEXR*:.4Z&1Q+GKLNX[1Y@7BTD_+9(=.:BV;:C*I"[O?JJ%/'%MN@5T<MG4
M!0B/WJ24@9]IFSD+II2=DN^-G1]JIJA&F6SR@U3#GV:+*>1Z;T$O10P@CR\M
M'_4BSP-9.4KY'A'= D(8,4*;4BQ(X;(O:U:C%+G.I:T.@8&L'W^]WH%E.S?C
M@]8_)&*:EK$0K'MB]-?W<:, VZW]6L(T*13/[:J#O8T-,UM4\KV,KIX>[TAQ
M(_=5+6TT>.19'S#_^!.S[8]*,:.S8FCWYI@ <A4\?A^KE\\AE"F,<]"=@=?H
M81K.GZ&-TW+]$H)Z 'WP'RN%#4+2!GT__M2^=R"0:.U*>T[J>>1RXRTK+?5]
M]>CIO!143.7AU6_?=78J2&GSQ)I43D4#W:K'(IZ^WT.6Z-E>QDASVEA*-FK<
M,O)#N4*:OU52J?#O ^CC3Y;J,H F^9R  MBQ#Z %=^!EZ:3F,X646-B;"@+!
MEKY45Z5:D4(O\&?DXF)GE)_M(?>F*ZL*E0Z3=5%MS.M6%*FA7HYK=X?1ET2E
MROK:VKJ&&$TQ^K=,N2J!PV_LQ<ZA2I=A?ST:L>GJ:_.II=8]Q!_V=:1G\?/[
MYL5T(^EPB6BS8V9OH03*>.-L,:[9OT>Z?];%#G",!:38-&LY2!@BG)O_S);D
MYY7W4 <G/5<PR&3+6;N1L2JYM%B=_W65-7HFEFRFOFS+E%*&6Q"W/.$M-'/Y
MYVXM(BV?UI]IOYSO_)D\WLF=!H<6M9=28N,Z_"<2SX8S5$'%%M0W5L0OG KX
M\V6O)>C LR+]/)AK>J0TF5:HE\6))Q:1*>,P]>DW^$W1S)RQW0![^0,CX<58
M(8X^KR.QLK-!)ZW$],="KH3%$S1)$5W4TKD_J.@[ FFUFL-^[]GOQM>GDR:8
M4%#.>90HS=NF;0D5RI,/U7NP_,'LZB71L# L<G\#<9XST,F,H 7K(RX_1]X#
MJ3S7DEA9#J;D,VK/V]LM*WH'=*XET*FGZ 80@X?JHD*:CQEW_VOV0R;;V+"2
M33>%\<BT^6T%7F"AXD/#8@TSYM,KP6%O2DC/=O/9$=LIU!Q*>6F I>!_L&.S
M(7VL\4_M"?&:9^1"V,WX)A8;.C%L.W86&.Z3WQ\*W1XG^6 P<J T'%2<P70[
MUW0#0E_^66]U/!QO/H@!16X/HMB009*G6-KW6B70)YE@R,<].4*Z5ZZH_.["
M;-J7-U1NN-SG5O[,=@<H4%?)M5M#P!/K&#97CVL179K4NM6ER]A+#+4'Q@LB
MOG4$E/?P@A?RT)C>#!8FX %+,8^]DT _3TO&5YN:BM>WOSU6B'FY-;*V830-
MBG>;.->BF#H_&29E=N$T9&4Z LB!\DH&>#9D7N3<$'/Q5P$UI%]O7]Q &(XE
M'>")P<T5+]7R]7->V/IPI152V@Y#-PP:';SO34\;(B:XUQ_]^O@L23:/5F05
MI#\M;TC_;' R46IK]J.)LJ@YIYXV5R?:8%7RTWC7=._]7!>R#WUW.FD'"@"X
M$9FAYZ$($"VDYZ@ ,FV[S07E#8V7=1HY$9SM(WN^>@#='IQU/")'O](1HBT2
MUI%Z)R"G040L3;5^G3Y4!@2M2LJVZ?9JG1"HU"J&R7S%C22F^^D^7>7JB0-/
MY</Q/9>K@]1PM:.-_ZXG8-.V$0]ZKY!01?-'OFB)NMM/M$1;6QJKH(VMR^4M
M0&XY40YI&\7HI?HFW[K7#R\:FT[";I0%]W0,R9 \%T%G/9ENS-<<T;)V-MV,
M!"O1$GQ0ZW$?@Q>3ZH"[[ "Z)A7#AZN_\<+.OA) <A3_IA2^27)O2U6%]@&^
MH_OYJ\^$-Y>*SR37-"?@HZ>_(M[L2>D_K/&=2//Q9O8UY'$H<@WN0O54!\E3
M]<A'SK'.TUKM>J?EU!^%'E=Z/PY47Y%W#5U:LTK?O/<)S>!+LZ=1PW01DR67
M.QM&^G=G0SM!IB(QYWF]A-UQ&MM3 KH#^B:/YI&M*MN[>QBJ2AI_<:KI>^M5
M/S9![Q'$JUPEETYKBL7**SLT#4V.\X]>"WIM=6M(Y=)NS4S;%K7!:.A.!0":
MBFYD6S?CAG0K,'.T1?8/4=9OS;XKF*#* $R5C/Z>NL-D]LVOL-Q]O8V$O4UW
MHPXP^>!O;6F+7%'%_M_@I*67=-VUVU)!#7OO$-7UJU#Q\]GCQR>2'5FV-C5X
ML4I&EYF"BFNR,D#I.YS71. 3UD:&%GYFP_OC;PAL9$P.%6D4C#3;93[HEJ>"
M#@C:''=%^NG3DNDEH.#"L)#3 \<>L[+[0B=$VKC^TS6G0CO+_V+&5A.OC+_F
M^#H^;B4!=5DO3@W&M(XAD.&8'?M(C+#<\'>QYG//2VDNW?6/%N)B6?DP#Q[,
M6CKR%A!QQ*"6*#O&ZOK<-U2)V8R0R47_'#>W\4M4$(;%@P%&'C7(Y!([EBYR
M92(U.^A 8B1/D9>XH2E/82P\>U\CY.L**G0? K>V:C[9R84L8Y7.ZE[&6+X"
MY\LG)Z*:3,2A^>(_>T',=4\N<;M<IN8:Q&7R!0>M)=SLDI1UV;;O@T79PIV+
MT\.6C^^-8T73RBU@6V@3L: $67U7J]TV*#F"39/?J)J^98XU,JU>H'T=L03S
M$H0B-%%-,0D-B*T:2B;?4GM1_% B;VXID0M-?PN(\M*[V6Z.T\K62O[/E^D1
MMP#7Q+.1B_*H"W9L)A;&JG>[M-__?Y^O_%\U3;;P6\"ZXB1H;['0IM"2@F_7
MW?%<2Z\A:23S0)210:%&7L:B@G/4(9N])#^-'S&/D:WGO?B,9>XT=:!_E$*=
M$C'\/.ZW97Z>KI(+\Z@?V?M=]<\?3U5F)I>?N"JW8^F,T,,73,(;U53:N"<F
M8CV@1?+M87*E51.-KXE7:83<=0WV5_#%VE_-&Q@9XC:C*[)#R-[5+>#T;M$M
M(!R$/,JZ!33R'NL>-$C"]T"$%H-?/HXU6#^+3S:]%_88[Z,$S@?7N+9J>O;(
MNQ/,::"*!';CC\2B0_;$OXM,#!^1'[C3J;5.NKE,)G9^N5IH^;_WYT% ?_?G
M:6H%-TA:P(O%BHKHS2(V!"K>MY0QX\P0M6@6.TPGIVJQ5$B4.F;+$N,[+#*%
M7);07KZA2YKC?=PD*8PEG_;+!(>G7'J%%462#5K,O#$L0W=\A[Z! :=0[:8R
MV$31EXK&$,6[_54C%R5WUN#WZH=TI[5BV2O:Y 'V>!-\&(W9-U6\GW;4G8%%
M-J0D9S6KYIV*O3^;GS0HYNXE4B3,?4YSGSOBY;O.JA:E;Q2?UD)D8J0?0O8.
ML!U#GO_ITB0C)_)K:JX%=7MC7^D36F?JNSC#"HL(C*\%O/'EK#9PF#JZY_W
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M27"!W>CX+UI8U=<*E&B18O1OQSP_X56>MPH94)42K(A^ZVUR!E681CME[J"
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MK8%\U)7LL3UFH6O0H16[L"*'%%Z/L"=6:64[W<R9;"+3-EP"HISV9@I3?C9
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M?X?"A4 !*.M)+,<V5/Q$M=7/L<F.LB?>TWC3*"(]6OCG4$80+R22XQ-BRK8
MXK+NJ.4M@#CXX;$Q>6 4&=W#PH;0GZ@3"=FO6F0UD!E0*'TW4+S)3G@<GH8C
M&6%7ZLG@^_G^EG;LNT,FV .(0%>]%].;LE'']/T]]IE7\CR-Y?II6<E=1=^0
M437S9IKTKCL3C>9Y74LEFQI1D9Y"1?,_8H_910A>BOQFHU]'YYY >9$]([<
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MG:%4M<ME%)"<.-$"(RGYF+K*;1I^!)GPR6@A5IEU;KO9(6+M=FU#<F1.A$5
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MGB]CS;_H\&>FD83=63OC\U'9MUFT$;66?.UF7Y3@D/S-Z*Y8Q?VGRN8-ZU<
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M87C>1+X,L3M6>1M]XE2]U=6J]5A]K0ON>:S.IK.E%^U7HV_/H+)N-4RU4T3
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MV#MHKLY,J?KZ@,[Y\M:X:<7!-LM$_NQTPJ/"4821Y<5K]W+K)?(JU$\:WRN
M9K**<, $8[_L)<0.O"C&L[N#F$9%=[8H]D@G>'%/!1A@?U+;TV2TI2PM/[Y'
M".YA9\,((@7#7W_-7Y4Y@B\:\E?/B"]@4^X:W)W :0!0!%U^Q_#G,ZWW,.3M
M\Y]\V:=/0HXOPJUR-6OUK=.5DEF4-$E835N\^U /)NQIO-TF#^R"3D,WV]*1
MF-I:X.7ID/85P'H!5.D-.4)'UUJCAK,,Z-4OXS[*=VIIO^I7Y*7PIWI$UVN
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M][-I 9;$\.?F&M$'JB!PP0[D*5:UIKX58[BJ#Y4TR_1PGIN1S'W]?=-DA6!
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M*P YCWIMRX1%T()>Q>O8ZCE26<LL_I UX[6 ?1\G@,PHQ0Y]:EM ];#>#-Y
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MN[OZH\NY7.V]RF)T,GQ1CD0^XQ[A-J4%K6,.I).*(G&"0_+79\Y6R<N,?<X
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M[! Q!!C-)TC;^_'FXK?OCBJWPK1J37>"B2AJY"37/#=R@ !79+-A]4@@Q<Z
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MF+'=0 RL42V*JK%V%HW1&8I'7](#EE:)+EA&K^D+74H\5S6:%4@C[PB;OZO
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M+GLVF^$'=\.UDV>$!MW(/9@"<RP+OBD'Y)@9+QJIP0569G03)%K9E]_&N2F
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MTC3?Y3WZ)[423&'QSSQ% ++R68Y2HEQ.FTQS$I0G@[ =DU'\<!1W]U&1 Z^
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M":C_JFE?TW;,I&J+)I&5I:9*#KKZYJ$"\G9YTFB_L)/&R4RJWGG;"+]VG-[
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MZN+QK](:_7]KZ@34WG!IV!*G?W1GVD[*#2[QN<ZN/O(@-^2)C$"ZJ)14E8J
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M[+BX=2^]_.,@%Z>D^EN5NSF?83]66+PV+7JWLF)H2;X;3_!GTO'B;(^@*P2
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MI@J2%0CX.'E^Q$<(2P"8[*K#2V=4ETG.Z,><>Q3'R\MX89\;CAK^,?MU4X,
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MB3(ER#")UL8'4B@H>^@3J=D34RK=83-4\^1B6RQ3E,%4I\,U78576W=!PRG
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M #Z1<+Q*K!&NG26&1<OFKES!-4B;5>=%[AQV[,'4ZDQ]T,GYR>Z38#8"@%:
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M@K)\<;Y'6.W,G&W/PD;&LC@2* 0V]A<[S2Z/9VZW'IDRF0KA\BNM>_]RZ5Z
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M'M+'7L4!"?8_KA+A-*)+7  ?D73^N&9D5PS(8OSQR5]2P"[C/YJ''9%T_\@
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MJWWV-VTNO4X:BDJ?N%M:>JFL/(S]^X5S<OF,MMG8W098?.#FA^*YM =]^SB
MS*Z!?RQ-!V4D2[^8R#@?@5T#S[,;[J/?QI'I7+O'9?WFD0*<0/MM:9'A(X<
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M\VLQ<NF(,*K!@RD5Z8YF<JPGXR,\,AQXE,N3=H_7#Y7(S5/E H. LUQP/!&
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MO9.U^F"ZRG&#KEOI+,&=H%J?2RQ+2U#/?]CFO\QW#9+W&VK@\9<;%,]PT--
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MWU$0#>G.0)T.^%3E]2K,0L8B+_P@OM0S2F[=8YWW+7'AVL>Y&3Q2P(MVQ!.
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M+YS4=!&]J:?]..Y^B@!5;+S4*><Q58C9B(PEK-J9*^X#_(S"KGBA6=KNHU.
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M^M/VF,G9M-ZGO>$1]HH+OF42J+=4F!;$:RE9!4R0NL]^+]2>W.>>872&)TB
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M=R>=?(:L+:PNZCU\=T,TX3J]O]C\9ML"]WN-&<1Q39E6U8&9ZYLNU<_=EB2
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MQB))P%D9>9Q%"Z6\1=2!1>:K)L0N"1CWAP<^F6O=W*M8C :0&'CD,SPON6N
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M+_HH( @JTJ2#4@2)@/0B$!7ITDOH2.^]URA($0)(%Z1([R#2>V^"]"*=T(M
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M\@5NCA0XLM+S--RNXB*-5*%.HN+!R= -O(/[#+64?6\)52._DFWYB>[C(=!
M,"7[+^:Y(:X7-UJ5(Q.#A_RR($$3O_B$H^,L77^M_LR6#10T?%)<#9V<QRS[
M7N8#*<T?FFAUK1TEH/D]MD6Z=A(&Q]&1]B]WH1S'FY\\%%]45TNK2GXW57YG
M\EXO<CRDMY3!GFX;]'7&4L.)/4M)DI'[%5Y4]V0U/$"_$]YECBB)'9#CT7HE
MP\*4XM\@8EZM?S2?,,SX^WM:_H^CS:X=IAGSP>J\,H-9ACML/UH(7]QU!=]]
MRLY'2"9#=ED!X2HN_";SB7O=";9X*>],%8SZL-N\78X&>/2@;9%GU*MHH%0
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MDCA.*%]P-WX]=E@_!G'1+D8_>41I,O:T_U2I7[DW<1)V4U!%% VPK3;8IDO
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M+8]&LA'DH?2WX0:9E4UQVX9O1>GBN_@R(EB;75"J+1%"Q,GT4ILH1#_R)PF
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MJ9^6R#T7U>$FL=N[C&?]Y'UEW*L/  38*O-R!+AE >]X -#,&]P[Q]] @%O
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MI7#"4.#+W-9U$<KI@9%=&K^LSAMK/#O_*NT[.ZR47<SSKJ.>N&U#M5>C.+N
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MRG +Y\D>]2*-!5G],U$W8$2*8!"YC7WB9Z?BPM\TY6N(DF$?J1*V1AASJZ1
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M%$[89BB2']=L9.HSCS*66ZQ:L(5FB:R3O\WD+=N(:.K-=O4UV[O/(: (QS[
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M*?SA_L9,$ZDTW_N,IWZ^)(LB4G<M/UT37GLL^?M7;YB18^2O<XKY$S]<PBI
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MKJXTC501CI\CO'SZ^F[Y'?=!E/N0X6(W76)3<X$/!<$2?AQR\OF,>*MX24S
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MQ$7'Y9A+2JWUI>B+&DD9#08<B/)<)IPE(3/Z_<!0107V^TBP5]/[Z:D$Y@;
MW2U JIM0>.(YLE/ <)^>E$BL$J'J5()F"CABP;Z26KS(N0&,1I@*YVXE>W?G
M4"8&*BC]D'[8ZLEZ?K?I^[(B)M2SY4#Q!I!#]<N?U&XT@O[Z=63O&#Y%[,7S
M.]&R#2&KG!TZY^(&ZG!,T#?SYNH4N?C99+.F.'W,DU]&[MBQ"7[6[PS7F?:<
MF#;VPAW0@R0IA62YQCBEM^]?.L=D_GZ*@W?+$I-[ZH'AU=?O>LSMC^W*N4-;
M:^7U/KPOO_=Y&+(Q5H.Y8U6V5>_0E1GZ^+VV^[/=$]X07(8RW"4BDN&LJ2(:
M[N91L=F7^LB/DSS2H%]VT&<MB'S7+M:HY<2<1&5)05U=&N;H[.:@OU'Z8U#8
M,XUIU-12)X :/_X1GIP"R;H"E.X,3G;K;/*+;@"(R$7TG:(N>.:T2@L&A[<T
M/N<LU2DO$ZUQTD6A8=IW;/Z?EJ+]7R=XM;[B$[HW@+:DT?UYMB(1?IFG+BVH
M+<J-1;(JKZH; *6*YZ_KC LREI6HWQTDI;?K'SK,#^?W%2B@S39[MF#,>[A!
M'_+S]$F3+H@2I=[I<9]GMLB,[Y<A_1S[+0"XNR*[A(CEA!.;3(0W&IQI;VL,
M/G7.DN <EL&T+#'1:\(=9,I?N!)]37DD^>!1Z9H,/ESCP+2-P8S$35'L8U\^
MM58MY7<X\Q6_$=Z6J<]*YJ-92'PGH?O[Z*]=^$$JD=0=@L-2?MN[N:'N-E94
MR1Y>XFE$'R?J<C4D/ R3L;2V+3/^[-1QI>]^,9G#Y3:"@(-8REG,FZF62FG^
MJ7)9CA;9MVVK''J@)#P,07DCX7(,L2T3W6O^@T@Q%RDE\:>]<QLX7_&[ :7J
M/:9/8CI-'PO-2(FFX;.$,$=>\ 6,<YS>K3.1F.IR5?(I0F/@2GJY@0->7'T2
M SXR.C> /G\.,>7B7F1L>$7:EX?X(HD+J+LG'2QOZLJ/R POX<].P=^Z"?9P
M@EFB7>?<R^1*U&V8P,:'OR9TO,,?*LM^N#7_R"=3YQ^POUMFKQ>K94'I/M2?
M1*;=6O [G7!8+]000@?24?,/X%?,=/D.5H=7ZK57QF1;%L\][SIV?I-QH2CO
M6>(AZ<XD_:.^/%YUA#;=^IYU/7/9P+PVD]<9IDDQ15>S<R9=?-K=9M0<2=1\
MMC.AZ5&A-(?$*/Z,,NI,OBATB1N<Q=_/";H&E,8C/2+.;P"DS[*XU^DI^^,7
M7K9B@M77C.6],[_XZB"C\#J>SAJ;?2LUB8P/P U9EUTB';F#TK/F2:60X"HZ
ME2YNF)[L]E$^5N)S]T!@&<906250&Y3#!XL/JKZS:B2O>_@N#T'DIJ(F)%&-
MSYN?'#$D4^UV3[&1MM5:,KN+7[!B:4J]BQZH3&LJ[?<.'H$,.NLXLD?)^L#.
ME(VN [AA1'7'J^\?FS$P, 6G6_FYYYOD#D4>X/:ZE(;@W0!*98K&,"S+!R1P
MY'<_:A/2[I'2=GZ6>88 UH",@*,N\ O+0_38KFD'?P(;'HN8^2?9+,)'(.Y^
M2#[5BCCH1-)NK;R 9B+7P*WIU.X&8!JBE:\JVAT/EEGV<NV[*UUP/<7] )CN
MN^%F*19/X[R60F^-1P.GW&H61,7:GI/;H7&J*M[D,JW>+0S(FLU0NL 4#=@_
MI;"YQZ5DN)XRQ9UN)Y<NYF_R6^_OO4!/SKQO ,&W:&,62*1ON& FHM6&K_B2
M,$.Q%E=K\#%7FTO1-F]TM:3.CVTE/LD&=VF8X0W@ZWG6#<!,"+JIT+38WG+,
M:0<ZVZ#&?N%I$Z4=V]&NKXV08DN9=T7<"Z/<80(>'83P-HJ:.[C[6V80ND6-
M]WY="@(<4U/2;+LFBO\L2GU_5J#5J9VP&N<W7Y\A8R8'@6)?#0ECVXZ@F^5F
M,HA?6TPRAVOY0;LE-BT\TL^<.X\NR<AKF7%M'"5C#(O;R=(L^\L*:-GLW0I5
M)^(,W3W$@2&K)(Q;=2OKT.L[12.R/)W'$#EV>3;+1@77Z]'J;J@0WHJI2KZ9
M2IZ][D7-+6/@6S6@EGE(\G+/%.&P#"="A2AQ^7C:AW$O&X%[M)G/>F3\L_.I
M:>6JN'/=HH3JQ@L""X(3XIS :&BK]"RR*>U"5K0ZE69 \0/CFF,_P5>0)D\S
MZM9U/3&"(CJA4S_ARXN$*"7+\L-=9Z5UY6:WKW';$1E*CBH,-CCL/U%7W9+L
ME<BR\JUD!^DAH9I1\M(1X3[>>U8"=GJD!&DE+-E,'82?BU[.</!YGX&MY@91
M*C< %BOXM1<(&YR8<Q3H?_5:IN;6=53HL2SM>4E++;]VXL!M[;?XCL/*M2\;
MB(/2*]JF"PEHE+>DF2@[O5S6:L)-?O),Z[37_+2H;$B%HG"Z>M4R8+73:JRC
M@(WG[.S-B5F(H4YST?+FU!%N[&SG^ ?SKYV/[D/),]N;6+J;!60I8#6/9A]L
MU/%5";;_-'Z?:9H3?K)^=#\3N1A&;K99_B/5=I;TM3C1=XIGBZA'\&:9G1$G
M42<\R'=U^0FG8JM0QO[*H37)S,Y@2IJ$-5U1#JH5AZB*2P4:^P0N5>ZP)I]+
M-*4TWO*U8A?Y0FG6O48[QY_:K9%"2C(N/6-U G\)NYJHMD1AN+)-V9/S/P0/
MO1!2I_B@Y6G>RA9V5@I<9JHV+T6%TZ=S0V4IJO4'/EA=!@AVX^-E41P>)D])
M3/ 6JTE6,>%,*Q>FC2.T)AL?WWXLQ\1_'$X4M9_]I9OO1*/H"OSA;Y1%^]3Q
M978&OIPDC?&Q3.N3QGR-=/YJE:+0R@J#=(3,1_U8PZ6M85'KU6+7]>H"[8[1
M2-;O*CG'BG4H(/95N@"V]@:@92KH\?PHL#/MCO\T![9>+P>BU2,+'&_DL;3S
M\37/H#FOIS&IZ]N_0[E6G[#E7C@/I_)0$:Y?]>!]G4.H9E^BR 8.MC)-.YR@
MN!W9Q#?V@$D %R6FTP/:+,,4;6R?7Y-WSS#!<KCMQ3S.3T1\^)GKWGU*>[>4
M@0_"UB]C//&"'$0B(+[B#G3(4C&)+^I/]V9<D_I6Q%=$,P@T?\QSR<]7YH@%
M"C[5#W?550%O?TS0D/?>Z _Z__:-9%V_\G\F)^D&V=R:K)Y^?U#_)Q';O]ZD
M^W_=__KO[;BG-@+<>4Q8NJ;T$/N6L C_<P(C6@6-UHT"RL3W\UQLT^GZ2IS+
M7/UJ?4K^-MF^M\\2JS:+;8F_ 3SW/O:3=*^>Y',$[G<)2?GAX)C< #K5J6QG
M]C_?*TWTL$ET3%)@TBJEX"%9QJFCW* <^A*8HYBDW./OH$O>=3)NMUDS@1;3
MJZ^M&MG?WV4QR ^GBA-A_MI)M((3;VIP R $WXZ7J2J%O6ZY 5 ;F1*C(JQ%
M-MWVO%_B_OKYJO:=<GWT]QC+@[&J?;<;0 @,!@1GF/ ,<CC/0AZ19VS3X%SJ
M9:J1_C$'EL/:U!E6'7V->L-GQ;35P*"6=21E..$V&\'EL*LI%3K#8;OBU_:Z
MK5O_O.0@T-MLW\G=DL=ET4:_K77I/BOZC.9T/64%^ AB 20TWIP!?!J0NE4Y
MA0C\VG?3?(N?HZ_M-]K!,G*,W.OK!A3Z:C> ^M#(<N>V#^<,EHN,Y<-GAOIV
MXCU)!P?BAT?Q@\SY(#NK^FFH64'63U^5<;<FY?5N=/LUVQ>%-X7\##A1';SB
M,O+.6#Y4%'^#]13=!Q(PF .-\+A<94IS8VIR-<G(/^*1&Z_F*K92*9AA_WU
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MT.(P*I9X\6="95-^MOG8SEI_[BB0D0WY?5K8,?I=QV*R[ : "V>,R*4USW_
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MJXR_\-1Y%P<-R?3"A$J2V,?6N_I+9"/(:"W[=$K&M!)+X]S%?9V?8<<0,(<
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MPRT9?^;GND$/C6R40-Z_FY_M:$?\L>%U3</;3Z"GZ9=DNM<-DIG8]I*#[)C
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M;>/HHJ^IC?#FIY;&R+:=O(9M;C*0L1XA"HPT9N*IC5 9IM#YHBS=:_G![H'
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M*HBXJD%P<9;09E=(E.F_O3F1I8EY]* BA9NC6?.MO:N1FEI=52@FGC5:9C[
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M2CS,BR]@T/GIHWRQVOY'OVG5"(%Q0M7]0KR6G'N9GJ(;[8V81BD0-=!<@SU
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M: T#)F^3?8CJ$8HH.R,7K+ 0!+CO_$5:%%@7G^/$Z[=[@0(*EGY8Z\D^O^G
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MOGOLK\# 4WC"VWY%O#YZDJW$+/^FSXZ5<SSQ$9*;KA>ST\9&.P%10A0T7=Z
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M5MR?4<37;'!4N4FR-0/P_R1XX97H@\ 2@:S*<K1EB%S[ $<X3P6/0<XS1UK
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M+$^LQ'8I4\U3[!-LS*BORSQ^2,>=?R&#:EF!WO8UQA]-I8KQSF2>>:@ELOY
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M7G'S3Z"]0BHJJK*7-/>^G[ML!**6?>3^SJ@EP\.+M'9"S-5Z_G%.F\*;EO@
M,CE'#T);&E]C5A"1Q^V1EEE@^#CCT.R]#Q/Q@=6]UZ5:F@\5.7F:%Z?C/#^8
M%C:D3)4<LFU2JQ(HFEFAFQ E PZF*;DS&T-+.#Z,^OU 1*&(#2HWZWMDXVUV
M3EHW'8N-T;C"QTMQ>:,I&UAB&^*DMA-*7IVO418L.>9I9<7[LD=EES'C#ATE
MAURU32>E9Q5I([:+>+N[C+?(CZY-N C#-YW"[3("$3NB>+1AG'+!V>$@#I^8
M/\).0<7QSIAN'(+Z?1?JZ=XA&*XOS;HK3XGB!$[ZBHPZQBHS4O(%4FQ!T'5
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M!*)\M@PT&(15Q PN:A%@39/M1=<8VCP?+U34^-V<SEJ$Q/9$;O;(=:_%XB'
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M(?AJ'$Y+DB(HIE:.WU#/5,C[P*VYJF(MQJFCB730C[?9G9%;"P4=NDQ\=C$
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M$ZDX^\\>;F.^*".:%;5IYM,<,L6W=Y236[X!O/.,#CL%P96DA=]HOKF,__S
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M+AB7,W8W-,8Q];_%)<P+:PEZK8G'<@NMI1\8@S'C8F2M/&*CO6LXL7<RZ^9
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M<>!RRR0 FU3Y\89K6:<; !G=V+TTG^6C- "$,U$"?<U4;-<(Y6E]\:$XP;[
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MORL/\A)79=^2,9X-PF$.;"%HZ7=+A!3O.&Y=,@Q>-P9V93W@P->?O6^1& H
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M(4NDX<L<+4E>9E$VG#Q1)G^TDJ;=Y69_:>HZF$+G( U7:G^TZD<7SE!>XHG
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M3Z 0RSWKL29!]\,.:6JX3K9U.K#6AA]YX/ZX?G_TXZ/' \\+P^P=<=["C'F
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MWB_U4PIHPV\$>+5C\+ $OJ4G((UH96;C4M!\9D9*%)'.>2=^XZ=B*)=/5_;
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MH I^FN/!ZS2 DVPT6A/<.1;DO]B^OUKKDX$O>P/J)$ #]!:O"BVX,*)?VM=
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MSO4L'DK@.A<U&,)XHJ*":\<#NPJL#90'69?JO[I9>CJ/%44#?,9E'=.BS&B
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M7[2EH8[3"EQ,M>]00N^[JWJ+PW$5)!PX<Z(@-4@<0@-&.R#4D[YRF'^ZU<*
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M2M:L%WL1>0>4 E4^*)6E#K3]-]=.%<'93@]_CB 78L],HI>IPFVY^JWP;V=
M[% 'PG-_"7#N=;5U"&A4;L;IL56R,=YE*B(NH/1EFX9T:O:[4UQ"Z'(7(4##
M6#*6?3(QJ$:Y("4VWL7+:*C+M#W#^#(EN<1\?<BVL](UE!3'8CQ$Z+&"AWO
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M_+',@Z@@6\M>, BRPW2U=LCM-W9\J@N9ASZGBK?[J$%IHZS&,?5*SH:#97G
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M.+:P[T]SD?Z7N= @WM>E'*F,0[>-+&%B"MA"<"<@^T['5=NG+<&NM^AT'MI
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M'AL:B;A. GXS$&V).R/ U J]X:6]0_96CV/IB4M&:D+ &/_80,4?=ZB#"!:
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M%U(9[:"!V5#B&2BI9(#R?Q[L&OF]TS%,+G\']6 ?24:"+F97N:H^1%T@5#N
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M=6 >S/L!]R.3/B__ZY'O<=6W+Y/FXP_*C:?OE[5?V;-Z\0[.9_!G:RX3W$]
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M^.O/[A@5\ST6^/DKGHSBU6S_V-A[LB:8$_:1I\Z\=H$;1?JSZ8E(>5>YK81
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MCT[.O#8J33<M,R(FZY1$@\$MDUJ#UMVM=:'V^<Y_YG/FIX"M[G3N^NM]SA$
MS12UE7.7-^_?.*N$>/^];$O1.G)R<LPE=7U6W$5\-/SJ3L6@%"ML"Q)?[2$C
M$>>^YT=W4*N.%I0\#$FY(2\96W8KCJY8/@B]"P,6=Q,FK@>8&@CC^#R*4]>9
M@%1</O9MN2VN)G)X6,?#S2GFX!,98XEH*W-E@"-<A96NVN[_2;=_'1RXAZP>
MV3(Q/3^>KR24[G?FRIX).X<&5]B==@^)C59KQ*G]XC/5IJ<MU#->5N-]KK&U
M1K"7$;-:HQ"#[Q@]6>Q# 1W?(]U%/&37'IK81=M<_08[8 *@V8# -@1V6B&J
M%(\L"HXRVPMX7.<3]]G#ZW2(%K;0Z+@C[$:0<Q^7*.G*XRD^3S$!4<O'V5XI
MRY;3HO'^=MG1N])8@>*[8_D6)@V=9H4N[)>T3F5$1 KX3-8S 4&:TS5*;.SJ
M><_0J=[*;,EPQY(2 2-V[<,>C\G0IG*^8.Y6C])%4>W,MC%9&729OXMY"W>T
M,6E97_H9\BQ=$[;2.$:PJ:G_<E5N^UWX=M<YJ+(:\@:<1> B*S"6^;%9TI0Q
M^3-*A0:^30Z*;W[L[+[F)I]G@Y)8Z< ?C8<P([^'H,%?7V)G?)T^"6":U?HP
M(Y_NH?1I+J_IYE6#([?J&V)T# <,AU5E5B>Y[3M'CPFDUNB>==;]71@K?^5#
M!;_?C_HZWN"57GG7[_&#CAJ]-QS-4.>R+(5=U@>%=*TYR8@Q.J?<R?CN1(N[
M6AY,"R(7&]%<J:R$0;+4<)9$T)VJZ4Q*^MBND<L$@K=Z;B*C$-*P^"ER)E\/
M; _6J[8#N1]F-E/OD_2J(FI_"1BGK,6CM(A8/A._6:$-_Z[>)Q1))^W.*W*G
M@"/?=*;AD=#(,"Y:[U4TW)BB12[)5M9(#W+C/3+>=OS,Z))&C5;'^UWXS8&5
M@%)5M(YU=<+J-V*@"7]QZAV$:<B>4C#O$J4PTM/QFZKO'Y&+O*#[=6IA56P+
M4Y60ZG>?*=P6Y/U,.J[N**%+'NRM;]5T2Q@V<3;K\L) '6:LW1G)XZ8L53^Y
M->[SC=V!"?PR_.3UN8&-O!9>M5!%'HK#'7UR]\4/_+,C?97@CHAP56_%-HBR
M76.K%Q8A379)435PB%A3R;@D%OL,2@8:X]G#]8J)$U5IF$,H'2_MU*=ZVL"7
M%DZIJ(3%4Q7M%1<KVE]; %8<[X66_NY+#_ZK3N>#E]-*AVPP(V<!V]Q_@EV(
M?^E?4R58P6 [8TIR\A@\_HPUM2?3>;W[P^&6U_SY1V@2([GABHM4C=V[F5Y.
MSB5IU/X2"T4=+2N+<$T5.<J2>]M_@BP;"6@$72\G.,I\Y'PI],OW+1G3H>Y>
MN21Y,]B4HY#K^PXO [O-?SP+_I;5:R9@>[H'GKCOD,/WOPTS_4M_Z5]5PIR8
MY0,P\X[M-N"_S;7^2_]OXF:._AM02P,$%     @ S81Q5#BV^,.QU@$ 63(#
M !4   !B9'1X+3(P,C$Q,C,Q7V<Q-2YJ<&?LN@=8$UVW-CQ(E2+2BS0I@O3>
MBX!TI?<JO4EOH49 0*D"@H("2D<(2)<NO8-TI2<@O45:@)#\\3GO.>]Y3_N^
MOUS_=Z[KN)([V3.S,VNOM?>LM>[)H+^C5X';FJH:J@ 6%A;P"O,"T% R0 7D
MZ@0 CQ\#W   $  X6#+ #4R+'+.A&><*X&#:6)BVY?N<W]\ .P#<GMYA / Q
M^X@QV_(8  P[?_WVC_R1/_)'_L@?^2/_0T7)U];3P=:31=WUZ5-'7U=[%P#
M?87]5TU!B:D=/KW"^9=V>UKJ7VUL83$ 2$O[>_OO]05![N]S_JDO_L@?^2-_
MY(_\D?_9(BPH+"PM*"0M+,HB*"DMAGD+_H?[,)4(X O8 IZ PU^?+( ZX H\
MQ;P<,?M= 7L 4YD :"@1NXN_O[>T@("G'[^M@Y>=([^]EX< R-9;0(A?4 "0
M50!YV]J[._JSV#DZNWK*<1ZV='"RN#K(<9J(/19\[*WLZ.*J'N+K:!"B;6@?
MXFXOY<"I($]"* N2!GEX>SCZV[* /)YZ^DF#Y%C_.KLTIOU[MP"KO*RO@Y.T
M_D/5O_7 ;,FQ_FTL04%!_$$B_%Z^S@)"4E)2 H+" L+"?)@>?'[!GOZV(#Y/
M/[:_G>"AHY^]KZNWOZN7)\OO;5L[KP!_.=:  %<':2=;)S$[!P<Q/CM;$0<^
M(2$'6SY;!Q$A/@<1$0<),2%)82<A.]:_J7>P_Q?MW@&^3__2[6 OX/C4T</1
MT]\/XPTA 5:!_V]U8EST+TK_0_=C;,3TD5;V=;3U=WR(@?SOJ>83%.(3%C7\
MYZGF%Q83EA7X-_UD!?[-0/\/>$M>UL%>VO[WF+Q\_TF]@://_[O9?NHJ_^\*
M['\R%7/DGQH8'9@%>//F35F!?ZW^W_M#X&_K#]/ZE]6*^27+_P_R1\D?)7^4
M_%'R1\D?)7^4_/=2\O>*U]$34^8&8>I9] *@#.#CXN+AXN#CX>(1X.,3$)(1
M86H,0BK2V\1DM%3T=+14M#1WF#COWF'D8*2A9>5GY>"ZS\/+0\\B("+ +<S)
MS</]^R18^ 0$A#<)*8F(*+D9:!FX_V\+^BM 1H"32EB-C<4*W"##PB;#0O<
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M-#:FEA@[N7;?%GSP%8B?S)$R>L,;)-AC$LOTKLS (=#?) 4-=,W/@3>GM-%
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M9W@'<<D7.96@[*K>A*MAB3CM:BWJ@'E'X2RZ\+G(Z(M9SI@P1C",9RL'"JK
MQN;=$R0XH)G&,/HY$OK7=SFMMOR<*#XFEA,\60N:*?+:Z6]T/18;RW*7S8LP
MU5O8,:3?Q*2R:Y[N8['&T:# CA"N%UW@UJ641K$"6)+!%7[77-"K?;5DP5?)
M;^T"*_$;_! FB2";AV!*4"K?O8RNAFWG]/(G 4@-%N?E+][?08;ZY090M<:W
M]F[?7@N>!+Q/GH@0_)A.FB^HHQ>0CEF9P]W+]Z?"M#S'2P:Z#(%!XNA;>3"Y
M7CL;I,"WXJEL'H+UAB;"P$>.3L.!BZ2TEW:M_5V7K[,%XBLJJ>(C!9-U93Y*
MVA[V_X)D,,B!)%3,"I+6A+YS?TN^7Z9JU0'-[.\8YO56^C6VR^!2E/5]E8MQ
ML))('U%?LF I&N*1V%A:PF2O\1/OTEM;_DNY I670\-1G3&<6L_/FVK@X -%
MR@CI4--*+!/C5+U!:'"91=%@9 9;LF(&W2![\G7SU:PHUY2AE5OS!:/IB#6K
M:='S[KH\8]2Q]13LX/U6Q%+QDM+2<]X:;$1.?75^F-)DP+XYG_0DT<#&:R$#
M82YK+,X"IJ]S='"%[LN(5#]'O^*OF2NNR^SQ0C%#J^NW5D(_K,5/(JR@NW3[
M4U;W5JT61MGO:I'R(@O>V\O=870WF^B^(G6GG$$#(MG)/,RGX^7:&@OATN!N
M1K47K5[%(*=+&2U$96&F>D_!H K+??8@VRVWS"HXF]94W8+%.]!Z<^:V;$_T
M7<*J1]6;#"DA:R@^\, /#S1@C6$\']N<03*=4Z!/T)]?,J UT82_;IFE.%I>
M15@:*1,IZB69(0<A;]>8N$%N]R5J?LF)=*($=:@Y?E _=IOME<"^=[10F^RM
MT**/2.D+L8GM"/+?%YN@LP!]MM@)QS6:E)5Q7953,&Z+W=" N?2\<P2H"&@C
M4Z??7YJDF74&P/(HU2@GTWW")<;OTLU+IZ<\D0XU]C\Z^33]>NYK$IQV3YL^
M1MIWMJ)C7(>M&0W$=+T[$E5=V#VK!/-ES("\^IJ=7VK$+];1/'#H%-"74SPT
MVS_J[B[N'S MH;!'R<M.M2CHM%R:I#?.ATG U,@T4*FVOH;2)W:0E $T8#XI
MZOW]^0R'4R*WW3$Q<0&OEG["/AH@3LEGG)7\L?[DQ8=,)TD@)'NU7B>!WJ.H
M6Z7XQV 8Y>J S;#!R6KZ!>$$(C)D_^C2=5\+YPO9^EI.(B9O[D:(;<@35T_4
MDX0IPFZV?B$D?];>&S1PH16X)I^124.J;;BD&7^VY>\DN?.MBE@.+SW<)FO1
M%&E5DQV@=2UNX2!G+?7P+5*0YUMT.4O $\/$6/PH.?>7T^W4+D&IF]K!%38(
MS>I4A7M2U^XF?:I:S, *I.7S_1M]M 'SZ@:7%*;3281I\05%8Q6R\->V^J;E
MHAE35D$=7@/],RANUTP)DELY'AP7!M$LX2]TJCLY?WW*S*.!L&<9GVMF$@S^
M7'NKD=)]XXL X;RK23M+%$F@U[V)R,&E.NJ]FWL\4UXHFBV:SYY3B0W:JGIK
MKP9*%F,Y%2*I?NAG4B?H9D>49,3U;)A^::XKK&AV1=F4?>^4#1*?&"?"\)5;
M<=-DJ9:X'4E(ZODTVCK]=-%GO&C [@5#^IS4:% F=7Z_=D,=2:LB><\=VJ4Z
MK+S)=K\:#!6(Z;@.L-DT7=WJJI*[!'?*B%A:62K4U)@$M<U<,6O,"< $F+?E
MF;,@R5<M]5<3RHEW3YSV+V=6:-U)/B+,#PZH%^0G&!0.A?K 6.D(DP10D.J;
MGER6V/X1GHVT7T/!W 5I$1W3TU#OB3(:_>*!*>'^Z0+);Q_:+A@'$%TM%Q.W
M5FSJ_3#1*J\[5VJR58TEBOSL'#2>*BZ\<I ;=S$CU4X+"M1BOL=5'/_4QYN#
MH_: =/B2\->=%Y5U<F[JT6\/*C98I)D22THA4#62%X_UC5V@Y0DC@L*)U22:
M I=[]?*)F2JQ-*D(0_W^+9[7DRAVE^:&,JI$H:6>7VE4/Y.4O$4&B=6WMRVH
M+Y_-A+$W#D>>)2BMW^JI8CN2HCH^;=;@ZU+!"QN\8[>ZQ@Y/F:WN@MH;:>CX
M!VR8)3T2+6LV+W/?K=XU[^^UDN[;_C@%L=&=]YX,SC6GV//60'[JCT/=<YT?
MW3&W6JA_/GF[.M-[JW]*DE8A1J4XC'<".H434I+E$[A[K)E&199W]@#55,4S
M\]1"?;:RHO' W34+.UDDNA.RK=LUJWV[;<X@@2QQY'.RF-M"QLFU#(KW4CR^
M*'^Q;2.R9''$CWVV>J!_.@,'#4BW6"L;!\H7"^O'I^WHSAY6G"Q1;QSJIXS6
M)ZF]?8?MB1.9R$1ZKRF/&%32=9E<DYDMGO:TLLBX^SI3\A<P2*>OXS:)B$0#
MK/>*4#O@+7=KQZ,%E%J+P+D#IE2E;R.DM)>5W3@W0:90W$DHTV+4?*U?V_@X
M(% NR&9N7U:J.&'A-&--F*"KYT,U.\5BBN;(%!*<;[,=9!X9#/E8SUW)^8 V
M<^S&,VV-S@HT$(_A:%PJ:,#&%0U\J ]NC F3DWA9[V.7=J'[Z:)6P>J3Y&J0
M;*21,HFFOUSA4B(\*Y8U64BW,+UY830'PPMI6<P&&B?6TWB/#KVI7ESB*HPU
M=Q C:G7@<BWUQ5LE*=<.Y.$_F0JF0^>$8. X:9626$]^_\(TGG?JB4792LM/
MK+45UXI#[+YT8"UK.*]9R?: ,I E3)^ZF5?!A!VV<1"5H;1:56;+?EL?O9*7
MKF6!QQ=\*:#\>)Y!^0^CX%LN:3*RV?*Y(_V\HV[/TW<G6VMA,3&Y>3 BTSV^
M)_6J]<3&M%TW@AHEJ?;JUVUH%-8=:M% %29N?:P/D:33F-6H[1IS[9)4G;0H
ML('&IA;O,-%]R40#.O5-KZR%X[)Q??%Z) <9I<3F+.>W(AAJWQE9"<\N6GSD
M/3L;J$I^2WNC:>5YQZ_[BVA@[A@-;-VTL)9& ZG,!FB@4AD-*%%1O<ODZ&R[
M(]K%U2U@I&^BYV67FPJ_HSH;8/J4#]H:;_:28++OHT9?J-!)94TKZ5?,1,AL
M@T\7+NG/ATR'! M$/WZO**$QH5+5+VL.E"R+X';179+EPX5_[]5Z\<:+^8@7
ME?%CF+6;: #)?=_^A.HXX!#YG%]AMQPL?2F@BXDH'G/7/N!U-S@(I/_SYRZF
MC._GZ3?N#=5Q/?/PZD<FNVLA4O-WY@N-!?N#*(;433+%;GX=9Q=B*RG2G4'Q
MN,Y*>.#EN)Q#;]';B PKA2??5+ T25LH3%MDUW4>26W@OR6L0WOM/N>/R5+9
M#T/4,DJS[K4%W"E1XV;S.E-3DF]"\N17,I,HELCL?H-VV]<2.UBZFHG-G>R8
M'\WU/%;HH4EP%"6Q]T4#.S.+PDTG))'C4 V8P(M+SSC_V4RXV/40@W3!_D/Y
MF,_!EX3PW=)[DZ=F'Y:-W<VR),HZB2&)T:=4V_(4""];GX+^T,K87(O7Y.RN
M=W7C514'=H+'BZB\OX?HS&MY=L;VK\'O3T19#@=B8BJ?JP+5R=5"3[1>32B5
M7Z1 -KMN.(*6Z70%.S5UH"HOS"B_,A*F!9&_Y_R2P.5'\SX;F_R:))+G.Y(D
MB.,PRO^'H]T(F]#Z)0\5<_XL;:N<I)+8_;VQD5I&:X@9%$X_I%!0R^^>>W>J
M5<Z%<[IXH>5 M8 ?#2A:/EJA934C:)S(F9*E:2($LQ1_T2'?%7%'L7QI#>1-
M_'G7ND67^37I\?1<D0N8V/^%_Y>Q6LHW$KXLPA'P#'O.S_-J.F&S'28?XZ("
MZI]NFBYZBM<5/'<3LK)!BBR*YL4W&^W!^)26+6[T8PWC*YZRX408+194O*A,
MI#-U$)3"P? ST%K7,#3)7+3!.50KAH\L0IWMD#]TC>VX\ACJ5,5Q'E=<DY,@
MEA"C!/[R@R4"1P(:/TX65US&/=T@\=5^MU6Y"Q:!,6,N%6R)B"S<HJ_=/G^U
MU#H1PVN7I)F8F%PA0P^I0JI/U05$>GP(_;&1Y"@4]YW,U,%34G;UI-=;@1R\
M'MJ&!@(5KK'<QJ-E"5&<28?U=.NQHQ9VK_LNU'>C0K!V+7CY"":3S/;M,\V2
MQ8M902'WK0^6-9C2H0*4)?%U%Y7D,Y!L.G%AFF5I9Y95,/=RA0(1R)J9R&S1
M8F%10S+;ZL(;#P_HIVJR=K36#MH[DT\@V6]+#&_LG=Z49P$/O"P#-^==TL\E
MNC2[N\V-N[T?>)+Q+:3FXQ,%!GMXE?-_$6<?,;SWGDK;!@]<M,X3%MMJDCJE
M(<U(GP5X[>71S-<V?/<D3>64I/6,.Y*L"JS*0YH5Y5#T!F561Y76!*?:US2R
M_1I3(#R#8)NE&!ZU59;P1#8S3@FM\@B07$:;K<$*"XSE'O_23'Y7%IL+#[JF
M^XHTGT$N+#R^=^_"UD9:EQ3.1!F!K7 ^XQ-T:5L]X3_\$H_I2(,%#?C?+KB@
M0$PWINO \FADBL.&=U]51R-9WG,A\12X=R*X+=2<Q5,\@![O!=IOS \>, ^U
MN*(V?TSL3O\2HND-#3/X82;0@>P0L8>2(B,#2"\1S)<D029S9\V.[Y9LQEXI
M,B\'*6QRSG^Q>:[P"W=:87<5O"4V'J8W6]@&9SYS4[B42TLLE:5A8T<!D1=S
M.%M73RWS0_VKW6]F*A55GEDW.ET?]BYP%?/8%C_VCBX8Y$I1B"6AMJ%Y6O26
M#Y4EULQ4Q9#_*(*62NWK,E ](_I\1JPHV-A)_A'W3]6)/@V&7Q$Y<CN-*4A2
MYX\_[A45>JD31W+$O&T8.6')]5E(WS;_!)+ C'^E:637Z5/*K.4;_K.:A8-K
M'8//'?73>Y,'70&Y-_&'=E$@^6D;&PO7!OVEY:'/G;>'9<"Y]3\[",6"66:=
M)W->QFZ(L H45"$244HEB,9R&6NS;:&.@PG9"T#.- TOXAGS6%-[*:IZKZID
M*X1(5 ?[])U[/2;30;0:P33[]E\<:R8=<EE P??(TA&8=%>&R.N;#WK92B$K
M&-O88L;F%*7\/FG)\/R:Q  1OEK^.&390\W8.-0?S"^9$7_(<D.#[;VO=.B4
M;/"J:1W!&[W)X3OBX55W&AX]/.D\X*D1[.JK>>Z?)ELV._+)UM$\T#LM)$"K
MXV1 G@8\L-5Q>LAY4N44I%[@RN[X4-<L*QG +KO7Z@P-0B8G8+C-+[#F-HIG
M5\>]V,+56W[*7VLTN87FPR4%)K'/2G[RK+RO&*"F;?8B^0Y_ALE$Q[<W1@A(
ML=FBJ'E Q9LKD+#7KV_7MVXJ9!C7(=I<V8<:FPT_J^H(,'3]GJ^X(S30:=Q^
M-S;TVB"XX26R+NF.Y]E73LY*@*VDJMX%=/PU)# CO[VLH/SK74?R+LN:#'9^
MU> Q]</EJA]0-H/O=8>+HW8B&A.@PLGD?YHS]:E3(BO]/IF6FYDN['3&-NOA
MI/7!>;UHX.*F:\<IYOMM,9)CACW%J&6*<3Q#U-KM_A:C.CZS+E@SZ%]W*BU0
M^PZ;5H D58.J((Z>D(J3#LBHPK]:NU.@E-YFKUA[FX9:#=EHH4[:8<%3N6?C
MX$W+\2[FBQL[S*='"B?TT%8?V48FL>G$$0VS0(&:9\#U_2M<"QH.OE1FRUP*
MWA(N/NN\K._,B?<WGK@DU<[M6Z(L>*J.^N/W6@W<>3-=V?4?/,B4 B[\WC])
M+HBV7(EKI8+RV7=_&[RUFY4M)CQ4^QFTF*RHZRTUKF>Q3'WTG(DJ&S&_I"$:
MI")>$2\<&13$&''^H<+]VB*C]%YA\@CS6?1[1V--W7!(<6["J30W5W[K\8)\
M*-P&F739>!T^B*E?Z,](24&A*N^ZI2UK7:G)-3C>/SHX&] B?Y:F+26VAOJ'
MOZLL,A4H3B$*.@VUL;.=!8TO[93@3>Q<@//F;F_HZ;9AN29A%IR6]S&Q_+WR
MRKJ@[8B2<H'8$[$GPP6NJ]&O5#[Y7!I:L\(Y2F*?PIHZ8F'JZ^'/OD9^]LGU
M?5"IUJ5PN_YQ:,\KU[F&65?*3YO^7)V1A#J!\AGSN\T/I0\2?$H6O3EL,JK/
M:7U)-ZT-MX=R5.C[I_0AQ*I,!ETNU])9ULSPC728W(,?9I >D:>\^?YZ+8P^
M4<$0#W>SNF_^30*'/YZK/R",YNTY 4+F(GLY#N,"5M?.30(-GJ1X>ZM]0P-L
M5O@I8>:Y;$WUL0.IKL1N/W6":1U09OV;5C5?.8UE\XAD0X*G,YDBIA )*M?!
M 7(T#^#+[V!R6GO&U'/E+$H_BY*4GLFIV^_<1['"^[*@[[;V!6#-:6:LY"D<
ME,]NLK60*ANV,X""KNYTPPZ@0@%A.$FI0R5'*7,**?4^:("Z8_UI \;-E)A\
ML5P=0R\FQ/\^4'K7#F[H35BW/[8_52 3K@6[E53B&GCN,,C[1N@E:Z.NQ.H)
MWQBN'SSL24SQC7#ZAPFR-99X+.'B*9NF$7A')DCVF,-3-1][LE\S1NVNM+>R
M]H!><T3TZCN^6V-\6NK&\=@LR>IFPQ[LY 2<N=]WMRWZDJG%Y-)GWOOU.AE\
M/'UK+F0EW2&GHS-9;R'GKI-\KO-:BPCE%AHE0S\"9T[T/R0:Q EY'D0NNUKS
MXC8#UFX:3Q1"IZR5_K3O_4A8^=N$F), #*^GN#1$ S1H8)VC&)/[:5!VGTU-
M*W1J,OL=:N\/"UR.B*9-P:435E[,RS5$XQ61#_,L4I-9W*9"2+*? J''R*-V
M,O@DZ-.EN\UGL?)>FJP\"1 ;2PBI^;' 39#Y9J]Y9-R("\1C3G@X<1_GJ&#Q
M^'*N! 'NS)0GZVB>9FG-@KD09KPE354DUE85F9JL;..5X_H27L#+Q,G\\KU;
M"W=XX%S+85,!C)G*-9<^QARE-/EEQ%M5>/\PN7MQCGZ%5E?C^01M25ES)[+!
MA"@T( B61TE'N^'^HTNU\.C#>Z[+6SPS?"@:1(@,&3%\5'1!U5-V$I*GBX\-
MQRN;Z(;"VAH@6?TTR?V&Z5WUM)778#RSH\V4NH[;8WS/0K4:KJHU%4E1NT&7
M/E8J8:>0[4F$5\\<M<^C9<>*R(+7WC[/AB*^L+8%F<TX-B/LQ8NP/=)".>P>
M;)D"*R.SIHF\=K#M?;9R[+?3[]U4F\\_@G,2K]UAF6]*+.NH;\M_V%)W-OF>
M=28IA:P^_23>0;.?ZTB3_>ASGPX?0Y>2P@U<;WFZABD!644OO":)=*?U X\%
M59^OG)_'0TZ)#F/EF=H;24J"&YX.OP85"=\_O_MR?%7%2S^3.OKW#8M;S!19
M]A3EJK]O"?^\S F'C 1EOEK\NI"?+99*^BDU%;G[:B[BGFN(RM3\O-+YL:IF
MDRIAO)K'XN8156,P]A8*[TO4LOZDF>O(2Q9:]D(0/F.S29R+[G?+W<QJ=PI1
M<6U$Y@.?R.CD4.)5I\]=T.WIC??UZOLCU3-;H=*&>T5\"ULA5!U]!/2Z_'7!
MK"FR=7YQ+.&$*9O6D24KG67;1];SXEO.#[;4.WM]@Q1(9,7 +G=TR"T.+ L_
MCS@8GU^\'(?&;_O+\;HT<U2^YSB.:?8X)MQ?&@L)W#6= P51;M_+FHDRW1JM
MT-(6GZC:CE"C"UWSPNLMU^07->#KTE1>#$]FR\1/3_.;;>EO><EKOI?^DU=5
M_\&FIPBR?-/# J5LTG$*YT0]=U\^4%C7?8-JU4$E0."&;(^5EK1E:^GT6S\=
M<Y0X[CBXH $R?P]W0ZT[H(/\U.[;QZR?; VK!XE]OHIEE8>93%4<9#.*CQ[.
M@(2S9.LY%Z)TUGF&GJYF[US><;<YG?KR$F_/H7HA\6J3:C>3F4C4I:[C'G)8
M;D%@5'K Q!8-./CWSRG$>!C'TC]/SSG=\H56-R6+WQ*MR-Z]#+AWM-F3I&#5
MKB7S@KX/IORB6]+1;[L%.Z^KA?NB6[<N76.6GX]H0PM#CZKHN'U2+TS:*@L$
MD*S*^BQT[=UGB5A(:^O#35.[HV_%:]RA(HT\_3.5)817/0-PYAY&@>YS/I?2
M\S?NYP6)S\KV+.:^8YMB<@<MW_P3_I-@NY06%4F_B]L*.3Y,U%/I/4R"=?4=
M3OZYJFEV.@+/3!.OUDZK-. ES_U-D9P!/JZV)!6SU8?)ZF]<)>5(*\-W7?6Z
M]5Z[CHJO&"3G"C#'/X=3%A;0GC1ZJ/]^JMW%YGB[% VLU/U^4K8QUC"78./%
M3W;=H7!%.BHH$]$$;ZMR57BTK@1A$H5P'3$63L@ZDY#U(;$&#EGW[2[5CX8A
M@"#/.SK-C/M<W7[?AJHE$Q]QZ$,@4Z?,UO_J'WB>&?>A=@$T,*#U&$/,!9"]
MO*3PN9&*S>LA&X&1=*C3FY(=<>D$-VKQ.17V!\4@H[.C$ >3\'_[S$TO4F*-
M4;GK:)PICZ0N*I!X.:2Z3TZP>[:AO[<M2';>]3OFW'\]T>C$1F(=8/GAY%2V
MXI9M5%%<(C>?R9NL7:%>UV(SJB@NB$>^?J_]@T\%99+,.2#\%P%E2.7*QZ%"
M=HP-/7F+VE\QI>K>,F\+&/&@ZL#^@E[+.FOK#H"*;77O.ML.@(T*TZGJ51IX
MRWV5ZN7%,;27KO*M+6L:RV6BY_Q])U?_*.A91=T[@LIZ+?^FCE1E,NZ?MN-'
MST(OLW?7&Z),'^IWW^G!NR%\H^"H])2HLV0[R*2R97:9YG6IY( 1)W-1\!R2
M7^ R$KR^B09L+36IX'RC;B&_RJ.'864:"^M+UT^3BZ^^FN/NKYNP3NW5]$'1
MP,0+E3"&U4JAE&(>>U,T\(H1#5R':F#JS6QH100?Q_)'+Z][B79FA8;\C3+Q
MZVN2\R(7<WX5X(%;: #55HA)FH^Y7T%NJAA=D)*:$!E39-(O!QK+ATZ1.<Q
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M:JSE</4:<$0^8.?COQDJO%D3'Y\^^6RTE\"(MHADTR0\S\^H0J10V/!N<"J
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M5Y;J-KM=Y6!UMW?L8O)'R/2<15 OJ+]AWG&E;.8TZW:XO7#3>);]P!.&AFN
M)QVXA7P^LF.\1)/G[HON?N=QOBK60FE'7\^1D]G%2T(CZ)0NUOW4Y*^33J:&
M1$E5'9R.C+(4.3.^&N;+G)UZ_'5YW(KA^' 316.A5VU_&9 W3 -&AQ2W[*Z
M,(1ZHV<G(;CY?5+$BT)&_]F"?^JO;GVDN&';L7@+K(/*D/)*PBH,0K MN;A!
M&?1M_F,["SCX-HF!;MUH9.YL.1:QP[DO1A0;8C]_2G))<3J,.L5)@F=_*B#M
M@>*\5X..NP5KD(?0-2_<5)5J7 .VA!>1;&S+_LT2EUJK#&>CN^^1N$EE[NK!
MN$3_$7**2'?<38AQL^( /;4?Z[3]F'>,#@*4?9V$K*!'5T0L[F[==;H9GC'4
M'%^6X:>5.;","5B!RS,Q=2V]=>H%,RPC]1RS_/1J0U6CZ,S@*ZI?1GA3R'0?
MQ,RMX;)"53<\P:O;[8ROW_D1PIU3L_02<FD$B6#QEE ZK(=@8E,0;K3V!+4'
MH/,<YV;.(Q8LQ^2M#OEUA?#U#M*UP'1L]E0A6@:!3B8))9@9R9D?\_[!L1-$
MI0,*!47*6^XYV:760C==7W(UUR;7GV+)L;I2JRM@=+1GRT$/SD&X?1QQK'Q)
M)K1X\8?[[4YXPT#'T@O7@ 8&[/OJ[1:<S:S)C4'GH9C[A<Z0@W@L)";7&#<T
M$HOG%]CXJ"@8>QDC*NC_H0.?_0\'/O[+@25P*54/[;5345;2&,J P(F2WT5)
M\$9-%/2#NS2M(!$/"X0]JG].&<7.@& V:5AI EY9MU],VC5DVPQT=:N?K9GO
M*(!H+L]KVL0FL_IX(M8&LZ1X@#-C8VG05NB&)^C.:4:-5Y3J)27_;\7/2EB1
MI8"4%I6ZOW::%")=LZ\!5EX*U'0>@UXO#V.&2.ZB %":]8"_I;[EG?2QQP$S
M=.1.V [VROG?+2F0S+\+ S\9J#:Q#Z7U0">(B46_?Y4%BAE@$H\2?2[.BVU3
M[%OQ^6BYWK\).@/@#"'G*:W%V(YY6!['NG9VO2,R/6SI!\F'TZ8FJ4!M+/./
M:#Q("",%_ZUAUPW>TT$G['UD2/+M9*%]]07]_=&PL!7&'_A#<P\$! \7"I%3
M/8J=HXK6UOBREH\/9:Q$>^<"4]UH3S?*HQX4=IX8JBYL6IQ(2;:ZL!V*S2QX
M5)!TO %'[2$D6'!^U'Q?]4C2$\TZ]FY(ZLOYYA@#MGY+AMS+YW7$S/RX)?E8
M?\T]&03;AN,(R5 6LCJKUZIJ8N5E3V5O?."%NK)F0!TS@GQTW^RHYKBBX\PN
MG*,!8I^R7HM^^ WY1A;Q\O4.:QPHC>%ARYI2"K9!$;T;C%",HNP@&[3UOQEG
MH()]<UQ1]YA*BO8&,4' ^#"%5_-)U\E=>Z WTX]@ PB[RV#5 ^.*Z7L8(&^1
M-FH*A.L&^#R29._0(J/)_G7<7WNHZXY<08B8W^X]OV^##FL*H7=;UMP@J(LX
ME)[.D=:+V O5(*T:M4'KA'CB!A)H:_1D56J\<R$FRD=H78L].5H1VKLB);WD
MH-I9[[HP#;:)R<YE8O6X_QEO+V]<M^S?.L 2*=DM@-1=T;$)&+65N=M-3$4V
M$H0!5F6L'"16!-GG+2AA)M7R07S@XZ(2+B-K&V"6%+?4#S>M$J!JZ0H2V"H1
M&NH^!LTWFJG_])7\C15+7%2=AC[H[VV;]='XR/K=+DT[UHT%J@?3/>N?CM4?
M>[B (0U;P*2_*U.#RN->7?NBUX#W/E3Y(U&Z"PS+CF<5?YME"7*VE6'V@D!C
MC.5U6<V*W&?TCZ4WKM-+YF-Y*@5_?>ZKY]%S8]Y.T7/1&1_5FP^K;! 5NJUB
MF^($IP7)16<%*HE;]2[MUP!KK1 VZ\L=[[.-E!(OJS.#%6 X=>#E4\UG( 5:
MFM.,T&;ANLDU?T'=-Q?\N<C<[GLPB: # 9GJL%623QXTY\&L:>;FHH<J<=RM
M&I4$4@"PE/F1L.&R;HIP3Y@)DH/44*ZU1HQK#N_2 DL^IB_QQ9-SM%(Q+3BV
M8S4+?%?&I@F7%[D/?.\_TC A.P_]7X[W,6E;/B2QJ?2R5DUT8&I79JD,2UOX
M363VZH%R#VLC].]5YY(Q&2#4VE8D$3*]8/W[FY(GINAQ33YU]Y"$7M.G/-T<
M=D[KKC?\5#Y4R:7-P_T8L$KUJ%L#-7J76V1HP<C<CX]31.:;SLP)_]&G=X^K
M!&Y[,QV"KIZZ+P@<W4!Z=L#GGC#8QEUX[$ ;?3$$D(')QH+E70[V0;OAG)RH
M=I74/.5M.I-$7#P=P++,_YY'=CM6,"[>X=+J)5ETGCJF8@AV]7CXPJ' <-"3
M).VF2Y$RA7.3[)IN2] IVQ%;V/<0HRI"O]U$ML*@L2.I .&*(]&.CI>321HU
MT0[5A]Q53C^(LXYV+Z?JJ-M3HNA1T\B=^,*ICT>38RDH# FD]B?L8$8RW/.!
M/&>H(D,G8:_P&O1?Y;>:9G)D^'!UG%P]-)W4HK9OI^XR"<$&"CLMAH1#CD4,
MH5,PZ):C20!-7 YLS;KNBYEYV(".SD19X]^2#1KF0(.DV5*2L8KE9ZAT)+C$
M-W%=N@90SWD96$79S/@216U\HB67%N5='RX!KT)I21X6B]2\ZKN5JM881CBW
M/_*  !^0,53E99!AL+GM^Z5'(!.3LE=V:#")4<+2?/!SMU%\%OOP&N!',_.W
M(_"V.U" JXQV!9^0[1V;LOBO*'$IC@$"6+___:%W*J_7WWUJ%UH'L\4EZ>%L
M(N9O3VF0]@4AHNP,73-^J/XI@$4@<?S(:/P"VTR #3()9+$5 M,6U=&IE$NW
M[9H$<,R2+GX]M*S8:)7U!)_).)97^BMJU/X(CK'XF6#V?"WX5M1MY[/2 2PY
M#PZG0#Z>&#04RU07::]2ASAHXLZNTPN^D&>[2!+7)=^2L.YJ /]@VCD7O>%N
M)#@;;.FZ^P&GZ,YVAZKC\^VB$]LTVUU5TGD5(B!([?I#-&9[\0+'-4C8Z3Q0
MT1!T;W:;TM=:I_;8L@>OC<KT=&V*(-_/Y/-1CBVL$7.5-*1X512]:3P5=J9?
M!;X_OR/2&\UU)T?WF4IJ.>TJ??7&"CVK447!Q)8ODFJ)XTIYQ.&W_3:&^1?Z
M!:)'LSQ9N<KT?-8H-I_D\)4/&1H2NFYTGE2V*T/="+07*G_DN&"H0CRVIWT-
M0.TVE2,;K$8#"VW'NI=<''J=P",QT;^FR%9)R!17'-Z:M-F?6[S^^.9AXML'
M+OZ7/<LFP90FD(8R.LET>NXWVSDX"5?@,852K-R2J*)G09R*?N>C< -R*::5
MC"9M8X!#4LJ(=M2D-]N(L_M;=;FG%4R^KA>AN\:\(5U3P5A*9:_1Z*J;O@E1
MSYP$+UP7OQ$<%6- *_MUD0I%N?U1!+\F?U$QM'WJV; /B;?72LUYH>-+/\3D
M97!JVT&USUKF^J%\HCKC'D1@=D Z.W^Q\<.S9S*_<ILJVV=0R#A9&)(QZN67
M==E1(_>>6D:L\!J]T)&4#/L$T\^::GLWF/3[NEL9J6NK>6/)I]$A!GZ3]"3W
MG8+OC^]+!$W9WOF&E71%3DY/Y\EKQU9%O?R>G0E+H''9"(YFF&A9$_;%X<$#
MZ)9"T\'J/\7L3AR6UB/4_NN-S7E1,QEGT_JB71#4@9=U",YMX:!=% /FGM[(
MV4G/O]\G6AYU;BU? Y;!XY>'?T>^62$0&Y8T4G+?T"]Z;ZMQ<%[DTEP<#>Q$
MZ^$"4@!.X4)<_K0GY"ZU.RA$]UQWOT;_].<HD?0O<_RC;0-SKFVMNA#MF4X]
M6PCTUY'7FJ^Q<^Z(@?7Q4^M:IPR9T5X6U]F2MSO-PD<$85S=*4REW8P2AG*>
M*HIE;,=4Q6E G6;$9.5YBEJX,Y&%I1,UV$P,&U*?@ZPMP3OY_?KA7A3HW&Z_
M@%J<]5O.NUJI5*GM?!7!PF5_N![D:PMBL9W20#9)>X+IV#I!ZN=WQT:8NK+,
MQR6<BV%_,MQ'@VLG>+-^3)0DPI4-[5Y&QK.5BZ_Y>Y>B&J7TJL^3"JME>GB\
M'-]DA7JJ'K9\T4OP^WLAZ<S@N.SO(Z_T K$2EU\V00>:EP$6&7>%FD :%>.&
MKRIJZCF8;@FVE]4&C3$U+"^7$-)&4JH/8WS8D'HQ7J#N%@3,<%X>DW'>4B50
MX[>?XD1RQ29MGW4-".ZZ!KSB1:=> _: 162AG>I%\2)G4GNW)?%5[U/IV']U
MS#K<\L"R5SJ\:*]/J/+FF=S3QDO]+$"P 6P7LE_.W4W4*R8R](8KX/^\:1&@
M<]!,>00XXH'Q3L[-,O!_[H9X$%ZTGIV6 8\6/[*.5(OS<IMQYZFO)\0[DX':
M_:7S6_MD^S]VB.7N=*<+1!5 .W)]!;,ISU]&UACZ?NH5DY(H/[NX76>LBK.6
M$(?3HKK,,9$^6N*=@%&.MCM*6,X5*>XCBD/9:E7@=,!OFU3%$P>OGF_2/16E
M03K(HMRY;5?#W]/&0G%RHQE"A9QKYN(W-\NJ+<JGD[6J>!U9W1H[\,)R!G7G
M)G\7S8Z]&#S-N+RO#YWJA*)(R[Z=15_B+>)HIRH#1526(?19O=J,@&T?)\VW
MGC<'38+6"* XK(-#MUAK?LF(T7ZE1. 4GC'UR5#& W#!3!?[7.Q+6(=8+Q=>
MV5O<"+LO.Z)NX?BILP6MXU7SOTA)75--)^=U![*85SFZ#\]CP X3OYH8.GS4
MWUM*J'VK%7PCOO!+7<)_Q7FR<7?E$!W*!=J=QK5"H<FJ,>7O]W5.FBZ=;&RN
M\,'E.UZ45$!@2=.+Y<7@JFA26]$?=C6YMLSQ3&(Q\?FS>\Z7DP01C0)^O"6?
M,CU\;9-^!<X>XLTQ.$%S/!8)H6MW\Z%3K;AT:Z^WHA")*5A69HMT%0X[2<*/
M;>D$\4"7A,?.PEY0K"Q$G#1GJ=?HT\1$-R<<+FHRA-*SQAG"Z>$HL,#!,+[W
M+A/]1U3,V''I4"-)6_+4.26,N]2XXF9H7PJF^Q!)R]#>=%S'7^6?9ECR=<>2
M*N]3QPQX(2ICC7PC@U+82-$RNWO1Z^LZPW><52[F^!C[85;F]:ZLNT1K[5RI
MXRR@!V7X)]U0FN);,CZ-\Q$G]=B!^[VUB1D\WY&.790!5,G>Q=S[.;&6=PS<
MS:OP4^_Q[6)NV>Y< \BJ'>R5,\"-U16D0P"SF)^F'PB9N7QAI]$D7HJJ58C]
M>%&4<>H4$Z.E=TE"BO/:!Z5AZIYE P@BT@9R>FNL!8&SV=ITGJ""7\N><ZM9
MB>8ZY+=T^TJ:/*4>RXVG*$UQ\XZQ]<;SX]=?,'SJ+?N>%6,99A$9Q/R^O^.G
M]&XKVC([\G%74DW%-R75RYA;5'B&GPG&\I9-BA"'.MAQA']]@Y7A<X?%](Z#
M:\!J-DE[N@RGVZHNRUIE LT$7R4V>30=:(DSG;M0U$[+4'-<60I7R]H31YS9
MZ5U.P=TJI5=/@*'--!F\XY=E6%P V2\[*\L!;MY7GS0&Z=?7?":/)?H*7K*?
M<"N#4?@D+&18<+$9%GVEX"!^)L>RRK@6"\(S,"]0SS9G!\YLRJA^R@E-4]+Q
M<"@;/[D&T+V[!GQ<U5I,O<PJRQV-AI=M0^]7^T-4/V G=[K,TCS9O6GY4,MJ
M-G[:(^NUDUJO(U5E70IC^1C<6UN'Q_$N:8+:%DEQX9YA;$I]W"%]98+JRP*3
MZ#<VEC<(!1>?J.H?:<JFJYR2J4.1A.:%+RB_._Q&-60N_GOY;<:+I-TS@**V
MT?#R6\(!-2%I[+.[Z6LD!CU-R :S?&AEU6R8(2WU[U?X2&MA.%+4Y.<1?>#Y
M;N]*%%@\[NVSP, (=[;)G\X/NR0@C;J*%1]RDA1)FTMG8UM\Z8UQJ4RQ8?'"
M'&?S%$VBN$B#_I3L>%7VYSP'[Z1_'1:[&(J+PTRV+0<MV)")7" &GC%PS#?0
MLF9MB%VX!L!CS+OJD8C%T/4F;1)^4UI.'TJ9YM8;T#O'A"Q';)'"+^X8@=UY
M[B8(.$3Q[T:]U\M":U8E[K8M+VNV+ZP_C:-+LN>!BI!O-A,=:0=0C&\D;LQO
M?' CQ.H_3B(0I]Y=C.(L=ZXF$ /V1L#S1 2$[)6[O^R[MDJ4!F:G/4?9*T3J
M:V>K=P6"=/#/BOY37&JG\Q_M>B5.78'4J[U*!#<DE? \>J1O/\,O440T8!7E
M<6CM#<IQ4Y[PLI5HV'%Z+N:U\6B2;D$4XCV#UL+)%U'L@A9JZBDB":LPD($Z
M@F+N VN0,587 41U_/>["925Z-\O89]M(LJX$*&?%$/<SYIB61,I(K\GO$)W
MJ9-07]RH0XRZMJOP+VJU\"5G?1TKD*;(*#BL/EF$X<*AXT3+[@$80SA5@81T
MG2]PQI[JSZK>,8B_S&'F;? T'3M 345YE6$5,(;8YK4_:]GJ-QX$ZRL83A<?
M% --MX=2ZAW2BTJLL>34/1C\9:RJB?E2+$%D5=.\U.&6_6^NMW&:".F2^+FG
MW>DQ<1&K_($9'25>%@@3I*\1?^\]40^7#R29!(S1&@MEM\<S-3.,7U9J;X]G
M&I<\@(3DC2:LME!0@\._W9$%6@563!]"MV&+02O[H=.NKGE&=\MEUBQ?6EP#
M&M45U^R'A8%7AX^0P0?W%%13\N[$* A&M2DN:P1UC.=I]-OUT6Q,H\BW.-W2
M9FW.2((9HPGZ8B;W<8#L5^+M&09=>SMQ#=A%.6+N3?U$FBO0D(0ZO"6^]ZDA
MA[DA';SCC-0+_5=QT?9C;)I/K()XCKAFF\;'6LB:[P+.-!DE25#G?^J"Y&O0
M1] U-T?4131JJM0&9ZWXY;@IQOUP2F:B>*2(553 O?6Z!I2XOH$N,/PZ'(+.
MF>^T,%<C]:\!3(Z8QI;3XD4JM&C2J^8DS9&O4K_#O$O6WKXS\^;T1RUA_8M4
MEZW182WGQSACKR@.X([_NCI1M?3,!7]65#;CH%8+.59M^2FUP,VB]J,7I]"1
M>E\)0V:[P*X,U?AM^:$T%W$Z/2>L7$#"KLF-([?TIQ7)P*7OY[./?RO<A/F(
M2'MM(DJ9>^C%*H^$(T021305*@8VO,>61)_S =CP,TS:JYO);"N!BSOJ.::6
MI)G,ASBJW>[9-!9+& [=+'BLM#2PON?<'T7O-P)=Q]CYN/]SS.^3__G=$O__
M>1&$!4Q CU6%%J_NX]SO.UO6.4Z@Q.H70*?M(!BR6PS5$'3LH"BV0P.Z%;:%
M20"M)=I!SFF2K@%RLL_H9_^O;J#43ZU2?I/L ^&NJCS 50UQV/ZK*RI10-TK
M7>,:4*E)$FI"08"5A5[R\UX#R(V%R6MKB]##A]:\X^4M)P<@%\&J19)M"9"$
MPT=2T8OV]9;#K.%= R$-?7%QR1HW!;(/Z[ ?_.Y@@BV#P>V&\>*;8^6 GPE3
MC&Y7V3H@I)X)Q37@&P3[4O4:T*6G)F]3I*/2#S[D2WQ(PC;(:=LB9SKCQ=M1
M(T!0"W\S)T$MR HZ_&[O!"B\$8'7BE_]2%O%):GSP%X]0<)N!&8":],P-NCP
MM^6NGC-[;:E9&OJSP*:@J5J^*KF2[ZT?V?*^Q+ED@[28HI1:'57_?A5JJ8*\
M29Y<,S7WD,V% YZG;)"J>:K+?^9(M%6_#I_;233QZT_!]RYM]/'+]IDH89,?
M.Y6TJH67)"Z(./S"8XD[4&8MTU ;3XD&^A!I9.?M/](3];6_"'ZSZ,7<49^P
ME^29;-=XG#8T "Q=W0U^ _2!::1^.Z0T'<]1+ZQ6RFV<Z*]_EV*;_3HG/8TP
M9%ZP&O]A1&HZ6-@.QB$RV\##KV%4H2O[NC[OHY"TW<6^3\*G9)=,U<O2.OR\
M>:::_#QJ%>(C#Z8<,6VC2N4R:75<0)L*;MFBO ;$/<"E/FUH>SVB%G,#Y\QF
M$"QGO1T0[&AXF;'P2R8G^!J0X7P58Z@^5B*40KA7A903.=JTNZ$NX.(M=28\
MO ,E;I0N> G'?-VW,$\4&:YB:%TC:=73DG]I-\2;S*NE\L5'F"E3+#=QYJTS
M&9I]A.QX;%$)5 \O!<F33]CZB&1\G_TBU/!Z?S3*T/%I<_8QE*9!7GRR0,-
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M,9@L#KD4E0-]EZ#$.Z*Q\_/;F9L)M9)$V<8]4WCO\T'+QEZ&V,#_5.V%93I
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MLX"E\A_E:2M=B2Q@X0]B*6[N Y2''A@S'R/Z$%,^A'&)<KBBVZB)[,/NUK&
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M1%]I"YL]6D0E9H[1GVB&5N0C>YTZB>UP!P=XV=0+&^MBDVG'T*H4),P6 EG
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M+73<;/>-AHG>5WQ%0_9;XHH[[D1CBCT-+1_KY,:,*IO?"6NU]JI> RYX&RD
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MJX'F7)BZT1&B5^4@0(X;N@2K]"A>G%N5=D)Q3@ZV%N.<0#SA.C83@"5*3*[
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M,ZO#Q*0R!BBMLBW$+B-7>0@KSP+(CFXL@'0)KJ5F)W&63&0!A57]+$ L@6Z
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MDW9,[&_OQ#=,;)3 ]<E*FQ! M<YOQF9HF+*"!]S86RY^X^8HD)QYM#.)WO
MJNQ3IY:,YXZEN 5.5[W](>2W;/"\6>)2_W#RS%L-JB]8C4JBM['&W0S1]FG[
M.6G[.\K?U[8@QY*51BF,IW:-\Z&K3[_QF:]L1O/=&K6'5$L<=A:76'6[/E7Y
M$=4F)SODE>%]Y[0MR%_1UE.XX0]OCMA>JVL)4!UV)N8??O4V^N@<].%,X4J"
MSRCCZJ^"9=:1^8"D'@^ "V!B7"&W(,OTA5?^70^G% G9&963OU(,D.P-@>Y-
MT6VO2\4D.D8Z$-H\+R^-YH'F&9EDT5'9?0>_YLR3/E"N"BKL_G?=!T>BQ2J
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M*#=TT?H'<RJ<^<<LLQ2V/8MC_YJXCBK+ =6Y6>RROR?!9+V#3E14D:[M6>5
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MUXBWTP;WI,OW<N^)8QIZV-G6X4^Q/+&Y3O1>F*R6]YL+JS//\8!4Z8N.23P
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M;YA_]!BNDR^9V+2MRGS]V_^!,V7AQXTG[,Q;-0H& 9S>0HH>WRPE_3-%@XF
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M?D3.<^#0:D,L9X1?HZ,0A.P#BNW_!CZ\)I'8D/8T_@*N_OKNL6$*#*%\J,M
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M#P;!7Z(L^N> 1Y+WB W21>K_G*LP7(Q@S.NW<VEA992??VCK.GR0LD?=-R@
M)QZTC; JQ"M:)C)-<9(2A.#,L+-2XISS.T1NYWCN0>47(2.*?5\P_D"IZC-[
M$,GED.RQ1^W,8I2;9J$+$;EP^ "^0A?R2W#YRO-VP7"5\79IS\B7H8K[I?V&
M./G$+".CV-W'=QX0=].I_%S;7QJ3O\,T:_KL=[VWV\#!;F']'TFKORS]+9$W
MZUYQ6G,.,+9,A.4K"=TU0'<MH;G1JBV@_RY^3"8K)R:^V2)&/$3P@T,LTN3?
M/']*VB$)G"E:^N\CB)JB.E%R0.\6F;?(8T,W\MA(;-Q"6O^$M/MK,<&<&.ME
M<0,CVTV.0RM=G.U3'[:;*[J)@R WI2FC1E?VW2"1I_GEM,O:_VGG#X)F/.0P
M@4(BOWJ.>8)W-*&YIJW?AE:/WZ=YNB^20A0'3JMOAM  UDW'WF>EO8Y)K9=F
MCX#TQMI'2,)=,KJDN_S8>? T7A'UR,""W_;V=&-&UH.\!T& <8;T\1]JR#Y+
M?.5SIA2G<K#2Z'M$[37Y'_$&L?2NI$/'.+K_)GHXR-6%^,@YSD7Q$CSN$B\1
M)Y[-KJ:K.#Q1?;9@C%X\\Y1:I!;13+,'NO;/%X%/X;M&833?EAOXL'SQ(0;?
M\ *QI_KT41D^_B )R)6(Z5G7RQLQ;>8U (I,"K7EY/R9;91\J&.SC">)__+N
MI],(5_LP5EL8"?>MVUYW#'WPZAD._40&0GV&8%'?IN5!L9_-@N 6&.(%A*FS
M(6K"GV$^>%[Q/BAY_=_N=AN#&Y1!0I1K!CNZW2 .M2JSG2C/G9 U!0<P#N_2
M5[PT*'Q-C;M'I78[K6Y1)"_C1R+WH<G<F^SUZ?7'<$WI#,OYT?9QAA+DUC*4
MUC;[NUR0^->P7X4_V>)_8 9DX!ED;1QV"EJ)"]7I^]I//1]I((LB93YI6VS!
M"H6KK\'9Z\CG;I0SKX7];&04@"T@]R1Y]R)$1CL=]Q.MC75CWX\EB$KH(HID
M&MFX:]D&>XB7N@(R=852XGCID<A5B.V9"D^&%E".NLF;%:3;9PSNM'/Z-!.O
M5),^-4!Y<T+9OM]*S#^ANIRD/;JFZ\8)G,!(#BRVV5Z^86_^V3NH*K$#)G+/
M^7ZCI/3-_/\^ MP.F_,9]4/C@ZGU6W4C.5HJ(>T'>Y-$AI6EK-!%<=E_4HO^
MD%D=5/M;T]^*)#_K_Q4KV?^KBX3COVSGZU#^UV*L!22R?RH_EDL8?3L'-,E-
M+Y?T7W:5,F<]!_BXG7I2H^2TS:?9V&H$"E6%WD[S)OT\)&U9D&R@QU-_JT>R
MB[B'VY,<^F4?@7R-3=R6\WVL@ B^!%'%YXICE^)^GGF4UK8:<Q(;8?3>(GX#
M!>,,,I3V5>W[I1U[U2MRC3Y*B_&?6[RY!"*L?2@FW)9LAY:17K;V"??[1DO"
MC5H@$1@<GB_\],T$8__M$4\';X' 4/8K<^XBU++,E(=E&@%=A8<1)3E1EK^0
M7VZG#_\Z!TBNIF8HU6R9?%DG&+F0O\/*#STU$,^2JF+=/>I3BF,X6W:6&B>:
M?FD9B."630DP&7'K<Z^HE60"LB4V;[(U78F'A[@RPB;D'*7_ ,JU*=5W[9@\
MS<2CI]YKK=P<)/]WH]]:ZQS@7KC#A3XA4 +]Y!?R9Y+V,NA&EE$A#%Z^OZ$\
M78V3A.[GJ91M-:'3#0\GFCWP$\S(<N4N^;D%?@R3(G'?%ZJD(M!(=Q:?7';*
MIM5T."/26\.'XNV9>R*F[C++?F2RN" RPRU?M]SVU(:H- $>%LB/?5D1VZ*Q
MJLKZPA$S7]:U,YL^&9(/21[/^Y3;[NW3PK55)%;K=KDZ8)L",6VG2<9'O593
MD;H>2F1K)#W+)*KA(T/==3NG/::BBM4$BTP!NQBM/0QSQ)WL)]H!YAL9]LWI
M7+>;!PI5G-IM^C<75P^3)F[V\TF\FK&N Q6Q_SI@_E'(\+SMFF2<.^$4@H70
M-PGO@@\55((6I=XUW2 MZ'GH)X^$2,BI>D56]'G13UD5"=)XVISI:<A1=[O_
M:T#[3PV P><ET%_;.>> &BC\/TQI@](\=H%U6$0GE'J94Z]%801 .Z) *]7R
M 7I,6$*DS#RPJ-J:R*1N>%-F/_V2E@,67W\3EO::J-8[V]:K4X 8L*G7;?:1
M+!OQ"%,VZ.17V&JG78E8UMVL/%%1'9.!.C"VR/C;1IF;NY=R3TMV5??9P[4#
MJX&HFO2<VP#I/"[OLKLVQ$?X]_T2K"RAURF&-W-H+T#>#R*4"^]"!^=L?EV3
MNE<>G7[_7G%QHMS L9^E[3>N0/7+GSZ2VLROUVE)G@-@<UA;W2>VW\*3+-2!
MY(3EP=#L @]ND[I*"P?J'I;H#D$+C?HJ>VD6]</+"Y)<^XO-*#P04H!)X"]5
M2Y=TWCM]TA9'Q<9Z]-?<TALY:]U 4;G&%PTP(MAXD.5O/(+TU.X&)H15HG.8
M-I>D:F/HK-13Z"\6U8O4V?\BIQFTSOVN<K/KZ[3N\ TI?ZNLOX@$>AKG "A\
M^1Y]8P,']#9X3,Z/)90X(5OQNLYQ-1);HR##:AO1]XF4>AZ>WS,;2=7C^XUK
MV6U_O7Q3.PV;84@R>!IK=._0H57X68C@YCU)7#GL4?47.ZAMC/5 MEH*D!/5
M7RYBJV.IVDUA[9MKY[.VYB+&'FPY?4)BG1]\)_&I,A+(<0X8,$1'GFKM>QC(
M8)M5H"Z716320L<;\A 2O#.)>+8,-=PZL;T(? Z A_V@U##,[5-1GA4D51&O
M"S(1[8]2BDS)P*;1.8R*ZN [YMX5MTZ;WA*OB-78-=K;<"62;2UO+09C;WRW
M?R]EWN+&ZCO9? K)S J=31V;F^<=7M7,I1,<$+']',I9(/0_2^2B_]+$+35K
MS'#_J_ 0NKST9W2]#$/D8N!6*#$?#!G_VQ<':NK09]R?MW1K^8)<:;;:&H*8
M)_RF?TW=]?*E5/==Q:[^EO ,D_X"5EG?8N^_DS8T95I]6C-H3S.I&H[T.NUA
M>:X:%L1%)XCU+3E)S]"![XV**Q=NV,&S0R'^-?K4'PQ/DKNW.4+LZJ1SX,-,
M/K$^R.W"<X >M*G<3A!- ]'P+=; 0RL29.*0J# VA>H>YJ024V#5[@N+HS17
MQSLZHBQ,UKPNR(P7Y=4S$:X2TIDJ[M42:W:!#&?[A7MDG?!7,I6UZ' %B;X@
M"XW(?H3G!&H:KMR,VEH%ITZ.[G^HVKUOUQ@[2<O"O$B]G.RZ1@=+NSJ?^5O@
MH?GL Z;X7/"'0+9.^#$QZ('-@,T,:Y$WTH1R%=K\JIO( /TU7PK]>0[8LW"9
M>+(MU!.,4!%P >Z3!7-+E%" E@^=#7N:(X\8$#V'S,3PTC#," *>%Y5P=QA.
MZ%JU#;JV1'E0[[%?&MJN3!4+ZO-3H+BO2NL<D\BMLKH[NEB.RRZ)+FYKC [2
MB9N[HS\"^V119.,&&I1])11K'P9Y:_EP1_KFG O?90A>UQK=HCE\E_]AH'*1
MGSDE-J]ZH$YA:GC6UUYNP"7_ ]PI!*FXNR)]!@4O:MMQ:Z9-CKG5:;GTMV!M
MQ-RLO0BG%)WJ:!1VC:VN/K8SB&VLB^@]F+*T?R EN5VV/_!;A2GE?7/G+:G]
M_JB&Q8NM2 !IS?K*_SJ\.V,9;2Q>@)/IF>2(CES4.!5")4\V?O \8K*-?$PR
MK,;<.]!_-G!#VP!E)J%P(L]/17^@N7"TAX[&:_P%;_[-N&,2/ =$VUU@BZQS
M@-CDGQ+  -L_>0DR9A=Q8-7A> []2_OO5;%F'_DM0M>8V_%$0HE]B>>'[)AO
M<\^.F7=;;0\56G6)[/WNE#$;MZ]L>S%KK$'<+"P_RX5/)REJ+3D:0[:0>G!7
M.\V..4_W@,CX*M8GH@_VN]PP!U5NZ=NC"QX$FH'M/D<O[?HSS?X%+\GQ'!I\
MF9W[W:Y;_A3A_.1BUQ\C4(J\LWI9X7:O93YF]X(XX(?9&M6#%/[3>IK*E<SH
MJMB-YG/ RCG@<9)T@,0K=YO71-Y4)06N:%._U&<E ]QRSAV#8L9/1-%FI.R5
M=OH^I9W@Q%#+R#8W,?:OY:K,*;&?E2C?P+XRX*3OH>> *<1:A=-5^B82XAV3
M>\"L5>'RL]+5KPYQ";ND>6I'/>#A/V@-!@7RU,MMXM9E4(' @31#:NNNU=*,
MSKS)PC^I"SH2HC-)"$9O#2SB-8PLQ9,RQO]S>X9S^Q*4#O7'VPR#T&0>_:UM
M_3*?15C+15(T6/TQ#V9[]S;W"L-9Q.*ID(/&(\FJ)<NF2THIM14'T!2U?N=^
MB "PEZ=2?Y.]XJY#7>SON%K+=+6+C7ME*S^$EQ<S=*HOT%$7F,Q0[.VDHC(]
M236A7-P0."/NBL)%63!*S34SUJ_RO3\R^1$_J)6_>L>59?W;S/$+RS)('H%Y
MUN$^YB+ VMF[K]"0?8FZM48:@3FF() V]Y K9UD[&4T6&G3^%N!VE5NCK.Y6
MFS8\!T0JV4A)8$O6*%8KN4JUTJIM/QVZGD)PW$H9M9D/,.LVYX!7Z9\]PLU7
MU'3(:>S<CP+_HC)\_]^F,LBYZ>FK:FUZVD66<H$5C)8ZO,.U#$)68%K- JW6
M4P8WYD1"N8W6'(?,DW^FZQ/DDS[>@,+;HAHO(Q>0"%*>S>4H+V_\08#L!2!]
ML?\$X%#1R?NCF")3#^:75>FR3J.*=3\'O!]N=5A@_OIMCBB$7Y%/75B']_"J
MIWD)QKA%Q!-7H<D[DUJI?2YV2H,Z_=/)_1W(?N.YL,AG=[C:#UXR>L#5:&//
M =<CULS\.?4P,TTH;K*6R67>/.O"WXF@\ACTVJ,QS#)F58L.EJO7OG<."!8L
ME!5\UA]@? XHTE#>$2L8M%7*_GCQ/TSZK<X(_7#+4'$Y7O<9U##$A*#[)%YE
MVJBT*/,D8%^8+O!U9K3X(=)XS0==NK;%9)1_F'SU2.A>V&@:+\F\UPYQIV[\
MB)3XF<]JB:].Z-\0'-YP('P=(9,T[[HZLNB(FAB.^!JIFCXPJ641PAZ2G43=
MUT:K9WY'1[7V\SPRR'7+$?[4>_40:B1Y"TJQ<@_(D&RQ\\GS74')TFB"-LO\
M!]]6Y>D&">#,0[1[SQ>BE%ZQF%NT:4YV7@J$L2IJ?I^RSJ;,'^TWTGHH2O-B
M@V9<_2KI7MX8.#4;F9',_CS5B%-E/(^X*G2<[:S1OXXPDC(0QTW>RK[BSA3
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MKZYM"^I?*J%@!O&&CRN-^%R!UR/5?E]:7!)(3]TV+F:PO@6D4KQS1[:HX"?
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M"S51+]J)KUI-H@7+WJ,%;33TB):AZ*5[^>> *0-H(-/?;MH/3+PH2S!'%N>
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ML7&G;:X=5J2N4M:KG%94J!>;HL1UQYTKSH(+5C)0PS9_#KA*5.1.1/]%&+C
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MB<^%F!%>MRID'W/Z6S-D9F;2XZA0'/A50:5:L^?T?F(/S!NXH:!;?=N']D<
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MGC/A*>L6RL<VU_,(0 .<2UX&XP>/ +J* ;\],_B7I( ]P:P58Q.79ILBVT9
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M[\PEBMZ#?)?SVLEB *]-2)(>*DWM8DT/:W/A?;IC)-))\AK0OGEZ!-"2/ +
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M<9U.D<Y)B/Y7"?I%RK-A:C7_#B5W?X;^=(76GR'&7]$JJ\^Q3A-#C:N8FK^
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ML4<D7H(Y>LJV+MR$_MVD+?HZKK+YM9 \!Y<(Q^<2W:Y/<&X9(K\')E:]+2#
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M1Z[%@RA' E25_S*-_7?U.U=N\/IM=ZG=;? GY;](!T5+[V<US;U<1FYBIP\
MS5]RX2@"B+^;"+\W&CG^.#"57E'(?D--2((X2^6!4D[3R$]K \UN*Z3M06?[
MUA87:%MVPYTB-D@Q58B\OY^\Z4E"4<(^^TA*SR.+'$+@.S;KR"+5)B&''HB
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M)RZQB=/"VZ^UP$Q5O$AMYJ0\?&+HM]P,U;8?];GO'<BGG+H,&/2YD-USZ@?
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MXC43=&I1OE<_G%>E;^/"I$W;2,>XT\L4OYRG=]@J4NKWE=42_H(Z -1O;!X
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M,%3&K3N>FMZ(5P!L2.B<[YFL#LW^#/U4,-E1-EW4+;CZC6I[T&+&5>F/N\P
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MPUDI_*ZY*PK<23PGX U=#IK6:F\5!YG+"ONZ?#S1:G^C@O6WX(GY'P,K7QG
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M'XU35S^Y"ZK?[1[Y? 8^4NQWSY$GSHY9Y(=T=HF?L[0EB(2<V6J2BH3B9(F
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M7A38HE"Z_^_7?X8WJY>#SHE"$5KQ[_+'^+],NO\9WJ__=VI7%;#)A"+2/VH
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M%&/#W S:S^\</%JZ)IS='G15CEX.;KL+>HD%%FX/C:F?-->TNT?O?8.AL(
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MC4'?0KI/N(?'^G*5O,ES@ZQ:^WM->ZW5..RZ#RAS!M)9<^9<.,_P:_[.V?$
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MN\"O3$P7>E[!/J/\C9@.-9XY^9$2!="HX5^//7UH,?SO1B@ 2^0O?0DL4U$
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M^'UZ5.KH/6 ;<^9.5]4+SO_]RV\EV?LQ\\BFAHM:+,")[GU:V[_?&_,_A-R
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M3<R7=X($M]O=]M#D*X8GW#PL.E*411SIU&2/_5L_9\][J;S<X_1=&ZR9_.5
M%P7.-[YJJX@Z[\N>NB4#$FVB]:AKN0G?FB&C$1/NR/RJ42A2<:$>E_7TFL7*
MR!PVP)=Z3'];+"D Q'BYNZ$,[CNMN_906S]O@U.J93!NDWT+-R J-&:H8.<"
M;A/.T9T.SV_U4LC,Q&;6X]"X*8N#N798@TH%]G)R$#BU!IR#AS6<A=8./'EJ
M[) A;J8O9R,Y",47;ZP9)-#3\WQ)=3/+#7H]<\I!=C!)S]6EH<P\R+'6*Q4Z
MRRWW$#=I^Y -M;&B5[BNXC-Y5JG>/0)NR<AW/,6/3?O^03];H]?9"61 F6W(
MX_,$!#IY5DD;XM$7M@/*/$#,YKF>4MWYF(/DF+]9\KU_QS2U6NC3X8#:)/]P
M-_H?3?]1-[Y?D/'-8]PO[]$HNZT%5UT)UKW6L\D 2_#6Y2_+,>_R@E9#,>;$
MCB:,V^Q"+)WOXQFS,HV6O:Q]CYT]IXE3-#?!U:=?.WDMD"#O)\WNICZG ,K3
M<BB *^NM&X\VH!Q*X/CRTF;C5:N3[G+N+Z>QEM=K[1LM/$/2Q/(=XLJ-QQ1?
MSF0FZBU*<. W= B(&XOI'2H=HNK8,0K@.9)Q(*/25#WU,9;+L:N^/:?T<6Z[
MCE#+U::+G\M9>3.;N3MI5BO$\<%&_=)0=&0W)BYI+'=!G@)P*)Z4ZZYTJ6<_
MV27!0TWN*+IH, 5TNGF6PUO2_U-N4$592?_FRTU7S_1;_9^KPYLL(*<KA#YF
ME>L&[[_L1U0G)9GNIZSGUEXPEI7OY<VLT6("J'<9",:GKG%Y""](QQ;0OPJZ
MCA;^^U?W0J2A8IF?-M/ED%?@L %O1J*QP2&6?;I_?(4"X'M& $DM[4!G8I>O
M9X7,,+I^%GN'4].SFGM!],>=K$[Q2U("9^N?ZSJ;_W+5'TLZ_G;%X(H W1O6
MK*^+S[_5'P=)@Y=BYRJ4)[QH&^WFU M/V9]D6&2]D4)8E0Q%E$6)8+A<OX>D
M"_8'%X=O/%722(TLGUSSU^MX_3X#O#TJ+F$HG3$#6L'B#]S8MUI2"Q>E4\VP
M#)XSSR06E**L6KM@:*VL" 6-E/Z%>/M "Y;G(C2%\F=U@V5^*(.^BX> ZT\3
MG7+BS;2?2>PI%A[CNPKG<>_V?(PB<:" IXOR!2N>.0[%+6P#LF%[HA]W%C:Q
MPJF7;]8N&.C$<R+ &$YWXIGV] OKE4^&2:B4Z]B;>'.47L>W[JW!T_?#/HW>
MFI&DKZS<]Q)S=[W+S!JTNUNG.=-R#;TCC) NH%>T6?"E4U.U^G>XP.G?3D)H
M+1/IN]NVL9"H2HXW;F[Z77+(:?%^[E!O#LNQ<R]J;KF@RV;%32$.7?';[*/0
M);C$4ADY;5)2>:W0(RK1;!Y(X[.?)4ZSB8\YI;V3D8H4ZF@T-I8;#<TGO4&Q
M$/<U")$XVEO%/5V?SR:+?OMQCD3KL;UB@*&#=4O'6S9%\7[=W6W7B!9.^*XF
M2V_B^YNR5;"U$TEK<&'(KQ!Z6!LA_]U/8Y$Z<_X#T)&()#BSR<ND$9-E_? X
MXXH[IT0_V'P;.P 6([6P;[*[R2"2;FFG9Z5H ]^U_H2Z)M&QB!'D<LM*K_,F
M%L@<#1]/V4&&+S^Q.WP1L.-D\VHUU<$Q_44&.\/!1V^'6\M3(H3"ZM*Q)Q92
M)#%U_ZV' LRH3[!!?3A:/'"O;8BZRA*(&R8T JS5C-2R/76JDNPMML.'L);7
M=L?7YR%ZTT[ "TLLZ;+;:7:\B>CJTQ2 9RB/ ="UM-^QY<8!5JWP=6CWHRQD
M@EGS5-+9IH2A NZ#SC:2KZL(G0'0 7*>=./<.?2N?@L%T-"-K&O %Q^<@*P;
MP<E<%;>#^*E*?ZI"$742?UPRR" K_?C_@%^7;,V.P,^5713 :=JZ\4VZ0S/:
M#4F,Q0]=+V&?^8=*".ZIJS[Y5=*N@,#A8AI=DF4\-E+]4YT<Z0;T-+)3@P*X
M=L@\B:BW2)[PB/ZY\M"<]@W$V>[1(*<KJDG*KM:'$MG_7 ?"YTGP'=K-4%)T
M- 40B#V;'/QR%?YSY:'ISNU;/<]# 42L4P $$5R!VG/)EI\KA?^:FK^FYJ^I
M^:.G!O*C$K+QF]21$BXXM-0JYCP%X*:#O&4$/!1[/MC:0[ZB:=!)7$&!3/_>
M8==<Y,.YAW)7J\RSMUG&,M(O'"0A[6RH\*G^MC/=P2\WE>FGQ6"-RMJ]K_NN
M!.U)+5-%40 Q4YNY&S*$]L#<_*:S38.K0-*GDKH(+Y0,D;7G6/(?CFQI985C
M =*(U@J/*?B=EA3+BR2?F;($*%Q3@]2!6]*C ,Y+:#O&09:'3U$-V\!F'[OY
M2GIG%,\M&"G5Y9YP>7)S;'!#R<1U,/W)EL7^'4];_,8AICTU=).7T1WFCN&,
M7!4U-?&T4E%9YHSXT/(K)DW(RA+4V3NBXL>\ECM5^#EP-E&;)OQ#L['1!GX?
M5UGM=\501E.SI"_>A-74NBEY?R^IQF,=AF51TNBKG<@(B(P:U?6=@+]6.(]2
M)UA11:_)/8G/VF/<@BQO;G4H;KV3?4-_03HKA/?E"ZHT/OI)331OZ+I4E1][
M O5Z[8E_E5*$>CZ?@R/3](F?NB#U)I:;T%''-*LK(G#J<I!:5$1]<G6%M_]!
M8F+,O)=94'>"@H9+H*^GI!AA)E9*3AP7F?R>Y>Z%H+([M>IBK\19$N^"1ZLN
MD^X4$63+QQ>RHO;*!,YVV0#(##N;MC6$GEHN/X]+I7RV5UW- X,4+H70<^1A
M;7Q=^_1L//V$3DA(Y&S/MV1NB16JABKFHPP#$Q\EZYV,Y[UFY2KR\0?N+$A^
M_Z<* 906O.D.^T \_:5*(5BV_]JNU$K.LKL[!V@:"53<V'NHVN)C$),CB 4)
MN[LY2^F()4SNP-&;IO2-) A!M^_0#/KL=/AX8:)GGKJ]E_1.J9Y;,DSS'$F>
M7.[HO'*GG5?-Y=%A)[+_?4^)IFAQT9!3?+%+3RH#/G>!,VSB^D>NS?MY(F[0
M!F!PGB79.1)GR8#(6V]VOZDNH)HT9NOM,U[,1S@VV=@1(-$F>D]0S[(B)^)@
MD)^*_.T7G\*&WLXG-Z?*O7&7W41^, AI'SU.?O"V@Z^OOL,!W'(C1'?:^5K,
M7H25V'7L<\(_ V[G,FJ])7M)E]PE_$09S@W&=@W/V#J1ESS(;MAD3Y%)+Z%&
M=YW*;K.QE,"K-NQ<FT^&=]G[UJTMYF-74W"CR@*;<5&O3)9095/[.>)!&WFN
M3+"=E-3097Y!3:]!!.U2$/@-7K3!2_S+S6"7HSV:LBW#0L_).?XEVXL0O>7L
MV2R-!![[-MTD&9IP-+M%^8?D(+#@?QEAHJW**J."30;TWBV=,4YWS]L\5IHS
M3N^:WU'/H)_:4&P/'!GV:=Z1>E6AK]._MC4\Y816,?$.JJ2G^L#F"W[90WP[
MJ45&EXTKC#Y!]#R'5-JMRHV2(&*3NL&WS#@C[!4D+:^G_N&W/GZ'J'1Q'0$L
MZ7XM9UM$MI*@_-J[8<C\\4Z"4=Y'UV 5PMF,I SE""F2<GW3%F@@S7-'V_'@
MX9I2A5+YJ:%3;U-X#H"9V\D37B!9^\2SA,KJ !S#@,?C7E7/KLV+*"UR<EG9
MAW_I!?LI2P9X&/'3W:[4FBW;4\BO26G(@2PD[T .ZN\*OQ?![_?B*(*[06]$
M[V2PY.;WIRG/+ ]V)*EV5V)[N2J,FQ*ODD<&SC"LQ8&OJMWJ&B?&[0')E0C%
MN&R1XPZ3=A?JU9U,.^<$^.>J*F+7":3F6>OV,7*28M:*BG/6NH@7IS&+G5KH
M5]*>$[=>"EKR>S-[-MOZU[R&M-&O6EK,G(FOHF!8':+,A.<RX78V.Y14\J4^
MP_@*688@%=FAEY7!;N:"N]F-5;O/!JR'^R_@XJYD+EJ M$N,[D_KH\D7UA:1
M0*R7+/U$NWU\::H7AE<UY03ULT,%=S_S=T\)E"]>L?[8FW3/LO?7$P,J C=N
MTYL[WUI.65;9Z,04ZVE?4(W7 7#"J_P;+T[TE,.#;YCKVCZOMZ7D+N$B4R*9
M.1_R?JT_(;](O6S5:FN41G"IJ<DFQBD$GZDF'%P\ET)VG]HE>Q=.ATMZ]%IE
MA9=)@1E](VE"SW0_1+_KNS.6PP'3,X_F5#DKEJ(!I3>3R4RE*V@X'/71?ZO'
M]/\#72LL2ZS;OM0BNKYZV7K^QWKN0( (5:+/@U=D5IXG10] -5.9%(!DGA'0
M4/0%2?; -S> '\0 2^682X;@BS<A!U;K#F<D!PI1K7N>J$LM MG*\]N'.&;0
M(CF( ,W][PTK5Z )?E&8 J"JLYX\[98E-L/75X+ZFS= 3R-#+/_'B5V:? ]*
M."&\=-*6;B&1KGMH1RO.0D*69GV].!FUU EK'Q,BS&9,@5<&;E@O&T-*"Q[N
MPD8.D5\E!7!#6ZHPUXK]2N]T=5^NGMO(SOP/AP+0J@.;7O?XR7T')5V09- 7
MQ>*R@@ U6?IYUBO_8K,XAHO5=^M&N+'S&%\)[PHPE?H0&KDR#B0+R"*G%XQX
MG8*65AO=GU^$WZ, 1J5^^ W.)9<2F-R=IBSCNK!B@A70? ML4L41@MY2?951
M7.Y[_LW6%Q'F@OHHVS6!8INQR#5M6']9Y#N8,VU:8T5V*6?(]$UL=,,3JU\.
M!?=XF0)@;Z:JG[I?3RY5"?M7,#,'R.":-5S/8K/=$&W_ZK*_)'0']0G#!]<J
MZG(LQ:Y=NM!0VN0L^<XC%J]LJU,ZX&2)70-V7-G59+_@<7V;[@76R\L!;=3L
MX@%6$L9$F4'F4%986;H7?S0Z^:^0IX;"\>8;Y[J^^MN7Q=-+?1@H<.7XHD;T
MZ]0;$TQ/H2'5?WB'=/78"R(H)G[;]A+;NU2N<,9!NC;<W_@>2+Y+EYV9<)R=
MLRNEPO_4]5VS8(C=/BK#3F_KWN\ZNWX*Z(05#?Q\7JGP<G'LXF$9HD@!8#7)
M6EA=]I^*_SR%5%AW+((%,%OAD(M\ZFJC'9CGX+ ?8]=+VU=])*F)?A+I=(^^
MEW2__QQZ$GWY82L#1_-]\OB/%+5UI7(B*Q,\]K6]7M"P=H)4=]9'MI1J-.L;
MK6ON40^S[/.XC[U=,,PW1ZEP*TP(T(@&5T#9*CY6U=L&VL0@7?(/= B;S2MP
M13D6F8M-%[.N7M?28J*AN@>.)KK@['#(4[5GFH-;DL8-$G$!..21I@&1/MC+
M@.P5[O2O^YXGF573<M>>'X*0F,VC06"P#H$_\F,FN;-,*[QJ66%#W/MHUBU[
MYZ"K3E=4)'J<'V+<;$,+1Z$JA& Y2Q=>&=9;7Y_ AC ='(3<S\J$L?>9B[=T
MXSR&%;CN!.9^_)X/NN=@P-W@B:RSE)JY(=4& DQ5NN!X[O07#,@TM-VZD,@8
M&U*&J62JG3H+TR1(IG:U74N].-+(7!QJV/+*#6N"!?10B\WXT?EL?[>W5_&V
M_8 U&?"$&7]H8Z5MLG.PNS[R25^N,F]1UD@P^K 19M,[<=)IBMV+Q;?G<\Z"
MO\1*843#\BLQ31;\;UN,#\#>%8/2JLX1>6L]V2I9LSYEAWM::N<O][-%]0@G
MDSX,NPV]QBGLAQ]JTDX:]"3R(I>/!?H,TJ*Z1)P/,Y -TE@&@V7Q/7RU?1+W
M6MS0S1NFI3I>[[3Q&?3L[G'>YFQZ/0[;FBZ+>P(;W@_DM C0 'O')<>NY>'4
M:-9O];WG>I/PK_FZSN8@& >P(_Z#9!&SC2]EAH4]^G7\ FG0*CZ.\6+")!J)
M( ;K;W!U/_97[.G!M']<?TMTSO5=J?JF!A]HQ47WZ1=,+RH540"ONFA!_GM7
M#(ZY C-+[I(UNW#@I2/E,@.YF*\+K$WN24^1>WTLBXG@3X.SWX<0:M &H>_-
MOAVE:+@:P3<>;E'>93WKZVTN;[I;0RY)V:$ 6I.RX9D8GU$-RUTNS 8<+XMJ
MC/WRNE9"*V,WS!QD7<"L*BF_8N@5N96;8E5\6R@57RTG$]O<72ANZ*&D'^<T
M2CMC),J*7J7.]=Y7K,!C>A;)+"<P55M]+R'@<S->2]Q,O9X8^Q8\!?#"$=V;
M0J\FY>K-X[(!1Z''NC0+$K0']'J>5N9Y$>2%0A<]?-9@B/?I">_G'RJJJ0>7
M&9N\X0J<?$\_Y<3[K?[*RT5J;)P$$O<0CPI,I'YY6_1N5!_*M(,G26MALW8-
MKCC 1SA=MS291 ,]KN9767P2H3'NRHHE4=MMU:X8,KE7M;LOM[-Z,\/2TI>,
MYW02,0_[$F@?3^"MIJV-2+H$^JN&&NHT+\\JIA?)W0B_QB>L'I1\(OE/E*-/
M77!5_2P?7:RZMNE#E8OJH?/;J&.(I.%$EL#T9R/#WK//MC@=;1N,"6V.3E-P
M8*%#&C'K#EO>">*Z ;*81+4Q1<":8B,QRMV9$WN@5-RMT[32(C!XQR%6HP_O
M_7\Z,Z!]^;8F:V=@N\ST77'L:\+P<$-YHL(Y /U$(H2(<9J$""EW2;0H"W&*
MSUTT ")EM]?&N\L^$?5B O7$7>YF3UZ1%HTZ",V8I&J<7PX9@OF:Z-K<U;7U
M!X,RH1IKG<X=MK11EMSO9Q(?1LA=2Q@--)-*32SX!EZ\271WY&@Y-H> )5@:
MW9>E@]W_W5QT/UU*@4YTL%EYGZT:MQKSBO??Z0\=!^^C5HNKYV)GKZ/C.=0E
M\F&RTO:O2Y.7.W(D;DUBA!IC]<8L-<Q9E4X_)XBF )<Z^]L\@Y.7W/W]M^ZL
M;<;YO7+M4.OR3SDW-53EB^=N2(!\.1]LN3VX&"2%L!^_D3@/A6>HK?57(1A?
M1(*\69K6)4G\MT6\!A<$6E<.4=@&\,$_5XMYGOJ8-\?J742#D)YRT8 MAY[U
M:3+=D3G0Q0J% W0V!6"F5V7]+,:O%C<]#\7U;.1>C8SYS/!4@9OS;7]$ZA]]
M&/;_0N?>UK)S2+$-1*8;;XN'R-W99(O#DW6QCL?/4]^E^DB_(>EA7H]Q7&)G
MUN&R'F#@E-Y=A!&A,TTXY2/]:K\38_2?BKFA1H@;]$;+=_&OC3.]$JQA7^D$
M-DQH!^8>F\10 )$I>CKHVM(X#Z#6?3*GMY9:\%LU0WFTB,HY6U/T3,[J<K=B
M8T*SF?%(HO+]*VB#/K>S7M)!KS5A,AN!*EI6=UN<5V&1V6BB(:YK$L@B>V.I
M; !Z=%+ES@W@U^HDR#U$^/OL,3)PWD<)KS[VM21)S4'(/+>V#CB+G-"J#T(W
M*P^CETT+)#&F7E$9'K]^%4%=Z+AZJW3FH97WKK!^273'&]S/U;GY_HR85VGC
M2C<%<($\V?]N8:.JV<9A( <MJVM8>7&U:9P82P$T,$(S7)6=&S*>[06C(I&C
M6]EZT->;!X(R=I<1PU_V!QA!MR#WA](J$WOJO)G=^ Z%=[#Y< /Q96J8>Z]/
MDJK!);HLQ7*H,7;80%C:(NBV# ]SKG_KQ$%L 9+![IJ*2'(>,-:V179A>,!9
M=JJ&HWO9IJ9>;^SAHIP-(H+X9H-8!8^S69(OY1XKA[(-2W;XY#8HZG:FO!";
MN,F]F0ML*,Y#["V.67Z/8+[LQ]9.33,="JPFPHQ.F^S#-R5:QQ44)7?AY'=)
M\R;S\QIZGTX4(]/K1^(]Q[86BN16(+0BNG%O;6T^H3<[1&K:TD<LO*_Z"C0@
MYXO/MPB'7ZR%2:H@2O'OFM&(LFV,#=.P06OPZ4]?)HYT;&)NJ1 <]/4W+.IO
M!+^155AK\W#GWHL3RWV9@;AE75FL/A49*0736(IM"-W0P6O&E LNE@D E/IU
MI*J2"SWE,,TI>C+;^L@"PY&O5_TD)F@7K22/Z<;!1(OT$I)KG2QJN4)8T<=A
M24 +])@B@5PD^>U;2/9Z[7KO:O3$GJ08&]N;@Z(T4[;1=]DW!,]D\^GD'G4L
MP?-_L%V644INIP 6&"B C9JD2;C5VN58\9B+%JP2]M=-GW3ZZ/2FIZS):;;'
MTL>OG<I6L"4CFE&9J]RA_4,*<X_#&])&48_OBERS3SJ?:V)X5%+JZ(.RD"6;
M5(]$9%WD'8>V!ST78-^[(U4:@6=DN(HS.R:]9-UBWA6\*9-C6J, !M+A");H
M0*.Y1_C&JL>@\ECRPZ'L14;\FMY>!2*=>'L5;/#PTY @]YVF%E1[B;7*Y+[B
M(03PARN51/1S%PM=C#_YSM[%?;8<+:L5#6EVUI9X]FB,)39]>&@=X>)B&^Z]
MI-4K09O%%9?Q?3@MQX+:4M6O[,[TVE:&:\H7YZ'M%T7.# /43#G1 I>_!Z1$
ME*XZZ'1)80E4#6HHH98+F>$N]F$"K"]'WAJ>*\2O#ZC@#QI'*P]&BF\*Q#[(
MD2CFP+:$0L3FK=Y= UD2* #]^%M17!BQQ'JBWIIU136V(0FW6IAN.<9L@16A
M-C8O<;LHZJWE"O!^UT'K^>!663VN*%0UOOGYHF+><I9X[%2.]<=>_MPW_5C;
M]-0K$M6"([<G:^(!DK?6H!%#&[*]*[FK#%>_R<C<R%LM"G-^$O(4C5LHR[7O
MVQ;265P"LCSO!BMA?MSX-?*W _KP\V,>9CQ!VJ6.&WZ(E6<\>>O*,0GGYFQO
MMG[^W%7^38PIO0A8R'](2I?Q,Q!C'XL*+=PM&N;K"^%O.K9\O5N^J4C4+JBK
MK'C ,<X#0F]X(F+F\87Q&M@9&,0C5"@$)KR@_*6/I7QX;]FENZ'[]6XFMRG!
MN1B&6!N "J[D40"OE;XH7/0L,\HEGA[B0>[-;>8NEHS3U;,73Z#Y,2J*7_@_
M/.E];+Z1BY+NA10*7Q+OV4D/U/7_V"32K+W^*F[<S-W50R.;5PGGO;Z[6G7@
M;;IW:/^V;\S9!GFSL5"]N18[>GO(ZMC*A:D/STA+NQN;3PQRE(W6"$@9%NPK
MHW61UCW$[J)=>WT]JH6*?,R(ZC2LU!?=H0S_2"B-!)KJ#INC/S)GTUC%F^5\
MQ$IS^W.J\,@*:V2U^B8'\42XC)^3$$A#] _T6/7/3GUS>@"_]4[@^-OU<$.M
M\=>>5!FM5ZL/GWKI\E?*WO/R"_&,"[4Y':]!ZV=ZJY?RD1PZ20S5T\\.H?6/
MP-;.L0HW#\68#.C[5"]#B+%_RQ/#GI"D6,/!'F0=!#]%]K <)PI!2(9NE[Y@
M'+N&5L.5(E$A4<Q3*+W0<KCOGK05.Q>B])VP\ZTU  7@B:_>O[7WTC!(X.PI
M%77;WG53->/%NG<\F8@NI/ZE,6:BH4W1@L.D9+=BS06K-[Y0,XX([W@OA-[J
M$HX<?J6XU%_I7(:E5A$M/4=>73P((TL0:A"R9!'6=E9GFJN\P3R0]>'+<P_:
M,(@8H6PF13']FH=BA*4;>R*85D8@^M-'Y=O%MAI#;V7QD,"4]67C?/,O]PIM
M>9JJNGQV@]:1%RPMDXE^&]"@A^&7/<$WIT..=<SI$KX2Y/,?+(=F\'Y[?G_K
M9)3;3.G[]-+(F<AVW>FGK4TCL<LITIJI![,#[Z<G">\(-^'E:M%.?>QM:21)
M?&^L;&HTBUL4S)=YI./RB/SQ^).-VH=/%1+71-KNJ<:;(8DS3GLPTLN<ZJ4Q
MR,%Q6#O]W),4]8HTMT);H;&F=C\:NEV+QO$R0SZRN>54FW@]P^UM\WIU_8*0
MY6OG#=Z7U'SQ-@Z:]Z2?P%!IX=^D;:>8F)?$E)H)B6TZJ]5<=J2?T?KI6[KC
MC!T/7RFJ[(ROW<GO, W^\DT]/6)F:,CQ>K6OYQ&VKJ(PW=1%YY@XU<<U>\;>
M5FSZ.#.4TS-]>;<;L\>F6Z(?[LUQKT,2W 9"*(!IQS[($BZ[C\QV^N-$'+3H
M)&M>L+?#S%QH9:5DGDZ?ED7/&RVUI9'E>J6SP5@)B<PTQ&*TN7&CP+.YGK7T
M@C+IM](S;-"GO#0+4I?+%*;:Y!ON&WX])_G "KAXUL%IJ>?M.[HD3<]"=ZL$
MW?O/XN .8K9'+/KUY@*K6M -IB^D.S[=-0@/G4K<JB8PUL7>]DT>-EC0]CO%
M/O&PJ<WYZU 3,7 S9\T7N7X7M+>-G"WL)1E0 .%F'>1J*O*+OCDMM$APB$;G
MSO--2XE<)U;8[;)AHP3HU>1RY%$B5WW#GE=;^T<[!^8@-9:<$W+/IJ=!>D.?
MB<89ND:&AHCHUY9==\]G?Z6UWRNW0]6S06@6$OG?<4[NR"4I@1OZ7EO)@B&0
MUO5%\!"_%*NKL>JG]@3F%V6SX@'FEE0#$??IY_1@O@U5$E#@8COAQ6HNX?RI
M(Z=YF*ERJ>9D)0S% @L[P3,Q01=#3,U;EV.'9C#<N"]Y.9:JBPP;NDUT+:4,
MNDRWA4*_R2T9%+8"$4Y\%27CM.^>L0N>.^O%F&;Y:8'%@(&A=87N=.&CUPP<
MXP 8<!+NKR=;%8=>;'%PF\M2>$Z?<-MF>NJ20\C^P#56%^&AQ%&@!F-$B5H(
MFD]]IW!=(CEHA71Z(@Y(N[ C*N;;V&K&\\#J$SW;Y[=A7HB4;BD&R\ZQ484L
MX6CM_6_##0;8EH-9<*B'W=9:D^$C4U[KQE648*A6():IG4?/"/E^5D]853GW
MNZP;ZG-E*X)_ZN6G3^W0[DJ/QB&@_TH%A]?-GF5,PA4N'HY M6(*X!SU]/1D
M"9+)%0'M(=EF++C;BU16#C66V/ 5%/@J,&\?+9)0P@\K=DO<=4%:.KF:%=^K
M4?RFN2Y4HXK4F\/<T8R\ZR#B4'[Z(8;&:6%?!&RS5I0@/("7Z Y:E#B-"X;3
M+L)NCBL+J]4S$*;#F"+L>GU(V6@*P%?#(G9*:/1;F::=']=#P]61:1, @-4A
ME )XXZ39J)[!S2P)%0O5#\ J:Z87//NQKD_Q0)\M\-4A3Z6KK)F)8RM)5$LE
M(63ZF3$>/*F*98#]B]P&!R^GWR-C=]!2F!Q.,90WP=(> XHAZ%I[WJ!7T,WH
M8]J$);L*X'K%TI,8,C 5B9H5C3;^-C-;Q@.)-=Y.7< 31/956$'1^8./KJ9!
M6^][*8#R$@J -W#*4EI%K-SY=LJ[I[RU*@MP1*7NE,@:HQ0KOLQ"\%;/,L/W
M>]!$#M4:XS7;I23/@5#7)'EEJH9H]V?JPGEU,(2H.K/,&;+3/"/\M'",HV7N
MQ>V=CM"3SY6X1FL=>FSLB/TZ:&G%B[-6% #^[/IWK?3%6@UUA)Q+$?G1>A:O
MQR6>K4OSSY:G!)6%3LBR5^.,/J=[WNK<W <)Z3N7O>,W,7O7Q.)U\WY3*232
M2;M!(X7 [DU[1)\1:9Z_N"WA';1]B@PB:L#RP@L4M&\#5J+&YMI4O=:AH$C7
M S$1G!ZI4CR8\17Z-2(A/;'MT++0C_]7[NQ_2J53IA%<X*OGO]7GL0;MC#*J
M*\,?%%2CF!(O-YQKZT353,->PC(]>:LW'/5;3MZ]W6.K-I\+:0"U5SS[EIB'
M7I?Z[+^T(";0YPW=%"^[GESALRC]7[7?\CRADY4"=>ZZ%7U<M1*R1UF;>3;5
M#MQIZ@GC#=E Z@?6UD5&5CE2.L<\\SQ*V:02H,5ZNVNZ_=BM Q6E VU<+C^G
MQ-LNN<=43U:,$FF/\(Z1-E&S;M]SGEEZ?.J'AV.G!%@7$P6KQEW'E%/-=VZ'
M%W]-G-MO6]M]6AI['9OVFD-%(D];[N7=;_:S;\MIKB=G_DLO^S]21N.-,,6(
MNA76 !GPQUIUL?,>&M<_ &V(2((;?ZL8+&A:)P/WM$H"O$>U"5EQW&I"ZO_-
M+"44N@N\D.(=)=JV]#@E[+@;/<?$-]M !K?@MBW=%8_,#)'>J%&R'-:W:7@D
M>X<">+]YC=ZH7K6@[\;3BIY5CI+B=Z:<(=.@C05M<*UEAIF'0GKNJZ#KJ3?_
MK]LGUXEYV6Y[F*+H2YY%S;/RD&&;I+!#>)+=MS2'O; (&DKDK*Z@ G.N?*(
M\N_ .VD>G?EV/3GLCPZ/^'\BI_&SA;;+XPQRQXJN5L(/K?;*/NA<TY3!&R7K
MY]O%ST<>/,>7E24]M[]^;$&,%ZS_NORSWRR_ND6_[-Z%</6^_U^#D%@03=[7
MX%[9C5]&0%'M](^0!>.W#JA)V=_U*DXWN$ 0A(?HFW=/SO2"5,]1S8.Q5.Q6
M2U_7-ZSB8^[JY_HIQ6;S9%]D0?-@O>4::L\4%;Y5Z\7D?)C5?Z_-.55^GFH#
MF[V,N?HI[U7WJ'/C<00+\%[*L5U8!^2T\-H***"(,R0MJ[+>PYH)1"3H[0E6
M/'+$7J-=6G=WSN#9.1Q;"?#9;(5E3EO&0I?.0M,!1!7)>UXL<[7OMG]*?;*E
MW=#]%F"LKGCYCHA_^M>RCI!"91O<9T0&!9"B/Y<\88J:(RVF#NQ4<12_58U3
M]:*])U/(J1'(O1+F'K2Z;1NIH>>RY<'1I!. +ELQ+,_$7BM?5]Y:,4XFL$58
M5;%7?):#WYKBNE7BA>LNU7#=6'"'!*ZD"':D9PRN31DQ\=]4H)<%OC8M#:*.
MUHU2D->9.><BY/Y27VUXP>A$523#^I1J>77=M=20<RXNR(;^+O_/*'[,=G%S
MO!/8PVU?^:+>[83EG>!!I_U5/20+W^[->1;#]N1I>\65^UM;.0L%@U=C+U$
M],W&Z3K#"G-\;V)?=)<LA(GWIW]V<,E$-.,J+\*7YR^CVLIB1Z7#J'$P-K$@
M"WR'_^;][14]LQ(G"B!JIWNU><\1$OG E,925X\"$"4KK=Z.1\"LFT?ELKLA
MSJMC-E\\VX!!MB<QN)88S-;Y1,.V-Q.73(P&J19@' 3Z[=>OV&SO(W0T)Y3,
M2E'X8R0K#5,<BC$O<;!S!$LJ>%DD7S5-X]/:6\&&'LS9>SWDAW+BCEBR\W.-
MV9SK3IB"V&$\),E04F>IE;IWGY+<=F3LEIV'VV!8?6;C)(B6*U<P5NK-)4C<
MY1HW:@I@2ZOZ!/;]B6W,\UK.7AOF7O''RR 7[)1*_W2W$P)-XG.XTCWNWD+[
MX&CJ[A8%0%/;NSE^9E[O10^V1[LT_OI5Z,T0[/Z=19YU='VXH;>8[6[8'*^6
M5[:5MLWJ]DYB5!'V00[J?B)U[DHB<Z1)D"QOS3IUKDM=]$4+L94F/YOX B8A
MG7+0A"3LT(QG^?I)]ZGO6@5C5H<'';?CD.E@R\IVQ]6<I6++'.+3@898'8O5
M9Z!6P,$,@/0-R=LN'&][<M/=7<K_ 8$W+:M13VV@S&[)?&#3_., VV3]++&^
M'B_*RRDX-0+3^%_$O6=44V&W!AA%105!I7>4W@4I4B,B77H)'6G2I+=0HR(@
MO0D(THMT(KWW#M)+D%ZE0P(! J1,O/7[9NY=<^_,6C,_SLK*6LG;SGZ?_3S[
MG'=O"U_&G,*%I>Y?'GU5 N-1,+[UB4U4?3>,KROUC>&%2,AMA^032/SO*/L)
M-2<PUBYRG>#16D9^4DAAU!O%"Y_[RS,!0*L*NWL6W"'1FM2F+P3C7CQ-+;7?
M+=FE$M7V3!/*OF+L/ZVP[#></@H@]2BP7T@TJKQ)%8DU(B>D2UFA*) <(DKZ
M77AY)EBQH5Z3(>_%B05-;7N$5!D7B8A6?E+M:?8E-OCD1NE]OFNJ#V5OST?1
M\@&U3].7U;L4K?Y(* ">>.RI.WQ"$9BD*"7@ ,,G6Z-K#N@A;'ESM3](;E6
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MQ=_%2832 -;NCLG4CJ(5JL(T4-'EQO,5 [V#KFTA'ZQ0UFE7L;)XX>JAA@-
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M6JM@4F*L13IC\[MP<]34*[.WA])*)7 6\'N(C>;=6RJTEF#JSF=O?!Q6 FJ
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M1 3(CJ=GO&0P81L,RGEG41_]:/K328R!]J_[2"_^W?6-,;V.7/"N)0)<06<
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M;ZP//=0H&R^<T"'8')6!"LR(@.7)@ 5O*)[7&[0B1@1$IY^E"N)Y;?][PR<
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M#R"QY15$P/'!(/2O^"#P1:;C>J!C7*1!9GT"@>%/[\OZM^TUTL-Q(8?Q-(0
M]I&O"!+_"_IO[+UW5)/=MB\<*U@00;I 4$"D*T6D1D2Z@/0."M*E]Q*B(" U
M @*"0(0 H2.]@_3>2Z03>B>A!@C)C?O[[MWOWN?>,\XYX^Q[]CCW_6..L9Z4
M9\TYUYIS_N9ZGC57)C$!'"C\7RS_RT]."R"_A0C\BQ"YW%T0E(T= ;"_F44
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MI-B;^P<6$@+ Y^):JE_2J^/S:OCB'U"S=R)Y:B4)@'E<.#&I>>O._ ;C^I,
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MH- &/(#DTN5373 :I>UW!1$'H!&(9ZW>IX,HC6<]T,KABHDJV')![:V9/1:
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M /@8+A.N?@::J&NWV#O>;;\E-J\;B=W%RT>JX6O(SR]KO\$(YJF/Q)1'8";
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MNOT$ (T;!H&3K7%'.=Y7?B\I\ 0VIHBS6PO#P*+&:X69&-"WWH;IA1( ;CG
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MT@[=-@;A(=N-NWN_8RP$=X^9C1A77Q  ".SO:"X?"EJC *WCA8S(G?!C(P3
M*GX*3P#P$^-L'H( &#BO/,>;8HK(B5.>M15V0 H[($9=T%_[)L99X&0-!$<
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MK_9&^WQ(UC74_81GK[4YIIO7W:&"3=:>S317Y4"6\HE6^QJ#VRPOY#(]X1:
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M=BZ.F15.M:A#I0TS2;X]X+9-3HW& Z"TB(MTJB939V0>5DYOJ;BVPO?3I,0
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M:3J8+AA%3U)(K7%4<V'DOPQE%[OZ$96VH2F,JM:O5A$-8*+=[9W5$0D^*E3
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MX3$/8^>$CH-/0Z54&2;+1O:7BSLP8BW*88BKW>D#N[K#E\X2D7P?C7>47T9
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MWJLG"AS,\;\^@29?7]&1=PQ+8H3*_G/-?R[;R[TBXO*O1*1B4W'(WT084&W
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M/>#Y!VJC91TE_@3,N[ XFTNV_;Y&97#O/AV(R.(\AJ0P5D0=:P_D\6H4%L!
ME;.P7'71/N;G7VT0+MM?/H(#?X(BD)"T:O;@ LDE-P>[.C8&C<?8XR=E\%NF
M;E*TDVVL<; >,SS 9>)X]0OF7:5I6C5$Z<T_VAO\$_\Q,MIX* '3:I:(H2!
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M^)KA"RS4F C^_28NU)FK$U@M/D5D)R-H+4::'D\$7 K-75$\5*O:\M R9W&
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MQV+-6+%[KI[)K^&+W\W]P3'4B:P^00O,$=]."P74%8\_12LLD=^S<<1UJ<;
MDEW2L<HSM6WTP["I4]GHGO&!T)U._"(^G!O-O(S#$!GNJ)06QO$X89D)VS?
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M;Q2]^HY]0BY)I@%JUE-@*0IUVJ6QO4JU256IBMYFNAY]$-^W>_8DA<.@D=,
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M1H^OBEPK&4:YC',+*R(\/C!G,J,.=IPGW_^$MUJ!JF^T=!BU;SUQR=F\3TN
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M#C7]_=-P/26P#ZKPY&/\%1_EJX#;5B%#,\[$#32)MVT-HB%<N,M97Q_L;Y-
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M:V<8R*/AY!OP%3Q;^/U]Z*>DT_\-?:LMBZM9-U]#&S]5[A0QLWUIVG,=_CO
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MFNK_'<' >Z@Q) TPCX$UR:W;=TWF"32P!VUUIXE;U&FB&_]$H4?/;EPO&"G
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MNT<<0&24C#3S.)E,H5I@$:E39:OM1S.HJ6:[]M]EO+"8MY1";4DAP.F5_2F
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MZT,UO9&C E,73UP/4!&AJ+GI<-W$V#Y-#XW=;.>)L.BQ-Y YB=[E@ODO>T$
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MOPS7_Q]I@>T8/J+6700)L$+E((J<UT2C0/OZDM#3'<*%6U+!_R/[- ?@A$D
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MO"L[@']"QTS&!,AT\.IUUJ,9T?:O(*YE4U4B C,E $+3'=3;N0J'M"409X&
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MPGOAU% ZI*1I.8_0^'ERAC+O_Y\0*<9@_U,4@U6Y &1VGRE!4<DG?/"([5)
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M_=KV_R&G[73F/4YQ2_O2CS)9#T*:.B+[]J4(%^VP"6"*OY652A-?3AX8.F_
M,^R/E_\TBEE?@/S>&4N^A?^$KY$.CU,N&5SD228(<7(*W+]S[B+J)8)[BH=#
MS4V?$?]*E?N<+@GU!> *SJQ!^5^X<N_:!8!"?L(,M/-*BG;)+6X2ZS9P 3"8
M/M'.\S3$_[(K*A37C/\D\VA\N>J_TM:RT*XXQ;E6_C-"$5SL]"LU'&-$4M?Y
M7F ^=I#AC_E9C!7?/?_8V>NR@S'>!M(Q8%Q;)?Q4#/KUS^6S_K@=_->?1.:L
M#>S^;,(I7SL^]\$'I6&T=O1ZTQY9Y,9<_V3QGQN"U4?^30C1PIF%I+8$&8.6
MS+6'<1;_HI;T_K-R=M3IOT]5R]'?@AN&[<V=!.'J_B]*9"EQXK= V)#5?=J_
M5 )*_I5]_TE&X.S"; D ][@#NQ=Y_SLYH%CI/Z@'B2"J<$$@\ONA//L_Y9V?
M6#P!B4R] O\19XR=K>[[QQ,7#RV L9X82EQ[ =G*H= %P)_5P/SLD +\'K1G
M*,E_6/N[-'7S7YZC#F6.4\[QQU5!3E78C6%-."7Y4/B6!'Y[SM##Q]FZC(?P
M[BFCU'0INR,\_HO*"6N,!_5:G;(TNI['-RUQ+O)G1>XE-@85U\*O'$C#:7%H
MC7&<L2R59E++'\C1%?KP 85Q!I+,!UH)B1E<X\?4>K(#=M=-61^_RB]EMU1D
MTH(5Y#\6L!B$;; R691KT@54:@C:/[R[+MED56]\E+GGE7_2T:NVER>9W[1T
MINXF/>88^C%C66W90W.7Y3TI0>MJQ/L&1F2O@[2H(2-,;@-$_OE:Y@^9^Q<
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MX0'Q725T8P7]^F,=H5B*79ZM/([N)U6#!!L$5RD>ZFU=L\,H@2SL3N](@BX
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MC#Y2>?>JI_ (5BJ_ST[X5VKRBE29H)QK_\XC'<+A0-N*6#0"'^+0P!:71+E
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MB@+!((@EU_J];K4H4=&#558F7!$J1WX<1[\^2Y[HEJXBP/ID,LJGE"W_QK[
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MS/@!77X<(W()G'QD<-KJDS3KH]YF;%L;\I"*)3,/X$7?"<:LY70X7!U^%0Y
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M[X7$"T_?H />;R86(DJVT9S([VUD60<,K9[52Y%N)04'$:"8;,? 1(NH[?6
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MB^#='F\9XL6GES=/?%6CBO0XE24%YME9:YF)Q7&??909*$@GO8]\K<]-\9)
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M!&JHH#]S 'YA7WCD7.Y/V-C'+V"U+PJ)(C.H0GO@7!_J[*A%23D&9<\G"8(
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M/VU?YW9D:C IYNXM( HK"?9-ZKM2.)X?83V:_OY3@6:,BJ1LL<>:N,OSM'L
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M._\=^RB-!9P#W?>D)?Y_$P!02P,$%     @ S81Q5%A4??:FR@  ]-D  !4
M  !B9'1X+3(P,C$Q,C,Q7V<Q."YJ<&?DNW=44]'W+QBZ"HCT*BA->B_21:6)
MB/0.(B EA!!IH2-*%Q 04*IT$ ("@5 "2)<N'1)JZ"60@$#HP_<W\^:M->N]
MM=Z;M>:OV??LOTZYYW///GM_]KGW7L]<+P'NO=#4T000$1$!WMQ<@&LTX!F
MA)CX/^5&2&\*V2TR,E)2LCL4%.2WJ.Y045'>H:2DODMWC_HN[5U*RGM,]VCI
M&1@9&:EHF%F8&%CH&!@9_C,($<E-'U*RVV1DMQFH*:D9_K?E^C> ]A91 [$G
M"1$W@)B6B(26Z+H+P 4 $)$1_9< _B\A(KZ9(SG%K=MW*&\:U-T#$!.1D!"3
MDOQGUC>UP3?U %):,KJ'DNKD] ;V%-P0!JD/27FW>)Y6MS,:CN)XI=^^#[]]
MAXF9A96-C_^1@*"0C*R<_&,%Q6?/-32UM'5>&!F;F)J96U@Z.#J]<W9Q=?/R
M]O'U@_H'?/P4$1D5'1.;G/(U-2W]V_>,_(+"HN*2TK*?-;7PNGI$0V-31V=7
M=T_OG[[^L?&)R:GIF5G4,F9E=6U]8W-K&W]P^._H^(1P>O8?7$0 $J+_)O]#
M7+0WN(A)24E(*?Z#BXC8[S\-:$G)'DJ2TZD;4-A#Z+FE/MQB>)J45]U^FT?:
M$,?X]OWH'29>F64^_'^@_1>R_S5@X?^OD/W?P/X[+A2 BH3H9O%(: %J@$NC
M_-C3A),NMOJ4Y1$6:#ZZBZWJ^#(J?D\&JSIE=5J,:(@>+A4-&1YTX'%H9+'I
M='GPV>P=%Q6>60?M=))CJL3Y2U!!<WNH3;N\S6S6U6NK7[@#JZH(/- O<3.T
M<E6;.4$=#<<V 2D2#FC9&NF5B_J7& :N=D%4"ANRFER)K?R)SR-1@91F>*>>
M<F"Q["=?,A[X8>J\M9*->R.=T+T(Q\^<A2N _<MLNX']J_KMX\?7 (1G2*CO
M&3]L?7P4W#*FDZMN8.M72-CIGN)DE;?EQ>EAMFE%1H1=#U&G#YGYS,L:WAF:
M_:SZIE6V9<OLC[>S1. 3HE9:-%7DKC8)3S%GE*(JG+*?9;J?:EO,U-]:BUSX
M+"&9;#"P;?I>!Z8DL]<=-[QI[W#[A=34T+RLDX_O7I.=8S!$ \I9C8_#T$1>
M\,N"C)Z-80L:6ZHC^P^<3"+-UZG7G7B:OE:.,43-A]_U_?PV8_$^TN2R0EF)
M*=/9'Q8*MMGB/D.A+SDU(AF_N,=:?>O]I@LP'I2@8(\ACDB?<MLJ;@D$GY",
M>%:[21GJZW'8[,TG([+A6U,;;0:V-)5!UH2/Q0.B7U&F<05N:9P,Z5WR4R<N
M)PK)@HZ:\51> )((4X[ZN2^Z/AS@'O$8%"(1*5CYI'K&M4DEON=SSY2C;W-J
M)>.[_E9<GA: .LJ3ZKUD;),%R#)9I\YY.J0LZ$2J"T+.&:^@H]'(E^\V70.N
MG-)9V+YZ>?8S%A_/C&F+O]#!@ SUE#I?ZRQGJQDUCGOP?NE)_LUM[1\QU+,.
M6I3\_%2B$+!Z:!UPX8%/C$9RY 2Z^K[?R6&=\!'VAY_[)UOI/)B[RS+HQV3R
MMA DU*T_A%C_MG;DB/49KT2W]4GK;#28EQ\,P.!UNV--X (0'P$U>&8;BQMA
MW+[BAU^F&IFPS;*U'>O!1M#8E32%>JF>D&M AM7@QG?ICR/]TL9U5?&V_#B/
M[U7HN?MBQRO:.&Q."757VD'OAJY(GL3O?AV6!Y[OK;(.8PU^&Y>V]&0VV_FT
M#?[\/LDF&N@";S2N*IC708>,.O]E,!L^:^NM8K&:!U*[@O,N,_4G9'9H&:8.
MF=.Q!N3SR!?$6/=KP.T_*M7#PW'XJ&ZVJ1;@<EC32S9XQE5187WQ5')=6[HK
ML6Z#^@;YPOGOWN]AC(DRRJUP,VE$:&K5Z1V%/;KWJV8MN_#YP_=%;:894PL!
MG(L:4+O.:T!\#C]^(^9"N)BO/MV!>B]7%OMOB+0&?.!AR71 \TVBDN&>E=+[
MD&,)[PL(7JE[JE49B=N/^'=N52:J%YN:\BIGWR]G9%UI@"/Z"ZD)A7M6O0X%
M(PV)J:Q*9ATVM&?Q>X57ELSF3UQSG*^EVZ*X7-SX15K)KU%;=OD>, ,LI]&7
M9[0@7)Q1/F(7^8>O2VODCM@CL'3J'4^3IZN'#31IY;87 7B:R#UQ*W/XN//8
MOVS;C1>M$Z '272:3#WF=X1?^-X?J&L7C>\D]2M*GPJT.KNJ>%X[R.N^YMV,
MGK[(;',,G&<\Y$3@RWLX17%JT;"'3!ER)44N"&9%6'?6^ZC(98^7+E]^?668
M9Y/>4VI-O9N'L:,G.'=7$R(IYQ4/36H(/M3_#FQ0_7V>X5OH=Z3HCU_,Q,Q7
MPWTO%L5V1,K@A2G8DQ"_QVM=QF+9C^79'P4C6OXM;*,N1H\8&5=#:2\TJ ^#
M!-J"I1:\RH"F52P-_O)6K-SOYB)8U=_<57UC=IEQN%,5S\F+=^Y$Z+VC%M]M
MY<-5UKZ/<2"M;H%_T=P9D/E\WYP8$L'#D_(YRW5)R"0V^0IQ2;_K\U:ZB<6_
M/RL5968;>O?,M2)YI^4\]]6HG3!0[5Z=DG@$(H1CROM2V*P.CKN**;,L38":
M.<P]S;%N=IK;;1.D*B(2[E_"U"%95^+MVEN%\'3H^DQ(T;8=K>/8!MS;RQ>F
M^&&]G +%X.\0'O4X1%/8.6TDJ?\\1"DTUR%#^9G&Q">.^QEF>]FK]?7E\_-J
MZ:&%FU5)0<P8KGLV TN;,IF9*NS:#:.R_J^2J^=UWP4U?__H8?2>]7OU%W2K
M=18D3%&<],)R2D29I&2&$-*I\7=Y[$)<K(7;ME?Y;S_I7CY+K803E[#3;&X:
M"0E'TW?KE1 +.[M)6,A>^A%W%*UAN?-CF8S6D]:D !<X'.$; *K,?6E@I[;-
MQ:6L?PV@QQI.=>I^U!Q-T6S(Z%\7M-PV;C6/>_#EL8FCV*+D,W2"PLZ5=-#K
MB2!*OKKBV(>YAD#V%O6EC(%A.R%&*O/JAD_<B9F/%Q9B P\N-6N^OL'Z7>GL
M'+C\2_.*\-XPL1T]6#B C&\P-6]M!L0S'DXN]NXSRB8TEJ,M7?!;32II\8&B
M%;_Z#_6.)S_7B(0_8?;8Z&1487 H^ZDJBV^M6N%B(+A;JWX'%[DNWEL9?U ;
MSX6-^&&H//7^_$4V]K?ZY]Z^(1!'/>QR/?D:$):[.CI@I-8IL) !NEQT[;E*
MUQ_I1^7JC&HPKN:^9##0 ##<H";4K =6,0>];6S$<\**2J+^G5-FR\*.%/(B
M%TP122-['Z/GE/*)*TH4'KP'EM,\0]=7 4-@XA.'U3,C93U2:VW2P$ 0J\X5
M;:CTYAWAC2U51>A/=&=&SD^0]YH=S8S+^#:3GX3.QJ*N;Q(R7-[,X*X\]K7!
MP>]+H<48514@)UT#_L<$R+TKP]M+IV"6KS:U)?X=K7_QEI.C$KNJHQ7MAP?.
MD;WZQSZ^N[!0 GBT9.;P)IK^<E,> XD>;^V+#TN9SM?E^VDU&]AZ+>NS0F<K
M]HNFE;D@ 3GN[WI HKO+KAC' 6G-Z83RNB@#P;G[(08?;?4Q^UQN5U)X\*?*
MRI5:Q#C\&L#>\HG-^S4"K?X!TH@>%-*9"WE=P&K[RM7P]W#AG']JNO'^V-I;
MZ5CS (-<WLJ%H<='.C=!M6B_1,MK:UMXHYPK(42M%:>9MT**&XJ%!LU8SUN-
M\/]^D,3[D+9^3GI0XD[U >9A\]N\B3:7$;K-I'GTB'W1MGR*I2O"-&6V9XM*
MS:UW0,#?$_U> KU"/8$=8:I!8>$5J/%0_?YU\6@)@]BOC<ENV_B <KF,?6^X
M:EP^\L4AQKE+1>Z\D^U52:%KAFI!Q7;M+._)Z]/8J1VVFA?<L6O'];K$D<^R
M"TB=$ZQ,"9,8<7;H_0H3&1LIW39J-[^30QO>"#Y:/;ZV5, A^=1#UIIN? .D
M5T@AV,)BWN*HY?P:D")4'!A9,L3,ZL57:^IWXCT-C@E)5TW+;_7&J77MLV2+
M/\6=1"#5R$N;5#\6Z,I(?9NL-#6GS8KAQ*@)D"W1<K1);' XNW%]MA7.M/5\
M.YJNHRJ6V1'#-5LD'4Z+4ACP;]9FL:X<S>)@_-,NTEIA96;I?XGRSQL?D1C_
M[+@BZHW6W=W]UY*3>##)N:(!36\7->HZ0[2KF!Z<6)Y[_+ \ GF(\:3IY#OY
M4PSV6#?\87^"AE,Y'E4D1G+1(S6*"+K+2,7LH_H23@2PS%K/'UK#.@K"+'PH
M='VUDCW[EF(@#-#.ITLBL\'2)\\,;F\;36 =4M#\O$&>JEWF/7;PV7 1F?2/
MC_'06@TN__E(G :]:&GE\OI%#O,-=R$&NF9;%#0FT[,12?Q^^'HU)9S&^K-+
MW_D3:%K_U8IN WR,&MLWUMKKS9/ZH)XY*_<Q,U^'(_7OXKT&VU2P2-<CD/C.
M!GBB#W+W=I&H^T5S\37@V::B\.\BPBSF",^'B**[SUIEU67HDNP6ZO@-K1B=
MVED1XONL<O^[7TXGCT)E 6:ZJ^H>0<GH)I+=1:'.#1K']ZKNQ*L&3J=IAY-^
M?D89&6^3R>E 5[[X6#;N]Z319QEDG6WV<&J6?;;@I!F<3?]55<E1R?=MN%G$
M8I C/B2J#%HC?"XJN((;C@>'^H"ID>$6)6D<7TT/+0P8#W0Z@\H3SB."K5;,
MXB[4. M3BB/*6G+2'6!]$&>P%+?5@(#.6R<IQ###ONE\>(&2/R;-SM*TK@YA
M>WP-D#U)$CFD9&\4%+8]\VVY!K#T!;6([W\U"]]4XT2J8_89'D7!FVWDA)M;
M3/5K;/2HDA^,$[\P?:?.G?9^]/C-74@8\!.N^R3F:$AZ*7AMN)IZO0026.K/
M;/F);G 3X*0*D5HW:N^Y _F EH6_1\5>C;U02]11NX2OY]XS\#V^YZ5?N>A&
MNW,E<PTHKX*Y5-W"^W7=1EJ=B\X1<HW'=CTJ^6EC*K[UU^_V!52ONOMX2C6'
M+6YE?5XW)HQB[#'EWRSO\V[BH$UJU/["8'$4*R\%W6F.QU\M#G>%OJU%QK!R
M@7J$7LD!XC1;:O@7/LNHI8BE+T WTV=<^P0\T-9H8/<H2 Y?#%MNBSIF>_YW
M:QK%7\?9%LTI:.KH0J>CZDH:Q@C^[LFHS?*P12I($D]B@LL^;L0$<]_GGW2_
M$"X<///>$BY_3NK"$_W=3XR$YGO<,2G'>M,UH,;9GT^T_G!J451?$B++:>F5
M*M>8NE99?>)_[E8Q;7S1Q.5P$\(7H 46F5U^7+C$;T%2[_"7=77#,WM4Z:*\
M(NH-G%"R$&L9(%P2?0(9T5A2XW [MCR:COR'MN'L-)Y$6I1W>I4%9V"T66'+
M\0OZ#ROEP5^2?G\1BGA,7I-F(]#[7;?H&F!V*9QM?+CM5?ICN0@;N+?OF!;G
M5UROV_A/EO$0EHXEPPR]IQ:QL'0Y]M++MW,SZH. 9:J1:6.*5SMT57_.'_?Q
M.I?UJEPUXA7/%I?;/LD.:*_$F>!OUR:PVP./OXR-T*:\+<NXI\CUO1! -+=D
M2O][JGC""633IG;@[,2Q0VDKE:TT*XQMP2(66@_'-JNRO'-1S-T+W%':NKHV
M3,.8E9<38&=_[%JJ'ZHYC-'4/JP=<I))NO&(Y;$:@ZH84(TVA)F0=FO\Y;B(
MZ#]1J;,]P5%48(S8?9U[]3A&AB7'<CK/Q_-)R/=-PVY2-5,C U8ASM2O>#N$
MI,KU%&0R=8$HY451^0NQ?ZH5^64N;0<4OZX!E;37@$WNRNDOD]F)97'K.A$,
M!MH_\F,% /]-*Y3LB ENO9:@=^A.E$EKY?!!]E-A@;2EYHU _P]^3@BY5_Y]
M(Y9S59F.!#X,#>'I45C3T^)R"*:GK2%!4#0C<%Y^:(Z;FG^S?S5&N2S$NNQ/
MWT8S]2M9L2*C=*>=T SEH [DYD'#Z^.TYG]N4_6)9N/CNCE'X"4L\;15BL7'
M9^/V4[R\K7GW"X&>LRP*7ZA[>1;*NW$G'7]=_=C<0]A&5\8K.71D,V:>/TR-
MTG1$AVM2\)H-Y-(AU1R6[7;C[^S=?]JI%TAMN-J.>5@R"!H<8DL!T>E3-RDF
M#X;+BQ0E\'3[*8IWQ V9[G1;#D>4U&>"@Y?+=<'4B[:WQJ!VNT4<( I)!5)!
M3W)YND;&3=U;>60&4Z/8 U^;D) 7&Q'Z,C[ %Y\]8^J:6IMZ,RS?GPKL .LK
M _<2\[<6N*IU1<4ZIO5JGKY SW94:Q9F)3,^(>&O=0_A(MCIINFX7\@76NIP
M-RFU.] QF0$>\XH_#&,]ZI5=9@O]?5Z*I \$<<9A=(5W(FK.]>+T"B\S=+A)
MH[3I:5_]7-85Z:8LV]:&J8@O]\9B+QR6LMW E%O5\U9HM'HH&U_YUC&$W!?,
M=YM.79$^=QZL^6X;H-"W_*,Q"UAU.'9YI?42<N2T.X'3+X('V*!/O6MJMPCW
M"]6HE'GPE.VF0.9(?EQ$X0EDH>]M1I"</!6NF<SBBR#9*WV*6A_6RFXDR7*,
MC/'H#5'2=15\E%5/WL-#W#<RS(.&RS_*<DZQ4W8-)0\R<%JZE!LPQ^5>\!(%
M*826J)=<%L]&Y@;S322+7 .07X3VM!)/DM(@:ROWA:9C6BF@5:^O 9\JUX-5
M9+/=MRR5%3U*IVGWD[=I61I266>D)&=>K:.T>;V2A?.-[07?7SH\GV_]5]4&
M"F9*?^R*^3E>,G)$OHJI*K!SZJL*1V\Y3>XXYV&G%=6BX,%VNF,/<9_!G'FN
M*C&-\'$'N:GC?GDXO02)HX?YLL0S.6CY="@-4K14GV/:EFU,[%T"WP?>C(Y'
M3O&0.B+ACL]4=S\R=@2YX\0:,=C03H2B7B)J&3Y>]XT?+$OO,.*\UB$Q*-U(
M6/DPL62B]BF4RD><!%JKW735EZA7'7K;$K6MQY!T=6)HX:=M+4RW'[ZHQL-!
M@FHXY=DU,3$=JU^4WT#-TUBAAMX614&!G=_YA%T]S+%[L]N+MHE__R%P:E&\
M4YGFH31;H'+)OC:@P. J%ITK[;'?W&N;982]8/]A":MIS]OZ!8.+@P$)8[*T
MSZ\!P<PD:Z9]?S@X#FVYG'%^%J%L.QDY5<!*Z^W$TODY"[<I(]<=D @-T\Q*
MZK>X[.90O[6#CR0L'-/,/X.D\32=H5&CVWJ%<M\<<-GS"56R18-N6,_#D$WM
MU]5!@AP'Q)\]#/YL)C#)LL5VN>VVJ:FE#RZ5?3?.+S(TY\]OS R)=[M<:-ZO
M:9G]5YGG6@#5TJH=$U66W'!53/U;G=S[8GST1[P3=:O.%_OGYJ32;RZ7VX=T
M(+C%#GD#*PWY"+A%0?WG3F*=DHX.@3[>_/ VH>1!S\>K9]/#.22X>$1T4<R%
MY+MT>5];T;&Z^WJPAW!$;>S"XT*2/DGKEPEF?-^?1]0^FF?=L.MH([DPRMM2
MI0=2JZK0V)TS-8+*M@WF-#GEOTG4BFUV9PG2)B%\Y[S)?T+-C9J.CT-Q[/MK
M8*5\P7>RP,*K&]J(-D[^ZN!XZG[2;&F5>JQRBF1=/E7&HI@R%KR3AOC=5Y06
M)*-G&]:^!H_YWR]#M%+@UHN *K"%#T7S5OKOP4Z10(%YW@8>\G>&#6):[(F/
M]^U441>TTWD$KW+++4O?YD(@PI3)T]9B3K]8RS5PK0D>PY4T&;V@W!=ISB&I
M%&]W#8A@EDEO9;2RH3%15 [867"S#&GDS^%)D*8K<XR=.0VQXKQ#E )?\_0?
MV?XW'HIE#XF]O-*>=2COXSMB_FEUVE<>I"(?TB:]" I2*)RUL9Q#;_F^MK9$
MQRGYYR,TH&]8NK2?])>0K'% ;)^MC$3EW,4_ZA$.I'ZE9W7N;%FO.]AYO_9I
MF;LFHQ-T\&]*0E"Q]5GLX"^"?+D6GL1THG)YRK[U:BIG1W?*>U:$#.Z+O6?N
MD)K);$6KG_:6]:4 2F'(B*"%2[?#C20J\Y79$*Q=;Y=L^<EE9)^@WGCY> YW
MZ1XHO)N[=?K-8X444)XM:!1QURVIRF]@;;;U<NRPS8%#PZVA]]4G'$ACQ*IX
M,L4 K'VDMSU?@7"NM-GFO)V@3[<IS]3D;^7RJKS"HB[AK= U0"'-+@58/=MP
MY("0_0C")$;ZH8(X.6M'EUM_0?,FF%_6XN8.?\<)S'/ V)Z84-Y5?T,-:94D
MZ&+L:"V#C"9-IXY\6MZN"ZN(H19-)'BGHLLX3QGYS&=?P*/<&Y7EN>3E+ZB7
M5.PZKI3Q9)<;4;*-!:X@[+^!N/NF J)Z=7!.:UMWX/LBQ)N+*G8'O\8RXU(A
M#]O)>0O43J#6Q>*<=?7C6;//JI5?K=SVZ$*P&T T.$*N_B3E[PY\_WZ08A.>
M[#C5K3XFM,)FH&1>V[N,)_(*VDD1LR$9O?:&DHI)8?Y#UL$U@-KV0F%:UL*;
M^M&+\:F=<YG<FOJ$O[SUU((C:;:R%@]<67*_IO+%;"A4B>'$.]I8")HWR55"
M27X?1F 7*UY'/FZ[/:O:^U-[M8SJ3M1<L[$T*S%=ET/L_A4]P<\ZI4LQ-^;"
MOG#1DE"\1P1>'Q"]L7KT_IPHMLM(R>&!I#,@9:32),#8M><5H[C3Q8"9;_W"
MU#7@ V0);XY\OM53?U\# 5OF<YF5AZ&:4X+W)_F_(Z]$<"K'I4W6;0ZI_W1F
M'=* 3.=\67B-EE2Q._XZW%K))E;O(SS([TK]NP;0!DDAQ\$=LUMIIAF,>5;1
MX'\ISL=6_NW]T6OQVCKD[QGL:Q.\S"F7N>BWU.A6)RYD"^RVV'P&IY.WCQ&6
M%:#B;2H___==>1G:Q5].G3+?1J 3OSE[JW+A7M7:5T#1KU,Z3@XV U+K:CH+
MMQ&^TX@39LFEVU0U+U?>!B]Q>MSBTX06[986%6G5A-(M' ,/$9B!LV$QP]I\
M1'+(:KT!TC*X,CE0:3-M<&M/60,WM=\98%MY;!F\EUG!;3XK$O!,3W3L>7<R
MWZ?GCD*?OU,B[CQ1AKQ^AMF/E#L[_O[3? 9ELQ.06NMFB@@PC1 =&N]:+>]K
M8K'XFFQA]5B!EVTYB'W)C@4*?DYP\!&/V%MMP67:J?N5P-9*_:<P<I2\>NO8
MAZ^(J(P/?\L$J1"$,4,D7:HTR9CM%:W8WJ>-D=OG^FDHS017CP5[<CZM/W>6
MF"@_5U'OP$N7,47G"]< 5R#>5S\_$3:LO2(YR:=W:6%SL#@7H 9!E%LIZ%=F
M(<!&4[)ZTK_//,J68>0G6F/)VWX-(,Z)K?[^SP5#WWH_";/V#K[2U"^#459%
MY3"VUM<@&G'#B1"P8Q'(/JV#7YM(X2&1M<"C'$EKOVYQ0%NTZ@,HO:W=W6<8
M2A4IJZ]M4>YD_<K/GT.$!9QT5-V=>4I9JQZ/MC(0AH?W.YN\FTA$*^/DFNQ>
MGUN3*W1/2%7P,8=<T!G?_TW; /F<-/3JJ_,K:9.*773SSK[_J?C%G8U@=[T7
MLALZRPH%WBDZV/.6RRDX,M>I#RR]:55U9Q,Q%#*MJ!+1WB:962M:(X^B@AX,
M?N=2':1N');LYF]>5J'O)B:JV$2%5#[@[3[>,<X=>,0JW,#A3%+RHRK3NVUV
MVNBJ0QNL+.GAH?51#!3[/>^T#BR)#.]29>V0)!HVT237)+.=:*4C#!@F;(%E
M_"9D=[[)0(H)L;JET@4L)LKXAKYUP;OWV[Q9%-PW9$LF704#&^);E-,/?2^8
MC;BP(L_S]I=L6V2#.2HNA_9+@"V6*M> JWMM-,$YZXOG%"\/Q Q92N)V(=A4
M;I88<U GZ6\4S7PO2V'*[RN.3'-%> [7V**QE$CQ:46!=+HU"'3NY_CFS<9G
ML[CY(,86).X:D&B[__Q[G8U1EY<U6M=5ME9?-/U;C497R0#T8B0[+RG%]ZZV
MDM=.+M6NCZCT[P#9RNJ2F2W+KYX8H(JB;,*MX94PQMNO(>%/LQRS(-:I/\HZ
M,QC!L#8:LQ+]I*UE-Z2&G;,9=3_,&UNT-]G*Z R[ D]L;>;''B9"!?)C <(4
MKW$TD;(@L_-7YYT9>GM%J>!Z:_-NWEEKD%+_!@\)!_Z#U>1RCB!!"[:3PT\H
M_XF:[067;IOZ_MI4C.MO_L!T+D9\SXL5E$=Y3XK&^ET3;M0P!7FJMCRVUSQ_
MRC,P*/0BBV= "V6#18VFM(X@A-"F=2I^KW$)$>5N4RC8<5S)@EM:<U <.LY\
M-4.TPL)7@3V=2H=%F4Y/3HW"Y=Z"W7QQ5''1U(_X^ZL[KBR!J6!DC9S4T@F%
M0M6W"Y/E6U><4#5]5WB+_LNKT2EOO+]#);4L?$NYM.C1ZH>5Z,\1\^O(0%P)
M;QDL-R*4VKT.J[5\552RQ87B9![_,<&#S#E;N#6Y]W+0!%GG9\'LR<[*]H2X
M:BAU93R-6C,7?HP"G0B?[%4DYD8"A;Y%:&W'9<\VMYBL%@2^7]1N1HRZK@=3
M_R"8/<?!O;3R-\]"OJ3<&Q.-^/F$(R$B_$-N3QZ8A  Y<OB)B/I7/TD5)]DB
M9W#:HW%>U>:![:P>!K8K"^.>F=6.^SPLGX'&VMWK<PX&^@0Z!9>T@\I$:B0?
M#9&,^$+JTD<,23Q?Q(;O+&O%H3L4J827A5GKJ+F/UW:Q.:C?5M::/0_8SN;4
MTEM2K4Z^-#JAQT63N$RBE.H?^K;].Y:Y&H7MIN+$^FR$563MYD>W%[*1(Z9@
M $&_9VI!>'RZ [P\N^XO(N8C,_ZV+F?+BFKLF=AXR^TK;H4'>!O.>-Q&IR+G
M1_Y$<-[6>H_+F%+IPIB(#9:%6N(."2(H:6(Z9@B7VW4-P&6X6187++?#""%V
M=+JAJK$("8F6"%B_%O_L?8-Z-27K,M74S.(+,CSO4$%Q>7ZWG\/=I)^:]5XC
M##%.O)58$(7H(6/_E\X(%9I^:J"0Q%?#L^ZTQ-;ZHX-_TZU1RI(F]O)\'Y!U
M9K667N)[ED,ZIYM[L+(]Q>*XY3;2V:UD"ZB<4H3N$1/>!67]<JI&)\(5!Y@!
MD'@E>)*YSD$I.IE]ZWW'"5XZ&0M]V5C[Y!Y^;5:TUU<RSZ+,9"VC(?_$&"0)
M)MYYJ>J#MY'C--MZME>)RJJHLK]&7!1?',B=:"8Y>">7$(@+[ IAQ5-\.C(;
M=8 C$5-U@CZ411GTCV;6GG)3/:/KU^$5&![3^:T\=>>KC?PCRS&]HX5IA&U;
MV;2(B?94O.PG#SJ#K3J47I!B78';SO*F7XC8]!7CYMF8:]-59G'=7A+HSD>Q
MZ/%>!Z(WW)PNT84ZR8#3,%:LD=[*?F1:1O9D5IPS0UI _A#$T_L[&9QYI*/_
MA-/L:PW'-:!"-"6G[F/5!3L27]5=16_C5N7OO&RCI5>'<'"5X<%&RE.-JC[3
M+O^]YDM_N;UQI!^E*N+2RK\I%\+*C^YFQL>IJ.^!IJ86[A&G^]#Y?W1AO5.J
M3UP?H2Q3P+#=/&NW8#HU/>\]K<^34<G#]<KKJR=^;3W9=@5T4&9Y'*BD(>A2
M%V#96[BEJD (S+.VB9?<A>\TP^S.I3#L-BKY.<"]$#.-)X/^C_S)_!_)(A?O
M!O%/"3L&B1>PRWZ;@S6.+Q]T%0(<*1'LT0"/G=]53&,A#(1F'4*1_4IU$>\0
M&-H$=(7Q<IM66SE] ,N#T>L<=&8*E+T*LF7X\F4QV$HN,W#Z&"5C^95F6=W)
MGK?FN=PB93$$+DU<09O ]2&21SG)HC]>W)7QSI2>3?.B#6S<8_UO-Z:U2F&R
MPZ:[CN6@#KH?7-127Y\8/+J31.#J3'KZ5I]FRY6V'L@=Y\1BY&%>'<<>LOS6
MO.IE%B9;/OQ"Q3-=4"RB^ 5"H@BY?0Q)$M&)CUX4'RS_$ 9EP2")-Y9&8MWW
M?8QK1AGA@JNC8A[PACU[@S)_(8T)1^;VM[U>S \46'DS4JX8F:-YDL?6P7<N
MFSLZNYC3;W90Q&7^?- WQX^.^E>U?<N=\FDL$8N]INU'4/!1XD#=-2 S< L]
MJ-IFM@QE1CN#YL X$,A[:D2[KFPG]ZY9!Z<4+B&Q8C.' _YKO"#'520ON8<%
MM:"15.!G\O+3V]<');P.LD,$1'LK"Z%O!6OW$IEBB)BX4')FA&-740,>^'F2
M!Y(5HP-UO>DGDP:1GK?O*P_W+NG'I'>&T([7#7&?G>C65D^(>GACQ3 ]%J#U
MY&TM'3.LQ>>]^+"Y0NT&C@3U&3Q%>TO ,9CAY]:-L1;UN_3T6#C7Y&#,ZNM2
M*?4Y8&MZ,52!D[&1?4Z/6%2$4H5\G!Z;[8-\3Y+W*]-#8]I%7O&WLF4+-<A-
M-P]63"[6OM]L0>OPK=56[P70A'O;W9T1A17G4G+5]#J)=OWA!$87Z,76-+)Z
M4K H&_U;)"7X:?Y"5H__HQ;KZ3]Z86-E9='+X55&>F_[)PD5G<+N#46JGSX.
MH1E[."DBX@U3%_VBYU LAH:R<T'(M0'>2TF;VNL(8'O6>A'?4.C$^0N9,D7/
MY.*T3"O@7MM@7PTN+:IX'FUCZ=(4#)NLX'(*=P$Y:,5RI*P5$*6^3/9-4)"E
M3OP0)%\\IZ&2&P4OU\E/K>1)IA1(2M9D<285IWK2KJ(-ZQ<*+CROU;?7U8>X
MKK951EK@*F-1K*,)B6^\O:;USX6"<_?!UP"S^+; ]:WI''@N+F8SQ$'M6"ZW
MI;+[7'[6B'_5^UM6: 77XLZ^)=SP.&5/S4%?W\=UU4%KJ8U&@^I>\<=BWM?^
MK<9 9Q;SB[_/FS47Y,.?.>P[9TV^(T"6'Z6Q6G6<">L /C_?T/_TK8/J@1$B
MOJ5ZO,[;V"30,G?PZL"6,VZ!<D^3;R-<6:GTF1_UU(>BN6X_B<:&!.#C^7=?
MJ6YS,)YF<G7Y%\\1Z#O-ZJ5FK:&!+W+ZK3[Z\2'3#&3 "BQ2J<+AJY!FF,>H
M+DK_]-L"9US+4NNJXS6@XU'>.LEE?,DZI9$#\YE(:#."AYQQ)1K?,]I;)WH2
MX:UGI!6E@QS=%?M72EQA*HTJ:&<QB+CS"<3"0757V#36=BQP+J0G.V/-\I3%
MMY4,-Q_]V>KFW@A:+5[)4U,#L3^+_,]9;!EKWBMR'!K8!"GC8&=HT9%([\ /
M0)K9'W0SSQ>,K:^P[]N$#D(,>OF;V(1:8+J+WR]7+VWC&_T96^Y-:,0STC[E
M_DQF$$91I!@KS//C/Y3H_QM%4O9RU<GD4!/R,$-$2)E:@ET'V^O)NOU[2$3;
MYK;H D:[P'S7,:R_6L2=SNK;]XM)%#4@$,MXX-MX#K$CV.E-K4TC>?*AH4:U
MH ?JQ3N<#YIK!9HB_L2RBNTYC:>A!*8DE1-PNN]_H/_\R&*"@1X=]S1/M$JX
M+!!]?(+KJ0J$B'XR*^F\$@'N1*=MSU9J3")OK$AU['%0L>ML 5?+:Z+'5$3_
MYAE7<QX3+FG"KR0(7NW.6N?O<H.._[H%],_OLEE/A[I8,;K4W\>XBCHF*DV4
M00EO+CQS1"]A-ZG5-< 0CTUK7F)G3\?]'<,N@6F 9HI1J/TZ]D3^J='QW=O<
MJCTZN?TZT3KWA/[L,H0%BVH$82'G^M!8O4?+]; B@E%G4\_W%6I#%49D+JVM
MN@_0N_85POY-KE[\=U$,(DV'JIB97('^S4-=2WPB-FHYE&;!3B[^,G>%^N&%
MO-=-9I 35:X!88(%DG7Y'KC^>2T5(S^'>A/I<+Z22B3UF_,:H!&TL0)&I7?E
M4@7I8<IIZ GTKU+T_RI+B\>\R^V\>I!VO&8T= ![D\Q<&V.J,_>"V3V!(GGU
M>(0+,T(0($.$_[O/?VZ,NTH$>PDMZI1:S@/]+ .UCBU@*\E3L^+N#S("YQ&"
M#Q#0/';-9U_4?]!4"51]4[8Z=[> ^O4RVRO+_Y3_  ]^U)7>%%DQA?LNOC[F
M(?HC200"^6.6[ -6H(?0?E5ZKZ^_0H.FZ+2EGY MOX44Q\0'7 -T)L7A9;!_
M#:*ZTK,S[<$0[N\>/'8BSSP+/1Y^3_HJR"</".QFQ,2<OW*=SF5 BBX/W!>L
MO%"H1*$D\%PHN0IF/],39KGZH;N= YWN@^8-[6F,[8N]XLMV:/+@=SWL\V8=
M]0'<);$B2*6RK62W6FJCYU8M R"5HXJI)'^-50F!.R/LMW5%*IEO+".;<7FZ
M#<Y4\C.(YZ^R3;[+<;T1(:5KJDDLH>E3HLQ[E%YIG#?2\\.M10\VGR=S'D_,
M#X3O'AY73-OC; M62I6)R'H_:-9RQI6X<:'SQ/:LM_]NP43JUQ?O%9_R>7<E
M2]\*L^>\"*,I<*G*4N4)F53EP66/?(Z,6;(1MT#@>F-E]JFL=4JAD;J/TG1G
M=E_2Y1=E=;H$SE?>)A4)C,2@G\Y<369@YE!NBHAP&30-^8W?,6^]W3H)NWAR
M:-U>YM_FE#0V#Z.UG01+WTHMTA(\'Z>[[ ><*<;BL<#CQ#&SKEQJV(4H4^Z*
M&C6TURQ=BY-WK"Z:K[[^N^C>HX[HD],*U<'^3@%FS]6L#[^!=O4JDX.Y=+E/
M<+M<L[;45P.M4:;(!E=Z\^IT@XPQ/";^Z:E32)\W=TI@.48>#5\*"U;7\ >W
MTW 1JGH,H0D#75=<S6-HW687V/Z>*'^]5;?T*X!)LLQ\O4STOMZ?H-%(7GK;
MHB=D# ;_:QJTN%*%&MMX9A=WW!02 :)J9<+M5?\D!!HW-[K^F/*0F3'#5L-?
ME+Y^!A$Q^,(KLJAP*B']+P(ZUU:]WU[&M)S^6Q'4,CDA?WP2$%&N2[VVZE>M
MRS@V9UT0XWPW1>>J.M-5:"#2Y ')Q^I+^-+? KPA(;&S*1(&R9_;EC>LB@2M
M=*>E.),5C/A#-N;X?>NFY'H;9VC2I,.!6KUJ]<7IRSNA#-0D[2A$K+BR"LPU
M0':RR8TMN%;)3I_#X$]U2_MWAM./]AD"4T\U6?BWZ.NGU9SL(JZX72W/.]\S
M90!C/*C8BE;)5U_]*L0-K0VVNM.)(A_^".I"D[\^-*NKFAWY'<*3TF7HEN%;
M$,J/%.V>2]E)WQT5H8^+-IWX?NA2)F%!C#Y](U5V11M&(S>A!AZ)1'FTK*AP
MZH)L0<\Z_MKJ^H!<W#<RG.%I AYOM0U7_R0DOV#P[V/KJQ[4>V ]-?S]7+\6
M.F""Z[JBGSZBH:>V55%=[#1-JY>81STZ!M7MCLCLE\HBRUD:GPPG1$D)">G
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M'/&2.CU..] 5>;UL3?KZL%_;&KP8.0<@80@9:B4Z-VT6-G=+[JYTH_RY:#Z
MH=;876VR:MCK&G!WEM1<\):L%HC[<B>K0.H+C6C*,1+/VW;;AX;==>$.;N%7
M6M/*9AK$G%!O ;I0YY^Y:-N-Z8XZ<T#">)5\-4G:'PT_35:A6''NWF<)DIX.
MHG'X05#3P)-R"DW2/X^TT>^2VMH'^_ZUMJ;>NO]UJ7<-+3_,KO2-NN&T[-UE
MRA6K3L5F4X6B9EG)H@O";#H#N-7*/5$Q-:S;]WDZQ/"9Y\\XD4]I3^22#E;
MC)NJ_#C-N!7*(>(=LYISZ[.[^4WU60O DB3OAVFT_(QAX/D1(:Q[U5"6(S%
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M@[&R'JYR(44O?;8TGR[\KGRS J7"N)9^D\P&H-KF64+D8M]AL!.!TF9\@;>
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M*F)#MW>Q37A/.CNW&:6FM4VF^N*+1KS SM70UK?+HQR<5>H ?*O2O?> 04Z
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ML]VS=T6LF,-J9KF#K?T>"DX%B?W.YFS7>^3Q>+M'=^(N<Q/NK!Q1-VM'YRV
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M5 $R-6(BO.&Z>S8]H]*T>DW82TF[+\656=[*00T_*W"EVY9Q)F0)FIR O:L
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M5R/V,4:H%*M5"T_;L$"Y]OJ]?4!XD6U3T\TI8ETAF,2Z\4UG8TOY/N[X#7W
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M.0(,[OIAII_]^A&1P^7V@L#R_*%SQ893BI%%4]P[2&Q@'Y/:_4!%/)+U +N
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MODLRSKCGK6C=,.E5^Q-U,9PS>GH4= 7.T*.-E)7N0R^#G"#%.W5*%3LC3A_
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MOD+%X F 2FK5K@1T0XC:2BBIEV.?.$@5A@'G51G-11K[&&+$'%8,].=T"''
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M,G_XUQN!F_X\ENW)JQ;6^E94@VM!Q0N:'HA@OR^\'U6>NLHX![G&H"AQ$T<
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MX2O5<X#\;[%^F=!AS&C 533K*,B>,W[N$5 /[G%R']*"5%VF60M]:/HHF6Q
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MM$&3ND&B4U?M:B_@U@95)YYXU%/3HZX,4C*^Z +EM]DH[#VX?Y93S#29>M0
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M6<'W0FIZ 2H%2-=LTZZ4O@<.&%5N]%2*G<L/N/VY?^3F49U"^G#E*E1O7SV
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M6.240FW-@UAON;&/D5*;07^3[:&0*PT#-+2@T";WH!STW+D8ZJ\BHY8[2>U
MRS_C'6[DAA.E^2Z1:Y4L<,LXUJ(*P(VT^[Y4JURE.SJH<DX3?[##9[UP]"78
MJ&3+_,D=2GR-VC0A;A3UQV_NY7#.*:X[15-]YSKL]5(!4?=]%VTW-MY!8@W:
M]0VO]\^\8,I[IOBMX:-,&^6HTJ/0D(LNR2/2$AX]!;AGZ5ZZ+N&2B:EOFJ73
MZK!W0OT !L76GBZ:V(==L?6-8+:#!XE)OKARE_RV;]53_3TN8E93-FS/FO31
M0?17]">Y2)U%,;T">?;?:I5V^^PU=Y<.17BDOTEWR6]]:=R7/^NG=>-ZC)E(
M0RZ.]>I&'%C&GK67+/SR!7[H?:;'TZRIAIK;6H;?>Y7EI&O4J7LNT-[2XA-6
M2(=5F*9?] '[?7+ 5TR&6,L7#2@=70)_D?N%Z5J-38M<8:]])TD^?HR7M&!
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M4 FW<TF$J+DTQN F5O$YI20A:H_DB^=C!'M A. ^#2.D2B!8L>.OGDJ>ZNN
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M'Q6W_D<+'H7_D^ZC=##U!U!+ P04    " #-A'%4WDJ6XG'6 @ $OP, %0
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M_RD$#1L'!P\7CPP?GXR=CHJ._;^;D!T ,0[F);X5!MIC )T8#8,8#=D#@
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M%F,>XC>QSX]62J6])1QNON:EX!45'CM0_Z ;Q2[PHQGG0CP*&.;S<C)*6C^
MV"3-^VF@/2YI^MFLB$G >T2D='7:*T5:-2;%;0#7&]</KXI6BYLR3_[X4RLJ
M6!$@.-TU5D#\1W=>==[[R24RW.5Z4%N^C4CM>3FX *#)I +7.AU@S!9!Z'X/
MB1T-UU*ABQMSL_[:B?6LEC(;TSW9[4U0N=\L#!NAHG2#Z%9# CN*QO8Z/4C@
M 61CH[+]0) (\?XCVI%QS4BTHSM1>-VUUOL"MMKB00V^+R!F+ .B8E:B*L96
M9PBZ%)ZU$3>T)X,)YJYAV"TP1%Z>\W.L8FJEF?Q1Y&("P%CH!ZN]T?LU\"1Y
M-?H<U!AL%V&PGBO6-W M-S45,$137G[<166?]9$V5FKOS7:\1,46=R']>V%C
ML]UG])*PRU6A%"AB767R5H I_E6;9>3A1D+[A\>!<M,2"7(^V[2J$K!#$)[?
M*X^U^-GS"D%</;M29?UH40M31?\HSR15S:\5JFX&X8<F97.QI,_',*-FG%QG
M[ -/(DI>D^XF]8..4N?AE":2*0?[WDQ[KPWOOGF=\";/5X-3:8"K[56GD#S8
M91S7K813WK>:])?U#M2;N2K.V,_=8JR"9KZ\O3[N6P[.((5F=G^H\+)<LA-/
M8S-3?*=R@A_JB3^\YBS-  N:B5?AO[!"95[]1'=>([>AOO6'J(R%25X+"51,
M(X%K46N,Q+L/YZ*%T+;V D4VZT/NG$\"+.(2O0QW:"=(0&*F?6:H_9OP[=#R
M!2KKJ=W?90=8<Z+^<F3+DJFA_<9_&W\^@;052R(Z'WA&L?,O,'#_-7!L5T9!
MJB\C)1Q@+&JP^XG%N^IZ2Q%N#R>^5X0^5AC!BR%:&%&?;@O-">2PJ2OH5ZJI
ML;SOL*(0C19SJ,9_K97*FD5$"U^%0@SA*26[.C[D1YF.G*M>>?H_'KI]PB2N
MI;W6R?$B[;ZD)X?2)V8O#9#-4 @-D,53>/+2?P;6H17!4<#5\AKX +8&IKI5
MFO0X%-<:7ZUJ\_H5.2?-Z26K>?*>X6Y)RB33]AP210^$K(&#\\<R3!Q<DS@O
M/GS]'J>%Z2J)PTDT(UE:A<J:GD^TX=R:C/$P?QW+_]0WO5HWY&)3&I&=X#[
M^G8#TN&F[U-_4%SA+<0H-WUV9<E+ZL^\_CWPN^IM-5YL,@9=$JZHA!7&'CLK
MQI#4TUO!22D&.%Z_TKCCX6KKU_0GQC4D) :,; :!"A(;=)ZW\N&OH-'K'@N@
M7Y<:R\H%F1_SFN9JV\ +I_SQ<$)_;UG VZD3$K(,+>?BKA04+ZH4C-[ 97Q.
ME(*'D1ZERL*"^>5^2!R?]T@,J/JL[>GT)HSR?<7;^DD68%'/@*1JL,/,YRNV
MW5M7G,[]Q&'_:50?4<ROAO='B^BHUF1J!P_)];ZIW7P3>*'.H]K5ZK9BU1U/
M!G]LZ(@$^B@3!UR*(Y[WU1/RQZ:=&,937X4]5?4YWV,%*L37ZM_SW'I ]Y#
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MM=\4.Y3YWK*MSCD%G^2I0]9*$G_G>JL+19O S-&A7A^Z(X^E'U,TU4)IW#/
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MF5T%#;]HK_G@'%_:*2&#0[I[0'?#\3-\)Q#OT5:\_/'25PFWW3<XSB+ZS<
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M^UJAW_SUF7VR)LAM3M(%3HVH#+@P=7K56PU]9R3D%#Q$T'0Y1%M)A0#VK*C
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M/ _'MS&Z5[FU;_Z["8;_Y5OCHV94OGRG%II>UQ%0HV[33CWG\P8TGP6LEJJ
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M1V5@<V&]GU 'FG\H/ -)F9$6/7?TDK$UM>6::<G"+IG.KRW_0V)#^!<MGV
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M?1-2FI[.HJ[LG?H[[O7?X\KD;[*EA_S39J)N01*_V,E28HTSO_OT9!^OX>J
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M:<Z.S(\9<CXL<A\:EOV6)O.1_'#%K;"&>V9%YLJ2A/U#3^KF?(DW[#( 46Y
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MR%U>1V;DJ?7U]H135 :WTO38WTAR>E89[3Q&NA:%<W=I'7[M.]>^C"%#"&Y
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M2P[YUU2N9\-K\5%_CR@31J !'%^1!/![+P^H/BW8Y>#>6:637<4CP=H>UQQ
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MZ>CO!-,1*SPJ,'V^_.QS-!H (2W8!P$MWKJ$MKDYE9NT"Y[WB$3LU4JV7M"
M\2^YUX(Z@/<\7E>/9@_O5XI:7#]R<*H/Y-?\XBW46T\=J!PA&G]F/>/< 9Y-
MQJH?9O(8RI@W?JJ$+(WE #,#+T, YU<GUK- U"NE8,C!'!H@_ZE$KD3@)A4-
M6/='!*$6FD^SV0 P_9FM+CUJF$!]X;Q+CO(U@:9 =Z1@)$/"CV<,'TG6H%I7
M]#*("=COE\\/5,5D(KR5W)U0.L^HY,;<W:P, 5Y,32:(Q[ Q641LH7E5_,'
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MBO5/KE]:UW-@+1.<,DP<W77)[A7G,(NO2.>,>[> VF/=5[*&97&J_)R$JB;
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MSGL(P@:.0HL;9/.F.6_.NB6K]AY*TT[@"Z21;V<4N^Z$5'L%*F\T-]A502K
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MKV& 5,$6#(#D\L, P2DD1(C &MV]#_=VR/.F56S8U8>O"G=LO3(L<46%Z&"
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M2JK@7<V3YG&4^/XVUPCH',8C_!FM6QO-/O+F(<.G=\U"KLAO>IL7@B:^S&
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MIUY+9:=&4QSAWYPHUISA^;GJS8(!.A_N4UWXK6* ?B5WUR9(8(U$:BJD6:E
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MAR!PI^SBBM!@N\ IX>.=M5K*7?D]G=@,C=@P-A[+QUCM5O5__PB,CW&):R%
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MS_;@WO;FQ"OMA.&<(] ]A[V-$.!LJSV9^SL<[+\G<*'!&CT[S'ZP )26/M#
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MVPJ$Q,4 2[(>O$488) & V  +"/44T\KV"'Q96(06MK\"H04/E]*_(CV/L4
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M %YP70(R9*12?8!5:7G'JD?DS)DIS!C(\A"&!T$)ZR.*5F[>&A&-?VQQP-C
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MJY+;R= Q#C.CQA<G7C0=+_;W4/ZX5%<R&!W7!]NS#ER\*$XM)GWD_4'_Z-@
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M==AWU3Q4.294[<*EY(=.3?#"5%K4]8]9P&[RG0DH7@P0=CQQZ0ZZO O16[9
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M7?;>]!H26#-:>(KF4-C!M0MD)# K)&G0HG4\*=Y$/I6_/?0UM7B^#X+G-]T
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M>B,T7>$YD<18+P1<F@/*LER8=PKB1,*0,>*?.,'+%"/@+?P/-X!/>4@"<*M
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M'U^?_Q1"=IT\NY_RV%/#XV7_08@,N(&=_A0];Z'WA>_$.I=C?-7>[+)YN5J
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MYHI9]WIC2'*_%&R0XLU\W,7_IJBFW+D,11)P@NYS+<?8K<V^H:3S(4D4F^(
M(A>@FV8\-HUT7JF-)FCVE HJ33..S9\PA\>6_2^#7]\?9B>3X1%;FY^5%_^1
MY98N/?3/O+==YI$>1AR+ALQ.00ITN-ZAOE0X7S8AUQ;BDGRO/''HC'7D40:F
M;8",Y@\9Z76&#2+D.PSTT5X6+X%(LH6&X7?AX3?6LT(+5!0;2"4HX^=+>/8C
MH*X9TMXSI+**1@W]FZU)0O.LJX\JK*0,'EX&MCGKT#?[T3OW?P 19 *["DJL
MM#:!;7M9K?"F.FTX!N ?18>%-&9#&,!5_"#(&OT?.=KP6T$'UW[E;M+! ,JA
M>V@0'._\-0:@#B)%LH7&9\?#[+'=+O_1#=*",P\]O8(!+'F"D/G@2= T"C)'
M>H:/3O4#PM7)+JZT_&^N].<IFLI!=4@,H)GKC.C74418P&6V_=\Y"F(#<4=@
M *] 6Z!33R3DBR0#%H5Y3Z!N,M%A\9#CKZQ1&6@R4F(,8% $ V#NP@#:M4XQ
M@&,($'D9W88!Y$"#493-8=HJ^DW8Q=K/VX LM35=A)2\\K!&OVXZX>/% *A5
M-C& BYNB/@\[QP!:T03[B&>/8H<; S" -Y!_'B0FB3^?>59K#CW.<D9-)DS\
M?'A72BU1& #V,JL50=9G)57+H3-#**)BNT?91 H&4:ARIPJ(P 2\S[LA.R#S
MVV<[5?%Q5D9&<_HFZ8HT0Q5:+6,;5^WNM2\S1LDB0>CKMI,RAH>WJ\HBW2R.
M'Z-!WHC%R;HW.#J<KP#7 6Y9Z37T]M.IR1;7N>0,+_SH,S4JEB#E.?^TJ'I-
M_RMFO,\ ^0T1(;\0(CU8S.^G@97MMX&U_-]!PK_0$%<P8C=J 7[ G;,>7KKA
M(";U$' LC0Y 2".P;W.!T(:O\6.F>%?>O=;J)>, U-2@VX8ORB21Q\K3VLW=
M[6Y_YYV0#6=3Y',1D0:I*$K@!T[W'*7-L2/L "79F_XA>4PA&*/8GO(#BQ[W
MU2\S<GQQ&DZ@WKQCL<)0+$)EGA+*]TB?/I1/K?WZ)YY?W^^;%*]I[*C=<^Y\
M=C@0W$0N=QR7L;FWL/K&?WG@=%;.XGS7#P,P:]0-#5+L3ND9.=$3LNG(?-Y?
MS\/IX;FO@&8X30K=P[XK*'GCT++-S,V/Q_5W&D:@36N%OKZD$!A8 T:2):8=
ME^D;0?R0JS451T5)SLJ!Q^8_.@+\97L=^IOM]?^V_[S]Y8^DN_%7_1A+>.DZ
M5J5@47;XX8/_MRC[?W,C)40F!P&!9GS7*3HI22'O2-=-O)7,HA"IS9WYMJ>A
M4?$&C^[ZCBY!UL!9GMY*8.UX)162!"L,H!<+@B0KIG:4!WYQ&643>1;]-1=^
M+[D7?C"?'A9=>,:H_O*,,;KPC E_WW*H=TD^IG!=O*$CK-!H0^\)\5$I 9DB
M?V9DFY>>)U;O#3_KI;2=9H)B $2;6%&W/Y\)F4V$()>])EY+JGHN1.&V%X+;
M<=U)AB]]YB#8*[GLK[2]">9<*>>6E"NR/0H:;]5OJJ@28[WN8$J9VL0N"N,E
M3QC.(])6$AA.B\PC,,NP9QQ_C9!?V5]X$UFS0%U9%5*$_L+QVE"7F>6S1;S4
M=7\U+WT(%GH4SHC5EHX)VO78%%/P<O2V5RHQN7/@R2P]/5J5\H"E"!C1^+&,
M'WS#%7<KRS5Z**Z -Y(>U7S#]46$FA"[M%Y<?4A.J$DD==S(Z.F-G8W.>=Y6
MW'*[-*%)^4W VLBCMN37YX-JOJ\.BXWG1$*YX_MW6Q.T<:L%Z,,>;Z,_DUUF
M/Z9WCG)>-^/VA+CG_O \?3,ZH6W!]'2/]KG7TWT-KE+1I^:%.3<#_*]9?>88
M?F^URV$'X4=7CREV<RFN6TSS^%WI<5K,:1(9QP"^#9N<IZ5QSC@0.? M7N]\
MOIKS+&RQ*6P[J0-(_*V?!=I':88K=A5PHG$6XQSYC:EBJ;,=S7+O1*%-/"_J
M^O>C[WQ1V1N=UG?;/\0H=;$<IE\WBLRT-M)?_L;VUC\P35EXY8> 4I*M8"+L
MP2IU,*52DH.M@/;+0HF+0N<_$8W21>%RUF<.$B1]OZJ3=SYQ!BOY< 6VSGE4
M$3N\AW;I0)1/6B:9G=RIF)$_"$]S6O3 C^&I4)SK%K0?%-(LZDXGHA)5YD,V
M+1'(S.=8P;28^NDG7V/$P>'\3T^9)(%?Z3YJ_C&F\7Y*_;_PS3_S"OR;R*K?
M"0C8_][QC\0# K]IX'_12LO_42NY;Y7]32LEG?0<&?X+;]'WDU>2M_G;%,3K
M>P$DD[Z9'4*_[B48>AI&K'1SR3@*S355(;" WW9G*%Z52^Z=\*=6BFXQ,E+U
MXZ8XCXV" 68E+@$:,2N+F(X&8F'ZC[.IG<$?K A3UK6\#GV;YEZ1.G&I" @(
M4/3VOC1(S1$2O7Z=ZI-%%@_7N.*).U>(' ^'TZ/HZ@RJ+:V%#\3MUW,6PC4N
M\\E)4)F_HE<*]>/@4W3G[*&93?1R9XK;@)!*WSY)U8M8(&CTHYA<'Y@Y4)!N
M#-Z'";7KQS/X](Q4%SX;BE#\GN)AH@/?7XE"B1UR4R^#L0=A /E#]3(BZ<:F
M8JCH@3U0BE>1ARY'=W+A0&GKPJVWP9+8FR_L?W6QWLSZG>"%'6=4RRI\\-*0
M'!6.WM_K@;/#!) #"/'5^:-8:\=,.8:DU$_@'D]Y+2H3RY(?RZ\NYVAY/<X>
MUK>4YU'[>M#-M0*ZY#<HS:).:6SL4;G +:M>^UY^YZ;BS+5.G*!FG,O5-Y/=
M83D<\LK&U.(O RZ*C.7V_JP%1C^:JD(46/I.[L70O= '_.2(+U\V [0U[S-)
MP0466!L6ZJ8=E1#VLY.\A4=*Y/<RGQ?$%&?>O!Q0M2^T);1?48N%9/AG^N4^
M"K9%-9VB/]CH+J,Q &(_ZBT(^2$,J=!(OYD4VMC%7.X2TL "B08A5JB3S9(.
MA/.HEHI&$0.$/O83KN!PQ#>S9WQ5P3#'IU7^I+?Y*@RBR4FN+#A7Y:VR30$?
M3G1Z)01:#4I3((T[A'/-ZSYJQ*4@OM)=H3Q@T@8B&7T=TS><[(RN!>79H_./
M9L1&OO$'1(W'"1]9ZH7K)JMS(E,6=\F_^6C!CP-1S#[<9IL](@I?(U5GGGX
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MW9^.QUKQ"7U*/R#OI9)I?(8O^;B/*/S,KI']->$*BV/R*4G1J1,R]-3FR7W
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MW@_+$211PBE^-9$R<4_&Z,M(O8;27TGK(:("'5%<^0T-O4\[8[3D@%RP7 R
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M'A:'BY,]6 )ZC3:4E(\6+I6/VC^IJWQOKF@=+B[:[ZG]94GG0(/6&G01$14
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M?B T3RR:FO:/$YB=R/'"%B ?X> E4)X&&MR>BH\]91CVE)V_3YF) ;R171#
M .Y"+J*VD+7'D^RG1VPG37AHF4-Q8 ^RK+EI7L,C"NV! 2PBL##4!0K/02E@
M )(0Q-K/_J<"*IO?HE90M"?XHVL0WH4!*';DJV./\(0L#ET< &E)00!1>QA
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M7J$E:#D4%?/US[# .Q@ 2^D_ S""MRHP@%O ORSV=!=A@> _;/J)V#_P>[K
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M&WXX1'=NE<5 92TWN0>!=RHAV%J-7(Q\H6_+1<<EO$O3'T:\R'FYHW^YTBD
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M%<<U3U%:LU+TW1-FIM;3PW,N-BJ4EMY0:&BI&)N6+LNRB%N'>4QF^RVJ=J=
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M@ =N6S+)]GJ,N$<2:646/'21(8[,!7$ZXXY]I7ESMIC2[(8+_:*O7.M=T/^
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M:!':*_.(H/(J[\_2PSN/A_\II&J$<:UZT_X#?KN$=H(6BI:B#T^=&D;:EM!
M$^@[TSXE"7XS<38LK$1H^HMF2$%^A&RH 0@Q.]9@<3?='4I0R"%&RES+WSY2
M!EY30!9NYRCBJY\O-?AXG)T/^\\9C(1+T2*5NL QGFLWCVGT4["]>Y?E57T^
M&"3D[T;NEIE0D)>ZEW&T8D:R5SYX]8_N9TY-W*6$TAT@_PZP^[2$#X3B/)ZW
M%(^_KN0R?@YY42U,LUNGUCQGZ\]T"R)%XRX:CM]R%=[D^?'<5*]2GD5Y71CL
MG%Q&OQAXVD;>O^I1/Z9L8D]S*G;4F."OMD,OB& V(H4[%%<.!]F_8Q62[G^R
M1H$PO>=MW&E,-.P(7^FAYYBLESRO2WP:W__33'5%!(4W!/3#7Y?06B^'1M+3
MPXU#W"ZIH$=I]_]4>N)Y^:Q4]/##.-!4DFLG(T9X00[.?64?^;Z^9B*=,O4F
M.3H0B=#,$6@D=)$;\?"6/T"[J(QMC7< 8S1>?-&6[_&&!K#ZN53#F<&@^ZGF
M'4I?X3KR;?+]KSK\\B6))Z?;_UL'R4H8TNZ\H>EVG)$2NO&L(*Y#ZOV+(N)F
MDX!::0LFT*4WVW1_L3P<W$&RFX/VGT,"V P;! 2K+-AF EQSQEO*NSXMHEAO
MOH2',30F&#)I6L1H_?+D"M[\=@>P,=X<*?*WV\6_G.GY+@M;F:]_4S]!G-ED
M_A6O0";Y/JE%@'_<H'\?9T%";?3NP.#NH1GH/#5]5Z-;3<626F#D21.)&Z^P
MF=2UTCJB:D4)+M]-3(ZTH) =%XQJ9GV19V>.:;&.S/1;:RL6FMN[$LZ"[B;L
MS@]G@E,2B;,YP Q7Z/<GS]@BT'\'P#&%"R>[PU8P[$2:S.L8%%@:/]\L=3R,
M?0I9Y6F6JA&<>*^6D*3I:.G+;$0T)KU&_A5^=I;DDY)C0LVLX!/UY)+"VJQ/
M(/H$L&]$"$_L%J.'(GQ[ZZBSDVT\;6RM3AC2&0;HV>:?$K\EXIH+(/<J.^V3
M)OI]HZ^A11%MQ)$&QI238_*0[,!>C]YJJ5^MQKT5]QJGDM(5<#W);C&(O@.(
MT67(Q/&KO[U09I(91TE;3C>QYCB:.!R96U>NXQ9& +YAM0& H49YD9/;4K[(
M5G??=6BT'JC[6K\H:)")*I/C5MCP8,.3B_XI<>D95%8:6P+3#8*V(0="UPW7
MH/1;#TAKNZ1_DZ]9Y*GQ0X/BL#N W9"RDCHCEUW^XWZ'S[Z.#(\.6X"#;1\K
M\A(=ME]OP/)2S2+@TR'M^%*T>\Z@@*O0JISSJ!]1,85F! UL1BWTGP<DN08"
M'B$9^2+GZRK7@;0MJ;OG.1P,1%I&;^\SK&YPAJF2T=\N7DM'LP;WY!#Y*=OG
M+<IZ,\X;Z,<3W.\I"TE:;V<P6VX@GLO0"8+<LQ53.:,0KB\RS?KI4(:!F@K?
ME%%*8XCR2TC5T.^[ V#Y<95[.>SLB)G[.!0_>'L^KO\-_^#^J^_;V/1I??*[
MFM)6?.1+=@'$+6/'FS8%8QNRH9\W(@SHRK.1["LO ^=;0093AS6$]R^TVMUC
MEW\]3AZBM<(*/&,#^*8CI.=\E5(DI7NHRTL?#C,+([)[OE@ZWA#:S'&4XXEP
M.G[N0H;G+B-SSI/]B95;A=6-NVG5W^)11OU88EBO4M,Q:Y>9;A5;7Y4.RNCZ
M;J,][S$$98\XPXF/[GKKM+%-YU/U[- @= :5;9AZXRQ]]?KL6#"?[-AY,C,A
MTC N*>"A%^\QC+#G2JZ^9)$MO$8AM*>.X G-5B(#QHZTQYRDO&BGJ5TC<@)>
MWG4EW=UXUHJE$J?2.)'.??EV-IEJZFE'8F(*CJ17R1W LOT2'SEQVZR/!BV-
M&6?$S.V;JN8[@ ,:P-3H%",W&ETR6\O>M,/CP(TS4H]VP#._QE5,K--F-^I3
MF>3P) =PN;J?P$/[8]NMB<FL[2 LR5$&PY*7,5_'7R?P#>*\\N0_6W7?IH2:
M_V?.6 ,D+.?$=5GP#E E8GRE1BY2%C,0M9ETX("\7FT/,45ZEK2%%_)DG>?8
M7CQ427CFR2Y"_CZQF8%DY"TB<DV*$(F-DIW(G_0S]A<ZBLH7UYVSV=+&\L"J
M<_YAG.5#FXTC"[C!@!U?DKJ/7.,80';JH(+_6?)0N=?UB9S+N?WB9H"$G^28
M!%/!;C83O/7K^-:UZ4+3BQY,Q>KRV !UB>J)Z=9X">WI=KQ<A"$L[)/UKM_N
MJ,#GX$.40O^Z =^A /IOF@#= ;ZV0*Y8;>=;JC-4;]),Z^O43^K#<BU4^?7?
MX\_2H]1JL@*O1V.NLUWA41V/T<;QR%V:RFNW8/)MJISHFA5GU2JFSNJV-38@
M/Y:XUJ/]H12NEQ&:7]37T]-/:"A/'N;:O!,^>#6H:67&(;I-.:)VI069J]:I
M;T;ZNA;A&-?,+C^S/OW5#R@/\ U?,TJ&M9K.O("G%)>NO"DEK*W^MNC<L(Z?
MOY@ N!"4X^AA>UZ6(I]].R+%U32#(I#**E&<4"YX^T3>+,'$) G[^F'WSCWO
ME6B4I"]L9-Y1:[3F>NO;M>VKU$>8D,DHZ[D^'(/ B=SC7G?CZONIW/3T,^[R
MVCI'1XRA>+=\/#H)TL=;TOAA,[<@WHO;AK@;1L4L6)5QM[KV@8>+'QZ<R\N]
MYL?O[PE)3QRC*RR)X]HS5Z\.^U9LUZ4MA^5.YM=[ JB;$_T\U+F_5;F0G/Q
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M*LZF0L^@^*@FH^%DS_446Z93(_@3#M6([87T?3MUK[A.,3FH**;=T)N-)(S
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M-PZU3#RSR:SL@/!#++9M"ZJEZC9O:($4/?*35WV'F$J5CN#$B\?K=(7&R7<
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MOW+*%JIFJZ9$'(R:Z5SX!4:WF:1#/2?5!BO?;:>*B&AT@=>L>GOKJ9T0OV5
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M=?&)++H)3PNBSW]4*K)_;^U.F^^/M%O!.*Y R?/6PU>,Q6C'25>L+-TTV4K
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MJTYV+=F2T"3XC@'[(9/)1:"D[RWY7HV&+2PZTW"$Z X00K .N2'6!B))V.X
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M-;.L6H_5Z@_YNM]WM>7$RD)O9'IOI%13/[V:G&+8;IWBTEJ%_6!S1[87G;]
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M-";E*31I\_D;YTD_U"$EWSL2,1;&7=(MWS-][P8FLK%I8J1I3-@5K$<TSY.
M)G_''E)M<N@XWO49GB-QO%%SI?09HN::.__,775@R325TQ!-+>6ZYP**IZ?F
MQ%OH"-2,"]N8OE:<;)DBZ_Y@INV=PL%QR&I)]>,B-V!J7E#BN-H-"Y&.^4IR
M69@'?JH.$P]/6]N!8#CN"W__%3Q#?WI,@N_EM,2_U<[^'HF@,;']K4CV(P=
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M:TO%>\PVT"@CM]8_4&56]KUD.,[(>*C'ATO#O=JLIQQ\%)?7_%4CM80WK^P
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M"?,#7,'=I\D.UZP:ZNE2\DHHDM5N&GN8E-+SWXVY_+^%SQSTA;OC)&9!OEL
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M/*C&A#FG>Q44U#4<Y]*5IUP&GOLO+L@\CDE-J?259"C2=6]X6?]%!C^+>EV
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M/83)FEBNJ;N\"](@N^7Y4)L8_0 ^D3-=7P4_C;_=*OA8RHR\&;1P/VDZBP?
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M+"#GP<F.GJ'?6BR01)?5-#"&2@\?9@7\B1.[A3(I$F=CSVAQC[JMT)) L>W
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M>\X#784Q7>W%QE#YS!-1G>]-C:'MW39%0;.43-HM[8T;ER00X-'DY;6B!<$
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MSEE!L,U/?F_G]0E<H^\5P 98_'A6@9+, KVSSNW?H[%LO[-8:6\PW5LTR;?
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MR%I3T"@P/\_]$BT]T[*3!-KDG4%*MF](U'B4?C,X-,*R%7EV A7U0<<'KF
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M^'"$6D9C1%9P 5M,>P=N#5?(DG3,D'AFDW#KM>9A^@TVSONNFKU0.#T/B38
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M_FLX/E:1(IIS7_X72(IH?9'8EPT"W[)]7UP\>J;>(/DL._RE%+4#67EO[RW
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M%37S_P-(VBIYHQYN">&^ ^M.+QMSE5]MV&=&VD0T(W/H/I5&9#5P6)4N&F$
MS3+ $KVGSQND]+XI<FK&E6]6:48/P8:(%)W8BTM\,@+<T)\4-,1>("RNL,5/
MB1U!@2[%^$^OTGO6W?ON[_E:5(X8,'M;K+1A "\.4'%A&,#GW'1RY _03S<,
M@&X% UBQNI)\C&H)O?[?QXT M1@@6A&*> R+(B8XCP2M9ANB%'B0.UT!:!/0
M^7.2ZTV$TB7PC\<Y+TYISEON> 42+>=!FEEICB@P@-[7+<@D*^3'?U17AHK_
M55W67S-@HV7J50P>7:_7US)88 #TQK]DR%MA#,-&=0,/-3C0#%&[*,U#- NJ
M8V<:M(ZB.:=&2+D_1T;]H] H5,(?;?AL<%WEM4"]EM=5 BL1AOW(LB.2J1\8
MP  2>"AZ& I_C."^EMMX\9SME]P*P,>-6L!U%@P@=@2$(,0 _LQ"4';]GI/A
MH%6?&U+>%[Y,O[I&\UJL7UWS/&\E[UJL+N"A 0?Z6=3NKN:A[R^QD/:_Q**1
MJ+RM^E,<8!H'K;VRT. _V@U9N05D0B-.RAAJD>DK85_?O+66BJG_B&L"C)W
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M#<B]JX:.3FC]\=F*UE_@]+'1%XRH<GV)^]SM.UB-@+JW='^8W*EF,HWDT=O
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M2'_O<OH9( FOL-V+'M5 BY<VQM8^U^9)</LV8@Q54->UB8F1YA#;00I3<,\
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MI_.]F>9_ T]<3]#!4ZEMKL+T)P/B36!B[_-53B$*=]POA@*H^=G@7GM=C_*
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M=\C%-.D&'9H^$$ZI/D/BJJ.%Q?!+ 7Y)J(QA.\#>[469_#!N[$,HL3M'HLC
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MGF#C)3%3#("X-CRXOH0&?,T!P[_)(Y3<V-" &!#2FQ(-N)B=.)F\@I1?<B-
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M:4&QT2#PY9[B%Z8)G38??R2*.1=N%EG+A+]I][\:I!,PNTV$[Y)H=B:(A/Q
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M*(A)*(A+<8A+*4A**DC+_<-S>"0"> +6@"M@]Y=O#D '< *>XC_V^/-.@"V
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MW]53$OV[!_T_T%HJ2G:V"K:_G\G-\Y_,/[#W^%_K[:=.*O\.8/^3J_@K_U3
MV\ '(!D9F9+HOS;_[]M#]*_QAR_]+5KQO^3XWR!_C/PQ\L?('R-_C/PQ\L?(
M_RPC_X)X[5WQ,-</CV=QLX Z0$)$1$Q$2$),1$Q*0D)ZF9H<CS$NTU%245 S
MTC$S,=(Q,K"P\UUG8>-A8V#D%.'DX;\A*"3(S"$J*2H@P2<@*/#[)@0DI*27
MR2[3DI/3"K RL@K\EP77#E"3$KZ__ )$P E<HB8 41/@N@$P ! 0$?Q%_IDF
M$%P"$1(1DY"272;'5ZBE BX1@$"7"$%$1(2$^*M!^.L (341S75Q->)K]ZQ)
M.#UH)4*3WI)RW:SJH+L_BN26M/$,([M,S\#(Q,S#R\=_0T!*6D963EY!74-3
M2UM']]:#AX9&QH],3&WM[)\X.#HY>WG[^/K!_ /"GSV/B(R*CDE^^2HE->WU
MF_2\_(+"HN)W)>\_5M?4UM4W-#9U=G7W]/;U#PR.C4],3DU_^SZSO+*Z]F-]
M8W-K&_7KX/#H^ 1]>O;;+P( 1/#/\@_]HL;[=8F0$$1(\MLO@DM^ORM0$Q)=
M%R>F4;M'8NUQC5,BE)3V9M+;J@XR+LG[2#H;S]'+]-Q2RSRHWZ[]Q;/_;XZ%
M_?_R[&^._8M?,P %B #?>2!J  *<:<7PYU[ZHW_TC_[1/_I_7"FY4 9]/LC%
M&-$:'^16$[WGZ1/;P!_[<MC]5(_3J:?@FF=7^!E4&).E]D87(B%):IB=^,FV
MM34N'/#AH@T;=^M,VW#4>]YS:%<ZD-^-PR/L8Z[<&7ON>;PCB*^376D$X^+\
MRW&:@C<*)%S6];3J/&DN,$S3.^57UJ ^LGF56D_>7-W>NX >LB,\!ZHYPY0G
MO*MT1E>C0 ^0;-D9O$DN3HH+NIQM,RFO^>]^NO0!>P0$T-$MI??M4@97FQ5%
M%IDJ".FX<C<:GRZ"W%4978"U2UX6X.Z<F*;A9RQ:S(99+RY:OYCKB"1]*Y%;
M<K'/I7R45^(X75GB:,0P]CY_WDQ;4N"0Z!4-R8:E%?)\9:IV99A=)?J=R3=-
MESHCHU!6N=EQ[BJ27[0$.S7&;S!:Z :EZZ4B+_*_"6/?&>KM\]D%MFXO>7[1
MNDJL$+-\1!G/KC)FPF"(O'C^4D>6H_%CMD37A&OBDQ"59WD-;1'!_"C*F$.S
M%XO7G'2+DS@O7A?0:%1K/61KEY=G/6)EG792):*]]T?_Z/\(!8LY+_[RI,8!
MWX(7<8!681#$2A+=IXHRS.G9F7>[A=Q[Z\LQ0;,]/S:HRYE88L3Z;LW.*]RL
M/EL&W5%A5EM8&;$QKA=7]$CJU,8UB/FFZED,L(;EZ\_F1 \%NEB?=W$COY=8
M>BX;4JY]!S_W0]0@,.&'E&<[D%^W:I%M2T=3T>^+VE8Z(XXEFQ8FS2&IBXN^
MK->VPH*\[F."1HXLH :CB*K#V>8#BH^G85/TB44W5Z^K*<=QR*I<W4Q_"J;P
M/H_Z^?:@,FEF74O5U"HKA#"[G:#OUL'^C)!MMZD8*^5'"#;2LA+9V[NCCX;F
MSSC3_S(S[[OF%F,H\#G-1H+R#FD%=-4XI):2WJG.-"*:(<??^I/I'!5%51TE
MTQ[IUB+O:[;IY_)(UQ<)9R0=."!OJC4(+8H#>$)PP+1@S,2H6ZOP BP ?-G$
M2?*[&K/_I>/U[[FP51 +O+>]G=7NRK>M^W !I&7C<ML+S_+C#%A=:JD2Y]%N
M%F<:*[$1%R%[?KJJ/48["R.+^K;=9!*/769FR7<+ZV'D(&)A_]P<'Q(3V;,@
M,]4J_"DBI1#FDR^F8_;T]A.;;EN>NI#2V",,N@A=M@B.3[L/(]Z#?KI7S$/A
MV-:<YD3#+]P!.'"CIL>E&TMA.:NRSX7NO*WDIX]JETJX4OU^;0GTXY>$#BW!
MKB7=&%@-F9I6>'M%UT4XF>\Q3(A$[O@KU+21,B);5D4!6=7:$.JRM_2JPSTZ
MJS"$4&*CBJ38%5I91*!)>_>/_M'_B4H2!ETD;;'*@W4&>;6?Z/$G&Z=R\E(/
ML?],+O8;U.;VV6AX=R1*"K=&O1(L1B=[QP^["_&D$ZJ'3T1YWE'N";R@)?B"
M)N](Q1(C!YT2AXZCL[Y,7]OM/>&X2O(8 !!'.T5Y,0#_'_VC_\TZT((RCJS9
MJ:^=D-Z5F%I1<HL([!^=YN(2N*--G(L#GJUV(@XE-Q?18B]P0$R%0S>"J$5^
MQ8W* LHP'9!IS'";:8S,EI3TKAP1V>Z.)3DDXND*NDQ)XJ/!,5>I<-KK1_X9
M%&\E,VU]*8N4WX&VH5;T:,^S;44HF,K)3Y:&E?ON0N_>Q@C@";5L6=1$"R\G
M4$!E9B88SI*2>S"3YQJH4UM0J34). ZZ #=%2L=UA"&H5+\6$W;1)E=>',9H
M[ZBRQ=&]R8.]U$;QE)H[!L0R5)5TG;H,@GV4$KH-E<WZ5%A'CCX'@1].I)*?
M9[4^5'E0Y\<J*E! D7.?'Q0<LS[<#;E,2<W[3/JUV3U_#4$:0;&%.S+[(%>O
M7LFI<BA6'(D#GG?B #?GQ!G)V#('H9_*-]_Q@9\#+O?,93$B"  'C 3B .X-
M'+ B^&ZD]D*RN\ET6X%GI*GF"3_WMX%^.2X*@@M^D%;,FH]H3/#E,=>9F1.K
M\*$'$52]!T"01(RFRV8V]RA&]^GX)O[9WT52_JB_<?2@'Z,).(U:*<,?H^-/
M3'<+5"A15W[>F^7J\ZY+U@,.0+;9&4T^3'3;[)?1<<O[5&9;38:M%:X^7HX1
MCQ:8"!P>LF"?W"7[&CA" OW[/&4R$QGE;<%K(/IP\J=0SGF][ TFS.N8 QP0
M!Z82:1$L,MLRE6J]DQ]<F&X/D1*_*J%,I@2:)6D5C$>".PS0MZ1@1\-TS@QW
MRS</KL=<4NI[,/K]&_LGC_C,]1#EE:X''R:O2VRE34TGQ=KOKIL &#5IYY8<
M+;0PW_,6EV(H.WAJ329Q4+^;@57G 4G(H-CW0P[CW)ULP9$6J9B9]1*W)V8I
MVD^;*>_F<R=TADAO5J@;H,N7LNYLN>SZH GC5>])>=XD.VL*M5 ^NJAX4VR
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MHGN1*8<0?5/O\^/R('>LYCOK1-8P/^HY@.QLR2_W:BH.,!JO*:!\[TQ?=RM
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MF3NHBMMFK\54-DZ"E"7C4\8Q]NBD G13;Y<N\C#!RXVVS3'5-RZ18<;P(3&
M9*KN*P1\C (FSC9^#OA+K\4)(<V4FYM94[\MW>"[F*_-.,>3^"]X@NW:=FY:
M:SWB@#SY.>P/A44HOG$Q77GH^MZB XCO<YU+,)\R_CF+ R1%+_ S_Z[S8\\
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M$0H=308^_BY1;R+!9#.$"Y:A#=)H\<#S9-QYRO5XW-#W.CP [HG#6N]7;4[
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M"=9@6W;-B'!9UYD0N0L#3P2>%%<8*E;N]58H\M5E["TYSG#33WI9EMS,]1%
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M]SIV)EM2]!>IM4C%7V"X,B%5XTS0<_=\2R68ZRR[7<=OM^NQCX)_R4ZX-#<
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M$&6YYN1D^[0V,_H*4[!3G[\R1ST "0GR440IMWL%%XL(4'T=SPDO9+AF/P^
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M<8>2@A=B;.![,WA N?,.I1SZ8B;$NZ79H %%?OUQ4CNLKAUR$G:10: "J?+
M^?8\\4B]TBBB-[@"#U"/KQV:^K^MJYH)JI*^Y/M9=U'*E3N7+P9E_0E:\?C_
ML??=<5$O6;X_1&F0T)(SC8"" H+DW*"21'(2$%"1)"(YAP81D9P$)2,9$5IR
M!LE)<E)RDAR:W$#3_=I[O7?NS,Y[^V;7W9T[ZQ_UZ? []:WS.U5UZIRJ.E4[
M5LGX0PER0WHA+Y@_Y=S;N5VT$R=9";F=.6L<*,76YZD'\I=B'7^H]\7DV2[
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M#7F:>24<F&=U;G;Q+.*&-SO#;R&M<CK24;C%0P]*/#JX[U?&6/?-= 1FB(!
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M?T^PQ1/;4B)O&!^?P$[/6:FV,;%@S46/IB()[N#JD!90#IO]M,^IW;WAF:5
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MN8863="K4)ULW!)/'A\7P=WMG=4FD+F1*4M5LBIKH>UDH>9$L3X2G&9HW'Z
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M@ZZ@.&O9V6SM;MVS3J(9B9US9X^)]J4:*_-L@KWQJJJHMEV?75B8H66)$L0
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MS$'T3=^KR8!>+%N$SL6(&W)36TV"TM'O^\[5\K'<167,F5.NYD+]^4L_FIC
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M-"?'"(]"7VL4VAE<Y?-X<J1<1G3'=T=_DOUX2!9OQP+%T+:[^M+/*;**[^G
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MF3#^70:CYT,YO#7;ZV%>95"??]/_&MZ^CC2JZ1>D,;_B2@-_N[N'P *IN5C
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MP#X#NVLMC%>H0*V'!>Z7#'R@M'LS,J)%&7A$R6L'I6$+9!]Q3R8G7Z5<\VF
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MY=]+UV/^<#/^6#\638L%XD+GS4]0D!-1U0UW<B(O[7E$Z,<JSSQOG]U0FX*
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MFW86*S[&IO>,C.H_?Y0XA_,1P<#U#94^F=)M$]K6[6.^%[BWQ=^T3UN(!29
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M41,$! &?%,_/'29G[Z$+6L/0]5,L8%MX:]89-B'?\6[3012RO2",9VZ&%.B
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M^JXU\G;$M:*]R/]YK^:W5ML']I(XJ-';/3/DO;@C21^3=G@ "1^43&"_)SW
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MR "6(:TL8D?Z7GY89=KBUILZ8 /^P)-9<>^P!MD)1#GY(R,H!9JA(? 1I*?
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M[FR]_PCQKL/ZX/97_G$OGXQYA]G";:QTQQYA =;JO5=/0)^Q"I%AITCYIHC
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M!0X@)UOUTA4^-MA3&J#;X&.#_1H>P(0 ZU:%S#AZJ!]\41(/Q#CA 30MTMH
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M*3^6LN="H65?'0=4E)G=",M32WZ449 <UC%>]#*%8W^3:QRZ\!PZ?JECL^*
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MKY9#. Y@_'WA&AWGR;'=A2 .Z(&>'4(OM:(Q4XS;I88A36E5C/CG&T<N4G&
MZE\>!S2RR_YPH\(_/XXG'][TS_?]5S;_Z=FHQ2C/G7MO0UM!E_EDRH%5<CU>
M,8-$<8#9Y<5+^/L_M^3_E<W_NFRX-"J-OZA/B9'M0H\VF?^S@>J_LOG/R ;<
MDV,G/><+FF>^\(RJ'"A12!_& 7]M;!S_7VS3_^=FDP/[XR_-"^A[;?/#+6/&
MC!*8_E<'O__U 7!.XBV1*D:QU?XEMR0GBF?G:J235QE\"0JR_2Y1G0 MK(:4
MBN))S?WN](AOT/)MG<O;&6U=M!;):P7K=8YLOX>;]?*9I> ]L^(I.3<;]KEH
M[=ZAPD.II92#AK)?.*#MA((ZW$9S0AU3$;R@''.^08.MVKQ4%AD76H)\*9%5
MBR9Z>I5PA[3<$SY:6K)"1KR3;HAI5P95.2HZX$RMB!75.OHH%?:3*Z!)]&[,
M:'5A%I$83P)!4+;^AJL-BPSX=A>]HLP;H(<5;VA!M_"RQ%'$K6*Z(8VZ7]P#
MNB'5#1.T4^9)X]UY"(^I*P&B1P]J7"3%IG5'2RNWEA%V+A1R]\_)HR7)F@S^
M4E="=[&>-KIG*;;)3AX2MY]?_@MEES>Y?M?IM5XY&%_[IU5:_]Y @G@1B^K7
MUYL?5>H)-@AF6I[5R4RS0N49L(Q<$<QX$AP/$,<PK5+HQ.E&S 4^".;I0M7X
MA*JH5$\IUTR,,G^/8_8CEA&9'[6@PF^7K?\(#[6JJ&29L-F3@/E2$.E-GN\^
M-SB'T/FPR5;CN#XY^,51GM0Q5U=![FFQH)37UDR-&JG$A^$?R-5 \$(,V;35
MF9/RY'%;@, /8L8?>O'2^,5,$T/L[0.D(+I,"EC7R;3OJ*UWRQ,)V%I&JE.T
M#Z0R.P6FR5UY,J.62*<$JW[2J+)@S-Y5;_5M$M8XKC/+$.[::#EA6+,O^!T,
MNHIARS/-&\N;/96M,VM(TL<[(<H!R:8<<C[L;M)3^, ')M("#QJ-1OWJ14,7
M2B,66BB-MJIOSTE.M-IKZE-V-TRS QR@3X*FG:9$SLP4[HE;GN]/-ARGA5GY
M"N6G  8J]JRCTJEPJ-Z7O*&!TO9CRE,/F\]ABS'7K;"/RZ.G#6OXKH=9Y2IP
MHA+@A A&4CE'(>@5;S:(X[?^LZBIP$Q.,!Q\?*K%/-GT(/Q>:+&:1'F"(MO3
MQ)4!COS>N]^JJ\M5..Y&BVNI<[_6IG^Z1-.39R\6T[IW'3$G@"+>NM7S@$L_
MD7V>UI!9QB1"3E5LXF%#V\^BT0(- ^4UT(+I52M?TF#M$9M/YJE7]%=\]D48
M";S(7H?W(5O:TPG;#4Z.JS])'B:\-]?*T#9_,>MY6<W+FOC.E38?GT?\'!M3
MK7Z"45A09>YRO0\WK-"?(#6+92RCQ0$6(2P;PR>E#WVOH%7?SMFZR!NM?>?/
M1Q3<R)QL$@JW[]3.A]T0"/IK(_ET]B P'^VD:GB3;H0;-KYFO:]W%N_!/@-G
M+\,P(FM"!1_:+1LVB*XY[J<J/0TQZQ.Q>'7CN,LM4:N[2E$EA<^-4ZNH7^*;
M 4-R4#,MVJE=V!0R!EM)V2;A[AK;LV!$^0%G_BEP%%FP0 SEQJ6$-[D]N2C(
MFF->W.VC'<)R=@*SYD@RB,\4MYTODE&(XR9[ KILV19S/$<OZLX#W%$X(,OR
MJ/1[^QS9J 2C&7=I!&5HA8@'DQ(Q?^QC4"^LG[,@%*;A.*B:_?II(N,2/7\H
M2KC=C@2=H^GS=(.'FR=W5;<B[N4/J5PJ%BGT:K9Z8#-EA'3MZ&+X@M2P5I_;
M*KXHD2/ IHC/DL4 ]Y 3#"N)#T_X1M$Q:M.L712W$'/SE[NZ3(32F(EEP(.W
M-\4)'/66E_T(-PP.-?3ZU53[=FUH"HM90$KG%9=$ICQ<\G<W7;G_:%$K(2,*
MU'4R1X0,WTPQ$CI0@S\DG4YZ:W2K,^TAH80G7"E[KCDO:^-DC+,D66?DQV8Z
MGL55_YT!][T>* 'XPY1W,U=4*:C2MC0[6-K(P^N9A3O-H'U@"\S9]RI:8V'G
MB8#I;<.FC>8[J*&0CY0SJ(/NF:55R77\,8XR&A07,QJ\ YC/&^:+;NSWF;04
MHO)FS;#N+=@ JRM=5,N@BB+V=K$LUGE3>]!."OPQM[=L,0:"DH]:*-[;Q@'5
MO:HKP^<HZ3Q'K:-!/5+1M4+:+++/5F4 "M'QJ9E^XP.6 UE=!ST.?2M7"TZS
M93U\)<U@&5 @Z3DYF#"O:KKX(>62WZ.KBD-?U:M.N@JQ<LJG?PR,&S)R.9+T
M(ZS0,.%%MA]H(6LZ9W5;4X*V:SXXL$C6Q6;&^I7DXJ==B8H7>UN*44<)516B
M.]20S$&V*8->K72;"S=(\,UW>I>!K/(>5C/$7:8:.0\21 4V@YMD,N/>>' )
M@<Y*_S9WC+0PV?DFS)L)Y5KFX_;%7;=SM/(L.+'GW3?&02VA;AU)Y,^VDRPR
MK>QF*.HV!)Y9R=20AWZSM%TCEM2H,SJS'$ABHL6S36:V;X9:*H4T#OLR3&%$
MC=6-1EV(M[;\"Y3IB .(^NYV[ * 9^F3ON4#::8P.7=J/V_& F_-\L9)"?TR
M4^--7X^7=I0+S[FZ2:]+,/ULI>GRW OT?C1'/I(WIE;D5/3,ED[/9'DE^^D7
M(9?UZ^R1/DM=@/,_=.#W/QKJ_7FQK_XIZLS-OP6VS+IN]6<:[1E"CUJ"Y/[J
M$8CC"O_XJ&9&?OR?%WGLMRO@[+_$[^*XHO*7<,<ZMKZ;%]95?YKOQ-^;<<*%
MH0]GTC_M_M17&P9>*'X9A9;8P?3_G@*$_LP%#F431"W_<8N]_\"ZY/^Y!>L$
M?P]TK'^F/IN)K=<)^H<?R".D9UZ]PPK)'X$..SXU:8BY7M\W#R-?>M7OC'XL
M,PAUK6QF1ZXDAV/$G7(V#=_S^X>H-T:2RI+90R*1F>V0H9L0(3<^=#WVN+OO
MT\+7GYJ/%5GB&J-/YXF M4;P_8V6RIC@W=V/K/RRMT,D *6X)YE%S!_+=%%,
M!9:Y[JYG!YJU*E[.0?YNDKVM^.,)4^6-;LB3YZB5Q(=>K!]J7#M/J34 Y;7"
MNT<,SDM;<(FY9*0!J%J&-T)"";K(P:WXV&"H[HWI&^)JA:]=P(N+=.BRQ@1T
MZQP'@&&R\W:GHF1WH/#*EC,ANATL(_JF-WZNL5YIMAUV!)3>V+&R<RK=+<QP
MN*6Q#B7KCD QZZ#TQB-[-,-RSGGC:K[/]/Z:K5W;]22MQ,M$]6"5C$\N7$-P
M@"Q5 W(-JU3J?RG:/\$!G D]3%1,_,B2LR>-Y]1IZW-N2:MF$/P31TE):QP0
MXNRP@ -N_@3?MZLD%KG#+/QV%DTSR.=P.DSX00_:-[D)/=IN.5-EU)W<S1D&
M@<^Y9I^'PDH7M)7TYF^.T+0-G2]1S;8A,3(H@[7NS"FY2-1U;,^RF=WN!'^+
MV[EHM_C$$!V:3!$UF,E E]WH]%0I8).!,$9205+F4 !OM*'$H:*W34->_^,\
MWI8)%_)S<!4JIJO^(G;V5;OBJ+2(S7[12W1H'^:RG)B'C/(0E_(FU&Z1U,=&
M8LE(2C(U<ZY+:H%GHRW;STS?5[J,5>I)%,K,;/?PLD ]8IRDF<Q>XP!VPZ)+
M>OZ& S8$7+:KNJ<QH%O>.O6H@N,X,X=;,=N^\D*9W"_%3YQ.G"+=2A,,1C_#
M!<0'>%:6H[EZ#:C=!VEE:'J'/('Y1EFDKE)3HX]*!W4R'4%._.;D#^\FA$Q
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MQMGUN+.,]Q4O*%]<"^>B[YCC&<9H)0CY%W(C8A4^"O%1#3IT %Y,D'^R0OZ
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M-O:T3F(9 KLJ]-S/IFVJNR/X%-?O?7Q\/GU=9#Y&^8R_78I\#$.=TYR:I^3
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MNP01>;%*WL>*=^1TAXJ8@?^7)-7VO[X]]*H?;BQ?7,C*@(%-OP%02P,$%
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M0N0L;_MW^9*]\PX(LX&C=T)IZ)25%RH@R$V=1Q8^?D*:'SY1[^3/K?X,!@C
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MRSRZ.W7YZZA=*GW<B#QQ?/?75'&,7(]*^MMBC#*Z[_$RNAGL@7"[.G57,Y[
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M0U;:*)Q2>YD*$<(R,UJ/S%(>-QA?CY=X+Q%$^W7"&FW62HH#\JLT\/N5+AS
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M-AA+PH^>K,W$9[)%5?:>YL3[/;<\N0S'JR;WAR3[2 D3'0GOQ7[G11<N!=:
M/V@@$N3FF&9(7\JD;3;M8FLF+K#>,"#CY4X\ /X)Z/X'GPFV^L_QY_,77&=J
M#(;_M5]Q^F]BI&@,[*>^-/@,O_<I2&TY\*VX@,;O)Z_0X[<3M=:GUX06->ZH
MXGT6^SVS3TZUR4+Y0T>S$U\A+HUM*C!<KYQANGR_?&1XXD7:=IC0!MO)Z4^L
M:"2\VC__/21,BRFAO*-;I(/)6+@Z-S>^^?@329@"C [#$*.D4;@-I\X>OM%<
MF0GMUWZ:?H.EG?68=)RMO6T8(W,E(^@\!79PRV2H"=7@!Z)W8@-U\M5-[GI<
MF?7BJ]2DD_Z\ZJM$F1I$:7H-CS0O.2TPG[^SF:AI^,+D?Q2SIGFI5I*<,'S8
M4!6D-O44:D^//D:81")Q@$[FPP2NK>_MG]4%-8='-+#*EKM)J)Q/;+MYUZOG
MS5[#!P(])W?#!*_9RW-3 ]((+.48-'BE@MFE51[IGN]0W"<]\&G=,OY5-)'@
M=Q;/?#4@R/K'&8)Y7.FB3&209LO7<K9O(XU/^=(QB<MHTU=;O;='P(Y4[K X
M)HFY:<M4UZOIK AC/E<Y3E4KN2$:YYJED0J,%/J0$1ZW*[P*HU.';I:A$S7L
MK]SW% N(YP+'-L8EQ<P8#\=)P\@QUB,'9T(N 6"[#$VNV\_MEC_>Z#$EHMU3
M95.A1,.6QU$(]/#R4=L%)UW61#>%B8#"QYXW%#\V+RTEDE7(?/2@WK!FA:JW
ML;RW"FC,RAY%(&0@3S+X9$CU3!U)25EZ&0/:=8H^G:F185D&I+*)DL4;"6'/
M23KA+4-?9[URSX6*HA'^$65;C1516$G'4_]7TB^;W##3EA.]W,ESZ?Q/R-JY
MOY+LA86"'!NM$T24S)9@E]2NQ@2SJH^51:%[5+'"<S91GNKJ7I:P+M&3JPL\
M.."#*PXX):A@1&M.>F*"QI>01'5T:+,\6Y$ 5Y# [''#V0FATHKTCO6EMM4<
M2!SV4Q6^SI"$R;5]Z\1J<< .S\'[C)%G=RWBFF#DLTS35UM2)1:RR"1/)_=^
MX $%7R+X% L_B?UT_N9^4=O3:0[:D,N@5#V2]?9YMQ^8RZ60 //G5X:C1%['
MZO3N=J?>.+W ?E!!+SFWW48OY<%L*4DT6;-_Y.L^TLOW$(2!T'0T@>-3MD*I
M48<[0Y&L/S&VQ2&IJFW[4]ZEMG/QL$7U)"Y'K64/!NCUKRM 2#PW-,!'@AD<
M9Q\F@R\":?T1V!;PT?1X6_4Z)APCBP.LAW% 7FS12G 74F-'_ VZT-*,9U3$
MK>-B^LW^XG[QW-QHHL1Z:8T5TCA?>$QC7104O)03-2&B]BT LO*P]"7UDN]J
MVE<"5:ZL%7#4 MU$=8BIU;B4X]HXMOUG2-[GI5W-5L,PKQY2Y_VD<! U1@BQ
M1S"WB([33#SZ+II[)>75>"19- ?M7/8QB%XT<^F59=#.V!M6?)[;-P\?V8%1
MKGAT_.,*/S;L.0&HUZ6NL0ZYV'G.\"/3I"%>XMK0]//(!V<.<#0QB*#"74I8
MNRN48!PNN2FK<YUUQ9L^BG=6T0)+_, FKAM$'RJ]K7#\1%38S5K-AJJF>TKP
MG40$H0LE_.7!GDY+1'<;E8JHH]4UU.!.V:RS02 S,U/SM20",IL:=57N@QU5
M1A71&><Z:Y#[8N=96[6P\*.F.)N3Z'2N_23#\-%&<"R75!UJ\<>>;6EGC3NX
MFB=QBQLVT<_X426ZY$@ZU(#]J"N:A?M;J.V/M7I00BA]$U*D)I DYSERMTF@
M43/LQ#9+,OVH!Z%1>91'XU&-]E@&TZ,-U<</Y[D4FX9_Y/CNFVN07KS4WLYM
MF@$E1H*BFBUM*\#/JNOWS">_T]'M#E1JNB:2'50$(^LP:?,@["=\ =_(M](Y
M$\,!GQ7Q6[O#$V;LDW&"+%2I9MU7Z.-E5C]EE4 HLRU%^R0RU5BLU_MP2WVA
M.%D\>TJ7$$W8.Q.5]0XJ,;GCJW-+-_G.IAOK/CL+KW@J68_"\: OES(Z3?8I
MU,^A$%VH49O6$?34UF^[9_22YPV#%FIJN1Y/EWZE0'"$1GRS<@ RZ*X+C;=2
MUP?3^Z<)]42>NO*$\7YY-._4/27[]JS4EB95KJ-/$&7N>\<IC@*-?JFY*:GW
MUKC676"+QMMQKR)@"[URAQ6\:,W03R@P0B03/" _SO3]QN[3-C :B=D@A#?'
M82_1S&3/?%<?H*%]0_.0[1X-]K8>;,FHC4F_V0O5UJE"F23JYDPT=4>11#$'
MC"0&'4]X8+^><M2I4%6A&&-3 O+GKW\:]ZZL!."?GF3WHAD9>^.@3@CK9VS/
M;:R6NZL)2PQ4KQ,<$6BLJ#*HR$'>L%=P.BU0MK74?_@JC##;ZR[(2'UT0S",
MNAD -C/Z-BTU/N$ >JC2F=]D]-*YS)YZ6\HM+2HDCW98UKIB$C>=5Z_Y.L;E
M2ET$V,E-L@O+\ZP\*="=T=WLXG5WWFOP$CF5>OEW/YW]N13.WQS@^W+8D?E_
MF'OOJ*:_+VTT"(+2D2(=I$H3Z;V)-)&B]"XB-0:D!PA%D-Y!0>F]%^E([Q&0
M7@TU >DEH08(X?)]Y_YF?C._F?O.G?>=]]X_SEK)REI9YYR]][.?9W_.V9_9
MI^66R\]##1K#!CD^SH>>Y^#"&\.+(,_0Q6L@G?X4UQV[Y4!>VLV++U2M)5UG
M^H#7$(EI#J1]9 "7 \SO>^TD/.L )BYU[Z<QV?A']&LP01^]?2]+5(?(%,3:
M_3JMR=UG]E@]QF#.[^D SDYU=M<4ELZQ%CUGA4ZL@JD.VU2HB!56Q#UE_/%6
MX5&3_+<</+06\DH19=1CH6,T5_'Z^'5'RMKUD]>: XJKI7ONR8=F*X""&\"G
M5/A=;'CY#:# 3-E5(,=H\_Q]SAJ2W]5\I6<EXI(L1/ZA4\O#B .ME$H;L2XS
MM=@F=?554NF#GQNM9+_'U'],R=,->OO015\]0QVP$PM][M(-"'?,N8O&*3?7
M@&<:]:;&66K=N=[/?^MS-"C)\I'$LLY2!$DH_F-&%E3!JF#?.F/RUGDDS$LA
MG_#,Z5\H!5E$!U_K;)MKB4,JN3(C/<?'-XDB+3I"U'%[&:Y-,6];+11T6R:Q
MN&H^Q;_&S=4RDQ[CQ2R1^UY1&F?3M"D4;?OV-Y;:N/Q9=HIEMQALRWZ:H]A&
M^3%(Y\7D#2 =? -0.#Y7)V$)#6"=$5O9M]H'0G\<0;(%/^ Z>V_FG%%O&?S)
MOANX<8NU[Q7."GTSG_Y-E<@>KF5'5+5)(:O.+.15HQ 'S^M-R%=SWA^PW@!:
M[F& [-T*^+*/%'K])9U:](V,YF:C1>?>ZWREF_,><A\0@4XV!DB@G7=O YS(
MI?)D"P9,-](LB,37W!M=):B:#.3=;&- #7>?69'NL<^<XH)*C6'\#TR^FK?6
M/EGY_#'.=5>1+BT[N*$3!SNVS#LI%OMB&3O'Q_DUVNNM'MN!7N+N&'-1:WRP
MPI'J"<OEQFUV%"H/G\98(\@8L&,!/+-BU]++ TMGG*F?*XA+.,QK%G7H5BFV
M' ,>8JR15F$=#([2VC5ELA(I/WN,^]MB@RWB=9^"17%V.P3F$,C.3YX"=F[B
MOQ?J2A3ZKJD"^!6KO[8Q7>>O6I&#=:"F&16SRX^R' [<Y'?JUCC.1[VQU(L0
M("J#60AY'E9/=G_L["/B?E^9UQ?^CV>LK$<XD*SL7N/EIV@@2@%+C@NLV&FQ
MV$C,[^&*FEWZL%-3RL)SU/W3_%1VG*  $E@[TT 6JE<54?NB5%K#(R%8\YE(
M%H$NZ63 EVX'::L>!28TVXKR=S\0I97#J^=S@,A/^0P1'$$74FMREX3+C>B:
M*E,(V42;9OXVTJG63&+^5(GG?7_]&X7AW6Z.&P#82 3%9X[60 3B+3JE6?U>
M15%%5!.:/9L8W'CW3A+ P^2FL^J ZW++#T/%KEE6XQ(+E?WDJ_&_23ZL+:.V
MC\#]_GT0[D:P[I29$H),1BB$[I]DD^@ <X'&SV)Y$R6M8WN3\+YMYIY7/F[S
M0QSB0>B01>7>!57YQ%$V'4F;@=^HS#J]H#N98TV5;BO4#3JA]"NAVH5PHV!!
M\K:("8$,0<H'ZDOM'QX6^>QFO V2CT0>?'//!SOW:K5W "_VK8W3_J0ZIC+>
M4=61/*^F04$QF=ZAG;N?K:Y>M]O ]](R5DA/I,0.1:Z4*L9'-JZ/7+M=(#9B
MZ\N2MYRB"EE][19] W#2Q4N\ 0S^T;@!6 9>.?/];KO]Q%95>?M5+W +O\U.
MX4*V5&'WEG" 0OTD(A76#68Z=X=<K@'C!$,W /QJ9UENQ BN62*J&"@R7/C+
M]ZYK?54@C=[%7$[ N/<1$#:;#N?C?@0"%<T(TKI1OV)P#@2LG(]7J75C60(I
M D9\%\PV]WT-B^9F^WV#$W/?!W:Y7Q#.($L[43HA :P8I5E]GW-3]_F%M1R#
M&!?H>F<EX)7+A2C.#<!:\+H,N AANF5J]K<S_BX<N%6&&A%1;YWM?.>8.X5P
M+ S;WQ3*&>2M_?-=+DP';B$8UB&"EM%!*P'MO4L^3U=Z'-8Q"/)$UY6!:"4'
MR*H<<$56'X;5QU-CQ&=.#LE-!/[DS#S/$W^+#Z=?12H= %G,D=QAE0J.).R]
M7I?FC@4Z=^H;<Q> 3''N&9LE3+NMU^DG?B,2\)G^I3VM!SL/8T5Y>^\F\):X
MY++.<M_NVD&]X.69U?5#3H"ON2]WF#P-VLIX1A0D+W/O :4LW"+^JRY3?I)?
M1H#8<6HXQTP;=SG:'>&<SRY+/U H;;[NH2KY5J?#./X<.!/H4.G[*M<QX,$4
M%MCN],>;5?:S(8"L_^<-H$/+S9(-;852QE(?.YK&519:.,#>R7MXN9)EW)O.
M_GSQ)CGF?"-(Y@8 8YK!DOW:43)L"0J6B9GC0S+T2W2P3%-V,[/_<O2YL^*H
M#0TSLNC'.6%//* U-(J0?2W[ZHK';) __:#".;>N>7#S<<#K@/+Z.35$X-U%
M8.==C ""Z9XPL(4F^VY_*_0\\PZ^+?,:0_AXW E.(E)9:0JB*1%7W^X\X[SW
MISVF[67?'>6?:L_(3'^AHU=U2+8ZZ64Y\[;3S+TN/2^B]Y\2O.7X5:C#L5E<
M" KX)=(^O<S;_#F$H[;G0/' .UD/8G+KNV%([EF6:V8'W#H466^L1&\G&48U
MFZR^QK9T^3?M#<"5/24!-RF?XTAU56C74@^Y".&9AK!<?T2T.GC<RCQQ])\?
M[<3%/MR.1EO-:R%Q:K[G*XQ.EQTAJU=+>KVS%#L/&\LX:":=+\99TFG7$X0#
M"5'[.@/9A&U^J\6=* _#1DM6\3T.8VO/;[: -2#.,?')H/P)S@X+,89.\".$
MWZ-H5KO2>?);Y?K16<1,T(4:-[LL5FQ^+A$[^F G"2/^V8G+L$&ST8S]2>#,
MZKLG@>%>@::G0_^AL.Z:@ #S=K&LTR<6PCX<[9.+A9.B*L\2^L'<(3_E^ *:
M!?$A\JU(:'R;%H(H>LL^W.3S(*-Z@:A/8GJ2[_7.X;_J^XQ[&[$.5A1+6U8D
M6NV?8JE:OG0UVNL%4SK:T9T/R'^:R(>0(R&=9)455:+-ZYU9OQYVO(5T\SWQ
MQLT"<!>_O%7R#BS$R^!H>$VJ=F11ME:&^=?Q=[5ORM]X=TEA2/0F ^30\BM=
MXL>+5I]G6.L-@)24J8X&KD&N,0^D-PL!UN#\'M^5X$Z[:S.5N08&/Q1)G]T,
M?.E(]9W5YP.F.-?3:C6TRFTTA_<&GJYWSK:M]3-SSV&LKB2<6L8B^07V7IY3
M7*=(&J1Z/%.YB$/X9JS!JC RZ)'5>#*,S(1'I9X!N%H 9"B58*:^8.SUDU84
M9SM 'L4&UNQJ*?H.?:"$0QYSFMBA?ZU>G1G TN^/W!V0)T?A%_/Y)_>3M^@T
MV]B=]VS.84V:$,!R]!SBU5H=W(H0;6@MO<O?]*91G_I]A5^8,,&R#=1I '4#
MZ#V,'%Y-5(AH (F?:T^0:U*)ET>R&>"X-<?ZD@5,XZQ@)U+HV\][O\9]3AH&
MD4P.^C$J)MET=TOND8J@Z?]X7)/!6?IT[B]L85E2%I[-#G%!OZEG2 [ !^^\
M/!Z_FCT][%^R@\(5PB%Z18XIEQD/;@#Y.Q5_(C_.$6H35#%4,\:;K@7P.G7>
M/UVYKU&*=LR)[GOR<[RRX%\G"XD ";"W^2TS SN-:J;'6D(UDYWS>7D,$P!W
M1(@S7!.S^J+>@NWA:GTCA LZ2-!254AY/E_N8\, Z=+7O3[G>">5FF,1 ;Q(
MA=YL@A4@_;,5DR7%FAWW17QAE9\#:J4ZEHCF[.A;?D1T*D#*I-8UJ<P200^G
MH^GACDA<<5L%^ N-.N!N6["-KNE,O-\[?#*RCGQ6,_AAN'Y(<0 AIP4NNB6;
MW*%%-X"YG!O A*!E)_SA+0MV3K@<MRX1RU!="UQ>J;>7QS:LTU=CLFC2;]-1
MR W@>3N ^3; DYM19->^G=@0:NZ>P M)%^; =D%L7"'R-O]!(P)W9VX )[2E
M\I2W::T7?'R]'7CB"? 5[#^\X+!DNP%4ZUQ_-8J%X$QS(L=B!#QVBQ5L4.+9
M9]%N8.;W[WM9T+OQ0^VIB'-,DB!%X%PQ]A=??VSL3%,7"P$8^E+7!2(%/MJ<
MY?JZSO)^#<D51!8OD8PN'O"-;;A=3@[:LM_TK12^"9.J?.=3%B2E+N;6H9.H
MD2O7MU,:ORNO)0T/M'>A0)>_HNM <>4EM[)<;'!>J$W)Q/\Q;/,I6+8,&+4D
MF 8]NLU?^;$'XC%?#%\Z7[ZSN467/1;*P/68W>PS4H7)YI5/RX3(&T!, /$6
M$*$E)AA:T83/=#!<YQ&NX!&O9-#FC8KOAD%[S':9)%Z).$G,EA.:^F@ST:[)
M1-*N99W", \G#DYT/L'D&O,IE67X?MFXAND>&-^18:109%:&Q]\!.]T SB+F
M,#+>A5"N9"!1O7C_PCW57^X9YW*[LVV&,(6>P$^7Y6C?"7X;PIY[7R)_34)R
MUI/\;P"$< C#K5&M$8&7Y\DW ,>I #F+97#= #,+.C!/6JRO\BS2('Z(-J3)
M^[LN%)5#:@6O>-A)(AL(![9KJ])D\=7TI8>)BS0-D8WO*2"E=SN=\(2W AAC
M; 3]V&*N2JB',6I(A;YY" ]S.<+?2KNC?N)>$G6#;NTS87Q5=DM\@H 9(.(\
MDK(_F[B-H**<QR\Z9",H8"\(L(:]Q ^2%@QGYONKL1SW1UG-KZ>QI .>$5(;
MZL\8WYPO)*(I# +N@O544-X]/GL8E3>IC2BGVA<1>\,-;0UTJW$#51 /Y)>E
MRO;..(RX*=^N9,"8_Y_XTX3:_47_#Z1D-<Q?W,_L;@T-](F_O'_+17(X :YN
M:*)>S2LM-?C'0NAU#,@[76N_R3NY56K4]WBVU24J"S=>$:U0:HS&U08:K__0
MC)X7^/VM,(:8N2 Y_G."#.%P.E:'3?#RZ :PX'O"$B7//R?[$&XP*TKRA$E=
MY?%#GB>'2P-JRQ=^]G27XP1):'L=M-J:SIWNG!Z0APNY*&&87X+AJZ<#QD*L
MDMRR]ITOSLGN@@,V>Y8I:B>JQ<2G81,O.'N+)O44'@_H*$$M9^"=Y VW&C"+
M#RDV4 HZ\PND&+P'3EJFB;.2B GO@JF9)U_,E4-HTPVSX?)QEX=ISN)/8T8R
M-P2@UE*;!VO(?H"W_G^RLFU.%AE &]BC@N#+U+NRVEMQ^'U57>>RT'#G=%ED
M2HZOX[_>!_:_:Y#]8QW['VK=!3A_*\>7^18E%@.][*:,:YK:F[CE+?JLY^2;
MY7;^4.$DYZ'-E) '-X ] ;;1KN9>4?)0.^9/I_FZR.KP4[,ZSS('7\\_O0#B
M.9J2/<4M856@:12@+[P[X&&3VRR6<3+/[O6GPL]OOK#C?9"FZ'?8AEF$)0+/
M0+Q#RT,D_6WEX!2QP9T/^"*&)3F$#R]IDLO,E5U+MU.\D\TR>CF0?/60S3\<
M[]QD]'W'PDZL*%1K=EL,"B^+EZZ>/QJZOK]NF$F%DYF/#E1'7K<JY3DV-E+4
M# NT*4GXN\[FS;;QY:"C7<X.$NT#=*U-P<K"\8J^LPU4.&HO)D1'".?V8.+9
M(!M2M]?+K$'9>G%%E>9FO=XNG.W3&J+"I1KLB<I\I3OWY%0T5  &4_6M)&Q3
M>RT&7]J_=""6#=J>_=.D7^V8<J561(15%\&L[IEYO-VXFVQ]2D? Q'M*A6-X
MK#EU2B>PC!U8WJ[,_O6Q*-*\;V79/(ZLN>300XOO=6OPKNX4Z$F50)QUB@,U
MC#T#4Q 3YX.H?J5(+2; IS/['C9E6'MK"YMDZO]A"S$=%61V.$;ZX)(YUO;-
MP=,Q/-X*M2)?1,-6#OXPE7L/ZF4TAQN/D2H=,1D>Q:*!A8S:E$>T8>-D_979
M8[IH44-DA9,&+3? 1M9@Z/&=N&]YCJ:\0RWRZ8YON%A_"N08GR>.9^;8I>I-
M>+0[<<0;3U6Z3(HO1KL3_J2ZC.U"5$TH4CU\-JFG;Z'A,2P4$$'A_(EHX^[
M4P:Z <GB'5/5S(J%:'_+'M@E-:A'YJNA"L$<'K-/^6==7+;@QP*3]VS4$2KW
M$LO@!HI= -^W98XM7*GY_.4%CHTI;&_IE4!WH&V7&3AI[2H PVG1!0'3D4HQ
M375!@95#%5GK:2Q^77T@/MJE]QS?_Z%R3>U7I&W879+XEZ>598\!U?(HP4^G
M( 6$6'@LA)/8F_)GN7W9;YF]8S@'#JO"LJ7"(\L0%8"*)]#%'\C9L$>QJ,2[
MG\2C*]Q\PHIT$I#1_#XI$#!2:&+V6ZFYZ8O+@X$?<MJ  :<9*AP=O4F/:Z?!
MBE,_/K\%+RDA'5K/L2HRWVA5Y%D\?-<K1'E*X#V[>XH9.-A9'KUK*JJ+K]T
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MYI\@/8[+DP%@;EX0G^5VHVELM,D.S0<+TT81O(EPY;AL'D1M(!P7&7]->*F
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MUE4=V)J;P-R1G&$JCU$MP17%P?<.>#O2"[9A8C5-D_P"%=9VRS:-D3:O_3\
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M='HXJ1VQEG_7)B;>%^'Y"0F$V*'(,-P"[VJNHZ;V5H!N^3)F7D\#/N.TKC&
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MGNW? #YR,=<FF^NCY1Z&B_H9GRPY;^Q>D9KIL^S8VT1:30>W9LO?ZG$*L,T
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M&HQMY?(G>^DE/Y 7QRMF$1?CI6-$1.IQ$.^9%\57@0S^4<T"'EKH6G[P8^9
M7_-QGQ>2,EY<>=Q?)OL-L+#ZSO12APC$/OYE:#0:J,A9]"; 1%U!XOI$=0+[
MDRM(P!3S"EWGYT@]4QR4FW(_0=:-_P'\\]&]BQTKM/$-@%9A*UOE!A!T= -
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MWE(,&17.IC3^CZ+=%19/OECF YEA<#U>Q C%8DP/)+-RHB8KO]T7I.1BX^A
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MPO_*]?''</J^FGU_OK;?&W4*FC)^I:S-3";<VK%R0OW@/<FM%<D)Y.V<?%\
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M#Y-OGP:B1]A_T#XU[:=@0B?7D&0%U*!$8=^=>12A?L^-'N,47;^2II;>JC1
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M!*?SI_Q)K1O2YLI:^M-:-IM).9*7;?7"=>@2$,:\*PV^;/:PANU>G7LD';4
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M)X3N?0^R<)_*PP9H+Z@#;HF2AH>\/J]P.D:PB64O5-L&+(CRN/M%W>JEH.X
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MLH3!UK.3#*("P?C^N![?U1X^;'=DBH!0*R!4%:-7^1@,?ME1#+3(=(E]<,I
M$8\L("FG2;N'"I?VP*L3CC76B1K?7H_+C_JV'?XR56&;W,G!YQ(Q"3^G?>+)
MB2NODK&ZJS_ZXB CH"S.^ZIY@BZF&%YI9X*-/1&Y\F*&/^8%6]3C@T,-L$%X
MTFRJC"-VQGK)F(>6&E;ZO+5(1Q3DF!CQEO*EY;3_&%\:WW[PD\'*F]AV[3CR
M UM57,\4K<DVCL)=D,0C./J8C1T5YQ 1 XDV8/TR4ZCJ35Z@V+Y:NLZ4!.L8
ML \RIJI>USP);:0U?S^DB!$2F3DJ2O$;ADJLL.W@3^_+>EY#83FB6CW_GAPC
MX07)TL1S8T'"V(>?V>KS H4F(D4XYCHA!G9L; +MS!H-7J8 JGX&RJ&)3U;\
M6.&NV+=8O<DH-EA,:MIK@E6MZ8_=MV7/NMRH<'<79YR,9HG0^FVN+6"(V@K;
M"9L7>H8V.G!97@"ZD"6CGS,/FVCWRF,_F;4E8RHX<5VR2^V['J%5]*N*P77J
M@8?M!/<?4Q)G=X7O-Y)PG;1M>B/=I+W]H\/D.B')F[AQJK.U1HA^*<SN[7VM
M:&BC6F[W4;DS>1+WK2JSO\B5UV+,$K2=YCZ/+V)G4^LC?'HN5S_8;-;&'-8;
M<:02*$7[EO,Y>$Z0]\MY:+E?4&1'^--;7R/]*;.EOJ@HRH[U+<K5&AT9/KK(
M%5;S&N+?N8^U*0@EM5GD2\>R^15/2?T6GKU&0>X1>RI9<NHA#9ZULXNJ-U-5
M!3-U\\"BZN;IY=-TGYR\-[\&1!5I;FTWB="VKAV#BN$T[96>8;V$>]?:?;.3
MH7.42G.-+\"228*?Q#8V.RD<LM?T#AS$-"&O.3=_UY>;2% N;)[J"R^X*U0,
M)#@3_QF7Q&I 8E:%"&]Q M7'ADM[<[ HSZJ\IJB#A*>O:D@XFGT(6EV,=+(_
MENHC^-GK#6I+;%_\KIA>PQ=X72RTVZ^"^6E2BFJ@)T;D6!'AE/?>5N?0W@WS
MIZ*IKP5^;I\.PJE@95>?J12OU/;B6*#2C8?AQU6^S6.=ZV=&(?=+&X4'<Z\N
M1EPHU L]V?'&S[Z-W@BFG; ?0"$,J]8-+ENTS[+)^=JU.3(K7DPQ!2OV"Y2G
M$H5<K]W'#8"S,?/4L:.8S]K-HH%5,GC8+KDIR2G\BVS(Q S<R/Y^N5/"1N1:
M)_EP7V/?\%J?[#5JOGCZ<,-JN)$Z'#C\[S9W_E&[$0O03!?Q)=?:NP+L=C/.
M^7RQC>%-K-:K[1U9@.O9?X<2^I&4Q?-0Z;4O*R7 D(*"%5L;=R4FES:#',DL
MUELBO(-[9(#AR=4?=>6V&IYF$JH77E/WU7 X\/;BTQU "@MJF_>B/S(\5UL.
M@![(ZAAU,9'GJS]=G_J+Q.,BCY:WIF;CJ2JT*&]_JLW04;!NY@89(K,'BH7.
M68:YHX@0]7FK>M6QN"KJ]BX49Q]ZT0=F2J\CIRNBE-SA6'TF>+LZ.9T+#B10
MY[8#[>>Q 9BWLE8AG?4Z(K466%]3A,]FB=2-X5<__W^![__9PU.U=^(Q4P1T
M,<;)D<(21-7ZVJPK;$3;&,]K_-CV+"ZLX;>Q+]]T3FNP,"1 T-4YQ^+3NPUS
M&I'(DZIP"9;..3&_,FN0Z3.[?(7R3^J/3!ED.9JVL[2\=2N0?'> !(^B@#_N
M3IVU!/W6VTVFN,=U!S=L/B:\E,CP)$&SHL_">P$B]?_#2@DG56$T)'.N 9$H
M_EE^#@DE'X[7[G8V/Z+?BH&$R81WI*NT@8[2\+EXJ"3!'I@F\R*NP09/8WLT
MSG:#V^3[O2T@Q?\QRGV<E"/\RY2K2+]_$\KX%W3Z]QPR]7_G*4S_K8L+?QNO
M?,T@N*+]';2)2K-$0!6$E?3IZ]L? >I+NJ'&"-&!%;S$@\X%*Z-JE1=9(/;Y
MP_C+L-]Q_1WQ>36E;XF)"V)'.04:B%?2)6R^*,$O6ND:IL6XG#YV?A$'?W\D
M[MP50&_<"EN%5#8&53(V-:<?MO3-WP$4F@< 5J*Z8NOBJMY'UH4JT2^1+&TZ
M'TV("^5SU&6)J[O^Z>[\]V0[?YG,_$*Z^[GXZU'5/U-*013N\6:Z[E9E0JVF
M+I:R76H8I,GIPBT5Y'*&,3>74KJ\L_H@KW.ZX 3X<7R E9*\F0[FN:/LU1@C
MER/!@HA>P:ZJ236]X4IO'1E(%OPT0>V4H>OW;XH&%*LXOJKEGG$WJC>F&ZH7
M 6PCO;9-?Y"DH': %VVU:U7(_CO 81AJIDKS?U:JX1F$-BP.$D#E&=6+6U(Y
M.%?(\PC#P+>B58 W,;L]-KC5^_08P_,.H 'GZI4DVA%LN)A<M#XE"H+BMG?%
MIVP-#<A2L_VV_HOT1\EV4^@<(<=H=0_%N1<9"VU$10"99]'$KQ6RYCDNE$6X
M?2S=9XMOM[.TVSG\I^WS<\@ M]MRZ.+"&TX7S QYVQ<778?(,3.=.ANVP>-?
M:[;KC-:TBOJ(N#<=V4,U<^R<C.,"LL[1J]_X"TW81];\&/-ON](>8RV[^7X+
MH-CWI_:5GFWCA;(YXGC6; +/;HJ>+1@K.$]6KST8*,OZ(8XGJJ-5K59RX&[&
MXXVP=CF*\_J#NPS^_Z8-]!_M#8ZW:<.&]WLEF%IF7\Q\#&%>^&H]1&_+>@=X
M>Z;_%ZT4M&]W@)*XVTEDZ=E@P(P\:@>E=?T_%D__=^,OG:M5?^UNE2+ZNPW,
M?_80\X >-1?MB11F95JX)QKM]LNV1DB/RG833\R@Z]X!_J4##?0<CMU]>2T8
MYZ9L>9@K !Z-G/M%EOR 3VTQ5&@SK-([NV??P&<UU-NO?>/9TFN4P\ZFU/!\
M:OB@F!M12] 8DO@.\&/U]N<= )RTYZ8SHC1]MGP'6)@3F,NR%+QZ6N8P\&[-
M90;E9OL_&E[(P+I?794)]6?X[7EZI?U*N>U*9:I/\:#+C[LVLI)JC15AXS>Z
M38CV]1_\E.D+[)"FCY\2:\E^>P$EI#RI_B./Q[]&S<Y#+#8EP9"S2^:#TV51
M!5$" ;1K;N0^SI_23@#@Y;I)"*>O[!KBV+67RZ]@Z")\4DYOFO85#1(=H?O#
MVGNYH]:\1NZ7I7J$*7.2),181X2G)47F4,B[4M)R]YQO/PT^:G<'>(3(<&(@
M9*/WP$+> 5AW'W<-K>F@U24.=+!5P^;B4Y\31' Q2R?%8&DB\,2'B ?"H@O5
MWU^</OE9')8BJ;EK1 !5JL+?O22D&N*H<]BX3L*8W3-_6MC>]KFWU2SF-<L9
MX(/F_H[JJ#'D/CC1_5^J#OU#$+Q5[TB[(\)4*I =(%;JA+<,,65_^"<&=OW[
MY$PG?O%W(CGH_Z93M?NWA?H71*C)F"STW,8JWBSFX9:'T!-QQ6+0=U_'&6;N
M'3"KPI"=]XG2YS*GK4==K,6+S)*!Y5\--_*BN8F3GFB47%.+W0&(VP@=V>2N
MD3A::S\FEP->O;(#1FJE$24S+<7F?K_^,M5AD#8G7&F,6U8VK!LTU=X*<8PR
M!2&Y<$-&RO;2;-E)GQ&.8)+I8970X?G9>2,"S!/ETU.V3 P2HY.R99KR(OO@
M5A$'2&;(U3G;%KEZ UGMJ?+SFS(LT!G0:,)40UW7TFVB=Q5KP5;SO='^YQXG
MC-"7VI-=.E@8A-%NP*^VR5CO4).D#5LCEG> NJO\D<7]UB*V+3:WY#<)=DOB
M?:,Q?+W1FS\V[@ B%9;-A+B/# ?Y4ASKT\57F7\([>ZN4K,U0R@4BWP/>.LV
M&5EVJLQVT.$FOUX[LMC]KB4!"_1O$)YC1QZ(G%4E'1WJ0,<5U##8.U^BDXF7
MK_K3(%IHB1&6I![HZO7JQ ?,H?+HY .Y>[A6QF$U];&CG=S7BTX)M?*ZLL3C
MGMM]R2O/8$L@YU=VS6BQ4P!_&W/Z:'SIF;0MQ49S[YJ$:,/":BU?#9C5(L7L
M^3Q]DF'_XNS,0RP,\WL;R\CSFD*8&N,9(_HW73]HAY705_K6V]AOZA6X0.7I
M4K%QCDR= S2-TV'RZIE,<ZX\FY4<;:U1;LP2QL@C]<-O^-M&VI]7QJE 8H8D
M=N=IXXDZ!][+1.J&84W_WX(A%XKLWKA'NZ0Q-GY @XJ=S[LTYF _O-^?_<JJ
M^I1-M^40/CX<T3%$IW7N(R\RB%:Z",3A:; FCMR&<'D"0/GAT"7_K S^H<.B
MF&\/SW6^>F2KU=2U0'TQXLN[.+4I3LRQBJ\AWQ[P2/]:.YVKTOV&I(+SD7"Y
M0 RVWV<6VD61F 6Q-K)_6:)Q.C9N?Z_"2>!DE1M643ZE3:H&]#" 'X>V"9?Z
M?=&?)9C;_I XPMWJ6RPDAKYCYWQRLJI:DWQT81Z\0LS%$/N9"._\U+VQ(IO(
MLTH=])8X&/+5O:PGGN!S09R_ZKJ^>N&AA5DV;?3[M[XCNO/7] H@OC'OB4-]
M_C/!;U:8$-^UZV<SM&:Z^]L!:*LC>4BYJ9A\HCCU;^"E_C;VP%)6A7,,MZH\
M5MOI"^=-+LS(]V7&4W/W4UHC^OK/#,^6@,BN,++.QCMG*\?B-GREH"$]*_A3
M0[[C<5'2<D3&]Q<;UX1[G<]\F?-6^(MR*Q<+=C[#B\Q9_YSC<A-9$-_Q,YOR
M$FL0FXOMJ)9"3JST+S(QT)C 1;5^+WT$ +V4/EFBJ!U[[3(B9YJ+LXW;?_]I
MT_>E^58J+.;C@?/!0>HK8$N3E<J]7[VC^53-WYZN8X1OEA<9N;6%+:K'Z;"I
M\"%"29$^@S5H)M'0JL74KD,$MAU:-35B,#,U!UDGP& 9.TF0\\3Z/1<:5V5C
M3%<G*,*!)/WY)=0Z750UEUI^W40<$69(PP;W0S5$RI:'!/]^M=';V1>[("P9
MH[HV<N6J&J[_YN*=F<%^D(US5/=P!1Z/N/0OX$"H_T0&+#^=.?)"8.JB^<S^
MWM.M6OZS"I4$V S=C\'1^Z$2NHG3K[SB\:-LF;M?X 94Y/OOZLSS[0 B)(=9
M_CTXMIU33-O6M[0+<<?4ZB\AM1Z@XI[0WZVKU#B60Y 2H[+I8J%4!Z:YU>D)
MQ5\&7MNXH4^Q /$A*9'\)@0!-G< NR7V5:N3MC:Y\IC%T]\!-6QM_WLLK9R@
M%<J48/5^73K9_<^8K9N$O(_9)"T2T0D\!B9*]$NL&5Y19!@O+X8F(-J/FH=D
MR4 5)5-)\K]W'238/)G EK'*_@]9/K^S/NK\@4&Q_SR).8@II%'^1:@.]2_R
MAQU&R>"7]L:XD27#N@#7*CN$+G2P?A5'MFA9H;S,)ORGZC.QEE@2Z;U'Z'!@
MY)]!.S5E*\ @_8^@W9(7.0"7C_CD^S)GHG2/ /#4E.4.$*E[D./! .+<_@F.
M;.5U0#%YON[13%=MG\L+W7J,HU%.#R&C>JK";<18N-Q^6^$AH#G@A/'E);L*
M^7N?9R9<O[95&)L[>@R7WYZ.9?E;"O.O^I+-,-;"Y?)S^P<.- VPZZ+$Y"#!
M#>(\CY#EP"+R[C_\CO-3.50\RCCZ/BOF->-__E?(*.\6*^!%]H)EA)<*(&Z7
MT(PH72O76WGI=N-N+F1&41LW^H M$[%<LB1;L*O_CH?OLZT@#J= !ND;M47_
MK_%7NDG\=<H.O[]JRVDTH>< 6X0"[&@L)PAIT_QT\HK)EJY#P5"VUO= ^R4Q
M7CK7C\BW<M*E;!,=!)Y #MT>]9U&9\R9LX*G;9^\$KB[A<[)NB3.=_C'6)I:
M>4&%&OP?BJE_Z'+XP=FZ12S_R/<5?9BC^)O#,93(RAT5;OTL!CAN7,@96XRF
MQC=V)Z[AU*L"A^'\9J8.1_FL$[OT?1CNV,&$$XO86O6X)%Y2_1.)V2S_CW'7
M&=I)BSM^XA9^=B5@>;>/3L1C;7].K &<6-PSY=?8:P-\<F/K26X27?>B#=GL
M) 8=P#=1<QK_X/:&VE(L%17V_6XH"5-D24L(D;I>YO-_4)0]M \+KXO1U&R=
MKCN4PTX?85ITP7!,#M^(?G4X^**N?*P-<RW&JF>5 &E4N:?X9&%OFG>1*,7E
MJ;GEAOM:Y%G:_P+T)79I=10D7WS*E@/*ZD(*/V98H1=#/7-LC!;(4:QP8,C:
M"'^V4=LSTCN [A/<*<4SD_VI-O@=P#J3=UQ"-8Q?F.,4U<CZF*;I#K /RGPO
M[P0]U @@1,1W3(J/).(H7]*K=P&\\0+]^2<# 5T ?&EC>T-']DHB/V/\Y]HO
M7\ZZ-^]+/$7$0U8ICN(46LQ;I)/KFHP2T/:P7DND H$=!B#7Y'JWN3,Y >^D
M],?)"DW+L=[>]\CA&JM+@L6$S)-S0)>.?8II:"8 )ZK'O^T6UTT-6%:>)6&6
M,H(IZI Z"4KS;%U+CJK:PR^UON3923E2$C4 FKF?+_;C_P85_MGSD/DDH>B8
MU*S7#(%>NB04IP6/GC((()!_/$0;9=HNV6V,/>E+6I0N3K#XT=\B<WR74:(B
MH/CM:E[1JVAWN20G8END<Y.Z++$EVON6XZ@S?%QB(T>MQCH/\O<+-1O>A^1"
ME7:I'1-V[+U6(Z\1YUUCOLW$HRWUO>#V&R]0"M \06XCUE-]![!.W$XA,:<C
MMM1#?2[$E+0H$0V[ T2[TA(-B7GCY33:.Q -/^ YQ!+:P\JM;+E:_T5#']4M
M(1![ F^P 4U&&:0<DH^K3S0X/[ZLRHV?4YA=_S#8PSKL_.B\M%)Y.N5E$191
MM=;WZW.2FO-C AL)LMK8?<-6 P7SQ!$="X[D7T)KM#+Z29!L8C%E_/ V9;M"
MFZG'%6?)5EFRF\;.KXAH;N0""-]F4"NRI)G"L7%E9ZS*=_SY8,<1C-9U1OHK
M>Q;DW ^TX?MU:U-V6?SW&67KZ;Y^?7M=K_D;1:L!X&0"V[9HD8^LT>NQ4=)D
MJ_%0<TA2F&1*/4DZ4&W5J#KKZ.!J^AVRMGJK!55\#+ZF8;[8/O)JYN\<O);O
M0;%-^FH2G5@+CK@W')"\+AFIBX^?>3)?A89P@;[W95M_2=_I1))97O9FBC D
MTN*FX/K!8_)KW<X'CS"HOOR.W"S_P_:#-;@2L:S6_@P;?2\-ZZ0O!Q&!':C<
MNA%'AV=XK"E65<K/SO ;&G.@2!J,-AS%&-9GS!,KBD6P>_VV3HEETR*U TZ3
M WAH7:@\D\)BQLUV;_[^[PLC[#XP5H1'#+Y68ZLKN?7LSS7O0R&ARK0KBZ/"
MR:/*\QCQMO018>U)4'1TH-9UL%"?GSSAU;?\LZ6<69W\@T(S]D[J\T%A_3'\
MO$@V],G_K,[]!UU/?RFY[<;%=&'CE[TT3*TS:YV-H<(7'ZG?Q]<3^_B]?"5.
M\W]5H^C&^=K? >*_] 2<CV]?<?C@>E[VKUZ1B0G> 0R/ A+F9B0CXR1Y[@"N
MV;E=F@\4<3<\&G0)]59D44#H0_#^X9%XC$3D!5A9+QN=?!@_C7-T634\2R3R
MV=.Y2D.T((9D6Y,SZ,]CJX[9JKZ+Y@"!?-?\1U,9[ %')6L:ZGK],4*M!6Y:
M_5#6@607>TPK063TT!W >.!J+N9OOV='<D,X5O/Y;'ZF1XF>=TX=;?ULEPX2
MPPV6SZ4F\Z%P(]HD9K1\Q\SJO!55*RC?:T(=[EMU6*[!'?=J@?,. +ME>P@Y
MJL>56MV[K+4E+3 ;SZRM\V;9R=]5DK6BX%L[BI_4I0ROI-$;JB->_F,O(+[6
MY Y092V9KOO8:/67R14E_QW@^N++5;U%%.K90N(=H+U*SH>#2-U8^/(?1>S_
M25+QOQTU;*]2=&YD9E_?-OZA5C"(KW]^!X@Q.5&9N/5?O /LN&U@57K_X K*
MILVZ ]!(?-5<E'?.47C$ZD%?VO/\'*NZ<E^2&K&H$BCM""SLM7U5=+*DL!;0
M/H/BCY%U4\E@AM,/YD=6RB"<J\UT9\\[">YGYFN<3O(%HVCR I'\(XE">9/^
M\K-=66+UKQ\JB:QTZM].;94<C:Q0WAL5!*FZO@/07F/K3FF?.H;>5](YGG:H
MS@%4\.Q9DM?[3BBM2?P=X/\A[JNCHGKW?@=!44($&3J4D"[I%I16NKN[NT&0
M<&A):>E&8A@:Z5! 8*BA0>D:6O)N_,5YSSGON>M=]ZYU[Q^LQ:P%>Y[]/)_O
M)[[[V7LWB2H"=1%[^KMM5B\:N7#PVB%@JY;RG,.FN0)GA?<RGG3A? ?].E*[
MR%>Z$_>2V)NS9U@;LHP03.EXW= ^$.NH>AX\!2\L!Q^1[OK;I\FO3U4AAZ.X
MOCK=K6B$X=)W7-7-2G_Y?4HO-2?<%O "6ZG&\YK>RB_9D83GT,W=GH"29@G^
M6$MTOPGR>0QUVF<0"(2%\AVC)N<&U+>Q-'R!(7%E#=4:"?CANK]V%4)U7;L5
M@!T?? /R#"L^:@$@@'M._Y]6Y[ P^OA*3N4LKL(J&:9O5_"1D25/1]5+[#O!
M#ZST6(%)I[^:OZ6^QD$]@H,"<IKE$ZLO>1$DW(K;+V+L#_B%+(A+1?_8,[,!
M\OVG+M4_/S?[_G_[!E]],633]4L1DG-=  Q,^FW__%E'\9J1CY/M5.:<PN_U
M%'*NU\O"B3O_A^CF[A.[BK88IQV%G):Z>'6++Y+.P;=U97+V?J7H$RXKU.8)
MZAT99GC;1K>Q@:[!%N%7GXK-Q]:\#!W$\@2BIZJ.#+7J3KGRK!OD:ASUD*J?
MZ3-B>@X="K\8@,*98FD[,IZD_>?/<.. =X,'E:?UF6L2^!H0O_6_)O!'&UG
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MXZ*_8#A2PG ,ZX"4OR_5F\^K4(<'_"!V^?TH2>6-&] !-C"0"KG+8F[*7_>
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MUMC:[0A]<S@P?M!$W.,T67RY^?,_+$+ED[.Y&]#3+&P_UH C<*7!/W\N+PH
MDQ$G7^1=X8@ DS@K*O)[0K;\\0+Z7V==MP,DD$O0P/@OGY&B'1:%B0$M7:<"
MP*2H[/T%,1S:,T <*6^?*%-Q"!B(.\VK+:0K,9>^9Q;73<,WH&R,P]3C_8!.
M$3H! *&_GOR^B'K[SP__!\))>BN<$_\#X?SH*XK,A%7Z*B!#HXIG\^JT=;>3
MBJH8$RAL*FF</5'+O>T4JT>YTLC%-_<4JJ!!NS]6ES5-U+P>NASB]O_(A/K_
MG;>H,^=)BR@P4SY8IANMQ+UDPA''T5[-6DH.RJL_3.M4)SW,I/IR&0:&C\CV
MY3-(F6M4C6T??56K&RLW@K[UWW;LP95:9.S&5Z$YP(G1/A[0W/ G_)R8ZZ<N
M/HE&9L[]!.6(9NT:53<QY!V)7:J.=K:JV%G5L<@Q#+D\OGVIL91AKW!V3%H^
MU];XTO[ZU;5:RD-)J2>3<=$.'UG#9O<OGVZ3)2U/H#0[H'G.O$929*0L?S "
MS\IT-%*V](YE%8';="<C3/S$]=BDH11FXW.C)4^V)BDGCRIL!:USJC;-%=_M
MCZZ)%$H^A PX$YF2:$??OTSS7-FJNK.VSBA[CGI(]7\C9 E*$MX6 [=4"8;^
M]YKR1NI:+%GTN+\MD34+^)Z9@/,?;0.Y.P#+?ZW,6M<$R.[;+=EA>+==!A5<
MBJ94%N\$K Q1GJ^V#;1JC@/  /,N77;[*0!50>$(')[[6FW5Q)_&SUSLDO_\
MPX@$^(O?D__=)JQ^?^"\O )2"L?^$H0_V/U?PM7%/V_+4C;TV<%7>OU/5_'_
MDH"QOV/T^K^7(.49(L]FGM36MXE5TF\_<1O<[JN[_W,(NA1>6;O^#9:J6K!D
MK!1/8VH$]UG)ZH#FTY*\KXDAEU=S''OG4;62H.JH0/Z-B9FE@<C16O9489C$
M:CH$&&U0C6;,F4QLP%C5M=LGFO?X=C218'S3>$0EV]MCJ7TG9'7WLU<S(14+
M*0B3N\BMK#2*] EN"R+MJZ%OK!3Y]O82U68"#%5]\:^J7[7'A8J1;XQ7]?[>
MZ:;AM:\F@]0()WIXMZ6>;H%%%VU,R@%3CA--@IAF\O,EY?[Q4.)24Y2*8GBW
M2ZGL,]S/G30OC%!.V^F0%4*F'T)B7&CS&8R])OHI0@!M^^"7_?]UIQR0 GJR
M%3J3#?ETOCHK9,^+]C3[3GZ?9_^._OZ2NLB*-*BE2S,J1L+1N?#P3JMK2+[Z
MAXD#GM"#Z4B-1["[1&Z5<G=I+1[_Y-Q47HN23\,#D+5.R75[7(/]/A8D9N<+
M9_^%K"_4&J/<2VT/CAC<*HD"[ 'L=+7)J4OG4;\W-PJ.,2._DJYT!NB+EC&5
MTBE^-%&(<76KZ);"?'Y3EBY=CQK=4@@2-23ICE]8*G1N0@/"]0I)%P+%IA(G
MW'%,4!?MF%.]1D.59QWD%*AR*:2O*/HU"H%P"#V6,PD@#CT?:2X-3ROYO'<D
M+%9LL_Y864-JM>;=)SIB>Z"$"J35RA\1(&&A7W[<@*RZG'Z-:V^*$*PKV\QS
MQ:@C FIJ_;IDHFG2(T&B<^AT^V4<>$H%NQX_X?DJC\$4D:<0@-U?'CWZ3Y+7
M[D]S)OOF<8]'ZLI<67^%R-&[I_<H6=2\^-<$2VM&W73*"1=-M4,SEUB?#O68
M8=VSE\W$J>+N\I5 ZDU 5Z)>OJJ'A?)QR=SII+)PS31F(I_F6W&PWOQKO\8H
MJLE2(<1- 5C_V\LRKS_X90T<G/00DL+6"B]RFAH/AH/:#@&34$=YH=PB_]]?
MR/3"Z5F4+%\JV+F.Y=R#VDR6OCN# LCUZ!B9VQCYZ.#:X#]"9FC:E])9=-HK
M&F(C*\OY)CT%X5P<ED[=)!6EI-0NY,%>]KGNI\,8(J_2P^6P+M7=Z':/005L
MB8ANV:R?+&1T1F2A6?L'^03]] _#HER:S/%-T7M"HEP$'JTT+>$]B*2I';50
MHA=MW3>@.W2B@16O=3\4VJ]5Q8\F(&7E3+VC\)7TQ4[_5JYX7R?TH?TQ]\,U
M0$$#,0XA)UF0>=)Z)/H[H3D!3I:3#/K&4';^6)10I5VQ*Z8NNUWJQK=FX3\H
M<NM%PN9;=,F2Z1B0#3\9&#<+)=];YD!VA("EDW*+PFS *'DNL_."7*$C6V?Y
MPZ*%?1J#R(+ 9+-&PB7A]V>8?LL^]=]LO',PV3O1N@II6R,#$KVAGBGO&53M
M* .2E!.9F4U8 %-6AO/J/VZU= A-?595>*F+[-[--?)PL/!P'+3CZA._W6JI
M[+TOX3UHN#[/.>)VY:,R4OLU[,.IG'.RM+'9_9?@Q;C@/F$F[W_K=7((Z2W9
M4!*=V:](P]\^H!LD*Q&Q3'<U.KK6JLR"DK-UZX-2IFV\31&A6<1=O!,#6K(G
M:[#OBY-C">IJ#)(YM=';SP3J\#0*AA-7D&H].<L+KT8<['?30L2(^41#;<9$
MB"[9VCX#0K+$@$P:*XZ[CK*^3S6+&YGNE.Z([E#N/:4H !()2LI)HL"?&VEE
MXZZ$Q##7B@%T)O83#'VD(]<(,DW11;D!H7 ?K,8# I8B.G<-/38"!=WO$Y;P
M'5_&?FCPP+-D3RI#]LL!U\ESW*XXCB&48Y7VBEFR#VFO?UT>).1+<NH1*T/H
M*U7/]H%:NE.7"QRF*>O\Q\) LL+:F[K?D:QD]V/N\'+6(^UU'NO!-3Z;0H-?
M)O=%.40^KHO4SNP\"\#:2A:XNT\E9_X,G9K"E>:R3-AS<4)D5&0R8>>\1:'D
M0L?*"=!B6Z?;8L _=OAU]^L>H-7B0'PJZLY[<CP%J*G3_GP8782OCE5>1W[Y
MISA[MG17:?@/!I$R2:8-=G9V 8W$R \N,I1&<:,)E@,*I<#2U,=D_Y\TJ7F1
M!IV"-Z!'GIE[*K!6&(3_Q(B,1Q*NMBU<.OK?[([[2U?'R3E5:^#,KR;BR\(A
MJ"<SO;Y')3;+.^"*ZR&V>]N+_"JU6>4BZDRYUI#\HLT3 54FVJ,M(H=&@:1S
M%)F"+1Z21D[-(1JFTX3(Y]?W(@1U62/@ZERM+"-&31>"\]A?%C\KJU*6ZS>/
M,Y<Q=X^/=]"PG.KPSQWU:O-KZA&LE^UP&HQ!W4VKZ[&I(A,,U:JV@A7G/0NE
MJYIX)@E??E,)Q<@/RG*F_^GQ68_D2$V+FXFO%NE#^\UX*O(]9_NYFIY@5ZI^
ML6B\E<M''VH&Y877QSG?6*-DF9@4D<^2\V>]"#V>R,V!Y<#G*_DZ,2K5R0J\
M([,]=H']\4(8S!WK2[YO]L/>C.^9P;GD8"-[M()YFM^%GO,6R[/[M5<87I(B
M7_#IV<@9;1HYVHPS7ZKD&<Q%V/A\6GT<@I7OX?>@&,H2(#^JIWRRR!S5)W$W
MC:(>7&NM%OT^G=N13[LR54E#1*NQ ;YC;V_D46?BX#BQ+4XA;==PKI'/UCZ,
M_QEM2T 1S0U7IMNKHIA1KLA:Y>F 2#XUZK;9H!^_W?(@B=7H--N]PT#BA!"Z
M+1WY<C4;SF\=AH[C9 DK5;UG/HOC41EP#W_:5CM]S:$?L(/+>OR+2MHVRH$6
M)N/P$SM2CJCZ%8I$.>6),JYW*GY\D; YQ>>#9QAZ@AI5XT96S!9:=ZZ6OE?"
M27[&)[1L4/QD5"VJD+7NO;N,$ZQ."%.>]W3^=>25+YB)PRR#2FFVXK 8@+&F
MT-Z&'[FB-1I^S-['!$_K1C#.7:7/5VRO^(_!1/43?13';6N_*@EO;Y'PSNWJ
MK*-KCW);=VMQIA:@8JKKCD(:#O((M=-/V3LJ;;%@5+-X84$&]OZ)&\&+"Q"9
M3AMMY1@ES'A]JP)V.P4%LW5$#NX-**!T8RL+O'Z2'(JPJ6J1)RKY@'\1]^=4
MM"\ZCJNFK]3PLV'[4HZY-O550K=@$_8Y@KE2+V(E_<1=XH\K)4I@)!F)^>'-
MF4L$<X&,O_ILS[W'[7B[!,S+&2!#BUS!&9'Y,A336[K5SDEEIU:CA9)"G]4E
M,\#Q <M^=/*-%\*#W_&"0]649_SK2[,0[@;3-R#[B]<!9CV^LT@5<RM7[9QJ
M6Z$W^=8:HA;0QGLJIVKPBKT"J_/D\-K!9TK@GSW3TD/=RETXOJZYB?/MKE8C
M:G;'@H*EC[WN=MG9H[ \<R2D:$V4G.SV%IZ;J@O==J##;) -%>D:,2>4[ 9G
M%6\U^L?5&LCCSB2^>& L[,BH0Z[^5;G.:GN70'IRCR+-/_LH9V@2,V<.#&EE
M'='?VUY&>EB@#&3D77FKS4EI5(U^TF(KU.ST&X'#OF, E49H62)@7F-2VC-H
MPA=;.:_,_O6,I)@MPE73?K#I[R(E*V.-2F7,7RTV,[)DM=_%I7)HG![:*Q"
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M@0V%':TQV\"6)QKF\SY5JPR==LKM"@WXSDU3K%$0QC)$1D9+8$O2,G?=$US
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M,I%)\%E2#VI#"XQ782 FV/LZ(_?,1S7ZW#CZ/.+1)QF^J6:D?@U!H9GP/[$
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M1)4Y,[[-F.?C5)GDZC]9VQ\_T*SS.9RH-:EM%<%,4JP\<8#>ZQ&T:[\U1U&
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M;;68:MJ7=VKOV*N#/.K;4NOY#A]?)/<YIL"E6<I(4V]+(IQ###Z;@K>EKW&
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MGZ$'J3!6'*8O!FD"(V:KV$+/>JT\ _6=;.Y<J#7_Q0M7:8JZ%./>UQF<QC0
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MN4E4F%VJ/%UW[B.:[D!I#"S&JSPK><X*;TP9AB$S4)ATNO\%-I, G(:C0]I
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M5NWD?&AYZJ\9D# B RX\+/!<>-7>5/=DEA[R]RITI#'XS"SZN$=R)\7Y"A0
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M,??1%%F^[ZK=4_;OA:+^FW Z]ZA9F\>2[\E+<*5WIY7 &(-':GODYP9O@N'
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ME9."N/MB.>C7)^4FL6,-)HK0GBG-)VV;NJGS%W5+>2%Z0SKJFA+3'F@57EA
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M]G<$J!VS*/<II>[DFVO0-@(3D.*CM=^H49W\,VD^PQ9]N9LS4ZO\&(YW^]6
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ML3[4>/\!88)]= I-7V7<3(GZ^6])Y)%8)>+U%[0_)^F61+B61QR37_36RWJ
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M-G/^PVM5UXN!J\Q32739[ZC9&UO<OWJH#=XPR,ASG+\@KQ=& CZ";&ZP@7E
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M3%/GGD>>\N20%1*XJYGC%+D F9W.N_AV=8GG?@3!E\C_Q5-44C1=;[N5'>K
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MAQPGC^4LX,SOX_3AG[-_668OCJR1Q"G?.>JHVO/SDC4,7JX(T2^Q("]X7#9
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MVFC [E'OPG*&3HF :B:3QX(?<+TL0OG\6#F78!^?FZCCI'S+KJI_M E3;WO
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MH-F'1R'JWB !:17N-VZ8/\%-2PJ7NY@(O['MDRU/RR2: UJ4UYDX?78][X#
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M_[_2[=N,.,OLS<NA=G4I628 #D";%7@%D;X!I!6'HS!R$:/7K9DW@!&-WAO
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MNF:6>GQ<+XEJ.#"$;PF_W9B7<*N";"U^GC@*;["-6GS?^0_5![]UQE#DXQM
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MA'(%,^)I+.QR5L>_:_J(;]R\A-+_&@ ,=>7]+R^[!__<%;JR%$C::L:TWQ#
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M8L,QUT'S[+JGT/3HQ8%;G=)*^X']^ 3(61G1V4YA'F(3S8DNX8K/?QZ!*TN
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M"RL24@-$8J:E&B4[IT]E/M=LS)2QV\)!YZ59H<7M;SQM)=MYO@LD9+AG2[X
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M/+^&%4*]N^6X&"67PM_T873?=ETJRM)5*2[X.-/_8RY9P:>%N1)4<M. HZ6
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MA/<Z3351TU?:9W9G6MCS5]]Z4FZ!8T/XRGV0(\))L_:(UKQ3;W9L8+Y@19%
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M71?IVC,T:NI_M-0_>+MNTVS.'#(_IS790F2B=@+$22*T6""7E3:6-=:D?/<
MQ]/<*%ZN9%ENO>+=]GL>=G=Q*^5158_QL<T]3=$+*T_"%[^&:L"Y.G.*MEEM
MK!%PEK<-<9=&"3Z10O [BW[G*%E_,>GW(67(XIAW,YK2JI2TSNOZ^CO[PJYT
MB>&:1I'FW;8\M^[R!3U<?FXGD*RRKCBY7@G6.'&(J9I;O0+@J:6.U1C!IW4-
M)KH=_&;2(WGJ7N"4VU+V\>KVXD;*LS(=L02-2C.GC-ZS]2[5"-%[IUO312T(
MU6@4%3V[ $V(,:*3FZ@U@Q_$.^3!64 .3>D6+)I'PI1,4=-!!S1KBS&]0^8>
M&>#6^%7+%*<:$-3*NLS;*?VCG;@-**Q4?+,DG,S?UR!D5X+%9?,ENN=7(JMT
M1=@.CF^MTXU$<-4;4\:*U:#FX=[&$@-$ :T-[TBXFU^W6NFW.R-W@)E-3T$O
MRC)NT:D)-@^&LB&YI=P;K@#[XN; HWUP1,&F,HQ2<?%NVICF_!J+ULLKP$?I
MAZ=B)V _4!<14O!^B(8_P[?YH!C%[K@WZ>6\(DFY0\0$ZBD].Z\_@DNC#Y'(
MO(MVVW3]UDP7PA9!<LWC\3=/,KW9=E(/'A92"DF,0*WM486WU]76T$S/I(7*
MJWZ5A7 P]=@4OW,2WAVJ>,88T&,XP4@;C>?M]:VHG^]1@''D4U=1RI!+]>O_
MECM/6W=]T_V27)Q0;Q0KG@8E)R?6V2#N_9DK2S.EE/VCC2KLCM@J7'\8SEB&
MR:Q*_-1:D&7(O(1'>[,[!OCYTG$YI'6BA+A'Z?J_&6YMV2S_.$3PT[<Y^9L;
MH8)^MZ*N_Y>3CQF#60=7 &_HAL23,82B,!>W5:0<;6C7(^F^!VZ?XUM2@T:9
MRD09[S1J<[0QG\:>*PG6ED5"V:9):"W+W4ZH5G'/QBM<C!8A/F-M^'<M30<9
M?5\PF8BCL^E]7;&MKGPELC<IXD8IIL<<;*9=@@ZUS-S48\L)&MCIY4X6?Y[P
M=VHG6#OUT6I2)VJXEFQ<@ R&'#M>5LED6+JDFY[P^#%NB(2WE8+:O.@\*.L'
M'8-?VQO4/E2VFAH:FBR6;Y>%*1N>CI= :"0L2AGN:C]8NW9K,G\4<MRFCYC?
M)GDQSD]G]*KTZ9S%1_T-Y6<_>D2#'5AQ(MTTEUU9F\4AD!I,]>(/O1?[^U!%
M=S_RP5=;JL]6*DXEYVWP%(ZJ_H;K_,$1ZSNHF\;SE=)1;?/Y0P,+39$/MRUE
M]O'E/G6Z+MT!\^J+HM7:@80ULC\[WY_PS!E(1T'%$[3VDR]6&CC<PZ"!Z/ZF
M74IS"KNYV5+DQ<_WO8XT)17 ;?9.H)^T?;SNF23#2]#]&;![/UA-[_ I.JK^
MV<I[6S7O\D=7 $*]:44:29YGH;=57XBX:W9[#A]FT FMRVH?I]!K&*V:,K/K
M@>A_H& /+<[TBS*;,R8E;2]]<=C=GS&2,_[\:))57N;=CVJ=8C/A62_DVROU
M+:M\KF5_;?K'=3E<FEM46HK:X?H<;,B?\@.:'M2)1XC%&4EG'EVY>S4I?2MX
M!<JU=OG7;OF'SLB.2W:E 237R]\R?4YKUL5 RQI_W6:]*E_%Y#F3N;:B_<DQ
M^9JG!0V-)>\KC,M7*,7PVVZX_*H)I5C;,X8F;YZG=U<JID#G<)'5;7(*8IU>
M[^I%(2%Q::[9%&>O]X+EQ,I+/\/$5T5)G>A'LXJ<!]?=3^,\#;6WH5!7+WIM
MNL* QZ4C*7O'E9FZXB.VO72A+87T;28O!")%/Z@L@DGXDX./: S3UDFV;,0F
MMYH[YMB6$@YT=45"EVO3M!OMF6SXO-4HQ2CH:#8X1*NK@S>S*FOB5I.D8B/Z
M%)TRJ,DMSC)L8EC0'E6"UHU$))&OC5R\-U TCD&X[R)QZIZ+N+MKMM)5PI?I
MC8WBB56BD97V\FBOSRD>O!5#6&ZR(>C99Z+9Z5Y*W)P-HL]B3CC3\<FRPVJO
M?[UMH#>ZWS&;=06 ZXX\:[1%0=6_,+QIJ&L09F2I%L'N"OTX:\Y,"KA08_(^
MR[?@S[OF\C5JT_?<I)D^?5]TQLG18,DWUS1 BM3"XT1?[N<2B]YT+8C21XL?
MQ^5U9YG9X8,4!?:C&24/B$82PESA*4I/GM@YR?#F,//? =7VO63G*KVI9/M)
M.(>@=/Y#(QO]&C3;4J$9@G[BZ_HQ26]3P1NM(9#S3K8'K(V N_BTO'$IVYA2
M2G*63OYH$]#,3FL[G&&^]2[*2EL?R8UAT9^US,Z>1)[5BSH)!3FU3=9#+?L$
MC4(NH&GHWAHBE^_P?(M(>6*^HO8!.;?P93W2LK+M-/ 7,EED2C$%0ZU)'ZH^
MXL*\_?[T,LTVIJXIAIU-QFEN3T]K52&4T5+:1"*(Q_P*8'P-X)-=8;N3!<$+
ME[+!:5LO>6 <\AZ2J!9G"<_]W*A._T_@W?B H?#'"3_&BZ^MEVYN/U)(FHNK
M>G=?N"#1G+VG=;J$MH0V:L,<\7F(+)8\1=!'S, 8A4^;_YJE^WN[C-J)/TKX
M+&@D?^YA$\M  >\HP!9#C?PRS<$2DB>I]./5F>JLRPX\M>*S3RL'G@S='<9'
M(]&=V*?5T#D_-\YBNIY?KA^N %6ML S'Z*,B9_ED"K;]SI^I0>R1_T?%#)$N
M4PU)C\8\C#QA64BFF -7=\J>X 297!=6<<GTAJ.JOXA<[O_>5B?S][J&_UCW
MSV(DT'3>7Q@3P(WB3QD<LG;LGQ(\_X*,)M1SD?"!>3'E+J+[#JVC9H5N>#._
MU"4YQ >V9E1T!:B/MDB8[?P\HJ);C^6LOWW]H>W7G '&=@7PC9V?.Z/<@NTN
M@XW53@VF17EE6[WHRM &OH6'.CVX50&Y=;Q%9WE>N#@&_%A&C+MM#O9-#,%[
M@E]KQ+%5FK1\N1/26+G^ <@ ;*\82W.-P>C"+["Y8[,B>P2)HZ.]!>69K?R+
M@4_H=&[+W",EP0#8CC7 T1>-)DY\$.YKGLW=6'_X;.(*,-<%7C#&"%[ZB0+/
M3V6+<["%._B\V:F5,(R6%\$5("6L_?)2Y4_O%X]67H;9:"5*DWV&+A;BZW<0
M3[50NY<X ,U4DOO*589>$M* \N[[J7VUT#6F&_#_5R5._WWRIC\3MKJ@PD0O
M'E@G=!BVV0G^,:Y)@LD>2FY1S5$=0^FXLH;=I:<L6I'+5L@:.<[.R]VCZY+/
MT3,;9_),5O^<(KPU3YQU.EZOJD1DI_>@4Q244&-;,Y1ODR;/F,"1W6FT=DM$
MCL7/'K=(Y%66>>@W/[QA.FC.GD;X1(VD.\RK(E@F<"G*^:1-G7 54@/$+=>L
M&@_05G2H(RP3#4[;?Z$38[]S U6<:*6)A9\4Z^;;.@M --TEQBWY:-H@O2$%
M"QN\8\FWXV#V-^*1;2MF_EJ,OG&RJ%N6+CX*(TO><VI5HQ!(:1PVHS+L12/E
M%> NWLY88;!C]05)*_DQM5Y/S%@9T<NB5AI#G4<D$7/"N\K(<F.Z(RQ.W*&0
M37X?F7H,ZXWG2_%%]ED&6H]KEQ-;J\IGS-\;XQV0K=4;77M#F2+W^PK4<\K0
MCG':N_?"8,FK;V?)1PH=ISRMFC4K8W:H.)-L6"RGZ%QQ3;,65+:G=#O-LU!/
MO+*XK-,W!&T"+?G.<Q99;Z!\XY11MP0V7]47AXAOA_96/6LP-_R >_8A:#N?
MBU^GWT_$S2RR1@V__(GFO'3T:IV,5W0/M RY'!M%7F[/F?JJU&)<WV8Q9$])
M9/1%WK?XJKD5?E U)<7?8W^)L[#VD.OCWED?[<:ZM7X%8%K9O&SB@:W=U9WT
M;PB %VWRJ4B[^#_Z1QTF%@Q(/+3CYX)9!X8&4RP)NOA:&TE<@^ -[913>A2_
MY\.:,1D+.N(4+?[:93'.%6-Q\0Y?O;.-U%7*<< M]@ECJ__/9P%KO%;3*!IT
M6+=&*'[?MDRE,F<2^DV8I[FY<@4($ &W6#_<C%+,,SN)TI8"X;M8RF B[!MO
MR LS5J[$0T385#2,3;:N?X$ ?8X2]&S- _]T*4M2V=M'41]+SLM$""4[+S42
MS3]R<<4\:BT[X==MSE^/"%C=.UJZ5QORH+Y'S1+AF+3T?$_,2NFI.\21VY0N
M*6MD85$A0?U]+S5;0?+"$%.2V/"8-$2MGJ/Y$=:OZL/6#\$<"3GA8V&/<&T>
M0H7#<$+H$!2_H#%G8J+?TM#B1&#@(D[#Z(,5'D[$4?ZZXUT/^;VSRP.-,+RJ
MHNH *3Z;W(?P4:\W0OFG,T>RX#'F7E/Z'.LY*W^2^'+S3#T#+?V9J<>E FS%
M2HHW$/(-B_7\2&B13#WE(6:4E"%RG(/T'38/6?IS;#<?TH;6[@B(X:'X[)$A
MBJ]@/Y7<%I6]E1\8PZ*;TVH5=3X3_B0U86=(KF^5LZ5(:,?\RX*\N!_4J#0E
MUWS;+6BPC@[OGAOU(:$?F(0/2&"^FP&M^JC]L2@'_+'\2Y0P77+=KM3PNKY#
M5?>K92[.Y;A:T@^7+^(N/J/$%:S%S-Q"%@<M#2@/UW4U*IESA9Z]R= 4B.+W
M,"Z07$PF%E^)2I?,G&)_U)'C'WN1U8Y[3M@S)/G0>^8Q[B_)D*2C:]N*.#R\
M:_]SIB%OHF$SO$?%.)=Y:86;?;"!-0FJH!LQ*/XZF\,F*$3+*P@$Q]C_@IX4
M<JKTY&2].F?2S6F@@[I*:-A;1!W;V&W9"=.7FM22R*#OGV5].<J;D1EJ<STL
MHBW[@/Q)1,[L=L,;+R4[H]+2N0GY!)XMBV_ \JNL33WP396-S7-*?MJ=L[3D
M36*EH;"^J5.#HH85>'.FGG+Z](9*Z@\=T[?+ELT,/[+(IJ>DJ3 [Z._CIDB#
M)>2SR\*A.*/"#8%+P+A'7+17MROMT\MUI1$383KALW@ZV8R:>B)%(BYA36Q]
ML-A9$'NQW./ ](]??T8%C6SQ.NKQ[P3$DW=GMS7/K>M7[Z6A)+S+(LPHQ@20
MS&M->6W5C!76JLHR9T?;Z_K2](5<S60EO^*-UCZ5[]].CVJ^?#QF8XGE]>J=
M')J\ C15Y)X+6\2MOL\9S*,1--K,!?5</LP*W=K.^H6VS"]:WVN3Z&;NQF$3
M/J^U@]#7@H9!(:?Q7Y>B0G>N/<]MPS\R(\>PVO0-[=#1L.1LG6F]R<3RARWS
MI;),AOY6DG#J S# !:2]=P5HF:/8U$X@8H[)XQ7/2T\)QF$4?.0P'_1W)O#=
M!1 K 39>>ZRC@[7WK'*R^6/]2R=V$(F8F,N1[>>R&@THJ=VIL5()'I?"UH.-
M<6V"L&1WT_3V3\-2)$#$S1N=-A*[O[#0[H^.^'KL IW&/(KA<5.%FT/5OPXU
M3M.W7"MRMUDIVU;JPDW%$^-TX@1Y:7W[G-PUSKK]6P1X1;)YV(T^1Z,0(*1/
M*)QDU8+=7E^.+2_^I;E N1%I+KU@1:B6W+QW\^/:FZ2#W!(,TQCC&G$CNC2Q
MB-,.2H5\"F&")#PZ0$X.)&)[:'DH;9O\>*P];E"O-6((*VE<,%D0:&I\C ])
M0KK@N/J8MU%&'9@48U\;0Z'I+G:*9HR!.YQ2/5T5/ ([62-#H3K=T7!8IO ;
M"['.&5ACD:^YL3U,V*\++^EY1M?/3J1(O'?M^QYM<R!1P1:GPQ1?8.DBFS5H
M16WYYG,)_UI7RYF.ZNI(6UP!E%0RQRUD\!:>!?NHO;NY,<;7@B-^3@=Q\G"4
M2W/(O9N1KO0')>VBT,PV!,KCZ=4U*R/SI"<+SP(=/V0E4!JRGF.OSY:V<'S.
M4F(1*3,H(BS;N:$D ],^Y#BHAFN#3AD%!CJ*&3JBJ"XUILVUO2TT[_)$U%-&
M>%+7B_>9N8M)18[R'M$&$VW;Y'++!'^[=B>F-?J#UB3*XYP%R^=?>_+G7AWH
MT+,/%-8O/*ZH*"V+V9A%8]<^^.+[$?3Q@.+RCJMF<XSPHDRS=:4H3HA? . +
M0OM"RI8]K$JZ&^F""(3 \,OPEVAR'Y*^?E?.0*:]^?><$9^QFYJ;K2=(ZW!6
M[XWE'\I:V+)PG&55$9_Q,$03U8H@O6N,E,#VK,EBM43EICQGL3*C/&]I6#MG
MGYWR2/S@>UJRG'5X3Q+5Z]F"JK=;<#&AL4NPK5,O5T:%H)^I\*Q/=.=N_WYF
M.PI.X"%UD<M7G>+P8=KX7)D6/3Q,EQ<M$KK)(%-3P:%FJ 8RLCYQ.SS.'?$T
MBL5 X4?C9[\\M;HQ86<ZK\6]#@8<>OG,DTGI#"F]S?3-Y-81?BY8>]V,]H"C
M+)Z6LXQA1N*,5_ZX;AI$V?IWB26=A5S&WPO&3VH<XHD16O@(;RHX[L )^*UW
MB]3WCF/YC@:YJU#7V+'+\9:IB[?* U\[932;"B9^,#^.TP1M&O310SAKV4>.
M>F$\E>V\?8\*^]I2YH$CL8Q&9LKMR>UKP&JIW;\0$TQ3,&;VZOLUV0B&:6]:
MT"B^S<]?0)3I?6T*IF;;^OGN7GQ=&4<G(VKUB;G M2E0^2U(@O-[XN;5[Q44
M_X%1U9\X;M-W+<!W^75H7*-HTF*6R7Y+X20<\MWP^FO%\_^W!=;__F*/ZJ5#
MU$3U+3P.5*RF#P)T\MV(0"63F2<]'$Q6&5U!UCNQQ<9&UU>E85$UX?WH_M;W
M)NY1/]?N*[6&?#4V&*@?F5=WTZN9(Z]QMB_82+F&5 XG^]N64VDG^.&PFKDW
MH+%!<C[UT!>Y(1S9#3@#]PZ-* <T$<NG9$4-;[$4>XAB0L1%P=%Y2>\O8*.M
M-G OU^.:E3R/N@)\)H:%.I&J.N:"2UN=;*\ ?[J#5H<UY>Q97]Q4OL25OP*T
M0@REZ<>R#IY6"UT!,!H2UQ3DY_7EAD P)A>\H'Y-5#ZS7@%N,ET!4'F_4L.A
M:J??]1)@6([DWZC5]=7YE\E8C3]_-EIC0D46D8/M>=('OB13OB9FQ+"]Q\J7
M'.%_67^++0TY<FE"88KOO.?<)'CGI>:X0 \L2-1/"$O#_^62$AW;'",X2SC*
M-'*(Z33G-*8Z=<<F$H[:0$?7+:+-M[D@W_7BZFY@ K-<5AH"_"<1E!!!\A!7
MX#;[3B6V>MQ GP&-WUQ.3SV"0K?[@@=W+!-H*A8I-?$P16MN3T]ZW>;\CJ9@
M)"YV_9 2E.CW9K)^MADJY0%O4%(M6RM[LRGFJ4D&J8INZC]MY_G?U9&NSA'3
M>05@+GQ]38Z9+JT-I"$Q'NH8" PUHTH':Q[??)!E?2= DAO_$6Z$WY;K;OM0
MU=.#-]D_GA"PZR4YJR*G.TV="7KP/GZM<&0<H1T7O\8<:]2?AST,LGJ-[&JL
MV3_-7GYQ#PF:]#,K>$PL^;@C=/#;$O4991^O-EU.IAMWB".7!#<A[[HJ2+&@
MJYS$U_";ALI^,H;B*#^9P-4MR_?H]2V6,%!GNOQV2VBI'"1W=3QH:2U_45*&
M-N<T,L78J+BJ'$;@0FX)5HD$E^OKI>=8%="VY85_7_R<H%'K_"*Y5;NWK"1#
M$0>I)PU,V.;)^93=?!MW]6?!O2#]UJR>I*I+\%YCUXDX$?\4?G] ?#S^%T6=
M;BDCVBTO75\ [1DQ@?H0WX_P.Q,;XV?=4D21HW#XHI9&2,], UZ&S8BGN3L^
MB#4S^9.=@V@ WSI_N%\,>8R:SBEZIKI8420%)V+Z?%PX!^-T+E>FM8.<2!,8
M7-;E] <_AX)PAG(-+#3=/NKL+*L?JG0+#FBT/2"H7J\8,HLYN!0SO0(4O,;F
M#8)-E4]9!0V.B:XW^'.%_1D:!;1!"WL(/4T1%'I_._(8%OWL\@26NC0^8$ H
M1@+\5/.$+[T:6DFOF:2EL'TK  ?@1'OO #UJR-P5%ZK%DN]XS8E<69_^(TYT
M4!XN)I5CD4R$J'UR/"]OFM$5;$[?(/9K#=_NMI(<'70$2Y:AO0F[NU5Z?F1:
M_J-GEJPL*G#2'_P&]!W3:FY$L)(HGDZ.GNXS%N21":)_@>ON'-'9T,>KE]Q\
M_4W<3"\0UYR_4#&;6@3/UZ'^_D7:.0L[XV_Z0 _?DG*AS4LT//[OBU;Q>!=W
M*:3F^^_U9PMK5EG/(%M@85+#>W3*0W70X;1X5Y,1Z[CTRLKW6]LC2TO);=76
M@6?.(6)&B^MP2S[12<XMY6B+FU[;_JKGX=T'GFX ]BI8(YAR0U0IQQ.:)>-6
M^%WOTQDW$&ZMH.*7?_+++LW/GV\V?^55 "V#X[3;_0/M).#8A[W+RML9I"#>
MYNH[[8 EH@LH3<LLA7]3DA@U'T6HR[N7KLP?I@[(9D(^H#MR],;X.;?(9%7=
M(1^9MQ_ON.U]@ZK5RWPTI\;&*UJ8"!$K;^,[EUOVR#2T"Y-VZUDH&A#,F6W>
M*]97B.3S#8-8OP,]IEJL"/=X0F<?$A19T+EA4.(S-E-/$%;%37\%2$<:Z)DY
M"8I$YZ9R+9;<9G C_KDHM*N^A=4]/BN .]IF-3I:YYENDQ<_PS\IOT_43]8W
MHJK;3)I'&\E1[8!7^T0N#9PWI/C>E4I;UE&%.H:)38SM,'OHY5=C*ITU>WF>
MTZ]RR;.J8(7?BA,6ZK&L(J^QQ_$Y1;4ET6\892O?$GV5QR7JD$#P<[B+WK(8
M3*W,*%)^/IZUQQUB>?3CG?:85/$* U;.:^_LA!Y5EU%<4S["^:ZF),+8VX%8
M9G/P6XB/@= F\(Z8O1%.NJU4KM05X!7SK7K !/\<EBBJ15.3 DE?FZDWI:/]
M\'A?5P9BA;*G[%>9"U?3):/]L$O2W,ZA 4%D'@M>LF,F/>@63,]YP[=! ^\1
MNOM)A1@8#VAUAF.@\6[,Q[B,T^])B&%,MPRZ/+3ND;XRO:^+ZJS:K:J.'T9A
M_&(>O9_LQ]%P O"\<] 1\8.27)VW;5[[>51OO7!PCO(RV)HU'0R-9?'Q>S?Z
MU.5\C_%49^-6$*5T5J]O[[BB?$UX=<0K[\LU&(Y5;DN]]'^!7MZ)M;0Y>391
M&=[GB-3Z!-@3[\Q35?C:IJ]Y+RV'?_*N?=O641K;F.]LS_BP8R??#(7:L"J9
MPX@*64+D/4MA5$(5MG/A>ZE#H,;[FG/M'L+>:LHV$#6[JEE+Q%-CJR]J&Z=J
M(X6FMW>M>4N#493AFJ_?8KP:$9PWF/M6N]$AGP> ;AW#8HK'^.(R?:O*WL=C
M%RWAM"'=18U,#V7'?N4R.MZ;OJ,M34R4F!G+I!*?(@_2*??Z04Q,2BP'<&1%
M/"[NJ%2E=*<=$42?5GEL@"N4C^"%N!Z<,&H7%80>MQ9Y;$3?0 V/C(*MM\0[
M.R'&HNQKFK!!EM<65%,&PM"T[,X#J9F&2"ZBW0-V(.=I8H*CRFNO/<5I SFA
M3!^I*&]KXCWRF:TS':LCQFQTW=8L#5?S59+2D:.J9_0KU,3P.Q8DW^W,Q/@U
MK4RL[]^!+U6\R%\/V5XMF(T[;,^P45^V0HO1.IBK7VP+N#&3JF@ER?W5:G5@
M3%$$68%8@P*,UVR7"\M@^K-.T"\0"VTAY2H&6E @VPPFA(L]0UTXMY"?E/0+
ME#!$RJ6_(1>KM'K6CW8NJ/K;/K9O+&-HB^_'CXOW0A+=EE21FA$WYCW=QT)=
M3-OKB38$!<?J2(;A!?=?!=L*RW4>A'EI4&[<YO&\C+8)Y\LW5?6(J%PET0TG
M=2DXT('*67+%*T]/M7S6>'Z>AC/@*('(D@F=YP9:Q*!;L]8*C6Z&,56V:)V<
M5H(_Y=+S[ND7SI_/B!"8O@E"K>Q1$#5LO7SW4"3!*REZ6ZU0Z>X+D9+5W(7<
M$:OT4IE:WXZ2$7B!EF* L=8]GW$\(?BF 5FK-?H65L;R@QD2 GLD-'/ 3@>C
M7C'/>2R?S#5:ED"7)510^8)G;F ^5%[6*FQE)[!0-KTNOQ]'_B+%8N_)&(ZA
M44*R=B4PD.\''*B,&'?(V<D<_I;.(V6[[/]J"70?.%09Q"YB:[48:MZJDW78
MUV1 TW0I+++VRYIA^[+O>$7):0MI XVIA4)J(DHQZ4$3R3/I!53?W"/&\L0"
MZ<7:U3L;IFVCE+.H;<-F/XN4Q)]43RMT1:HM[!)-;OZ:DK:GM?.+N?N&!YS]
MZ"R\8Z3NX9Y7'NK"6J5XB/_.=@%<O;O,Y!T3S2]7JB.RK#PL&'T99<WD7,5K
M0;[U5'\B$$;+W7L&858X7$E@3A,U-\QMS/TZ"I0UHZ"6*/HY94']DOP*\*$Z
M@.=+Z//&C?0'BU^E77;#)>@-,+*J/_3V:E@\GTA5N6O@?@<_V%QS5X?=P$KE
MF%=MM_ORX^M$>QN;HXAE9+\N[IJ*WP!FGQ1Z%.(0O> ]8?*4(2%AT[:5,!\^
MJN:2O-V):^<<VD=X!= OA5Z?R;VH9HG'T07DMX<+)G;,X4]3PJN2P-%V/!ZW
M:P+#)\34'K.^VR/"QM>(Q'T</M$Z5#]0L'1O>\#6:GD%: H9JU^# D_6KR'R
M-2J6@1H<\H>?'UX!L!K&%XEOQ\\5_.U)2-^771OI/]X#[J7Q%YY1MU^<P:[!
M[]9&XT6&5&5@T#,=V)]N8%3BQR\(C"XOKAD)F>RQX[O+H93IEE9*>/V?[V#9
M>J&7?D57 *_D*T!0VKG(+YCYFYWW:DP1#*I#5:EA&6$@%P_\,?G3&DB[Q\O?
M'D"W&'/+=,5_C'\S[Q<AB!BW'R6?68R$;RCVK&6DK!9;Q&K7;IA[47DK5E>&
M#714MM>7C^R!D'6T'A+^C?'0UTZ:GMI+7I>&'9+C[Y.5U:;')7^Z&,CLM>;X
MO"P*F]39_47E?%:T-(9PF_#@-,L[$O/0%- XU'Z4&@3Z-?^?LQA^'^+P>^_!
M_Z!E?QWO#OT+:G[UFRSO?\$<'@@>^H=&E +&U'.I"%+M4(;K=-_+>H (,^ZJ
M;X ^$[#VM^4YU%F[QNUU;S4Q#HEF6=-0NRM \P4['^RFN=-:M;[<RWV@)NR:
M$3\%WUO;"/-]W+TP(R"'1L ?,P)W[M7J]):S3'C_UJ6[\(DWC J3C,(+*KT
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M.N-BM_?^DRR+OZ9P]1;I*0F#AM5*5O;=7SY15%YN9G>VK4&2-GYZDM>__KC
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M""5D@#VTC16=? _C8;5L.,1C:;G*,*-$&X43?HUE[]N+S"0E=S[/"!3_\!
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MK(DL]#8>KX(?@9DL*U=N>7_]^ #>*4G+CTZ>C1\-5+R1%O/9]L%1BTC,_JE
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MV/)>8 JD3?;F;,=W1R$'^;\[$?]T+75V5R=,:$3&-: U%,F)01M %HVO >'
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M;S#\_#:JGX/@Z"@K%V^7*>,O/L5Q10Y8UUQ#6+^G% WD*QWS&2H:THESQ@O
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M<.&A<\J*%S<23IA.W3X#A3;Z'@;8HCCR%VI#N(>JOR]*\.49/6(,TTX C_Z
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M:MLURZ-:=93<=B4PQ"BC77"2VZFT^6NP^&69!";JU8\COVQ^",?>;&8^3Y(
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MN#E.!S%'?5?B#+>)U$-D$,0H)Y(M??P__:C*?Y7_*G?E=N:_ 5!+ P04
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M7Z1\%,!]#X@/:,2KN1. 6K@XO'/G^,P: 3A 0?=9%H/8H3VX NB4)8[^8"*
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M?Y+DVZ#3!.7Q0V"Y31AQ)!X[6#(=5(F4GWE$IO':H=1X/AX=PJ U9T9M/\:
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M<ZM0-B,J=SMHKN6QMZ[6,W<.IF?\[=]"<:I^L^_0FDH-48&-@Y7)(%$/<>'
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M2K$ZC$X@P@$6DB_ID!)-,97Z:DZZ3L'/XQV=T^[!FUW_X?'YH@7VI2<.<'[
MCOUB5]%_/G;RQK*DF"'E$ =XZMI*CIA!J.:(Y"$]9]^J>Z<V'URNW_,?W3-V
M]W[4#KJDY0?MX7WUMKU)DY[Y3G>Z+@TOZ6!IRULY6M6<IB:Q84KT:]/[]J\[
MKH47L ?&OTZ1%E(5U5,782)MJXO$#F_F:WJ2M(@Z'/XH,*0Q!&AO9%)"UMW
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MW,'([?>!H8Z>G^2"-_B*P4L^NGM,FU%5J[D.6\N:'<X](/WM=/F?3@(-[*:
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MGO(LQWS5KC.\M24H9,I* [/F0-K4!7G@4$T?:&'VH+F506"XC_9,;-<_R%7
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M+X,@?!5O=#Q HK7L:K?D9B=>WDU#UI'Y6Y=JA8Q^?EN@+W?W>FHVT\^E<&N
M/9^E5 *!L5M[9$B4<Q\^N*$A9C3ZIS0V912SO.YS[G71]8,<K>]8-,":$HR\
MG%D[Q]@WM*#"5@>4=9(DCJI;I?6RY19Z$#3 *.^E9%O?-1R 7F1QT/*E)=D+
MH(=8SQO"B<\Q@Z.!>5PN[A^*XZCM0_-"\QA$J*&<(K5Y9=N]H]O/B2X7:D>#
MATM'312/F[#R^-BOS!L$]97U@K4?73(^PK:L8Q/%K'VT39,O4SZ0;W2N)J=B
MR/X>T/HCM5)J#>='AXK'8"IQ@-$"8Q%7$#ED_=4$Y" 9&Z4T]Z_%3?'TV#U-
M-/^) /:?^7[5(GQ :!][<GZ,P/>8(37L5Q!7W7$(]F5C",:/#'.GB>S!CG()
M*N"D[=,BC_4 >U6T%O:]KI52Q@#-NK>;$PZ@WY\H73L^M<6:AQKH1^E,E[!?
M635B8KW76P7RL)=;QR*9QZGRRR)+58);X,,G[!,G/9=DG=/I9-6NEJ+HL<BN
MW;7'SGM]5&>/0JJAHY(@V_?UBY06@RQ-&7I8RZF9_!XR5?7H$\CGOF15K]WC
M=)6"LIXK=#08#D.'DT.FYR#;O&K_7MF4ZZ>+%Y77_%?7:IC;!?]8HCF, PB8
M"M5 >F=Q@*_P (XB,KH7CE%@6A,)5XRK28_E#FM04WN3A4U"X9;8+2?N3ZB2
M+&57!W"QX1-(54&XG\?;#;61AZ[GE,.WT3+E(8HAJM.L HJ.62S?"ZS<&6_T
MO"9D2H0J-,[8B-E;T%$]^3K(U5U4F5$ VQL^EF)NEM'0=$68Q2WL?Y@8E2&X
M4'"ZB[XLO3!$)6;/S#2,LU^[CW.29W,2DQ4]%/?G3D0Y9QGMMCYQ\#C7ZR"I
M"C'#UFIB:=GWP@5&$FE4?TU6EW^@,HLH4B:3/958G,\6;>7C">FH?7OWI&N*
MQKI!K@?XN6B99-:P33UHMZJ7;/H%M@;20R><LA7$YW PT=)IJ?(P!FYU@/HB
M/]5\O7H1^?CX+'[&#II3_>.B.%7Q9)GF!4': \(-)7)WI^AGBX)%JF(?1[4*
M?EF60/:N)I!<"']EK#(=9$85B+EK7SN%9=V>HG[KUB>+&2>HH%+0EBY6%4,R
M3*?N'/B+QK@-I+\3:&AH^?)A24#!^A:#!\W.@6Y@CABG$C[<_%!?J&TL[K8X
M%^<XS]2V=LM6DK[P*RWH@ROJ1OP5\0F0R$O+J_1PDZP6\ZW]\^D&>#$^1MUD
MQ]4Q6:=R?E"(H5?]]R%16]G#<;Y#+-!K:.J$S=*HAX. Z:/E\4#F3Y:3@C95
MDWZGD*Y&[N=0LF*-(GT3>M#>U<P.:%45!YCPQ &>X@#7XO_ZSA7O:D#7XGL.
M:/?5IE =V4FS&!96R]MZON_#<_P1_!W(T@(P3UUTYST96H#K[@R&2_NCO8?N
M-6R%3OEN@ISDGV44!=Z!Y8[O3ZN-\WZ,C2AIYGQ@+A[T3NA*-V8'=J*WC&UW
MA6RKF(S^AQ.7//0.6N *_4+UQ%NP'TRC>'2:YMOV7\V]\A_ZA+<W_[%4J94N
M(R0HU<\-U!FCA6"+$QDF7=)[0-)'^VRK*EKWG&H31N+N:@:_6]WP9Z+)-(%I
MC ^2"U$ZWT4 @;:5-M+"<?"1[W%KCYX)ICE87, 0^UCSC/N%L8F$T^:N6MM:
M>9$Q_XN]]XR*:MO612<"(J DR4A04** !,F4J&3)4:*2@X#D3!$D2"H! 24J
M2 Y%SD$R$B7GG)-0Q **JE>LG9;KG'W/?:^=M]<^]_JC-QJMJE=5[W.,[_OZ
M&&/./N'BDSJ"W+?1E((UMF94O W3=4\C92R3[>8^0W3 H&81Y"RC@L-L+'BY
MPH"(5B+B[D!%FVN^7%WEC]OB,[^=D:0^S TWB1?.HDW_7*&&ON[:;Q%JKJ=.
MHKK_[,"1=6?#+734CR 7W\!14-.J0%L;4S_D=K;RQ;4VRTB7PM3H!]\T]ASD
M:Q%1RW,_]QCRV'$S#.87$B5;8D9^CZAHUYE=T"KD'?;8QS@AVQ .;@43ZCRG
M*BALF. 4ES&6PDIUD";3GN1GUDK V_BX(IC+][J/S"0FS+6ZR4OELDQIW)H%
M;1D,&(ING20$Y62#+3=#5* 47D\H:3 8C*?\V=>MM,>KU+(HT!KU\W,%22UB
M VNS(43_'QKR!2SVIDLN6EN_RS(Y_FH^$AL)?EP^H8V0_$XC%>19NQ-_Y<'J
M4V.C*5CG_(N#N0RR!;;WK%7L83@ZR=?-;FM$:UEN': 'L'Q;PVW#&Q9<'D2R
MO-R1I+:!$&@1D'!@PRL/ T$2Y/,B)*-'=&F^&-T4#PV R&V*L^A6I"_0Z&[I
MU:G(E3S$V>/9FTL!"4/WMMH\-"J#8YXU5@?UN=&&\+P+8V"J<*7C[0-A*(8Z
M[2$'$^J@)_BD2X:WLC5C/UL7V+A>^$B99>QE;TQ*SFR,>K788/:6;E?-E,NV
MNYX[MXG\0T2.0L/K7$TYD\5C/G,W5-5$I+DS4CU5Y7[MF62>A5E@^I.^'.DJ
M*RIU5K08:A[JL92^45$Y4O^J+W'1%?'V)GC, @4DJ__49\SNG[Z"%GRI.7-<
MIS1<Z.KDXXQ6&'H8W U! >,JC8>\!D,&]W]?&5%R5:Y3-1R"6R%H#;O'C'A?
MU3B7B@(DK(X3T#JD:<'P[0W^>7']^N&W]Z[Z2'7V+SLJ74WZK,KN$IC(CU?&
M)F]Z'XPYO9[/;DAM(5 36!^;#$_P]'^,+=7Q;%]F*<-V#.LSB^5=X\DLS61)
M-UG0H[10-@5"-G@C>A+<%T!6-1Z0S;CQ(I_6<R'K1ZL,PU# /LD0> O]]X'^
MV#\JG<$"Y ;A5O7\2_"RI>Z 3R#DM^>2YJ& L?"Y,PRH&%SB\O/DD559!_P;
M";%94X>)M=R/!(A$GXM=76$\&PN#BZ EZYLGK8.%631?GEVGP*3G,Z&K.KX3
MSJ>W=W2;MH4[(2/BLZ:'M(;CM'5;'7K2W>4T/)E'YT>SMD!W43'0U&A0>]J[
M9AXRTQHJ+;X<B;-EH.$I=K$6\K)^),#]Q#8ZHH6>55"/H 43\DKS S7OFZ3E
M@L_]248;ZEG4ZC,S0T,FWKC_%6Y%XB_DK#N;S=$2PA@GV7\^[^11X*Z%+BE.
M<2T;+S??/F1_10&T7KVEJ2>L7HV\W^OXT9<_)0HME+E1P/J54B0#N/-M#K@F
M]8QZ-#@(72,,@K;:Z2\ 37 KX2DQ/]>)&KH*UNFCW\4?.Q)F0P%5W6B9)=3_
MAGZ?<!B=\%PPHS:8G*PC[!.G0V;O0]AW6Q^0:&I[I3@1N!.$=BW,040HP-0D
MX@Z4 C0J'N]8X#W#T0]^!\9,[:L='K;ONP!WPDSE-'C<]@_'8.:67W@:WAIU
M<A?84:GLE&ET'8"PO"2*RP:-AOB_45^MI#%*M30UW280PG(Z;+.UIB<I$Z%A
MMA$'5^I%G5<-R.B=%3-F;>FI-8]HW%)7THDT#G(BG1X<LFVT_^KVWCMO,7S#
M*N,YE/$1Z=KJJ00HV2,K' U^\B.@K9F\/B2]1;S'VMLI_09-B]NQ&98T2!TY
M=\ ;MW]ER^#M$NB4Y$CI[,1JHU66K6P#6FK<]_6QT@V#6LVU6D/(:9)=T]PI
M^K.F""]R#!(-3']^D+;(Q:(A5^<NNLJ:?GF &%>1)&OWR/I#QZN"_F##?8:-
MN>,Q%"!5__)_]:('FHX=(-#3%#+TK%5'%PJGM^A;Z^\?II*UY>BLD&_C:@33
MF!HTGK,BK#_#(&&:X&"7Z*GD4JMO18%((M H8?\*PMI\D0YR4;# .LG?,QK<
MKRCT];QEOW^9O8,O3R3"6JUDB-%%W"21B"X$MYN^FWFOL :/?Z-=]1PG,<*9
MVRWT_48!6X&8[MC1^<!F*K[32^.%L6$F/06O4YQ!_GF?:E"L">)W6TL;#T=A
MDY-M=L#4+19BG$^85^JF_GZ77J&>F+0:>>;9W+X8AS-V<-?,W0&N7MK?K5IT
M'2TRP+/8IPN7=>$3[V&Q74D^&ILIOSO.A[^8&<A!G>\Q?*V=:D15D_[KDM^I
M+XBMCB.Z58ZKH,>1VL$-SQ$RL0+VVR+5NK'0^%9'?S3QE@=ZX)K613RNY8DN
M,8;[T8H'I<&46I.%[_/HVN 9.SJSQ9+DQFK[;3IXI#[38AZQ=MQW2$GL*<J-
M+U\S2/;FL)^]H68/XYDHZ&L[6'DM@:3-MX='@JAGX%]+\ M8WXH_E[T2?M*U
M=AJ:N& 8?#=2EK^[JHN=.?X5I?>\SX&WX-?+_+N$W<M:**NID')_I=>I[OI8
MW*X;N," /G8V*H[:_[ZW\3)7--?#FKEW?P@188=5TNA?5E(OZ@LBDN&O-=#:
M.^\@US%+OHC-[WH9^? ^5BO)IYO16;1"W_KK7\'1^C>P/%UBX>3<=#D G^%)
M"<A'NL>[!LRVE!>8N\47MWW$?1I)+:C=IZIS-TL7RAB]!T;$HA%_:W'ILJ+]
M@;S'*.#W R_\31S/;,MK^IY0-'MB/K''::T5W-6(F^=K> &NH^ER<-PUJ"^T
M#,M?U_+PI&WP,M6 F&UF'5RI>:"JW/I8*<WP8TO<4*P>ML7]J?AE"/U>L#].
MZ [G/>3 .:M?L\V^ZQJCT'ES#1=<K?&(%HUT(&1?D2CC(JX7&51O<K.HL^C;
MFQ1N<9.7 [Z[P\BK]4*B=@N5$+>1>4RJIDY0%%7! _X'W#D_O+AL.%_&+^QO
MEFE5R"K8N8QM.K#NN3_)\7Y5LO;N/K?,V2[TZ>].I*QI+=X+%H=:9XW7C:GJ
MR17CDHC>B>F O3@Z)!NP^L<3!EYK)EL*GJM--0\VJX4C\^Q$'O8S_^'\"3I3
MN.#E5Y=/M*9  _]@O7]Y#RC2<3GUA_7(96<,G+(_Y1G3BV=VB#@!%%"4-'=V
M\W*Q^/?Z/.B2,OYZ*O](B<2246]O9\4/J(N*H?,47 &K&%CO56H]I&-(E$_:
MD2\_E=BYLW9F?@@U@!+#CA/O!2S)<M['?<OYP/$F:_LHR!,%T/6OLLY/YE I
M>[LP\RL&RKEU7L2;;UP8[MX;,;&C0<CI6GPHKTRX_5CD:5(I(;0'3'UL,6 4
M81SQ.,TW-_T39KE[8[,^S2LMC]:\;I_%FSLCD'UZ/ZA<=KNL8Z[]I#"-*=_*
M=D9(:IL ./Y)V^_U[,O?GS':#0;M*Z/UB8/ALO7$#+G,Q"U3;2+I[+R.C><>
MC!Q1AKAW5]'%D#OA'\X3X0W8F>Q)1_1/I1L5B3SA@:H&5QUM2Q=XZ.^V@@FF
MM#_.UPJH&B\'\;UH/5^VUXI(%QI1]:^QZ&9I4TD/=MK\)ME6.[UXN7PV88.F
M458T0]=[M*/1FF'*$"WD.K7\X&'*P\Z)L%PK"V5]S.7K+[!P *X*QW['A)->
M$%*B LW+H'<9X6&!U/;>G**%:7FA4)57.V<I2C!KI%2WW1E,Z>+&UB@?FL.O
M3J)U"RGR<5WEXDYI8:VQD_JI@ZX[6DB\10=-1S:\ 2)RPMZ[R#,P.%7KP,M_
M]V&\8I[;WJ_/7M)"SLW#*W>I>31+FEY?/5JKXHQ&G'5LJ,7C>F4;5K0)DXP'
M;\K'X_G4YKI^A2&$"NR*K.V]86H1]5?D+NR4H!D-6A@$5EBY^,PFUXV<II;;
M@"E!)-H>@:UM?OF]B7M3;<(:*4&3MI^=:;]\8^<IR[*J23V&4)V=JZ4EBXKD
M8+L;_F"F8!GKD(JPU$F&UA>J-L"57Y75)E:,NGZX;2F'KV<[^65)Y*)F\>/O
MN\SH-G#"9MX6)<I]'[>B<)4QND_1$T*($W42R3M8U$ ,[G2X;!0?C'S#;F U
MV*(P(E2?0I[R4D[03F1S-LL<1H%\2BN-G "O#^>#WH#VL8=!6_/@=?[J?_9"
M+^$)JP>:2^:TD%)H1FA!FG_6"E.XU+_@<17PX8-+^2N B+N-EK^2Z%G>1DF[
MMD[5/MSXKY2_/'#TF.6V.[=# 65;!7M<B) S\PN'RSZY\O^@T<JOC?N,&ZE'
MG9>]9>NI4W^\/D)7/$UH =(Y69F&2+.P1FOE^YO@HPTNI*]U[T^9'(;:!*ZF
MVELI8@WPF9R9&)^-O86K:=M=A9=(9+<V<8^>X%V5VQ>BJV+<SPI4=&)[+!+V
M(#HC_+,FF* F9<W@/HP&*8>5^D,2$>B:D-H:<:6K+:.L^OQ5J]>[]GP>[V^W
M\/:]#=:4&T>-A_DU3.,.;MZ3NMK;>IU0Z;W?80$WJ3E5]3?MM3Y[)RM5]9S:
MVJS,"O% *'DP4IX8#6+IX'6S^LPZ'?I3#FED,UKZ?D[HP#Z^(,B?\P M2I>-
M_72"9:-\U9"R<?4&"D!/R>-D<S\4X ;IWQ?FA9Q0(1KY7'YW#T!V'1H][HAG
MH2$$G0 VP[^?EQTVN&PO0'\I6M%5T&,R_(LUY.R%@N%Y\$7UV2UHTR[\9*1Q
M-NR4W\Q+%P=)8LV+ !D#]G.>X*,\I?D3A.?FW*XD(@'JI?K==)CO@S.[]LDW
MTU0^@DS>N3W&(_ZYOL^1KL@R43M3MH\\*AO0Q;Y*"5/PC8W\ #R;.XP;11IG
M!X17X,BN%CF(W.C,9Z+HVVBMRSYFV<%(U]A-]GUSCL2)G4; DQU2,4V\+TG]
MCO>'S+Q/>9O:#0UU>Q6Q5^(O_R)V-<9^B** ]F4]A%RU-F&/:2 /J+Y8^F!I
M#ZK[TVX&^LLV*'R88([6KI\^O/S0S_3AJ[OCN_3UU]Z^4*6?WKG>QI>EF+H_
M/M^=SJH*#;'JLBF'HVO%M<9KH.6[.6 T/)G5:];E_7XW9%1P=ZDQ:BP&7"V]
M]ENK*.G"/^P_%" >H'-]A_YLA_D@-_6?OG39J*J:2ZT9@HC(0-+O"Z* 4&%Y
M2R1CL'HE#<F.!$?]%SWSPTFP\!R,*YS<+JCBA*B!LYQI7YOU_(L]\WX'XIKF
M&H0/O /!U6?C-*ND\S+4V 21]6\8L&=-36]6QB68<.CVQ+^R4L+3I0)]0N3E
M$:0;O-=KZ%AV']]0;S)BDTH8S!T:.VN<]8AO+J#93KA5DY3WUH[&BD18JLXG
M"_0N%T0)7IJ310$>ALOEZW$N4=K:39:V#]NPC/CHOAK5[2X1(CPW0+ORB+CJ
M;'5G>ROOW5.Z2![_EA7;Z/7X.6?'W-]-:"CW6$C 8A+4H3;*;LE,K5V+S?Y4
M*^OW![,(86J/XVYHBEEA&5_?S&$GG+?_BOA*'VM +6MD3C&*OB1!+Q65N#($
M+U*TX'3%DJ]G:>"Q&3.6Q1T%2L>ZG</LI:SL]T AQ$/K5ERD"-FAM*&[%=\S
M!014<U38<C1"Z+*8<P[;'+PU*T',K)NBW7@YG@;.&V.#';3S(P+T-^\G3&\;
MBFMAT2],=M"'+,$*YL+Q&6H&/\2LO'_'TN]5"/Z0TT &=]!>CM&K#4\K<7=I
M"I[%V148"B=LK_!AMBBQ\J&1SS,QCVOK"91V8EQ%%!%^ISYDUF2GHK]/2!!'
MG=Z5E5GB-7<?U#FZ)\\.9Y=G'^K$A&$%Z):O@ GK[$TS+><F='HR*9>,OC^3
M8,,08K,?2DHZ'^T/0=[3UM7AHZ,'5QC(<)=@B3">+'MU3&7M%PI7Z126RMKV
MJQ%^6$@/#%^YFZ;C7+,OQ/7[S=O"W44C7C>Z^>Q.6>/[VP(8B$XH:(]/@,A+
MOC3RZ+DMIOPJSGE371:S^-'6Y.J'FKY UZSBJ;5V#>UCVUPP-WLZV=WK3YG.
M[IXF"=D(:7S5])^I]I&!H8!K;@QNA8.+=COT)1]NW9MC]G'@3:UC3T,!@2(H
M0&4.$8,NX[<PF\49XIMTCGH+\ZZ'7?\@NX2Y*D5+27"A-&\]%-..I'$[B3
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MN\LOK6<)!A!/%W7A5.:8=%[WRSL/Q2"+[ )*<-.%<_S8CZ.+>SF=\O'8CH>
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M_+]T<O)D Q_ O/L1 5N"D--]Y.76X8R*'A?BML%=%/"Y;W<?C.2$P!_7R:.
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M"/)J'/3E!UF%508L. ?6O>KBY-=N\1MX+WV["?$XM;F><6'DW5 #E9O5R.,
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M&NW?8Y_"[H*>)E T/X>X1(][R<)NE&W3+@V;8_OU[2:]LU[OCP33#+4H]R]
M</6"1O5>U=2&+S\/&%%' ?U*%SA;0^T-% B:41]F67O/N]V6DWJ>?@UQO+?C
M#']D=\[TJZ6(EV&LEN^"2E)BW)DCCFSTC5^:$J38)"BV2T=1<BV'@]D4\(^-
M:QMA#].-L]U"K^TX32Q%2@==Z6>Q&%7$8""@H5H;N]H0M9?UYA""[>9#2]]R
M/&=>'A['E%07Z5%+MXP"?"D!/."_$V(P$^$!BZU[TK[E"M[O9(Z+C2C[I6-#
MU'&F'*^?FS7([N%$UG%EPDNVV@R)7Y5S$5DK<<=-!TI%T" ]N,VH7@Y(<5=1
MKM'X#-6AN=DFHN&S]8WAZQ(/E"B=F9SF8<\;]X+AYLC &684 !C_=BCB&V@A
MKP[][R,%:^1I& H(@TK"G6$4"O#8M.E-#\F,D7S-L:LS<>LL1E-/3&R8P[D+
M[.!/$+PHX/$/- 3[/D !,'Z?EF=%@Y\MRKIIK 4G*GETFXO]/4Q\<?@P#B"M
M]?2M]-<:N 1:#:]/7&3)-3J<6)!N:WJY%W=*SUSW>3$W*SX]/0:V"H'R/;%9
M,"2<R82^;M 1:V%GXI#"4*[F=/Q.!,KP)N\JS-!_PGZ=2$J"[/'8HX%MVXC>
MN!AC.R$AGI97(1TP3#Z,E<;2_I9:%' -[G"@ R/E>9)GS9'_,O'"1.5Z5*UH
MD%'K._?SZJ;.?"Y(RO4Q)Q1 NI%*(DI+&CV]L8 ]^33CX\-;7Q*E.:KNZG['
MF&+RO$#3?-5%?CZH")/^AEZRH=EU(]-S\5W].4]:&.3521X(HXZF<-/G_C#R
MKEL73N@J C0^J#[9HX<8Q!;-#<30&KXYA77NBF"<Y)KRF;B(>GF<_^, V9-X
ML%5+54 -[!M.XB_TSD5ZT=MYIC4/;=8\X8MZU.CA]N'&.H[+J3KD1.96PJ(H
MU[ER!-<C!5"[Q]WEL_H/^P86>- DK?":"CP!2L%^(4%:G$'^Q[L2@_SX?O;@
MC.=Z/?5,"3.TP8M2%IAKA%<V:D[:Y\*YW0X,BZT5")^96#LWC3\S^; HQ6#7
MLO+A<%.PD^SPZ,Z=#NHO5L2D+]C" 58+X#]N\_Y6>_Q<P*UC;EG]Z>MH4!YX
M/*S[$=S]M=/RVW+]%X!.'_-X,6;G+%R0R=$7]\Q$&4=MWNX4<Y/^F&H8?%BH
ML\&^FGH%.7CF'=@R#@]X&CTYN'FVN%(XG]CS@"K3DEO-HI,&]L[1[_LA--UI
M1VI(<^A%XY M8W59E023FI1#858]\/Q/EA&_EE3_7]F?OO)'2 L_@&&VS1%>
MC?)>:"\_QYZ%FQW,SY6H^-<M.V.A@+E[-= WXH+Q:*U.L./L.40Q-2CMOV-$
MJ7(G17 GELU^5\7+:J\(9M[L;3#"..=H23]E4_6-D$ZVHUI_"P5<@5)=Q(HJ
M'1L2;\Y2)_?'>UZK\:7SEX&_$.LJ NWA 6<BK6?+XE1[F5D%T^$=+ZV9SL$-
M&@X4FXHX2P9W]W07.R)][KBMCV\Z:$?PC,ZLU3S0V3%&L'PN;>+X>D$Z"MF1
M7;3;G@,F+(BJ;EJ=B'PQU#9JH<_J,T9$/+_X@&"_B-A;M;%RZYK>4HO'"J>_
M)YI+V.]^@J6,4Z9B@+'4.$FC9DC>&"1.M:&RZ:K2]<+Z(Z.EU\155PZ5'"I,
M>K=H H*KW!VLXN)>C_84*[&AK?W7[TPI]!F_:6$U6"%8A(0?+FVR8,X@[/-F
M+.BNC![9B'ZJ*2F.<PLK7)G.E>G\(0CE@M^ :;6F$AU%&$RU*E@9E_DQA74&
MO_QF1. N'COE=J)>.HK$V9I,^<C3;^F:KL#!PP5C#8\Z/-/J;KQ:YPZ>KY=7
M#Y88,!UU3M9D\N^:P6"OEC72)I#!3")\$BW\'>?_8>\]HYK\VGS_&U% *1&D
M5P44I(OT%A%I(L4"2 T(2(D4*1(A$'J3(B"@= 7I1:47"4@7Z4TZ)'0,))00
M((23WS/G_->9,^N<F;5FGIGGO]:\V.^2K-SWWOOZ?C_7WM?>,[)9J)LU7 C:
MS62GEQ=K%/ZL^BOT#!R%,(7R[/ZNS-@F@>%Z6-\H5!T.&8GAC\9B7"8PM-)^
M72=11(/-PW+#SFCP#[*4LCK1T9"Z4TEC/QO:&-F,VG_',A[D,CQ>LF[ @8TG
M)04(;_*OQR59; =/L.B/N'';W\*D'XA@D<%@UF9]'&W'<4I"5/I0NZOCFO:R
M^I?M>6HAM8C:0"GXR]"E\1_.G*KYYA%U@L^TS-Y'E;\['2&L1)/6!>(]%7JH
MRX<A4@OP9X3AC\XOMQH'(\J71F9#6P)4QYFO='F<I*E2J'WZGK!DVLG%%SU]
M?E*J#:]ZMS]% D.[/:US9&;HHZ"&/N__%B1!<,75=<X+$SH=EKX;_XG/D9FD
M02D'5(;%:%E[;7YJB:V,5;N$Z.W9R#G8\S\#/MVH_*@F ;?[2G"$TI>Q;B'*
MK6X0RO4P3T<%7\=K*_1<I9BD3HP!]AM%5X4(@[AD@Y$\'&_>DO_+3[T1\W@F
M,5N01M;,.]Y?L&6?GDHG@BWN]@/"AZ6U[]]BI^=G+J>EOIB)?>!WV;^XK:UU
M/4"8LN9_1<4*-\21R"L^/!5YM@\/F>I:ND[4?1;J;&+G>UQE%I'\DB-V5MBU
MR\FC?L"K#?U[B-K!F@O7A_8CF"LVWUY2;(=*-+FYO24[2J( *1VQ#K9.("SA
M?H O:<A'$&\J]98W8NH;'B?:@VRWA$BA!Y4<!%ULQD-"1H4L*7]4XY.&Q%93
MK9 W)O/]4':9?_;40>M5!H(F]HT1(:V,1^/Q;?6/&C?<W!(6ZMT*9(2*56?J
M)L^U]([*](FSZ=6-5I<Z85Y@WFHSWXH5H2#Y'>8]&!6KMI)8,!@ISZNIJE7G
M-NJ2*J(^VIHO-Z*67]HYXE8Q.P,@J6? L1Z+=TH_P9^D#6)%3*X@24F=5M?_
M?1>_1Z,&V9T":88-BE%ZX]6U\P*&[ZITUCZ5Q.LNGBIE7IJI *,DV\O!*(,T
MNT*70U_6B=HZB+-[E2M(J*>O3O"RVN''7! (!\&8%EOJ#!'DM6,&N!<M-_F:
MWR88Q;PJ/DZMN$Y\B4OK?!E9\QUW_:?"!8L'-; V'IA4T7YEB8H\=K)-C>&6
M1,(G,PTOXNV!\U7R%3R["T&HQ@F;$K.H2U2Z0I\!N#'#9QSRP8UG\_(/9V<[
MO?A)!C3EK@+X>$+XTM9']\KREGQ&Y&L63%VR,&]0P2R?)WV *MEZ4NL5!41(
MLC@-^C391$&TGM8=:JODN-64%SMSNM6XN![XTUH0V+UX?HGRY[2&WN'UPIZ@
M=\*)7KY4&=)]^2Y[EXM=/7P%R]>3&$!#X4)?*A]5WB9;OVM0-(]\AQ^=E[.\
MG+RHATUXG88$P\N:!@CA(N!G6O#_QBB((&&/9'ACDM1N;DH*=H=8F/:JJ9P!
MR;TU9\"7B90S(-=BB'IB[-_1F__/9CJ(K):/;79?=&?<2%/CGKQ>-2J)F8)_
MCI"C%>'+2'WTVL2P9[($+H:S@ TN%226&0I]>(4],M4&KHCPE.GP2&O]\6.\
MP^/#TDTTP=D1))>R*TMG=%?FQ:SU2X&+3 W3912+F(%M1).UXXD*K*Z+)#\A
M:W$&,&TE6VV\DBK3O:+.&?EA0/UG$5BD&'WZ\0[OT=_>BQ<?DX_%W)6E@N_%
M&UX9_GT66DD<=\[G,1 465;.@*JTA&9#M 4F0,6PI"6W]FNK+8A3XD?GWN$3
MOTO H9]PB5_CO%HTO-'"M07Z^L+7'I1^H;NU$KH<L/S4G+/D&MG9!&&>!7>\
M&<^Y+_>"WPB;J?]=+N<MY:'OB6G9_^P8.-(!][@KB30LN30E.V60I*(AGEN[
M:]?][H8#;5;#.C#@!3'Z__KP OVKT_U*ADVE,-WO&'&'+*,S@/&)&/4&)-LO
M_'2@N-@2LO!K;W:V9Z1/-+/JJZ+@Y'K'L+8*DZ929+RFR.8<.V,(?: _H790
M;Y1H6S(-"]RHV/_MEB5>8-N7JQ(0^/T8EPYT5Q:= 0X\K_"'[=/;<2\%5"NR
MQ*1G(A2G5G=F\X:>JZ#'<LR/\NZ/R-)[/8HT'!%;;6[Z4-O-+&SVGL2"3VMS
MCZ3';K4%ZA/XI@__W/C>3D5SYT<7S2+F_/&NH4(GX"?^]TIHV, 2NM78L;$.
MS=H59K_EYGX()4M_.6",_4J\\'JR.\N]VT,_SPD,>K3W:RS)SA,OE2Q\Z0DH
MAV26\)XXRZLTF>X$J:)^4U,K'WASO-R[(&/-HV/.L/Y@+H0-C+U]AS>GB#2:
M _J3P]K]9(SJ9>/TD/ Q"9>4X7!B2*#"?%5RP6LHS*F6)!X<\91*C.(?8K]=
M/0EL*GLP]^N&<.3RPQ)=\BN5I/[V;,9L4L#=3#"\>UF F6)#C8?P87&!I5'[
M(RSB)^JU&J8)G'+S6& I8<5*']Y4$=A[_+W952@2K@GUT^87K3>GW)^E/8>@
ML,BAW@X4(D!0+'5A1&>>/>?;FI*IAW8#FB*?(].D>C"'GA[*9!_&^=_K/?_6
M]E>MVE]>-%7!-LY7)4G*^.&F[N(E("D&E\-&&N6],F2?--..[:^<NR8 U_X9
MQ'>\KBZT6:)^4"DZ=@:X@+FL?IX!4Q.-UCF,)\&VSCS:#<_;P$&YH(JBRCC7
M,\ 9$O6VMU&OCROXM%=L#$3TI6H"@0(GV(HVLT6P?ZY< \M,>X=?2CCDSLPA
M7,X%%115:+<AF%6$T+];AV1EY/U]9=^A^[)@:\M@&-VNJ<!\X^8_[)+4.8KS
MC&_]8@A)IWQ+;!@:*^9NUX+-NT\ 7E?[-<K)0S?MB9:9RG2PRP[=B\9A^.-S
M\&^4MAX+&+IFQ/L]\+4[W(BN+'-$5 X/F]:(O9E=B$YUZ:/R% F+-3?PS+.+
M^P\A#UUJMQ;/@/"T(:?$6ID 7G67-X?1,5?J<$?::C5[D#_=2U[E<.T<JP9]
MK!.6S42H;,3!=&OW*'+S0H"SERO+2O[$Y"5>CL2\Q'^ZO4F& MO](X?-1>T2
MSO*X-B&WMLX';Q)VCR7A'<>[M"-UQ2,RJYV3G23J$:)1E=&!/*'W6[#7.S^$
M+%MJJWC\^D5C\DC1.M)W7:3F&RP9[TWX*#O7E7DX_:($*U@HRK-\/H(=?KE"
M+D1;T :O6(%\>EI8,V?WL*H:2QWA>[];DF=$MB.9;[M$2YUR03#GA2=%\2(K
M,@'_ *>:6@A]Z8(W6M#DM+QGA+D5+4V!^0!2:ZAPQQM61QBR0^L,@OKI8P1?
M(,)N[Y%5.P9/%IFMM!Q MB^!Q=S"S.7;!AN]:DT5J\ZWN/!>H4P[E<3,Q>R:
M9;YOCL38;/XSH%('N7_[#ML9  T"HQ(5., O_J+"F#]P$:^3:X8YQVR5R'T.
M:,)IA1_LGRC6A\1"]@EW<TB=6SNG5.; GON4!DF['$IJ:S\#M,2]OB'Q:QB;
MK6(*Z3/@QX-G(GXL,:Y%H,48T4^G[\#+?A/(/]S@_6>C)"48M26VL$,=32;/
M&94)PY<\6[V<;"?7?USV7/1^]$1N^X,@]\NWH"+),E<?Y8ME/C0"#37U=Y/:
M^5>L#(VT/QN/J"A_(@3*)=P=$?,>LZ&DU?-^XSOIQ$&$KH&N!([N00,OUH_L
M9S%8\)CCKYQ/.X?VO,=NFZX"S'P=+;@X8*"X?08X?N?JPCJ;IM?%'? 8Y]9?
M2I4S#]O^PU:<3*=K! ->SJ+?ZE"_@3.3GS9Q%+RU>DB>*?I&<.>Q&_6$,Z!$
M]^6+R6?SJS3H&MM$?I$;E^F\W1 [)3F+A<3,^ ]DBRR//.9WP2"=()'F_6FQ
M KC#")MT>W?Q[=B+W\L_QP+?['+>A5N_##+-KJ:X?@9T(]E=S*T&<GRP4_/S
MJZPA]YQ6KY;>/&_G^+$L82I[U&*XY?J<IG\AQ'S::F.[['F=]]W-GS\][W!T
M+1'2)S/P7Q*;I1[Q,;R8^.4/;U=S'?]ZB(OKGG1?2M\?#.,5PTW&RO3%:72E
MRQ9D. :)\RKDQ^@.>M6\)[80'56\<T&Z_X0Q:\T0-!($8],_<8R6I<&$4J[<
M0<I4\=U3[SW>Y^G)!7&>YJF)N7#*HF :[::&SK?O"8Y)\"MXE*D]'3NPC-?E
M4:=4]=KC15DH*A[T^_ Q-5N!XENNN5A?JZE)&N&J8M?)]_AU3JOH8C>'LE?\
MU*;?I/@='L=V2=HIV"1*XL/'S<D$5U?O/U9##CDNJ=.@9[^[ DXFY_P,DNT^
M;L@=/T^&\I1G?3L?P]YU+F'3/WDLG3"##\2N;#?@H/I-M=&DOH);#0WO02G
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M&I/5%VI5NNO"V57.[6__EEC;R_'LE_J/,X!])0I8M%F^A%>5;C<=0=A;/3;
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MIVQT 10Y(9>:;O!IHO;+#X.O13=O=;%=M?H)H+]PFYI:+@0CET%%B-^.#\^
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M+**]6V%A3M!<% ^4L]BAW5CO[TV: %>U!/AJAR XCQ[M]J$O? Z%96,)!<+
MGCFF\!VS=5/4@'% #R7O.!E] )*D%6%S'GT7QU66WOG.VL52)/SD@=DE7<JX
MUL1,G_-^G$"IPXG\-,RK>UH["BY9IHN'BG9D6R@/-]1&]-+R!\_D"N J7_XC
M;XB-04W,[TI*;-.L)2A.B5!Q'+05.^72B)>5OTA)'9CF\N@6XX^5"*PO7O\4
MQ"7V<)!+6UHLJIVN0AJT]-#BJ;F9XY]77RRVMU:TV, IAIJ G$Z24[IBHGU<
M!,=3>\9U30W70C.SV[)96=^;I-K9/QD+[;(\BP%"-G\,'+K/N-K43V6UO+#%
MKU7<WB\4+V\T/_UP-<YFVO0GS;G% _:-F-08H-RUX/>4HK^RLO\KVY#A>R4Z
M^XO&Z>1PV/=Y:/\A_F2X< /]2FU42J=!M8[;RS@AKEF$RC"ZV@.\19(DB=0Z
M1"B.V@_GO\G$^)PW%<?1&E891K0(V%<'/W6N>GO/AO&D"G/GB@8*=&YF]B+F
MP)VA4VI 4.\]2X3?+KVWW*24M87V2T<9K[:KLTD=2RG=10*A#^/DNOEP:^YG
M0& :4>0'?U>P@%%)'L43FTM F4P3Q4M\L-V+&P/PMDO;@Y,<I4_(IE8] .%<
M\+3O==%L)Q1Z:3O).9/_ZH$@5K1?C9_HAYT,)LZ("G$.?&F 5%G4[Z+<CYU.
MJ8?LC]'E\'X4'SMA 748Q5_S?A;2LY,1(-U+$P/V"!UMDC-L$:;\'<A/&OW2
MMKJQ .*_HONSMM@CA_^D*[)RO!ZO"NUN5EX<Y();X<[7>;QYLY9(5B=9Y4FU
M)X&=@X6'ID(\7ZT[L5MXNY"%GV.!U^X+I45P6C41WV $$K[O6ZOV!UQPL',N
MF-)T++30@+I>PL2S&_%?W0<\A"E[B3=/Y&'*FL,.=9-Y 6['*-4DRYX'SR2/
M5W.)R,?)!";1N!R\P]!D]\3T$W,,X6OZ@-ZG<DX.JE[&5]L; Z0F?__)$=E^
M\G"^;M!.:IT$'RM= M+:2)>&FFD_57Q8FKEUWI+#WJY1-^-D8&YP79G"8O\_
MB"VT7YZ7-QFQF+N7K"'R+DF16;HQ,81&59WE.C/%JA^H-8<6!D'1U\54LS76
M0A%2Y<EJA'>-S#^3]QC8#VY\EZY'O,D&@QG@U!+E[DSZ 3*EKH[<'Z;M;0PL
M>$)*^> 4B>E';I+1?*Q$?9DTSE>E%7-+\3M_UMGY<QYHU?-H @%L.,32^05F
M61ZFISXZU;__L#ID30L(*#P+?Q4;GV%1O"U:@N4+DH%$IH/PS\.O,&%:4*N/
MZ)*1I8P;OQFH4;I'&B0FOCC$WDSG&7"(0I!N-.V$3'=W] U&XST(M8:,<N]M
MW_=(HE*>S7W!]-K&KGT& F[]:QL$_VM7MEAVUS :BS-A.+<LE+C:A.YCH]">
M^MT\\6B!=0/5)T'@V<JB]5Q0!M(A@5K_PL175,#=<93PIZ[)7X\*,U4BJ4E3
ML2?IQT(/O]2-RS25JQVH]$'KK2\^/NGY^22A)_VK)@"/=LV#G2Q2QV]7>L_Q
M6SV^_XZ=N!*=S?7>Z^W3RN,ZWE.&EXF3?I!8<I>]K)SJ7DP ]1?<;3"-<X4O
M>[Y,%OPF?(E*H6N^,#D18C!\AQ>!)L@B"$:-OY1F$ZU<"A_8>DQ\?1MW;9/9
MI]L=;IH:^%/.5ZXQ(;IEU%U,^5/MS.HURSVA\@ A\M^8.3&=FIV#P.S^3.SV
MUXIFS9NS=M\Z-LV'J7%<P4-KH]$.R2=4QK^?1 RFSC[[+A(#'&G@+;\VU1+R
MBE3[RX8^#J]0Y,<6"0U$QD,+"&< -M)LW.< EQ:*R6_,[/J$GU]0\_!F-S-B
ML BBH,QY=YG!0"WZ4Y":^7?"(8[2"-O1PL?+G*KZS"FN:5[[?-,1NZ!F760W
M'*V"KO$ATQ*R'<((LW7S05ZI&7^;+BDR^B#IKER(NC//[7 5@&(M.7M\>\R(
MNILS, <&=BE\/VW ?P:$%3S?4\FKXW-R\XI/V4)6"_W(TNB:D//;B5@\T2JU
MB>!P#:8HC!2,RS]P$,STI7LY0($O$:9<^<Z%[DX@RB_]KJ;7^,$TNVDR3'.U
MOC["'DX1OL KW1W?Z64=CH4\(E26_SK,5G47TGFB]FANJDS^BOR+"Y?NQC<(
M9-_*7/T>\Y=F@J?=4?+3E0)8K10YVSI1N4\],,?-1!(?["1QUK26:( ;1[8O
M4,YM[KKZU_+JOQ,_ \1OV+PB4::J_6C1)MO,F848!!,KUY%@*N6UYG$)W>6"
M/W7@^6<>:OGX7-#STW023VWRQWZTJ\%X?G-S7++A&T JLHGN+86GU$6!X$EZ
MZZ8SX*)6Y1EP5R@*O$,B<U:O\9#%3+LSE.5[-919*E<'K1Y40@50#EU*"E(P
MI-_TPR?8^EP8##[H<JZA;?I\:_;I95:S>4UJ>8%,J4%DN8^Y5J%OL5C!G@9R
MA,[>E:W2;?ZYUVAORK$_NM)O^._G\U06T([MNFH"!#6%_;DWI1L#HV9I5R]2
ML,-Z,4VT@R6Q.&OHB;+SO/P0W,<_EQ"B:F@X4EZVG/$G3?B>EM4FQ0/<7/R3
M151+4@GG?$,!S$LGX\FDY+-OWX*>ZWY6 =VA?F1HHRA#$=CB>)H/=T 5P4WY
M0F5ZYV3Z3A16Y/##@;N+5=\P@IY:C[?CO^]9C9T!U9/MZP4WN=/?;2JIO'I/
M33J^2DIY0AJ!T/<O-LLU!C=<_&*(9UZHRTE[]0>=W-V02PNN6FM77J"$N>T\
MFORTZZ-O82N'.2Q'66(>KW=\%7QUI&T$G=R*P IU+M##[XUMOU!1D[PW,70T
M$O#I<JC;HL+5;$]HPW_7=_V;:[<& M6F+!?@3)-)_6;3LC&.QMO1(K?Y6L\M
MA/O)2CO9U8?H.,;9QV@*KZ-%?FJ1_7XNZ /B>0(?S/'.UV8LOI)_:C,]?/=[
M,X:#?U&Z1,PB:#'B?.PBG&CJA4(&W8(BF05P$3DE;<^1+A&K4*JJGST]3[[.
M<A%J]W8/!/?27_!5Q4=_AFN.PG4_NC!93)O-E8\Z5VFO"HOX"FL/W#G/0 ,V
MQ[L 73CYF&J^BQN/K&')#VNK0NTN)]7/R5&+1(\/?J%J,3O-2JPD*>GZ%K3:
M5.GY?TB_-J(P$PYI_9;PXWLR.NU'E@7*?IH:+XA/Q3P;+=NU4@1$_W1)711:
M4?&?U,0V+;E]P/9IIM+JZJ]^]%9O^NX]#>%AT59^8H]+GLS^#6P[_?6F*F\0
MEG#/MUI97_D91CXSJ\'HZT9_\#W-NETM-XAZYLGLO;BFT+;XD>"%VS$+E[6H
M9.^U52YZZ72<_U5J)R2Q,A54M^A$N>$BNC88 6$A6N01[T  XD,M:'&FIKN/
ML!&N@</X6;-2W9UV(4%/=?2XFA!A6S(RD*IA8OIZ]O*W-F?:3+%D.0_0%^!K
MMX,,Q>0P1&+]F+I;,GK:CQ"N8B@1Y_PRK5;K>VJ__5V8R-OBHP!:3VW%J\N;
M,#V4:3R)CZA3A77O%#IQK=G+]YA3I.MMQNBRM!X-?6FC[]GJDKJC%O^I"JY9
M:0:S:T^;GBA:$7]AZVS?;=*MR;N\"/(473V5.T$+=354^%A1FY"5PE];][[&
MRIQJM4W"$CV[Q+*O75> $@ J*JK\X+W ![]'4$2+B@N@?/HV_<31KA;%? /*
M6A1)BJ!?KY;=3-9X(M3!#_+*HBJYJ$PX3!Z_U2X'Q/^1"S L%SH@1S<"!<GN
MR:&;]$9VQ#21:$E +O'PM1\/1J0?[,CJ9>BZ$DMEF&BLWA4Q3 $V!QR"?D;4
M%0PA,8LJDKBJUOF;U=D6 ;8R^#K]W<ZB1,H+!QP*;EG1E9*$-R<&)4>-ONT]
M=;S&-19AB_[='"37,P!^F N"XM(Z0 PPD.&):=3!^?#WST7MCPHR3L<V PL!
M7_X62T+TB3HAN4O+@OYR2W1^7=_*CS, ^1Y1B\X%SUGZ,4&SL-W!*E"<NV7J
M+J/JY/LS8$.I?*\NM7#T9>\S<&-#-S<%Q("H1.!8RJ&(JKP>ZS+]8_&T=H5*
M +S?KTA[L'Q"ULQ+!)\394)H9PLY&D81^T'W7TCM73GEMR7]Y&L$E08"DV.\
ME['RD<WT!0%OVOW@K]J"]IZ#9:KX3+UZC[UY@BHB_F>(R<@AW<^*/ VN0.Q[
MLT ?ONFDAZ_I-(_PU[3^3C-):HI7[#4#5$Y,;J];2R,8-4JS'M_=^UB3-";T
M^\:T\1Q[SD'#@)$1M:.F[=-V5.?WV$W3QMO3H2>==54IEK&O;CRB7H:^^H\3
MSW9\$-;U,#:00Z?Q@:OJ=H;"=YW+#@7&)B9&RIFWKOHH>RA-"+4BH]48(Y<&
M<G+G-UG-)3[;-MXLWUY^"I^0T/$1#^JLZMED@*T;%&(841B-'SET7_-^X0^5
M4D:F.= O9)R,/\1D=X3/G 'GA,KA>XMG0+#:;5Q!*&M5H8:CJX,:/*TY\^,[
MRM@@"H4>U9>9?L^"U-K)4ZZ]';Q_RQE,X.$[ U@>3Q'>W!MS,UDPG) Y*?[-
MQ!^RP1.OA&6 KA@2' 9Y$8,#;\@_:W@&=&W5$32QDIV!5(0XYPKH;>=*9[I'
M>;2OIW+$PA@N,:Q-!*E%_&M+=?_PU0@7 7OL!18TI!K2X4[0;!8X VA('^3F
M3)_>K7A"')K9?XX7_YE 8/L,P'R[R./8$$?='4$O.VTE9&#G;E_<\Z%J3X<Z
MH -0#3F9'$%<(/%*MN^<ZZ0?LW&9)-2WN&W^/K([%E8X3E7=:D<^WXD$8]\2
M/C0_+M%H,ABQ#,B40EEDYYY>MCF]?S(Y\?<O^S,=@-24SZ&F"<_ZS<)C$UZ*
M%IV4\X?1YGAP?"7A*O.@O>1PV4"4Y?MQ)( 3N7\H_0!<=?[\Q?.+O)Z>Y]#7
MJG[C!H0I8['(/W5Y"P2WKD/+R<JX\;&+M\7?:\;)TRVRGJ^EH%1Y3N;$I7=P
MH3- _3N4=$P>2E&5@EAW#"T:1+V>>GRWVZYXRD*B1Q,E_X&3(B@X)9*R5KT5
M72#Z^0R(J,3)GP(R.0.&))$@U8REP;8LMJ6"2M\B9\[PT[$TH]<,=9HTE!XO
MXDH44=^9FMT7N[L"+%"0J!IZ\)/1%V7HFIJ]\?*^E7ALO:)0/'3JOPLQ_LU-
M2N4EJ@EQGB#T"$<_]MSAVYN;EQ7V>**>6"XNLMI<[*9,/[JQAG;OY&-R>227
M56+Y$2P]O5%;6GOKS[E4@4W] &T<],>A]2V"5=GZL<?<:T&H>*,]_0X7]<5!
M/KE9KRUKNQ,%6'N[GWQ8I8IBJ>6,T_&8_#>5X7F%\,)%BCX[L:;[*9NW=N[P
MDON EA(M23P#8*%G ##XUZ6%AVT(-KC..$G(;!I6L66:K._T7*+.I//RV[ *
M@^'YEJC__7A364'.BBP?J9@)TH0SZ%Z\PS,$X'1NCOGA'>[4[]C!]A8!7.H'
M5-9=CC.@QGLB[F/B]2.=N+XB$<];27XV)Y,6^DGW(H12'9^B-<4&NBGN;.K^
M(?LM'J+-.-&W'!S<PJ@IMFOPP)<SWY'#(/8A,IS*PQZ,Y<U]2S?(:=F&H\:7
M8 _2(E]*KP]>FIO3[.%]4"Z6(X6FS6H@'7+CK*MP>:UIX,N!O+H%&R/YOK55
MY2OUB;5EL24_GV1/F;KY.7*@$L+Y+GGO1*1S .437[WS,&GOMQ;Z#.]1XX22
M?S,(X'-P!GF%3IS:$?O%V7R8#X(GNEK3UC+3Y^V/;P4BYMH6TX%.+!C#44@P
M;&=MX<+%)\+<9:(F^AU&'SS*R[<169, K@(,%ZDYT K,Y14^DM-LJ(F,DJ?3
MW07KG)1YBJG&MUD8N$-RU[P8@X.K[8I5^"RP"6W@"V2?'O%S2^/+> 4>5&VU
M8%'6+X!.^MCV6Q7H1GD:)A%=L-Y\%VM.V;I(P!D0;:':&V/A]/O(MG56"CEG
MPRZ]OVA7#KPBOV^JS]?3?CPMSWM!B[DO;,^Q^=':\/0B:U-.>+JE'_@'@MY<
MDR_M#&!:+_#IDMH53CP#<*NRJSG5I6? "R+'L*R_@]ICB+HBWYSN-3C?KR(B
M=#R0SXH<6B):N!HL _?T:@49@H[T$@G<,< BTKE<0G0AS!"V2=<8\$<ZSY<K
M(56;!#Z^M$6ZX@(J@0M@Q\<&K$AMW"_ZQ]YQ20<$[IBO(IRYWH4NEA/=/";9
MY'"%JH;ON8YNEI\!H7*#4*QC^ZW>\;*.T/5?3P/#C*C=_UD5TM_.=",+PSX+
M]@P@G?]+-:%1A#?84DN"PVG6Z7>?PEF$TU&+Z>]\WYF5/P.8'N0">Y?_$/44
M^)]7*OUG'>*F\ZOH<V:X,8=@)B#:"_<]N0=[_"-$SXJC"UDLR26><_GC&>!B
MK7XL@;@$_"8LH4Z05$2)[\VCW)VO??BGVH6W.. KD1^GRT-_+TZV+Z<^T^T5
M$IST09&#/.DVH;2HTPXV8LBEUSBC]R7J#_V 5)Y8]_E=795TM/O^2;_(L86X
MP014K\A ,,);>#V 1B4&J(1HP=D)U'E0OPN1,<W&'NZHQL>"G/#73UOIM'>X
M2CV5Z$!>UBQ+";2;+9*3Y?MQ#./;$L]M&"AF.-<N_,8_S-8/V%HR!+4O02YN
M-/)4N<=WS=DNQ+I?A??'3RF"XP"G:;,99_Q+\Z<SG:[NE\+_5[[Z@O[?L6Y^
M;8&KFH<+0H#X,R"+N@NTW?GUW5^+5 D^=G39OG2Q;?;)XLLFU=*>0%;2T+1C
MF,I-UR4DR].Y 3'VS@LK46:4VO6)];>L/[0**+*C50/.@&Y>4!5N(6S;F_[^
M:PQFFX,CO^ZJPG1;A#3-IJKHSW^AM;GTD@3G'0#A2R:M5LTS %7JVW8&<*M<
M1R<P:7Q<#S5B\Q)H/,(OF5Z2?CWK?VD9_']\OR*R=8%"!D0!JZ#W?S!V(/HF
MZN&P7;W3S\L_G^P;D<=M\3_V/J%_K7$<;]<Y+/53[3T==]@M%T-)_YS#*H,>
M&0 \O2Q8_$??<J(MH;!19BZ@U#(L0F7%%<U#?5*2)WAR96RRD#0*86Q9*.Y>
M+!=Y,6/V)<W( 1P(64I8SUT^29R#EIZF!W*? 79.DJA3$VZ(B^ZW_J=>+"V!
MA^,]@R>Y?NG P1EPD>#2W49B_3I47=/Y/5-=GC%4P,=1;3D)P?G[/R-7LP:9
M'M1K3F]O3\]W&G1\L=<F2M'A=G)I;9,1*7(LTER%#V[&G><%(B;;_: N6L=K
M/4W!+UI&W\?<&ICEM@U9:N(V.M]"0;#%;J-;_53G*H(+-_6\'+G+?;PNIRP_
M:WBFYTBMV,/>_>"E%1M19)#LK(9R/IT!BTR(<'C IQFB$78YT#H4BOJN)MX9
M:S)DR<_DGT)YGL1227XOH"[D$88<14YPX#/@RAT^Z_46!NQ:Q+9]_9",,KV<
M\V.[7JC;UU3+M?/!H_RUT%:D(\:P^W!>9/Q*URXTSJ76+,SE84\QTF]_EEJA
MWQ\#,#\T@EAFJ"JMKCS^)=4Q<GY WN9*PDC0M0G9-_24V@WCLO[O:JIJ8GO%
M*F  0MH/4!1$U>>$\S%W=Q!JHM$C9T#5TI<L@3?>,].:KAVL[  W1>O@1'/V
M87L.DYJLMD0EFI_$@YW+]S2\$'4WXL$YK<N[W<%[2.X5+0914[S>&?!6,AJQ
MA0*=7EBG7'?!(CE)PZ;6'+C5PJ6YV^VT)>*A87NI&RGO,8\6A#5B;PE4NAS*
MV<28]5S*$\S^T>)VFK-3MJ/BC,[AV6*[;&;1*S'LY7,USG0@,=^V(9Y*3FCC
M#M,9T&X$1>Y?U27['DFRY)1.-U.@HHF.BZY@2-/H0);LPH?&L:_NDB_*0I.H
MC1HVYLN<2#+8[B@)_99H%+TTR>/V\LQ<7HOJJ]!,_XFIJ^=T6WGT@==K'0NQ
MC6SMQO'3J)NR/.;V"SRQ8FRT QRS:TZ"=A_5QM?\?#%F["W1/F1&&G1TE*-)
MIZV\%7(<;F_4CF.)PSKJUQ%R<*4=@=*3SRQZ7BSOY<;8SY9L=VB\A2DS20.J
MK:J: ?2HP4O.@=+8N8&$LAEML=M:QMRYXK1VD1I3X8#EL&PYN,-<O*(\S[)\
M/&7VF<YG:_0LKSIU".AJ"/TSV F*-Q*[=<]*PSI)R_G]Y^_5HHVZO^G>4M^A
M]O2@'@N")^"M)B0P.1W9C,B !9OWADS;/1I)2128E,<'0A/?X(_)"$H+QE>$
MWAGSU<W?N"K0 ?KY2&:/FY$TFA5VT*4J?&Z3-,$4'38"N]D9JC8H!<DD!5I?
M[#( 6Q]@LB_BNMZ@SP!017GN@WY>3%*[\(P@*!9C.ZB&OHJ7K91+*9S=T"\P
MM'._'JJ]PF42_4!3R74FUFZZQ8/@R$<414PC3+&N>4B\*P&&CJV]FR Y&)7T
M6O"F: Z^B'*CA.S U72Q?,1L_<G3B!K(Z3G4WTYK_Q<IYJ+_ZM+U?T9/MTWK
M)S_"D%^JYY0.=-1LOX\)UHKXVXA).^Z7662Y=[U*8_7H7>JGJ9GM8O^Y564C
M%;>0LV_P7H. :ISNF4 LW\Q%_%9'[J?[ 9_Q.USD:/%]Z0P@\I$=5(_/"-VB
M8^C"WR'^<SMV(IGG8?)+;E_+-NS%_S@EWEEVM.O9S#A"B]9_&>0XUW(?F_-C
M@9.H%[/V=-3VY)[6HV_6\[-V_<G%RROO]WI/H7_ 4>D2&2B^R/2!C HK\:QW
MJ9WYC8%OF:]-:/SYK$X474.&@3EE!B.F72?#50RY+*?;/7=<$84L'VC<&I8=
M/*5IUE;;*)DI(L\ NCX<->GU!I+ =@9,5*PM'K9)LL&$4)H%=>6?WU9%W'P8
M*\\U(Q;&<&L36DVVNLD$\E  UR$)5 =52X9Q:@RXPBC^86_1C&+)ZR8^9N(?
MJ)CM=P/" =_]AW];8'P UZQ/, IMX_1IGYF1@<H5"FJ(+<6;J.4%J3U37GF]
M.*I"C:M<<F^?HY#!7+DW^2N6HJ')WTFE+_+ ;LU[GX=Z%3I? [H ,S5%)IT8
M8R<2 GPE5/K>9-#D)V(!CN=DR:1<%ZDCBB:<1PQE_-5S+&2?T3%$3?DY<-2:
M?D(V0UQZYL&D";0O"H-V%E^ZQ/%;6(@I.3;G?@X^C.#CC\ZA,9]?3^0X$.>9
MOQ<<N#^LP#6N_>KH2?#">09]7R,X&.M:WN'+.L\T]#%=",2=N/&E5(#RK3KM
M6_4=*WH 3G9]TS$#[=KQW=V<<KD^HL:[^>G]#YM'FAU2IN[+%ZWE&(1F3/K,
M^>(3<;4Y^4Y^WHV!P84M1PYOU_KH#_,]%>:"P]6SB6C! ,EB@EZ[WUQK_00<
M_'GS"D7P];EWGE_X3,Y/A&?%%62]J#T.*)/[(CD70_-#^)BB$_ *5,4^41,G
M0!%+;P*^I-895XN/* JT)0B-BE#@;S3S+4UVS>2$-WH1Y%%4;XH0'353MD[&
M#X;/Z?XVCJ)K4*0#W;V5&',<7U4# 3DU;A9-ROC3ZPC-L:46RRT4+#I1KDJR
M$.K,3C\UFQ40W'\<>T\HR9;-O_CV2YZEISM+0L&2ONT)KZ[*7O=8HT]X2\KG
MZ0V\[LJ,^=VW=W/F-(U*P%=ORF D#4?$-6N3[5SMW)0T72]UA6*-+ICGGFMQ
M/:U K#X\ ^H63C]"=$W[D36#Q)]@_,D94"U,.=/"C>@5PQ:>!K\@L\Q=4UW+
MA?:$H^O9S&07)YY#BKJ_\1\</T+NANBV<B?YF[Z#[>'#L#EA\#XK"4,,1M=3
MI52;]Q$??F4YD+;^&!6D:O9>)/6?[D-9)BF??FR^N20I/:GSLM)%+W%ENG[7
MB$R7D@)8RQ-4BS?.M].=BZC7S,HT*%675=OYV;FH#3+$PN$,FE1K-75<-)Q*
MMIIH;AKD,/"VN!V*=\(>2JB> >%@[ASC7 ;)SAQFN#M.CO!47Z7KXLP+<Y/,
M6,93JN%4KX/!6M$ZK-"?[G(HK]5:G 1#G)-'8"\K[U(WTMBP6VCLTK'H#S"(
M>'L1"A9J3[<T&>B+EF!W3X<<9NX1O/=91HRHE9<D 0*T%1](QO=Z5[,(P<RX
M43W27K;A:&%N64(,B6VH)N$<U#RB,'_:<G[:>52%3?H>76+*72VN"HHU'M&&
M"G>4)#$9S(3X+4U6(<UT )E+L-/ =I:J+YV*C!K$82TM.IA;E-Q4#='FU0PA
M?U\?N:0F!2,91EI3I#VITED>D[AA =5\ZZ#Q1? K3ZNQW4'K#D1,';7S)ELR
M2:]?\C'.F&!R;49O+\P%IM!Q57A3H=OO&(*>#'%7<<5.Z'B_G[8X5?-ICF#9
MDC)VL*=LF.X(G@U2GI3%:J JP\35>'\3$*;(FJ$:GMO>TIVP'\QOTX1@=ET&
MKZG/<^-BF2A02)S_&;"9BUC&^)X!Y\DXY'@&_!CZ=@:$(4E,"W^0-]QOGSS&
MJ&EA(MW@@VF*&SO6.V0;P-?&MZ\(0YP!5&\1.&.H/BXM0C9CO&I$13L?,B=U
MW::F)<;T*ET2R]/L"X#KOYI5_<<EGI<Y+'!_ZO:%<W,N&2F5GT\[8_4'CG06
MT<-:3T]OS9K:_V_) !0D=AZ<A@)WG$MW?NW==T.N$:YS<<_ PYYR?.#6'V:C
M"XAP->I&LL'C>/S0^7I57/]\H4?'RECMJ[63@5F_ ]72;9I/\32/V!GMXF4O
M1?UU=C.@*AI.4,4>@R-;SH<,>$,P>LV6D/JUPS"/#_L/NR>%OOM6_Z<<9F?B
M'J6B^1EFH9EA/+EC]^U;Y([.T3(>8'B:HYYL;KR7AH&^]*MM8:^S^M$YO[1
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MG7).6R@R/:/#LV/NK2<WI*I\3%'AELG&B<M6C*O#Y<[49D\XS?7NA\/Q:34
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M>O=V8%T(%TM_-6VU17#'X._Q8-*##7![!+]R*)X<3I W0[:(1:<)8_O;[/7
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M9[::=4_CF;Z_.&4V[LO\>% ]%-'_?>/$85QV.(0>O?V(]3$U\*")'E@[^([
M6>N'(O?)OQ !4"Z)3.6#7O4OB+6>GJZ*;.+U'$7;VR(8#=XM]M9QDAWYQ)LU
M>#6$-8F%U;[*<81;9_U,9"[C'Y1H^+CESAL<]%LQ?#\<0!/$X=U<6,@9#+)?
M['1(BH%Q$B2."G4E JON:\9C42_17)=VM$=?W)J8U7B1!&(2R:O4O%J(,VFI
MU0]VDQI2A+P>.]3:W.#0^J5J&=][R09$B3YZFXM%M-(9Z93JWSIX8&J,\(BE
MG\^:"2#%UG,(,9PDME=U2)'/"17#8:J<Z)433"O9>_F6-JL0]1NJ)]"Z((D
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M6'Z=</=*A;8E!';PU'6KV<F7ONT1LLRZ99H<^ZN.4K$X\7),<V[G,@M6.31
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MAU7G$\2SN(:089&HRC!4WA>6=+>03C5R"YQA<.$X<B\/>S_+:%[]GNZ)K]&
M,I!KP"9U74,\^;Q*MT1%"\FZ9L_ 7$UW74RC?=I4_(>DOA9M!H(/D>2S3!0Z
M6B8>VC7\VM:E  O&>\8BW5]643&R*YM'DOLKL.W71$CQRD%JPF41T%ZZP=;Z
MKW@HRWY"B6N4)4;)>_]$W=GFU/VM*IZ.AN!I_M.Z]7>[I=+V=U] 'HT1%?<N
MZ@^F<YJUB8&?4@#UP^!*/76V[G_Y'I":?V=F"<0GL];)R@5P2]?+)NW3L6O1
MV0<,?*2GAMF&U-)[>%$<L5X*.E(6:1 O4N#XH7^]1D;@8;^KW0=9T"DBC]_<
M1V7>X_MA=VR 2,5LJ+B30OE^DT!:&G=T8JN/1!3X99W&"!P3LL]6'^$F)MX>
MJ[<!VOIVM(G*%BZ>Y(6_GUWN.A.36P#1IP"TBR\$'YR? K$9VT_+$BR^OK=,
MU.W[TFT\;:WRM/[8Y,:,'K+(M^<U!;"S15HW1)>B+WC()O.+[-MVM!-/'QE6
MKOD^0A:.R60463O[.9%>9-Q<WV_:WC97G^\90]\;K)B$&>SH7'-OKTB1;(9D
M]OQL^'!DV"^Z+-QE*&ZIG8#XV=#E\&N*XUCA+8%SS9@AT@-\T1B>BS[*J=M[
M;OT:LBMT_"/ FJA:9$_ F!/@6.?PE. #!Y./GJ\797A4[K;7'X\D48"@%]6H
M,P%]*@)]!W?F.2R'B\)Y+0.V7,#3M$R$:*3Q4@LN[:O:A/60_OV#ZH:9$N(9
M_8U-&<NU!R)O<,C6GE.P!BL#XX1Q<UF055W+XPLK\N,S0==J[ \9-;C*N0*Z
M2TVAJ0H7$PWOF!+!.X]1X U69PJ0]:4XN(J 6,@Q1XQ>G:$ FCJ/PM%@'#D/
MI/9;S/O^WZ.1=&::#[\/;3(5YSJP#=*%^+@5:VBJF7K'*+'/U8!/K'M?JA9+
M>Z)N*86YJD%C<.H^WX@W-;7$(1;2"2'DI@%J^J"O^4/_:W,M/Z=T50I4TBKI
M/0L-P1"T0_.- C3<+2\2$]MPY"\K";T2+#@>G]FHMW+#HE?/=%]$/Z](7G8-
M8U5.!<3?./[9Z"T^[YG#@+G4ZGA744X5[:O'1IQ&KCU=2XQD_2A^6)&2'GTB
MJ>ZY@8F\N'_/1DF3H7J;TLP!!7BPX8!$DA_HIY""G<!['C(SX45"L-)2R ;F
M\Y[@9S\1T+E6G\LS#LDIMV>)^&MIEJ*WQFK1<>W#71<-!=;D:VK\$Z!O-Y]3
MK]"MT/^N,-''$$-B;^6:"=E;46)GVJBP"^#5LQ%O8SUTDI?GMHK<-Q:FG4?]
M:7P9> Y*M*8 2- YQ*P%!9A?W[S^)7)\6FM+P.CS&^W:V-&GNI):0IDGZOWP
MR$T(7=+><,#I?LOZ^]UTI'7)MF72^[;3O(OA_8%*&#(;!:!6*#RU0M&#R.(U
MV\%D5D)\MO^CDAJ\63&*-_6/GSS%Q=J9@J=,8S!UC_L:')C<%',HP.MP]!&\
MM<JB<K2D>:VN?;K[] %V360%P0#KU,"/A&.'E93=EU4Q5A%8A^;9$WJ8%Y+*
M<;KWY3.9QO\?9M>H=[\M,(;VE>W7U7#ZQT:K!MN+99L%2<F+X8^+5=9LOBC$
M:BW3KNEH7,_MW_I4[EBB=;;0,<TB\BW+,C1=EE6+:?#;P\($_B1/B^!32L'"
M)S9'(CP+)N3%)&0<5C=S$KL3.,5YXF>.6[6:E#+@ZRNH,2C:]WK_/HCU= +V
MV3.5GY;\'XWP;S5KCH[$E1V6'AQI'FB75C.T5(0^<^2X<^Z%BJ%K[:SO6Q:R
MDK(M[>J-OZ.YY+^WY"3>@"_MQ84]6<4[7)*MT"!9V7;EJ558F"Z[LVR?F0?/
M%=0*45&2C@/Y,(I*E%%W\-O-/2S^FJEM$-;+C<,WUMG'OIQ&6\JWRQ]_KF(A
MO 0!"#\#"M!81HUG6UI9,E=-,V+OY'##]ON&WP'_UT?+74.6_&I.9[XB7E$P
MN=I7H5DSB(T M09F]Y,!HM#(Q?(WA3UY7_=OIV8_IK)R_Q!5'F\T,GI<HJ7.
M?!O2+WU\_$SL^>Y4<3"@,5MYV6BWRU?09?HD07T.%>Z;WD4!PKM64Y= UR"E
M#[D=)UD FFYU;VG@*7NO\G"Z^\G'/F[:%ZXV_-(Z2?ND3Y7WSAPRR)P'IQ*%
M^&JNN&X\6I94/^96:33ZJ>/>,@/IL];>U:K_S*!4WY2VLZM4KAHR?2WCO-KE
M2U%\6)IVM2,9-V2)^ >>E.936_$:Q\=C7[RVO.(Y0(3E=3.)MCQS1#!9T*CM
M?AFSYO?JQ"-:(V0)O%D'9PBYMT[7U2RK3&R>Z0@%/"G >>F%H7H.6$*WNL',
ME^Z.FDS/NS\0] "9;0GQ?2N?WU]LZ$K2SRC+O/M]7P+6WO=]VYNJ)%^K>X(Q
MO&Z'VVXQO !O+ZU)EEMSO>"BO-Z.L*[11(15$_,D7S;8I@Q<O4B]<RNT$@?Z
MY0XDD]94TI) ]5LT*-4W86-;:.DNUY%RDMF#ZC ##K[H8)%ER-B-67ABZ^WH
MV^T))O?=)UGY5C<K]E%9PK1+#6,8IR@\M"V#)PC/:'&0+]\>YA9(/@$93I^S
M;:B@ *_J[+=6G!1<T]_>ZKZM\0>*')KJW"B<O(OMB2F[KV5[=_)K?#2K8*_%
MD:#V[*5C]LV@^0B;R^9S3L&,^QV:(,)*)DO6^M(?N6@*4-XV\=(H<_"R>$';
MMN2( *@PQ'L1^L"PR_>;F>;!1$F8:*)3WQ8_CT%O%0E<!,"OJ_L(82"AQLLM
M,QL2&Y>+5&:.%3=YG2>L/*:6?& 399>/P^4Q]CL0@C7D,@7H-:2>@< *IF;N
M3-H_]P0D"1(YD$QR?[57/*ROK@WIZ><@<D]+PRK86E +P/)'!T%?]O[]9-:6
M^"@L'1)=)#!F=+$*3S=H-=$TJ)H;)T.J8W#?3/TX_ZNU$Q1V="MX%...,KMR
M+)8OSQJ;8941J<@RK^0;O[/\6DEP'A)MKI ";TG4DCH<#\NY.?E'_A:<T)R'
M>=1X'N"9=3X)"Y^G #$YDA"I@HYE>^,TM$LT: F3"5V@P0P=@.EK+UA^PF07
M?U!*_JIBY;>*Y[>DBPP_F[A!YTQ0:U: !/O+.G]>T?4QP$675$A(910OUX!P
MM "-B0?-CV=$*5PQTHGOC^_5Y:&^FLPY;I%@&D$/!:]TYQRCG)RW[^Z^3CK_
M<Z="2&C)#;)ND/?W[35^]]>9=Y1HYF(<[ZY3-!EMU+>*M[3A*Z'C%A;*9RLR
M'6EAH6_%SM";P7S],-^UDV.BVX-^;+A,G>9]1_,#@58GRE#3PN ,@5:6 ES0
M)$I#T= C)AT*$"B%P,NT4 "TX&K#GLP48I:+ N"?(O[Z5YJ)/Q_!F,Q!P,PV
M<*SWV1[1YXJU;GS]&5]6&'%*+[%3F(?.)X4H:?Z1 JB9C9!I4!2 S0R,GADC
M]S3RWJH8V=P_W#;G6+AS=N(D@UO2&L=1+P/J/W*9^<^:<'83:;,(D="P::Z$
MF5;>>V+9XZ6N")NVB8O-E::)W0R<Q5M;1Q,/!E*W]6N#QT\]D9Q\."_-NY 8
MI'K)OH[\R2;'J,,O?PIMXW#N9R*$[]Z=+<B)6BD,M)2<^,6G/("AE#Q4Q0ER
MK*03&SP*G4-2 ![>UU1J*83/?5/KF0?/:E%X]^LGLV6XX@LJM03=(+DF3@XU
MG\\7Y!"IZ*/']$XKDG+WZJ0[K&<=]+Z:,JM,N)Q1S24E_>5 (.-#;,NT)%XB
MUI.EE!#^N++>Q2W^0@0UU#T9?C2D#"?>P27GH-9NC=DEN\^8@>\[]GZC'<Q
M3\ZR&!^Q-#:46+D4>@?(5O)$#!2!:%=VF!O4*4!]P0I_ H:)[8ED_L;(3M%+
MLIGRL[C2I?XSR\$$DT;CD2@9&KLL(QT_B<LMEJ<Y]KV5A(]2CZ2H!XM-R1'U
M#KCYP?-L4+!HIN!S-7+?''*/MZTN[D&_-(D%$HNY7Q+V8QA<<U'X(ARV!C\:
M^M']Q26OM;]S;B-KQJ?AF<>> 5<NW":?*2>G+#3;J_PVWL2DI<8R\N*9/&6
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MMF4!'FI^R#,SV1W6EI6C/E]WBK46?-)D/TDD-"P8EH6[]Z\4\\[\WO#PEC%
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M6'3O#7E0G??=KX'> LCU\4!Y1!#X0BXA?,YN=OB9R;/^'SDMD37W5L;&KC$
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M&<;8(TI.9HEEP9(N]RO6O*BD $'7P4=,KM7(#2K*Z )?.RMBIJ[YQ,ZCH>,
MV5_9\)W@QT9DU XA_R)>;)"L6L/ D":T\?'MG^M%;H/.^7.XO86%W%<'^]X2
M=46V^'\I\^B)S5 9<"DJ*%ICF:VIT*0R@4"FHT%(B$.'NT6!AL,6L;B!E60!
MSX8CU/T7OP0,C*?!N'K"'<65C8>]HD A]&3/T55D:7C(]LWJT/JLW HWW)L+
MNX\AJ^;* 9>[;+>U&K3!G=#&/H.0-=_%/W5T:AGF>UJTEO%T]?FSX,OFRJ&#
MJEH.SJX"YO>B,)-\YTXU'6VAE%3 >-<:DZQY,]WN/,MG 8/'P0FG.7ONJA(+
MQAI=,JX5"3[K$K?:L_OR<0"J=MTPTDME[G.]&X$]#X9NK;_EUP5I,<X^,D_]
MN!1KDFR5-'HNX@[8X"]!TE>V*__%=&=2<VA1YEIR^6H ,K]6J+N8FL5]K-/(
MH12 W_"W7> 6"^E:;/69Y;T_]8,>"1&BB+<H0+]NUA]ZZFP__\M^!<6@^;B6
M"#*G[5% KFNN#)'=,'C\GI:7Y(GHB; [)XEU<D>16R+QA!C<M@XA:8Y06F>\
MM#;T_&-/I/:+*I92%%](?)B2ZWXF8\\9?V><1)27NF-!4>@$EL2NQZMM=<#X
M:%BE*897@B T&\<UI05'Y,KD[$W63;W.>")/QG/<P$SFR\SQ7B>]5WJ6[92"
M3C$8WZ#]?(+O(_G0LI3,A+1?D-YF][]/,(0E(^R&I).>M";MW6MNY/7*BGY^
M5*RP_WO2HAVH!!PHW9F4.B<C]L3!B75Z,J;AG?T'D/&^GZ*(F<(/$665:1$3
MVZ<"NLU!K!<] &8 E>$O<FR@>LR'SXCHDP6F['+=2 ]?N3'TQ?77%32357 -
MT?-,<W7VXWA\52;3=WU>?#D'W#426/EGZX+# FHN)F8PO '/U))?U">A4NM!
MU,B:A262CGN61%:-@4/,P7-^\OD9KNB8B<^-VW&2QD<*]18X@P)G7.[!.SQ]
M/ H\)KUIK'G?YJW%.<7#M]_ 4TW"$%6(7!/J\_XVJYTY5V_NL$Q!>U%AYMTE
M#8M=UT8]XD-?0/Y:H!+MW.A;\DB]\%AZYM1VTV8=HO@&]!0;J-PP0O;<::W
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M2<3*BD-F<0#B\+H!].!T)96;](X\NCR?0H N7/.@9E_WO_1JETO9:%LSA/D
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MMJQNX_@PDJ#M9TG!]BV"/0(M*3.9'WXN3,+D<-.+[@XB"K28(O=7D0'A22*
M]!*YL_ZK+P#G M*A'\SN)DE=8[FKSQK;R+8 ;&]A]*#H8DW=^P*]&W C'/1
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ML;/N5[>V9:IK)3L8U/B255%Z9_G1O6BT:0A0:Q2#4)XJ1GY;/$XH.L/3"'[
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MX'I:1ESF0<?)1#=9I78'[VVSA36I]6MB^LTVYMH=1>JN>QF2=KI!=M5E1$"
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MBEXOG+KYML_KL<KI"]X;#8AK-E 'ZK$X)*;?8='ARJ=@2\!9D'0T]R'@C(_
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MU'6'!W2+-$H#79C*!ZAU:(HQMR,T]-^U[%Y"9B[8X?8<YG%=PO)&.H'YRR0
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MS$7[AEB,9%A]SMU^<"$+UYG0&@.S!?2#.2ZB-,\4*KW/UUB9>MZ^$35!<P=
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M0ETG!95J3$;! ?\0X[MW7J]7Q8"5YX"YQ0%[#XK Z%G<4QX745]Z@@]IBPU
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M%C0C2T->&>IC^RPO\EHT8;795J/:+[>MIBBV/BT]I4(.6M#,BTTD/1[UMJW
M2R=.*.AQB"QY^A7DGZ$F+G$M*C\8:_0UQM=$*"@ZU;"-->9/J*]RRDR)KC'%
MAA;=MTI0<:#TB<&#K@:-!#$.^V+F3X2FG9X=6KJ-+[@1KL%F";_]C**:'>$<
M$/;<H;BOT9?G M-%=FVF9Y4_G@M6:FQ 5W^KAKS=B"K-?I"::G^I>)\_Y@_B
M:M!/$,.I$NLU0Q?#OQDE)LY!KO Y^\LD(,&H>VQ")H'(:W%YL7K,^Y#_W(+U
M#MN)FPTJ*(UYM8GS+!7VK, EJ<,D)?4]ZP:'7VUR$"4-^3$VH'E!;*+!H'8:
M%%[%#N%9Y6M\U[LR);@%G&D;?5Q'7%&Z!3W8V/1<G_B:/;174:%7U#[<$PO
MKT#6+.F)?4V4@SZ:!0^\2W71J>B/;P8J^"XJQD.&O1K9G_S<"NK+=1RKAX'^
M](\QQX'GLI]282PXS[(4X$CGQ$ YD=M_8XOI;QK80=NB+T %S.LS'&<IDO(Z
M%02$2<.(V6LKU(/S\(>ZR]QKU8V[,<"R@CQNMI7(],M+C&'<5 OAXY/0FPR?
MU.@)0@T/_N\7:?[/#3-D!X)5.1A&X[? 4I)Z5)HE=44RZX7+]HTRAB<K>8 C
M 6GJ1@=5-A@;HG"?"/SRX1SCI.J6GL<G#B\D CY?6D8"5I]&DH"+5'\;,12?
MRN _*;/\S;=S.E;PJ1[PY'TSEN-Y\[U"E4U2.+>2G3+U!R(3O#WAF-D%OK.$
M.#4 H/L#6XZ%C0TBB' 7ZX\)*;_1]D\#1P0&5HSAE9GQA0N6L4;$.PVT&[2>
M8&^/&NKA)^">_?L^)" 8VR#6"HJD;HT,=Y&@]_-C6*NO/^-7'Y;D5'3V,J4)
MH'G.$^62<ZE.49<*[@\T_$]]]O3FB"JQ*Y(Z2(=ZGZ\_0V_+5$?+?/ADSQ[2
MZ2[G;YC)1-$]#:5ID9;V-+> :K=_FVR)XZE02@/^ZGS)^U-84,[-4J\ULQ)%
MIIW&ZCE3D^;..-M*47DY*J)U\LS5(:G.KJZU9F+ND)JSKPI62HCY8K+-X^W;
MKN/?,51N7"H$^)']2PSN)?+8+S!9G#/7>1P7(N=A\<IMOP^OQ4ZK,B/,&X_F
M BA46$@ &PS,'TID7)>1LZ$)2 LU-DEFAU6<,M:N/KS(_3/$#-XR^X:+/6'^
M++YA0>0V]OF(]Z,_+>@HK?>/P#^87]CPNG<LWI?=TCPQ;&"(F-!CJ/6VY8]?
M8/4X[?-'AN3&@R*S.&.N?1S6JGY^OU\EVJ,/@,I@$B)]E"A=Q# 6%]XXWE.%
M%BH83JDGQ'Z):61Z]?BF^VO9#40V6KP4LP"F=O0?T2YWV^*N'3]KZ[YLV9*H
M3#W7[-!A2. N2F45DJJSM%DN('Y%-5V6U\29MK_J?UPME+3*&7QV ?#U_L>H
MH_)\&7Q=DP1TUY  1Z0,H0[O2;R>?Z!QJJE<T5P)VSD*^',Z<*^'!%AY)(C-
MWC_(9BAM^J<HI-EL>\(1;Q83F;J(((A16FO_&H2+Y#[+]>(?:>)Z4/@P Z%=
M;^2YQAZ73P*XQBWJ#+P5Y2:-ALJJ-@BGDY""=%;]T1<OL3[F;Z'"Y@H/3\1P
M&X1KLG_4<B,(K,5EI;BD)^RC>16.(K:4!*WRO[K96BV$5IPUG&6=VP(W\@Y3
MR'39T^W.1 T+BR'=>/!BUB7*]_'F.+<V"P'<C2A4'_OS"OM!.S>)B3TY%WO]
M8)^P6E<]N;V)"P$7_ EHVXK-">@GIF&=:=/G(ZA*$B R&KO(Y>_X^,B@B0UF
MB169&_1^X'=P*?[<C)/63TS\F^"E3SXMLEL6^SCL_'Y^^P!=AL"7&S(U=,OF
M4^&8C]/!G,GT"+T K)6:S4?[7R6!8E:\+ \/G02Q0?[E;<G6V\SSEEP*%Q;<
MKA,0.G6X[>3#;^WVOW]LW!8=F\& [M%W-H[%S/544J?YW+*^PS/1= )9L\Z_
M(&5G Y7K7M3!B8;;!++&+&-U:R(<NJAL2IQ8;#U:+Z*%Y@[;P3>@D 6#KWFE
MJT,FQABFHJ&J\F_G/U,&=^PC<PO*8I5<3!ETT;=3BMV:,K:0"-/H89W\7W\8
MXHG,8VC3>4ZE@?8QD0 %HS8C-6\S40SK4=2VFB.,%4<LG$=$WG6L_YUK8E[:
M439X3^@*C2U'X>V&":'[=MZO@E_0B#X_0I;N'$XBK79%@VP6D-0$?TMFV%,=
MK@E\B7U60&3$[WL?EQ[Y,>%_'+U[?1_Y",\?WB1-R#F/(U9=Z N5G1;4.>_1
M$Q^[9/71MY531;9/>;Z&/!<'!,LF*M-(+7$6' ])]>LM?T>I=AM)$;WT;6NF
M*1Y9,7!OIWAA#2T7_B@GW>7.Z^[M \?5@U-ZI^?(&P&Y;PF6N%WR$66%2*>(
MNFU;]C74JK78#!IX]H]R-6KRQ\[YR402V0CU XLY&S5RDN_7$!.5X(,P85L_
MYWY5&Y^ ^-$]%^;=9$^TP9VQ@JT[!H8NQ-3RGVO?OS1PF>(Q\WT#<9+LD"WZ
MR8$Q84LG=98[Z7S*$DOO).A9;$E P%B5$EW[0N:]5A+PJ^GN,&]5$OAE:@4Z
MJNUQ@MK1B]W&^Y@+@73^S/8;6)FQ+% 30@,%:=@+:>H[]TZF*R'YM4JG!\*I
MS\Z@:"[W0Q<_^[1,_=',V&S0_(_DNH&,;9>!^&8GH\>>(HU-V5]51Q^: NPX
M7O%]-__C4'32'+P]4+7-W8D-&STG#KG1:_W<EWZP@UZ3YUJ/#']2&[+1?]K'
MXZ)@B@FN_:=ON$!!_N"D[S$L.N]ZRNS3G!BA%;K0?UE%D=@!V;$E^GV!_WH*
M7RT4FA9J(P%..T?\Z1IGX53$F,1@6;$(1!7GAV TE?W\VJFRXL:D0JR=]KN0
MFCK7<'"94#$9SU8-PU>?D[EJR_>_>9#*8987T<P+)"#\.*@2Z9@X90GFZ>%Y
MZWW[W'7U9VW?.(&R#2+K\#SRC,*._,A:,Z$(6"#[5\G98V;19IPXG)"^1N0B
M_KP>I(R/:PIQRP;;_M'@CLY:DF5_7J.2.T0&P.UR,"D2D"T\2^"4(<-A$R(+
MX?Y<,Q5D$,)V,4VD<5.K.U%J)!ZP"FL7YZ0#?"7_.YO._&T4$;Z<]2A&8*2R
MX1MUMC=/5B@:C@%5)83#9)9-"%#0%4LQUI#JR<+#)$+SW,T$#Q6NCMZ"O$_A
M9-[]"1#JAGF<J$)5VX)>5:>)'1SDH/T,717RE+>T?Y" )E]0'FQV 1E-E"6D
MP81=1>T3[TPZFQA^BN6V62M_W0^?X6L 4Q)[LVZ.H1N:;YC1,?;5G<@M:*>"
MP/6(:/Y1!\I$?$*G,COLX:=?C2.IU9[5'<-><]T5]CG52O8#GV7WSM6#*(E]
M67?PH _>"])<H')7G]Z&,HX C5-EW.U+>U)[R+ F-H)1RSN*^2U1V6WQ2/2'
MPZ3F,K-=I3#*B7KRNITRXS+:E"@?!;+K&+NI+!,W&'6#8M5OK&8;.?Z+ LY7
M6*ZH/Y@+FRF OUP#[5%7D+>,%PF@;E)_P(JIW;(P+H)&=I@8%BHF3X2E1G^C
M_WX4:3-<N]SP[:-_RF3<?>/3?C,=AV>:_3+R+O?4AI:T$?=T*EUJ) 2FSWT"
MH)Q"AF-M_3V^OTIOULS&S3RWDK'!,B^50Y$F;^[&''T(N.&6XL=?N&;.%[:H
MAJI(=_$Y-DW+#(Z_M'B^@/-/RXI28W'-U0\+>J\;3U'W!18%I%-*5S[//K,(
M#, +VG6OC0ED)<B[GEU4SO0\M.##2FGL3NS:-(1P4+H&?FN$"/KI^$'D'PWY
MQ;&L<8(-T:/.DOB,R1]6RM/VK,J1)BMN3;<=?8Y,99<;7#OH8N#7!M;, A%A
M^SU_&C;CJ&N,:N6550?6S.D2V@U87+1.$<]#/,C, H0K;2H.^7QJ\FF@ATAU
ME!9H<\.(X%[QAP2$VLW"5$==)408V=4V'^ZX]>*/#<4#W2R3SD_/<NRQIQD=
M4^]-BEU:3945'^<I4XYQ^T342!BJ-C!@$A0PX 18SB5LT2J"YO2/FC?V&0H-
M"T\=LRQ?X4Z,ZEKK[DZ(!6[5-=\B2M4CZ#:'^E4./;7=GVXZ7U"9KETBHB:>
MF:'N*3R9.=B3NQ7\F1EUIDO5PG8-X^=18-YID&U#Z]2>"[]Z*A?$U[#^.9<$
M8$K^]O%2)L8Y-9L1ZH=*C;O5?SD]R]/\VX?++/]_O<>@Z#E]<)Y@]DY.]PVQ
MJIFA&T$C.O@C[0_&?Q@O$CT"D_%S#1/[O:,BG[+$,,S<#Y.JI[,)<#S5%$CB
MJB.#SG'(:$+SAR[11(6C@-J.V>=>;#4QDM/7YQX$\H3J-;25V"YYSN8[U7FX
MO0JT7EZ0_1+Z?*I7I95E Y'OWX6WC+C8[)JHLL$YQ7VI;S#R4(?\\G'QT-H'
M!P#_B;3'-[.XCZ?' 7JYD9_U/KUB^U1A.KM'C2I^Z"+K*9IZIMIRK^M&#.RC
MV<>\N+#X#OH'F*,-BUPS[)O3.V>A2 ^O#=ZIXJJMDW)D]OXQ5MMXF?FS2;.D
MM&2K7J:@=%H?X9"HI@G?R('+Y>)^,6Q"*F>WR+/!J$&@;6TK>KC-U(-GK*]$
MOPC<=&=H-,!)?PC(<_2]ZG2%Q7QY*OO=:^F0"53LXEG6?*!;S92]0,]&C.$0
M!D0V=NS\),!#>>^J15PIT,0^ LS1: )D T3GD26&6RXMA,:89@A)I_*I4805
M]%/5E<T:1&C',1Y<,O)*-/T1U?2E$##\F/[."[>F6+/[*^9*8J;=&/F-Z#+,
MUYQ&N)* C4ABKZ!R-&A7W)0$8/]FW;B99%W\B1(1TJ_]\!3E\&Q^XDO%IT\)
MJL9P1N4E:S)"1OX-,LPT6,D.2*#-1YM54Y\ENTLG5N?#<WXDKAJ*L5[0J7^9
M<*CF5UWU:/8JB\IKG2DG\;.=9+C<:*0.WC#E:T<Z$S'P"[XD1DEG,)65>WD-
M6[-F>"HTMY&AJ.+DW\7U.E%/9#)^\?2)OUW=ZHFP4*%!G_PT+W8YKBC@R<-P
M)</2AE4#0AJQ09<$^(#/4NM\?R(__\P='9>>1&=H' 9OSC[!_^T8-XOQ%_U<
MK&GKM6%S-U;I]"Y+O_C(B6%_6MX.+IG--??ZT,O=I2>Q,?4O1B/;ABO!YD:F
MYDGZU!O6_$$3_JLR;?78@YEHC@K07E2S[]U#3A)PM4]CT2:!:A;>HKPG51;0
M;B)=-T\"KD@[3VC?9\%P%Y=1KT1V!G@?VU41;YM'P13>4?X!WV4YX$!@F7^L
MMMI\WDQWK-J34RS)8K08-,ZS9H@H@E>XL9=_HB !L 1\67\="3C_*T.,QG2;
MQ:_K(U%1644HN^R)\PC^'J1N,/QMW*7\7P(Y,4MR#_\-S,"0U@QQ.[I$,"76
MF9$ V8W)H.OP+EY<S5GH%IFF4%CPGIC"?VBTS>YWKQQA+#R^$+@74-L)CIZY
MQALN5I):!WUT@\_%W^_.N<Y9!RO-Y30)DI$"'/^!"(,]( $A9(;]-I?(3 (Z
M+8_P>"KB11!1-%AI- =-<P#'#<3O*3,[>4*'9O5C)K1%WF5T]<98^F==7.R_
M9W'RWZI7_H+(C7<-FV=GJ(8F&-1\>TOED$*T/S  W0.]I(/RQ\&=?)1>Y0?O
M]=(CW)HM@HI9E-_;D "*; 8[0M["'04A',9TU,7^BKF&L][T(? H;K?0[)#U
MQ[%1ZY/>;?,N.YM$L*?Y:[7%@;<F!RHCWB??_*SAOI>43GEL=IE-.RT9%+3G
MY'_,X;FR?I;DBH-99YD^O::,EY"/KZ+HQ=K,(<.SA EA[%-0_^]<0_=A::(K
M:7J2SI3QNHNMG!0;+X(X<?WE"XTFBO?:#QAGIC5_O,!0*Z,[<+E9^3$G;^?S
M0^8(@7,0'48^8W[6]&V#-9[>BPN*$><27C%1+#9QG"4MFE= *SN>D("9FF&;
M%A+0'*]\H+5O27_*A@-%^$@E1);F9_K]V=&8 "GE!JF0=U1=3O#5Y[?#59A5
M6H"7%-K_^\N%_C\/HP_$0?CN(RGX\88;"<A-;'R(;CYX2\;+M\B[!6L*/^-(
MIE@& 40A@D9+$V7CL()V@2;$6S2?M^WVI";?T^^,82GGO=47&I6);&)DP'OQ
M*QF]L#83TG$[;^"4I4I\4*V-%W5CR\,3-"NHJQJN'%?*.R<K'A.)RM3;). ?
MTGJ!K>;Y'"(;V2@ZN9U29)" Z%(X+<P&9QGKO5H52*F?NG!@8/=X8NS1>8&N
MW\GTH>@>(JN8#@GX7+9! @ L"8@I0\SO;)( ^SD&ELF-@^/30R3MZYOA6Z&4
M=5K[M($.E-C5_[6PHH(7=$796?-)@UT%CNC>Z'-$"?JRDWZLB_XP[]N6:=^*
MN'*JN:#S>@5<2QR5\+LXH6'_=/<HKN&U &O;'O]["Y0*E\&)AD,B1)G*]7?H
M/>ZU&G$+%XM:5G7ET!_@GX;(5M U8T+2O&B,B)TA0K=:FSVJ0D9],"Z7>UJ%
M^]<9!%U7';$[9@JI373@4^4HK_]M_KCUO.]Y#J,!D^;-V04Z=K/TD_G(M^S:
M,38=^F;:E)W-TW]LSG_;^T&%572@-#K(Q:OE?0C94I!-$K)TNB$D](A!B-IV
M6RG-)=N^C"'/'Q$L:0R3Q^T\&'(ULCVH%N?I6>/[^0(^^PC[ 4ISX)>DC7\4
MQ(O?KI+JT^)G_*)E_/.'G#P9CM];C*6E#T-J'0H"R^3E,8-R$]_,,I" N3(&
M(E\3_*P ??\S 4Z\ZK;)R0X>5B !J*-F:]1C6%^3KHP+I6Q79Z!.H.;_?[W3
M_K>/6K&W<+HOA(SY'D513AW)11<?4=JXRTF^/WIB;>$!>V4',<#O(':HU"GE
MG*DR@[9_39_SKGBFS6Z[V^MI"7][3DC1?[3Y]!*""]ZU-$'F\1 M\A$1V?A[
M.8%![/I)-Q^P#37OT?@#QQ/_G)_)Z68T5M7%EXK5^I;:QG+8.#J6?^">35O^
MTN8FQ4;Z;D_"A/WCFA&UPHJ*]T$O_V "Q1_=#$D@'';U@V]>Q0S5SD[ ,49)
MA @0E7&W=04JCK_!0%:BNUV0X9O9%473K- F>#8#6A+./NLT8<;6/>[0E:/$
MIO/ N[2+$7[U?M1KQ<L<. \S4+RR(Y)^->M5_IMLN=]SBP/WXZ<9L#O*<X#R
M##*E1(\$/$NEN]W1)UZ?>5W(P!.UQ.^$'U985-K?R:(Z2RW;5FAHYK(\2U1J
M?EGQ<@ADEY0"4J-:%Z#L03]81'"</A_5ZUY?V'DJ(6TU+&QS6WPOSG]QM")P
M8Q#&<"+F-/'A@^]B0&N>:580QOE1TK<]D>Y\HN(>\YYO! Q$1AU4+P(3VOT-
M&M_8 EMLOY<P/IY_Q(^33)]3]!/ +19L.#7$^_E&07;U5QU)BUX5</1*TM[:
MJE#.?Z6F,'N%BI*_VBERPAM\3/47#5B>A3^W_ETNJGECM:0X4.-9'2/3\&<N
MLSC6/JR[QUEW X1W)*,)Z\8AVSF=N#.P*FX@^#J>!*0SV>75+/60N;W=BV?/
MW5"E\D^HMK#O'\+K347(0"@>DM9,2+"_;J2+2IQO;K[UJWD$,53O: 49(]SN
M%;2^HT_XXI-BL?.T\EM"X%;O4_H9FQ!$?JF?"PF(0S6<%DW1V"JWNTH3&^$F
MH</M_LM(_H_5E5>FTNSE'QQV+1&9US0$E\Q&EW/B6>TX^D>LQR=F3U6'MBJJ
MG_5 IZ/8;_Q1(*:T;4PLI9_M3O6=?YIB'LSGQ[H-MD"-_())K4[D'8[)DTU"
M)0A7%C_9QL:+:NA(%?@]4I@(3JMC^<'_^=@:%0ZCOSJ3LG22UATO=J54GO?7
M+D1(*.[AEDC)@D0O"?!^@/E35M0SW_E9FFZ_5[KG;)1]\IAAK/J4F;RHFUT[
MVWSMCRNET/9G*0J(#A(@N%'0:9<4IT$M[TLK>HZ>8]1WT_.Z!3!8ZFYO[#I)
M3%>B6A(_7JZG,64W91JW=V&B66.[,/!;?]!"1&O?Z?2U\_XM]4SED!?D]>L8
M^;N(ZBY%+U8 ^Y"D(P/05H;ET>\ $A!\C03@F8-B"G;/OF@OKUH[UB<;'NR6
M_+0HA$2;P;-[H8XL88>*ETJU37]LM[.DOIK$]H4LGM90(-KR<\I>QV8X0OYZ
ML8^=SS3-R'_QX^<_'/ZXRI]N>V .J;[PNB3=VA^O2RZV3"VR;JJ<"E7DU.19
M/$].'"^^)YB<^^SKH>Z\&I/AQ7]0&#?CCY>D QN,?<X HQQS3=W#PP1:IS <
M" _S:>;!R YM!OT)#4^V$1L3CD2AM4&TW*L2O;BR=SG?]FY2EZLQA_GZ2FEU
MMZHQZ;$8<2Z(7'N*IXH1L8&R2OX"Z.Y8#?BT]/O-!3'_&C3]62K(N!*_;. H
M6/X[M4VPZ.9S0# 6D*<V$2BA^[? ]G\ <)OSCB'L_9_/F#QP-]I.LZ9+^*JF
MPZ%)J\TA4-X91AUS%]@[%\SY'Q5-_W]!Q*/_;L&$$<6B99P%'4XC[<)RCACJ
M_(\3NGB>=R#U^Q.(AYZ;D!4$&W&0*(H72W/)8<:=O?5X:S<MS^ 'YB:>N['N
M0+DVP +3Q.6'?.;OD*MZ9N;2/:%VTC4[?.D^Z[XLU_Z?%3*XIO-\_D<$QFI7
MKU@^9ZY[_@.MHLI)X=]XAZJ9?1B1%CJ+&:89J0R0UXP_&)&Z_50I(#C(?J"
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M/\O1SNUPH\GV6_"KZA0?K;"1PG7%3C6GC71BRGRIR#ZGS[&0D,$M6!>#GC]
M)0Q5 , 7ZU8BD+K(\F0V! 1RR-R;7I>KYB>"W;HU5^P7H^I6;"Z@O'&K6H7A
M;&\=KK6AP(E7;N>23<D>=#-V_7E=NN;R[ZZ:$?HW@9<Q_ANER8NK^@<HARZ-
MQF:ECJ)WKEV9Y'-G8?7_$%;]3PWFA^:^FB'3_*/"N0Y=]$CWX$).SZ3OSVWN
MP 3G8.7_K#EY$WKC605X8GGA;$=DK&\_3F=LKCM'VM#XX-UX*Q4W5QWS?FEU
M<?Z,]F_C65,PW[V*.RGQBNYT'(E.:Q1.,9!Z-7:%V((8B5X,P* '"<7S=Y(
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M^>R2E4V_=2,TE^>^A((+_H5;4L.Y]-PB(C._F7-H/'=2L1\X_4,$/*R*N9M
M=S^OY/LR?&+KE4PUBY 27_/T[MB[3 [<+)H(H&V0%ZC@3Z=VX?<8/U :Y5@'
MO>JL@][!^1UVR/&6C8A<*#4DH;3J.=_G_%R-5@&\OS'@L,$+NK:]P!I)SKV\
M4K9BX6=J+ PK)B7%;P^U+J]'X;8XDU(K83V[S,=<.] PLIHIS"[O\GJX9S>D
MJ\KAG7M2YE'"@#\Z"93H9Q,62(Y[-?BQF6?,4UWC97?0"&>0X"_SCJ_GCO"+
M6/0W"+J%\=O[I=T$<1"&5I(VWKT(MT<^VTA2^%.KETDE10E%1WOTP"<P,KD=
M=HD$#J=KMULPC8C)2K>=$L@PD?X0X64)1_I[OE,ZO)2^% :$Q]5@E#-84/7\
M82TAS:'%"6*(EJ#@Q,S^.5@Y2]+Q.-[B94>C*,/9N]*8W]KDO>< 9?AYX(QH
MIKF) &=H;%IQ9(#C*5 1V=[0!A-HO74TMT($A.A#OYXWV%@UI5(L<M 0 ;_T
M^_NO@DI5SN0\+O==Z5+!H :7C+(5MUZ;N<KW036):! 7[3BA2 +. 6PB F)E
MIO(;!SW'\3H%VWI(FZ;[/]I(F&AN N$6^NFS>%LL;=U9Y26%T_-PD550S$W=
M"^C7T,,VO]!?_BM*A7Q1U3S)]G$KB3/-P9FR#T/BS5VPOX-4+X'0V$&CR,7&
M52\_LV\HLJ9;J_Z<(:EO;S#<SR1QRJK)QL47Q!Q7>\$)>ZN$O,8+%1QVV7 I
M D3E(]W]G8U:S9PJ6-SMP6Z+7 HHRM,/&B-'Y<#TLOZA4 W&I*3< KL*-<*6
M&P;8JO0T/]3L%W#NSGBW,1E4)?7M_(SE'I0&NEZ:C"LA D8=C6)0>IG024,3
MQ$6N\7E$=%=;(,4D36!4D9)'?E,N2B5F75L%,ZD)VG)VTK]<@E_>\OEMZ ;Y
M_>W;69HQ:[7=94=M,]M&G(5K;<PE#MF26@.,$B'U X?(13'%;)K@8?=B\+_'
M0;>#S_>*XB!B8TKGQ;UZ1("_&Q$@K[/C-NVHA=CNIYQ!9S?2$)HT)D!4&R.7
M\]ICT"8>\+H>&EF1=JD[1TG8^329JG)%=XTUZZL/H V"N,^Z7!AKY$/W_ K*
M=[%,9XQRV5^2VPP#@9@;VSZ)6&W\H-GV2 0V^]=V=1CO![\?^\P?H8G CY-7
M!'H5K15&O]3P6>E$%7KK-1& >$L8=D %*_V>T \77!_UL&FH-B2-"B4"^$I?
M'0VRG7;X)@3R39I?U"=T7>Z('])*^\P:)<TOUV9*HF-5A1IY_\KZ7=.05+=5
M5ZF<',2'\'6F9XW46YW)!/A8?*"9XT6O\IFS 2]0,"* ]'CPM!0J@<3-NX[A
M+ ]L5.[RI=&+=3'H=5GLFG6-N4S@J-8"G)H('+,BA7FU(_"\.CU#SA?M<D+"
M?P< ++)%\[[!$(4) RQMUL6=V?,JQ4 VAY#?C-=VV!&DJP;A8D=@X4G#D ?P
M8EF-B -W=!,D^%L.*XH6?520UMG,]B&X -C*";S@%XU'22.Z\"&7^4H5A&:;
MTF$SF07^23##6"YZZ!H^1)A K>ZF=^;)E.7Z3\-%%;%C/V^)I(96;AY]DXW[
M+:/I["L7(FQ7T4O>#FH$/_G*1Z*+GCV^WOC7/I,M(:ZF/MYO-Y$(R&638XOU
MD8HO) )*OS#6^YH4]JOTV[X^O"51>]"DG#-996=ANSKFE,$4!'_"-E;N,#-6
MP>E0-'^]#\ O"0A0D=%E2N,MED4Z5*>2HWG7.O6]1V7MU]*6YW7TO_9^L+>,
M%!M937P!"C]%N&G]HC^4YCJ0*:@OU=-']AT5-"IEVYUHR;N6*$AW?C9ZT?EJ
MG3E36-<&]_E7!XQ_'4:HZX@D A8-2LTHP_S:8=MF,U2$L2^P(<:AX.6T3"=/
M4=;A-MA8*L;T7K/ 8<'B\4J,J5YGM]&SFN.U7AJ(6K7))4PC\5*F^SH1P.8@
MY1PN%0SM:DJLA.XG.6_QVE.&,6J_[W?U?'(T5P1*/H;?D:']^2?F"/CLO)L#
M."J1/;-:-D-^I5L_!@ZRR*XD'V^X5.#VS=*DG;2I-IG5+E\6*1E/(F;) OP?
M$78TVHZ,CGT\3 5F+Q4S[,/&7M7AL?JZKTH? $C>\Q"&V]IP'OK+A)?'3T=P
M6\*=HR\GG7\\+VMT\Q,I4-H:]P->V_Y]>>&S?/4'Q"&.^OV::*D'>!WI<T23
M1B[4*P8^X!P@BUAL@#/P(J(?CS6Z#Q&I- G(?YNJ">:_#I69=%1P[Q7J4-LU
M7HE"?V[KVDGO8P4,H;I2F$>)@$D5Y<'+PX@:[B\>>I5)]"7FD?6TU!;N3XYO
M3DQ+:+O"/BP40.UZK^1>P^+%*@A7U+5-']YPB&R<G!H*JGEZ$:W?TLSJKW;1
MT-M^7<V7<>$Y8>BB'<IWD;KGP-BZAYJWH;9+AC5FK-"3#J7'H.!,QGFU\\T3
M_@&U1( 1'2R/-/];^M:8)R>?S >-NU1\6@JTG1[_J3F+$)4\N_L.5_64?<29
M]75-T_@;:I'7M^^.W%?FI(*U3,YZ8B9G1'DUOU*;V/)RV&O9\TUD\31V"I%2
MS E0H#.G1$_QC#D37"^G#XKE!G62J4XTS;&3.V=9&V:48Z(!E'K-- 8O1BN]
MX4Q\$=F<UXMJ)0:D5I:\2V*FBPV:PSJ3SU_1^3-]$\L83>?(YB'?;:/:C]TT
MF?R&5\?J: \M+':2E<CGE;.^3].X$''^VV)>4+?.S+@'L@%3^1@-[#FRS70[
M(,P$Z71469RN'Y9+,,EZ':9[;O!.=NATCG;S*M%R&3:E>_X>U3N:#:@\$O[V
MK:#.@_VR +3R?'G_?%F<\*4*V 8,"F3!UGR"'\,U+G1"M^PX7U4?=-YW-">Y
M17IIKSD33)!G9;W*&AKHAII9,.8&084\YM+["KX4&0^WS+>7)>Q#5*E=(1/U
MQ['V3W53;:(@ZCA!_R4FK@F/W@GD*&UK0\(L?YTL:==-F\A(-R7:#1!)H\DB
M%1Y8["/<H:,B@YU)H+N&].6\)Q:G,F"HPIQ9QS H>83X>C(\#WF.Y7,76#45
M0KT S1CT/L&W(-*) )MD2US%'9U/)^Z\_I$W\"WY2K0ZXMWV8^T.VM%%IAZ3
M!!(\E421)[6Q\+ G>+JW54Q*='=.*KK2LJ8F3I=<QH#K72QLW@/5:+P<$_(1
M8H>>E:5YEX3BM1M1M*FVTF=Z6_;GO9+6)O@#[AM!(4"?T+A&! R10Q 82H(:
M10H18))_I3S5]>/6?'K.G 3@1E$]O$JSBK2/:"5R8CYB]ELTR7QLVO7\^A/W
MX*(=Z9F6=C+#"=ST*WSO3X\13+CUI20,+%HC]P-#C.9X2BD[;TNTR>J813[G
MLQ.Y\>-$ET7ZR@!A?1RXF,5,M\98HGGTYHJ-9?&I$OY.!A+S%.,&.:5E[J1I
M5^E7FP^,VCP5-DK([K9TKU?JE&!:^M+,4>\18-9]*^=[.1%@Z![YZ/S9V>!P
M$V]/()F/')@9\B( K$\NF_$%YE#GS7"8Q_TTYZ+:X.*>-^(9M<37=I8O'_]$
MV 0INKAN=^/[ [YA;%1&CA A]3IVU+DMC3&[=#0\?^S2]F\0-IE 2Z)'T[F,
MAK?O5I8MTMH9@E;U9E?A39#(]_.&O$?2];R)6.YVY!V<TCM3Z7:IVLH&V_:L
MY\Y\L"><-Q*T2>0[=$8(SW!TAN..E?/BIC2F\\KLH<)V4GL60U;?K^%2\5N2
M@4+O+DMLN[O\#QJ,FW8\#SM/ZD8=ZL=A82),_6"=^-ZJRJ_=CU@T?[*N+%&Z
M@Q^!C;<6J;BPFE&>U[7). V-F3\9CG.$!P2E7](M-%&B%R,%( HH-<WK/E /
M@DGWR9>8DDGR5B6<S:'<^(1/_I\3 LEEFJ<Z*SE<Z ]SLE#!%:]XDB@.S/^P
M<RL@4XLV83A7&]R!X,E=)2M&PLZ\)+<"L57#S#$[2"+@4<S]*P"\ SUZ7+(X
M(]^N3]<L5C.4^+=R=,GPWGO,")+KZXGIST"YJMP+02+@KT4[Z+@5>$E:S'$2
M/>3$!X%2E*_&.Q3,LE%?Z_H1; <N%8-U-JG:IZ$*#_=[\Q%/+P5L$&5#^XV\
M&+)6;];;E8[F3];']OF3].M5IB%)5@-4+V=>#,B]=S>37"K>1H8M,CC"%[21
MUF/J(0M2,E;X:I F"OC2+&5Y< :D/-K(86-3M$EW8"]6O4GZ[.-![@Q@OK:,
M][MP)"/64=X@OMT,E&80#60WWI4?- AVFC(\N.TS.%$OU"AG(XFR6Q-WB?-J
MJ-^NL7+^GK=49R(N!\>%8SI[4:(+WV>2?LG"F].MYIGOB*MR3@_'S'<.RD_4
M+=Z'W,!HX_1V[*HK#!?:;C1ZAZY.[0%BZU1F8TRN=7BSRF%O+89 2(L<C#R>
M:[K;W/<9>:_*7,;\Z64+B:R2ZEEV.Y*E\0/*D35 R,+B@[-+J&1S!QFO5&9Q
M7<I7DE^=$HBDOQLV]#UOS^%F1BY>"PO."LV7ZEOUKH$'XRE($F>GCX'\MHK#
MTV]&?UC>P,4FA)*<$1@0>01VO&P-+CS?P&!^L=N*'#Z8N<;3)A)L9_HS_B#3
M;^F2M^,*8AJ =REI^%?7"HS![ZPJ?R?Q1]316^L/,%2O6$23+IV<,[6G)LR
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M$@-W.]X& YH99GWVVVOT ]G*_:.H.P5AZY:&CSD=WP11OHF/>;GU9 2AG9K
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M:.GJ7BK0DO>1N]+KUB9=I_!^K:A9PS9J5"Y,TUFOO64&]'XK<^'&*A18RW%
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MO?"<T?R? GF:$&_S'. S(4Q ,7<[X2&N[L-R0R_LP9S]8$[GS[GPXY"4.W.
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M<'_,O!&-IFO-T.P2GY!J_NQ_3[S:Y4R1(?P%VFM)-]3E)7<-VLS4&X-$L^R
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M;]Z8KVSV]'K;Y!?4);NK&4R(7-Y02=.9$-";&"!OMAP@)4NZ*^4^]ADW#J+
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M'>_U%93$NZ6"E\V:M]F54O@R&ZV9\C$*UJ?G0010-K*XPZ1;ZY]SKI251ZF
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M;BU>*(4]1^X_8!&?OT+%."+@>QVODHU[_C!!!$=I.%-8JF3S:)OE@-[UV.*
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MOH#;[+5774&4 !N[0;;))E:Z#$V[N[JH=?*)>@@1(#=KTCO+93T1-IF@W[L
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M6,=&0=C'J5?W(8%;.OV+8A%67YV8PE&"B8?6SJ;;/^H+L[]D+7?%T ZW2).
MRQ![P0(^O9K*Y-]';71?*60E2<:M2)FGG2D2W.LO"[@(540,'YL6] 7E<5_>
M2IC2^+YZZ2X_"6A/JTUN,.W&!S>PW<X1=TE9'*0I6)^WJL?-.Y7(9+'A::2L
MF/*3A6JM/R$*^[$WWY>FTKZ(Y$>_D?ZW2/^H],>5-G0"G.K740*O7T<)C,@J
M4HDN^/ROSN $-L;&AI5AD>6E9NQCD)TA8\;*8RDQB-Q\&6IBKM$T9F5X[/!>
MW(Y2O])>?V5 ^PYWK6'D=O.*\;0(UK%+R6AXZWO8A6Y/^%0^HB>EA?W];^-"
MVXSN5U:D0NK>L0>="H:,$!EAA\W%1T/VTM'+J?EC?'WM]5N=/+C6@'>J 5?!
M4>)L?H_T4G8-D2')\T^Q6'\PR\]ZQAK_A6\U;_<WYJUE[E@23[B^QUV!T!@9
M(^VUU1\-WBZ-O;HF91J=-:U-4^""H9R/<EE]WK$NPQ%YK/]PT+/6%BQH-.PL
MDL@RY7&F@VI%,'1,B1+&8#@]Z##L4"QM5)R*)LI-O48\FN,XN=G2J<44NIP,
MF]JN6G[J+Q"/?PJ/G/+A?#>5)B;;JN7@I+B_*9447UK2S]W.X2AF$M% B9-<
M1S(J790.\E0I<#"-JCC0XH^Q7PX7; +-/&F8C\(-N*N;XQK79JEQ?.$2G67"
MU.I5=>45B=T^%18M4N*!5+SS,<&5Z($[1TD,#&''K0*ODIUJ)3>WK=\TZ7G;
MGS WS%X-;JR[_'7P\:0ERZ$.-PGHUM2Y/8?2>2R8CH[<K/%:ZK_P0'AI=%_K
M9FQ6V:R)$9'BVC7$H^FU^M**\,V#[(ILXW4-N=*GC=<):N2QP8GNQ=7PO>US
M+[C8EB->=^!"K$+P/75J&O,#:P]:JF<@!F?IZB=3\J4G]=,*>"V?6>/N5Q#E
M+8,R8,/-EM<G)9S=VS!3F9HR5Y!S5"O@-_ V/L&V!63T/4V?<A2B;3#5ID2:
M_U/D[JL_#=RCE+%I@NQISB!?C[?1H?9RN8Q]H1@SUDB&! 2F'-M6@LG&@>8Z
M/LS5BE>Z67M$Z.F-V_!/1W='GU_8HJ"J4"K;?OJ6;"U*LL*]<Q[>%C[8) &%
M*X^X)[5=8F:/V\;UAU>+ZX-N"Q?2M0L]$./4T;,$YQ-[O/7G)*J8PWE+*IYH
MO%B9Z[VUR2*&VV<]E,0<PXWN.)0/0OLJF/5:\B0ZWO\><YZ:(C$JS2VER/RM
M4#]K\CVH8:X38?A(PN C*T%CUS5L[IP$Y,S<Y0=:$9(6VD;//'I9?G\U\LGC
MA3HK[XDUGU*B*E-O9)M1VZ.#R@@/K>.3,);/>=<3U5>F.KG<:N^M#G/7O%]H
M;[Q%H%I<'LL<YZG5HVY=%BZZNVN=NJ7T9N/UHP4</DI2X+7#O<&TA$&G4VBZ
M3/9P "W[8G)SKA*/PU5#/4>MG/<F/5F3##<W"T6CH@Q1S=L7(2\46)T^:L(J
MHEUVI%.+-B]_Z_;LW-\O3(F\$=NB=>FK"[3ZP4\35[3%<9C RLHZ['2\H7,+
M<0O$?-E/4N7+#1(P@>C2;.H NV!FO_<)C/^W2U:C>0GXQ/EDW.%+$E#TJ<[L
MZLEOVBNEEG8S5%%/_<9S7O8Z&K1;K3]9W1IV<"ZV?/7PAC9_&5=.&$$8;Y0#
M5\:[>7B[+ ][F5D\^#UTYWKU\LXG>1-W,0K>*#HU;>_9*Z<?)&K9C6-U<;2?
M)QM#6N*GPN&?NRGCH"LWPBHHQWDB,4K,^$LZ80C6;T-9(U<)O;!QI2>MRTO\
MKZ*>D@ /V</"OFKQV]=;N^D-61S[)SI_YNC<'!V\D\7.=R.W'[;;A%F"G(6N
MT<]02U7OX,35:VY/,!T_M=M:0OLUXHVP0]"PJRE18NL.GP/*!AN-[_M+O8#4
M>(Q5'PLVAD+H:82^NB5O_=@:33KVFOLDN?S ?$:'%Q^$E52 +FYC3@6-V>[O
M"+P+#*S[R1PX'\HB0XEC+:QNDRMK#ZEC=#1*^3"DX^_Z^(GXIV=7[C<_^6J>
M:A,NT^M5UD+0P=XX;.&\,GZO?'18NR(&*?>LZ:E8W)V,4 Z:Q+E4/R-G&GC1
M(WZ]MO[#YT[9W>61IT):L0(N@H:^AYO]"Q7!VJ-P]>>5S/>%G7=D!6J^'5\Q
M"# 8KQY#!'\RP7LHEPQ)C$PX.]!%4WFLZWR3Y9L>"_%8J5R-;1MI\7354?U$
MH'J@$*_!GU]@W7(,#OL1(5EK.-2X<K:MXLI+(:J'XOOYVW@3+AH2\!%UGTRP
MWQ1J6+DQQ$I<F]RY7_BTZH,D4P\):.K$0D]ICJ'$LP6>Z:&Z!C^X5#C7'77S
M[LT."4.KOMY,:QI490IO^M^2CE'P/0[4 KF -]S8G+TVOIE?>.=B4.;,-:J/
M M^N!:@"GJ\-I<-J+,B4FJEA!^]A7#IBJ.!JS'LN45%:1 \?.?%W,L?_O@O0
M"G'0X;#$(YO&+,&#63"T5X7-FT]]N$OS3"P_K@I15=+<2F,\?0>_Y;SPF;E5
MT\,_3XO%85;^101U?%>Z^5.089\?;N@;.CI]AC@T>Z[H[<KYJY#;5#A+&=<!
M4%==8CHHJ?25_W8@E.O9GD%-TFISU42T.!].#5-D4A14)[VNCCU@_ZJ4A7X/
M<7JT4UC#XT%_2^IVV[X,C\/+&$3F>+V3Y8TA@O1"KB3&;VG3#RX0+51GIEGB
M?\Z2\0K"EC)(F:WLGZ^Y[6/JL0-(&N2:+0GHI$81I:'R^(HVN:LY)UI3^,*V
MD]Y!!O+TX82^,7[Q2A/'IF!U='2;F%N;/26&3;"W?B&=R$("!LB$/8$90G")
MQ=M#0B%[XL@?(62.RYX.TOQ4,T5D RW$GM+,'5TG\\BV-1(0&HRW)@%WI8D:
MYB0 5P7LI?R-]#?2WTA_(_V_B%2-!,'"M'"&(:[Y:])0IZ_?9I:UEXM=)EMU
MNAKHN^([,,IL!GJJ  R%D<K$WU5_3#L(5U$Z >&-K+#:GUR#JRX&6GG?HSVO
M9"6X=>KQ""%OKUU $*B%Q=5,>D;  OUNWT4ULL8NF*!*TKY4U-/,ME3TY\QJ
M<LT=F-&"5GJ/C,:UOTQ+,X&+]*$IR!4/C-DH5PE4"#$$V=$O( &;[,S$L!L!
M.E %@B<6'$'07EIS]11F6SR8>&8=U<EUAT4\059IL63AWLC:BODH[Z=OE@7?
MO8:?#QQ&@XBJ&'GBKUW6 55XR1<!//(@Q>[;D35Q5O-M4=MHDO+1SP&JW@"]
MS-^Q]N5Z][-X8V:87A]<5^:NR5A2;Z+N9YEI1\/LNN02U'@JR[TO'H2 /?.X
M*&E3Y^ECU&3AD.B/86V/<BP-0WY?0KSZ^NB5F[:G7'U4Q4\K["MSGV>L3XP-
MD+#J+R2 6V?!,N!$9$(CQ34<'7O\+?L%TU(5%1\)4+NT9(='XOQ;\YPR-]QF
MR[)*X-%(SSH#N+7;CZ2&I6NBJ[-UX5AP,*;F\@*[!=L$8?Q^I\*4VTH78M=Z
M.)VKP<A2?/W(5D^!QK$M<_W>=K)!0L41@K=M-[?7R7AMXU>>Y]@M/'3#A^PQ
M.:U=PL5.@IKD#B.3FTD -M8A$7KZ=OIHUE!)>]9P^L?A)%)@!^:2><NV-$<O
M,UD*K8HMN==9Y=)NAC7E?35/?%$41<D8Y;MEXX[4MSRW4#FF,ZGWJ$UYW,ZU
M13[^./)89,$[V?\307RP]/3A#*9P/B)) _7EPR8R'LTZH 2&%8XO-6T8L=UH
M\?,Y*!T.2,=,%;W#SGA,&U4G+3JHT[^]IZ_U[MYD@5?23$_VAW0_$0PEF>;$
M;!/KK,BRRV,XL"$!\>!'9-^.3$$''2R,VJ)!#W&@9K,/$-72A!W,:D02/RZ!
M\FF:$]\\.-0+18W7TBL;W[Q1E&:VQ,U;V2V2%*P UG5Z\<91*XQ/ZYV'!R;
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M/AO.%*HKN^9W!YP2:XHKX; 0VA"!192QC;P?.JB!NAR<@CTT5(<_5(G.E2Z
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MZ: @SP]\;480!MZA/5\1JE>JHTWR[7Y77&7O'LW539]_#N;S4=CQL(P@ 1?
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MIM4Y!N(=^WJ:A4CVSRC=41>Z&BE1&?V*^-KOJXX_Z <2^ZBH *Y@5?@$N1_
M2\&NI]D*9R'%;O5].ZM3%9SP:6>"FV4NMGEQ*QHG-?2T+&)34LOFLF)4(0L&
MTA;=MMS/VG!MG_):'"TQLA<'"I>8H[9G-NVK>"Z\6:#O&>/+]U57/N$YL"\Y
M[TX<JKLY6IB3W,1%Y5^@=/YZIE>2;7N>K_4%MS[9XP&JP1&C)((@?BD+KE[E
M?'NQM[36AJ[CFDB=[(@7_W>.F"R-G\,R,OL"_R%I1@4A%@,2: 8'L9\I^U'2
M8^ZG:UGF40?7]L]Z\YPU#&&D^)%W(@F7-^N7F826^O9/]"X].WX*GROP\T[,
M=)BD3:9]GV'2;&,'M#Q7#GKDV[DTDJ:YKMEK_FO7.EM;P7"@9OQ*IMZU;H4H
M)@._!#]=*I0#Y)R"; ;\?F+[U8JJC'5W"W,+ELPD<=J?P:$L]*$-N[1*K@_*
MUM[$6BV2A>98$3JLA:-]X^].2R,U7M1Q1 *\C%.^_W4P<Y&"]8+6KVWYW>;)
M_ JZ2<MGNUP3;YZR<YH__LKS)69&T.6S8\I6_,>FX@V_K*0/[)[^U2_#P:WA
MZ330,!( VD.''I\]5@MS\U6L&=?V[(6M][%\R06^?&ZC\]XOS,[]F=+WKL#L
M?32[7NG(=:KS6B9CC\"1"0++?YTUOX6@BG_TD:!-[/O_MQ5JYO[+!JF4G?</
MURT::\Z-\OQ>HY9)VI==5;,5.0[Y<YZ6%NWT$.T6W;-5-]^<#TYW.%9]WW%P
M')#O7221R6RC>HF:#NBCDCF#?N3/^5N_?IG9!ZDMZF[OD^*I+MZ[>]<6\_^:
MS%GZY!$8L2MEN-L0#@O+]8C<=@]7=^X8XQ;YCQ<8'[>9476S'M7Z&7W4Y%9E
MUQ04X(XJ$6V@'$EI+\&A0O:I<396B]K<ZYL)YVJ8<0KO.,M#>P'GO[:Q*@%(
MAVP33=]<"Q4[)[J>Q&D-GM]9V[2XS@%W"QQTG:IH/V9:E$:X(IUOE!;04XQ:
MW$O(?"$>W*92:+0PWO0!M! _@OSJ4D8=BP$+]IX\"S^!U^*GRIA/5F7['3<+
M7##;&.ZJHLK(E=FG(,:!2L]XG=]8GJM7YMH#GXJ\0*PP:XW*$Z6\1<6;;58D
M0&C+]5-T_<W'3@^'=B:),RY"+MS?0NHVXRJ](+_)I%_\_!^<Z_>?GGPD$SY#
M&^L:ZBK9Z_A;4GEN0NZ+'=$%/97U%BS$G-:I87BIOA7,4#,^2XV]IYG5TDXC
MM/*-CU/%2^#B :7" -70:Z-X.!]^F3FF3!U+ L*?Z6N.+UTNE^15EX76,9FM
M&++P.? %/H!);I3^RV=IDS3>T7%E;&%>WM>SQB;=;L'3GZZV+T4>C:OA>W&H
M%E/D5"F$VG3.=)O_9O"#-Z_C1^P"@ !Y51@X#'$-_JP6I_;&*1^O*+SW<_MZ
MS)953D>=N6J#=R><YA:?Y/;K?V$UKE\W2+H&B&EBE*E5834D@-/H$7XT$Z;5
M9#NTK9D O;F%?T%TFD?-T+F56K-_ZY=9.GM"UCZC5+@)OCF'(%82>C;0D:UW
M:#MT&#$0D>H;XQ>4&B@?Y_<X9><G0H9@,22L;SRNP$#CI]GH[:RTR$1-/+*N
M4(PXZS$;J/3VTS=H&)).HC]\EL4"JF48--IC)%5\1X0RIB4F/49E2Y%6>?U?
MF BFQJP5RID$BIP$O:SA'DO^JOWYKE.NQ9W;&?#(+)YK07$7.W_8Q;359@=>
M$NRIDR%HC-1QP.QTJ@:&1K==;Q-J+*Y[[31=:0'492<LX4HWX'XV9V'<"O3Q
M).!*)Q)?!1S+1>Z"0I1NX2,6+VOIQBZ>?U'UJ$9/T*RR#%91Q,<CU*Y@E#/P
M;[XPU#-'GP&F(P&.T3Q-1B_+/U@MM^&V%MJ3#R(0+PL924 U]%XF7;M+.:[E
MU:7"1K;/EYA9VN2L.?-6M:_'(YU[E65U3<SY^7)/N-,@@-/:,7"4_*#DU4(.
MYGF*=\(KUZP-RL=!YYD>/NW0E:<0P,I31!X[UCGB\XLK,-;S"^<Q4_D7)]UV
M3C]6(-ZAL^S_LNO1[XA7G.1LQMMB.6%+9B/"&*%K#CPQBRNZX6=+P$)/#R?H
M 1]TINN3%'_J\ (;NG[>^T4=:K^)LE!QM=7Y8WTV2SC+/RJDR8Q>W1IE\;UZ
M[%]\44VN0^.LUUK]!\#O(!&GWS"Y?#SAD';S:])RWTATYDXW2G7Z_-)>87D-
M7SNX1#IT2X+Z5>SY@.SFAR^D8!]]HXH>*/<-5_,R1)VAE?W!-G#Z'NX3L%A/
M9>E@VH+Q\,G0"$^4O9'&3/7XB5^<7FB U*D&5<E?: ?%(OC*,P0?C 2TI82]
ME#C+IA/R<6<H0#4HREQ0+7^^PHCU2;5^<)0H6@J+>HDA7#XQ=DCC+/F6M"[(
M!YV[!]C9ELRV4Z9/MU-^;><K"'"#BI/]LLX=D5.O6!*@<0X($(>*KHT-PN^?
M%GAI2CYBF+"/OJ4!ILDOW^36VQ.3(OCT!LA"9>"7GH)+J6)&WLR:K@6E:9SH
M]N^"LX  >E\;Y\_&O38!KIRM^6O62:P&8E7Q+RXHJL*7L%;0!A)0RA=1P\H@
M_=WN2GA<@LY6'SYVO-N6L/'3]"A/QT0'TRC[RGO4@>:MS!&B=6X\59=JJ/0?
MS+#ZHUO918,BA9CKNZL5%0G&GP"4Z!M-ZJ!^7NO(HV9=O!O9"8XP-)H5P&?X
MWTRVL[&3.$@QO^MTAD<(>/"[];6GY>9+5!ST>S/6^'KB[P$^Q,9Q\+'P9\JV
M^J?;1XR2V\<D 'IZ57#V=B%/26G*BD<YO[4#QS$@AGP#@VRB2 !W:"WY'QLD
MX%.K/R2R-.^#3Y-<>:*->WG)G*FF2Z)8 H/?FWZP*7!T<N _YMDKI\,,&V^5
M"RE,3:[0NJ+EQF_1IZ7)'76ZM,M'F7)P2KT(#5;0]A/:TZ'_/CTCVJ12;UU_
M\N4['Q9] ZNS66UC?R.QO6+.U2;N2*I<K%BU(O;=V\ )F371*"_%CWC4B;Q]
M%31D:Y\$4&IZV/ADM[A8CBZ+"86CQ)FL=P4#+W*D+K&P]I(%H^J+:H"RS\+F
M%JHT\S1LZH>SI3SNS=A0&.2A'MX%=-PO;EN^^W-F5!@Q VNY;8K?K!,?%Q':
MWGO>V/HJS^6W^)!H[SB#SU:5.V+^[D[?^=//-DQ%T5BSH-^6GE +4Q_T:8G0
MQ-X<S7258SE/KV5VU:MAB?U;NS+BS4\P<YW$=]B5,6V^WV';-9H"(1I&*V;F
M,6SW?7[0U3Y04?#JQ3-CR\DL9\@"UM[&/M7"EOZ$Y_7R@KK\.Q0Q1?3',:U<
M C\EY4'FZ.W"%6Q_B- 'Y=IW.?'4UAY/U;D"BON)JO[)H7!%JP7HY0G[JON"
M3&69*LR.\]^VVD<2$W1RT>?Q>\IXS/QO+><NNR;X66,D][P >#?NN$F$@F"
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M-E)=\[#4/]%RD$-$8.TTA_=>R3PKN#[&3=]\YMRCTYZ9,"1BC^(GZA()^)&
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M&O_Z6/.J7PS,1H:5"MMN"OR4Y'32'O+TE;10.Z;VOS#<XQ06=W9JBJK.W[H
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M$OT$38'3V9S[@G_?EH(*-VL3/%M1(2(&*BJR?XUZ(TW%.EEI?J)[?KL)&C0
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M/S53@?V+H?]L[1BRF9H8L^CQ#5#UV>^_'&_A\.17%+VNZ"Y@)D/ 4'2EPJC
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M,BU:'CB,UQ;/<89HN=ZF;"#3O+JE2#8-X[#GZ'4P(?;DRSKI$(DIW1A'W_>
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M(]<3SWVXH64I=Q,0H'_EL073)&L0Y:8CCA4$M'C,;:><$_MOILV&?WQL$2+
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M8YX'BXT-"1^><"2KW=?A*X>!^"&X3??7JR;M3L(T;,]=A1.$U*J%7B6&4]9
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M^J4H&H-N,A=^O.M(,T1G%]FVH#G4ML[_^]YAO%61$$/.]D\Z0K%0JL+;(4V
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ME__[GG+/+>=\Y]SS?/?>Y[IV?LGLF=FS9LV>M6:MR=[XW_@%X.8S115%@("
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MU<="&<4'JS 9.7FS>,64\M]G>:$'4?[RXJ.R5@L>OA:-T]/7^QL&(RV-,HM
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M%K7G_^V4KFZPQFO)=? 3B/%0F8WUUKSF"-)]#CT%H7I:_+M+64]1_:HOO79
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M?>)$",KXEMCE13P;<\JBFP^%+,+;HF@VJ*%Y UM:-2/VL\U#-A[NP=\#Y4#
M=R)G>9]H)2^D'Y6-#5(H\IYWOD&P*U9EM>EW6&"H;(: 4CY_-EN\I&.!UB?Y
MW#M<4SXSO>,.N,W=73S [M/?*;K%>ZJ![$=$[;K='96%V$-E96L&CQ44H^R<
M$F04:23M&Z\LB6_.\6/6[!=!S"J+V MB'P5^R)VA5-Y3^X#5JU,J+5Q+HV]+
MSVW0Q)$9)'OM1JV2HS'4_5H/YYSF2NJ<1F]8R8\=Z/$+>SKPAJ\IB.OTR,VF
M[PK(L:8=K=MK)SBY>]^:)Q4'D<^?RY>;D&1W6CA^R?EDYUG6,U83,YJZQAD0
M,Y(YCBY.WC:F0#A>O^UK7ECRC8#RI]$C,+BOA>N@FV[9I"+6:*.9%/V@Y%CO
M;ACTOF(^L57D _[LK3I%6%L][,JYR_"Y%=(LN_^-:QZTSZ!'[H>C5"OH[H-P
M%O.C;<@-/P/C=%/CDFM89>U8A[/3R2V/,?"7);&%N.&UD#9XUOFKT+4EN;QL
M_LYAW3MC-3??%3M%H\/-2+W-TN./EFF47!Q9CG?+%7B#E+2C>Q4?@0)]IK&J
MFU-N>R%B861*D:I]/!983<6!V17WKX><$!98E?'& AE?FLSB^ <;GUS!V]\#
MS14W@ZQ/-6HW,+J.-\'%"_=K)TOU5,3[ANZ,":;)J]&HSJ9FN8II*OAH#O_O
MCHO^X/\.>#)$-1/A@3:G)>8T#QPU^/OIQJU3D.G!@YV'".^?3 .BPW6(__K_
ME_5;?//9'9ZYI$ZYZB79=!:[W1;[(JYO9J=DK=IA%7Z!N;::1EM>.5-M'4_(
M8%Q/F*DN%A.XO,UASPXSF##6T(;6FK-K]=B;C0J/[H?Y_;SOV!"3T1"956-=
MRJ\(B>@8C_ :8_[L9F S88^X\IF3SCPJ [&8@ <VW^&!WLM%RKXHV6.[-?^)
M<TDA)G9U]Z:S64W5:Y7C'DO<J]U*W6Q![O[EXBT_*CS (1<AW^47]-6FF7EH
M<?C0X&55Y4=33A/C2^>&>W0\D%9W4-TY-35G=[*Z.T[OG!S+W4F/CCKGDCFQ
MU3+QC=M^C=WMKX E3;N+1K4UZ;O%ERP;>+Q>X7TLD[=0$GF=B8EI)^8H?\@(
M6NS'R;C$NX_@+1^RWW_:Q2O#QF>!E>'$E(G#J3!)1^\G0-9U@<4^B,H'+OYS
MIBW<W[K5)>$VO+D/Z*XZA9N%:PV]"O_I]'J-(3C^U%6?*[&'*Y!1\;(-%ZQ,
ML;R KV-[.K<ON\#@E$"F 4CTA]3 K[DW/P9KU*7@UN&2(40_2]@UZ^+=_;VC
M1=[)E=N,:O[5UAA=<**$8)@"K(D/\461*K)5@5:7P"K.V(<<:]))]S<9'VQJ
MSE_*J(>-++F4<=[A+QGY#(;L9!6R9C;T&Z]XJWZ>Y*")^DI21A)M>T$W;R+<
M^9950LOCG4YD[_@TA/HKG;>;+-O:L4FY=]MX.D\ZGQV:)<%TAO(DX ,>B)S(
M@U(N#H2@\(!&+.MM-H,D]-KLP*/8YZXL[X!#4"2D.*M>6&_<-#QW&S+F(%=I
MXAN+^/EEY*/1L)0CJX_<D"PLK]NQN&M#C.G!R8MHKN#T)BC[@CGHUX&Q"<EV
MDV7-AU(?;=F$R57);7]Y\)R@$D[&^$"!\?G6_=:1XY>\56Q3X/J-Z67J_.LR
ME190QW9]DX^'RI4E%+\-ICKCPE?2HG3>>L7AH*6$W2 "5Q#]9NQF H/S^DE%
M[ CC$K4")UOQBQA_[X7WOJ+]7KET@T$_G:"V TV\$6J[)XB2D]//B_3%0TM^
M]!>IKG+,VI$'AJ.YXXW9=>SWK[WEKEZL"Z.T6YJ0XYL$ ( 86+]*J]6URECL
M,XH6=8:<35I3?7Q;[!_*4TKM_V_\"TK)A([:QN*!ZXYA1^0N.&K'<M_JASBE
MWQ+;;1\BYMX,:CSKP .?#/! 03L>N)=Q4=W\(:OY4R*U965!5RKOY)U_T$F;
M&F^V)XN@R:7'J&,X<7;A)@V$VN [- OZ4=.1Q;\OUH DU8JMKG0"R>V/!Q;E
M4"G6"$<L\4:LB4S/@=\N=+K.UQ=2D%5KN_I[ZG<PTO:E@]/D1G[O^#GI2V1\
MK+S?O^Q"I2ML,DZYJD%%O,1KZT6(^O,7+>SDV^JKDF=OL!.UFD8'2+LYIQ6W
MYA4Z3(Y26?[ODGR;\63UM*N?4AQ9JTKJB4)YNN@>%HEIFLC=DY)IZH^ZB\IH
MF<<HX#C:D7",LM_8BJI8A@66_N=I\%8$SG0#(2?5Z15_Z"'Z6H,UL&UJIM'B
M;1KR@,A.Z88NI[N<"*\77PU#5,<2KV(IAV$_5T*816F/08%P:&BYK%D[HJ*S
M.1&YY>MH@":#<-R+:&\Y]C-)N>M,)NS^8[:'<;4IUCJ[-G QC5YY6:LT7(21
MRO]:_I &TQ=DV8AVA_J.=;7.*5?TI69UAT[Z#6ID0:OE+O64'T+HZ+1F\/B8
MS2JA#AO8.%1K%M#R V[+U#+(W<R3%6YI%MHMV?B\+O550@BXZ0[LGU13Z=\T
M/PP=Z2PC/KJ9,S:W1N7=BA>L2&Y\9/FD_3M _[.NKT\?0W J[\N,)J)8+SX#
M^^+''[7*9>DU)KU^S3F$=8H*5,/&JJ*%HDYJ_J::A1CN%B^A]Y4)Y4,<SOO1
M(S.]+EP=KCWKP#8)W?"0 ?(@M9U98U+WVXRW=3/VLI/9ZE0>RLAS&*KA,2:
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M=NC];WY:20+A$VBB(TXJRO80<05#\A3C_15F:7VSEF)ZK?;+IP3WC01VRA8
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MY==/'TY&O9S2D.H'_<^+O.@D\XHK*$MYC?>$^*+$1_2/:C(<EOGOT%&8V&#
M6V?&[@%MQD+E:%W_$I\G-->RH*J&0N=H-Y TC@CTK77/^"KJRK":(W+\:TE]
M6@)*351XC9+O#>6/FA7C K2CP5_OEBY:YD3XBO<?%Z0HIULR1Z(_L0- &^$/
MPE2VO!244&O4H@F!P-BVA="1)8-( 4N6V8DM[(I&V=M[B[;M9/%OG:X[8ZWZ
MZ+PWBKR.RMT1+J0QZH6A'C7:P^M9H:<T;_Z-U]#^!>"W+W+$@IHQ'H[?GA9W
M:S3J^% $+Q2 3X:>'6T.H"G"[)%@BOGUD\8GWH1/?Q(_6W[7/L,":FNZ44-W
M)&LA^V1*P&0$OO!TJ9\^4F)!)ZL^J(WUWJ.^J<KJO<''7%RPI>*J=;<%!%!%
MEG$#DV^"8JN4+?JR+-KQ$67DI]M=JFM&^4;->\QM;50NTDQK6N6 >U954\O#
M7_[Y.'AY/1L/E$5>+CR*N;YZOE84V?DS>D:"ZX)OK7/8"EL"SFZEA^HEV*)[
M([+[MI$))TWUV\4W\_M@HBL"<HUJ*)IN76W##7M?4Q'&FOTRP^[4(A)@QS0R
M*$^#=5/52*8#S"I_I[UP;F-8WT:U[$XTX4K[E=1M';!GI$&^^X"PR<LAXPJD
M1XF% N^N;.,)#"8X<8J[Q81E2QSY'AQVBY<C\!4C*3' %I^&%#JE.S(Y.TC!
M P__"WOO&155UZT+;@0I0((DR10*"!(E9PH#68*2E*BB1,D9"@I!0+* @"(Y
M9R3G'(H@.0J2<Y(J8@%%U2W?[]P>XWY?]^U[QCE]S^CN]\<>C%KL/==<<\[U
MS&>N6GN56([>08GA[\4W'E1S*MG"ZI3K*J>RE'M*O&OF7 SW',QS..:_E1])
M[(V1H-4F\*]1G#X.2;O8)3.[RL.3YQY5(7C_9NW2[[!Y$T,Y979B6)/9*&]5
M*;X?"VZ"LV\,GQFQO5DBOP_KD![ %.E/&%@.WK*8KWAT]F4-^A.S^X8T&:]'
M_BN2(]6F$FQ>42LH$5];NP4I'%U;.TT+Q+3FK4,727",D&44MH</PL250'$
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M^9A1[=[L)"QP8WX*A_$4VW"^I%6P!_#I:?VAL%7*=WD8JGD/'/-(_[R(UH/
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M>:=TQ7? P8ELOMA /$Y9EIK-<STTD+> @91H*4!F(GX(+8\%8JV7TRX)9K'
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M6,H;OQ]FAT*VK2>[8,P'VU]HHV4RWAYIVIZ4PMGNVS%$8<[^38)1+%K:REC
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M"I2$JS910J:3B$MEW9KQ TYM1N[O$!'3>Q07ZZ!<F/0%?N<3\]$26DG6YX.
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M+9$?YD/NU/AO+%O(%:&7*RR/NA>990VLIAC9.PFLU]L*Z;M)XA(\/OM#+MH
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M$+@O_!7Z(C9JMJ_N@'_T&C(Q$?0;DK_E$@R]"?PG:5AQ9+)+]@_2\+;E];^
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M57+X7IHJ1</?>F"MSD+8%,VK=!A'6^#![@!9GZ=]#Z[E- \A%GNAT)9\;\9
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M1O>>3]/6O:6G]<%K<[89DKO,U^6YVMT7:4['J7%]ZLGZZ.U+#+#?3Q^I>7>
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M/_74-LCHB=48A*F:0>N-*FZ\ORC$ _8:C?IX!EQ/O^FU@Z!"CCH_++ :S_K
M956%HEY1'I,N3#E0, 9/8\KM?@5DO)DY+#1LBI?FGI@*%B*\[.9CIX0:;0NR
MMU^=PZ6]<)C.KIAPX 1/5&'2"7[G:E,:U-J %\<0"5%P)_24;T"!EN1+#4@L
ML=Y(C(BKP[:L!?6Y9IZ,8=3P<HBYM>468NV?.L1_T47E06P'@9O9Y30T_@Q0
M[C)7,^AI+ LG1!^3>@;_],#9I8.:C!**<F;7WSYP$DN:3:*VK.97:N^7]S=
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M;0&%80I]5'S!)NGJGRID)*3K0CHS;M:$G"@FK+(F3"&9*ZNJ,%>3$4F6QIZ
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MI'K8G;.L-*1'INI:8 'SJSJ1>:74WJ2V;2[I3HX@)9&W#,YX@(^C"#ZO-_P
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MSO/JA=>_[K&M;^9X[3"=RW%&P40BIP#)=:Q%F6#D!;O58CIXUH8Q]"Y+=[2
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MO@))T#\$P%:OEOR4Z\RJA-Y$L9;:_5;K->NWR"*[JY][SYTU;V+UDSV='-_
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M#3/1EM1Y>COZ0@0/1$<J7H[C@12#.AG9>X:2'5Z\IJ?K7Y:4R]0^?JO+W+5
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M GT$(:Q-]>&#&^10?LQ:1L@K3F0!8"K_Y-YMXTOP?0H.+GX6W#&HO]?)_1&
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M4_8TR79G8?,JZI*>C%#Q.\>U>XZAI2@Y<JN_$]CK*6BIR5S8C]MA".M5V20
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M_6'FWY.0"AF?O:;S(+/=^D_SB?H%M7)933G/24^CVD0785:T;87$^90X[2N
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M&5I_W%OR[XJ@9*E5G\_\FCI6V,E'=:)7[0 AG+6V*O!NBQ"8J5@3TOBBS\=
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MH8:*/>#Q^P;?&0%09B[#E+SOJ<KHFFG<N:"P\Z>SCSN74=SXB ^U7:\VJ*Z
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M2'(3D61\OF_%?V#O/<.:ZM9UX8F(0:I(D0X*"AIZ[P$+36DB1%I0 >D=Z9
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MXT1-8[T6-S,A#7M'QAZ:D@K=QZ^CFDZN,H_W&.]VL][# >G8V%,5_.0Z/M1
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M385@Z !7?!XU$7G$>S;5>BN2A14$7^F"XT#F\[HW'/EJG5TRH9F>&C&^]IY
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MB23MW0L)$&*F'>#8U'W3P)7Q2A/T^ <SPDK1I!A]K:1PNS>8<YO6X]X]?BO
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MGE1R,)UI@NH,IJ^+?4IVV-G2OU_&%7?Y1+<B<.N-)96*H??/]%C-2'?W:N
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M@OH@1'+LEL84,I9N^9L))['3?=GU>85)8 D33IOK9-V"[V4OP3.-BWD75#A
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MI7'F%TH2G\Z8:\KVU!FH+E)/8C]5B1W>[S+J*;^3C5B?VL<[D*5BGQ7GCV_
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M>YGY?L@W!!:_Y:,6^<Y89<&-&V.5;RE>#OC%AXCF@ER[N?;2!3V"1$K/$HC
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MTY8%A2:_W$HT]&*@-JYH88<ND_KN[.F;%Z41B2\4V3R*[RO$I;UN)ES1G;\
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MODBF7_Q"YS^V93 _^9Y_J/X:3#:%KH6[%P7Z #A_"]U*\HQ[I"1,]GFTT7&
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MT[X+('TX*._501>45FALNE[KW)]9>*=\XO>]P3YF+R^KEQ!^J.P&O"QH_*>
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MJ+ASNX=!2I\EXZWRU@J,,(?YOJSY/T<BW9V>N>4\I_N2E2%+3R^?GGD7JCU
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M5#BQS'"AK_*G&F3P=?!AVYEM-2)0Q7R@XN=TXD4$\@=1TS%$P%$(18ZS<K6
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M*O*UE\TZ^,0MOM)*?XGT^UA5Y)RLMJ4S'U%D_(TJ2N:.F+H$?Z#L)_UQ0])
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MUN2>H\PYN]?]KJDIBV(HX$()!ZPE2JO7M+/R^-[G$#ZRK=>1A(0=IT8DY5J
M!&;/V*/$_J#G4E6B,N3=VBX@YI(%&6DH'D%:#36PS4QU,VDX?^P2<EA+?!$?
M\ZU!#"V2-Z_(!S.)H;K8LMXL?5_8(:AE$^J[*#CI.Y],N@'!VB!"9O9$03"]
MU$$$N JAX^'78N9>GWEE)XSC)?E!YK-;+]H!X\@:*F*PUS1M'N1UOA2>6^M)
MO527\3+Z:+Z>\W?_>:%P<N"!M9E#<3_]4G>\G'*P]J'Z853=D>7X)Q=5^F#O
M_6+/@Q=8^RR<_*@;F-,\O+:</GI*EUYWI=<G#?0>=VUW\5(8@;00 2:OW99Q
M]T/<!5N?9Q$A-;X.BH[,AJ+Z%E%5,<Z:Z.,^C&N'QV=L4JLFV2B_JH@(4XFC
M5Q1P9*"P\*'KI_95M2$(R37Y(I,YK1#A"<G."'[!K>%8?FM8)P"EW.-8$;DT
MT,#JQ9UFD>!6=&G20O;SP#G9GS>NJF]':WKW_3[#I*YF]!L+!/!I?F<SL!M&
MP[.C5P.FF.N_*-BOJ/.," <&J+(OC-1'S+-&7O7S1M,9C[@MI@L9?:1DF+M5
M+221UTD6/17E-X/>OHT)KO+V2J>+VY%_&\E.Z/ 1#C/%Q)FY2&IG" Q%G"C@
MH/I].#!P'%T'D7^'(!%H<PHM\Q/_ON5^N=PR?Z)N^EZ*S<YM(W;= /W9V? =
M9$@ #;8L!SNA7CTJXJZ<U2'B2-Y>7';>+"<P_7&?X_"VTB4T/B=\CVKKPKZG
MB5FKY3-W\[F0:E[ZGU>HEY48<?KEV$^?S$S5[/$(;_M+7474#8\I S9.-W;*
M*GYY95I<=*+"'Z"HQ-Z_1UJ(&M<?=M1'J[+O!C?^F"1-=_V1?'2H.;+?]RI=
M9'C+87$'::E>:-UTI'63<F&2NU )8;SO- 9KM'>^MA(ATNC*>:THLXI?FL3S
M>#8(HI]-D8M3Q<KGX.Z-N*7TJNYX\9:JJ56] *R[R/PZ?D;3>JTHJ@I%8-/0
MC$W',B\J-)6URN.:#]HGO\;C,]5V*:,CV6+[/G,E'\H=]1PD8I'4:-1KJ;S7
MKV7E7G=ZD6O=5IY1J,H&]K,HT@A]$I-J&-?;AF=)<$MO/*XL7;^."YDG]X!5
MA(1=K,:P)&1\C'6RIQ@W\V7G>B.YIP<J/<H=5@9K'JN#V@B$5=RY9U 5NUD>
MUG'E;).(FL6DY0_?T7>$04[4G-W4BNR)E.RQ Q'8'UP7":GR$\/*S*7 0XYM
M#J*C;'/-9TSX#QDG6WENF'DZZ"MDDY N==S;1Z8-6V%AF/B>BC?YME_2VZX&
M[%TL>;6O_&H?68H3KR+0UPO83)WPRQX_8\;T=8!@=IIWIZSV6PP$=@5:=(8N
M0TD>3 ;JZ'L<4CXYP<)^]T3&]:/E2U,L?C#R.ZHM;G.'W-T@<&(#1]MXS@Y4
MR LK2A78+C@D.B\\,S%[^_+%:8F<ST@V/!*UK OB713^HWD2FI2@3A>"FDPA
M FKJ&A^.4YU"0'A3)*KKH%(A?'ZOT\'A:S]S#4/=5OU#55:+V;2QC1<D>\5R
M"P?EHQ/WG[Q2'=3M\*177Y:J]9<))H6B.68;J+".'6UP!K<H>=W0OB?+ZCQ7
M9Y4ZQQJ5QG22CX4.(K]?Y<=J^LJ,641K7L^PMPBE2'JO0QGIQF;9\7DOYT,T
M:JZOE4HTC(<S1J],]>6K=SE5'CTJO$U\BNUG>(\AS77;\U5;[)!7U\+V'%BZ
MY4].X(G>/]F.="J55G4"6YW35>7\Q5%6U]\7^FG30R]T.3;Y=[Z!+ KU*CAS
M'[; (T>_1&V%3P4-\1PS5<.F)E5_&G(19/LL%'/99[QD#G*'12MZ-!3MU<OL
M?</T124Z?*1\0]E;)!TW!B\TQ"$AZ.W6;1*_Q]6E9<-7+2M'&%2>GF^XS^EU
M_=1U R2TY8UV!O)1%HD*DR[;KT57@U>$'Z@=#9%?"[I*E(?A:/@$*T'=N@-'
M 6JZR4S6:4%YJ!F%_K3JC< Q'A)4"I!8.D*(*\S"H ..UIXY8BE&@7=R]_J'
MF5BBIOFU(%CQ7\L(M&_^.S=G_6G5N:'@GRU#6QZ $3_. Q%"" MLB$>F0"U$
MCP1LL?#5=T)K<JDP3-95*#J324?%A?M_SY=2M ;(QI['CN:K\Q4Z9Y<:O8\^
M]5*4'W'W>(7 H@W&7-M^./HQ'1%@-H<M0,8"H<Q>'W6'%S"<1D6;O==?%M;U
M9NVH;HM9V2@6<!+8*0C9,S@P]QR,9_!4+7":T(7-T.W70]51Y4.W^YG4A;.-
M[M^K=M-]^.8ZU='H5R@9@5>T!<)Y]YJ45Z'(P_&IP!RWJYPA?,CNFV0^C# -
MW$6LA1++:I4'J8Y<BJFI][(V7S?I$E6DHY-6S;8ABE$)>(HZ)X+0J7I?'F5&
MP&$^/%TZ=.M<F:3?3K[A(YU29&C/<FNG_8"J1U=R19G7>BW]PVA;@V)U^,;"
MI;RK$OS]T@4[=<_8M;_)T9NE=6RFS >]?\V1'<L/:QY0%Q0_?LG>L6(F\QIN
M+?DX=WS:7FZ\^[Q[_.:(,Y<X&1>KY6"D_TSW2Y[8W_(0!!\+YFR+49 CCT#Q
MM TO,'U!2>T-C$-N:M72@3MBZ2[9^-=BCYQCT]7NA2\0Z'',L"#/\:#1@Z9A
MCI_78IS&ZMZ\X%K9KGRZ*CEH_R\4]==B9W$9R+.1'S;Z""(X 5AXHH^;P$,Y
MD['.GY#.7>73 'U43_2KU._!CP*^)?M7%J#]'41YH]='[,,&[EC?[V[A"Z3Q
M8HV0FNA[!6?F9Z'N?.;(,M__#I'.LGA%L?WL@XU7,",_2;0@[CJZT%BL7NZE
M.H_R]8B>+LM4AZZ.%5,PT_4%5LXP%4N=9.2F">X,&_-=?M7+</XZI>I2.ZUS
M'X;#0KZ7RJ@2PQ)EG3<N?6)?K6^EV,@GJ[20,V=0D(BUGWT?P(/5YV;15*]0
M"5:S>I^Y<U# M455C8G3-M\?O!?%+Q*Z+&/-*\LNZ#R29=,!97/7B F#L%WZ
M_%G)L6M0HX*]>U%Z1,%CVG!EH!(U%X\S(P(WN5D)1*"7"+07# 1 "-_$L*)M
M(^/[(U_<;84/2V^-I,.VV>BKT[92K=+3GOL:E.F9ZBLQ8\/0/0982W\;IWP-
M!TG3=JMP$YDGYK1G>@13H^4]F0_H6NB8Z3B\&.\,:SBFW[GM>GQ4L(-:O@F]
M)20_/]I<K71E35H?Z>>V$6$4&3MYQF_F;:3$UF1]P(/1"ODY:(N1$MO3)&-[
MN][\-BF"#R/%6[[N%S<X4XHI?&[X57V"=WF 0U@2"]W+-9A(F*]$E9GJ3T,C
M6A'H-_)J/)G72&P/;M#>3FG>GAE4/-A#VF4$*AGABZ"+;OT@'(. =("G'C9'
M]Q)WW1^]TE*5I 09^"DR/696?+$T*NM)UV*)Z?)[C/VL#TYWN!#97NK64?6B
M\<'F]//'U9^A_LY#QZ/NLT2 %OG:3SQ[=>UZC8GL;7-7D0'L=F3J_=.%8FH.
M#&W4]DQV8KGAIV(^,"\U7,:G*DC.H\Z9KQ\:)&>QLL9YEUZLZW]-$_V<VNID
M'ZF7^:9/'DW7V$LZ]ZWZN#C-/=?4M%SX]$2-SMLKO/%!*BLQQAXUF5BZ!:8D
MEOA>!]]<H\Z#3;3ZTM2M[E;Z=0/>!=Z\Q? ]P:.^#DCI],=\^]'QX(B"<;;B
M%=NOK$W?.ZKC;EC35)_RFG4_6 K=Z0OC 7W$7,'$#*)OGUAUUI5Z_4;BZ<GG
M1=$R-#5;35P&Y82!JC@[R!D_J+O@5J+OA+>9VHU>IRO0;V5U=">"%=&?R&?"
MW#E]<Q\_(@*/R_2O7*&0M7FD9/Z>Q+MKT2 /IX]U1#'6R9R./P U/7-IS5%?
MARZEG]MC:Q(UL[]U3PUR F*]+IE:(O#Y+>I81! #&P>.X.S[E8ZL[B7?Y+WI
M#0915$K<R!91&J6XJA4=T>>C-.(1W4N!D>1=FQ_K0;#('G"JJE7SKB),HSZX
MY\%.JV['<\Z>MW1?QM@%U;1"^'A2BS\JZA4[N&O<Y#(0_S)URUA:E<*%_C D
M=S' '4/Q\IF4O6BH_C@\XA'%/?7%RB]&_$];'4DO7WP;"/C9I"=LH\@)I.LH
M.@6-2R7Y=BQQ56_0_"S6/[C;O*]V-X1$^NC-A,/*ZF.B*ZZ[^TOLG@@]>+?L
M[C9#W9&]2:M7?^>;\V#>!QH]+!5ZJBA@0,JKMW**\!R%>#)C>O2NS0E+VAQP
M#CWIV3MWI^A6%V_TTM9/X]D0G;3(MA0RQ[5M&+3E1 !;]$E').=CEO?1>^N$
M4)X/WI;0=TAGK"+ZFW8P#Z2F)/G(::6F6K),C:<-]O8RJ4#Z^[YZP/.MCLKY
MH%^%&<\1G-#%U'40JC7_6L7W=&_V>P;F+]<"D%2?1>W=2R@2C6(4#4+P$/Y2
M4]((*\W!)41L'Y_$@XF[!1: G&*>>@=G6FHF M27,\-W:1N1443 ";)O['D"
M^M%6VQ]<_!^F&;>;X.Q</V+FRB:@?RXK0?+A$^&+$5XVA#KPTN_I]2XU&T2
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M'\O9KKJT^'B()VHM_(CVFX/!;$AKF[>%L!)"7%^_NZA5.#9VL]N%SG(/613
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MV-NXU%,!<A*)S4PHRNW94.5)5TSP!)L9%GQ9@E.6UGD_RK+E?2=BWQ@_BK3
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MJK]1VEG3_N:&J:,79!$>4!4]>>3LE[_1$/5MA"4G@$O4<Y+")3OCQBFZSZ)
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M,K(:CA"/0CH#E>HE,Z%OT@F]CX]0CD<*7L>_FBR]4DTL&V/$[&=3ARP/>?Y
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M73E*:V?;U+B_UW*P&ZL5&%X@-B(=:2<% TLF.2QV.;=2H$<XO]8<7[,'XJQ
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M9$B'_!+5SM:#*D-7BK/&8E]/!\:=8R37*S=$BBS#+5Q6?D-%8\.U%^V2'N<
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MGUFA>XXA?<9$KXMPHJYEE1W.265D(7U>G3.&S]UCSRXG@-_Z(&Q+6NE,3N*
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MH^YN*AJ'FOU1VK[!'4\;&$-N8WNC_<1"%0TV7'>S@@7>])%TX#EN2J\O;@4
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MB$S!,^J0IS_3XDRL*^JM:NYGOF 0XU(4OC2P0$#W6?$$]IF>/*^%P_5A*84
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MI<<$>Z-119Y,9MR<6]ZNC_K<Y>,"')."J%;6\UM2HJ^1?.G%W(B4L#>06J?
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M77+Q6&>'(R9LY^: U&DD0Q21-]@?.ER5Z)PWH^DD)L+-!GF'@>>\<F3)F!4
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M_$3_GH6*_WLPS",G^8AZHTJWM'R*U\2^?_;C/B7'T.?1K=$TRU.X5]B&!!Z
M+JP/.9!>PU:Y8AMW\"7Z X@W_MB=1_VH-HE'LU[#^4<L5JST@=E2WB\+8E=Y
MC-00BRE5LEVD.$,(5)>&FZC*N[/%EUK^"EM3<Y@Y.GAW\:9+["7@=<..DL)U
MI3LE9GXHZ]^4%KH9XX#/P<)K-">B!Q*7^5W[:SI$I'.C'(2+K:M&2U2SV--O
MWCM7=B5#R7I<<F?#,D%1\55-+2_SZQ9?Q[BLA0(C)5C,U&2=BI#SBZ')W3\]
M4ZZ3$^QPR4NE]5;EBF^+')<0 L]!+0',GB 6^J4>'Y_<QD\IB>NN=Z-BD'?H
M @=H%S(CY8*C?&A^]D9JO>\'_M#7+I9_V,^2[?8%*D2AU5R.'PQ6[60])P92
M(:>4KFY8_0[3<BXP_5%9.>^5SB:.3((YTY; W$,5@7&/BDK>8FZ7P@1Q:9 +
MJY6&[+%^3J<%60X_](XP32$?F$FUAK?IL(@Z\(X"SV@RZ(P/_FD4M:3P3VO<
M_S;GF/[W6&P4] 77>\UUTVX ^Q3=A0C3V5X\&%*#$RKK+80#;M\TOF-"-EE@
MRA<#W3/7Z.%L\72XA5'G+KU*\$.EF'6[):+'K28BY^2I+_#D.%[7K2&2-=91
M,Z8XNY"$CE)4IES92#T;3ROQX#T-V5"RIWQ_,&B]L68QO'1^E:1XU%^0YC9V
MZ-'2>&<4)O$K,;'S!#D;EC)3Z+M(??.\R')*8;3!C$5;P2:'[&0_4.7(:'AP
M55K&5"SM"ES^0"&MSKJFV/4I/DI)"-\^M72OGS]Z^(3WQ:^#G882K>[HUXT@
M):_M[BY]>HVV;E?B+1=W'$AGLSS5S$=.J@BPILA0A:L)5>W"W)W>#05F/35<
M!N^]08:@D[461$M6.MM-X&[7&Y=_.2/7Q=ZYRA\.A_$BK'(@)P'(+IH/ITBP
M&.]N7.@26G"*,3'@+;U'O[IL_$TU/DR_5I;1C..:!E2L[<")V[:LXK$!@$,1
M6.P(O8.^=O3VO\.!OZ?L.VQSQX!*,6I<-X(,I"/>U[Z9[0C+#X'C-/OW(&2!
M'6JDD14>1+NTW-B&COGKEDHE!E[_.!V"?_FG2S#//PAU__\<5D*!,Z!=P3]G
M+GS?HCW Z"\_>)\\!H+UP@G1>(7YNQ!M)?WW$5RV:>&Q,1SWZ&05+LK_MW*#
M%,7S'JQJ-[=5UR4C JZ<PL]N)5'N35B:-C9\=BASU3F(B-,2T/_MTKW9+1]T
MF$O@Q0W6^Y+J>=/*KR<URU2N=_@I?L)HT.J'/2>=30>VBN=BYAD[%F,9&-X#
M'XH/7SCL(R97D^'XE1\<'\NOVE9^[ISGM-;TBO=)N&,I"]:O@J[G/<M-B-$H
ME]OAW^SKX?' ,1<'O6";/ PQ.TU=B3E/7]TO,)IE0AW F=-H]^Y'LX_ Y%Y?
M-NH'Z5MFS.M<&?<-:ME]^.5)Z9*U51+?G3^V YQT<)"PF;Z6U"@.Z\@/NOWW
M-@'@]@">:U>$3'R4V'-?F 9?6>]^)FQ6JP3'0T**8>H29OSNW5&XEWHZJN!W
M^^@!J_$PHM_(/IS%P;2R)J\J]F+=P/BK)]:_0-.Z6&<_]*8U'JEM]>&R6H%I
M.[B*^]% H=A1RAXIGL?-ZBL[D3#14O(P\II3NA  L (^X^LE;/!YY='1A"S4
M]\-=36S51_*"L?4CW>"G -ZW^M^RZA?&_EMH^3_^Q'8!2<;IM,VBW6")RT$^
MB^D?WM_V.^GEFXPJ*FY!F)_.;=WD6+K(,]?&FR\^=21KKX!H"49\;+WX[SS:
M@@^8.^70XJ-*U\$S5QEW1]04U'D;HY^5-T6HRE5J3'YR2Y3;!ILBRY*>UX(M
M(W"+Y)37E3I"(0ZG.+4O0;VGC44(\CL&>C=#LBP7!4$4F8IK<4S9(_EL09[7
ML2=)^OG6GKR0$%*7_$=WZ E@KIE\)._N/:+MXW+590&AK^TR-\%WB.X<$F#M
MB#W!1E'AT[Q6B<8('(;>][_8>Z^H)KNV:S16+ B*@O2H("I-Z34@(KU)A]"D
M]]X#(0\BO41 0+KT&I 2>E-*Z)$:.D*H"2U **%M?,<^V._[[?_?!_OH^\=W
M<!\D(QG)?:]US6O.=:UK+H,&6(?2*PT^%SS5%PDS+:]#.U4J@YBUC9=E[/C%
M9^U/;]/L;_QTSSR%Q"L=13.-[;L8RC[1%2;7>KUG9UC*[376Z;.W6!/^AT%_
MZGQ!QS,Z_:&_.>O-MI\?(45EX4T*!:\-"ENW_Q9 _7E.](X&N)M\#RR^-?\P
MO,_XX+S&%!^3@+QCEWNLCPXKV; 5*0N%G[H=;2ZJ19A0(=^4/(* FMOS6KC:
MG@L6DGD92.)0 <3.(]7A:?U1>MRY]BS-FVO!.%J8E+; JT2L5IV2SM1R(Z/?
M01E0.5YG!&G[-$Z?119%$%[+O0" 2>RV&G:I1VJ1Y:_,O^;/ILH-3S&WVG,C
M;-WBB@P4:-2:Q-Y(M(P=H'Z9Q# SC^]#)96%[%['LH2:QCWMUC).W1LEZ:Y@
M G56%,J#>B?TNGA1&4@<D))XVP/XR-:;IQL?&189W6'AK.$'5]SH-,U@CTBK
ME4M*P#Y/U"8AC^,E57*^*-$WI)601WCZ=L43!"07F"J2-7UW66;;)-LH#PLO
M ,%U+5;B\"2,]64V,6%<[^';/^I1,&*&UUG3K43L<9@P&#$$O3%;@X6RQGP[
M)RIX$L BL=CPMU\\VPX.G%V5)KN]Y7)](].<Z$@C8)N1;='RT8C=VTVF4!HG
MEO09GI/&":SX_H!6'0&YW"'S>:-4,M0/1M Z^QK<#W>8$5QE8:Z^>=WBOHSO
MO<P8(D>S>->UD/,#!@S(6]V10'4^3^-6XNP4(PV%;.5,RHO$XEO,8+XP41,>
M-;$0">32SM&G\W4+D^K*!/1IM>D(H3"I$Y/H=LMXX5M%EW<%'H5X;<W]LQ]N
MN/?XI.]X)/"ZB[NQIE!XV<$M;+V5U7$EX^7LL%V7 ,5-2;+_>0S3Z2&"II)8
MO[BS_%XKDT5W#/@]=3E2GY8\@]G-(,=O8&:O 5?GDCB8!MA?4=>^Y$>R_ M9
M_L,YWSC4V)> /5>HN23AQB-_D441]B]D@9R%PY9$2F&8/MB:KL"_ENG^R^(*
MKNL"0/?-] +P^:\ >9C[7\WSUV0"_,XQF;L?N"Y3K F)G9[(NXUE]&E=X-O(
M_#?S_"L[:N?O&YTOR5I47"/I3PFAJECRK\UTY?]=>DW9NF]!>$N17>G)]*'K
M)XODZEZI/?RQ0-!""\QP[PR*JS>X5IY=%][R3'9\E]\V\^N??R2/BG,H.[[_
MZ"X__[%T%;*//2IN3@OV@+ MI%E8)3:%8!>I.].6IW2>QKR=@<+F$)LO%CT>
MZL?SF+QY\+,+0JF3,]G-#7^;JW/O=]!^.4_#$9+E(:/7!-G1 7"U)3GG:'%Q
M?,]ARP@86!<_0:HMNP2-NSFC2L7$)P'\R!6AN9<M=0T2FKPOQ4+N4O!"U^"+
M5=-%M8FO4WBJ:^;JL&6X@$$I#X@G=;MMZT.NK6=<@J/7LH3I\.=CAJF+-PIK
MYQ_H.JM2P@Z+??6,F!RI5_$$4-?P^(3AKI?'!0!5DCM\:F!>" Y7)F1MW2W<
MH"QOYM:U#_0V&$?X2^8/0'T6Q7RTT[_]8+S!2GSB<;/E_EF1I .7V6Z7RMU?
MD8\2=?7F5F8M7]@&H_H9#V>G6H+/\B6>@O6.:$CC=#]Y97%>PMN/<JIT5P5K
MO9U39=TD(SE=-XT3'U/2%_4J$RJ.>A8*;LDXJ?_V-P&E_QAQ8HUF=:H'>'/-
M7  4]U785GI1"GY7V!,RW3+3@,THA(]:-+^1(I/2YGCP:<Y0DI<$+N8[9*7F
M5,RS<# 1SCG,1P>0Y&/T']LV)3R,7(8@CX%T\+9?N2(+8B:Z.&C\"=]1?'OK
M/634C,KR61[IN&@LY?7VF_-E:'NNW<'4\F>AQ#C.'XI9"0F!?_Z1>R?WCF,7
MHW23QY)%C*^L:]"/8&+I?^THEE."@6:O(JGWPP.]^#;Y-MP\^$__CMWKJ4[P
M*O++BF8YL&34>QD'99#Z>-/=V/5%)U(_X4:+.V;IX (0D#4:\)QA4CQ,TFLN
M!RX]6=)VX+8!31A?S1_FCVC6HRPJ%W4.;YW\\4PUV>%*'=S9ZZ 4JM25I!OS
M(F0A5C280JX(=6];[>],,MQ[9,Z9([$?VQ]7<0MWA*]>:7)R9C)16<Y1'**F
M!?+=F[L 0#*S?'"':MXZE*Z-3,G-L*G#@HU<;@L_YN79J"B2%9Q'[L8_DN#=
M5TW61>UNW!(P3C?=E7T40N02O=SZ7B;'FD0YF4;MX2\Q[A)ZC-U@T+_0 ]FB
M)6%B9WQ"/]1.S=N:%602H\\%^#-X&@RT+9._83/3,B^_T/?#G67L<P3J2J D
M&+R;"GMD JY4'>$KE^1>D9A##H&/1G&IG_P_4\S P(:E(O%BBAPT:+#)4RG'
M7>L,]PF_<433N;]I WTJQ5*UNLS3X/\IJ?UO2VI:Q+N!Y+Y,K:31*YR86(.S
M7?<-]D;[Q B7P?;SJ_9W_'+<$(,4'/&CN<+UUT_;O23!0[*+3JB\F@J;"CKQ
MF4*ZDX)3=EI_&7-^RX[/ -=>H*'NE_7LE75C7I=&>,&/0N*T033W%9[XI?TI
MT-MS9';NMS)(RA%>>4X[XU) U%C5L(QQY<MXQH>L[Z8<M^PNVH?Y+].JGH%<
M=?@O  ^,%1[W'DT?^IB8Y.E6/.;9K@U@&W'X5EI[_<TY4Q0L3W?DU-2T<%:<
MA^^T7N2EG(LDP@<B?58$O:L,\]%W@P&=$2J>)3 SW-#T^YG[5[!GI1"@(BC,
MG;G/%QLM,>Z8''OVRW4$KRL7P8^EA0F?"0K"$GRC! .UNE$/,NV6D KDO"*J
MHN;[.1-EBRL2037C"&[L/&,H,TY&03#+F=QT=J<@:PKVJXEB_'Q/ON;M_.Z(
ML.1K=_BZC@7&26<T-7$N2D*FC:ENC1WZY1CN<#[W8U#\ G#JVOJKK)-7.?#W
MEN;OQ1:_5(WHTMT<JL0_[B- Q?G0KL<0IHCH"\!KTV B"0@V[MFG,*\]JEA,
M]F?XD[JI\1"YL+LCZ]<;.0'?UET^["RGPLT_(O;9#QB?VSY]:F3^4 3HV[T0
MZ>5NXN!OE&I */BT.O(G_LQI?D%U.,<;=0BUWQO1L0^S>O."-"V[FUFP8T%/
M=.'/L5J"IP^4#*;".2JMA1#V-'/,XQ_#@X[O5YXVN@^%K>]3SZW#'E*M,+RO
MEI6O 01HU#^5.]%.^.NR@0F]OB?(_<EB9];KX43@Z*C$[9T3Z+?80Q9_RI,E
M/TR!7(8 :*Z@%\MNRJ&^FN(_!*IJ9Y88/>4KE'/-S63#IOW@; [#E8H]-''W
MISQ*\[==J*UK_79,^),6"C*6FLGHY=B[ *CJQ,EX %=32 Q_3@QMO> ,_A7=
M/#&4AQ> KA+^=NF)XG2EA30'G-ES*:'>6.+A*2M]P(;OZ06@;G[APYQ/@5I5
M6'U"ZMFHP()]@YCOUM))L0$PT>ZNBJ*<)@>L9',$OV["73ASQLS78-VJ?Q37
MM3MK295 +OI(I!B<%%W*?WH?_60;25E;!K+_Z9EY7SPBW/FG,<,^$0BNMR[L
M8P44'?O%@.S./FTQKE;,^,N-/."CBQVD/+WD,/BAW--W/UJLJ:K>2PF?31[L
MHQ&^3&.M$]R/?DWJXE$CXY$OL0W-)F*GNZ!7?C=F1- FJ8ML2?<6V\"JJD*^
MUDRN&H8^>VK!._ERS%GW?(,[HZM88^/W/F[^.:?6N7U=,1$WZ=&]+E=AU)Y&
M?$J@0 7<Z28K0Y\WZ\6C(/YVM,EO8!.7_P&3;&A\-VCI-17E!<"(=VYV^]F$
MVJS(.C%OPQ\U4+1^$"#ZHR'=_&QQ"?M<&$]$^ J4O#<,OPLQ5?%]^,M\$B I
M>)-R7=/@-M>6N<;QDA<SDB+9$%5F@'M@R"W%@F/_U5W&6_"L[BY49@YKYB&Y
ML%_6J,)9^EC<^\R>IO3QZ'!VQ*M'_P?4<;5TJ7QMMS7&_-IW U7LVMI&61-R
MN3+C\<32DKZ.Q-E%U !:^*#3?DZAUH=XLS[$]*!(:CMSU4#VF1_C[*BUUM=<
MZQN0/?C></5"%=( QJU>C_H!.D^(+N@Y@,JJ9PB?RR)PFJRN3863+$PMGQH>
M*:?R&"BE.+Y[&VI9=$W$ 6(=>#3.M9+$8B?+8-U;-(/RDHP$+A@<0%*-;3"Z
MKT_9CYG;+L4M)Y$_AJ91_?.>HI#(9J;B5%\1Q?OQB!&C2&B'Z"=*<5?PP,NA
M?=]9++-U7Q3Y!>#Q)<FN*N?.JHV;VI1<SKX*.;P^_JO2;IP3\OH"8'(!0,A\
MJ6_\*L[A,W K%DTY<>)$75"D1O,#;4MY[Q9K',\("PD#-'=]T\H#Z^,9*<@2
M:&7=T9=[1788D\O<O+9,8<X^2&LU%HWL2'U7\UM6[6G%NB[27JNB(4+$RKER
MLYM=%98T_,,3P5.V<3[D--]$V13E]W"&-);^4A!)3K-+3JO%PGB(6EA72_"D
M,-> OL-V\UT+>YBO@'[!W%+=QZ1_J;A4TGM986_N4$ EOQ66<V>WF-K>7X 0
M28<D[73I=S%<XO=]E.,Q&/R[*.GD_;M,B@8]6VR^SW?EG5^O''9C)1*PF=5J
M@8YEIWS<Y53 VJ6%5"?72AU\%/&PW'TGI2R_QZDD.)).9+_M'.FW^#BTE*AR
M1TE?XN!7SK;G5#MF+L+K<YDIF +)!N]W?,?WW;$I-=EUSSW#!SB>,[SUG9#_
M/6Y:^@>W-U46) ANLI4R>T3,JPTZ=?6T9M]"VAJ6"V/MWJPIG#\U>ORYU.-H
MP\S^_12%>Q^DMAQK(O7YLRO5Z.D\3]%9.A J]*)*@-_D;@^=+5=.AQWO9AT%
MWV50ETTOK 32U)<Y<%^I=?@"F[0\D$#V&Q\U;M@S!6?]C*VI98*/PI!XXZ&=
MD9_CXR102U::X>R-6<Q1 NTA"HSOU#[0FGGP,_ZCG3D/>VFM7/;:+F\[=9S0
M5LXO'M)'6 8[\2"5Q?B2*;VQ=\6D,6=B]75U>&U<NK2V]=^H.>7@H.P'%87Y
MF5;W?G1!X!T0..185=51#;-=_&E-FJW G=SI([2X#B>/WQ=(-?>IF.4L6TY\
M=XT"^O;\7;7C.$?T35N&<%40K%4O,<4DV?[J"]*X,TX.P9B](L;A"7NUK-YP
MM<!);9^D+1/:OZ<J&'4! &_P-VI5[7Q3D,1P^EX*/W-2Q,I8\')3L=I@>=MI
M:]?G$#&9<9KQL:8C OS ?>9DU)L^][$-AH.Y2S636Y2@/S3+-9ZUU-H'1]78
MC8V^*EBOHB.=-L*VRR!0VVH6C4%] Z4X(O0VB^3&2N[(9L"DW:'N78P8A+DM
MHF\G)G=X(O!EA][JKHFSXD2J^E[ZT\_GR_+HW2T0NZ'<BN"XGX<7G+4O/BIF
MS'7!Y$7_9"(1.UZ(3($6*@ /?4DKU=5&T@XJC*$LZ\32I5"JP=0W,I/,;O-G
M$/R^OP%JCVF^/,^-9/]$X99XFGEYLY,-G^^7NFWT+O7GA&C57X.FG.;4(*OU
M8VU5/_@Z6!O-U7?)"'/_&]8N!D<+'*.*,$ L^$56:>H\5F*EF/V/J9+W@3>;
MDYH3L0]/Q=F_K,H7%9#07*90GP/ZAX58)MU)1:LC)(T1.>/(YF&3RK8]-PPP
MZNG-:#Y)*5]4HHTHGN1F11O>(%X&A$YNG-R!8>)R(-,]=TV[. -<N(-:[P:%
MS];$?EE81^^RW^9S[$A37[BD/UDO7T9'S%S]MK[.%Q6;;BOS\$K=>QD\E\\-
MX4QEQ.E=\T6X3Z&*3"(W4+FZ*4:)X"PD\:$-OR4&Y5"YO<*_6;T2HC9WP^,4
M?Q4/MB:H-.=^_#P':OT,!$^/(#\G:7H"O>%GUT]T!%L=:"R;([>#SJ\F?EH1
MHQG]4UWU4*&GZ^?N:HU]ZCB7]\M&<AJ1&)AXBA$HT9Z?+^,- Z%MOWBJHV*^
MV*#$Y?L5U"@,S,EMUKF<F5XP>9:B<1.=M@17<T8(3N$W*0\,=*R^>)JY@&!=
ME1[V734GVE&1B3-7!:&W)7NK2XT\#'2N):--^L_DI-42*+^QCK(9P"O$7DEV
MM(,H)+MRFRY#9=:1B_7+H*HJ+YFR)[:%G8E216E;PNJDO^X\HV6,2IH97DS&
MXFJ-<CTU.;-SXOGA+F;TZ-1H(=+YL8_BRMR.V.RQ8_2T/#JQO8BLD?X(J#5D
M*:1+$P],8:IKMRZ\V?K!<2/KO$>HDIR#S>_0$-/>6HUIUZ^&"8&'86.,3NL7
M .4OT!6) J3CN^S\-+6'O+_0#_I>-JME>L*9?AX([Z,Y_&=V-6>$#$FZ?G_0
M]Y*KZ]*S_PK\)E<T]:"_P'D7 ;B]"C]["IN"'80Z4'QJML-HU?[^(T2VS"(&
MR81)KYM(A^30R4T!TU;TRN2(8'4[)>^95+5AXSD#&R>*+FOM:R+8/"C=GW0!
M<5#^!*\@EM\.Q;Q&^?U\TZ>\/<R<4%87;UBS-A;(^&#HZP'J,-KO9,W1NB!W
MIW7K^YU U\V8U;FFTU_E M^ANN1_TFG%WR>N; YF.&ZRIOK8^K2A6T <HK16
M594&1094@JZ#$$8M$G1W!GR6E70%LH>3+Y7W#!U#REP/6+T 5) @$8093G1M
M5%K.P&^OK$(5_DYNRX6;/JS[;+7\M?0Q\2>?O+.Z*)D>P:+=2349\79)!@%K
MLJBS??NR(_N"ZU49<EA[0<GGAWF]C)WV=?I3DQ8FW!^^H<N91Q.%0N:L;D@=
M2DJ#C=F3G2QT&'T_EN/UP<CA=9+>EZBJ2TD;2$DH5K^FBN_0.5=+6%Y.C=JX
M#*11KUV&40Y*!@EGU02X.7!J?\B-<G:Y;C-.,H\&G&,P^RC*/WHW/E-SOVCY
M6E8%U3Q?;N2W$8XTDEENA#T'D)>N*FU'<+7^X+#  !?;[O1$.IQ59'O&?+C$
M>*J3+0L0G\B2T3K[J-XO:BCZ>AT@8*MT?9G3B>DJ-2? ^(:5\O#4[*O9SR1*
MQ5EDG1(^5^3XZRJ1^FNVH4KT<\6^YOFB0;Y,1;R#4](55Y+N8W)<PQ=-S"5/
M-%))=8JVSY"O=AQ2B3P#G[T:"S3]'PNN_XT%UZU-I$)I(Y([-R.A<(D];;^T
M<9*'CBQ0EZECT%KKK.^&9O0I[#6A3*V#W-$RE"R$([,C91T9PE6;$0H?KMM^
M9'PS[A8IK4P2O!ZEG#L[8+.RNVG&$Q5W$\;>,;8=MWOLZ*3'3FGR'50LMOG.
MCT&8SG=P3F1?(+C(L*E6?:;^3H=%T/D:]1!MW&1%.2TVFA/Q0[VJ3?P = &@
M[SUYMBE38]K 4H_ZCI\92^W)3O$A,IV8*2]9F,?6GNX9;M:4LJ0<K$\FSKT'
MW/?Y W6=&$]!W+:VSC_FDXO&KQ02]SO=F9\,G_?Y.X</4D#\$HGY1R8Z^LB;
MSXR&^,RWK>L.$5#;.)Q55.57=D@F@CZDAM\)^;#8QY;^81#Z//0",%X:;65[
M^BU+KX^X!)7*-S;B3EY 1CQL4/4Q.=R[U#0G'6YZ_+*6,ZOB]]7V)(CLSQI%
MN22-C33EXT0(C#^VIDI]UV.[R Z+N=AH;(U7EC;#%5XR7!/^"<RWJ1I^EF)3
M]F@C0JWI"L#SY^;:*W$9NEH;TV "W11O00P6^<$HMJMJQM[9]9'EXH=>P;WY
MRZG]P5>(OO-P<O5LQCR'T3P?VLSA_:Y65"O ?XDV'7+FXG?&P:9 [_A6SGGD
MI'U]4UGB>>]@E<H0$_;NV./6U6V3J_XZ.\&83P+-Q@9XVV<1MOF6L5\WE]-B
MI"1G!4B4);C(G"/_)NO#C-F HT-FY%X2JM%(K M(X6QA>JMU8EGIQGPFFS(D
M P%6_YI3J]F/4B\(^Q3LF%-$<(0'>P*I[>X^K\Y">"]MWO)!CS)'&_?]N0#<
M[32WJSFD8)%O(Q] B;GB<1R]IPP'Z#LXYO?#/94*+CFN:XJ!&.!LV78G\[.4
MWI\WZLTYPQCNJ!7N2X))#N+:HOXCDCS][#H(_7=<;AYB%P#V.=R*L ??0;VL
M6\72 ?J2A2P;;WY'09T/=#*FY'-TGD_$ 'H.RC-@ULFY]+%UH[JVER'^8$KJ
MU"08*F=?Q+ I82$_TL?"4+,W>CC@*XRK+!XU1DVZK%!K1J8>1?\LA-GHT5)<
MOU9B 3$_IN]O:OGT9WK]0+52M#)DRGUD>?M(*[:=492O6-Y_!4W'A#FUYT4K
MB4)''RMVYG+FU1_V;!IK*H HRR;7I(KHL"V"0UF\K\EO\OVF_[W3T.=9"DU\
MSPY%G;".O>+V]OFT]2?MM/T"(-7I*4%E;VLAU'2[E?(@=#?_L44#,6)J/KOD
M4M.,(M,Y$)G;K!]#:W!)G2F!GW TYB>_L/"VRZ%F +>HO*-]0!ON528;T(I5
M[*1)ZJ]KB=#J(S/];5TT(#J,$U-[*%\E#]!$G^W8MC U^&AC$Z0^4@RWKT?T
M(=60/L5+JHJ?5J>/U,H79/[9:NE[-(6:.H0_.;Q$%.SQJ-"<A_==ZKK>N-M=
MH.8 9'0QCG?=._)JG-DJYC?01!.L5-)^D)L.[[ZR3V0^'^.B6,EK(O /R?!,
MLP%6)14;7?/#EA18'']6C%Q2*<-EXDY=_P$^O4#D&LY/>]KY/D_(]7C6N._G
M)N"![XUB=_6#2XJAOF49O>^JKDJBP7\L1\7QA6.@XU..ZJIO)2_QX_7+#]][
M[&L^=1SZ9$OLM?L_8 U!VZ_4U_K%S5)M@T&:E(<B^&'_E0L ")\TQCU,E^HZ
M-7_F;N2Y>*]L=L<^N6[$O#EY\J@+*OFKX>,K1HF4]DT-!1>7)D\24!$=)V._
M.G4!J,?6B,&B[0SE&"&97W*I)4ZA,YC7BPK1P=.LOA] PAN270V+)#H^-:DF
MN3'K&E7'=!<UC(T$$;ZH%#:B2>_ $9:^UYAF46%\/K>?<;]EUH^C[LXE">X8
M*ZFM;!G-7?*-70[RK^]V/F\VX%7=0&&X"WYC:T)@1X>6AD*T:ZXC$@FC/MX:
M@A#^#)L)!@9OU\QO)SI,Q,\!;#^2Z2(5G-G&EA[^\_;PG% BP=I #TUON#%1
MTBA,NR79E5[_92O6;&Y7Y*''R\[S4%($XD;C/#1KZ<O5K#!C,1@)[X"HIK^#
MOOK2"BT,G$/9_6RHRE2QUQ^:S$E.<KD>&]1SKM4A\UU@(+& 1;F4*_RE$#EE
MDV2>)Z^QP;I792([PL4["^TPKK*"3XPV4Z;DY&G;/M(LY1I$V@LT+1W_;AE%
M%V S%=]*ME?D@K\D+NM3MX8'7LNB-@>/1G5MO51=X@@\AK++?)D5]^H.:W1/
MZA+=&Z_:&N7JJ%BZH1YWUF"- 'B</VP(4AO&OL0??))=R C 70#4#5OAR+[<
MICTS3PNUY!W=X!OAF_J1I<U1G>H].G_<8S%X'6Y^SS%^?%%!W<\X-L!C(MT6
M:*WV@W?%+@S%I2M#R S+D]]BB?/1*VTTW)G^ %3%P=B7FEY 2(YI&1_9PZ.L
M8_):NY(ZC>D<)1?'JVPL7C]*TGCSM%)BW5D- B5&E;C\EA5L$XW/? M+AU)0
M]-Z1/RT7+ER.2* 3.P\+E1OF?HU<0XH%53ZW?%4'N'W#;_4L4Y&4TT;ZW) (
MMZ5NJ"I5#(R(VJ&6VMPV$5WK63&4=EAUN-)%"X5"O 7V5]N[%X?VE4SMBGAB
MM82N-!2O%OS6E>"] %#A_/0?Y>(47RLQ.7 .R]V'KUH^X<5>-T<HE*J0'Q9*
M'?L2]ZF=90.=7G^[_R!BBR.*?$GK,<1'</-I%^%<4I&0?9+IZROBH$UX?*J$
MT+X]A?X-O75) LIS^YXW;^96OI(?"G2<@3'#$K12-XU?U,'-*O2J)K"Q1R2=
MC)R[<J[DJH+<LHJ$F=\*$T;X!S/@QMN/GDC'R+V@[LR;[="-F[ERTO2#2:2G
M)"6QCT&XXNG+-O?&B7$'H5@4^W'H(:?H:H3-E3B#E<=B=,^9*C+MFA=OMU;O
M[[??\$"3S<!W$)'RB"U:N:O$ ^!PLNL" ?HBZ<&3PRD84,WNIO:0<YS:O8&'
ME2BV8<"+^-TK^F#_)!K>1)&7Z#50B8*'Z[W?-9R]LSQIUP9![#034QV"XBZX
MRSL+-/MB.*2B:)(@]^#'4NPEU\C3LZCXVI#>ZQ>(.E[)PSCJC&5% )O4U?J.
M2%#V@U3G%=O%5Y<?.R'BU""#TO>H%K5T*0*LND3], 8+J?#G^I;"+RX "'T5
M2WOK.\$?+5;KB"53'JJLQL==,,4NF?3F\,%?H2S/:AYO11$[W1O4+2V9*B7S
M/)32R$FZK-%?JM5EK-[\M_0)O]*@(UMT:.!\C >C#]6&*YTES-S8L\FX2A19
M/O]5EQCJ7[@]:(.,C#B,U/JK\<SN 0N[>="Y ,HG4BVB5\#"07B?97JJX8\U
M"X,.S['2'7GQA4&>?8&@8F,4(X]ID&H4&7/;WT,;$#U+4\A),M;[MTYON.KJ
M#OOV9'[C"T+7E^5Q;)BS>1\*/5!:F-AF ZX_>#(ALGH[EH1AN;<_+.?N'T39
M>D.5#S-_AIUJH!.XI2D5IBPK&"-\OMIL>98XMR@<1S-5"^2Y\Y81X*=9TQ#I
MUOI)X/$H6Z+&K0 QOS?[!XAO1)\$X[F/RM'_D$D:__H>KZ9&'A(Q&^"T+(>=
M9JZ>OSL#QJ4$4A4G/XZMH]R*/WNU.[MW@W07ZLKW3+:5U2)P$'1FEUA@S54\
MW?2BWVI*=2C-6J#(V\:3XSA;=H)E]I\")@I)A$R.,Y>OLXL0O]\OFM5\ /YM
MM!^0XX2-;L9L48"A?DN5/7@KBZGCG<U/6X/BJ$M17GQ0&U.EX,BMK<3HU;UT
M>,KQCC0,XIT3?*_C%*!QY1+8O]$<HO+6[SL>6UDORXO@YL_L!JM-71=OL=9]
MK+A7P'HXK^,IYUT=8JMUT^K)$R80X>B28\">U+YW.8H'!&;X#5^K( 241U/H
M/8E]YRB\!/,,A1Q7+89V.#X7%R4])_8;>]2U<<O)R6V >.::8T9KFNT(2CPJ
MWV,,F%J!X&.A@]@=WPH,8J!I.GQVK#)@R3AHKKJ >C 6%>VF93$RR:QKFG<!
M^&C,*LANR;A4  HG2N0W9%*UNY<[5GQFO-'W\5K4$FSC5\%YCQ'O['/MO1<B
M)^TORD"@>X)T3ERUBK).C(XL:=CC@_+" J U ]^NB(YGL3N7XW%&PH[@0+4V
MS8?:9!Y\8+=D(UF,7P2)0\7V1F3G$W/7#);IGK\3LOS.$9V%1=/)^^B3TU5;
M"4+FJLD[FX>W!8X2Y0,_1&<FQ80TD9LT"L*'=W5?E[#-]G"798S3(O1=T&EE
MOG]64@LFVJK$U<T'#"TL5F,SP;\Q_$-,A$9RQA<R@Y!_0!Q7<8122[^.;E^>
MW?)::A24VX]4AU/_M*L[RAHG\)I9GI.,*2!ASJ;ALU>#IG"L6\#N%MU)=CW'
M/6ZH!/JPD.>%R)/5+R YI(WMP3I]-UB'QY$SP(E,,3&,;C%RU??I902+N[VR
MYABD<-=Z;5DWFB@<P5-KN/S/*>Q;GOU:C9&\ZE*$2D[6=@2FJ@YY/C!+2]E8
M#M@WU^*-CIF^Y?0DO(H\O%I0> U6E%M1;_#!W-]<Y%YFGL/4^BM7R\!_@,$@
MTAE[D W7#4R"X&:I"P/.=>;##;'NO#VJ+;:9"*GN+N$>Q -?@8%J745>=1<U
MH-KZ!UQ8@U'#U%;WEQT%XG688M-07F+H=9^5]_=0HT"\0C1%W *Q3IIGJN^W
M*UHR-$\M1X4KO6OQ%NJ#K-B8BL2<=@K;AU\\:5&,'@*C=\7TV:@L #->!Z6Y
MO.,)K$FZ(=8+<N6C]!O5DQV1_T 88>Q8Q]&\MAB6W4RU<J3'E%V3&)D[?-UP
MA#\<\_.\2"+AN8P#Y226B!+@<DOY_O<@S/]88O#K_(^M!V5I0H0LG*G)D<:^
M./J_M.=@6_]]-S"B8GZ;Z@7E*6WP(W5#,OG_KSZN_S^7;F]F;>AIA,XE7@//
M'KN::&/^_0VC.DELQZ_6G<F*?_-)P0QD_C]=5%1?'PW3 (_4[[S,KJ?XNTOZ
M2B6T78^4;[!L? $XLYLJ;9;RBN^2["X.8PRH*ZM8N&E0NVZHBK!\G1*O7 <(
MZI98;8;<(RT$06#$DC!"2+8B[>7SE!1">DN;TSF9XJCD>^/$ A8@Y(0N6)[;
M5'[NZ_)/LB?4/FW"&Z"SDL(XOA*;:(=6&-T% .5Z9O]YE'.NXRQ=EZ^(I;QU
M>;@VRJ@_=[#,7J=Q*.4&]#M1!$6PJF10<<U2,=/TZ"_H$^YY<6\3]ZN@E8\K
MXOJ?O5A48?X]4P212;CBN'T?=:*TJ3)K\QS9*W%]>+4Z8\UH*^J=WD*E*#41
M",94UF9VT(\NOE)L9UXX#&,4JO&CQXQ1/ZNH;TBH3V9@9/Z3@FWB\!J'Y/:7
MG]1Z7?Y(2E0M2Z8!P_B&=O)S-9''HT[Y@LF.I3QU_J9BKO-P-3O/KGHF!'KR
MJR4:<TFU \;GQ/QD[XVUM"!E8BI'U1V8>V#C%<\9ZKK;MO':YST"HV[/9T($
MX<_IOD5A"UX0"B2^L(QS^5?]G$:?WL7K-*FX,KH;2#W]X]BS.AH1>TUU(#O2
MZVO-.*WCY)\K<Y6K=5!0HA[&[0+@1W> /QK_FA)%_Y7'=AS_ZY_^25"(*+"]
MV2W@"89>#%W9WF]R]M$OXK5INE?%XA7/G(UH_Y4MGL:CT&;_0,)>)WU9:(F4
M/3"9J3386VXOL$^>DN[:]_*\:I"48^6SX^E=8GE&JPWZ@;10F&,IJW(?2[F(
MN.6RB1JXP7E>?K$+=<@;(/>UTVHJ-Q%3]3J!/L$!2X<"G2/+R5V,YX)X*._<
MRQ%F:2U?  \;Y+4$.S\X#KI!I.TUJQ\?<\2VJ(!D:9<R6L[G-TB8L<&A3\JG
M ?$9[#D?UB!J_W#ECPH\KZF6IC^TO.YE/@J]!Q7*7O\6PV&1%'7:[ETOD;"G
M]LG_;<O#L4<9U[PNQ7!MQ3D1^GIANI"[>GOSUO2RR;<=/Q[@R'"3LC_TW&;3
M?%\5F/9<YF<K9*/*T_D9[O;53X5U=$O7!MF%EWWF-I\OJ)O82LR*CB.Z"AO2
MLWN#OAV=AD!!^,=:-4+,4O>"GGZ0!;D;&WI*Y,DE>6F./#7HX6::MIGM&>3K
M*2&]WYNJ?_/4ALSE-M.9,![L2(W(B&6\ ?.MME@B!>F15+_7-"[H_B+L8G&V
M6]>GFG%X*M9^GA\7 +5SI 33/>LP5<3> =TIE"-S]IE!_Y9@ :TXA'YNYY1W
MUA;A@MA%;8B]Y"==X=,?8![_S"=ZMG'M:+]T-<9RE+Q+4 <]-R7KT^DY_C 9
M@55R332['KI#AP>#5])RY(S?].:\F(G=5OSCJDNE &5;SV&7;-*"K^Z7/%C?
M//O6WY'A0@&;*X%TA$C>SBGO/SV!]4GIFE;9SPK.\?^Q##\=X%B[E9?;T'Z_
MVC3^!0'JPB'#[TL=,M%'D?5#;3\WI8M+$.V7.?>J#7^9*\<18E"EON$<"X<J
M@"BL:K]TTGP#*[AWTW,0U%Q2/O*"3_[6,NS,LV>RVR!HT+YDZ&#GGTL&BR]E
M!8N>Z,[37OM>0@W&++_-.=W3L8_>LKODB[EO_J.]K&RK3BTZ<U?5$T9:^,MQ
MD7G_XKC8^4G-<\7.PS-HSR52+Y2WZFY%'-W]?VE!:ZRB7$RK,UFX!&5CTPEJ
M0NLF]KQ$]0( D3RK*Z_\M[/-C(Y>8UE2'YP*^EG_9VO9$JP2?1KK3'Y)#[["
M2 \Q9;H@V&+?6,K($<O:W[K9O7^M V?71RG0$3N5Y+7H :O<6)]#*@GP*O'5
M=<%=40+FF'Z#Z"8Q^ &6<<^U(5<"<JPT7X[C\%'2% %1\J4[T>RA+3_ZN4!Y
MY,*J<UN05(RWU8[@SE)&"&*<KUU&^@6 ?:7,0=]RQH"EEGK]G6C:<+QP(XC;
MD9O7=V82;;)S4)0U[-\JL1>@VB6,QJX;B ;Q/6:>'ZYWU&!(#N)T1"K\_ ,$
MXQ/$4-(O1ZM&4W^*9@/O&Z)>/[!2#HJR9AD=E>#%L-2UG C>'!DIR,X$]]<.
M6XQ8/PRJ#UO]CC\: _FI.2HN<(]NVNSMGKT%#G]]V<O[7C57M4) Q_'E]%:;
M"4P'C3 8\F0=XR_@_>',2G5%9"UG] 3S@J&ZN!*8-)6>TW, >B>=.:LHSS+"
M"E/T=-F-J1AET0=1C+23.DN3'H;KR_[NYHOI\!NO27Q:&T+:_J?+Y(OKB.09
M9'?[_OJ(0>\E_U5K@?AE7 ""#7[[RXE/.534]84 W$!DR(_KO1CY^10A07-,
M7LPQ(G":,YTA-HJ<-(:PTZ1(%BAU;-F5F:YCS,AA)*[9QXQSLPUQ4[DU+CE@
MOXA=V<:#:2"I9]ES)*F]$B<6B5#FK[)?5RMOJ_+@9'R2(%!$88K@W$8KWZLM
MT'D"PJ/6_GO_N6D45Z/P<=CYG4%"4GA>$_+Q$_\:?!V%Y&>>_?+$<[;S(=U:
M".;@6>N7P*8X%T37JMKQZIG=+%UG[E"P@[+MB-M,Z*8[#O@(F1H9;)O(D?2A
M@^:<YC+A2NFW"(^S#INE_S87@\(F#P_+X'*$_(2L-9X^/J?Z9.DJ4Y3(B^_7
M8=1N)&2:!%N3_O-XB]>8Y1??KTW7E>=$"ZA1]I%YH;MQVJ2YCX2'0>IUZ&M'
M-7/GJ,.X(+>F0DZ^0W@+E&,V@.;TG1\#WD I_MOLF"QVY#F9%PD3-NOC+/N[
MGW=:8IVZ;N&\N:<,_5[2MJ;F*[F$KBWZQ[.*:#K%A&(/D()9!O!^R0<P'PX/
MOR]C[FG/K\S#6\XNYY[1A>CQ86T5Q)U\/5FML1_PIW0AV*YA[.MNT*XR)8T0
MRCZ!?-HZQR2<#2\ Q))V#XME"_BP*9B@4I6W4U9E:N>4Q1G^9CHJ@:R>N%^:
M;MX1*^WQH]M;?MKU-_'4/KYN1/G0:HFI=&YR$PZN+QQ@VC_8T*2D PI"_L2?
MV9L4CZJ]"ZBX%Y/T8?39J /BSPQUS- HN8L<L9 ;(9=T(U=E1:3=B0QTY0)P
MISTVA/B1IXO=CR.DMDD_<.V>P2\!AOD/![@#T!TZ[(B%C$FBJOO(Z6%9B7((
M@]9\LU%J"14%3PHA74TCY0*@:?#%I013</AV_Z L!:-GD,JWM\E2V.5WQI'H
M\8)VKFNHZ.:F>TY3RBN!HP@L'5"(\928)!CD#@S/_/#S/OD/)]?#0XAYGAN?
M7;R14IV@(+,P4^N=IKEG3?5(FNGS#SQ#4)YU<"E_J1HR?!9:/+CBF:CPJ/)>
MW4SK:K-.)'BVV.6[-#Y&8ALS7N?GHY^+[\&#YRWCY#^%H/Z\4KIG6<>.$1VK
MLRVC2ZY,CX&6Y(ZP65BN>D&\]\NX!V^+)\!%@&>0C7U:Y3O?]T9(NH_6)^T\
M9'4G-O@GKV@S,5P QHRNPW"8-8Z,$01\_F^17E?J%@?MS:9)IEO01^KZ7_^[
M.BGH..712;JXPPD(=GM3-Q5^LJ>P8$]R"0?=M*.BE3BS'"\RS&_=?'O#_LWC
M ,^^'C,&]YX>@4DE33J0*CN#:[&MNY2HXYW/GV1!:K \U^WOR$XL]05 F^&^
MY+7]<NG6D<'Q*T<@'Y+?N&%LI%YO(;89PK\8HR^_8E'AUT%3VJGMPXB=*IE3
MY <IJ0;':)HSGM,>[".8-/W<FOT"D/U&MNZS1KY5$EY++]NV,Z4-5./C%1[2
MA[,E8WRJM#\-2XNPX^:E1ZZ-UV=2XJ[.[0U*U7K3=8D]P&LCY:<UJGDD>Q\7
M!/RY "BB?YLG<HBPQ(\$H8J*"V1ZA*LM<*S;[OGT6 /[H,-O>Y3BI-KQFO+R
M[Q4IMWGY!(?5F 9<'ZN'/[E[ >!ZM"2T '[+G9<31GM^SO^+@+D;2$KI\K!^
M;&]C?R?"VM;>_F;1DWJ-+!8@#^T6SQE[01C2,E9\[1^;D5KC.J9HEW-:S!:_
M7TFDB,2:PP.4(VIDKNRV\;CM<GP8@Q/9.A&OU\L;LS:D **KSSGZ;.\"6D+=
M?W+\(>/T@/4"X''N"?=D6LDKY?\=8N_)^))<5LBZ0#6D?IL21]6S.BWJ$ ;H
MZQ;?.Q<8MPU@<Y085_(T20[\X+Y!5H!TI!=XC@B:D@%U[SLC#>TT#&3)_;]
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M3)#,KFR/6<L^&A7%V"P*NU0@YY'W3[[3MSN(JNF^Y>ZPFX)!IWI;[2=(Y.-
MHA$S]2><R@G$OU!LM<HO8A4[1A;L;^MN;NNZ_&N7A\'D[J&2%\O)V)SQT2Z#
MWH&XBL?J4<Z'"\")T'&G]AU^MC2+>=Z9(W\5!Q61PJ'H!9!NUNH<5PB4PN^5
MD*7R=V:RBL/R[P&T=C0-(4'Y22+^,OBSC@L _=[XB!GA1O$Q80<5;$G').=B
MW[ C%)I=Z:=G>OS6$BUU-C3AIZU>L#%3;S0TPIZI%RVJKAMGW:+_2P)U2_/K
M1&MO[NK68F;.)%=-YIT<ZR4-WP-J\QZQNNPUTE%!;:R67+UO@:]!A4[ (/3E
MKIJB2*A96NPF75: "<+P1,3I'M R)YFBT[*[0 Z8E.9=\HP^ON?4SK#AMER1
MX9T4\JTBEM Z:JN7@W+4W#(OXZ:RR"G]=9:K?>E*3VSV N'#-0A3L7_*;+NG
M'O"78O(\2?(G]9>3C",9^3F$4=<@MSV1[N_+OF*T+(=TX8@[$H;.<W@]2YU9
M4#;1AD<!\TR,:9J2FU7#(F4>:='\=]6<&L(W5"%FB<D\S/H#  L[KTB)6YN&
M7?F!>H7K%P!<63;I[>.@B&4DYU[\N4_9%!N52+34U5<28^@Y*C<R5>2PB3"[
M'/+C;*$=T39-PVGE4018U4\'NDKZ3:DXE2*A:L^. \Y9-9KUTS<V\FW=EZ_;
MU#IMCM#R$"AX1I&.HWQIG>>4:]H;A8+_8-YGKW9@-::#Z$1VB-UQCO/:+V[P
MB]ATL.:4L*A4G ^0CM>8?>AI]R3@[?KQ2NDQ2XQ(X=3O*DOW%%4>OQBN/K<L
MS7_(%+T3M;^<1#34=+SISK8!,FKOT37.H08SD?!/^1@/@=9P[[L>Y+)O3TKX
MO$WQ)@+^;ZP)Y%8_8[J<@LI5-C?73;X'O*Y3$6H_Y'*G3+\M.UOO35DWU_*K
MA84P%IT4NHW1')ED(:NVE+,T64 5;1L27]:<E4P7=4:7JR5-G-56E-OOA!K\
M7K6*@<6/F$%@+5"[FJ*%U+"-_-AIWNOFOR% R+I'*]UM?H^6N-5!_&[H3 "!
M24A#9E&^2<I%GVM.N"*H'D"6[Y<)7O?Q%R]REZKV#Q:WXA;(1$94OI%XB%>A
M0!R\@AS7G0H]V>#8H+R+:$H15W#P9<]7;?8J@YPLMKCN7 !"N1[KQ.P*_ZKX
M2/$(Y@-4)+UH$Q75GPQ/J*6[Z;4Z^FK_()MG.3\>M,%R,%%@?'>VXC=G #B8
MB5V2<ZN;VDN>TLXY4<Y.=_1PP?M1[^(3RN9[%"(ESYCWLZD,:'.^>;W$U@@7
MD0WHM/1M*AU J]VOA9LX'5P_6-=XAHW5+'U"4#V1[&<W#,DQ>WDL<BUM/+HR
M\=IP=LS, 35D5K#PNHZ;I5Z%-1#A 0:;NVSKT_S.5-8YR+R-_;O3VM#S>=:8
MBIWSNIT;V26?UO:"O-O41N7#$MP:M& >WI=)3]<\%U7K!$,K[MI5-3.XU"Q3
M/Q?D"2[037-Z]+<7^W_ZL/]7?=B3;[0^N:HZ8&.0QOI>66CCT=]TI"A3,_--
M0\2AS@5  CED]Y F+ HCY)MA7YD80O7&&;-]F:<S[%-:PK:<$1ZUO0;"?W/O
MG0-QB\-RC53AY:P0PM(N!S.)MU)7BM-GI:HLZ]ZHKH,^VM')8F,&218G33]D
M#VU^E6G-5J/<U9.,N&TEKJ5&-I!FA00_W,^U5\=0^W=,)K?H<20"\][LS'OO
M(UB<?YO%;WQ/H\[Y]@Q1+]TW/ZII\6OGANW95XJQJ],A#@\R?V6^<9M-<^YX
M?0M\U-[N-CES_4K%GH1D2T$1V0F20).Z,!E [U,GN][R6Z&6\[:&^,^-G&S=
M*1/:4]O\([GV88,90X'F/G/RP*KVK'-J4.IXRQ-";<<2@2E_+)C&9CI<JV:E
MS4E5KFC 7'TD4C-^C/%;L+']Y#M1B8*&*1Q8I]S^8:28!6?.888&10Y&@IB$
ML*UIT9>/DH,)*T/@4L;>EV-E."8NG9N7ILYI";CY\0(@="=G%++2./#BUZ$7
M^=[,O(J;WJI%Z%-HZ O,?KF.0(*=Q#XEFOV#C^BN>U&M=-3.:K GT^...<^,
M'4I#I_,%IG^( L3:=I&M,O[QO='XF2]0D_$F/X7:J\YO7L[O'PC@,ZX1!!!-
MA$GYJ\FTW&\E-X%JD+Z)$W8ON6%3GB\(DRFMA!03W]EO9T77139UIV99WW:[
M%<1VWG7@P5#W#2#@Q>I-6ID:28G05]J4>8:"V&LW,[ALW>\F@I1;.;=$'A%5
MFHN/:R\ 5E^F3]3[M9/>%:,:TS1\K?,,]>0W-1"9;K;N5XUZ>Q[L#Q@AX2MD
MCY9J)!*\[OI_3!GHKHZDJ3CM,ZCAV;^<7 GIUK<<Z">JPI:N#->SRZ]]]A3<
M>$1R_]MHV"H#_R*)AJQLF'($8DY3\-7?( _.(9AX_;7!)8\'9T.JN5+!CY"K
M3'_]P_X[D]J4@6"V=.VR)8ZV_>]WO%7VA/+,C?P[2W0<*E-033HZ F/71!C/
M<%1JU*&>5\I2%OGTA3Y$;$?%>+G5?D@_*CT)ZUV-PDAY.M?#&<?H.-$O$%Y=
M<APQ^8R))Z&*I5PJ3LVMR+?CC;[43186B^;(HM48VQ+[:FO&\7:PGP;TZUZL
M]J#:JZCQDT:SG),W XX"&=AUE1, L6 P*"'9#&@G&PB7 F>CYM)J)(7*R8XU
M5M_F6'NYIY2V*PQO.4V.\MOT7P&YY%X %(^<L?-=7 8:&">NIS4>$2)T_LMR
MC#>_>,ZON9M(^VL19N?2%V_O3X\<V#/U!^9XB84<&K]%?_3S*@<2NI(69J75
M^!PTAN'$C ^#\N:9]1G$QOSENS]Q/M1[ G=:>O/$<E8YO%H)-W\DD5MR\B4=
M5QVZ8C(524+M$I0U)XS.O*Q;[N<_;H+4"LN4E(8\*"DF??OGS%O[LW*8"X:@
M] TF-_!)X-5OOU_*:]*V,Y\THURU@[*+)*%SRCM\#N\);YIO]-&N>3A:W\OK
ML"N^NIH=&#B,#"ENH,_M2TLS/R;!%;MKZF[:&JNE?[TVH$MX5.O=8"MXT#VG
MU[WDI;EMG%/9I%'Q9T%;6SB/0V*U[ BX^#J]@GOB6.4?VLQ#J '>N,"NQ"-;
M?G"?:&R_3'D-EU3+GIBD@[_K?(O)X,617/EX<S9FD0O]V3EG."^8^PIZFRD5
M)'0I[2!-QZA4+6B+262:Z4L=/T^04*_$U^VJFP,6MN?B0\3;XY1O<E>/WM6(
M/CR;ES)Z[Q7)IB@H-UQOA*W??Y @FGD]"NNXKG"@"?[47]3%IW;R<O^,W7>H
M_'EU?53-&*=7*WB4YMKI8JX!W_IID7ODUWXE#;& !#,&$W6P^N0)C#V%PR25
MMM"=ZWVYLWV4JX&@5T%0C.T/_5T.LRF,_9V5M,&PMI3QF1T>(R>X??7??) 0
M:^U :;?.^90=0'9*,/94L/&48:")>/"VQ!,\1753H41@%:3?<)G.8J7^TVSI
M-_[?3]FP5<.^[UNP1IO\^T;/O\?]_7M3J9'>/):/7'+GB[H,]2^/_XN]]XQJ
M:FV[1G&C8@-40)"J@B @($B'@,*F"Z'W(B"]28= "$JO$1!06D1ZC900.DH+
MTD(-O?>>0$AH@<-^WG/..,_>X_W.G^_/\XWWQSU&1M:/M=:]QIKWG.NZ[CG#
M_N:R1+KQMX0-\WRS,VLH_1DG..G?C99D_IZN01<DZJVT\%J!5E_A7Q_W].O=
MD62C$>(Z1L."MB):TW=..P&\L!%ZW 79$R3\\^$?/W9I*];2MO.MV=,:0G>L
MHU'UP?M.^8VA;V.M*OD?;Z7A'[.G*:_EQW[R*SW^_GPZ>IT3,:/'4?6XWD#7
M9GQMY<4[!(KSBTM3B:V:YDRQ;.5JC8Z0N^!Y3PJS)N;,FBW/"5&T$>U0#=BL
M"^NV(L%6+]=Q/21*=>STQB;D4\[VDW@O?GT;?PKAT1I;5S^MWR)PPKTQD1 <
MU?[::VSCF(\RQV?NF20DN37S(>O'M.29J-3=Q16GK"NG6H':3=B:-*\9&7*/
MRO*Q9['CW=T%NS_P+"6+??+MH/CZCQ-GG:P1[GB9@J'F$APD4KC,XV'^*)U=
M'1.2O>@M%4-6<4"2N=8E#;J^GK^IMF%:&F@I71$?"O%)!M$4#H562S/8ZI(V
M] J*QY,6(L)F U[33<?KG":*L9CBV3?,86P1+L[.Y\HY;]Z=%5/@X=))G0].
MP/L*^4]JMG'=!/2W0Y%U&7#K5"L_E1CS(=H#X#32UGHOX@D&U6G+.NOMO[R=
M5Q:39J2F8,<>MAS$4-[R"W(OBT_YSXZX:LL/:Q^"R<Z?@PS8."*V\YY$F4U(
MD7BSL*3./+NROJN8BLBG_+Z[#YF7?0EE-AR8R*G;DA4QGY^ZL6_%<>DBQV@!
M5==9L*\/\5P#F'3C"[*J$X/H#1GV1BRMJMZUGT$?%=GSP=2G>G,;LG1\'"$^
MV?>G8 1?UC52THYYX() )7A9\+U[1/70^F;8UW5%[OR[!0RKF?F;F,D17KX2
M6]'U]V#H>X""8WF:: 07U\-UWLSN24.\OU=C)NE.MJNA#F7=C(F:[<M8" ]E
M\,8YK6?V_M?;CGX=;VJ:0]*&U0"U2[+);VK\=LZ*_=L^]\4/1I@G!S&99^@5
MEBG1>?#**(&Z=82U'B-JI.K=34[ -</#9ZLEDY/ZL^F.MYG_8FZ)N?U?%#NS
MDISJ(MC6HK>>6]Y&LJWE63D0\E0_0=!T@T:M!A0B*WH)P[1FQL;/RG7>_X^Q
MZ#^-1:]W31F(Z"\0GRV).+[^+*+QNLZ/64_)_:%OZ:U[A@8Q(ZM(./MTHZ<1
MO?ZV09[/JVXE@#^]CB%2,^JE&:"OY:IO:5TID&MLLL&2EWG(0*)NIT,KD4S=
M*]&(#3A4+)-E@CPH3W[):L)PWS@><0_YLPSS W#)]_,A=FP'::.ZBH%-;QX@
M'_:QF]R:DO3CNYSA.,H"MC9<,2%T_XNLW=HD]-&)_N9&:5L\3/Z-$TL!R\;I
MZWTOP:!^DU@],^/=.7F$&$W-X-3'@ ]3,H@A<.R'C*#P2FF=!06<(I2O@NFA
M^\?7LNW4UCMR1>7?DR7VF^676V*;&2$Q](J*QUH@WTV:&4B=A=CD&6\F8LF5
MGJ@\OBDE(]MD/K4(#C#"\E>(Y)V]N>LRL;]S?A<X:T$(\TRE9XR/RYO>%'IL
MR;G&8&K-VW!:NV-&$\:L -,-_-ANO=ZOZ0:.8:6K@O[<67GYMA;E.48^=XJ8
MA#B4K=0[G_-#$O#PK/3.84?S1\B 7,L_NNO6Q>?P+%%PAT'O'CY7*?M2IM5X
M$7VF$$_D.$QUIW714JO>&>OYO#F/GA'A[>;CA9WB*]^X_1;,*Z" ^<88D;H&
MR7WG? PTI=F(?@=J*B D5-=E6E^0^0>?,Y] '4UD*3<,& \1';GK![G!.Y2)
M?A=D?H3K-<G*M5^T\H;R#L>)LA'G/#)R'9<'GN R IYMRR V4H1,'&]0-NR=
MW< ?GHQ]L)"305$V<E&&38/FYT.T?\$=6>F')[ZY_^Q_#P#\PI>K#*M;6&]E
MQ_OI,7I[V[4 OL9FQ.KHWY^ 2V/9.E1$ "+Z?JS^FI9?50][0-2.>&JJH\2I
M=N!*>[X8WI9B;'C#-#'V.WR 4&BUKI_*,_W514,B'U'1[^1?7:,SAA=NF>C;
M.&'LF61I;%:D^"1/Q=/=]K/,L@"VR'"V<4$VL8P_5RR8?+S_4D@<(%'R8S)<
M!N$!D,;*9I?=\-JGOB SQ'@4QL3>PM3D#"&V=TZM4C _=QG.$14N5HKBY]Z_
MN7/R!2NLU1'2$)CQ)G[\#$%^1BSMDQES.S[!''X/0]&MCB;WA\;H:BEX,H;]
M'Q $3$<;K%(;H%N-$C\.&"87U4("-L,Z6KXX:;^;!*OK)US9,5&(7-OC\\%O
M&24:[[+PYF6-(#F+U)T2$CJ\6LWN/&5%\8E\LO(K]C!,WN0M3.G=%2_>L<E2
M]^+^.E77JV+9Z:X9H_$M>C.W:K;V]MEF184"NU=TQ& \SZA:PN_=F8PMPYTU
M$<;)6*_RZ(  KY5==H7#Y[*=M3@<^6LS]>VL70X>Y5G;-VSI;+-EM+D$3O-N
M20U]F]&*:;^'!34IJLNQU =[AN=\1]D+Z-L;-*HB-VR_YK@4)Z$R=JPDD85P
M+BRTLRA_C+^\W*)_>%(>H9=S]8X@\X?=IBU[Q=Q#)2IV.GFJI8=-:&>3NS//
MSM%<\:%Z]LV<?GK61N]&^0:0V(>+:%-($++:10[5[I_8NBCQR<.GULU"#DQI
MM?8L?U**_GE!#TU[B[U;Z%V_I=;*6>X)O@Q;.7^)">:(TZ7349Q,:EZ?^^)-
MX=]4ZV4K@CYLWJTG%V3&IV-+D Y*L;9ZL]GH;VAO(>D_.:(Z5Q(D[0 *@6W?
MCFP?--:/L& XDR??,DDLAZ.,\>]'\G1F[7KLQ*,-O=^1EMIE>!UD)VAX2BPI
M6 !)<[,5@>1+&]6&K+-S:[:H;^N&1)TM"XLCL?EX&,Y$UZLV2T1!MJ-EL*6^
M[31YQYR&! U\O#!Q6XWA:X2W PI.$B&6.[\9?2Z7X54Q&MQ:VG8]V\A^$&<S
M%S6F/LC>X'98BGI_XDH@%/$%O3!1RE<D.ZZE@!,AT^5(0A$V#MK6I#^>2_DT
ML[U!M'Q>D5T.E+09,$8_;\)VYRB\_5E4BF:=C1!S//T@::O)BH101_/4Z"A1
M4L_F'Z[[9EW#E#7^V>)X6GL<H8/N!E.4>9T::'TM2%]-K=B88FE._C6S-0G\
M^+P;=;NK9,)B:@9*=+)HE>&):(];:Y6N9OGZX1R[@R^/[.<W18KSZ*3G]:B*
M?M#125OZ<RQ'Z@63K*C2.S8+8X(+FWE]36-%'.>!])A6W#?O0%" 0=(13)M>
MK"N)G/'.6:_[N('%@MM=XW506.;!X\;X!U>?.U]9:(, ,7F'BM53(2&N,^A\
MKP:E=&"XRO6'G]D&]/*&SOI?H8]/QK[(GRJ8*$D[3P+&$LDTI3L.3T#Z7-$R
M8L!B]=4-;--GM=_W:0'H4ZZ1(+T5#XWMTVNQK1/&2C7\:=UU[']U;PTALL0[
M>5>F8),?UXR;&5URM1672O.^L^?O[9[>,Z^8A\6+_FA]-)+]J>4,/QLM64$@
M%*ZD"@A"3++177B G!1KAMX7/*EOF&UMR[B&)Q6C9=K9TI @3SY6V&<4W]XU
M)R!>;J"Y%VN"4>WJ^]A^G:Z$\HNKU.B74E5<+%LG7-XN"Z0O!//48VU[OO/Y
MQ?7ZV^)R/UAX96;GG/3[2@."K"3*5;I7-PPK<^P[:/GH>@W_M:?A[ZXX>,F_
M6<X:ZQP-"AT9'8S](R1P"?*W'6_Z8D>];=1G''^QI<S'?_/%:9'[I]]L42J$
M8:GC@NPF[-W9W]QQJ/_-;_::15RFUM%?\=4)EUI'D]R,D&%]R6DDQ1RK=Y!I
MT394=<5R0N7TD#^J^,L4IXEE1?0/BW7D6Q!N]%8VUE^S*-M''Y:B).B&IXT.
M]W1SJU B8P_9*6B^I*&*Z PGDK)X"Q)[1_@<:1[%IHUJM(ODQ>N5$I#"X:A:
MAO)H=6GKYW)0D (B;.EYDF*7Y*=1QVRA@F(E(0Q,3'H 8UG188B[WI3GYS/7
ME[7+*=$Y^"1D(&MG1[<TT'-AJD2L'JPX^U2/HT2=U8_L4BI7:R>-A*_/=ANG
MY SUYH0M76+X6&'>,"&+M[41B/N^N=0QAMUXR3OQ^N639,$:7.R[N]3O \9*
MC]P6P\/ N26SYDHN8A)&G+%LC9!)E@ICU9<?F^(9Q>OI2KICS0LGS:0DT,<D
M1]ZF>P+/7;,_NZH\\49IY+ B9-*7YJB<?.4F>[0^.O@MV,;59U#%.QF8-=8,
MX+^ZN69PR!@]CKD"^YRU-L"(SE)3]&D=I4F5/TA=(K81L7/Q_(PTIR5%7W8N
MK]\(8'AB(+%(?;TF<X&0;'$%W#)%/C;;%+)47N2RZ'8?_'V,F/ <YF\HIO2)
M(!.J![]S=._,>\4!2RW!T6\F?U<PY9R-Z#1:0#L_#8WN&'6C9] T,)#A0HZT
M5+EBP&=P9 T L#4M3;$4)?WFX:[XGY35N'&H FM^<^=0BR6,RC",OE))RG=B
M#6IQX@A04,(%$$ #TESS4;O"7QKS/[#*]Q:(JS UP%Z;VSYH:---TB "MFU-
MF+UY?P?,/-ROGJ-Y-.A]/2QB1IP"9@KQ.C&07[!@,?9KTWZ0N\U@W9 T *D'
M.*&%U3+I=7#J'<FDQLA!U=^US5?:/I 6-IT&RKP ;$!8?Z4IF2 QZO+!_2&R
M(=>X)3Q\S":A0Q[1IO%BQ55M5XI2WE1M*RPJ7I\5%DDQ5.C(&#VGTOH.')0U
M.PJ4'RU;31C=X6"1^$TL./XXN]1[NT96#EPRE#%B[9V;<'(=F*+;8=#,&9;]
MU*DYPC+;R=/!YSB*,/^._\JVU-)DT]R"Z9@D(?9@FDK1??BT,, :T^PR[/:H
MKC[^[<_01\E=OW]18)IT%(X6Z"-*K:HBWM1:?>-^NQ423/$>S-M=INU-5U:T
MLRCNFO* QU"\X21KBI2X+TO^%W*-)&R\B?O8 K\@,V]T,R1]@VE7QP\-=3N9
MI#P\X'C'7K&!'#_W[O +(7RKQ?+5AF\^%,AW6PS+8?EUOI=#W5W'S*/8=RCC
M49K,V*)?6L8!%GL:C]GHD^2E.H*G-Y+C,">G6L@1@7MI([4SK)K,'@69.4/-
MF5AXY/,S@P(%;^<\^6=/U?X D8]?D%7S\'"19\4_R73J9/K^],=:GDDXZH/Q
MG WE_@=H?VF;E35SO"SCLC?U:\4>L^X'!/-1N(U]=A'.A-#I2&KZ*D=I*9'6
M^;1'^4]'1,7]'3V94;E9]E\HNN\P+P/:S+[ML._1O(+_8W?[ORJS<,"\1E5H
M.],53%QU1]13S3.&-5I?<L0732O4:2@X5-OE"SE*\/TR99P0,I;X728O*%[\
MTOAL+9XW+Z573^*Y&LV&V3V8IQA->F(O4KRPN:WVO:#9G<F :_T4:YJW'TS%
M4O?7$%)&NC57)<8JCBN@0]#M_9+$EH)+&E7NEZX9TEK/,EL2D'"MT8W=A2F>
M3HU5)MJIHQ3B#+WB2#-M=)S:'*@Q"$$ED+]_Y(TN*GNT(A":5AGZ/!?4F.9N
M\:5\<%-1-H_'H4S\6+?RE/H<X><;*^L08SM,&(^ZFI7/:;ZU?GF>>5=9E]"!
MG;X*(\:U\]JZO:QF^VTG;PTP4,16F >8")#,VEALB9IT"T%$XC<^-C3W?J)=
M\AV-*,CS3A-(6E1C@+N$Z[]BN!(_SSIQ2(<ME:7-PV%^3(81%H]-7:\NN9)M
MHF:;F!1(WT6H;T[FY1571WZ[UN7L17X.HMZ-WLFB*^2BZ<M)5S3\*F?"OJ4_
MI%I^ZV!7]F1D?/O!LXENK& 6[^K<G?.AM([5RD3'FS5]2#M[#]!]\0/J0(-J
MOZG%F@2[><R(\+%9C,_^%[;#Z.99TE:\;G$'_.5H3FRVEDJG"1O/^9 Y6T3[
M['.+BJNM:T^D(6CQIBMXD=XM\_NUHXVRI*_,1E]3WU[1\)?+01;A2]* D6SM
MH%QB8E=_D"G%[_/[4DD;9J(A92B'Q1BUGO:^-$FW*YZ#OZ3MAD7VY-(*5&IA
ML,4*"V,4O]E]N_B-E@I8C#?AX+&1I1'3HP2A)7% M@QBW:>E$E.'+6B+@WCR
M]KQTL97*=0:/[MTG6EO8^ODNRH9-M>%,7[UQ3(@;KWF$#2;0P9:@#]:S!+"L
MWS]I="3G*!P\L;P@X[M[PCIZD#&4QQ_ EBVIRZNYG-Z$[@L?ADLKP*4'9OW=
M4']HRX:P5&V8A\Q?D%W;#&(;66JHK^=CS$C<%V3^0ZKP$"Y:ASU'+&2^WL4X
M=XYW3D#S)=VWS)O<6:M*UY_RO=/<AAX\?*B\3$0C0,(\$@H'?,"L3J74%-JT
ME?&-[)&[;WKY[UO78N$-+1@$7#H]CE'IRULZ&=@,$4Z&W2TKMF_F%S4X$ [^
M_5&ZT_W\!]7:^%C%G-.]Z8V86REW=(;96A5 NCP!>GM\4,E\,V,]JV]U62?W
MCYYLNHBJ#=]*HI'M^;61@C\9JS]CAVI45HKY(C^A!,\?/M4$U:Z#*RS$'"3/
M)GE?I+VPHBA\>/C7MA3@6'RAK\GLM!QLQL"&Y32(+G:X.$.[(H_G4L@\U6N3
MWVRY[S>L.N"LO[=S=]K52E1Q'14,? -5[:@Z^O6MQ]DF2[FL._8#NV)3U<S6
M6OJ,W*JX[[19GS1O_P2'+0N >LE<?FF/WG33.%<_S6NHE?S:8Z-/X%46:"U<
MQLO_20#>\Z:!;W2ES,Q0D*#])*:,("RXPU>MLF^]=R5C3P:Q\>"'R8P"TZ\G
MJJ7?SG)99T>QZ \[(K=9.)DBW&873/P\3':+M@[I\!8_@<R T>&)35]*Q(MB
M$T^O^P&PUSKZH3G7.$*HOP2HEG^&VD'?D&?^"Q'RHU&K&QU.2JYVOR+#@>;)
M+L*'YA3&!RSRZ[02?".]R)K)MA42K_GDM,O5>(?!<>:U/\H[K@_PWM18C;H_
MU4KWBJ[@3I#Q8M%4IR^U:G.N=4C:2D)AM9;"JW]E7OU[W:VA_F\1+IC4?YE#
M0B'_2&>9%_AG;6ZW5S;:8P$2?@F@_A%O_W)^0$)/RJ1(EWA#6/RO>L#_1_7[
MSK?$QCLK82=V8'^ONR6<_SW%Q?1R>8X1T'<"SD._7V+_#^%_+0#QKP]L<W-Y
M#VR#'WO?OX,7N3^Y?* ?:[VA$D\E&:(N]&8M(BGMHYJ-I7'EZSKPYO6JH$;K
M+6/N*]&8["J48\2VTP"FHN:XB!%]4.:/YTI959V(&R=OR0NL.GWKM]0A0S[B
MTO*#T7[19:KFX:L-:B(#Q+]DZ[#JT4<*<?@?I#(.['0096W:88A%^4S([QF,
M\NLUMWRIT<'D_ 2T\?GO\>,<I:..Q3X==<[533E@;N(%F=])RP\X-PX(1?#Z
MVR;SYYL$JW0E5&4!B568>A8V_1 @-G7*UCG@&M>Y\3V24UA-34B["M_R<JE+
MXG6 _T;(EH5QD;P:6QK8,;> !T%X@V+EP''%<+2/&0#O(_V?LK-%R<Z6+[6=
MY/4G%#"L)E1T>FCXD?F*0'Z>T\?KI78K][YB-;R<9&J$K"'V('>(7T^3IA-\
MGCRL$9/W8&+)ZJ5 J8'*=FQ;\6_*Q9A,56TF<0MI NO:ACD:BUP<17W<K5&1
M4G>=OMMO4G5!5D.A#Z>]( N];]*K:F?]Z+0N"2H_60^@;R/6C)_J\$)^'FS]
MY9%FK:(B\K1N?00EZ:E7I#M*T8&^.[,U*R+YO:&I.G'-5H5<J,'K-PMUF45%
MO9C^/7_+#^-7?A+*?0U'+,VL>"4,?)C)]]>.(LL3P6ZJ6$Q:5;>A0&K&C8,S
MB6U "<A1^/L,7HE3<*2]FW\L21)*?I2C@P5CTP:4=0]O-PQ&6,DV.HW2$Z+3
M7!0Y9U9^UAV0WY>-@!X[;)FSS$.B)%EP6;;3&PG! S0S8>\K_0A]WKQPQ(-H
MZB168S:-@),Q.D>O+7XO),"94X!)3BC/R2,3OG,-=UOE**=(R?E':9:.JWIQ
M1!(CG)C6N/<SB"6FC3BL;/T>VG#KU:XN_B>^P+[$&ES"-TW6G>&Q"5!"(GPP
MGD8*@5 A*QF*&]2@0DO+GEZD:+NM1Q$7L [8;BR:'O#=M.?YG7?/.EXKG&^P
M(YL\6VYZ-?0$^%PS%UG:N\XR-]E$KC=2'?5)\<H^85^Z!8[0JL+@=V2F8[PG
M\% 64C/B5G3L\+;=X5=)UNZIQ,T3(<>W>\EZJ)RW! *A-%VQ=LB-_</R#*O2
MK/4T)O;Q;I58A@'@.G HK=YN:O>!D>G9)>!2#R$,5EU"'952AL6:1Y#WVK/I
MF6TJ2$XT'6/:"N\&)@*',NOV]P,.AC=,>&U;^U+N_31UY<I*AA8HK3I"[Y&V
MSN8@"9CD.AVZ!]G^Y1%,V+U6#\["8;.2ZX=O(?5MM2<&A9OZ3V2LP3FD)'QY
MB-*@5U+^5[/&!IC":]*B;,/&GI&8<2#R:_0$4AGDZDQM7-O*PUPI6!:9#"I6
M/A%8$.B,XS*NJ!ZT\8KW&V6?7J%X%36#]MPP'W5Q8XCC"$M1>$NU\%'BQ* ;
M=O."S.:2TSE,]N67%(*SF$2Y'PF:?9Q28_="?1,Y[$S/O3R^\<-D5TCR2=%S
MSRY- *!D>:N;&?V)Q$2QDW&_7+%FZHN8:I;XF#AJP^!Q]7,95QZ;"CVB2-?*
M-#Y1S:I1<\738"0P9T/=4&XD.=WWKQ13Y=;_R*C ZP\+J;6E=/$S(1F'^=?L
M(CP#='5,=G8Z3-^RL\^F*!,%S!V3GN9PEW5.%O$54N0Y(4I YXBKF!70:/[U
M-RG6(9,Y3G0<[N<0GM%30<L=-98H9^B6L2>>/64RRP;G[BW%=F=ZVN%U:!0R
M>6YF $*]9'';3VEI+;[\4*7L77UZEW;P;F)0*,U??9GXF(XYZQILWWP33T7F
MU^<-+7%@*"+(?/TD!<85QS]?O?A"AR-_[M@6>#26]R&Q2$;?SZA#];-]?351
M$L84*(?A7^+S]A2=AJ"54#@0$M,88G04![_9EY=WB$I]W#F:IK$<WX<OC^DT
M?_;Q@LS@O#N&8W?2Q(&MO6?L@JQ,M_J2_4^4Y[FE''!:M?C](<%.@AD32;$V
MN<!(0V0X% ",2CPRT!SQPM/3\^\.G;5W]0(A.GLF8B>COW2X1U@92%<[E"RW
MC(U3PV>>$\(4?C+\NES]@\]IDO2K[@':'NTA<',R$4/U3@JYB=*-#P15JXN[
M]>N&_*@[U'/GE (<P+R5E2F]$U>OHZUWS)N6YF(/_!I^<KV)FG!-X6OX_ FX
M^Q44P54",@C=D+E1-VQXX^D,=6 +( AFO.[*SJB1-:PL>8?9<TIVJ,++FB/=
MA#5,NA5Q4Y4VSZN7[XI-G4FD@)@*O\FJ,^SU'*Y\[-<)IF+^W&OZN GIAL9!
MO*![C*W8V>P"-9:.W@\AE*A=,*5"WIGY0)*!<M2G'_V>5U SG-6P"BW-)$0_
M2+N#IZI(44 =_6VGQ<$I4TQEW_LI!,FV^!;2E%7&";IG>D$6UV(?$X"^TA1W
M1&.JWF2(G>,V8%E&@W#PR//'-<W)G#4*-]&/16$+=-V.C,WI)9TUT?T'\0U)
M\23TB,$=;/5N!K5'O$.T5DQA-4ON>KTZ,?+I".8/]H38"$<N[84F ,FI.'SB
M:2*0D_/NG24> +AV0[=1E@61^;%S,+YEAN)'>>N<SA#?]B=KR@\-Q* YU8TX
M$8TAY;5X&RXC/<2D'6_!U RB[6I4 L G87S(KT=]9+MZ4/@IM'QH;E9K/&#L
MST"]W%W>^W2LS?H\3)D>? [JC1!AN].MHPLRU2*5WT;LTX$JT$QOO0VZX:ZU
M1J[W!PXE[TUSW#^A6#Z4%_>?<U]74;(<P3H],+OG8BV*@5>SR4/=@'D.]K-L
M 0&>*7SLH!JEUSM:VT\P:[-#2\PO0TTQ.0BSU^PV]L$'9$MNQOM[]QPDPXM*
M<LQR&NW$IQDNR&X<LK8V"6T!'Q C.242/O#D),Q-UK-P*54VCV2;'(VR']?I
M41P!*PBECCHNQ>X@]H6#-S/6@F[WZ.J?K9\P/Y#D[R+DO%WZ=LZ^8X[$0A='
MH2%IO+=7NVQOI_!^R(R901'5/9HYATJ=;00GWO1^68KU8=N&ZJ@MP"90G:S2
M*7Q*0!/W=X8L:*][P0M5L: 7A1T!3X%FU#1\R?YCKBEKX[,LS=4XOEA?C ='
MP@_JTTHJH2L[,"T3B,V=8L U3\A-:0K_>;8[>6%G6<ZG9+*-LQ1=,6/D]6D[
M[ A;EF!X\F?$L#7>T%SU8#H_98O-4O];*)),+Z^"<JQ,_<X3_N3TA,(_LXSG
M#XL<1(<PKRYAEOQ_\J[_5WG7E)SB>=^#V?4>UVTZ<F?? <V/['12@\R9_U 0
M?(A^@/E5:!,9'T)75NU]QL.],-.U6*9\)X=UI3!MNACS+;@XC3W&_1>SGB>-
M"[][EO2 1M-\G 6P4[V=AHMT2"-0>'@([RM3^EDS2WT45FAX[ZOQIHH4\3.<
M""6"G?#LA/"C#!F&(\E576":\A?RK%4)(-'D-/GX\P79O;PQ&7;SK:K,[@,)
M%@HC)$%K:\.\W$++<R*+U9,J4$IK>DO:P?L.S]WW%V304Y'5DOEC 41HVGQ@
MQ@G$ER7.>!3.[XV^!\[7JIQ#RI^1!;!^K]]Y<$'FD\VD7!?G.3<^-M3*DUN*
MB5BC*T;?!J:DSSCR=4;7:PS?/8:@BPBE97*+9T7Q&$!';;^N-[K,MYE_[+FE
MEP*#+?GM@X!3_:?E36[DE%M5 _N0/"?]>T<&\K];K>PT3/?C=BV/@HB:%9]^
M^336 /4(^!/&7;[=\@=]R7->=D?O*4 ?YPRKZ]T:&I?VWD$W#!#<.9(.RJ!S
MV5G6ZL25^ +3"N9A=5[3'NQL>._3VLBS1KM#ECYOS:>U:<]NOS]"4]1UN(,H
M^V:3"GK[YMR803 <G)7MO@@3&XW_/G(W!=@0MGU\OH>P-&Y\CU,U RK&F^BP
M2":%-K.UG_!VPJG#K1%>L-N<<ZF6>PU;&Z:I48=@Q5.5UPZBXU]?R_)D;09$
M+TLK+$8%NKN\PQVL;',5O 5'$(O#OP: ^0M3WIQ:ZJ$4 .20X,+Z=F/!\<TP
MGG$_;D]C+2DVJB-OSJ%7M2Z[X(HSI8$Q-[N%X0+[ U7X&06RCK7Y,,$N%]%H
M*1\$(X%*O,$0@C_?Z^,;>(LR[U/QCIF<C^%\^L6?U^QG+ ZY)X\>/L5093_N
MV9V6W2N;FSU/QHC4*S$&R[Q]P9M0E:Y)^>' Y8+,%^&X<9(;+E=%_34H:_9C
M'8]VAAX&A5=4C^YVYY:_,;IM6'_ %.B<"?+@:4YU *3?77(,8CTLH/Q5ER1>
M$N,J\/0&BBU,TMN.^QGCTG[I=29J@WOB]H<V 3WAS9&OQ&.D8? +LM)1$[8(
MW.9DK(6=:<\G$,S"AU@R-I@+^BRZU;H&._,]<_)H/3&[ORB5[I[X!;_]>@^F
MJ@T5C3U[H,?,4K3=LV_O:\Y:K>9O\(V\$(\JPI<+F([Q>YUB##7&?F]3%Q26
M0]LM:-F;WZ;"&FR6I&$6"D21W0NR*K&P:@B]2=/."GQ2ZV.EV)<MV&'.-_8!
M?;_8/^T'G3S?M-R6/!S*2I44F$":81!@#@60[*4L;MJ'@'3&[0KI=IW(C*@D
MGA14##KC"_\4=?<7/''EF\Y:FQ[M"*5Z!8=F:MAYXD'"I%@),9[G8)PVRM6H
M4I&G<Z"4^TQ7@C&7<_J6^8B6IN;_:]KU-P-< U]3KD[T,9=D"^G]?]6WAOY5
MW\+M;1==D#VU.CUO7OYK3^_87 E1(?#:/VURS28B<!JF MA+V@M_L7WKWY/3
M)_Z]!;?\C!Z7T!=YS@2H^H<![K[LA-VY,C(<LM4M2[JY-<:;U8*SV>QS.+N'
M_ZN=[_J'_Z<S2)T[A4)X\]D5IO%!3$HTV=M0'4:6H9!U'L=G5Q*5ZFY%GVV3
MJF68CG(W*72H+\CN#XY8"2C3GTZ<SHZ>\%G0!DU?D-%>3RHVM']BBA+X6N=S
MPM<0[W-Z,J;QT+Q80M!3%WO@]B[0>J$K#R<"G_C=3EY#420STV&"1+J(+I39
M,81IT&/%60!A(-T7&R<NQ:4.*[ 2U@LR$J@39UYAG6T2M0I\\6)^)4(3^!;,
MBY?T\V:8J<(>V]*T+[*(*TR$AY1RIKL)I 3IR;5!+7=V3$=3H_-PLE&[?#=;
M.[=S"D[M!B ^"*\F[3G3H;4 ^_-],<\9I4)6!,H!%'@B@_3V**I12HB.A>H3
MB:6.$IX<-2P,KWGBU?0JIM0?%.7W6UF>-J.6\>C#\G#,HAJOF^#4(^^EV9+U
MH&<W<DXU72B:@UIFV%1_X:XWN12;51K]KG_:N?<Y_@6U^[83Q(-GYLVC3;W4
MMMWRSG3#R4U0<$._:N8,R9/DQ(N:O'T4HBXX!4L1.7_=I'Q8PJAW=DW[1OR[
M0.ZMN3]J^$/3 A__<?#H\)"-Y+B6PJKW=AMD^.9-D;[VY)3I<?Z!9@,VZQMA
MT[TB.BNSA7S+/($UE2)26%"8+T4V((2T394+,K N];O>8_K#?QDXA^SU=\V+
M.)4?:A15BP/^ E5-MCS8B07/[:Y-'SIB1QSG)STP7!/UN+['@5(K&;X'@*F%
MF6+C\1Y6(3T(P59D6-V!97\>JS1V1H0_PG+%L:G5U:K(>&7*48VOD>9 AY0T
M.B:S0)P7"5"R_FPDS)"+A3JD4[M,L2J)R3,GUXP*@L:DU?A$MCZ9DQT@.>6E
M3,BT[EXWN0KMKN5^G'0JO\,"+&#]DJ<M#9=7I;-[:MN/\'J:9&MAOU8#*3-^
ML*;>\/K>S/!4DU;]*+\U4O$>#HVCML@#<B+LZWW3GS=PK<7EXONEK"I<3#?S
MMU3*"S<6OTP;=1=$/;Q!XDVZ%'7;+*I*&>#%-EF='9AJ9U+[ <K[=J>O8G^=
MM!=ZJ*&PS 41Q_?4>X[]258NB,W-N--SU/ P1V6P*JNW:T3@_FH[VGF:!/BY
M=S3<3%W3LKCW0,'>L@,IX7+Y2J+%9%#%8X7G?5ET/T:D;0A21XU=+0UU$6=5
MGP\IQ@TFTPP^X-4?J!/TS=5 Q^6SS:5@=3^_:9/88RU\G<\?F?8!2L5U>?F3
M)*AZ#;(_L#99]M&U-[I94EY%]O _=HDR]3/7KTZQ4AA[K+D!'.QS7_Q;M/E_
MHF7L7ZV"5VVF!>7B2J*-GUUIJ!@9_M,R2H3K\G?<W?&?5,KY2E3C78!-QV?D
M/V6=!:X=A72RDBM[T4_PV$'N956V*LVQ5R*"+ W+.A/*P'']_!/)AKCI(/9L
M. 8VR;3H+'OGC.;I=(23>ES!57S*(TA82XM%AOE#)X#5_II.&J#?Y].$ZT_X
M:SP>'L!3L,-EO5P;0\_,1SO98/?2>\'_>3;C1T_>0%2!>RWQL"1-&E=:(<4V
MMTPS-@(QWFT>='GNX>)<'((2Z9CQ:]!@G!O_TS#59ZYQ;A:5!X[^7G0HRUL0
M7107"J?/IH@Y?RPL&586+-N@QP.YID.:',_J)&">UB./<]R(2H&^Y4R=C+PS
M3BI>-#=_;VV6[)GE1Y29!Q;WU,^ QYK!59C:C2)58,9&.X^N_7 R8*>H).^W
M^_N)SSLH\25,^9S%+^^;U9^7\>M@03UII<4=T25@O+B%39N@J254TWW$>JAN
M1D8!67^_?^*.!Q4 E>>F+:8?(_%8NV=28PMY1FZ[W\WD(FGB1[W'>96J:8QE
MZV>CR<(IFK+7W)SIG'R]>0W3=,Z;5UNO<M=&-^28L<G_NY%?C*R3&0K)1[J!
MIUNS+M(I'-H9(5V0A0LQ8'J:JC,+^-<BSF3':'3<.#<U MS/<=N ,!])_<0T
MWVAR5OEKAX<6$$<TKJ!5PHITGKXO1*(F*N%D,75J++:GP-HPURD2)]<=I9YA
MB6U!0TU2#Q$F).,6*1Y %^Q:1IJP!]\C^,W2:;YXJ+1?+"8IJ=A0]8MP0;:%
M80L/M!(I_*9XK,I3M#?,VH9I2'?RKH_P9(Z%A 4X)1:T51R+\3D+U[WK-^>3
MG&2.TB '0SJKA6>$Q,=#9;GWH/"F=T>)%(F6'Q!*P"[]K)2A">,(=M^532=8
MZNR*7>Z6BH(P43AG2'M"K&2E'O_7&3.AD8FC?PI=:KAO^/R)30QQ()=KQ>/5
M;H#UT ]I8'8C*%2(-S"W:&,7O*$'Y>_\[%@DQA@>WO#>NOGC06F ABS;!9EA
M49GWEIE6S>XDJ9;K)$!/I"E4W<%.HDL0O_:#<*+7!'P=/:LE[%!!$9BT#G!*
MG4\"I 56%M#S-S"<)*]FLR+L[.RE.[/T@ LL8V.;3OB7!/#PKO!>^(E?G>F;
MWTSW$B[(I*WQ,M\P K]D_UBGGZ6I; F0%9U_\/;<.>2J\KQ[ TM8P+6F1I^*
MY^[\(UK!0D!$8#E/0Q$7S:[0&;.]@NXFBDC!/%SXO?%@\NXMX[]%H?R/(<E_
M:TCR?P\:5ZFAQ?^"9_+HH[J"#7H9"@S7Z,YB%H,+I_OJ$[$G7+(=1V,K\,A
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MUODKC-&&0(9EEGHSDHTI9S'49!H(^G% C0[8FJR6Z]ECJ><X(.>A2N>$"^B
M<3KNS0H1YP #+7)*"(5M!Y8%JCVZ5 1^($R[/Y_GV98SW7[8G5M$0V*#]FUL
M2(.,&$S1G6;U_,1KZ)H,G8+5KX?1%*FO$7?--AK6>ID,TP(G&7; A>YT8/X3
M)')^]PU9@C:2=)I$<"@T5>0V^]"V=.;Y:8')3H-9R<IY]SQ(&+JXO7X\9%M6
MULWQ0QCZC=TK'D47%8\KA0M^&!$*4(20IF:6U(HW$I])1]44'K!/_W9T0\5X
MS9[7.XN+7'TZ3,KZ'.^7QK-!9_QAN8X'OQ/Y0!WI,4*W+YVQ&.T7DA8JLSKZ
M+_06&6;H *<R6^3I3Q6E"@X&KSPW-Y/6F/0Y9FUQC2TG*[OTX2/>[=4@6#5U
M'>:Y6Q2QLZ["YX3+F;QKQACT/281C>VE T/\J09L>/X)F;RI<5YHKG%KV8%V
M'DU"B$%UQ)*70<<)32;^J?7#([9UQ[PE3C:ER2THY$3,H-S=\H4G@^J'UP^-
MCZB[DU-?EY_2ZDE9F2=GU$:' CO$*<O/Y,'2\KXMU\&SYE$!$(]WZ#V2MGJD
MU[A^G 6AGF5[='Q)TD*NW*E(;*F5(KHBLE!UGC&0%(L; YVV;@:&Y18&E;-I
M';PG:T21G*1&=?VNZ40BJZOW@*?W^+HGR&BW+$(R:8MA&LU,8XX\W.:BI%K3
M6L:S:YZM1N/D_YC4.P_F$GV$-VBRM5?^LO.L)3J'#W9VA(@E[CV&]#?/8@FG
M"AA)[W&I>HE-J0:=+4_.?B6_'\34C+WTTCQXI!0'U>]T]A _T+9_;]C$68_Z
MT'8(630&4MQ\BU%L2U06!<=6L0 )5*,=5<A:UW>4<@PVZLTNJ30ME#6SISX?
MB+RSA7J!/OP!)T_-HP/3BU6$U1H4(B)<A>]A#N($'A1 L%XKR79BJ98(+]RZ
M=(O<YL6@7P(+1%[N<YQ,6$+<?)FK]L7KJ-=E0D'Z'F.2P;<W)HX?(\FWJP?@
MI;0^%C80#D+TP:-*2YAZ=* !!I0G$+I*+#8OBEC_626B5BT4P$<&0YA<P"?<
M^[#Z?G=OL'Z<L=?I.+,V3<XLO3$=Z;?[)D1TI>NPS-OKC!L%#\;RE6R'K9*/
MB-?3F+R%&R"#G)E(\P$O5*NTV8\5K_Y0]]2)NMH44L(V^7;,40T1>;;"/?_'
M]RJDR79Q]SQC4QTO1;K_89WQJ+Y]XZ=A<"IHTC'=R_Z$YD%(F+T9N9'X*7/,
MZAVH^13*:(?3D 3-:<\S^YX3ZV$2H5-]G+I+OI,J@R_\:H;,\%'>8P@!2KFH
MYP38S^Q G2$L$:)+!Z:65QV+H=3QGLYM*SI0O9L D#)I)[8+J>V]$%(5_!_E
MX+_(09OX#M?B1I!/.AIFCN2,*[_T%CEX*FGIVFGURO9KKY26%]%#1AWJJ=#3
MA\DM[F1RG6>OHQ_F0%S7B9Y2Z>]!"@800B=L%)5I\T"\'N6W;!&2;6-=&>&:
MCUK^0 =8J H&F"QF@/<"^TT;#K4#HO]42)?GXDY4T=;(H8)V^%#J-CO>H+D@
M5,O=7QUMQ_9, ")@RKH)P=_+3(WHW>52!3S>K"SCQHB3\$9>A<9=?\=*7W[6
MIZEK]<?X7C9^Y"-L0E8KR=RDR.G\7&E1/N]D5"$7[10G*0.V,^=E,%*BR31-
M2Z0#^XDD3-KP)9E^,C]O3:+D2!*1C[ *840]@@1S.\NRN\<1OY=&W7>:-8[X
M<(4.7)IK5^G=%5<%D.H41ZHO!34I?LS,-@E<_2,M?T;\C>/H#++@JA*'EYZC
M/PH'@W-35'O-^Q2UE)=O&::8OD*=L//$/@6-/1S"&,^$6YCF2IR/$ QP3?Z\
MVR$93W*;8(-,M@<]Z'*>&63UJBY<6AEO^NY9N6ZJ>D+SS-]4:6=?4J'%4&",
MMTV-%$[QQM(W**&@7;U]@+,9C>OD3!)7?SE@"GM^F><L3::"GV8\3S.*^*/W
MVITKP[#N%-^V^[+(-/0RG $Y /\T'TH3)56ZC')[)]YZPG-.\84O*M1ECR%:
MEB(#M%3 KYQHGR%<HGE-6C9RJJ<8OQ1O82G$ F>2+)F=-#;<2-1/$J[=/&;X
MGI.H>>3.&?#2'!WPQ%S?F]]8QU!T(:2I'2!A].0UVL@L.6^BV6>'7HK= -5>
M@6#'JE&^XS@-QV-+GC/<XV&6FZ*);JU%9RD2PH9KDCWBCLOP[&[C--)8=>&Z
M-D/) \V#T #$%<M)WI-L$LTRQHW55JU\N88$ 8+Y6.G"W[=950X>;L: "H&#
MI)68CY=-37\;&$NT@"K=A]XD%(2A'H$'C)OW_.(FVSSU^^CO?AH5.V=YS[Y'
M!;HI/>'-V9((!;[A+5[OK@>4ALM(AHA?RBC765O0=>.K*]TQP(O3#N?@]TU/
MG<S.MRY74!T=*;] KD8RWEU3)K1WER)+.O>>?1Z9$6&AI\H=^2WW"CE,G :!
MJY#(V[QX5%,!XY#A$F>BXX=Q_]D;8WH.W><7_.IV/OA . F. ^U3ZP$$^,JI
M-6++>//L8$0HF.8%AAOM=F^K_CRF!=,0KD,V;W;<3B2XNI,.?XD6@A.>?]I;
M$2Q+O3OZ\#6^@\_&*J4% 55[A[(R_+5334[)JGR?'^B6_(W)O_]-<'%G!JRX
MA+V.6^2^[N]SVG>\>\E67ZY/D#F569[9Y>^(7O_&;_S&;_S&;_S&;_S&;_P/
M@8DTL3GO(M:0^WGD..<@Q=N-@S9?4.NJ[Z;N87OZ*_&Q9B.>*_GPPA^!7;]Z
MW9CN/."$@7@VXGJWU ^5^]_H0.UH>:IG%'7<9B%W+7JW[\+TK(!IXZ+*\7_[
M]_G@&J=,=XLI.0?T$1)CH-)MWM>[W!WE_:OY)8$]6L7[,B@3=,#-+</32_/@
M>XX6DOF4:_Q48NJ!\C'PNN?Q42A1PU7WET;O7SW=P: *K)TV$,VCW.C:$E6Y
M/W([!&8'259ZO=O!I*,*W=_JQ'PK\^)G=M*FMB:#*L?74<2=+GL7V*<:=-TN
MA/B<.@0LG\_ GOONVS.K(?^?^G9<4GCCC)W'AC$9\P^8EN_ILU8RG:M9GE[+
M>YY"4:BH*7&]'3UUAKE0QV]@"53[',5$NPJ=\G)?*14PS/=HS%&P?*-4O\+D
M"6Q_/,_$?^Z?"YK/2SL&)W'A:!_BY.-J,P9&E4=4GWN<L-_DD[-@2A@MJ?&C
MC0J7)2D$"S!$WS*1^,1_QD^._R!&A@Y,9(*/U$#3ED\BKW0H7OLXB'6(6[]T
MV?14#-'Z*38U>^;<=O[Z-A,UQX%BBLO4*L<S!KZY5A)UL^NV5(%XU(&*G9!V
M[>_WSC.NBC['\O'A9L+X,O.LMR4*/T=,K<D-8RP>4KMWN(.T2>&3WA>'5SF5
MSW1-AQ5+KZBX8+7'"#OB>*8IMU"(=>10(YGQ5N]ZR:C8F''3X^+J6+5SMM%'
M^I^ F]Y7@QHMM[=,GT\:#RTDN(6X:(=72_!DJM&!-VZTDW3 KH-IL9PB#MO'
MCB;=<7Z)&K@.HHF5493P3(U)%Q]5Z5=FCG^EMGI5S#B,QD82@^;A46A&.F#N
M&(+AIHA)AX%Y;>/P1SZ6G\5$W*2)!*QSK<+O4=BI\0AOLM0-[RE1MV;YI.(#
M)1*W9T:_,U/J3-"-"DFO/BV.T,Z '9;-I#H0"J?#LY?EO4/"U3DJJB(D6[RN
M\ 5MY+(Q35OZ(:#/I6O1(249<3)#NN.?;R]W,"D'8LXI2R#L\&AL9.3ZI*W2
M,Z)J4<+*T%S;F@/1D<_UC5;7M1UFHCT3[? \7O(VMUEQBCL=,'D_]T+CW%>)
MC]&+= !^T?-*,JC;/2/"&<23&^PI\2[4VVF<Q=G440576IM4+0GS3"Q:&0[Y
M'H&J&PTEYK?\;2&,RX1U'BMEKOI>Z40VQ9CP<EFM%B\ZX!&40@G7^.!>K(H7
M>+B59X35.FVY\N:"F(2D?TE2[XXQ'3@@CY\/WAH/_K2XZUKLG?FY_JEH?MI+
MR[8J,U^?!:99$\R*(!EF,\Y,L4NP#"U5^*']C;33F=B:/7/QY)B6ST&:9'DI
M@,38FIWKHB@Y6/:4LAB?PN)-[A9&)*/8^5(WL[8@)ZW&!(-OI]O$&?G1@>Z\
M!O4(&/'V%B06X;UW]Z/]I:>0IQI1&3:<,BQB*](UWX-"\EYOG=FE652 24*.
M8=*RN/SL+%ONTKD4MEPS6^^/;C$ 3Y%GS +DK HXQ3,P^TE:XSS<M-X21-FJ
MB#(W>T$0[@!_JV@_BG#&B0=NAZ%/6%]JFF9?.GI,GG  FXZTI?6CRE!A-5YX
M"<>@.@XZH%).UC$6["WMP7^!O9<"II^Q3KZF0F=1GW\>,U(0 F>OD77,71I3
MZ/\0O208S\]Y?L)!U>EK!61<BF'7<A(3G,2-=\F5M#::>^_^Q+1!SF$J"FN6
M8K@+_E8E3X'B S%XR/99TKM=\V6WH1\US^3/C8U].9'UDKWI^67P,G9&A."X
M[4B:9<*"#JAFY]IR?)O_KFO)'R^H17SM&N&CY/JW'8)TD>>K$<O5&:VXFQ9@
MGV16-N,I6("SR+1EEGODG>(J;;V4I%T!9_YW1[\?6A)YAM4LZ4D^?G^DT>WP
MHL Q)IVOO-<(3!L%#>U#1*R91 _*&AT<-4B*T2GV&]>+.E=>7ANKQ0D\8)LX
M\CYG&4T2CEP-1TU="/*GJ+58<ZZ9M"IV57ZI?$U@53B_O*=#^?F76Q#6FML?
M;;9E0"(K-RLK(V3,7^).16KMA'9^ZK%W47>N**X,7>($<E]5N)SQ@?(/1+9A
M9% 3F<@S?24HL/LUY]5'9%BHAOH!T7R^RXW?RI<X@K(IRXN1OFAVU.0^:J(H
M IHS<MO=?D7;M+NZ\%&9T]>O#)$X=)LO^L92TIFN+6FV;!M]3W=%?Q?YFPIT
MP#WRQ@[W-.>V#XYE2>B[>^J=34@M-<6Q/ ,UGXXT0!A0TVEG:#WH4X*XS,"U
MN4X[MDX_KDN.%FK#VT'A][AO\@K![_GC"+SPGY$_T+VNI&UQ\/(ZHJ+-\MJ[
M3[S(S@5O*_9=\W12(K1?KKO4F&>3#MPK/RQ<\'-21.5=I*B1;,DPQ$UJ E((
MFF)KT,]=@U@CNVRUH7JJ(ZOY03LVD+/P(C1(T=X1S]A0-M1;%!!JX?QYU$<O
ME AL;R4?B?OOCH5B@OVS?M477Y\+U?>OQ0SL,B[87J_3)<5/W5>TQ?.011WB
M>%0-;T2?\'UGF<6+[O-1]BDBQ7Z FP3S5[;&1%;0*FCKM<XY+CR?A=C>?F%R
M94.\F88Q&+J[W0K=O->;DK"HJW#QP;N 1YZ5:TPV6S#?I,MH4QRU!?UT."WX
MZ0#C6G#0$S[J N. *$4K<T3A?")K1?N7\4D]9SIPVMHH+MEN$NW<6(;=$J[:
M9=[AT>V1]J@QV2X[\*Y.@N/$UDN^Z66S'[C6">_Y()>F/K%,A>&K-TZ!&Y8'
MV[-65?CLIYZ(X.\?1,W.H!8VX;KN]GX+,H^WCJ9 B)\+XFKN(L;#;GDZ5(%W
M-6U[ZT3<IVGL((:AZ]&'YI).Z+5!0H49LY3Z?!1^&$\)A:>:[!P?>;CS98!6
ML9+95>(,/V%H.T@6J/Y9D#:H((LOL,Z.]!P71YX20C_/L3DF<:F(\?B)TX&F
MU'A4C8*!@F!+ 0[=<OA)94U@^X]")UJ!<O@HU8IQ5%F:<L.195%,E(<X<=II
M+>DC]+KU^&&: +3 W9VE?_AI8P<=<%(Z<22M/QYA@^L?EGI+J%C3ZSEX*07Z
M**Q?>>PUA@EYXD?>_>8<EKPP[-=/?%_&Q_GJ7C-43K7OJ\]V_^'"J,P^QWJP
M<>SZ^!AQJ^#QIQX[BO3DJ/+5]*$P9A_7PJVM]CS$,O[BW.8MO%YLM/H&]N*%
M'8.2ETI4D512O;<4A&WK*L>GN=[;$Y[-*GSC'E,_Y+]]-OTJ<U9INSQ?2<D&
M B*U:^ %(GG?C9F?^<ICZ(9]*C(O'CC&U*M\QEJL_'B40P5VK9_<O@!U^<C'
M5U9-LL8+C74*C)[N4N7B@1)3(:LH3Q\EGFDWW_XF[MG8QA^S 8^G'3RE@LB-
M?554674-\&3 ]T-DGU+'1/#69Y#.HMD3\K5E3JVR6 %MN\W]=Y&:GCM!%?GC
M]9S:HQ3^2NO$Y][QU0QT0&QY485/BZP\BK7,T9!:?6%B&;G]F#=GP0L>8B3:
MBXU^ X:0(Q?1:_U?P2 $),O]C1%9.FGRN/<V\Q%E??YLWOK\UBFW!N-V8" C
M_0G_G<:K0_Z]G-6RQ$@;8+?LZLG'1X(N6O?.P0&$+DT )P5[2@<61:22"[@^
M/_QYE+5)_,8PKU,S8&&;)%B(VU)^,E-]4(6<ZTEEV,K-DYU2"_OXO;#1*0ZR
M DE1ZA^JZ6Y!'YG%,X4(HPU['A5]&AE6'/6'2-HO3!"I(E^5!1=<,:"9B'EH
MSZ-J8<C2)U2%0C'*G:;+L.USE8NC?=E,KJN$B]FDO;0Z/,+;^\2N@<@$[!2$
M(I+6LS8SM(RN >A W/?:H.Y2=[@?@C\;8=CO*%CC:NS$7U367,_S>EMD\ ?@
MK9[B7@S#,\]UV<]WVX)@FDJJ'NU8\>!G[OIR_"5VK9]B/M-V(Y:\ES+]:4>6
M^%CQ)IR7[YBUSK(%]Z!:587?SVP9S4*L(8=+##ILE!UN\",J"*_VV$?IH@KO
M? ,LI-,V 3G</RSI/)$40#WANJ\2%#)V(,@,'PV/W\Y4M!.FW?^P9W4]#11P
MD9.7QLYL$ 2KV#]:S@Z 3)>I^,5%/9JDJ9D54LBO[\*G5#=< ?$H><\[Z/JT
MI(_D[5I]E&!R(%S-M9SH[;N5IP31]M=YH<ZX#D_A]5U36FZBB5F[E8-!]N)Y
M88IA^ZX,)=.!5DXI.C XWAPF'#176AMOGG"F*? ,W[&SB\L) ('<SCXP,')(
M\(W=.WQIM?<!!!WXB%#V(V/A#ILXGK+&H3.06CWIUF$,)\(HNJWSY:N&)]IZ
MU\">.@N0:I/UT%(6*C]6RVCG+<N[\)RQ,Z@\P&N^R?&DL#^%\]DG94O#@0)>
M(N,(^U@ES)\.G(24R>9_(#VZ4P!>0[DH_= E54X,2H,.:'R4&E^:MA@N>1ZH
MM;RZ:.:$0T^^J!.KNMTW<_WLTZ833'+G43606A6PKL;4J@R3JO4GXU,[/)A)
MHXZ[Y4?3"M^E^GPF&[32 1Y%<#;)D:SLSI5T"E'4QF_B-'=\9'M?+;1!62J,
MQL&'=K6X)B"#SWD74;V]A2T%W#"XUX;>%4,AQ>=72VLE%XUZ-^;KWXI3'DYE
MNS!6)IL@AM4@O55D-Z/="!_%S6EPY!J%,26L575DIT4BE61"U*%VF@F"5V$%
M$HPSVS0*BF)3"]Y.I -1FMZH[7>E&VGPI9B%"[XK&%S/T#H%3P>PJ71@6O?G
M)?&/R^F]2[UI9ZT'2C$T[D0S.I $(?W\FTB2C;T7;8][3^])X3_BJ\Y_XHN<
MAD4,94:47)!*S"IKYL^)J02-7EWQW^E/,AQ1S_A>]'G8U/,IR,YMM\=9AW$I
MTA_%]:@_KZN!6O:]<N@IS,WABP*#62\\2=\M>I'(HLA6I+K-5*9 M5T!^6..
M<[9XVCW5B%+4"A#P_\K 1%19ZCWC:?]/O*_B<\$O?Q;!\TQFE*9YF#V.,;Z;
MO6F^O_%<Y!1XC%#0! YF,J.B:URF3/=Q;J0F&;\6"6YG$Q'>X\&;K7V89!;_
M8 '^_&Y*#MYVFQQXN Y252<I.,G6;N[FE !L8TB"F/KE2L4GS_'[=F33.D8"
M['R_9S-N@1;F2:B+<Y")[)NRX3WSF3 RP1KN1&NLLJ]#XT!JQD^!"X<%CJ%F
M^\;'A^HXZ8!?FLSX:>@77M267OIEQ?Z)@E5;O/JD8V 75J5D4_2>QZ8]%/]E
M''N<+[]W]RQ9 G$7#UX5Q35JA[4<I2;=CS8$_>"QO*Q*!Q1C(?,Y=."=>0L=
M>(3B00AT(;EVD!?ZMZH5ICL=Q'E!NXOD@ULB._T]0W"L^(O=@S&7JL A)963
M)G&WQ))N-/BA:CP9;H%:Q8>6MTWQL'HZ$,I9=[%+1QXUE#1U09*30DQ0E;,V
MW+K6@PKPY%S![CD+I_L5A?J2./'R<VWC["&2X)LO"FZM?EWF)J[#O>#(;C C
MQ=YAR"%G6N/T%U"[M6!WR[>GNA$RZ*ES& G,1&H?!B2N>#]]A*+08R]]E6_H
MQB57R:]70?/SI+=TX# D%D"VN(NT##E&2ED1E,3@\H.;@4.MG?&HD&M+F:6.
M_=_@N'MZO:DD#EN^'$OIM#",5;Q,3&+..[SOZDY_;\G?%==AV-E;S@Y(:PFW
MK(K)D ND[J!X$E/,CN-M/\LJ<W76"$_9*R(G#/U%'C_]GB4O>9P.B"HP$\&D
M"S.A:!ZIFB+_N>:>/:_KQZ@W ZY]\A"IF<Q'!RR'[M>NI1U(#C<7EANTPH9_
MD^?79 K?(YZ;XEAQGRO-LN#'[9EXT^R5D#TU+S_?YHW-0UG"@I^?;12*N<!$
M!QAM)ZG&NOW*'/DID^_5QHPA!(_['<)I[^MII/6QN@VJKW.(HBK.H*5*-9HG
M+&?TZF3H^1TQ[.I;1GPR*!X)##7G(WN0+NUM!H9?EB"SNY+#?*7D@,F*/LB1
MQ5NIS&51@)(?,^6*CPV$ 64CF-BD+[DHDYWC$=WZ+$!/TVSFW61%DQV*$9YO
M=I":BSQN8W:T*X-/L5,ONDU<6@-[OD'ZTA&5Q02 A*$Q%Z9]'O*I&29/C@MW
M=7CN&GQ U0NOF:$"R\EM3K.[J';;;SOE-.:S^$8U4BW^Z*+RD=K()IFEM20+
M=#P3^S!ZS;.%2N8F0VF'QW%H$Y(EKN]F7\EP^-7YEM[WKC%EMN^(D''P>\#;
M[>^H?_X3>@3Q'2935+\032U7SUN==JT?3OB*B4H&-:R'R8M3!.'E0>$ET<C;
MI5[HKH..6HO+>D@!DJTN]1U-WLCD<YW&Q_7Y\^,;2ZF5S_O@F\//FV,.H28^
MC(G7-Z)L1_=,J4.TP=B>EZL)&YR;GK)L#%XOX56VS;O.NGXY\'^5=V9!36W;
M&@Y&92L@XA8;NJBT'H0HB(! @D<4$:51MT!@$Q1I!");(1)"$P01(D(4!500
MD#;21:0)/83>C1(0(?0D0.A)0IM DI43G\_+O57WU'TX#_-AU7H9-<::\Q]?
MU3_7<%^[[I<=20^\O#P< ;LF+(-I458\;7<LV'T8=\UIJ^'*D=!(%M:A%V:4
M^E48&02.$GZ8%X'L*DG?S*"M*:\6%,X]P>89DNOQE9T[7E6O]:D0%I$%7!79
MQA7:TC^''Z3XJC,[^X*"_WJ1AO-<GG\U%C-K#CDN E&,RJN@@+94]>[Y XO'
MIA->CT"06&$JJ84P!&T?$(%V *;JA#@(?^^P2=.7K]B\TU4UT<X\6^^11LY[
MH7<_W-?V*=8UG8N:&CMDX>(FE5[W1$Q;X-598*_^1V='@3??1;N48)^(8PX/
M!L$VMFWY^T;-.I;XN;5IY!'=&."2P1:<?P7#6MQ,X,U]X7F._^G:7V.6=53R
M4.F^6H>ZZUL*PACAVSK9( Z;L2\UV[69XZ*VUME;15',40LR(X+[Y_Z7]EKM
M*>/U5P$KV)GQ2?\O:I&0<7V_!57E*]O 'YL>&$*;?R3W_$R9L#";_.J<>!O?
MOII&A(]=G#/I =_CZ=\/\5%+05A&IYB.G3S2P4]/ZN%!F[:144NL]&:FKGK[
MOJ_R-6^HEU22F!P>=!+\CT&IKF@"BZ4W&LBO?TPK##7AG"O\.-^GD1NX]OV$
M"'0P86(46"6PWH,XR'V,!E7#BR(0ZWH8#@7DXJA8#DJ3[IKO-=GRZ>PB4P0*
M"L%1]1I'@0JV77[*$=>J/,E.X/BO04FRPC!9H8IOGC#G5&X-IR3NA*I>@;D5
M*!VO\V!!!-J)UIY0TBAY38R]IC927Q.<VU@M].T57*<?";5BW.HKD4?<>_J/
M,E"P7))2DADU]Y@Q;HC;>DC\6F=X4BU9YOG?W=F T[&-38,IG,*&5@4I5L[2
ML_D.5>LBKDM+N&?=H +:C#R,L9F9--.=M/?73FXV'5PPYQ,EKRXT* MDWNM<
M\3F_%I;E.G[G5/@B="6?7S^W@]16#+MNR&A0V^D!H0%8*+D^,*.,E>W7(/7'
M_9>GCQ[[+.Y"'O)I3BO6%#CG+0:V9A.QZTV[!68J\>^0DP [%T.- !1X9>;]
ML-8R:^6W)C8(MS/5EESS.2TP=&IG')2@,[2/J4\R%H'R2,Z-1^'3;^=P&PL9
MW0JT%4N*\DWG_F+= 7KX<F^J'MSHKBT'@ACG17,*^*V 3-_9*HU;R>/R\:D!
MTB_=UV\*^X;?RN.\#HF%,CAFB[]*2^<MS4X.I(A R#.X985-_Z?I.VHXL&04
MZ]X!P[+?!38A1(!3XM Z(6F@[-QQ&]$:4-!RD,@,(OM#A81-6>Q%(^KP[T*;
M.& :\O=5MD L,VK/IL5:48:;/_\3*=^P?X+7;6;D_(V(&C#P_Q S-I$>BZO_
MTS):(!60S=N-4K "V_2\&:OBQFIRPRQSSZA(<B2=RWZ@9YP_'=(;,SP-H6A^
MXLHO3)0?CBUR: Y133=6@S>7Y ,(2[:+33S?V*?&*9$^%BY\6':/P)(5E*T;
M?'C("6D#U.H<T8KX]_*+]3.J>3B\[%\G)2;"NS9U3>4W\Z3E\Y,NAQ<"\HO;
M;8R^]1'\SWOM+\;,#F;,.X5+<HI@,IQUA!]HIX.7$?@3K"GD<7%M(;J&G'SX
MJ,.-?-C408G5:&XLVA82>BW#,L4^<: O\!L\?&[W0&B0ZGH1*<'U4$SSYE^Q
M[+;U-&8H0\.8,(@%DL9X7'IEH=>DE<$'N7=JC_TW/"A;[[[R\2R3GPKD)C-<
MVR%U-OOHC#\CT6F?L4II>I.=Y$5&:K!N@]0RWIJ<%8EC3@]HBNLD91*"7\Y[
MI_I&7UI?8OSXHFL%ATVY@0EH/IF+E(.ZK-4""/T@^P43A^>^2#!:!))9#)CP
M?MU9VKG4='E5V@,/[%2)C( E(.7FJ9C*PB IFS$YCQNV1O-I&Z1CPCR"P!H%
M7WPG O7BK_%0G-E6.UZDC+-#[;M(>1,5)Y/SY,M($I;5< HC4_<P.S;KV+4H
M,18VB8^4P&T%D+CH7O57^P/A6MU/^#NF^#\@B#7(\%Z+U^VE>DJD7S]E-%JT
MIF1("9",>H1:POWD7=V7YR/XQ4"G\O7 =!A/L8"7?>OYO"YH)(TY44,$&.N9
MLI95/QQ<>/[3IZ>=IL-"T[ 0Q%:4+4V3@XRM,+GQ?6]P(M%86^"&);!H@PA8
M\@!"Z?8-Y58+57_^M.Q5#A6/+!L3@? 54\'N>LWQ&C,M>K.ZK>LOMI^#D$-L
M:V"<9A#O<Z'6HQV<'K[:B:6+0"$#5=#8[[63;O!9X55:S\1OH6#-%N'>$"='
MTS(]_?T!:5K*/QW2,85TFT]%O":?AZ-:<?S:$2 X6ASL1N:^QDDO06((=9NA
M";R0;P6ZL='%C6F)UV+;4A7?RFXQ7:LGH7LJR^B^WX\G>"8>ON3_*& .ER1&
MPUP!9,4KQJ!'1SWICCYK"V%WCJ42:[8+%)+?%J\ W8\YMV%_VTNN^K:=(N#4
M8$S9("5-K22-1V6-\P++[AH.D37+H^LM5TF?S^KH>IOJ50['!2>>-7K4FD$'
M"1D;I,2*"9D.HL!MP,]-L6_YD9NN+.?U8,A-\ 0 QESQABD[;:+NZ_]TS^XT
MDRS&%GMA0FR!KEYZI139DW4FH<AVHUC!'$->-AH)U3!BBT#E3-*;CZ^Y5I0Y
M;59CK,IO,>)6=RBO_9>KW#'HIG!A#2U,._6'^7"]F1@2XGLDNT;JXQ7KX\.L
M1"#IJ3ODK-FY1L&#U%\/[G.-B6(.JW$+K:T=[*T=I/U$<KK/P>*VH&+FS :.
MMG?TXM3%L!8HL<KQ^_&>:_M<!-I=;*I(_UIA5(D_X$A[$60$T 'TU/@13C\W
M#GI@O%OSKZ&M),>$IQOBSS*P!UQGR(ACRR/5*W)LZ+.G"CJ4?A^$7$1Z"N"\
M$'=ZO>Z1*7QX;[E_6&':LLM:N4JATX0T(#_(TVUS^FA98]RE=](,*7R)-<#*
M_,]<S2?8EV_V/M.>) VK GOX(I!4RJ2TZPG"33[,Z\"7+3Z.6?0%LN4VL=8W
MT$#+BC""1,*E&QDW,+L[6AIPP[#NTG@&-VPPFU#2#\SF8SG(X:Y? ^B>/?T)
MFSCT<?.^)&=K1/:*0[DX.::-5/\2K4S9KD4D3YV ]_LH1YF,BWV)V^MS@+BX
M[.M*YB"!/5PBYO1U806I"R?]Y$V'^I05S<LSXO'-+=KH3SO)&5('A*=1242G
M%@<U;U>THO3/K+I5/WQ13N"ZD\6I0Q,;]N H^O[^T!3'E6<?U5LL1BP.W]2_
M=X3*Z4()9S:6D;G?/K8?V:WRU*Y@_QUS^[E=X#-U)QEF)I2::XC'*2CEBO+@
MYO;G4<DZO>;*CIMLYUOVYO\V$_C_:,DFX'Q(@Q=PWM##3K[SG\+>,5X=Z9A=
MZA[2"$\7]QY4)!)HK ^GBD"_T>@=$:A B=-I66W540^8=RT62W&U\Z[O+H%"
MX7QK',6PO#'^?-]"#7H4Z_<]_N_$'*>MN_;-(V1O:KA8:K\0EHK@7F$Z6889
M/D&+_#&A@KNX%*\!+)"1T?O&3O([LKQCR8'12'C9]:CTHGM!E=IH08?B@="^
M#^/6E4%6&2TT4BN6)O@]H,-582#A0^X"C71'%36A_(WY.%F[']4T)^DC?)A7
M?F7IZ"LKY3T')3@I2^+>>N?@CU"9,%0))MVC_T'.GVSEEIPVQYR(%?4J>+O)
MYB:I!H6Z4TJ^HC/EF.6R;&&7>6\VDVM@\)^S!]PXCS]8*%TH+6<MSII]T:_K
MC,5H_V%G!UX>VCP+6/4E?1%F@FH9WBOD)4$8F_V>KWWK!Z/_[+P?\]+IKR\^
M@97V8^66';PS9;L;E7 4';<!V(EAW_?A69^=BU:N]!8Q+#M5E7=5PI^*8=Q/
MH,WSD&QA@T8PCRX?ELNM:=HZ'B5QX#+NJ1=KVR%('( 'WP)',0V$Q"E$CY-R
MRA&>F7SFF%R"AJ?&[87*)6P5>[CASQX</;7!A&8 _>RCT+9^.VR(E2_%M4;[
M/CK_!%F\WA\M]X68N?W$'*()=",_0YZ%[QFK8"Y<*!0+A]2W$QE*5V4U=IFI
M05(JPNX22TOZ[0KG=NG\O[DS)#)("&I8KLN%!R,>KXY>:#*[E2 "(58S) 2'
MZS@B4!P)G3ID6+=:'L4$$Q\.4;DQ/IL^_W8= (SG41C!=>[TZL!!HZ!TP^4>
M):[J5G]&3 .XG&/S6FE_/CMX= @^?O=\*;"!+O_/(.E_T9(4#?T+4$L#!!0
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MXX5Y6L5C.O[A[F8#U+^V]V.CXQ\PJ;71X)\S!@$\&OQM9&#YR@QL:/2C#*I
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M(XSI_3#$,#(E%T\G"%M.1QN4*)U%((2C1&(<, \X:<H4U<7HW\6YH-PMYK/
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M-)]&W!5L^DQ,Z97%]3E[_LE2W"GP@GZ-(6Y0A1V(,BOS8+XTC634<9\[$L=
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M;@$/ZW/1U-#B26T<.(&\8V<<;C6&$-I3=B9F,D5==:UI]E [Q81>=#=VAXM
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M9UI540U6&=!X/#JUK0IIIPSO9V*FRDH<'"T/-.VP1E-E#Y2$;9]?*,M\@:Q
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MSYTJ9L6"& &ST=%MT-ZKHH482VD#'6WW/ZCQ$^(N9S=K%^XZQEELJK;3VYQ
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M>B1L36E6&'/R&X2A1QH>);@D)MGU/=KT6>8XR%77>3AV)LC(!ADN]D%%!@Z
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M)F377!:?A@4CB"4[SSY4<8B4P [PSJWC6,EI$!Q8CNS<(S+.YX5P?*?=2%H
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M3U)8SQQ*JLEDQLUE'H"PK(US3*>0P4EGL,CB9'5YG9,;%\JH.>ML]#&ZJ"W
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MD4Q_450T]-7:IX\<HX>W5  VOCG#$^7CGDL/_4G^D%C#=:(1-CD%R0]A7/)
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M%F_@K#@K';FO1NJJ+HQ+UY<&YNI8D GD@.V<@GT2T;DHD:-U= \OS]WSXAV
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M_FL 3!*B(Z;#=F[VHUN1?9G"HF>IR@PQ0"TI<1R-V<EUY#>ZL 25_H7)W@Y
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M/H6W$G)"#3X3H?IR>L@SW[EC ?,.N.M#;AXN4_:1'9Q.+)CL=_Q-16O%-8(
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M#,WY#!V6<%&E^*C7Q9\5^M=N'W :IJ(6KEOD3"U/@@BJ!,'*$ZY0"#8?%1Q
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MLDA8,(^W#Z8K4#EGF[(Y=6TRZ;Z,T5IGD\:]PEG4(PI]66X,1+TF(WW"=&V
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M-'"801?G=BBN!4AQ.Z5"$D'J*PDZB/D$&,<0;#-FZGH=S'#*_I#?]\_]O]#
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M(5PC?T59GJ/X>77ZI?JODH0HW#&0S\<BL1[?Q/C C%2-,H).WH=S$.!6?9-
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M:\.7MZU+&*>^3')R/%=5N#*TX_8XNJU8HHN?Y3ECHVK$>&D1 BG7K.<M644
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MKT8TBC-3#%ILZ+B5%VVLSYE7C^,2-CW;52F37%@?".0&DG$R)<4PAR:E6N*
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MTT'N%Z?4AOZ9ZCKH+S>6*3VHKG/ EZD30'E)/W']"U7$D)$L69*DW%['%:!
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MT!,W9UU%!0VC3#(QZ>BFCXEB),(^0J0F[>@7/DH>_!-U,WN,,U5Y6PCDC]'
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MDON),Z+I\S5NQ3?'FHX>4O $D3UQ5+.F8?/.4]V1IC]=+:O1?V4HC_(^O/S
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M\W>&YXU"GQ% /28#(S<A3[18/M<5"Y;-N],71FZK>=F$U&NGOMJU;HTO2_4
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M.C5P)PHSU@218*S[; @Z7^KCWZ8 ]/D$J<:E=*2^6]%U_F7,-QQXTF(6/,^
M(X!P4;8V(Q>:L*T/(-]PP$TY.P+H$CN1CQJ5 !1$/LIRP$=?_<A'B=1+;V3F
M,TD,%G"2[?70K]MGL-XTMLV8"A'GY4/4G7OVJ.04_,LS%?^ _J3'8H>/@I8O
M^W,20#$+>W%>L%J-P[BXJ_DYKX\E+TZW:@PY[9!'G56XL=GXZ6@"MCJE#,^S
M*"4Z44Y6XU)>'"C1)J2Y%_+^^.5O]B?COUA1-5?>.>/9RL$KM T$XM3Q32O@
M=RDP;0NKVW\C@/REX\ - H@>J!M^ YDC209Z/TH&1(#QWPS[H^T5/ F@4"]#
MH*?Q>]<\N;Y*H&ED%8C]C<]Q/$D L6@#/1_QNB1]MPW[E7_M1Q[Z^X>\4$'^
MD;,7_T^'^W\OI2'^I!1JRQ8XU>9B^\&?K$FR.7R)S5)1'/KF!^?RJUXNG<76
M#>Q,:(1Y?X:*P8=OJ>3-D3HF#K#S"%1S8BM&VMLP9+GZVA/T!<,KW(7B0!EM
MZ_&ZX6V<M7 3@_1 ;^S7L8_KZ;JYU@UBM3M%"$OX01Y( (UHS!!ACFX4""JG
M:_41("XVY+[YP6'9YEY"; RVC !"(.6ZL^+W-FJD[CME@W>(_]OA8'I[%\AC
MF7<$*LWRB(_SAD==L*0Z>+.. +(PXL1JX4M#CV.-1L9Q&B:="CRC1!)$,E9?
M+DE<W&L<J8;OPJ>MM*[^+)(D)M=DCVPU:N! *.,XU.X$GFTO.6855!L&WE\'
M9A7^!Q>0+(79H3Q_ET3U\H_D"?%S\B1!A7E.  '$X&G4CZ@NA^BYW/ZN+2(G
M+Q- "GC5G[.G]A[.P1\W1-O>,H=00'50]FW7>$2@#WNJ1W[W'71747E![-<S
M;VZ<?F88^Q7$H>42\1C]Q BYA5=\,3=,O0O-FN=,[E5F:YE,_<;C8DK;6@-[
MH%9X\[KNO6/W*,78+\=&1??[09(1XU[NC[Z QWQ9W'+&7*:S9^]8GW>/=:0S
M?)WE'$*G\_KZ [>O#?(U;(BMW8+N!_@US(GC&?G\?R?V].O@,!U# $'E"""Y
M5\7/.S>E@\!?H5AP"FD=_$JGZU]+4#T[ZP%4/3[JNZ1(V@G$A2OX&T+U* L!
M%)9!3&I[@4O_&#_<M;+P!_OA'IK!S&"#C-SW0['_$2"Z76U#*=3EYT(PZ/OW
M@]4[I#P;R,B9W\U2K<\9<V38)4.=EK12&74 5R\7Y2O=>Y8.765C<_Q%GA<T
MW4-.7J5E*Q03;Z.+#!&0F,A3)W?E5APR)N:S+#PWTN4E.,5U.C=B-%;W*-=V
MZ%4)H IXZRO@]$=PK5G0Q!?RS'YKB+5H>/8E;$)902O9#(@,Q0(Q0K^W1YNV
MJ5Y4<?6DX4#8VPZDU:6UY?;+P]BP]ODUI]OJ91MF+_2&7Y]!E^R9[GDE,EJI
M=>E8Q%OL;R][4&9EM60-%@U^5GAP5__]HZOD&:/QB5O][]]GA^:FJ@C=R:C3
M*=NBD#.$:R&>#_NF+[[+O#H:Q0QB^,3"2!WJ=4['V/:#=BJ]5N38]E#_QKK,
M"]11WDO@S0;()K4)O\N$#6D&WC@0ZQ7VXN=*+DN@,G(A$HXYE(803EVKPFIB
M.YIW#YLKA>+V()LL1CJ[L4,A>,E-:%@?6O$-\<T00*1)".@!?$4$ 23K=3"\
MJ!6ZUH:EVE#\/QQY2VT"9 ([QGOT'Y;+-05VH<D"A7S,#CMMZS1%T)=>C%TR
M%Q8PEQF O6/(#F1XM^JN[10F CR.A,\^I&ET(QU?4-1A"O#>KTX2$:;YMFOB
MD?T;\V<'K-#1FN+/3RZ4QU *!H?E3NG5L;F#K^:YT&Z^:X1.[8Y@@TY2'9Y+
MI%@K]K=-B0F7?"L9R_JFX4OSK0LGIS.@8;)F^G?ZCU*QLS[-<QWI69]G_Z;J
M@16?X(5682R67-,43UYUEO-;9W_!IS*F6FL9?=Z2S,ED]- C2@E) -JS!]8Q
M<JR;NZ[3=^&#^+<_C<$_F\ 1_;_H9<;_O9>9Z[_U,M-C#R?RAB#DQ(XJ>'.+
M "J0-Y:S]F*JI2+5.7_%*)'2DS_R[4EYFN\#8&$24.F_Z$L%(R. ^(&O>-AO
M'3*36FKH)**K_C'.*QD/Z4[X UZBG_[TS[T]Z(Y=MG7IN%^LX-+\TG7YHU6T
MR?2X[LNK@AM766&)Y!>M4WU+;>Q..'](F7!PX]/H<+O&NQDLJ58^PKGA8-_7
M1P]],VJ1G\Z@PR&V54>WI.O67<J2J6O3G6Z5:^2H+&,JXY!UB=XW)";KIEWS
M:U7G_+/G@'F+?HG\32V)X.3#&.TRIQ[+G9@E+MTD/F^5JS:=P!FD/0$D  ;'
M6ZN1VC+@[R= 7GA03?"O%GRS_8@I4%137C;INZZ!T3N7ZTB;UUR"H8[O*N.%
MRG&%7#-# ^;&V\:0RE0>?OMI3IWDI"KN4Z=]CPD;+UK%A7\Q1?4EY9W-).>Z
M4>P6?I528G2GSD=S4JA[$:&(*G6LR18C@!))1Y:O-H9GOG7M3N'9]V(XZ7[V
M2A1UQ K@^!+2S]#;/K13W7U]D,JX5 +KQP)Q<S\BR<!W).G]&R-)'T:07V[\
M/)&P8$[TYU674]J #V1U)/8I>':DP285*[R.4PY=@[=MBBY$+AUD_010-WQC
M^,E8J2"'1(A+C=_9_+7$A"M1'[AI!P,4;WF&*94,7#YSK+[A,!.=LC:1K,@\
MB-AV[KD4[QNC]:CZ4:;2MW%Q&@;)1_*4%YCC,QO\(]JN^',;YVWM)(ZMKHRE
MIE>569\7M7W;E%/A6\57>6,RV^F*>O7A<.>:A))[(-W;GU.*I6^@5L"I/Q 9
MRFV79W]WAD('U&V3& ID7TBW4"0F:9%(*@)^8BA_4$)W1]?A*Q2)?T:.I/
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M>>,? U& 7YB'\CMG+/T5EP-L0.[G_,-J$1O'CHG [VS^$TTA1I^SY"21).-
M)#''ZF_@*.:G)$G2_2L_%LA,^9&J<87[5A*APKL)HX%Y3 :REC#':(<C=?&M
M8_5WI_+M&,1;C:769"F@#@N D$>@7VMI.[E]AKWQQ\NC/_BVHD)S*0X[(R%5
MV):\Q_VG2H^691K:"(9]Z*N]Y&T>K1"<<-&>)<:]&?G0[EK&22X1O_NZY&?G
M S6^^$4>40OS\H__T_?_W4.1^]\;_4>RN\%WZ_"0322&N)/[?CR4(\=*$$"C
M.-;?:"?UBQ<F8"+7J)J8])#H@Y7K06'E?R(C1AOCL;B<F#TV&_R1?\*4L/\6
MIAQ<*%G&J;!/0G&NH1AT(9ZENY+$SX"D&3_*"2/$ :'95-7;V(5N=6T[ <L;
M6U",EO3RY[8P*:HZ<OR5=0+H,QQSQ$U[UP_6,XI\#-;?BV.2'.>F)H#4B;1*
M3:8B38QWG@#JJ=M+K+.L)OYSCQ!Q\\F[@(4A(69Y&^*</O>C$=JR3H>?,+CW
MWK]N*DL /3@4U?;@?N%DJ9JP>_NF'D4K=3QK24I>X^9^;%?OO$C_*\]HTJR$
MA@:P9A?X'K=(7$>BSUQK1)%2T;QIBL5/6]T6O#8!P3F1*($0>G8X=.T2GFWO
MC<P1DN$-HD_\#BTF^"NN$\A0?OF]B[[W/9-^>X;@'UT!_XO+H7,$T/P(#HU7
MR)3,T[E5<6&VN>7""XW]D7:];C^V69?V ]GC'0$4ND/:Z^DD)J$4N@8E,@G;
M[TR"R,%AV)V#XWD]*XDV,2(3]PA0^?1$X^0->SXSW_S,;U<N\_.&N"7Z>Y"Y
MCPT_87-%;)6,U]5"SJT10$P"5,#'O-W;L!4W+#":X/ -0KZPC2F:>>6CSL2=
M51^D$KYTIMXT+$[AYKB0+'V*U8U]9ETMV1KID:T=L*(A;F+S''&S)\G^^0[6
M/R^'*/JI' (Z@3.<%?YM7?+T( %$I& ,>_3$;*Q<?]H)2HF</ -9*"2YD+3'
MI:6J=D>VYW'JRY^D(MJP=PD@, :*\P$6.[X[IOSQ-,"J7] ?A752X@'QJ_J1
M/RQY,;62V_Q'@8,7,FG]N<[6$J^)SALU2R^ ['  P?@'*PM_<#+G[U<X2)<Q
M_"6@GH.X!PT(H&T;-+S:JP\@XE\/ALEW[%"P_0B.&-([CB+@WW" =F\- 536
MU@W,*>W$3<C<7*5B!.^^55O,(#+S'DO(T_U3%U99-K M_$RK/ $X2:K)(B$,
MYLT=(G7"^< *C$[)T1) =X%-:I/TYK;QF"QLJZUL43CWD'S:C0R>>9V/8[4,
M8FV:+2:)80CSBB\1Z?+R\^]7[-#?H!XRG>[[\K&V#"%E8Y*RTGZ6LRXCM&EI
MZ%#=Z7-K$:\F/T0IN<7LO8W3$=7;'I><.^\9&5\:_"YH+:Q.;.'VDJ^0(IO^
M<97->Q-,;<GS5IW?I=!3+;9X*3[(0A <<SP-898N3S5>A57=N.9#00 QOP!&
M 0Q=%KRZ-=MA;6H=&U)<(-7^MSDA>05L.> 7 !8=!#'L/\#1O4T&,B K@*RQ
M[I 7X^9!U.> 3.#PP=CHMWCZ/;\4Q=V\&0Q#5/.!-G&D#5-, $G7''V]&Q8A
MV^L)KX%2+\C0=.IKMJ-%KC7APSLS\U/8E,A/-35$V#PJN:<.2H-QIZ9OE6/R
M6*KL\%S8FV6("Z\-Z>SJ!]G49!1N((=/"9S8#PKU@K)(-KTGAI_F0-5=Q,22
M';VI1#=?ITCO$D6$$LVGA)S"A)20Z])6>\?%I6-F\+".D1.NP2[&J-3/:ZQ'
MT4LPBYM7"P]74Q^S"V[8:PH>6@OI>Z=='K79C0_(N'WO[X,;V;^(&U "Z-)%
M07P%9-MJP<J.7Z[O&W "N0LH_ F. $<200C*0HKJ2=M$ND%6!/WM8Q-/7 PV
M6!2RM8ALE.C#GNS:AN%GJ-:0+7^@Y\V_G)Q,;A7Z'?<)O1^PG^.@B_DEYQ Y
MQ=JI"14"J+B# +J28XU5S"%F70<<85J",IDR-J/*75Q&Q_HYEX#L-9JY10WA
M#M9!(R@ZO<PL/K,C2LQ';<Y7)*K-$U4D::?'+]%1_;)]XH/,4R99#)ZF%A42
MM,<5F2Z_WJ4'P)/&*D1G]-YXL^.?<.?"O_GJ4:F<WL-;.IRQM<[Q9#(2 F !
M39(O)$,9@QXR:C_UM#=C"DQJ<8,+E13.^I(_D'UV;.Z3T]Z)<1D9X%PY=-IS
MD3=K"#I<'EQ94_CUYED7AA^H0 30T6L#>2[&WAG<.>C9;:.D$P^C#'PTD4+N
M&FTEZ51!1[)>"+]@JI6K=#YY<T2!#E\Q'<.VY8^<=FDZWESRL5/W@EU*!72U
M[NZIM4'F\/.&U*4"KV6Q\I:?IAOYJ**5TTJECUM]'^ N4#2R1SX(]-!!-L^2
MMNY<$M: F&G<5WP"F:0FQU(10'(V&=A;LT2\98+RUR]P"[;^C2HWTTG'J<OP
M29OHA>ZSO/!DP4+[2R30,>H>F3Q@'WO41)H&;MMTF"S2V+7%+-\"7N&!)(1)
MW1WBHJ%91G:+CF$/0"<TCA+U%;"2]([IL+._I\U6E#/J_70RE^Y$=5OHZ%#)
M\:W7E"FWS2'K.&"4OAC"](67-U^5)Z*_\?3]D7HWCNNUU58;=)H=E%,3="?;
MP==<%(8@X'4Q NAI7'8BRYI;04[O#72I:;.GQ2@9Y\-UU2-[/C,GA7(ON'4N
M"S@?/T)A[ N![MKB9KK<V'E&9+&S%]7.; E]$+_QO])$_[KY#O^NB:(/--%
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MQ&C/G\<)4@:S880&V_Y8YD<B(F&_/I0E@7B+:C-%I0"'+6R5'[HA_0J^_)
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MQ?9LU]5Z7C;<E]XXBSQW+BSR8GC/'=;R:]4#$7=$V6)#5-65&>\=U)=-V.?
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M_/9[)R1L:H(1;<#Z&3V94?G$QZ"$-Q"<^R9 ES3-1DV23)09Q,5BB3!_Q(J
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M=GX/_ISPC#9F$4XXF!EM?%+*C@9OB0.?KW#+!&K;X99XUZQFC2G7Y3L[P,-
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ME";T\2 9G\</]9K=\ZS4(\)\)Y1(7V&RD%DPGBK.4\S;/^U\*HC]\1#=N%'
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MOZ;)L!N@V'-K/N,1M&S&4]\G'"O/^5XCE)06%&+A0U&-A_Z%_"4.Q"IT/.A
MPTYA3I<_7$;8_>_<8]$J!0D@D^^<$=;7 M1>H $0Y4% 3_U.S;#O49<GVS=H
MP(S>"1I"S^_LG17&3G]D45-AI54K866)3.1ID<H^F&SEB,!$#;FS.LS"%HUC
M57JDTIF"G3P2DILA\:/>^R7@2[F>@97PZS3"UQWGCGK\\QF]Y7\.R"CUZ9]C
M>8Y %.6-AEB,7;XG.M@P4>HKE%]*>(L1UT?]R<:=3G:::;\@7J.WU5DR7_+&
M_=W5][MT]D5<X2LA^RA;+G(]((AA:O95OX5:,'X<&ADHN(D-I]Z%+J_EY[F5
M&RL.,X0'A6=D1K)YH]#4SS+\:"#@9&YS^J"O'8]-8B2OGOLWVZ4ZN:ZM7,@9
M"A7%JD<--JK8_OO/"NLA]7_.S= /9(]?"X[ #U;#%*+_UB;ZK  6(J!V/M8C
M)E^4&*]MWWG$U%G'^][\KQ38M"72<CXNQ-04@.#/&.E#*XDW3;:')^[OC<,&
M^]TFA.S+4N$@B1&7\4080,XI=5U$YB%^OL/^B8K*N?V%B<X0,%N?CT3Z>7MT
MBVC+528S58_--T4I.]#:[+G!_9/W&--61$!*&PJ?@KY',]$[MBF-R140EKU'
MA(XE"D(;=>\PE(DHJEQ7?<J[>R0--G54GHA)77'P(!0&@FJ9B3)ZR055X[_-
M7?E,TJ]-:.VE "6%Q&)76UX>!>LMY)3,ZW8BY[9WWL:$O,%7^B[504?MF+>Q
MY#KRBA5,7'4\O>[\&ZCE5)L&3S JS"]1#K ,)<2BJTE(QVHE$]H^B&XOM/28
M5T]SGMW),G,>)@TDB1S>4.V[R_HA'Q\'DE<L)9+N)(U?U%$$V6HHL))0-CSW
M_)+96?9!+%*P.M4>22@X7DP^ 6?U&#^\46+JA/V0'P/9<XG;E70Z!JTC,:&B
MI\/O6C;336O"-N+M'$Z:HQ7P$PUD@&-CI$GW@ 5%KN;Y*Q)?Z95>O9UVZ]B4
MMX_6-M<9+-1R/FS&\/@];:6I7L6VX4J>L_O1WB=50C_F?"&"3%Q8K7%X:JL7
M!3F?87C$@MOP:5!SF5HJ9/?X'.$U(K85,1:9>@\(?%FA 54[5X]NIBR(:X@_
M")!X/_FA%7 2=3;LBY;R9/#YM?[9_H/DB)'WK3-WM+SE:((&PZM&;E -<[F#
M[];)>N!AT$ZOKDXTJ.V'Z)%RX8I][FUBT\'Q^\(IR/<SCM5H_JO@[Q*"_/1A
MAL$%9CW<?V2?!#W*C^*6UJI"U:W3R)"+>7G(24)F%&WWQIYCD+4*]9U);/+R
MR^C%QLE+'';/ WL=*9YE^"RC'1QJ2*-[XUU+U.,&(6F.M.W\26COM6AYA*)\
MO\B>#\F.>F=W(JO AE982RACJ8.8VD3'J*_JDY8L?RDA)_;X)ZC:Y?8"_>S7
MMP=C1:H7N8WE RZY-4_EF\D,&7H3[P&["U>^DS_9E^J.Q']09V3U,80'NUFV
M][_[)(2*V'Q,%'M:@'IJ>'9#8,6\[$0,5==4->2MB1X8:> 3Y?O"GUP:KO]]
MD=W[LWX4$%,@^3$S4]Q+1PDEMDRE8Y"]9UUH=RE0([#:L'3< CXX/:6:/[VG
MREU???L9_W1# ==0-9A"4:#2&M$R_R2LBVM11#LJG>KNJ[^;@DLN::(<,ZKX
MKL52%+$R0IRFN<B1ENAJ5OV4"+M7'[OHCXGLAR4:9\S:C=B" PD1R,G$6-V?
MS'U582JVD"_Q_8Z"9+O1ML"9GQH1=/U3Q4?"K]]Q3^6O"&:]W&KX7NAFQQ<;
MP5 %1E^R7B?L2RP8,*/EA+"G:B(2U)6A.\MV:A#<V&*?/GVEHA%EIN*)H6E?
M29!=&8(^#3XJ4!*,'SF-\VC)3;"7:;?;25'F&'ASAQIB44V>M!U1D!\SBO$(
M* W[<QG*</3R9U$_@W(%V[.<R;[%:,59LA%,K.+D.?C(@8"G!Q6[OMV\_VC9
M=FG+RD&(+U= OC'0Q>TU=\S <86X#=.;7^X]1L[.-DKR0'KX$KEI!6^QNDI!
MS2@*;,QP#P"<VK8>X?^B2T7H@IE85<H\=Z0VJ=Q;1Z:*^ZAYG!+,<!P"!B$6
MT+?TG5!L#F8J9TI,\CV7:+!-347^=F/WU"Q7W>I9<7(2HO_5AT!J,R6<MJIF
M/1-GN<,89YPUL\<TCHSRG5J1^8NRT>KYSB$ T]VK-1J:&H%DC!3I)YJ2<8.S
MK:?4A$P +4U&J%Q*AHXW<>?(K%0? M4<)\?-U>DG3,E<'B;_<8S77\<X11Y@
M$)^1#^@@8W+W/- 1_:BA47+F#BO8S*Y$E.5#C<1WE"Y&%\Y/MFZ?[2^X-80R
M1HLP:+KUMG4 9"6W'+W=RZKWXPW=1+UDVI4(71'^Q5*VYK\$&IXW37"<T;U1
MMR6S1^#8;[9X[F[93I2D^V3$E.]M*X64CTQ=@_YNGMT#?J8&_'![/ XFE77'
M-7<%E$C>;8.=YYRE@KZAM?Y 6'I2?)M&&-U6E0Q*O=$!^C$V"Q+Z]X#G"MD_
M<4LL)AGF^SR[-^;J*#6^NJ>G'_7PSG/JN"S69N9WP_B4K4"<8_X/HI+IDB;<
MH,?D06;%?(0@0U2 5QCQBFQ;P?/Q#N;.M2T\5?6ZZ>QAKZ5NHIOJ,>FHG]([
M.GJ5%?Y(L*^>1(ZF$W6URRL-.1=?E<+5K3Y-YDZ]OO[X)@&+51K_N2SAWT.Y
MMQ50;. Q7+T@45-/]*AA:LH28@Y^B3'@6=Z5U$)4JQ^>Z(5?6BDX3OGK6WQ?
M*^ 9D*_D]8X('44B"8.[ET2DVX/6&B;PG_M\\)LZK!"W DU'V!AT\N@=0%!,
MLLM-/4BQ;:_1]@Q9L2CW_JKI#8U"6[UQ?O)VXW54B2<+WZ:B$DN$HQ'K9S.+
MVY4?*IV8Z1ZK=-'>/5GQ<[7%TJ-YOQ )VHRUXX:BY5>963;@6L<><'!B* F&
MF&,V1I8O[J;WCM>+9-'T!13L8L>+9.0;5\$$>9J=_@!=O9L)[G?V#PBO7D%L
M3*HC0]Q<59CZUFID 32_+#].RZZFH?09E\H8F#<TLKE7TQ&3NH3,Y%A,^$H;
M) PN\<J#99VAT\]<(AC(BYR=&Q=&W;4/T-LNTZ("*SA?CGEUB:8\5W&5Q V7
M/4A6D7#YC8RGS,((?1^WJMT'OT$WS/2[<:M#\*K74)R1R /T/: C8]V)\@F
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MNFM&EE'W:3%K7UU!R=XX/]N+;&;,C".)4% 3F]4Y,GL8[_''SV"/US%8CMB
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M*>%'G<^8I:P@ANS1^.$8>"RR.,H?.JGSKS'#S#._+#6R;8?L[+!;PBB7/==
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M!;$IR2/6G^]ZGX+Y>1;3VO1#-UD2E=FCQEW!+B9JFNU20O[ A/R)%DK;M(.
MGL'-ZGO LP7K3.K)FC3*BY#!<?HPCN4!CO1N9JF^R*.;^N'W?;V 3=%$@_JR
M^5-E.^I3#I)]-MU&D?F=>.^JVFDP9\&E%\GQG )):W5M)I .5,[&_:'METGD
M>N6GMEY,R)?Z"21X[X&08-=4!9*;VRP(YFDEWIU&O'R$VN^)W[=)28^.7H;[
M\*4.S;[YX3),5%O[%X,@1I+UEZF&LZ>@(-2"[I5*3=V#V[MC0HEXNS=F\FA3
M@M5&R'#UH8S\K O92Z</@ :=F2)AD#>80(8CE2^%*5O>_('IW[)\M,;.'%VU
M[N[Z+JNQ?:'YU43XD6#1AMW'B[G?4U 2!O)J"#P+[5W,H_]S0_P?(]%IZ3\F
M^X9^-C4+HQ9BIV5*__VH$/I#NJ8 >-(36=(DPQ3!/M:]O!JVA%6#]T9G2O 1
M93F/:(C9L!>VHPGVV_R:"L1V;2AA!!BE[HR$) B$XYBMAZ<4I- G<'T8?$ZK
MV%G+XZ+I 9,\$3?2WYZ!%5;$=[^J10WRGY/&=0835/2QQY=$Y54)%WT7^T2V
MG<KUERI-"S33<1E0:$3@HM.0>K[B"=I?F)!^PU[2]?87<-K67OMX5%6.G/X<
M^K%J9B=4-$"V:LI\:@T(X:'GNDNLAWT<[7VJ@:,D;G&=39C<+#_7B-0\YO5E
M +W@+,60X68_?JV&]>CKI7%V:T\!:WW:9+-6=V6QFIIZ0EK<[/DUO' BC*PI
M"ZOD#W>@M'V52$^(%?CZY^;&EK*!T]CWN1H'-2LAC60^6>3^/6#)ND7*4ZY#
M.(8?,=B07U6%S'>@1'X0D&R&$#G0"KY)_XIF<B [4(M8-!/IR7QV1'VCZ ?9
M49I6*:GHP>W E]L[27C_L3*0,F _#['^K3UVLNH#7?)AZ@[\\+LM1<C>L7"^
MVDAAO?.XU-_\L*&FM:7>.MS9)0'+@NJ9_#G#U3QA/R^)BALZ&[X4ZX(D1;$%
M%1>ZFLZ_Z/5?:_&,*Y0SJ]DO#4ME"^GGTR9&CVY><11;FR)V[#22CG+-0VMS
MD)2*]5^[]THL1:DBRY1X6'B(=B8_9EJM7KJ1QDV6TIN'IG]\)"2]V>@;\D=6
M$A-3]-$S[XG*6/_CMH"::GAU$5 HS$'H/#IC)?23V6Y-I?98&<H'-E[$IVF9
MO0WEPQXO/$.?,08.8ZSHI@U\#A=<P[9>D8V=3 ^HU@ H&ZC^(S4S_E.%3)4;
MOAGP4M"Z#_9W8HL)-V[Z,?F*X=]%FZ_!D>:]M!U?E]^]>U>_JQ*ABYPD]MU=
MNI7H)%BYGG%[BM!Y@P\>S>=XT>58?F[QJ:]]#?\00Z6$4"_!"$D]_765A[%H
MK+$?=$;9^"DBLM&<Z#$+Q>8?)OKT^&YE$FT+H3X$*M--/ 5JUX)EJ 62U3@N
M'5K6_,[%75@;)R?[_HA)4[4;!P!PBM$JUV)B8H+NP/&2 BYE]];J,Q7J&:49
MT4HZ6&;!(T)X$?CI*\'2PL9$# ,S?>?\LZ\I0X>?M0U\]2$6F9;AU.0;KK[U
MIOH5PJ1X+6 %'RB-%FR..I? 7U!T[NQY*_L7+/+KT6Y27Q_&-S+LS,*(*<\+
M&B SA]8]P%N$1Y//*.WW(IM'F$,A>]9\;4C 2V07]O?3-@K6#7U31T"?YZ_Z
MJXKU9I_I6$T&>5)#[94:\3P\)G9#G]K;V?(&(%=CSI1G-WED]Z_:DS[[<O<*
MDH@E*JC))[+A1R2XGAT46R49RY;3S2!"$:R5',-AHGB-N;(+E$/&@=^IR,Z>
MJ%EK"RN!$8'29.FF)VH?M\L^ME?]Q1IX,?!]H_-RU <J[1RYY,1Y6]AXSOJ*
MT$1B9C3(C^ND<0XQU23V\JHLY/9W*-_<P%O#NB7YO_H_#%O-7@/14814&K+N
M$6A>^:GC1MZ$%QE\8OK*:<-3=UDN_B+6N4=I/&^+Q1.;?P*(%VV>/J!>3?63
M$0-\+0__@;N%6P)B^9:LOH ,5$!=>+OC'".\Q M&/$2E)E5,F9Y]HC[T1-:Q
M1>]N#X"E'3_T D;/'K=X> ]X5Y *%:D=@ZTLKMO11"V'Q?P@" KTH7*ZFA8^
M$5Y @+UJOSD4R16):O.\6(\<_P[JWUD.)"&G2R*G?H>%4RY?7+@W'K:X/#9E
MY]*=0U%4I>Z@:.'A.H[H/O]F]33N5IZ18+PG,H^2_PWR;A\HN!UO<&:.4M8^
M+#QIG-C)P5DHJKQ$("%)F2&43[XL]W!7A"8R@?K:T/0N$=<AR,RZ4H8;-S^W
ML.DAKDL79JYS[?X]%)/;VB):9X?7PKSBJT@*67>);D-&AX?$!Z=+;0[E*"VM
MR2T/547UR/GY^,:3B9ZCIE?3%&+M-M'K<R""&/<*F=>]1?._LE]312N=;L\"
M7>Q)$M)I'^AJH7I/WG@9IR^!DQ<T7GST/(W4G8/^DSNS2"@301(:*,&RYEK6
M8EX$(1!^'RIYS30RKS^@D=5WCL[ [FP67U0\;"YM+L)9C5I9M*:&T8=$><=U
MKD>[J,K 5&&S=]8-HZJ0EXWW %2E0)/?XW7>FIJZI+]BI\^)B! 2GH*F6.^K
MOF!X4W=701S\=ZX$RI/1R;HBTHG(!05E<3C=>''"ONA(S[L=/':7]KW:159
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M."/S*,6R&814PKI.LC<372ULMM#5+3_L.1;H:.R"'_!=V%P13E17,76<_5G
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M<&QP7H1=:<0^R.+3T_NJF3:^%\9=-[,7IS9R8WP#0:\'!:X!-JN'#@<?UX*
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M='V4,4WE*Q&1$U]M[QH ?SI*+AGR4IKNAH]K%A32[B5SYSD?Z1Y/E\\)IPD
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M$KF)5S9R&YB7K$2U4*^B\"G!/3_P;'('\E-=LE<_1*L.1&DCV[;LE[!V =<
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M5;V5X>+21]MUBC@C]D7 *M-%16,(=;OBJI-J5*>GZZUORS4>2C3ZQKP3\L<
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M1SK\.)563')XXHH',$@.CZ2"8[T;PLB%7:NV**OV;EY8]?VCA4.P>O8%= 9
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MZP_SBHT]:E!WIZBF"&]?7C'.-=PH&T5'&J6"U& -:Y&LKM<U+IGYT8C$$NX
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M'>3M HGF*;&)G*$F5TL66.))##!!NJRUJ;ZK1>OLRU$ C[P $N!AQ&F=.$8
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MB6I\%X[.*.,;D*N=B^W]O;A7=4EJ,A/N4!L?!MD2:98DRM5YR[3R4G-;E4=
MJ!2F91'G(!RT@S G4%T A3390/AD5,)":\U=XAVVMWAG.TX8O<+%D,7Z;O#2
M3;?"-EAP9@$9U2!J'E#*+CI,EB#>3/02;?!J,$ZUN\=K@PAZS)[;0Z^<^M4&
M(5;Z/H.\(E:)HY%#Y7&:F"NKW$=)>C8;3=Q4XD;I#VD3D^C*VJD]SW*S#DC,
MB)&,F-,P;7T,]NQFFQ#'%N7,V.SU'(FAOM\BXN"93L_3K&-J^=FP@21LF>(X
MEVF TT-MD;.GY>3$UAM1 *<7:>9$CE 2)P/FQ)PS3<?,2393*\DAKG"0LUAP
MH;,^<[W+%3<DSYYA$PCPMS,,\Z&9!;=[-$_QI:KR72(A%+L-]JOCP"VL706F
M:_R$T&41T:'MZ_9$G#40I&7G1YFI!85K:8J>"#IQ15ACY,D@;O@%Z\S9ML5,
M("^GN6X+D@I10X@Z]7X_/7J6Z@%'MYRS1!S23-7S3":NSO&P.:",=8 RYX1'
MU$(.O)U-VG2UP2%/&X>;NGPSG8J[HY@ZIK,<Y( MBS:7!]%5ZOY8GD!/$55G
MY+AK^TS <TWDH O0N#;X8AS@8KN:)GL#*!0%<=8;15FELYH-@IK%=@56:L$(
MS6A#%5$1;SU3XH&VS>G*=LL>.C\+$(C].BJ6B@XO\(D=9)8^;&T[)4N&$"[
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MD54?HY:Z.J_E2JW[%-3>5O4Q:C=E< A2*[Y-IFE&W2@U@7!B,B60.4W-89B
MIR2.$A"%P"B$+_!;NN]0_S%MR%[J!A=VL(BMJKIY=:;D+0V/NOO8@7MET'HN
M76;)!WA(QTLNK>)&<(>%()YLQAY3]4Z:W3NLQ0>HV;W3/#VL.?M++\?CUK]3
M,^7CK,@=[SXJ$#QR21Z[7NN@JK.RO\/Q*XI7?'".7[ETUAN6<QES*FOLRD77
M;RM[_$IW, ID,8,(>H&1T!)9$N/2S><839(P-$?1!4I.;^E^/*-XA/[3T4MO
M7IR8=S]$W(] ZOG(4!B^'YK=@*!;JBZE'E])E?GUR2H]\C NX9,?B7.G2H^O
MW#E:Z<%S;X*W*MXJ^, 2Q-^,-7ORT/?4U^QQ3R_Z6[]FY])'NM\M7WZ4NW[0
M<GKP\-COG%9O$SB?DG5[YVZ[>4.IK;)N<JG,_"#V;DIED(ZAZ@DD_AK@B2H]
MR5%=-9@?'@>A4$'R@0"+4<Q++XZ8JQX'H-#I!P10Z.P"ESS.D6-/=M[8H_',
M..X;:ZO2@RJP8V_3>F5^,?TWU;+Q+BWH\02>2(U:6FDU!@XO=?J;M!57=U+U
M"*'':A.E$=-6-^&':EX5/%92L+J+6THP>!\X?A@7X\;I)H9 #T"7GPN_.Y?=
M2?)X$X<?+7F\HV23!O5-*1MGJ+HE>%GT*+]\5+_O,*J+5;[3$6=SZ_#!BM>C
MO=VX.#[PXC#'FU>' %YT^A'E3UR5MI(@[L^5;Z]Z5?YDE1WOINP=FM@J'UG9
M>;)V+P9X<Y-[Z?6+WVZO?'GG\2NWYU,>E7HTXL/-JS,?KZ,/G#/*8R4>7]/%
M28U9%=3>+0M_=/&3#'X,9)<3;%W,W0-U[3]B"F[=_>O.V8^U@:NS'O]_-X2+
M9O^.6X'M_LVP@]L/ ?W+V<&5AK^]EC!#_T=9@G.>.OMOGBF<CXS]'V00UQ_;
M^M])NQC^BG9Q+GTDBG@(DCP:=-P"(U)LU9>-W F1/ 'KO[GHK?3)[/.F8%VP
M(^M)Y7;>Q:''3RHVCRTG>HH\Z7$'>6L&E)-5.\=5F37Y4YR#IW[P[(W#13.7
M:TJ=-VZNGYN_?MG^>=_W-J$GUG-IZ-#ME>YH^G^)";O3G'S0.%GN/LZV[WAC
MY#+((YG,6'AC9(=NXWCE%3>7*/KZA<=897_] KR/3.(14D_8X7.I3-$WGS4.
M]];_MNA.,_W!_WRHD0\U\J%&/M3(AQKY4",?:N1O5"//>OC_>^BE[H/WG>Y[
MZ<WW_\:UQ;6[_HJ?"R5_51UWO?\GKCWGF7?]P[L_]YZ[GG/M[N?<=<]S[GK_
MVZ]]RK6[KMU]]]WWW'77M5N?9SSSW@][^K/NNN=I=S][%(@^\MI=3[O[[KNN
M/?V>#__P9SSKF<]Z]M/O>=J]S[C[F=?N^K#G?-1'?\S'/O=3B6=]W,=_ CPS
M3]V_?.N[[B.W1M'_TV]^U2_]RKN?_X)/F[0_])87377KY=_P+6_^R5]\(8(N
M:>]M?_2)G[ZVFR_[QF_[U?=@\X6L^E_\33_USC\>&_NDL1L7?7FX,]?NNON>
MI]_[M&<\<[QK/.?:7??<_;2[GW[O,Y_UC'N?=N\]E])/>\[3/^I3X7O)C[YO
M:Q4?,WGY-[SYCY[QL7+Y3[[M;>]\_A2=+^KF!W_H+2] %/N+W_/'SU5?^<]_
M\9<^3?^27Z:TZAN__5>6SI>^_?V_?NW#[QD5/>>>YUQ[Z;4__..??-$SO_6^
M_*N>TC]O_*;W)9#PHE_^GM\(OOZ+]_*_>^V7XJ] _N?K?_B>OWC'[VQ^^P>^
M[NU?]+VK=]_X P?YJ&__U*^X^:*O67W+U[F_^U.__&LO^?D/_YP7R^]\U<M_
M/?ZAEZW*/W]5^"^^@OG,K_V%[+M?R<XJ\!/?]/D>]$;V>=[;O_=YS>M^R_F4
M![__7<F+OU%\P_PS\7<?^,]]\VOQ\B.C'WM7\*[KU7MGZ[?^P??YW_JNM][_
MM/](_NB/W/OJTS?\Z;O?\2FO_MSE#WS?=WV$_&+DS<X_>/>_?/OKS+L_1_Y$
MZ7]_(_D17_*UK[[YO!]EW_>S/_-??O);?^YW_O/+_^!'^E=-^6_[H_+;/^XE
MO_/1W_]5_\O'2^9[OO __+W_P_GY]1]__HM?_0O@:S[GY5_V13_ZT6_\C(]]
M[]M^Z>>_][1Y1_XK7WXXOMY] ?;Z>]L?;C[IO_[,,]_Z1[\'O>U=+WO%AUW_
M M1ZYQ?_WC\C/OEK?O%KAI__7W__^W_K+]YCC:;Q%_SK;D#?^%U/?_\U\N]G
M;_I/S_N.+W_=NY\5__*UY_VKS_[LY9\..U=[X#4_\I(?>7WWUC]=KV\\ZX>W
MY3=_V_/>\H*7//L[?NWP:N_3OC3XL;=@[_HWK[@)O/RNW_M.[7/?\I:O_'??
M\][7O(%2U"]=O,Q[^GM__?3Q_W7^L7_Q+=?__L=]]XVOO?[<S0M>^'G+Y%NG
M_[Z^^Z7O_M,W?=6/'+>O_&]?]F.?^-X?=-\A?)]36>D[?_SU[?=^Z>M>];6[
MKWS7KW[9EX5O?\O?^^9/^WZ9E3[BI[3]Q][XMN][ZW?]YI=,_^VG?0XBOOC3
M_Z^?_@K[1=^4O_<GO]_YZ:]^]<M>47[M\^[YB1_[S"]_\(7*&[XW^T?FGS[[
M==5OON.[;KSO?;__^3_[)R_-OK.YZ^>^0DO>N_WFZ"?^P<>T/Q7=\S[D_Y1^
MX[?>_I5?]?)W5&\0A/M^]A.^_M=>]LQ7?C;PS>^3?O>G?E!!_G#^;:]^OO0%
MG_V;RS]YQ@]\??*U/\K^S@^]#Q37?_IYQO?D'W__^Z^];'U]\GO-&_YI^;;O
M?N4/OO8?O3%^W\LFKYA\R;N?"\R^ZV737VJ_>O(3;Q%6/WSO1[[\N?>)_^QC
M_N(+7KG^%N%-K_^QUW^^_%GZ#_S0?_KY3_J9][ST$W_ES?_Z__G57W_)Z87/
M_H*?_=V/^\W_Z4U?!OS):[_GKC?_#HS_1^E?_P#_QG^(O, RG_USW_/=_!N
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MA(-1>3<7X9N2D0?F;;B<LT_(](V)_P#0E YM3%H_W<R<J4R^/N.UCCZ*%'\
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MGCSS@=/+HFM49?#)LZEJ]O/XXJ!.&W<4IZ8(D.\A?-NPBF)BT2H*(S*^%<3
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MG+G[5R".:"55#KFL8WP3J:5MLHV0FY) !HI#H7=3*/<29Q"@2PG5]"*R@@_
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MA/+=H2(!&#.H4.MM+2K25A'?-OHULR\?@"R7W)5_"%;-+5VY(IVDKNC&G!\
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MHXQ_2>*^D^M-D@[=W-'GJ8P4Q\9_B^>B[\@*ID<6^&$\Q/K;A(KJG6*A\S1
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M09;6.UQ)!0SMZ#[6Q[>13E$;,7S?\F>K+9*G@,XUAKK#6_B>2L7+JRMJI97
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M*6[GHY_S;1_*22H+= [+22P3??<2@@K4&6\?WEPA+-HLVCU=D-I>HP_2 ND
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MV$(,O2N^&&HQ$*2XN.F22&.@XGPCA3 @;A:?94GMSNX22,KVX=2H51&EM+Y
M:!.2#-2U8.\G8'/9+IO"H(\'>]["/X<M_&;0[B;0FL$]-]?US>#:KFM&_XD&
M?=(F</T'[W.Z2!-D8<4HOR^HSPGG^WE=>XU /9+P5+65*2W7J_4=6RAUX:9%
MH_:UF9K9S1DA$TEM-F_#;!4OUEZ&KG"W.(\#X FI.J.R7&+-_]*?G59^F9NI
M6\"G!,%0_VNFSAW8AC;D*F>$;&Z>/1KZDLBJ6HC/9?-'12Q59*MRF?M@K8 Z
M6O<U<Q37K),&(NN67@*ZE/WP2X#%)?[RS'CK,:;6B"K4(-]&EM8D'\)V+Y(%
MC=6\!=\!,9K)E7:(Y+8'2>'\./=%NJ.Z[(#,5Z# %]JYKG;>DPB?@W2"@WR^
M XAI.I]G.M_!3LE<NM#C3J!E8M!_5MDK%/ 1=(V$5Z!LE-#]\'AZ/7=Z_=3]
M\#$C??.Y<G43>Y\=79%86YQIFEB70-KF:YX@W.?K&8'_YG9=W^MP-T'L"KXZ
M2C?T7#%\WC%TB7W^/S^H_+^HXJWWS5GJ'D_*H;7^04%O^Q=WK<1Z^G^$V/_U
M5Z1_;9_:"4IH>HR.UJTP]E[VC/3Q/)N8F_[\>2:(#?/,>91!E#RW+%SP3$S\
ML[O*N(1-Y*_R+DV,Z[(7$2=?Q%&?8OQ4Y%UO'<K B3WKCN5JA@-EZU")\86I
MUU"X3R[E7MQV$I!3GI8%IH]4,[31B: )C')/<:0NRVJ3V7)[II9_O_J0*BG-
M6UOP]8]XL$WGQ>4S\GWH+[(=I4?5 )O!RMT?C.ZX@5%FOU/Z_'##:IJ3@_82
M@F,=;R6#J3;1AY4><]SL*B4MD4PLC]$TK$.=DDQ*N!J-[C* ,.'=3)7"_Z"T
MRS1_V8GV+SDW9-=C]GUVD%I146W\@XHT_6*F7/L&>?(INZ%WK94%U^T8<PN/
M2YD+=CW\@\INJ(G\V73BSO+@A! ?*:W!E[=RQA W.'++BHZJ??K6_Y=C%RL=
M[]%RJ#26A>+Z.WC'8'KCN/07FIY!C;^KXU(R28<7(:YN<)10I#TLB8%<;8H;
M;UDWQ_>G]>ZCUP/$^"\P\M(5')%_"G$=S,3Y<I 0C4;'9+:4:LJ9I@8&$U(+
MP,'&>4R%UT*#3O?7^]6''&./"W0P!P9W2YI2*TS[?*@ 'WU;S;@+GUNL8G<P
MFH5+CO2A,$XS>XC]JA['B"=5_:#6;G+*][MN2W0K'8#56.H1B:/7<VO[9KR7
MEMKUW4_YN179;.I'[<9EG!Z<%E2?'VG6L+%9L>;F<E5T-'^D=JLRA(3C:K**
MN<)4!NZ4N\WCK  3<):UE+??SP TFQC<;YOHI!/!@2R3#3KH=&\'=+ X?"2)
M&Y;\.8$FLPG(YVQ$)IIGCI$KT<+S$K^KDVT+G^)B1JHRF[,$GW>,VDEAH,6$
MEEZUIK4]9K-DMC<?;[@/B_E7)B7=&8-5@;8)G0Y44O)NX.^ZI@@=<*P$'6_3
M(JWI:DM!#:F98^PY4CCJR)/G#"Q86,3(9SH#M;)I&5('P?I<]'^SE+HN?RJI
MNCNC=[>:8GYC-SV4^H*5H0)(D_SJD?";E"1K+MD>ZA&,6\\-1UZ#ZV]7\%TR
M?'[?@8@4TFB*N;T_?SH^]VB4.Q9GY^1 ]IQB,9;1N.,TY\CL[#H*<WFE-K##
MNGY+Y+ #_2@U5D9%*C>,9_%G;:"P+'$!>2E#@R8LG<F\']NZ+_)P!1(LB+**
M-,NG<7(DH'4XG[@O,:CPE5FAHL7M9!WQ]K )T3GY)N+CM9<-$-"=J?2N\F;(
MZRY\3GM.2"W4PUK-N+WOZM,*O!N- 43 .ZG9D%^V(X1S)TOQHS+'1F2(Q_-P
M!;,_W=M2+KE.Z%^6;UZ:@>(^\]+_00W3WS\,F?\I^%\RC\7IS1?IVX5N;W'[
MMX=R&?YFP) 9^P+&6$LQ4GC<(CL"!W[<9:I+**<<OQU?%\6GH,@>NV5XX:1[
MJ#TG,1N-I<LSIPX1.E1KS:.8D:C##(!_HZ9KIU011HV*20IX>D,GZ"9,+4%_
M7IY-@(1W9X;$F$(;#,;C;9D5D$"UFH(T%DM@3Y6CQJ426P;KT< ##=W@*@S'
M+@6>/L[;/Q1%,@QK-_R!RXMYE7D8G;CHFDD=$'^R^R]1$W_*B-.&]N]T?.]"
M=-FNQ#@+)DQ'H)-9@<-?.P R;F%;311,24U9YJA0[:*MK4+E;_6'Q(QT_X?U
MRAEK\%*9SV#F&%@N.1.")B3#?\M*W21_<?#4D;_G=N#'-QI*>*J6XT>GB):P
MQ)*^2$!3A8>9NUQ62ITTLL#0:?B6O^78\(8NV_3ID\_83NI;VMW]8QW4C7J!
MA?0T&R+%_(!+==NB)*F4!VS$%K1G)4ZTXZ08U7 )%C?+[;:Z58%;!?%S"1J#
MI)GQJJ4B.<_<OE"V?6R+Z'WV1-6FA $-8=4-81<&++2D!35D+5+!M0N:U*S7
MC#B*"NP008[!OML9TK<)TG=(7_>>3T9SF&:S0]]]9A#/8_-#4M5KR\ _*!*1
MROW^/S7:N@/&&8D7PHR?&B-I*<=U;K;_%W]$J=?GY%CL9/XL?Q-98+#[7J+,
MA*6S_YC<?(I5FRY%D6Z5AHLN/'CV&M?/%-MV_>K.(R:S5]1SXR_NYULL4G02
M#^9P_KD=R5YX?[QVAST0#@O9G-\J<]62D@[J(?X- /^'T\7T8M^)/=^ !8J6
M"Q7'!$4_RL(QEVQPS]6^I,R%Z8S!."V+&,7)GN0(4R85K5G*UFAB AF/W&(+
MFT7L";:?#HQ[:&U@?7&G8I/+/N9 Z>JU5@IT@$)3+VUT6@,Z+7M?*7SL3$3M
M U<LPN,<F5 (U54E2UWC_6;X/9J)@&?$S+*N4%:>CP&*PTL!HK.JHE]]E+Z(
M+OVYH6?7EU48R)Z?_&%;4^OC'M?*'IO1)S;27)K"E?F?G:+[OT\99JZ>;2#5
M)S1Z+^).VV+YGNA ]3Y:?W?)N.[Y/>4YVZ.,'X[(5HIKO"1@JB?:-61?^PMI
M39HBUU>A-<J2=\?%*G 'G,UPL 4S@#)=*D$OIR7?2.#2WJZP"WN$:TMPZ;(%
MN.$9-!NW5>+'!TJ[/4FQ,>3XFFBDW=N4$RV^3%M[.ES! _*2&.>064W7;$DW
MWK3J"A\QXO[Q?: !3[*9 N0RR2AE\&?0D%!0,GSDP'VFY5 S/_@5N^N).M0Q
M)B0_?D%@#&;IG<4C#PN(X,-<'F8G5&0K&&PG(S7YS>,EKGP@-+P((Q>#, %%
MQ9>RM8#A.I"YVB<5:Y81K:[#%K3\GK)7U\WG+:W>)>Y,[Q$0].%L]B+.\^YU
M@4X_6(>OV\R$G:2UZ\VLMBYQ# 'R()TFZ,*M=&3*Q+6$EFKHMM&F$'\17 YZ
M#$79W<GH7QGCY*MW6HY Y3L"+("-I4,VVY[MPMZ*YNJX0LZFM,DZJ;IP07K!
MUK]KR&'AX($Z;.L*#:I5ZMJ6T1UV0A1J-IT+,Q94N5859=:'4<>Q<6]C@D>:
MY5?40\B1T Z^\8SPINU%=E8WMV=MK!&WNUXT]:M$;7JZ541L ?Q*7Y@3X.K,
M/K6?T$8I6;+6[@5CE/>I6&W_0YH.6&-^G*:73_*K4#!14$9^HSJLK.CO[W_=
MJB<I*@2\I,?&HAGS?TX!5,1'EA=XH\:JPNE>Q0I)%[9)'TCB.FD' M,U6BA,
M%DR]@:.7QG$>!Y4;=/<K<P=;9@6]Z8')W =Z6-*<N'M25CM==_Q;A[HECMP+
M'WB'2G$.4[U=FD-WBPNV5WA?G<>&6QO3$XZ4RY(C57A2%57X;6D6L]U:3/C]
M]&0^\Z8NW!J?(\+(@]5CQ];@)8D1L"G)- B8H;A%,J%(#G]=MP\%^C WOOR#
M6J,SN"MNK$,E:CKPNL#6?MY7;_&:6F"+Z/?NR EU&D;12AIM7AZHU27B<0&Y
M0I@-N%M22&V_B;)*E,;#M>"0B5'-C'P>0+80'>,3PEJ^.(I["\/M8COY;UY&
M)]YNN,&L)'[C"B+T#I0XW6M1!$K;,,AL\4AN8M,9W8A8H@=;6N@N"9Y?P7QE
M1N?]_:J_+OP[4Y@SE<D)G,6 G(C% (PKD_VI"^::>JM0M8(4MG4GNSHKIDMV
M!'&UH1D\059<UTM^.K#^2*6)L^^+VDF!8&$I #HUS-=^H;< .['3%VZ1^;OD
M9<?QK"E,":+33/30&.K?_,9[ $GN$O:_0!V$P#W'Z8._E!FF_,AU3:]VQ99>
M-$$B#(U=O2X73K4+/&PU08\-E>T@+[>^X"5-^U,246R[946!!G[.T0O@R/7^
M+IA4<6$TP$^UP.=Y'9$&I%HQO3P4"^T_VM?&O5!0HUD135KK6-\1=]LKJ3X@
MOO*NV3R[0^5QYI?6T\DQQ<5A[!7DC5F0P!>SG]<]H+,-DN+P^=!F!(P*=)-H
MS=TXRPGJ1E#%[/T^ILI!B33<U&,ZG>3:S/<W=(KU>USVU%(5YCPG<2JNC6TK
M7!*J6T$47(?5%8ST%OEI;']!J)T*ST,W=<2:>4;3<-'F8N9V-Y30(ML=QLXL
MSKQQ?*D@%T]9]Y^G1/[23?+IJK?E'5!UO*[=[CZ>G\'&NEBU.&'I0+*P3M+<
M6)E#R*:MUR6G?1'=Z5<W*M%P0'TQNK;:N9X=$BY=OO@12YR YX.953\LI<=$
M17.)<*O#:["ZUOFC_\1&N%'IH'G ZQ^4W5(WS=1:BR3WI1Y9K-;4/+A63;0+
M<1_XO2+1F)NN-!]_+T(H8,L\T= %Q/+S_XMM:.)/T//#[(6:!1)PP_V#DFD9
MIJQG@_3?;(G9O6#;&AN>K+QV,J&DHMDF&C[NE)3>S=0W0Y;!#84N.P]_X7$'
MO9-[6:306;['W+Q51$\_W!F7]*%$ODO>!(X(,C*^96[IG%OE> :QE3(7S]XY
M!A(WT"K^GCUOKSK4%,X[QTTJ1JR%$).(YIF4*&MJW,A7#7GW;=9E&%J?V<[K
M'NW8T>X8Q37+,]^?B1@O# R7AKPY]^5&M<?\W2 CPQ#]2H3A018_0 *6]ZIF
MVM<=5+5POB]U4ZT<<.UPCQQ:>C#CR]&"C.?SC\WW'IP-*.BWC8V0QKU!2C'<
MTWV.3@=[W.56A.9 )1RY%W4VFYU#4/".TZ&]BH)JB@SDT1&REOX4\?%+,T!I
M.% \\43N#Q+(POY<3;>VF5>*Q4Z[-@J*0-! A!/_PUO-:M.)VW.=ZNL=&!>6
M+1'9,9_W^1,6OK(L,K"\(M"]9?\/'>LF+8HMR8\5_JW4QC9 "@C2I9U_-Z]4
M\^ \2'0PT*$?VJ%$RYE)@-,$E^=FJL%8&']U+'&GJ;"KG/N2>U#9M<J8*%V=
M-;3^D:88I^.<:3P_WN=@(\@\V6S;9#*SK.F71OG3-5<]Q89QZE1\3NE&8LCU
M+.B/@#JM\-O8)S)UK!-LD$??ULJ.X7L\N"R0+1YV<=7A3T.VU/D*S+9:_!?N
MROU7':^4\^H.3\+_A[JWC(ZK2=*$94L6HRUF9F9&"\IB9HN961;9%F-)*C$S
M8XE95HF9F=EB9MIW>G:[WYG>[IW=,]]W3O^Y\2=/YLV(R'@R;MR("+5X#T<6
M,A5H/G:PX:+!1I4.W^?5AQP_ZT,DZ+[S.+[&[UK"[':VWCC?,JAXD%G_A;(&
M$+8TBC/US17B(!*#?ZK*8W]SW=>;%W)D6G>+5P?*B<")+KZP8Y@C0NW*Q=CT
MY?U&^!F0-![&1S7>&?52*F*R'2 KM1!EI^&:]KDP4JPN&LUM96U8"W>SO'@<
M7"#<+X&34H)D*._% #L+AB[?_IU.#V_I,QCK_IDV:20L>6E^V0'0V:A^"7U1
M47"Q2*7-1*#R:>2$E;D40[^9R6[5&38W33F8DH:N4;*7!!P6FH)?KC^T8V?T
MD:X,#]F?'[Y[8&#*4NKJMP9E\WQG]SJ(;%M55E=27WRR6,;X@^/H+[;^5N.#
MD39#50:W@FLF7,P4V4]T3*Y- JZ>@VW?GI';' -=8W*8NEJ(697VF,)<O)].
M',Q?&GE6325\_ [A8TL03.3!O9G0&]UZ[GNZAB*>VO275VXUD_N@CPZ[0 !
MOJW]:TL-M3,==(W%<5SX;4;X%S4>0EQCN?[&M;E;2P$^1M_HZ"%!IO:O.MDU
MB127S! FIPPT^C1%N_>)1 UKG=\T-#Z&J>W-),GM^OXH-)S2OD(\[32\J9-[
MIRVK:JR-Y$)L"MIIOKLI33-:0"\M&H5)'0;OY!I5XY*$\&'6&#'P'V$;4UQ,
M>-NO_%3))S0[N"&HL_0OW07B[M6TWTS)4)<N%F9*&I4Q\K 00]KY$_;'^YGW
M#61L$E0-1\47:(C:30PJ3,4RNBD2O?OHF/>IE2##'5ZEGS-J[6MS_*F.<X,1
M']O9B;L&!<]-8HD(4IFE,@68)AR+ZQKK.WR?':UFGX_TF 10+8U]WETI)WY:
M.D2\-,,NAV_NPJHE8F=>/-)$BC-<=$UDIB?DUU$2S]@3C*#NG=3S,G,B2&>&
M37V1%;DDVN[4]AFS(3)-*T-1'F@ U&=5);UX)3_0F_3+2["-#BV@N+=*.8>J
M#8@;96"AA:%7:;B2$C3LAC01@:QC*QEYB&&P"#U!YRE?/(L?OC.C&!.U,0]3
MRFJ!AWEWS.+I?H3*LL,GG3)\#.7@H%:34-E=0J&A<)=2<NK2%'MWO;Y9S#J(
M0^D]?#* XK]J@1C>?D(\/=EB(3OD<!*:5N^O 19.)3T&17W]1*G6S-6^(.C,
MBVS-#,B(P75[10B=0YD9QSQW%MNS^P#V>RB1^=#W2Z_4*9O8^#IZD-)?&V&^
MQ*?8+0H5+STPRLF\SS%4-JM7Q7/%:RH;@9O:D6UBU$#0="9:(K)<23PZV53/
M!L:@1MFY-GGOE/-$5W93F5<2ZL2-_\[HQL.DF"T_-9C&79E[5H%Q^)A=.=DY
M$1/^6L[*0HLZ=<CT1W]!C%=5C2Q72Q?JDRSQS!$Q9H QZBWI<OUW$IMQ?:83
M@R:@<BL.7.Q,[6\P)]Y (#%.:D0VE]M3%QZN7*PF-GOHTVU3\3->=O1*B.!T
M.3:^I%K\P=>(%4)"YNGO?KX1C]7W_>NC,FO\E,;X]2)"E'V@=\A5>\I6OVWS
MN$TM"D7!>$0T- C+-4S8=M36&-N)-.\2.3&V&\QP-V2W*.#KK+_2<-8M1+B[
M>Z$YMVL$91E,U:^,+=:;B1O>C'H34]&GR*)4I%*\\_^X3L/RE>4X3AOR<!,L
M1#D;QTG827KR&3?:^N HD*!8_=\R:1@DW@F>WM^L);W8U'/QI(?5PNO&XT\$
M8W\FZA'U30PE\B\/3WCX*)$+<Z&\;3CR%:^',Y9V<9Y"1T _N_[)_(*3.YGO
M?=W*\B,J/=<)K[XA])0,=-WOEE-D(W.^E#GH+05Z'$K[4^P^G<FM??3))1EH
M%>R+LXBUPCD=H)/7FBI;_8NV/OS]2(V*)@X#^6 -4+?:=+:,&EZ 4@UL;+^(
M@(BK*QV$C.TS8#@'_,HO27AC$_N7EQ8G>:;OQ'KM7O;6C[K-(KC7;'FQQ'WZ
M[GC]_5'VR*?^SL#?;[[Z+BO>+^N%Y-KGF;$=Z0FNW"MQK$*1OH5#Z>!:]MM.
MDM(6_X/1]6R]HSTW:XH5Y:/X$3G !PC\[&P_LSXTAPJ-;^W#Y[[E'%Z)VSD4
M%$#)M16: *VGG[ATRQ+7?Y>@+W2I0?]U6]<<[BGNEY=Y6U]3-<4;%.5^SH>/
MZE+;BL]</+U!..\OANBYCM-])DVEVVY1D'WXAN<0^"F2]W2>;W4)-]7_^CW_
MLL-GP(3&-$S06M %=KC-Y^4J,)7==+3F&^/N<J/L7BI*&H\T\JR^6VT795PW
M%>8PH=-91_E<\ZD-[CS?&%F%C9A+^I8MM&@S90;4^YVR?L(XF8'<J,MAAF5"
MI[YY80#E-Q03W#[__?:_C&6FA$)@^$I]XBWAA 3Z<63%SG7RL6MKRY8H\:2F
M8NB+@+3P)!5VOFY5^!?&!GW7/,U:V\<N:J'=U!%G!Q"CL-"4M#3 'US/FZ>K
M&LH+]X=3\2%63S].,]8;U1AM;(+_SD/R!M\6!VY#AKSGO@87K$ 1&Y6%M,EX
MXL.9\L-5/5W\=@_%<O)B<YLMKG01NKO@4C=::5I]%0?%[$-%WDE7L%V2/3'+
MNM^YWH$D:S^.U Z5VM%:1-*W-2'WVD8^CRFKK32IL ;CU5HUUX3Z6=[ T^+2
MF(&K/*F1J*0IWI1:W.7?D\VMZ;)A3AL7(]Z8?TB8C5"G9!8+[;!OG1O14HPJ
M?J8:F(\N[9(0A4.9-+ _L-\^%2T8H?#/.WKWU01+7"45&.YC1ED(B0OF2R)T
MB ;MLDC1EB#+EN%^D5W^.E)$K%;)&Z?$C.9%D(+LY!UGOW(SE4X^Z/D?.BZ:
M&%"0K3,*-QE0;ANP="BXH3XXG9-]9Q26V9*EX.WM4/6NZNM0<#41'+I&6_?#
MFV2\])TV\!JN]_[S/%A$ER[7=M\^/(?>5EUA"6QJ9WK[N?CFV%SAT\U.;S)(
M9OF;I2VZ:1?BYQD&B<$\*2]O1G(]8BYI,*&"^[DP3PQE*]6I!S9!5? ?B!>%
MV\WX]P&0A1\YO;B+1(GX#0\<@T(:[6.P.!G!("B(0I0MD,;L!LW?C\("[<)'
M66V (J=/YY@]9XS;U 5 82#)40]E5F)CR.(T3*C.WO8;<_[SZ;%I0V :Z(M$
M=<8H/;H8@W8D::-EY=KG6!IY\HM/4E/.<97I[WC97+TY-]T?GC;90K1IYNM'
MD:^<B+$?"16DN?)5-?BF(>?\V4U[J60#_#P@":G)YI Z-!%((Q*@6T]>75 9
M(VB;7=9 C-0NUQ;4*F1&2FIF4[+_S<6$0%56<<E.KD#@ALBN##M*%KLTIU[N
MU/VD"399$UH-CY@,.Y;\!.&GQP!#ZND4XX*LH$G8WD9< 9$)J64K([JH1+S7
M]?D8YF,;($&QM>3W0,H8Q5BZ#8SA%=EZ$/=B.;C!/.[XGFC3RFF-*@0SE>29
M RHV 32@X\5GDS:74V0#!,:"?FI2;X)_X3^W,YHMVUW<?6[.<<LEQ9QF3!ZA
M_L)B.$+ F&75;*X@'J GC>@2K._]60\>6(LL=&3[=);_A5RBS>MHR6ST.\86
M2H\3(#]J,3L0T1-^<20R?9PHY[+YU&H/LM9;>J^PQ7U!@Z.I)D8*"O[!@Y3M
M(K]P;Z7WFF@>FY<FI);PL>]B7_QW5;6F32K5U<Z?=<_-X@JK$CMQR2YQ8J*N
MDIZO=H\8#R8^'$YRRG8^GO_G-YB?"]%&%>F,N?"&EZ;,M(^LW3@*!.SJ%QH#
MG8YQ5(06DV9&[[(S @/N]*NR#UN2[HLO=INQ&V->W!'IXQN.9@YLMIK =F'I
M#6AT(6AEHG-Q8NRU*:GDKI8[6H 5<BPC<-/CT(92<^\RMV2G?+7G;HE%[ DR
MO[],-=2ZGU_4V6W5X23DHFH78Q>ZWWU/[57L%I%>!]3(R'7R--6;.>N"&X^M
MSF9D^PY<:%8 E>5/B6R%B2!38V\&"U*2802SADQ[]2Y]K:3E=?S:)]0,FZV%
M%%5A5/7X4O;(Z!DV+RNAVN9HG0'G\GB@?1Y*9N&\&2X > 0736NW%?JMX;<V
M'%;.6K#&3B4JT_"Q.^X&,[\O^7''C&?LOYB4L,,W1F'L.U[DMPM^Q5(-U'<1
M+FE58:DHFP@MK2,TES#"S;?/OLUO:(K@<->1( W91D[I64^!^A",U!F3',X/
MXO1>2$1)%SI&:H;>.RA)(S%L-@L-;M5GAN_TRRR85STTN?:P)'Y "C^>U-GR
M_3I59ZLPZL"4()M7F-NU![=7#8"!X?+[1'Z"9T9*/Q$8QO=-3:OP()OZ(I"#
MN18G7XQ4M$9N;W?8&R2UFM%I_!JQPL+^A\5BV=N\^:(C5,?V!D5Q&]R;HS.^
M7S?[R-U$!YLAN6V^LRD1$Z$Q2?LN%*-?'%](YET?3&XE (GPJ; =\ST@8O*E
M59N]J8Y%30%/PL&8I3/J[*8"Z MH2#KVM3*T99Y>5/H69:,R;/.N_C-9^@@;
M[]*MX,]OGM]D'WC9/BA97_SF=:%]-6:+V5G.J2(96D-%/]G^&0(R5$OYM8 B
M\^0];W3&S3]M9]<9N9J<7[Q7&:D=# /99;LOXP)+CBSC'_:$C0])+-UE6FV!
M.8SS'#["C#->=#T\?V!39?STAV^:2(T^[^].<O!=ZNAA]WYXJKV,I5WG@MI)
M6A?]=^^G&DZYTN4$6<,IF9A0#K8D0J9@<E2A&#3\5+@Q;/<)^/M]_6*SJ6A"
MON/O)G!8KN.SDDC[Q<@F-<W@&3G%.[J#W>+8SBT@#:<SY<*!V\1&'<@8-X!N
M(P4LLZ0G52ML4J[E3J09JM"5^#C\@1$,Y54PCN*AEK#.<QAXHW.\G(4_!X/J
MC_A57S!H;*.A)>'9ETLOL]HDYN9+HQ A/!_+>3!2K;4%GM:$I7'9%0N%3!3Z
MXF8214K3906, HHGC5V[;]E#BF]D*\6QT-&Q;^O+_'86M>_^D;+@+0F=$'%6
MW-KR!O'X=F9TUJ9P8^>C\'>/3:]:GEV>.1PCHO0+J@X,140=:]\;.T/<F-D[
M!<BRNSHJ)T"\]O'PG3>P?$%" 2>87=+9JH3H<5Z$B^YC@&24Q'E=@M+OBT[D
MA!U:,%QC@?L<*=)ET].3=U!"]F-\!?VBUMS4$H$!QP_Y(VLM=1K*,NG$I/=,
MN)"!Q&&SF-S?X=$<K(N@?O%^O)ZU.%[]5!LPH04Z17NE_2I+A$I8.CP*?MJZ
M@HYOIX7_&1AR5?3O2,J(.%R;'?_,6W[9%QL=T=M==,1'^J+P8C8_7-YJ+^CR
M^7%TD3V:O;]N$<4X_(R(;MXS%_BU4O_F=T%^<45&_#687]N@5G? Q27==HZM
M,_T.?7*D(A$C8$OKQ(?7'@M 96:Z-Q+.RC@789ZHV10L@6RX!C!U,3&\2F?&
MPC=!KN<).P(0U4'$5*QK%)3)<(H$'*M+3OK"Z8U;H><B"FV,FVA+7[;2<BZD
M(HQ;*UM[QV0]CF&)7";XO>3>%=+S2&M'Q.ARV04<%(=-3D[!(0%89ZL2()"Y
MAJI07WPY"=A[@:CK9,JZIG6\9F!X+3&*[;WY^WWD&E7#X]B">JX*'*#.?",#
MRF)2%1<#-R$ZJ>7$SVP*2$@ +%$J="\\YB0LM#2;70B QW(PS?:3_6(+W?8<
M73[(<S-:WV?5)14D/70'H%BEC'9R6;O#X1OC3^+KVP%Y4/DTY.9Z->^6E*;J
MA(?MN-8J"@(3K4R_M>Z I$'[[3TKS3T@3;HAQG\0,/@OD7]0\6!Y6Z2R]:)S
M^^XOY4ZFF%3_>!Y-S_MZ?!9]/*M\/-O[X_'4[@B\6KV*KE>VB[D(,XI.!12U
M)/O(_+@R)>&)5]\9<,4JI?NHS^,@_4&]VP,*T#?G!Z+4\>>99C093^70DPUZ
MLA3!R!A%^SBI-L4=0O1S.EB+/8\%D$5;JT\*\V4PE?,@CVH<9F](-N+UX:</
M[09N!P()F@^YT7@/Q0^I!3 &0NE!H&@#G[7$UZ$F!BV(EO6![#JORT@&0?H5
MRV1Q)N.XI/F6'5,\*7Q>Z%7#SO;LA(=^JF6S>[AQ&<W4EG:CI/\H;%4PL^X/
MG.F]Z/F##E-XUTD<\BS-3ULZ&LJM:%UDKAA"!='IC;EDP,E5)/NO!J23TP"+
MG][OMXA7!!7/<P)4#!TV@5#=J\'*<OV]R@83#PQIF+G3B#)7'1YJ:CPE3':J
M@2?VAGW\TNR>C;YC9#Y$_[$Y]W^IQ<M?R?]CG*W*8Z\?8BD6@$']$\\MB%%W
M\V97$TNVYA.@V8W]A!*=6(@06SVY#>?:570YWMMR&K6VBY"X<[#Z3H!1 +FX
MY^L69,$J]TAM=G36'Q8%X!(5D.7 S>HBX)+0Z'C(:Q/$ADJ5:B'^N]AQB/JZ
MJ9!#YS0"K3L;FB.#L9()+;GQL<5=0& T(M();FA H6X>H3V%%<O';FM[YQ/;
MD/>-TY=HS:*$ FY0QE8NXMYZVZP-8X8)D,[]^:G3RW)VR]>]G\>7'77#H:,,
MTS\19_.>UE6)UZRTTG%874_J<8$?W[?;Q"XBU6O1189DPOA9,V03D\-Q'9I;
M1T]8>7)K18S!2]" Q,6>$/IX?M*H\/1W23+N7=^1# 6[&K?-YM@WGU5>R>!M
M8]%:23C>4?(''A=6G7;[1FFI6]!5PS@A\"M^HM_580F-Y!./W Q"B&]LU[#9
MY&"G=E&FD/FE=43LA+P3? E%GF\OGZ5C^L&+LDWJ)DV:,<J_U8$)OV <L^B]
M24D17U$^N;2J7.&:;-"8;S)MRG-U,/7/?H6O/W'W1J^N<V?_Z3031WVGK]'
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M]5F6J+#2Y9S/J!A+A5?%:!R24QE5X3/)!A*NZ)ML/2=RU,8>__V$D*#>Y'B
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MBXNR0_&SJYB5;MUL=2=P7%*M;&X*M[#HK]V^AL,CY;SC?>\DEAO[J*:Q@@0
M$9G]YD03. Z*Q9XUT+'9"Q^WW,AOH>4%W3H?F3T4C@!W49VTAG6H5. [V%^'
M:Q#KGKZ[, B+MK%JR0T<3Q6U[3OZZA1$N?["-6AFPV8INQ1N=*+:;=[-,]IF
MR@_.P3+;*<WE[V"@[8U7T[SO/RQ4!47]RUEQ;2D!%!DSSAJ;L1-X+U5^+Z&5
MRK'W&S5,>I"\$C@<4D^MK3'?..X3R?<")*PNC(0ER1@UO-O=6JP.I,AY6[I'
MBVKMD75E3XG0)9\>^Q0@!A@T;:ZJL(5P6P>$7J2P%J2PMBX-#LMUY+PQ<=!K
M0%+! *DJ?'[;7%FR$%^W ^HE+##PWS>CI-5""=_:<W,>U_=M*%\4MW?@#6K#
MAP\N)1!O^G2Q[E!NA=TYLN86F+)UX_9E+P?V1][VJM=Q3[TL4< % DE(?PAV
M9C ?$<=W-+[WTKLC7A0T$@^50^S:E2!-U-I!?<P5:64>U&G'1:"8M*PJDZG!
M]-$J;G%:[@')CGWZY$]S&1,;H_=T]-8%9OD9.^?>#&7JA7-2%!<$8E8?C?(L
M6F.K^SC/9?:_Q1V ML\'/<8AV"X1MKK\+D [?-I9.#X&H**CR[)[1S<U5L2L
MX>4P%VGH(*/OI\@*[U_FAB?XB[C+JWGE&UM,YDNGG46!3?W8&T,MJ<=$=85>
M+0Y424.+@N!0+ZDA"9/P7%B<)'"^T.:I(8R4=L9#H69LX1L4V:K$I'V*>2<5
M3A3EY%.Y."6@$\*.$^ 1_1/I[!U"F^)$7(@8Y#'O0I4K).*:,D+!4Y?N\B<?
M%? @L&"4B,QH///$-OHH,4,4I%!?OG_X9:*F8AVWIGF<M7-85\.  $4BUT.!
MF@7(GU+%%WDXIRBT2\JMW3+F5?!()/82^=[NT<E=8ID7XKD$P=],+X\'6RCC
MQ8P']<7YW%Q+80,5@O;1F8FZ^\3P\B6GX1A,%TDL@F4=>$,P[A>OU;O&2*=3
M+:"1C%!2X?:3&'0Y]\8/DL_G9;;FFG/WDWS/8WOR(O9^@>< # N.\T8NW%]H
MBU.'#A%:K&L)G>:-49&3-<4$3$"YTI*$L8T"E<[K'2YE>__-SH2[1Z>!FX#E
M<](O^O  "VX7U;:X?0D0!VT]E_[T'IEC(739V49>XU7B> _WR$_A)V49%ZF>
MY4Y7-K**75]Z+IT'X:$32AZEJ2EWH8:YE;[$YF6S&\^B,M>UQ-552#E'QZVF
MJ6 ,1"P*N.Q>N7S]!K7KDYAA>2F\O4:[FRE -=V2@<"0O VM0(3IJ4E^++8S
MCYG;_$Y]D!!@.9E3>#O$%X7RL-[OMN 2)"GMD_Y"\%7L.[E0V7.OPKV&1>9Z
M^KKEUS.\=6FXZ/&!:+5.-G1FC%?O#I?V OTQ+-6_V^[_YS%R^GTGW[MZEHMF
MP1<B9C\,T1!.&#X!K_N&#RLN T/SY<:^GSP)>9OFZX.CFDPP5[XN.^'R'H2?
M==!0B =6#$FM8P"68FI^RVA83&)+X;.BJ_JV=HZ\%*@=N ?/X-<23:M+/.UD
MNA&NEI90L]]@4A%B\^KM#:;*PDN;5+\SUPB#ANK=B?0W63:="(-YTK9 C%=7
M][HU919POMOO[#1>[?^S&GPN?8.*8]$0'M]_L%%)N*MZM9B#&!)LOF:MWF;I
M3_E5Y9UZ_X&V'B32U6[G=P;76)'#;U"/&WX.FK$<<XUVSSRH@.]O4-%]&X/K
M%[THTK*']T""^PA;M?IQ_*D_@5:WK4'[]=D+2MP;5 F)8P1NCO"%:^-6:O,;
ME$FW8_ZICV*]K"#M/U--!0RWY<Y(.YJH<0H!0+.2/$O]G84!3W#G_"U[0?U)
MM+,-*+::ZY;XMM.:9$=">4<V*4C6GU?NJ7^TVI+G8WO>LC^*7OA)B<H E(N$
M"VR,PA.ZW7@L]O5!Z7[=+E/F6C1%KD^(+GZTX8$\B\R18)%!&7S%W/K&748W
M9>8(WB!B>FQO$C%COC,&)F%$&RP;_32G,_L+W*\AO-]A/28[;JDK.8MA;J,-
MV#"^'B<[K=".X%*!G?W?2Y=(#Q@G!GOT'I!:P=OGO2?Q.\^Q1UY!/[_/7@4/
MH3\=HZ]6KS).Z$\=2_\.Y"-4FO_<ON#[/VQ?\#])19K977KW16=%5GZ0XI^[
MKHW]K>M:>1:73=Q?^:DI$''67O(]:G#_]X'+>7B?8WB<_?C3N/H;%%.&RQN4
M >8FUN*?^?]YVN$"B3R1*>25-:RY'$>XY:ECSQK>W+JJZ TJ[<RM#$W1X/6N
M9/W$91%.)[$YQ+S_@^C#Y(PTU!M48LF11\@K#L(6/.JDZN9]S!_V275+[=[;
M5XB8B27WI51[/\KJO]F_!3[@7KZS4?)VVZ7_*FN5CQ6P*CN'3U\V-6IJZI2=
MHTD4W3!1F#+ PGU^Q\PZUANO @+A54Y.D4?=$)D*5/FI:?7H<W%JZTQL=-GL
M.8VX3:#J!\A_6]MNMLCD)KU52/E&55BO+=38PBU8L)KS^71UJMPN@D% H%33
MN"<UI.0RQD/[<3S[!<?/Z=FH6K6,+U80_Z3V 8-#7RB*EA?(EZIOR'C$_0LI
MRO7:^\Z]<--8S6-P?+)^!^>28JES1.TLR/S;R</H;=#I1<:UH^?S<^B-[!7&
M^TV2_=9]@27UE;_]^_]7@EW@\NBN^P:%638^C1&-^ :5)R+H=Z!KO:G\OS]0
MDKK<PV=\(=O?=44 B%EI<B07TX] AF?Z>K=TK ?/U^ZM\5TY*VUAZWGJO[*U
MT@-GW5OE#8H@;GQR:G\3*W(3BWHUZRZS[%67?_^U@P["4/MG*815&%Q(EEZM
MNVQ@CQC<&M1'#^W1,-BW"_F.O?CMO0Y7*:X,RGD?W>J[C9N1:*GWOQ00KK_B
M2/^A>\^OF_;G7UN=PAWNRC_6*JR3):9A/W8P-S>2?M.7%;RH^).8&;E[G]85
MWJ F%D4>8^_@P>&?SG!D_>C*LFX%>1 5]GN>U&HA@?_8GOREY_LB?5(_641E
M6ATW1*"T9)V,B-,, +"OX=K07IXW0?0^3\3@W W$%4[80[X:&_AI%.'\\I[W
MBOT]ABE@SJ98X\,<Z==^;]]2^THNBZ^' E_7VQE*"UGPFEARY<)UW3E<,X42
MY)*(%VLUHM+C:4\NNS]3!7 /^T"1=+\K?F .HQ=@)]HY(O<'0'W*7FY67*']
M5]0#(<+"R\^W^Q;Y%>2JVKWF7YAHC.2#8T=^<14, (AZW-Z@$"ERY&)Y+\7@
MD!%5>$PFVO/EMK0!V/?G[ZV R34.R-:_*@I"YNWNA%KL;+S7P-4?.M\QC J8
MU#LCOJQ!MP6R27U)<44:/%DD<>"6VJ31E^D?%1OXK+EEA"A&TI/:3QXZ?]^&
M@V/,U]B ENGY 57);NBYXD;/5N#F]K1Q]L_25V9:?D6%BUA[@[H0*U)G#)O_
MW@3ALA57C!FN6CG#IM#S.'C*\!(2>EZY5;)13DH[.")W&$L$>BZ_07'XKYZ_
M-L5&7Y6RKMC'9KWHC."@%T2\00UR>(]3,;GTU?TWW\&P?&H7O@I.7S+LJL&^
M-HJ0@4$S+>0?\OC(^?VLZLC=OX!BAP=%B.*5;26EY\1[N!"I \+POX2IUM00
M)]C7TNRKZ-56BS X^^2E*:\NKV"?/7,^V,Y&513?Q*F8N,M!#.IF]XKGM9=L
MQR&[(\OE]@U!W>33$,21858Y0'][EFNFM:#DY4.2LED61>K"7:8/O5!0?IIV
M0=\2\%+@5O=HT^1?44G_#\8JO$HM02.AX268J/@ ?\WR(I'WYF!X?:%?1L@H
M4<AO34M(#/GB:.]Z-]I Q, C<T1PJ2.B>E9T^DJ?0>>L.*%Y$S+9@TMM8BZ
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M1JL:;97-.(X6EY\P+<>/ZX%N@Y,\8.5)6I3%]\'_=;K17:AE@T[X )DSVD9
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M@L_]W$T;'N\6[FV,;D6[UWTRW 3AV/Y0[Z,&=D)]]2K%Q#ZFL[/X ;D^4JC
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M2<P>\J=T^BD,ADP-AYS"'2N]HN?%I46<E(227QS]D2=OS ABAH@?A'1/ *W
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M<J;R,@W8MAY()CU6\@9*K/J%"'3I38W\O_E2QGN,1-EZ0&,89/#?.$@DC!O
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MLMDT!5 ]F<5!&2U,=Z(1X1=(3,CTO!U@9V\<+;2:.SUH79:0JJ]+4NPEH,X
MHM/'^_.MD0?'HS8=L\SN+M32M!YZG=>'CO9*8)KC8!$PU$N7"YA*'ARM\</*
M>7J<MQ+ 28)9G'-<:C;:"OI@/RSYM\=4-_^CL?>G_]TN4%,M;5-8HN<*'BLA
M<F/E3)2@?X.BHJM>G(TRJF 5*XB=B@,LFIO]$N[EH9&V/YD\@Y9FL,VF<_N'
MT\&K<W^>K/( #9:,[RKCL!-('>K/H9=.MB+4X#!\ZA *ZRL%$*>+4@DC>A"
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M%SD3N?!P_<,N778&&D#X,SZ?BI+\3WL3)2VYQ"45-2,YPU&MH^Q<7XGB$'"
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M2186H!]$8';W$F@9A(3M"]4^Y#>MIA0Q=;&QNX0*)<(4-@.*W\Z5Z&FU6;!
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M^<-!>I>N($6ZTFM D"B]2.]%(KT$"+V&1$"J @(B"DI45$1$E")50D=01+J
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M_2I0/2 X,LG/SR-1PSPX0C7)U#7 0L7I7(BVD6X<-%#+3>/WY6Y'.]5X5VB
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MHTUP3)"1H8-3Q'\ J/_@'N5_]N9JI/"[,9(16&6KAFHG:D<H6 5&6]MIGU,
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MRBF98T<'Z-Y1'4%E/D&+#>!Q@()+38T9<S%-F=A56FN^O+M8)#:6L+\;7'L
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M!!&>\1@\"TNT3X(%;^=Y@V5P9AM!<.IIW/0DUI7V.E/K!)=/15069K&GY--
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M_ BCT)6!NLIFHIS1-,I9H'W(H":<D*ND6'T#PI'^;KY#7DXN^-;J:<0>MM]
M=)+J635:O3$CF'P=&Y6FU?Q!05,=GR52E,8,6MT&7;TRT97*MXU7Z4M-TK+E
MHO( 1G="BVJ,.R<[1:L]/DA6WM&/S(+L';V38! #SO8P;?8 (HI#<J=U:0)8
M4H5UMM'$C\4(36(\%GD?$S3_(/W,@T\7NP(KY1(@%E*MB@7\^,/Z&32N16!
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M1Z:]7]61._KT $+6!07:0$7NUZ&5J+ )9G"<1A^:DS0]W4)UT=AP;0C1=M$
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M.VA;T"+@%=V'XNE?_WL*=>[!9>"4[\;JZM@09LX,+U,^\G6UD$]_S_<XY5U
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MO\'@$!6,U^EXE"/Q2;+*IEXM>@RM66CGWFF].NJCK G\D+^M75;QMJEY-UY
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MC&J3S(()Q+'1&OZ/Z<6R075^IM.2R6U6/@H'X22>:46]M0&T:.W <</QF<P
MV\W%#WZ14*,4,I5PG]DTI5A12DT(S%,>6D#:*[6H0S?P(SC\9K_@17$I\"E%
M;=1C7U!0U[R;/%76JWN#3+J%).Y/*T]OT&0E+^+Y<:48@RX]>3U5B/9JL#-\
M2-7#T]&[J'<8,BPF4++3?^WUU+JGC0^685%HGC"^^4[\G#0^+[WP(MTR[U02
M\G:M7*634ZH&@2#0%-5A?ZCU>5GS:9^%T?0]R/#9[E/=VKT2$[IM,Q!=I)[E
MAN.$Q_6 <IZ%-75K\FN(F!M4J'^NK7\V)Q2-0!]._6<$)E1YUGXWT;([U_[
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MA#:Y92,V^$#*0'#*/NL28/FO?<UY2M\H1-M?F1!YZ*;,)U)NP8=[-5>_O'5
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M9B&]CPB2XXY&D1A#AG2Q,JNB48IO^6JDX+WQ,'8Z[5MB.G?)3H<<LS3U;Q\
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M\\[R=LN]1:L!:AL#9CPZTAE4-+26%V97://R"FWX?0_F!/L$L5R]:2FI-/"
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MN"B3!+N%/,*+JF&MI=N_\+1$TB^$97S9-.1YN:4B2!.P0QZHSD C[FH,*2V
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MG:@JA>>"/S.3H?/TN"'7JP,_I#V>9./Z.1;F_9,,HQ;&P4_?ADQQ)<F\I=
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MJ>%@;GM8L)'\M2%5EN)L90E.N"37?B:Z^VV&\YV"0: .$%DQ6SG46_UY4:W
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M+O20-$/@ZB*A>&?)D!A-'H!Z)8B=7%1*TG]N#"LB\S>J_WZM^O_Y!,')2%@
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M6J!4&A;<NZEWB'C_8(^7[> *[36]=D3.:@Y.?=KXM7IR0=NK<%PC5CL&H>\
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M[)# HR5__R_>WBHHKB:,%IT$ @E!0@AN2; $=X).@. 6W"&X#.Y. @&"6X
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M1T5+)T;.;+;4-(H69AV1M@]D/7_\M)]09">5+H6IN,^4V%YH)+.4XWYT N9
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MK5KDD\WH=1";<="9_OJY'N>TO*,%)4*;453^H$YW1^A[$'& [$PKO5#8Y6Z
M4/YNLS+.^GN/:ZO4P[*<G]6 KPN#M,@3T[+K(+9 ABL;E#]AYBL^Z2*X?B_V
M:'7?6\/%P\_++NEX?IY848>]I:P\.G82=_'43"ZE4;\W&)=3%S%W!DN#ITQ_
M]Q)6[5W@2SWE\#&AA?%>O58IWI@MO\<XQ[[".% )NB&+DGUB6Y'8YKR;^MN4
M(M4-X0#^4(I[TH08[WX0F5KD<W]6Z>*;(<]" ^KHZ,:?3,U%2_(M-<]MQ"P#
M5F,=[$P8)SPZ:(8<:MCNPD'OP4Q$Z1$9B=5?_,+F#PE7CQ^=&.E*Y"[M>!XY
M.9KJYO02X O1&37<4G_JV3I/(/_.<[VZIWM/9D*)><;TVZL#[C987-W1EN'Z
MW! NKZ?@](C23LGRVVZGKOC;?8/ R][ZOMD51X,-_11M"265, L%:]4=ER?A
M1$,'DRTE_.6@DDOPQT'7-V$,<=1[OPJLM[]4,^8)(-1ICK$)%C3W-"3":.E[
M7%36C5EZO)+A*X.(%LU7-0IT\SN^5:L21*)D?#DH(N4YHC4NBOW91!_@Y[/J
MK?V7<B#LQ!^;&62>PUPY#J3B'UDJ08VU4Q48!@209-5@8'S5T,YU;TIT9SCN
M2I]6;'9,V.75YGD=_B2&FTPDXA^I< TH6J>6FGSD@BZ 9KN\7#82DLKC^[N#
M13?]W9..]=3(3R)]J]3'LB%IZ_B%T/$QF:#"LYWCK1E<.NA?>S*<_7[1$J<\
M_R.0CI#9"XK"J>U'6R^(D]L^6O>X#F#1S*D@PV]O3]220%X-J?N&_N64YEEQ
M SK"B85I6&\R>5)@ 7-$OO@KW'-S&K5\=JZVAUQA@^[4RTIXB'Q 0!GZ.8U-
MW@QW7%_FT$%QS6G94L.M^(:I2?GQHB8!NUMO8$- CT0;6]MT )=%,1$Q*$E@
MYJ@-$;(R2JT@Z!MD7&#VBS@[0OBBD@A6,PBV]W.JFNKS+NBQ<1>KG_UNS99,
M\OY=(V5LNSZA2(**[<%BVU58I1Q3:(N=5[4AOTYB_<1+,9Z3OQY#U1C7CTX&
MME UPF [_=K 4*5)A)(%C;_T4JE1"7O0P6,8R^^OK."^ B$1,:'9>\^LF4W)
M^Y'W!)L#']]\NZ84IB@1(**JK%XGC1ZT(^DEUUB5-<;IME1[+]:375W#]\+O
M46)RG]E8^8JA_HTC[ZJ"4_5P/+WHE)T1P,6E==-KZ?W22Y'R-@UJ9XJ;H$^.
M.-'>XC^'7@^-XL5^ZVA)RKY$=AQIGO+)3$(#N?H:J%8*/84B23?;I[(Z)HZ.
M/^,KXE[7;UHTC@0:NI:8"$4*.+I(NV[NDT"[R][A>,8@+%T/#9/\/2"4_\ ]
M B,&?(5Y5-!GX\GHS:('S7Y^'?R6S K:M PECRW>&A0[Q47JH'29=#A%CGW3
M>RW8:6XN:MK0WL%<TRAZ1$3DY>JSH/'@TQ2[?PDZ%^EQI[)36\-[E\7E\/(+
MGG#7#>/G\AB:EVP7D#6U(\ J60!I$:I!>6*S*EX%B06'%HS4K'>;HY(6,AE%
MJLTEU^*(H '$B)/P8))6!:2:4N/L7(^(25I^^AMRG0KDTOX+Q_Z>L,Y1+#>Y
MU]Z0^G]D-_.><=(C'D<?)2+JZDD4=HF.'C'?UEUB25K7]6$$KECY;DAG?XPA
M3HRJT,9)JP,9PD=7-WW3Z<P+M1$W&Z<K0Z9L++O)#>Y[SG08\0BII+G Z<05
M%4]7MA)A74W[<VZ83+_@I@[3<1-C_:2I@L.*5YLWMM33WS"!Z!?9ZF/(?.+L
M>99VUM7^.ZG[XW=,L>M)Z,#E/&G1A#)LRR%F654IW(WQ;T9JD=#,>.)EN_/W
MT_SS[(A0H239OV>#+V\F9//S4A\I)H\QO+9N$I#()6.:K>3\,\EH5S_H6S'F
M-?D[/$K/!4(G:N4E!$SSN^B^=<HI,]T?PV^8O?7*,4\]751HX*78L@ZX+:$O
MA7Q .NST9YR$>[YG#*O[F3DVS7%$J5[8U(V8^DHA9O4J^[# J_S^S;3U9.[$
M]A1VX@)G"C88/YAE=$![_EL/28*$Q=)D@XO?KF<JWW[VJ];VR6N.N&]%BT<I
M9#)VS/J\4B_]N(>^7.,6@F3XO59H:MNG-IL;DDCUPBHJ&54JPC2^S!]\E5.]
M'.C9T&Y$9F57S 8[52$)\RJJ':FW+1^_H<;J1OSZ0A+R[*)/&.IHH=+>7&V<
MIJ%G<C*L\F.6Z?Q57XQ;^=R>_B!C'=:"&,WZ<]3%91R0=Y:;J7'Y?!CM^^$H
M^6;.-6]L6S_?Z9H!R7"KF^"C:9B JEE53Q(VCS@<CNI$.#U^%V/I.6#Q.WMF
MOYU&&&J:Z7:!3=^VE#.<L5'ZW)[!U= E+Y/\MEJUE)<O0'U]F:WSEGTQ%5IJ
M=RN1Z<3'L7S4;=CUXM+&[540<X=P, B"$AY:&^MLT_98C?!3S47ZW5&FKALJ
M)1?NG6Y0])Y]VE8^O_X<)Y(Q_2^!>OZS#Q+S?0 \(4"F=/P0>X,T/U#1F\/M
MOG_;F*U"N(QIS.<U_-%#H?3C9\WA%T..+A9@_ .@7@CS$FMC[A"(M^)3VU5C
MO_C<B1YN0F<]74%"@=[2$M,?HS/G](5)ZTW_3.U?JMXK/<BI3\/0*"#A5T4-
M.4JG(]/ 9ZVB[&%A[:$N)R4B 9V,:=_9A A&>V->/NK<,\79%[JFZB]V]?=U
M%=\Z@J?;-&9+,]8*"[,/^S+^SK8G%<:=47UZ3)2;UP0/5,2[,_DW#KW@+E^)
ME__)4!WF8P28#S,!Y!OBTKUDND(-B]#CG%= FY8,4"DMI9*$ZKS8K_-O]Y!S
M3"Y$#^6*?HJQ0_6L11.1^&@B3.-:91!'ZL85E[1 A51_4$+<1).<>FB$K.:N
M5MRT3-T%P=C\"2H*O3;WGSSU8_7Z>/4!$)U__[8=)?!_JV#K0G?HAG^7@S.^
M>]I8M,P#8.(%*O/?^[WOZ(Y'>0D=D?^[37K=^?YIT0, K\..>\LX?@[X_UV/
MX@4]*5Y H_]TN)-0TPNU>X;@U9;@>\[X_^D1D(&Q_ZDU$#&_6F=Z1TP4V8%Z
MFXEY=Y5,J#U_Y_Z? -=.$#P!1,4^ (*.'@"H9N#_T'\'P__8]@$081$T$7SQ
M28+Y/Q7/^31_45E8U^)R9>J>L XEY.U-P]!)3ZPUC'C$ U^SW$!?WOHBVMRX
M2%!^/1IAQF^F.3::8DW#\?8IL$Y"V&ZT)X/7TNGKM/S Y4)=])%1Y:Q)JF&"
M@($KR+X[(B5FT;3'F<C02'9\R7 O=4*)&I^7M_=/Z/%3L-U@0RE)E/QB2GU\
M?U6 M&5SI'9B??E+7,H=L*,)#>L="+=7DU?AY<7GA>N]>](Z[[?B8SRH,+\)
ME+1VYA&=A>$ =V@\8\4?ISN^S[;>!V(ZUSI7:(OVE,WF+PMG\[)226I&"40;
M6NUO]AT\VOQ$35GM>!UC /&\LMXW;D0F?S)V*E@RIG=O@]+*;N8T2),,77(W
MZF6DDS;/6D*RO\8;Z5I],-0TM%6PJ)1;=Y0][Q62GS.(;<M?ZGH56?_.,L1:
M1OFRYPF^6IM[$-/X:Q^!][F&AF#K]?VKO17\LJ<;7WU_ 39L&4O$!TH"6-:'
M BWZIVS/5%S8,9(6K@3[.Y8ZRH<6!)1BP76NXR] OR<84Y6H5P\'#X/&$,9D
M&\IM@E,U"IZ/*1F3K([.(R238U(8&"C!CV&5QN6QNAJVP1-0)7\?_)J$9V;O
MS'6K'FD]NM%E00LN!7=3FP46#X\(@A%H8REWQNB&U[X@G _WN\Y%:F!+##,J
M:H4]F-R8:W';O;"L#[O"THP[!E"0_%6V>Q[W,;1NE=+.;;]YYC@=Y.O1D"%9
M+W?FQ1X'EU+LJWH\X(9%DERU\Z=LR40*(S59R1E 6G!7([48EC(X45GT?H@U
MT:6&R(V!@2ZL:3W- )7IN1Z,LX"*5YD8R2XLJ\C )I%:JREW?+^52UU%)F@,
MHUC5\_:+:_/,W:LU6#$V-C59D;>H_QO9+?W\4]]$NS',==,3"^R$"NH>DYHZ
M\K2U25:MFN.4@?Z>(VI>_ZMC/,>'<T]*+5C$$[O01]/P/(_HE=V&2OO$A;"'
MWF7*>"?53V)B:M/TM!\-[O?@&-^#)!Z8K<=33R9DZ)+1L_SH;J_],&7T[)4=
M((K^5^!LO(\40!C^.RZ%O@=>-.D,$<@TEMI>5R,T5'#TWW&R=6))E;ZRPVK@
M=$'<=&$32>JT4ZY6/ !(')Q^V1//&^Q-+G5A-R[XN_T8-9%AV69]ED#C"O,S
M?-UTOHIY=7*E,2U&7V#;\8+]$N'*Z.R(T*\KJENWK>1D_O6WQGG -ML:FU3T
MVSZ/:4Z[$%(W/.B_%4BFH9<M^E#J@ZMSC[K7UHL*+D0L3-I>.Z'3&VU!+4&S
M(/H^.!L'_6<91[)SU9>,8^]T:AM3TG7V7Q.>B+#CQ-,<#PS@Y@RM/C.PR_"&
MK9+8 HD#Q(M UXMT>1E?9C")F\*?\=::P_&]<8!<KGO&/H;UI2SEQY7@Z9O6
MQ9A<+O"'%=:1DMVEY*GI8PFB /[&TYGL3.9,_EI[)7..R0_Y'(S$*3<1I=98
MXH!.@0N6+F.ZQ2G=.<ZZ94FN@O'#UR%DD8K<:-4M[YV$B:=C6"V>D#=(;]B0
M6HB@EYN*IW?1O@&TZSWS+\%E$6: _*\7/2=NCQXUCBG>1J^E]12CL *J1_QI
MVZO!,@Z+1875-O61F3MG"2\DW_+B3C=\@!C2:_#;-O/X[79P35GL- 83Z)+$
MQ+'F75MX!W?Y+63GDRQB)$^99N.90HT,!AD%U<HCOR;N: \35A\-:L5\</*[
MKN B79+T+? 9,DA:HJ:5&''X\C>)60_H9BU#WWL29M+>=&1P&_YSRL=>K1K:
MG\-<6JID13J<+ I,%1N*6,2];?"4^5CZ[=Q/QVJ?*UR">/^,7RB6L!H,F;>(
MC4SA0#B+_M7P?:+'\]J3%;1S&!0]'-7QW.&2B +S:9(_<Y 1*O%Z,LJH'- O
M$T<3*7^X8=TSG^TSRC8NII"K4- B]WSD2KNF[E?/F^5F7^8,)L#EZ*2A[3TT
M]K3YGH.EGYPJ;!0^R'%(-:?6HB!4KWL])[P<KAG^Q6<'V[HR0 ZI^N?ZB@.$
MKRF]O7<;UOMC9_03+V_?*WF15*N#SB>[ZE^V2B-+"_RL,QTM"//F)N?W:E?N
M*BDP60,]0PDBCUWVR7&S98E(ITQ%4:!U@<HT7^ BAZ,CQV?CEF#8L :W[?P#
MH)G$V6"]CBSJH"^T[\6 @P/"0ZV:C\9$4O2G'4\,+QE^15L5D7!Y\V9J-2KU
M;-VT;I]*.6%1INC+UM$7/JM);?'^C[0? 7'OH-T[5HAE0G'1KL7 L.7V7&_7
MC>>E V>%9QM0E<U^"O<$U\2I#\65D#)].[ZQ<LK"ZKII'ALKFG(Z*Z/*4Y=_
MY5=L>S&$]*]MS@OG5K[U>2=(05-SR+/E%'-F23SFNZ@RET?:[IW78%N,##"*
MX"K'F;:55V^/XZT2[_U1L"]U>CA?DO2[RZ5Y,7>E%",.]W%P*SW3Z@_PC#,S
M6J($B[=>"%YF62>!LOAVR%9W6E24M# P(<61'U9?%MH2NZ4:G+-A(H,(IC9B
MKBTT7AH=(2U0319)4DC@N1FX-']V2P?=[2 X,="#%#42.<T) 2H^!9=3?_I-
M%*SFM_-3G]=X3!DJ83)S%(.O'34VQ2+$+3O<HH=!W1_[4XU7:OQW9AFOU/^?
MCHF9[X8=+_CW_Y,>/U+XS<<?KG*CBUTV*I^XK+R9.#P^8<I4#UE1\KG:'*0[
M>>_[-_XZCN\"\JD=JI^2'D<J"53S.P?2+XQ42)-6B'[/"/N;]%?BD.TZ$S?N
M 0 A+20?'T>VM.@+./+>JDCP)]WVV^Y4?4K4_IW4KRT5=$)!ZZ(V%2]^NCP\
MX3,EE7/T))5?14K/$G^(I'_'QS5.@5!5] CB,-,J[(C@\ *UB IE2 U\QM7"
M<K:6"*W4LMS)3H'U($HN3.N,E:N'2E94IXP4RW_ @Y^\"GX*HT=D7-HBFJ[G
MTW74A5>I?!X :%85:[3*Q :TN:$Z:KM[+2Q^C%V'.8TA,<SF6C0>+'(B'=%]
M^V2[NO@NFP*C4&C8O-3K!<ER=*=2U8J3_"*4C#'VK0BFMT\S81[/'U^;/"H
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MWN&11PI4N\'W5:K-D_R[!7H?@.^'SH-Y-$XT_95I=WG)Q9$056JALU]NY7+
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M 0V80//TK!]AK1$W("WGG,M \8S7.FF$G$X<^9UZ%N2X7.=OWYNUA#(0\L#
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M8L_+=[/EWH!*Y=ZUGC8Q?\)BG9-^]V1'#H*MZ0)?4^C&'M6-;9UD9MB$P2Y
M,NO:'/2EE7>3/^Y1::V\5GVL(;%(OA,QOJ2$WR9(VP0].NE.]F;,O)4CPZF,
M\E>V-M3Q=':PKKN,DDW:-?71=CT63UE((5&@XY,;V>HYF$HT+K8#?UN6C\.(
M=C6VN*XBV8/.#CS4#*<4MP>3[UDY&PL?"I7K9GR1BZHM$11D@_YSH]@M"+B.
M[6\0>; W"QK;HK9ZJZLS%=7O[1=0E?2S%' OZ<D*^]8HPAX?6@#1%,3XUP9:
ME Z[>?+[Q".<HR,.?4^0<=?_2$RUB!(L\=LX,-X2%\YDCFG19&]*3Z4JL]5_
MI1#+HW7PX^YCPANK4[N.%"K'W)T =K.N6_>QZKS%"M^J:G+%C6TKE$BV!^HP
MW!XI2B$/+P+K3.9XC$F!P^U>D*4^;N7>@(SSK@LSRV0JB,M&XC^^&]*ENQ1V
MC 'AG#!YW6":+9MU6+)B>E/51RX!ZP<N4X<'[XE\3 )M::0*)$2&F6B#R7L3
MIK@ZS!?V&&5?Y*LQ3/HMV^41OB$@W.!G+N@7G)G3>)I9K-A!O$[*/9:)Q:&6
M$HO^G(4OH_9,#RVSM.5T;I@:E-]@^ 5XYUN/K>259H?7(JR*^3*=9XOS3OGK
MU(!:72B33,DBUW#%/_NAN_CL"!;\&CI[E-?NA29?6UOC="U>(&&]DO$<('?+
MW.$7CXIX"T"B&%\EG;VJJI CPCFS!$5HRR\UHJJ>Q7!Z%GP#<1]66*Y(SD)K
MPV%Q"G;2?5TA1DVWLW=BO5!/<C_V>6_;Y26+C!U?:IL\YH*+& ::Q\]*,90L
MR+<P&L]>;A6GO.$T/7UN;40AO%Q4OPXU6V:T!?\#"\+?Q-IVG@-H(B3_+MV8
MK6T-?=S:5),R^S"RE_63AR-56.?0P0UZ/(W&E1'5E;.B<\#N)IHPG/<K@AO+
M_M7?]X9IYJL^MTO5KO1#Z(54U?;'<RK];!A*!_:Z-OP%/W!H5#4M@K3[,L]5
MX/8UR6/3^UF$R>CDA;H6HU)[/F4"X\C6.:#^]ECV3Z<7NPY+*L\&#WE=57I]
MK:8*N,@'EKN.-4Q)\)B$KLX9PU"_I<WQ3"#&?)D>G[@JU,:%*8Y1A)#N&Z4C
M$?PXJYE+YKV_WZ37"*ZI2)92'6^TI>)!6&AG'D]^EM$%XK"W>]Q)@.^]L6%/
MSG=R5_I,HFK?J1RSG<825(A7O*(92O^>Y6N5&GE+B,X_L"V\2)4-84X72EO.
M.AZ- 2/8]G>*UX1G%) [9473@@?P9U,.I(6X*RJ6Z((;:^E_[_Y4T_8UO$*"
M@>P3!X?VBG*@B% -]+>Z@RF2D-TEZY/GE.X4R/?W.".RH=_D<1@O/OH;$8(/
M_194H(]H04P>.[G$2^<_2:/K\3U(+62AI>;7+?(?MQ576O!-:8"SF!?5+)SI
M-?>H[+ANG07T@8MM)A,$F2^>FG:6G0-FRJ[U$)]&F ^+*0T".1:*3<5W1QN'
MI>3^5ZY@_W?[^-/J'! ZD:<-N/=\^#+#HKO[+8F/<-Q3IN:S,8]Z**-FND/"
MA75P%6PO;P9&&5EKB'^GV938!I".YP#7TXFB_*@3:(YU?L['IW@:,N/=J2.*
MSJ9M],;M\AWSS,.ONV&VE 4C%$);'G;^2?]##9&$*EG*.S; !YD2H3Q$CQ78
MW&37G32W.T9)[AD!/K2_;4NDJ=[ /O7>BQ'[[,^UU=%WI($]0;/G80]7\A):
MV$KOT\]HBD[L*6P>.C)^=[I7BK]QD!Q#P\M&\QV^V4S1Z)A.K[D"M%<TF0-?
M.K)FB*W+P$VV%CRJYP\OU9:$0JP=7.XES76F\GH2"MB6WY3M;$W5EJ,(HX(*
M7W?=QUM4,Y6:[ >68X>VD4ZA\4XL09NFB$1CY:R7/M'1Z5.1GS6[WOF$^G/!
M\Y'.>?.^JS*=5SEFV"$2QG3N-B>HWY/#%;4^VUP'J^]^KBO'WGHM.@*@>_V,
M#I^'YMCM^/('1*_PSV13EM",Q4P =DYJNI3#FOD:0[?_8KL0D\VQ#%68SCCQ
MN7!KZ]O!4JNY3M=)>W/G93%1P&5 :B-)XH_8U%>;#R\6#0WG]D-MMD=0MAMA
M%2%!+1K!EB;>@08D58M^M>.)K2.0)QE GN1G)!7YJ5:JJP:-+]H:C#W=FGU9
MM71W@#7UL>Q"@_/-#^F;7#\%6FF/WN3BR?[X$LR D>/*@1ORVO,V0QX2DX5<
M!U26W]3@ A?SAW?6='5T:]3\MX.!Y>"JV%UI),*X0PW*HMB*0!RW=KF=;$%$
M/[V<S!?,B*_VB78RZQ=B>7+PK46]2R;(I0@83?IS%E:@FB(5JNJFB'2M0V*8
M],@_^=)C9]X4RO@[VCRQS/:=WY!/22W&,ZWKDU(:T586Z:QVL;(/W,I(,\1H
MX'.K#QGM)OVB2>9_\3 RG3_AE7W05;,FO-O71;>F%U,>VM\0O@$@J+C=#?/(
M17U@B/*-G_*1[?1R63/)8N99Q7QS@TF]9EV3N/0 XK(CG%0-6OFRQ(M71),,
M[V,JB_A.$H02;K*1:K2]7;\II'H,L@O;:#\>XH#0[X[2L)V>KC(EY][&TO0-
M&S[!UE@O+> K!^:>(2-'+J62/-([:0,$OHL+K;QOIJ'.*;W, 8O@'<80;%-F
M<,O]8YZU1W(=$I>UWR1Z/'N2^]95E:8BF"8>Z09E#+K#$[KKL/%G]-FNEZLK
M_:.E9YRG78[4S"GZ\-*"F*Z5Z272LM<8_NDC->9/2V+V#&'BY+*-K&F<^@DN
M$MO;2%#!EY0?;=MRV=HT9?CGKEQ-'BH*VH2M;>_;N>X:8VDL:B;5KP,3U24<
M2U]81 C4AQNH&78*S@B8$085XYAOR?Q<N!VT<F@O3["/&,^ UEYN+"+!=-.,
M:B9F=.+:+-RZLY6= H"B?-O'\F3:>(+B''D:Q*E^$:LSJ^-QOYV?*6/U;-8J
M-:@E.UE'A5@8N[.W%'$43)^-4GSLP/GR?9Y<G3@OXBO75K$4\OI<%]I=#%UL
MD=D*ET?LHG#AL$E8[+A5_XH&0VV.DH>HOH?FPIQ5"\@5<DL=<8"6/0<,RB5&
MSQ-5>EY*548<()[FMPC^W3-GA_QQB^A%[D:8NR1<\F&F>W-BO'Y?.S?1S$0[
M\K> G+&!K^WK!O#3XY);^5T;/-QL]E #?U:S__2JY7\S]7%M@,[X[XDKOJ;C
M!CV^USY> ?GY+F5Y(.?*6,T8'7^#\)*@7;$UX[D\G%UC=F<;,&7_$9;EJ9O-
M2*/T9F+7V"!GLM"MECV?WQ+,50;$A>JH4[%\?%DOD(U\I0L-9%RP[O+_6JU;
M:M=3IRI4UT'%UMSLH:$*X ^&S\#P4C*[KLX$N8B?N]]JQT7@6)8S$).-KE1<
M4S+Z':PV@[&"LULM=I2T\UW(*0(:Q-.Q= '/#&',^U8>(H,J=+M?F/S*64VG
MW;!*G5_.^+[]AGXL[O-PL]3U6;/UAFP>;N9($Y]<[,26+50^&^,:[W&<;&98
MGZ$6= 2AO2U9_$%XS+]7KB#=OI41DH_=I.@$!GS-ZE0NVV3Y6G:W$FZ[?/AJ
MXY.X6UW1BV^[N(+LOX10/6TK^QXDKX-'0@IL\>&5B.VWA*>9IH,B<]X''[OH
MOSOTW5C[HCZK3/,:87R5/,.A*1EKG&-A)/N\-D;]J4(UC8XJ+UI']I#N)'B3
MLU(WW ,JO?DS]-8C^_$ES6WO9L3BR=(^1D,VS 08_P4QN:\.$OWDHF^K/^EP
M5W_AZ1V^Y,\7-#WQWX@6-6G=]H TPXGN@)"WDYU=7!97A"W\CSH>+QQO5NBO
M+:,DNL@,F,6C):50#QK;*5GI<\#MJOAZL<<.\0_#:1ZI*O;A0U?9,\OMM$)#
MR^Y_?^K^76B"?>YS?#Y0C(KC79 J_655Q=9'8/2AUX%# 5W9R><*H:/%;\0F
MQ>6?@;OF:R NO%G'3$ ;3XIE0N]XVZ0Z!U7*Y[<LY;2J&B/C>1&(C3N6?7Q0
M7 )>DJ(\CZ_^E#HVM/WN>6) $/A$13T@VWOX^K;JFN+^TNTQ%VYJE%%/W4__
M7V\/;OF[Q"C9Q0JJ\Q6\F<TZ75XKWGD3[ECBUC3;>1C>=C5\]JID\4E2X;N_
MSAIG'EL'A-FTE**X)%)I8$RFO6YS^NKMU*_<9K4N.6L2;A$'T$@-932OIA"V
M/LG_>YAU"/8<X"PW7/Q@(,I=5I"::O9-_T:KY@:(V4TY,33_K\1+9[-+@\J/
M;P<<'0^^@FP WX 0TE4E83KU,P@)MBF:N73%6Z:2S._NJ9CT[T78G/EVY K
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MKJ;*$W>);"_7,*(V R)*PZ]&C"&I%&V3I34TEPQO#4G<0# O^C10?0KRS&^
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MNY!P)3Y/7\B+M [DE].YNQKQ-J3J<T"D&]%]+$*!/(311R_3=Z$90%TGAV[
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M#(A+'^2YT[[G6.9;V'G@W8,.!FY-%MR:2*GXMH-J+8K86Q;$QJ(K< 5HIL2
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MH=[*9\;[9"<R7L5](WW_YV2JO!^![>$RN-?X^#5PC R:)[',.W0%MI.HFVU
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M"".814Q!,6:CO]16-#,)=\,>8.%=')CDGNF&5HPN3KM@N"B\D"U%XEU&U0#
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M.IF2;#*B"L%AYOB>_+G!_#^F0\^K()DQJM*>A:=1B59=9<]N"PVRL#_NZ4N
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M%,P_DY!^<+SPZ$YQ69C)Q)$&"V'5.)Z?Z2H^?,_C#23>.$<N>.^+WMC=_.
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M^G/&E^8N;ZQXL%@NI_4JAFOPU.&)PWCIP9P-8(_R#.AZFR21FU2)= #/03N
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M"YXN!^YK8;4M>E6JW2]Y+B#$Z]OX:T'K1)IJO* N9KL/SM=F7QFD )5KQBB
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M9-5LJV3MQGRN[7KV+6X=1J3IPC\D/,%%XO6" HW17@36NAZ2 56..40P$42
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MVVBE[ ^(H"ZUU7)%[)ZI%97[+;^RY#&?J-9^%!'N>(Z)B#@0>IT5:5=F&-/
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M:]%+:Q<7HSU*:K9EY>4#Q;_&"MYEWQ6=2^3?7WL15I%M^XEQW,AX^ I0QWD
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M/P/+__H4Z&WC.TR^!CLV'IQ;I.MMK$?:0 7H)X&L?XFW)NMA-R @=-:.<O_
M\_&EJ0.G!MZW!;^2:R6T&:H'*!)/KP"T5X NXY2X_'SZ(O):Y&^9[%=O_#F
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M+ QFVG"9"5HI=ECQZH48&O1(A_HZAV,>P9Q^1_.? M:+=/BU7E5=WT90S"R
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M]")!Q+&;FEPBO1W .!/PM68Q4,0QD&V;PV@3W_F\&N7\)8J+_6-M6=67Q$'
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MNP]#F92VXY_.0!I+(=W(J+'PKK@UOGMA2=]V5CJH,._1F;VN\ZN](@MCZY"
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M[)[)E,4]P4_J3)XNCY4+I%T/@1R>T6DN9@"?FIV8S^(>7JVK-O6Y1KVQA]O
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MG@N4\U(YORW;6K1M!>H%/"UJUM7X?Q(1#7=(@,DE!-)$A7]^ ZA92;D!E,:
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M =B#YLM[?.DOB7?"CZJ0KMYG40O#KT5K$W?#$05_4N(8>#-X[_!&6J0OX;M
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M#Q;KQ'-(/TJF-%-]^^0^2F6B!4X]<IOTROH^[>1\YMJ@&<QE,+&X;+*IR>+
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MJ8C$6MO"G3+**XG+%%BK(LS7PVI-AHBB7*T.K^K]V+.E2FL48P+=(R\8>(%
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MC5HSW5]SXA^= &QO4NJ=4/O)LFF*^]9IBT:9,T#W8QI<\MSN+K?,P\%VQX<
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MH99%$=/(*I$_VWNGS@YDU_9&HYC819_$Q[9)5Y>WMS-"C8N$I)JGQKQHKPZ
M94< '*RJ-L1-I_'N5RINM6BT2?/)PQ#/8*ZI^!:#[:,Z4FA@Y<&%/U'R N+O
M9H84Z!9IHY:\(%/6 O.4*E2PE*A=Q@A=H<1O;7'J*)*C[06:U2TT-JG<JUR8
M^$0QZ+'[1.VAG-T=NNW=S3>2L:$I(19=CI3FLX)3,7B'()6;.NKC6NZ9X4?>
MZKNYCQKT#$V#;Z(<P.FL&OHL:E[#.*'/)W7U'JZ<WNE2[.NA:57B=N53K],P
MX2WJ N&GLA2QBUU4(X!UQT427I0("QX_]=YW&* 9,:$PI@L,2/QTRV]N@/0W
M:!<U<!7WZ&L(+4/)XHCV@Z_D%S[Q/%Y;UN4Y?E9;=5O7_%YSJ!J\P/]Y9?#C
M$V!%58TWY"\=E*Q"-,'3=?++]"W<(V3/!RM8^"F.G54/_@HX<GV>%V!K/":8
MU$6+;RSI0/^.[R=BH@[1<0MLOVJ87O7BGHX=);C6M-3DO@;[<918/-'JV%3C
M+VU,=K%)<^)J:9/N0[X?\)V<0RF5M96>(*,;_[R97JXH%XW7Y%?$!K9:&)(O
M<]SM[MA?66$'"'W<LJ/KD\'N^S"B^F("=JXNC5HG+<<'Q$#5V8NX'?TZGOW@
M+SUD(<U=,+O3^CF@^DH5Q9AL<INP%WL8E'2TQ_P]8VG*[37_@03[B'JQ4(HV
M85FP 3D#I%X3"2%ND5R)?0D4K\*-1E!B,]S/JSA87^+4;"TXZ!YC$_=OV.\&
M:^;57IUWJL( #<\7<B3QIS5I>47I8%&XE>^WAB^<P2>D<)*V#UEI,:G1I<G]
MF"?.44&K&J%FWK#>L-SBOD"Y7S_%@UML181X7O]65W+V%3]"DJO[G25X57V7
M"6&^[OENDJ*PC(YJ))4L-L%ON&7)Q%?P&#*L2R=(?H!P8Y5AG\^8K^+U K+@
MVP?EE$NU7CI;]MFG)H_K'"LJ+#95F*+0B5X;.9>#>\(.-P=\30LK&IN08G$H
M^JF/.1-P%^N]^=* =:,":E<>2R.1OKIR<FWBB,F&F\-TFL2K_'ON!Z5R#O7]
MU?U-B64D)W7(LPQF37P=#9,)Y,N(8*IA5[K0#"-]B\<4MKG=OD6'HW(8"V'O
M+84F9 G'[V"_:9FUVF$6Z.<7:ZGF>.M#9 >E%#$)=]NCH6@1%.7(\F(<W1;_
M)K+<"U&)VS;DYN-;$=-JC'1P4(^^Q;G#'O60M'4.8 [C]K)[*KT^8BXP[7=L
MMA>V76OK'H;$P F0,%Y@+/R[92?RZIQ'EF3>[4K"R;R=U2RT3W/LFG,(1/QK
MGF8[;S*O8.N_Z*YS %D%UQ5:U N?;3,C/N7Q6B+;=C2^/"Y<N@^K#V0HCFYX
M#!XPE'@4E)C#F'76COXW[=DM-XV"72$QB#_$NC52[\;3M/_LO>C_)?KQAL4.
M:FS.R??-TV/,(S?IB\;N ]/5,REL'Y=J$3O\Z&#+CE:A,8H((04'*=L(;>E)
M:<F:4NMW<OX>\LT^/[S]IOCUE)GUHC5@$J@*FG .P'_2ODM.QX=I00V)=NJ3
MJ.12S_*Y[I<"SGZJ:G5#;])2#!K8'?%\C/B($XM;W< 8!P%R^>)LDFAWH_2_
M%>X84TWVV879LA\_EAFO+O:"_=ZV5PRH;J;]X;9?+V_X,SWH]O1=?GZF@M%&
MDQ%(NIAJF_]3T_Y4F:)+7=@W>UQ3F\CQ6O L'R>M$ 76WXH_'HVD:A%VT41T
MY[&#(*&(I(V*Z,6>+&TT_TOYD^3,_  H?:21^1M1'I%%8;_H/?_@/R23L^]2
M+%&2+WU:^6SLI0L*/2RGM_ZX$ZM"+&]6W]7L#4?<2TJW8K7T%Z/C/Z;<0%.O
MF>5'S)T<Q\!,"PL1*/*$;OW-8Q5,OB[3SENAJ(HXYK].K\IY^1Q]GOCJ*Z,2
M21Q/OAZ&-FU./%HM>9-Q-V?295 QRTAKLB;L.$QA_V"Y;T>OD*)(7/M28#T_
MK(QT]5\U++'6<;8X<<3[14Y7A(OW=2$3L^AZ)+++@0]BCC('_U'9_T?W&6*/
M&1XK;ENR!RW2EK^8B""%A0B,.@R7,!KWIB@$%N6#0XK=4[VR+1X(]!V\W34:
MB@COT.=RQ3;K]D()8!E>RJ6IE81%[\HO6T"FER]7&L,U[!H_>>8Y6KR.XN"[
MRJW;)F[7ES1K0N.W6Y2C-MD"=J;4J;IT_43I'HL?. 2UY6';)'[OPV/AUQ59
MHAJ55C-C*7'PNDR7HSE5%[D?]<Y](G%;34(3-"4K1Z-14S_M/7GXD?%21U!&
MCS+-4XMJN2$KQ*?2/1&PL=Q4\U8GL/9U;$!;_%36*R9#W3&8GL>H,":^\B]M
M9M(T]^T H8^_+-'4(1 -[ &QJ$<AV*P]Z"1PV4[Q!-5:4CS@M;WSG%?A#]?D
MBJ1UVCUS-6'G-]?0^E;QS)KSMU9&F;DTG<5GZE8EE )J_[9D56:>^L$[M"EF
MR]"8-L!>,QU^1DEBQ[/KP/VCWI>-2SIQ+OJ8C-U_.D,0C'WRV@JKRJ$\A^C?
MEE3Z":+_A<WOMMK3-&6)AG$48;';J20Q2_/69E@.UZ2!U0_:J*'Y#NSD23C!
M9[$;1-_*289WR<K_R))*"QH6K!B3B#QHU?!^/HP(W2A=46MP'6;>[5MG+^))
M:TDW#U>:VV][<PZH_!-U#G"%LGOP],5^F60N*NE8L1L-"1?I)5AI?+?0,,_]
M)=?.#^#BL_QF&4O]#2(\1L3 *_7?C9.;;*QK2SC""Z,=+<+UMR96?K!]H5*B
M+2NN:5JN%77[D*7V^D;9@V>-R)'Y;IZ+;=$G0<49YX"904?,S9/,A;O<>_PJ
MBHF1?;OQ5V[S-P"F]32E'F;D9#TT[N_'[FRG'_N@WJ\505[UP%)GA\XBR=%$
M%EVR"7Y8M]OA[F19@!$+)&&DJ:4Y#<S(D'(5LFL5#7@U=!^0>B7"/6(22+!%
MWX!Y$O]9N'26?<BDL[M)S&(A&XC4R/B+'X>Y<3T7IA$=1J8P!WWA+=T!)0(9
M8)SG@"N:9TG/JNT?[H*8R0,CN*<3Z!W^1U-F8LS1F2+6'ZH0W(>! ]\90=(!
ML\#W2(+>:*(*#RBA&>2%#F;IM@0V3;[<F=3;1U]:RN;-T'-XQ)[#[)<8J\F=
M1JR1QQ[M?V-#)T1YWRB2-NA':VC44LI+L7,#QY8!F_I*(H-TS:E-T.GP1[AX
M*,'01\ .QD94Z9:Y2<[:<B#'E9X5*;U/K\"Z3:]E#^6^=[\[FWJ9F-8N5>]T
MZ$^E/SMUAW?94P>F'GM,.\ 3FSFJ(5,J=<X-C]OJ&[5;GU^^IOFO4,JA8&4K
M"\R-@.M#TMJ2WW9>5'!1T1RC<M?IX.M-IP_J!<GX4[:4!R"ZB!X@]T[$97B'
M74$EV0*3-?J6\JP,[K@PHTLC7MX\HMEG&@5K<G^0IDVWNR1T6TZ)W!;E(.+'
M<F/)7[+@O7NMPULSDX\?S* ,!2(N@YX.URW36DXQ Z$-K=#83G'S[Z/S&0A;
MW+=,9&XSXI<)6<PD05,/C_Y=W7=K@9N0A$BJ9:FB1TWX2&G/T&->FV>\>$NU
MB?N9.?O3:^[5C;=_P1?AZ^7/ #6JJH=-SVC"G8FC'SLB=;4_;W#-FB:1JB'U
MB_9FM'\],VBOJC*,[J9'A, [GH#PJ=1;1.F$,I@]&5[BWL9,,?_2>U*1SP.O
MW#A>U?:7]07/[*HN9EX?3GS3W7#F\U[>9V<HEC-%?"2A6Z\O5T0"6I PKY5;
MMGWHOAE2\TW=*NXY^]KJ!F;NE$HW>@[ ^&PO+K',A"VU(/LN3.\X!+7@;OG\
MP *#<9!:$672'DEB?).>K@Y;P9?*0<=9?JN09@CG@)UA@OQH]XFAKF>9S4[=
MM&(YKGE"NC)5[E<OI0JD(Z_08,4RA)YQHE[G7_9)!M)3[/&VY:)4=A9>:[+W
M[C*DS3;P$_0EPMTP+N[>: S^0YW.Y>\BK=ZG5*8V@G$F*#E",/@CE=W"_A7#
MO<,934V.YRU-/U(9.OT/=H*QLI<IV;.B?VS^0AD(%/"[ 2(WRXWZ@;HKO8J;
M8O[J:5^10A[3JQ8>\NG9U0F0'LP8HB0VW6VZ$Z8DC:TMFSH':&_]^77F?!%7
M]YA]_XN^&_N?08,'DF5BMW<N!)$40AB-EXP G@,Z]<HV6F6K/YHWC=<$U$_R
MFBAC3!N;OOU-NO7IIPND=Y%[6^YOV.FS<T"';*LD=2B"83RP=)[.^&-GA.(G
M3Q[?=QFM8U;_3$A%=S;>B<?K#SURLX=$?Q^NF3Z,M+M@8WAT'A^YY0L812[0
MFPC<T>9]UV@8]OOF4XB9AAW-V!M)>0TY_FO?$M,"%'*U78<P&/O6Y7T<R?="
M+5UA;N1R0E?[?G D1=3U@MEYW#-LWF%;DBCEX076_=<?.J4N6&4>KQKC4AIC
M-5,*E$C'[0CR7;K.MLB;5+N@1ES")6"S"8>'3,GLC_F<]G- PQSHW?;?,,<#
MJ*[M;)_K93UV8;_>+VRL7D]IW@"VKT!LIWHM2KU#M!35"'^#>-YZY]RL.#O:
M;\4)<;3CF)M!A#9]+Y4N=>:DQ1TME *OO?R A*IASN53H<<JK%>-Y7VU)!S"
MK'8?_OWP-<^6SFB >8J?_OCXN.1>A=/W__'8X&6EY%B5?*D$TU?9'T(+N7HW
M+O631_'@2*K@YCD *W";X!.M=.%@9?I/C0N^VLX;52,RP[YX-3,KQ/]5(25=
MK(N*F\WNQ\ *BMJT)MAU6568H\.GPA-SJ]%E?<1&Q5HE33@@L)_6D0 !^IA:
M&G_%3[RM3/>XL=G3^]4,=+4-7WP.^ [OQ47CKE% I<$9@QWG $*RA\U 7%E
MTXRT=,U&QH([(*?9_>9XB>B<*Z"86XVSP^2"3:K()?!3E8TVSEJ?*Y 2>&>G
M,BE+.>F+K8+#AL8*6Y]43X,>6]FW+^G+TG*"&5A;SK-+E ?D9XNX!'5%]=?O
M:[1D'"9V=MEW-<). _-$TN4Y2=^%;BNP?!%J\>YA[^#)%_]6?.DIXQ6!J-J2
M^%R(__!\RY OF>>I8\F$A:&GSQ]T7BSO*8@B\)-*"Q/Z"5/XO*YN&?OR\%0U
MU="0P0V/&*'/!PO*TFC("F-$$,)9._?R&Z9BG5Y?OY<?^;^]6_5_ *#B.HX
MV7M[$RD  R\/FW4I1]S-[&9OZ70[&:Y1R;+(%49N97%Q*U-V#IYAKHC$OS$&
MZYU*4CL;6;:1Q%N]/+V1X0KN>8*95)$3@W?@J['7O/9H786KO&G<VK$ OB-T
M0/X[K)%H@[2<EW+=]!KG 9S"J=N+NZ4-C.AOS"@B!"VX!_[V?NQA9M-]M[EZ
M8@"4+<F6\EK51T;X\@_4)V85F?$;%FF%7Y24T=Z)KRPM0'07?C_G''"=RDT=
M1W+X',F\=[C]"Z:[7.)MLZJ8:Z,C]"N[)!TE:;-ZT*\O\7/5_A5X'=SK\R:+
MI1<4I5X4Z2WEM5U3.FM2/2O)&FU+Y_ \^)<C4^*--[*R<C^S5N'X$A !@J8+
M/GTP%2$1K&$Q'L%+K@;K%CL,:FZYH#8EBS3FR3</,GJ%';@KZUTP"(:+FG6)
M6&@5)J]60 BG/2G#)1Y!RO)VMIX?F,;5[Y@++D>A6I^]!\7A62']5/>3^[XR
M;,_%*Y3[B=4YLN5&XQ\-?ZO.'(P_''.WV9] CMC*^-SI?;:!+IZ*,@ZU#R\]
M#/<AA_+'4EAG25F_J$P4$Z+*]O)R",_"_LAN6"X]Y*Z%V,3=M1F6P$"!4"?
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M2*^U\SPHM0I/P1&TS*A0+8$C]++@@",J(SP!5^@+\3^XIA5#(4!.<8 NE(N
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M89(ORO$J'#Q1@,:7V0TRD 9]7 4/CA5D&*42FM -\F5RN"SK@7@Q/\@7@8#
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MLXUBI&C0 3.*Q">+R"HIYGT*0 L<(7\0-C-<%)7?[,5YS1X.)B@C*,PJH@H
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M0"Z]XQ.:0 #!)C"P:#(%BZ?@:"P&#<'&X*ED @7-P&$(:#*=_ &['/ZO9,A
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MDW\(#:R?6'&#>5A/;H5A+<YT[7PU,\T>\G;&GZ1Q,H<_S]_L?;F6.$^>2)K
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MK+IM&H3FE!;159TWK<OH3!:^NE!]O:E,G8%WW24G3BJ5IF U[4O)XG7=^Y:
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M:]U@F&TM=56W89=]&_]M/J&QS!]&>*59,N[OECC\#X0%UO8(]?",=)IF^Z9
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M;^[><_=W0.C /PB7_Q+^5S(5B34(AL40B-S0[W>RWJ&J8P4R(Y_-$*TPJ*1
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M;IL8[Q 1P]#5"[]2>C\R8;V5CTDJYESS/2FX0+[HB;"[5RI?K153^WHFBZ$
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M5^2*-0ZE\6.)LL[%X#I+D1165JB![D)279N6SCO%+E7_MK8Z[@ OV.G%_ [
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M"L08Z1)[>H_S<Y7H4')NE(RI)ZY-=$^A=F1"'M-+K,,GTS,Q'XFJ"Z(^4>R
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MW_9[/_)O8"A^COFC199,_]7F=\4\:RS^UEN*1,?3PI4FY"#WUZ+X*O^&%W7
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M#UF=!3)  $2Y1"FS!&/GD)@7)#7I9PW]9Y+%NXX[KZ>&_5_$L<,DUM[@JM<
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MC%(48('!&#8=4$SO#72+<Z?KO7TG>:QG$I%Z@JD8EM+1QX?O.;YC6[.G3=O
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MJ#YPA\ P-'$9UHLP7A#TDER5_3V8^C+^P$318V2HGO,!KN4R6P:2Y@-VC:K
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M!DY9;MR).W0C151QVB6*&9;L^G-U7Y$O:@,+BME)IQ"M4S272CH5.Q?+Z0F
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MP2089E]X'X2M=1=-JDI[CLL]^4-1S?-D]^%R986&5/4W7-JI_6>=]CSQ\JC
M#]Z0$6V(2-ETHEP,?M0V#UHY'G"BV99X#UZAV6^H.7E,]1IY4%CE)@<K.'S\
MYD?\!]99[BN%KL@"1S\GFOU0<P72/\9S[$V2NV9-9VSD%,;<F>Z!"\THN5=I
M3VX];WU\7)53D%U0@/+.,(LA5Z-VELI5)909YV')Z"5MF>QL='YI__'$$>;7
MZH,K[U8F-:6/V@<@-0RJKSZSO:CG>Z-)(6=L5.?BD<DOUTW2%G5K4R(LQ 0.
M)>FZQ]Y-,&X(UPUZYDW,C;B;8#BWI]XIL@!U<?E>D*<K-@=93A$T9N(Z2KQH
M6#-J(Z5JN]$%G:.UFBV"?OGAKV1[>VTBET/+'%YF?=SH]#Y[ XL3*PHU4G*M
M$AC:0/GI&5=[$^$^I$$;0<C4MJ<IW--/3C'N2WL&\R-VK[4@Q[$3''=WG&+L
M*KWS)$5PL/?G.3'K-#=<1M]J6=\Q=>L0*EATO$O63B_ND?>79Q8;W^H%&1EJ
MF9[$>?7UKV=Z>M3/_:-L)JJ&<))02=Q<INB=9DA#^RL6BY[62M2Q@TES3F8R
M?KS1PP+U_N'X44>2%2D$;8_I-JF N+]DXKUH1OI@'LWH=%DGQ='O58.XL;MG
M#U;EJ@7''>&ZL#M.,48W9J_X7. ?'M>_Z#=^44F\\_G+Y+%%W*S1HCK)=_B$
MA8,VOPHO0[U1^01Z-*P4#H</M:3RB\6\A\-Z=@W3+W3XQU&;Z7!<](MMJ1L]
M.W@(AXG!1OF$+=EZW=FRAU%\[V>+LL/J':PXPG[WX*':\I.<56*RU,9:7^;I
MU[7BIA.\ ;NN1T6U:.U@EULTN+OG-B=[_&V8KV8CJYH?K-*#HHE;'-60EN('
M.K-S']Y9VB2*>2[L]YP65O)A7%3'*\IIQ/U$Q5*4I;32RUN]00LZ^=#%AH^+
M8(-BLH&L"#4B];K<_!N]\_P2Z>WQ^S9K2)6.-A]21YE!_T(QWB*_(E(+E6JO
M(;0#%8&1X#08G>'G+K9?^;8J_:*T<N"[Z;LR^($^'X&Z /=@B)R.7DQ!35Y<
MP4%<^^ >18?D5Z%W\%L](R$? R/7L$SY>?7B!\!(R@>@<Q)8U3_I3#_Q"YTR
M6J=3D3"=NMSYTB@.JD7/VQ"WKB&F,:W 8I#08M!L.5#<MH;8R@P34(71X(DX
M$Z8YK<_G2<PCS<&'+,O*0'%:!6Z+NWS5LGZ_5NJ!!%SZM5[%=/QXSK."V7+O
M6CL>_^9/1TQQY6A_,A>>BQIG#"K;#F>@JE1>E<1D3:4=R,+)D5YC7$)BCI9X
M!7.*BV_4W1 RXH-I,!-DY2Z2'Z*IES2IPCI#&"[FA>Q6J2P?X5*A6<IX[&C=
MD4\67>G[G[Z3?.8;(C)4FCS,S>2-&\16$+NEKB?6:@9HT:0>N6BY:@.[RA5J
M7TO.E!S00\<5HQ4#$THWN2,&PD(J#%.49MXI#DL)X=MT[^5ZD-PU[%XLNK6X
M?&ON4+@D)A.Y^LK)[&[(U'']9S;E%U-SLD.O1]S(CC=2NS-WH#<JH8.LAT=3
M34F5 -NW1-%W7H&R+J+JVU7Z9I%XDLB1=#O3=T>KI.L^U,V8\']DLM-TDX9)
M#PE<'4N6O6_MA;:'+@T]#-$Y5(*3$BVS4NHTZAT<%;@HM[6^OC\:+5I3\_((
MO_BU_HNZ<\5EI#E8NN>?./-/I'#_76T':LAZ>F( "(&.4#-+AYJWV:KO;U?C
M5>Q4$8E]M&%0<2+EJE$43W:B%<^I>USRJA<D8N?E>[F@K>,,->@#A5<6CX11
M7H"YGR#^)??C4IP]9OK01<:G7 ]+O]L4!]S^;74<R;8W*0<NE'.P)+&)Y((
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M-R4?$[*&<$2'%)@=IOEUJE6FVG[.8LA%XN+3CQQD=H=]&I>@;ZB=><ZX[=Y
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M^1>.#XOT*1',SI'>FBP4X[I8AB^"4(OB*]/_:>'^>PTUSPMQP4.12A%@!7<
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M@N%+FKLMH0DCYE'F<T;UWP=IR$]=&8;LW32 ]5 >6#S;N=")_=G=C^FI'K:
M3BQ[ LP6SM'.SJ_;\$HW2X)_VNPHB[@HP0I1DZ*I5BZKY/8\BNUK\ATRL1U]
M<N&0%-=8;^YIO6O\+P15&_"?$.(BX(RWTOIOF^9@GPAQ5F%\W!0JA=V7M4W/
M:MAZ:KSI5H[_"5U9)*_@M'A)#%7,IJMDIW+(M$Z17%U4D':#K##N'L=OQ.G_
M1'V7G6*JH(Z+"R1(J3_B2,C2:/8%$+G81V8'6#_A3SNYOE4.5?,:FCJDJWW,
M97>^YST['HGM!5:L>>)/HB,.'!;'E2:Q6\@C$-E>GL'+Q, ,>J?1<[!XR)58
M10)EW!Z8MV+= O#B0QG<E4)[^PJY5%&%YOK<EQ0X"0CD24_K"MP*FM33 %7!
MGK6&F#C'OVBL?NZ+[?2KSHR?VP!ETB<F^7CT 9=4D]V4DY?0JICI-YTAS] S
M'_.0X=23?'I8,<((_[(R<R<6TM6L0=(/*4-1I[';.K]2J*>!E1/(/4!7+F75
M8*-7O,(:0OPB>@B-IF$@K4LX$$T?(:3!4\\89&[BT]/KO^0P(QFN>23)'-R*
MB A:H( W!"@+4S!G# -@.54H3Q[O@$4:S&N$FGO/M75_7)1!-0.#=[% <P8)
M.KG.K ;*8 YE@F5Z,6WH+=S6XI]?DV"-Y5?N#;/1?#*X#'84^*IY.PV9WNQM
MV':$%(T]&$\+ SSYC0O,O8Y%-64'26=L_H_G?/Y7R\0.*U<5EFUGRG267%$*
MK4G9[6>U[.# N5J7_^3Y]$G,<<'C0V^/W(L(<;O]Y<T>C2:30]>^&(U(,7<O
M0YB+\@R!=)CWGDB;D?=!4XVX_>'5S=NCR+I_\FRY6^<.'C$&[[4C$@BU$4:I
MA]S;G[=%DVQ 7\81O#+8F5&;Z1Y9#@G3^!<^A$O.]+W5G=E9=WG/$O:G\"62
M</!Q-X' 2EG4C2<34UZVA,Y9;Z(?WCO&4C"5_BK/O$ZZYY"ILKVIJHECZH D
M/\.4ECP@-=W". G>M.N7HV(?NL1=$[XMTV-7I]0 W#_^1<!BZN'#+T]/D,*9
M ,,,:J8K1VH,AG6/5\:&R/P_;)U[(-/O^_]7$A*KD)PK)(3D?%PJYY <<UHE
MQ\6<C[,5(><0RO'M?#9R/B[G,SGG.$,YCLUQ;+;?^OS[^_ZUOU[;O?N^KNOY
M>-[WZ[YOMQ3%R*>0S(!3QP0WQ!+?>)L0(\;>)<(L9V4FZ"5Q#N0QI/HU7288
MUI!J<I<86'[>7P=C40\:7-Z;9US.M=+D^XQPX*/K9>3+#)+O&<J=$XJF09<%
MMQ6?9[2P$Q^0)X['@8P$OG9LD>5_"4&R!]JZ@7VLZQF%X33<-78?^OHO1;:8
MA2KT\'B:N.NVE</IH^G&<T/Q/]8ZQXO^S.X7[NN5DN)Z.45/$.1;7,OUYRQ\
ME_^Y>5!'"\WQ9[S#3AI1>6M&\3D:")-8X8%/1>J]R7<RU#[V)>_\J.-_":15
ML[?RJ!U\VOE^H*916$?LU!,1CXXZTWDG;Q[X7/U*O/5\^.D6W& ,G,O+<%X"
MLLOPM(Z<MR#P%VZ8_BBQWW&JM!;0AQ__L9)M'[D2)D3,S0^R_'='ELYY)EG$
M3W_4"K?W@417NBG7W\:5%D@_:U#$SV'*<Z7R:F'PA5OEDC:W[!L0J_+(-G10
M]$.0]BYW#WBKQD'42U^.B/3$;46>_\*#=L X]O8 ING24A((=S.MX'=AFKNG
MIQVKX9.VLMZ/OP,3(T^%5GJQ:D0Q@LY1.4D49_84[ZGAWQ!(?TATH "\FJ3#
M\=%PZ3<PR6%)\4E!]I/YO=H0OL,,S,*--I'H5?BN'#Q""=5 ^I/3-CV.>@_]
MA-MB.J8 9NM_/K)( )@+7N_+;*EYP+7Y\0CY'\AAE)?<C^"M%;46;N,A@#LY
ML?/T*]537@W)"@L4P%5/\1=G@&Z.",!%2.%UC+BWAO+!G_I$Z+XF,W 3W/&M
MF*AHO 6N_@-.T_RCQT9$49]@PEF2(^)"$#B++(P-A/@$IG1.E21[,44%F,ER
M%FV[OUMS>0TQ2/A>2R/W/C_-'QOZA3]F_!RC;.M&N/6'Q8)7/*.@.51+P#^+
M//S2?[]]LCR\^%;YO)LN5:Q G*5F'7#E&64ZE;54WNI2QQ_.-T?MO([9/2QK
MAX#!>(4G<AJ_.8R^N#V21S:G'+>=IS&W5&7-;NN1!]%A#?MB;;]8)M5C&H\/
M)/? NO_N[:(BMAT%, ?12E[O@#/@3":/_^,JY:BI"=N=D2>.5?;;/%YH?.G'
M]$7=QPQ7+]\IX628U[Q])@:48CK\#_,^T$O8,!WM,(CL;X5KKJ(^M=B5^=%T
MR9ZUA90X6XB7.S7WM58V!D(^^PIKS-^]-IAD;Q32]U:1,U$/?]R<ZWA6E^90
M[CS=!$=5$U].<_7SAQO^[DX<>>S37_LMOH'[AM8VN!&$^XFF16U\(U#%EK:8
MS'80WHN.0/PP:V?2W]:M)WABXFY"3,MLD]$ZXRN.;]SCDM;?"WDP#Z]=4P-$
M]C)A1IPL;$:B)]"NKDVJJ6![+]NV^ 6Y\+BZ;DPA6P$RT5(IOW4QL[1ZBN];
M0$JL3+EMIZ)KA'_I5HJ%;.P[""-#1::N)0N_ZY=N#B7;A86Z7X_\95+ $&=0
MG5R'SQ1;.<(>#=!\5_A7NX!)]/S6DXL4 /I>JRB&#RM%%"4,8,5:#''0ISA8
M F(0L4,X8C0Y^W'["_QZ_)9Z %L+_R@_KW\#*@V*T\LT9=^T;=]/J<[7<<:V
MOHQL]G7='31#^<"A8^"F5+X=;9Q0UYE*6W8!207'F_W&+]A<W*4L)UGXRZ&=
M7=_ML\A!0A)1A#Q" ="1^-TK"&D_ERZ,'::!42H]F>GIW")%M!FQS&QJMK\Y
M]_DQ2RJ#2?IRV#U$_*''F<:[L3CERJD;2R>AY51SRQ=^:+91&(5R'IV%:DX7
MUH_#+V^>#>?IS(N/9$'?5\OW/"Q/IO<__7S)=C=SJ9"HL)WU X&]4SR_*0L"
MDL2R"<&KGP\7C70BA3(:^B+5AUS],;YT_$)0.IXIF/"(<.><?C^, N"15DX'
M4<M=J<FQ=/'P8.TJ,K<UJX_T+0?E2P%@/K8Q(L8D<5 RHQ%)M)\"<$0RD0?0
MU0!SF-XR@EZ[I"_SG85U;$(*>X($=Q+F!3?NG1T='4>WQTMJYI2*ZWA&P:W0
M:P'F<7EAFD^8R]^K:'5[NS(@-C57N]E.@%&(]^ 0D..[7]3B37LJHC];>UEO
M2&I).BX6-*\2U#A'\"=:DT<Y8P[="+G'@3AR(J/;C*+7BZ779]]F^6\'W<I"
MZAP)+I/]<H=WS\_.>T/X\GOI!V"1&0:-@B<[, 9U^"R,]SP39(^*@]_D'/U$
M8E]6>=OKTW\UP#GOBQSH07PE<WCTAY_O/!X]A!2UG']JH]^<3EBP@LGBGLOB
MLA.T!296C6,>][\U %SHO]<2X><;%]UH)U\X3_52_!O%Y_R/+.*-PGAS#>S3
M.1&JMKCDR',I0C^>6IGU")[%_;;9U#I) 417W/F2ES#K%/_4OD%>/JD'_#LG
M2>6I[:49@ASQ&7P =$WF?AE,'9>BAG/I&JT5:IC(;:I>6W9- MB->O2Q^KY6
M0#XEWU'U[L=*UU,#RAM)X 61],RN$,&V_4IG/>@@+"$K]:O9;D\6D9$$G'YP
MIZF&X+D<6&KY]4:GM*RDLD?NU3!3[FL:]'<;1Z.RJN-VYG%"'7'E?M7M-C1C
MAT=*AOD3\7G?48W<SHS-OAW![HF_6&Q@,*7> :OX=,M_4;EC3(W*RI!B995G
M*:88*.I;U?]E&F$L18AVFQ867)Q&>">*695G@0>HS\23,^R6"KL>W!VA%?].
M_H%VNXC_.EUD*4:"(+83[&WMBR'9RT)3+9E>A*F15WL/$.BW*+M!/]N'N2&%
M.B^F)2,7O;3?+XZNIE.I\(>5/>1S]Y/R))W$A+%F8>V:-.V*5IZX7U=$^Q .
MH'D$9@^K=J<6MULLP-G1^[<M"<$>[U.Z4-3_2A)M*RL_\DATIC2SEO-K?K^A
M-%&J%!B9^[F@Y%?"5[#Q+JM9&'P,A7N!# =5VV3+IA2A%R"\MS\QG=E_Y\MX
M(+#.:YO 'XT?2%ZX0.?*Y"\4"EJN(5^>D@GT\X9>]4O4KHW7_.[)I>YQ!Y;^
M1^WEBZO<T9FY4 Z5KQYE=N:!6D8^Y+I=_X;8VX-%)L<R$'7=VN.CNJB_01GJ
MGJBKJJ)^OJMRGU[/P"1*+;8MK'N>#%]0,-VMR+NLP<%A>B%,DZVJ;-L4SC7N
M*G'$V!S(Q24_5+U@I<4?R<KSZGLE@+>@P8Y#V*,6:3L5HZ7#C7<JWQM?RB\1
M70-%@W#FH^%DNI:$F8XS^^)5X=P^*6$B4[;JQT7=3+_1E-CEU ,NZB <Y_/F
M#7OCMOIWYG=[>2OZ1>).HI_QHCM$IPJ_K!;RVAGL.<&9,FGA#P:<#!),DDB)
MD#WMW$.1R-/"92$2VU-,5D\@T5J6#!FEA[ _YX_E>0ZLUEDGF'H/$.T??U=F
M=@?KE$*M8M76.)>[WD!>I @Z-J"D9MI7<82&P.?2DRDIV_-_Q=C6J9B/<AJE
MA0];<)LMB4_G5$+*HBRU)H>]O1X+K<5XN/<P<M\7N-AYM\VVE>I!Y_U,57P'
MZW$&G^]-P(:X(L2S8X.REJY?C29"29#WLI:179JI7[FLJ:5KQ,K'_T.'P>R*
M2-%@W=[?).R!ZD)."^K8[[P21D<TL-"F .C;D,TO/EY*W*QW6K-Y O0(#Z=I
MOF/'0:,\4V0FIF-4**X343B;<2C)6CIAXMBO(U'BJZ8..R$^_7?- 9R3!)C<
M]2IH:<+?:W6>%_PQ_E6K4BXO4?)Z,0_]RZ'"X)RV@&G0<GW3UY0M+PH@/-G=
M(J2O82I5FV_#5)#QL!WY%)BP"M',O.9S\(,TRL?1-6M_$SY2;@(?V%VJT^_M
M0> ,@:<JZ(BL8ZZ4TROXR/-[N'IL+E&>9(=/&LG& S&7TW*V4O.67$;RCB-*
M-'8":J*+?B#0DK5!>AB)WS/+['$P):?2C;8+.-[B K#F7S5/%SO6^(&VK@ /
M^BWZV\LS:PI988WYBOL99K>*9:?VIM!>90A+M]%QW?#\E+'.%_D*36[1UND!
M DC[">UYW5S<2.1Y'WYT)YRH2GJ$J_U;NP*\0 !JC[]G@9W(W;Q><GM'\5W5
M!J!?X,,%(;;]N%B4L\$L^#'^4G*31+N*7-=-]U(*H"!&ELLX_H.2#S^)J-VC
M2WO[AD_ZZ]507*=,%X*V^_R8B+7]U1LDU.!)!RT;2X?^<*4R*N+[Z:"%S35\
M<A6UFG9=<YYC+B]V3"VOP#!A0P?GK9XVZM3-7@OC>*G6OG9#D?-<ZSP3!B7>
M@__B+*](4.7U W=:'$U<BAPT'E]1SZ  FKD'O_6K -Z6=2T+RQQ*D![*M4//
M[JDR44?4&1&J#F4Z4%;&OG2/H@#JVXZR"_@V!3M_SXF-=XZX!:B\GLDU(W$0
MU#T]!?]T)>H)) R+LOOZ+(ST)FBK:!^56TNMW$3E$ Q>_'I_-/QV],E4A@U1
M/VQ?"ROQ2DO$[C-/K)K)[4KYVP%FVV@LPS+?+.38MBJFY1^!=@>YA>D&*<[K
M:.^)TQ4]5GT1*)7T4HT*H/M9T13 >XG@MRO/<'L[JQB..T;[HT6GSEV!7?%?
M0'O5UN:@*P>IVYG1N:XG3D%8T4RXW6$.QDKTV+Q)JJFZOOE>ZI1C6FV]9G<;
M$-]6B]L#1YGBR%4EC@%Y%Y*5AE6W="T_=UXLH\F^>N%22$@?%:4"_.B.VP@T
MOK[<JO?/,T@*A=UCN]*381OGL$(MG"*"@YQT5-@._$@!5$M@V3 SDRW\RZB+
M6_%/GBRHGW^K6K"HP@J\IY& <;O(RPMX&D;^(]3>D_%(L"R*UO8Y:E.M@]!?
M'YHK)UM+,$XUVYAS$47IGF9%'IKMKJ$J'=JU^!T087#&9X]??=L<^T"'8CL
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M+[/4 -QWV?Z:9K^,;A3I+OP;^,W*FEL/! E/^!I8Z);3$G(<>]X YR4/,;O
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MEQH0U21W8[%=LLD^\343HU*?8EG!0+OOWW  #H',)/B<%S[)CFE*%&D"X:8
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MD'=VTDL!S"&[P3C#T<\!P$Y$^)?%30OF;%8/M*94TD'>'%+4ZA$%,'B+_C9
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MS%+358CEKZ!;TJB/"-Y:"69"P;!7Z>@MBWDU6W_OZ[%:[T MD?S-7"^]X[5
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M- 7YDK4U,1*_4!(?04N)M1;.&3J9Q?-.[5Q8ZN$?<-D!$=1@RF*MHM1_AN&
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M'T*3[@>>G>(>8QO3,6@RG0QVTVJZZM[$<84X=^#*1@ ]0_'4-Z*F(.#2 !^
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M^D[C_3O/P1'_YOPX*?HFI#L7W>/4\HUZ %MX11T(G/OI**\3+SA,;>___0(
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MG3N5 B#I%\#!_SUY/A>CY:;_:%J&GIGXH"[EU7@5VU# -_.J<[4\0;ZYX@N
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MZ?>[ZAJO'O'^5%U7"\"7[S":U59 K2R39V&Y7W?7B5*AG<OVD>L;^OC,A0M
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M/G%&;6_<G4^/VGF_E6:>\3<]#8&\E17F5V05_GZ5O/'F^*0:U&&<:&18:4K
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M:GGQZU0W;-;#AMZWVOH"@W"3NM!4,\KY./I9^N(K#U'=!Y7O.MY_I2U=QH[
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M.$N^8/G5'ZN1ZTV-:14&DBD?O1K>1N*U(.4Q'PZ&E7Z+@I_]E]:ISMF"!*'
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MHOSIR@('O+S(TR8B5:#W/.>$FXMM?#5VO&G3]X'X(\MY^H""N;'5/CZ(];=
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MGG6N+A&WZZ]/Y!Q[5GCKY9,<?16%IQVF@_^O..-_-/M#SMPD3JIZ.YWL?G-
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MO5RRX*+0T/'JHZ Y4X_;-0<(&BS%&OH=7"<O9:C>I:+)^7P3'7;US<1-S^]
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M^=<,T*")8\=+0[*S*L.YVJB^?Q?W =C:SW91IU*)_J04?!UB%3(O3P#Q0)6
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MH_A9M:!T <<<0*U0V &!SY1'RX?G9Y"I_4]-,G]:&N4Y7@WSZNNCVQR,JM*
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M/@8]SE2890*&TJNF:EW!+[YTJM8L_M[Q2\"/_')NZV+KD%>%\#ULG.J=&V/
MTWXY_(/5FZ&]N'%/X$],[!:L$5=?N(27YBE^XQWZ=/Q1]LP8M_!-;;/-P_Y[
M:6-KUNI6\H^6K^ED!QL:KN=J\_>T:O$Z//?@_K 'FAPDHLZ%[P21Q6Z!ST2$
MB[],5Z:&!,U''Q:X69R#R93MU_]M'"VD91;'1- ;DWA'HB0O :24NMNH3A7E
M<=VIX2W86=*=:XWODIO*"F[$(!S-U07XW?YV%'J/VH6BI7G6K+:E8RZ.-B,!
MOXX&A<1J*< ^].BSM<OG_=^?/R1JDA%$5M5A/WTD,M%]]G8>36MYGC8X2:!E
M$X"%=B/#88[L\W;=^HP\T[GU6;F7F7-AQZZ89!EE9P+R]V )<HZP']K/X5E8
M6VC/-;B96&>&WG@E3Q TQ61;/_ M>5-7=^WF[H&Z\^4B)VA2JM'=QT)_"1'P
M?G ^[$70B AOMJ<K\T/+%S'D4IA>[/*JZV7(Z?RK>RK%]L#T7V_DP.Z*1HPZ
M"O4C=D(!*IE40VE#),MX' :([22QQ5:UX57&Z'*5YMMW[]"*CR9=#55=7H6G
ME1U\/0$3\/%ZX-'(+-C>3/8IK#,8R2#(146RO;L0>Y!:HR8Z,2QV&7[Y[=>U
M/PGS76J4PZMJAS6=^?U@/@LCT/O\P20N1P,+L_ 5 PB#:;<H2;A)IGJ;?J0"
M+JZ,V[J$>FT1HE3=]^QDS[X'-QVTWV=6*X+[8D^1 I$3/^DY*R4 %XMDVK4W
M6:?57?;]HUUTJ:87?>!\J\^Q?!>UV^56<[XG3-'#Q<_AC[%ZT+J%<!]S%(%@
M!]@B:G>8LC'Y0J#,K7+F].<OUM'AH?[S*\_<VI%3/FL3U7O6'FX\VGMJ[VUC
MQL+V_%A$9E)L^*H2)%Q"G4#/"LHL4F00>C',<C\X8R@1]+HG];""]H?)4_G3
M=YN?;/I*\<V2Z@<YDK6THA5JD#>BBYC49)"F.<R(NO[C570%1M?[JGSFX7UA
M#R]F/A'J#EU"*YI#:O42;A 'CVNK_D84_J7,SY-N?=.J\5'1-ONVF5V0Q<D[
M)A4B*>,:"9=T;O@X.?()A'A:#)FK^%7R*$0QK!W;R9^D6(4U7L Z +R4&>61
MW\3&+\C)9?G"4/A]C;WZKK/>;PN0/[D_=IH>2]'F?\\[CH/&X?TQ*5LP,4X(
M RZV!;L>54"WG-M,2L#@J.$8;H[)C&TFY\W+R_-?YBP[2VG7:2)/-BV[FB,=
M3<Z_Z%5*N324.'\#(B"TS8L0!'H]MBN>)7$]VY0[= NV6Z8$0'40I](/U1I,
MS#>];LB<8\^OT!ZJ!K]5O+]B4BD:@TRM@T09CX*J22S9^8"6VD_@!Y%6>7X)
M',.7W*: E=BK+, U0T/W;>N%]M[>;O0HY"_=>MLJ2( )NLVNG.J&[GA\8%(W
M4>50Q,!+\"RYW>B[_5_%3_*<T&X),A%M1DE4B6P^6_/+?)[>^';I[=Q[J^@?
M32 KAW"RV#,C6:9^72%+LJT:PV-TTM 86*-X+4N_)P0S7R:ECOXQ=98?40]1
M-5E6(#>W69*]#RLUA%/F& _AZ<H )@F[!5OFHE8>?.$2/SRS2\;'&#=7-+GX
M8!YG&'AYP832L=L%:DA>/UZY5=-^=@LFA94%'J[?"ZYT7?OZ55PO=^;/ML3H
M@L33&>=OVLY49&\0!@9NHRQA?W%.@ 'TU3C>KA&L'MU=T@Y82/H59=F2_;3(
M3;.EOMS[Q0MMV*U?<UD.KHPMF"\) L+@LAM=%&T!^M&IH%4=41Q] 4QUC%M9
M=R;ZDYZJ9;@T7K%5/SR?>+3>QJ)1U4++[+$E+/I9 EL%:PB,K[A48(-K@-4'
M3%2GPD$PTG$,1PVC^K]V2N@TL[C?]@8==78^#=6[_M;P5]^_V?Z[F32;M'P!
MR&%8=P;Q=ZMH@9%T4[>N&=G1BM]!2+<8 ?LS'[[.7,R5=8O?<5+FM-74Y9+N
M7>HIO_?\G]=%_K=6C*EZ/KQ\K:DI5R<&'1;@F^V\6\FF0//1,QC,Y\%P894P
MY GY^+[C*'\">[^'QA9LY-( + K.D>+#!\#Y>)])<-Q!W ?2[FM@22&%OKO.
M82^WC"*C$$S HW5[GVD7-.1>]&VRMKSO?OCWT3[OJ5M5X6PD[Q.U'M\%SU X
MG,I$LARJ04]:7K[A:+,52:)NP+<\HEW]M,P8WU<;C[^4L%[:-REW//C9VU4*
MYB1T%1SR2M'KQQTF/-B="GJ$A+!W,:(7>#(?<M#<5\'9F8<B5>S,75%'=[1V
M:U0NJUC&K"^WL -X4/J3P9WXUHH D]G[J%@=(..Y%MLO>;#SMK&+^_&7$K8J
MW_VONBC9JFFX7%A[S&?";V$]+G7.4B#AW_Y9]_^IA:+D>5(!*!4</*JV;6KS
MLWX"PU[AY\G1A.9G5[JGEH3NNJ?'U3<8>S'BXB UA:83R%P4W8",@4<YV_XD
MU7#^*'0+<,*%KC[HO:N98CIP)WLJ3HM_?^._\.G\?]M06Y/_ 5!+ P04
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M[_(Y_["NPB1])%(?)AD(. L!9(0!! ,&, UH'.*8A)E6<.JQAT]N,Z(.7U
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M3,X1D@ADJ7)&85$:A(1@B(11J.C.XZ?V<5X/R+JQ1YC>0FDX#:Z7.!4P)TG
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M.%Z8OO@(%PXS%7=;>\6DQ$>,[L\_?.P&F^7=3R86G2'?SU*BJH7Z+ $09B'
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M+1%DUX1IE0ARTCW&)8+<H!@8PLE8KAK%<[43=;MX@Y_S%9[/TC@,&,THH&&
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M7]S/A.5BQ2<:&[DT<;_)AX6(SUP_-"[V315MT%F1W*U7Y0HO6)5$#2)(Y-0
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MG7L&;Y6I#;?[8BEX6<JI%YZ_XYN@YEG$:0!#+/FD00)@0 .0Q8P &F8QP:F
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M>KE=E*MB77N'J3GHXV>\:'SH-Q;N>=#_(A^]>HM7?),G8Q:R.,-1Z(. BA1
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M>Q"HY*:5@5YUBU7.\OEZE7_A#YRNBUQ5"/X@OY6W2U7X;882(F*."1!5,:/
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M&$X.=]VO'%@+I#YM?IROULMJ0;7:2IHT>?SO%DNMIFLE'^?U,FNBTI0J790
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M%]GOUX*]0L1XX.^N\3O@5FX%>H!"OSON6KNW&7(0M=^!U\U^T&6(=F;@M.Q
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M'T?%V_[9^SDJY%I;UMXJZMJC\)P=L2]M=^K;QP^;*^I#T_?QP_]02P,$%
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M8Y8>Q=E^D,@[L$[U&OMTM;Z'7&MDYK.Z%) "7V(%,^-.&()[EH5VYZ#!>5:
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MB4\4<$X'0&)46^U+%&U:36Q!W%9 ]#\#$(?65 ?@NQHAH2I1U^*.K+#66N8
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M-M%VJVB3#[S86MYOT*()L=&TIN;F\MH+OF\^7JRHP(5-*1<(,M8I\<* 2T5
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M<SW?\G0Q6(9&2E[[7>?:LR<'B'4\-L'#H ]8$C8:<_YP8D>>,M-J=VRLM0Z
MN1F8\S%\N[[ .*?UA!JAN%#O?3@&,<8,/ H*PYF/MM%UG;LH&GG<3+-3AP'D
MWP&.;AD(=D?H$D5P,=$6+PVKTU)J5P[%P#F735':)"^;X&I;"D>>/M,LN=M
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MA\_LT^DI[G*2 W.NY !2,@J'8JK)9\<!=;T+Q"*WJ4UR[4Z2NKTFN@^0AE'
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MU:@(:!^J^S5\#\'7/0TJVNKQB9JY/2IM[WC28QBZIO6U]R"Q"*NRIBTXE!A
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M^O#Q\/E__._#-R]>OO]0[UQ__*]=\E>W/*5)[NI'U Z4M]I,Z#D'G[(H-(8
M)LM4P9? 1^,@(%>"96=TH^[(5^G8.P^_FJ<_:K$X(6SSY+?S%=[6U84QGY1G
MDAAVBACF&D*J5Z>XSQRMLC:UN16R-8GC)K3VP,>-I'H3I>QL?;[B(L['M3]O
MPZ*:ZZ^X1SY]BZ<^DGVZGYLV]DH&B@4Q1Z#(T(**WH"+14%,1LB0'5.A47YP
M6'MU?MZT7B3/OC\_"LO-N=+$AA"P'B=I9F6=^1C!9Z% "A&*3_3_TN;TX!ZB
MNK))#\' W0=]^PF^@S#QW+O;B.?Y_/C+?%8O2:UOJP=%,K+2092U73]G)!\O
MR;\SS&<IA3*ZS1RO>\GJI;?$GLJ_L=$-I8D.8'6-A]/K5L4SZY-/0-&(J[-L
M&(4KQ4+6M%F7Y+@6;5H7WDK.R# :3MVWW.[?3_8= *A.[IK/UBOL]$I=3,4'
M1R(Q6@A0%%V"]QC $2\Y(M$@V]P(ND%*#_O87NJ]94K:[K+N 2S5 I_:XS?G
MQ=@Y,LT"Q1HIQPP*"T4=HH[/\ICM^L [M4F>WTI.+Y<4A]VT]I?\V&=RE\#_
M]WE-@KV??OJ\6KX]J0OAL-#W</D.%Q\^DYPGOH14F)+D*M;Z?D?!IG.U_S]:
MGM#')-6U6Q!W'-0]Y*WCFIL!-#Q_#'%W8(;67+U>+D\POSA9$&_$R'2>U[PL
MG\]G7^E-I+7#LOE\5?.FEYKW\Y*84]%"(1M+ZU K"))G2$5&X5BB@$4T<K;W
MH7M<PS8</$?0XMBV;\/3P<GJ\WQ1IYM,6"!SGYRND_MRO>+K:,MG",%JIA6S
MW%W/:]YAWZX_>=S2E(%MV%YBZ\!.7;+!-U@)J",S@H&IK>D45O@B^9&:"V0\
M.2=DNUG'=Q U;OG*\!9F*/GW!:5W87&X6$>U^>_AZ 3/=_',8BX4L8+E-M3!
MH'5 DF.@I5..BYAT:35\^(?$C5O)TA1:@^BC XB].WOO[0O&HXVHG */CJ(7
MR3QQ$R245++2@B1VO79NL#ON]]$U;DG+\, :4 O=8>K.E6($6J>3@DP!,BAK
M#<0H%6B5N9$J>\5;-:'9AKYQJU%:8VP0K3RI*I-G!Q]>OGA^^%N]=W3P\?7A
MVYU/=F\^J=UI[@^H'N@$]^+ OP9>QU]PMEPS<'KEH$[57:[A$<,2\[OP?=WI
M[^(^L_9),7+.)2N*[%,(X (O8+1A.COD%MNLY/WHWKN%Q[9O?W;Y[9=**A(&
M7FNHHS+DC5:_U/MD0$B92S!>"MMF<]V3\'%39H^(U1M-1!Y1X4_;MNY^Y_[>
MYSVBG6UX W]?!!=5>*Q1:U[GP%2&X G!C*%G#G-VH<TY[[C6]M(AR_4E=O!G
M6&S<FL,OE:!E=6DV!FFY/#G>?._:C7"E283>.W VUWZ12I!WK3,D&14MT\2R
M:SU79@@^GK8M?@"2[ZD2>FPX=!!BW<;]905<YOX@K:9?IZOOUSA.25@A:!\B
MYFP]A:9MR3M7Q] :VHLH" C-:]AVI'W<0Y'.0-]0[1T _6T]!EJ26-_3Q\4T
MK:[F2&[GT2J=K(L(J +Q*"E"=D4K<-$J[Q(%RKQ-;<(NU(Y[>#,BF)NKM@/X
M7BS8LUO\IQTB;E^_!T?K1ZX/0-]CFG^:U?S?YHATK8I+C;NL--8D7F?L,HHE
M' >?:?]*(D51Q]&S1O<,F[$T[D%4%U9]3) \[8!SL&L;/W[R(P:ACW)]8T_D
M&\^$R]J#7I?Z:^O QU @9T3+ F.%MQE=T%\X>F65DN9FGS8C49Y]OSU&.:T0
M](HV+\-!FY3((Z,/T9<:?WB4)I2B9!MO93 6GG00^A#\/M0?;P."#OR:#>5G
M8Q=-\L9(5AN8YEI6$1""\AJ021:<RB&6-NVKKY#1S<65QX3"]:X(.^NE U#M
M+K@+MF>Y-A!_&X[/AQ!9--(JA&+K[5A6:N%8KIW#HR$'C<3+VV1+6W S+L3W
M -=UNSFVICM ^[6H]_1NB/.)I(@(GE-4JPP6""(ZR$Q@$(ZX2FW*N6XE9V23
M.CI*YD.KK /<G<>8%[G"LY&BAFNGO*GCDBF&-5F ,[%>WY4Q"<%9X(T:3=Q%
MTLC7>GK#WS"JZP"#9S)9;R0U\8PV.[!2U**FK"$JK<%RSGQF.99&L+M,13<7
MR$9T'G?62D>(.EUEV9?"G3%@D0M02=-Z8,74<5-6!F5E;!13]^2O[:[/.X"Q
M@W#'OH1S0'IBE?ZSN[<L%_1D'J6SM#X0*=IG5H'VWO/$N$&\!HR[FH%>?7 ?
MFMY%0?.!I-6%IJ_LD.].%NDSF<E+#.5@E!=%@[&F]BYRCGRU(DE0QI8B4&0G
MME?_#]XV<COJ(3$QI%P[V"W^1MOIJG(35B>;EA!&1^.\<."<JDVT.-)G&D'K
M:).G=9!\:K)AW"!EW//@/CR1_?33&\!.5Z"-M,_6+3>DVOY?9PFQ'L;%@*D@
M^?T4 +2'6 ^.R9[JO0\L.\BZ [C<7$<7R^SM?(:GUO=\5T[6.T[;L)2U?4T-
M]A36&8:IY$"L&=>H;]1#R.P(8KN XLZ,Y= :Z@%^)W&)_SRI[9*^TH?S%*_/
M7DJ="Q2*$4 Y(R'4!B8"G0PVV:)5FV3D'02-6R'2Q]8XA*[ZA-SI*G7<1*E5
M)%>RUJQH;4@X+$%)M&"9U:6X1P-=#YOE( K_,8AVD'Y_,#K+R%/L06R8FE35
MH%@4$)D*()$9&1!9N=Y(J V$>M@(!U+U_0#:0>X]@.='9OPN*_[F_$(N6L:C
M)8Y54@KJ%5D()E%4[6*R$@WM^FUF%>U/^[C-&3K93!\7 1U@_E(+B^?ARW05
MCC;EUG6 W>(KYE?SQ:N3U<D":X^F,$LX026YCN3&&HQK7Y9!T,P +\2>(O\Y
M^S8%% \FM?/3ZH&Q='=OD@:*'3NYN[-P#V:SDW#T>I86=?K&8;GHJK$1SSM<
M)*S3-R[)[_!DM5R%69[./DWBNGDC61>E4P9%NR)X9P,X#+Y$H[.]GK2YKV?7
M"!QT?H3>9E$\'<QTL"7L+*>SMI('.:_GU9R9G$N=:U+,VF%Q@+7"5J6@P4GG
MR<?TT23&7(R-+AFV8VKD!/VXVTPO8'G*Z^;T@N8Z1;E\/=O<W/D'UE:MF ^^
MXB)\PO4/7X05O@K3Q;I#SR0S)1.3@J">'*D-,P7\0H(I07"6I8ZJ40?3QV5T
MY"S?$UU?CP"J7M9<_+%XXAWB^?OZPNF9>,[%P"<)N3&9)] QNGHMVD LH@ :
M%K(3+/+0*&74B*.1P_L.5M'8,.EEN>SD M</50KG'9KY)#BEK7$.F!!U3BMM
MS[X(!:*8$E-,=:I]7_O/+5R,VSFRAV4Q!AR>\E+83 1Y/5NN%B?K=.1AO<'[
M\7.8W6HL/M;!L!?[J_%<2F<$"%?$NAP;0O$>LDI99"UM2&UNQX[#[[A-,Y_J
M\GH\B'6P$$_;%YPF4VZ(Z^6W^BE.1+))T=X*.K@(B@7BB@D-V:08DI ER3;1
MSG;T;05T]Y,"O8$*.P#FSD+=)#(V0RW.UN@DDCNHG0I0M.<DW^ @JHC +4L\
M%*M1M"[2&H"-K6#N?U*8CP>(I[P:=DQ$T#Y5=$ -MB023V$)?!WODA&C\UH'
M(=H48(^:W=KC^N9]+8+.6VNM"5VN'8;+/Z\],=[.5_^%JXL&0I=[QTTR<I%M
M"J"D).<^A@!16 U22\^T"27IQE=!6[*WW4'QSWI2W!^".C!WS81RFD*:+TZ_
M57^/3V206@GRU",W=:!D*A"#L4"ALZ3M@6Q@H[#P<?G<;J'];*?/3P!3/_.*
MNWC2YH^N!].3HKR710DP>GU%7C&()B,(1)D<YBBR>UJ+[T<L;[<.?]8SZZ>!
MM*?=?_&LGG->?M1X>_ &C0]_]2-V<-Q3+IVT>.0^Q7K+P+.B01FCP26GP"F'
M0<0<;&R3RQBYQ>.N9NL\V+NDWO?3Y1^O%HBO9[1>R="\)P8F*N0D=0UZUW/%
MR;9!**;>M-=%:,M=%&UVHN:L/>V6D _ ^V!)HR:@Z<#/V_DL_C:!U-1R[;_U
M$1?'?.*8%YK%#%E) :H8!BXSVFW)-6!!RZ!8HZMBS7AZTJ,-]EXWX\.DEP4S
ME 4YD\3?YZ3!Z=%T]7UC0YC3.D>$G#19CCH PI/] )T-RBR+%\+TO_'<SMR3
M'JC0S=8S '!^UK7T8OIUFLDM7PLDRI302-J-:?NEP#1%<)$LC(P9O>&,DWEY
M.BOI,FM/>AY#=^MH9]#\A'F!L]DNCY,*N/ZVL:/_>[GO). /Q;$@)<44G)''
MA 6<X!90.998K#?#X_\?\-\X"KYT">S]_.CHU7Q1?SB)24M7G $NA:R)>0N>
M*PG2,(&9224:]19KP\_3#NT?@.RA[V8, (^G[%+=E,+F3MB$'$I,]<H^M[1#
M*RL\A)KJ1^+=(@M)-!K7-C@K3_0&^H#X;+=D=@#+SJOER_J ]<,J+%9=K)FK
M-49_6\R7RPG+CF/ .O\N5A_2:PB>!1 ^:^0J$.8["SSN9N:)7E+O=]WL"Y@>
M]IGJ,6]J*%^<+,XOGFQJ*R\?IKW\AHLT)3E,A(]1F-H-RX8 BAD)7IL"3&G.
MBO<\BT:7^!Y,ZQ.]1-X0\6W5_7! ^PV@9_@I;#+)G?A/).R"T]K)97DPRR^_
M?9DNUD]87E0:1X&H>56#%G6A!PBI-GV65N@HI;.QSWCCAZP]T:OA_>X3PX+I
MYUED-_W.6+(-/ I(2+I1'#-XD0QH[P+R5)CEC>;MCA*D]'<SO-]%M!]8]@Q2
M7LYR%RMF<T5Q8T0V9Z_S^JV;LDF%\Z(9 U%J.5\IM>EW6D_>1,=0U,/:+A?2
MMAP^[2/\$?-C32#40R2SIUQ./=[:[?)4 /^GO"]K;NM(UGR?_Y(QM2\O$T%+
M=%]-R))"8D]//R%JR9)QKP3J@J1MS:^?+!#<0(+$<@JG0/>#FM8"Y/)55F;E
MQEATN<0 ==9O+0'BX!,BR*285;D4DSI+WZ]CY;B3]2,>EOU \0I.Q3VSL-)T
M=Q,A?II/$U8GH2R=!!-5]%8J,A12@Q*H(<K((+&LK"O&NM[*+7?F];B3]WTD
M:5K ZN]S\"8\HUWLI$PJDVR4("=8!P:X&,N<9=*KN[:.Z[2]FF1/$YR/<RRW
M MWQI(?6CD#?I ?]H8#HVPU958J,DR,O(5L'0:D(D<)D%,9E=",E6X=C\M6D
MD[HXF2.![QANRI=$<\/]9M+ATCJKH@4=ZR8#,F3D]B@)7L8LC:B%ZR/-"AN4
MSU>3^CJ*T]D.@L=P0/=-?SPK+)>,LDD$8,X9H-@D0T3/(&9&*@^2V4[KEO9B
M^]7DX+HXOMT ]!6<YDUC!,^T1 RDQJ0**,D+N!@C<,R%)^&=/.YGH%>3X#N&
M$]H"='^;E.#S$HO<2JTU2$$V2V7'JQN"@"';['*1SO69<=^/[W%/[Q&_W!X0
M;J_@LKR7/WI6+%:(Q&TID+W(H)CU$%!GH-]5.HGD8VC3"G0@!L<="'_$QZT%
M@%[!N;K;;W2GVSN%1>YJMV<&%ZI'+K4$YTDB)5811>$X=C85>!.VQIWZ?L1G
M:#BP]')RXLO"B%M[TI^Q+BRFWW]S/EN(YBI\JZ,]Q,3['%+D&K*LQD61T^](
M<1!#=@EEMMAH2OP(S!YWOG% J ^\[*<U[E[!T=S:M5XG.3Y1(0:=-+D#)2-)
MSFD()G*(IG 7A-7*-4QR="&#XTY/]GN01T+I*SC?ZWWY]2*2RD?',ATUBIQ!
MA4(F,%@.N9;F!I>DSWUNS-N!V>-.6?9[8EOCKI>C.<S[\CN2Q'1V,4W7&S-<
M3$QDC>"%(QL5D@9GZ2=DAO/@'!FL/E]FUK)TW*G%QL=L= R]@L/TLH=P\O7K
M?-&,N"*HX*,/-COPD<7J$$@(U@?0UA@A1+3Q:+N6UK!\W%G$?@_C83#8RV$=
MQCEX* @^22I'G8L#+<DS5Z44\$8;P.@DAD3QMRZ]^YXK/!WI8MIC<C'W0=%K
MF<+XF4S-?%K-SF*FQ@$F,;[PC:-,8]Q&"GU,9+0Q(6+AH#,GVV^9 U=R;2LO
M-F0ODK-M+-[($QF7*OM8=B^$/:MGOUZ>1@O,$+V/=7H%AUB7D1:=DW#9>MLJ
M6AJ*A:.>N[@-?A]= :. H ,/ZIIR^LLG?TTO)E[99%4Q0#ACH-!Q<%DXL)QC
M-@X5DVU"D =DC)R%&@<*J_N/=]9+!Z#:77!W;,_RIV]A]B%\Q[?G]9UN$IR2
MB,2T9.AKWP '[VT!FRTKC$5&;EYGK2OKN1D7XGN :[#>D8$TW0':5SR]WW Q
M*H%'%8,M$HIT=:A5G1R'DH/QT5FC1*(_;@+7)\GI/+'?'"7G0ZNL ]SM'%"_
MOUUYR!QQJI.!ND(0% D4 A*DHK1&8LK<I\[:%&YI'SG#W863<& $'#/F3__[
MBJ+O=S,Z]U<+K:PNTKQ=SGE_Y!M/J$5V%$@85M=,DWDA&Z& J2 3II"9':E=
M=E ^.[\=!D;Q4(>H/:3^'@?N9NHZ,N.83L!U?<&MR<)@.$FG,.TYUS[[SH:-
M;\OBD1ZS ^#\\$=R!] =SRR7G<7S<,[&!)-B%!S6C=@V ?V$X$-RP*4-03-2
MH>JLE6!+#H^T3/(UG<@](/>JK\?K'/ZM7 0K(06-P)BB:-?5*AJG*#95'%TP
M(C+;6:?JEAP>:?WC:SJ*>T#N%8QE?U$\RT$9]R3$2\Q"!+)305'8X8P%ET0D
MBZ4L3R5EQCM[/MF>R2,MF'Q-YW(_X/T=CN:J6Z]8L;Y8"S+5KDN5-02R8I""
MDD%XHXLYMMMREUBRO]+)UW0L]P'=L8]?V5PX*TT7"W?_+=F5VT7&]Q7M6 KD
M6F10NE01N@#>&802K+:<1,A,9^/.V@CB2./2HWF0;0;*5QV2;BZ^B?52H5 !
MK, "RK,"0=6962RC19:$T<?V<K0Y]Z_^G;?=\>G0%&R%Y;_=&_'+XN,>C2K2
M0LR9Q(<J0[#9 N9,'I.(GO%C,P5;BN!(;_._E3UHB>I7[10\?#1\67",&1Z8
MBV1-Z_8$SQBX; ,4<A*#M(K91B7&W8C@U;]TOP)ST!+5K]H<W)LF_;+4E-0I
M\1R!\SI4MZ2Z+EPA).5T3(6CR'ADMF ;_E_]T_HK, 3-\/RJK< 6T96SILC"
M&8CH7)V)Z\!I-"!E+#:88)0\VA++82S ,;_BOP(+T C+@V8 1N[X7C11/!)^
MPX;OY[]PE'[O+6301[NW](D7&14423>6,B*2R\HM2,%EU-(%Z]BK;O<^)22>
M_T3\@O,_I@G76)!OBX^DGSZ6SYC.O\ZF_X^(6IS!!:7771S5/ F% 6) !,6D
M N]+@>(82]DKD72CJ+8%.T?=!KX-KM>W@8\%C@[<PG<S,GKXA12^N#C?+UE<
M](IJ52C230F$<@Q4"!E"4 F"L9$B7U^XL4UP_@Q1O;2+CP:9\S;ZZQ>*RPY0
MQ.REL F,KH\NSC)P+F5POH[^L499UB:S\"Q9X\)Q,.5O!JH=--$!K#Z33HB
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M\-D9T#P)7U1&*]LD.P=F9-PGVC&AW4K;1V*5KW=LY/^\NKA<[/>89.<-FIA
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MDJJDZ@L%R*YP0\"2-Z86L<:MT*8'7!OJ[K;1:7(N50'7=@"OSD6.L)0#"(+
M!O^-?^*/7@,KTWNP4WAU0/C!B3=R7X/<P%E.68>Y8(4D=$PD684[([@^AD7)
M!PU&[A31(I(&TO9PN62*9R^.O!-W[(V.N\-$84X4Z<SIA6U$R4HN6$ZA[CF3
MRSH3/ -65<B4[A0*W3'T7/OWP7\MYA]7N@_RVY;NBZ/A:*S;$59*<*Q)L\KD
M3N-,R@I)[,7%ZF=5=R:UD>4QY5UKQC,298Q^HK-^..E_*=*GXI](8V01GE9?
MN'*^>E5/<M0<R97L[O^PZYX[?/1.[#=Q/RUAB9;YSCQ<\L1MV8_=C=[^6TS_
M!E!+ P04    " #-A'%4)&LOT @)  #6+@  %0   &5X:&EB:70S,3%?<30R
M,#(Q+FAT;>U::U/C.!;]OK]"$VIZH"HOYT$>T%2ED_1V:FF@0MB>^;2EV-=8
MA6UY)#DA\^OW2K))(.%-#^G>Y4.(;4F^5_?HW'.E'/XR..U/_C@;DD!%(3F[
M^'0\ZI-"J5+Y5N]7*H/)@'R9?#TFC7+5(1-!8\D4XS$-*Y7A28$4 J62;J4R
MG\_+\WJ9B\O*9%S10S4J(><2RI[R"D>'^@Y^ O6._G'X2ZE$!MQ-(X@5<050
M!1Y))8LOR3</Y!4IE;)6?9XL!+L,%*E5:S7RC8LK-J/VN6(JA*-\G,.*O3ZL
MF)<<3KFW.#KTV(PP[V.!-7VW5?>]:J/1=AO3_6J[X4]K'?!J'7^_ RWXCX-&
M5K"Y[2/5(H2/A8C%I0#T^[NM6J(.YLQ30=>I5G\MF'9'ASZ/%;Y,8&?[U8ZQ
M-I*":U6B(;N,N\:?@NV:/W9YR$5WIVK^#O23DD\C%BZZOTU8!)*<P)R,>43C
MWXH28U"2()AO&TKV%W0=!\TSE_/,7APG9#'D]CNUZJ\'Q@H/7"ZH#F(WC3T0
MNE7A:'@=L"E3I.Z4G=N^/.[%A@G8W,G%0(%X%]\+1_WA>#+Z/.KW)J/3$W+Z
MF9R-1R?]T5GOF Q_'_8O)J-_#_$VMAB.M]Z9LXOQ^47O9$(FIV1\<3PD3IV6
MG,8NW2.G8^(T/7NQ]7Y@&"9?AN0<YW\\FHR&YQB+_I?>R3^'I->?Z"@YG7JC
MN/5^],Y);W!Z-AD.R&IHT"^#MGJUAKYLO1<F%+WQI][)\+QT^OOQ\(\\"K5J
MM;9F_D.K_WL[T-CHP*A(!G3&//*U3(:)5,#B(G%!*.8OB JH^K#3;!\\RY'<
MA81Z'F:H4@B^ZM;WT1P3-884&JMNR6DG;T_JM2<Y[91SH__^*3^X-2T=/0<C
M$M 9$ $S!G-,["I@DO3B.*4A&4/"A2(\)I^YB(A3+?V+^%Q@&R +H(( 3J='
M!N!"- 6!V:BH,[]#N$\^A=2](@-&(QY[9!* H FDBKFR2$:Q6\;0=GZVT-:V
M*[2?J,3H8/2B!;F*^3P$[Q**-L+"AM;C^/Z8HZ[#X2F+"8T7)(V52 '-1Z5G
M1!^&DY((KP1#5/C4Q5N"\ @%B.*VW5J#&$$A)14+W22B5V!0<S.FQ'L>&H.O
M#(UBQ'?H!BX3J!"Q68S=B5$\9!XP-R RU1_+_G,0D VB'8B8#%%*:E4Z9RI
M!V4"KC%0CYN@:=Q#-V?8S2/3Q>HT_(Q8K/\@6 3BLQBCK8&SC&X1@8C-\;%8
M><YB9)_(B&'\[H:I9A]$T$HHBX@^)L(%21  &KL:TV&X!&>&"WGGU8A_SY1*
M1=TB#;$!(I(C;,SKI+''I3(@?LCG,H>K@$LF%=99BE!]T]J-5A974"=S8]:L
MW1+@]?3,O"Z5-[8&;NURNZ&=G]P*SX>==LUI'<@,4YG(T&S!?9_AI0G<B% !
M!B(8<C8-P:0[0%Q.0R8#W5PWBY I-5OJ:X])-^0RQ7Z:0P4/+582P5WP\+8D
MNP@-#Q!K-O[#:S>@\260'M+3. VQA2D'FKNP9[J:>D!?[=UDVU6<80N=LM](
M&YE*>5M(BVX-BCKE?3,- Y"H\S%P)OT\'NRBSHPN3>73N^@4-05$2/8FF_1X
M*G  )) 9DX:6L!7$9ARMC)>$MDJ* D+\@JC,LMX2-L6,,/5#AN2&MD@>,L]L
MYLAT*IG'J&#: 69SLZ'I6(^42ITOS<*1)KD:$N,2T""%I*D[)107E)N&5',O
MNF6,6.9=[&&S^*KXP&]3T V1'K$_>)OI\+O ]D'*>QI8IUL#5N/Y[AD5]!)5
M=F"4F8YKD@J9:L[ (&)MBWH>)1*&[83+,JG72^U:O?UAI]$ZJ#=*C5:GO6^0
MJ1_4.[6;!YVZ4]_[&T/SIHSB;DV0<D89SFB8FF6GUP?X/JH1-H,8U?*ZJKA)
M6T^@$7NY66@8.L&.2 '2RIDI3]7]%CR%Z.A-:]!:S7]<9Y-IK@(--8*=";3'
MH$N_X =$F+<]"#,)RT9N'0&ZLLN$AWFR$69,;V?%5@_KJ!,=QQ69;,>RY(Y)
MB+MN*G2<5QA_PZ@1EPKOZ\TR'$NZ.-"?*28,''KWGBX^ A:KN#NM,\-=36*Z
M*-7UJMFIL';M6:L"*F_2(V8C:@ .GDG-9CZHY#$JN@66GE<09A7JG?;%5T_1
M_:#^L2O+YG8!_F4ZWVQZ>?E:*2Z921/E*EZ7)*41]^3@%]<EV(UI%&68XL(R
MJFYC;N"0D<G;\$ :F'(J#-=Z#.TS@^PBJI%UI69U_*_%8+X4X<^4H?EFV:6Q
M:PK9O<UU0Q[&U?.SA-O3PZZ5E3-8.U'+>TVY4CSJ5I==Z!3E9:K6NSQR"&<_
M [%<!I=0FN*2O2I1'^>^2\,Y7<C"&Q_\_;]L>EN1TPM#HLL9AFM."U!=_KH,
M<)%D0N6F?)EC:+7R )FSNRV$S YCOOWRK*6751JVDM] ]=3#CA)NF/[>93IE
M(5.FB]"'L,@21OY(U#XRC2(LE_X"XTR683=N5#TN;7"@2P1PMH;:>N%M+=*V
MI^8QW-]#3>,+I,\B!AT,XR-LS'9PAJ^BE00LGO%P!EH7Q,@H=E=;9$D"HB3D
M"\"G\X#;S$!OH1?1]B:BJ?QT##QX5G]TJ#>D8,F^P@-1PBB$-)'0S;\<8'Y+
M0KKHLMC,I>ET</M539SXF4Z2*+.R,TV#-?LX8]).NUQM[6LR56B-\O(79SQ;
M-CQ;4=[ZLT:]W*RV[GU<+3OW/GMHV'JY7;V_YTM';33+K4[S1<,^_,IFYV53
M\/"H^]7[75GM63%!LX%#:,B$QA\+]<*=M-:M)=?$R:G&(D$OM#5T\*3P/D?&
MQMT!KFNC8,A7*MS@PXZS7SUP6N;<\<Z1=SXQS_/9GNC?]=HNA^]^SK_9YT^+
MVYKM17YMBN6[>F7VEZ3Y7/L5P#-<K6I'"\]O^K:KXIUG4B^"GPX>3W0JRW[(
M2UT<F9A=;9+;]U*/W^TG,?>NA/?]I<Z90%&NU6>1] ,&/AE>@YOJFI"<VKIZ
M2PS5<GR0U<9;8M+NF6 H!!-4@FNSMO?LE/5*OKM3YYN3TB<.\V A_71K_C>'
M,=-?,0K\U?+_=;VV8X>G8G_Q;7Y[?O1?4$L#!!0    ( ,V$<50*W32O]0@
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MWWBS8_F9OV2B7W?I_ =02P$"% ,4    " #-A'%4;::K2U,(!   )1X $0
M            @ $     8F1T>"TR,#(Q,3(S,2YH=&U02P$"% ,4    " #-
MA'%4G"^MJCT-  #3A@  $0              @ &"" 0 8F1T>"TR,#(Q,3(S
M,2YX<V102P$"% ,4    " #-A'%493%0E5,;  #$"0$ %0
M@ 'N%00 8F1T>"TR,#(Q,3(S,5]C86PN>&UL4$L! A0#%     @ S81Q5#=V
M)U,&,@  (C$" !4              ( !=#$$ &)D='@M,C R,3$R,S%?9&5F
M+GAM;%!+ 0(4 Q0    ( ,V$<50[H\:$:<," ,?. P 4              "
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M2P$"% ,4    " #-A'%44UFMPS2. 0#^X0$ %0              @ $-V!8
M8F1T>"TR,#(Q,3(S,5]G,3<N:G!G4$L! A0#%     @ S81Q5%A4??:FR@
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M+3(P,C$Q,C,Q7V<R,BYJ<&=02P$"% ,4    " #-A'%40?0H>FZ7 0#,(@(
M%               @ &[LB4 8F1T>"TR,#(Q,3(S,5]G,RYJ<&=02P$"% ,4
M    " #-A'%4T/DRR'+"  #B\   %               @ %;2B< 8F1T>"TR
M,#(Q,3(S,5]G-"YJ<&=02P$"% ,4    " #-A'%41@+K![M7 0 T#P( %
M            @ '_#"@ 8F1T>"TR,#(Q,3(S,5]G-2YJ<&=02P$"% ,4
M" #-A'%4N!FQW5AP 0!CP $ %               @ 'L9"D 8F1T>"TR,#(Q
M,3(S,5]G-BYJ<&=02P$"% ,4    " #-A'%4^8(5S]&> @!<_@( %
M        @ %VU2H 8F1T>"TR,#(Q,3(S,5]G-RYJ<&=02P$"% ,4    " #-
MA'%4XX07&'*&  !-Q0  %               @ %Y="T 8F1T>"TR,#(Q,3(S
M,5]G."YJ<&=02P$"% ,4    " #-A'%4_<*=8)=? 0 CWP$ %
M    @ $=^RT 8F1T>"TR,#(Q,3(S,5]G.2YJ<&=02P$"% ,4    " #-A'%4
M0"A/M/K#  "I;0@ %0              @ 'F6B\ 8F1T>"TR,#(Q,3(S,5]L
M86(N>&UL4$L! A0#%     @ S81Q5 W.7R",<@  _%4% !4
M ( !$Q\P &)D='@M,C R,3$R,S%?<')E+GAM;%!+ 0(4 Q0    ( ,V$<51[
MD(V5"0,  +8(   5              "  =*1, !E>&AI8FET,C,Q7W$T,C R
M,2YH=&U02P$"% ,4    " #-A'%4)&LOT @)  #6+@  %0
M@ $.E3  97AH:6)I=#,Q,5]Q-#(P,C$N:'1M4$L! A0#%     @ S81Q5 K=
M-*_U"   /2X  !4              ( !29XP &5X:&EB:70S,3)?<30R,#(Q
M+FAT;5!+ 0(4 Q0    ( ,V$<51FF;]BC 4  $DC   5              "
M 7&G, !E>&AI8FET,S(Q7W$T,C R,2YH=&U02P4&     "  ( !/"   ,*TP
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
